username,date,retweets,favorites,text,geo,mentions,hashtags,id,;permalink,,,,
brandonmancini,6/7/2014 19:22,0,1,“ @ ONAcom: # ASCO14: New drug effective for metastatic # prostatecancer - http://ow.ly/xEYjG # pcsm”,,@,# # #,4.75418E+17,https://twitter.com/brandonmancini/status/475417583748145152,,,,
YOGAontheSTEPS,6/7/2014 19:01,2,0,# ASCO2014 Reports on Early-Stage Breast Cancers http://ow.ly/xI0YU,,,#,4.75412E+17,https://twitter.com/YOGAontheSTEPS/status/475412142976696321,,,,
ONAcom,6/7/2014 19:00,0,0,# ASCO14: New drug effective for metastatic # prostatecancer - http://ow.ly/xEYjG # pcsm,,,# # #,4.75412E+17,https://twitter.com/ONAcom/status/475412126044266496,,,,
LivingBeyondBC,6/7/2014 19:00,3,1,# ASCO2014 Reports on Early-Stage Breast Cancers http://ow.ly/xI10B,,,#,4.75412E+17,https://twitter.com/LivingBeyondBC/status/475412115646611456,,,,
OncLive,6/7/2014 19:00,1,1,Dr. Naiyer Rizvi on Nivolumab Plus Erlotinib in Patients with EGFR MT NSCLC http://ow.ly/xJ57t # ASCO14,,,#,4.75412E+17,https://twitter.com/OncLive/status/475411963871522818,,,,
SassyCell,6/7/2014 18:48,0,0,"@ CR_UK Thank you to Nick Peel, that was a fantastic review # CIM http://bit.ly/1q0jvUI # immunotherapy # ASCO14",,@,# # #,4.75409E+17,https://twitter.com/SassyCell/status/475409002189586433,,,,
RyhMd,6/7/2014 18:40,0,0,"# asco14 post chemo thorct RT in Ext-SCLC, benefit 18-24 months pic.twitter.com/owvBmzkjCV",,,#,4.75407E+17,https://twitter.com/RyhMd/status/475406898947031042,,,,
RyhMd,6/7/2014 18:39,0,0,# asco14 Erlo+Bev in EGFR mut+ pic.twitter.com/sx3WCpZHlr,,,#,4.75407E+17,https://twitter.com/RyhMd/status/475406643035795456,,,,
RyhMd,6/7/2014 18:38,0,0,# asco14 EGFR inh in mut+ pic.twitter.com/oqzrKtLA1k,,,#,4.75406E+17,https://twitter.com/RyhMd/status/475406380044521472,,,,
BairdAM,6/7/2014 18:26,1,1,"RT @prIME_Oncology: A discussion on non-small cell lung cancer treatment from # ASCO14 # lcsm http://youtu.be/874zxhyslbY?a """"",,@prIME_Oncology,# #,4.75403E+17,https://twitter.com/BairdAM/status/475403379640778753,,,,
BairdAM,6/7/2014 18:25,1,0,"# lcsm RT @prIME_Oncology: A discussion from # ASCO14 on second-line therapies in NSCLC # lcsm http://youtu.be/Dx9qg8Camuc?a """"",,@prIME_Oncology,# # #,4.75403E+17,https://twitter.com/BairdAM/status/475403162249998336,,,,
drdonsdizon,6/7/2014 18:21,0,0,@ Quintiles And at 4K for sequencing- that's still too much. And still remains mostly unactionable. # ASCO14,,@,#,4.75402E+17,https://twitter.com/drdonsdizon/status/475402152009953280,,,,
drdonsdizon,6/7/2014 18:19,0,1,@ yzafar @ ASCO @ theIOM Right- cost and value are not debatable; they are conversational! Looking forward to outcomes of the discussion.,,@ @ @,,4.75402E+17,https://twitter.com/drdonsdizon/status/475401666309525506,,,,
drdonsdizon,6/7/2014 18:18,0,0,@ teamoncology When costs enter conversation... @ ASCO # ASCO14 http://www.kevinmd.com/blog/2014/04/treating-cancer-paved-patients-financial-despair.html …,,@ @,#,4.75401E+17,https://twitter.com/drdonsdizon/status/475401362432606208,,,,
MyelomaTeacher,6/7/2014 18:15,2,1,MT @ OncLive: Dr. Dispenzieri @ MayoMyeloma discusses # CD38-targeted monoclonal antibodies in # myeloma http://ow.ly/xJ9jq # ASCO14 # mmsm,,@ @,# # # #,4.75401E+17,https://twitter.com/MyelomaTeacher/status/475400653163212800,,,,
drdonsdizon,6/7/2014 18:11,0,0,"@ brianreid How many said value""???? # ASCO14""",,@,#,4.754E+17,https://twitter.com/drdonsdizon/status/475399764826423296,,,,
OncLive,6/7/2014 18:10,3,0,"Negative ALTTO Results Reverberate for Lapatinib, Novel Clinical Trials http://ow.ly/xJ57s # ASCO14",,,#,4.75399E+17,https://twitter.com/OncLive/status/475399386974126080,,,,
ConquerCancerFd,6/7/2014 18:04,0,1,"Great pic of Dr. Sandra Swain, past @ ASCO pres. & Campaign Chair for Women Who Conquer Cancer. http://ow.ly/i/5PBBb",,@,,4.75398E+17,https://twitter.com/ConquerCancerFd/status/475397966002683906,,,,
HelpSaveDarcy,6/7/2014 17:12,1,0,Recent # melanoma highlights from American Society of Clinical Oncology @ ASCO by Melanoma Institute Australia... http://fb.me/3k3A67uuu,,@,#,4.75385E+17,https://twitter.com/HelpSaveDarcy/status/475384772790083585,,,,
OncLive,6/7/2014 17:05,1,0,Zoledronic Acid Can Be Administered Less Frequently in Breast Cancer http://ow.ly/xJ57r # ASCO14,,,#,4.75383E+17,https://twitter.com/OncLive/status/475383000252039168,,,,
OphiraG,6/7/2014 16:57,1,3,"@ sandragionas thx 4 being a Dragon"" # CSWA2014 gr8 opp 2 pitch untold story of women's cancers -health equity issue! @ NCIGlobalHealth @ ASCO""",,@ @ @,#,4.75381E+17,https://twitter.com/OphiraG/status/475381090761199616,,,,
HelpSaveDarcy,6/7/2014 16:41,0,0,Video highlights including # melanoma # treatment news from Day 3 of American Society of Clinical Oncology @ ASCO http://fb.me/6H4IhW4Mx,,@,# #,4.75377E+17,https://twitter.com/HelpSaveDarcy/status/475376983690342400,,,,
learnhospice,6/7/2014 16:19,0,1,“ @ subatomicdoc: communication skills curriculum for oncology fellows http://bit.ly/1mxaiB6 > @ HopkinsMedicine # hcsm # ASCO14” wonderful # hpm,,@ @,# # #,4.75372E+17,https://twitter.com/learnhospice/status/475371556756271104,,,,
subatomicdoc,6/7/2014 16:17,2,0,Across the cancer continuum: A communication skills curriculum for oncology fellows http://bit.ly/1mxaiB6 > @ HopkinsMedicine # hcsm # ASCO14,,@,# #,4.75371E+17,https://twitter.com/subatomicdoc/status/475370875710353408,,,,
Beleenn25,6/7/2014 16:09,0,0,# FO # rica # piba .... # xdios .... # ASCO14,,,# # # # #,4.75369E+17,https://twitter.com/Beleenn25/status/475368916383195136,,,,
EdithPerezMD,6/7/2014 16:06,0,0,"Fantastic # ASCO14. Important data for research and practice. Enthusiasm, especially for our predictive immune gene signature @ MayoClinic",,@,#,4.75368E+17,https://twitter.com/EdithPerezMD/status/475368096970964992,,,,
OncLive,6/7/2014 16:05,3,2,Adding Chemo to ADT Confers Dramatic Survival Gains in Prostate Cancer http://ow.ly/xJ57q # ASCO14,,,#,4.75368E+17,https://twitter.com/OncLive/status/475367917815889920,,,,
darioT_,6/7/2014 16:02,1,0,# Nanotechnology # NBTXR3 from @ Nanobiotix at @ ASCO 2014 # phase1 # sarcoma trial-NCT01433068. http://meetinglibrary.asco.org/content/127447-144 …pic.twitter.com/bXfwjNQJOk,,@ @,# # # #,4.75367E+17,https://twitter.com/darioT_/status/475367144923086849,,,,
eMPR,6/7/2014 16:01,1,0,Screening for lung cancer could become as easy as breathing: http://ow.ly/xIG67 # ASCO14 # oncology,,,# #,4.75367E+17,https://twitter.com/eMPR/status/475366969823477761,,,,
ONAcom,6/7/2014 16:01,0,0,# ASCO14: Early # palliative support for family caregivers reduces # depression - read more http://ow.ly/xCkwU,,,# # #,4.75367E+17,https://twitter.com/ONAcom/status/475366901309517824,,,,
NicoleStoutPT,6/7/2014 16:00,1,0,"“ @ fischmd @ ASCO: Professional orgs role in supporting MDs to improve # healthcare value, via @ JAMA_current http://ow.ly/xJWct @ APTAtweets",,@ @ @ @,#,4.75367E+17,https://twitter.com/NicoleStoutPT/status/475366586145308672,,,,
appistry,6/7/2014 15:35,0,0,. @ Forbes reports: # ASCO14 presentations bring hope to the future of # cancer http://ow.ly/xGdTc @ ElaineSchattner # PMED # oncology,,@ @,# # # #,4.7536E+17,https://twitter.com/appistry/status/475360320681414656,,,,
OncLive,6/7/2014 15:05,3,0,Dr. Jedd Wolchok on Ipilimumab After Complete Resection of Stage III Melanoma http://ow.ly/xJ57p # ASCO14,,,#,4.75353E+17,https://twitter.com/OncLive/status/475352785404567552,,,,
Asthika,6/7/2014 15:03,0,1,Forgot I took this pic. Caption: Immuno-oncology was so hot at # ASCO14 they had to call the fire dept. pic.twitter.com/7FBsrZUJWA,,,#,4.75352E+17,https://twitter.com/Asthika/status/475352349796737024,,,,
OncLive,6/7/2014 14:10,1,1,Panobinostat Combination Improves PFS in Multiple Myeloma http://ow.ly/xJ57o # ASCO14,,,#,4.75339E+17,https://twitter.com/OncLive/status/475338949901430785,,,,
JaneyBusby,6/7/2014 14:07,5,4,THIS is the face of a FIERCE FIGHTER @ genentech who NEEDS # ExtendedUse NOW to # kickASPS PLS do an n=1 pic.twitter.com/5t2WATDJKI # ASCO14,,@,# # #,4.75338E+17,https://twitter.com/JaneyBusby/status/475338189092044801,,,,
JaneyBusby,6/7/2014 14:05,0,0,@ 4Nathalie meets all criteria 4 # PDL1 # PD1 except 4 age(15-1/2) Read her blog http://kickasps.wordpress.com/its-hard-to-fight-when-the-fight-aint-fair/ … & FIGHT pic.twitter.com/yKV5pNvvG1 # ASCO14,,@,# # #,4.75338E+17,https://twitter.com/JaneyBusby/status/475337882580692992,,,,
ventana,6/7/2014 14:01,8,2,RT @ ASCO Explore this infographic on the link between # obesity and # cancerpic.twitter.com/TmcbVV4Lb8,,@,# #,4.75337E+17,https://twitter.com/ventana/status/475336740954464256,,,,
drol007,6/7/2014 13:56,0,0,Helpful digest of @ ASCO # ASCO14 & associated media output HT@CR_UK & the blind mole rat DNA sequence too http://scienceblog.cancerresearchuk.org/2014/06/07/news-digest-asco-conference-immunotherapy-blind-mole-rat-genome-and-more/?utm_source=twitter_cr_uk&utm_medium=cruksocialmedia&utm_campaign=owntwitter_tweet …,,@ @CR_UK,#,4.75336E+17,https://twitter.com/drol007/status/475335616516067328,,,,
Salva_Rguez,6/7/2014 13:53,1,0,"@ encarnadiazg sí, pero por lo menos que se va a aclarar algo y, en su caso, los gastos de los juicios,superaran lo que se confisque # ASCO14",,@,#,4.75335E+17,https://twitter.com/Salva_Rguez/status/475334746508378112,,,,
fischmd,6/7/2014 13:15,5,1,"Screening, assessment, and management of fatigue in adult survivors of # cancer: @ ASCO http://ow.ly/xJjFL # hpm # PallOnc # supponc",,@,# # # #,4.75325E+17,https://twitter.com/fischmd/status/475325118286422016,,,,
CANcerviver,6/7/2014 13:14,0,0,"RT @ ASCO: Past, Present, & Future Challenges in Breast Cancer Treatment ... http://tmi.me/1enOe3",,@,,4.75325E+17,https://twitter.com/CANcerviver/status/475324862211571714,,,,
ndccharity,6/7/2014 13:13,0,0,‘How modern medicine can help patients achieve a # GoodDeath’ @ ONAcom http://www.oncologynurseadvisor.com/how-modern-medicine-can-help-patients-achieve-a-good-death/article/349875/ … by @ Kathybphd # ASCO14 # Oncology # hpm # HomeDeath,,@ @,# # # # #,4.75325E+17,https://twitter.com/ndccharity/status/475324610716516352,,,,
OncLive,6/7/2014 13:05,0,0,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xJ57n # ASCO14,,,#,4.75323E+17,https://twitter.com/OncLive/status/475322602123452416,,,,
FightCRC,6/7/2014 13:05,0,0,"On June 18, we'll be discussing the latest research & treatment news from the @ ASCO conference during our webinar - don't miss it!",,@,,4.75323E+17,https://twitter.com/FightCRC/status/475322568577392640,,,,
medpagetoday,6/7/2014 13:00,1,1,Gilotrif improved overall survival in a single subset of advanced non-small cell lung cancers # ASCO14 http://bit.ly/1rR9NZM,,,#,4.75321E+17,https://twitter.com/medpagetoday/status/475321318808625154,,,,
OncLive,6/7/2014 12:10,1,1,Lenvatinib Likely to Become Standard in Resistant Differentiated Thyroid Cancer http://ow.ly/xJ57m # ASCO14,,,#,4.75309E+17,https://twitter.com/OncLive/status/475308762321145856,,,,
fischmd,6/7/2014 12:08,3,1,"A nice shout out to @ ASCO: Professional orgs role in supporting MDs to improve # healthcare value, via @ JAMA_current http://ow.ly/xJWct",,@ @,#,4.75308E+17,https://twitter.com/fischmd/status/475308307880898560,,,,
leonardkish,6/7/2014 12:05,0,0,@ kneepainoptions @ subatomicdoc @ ASCO How times change.,,@ @ @,,4.75308E+17,https://twitter.com/leonardkish/status/475307659772448768,,,,
ONAcom,6/7/2014 12:02,2,0,# ASCO14: Expanding # NCI Community Cancer Centers Program in a rural community can up clinical trial enrollment - http://ow.ly/xweUY,,,# #,4.75307E+17,https://twitter.com/ONAcom/status/475306763793989633,,,,
SpringerClinMed,6/7/2014 12:01,0,1,Interesting to see how # ASCO14 oncologists are using Twitter: Why I Tweet http://ow.ly/xIlRa,,,#,4.75306E+17,https://twitter.com/SpringerClinMed/status/475306440144728065,,,,
subatomicdoc,6/7/2014 11:56,0,0,@ mleis @ Boehringer Welcome to the future. # ASCO14 is an example of # edoctor emergence # hcsm,,@ @,# # #,4.75305E+17,https://twitter.com/subatomicdoc/status/475305214229368832,,,,
Boehringer,6/7/2014 11:55,1,0,In the USA, it (lung cancer) accounts for 228,"190 new cancer cases annually"" Dr Maya Gottfried http://bit.ly/1j1RTda # ASCO14""",,,#,4.75305E+17,https://twitter.com/Boehringer/status/475304994837897216,,
BiologicsMcK,6/7/2014 11:45,0,0,"At @ ASCO’s 50th annual meeting, researchers shared new advances in breast, prostate & colorectal # cancer treatment. http://vrl.ht/ECF8",,@,#,4.75303E+17,https://twitter.com/BiologicsMcK/status/475302532609101825,,,,
OncologySurgery,6/7/2014 11:39,0,1,"RT @ ASCO: Register today for the new Palliative Care in Oncology Symposium, Oct. 24-25 in Boston: http://bit.ly/1xokTWr",,@,,4.75301E+17,https://twitter.com/OncologySurgery/status/475301098387808256,,,,
jtriestm,6/7/2014 11:25,0,0,Test IDs Ovarian Cancers in Which bevacizumab Is No Good http://www.medscape.com/viewarticle/826384?src=sttwit … # asco14 # gyncsm,,,# #,4.75297E+17,https://twitter.com/jtriestm/status/475297451109134336,,,,
ASCO,6/7/2014 11:01,5,3,"Sample select presentations from our 50th Annual Meeting via Virtual Meeting on Demand"": http://bit.ly/1oKjSW0 # ASCO14""",,,#,4.75292E+17,https://twitter.com/ASCO/status/475291531138830337,,,,
OncLive,6/7/2014 11:00,0,0,Dr. Suresh Ramalingam on the Results of the Phase III REVEL Study in NSCLC http://ow.ly/xJ57l # ASCO14,,,#,4.75291E+17,https://twitter.com/OncLive/status/475291277547028480,,,,
scientre,6/7/2014 10:33,0,0,@ djsampson @ 3NT @ ASCO @ symplur Twitter app?,,@ @ @ @,,4.75284E+17,https://twitter.com/scientre/status/475284386602967042,,,,
CCO_Oncology,6/7/2014 10:30,0,3,Independent Coverage of # ASCO2014: 4 Capsule Summaries of key findings in # BreastCancer # CME modules coming soon! http://ow.ly/xIQqN,,,# # #,4.75284E+17,https://twitter.com/CCO_Oncology/status/475283783298854913,,,,
OncLive,6/7/2014 10:05,2,0,"Ibrutinib Triples PFS, Doubles OS in Phase III CLL Trial http://ow.ly/xJ57k # ASCO14",,,#,4.75277E+17,https://twitter.com/OncLive/status/475277337576353792,,,,
ONAcom,6/7/2014 10:01,1,0,# ASCO14: Fewer than 5% of adults with cancer enroll in clinical trials - read more http://ow.ly/xwdYj,,,#,4.75276E+17,https://twitter.com/ONAcom/status/475276387885285378,,,,
SHAREing,6/7/2014 10:01,0,0,"RT (plz) Dr Dizon reports # ASCO14 news vis-a-vis # metastatic # breastcancer: Th 6/12, 12:30PM ET http://ow.ly/xlSQO @ MetastaticOdds",,@,# # #,4.75276E+17,https://twitter.com/SHAREing/status/475276376799735808,,,,
Prof_ChrisMason,6/7/2014 9:54,0,0,MT @ matthewherper: 8-patient cervical ca study is more important cf all the much bigger studies @ # ASCO14 http://www.forbes.com/sites/matthewherper/2014/06/02/scientists-prime-the-immune-system-as-a-powerful-cancer-weapon/ … # CellTherapy,,@ @,# #,4.75275E+17,https://twitter.com/Prof_ChrisMason/status/475274592274350080,,,,
mleis,6/7/2014 9:43,1,1,"Holy moly MT “ @ Boehringer: nearly 40k tweets over 5 days"" Julia Knebel http://bit.ly/1mYaUjh # ASCO14”""",,@,#,4.75272E+17,https://twitter.com/mleis/status/475271737513623553,,,,
Boehringer,6/7/2014 9:25,3,0,"The coverage on social media has been impressive this year with nearly 40k tweets over 5 days"" Julia Knebel http://bit.ly/1mYaUjh # ASCO14""",,,#,4.75267E+17,https://twitter.com/Boehringer/status/475267202661502977,,,,
OncLive,6/7/2014 9:05,0,1,Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer http://ow.ly/xJ57j # ASCO14,,,#,4.75262E+17,https://twitter.com/OncLive/status/475262217240457216,,,,
medpagetoday,6/7/2014 9:00,3,1,Xtandi can markedly delay chemotherapy in men with progressive prostate cancer despite ADT # ASCO14 http://bit.ly/1rRLlYd,,,#,4.75261E+17,https://twitter.com/medpagetoday/status/475260897061920768,,,,
DrHubaEvaluator,6/7/2014 9:00,0,1,BLOG: Immunological Dreams at # ASCO14 - Two things caught my attention: 1) The 5-year survival rate of all cancers... http://ow.ly/2HHwli,,,#,4.75261E+17,https://twitter.com/DrHubaEvaluator/status/475260887499292672,,,,
nvhstewart,6/7/2014 8:17,0,0,How it should be done... @ yzafar: Ganz: palliative care does not equal end of life care # asco14 pic.twitter.com/se3y5NswjN,,@,#,4.7525E+17,https://twitter.com/nvhstewart/status/475250289679679489,,,,
OncLive,6/7/2014 8:10,0,1,"Today we're going to be spotlighting the most viewed articles/videos from # ASCO14 View more, at http://ow.ly/xJ57i",,,#,4.75248E+17,https://twitter.com/OncLive/status/475248356470824960,,,,
JediPD,6/7/2014 8:05,1,0,A Post: Immunological Dreams at # ASCO14 http://jedismedicine.blogspot.com/2014/06/immunological-dreams-at-asco14.html?spref=tw …,,,#,4.75247E+17,https://twitter.com/JediPD/status/475247100129968130,,,,
wendyselig,6/7/2014 7:58,0,0,At # asco14 with @ TJsharpe celebrating # melanoma progress. @ MelanomaReAllipic.twitter.com/h8J3v03Z0d,,@ @,# #,4.75245E+17,https://twitter.com/wendyselig/status/475245379328671744,,,,
tealtoes,6/7/2014 7:50,5,3,# ASCO14 wrapped up this week. See the Ovarian Cancer National Alliance's roundup of research. @ OCNA @ ASCO http://fb.me/3f1LE2fZo,,@ @,#,4.75243E+17,https://twitter.com/tealtoes/status/475243437311016960,,,,
EVEPIE,6/7/2014 7:49,2,1,Editos à découvrir chaque semaine sur @ cancercontrib une touche d’humour de @ dubois_damien. # ASCO14 le dernier http://goo.gl/Rt24MW,,@ @,#,4.75243E+17,https://twitter.com/EVEPIE/status/475243038839947264,,,,
OncLive,6/7/2014 7:15,0,0,"Angela Dispenzieri, MD, discusses excitement over CD38-targeted monoclonal antibodies in multiple myeloma http://ow.ly/xJ9jq # ASCO14",,,#,4.75235E+17,https://twitter.com/OncLive/status/475234509538209793,,,,
BairdAM,6/7/2014 6:47,5,2,"# lcsm RT  @ Boehringer: ""Lung cancer is the most commonly diagnosed cancer worldwide"" Dr Maya Gottfried http://bit.ly/1j1RTda # ASCO14""""",,@,# #,4.75228E+17,https://twitter.com/BairdAM/status/475227587220738049,,,,
SeqComplete,6/7/2014 6:01,0,0,buzzz at # ASCO14 http://tweetedtimes.com/search/%23ASCO14/en …,,,#,4.75216E+17,https://twitter.com/SeqComplete/status/475215872358117376,,,,
BORJAKAISER,6/7/2014 5:40,0,0,La primera vez y espero que la última que voy a pisar La torre por culpa de mis colegas ... # ASCO14,,,#,4.75211E+17,https://twitter.com/BORJAKAISER/status/475210793290842112,,,,
MelanomaMom,6/7/2014 4:34,1,1,RT @ HealioDerm: Ipilimumab nivolumab combo demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5Zj,,@ @,#,4.75194E+17,https://twitter.com/MelanomaMom/status/475193963301711875,,,,
OncLive,6/7/2014 2:20,2,1,Pembrolizumab has robust activity as a first-line treatment for patients with advanced PD-L1-positive NSCLC http://ow.ly/xJ3IL # ASCO14,,,#,4.7516E+17,https://twitter.com/OncLive/status/475160238254194688,,,,
ohmsonite,6/7/2014 1:26,0,0,@ bradloncar @ BiologyFool Pretty good summary of # ASCO14 except he kept confusing Imbruvica with Iclusig. Thx for sharing.,,@ @,#,4.75147E+17,https://twitter.com/ohmsonite/status/475146736675999744,,,,
fischmd,6/6/2014 22:42,10,6,"Screening, assessment, and management of fatigue in adult survivors of # cancer: @ ASCO http://ow.ly/xJjp7 # hpm @PallOnc # supponc",,@ @PallOnc,# # #,4.75105E+17,https://twitter.com/fischmd/status/475105495087185921,,,,
subatomicdoc,6/6/2014 22:09,0,0,Thank you @ drnic1 @ ASCO @ 3NT @ pshaheen75 @ brianreid @ WoodMD @ DrMiguelPerales @beardslc @ mtmdphd for your RTs! Much appreciated :),,@ @ @ @ @ @ @ @beardslc @,,4.75097E+17,https://twitter.com/subatomicdoc/status/475097067074121728,,,,
rschilsky,6/6/2014 21:55,3,1,Major contributions to # ASCO14 by UChicago faculty. http://cancer http://conversations.uchospitals.edu/featured/uchicago-leaves-its-imprint-on-the-50th-annual-asco-meeting/ …,,,#,4.75094E+17,https://twitter.com/rschilsky/status/475093754253434881,,,,
fischmd,6/6/2014 21:54,2,0,"RT @ AJPB_Journal: Stopping Statins Safe, Cuts Costs, in Terminal Patients via @ Medscape http://ow.ly/xGas0 # ASCO14",,@ @,#,4.75093E+17,https://twitter.com/fischmd/status/475093358667649024,,,,
JackWestMD,6/6/2014 21:38,2,0,Benefit is tiny: too low bar. MT @ OncLive: Adding necitumumab to chemo improves surv in adv squamous NSCLC http://flip.it/ohVeN # ASCO14,,@,#,4.75089E+17,https://twitter.com/JackWestMD/status/475089495990497280,,,,
OncLive,6/6/2014 21:30,0,2,Upfront necitumumab plus gemcitabine-cisplatin significantly improves survival in stage IV squamous NSCLC http://ow.ly/xIktR # ASCO14,,,#,4.75087E+17,https://twitter.com/OncLive/status/475087317687095296,,,,
medpagetoday,6/6/2014 20:30,0,1,ASCO: Gilotraf ups survival in some lung cancers. @ atscommunity # ASCO14 http://bit.ly/1rR9NZM,,@,#,4.75072E+17,https://twitter.com/medpagetoday/status/475072152547237890,,,,
OncLive,6/6/2014 20:05,1,0,Dr. Angela Dispenzieri from @ MayoClinic Discusses Anti-CD38 Monoclonal Antibodies in Myeloma http://ow.ly/xJ9bV # ASCO14,,@,#,4.75066E+17,https://twitter.com/OncLive/status/475065863125880832,,,,
djsampson,6/6/2014 19:00,0,0,@ 3NT @ ASCO @ symplur key to keeping it manageable for me was iPhone app that let me limit to only those I follow,,@ @ @,,4.7505E+17,https://twitter.com/djsampson/status/475049708801773568,,,,
ESchattner,6/6/2014 18:54,4,2,"MT @ 33charts: Social media and cancer communities, # ASCO14 talk by @ subatomicdoc, @ SlideShare - http://bit.ly/1rS6nWD",,@ @ @,#,4.75048E+17,https://twitter.com/ESchattner/status/475048126915424256,,,,
33charts,6/6/2014 18:46,0,1,“ @ subatomicdoc: My talk from # ASCO14: Social media in clinical practice http://slidesha.re/1jXEfHE via @ ASCO # HLTHTOP # hcsm”,,@ @,# # #,4.75046E+17,https://twitter.com/33charts/status/475046103901949952,,,,
jagasquet,6/6/2014 18:39,0,1,Five questions raised this week in # pharma after # ASCO14 http://www.firstwordpharma.com/node/1215453 via @ fwpharma,,@,# #,4.75044E+17,https://twitter.com/jagasquet/status/475044252968181760,,,,
jagasquet,6/6/2014 18:34,0,0,3 Pharma Giants Battling for Immuno-Oncology Dominance http://www.fool.com/investing/general/2014/06/06/3-pharma-giants-battling-for-immuno-oncology-domin.aspx#.U5JBZ2BAWOU.twitter … via @ themotleyfool # immunotherapy # ASCO14,,@,# # #,4.75043E+17,https://twitter.com/jagasquet/status/475043083747225600,,,,
jagasquet,6/6/2014 18:31,0,1,# ASCO14 Oncology Stocks: Recap and Scoreboard http://raygent.com/biopharm-portfolio/asco-oncology-stocks-recap-and-scoreboard-agio-mdvn-sgen-winners/?utm_source=rss&utm_medium=rss&utm_campaign=asco-oncology-stocks-recap-and-scoreboard-agio-mdvn-sgen-winners …,,,#,4.75042E+17,https://twitter.com/jagasquet/status/475042363203928064,,,,
nycdoc29,6/6/2014 18:14,0,0,“ @ CancerNetwrk: Ibrutinib Shows Huge Benefit Over Ofatumumab in CLL & SLL http://bit.ly/1j49Wj7 # ASCO14” - Who really uses single Arzerra?,,@,#,4.75038E+17,https://twitter.com/nycdoc29/status/475037992823050241,,,,
AidanBaker,6/6/2014 18:14,0,0,MT @ nishadoshi Twitter & cancer--reminds me how librarians can use twitter # ASCO14 http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … …,,@,#,4.75038E+17,https://twitter.com/AidanBaker/status/475037942231367680,,,,
nycdoc29,6/6/2014 18:11,0,0,“ @ JSweetenhamMD: reading # ASCO14 - ibrutinib likely a game-changer for patients with CLL” ~ YES though not needed for majority of CLL pts.,,@,#,4.75037E+17,https://twitter.com/nycdoc29/status/475037377640280064,,,,
AsimJshaikh,6/6/2014 18:08,0,0,"Back Home - Enjoyed the vibrant , informative, academic and scientific ( relating to society : indeed ) stuff discussed at # ASCO14",,,#,4.75036E+17,https://twitter.com/AsimJshaikh/status/475036477639098368,,,,
OncLive,6/6/2014 18:07,0,1,Pembrolizumab Induces Robust Responses in PD-L1-positive NSCLC http://ow.ly/xJ3DN # ASCO14,,,#,4.75036E+17,https://twitter.com/OncLive/status/475036363705028608,,,,
UCCancerCenter,6/6/2014 18:06,0,0,Happy # ResearchFindingsFriday! Highlights of @ UCCancerCenter Research presented at @ ASCO Meeting - http://bit.ly/1p3SZfS,,@ @,#,4.75036E+17,https://twitter.com/UCCancerCenter/status/475036077431218176,,,,
_Phenomenome,6/6/2014 18:04,0,0,Thoughts on the benefits of twitter and tweeting from oncologists at # ASCO14 http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … via @ nishadoshi,,@,#,4.75036E+17,https://twitter.com/_Phenomenome/status/475035579659599874,,,,
nycdoc29,6/6/2014 17:57,0,0,Oncologists: Why Tweet ~ unfiltered forum to voice opinions ESP for private practice MDs who increasingly sidelined in reg channels. # ASCO14,,,#,4.75034E+17,https://twitter.com/nycdoc29/status/475033697432141825,,,,
WWFH_WA,6/6/2014 17:55,0,0,RT @ drattai Clinical trials are ongoing to answer some of these remaining questions. Trials are how we make progress # ASCO14 # bcsm,,@,# #,4.75033E+17,https://twitter.com/WWFH_WA/status/475033200117678080,,,,
DrBobGoldberg,6/6/2014 17:50,0,0,And puts @ asco rationing app into stark relief. # ascorations https://m.facebook.com/photo.php?fbid=10100579460768034&id=26311561&set=a.648426880434.2196840.26311561&source=43 …,,@,#,4.75032E+17,https://twitter.com/DrBobGoldberg/status/475031980980322304,,,,
mtmdphd,6/6/2014 17:45,1,0,RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplur,,@ @,# #,4.75031E+17,https://twitter.com/mtmdphd/status/475030683250094081,,,,
RolfeYPB,6/6/2014 17:37,0,1,# Immunotherapy created a stir at last year’s @ ASCO # annualmeeting w/ some # MDs predicting a revolution in # cancercare http://nyti.ms/1nXvwLa,,@,# # # #,4.75029E+17,https://twitter.com/RolfeYPB/status/475028833632927744,,,,
nishadoshi,6/6/2014 17:29,1,1,Thoughts on the benefits of twitter and tweeting from oncologists at # ASCO14 http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 …,,,#,4.75027E+17,https://twitter.com/nishadoshi/status/475026800683520000,,,,
MyelomaTeacher,6/6/2014 17:27,1,2,# ASCO14: The Impact of # Race and Socio-Economic Status on Survival in Multiple # Myeloma @ IMFmyeloma # mmsm http://m.youtube.com/watch?v=v6EdYahEMfw&feature=em-uploademail …,,@,# # # #,4.75026E+17,https://twitter.com/MyelomaTeacher/status/475026146816720896,,,,
TuftsB,6/6/2014 17:23,0,0,@ ASCO 'and how does denial of medically justifiable care help me as a myeloma patient? Save money lose lives # mliwi,,@,#,4.75025E+17,https://twitter.com/TuftsB/status/475025173054513152,,,,
ProjectInno,6/6/2014 17:20,2,5,We were honored to officially introduce our white paper on cancer # innovation at # ASCO14: http://ow.ly/xITgW,,,# #,4.75024E+17,https://twitter.com/ProjectInno/status/475024348479520768,,,,
MyelomaTeacher,6/6/2014 17:17,0,0,# ASCO14: Remission of Disseminated Cancer After Systemic Oncolytic # Virotherapy # myeloma @ IMFmyeloma @ mayomyeloma http://m.youtube.com/watch?v=d6pJBfexmpc&feature=em-uploademail …,,@ @,# # #,4.75024E+17,https://twitter.com/MyelomaTeacher/status/475023809272352770,,,,
appistry,6/6/2014 17:15,0,0,Thanks to all who came by our booth at # ASCO14! cc: @ ASCO # ASCO2014,,@,# #,4.75023E+17,https://twitter.com/appistry/status/475023195247243264,,,,
gthuang,6/6/2014 17:14,3,0,"Major themes from # ASCO2014: big pharma and post-IPO biotechs, as @ alexlash and @ benthefidler report: http://www.xconomy.com/boston/2014/06/06/post-ipo-biotechs-have-news-but-big-pharma-drives-the-asco-boat/ …",,@ @,#,4.75023E+17,https://twitter.com/gthuang/status/475022971120009216,,,,
teamoncology,6/6/2014 16:48,0,1,"Based on this new data, Zometa at least 1 year for every 3-4 W & then every 12 W for BC bone met. http://abstracts.asco.org/144/AbstView_144_129791.html … # ASCO14",,,#,4.75016E+17,https://twitter.com/teamoncology/status/475016358661337089,,,,
teamoncology,6/6/2014 16:46,0,0,【 # ASCO14 Important Update】U can give Zometa w/less frequent interval to breast cancer bone met. http://abstracts.asco.org/144/AbstView_144_129791.html …,,,#,4.75016E+17,https://twitter.com/teamoncology/status/475015874466701312,,,,
teamoncology,6/6/2014 16:45,2,0,【 # ASCO14 Important Update】Early support to caregivers improve their QOL. Something that we forget to provide. http://abstracts.asco.org/144/AbstView_144_131678.html … # BCSM,,,# #,4.75016E+17,https://twitter.com/teamoncology/status/475015662457204736,,,,
SHAREing,6/6/2014 16:45,1,0,"Join us for a webinar w/ Dr. Dizon on news abt # metastatic disease from # ASCO14: Th 6/12, 12:30PM ET http://ow.ly/xCskd . @ metavivor",,@,# #,4.75016E+17,https://twitter.com/SHAREing/status/475015573995544576,,,,
HelpSaveDarcy,6/6/2014 16:44,0,0,More # melanoma news coming from American Society of Clinical Oncology @ ASCO # skincancer http://fb.me/6QBF1prPw,,@,# #,4.75015E+17,https://twitter.com/HelpSaveDarcy/status/475015332499697664,,,,
teamoncology,6/6/2014 16:43,1,0,Why do Oncologist Tweet? http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … # ASCO14,,,#,4.75015E+17,https://twitter.com/teamoncology/status/475015240514424833,,,,
CHI_CIRI,6/6/2014 16:42,0,2,"Exciting, new # connections made at # ASCO2014 by @ CHI_CIRI staff and Dr. Dax Kurbegov - @ CHI_Updatespic.twitter.com/6PWUxwyd1X",,@ @,# #,4.75015E+17,https://twitter.com/CHI_CIRI/status/475014859596120064,,,,
genection,6/6/2014 16:41,0,0,"Look at # ASCO14 highlights, including news about Imbruvica from Pharmacyclics http://www.cancer.net/research-and-advocacy/asco-annual-meetings/highlights-day …",,,#,4.75015E+17,https://twitter.com/genection/status/475014753329229824,,,,
DrBobGoldberg,6/6/2014 16:41,0,0,@ ASCO: cancer patients have duty to die if they cost too much # ascorations,,@,#,4.75015E+17,https://twitter.com/DrBobGoldberg/status/475014569606516736,,,,
fwpharma,6/6/2014 16:30,3,1,Been out of the # ASCO14 loop? Read our Friday Five – 5 questions raised this week in # pharma pic.twitter.com/A3VzIcJIow http://bit.ly/1kFGvbt,,,# #,4.75012E+17,https://twitter.com/fwpharma/status/475011855522754560,,,,
BRCAresponder,6/6/2014 16:29,0,0,@ ASCOPost @ ASCO # ASCO14 You've been quoted in @ BRCAresponder WEEKLY news https://storify.com/BRCAresponder/6-6-14-brcaresponder-weekly … # cancer # research # BRCA # Oncology,,@ @ @,# # # # #,4.75012E+17,https://twitter.com/BRCAresponder/status/475011716657324032,,,,
CCO_Oncology,6/6/2014 16:16,0,1,CCO's Independent Conference Coverage of # ASCO2014 is now available http://ow.ly/xIQcG,,,#,4.75008E+17,https://twitter.com/CCO_Oncology/status/475008365190713344,,,,
LDGreen66,6/6/2014 16:11,6,1,ASCO Oncologists: Why I Tweet http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … # ASCO14,,,#,4.75007E+17,https://twitter.com/LDGreen66/status/475007168630906880,,,,
scientre,6/6/2014 16:05,1,0,ICYMI AduroBiotech licensed LADD immunotx platform 4 prostate cancer http://ht.ly/xHXms Phase1b meso # asco14 http://ht.ly/xHXjs,,,#,4.75006E+17,https://twitter.com/scientre/status/475005521104502784,,,,
urotoday,6/6/2014 15:58,0,0,"Keane's Corner - Listen to editor-in-chief Tom Keane give his June update, focusing on # ASCO14 http://bit.ly/1lbRoS3 pic.twitter.com/RXT5iC7q0K",,,#,4.75004E+17,https://twitter.com/urotoday/status/475003806057390080,,,,
HelpSaveDarcy,6/6/2014 15:54,2,2,Examining the # history of # melanoma treatment success from American Society of Clinical Oncology @ ASCO http://fb.me/6zf5xVd1q,,@,# #,4.75003E+17,https://twitter.com/HelpSaveDarcy/status/475002774157930496,,,,
OncEd,6/6/2014 15:51,0,0,Missed # ASCO14 in Chicago? Last day for early bird fees to register to Best of ASCO Canada on June 19-20 in Toronto http://www.oncologyeducation.com/events/upcoming-events/asco2014toronto/conference-details/ …,,,#,4.75002E+17,https://twitter.com/OncEd/status/475001968063037440,,,,
MelanomaReAlli,6/6/2014 15:44,1,0,. @ ONAcom shares new treatment options for advanced # melanoma http://www.oncologynurseadvisor.com/asco-new-treatment-options-available-for-advanced-melanoma/article/349798/ … # ASCO14,,@,# #,4.75E+17,https://twitter.com/MelanomaReAlli/status/475000236075929600,,,,
disparityreport,6/6/2014 15:42,0,0,Why do oncologists tweet? http://bit.ly/1nnUSkx # ASCO14,,,#,4.75E+17,https://twitter.com/disparityreport/status/474999753248210944,,,,
drseisenberg,6/6/2014 15:30,0,1,# ASCO14 # Burnout and # Oncology—Identifying and managing physician dissatisfaction in a modern practice environment: http://connection.asco.org/Magazine/Article/ID/2858/Burnout-and-OncologyIdentifying-and-managing-physician-dissatisfaction-in-a-modern-practice-environment.aspx …,,,# # #,4.74997E+17,https://twitter.com/drseisenberg/status/474996708762337280,,,,
ByJonGardner,6/6/2014 15:03,0,0,". @ AndytweetM forgive me. That was a mistake. Bladder cancer, not ovarian. # FierceASCO # ASCO14",,@,# #,4.7499E+17,https://twitter.com/ByJonGardner/status/474989869039886337,,,,
ESchattner,6/6/2014 15:02,0,0,via @ LizDowling2: # Oncologists tell us why they tweet at # ASCO14. See the video @ medpagetoday -http://bit.ly/1kE64eb,,@ @,# #,4.7499E+17,https://twitter.com/ESchattner/status/474989661937737728,,,,
CancerResearch,6/6/2014 15:02,0,1,Fundraising with Team CRI has never been easier. # CIM2014 # ASCO14 http://ow.ly/xyADA,,,# #,4.7499E+17,https://twitter.com/CancerResearch/status/474989610221973505,,,,
fischmd,6/6/2014 14:56,1,0,"MT @ jburzawa: Immunotherapy treats # cervicalcancer with success, via Nature World News http://www.natureworldnews.com/articles/7356/20140602/immunotherapy-treats-cervical-cancer-success.htm … # ASCO14 # gyncsm",,@,# # #,4.74988E+17,https://twitter.com/fischmd/status/474988309476020224,,,,
MedClerkships,6/6/2014 14:54,0,1,“ @ AU_Antigua: insider look at what it takes to submit & present research to the @ asco annual conference http://n.pr/1nHKoQt ” Great find!,,@ @,,4.74988E+17,https://twitter.com/MedClerkships/status/474987668850233344,,,,
AU_Antigua,6/6/2014 14:52,0,1,An insider look at what it takes to submit & present research to the @ asco annual conference http://n.pr/1nHKoQt,,@,,4.74987E+17,https://twitter.com/AU_Antigua/status/474987086601142272,,,,
CancerTherAdvsr,6/6/2014 14:45,0,1,A Fellow's Perspective: Overview of the # ASCO2014 # BreastCancer Plenary Sessions http://ow.ly/xIzVE,,,# #,4.74985E+17,https://twitter.com/CancerTherAdvsr/status/474985333848031232,,,,
MyelomaTeacher,6/6/2014 14:36,1,1,Overview of # ASCO14 by Dr. Paul Richardson @ DanaFarber # myeloma # mmsm http://m.youtube.com/watch?feature=em-uploademail&v=IhzEEiYCPKY …,,@,# # #,4.74983E+17,https://twitter.com/MyelomaTeacher/status/474983216214839296,,,,
FocusonCancer,6/6/2014 14:31,0,0,4 treatment combos including FOLFOX/FOLFIRI/Avastin/Erbitux provide similar survival in colorectal cancer. http://bit.ly/15408Sm # ASCO14,,,#,4.74982E+17,https://twitter.com/FocusonCancer/status/474981888835059712,,,,
medpagetoday,6/6/2014 14:30,0,0,ASCO: MET-Targeted Drug Flops. @ atscommunity # ASCO14 http://bit.ly/1rR9qOA,,@,#,4.74982E+17,https://twitter.com/medpagetoday/status/474981595003121664,,,,
dytcmd,6/6/2014 14:28,1,1,". @ montypal @ ERPlimackMD @ ASCO Instd of massaging data to show benefit to adj chemo, we shd strongly rec for NAC--it has better data! # blcsm",,@ @ @,#,4.74981E+17,https://twitter.com/dytcmd/status/474981284109107200,,,,
LizDowling2,6/6/2014 14:27,0,0,Oncologists tell us why they tweet at # ASCO14. See the video http://bit.ly/1nnQuSI,,,#,4.74981E+17,https://twitter.com/LizDowling2/status/474981032240746496,,,,
fischmd,6/6/2014 14:23,8,9,"Oncologists @ ASCO explain [on video] Why I Tweet"" http://ow.ly/xIBfV w/ @ AneesChagpar @ gcolditz @ wallyjc @ fischmd @ Ovatars @ rsm2800""",,@ @ @ @ @ @ @,,4.7498E+17,https://twitter.com/fischmd/status/474979791008174080,,,,
DrBobGoldberg,6/6/2014 14:16,0,1,. @ healthyliving What @ asco left and what @ ahip wants to remove.. The Patient as Person &Stakeholder http://huff.to/1k0NlmW # ascorations,,@ @ @,#,4.74978E+17,https://twitter.com/DrBobGoldberg/status/474978131787264001,,,,
OncLive,6/6/2014 14:15,0,1,"Over the weekend, we're going to be recapping our coverage from # ASCO14 To view our full coverage, visit http://ow.ly/xIpO9",,,#,4.74978E+17,https://twitter.com/OncLive/status/474977841529249792,,,,
3NT,6/6/2014 14:06,1,1,Why Clovis CO-1686 was not an # ASCO14 loser - my post for subs. $ CLVS http://3nt.co/CO-1686,,,#,4.74976E+17,https://twitter.com/3NT/status/474975572507238400,,,,
RxProcess,6/6/2014 14:00,1,0,# FF more ASCO social media contributors @ n8pennell @ yzafar @ rschilsky @ YupOnc @ subatomicdoc @ JackWestMD # ASCO2014,,@ @ @ @ @ @,# #,4.74974E+17,https://twitter.com/RxProcess/status/474974106774147073,,,,
TargetedOnc,6/6/2014 13:30,0,0,"New Combinations With Idelalisib, ABT-199, and Rituximab Demonstrate Efficacy in CLL http://www.targetedonc.com/conference/asco-2014/New-Combinations-With-Rituximab-Demonstrate-Efficacy-in-CLL … # ASCO14",,,#,4.74967E+17,https://twitter.com/TargetedOnc/status/474966640019648512,,,,
OncLive,6/6/2014 13:20,1,0,Necitumumab Delivers Rare Survival Benefit in Squamous NSCLC http://ow.ly/xIjLq # ASCO14,,,#,4.74964E+17,https://twitter.com/OncLive/status/474963969862803457,,,,
BioWorld,6/6/2014 13:19,3,2,Still have an # ASCO14 hangover? Play hooky and check out the titles on our 8th annual biotech summer reading list: http://bit.ly/1mYtbgB,,,#,4.74964E+17,https://twitter.com/BioWorld/status/474963717847658497,,,,
LurieCancer,6/6/2014 13:13,0,1,RT @ ASCO: 'Oncologists: Why I Tweet' http://bit.ly/1pMcgCF interviews w/ @ AneesChagpar @ fischmd @ rsm2800 via @ medpagetoday @ NUFeinbergMed,,@ @ @ @ @ @,,4.74962E+17,https://twitter.com/LurieCancer/status/474962170015678464,,,,
TuftsMedicalCtr,6/6/2014 13:05,1,0,MT @ tuftscancerctr: Congrats Tufts MC fellow Gunjan Shah @ iConquerCancer merit award & # ASCO14 travel award winner! http://ow.ly/xHFta,,@ @,#,4.7496E+17,https://twitter.com/TuftsMedicalCtr/status/474960220100513793,,,,
YourDiseaseRisk,6/6/2014 13:03,0,1,MT @ ASCO: 'Oncologists: Why I Tweet' http://bit.ly/1pMcgCF interviews w/ @ AneesChagpar @ fischmd @ rsm2800 @ gcolditz via @ medpagetoday # meded,,@ @ @ @ @ @,#,4.7496E+17,https://twitter.com/YourDiseaseRisk/status/474959870328725504,,,,
Sermo,6/6/2014 13:03,0,0,"ASCO conference roundup, physicians share what they learned. # asco14 http://blog.sermo.com/2014/06/06/asco-conference-round-up/ …",,,#,4.7496E+17,https://twitter.com/Sermo/status/474959843548069888,,,,
CancerResearch,6/6/2014 13:01,0,0,Text JOIN to 80888 to make a $10 donation! # ASCO14 # CIM2014,,,# #,4.74959E+17,https://twitter.com/CancerResearch/status/474959303208886272,,,,
LungCancer_Can,6/6/2014 12:56,2,1,LCC President Dr. Leighl shares some new advances in lung cancer research and treatment as presented # ASCO2014! http://lungcancercanada.ca/news-updates/lcc--asco-2014.aspx …,,,#,4.74958E+17,https://twitter.com/LungCancer_Can/status/474958097979408384,,,,
PoschChristian,6/6/2014 12:53,12,8,NRAS-Mutant Melanoma - worst prognosis! # NRAS # melanoma # ASCO2014 pic.twitter.com/vM4JGwU7mA”,,,# # #,4.74957E+17,https://twitter.com/PoschChristian/status/474957197726990336,,,,
CancerAdvocacy,6/6/2014 12:51,1,0,Reactions to the # ASCO14 meeting; @ sfuldnasso Cancer Policy Matters Blog post http://ow.ly/xIn4d,,@,#,4.74957E+17,https://twitter.com/CancerAdvocacy/status/474956647438516224,,,,
kneepainoptions,6/6/2014 12:40,4,4,"10 tips for use of social media from RT @ ASCO # hcsm # ASCO14 pic.twitter.com/RM77u6ZW2h http://ow.ly/xASJo""",,@,# #,4.74954E+17,https://twitter.com/kneepainoptions/status/474953978107936768,,,,
frozenwarning,6/6/2014 12:37,0,0,@ gorskon @ ASCO @ medpagetoday I demand to know why!,,@ @ @,,4.74953E+17,https://twitter.com/frozenwarning/status/474953302598512640,,,,
gorskon,6/6/2014 12:34,0,0,"Heh. Here's betting that neither @ asco nor @ medpagetoday will likely ever ask me why I Tweet and blog, as I'm not exactly what they expect.",,@ @,,4.74952E+17,https://twitter.com/gorskon/status/474952485271269377,,,,
EIannelli,6/6/2014 12:33,2,3,La famiglia oncologica va sostenuta! # ASCO14 http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=21892 … @ favo_it @ InsControCancro grazie a @ mritamon di @ QSanit @ ailar_it,,@ @ @ @ @,#,4.74952E+17,https://twitter.com/EIannelli/status/474952350004961281,,,,
AJCCancer,6/6/2014 12:30,1,1,RT @ JeffGershenwald Let's begin a global dialog to achieve superlative value in # melanoma cancer care now # endcancer # asco14,,@,# # #,4.74951E+17,https://twitter.com/AJCCancer/status/474951365236518913,,,,
EinsteinMed,6/6/2014 12:25,0,0,RT @ subatomicdoc: My talk from # ASCO14: Social media in clinical practice http://slidesha.re/1jXEfHE via @ ASCO # HLTHTOP # hcsm,,@ @,# # #,4.7495E+17,https://twitter.com/EinsteinMed/status/474950105230241792,,,,
AneesChagpar,6/6/2014 12:13,3,1,@ medpagetoday @ ASCO Video on why oncologists tweet featuring @ gcolditz @ wallyjc @ fischmd @ Ovatars @ rsm2800 http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … # ASCO14,,@ @ @ @ @ @ @,#,4.74947E+17,https://twitter.com/AneesChagpar/status/474947083469094913,,,,
AneesChagpar,6/6/2014 12:06,0,1,Hey tweeps! Check out this video from @ medpagetoday @ ASCO re: why oncologists tweet. http://www.medpagetoday.com/HematologyOncology/LungCancer/46176 … @ fischmd @ YaleCancer # ASCO14,,@ @ @ @,#,4.74945E+17,https://twitter.com/AneesChagpar/status/474945484478763008,,,,
TargetedOnc,6/6/2014 12:05,0,0,Addition of ‘Smart’ Alkylator TH-302 to Dexamethasone Shows Benefit in Myeloma http://www.targetedonc.com/conference/asco-2014/Addition-of-Smart-Alkylator-TH-302-to-Dexamethasone-Shows-Benefit-in-Myeloma … # ASCO14,,,#,4.74945E+17,https://twitter.com/TargetedOnc/status/474945097927503872,,,,
CancerResearch,6/6/2014 12:02,2,0,How # Immunotherapy bridges the gap between academia and the clinic: # ASCO14 http://ow.ly/xyADv,,,# #,4.74944E+17,https://twitter.com/CancerResearch/status/474944361210589185,,,,
Globalmess2020,6/6/2014 11:54,0,1,So the deal is that $ PFE wanted to buy $ AZn not because of tax inversion. $ PFE sees pipeline in lung cancer drug which killed $ CLVS @ Asco,,@,,4.74943E+17,https://twitter.com/Globalmess2020/status/474942523039678464,,,,
Oncoinfo_it,6/6/2014 11:50,0,1,Analysis of # ASCO14 twitting during congress days http://tinyurl.com/nvzd2wr @ ASCO @ PAscierto @ lucadf @ salvo_fedele @ Tecnoetica @ eugeniosantoro,,@ @ @ @ @ @,#,4.74941E+17,https://twitter.com/Oncoinfo_it/status/474941499604758528,,,,
PMedcn,6/6/2014 11:50,0,0,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xHx3v # ASCO14,,,#,4.74941E+17,https://twitter.com/PMedcn/status/474941383544152064,,,,
EuNGSeqConf,6/6/2014 11:50,0,0,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xHx3u # ASCO14,,,#,4.74941E+17,https://twitter.com/EuNGSeqConf/status/474941382143279105,,,,
AbelsonTaylor,6/6/2014 11:40,0,1,"Doctors find success with immune therapy against cervical cancer, according to physicians at # ASCO14. http://bit.ly/1mXkaUS # progress",,,# #,4.74939E+17,https://twitter.com/AbelsonTaylor/status/474938886779846656,,,,
power4patients,6/6/2014 11:31,0,0,http://ow.ly/xEk0A Carol Preston interviews physician experts and patients at # ASCO14,,,#,4.74937E+17,https://twitter.com/power4patients/status/474936583771406336,,,,
asocientificas,6/6/2014 11:31,0,0,"50 años de @ ASCO. Con motivo de encuentro anual, el lema de su presidente @ YupOnc, Illumination to Innovation""...http://connection.asco.org/Commentary/Article/id/3897/Illumination-to-Innovation-Transforming-Data-into-Learning.aspx%20-%20you%20should%20have%20a%20tweet%20for%20this%20already …""",,@ @,,4.74937E+17,https://twitter.com/asocientificas/status/474936561931669504,,,,
CancerTherAdvsr,6/6/2014 11:30,0,0,# ASCO14: # HPV-Targeted Adoptive T-cell Therapy Induces Regression in Metastatic # CervicalCancer http://ow.ly/xHPdv,,,# # #,4.74936E+17,https://twitter.com/CancerTherAdvsr/status/474936328258613248,,,,
JSwatercooler,6/6/2014 11:30,0,0,"Worth a watch on # ASCO14 virtual mtg @ JeffGershenwald talk balancing the costs and benefits of new melanoma therapies.""""",,@,#,4.74936E+17,https://twitter.com/JSwatercooler/status/474936282238701568,,,,
TuftsMedicalCtr,6/6/2014 11:05,0,0,"RT @ tuftscancerctr: AutoBMT for myeloma in age >65: better survival, cost effective -Gunjan Shah # ASCO14 # mmsm # bmtsm http://bit.ly/1kp7wQl",,@,# # #,4.7493E+17,https://twitter.com/TuftsMedicalCtr/status/474930079043420160,,,,
HealioDerm,6/6/2014 11:05,0,1,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5Zj,,@,#,4.7493E+17,https://twitter.com/HealioDerm/status/474930064526946304,,,,
CancerResearch,6/6/2014 11:01,2,1,It's # WhiteOutCancer Day! Join us--put on your white! # CIM2014 # ASCO14,,,# # #,4.74929E+17,https://twitter.com/CancerResearch/status/474929143919165440,,,,
WinshipAtEmory,6/6/2014 11:00,0,0,"Why do docs tweet? Fun segment by @ medpagetoday, and featuring our own @ wallyjc, answers the question: http://ow.ly/xHDRi # ASCO14",,@ @,#,4.74929E+17,https://twitter.com/WinshipAtEmory/status/474928818889961472,,,,
CheckOrphan,6/6/2014 10:57,4,2,Study at # ASCO14 by @ carisls shows importance of # tumor profiling in # Cancer # Treatment # RareDisease @ ocinstitute http://ow.ly/xI2At,,@ @,# # # # #,4.74928E+17,https://twitter.com/CheckOrphan/status/474928165228654592,,,,
Boehringer,6/6/2014 10:55,9,2,"Lung cancer is the most commonly diagnosed cancer worldwide"" Dr Maya Gottfried http://bit.ly/1j1RTda # ASCO14""",,,#,4.74927E+17,https://twitter.com/Boehringer/status/474927484488912896,,,,
Sandra_Marticio,6/6/2014 10:47,0,1,5 things to consider in # pharma this week: http://www.firstwordpharma.com/node/1215453#axzz33s1AngxT … # ASCO14,,,# #axzz33s1AngxT #,4.74926E+17,https://twitter.com/Sandra_Marticio/status/474925545499537408,,,,
emeoenezetaye,6/6/2014 10:40,0,0,El Universal - Los Estados - Un cura VIP... Y pederasta http://www.eluniversal.com.mx/estados/2014/impreso/un-cura-vip-y-pederasta-94998.html … vía @ El_Universal_Mx @ asco @ guacala,,@ @ @,,4.74924E+17,https://twitter.com/emeoenezetaye/status/474923915605590017,,,,
TargetedOnc,6/6/2014 10:40,3,2,Dr. Spigel provides an update on research into MPDL3280A for the treatment of patients with lung cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Research-into-MPDL3280A-for-the-Treatment-of-Lung-Cancer … # ASCO14,,,#,4.74924E+17,https://twitter.com/TargetedOnc/status/474923770671804416,,,,
ONAcom,6/6/2014 10:38,0,0,Happy Friday everyone! Enjoy the weekend. @ ASCO @ DanaFarber @ ecancer @ HealthyLiving @ ihadcancer @ kevinmd @ NCIMedia @ Nerdnurse @ nconnorg # FF,,@ @ @ @ @ @ @ @ @,#,4.74923E+17,https://twitter.com/ONAcom/status/474923353749618688,,,,
JSweetenhamMD,6/6/2014 10:37,5,1,Currently reading http://www.ascopost.com/viewnews.aspx?nid=16278 … From # ASCO14 - ibrutinib likely to be a game-changer for patients with CLL,,,#,4.74923E+17,https://twitter.com/JSweetenhamMD/status/474923068444254208,,,,
fwpharma,6/6/2014 10:34,1,0,Friday Five - 5 questions raised this week in # pharma ( # ASCO14 edition) pic.twitter.com/A3VzIcJIow http://bit.ly/1kFGvbt,,,# #,4.74922E+17,https://twitter.com/fwpharma/status/474922347615760384,,,,
OncEd,6/6/2014 10:25,0,0,# ASCO14 Video Update: The Future of Targeting EGFR – Dr. Ron Burkes # LCSM http://bit.ly/T4iQH3,,,# #,4.7492E+17,https://twitter.com/OncEd/status/474920097124188160,,,,
ConquerCancerFd,6/6/2014 10:24,1,0,. @ ASCO Connection Interview with @ iConquerCancer Long-term Int'l Fellowship recipient Dr. S Obayo of Uganda: http://bit.ly/1rR5jlI,,@ @,,4.7492E+17,https://twitter.com/ConquerCancerFd/status/474919643707342848,,,,
SassyCell,6/6/2014 10:18,0,0,"@ ASCO ! You! Wear WHITE today Jun 6! Support # immunotherapy to # WhiteOutCancer , ALL of them! # CIM2014 http://ow.ly/xyADr",,@,# # #,4.74918E+17,https://twitter.com/SassyCell/status/474918191983239169,,,,
OphiraG,6/6/2014 10:15,1,0,148 # CARES sessions >2000 participants 88 countries -peer led edu 4 # cancer awareness & screening @ ASCO @ uicc @ NCIprevention @ ncdalliance,,@ @ @ @,# #,4.74918E+17,https://twitter.com/OphiraG/status/474917592352968704,,,,
WorldCongress,6/6/2014 10:13,0,1,R. Hauser @ ASCO about Efforts for Outcomes Driven Models - Integrate Support for Federal Quality Initiatives http://http://bit.ly/1ofsjqJ,,@,,4.74917E+17,https://twitter.com/WorldCongress/status/474916998775058432,,,,
SarahKarlin,6/6/2014 10:05,0,1,$ AMGN Amps Up T-VEC Story At # ASCO14 With Filing Plans And Combos http://www.pharmamedtechbi.com/publications/the-pink-sheet-daily/2014/6/5/amgen-amps-up-tvec-story-at-asco-with-filing-plans-and-combos … # cancer,,,# #,4.74915E+17,https://twitter.com/SarahKarlin/status/474915101498429440,,,,
subatomicdoc,6/6/2014 10:04,0,0,@ MeredithGould @ ASCO Thanks Meredith!,,@ @,,4.74915E+17,https://twitter.com/subatomicdoc/status/474914682692591616,,,,
WinshipAtEmory,6/6/2014 10:02,2,0,"Winship # mmsm expert, @ SagarLonialMD talks w/ @ medpagetoday about drug Combo Extends PFS in Myeloma"": http://ow.ly/xHCmT # ASCO14""",,@ @,# #,4.74914E+17,https://twitter.com/WinshipAtEmory/status/474914208333987842,,,,
CancerResearch,6/6/2014 10:01,0,0,Fact: # immunotherapy research took off at the same time lung cancer did. Why? # ASCO14 http://ow.ly/xyADt,,,# #,4.74914E+17,https://twitter.com/CancerResearch/status/474914039861370880,,,,
OphiraG,6/6/2014 9:55,2,0,Personal stories # cancer multiple languages # bengali # hindi # chinese # urdu -peer led advocacy works! @ NCDFREE @ ncdalliance @ ASCO # CARES,,@ @ @,# # # # # #,4.74913E+17,https://twitter.com/OphiraG/status/474912564359749632,,,,
Cascadia,6/6/2014 9:54,0,0,Thxs for bearing w/ my flood of tweets - death of @ RudolphMD 2 confs @ HDPalooza # ASCO14 chats # HITSM # bluebutton chats overwhelmed even me,,@ @,# # #,4.74912E+17,https://twitter.com/Cascadia/status/474912199593324545,,,,
ASeizew,6/6/2014 9:53,0,0,Strength of the $ IBB this week after # ASCO14 is surprising me. Quality names are gaining momentum again.,,,#,4.74912E+17,https://twitter.com/ASeizew/status/474912001836068864,,,,
MeredithGould,6/6/2014 9:53,0,1,RT @ subatomicdoc: My talk from # ASCO14: Social media in clinical practice http://bit.ly/1nWgAQ5 via @ ASCO # HLTHTOP # hcsm,,@ @,# # #,4.74912E+17,https://twitter.com/MeredithGould/status/474911883653562368,,,,
Oncoinfo_it,6/6/2014 9:46,0,0,Nuove promesse da brentuximab: intervista a Massimo Federico http://tinyurl.com/nrtpucx # ASCO2014,,,#,4.7491E+17,https://twitter.com/Oncoinfo_it/status/474910224277848064,,,,
OphiraG,6/6/2014 9:46,2,0,Imp 2 understand barriers 2 dev & test solutions 2 reduce inequities # cancer care @ WCHospital # CARES @ CancerCare_ON @ ASCO @ NCIGlobalHealth,,@ @ @ @,# #,4.7491E+17,https://twitter.com/OphiraG/status/474910166149001217,,,,
subatomicdoc,6/6/2014 9:46,21,15,My talk from # ASCO14: Social media in clinical practice http://slidesha.re/1jXEfHE via @ ASCO # HLTHTOP # hcsm,,@,# # #,4.7491E+17,https://twitter.com/subatomicdoc/status/474910120963747840,,,,
Oncoinfo_it,6/6/2014 9:43,0,0,Tumori HER2 positivi: le riflessioni di Paolo Pronzato http://tinyurl.com/kbzs9sx # ASCO14 @ barni_sandro,,@,#,4.74909E+17,https://twitter.com/Oncoinfo_it/status/474909362541297666,,,,
OphiraG,6/6/2014 9:41,1,0,Laura Heller @ CancerCare_ON reviews evidence 4 lower # cancerscreening among newcomers & immigrants # CARES @ CIHR_IRSC @ ASCO @ NCIGlobalHealth,,@ @ @ @,# #,4.74909E+17,https://twitter.com/OphiraG/status/474908932058906624,,,,
TargetedOnc,6/6/2014 9:35,0,0,From # ASCO14: Dr. Ezra Cohen on new data on immunotherapies for head and neck cancers http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/New-Data-on-Immunotherapies-for-Head-and-Neck-Cancers …,,,#,4.74907E+17,https://twitter.com/TargetedOnc/status/474907357219418112,,,,
OphiraG,6/6/2014 9:29,4,2,Hot off the press: # CARES toolkit peer-led # cancer screening promotion 4 newcomer # women @ CIHR_IRSC @ ASCO @ uiccpic.twitter.com/ZBKRDRgkXx,,@ @ @,# # #,4.74906E+17,https://twitter.com/OphiraG/status/474905997996482560,,,,
NBCCStopBC,6/6/2014 9:16,0,0,Commonly Used Drug Saves Fertility for Women With Cancer http://buzz.mw/b0svm_f via @ nytimes # BreastCancer # BCSM # ASCO14,,@,# # #,4.74903E+17,https://twitter.com/NBCCStopBC/status/474902535862767616,,,,
BiologicsMcK,6/6/2014 9:15,0,0,. @ ASCO discusses their new initiative to help define clinically meaningful outcomes & achieve high-value # cancercare http://vrl.ht/EB9C,,@,#,4.74902E+17,https://twitter.com/BiologicsMcK/status/474902292198457345,,,,
yzafar,6/6/2014 9:12,10,7,My favorite quote from # ASCO14: Due to molecular characteristics," all cancers will become rare cancers"" - Neal Meropol (...oh"," and ""value"")""",,,#,4.74902E+17,https://twitter.com/yzafar/status/474901683173326849,,
mtmdphd,6/6/2014 9:10,4,0,There are many barriers to accrual and one of them is lack of education... @ ASCO http://ow.ly/xCoP0 # ASCO14,,@,#,4.74901E+17,https://twitter.com/mtmdphd/status/474901088014180352,,,,
ASCOPost,6/6/2014 9:08,2,1,Lenvatinib Yields High Response Rates in Radioiodine-Resistant Differentiated Thyroid Cancer http://ow.ly/xHFTT # ASCO14 # hncsm # hncth,,,# # #,4.74901E+17,https://twitter.com/ASCOPost/status/474900704487038976,,,,
ASCOPost,6/6/2014 9:06,5,3,Cediranib + Olaparib Significantly Increases PFS in Women w/Recurrent Ovarian Cancer http://ow.ly/xHFfr # ASCO14 # ovca # gyncsm,,,# # #,4.749E+17,https://twitter.com/ASCOPost/status/474900108853936128,,,,
jcoolerr,6/6/2014 9:04,0,0,@ AdamsLisa @ ASCO Did traditional AI work at all? Maybe few months?,,@ @,,4.749E+17,https://twitter.com/jcoolerr/status/474899615288795136,,,,
CancerResearch,6/6/2014 9:02,2,0,# WhiteOutCancer with us today! # CIM2014 # ASCO14 http://ow.ly/xyADr,,,# # #,4.74899E+17,https://twitter.com/CancerResearch/status/474899014350307328,,,,
OMedLive,6/6/2014 8:59,0,0,Another # ASCO14 highlight: Should TNBC Subtype Affect Local-Regional Therapy Decision Making? http://bit.ly/SfA17v,,,#,4.74898E+17,https://twitter.com/OMedLive/status/474898459297075200,,,,
EmergentAustin,6/6/2014 8:58,0,0,@ PPPResearch @StephenHDunn Would love to see the infographic on social media insights from # ASCO14,,@ @StephenHDunn,#,4.74898E+17,https://twitter.com/EmergentAustin/status/474898024695889920,,,,
subatomicdoc,6/6/2014 8:50,2,2,Adjuvant! Online Performs Poorly in Older Breast Cancer Patients http://bit.ly/1l9EJza > @ ASCOPost # bcsm # ASCO14 # decisionsupport,,@,# # #,4.74896E+17,https://twitter.com/subatomicdoc/status/474896024931418112,,,,
chemobrainfog,6/6/2014 8:34,0,0,. @ symplur Can u provide comparison of # ASCO13 and # ASCO14 to include participants. Curious re: increase in number of tweets fr non-patients,,@,# #,4.74892E+17,https://twitter.com/chemobrainfog/status/474892162321371136,,,,
chemobrainfog,6/6/2014 8:33,3,1,One yr later. WOW! MT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (4 days prior to start to last day) @ symplurpic.twitter.com/x8Vm18fyrH,,@ @,# #,4.74892E+17,https://twitter.com/chemobrainfog/status/474891708573163520,,,,
ABenderRD,6/6/2014 8:07,0,0,MT @ KarenCollinsRD: RT @ AneesChagpar: Chk out Melinda Irwin tlkng abt her studies @ YaleCancer @ YaleSPH at @ ASCO http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/587 …,,@ @ @ @ @,,4.74885E+17,https://twitter.com/ABenderRD/status/474885403607334912,,,,
CowenResearch,6/6/2014 7:58,0,0,Read Steve Scala's '10 things we learned at # ASCO14' - large pharma takeaways for $ BMY $ AZN $ MRK $ LLY $ RHHBY,,,#,4.74883E+17,https://twitter.com/CowenResearch/status/474883118890242048,,,,
PDRennert,6/6/2014 7:56,0,0,@ jq1234t @ LifeSciVC @ AACR @ ASCO with CARs we need the make/model too! Likely this will also be true for bispecifics - they will-b different,,@ @ @ @,,4.74883E+17,https://twitter.com/PDRennert/status/474882524968001537,,,,
PDRennert,6/6/2014 7:54,0,0,@ jq1234t @ LifeSciVC @ AACR we were waiting 4 Blin'mab phase 2 data @ ASCO b4 judging. Now waiting 4 more data on CARs b4 judging. with CARs..,,@ @ @ @,,4.74882E+17,https://twitter.com/PDRennert/status/474882113833930752,,,,
UMRogelCancer,6/6/2014 7:50,0,0,Dr. Hayes talks tumor biomarkers with @ medpagetoday: http://umhealth.me/1ofk0Ly # ASCO14 # cancer,,@,# #,4.74881E+17,https://twitter.com/UMRogelCancer/status/474880939244658688,,,,
economiauasd,6/6/2014 7:41,1,0," @ UASDFCS: Resultados en investigación cáncer vejiga http://www.resumendesalud.com/do/index.php/categoria-oncologia/8466-primeros-resultados-en-investigacion-cancer-vejiga … @ ASCO @ RocheDiaUK""""",,@ @ @,,4.74879E+17,https://twitter.com/economiauasd/status/474878807963602944,,,,
UASDFCS,6/6/2014 7:41,0,0,Resultados en investigación cáncer vejiga http://www.resumendesalud.com/do/index.php/categoria-oncologia/8466-primeros-resultados-en-investigacion-cancer-vejiga … @ ASCO @ RocheDiaUK,,@ @,,4.74879E+17,https://twitter.com/UASDFCS/status/474878754225782784,,,,
ecancer,6/6/2014 7:40,1,0,Prof Peeters discusses second-line treatment of metastatic colorectal cancer at # ASCO14 http://ecancer.org/video/2911/kras-nras-and-braf-mutations-in-study-of-panitumumab-plus-folfiri-for-second-line-treatment-of-mcc.php …,,,#,4.74879E+17,https://twitter.com/ecancer/status/474878534239154176,,,,
power4patients,6/6/2014 7:30,1,0,http://ow.ly/xEjZq Carol Preston interviews physician experts and patients at # ASCO14,,,#,4.74876E+17,https://twitter.com/power4patients/status/474876045796335616,,,,
intervalolibre,6/6/2014 7:16,1,0,Quimioterapia neoadyuvante en cáncer de ovario avanzado podría disminuir complicaciones. # ASCO14 http://am.asco.org/neoadjuvant-chemotherapy-initial-treatment-advanced-ovarian-cancer-may-decrease-complications …,,,#,4.74872E+17,https://twitter.com/intervalolibre/status/474872493669625856,,,,
drcbsteer,6/6/2014 7:13,1,1,"MT @ ddembe 27 hrs flight time, 9 hrs in transit lounges, a 12 hr time shift forward, 5 cities, 2 continents.. lots of jet lag to go! # ASCO14",,@,#,4.74872E+17,https://twitter.com/drcbsteer/status/474871692590727168,,,,
OncLive,6/6/2014 7:10,0,1,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xGv2p # ASCO14,,,#,4.74871E+17,https://twitter.com/OncLive/status/474870916728770560,,,,
LPMissy1202,6/6/2014 7:04,0,0,# FF @ cancerpre @ theNCI @ abolishcancer @ LFPancreaticCan @ MACancerFDN @ curePCcampaign @ ASCO @ DanaFarber @ AACR @ cancer_connect,,@ @ @ @ @ @ @ @ @ @,#,4.74869E+17,https://twitter.com/LPMissy1202/status/474869385564536832,,,,
audvin,6/6/2014 6:51,0,0,"Oui! “ @ subatomicdoc: Based upon massive success of # ASCO14 , more ontology to come. Thanks to @ audvin @ pfanderson @ symplur @ asco # doctors20”",,@ @ @ @ @,# #,4.74866E+17,https://twitter.com/audvin/status/474866267766398976,,,,
subatomicdoc,6/6/2014 6:51,1,0,"Based upon massive success of # ASCO14 , more ontology to come. Thanks to @ audvin @ pfanderson @ symplur @ asco # doctors20",,@ @ @ @,# #,4.74866E+17,https://twitter.com/subatomicdoc/status/474866071066132480,,,,
Oncoinfo_it,6/6/2014 6:48,0,0,La videointervista di Alfredo Falcone sull'analisi post-hoc dello studio TRIBE ad # ASCO14 http://tinyurl.com/qcyuhws @ carmine_pinto,,@,#,4.74865E+17,https://twitter.com/Oncoinfo_it/status/474865380071309312,,,,
siriusinvest,6/6/2014 6:47,0,0,"@ RNAiAnalyst finally, someone with rational view! :) That $ CLVS PFS curve is just impressive - should have gone up after @ ASCO IMO",,@ @,,4.74865E+17,https://twitter.com/siriusinvest/status/474865152324829185,,,,
Oncoinfo_it,6/6/2014 6:43,0,0,# ASCO14 Combinazione FOLFOXIRI e bevacizumab in prima linea http://tinyurl.com/lgtc2fj @ carmine_pinto,,@,#,4.74864E+17,https://twitter.com/Oncoinfo_it/status/474864136686301185,,,,
Boehringer,6/6/2014 6:30,2,2,"Lung cancer is no longer just one disease."" Dr Vera Hirsh http://bit.ly/1pA2PpL # ASCO14 # lungcancer""",,,# #,4.74861E+17,https://twitter.com/Boehringer/status/474860808359649280,,,,
SeqComplete,6/6/2014 6:01,0,0,buzzz at # ASCO14 http://tweetedtimes.com/search/%23ASCO14/en …,,,#,4.74853E+17,https://twitter.com/SeqComplete/status/474853488560971776,,,,
PatriciaMWinter,6/6/2014 5:13,0,1,"Our 5 favourite ASCO 2014 moments"" http://shar.es/PbzGE via @ Boehringer - # ASCO14 # LungCancer # HCSM # HCSMEU""",,@,# # # #,4.74842E+17,https://twitter.com/PatriciaMWinter/status/474841622660665344,,,,
SergiAlc,6/6/2014 5:13,0,1,Lilly muestra resultados positivos de dos estudios fase III en el congreso de oncología # ASCO14: http://ow.ly/3lr9ks,,,#,4.74841E+17,https://twitter.com/SergiAlc/status/474841463050997761,,,,
danielebanfi83,6/6/2014 4:50,1,1,Il futuro della diagnosi del tumore al polmone. Il presente delle cure. Qui su @ Fondaz_Veronesi https://www.fondazioneveronesi.it/articoli/oncologia/tumore-del-polmone-la-diagnosi-un-soffio/ … # ASCO14,,@,#,4.74836E+17,https://twitter.com/danielebanfi83/status/474835626194657280,,,,
Boehringer,6/6/2014 4:45,3,0,Our 5 favourite # ASCO14 moments: http://shar.es/Pbwm1 - # NotJustOneDisease # LungCancer,,,# # #,4.74834E+17,https://twitter.com/Boehringer/status/474834354804252672,,,,
oncobretagne,6/6/2014 4:39,0,0,# ASCO2014 les depêches APM du jeudi 5 juin http://www.sfc.asso.fr/spip.php?article2959 …,,,#,4.74833E+17,https://twitter.com/oncobretagne/status/474832852040024064,,,,
lymphomahub,6/6/2014 4:28,0,0,Big theme @ # ASCO14 The Pathway to Value and Innovation | ASCO Annual Meeting http://am.asco.org/pathway-value-and-innovation#.U5F7iIWVrcw.twitter …,,@,# #,4.7483E+17,https://twitter.com/lymphomahub/status/474830205790330880,,,,
ArcagyGineco,6/6/2014 4:16,0,0,Nouvelle génération d’agents immunothérapiques : les anticorps anti PD1 et anti PDL1 très prometteurs dans le cancer de l’ovaire # ASCO14,,,#,4.74827E+17,https://twitter.com/ArcagyGineco/status/474827071123099648,,,,
fwpharma,6/6/2014 3:50,0,0,Check out 5 questions raised following # ASCO14 pic.twitter.com/A3VzIcJIow,,,#,4.74821E+17,https://twitter.com/fwpharma/status/474820573214695424,,,,
fwpharma,6/6/2014 3:45,1,2,Friday Five – 5 questions raised this week in # pharma (ASCO edition) http://bit.ly/1kFGvbt # ASCO14,,,# #,4.74819E+17,https://twitter.com/fwpharma/status/474819329494884353,,,,
OncLive,6/6/2014 3:15,1,2,"View videos filmed at # ASCO14 - Featuring Drs Byrd, Wolchok, Ramalingam, Spigel, Younes, and Pegram http://ow.ly/xGv97",,,#,4.74812E+17,https://twitter.com/OncLive/status/474811743819272192,,,,
nmunozm,6/6/2014 2:46,0,0,"“ @ jagasquet: SQUIRE: Statistically significant, but is it clinically relevant? # lungcancer # ASCO14 http://kantarhealth.com/blog/stephanie-hawthorne/stephanie-hawthorne/2014/06/03/squire-statistically-significant-but-is-it-clinically-relevant- …” Claramente No",,@,# #,4.74804E+17,https://twitter.com/nmunozm/status/474804406014443520,,,,
TransgeneSA,6/6/2014 2:30,1,0,L' # ASCO14 : résultats encourageants pour l' # immunothérapie. La lutte contre le # cancer continue http://ow.ly/xBsfr via @ Doctissimo,,@,# # #,4.74801E+17,https://twitter.com/TransgeneSA/status/474800530808897536,,,,
OncLive,6/5/2014 23:10,1,3,"Negative ALTTO Results Reverberate for Lapatinib, Novel Clinical Trials http://ow.ly/xGuWZ # ASCO14",,,#,4.7475E+17,https://twitter.com/OncLive/status/474750055413714944,,,,
brianreid,6/5/2014 22:49,0,0,Curious: any # ASCO14 peeps just see the special screening of The Fault in Our Stars? # asktfios,,,# #,4.74745E+17,https://twitter.com/brianreid/status/474744828849582080,,,,
DrAttai,6/5/2014 22:24,0,3,"Ok with # ASCO14, # bcsm, and # igsjc I think everyone has heard enough from me this week. Back Monday for # bcsm with info from # ASCO14",,,# # # # #,4.74739E+17,https://twitter.com/DrAttai/status/474738642540175360,,,,
Wednesday_8,6/5/2014 22:09,0,0," @ HemOncToday: # ASCO14 # Afatinib extended OS in EGFR-mutated non–small cell # LungCancer http://goo.gl/AiFz9m "" # lcsm""",,@,# # # #,4.74735E+17,https://twitter.com/Wednesday_8/status/474734709168427008,,,,
KultureKatalyst,6/5/2014 22:08,0,0,# THC # TherapyThursday # CBDa # CBG # CBN # ASCO2014 # BCSM # Amannabis # CannabisPride # Selfie # Dirt&Co # WestCoastPurest http://fb.me/1aXz6BIBo,,,# # # # # # # # # # # #,4.74735E+17,https://twitter.com/KultureKatalyst/status/474734572693774337,,,,
PublicHealthRTs,6/5/2014 22:05,0,0,RT @ ASCO: Understanding colorectal # cancer survivors' needs & preferences for # survivorship info http://ow.ly/xAAHz # crcsm # JOP,,@,# # # #,4.74734E+17,https://twitter.com/PublicHealthRTs/status/474733708914982912,,,,
OncLive,6/5/2014 21:20,1,0,Panobinostat Combination Improves PFS in Multiple Myeloma http://ow.ly/xGuNG # ASCO14,,,#,4.74722E+17,https://twitter.com/OncLive/status/474722403223101440,,,,
TargetedOnc,6/5/2014 21:15,1,0,T-VEC Demonstrates Utility in Combinations and as Monotherapy in Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/T-VEC-Shows-Promise-in-Combinations-and-as-Monotherapy-in-Unresectable-Melanoma … # ASCO14,,,#,4.74721E+17,https://twitter.com/TargetedOnc/status/474721129035489280,,,,
ndphealth,6/5/2014 21:10,0,0,"The ND&P Health Daily"" is out! http://paper.li/ndphealth Stories via @ Reuters_Health @ ASCO""",,@ @,,4.7472E+17,https://twitter.com/ndphealth/status/474720037274931200,,,,
EagleMyeloma,6/5/2014 21:07,2,4,Continuous vs. Fixed dose # Myeloma therapy # ASCO14. It seems clear PFS2 benefit = overall survival benefit. http://meetinglibrary.asco.org/content/128803-144 …,,,# #,4.74719E+17,https://twitter.com/EagleMyeloma/status/474719223747731456,,,,
fainfosalute,6/5/2014 21:03,0,0,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers # ASCO2014 http://bit.ly/1jXHjU8",,,#,4.74718E+17,https://twitter.com/fainfosalute/status/474718228439379969,,,,
NirajGusani,6/5/2014 21:03,0,1,Hi Matt @ subatomicdoc @ PancSMChat - you did a great job getting the word out about this chat at # ASCO14 # PancSM,,@ @,# #,4.74718E+17,https://twitter.com/NirajGusani/status/474718128337719296,,,,
lcrf_org,6/5/2014 19:59,0,0,Hey Dusty/Kimberly/all @ DustyJoyDotOrg :). Safe travels home from # ASCO14 ?,,@,#,4.74702E+17,https://twitter.com/lcrf_org/status/474702192260431873,,,,
subatomicdoc,6/5/2014 19:33,0,0,I just gave $50 to @ ASCO for its 50th anniversary. https://secure2.convio.net/asco/site/Donation2?idb=1983912806&1880.donation=form1&df_id=1880&idb=0 … Thanks for the suggestion @ CliffordHudis,,@ @,,4.74696E+17,https://twitter.com/subatomicdoc/status/474695586860781568,,,,
timfenske,6/5/2014 19:22,0,0,Front-Line Lenalidomide Plus Rituximab Shows Promise in Follicular Lymphoma Martin et al # ASCO14 http://dgnews.docguide.com/front-line-lenalidomide-plus-rituximab-shows-promise-follicular-lymphoma?overlay=2&nl_ref=newsletter&pk_campaign=newsletter …,,,#,4.74693E+17,https://twitter.com/timfenske/status/474692817609326592,,,,
jagasquet,6/5/2014 18:36,0,0,"SQUIRE: Statistically significant, but is it clinically relevant? # lungcancer # necitumumab # ASCO14 http://kantarhealth.com/blog/stephanie-hawthorne/stephanie-hawthorne/2014/06/03/squire-statistically-significant-but-is-it-clinically-relevant- …",,,# # #,4.74681E+17,https://twitter.com/jagasquet/status/474681264105357312,,,,
ARUPLabs,6/5/2014 18:25,0,0,RT @ CancerNetwrk: Improving Colorectal Cancer Screening in African Americans http://bit.ly/1mblqlz # ASCO14,,@,#,4.74678E+17,https://twitter.com/ARUPLabs/status/474678344244817921,,,,
ElizBlanchardMD,6/5/2014 18:17,0,0,@ ASCO Misleading headline! That data will be presented later. Exemestane has better DFS than tam when both had OFS http://www.ascopost.com/ViewNews.aspx?nid=16280 …,,@,,4.74676E+17,https://twitter.com/ElizBlanchardMD/status/474676433173090307,,,,
gwyd,6/5/2014 18:15,0,0,“ @ mtmdphd: RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplur” >>nice work,,@ @ @,# #,4.74676E+17,https://twitter.com/gwyd/status/474675964212158464,,,,
Agendia,6/5/2014 18:15,1,0,@ beitsch @ whitworthmd Thank you for the great talk on # MammaPrint and BluePrint @Signature at the 95th # ASCO14 # bcsmpic.twitter.com/YHLrLxd1SQ,,@ @ @Signature,# # #,4.74676E+17,https://twitter.com/Agendia/status/474675928074027011,,,,
mtmdphd,6/5/2014 18:10,0,0,RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplur,,@ @,# #,4.74675E+17,https://twitter.com/mtmdphd/status/474674568620408832,,,,
UCSFCancer,6/5/2014 18:07,8,4,"MT @ theMMRF: # ASCO14 Dr. Tom Martin presented impressive early # myeloma study of # SAR650984, monoclonal antibody targeting CD38. # MMRFASCO",,@,# # # #,4.74674E+17,https://twitter.com/UCSFCancer/status/474673937591586816,,,,
HealioDerm,6/5/2014 18:05,0,1,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5Vl,,@,#,4.74673E+17,https://twitter.com/HealioDerm/status/474673346119237632,,,,
CancerDotNet,6/5/2014 18:05,4,0,Calling all artists for the 2015 @ ASCO calendar! Anyone affected by # cancer can submit artwork (free) by 8/2: http://bit.ly/1rC1v7V,,@,#,4.74673E+17,https://twitter.com/CancerDotNet/status/474673300472606720,,,,
renalandurology,6/5/2014 18:01,1,1,Long-Term Testosterone Therapy Does Not Raise PCa Risk -- today's most popular article. http://bit.ly/1pJ4zNH # prostatecancer # asco14,,,# #,4.74672E+17,https://twitter.com/renalandurology/status/474672358809432064,,,,
Globeathon,6/5/2014 17:53,1,0,RT @ OCNA: Read our round-up of some of the most promising and thought-provoking ovarian cancer research from # ASCO14 http://bit.ly/1unuoCH,,@,#,4.7467E+17,https://twitter.com/Globeathon/status/474670448824045569,,,,
LIVESTRONG_NL,6/5/2014 17:50,0,0,50 jaar Innovatie in # oncologie # ASCO14 - http://ow.ly/xGkNh (via @ Medicalfacts ),,@,# #,4.7467E+17,https://twitter.com/LIVESTRONG_NL/status/474669504107397120,,,,
subatomicdoc,6/5/2014 17:40,1,0,Lenvatinib Delays Progression in Radioiodine-Resistant Differentiated Thyroid Cancer http://bit.ly/1j4mXsZ # thycsm # ASCO14,,,# #,4.74667E+17,https://twitter.com/subatomicdoc/status/474667122564812800,,,,
TargetedOnc,6/5/2014 17:40,2,0,James P. Allison on the potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/The-Potentiation-of-Checkpoint-Blockade-With-Oncolytic-Virus … # ASCO14,,,#,4.74667E+17,https://twitter.com/TargetedOnc/status/474667053497196545,,,,
MyelomaTeacher,6/5/2014 17:38,2,4,@ theMMRF June Newsletter with research updates from # ASCO14 # myeloma # MMSM http://support.themmrf.org/site/MessageViewer?dlv_id=54641&em_id=32101.0 …,,@,# # #,4.74667E+17,https://twitter.com/MyelomaTeacher/status/474666617595789312,,,,
DrNickPeel,6/5/2014 17:33,0,0,. @ DrLen wraps up # ASCO14 from immunotherapy to 'omics stuff - good read http://m.cancer.org/aboutus/drlensblog/post/2014/06/04/asco-2014-if-immunotherapy-is-the-queen-of-the-ball-then-panomics-holds-the-keys-to-the-kingdom.aspx …,,@,#,4.74665E+17,https://twitter.com/DrNickPeel/status/474665273296175104,,,,
jtriestm,6/5/2014 17:31,0,0,# asco14 RECAP CURE mag http://www.curemagazine.com/index.cfm/fuseaction/journey.showArticle/id/9/enableStageSubMenu/2/article_id/2289 …,,,#,4.74665E+17,https://twitter.com/jtriestm/status/474664891132166145,,,,
cancercommons,6/5/2014 17:23,1,0,Immunotherapy drug MEDI4736 shows promise for some patients w/ advanced non-small cell # lungcancer: http://www.cancercommons.org/news/astrazenecas-medimmune-presents-encouraging-immunotherapy-data-at-asco-2014/ … # lcsm # ASCO14,,,# # #,4.74663E+17,https://twitter.com/cancercommons/status/474662804059070464,,,,
djsampson,6/5/2014 17:19,1,0,"w/ shoutout @ rsm2800 MT @ drlen: # ASCO14: If immunoRx was queen of the ball, panomics holds the keys to the kingdom http://tinyurl.com/ku76ehk",,@ @,#,4.74662E+17,https://twitter.com/djsampson/status/474661822126358528,,,,
Orisabattini98,6/5/2014 17:17,0,0,Encima q no me la banco me pone Fav . @ ASCO,,@,,4.74661E+17,https://twitter.com/Orisabattini98/status/474661391748829184,,,,
OncEd,6/5/2014 17:02,1,0,Missed # ASCO14 in Chicago? Last day for early bird fees to register to Best of ASCO Canada on June 19-20 in Toronto http://www.oncologyeducation.com/events/upcoming-events/asco2014toronto/conference-details/ …,,,#,4.74658E+17,https://twitter.com/OncEd/status/474657652106997760,,,,
TargetedOnc,6/5/2014 17:00,1,1,New Data on Immunotherapies for Head and Neck Cancers http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/New-Data-on-Immunotherapies-for-Head-and-Neck-Cancers … # ASCO14,,,#,4.74657E+17,https://twitter.com/TargetedOnc/status/474657150879662082,,,,
KarenCollinsRD,6/5/2014 17:00,0,0,RT @ AneesChagpar: Check out Melinda Irwin talking about her studies @ YaleCancer @ YaleSPH presented @ ASCO # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/587 …,,@ @ @ @,#,4.74657E+17,https://twitter.com/KarenCollinsRD/status/474657145737080832,,,,
ONAcom,6/5/2014 17:00,0,0,# ASCO14: New drug effective for metastatic # prostatecancer - http://ow.ly/xEYhO # pcsm,,,# # #,4.74657E+17,https://twitter.com/ONAcom/status/474657063357140992,,,,
DrMiguelPerales,6/5/2014 16:59,0,0,MT @ TuftsCancerCtr: AutoBMT for MM in age >65: better survival AND cost effective! -Gunjan Shah @chiku52983 # ASCO14 http://bit.ly/1kp7wQl,,@ @chiku52983,#,4.74657E+17,https://twitter.com/DrMiguelPerales/status/474656813883736064,,,,
CancerNetwrk,6/5/2014 16:52,2,1,Ibrutinib Shows Huge Benefit Over Ofatumumab in CLL and SLL http://bit.ly/1j49Wj7 # ASCO14,,,#,4.74655E+17,https://twitter.com/CancerNetwrk/status/474655054742712321,,,,
OncLive,6/5/2014 16:50,2,0,Dr. Ramalingam from @ WinshipAtEmory on the Results of the Phase III REVEL Study in NSCLC http://ow.ly/xGcc8 # ASCO14,,@,#,4.74654E+17,https://twitter.com/OncLive/status/474654466470604800,,,,
evaluatepharma,6/5/2014 16:45,0,0,# ASCO14 Event Analyzer – 2014’s winners and losers http://ow.ly/xFliV,,,#,4.74653E+17,https://twitter.com/evaluatepharma/status/474653227523506177,,,,
MelanomaReAlli,6/5/2014 16:42,1,1,Glad our science team got to hang w/ @ TeamTJSharpe at # ASCO14. http://www.philly.com/philly/blogs/patient1/The-rookies-guide-to-navigating-the-2014-ASCO-annual-meeting.html … Stay tuned for our upcoming Q&A!,,@,#,4.74653E+17,https://twitter.com/MelanomaReAlli/status/474652552223408128,,,,
carisls,6/5/2014 16:37,1,0,Dr. Santosh Kesari from UC - San Diego discusses the significance of # glioma # MolecularIntel research at # ASCO14 http://youtu.be/vLsIpM04wug,,,# # #,4.74651E+17,https://twitter.com/carisls/status/474651230711455745,,,,
HemOncToday,6/5/2014 16:31,0,1,# ASCO14 # Afatinib extended OS in EGFR-mutated non–small cell # LungCancer http://goo.gl/AiFz9m,,,# # #,4.7465E+17,https://twitter.com/HemOncToday/status/474649807651614720,,,,
GoHealio,6/5/2014 16:31,0,0,# ASCO14 # Afatinib extended OS in EGFR-mutated non–small cell # LungCancer http://goo.gl/AiFz9m,,,# # #,4.7465E+17,https://twitter.com/GoHealio/status/474649806477221888,,,,
KomenSWMI,6/5/2014 16:25,0,0,SGK Scholar study proves need to better understand long-term effects of salpingo-oophorectomy http://bit.ly/1kxSSpT # ASCO14 via...,,,#,4.74648E+17,https://twitter.com/KomenSWMI/status/474648162578464769,,,,
frantasticpeete,6/5/2014 16:23,0,0,@ CancerDotNet @ ASCO @ YaleCancer- I beat Stage 3 Melanoma!!,,@ @ @,,4.74648E+17,https://twitter.com/frantasticpeete/status/474647651799941120,,,,
brianreid,6/5/2014 16:04,0,1,"More on tweeting cancer docs. 83K tweets, 1,600 use the word cost"," 200 say price"": http://bit.ly/1kzknAw # ASCO14""",,,#,4.74643E+17,https://twitter.com/brianreid/status/474642846507872256,,,
YOGAontheSTEPS,6/5/2014 16:01,1,0,Join us on 6/24 for a webinar on updates from # ASCO2014 @12pmET! http://ow.ly/xFAQ1,,@12pmET,#,4.74642E+17,https://twitter.com/YOGAontheSTEPS/status/474642061745201152,,,,
LivingBeyondBC,6/5/2014 16:00,1,1,Join us on 6/24 for a webinar on updates from # ASCO2014 @12pmET! http://ow.ly/xFARr,,@12pmET,#,4.74642E+17,https://twitter.com/LivingBeyondBC/status/474641895239737344,,,,
stefaniei,6/5/2014 15:53,5,1,It Came From Chicago! The must-have swag at # ASCO14 was this 'T-cell' blob via $ BMY http://on.wsj.com/1paE9Sr @ Pharmalotpic.twitter.com/NQ6ThX4k8o,,@,#,4.7464E+17,https://twitter.com/stefaniei/status/474640062983200768,,,,
ConquerCancerFd,6/5/2014 15:50,6,1,Thanks to all who supported @ iConquerCancer during # ASCO14! Together we raised more than $55K to help build the future of cancer care.,,@,#,4.7464E+17,https://twitter.com/ConquerCancerFd/status/474639511587401729,,,,
salutedomani,6/5/2014 15:41,0,0,"Melanoma, ipilimumab mostra netto miglioramento della sopravvivenza libera da recidiva # asco2014 http://lnkd.in/dgDmH7z",,,#,4.74637E+17,https://twitter.com/salutedomani/status/474637184025505792,,,,
Loftus,6/5/2014 15:35,0,1,Said green blob http://on.wsj.com/1paE9Sr via @ WSJ @ pharmalot What else stood out at # ASCO14 exhibit hall? pic.twitter.com/oWyBceUNop,,@ @,#,4.74636E+17,https://twitter.com/Loftus/status/474635703180361728,,,,
genentech,6/5/2014 15:35,0,3,MT@ASCO: Twitter data from # ASCO13 vs # ASCO14 ( 4 days prior to last day) via @symplurpic.twitter.com/HT2lZyqbPm # TBT,,@ASCO @symplurpic,# # #,4.74636E+17,https://twitter.com/genentech/status/474635527388684290,,,,
jtriestm,6/5/2014 15:28,0,2,http://www.ovariancancer.org/2014/06/05/2014-asco-research-round-up/ … # asco14 # ovariancancer # gyncsm recap from @ OCNA,,@,# # #,4.74634E+17,https://twitter.com/jtriestm/status/474633894927409152,,,,
mtmdphd,6/5/2014 15:28,7,6,...physician conversations about multiple myeloma on Twitter more than quadrupled b/w 2012 & 2013 http://ow.ly/xG1RH # mmsm # ASCO14,,,# #,4.74634E+17,https://twitter.com/mtmdphd/status/474633795162103809,,,,
Loftus,6/5/2014 15:26,0,1,It Came From Chicago! Bristol’s Cancer-Fighting Green Blob Was a Hit at # ASCO14 http://on.wsj.com/1paE9Sr via @ WSJ @ pharmalot,,@ @,#,4.74633E+17,https://twitter.com/Loftus/status/474633457151115264,,,,
Frank_S_David,6/5/2014 15:21,0,0,Hope2c this at next @ ASCO for presenting tumor size plots: Stunning data viz by @ UpshotNYT http://nyti.ms/1pTR8Yr HT @ onceuponA,,@ @ @,,4.74632E+17,https://twitter.com/Frank_S_David/status/474632177016008704,,,,
JaneyBusby,6/5/2014 15:21,8,4,Share the story of a tough teen fighting cancer! @ 4Nathalie needs your help to access meds! # ASCO14 # kickASPSpic.twitter.com/F0gfOSjRwE,,@,# #,4.74632E+17,https://twitter.com/JaneyBusby/status/474632123786080257,,,,
AndreasKleinMD,6/5/2014 15:18,0,1,RT @ TuftsCancerCtr: AutoBMT for MM in age >65: better survival AND cost effective! -Gunjan Shah # ASCO14 # mmsm # bmtsm http://bit.ly/1kp7wQl,,@,# # #,4.74631E+17,https://twitter.com/AndreasKleinMD/status/474631427070652416,,,,
crrogersPhD,6/5/2014 15:08,0,0,MT @BayerHealthCare: There's a 50% chance of some1 w/ # coloncancer passing it onto their children. Learn more http://bit.ly/STP4Vp # ASCO14,,@BayerHealthCare,# #,4.74629E+17,https://twitter.com/crrogersPhD/status/474628758859563008,,,,
HealioDerm,6/5/2014 15:05,1,2,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5TY,,@,#,4.74628E+17,https://twitter.com/HealioDerm/status/474628095056826368,,,,
CancerTherAdvsr,6/5/2014 15:05,1,1,# ASCO14: Early # Palliative Support for Family Caregivers Reduces # Depression http://ow.ly/xDfim,,,# # #,4.74628E+17,https://twitter.com/CancerTherAdvsr/status/474628042997112833,,,,
falsoguaritore,6/5/2014 15:03,0,0,Tolero Pharma Positive Interim Ph 2 Results of Alvocidib for the Treatment of Front Line AML at # ASCO14 http://obroncology.com/newsletter/sharethis_helper.php?id=44883 …,,,#,4.74627E+17,https://twitter.com/falsoguaritore/status/474627486832427008,,,,
SkinMelanoma,6/5/2014 15:02,0,0,Don’t forget about our # video explaining how DecisionDx-Melanoma works as presented at # ASCO14 http://tinyurl.com/nav9h6c,,,# #,4.74627E+17,https://twitter.com/SkinMelanoma/status/474627372944072704,,,,
CaraintheArts,6/5/2014 15:02,0,0,Adolescent and young adult # cancer survivors report long-term side effects. # ASCO14 # AYAcancer # YoungAdultCancer http://www.oncologynurseadvisor.com/adolescent-and-young-adult-cancer-survivors-report-cognitive-sexual-late-effects/article/349697/ …,,,# # # #,4.74627E+17,https://twitter.com/CaraintheArts/status/474627306699644928,,,,
LuisLuisjos,6/5/2014 15:02,0,0,Simplemente que # ASCO14 :3,,,#,4.74627E+17,https://twitter.com/LuisLuisjos/status/474627247509622784,,,,
cancercommons,6/5/2014 14:59,0,1,New targeted drug Cyramza shows promise for treating stage IV NSCLC: http://www.cancercommons.org/news/cyramza-yields-a-modest-survival-benefit-in-second-line-nsclc/ … # lcsm # ASCO14,,,# #,4.74627E+17,https://twitter.com/cancercommons/status/474626559777992705,,,,
CancerNetwrk,6/5/2014 14:59,1,0,"FOLFOX Plus Ramucirumab Fails to Improve PFS in Gastric, Esophageal Cancer http://bit.ly/1l9gDnZ # ASCO14",,,#,4.74626E+17,https://twitter.com/CancerNetwrk/status/474626468442832896,,,,
Primary_Immune,6/5/2014 14:52,0,0,@ nature @ ASCO | Seems Like a Great Idea - A Cancer Drug Failed Late-Stage Trial But Had GREAT Results for 10% of Patients - Give a 2nd Look,,@ @,,4.74625E+17,https://twitter.com/Primary_Immune/status/474624696034406400,,,,
ASCO,6/5/2014 14:31,11,2,Download # ASCO14 slides to use in your presentations: http://bit.ly/1k5KSbo,,,#,4.7462E+17,https://twitter.com/ASCO/status/474619606083321856,,,,
medpagetoday,6/5/2014 14:30,1,0,ASCO: Zykadia works before or after targeted lung cancer treatment. @ atscommunity # ASCO14 http://bit.ly/1rOsey2,,@,#,4.74619E+17,https://twitter.com/medpagetoday/status/474619181392875520,,,,
UCD_Cancer,6/5/2014 14:29,2,2,"As the temperatures heat up in # Sacramento this week, make sure you stay safe. http://goo.gl/vrTjFD @ ASCO pic.twitter.com/qwSfqqGWLr",,@,#,4.74619E+17,https://twitter.com/UCD_Cancer/status/474619065604902912,,,,
MelanomaReAlli,6/5/2014 14:27,0,2,. @ sloan_kettering showcases cancer researchers' work at # ASCO14. Featuring an MRA-supported investigator! http://www.mskcc.org/blog/msk-s-expertise-immunotherapy-draws-media-focus-2014-asco-meeting …,,@,#,4.74619E+17,https://twitter.com/MelanomaReAlli/status/474618611252723712,,,,
ByJonGardner,6/5/2014 14:25,0,0,. @ FiercePharma thanks for having me. Special thanks to colleague @ AmyEPVantage for running onc forecasts. # ASCO14 # FierceASCO,,@ @,# #,4.74618E+17,https://twitter.com/ByJonGardner/status/474617924502962176,,,,
ByJonGardner,6/5/2014 14:21,1,0,The kerfuffle over CO-1686 will take some time to work itself out. $ CLVS # FierceASCO # ASCO14,,,# #,4.74617E+17,https://twitter.com/ByJonGardner/status/474617007716171776,,,,
AlpineBV_Miller,6/5/2014 14:20,3,1,Reading # ASCO14 posters I only had time to dash & snap. Did you know generic docetaxel is more costly than branded? Abstract 1015,,,#,4.74617E+17,https://twitter.com/AlpineBV_Miller/status/474616845748936705,,,,
FiercePharma,6/5/2014 14:20,0,0,"OK. Well, thanks to everyone for participating and a special thanks to @ JonEPVantage. # FierceASCO # ASCO14",,@,# #,4.74617E+17,https://twitter.com/FiercePharma/status/474616650155978752,,,,
FiercePharma,6/5/2014 14:18,0,0,Fascinating. @ JonEPVantage Anything to add? # FierceASCO # ASCO14,,@,# #,4.74616E+17,https://twitter.com/FiercePharma/status/474616307162169344,,,,
ByJonGardner,6/5/2014 14:17,0,0,$MRK’s PD-1 pembrolizumab has risen an almost equivalent amount. Expect H&N data to drive further upgrades # FierceASCO # ASCO14,,,# #,4.74616E+17,https://twitter.com/ByJonGardner/status/474616004480618497,,,,
ByJonGardner,6/5/2014 14:16,0,1,"$ BMY's nivolumab 2018 f/c has risen $2.5bn, which is why its # ASCO14 data was so interesting to me. # FierceASCO",,,# #,4.74616E+17,https://twitter.com/ByJonGardner/status/474615859282202624,,,,
ByJonGardner,6/5/2014 14:16,0,0,$ RHBBY's Herceptin had an $800m downgrade in its 2018 f/c in the last yr. Other BC agents growing. # ASCO14 # FierceASCO,,,# #,4.74616E+17,https://twitter.com/ByJonGardner/status/474615771596070912,,,,
ByJonGardner,6/5/2014 14:16,1,2,EvaluatePharma's top 10 downgrades. # FierceASCO # ASCO14 http://ow.ly/i/5ObHs,,,# #,4.74616E+17,https://twitter.com/ByJonGardner/status/474615658999984128,,,,
ByJonGardner,6/5/2014 14:15,1,1,Yes. Here are our top 10 upgrades in the last yr (top 10 downgrades to follow). # FierceASCO # ASCO14 http://ow.ly/i/5ObEU,,,# #,4.74615E+17,https://twitter.com/ByJonGardner/status/474615468985450497,,,,
FiercePharma,6/5/2014 14:12,0,0,Q5: Are there any oncology drugs for which the consensus views have changed recently? # FierceASCO # ASCO14,,,# #,4.74615E+17,https://twitter.com/FiercePharma/status/474614828984971264,,,,
ByJonGardner,6/5/2014 14:12,0,1,NCI cervical cancer project looking to expand at academic centres. May need more work b4 industry wants to license. * # fierceASCO # ASCO2014,,,# #,4.74615E+17,https://twitter.com/ByJonGardner/status/474614752296321025,,,,
ByJonGardner,6/5/2014 14:11,0,0,# ASCO14 featured an NCI project using adoptive T cells to treat 2nd line HPV-positive cervical cancer. # FierceASCO,,,# #,4.74615E+17,https://twitter.com/ByJonGardner/status/474614609052463104,,,,
FiercePharma,6/5/2014 14:10,0,0,OK. Q4: Were there any earlier stage projects that showed potential? # FierceASCO # ASCO14,,,# #,4.74614E+17,https://twitter.com/FiercePharma/status/474614359176794112,,,,
ByJonGardner,6/5/2014 14:10,0,1,Roche's data in ovarian cancer was described as overwhelming, so you may see upgrades for its PD-L1 project. * # FierceASCO # ASCO2014,,,# #,4.74614E+17,https://twitter.com/ByJonGardner/status/474614222778028033,,,
ByJonGardner,6/5/2014 14:09,0,1,"$ BMY's nivo (no. 1) had a disappointing # ASCO2014 on tox data, I would watch to see if f/c changes in coming months. # FierceASCO",,,# #,4.74614E+17,https://twitter.com/ByJonGardner/status/474614066208837632,,,,
ByJonGardner,6/5/2014 14:09,2,2,"Here are the top 20 pipeline drugs in 2020, from EvaluatePharma’s forecast. # ASCO14 # FierceASCO http://ow.ly/i/5ObnH",,,# #,4.74614E+17,https://twitter.com/ByJonGardner/status/474613958125842432,,,,
ByJonGardner,6/5/2014 14:08,0,0,"There may be some further down the order that change, however. * # FierceASCO # ASCO14",,,# #,4.74614E+17,https://twitter.com/ByJonGardner/status/474613666323914752,,,,
FiercePharma,6/5/2014 14:08,1,0,That's interesting. Q3: How about pipeline drugs? # FierceASCO # ASCO14,,,# #,4.74614E+17,https://twitter.com/FiercePharma/status/474613632459087872,,,,
ByJonGardner,6/5/2014 14:07,0,0,"I can't see any data from # ASCO14 changing forecasts for Avastin, Rituxan or Herceptin, for example. # FierceASCO",,,# #,4.74614E+17,https://twitter.com/ByJonGardner/status/474613518067851264,,,,
ByJonGardner,6/5/2014 14:07,0,0,"Here are the top 20 marketed agents, according to our consensus. # FierceASCO # ASCO14 http://ow.ly/i/5Obg8",,,# #,4.74613E+17,https://twitter.com/ByJonGardner/status/474613370801643520,,,,
medpagetoday,6/5/2014 14:05,0,0,"Orteronel delayed prostate cancer progression, but without survival benefit # ASCO14 http://bit.ly/1umug6g",,,#,4.74613E+17,https://twitter.com/medpagetoday/status/474612875395211264,,,,
FiercePharma,6/5/2014 14:04,0,0,"Q2: Getting to forecasts, EvaluatePharma recently updated its sales numbers to 2020. Will # ASCO14 affect any marketed agents? # FierceASCO",,,# #,4.74613E+17,https://twitter.com/FiercePharma/status/474612772207349760,,,,
ByJonGardner,6/5/2014 14:04,0,0,"$ RHBBY had new data in bladder, $ BMY in ovarian and lung, and $ MRK in head and neck. * # FierceASCO # ASCO14",,,# #,4.74613E+17,https://twitter.com/ByJonGardner/status/474612710605615104,,,,
ByJonGardner,6/5/2014 14:03,0,0,"We had encouraging data from immuno-onc agents working on the PD-1 pathway from $ RHBBY, $ BMY & $ MRK # FierceASCO # ASCO14",,,# #,4.74613E+17,https://twitter.com/ByJonGardner/status/474612551901528064,,,,
Primary_Immune,6/5/2014 14:03,4,4,@ nature/ @ ASCO: 2nd Chance for Drugs That Failed # ClinicalTrial But Worked for Patient Subsets http://www.nature.com/nature/journal/v509/n7502_supp/box/509S55a_BX1.html …pic.twitter.com/L6p1MEIkJj,,@ @,#,4.74613E+17,https://twitter.com/Primary_Immune/status/474612546511437826,,,,
ByJonGardner,6/5/2014 14:03,0,0,The most important finding was that there are signs that immuno-oncology agents work in many more diseases # FierceASCO # ASCO14,,,# #,4.74612E+17,https://twitter.com/ByJonGardner/status/474612437434761216,,,,
drdonsdizon,6/5/2014 14:03,6,1,"Nice touch @ ASCO! We need higher-quality data"" on preventive care for # survivorswithcancer http://bit.ly/1nKUH6g pic.twitter.com/r5XDmWrxyW""",,@,#,4.74612E+17,https://twitter.com/drdonsdizon/status/474612397429514240,,,,
FiercePharma,6/5/2014 14:02,1,0,"OK, let’s get started. Q1: What stands out as the most significant finding at this year’s event & why so? # FierceASCO # ASCO14",,,# #,4.74612E+17,https://twitter.com/FiercePharma/status/474612204155965440,,,,
ByJonGardner,6/5/2014 14:02,0,1,. @ FiercePharma Thank you for having me. The Londoner is checking in from his family's farm in Central Illinois. # FierceASCO # ASCO14,,@,# #,4.74612E+17,https://twitter.com/ByJonGardner/status/474612120194404352,,,,
FiercePharma,6/5/2014 14:01,0,0,@ JonEPVantage brings a wealth of knowledge on the U.S. primary healthcare market and regulatory affairs. # FierceASCO # ASCO14,,@,# #,4.74612E+17,https://twitter.com/FiercePharma/status/474612100015607808,,,,
FiercePharma,6/5/2014 14:01,0,0,@ EPVantage is the editorial arm of @ EvaluatePharma Evaluate is a market intelligence firm focused on the life sciences # FierceASCO # ASCO14,,@ @,# #,4.74612E+17,https://twitter.com/FiercePharma/status/474612031505838080,,,,
CancerResearch,6/5/2014 14:01,0,0,Text JOIN to 80888 to make a $10 donation. # CIM2014 # ASCO14,,,# #,4.74612E+17,https://twitter.com/CancerResearch/status/474611993249579008,,,,
ONAcom,6/5/2014 14:01,0,0,# ASCO14: New drug effective for metastatic # prostatecancer - http://ow.ly/xEYgs # pcsm,,,# # #,4.74612E+17,https://twitter.com/ONAcom/status/474611939356971009,,,,
FiercePharma,6/5/2014 14:00,0,0,So let me welcome our guest tweeter Jon Gardner @ JonEPVantage to the # FierceASCO # ASCO14 tweetchat.,,@,# #,4.74612E+17,https://twitter.com/FiercePharma/status/474611852656525313,,,,
FiercePharma,6/5/2014 14:00,0,0,"Hello, everyone, and welcome to our # FierceASCO chat with @ JonEPVantage, a reporter with @ EPVantage. # ASCO14",,@ @,# #,4.74612E+17,https://twitter.com/FiercePharma/status/474611637509693440,,,,
suvikki12,6/5/2014 13:59,0,0,Writing @ ASCO reviews and trying to narrow down to a couple of key studies/ articles to focus on.What would you pick? # ASCO14,,@,#,4.74612E+17,https://twitter.com/suvikki12/status/474611552369512448,,,,
cancercommons,6/5/2014 13:59,3,0,New hope for a targeted drug for ocular melanoma: http://www.cancercommons.org/2014/06/05/melanoma-of-the-eye-better-diagnostics-and-future-treatments/ … # melanoma # ocularmelanoma # ASCO14,,,# # #,4.74611E+17,https://twitter.com/cancercommons/status/474611479883169793,,,,
damiangarde,6/5/2014 13:57,0,0,Follow @ FiercePharma as @ EricPFierce and @ JonEPVantage wrap # ASCO14. Or tune in here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …,,@ @ @,#,4.74611E+17,https://twitter.com/damiangarde/status/474610986037829632,,,,
montypal,6/5/2014 13:52,0,1,@ ERPlimackMD @ ASCO I agree entirely. Hoping that this data will continue the (slow) trend towards referrals to med onc for neoadjuvant!,,@ @,,4.7461E+17,https://twitter.com/montypal/status/474609814308274177,,,,
cancercommons,6/5/2014 13:48,1,0,"New targeted drug shows promise for treating ALK+ NSCLC patients, w/ or w/o crizotinib resistance: http://www.cancercommons.org/news/xcovery-presents-interim-phase-1-results-of-x-396-in-alk-positive-nsclc-at-the-american-society-for-clinical-oncology-annual-meeting/ … # lcsm # ASCO14",,,# #,4.74609E+17,https://twitter.com/cancercommons/status/474608691862601728,,,,
TuftsB,6/5/2014 13:47,0,0,@ chemosabe1 @ ASCO - hopefully this is a real discussion and not a preconceived insurance - ASCO alliance to deny medical care # mliwi # ASCO,,@ @,# #,4.74608E+17,https://twitter.com/TuftsB/status/474608478938755072,,,,
EPClinicalTrial,6/5/2014 13:39,0,0,"The winners and losers; an # ASCO14 post-mortem, via @ EPVantage http://ow.ly/xFe0W",,@,#,4.74606E+17,https://twitter.com/EPClinicalTrial/status/474606439470993409,,,,
BoschBarrera,6/5/2014 13:37,0,0," @ Roche_spain: eficacia de erlotinib con bevacizumab en cáncer de pulmón EGFR mutado # ASCO14 http://www.efefuturo.com/noticia/una-combinacion-de-dos-farmacos-mas-eficaz-para-un-tipo-de-cancer-de-pulmon/ …""""",,@,#,4.74606E+17,https://twitter.com/BoschBarrera/status/474605940277526529,,,,
JaneyBusby,6/5/2014 13:36,5,4,THIS is the face of a FIERCE FIGHTER @ genentech who NEEDS # ExtendedUse NOW to # kickASPS PLS do an n=1 pic.twitter.com/5t2WATDJKI # ASCO14,,@,# # #,4.74606E+17,https://twitter.com/JaneyBusby/status/474605656771534848,,,,
JaneyBusby,6/5/2014 13:35,0,0,@ 4Nathalie meets criteria 4 # PDL1 # PD1 except 4 age(15-1/2) Read her blog http://kickasps.wordpress.com/its-hard-to-fight-when-the-fight-aint-fair/ … … & FIGHT pic.twitter.com/yKV5pNvvG1 # ASCO14,,@,# # #,4.74605E+17,https://twitter.com/JaneyBusby/status/474605348897050624,,,,
HelpKeepasister,6/5/2014 13:34,0,0,OCNA has posted their review of promising new treatments for ovarian cancer from # ASCO14. My blog post will be coming soon.,,,#,4.74605E+17,https://twitter.com/HelpKeepasister/status/474605238205181952,,,,
JaneyBusby,6/5/2014 13:34,3,3,This sweet teen asks with all her - please @ genentech @ Merck # CompassionateUse for @ 4Nathalie pic.twitter.com/7As4Dy5T0L # ASCO14,,@ @ @,# #,4.74605E+17,https://twitter.com/JaneyBusby/status/474605108282413056,,,,
carisls,6/5/2014 13:26,0,0,Caris # ASCO14 posters are available on our website. Thanks for a great meeting! http://goo.gl/rWvilc # colorectal # Gastric # appendiceal,,,# # # #,4.74603E+17,https://twitter.com/carisls/status/474603149286981632,,,,
CancerTherAdvsr,6/5/2014 13:25,0,0,"RT @ mtmdphd: Internet, Social Media, Privacy Regulations, and Clinical Trials - # ASCO14 @ mtmdphd @ obogler @ rsm2800 @ ASCO Univ...",,@ @ @ @ @,#,4.74603E+17,https://twitter.com/CancerTherAdvsr/status/474602892104847360,,,,
UASDFCS,6/5/2014 13:21,0,0,Revelan resultados positivos en tratamiento para cáncer de piel http://www.noticiassin.com/2014/06/revelan-resultados-positivos-en-tratamiento-para-cancer-de-piel/ … @ ASCO @ US_FDA,,@ @,,4.74602E+17,https://twitter.com/UASDFCS/status/474601949308788736,,,,
infdisease_news,6/5/2014 13:20,1,0,# Hepatitis C Reactivation Does Not Worsen Survival Outcomes for # HIV+ Patients Diagnosed with # Lymphoma @ ASCO http://ow.ly/xDBX2,,@,# # #,4.74602E+17,https://twitter.com/infdisease_news/status/474601625878011904,,,,
urotoday,6/5/2014 13:18,1,1,# ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate ... http://dlvr.it/5tv2sQ,,,#,4.74601E+17,https://twitter.com/urotoday/status/474601070455300097,,,,
myCME,6/5/2014 13:15,0,0,Reduced-dose radiation safe for certain patients with low-risk HPV-positive oropharyngeal cancer http://ow.ly/xAxxJ # ASCO14,,,#,4.746E+17,https://twitter.com/myCME/status/474600378978557953,,,,
OCNA,6/5/2014 13:05,6,2,Read our round-up of some of the most promising and thought-provoking ovarian cancer research from # ASCO14 http://www.ovariancancer.org/2014/06/05/2014-asco-research-round-up/ …,,,#,4.74598E+17,https://twitter.com/OCNA/status/474598016259981312,,,,
FightCRC,6/5/2014 13:02,0,1,"Don't forget - our next Monthly Patient Webinar is June 18, discussing the latest findings from the @ ASCO conference, MARK YOUR CALENDAR.",,@,,4.74597E+17,https://twitter.com/FightCRC/status/474597155865632769,,,,
CancerResearch,6/5/2014 13:01,0,0,Have you been over to our blog lately? New content is up weekly! # CIM2014 # ASCO14 http://ow.ly/xyADm,,,# #,4.74597E+17,https://twitter.com/CancerResearch/status/474596908892438530,,,,
mtmdphd,6/5/2014 12:59,6,4,JUST RELEASED! @ ASCO Research Program Quality Assessment Tool: Basics for a Quality Community-Based Research Site http://ow.ly/xFzTV,,@,,4.74596E+17,https://twitter.com/mtmdphd/status/474596388001837057,,,,
mtmdphd,6/5/2014 12:57,0,0,. @ ASCO Commitees - http://ow.ly/xFz2W,,@,,4.74596E+17,https://twitter.com/mtmdphd/status/474595835402289154,,,,
TargetedOnc,6/5/2014 12:49,1,1,Dr. Flinn from @SarahCannonPR discusses two clinical trials looking at IPI-145 for hematologic malignancies http://www.targetedonc.com/targeted-communications/Two-Ongoing-Clinical-Trials-of-IPI-145-for-Hematologic-Malignancies … # ASCO14,,@SarahCannonPR,#,4.74594E+17,https://twitter.com/TargetedOnc/status/474593923659497472,,,,
AndyBiotech,6/5/2014 12:48,2,5,# ASCO14 Scorecard -> @ JacobEPVantage: The winners and losers: an # ASCO14 post-mortem http://ow.ly/xFe0W pic.twitter.com/5iGEf6Pwqj,,@,# #,4.74594E+17,https://twitter.com/AndyBiotech/status/474593539331215360,,,,
lymphomahub,6/5/2014 12:45,0,0,Be sure to follow # lymphomahub Steering Committee members @MarekTrneny and @ StefanoLuminari! # ASCO14,,@MarekTrneny @,# #,4.74593E+17,https://twitter.com/lymphomahub/status/474592962593435648,,,,
mtmdphd,6/5/2014 12:45,0,1,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.74593E+17,https://twitter.com/mtmdphd/status/474592901717303296,,,,
JaneyBusby,6/5/2014 12:45,2,2,Share the story of a tough teen fighting cancer! @ 4Nathalie needs your help to access meds! # ASCO14 # kickASPSpic.twitter.com/F0gfOSjRwE,,@,# #,4.74593E+17,https://twitter.com/JaneyBusby/status/474592851037155328,,,,
SafeMedicines,6/5/2014 12:44,0,0,@ ASCO Have any data on # FakeDrugs @ TuftsB @scottlags @ CathyWindels want to know if you track fake oncology drugs,,@ @ @scottlags @,#,4.74593E+17,https://twitter.com/SafeMedicines/status/474592610435088385,,,,
carisls,6/5/2014 12:39,1,0,Caris # ASCO14 posters are now available on our website. Thanks for a great meeting! http://goo.gl/rWvilc # Sarcoma # glioma # gyncsm # bcsm,,,# # # # #,4.74591E+17,https://twitter.com/carisls/status/474591273643700224,,,,
roche_es,6/5/2014 12:33,0,0,En @ efefuturo hablan de una combinación de dos fármacos que mostró eficacia en un tipo de cáncer de pulmón # ASCO14 http://www.efefuturo.com/noticia/una-combinacion-de-dos-farmacos-mas-eficaz-para-un-tipo-de-cancer-de-pulmon/ …,,@,#,4.7459E+17,https://twitter.com/roche_es/status/474589870535368704,,,,
TargetedOnc,6/5/2014 12:30,0,1,"David Spigel, MD, from @SarahCannonPR, provides an update on research into MPDL3280A for lung cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Research-into-MPDL3280A-for-the-Treatment-of-Lung-Cancer … # ASCO14",,@SarahCannonPR,#,4.74589E+17,https://twitter.com/TargetedOnc/status/474589185660432384,,,,
nxtstop1,6/5/2014 12:30,0,0,@ ASCO @ mjseres @ chimoose Delighted! You do such a service!,,@ @ @,,4.74589E+17,https://twitter.com/nxtstop1/status/474589123181686784,,,,
CancerTherAdvsr,6/5/2014 12:20,0,0,# ASCO14: # HPV-Targeted Adoptive T-cell Therapy Induces Regression in Metastatic # CervicalCancer http://ow.ly/xF6m8,,,# # #,4.74587E+17,https://twitter.com/CancerTherAdvsr/status/474586576375541761,,,,
ecancer,6/5/2014 12:18,0,0,Dr John Byrd discusses the RESONATE study looking at patients with CLL at # ASCO14 http://ecancer.org/video/2901/ibrutinib-significantly-delays-disease-progression-and-extends-survival-in-resistant-or-relapsed-cll.php …,,,#,4.74586E+17,https://twitter.com/ecancer/status/474586095397912576,,,,
cancercommons,6/5/2014 12:18,0,1,Ipi + nivolumab combo shows promising results for treating patients w/ advanced # melanoma: http://www.cancercommons.org/news/ipilimumab-nivolumab-combination-demonstrated-encouraging-activity-in-advanced-melanoma/ … # immunotherapy # ASCO14,,,# # #,4.74586E+17,https://twitter.com/cancercommons/status/474586042625191936,,,,
chimoose,6/5/2014 12:10,3,1,"For those who asked, the slides I just shared at # Doctors20United against a common enemy: http://slidesha.re/1pTYDi1 # MDigitalLife # ASCO14",,,# # #,4.74584E+17,https://twitter.com/chimoose/status/474583986522816513,,,,
MyelomaTeacher,6/5/2014 12:06,0,0,@ ChrissyCmc I've read about the great results of # SAR650984 coming at of # ASCO14 Glad it's working 4 your hubby! # myeloma,,@,# # #,4.74583E+17,https://twitter.com/MyelomaTeacher/status/474583106888818689,,,,
DrMisialek,6/5/2014 12:06,2,3,Early Palliative Support Services Help Those Caring for Patients with Advanced Cancer @ CancerDartmouth @ ASCO # ASCO14 http://cancer.dartmouth.edu/about_us/newsdetail/70945/#.U5CVSlsCPmM.twitter …,,@ @,# #,4.74583E+17,https://twitter.com/DrMisialek/status/474583026023030784,,,,
UMRogelCancer,6/5/2014 12:05,2,0,Dr. Maha Hussain weighs in on results of # prostatecancer study presented at # ASCO14: http://umhealth.me/1h589yG,,,# #,4.74583E+17,https://twitter.com/UMRogelCancer/status/474582745495371776,,,,
HamiltonCHN,6/5/2014 12:04,0,1,The 2014 MDigitalLIfe Social Oncology Project Report by @ w2ogroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report … via @ SlideShare,,@ @,# #,4.74583E+17,https://twitter.com/HamiltonCHN/status/474582639278432256,,,,
planner_media,6/5/2014 12:02,0,0,RT @ asco: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ symplurpic.twitter.com/1lD0RCCmbh,,@ @,# #,4.74582E+17,https://twitter.com/planner_media/status/474582110993649664,,,,
emilycfreeman,6/5/2014 12:02,0,0,@ subatomicdoc: Early palliative services help caregivers for pts w/advanced cancer http://bit.ly/1owjiHQ > # ASCO14,,@,#,4.74582E+17,https://twitter.com/emilycfreeman/status/474582043272036353,,,,
evaluatepharma,6/5/2014 12:02,0,0,# ASCO14 Event Analyzer – 2014’s winners and losers http://ow.ly/xFkzp,,,#,4.74582E+17,https://twitter.com/evaluatepharma/status/474581989321109504,,,,
CancerResearch,6/5/2014 12:01,3,3,Hashtags to use this June: # CIM2014 for # CancerImmunotherapyMonth! # ASCO14,,,# # #,4.74582E+17,https://twitter.com/CancerResearch/status/474581892881473536,,,,
MedscapeFrance,6/5/2014 12:00,0,0,Mélanome métastatique : la révolution thérapeutique se poursuit # ASCO2014 http://www.medscape.fr/voirarticle/3600669?src=sttwit …,,,#,4.74582E+17,https://twitter.com/MedscapeFrance/status/474581589033119744,,,,
mtmdphd,6/5/2014 12:00,0,0,@ VWadhawan_ERG The crowd was great and really added to the experience but the slides are available via @ ASCO U.,,@ @,,4.74581E+17,https://twitter.com/mtmdphd/status/474581498298122240,,,,
HemOncToday,6/5/2014 12:00,0,0,"# ASCO14 TEXT, SOFT trial results emphasized reduction in # BreastCancer recurrence for exemestane vs. tamoxifen @ umich http://goo.gl/enfFdT",,@,# #,4.74581E+17,https://twitter.com/HemOncToday/status/474581489733357569,,,,
GoHealio,6/5/2014 12:00,0,0,"# ASCO14 TEXT, SOFT trial results emphasized reduction in # BreastCancer recurrence for exemestane vs. tamoxifen @ umich http://goo.gl/enfFdT",,@,# #,4.74581E+17,https://twitter.com/GoHealio/status/474581488923865088,,,,
scimegaresearch,6/5/2014 11:58,0,0,"# ASCO14 Is A Wrap: If Immunothx Is The Queen Of The Ball, Then Panomics Holds Key To Kingdom # oncology # scimega ^RL http://feedly.com/e/J6PQcc1w",,,# # #,4.74581E+17,https://twitter.com/scimegaresearch/status/474581076766380032,,,,
TargetedOnc,6/5/2014 11:55,0,1,Follow-up of nivolumab + ipilimumab presented at # ASCO14 shows unprecedented survival rate in melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Very-Very-Impressive-Results-Seen-With-IpilimumabNivolumab-Combination …,,,#,4.7458E+17,https://twitter.com/TargetedOnc/status/474580285984899072,,,,
mariempowers,6/5/2014 11:51,0,0,"Funny, but true, # ASCO14 musing from @ BioWorld's @ ORandyO: http://bit.ly/1meKisW",,@ @,#,4.74579E+17,https://twitter.com/mariempowers/status/474579233964965889,,,,
XVIVO,6/5/2014 11:50,0,1,Had a great time at @ ASCO this year. Thrilled to see FIVE of our # medicalanimations showcased there!http://www.xvivo.net/blog/archives/annual-american-society-of-clinical-oncology-show-2014/ …,,@,#,4.74579E+17,https://twitter.com/XVIVO/status/474578921590358017,,,,
subatomicdoc,6/5/2014 11:50,2,1,Early palliative services help caregivers for pts w/advanced cancer http://bit.ly/1owjiHQ > @ ScienceDaily @ CancerDartmouth # ASCO14 # hpm,,@ @,# #,4.74579E+17,https://twitter.com/subatomicdoc/status/474578912006377472,,,,
scientre,6/5/2014 11:47,0,0,@ fischmd @ ASCO Agreed - Opportunity knocking!,,@ @,,4.74578E+17,https://twitter.com/scientre/status/474578165567078400,,,,
ONAcom,6/5/2014 11:45,0,0,RT @ ASCO: Understanding colorectal # cancer survivors' needs & preferences for # survivorship info http://bit.ly/1oTf3K0 # crcsm # JOP,,@,# # # #,4.74578E+17,https://twitter.com/ONAcom/status/474577720459145216,,,,
Mel_A_D,6/5/2014 11:44,1,0,Improving Colorectal Cancer Screening in African Americans http://bit.ly/UeY5cH # ASCO14 @ TJUHospital @ KimmelCancerCtr @ EinsteinHealth,,@ @ @,#,4.74577E+17,https://twitter.com/Mel_A_D/status/474577441697304577,,,,
ASCO,6/5/2014 11:40,2,1,Illumination to Innovation: Transforming Data into Learning http://bit.ly/1n9s6nM @ YupOnc blog # ASCO14,,@,#,4.74576E+17,https://twitter.com/ASCO/status/474576471991013376,,,,
lenstarnes,6/5/2014 11:37,1,5,@RazorfishHW SoMe in HC always stopped by regulatory...not necessarily. Check out @ Roche @ Boehringer + many others at # ASCO14 # doctors20,,@RazorfishHW @ @,# #,4.74576E+17,https://twitter.com/lenstarnes/status/474575651110793217,,,,
jrgralow,6/5/2014 11:36,2,2,Nice article from @elaineshattner: Revisiting # ASCO14 & Considering the Future of Cancer Science & Care http://onforb.es/1x19RWM via @ forbes,,@elaineshattner @,#,4.74575E+17,https://twitter.com/jrgralow/status/474575411704107010,,,,
power4patients,6/5/2014 11:31,0,0,http://ow.ly/xEjXJ Carol Preston interviews physician experts and patients at # ASCO14,,,#,4.74574E+17,https://twitter.com/power4patients/status/474574130059423744,,,,
UCCancerCenter,6/5/2014 11:26,0,0,"Tara Henderson, MD, MPH: Women who survived a childhood cancer were at elevated risk for breast cancer http://bit.ly/1ulXYs7 # ASCO14",,,#,4.74573E+17,https://twitter.com/UCCancerCenter/status/474572853615296512,,,,
jrgralow,6/5/2014 11:25,2,0,# ASCO14: Higher Breast Ca Risk for Childhood Cancer Survivors (even without radiation) http://www.medpagetoday.com/HematologyOncology/BreastCancer/46162 …,,,#,4.74573E+17,https://twitter.com/jrgralow/status/474572809222356993,,,,
WWFH_WA,6/5/2014 11:25,0,0,RT @KUhlendorf50 years of # cancer research and progress and so much more to come. http://Fromhopetocures.org # ASCO14 http://ow.ly/xsmBC,,@KUhlendorf50,# #,4.74573E+17,https://twitter.com/WWFH_WA/status/474572678071091200,,,,
CancerTherAdvsr,6/5/2014 11:15,0,0,# ASCO14: Ibrutinib 'Effective New Single-agent Therapy' for Relapsed/Refractory CLL # leukemia # lymphoma http://ow.ly/xF6dn,,,# # #,4.7457E+17,https://twitter.com/CancerTherAdvsr/status/474570163493552130,,,,
fischmd,6/5/2014 11:08,0,0,@ scientre Agreed. But hope springs eternal. Looking forward to # CancerLinQ from @ ASCO and various # IBMWatson projects etc. # healthIT,,@ @,# # #,4.74568E+17,https://twitter.com/fischmd/status/474568490146615297,,,,
JacobPlieth,6/5/2014 11:06,5,0,"The winners and losers; an # ASCO14 post-mortem, via @ EPVantage http://ow.ly/xFe0W $ BMY $ CLVS $ TGTX $ NLNK $ MDVN $ INCY $ MRK $ RHHBY",,@,#,4.74568E+17,https://twitter.com/JacobPlieth/status/474568034401931264,,,,
nxtstop1,6/5/2014 11:02,0,0,@ mjseres @ chimoose That's All @ ASCO !! They R amazing!!,,@ @ @,,4.74567E+17,https://twitter.com/nxtstop1/status/474566975692099584,,,,
CancerResearch,6/5/2014 11:02,0,0,An interview with Dr. Jill O'Donnell-Tormey all about # Immunotherapy # ASCO14 http://ow.ly/xyADj,,,# #,4.74567E+17,https://twitter.com/CancerResearch/status/474566894008410112,,,,
ONAcom,6/5/2014 11:02,0,0,# ASCO14: New drug effective for metastatic # prostatecancer - http://ow.ly/xEY7T # pcsm,,,# # #,4.74567E+17,https://twitter.com/ONAcom/status/474566887649865728,,,,
MatthewHSimmons,6/5/2014 10:59,0,0,"Nice from @ obogler: Social Media are Media: if you wouldn’t put it out in a traditional media channel... ""http://ow.ly/xBVuG # ASCO14""",,@,#,4.74566E+17,https://twitter.com/MatthewHSimmons/status/474566101385216000,,,,
TuftsB,6/5/2014 10:53,1,0,@ VOInnovation @ ASCO @ YaleMed @ MLIWI - from personal exp problem is income loss not care cost. So why ration/stifle innovation? # mliwi # asco,,@ @ @ @,# #,4.74565E+17,https://twitter.com/TuftsB/status/474564765222973440,,,,
AineKyle,6/5/2014 10:50,7,3,Free # ASCO14 white paper discussing activity of anti-PD1 & anti-PDL1 therapies in novel indications: http://goo.gl/BSXWdo @ Datamonitor_HC,,@,#,4.74564E+17,https://twitter.com/AineKyle/status/474563812113518593,,,,
ByJonGardner,6/5/2014 10:45,6,1,"Today at 2pm ET, @ EricPFierce and I will have the final word on # ASCO14 with @ FiercePharma's # FierceASCO tweetchat. Be there!",,@ @,# #,4.74563E+17,https://twitter.com/ByJonGardner/status/474562588916088833,,,,
MaurerStats,6/5/2014 10:44,1,0,MT @ lymphomahub Worth signing up for: lenalidomide+R2CHOP in DLBCL presented by @ GregNowakowski at # ASCO2014 http://ow.ly/xF9ds # lymsm,,@ @,# #,4.74562E+17,https://twitter.com/MaurerStats/status/474562494233473025,,,,
lymphomahub,6/5/2014 10:43,0,0,Sign up for virtual # ASCO2014 and view 'Building up on R-CHOP in DLBCL: Tackling the Microenvironment' http://ow.ly/xF9yI,,,#,4.74562E+17,https://twitter.com/lymphomahub/status/474562246824456192,,,,
lymphomahub,6/5/2014 10:40,0,0,Worth signing up for: lenalidomide + R2CHOP in DLBCL Phase 2 study presented at # ASCO2014 http://ow.ly/xF9ds,,,#,4.74562E+17,https://twitter.com/lymphomahub/status/474561506814992384,,,,
PatCareOnline,6/5/2014 10:39,0,0,RT @ CancerNetwrk Improving Colorectal Cancer Screening in African Americans http://bit.ly/1mblqlz # ASCO14,,@,#,4.74561E+17,https://twitter.com/PatCareOnline/status/474561073602117633,,,,
JacobPlieth,6/5/2014 10:33,0,1,"I just wrote a story about the # ASCO14 risers and fallers, and realised that $ CLVS was the best-performing stock of # ASCO13",,,# #,4.7456E+17,https://twitter.com/JacobPlieth/status/474559710973407232,,,,
MaverickNY,6/5/2014 10:33,0,0,@ ASCO your web content staff are really swift and helpful with queries - thanks so much to Steve!,,@,,4.7456E+17,https://twitter.com/MaverickNY/status/474559696750510080,,,,
VOInnovation,6/5/2014 10:33,0,0,# DYK only 8.6% of # cancer patients struggle financially to access cancer therapies? → http://bit.ly/1ulMrJm @ ASCO @ YaleMed @ MLIWI # MLIWI,,@ @ @,# # #,4.7456E+17,https://twitter.com/VOInnovation/status/474559649476145155,,,,
TargetedOnc,6/5/2014 10:30,0,0,Pembrolizumab (MK-3475) Produces Long-Lasting Responses and Improved OS in Melanoma: http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Pembrolizumab-MK-3475-Continues-to-Deliver-Impressive-Results-in-Melanoma … # ASCO14,,,#,4.74559E+17,https://twitter.com/TargetedOnc/status/474558976781475840,,,,
ElinSilveous,6/5/2014 10:30,0,0,"@ ASCO You're quite welcome. If the upward curve continues to # ASCO15, your reach will be off the chart! Or, the chart will just get BIGGER!",,@,#,4.74559E+17,https://twitter.com/ElinSilveous/status/474558891100213249,,,,
modrnhealthcr,6/5/2014 10:25,2,1,"Algorithm that will help # cancer treatments evaluate treatment benefits will be available in the fall, @ ASCO says",,@,#,4.74558E+17,https://twitter.com/modrnhealthcr/status/474557582603194368,,,,
OncologyCentral,6/5/2014 10:24,0,0,More # ASCO14 news - # survival benefit observed in women with advanced # breastcancer treated with # eribulin http://bit.ly/19MA7os,,,# # # #,4.74557E+17,https://twitter.com/OncologyCentral/status/474557390952865792,,,,
Oncoinfo_it,6/5/2014 10:15,0,0,@ MP_3855 ad # ASCO14 nuova terapia in II linea nel NSCLC #8006^ http://tinyurl.com/m8d34p7 @ MassimoDiMaio75 @ WalceOnlus2006,,@ @ @,# #8006,4.74555E+17,https://twitter.com/Oncoinfo_it/status/474555224384753664,,,,
Boehringer,6/5/2014 10:15,2,0,BLOG POST: The changing face of # lungcancer - from biology of disease to treatment http://bit.ly/1j1RTda # ASCO14,,,# #,4.74555E+17,https://twitter.com/Boehringer/status/474555137525305344,,,,
CancerNetwrk,6/5/2014 10:13,3,0,Thoracic RT Yields Improved Survival in Extensive-Stage SCLC http://bit.ly/1tLhyvL # ASCO14,,,#,4.74555E+17,https://twitter.com/CancerNetwrk/status/474554693717602304,,,,
Oncoinfo_it,6/5/2014 10:12,1,2,# ASCO14 Obesità e carcinoma mammario http://tinyurl.com/lj4mxqm @ barni_sandro @ komenitalia @ EIannelli,,@ @ @,#,4.74554E+17,https://twitter.com/Oncoinfo_it/status/474554327278055425,,,,
ElinSilveous,6/5/2014 10:10,0,0,@ ASCO @ symplur Wow! Significant increase. Nice outreach/buzz. # ASCO14,,@ @,#,4.74554E+17,https://twitter.com/ElinSilveous/status/474553922145632256,,,,
ElinSilveous,6/5/2014 10:09,0,0,“ @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplur pic.twitter.com/Us4shHqKXo”,,@ @,# #,4.74554E+17,https://twitter.com/ElinSilveous/status/474553577726177280,,,,
Oncoinfo_it,6/5/2014 10:08,0,0,"# ASCO14 Un programma telefonico di supporto per caregiver # LBA9513, # LBA 9512 http://tinyurl.com/nywp47m @ WalceOnlus2006 @ CancerCareMASCC",,@ @,# # #,4.74553E+17,https://twitter.com/Oncoinfo_it/status/474553237916614656,,,,
CancerTherAdvsr,6/5/2014 10:05,0,1,# ASCO14: Biomarkers Fail to Predict Platinum Chemo Response in TNBC # breastcancer http://ow.ly/xDfnm,,,# #,4.74553E+17,https://twitter.com/CancerTherAdvsr/status/474552616509530113,,,,
cesif_ES,6/5/2014 10:05,0,0,Cinco días contra el cancer # ASCO # ASCO2014 . Vía @ elmundoes http://ow.ly/xEbEk,,@,# #,4.74553E+17,https://twitter.com/cesif_ES/status/474552587371679744,,,,
Oncoinfo_it,6/5/2014 10:03,3,1,Fertilità e cure oncologiche ad # ASCO14 # LBA505 http://tinyurl.com/qhsz2e9 @ EIannelli @ komenitalia @ favo_it,,@ @ @,# #,4.74552E+17,https://twitter.com/Oncoinfo_it/status/474552029789319168,,,,
LungCancerFaces,6/5/2014 10:02,2,2,# LCSM hits the road: Last week it was @ JFreemanDaily at # ASCO14. This week it's @ findlungcancer at # doctors20. You ladies ROCK!,,@ @,# # #,4.74552E+17,https://twitter.com/LungCancerFaces/status/474551934091665408,,,,
CancerResearch,6/5/2014 10:01,0,0,A new webinar goes live today! Are you registered? # CIM2014 # ASCO14 http://ow.ly/xyADf,,,# #,4.74552E+17,https://twitter.com/CancerResearch/status/474551575034474498,,,,
braincancer_AU,6/5/2014 10:01,0,0,Read our roundup of some of the big news in # braincancer to come out of # ASCO14 http://buff.ly/1pSWTpp # btsm,,,# # #,4.74551E+17,https://twitter.com/braincancer_AU/status/474551462648098816,,,,
RevistaOBI,6/5/2014 9:54,0,0,"La inmunoterapia, foco del debate en @ ASCO, una de las mayores reuniones de # oncología del mundo http://bit.ly/1p9FI34",,@,#,4.7455E+17,https://twitter.com/RevistaOBI/status/474549948969930752,,,,
jdflaysakier,6/5/2014 9:54,6,0,"Pour info j'ai mis sur le blog les points forts de # ASCO14 :immunotherapie cancer du sein, cancer de la prostate, http://www.docteurjd.com",,,#,4.7455E+17,https://twitter.com/jdflaysakier/status/474549930418536448,,,,
DrLen,6/5/2014 9:54,1,1,This sign provided a little humor & some food for thought at # ASCO14. See http://tinyurl.com/ku76ehk for infopic.twitter.com/iEJwj3DltD,,,#,4.7455E+17,https://twitter.com/DrLen/status/474549886625804288,,,,
ChristianeTrue,6/5/2014 9:51,1,0,RT @Datamonitor_JH: @ Datamonitor_HC's # ASCO14 white paper now up for non-subscribers check it out http://goo.gl/BSXWdo # pharma,,@Datamonitor_JH @,# #,4.74549E+17,https://twitter.com/ChristianeTrue/status/474549046838059009,,,,
Medicalfacts,6/5/2014 9:51,1,0,"# ASCO14 highlights maandag, vooral veel immunotherapie bij melanoom - # ASCO14 Maandag op ASCO begon vroeg met een... http://is.gd/4AffMF",,,# #,4.74549E+17,https://twitter.com/Medicalfacts/status/474548953338642433,,,,
DrLen,6/5/2014 9:50,4,0,"# ASCO14 wrap: ImmunoRx was queen of the ball while panomics"" are keys to the kingdom http://tinyurl.com/ku76ehk""",,,#,4.74549E+17,https://twitter.com/DrLen/status/474548754788675584,,,,
AndreasAbt1,6/5/2014 9:45,0,0,"MT Wow! Impacto RRSS...  @ TalentsPharma @ boehringer : Comparing # ASCO13 & # ASCO14 Twitter data https://twitter.com/ASCO/status/47391664832841318/photo/1pic.twitter.com/Nr9wdE079N ” @ Farmaindustria""",,@ @ @,# #,4.74548E+17,https://twitter.com/AndreasAbt1/status/474547536691490816,,,,
TalentsPharma,6/5/2014 9:40,0,0,RT @ boehringer @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (4 days prior to meeting start to last day) @ symplurpic.twitter.com/pHV81FFVqi,,@ @ @,# #,4.74546E+17,https://twitter.com/TalentsPharma/status/474546214059646976,,,,
DrDeborahFisher,6/5/2014 9:40,0,1,"# ASCO14 Similar Survival for First-Line Avastin, Erbitux in # Colorectal # Cancer http://shar.es/P0KQr via @ sharethis",,@,# # #,4.74546E+17,https://twitter.com/DrDeborahFisher/status/474546186251030529,,,,
OvarianCanada,6/5/2014 9:30,0,0,Ovarian cancer research highlights from the American Society of Clinical Oncology annual meeting: http://bit.ly/ascoreportOCC # asco2014,,,#,4.74544E+17,https://twitter.com/OvarianCanada/status/474543877329006593,,,,
DrDeborahFisher,6/5/2014 9:30,0,1,# ASCO14 Maintenance # chemotherapy may be effective for # metastatic # CRC colorectal # cancer http://shar.es/P0y96 via @ sharethis,,@,# # # # #,4.74544E+17,https://twitter.com/DrDeborahFisher/status/474543871074914306,,,,
DrAttai,6/5/2014 9:30,0,2,@ LguzzardiM I meant bias in using SM as trial recruitment / education tool - that's what @ mtmdphd and @ rsm2800 discussed at # ASCO14 # igsjc,,@ @ @,# #,4.74544E+17,https://twitter.com/DrAttai/status/474543733862842368,,,,
DrDeborahFisher,6/5/2014 9:27,0,1,# ASCO14 Higher # breast # cancer risk for childhood cancer survivors http://www.medpagetoday.com/HematologyOncology/BreastCancer/46162?xid=nl_mpt_DHE_2014-06-05 …,,,# # #,4.74543E+17,https://twitter.com/DrDeborahFisher/status/474542986668154880,,,,
Datamonitor_DF,6/5/2014 9:26,4,1,Check out @ Datamonitor_HC's free white paper on # ASCO14 highlights including analysis on $ PCYC's Imbruvica for CLL: http://goo.gl/BSXWdo,,@,#,4.74543E+17,https://twitter.com/Datamonitor_DF/status/474542786541547520,,,,
SWOG,6/5/2014 9:26,0,0,MT @ MyelomaTeacher: # SWOGonc Ph I/II study of optimal induction 4 ND HRMM # mmsm # myeloma # ASCO14 http://abstracts.asco.org/144/AbstView_144_126521.html …,,@,# # # #,4.74543E+17,https://twitter.com/SWOG/status/474542715846135808,,,,
xavigranda,6/5/2014 9:25,0,0,Resumen de # ASCO14: Cinco días contra el cáncer http://www.elmundo.es/salud/2014/06/05/538f440922601def178b4571.html?cid=SMBOSO25301&s_kw=twitter …,,,#,4.74543E+17,https://twitter.com/xavigranda/status/474542571193004032,,,,
AdamsLisa,6/5/2014 9:21,2,2,Hope those at @ ASCO will not think ER+ metastatic breast cancer figured out. Mutations make some(like me) immune to trad AI therapy # ASCO14,,@,#,4.74542E+17,https://twitter.com/AdamsLisa/status/474541556247326720,,,,
mtmdphd,6/5/2014 9:20,8,6,"Internet, Social Media, Privacy Regulations, and Clinical Trials - # ASCO14 @ mtmdphd @ obogler @ rsm2800 @ ASCO Univ http://ow.ly/xEy8f",,@ @ @ @,#,4.74541E+17,https://twitter.com/mtmdphd/status/474541221244055552,,,,
nocopas,6/5/2014 9:17,0,1,. # ASCO14 Only 8.6% of patients feel cancer has caused financial burdens. http://jop.ascopubs.org/content/early/2014/05/27/JOP.2013.001322.abstract#JOP … client,,,# #JOP,4.74541E+17,https://twitter.com/nocopas/status/474540634347298816,,,,
Joe_Hedden,6/5/2014 9:17,2,0,@ Datamonitor_HC's # ASCO14 white paper now up for non-subscribers check it out http://goo.gl/BSXWdo # pharma,,@,# #,4.74541E+17,https://twitter.com/Joe_Hedden/status/474540610683432960,,,,
Oncoinfo_it,6/5/2014 9:16,0,1,Grazie @ PAscierto per l'autorevole overview sul melanoma! http://tinyurl.com/k8euylk # ASCO14,,@,#,4.7454E+17,https://twitter.com/Oncoinfo_it/status/474540231811948544,,,,
renalandurology,6/5/2014 9:12,0,0,Long-Term Testosterone Therapy Does Not Raise PCa Risk. http://www.renalandurologynews.com/long-term-testosterone-therapy-does-not-raise-pca-risk/article/351136/ … # ASCO14 # prostatecancer,,,# #,4.74539E+17,https://twitter.com/renalandurology/status/474539291591598080,,,,
CancerTherAdvsr,6/5/2014 9:10,0,0,Name your top 5 studies from # ASCO14 and share them with us!,,,#,4.74539E+17,https://twitter.com/CancerTherAdvsr/status/474538812295507970,,,,
carisls,6/5/2014 9:10,4,3,"Groundbreaking Caris Registry data at # ASCO14, showing great improvement in survival in ovarian cancer patients http://goo.gl/ityr1e",,,#,4.74539E+17,https://twitter.com/carisls/status/474538683035422721,,,,
SassyCell,6/5/2014 9:08,2,3,Dr Allison on Checkpoint Blockade + Oncolytic Virus http://shar.es/P0lrv @ MDAndersonNews @ CancerResearch # immunotherapy # ASCO14,,@ @,# #,4.74538E+17,https://twitter.com/SassyCell/status/474538344756424704,,,,
HealioDerm,6/5/2014 9:05,0,1,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5RX,,@,#,4.74538E+17,https://twitter.com/HealioDerm/status/474537551160967168,,,,
TargetedOnc,6/5/2014 9:05,1,1,Analysis of phase III study presented at # ASCO14: Adjuvant Ipilimumab Improves RFS by 25% in Stage III Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Adjuvant-Ipilimumab-Improves-RFS-by-25-in-Stage-III-Melanoma …,,,#,4.74537E+17,https://twitter.com/TargetedOnc/status/474537498673430528,,,,
DrAttai,6/5/2014 9:02,3,4,"@ LguzzardiM although @ mtmdphd and @ rsm2800 gave great SM / research talk at # ASCO14 - lots if pitfalls, pot to introduce bias # igsjc",,@ @ @,# #,4.74537E+17,https://twitter.com/DrAttai/status/474536776082538498,,,,
mtmdphd,6/5/2014 9:02,0,0,RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplur,,@ @,# #,4.74537E+17,https://twitter.com/mtmdphd/status/474536694520483840,,,,
CarlyHFierce,6/5/2014 8:56,0,0,# ICYMI: Amgen to pursue T-Vec approval despite PhIII survival miss http://bit.ly/1oYJvCE $ AMGN # pharma # ASCO14,,,# # #,4.74535E+17,https://twitter.com/CarlyHFierce/status/474535145320747008,,,,
canceropole,6/5/2014 8:55,4,0,Vous n'avez pas pu vous rendre à l' # ASCO14 ? Retrouvez les vidéos de toutes les sessions en ligne http://ow.ly/xEgka,,,#,4.74535E+17,https://twitter.com/canceropole/status/474534935475519488,,,,
ONAcom,6/5/2014 8:55,0,0,RT @ ASCO: Momentum to establish cancer survivor programs increasing as cancer survivor population grows http://bit.ly/1hW1a6p # ASCO14,,@,#,4.74535E+17,https://twitter.com/ONAcom/status/474534933038637056,,,,
CancerDartmouth,6/5/2014 8:54,1,1,# ASCO14 offered compelling spectrum of finds w/ implications for most every form of solid tumor http://onforb.es/1x19RWM HT @ ElaineSchattner,,@,#,4.74535E+17,https://twitter.com/CancerDartmouth/status/474534608273305601,,,,
DrGlenWeiss,6/5/2014 8:51,0,0,This is no surprise based on the earlier phase studies... # ASCO: MET-Targeted Drug Flops http://www.medpagetoday.com/MeetingCoverage/ASCO/46158 … # lcsm @ cancercenter @ asco,,@ @,# #,4.74534E+17,https://twitter.com/DrGlenWeiss/status/474534035348127746,,,,
dhovekamp42,6/5/2014 8:48,0,0,$ AZN # MedImmune data support rapid progression to Phase III development for # MEDI4736 (PD-L1) # immunotherapy # ASCO14 http://www.marketwatch.com/story/astrazenecas-medimmune-presents-encouraging-immunotherapy-data-at-asco-2014-2014-06-03 …,,,# # # #,4.74533E+17,https://twitter.com/dhovekamp42/status/474533294961598464,,,,
DrMarkham,6/5/2014 8:46,0,0,:) RT @ DrLen: The smile from # ASCO14 that says so much about cancer research & cancer care--and why we do what we do http://tinyurl.com/ku6au99,,@,#,4.74533E+17,https://twitter.com/DrMarkham/status/474532589517426688,,,,
EmmaPettengale,6/5/2014 8:39,0,1,Results from Phase 1 trial of OMP-54F28 targeting # cancer # stemcells show generally well tolerated # ASCO14,,,# # #,4.74531E+17,https://twitter.com/EmmaPettengale/status/474530962966335488,,,,
SAKK_ch,6/5/2014 8:35,0,0,Neue Behandlungsmöglichkeit für junge Frauen mit hormonempfindlichem Brustkrebs: IBCSG präsentiert Ergebnisse @ ASCO http://bit.ly/1p9sPpA,,@,,4.7453E+17,https://twitter.com/SAKK_ch/status/474529999744417792,,,,
power4patients,6/5/2014 8:35,0,0,http://ow.ly/xEjO9 Carol Preston interviews physician experts and patients at # ASCO14,,,#,4.7453E+17,https://twitter.com/power4patients/status/474529891208417281,,,,
aicrtweets,6/5/2014 8:34,2,0,MT @ KarenCollinsRD: MT @ ClevelandClinic: Obesity on its way to replacing tobacco as #1 prev/modifiable causeof cancer @ CliffordHudis # ASCO14,,@ @ @,#1 #,4.7453E+17,https://twitter.com/aicrtweets/status/474529770076930048,,,,
DrAttai,6/5/2014 8:31,0,0,@ Hawleysaraht @ AmaliaCochranMD yes several SM sessions at # ASCO14 also @ ASBrS and @ SocSurgOnc - great start # igsjc,,@ @ @ @,# #,4.74529E+17,https://twitter.com/DrAttai/status/474528949196685312,,,,
damiangarde,6/5/2014 8:28,0,0,Reminder that @ EricPFierce and @ JonEPVantage will join forces at 2 p.m. ET to tie a bow on # ASCO14. Follow here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …,,@ @,#,4.74528E+17,https://twitter.com/damiangarde/status/474528284026634240,,,,
drdonsdizon,6/5/2014 8:28,4,2,"GR8 article by @ ElaineSchattner in @ Forbes on # ASCO14. Big picture issues, expressed easily. http://www.forbes.com/sites/elaineschattner/2014/06/03/revisiting-asco-and-considering-the-future-of-cancer-science-and-care/ …",,@ @,#,4.74528E+17,https://twitter.com/drdonsdizon/status/474528229630676992,,,,
rbsalute,6/5/2014 8:26,0,0,# ASCO14 ultime novità contro Nsclc e altri tumori http://www.doctor33.it/congresso-asco-ultime-novita-contro-nsclc-e-altri-tumori/ricerca/news--24467.html#.U5Bh59O9syo.twitter …,,,# #,4.74528E+17,https://twitter.com/rbsalute/status/474527729090441219,,,,
TargetedOnc,6/5/2014 8:20,3,1,HPV-Targeting Immunotherapy Demonstrates Activity in Cervical Cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Immunotherapy-Targeting-HPV-Demonstrates-Activity-in-Cervical-Cancer … # ASCO14,,,#,4.74526E+17,https://twitter.com/TargetedOnc/status/474526210358542336,,,,
Hawleysaraht,6/5/2014 8:17,1,1,@ AmaliaCochranMD @ DrAttai sessions at professional meetings one way. good SM session at # ASCO2014 this year # igsjc,,@ @,# #,4.74525E+17,https://twitter.com/Hawleysaraht/status/474525497355816960,,,,
GustaveRoussy,6/5/2014 8:03,2,1,"# ASCO14 Bilan du congrès @ ASCO par le Pr Alexander Eggermont, directeur général de @ GustaveRoussy https://vimeo.com/97325451",,@ @,#,4.74522E+17,https://twitter.com/GustaveRoussy/status/474521878590418944,,,,
DesanctisJuan,6/5/2014 8:00,0,0,La obesidad es factor de riesgo importante en el desarrollo de cáncer. Congreso de oncología USA # ASCO14,,,#,4.74521E+17,https://twitter.com/DesanctisJuan/status/474521056762658816,,,,
AaronCohenGadol,6/5/2014 7:50,1,1,Announced @ # ASCO14 : Test to begin this fall of Yervoy and nivolumab for glioblastomas by @ NRGOncology http://ow.ly/xCzGx # BTSM,,@ @,# #,4.74519E+17,https://twitter.com/AaronCohenGadol/status/474518520555114496,,,,
jgjassolabelm,6/5/2014 7:49,0,1,@ ASCO bravo & go on read our blog we are preparing a programme for hope oncology …http://lblm-assoinfopresse-interpanorama.blogspot.fr/,,@,,4.74518E+17,https://twitter.com/jgjassolabelm/status/474518440620072960,,,,
BioSequence,6/5/2014 7:31,0,0,Nueva terapia dirigida prometedora para # cáncer de vejiga http://bit.ly/1he5faZ # ASCO14,,,# #,4.74514E+17,https://twitter.com/BioSequence/status/474513820988502017,,,,
LacertaBio,6/5/2014 7:28,3,1,Wow: RT @ Boehringer: RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting... pic.twitter.com/SPujMpfJl9,,@ @,# #,4.74513E+17,https://twitter.com/LacertaBio/status/474513174889517056,,,,
LeemFrance,6/5/2014 7:25,4,2,Approche innovante : la # radiothérapie boostée par des # nanoparticules http://buff.ly/Ubxayy # ASCO2014,,,# # #,4.74512E+17,https://twitter.com/LeemFrance/status/474512206147891200,,,,
FierceBiotech,6/5/2014 7:18,1,1,"Join @ FiercePharma's @ EricPFierce & @ EPVantage's @ JonEPVantage today, 2pm ET for an # ASCO14 chat. Follow # FierceASCO. http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …",,@ @ @ @,# #,4.74511E+17,https://twitter.com/FierceBiotech/status/474510592259395584,,,,
AtriumHealth,6/5/2014 7:14,1,0,What's hot at # ASCO14 - Day 3 Coverage - http://bit.ly/1ujsSS6,,,#,4.74509E+17,https://twitter.com/AtriumHealth/status/474509436426280960,,,,
thinkemotive,6/5/2014 7:13,0,0,# ASCO14 Through The Eyes of The World’s Physicians http://bit.ly/1pHDZV9 Check This # Infographic for More Insights http://bit.ly/1jQdHYM,,,# #,4.74509E+17,https://twitter.com/thinkemotive/status/474509222869475328,,,,
lynnvos,6/5/2014 7:02,1,0,"“ @ Boehringer: RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data via @ symplur pic.twitter.com/C4UwVgHTDl” doubled but still low, @ lynnvos",,@ @ @ @,# #,4.74506E+17,https://twitter.com/lynnvos/status/474506481753423872,,,,
ecancer,6/5/2014 6:51,1,0,A review of data on mantle cell # lymphoma: @ ProfMcVie interviews Prof Cavalli at # ASCO14 http://ecancer.org/video/2881/mantle-cell-lymphoma--a-review-of-data-and-expert-opinion-from-asco-2014.php …,,@,# #,4.74504E+17,https://twitter.com/ecancer/status/474503777526226945,,,,
AndyBiotech,6/5/2014 6:49,0,2,@ JacobEPVantage @ biosimilarz @ ScripMandy @ Datamonitor_HC Roche's mkt cap has also gained ~$4.6bn since # ASCO14 abstract release,,@ @ @ @,#,4.74503E+17,https://twitter.com/AndyBiotech/status/474503206769557504,,,,
PhysiciansMoney,6/5/2014 6:40,0,0,Companies that made waves at # ASCO14 and could be good stock picks: http://ow.ly/xC9Eg,,,#,4.74501E+17,https://twitter.com/PhysiciansMoney/status/474500939429453824,,,,
Boehringer,6/5/2014 6:39,8,5,RT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ symplurpic.twitter.com/zOGMsGhSpr,,@ @,# #,4.74501E+17,https://twitter.com/Boehringer/status/474500721199816704,,,,
OncLive,6/5/2014 6:25,4,0,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xDxo6 # ASCO14,,,#,4.74497E+17,https://twitter.com/OncLive/status/474497128912674816,,,,
Boehringer,6/5/2014 6:09,69,202,"New LUX Data announced at # ASCO14, join a discussion with Profs Yang & Schuler on 11June. For nonUS/UK HCPs. https://bi-asco.meddigital.com/",,,#,4.74493E+17,https://twitter.com/Boehringer/status/474493289832656896,,,,
TransgeneSA,6/5/2014 6:05,5,0,Données encourageantes à l' # ASCO14 pour les produits Transgene : succès cliniques en # immunothérapie http://ow.ly/xBqv8 # biotech # cancer,,,# # # #,4.74492E+17,https://twitter.com/TransgeneSA/status/474492116685844480,,,,
drdonsdizon,6/5/2014 6:04,1,3,MT @ Globeathon optimism that immunotherapy may play a role for cervical cancer RT @ gyncsm: news from # ASCO14 http://bit.ly/1ujYCXd,,@ @,#,4.74492E+17,https://twitter.com/drdonsdizon/status/474491852344033280,,,,
abcdiagnosis,6/5/2014 6:02,0,1,# BreastCancer Treatments: When Less May Be More http://blog.dslrf.org/?p=2042 MT @ DrSusanLove # ASCO14,,@,# #,4.74492E+17,https://twitter.com/abcdiagnosis/status/474491538329063424,,,,
SeqComplete,6/5/2014 6:01,0,0,buzzz at # ASCO14 http://tweetedtimes.com/search/%23ASCO14/en …,,,#,4.74491E+17,https://twitter.com/SeqComplete/status/474491095469264896,,,,
cancer_beauty,6/5/2014 5:53,1,0,@ Roche_spain: La prometedora alternativa a los tratamientos tradicionales contra el cáncer: # ASCO14@elmundo_es http://www.elmundo.es/elmundosalud/documentos/2014/05/inmunoterapia/inmunoterapia.html …,,@ @elmundo_es,#,4.74489E+17,https://twitter.com/cancer_beauty/status/474489294753923072,,,,
canceropole,6/5/2014 5:45,0,0,Le congrès de l' # ASCO14 s'est intéressé aux innovations thérapeutiques mais aussi aux patients et leur qualité de vie http://ow.ly/xEhAX,,,#,4.74487E+17,https://twitter.com/canceropole/status/474487052218929152,,,,
fundacionsi,6/5/2014 5:32,4,1,"Congreso @ ASCO : la inmunoterapia y los tratamientos combinados y personalizados,principal esperanza frente al cáncer http://www.elmundo.es/salud/2014/06/05/538f440922601def178b4571.html …",,@,,4.74484E+17,https://twitter.com/fundacionsi/status/474483832234979328,,,,
DasLebenshaus,6/5/2014 5:30,1,1,# ASCO14: Results of phase I study of nivolumab+ipilimumab in mRCC promising. http://bit.ly/1jTU16i # kidneycancer # IKCC via @ daslebenshaus,,@,# # #,4.74483E+17,https://twitter.com/DasLebenshaus/status/474483279047835648,,,,
redaccionmedica,6/5/2014 5:27,1,0,"Industria | Combinar cobimetinib y Zelboraf,de @ Roche_spain , permite detener el melanoma durante más de un año http://www.redaccionmedica.com/secciones/industria/combinar-cobimetinib-y-zelboraf-de-roche-permite-detener-el-melanoma-avanzado-durante-mas-de-un-ano-8013 … @ ASCO",,@ @,,4.74483E+17,https://twitter.com/redaccionmedica/status/474482680483291136,,,,
nxtstop1,6/5/2014 5:21,2,1,GLOBAL ASCO. MT @ LizzieMEvans: # MDigitalLife's data set of Non US physicians used # ASCO14 post; # Doctors20 in Paris! http://bit.ly/S5iXRD ”,,@,# # #,4.74481E+17,https://twitter.com/nxtstop1/status/474481108881391616,,,,
power4patients,6/5/2014 5:19,0,0,http://ow.ly/xEjVv Carol Preston interviews physician experts and patients at # ASCO14,,,#,4.74481E+17,https://twitter.com/power4patients/status/474480710699741184,,,,
JacobPlieth,6/5/2014 5:16,4,4,Since # ASCO14 abstracts went live $ BMY has lost $7.6bn of mkt cap. $ MRK has gained $4.6bn. I'd argue the needle moved a bit @ ScripMandy,,@,#,4.7448E+17,https://twitter.com/JacobPlieth/status/474479891489247232,,,,
Oncopraktijk,6/5/2014 5:05,1,0,50 jaar Innovatie in oncologie # ASCO14 | MedicalFacts http://www.medicalfacts.nl/2014/06/04/50-jaar-innovatie-in-oncologie-asco14/ … via @ MedicalFacts,,@,#,4.74477E+17,https://twitter.com/Oncopraktijk/status/474477049537515520,,,,
Clover_Acceso,6/5/2014 4:26,0,0,Cinco días contra el cáncer http://www.elmundo.es/salud/2014/06/05/538f440922601def178b4571.html?cid=SMBOSO25301&s_kw=twitter … vía @ elmundoes # ASCO14 # Inmunoterapia,,@,# #,4.74467E+17,https://twitter.com/Clover_Acceso/status/474467395902242816,,,,
HollieMatthews,6/5/2014 4:24,1,2,# MDigitalLife new data set of Ex-US physicians was used on this # ASCO14 post; to be announced at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74467E+17,https://twitter.com/HollieMatthews/status/474466776667787264,,,,
oncobretagne,6/5/2014 4:16,0,0,"# ASCO2014 Prostate, poumons, mélanome : les grandes avancées thérapeutiques présentées à Chicago http://www.hopital.fr/Hopitaux/Actualites/Actualites-medicales/Prostate-poumons-melanome-les-grandes-avancees-therapeutiques-presentees-a-Chicago …",,,#,4.74465E+17,https://twitter.com/oncobretagne/status/474464779143503872,,,,
oncobretagne,6/5/2014 4:15,0,0,# Cancer # ASCO2014 retrouvez les notes du Docteur JD http://www.docteurjd.com/,,,# #,4.74465E+17,https://twitter.com/oncobretagne/status/474464591624552448,,,,
networkpharma,6/5/2014 4:13,0,0,THIS >> Infographic: Insights from # ASCO14 at http://bit.ly/1mVIfvp # medcomms,,,# #,4.74464E+17,https://twitter.com/networkpharma/status/474463979512025088,,,,
teamoncology,6/5/2014 4:10,0,0,True RT @ ASCO Momentum to establish cancer survivor programs increasing as cancer survivor population grows http://bit.ly/1hW1a6p # ASCO14,,@,#,4.74463E+17,https://twitter.com/teamoncology/status/474463315243331584,,,,
teamoncology,6/5/2014 4:10,0,0,Nice. RT @ DrLen My favorite slide from # ASCO14: a 96yo w/head & neck ca who responded 2 MEDI4736. Note the smile! http://j.mp/1oebPPv,,@,#,4.74463E+17,https://twitter.com/teamoncology/status/474463185031147520,,,,
ecancer,6/5/2014 4:03,2,1,PD-1 targeting antibody shows long term responses in metastatic # melanoma patients http://ecancer.org/news/5737-asco-2014--pd-1-targeting-immunotherapy-mk-3475-has-high-and-long-lasting-activity-against-metastatic-melanoma.php … # ASCO14,,,# #,4.74462E+17,https://twitter.com/ecancer/status/474461546454974464,,,,
PPPResearch,6/5/2014 3:58,0,0,"Lets do this for # BIO2014,too.RT @StephenHDunn: We've reached the digital tipping point: # Infographic: social media insights from # ASCO14...",,@StephenHDunn,# # #,4.7446E+17,https://twitter.com/PPPResearch/status/474460343738318848,,,,
US_CCS,6/5/2014 3:51,0,1,Follow-up of Concurrent Immunotherapies Shows Unprecedented Survival Rate in Melanoma http://ow.ly/xEb6y # ASCO14,,,#,4.74459E+17,https://twitter.com/US_CCS/status/474458526690316288,,,,
LSVCo,6/5/2014 3:51,0,0,Follow-up of Concurrent Immunotherapies Shows Unprecedented Survival Rate in Melanoma http://ow.ly/xEb6v # ASCO14,,,#,4.74459E+17,https://twitter.com/LSVCo/status/474458526040219648,,,,
Medicalfacts,6/5/2014 3:50,0,0,# ASCO14 Beter effect van afatinib* dan van vergelijkende chemotherapie bij patiënten met EGFR-mutatiepositieve... http://is.gd/O9sELW,,,#,4.74458E+17,https://twitter.com/Medicalfacts/status/474458326714286080,,,,
nkysmr,6/5/2014 3:50,3,0,日本ではまだタバコの問題も根強いと感じています。 RT @ teamoncology: 【 # ASCO14 Update】米国臨床腫瘍学会は、肥満を次世代のタバコとして捉える見解を会長が述べた。肥満の方々、肥満は単に高血圧とかの問題ではありません。がんになりやすくなります。,,@,#,4.74458E+17,https://twitter.com/nkysmr/status/474458107494428672,,,,
OncLive,6/5/2014 3:20,1,4,Follow-up of Concurrent Immunotherapies Shows Unprecedented Survival Rate in Melanoma http://ow.ly/xDxeB # ASCO14,,,#,4.74451E+17,https://twitter.com/OncLive/status/474450603587158017,,,,
cgil_sv,6/5/2014 2:59,0,0,"Uash!  @ mvsiguiendo Esta historia de # ASCO14 se ha compartido 64.000 veces en el facebook de @ elmundosalud"". http://www.elmundo.es/salud/2014/06/03/538cc4d7268e3e537c8b456d.html … …""",,@ @,#,4.74445E+17,https://twitter.com/cgil_sv/status/474445328163545088,,,,
mvsiguiendo,6/5/2014 2:51,3,2,Esta historia de # ASCO14 se ha compartido 64.000 veces en el facebook de @ elmundosalud. Por si os la habéis perdido: http://www.elmundo.es/salud/2014/06/03/538cc4d7268e3e537c8b456d.html …,,@,#,4.74443E+17,https://twitter.com/mvsiguiendo/status/474443337538490369,,,,
elmundosalud,6/5/2014 2:29,14,3,Por si estos días te has perdido algo de # ASCO14 aquí tienes un completo resumen: http://mun.do/UdMfj4 # Cancerpic.twitter.com/G5hF3agCNa,,,# #,4.74438E+17,https://twitter.com/elmundosalud/status/474437870196101120,,,,
MelanomaAus,6/5/2014 2:28,3,5,New research shows ipilimumab with nivolumab achieves long-term survival in advanced # melanoma. # ASCO14 http://bit.ly/Sw3ESB,,,# #,4.74437E+17,https://twitter.com/MelanomaAus/status/474437468079816704,,,,
braincancer_AU,6/5/2014 1:53,1,1,Read our roundup of some of the big news in # braincancer to come out of # ASCO14 http://bit.ly/Sw8DCG # btsm,,,# # #,4.74429E+17,https://twitter.com/braincancer_AU/status/474428768182747136,,,,
MelanomaAus,6/5/2014 1:34,1,2,Dr Georgina Long reported at # ASCO14 results on COMBI-d trial. # melanoma # dabrafenib # trametinib http://bit.ly/1mVh83m,,,# # # #,4.74424E+17,https://twitter.com/MelanomaAus/status/474424014073790465,,,,
salilkallianpur,6/5/2014 0:46,1,0,@ AstraZeneca aims to regain prominence in oncology with a splashy exhibit booth at # ASCO14.Just in case you ask why pharma goes to doc meets,,@,#,4.74412E+17,https://twitter.com/salilkallianpur/status/474411848767258624,,,,
SyneosHealth,6/5/2014 0:45,0,0,. @ EmergentAustin Lots of great studies from of the show! Hope you were able to visit our booth to discuss with our experts # ASCO2014,,@,#,4.74412E+17,https://twitter.com/SyneosHealth/status/474411731226488832,,,,
SBzFR,6/5/2014 0:09,0,2," @ CLebacle : ASCO : survie spectaculaire ds cancer de prostate métastasé | Quotidien du Medecin: http://www.lequotidiendumedecin.fr/specialites/cancerologie/asco-survie-spectaculaire-dans-le-cancer-de-la-prostate-metastase#.U47otNJ7PU0.twitter … # ASCO14"" # urology""",,@,# # #,4.74403E+17,https://twitter.com/SBzFR/status/474402546728308736,,,,
TargetedOnc,6/4/2014 23:30,1,1,The Potentiation of Checkpoint Blockade With Oncolytic Virus: http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/The-Potentiation-of-Checkpoint-Blockade-With-Oncolytic-Virus … # ASCO14,,,#,4.74393E+17,https://twitter.com/TargetedOnc/status/474392770682294273,,,,
OncLive,6/4/2014 23:20,1,1,Dr. John Byrd Discusses Results from the Phase III RESONATE Trial Comparing Ofatumumab with Ibrutinib in CLL http://ow.ly/xDxa4 # ASCO14,,,#,4.7439E+17,https://twitter.com/OncLive/status/474390207606030336,,,,
fischmd,6/4/2014 23:06,2,1,"Duloxetine vs. placebo for tx of aromatase inhibitor associated joint aches in # breastcancer, S1202 http://ow.ly/xDTdd # ASCO14 # SWOGOnc",,,# # #,4.74387E+17,https://twitter.com/fischmd/status/474386873415401472,,,,
tannyruzr,6/4/2014 22:52,0,0,"# ASCO14, el mayor congreso mundial del cáncer, revela nuevos logros en inmunoterapia http://bit.ly/1x0Cqnc",,,#,4.74383E+17,https://twitter.com/tannyruzr/status/474383122508038147,,,,
hayeslat,6/4/2014 22:33,1,0,Key points from discussant after # ASCO14 talk on AYA cancer genetics. @ heycriticalmass @ FoundationATCGpic.twitter.com/rs5Paww610,,@ @,#,4.74379E+17,https://twitter.com/hayeslat/status/474378529816055808,,,,
Globeathon,6/4/2014 22:32,0,1,RT @ OvarianCanada: Missed @ ASCO's annual meeting last weekend? Here are the # ovariancancer highlights: http://bit.ly/1rMVbdC # ASCO14,,@ @,# #,4.74378E+17,https://twitter.com/Globeathon/status/474378116916183040,,,,
emilycfreeman,6/4/2014 22:29,0,0,"Shared Decision-making Ups Clinical Trial Participation, But Few Still Enroll- http://lnkd.in/dHxFQMf # ASCO2014",,,#,4.74377E+17,https://twitter.com/emilycfreeman/status/474377381386260480,,,,
OncLive,6/4/2014 22:25,1,2,Adding Chemo to ADT Confers Dramatic Survival Gains in Prostate Cancer http://ow.ly/xDx54 # ASCO14,,,#,4.74376E+17,https://twitter.com/OncLive/status/474376355619307521,,,,
Globeathon,6/4/2014 22:21,0,0,@ drdonsdizon is optimistic that immunotherapy may play a role for cervical cancer RT @ gyncsm: news from # ASCO14 http://bit.ly/1ujYCXd,,@ @,#,4.74375E+17,https://twitter.com/Globeathon/status/474375359882727425,,,,
TargetedOnc,6/4/2014 22:00,1,0,T-VEC showed promise in combos and utility as a monotherapy in subsets of pts with unresectable melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/T-VEC-Shows-Promise-in-Combinations-and-as-Monotherapy-in-Unresectable-Melanoma … # ASCO14,,,#,4.7437E+17,https://twitter.com/TargetedOnc/status/474370100242702336,,,,
PamyCW,6/4/2014 22:00,0,0,"Day55 # 100happydays -goodbye Chicago, it's been real. 1st # ASCO14 & time w/ the bro @ adampwille Good 2b back in # NYCpic.twitter.com/F6mozIf2Cf",,@,# # #,4.7437E+17,https://twitter.com/PamyCW/status/474370073495621632,,,,
HotelMelanoma,6/4/2014 21:54,0,0,Have any ipi v. interferon trial results been reported at # ASCO2014?,,,#,4.74369E+17,https://twitter.com/HotelMelanoma/status/474368561771999233,,,,
myPathMelanoma,6/4/2014 21:32,1,0,Pivotal clinical validation study of # Myriad myPath # Melanoma test presented at # ASCO2014 http://www.news-medical.net/news/20140602/Pivotal-clinical-validation-study-of-Myriad-myPath-Melanoma-test-presented-at-ASCO-2014.aspx …,,,# # #,4.74363E+17,https://twitter.com/myPathMelanoma/status/474363071108874241,,,,
JediPD,6/4/2014 21:23,0,0,Working on: Immunological dreams at # ASCO14 (Post) Thinking about Checkpoints... What do you think? Any suggestions?,,,#,4.74361E+17,https://twitter.com/JediPD/status/474360928478437376,,,,
OncLive,6/4/2014 21:20,1,2,Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer http://ow.ly/xDwUO # ASCO14,,,#,4.7436E+17,https://twitter.com/OncLive/status/474359961280331776,,,,
AneesChagpar,6/4/2014 21:15,0,0,"Clinical research infrastructure in this country is in grave danger"" @ rschilsky @ ASCO # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/606 …""",,@ @,#,4.74359E+17,https://twitter.com/AneesChagpar/status/474358929611169792,,,,
drdonsdizon,6/4/2014 21:14,0,0,@ AneesChagpar @ ASCO TY anees! Only snippet. :-),,@ @,,4.74358E+17,https://twitter.com/drdonsdizon/status/474358451359842305,,,,
AneesChagpar,6/4/2014 21:12,4,1,"ASCO is an international organization...concerned about controlling cancer worldwide"" @ NagiSaghir @ ASCO # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/602 …""",,@ @,#,4.74358E+17,https://twitter.com/AneesChagpar/status/474358180055494656,,,,
AneesChagpar,6/4/2014 21:10,0,1,@ drdonsdizon Did you see your video on HPV and cervical cancer @ ASCO? # ASCO14 See here: http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/595 …,,@ @,#,4.74358E+17,https://twitter.com/AneesChagpar/status/474357669273149440,,,,
AneesChagpar,6/4/2014 21:09,3,3,"Experts in # bcsm (like @ CliffordHudis, Hortobagyi, Norton & others) share their views on # ASCO14 abstracts @ ASCO http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/615 …",,@ @,# #,4.74357E+17,https://twitter.com/AneesChagpar/status/474357219392114688,,,,
AneesChagpar,6/4/2014 21:04,3,1,Check out Melinda Irwin talking about her studies @ YaleCancer @ YaleSPH presented @ ASCO # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/587 …,,@ @ @,#,4.74356E+17,https://twitter.com/AneesChagpar/status/474356075718664192,,,,
CancerTherAdvsr,6/4/2014 21:00,1,1,Nivolumab + Ipilimumab: 'Unprecedented' Survival Rates in Advanced # Melanoma # ASCO14 # SkinCancer http://ow.ly/xDe14,,,# # #,4.74355E+17,https://twitter.com/CancerTherAdvsr/status/474354990887481346,,,,
MaverickNY,6/4/2014 20:59,0,0,"@ Gene_Antibody @ ASCO @ 3NT that's exactly how it was, especially the hill on the # blisterwalk lol",,@ @ @,#,4.74355E+17,https://twitter.com/MaverickNY/status/474354894913413120,,,,
AneesChagpar,6/4/2014 20:58,1,0,"Check out @ YaleTomLynch @ YaleCancer talking about the REVEL study -- who benefits, at what cost key # ASCO14 @ ASCO http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/567 …",,@ @ @,#,4.74355E+17,https://twitter.com/AneesChagpar/status/474354507703259136,,,,
TargetedOnc,6/4/2014 20:45,2,2,Research into MPDL3280A for the Treatment of Lung Cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Research-into-MPDL3280A-for-the-Treatment-of-Lung-Cancer … # ASCO14,,,#,4.74351E+17,https://twitter.com/TargetedOnc/status/474351238495367168,,,,
drseisenberg,6/4/2014 20:40,2,2,RT @ DrAttai @ obogler raising awareness for male breast cancer via http://thescarproject.org/ # ASCO14,,@ @,#,4.7435E+17,https://twitter.com/drseisenberg/status/474350074550427648,,,,
OncNursingNews,6/4/2014 20:35,0,0,"Once a Year, Cancer Research News Comes in a Flood, Not a Trickle via @ NPRHealth http://ow.ly/xCiWa # ASCO14",,@,#,4.74349E+17,https://twitter.com/OncNursingNews/status/474348652019068928,,,,
WayneKoberstein,6/4/2014 20:31,0,0,"Special shout out, thank you to ASCO's pressroom crew, esp. Aaron Tallent, and all who helped me meet immunoTx experts # ASCO14 @ RfwrightLSL",,@,#,4.74348E+17,https://twitter.com/WayneKoberstein/status/474347811815706624,,,,
bioclinica,6/4/2014 20:30,0,0,What will the future bring for cancer # immunotherapy? http://ow.ly/xznWp # ASCO14 via @ roche,,@,# #,4.74348E+17,https://twitter.com/bioclinica/status/474347568231899138,,,,
OncLive,6/4/2014 20:15,2,0,Novel Rituximab Combinations Highly Effective in CLL http://ow.ly/xDwPB # ASCO14,,,#,4.74344E+17,https://twitter.com/OncLive/status/474343656485584896,,,,
DrMiguelPerales,6/4/2014 20:13,1,1,. @ cells_nnm TILs for cervical cancer is very interesting but think how much can be done with HPV vaccine for prevention # gyncsm # ASCO14,,@,# #,4.74343E+17,https://twitter.com/DrMiguelPerales/status/474343142582259712,,,,
GenomicHealth,6/4/2014 20:10,0,0,Thanks to all who supported us at # ASCO14! We look forward to seeing you again next year.,,,#,4.74343E+17,https://twitter.com/GenomicHealth/status/474342582085234688,,,,
CancerTherAdvsr,6/4/2014 20:01,1,1,# ASCO14: Ramucirumab + Docetaxel Improves Survival in Stage IV NSCLC # lungcancer http://ow.ly/xDdJg,,,# #,4.7434E+17,https://twitter.com/CancerTherAdvsr/status/474340189641654272,,,,
RyanNipp,6/4/2014 19:53,2,2,RT @ rschilsky: DFCI presentations at # ASCO14. http://www.dana-farber.org/Research/ASCO-Annual-Meeting-2014.aspx?track=asco … @ DanaFarber @ ASCO @ OncoBellmunt,,@ @ @ @,#,4.74338E+17,https://twitter.com/RyanNipp/status/474338224677347328,,,,
PhysiciansMoney,6/4/2014 19:50,0,0,3 biotech stocks with growth potential based on their presentations at # ASCO14: http://ow.ly/xC9pB,,,#,4.74337E+17,https://twitter.com/PhysiciansMoney/status/474337365943918592,,,,
TargetedOnc,6/4/2014 19:30,1,2,Ipilimumab + nivolumab showed a 40% objective response rate in 53 pts with adv melanoma and a OS of 80% http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Very-Very-Impressive-Results-Seen-With-IpilimumabNivolumab-Combination … # ASCO14,,,#,4.74332E+17,https://twitter.com/TargetedOnc/status/474332397937627136,,,,
MelanomaAus,6/4/2014 19:30,0,0,"Research results from immunotherapy trials in # melanoma deemed exciting"". http://bbc.in/1uh3yvU # ASCO14""",,,# #,4.74332E+17,https://twitter.com/MelanomaAus/status/474332319168610305,,,,
rschilsky,6/4/2014 19:28,0,0,DFCI presentations at # ASCO14. http://www.dana-farber.org/Research/ASCO-Annual-Meeting-2014.aspx?track=asco …,,,#,4.74332E+17,https://twitter.com/rschilsky/status/474331853218791424,,,,
surgeryceleb,6/4/2014 19:25,2,0,"# parkbom Plastic Surgery – Accused Of Plastic Surgery, Signs Of Being Unwell Was Her Best Defense http://goo.gl/IY0EaL # djka # ASCO14",,,# # #,4.74331E+17,https://twitter.com/surgeryceleb/status/474331170201956352,,,,
MelanomaAus,6/4/2014 19:21,0,0,This week we presented our latest research at # ASCO14 . Here's some of our recent developments in # melanoma research: http://bit.ly/1pSika4,,,# #,4.7433E+17,https://twitter.com/MelanomaAus/status/474330004017254400,,,,
HealioDerm,6/4/2014 19:05,1,2,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5PQ,,@,#,4.74326E+17,https://twitter.com/HealioDerm/status/474326056804302848,,,,
urotoday,6/4/2014 19:03,0,0,# ASCO14 - The site of visceral metastases to predict overall survival in castration-resistant ... http://dlvr.it/5tPCpM,,,#,4.74326E+17,https://twitter.com/urotoday/status/474325651495739393,,,,
bmsnews,6/4/2014 19:01,0,3,Thanks to all # ASCO14 attendees for another great annual meeting!,,,#,4.74325E+17,https://twitter.com/bmsnews/status/474325073613324288,,,,
CancerTherAdvsr,6/4/2014 19:00,0,0,# ASCO14: Genotype-directed Afatinib Ups Overall Survival in Some # LungCancer http://ow.ly/xDdzI,,,# #,4.74325E+17,https://twitter.com/CancerTherAdvsr/status/474324838413533185,,,,
MelanomaAus,6/4/2014 18:47,0,0,Immune therapies for # melanoma: new research using the body's own defences to keep # cancer in check. http://usat.ly/1l4xoAK # ASCO14,,,# # #,4.74321E+17,https://twitter.com/MelanomaAus/status/474321461952675840,,,,
DrAttai,6/4/2014 18:46,0,0,"@ cat_guthrie DM me, happy to discuss, but let me recover from # ASCO14 and # igsjc first!",,@,# #,4.74321E+17,https://twitter.com/DrAttai/status/474321261292965888,,,,
corp_UNC,6/4/2014 18:45,2,0,"Cancer-spec outcomes of young adults w/o insurance Aizer, @ qdtrinh et al http://ow.ly/3llyvI Comment: http://ow.ly/3llyKV via @ ASCO",,@ @,,4.74321E+17,https://twitter.com/corp_UNC/status/474321022339268609,,,,
CancerDotNet,6/4/2014 18:30,2,1,"Catching up on # ASCO14 news? Search using a common disease hashtag to help filter, via Symplur: http://bit.ly/1oGZo0p",,,#,4.74317E+17,https://twitter.com/CancerDotNet/status/474317308652163072,,,,
elaineleung,6/4/2014 18:24,1,0,Reporting bias? RT @ SusanGKomen: Reduced QoL after risk-reducing salpingo-oophorectomy http://bit.ly/1kxSSpT # ASCO14 # gyncsm,,@,# #,4.74316E+17,https://twitter.com/elaineleung/status/474315762212282368,,,,
SusanGKomen,6/4/2014 18:10,3,5,SGK Scholar study proves need to better understand long-term effects of risk-reducing salpingo-oophorectomy http://bit.ly/1kxSSpT # ASCO14,,,#,4.74312E+17,https://twitter.com/SusanGKomen/status/474312194939977728,,,,
TargetedOnc,6/4/2014 18:05,1,0,Adjuvant ipilimumab reduced the relative risk of cancer recurrence by 25% vs placebo in stage III melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Adjuvant-Ipilimumab-Improves-RFS-by-25-in-Stage-III-Melanoma … # ASCO14,,,#,4.74311E+17,https://twitter.com/TargetedOnc/status/474310905959030786,,,,
urotoday,6/4/2014 18:01,0,0,# ASCO14 - Final results of EORTC intergroup randomized phase III trial comparing immediate vs ... http://dlvr.it/5tNCvl,,,#,4.7431E+17,https://twitter.com/urotoday/status/474309970037456898,,,,
ONAcom,6/4/2014 17:50,0,0,RT @ ASCO: “Early Stage Breast Cancer: Can Subtype & Tumor Size Predict Who Benefits from Chemotherapy?” http://bit.ly/1p4atX6 # bcsm # JCO,,@,# #,4.74307E+17,https://twitter.com/ONAcom/status/474307188295753729,,,,
AaronCohenGadol,6/4/2014 17:50,1,1,Announced @ # ASCO14 : Test to begin this fall of Yervoy and nivolumab for glioblastomas by @ NRGOncology http://ow.ly/xCzn2 # BTSM,,@ @,# #,4.74307E+17,https://twitter.com/AaronCohenGadol/status/474307136978034688,,,,
CancerTherAdvsr,6/4/2014 17:45,0,0,Onartuzumab: No Survival Benefits in Advanced # LungCancer # ASCO14 http://ow.ly/xDdh8,,,# #,4.74306E+17,https://twitter.com/CancerTherAdvsr/status/474305914473037824,,,,
whysirsf,6/4/2014 17:45,0,1,# MDigitalLife's new data set of Ex-US MDs was used on this # ASCO14 post; to be announced at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74306E+17,https://twitter.com/whysirsf/status/474305870365343745,,,,
ASCO,6/4/2014 17:41,0,1,Top 3 Most RT'd Tweets from @ CliffordHudis' # ASCO14 Pres Address http://bit.ly/1ktBLp1 http://bit.ly/1ktBLp1 http://bit.ly/1hvByTq,,@,#,4.74305E+17,https://twitter.com/ASCO/status/474304883110473728,,,,
DrTaraSmith,6/4/2014 17:40,0,2,@ OvarianCanada Thanks for the summary of # ASCO14. Great research and so much hope for treating # ovariancancer,,@,# #,4.74305E+17,https://twitter.com/DrTaraSmith/status/474304704378187776,,,,
PresCancerPanel,6/4/2014 17:37,10,4,RT @ rsm2800: Potential for bias in clinical research by patient use of # digital social networking http://1.usa.gov/Su1pz2 # ASCO14,,@,# #,4.74304E+17,https://twitter.com/PresCancerPanel/status/474303844445585408,,,,
salutedomani,6/4/2014 17:35,0,0,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers # ASCO2014 http://lnkd.in/dmXEdGk",,,#,4.74303E+17,https://twitter.com/salutedomani/status/474303386263625728,,,,
TargetedOnc,6/4/2014 17:35,1,0,Cervical cancer pts achieved durable CRs lasting 15-22 mos through an adoptive T-cell therapy targeting HPV http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Immunotherapy-Targeting-HPV-Demonstrates-Activity-in-Cervical-Cancer … # ASCO14,,,#,4.74303E+17,https://twitter.com/TargetedOnc/status/474303374809370624,,,,
teamoncology,6/4/2014 17:34,0,0,"TY!! RT @ knwachter @ teamoncology, you're a star RT @ ASCO: RT'd from @ CliffordHudis' # ASCO14 Pres Address http://bit.ly/1ktBLp1",,@ @ @ @,#,4.74303E+17,https://twitter.com/teamoncology/status/474303269334835200,,,,
AndytweetM,6/4/2014 17:21,0,1,"PI3Ki (BYL719) + MEKi(MEK162) v.active in KRAS mut. Ovarian Ca. 3/4 responses, 4/4 CBR ~ 40 weeks # gyncsm # asco14 pic.twitter.com/2WmQvUzKtf",,,# #,4.743E+17,https://twitter.com/AndytweetM/status/474300016627318784,,,,
CofoMan,6/4/2014 17:21,0,0,To # hcsmeu: take a peek at non-US MDs engagement at # ASCO14 via # MDigitalLife & more to come at # Doctors20 on Sat http://bit.ly/S5iXRD,,,# # # #,4.743E+17,https://twitter.com/CofoMan/status/474299891125342210,,,,
CofoMan,6/4/2014 17:16,0,0,# MDigitalLife's new data set of Ex-US physicians used in this # ASCO14 post; more to come at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74299E+17,https://twitter.com/CofoMan/status/474298772256997376,,,,
Coping_Cancer,6/4/2014 17:14,4,3,"Advances in # breast, # colorectal, and # prostate # cancertreatment presented at the 2014 @ ASCO Annual Meeting: http://www.cancer.net/blog/2014-06/advances-breast-colorectal-and-prostate-cancer-treatment-2014-asco-annual-meeting …",,@,# # # #,4.74298E+17,https://twitter.com/Coping_Cancer/status/474298048085258240,,,,
SarahCannonDocs,6/4/2014 17:08,1,0,VIDEO: # SCRI Dr. Spigel on NSCLC studies at # ASCO14 & current anti-PD-L1 antibody study @ OncLive http://bit.ly/1kDcSru,,@,# #,4.74297E+17,https://twitter.com/SarahCannonDocs/status/474296568372559874,,,,
drdonsdizon,6/4/2014 17:06,0,0,@SHARE @ MBCNbuzz @ MGHCancerCenter # bcsm My interpretation of OPTIMIZE-2 http://www.cancernetwork.com/asco-2014-breast-cancer/less-frequent-zoledronic-acid-ok-breast-cancer-patients-bone-mets … # ASCO14,,@SHARE @ @,# #,4.74296E+17,https://twitter.com/drdonsdizon/status/474296119426441217,,,,
Gene_Antibody,6/4/2014 17:05,2,2,Couldn't make it to @ ASCO? Here's a quick POV on what it was like: http://ow.ly/xDlhu # ASCO14,,@,#,4.74296E+17,https://twitter.com/Gene_Antibody/status/474295796150853633,,,,
TargetedOnc,6/4/2014 17:05,0,0,"Ezra Cohen, MD, from @ UCSDHealth, discusses new data on immunotherapies for head and neck cancers http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/New-Data-on-Immunotherapies-for-Head-and-Neck-Cancers … # ASCO14",,@,#,4.74296E+17,https://twitter.com/TargetedOnc/status/474295792308846592,,,,
wendyselig,6/4/2014 17:04,2,1,The 50th meeting of # asco14 will be remembered as a major inflection point in our fight against # melanoma and other cancers. @ melanomarealli,,@,# #,4.74296E+17,https://twitter.com/wendyselig/status/474295628143812608,,,,
AnnaS_ERG,6/4/2014 17:03,0,0,"IBM’s Watson is an important, but less trendy, discussions taking place at # ASCO14 learn more here http://www.environics.ca/environics-health--pharma-blog … # environicspharma",,,# #,4.74295E+17,https://twitter.com/AnnaS_ERG/status/474295300983914496,,,,
CancerNetwrk,6/4/2014 17:02,0,0,Improving Colorectal Cancer Screening in African Americans http://bit.ly/1mblqlz # ASCO14,,,#,4.74295E+17,https://twitter.com/CancerNetwrk/status/474295107165102080,,,,
drdonsdizon,6/4/2014 17:02,1,2,Thanks for reaching out to me @ annaazvolinsky re: OPTIMIZE-2 trial on ZoledronicAcid. Great piece! # ASCO14 http://www.cancernetwork.com/asco-2014-breast-cancer/less-frequent-zoledronic-acid-ok-breast-cancer-patients-bone-mets …,,@,#,4.74295E+17,https://twitter.com/drdonsdizon/status/474295097308102656,,,,
CancerTherAdvsr,6/4/2014 17:00,0,2,# ASCO14: Apatinib Associated With Improved Survival in Advanced Gastric # Cancer http://ow.ly/xDcOG,,,# #,4.74295E+17,https://twitter.com/CancerTherAdvsr/status/474294589797711872,,,,
BestBreastNews,6/4/2014 17:00,0,0,"RT @ YSCBuzz: 10 Years of Hormones for # breastcancer Cancer, # ASCO14 Says. http://bit.ly/1rM0WZj",,@,# #,4.74295E+17,https://twitter.com/BestBreastNews/status/474294580204957697,,,,
urotoday,6/4/2014 16:59,0,0,# ASCO14 - Association of higher institutional volume with improved overall survival in clinical ... http://dlvr.it/5tMB7j,,,#,4.74294E+17,https://twitter.com/urotoday/status/474294290609213442,,,,
Medicalfacts,6/4/2014 16:50,0,0,"# ASCO14 highlights maandag, vooral veel immunotherapie bij melanoom - # ASCO14 Maandag op ASCO begon vroeg met een... http://is.gd/4AffMF",,,# #,4.74292E+17,https://twitter.com/Medicalfacts/status/474292190353817600,,,,
abbottmd,6/4/2014 16:50,0,0,Chemotherapy for Lung Cancers: Here to Stay | 2014 Educational Book # ASCO14 http://ow.ly/xAFth,,,#,4.74292E+17,https://twitter.com/abbottmd/status/474292085248778240,,,,
ERPlimackMD,6/4/2014 16:44,0,0,@ montypal @ ASCO the place for perioperative chemo is before surgery - neoadjuvant - where there is a clear OS benefit.,,@ @,,4.74291E+17,https://twitter.com/ERPlimackMD/status/474290633582977024,,,,
caitlin_hool,6/4/2014 16:38,0,0,Had such an amazing time at # ASCO14. Especially because MSK's immunotherapy guru @ wolchokj joined Twitter!,,@,#,4.74289E+17,https://twitter.com/caitlin_hool/status/474289002875748352,,,,
sloan_kettering,6/4/2014 16:30,8,7,MSK's immunotherapy expertise has been all over the news this week. Here's a recap: http://bit.ly/1kyoR9i # OnCancer # ASCO14,,,# #,4.74287E+17,https://twitter.com/sloan_kettering/status/474287048300298242,,,,
Jdtay04,6/4/2014 16:29,0,0,"@ fischmd @ ASCO About asking the right question, where might one find trial immunotherapy for 'rare' carcinosarcoma/uterine cancer?",,@ @,,4.74287E+17,https://twitter.com/Jdtay04/status/474286933427101697,,,,
jagasquet,6/4/2014 16:27,0,0,Insights from # ASCO14. @ ASCO # socialmedia http://www.thinkemotive.com/infographic-insights-from-asco14.html …pic.twitter.com/5t22EsfHMe,,@,# #,4.74286E+17,https://twitter.com/jagasquet/status/474286388943544320,,,,
humanimmunenews,6/4/2014 16:25,0,0,New Therapies Harness Power of the # Immune System Against # Cancer @ ASCO http://ow.ly/xCRRD,,@,# #,4.74286E+17,https://twitter.com/humanimmunenews/status/474285762465505280,,,,
NBCCStopBC,6/4/2014 16:22,3,3,Many researchers are looking to the immune system for # breastcancer http://buzz.mw/b0sp1_f # BCD2020 # BCSM # ASCO14,,,# # # #,4.74285E+17,https://twitter.com/NBCCStopBC/status/474284958312579073,,,,
ASCOPost,6/4/2014 16:21,8,2,Adding Docetaxel to ADT Significantly Improves Survival in Hormone-Sensitive Prostate Cancer http://ow.ly/xDiUJ # ASCO14 # pcsm,,,# #,4.74285E+17,https://twitter.com/ASCOPost/status/474284758294614016,,,,
ASCOPost,6/4/2014 16:20,5,2,Adding Lapatinib to Adjuvant Trastuzumab Does Not Improve Outcomes in Early-Stage HER2+ Breast Cancer http://ow.ly/xDiPk # ASCO14 # bcsm,,,# #,4.74285E+17,https://twitter.com/ASCOPost/status/474284537829425154,,,,
thermofisher,6/4/2014 16:15,2,0,"And if you follow meetings like # ESHG14 or # ASCO14 on twitter, what content do you want to see from us?",,,# #,4.74283E+17,https://twitter.com/thermofisher/status/474283311465242624,,,,
CancerTherAdvsr,6/4/2014 16:15,0,0,# ASCO14: Adjuvant Ipilimumab 'Promising' Against # Melanoma Recurrence # skincancer http://ow.ly/xDcJe,,,# # #,4.74283E+17,https://twitter.com/CancerTherAdvsr/status/474283210965516288,,,,
OncTimes_AsstEd,6/4/2014 16:14,0,0,And the HOT topic from # ASCO14 was... VOTE NOW! http://journals.lww.com/oncology-times/pages/Quick-Poll.aspx …,,,#,4.74283E+17,https://twitter.com/OncTimes_AsstEd/status/474283148717465600,,,,
mtmdphd,6/4/2014 16:14,1,1,Studies show rise in oncology social media ahead of 2014 ASCO event - @ DrJosephKim http://ow.ly/xDi2B # ASCO14,,@,#,4.74283E+17,https://twitter.com/mtmdphd/status/474283108007936000,,,,
smuruguay,6/4/2014 16:13,0,0,"La # inmunoterapia en # # ASCO14 , el reconocido evento de # oncologia",,,# # # #,4.74283E+17,https://twitter.com/smuruguay/status/474282920631623680,,,,
OncTimes_AsstEd,6/4/2014 16:13,1,0,Prostate cancer: Little/no survival benefit 2 immediate ADT after PSA-only relapse # ASCO14 rpt http://journals.lww.com/oncology-times/Fulltext/2014/06100/Prostate_Cancer__No_Benefit_to_Immediate_ADT.4.aspx …,,,#,4.74283E+17,https://twitter.com/OncTimes_AsstEd/status/474282878423945217,,,,
ASCO,6/4/2014 16:10,0,0,Please be counted in our 2014 National Oncology Census. No user ID or password is required http://svy.mk/1o86eJy # ASCO14,,,#,4.74282E+17,https://twitter.com/ASCO/status/474282086426488832,,,,
ventana,6/4/2014 16:05,1,1,# Immunotherapy drugs show promise treating range of cancers http://ow.ly/xxulV @ WSJhealth # ASCO14,,@,# #,4.74281E+17,https://twitter.com/ventana/status/474280804785598464,,,,
TargetedOnc,6/4/2014 16:05,0,2,"James P. Allison, PhD, from @ MDAndersonNews, on the potentiation of checkpoint blockade with oncolytic virus http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/The-Potentiation-of-Checkpoint-Blockade-With-Oncolytic-Virus … # ASCO14",,@,#,4.74281E+17,https://twitter.com/TargetedOnc/status/474280704168443904,,,,
ASCO,6/4/2014 16:01,1,0,"Considering purchasing # ASCO14 Virtual Meeting subscription? Preview content w/Virtual Meeting on Demand"": http://bit.ly/1oKjSW0""",,,#,4.7428E+17,https://twitter.com/ASCO/status/474279840842260480,,,,
ONAcom,6/4/2014 16:01,0,0,# ASCO14: Early # palliative support for family caregivers reduces # depression - read more http://ow.ly/xCkuK,,,# # #,4.7428E+17,https://twitter.com/ONAcom/status/474279762392014848,,,,
RareCancerRF,6/4/2014 15:57,0,1,Really enjoyed meeting @ CureSarcoma at # ASCO14 to discuss solving issues universal to the entire rare cancer community.,,@,#,4.74279E+17,https://twitter.com/RareCancerRF/status/474278752672038912,,,,
MTSLNews,6/4/2014 15:55,0,0,"$ AZN $ BMY $ MRK $ INCY $ PCYC Contrary to most, # ASCO14 seemed to be more biotech than Big Pharma http://bioinvest.com",,,#,4.74278E+17,https://twitter.com/MTSLNews/status/474278349465223169,,,,
Medicalfacts,6/4/2014 15:50,0,0,# ASCO14 Beter effect van afatinib* dan van vergelijkende chemotherapie bij patiënten met EGFR-mutatiepositieve... http://is.gd/O9sELW,,,#,4.74277E+17,https://twitter.com/Medicalfacts/status/474277074564550658,,,,
montypal,6/4/2014 15:50,0,0,@ ASCO I disagreed with the sentiment on stage that more meta-analytic data would be helpful. Will only confuse of adjuvant further!,,@,,4.74277E+17,https://twitter.com/montypal/status/474276976320983040,,,,
DrGlenWeiss,6/4/2014 15:46,0,0,"“ @ fischmd: Boolean querying post @ ASCO mtg: try this, for example--type into the twitter search bar ALK OR EGFR # ASCO14""” neat""",,@ @,#,4.74276E+17,https://twitter.com/DrGlenWeiss/status/474276072876281856,,,,
evaluatepharma,6/4/2014 15:45,0,1,"# ASCO14 – As @ Pharmacyclics stays ahead, sustained response awaited http://ow.ly/xCrG0 $ PCYC # imbruvica",,@,# #,4.74276E+17,https://twitter.com/evaluatepharma/status/474275709507346432,,,,
CancerNetwrk,6/4/2014 15:45,4,0,"Similar Survival for First-Line Avastin, Erbitux in Colorectal Cancer http://bit.ly/1iXKb3W # ASCO14",,,#,4.74276E+17,https://twitter.com/CancerNetwrk/status/474275653995741184,,,,
OMedLive,6/4/2014 15:42,0,0,A great presentation from # ASCO14 about chemotherapy remaining a vital component in treating lung cancer. http://bit.ly/1l6kBhn,,,#,4.74275E+17,https://twitter.com/OMedLive/status/474275012921540608,,,,
lenstarnes,6/4/2014 15:40,0,1,@ escardio Food for # ESCcongress thought?: see @ Boehringer 's social media summary of # ASCO14 http://bit.ly/1m1cLSF,,@ @,# #,4.74275E+17,https://twitter.com/lenstarnes/status/474274623090356224,,,,
mbcalliance,6/4/2014 15:37,0,0,"Webinar w/ Medical oncologist Dr. Dizon on # ASCO14 news relating to # metastatic disease: Th, 6/12, 12:30-1:30 PM ET http://ow.ly/xm0P3",,,# #,4.74274E+17,https://twitter.com/mbcalliance/status/474273760879845376,,,,
DrPaulyDeSantis,6/4/2014 15:37,0,1,"Well my top two # ASCO14 pics both did well, glad I took some profits in both $ CLVS and $ INCY, now down on $ CLVS, still up nicely on $ INCY",,,#,4.74274E+17,https://twitter.com/DrPaulyDeSantis/status/474273751329435648,,,,
lenstarnes,6/4/2014 15:37,0,3,This is good.This is how pharmas can 'add value' MT @ Boehringer SoMe summary # ASCO14 http://bit.ly/1m1cLSF # hcsm # hcsmeu # ePatient,,@,# # # #,4.74274E+17,https://twitter.com/lenstarnes/status/474273725182119937,,,,
NateDahlPharmD,6/4/2014 15:26,1,0,RT @ CancerNetwrk: Drug Combo Improves Quality of Life in Multiple Myeloma Patients http://bit.ly/1nPdTzF # ASCO14,,@,#,4.74271E+17,https://twitter.com/NateDahlPharmD/status/474271071445606401,,,,
micaelacollins,6/4/2014 15:23,0,0,@ PharmacistScott @ CaulfieldTim @ ASCO BUT THE WATER REMEMBERS!!!! Oy vey. This is too nebulous to even qualify as # badscience.,,@ @ @,#,4.7427E+17,https://twitter.com/micaelacollins/status/474270284661268480,,,,
NateDahlPharmD,6/4/2014 15:23,0,0,RT @ HemOncToday: # ASCO14 Intraperitoneal # chemotherapy underused even among patients with ovarian cancer @ DanaFarber http://goo.gl/3nKtgR,,@ @,# #,4.7427E+17,https://twitter.com/NateDahlPharmD/status/474270196165644288,,,,
DanaFarber,6/4/2014 15:20,2,4,DFCI clinicians and researchers discussed their new findings with the media at # ASCO14. http://bit.ly/1x6HlTO pic.twitter.com/WwzZR8ESii,,,#,4.74269E+17,https://twitter.com/DanaFarber/status/474269382504632320,,,,
Perthera,6/4/2014 15:15,0,0,What It Costs to Be an # Oncologist http://ow.ly/xxueQ via @ CancerNetwrk | # ASCO # ASCO14 # paymentreform,,@,# # # #,4.74268E+17,https://twitter.com/Perthera/status/474268249602129920,,,,
maryguiden,6/4/2014 15:13,0,0,RT @ djsampson: Why did this picture mean so much at # ASCO14? Read @ DrLen's new post. http://goo.gl/nO9P8j pic.twitter.com/vBJIV2KOTx,,@ @,#,4.74268E+17,https://twitter.com/maryguiden/status/474267822185779200,,,,
CancerTherAdvsr,6/4/2014 15:12,0,0,# ASCO14: Discontinuing # Statins OK for Terminal # Cancer Patients http://ow.ly/xD9yf,,,# # #,4.74267E+17,https://twitter.com/CancerTherAdvsr/status/474267344920137729,,,,
dermanewsok,6/4/2014 15:11,0,0,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers # ASCO2014 http://bit.ly/1nfMSCc",,,#,4.74267E+17,https://twitter.com/dermanewsok/status/474267102270865408,,,,
antoniocaperna,6/4/2014 15:11,0,0,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers # ASCO2014 http://bit.ly/1nfMSCc",,,#,4.74267E+17,https://twitter.com/antoniocaperna/status/474267102166020096,,,,
salutedomani,6/4/2014 15:11,0,0,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers # ASCO2014 http://bit.ly/1nfMSCc",,,#,4.74267E+17,https://twitter.com/salutedomani/status/474267101268434944,,,,
UASDFCS,6/4/2014 15:09,0,0,"Inmunoterapia vuele a ser protagonista en ASCO, mayor cita oncológica http://z101digital.com/app/article.aspx?id=128357 … @ ASCO @ DanaFarber",,@ @,,4.74267E+17,https://twitter.com/UASDFCS/status/474266816391311360,,,,
djsampson,6/4/2014 15:09,5,1,Why did this picture mean so much at # ASCO14? Read @ DrLen's new post. http://goo.gl/nO9P8j pic.twitter.com/ZKOjVx1drZ,,@,#,4.74267E+17,https://twitter.com/djsampson/status/474266708333445121,,,,
ONAcom,6/4/2014 15:02,0,0,# ASCO14: Ginger extract improves # chemotherapy-induced nausea - http://ow.ly/xzRGy,,,# #,4.74265E+17,https://twitter.com/ONAcom/status/474265070697193472,,,,
CancerResearch,6/4/2014 15:01,0,0,A radio interview with our CEO: what is # immunotherapy? # CIM2014 # ASCO14 http://ow.ly/xyADa,,,# # #,4.74265E+17,https://twitter.com/CancerResearch/status/474264723543064576,,,,
COI_salud,6/4/2014 15:01,0,0,Durante # ASCO14 la inmunoterapia se reafirma como la gran promesa en tratamientos contra el # cáncer,,,# #,4.74265E+17,https://twitter.com/COI_salud/status/474264697328635904,,,,
Salud280,6/4/2014 15:00,0,0,RT @ HGUVALENCIA: Combatir el cáncer desde dentro http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html?cid=SMBOSO25301&s_kw=twitter … vía @ elmundoes @ ASCO,,@ @ @,,4.74264E+17,https://twitter.com/Salud280/status/474264439844519936,,,,
WIOvarianCancer,6/4/2014 15:00,1,0,How a new treatment using a person's immune cells is helping to fight cervical cancer. http://nbcnews.to/1l3TAv0 # cancer # ASCO14,,,# #,4.74264E+17,https://twitter.com/WIOvarianCancer/status/474264379299336194,,,,
IMFmyeloma,6/4/2014 15:00,1,0,Video from the Partners in Progress Award Ceremony at # ASCO14: http://am.asco.org/partners-progress-award-and-lecture …,,,#,4.74264E+17,https://twitter.com/IMFmyeloma/status/474264337054318593,,,,
knwachter,6/4/2014 14:56,0,0,"@ teamoncology, you're a star RT @ ASCO: RT'd from @ CliffordHudis' # ASCO14 Pres Address http://bit.ly/1ktBLp1",,@ @ @,#,4.74264E+17,https://twitter.com/knwachter/status/474263519081533440,,,,
HealioDerm,6/4/2014 14:53,0,1,Ipilimumab nivolumab combination demonstrated encouraging activity in advanced # melanoma @ ASCO Meeting http://ow.ly/xD5Fc,,@,#,4.74263E+17,https://twitter.com/HealioDerm/status/474262671056183297,,,,
_laura_fm,6/4/2014 14:53,0,0,@ PharmacistScott @ ASCO Amazed this gives people CME credits!,,@ @,,4.74263E+17,https://twitter.com/_laura_fm/status/474262596682805248,,,,
AlpineBV_Miller,6/4/2014 14:50,0,0,"@ ASCO @ PDRennert Thanks for the info. Might want to note that on the Poster Not Available"" graphic.""",,@ @,,4.74262E+17,https://twitter.com/AlpineBV_Miller/status/474261903347576833,,,,
HGUVALENCIA,6/4/2014 14:47,0,0,Combatir el cáncer desde dentro http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html?cid=SMBOSO25301&s_kw=twitter … vía @ elmundoes @ ASCO,,@ @,,4.74261E+17,https://twitter.com/HGUVALENCIA/status/474261177573187586,,,,
JeffreyCesari,6/4/2014 14:41,0,1,Good bye # Chicago until next time. Love this town. # travel # usairways # ASCO14 # Shimmer,,,# # # # #,4.7426E+17,https://twitter.com/JeffreyCesari/status/474259625160626176,,,,
TargetedOnc,6/4/2014 14:40,0,0,T-VEC Shows Promise in Combinations and as Monotherapy in Unresectable Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/T-VEC-Shows-Promise-in-Combinations-and-as-Monotherapy-in-Unresectable-Melanoma … # ASCO14,,,#,4.74259E+17,https://twitter.com/TargetedOnc/status/474259321258528768,,,,
KimmelCancerCtr,6/4/2014 14:38,0,0,"RT @ fischmd: # ASCO14 themes: # immunotherapy, value, # obesity, learning healthcare, systems biology, # genomics, # exercise, # PalliativeCare.",,@,# # # # # #,4.74259E+17,https://twitter.com/KimmelCancerCtr/status/474259016890458112,,,,
ONAcom,6/4/2014 14:37,0,0,RT @ ASCO: Missed a session at # ASCO14? Watch it on Virtual Meeting - http://www.asco.org/vm,,@,#,4.74259E+17,https://twitter.com/ONAcom/status/474258672441638912,,,,
TurnaRay,6/4/2014 14:34,0,0,"Latest issue of @ PGxReporter is packed with # ASCO14 coverage on Negative Trials, Targeted Combinations, Avatar Mice, NextGen EGFR inhibitors",,@,#,4.74258E+17,https://twitter.com/TurnaRay/status/474257852895211520,,,,
j_pennett,6/4/2014 14:32,0,1,Excellent update of findings from # ASCO14 at Jeffries conference,,,#,4.74257E+17,https://twitter.com/j_pennett/status/474257285871853568,,,,
BosBizDon,6/4/2014 14:30,0,0,"Despite a flurry of presentations, # ASCO14 resulted in more losers than gainers among local biotechs http://www.bizjournals.com/boston/blog/bioflash/2014/06/oncology-conference-results-in-more-losers-than.html …",,,#,4.74257E+17,https://twitter.com/BosBizDon/status/474257006308511745,,,,
CancerNetwrk,6/4/2014 14:30,1,1,Drug Combo Improves Quality of Life in Multiple Myeloma Patients http://bit.ly/1nPdTzF # ASCO14,,,#,4.74257E+17,https://twitter.com/CancerNetwrk/status/474256890525134848,,,,
OSUCCC_James,6/4/2014 14:30,0,0,# ASCO14: # Ibrutinib Significantly Delays Disease Progression and Extends Survival in Relapsed # CLL http://bit.ly/1kL4Jfs via @ ASCOPost,,@,# # #,4.74257E+17,https://twitter.com/OSUCCC_James/status/474256839497252864,,,,
medpagetoday,6/4/2014 14:30,0,0,ASCO: Targeted treatment combo stalls NSCLC. @ atscommunity # ASCO14 http://bit.ly/1rHI6T8,,@,#,4.74257E+17,https://twitter.com/medpagetoday/status/474256780227133440,,,,
christinemphmd,6/4/2014 14:22,0,0,Watching # ASCO14 sessions that I missed on @ ASCO Virtual Meeting. May have a little annual meeting withdrawal!,,@,#,4.74255E+17,https://twitter.com/christinemphmd/status/474254951208980480,,,,
survivornetca,6/4/2014 14:15,1,0,RT @ ProstatePost @ medpagetoday # ASCO14 Combo Hormone Tx Promising w/ # prostatecancer http://www.medpagetoday.com/HematologyOncology/ProstateCancer/46133 … # Cancer # menshealth # survivornet,,@ @,# # # # #,4.74253E+17,https://twitter.com/survivornetca/status/474253005294804994,,,,
HemOncToday,6/4/2014 14:11,0,0,# ASCO14 Intraperitoneal # chemotherapy underused even among patients with ovarian cancer @ DanaFarber http://goo.gl/3nKtgR,,@,# #,4.74252E+17,https://twitter.com/HemOncToday/status/474252094502096896,,,,
GoHealio,6/4/2014 14:11,0,0,# ASCO14 Intraperitoneal # chemotherapy underused even among patients with ovarian cancer @ DanaFarber http://goo.gl/3nKtgR,,@,# #,4.74252E+17,https://twitter.com/GoHealio/status/474252093583527937,,,,
TaraAnnGall,6/4/2014 14:10,0,0,Physicians both nationally and globally place value on sharing info from # ASCO14 with docs from 36 countries tweeting http://buff.ly/1jQLhOg,,,#,4.74252E+17,https://twitter.com/TaraAnnGall/status/474251759268147201,,,,
COI_salud,6/4/2014 14:01,0,0,La reunión de la Asociación Americana de Oncología Medica # ASCO14 presentó el MEDI4736 con resultados sorprendentes contra # cáncer de pulmón,,,# #,4.7425E+17,https://twitter.com/COI_salud/status/474249645200506880,,,,
CancerResearch,6/4/2014 14:01,0,0,We've built a whole page of resources: just for you. # Immunotherapy # CIM2014 # ASCO14 http://ow.ly/xyAD6,,,# # #,4.7425E+17,https://twitter.com/CancerResearch/status/474249531404861440,,,,
BladderCancerUS,6/4/2014 14:00,0,0,Personalized Care vs Precise Care: The Geriatric Oncology Model # bladdercancer # blcsm # ASCO14 http://htl.li/xC9yQ,,,# # #,4.74249E+17,https://twitter.com/BladderCancerUS/status/474249409518370816,,,,
DrLen,6/4/2014 14:00,5,1,The smile from # ASCO14 that says so much about cancer research and cancer care--and why we do what we do http://tinyurl.com/ku6au99,,,#,4.74249E+17,https://twitter.com/DrLen/status/474249322440450050,,,,
eugeniosantoro,6/4/2014 13:58,1,1,Due modi di intendere gli hastag in medicina. Prova con # asco2014 e poi con # anmco2014 . Quanta nostrana arretratezza sui # socialmedia ..,,,# # #,4.74249E+17,https://twitter.com/eugeniosantoro/status/474248968416018432,,,,
ConsanoMolly,6/4/2014 13:56,1,1,New blog post about my time at # ASCO14 as a # PatientAdvocate: https://www.consano.org/blog/single/63-thoughts-from-a-patient-advocate-at-asco14 …,,,# #,4.74248E+17,https://twitter.com/ConsanoMolly/status/474248370085584896,,,,
novacarerx,6/4/2014 13:55,0,0,@ PharmacistScott @ ASCO Clinical Homeopathy - ? Oxymoron.,,@ @,,4.74248E+17,https://twitter.com/novacarerx/status/474248018431324160,,,,
JimWeissW2O,6/4/2014 13:54,2,0,# MDigitalLife data set of ex-US physicians on this # ASCO14 post to be announced at # Doctors2.0 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74248E+17,https://twitter.com/JimWeissW2O/status/474247737890709504,,,,
abbottmd,6/4/2014 13:50,0,0,Should Triple-Negative Breast Cancer (TNBC) Subtype Affect Local-Regional Therapy Decision Making? http://ow.ly/xAFmI # ASCO14,,,#,4.74247E+17,https://twitter.com/abbottmd/status/474246763407474689,,,,
ASCOPost,6/4/2014 13:46,2,1,Chemo + 1st-Line Bevacizumab or Cetuximab Offer Similar Survival in Metastatic Colorectal Cancer http://ow.ly/xCV76 # ASCO14 # crcsm,,,# #,4.74246E+17,https://twitter.com/ASCOPost/status/474245766295613442,,,,
HanBarrington,6/4/2014 13:42,0,1,@ PharmacistScott @ ASCO Dangers of ignoring true spontaneous bruising aside; favourite eligibility requirement: optimism. # HowToSpotQuackery,,@ @,#,4.74245E+17,https://twitter.com/HanBarrington/status/474244699461410816,,,,
mtmdphd,6/4/2014 13:39,1,2,"MT @ IMFmyeloma: Great article about Mike Katz, honored with the Partners in Progress award at # ASCO14 http://bit.ly/1p4DNN5 # mmsm",,@,# #,4.74244E+17,https://twitter.com/mtmdphd/status/474244135042711554,,,,
DoctorCanBob,6/4/2014 13:38,0,0,@ PharmacistScott @ ASCO @ CaulfieldTim I suppose this was touted as integrative medicine,,@ @ @,,4.74244E+17,https://twitter.com/DoctorCanBob/status/474243689292648449,,,,
TargetedOnc,6/4/2014 13:35,4,2,"'Very, Very Impressive' Results Seen With Ipilimumab/Nivolumab Combination in Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Very-Very-Impressive-Results-Seen-With-IpilimumabNivolumab-Combination … # ASCO14",,,#,4.74243E+17,https://twitter.com/TargetedOnc/status/474242999099355136,,,,
DoctorCanBob,6/4/2014 13:34,1,0,@ PharmacistScott @ ASCO @ CaulfieldTim How can @ AMAMedicalAlarm give # CME credits for attending # homeopathy convention?,,@ @ @ @,# #,4.74243E+17,https://twitter.com/DoctorCanBob/status/474242759780347905,,,,
WCMCLymphoma,6/4/2014 13:32,0,0,Routine Surveillance has Limited Impact in Detecting Remission of Peripheral T-cell Lymphoma # ASCO2014 http://wp.me/p1hbFd-vTH,,,#,4.74242E+17,https://twitter.com/WCMCLymphoma/status/474242188574859264,,,,
big4bioBOS,6/4/2014 13:31,0,0,# ASCO14 results in more losers than gainers among # Boston-area # biotechs http://www.bizjournals.com/boston/blog/bioflash/2014/06/oncology-conference-results-in-more-losers-than.html?ana=twt … via @ BostonBizNews # cancer # pharmaceuticals,,@,# # # # #,4.74242E+17,https://twitter.com/big4bioBOS/status/474242157419577344,,,,
PharmacistScott,6/4/2014 13:29,0,2,2/2 more quackery from @ ASCO pic.twitter.com/JxZ224l2mt,,@,,4.74242E+17,https://twitter.com/PharmacistScott/status/474241575216611329,,,,
DrEpid,6/4/2014 13:29,0,0,"@ PharmacistScott @ ASCO Wait, how did this get approved for CME credits? Presumably the last session is one slide: DON'T.""""",,@ @,,4.74242E+17,https://twitter.com/DrEpid/status/474241573367316480,,,,
Big4BioSF,6/4/2014 13:29,0,0,"# Biotech Stock Roundup: @ Gilead, @ Pharmacyclics Impress at # ASCO14 - Analyst Blog $ ABBV $ BIIB $ CLVS http://benzinga.com/z/4609504 # SFBay",,@ @,# # #,4.74242E+17,https://twitter.com/Big4BioSF/status/474241530262081536,,,,
KreaNova_NL,6/4/2014 13:29,0,0,50 jaar Innovatie in oncologie # ASCO14 - Medical facts http://bit.ly/1nfbevT,,,#,4.74241E+17,https://twitter.com/KreaNova_NL/status/474241439560245249,,,,
PharmacistScott,6/4/2014 13:28,7,3,"Colleague brought this back for me from @ ASCO. Quackery, it’s everywhere. pic.twitter.com/hVisLie7em",,@,,4.74241E+17,https://twitter.com/PharmacistScott/status/474241373906808833,,,,
IMFmyeloma,6/4/2014 13:28,2,0,"Check out this great article about Mike Katz, honored with the Partners in Progress award at # ASCO14: http://bit.ly/1p4DNN5",,,#,4.74241E+17,https://twitter.com/IMFmyeloma/status/474241184533991424,,,,
evaluatepharma,6/4/2014 13:15,0,0,Who will be the # oncology giants of 2020? Join the post # ASCO2014 @ FierceBiotech Twitter chat w/ @ JonEPVantage on Thursday 6/5 at 2pm EST,,@ @,# #,4.74238E+17,https://twitter.com/evaluatepharma/status/474238062483238912,,,,
twittmanda,6/4/2014 13:14,0,0,@ subatomicdoc @ ASCO That was the issue too many GREAT! Spares or for @ djsampson maybe a portable charger.,,@ @ @,,4.74238E+17,https://twitter.com/twittmanda/status/474237722559672320,,,,
subatomicdoc,6/4/2014 13:12,1,1,"@ twittmanda @ djsampson @ ASCO Yes, I may need to carry spares. The meeting had so many great things to attend, no time for the cafe! # ASCO14",,@ @ @,#,4.74237E+17,https://twitter.com/subatomicdoc/status/474237284636966912,,,,
CancerTherAdvsr,6/4/2014 13:05,0,0,RT @ ONAcom: # ASCO14: Ginger extract improves # chemotherapy-induced nausea - http://ow.ly/xzRwL,,@,# #,4.74236E+17,https://twitter.com/CancerTherAdvsr/status/474235549759594496,,,,
COI_salud,6/4/2014 13:04,0,0,El ejercicio físico reduce estrés psicológico en pacientes con # Cancer de próstata # COItecuida # ASCO14,,,# # #,4.74235E+17,https://twitter.com/COI_salud/status/474235293223354368,,,,
BladderCancerUS,6/4/2014 13:02,0,0,New System for Treating Cancer Seen as Hopeful # immunotherapy # bladdercancer # blcsm # ASCO14 @ nytimes http://htl.li/xC8EU,,@,# # # #,4.74235E+17,https://twitter.com/BladderCancerUS/status/474234745942188032,,,,
CancerResearch,6/4/2014 13:01,0,0,"When we work together, amazing things can happen: # ASCO14",,,#,4.74234E+17,https://twitter.com/CancerResearch/status/474234473471836161,,,,
ONAcom,6/4/2014 13:01,0,0,# ASCO14: Early # palliative support for family caregivers reduces # depression - read more http://ow.ly/xCkty,,,# # #,4.74234E+17,https://twitter.com/ONAcom/status/474234466194690049,,,,
Boehringer,6/4/2014 13:00,1,2,SOCIAL MEDIA SUMMARY OF # ASCO14: day 1-5 ASCO social media activity http://bit.ly/1m1cLSF # lungcancer,,,# #,4.74234E+17,https://twitter.com/Boehringer/status/474234225789788161,,,,
BCRFcure,6/4/2014 13:00,0,0,"WATCH: If you missed @ CliffordHudis' presidential address at # ASCO2014, check out this video: http://ow.ly/xCwpj",,@,#,4.74234E+17,https://twitter.com/BCRFcure/status/474234209599770625,,,,
twittmanda,6/4/2014 13:00,0,0,@ djsampson @ ASCO I agree NO apology at all and just FYI.If you like your phone then just get a spare battery/ portable charger till at cafe!,,@ @,,4.74234E+17,https://twitter.com/twittmanda/status/474234177806544896,,,,
MelPalMD,6/4/2014 12:58,0,0,"New to Twittersphere, it was fun to be part of this # ASCO14 pic.twitter.com/G7howPzks5",,,#,4.74234E+17,https://twitter.com/MelPalMD/status/474233799656484865,,,,
twittmanda,6/4/2014 12:57,0,0,@ djsampson @ ASCO David I mentioned to Matt @ subatomicdoc that maybe a spare battery for laptop/phone would help.Recharge could be at cafe :),,@ @ @,,4.74234E+17,https://twitter.com/twittmanda/status/474233548438650881,,,,
JamesPPinkerton,6/4/2014 12:57,2,4,In wake of # ASCO14...new # cancer therapies have reduced hospitalization costs by $124b and patient out-of-pocket cost by $240b since 1990,,,# #,4.74233E+17,https://twitter.com/JamesPPinkerton/status/474233461029744640,,,,
JamesPPinkerton,6/4/2014 12:55,2,1,In wake of # ASCO14 # DYK the cost of treating cancer remains under 5% of total healthcare expenditures? # medicalinnovation saves money.,,,# # #,4.74233E+17,https://twitter.com/JamesPPinkerton/status/474232905993314305,,,,
AaronCohenGadol,6/4/2014 12:55,1,2,Announced @ # ASCO14 : Test to begin this fall of Yervoy and nivolumab for glioblastomas by @ NRGOncology http://ow.ly/xCK6L # BTSM,,@ @,# #,4.74233E+17,https://twitter.com/AaronCohenGadol/status/474232885025992704,,,,
JamesPPinkerton,6/4/2014 12:54,3,2,"In wake of # ASCO14 it's worth knowing that since 1990, # medicalinnovation has led to 70% reduction in hospital.; $320 billion in hc savings.",,,# #,4.74233E+17,https://twitter.com/JamesPPinkerton/status/474232641848635392,,,,
JamesPPinkerton,6/4/2014 12:51,1,3,"In wake of # ASCO14, worth noting that innovative cancer therapies represent only 1% of healthcare costs. # medicalinnovation",,,# #,4.74232E+17,https://twitter.com/JamesPPinkerton/status/474232040691609602,,,,
Medicalfacts,6/4/2014 12:50,0,0,# ASCO14 Fase II PEAK studie: Verbeterde overleving met panitumumab bij gemetastaseerde colorectaalkanker versus... http://is.gd/pPDeYS,,,#,4.74232E+17,https://twitter.com/Medicalfacts/status/474231752517746688,,,,
KarenCollinsRD,6/4/2014 12:50,0,0,MT @ ClevelandClinic: “Obesity is on its way to replacing tobacco as the #1 preventable/modifiable cause of cancer.” @ CliffordHudis # ASCO14,,@ @,#1 #,4.74232E+17,https://twitter.com/KarenCollinsRD/status/474231661064769537,,,,
cancercommons,6/4/2014 12:49,0,0,Highlights of new strategies to improve quality of life for cancer patients & caregivers at # ASCO14: http://www.sciencedaily.com/releases/2014/06/140602102053.htm …,,,#,4.74231E+17,https://twitter.com/cancercommons/status/474231450074902529,,,,
ProstatePost,6/4/2014 12:45,0,0,@ medpagetoday # ASCO14 Combo Hormone Tx Promising in # prostatecancer . http://www.medpagetoday.com/HematologyOncology/ProstateCancer/46133 … # Cancer # menshealth # survivornet,,@,# # # # #,4.7423E+17,https://twitter.com/ProstatePost/status/474230375275704321,,,,
GustaveRoussy,6/4/2014 12:43,6,2,# ASCO14 # VIDEO Interview du Dr @ charles_ferte @ GustaveRoussy : séquençage et bioinformatiquehttp://vimeo.com/97344011,,@ @,# #,4.7423E+17,https://twitter.com/GustaveRoussy/status/474230033553588225,,,,
ShannonWestin,6/4/2014 12:40,1,0,Reduction in breast ca risk from BSO limited to pt with BRCA1 mutations. No impact on survival in BRCA 2 http://bit.ly/1iWBwys # ASCO14,,,#,4.74229E+17,https://twitter.com/ShannonWestin/status/474229104967823360,,,,
eMPR,6/4/2014 12:35,0,0,"Fish, exercise could prevent recurrence of colon cancer: http://ow.ly/xCGF4 # ASCO14 # oncology",,,# #,4.74228E+17,https://twitter.com/eMPR/status/474228021033857024,,,,
fischmd,6/4/2014 12:28,2,0,MT @ ramalingammd: Median PFS likely > 12 months with CO1686 in T790m positive # lungcancer pts. Wow! http://ow.ly/xCDkT # LCSM # ASCO14,,@,# # #,4.74226E+17,https://twitter.com/fischmd/status/474226158633222144,,,,
Boehringer,6/4/2014 12:25,2,2,Stigma tops our poll of the biggest challenge faced by # lungcancer patients # ASCO14 Still time to vote http://bit.ly/TAW5Ly,,,# #,4.74225E+17,https://twitter.com/Boehringer/status/474225356749422592,,,,
Larvol,6/4/2014 12:25,0,0,"Now that # ASCO14 is over, what’s the next big conference you’re excited about? Maybe we’ll see you there.",,,#,4.74225E+17,https://twitter.com/Larvol/status/474225350680281088,,,,
Joe_Hedden,6/4/2014 12:22,5,0,"@ Datamonitor_HC's # ASCO14 white paper now up for subscribers, non-subscribers tomorrow! http://bit.ly/1marlYm (logged in)",,@,#,4.74225E+17,https://twitter.com/Joe_Hedden/status/474224737284288513,,,,
PDRennert,6/4/2014 12:22,0,0,"@ AlpineBV_Miller @ ASCO bummer. Half the posters I've cued up are blank. 1 said author did not grant permission"""," not clear about others""",,@ @,,4.74225E+17,https://twitter.com/PDRennert/status/474224716434006016,,,
humanimmunenews,6/4/2014 12:20,2,0,Great # Immunotherapy highlights from the @ ASCO Meeting in Chicago! Check them out here: http://tinyurl.com/m6xbbp7,,@,#,4.74224E+17,https://twitter.com/humanimmunenews/status/474224107702480896,,,,
Innoveren,6/4/2014 12:14,0,0,50 jaar Innovatie in oncologie # ASCO14 http://bit.ly/1l5GGN1 . # innovatie,,,# #,4.74223E+17,https://twitter.com/Innoveren/status/474222582330560512,,,,
scientre,6/4/2014 12:12,0,0,MT @ mtmdphd Boolean querying my # ASCO14 tweets helps me use all of those as notes for answering questions from colleagues after meeting...,,@,#,4.74222E+17,https://twitter.com/scientre/status/474222120231514112,,,,
TargetedOnc,6/4/2014 12:10,1,1,Pembrolizumab (MK-3475) Continues to Deliver Impressive Results in Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Pembrolizumab-MK-3475-Continues-to-Deliver-Impressive-Results-in-Melanoma … # ASCO14,,,#,4.74222E+17,https://twitter.com/TargetedOnc/status/474221663622791170,,,,
BladderCancerUS,6/4/2014 12:10,1,0,Immunotherapy drug shrinks tumors in early # bladdercancer study # blcsm # ASCO14 @ chicagotribune http://htl.li/xC8g7,,@,# # #,4.74222E+17,https://twitter.com/BladderCancerUS/status/474221596107112448,,,,
OncologyCentral,6/4/2014 12:09,0,0,# News from # ASCO14: Study highlights extended # survival in resistant CLL with # ibrutinib therapy # cancer http://bit.ly/19MA7os,,,# # # # #,4.74221E+17,https://twitter.com/OncologyCentral/status/474221427156353025,,,,
Oncoinfo_it,6/4/2014 12:06,2,2,# ASCO14: al centro l'immunoterapia. La video intervista di Paolo Marchetti http://tinyurl.com/mypddrd,,,#,4.74221E+17,https://twitter.com/Oncoinfo_it/status/474220537578000384,,,,
myCME,6/4/2014 12:05,0,0,Seeking a second opinion prior to chemotherapy important for # Oncology patients. # ASCO14,,,# #,4.7422E+17,https://twitter.com/myCME/status/474220341280407552,,,,
CancerTherAdvsr,6/4/2014 12:05,1,0,"Thanks for a wonderful time in Chicago, @ ASCO ! We got so much great coverage from # ASCO14 http://ow.ly/xAIm3",,@,#,4.7422E+17,https://twitter.com/CancerTherAdvsr/status/474220339166470144,,,,
fischmd,6/4/2014 12:05,1,4,"Boolean querying post @ ASCO mtg: try this, for example--type into the twitter search bar ALK OR EGFR # ASCO14""""",,@,#,4.7422E+17,https://twitter.com/fischmd/status/474220303418417153,,,,
ONAcom,6/4/2014 12:02,1,0,# ASCO14: Ginger extract improves # chemotherapy-induced nausea - http://ow.ly/xzREv,,,# #,4.7422E+17,https://twitter.com/ONAcom/status/474219704006246400,,,,
JacobPlieth,6/4/2014 12:02,2,3,Some nuggets from my chat with $ PCYC CEO Robert Duggan at # ASCO14 http://ow.ly/xCxzi $ GILD $ ABBV,,,#,4.7422E+17,https://twitter.com/JacobPlieth/status/474219530127159297,,,,
AlpineBV_Miller,6/4/2014 12:01,0,0,"@ PDRennert @ adamfeuerstein @ ASCO support email says the slides and the VM are separate products. So, another $150 for the slides...",,@ @ @,,4.74219E+17,https://twitter.com/AlpineBV_Miller/status/474219396974792705,,,,
CancerResearch,6/4/2014 12:01,1,0,"In 2013, 86% of our revenue went directly to our research programs. # CIM2014 # ASCO14 http://ow.ly/xyAD2",,,# #,4.74219E+17,https://twitter.com/CancerResearch/status/474219386270924801,,,,
moxiemegan,6/4/2014 12:01,0,0,What REAL Celebrities are up to # science # ASCO14 http://www.asco.org/press-center/new-therapies-harness-power-immune-system-against-cancer …,,,# #,4.74219E+17,https://twitter.com/moxiemegan/status/474219370504126464,,,,
IntelinLife,6/4/2014 12:00,0,0,RT @ pharmaguy: The Emerging Virtual Medical Meeting: http://bit.ly/pmn1305-02asco # ASCO14 # medical,,@,# #,4.74219E+17,https://twitter.com/IntelinLife/status/474219241345142785,,,,
CUCancerCenter,6/4/2014 12:00,1,0,# ASCO14 presents results of phase 1 trial of OMP-54F28 targeting cancer stem cells in advanced solid tumors # cancer http://ow.ly/xCwYL,,,# #,4.74219E+17,https://twitter.com/CUCancerCenter/status/474219104724090880,,,,
MTSLNews,6/4/2014 11:59,0,0,"$ PCYC The # ASCO2014 conclusion for Imbruvica -  The New SOC in CLL"" - Standard of Care - http://bioinvest.com""",,,#,4.74219E+17,https://twitter.com/MTSLNews/status/474218881880711168,,,,
JacobPlieth,6/4/2014 11:59,1,1,III in I plan for pembrolizumab. @ JonEPVantage interviewed $ MRK at # ASCO14 http://ow.ly/xCwUN $ AZN $ RHHBY $ BMY,,@,#,4.74219E+17,https://twitter.com/JacobPlieth/status/474218773080453120,,,,
mtmdphd,6/4/2014 11:58,1,1,"Need an # ASCO14 review on lung CA? Try Twitter search: # ASCO14 # lcsm Can try with cost"""," ""Hudis"" etc. Got hashtags? Got review. HT @ FischMD""",,@,# # #,4.74219E+17,https://twitter.com/mtmdphd/status/474218659788107776,,,
AstellasUS,6/4/2014 11:55,0,0,"Congratulations, @ ASCO for hosting a successful 50th meeting! See you next year!",,@,,4.74218E+17,https://twitter.com/AstellasUS/status/474217787846852608,,,,
A_Karunaratne,6/4/2014 11:52,0,0,Yeah that how those mtgs are # ASCO14 @ DrPaulyDeSantis,,@,#,4.74217E+17,https://twitter.com/A_Karunaratne/status/474217050877861888,,,,
mtmdphd,6/4/2014 11:51,0,1,Boolean querying my # ASCO14 tweets helps me use all of those as notes for answering questions from colleagues after the meeting...,,,#,4.74217E+17,https://twitter.com/mtmdphd/status/474216893662777344,,,,
BCRFcure,6/4/2014 11:50,0,0,RT @ jrgralow: # ASCO14: Trastuzumab may be beneficial for small HER2+ Breast Ca - but few w/ negative nodes avail for this analysis!...,,@,#,4.74217E+17,https://twitter.com/BCRFcure/status/474216687324385282,,,,
BCRFcure,6/4/2014 11:50,0,0,Considering the Future of Cancer Science and Care: great # ASCO2014 summary by @ ElaineSchattner http://ow.ly/xCuJo,,@,#,4.74217E+17,https://twitter.com/BCRFcure/status/474216635021410305,,,,
myCME,6/4/2014 11:50,0,1,Chemotherapy first may help patients tolerate full regimen of treatment in rectal cancer http://ow.ly/xAy2B # ASCO14 # CRC,,,# #,4.74217E+17,https://twitter.com/myCME/status/474216611487158272,,,,
PDRennert,6/4/2014 11:50,0,0,@ AlpineBV_Miller @ adamfeuerstein @ ASCO OK fair enough: took AACR 3+ weeks. ASCO did say all available w/in 12 hours tho,,@ @ @,,4.74217E+17,https://twitter.com/PDRennert/status/474216565462683648,,,,
AlpineBV_Miller,6/4/2014 11:48,0,0,@ PDRennert @ adamfeuerstein I emailed @ ASCO about not being able to access slides. No response yet. My guess is posters will take a few days.,,@ @ @,,4.74216E+17,https://twitter.com/AlpineBV_Miller/status/474216252450566144,,,,
evaluatevantage,6/4/2014 11:48,0,0,"$ MRK plan gives it first crack at PD-1 approval, @ JonEPVantage spoke with David Mauro at # ASCO14 http://ow.ly/xCuGU # pembrolizumab",,@,# #,4.74216E+17,https://twitter.com/evaluatevantage/status/474216059252531202,,,,
kbnewport,6/4/2014 11:48,2,1,Palliative Care Benefits Patients and caregivers when initiated at time of advanced cancer diagnosis. http://www.medscape.com/viewarticle/826011?src=sttwit … # hpm # ASCO14,,,# #,4.74216E+17,https://twitter.com/kbnewport/status/474216054948769792,,,,
brianreid,6/4/2014 11:46,2,0,"The World Cup, # ASCO14 style: US vs. the world in the number of ASCO tweets (via @ mdigitallife):pic.twitter.com/bFHxok4Oib",,@,#,4.74216E+17,https://twitter.com/brianreid/status/474215616350416896,,,,
HelpKeepasister,6/4/2014 11:46,0,0,Results from the clinical trial I was in (and had to leave due to lung damage) were reported at # ASCO14. The... http://fb.me/6Bv12aiqZ,,,#,4.74216E+17,https://twitter.com/HelpKeepasister/status/474215510544879617,,,,
n8pennell,6/4/2014 11:45,0,1,Anyone know of good free analytics program to assess Twitter data for # ASCO14?,,,#,4.74215E+17,https://twitter.com/n8pennell/status/474215298271555584,,,,
brianreid,6/4/2014 11:44,0,0,What did ex-US docs think about # ASCO14? @ chimoose has the numbers for @ mdigitallife: http://bit.ly/1h9ZCdV,,@ @,#,4.74215E+17,https://twitter.com/brianreid/status/474215104268206080,,,,
evaluatevantage,6/4/2014 11:42,1,0,"Rounding off our # ASCO14 coverage: As Pharmacyclics stays ahead, sustained response awaited $ PCYC http://ow.ly/xCtj9 # Imbruvica",,,# #,4.74215E+17,https://twitter.com/evaluatevantage/status/474214685546659841,,,,
evaluatepharma,6/4/2014 11:40,2,1,"# ASCO14 – As @ Pharmacyclics stays ahead, sustained response awaited http://ow.ly/xCqeY $ PCYC # imbruvica",,@,# #,4.74214E+17,https://twitter.com/evaluatepharma/status/474214063032258560,,,,
cenmag,6/4/2014 11:39,0,0,@ scientre @ lisamjarvis @ ASCO @ deirdrelockwood @ UWMadison We do try to be as omnipresent as possible ;),,@ @ @ @ @,,4.74214E+17,https://twitter.com/cenmag/status/474213909323599872,,,,
THCBstaff,6/4/2014 11:39,0,0,"ICYMI: In 2013 U.S. doctors tweeted about # cancer 82,383 times. http://bit.ly/1kmLgaM # ASCO14",,,# #,4.74214E+17,https://twitter.com/THCBstaff/status/474213867346616320,,,,
InnovatieNL,6/4/2014 11:39,1,0,50 jaar Innovatie in oncologie # ASCO14 - Medical facts http://bit.ly/1i0KGKl # innovatie # mdbtw,,,# # #,4.74214E+17,https://twitter.com/InnovatieNL/status/474213760723197953,,,,
LizHIVHep,6/4/2014 11:38,2,3,"# ASCO14: # HepC Reactivation, Brain Involvement Don't Worsen # Lymphoma Survival for People with # HIV/ # AIDS: http://bit.ly/1oavfoh",,,# # # # #,4.74214E+17,https://twitter.com/LizHIVHep/status/474213726946480128,,,,
Drchik23,6/4/2014 11:38,1,2,@ MDsearchlight @ DrPaulyDeSantis I'd agree. But after # ASCO14 I'm more bullish on $ pcyc than b4. Data was much better than Arzerra.,,@ @,#,4.74214E+17,https://twitter.com/Drchik23/status/474213721590337536,,,,
mnewtonPharmD,6/4/2014 11:38,0,0,"Great # ASCO14 meeting, but time to go. Two # WVU posters, excellent sessions, and a beautiful city. # chicagopic.twitter.com/eiAqro3NRq",,,# # #,4.74214E+17,https://twitter.com/mnewtonPharmD/status/474213651780337664,,,,
scientre,6/4/2014 11:37,0,2,I run into @ cenmag everywhere! @ lisamjarvis at @ ASCO & now @ deirdrelockwood at ChemBiol Interface Career Devlpmt Conference @ UWMadison,,@ @ @ @ @,,4.74213E+17,https://twitter.com/scientre/status/474213319881289729,,,,
IONELung,6/4/2014 11:37,0,1,"Abstr 8030: X396 is a novel ALK inhibitor with activity in ALK+ NSCLC, still early in development # ASCO14",,,#,4.74213E+17,https://twitter.com/IONELung/status/474213293062889473,,,,
stales,6/4/2014 11:36,1,1,RT @ ASCO: . @ drdonsdizon questions preventative med in patients w/ mets cancer during # ASCO14 http://bit.ly/1nKUH6g # bcsm # ASCOconnection,,@ @,# # #,4.74213E+17,https://twitter.com/stales/status/474213025545981952,,,,
stales,6/4/2014 11:35,4,0,RT @ DrAttai: Why women are choosing mastectomy - influences beyond the surgeon # asco14 # bcsmpic.twitter.com/SU0zefUqL6,,@,# #,4.74213E+17,https://twitter.com/stales/status/474212928959578112,,,,
myelomabeacon,6/4/2014 11:35,3,1,Detailed review of the key # myeloma-related oral presentations given at # ASCO14 this Monday: http://www.myelomabeacon.com/news/2014/06/04/asco-2014-multiple-myeloma-update-day-four-oral-presentations/ …,,,# #,4.74213E+17,https://twitter.com/myelomabeacon/status/474212818607431680,,,,
IONELung,6/4/2014 11:33,0,1,Abstr 8023: Nivolumab+ipilimumab RR of 11-33% with different doses # ASCO14,,,#,4.74212E+17,https://twitter.com/IONELung/status/474212425349472256,,,,
CancerNetwrk,6/4/2014 11:32,2,1,Apatinib Prolonged Survival in Advanced Gastric Cancer http://bit.ly/1kHljNj # ASCO14,,,#,4.74212E+17,https://twitter.com/CancerNetwrk/status/474212090568527874,,,,
IONELung,6/4/2014 11:32,0,0,"Abstr 8021: Medi4736 – 155 NSCLC pts on phase I with ORR 16% (25% in PDL+, 3% iN PDL1-), no pulmonary toxicity noted # ASCO14",,,#,4.74212E+17,https://twitter.com/IONELung/status/474212049887985665,,,,
IONELung,6/4/2014 11:31,0,0,"Abstr 8020: MK3475 – RR 23% PD-L1+ vs 9% PD-L1- No differences between 2 weeks vs 3 week schedule, favorable toxicity profile # ASCO14",,,#,4.74212E+17,https://twitter.com/IONELung/status/474211934120968192,,,,
JefferiesEvents,6/4/2014 11:31,1,2,Don’t miss “Key Takeaways from @ Asco” w/ @ joshuabrodyMD Dr. Chandra Belani of @ PennStHershey & Dr. Dawn Hershman of @ ColumbiaMed # JEFHC14,,@ @ @ @,#,4.74212E+17,https://twitter.com/JefferiesEvents/status/474211772149530624,,,,
zorgnieu_ws,6/4/2014 11:30,0,0,50 jaar Innovatie in oncologie # ASCO14 http://wp.me/p2ZL1H-6tW,,,#,4.74212E+17,https://twitter.com/zorgnieu_ws/status/474211615689039872,,,,
voixdespatients,6/4/2014 11:29,1,1,# Cancer du cerveau de l’ # enfant : les promesses du progrès # thérapeutique http://www.voixdespatients.fr/a-la-une/cancer-du-cerveau-lenfant-les-promesses-du-progres-therapeutique/#.U487GFh_tJ8 … # ASCO14 @ GustaveRoussy,,@,# # # # #,4.74211E+17,https://twitter.com/voixdespatients/status/474211339016355840,,,,
AlpineBV_Miller,6/4/2014 11:28,2,3,"$ MDVN PREVAIL has stat sig improvement in QoL. Physical well being (WB), Family/Social WB, Emotional WB, Functional WB. # ASCO14",,,#,4.74211E+17,https://twitter.com/AlpineBV_Miller/status/474211196036722688,,,,
AlpineBV_Miller,6/4/2014 11:27,0,0,$ MDVN PREVAIL median time on drug 16.6 months. # ASCO14,,,#,4.74211E+17,https://twitter.com/AlpineBV_Miller/status/474210953954082816,,,,
BeaufortMem,6/4/2014 11:25,0,0,"RT @ USATODAYhealth: Immune therapies improve treatment of some cancers; at least six promising studies at # ASCO14, http://usat.ly/1kpMv7W",,@,#,4.7421E+17,https://twitter.com/BeaufortMem/status/474210296295620608,,,,
AlpineBV_Miller,6/4/2014 11:25,3,3,Missed $ MDVN PREVAIL oral # ASCO14. Watching now. Updated OS has Xtandi not yet reaching median OS after 26.2 months of follow up!,,,#,4.7421E+17,https://twitter.com/AlpineBV_Miller/status/474210248044335104,,,,
aicrtweets,6/4/2014 11:22,0,0,RT @ eugeniosantoro: The 2014 MDigitalLIfe Social Oncology Project Report by @ W2OGroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report?ref=http://mdigitallife.com/socialoncology/ … via...,,@ @,# #,4.7421E+17,https://twitter.com/aicrtweets/status/474209527689392128,,,,
TargetedOnc,6/4/2014 11:20,0,0,Adjuvant Ipilimumab Improves RFS by 25% in Stage III Melanoma http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Adjuvant-Ipilimumab-Improves-RFS-by-25-in-Stage-III-Melanoma … # ASCO14,,,#,4.74209E+17,https://twitter.com/TargetedOnc/status/474208975547023360,,,,
eugeniosantoro,6/4/2014 11:20,0,0,The 2014 MDigitalLIfe Social Oncology Project Report by @ w2ogroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report?ref=http://mdigitallife.com/socialoncology/ … via @ SlideShare,,@ @,# #,4.74209E+17,https://twitter.com/eugeniosantoro/status/474208972920983552,,,,
COI_salud,6/4/2014 11:16,0,1,# nivolumab registra supervivencia del 24 % a los 2 años independiente del perfil estrogénico y molecular del # Cancer de pulmón # ASCO14,,,# # #,4.74208E+17,https://twitter.com/COI_salud/status/474208133846269952,,,,
Medicalfacts,6/4/2014 11:15,1,0,50 jaar Innovatie in oncologie # ASCO14 http://www.medicalfacts.nl/?p=207102,,,#,4.74208E+17,https://twitter.com/Medicalfacts/status/474207926828404736,,,,
CancerTherAdvsr,6/4/2014 11:15,0,0,# ASCO14: Prophylactic Cranial Irradiation Doesn't Prolong OS in Extensive Disease-SCLC # lungcancer http://ow.ly/xAIqI,,,# #,4.74208E+17,https://twitter.com/CancerTherAdvsr/status/474207801066409984,,,,
annalisec,6/4/2014 11:15,0,0,# MDigitalLife's new data set of Ex-US physicians used on this # ASCO14 post; to be announced at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74208E+17,https://twitter.com/annalisec/status/474207703523270656,,,,
ONAcom,6/4/2014 11:10,0,0,# ASCO14: Early # palliative support for family caregivers reduces # depression - read more http://ow.ly/xCkpw,,,# # #,4.74207E+17,https://twitter.com/ONAcom/status/474206514690150400,,,,
abbottmd,6/4/2014 11:10,1,0,IBM’s Watson-Based Oncology Computing System Recommends Treatment with High Accuracy | ASCO Annual Meeting http://ow.ly/xzSh5 # ASCO14,,,#,4.74207E+17,https://twitter.com/abbottmd/status/474206506771308546,,,,
TaraAnnGall,6/4/2014 11:07,0,0,@ MDigitalLife latest addition of Ex-US physicians used in first analysis of physician behavior at # ASCO14 http://buff.ly/1oamlHy,,@,#,4.74206E+17,https://twitter.com/TaraAnnGall/status/474205819702349824,,,,
COI_salud,6/4/2014 11:06,0,0,La # Obesidad aumenta un 34 % la mortalidad por # cáncer de mama # ASCO2014,,,# # #,4.74206E+17,https://twitter.com/COI_salud/status/474205620631920641,,,,
SvenC,6/4/2014 11:06,0,0,Get a sneak peek into our unreleased # MDigitalLife Ex-US physician dataset in this # ASCO14 post. # Doctors20 http://buff.ly/1oalGGb,,,# # #,4.74206E+17,https://twitter.com/SvenC/status/474205570229350400,,,,
myCME,6/4/2014 11:05,0,0,Breath Test May Help Detect Lung Cancer http://ow.ly/xA9Np # lcsm # ASCO14,,,# #,4.74205E+17,https://twitter.com/myCME/status/474205320840224768,,,,
COI_salud,6/4/2014 11:05,0,0,"Reducción de peso es recomendado sobre todo en pacientes con # cáncer de mama localizado y en etapa premenopaúsica"" # ASCO14""",,,# #,4.74205E+17,https://twitter.com/COI_salud/status/474205288258490368,,,,
corp_UNC,6/4/2014 11:05,0,0,T.Salz ( @ UNCpublichealth alum N.Brewer lab) Colorectal Cancer Survivors' Needs & Prefs for Survivorship Info @ ASCO http://ow.ly/xBHZG,,@ @,,4.74205E+17,https://twitter.com/corp_UNC/status/474205219262562305,,,,
P_Thornton10,6/4/2014 11:04,0,0,# MDigitalLife new data set of Ex-US physicians was used on this # ASCO14 post; to be announced at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74205E+17,https://twitter.com/P_Thornton10/status/474205084524347392,,,,
AaronStrout,6/4/2014 11:04,2,0,# MDigitalLife's new data set of Ex-US docs was used on this # ASCO14 post; to be announced in Paris @ # Doctors20 http://bit.ly/S5iXRD,,@,# # #,4.74205E+17,https://twitter.com/AaronStrout/status/474205044703649792,,,,
JoleneScience,6/4/2014 11:02,0,0,"Post- # ASCO14, looking forward to the olaparib FDA AdComm 6/25 $ AZN",,,#,4.74205E+17,https://twitter.com/JoleneScience/status/474204570843766784,,,,
nxtstop1,6/4/2014 11:01,1,0,"PROGRESS,SCIENCE,NEED EDU & $$ MT @ ElaineSchattner: @ Forbes:Review # ASCO14 & thoughts re Future of Cancer Science&Care http://onforb.es/1x19RWM",,@ @,#,4.74204E+17,https://twitter.com/nxtstop1/status/474204381458345984,,,,
CancerResearch,6/4/2014 11:01,2,0,Help the promotion of Cancer Research Month in your state! # CIM2014 # ASCO14 http://ow.ly/xyAD1,,,# #,4.74204E+17,https://twitter.com/CancerResearch/status/474204322822381568,,,,
DrYashGad,6/4/2014 11:00,0,0,# MDigitalLife's new data set of Ex-US physicians used in this # ASCO14 post; to be announced at # Doctors20 in Paris! http://bit.ly/S5iXRD,,,# # #,4.74204E+17,https://twitter.com/DrYashGad/status/474204044370522112,,,,
carisls,6/4/2014 11:00,2,0,Caris' Dr. Rebecca Feldman discusses importance of small-bowel adenocarcinoma # MolecularIntel research at # ASCO14 http://goo.gl/ASrTO0,,,# #,4.74204E+17,https://twitter.com/carisls/status/474203994319904769,,,,
PharmaFrance,6/4/2014 10:57,1,1,Le 50e @ ASCO consacre le nouveau rôle de l'immunothérapie contre le cancer @ Sciences_Avenir,,@ @,,4.74203E+17,https://twitter.com/PharmaFrance/status/474203369368981504,,,,
myCME,6/4/2014 10:55,0,0,Goserelin Helps Preserve Ovarian Function in Breast Cancer Therapy http://ow.ly/xA8WG # bcsm # ASCO14,,,# #,4.74203E+17,https://twitter.com/myCME/status/474202780522270722,,,,
PandaINT_rec,6/4/2014 10:55,0,0,@ Merck # drug shines at @ ASCO - http://bit.ly/1hZemYc @ pharmaNewsDaily @ PharmaNews # pharmaevents # pharma,,@ @ @ @,# # #,4.74203E+17,https://twitter.com/PandaINT_rec/status/474202739212566528,,,,
myCME,6/4/2014 10:55,0,0,Exemestane Superior to Tamoxifen in Early Breast Cancer http://ow.ly/xAw3U # ASCO14 # bcsm,,,# #,4.74203E+17,https://twitter.com/myCME/status/474202704051732482,,,,
JoleneScience,6/4/2014 10:54,0,0,"@ DrDavidStraus Hoping Adcetris in place of bleo will eventually help cHL pts, esp older pts; updated link: http://bit.ly/1p6zalD # ASCO14",,@,#,4.74202E+17,https://twitter.com/JoleneScience/status/474202417253216256,,,,
OAkkerman_ERG,6/4/2014 10:53,1,1,20% of Tweeters generated 69% of the conversation at # ASCO14 Stay tuned for our take on what it actually means # EnvironicsPharma,,,# #,4.74202E+17,https://twitter.com/OAkkerman_ERG/status/474202275762941952,,,,
AAOHNS,6/4/2014 10:52,2,0,Study Presented at # ASCO14: Most Oral HPV Infections Are In Men http://huff.to/1l0Mur1,,,#,4.74202E+17,https://twitter.com/AAOHNS/status/474202143012839424,,,,
a_silverstein,6/4/2014 10:52,1,0,"Opting out is not a great idea moving forward"" MT @ mtmdphd: Brave New World of # hcsm: # ASCO14 http://ow.ly/xzXmK""",,@,# #,4.74202E+17,https://twitter.com/a_silverstein/status/474202043331014656,,,,
OncologyCentral,6/4/2014 10:51,0,0,Did you attend # ASCO14? Discuss your meeting highlights with us on the # Oncology Central forum http://bit.ly/19MA7os,,,# #,4.74202E+17,https://twitter.com/OncologyCentral/status/474201907649851392,,,,
MelanomaReAlli,6/4/2014 10:46,0,0,"# ASCO14 coverage: Once A Year, # Cancer Research News Comes In A Flood, Not A Trickle via @ NPRHealth http://www.npr.org/blogs/health/2014/06/01/317402871/once-a-year-cancer-research-news-comes-in-a-flood-not-a-trickle …",,@,# #,4.74201E+17,https://twitter.com/MelanomaReAlli/status/474200615002730496,,,,
RevistaREGIO,6/4/2014 10:45,0,0,RT @ _SEOM: Oncólogos y periodistas pueden ver los resúmenes de lo más destacado de # ASCO14 http://www.seom.org/es/acceso-a-onconexion …,,@,#,4.742E+17,https://twitter.com/RevistaREGIO/status/474200217588609024,,,,
ASCOPost,6/4/2014 10:44,2,2,"Ceritinib Shows Rapid, Durable Response in ALK-Positive NSCLC http://ow.ly/xCgR9 # ASCO14 # lcsm",,,# #,4.742E+17,https://twitter.com/ASCOPost/status/474199971773022208,,,,
DrPaulyDeSantis,6/4/2014 10:43,0,0,"@ Festivus159 @ AndyBiotech @DionCapital actually the data at # ASCO14 showed co-1686 retains WT EGFR activity, while AZN inhibited WT >80%",,@ @ @DionCapital,#,4.742E+17,https://twitter.com/DrPaulyDeSantis/status/474199792784920576,,,,
Boehringer,6/4/2014 10:43,0,1,SOCIAL MEDIA SUMMARY: Day 5 at # ASCO14: our picks of day 5 http://bit.ly/1m1cLSF # lungcancer,,,# #,4.742E+17,https://twitter.com/Boehringer/status/474199657892306944,,,,
ventana,6/4/2014 10:42,4,2,Media Release: Ventana & @MedImmune collaborate to develop custom PD-L1 Assay for IHC # clinicaltrials http://ow.ly/xCgiR # ASCO14,,@MedImmune,# #,4.742E+17,https://twitter.com/ventana/status/474199635285004288,,,,
MarekTrnenyDr,6/4/2014 10:40,1,0,# ASCO14 LBA7008 R/R # CLL ibrutinib vs ofatumumab interesting data more on the # lymphomahubpic.twitter.com/B9yJsyGupd,,,# # #,4.74199E+17,https://twitter.com/MarekTrnenyDr/status/474199027500978177,,,,
DanaFarber,6/4/2014 10:35,0,2,Dana-Farber research and highlights from the annual ASCO meeting: http://bit.ly/1x6HlTO # ASCO14,,,#,4.74198E+17,https://twitter.com/DanaFarber/status/474197641577103360,,,,
Chiltern_CRO,6/4/2014 10:34,0,0,Sent @ SurveyMonkey to colleagues yesterday for # ASCO14 - what did you think? # sessions # ASCOconnections,,@,# # #,4.74197E+17,https://twitter.com/Chiltern_CRO/status/474197475624890369,,,,
_SEOM,6/4/2014 10:32,2,3,Oncólogos y periodistas pueden ver los resúmenes de lo más destacado de # ASCO14 http://www.seom.org/es/acceso-a-onconexion …,,,#,4.74197E+17,https://twitter.com/_SEOM/status/474196939182198785,,,,
ASCO,6/4/2014 10:31,8,4,Missed a session at # ASCO14? Watch it on Virtual Meeting - http://www.asco.org/vm,,,#,4.74197E+17,https://twitter.com/ASCO/status/474196697334415360,,,,
zorgnieu_ws,6/4/2014 10:30,0,0,# ASCO14 Beter effect van afatinib* dan van vergelijkende chemotherapie bij patiënten met EGFR-mutatiepositieve… http://wp.me/p2ZL1H-6tP,,,#,4.74197E+17,https://twitter.com/zorgnieu_ws/status/474196515452231680,,,,
zorgnieu_ws,6/4/2014 10:30,0,0,# ASCO14 Fase II PEAK studie: Verbeterde overleving met panitumumab bij gemetastaseerde colorectaalkanker… http://wp.me/p2ZL1H-6tO,,,#,4.74197E+17,https://twitter.com/zorgnieu_ws/status/474196503100002306,,,,
Medicalfacts,6/4/2014 10:26,0,0,# ASCO14 Beter effect van afatinib* dan van vergelijkende chemotherapie bij patiënten met EGFR-mutatiepositieve http://www.medicalfacts.nl/?p=207101,,,#,4.74196E+17,https://twitter.com/Medicalfacts/status/474195536443355136,,,,
myCME,6/4/2014 10:25,0,0,Ramucirumab + Docetaxel Improves Survival in Stage IV NSCLC http://ow.ly/xAO2t # ASCO14 # lcsm,,,# #,4.74195E+17,https://twitter.com/myCME/status/474195194070728704,,,,
davidgrahammd,6/4/2014 10:21,0,0,“ @ Cascadia: @ djsampson: would suggest # OncSM (rarely used vs # CASM) to keep your Oncology community intact after # ASCO14” @ drdonsdizon,,@ @ @,# # #,4.74194E+17,https://twitter.com/davidgrahammd/status/474194346137640960,,,,
CancerTherAdvsr,6/4/2014 10:20,0,0,Cetuximab + FOLFIRI Beneficial in mCRC With RAS Wild-type Tumors # colorectalcancer # ASCO14 http://ow.ly/xAIaC,,,# #,4.74194E+17,https://twitter.com/CancerTherAdvsr/status/474193930167545856,,,,
mtmdphd,6/4/2014 10:20,1,2,MT @ StefanoLuminari: # ASCO14 O'connors summary slide about exportins - XPO-1/CRM-1 @ lymphomahub pic.twitter.com/0lLDF1V6J8 # lymsm,,@ @,# #,4.74194E+17,https://twitter.com/mtmdphd/status/474193886240587776,,,,
eaonc,6/4/2014 10:18,1,0,MT @ StefanoLuminari: # ASCO14 @ GregNowakowski conclusion slide on R2CHOP for DLBCL @ lymphomahub pic.twitter.com/oGrF3mLbxu # EAOnc # lymsm,,@ @ @,# # #,4.74193E+17,https://twitter.com/eaonc/status/474193446971113472,,,,
mtmdphd,6/4/2014 10:17,2,2,MT @ StefanoLuminari: # ASCO14 @ GregNowakowski conclusion slide on R2CHOP for DLBCL @ lymphomahub pic.twitter.com/twAyy7QE5V # EAOnc # lymsm,,@ @ @,# # #,4.74193E+17,https://twitter.com/mtmdphd/status/474193260270059520,,,,
DomenickBertell,6/4/2014 10:15,0,0,# ASCO2014 takeaway: http://Mycancergenome.org comes up often as a key database to aid in curation / interpretation of advanced diagnostics,,,#,4.74193E+17,https://twitter.com/DomenickBertell/status/474192833172078593,,,,
TargetedOnc,6/4/2014 10:15,1,1,Immunotherapy Targeting HPV Demonstrates Activity in Cervical Cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/Immunotherapy-Targeting-HPV-Demonstrates-Activity-in-Cervical-Cancer … # ASCO14,,,#,4.74193E+17,https://twitter.com/TargetedOnc/status/474192748426579969,,,,
LillyDiabetes,6/4/2014 10:15,2,0,It's been an informative 4 days at # ASCO14. See you next year Chicago!,,,#,4.74193E+17,https://twitter.com/LillyDiabetes/status/474192716545687553,,,,
DomenickBertell,6/4/2014 10:14,0,0,"# ASCO2014 takeaway: Given pace of advancement, and spiraling complexity, most practicing oncs will need curation to interpret NGS results",,,#,4.74192E+17,https://twitter.com/DomenickBertell/status/474192433396187136,,,,
OCNA,6/4/2014 10:14,1,3,We are back from # ASCO14 with lots of exciting news to report about ovarian cancer. Stay tuned for our update http://www.ovariancancer.org/research-advocacy/ …,,,#,4.74192E+17,https://twitter.com/OCNA/status/474192351569924097,,,,
DomenickBertell,6/4/2014 10:13,0,0,# ASCO2014 takeaway: Samples from biopsies can also be problematic for NextGen Sequencing (NGS) - mix of tumor vs. germ line cells,,,#,4.74192E+17,https://twitter.com/DomenickBertell/status/474192165837352960,,,,
DomenickBertell,6/4/2014 10:11,0,0,# ASCO2014 takeaway: Bioinformatic analysis of WGS results + interpretation also highly variable and apparently often problematic,,,#,4.74192E+17,https://twitter.com/DomenickBertell/status/474191818062450692,,,,
DomenickBertell,6/4/2014 10:11,0,0,"# ASCO2014 takeaway: Variation in WGS results from different labs (different protocols, different equipment) is stunningly large",,,#,4.74192E+17,https://twitter.com/DomenickBertell/status/474191635660541952,,,,
Boehringer,6/4/2014 10:10,0,1,"“It's not the patients that mutate but the cancer within the patient Day 3 at # ASCO14 by Julia Knebel # lungcancer http://bit.ly/1onvYkl""",,,# #,4.74191E+17,https://twitter.com/Boehringer/status/474191421617225728,,,,
Medicalfacts,6/4/2014 10:10,0,0,# ASCO14 Fase II PEAK studie: Verbeterde overleving met panitumumab bij gemetastaseerde colorectaalkanker versus http://www.medicalfacts.nl/?p=207097,,,#,4.74191E+17,https://twitter.com/Medicalfacts/status/474191406702297090,,,,
survivornetca,6/4/2014 10:10,0,0,RT @ jrgralow: # ASCO14: Removing Ovaries Cuts Death Risk for BRCA1 # women http://www.medpagetoday.com/HematologyOncology/BreastCancer/46135 … # Cancer # WomensHealth # survivornet,,@,# # # # #,4.74191E+17,https://twitter.com/survivornetca/status/474191392734859265,,,,
DomenickBertell,6/4/2014 10:10,0,0,"# ASCO2014 takeaway: Cost reductions in WGS have hit a plateau well above the $1000 genome – more like $5,000 - $10,000 minimum",,,#,4.74191E+17,https://twitter.com/DomenickBertell/status/474191386682458112,,,,
SeqComplete,6/4/2014 10:07,0,0,"mt Twitter / ASCO: Comparing # ASCO13 & # ASCO14 ... pic.twitter.com/4RRJTdxHGA, see more http://tweetedtimes.com/search/%23ASCO14/en …",,,# #,4.74191E+17,https://twitter.com/SeqComplete/status/474190761236631552,,,,
drdonsdizon,6/4/2014 10:05,0,1,So happy that C Hinrichs' study in # cervca is getting wide press. # Immunotherapy @NCIBulletin @ ASCO # ASCO14 # gyncsmhttp://www.natureworldnews.com/articles/7356/20140602/immunotherapy-treats-cervical-cancer-success.htm …,,@NCIBulletin @,# # # #,4.7419E+17,https://twitter.com/drdonsdizon/status/474190149103144960,,,,
Pattytsheridan,6/4/2014 10:04,0,0,"Wow!! “Obesity is on its way to replacing tobacco as the number one preventable/modifiable cause of cancer.” - @ CliffordHudis # ASCO14"",,@,#,474189934128283648""",https://twitter.com/Pattytsheridan/status/474189934128283648,,,,,,,,
Cascadia,6/4/2014 10:02,0,1,@ djsampson: @ davidgrahammd would suggest # OncSM (rarely used vs # CASM) to keep your Oncology community intact after # ASCO14,,@ @,# # #,4.7419E+17,https://twitter.com/Cascadia/status/474189531629883394,,,,
FierceMedTech,6/4/2014 10:02,0,1,# ASCO14 Almac Dx spots ovarian cancer patients who would be hurt by $ RHHBY's Avastin. http://www.fiercediagnostics.com/story/almac-asco-dx-spots-ovarian-cancer-patients-whom-roches-avastin-would-hurt/2014-06-02 … # ovariancancer,,,# #,4.74189E+17,https://twitter.com/FierceMedTech/status/474189497672818688,,,,
HollmerMark,6/4/2014 10:02,0,0,# ASCO14 Almac Dx spots ovarian cancer patients who would be hurt by $ RHHBY's Avastin. http://www.fiercediagnostics.com/story/almac-asco-dx-spots-ovarian-cancer-patients-whom-roches-avastin-would-hurt/2014-06-02 … # ovariancancer,,,# #,4.74189E+17,https://twitter.com/HollmerMark/status/474189497664413696,,,,
drdonsdizon,6/4/2014 10:02,1,0,Let's hear em! RT @ davidgrahammd How do U keep twitter engagement alive post # ASCO14? Contact @ drdonsdizon or me with tips/suggestions # hcsm,,@ @,# #,4.74189E+17,https://twitter.com/drdonsdizon/status/474189400042389504,,,,
eMPR,6/4/2014 10:00,0,1,Immune-based therapy may help fight advanced forms of this gynecologic cancer: http://ow.ly/xC0rY # ASCO14 # oncology,,,# #,4.74189E+17,https://twitter.com/eMPR/status/474189027286216704,,,,
DrMiguelPerales,6/4/2014 9:59,5,1,"Revisiting # ASCO14, and Considering the Future of Cancer Science and Care by @ ElaineSchattner http://onforb.es/1x19RWM via @ forbes",,@ @,#,4.74189E+17,https://twitter.com/DrMiguelPerales/status/474188790630600704,,,,
djsampson,6/4/2014 9:58,1,1,"@ ASCO @ twittmanda No apology necessary! More power would be great, but a better phone probably would have saved me.",,@ @,,4.74188E+17,https://twitter.com/djsampson/status/474188320704962561,,,,
mtmdphd,6/4/2014 9:55,0,0,Navigating the Brave New World of Social Media in Medicine: Getting the Most Out of Technology - @ ASCO [6/1/14] http://ow.ly/xzXmK,,@,,4.74188E+17,https://twitter.com/mtmdphd/status/474187616976637952,,,,
jrgralow,6/4/2014 9:54,0,3,# ASCO14: Trastuzumab may be beneficial for small HER2+ Breast Ca - but few w/ negative nodes avail for this analysis! http://www.medpagetoday.com/HematologyOncology/BreastCancer/46132 …,,,#,4.74187E+17,https://twitter.com/jrgralow/status/474187490039848960,,,,
mtmdphd,6/4/2014 9:53,0,0,The Social Oncology Project - 2014 - via @ BrianReid @ MDigitalLife @ W2OGroup http://ow.ly/xC6za # ASCO14 # dox # in,,@ @ @,# # #,4.74187E+17,https://twitter.com/mtmdphd/status/474187107481948160,,,,
jrgralow,6/4/2014 9:53,0,0,# ASCO14: Removing Ovaries Cuts Death Risk for BRCA1 Women http://www.medpagetoday.com/HematologyOncology/BreastCancer/46135 …,,,#,4.74187E+17,https://twitter.com/jrgralow/status/474187084173824000,,,,
Czarnowski,6/4/2014 9:53,0,8,We support healthcare research by transforming it into a physical space. Until next year @ ASCO! http://www.czarnowski.com/healthcare,,@,,4.74187E+17,https://twitter.com/Czarnowski/status/474187072061075456,,,,
TheBirdieLady,6/4/2014 9:51,0,0,Dedicated to all the # ASCO14 participants... pic.twitter.com/Obi0nWWCP0,,,#,4.74187E+17,https://twitter.com/TheBirdieLady/status/474186592949927936,,,,
mtmdphd,6/4/2014 9:49,0,0,"@ davidgrahammd @ DrDonSDizon - cross leverage ASCO specialty meetings, link to blog posts, discuss implications for # ASCO14 results...",,@ @,#,4.74186E+17,https://twitter.com/mtmdphd/status/474186271657836544,,,,
AndyBiotech,6/4/2014 9:49,1,2,Merck KGaA moves its anti-PD-L1 into Ph2 in Merkel Cell Carcinoma despite disappointing early data at # ASCO14 http://clinicaltrials.gov/ct2/show/NCT02155647 …,,,#,4.74186E+17,https://twitter.com/AndyBiotech/status/474186211230482432,,,,
djsampson,6/4/2014 9:49,1,0,@ twittmanda @ ASCO Power was indeed an issue. My phone died at multiple sessions; maybe I need a new phone!,,@ @,,4.74186E+17,https://twitter.com/djsampson/status/474186134990241792,,,,
CancerNetwrk,6/4/2014 9:48,1,1,Role of Neoadjuvant Oxaliplatin Unclear in Early Rectal Cancer http://bit.ly/1kAPKty # ASCO14,,,#,4.74186E+17,https://twitter.com/CancerNetwrk/status/474185887602212864,,,,
LSVCo,6/4/2014 9:45,0,0,RT @ drsteventucker: The fascinating anti-cancer genome of the blind mole-rat. # science # asco14 # genomics http://sciencenews.org/article/blind- …,,@,# # #,4.74185E+17,https://twitter.com/LSVCo/status/474185093914046464,,,,
AlpineBV_Miller,6/4/2014 9:43,0,1,"So, anyone having # ASCO14 withdrawals or are y'all just glad to be home?",,,#,4.74185E+17,https://twitter.com/AlpineBV_Miller/status/474184715482955776,,,,
Acedotor,6/4/2014 9:43,0,0,@ AstraZeneca INFORMA DE LOS RÁPIDOS AVANCES CONSEGUIDOS CON SU PIPELINE DE # ONCOLOGÍA EN @ ASCO 2014: http://noticiadesalud.blogspot.com.es/2014/06/astrazeneca-informa-de-los-rapidos.html …,,@ @,#,4.74185E+17,https://twitter.com/Acedotor/status/474184630313439232,,,,
ASCO,6/4/2014 9:40,3,0,. @ drdonsdizon questions preventative med in patients w/ metastatic cancer during # ASCO14 http://bit.ly/1nKUH6g # bcsm # ASCOconnection,,@,# # #,4.74184E+17,https://twitter.com/ASCO/status/474183824705081344,,,,
davidgrahammd,6/4/2014 9:39,5,3,How do you keep twitter engagement alive post # ASCO14? Contact @ drdonsdizon or me with tips/suggestions # hcsm,,@,# #,4.74184E+17,https://twitter.com/davidgrahammd/status/474183700754608128,,,,
KaylaRodrigue11,6/4/2014 9:38,2,0,Twitter gives MDs outside of US an active voice in # ASCO14 dialogue. Great review by @ chimoose. http://bit.ly/1l5mdYE # hcsm,,@,# #,4.74183E+17,https://twitter.com/KaylaRodrigue11/status/474183416238194690,,,,
JonnyJPatience,6/4/2014 9:32,1,0,# ASCO14 attendees: Have you seen the collection of our favorite oncology articles this month (incl. 2 FREE papers)? http://bit.ly/ERASCO,,,#,4.74182E+17,https://twitter.com/JonnyJPatience/status/474182009666162688,,,,
CancerTherAdvsr,6/4/2014 9:30,0,0,# ASCO14: Necitumumab + Gemcitabine-Cisplatin Ups Survival in Squamous NSCLC # lungcancer http://ow.ly/xAI1l,,,# #,4.74181E+17,https://twitter.com/CancerTherAdvsr/status/474181449697226752,,,,
JediPD,6/4/2014 9:28,0,0,@ DrAttai Enjoyed your # ASCO14 conversations!,,@,#,4.74181E+17,https://twitter.com/JediPD/status/474181016043917313,,,,
OMedLive,6/4/2014 9:20,0,0,Great few days at # ASCO14. Informative presentations & engaging conversations in our booth. What were the highlights for you?,,,#,4.74179E+17,https://twitter.com/OMedLive/status/474178811438043136,,,,
OncLive,6/4/2014 9:20,0,0,Novel Rituximab Combinations Highly Effective in CLL http://ow.ly/xA1X6 # ASCO14,,,#,4.74179E+17,https://twitter.com/OncLive/status/474178807164059649,,,,
Kreftforeningen,6/4/2014 9:19,0,4,Vi har vært tilstede på den store kreftkonferansen # ASCO14 @ DagensMedisin har samlet noen av sakene som kom frem der: http://www.dagensmedisin.no/asco2014,,@,#,4.74179E+17,https://twitter.com/Kreftforeningen/status/474178631443709952,,,,
GlopesMd,6/4/2014 9:16,0,5,# ASCO14 Daily News - American Society of Clinical Oncology Activities in Brazil http://lnkd.in/biPRT8c,,,#,4.74178E+17,https://twitter.com/GlopesMd/status/474177762845270017,,,,
DRGinsights,6/4/2014 9:12,0,0,CLL: Clinical Practice on the Cusp of Dramatic Change http://tinyurl.com/mkhc8hz # ASCO14,,,#,4.74177E+17,https://twitter.com/DRGinsights/status/474176767889260544,,,,
HemOncToday,6/4/2014 9:10,1,0,# ASCO14 @ MassGeneral doc discusses how # HPV targeted T-cell therapy shows promise for advanced cervical cancer: http://goo.gl/thT1kW,,@,# #,4.74176E+17,https://twitter.com/HemOncToday/status/474176440112807936,,,,
HealioAdolMed,6/4/2014 9:10,0,0,# ASCO14 @ MassGeneral doc discusses how # HPV targeted T-cell therapy shows promise for advanced cervical cancer: http://goo.gl/thT1kW,,@,# #,4.74176E+17,https://twitter.com/HealioAdolMed/status/474176439290691584,,,,
GoHealio,6/4/2014 9:10,0,0,# ASCO14 @ MassGeneral doc discusses how # HPV targeted T-cell therapy shows promise for advanced cervical cancer: http://goo.gl/thT1kW,,@,# #,4.74176E+17,https://twitter.com/GoHealio/status/474176438535741440,,,,
MarekTrnenyDr,6/4/2014 9:07,1,0,# ASCO14 abst8508 sirolimus + vorinostat for R/R Hodgkin # lymphoma - combined targeted therapy - more on # lymphomahubpic.twitter.com/OilOTxSCHE,,,# # #,4.74176E+17,https://twitter.com/MarekTrnenyDr/status/474175711323099136,,,,
SethBla,6/4/2014 9:05,1,1,MT @ ASCO “Will Watson help make rt decisions 4 pts future” http://bit.ly/1kmwnFo incr in therapeutics will incr need 4 better algrthm.,,@,,4.74175E+17,https://twitter.com/SethBla/status/474175097218285568,,,,
MarekTrnenyDr,6/4/2014 9:03,1,0,"# ASCO14 abs 8502 PET restaging data in follicular # lymphoma, important data! more comments on # lymphomahubpic.twitter.com/9Ex4LFRfvC",,,# # #,4.74175E+17,https://twitter.com/MarekTrnenyDr/status/474174648058650624,,,,
ONAcom,6/4/2014 9:01,0,0,# ASCO14: Ginger extract improves # chemotherapy-induced nausea - http://ow.ly/xzRwL,,,# #,4.74174E+17,https://twitter.com/ONAcom/status/474174161162895360,,,,
bioclinica,6/4/2014 9:01,0,0,RT @ Roche: What's the difference between overall & progression-free survival? Test your # ClinicalTrials IQ: http://ow.ly/xwysZ # ASCO14,,@,# #,4.74174E+17,https://twitter.com/bioclinica/status/474174102929145856,,,,
CancerResearch,6/4/2014 9:01,3,1,"Webinar tomorrow: Harnessing the Immune System to Treat Melanoma"" # CIM2014 # ASCO14""",,,# #,4.74174E+17,https://twitter.com/CancerResearch/status/474174102115459072,,,,
medpagetoday,6/4/2014 9:00,3,2,BSO markedly reduced the risk of death for women with BRCA1-associated breast cancer # ASCO14 http://bit.ly/1rKTBsZ,,,#,4.74174E+17,https://twitter.com/medpagetoday/status/474173739915948032,,,,
IngeDiepman,6/4/2014 8:57,1,2,"Alle journaals www.oncologietv # ASCO14 online. Afl 4;borstkanker gastro-intestinale tumoren /Sabine Linn, Kees Punt en Hanneke v Laarhoven",,,#,4.74173E+17,https://twitter.com/IngeDiepman/status/474173128827236352,,,,
CancerDartmouth,6/4/2014 8:55,1,0,# Dartmouth researchers: Early palliative support services help those caring for patients w/ advanced # cancer http://dartgo.org/asco # ASCO14,,,# # #,4.74173E+17,https://twitter.com/CancerDartmouth/status/474172664622624768,,,,
CancerTherAdvsr,6/4/2014 8:55,0,0,"# ASCO14: Less Frequent Zoledronic Acid for Bone Metastases Safe, Effective # breastcancer http://ow.ly/xAHUR",,,# #,4.74173E+17,https://twitter.com/CancerTherAdvsr/status/474172551972016128,,,,
myCME,6/4/2014 8:55,0,0,Lenvatinib: New Hope for Radioiodine-resistant Differentiated Thyroid Cancer http://ow.ly/xAOwl # ASCO14 # endocrinology,,,# #,4.74173E+17,https://twitter.com/myCME/status/474172524390281216,,,,
motorrecilla,6/4/2014 8:51,0,1,"Only 1 day after # ASCO14, missing feeding my brain with science. Good bye # chicago, and thanks for your hospitality!",,,# #,4.74172E+17,https://twitter.com/motorrecilla/status/474171670316744704,,,,
trialcard,6/4/2014 8:50,0,0,30% of women diagnosed with early breast cancer will progress to advanced disease. # ASCO14 # bcsm # pharma MT via @ Pfizer,,@,# # #,4.74171E+17,https://twitter.com/trialcard/status/474171290711261184,,,,
DMGrayMD,6/4/2014 8:50,0,0,New # research presented at # ASCO14 suggests fish & # exercise may prevent relapse of # coloncancer. http://consumer.healthday.com/cancer-information-5/colon-cancer-news-96/fish-exercise-might-thwart-return-of-colon-cancer-finds-study-688450.html#.U48Sv_U5qMk.twitter … @ AmericanCancer,,@,# # # # #,4.74171E+17,https://twitter.com/DMGrayMD/status/474171250487857152,,,,
CRC_Medical,6/4/2014 8:49,1,1,"@ BRCAresponder @ ASCO looks like a great # book, thanks for sharing Amy! Feel free to check out our # medical library at http://ow.ly/xBVG2",,@ @,# #,4.74171E+17,https://twitter.com/CRC_Medical/status/474171090156408832,,,,
mtmdphd,6/4/2014 8:48,0,0,Speaking at # ASCO14 on social media and # bcsm - @ obogler http://ow.ly/xBVuG # ASCO14 # hcsm,,@,# # # #,4.74171E+17,https://twitter.com/mtmdphd/status/474170716859146240,,,,
quantabiodesign,6/4/2014 8:46,1,0,@ ADC_drugs Thanks for all your retweets. We do appreciate it. @ ASCO,,@ @,,4.7417E+17,https://twitter.com/quantabiodesign/status/474170262381137920,,,,
Boehringer,6/4/2014 8:45,41,132,Join # lungcancer experts Profs Yang & Schuler on 11June to discuss BI LUX data @ # ASCO14. For non-US/UK HCPs https://bi-asco.meddigital.com/,,@,# #,4.7417E+17,https://twitter.com/Boehringer/status/474169984235864064,,,,
PharmSource,6/4/2014 8:41,0,0,We covered # ASCO14 this week! For updated oncology product changes see the PharmSource Lead Sheet http://bit.ly/1hdbfjx,,,#,4.74169E+17,https://twitter.com/PharmSource/status/474169179126632449,,,,
EmmaPettengale,6/4/2014 8:38,0,0,Nektar presents positive preclinical data for new # immunotherapy NKTR-214 which selectively activates IL-2 receptor complex # ASCO14 # cancer,,,# # #,4.74168E+17,https://twitter.com/EmmaPettengale/status/474168191892328449,,,,
DrDeborahFisher,6/4/2014 8:36,0,1,"# ASCO14 Fish, Exercise may reduce risk of # colon # cancer # CRC recurrence http://consumer.healthday.com/cancer-information-5/colon-cancer-news-96/fish-exercise-might-thwart-return-of-colon-cancer-finds-study-688450.html#.U48Sv_U5qMk.twitter …",,,# # # # #,4.74168E+17,https://twitter.com/DrDeborahFisher/status/474167874555097089,,,,
oh_henry,6/4/2014 8:32,1,0,@ DrLen Great piece on the # ASCO14 melanoma studies! Here's our explainer on the science behind them: http://scienceblog.cancerresearchuk.org/2014/06/02/new-immunotherapy-drugs-hit-the-headlines-how-do-they-work/ …,,@,#,4.74167E+17,https://twitter.com/oh_henry/status/474166865733099520,,,,
ByMadeleineA,6/4/2014 8:32,0,0,Impressive data with $ MYGN's myPath # melanoma test at # ASCO14: 90% sensitivity and 91% specificity. To help where diagnosis is difficult,,,# #,4.74167E+17,https://twitter.com/ByMadeleineA/status/474166800868212736,,,,
cipomo,6/4/2014 8:25,0,0,# ASCO2014 Fasola: Bisogna garantire parità di accesso alle # cure e sostenibilità dei costi http://www.panoramasanita.it/?p=3177,,,# #,4.74165E+17,https://twitter.com/cipomo/status/474164916971384832,,,,
cipomo,6/4/2014 8:23,0,0,# CIPOMO # ASCO2014 Fasola: grandi attese verso farmaci immunoterapici @ HealthDeskNewshttp://www.healthdesk.it/diritto_alla_salute/limmunoterapia_anticancro_una_promessa_insostenibile/1401878471 …,,@,# #,4.74164E+17,https://twitter.com/cipomo/status/474164464057856000,,,,
OncLive,6/4/2014 8:20,0,0,Lenvatinib Likely to Become Standard in Resistant Differentiated Thyroid Cancer http://ow.ly/xA1Ed # ASCO14,,,#,4.74164E+17,https://twitter.com/OncLive/status/474163760941518849,,,,
VincentRK,6/4/2014 8:19,2,3,Agree. It is meaningful. MT “ @ OncLive: Panobinostat showed meaningful clinical benefit in R/R # myeloma http://ow.ly/xAeaX # ASCO14”,,@,# #,4.74164E+17,https://twitter.com/VincentRK/status/474163609736445952,,,,
Boehringer,6/4/2014 8:17,0,1,BLOG POST: Read our roundup of day 4 at ASCO by Julia Knebel #lungcancer # ASCO14 http://bit.ly/1kG1JB5,,,#lungcancer #,4.74163E+17,https://twitter.com/Boehringer/status/474163102628741121,,,,
davisa20,6/4/2014 8:17,1,0,Amazing! RT @ ASCO Comparing # ASCO13 & # ASCO14 Twitter data (4 days prior to meeting start to last day) via @ Symplur pic.twitter.com/ovqwvsZ1Ug”,,@ @,# #,4.74163E+17,https://twitter.com/davisa20/status/474163056743030785,,,,
zitorikruz,6/4/2014 8:08,0,0,"Barcina dandose pote en Leire,como un gato con natillas/ # ASCO14",,,#,4.74161E+17,https://twitter.com/zitorikruz/status/474160724458352641,,,,
Dominic_Tyer,6/4/2014 8:04,1,0,AstraZeneca shows off cancer immunotherapy http://buff.ly/SsGk86 # pharma # ASCO14,,,# #,4.7416E+17,https://twitter.com/Dominic_Tyer/status/474159667816693760,,,,
DrDeborahFisher,6/4/2014 8:03,0,1,# ASCO14 # Oophorectomy may reduce mortality in women with early-stage ER-negative # breast # cancer & BRCA1 mutation http://www.medpagetoday.com/HematologyOncology/BreastCancer/46135?xid=nl_mpt_DHE_2014-06-04 …,,,# # # #,4.7416E+17,https://twitter.com/DrDeborahFisher/status/474159612141121537,,,,
BairdAM,6/4/2014 8:02,0,0,"# lcsm  @ ASCO: Read Educational Book articles on topics in Lung Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1jY247M """"",,@,# #,4.74159E+17,https://twitter.com/BairdAM/status/474159273899859968,,,,
BairdAM,6/4/2014 8:01,0,0,"# lcsm RT  @ OncLive: A number of ongoing trials are investigating MPDL2380A in lung cancer http://ow.ly/xzPt2 # ASCO14""""",,@,# #,4.74159E+17,https://twitter.com/BairdAM/status/474158991145066497,,,,
MatthewHSimmons,6/4/2014 8:00,0,1,Nice analysis on # ASCO14 from @ thinkemotive: http://www.thinkemotive.com/infographic-insights-from-asco14.html …pic.twitter.com/a10pmNM9cZ,,@,#,4.74159E+17,https://twitter.com/MatthewHSimmons/status/474158872446664704,,,,
WilliamDale_MD,6/4/2014 7:55,1,1,Agree! Honored to be among this group! @ rsm2800 @ chimoose @ ASCO @ CliffordHudis @ mtmdphd @ DrAttai,,@ @ @ @ @ @,,4.74158E+17,https://twitter.com/WilliamDale_MD/status/474157611227807745,,,,
MarcusOrton,6/4/2014 7:52,0,1,Too easily @ subatomicdoc: “We build too many walls and not enough bridges.” Sir Isaac Newton (via njoi) http://tmblr.co/ZzLuQy1HQxyZp # ASCO14 # hcsm,,@,# #,4.74157E+17,https://twitter.com/MarcusOrton/status/474156790448685056,,,,
Sports_bios,6/4/2014 7:52,0,1,"$ CLVS and $ PBYI are very interesting cases post # ASCO14 .. me willing to bet one drug works, the other - Hahaha.",,,#,4.74157E+17,https://twitter.com/Sports_bios/status/474156658143141888,,,,
HPE_magazine,6/4/2014 7:51,0,0,Dr. Bryd from # TheJames comments on # Ibrutinib RESONATE™ data presented at # ASCO14 http://bit.ly/1kFp2ec via @ HPE_magazine,,@,# # #,4.74156E+17,https://twitter.com/HPE_magazine/status/474156463150342144,,,,
MelPalMD,6/4/2014 7:51,1,1,"@ obogler @ rsm2800 @ mtmdphd at # ASCO14 on social media, cancer care & cancer research http://wp.me/p3daDY-ij",,@ @ @,#,4.74156E+17,https://twitter.com/MelPalMD/status/474156434460917761,,,,
Sports_bios,6/4/2014 7:49,0,0,Hangover day post # ASCO14? Pretty quiet bios stream this morning.. can we get another # Panic-Citi ..,,,# #,4.74156E+17,https://twitter.com/Sports_bios/status/474155873393065984,,,,
rbsalute,6/4/2014 7:30,0,0,"# Asco14: sugli scudi nuove strategie su genoma, immunoterapia e nanotecnologie http://www.doctor33.it/da-asco-nuove-strategie-su-genoma-immunoterapia-e-nanotecnologie/clinica/news-51481.html?xrtd=CLSRASRTVRRCPRSAACVXVPT#.U48DHw-6-8Q.twitter …",,,# #,4.74151E+17,https://twitter.com/rbsalute/status/474151174392659968,,,,
IAmTonyNoto,6/4/2014 7:24,0,0,"Are we getting closer to cracking the code in treating cancer? http://bit.ly/TcF3my -after the @ ASCO event, more M&A may be on the horizon",,@,,4.7415E+17,https://twitter.com/IAmTonyNoto/status/474149691903315968,,,,
OncLive,6/4/2014 7:20,3,1,Panobinostat with bortezomib and dexamethasone showed meaningful clinical benefit in R/R multiple myeloma http://ow.ly/xAeaX # ASCO14,,,#,4.74149E+17,https://twitter.com/OncLive/status/474148603221798912,,,,
subatomicdoc,6/4/2014 7:14,2,1,PHD Comics: Art vs. Research http://www.phdcomics.com/comics.php?f=1714 … via @ phdcomics # ASCO14 cc @ theNCI,,@ @,#,4.74147E+17,https://twitter.com/subatomicdoc/status/474147217687584768,,,,
teamoncology,6/4/2014 7:12,8,4,【 # ASCO14 Update】米国臨床腫瘍学会は、肥満を次世代のタバコとして捉える見解を会長が述べた。肥満の方々、肥満は単に高血圧とかの問題ではありません。がんになりやすくなります。,,,#,4.74147E+17,https://twitter.com/teamoncology/status/474146725318254593,,,,
RichardWJoseph,6/4/2014 7:11,0,2,For awesome insight in GU cancers # ASCO14 follow @ ERPlimackMD @ montypal.,,@ @,#,4.74146E+17,https://twitter.com/RichardWJoseph/status/474146392827772928,,,,
drphil_urology,6/4/2014 7:11,0,1,"RT @ dytcmd: #of RFs predict seminoma surv relapse # testiscancer RF= >4cm, rete testis inv MT @ ASCO SWENOTECA http://bit.ly/1oSpjSQ # ASCO14",,@ @,#of # #,4.74146E+17,https://twitter.com/drphil_urology/status/474146368089763841,,,,
seniorhomes,6/4/2014 7:04,1,1,"RT @ JNCI_Now: When caregivers began receiving palliative care support at time of patient’s cancer diagnosis, they had... # ASCO14",,@,#,4.74145E+17,https://twitter.com/seniorhomes/status/474144592409817088,,,,
subatomicdoc,6/4/2014 7:03,0,0,"@ NirajGusani I won't be as hyperactive on # PancSM as I was at # ASCO14. Besides, I need to learn more from you, @ MKatzMD & @ DianeReidyLagun",,@ @ @,# #,4.74144E+17,https://twitter.com/subatomicdoc/status/474144365250891776,,,,
PulmaoSA,6/4/2014 6:59,0,0,50 years of progress in # lungcancer research http://bit.ly/TXJxxV # ASCO14 # quitsmoking protect # life,,,# # # #,4.74143E+17,https://twitter.com/PulmaoSA/status/474143495003713537,,,,
mtmdphd,6/4/2014 6:52,0,0,MT @ DrDavidStraus: Age but not G-CSF use increases risk of bleomycin-induced lung toxicity. # ASCO14 Abstract http://abstracts.asco.org/144/index.html # lymsm,,@,# #,4.74142E+17,https://twitter.com/mtmdphd/status/474141580538818561,,,,
dytcmd,6/4/2014 6:49,2,1,#of RFs predict relapse # testca MT @ ASCO: Surveil w/seminoma # testicular cancer & no risk factors SWENOTECA http://bit.ly/1oSpjSQ # ASCO14,,@,#of # # #,4.74141E+17,https://twitter.com/dytcmd/status/474140819705040896,,,,
osservasaluteaz,6/4/2014 6:47,0,0,"@ AstraZeneca, buoni dati dall' @ ASCO per la pipeline oncologica: http://bit.ly/1nNyqVt via @ PharmaStar",,@ @ @,,4.7414E+17,https://twitter.com/osservasaluteaz/status/474140362442043392,,,,
DonnaYoungDC,6/4/2014 6:47,1,0,ASCO 2014: High cancer costs: Not 'victimless' for anyone http://bit.ly/SsHyjY # pharma # biotech # ASCO2014 # highdrugprices # drugcosts,,,# # # # #,4.7414E+17,https://twitter.com/DonnaYoungDC/status/474140306888458241,,,,
puntu1,6/4/2014 6:40,0,0,"For patients, value is tied to goals; revisiting regularly is key to high-quality care - @ hmhyltonpac blog: http://bit.ly/1ktHr2p via @ ASCO",,@ @,,4.74139E+17,https://twitter.com/puntu1/status/474138562162470912,,,,
OncLive,6/4/2014 6:20,0,1,Monoclonal antibodies hold the potential to revolutionize treatment for patients with http://ow.ly/xA18b # ASCO14,,,#,4.74133E+17,https://twitter.com/OncLive/status/474133487302500352,,,,
HallandPartners,6/4/2014 6:14,0,0,How immunotherapy is changing the game http://bit.ly/S7zx3f # ASCO14 # oncology,,,# #,4.74132E+17,https://twitter.com/HallandPartners/status/474131980943384576,,,,
subatomicdoc,6/4/2014 6:12,1,2,"@ NirajGusani I also spoke to @ PanCAN at # ASCO14 & explained what a great opportunity the will be to connect w/ PTA, caregivers, MDs # pancsm",,@ @,# #,4.74132E+17,https://twitter.com/subatomicdoc/status/474131662667022336,,,,
AtriumHealth,6/4/2014 6:10,4,1,. @ EdKimMDLCI weighs in on how immune therapies are improving cancer treatments ⇒ http://usat.ly/1rCQraB (via @ USAToday) # ASCO14,,@ @,#,4.74131E+17,https://twitter.com/AtriumHealth/status/474130942332645376,,,,
drsteventucker,6/4/2014 6:06,8,4,"Great writing from @ ElaineSchattner - Revisiting ASCO, and Considering the Future of Cancer Science and Care # ASCO14 http://onforb.es/TcspUu",,@,#,4.7413E+17,https://twitter.com/drsteventucker/status/474130033674838016,,,,
PMLiVEcom,6/4/2014 6:06,1,0,AstraZeneca shows off cancer immunotherapy http://bit.ly/UaLLtO # pharma # ASCO14,,,# #,4.7413E+17,https://twitter.com/PMLiVEcom/status/474129969632002048,,,,
roche_es,6/4/2014 6:03,2,1,La prometedora alternativa a los tratamientos tradicionales contra el cáncer: # Inmunoterapia # ASCO14@elmundo_es http://www.elmundo.es/elmundosalud/documentos/2014/05/inmunoterapia/inmunoterapia.html …,,@elmundo_es,# #,4.74129E+17,https://twitter.com/roche_es/status/474129362204123136,,,,
SeqComplete,6/4/2014 6:01,0,0,buzzz at # ASCO14 http://tweetedtimes.com/search/%23ASCO14/en …,,,#,4.74129E+17,https://twitter.com/SeqComplete/status/474128710430650368,,,,
zorgnieu_ws,6/4/2014 6:00,0,0,"# ASCO14 highlights maandag, vooral veel immunotherapie bij melanoom http://wp.me/p2ZL1H-6tk",,,#,4.74129E+17,https://twitter.com/zorgnieu_ws/status/474128554519560192,,,,
thinkemotive,6/4/2014 5:55,3,7,Infographic: Insights from # ASCO14 | The Power of # SocialMedia in Healthcare http://bit.ly/1jQdHYM # digitalhealth # digitalpharma,,,# # # #,4.74127E+17,https://twitter.com/thinkemotive/status/474127227739971584,,,,
Medicalfacts,6/4/2014 5:49,0,0,"# ASCO14 highlights van dag 3, vooral veel melanoom nieuws http://www.medicalfacts.nl/?p=207080",,,#,4.74126E+17,https://twitter.com/Medicalfacts/status/474125698983272449,,,,
TransgeneSA,6/4/2014 5:45,0,0,L' # ASCO14 : résultats encourageants pour l' # immunothérapie. La lutte contre le # cancer continue http://ow.ly/xBrAs via @ Doctissimo,,@,# # #,4.74125E+17,https://twitter.com/TransgeneSA/status/474124719609106432,,,,
GustaveRoussy,6/4/2014 5:38,3,2,ASCO : survie spectaculaire dans le cancer de la prostate métastasé | Le Quotidien du Medecin: http://www.lequotidiendumedecin.fr/specialites/cancerologie/asco-survie-spectaculaire-dans-le-cancer-de-la-prostate-metastase#.U47otNJ7PU0.twitter … # ASCO14,,,# #,4.74123E+17,https://twitter.com/GustaveRoussy/status/474122932008939520,,,,
EmmaPettengale,6/4/2014 5:37,0,0,Interested in the recent # ASCO2014 ramucirumab results? Check out Herbert Hurwitz's #'ExpertOpinion on the drug http://bit.ly/1jQd9C7,,,# #,4.74123E+17,https://twitter.com/EmmaPettengale/status/474122720914210816,,,,
EmmaPettengale,6/4/2014 5:29,0,0,News: @ MerrimackPharma Presents Phase 1 Clinical Data Supporting 4 New Antibody Therapeutic Programs at # ASCO2014 http://www.globenewswire.com/news-release/2014/06/02/641215/10084204/en/Merrimack-Pharmaceuticals-Presents-Phase-1-Clinical-Data-Supporting-Four-Novel-Antibody-Therapeutic-Programs-at-the-2014-ASCO-Annual-Meeting.html#sthash.yKTZd9Ei.dpuf …,,@,# #sthash,4.74121E+17,https://twitter.com/EmmaPettengale/status/474120714635968512,,,,
Consalud_es,6/4/2014 5:20,2,0,RT @ _seom: Oncólogos y periodistas pueden ver los resúmenes de lo más destacado de # ASCO14 http://www.seom.org/es/servicios-al-socio/formacion-y-recursos/onconexion-2014 …,,@,#,4.74118E+17,https://twitter.com/Consalud_es/status/474118371857170432,,,,
TheBirdieLady,6/4/2014 5:18,0,0,Another # ASCO14 is over... So many things to kick-off now.,,,#,4.74118E+17,https://twitter.com/TheBirdieLady/status/474118030902165505,,,,
CambNetwork,6/4/2014 5:16,1,0,. @ AstraZeneca’s @MedImmune presents encouraging immunotherapy data @ ASCO 2014 http://bit.ly/1kC0jg7 # membernews,,@ @MedImmune @,#,4.74117E+17,https://twitter.com/CambNetwork/status/474117439874408450,,,,
MBLoberg,6/4/2014 5:14,0,0,Anbefaler å lese mer om siste nytt fra årets @ ASCO # ASCO14 på @ DM_ASCO @ DagensMedisin sine sider: http://bit.ly/1kBZSCs,,@ @ @,#,4.74117E+17,https://twitter.com/MBLoberg/status/474117061992787968,,,,
EmmaPettengale,6/4/2014 5:14,0,0,News: Incyte says early data suggests synergy between ID01 inhibitor & ipilumumab in melanoma # ASCO14 # cancer # clinicaltrials,,,# # #,4.74117E+17,https://twitter.com/EmmaPettengale/status/474116967558041600,,,,
MBLoberg,6/4/2014 5:11,0,0,@ DagensMedisin Utpr.enhetens Olav Dajani @ Oslounivsykehus har presentert to av sine kliniske studier på @ ASCO # ASCO14 http://bit.ly/SsszGJ,,@ @ @,#,4.74116E+17,https://twitter.com/MBLoberg/status/474116152365694976,,,,
OncLive,6/4/2014 5:10,0,1,Long-term follow-up demonstrates nearly doubled median OS with the combination of ipilimumab and nivolumab http://ow.ly/xzUIv # ASCO14,,,#,4.74116E+17,https://twitter.com/OncLive/status/474115897725300736,,,,
BIGagainstBC,6/4/2014 5:06,0,0,ALTTO Trial Findings Raise Questions on Approach to Drug Development in Early Breast Cancer # ASCO14 http://am.asco.org/altto-trial-findings-raise-questions-approach-drug-development-early-breast-cancer#.U47hN5hkGBw.twitter …,,,# #,4.74115E+17,https://twitter.com/BIGagainstBC/status/474114862906236929,,,,
vallhebron,6/4/2014 5:02,0,0,"Josep Tabernero, director del # VHIO i director clínic d' # Oncologia Mèdica # hvhebron, explica les novetats presentades a @ ASCO a @ elsmatins",,@ @,# # #,4.74114E+17,https://twitter.com/vallhebron/status/474113831195930624,,,,
BMCMedicine,6/4/2014 4:56,0,0,Promising new trial results for treating # melanoma # ASCO14 http://bbc.in/1l1XZyn via @ bbchealth,,@,# #,4.74112E+17,https://twitter.com/BMCMedicine/status/474112340578033664,,,,
Getaskincheck,6/4/2014 4:49,0,0,# lionsclubs # campbelltown tonight about share why @900kmForACure is so important @ MelanomaAus @ Rustyburgher # melanoma # ASCO14,,@900kmForACure @ @,# # # #,4.74111E+17,https://twitter.com/Getaskincheck/status/474110708502642688,,,,
Medzineapp,6/4/2014 4:46,0,0,"Post # ASCO14: New Approaches Highlighted to Monitor, Treat Lymphoma http://bit.ly/1rKDZ8H",,,#,4.7411E+17,https://twitter.com/Medzineapp/status/474109842966466560,,,,
ecancer,6/4/2014 4:45,0,1,Prof Schlumberger talks to # ecancer on the phase III SELECT trial looking at # thyroidcancer http://ecancer.org/video/2900/phase-iii-select-trial-shows-lenvatinib-to-be-effective-in-resistant-thyroid-cancer.php … # ASCO14,,,# # #,4.7411E+17,https://twitter.com/ecancer/status/474109729091092480,,,,
Cotomar6,6/4/2014 4:42,0,0,No sólo es el precio.Hay mucho más. # ASCO14. @ ASCO pic.twitter.com/SfTv81ZOcW,,@,#,4.74109E+17,https://twitter.com/Cotomar6/status/474108829563887616,,,,
favo_it,6/4/2014 4:37,3,3,RT:all' # ASCO14 con il presidente # Aiom Cascinu:si rinnova alleanza medico-paziente contro il # cancro!pic.twitter.com/BNOjvvuUm5 via @ EIannelli,,@,# # #,4.74108E+17,https://twitter.com/favo_it/status/474107771408101376,,,,
pelletieramelie,6/4/2014 4:27,0,0,"RT @ davidbeme: Cancer de l'enfant, nanoparticules&radiothérapie, erbitux vs avastin... Sélection d'études # ASCO2014 http://ow.ly/xA75f",,@,#,4.74105E+17,https://twitter.com/pelletieramelie/status/474105134608547840,,,,
catherinemboyle,6/4/2014 4:23,0,1,Immuno-oncology marathon," not a sprint"": key Deutsche Bank take-away from # ASCO14""",,,#,4.74104E+17,https://twitter.com/catherinemboyle/status/474104060942249985,,,
biosimilarz,6/4/2014 4:06,1,3,Data that supports Biocad's AcellBia (rituximab) approval in Russia presented at # ASCO2014; http://abstracts.asco.org/144/AbstView_144_133048.html … # biosimilar Enough 4 EMA?,,,# #,4.741E+17,https://twitter.com/biosimilarz/status/474099902289813504,,,,
ADC_drugs,6/4/2014 4:05,2,2,Visionary RT @ roche RT @ genentech: Ehrlich vs. “the nemesis.” A scientific tale of conflict & discovery. # ASCO14 http://ow.ly/xmQan,,@ @,#,4.741E+17,https://twitter.com/ADC_drugs/status/474099666062417921,,,,
ADC_drugs,6/4/2014 4:03,2,1,"MT @ quantabiodesign Nektar Presents Positive Preclinical Data for a Novel Cancer Immunotherapy, @ ASCO http://bit.ly/1kG7jDu # ADC",,@ @,#,4.74099E+17,https://twitter.com/ADC_drugs/status/474098989462462464,,,,
NIHRCRN_nwcoast,6/4/2014 4:01,1,0,Skin cancer # ClinicalTrial shows promise http://www.bbc.co.uk/news/health-27674658 … via @ bbchealth And @ asco,,@ @,#,4.74099E+17,https://twitter.com/NIHRCRN_nwcoast/status/474098512381366272,,,,
LurieCancer,6/4/2014 3:36,1,1,RT @ heidisa: This. # ASCO14 pic.twitter.com/iQ9cDMZsDV # ayacsm # aya # genomics,,@,# # # #,4.74092E+17,https://twitter.com/LurieCancer/status/474092236729098241,,,,
cure_talk,6/4/2014 3:30,1,2,Catch up on what you missed at # ASCO2014 with @ theMMRF http://www.themmrf.org/living-with-multiple-myeloma/2014-asco-coverage.html …,,@,#,4.74091E+17,https://twitter.com/cure_talk/status/474090922116788224,,,,
cure_talk,6/4/2014 3:21,0,1,"# ASCO2014 News: panobinostat, SAR650984 and daratumumab http://multiplemyelomablog.com/2014/06/asco-news-panobinostat-sar650984-and-daratumumab.html … # mmsm",,,# #,4.74089E+17,https://twitter.com/cure_talk/status/474088542985920512,,,,
OncLive,6/4/2014 3:20,3,0,A number of ongoing trials are investigating MPDL2380A in lung cancer http://ow.ly/xzPt2 # ASCO14,,,#,4.74088E+17,https://twitter.com/OncLive/status/474088216145190912,,,,
drkknandra,6/4/2014 3:05,1,2,@ ASCO @ symplur can't dispute the data - Twitter is the way forward :),,@ @,,4.74085E+17,https://twitter.com/drkknandra/status/474084604601966592,,,,
Pharmafocus,6/4/2014 2:58,2,1,Merck drug shines at ASCO: http://bit.ly/1pEsEoP # asco14 # cancer # melanoma # pharma # health,,,# # # # #,4.74083E+17,https://twitter.com/Pharmafocus/status/474082789311381504,,,,
brettwells,6/4/2014 2:58,0,0,Merck drug shines at ASCO: http://bit.ly/1pEsEoP # asco14 # cancer # melanoma # pharma # health,,,# # # # #,4.74083E+17,https://twitter.com/brettwells/status/474082788682235905,,,,
osservasaluteaz,6/4/2014 2:56,0,0,"# Asco14, l’azione dell’immunoterapia nei pazienti con melanoma metastatico : http://bit.ly/1oRSSUG via @ QSanit.",,@,#,4.74082E+17,https://twitter.com/osservasaluteaz/status/474082126997245952,,,,
NL4LiveSTRONG,6/4/2014 2:55,0,0,RT @ livestrong: Fascinating posibilities out of # ASCO14: “Doctors use immune therapy against cervical cancer” - http://bit.ly/1pPCOjF,,@,#,4.74082E+17,https://twitter.com/NL4LiveSTRONG/status/474081881085190144,,,,
NuCana_news,6/4/2014 2:50,0,0,Presented at the # ASCO14 - Acelarin achieves high disease control rate in patients with advanced cancer. http://www.nucanabiomed.com/news.html,,,#,4.74081E+17,https://twitter.com/NuCana_news/status/474080777609953280,,,,
Roche,6/4/2014 2:49,4,3,RT @ genentech: Ehrlich vs. “the nemesis.” A scientific tale of conflict & discovery. # ASCO14 http://ow.ly/xmQan,,@,#,4.7408E+17,https://twitter.com/Roche/status/474080379050405890,,,,
MelanomaAus,6/4/2014 2:44,1,0,Research from # ASCO14: Treatment with ipilimumab in high-risk stage III # melanoma patients decreases reoccurance. http://bit.ly/1x52WMj,,,# #,4.74079E+17,https://twitter.com/MelanomaAus/status/474079250480246785,,,,
OncLive,6/4/2014 2:15,2,1,Investigational Immunotherapy Granted First Breakthrough Therapy Designation in Bladder Cancer http://ow.ly/xA1yy # ASCO14,,,#,4.74072E+17,https://twitter.com/OncLive/status/474071838495350784,,,,
OncologyTimes,6/4/2014 2:11,9,6,Amazing inc! MT @ ASCO: Comparing # ASCO13 & # ASCO14 Twitter data (from 4 days before mtg to last day) via @ Symplurpic.twitter.com/Zq3cGP9seH,,@ @,# #,4.74071E+17,https://twitter.com/OncologyTimes/status/474070849176104961,,,,
CureTalks,6/4/2014 1:58,0,0,Men with metastatic # prostatecancer may live longer with # chemo first - Medical News Today: # ASCO2014 http://www.medicalnewstoday.com/articles/277621.php#.U460j2R_vYs.twitter …,,,# # # #,4.74068E+17,https://twitter.com/CureTalks/status/474067686662500352,,,,
AhidegDr,6/4/2014 1:56,0,0,@ DrAttai got it so right! This is about patient centered care & so much more - are you listening # ASCO14 ? http://www.bcsmcommunity.org/reasonable-fear-prompts-extra-mastectomy-decisions-an-opinion/ …,,@,#,4.74067E+17,https://twitter.com/AhidegDr/status/474067041666625536,,,,
elopezgavito,6/4/2014 1:34,0,0,"Genetic Alterations in Paired Samples of # Ovarian # Cancer | ASCO Annual Meeting http://ow.ly/xxTU8 # ASCO14 @ jorgemontalvosm""",,@,# # #,4.74062E+17,https://twitter.com/elopezgavito/status/474061585892511745,,,,
scooperpr,6/4/2014 1:32,1,1,Finish how we started @ VirginAmerica. # ASCO14 at the Big 5-0 kicked my butt but packed w memories. Cc: @ RS_Flinnpic.twitter.com/ae0WXT0dAC,,@ @,#,4.74061E+17,https://twitter.com/scooperpr/status/474061217888493568,,,,
lenstarnes,6/4/2014 1:31,0,0,@ chimoose Nice analysis of # ASCO14. Trying 2 reconcile Ur stats with those from @ symplur showing 7879 particpts/41714 tweets same period,,@ @,#,4.74061E+17,https://twitter.com/lenstarnes/status/474060780535422976,,,,
OncLive,6/4/2014 1:20,1,1,"Survival Comparable With Bevacizumab, Cetuximab in mCRC http://ow.ly/xA1oE # ASCO14",,,#,4.74058E+17,https://twitter.com/OncLive/status/474058005663973376,,,,
darrenfergus,6/4/2014 1:19,0,0,Post # ASCO14 Boehringer Ingelheim has inboxed me about their advances in NSCLC. Credit to their direct marketing from the States!,,,#,4.74058E+17,https://twitter.com/darrenfergus/status/474057854853214208,,,,
dr_psr,6/4/2014 0:33,0,0,NGS Identified Genetic Alterations in Paired Samples of # Ovarian # Cancer | ASCO Annual Meeting http://ow.ly/xxTU8 # ASCO14@abbottmd,,@abbottmd,# # #,4.74046E+17,https://twitter.com/dr_psr/status/474046220986363904,,,,
DraDianePerez,6/4/2014 0:27,9,10,“ @ NTelevisa_com: 1:Salud con @ dradianeperez Los más recientes tratamientos contra el cáncer http://ow.ly/xAo7P ” @ ASCO 2014,,@ @ @,,4.74045E+17,https://twitter.com/DraDianePerez/status/474044734181109760,,,,
rsm2800,6/4/2014 0:12,1,1,@ chimoose @ ASCO @ WilliamDale_MD @ CliffordHudis @ mtmdphd @ DrAttai Great company to be in! Thanks.,,@ @ @ @ @ @,,4.74041E+17,https://twitter.com/rsm2800/status/474040864746917888,,,,
globalmcures,6/3/2014 23:38,0,0,SELECT: # Lenvatinib Improves PFS in # ThyroidCancer | http://am.asco.org/select-lenvatinib-improves-pfs-thyroid-cancer#.U46UoaC43Ds.twitter … # GlobalMedicalCures # Cancer # ASCO14 # HeadandNeckCancer,,,# # # # # # #,4.74033E+17,https://twitter.com/globalmcures/status/474032533986766848,,,,
hollikawadler,6/3/2014 23:31,0,2,Back home in # NYC. It's been a whirlwind week of # ASCO14 Time to decompress with some mindless tv,,,# #,4.74031E+17,https://twitter.com/hollikawadler/status/474030677680070656,,,,
ASCO,6/3/2014 23:26,5,1,Top 3 Most RT'd Tweets from @ CliffordHudis' # ASCO14 Pres Address http://bit.ly/1ktBLp1 http://bit.ly/1ktBLp1 http://bit.ly/1hvByTq,,@,#,4.74029E+17,https://twitter.com/ASCO/status/474029470345465857,,,,
ASCO,6/3/2014 23:26,10,1,. @ subatomicdoc discusses 6 key ways we can make lung cancer screening possible http://bit.ly/SqinhW # LCSM # ASCO14,,@,# #,4.74029E+17,https://twitter.com/ASCO/status/474029287885250560,,,,
OncLive,6/3/2014 23:20,0,1,Panobinostat with bortezomib and dexamethasone improved PFS by 3.9 months in R/R multiple myeloma http://ow.ly/xAc3Q # ASCO14,,,#,4.74028E+17,https://twitter.com/OncLive/status/474027804728631296,,,,
RyhMd,6/3/2014 23:16,0,0,# asco14 Adjuvant HER2 stage I pic.twitter.com/4CkE2cC1j8,,,#,4.74027E+17,https://twitter.com/RyhMd/status/474026814512197632,,,,
BRCAresponder,6/3/2014 23:15,1,1,RT @ JoannaRudnick # inthefamily is streaming FREE! http://to.pbs.org/1nIuqWj # bcsm @ ASCO @ igsjc # brca # hcsm @ pinkandbluedoc # hereditarycancer,,@ @ @ @,# # # # #,4.74027E+17,https://twitter.com/BRCAresponder/status/474026594634178561,,,,
iman_elhariry,6/3/2014 23:05,0,1,"@ ASCO have been going to # ASCO for the past 15 years. This year has been a great experience, great attention to little details. Thank you!",,@,#,4.74024E+17,https://twitter.com/iman_elhariry/status/474024069323440128,,,,
EliteYoda,6/3/2014 22:41,0,0,@bman_alerts The force is strong with $ AGEN @ Agenus_Bio # ASCO14 # Immunotherapy # Checkpoint # Modulators # AGEN # Agenus,,@bman_alerts @,# # # # # #,4.74018E+17,https://twitter.com/EliteYoda/status/474018194055651328,,,,
scientre,6/3/2014 22:32,0,1,# asco14 MT @ OncologyTimes NYT Well post by @ MikkaelSekeres reflecting cancer pts experience after their tx ends http://well.blogs.nytimes.com/2014/05/29/life-beyond-the-cancer-clinic/?_php=true&_type=blogs&_r=0 …,,@ @,#,4.74016E+17,https://twitter.com/scientre/status/474015929475817472,,,,
AdrianParisPR,6/3/2014 22:31,1,0,Content Marketing lessons for - and from - Canadian Non Profits: http://ow.ly/xB1De (Slides from @ mo_flow via # MarketersUnbound) # ASCO14,,@,# #,4.74016E+17,https://twitter.com/AdrianParisPR/status/474015613053313024,,,,
RyhMd,6/3/2014 22:26,2,0,# eha19 # ash # asco14 Plenary abstracts at upcoming EHA pic.twitter.com/Ei1zLYUuTt,,,# # #,4.74014E+17,https://twitter.com/RyhMd/status/474014360113672193,,,,
NirajGusani,6/3/2014 22:23,1,1,Hope you enjoyed # ASCO14 @ subatomicdoc & thanks for helping us get out the word about # PancSM Chat Thurs 6/5 at 9PM ET.,,@,# #,4.74014E+17,https://twitter.com/NirajGusani/status/474013522766987264,,,,
OncLive,6/3/2014 22:20,2,2,SAR650984 showed encouraging efficacy as a monotherapy and in combination for patients with multiple myeloma http://ow.ly/xA0IJ # ASCO14,,,#,4.74013E+17,https://twitter.com/OncLive/status/474012705238446080,,,,
martinfrogers,6/3/2014 22:14,0,0,$ PRR $ PBMD Prima BioMed's CVac shows promising OS trend for ovarian cancer in phase IIb trial at # ASCO14 http://on.wsj.com/S4JPkE,,,#,4.74011E+17,https://twitter.com/martinfrogers/status/474011197516169216,,,,
drsteventucker,6/3/2014 22:12,4,1,The fascinating anti-cancer genome of the blind mole-rat. # science # asco14 # genomics https://www.sciencenews.org/article/blind-mole-rats-are-loaded-anticancer-genes …,,,# # #,4.74011E+17,https://twitter.com/drsteventucker/status/474010678148075520,,,,
n8pennell,6/3/2014 22:08,2,3,"# ASCO14 had tweeting from podium AND while presenting, but didn't see selfies from podium? Maybe ASCO15 @ JackWestMD @ rsm2800 # raisethebar",,@ @,# #,4.7401E+17,https://twitter.com/n8pennell/status/474009862154637313,,,,
Linda_ADAO,6/3/2014 22:03,0,0,CONGRATS to @ ASCO on your 50th annual meeting. We look you to improve treatments and cure cancer. # mesotheliomapic.twitter.com/kEWHmjm0m0,,@,#,4.74009E+17,https://twitter.com/Linda_ADAO/status/474008552088952832,,,,
Globeathon,6/3/2014 21:59,0,1,Relevant news from # ASCO14 RT @ ONAcom: Obese patients with gynecologic cancer are rarely counseled on weight loss: http://bit.ly/1rJLL2F,,@,#,4.74007E+17,https://twitter.com/Globeathon/status/474007479274045441,,,,
DrMisialek,6/3/2014 21:50,3,1,The Future of Cancer Care http://onforb.es/1x19RWM @ forbes @ ASCO # ASCO14,,@ @,#,4.74005E+17,https://twitter.com/DrMisialek/status/474005317110353920,,,,
DrMisialek,6/3/2014 21:36,0,0,"New Approaches Highlighted at ASCO to Monitor, Treat Lymphoma @ ASCO # ASCO14 http://am.asco.org/new-approaches-highlighted-monitor-treat-lymphoma#.U4533aPkuoc.twitter …",,@,# #,4.74002E+17,https://twitter.com/DrMisialek/status/474001728644186113,,,,
UrologyMatch,6/3/2014 21:32,0,0,“ @ CliffordHudis: Read @ ASCO’s State of Cancer Care in America 2014 http://bit.ly/1iwTfSn http://bit.ly/1gnoHeO # ASCO14”,,@ @,#,4.74001E+17,https://twitter.com/UrologyMatch/status/474000794853724162,,,,
DrMisialek,6/3/2014 21:31,1,0,IBM’s Watson Computer May Be Assisting Oncologists in the Future @ ASCO # ASCO14 http://am.asco.org/ibm%E2%80%99s-watson-based-oncology-computing-system-recommends-treatment-high-accuracy#.U452GBQm-EE.twitter …,,@,# #,4.74E+17,https://twitter.com/DrMisialek/status/474000384734679041,,,,
CliffordHudis,6/3/2014 21:28,9,9,Read @ ASCO’s State of Cancer Care in America 2014 http://bit.ly/1iwTfSn Watch Cap Hill briefing http://bit.ly/1gnoHeO # ASCO14,,@,#,4.74E+17,https://twitter.com/CliffordHudis/status/473999632154910724,,,,
CliffordHudis,6/3/2014 21:25,0,1,Agree & Thnx! MT @ dhjutsw1: @ ASCO # asco14 Terrific AMl. Kudos 2 Jean Colvard & awesome staff. Gr8 prgrm pic.twitter.com/bdzWvQxDwy,,@ @,#,4.73999E+17,https://twitter.com/CliffordHudis/status/473999056696401920,,,,
mikemejiamd,6/3/2014 21:24,0,0,Oligometastatic # lungcancer # ASCO2014 http://abstracts.asco.org/144/AbstView_144_129339.html?utm_content=bufferacb41&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer …,,,# #,4.73999E+17,https://twitter.com/mikemejiamd/status/473998779947839488,,,,
CliffordHudis,6/3/2014 21:24,0,0,1yr=blink of an eye! MT @ ASCO: Deep thnx 2 @ CliffordHudis for pres svc. We're grateful & welcome yr ahead w/ @ YupOncpic.twitter.com/OGHovdXFkW,,@ @ @,,4.73999E+17,https://twitter.com/CliffordHudis/status/473998575102218243,,,,
CliffordHudis,6/3/2014 21:20,0,0,@ HenryJOncology @ ASCO Thanks!!,,@ @,,4.73998E+17,https://twitter.com/CliffordHudis/status/473997716985356288,,,,
OncLive,6/3/2014 21:15,3,1,Concurrent nivolumab and ipilimumab produced an unprecedented 1- and 2-year OS rate of 85% and 79% http://ow.ly/xzVbX # ASCO14,,,#,4.73996E+17,https://twitter.com/OncLive/status/473996393141387265,,,,
AlexYperifanos,6/3/2014 21:15,0,0,# Truth. RT @ CliffordHudis Obesity is the new tobacco. See @ ASCO resources http://bit.ly/1puQK2p # ASCO14,,@ @,# #,4.73996E+17,https://twitter.com/AlexYperifanos/status/473996322110853122,,,,
CliffordHudis,6/3/2014 21:13,0,2,Thanks! @ sloan_kettering support made this year possible. MT @ DrAnasYounes: @ ASCO reception for#ASCO14 president. pic.twitter.com/6ElI5wA8T8,,@ @ @,#ASCO14,4.73996E+17,https://twitter.com/CliffordHudis/status/473996029864316929,,,,
DrAttai,6/3/2014 21:06,1,0,TY! RT @ chimoose Congrats to # ASCO14 most mentioned! @ ASCO @ WilliamDale_MD @ CliffordHudis @ MTMDPhD @ RSM2800 @ DrAttai http://bit.ly/S5iXRD,,@ @ @ @ @ @ @,#,4.73994E+17,https://twitter.com/DrAttai/status/473994131442638848,,,,
teamoncology,6/3/2014 21:03,0,0,肥満の解消はがんの罹患率を助けると思われる。 # ASCO14,,,#,4.73993E+17,https://twitter.com/teamoncology/status/473993353176952834,,,,
nbferrara,6/3/2014 21:01,1,0,News for cancer patients from the 2014 ASCO Annual Meeting: http://bit.ly/1jM9eGo # ASCO14,,,#,4.73993E+17,https://twitter.com/nbferrara/status/473992933679452161,,,,
JackWestMD,6/3/2014 20:58,0,2,TYVM! RT @ chimoose: Congrats to # ASCO14's most-mentioned! @ DrDonSDizon @ SubatomicDoc @ JackWestMD @ TeamOncology http://bit.ly/S5iXRD,,@ @ @ @ @,#,4.73992E+17,https://twitter.com/JackWestMD/status/473992133095854081,,,,
NeoplasicasPeru,6/3/2014 20:58,0,0,@ noticiAmerica Presentan nuevo tratamiento para cáncer de mama a nivel mundial con aportes de médicos # INEN # ASCO14 http://www.inen.sld.pe/portal/prensa/notas/626-np-020-14.html … …,,@,# #,4.73992E+17,https://twitter.com/NeoplasicasPeru/status/473992076309184512,,,,
Awesomics,6/3/2014 20:56,0,1,"# ASCO14 stories via @ dailynewsgw: More NGS-guided cancer trtmnt, Negative # ALTTO trial, pediatric complics, AML, more http://www.genomeweb.com/search/apachesolr_search/ASCO …",,@,# #,4.73992E+17,https://twitter.com/Awesomics/status/473991600129843200,,,,
Awesomics,6/3/2014 20:53,0,0,Frontiers in Precision Medicine & other Genomics-Oriented Sessions at # ASCO14: http://am.asco.org/genomics-oriented-sessions … @bigsciencemedia,,@bigsciencemedia,#,4.73991E+17,https://twitter.com/Awesomics/status/473990916533784577,,,,
Carpowich,6/3/2014 20:50,0,0,"Immunotherapy emerging as 4th pillar"" of cancer treatment"," via @ HoustonChron http://ow.ly/xAOlU @ ChronMed # ASCO14 # cancerresearch""",,@ @,# #,4.7399E+17,https://twitter.com/Carpowich/status/473990128797372416,,,
womenofteal,6/3/2014 20:50,0,1,# gyncsmRT @ subatomicdoc Meta-analysis of prevalence and moderating factors for cancer-related PTSD http://bit.ly/1gyZmov # ASCO14 # ayacsm,,@,# # #,4.7399E+17,https://twitter.com/womenofteal/status/473990123734851584,,,,
CancerTherAdvsr,6/3/2014 20:50,0,0,VIDEO: @ CliffordHudis talks about the important advances in the world of # oncology during his presidency # ASCO14 http://ow.ly/xAHtx,,@,# #,4.7399E+17,https://twitter.com/CancerTherAdvsr/status/473990115061035008,,,,
intervalolibre,6/3/2014 20:48,0,0,Publicado ayer 2/6/2014 en @ NEJM: Exemestane + supresión ovárica en cáncer de mama en premenopaúsicas. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1404037 … … # ASCO2014,,@,#,4.7399E+17,https://twitter.com/intervalolibre/status/473989758100574208,,,,
chimoose,6/3/2014 20:47,5,6,A preview of my # Doctors20 preso: How did the world's physicians respond to # ASCO14? http://bit.ly/1jPtas6 # MDigitalLife,,,# # #,4.73989E+17,https://twitter.com/chimoose/status/473989295561121792,,,,
womenofteal,6/3/2014 20:47,0,0,Yes Evidence based guidelines are key MT@CancerNetwrk # ASCO14 Overdiagnosis/Overtreatment Cancer:Point/Counterpoint http://bit.ly/1x20KVT,,@CancerNetwrk,#,4.73989E+17,https://twitter.com/womenofteal/status/473989275822735360,,,,
chimoose,6/3/2014 20:46,0,1,@ alessiominuzzo Your tweet was featured in my # ASCO14 wrap-up; thought that you might like to see it! http://bit.ly/S5iXRD,,@,#,4.73989E+17,https://twitter.com/chimoose/status/473989049435189249,,,,
DrAnasYounes,6/3/2014 20:41,9,2,Enrolling patients on R-CHOP in Combination with Ibrutinib in DLBCL http://bit.ly/Srxx6y and http://bit.ly/1i0s25F # ASCO14,,,#,4.73988E+17,https://twitter.com/DrAnasYounes/status/473987972384030722,,,,
A_Karunaratne,6/3/2014 20:40,0,0,@ DrPaulyDeSantis how is # ASCO14,,@,#,4.73988E+17,https://twitter.com/A_Karunaratne/status/473987584629030914,,,,
twittmanda,6/3/2014 20:36,1,2,@ ASCO The overwhelming response to this year was summed up with WOW! & GREAT! You did an AWESOME job with all the logistics! TY # ASCO14,,@,#,4.73987E+17,https://twitter.com/twittmanda/status/473986688348209153,,,,
twittmanda,6/3/2014 20:29,1,1,@ ASCO The issue I heard was not enough time to present and attend another and also recharge! GREAT tweeting and I'm sure networking w/office,,@,,4.73985E+17,https://twitter.com/twittmanda/status/473984883992186885,,,,
twittmanda,6/3/2014 20:25,0,2,@ ASCO VERY helpful! Thanks and thank you especially for making the wifi so great for attendees! Powerstrips for next year?,,@,,4.73984E+17,https://twitter.com/twittmanda/status/473983849483866112,,,,
RielyMD,6/3/2014 20:21,4,1,I did it MT @ mtmdphd: Celebrate 50 years of progress.Invest $50 in the future of cancer care @ iConquerCancer http://ow.ly/xzQMd # ASCO14”,,@ @,#,4.73983E+17,https://twitter.com/RielyMD/status/473982726228283393,,,,
DrZahwa,6/3/2014 20:18,0,0,RT Pathologists: RT mayocliniclabs: Didn’t make it to # ASCO14? Check out our blog to learn about our latest adv ... http://mayocl.in/T1r6rl,,,#,4.73982E+17,https://twitter.com/DrZahwa/status/473981961057226752,,,,
TrialsCentre,6/3/2014 20:16,0,0,CTC and the oncology investigator groups in Chicago to present our cancer research # ASCO14. http://bit.ly/1knXNL8 pic.twitter.com/Udws0OuMaW,,,#,4.73982E+17,https://twitter.com/TrialsCentre/status/473981705288548354,,,,
TogoRun,6/3/2014 20:16,0,0,"As summer approaches, # ASCO14 reveals exciting new skin cancer trial results: http://www.bbc.com/news/health-27674658 …",,,#,4.73981E+17,https://twitter.com/TogoRun/status/473981484596867073,,,,
ASCO,6/3/2014 20:15,4,4,Surveillance (not chemo) is an option for patients w/seminomatous testicular cancer & no risk factors http://bit.ly/1oSpjSQ # ASCO14,,,#,4.73981E+17,https://twitter.com/ASCO/status/473981316799537152,,,,
JasperCapital,6/3/2014 20:10,0,0,Should Triple-Negative Breast Cancer (TNBC) Subtype Affect Local-Regional Therapy Decision Making? http://ow.ly/xAFqv # ASCO14,,,#,4.7398E+17,https://twitter.com/JasperCapital/status/473980006851280897,,,,
BayerPharma,6/3/2014 20:08,0,0,Thanks to all # ASCO14 visitors. We look forward to seeing you next year! # ASCO15,,,# #,4.7398E+17,https://twitter.com/BayerPharma/status/473979643821715456,,,,
teamoncology,6/3/2014 20:07,6,1,肥満はがんの原因である # ASCO14,,,#,4.73979E+17,https://twitter.com/teamoncology/status/473979249548722176,,,,
mariesanguinett,6/3/2014 20:04,0,1,Always Learning is out! http://paper.li/mariesanguinett/1317377080 … Stories via @ ChEnected @mooteu14 @ ASCO,,@ @mooteu14 @,,4.73979E+17,https://twitter.com/mariesanguinett/status/473978596432683008,,,,
yukitsugu1963,6/3/2014 20:04,3,2,アメリカ人と日本人の違いはあるでしょうが、タバコをやめた医師として、身にしみてダイエットしたいと思います。RT @ teamoncology ついに米国臨床腫瘍学会は、肥満をタバコと同じくらいにがんの原因として捉えました。つまり、肥満を撲滅することが大切です。 # ASCO14,,@,#,4.73979E+17,https://twitter.com/yukitsugu1963/status/473978586324418563,,,,
teamoncology,6/3/2014 20:04,0,0,TY RT @ chimoose: Congrats to # ASCO14's most-mentioned! @ DrDonSDizon @ SubatomicDoc @ JackWestMD @ TeamOncology http://bit.ly/S5iXRD,,@ @ @ @ @,#,4.73979E+17,https://twitter.com/teamoncology/status/473978510696919041,,,,
WIOvarianCancer,6/3/2014 20:00,2,1,How a new treatment using a person's immune cells is helping to fight cervical cancer. http://nbcnews.to/1l3TAv0 # cancer # ASCO14,,,# #,4.73978E+17,https://twitter.com/WIOvarianCancer/status/473977630018908160,,,,
GenentechJobs,6/3/2014 19:59,1,0,Interested in working for us? Visit our career site http://bit.ly/1d789aG . Search # ASCO14 for relevant # jobs here & on Facebook.,,,# #,4.73977E+17,https://twitter.com/GenentechJobs/status/473977223649562626,,,,
WilliamDale_MD,6/3/2014 19:58,0,0,"Thanks! MT @ chimoose: # ASCO14's most mentioned! @ ASCO @ WilliamDale_MD @ CliffordHudis @ MTMDPhD @ RSM2800 @ DrAttai http://bit.ly/S5iXRD "",,@ @ @ @ @ @ @,#,473977048889712640""",https://twitter.com/WilliamDale_MD/status/473977048889712640,,,,,,,,
audcarson,6/3/2014 19:57,0,0,Would love to attend @ ASCO meeting someday. Fascinating. # ASCO14,,@,#,4.73977E+17,https://twitter.com/audcarson/status/473976851811954689,,,,
GuneetWalia,6/3/2014 19:57,1,1,Portal for 2014 @ TheALCF Young Innovators Team Award for translational # LungCancer research now open! http://www.lungcancerfoundation.org/research/grants/apply/ … … # LCSM # ASCO14,,@,# # #,4.73977E+17,https://twitter.com/GuneetWalia/status/473976812003815424,,,,
IndustryNightIn,6/3/2014 19:57,0,0,Sorry so late friends. Long day at the office @ HiltonChicago # ASCO14 Here comes your # industry line up.,,@,# #,4.73977E+17,https://twitter.com/IndustryNightIn/status/473976721704620032,,,,
teamoncology,6/3/2014 19:52,18,5,ついに米国臨床腫瘍学会は、肥満をタバコと同じくらいにがんの原因として捉えました。つまり、肥満を撲滅することが大切です。 # ASCO14,,,#,4.73976E+17,https://twitter.com/teamoncology/status/473975570418511872,,,,
ottohoffmann,6/3/2014 19:51,0,0, @ EFEciencia: La inmunoterapia vuele a ser protagonista en ASCO 2014," la mayor reunión en oncología http://www.efefuturo.com/noticia/la-inmunoterapia-vuele-a-ser-protagonista-en-asco-2014-la-mayor-reunion-en-oncologia/ … # ASCO14""""",,@,#,4.73975E+17,https://twitter.com/ottohoffmann/status/473975289542746112,,,
teamoncology,6/3/2014 19:51,1,0,Hot stuff from # ASCO14. Obesity the next smoking. Need to reduce obesity.,,,#,4.73975E+17,https://twitter.com/teamoncology/status/473975266427957248,,,,
chimoose,6/3/2014 19:51,1,3,Congrats to # ASCO14's most-mentioned! @ DrDonSDizon @ SubatomicDoc @ JackWestMD @ TeamOncology http://bit.ly/S5iXRD # Doctors20,,@ @ @ @,# #,4.73975E+17,https://twitter.com/chimoose/status/473975194688552962,,,,
abbottmd,6/3/2014 19:50,3,1,NGS Identified Genetic Alterations in Paired Samples of Ovarian Cancer | ASCO Annual Meeting http://ow.ly/xxTU8 # ASCO14,,,#,4.73975E+17,https://twitter.com/abbottmd/status/473974974747652096,,,,
chimoose,6/3/2014 19:50,7,2,Congrats to # ASCO14's most mentioned! @ ASCO @ WilliamDale_MD @ CliffordHudis @ MTMDPhD @ RSM2800 @ DrAttai http://bit.ly/S5iXRD,,@ @ @ @ @ @,#,4.73975E+17,https://twitter.com/chimoose/status/473974923946242049,,,,
teamoncology,6/3/2014 19:50,5,1,RT @ ASCO: Will Watson be helping you to make the right decisions for your patients in the future? http://bit.ly/1kmwnFo # ASCO14,,@,#,4.73975E+17,https://twitter.com/teamoncology/status/473974916992094208,,,,
drmikesevilla,6/3/2014 19:47,0,0,RT @ chimoose: Take a look at # ASCO14 through the eyes of the world’s physicians – # MDigitalLife http://bit.ly/S5iXRD,,@,# #,4.73974E+17,https://twitter.com/drmikesevilla/status/473974221089959936,,,,
ASCO,6/3/2014 19:45,4,0,Will Watson be helping you to make the right decisions for your patients in the future? http://bit.ly/1kmwnFo # ASCO14,,,#,4.73974E+17,https://twitter.com/ASCO/status/473973757573210112,,,,
chimoose,6/3/2014 19:42,3,0,Take a look at # ASCO14 through the eyes of the world’s physicians – # MDigitalLife http://bit.ly/S5iXRD,,,# #,4.73973E+17,https://twitter.com/chimoose/status/473973019979685888,,,,
Boehringer,6/3/2014 19:30,1,0,PRESS&HCPs: Acute Myeloid # Leukaemia mainly a disease of later adulthood. Prognosis worsens w/ increasing age http://bit.ly/1edV8Lj # ASCO14,,,# #,4.7397E+17,https://twitter.com/Boehringer/status/473970084629581826,,,,
SusanGKomen,6/3/2014 19:30,1,0,“Phase 3 CT suggests std adjuvant tx for erly-stg HER2+ shld remain trastuzumab w/ chemo”–Dr. Edith Perez # ASCO14 http://bit.ly/1oPmEJG,,,#,4.7397E+17,https://twitter.com/SusanGKomen/status/473969998700892162,,,,
CancerTherAdvsr,6/3/2014 19:25,0,0,"# ASCO14: Siltuximab Indicated in # HIV -, HHV-8-negative Multicentric Castleman's Disease http://ow.ly/xACIH",,,# #,4.73969E+17,https://twitter.com/CancerTherAdvsr/status/473968671040081921,,,,
OncLive,6/3/2014 19:20,1,0,"David Spigel, MD, discusses current trials investigating the anti-PD-L1 antibody MPDL3280A in lung cancer http://ow.ly/xzPkb # ASCO14",,,#,4.73967E+17,https://twitter.com/OncLive/status/473967452980641792,,,,
EIannelli,6/3/2014 19:19,3,4,# ASCO14 con il presidente Aiom Cascinu l'alleanza medico-paziente è realtà uniti x vincere la vita contro il # cancro!pic.twitter.com/Vj0Tkcp63U,,,# #,4.73967E+17,https://twitter.com/EIannelli/status/473967323515084800,,,,
cancercommons,6/3/2014 19:19,0,0,Lots of cancer news this week from # ASCO14! Keep up with the latest news you can use on our news feeds: Lung... http://fb.me/6P7209k1d,,,#,4.73967E+17,https://twitter.com/cancercommons/status/473967288249356288,,,,
ASCO,6/3/2014 19:15,3,3,SELECT: lenvatinib superior to placebo in PFS for thyroid cancers http://bit.ly/1pPd3Qx # ASCO14,,,#,4.73966E+17,https://twitter.com/ASCO/status/473966231502864385,,,,
myriadgenetics,6/3/2014 19:05,1,2,Watch this video to find out more about # BRCA1 and # BRCA2 # genetictesting! http://bit.ly/1dgAjP9 # hereditarycancer # ASCO14 # ovariancancer,,,# # # # # #,4.73964E+17,https://twitter.com/myriadgenetics/status/473963603989524480,,,,
mtmdphd,6/3/2014 19:02,0,0,"MT @ timfenske: Phase 2 trial of GS-9973, a selective Syk inhibitor, in R/R CLL. ORR 64% http://www.mdlinx.com/oncology/conference-abstract.cfm/ZZ44589356B2C342A082F333A524A1BD5B/14621/?utm_source=confcoveragenl&utm_medium=newsletter&utm_content=abstract-list&utm_campaign=abstract-asco2014&nonus=0 … # ASCO14 # lymsm",,@,# #,4.73963E+17,https://twitter.com/mtmdphd/status/473963033228632067,,,,
ONAcom,6/3/2014 19:01,0,0,"RT @ fischmd: # ASCO14 themes: immunotherapy, value, obesity, learning healthcare, systems biology, social media, genomics, exercise,...",,@,#,4.73963E+17,https://twitter.com/ONAcom/status/473962831029620736,,,,
Pathologists,6/3/2014 19:00,0,0,RT @ mayocliniclabs: Didn’t make it to # ASCO14? Check out our blog to learn about our latest adv in cancer testing. http://mayocl.in/T1r6rl,,@,#,4.73962E+17,https://twitter.com/Pathologists/status/473962332020690944,,,,
timfenske,6/3/2014 18:50,0,0,"Phase 2 trial of GS-9973, a selective Syk inhibitor, in R/R CLL. ORR 64% # ASCO14 http://www.mdlinx.com/oncology/conference-abstract.cfm/ZZ44589356B2C342A082F333A524A1BD5B/14621/?utm_source=confcoveragenl&utm_medium=newsletter&utm_content=abstract-list&utm_campaign=abstract-asco2014&nonus=0 …",,,#,4.7396E+17,https://twitter.com/timfenske/status/473959988415590400,,,,
JediPD,6/3/2014 18:50,0,0,Eureka! Cancer Care Cost Reduction! # ASCO14 http://www.marketwatch.com/story/cancer-care-administered-by-oncologist-owned-practices-costs-3-to-14-percent-less-than-hospital-owned-oncology-practices-2014-06-03 …,,,#,4.7396E+17,https://twitter.com/JediPD/status/473959835348647936,,,,
timfenske,6/3/2014 18:48,0,0,O'Brien et al # ASCO14. 3 yr update of ibrutinib in CLL. 78% ORR incl 56% in R/R pts with del 17p. http://www.mdlinx.com/oncology/conference-abstract.cfm/ZZ44589356B2C342A082F333A524A1BD5B/14601/?utm_source=confcoveragenl&utm_medium=newsletter&utm_content=abstract-list&utm_campaign=abstract-asco2014&nonus=0 …,,,#,4.7396E+17,https://twitter.com/timfenske/status/473959531693625345,,,,
ASCO,6/3/2014 18:45,8,1,5-year price tag for low-dose CT lung cancer screening estimated at $9.3 billion http://bit.ly/1p4GeiO # ASCO14,,,#,4.73959E+17,https://twitter.com/ASCO/status/473958609156456448,,,,
twittmanda,6/3/2014 18:42,0,0,@ XRT4U @ ASCO And Twitter did tame the beast of attending more than one session at a time!,,@ @,,4.73958E+17,https://twitter.com/twittmanda/status/473957807146799105,,,,
twittmanda,6/3/2014 18:41,0,1,@ XRT4U @ ASCO It is very much appreciated as the info was coming out faster than I could listen&RT :) I had notes but also RTd to have more,,@ @,,4.73958E+17,https://twitter.com/twittmanda/status/473957678629142528,,,,
CancerTherAdvsr,6/3/2014 18:40,0,0,# ASCO14: No Benefits from Neoadjuvant Gemcitabine + Carboplatin + Paclitaxel in Nasopharyngeal # Cancer http://ow.ly/xACuS,,,# #,4.73957E+17,https://twitter.com/CancerTherAdvsr/status/473957313909235712,,,,
XRT4U,6/3/2014 18:34,1,2,@ twittmanda @ ASCO Thanks. I've always enjoyed helping others understand. ASCO can be intimidating. The Twitter group tamed the beast.,,@ @,,4.73956E+17,https://twitter.com/XRT4U/status/473955862617141249,,,,
a_silverstein,6/3/2014 18:33,2,1,". @ networkpharma People tweeting same amount, but WAY more people tweeting. Pretty cool. @ ASCO pic.twitter.com/6T7P0UptSy # medcomms # ASCO14",,@ @,# #,4.73956E+17,https://twitter.com/a_silverstein/status/473955729565437952,,,,
drsam,6/3/2014 18:31,0,1,Another great part of # ASCO14 ... Got to visit my brother (I am the one with the hair) pic.twitter.com/t2TQGAgL9D,,,#,4.73955E+17,https://twitter.com/drsam/status/473955181797728256,,,,
ASCO,6/3/2014 18:31,4,0,"Ed Book Invited Article: @ gcolditz discusses cancer prevention, intro by Gini F. Fleming, MD: http://bit.ly/1rdpKsE # ASCO14",,@,#,4.73955E+17,https://twitter.com/ASCO/status/473955059609264128,,,,
medpagetoday,6/3/2014 18:30,2,1,ASCO: Time to change lung cancer surrogate endpoint? @ atscommunity # ASCO14 http://bit.ly/1ueTbZH,,@,#,4.73955E+17,https://twitter.com/medpagetoday/status/473954791207358468,,,,
genentech,6/3/2014 18:25,2,0,Ehrlich vs. “the nemesis.” A scientific tale of conflict & discovery. # ASCO14 http://ow.ly/xmQan,,,#,4.73954E+17,https://twitter.com/genentech/status/473953606744297473,,,,
DrugInfoAssn,6/3/2014 18:19,1,1,Merck steps up with more positive data on immuno-oncology star pembrolizumab http://www.fiercebiotech.com/story/merck-steps-more-positive-data-immuno-oncology-star-pembrolizumab/2014-06-01?utm_campaign=SocialMedia … # ASCO14,,,#,4.73952E+17,https://twitter.com/DrugInfoAssn/status/473952105804206081,,,,
myCME,6/3/2014 18:19,0,0,Cetuximab + FOLFIRI Beneficial in Metastatic Colorectal Cancer with RAS Wild-type Tumors http://ow.ly/xAOeh # ASCO14 # CRC,,,# #,4.73952E+17,https://twitter.com/myCME/status/473952056403705858,,,,
Paneeshas,6/3/2014 18:15,0,0,“ @ ASCO: PANORAMA 1: Addition of panobinostat to BTZ + DEX in R/R MM extends PFS by 3.9 mos http://bit.ly/1kAco5k # ASCO2014” Good news,,@,#,4.73951E+17,https://twitter.com/Paneeshas/status/473951167970410496,,,,
ASCO,6/3/2014 18:15,5,1,EORTC 30994: era of old chemo adjuvant trials in muscle-invasive bladder cancer may be over http://bit.ly/1x1ie4I # ASCO14,,,#,4.73951E+17,https://twitter.com/ASCO/status/473951141240135680,,,,
myCME,6/3/2014 18:15,0,1,Nivolumab + Ipilimumab: 'Unprecedented' Survival Rates in Advanced Melanoma http://ow.ly/xANWp # ASCO14 # dermatology,,,# #,4.73951E+17,https://twitter.com/myCME/status/473951108386131968,,,,
LifeSciAdvisors,6/3/2014 18:14,0,0,Ambit Biosciences $ AMBI Announces Data from Clinical Investigations of Quizartinib @ # ASCO2014 # ASCO14 http://ow.ly/xANPm,,@,# #,4.73951E+17,https://twitter.com/LifeSciAdvisors/status/473950763979243520,,,,
networkpharma,6/3/2014 18:13,1,0,RT @ ASCO Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via pic.twitter.com/Tn6pnNlAZg # medcomms,,@,# # #,4.73951E+17,https://twitter.com/networkpharma/status/473950601919750145,,,,
Cgrimes3,6/3/2014 18:12,0,0," @ je_keane: "" @ cmartindedios: @ ASCO # asco14@obogler elements for effective # socialmedia pic.twitter.com/knkkns8Abn"" great slide""gets you thinking""",,@ @ @ @obogler,# #,4.7395E+17,https://twitter.com/Cgrimes3/status/473950325703864320,,,,
TargetedOnc,6/3/2014 18:10,0,1,Dr. Gralow from @ SeattleCCA on Comparing Toxicities and Patient-Stated Preference in the SWOG S0307 Trial http://www.targetedonc.com/conference/asco-2014/Comparing-Toxicities-and-Patient-Stated-Preference-in-the-SWOG-S0307-Trial … # ASCO14,,@,#,4.7395E+17,https://twitter.com/TargetedOnc/status/473949836358582273,,,,
JTCancerCenter,6/3/2014 18:10,0,0,# JTCancerCenter wraps up the EPIC # ASCO14! We were happy to be contributors of valued abstracts of our advancements! http://ow.ly/i/5MHZ2,,,# #,4.7395E+17,https://twitter.com/JTCancerCenter/status/473949796063928320,,,,
hACareConnect,6/3/2014 18:08,1,0," @ Cascadia: # ASCO14 # hdpalooza is @ PCORI National Research Network game changer 3Vs + 3Ps = 3Rs. pic.twitter.com/URSZ4bKOJS Great Framework!""",,@ @,# #,4.73949E+17,https://twitter.com/hACareConnect/status/473949263777366016,,,,
efrenbolivar,6/3/2014 18:07,0,0,Estudios TEXT y SOFT Exemestane + supresión ovárica es superior a tamoxifeno en adyuvancia para premenopáusicas # ASCO14 via @ drapaolaceledon,,@,#,4.73949E+17,https://twitter.com/efrenbolivar/status/473949090623942656,,,,
appistry,6/3/2014 18:05,0,0,# CloudDx delivers results for some tests in as little as two weeks! Stop by booth 16152 # ASCO14 to learn more! http://ow.ly/xAeuy ...,,,# #,4.73949E+17,https://twitter.com/appistry/status/473948602809602048,,,,
urotoday,6/3/2014 18:05,0,0,# ASCO14 - Poster: Establishing a neo-adjuvant platform for developing targeted agents: Androgen ... http://dlvr.it/5snFCl,,,#,4.73949E+17,https://twitter.com/urotoday/status/473948512925646849,,,,
efrenbolivar,6/3/2014 18:04,3,1,Estudio ALTTO: Añadir Lapatinib a Herceptin no mejoró SLE en adyuvancia # ASCO14 # cancerdemama vía @ drapaolaceledon,,@,# #,4.73948E+17,https://twitter.com/efrenbolivar/status/473948382629621760,,,,
Gene_Antibody,6/3/2014 18:02,1,0,Phew! All the new data from # ASCO14 has got me spinning. Thanks and see you all next year! http://instagram.com/p/ozDfoRQ9wF/,,,#,4.73948E+17,https://twitter.com/Gene_Antibody/status/473947756914941953,,,,
ASCO,6/3/2014 18:01,0,0,"Ed Book Invited Article: @ LarryNortonMD revisists Cancer Log-Kill, intro by @ CliffordHudis: http://bit.ly/1pvafaY # ASCO14",,@ @,#,4.73948E+17,https://twitter.com/ASCO/status/473947611796230146,,,,
jenniferjstauss,6/3/2014 18:00,0,0,"@ mstory123 That would be great. Have seen a few things zing by from # ASCO14, but have been out most of the day. :):)",,@,#,4.73947E+17,https://twitter.com/jenniferjstauss/status/473947405759418369,,,,
myriadgenetics,6/3/2014 18:00,3,0,Data at # ASCO14 show importance of testing patients for # hereditarycancer syndromes after 1st # cancer to avoid 2nd.http://bit.ly/1u88lQ8,,,# # #,4.73947E+17,https://twitter.com/myriadgenetics/status/473947268052033538,,,,
twittmanda,6/3/2014 17:56,0,0,@ XRT4U @ ASCO I think you were a great contributing part.Help w/ questions and clarifications that many of us that could not attend had too.,,@ @,,4.73946E+17,https://twitter.com/twittmanda/status/473946382047264770,,,,
mtmdphd,6/3/2014 17:55,0,0,Celebrate 50 years of progress - Invest $50 in the future of cancer care - @ iConquerCancer of @ ASCO http://ow.ly/xzQMd # ASCO14,,@ @,#,4.73946E+17,https://twitter.com/mtmdphd/status/473946013472800768,,,,
Sharsheret,6/3/2014 17:54,1,1,Report from @ ASCO: Obesity associated w/ poorer outcomes for young women with # breastcancer. Learn more at http://www.sharsheret.org/blog/5150/reporting-asco-obesity-and-breast-cancer …,,@,#,4.73946E+17,https://twitter.com/Sharsheret/status/473945772145135616,,,,
XRT4U,6/3/2014 17:53,0,0,@ ASCO . A small vocal group have done this. I could not make the meeting. I felt I was a contributing part.,,@,,4.73946E+17,https://twitter.com/XRT4U/status/473945670303244288,,,,
Boehringer,6/3/2014 17:50,2,3,"Wow, what a busy few days. As we go home from # ASCO14, the only thing left to say is thanks @ ASCO - see you next year!",,@,#,4.73945E+17,https://twitter.com/Boehringer/status/473944808822542337,,,,
FocusonCancer,6/3/2014 17:46,0,0,Taxotere to androgen deprivation therapy improves # survival as initial therapy for advanced prostate # cancer http://bit.ly/15408Sm # ASCO14,,,# # #,4.73944E+17,https://twitter.com/FocusonCancer/status/473943900206268416,,,,
LIVESTRONG_NL,6/3/2014 17:45,0,0,Menopausal status may predict risk breast # cancer mortality among obese women w/ ER+ breast CA http://bit.ly/1nYxY4d # ASCO14 (via @ ASCO ),,@,# #,4.73944E+17,https://twitter.com/LIVESTRONG_NL/status/473943589978771457,,,,
appistry,6/3/2014 17:45,0,0,Did you check out our new On Ramp Program for # NGS analysis? http://ow.ly/xAHVk Chat with us today at our # ASCO14 booth!,,,# #,4.73944E+17,https://twitter.com/appistry/status/473943584249348096,,,,
ASCO,6/3/2014 17:45,1,2,Read Educational Book articles on topics in Lung Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1jY247M,,,#,4.73944E+17,https://twitter.com/ASCO/status/473943581678243842,,,,
ASCO,6/3/2014 17:45,3,2,"Induction chemo with TPF increased OS, PFS in locally advanced head/neck cancer http://bit.ly/1n9aUi4 # ASCO14",,,#,4.73944E+17,https://twitter.com/ASCO/status/473943539672313856,,,,
markstory_,6/3/2014 17:45,0,0,@ jenniferwindrum No prob. I am seeing a HUGE amount of interesting research coming out of # ASCO14. Will pass anything else along I see.,,@,#,4.73943E+17,https://twitter.com/markstory_/status/473943461985402880,,,,
bioinfosm,6/3/2014 17:42,0,0,+1 RT @ ryandaniel Pumped to see all of the inspiring tweets from # ASCO14! # healthcare # oncology # pharma # socialmedia,,@,# # # # #,4.73943E+17,https://twitter.com/bioinfosm/status/473942732046475266,,,,
VistaMME,6/3/2014 17:41,0,0,Successful @ ASCO this year! Our groups we had in from France really enjoyed it! # Chicago # ASCO14,,@,# #,4.73943E+17,https://twitter.com/VistaMME/status/473942648445603841,,,,
AlpineBV_Miller,6/3/2014 17:40,0,0,Standing here at O'Hare it seems airlines are helping fight obesity by forcing people to sprint for connections. # ASCO14,,,#,4.73942E+17,https://twitter.com/AlpineBV_Miller/status/473942403900919811,,,,
dhjutsw1,6/3/2014 17:40,10,4,# ASCO14 # LCSM Chemotherapy for Lung Cancers: Here to Stay. Nice review from @ ASCO Ed book. http://meetinglibrary.asco.org/content/11400375-144#.U443M9xFr7g.twitter …,,@,# # #,4.73942E+17,https://twitter.com/dhjutsw1/status/473942359109926913,,,,
Boehringer,6/3/2014 17:40,1,1,# PRESS & # HCPs: Why new effective drug therapies are a big need in # AML- http://bit.ly/1p0YxFp - # Leukaemia # ASCO14,,,# # # # #,4.73942E+17,https://twitter.com/Boehringer/status/473942241296121857,,,,
MyelomaTeacher,6/3/2014 17:38,1,0,@ SWOG PI/II study of optimal induction 4 ND HRMM # mmsm # myeloma # ASCO14 http://abstracts.asco.org/144/AbstView_144_126521.html …,,@,# # #,4.73942E+17,https://twitter.com/MyelomaTeacher/status/473941744308858880,,,,
LungCancerFaces,6/3/2014 17:38,2,1,The human touch MT @ fischmd: Value of physical exam in advanced # cancer pts? Pts perceive it positively http://ow.ly/xAEcU # ASCO14 # LCSM,,@,# # #,4.73942E+17,https://twitter.com/LungCancerFaces/status/473941704567840768,,,,
ShazzaHudson,6/3/2014 17:37,1,1,“ @ KKatielindsey: FREE online lectures in Supportive Care and Palliative Medicine http://bit.ly/1ceJEpU # ASCO14 # endcancer” # hpmglobal,,@,# # #,4.73942E+17,https://twitter.com/ShazzaHudson/status/473941597634035712,,,,
PDRennert,6/3/2014 17:36,0,1,after # ASCO14 we started reading up on # MS for # AAN14 week. This Credit Suisse report on $ BIIB drove us nuts http://www.sugarconebiotech.com/?p=659,,,# # #,4.73941E+17,https://twitter.com/PDRennert/status/473941366993477632,,,,
Datamonitor_DF,6/3/2014 17:35,0,0,$ PBMD Prima BioMed's CVac shows promising OS trend for ovarian cancer in early phase trial at # ASCO14 http://on.wsj.com/S4JPkE,,,#,4.73941E+17,https://twitter.com/Datamonitor_DF/status/473940983743131648,,,,
ASCO,6/3/2014 17:30,1,1,"Read Educational Book articles on topics in Leukemia, Myelodysplasia, & Transplanation from # ASCO14 speakers: http://bit.ly/1jY23AM",,,#,4.7394E+17,https://twitter.com/ASCO/status/473939919526580225,,,,
BaharGholipour,6/3/2014 17:29,0,0,Some Antibiotics May Slightly Increase Colon Cancer Risk # ASCO14 http://shar.es/VN12h via @ LiveScience,,@,#,4.7394E+17,https://twitter.com/BaharGholipour/status/473939570493362176,,,,
CancerNetwrk,6/3/2014 17:29,0,0,Apatinib Prolonged Survival in Advanced Gastric Cancer http://bit.ly/1kHljNj # ASCO14,,,#,4.73939E+17,https://twitter.com/CancerNetwrk/status/473939482236825600,,,,
ANguyen_ERG,6/3/2014 17:28,0,0,# ASCO14: A Year Over Year Twitter Review http://bit.ly/1mPhUiv # asco14 # environicspharma # cancer,,,# # # #,4.73939E+17,https://twitter.com/ANguyen_ERG/status/473939420899328000,,,,
Gene_Antibody,6/3/2014 17:20,0,0,"Heading home? Watch A Magnificent Obsession"" w/ Dr. Paul Ehlrich & Fritz the dog! # TGIScience http://ow.ly/xmV71 # ASCO14""",,,# #,4.73937E+17,https://twitter.com/Gene_Antibody/status/473937277651914754,,,,
FightCRC,6/3/2014 17:20,2,0,"Don't miss our next webinar, June 18 @ 3PM ET which will recap research & treatment news from the @ ASCO conference! # ASCO14",,@ @,#,4.73937E+17,https://twitter.com/FightCRC/status/473937267715604480,,,,
CancerTherAdvsr,6/3/2014 17:20,2,2,"Daratumumab Safe, Shows Activity in Relapsed/Refractory Multiple # Myeloma # ASCO14 http://ow.ly/xAyyQ",,,# #,4.73937E+17,https://twitter.com/CancerTherAdvsr/status/473937215299411968,,,,
SethBla,6/3/2014 17:19,1,0,patients w # cancer freq ask about complementary/ # integrativemedicine. We need to continue exploring options. http://bit.ly/1x2UxZC @ ASCO,,@,# #,4.73937E+17,https://twitter.com/SethBla/status/473936970343673856,,,,
apw,6/3/2014 17:17,0,0,# asco14 # Cancer : l’épineuse question du prix des traitements http://www.lemonde.fr/tiny/4430785/,,,# #,4.73937E+17,https://twitter.com/apw/status/473936513085235200,,,,
appistry,6/3/2014 17:17,0,0,"We’re here on the final day of # ASCO2014. It’s not too late to stop by booth 16152 to discuss # genomics, # CloudDx and # Ayrris",,,# # # #,4.73937E+17,https://twitter.com/appistry/status/473936512795414530,,,,
ASCO,6/3/2014 17:15,0,0,Read Educational Book articles on topics in Health Services Research from # ASCO14 Education Session Speakers: http://bit.ly/1jXPcgQ,,,#,4.73936E+17,https://twitter.com/ASCO/status/473936019062939649,,,,
ASCO,6/3/2014 17:15,6,3,Rectal CA: Adjuvant FOLFOX after neoadjuvant therapy + surgery associated with HR=0.66 for 3-year DFS http://bit.ly/1x1hbSb # ASCO14,,,#,4.73936E+17,https://twitter.com/ASCO/status/473936015736840192,,,,
narumita,6/3/2014 17:15,1,0,"頻度的には少ないがんですが、予防効果を積極的に評価する時に考える情報になってますね  @ taniatsu: ワクチン接種したほうがいいのかな(~_~;) RT @ narumita: "" @ teamoncology: オーラルセックスは、咽頭がんのリスクである。 # ASCO14""""""",,@ @ @,#,4.73936E+17,https://twitter.com/narumita/status/473935977321222146,,,,
Boehringer,6/3/2014 17:15,3,2,“Collaborations are very instrumental to advance science” Frank Hilberg on # lungcancer research http://bit.ly/1tz9det#notjustonedisease … # ASCO14,,,# #notjustonedisease #,4.73936E+17,https://twitter.com/Boehringer/status/473935970018918400,,,,
survivornetca,6/3/2014 17:15,0,0,RT @ FoxChaseCancer # ASCO14 comes 2 close we reflect on its impact on the # cancer world. http://onforb.es/1x19RWM @ ASCO @ ElaineSchattner,,@ @ @,# #,4.73936E+17,https://twitter.com/survivornetca/status/473935950796435457,,,,
LIVESTRONG_NL,6/3/2014 17:15,0,0,Immune therapy revolution continues # ASCO14 - http://ow.ly/xzW8V,,,#,4.73936E+17,https://twitter.com/LIVESTRONG_NL/status/473935946354671617,,,,
scientre,6/3/2014 17:13,0,1,"# ASCO14 MT @ davecrumbacher OpenFDA uses Elasticsearch, NodeJS, and api-umbrella. Open sourced at https://github.com/FDA/openfda # hdpalooza",,@,# #,4.73935E+17,https://twitter.com/scientre/status/473935460868169728,,,,
scientre,6/3/2014 17:12,0,0,# ASCO14 MT @ davecrumbacher Silverberg @ skram demoing app uses @ openFDA data http://bit.ly/1kAHutD # hdpaloozapic.twitter.com/azhwMgdlZb,,@ @ @,# #,4.73935E+17,https://twitter.com/scientre/status/473935342165164032,,,,
scientre,6/3/2014 17:10,2,2,# ASCO14 MY @ ahier & @ med_watcher created # hdp visualization layer for @ openFDA data - api is killer! # hdpaloozapic.twitter.com/ycQ8ufyOGz,,@ @ @,# # #,4.73935E+17,https://twitter.com/scientre/status/473934884721815552,,,,
CI4CC,6/3/2014 17:07,0,0,# ASCO2014 Cancer Center CIO's Fighting Cancer Together: http://www.cio.com/article/753013/CIOs_Join_Forces_to_Battle_Cancer?page=1&taxonomyId=3172 …,,,#,4.73934E+17,https://twitter.com/CI4CC/status/473933966743851009,,,,
NextGenClinical,6/3/2014 17:06,1,0,One last glimpse at # ASCO14. See you next year! pic.twitter.com/tqeoj3oZr5,,,#,4.73934E+17,https://twitter.com/NextGenClinical/status/473933777987575811,,,,
BioWorld,6/3/2014 17:04,1,1,"Lively, informative, hope-filled # ASCO14. Done. pic.twitter.com/cMFnoTQTiY",,,#,4.73933E+17,https://twitter.com/BioWorld/status/473933223441862656,,,,
je_keane,6/3/2014 17:03,0,0," @ cmartindedios: @ ASCO # asco14 @ obogler elements for effective # socialmedia pic.twitter.com/kaqiew6yBN"" great slide""",,@ @ @,# #,4.73933E+17,https://twitter.com/je_keane/status/473933056307236866,,,,
KarenCollinsRD,6/3/2014 17:03,0,1,MT @ DrKateWolin: LEAN stdy finds wt maintenance w/ @ aicrtweets print materials in breast # CancerSurvivors # ASCO14 http://bit.ly/1rEujwz,,@ @,# #,4.73933E+17,https://twitter.com/KarenCollinsRD/status/473932938078199808,,,,
ASCO,6/3/2014 17:01,1,2,Read Educational Book articles on topics in Head and Neck Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1pfEiX5,,,#,4.73933E+17,https://twitter.com/ASCO/status/473932526696677376,,,,
YOGAontheSTEPS,6/3/2014 17:00,2,0,Join us for our free webinar cover updates from # ASCO2014 on 6/24 @12pm ET! Register here: http://ow.ly/xzJnR,,@12pm,#,4.73932E+17,https://twitter.com/YOGAontheSTEPS/status/473932271452295168,,,,
LivingBeyondBC,6/3/2014 17:00,1,0,Join us for our free webinar covering updates from # ASCO2014 on 6/24 @12pm ET! Register here: http://ow.ly/xzJr4,,@12pm,#,4.73932E+17,https://twitter.com/LivingBeyondBC/status/473932230444609536,,,,
MayoCancerCare,6/3/2014 17:00,0,0,Chemo following radiation improves survival in adults w/ low-grade brain cancer: http://mayocl.in/1krxse3 # ASCO14,,,#,4.73932E+17,https://twitter.com/MayoCancerCare/status/473932155660169216,,,,
Pharmacyclics,6/3/2014 17:00,0,0,Thanks for stopping by # ASCO14! Learn more about PCYC and our therapies in # cancer care http://bit.ly/1p6oHGj,,,# #,4.73932E+17,https://twitter.com/Pharmacyclics/status/473932148676624385,,,,
iurojc,6/3/2014 17:00,0,0,Thank you all for participating & following the June # urojc inspite of distractions from # ASCO14.,,,# #,4.73932E+17,https://twitter.com/iurojc/status/473932146340397056,,,,
CI4CC,6/3/2014 16:58,0,0,# ASCO14 Cancer Center CIO's fighting cancer together: https://twitter.com/NCI_NCIP/status/473915916296519680 …,,,#,4.73932E+17,https://twitter.com/CI4CC/status/473931740314992641,,,,
MMMnews,6/3/2014 16:58,2,1,MedPage Today launches new cancer app http://bit.ly/1mPblwd # hcmktg # pharma # ASCO14,,,# # #,4.73932E+17,https://twitter.com/MMMnews/status/473931717388931072,,,,
DrMarkham,6/3/2014 16:55,0,0,"@ ASCO All of my emails to ASCO addresses bounce back. Any one there you can point me to, who can help me troubleshoot?",,@,,4.73931E+17,https://twitter.com/DrMarkham/status/473931029183332352,,,,
JasperCapital,6/3/2014 16:55,0,0,IBM’s Watson-Based Oncology Computing System Recommends Treatment with High Accuracy | ASCO Annual Meeting http://ow.ly/xzSXG # ASCO14,,,#,4.73931E+17,https://twitter.com/JasperCapital/status/473930899252195328,,,,
megtirrell,6/3/2014 16:52,2,1,$ CLVS CEO: We can win on PFS http://www.cnbc.com/id/101727499 # ASCO14,,,#,4.7393E+17,https://twitter.com/megtirrell/status/473930123448975360,,,,
fischmd,6/3/2014 16:51,3,4,Value of physical exam in advanced # cancer pts? Pts perceive it positively! http://ow.ly/xAEcU # hpm # ASCO14 # FOAMed,,,# # # #,4.7393E+17,https://twitter.com/fischmd/status/473929961003167744,,,,
Boehringer,6/3/2014 16:50,0,0,# PRESS: Heading home? Visit NewsHome for # ASCO14 highlights & # lungcancer info. http://bit.ly/1otvvQM,,,# # #,4.7393E+17,https://twitter.com/Boehringer/status/473929688318889985,,,,
myriadgenetics,6/3/2014 16:50,1,0,Data from 2 clinical studies on Myriad myPath # Melanoma show it can differentiate melanoma from benign nevi. http://bit.ly/1qFsz5H # ASCO14,,,# #,4.7393E+17,https://twitter.com/myriadgenetics/status/473929617556791297,,,,
KKatielindsey,6/3/2014 16:45,0,1,FREE online lectures in Supportive Care and Palliative Medicine http://bit.ly/1ceJEpU # ASCO14 # endcancer,,,# #,4.73929E+17,https://twitter.com/KKatielindsey/status/473928512944889856,,,,
SeattleGenetics,6/3/2014 16:45,0,1,Thx to our # ASCO14 booth visitors for helping our @ iConquerCancer donation grow & celebrating 50 yrs of making a difference in cancer care,,@,#,4.73928E+17,https://twitter.com/SeattleGenetics/status/473928490903822340,,,,
LIVESTRONG_NL,6/3/2014 16:45,0,0,Early Stage Breast # Cancer: Can Subtype & Tumor Size Predict Who Benefits from Chemotherapy? http://bit.ly/1p4atX6 # ASCO2014 (via @ ASCO ),,@,# #,4.73928E+17,https://twitter.com/LIVESTRONG_NL/status/473928437392896000,,,,
ASCO,6/3/2014 16:45,4,0,PANORAMA 1: Addition of panobinostat to BTZ + DEX in R/R MM extends PFS by 3.9 mos http://bit.ly/1kAco5k # ASCO2014,,,#,4.73928E+17,https://twitter.com/ASCO/status/473928423078129664,,,,
AndyBiotech,6/3/2014 16:44,7,11,$ AMGN CD3xCD19 BiTE Blinatumomab in rrALL CR/CRh=43% pic.twitter.com/8206tWjso6 Fatal AEs pic.twitter.com/xhagZ0PSs9 via @ AlpineBV_Miller # ASCO14,,@,#,4.73928E+17,https://twitter.com/AndyBiotech/status/473928118365741057,,,,
insanity_later,6/3/2014 16:42,0,0,"Hola soy su oncólogo y ya verá que se va a salvar, ¡¡POR MIS COJONES QUE VA A VIVIR!! (Se toma un puñado de Prozac) # oncologia # ASCO14",,,# #,4.73928E+17,https://twitter.com/insanity_later/status/473927631100862464,,,,
kino_56,6/3/2014 16:40,0,0,Ipilimumab demonstrated efficacy in the adjuvant setting for patients with melanoma http://ow.ly/xxVtB # ASCO14,,,#,4.73927E+17,https://twitter.com/kino_56/status/473927198395863040,,,,
MattBultitude,6/3/2014 16:39,3,2,Impressive 38000 Tweets;7000 users MT: Comparing # ASCO13 & # ASCO14 Twitter data(4 days prior to last day)via @ Symplurpic.twitter.com/arbMt6q11D,,@,# #,4.73927E+17,https://twitter.com/MattBultitude/status/473926929595125760,,,,
hospicedoctor,6/3/2014 16:38,1,0,"“ @ markaorourke: # ASCO14 Prostate ca survivors with high distress had high cytokines. With exercise program, distress down & cytokines down.”",,@,#,4.73927E+17,https://twitter.com/hospicedoctor/status/473926762405982208,,,,
drdonsdizon,6/3/2014 16:35,0,0," @ Bettyaak: Nice to have met u @Patient Advocate program of # ASCO14 In addition the campaigner for # BringBackOurGirls"" honor is mine! MT""",,@ @Patient,# #,4.73926E+17,https://twitter.com/drdonsdizon/status/473925997629165569,,,,
montypal,6/3/2014 16:33,0,2,@ ERPlimackMD Great to find you on Twitter! Loving your posts on # ASCO14 -- also though your # bladdercancer # biomarker poster was awesome!,,@,# # #,4.73925E+17,https://twitter.com/montypal/status/473925376784084992,,,,
LiveSciHealth,6/3/2014 16:32,0,0,What can be done to reverse the amount of abused children? @ CDC_eHealth and how to ease # chemobrain @ ASCO http://whtc.co/43mx,,@ @,#,4.73925E+17,https://twitter.com/LiveSciHealth/status/473925188627603457,,,,
PSUCHICA,6/3/2014 16:31,0,1,"# ASCO14 Done, Now on to # DIA2014. Can't Wait to Celebrate 50 Years!",,,# #,4.73925E+17,https://twitter.com/PSUCHICA/status/473924925653544961,,,,
evaluatepharma,6/3/2014 16:30,0,0,# ASCO14 – Growing PD-1 uses fail to stem Bristol selloff http://ow.ly/xzsEL $ BMY,,,#,4.73925E+17,https://twitter.com/evaluatepharma/status/473924767116836864,,,,
CancerTherAdvsr,6/3/2014 16:30,0,0,# ASCO14: Lenvatinib: New Hope for Radioiodine-resistant Differentiated # ThyroidCancer http://ow.ly/xAysd,,,# #,4.73925E+17,https://twitter.com/CancerTherAdvsr/status/473924699106598914,,,,
medpagetoday,6/3/2014 16:30,0,0,"John C. Byrd, MD, on the RESONATE trial. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1udXZhT",,@,#,4.73925E+17,https://twitter.com/medpagetoday/status/473924602477809664,,,,
Bettyaak,6/3/2014 16:29,0,0,@ drdonsdizon Nice to have met u @Patient Advocate program of # ASCO14 In addition the campaigner for # BringBackOurGirls,,@ @Patient,# #,4.73924E+17,https://twitter.com/Bettyaak/status/473924452514684928,,,,
Cotomar6,6/3/2014 16:28,0,0,Practice Changing Results . . . Chemotherapy Up Front | ASCO Connection http://connection.asco.org/Commentary/Article/ID/3900/Practice-Changing-Results--Chemotherapy-Up-Front.aspx … vía @ ASCO,,@,,4.73924E+17,https://twitter.com/Cotomar6/status/473924325553106944,,,,
CancerNetwrk,6/3/2014 16:28,0,0,BLOGS from # ASCO14 The Presidential Address: Setting Intentions http://bit.ly/1kAPKty,,,#,4.73924E+17,https://twitter.com/CancerNetwrk/status/473924316636393473,,,,
NCIGlobalHealth,6/3/2014 16:25,2,0,"14-15 ASCO Pres. Dr Peter Yu, underscores the importance of improving the lives of those w/cancer globally at # ASCO14 http://bit.ly/1iQwvHG",,,#,4.73923E+17,https://twitter.com/NCIGlobalHealth/status/473923431763673089,,,,
ryandaniel,6/3/2014 16:25,1,1,Pumped to see all of the inspiring tweets from # ASCO14! # healthcare # oncology # pharma # socialmedia,,,# # # # #,4.73923E+17,https://twitter.com/ryandaniel/status/473923426810601472,,,,
CANcerviver,6/3/2014 16:24,0,0,RT @ ASCO: Momentum to establish cancer survivor programs increasing as cancer survivor population grows http://bit.ly/1hW1a6p # ASCO14,,@,#,4.73923E+17,https://twitter.com/CANcerviver/status/473923322506272769,,,,
CANcerviver,6/3/2014 16:24,0,0,RT @ ASCO: Understanding colorectal # cancer survivors' needs & preferences for # survivorship info http://bit.ly/1oTf3K0 # crcsm # JOP,,@,# # # #,4.73923E+17,https://twitter.com/CANcerviver/status/473923295356530688,,,,
CatherineGOI,6/3/2014 16:24,3,1,Congrès +++ ;)) Cancer : des solutions pour améliorer la qualité de vie des malades # ASCO14 # cancer http://www.lemonde.fr/sante/article/2014/05/31/cancer-des-solutions-pour-ameliorer-la-qualite-de-vie-des-malades_4429677_1651302.html … via @ lemondefr,,@,# #,4.73923E+17,https://twitter.com/CatherineGOI/status/473923233243082753,,,,
JackWhelan,6/3/2014 16:24,0,1,"Agree! The brightest minds and most passionate hearts in healthcare were here at # hdpalooza even more of same we're at # ASCO14, co-operate!",,,# #,4.73923E+17,https://twitter.com/JackWhelan/status/473923217808035841,,,,
jonathanagin,6/3/2014 16:16,3,1,It is clear the future for effectively treating kids w/ cancer depends on solid molecular profiling. Thx @ carisls for proving this # ASCO14,,@,#,4.73921E+17,https://twitter.com/jonathanagin/status/473921116529238016,,,,
bpowersphoto,6/3/2014 16:16,0,0,# selfie in the # shadows on the way out of # asco14 in # chicago @McCormick Place http://instagram.com/p/oy4N_vLH4t/,,@McCormick,# # # #,4.73921E+17,https://twitter.com/bpowersphoto/status/473921080847917057,,,,
ASCO,6/3/2014 16:15,22,7,Momentum to establish cancer survivor programs increasing as cancer survivor population grows http://bit.ly/1hW1a6p # ASCO14,,,#,4.73921E+17,https://twitter.com/ASCO/status/473920937596035073,,,,
LIVESTRONG_NL,6/3/2014 16:15,0,0,50 years of progress in lung # cancer research - http://bit.ly/TXJxxV # ASCO14 (via @ ASCO ),,@,# #,4.73921E+17,https://twitter.com/LIVESTRONG_NL/status/473920855547072513,,,,
News_Biotech,6/3/2014 16:13,0,0,Checking in on Big Pharma's big immuno-oncology race http://bit.ly/1nadTac # ASCO2014,,,#,4.7392E+17,https://twitter.com/News_Biotech/status/473920329580937216,,,,
drsam,6/3/2014 16:12,0,0,Even bigger! # planespotting # ohare # ord # chicago # asco14 # iflyalaska http://instagram.com/p/oy3wgLKviI/,,,# # # # # #,4.7392E+17,https://twitter.com/drsam/status/473920065352392706,,,,
Boehringer,6/3/2014 16:10,0,1,How do you think # lungcancer diagnosis can be improved? Take part in our poll http://bit.ly/1kpW8U2 # ASCO14,,,# #,4.7392E+17,https://twitter.com/Boehringer/status/473919677228273664,,,,
OncTimes_AsstEd,6/3/2014 16:08,3,0,What do YOU say was the HOT topic from # ASCO14? Take @ OncologyTimes' new QUICK POLL... http://journals.lww.com/oncology-times/pages/Quick-Poll.aspx …,,@,#,4.73919E+17,https://twitter.com/OncTimes_AsstEd/status/473919266798829569,,,,
DrHedrick,6/3/2014 16:07,1,1,"Amazing. MT @ fischmd: # ASCO14 : immunotherapy, value, obesity, learning healthcare, syst biology, soc media, genomics, exercise, pall care.",,@,#,4.73919E+17,https://twitter.com/DrHedrick/status/473918834332925952,,,,
myriadgenetics,6/3/2014 16:05,0,0,"Before you leave # ASCO14, visit Booth 2039 to learn about Myriad’s superior accuracy in # genetictesting & variant classification program!",,,# #,4.73918E+17,https://twitter.com/myriadgenetics/status/473918293519003649,,,,
drsam,6/3/2014 16:03,0,0,"At # ohare and ready to head home. See you next year, # Chicago! # asco14 # iflyalaskapic.twitter.com/CZmRe7eSh1",,,# # # #,4.73918E+17,https://twitter.com/drsam/status/473917803305529345,,,,
Carolyn_Noel,6/3/2014 16:02,0,0,RT @ medpagetoday: Combo attack on metastatic prostate cancer androgens resistant to hormone therapy # ASCO14 http://bit.ly/1ueYdoP,,@,#,4.73918E+17,https://twitter.com/Carolyn_Noel/status/473917638432014337,,,,
moorejh,6/3/2014 16:01,3,0,indeed # genomics RT @ ASCO: Collecting family history is still key in the # genomic era http://bit.ly/1klFRL6 # ASCO14,,@,# # #,4.73917E+17,https://twitter.com/moorejh/status/473917366024146944,,,,
BayerPharma,6/3/2014 16:00,1,1,We had a great time at # ASCO14. Hope to see you at # ASCO15 in Chicago in 2015.,,,# #,4.73917E+17,https://twitter.com/BayerPharma/status/473917221652414464,,,,
medpagetoday,6/3/2014 16:00,2,0,Combo attack on metastatic prostate cancer androgens resistant to hormone therapy lowered testosterone levels # ASCO14 http://bit.ly/1ueYdoP,,,#,4.73917E+17,https://twitter.com/medpagetoday/status/473917116836364288,,,,
MelanomaReAlli,6/3/2014 16:00,0,0,Some # ASCO14 highlights from @ TeamTJSharpe! http://www.philly.com/philly/blogs/patient1/Findings-from-Melanoma-Monday-at-American-Society-of-Clinical-Oncologists-ASCO-annual-meeting.html …,,@,#,4.73917E+17,https://twitter.com/MelanomaReAlli/status/473917105549488128,,,,
RichardWJoseph,6/3/2014 15:59,0,0,# ASCO14 the tipping point for immunotherapy in all cancers with the profound pdl1 bladder and h&n data driving the point home. @ ASCO,,@,#,4.73917E+17,https://twitter.com/RichardWJoseph/status/473916963643592704,,,,
ASCO,6/3/2014 15:58,44,25,Comparing # ASCO13 & # ASCO14 Twitter data (measures 4 days prior to meeting start to last day) via @ Symplurpic.twitter.com/HT2lZyqbPm,,@,# #,4.73917E+17,https://twitter.com/ASCO/status/473916648328413184,,,,
ASCO,6/3/2014 15:55,0,1,Dr. Glode discusses a new report from # ASCO14 on hormonal therapy for prostate cancer http://bit.ly/1osxqlr # PCSM,,,# #,4.73916E+17,https://twitter.com/ASCO/status/473915807345688576,,,,
fischmd,6/3/2014 15:54,25,14,"# ASCO14 themes: immunotherapy, value, obesity, learning healthcare, systems biology, social media, genomics, exercise, palliative care.",,,#,4.73916E+17,https://twitter.com/fischmd/status/473915699291631618,,,,
PNHP,6/3/2014 15:53,8,3,We spent last weekend at # ASCO14 signing up new members - join them and us at http://www.pnhp.org/join . # SinglePayerpic.twitter.com/Uvhk6iIgmA,,,# #,4.73915E+17,https://twitter.com/PNHP/status/473915416671432704,,,,
PatCareOnline,6/3/2014 15:51,0,0,Big News from # ASCO14 RT @ CancerNetwrk Docetaxel With ADT Improves Survival for Metastatic Prostate Cancer Patients http://bit.ly/1tzRRON,,@,#,4.73915E+17,https://twitter.com/PatCareOnline/status/473914837060575232,,,,
cornide,6/3/2014 15:48,0,0,RT @ _SEOM: Oncólogos y periodistas pueden ver los resúmenes de lo más destacado de # ASCO14 http://www.seom.org/es/servicios-al-socio/formacion-y-recursos/onconexion-2014 …,,@,#,4.73914E+17,https://twitter.com/cornide/status/473914181834797056,,,,
CancerNetwrk,6/3/2014 15:47,2,3,Continuous Therapy Best in Newly Diagnosed Multiple Myeloma http://bit.ly/1pPHeXK # ASCO14,,,#,4.73914E+17,https://twitter.com/CancerNetwrk/status/473913883510312961,,,,
Pharmaspectra,6/3/2014 15:46,1,0,RT @ DrLen: My favorite slide from # ASCO14: a 96yo lady with head and neck ca who responded to MEDI4736. Note the smile!...,,@,#,4.73914E+17,https://twitter.com/Pharmaspectra/status/473913573425438720,,,,
FoxChaseCancer,6/3/2014 15:45,5,5,As # ASCO14 comes to a close many reflect on the meeting and it's impact on the # cancer world http://onforb.es/1x19RWM @ ASCO @ ElaineSchattner,,@ @,# #,4.73913E+17,https://twitter.com/FoxChaseCancer/status/473913390927474688,,,,
ASCO,6/3/2014 15:45,6,1,"IOM Report highlights gaps, provides recommendations re: delivery of high-quality cancer care http://bit.ly/1kmuvMP # ASCO14",,,#,4.73913E+17,https://twitter.com/ASCO/status/473913388595429376,,,,
ERPlimackMD,6/3/2014 15:44,4,0,. @ davidgrahammd on # ASCO14 speakers: “They're in this bc this is really their life's interest.” http://bit.ly/1u1Fb5t via @ ASCO,,@ @,#,4.73913E+17,https://twitter.com/ERPlimackMD/status/473913220961665024,,,,
dfineinc,6/3/2014 15:44,0,1,t-RFA # advancement in treatment of bony # metastases other therapies prove inadequate # ASCO14 http://www.dfineinc.com/Press-Releases/2014/NEW-STUDY-DEMONSTRATES-SIGNIFICANT-PAIN-RELIEF-FOR …pic.twitter.com/Vj7ZpC2dEf,,,# # #,4.73913E+17,https://twitter.com/dfineinc/status/473913196030349312,,,,
_SEOM,6/3/2014 15:37,9,3,Oncólogos y periodistas pueden ver los resúmenes de lo más destacado de # ASCO14 http://www.seom.org/es/servicios-al-socio/formacion-y-recursos/onconexion-2014 …,,,#,4.73911E+17,https://twitter.com/_SEOM/status/473911269775249408,,,,
ONAcom,6/3/2014 15:35,0,0,RT @ ecancer: Adjuvant ipilimumab improves recurrence-free survival in high-risk # melanoma http://ecancer.org/news/5748-asco-2014--adjuvant-ipilimumab-improves-recurrence-free-survival-in-high-risk-melanoma.php … # ASCO14,,@,# #,4.73911E+17,https://twitter.com/ONAcom/status/473910813611532288,,,,
CancerTherAdvsr,6/3/2014 15:31,0,0,"RT @ drdonsdizon: @nextprinciples: Thanks to @ drdonsdizon @ Roche @ scientre @ audvin 4 driving # ASCO14 conversation https://twitter.com/nextprinciples/status/473886737660256256/photo/1pic.twitter.com/TUu7RZWNLB ""...""",,@ @nextprinciples @ @ @ @,#,4.7391E+17,https://twitter.com/CancerTherAdvsr/status/473909824099721217,,,,
evaluatepharma,6/3/2014 15:31,1,0,# ASCO14 – Cell therapy gets a hearing with early NCI data http://ow.ly/xzrO1 $ DNDN $ ABPI $ AGEN $ BVTIQ $ GSK $ NLNK,,,#,4.7391E+17,https://twitter.com/evaluatepharma/status/473909791098949632,,,,
myriadgenetics,6/3/2014 15:30,0,0,Did you know that # genepanel testing identifies more clinically actionable mutations? Visit us at Booth 2039 to find out more! # ASCO14,,,# #,4.73909E+17,https://twitter.com/myriadgenetics/status/473909491272933377,,,,
NancyGBrinker,6/3/2014 15:29,0,1,Study co-authored by SGK Scholar Dr. Ann Partridge: “Drug Saves Fertility for Women With Cancer” via @ nytimes http://nyti.ms/1oPpuhQ # ASCO14,,@,#,4.73909E+17,https://twitter.com/NancyGBrinker/status/473909351074131968,,,,
conkers3,6/3/2014 15:29,0,0,$ ARRY up 1% to $4.20 Two # Array-Invented # MEK Inhibitors Showcased At # ASCO2014 Six Phase 3 Pivotal Trials advancing http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=RssLanding&cat=news&id=1936439 …,,,# # #,4.73909E+17,https://twitter.com/conkers3/status/473909297999806465,,,,
cancerassassin1,6/3/2014 15:27,0,1,If someone could calculate the #of man (and woman)-hours it took to do all the work presented at # ASCO14 ... I bet the #would be HUGE.,,,#of # #would,4.73909E+17,https://twitter.com/cancerassassin1/status/473908776521969665,,,,
ERPlimackMD,6/3/2014 15:25,0,1,"MT @ fischmd: Best home run # ASCO14: Sweeney, ADT+docetaxel vs ADT, survival incr in PCa by 13 months http://ow.ly/xAeCf # gucsm @ eaonc",,@ @,# #,4.73908E+17,https://twitter.com/ERPlimackMD/status/473908443372204033,,,,
MGHCancerCenter,6/3/2014 15:23,0,2,"# ASCO14 winding down - Thank you Chicago for another great conference, great research and great hope for the cancer community",,,#,4.73908E+17,https://twitter.com/MGHCancerCenter/status/473907791178899457,,,,
cancerassassin1,6/3/2014 15:23,0,0,"To paraphrase Ronald Reagan,Are we better off than we were 10 yrs ago?"" # keepmoving/support # cancerresearch # ASCO14 pic.twitter.com/4qYMAiJoDc""",,,# # #,4.73908E+17,https://twitter.com/cancerassassin1/status/473907746631589888,,,,
DrZackaryBerger,6/3/2014 15:21,0,0,"plenty of data. need ++ communication, relationships MT @ cancerassassin1: # ASCO14: more tumor tests than ever. need + knowledge 2 apply info",,@,#,4.73907E+17,https://twitter.com/DrZackaryBerger/status/473907367495876608,,,,
DrAttai,6/3/2014 15:21,0,1,+1! RT @ RyhMd It's imperative to stay motivated to keep up with the avalanche of information in oncology # ASCO14,,@,#,4.73907E+17,https://twitter.com/DrAttai/status/473907238541611011,,,,
DentalOncology,6/3/2014 15:16,1,0,Doctors’ knowledge of science requires investing in education," starting in elem. school."" @ ElaineSchattner http://onforb.es/1x19RWM # ASCO14""",,@,#,4.73906E+17,https://twitter.com/DentalOncology/status/473906128997609472,,,
OncLive,6/3/2014 15:15,1,2,Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer http://ow.ly/xA1i5 # ASCO14,,,#,4.73906E+17,https://twitter.com/OncLive/status/473905858783752192,,,,
MatthewHSimmons,6/3/2014 15:15,0,0,Multiple single gene tests moving to multiplex testing & monitoring (from @ Roche) http://ow.ly/xp8mJ # ASCO14 pic.twitter.com/xwlFyYIk7p,,@,#,4.73906E+17,https://twitter.com/MatthewHSimmons/status/473905856183271425,,,,
MoffittResearch,6/3/2014 15:15,0,0,# ASCO14 is wrapping up. Share your experience. # moffitt # cancerresearch http://bit.ly/1kikn7U,,,# # #,4.73906E+17,https://twitter.com/MoffittResearch/status/473905826043006976,,,,
ASCO,6/3/2014 15:15,10,3,Negative ALTTO trial casts doubt on neoadj. pCR as predictor of adjuvant benefit http://bit.ly/1hvV3Lv # ASCO14,,,#,4.73906E+17,https://twitter.com/ASCO/status/473905810830286849,,,,
JanssenUS,6/3/2014 15:14,1,1,"Thanks for stopping by at # ASCO14! To learn more about our advances in # cancer care, check out the Janssen newsroom: http://bit.ly/1jZPlAC",,,# #,4.73906E+17,https://twitter.com/JanssenUS/status/473905616671760384,,,,
cancerassassin1,6/3/2014 15:14,0,0,@ AdamsLisa - Thanks for your input and response. We gain energy & excitement b/c of work shared at # ASCO14 to take home to our communities,,@,#,4.73905E+17,https://twitter.com/cancerassassin1/status/473905456125997056,,,,
cancerassassin1,6/3/2014 15:12,0,0,@ TGSOFL @ AdamsLisa - I am very sorry for your loss; we have much work left to do but are invigorated after # ASCO14 to get the job done,,@ @,#,4.73905E+17,https://twitter.com/cancerassassin1/status/473905089753542656,,,,
Emory_R,6/3/2014 15:11,1,2,"# ASCO14 stock tracker now includes performance since data dump, since conference start. Winner: $ TGTX Loser: $ CLVShttp://buff.ly/1uez7GR",,,#,4.73905E+17,https://twitter.com/Emory_R/status/473904705551478784,,,,
Perthera,6/3/2014 15:10,0,0,What It Costs to Be an # Oncologist http://ow.ly/xxtVt via @ CancerNetwrk | # ASCO # ASCO14 # paymentreform,,@,# # # #,4.73905E+17,https://twitter.com/Perthera/status/473904548223123457,,,,
PublicHealthRTs,6/3/2014 15:10,0,0,"RT @ USATODAYhealth: Immune therapies improve treatment of some cancers; at least 6 promising studies at # ASCO14, http://ow.ly/xwBJu",,@,#,4.73905E+17,https://twitter.com/PublicHealthRTs/status/473904547585613825,,,,
Boehringer,6/3/2014 15:10,2,4,“Now is a critically important time to invest in the fight against # lungcancer” @ LungCancer_Can http://bit.ly/1l0JElO # ASCO14 # hcsmeu,,@,# # #,4.73905E+17,https://twitter.com/Boehringer/status/473904538005823489,,,,
livestrong,6/3/2014 15:10,10,11,"Fascinating posibilities out of # ASCO14: Doctors use immune therapy against cervical cancer"" http://bit.ly/1pPCOjF""",,,#,4.73904E+17,https://twitter.com/livestrong/status/473904472083943424,,,,
myriadgenetics,6/3/2014 15:10,0,0,Attending # ASCO14? Visit us at Booth 2039 to find out about our # companiondiagnostic BRACAnalysis with # PARP inhibitors! # ASCOConnection,,,# # # #,4.73904E+17,https://twitter.com/myriadgenetics/status/473904451569192960,,,,
CliffordHudis,6/3/2014 15:07,0,0,@ HenryJOncology @ ASCO thanks!,,@ @,,4.73904E+17,https://twitter.com/CliffordHudis/status/473903832628744192,,,,
marklewismd,6/3/2014 15:05,0,4,More great # ASCO14 tweets by @ ASCO @ ASCOPost @ CliffordHudis @ yzafar @ drdonsdizon aka how to feel you attended a meeting when you couldn't,,@ @ @ @ @,#,4.73903E+17,https://twitter.com/marklewismd/status/473903359481491457,,,,
Tony_Calles,6/3/2014 15:05,1,1,Caught me in action. I guess It was a good question. Thanks Cloud for the pic! # ASCO14 pic.twitter.com/w5cZsUJL0F,,,#,4.73903E+17,https://twitter.com/Tony_Calles/status/473903209531338752,,,,
SitemanCenter,6/3/2014 15:03,0,0,New drug may boost survival for advanced prostate cancer patients. Dr Bruce Roth of Siteman comments: http://goo.gl/QrZhaC # ASCO14,,,#,4.73903E+17,https://twitter.com/SitemanCenter/status/473902697859399680,,,,
ONAcom,6/3/2014 15:02,0,0,# ASCO14: Obese patients with gynecologic cancer are rarely counseled on weight loss - http://ow.ly/xwfnT # gyncsm,,,# #,4.73903E+17,https://twitter.com/ONAcom/status/473902512769368064,,,,
ASCO,6/3/2014 15:02,0,0,Need a ride to the airport? Reserve space w/Go Airport Express - # ASCO14 attendees receive a 10% discount http://bit.ly/1mh7Cb1,,,#,4.73903E+17,https://twitter.com/ASCO/status/473902511011942400,,,,
EFEciencia,6/3/2014 15:02,2,2,"La inmunoterapia vuele a ser protagonista en ASCO 2014, la mayor reunión en oncología http://www.efefuturo.com/noticia/la-inmunoterapia-vuele-a-ser-protagonista-en-asco-2014-la-mayor-reunion-en-oncologia/ … # ASCO14",,,#,4.73902E+17,https://twitter.com/EFEciencia/status/473902444103999488,,,,
CliffordHudis,6/3/2014 15:01,2,1,great reason to attend F2F mtgs too! MT “ @ mtmdphd: . @ davidgrahammd on # ASCO14 talk to speakers: http://bit.ly/1u1Fb5t via @ ASCO”,,@ @ @,#,4.73902E+17,https://twitter.com/CliffordHudis/status/473902429894115328,,,,
CancerTherAdvsr,6/3/2014 15:01,0,0,Safe to Postpone ADT in Men with Asymptomatic # ProstateCancer and Rising PSA Levels # ASCO14 http://ow.ly/xxYq2,,,# #,4.73902E+17,https://twitter.com/CancerTherAdvsr/status/473902287610716161,,,,
marklewismd,6/3/2014 15:01,1,1,"Couldn't be at # ASCO14 but catching up via @ fischmd @ subatomicdoc @ DrAttai @ mtmdphd It's not Friday, but there should be a # FollowOnc",,@ @ @ @,# #,4.73902E+17,https://twitter.com/marklewismd/status/473902207373688832,,,,
KUhlendorf,6/3/2014 15:00,1,0,"Value of # cancer medicines to patients, society, economy http://www.phrma.org/the-value-of-cancer-medicines-infographic … # ASCO14 @ PhRMApic.twitter.com/GZymfWnvcy",,@,# #,4.73902E+17,https://twitter.com/KUhlendorf/status/473902151388123136,,,,
HenryJOncology,6/3/2014 14:58,0,1,"@ ASCO @ CliffordHudis Absolutely fantastic # ASCO14! By putting on such a great meeting, you have done a great service for # Cancer patients",,@ @,# #,4.73902E+17,https://twitter.com/HenryJOncology/status/473901513660583936,,,,
ASCO,6/3/2014 14:58,0,0,@ drmikesevilla Glad you found the # ASCO14 tweets helpful.,,@,#,4.73901E+17,https://twitter.com/ASCO/status/473901465678147584,,,,
SeanKhozin,6/3/2014 14:55,3,0,Great to see friend Hinrichs' promising results w adoptive T cell therapy in HPV+ cervical cancer RT @ drsam # ASCO14 pic.twitter.com/OkKo1vamxR,,@,#,4.73901E+17,https://twitter.com/SeanKhozin/status/473900762465304577,,,,
Carpowich,6/3/2014 14:55,0,0,"Nice recap of key research advances for women's cancers, from # ASCO14, via @ theNCI http://ow.ly/xzBan # cancerresearch # womenshealth",,@,# # #,4.73901E+17,https://twitter.com/Carpowich/status/473900702012833792,,,,
urotoday,6/3/2014 14:54,0,0,# ASCO14 - Poster: Safety results of the enzalutamide expanded access program in the United ... http://dlvr.it/5skBRq,,,#,4.73901E+17,https://twitter.com/urotoday/status/473900567316529152,,,,
urotoday,6/3/2014 14:54,1,1,# ASCO14 - Poster: A randomized phase 2 study evaluating optimal sequencing of sipuleucel-T ... http://dlvr.it/5skBPp,,,#,4.73901E+17,https://twitter.com/urotoday/status/473900563025784832,,,,
HenryJOncology,6/3/2014 14:53,0,0,"# ASCO14 # sarcoma poster highlights: mtor+mek inhibition may work in lms patients. Also, no to tx holiday if using trabectedin in 2nd line.",,,# #,4.739E+17,https://twitter.com/HenryJOncology/status/473900389046054912,,,,
medbiomarketing,6/3/2014 14:50,0,0,RT @ ASCO: Plenary # ASCO14 “This is an almost unprecedented improvement in median survival…this is transformative“ @ cliffordhudis on E3805,,@ @,#,4.73899E+17,https://twitter.com/medbiomarketing/status/473899495940702208,,,,
RyhMd,6/3/2014 14:50,0,0,Being in Chicago heading to clinic now right after ASCO # ASCO14,,,#,4.73899E+17,https://twitter.com/RyhMd/status/473899453083312128,,,,
diablovalleyonc,6/3/2014 14:49,0,0,Patient study summaries on # melanoma & # cervicalcancer from # ASCO2014 patient info website http://ow.ly/xAnZe http://ow.ly/i/5MBAf,,,# # #,4.73899E+17,https://twitter.com/diablovalleyonc/status/473899414088843266,,,,
CaliforniaSkin,6/3/2014 14:49,1,0,Patient study summaries on # melanoma & # cervicalcancer from # ASCO2014 patient info website http://ow.ly/xAnZd http://ow.ly/i/5MBAf,,,# # #,4.73899E+17,https://twitter.com/CaliforniaSkin/status/473899413338079234,,,,
umichmedicine,6/3/2014 14:48,1,0,RT @UMCancerCenter: New # prostatecancer study paves way for potential treatment changes: http://umhealth.me/1h589yG # ASCO14,,@UMCancerCenter,# #,4.73899E+17,https://twitter.com/umichmedicine/status/473898963226333185,,,,
CancerResrch,6/3/2014 14:47,1,0,How Scientific Collaboration Can Improve Our Approach To Fighting Cancer http://www.forbes.com/sites/robertglatter/2014/05/31/asco-2014-how-scientific-collaboration-can-improve-our-approach-to-fighting-cancer/?ss=pharma … @ ASCO @ ASCOPost @ Forbes # ASCO14,,@ @ @,#,4.73899E+17,https://twitter.com/CancerResrch/status/473898882053971968,,,,
afreshchapter,6/3/2014 14:47,0,0,Another day. Another flight. Thanks # asco14 for a great few days in Chicago. See you soon Toronto.… http://instagram.com/p/oyuFTmsgQd/,,,#,4.73899E+17,https://twitter.com/afreshchapter/status/473898790949117952,,,,
evaluatepharma,6/3/2014 14:45,0,0,# ASCO14 – Cell therapy gets a hearing with early NCI data http://ow.ly/xzqn3 $ DNDN $ ABPI $ AGEN $ BVTIQ $ GSK $ NLNK,,,#,4.73898E+17,https://twitter.com/evaluatepharma/status/473898277503770624,,,,
ASCO,6/3/2014 14:45,11,6,"Bevacizumab, cetuximab, along w/FOLFOX or FOLFIRI, offer similar, strong survival rates in metastatic CRC http://bit.ly/U9aUFx # ASCO14",,,#,4.73898E+17,https://twitter.com/ASCO/status/473898277034020865,,,,
MayoCancerCare,6/3/2014 14:45,0,0,# OvarianCancer Subtypes May Predict Response to Bevacizumab: http://mayocl.in/U80PZo # ASCO14,,,# #,4.73898E+17,https://twitter.com/MayoCancerCare/status/473898171169783808,,,,
ASCOPost,6/3/2014 14:40,7,2,Adding Docetaxel to Androgen-Deprivation Therapy Improves Survival in Hormone-Sensitive Prostate Cancer http://ow.ly/xAmxM # ASCO14 # pcsm,,,# #,4.73897E+17,https://twitter.com/ASCOPost/status/473897075378499585,,,,
revolvercrack,6/3/2014 14:38,0,0,"# ASCO14, el mayor congreso mundial del cáncer, revela nuevos logros en inmunoterapia http://flip.it/2QS3G",,,#,4.73897E+17,https://twitter.com/revolvercrack/status/473896516604948480,,,,
SylviaNorman11,6/3/2014 14:37,0,0,Striking Results With T-Cell Immunotherapy in Cervical Cancer http://www.medscape.com/viewarticle/826062?src=sttwit … # ASCO2014 # cervicalcancer,,,# #,4.73896E+17,https://twitter.com/SylviaNorman11/status/473896335196708866,,,,
bajenlandet,6/3/2014 14:35,0,0,@ ASCO why cant i look on the virtual video from website?,,@,,4.73896E+17,https://twitter.com/bajenlandet/status/473895709566316544,,,,
MartinStockler,6/3/2014 14:34,3,1,MT @ fischmd: Best home run # ASCO14: 13 mo survival benefit adding chemo to ADT Sweeney # prostatecancer @ ANZUPtrials http://ow.ly/xAeCf,,@ @,# #,4.73896E+17,https://twitter.com/MartinStockler/status/473895640028569603,,,,
drcbsteer,6/3/2014 14:31,3,0,# ASCO14 # thingsIhavelearned # crcsm Oxaliplatin should be considered in adjuvant therapy for high risk rectal cancer,,,# # #,4.73895E+17,https://twitter.com/drcbsteer/status/473894690073608192,,,,
CellSymposia,6/3/2014 14:31,0,0,Sad that # ASCO14 is over? Join us for # CSHallmarks in Beijing & hear Jim Allison on # immunotherapy & # ipilimumab http://ow.ly/xiJvk,,,# # # #,4.73895E+17,https://twitter.com/CellSymposia/status/473894647409164289,,,,
genentech,6/3/2014 14:31,4,2,"From flying cars to chocolate bars, see kids’ predictions for the # Next50 years of science # ASCO14 http://ow.ly/xk7AS",,,# #,4.73895E+17,https://twitter.com/genentech/status/473894643760136193,,,,
cordekroon,6/3/2014 14:31,0,0,“ @ jrgralow: Back to the Future: Family History is Still Key in the Genomic Era # ASCO14 Annual Meeting http://am.asco.org/back-future-family-history-still-key-genomic-era#.U42-YXa4AH4.twitter …” # daretolisten,,@,# # #,4.73895E+17,https://twitter.com/cordekroon/status/473894636361367552,,,,
GenomicHealth,6/3/2014 14:30,4,1,. @ UCSF study: # Oncotype # prostatecancer test can predict cancer aggressiveness despite pathology variability http://bit.ly/1rIfUzv # ASCO14,,@,# # #,4.73894E+17,https://twitter.com/GenomicHealth/status/473894418345627650,,,,
nanostringtech,6/3/2014 14:30,0,1,"Bastien et al present Clincial validation of the Prosigna breast cancer prognostic gene sigature assay…"" at # ASCO14 http://abstracts.asco.org/144/AbstView_144_132312.html …""",,,#,4.73894E+17,https://twitter.com/nanostringtech/status/473894393510756352,,,,
drcbsteer,6/3/2014 14:29,5,2,# ASCO14 # thingsIhavelearned # immunotherapy results in multiple tumour types are the tip of the proverbial iceberg. # muchmoreto come.,,,# # # #,4.73894E+17,https://twitter.com/drcbsteer/status/473894282458587136,,,,
RyhMd,6/3/2014 14:28,0,0,It's imperative to stay motivated to keep up with the avalanche of information in oncology # ASCO14,,,#,4.73894E+17,https://twitter.com/RyhMd/status/473894077944328192,,,,
drcbsteer,6/3/2014 14:27,4,3,# ASCO14 # thingsIhavelearned # prostate Docetaxel + ADT VS ADT alone improves med OS in men with CSPC by 13months,,,# # #,4.73894E+17,https://twitter.com/drcbsteer/status/473893751430328321,,,,
dgermain21,6/3/2014 14:25,0,0,@ fischmd @ ASCO Any other home runs to share? Would love to hear about other OS/PFS/etc… incr >12 months.,,@ @,,4.73893E+17,https://twitter.com/dgermain21/status/473893361334501376,,,,
UMRogelCancer,6/3/2014 14:23,1,0,New # prostatecancer study paves way for potential treatment changes: http://umhealth.me/1h589yG # ASCO14,,,# #,4.73893E+17,https://twitter.com/UMRogelCancer/status/473892699863797760,,,,
fipco,6/3/2014 14:20,0,0,. @ drsam # ASCO14 like this? pic.twitter.com/1B3IraU9EY,,@,#,4.73892E+17,https://twitter.com/fipco/status/473892048761012225,,,,
villeodell,6/3/2014 14:19,1,2,An Industry Perspective on Innovation in Oncology from @ MaceRothenberg of @ pfizer http://am.asco.org/how-progress-happens-industry-perspective-innovation-oncology … @ ASCO,,@ @ @,,4.73892E+17,https://twitter.com/villeodell/status/473891859144929280,,,,
fischmd,6/3/2014 14:19,2,0,RT @ rschilsky: Apple announces Epic deal! http://www.advisory.com/daily-briefing/blog/2014/05/apple-unveils-new-health-app … # ASCO14 # healthIT # hcsm,,@,# # #,4.73892E+17,https://twitter.com/fischmd/status/473891811501809664,,,,
drdonsdizon,6/3/2014 14:17,0,1,"@nextprinciples: Thanks to @ drdonsdizon @ Roche @ scientre @ audvin 4 driving # ASCO14 conversation https://twitter.com/nextprinciples/status/473886737660256256/photo/1pic.twitter.com/f8S7cyEhoU "" very cool graphic!""",,@nextprinciples @ @ @ @,#,4.73891E+17,https://twitter.com/drdonsdizon/status/473891336291385344,,,,
CancerNetwrk,6/3/2014 14:16,1,1,Blog from # ASCO14 Overdiagnosis and Overtreatment in Cancer: Point/Counterpoint http://bit.ly/1x20KVT,,,#,4.73891E+17,https://twitter.com/CancerNetwrk/status/473890944128122880,,,,
NBCCStopBC,6/3/2014 14:16,0,0,Learn what's new in # cancer # research w/ this searchable collection of studies from the @ ASCO Annual Meeting: http://bit.ly/1hVDUW0 # ASCO14,,@,# # #,4.73891E+17,https://twitter.com/NBCCStopBC/status/473890879661694978,,,,
JasperCapital,6/3/2014 14:15,0,0,"Cancer Survivorship Program Models in Academic, Community, National Settings | ASCO Annual Meeting http://ow.ly/xzSco # ASCO14",,,#,4.73891E+17,https://twitter.com/JasperCapital/status/473890749462102016,,,,
MoffittNews,6/3/2014 14:15,0,0,. @ NPR shares how # ASCO14 assembled one of the largest # cancerresearch meetings of the year. http://n.pr/1kBDC6I,,@,# #,4.73891E+17,https://twitter.com/MoffittNews/status/473890745888555008,,,,
ASCO,6/3/2014 14:15,10,6,Docetaxel added to ADT improved OS by 13 months in men with newly metastatic prostate cancer http://bit.ly/U9aUFx # ASCO14,,,#,4.73891E+17,https://twitter.com/ASCO/status/473890722014588928,,,,
OncLive,6/3/2014 14:15,0,0,Panobinostat Combination Improves PFS in Multiple Myeloma http://ow.ly/xAapP # ASCO14,,,#,4.73891E+17,https://twitter.com/OncLive/status/473890648605872128,,,,
Tony_Calles,6/3/2014 14:13,1,2,"As # ASCO14 50th ed. comes to its end, It's time to say thanks to everyone involved in this fight against cancer. Have a safe trip everyone!",,,#,4.7389E+17,https://twitter.com/Tony_Calles/status/473890149672448000,,,,
pharmaguy,6/3/2014 14:13,0,0,The Emerging Virtual Medical Meeting: http://bit.ly/pmn1305-02asco # ASCO14,,,#,4.7389E+17,https://twitter.com/pharmaguy/status/473890128788979714,,,,
oncotuits,6/3/2014 14:11,3,2,Docetaxel +bloqueo androgenico aumenta supervivencia 13 meses vs solo bloqueo # cancerdeprostata http://ow.ly/xAeCf # ASCO14,,,# #,4.7389E+17,https://twitter.com/oncotuits/status/473889601300340739,,,,
evaluatepharma,6/3/2014 14:10,0,0,# ASCO14 - Academia gives # Erbitux another chance to gain share in colorectal cancer http://ow.ly/xz5d3 $ LLY,,,# #,4.73889E+17,https://twitter.com/evaluatepharma/status/473889413731475457,,,,
cgblanc,6/3/2014 14:09,0,0,@ ASCO xfcc,,@,,4.73889E+17,https://twitter.com/cgblanc/status/473889242234757120,,,,
kbnewport,6/3/2014 14:08,0,0,# hpm # ASCO14 We've been wondering... Thanks to A Abernathy: Stopping statins may benefit terminally ill patients -- http://www.sciencedaily.com/releases/2014/05/140530142416.htm#.U44O32W4K0w.twitter …,,,# # #,4.73889E+17,https://twitter.com/kbnewport/status/473889037522972673,,,,
ASCO,6/3/2014 14:08,4,1,# ASCO14 has drawn to a close. Our appreciation to all that attended & contributed to the conversation. We look towards the future & # ASCO15,,,# #,4.73889E+17,https://twitter.com/ASCO/status/473888875870687235,,,,
HSGNews,6/3/2014 14:07,0,0,"It was great to be a part of such an incredible, informative show. Thank you # ASCO14",,,#,4.73889E+17,https://twitter.com/HSGNews/status/473888819222048770,,,,
urotoday,6/3/2014 14:06,0,0,# ASCO14 - Poster: Enzalutamide monotherapy: 1-year extended follow-up of a Phase 2 study in ... http://dlvr.it/5sjM6y,,,#,4.73888E+17,https://twitter.com/urotoday/status/473888372063084546,,,,
urotoday,6/3/2014 14:06,1,0,# ASCO14 - Poster: Sensitivity analyses for radiographic progression-free survival (rPFS): ... http://dlvr.it/5sjM4m,,,#,4.73888E+17,https://twitter.com/urotoday/status/473888368124633089,,,,
Boehringer,6/3/2014 14:05,1,0,"Cancer is not just one disease"" Day 3 at # ASCO14 by Julia Knebel # lungcancer http://bit.ly/1onvYkl""",,,# #,4.73888E+17,https://twitter.com/Boehringer/status/473888175023480832,,,,
abbottmd,6/3/2014 14:05,0,1,Back to the Future: Family History is Still Key in the Genomic Era | ASCO Annual Meeting http://ow.ly/xxT7g # ASCO14,,,#,4.73888E+17,https://twitter.com/abbottmd/status/473888170850127873,,,,
GScheiber,6/3/2014 14:05,0,0,“ @ TransgeneSA: Nouveaux succès de l'immunothérapie face au mélanome via @ LePoint http://ow.ly/xzgtP # ASCO14 # oncologie # santé”,,@ @,# # #,4.73888E+17,https://twitter.com/GScheiber/status/473888124926697472,,,,
nycdoc29,6/3/2014 14:04,0,0,"“ @ RxPertise: Many doctors at # ASCO14 say no major, routine impact from the ACA # healthcarereform” I disagree as a private practice Doc!",,@,# #,4.73888E+17,https://twitter.com/nycdoc29/status/473888007075168256,,,,
ConsanoScott,6/3/2014 14:04,0,0,"Loved visiting # chicago and # asco14, but so happy to be back in # PDX! There's nothing like a warm sunny day in the Pacific NW!",,,# # #,4.73888E+17,https://twitter.com/ConsanoScott/status/473887930549694466,,,,
GuneetWalia,6/3/2014 14:02,0,0,Mark Kris: Chemotherapy key part of curative # LungCancer therapies http://www.cancernetwork.com/asco-2014-lung-cancer/asco-chemotherapy-key-part-curative-lung-cancer-therapies … # LCSM # ASCO14,,,# # #,4.73888E+17,https://twitter.com/GuneetWalia/status/473887543034146816,,,,
ASCO,6/3/2014 14:02,4,3,"# ASCO14 Virtual Meeting: Access videos of presentations, abstracts, podcasts, iMeeting apps @your convenience http://bit.ly/1tVXB8r",,@your,#,4.73887E+17,https://twitter.com/ASCO/status/473887439946514432,,,,
ASCO,6/3/2014 14:02,0,0,Invigorated by the lung cancer track at # ASCO14? Follow up with e-learning courses: http://bit.ly/1mZaa28 via # ASCOConnection # lcsm,,,# # #,4.73887E+17,https://twitter.com/ASCO/status/473887412599656448,,,,
Elekta,6/3/2014 14:02,0,0,How can we make our booth at next year’s @ ASCO even better? Let us know!,,@,,4.73887E+17,https://twitter.com/Elekta/status/473887396522909697,,,,
Roche,6/3/2014 14:02,0,2,"Thanks for a great # ASCO14, see you next year.",,,#,4.73887E+17,https://twitter.com/Roche/status/473887374238564352,,,,
CancerDotNet,6/3/2014 14:01,2,3,Thanks for a great # ASCO14! Remember: http://Cancer.Net is @ ASCO's patient website for 24/7 # cancer information http://www.cancer.net,,@,# #,4.73887E+17,https://twitter.com/CancerDotNet/status/473887318068436992,,,,
erschuur,6/3/2014 14:01,0,0,Great news for # prostatecancer patients from # ASCO14: http://www.nytimes.com/2014/06/02/health/early-chemotherapy-extends-lives-of-men-with-prostate-cancer-study-finds.html?hpw&rref=science&action=click&module=Search&region=searchResults&mabReward=relbias%3As&url=http%3A%2F%2Fquery.nytimes.com%2Fsearch%2Fsitesearch%2F%3Faction%3Dclick%26region%3DMasthead%26pgtype%3DHomepage%26module%3DSearchSubmit%26contentCollection%3DHomepage%26t%3Dqry135%23%2FAmerican%2BSociety%2Bof%2BClinical%2BOncology%2F24hours%2F&_r=2 … 14 additional months is huge!,,,# #,4.73887E+17,https://twitter.com/erschuur/status/473887138191114243,,,,
CancerResearch,6/3/2014 14:01,1,1,You can take the CRI Pledge today to show your support of # immunotherapy # ASCO14 http://ow.ly/xyACV,,,# #,4.73887E+17,https://twitter.com/CancerResearch/status/473887125809938437,,,,
MSKCC_Library,6/3/2014 14:00,0,0,"v @ CancerDotNet: Looking for # ASCO14 research highlights for people w/ cancer? Full, interactive PDF patient summary: http://bit.ly/1jM9eGo",,@,#,4.73887E+17,https://twitter.com/MSKCC_Library/status/473887006893027328,,,,
lenstarnes,6/3/2014 14:00,0,0,"# ASCO14 Latest @ symplur Twitter analytics: 11k participants, 52k tweets, 170m impressions. WOW! # hcsm # hcsmeu # hcsmca # hcmanz",,@,# # # # #,4.73887E+17,https://twitter.com/lenstarnes/status/473886900588404736,,,,
myriadgenetics,6/3/2014 14:00,0,0,Are you attending # ASCO14? Visit us at Booth 2039 to learn about our extensive patient advocacy efforts! # personalmed # hereditarycancer,,,# # #,4.73887E+17,https://twitter.com/myriadgenetics/status/473886899019333633,,,,
medpagetoday,6/3/2014 14:00,1,0,Herceptin beneficial for women with small tumors according to meta-analysis of randomized trials of the drug # ASCO14 http://bit.ly/1rIh51T,,,#,4.73887E+17,https://twitter.com/medpagetoday/status/473886883739488258,,,,
erschuur,6/3/2014 13:59,0,0,# immunotherapy was the darling of # ASCO14 this year: http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html … # cancer # oncology,,,# # # #,4.73887E+17,https://twitter.com/erschuur/status/473886729460383745,,,,
ChristiBaus,6/3/2014 13:59,0,0,@ ASCO Can you talk about any Non-pharmaceutical products for pain management? Please consider mentioning: http://goo.gl/QH7nLX FDA Listed.,,@,,4.73887E+17,https://twitter.com/ChristiBaus/status/473886625861476353,,,,
RXMOSAIC,6/3/2014 13:58,0,0,"Many doctors at # ASCO14 say there is no major, routine impact from the Affordable Care Act yet: http://reut.rs/1krpWj2 # healthcarereform",,,# #,4.73887E+17,https://twitter.com/RXMOSAIC/status/473886577236516864,,,,
GuneetWalia,6/3/2014 13:57,0,0,Potential breath test for # LungCancer?Compounds in exhaled breath allow detectng cancer presence &stage # LCSM # ASCO14 http://www.sciencedaily.com/releases/2014/05/140531154834.htm …,,,# # #,4.73886E+17,https://twitter.com/GuneetWalia/status/473886138143227904,,,,
djsampson,6/3/2014 13:56,2,2,And I'm gonna say it. This was the year twitter made # ASCO14 incredibly productive and enjoyable.,,,#,4.73886E+17,https://twitter.com/djsampson/status/473886075652698112,,,,
asclepiacap,6/3/2014 13:56,0,0,"$ AZN presentation at # jefferies runs thru '9291. Licking its chops from # ASCO14, mentions potential to file 1Q15. No other talk of '9291",,,# #,4.73886E+17,https://twitter.com/asclepiacap/status/473886048133869569,,,,
IQVIA_Biotech,6/3/2014 13:56,0,0,Thanks @ ASCO for a great meeting and thank you to all who stopped by our booth to say hello! Looking forward to next year! # ASCO14,,@,#,4.73886E+17,https://twitter.com/IQVIA_Biotech/status/473885963840933889,,,,
z_phd,6/3/2014 13:56,0,0,"Thanks, @ ASCO, for a great # ASCO14! Looking forward to coming back for # ASCO15!",,@,# #,4.73886E+17,https://twitter.com/z_phd/status/473885911550136320,,,,
fischmd,6/3/2014 13:56,12,4,"Best home run # ASCO14: Sweeney, ADT / docetaxel vs ADT, survival incr in # prostatecancer by 13 months http://ow.ly/xAeCf # gucsm # EAOnc",,,# # # #,4.73886E+17,https://twitter.com/fischmd/status/473885903644286976,,,,
djsampson,6/3/2014 13:54,0,0,A huge shout out to @ asco staff. Amazing job in the press room and the conference... and you did it all with a smile # ASCO14,,@,#,4.73885E+17,https://twitter.com/djsampson/status/473885354554961921,,,,
EPClinicalTrial,6/3/2014 13:53,0,0,Growing PD-1 uses fail to stem Bristol selloff http://ow.ly/xzscP $ BMY via @ JacobEPVantage # ASCO14,,@,#,4.73885E+17,https://twitter.com/EPClinicalTrial/status/473885113273823232,,,,
LGG1,6/3/2014 13:51,0,0,"It's an honor and a joy to work @ ASCO + lots of fun. Thanks to the faculty, attendees and staff at # ASCO14 for keeping me so inspired!",,@,#,4.73885E+17,https://twitter.com/LGG1/status/473884705394548736,,,,
existent_io,6/3/2014 13:50,0,0,"# ASCO14 the finish line is near, so many discussions in the fight against # bcher # btast # cxca # hncth # lcalk # srcb # lylal # cancer",,,# # # # # # # # #,4.73884E+17,https://twitter.com/existent_io/status/473884467417722880,,,,
Cancer_Genetics,6/3/2014 13:50,1,0,Miss us at # ASCO14? It's not too late to learn about FHACT # cervical # cancer test. Sign up for the http://www.cgifhact.com/webinar this Thurs @ 12 EST,,@,# # #,4.73884E+17,https://twitter.com/Cancer_Genetics/status/473884407594356736,,,,
GenomicHealth,6/3/2014 13:50,1,1,New $ GHDX data: importance of using multiple biological pathways to predict # prostate # renal tumor behavior http://bit.ly/1rIfUzv # ASCO14,,,# # #,4.73884E+17,https://twitter.com/GenomicHealth/status/473884364481105920,,,,
jodyms,6/3/2014 13:49,0,1,"YES @ drdonsdizon: Big theme here at # ASCO14, even in midst of amazing progress- Balance innovation w access. Everyone w cancer deserves this",,@,#,4.73884E+17,https://twitter.com/jodyms/status/473884180065951744,,,,
erschuur,6/3/2014 13:48,0,0,"# cancer drug prices-FDA chief discusses at # ASCO14: http://www.reuters.com/article/2014/06/01/us-health-cancer-fda-idUSKBN0EC13W20140601 … # FDA shouldn't be the price filter, payors are better equipped.",,,# # #,4.73884E+17,https://twitter.com/erschuur/status/473883881473466368,,,,
jdflaysakier,6/3/2014 13:46,1,0,Once more the # ASCO14 press staff has done a great job. Many convention organizers would be inspired to come and learn.,,,#,4.73883E+17,https://twitter.com/jdflaysakier/status/473883425154539520,,,,
myelomacinderel,6/3/2014 13:46,1,0,Paul Richardson spks@ASCO on Panorama I Virtual Meeting # mmsm # MMRFASCO # ASCO14 http://wp.me/p34VtR-13a,,@ASCO,# # #,4.73883E+17,https://twitter.com/myelomacinderel/status/473883381533773825,,,,
Boehringer,6/3/2014 13:45,0,1,# HCPs: # DoYouAgree? Targeted drugs & intelligent drug combinations is the future of # lungcancer Therapy http://bit.ly/1gNI2KN > # ASCO14,,,# # # #,4.73883E+17,https://twitter.com/Boehringer/status/473883174771384320,,,,
ASCO,6/3/2014 13:45,8,1,AI provides longer DFS than tamoxifen w/ovarian function suppression in premenopausal HR+ early breast CA http://bit.ly/1mO36Rh # ASCO14,,,#,4.73883E+17,https://twitter.com/ASCO/status/473883139300155393,,,,
SitemanCenter,6/3/2014 13:45,0,0,"Thank you, @ ASCO for another great conference! As always, we look forward to seeing our friends and colleagues next year....",,@,,4.73883E+17,https://twitter.com/SitemanCenter/status/473883138910068736,,,,
survivornetca,6/3/2014 13:45,1,0,RT @ ASCOPost: Adjuvant Exemestane w/Ovarian Suppression Better prevention 4 Breast Cancer Than Tamoxifen http://ow.ly/xA3AI # ASCO14 # bcsm,,@,# #,4.73883E+17,https://twitter.com/survivornetca/status/473883103891439616,,,,
Xcenda,6/3/2014 13:45,1,0,# ASCO14 is a wrap! Fantastic sessions this year! Missed # Xcenda's posters? Visit: http://bit.ly/1jXRsje,,,# #,4.73883E+17,https://twitter.com/Xcenda/status/473883093539893248,,,,
ProfJohnCrown,6/3/2014 13:44,4,6,Amazing to think that biggest treatment story of # ASCO14 was chemotherapy. Benefit of docetaxel in metastatic prostate.,,,#,4.73883E+17,https://twitter.com/ProfJohnCrown/status/473883051433660416,,,,
jagasquet,6/3/2014 13:43,1,1,@ AstraZeneca provides updates on progress of oncology pipeline at # ASCO14 See the slides! http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DDownload-presentation.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285673317058&ssbinary=true …pic.twitter.com/DzMkA0Fboj,,@,#,4.73883E+17,https://twitter.com/jagasquet/status/473882673513918465,,,,
RyhMd,6/3/2014 13:38,0,0,"# ASCO14 can't have enough of gold coins"" "," ED pic.twitter.com/9jAukAtdIW""",,,#,4.73881E+17,https://twitter.com/RyhMd/status/473881310885187584,,,
precepta,6/3/2014 13:36,2,0,"Novo dispositivo pode identificar # câncer de pulmão no ar expirado, segundo estudo apresentado no # ASCO2014 # oncologia",,,# # #,4.73881E+17,https://twitter.com/precepta/status/473881026495000576,,,,
n8pennell,6/3/2014 13:36,0,1,Byers: Why responses in RET amp pts so low? Maybe not real target but maybe definition of RET amp too liberal (much like MET). # ASCO14 # LCSM,,,# #,4.73881E+17,https://twitter.com/n8pennell/status/473880864716124160,,,,
RielyMD,6/3/2014 13:34,0,0,Byers: reasons for poor performance of FGFR inhibitors: not true driver? cutoff for amplification too low?molecular heterogeneity? # ASCO14,,,#,4.7388E+17,https://twitter.com/RielyMD/status/473880422183874560,,,,
heidisa,6/3/2014 13:33,1,0,ICYMI: This. # ASCO14 pic.twitter.com/wmA9arcn79,,,#,4.7388E+17,https://twitter.com/heidisa/status/473880193589723137,,,,
Merck,6/3/2014 13:33,2,2,Check out our # ASCO14 photos: https://www.facebook.com/MerckBeWell,,,#,4.7388E+17,https://twitter.com/Merck/status/473880177202987008,,,,
RP_RP_RP,6/3/2014 13:33,0,1,“ @ scientre: Kris: oppty to add chemo to immunooncology drugs. Slide has potl + incl inc antigens # asco14 pic.twitter.com/W3fsXTalUZ” @ NinaBeri,,@ @,#,4.7388E+17,https://twitter.com/RP_RP_RP/status/473880143195541504,,,,
RielyMD,6/3/2014 13:33,0,0,"Nogova #8034 BGJ398 in 20 FGFR amplified pts, 4PRs. Paik #8035 AZD4547 in 13 FGFR amplified pts, 1 PR. More to learn. # ASCO14",,,#8034 #8035 #,4.7388E+17,https://twitter.com/RielyMD/status/473880134509166592,,,,
jagasquet,6/3/2014 13:31,0,0,Goodbye # ASCO14. Ready for # ASCO15? http://www.asco.org/meetings/2015-asco-annual-meeting …,,,# #,4.7388E+17,https://twitter.com/jagasquet/status/473879678550151170,,,,
AndytweetM,6/3/2014 13:31,0,0,“ @ TommyJohn00: Cdk inhibitor in kras mutant nsclc dcr=50%. Very interesting! # ASCO14 ” implications for kras mut. Ov cancer too ? # gyncsm,,@,# #,4.7388E+17,https://twitter.com/AndytweetM/status/473879656828256256,,,,
drsam,6/3/2014 13:31,0,0,The only thing that could make this last day of # ASCO14 better would be getting an upgrade from @ AlaskaAir on the flight home # iflyalaska,,@,# #,4.7388E+17,https://twitter.com/drsam/status/473879613886566400,,,,
ProjectInno,6/3/2014 13:31,2,1,The US will spend $201.5 billion to fight cancer this year: http://ow.ly/xrNwy # innovatenow # ASCO14,,,# #,4.7388E+17,https://twitter.com/ProjectInno/status/473879552931151873,,,,
TeamTJSharpe,6/3/2014 13:30,3,2,Melanoma Monday @ # ASCO14 - http://eepurl.com/V9TsD,,@,#,4.73879E+17,https://twitter.com/TeamTJSharpe/status/473879483670224896,,,,
BCH_Innovation,6/3/2014 13:30,0,0,@ US_FDA's Pazdur at # ASCO14: We must all work together to cut # drugcosts. HT @ medcitynews http://on.bchil.org/1tEX3RB,,@ @,# #,4.73879E+17,https://twitter.com/BCH_Innovation/status/473879355303923712,,,,
MidAmPrint,6/3/2014 13:30,0,0,We hope all # ASCO14 attendees have had a great time. Enjoy your last day & safe travels back home! @ ASCO,,@,#,4.73879E+17,https://twitter.com/MidAmPrint/status/473879348903034880,,,,
eMPR,6/3/2014 13:30,0,0,New studies presented at # ASCO14 show positive results for advanced melanoma treatments: http://ow.ly/xA4GO # oncology,,,# #,4.73879E+17,https://twitter.com/eMPR/status/473879326900097025,,,,
diablovalleyonc,6/3/2014 13:29,0,0,News from # ASCO2014: Young women with # breastcancer may benefit from ovarian suppression and # exemestane http://ow.ly/xA9WO,,,# # #,4.73879E+17,https://twitter.com/diablovalleyonc/status/473879277474435072,,,,
WCGClinical,6/3/2014 13:29,0,0,"Had a busy but productive # ASCO14. Enjoy having the opportunity to meet colleagues in person, & continue to learn & share knowledge.",,,#,4.73879E+17,https://twitter.com/WCGClinical/status/473879212374650880,,,,
TurnaRay,6/3/2014 13:29,0,0,# ASCO14 presentations discuss value of negative trials & incremental advances http://bit.ly/1tEWK98,,,#,4.73879E+17,https://twitter.com/TurnaRay/status/473879173661216768,,,,
RielyMD,6/3/2014 13:29,0,0,"Gainor #8031 biopsies from11 patients with acquired resistance to ceritinib: 6 new mutsin ALK, no ALK amplifications, 1 with EMT # ASCO14",,,#8031 #,4.73879E+17,https://twitter.com/RielyMD/status/473879137133023233,,,,
AlpineBV_Miller,6/3/2014 13:28,1,1,"And that's a wrap for me for # ASCO14 Thx to my fellow Tweeps for helping me see"" way more than I could alone!""",,,#,4.73879E+17,https://twitter.com/AlpineBV_Miller/status/473878907637493760,,,,
n8pennell,6/3/2014 13:27,1,0,Dr. Byers: PROFILE 1014 establishes crizotinib as standard of care for newly dx ALK+ NSCLC pts. # ASCO14 # LCSM,,,# #,4.73879E+17,https://twitter.com/n8pennell/status/473878556066725889,,,,
drsam,6/3/2014 13:27,2,1,Closing thoughts on the use of adoptive T-cell therapy for epithelial tumors. It's the antigen," stupid!"" # ASCO14 pic.twitter.com/JMwqg8v66J""",,,#,4.73879E+17,https://twitter.com/drsam/status/473878546171973632,,,
duemed,6/3/2014 13:26,0,1,Saying farewell to # ASCO14 It's been a great experience! See you all next time. Save trip home you all!,,,#,4.73878E+17,https://twitter.com/duemed/status/473878421752127489,,,,
RielyMD,6/3/2014 13:25,0,0,"Mok#8002 Profile 1014 very impressive waterfall for chemo arm, but 45% RR as comp with 74% for crizotinib # ASCO14",,,#8002 #,4.73878E+17,https://twitter.com/RielyMD/status/473878214524538881,,,,
RielyMD,6/3/2014 13:25,2,0,"Mok #8002 Profile 1014 Crizotinib longer PFS compared w/ cis/carbo+pem in ALK+NSCLC, HR 0.45, mPFS 7 vs 11 mo. Byers Landmark"" # ASCO14""",,,#8002 #,4.73878E+17,https://twitter.com/RielyMD/status/473878189987868673,,,,
OAkkerman_ERG,6/3/2014 13:25,0,0,# ASCO14 Immunotherapy – The Way of the Future? # EnvironicsPharma http://www.environics.ca/environics-health--pharma-blog/post/69/Immunotherapy--The-Way-of-the-Future …,,,# #,4.73878E+17,https://twitter.com/OAkkerman_ERG/status/473878126142160896,,,,
LGG1,6/3/2014 13:25,0,0,Must read RT @ mtmdphd: Science & Society: 50 Years Later # ASCO14 Presidential Address by @ CliffordHudis http://ow.ly/3ljVbY,,@ @,#,4.73878E+17,https://twitter.com/LGG1/status/473878075181379584,,,,
kellykcotton,6/3/2014 13:24,0,1,"It's over already?! # ASCO14 has left me inspired, proud to be part of ASCO's mission, & honored to work w/such incredible people!",,,#,4.73878E+17,https://twitter.com/kellykcotton/status/473878021183897601,,,,
drsam,6/3/2014 13:22,0,3,Upside of this approach: NK cell engagement and ADCC. Combo with checkpoint inhibitors = be careful. # ASCO14 pic.twitter.com/V6NsRvGofQ,,,#,4.73877E+17,https://twitter.com/drsam/status/473877314351034369,,,,
RaphaelRousseau,6/3/2014 13:22,0,0,ASCO 2008 abstract 3007 on BMS' 4-1BB moAb: same abstract number today but not as good an outcome for Pfizer's moAb # ASCO14,,,#,4.73877E+17,https://twitter.com/RaphaelRousseau/status/473877288312786944,,,,
ben_ellingson,6/3/2014 13:21,2,5,@ NBTStweets here is a pic from my presentation at # ASCO14 thank you for your support pic.twitter.com/w91t67r4yq,,@,#,4.73877E+17,https://twitter.com/ben_ellingson/status/473877129793245184,,,,
SinaiChicago,6/3/2014 13:21,1,2,"Mount Sinai Hospital has been honored by @ iConquerCancer of @ ASCO for high-quality, community-based clinical research http://am.asco.org/conquer-cancer-foundation-honors-eight-community-practices-excel-cancer-clinical-trials …",,@ @,,4.73877E+17,https://twitter.com/SinaiChicago/status/473877034171514880,,,,
michelerhee,6/3/2014 13:20,0,1,"Took the test http://1.usa.gov/1kGfdNn . Turns out, I had cancer-related PTSD. # notsuprised HT @ subatomicdoc http://bit.ly/1gyZmov # ASCO14",,@,# #,4.73877E+17,https://twitter.com/michelerhee/status/473876936536887296,,,,
drdonsdizon,6/3/2014 13:20,0,0,@ AneesChagpar so right! @ subatomicdoc @ mtmdphd @ fischmd @ DrAttai @ ASCO,,@ @ @ @ @ @,,4.73877E+17,https://twitter.com/drdonsdizon/status/473876817280253952,,,,
RielyMD,6/3/2014 13:20,0,1,@ politikaterina PDXs can help us triage potential treatments and learn about heterogeneity in response. # ASCO14,,@,#,4.73877E+17,https://twitter.com/RielyMD/status/473876816009371648,,,,
CancerTherAdvsr,6/3/2014 13:20,2,0,RT @ DrLen: My favorite slide from # ASCO14: a 96yo lady with head/neck ca who responded to MEDI4736. Note the smile! pic.twitter.com/B1qUm6ZtYp,,@,#,4.73877E+17,https://twitter.com/CancerTherAdvsr/status/473876798611402752,,,,
drsam,6/3/2014 13:19,0,1,Pfizer isn't only CD137/4-1BB drug tested. BMS has one.Shows toxicity of immuno activators. Harder than PD-1 # ASCO14 pic.twitter.com/M7Rfux89kw,,,#,4.73877E+17,https://twitter.com/drsam/status/473876764150624256,,,,
n8pennell,6/3/2014 13:18,0,0,Politi: STAT inhibitors may be more effective in the EGFR mutant NSCLC population. # ASCO14 # LCSM,,,# #,4.73877E+17,https://twitter.com/n8pennell/status/473876506046119936,,,,
nycdoc29,6/3/2014 13:18,0,0,“ @ Stocks_Biotech:Incyte: pivotal Phase III data in PV show that Jakafi (ruxolitinib.. # incy $ INCY # biotech # ASCO14” this is game change!!,,@,# # #,4.73876E+17,https://twitter.com/nycdoc29/status/473876423175065601,,,,
AneesChagpar,6/3/2014 13:18,1,2,@ subatomicdoc @ mtmdphd @ fischmd @ drattai @ drdonsdizon ....and it's just fun to interact and log great memories & epiphanies! @ ASCO # ASCO14,,@ @ @ @ @ @,#,4.73876E+17,https://twitter.com/AneesChagpar/status/473876391956852736,,,,
RielyMD,6/3/2014 13:17,1,1,"Goldman #8026 KRAS mutant cell lines more susceptible to CDK4/6 inhibitor, LY2835219. In trial data 55% DCR in pts with KRAS+ NSCLC # ASCO14",,,#8026 #,4.73876E+17,https://twitter.com/RielyMD/status/473876216622354432,,,,
RaphaelRousseau,6/3/2014 13:17,3,2,experimental therap in immunology: best attendance ever at a Tuesday morning session # ASCO2014 ! Now to the children!,,,#,4.73876E+17,https://twitter.com/RaphaelRousseau/status/473876012841713665,,,,
nycdoc29,6/3/2014 13:16,0,0,“ @ Stocks_Biotech: Gilead Phase 2 Results for GS-9973 in Relapsed CLL $ GILD # biotech # ASCO14” interesting data another weapon in arsenal,,@,# #,4.73876E+17,https://twitter.com/nycdoc29/status/473875976393605120,,,,
HemOncToday,6/3/2014 13:16,1,0,# ASCO14 Dr. Steven O'Day @ UCLAHealth highlights how MK3475 induced high rates of durable responses in # melanoma http://goo.gl/xUMA6w,,@,# #,4.73876E+17,https://twitter.com/HemOncToday/status/473875957972213760,,,,
GoHealio,6/3/2014 13:16,0,0,# ASCO14 Dr. Steven O'Day @ UCLAHealth highlights how MK3475 induced high rates of durable responses in # melanoma http://goo.gl/xUMA6w,,@,# #,4.73876E+17,https://twitter.com/GoHealio/status/473875957204680704,,,,
jtriestm,6/3/2014 13:16,0,0,# asco14 Where we stand in the fight against cancer http://fw.to/8QryhqC,,,#,4.73876E+17,https://twitter.com/jtriestm/status/473875831194804224,,,,
drsam,6/3/2014 13:15,0,0,"Well, that's the last data talk for me for # ASCO14 . Hope I did you proud @ MaverickNY.",,@,#,4.73876E+17,https://twitter.com/drsam/status/473875600159944704,,,,
jtriestm,6/3/2014 13:15,0,0,# ASCO14 Why these 3 biotech stocks are making big moves http://fw.to/2z6eZ6D,,,#,4.73876E+17,https://twitter.com/jtriestm/status/473875575124144128,,,,
OncLive,6/3/2014 13:15,0,0,Anti-CD38 Antibody Generates Excitement in Multiple Myeloma http://ow.ly/xA0ti # ASCO14,,,#,4.73876E+17,https://twitter.com/OncLive/status/473875574398939136,,,,
wbbsec,6/3/2014 13:15,0,0,All # ASCO14 discoveries began with people. Refreshing read by @ ChronMed http://bit.ly/1ueofIT via @ HoustonChronpic.twitter.com/RlHofU5tDH,,@ @,#,4.73876E+17,https://twitter.com/wbbsec/status/473875510695854080,,,,
RyhMd,6/3/2014 13:14,0,0,@ ASCO Proud to be an oncologist and member of ASCO # ASCO14,,@,#,4.73875E+17,https://twitter.com/RyhMd/status/473875257317933056,,,,
AlpineBV_Miller,6/3/2014 13:13,0,0,"Sorry. The Rosenberg TIL data are cervical cancer, not ovarian. # ASCO14",,,#,4.73875E+17,https://twitter.com/AlpineBV_Miller/status/473875196278243328,,,,
n8pennell,6/3/2014 13:13,2,0,"Dr. Politi discussing new targets in NSCLC. RICTOR amplification new target for 8% of NSCLC, either alone or w other muts. # ASCO14 # LCSM",,,# #,4.73875E+17,https://twitter.com/n8pennell/status/473875155882868738,,,,
davidbeme,6/3/2014 13:13,2,0,"Cancer de l'enfant, nanoparticules&radiothérapie, erbitux vs avastin... Sélection d'études de l' # ASCO2014 @ doctissimo http://ow.ly/xA75f",,@,#,4.73875E+17,https://twitter.com/davidbeme/status/473875130909986816,,,,
AlpineBV_Miller,6/3/2014 13:12,3,2,"In Rosenberg's hands, these TILs are incredible. Two cervical/HPV CRs. If he gets CRs, they are cures. # ASCO14 https://twitter.com/AlpineBV_Miller/status/473873791295057920/photo/1pic.twitter.com/jdFkEM6rZj",,,#,4.73875E+17,https://twitter.com/AlpineBV_Miller/status/473874990203674624,,,,
drsam,6/3/2014 13:12,0,1,Hinrichs: limitations of this small pilot study. # ASCO14 pic.twitter.com/fz41AQhtGZ,,,#,4.73875E+17,https://twitter.com/drsam/status/473874916232548352,,,,
nycdoc29,6/3/2014 13:11,0,1,"# ASCO14 - RESONATE Data - Ofa v Ibrutinib Phase 3. AEs between 2 arms similar, long term reduction of infection in Ibr. Afib in 10 pts",,,#,4.73875E+17,https://twitter.com/nycdoc29/status/473874701652332545,,,,
AndytweetM,6/3/2014 13:10,2,1,Tumor Size is Defining Factor to Response from Anti-pd1 drug: http://mayocl.in/1kCz7ZB # ASCO14 @ RichardWJoseph as lead author,,@,#,4.73874E+17,https://twitter.com/AndytweetM/status/473874484534206465,,,,
RielyMD,6/3/2014 13:10,0,0,@ politikaterina from @ YaleCancer discussing # asco14 poster highlights in NSCLC metastatic. Great overview of diverse abstracts # ASCO14,,@ @,# #,4.73874E+17,https://twitter.com/RielyMD/status/473874470885937152,,,,
EMDSerono,6/3/2014 13:10,0,0,Thanks to all who visited our booth to learn about all we’re doing in # oncology. What was your favorite part of # ASCO14?,,,# #,4.73874E+17,https://twitter.com/EMDSerono/status/473874364124119040,,,,
clustinthewind,6/3/2014 13:10,0,0,# colorectal # cancer Screening Rates Improved Among Black Patients | @ ASCO Annual Meeting http://am.asco.org/crc-screening-rates-improved-among-black-patients#.U44BBkDFl2s.twitter …,,@,# # #,4.73874E+17,https://twitter.com/clustinthewind/status/473874305160183808,,,,
AlpineBV_Miller,6/3/2014 13:10,0,1,Now they are working to figure out how to get more CRs and tell who is likely to respond. # ASCO14,,,#,4.73874E+17,https://twitter.com/AlpineBV_Miller/status/473874252517892098,,,,
drsam,6/3/2014 13:09,0,1,Trying to understand the implications of the HPV-targeted ACT responses for prob of success of CAR-T in epithelial tumors. Thoughts? # asco14,,,#,4.73874E+17,https://twitter.com/drsam/status/473874162126053376,,,,
nycdoc29,6/3/2014 13:09,0,1,"# ASCO14 - RESONATE Data - Ofa v Ibrutinib Phase 3. mPFS not reached in Ibr, in Ofa 8m. ORR overwhelming favor Ibr",,,#,4.73874E+17,https://twitter.com/nycdoc29/status/473874026717536256,,,,
drsam,6/3/2014 13:08,0,0,Hinrichs: why does this therapy work in some HPV+ but not others? # ASCO14,,,#,4.73874E+17,https://twitter.com/drsam/status/473873896710475778,,,,
osservasaluteaz,6/3/2014 13:08,0,0,"# Asco14, uno studio clinico sul diventare # mamme dopo un # tumore: http://bit.ly/1nY4cwq via @ adnk_salute. # fertilità",,@,# # # #,4.73874E+17,https://twitter.com/osservasaluteaz/status/473873749553713152,,,,
drsam,6/3/2014 13:07,0,0,And here is your CT scan to show what it looks like. # ASCO14 pic.twitter.com/JEU6FnDDAv,,,#,4.73874E+17,https://twitter.com/drsam/status/473873737092067328,,,,
JediPD,6/3/2014 13:07,0,0,@ mtmdphd @ drsam Interesting a Prostimulatory PD-L1 and an anti CD20 combo...Logic? # ASCO14,,@ @,#,4.73874E+17,https://twitter.com/JediPD/status/473873714250276864,,,,
drsam,6/3/2014 13:07,0,1,Kinetics of response to HPV-targeted ACT # ASCO14 pic.twitter.com/W3DOxMMq9l,,,#,4.73874E+17,https://twitter.com/drsam/status/473873568199999488,,,,
JSweetenhamMD,6/3/2014 13:06,0,1,Heading back home from # ASCO14. Another great meeting. Kudos to Huntsman/ U of Utah investigators. @ huntsmancancerpic.twitter.com/isunMWxUMd,,@,#,4.73873E+17,https://twitter.com/JSweetenhamMD/status/473873427837620224,,,,
RS_Flinn,6/3/2014 13:06,0,0,"From cancer to cars - saying goodbye to Chicago and # ASCO14, heading to Detroit to moderate a panel at a telematics event",,,#,4.73873E+17,https://twitter.com/RS_Flinn/status/473873364944048128,,,,
drsam,6/3/2014 13:06,0,1,"Hinrichs: responses seen in cervical cancer - 3 responses, two prolonged CRs. # ASCO14 pic.twitter.com/aOKUISrVup",,,#,4.73873E+17,https://twitter.com/drsam/status/473873245930659840,,,,
EmilyAMuse,6/3/2014 13:05,2,0,RT @ EWidera: Most clinical advertisements by cancer centers use emotional appeals that evoke hope and fear http://www.geripal.org/2014/06/cancer-center-advertising-selling-hope.html … # ASCO14...,,@,#,4.73873E+17,https://twitter.com/EmilyAMuse/status/473873103802880000,,,,
AlpineBV_Miller,6/3/2014 13:05,0,4,A little impressed Wall Street correctly put together a raft of geeky data at # ASCO14 and is rallying $ MDVN,,,#,4.73873E+17,https://twitter.com/AlpineBV_Miller/status/473873086761406464,,,,
MayoCancerCare,6/3/2014 13:05,1,1,Tumor Size is Defining Factor to Response from Promising # Melanoma Drug: http://mayocl.in/1kCz7ZB # ASCO14,,,# #,4.73873E+17,https://twitter.com/MayoCancerCare/status/473873004209139713,,,,
drsam,6/3/2014 13:04,1,1,Now up: adoptive cellular therapy for HPV+ cervical cancer. Still an impt population to serve. # ASCO14 pic.twitter.com/NHTf3mqMud,,,#,4.73873E+17,https://twitter.com/drsam/status/473872779901542400,,,,
mtmdphd,6/3/2014 13:03,1,1,“ @ drsam: CD137 + ritux in NHL combo planned # ASCO14”. # lymsm,,@,# #,4.73873E+17,https://twitter.com/mtmdphd/status/473872611248992257,,,,
KinzieHotel,6/3/2014 13:03,0,0,Thank you again to everyone who stayed & is staying w/ us for # ASCO14! We hope you enjoy(ed) # Chicago :) @ ASCO @ ChooseChicago,,@ @,# #,4.73873E+17,https://twitter.com/KinzieHotel/status/473872518395092992,,,,
slmoseley_phd,6/3/2014 13:03,0,0,"..as a nation we don't have the political will to prevent cancer."" Graham Colditz # ASCO14""",,,#,4.73873E+17,https://twitter.com/slmoseley_phd/status/473872510996320256,,,,
RyhMd,6/3/2014 13:02,0,0,"# ASCO14 Thanks to all who tweeted at ASCO, added amazingly to ASCO experience and learning, exemplary of putting technology to good work",,,#,4.73872E+17,https://twitter.com/RyhMd/status/473872428766994432,,,,
Novartis,6/3/2014 13:02,2,2,Learn more about # polycythemiavera and the need for new treatment options http://bit.ly/1ipAxGQ # ASCO14,,,# #,4.73872E+17,https://twitter.com/Novartis/status/473872369380257792,,,,
drsam,6/3/2014 13:02,0,0,"Well, at least Merkel cell cancer didn't get left out this year # ASCO14 pic.twitter.com/XRcrme8d4Z",,,#,4.73872E+17,https://twitter.com/drsam/status/473872364346699776,,,,
Roche,6/3/2014 13:02,2,6,"Overall, nearly 40% of # healthcare stakeholders were not familiar with the PHC concept. Are you? http://ow.ly/xp8Ga # ASCO14",,,# #,4.73872E+17,https://twitter.com/Roche/status/473872347792150528,,,,
Boehringer,6/3/2014 13:02,106,152,PRESS: There is large unmet need for effective treatments for Acute Myeloid # Leukaemia http://bit.ly/1p0YxFp # ASCO14,,,# #,4.73872E+17,https://twitter.com/Boehringer/status/473872292985192448,,,,
siriusinvest,6/3/2014 13:02,0,0,@ AdamsLisa @ ASCO hv read your blog. Admire your strength and courage! You'r giving hope to others. Thx! Martin (lost mom in spring to NSCLC),,@ @,,4.73872E+17,https://twitter.com/siriusinvest/status/473872237410668544,,,,
TommyJohn00,6/3/2014 13:01,1,1,Nivolumab single agent has good pfs/OS rates in pdl1 neg patients # ASCO14 # LCSM,,,# #,4.73872E+17,https://twitter.com/TommyJohn00/status/473872223359737856,,,,
Roche,6/3/2014 13:01,7,5,Bringing medicines to patients faster: About opportunities and obstacles. http://ow.ly/xp8wW # ASCO14 # healthcare,,,# #,4.73872E+17,https://twitter.com/Roche/status/473872186722500608,,,,
SusanGKomen,6/3/2014 13:01,5,3,Study co-authored by SGK Scholar Dr. Ann Partridge: “Drug Saves Fertility for Women With Cancer” via @ nytimes http://nyti.ms/1oPpuhQ # ASCO14,,@,#,4.73872E+17,https://twitter.com/SusanGKomen/status/473872186365579264,,,,
nycdoc29,6/3/2014 13:01,0,0,"# ASCO14 - GS9973 -AEs neutropenia. Efficacy in CLL 95% nodal response, ORR 49% impressive waterfall. PFS at 24w 70%",,,#,4.73872E+17,https://twitter.com/nycdoc29/status/473872167407726592,,,,
mayocliniclabs,6/3/2014 13:01,0,1,Didn’t make it to # ASCO14 in Chicago? Check out our blog to learn about our latest advancements in cancer testing. http://mayocl.in/T1r6rl,,,#,4.73872E+17,https://twitter.com/mayocliniclabs/status/473872159883165696,,,,
drsam,6/3/2014 13:01,0,0,CD137 + ritux in NHL combo planned # ASCO14,,,#,4.73872E+17,https://twitter.com/drsam/status/473872103423213568,,,,
ElderCareTeam,6/3/2014 13:01,1,0,Researchers at @ ASCO say early palliative treatment in advanced cancer patients benefits caregiver/lowered depression http://ow.ly/xzvlp,,@,,4.73872E+17,https://twitter.com/ElderCareTeam/status/473872103264235520,,,,
bioclinica,6/3/2014 13:01,1,0,RT @ Roche The # oncology treatment environment has changed substantially over the last couple of years. http://ow.ly/xp3Rs # ASCO14,,@,# #,4.73872E+17,https://twitter.com/bioclinica/status/473872081831362560,,,,
SarahCannonDocs,6/3/2014 13:01,0,1,Thank you for joining # SCRI at # ASCO14!,,,# #,4.73872E+17,https://twitter.com/SarahCannonDocs/status/473872076324241408,,,,
drsam,6/3/2014 13:00,0,4,Not nearly as exciting swimmers plot for PF-05082566/CD137 when it follows PD-1. # ASCO14 pic.twitter.com/Spjb5Ywgrh,,,#,4.73872E+17,https://twitter.com/drsam/status/473871969121599489,,,,
FoundationATCG,6/3/2014 13:00,1,0,How can you be sure that no stone is left unturned for your patients? Find out here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73872E+17,https://twitter.com/FoundationATCG/status/473871824343023616,,,,
RaphaelRousseau,6/3/2014 13:00,1,0,would pushing the # CD137 (4-1BB) accelerator do better than lifting the # PD1-PDL1 brake? # ASCO14,,,# # #,4.73872E+17,https://twitter.com/RaphaelRousseau/status/473871804126085122,,,,
Advaxis,6/3/2014 13:00,1,1,"“The results for a single treatment cycle of ADXS-HPV are very encouraging,” said Dr. Robert Petit. http://bit.ly/1tZWhAr $ ADXS # ASCO2014",,,#,4.73872E+17,https://twitter.com/Advaxis/status/473871785801166848,,,,
TommyJohn00,6/3/2014 12:59,0,2,Combination nivo ipi not as good as in melanoma # ASCO14 # LCSM also very toxic!,,,# #,4.73872E+17,https://twitter.com/TommyJohn00/status/473871689315790848,,,,
drsam,6/3/2014 12:59,0,1,Clearly way better tolerated than an CD40 drug. But little response seen. # ASCO14 pic.twitter.com/e9M5HEKSBj,,,#,4.73872E+17,https://twitter.com/drsam/status/473871568712376320,,,,
GuneetWalia,6/3/2014 12:59,2,2,Portal for 2014 @ TheALCF Young Innovators Team Award for translational # LungCancer research now open! http://www.lungcancerfoundation.org/research/grants/apply/ … # LCSM # ASCO14,,@,# # #,4.73872E+17,https://twitter.com/GuneetWalia/status/473871539469680640,,,,
Genomics_Guy,6/3/2014 12:58,0,0,Illumination to Innovation: Transforming Data into Learning | ASCO Connection http://connection.asco.org/Commentary/Article/ID/3897/Illumination-to-Innovation-Transforming-Data-into-Learning.aspx … via @ ASCO,,@,,4.73871E+17,https://twitter.com/Genomics_Guy/status/473871314151673856,,,,
nycdoc29,6/3/2014 12:58,0,0,"# ASCO14 - GS9973 Syk inhibitor in Lymphoid Malignancies Phase 2. AEs grade 3/4 pneumonia, chest pain, afib, increased AST/ALT, anemia,",,,#,4.73871E+17,https://twitter.com/nycdoc29/status/473871267360428032,,,,
n8pennell,6/3/2014 12:58,2,1,"Reck: Responses seem higher in PDL-1 pos pts, but so much variability of assay for testing that it is hard to make conclusions. # ASCO14 # LCSM",,,# #,4.73871E+17,https://twitter.com/n8pennell/status/473871262042050560,,,,
RielyMD,6/3/2014 12:57,2,1,"Rizvi #8022, nivolumab + erlotinib in patients with EGFR mutant cancer (usually at resistance), median PFS 7 months, # ASCO14",,,#8022 #,4.73871E+17,https://twitter.com/RielyMD/status/473871130517049344,,,,
drsam,6/3/2014 12:57,2,2,"Worst part of immuno activators: having to start at the MABEL. Long dose esc, requiring novel trial designs. # ASCO14 pic.twitter.com/0hXzB1Fk2q",,,#,4.73871E+17,https://twitter.com/drsam/status/473871006478508032,,,,
n8pennell,6/3/2014 12:56,0,2,Dr. Martin Reck discussing PD-1 and PDL-1 abstracts in the lung cancer metastatic poster highlights session. # ASCO14 # LCSM,,,# #,4.73871E+17,https://twitter.com/n8pennell/status/473870955929174016,,,,
RyhMd,6/3/2014 12:56,0,0,# ASCO14 DLBCL subtyping: new concept with imminent therapeutic implications pic.twitter.com/8bvZ8U1oHp,,,#,4.73871E+17,https://twitter.com/RyhMd/status/473870789964333059,,,,
drsam,6/3/2014 12:55,1,1,CD137/4-1BB is actually Pfizers second attempt at immuno activation. They had a CD40 partial agonist Ab that they killed. # ASCO14,,,#,4.73871E+17,https://twitter.com/drsam/status/473870670372147200,,,,
RielyMD,6/3/2014 12:55,0,0,"Brahmer, Abst 8021, MEDI 4736 response rate in unselected patients 16% # ASCO14",,,#,4.73871E+17,https://twitter.com/RielyMD/status/473870617004232704,,,,
deeaher,6/3/2014 12:55,1,1,“@nextprinciples: Last # ASCO14. hashtag heat map # meded # genetics # hcps # clinicaltrials https://twitter.com/nextprinciples/status/473865129595912193/photo/1pic.twitter.com/yRfrlFJxdk ” @ SAPHealthcare @ SAPStartups,,@nextprinciples @ @,# # # # #,4.73871E+17,https://twitter.com/deeaher/status/473870514340245504,,,,
CitelineMarkY,6/3/2014 12:54,3,0,New Citeline Blog # clinicaltrials # citeline # ASCO14 http://lnkd.in/dYPydAt,,,# # #,4.7387E+17,https://twitter.com/CitelineMarkY/status/473870371062419456,,,,
TwtTimes,6/3/2014 12:53,0,0,@ SeqComplete your search paper ' # ASCO14' is ready: http://tweetedtimes.com/search/%23ASCO14/en …,,@,#,4.7387E+17,https://twitter.com/TwtTimes/status/473870167911714817,,,,
RyhMd,6/3/2014 12:53,0,0,# ASCO14 pic.twitter.com/YoEavgZk8O,,,#,4.7387E+17,https://twitter.com/RyhMd/status/473870093386919937,,,,
carisls,6/3/2014 12:53,0,2,"Dr. Barbara Pockaj, @ MayoClinic presents CMI data in TNBC at # ASCO2014 # bcsm # breastcancerpic.twitter.com/5hFx2S5WqV",,@,# # #,4.7387E+17,https://twitter.com/carisls/status/473870073052946433,,,,
ECMC_UK,6/3/2014 12:52,0,0,You also saw # ASCO14 Day3&5: Johann de Bono &Chris Parker @ ICR_London @ RoyalMarsden clinical development in advanced # prostate # cancer 8/8,,@ @,# # #,4.7387E+17,https://twitter.com/ECMC_UK/status/473869955323412481,,,,
Ludwig_Cancer,6/3/2014 12:52,0,1,Ludwig collaborator @MedImmune presents encouraging # immunotherapy data at # ASCO14 http://bit.ly/1rHCh82,,@MedImmune,# #,4.7387E+17,https://twitter.com/Ludwig_Cancer/status/473869909127356416,,,,
CureMelanoma,6/3/2014 12:52,1,1,Glad u did! MT @ Melanoma_doctor: Exciting...my choice as a junior faculty years ago to focus on # immunotherapy for # melanoma & now # ASCO14,,@,# # #,4.7387E+17,https://twitter.com/CureMelanoma/status/473869845097107456,,,,
ECMC_UK,6/3/2014 12:52,0,0,# ASCO14 Day4: Jonathan Ledermann @ UCLHResearch @ CRUKLondon“no prospect of conducting RCT in rare tumors-howto change?”via @ ShannonWestin 7/8,,@ @ @,#,4.7387E+17,https://twitter.com/ECMC_UK/status/473869844748988417,,,,
gg_schwind,6/3/2014 12:52,0,0,RT @ CI4CC: All # ASCO14 attendees welcome to join @ CI4CC and our Cancer Genomics &Informatics workshops: Go To http://www.ci4cc.org ” @ ASCO,,@ @ @,#,4.7387E+17,https://twitter.com/gg_schwind/status/473869805666439169,,,,
ABenderRD,6/3/2014 12:52,0,0,MT @ DrKateWolin: LEAN study finds wt maintenance w/ @ aicrtweets print materials in breast cancer survivors http://bit.ly/1tBHbPJ # ASCO14,,@ @,#,4.7387E+17,https://twitter.com/ABenderRD/status/473869800616505344,,,,
drsam,6/3/2014 12:52,2,2,As we get close to the end of # ASCO14 I have to send a shout out to # asco who significantly stepped up the WiFi quality this year!,,,# #,4.7387E+17,https://twitter.com/drsam/status/473869732043825152,,,,
ECMC_UK,6/3/2014 12:52,0,0,# ASCO14 Day4: Gill Levitt @ GreatOrmondSt “Implemntn of # Survivorship Programs in a Nationalized Health Care System”via @ LesleyLesleys 6/8,,@ @,# #,4.7387E+17,https://twitter.com/ECMC_UK/status/473869732022849536,,,,
nycdoc29,6/3/2014 12:51,0,1,"# ASCO14 - long term Ibrutinib data being presented in e354. OS at 36m no median yet, even with high risk cyto. mPFS not reached yet",,,#,4.7387E+17,https://twitter.com/nycdoc29/status/473869650296836096,,,,
ECMC_UK,6/3/2014 12:51,0,0,# ASCO14 Day4: Ian Smith @ RoyalMarsden “endocrine rx for breast ca. long term ER+ do less well than ER- due to late relapse”via @ rsm2800 5/8,,@ @,#,4.7387E+17,https://twitter.com/ECMC_UK/status/473869623356821505,,,,
ASCO,6/3/2014 12:51,3,0,Illumination to Innovation: Transforming Data into Learning http://bit.ly/1n9s6nM @ YupOnc blog # ASCO14,,@,#,4.7387E+17,https://twitter.com/ASCO/status/473869500367261697,,,,
ASCOPost,6/3/2014 12:50,1,1,Adjuvant Exemestane w/Ovarian Suppression Better at Preventing Breast Cancer Recurrence Than Tamoxifen http://ow.ly/xA3AI # ASCO14 # bcsm,,,# #,4.73869E+17,https://twitter.com/ASCOPost/status/473869392233910273,,,,
DebiopharmNews,6/3/2014 12:50,0,0,# ASCO14 How do we develop drug today? With the future # patient in mind! http://ow.ly/xwtOO,,,# #,4.73869E+17,https://twitter.com/DebiopharmNews/status/473869347619082240,,,,
RielyMD,6/3/2014 12:50,0,0,"Schüler et al, Lux Lung 5 - improved PFS but not OS for continuing afatinib and adding chemo vs chemo alone # ASCO14",,,#,4.73869E+17,https://twitter.com/RielyMD/status/473869336604868608,,,,
TargetedOnc,6/3/2014 12:50,1,1,Chemo + standard hormone therapy prolonged life for men with newly diagnosed metastatic PC by nearly 14 mos. http://www.targetedonc.com/conference/asco-2014/14-month-survival-benefit-demonstrated-with-upfront-chemo-in-prostate-cancer … # ASCO14,,,#,4.73869E+17,https://twitter.com/TargetedOnc/status/473869325372493824,,,,
mfrimawi,6/3/2014 12:50,0,0,Thank you # Chicago for hosting # ASCO14. Here is to a world free from the fear of cancer.,,,# #,4.73869E+17,https://twitter.com/mfrimawi/status/473869247932669953,,,,
ECMC_UK,6/3/2014 12:49,0,0,"# ASCO14 Day3: Charles Swanton what is tumor heterogeneity &how will it play a role in development of agents for CRC”via @ JeffreyMOtto 4/8""",,@,#,4.73869E+17,https://twitter.com/ECMC_UK/status/473869200092823552,,,,
ECMC_UK,6/3/2014 12:49,0,0,# ASCO14 Day 2: Tom Powles @ QMULBartsTheLon @ CRUKLondon“PDL1 inhibition in 2nd line # bladder # cancer”via @ Prof_Nick_James 3/8,,@ @ @,# # #,4.73869E+17,https://twitter.com/ECMC_UK/status/473869089434505217,,,,
RyhMd,6/3/2014 12:49,0,0,Obesity: a killer in ER+ breast ca # ASCO14 pic.twitter.com/JhM9QgkZts,,,#,4.73869E+17,https://twitter.com/RyhMd/status/473869064771616769,,,,
ECMC_UK,6/3/2014 12:49,1,0,# ASCO14 Day2: Michelle Harvie (chemoprev. group –UKTCPN) @ CRUKManchester “role of nutrition-another important topic”via @ abcdiagnosis 2/8,,@ @,#,4.73869E+17,https://twitter.com/ECMC_UK/status/473868973537509377,,,,
RyhMd,6/3/2014 12:48,1,1,"@ RyhMd: circulating tumor DNA, fascinating concept # ASCO14 pic.twitter.com/nj06AGznTy",,@,#,4.73869E+17,https://twitter.com/RyhMd/status/473868948295798784,,,,
drsam,6/3/2014 12:47,0,1,"And finally, this will be an interesting case to see if FDA and EMA have different views of need for in vitro diagnostic for PD-1 # ASCO14",,,#,4.73869E+17,https://twitter.com/drsam/status/473868684155305984,,,,
ECMC_UK,6/3/2014 12:47,0,0,"Lastday # ASCO14 who have you seen from ECMCs? Day1-P Workman @ ICR_London we only have rx for 5% of genomic druggable targets""via @ DrLen 1/8""",,@ @,#,4.73869E+17,https://twitter.com/ECMC_UK/status/473868624747577344,,,,
drsam,6/3/2014 12:47,1,1,"Also, cost of PD-1 drugs may influence regulator and payor views of value of patient selection on imperfect biomarker like PD-L1. # ASCO14",,,#,4.73868E+17,https://twitter.com/drsam/status/473868483529158658,,,,
duemed,6/3/2014 12:46,0,0,"Met-NSCLC PH session: Dr JW Neal is reviewing EGFR inh: Various designs of erlotinib vs noveldrugtinib RCTs"" LOL in the room! # ASCO14""",,,#,4.73868E+17,https://twitter.com/duemed/status/473868280026132480,,,,
MaurerStats,6/3/2014 12:46,0,0,MT @ nbferrara Drug combo may be highly effective in recurrent # OvarianCancer http://1.usa.gov/1pCDCLw via @ NIH @ NCIMedia # ASCO14 # gyncsm,,@ @ @,# # #,4.73868E+17,https://twitter.com/MaurerStats/status/473868272450813952,,,,
drsam,6/3/2014 12:46,0,1,Agree strongly with audience question that having the PD-L1 expression data would help with decision to retreat with PD-1 # ASCO14,,,#,4.73868E+17,https://twitter.com/drsam/status/473868254868287490,,,,
UASDFCS,6/3/2014 12:45,0,0,Constatan la eficacia de combinar fármacos en un tipo de cáncer pulmón http://z101digital.com/app/article.aspx?id=128252 … @ ASCO @ hvhebron,,@ @,,4.73868E+17,https://twitter.com/UASDFCS/status/473868170340470784,,,,
drsam,6/3/2014 12:45,0,0,Surprised that nobody is asking if the FDA has informed the companies as to whether or not PD-L1 would be needed an in vitro dx? # asco14,,,#,4.73868E+17,https://twitter.com/drsam/status/473868102313050112,,,,
Boehringer,6/3/2014 12:45,2,0,# HCPs: What do you think has been the most important change in # lungcancer Tx in last 50 yrs? # notjustonedisease # ASCO14,,,# # # #,4.73868E+17,https://twitter.com/Boehringer/status/473868082856075264,,,,
Pharmacyclics,6/3/2014 12:45,0,1,Phase 3 RESONATE IMBRUVICA (ibrutinib) results to be presented in E354a at 11:57 am CT # ASCO14 http://bit.ly/1p6oHGj,,,#,4.73868E+17,https://twitter.com/Pharmacyclics/status/473867992049004544,,,,
OmidHamidMD,6/3/2014 12:43,8,8,Margaret Callahan @ sloan_kettering teaching all of us about # immunotherapies and response @ ASCO # ASCO14 . Phenomenal doctor !!! @ wolchokj,,@ @ @,# #,4.73867E+17,https://twitter.com/OmidHamidMD/status/473867476455788544,,,,
TommyJohn00,6/3/2014 12:42,0,0,"“ @ n8pennell: Dr. Joel Neal discussing abstr 8013-19, 36 in metastatic lung poster highlights session. # ASCO14 # LCSM”. Doing great job too",,@,# #,4.73867E+17,https://twitter.com/TommyJohn00/status/473867442465173504,,,,
drsam,6/3/2014 12:42,4,4,Callahan: Immune system too complicated for a single biomarker. # ASCO14 pic.twitter.com/MZE0N4UxnB,,,#,4.73867E+17,https://twitter.com/drsam/status/473867268791611392,,,,
EricGlazer,6/3/2014 12:41,0,0,RT @ subatomicdoc: Meta-analysis of prevalence and moderating factors for cancer-related PTSD http://bit.ly/1gyZmov # ASCO14 # healthanalytics,,@,# #,4.73867E+17,https://twitter.com/EricGlazer/status/473867171677085696,,,,
gg_schwind,6/3/2014 12:41,0,0,"Dr. @ rschilsky on Reversing the Decline in Federal Funding for Clinical Research | @ ASCO http://am.asco.org/dr-richard-schilsky-reversing-decline-federal-funding-clinical-research#.U436aslfjhF.twitter … Bleak time in biomed res""""",,@ @,#,4.73867E+17,https://twitter.com/gg_schwind/status/473867123765161984,,,,
DoctrBenway,6/3/2014 12:41,1,2,Getting # ASCO14 interpretations from @ adamfeuerstein or @ MarketWatch is about as valid as getting news from # FoxNews,,@ @,# #,4.73867E+17,https://twitter.com/DoctrBenway/status/473867114747404288,,,,
coileain,6/3/2014 12:41,0,0,Last day of ASCO. The immune response and TNBC. Response to anti-pd1 mAb MK-3475 and PD-L1 expression in melanoma. # ASCO14,,,#,4.73867E+17,https://twitter.com/coileain/status/473867093155119105,,,,
DebiopharmNews,6/3/2014 12:40,0,0,# ASCO14 We are convinced that developing for # patients will shape the # future of # medicine http://ow.ly/xwtK1,,,# # # #,4.73867E+17,https://twitter.com/DebiopharmNews/status/473866765609730048,,,,
drsam,6/3/2014 12:38,2,3,PD-L1 not the same as BRAF. Not ready to be used to determine eligibility for PD-1 inhibitor therapy. # ASCO14 pic.twitter.com/5vwx0kEfPb,,,#,4.73866E+17,https://twitter.com/drsam/status/473866271348383746,,,,
CliffordHudis,6/3/2014 12:37,3,1,"Looking for more and better next year! MT: @ YupOnc: @ ASCO An incredibly productive year at ASCO under Cliff's leadership”""",,@ @,,4.73866E+17,https://twitter.com/CliffordHudis/status/473866179325730816,,,,
AseBio,6/3/2014 12:37,1,0,. @ Amgen pads its PCSK9 lead with latest data on a potential blockbuster http://www.fiercebiotech.com/story/amgen-pads-its-pcsk9-lead-latest-data-potential-blockbuster/2014-06-02 … # ASCO14 # pharma # health,,@,# # #,4.73866E+17,https://twitter.com/AseBio/status/473866011351871488,,,,
ESchattner,6/3/2014 12:36,1,0,"HT @ ASCO: Insured young cancer patients fare better, live longer, @ reuters - http://reut.rs/1krpWj2",,@ @,,4.73866E+17,https://twitter.com/ESchattner/status/473865940392607745,,,,
n8pennell,6/3/2014 12:36,0,1,"Dr. Joel Neal currently discussing abstr 8013-19, 36 in the metastatic lung poster highlights session. # ASCO14 # LCSM",,,# #,4.73866E+17,https://twitter.com/n8pennell/status/473865874164568064,,,,
Melanoma_doctor,6/3/2014 12:36,3,4,Exciting to see responses to pembrolizumab (MK-3475) in uveal # melanoma and brain mets. More discoveries await! @ OmidHamidMD # ASCO14,,@,# #,4.73866E+17,https://twitter.com/Melanoma_doctor/status/473865808540864512,,,,
MikeNGladstone,6/3/2014 12:36,1,0,# ASCO14 takeaway: still the wild west of immunotherapy. Decades away from maximizing utility. Unimaginably more progress will be made,,,#,4.73866E+17,https://twitter.com/MikeNGladstone/status/473865719939997696,,,,
DoctorEdny,6/3/2014 12:35,0,0,@ JohnBristowe: pic.twitter.com/0eFZTbd4QA. Sums up my # ASCO14 coverage. Off to wander in Chicago sunshine to help reset my circadian rhythm.,,@,#,4.73866E+17,https://twitter.com/DoctorEdny/status/473865621579784196,,,,
cypress_simp,6/3/2014 12:35,0,0,"# Statin Use Can Stop When Illness Is # Terminal, Study Reports @ ASCO http://wp.me/p13lz7-389 pic.twitter.com/L0qSfdBrPH @ cypress_simp @ cmccann1",,@ @ @,# #,4.73866E+17,https://twitter.com/cypress_simp/status/473865513253498881,,,,
subatomicdoc,6/3/2014 12:35,4,3,Meta-analysis of prevalence and moderating factors for cancer-related PTSD http://bit.ly/1gyZmov # ASCO14 # ayacsm,,,# #,4.73865E+17,https://twitter.com/subatomicdoc/status/473865453606293504,,,,
BIGagainstBC,6/3/2014 12:35,0,0,Dr Larry Norton comments on the importance of the SOFT and TEXT trials # ASCO14 - http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/577 …,,,#,4.73865E+17,https://twitter.com/BIGagainstBC/status/473865443828965378,,,,
urotoday,6/3/2014 12:33,0,1,"# ASCO14 Abiraterone Acetate in mCRPC Patients Previously Treated w/ Ketoconazole. Listen to interview w/ Won Kim, MD http://bit.ly/TaoUht",,,#,4.73865E+17,https://twitter.com/urotoday/status/473865018849501184,,,,
CatseqBiotech,6/3/2014 12:33,0,0,At the end of the day # ASCO14 pivot into exciting space @ ldtimmerman @ naomikresge @ robertlangreth,,@ @ @,#,4.73865E+17,https://twitter.com/CatseqBiotech/status/473865016504885249,,,,
montypal,6/3/2014 12:33,0,0,@ YupOnc @ ASCO @ CliffordHudis Congrats on a wildly successful mtg! Going back to clinic with practice changing data for my patients!,,@ @ @,,4.73865E+17,https://twitter.com/montypal/status/473864963703189504,,,,
Melanoma_doctor,6/3/2014 12:32,1,4,Good to confirm that pts Rxed w MK-3475 have improved OS if responding by immune criteria even w RECIST progression # melanoma # asco14 @ ASCO,,@,# #,4.73865E+17,https://twitter.com/Melanoma_doctor/status/473864838729707521,,,,
wickenstones,6/3/2014 12:31,0,0,A nice review of NICE and value based pricing in oncology at # ASCO2014...http://tinyurl.com/pb33zca,,,#,4.73865E+17,https://twitter.com/wickenstones/status/473864588522700802,,,,
ASCO,6/3/2014 12:31,1,2,Did you attend the family member session at # ASCO14? Read @ drdonsdizon's lessons learned: http://bit.ly/1lvRsZo via # ASCOConnection,,@,# #,4.73865E+17,https://twitter.com/ASCO/status/473864535951286273,,,,
nbferrara,6/3/2014 12:31,3,1,Clinical trial: Drug combo may be highly effective in recurrent # OvarianCancer http://1.usa.gov/1pCDCLw via @ NIH @ NCIMedia # ASCO14,,@ @,# #,4.73865E+17,https://twitter.com/nbferrara/status/473864502044536833,,,,
CancerDotNet,6/3/2014 12:31,1,1,Our YouTube channel offers the # ASCO14 videos from @ ASCO leadership about scientific highlights http://bit.ly/1pCLlsV,,@,#,4.73864E+17,https://twitter.com/CancerDotNet/status/473864475502981121,,,,
AlpineBV_Miller,6/3/2014 12:31,0,1,"Discussant (Crystal Mackell) sez blina tox is quite acceptable"" in this B-ALL pop. Seems an odd statement w/ 15% death rate. # ASCO14 Thots?""",,,#,4.73864E+17,https://twitter.com/AlpineBV_Miller/status/473864465231147008,,,,
DebiopharmNews,6/3/2014 12:31,0,0,"# ASCO14 The more the # patient benefits from our drug, the more accomplished we feel http://ow.ly/xwtEe",,,# #,4.73864E+17,https://twitter.com/DebiopharmNews/status/473864444070871041,,,,
TommyJohn00,6/3/2014 12:30,0,1,Last session for # ASCO14...... # LCSM,,,# #,4.73864E+17,https://twitter.com/TommyJohn00/status/473864433991548928,,,,
FoundationATCG,6/3/2014 12:30,1,0,Not all molecular testing is created equal. Learn about the differences here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73864E+17,https://twitter.com/FoundationATCG/status/473864274960732161,,,,
CancerTherAdvsr,6/3/2014 12:30,0,0,# ASCO14: Bortezomib Regimen Prolongs PFS in Patients with Mantle Cell # Lymphoma Ineligible for # BoneMarrowTransplant http://ow.ly/xzQrR,,,# # #,4.73864E+17,https://twitter.com/CancerTherAdvsr/status/473864258145751040,,,,
Pharmacyclics,6/3/2014 12:30,0,0,Starting now! Dr. Susan O’Brien presents 3 year follow up data with IMBRUVICA at 11:33 am CT (E354a) # ASCO14 http://bit.ly/1p6oHGj,,,#,4.73864E+17,https://twitter.com/Pharmacyclics/status/473864201748766720,,,,
myriadgenetics,6/3/2014 12:30,0,0,Multi-gene panel tests result in significant treatment changes for # cancer patients. Come to Myriad's Booth 2039 to learn more! # ASCO14,,,# #,4.73864E+17,https://twitter.com/myriadgenetics/status/473864197533466624,,,,
drsam,6/3/2014 12:29,6,3,Hodi: RECIST alone insufficient response criteria for this class of therapeutics. # ASCO14 # immunotherapypic.twitter.com/gQXM20UEa0,,,# #,4.73864E+17,https://twitter.com/drsam/status/473864108400316416,,,,
OSUCCC_James,6/3/2014 12:29,0,1,Dr. Bryd from # TheJames comments on # Ibrutinib RESONATE™ data presented at # ASCO14 http://bit.ly/1kFp2ec via @ HPE_Magazine,,@,# # #,4.73864E+17,https://twitter.com/OSUCCC_James/status/473863951563128832,,,,
drsam,6/3/2014 12:27,2,1,Wow. Big response following Pembro retreatment despite pseudoprogression # asco14 # NeverSayDiepic.twitter.com/xG5KUPqN3m,,,# #,4.73864E+17,https://twitter.com/drsam/status/473863646037028864,,,,
scientre,6/3/2014 12:27,1,1,Safe travels to both! MT @ Gene_Antibody The # blisterwalk can be fun when you run into your buddy @ MaverickNY # ASCO14 pic.twitter.com/YMYPVdxUp1,,@ @,# #,4.73863E+17,https://twitter.com/scientre/status/473863437068816386,,,,
YupOnc,6/3/2014 12:26,3,2,@ ASCO @ CliffordHudis An incredibly productive year at ASCO under Cliff's leadership,,@ @,,4.73863E+17,https://twitter.com/YupOnc/status/473863334391857153,,,,
lucadf,6/3/2014 12:26,4,1,Obesity: a major cancer risk factor? @ Oncoinfo_it # ASCO2014 Interview to @ CliffordHudis http://tinyurl.com/lx4zaq3,,@ @,#,4.73863E+17,https://twitter.com/lucadf/status/473863178896814080,,,,
drsam,6/3/2014 12:25,0,0,Hodi: delayed pseudoprogression. Look at those spider plots carefully. # ASCO14 pic.twitter.com/dSSHFwCTIA,,,#,4.73863E+17,https://twitter.com/drsam/status/473863095379447808,,,,
Cortellis,6/3/2014 12:24,2,0,Results of PROFILE 1014 P3 trial: crizotinib presents superior PFS and ORR over pemetrexed-based chemotherapy in NSCLC patients # ASCO14,,,#,4.73863E+17,https://twitter.com/Cortellis/status/473862859139477505,,,,
drsam,6/3/2014 12:23,0,0,Top of the feed. How meta. # ASCO14 pic.twitter.com/jkxlO3MWEt,,,#,4.73863E+17,https://twitter.com/drsam/status/473862629476155392,,,,
aftimosp,6/3/2014 12:23,0,0,Confusing: Relapse-free survival not different for BRCA-mutated # BreastCancer in case of pCR or non pCR after neo-adjuvant chemo # ASCO14,,,# #,4.73863E+17,https://twitter.com/aftimosp/status/473862581627932672,,,,
drsam,6/3/2014 12:22,0,0,"Also, Donald Rumsfeld's known knows and unknown unknowns"" being the other good science line from # GOP # ASCO14""",,,# #,4.73862E+17,https://twitter.com/drsam/status/473862245047205890,,,,
OncNursingNews,6/3/2014 12:21,0,0,MT @ OncLive: Adding docetaxel to hormone therapy extended life for men w/ prostate cancer by almost 4 months http://ow.ly/xzYwa # ASCO14,,@,#,4.73862E+17,https://twitter.com/OncNursingNews/status/473861996933570560,,,,
AsimJshaikh,6/3/2014 12:21,0,0,"# ASCO14 4 scans over 2 years in select patients with DLBCL , good ? pic.twitter.com/WoC2SRRieU",,,#,4.73862E+17,https://twitter.com/AsimJshaikh/status/473861943879815168,,,,
drsam,6/3/2014 12:21,0,0,"Repubs have the best one-liners for science and Hodi supports: important thing in irRC is to confirm. Trust but verify"" # ASCO14 # GOP""",,,# #,4.73862E+17,https://twitter.com/drsam/status/473861943355138048,,,,
SarahKarlin,6/3/2014 12:21,0,0,@ ASCO thanks!,,@,,4.73862E+17,https://twitter.com/SarahKarlin/status/473861937152155648,,,,
boehringerus,6/3/2014 12:20,1,0,# ASCO14 ends today. Thank you @ ASCO for once again organizing an incredible meeting! See you next year!,,@,#,4.73862E+17,https://twitter.com/boehringerus/status/473861797074960384,,,,
DebiopharmNews,6/3/2014 12:20,0,0,"# ASCO14 The # patients are at the core of our business, we care for them! http://ow.ly/xwtyl",,,# #,4.73862E+17,https://twitter.com/DebiopharmNews/status/473861772257267712,,,,
QIAGENscience,6/3/2014 12:20,0,0,Wrapping up an action-packed # ASCO14. Hope everyone had a good show & has a mellow trip home.,,,#,4.73862E+17,https://twitter.com/QIAGENscience/status/473861689063260160,,,,
Melanoma_doctor,6/3/2014 12:19,0,0,Kefford: tumor PD-L1 expression correlates with but does not preclude response to MK-3475 # poorbiomarker # ASCO14 @ ASCO # melanoma,,@,# # #,4.73862E+17,https://twitter.com/Melanoma_doctor/status/473861636043059200,,,,
AlpineBV_Miller,6/3/2014 12:19,3,2,"Blino efficacy. P-, ALL. Pts were primary refractory, early relapse, relapse <12mo after SCT. # ASCO14 pic.twitter.com/JLLChX6Jdf",,,#,4.73862E+17,https://twitter.com/AlpineBV_Miller/status/473861631559352320,,,,
CANcerviver,6/3/2014 12:19,0,0,RT @ ASCO: Menopausal status may predict risk of breast cancer mortality among obese women with ER+ breast CA http://bit.ly/1nYxY4d # ASCO14,,@,#,4.73862E+17,https://twitter.com/CANcerviver/status/473861575435382785,,,,
pernelle44,6/3/2014 12:19,0,0,# Doctoctoc voyez-vous une contradiction? # ASCO14 2/2,,,# #,4.73862E+17,https://twitter.com/pernelle44/status/473861505545682944,,,,
brentgendleman,6/3/2014 12:19,0,1,“ @ 5amsolutions: 5 Ways HHS is Bringing (Big Data) Power to the People http://info.5amsolutions.com/blog/bid/183126/5-Ways-HHS-is-Bringing-Big-Data-Power-to-the-People … via @ 5amsolutions” # hdpalooza # ASCO14,,@ @,# #,4.73861E+17,https://twitter.com/brentgendleman/status/473861472301641729,,,,
drsam,6/3/2014 12:19,0,0,This is why we need to color those spider plots differently. # ASCO14 pic.twitter.com/RquHKBiGrR,,,#,4.73861E+17,https://twitter.com/drsam/status/473861441322094592,,,,
MediTech_Media,6/3/2014 12:18,0,0,@ ASCO Great job of carrying out the theme of Science and Society. Encouraging # cancer research taking place with patients in mind. # ASCO14,,@,# #,4.73861E+17,https://twitter.com/MediTech_Media/status/473861398792265728,,,,
RarePOV,6/3/2014 12:18,0,0,@ ASCO Thank you!,,@,,4.73861E+17,https://twitter.com/RarePOV/status/473861187197992960,,,,
annaazvolinsky,6/3/2014 12:18,1,1,# BRCA # breastcancer expert discusses BRCA-tailored treatments and # ASCO14 presentations http://www.cancernetwork.com/asco-2014-breast-cancer/asco-treating-brca-positive-breast-cancer …,,,# # #,4.73861E+17,https://twitter.com/annaazvolinsky/status/473861174681796608,,,,
drsam,6/3/2014 12:18,0,0,Now up: Hodi and immune-related response criteria and Pembro. # ASCO14,,,#,4.73861E+17,https://twitter.com/drsam/status/473861167358562305,,,,
drsam,6/3/2014 12:17,0,1,Kefford conclusions seem to support this too. # ASCO14 pic.twitter.com/2ybhOVefrn,,,#,4.73861E+17,https://twitter.com/drsam/status/473860929545699329,,,,
BoysenMeb,6/3/2014 12:16,0,0,Sidste tur med Rute 4. Tak for denne gang. Det har været stort på alle måder # ASCO14 @DagMedicin pic.twitter.com/wyKK9uHPgo,,@DagMedicin,#,4.73861E+17,https://twitter.com/BoysenMeb/status/473860849086767104,,,,
drsam,6/3/2014 12:16,0,2,Data would seem to indicate that you should treat all-comer melanoma with Pembro regardless of PD-L1. # ASCO14 pic.twitter.com/rxSxEK5q0f,,,#,4.73861E+17,https://twitter.com/drsam/status/473860777607041024,,,,
survivornetca,6/3/2014 12:15,0,0,RT @grwakefield49: MT @ pfizer: Infographic: 50yr # cancerresearch & counting # asco14 pic.twitter.com/zKwDuDm5m6 @ Deadline2020,,@grwakefield49 @ @,# #,4.7386E+17,https://twitter.com/survivornetca/status/473860455098634240,,,,
Oncoinfo_it,6/3/2014 12:14,0,0,Our last (but not least!) interview. Thank you @ CliffordHudis! http://tinyurl.com/lx4zaq3 # ASCO2014 @ lucadf @ PAscierto @ ASCO @ fischmd,,@ @ @ @ @,#,4.7386E+17,https://twitter.com/Oncoinfo_it/status/473860372144095232,,,,
CancerNetwrk,6/3/2014 12:14,0,2,ASCO: Treating BRCA-Positive Breast Cancer http://bit.ly/Tam0sM # ASCO14 # podcasts,,,# #,4.7386E+17,https://twitter.com/CancerNetwrk/status/473860328342970368,,,,
drsam,6/3/2014 12:14,0,1,Are differences in responses between selected and unselected enough to warrant a PD-L1 predictive biomarker? # ASCO14 pic.twitter.com/7itP3Lrtva,,,#,4.7386E+17,https://twitter.com/drsam/status/473860289184542720,,,,
AlpineBV_Miller,6/3/2014 12:13,1,1,Blinotumomab deaths in this trial. 28 (15%) # asco14 pic.twitter.com/oIyi3qtxFu,,,#,4.7386E+17,https://twitter.com/AlpineBV_Miller/status/473860124503969792,,,,
heidisa,6/3/2014 12:13,2,1,MT @ brianreid: Breaking Bad," Angelina & lessons from # SocOncology report on cancer discussions: http://bit.ly/SYoTwP # ASCO14”""",,@,# #,4.7386E+17,https://twitter.com/heidisa/status/473860085677314050,,,
CancerNetwrk,6/3/2014 12:13,0,1,Adjuvant FOLFOX Improves DFS in Rectal Cancer Patients http://bit.ly/1l34Lnx # ASCO14,,,#,4.7386E+17,https://twitter.com/CancerNetwrk/status/473859947475005441,,,,
brentgendleman,6/3/2014 12:12,2,0,# hdpalooza # bluebutton # ASCO14 open FDA data released on adverse events,,,# # #,4.7386E+17,https://twitter.com/brentgendleman/status/473859834463662081,,,,
drsam,6/3/2014 12:12,1,1,Kefford: PD-L1 positivity is partial or complete membrane staining on >=1% tumor cells using 22C3 Ab. NPV = 87% for response. # ASCO14,,,#,4.7386E+17,https://twitter.com/drsam/status/473859816952037377,,,,
5amsolutions,6/3/2014 12:12,0,0,Only 3% of cancer patients qualify for clinical trials. Let's learn from the other 97% too. # ASCO14 http://www.asco.org/quality-guidelines/cancerlinq …,,,#,4.7386E+17,https://twitter.com/5amsolutions/status/473859732302987264,,,,
TuftsB,6/3/2014 12:11,1,1,At OHare. Thanking soldiers for service. Like them anyone involved in cancer care must try to leave no person/patient behind # mliwi # asco14,,,# #,4.7386E+17,https://twitter.com/TuftsB/status/473859500240551936,,,,
Roche,6/3/2014 12:10,2,3,"Take our quiz, test your # ClinicalTrials IQ: http://ow.ly/xwAR0 # ASCO14 # healthcare",,,# # #,4.73859E+17,https://twitter.com/Roche/status/473859335454752769,,,,
DanBudwick,6/3/2014 12:10,0,0,RT @ FoundationATCG Take the molecular testing challenge & learn about comprehensive approach: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,@,# #,4.73859E+17,https://twitter.com/DanBudwick/status/473859333168832512,,,,
DebiopharmNews,6/3/2014 12:10,0,0,# ASCO14 # Innovation is precious and we take care of it by transforming it into a drug for the # patients http://ow.ly/xwtmK,,,# # #,4.73859E+17,https://twitter.com/DebiopharmNews/status/473859270073933825,,,,
NextGenClinical,6/3/2014 12:10,1,0,Our heads spinning with slides of mutation variations and our feet weary from the # blisterwalk. Good bye # ASCO14! pic.twitter.com/u8I2II639a,,,# #,4.73859E+17,https://twitter.com/NextGenClinical/status/473859262494801920,,,,
OncLive,6/3/2014 12:10,2,1,Follow-up of Concurrent Immunotherapies Shows Unprecedented Survival Rate in Melanoma http://ow.ly/xzUtF # ASCO14,,,#,4.73859E+17,https://twitter.com/OncLive/status/473859202822467585,,,,
evolutionraad,6/3/2014 12:09,0,0,# ASCO14 Big Four Labs wager $1.3B on next-gen cancer drugs based on: A- Trial & Error; B- neo-Darwinism; C- neo-Lamarckism? A&B=Flunk C=Pass,,,#,4.73859E+17,https://twitter.com/evolutionraad/status/473858966968348672,,,,
UCCancerCenter,6/3/2014 12:09,0,0,Promising data from UChicago and Cornell haplo+cord faster engraftment vs dUCB transplant w/ better platelet recovery and less GvHD # ASCO14,,,#,4.73859E+17,https://twitter.com/UCCancerCenter/status/473858924408745984,,,,
5amsolutions,6/3/2014 12:08,0,0,"@ 5amsolutions, @ ASCO",,@ @,,4.73859E+17,https://twitter.com/5amsolutions/status/473858807526092800,,,,
CathyEngMD,6/3/2014 12:08,0,0,"# ASCO2014, abs3509. Our interesting results from mdacc on # mCRC looking at MT discordance btwn primary vs met site, # endcancer, # crcsm",,,# # # #,4.73859E+17,https://twitter.com/CathyEngMD/status/473858782943272960,,,,
MaverickNY,6/3/2014 12:08,0,0,"@ drsam roflmao keep it up, keep it up! # asco14",,@,#,4.73859E+17,https://twitter.com/MaverickNY/status/473858669319573504,,,,
AlpineBV_Miller,6/3/2014 12:06,0,3,"If you answer your phone in an # ASCO14 session, it damn well better be a patient emergency.",,,#,4.73858E+17,https://twitter.com/AlpineBV_Miller/status/473858348270780416,,,,
JSchneide12,6/3/2014 12:06,1,2,# ASCO14 is a wrap. One last thing to-do in Chicago before heading home (and getting back on my diet). pic.twitter.com/3FGKnGzcaH,,,#,4.73858E+17,https://twitter.com/JSchneide12/status/473858324492857344,,,,
IONELung,6/3/2014 12:06,0,0,First-line trial warranted for crizotinib vs ceritinib? Response to ceritinib much longer in crizotinib-naive ALK+ NSCLC pts # ASCO14 # lung,,,# #,4.73858E+17,https://twitter.com/IONELung/status/473858321146183680,,,,
JanssenUS,6/3/2014 12:06,0,0,Head to E354a at 11:57 am CT to hear results from a Phase 3 study in # leukemia & # lymphoma # ASCO14 http://jan4.me/1rtaFDA,,,# # #,4.73858E+17,https://twitter.com/JanssenUS/status/473858267656237056,,,,
drsam,6/3/2014 12:06,0,0,Now up: Kefford and PD-L1 expression as a biomarker for response in melanoma based on Pembro data # merck # asco14,,,# #,4.73858E+17,https://twitter.com/drsam/status/473858210667823104,,,,
BayerEspana,6/3/2014 12:05,0,1,Sigue las novedades de # Bayer en # ASCO14 en la cuenta de @BayerHealthCare (información en inglés),,@BayerHealthCare,# #,4.73858E+17,https://twitter.com/BayerEspana/status/473858002462986240,,,,
MelanomaReAlli,6/3/2014 12:05,0,2,PD-1/PD-L1 approaches show great promise vs. # melanoma at # ASCO14 via @Bloombergnews http://ow.ly/xzHZI,,@Bloombergnews,# #,4.73858E+17,https://twitter.com/MelanomaReAlli/status/473858001104023552,,,,
myCME,6/3/2014 12:05,0,0,Incoming @ ASCO president Peter Yu MD Discusses Transforming Data into Learning: Video http://ow.ly/xxzoz # ASCO14 # oncology # healthIT,,@,# # #,4.73858E+17,https://twitter.com/myCME/status/473857988533682176,,,,
mendelspod,6/3/2014 12:05,0,0,RT @ chempetitive: Check out # Chemunity for a look at some of the big developments emerging at # ASCO14 http://bit.ly/SqjU7y # Cancer,,@,# # #,4.73858E+17,https://twitter.com/mendelspod/status/473857957823012865,,,,
drsam,6/3/2014 12:05,1,2,"Holy cow, @ MaverickNY ... How do you do this for a whole # ASCO14 ... It's exhausting!",,@,#,4.73858E+17,https://twitter.com/drsam/status/473857911249051648,,,,
drsam,6/3/2014 12:04,0,1,Adaniel: Conclusions. # ASCO14 pic.twitter.com/qUYyU5B42L,,,#,4.73858E+17,https://twitter.com/drsam/status/473857802557865985,,,,
eMPR,6/3/2014 12:04,0,0,Exemestane vs tamoxifen in early breast cancer: http://ow.ly/xzVeT # ASCO14 # oncology,,,# #,4.73858E+17,https://twitter.com/eMPR/status/473857719276142592,,,,
NotiSalud,6/3/2014 12:04,1,0,“ @ elmundosalud: Lo mas interesante de # ASCO14 probablemente ha sido la promesa de la inmunoterapia contra el cáncer http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html ….”,,@,#,4.73858E+17,https://twitter.com/NotiSalud/status/473857681804259328,,,,
ONAcom,6/3/2014 12:03,2,1,# ASCO14: Obese patients with gynecologic cancer are rarely counseled on weight loss - http://ow.ly/xwfmu # gyncsm,,,# #,4.73857E+17,https://twitter.com/ONAcom/status/473857466787434497,,,,
drsam,6/3/2014 12:03,0,1,SNP germline variants and resistance to ipi in melanoma. Someone call # 23andme # asco14 pic.twitter.com/1lVjfIjmxo,,,# #,4.73857E+17,https://twitter.com/drsam/status/473857423870926848,,,,
DebiopharmNews,6/3/2014 12:02,0,0,# ASCO14 Convert your molecule into a successful drug http://ow.ly/xwtfL,,,#,4.73857E+17,https://twitter.com/DebiopharmNews/status/473857346629025792,,,,
Boehringer,6/3/2014 12:02,0,0,PRESS&HCPs: Heard our LUX-Lung 5 # lungcancer clinical trial datatoday? View our infographic http://bit.ly/1oJKtQA # ASCO14,,,# #,4.73857E+17,https://twitter.com/Boehringer/status/473857232887873536,,,,
MoffittResearch,6/3/2014 12:02,0,0,Dr. Damon Reed will present on Insights from Studies in Bone Sarcomas at 12:15 p.m. Will you be there? http://bit.ly/1kikn7U # ASCO14,,,#,4.73857E+17,https://twitter.com/MoffittResearch/status/473857144509710336,,,,
drsam,6/3/2014 12:01,0,2,Adaniel: let's now do our pathway analysis. Dendritic cell chemotaxis and chemokines at the top o' the list. # asco14 pic.twitter.com/meEaRWpFt5,,,#,4.73857E+17,https://twitter.com/drsam/status/473857079954792449,,,,
CancerResearch,6/3/2014 12:01,1,0,Use hashtag # CIM2014 during June and we'll retweet you! # ASCO14,,,# #,4.73857E+17,https://twitter.com/CancerResearch/status/473857047696773120,,,,
JSweetenhamMD,6/3/2014 12:01,0,0,Basket study design - new concept in cancer trial from # ASCO14 @ huntsmancancer,,@,#,4.73857E+17,https://twitter.com/JSweetenhamMD/status/473856987382693888,,,,
Novartis,6/3/2014 12:00,1,0,# Novartis announces data in # polycythemiavera # ASCO14 http://bit.ly/SqjwWF,,,# # #,4.73857E+17,https://twitter.com/Novartis/status/473856849880825856,,,,
medpagetoday,6/3/2014 12:00,0,0,Adding Avastin to first-line targeted therapy delayed progression in a subgroup of NSCLC # ASCO14 http://bit.ly/1rHI6T8,,,#,4.73857E+17,https://twitter.com/medpagetoday/status/473856776551411712,,,,
DrMiguelPerales,6/3/2014 12:00,0,0,RT @ giomarsi Cancer: l'immunothérapie continue à faire reculer le mélanome http://leparisien.fr/flash-actualit … # ASCO14,,@,#,4.73857E+17,https://twitter.com/DrMiguelPerales/status/473856749532098560,,,,
FoundationATCG,6/3/2014 12:00,1,0,Take the molecular testing challenge and learn about the comprehensive approach: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73857E+17,https://twitter.com/FoundationATCG/status/473856725402284033,,,,
drsam,6/3/2014 12:00,0,0,Adaniel: here's your top 20 list of genetic variants for your enjoyment # ASCO14 pic.twitter.com/96d30aO1Dy,,,#,4.73857E+17,https://twitter.com/drsam/status/473856678253711360,,,,
dramarivirg,6/3/2014 12:00,0,0,Gepar Sixto:beneficio d adicionar carboplatino en neoadyuvancia es marginal (11%) en # cancerdemama triple neg sin factores d riesgo # ASCO14,,,# #,4.73857E+17,https://twitter.com/dramarivirg/status/473856638915735552,,,,
TheCuckoosNest,6/3/2014 11:59,0,1," @ fischmd: http://bit.ly/RH2mDC # ASCO14"" What happened to all the tobacco settlement money? Oh yeah"," misused by the state governments.""",,@,#,4.73857E+17,https://twitter.com/TheCuckoosNest/status/473856561052672000,,,
pfizer,6/3/2014 11:59,4,2,PFE’s Mace Rothenberg: We’re learning how to use the immune system to improve outcomes in difficult-to-manage cancers # ASCO14,,,#,4.73857E+17,https://twitter.com/pfizer/status/473856556296327170,,,,
ASeizew,6/3/2014 11:58,0,0,@ megtirrell @ ASCO poor $ CLVS got a big head start.,,@ @,,4.73856E+17,https://twitter.com/ASeizew/status/473856250695135232,,,,
drsam,6/3/2014 11:58,0,0,"Adaniel: whole exome germline sequencing of 45 melanoma patients (so far) rx'd with ipi, stratified by response. # asco14",,,#,4.73856E+17,https://twitter.com/drsam/status/473856246563352577,,,,
SarahKarlin,6/3/2014 11:58,0,0,@ SDFatPhRMA @ ASCO would love to be able to see this link as well!,,@ @,,4.73856E+17,https://twitter.com/SarahKarlin/status/473856207456071680,,,,
HealthAroundMe,6/3/2014 11:57,0,0,# cancro: preservare # fertilità delle pazienti in terapia per tumore al # seno mettendo a riposo le ovaie ( @ ASCO) http://www.healtharoundme.com/blog/cancro-ovarico-8maggio-giornata-mondiale/ …,,@,# # #,4.73856E+17,https://twitter.com/HealthAroundMe/status/473856105370902528,,,,
AsimJshaikh,6/3/2014 11:57,0,0,# ASCO14 GEPARsixto : family history + ; platinum good in tnbc Na,,,#,4.73856E+17,https://twitter.com/AsimJshaikh/status/473856100975259649,,,,
aftimosp,6/3/2014 11:56,0,0,GEPARSIXTO: germline alterations and family history drive the pCR rate improvement with neoadjuvant carboplatin in TN # BreastCancer # ASCO14,,,# #,4.73856E+17,https://twitter.com/aftimosp/status/473855833718415360,,,,
MaverickNY,6/3/2014 11:56,1,2,@ Melanoma_doctor such a welcome change! I've been in Dev Therapeutics sessions where there was a dozen of us and dog # asco14,,@,#,4.73856E+17,https://twitter.com/MaverickNY/status/473855730588864513,,,,
betht0002,6/3/2014 11:56,0,0,Heading home after a great # ASCO14. Looking forward to # ASCO15 with the # LCI team @Carolinas,,@Carolinas,# # #,4.73856E+17,https://twitter.com/betht0002/status/473855698611097600,,,,
IONELung,6/3/2014 11:56,0,0,Interesting PFS data with novel agent ADI+ PEG in mesothelioma: Warrants further study! # lungcancer # ASCO14,,,# #,4.73856E+17,https://twitter.com/IONELung/status/473855686284439552,,,,
sueziebland,6/3/2014 11:55,0,0,A surprisingly good(& engaged!) turn out for our session on patient engagement given it was at the tail end of # ASCO14,,,#,4.73856E+17,https://twitter.com/sueziebland/status/473855622459715584,,,,
Melanoma_MRV,6/3/2014 11:55,0,1,# ASCO14 http://tinyurl.com/pkrehud Real promise for predicting benefit from Ipi in melanoma-genomics meets immunology!!!pic.twitter.com/4fiUYluyTA,,,#,4.73856E+17,https://twitter.com/Melanoma_MRV/status/473855565072842752,,,,
Melanoma_doctor,6/3/2014 11:55,2,2,"While I’m listening and tweeting at # asco14, Mrs. @ Melanoma_doctor tries to keep up with orders from @Letterkandy http://ow.ly/i/5Msa8",,@ @Letterkandy,#,4.73856E+17,https://twitter.com/Melanoma_doctor/status/473855557582225408,,,,
scientre,6/3/2014 11:55,3,1,"Q&A chemo session: Why some cancers (eg testicular) respond so well vs others? Lots of research, no understanding of the biology # ASCO14",,,#,4.73856E+17,https://twitter.com/scientre/status/473855537332105216,,,,
myCME,6/3/2014 11:55,0,0,"Bevacizumab, Cetuximab Equally Effective for Metastatic # ColorectalCancer @chemoadvisor http://ow.ly/xxyOk # CRC # ASCO14",,@chemoadvisor,# # #,4.73856E+17,https://twitter.com/myCME/status/473855504075489280,,,,
abbottmd,6/3/2014 11:55,0,0,"Cancer Survivorship Program Models in Academic, Community, National Settings | ASCO Annual Meeting http://ow.ly/xzS6W # ASCO14",,,#,4.73855E+17,https://twitter.com/abbottmd/status/473855498924482560,,,,
drsam,6/3/2014 11:55,0,0,Next up in S100a: Adaniel and germline determinants of response to immunotherapy. # ASCO14,,,#,4.73855E+17,https://twitter.com/drsam/status/473855458558484480,,,,
CancerTherAdvsr,6/3/2014 11:55,0,0,Trametinib + Dabrafenib Improves PFS in BRAFV600E/K Mutant Metastatic # Melanoma # ASCO14 http://ow.ly/xvslZ,,,# #,4.73855E+17,https://twitter.com/CancerTherAdvsr/status/473855455446716416,,,,
UHhospitals,6/3/2014 11:55,1,1,New way to predict response to # chemotherapy in triple-negative # breastcancer http://ow.ly/xzcKD (via @ ONAcom) # ASCO14,,@,# # #,4.73855E+17,https://twitter.com/UHhospitals/status/473855431920873472,,,,
DrMiguelPerales,6/3/2014 11:55,1,0,MT @ OncLive - @ DrAnasYounes from @ sloan_kettering on R-CHOP in Combination with Ibrutinib in DLBCL http://ow.ly/xzCJt # ASCO14 TPS,,@ @ @,#,4.73855E+17,https://twitter.com/DrMiguelPerales/status/473855385989050368,,,,
Jdtay04,6/3/2014 11:54,0,0,Learning to ask the right questions at # ASCO14: http://bit.ly/1kRFkFx CC @ fischmd @ ASCO # ASCOConnection,,@ @,# #,4.73855E+17,https://twitter.com/Jdtay04/status/473855374173294592,,,,
MaverickNY,6/3/2014 11:54,0,2,"Oh man, on bus back to hotel... Waves of exhaustion hit. Oof. # asco14",,,#,4.73855E+17,https://twitter.com/MaverickNY/status/473855178723303424,,,,
DrGlenWeiss,6/3/2014 11:53,0,0,ASCO: Vit D Not Tied to Breast Cancer Outcomes http://www.medpagetoday.com/HematologyOncology/BreastCancer/46116 … # ASCO14 @ cancercenter,,@,#,4.73855E+17,https://twitter.com/DrGlenWeiss/status/473855025798586368,,,,
TommyJohn00,6/3/2014 11:53,0,0,Dr Snyder: Neo antigens. 51 Tetrapeptides predict response to ipi! Mutational load doesn't guarantee tetra peptide but incr chance # ASCO14,,,#,4.73855E+17,https://twitter.com/TommyJohn00/status/473854981968105472,,,,
DrGlenWeiss,6/3/2014 11:53,0,0,Anti-HER2 Combo Fails to Improve Outcomes in Early Breast Cancer http://shar.es/VMnpg via @ sharethis # ASCO14 @ cancercenter,,@ @,#,4.73855E+17,https://twitter.com/DrGlenWeiss/status/473854887210393600,,,,
drsam,6/3/2014 11:52,0,2,Next speaker up to speak about neoepitopes ... # ASCO14 pic.twitter.com/RZl881etMi,,,#,4.73855E+17,https://twitter.com/drsam/status/473854865844604928,,,,
t_andreiu,6/3/2014 11:52,0,0,Goodbye # ASCO14! It was a great time. See you next year!!!,,,#,4.73855E+17,https://twitter.com/t_andreiu/status/473854768398352384,,,,
sloan_kettering,6/3/2014 11:52,5,5,New form of immunotherapy shows promise in early # breastcancer http://bit.ly/1kFxvOJ # bcsm # ASCO14 # OnCancer,,,# # # #,4.73855E+17,https://twitter.com/sloan_kettering/status/473854630066024448,,,,
drsam,6/3/2014 11:52,0,2,Neoepitopes and clinical benefit in response to ipi. Mutations can (but don't always) make new epitopes. # ASCO14 pic.twitter.com/olGT90ZLay,,,#,4.73855E+17,https://twitter.com/drsam/status/473854625464852480,,,,
RarePOV,6/3/2014 11:51,0,0,@ ASCO Is there a different link? That didn't work: Thank you for visiting http://ASCO.org . The page you requested could not be found.,,@,,4.73855E+17,https://twitter.com/RarePOV/status/473854617923514370,,,,
Melanoma_doctor,6/3/2014 11:51,3,2,Developmental therapeutics immunotherapy session at # asco14 completely full with spillover to secondary room # signofthetimes @ ASCO,,@,# #,4.73854E+17,https://twitter.com/Melanoma_doctor/status/473854451795902464,,,,
DebiopharmNews,6/3/2014 11:50,0,0,# ASCO14 Successful in- and out-licensing for breakthrough drugs benefiting the # patient http://ow.ly/xwt9e,,,# #,4.73854E+17,https://twitter.com/DebiopharmNews/status/473854286016053248,,,,
NickiDurlester,6/3/2014 11:49,1,1,# ASCO14 Future of # cancer science & care. Who will pay & how much doctors know. Progress is real. @ ElaineSchattner http://www.forbes.com/sites/elaineschattner/2014/06/03/revisiting-asco-and-considering-the-future-of-cancer-science-and-care/ …,,@,# #,4.73854E+17,https://twitter.com/NickiDurlester/status/473854072122925058,,,,
AlpineBV_Miller,6/3/2014 11:49,0,1,"@ MaverickNY @ drsam @ MaverickNY GRINSOME, in this specific case. # ASCO14",,@ @ @,#,4.73854E+17,https://twitter.com/AlpineBV_Miller/status/473854057648771072,,,,
drsam,6/3/2014 11:49,1,2,Searching for neoantigens in cancer ? Try this. # ASCO14 pic.twitter.com/GUi1X4wnJz,,,#,4.73854E+17,https://twitter.com/drsam/status/473854034801987585,,,,
RyanNipp,6/3/2014 11:49,3,0,. @ ASCO Research Round Up. http://www.cancer.net/sites/cancer.net/files/2014_am_rr.pdf?et_cid=33859001&et_rid=36187957&linkid=http://www.cancer.net/sites/cancer.net/files/2014_am_rr.pdf … # hpm # ASCO14 pic.twitter.com/xrSW8Ek1Rp,,@,# #,4.73854E+17,https://twitter.com/RyanNipp/status/473853922286002176,,,,
drsam,6/3/2014 11:48,0,1,Mutational load and clinical benefit to ipi in melanoma # asco14 # neoempiricismpic.twitter.com/fACsSTkmXJ,,,# #,4.73854E+17,https://twitter.com/drsam/status/473853742907813888,,,,
TommyJohn00,6/3/2014 11:48,0,1,Neo antigen landscape # ASCO14 tumour neo antigens may correlate with response. Mutational load correlates with clinical benefit,,,#,4.73854E+17,https://twitter.com/TommyJohn00/status/473853685999476736,,,,
jrgralow,6/3/2014 11:48,1,1,Comparing Toxicities & Patient-Stated Preference in S0307 adj breast ca bisphosphonate trial # ASCO14 http://shar.es/VPNNm via @ TargetedOnc,,@,#,4.73854E+17,https://twitter.com/jrgralow/status/473853684078485504,,,,
RichardWJoseph,6/3/2014 11:47,1,1,@ rschilsky @ montypal Nothing more professionally gratifying than providing hope for long term remission through these therapies. # ASCO14,,@ @,#,4.73854E+17,https://twitter.com/RichardWJoseph/status/473853532337356801,,,,
scientre,6/3/2014 11:47,1,0,"Summ 1) chemo relevant tool treating pts w lung cancer 2) markers need work 3) formulations, combos w newer tx r future for chemo # ASCO14",,,#,4.73853E+17,https://twitter.com/scientre/status/473853473315123200,,,,
drsam,6/3/2014 11:47,1,2,"If more mutations predict better response to immunorx, what are implications for pedi cancers which are genomically less deranged # asco14",,,#,4.73853E+17,https://twitter.com/drsam/status/473853362870304768,,,,
OncEd,6/3/2014 11:46,0,0,# ASCO14 Effect of lenalidomide w/R-CHOP on negative prognostic impact of nongerminal center phenotype –Dr. Nowakowski http://bit.ly/1u5pbPS,,,#,4.73853E+17,https://twitter.com/OncEd/status/473853145534431232,,,,
ecancer,6/3/2014 11:46,0,0,Watch Prof Efstathiou and @ ProfMcVie discuss breaking # prostatecancer news from # ASCO14 http://ecancer.org/video/2909/summary-of-breaking-prostate-news-from-asco-2014.php …,,@,# #,4.73853E+17,https://twitter.com/ecancer/status/473853117692653568,,,,
dramarivirg,6/3/2014 11:45,0,0,S.oral # CancerdeMama triple negativo: combinación d inmunoterapia anti PD y PDL1 con Inhibidores de PPAR con resultados prometedores # ASCO14,,,# #,4.73853E+17,https://twitter.com/dramarivirg/status/473853109748649984,,,,
TransgeneSA,6/3/2014 11:45,1,1,Nouveaux succès de l' # immunothérapie face au mélanome via @ LePoint http://ow.ly/xzgtP # ASCO14 # oncologie # santé,,@,# # # #,4.73853E+17,https://twitter.com/TransgeneSA/status/473853026407817216,,,,
TargetedOnc,6/3/2014 11:45,0,0,Comparing Toxicities and Patient-Stated Preference in the SWOG S0307 Trial http://www.targetedonc.com/conference/asco-2014/Comparing-Toxicities-and-Patient-Stated-Preference-in-the-SWOG-S0307-Trial … # ASCO14 # bcsm,,,# #,4.73853E+17,https://twitter.com/TargetedOnc/status/473852980761198592,,,,
Roche,6/3/2014 11:45,6,5,There are diagnostic tests in development that can investigate tumour tissue for multiple # biomarkers. http://ow.ly/xp8mJ # ASCO14,,,# #,4.73853E+17,https://twitter.com/Roche/status/473852979075096576,,,,
notSoJunkDNA,6/3/2014 11:45,0,0,@ maverickny don't tweet while walking down the stairs! # asco14,,@,#,4.73853E+17,https://twitter.com/notSoJunkDNA/status/473852949291335680,,,,
drsam,6/3/2014 11:45,1,1,Snyder: elevated mutational load associated with but not sufficient for response to ipi in melanoma. # asco14,,,#,4.73853E+17,https://twitter.com/drsam/status/473852935537827840,,,,
TransgeneSA,6/3/2014 11:45,1,1,Le congrès de l’ # ASCO14 en bref : http://ow.ly/xzf8q via @ lemondefr # oncologie,,@,# #,4.73853E+17,https://twitter.com/TransgeneSA/status/473852903128834049,,,,
Melanoma_doctor,6/3/2014 11:44,1,0,"Exciting to remember my choice as a junior faculty person many years ago, to focus on # immunotherapy for # melanoma -- and now THIS # ASCO14",,,# # #,4.73853E+17,https://twitter.com/Melanoma_doctor/status/473852840793083904,,,,
jrgralow,6/3/2014 11:44,2,0,Yikes! Not even done with # ASCO14 and San Antonio Breast Cancer Symposium abstracts due next week already! http://www.aacr.org/home/scientists/meetings--workshops/san-antonio-breast-cancer-symposium.aspx#.U43tN6UZ5AY.twitter …,,,# #,4.73853E+17,https://twitter.com/jrgralow/status/473852744910897152,,,,
MaverickNY,6/3/2014 11:44,0,4,Funny so many people queue to go down the escalators - Ron Levy and I skipped down the stairs instead # asco14,,,#,4.73853E+17,https://twitter.com/MaverickNY/status/473852651999072258,,,,
dramarivirg,6/3/2014 11:43,1,1,"Sesión oral # CancerdeMama triple negativo: subtipos y asociación con factores inmunes: niveles d PD-L1, CTL4 y mutación d BCRA # ASCO14",,,# #,4.73853E+17,https://twitter.com/dramarivirg/status/473852537582649344,,,,
AndytweetM,6/3/2014 11:43,0,1,# ASCO14 immunotherapy sessions- packed room and choked in the virtual world! so many tweets that it caused this : pic.twitter.com/mLjLpt9ksg,,,#,4.73853E+17,https://twitter.com/AndytweetM/status/473852526740389888,,,,
TommyJohn00,6/3/2014 11:43,1,0,"Finally the wifi works consistently now that people have left # asco14, must've been overladen",,,#,4.73852E+17,https://twitter.com/TommyJohn00/status/473852471492608000,,,,
NCRI_partners,6/3/2014 11:43,1,1,Looking forward to seeing updates from colleagues who presented at # ASCO2014 at # NCRI2014. Submit now http://bit.ly/submit2014,,,# #,4.73852E+17,https://twitter.com/NCRI_partners/status/473852469530095616,,,,
drsam,6/3/2014 11:43,4,0,Immune checkpoint inhibitors as the savior of cancer vaccines ? Someone call the MAGE-A3 folks at GSK! # ASCO14,,,#,4.73852E+17,https://twitter.com/drsam/status/473852434226245632,,,,
jrgralow,6/3/2014 11:42,1,0,# ASCO14: How Scientific Collaboration Can Improve Our Approach To Fighting Cancer - from Forbes http://ow.ly/xzQXL,,,#,4.73852E+17,https://twitter.com/jrgralow/status/473852155808735233,,,,
melanoma_Drs,6/3/2014 11:42,0,0,"Anecdotal reports of response to MK-3475 and Nivo in metastatic uveal # melanoma, should do Ph2 trial # ASCO14 @ ASCO",,@,# #,4.73852E+17,https://twitter.com/melanoma_Drs/status/473852118009667584,,,,
Melanoma_doctor,6/3/2014 11:42,1,0,"Anecdotal reports of response to MK-3475 and Nivo in metastatic uveal # melanoma, should do Ph2 trial # ASCO14 @ ASCO",,@,# #,4.73852E+17,https://twitter.com/Melanoma_doctor/status/473852117401477120,,,,
MaverickNY,6/3/2014 11:41,0,4,And that's a wrap # asco14 for me - only one last # blisterwalk to go,,,# #,4.73852E+17,https://twitter.com/MaverickNY/status/473852033997762560,,,,
JFreemanDaily,6/3/2014 11:41,2,4,"We need a Fitbit challenge group for # ASCO14 -- i've logged over 16 miles in 5 days just walking between hotel, bus and events.",,,#,4.73852E+17,https://twitter.com/JFreemanDaily/status/473851954398232577,,,,
Lau_uribefig,6/3/2014 11:41,0,0,"Biología de sistemas, Genómica, inmunoterapia.el futuro en el tratamiento de Cáncer # ASCO2014",,,#,4.73852E+17,https://twitter.com/Lau_uribefig/status/473851910584565760,,,,
mtmdphd,6/3/2014 11:41,2,1,Celebrate 50 years of progress - Invest $50 in the future of cancer care - @ iConquerCancer of @ ASCO http://ow.ly/xzQH6 # ASCO14,,@ @,#,4.73852E+17,https://twitter.com/mtmdphd/status/473851861980950528,,,,
ohsuaya,6/3/2014 11:40,0,0,RT @ drdonsdizon: My 5 from # ASCO14: 4) POEMS preventing ovarian failure in young women http://abstracts.asco.org/144/AbstView_144_129172.html …,,@,#,4.73852E+17,https://twitter.com/ohsuaya/status/473851787783733248,,,,
Notes_of_Hope,6/3/2014 11:40,0,0,RT @ drdonsdizon: My 5 from # ASCO14: 4) POEMS preventing ovarian failure in young women http://abstracts.asco.org/144/AbstView_144_129172.html …,,@,#,4.73852E+17,https://twitter.com/Notes_of_Hope/status/473851786718351360,,,,
Roche,6/3/2014 11:40,1,1,"Personalised Healthcare (PHC) has powerful benefits, but are some stakeholders missing out? http://ow.ly/xp8eT # ASCO14",,,#,4.73852E+17,https://twitter.com/Roche/status/473851728971202561,,,,
DebiopharmNews,6/3/2014 11:40,0,0,# ASCO14 Our unique # patientcentric business model for # success: Debiopharm Group http://ow.ly/xwt3x,,,# # #,4.73852E+17,https://twitter.com/DebiopharmNews/status/473851714819600384,,,,
TommyJohn00,6/3/2014 11:40,0,0,"@ MartinStockler forced into overflow room which is around the corner"" 10mins away # ASCO14""",,@,#,4.73852E+17,https://twitter.com/TommyJohn00/status/473851684737667073,,,,
MaverickNY,6/3/2014 11:39,9,8,The anti PD-1 and PD-L1s clearly have different tox profiles by drug. Pembrolizumab and medi4736 both look cleaner than Nivo # asco14,,,#,4.73851E+17,https://twitter.com/MaverickNY/status/473851425752358912,,,,
Melanoma_doctor,6/3/2014 11:38,0,0,"Pembrolizumab (MK-3475) dose going forward 2 mg/kg q3w, goal of study accomplished # melanoma # ASCO14 @ ASCO @ ASCOPost",,@ @,# #,4.73851E+17,https://twitter.com/Melanoma_doctor/status/473851219711377409,,,,
echo_nyc,6/3/2014 11:38,0,0,Always classy to open the q&a with hey, are you sure your data was right," I thought it looked funny"". # ASCO14""",,,#,4.73851E+17,https://twitter.com/echo_nyc/status/473851126047993856,,
MaverickNY,6/3/2014 11:37,0,2,"Gotta run to catch plane now, @ drsam may tweet the 2nd half :) # asco14",,@,#,4.73851E+17,https://twitter.com/MaverickNY/status/473851063125438465,,,,
KoontzOncology,6/3/2014 11:37,0,0,Another fantastic time in Chicago - great # ASCO14 meeting and wonderful time catching up with colleagues. Now heading home.,,,#,4.73851E+17,https://twitter.com/KoontzOncology/status/473851038273769472,,,,
DrLen,6/3/2014 11:36,22,24,My favorite slide from # ASCO14: a 96yo lady with head and neck ca who responded to MEDI4736. Note the smile! pic.twitter.com/v0uA36cmw8,,,#,4.73851E+17,https://twitter.com/DrLen/status/473850654604394496,,,,
JoleneScience,6/3/2014 11:35,1,0,GS-9973(Syk)@ # ASCO14: $ GILD to start P2 trial in CLL pts r/r to other PO agents,,@,#,4.73851E+17,https://twitter.com/JoleneScience/status/473850578674933760,,,,
mtmdphd,6/3/2014 11:35,5,0,. @ davidgrahammd on # ASCO14 speakers: “They're in this bc this is really their life's interest.” http://bit.ly/1u1Fb5t via @ ASCO,,@ @,#,4.7385E+17,https://twitter.com/mtmdphd/status/473850496760156160,,,,
CaitlinDemchuk,6/3/2014 11:35,0,0,Recovering from # ASCO14. Missing the sights and sounds of Chicago!,,,#,4.7385E+17,https://twitter.com/CaitlinDemchuk/status/473850460148092928,,,,
RichardWJoseph,6/3/2014 11:35,0,1,@ MaverickNY @ OmidHamidMD thanks so much. Manuscript coming along nicely. Hopefully it will be well received! # ASCO14,,@ @,#,4.7385E+17,https://twitter.com/RichardWJoseph/status/473850410676289536,,,,
Fisiomedico,6/3/2014 11:35,0,0,RT @ elmundosalud: Lo mas interesante de # ASCO14 probablemente ha sido la promesa de la inmunoterapia contra el cáncer http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html …,,@,#,4.7385E+17,https://twitter.com/Fisiomedico/status/473850394486255616,,,,
Melanoma_doctor,6/3/2014 11:35,2,1,Pembrolizumab (MK-3475) shows activity against Ipi naive (37% RR) and Ipi refractory (26%) # melanoma nice job by @ OmidHamidMD # ASCO14,,@,# #,4.7385E+17,https://twitter.com/Melanoma_doctor/status/473850346893500416,,,,
hendri_agus,6/3/2014 11:34,0,0," @ CancerResearch: Start # CIM right with the definition of # immunotherapy: # CIM2014 # ASCO14 http://ow.ly/xyACM """"",,@,# # # #,4.7385E+17,https://twitter.com/hendri_agus/status/473850168488382465,,,,
OncLive,6/3/2014 11:34,1,1,Dr. David Spigel from @ SarahCannonDocs Discusses MPDL3280A Development in Lung Cancer http://ow.ly/xzOZF # ASCO14,,@,#,4.7385E+17,https://twitter.com/OncLive/status/473850126386331648,,,,
scientre,6/3/2014 11:33,3,1,Stinchombe: lung cancer patients that are helped by chemotx. List includes pts w genetic mutns eg EGFR & ALK # asco14 pic.twitter.com/ppEAfUrvb5,,,#,4.7385E+17,https://twitter.com/scientre/status/473850060846153728,,,,
Acedotor,6/3/2014 11:33,0,0,Noticias de Salud: # MEDIMMUNE @ ASTRAZENECA PRESENTA DATOS D INMUNOTERAPIA ALENTADORES CONGr @ ASCO 2014 http://noticiadesalud.blogspot.com/2014/06/medimmune-de-astrazeneca-presenta-datos_3.html … via @ Acedotor,,@ @ @,#,4.7385E+17,https://twitter.com/Acedotor/status/473850029459795968,,,,
evaluatevantage,6/3/2014 11:33,0,0,ICYMI: Growing PD-1 uses fail to stem Bristol selloff: $ BMY $ RHHBY $ MRK http://ow.ly/xzOWx # ASCO14,,,#,4.7385E+17,https://twitter.com/evaluatevantage/status/473850007456874496,,,,
MaverickNY,6/3/2014 11:33,1,1,Agreed RT @ drsam: @ MaverickNY That's not GRUEsome. That type of response is AWEsome. # ASCO14,,@ @,#,4.7385E+17,https://twitter.com/MaverickNY/status/473849999957458944,,,,
NCAresearchNHS,6/3/2014 11:33,1,1,RT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 http://bit.ly/1kyrh87,,@ @,#,4.7385E+17,https://twitter.com/NCAresearchNHS/status/473849845724110849,,,,
drsam,6/3/2014 11:32,0,0,@ MaverickNY That's not GRUEsome. That type of response is AWEsome. # ASCO14,,@,#,4.7385E+17,https://twitter.com/drsam/status/473849784826990592,,,,
drsam,6/3/2014 11:31,1,1,Ready? I got that awesome SCCHN picture for you! # ASCO14 pic.twitter.com/GfbTcilzdm,,,#,4.7385E+17,https://twitter.com/drsam/status/473849542857605120,,,,
Genyi1681,6/3/2014 11:31,0,0,Fuel for last day of # ASCO2014 from # GlazedandInfused - blueberry lemon-glazed! So yummy! :) http://instagram.com/p/oyXrW_mfGi/,,,# #,4.7385E+17,https://twitter.com/Genyi1681/status/473849519558246402,,,,
MaverickNY,6/3/2014 11:31,1,1,Topalian: H&N response in 96 yo pat who is pd-l1+ is remarkable # asco14 dramatic pics if a little gruesome,,,#,4.7385E+17,https://twitter.com/MaverickNY/status/473849516492595200,,,,
CancerDotNet,6/3/2014 11:31,0,1,Patients: Find a roundup of podcasts about the # cancer research headlines from # ASCO14 here: http://bit.ly/1kv30Qn,,,# #,4.73849E+17,https://twitter.com/CancerDotNet/status/473849403380609024,,,,
UNCurology,6/3/2014 11:31,0,0,"Place of readmission and outcomes after major cancer surgery Stitzenberg,Chang @ m_e_nielsen @ angiesmith_uro # ASCO14 http://ow.ly/xpkPG",,@ @,#,4.73849E+17,https://twitter.com/UNCurology/status/473849358090522624,,,,
scientre,6/3/2014 11:31,0,0,MT @ AdamsLisa I am tweeting a lot of cancer info & chatter today. @ asco # ASCO14 conference is gd reason for met patient perspective I think,,@ @,#,4.73849E+17,https://twitter.com/scientre/status/473849351824211968,,,,
DebiopharmNews,6/3/2014 11:31,0,0,# ASCO14 # DYK US market accounts for 41% of total # oncology drug sales http://ow.ly/xwsS0,,,# # #,4.73849E+17,https://twitter.com/DebiopharmNews/status/473849347948695552,,,,
JediPD,6/3/2014 11:30,0,0,@ MaverickNY Curious about the shared epitopes between thyroid and colon crypts? # ASCO14,,@,#,4.73849E+17,https://twitter.com/JediPD/status/473849326964576256,,,,
corp_UNC,6/3/2014 11:30,0,0,"Popn-based Rx receipt in prostate cancer pts who initially pursued active surveillance N.Sheets,R.Chen # asco14 http://ow.ly/xqBD6 # pcsm",,,# #,4.73849E+17,https://twitter.com/corp_UNC/status/473849280680435712,,,,
duemed,6/3/2014 11:30,0,0,I love all the people who tweet these wonderful high-resolution pictures of the presentations at # ASCO14 Thank you so much folks!,,,#,4.73849E+17,https://twitter.com/duemed/status/473849278658404352,,,,
eMPR,6/3/2014 11:30,0,0,Ramucirumab extends survival as second-line NSCLC treatment: http://ow.ly/xzns4 # ASCO14 # oncology,,,# #,4.73849E+17,https://twitter.com/eMPR/status/473849178549141504,,,,
FoundationATCG,6/3/2014 11:30,0,0,Think differently about Molecular testing: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73849E+17,https://twitter.com/FoundationATCG/status/473849174774259712,,,,
EncoreBioMed,6/3/2014 11:30,0,0,Cetuxumab + # chemotherapy as effective as bevacizumab + chemotherapy in # colorectalcancer # ASCO14 http://bit.ly/1iPoeUH,,,# # #,4.73849E+17,https://twitter.com/EncoreBioMed/status/473849142469754880,,,,
MediTech_Media,6/3/2014 11:30,0,0,"Dr Soros, there have been thousands of studies, but still no predictive biomarkers for # chemotherapy in # nsclc # ASCO14",,,# # #,4.73849E+17,https://twitter.com/MediTech_Media/status/473849105559859201,,,,
medpagetoday,6/3/2014 11:30,0,0,"Lori J. Wirth, MD, on the SELECT trial. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1rHDFYr",,@,#,4.73849E+17,https://twitter.com/medpagetoday/status/473849094201278465,,,,
MaverickNY,6/3/2014 11:29,1,0,Topalian: findings in keynote001 in ipi naive and refractory are consistent with different MOA of ctla4 and pd-1 # asco14,,,#,4.73849E+17,https://twitter.com/MaverickNY/status/473848897631440896,,,,
OncologyCentral,6/3/2014 11:29,0,0,More # news from # ASCO14 - lenvatinib yields positive results in differentiated thyroid # cancer trial http://bit.ly/19MA7os,,,# # #,4.73849E+17,https://twitter.com/OncologyCentral/status/473848893751689217,,,,
evaluatevantage,6/3/2014 11:29,0,1,ICYMI: Cell therapy gets a hearing with early NCI data: http://ow.ly/xzNTE # ASCO14 # Provenge # NIH,,,# # #,4.73849E+17,https://twitter.com/evaluatevantage/status/473848891503575040,,,,
DoctorEdny,6/3/2014 11:29,0,1,MEDI-4736 Anti-PD-L1 Rapid and durable response example in PI trial was in PD-L1 negative tumor # ASCO14 pic.twitter.com/Qqp83TUFvz,,,#,4.73849E+17,https://twitter.com/DoctorEdny/status/473848864441921536,,,,
mtmdphd,6/3/2014 11:28,2,0,"Illumination to Innovation: Transforming Data into Learning - Peter Yu, MD @ YupOnc http://ow.ly/xzNNA # ASCO14",,@,#,4.73849E+17,https://twitter.com/mtmdphd/status/473848711307874305,,,,
twittmanda,6/3/2014 11:28,1,1,Thank goodness for @ mtmdphd and @ MaverickNY for being at # ASCO14 while @ subatomicdoc travels! Thanks for being superstars!,,@ @ @,#,4.73849E+17,https://twitter.com/twittmanda/status/473848631192064000,,,,
IONELung,6/3/2014 11:27,0,0,Promising DFS for EGFRmut patients on erlotinib but primary outcome negative - further studies required! # lung # ASCO14,,,# #,4.73849E+17,https://twitter.com/IONELung/status/473848557288841216,,,,
DoctorEdny,6/3/2014 11:27,4,0,Overview of PD-1 pathway blocking drugs in development at most crowded # ASCO14 Tuesday morning talk ever pic.twitter.com/2vutGRmSsK,,,#,4.73849E+17,https://twitter.com/DoctorEdny/status/473848502955835393,,,,
Pharmafocus,6/3/2014 11:27,4,0,"Bye bye # ASCO14, it's been a blast - full conference report to follow in our July/August edition pic.twitter.com/nhVlCOtyYU",,,#,4.73848E+17,https://twitter.com/Pharmafocus/status/473848483347443712,,,,
GustaveRoussy,6/3/2014 11:27,6,2,"L' # immunothérapie, thème-phare de cet # ASCO14, monte en puissance. Lire l'article : http://bit.ly/1iPs9k4",,,# #,4.73848E+17,https://twitter.com/GustaveRoussy/status/473848449927221248,,,,
CI4CC,6/3/2014 11:27,0,0,# ASCO14 Thanks to all the vendors for a wonderful show also... What a massive breakdown of hundreds of booths!!!,,,#,4.73848E+17,https://twitter.com/CI4CC/status/473848380817694721,,,,
tracyrode,6/3/2014 11:27,1,1,What's your best # ASCO14 memory/encounter?,,,#,4.73848E+17,https://twitter.com/tracyrode/status/473848340313305088,,,,
mtmdphd,6/3/2014 11:26,2,1,"Science & Society: Fifty Years Later - # ASCO14 Presidential Address by Clifford A. Hudis, MD, FACP - @ CliffordHudis http://ow.ly/xzNpv",,@,#,4.73848E+17,https://twitter.com/mtmdphd/status/473848278250180608,,,,
drsam,6/3/2014 11:26,1,2,Competition in the # immunotherapy checkpoint inhibitor space. # ASCO14 pic.twitter.com/zBqrYhquAb,,,# #,4.73848E+17,https://twitter.com/drsam/status/473848228060725248,,,,
IONELung,6/3/2014 11:26,1,0,The 3-4% of NSCLC patients with truly high MET expression who benefit from crizotinib tend to be smokers # lung # ASCO14,,,# #,4.73848E+17,https://twitter.com/IONELung/status/473848217843814400,,,,
GenentechJobs,6/3/2014 11:26,0,0,# ASCO14 VP Talent Hunt in Clinical Dev: HER Signaling: http://click2apply.net/431863t & Signaling: http://click2apply.net/431946t pic.twitter.com/e2owqlE42b,,,#,4.73848E+17,https://twitter.com/GenentechJobs/status/473848104794324993,,,,
TedOkonCOA,6/3/2014 11:25,1,0,"Once A Year, Cancer Research News Comes In A Flood, Not A Trickle. http://ow.ly/xzhiS # asco14",,,#,4.73848E+17,https://twitter.com/TedOkonCOA/status/473847862988914689,,,,
cure_magazine,6/3/2014 11:24,4,5,Loved meeting up with lung cancer advocate @ JFreemanDaily at # ASCO14. Looking forward to this Thursday's # LCSM tweet chat at 8 eat.,,@,# #,4.73848E+17,https://twitter.com/cure_magazine/status/473847723557683200,,,,
IONELung,6/3/2014 11:24,1,0,Disappointing outcomes from erlotinib +/- onzartuzumab in advanced NSCLC with MET overexpression # lung # ASCO14,,,# #,4.73848E+17,https://twitter.com/IONELung/status/473847695879450624,,,,
GustaveRoussy,6/3/2014 11:24,3,1,# ASCO14 2 studies @ gustaveroussy on advanced soft tissue # sarcoma Press release: http://bit.ly/1x174wH,,@,# #,4.73848E+17,https://twitter.com/GustaveRoussy/status/473847639117942784,,,,
nycdoc29,6/3/2014 11:24,0,0,“ @ evaluatepharma: # ASCO14 – Growing PD-1 uses fail stem Bristol selloff http://ow.ly/xzscP $BMY” - way too early to tell clinical value,,@,#,4.73848E+17,https://twitter.com/nycdoc29/status/473847613067128832,,,,
AlpineBV_Miller,6/3/2014 11:23,2,2,I was in a developmental immunotherapy session at ASCO in 2005 or '06. Might have been 2 dozen people. Half were prob lost. # ASCO14,,,#,4.73847E+17,https://twitter.com/AlpineBV_Miller/status/473847498965262337,,,,
aftimosp,6/3/2014 11:23,0,0,"Proposed mechanisms of resistance to neoadjuvant chemo in TN # BreastCancer: 1- immune depletion, 2-MAPK pathay activation, 3- miRNAS # ASCO14",,,# #,4.73847E+17,https://twitter.com/aftimosp/status/473847462499995648,,,,
howazzat,6/3/2014 11:23,1,0,# ASCO2014 network. This should be a target in new clinical trials with MEK/ERK inhibitors 2/2,,,#,4.73847E+17,https://twitter.com/howazzat/status/473847379477929984,,,,
HughMcCafferty,6/3/2014 11:23,1,1,Always slightly odd to see people popping out for a cig break at a cancer conference # ASCO14,,,#,4.73847E+17,https://twitter.com/HughMcCafferty/status/473847339640442881,,,,
montypal,6/3/2014 11:22,0,0,@ kmargolin Kim glad to see you on Twitter! Sorry I missed you at # ASCO14,,@,#,4.73847E+17,https://twitter.com/montypal/status/473847209331392512,,,,
AnneBooms,6/3/2014 11:22,0,0,3/3 talks promoting ANPs addressing early PC to Oncology Patients. The earlier the better!! # ASCO14,,,#,4.73847E+17,https://twitter.com/AnneBooms/status/473847199139258368,,,,
CI4CC,6/3/2014 11:22,0,0,All # ASCO14 attendees welcome to join @ CI4CC and our Cancer Genomics &Informatics workshops: Go To http://www.ci4cc.org,,@,#,4.73847E+17,https://twitter.com/CI4CC/status/473847183763316736,,,,
IBCResearch,6/3/2014 11:22,2,0,"Kudos Dr. Radovich, et al, on their RNA sequencing work in # TNBC. Abstract 1002 # ASCO14",,,# #,4.73847E+17,https://twitter.com/IBCResearch/status/473847170907766784,,,,
theMMRF,6/3/2014 11:22,5,1,The 3rd @ theMMRF blog from our onsite coverage of # ASCO14 with the latest # myeloma news is now posted! http://www.themmrf.org/asco - # MMRFASCO,,@,# # #,4.73847E+17,https://twitter.com/theMMRF/status/473847126532055041,,,,
OgilvyHealth,6/3/2014 11:21,0,0,"OCHWW’s David Bonnyay, Michael Zilligen & Heather Linton stopped by a vendor booth @50th @ ASCO Meeting in Chicago pic.twitter.com/MLfL8TmQ58",,@50th @,,4.73847E+17,https://twitter.com/OgilvyHealth/status/473846944625078273,,,,
howazzat,6/3/2014 11:21,0,0,# ASCO2014 significant depletion of immune cells in residual disease in TNBC after neoadjuvant chemotherapy have highly activated MAPK 1/2,,,#,4.73847E+17,https://twitter.com/howazzat/status/473846890518556672,,,,
cancerassassin1,6/3/2014 11:21,0,0,To stir the pot: I often request KRas testing on some # colorectal # cancer patients who develop resectable mets including brain # ASCO14,,,# # #,4.73847E+17,https://twitter.com/cancerassassin1/status/473846843500032001,,,,
montypal,6/3/2014 11:20,1,0,Wondering what people think of PD-L1 as a predictive bio marker in RCC and bladder after this meeting # ASCO14,,,#,4.73847E+17,https://twitter.com/montypal/status/473846767562137601,,,,
MaverickNY,6/3/2014 11:20,2,3,Segal: no grade 3/4 pneumonitis # asco14 they all love to dig at Nivo on that aspect,,,#,4.73847E+17,https://twitter.com/MaverickNY/status/473846760058933249,,,,
MyelomaTeacher,6/3/2014 11:20,0,0,"# ASCO14: Sunday's Top Tweets, the @ storify slideshow by @ brianreid https://storify.com/public/templates/slideshow/index.html?src=//storify.com/brianreid/asco14-sunday-s-top-tweets#21 …",,@ @,# #21,4.73847E+17,https://twitter.com/MyelomaTeacher/status/473846754769522688,,,,
evaluatepharma,6/3/2014 11:20,1,0,# ASCO14 – Growing PD-1 uses fail to stem Bristol selloff http://ow.ly/xzscP $ BMY,,,#,4.73847E+17,https://twitter.com/evaluatepharma/status/473846734540800001,,,,
DebiopharmNews,6/3/2014 11:20,0,0,# ASCO14 # DYK High pharma investments & cancer therapies account for > 30% preclinical & phase I clinical developments http://ow.ly/xwsN1,,,# #,4.73847E+17,https://twitter.com/DebiopharmNews/status/473846656619003904,,,,
pick1998_2,6/3/2014 11:20,0,0,@ megtirrell @ ASCO Every year like this. It is called post-ASCO sell off. This year is mild because we have already seen a big correction.,,@ @,,4.73847E+17,https://twitter.com/pick1998_2/status/473846613384110080,,,,
myriadgenetics,6/3/2014 11:20,1,0,At # ASCO14? Visit Booth 2039 to learn about Myriad’s superior accuracy in # genetictesting & variant classification program! # ASCOConnection,,,# # #,4.73847E+17,https://twitter.com/myriadgenetics/status/473846575387508737,,,,
Medzineapp,6/3/2014 11:19,1,0,Induction Therapy Provides Benefit in Locally Advanced Head and Neck Cancers # ASCO14 # Hcsm # HeadNeckCancer http://bit.ly/1ktOEzs,,,# # #,4.73847E+17,https://twitter.com/Medzineapp/status/473846505649238016,,,,
CI4CC,6/3/2014 11:19,1,0,Thank you all for attending # ASCO14 # CI4CC party at the Tavern on Rush Monday night. Excited about Cancer Genomics Workshop Nov 10 SanFran,,,# #,4.73846E+17,https://twitter.com/CI4CC/status/473846463454531586,,,,
cancerassassin1,6/3/2014 11:19,0,0,"Molecular profiling -where the field is going includes: next-gen sequencing, whole exome sequencing, demystifying clinal evolution.. # ASCO14",,,#,4.73846E+17,https://twitter.com/cancerassassin1/status/473846399583268864,,,,
scientre,6/3/2014 11:19,0,1,Soria: whipping through examples of levels of evidence for markers and chemotx # ASCO14 Suggest virtual meeting if interested,,,#,4.73846E+17,https://twitter.com/scientre/status/473846399529123841,,,,
MaverickNY,6/3/2014 11:19,1,1,Wow on H&N responses in pics!! Emerging data also in gasroesophageal and pan can with Medi4736 # asco14,,,#,4.73846E+17,https://twitter.com/MaverickNY/status/473846363143565312,,,,
drsam,6/3/2014 11:19,2,0,"My favorite clinical sign: the beginning of a smile."" 96 y/o with SCCHN and great response to MEDI PD-L1. Very classy line! # ASCO14""",,,#,4.73846E+17,https://twitter.com/drsam/status/473846352934633472,,,,
OAkkerman_ERG,6/3/2014 11:18,4,4,# ASCO14 buzz for positive immunotherapy may be tipping point to shift treatment mindset @ mtmdphd @ lenstarnes http://www.environics.ca/environics-health--pharma-blog/post/68/Yervoy-Dominates-Physician-Conversations-at-ASCO …,,@ @,#,4.73846E+17,https://twitter.com/OAkkerman_ERG/status/473846305140535296,,,,
megtirrell,6/3/2014 11:17,2,1,"Nasdaq Biotech Index has avg 5% pullback following @ asco, RBC's Michael Yee tells us: http://video.cnbc.com/gallery/?video=3000280770&play=1 … # ASCO14",,@,#,4.73846E+17,https://twitter.com/megtirrell/status/473846004299468800,,,,
drsam,6/3/2014 11:17,0,0,Gross picture time! # ASCO14,,,#,4.73846E+17,https://twitter.com/drsam/status/473845992647700485,,,,
MaverickNY,6/3/2014 11:17,3,1,Sagal: good ORR in pd-l1 high pats - 39%!in NSCLC 50%!in scchn # asco14 wow on latter,,,#,4.73846E+17,https://twitter.com/MaverickNY/status/473845916924129280,,,,
drsam,6/3/2014 11:17,0,0,Is the ORR and DCR difference between PD-L1 pos vs neg tumors enough to warrant screening or do you treat everyone? # ASCO14 # ventana,,,# #,4.73846E+17,https://twitter.com/drsam/status/473845855867248641,,,,
scientre,6/3/2014 11:17,4,2,Soria: SLFN11 over expression and irinotecan & topotecan? # asco14 pic.twitter.com/I9FaNo7g5B,,,#,4.73846E+17,https://twitter.com/scientre/status/473845838050238464,,,,
ErinZwirnPR,6/3/2014 11:17,1,2,@ cure_magazine post on @ ProjectInno mission to get innovative cancer therapies to patients sooner: http://ow.ly/xuWog # ASCO14,,@ @,#,4.73846E+17,https://twitter.com/ErinZwirnPR/status/473845814058823680,,,,
nycdoc29,6/3/2014 11:16,0,0,# asco14 - RESPONCE Trial - Rux in PV - durable responses. < 15% d/c. Splenic and HcT responses. Home run! Congrats to PV pts & $ INCY,,,#,4.73846E+17,https://twitter.com/nycdoc29/status/473845802587398144,,,,
cancerassassin1,6/3/2014 11:16,0,0,Met site KRas discordancy: brain/bone> lung/liver> nodes. And also more in chemo-treated tumors. This is impt to rx approach! # ASCO14,,,#,4.73846E+17,https://twitter.com/cancerassassin1/status/473845793074339840,,,,
carisls,6/3/2014 11:16,1,0,Caris' # ASCO14 molecular profiling posters can be found online at http://www.carislifesciences.com/asco-2014/,,,#,4.73846E+17,https://twitter.com/carisls/status/473845650027970560,,,,
JoleneScience,6/3/2014 11:15,4,1,As # ASCO14 wraps up: what onc drug targets have & haven't worked so far (approved vs suspended) @ BioMedTrackerpic.twitter.com/OYF78uTC3o,,@,#,4.73845E+17,https://twitter.com/JoleneScience/status/473845496067657728,,,,
MaverickNY,6/3/2014 11:15,2,1,Sagal: case study # asco14 pic.twitter.com/FwNWg2QPI0,,,#,4.73845E+17,https://twitter.com/MaverickNY/status/473845444674863105,,,,
myCME,6/3/2014 11:15,0,0,Docetaxel + ADT ups survival in metastatic # prostatecancer http://ow.ly/xxwlT # ASCO14 # urology,,,# # #,4.73845E+17,https://twitter.com/myCME/status/473845395496644609,,,,
PhysiciansPract,6/3/2014 11:15,1,0,Great coverage of # ASCO14 by our friends at @ CancerNetwrk. Check it out. # oncology # cancer,,@,# # #,4.73845E+17,https://twitter.com/PhysiciansPract/status/473845328097996800,,,,
robinwarshaw,6/3/2014 11:14,0,0,What does high-quality cancer care look like? Experts on IOM Report | ASCO Annual Meeting http://am.asco.org/charting-new-course-system-crisis-iom-report-delivering-high-quality-cancer-care#.U43l17tpV9I.twitter … # cancer # ASCO14,,,# # #,4.73845E+17,https://twitter.com/robinwarshaw/status/473845279779594240,,,,
WCMCLymphoma,6/3/2014 11:14,1,0,Romidepsin plusLenalidomide is Well Tolerated for Patients with Relapsed Lymphoma and Myeloma # ASCO2014 http://wp.me/p1hbFd-vTE,,,#,4.73845E+17,https://twitter.com/WCMCLymphoma/status/473845273643343873,,,,
MaverickNY,6/3/2014 11:14,3,2,Sagal: waterfall plots # asco14 pic.twitter.com/7w5BCNFeBa,,,#,4.73845E+17,https://twitter.com/MaverickNY/status/473845179200589824,,,,
CI4CC,6/3/2014 11:14,0,0,# ASCO14 Thank you all for the retweets and joins over @ ASCOPost 2014! Great conference.,,@,#,4.73845E+17,https://twitter.com/CI4CC/status/473845159642546176,,,,
NitroDigital,6/3/2014 11:14,0,0,# ASCO14 finishes up today. Have you attended? What's been your biggest takeaway?,,,#,4.73845E+17,https://twitter.com/NitroDigital/status/473845107176005632,,,,
scientre,6/3/2014 11:13,1,0,Soria: Amy consensus for grading levels of evidence for clinical decision making? Slide w refs # asco14 pic.twitter.com/mdsxZGhBjk,,,#,4.73845E+17,https://twitter.com/scientre/status/473845045914009601,,,,
Jdtay04,6/3/2014 11:13,0,2,# ASCO14 rare gyn cancers just another genomic insult. Not rare to the patient s immune system. Combat cancer tolerance!,,,#,4.73845E+17,https://twitter.com/Jdtay04/status/473845035189157889,,,,
drsam,6/3/2014 11:13,5,3,Would love to see spider plots for immunotherapeutics highlight those patients whose tumors got bigger before they got smaller # ASCO14,,,#,4.73845E+17,https://twitter.com/drsam/status/473844985565945856,,,,
IONELung,6/3/2014 11:13,1,0,Ongoing consolidation chemo debate: No PFS or OS benefit from cis/docetaxel after concurrent chemo/XRt in stage III disease # lung # ASCO14,,,# #,4.73845E+17,https://twitter.com/IONELung/status/473844963466575872,,,,
cancerassassin1,6/3/2014 11:13,0,0,Molecular profiling # colorectal # cancer and KRas concordance: for first time I am seeing subset analyses by metastatic tumor site # ASCO14,,,# # #,4.73845E+17,https://twitter.com/cancerassassin1/status/473844942683389953,,,,
MaverickNY,6/3/2014 11:13,4,2,Sagal: decent durability with Medi4736 # asco14 pic.twitter.com/B6vsolg7F5,,,#,4.73845E+17,https://twitter.com/MaverickNY/status/473844938921488384,,,,
aftimosp,6/3/2014 11:13,0,1,Rationale to combine platinum + anti-PD1/PDL1 agents + PARP inh in TN # BreastCancer ? # ASCO14,,,# #,4.73845E+17,https://twitter.com/aftimosp/status/473844854955716609,,,,
MaverickNY,6/3/2014 11:12,3,0,Sagal: selected AEs # asco14 pic.twitter.com/N6zFesNWxX,,,#,4.73845E+17,https://twitter.com/MaverickNY/status/473844711279841280,,,,
AndytweetM,6/3/2014 11:12,1,0,AstraZeneca's MedImmune Presents Encouraging Immunotherapy (anti pd-L1) Data at # ASCO14 http://bit.ly/1rHCh82,,,#,4.73845E+17,https://twitter.com/AndytweetM/status/473844687556866048,,,,
MaverickNY,6/3/2014 11:11,1,0,Sagal: serious AEs # asco14 pic.twitter.com/UZVDTLtiU0,,,#,4.73845E+17,https://twitter.com/MaverickNY/status/473844528806633473,,,,
howazzat,6/3/2014 11:11,0,0,# ASCO2014 AR negative TNBC (quadruple negative) over express PD-L1 and CTLA-4 targets. Can we use them as targets?,,,#,4.73844E+17,https://twitter.com/howazzat/status/473844475383791618,,,,
scientre,6/3/2014 11:11,1,2,Soria: buckets of chemotx (cell cycle targeting agents) # asco14 pic.twitter.com/ZHimp6hNh2,,,#,4.73844E+17,https://twitter.com/scientre/status/473844451841171456,,,,
mtmdphd,6/3/2014 11:11,0,0,@ drsam My #1 take away from # ASCO14 is ImmunoOncology has moved from proof of concept to the main dev pathway... much to do but promising,,@,#1 #,4.73844E+17,https://twitter.com/mtmdphd/status/473844449143816192,,,,
nycdoc29,6/3/2014 11:11,0,0,# ASCO14 - RESPONCE Sympt response across board in Rux at week 32. d/c rate < 15% with Rux at 85 weeks,,,#,4.73844E+17,https://twitter.com/nycdoc29/status/473844401601777664,,,,
aftimosp,6/3/2014 11:11,3,1,PDL1 expression is correlated to BRCA1 mutations in triple negative # BreastCancer . Also to androgen receptor negative # ASCO14,,,# #,4.73844E+17,https://twitter.com/aftimosp/status/473844365291692033,,,,
GustaveRoussy,6/3/2014 11:11,3,1,"# ASCO14 Pr Schlumberger @ GustaveRoussy Etude sur le lenvatinib, nouvelle thérapie ciblée - # cancer de la thyroide http://bit.ly/1pP58mb",,@,# #,4.73844E+17,https://twitter.com/GustaveRoussy/status/473844306718261248,,,,
MaverickNY,6/3/2014 11:10,2,1,Sagal: tumour types in dose expansion # asco14 pic.twitter.com/fg6Q5AYpCd,,,#,4.73844E+17,https://twitter.com/MaverickNY/status/473844286476529665,,,,
MounaChampain,6/3/2014 11:10,0,0,# immunotherapy # BladderCancer # AntiPDL1 # ASCO14 # FightCancer http://www.gene.com/media/press-releases/14566/2014-05-31/investigational-immunotherapy-anti-pdl1- …,,,# # # # #,4.73844E+17,https://twitter.com/MounaChampain/status/473844208764456960,,,,
DebiopharmNews,6/3/2014 11:10,0,0,"# ASCO14 Phase I basket study Debio1347, # FGFR inhibitor in solid # tumors (abstract/poster # TPS2629) Find out more http://ow.ly/xwszp",,,# # # #,4.73844E+17,https://twitter.com/DebiopharmNews/status/473844135800369152,,,,
asembiarx,6/3/2014 11:10,0,0,Not at # ASCO14? YOu should at least read their report from March of this year: http://jop.ascopubs.org/content/early/2014/03/10/JOP.2014.001386 …,,,#,4.73844E+17,https://twitter.com/asembiarx/status/473844087737843712,,,,
MaverickNY,6/3/2014 11:10,0,0,Sagal: on Medi4736 dose expansion # asco14 pic.twitter.com/Nd410HpQb5,,,#,4.73844E+17,https://twitter.com/MaverickNY/status/473844080209063937,,,,
scientre,6/3/2014 11:10,1,1,Kris interesting reference # asco14 pic.twitter.com/YG8BQWblgv,,,#,4.73844E+17,https://twitter.com/scientre/status/473844075268169728,,,,
cancerassassin1,6/3/2014 11:09,0,1,Re:profiling of # colorectal # cancer: haven't heard anything at # ASCO14 about KRas G13D subset responses and follow-up. @ yzafar @ skopetz,,@ @,# # #,4.73844E+17,https://twitter.com/cancerassassin1/status/473844046197440513,,,,
nycdoc29,6/3/2014 11:09,0,0,# ASCO14 - CHR 23% in Rux v 8% in BAT at week 32. RESPONCE trial in PCV,,,#,4.73844E+17,https://twitter.com/nycdoc29/status/473843972235091968,,,,
scientre,6/3/2014 11:09,5,2,Kris: oppty to add chemo to immunooncology drugs. Slide has potl + incl inc antigens # asco14 pic.twitter.com/Gpm0jB1UJN,,,#,4.73844E+17,https://twitter.com/scientre/status/473843886809690112,,,,
jrzalcberg,6/3/2014 11:08,2,0,# ASCO14 The biomarker story in colorectal cancer is clearly maturing which will undoubtedly improve options for personalized therapy for pts,,,#,4.73844E+17,https://twitter.com/jrzalcberg/status/473843782056947713,,,,
MyelomaTeacher,6/3/2014 11:08,0,0,# Myeloma Hope at # ASCO14 # mmsm http://myelomahope.blogspot.co.il/2014/06/my-life-is-worth-it.html?m=1 …,,,# # #,4.73844E+17,https://twitter.com/MyelomaTeacher/status/473843777631944704,,,,
chicagocapman,6/3/2014 11:08,1,0,ANOTHER GREAT # ASCO14! Thanks to all our fabulous baristas and wonderful clients!!!,,,#,4.73844E+17,https://twitter.com/chicagocapman/status/473843737341083649,,,,
MaverickNY,6/3/2014 11:08,2,0,Lutzky: rapid and durable responses in melanoma. Not much efficacy data. # asco14 too early,,,#,4.73844E+17,https://twitter.com/MaverickNY/status/473843692827336704,,,,
nycdoc29,6/3/2014 11:08,0,0,# ASCO14 - 3x > Pheb in BAT arm vs Rux at week 32,,,#,4.73844E+17,https://twitter.com/nycdoc29/status/473843594705780736,,,,
adeeconda,6/3/2014 11:08,0,0,A very promising avenue to treat the most advanced tumors “ @ rschilsky: Immune therapy revolution continues. # ASCO14 http://www.usatoday.com/story/news/nation/2014/06/02/cancer-immune-therapy/9775005/ …”,,@,#,4.73844E+17,https://twitter.com/adeeconda/status/473843589848768512,,,,
AlpineBV_Miller,6/3/2014 11:07,0,1,Anyone else pleasantly surprised by the $ EXEL cabozantinib+erlotinib data in erlotinib NSCLC progressors? # ASCO14,,,#,4.73844E+17,https://twitter.com/AlpineBV_Miller/status/473843507401355264,,,,
nycdoc29,6/3/2014 11:07,1,0,# ASCO14 - RESPONSE almost everyone crossed over from BAT arm to Rux. 60% pts in Rux arm had HcT control,,,#,4.73843E+17,https://twitter.com/nycdoc29/status/473843327285334017,,,,
MaverickNY,6/3/2014 11:06,1,1,Lutzky: drug related events of interest include colitis and hyperglycemia # asco14 pic.twitter.com/jtAYs2kKWN,,,#,4.73843E+17,https://twitter.com/MaverickNY/status/473843263108292608,,,,
MyelomaTeacher,6/3/2014 11:06,0,0,MT “@ArielaLMarshall: # ASCO14 new addition 2 # myeloma treatment options - # Panobinostat added to velcade/dex http://meetinglibrary.asco.org/content/125334-144 …”,,@ArielaLMarshall,# # #,4.73843E+17,https://twitter.com/MyelomaTeacher/status/473843116202799105,,,,
FierceBiotech,6/3/2014 11:05,4,0,"Join @ FiercePharma's @ EricPFierce & @ EPVantage's @ JonEPVantage Thurs, 2pm ET for an # ASCO14 chat. http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … Follow # FierceASCO.",,@ @ @ @,# #,4.73843E+17,https://twitter.com/FierceBiotech/status/473842996941963264,,,,
MaverickNY,6/3/2014 11:05,1,0,Lutzky: adverse events # asco14 pic.twitter.com/7MzGR2nlRO,,,#,4.73843E+17,https://twitter.com/MaverickNY/status/473842891035783168,,,,
Cognicum,6/3/2014 11:05,1,1,“ @ Roche: Investing in tomorrow's leading scientists http://ow.ly/xp88e # ASCO14 # meded” https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,# #,4.73843E+17,https://twitter.com/Cognicum/status/473842816758849537,,,,
scientre,6/3/2014 11:04,1,0,Kris: which has more toxicity: oncoprotein or chemo (cell cycle targeted)? Notes caveats incl length of tx # asco14 pic.twitter.com/iwkwUZtXI9,,,#,4.73843E+17,https://twitter.com/scientre/status/473842741294927874,,,,
drsam,6/3/2014 11:04,1,1,Anyone know - Is the Medi data the first look we will have at PD-L1 or any checkpoint inhibitor in pancreas cancer? # ASCO14,,,#,4.73843E+17,https://twitter.com/drsam/status/473842739641987074,,,,
MaverickNY,6/3/2014 11:04,1,0,Lutzky: dose expansion cohorts # asco14 pic.twitter.com/yl3OFbQ1B5,,,#,4.73843E+17,https://twitter.com/MaverickNY/status/473842629395120129,,,,
brunorbastos,6/3/2014 11:04,1,0,Jornalzinho do último dia da # ASCO14 great meeting. See you next year! pic.twitter.com/E84vyxf1Kf,,,#,4.73843E+17,https://twitter.com/brunorbastos/status/473842576923963393,,,,
MartinStockler,6/3/2014 11:04,0,0,Developmental therapeutics orals standing room only! # ASCO14,,,#,4.73843E+17,https://twitter.com/MartinStockler/status/473842556459954179,,,,
Cognicum,6/3/2014 11:03,0,0,"“ @ Novartis: Starting now at # ASCO14 in E354a: new Phase III data in # polycythemiavera, an incurable # bloodcancer https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …",,@,# # #,4.73843E+17,https://twitter.com/Cognicum/status/473842539276283905,,,,
cancerassassin1,6/3/2014 11:03,0,0,@ skopetz: Re: # colorectal # cancer discordancy: real question is choosing EGFR rx: based on KRas status of primary tumor or met? # ASCO14,,@,# # #,4.73842E+17,https://twitter.com/cancerassassin1/status/473842425140490241,,,,
scientre,6/3/2014 11:03,0,0,"Kris mentions vigorous discussion yday session, rather than focus on if glass half full vs empty, need to use what is in the glass # ASCO14",,,#,4.73842E+17,https://twitter.com/scientre/status/473842310820941824,,,,
DiplomatRx,6/3/2014 11:02,1,1,# ASCO14 has been a great experience – thanks for a well-run conference! @ ASCO,,@,#,4.73842E+17,https://twitter.com/DiplomatRx/status/473842243577839616,,,,
abbottmd,6/3/2014 11:02,0,0,A Changing Practice: The Controversy Over Obligations to Return Incidental Findings in Genomic Sequencing http://ow.ly/xxSWK # ASCO14,,,#,4.73842E+17,https://twitter.com/abbottmd/status/473842225965961216,,,,
mtmdphd,6/3/2014 11:02,0,2,Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlYwT,,@,#,4.73842E+17,https://twitter.com/mtmdphd/status/473842212300935168,,,,
MaverickNY,6/3/2014 11:02,1,1,Lutzky: dose escalation and treatment schema # asco14 pic.twitter.com/tPQkvPgl95,,,#,4.73842E+17,https://twitter.com/MaverickNY/status/473842190566035456,,,,
djsampson,6/3/2014 11:02,0,0,Take the train. # asco14 pic.twitter.com/j9Zq1wlgXl,,,#,4.73842E+17,https://twitter.com/djsampson/status/473842143392722944,,,,
CancerTherAdvsr,6/3/2014 11:02,1,0,RT @ mtmdphd: # ASCO14 Combo Rx Dev - Crowd comment - Preclinical doesn't always play out clinically. Pharmacology includes understanding...,,@,#,4.73842E+17,https://twitter.com/CancerTherAdvsr/status/473842137629753344,,,,
Roche,6/3/2014 11:02,5,4,With # diagnostic tests in development you can see multiple genetic defects in the same tumour cell. http://ow.ly/xp833 # ASCO14,,,# #,4.73842E+17,https://twitter.com/Roche/status/473842116914073600,,,,
bmsnews,6/3/2014 11:02,3,2,"Phase 1 combination data from our pipeline in # lung cancer presented today at 11:30 am CDT, E354b # ASCO14",,,# #,4.73842E+17,https://twitter.com/bmsnews/status/473842064254566401,,,,
Roche,6/3/2014 11:02,1,3,Investing in tomorrow's leading scientists http://ow.ly/xp88e # ASCO14 # meded,,,# #,4.73842E+17,https://twitter.com/Roche/status/473842060941090816,,,,
NCIGlobalHealth,6/3/2014 11:02,2,1,"Dr. # Mutyaba presents research, supported through CGH and BIG CAT grant, at African Cancer Forum during # ASCO14 pic.twitter.com/bnDpCpP9pf",,,# #,4.73842E+17,https://twitter.com/NCIGlobalHealth/status/473842053986922496,,,,
DebiopharmNews,6/3/2014 11:01,0,0,"# ASCO14 Clinical PK/PD model for Debio 1143, antagonist of IAPs in # cancer (abstract/poster #2585) Find out more http://ow.ly/xwssi",,,# # #2585,4.73842E+17,https://twitter.com/DebiopharmNews/status/473841997833592832,,,,
scientre,6/3/2014 11:01,1,2,"Kris running through examples of chemo in combo w oncogene tx (here EGFR, also ALK) # asco14 pic.twitter.com/s9NCPVsXwh",,,#,4.73842E+17,https://twitter.com/scientre/status/473841943609630721,,,,
MaverickNY,6/3/2014 11:01,1,0,Next is Lutzky on Medi-4736 anti PD-L1 ph 1 solid tumours # asco14,,,#,4.73842E+17,https://twitter.com/MaverickNY/status/473841897879130112,,,,
JanssenUS,6/3/2014 11:01,0,1,Dr. O’Brien discusses long-term results from a pooled analysis in # leukemia 11:33 am CT (E354a) # ASCO14 http://jan4.me/1rtbNXN,,,# #,4.73842E+17,https://twitter.com/JanssenUS/status/473841839397535746,,,,
mtmdphd,6/3/2014 11:01,2,0,"MT @ cancerassassin1: @ skopetz: KRas concordance decr to ~65% in Tx;d colorectal # cancer met to lung, brain, peritoneum, bone. # ASCO14 # crcsm",,@ @,# # #,4.73842E+17,https://twitter.com/mtmdphd/status/473841838580064257,,,,
CancerResearch,6/3/2014 11:01,1,1,Start # CIM right with the definition of # immunotherapy: # CIM2014 # ASCO14 http://ow.ly/xyACM,,,# # # #,4.73842E+17,https://twitter.com/CancerResearch/status/473841836906512384,,,,
aftimosp,6/3/2014 11:01,0,0,Lymphocyte predominant # BreastCancer : > 50% TILs (iTILS or sTILs) intraepithelial and stromal # ASCO14,,,# #,4.73842E+17,https://twitter.com/aftimosp/status/473841809442234368,,,,
cariknits,6/3/2014 11:00,0,0,"@ AdamsLisa @ ASCO Happy that you are strong enough, well enough to tweet and share valuable info!",,@ @,,4.73842E+17,https://twitter.com/cariknits/status/473841702562975745,,,,
Novartis,6/3/2014 11:00,8,3,"# Novartis announces first-ever pivotal Phase III results in # polycythemiavera, an incurable # bloodcancer # ASCO2014 http://bit.ly/SqjwWF",,,# # # #,4.73842E+17,https://twitter.com/Novartis/status/473841694941913089,,,,
nycdoc29,6/3/2014 11:00,0,1,# ASCO14 - RESPONSE data in e354 - Rux in PCV,,,#,4.73842E+17,https://twitter.com/nycdoc29/status/473841667737661441,,,,
survivornetca,6/3/2014 11:00,3,2,RT @ ProstatePost RT @ sloan_kettering: MSK's Michael J.Morris on Benefits of early chemo on # prostatecancer http://nyti.ms/1hMF4Df # ASCO14,,@ @,# #,4.73842E+17,https://twitter.com/survivornetca/status/473841637857050625,,,,
cancerassassin1,6/3/2014 11:00,2,0,Re: # colorectal # cancer discordancy: real question is in choosing EGFR rx: choose based on KRas status of primary tumor or met? # ASCO14,,,# # #,4.73842E+17,https://twitter.com/cancerassassin1/status/473841631175528448,,,,
Cascadia,6/3/2014 11:00,4,2,# ASCO14 # hdpalooza is @ PCORI National Research Network game changer 3Vs + 3Ps = 3Rs. pic.twitter.com/81BMr6tUEp HT @sleepapneabook,,@ @sleepapneabook,# #,4.73842E+17,https://twitter.com/Cascadia/status/473841627078066176,,,,
FoundationATCG,6/3/2014 11:00,1,1,Understand the difference between comprehensive and “hot-spot” # Nextgensequencing Video: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# # #,4.73842E+17,https://twitter.com/FoundationATCG/status/473841626927104001,,,,
howazzat,6/3/2014 11:00,0,0,# ASCO2014 sTILs and iTILs are predictive of pCR to neoadjuvant platinum based chemotherapy in TNBC,,,#,4.73842E+17,https://twitter.com/howazzat/status/473841601534758912,,,,
ProstatePost,6/3/2014 11:00,1,0,RT @ sloan_kettering: MSK's Michael J. Morris discusses findings & benefits of early chemo on # prostatecancer http://nyti.ms/1hMF4Df # ASCO14,,@,# #,4.73842E+17,https://twitter.com/ProstatePost/status/473841601328861184,,,,
MayoCancerCare,6/3/2014 11:00,1,0,"ALTTO Test of Dual HER2 Blockade Finds Single Agent, Trastuzumab, Remains Gold Standard: http://mayocl.in/1jNvvnh # ASCO14 # BreastCancer",,,# #,4.73842E+17,https://twitter.com/MayoCancerCare/status/473841569762902016,,,,
BRCAresponder,6/3/2014 10:59,0,0,# ASCO14 Forbes Magazine Cancer Conference Winners And Losers http://pinterest.com/pin/539939442798532076/ …,,,#,4.73842E+17,https://twitter.com/BRCAresponder/status/473841522417602561,,,,
MyelomaTeacher,6/3/2014 10:59,1,0,Register now 4 @ BrianDurieMD 's Post # ASCO14 # iMWG14 # EHA14 webcast @ imfmyeloma # myeloma # mmsm https://online.myeloma.org/NetCommunity/myeloma-updates-2014-post-asco/eha/imwg?erid=4350431&trid=9e49b154-eaae-4455-b746-5a1b806a6e5e …,,@ @,# # # # #,4.73841E+17,https://twitter.com/MyelomaTeacher/status/473841493925306369,,,,
drsam,6/3/2014 10:59,3,2,"In the Pembro swimmers plot, it looks as if every patient is swimming strong and could win the race! # ASCO14 # merck",,,# #,4.73841E+17,https://twitter.com/drsam/status/473841413247873024,,,,
scientre,6/3/2014 10:59,0,0,"Kris discussing NEOSPHERE breast cancer trial, similar design (neoadjuvant), diff drugs # ASCO14",,,#,4.73841E+17,https://twitter.com/scientre/status/473841362740445184,,,,
MaverickNY,6/3/2014 10:59,4,4,Hamid: pembrolizumab conclusions # asco14 pic.twitter.com/ubsFEDieSG,,,#,4.73841E+17,https://twitter.com/MaverickNY/status/473841360878186496,,,,
News_Biotech,6/3/2014 10:59,0,0,ASCO spotlight burns Puma shares http://bit.ly/1ktKmIk # ASCO2014,,,#,4.73841E+17,https://twitter.com/News_Biotech/status/473841347338588160,,,,
aftimosp,6/3/2014 10:59,2,0,4 significant immune cell types associated with pCR. Most significant was activated memory CD4 T cells # BreastCancer # ASCO14,,,# #,4.73841E+17,https://twitter.com/aftimosp/status/473841297993003010,,,,
darthclue,6/3/2014 10:59,0,1,"The information coming out of @ asco # ASCO14 gives me hope. And given how this week is going, I need a lot of that right now.",,@,#,4.73841E+17,https://twitter.com/darthclue/status/473841286420889600,,,,
cancerassassin1,6/3/2014 10:58,0,0,"Kopetz: KRas concordance primary vs mets decreases to ~65% in treated colorectal # cancer mets to lung, brain, peritoneum, bone. # ASCO14",,,# #,4.73841E+17,https://twitter.com/cancerassassin1/status/473841194108080128,,,,
MaverickNY,6/3/2014 10:58,1,0,Hamid: PFS CURVES for pembrolizumab # asco14 pic.twitter.com/gj8NL61WAo,,,#,4.73841E+17,https://twitter.com/MaverickNY/status/473841178845405184,,,,
drsam,6/3/2014 10:58,0,0,"@ MaverickNY : not only will you have feet problems from # blisterwalk, you could be at risk for # twitterfinger # ASCO14",,@,# # #,4.73841E+17,https://twitter.com/drsam/status/473841076088754176,,,,
scientre,6/3/2014 10:57,1,1,Kris NEOSCAN trial neoadjuvant switch therapy guided by PET response # asco14 didn't see path CR they wanted pic.twitter.com/pLgM4LKKVu,,,#,4.73841E+17,https://twitter.com/scientre/status/473840961286856704,,,,
drsam,6/3/2014 10:57,0,2,Interesting difference in immune related AEs between Ipi-naive and Ipi-refractory pts in response to Pembro. Interesting biology? # ASCO14,,,#,4.73841E+17,https://twitter.com/drsam/status/473840851450224640,,,,
VerityStream,6/3/2014 10:57,1,1,The Winners and Losers from the annual # cancer # conference # ASCO14 http://hub.am/1ub1m98 via @ Forbes,,@,# # #,4.73841E+17,https://twitter.com/VerityStream/status/473840781997142018,,,,
cancerassassin1,6/3/2014 10:56,0,0,"Kopetz: KRas concordance decreases to ~65% in chemo-treated colorectal # cancer metastasizing to lung, brain, peritoneum, bone. # ASCO14",,,# #,4.73841E+17,https://twitter.com/cancerassassin1/status/473840697192103936,,,,
t_andreiu,6/3/2014 10:56,2,3,It's is seriously cool seeing a Standing-Room Only Developmental Therapeutics/Immunotherapy session! # ASCO14,,,#,4.73841E+17,https://twitter.com/t_andreiu/status/473840690938388480,,,,
MaverickNY,6/3/2014 10:56,1,0,Hamid: 4% CR in ipi-N ORR 33-40% depending on dose. 26% in ipi-R # asco14,,,#,4.73841E+17,https://twitter.com/MaverickNY/status/473840673272389632,,,,
aftimosp,6/3/2014 10:56,0,1,Incremental increase in TILs is associated with improvement in response to neoadjuvant chemo (platinum based) in TN#BreastCancer # ASCO14,,,#BreastCancer #,4.73841E+17,https://twitter.com/aftimosp/status/473840595640016896,,,,
AdoorAmanullah,6/3/2014 10:55,0,0,ALTTO Disappoints Clinicians and Upends Research http://www.medscape.com/viewarticle/826077 … # asco14,,,#,4.7384E+17,https://twitter.com/AdoorAmanullah/status/473840497753325568,,,,
Novartis,6/3/2014 10:55,1,4,"Starting now at # ASCO14 in E354a: new Phase III data in # polycythemiavera, an incurable # bloodcancer http://bit.ly/1i93rtE",,,# # #,4.7384E+17,https://twitter.com/Novartis/status/473840352630419456,,,,
MaverickNY,6/3/2014 10:55,1,0,Hamid: immune related AEs include hypothyroidism and colitis # asco14 pic.twitter.com/5FS7yELLLe,,,#,4.7384E+17,https://twitter.com/MaverickNY/status/473840301262790656,,,,
cancerassassin1,6/3/2014 10:54,0,0,"Kopetz: KRas concordance decreases to ~65% in treated colorectal # cancer metastasizing to lung, brain, peritoneum, bone. # ASCO14",,,# #,4.7384E+17,https://twitter.com/cancerassassin1/status/473840266856501248,,,,
duemed,6/3/2014 10:54,0,0,"“ @ drdonsdizon: Big theme at # ASCO14, even in midst of progress- Balance innovation w access. Everyone w cancer deserves this.” Agree!,",,@,#,4.7384E+17,https://twitter.com/duemed/status/473840157876297728,,,,
drsam,6/3/2014 10:54,5,3,Watching @ MaverickNY at work in the front row of S100a at # ASCO14. She's a machine. Camera in one hand and iPhone in the other.,,@,#,4.7384E+17,https://twitter.com/drsam/status/473840104730292224,,,,
scientre,6/3/2014 10:54,1,1,"Kris: things we can do better, using major pathological response as surrogate in neoadjuvant setting # asco14 pic.twitter.com/acDUkvAmk1",,,#,4.7384E+17,https://twitter.com/scientre/status/473840052511191040,,,,
MaverickNY,6/3/2014 10:53,1,1,Hamid: summary of pembrolizumab exposure # asco14 pic.twitter.com/KNlehBjrho,,,#,4.7384E+17,https://twitter.com/MaverickNY/status/473840007053324289,,,,
cglifeagency,6/3/2014 10:53,1,0,Check out our latest # Chemunity for a look at some of the big developments emerging at # ASCO14 http://bit.ly/1iPimuw # Cancer,,,# # #,4.7384E+17,https://twitter.com/cglifeagency/status/473840000488861696,,,,
lrlee,6/3/2014 10:53,1,0,MT @ AdamsLisa: If you/loved one has cancer @ ASCO meeting going on for last few days. Check their feed for latest updates on clinical onco,,@ @,,4.7384E+17,https://twitter.com/lrlee/status/473839979722833921,,,,
drecroach,6/3/2014 10:53,0,0,How many will attend the Best of Asco meetings? How would you rate them in value? # ASCO2014 http://bit.ly/1oS8mId,,,#,4.7384E+17,https://twitter.com/drecroach/status/473839955144634368,,,,
scientre,6/3/2014 10:52,1,2,Kris keeps mentioning that a genomic guy...timeline for chemotx (cell cycle targeted agents) # asco14 pic.twitter.com/dnjPxLCkTC,,,#,4.7384E+17,https://twitter.com/scientre/status/473839701359861760,,,,
drsam,6/3/2014 10:52,0,0,"@ drsam: Good on # Merck for doing randomized dose finding with Pembro. We need more randomized dose ranging in onc studies, IMHO. # ASCO14",,@,# #,4.7384E+17,https://twitter.com/drsam/status/473839663711395840,,,,
yzafar,6/3/2014 10:52,1,0,It's not just cost MT @ drdonsdizon: # ASCO14 theme in midst of progress- Balance innovation w access. Everyone w cancer deserves this. @ ASCO,,@ @,#,4.7384E+17,https://twitter.com/yzafar/status/473839597781524480,,,,
MaverickNY,6/3/2014 10:52,1,0,Hamid: Keynote001 study design # asco14 pic.twitter.com/fQ1KhZ3Y0k,,,#,4.7384E+17,https://twitter.com/MaverickNY/status/473839526033756162,,,,
AdamsLisa,6/3/2014 10:51,5,7,I know I am tweeting a lot of cancer info and chatter today. The @ asco # ASCO14 conference is good reason for met patient perspective I think,,@,#,4.73839E+17,https://twitter.com/AdamsLisa/status/473839488889028608,,,,
AnneBooms,6/3/2014 10:51,0,0,# ASCO14 Bakitas promoting ANPs to talk PC to Oncology Patients at time of advanced disease diagnosis resulting in better QOL,,,#,4.73839E+17,https://twitter.com/AnneBooms/status/473839467485085696,,,,
drmikesevilla,6/3/2014 10:51,3,1,Shout out to @ mtmdphd & everyone else tweeting out at # ASCO14 conference: American Society of Clinical Oncology http://am.asco.org,,@,#,4.73839E+17,https://twitter.com/drmikesevilla/status/473839421465563136,,,,
scientre,6/3/2014 10:51,2,1,Kris referring to chemotx as Cell Cycle Targeted Agents... The targeting is resp for on and off target tox # asco14 pic.twitter.com/G3Px9O2qUa,,,#,4.73839E+17,https://twitter.com/scientre/status/473839394089353216,,,,
preventcancer,6/3/2014 10:51,0,1,The Prevent Cancer Foundation was pleased to participate in the 50th annual # ASCO14 conference in Chicago this year. pic.twitter.com/Gx2T10idZK,,,#,4.73839E+17,https://twitter.com/preventcancer/status/473839339315920896,,,,
mtmdphd,6/3/2014 10:50,1,1,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ BrianReid @ MDigitalLife http://ow.ly/xzFWa # ASCO14,,@ @,#,4.73839E+17,https://twitter.com/mtmdphd/status/473839179202572288,,,,
MediTech_Media,6/3/2014 10:50,0,0,"Chemo drugs work, you just have to know how/when to use them. Dr Kris # ASCO14",,,#,4.73839E+17,https://twitter.com/MediTech_Media/status/473839172428386304,,,,
MaverickNY,6/3/2014 10:50,2,2,Hamid: nice mention of @ richardwjoseph poster yesterday # asco14,,@,#,4.73839E+17,https://twitter.com/MaverickNY/status/473839121748992000,,,,
DebiopharmNews,6/3/2014 10:50,0,0,# ASCO14 Phase I/II Debio 1143 combo with CCRT in # patients with # HNSCN (abstract/poster # TPS6097) Find out more http://ow.ly/xwsiu,,,# # # #,4.73839E+17,https://twitter.com/DebiopharmNews/status/473839095668822017,,,,
BRCAresponder,6/3/2014 10:50,0,1,@ CRC_Medical one of a kind # medical book # BRCA # hereditarycancer # mustread http://www.amazon.com/Letters-Doctors-Educating-Professionals-Experiences/dp/1939776295/ref=sr_1_1?ie=UTF8&qid=1401806807&sr=8-1&keywords=letters+to+doctors … @ ASCO # ASCO14,,@ @,# # # # #,4.73839E+17,https://twitter.com/BRCAresponder/status/473839084277084160,,,,
drsam,6/3/2014 10:49,0,0,@ OmidHamidMD presenting Merck PD-1 data. Not only a great doc and presenter but sharpest dressed man in the room with best glasses. # ASCO14,,@,#,4.73839E+17,https://twitter.com/drsam/status/473838982959087617,,,,
scientre,6/3/2014 10:49,3,2,Kris: this is what I usually do (lung cancer genomic slide) # asco14 see for recent ref w updated data pic.twitter.com/oEDD6aL2l6,,,#,4.73839E+17,https://twitter.com/scientre/status/473838897051762688,,,,
drsam,6/3/2014 10:48,4,2,5 years ago," a Tuesday morning session on immunotherapy would have 20 people attending."" Today"," SRO. # ASCO14""",,,#,4.73839E+17,https://twitter.com/drsam/status/473838538488676356,,
scientre,6/3/2014 10:48,0,0,"Kris: our goal shouldn't be to get rid of chemotx, should be to cure our pts using what drugs work. # asco14",,,#,4.73839E+17,https://twitter.com/scientre/status/473838522139701248,,,,
myPathMelanoma,6/3/2014 10:47,1,0,Last day of # ASCO14 did you miss our data? Learn more at http://isthismelanoma.com # melanoma # myriad,,,# # #,4.73838E+17,https://twitter.com/myPathMelanoma/status/473838449913368577,,,,
christinemphmd,6/3/2014 10:46,0,0,The price of add'l month of survival time inc by $600/yr (p=0.02). # ASCO14 http://tinyurl.com/ow4b65x # financialtoxicitypic.twitter.com/z6uhwJptGq,,,# #,4.73838E+17,https://twitter.com/christinemphmd/status/473838224365084672,,,,
cancerassassin1,6/3/2014 10:46,25,14,#1 thing I learned at # ASCO14: we have more technology than ever to test tumors but need more knowledge how to effectively apply this info.,,,#1 #,4.73838E+17,https://twitter.com/cancerassassin1/status/473838215304978433,,,,
AlpineBV_Miller,6/3/2014 10:45,0,0,@ MaverickNY @ ASCO Can you set up overflow room? # ASCO14,,@ @,#,4.73838E+17,https://twitter.com/AlpineBV_Miller/status/473837953819893761,,,,
mayocliniclabs,6/3/2014 10:45,0,0,Visit S406 to learn about molecular subtyping of colon cancers and distinct prognostic groups. # ASCO14,,,#,4.73838E+17,https://twitter.com/mayocliniclabs/status/473837899763707904,,,,
drdonsdizon,6/3/2014 10:45,2,1,"At end of # ASCO14 Define relative value of cancer Rx: Consider 3 things: efficacy, side effects, & cost. @ ASCO @ yzafar",,@ @,#,4.73838E+17,https://twitter.com/drdonsdizon/status/473837809489301504,,,,
ASCO,6/3/2014 10:45,1,1,@ subatomicdoc discusses 6 key ways we can make lung cancer screening possible http://bit.ly/SqinhW # LCSM # ASCO14,,@,# #,4.73838E+17,https://twitter.com/ASCO/status/473837792062361600,,,,
drFabioYMoraes,6/3/2014 10:45,0,0,"My first poster at ASCO Meeting. Felling great . Thanks Katz,MD; Santini,MD! # ASCO14 # ascoChicago # ASCOActionpic.twitter.com/Iu0j0pQzDH",,,# # #,4.73838E+17,https://twitter.com/drFabioYMoraes/status/473837779559124992,,,,
howazzat,6/3/2014 10:44,1,1,"# ASCO2014 Last day today, at oral breast abstract cancer session.",,,#,4.73838E+17,https://twitter.com/howazzat/status/473837640006250496,,,,
MaverickNY,6/3/2014 10:44,0,0,@ OmidHamidMD is first up on MK-3475 in ipi refractory and naive melanoma # asco14,,@,#,4.73838E+17,https://twitter.com/MaverickNY/status/473837632422969344,,,,
CecilioCastro,6/3/2014 10:43,2,1,"RT @ agencia_sinc: # ASCO14, el mayor congreso mundial del cáncer, revela nuevos logros en inmunoterapia http://flip.it/nKMPz",,@,#,4.73837E+17,https://twitter.com/CecilioCastro/status/473837495776706560,,,,
CitelineMegC,6/3/2014 10:43,1,0,@ citeline has a new blog up! # Immunotherapies at # ASCO2014 –Look Past PD1 and PDL1 http://bit.ly/SVNyCm,,@,# #,4.73837E+17,https://twitter.com/CitelineMegC/status/473837427535388672,,,,
OpenCancer,6/3/2014 10:42,0,1,White House blog featuring @ OpenCancer http://m.whitehouse.gov/blog/2014/03/20/geeksgetcovered-unleashing-entrepreneurship-through-affordable-healthcare-0 … # ASCO14 # HDPalooza # cancer # bigdata # opengov,,@,# # # # #,4.73837E+17,https://twitter.com/OpenCancer/status/473837207388962817,,,,
drsam,6/3/2014 10:42,0,0,I spy Merck and MedImmune senior clinical leadership in front rows of S100a ... Very exciting! # ASCO14,,,#,4.73837E+17,https://twitter.com/drsam/status/473837173418913792,,,,
drdonsdizon,6/3/2014 10:42,8,2,"Big theme at # ASCO14, even in midst of progress- Balance innovation w access. Everyone w cancer deserves this. # ASCO14 @ yzafar agree?",,@,# #,4.73837E+17,https://twitter.com/drdonsdizon/status/473837161016356864,,,,
twittmanda,6/3/2014 10:41,0,0,@ DrAttai @ ASCO Safe travels! Thanks so much for the tweets and your perspective!,,@ @,,4.73837E+17,https://twitter.com/twittmanda/status/473836970385227777,,,,
MaverickNY,6/3/2014 10:41,0,0,And Dev Therapeutics is full already. Air is buzzing and electric! # asco14,,,#,4.73837E+17,https://twitter.com/MaverickNY/status/473836969349636096,,,,
ByJonGardner,6/3/2014 10:41,1,0,And $ CLVS down another 15%? I thought the CEO had put all fears to rest in his CNBC itw yesterday. Hmm. # ASCO14,,,#,4.73837E+17,https://twitter.com/ByJonGardner/status/473836826344837121,,,,
AlpineBV_Miller,6/3/2014 10:41,0,0,S100a filling to overflowing. # ASCO14,,,#,4.73837E+17,https://twitter.com/AlpineBV_Miller/status/473836753934352384,,,,
jrgralow,6/3/2014 10:40,2,1,. @ drdonsdizon on HPV-targeted immunotherapy in cervical cancer # ASCO14 http://ow.ly/xzDNe,,@,#,4.73837E+17,https://twitter.com/jrgralow/status/473836639589249025,,,,
DebiopharmNews,6/3/2014 10:40,0,0,# ASCO14 Phase I study Debio 1143 combo in # patients # leukemia # bloodcancer (abstract/poster #7029) Find out more http://ow.ly/xwrHA,,,# # # # #7029,4.73837E+17,https://twitter.com/DebiopharmNews/status/473836579447128064,,,,
TuftsB,6/3/2014 10:40,0,0,"@ CliffordHudis @ ASCO -what value:"" do admins provide? ASCO bureaucrats in bed with insurance lobby at patients expense # mliwi # asco14""",,@ @,# #,4.73837E+17,https://twitter.com/TuftsB/status/473836560421769216,,,,
drsam,6/3/2014 10:39,0,0,Standing room only for development therapeutics/immunotherapeutics # ASCO14,,,#,4.73836E+17,https://twitter.com/drsam/status/473836361191919618,,,,
DrHedrick,6/3/2014 10:39,2,2,@ HelpWithMyeloma @ mtmdphd Interesting data. However I think we have reached maximum consonant/vowel ratio in these drug names. # ASCO14,,@ @,#,4.73836E+17,https://twitter.com/DrHedrick/status/473836333790941184,,,,
HemOncToday,6/3/2014 10:39,1,1,# ASCO14 # ALTTO: # Lapatinib did not improve outcomes for HER-2–positive # BreastCancer @ EdithPerezMD @ MayoClinic http://goo.gl/KGqR0J,,@ @,# # # #,4.73836E+17,https://twitter.com/HemOncToday/status/473836306423091201,,,,
GoHealio,6/3/2014 10:39,1,0,# ASCO14 # ALTTO: # Lapatinib did not improve outcomes for HER-2–positive # BreastCancer @ EdithPerezMD @ MayoClinic http://goo.gl/KGqR0J,,@ @,# # # #,4.73836E+17,https://twitter.com/GoHealio/status/473836305408069632,,,,
DrMisialek,6/3/2014 10:39,2,0,Expanded Health Coverage May Improve Cancer Outcomes in Young Adults: http://www.bostonmagazine.com/health/blog/2014/06/02/expanded-health-coverage-may-improve-cancer-outcomes-young-adults-study-says/#.U43dvqj1BSM.twitter … @ HubHealth @ DanaFarber @ harvardmed # ASCO14,,@ @ @,# #,4.73836E+17,https://twitter.com/DrMisialek/status/473836300907597824,,,,
drcbsteer,6/3/2014 10:37,0,1,@ Gazulides @ jrzalcberg Tweet appeared onscreen at morning review session. # ASCO14 pic.twitter.com/H5EfdGt2bq,,@ @,#,4.73836E+17,https://twitter.com/drcbsteer/status/473835856931745794,,,,
ASCO,6/3/2014 10:37,2,1,@ drdonsdizon questions preventative med in patients w/ metastatic cancer during # ASCO14 http://bit.ly/1nKUH6g # bcsm # ASCOconnection,,@,# # #,4.73836E+17,https://twitter.com/ASCO/status/473835830470275072,,,,
SkinMelanoma,6/3/2014 10:37,0,1,"New # ASCO14 data confirms the previous validation study, DecisionDx-Melanoma helps refine prognosis for node-negative Stage1&2 # melanoma pts",,,# #,4.73836E+17,https://twitter.com/SkinMelanoma/status/473835780981260289,,,,
adeyanjubiodun,6/3/2014 10:37,0,0,# ASCO14 are we winning the war against cancer or are we still waiting for the Big Bang?,,,#,4.73836E+17,https://twitter.com/adeyanjubiodun/status/473835772366585856,,,,
CancerNetwrk,6/3/2014 10:37,2,2,Docetaxel With ADT Improves Survival for Metastatic Prostate Cancer Patients http://bit.ly/1tzRRON # ASCO14,,,#,4.73836E+17,https://twitter.com/CancerNetwrk/status/473835770923712512,,,,
cancerassassin1,6/3/2014 10:36,0,0,Ok still here at # ASCO14 - tired but still excited to attend Clinical Science Symposium on # colorectal # cancer at 9:45. # onlastlegs @ ASCO,,@,# # # #,4.73836E+17,https://twitter.com/cancerassassin1/status/473835700106711040,,,,
TuftsB,6/3/2014 10:36,0,0,@ CliffordHudis @ ASCO - revenue is what patients provide & we were cut out of stakeholder panels trying to limit our choice # MLIWI # ASCO14,,@ @,# #,4.73836E+17,https://twitter.com/TuftsB/status/473835612425183232,,,,
MaverickNY,6/3/2014 10:36,0,1,@ Frank_S_David avoid rushing from ph 1 to 3 would be a good start # asco14,,@,#,4.73836E+17,https://twitter.com/MaverickNY/status/473835579814457344,,,,
OncLive,6/3/2014 10:35,4,0,Dr. Anas Younes from @ sloan_kettering on R-CHOP in Combination with Ibrutinib in DLBCL http://ow.ly/xzCJt # ASCO14 TPS,,@,#,4.73835E+17,https://twitter.com/OncLive/status/473835390647148545,,,,
FORMAInc,6/3/2014 10:35,0,0,Useful tools and information on one's journey to cancer survivorship http://bit.ly/1pOZRuP @ ASCO,,@,,4.73835E+17,https://twitter.com/FORMAInc/status/473835373190455296,,,,
myriadgenetics,6/3/2014 10:35,1,0,Myriad's BRACAnalysis CDx predicts platinum response in metastatic # breastcancer patients: # ASCO14 2DAY 9:45am E Hall http://bit.ly/1tWn80k,,,# #,4.73835E+17,https://twitter.com/myriadgenetics/status/473835258593288194,,,,
BCRFcure,6/3/2014 10:34,0,1,Our grantee Dr. Graham Colditz highlights primary role of # prevention in # cancer care http://ow.ly/xzCC5 # ASCO2014,,,# # #,4.73835E+17,https://twitter.com/BCRFcure/status/473835072005873665,,,,
Frank_S_David,6/3/2014 10:34,3,3,Main takeaway of # ASCO14 combo Rx panel: plenty of data-driven hypotheses; next frontier is better ways2 predict tolerability in clinic,,,#,4.73835E+17,https://twitter.com/Frank_S_David/status/473835002992422913,,,,
UCCancerCenter,6/3/2014 10:33,2,1,Rena Conti shows newer cancer drugs more expensive vs older & contributing factors. Cancer economics big at # ASCO14 pic.twitter.com/SC5tOBiUD1,,,#,4.73835E+17,https://twitter.com/UCCancerCenter/status/473834951410868225,,,,
mlazqui,6/3/2014 10:33,1,0,"# ASCO14 RT @ javierDcastro: Después de una década, necitumumab ofrece por 1 vez un beneficio en carcinomas epidpic.twitter.com/QFKnhXbQ61",,@,#,4.73835E+17,https://twitter.com/mlazqui/status/473834911573757952,,,,
info2farma,6/3/2014 10:32,0,0,Presentan tratamientos contra cánceres agresivos | Instituto Carlos Slim de la Salud # ASCO2014 http://www.salud.carlosslim.org/presentan-tratamientos-contra-canceres-agresivos/ … vía @icslimsalud,,@icslimsalud,#,4.73835E+17,https://twitter.com/info2farma/status/473834524879503360,,,,
MaverickNY,6/3/2014 10:31,1,0,If you're going to the Dev Therapeutics session at 9.45am be quick as already filling up fast 15 mins early! # asco14,,,#,4.73834E+17,https://twitter.com/MaverickNY/status/473834331623149568,,,,
GeneticCouns,6/3/2014 10:31,2,1,RT @ GenomeGrl: This GC is happy to see that the hereditary breast and CRC session at # ASCO14 is completely full! @ GeneticCouns,,@ @,#,4.73834E+17,https://twitter.com/GeneticCouns/status/473834270348570626,,,,
SarahCannonDocs,6/3/2014 10:30,0,0,ibrutinib efficacy 3 years post-initiation of monotherapy for CLL. Join us & talk to # SCRI's Dr. Flinn re: the study 11:33am E354a # ASCO14,,,# #,4.73834E+17,https://twitter.com/SarahCannonDocs/status/473834196260388865,,,,
CancerDotNet,6/3/2014 10:30,12,3,"What do # ASCO14 research highlights mean for people w/ # cancer? Full, interactive PDF patient summary here: http://bit.ly/1jM9eGo",,,# #,4.73834E+17,https://twitter.com/CancerDotNet/status/473834187288772608,,,,
DebiopharmNews,6/3/2014 10:30,0,0,# ASCO14 Final PK/PD phase I Debio 1143 (AT406) # patients # cancer (abstract/poster #2532). Find out more http://ow.ly/xwrkT,,,# # # #2532,4.73834E+17,https://twitter.com/DebiopharmNews/status/473834155961511936,,,,
PaulaKimTRAC,6/3/2014 10:30,2,6,Thanks @ drdonsdizon @LindaSueHouse for sharing on stkholder engagement w/our ASCO-GALA Int'l Patient Advocacy Wkshp # advocacyleader # ASCO14,,@ @LindaSueHouse,# #,4.73834E+17,https://twitter.com/PaulaKimTRAC/status/473834136558268416,,,,
eMPR,6/3/2014 10:30,0,0,Screening for lung cancer could become as easy as breathing: http://ow.ly/xzmUC # ASCO14 # oncology,,,# #,4.73834E+17,https://twitter.com/eMPR/status/473834110801432578,,,,
OscarPicazo,6/3/2014 10:30,0,0,# ASCO14 Recordando a Antonio Bru http://ow.ly/xzBGM http://ow.ly/xzBJU Aún me indigno cuando recuerdo lo que sucedió... # salud,,,# #,4.73834E+17,https://twitter.com/OscarPicazo/status/473834104107327488,,,,
evaluatepharma,6/3/2014 10:30,0,0,# ASCO14 – Damp squibs mean Lilly ( @ LillyPad) has it all to do http://ow.ly/xzr6L $ LLY,,@,#,4.73834E+17,https://twitter.com/evaluatepharma/status/473834091054653440,,,,
Boehringer,6/3/2014 10:30,1,1,BLOG POST: The next 50 yrs of # lungcancer: Dr Hirsh looks ahead to the future http://bit.ly/1pA2PpL # ASCO14,,,# #,4.73834E+17,https://twitter.com/Boehringer/status/473834064580202496,,,,
subatomicdoc,6/3/2014 10:30,2,1,Hypofractionated radiation for ductal carcinoma in situ (DCIS): SEER-Medicare study http://abstracts.asco.org/144/AbstView_144_129209.html … # ASCO14 # bcsm # radonc,,,# # #,4.73834E+17,https://twitter.com/subatomicdoc/status/473834063720370176,,,,
nanostringtech,6/3/2014 10:30,0,0,"Isakoff et al: Identification of biomarkers to predict response to single-agent plat chemotherapy in mTNBC"" # ASCO14 http://abstracts.asco.org/144/AbstView_144_130285.html …""",,,#,4.73834E+17,https://twitter.com/nanostringtech/status/473834036326957056,,,,
DrAttai,6/3/2014 10:29,1,1,@ ASCO yes - I will be there!,,@,,4.73834E+17,https://twitter.com/DrAttai/status/473833971437293568,,,,
DrAttai,6/3/2014 10:29,1,1,@ ASCO thanks so much for the warm welcome and the great meeting - see you next year!! # ASCO14,,@,#,4.73834E+17,https://twitter.com/DrAttai/status/473833928441466880,,,,
Cate_Fontanella,6/3/2014 10:29,0,0,"# ASCO14 last day, waiting for TNBC oral abstract!",,,#,4.73834E+17,https://twitter.com/Cate_Fontanella/status/473833862750277632,,,,
TuftsB,6/3/2014 10:29,0,0,@ yzafar @ ASCO @ CostsofCare ' listen to doctors not the insurance company lobby that tries to deny critical innovative care # mliwi # ASCO14,,@ @ @,# #,4.73834E+17,https://twitter.com/TuftsB/status/473833772454907905,,,,
evokekyne,6/3/2014 10:29,0,0,From @ ASCO to @ BCS! Busy few weeks for the Tonic team!pic.twitter.com/KHQflxlXPG,,@ @,,4.73834E+17,https://twitter.com/evokekyne/status/473833763173335041,,,,
adeyanjubiodun,6/3/2014 10:27,0,0,# asco14 the conundrum of triple negative breast cancer continues. What is the way forward?,,,#,4.73833E+17,https://twitter.com/adeyanjubiodun/status/473833367730147328,,,,
TuftsB,6/3/2014 10:27,0,0,@ yzafar @ ASCO @ CostsofCare -O want a doctor willing to fight cancer as hard as I do with as many weapons s at their disposal # mliwi # asco14,,@ @ @,# #,4.73833E+17,https://twitter.com/TuftsB/status/473833346481782784,,,,
TuftsB,6/3/2014 10:26,0,0,@ yzafar @ ASCO @ CostsofCare - I trust doctors with my life when they wear white coats not green eye shades # mliwi # asco14,,@ @ @,# #,4.73833E+17,https://twitter.com/TuftsB/status/473833097604374528,,,,
jodigralnick,6/3/2014 10:25,0,0,"More of @ megtirrell excellent exclusive intvw w/ $ CLVS CEO, talking competition with $ AZN. http://video.cnbc.com/gallery/?video=3000280995&play=1 … # ASCO14 # CNBC",,@,# #,4.73833E+17,https://twitter.com/jodigralnick/status/473832843555377153,,,,
ProjectInno,6/3/2014 10:25,0,1,Our white paper outlines 3 steps to accelerate cancer innovation http://ow.ly/xs2sR # innovatenow # ASCO14,,,# #,4.73833E+17,https://twitter.com/ProjectInno/status/473832814983786497,,,,
carisls,6/3/2014 10:25,1,1,"(AR)-negative TNBC may benefit from inhibition of PD-L1, CTLA-4 and IDO-1. http://goo.gl/pSeoOt # ASCO14 # breastcancer # MolecularIntel",,,# # #,4.73833E+17,https://twitter.com/carisls/status/473832796260433920,,,,
carisls,6/3/2014 10:25,0,1,Caris # MolecularIntel study by @ MayoClinic researchers suggests immune-targeted therapies for subsets of TNBC http://goo.gl/pSeoOt # ASCO14,,@,# #,4.73833E+17,https://twitter.com/carisls/status/473832780535975936,,,,
ONAcom,6/3/2014 10:25,0,0,RT @ NCIMedia: NCI at # ASCO14: A brief overview on research in women's # cancers: http://1.usa.gov/1pLOoMG pic.twitter.com/dsOimAphYF,,@,# #,4.73833E+17,https://twitter.com/ONAcom/status/473832773854437376,,,,
Rad_Nation,6/3/2014 10:25,0,0,Hypofractionated radiation for ductal carcinoma in situ (DCIS): SEER-Medicare study http://abstracts.asco.org/144/AbstView_144_129209.html … # ASCO14 # bcsm # radonc,,,# # #,4.73833E+17,https://twitter.com/Rad_Nation/status/473832729851990018,,,,
TuftsB,6/3/2014 10:24,0,0,@ yzafar @ ASCO @ CostsofCare ' we arent data. There is no average patient response to treatment or recovery. No one size 4 all # mliwi # ASCO14,,@ @ @,# #,4.73833E+17,https://twitter.com/TuftsB/status/473832606749163520,,,,
OscarPicazo,6/3/2014 10:24,2,0,"RT @ agencia_sinc: # ASCO14, el mayor congreso mundial del cáncer, revela nuevos logros en inmunoterapia http://bit.ly/1x0Cqnc",,@,#,4.73833E+17,https://twitter.com/OscarPicazo/status/473832586247434240,,,,
HollmerMark,6/3/2014 10:24,0,1,Merck will work with Sysmex to develop a colon cancer Dx that guides treatment for the drug Erbitux. PR - http://www.fiercediagnostics.com/press-releases/merck-collaborate-sysmex-inostics-blood-based-ras-biomarker-test … # ASCO14,,,#,4.73832E+17,https://twitter.com/HollmerMark/status/473832485164314625,,,,
SiemensHealth,6/3/2014 10:23,6,1,Thank you to everyone who stopped by the Siemens booth at # ASCO14 to pass the Baton to support @ SU2C! # TheBatonPasspic.twitter.com/yL19E24cGl,,@,# #,4.73832E+17,https://twitter.com/SiemensHealth/status/473832393095147520,,,,
NotesOnNursing,6/3/2014 10:23,0,0,MT via @ JHARTFOUND @ RevAmyZ : Guess who is at @ ASCO talking about # geriatric # oncology? @ WilliamDale_MD # hcldr http://www.cancernetwork.com/asco-2014/blogs/personalized-care-vs-precise-care-geriatric-oncology-model …,,@ @ @ @,# # #,4.73832E+17,https://twitter.com/NotesOnNursing/status/473832335377715200,,,,
csresearch,6/3/2014 10:22,1,0,US Pharma: $ MRK and $ BMY providing further reasons for excitement in immuno-oncology; $ LLY ’s necitumumab leads to questions # ASCO2014,,,#,4.73832E+17,https://twitter.com/csresearch/status/473832092758196225,,,,
TuftsB,6/3/2014 10:21,0,0,@ yzafar @ ASCO @ CostsofCare - and we patients reject your rationing and limits on medically justifiable care and choice. # mliwi # asco14,,@ @ @,# #,4.73832E+17,https://twitter.com/TuftsB/status/473831967147180034,,,,
PaulaKimTRAC,6/3/2014 10:21,0,1,". @ IMFmyeloma congrats Mike Katz for # ASCO14 Partners in Progress Award, well deserved! # advocacyleader",,@,# #,4.73832E+17,https://twitter.com/PaulaKimTRAC/status/473831790583357441,,,,
TransgeneSA,6/3/2014 10:20,2,2,"TG's team # ASCO14 : H Shah VP Med Affairs, C Monohan AD Regulatory US, JM Limacher Senior Med Dir & P Archinard, PDG pic.twitter.com/8oODrdTQfe",,,#,4.73832E+17,https://twitter.com/TransgeneSA/status/473831681053700096,,,,
DebiopharmNews,6/3/2014 10:20,0,0,# ASCO14 Debio1143 results in # HNCSM Find out more http://ow.ly/xwrfV,,,# #,4.73832E+17,https://twitter.com/DebiopharmNews/status/473831596857237504,,,,
LillianErdahlMD,6/3/2014 10:18,0,0,Moran: BCT and mastectomy appear at least equivalent in TNBC but reasons not clear in literature # ASCO14,,,#,4.73831E+17,https://twitter.com/LillianErdahlMD/status/473830982580436993,,,,
exerciseworks,6/3/2014 10:16,1,2,"Effects of equivalent weight loss, with or without exercise, on sex hormones related to breast cancer risk http://meetinglibrary.asco.org/content/133888-144#.U410uoxbqGs.twitter … # ASCO2014",,,# #,4.73831E+17,https://twitter.com/exerciseworks/status/473830620393521152,,,,
Cascadia,6/3/2014 10:16,1,1,Thanks Len @ lenstarnes: Excellent study by @ MotherinMed MDs' use of Twitter http://bit.ly/17fMwpr # ASCO14 # hdpalozza,,@ @,# #,4.73831E+17,https://twitter.com/Cascadia/status/473830551737356288,,,,
mtmdphd,6/3/2014 10:16,4,1,"# ASCO14 Combo Rx Dev - We can learn, even from negative trials. (good notes for need to publish negative data, assume good methodology)",,,#,4.73831E+17,https://twitter.com/mtmdphd/status/473830529385500674,,,,
ASCO,6/3/2014 10:16,8,2,Top 3 Most RT'd Tweets from @ CliffordHudis' # ASCO14 Pres Address http://bit.ly/1ktBLp1 http://bit.ly/1ktBLp1 http://bit.ly/1hvByTq,,@,#,4.7383E+17,https://twitter.com/ASCO/status/473830471588392960,,,,
HealthCoreRWE,6/3/2014 10:15,0,0,Discuss comparison of cancer costs based on practice ownership # asco14 11:30 to 12:45 p.m. in E253. http://ow.ly/i/5LOBD,,,#,4.7383E+17,https://twitter.com/HealthCoreRWE/status/473830382568480768,,,,
nbferrara,6/3/2014 10:15,0,0,MT @ ASCOPost Ibrutinib Delays Disease Progression & Extends Survival in Relapsed CLL http://ow.ly/xzw6y # ASCO14 # lylsm # lylcl,,@,# # #,4.7383E+17,https://twitter.com/nbferrara/status/473830339123892224,,,,
HealthCoreRWE,6/3/2014 10:15,0,1,Metastatic colorectal care and treatment averaged $105k from oncologist-owned practices vs $113k from hospital-owned oncologists. # asco14,,,#,4.7383E+17,https://twitter.com/HealthCoreRWE/status/473830288792223744,,,,
OncLive,6/3/2014 10:15,1,2,Ipilimumab demonstrated efficacy in the adjuvant setting for patients with melanoma http://ow.ly/xxVtB # ASCO14,,,#,4.7383E+17,https://twitter.com/OncLive/status/473830276716843009,,,,
Coping_Cancer,6/3/2014 10:15,1,2,Learn what's new in # cancer # research with this searchable collection of studies from the @ ASCO Annual Meeting: http://bit.ly/1hVDUW0,,@,# #,4.7383E+17,https://twitter.com/Coping_Cancer/status/473830272388333568,,,,
mtmdphd,6/3/2014 10:14,0,0,# ASCO14 Combo Rx Dev - Q/comm: you cheated a little on serial/parallel. A: Fair comment. Nomenclature may be wrong (too simple).,,,#,4.7383E+17,https://twitter.com/mtmdphd/status/473830204847030272,,,,
NBTStweets,6/3/2014 10:14,0,1,Adjuvant Chemotherapy after Radiation Improved Overall Survival in Low-Grade Glioma http://bit.ly/1rH6VhX # ASCO2014 # Btsm,,,# #,4.7383E+17,https://twitter.com/NBTStweets/status/473829960646270976,,,,
clarisssv,6/3/2014 10:13,0,0,"Ayer en # ASCO14, mañana en @ diariomedicopic.twitter.com/qPnNLTffKD",,@,#,4.7383E+17,https://twitter.com/clarisssv/status/473829862130479104,,,,
laurentingels,6/3/2014 10:13,0,0,“Obesity is on its way to replacing tobacco as the number one preventable cause of cancerCliord Hudis," MD # ASCO14 pic.twitter.com/xOoWDJStN4""",,,#,4.7383E+17,https://twitter.com/laurentingels/status/473829843529138177,,,
DrLen,6/3/2014 10:12,3,2,I have to give a shout out to the # ASCO14 meeting app. It is one of the most useful and best organized apps I use all year. Thanks!,,,#,4.7383E+17,https://twitter.com/DrLen/status/473829682459451392,,,,
ShannonWestin,6/3/2014 10:12,0,1,“ @ MaverickNY: Wow what Gordon Mills and his team at MDACC are doing in proteomics is mind blowing! # asco14” honored to call him my mentor,,@,#,4.7383E+17,https://twitter.com/ShannonWestin/status/473829670094254080,,,,
yzafar,6/3/2014 10:12,18,8,Recap: @ ASCO proposes a value framework to categorize treatments by value # ASCO14 @ CostsofCarepic.twitter.com/QHWUZUe8Xl,,@ @,#,4.73829E+17,https://twitter.com/yzafar/status/473829483024093184,,,,
LillianErdahlMD,6/3/2014 10:10,0,0,"Moran: limited data on APBI in TNBC, should only be done on clinical protocol # ASCO14",,,#,4.73829E+17,https://twitter.com/LillianErdahlMD/status/473829150097412096,,,,
Aiims1742,6/3/2014 10:10,0,0,MT @ MaverickNY: Wow what Gordon Mills and his team at # MDAnderson are doing in # proteomics is mind blowing! # asco14 # endcancer,,@,# # # #,4.73829E+17,https://twitter.com/Aiims1742/status/473829132409659392,,,,
CancerTherAdvsr,6/3/2014 10:10,0,0,RT @ drdonsdizon: My 5 from # ASCO14: 4) POEMS preventing ovarian failure in young women http://abstracts.asco.org/144/AbstView_144_129172.html …,,@,#,4.73829E+17,https://twitter.com/CancerTherAdvsr/status/473829104287227904,,,,
carisls,6/3/2014 10:10,3,0,"Quadruple negative # breastcancer (i.e., lacking the AR protein) may benefit from immunotherapeutic agents. http://goo.gl/pSeoOt # ASCO14",,,# #,4.73829E+17,https://twitter.com/carisls/status/473829049899696128,,,,
Groz_P,6/3/2014 10:10,0,0,Naive question: Why are most # ASCO14 stories in @ nytimes published in the Business section? And today is Science Times day! Cancer=$$$,,@,#,4.73829E+17,https://twitter.com/Groz_P/status/473829040668024832,,,,
DebiopharmNews,6/3/2014 10:10,0,0,"# ASCO14 Phase I-II Debio0932, oral # HSP90 inhibitor, 1st & 2nd line # NSCLC (abstract/poster # TPS2632) Find out more http://ow.ly/xwr9c",,,# # # #,4.73829E+17,https://twitter.com/DebiopharmNews/status/473829029326635008,,,,
TargetedOnc,6/3/2014 10:10,0,1,"Frontline Bevacizumab, Cetuximab Equally Effective in KRAS Wild-Type mCRC http://www.targetedonc.com/conference/asco-2014/Bevacizumab-Cetuximab-Equally-Effective-in-KRAS-Wild-Type-mCRC … # ASCO14",,,#,4.73829E+17,https://twitter.com/TargetedOnc/status/473829004051746816,,,,
mtmdphd,6/3/2014 10:10,2,0,# ASCO14 Combo Rx Dev - Crowd comment: The cutting edge is genetic modification with PDX...,,,#,4.73829E+17,https://twitter.com/mtmdphd/status/473828967082762245,,,,
peterculpepper,6/3/2014 10:09,0,0,$ PVCT # ASCO14 http://www.pvct.com/pressrelease.html?article=20140603.1 …,,,#,4.73829E+17,https://twitter.com/peterculpepper/status/473828823184588800,,,,
OncEd,6/3/2014 10:09,0,0,# ASCO14 Video Update: The Future of Targeting EGFR – Dr. Ron Burkes # LCSM http://bit.ly/T4iQH3,,,# #,4.73829E+17,https://twitter.com/OncEd/status/473828804247298048,,,,
DrAttai,6/3/2014 10:09,0,2,Following the last bit of # ASCO14 on the way home - thanks to the die-hards who are staying till the end!,,,#,4.73829E+17,https://twitter.com/DrAttai/status/473828786077569025,,,,
BetaPharmaNews,6/3/2014 10:09,0,0,Till next year @ ASCO # ASCO14 pic.twitter.com/UvPicmCkoW,,@,#,4.73829E+17,https://twitter.com/BetaPharmaNews/status/473828700983951360,,,,
JFreemanDaily,6/3/2014 10:08,1,0,"G. Mills, MD Anderson: Wiring pathway for a given targeted protein varies across tumor types (breast, lung, melanoma, etc) # ASCO14",,,#,4.73829E+17,https://twitter.com/JFreemanDaily/status/473828691299299328,,,,
CRC_Medical,6/3/2014 10:08,1,1,Last day at # ASCO14! Come say hi to Nally at Booth #23128 and ask about our special discounts on amazing new # medicine titles. @ ASCO,,@,# #23128 #,4.73829E+17,https://twitter.com/CRC_Medical/status/473828665214914560,,,,
LillianErdahlMD,6/3/2014 10:08,0,0,Moran: Difference in LRR by type of surgery more likely due to tumor biology than extent of surgery in TNBC # ASCO14,,,#,4.73829E+17,https://twitter.com/LillianErdahlMD/status/473828566824534016,,,,
elmundosalud,6/3/2014 10:08,5,2,Lo mas interesante de # ASCO14 probablemente ha sido la promesa de la inmunoterapia contra el cáncer http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html ….,,,#,4.73828E+17,https://twitter.com/elmundosalud/status/473828497828237313,,,,
UCCancerCenter,6/3/2014 10:07,0,1,"Hedy Kindler describes first-line treatment choices for advanced # pancreaticcancer & regimen, patient and oncologist factors # ASCO14",,,# #,4.73828E+17,https://twitter.com/UCCancerCenter/status/473828300037820417,,,,
scientre,6/3/2014 10:06,2,1,"Q&A in combo session: any hints in preclinical models that combos are toxic? A: Don't know for sure, virtually all efficacy focused # ASCO14",,,#,4.73828E+17,https://twitter.com/scientre/status/473828101420773376,,,,
healthtalkorg,6/3/2014 10:06,0,0,Fingers crossed! MT @GSK_Conferences @ SueZiebland http://healthtalkonline.org should be established in more countries inc. the US # ASCO14 # Cancer,,@GSK_Conferences @,# #,4.73828E+17,https://twitter.com/healthtalkorg/status/473828069866999808,,,,
jalopezg70,6/3/2014 10:05,0,0,Highlight poster from the # GEIS group about miRNAs in high risk intestinal # GISTs # ASCO14 http://tinyurl.com/n6bgz9v pic.twitter.com/6v9xGw1tBe,,,# # #,4.73828E+17,https://twitter.com/jalopezg70/status/473827905978396673,,,,
nbferrara,6/3/2014 10:05,0,0,Early Palliation in Cancer Patients Eases Caregiver Burden: http://bit.ly/1n8JfOn via @ MedPageToday # ASCO14,,@,#,4.73828E+17,https://twitter.com/nbferrara/status/473827814329040896,,,,
DoctrBenway,6/3/2014 10:05,0,0,Which would you rather: need a ventilator and lung transplant or take insulin? $ CLVS $ AZN # ASCO14,,,#,4.73828E+17,https://twitter.com/DoctrBenway/status/473827784629170178,,,,
bioclinica,6/3/2014 10:05,0,0,"RT @ ASCO: # ASCO14 Top Stories, Expert Editorials http://bit.ly/1n8yiMJ # mededpic.twitter.com/dFVH4G2nt7",,@,# #,4.73828E+17,https://twitter.com/bioclinica/status/473827767969398784,,,,
GenentechJobs,6/3/2014 10:05,1,0,"The # ASCO14 Talent Hunt continues: Companion Diagnostic Leader, http://click2apply.net/419110t Retweet please.",,,#,4.73828E+17,https://twitter.com/GenentechJobs/status/473827760658341888,,,,
MaverickNY,6/3/2014 10:05,3,1,"@ mtmdphd @ drsam @ DrStelling cell lines are useful for figuring out resistance mechs, predicting if drug works in man, not so much # asco14",,@ @ @,#,4.73828E+17,https://twitter.com/MaverickNY/status/473827746708475904,,,,
ocurare,6/3/2014 10:05,0,0,"Vaya, qué desafortunado el HT en español MT  @ agencia_sinc: # ASCO14"," el mayor congreso mundial del cáncer http://bit.ly/1x0Cqnc """"",,@,#,4.73828E+17,https://twitter.com/ocurare/status/473827705180659713,,,
mtmdphd,6/3/2014 10:04,0,1,# ASCO14 Combo Rx Dev - Crowd comment - Preclinical doesn't always play out clinically. Pharmacology includes understanding combo safety,,,#,4.73828E+17,https://twitter.com/mtmdphd/status/473827501051879425,,,,
drdonsdizon,6/3/2014 10:03,3,1,If at # ASCO14- I'd love to hear what everyone's top 5 were too.,,,#,4.73827E+17,https://twitter.com/drdonsdizon/status/473827407028178945,,,,
jamienholloway,6/3/2014 10:03,0,1,Been loving all the # ASCO14 tweets from @ drdonsdizon @ rsm2800 @ drattai Many thanks all!,,@ @ @,#,4.73827E+17,https://twitter.com/jamienholloway/status/473827262023098368,,,,
Frank_S_David,6/3/2014 10:03,6,4,"We have no idea what we're doing"" re combining immunoRx and targeted therapies: Audience member in # ASCO14 combo Rx session -> yup""",,,#,4.73827E+17,https://twitter.com/Frank_S_David/status/473827204527562752,,,,
DebiopharmNews,6/3/2014 10:02,0,0,"# ASCO14 Final Phase I Debio 0932, oral # HSP90 inhibitor, # oncology (abstract/poster #2550) Find out more http://ow.ly/xwr0V",,,# # # #2550,4.73827E+17,https://twitter.com/DebiopharmNews/status/473827075573710849,,,,
ASCO,6/3/2014 10:02,1,1,Last day to become an ASCO member at # ASCO14: Visit a Member Services Desk to receive a membership dues credit & thank you gift,,,#,4.73827E+17,https://twitter.com/ASCO/status/473827065926795264,,,,
melisawongmd,6/3/2014 10:02,0,0,Thank you to @ jvonroennmd for the best talk of # ASCO14 - Lessons Learned from Personal Loss,,@,#,4.73827E+17,https://twitter.com/melisawongmd/status/473827052530204672,,,,
mtmdphd,6/3/2014 10:02,0,1,"# ASCO14 Combo Rx Dev - CDK4 w/ MAPK pathway inhibitors (eg BRAFi, MEKi) - could be good...",,,#,4.73827E+17,https://twitter.com/mtmdphd/status/473827049711226881,,,,
LillianErdahlMD,6/3/2014 10:02,0,0,Moran: Locoregional recurrence may be LOWER for TNBC patients with BCT than with mastectomy # ASCO14,,,#,4.73827E+17,https://twitter.com/LillianErdahlMD/status/473827048889516032,,,,
FORMAInc,6/3/2014 10:02,0,0,In case you missed it...ASCO daily highlights and links to presentations http://bit.ly/1pCA7Ve @ ASCO,,@,,4.73827E+17,https://twitter.com/FORMAInc/status/473827018732503041,,,,
drdonsdizon,6/3/2014 10:02,3,1,"My 5 from # ASCO14: 2) Melanoma- Adj Ipi http://abstracts.asco.org/144/AbstView_144_130118.html …, pembrolizumab http://abstracts.asco.org/144/AbstView_144_133842.html … and ipi+nivo http://abstracts.asco.org/144/AbstView_144_126008.html …",,,#,4.73827E+17,https://twitter.com/drdonsdizon/status/473826980895289345,,,,
CancerResearch,6/3/2014 10:02,1,0,Text join to 80888 to support cancer immunotherapy research # CIM2014 # ASCO14,,,# #,4.73827E+17,https://twitter.com/CancerResearch/status/473826966790238209,,,,
MGHCancerCenter,6/3/2014 10:02,1,0,"11:30-12:45, E354A: Dr. Gainor talk: Evolution of resistance in ALK-positive patients treated with ALK tyrosine kinase inhibitors # ASCO14",,,#,4.73827E+17,https://twitter.com/MGHCancerCenter/status/473826939766325248,,,,
GenentechJobs,6/3/2014 10:01,0,0,Have you checked out the ASCO Educational Book articles? # ASCO14 http://bit.ly/SLvfQa,,,#,4.73827E+17,https://twitter.com/GenentechJobs/status/473826879648972800,,,,
mtmdphd,6/3/2014 10:01,0,0,"# ASCO14 Combo Rx Dev - Q/comment on pre-clinical modeling issues. Immune, scheduling...",,,#,4.73827E+17,https://twitter.com/mtmdphd/status/473826839400443904,,,,
drdonsdizon,6/3/2014 10:01,3,2,My 5 from # ASCO14: 5) Federal support for clinical trials! http://meetinglibrary.asco.org/presentationBySession/6723/1380?media=vm …,,,#,4.73827E+17,https://twitter.com/drdonsdizon/status/473826796740165635,,,,
jrgralow,6/3/2014 10:01,0,0,Colon cancer screening benefits those >75? # ASCO14 http://ow.ly/xzw6o,,,#,4.73827E+17,https://twitter.com/jrgralow/status/473826780722528257,,,,
CancerResearch,6/3/2014 10:01,1,0,"When you text JOIN to 80888, you can make the easiest $10 donation of your life! # ASCO14 # CIM2014",,,# #,4.73827E+17,https://twitter.com/CancerResearch/status/473826750942945280,,,,
mtmdphd,6/3/2014 10:00,0,0,# ASCO14 Combo Rx Dev - We are seeing complexities of immun-onc development. We gotta figure it out.,,,#,4.73827E+17,https://twitter.com/mtmdphd/status/473826649268424704,,,,
LGG1,6/3/2014 10:00,1,1,The Changing Landscape of Palliative Care # ASCO14 # pallonc http://ow.ly/3ljDlj,,,# #,4.73827E+17,https://twitter.com/LGG1/status/473826588954726400,,,,
agencia_sinc,6/3/2014 10:00,11,5,"# ASCO14, el mayor congreso mundial del cáncer, revela nuevos logros en inmunoterapia http://bit.ly/1x0Cqnc",,,#,4.73827E+17,https://twitter.com/agencia_sinc/status/473826530334740483,,,,
FoundationATCG,6/3/2014 10:00,1,0,Celebrating 50 years of Science and Society # ASCO14. Read about the possibilities ahead: http://bit.ly/1kmrISN,,,#,4.73827E+17,https://twitter.com/FoundationATCG/status/473826525020975104,,,,
cardinalhealth,6/3/2014 10:00,3,1,Didn’t get to our booth at # ASCO14? Learn more about Cardinal Health Specialty Solutions at http://www.cardinalhealth.com/SpecialtySolutions …,,,#,4.73827E+17,https://twitter.com/cardinalhealth/status/473826501545037825,,,,
nanostringtech,6/3/2014 10:00,0,0,"Fitzal et al present Predicting local recurrence using PAM50 in postmenopausal …breast cancer patients"" at # ASCO14 http://abstracts.asco.org/144/AbstView_144_129165.html …""",,,#,4.73826E+17,https://twitter.com/nanostringtech/status/473826491562614784,,,,
cure_magazine,6/3/2014 10:00,0,5,"Patient-centered research: Engaging pts & advocates 2 help design & carry out research. It's happening, let's make it better # asco14 @ PCORI",,@,#,4.73826E+17,https://twitter.com/cure_magazine/status/473826488173608960,,,,
SarahKarlin,6/3/2014 10:00,0,0,"# ASCO14 Boosts $ AZN's Standings, And Options http://www.pharmamedtechbi.com/publications/the-pink-sheet-daily/2014/6/3/asco-boosts-astrazenecas-standings-and-options …",,,#,4.73826E+17,https://twitter.com/SarahKarlin/status/473826485795835904,,,,
MedscapeOnc,6/3/2014 10:00,0,0,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73826E+17,https://twitter.com/MedscapeOnc/status/473826464245100545,,,,
Medscape,6/3/2014 10:00,0,0,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73826E+17,https://twitter.com/Medscape/status/473826448021540867,,,,
rschilsky,6/3/2014 9:59,14,6,Immune therapy revolution continues. # ASCO14 http://www.usatoday.com/story/news/nation/2014/06/02/cancer-immune-therapy/9775005/ …,,,#,4.73826E+17,https://twitter.com/rschilsky/status/473826270577299457,,,,
drdonsdizon,6/3/2014 9:58,7,3,My 5 from # ASCO14: 4) POEMS preventing ovarian failure in young women http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.73826E+17,https://twitter.com/drdonsdizon/status/473826069762424832,,,,
CorbettSocial,6/3/2014 9:58,1,0,RT @ Roche: What does it mean if there is a hazard ratio of 1? Test your # clinicaltrials IQ http://ow.ly/xwz8d # ASCO14 # CAHGTrialsTuesday,,@,# # #,4.73826E+17,https://twitter.com/CorbettSocial/status/473826050695528448,,,,
mtmdphd,6/3/2014 9:58,1,0,# ASCO14 eQ&A: S100a -> 22333 texting (charges may apply),,,#,4.73826E+17,https://twitter.com/mtmdphd/status/473826025982279680,,,,
scientre,6/3/2014 9:57,1,0,Lauring: on caveats to isogenic cell lines # asco14 pic.twitter.com/BVppWCPhKU,,,#,4.73826E+17,https://twitter.com/scientre/status/473825923822014464,,,,
Worldwidewh,6/3/2014 9:57,0,0,The global medical community is poised for the final day of the 50th annual meeting of @ ASCO in Chicago # oncology # WWH,,@,# #,4.73826E+17,https://twitter.com/Worldwidewh/status/473825840799973376,,,,
LungCancer_Can,6/3/2014 9:57,1,2,We wrote a post for @ Boehringer's @ ASCO blog: http://asco-2014.boehringer-ingelheim.com/2014/06/02/now-critically-important-time-invest-fight-lung-cancer-canada-join-us/ … See their blog for many more articles about the future of lung cancer.,,@ @,,4.73826E+17,https://twitter.com/LungCancer_Can/status/473825784767852546,,,,
mtmdphd,6/3/2014 9:57,1,0,# ASCO14 Lauring - Use of isogenic human cell line models - complementary models. Not used alone. pic.twitter.com/sN3gBHd344,,,#,4.73826E+17,https://twitter.com/mtmdphd/status/473825761925664768,,,,
drdonsdizon,6/3/2014 9:57,11,6,My 5 from # ASCO14: 3) Immunotherapy for solid tumors- HPV+ # cervca http://abstracts.asco.org/144/AbstView_144_129263.html …,,,# #,4.73826E+17,https://twitter.com/drdonsdizon/status/473825705965264896,,,,
cure_magazine,6/3/2014 9:56,0,0,Researcher/Patient: It would be wonderful if one of the plenary abstracts one day is given by a patient advocate. # asco14 # patientengagment,,,# #,4.73826E+17,https://twitter.com/cure_magazine/status/473825675942830080,,,,
mtmdphd,6/3/2014 9:56,0,0,# ASCO14 Lauring - isogenic human cell line models - She et al. Cancer Cell 2010 - support target pathways. ?tox pic.twitter.com/roKNrfZl9p,,,#,4.73826E+17,https://twitter.com/mtmdphd/status/473825638546018304,,,,
DrStelling,6/3/2014 9:56,0,0,@ drsam @ mtmdphd I know. I'm more on the chemical mapping side of things: gotta know the territory b4 'bombing' it w chemotherapies # ASCO14,,@ @,#,4.73826E+17,https://twitter.com/DrStelling/status/473825545588080640,,,,
HemOncToday,6/3/2014 9:56,0,1,# ASCO14 # Enzalutamide extended survival in metastatic # ProstateCancer @ DukeCancer http://goo.gl/Owzbu4,,@,# # #,4.73825E+17,https://twitter.com/HemOncToday/status/473825440239742977,,,,
GoHealio,6/3/2014 9:56,0,0,# ASCO14 # Enzalutamide extended survival in metastatic # ProstateCancer @ DukeCancer http://goo.gl/Owzbu4,,@,# # #,4.73825E+17,https://twitter.com/GoHealio/status/473825439312805888,,,,
GenentechJobs,6/3/2014 9:56,0,0,# ASCO14 Talent Hunt: Clinical Scientist Specialist: http://click2apply.net/0412468t Retweet to your network.,,,#,4.73825E+17,https://twitter.com/GenentechJobs/status/473825435990511617,,,,
OmidHamidMD,6/3/2014 9:55,2,3,"@ SarahCannonDocs Jeff Infante I'll have to have a marriage counseling session for staying at # ASCO14 till Tues.."" # funnybuttrue""",,@,# #,4.73825E+17,https://twitter.com/OmidHamidMD/status/473825274782429184,,,,
mtmdphd,6/3/2014 9:54,0,0,# ASCO14 Lauring - isogenic human cell line models - compelling pre-clinical cell line data disappointing clinically pic.twitter.com/VgtW9g0tlu,,,#,4.73825E+17,https://twitter.com/mtmdphd/status/473825061187510273,,,,
jlserna,6/3/2014 9:54,3,3,La inmunoterapia anticancer ha sido la protagonista de # ASCO14. Parece una opción prometedora. http://www.elmundo.es/salud/2014/06/03/538d8f8fca47416a3d8b456e.html …,,,#,4.73825E+17,https://twitter.com/jlserna/status/473825045618229251,,,,
aicrtweets,6/3/2014 9:53,0,0,RT @ DrAttai: Dr. Cassileth - a crucial component of integrative oncology is EXERCISE # ASCO14 # bcsm,,@,# #,4.73825E+17,https://twitter.com/aicrtweets/status/473824915150614528,,,,
cmartindedios,6/3/2014 9:53,1,0,@ ASCO # asco14 Patients Advocacy area is increasing pic.twitter.com/xEG4Ot68NJ,,@,#,4.73825E+17,https://twitter.com/cmartindedios/status/473824792177422336,,,,
drsam,6/3/2014 9:53,1,1,@ DrStelling @ mtmdphd Inside industry in my experience it's a screen but (hopefully) nvr enough for go/no-go to the clinic anymore. # ASCO14,,@ @,#,4.73825E+17,https://twitter.com/drsam/status/473824763282857984,,,,
mtmdphd,6/3/2014 9:51,0,1,# ASCO14 Lauring - Use of isogenic human cell line models - PI3K pathway mut respond diff to pathway inhibitors pic.twitter.com/yLktOHIt3D,,,#,4.73824E+17,https://twitter.com/mtmdphd/status/473824372176592897,,,,
MaverickNY,6/3/2014 9:51,2,2,Google Cancer Proteasome cbio portal to see the data Dr Mills is discussing. Downloadable. # asco14,,,#,4.73824E+17,https://twitter.com/MaverickNY/status/473824271811493889,,,,
drsam,6/3/2014 9:51,5,2,@ DrStelling @ mtmdphd @ drsam: @ DrStelling @ mtmdphd Oooh ... Both me and @ xkcdComic would disagree ... # ASCO14 pic.twitter.com/dtvWAFEUVP,,@ @ @ @ @ @,#,4.73824E+17,https://twitter.com/drsam/status/473824232603131905,,,,
scientre,6/3/2014 9:50,1,1,Lauring: PI3KCA and AKT1 mutations in a luminal breast cancer model # asco14 CCR2013 paper pic.twitter.com/4TaCy06Ht9,,,#,4.73824E+17,https://twitter.com/scientre/status/473824063362973696,,,,
myCME,6/3/2014 9:50,0,0,Molecular Subtyping Pinpoints Optimal # BreastCancer Treatment via @chemoadvisor http://ow.ly/xvgNw # ASCO14 # bcsm,,@chemoadvisor,# # #,4.73824E+17,https://twitter.com/myCME/status/473823988108759040,,,,
Roche,6/3/2014 9:50,12,10,What does it mean if there is a hazard ratio of 1? Test your clinical trials IQ: http://ow.ly/xwz8d # ASCO14 # pharma,,,# #,4.73824E+17,https://twitter.com/Roche/status/473823980886192129,,,,
OmidHamidMD,6/3/2014 9:49,1,2,@ ASCO # ASCO14 Jeff Infante @ SarahCannonDocs educating me us on Innovative Strategies for Combination therapy # thefutureofcancercare,,@ @,# #,4.73824E+17,https://twitter.com/OmidHamidMD/status/473823875612958722,,,,
mtmdphd,6/3/2014 9:49,1,0,# ASCO14 Lauring - Use of isogenic human cell line models - Comparison of PIK3CA & AKT1 mut in luminal breast CA model pic.twitter.com/u7rCPHO0Xq,,,#,4.73824E+17,https://twitter.com/mtmdphd/status/473823839336427521,,,,
DrStelling,6/3/2014 9:48,0,0,@ drsam @ mtmdphd Life: it's *not* a physical science. Yet! :) # ASCO14,,@ @,#,4.73824E+17,https://twitter.com/DrStelling/status/473823652216320000,,,,
drdonsdizon,6/3/2014 9:48,11,9,"# ASCO14: 5 Stories that stick with me: 1) Prostate cancer, give chemo earlier in high-risk patients. http://abstracts.asco.org/144/AbstView_144_127755.html …",,,#,4.73824E+17,https://twitter.com/drdonsdizon/status/473823650802462722,,,,
IrishCancerReg,6/3/2014 9:48,0,0,Study suggests combing two innovative treatments for malignant melanoma may help improve survival rates.See http://www.irishhealth.com/article.html?id=23697 … # ASCO14,,,#,4.73824E+17,https://twitter.com/IrishCancerReg/status/473823574193876992,,,,
SeanKhozin,6/3/2014 9:48,0,0,Chemo a thing of the past soon? Dr. Pazdur on new cancer treatments. It's great to be part of his team at FDA # ASCO14 http://goo.gl/kihKHb,,,#,4.73824E+17,https://twitter.com/SeanKhozin/status/473823553297465344,,,,
megtirrell,6/3/2014 9:47,4,3,Second clip from $ CLVS CEO intvw is up -- Mahaffy on competition with $ AZN: http://video.cnbc.com/gallery/?video=3000280995&play=1 … # ASCO14,,,#,4.73823E+17,https://twitter.com/megtirrell/status/473823402038661120,,,,
MaverickNY,6/3/2014 9:47,3,6,Wow what Gordon Mills and his team at MDACC are doing in proteomics is mind blowing! # asco14,,,#,4.73823E+17,https://twitter.com/MaverickNY/status/473823335194066944,,,,
mtmdphd,6/3/2014 9:47,0,1,# ASCO14 Lauring - Use of isogenic human cell line models - Knock-in PIK3CA mut activates mult onco pathways. # bcsmpic.twitter.com/KYX4pk8dcx,,,# #,4.73823E+17,https://twitter.com/mtmdphd/status/473823292235595777,,,,
TuftsB,6/3/2014 9:47,1,0,Innovation is not a car. You don't turn the key to start.or stop. It must be an ongoing uninterrupted process # mliwi # asco14,,,# #,4.73823E+17,https://twitter.com/TuftsB/status/473823202071052288,,,,
cmartindedios,6/3/2014 9:45,1,0,@ asco # asco14 Patient engagement on the internet @ Roche_spain @rodas_spainpic.twitter.com/AQHVi0YSnK,,@ @ @rodas_spainpic,#,4.73823E+17,https://twitter.com/cmartindedios/status/473822900202778624,,,,
drdonsdizon,6/3/2014 9:45,0,1,"Impressive stats! MT @ mtmdphd: >48K Tweets. N=10,313. >160M Impressions. # ASCO14 analytics: via @ symplur http://ow.ly/xzeF5 [5/1-6/3]",,@ @,#,4.73823E+17,https://twitter.com/drdonsdizon/status/473822844967591936,,,,
scientre,6/3/2014 9:45,1,0,Lauring: approach they use for gene editing is AAV mediated homologous recombination # asco14 pic.twitter.com/6CbSeAXygp,,,#,4.73823E+17,https://twitter.com/scientre/status/473822823501541376,,,,
SpecialtyPTimes,6/3/2014 9:45,0,0,‘Smart’ Alkylator TH-302 Shows Clinical Benefit in Early Multiple Myeloma Trial # ASCO14 http://ow.ly/xzjAc,,,#,4.73823E+17,https://twitter.com/SpecialtyPTimes/status/473822799329775617,,,,
merck_es,6/3/2014 9:45,2,0,Los mitos de las dietas anticáncer # ASCO14 @ elmundosalud http://ow.ly/xxMYc,,@,#,4.73823E+17,https://twitter.com/merck_es/status/473822778073051136,,,,
evaluatepharma,6/3/2014 9:45,0,0,# ASCO14 – Cell therapy gets a hearing with early NCI data http://ow.ly/xznzv $ DNDN $ ABPI $ AGEN $ BVTIQ $ GSK $ NLNK,,,#,4.73823E+17,https://twitter.com/evaluatepharma/status/473822777028661248,,,,
CheckOrphan,6/3/2014 9:45,0,1,Improved early diagnosis proactive treatment in rare genetic cancer # ASCO2014 # OvarianCancer # PleuropulmonaryBlastoma http://ow.ly/xztaG,,,# # #,4.73823E+17,https://twitter.com/CheckOrphan/status/473822775057346560,,,,
mtmdphd,6/3/2014 9:45,0,1,# ASCO14 Lauring - Use of isogenic human cell line models - AAV-mediated homologous recombination pic.twitter.com/TkUeF4JV7F,,,#,4.73823E+17,https://twitter.com/mtmdphd/status/473822745457741824,,,,
AlpineBV_Miller,6/3/2014 9:45,0,0,@ adamfeuerstein Only wimps leave early. # ASCO14,,@,#,4.73823E+17,https://twitter.com/AlpineBV_Miller/status/473822665556643840,,,,
mtmdphd,6/3/2014 9:44,0,0,# ASCO14 Lauring - Use of isogenic human cell line models - Gene editing technologies - Cai & Yang Curr Gene Ther 2014 pic.twitter.com/NwMpGYSV0I,,,#,4.73823E+17,https://twitter.com/mtmdphd/status/473822573956837376,,,,
scientre,6/3/2014 9:44,1,0,Lauring: slide with overview of gene editing technologies # asco14 pic.twitter.com/yTKfurRE2o,,,#,4.73823E+17,https://twitter.com/scientre/status/473822555930124288,,,,
Neil_Gottlieb,6/3/2014 9:44,0,0,Really well done # ASCO14 A well run and well attended event. See you in 2015.,,,#,4.73822E+17,https://twitter.com/Neil_Gottlieb/status/473822447519932416,,,,
mtmdphd,6/3/2014 9:43,1,0,# ASCO14 Lauring Use of isogenic human cell line models 2 predict driver mut effects on drug sensitivity or resist pic.twitter.com/arU5Tt3r3i,,,#,4.73822E+17,https://twitter.com/mtmdphd/status/473822397749923840,,,,
scientre,6/3/2014 9:43,1,0,Lauring: isogenic comparisons diminish confounding by other generic changes in the cell # ASCO14,,,#,4.73822E+17,https://twitter.com/scientre/status/473822371078750208,,,,
drsam,6/3/2014 9:43,1,3,"@ DrStelling @ mtmdphd Oh, Dr. Spelling, you had me at spatio-temporal"" # neildegrastyson # convergence # science # ASCO14""",,@ @,# # # #,4.73822E+17,https://twitter.com/drsam/status/473822282281144321,,,,
DrStelling,6/3/2014 9:43,0,0,@ mtmdphd Are these 3D tissue cell cultures? Otherwise any drug screening w them may be meaningless in vivo. # ASCO14,,@,#,4.73822E+17,https://twitter.com/DrStelling/status/473822251565858816,,,,
scientre,6/3/2014 9:42,1,0,Lauring on somatic cell gene targeting # asco14 isogenic human cell line models pic.twitter.com/IdbTWhDyP3,,,#,4.73822E+17,https://twitter.com/scientre/status/473822131609174016,,,,
drsam,6/3/2014 9:42,1,2,The # NewYorker for the win! # ASCO14 # iphone # apple # FTWpic.twitter.com/kdKYWyCMLs,,,# # # # #,4.73822E+17,https://twitter.com/drsam/status/473821916638502912,,,,
MyelomaUK,6/3/2014 9:42,2,1,Our Tuesday round-up from # ASCO14 brings together # myeloma highlights from the largest int'l cancer conference http://bit.ly/1rBALUX,,,# #,4.73822E+17,https://twitter.com/MyelomaUK/status/473821906705997824,,,,
sdaryanani,6/3/2014 9:41,1,0,Que se prohíba la venta de cigarrillos libres de impuesto a nivel mundial # ASCO14,,,#,4.73822E+17,https://twitter.com/sdaryanani/status/473821897797672960,,,,
mtmdphd,6/3/2014 9:41,2,0,# ASCO14 Lauring - Use of isogenic human cell line models - Mohseni & Park JCI 2010 pic.twitter.com/9jdaRyVoSW,,,#,4.73822E+17,https://twitter.com/mtmdphd/status/473821866742661121,,,,
mtmdphd,6/3/2014 9:41,0,1,# ASCO14 Lauring - Use of isogenic human cell line models pic.twitter.com/2uZyYHx2jJ,,,#,4.73822E+17,https://twitter.com/mtmdphd/status/473821737939787776,,,,
GenentechJobs,6/3/2014 9:40,0,0,Last day in Chicago. It was terrific catching up with industry colleagues and making new connections during # ASCO14.,,,#,4.73822E+17,https://twitter.com/GenentechJobs/status/473821617026379776,,,,
martinfrogers,6/3/2014 9:40,0,0,Incyte's $ INCY 'IDO' Cancer Immunotherapy Causes Investor Scrum at # ASCO14 http://www.thestreet.com/story/12730378/1/incytes-ido-cancer-immunotherapy-causes-investor-scrum-at-asco-14.html … what about $ PBMD $ PRR for ovarian cancer?,,,#,4.73821E+17,https://twitter.com/martinfrogers/status/473821418996514816,,,,
PresCancerPanel,6/3/2014 9:40,0,1,RT @ CancerDotNet: Want a recap of # cancer research headlines since the start of # ASCO14? Find them here: http://bit.ly/S2wtW2,,@,# #,4.73821E+17,https://twitter.com/PresCancerPanel/status/473821418841722880,,,,
TuftsB,6/3/2014 9:39,0,0,@ rschilsky @ ASCO -we must have bureaucrats but they must add value to each and every individual patient. No rationing allowed # mliwi # ASCO14,,@ @,# #,4.73821E+17,https://twitter.com/TuftsB/status/473821355012788224,,,,
giasison,6/3/2014 9:39,3,1,+1000/RT @ DrAttai: Dr. Cassileth - a crucial component of integrative oncology is EXERCISE # ASCO14 # bcsm,,@,# #,4.73821E+17,https://twitter.com/giasison/status/473821350742593536,,,,
NotreTemps,6/3/2014 9:39,0,0,Bonne nouvelle: vivre plus longtemps avec un cancer avancé de la # prostate @ ASCO http://urlz.fr/q5s,,@,#,4.73821E+17,https://twitter.com/NotreTemps/status/473821335098241025,,,,
mtmdphd,6/3/2014 9:39,1,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - Cancer Combo Rx related to Magic J and HIV Rx pic.twitter.com/0CoqsAvi9Q,,,#,4.73821E+17,https://twitter.com/mtmdphd/status/473821316588384256,,,,
scientre,6/3/2014 9:39,2,0,Infante points out models of combos PI3K + MEK were fantastic. Was in clinic that saw the issues # ASCO14 Better preclinical models?,,,#,4.73821E+17,https://twitter.com/scientre/status/473821231708647424,,,,
ECMC_UK,6/3/2014 9:38,0,0,Innovative combination session at # ASCO14 demonstrates successful serial and parallel combinations but issues with tolerability of regimes,,,#,4.73821E+17,https://twitter.com/ECMC_UK/status/473821126213132291,,,,
ThisIsHillarie,6/3/2014 9:38,0,0,“ @ CureMelanoma: Ipilimumab Safety Issues Remain http://ow.ly/xzdIY # melanoma # cancer # ASCO14” too toxic for @ omnibishop,,@ @,# # #,4.73821E+17,https://twitter.com/ThisIsHillarie/status/473821075659571201,,,,
cmartindedios,6/3/2014 9:38,1,0,@ asco # asco14 pic.twitter.com/T1VqKAOXCI,,@,#,4.73821E+17,https://twitter.com/cmartindedios/status/473820961146679296,,,,
mtmdphd,6/3/2014 9:38,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - With better drugs can exploit pathways rationally. pic.twitter.com/6sqJ6H3KxH,,,#,4.73821E+17,https://twitter.com/mtmdphd/status/473820921820495872,,,,
aliepea,6/3/2014 9:37,2,0,"Wow, thanks @ERJournals We loved your article on # cancer mortality cost and have tweeted it to celebrate # ASCO14! http://bit.ly/ERASCO ”""",,@ERJournals,# #,4.73821E+17,https://twitter.com/aliepea/status/473820896009134080,,,,
scientre,6/3/2014 9:37,4,3,"Infante: 1 of greatest disappointment in combos PI3K + MEK because tox, can't get to regimens pts can handle # asco14 pic.twitter.com/Hq2HvNRtNA",,,#,4.73821E+17,https://twitter.com/scientre/status/473820811548438528,,,,
mtmdphd,6/3/2014 9:37,0,0,"# ASCO14 Infante - Serial vs Parallel Pathway Inhib - PI3K + MEK impressive in cell lines, tough in pts pic.twitter.com/38o8mcu8dl",,,#,4.73821E+17,https://twitter.com/mtmdphd/status/473820754606174208,,,,
MaverickNY,6/3/2014 9:37,5,7,Ooh Dr Carbonne discussing how proteomics can identify pats with wt EGFR or squamous lung cancer who might respond to erlotinib # asco14,,,#,4.73821E+17,https://twitter.com/MaverickNY/status/473820720527847424,,,,
MsDonnaChung,6/3/2014 9:37,3,0,@ bbchealth: Skin cancer trial results 'exciting' # ASCO14 @ RoyalFreeNHS @ UCLPartners http://www.bbc.co.uk/news/health-27674658 …,,@ @ @,#,4.73821E+17,https://twitter.com/MsDonnaChung/status/473820686126157824,,,,
TuftsB,6/3/2014 9:37,0,0,@ rschilsky @ ASCO - value involves more than return per $. Involved being there for life cycle moments that can't be quantified #mliwi#asco14,,@ @,#mliwi #asco14,4.73821E+17,https://twitter.com/TuftsB/status/473820661753057280,,,,
mtmdphd,6/3/2014 9:36,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - PI3K + MEK - parallel pic.twitter.com/DWkH98Be9y,,,#,4.73821E+17,https://twitter.com/mtmdphd/status/473820557830402049,,,,
carisls,6/3/2014 9:36,2,0,Caris' Research Suggests Immune-targeted Therapies in Subsets of Patients w/ Triple Negative # BreastCancer http://goo.gl/9Kds0P # ASCO14,,,# #,4.7382E+17,https://twitter.com/carisls/status/473820397712859136,,,,
sonialf,6/3/2014 9:35,1,0,The Changing Landscape of # Palliative Care | ASCO Annual Meeting http://am.asco.org/changing-landscape-palliative-care#.U43PGgkxI-8.twitter … @ fischmd # asco14 # hpmglobal,,@,# # # #,4.7382E+17,https://twitter.com/sonialf/status/473820377085255680,,,,
mtmdphd,6/3/2014 9:35,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - Proof of concept for parallel inhib - AI + mTOR. # bcsmpic.twitter.com/I41PD6v3EN,,,# #,4.7382E+17,https://twitter.com/mtmdphd/status/473820323456876547,,,,
PCORI,6/3/2014 9:35,1,1,Get a preview @http://www.pcornet.org MT @GSK_conferences: Are you aware of @ PCORI's pcornet? … # ASCO14,,@http @GSK_conferences @,#,4.7382E+17,https://twitter.com/PCORI/status/473820275478630400,,,,
corp_UNC,6/3/2014 9:35,0,0,Managing comorbidities in oncology: RCT of contin'g vs discont'g statins in setting of life-limiting illness # asco14 http://ow.ly/xqATW,,,#,4.7382E+17,https://twitter.com/corp_UNC/status/473820206964695040,,,,
scientre,6/3/2014 9:35,0,0,"Infante: with PI3K + MTOR combo, situation was different. Off target effects (side effects) made difficult for patients to handle # ASCO14",,,#,4.7382E+17,https://twitter.com/scientre/status/473820205467328512,,,,
mtmdphd,6/3/2014 9:35,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - parallel AI + mTOR # bcsmpic.twitter.com/fkjcBAC3LS,,,# #,4.7382E+17,https://twitter.com/mtmdphd/status/473820163217715200,,,,
jrgralow,6/3/2014 9:34,0,1,Great MT @ UCCancerCenter: Artz shares expernce as caregvr & oncologist don't try to walk in pt's shoes," just make shoes fit better"" # ASCO14""",,@,#,4.7382E+17,https://twitter.com/jrgralow/status/473820097854050304,,,
sonialf,6/3/2014 9:34,1,1,"MT @ fischmd What's in the # palliative syringe? 45% communication, 30% interdisciplinary teamwork, and 25% symptom management. # ASCO14",,@,# #,4.7382E+17,https://twitter.com/sonialf/status/473820073321168896,,,,
mtmdphd,6/3/2014 9:34,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - PI3K + mTOR -> toxicity pic.twitter.com/haK2cJGnJ3,,,#,4.7382E+17,https://twitter.com/mtmdphd/status/473820009005711360,,,,
mtmdphd,6/3/2014 9:33,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - PI3K + mTOR - not as much success pic.twitter.com/SFChl1o9mX,,,#,4.7382E+17,https://twitter.com/mtmdphd/status/473819782731411456,,,,
scientre,6/3/2014 9:33,2,1,Infante on BRAFi + MEKi combinations: impt to remember that we were able to give full dose of both # ASCO14,,,#,4.7382E+17,https://twitter.com/scientre/status/473819755506593792,,,,
mtmdphd,6/3/2014 9:32,1,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - BRAF + MEK # melsmpic.twitter.com/2imK6FoHXd,,,# #,4.7382E+17,https://twitter.com/mtmdphd/status/473819639474966528,,,,
VUMChealth,6/3/2014 9:32,0,1,We agree! MT @ subatomicdoc: @ ASCO Thank you for leading the way for 5 decades. # ASCO14,,@ @,#,4.7382E+17,https://twitter.com/VUMChealth/status/473819609972613121,,,,
CynthiaManley,6/3/2014 9:32,0,0,"@ UCCancerCenter Wow, that is powerful. I hope you are enjoying # ASCO14! Wish I were there. Miss getting my cancer science geek on.",,@,#,4.73819E+17,https://twitter.com/CynthiaManley/status/473819448215101440,,,,
mtmdphd,6/3/2014 9:32,0,1,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - often start at 50% dose for combo and ramp up fast --> get tox pic.twitter.com/lQ2cg6zRk7,,,#,4.73819E+17,https://twitter.com/mtmdphd/status/473819426010066944,,,,
jtriestm,6/3/2014 9:31,0,1,Neoadjuvant Chemotherapy as Initial Treatment in Advanced Ovarian Cancer May Decrease Complications | # ASCO14 http://am.asco.org/neoadjuvant-chemotherapy-initial-treatment-advanced-ovarian-cancer-may-decrease-complications#.U43OOdO1_FQ.twitter …,,,# #,4.73819E+17,https://twitter.com/jtriestm/status/473819384972972033,,,,
AlpineBV_Miller,6/3/2014 9:31,0,1,"ASCO Daily News! Find out why thousands of doctors are fleeing Chicago!"" # ASCO14""",,,#,4.73819E+17,https://twitter.com/AlpineBV_Miller/status/473819268136837120,,,,
corp_UNC,6/3/2014 9:31,0,0,Nice Reeder-Hayes/Carey comment on VazLuis & Fehrenbacher # asco14 HER2+ breast ca studies http://m.jco.ascopubs.org/content/early/2014/06/02/JCO.2014.55.7249.full.pdf#page=1 … # bcsm @ ASCO via # JCO,,@,# #page # #,4.73819E+17,https://twitter.com/corp_UNC/status/473819249887416320,,,,
VUMChealth,6/3/2014 9:31,1,0,"MT @ UCCancerCenter: Andy Artz shares as caregiver, oncologist don't try to walk in patient's shoes"," just make shoes fit better"" # ASCO14""",,@,#,4.73819E+17,https://twitter.com/VUMChealth/status/473819245890269184,,,
Roche,6/3/2014 9:31,1,0,It's the last day of # ASCO14. What were your highlights of the conference?,,,#,4.73819E+17,https://twitter.com/Roche/status/473819198691753984,,,,
SequentaInc,6/3/2014 9:31,1,1,"Ciao # ASCO14! It’s been fun, but now to # EHA19. Sequenta will share # MRD data in four presentations http://ow.ly/xxXol",,,# # #,4.73819E+17,https://twitter.com/SequentaInc/status/473819186440196096,,,,
jtriestm,6/3/2014 9:31,0,1,NGS Identified Genetic Alterations in Paired Samples of Ovarian Cancer | # ASCO14 http://am.asco.org/ngs-identified-genetic-alterations-paired-samples-ovarian-cancer#.U43N8HjBoW8.twitter …,,,# #,4.73819E+17,https://twitter.com/jtriestm/status/473819146912681986,,,,
mtmdphd,6/3/2014 9:31,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhib - RAS/RAF/MEK vs. PI3K/AKT/mTOR pathways as examples pic.twitter.com/gmhlraxzyw,,,#,4.73819E+17,https://twitter.com/mtmdphd/status/473819142441549824,,,,
scientre,6/3/2014 9:30,1,1,Invoking electronic circuit imagery MT @ mtmdphd # ASCO14 Infante: Serial vs Parallel Pathway Inhibition pic.twitter.com/DY8B8cXNxH,,@,#,4.73819E+17,https://twitter.com/scientre/status/473819110636134400,,,,
SarahCannonDocs,6/3/2014 9:30,1,0,"# DrInfante: “Combo regimen toxicity depends on how clean/dirty the drug is, and the extent to which monotherapy toxicities overlap…” # ASCO14",,,# #,4.73819E+17,https://twitter.com/SarahCannonDocs/status/473819091678277632,,,,
jrgralow,6/3/2014 9:30,6,2,Video and transcript of # ASCO14 Presidential Address by @ CliffordHudis on social justice and cancer care. http://ow.ly/xzq2x,,@,#,4.73819E+17,https://twitter.com/jrgralow/status/473819048044949504,,,,
MediTech_Media,6/3/2014 9:30,0,0,"Insured # cancer pts receiving IV chemo in physician office vs hospital outpt setting had lower # healthcare cost, Fisher et al # ASCO14",,,# # #,4.73819E+17,https://twitter.com/MediTech_Media/status/473819020236308480,,,,
fischmd,6/3/2014 9:30,13,5,The changing landscape of palliative care http://ow.ly/xzoRL http://ow.ly/xzp9d http://ow.ly/xzpUS # hpm # ASCO14,,,# #,4.73819E+17,https://twitter.com/fischmd/status/473818989144313856,,,,
CureMelanoma,6/3/2014 9:30,1,1,Ipilimumab Cuts Relapse but Safety Issues Remain via @ medpagetoday http://ow.ly/xzdIY # melanoma # cancer # ASCO14,,@,# # #,4.73819E+17,https://twitter.com/CureMelanoma/status/473818922173886464,,,,
VUMChealth,6/3/2014 9:30,0,0,@ JFreemanDaily Our bet is that the chemist lists this as an # ASCO14 high point too. Happy for you on that NED!,,@,#,4.73819E+17,https://twitter.com/VUMChealth/status/473818913013514240,,,,
myriadgenetics,6/3/2014 9:30,1,0,Myriad will collaborate with leading experts in an innovative study to accelerate # hereditarycancer research. http://bit.ly/1u8KlfU # ASCO14,,,# #,4.73819E+17,https://twitter.com/myriadgenetics/status/473818896424648705,,,,
mtmdphd,6/3/2014 9:29,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhibition: Successes & Toxicity Limits pic.twitter.com/pGLA15cHKO,,,#,4.73819E+17,https://twitter.com/mtmdphd/status/473818875734138880,,,,
Cognicum,6/3/2014 9:29,0,0,“ @ Merck: @ ASCO Thank you for a great meeting! We've especially enjoyed the conversation in social media. # ASCO14”https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@ @,#,4.73819E+17,https://twitter.com/Cognicum/status/473818873742254081,,,,
scientre,6/3/2014 9:29,0,0,Infante: Need cancer combos because of tumor cell resistance as well as heterogeneity # ASCO14,,,#,4.73819E+17,https://twitter.com/scientre/status/473818782256087040,,,,
VUMChealth,6/3/2014 9:29,0,1,MT @ JFreemanDaily: My peak # ASCO14 patient advocate experience: meeting chemist who designed my targeted drug (which made me NED). # LCSM,,@,# #,4.73819E+17,https://twitter.com/VUMChealth/status/473818763817926658,,,,
scientre,6/3/2014 9:29,6,4,"Infante on cancer combo tx: we don't want cancer whack a mole"" # asco14 pic.twitter.com/hSZVL8Tiy6""",,,#,4.73819E+17,https://twitter.com/scientre/status/473818634297819136,,,,
mtmdphd,6/3/2014 9:28,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhibition - Whack a mole in melanoma # melsmpic.twitter.com/lJLwG2OlOk,,,# #,4.73819E+17,https://twitter.com/mtmdphd/status/473818542773506048,,,,
DavidGimenez12,6/3/2014 9:28,0,0,$ THLD. @DavidGimenez12preliminary safety and efficacy TH-302 looks promising for patients R/R multiple myeloma # ASCO14,,@DavidGimenez12preliminary,#,4.73818E+17,https://twitter.com/DavidGimenez12/status/473818482925383680,,,,
mtmdphd,6/3/2014 9:28,0,0,# ASCO14 Infante - Serial vs Parallel Pathway Inhibition pic.twitter.com/qqUUc8qcec,,,#,4.73818E+17,https://twitter.com/mtmdphd/status/473818415493177344,,,,
UCCancerCenter,6/3/2014 9:27,4,1,Andy Artz shares his experience as caregiver and oncologist don't try to walk in a patient's shoes," just make the shoes fit better"" # ASCO14""",,,#,4.73818E+17,https://twitter.com/UCCancerCenter/status/473818338343542784,,,
DrStelling,6/3/2014 9:27,0,1,@ mtmdphd Not sure how far mere genetic information will get us in the molecular war on cancer; we need biochemical phenotypes # ASCO14,,@,#,4.73818E+17,https://twitter.com/DrStelling/status/473818324779151360,,,,
LaVoieGroup,6/3/2014 9:27,0,0,Xcovery presents interim phase 1 results of X-396 in ALK+ NSCLC at # ASCO2014. http://conta.cc/1kzPbQG,,,#,4.73818E+17,https://twitter.com/LaVoieGroup/status/473818310749220864,,,,
Merck,6/3/2014 9:27,0,2,@ ASCO Thank you for a great meeting! We've especially enjoyed following the conversation in social media. # ASCO14,,@,#,4.73818E+17,https://twitter.com/Merck/status/473818208995405824,,,,
mtmdphd,6/3/2014 9:27,1,1,"# ASCO14 Infante - I'll have to have a marriage counseling session for staying at ASCO till Tues...""""",,,#,4.73818E+17,https://twitter.com/mtmdphd/status/473818140409737216,,,,
mtmdphd,6/3/2014 9:26,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - Expand PDX effort and make models widely avail pic.twitter.com/FLEIMf9y7D,,,#,4.73818E+17,https://twitter.com/mtmdphd/status/473817935996137472,,,,
MediTech_Media,6/3/2014 9:25,0,0,Prince et al: higher incidence of hospitalization in metastatic # nsclc pts receiving chemo in real life compared w # clinicaltrials # ASCO14,,,# # #,4.73818E+17,https://twitter.com/MediTech_Media/status/473817847303389185,,,,
mtmdphd,6/3/2014 9:25,0,0,"# ASCO14 Ellis ComboRx Profiling & Heterogeneity - Bayesian learning as you go"" stats designs for early stage trials pic.twitter.com/K19kXsvK0C""",,,#,4.73818E+17,https://twitter.com/mtmdphd/status/473817808267010049,,,,
scientre,6/3/2014 9:25,3,0,Ellis thoughts on how we can improve tx based on cancer mutations/rearrangements # asco14 pic.twitter.com/8rc00LfBh9,,,#,4.73818E+17,https://twitter.com/scientre/status/473817773647601665,,,,
CancerResearch,6/3/2014 9:25,0,1,This Thursday: a brand new # CIM2014 webinar. # ASCO14 Register now: http://owl.li/xswnM,,,# #,4.73818E+17,https://twitter.com/CancerResearch/status/473817683394564097,,,,
mtmdphd,6/3/2014 9:25,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - All clinical trials must have genomic consent & nl DNA collection pic.twitter.com/ei6WBySNxy,,,#,4.73818E+17,https://twitter.com/mtmdphd/status/473817631716159488,,,,
scientre,6/3/2014 9:23,3,0,Ellis: finding drugs that will impact pathways related to 1off mutns # asco14 pic.twitter.com/sji0EiDZtk,,,#,4.73817E+17,https://twitter.com/scientre/status/473817221261963264,,,,
MediTech_Media,6/3/2014 9:23,1,0,"MD Anderson study finds efficacy is overestimated/toxicity underreported in early # clinicaltrials of breast, lung, prostate # cancer # ASCO14",,,# # #,4.73817E+17,https://twitter.com/MediTech_Media/status/473817161388294144,,,,
DrStelling,6/3/2014 9:23,0,0,"@mrnaley We are a v long way from curing"" death. MDs (esp in USA) need to internalize this & alter priorities # ASCO14""",,@mrnaley,#,4.73817E+17,https://twitter.com/DrStelling/status/473817146569408512,,,,
mtmdphd,6/3/2014 9:22,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - best assay for cancer will be an unbiased screen of the cancer genome not panels,,,#,4.73817E+17,https://twitter.com/mtmdphd/status/473817116156510210,,,,
AMarshallMD,6/3/2014 9:22,0,0,@ ASCO New addition to # myeloma treatment options - Panobinostat added to velcade/dex prolongs survival http://meetinglibrary.asco.org/content/125334-144 …,,@,#,4.73817E+17,https://twitter.com/AMarshallMD/status/473817053145874432,,,,
scientre,6/3/2014 9:22,1,0,Ellis talking about vast majority of non recurrent mutations. How to handle 1 off mutns? # asco14 pic.twitter.com/mS8n6OijQI,,,#,4.73817E+17,https://twitter.com/scientre/status/473816902708789248,,,,
MaverickNY,6/3/2014 9:21,0,0,"Haha! RT @ Gene_Antibody: After 4 days of # ASCO14, my disulfide bonds are breaking! Hopefully hoverboards are invented in # Next50!",,@,# #,4.73817E+17,https://twitter.com/MaverickNY/status/473816870077091840,,,,
ASCOPost,6/3/2014 9:21,5,4,Ibrutinib Significantly Delays Disease Progression and Extends Survival in Relapsed CLL http://ow.ly/xzojy # ASCO14 # lylsm # lylcl,,,# # #,4.73817E+17,https://twitter.com/ASCOPost/status/473816827223875584,,,,
MayoCancerCare,6/3/2014 9:21,1,1,"Immunotherapy may be an option in challenging # BreastCancer, @ MayoClinic study finds: http://mayocl.in/1n6i5rq # ASCO14",,@,# #,4.73817E+17,https://twitter.com/MayoCancerCare/status/473816630389387266,,,,
DCPatient,6/3/2014 9:20,0,2,“ @ MDAndersonNews: How the Joy Diet helps one # cancersurvivor: http://bit.ly/1pCt3bo # cancer # endcancer pic.twitter.com/mRcJWJ855B” # ASCO14,,@,# # # #,4.73817E+17,https://twitter.com/DCPatient/status/473816587318083584,,,,
martinnaley,6/3/2014 9:20,0,0,"Patients value quality of life and symptom control, often not the same endpoint criteria that oncology trials measure. # ASCO14",,,#,4.73817E+17,https://twitter.com/martinnaley/status/473816561510547456,,,,
DustinSmithPhD,6/3/2014 9:20,0,0,"MET may be impt to cancer, but maybe it enlists other proteins that make tumors grow - A. Sandler # ASCO14 http://ow.ly/xwq4K",,,#,4.73817E+17,https://twitter.com/DustinSmithPhD/status/473816561090715648,,,,
LungCancerFaces,6/3/2014 9:20,1,2,Congratulations! Thank you for sharing it with us! @ Tony_Calles: It's out there # ASCO14 # LCSM pic.twitter.com/Oqx5AmipkE”,,@,# #,4.73817E+17,https://twitter.com/LungCancerFaces/status/473816555219091457,,,,
Gene_Antibody,6/3/2014 9:20,1,1,"After 4 days of # ASCO14, my disulfide bonds are breaking! Hopefully hoverboards are invented in # Next50!",,,# #,4.73816E+17,https://twitter.com/Gene_Antibody/status/473816454727757826,,,,
mtmdphd,6/3/2014 9:20,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - Li et al Cell Reports 2013 - ESR1 variants endocrince Res. # bcsmpic.twitter.com/a535HzWedX,,,# #,4.73816E+17,https://twitter.com/mtmdphd/status/473816446133231616,,,,
scientre,6/3/2014 9:20,2,0,Ellis: getting closer to patients by modeling tx in pt derived xenografts Li et al Cell Reports 2013 # asco14 pic.twitter.com/3OdXUWcHcm,,,#,4.73816E+17,https://twitter.com/scientre/status/473816416626679808,,,,
drcbsteer,6/3/2014 9:19,10,1,# ASCO14 # thingsIhavelearned # melanoma PD-1+IPI combination- Higher RR and Unprecedented 2 year survival rate = 88% (in 3mg IPI cohort),,,# # #,4.73816E+17,https://twitter.com/drcbsteer/status/473816276230737920,,,,
mtmdphd,6/3/2014 9:19,0,0,"# ASCO14 Ellis ComboRx Profiling & Heterogeneity - Patient derived xenografts - estab the genomic oncology playbook"" pic.twitter.com/H3QSZRT92N""",,,#,4.73816E+17,https://twitter.com/mtmdphd/status/473816148715110400,,,,
MoffittNews,6/3/2014 9:18,0,1,Thank you @ Kbiopharm of @ BioPharmInsight for speaking with our Dr. Hatem Soliman at # ASCO14 http://ow.ly/i/5MibH,,@ @,#,4.73816E+17,https://twitter.com/MoffittNews/status/473815945186910208,,,,
jrgralow,6/3/2014 9:18,0,0,"Despite Lukewarm Clinical Benefit of PI3K Inhibitors, Optimism Remains Regarding Biomarkers & Combinations # ASCO14 http://am.asco.org/despite-lukewarm-clinical-benefit-pi3k-inhibitors-optimism-remains-regarding-biomarkers-and#.U43K8LdTkRU.twitter …",,,# #,4.73816E+17,https://twitter.com/jrgralow/status/473815932586844160,,,,
mtmdphd,6/3/2014 9:18,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - an answer to the ALTTO trial... pic.twitter.com/sxQT29RIMJ,,,#,4.73816E+17,https://twitter.com/mtmdphd/status/473815921174130688,,,,
scientre,6/3/2014 9:17,1,1,Ellis: describing breast cancer trial with genomic triage and phenotypic monitoring # asco14 pic.twitter.com/VlrChzxKTJ,,,#,4.73816E+17,https://twitter.com/scientre/status/473815812789530624,,,,
DrMarkham,6/3/2014 9:17,0,0,@ ASCO My pleasure!,,@,,4.73816E+17,https://twitter.com/DrMarkham/status/473815742442635264,,,,
subatomicdoc,6/3/2014 9:17,4,0,Oligometastatic non-small cell # lungcancer treated with curative intent http://bit.ly/1jZXZim # ASCO14 # lcsm,,,# # #,4.73816E+17,https://twitter.com/subatomicdoc/status/473815660712456192,,,,
drsam,6/3/2014 9:17,0,1,"Via @ DShaywitz - wow, look at how liberal us # pediatric # oncologists are. Proud to be in the # LLQ # ASCO14 pic.twitter.com/HqAftcrmLM",,@,# # # #,4.73816E+17,https://twitter.com/drsam/status/473815637295632384,,,,
MRFCureOM,6/3/2014 9:17,0,0,"RT @ CureMelanoma: The main # melanoma session at # ASCO14 was packed w melanoma researchers, oncologists, scientists… http://instagram.com/p/oyIKZMulbz/",,@,# #,4.73816E+17,https://twitter.com/MRFCureOM/status/473815625090215936,,,,
mtmdphd,6/3/2014 9:16,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - how do we combine Rx? Genomic triage and phenotypic monitoring pic.twitter.com/IH0HuT0489,,,#,4.73816E+17,https://twitter.com/mtmdphd/status/473815574460375040,,,,
taniatsu,6/3/2014 9:16,0,0,"ワクチン接種したほうがいいのかな(~_~;) RT @ narumita: _φ(･_･  @ teamoncology: オーラルセックスは、咽頭がんのリスクである。 # ASCO14""""",,@ @,#,4.73816E+17,https://twitter.com/taniatsu/status/473815532261474305,,,,
martinnaley,6/3/2014 9:16,0,0,"Ethan Basch: With increasing emphasis on value in healthcare, how can we assess value without input from patients themselves? # ASCO14",,,#,4.73816E+17,https://twitter.com/martinnaley/status/473815521356705792,,,,
CureMelanoma,6/3/2014 9:16,0,1,"The main # melanoma session at # ASCO14 was packed full of melanoma researchers, oncologists, scientists… http://instagram.com/p/oyIKZMulbz/",,,# #,4.73815E+17,https://twitter.com/CureMelanoma/status/473815406721785856,,,,
scientre,6/3/2014 9:16,2,0,"Ellis: therapeutic roadmap for luminal type breast cancer # asco14 biology roadmap Cancer Disc 2013, 3, 27 pic.twitter.com/d6InrfKWwz",,,#,4.73815E+17,https://twitter.com/scientre/status/473815396148338688,,,,
mtmdphd,6/3/2014 9:16,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - MDM2i in BrCA based on therapeutic roadmap... # bcsm,,,# #,4.73815E+17,https://twitter.com/mtmdphd/status/473815391274160128,,,,
nbferrara,6/3/2014 9:15,0,1,Chemo following radiation improves survival in adults w/ low-grade brain cancer: http://mayocl.in/1krxse3 # ASCO14,,,#,4.73815E+17,https://twitter.com/nbferrara/status/473815260567453696,,,,
HealthCoreRWE,6/3/2014 9:15,0,0,Oncologist-owned practices provide care and treatment for cancer patients that costs less @ HealthCoreRWE # asco14 http://ow.ly/i/5LOld,,@,#,4.73815E+17,https://twitter.com/HealthCoreRWE/status/473815225234624512,,,,
mtmdphd,6/3/2014 9:14,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - Roadmap for Luminal-type Breast Cancer # bcsmpic.twitter.com/Yz76k8vEr3,,,# #,4.73815E+17,https://twitter.com/mtmdphd/status/473815109525966849,,,,
ahkeenan,6/3/2014 9:14,0,1,Lilly's CYRAMZA improves overall survival in # nsclc http://goo.gl/lLRFIZ # ASCO14,,,# #,4.73815E+17,https://twitter.com/ahkeenan/status/473815051032215553,,,,
jrgralow,6/3/2014 9:14,0,0,ASCO Honors 50th Anniversary of Surgeon Generals Report with Continued Tobacco Cessation Efforts # ASCO14 http://am.asco.org/asco-honors-50th-anniversary-surgeon-generals-report-continued-tobacco-cessation-efforts#.U43KICDqaqo.twitter …,,,# #,4.73815E+17,https://twitter.com/jrgralow/status/473814977313132545,,,,
GuardantHealth,6/3/2014 9:14,1,3,Avail online: 'Use of GUARDANT360 noninvasive tumor sequencing assay on 300 patients..' http://abstracts.asco.org/144/AbstView_144_135280.html … # Cancer # ASCO14 # Guardant360,,,# # #,4.73815E+17,https://twitter.com/GuardantHealth/status/473814971219193856,,,,
scientre,6/3/2014 9:14,3,0,Ellis: what are the actionable targets? Slide with breast cancer data # asco14 pic.twitter.com/NLhk9dGEbR,,,#,4.73815E+17,https://twitter.com/scientre/status/473814968874582016,,,,
drsam,6/3/2014 9:14,0,0,"Last day of # ASCO14 : one more # immunotherapy session and catching up with old friends and colleagues, then home.",,,# #,4.73815E+17,https://twitter.com/drsam/status/473814927681925120,,,,
FoundationATCG,6/3/2014 9:13,1,1,"There are still options for pan-neg ADC # LCSM: # FoundationOne identifies actionable alterations Poster HiLi: 8-11, E354b, Ab 8029 # ASCO14",,,# # #,4.73815E+17,https://twitter.com/FoundationATCG/status/473814826209517568,,,,
mtmdphd,6/3/2014 9:13,0,0,# ASCO14 Ellis - ComboRx Profiling & Heterogeneity - Big data creates excitement for new targets but also frustration pic.twitter.com/6cufaiYD7G,,,#,4.73815E+17,https://twitter.com/mtmdphd/status/473814802393886721,,,,
FoundationATCG,6/3/2014 9:13,1,0,"Potential new molec tgt in # LCSM identified by comprehensive # genomic profiling by # FoundationOne Poster HiLi: 8-11, E354b, Ab 8027 # ASCO14",,,# # # #,4.73815E+17,https://twitter.com/FoundationATCG/status/473814708630585344,,,,
scientre,6/3/2014 9:13,1,0,Ellis on genomic complexity of cancer # asco14 Mentions potl use circulating DNA as marker pic.twitter.com/uFA0rrMKsj,,,#,4.73815E+17,https://twitter.com/scientre/status/473814645837692928,,,,
mtmdphd,6/3/2014 9:12,0,0,# ASCO14 Ellis - ComboRx based on Profiling and Heterogeneity - complexity creates opportunity...eg ctDNA Pt tracking of cancer,,,#,4.73815E+17,https://twitter.com/mtmdphd/status/473814546776219648,,,,
kino_56,6/3/2014 9:12,0,0,@ ASCO: Bevacizumab + chemo = no benefit in HER2- breast cancer; may signal end of bevacizumab in this setting http://bit.ly/1wUvPLb # ASCO14,,@,#,4.73815E+17,https://twitter.com/kino_56/status/473814502832885762,,,,
mtmdphd,6/3/2014 9:12,1,0,# ASCO14 Ellis - ComboRx based on Profiling and Heterogeneity - Genomic Complexity pic.twitter.com/yfPOTm1Ogm,,,#,4.73814E+17,https://twitter.com/mtmdphd/status/473814449770340352,,,,
scientre,6/3/2014 9:12,1,0,"Ellis: breast cancer subtypes: luminal B, HER2, Claudine low , Basal like, Lumin A # asco14 pic.twitter.com/fVakKFkEyv",,,#,4.73814E+17,https://twitter.com/scientre/status/473814386982027264,,,,
jrgralow,6/3/2014 9:11,3,3,Dr. Aron Goldhirsch Receives # ASCO14 Gianni Bonadonna Breast Cancer Award and Lecture http://am.asco.org/dr-aron-goldhirsch-receives-2014-gianni-bonadonna-breast-cancer-award-and-lecture#.U43JVPQFPpU.twitter …,,,# #,4.73814E+17,https://twitter.com/jrgralow/status/473814213597491200,,,,
mtmdphd,6/3/2014 9:11,0,0,# ASCO14 Ellis - ComboRx based on Profiling and Heterogeneity - Breast Cancer subtypes # bcsmpic.twitter.com/HvcJZxEX9Z,,,# #,4.73814E+17,https://twitter.com/mtmdphd/status/473814196946096128,,,,
MediTech_Media,6/3/2014 9:10,0,0,"Most common concurrent mutations in pts with KRAS mutant adeno lung # cancer include TP53, APC, TSC1, STK11, Riely et al # ASCO14",,,# #,4.73814E+17,https://twitter.com/MediTech_Media/status/473813982302961664,,,,
ventana,6/3/2014 9:10,0,0,Great dialogue on social media's role in clinical trials http://ow.ly/xrF8Q # ASCO14 # cancerresearch,,,# #,4.73814E+17,https://twitter.com/ventana/status/473813938682204160,,,,
scientre,6/3/2014 9:10,1,0,"Ellis: on types of heterogeneity, sometimes surprising that another works # asco14 combo tx session pic.twitter.com/9P0dev3no8",,,#,4.73814E+17,https://twitter.com/scientre/status/473813894105165825,,,,
mtmdphd,6/3/2014 9:09,0,0,# ASCO14 Ellis - ComboRx based on Profiling and Heterogeneity - Many types of heterogeneity... pic.twitter.com/0Jqgj4isbV,,,#,4.73814E+17,https://twitter.com/mtmdphd/status/473813816984076288,,,,
ASCO,6/3/2014 9:09,12,1,"# ASCO14 Top Stories, Expert Editorials http://bit.ly/1n8yiMJ # mededpic.twitter.com/sEkLln6xZH",,,# #,4.73814E+17,https://twitter.com/ASCO/status/473813732855148544,,,,
AndreBallalai,6/3/2014 9:09,0,0,"Will the Immuno-Oncoly war"" on # ASCO14 be just more promises of future results?""",,,#,4.73814E+17,https://twitter.com/AndreBallalai/status/473813700995219456,,,,
Tony_Calles,6/3/2014 9:08,6,5,It's out there # ASCO14 # LCSMpic.twitter.com/tpVZKc1e8w,,,# #,4.73814E+17,https://twitter.com/Tony_Calles/status/473813579284881408,,,,
scientre,6/3/2014 9:08,2,0,Ellis: approaches to profiling cancers # asco14 combo tx session pic.twitter.com/ylp3uPPhBz,,,#,4.73814E+17,https://twitter.com/scientre/status/473813561035472896,,,,
mtmdphd,6/3/2014 9:08,0,1,# ASCO14 Ellis - ComboRx based on Profiling and Heterogeneity - pic.twitter.com/lEaiPejnTf,,,#,4.73814E+17,https://twitter.com/mtmdphd/status/473813547403603969,,,,
ByJonGardner,6/3/2014 9:08,9,1,"You may think # ASCO14 is over, but there is still @ FiercePharma's # FierceASCO chat with me & @ EricPFierce, 2 p.m. ET on Thursday. Be there!",,@ @,# #,4.73813E+17,https://twitter.com/ByJonGardner/status/473813352784097280,,,,
jrgralow,6/3/2014 9:07,0,0,Education Session Addresses Evolving Clinical Management of HER2 Breast Cancer # ASCO14 Annual Meeting http://am.asco.org/education-session-address-evolving-clinical-management-her2-breast-cancer#.U43Ig5QmBLE.twitter … # bcsm,,,# # #,4.73813E+17,https://twitter.com/jrgralow/status/473813268239106048,,,,
GustaveRoussy,6/3/2014 9:06,5,4,# ASCO14 Etude Dr Bonvalot @ Gustaveroussy Doper la radiothérapie pré-op pour limiter la chirurgie du # sarcome (vidéo) http://bit.ly/1o3KWOe,,@,# #,4.73813E+17,https://twitter.com/GustaveRoussy/status/473813018221219840,,,,
UCCancerCenter,6/3/2014 9:06,0,0,Gini Fleming kicks off last day # ASCO14 chairing highlights session including promising melanoma immunotherapy data http://bit.ly/1kzNRgR,,,#,4.73813E+17,https://twitter.com/UCCancerCenter/status/473812970846572544,,,,
brunorbastos,6/3/2014 9:06,0,0,The blue carpet! # ASCO14 pic.twitter.com/UK0kiHKgW9,,,#,4.73813E+17,https://twitter.com/brunorbastos/status/473812868211568640,,,,
jrgralow,6/3/2014 9:05,2,1,"Patient Education: Where Data, Information, and Knowledge Meet to Advance Outcomes from @ rsm2800 # ASCO14 http://am.asco.org/patient-education-where-data-information-and-knowledge-meet-advance-outcomes#.U43IEVNieP0.twitter …",,@,# #,4.73813E+17,https://twitter.com/jrgralow/status/473812812037226497,,,,
Boehringer,6/3/2014 9:05,2,2,# PRESS & # HCPs: Why target angiogenesis in # lungcancer? Learn why it's an effective target for treatment. http://bit.ly/1onhXD7 # ASCO14,,,# # # #,4.73813E+17,https://twitter.com/Boehringer/status/473812762213498880,,,,
myCME,6/3/2014 9:05,0,0,Autologous Immunotherapy for Metastatic Renal Cell Carcinoma Shows Promise http://ow.ly/xxx0p # ASCO14 # Oncology # nephrology,,,# # #,4.73813E+17,https://twitter.com/myCME/status/473812721818148864,,,,
CancerTherAdvsr,6/3/2014 9:05,0,0,# ASCO14: Bortezomib Regimen Prolongs PFS in Patients with Mantle Cell # Lymphoma Ineligible for BMT http://ow.ly/xvskq,,,# #,4.73813E+17,https://twitter.com/CancerTherAdvsr/status/473812679866740737,,,,
ASCO,6/3/2014 9:05,0,0,@ AdamsLisa Thank you very much. We hope you've found the # ASCO14 Tweets helpful as well.,,@,#,4.73813E+17,https://twitter.com/ASCO/status/473812633314160640,,,,
Pharmacyclics,6/3/2014 9:05,0,0,IMBRUVICA data published in @ NEJM will be presented on Tuesday at 11:33 am CT (E354a) at # ASCO14 http://bit.ly/1p6oHGj,,@,#,4.73813E+17,https://twitter.com/Pharmacyclics/status/473812631682166784,,,,
NCIMedia,6/3/2014 9:05,0,2,It's the last day of # ASCO14! Don't miss out on interesting sessions featuring NCI staff today: http://1.usa.gov/1o3LDam,,,#,4.73813E+17,https://twitter.com/NCIMedia/status/473812612984360960,,,,
mtmdphd,6/3/2014 9:04,2,2,# ASCO14 Park - Combo Rx - We underestimated cancer decades ago. Now how to use -omics to develop rational strategies pic.twitter.com/3UZGcgAieC,,,#,4.73813E+17,https://twitter.com/mtmdphd/status/473812539109683200,,,,
michelerhee,6/3/2014 9:03,1,0,ICYMI Adjuvant Chemotherapy after Radiation Improved Overall Survival in Low-Grade # Glioma http://bit.ly/T9TNT4 # ASCO14 # btsm # LGG,,,# # # #,4.73812E+17,https://twitter.com/michelerhee/status/473812284742311936,,,,
jrgralow,6/3/2014 9:03,0,0,"SHAPE-2, LEAN Studies Highlight Benefits of Weight Loss in Breast Cancer Survivors # ASCO14 # bcsm http://am.asco.org/shape-2-lean-studies-highlight-benefits-weight-loss-breast-cancer-survivors#.U43HjoylXbc.twitter …",,,# # #,4.73812E+17,https://twitter.com/jrgralow/status/473812236931067904,,,,
mtmdphd,6/3/2014 9:03,1,0,# ASCO14 Park - w/ eQ&A - Overview and State of the Art for Evaluating Combination Therapies Preclinically pic.twitter.com/KFBVo8Kilk,,,#,4.73812E+17,https://twitter.com/mtmdphd/status/473812169859923968,,,,
LillyDiabetes,6/3/2014 9:02,0,0,Today's the last day of # ASCO14. It's been exciting to see all the advances in # cancer research these past few days!,,,# #,4.73812E+17,https://twitter.com/LillyDiabetes/status/473811958232535041,,,,
corp_UNC,6/3/2014 9:02,1,0,"Place of readmission and outcomes after major cancer surgery Stitzenberg,Chang @ m_e_nielsen @ angiesmith_uro # ASCO14 http://ow.ly/xpkoR",,@ @,#,4.73812E+17,https://twitter.com/corp_UNC/status/473811941123973120,,,,
Novartis,6/3/2014 9:02,2,1,New Phase III findings provide scientific support for targeting key pathways in patients w/ # multiplemyeloma http://bit.ly/1tBkUBo # ASCO14,,,# #,4.73812E+17,https://twitter.com/Novartis/status/473811923470155776,,,,
ONAcom,6/3/2014 9:02,0,1,# ASCO14: Obese patients with gynecologic cancer are rarely counseled on weight loss - http://ow.ly/xwfao # gyncsm,,,# #,4.73812E+17,https://twitter.com/ONAcom/status/473811917023485952,,,,
JacobPlieth,6/3/2014 9:02,0,0,Any interest from industry? MT @ JonEPVantage Cancer cell therapy bound for academic labs in post $ DNDN world http://bit.ly/1nKFhic # ASCO14,,@,#,4.73812E+17,https://twitter.com/JacobPlieth/status/473811875457949696,,,,
AstraZenecaUS,6/3/2014 9:02,0,0,Two @MedImmune presentations on key data from 9:45-10:45 CST at # ASCO14,,@MedImmune,#,4.73812E+17,https://twitter.com/AstraZenecaUS/status/473811862493339648,,,,
SarahCannonDocs,6/3/2014 9:01,0,0,"# DrInfante: Serial versus parallel pathway inhibition doesn’t necessarily predict whether toxicities will be cumulative..."" # ASCO14""",,,# #,4.73812E+17,https://twitter.com/SarahCannonDocs/status/473811810580463616,,,,
nbferrara,6/3/2014 9:01,0,0,# OvarianCancer Subtypes May Predict Response to Bevacizumab: http://mayocl.in/U80PZo # ASCO14,,,# #,4.73812E+17,https://twitter.com/nbferrara/status/473811777772609536,,,,
HealthCoreRWE,6/3/2014 9:01,0,0,"Listen to HC present on comparison of cancer costs by oncology-owned and hospital-owned oncologists 8-11 a.m. Tuesday, June 3 E354b # asco14",,,#,4.73812E+17,https://twitter.com/HealthCoreRWE/status/473811736962031616,,,,
CancerResearch,6/3/2014 9:01,3,2,Are you ready to Take the Pledge with CRI? # Immunotherapy # WhiteOutCancer # ASCO14 http://ow.ly/xyACJ,,,# # #,4.73812E+17,https://twitter.com/CancerResearch/status/473811681827885056,,,,
subatomicdoc,6/3/2014 9:00,0,1,@ peterbachmd Six critical factors in lung cancer screening becoming a reality http://bit.ly/1kCnp0V # ASCO14 # lcsm / Thoughts?,,@,# #,4.73811E+17,https://twitter.com/subatomicdoc/status/473811495877623808,,,,
BayerPharma,6/3/2014 9:00,2,2,Thank you # advocates for sharing insights on how companies like BHC can partner to help make a difference for # cancer # patients # ASCO14,,,# # # #,4.73811E+17,https://twitter.com/BayerPharma/status/473811441909522432,,,,
mtmdphd,6/3/2014 9:00,0,0,"# ASCO14 - Innovative Strategies for Picking Combination Therapy Regimens - Chair: Ben Park, MD, PhD - S100a - 8:00->",,,#,4.73811E+17,https://twitter.com/mtmdphd/status/473811412892925952,,,,
myriadgenetics,6/3/2014 9:00,0,0,Myriad's BRACAnalysis CDx showed ability to predict platinum response in metastatic # breastcancer patients: # ASCO14 TODAY 9:45am E Hall D1,,,# #,4.73811E+17,https://twitter.com/myriadgenetics/status/473811377362960385,,,,
ByJonGardner,6/3/2014 8:59,6,0,Cancer cell therapy bound for academic labs in the post-Provenge world: http://ow.ly/xzkbc # ASCO14,,,#,4.73811E+17,https://twitter.com/ByJonGardner/status/473811321717526528,,,,
AlpineBV_Miller,6/3/2014 8:59,0,2,# ASCO14 clearly wearing people out. 8am and almost none of the posters are up in S102.,,,#,4.73811E+17,https://twitter.com/AlpineBV_Miller/status/473811280353312768,,,,
Curiolog,6/3/2014 8:58,2,0,# cancer : l'immunothérapie nourrit l'optimisme http://www.allodocteurs.fr/actualite-sante-cancerologie-l-immunotherapie-nourrit-l-optimisme-13585.asp?1=1 … # ASCO14,,,# #,4.73811E+17,https://twitter.com/Curiolog/status/473811073556963328,,,,
AdamsLisa,6/3/2014 8:58,2,3,If you or loved one has cancer the @ ASCO meeting has been going on for last few days. Check their feed for latest updates on clinical onco,,@,,4.73811E+17,https://twitter.com/AdamsLisa/status/473810854358810624,,,,
jrgralow,6/3/2014 8:57,1,0,.@ASCOPain & Symptom Mgmt Award for study of zoledronic acid & aromatase inhibitor-assoc pain # ASCO14 http://am.asco.org/dr-cesar-augusto-santa-maria-receives-2014-pain-and-symptom-management-merit-award#.U43FpbGKhv8.twitter … # bcsm,,@ASCOPain,# # #,4.73811E+17,https://twitter.com/jrgralow/status/473810711986974720,,,,
mtmdphd,6/3/2014 8:57,0,0,I love that MCC S100a has tables upfront. # ASCO14,,,#,4.73811E+17,https://twitter.com/mtmdphd/status/473810629015252992,,,,
teamoncology,6/3/2014 8:56,1,0,"Wow, you can do neoadjuvant chemotherapy safely in ovarian cancer. Very interesting. http://am.asco.org/neoadjuvant-chemotherapy-initial-treatment-advanced-ovarian-cancer-may-decrease-complications … # ASCO14",,,#,4.73811E+17,https://twitter.com/teamoncology/status/473810541178138626,,,,
HemOncToday,6/3/2014 8:56,2,0,# ASCO14 @ sloan_kettering study shows # cetuximab plus chemoradiation failed to improve OS in esophageal cancer http://goo.gl/EkDGA1,,@,# #,4.7381E+17,https://twitter.com/HemOncToday/status/473810400870674432,,,,
GoHealio,6/3/2014 8:56,0,0,# ASCO14 @ sloan_kettering study shows # cetuximab plus chemoradiation failed to improve OS in esophageal cancer http://goo.gl/EkDGA1,,@,# #,4.7381E+17,https://twitter.com/GoHealio/status/473810400119894018,,,,
mtmdphd,6/3/2014 8:55,1,0,. @ ASCO Social Media Info http://ow.ly/xt4Pr # ASCO14 Tweeps: http://ow.ly/xt4Ps Ten Tips: http://ow.ly/xt4Pt,,@,#,4.7381E+17,https://twitter.com/mtmdphd/status/473810139691372546,,,,
teamoncology,6/3/2014 8:55,0,0,It seems like very immunotherapy works in melanoma. It is just impressive. http://www.medscape.com/viewarticle/826022 … # ASCO14,,,#,4.7381E+17,https://twitter.com/teamoncology/status/473810086519787520,,,,
teamoncology,6/3/2014 8:53,0,2,"【 # ASCO14 Important Update】Bevacizumab, Cetuximab Have Similar Survival Benefits in CRC. So which one do you chose? http://www.medscape.com/viewarticle/826020 …",,,#,4.7381E+17,https://twitter.com/teamoncology/status/473809765265465345,,,,
TOM3ontheroad,6/3/2014 8:53,0,0,"“@cityofhopenews: Plenary # ASCO14 # CancerResearch: # Erbitux, # Avastin fagainst # ColorectalCancer http://breakthroughs.cityofhope.org/asco-2014-colorectal-cancer-erbitux-avastin … うーん、、、",,@cityofhopenews,# # # # #,4.7381E+17,https://twitter.com/TOM3ontheroad/status/473809691890302977,,,,
OncoExplorer,6/3/2014 8:53,1,1,Thanks to @ ASCO and everyone we met with at # ASCO14 supporting Community Oncology and dedicated every day to improved patient outcomes!,,@,#,4.7381E+17,https://twitter.com/OncoExplorer/status/473809659376447488,,,,
teamoncology,6/3/2014 8:52,0,1,Major disappointment in # breastcancer research at # ASCO14. Adjuvant lapatinib had no benefit by adding to trastuzumab. # BCSM,,,# # #,4.73809E+17,https://twitter.com/teamoncology/status/473809421647093762,,,,
Global_Market,6/3/2014 8:51,0,0,Last day at # ASCO14 - let us know if you want to meet up to recap learnings from the meeting!,,,#,4.73809E+17,https://twitter.com/Global_Market/status/473809186212433920,,,,
ACCCBuzz,6/3/2014 8:50,0,0,RT @ CancerSupportCm: Thanks @ OCNA @ ACSCAN @ ACCCBuzz @ GSK for a great panel on personalized medicine. # ASCO14 pic.twitter.com/kQ7TgiMO9D,,@ @ @ @ @,#,4.73809E+17,https://twitter.com/ACCCBuzz/status/473808964883607552,,,,
MSKCC_Library,6/3/2014 8:50,0,0,RT @ rsm2800: The Healthcare Hashtag Project http://www.symplur.com/healthcare-hashtags … Follow meetings & communities of interest # ASCO14,,@,#,4.73809E+17,https://twitter.com/MSKCC_Library/status/473808897330118656,,,,
TargetedOnc,6/3/2014 8:50,3,1,ALTTO Trial: Dual HER2-Blockade Strategy With Lapatinib Fails http://www.targetedonc.com/conference/asco-2014/Dual-HER2-Blockade-Strategy-With-Lapatinib-Fails-in-ALTTO-Trial … # ASCO14,,,#,4.73809E+17,https://twitter.com/TargetedOnc/status/473808883073691648,,,,
teamoncology,6/3/2014 8:49,3,0,HPV感染が問題ですね。 ワクチンの効く可能性はあります。RT @ syutoken_sanka: HPV感染が問題になるんですか？そうするとワクチンが少しは有効と言うことでしょうか @ teamoncology オーラルセックスは、咽頭がんのリスクである。 # ASCO14,,@ @,#,4.73809E+17,https://twitter.com/teamoncology/status/473808795479465987,,,,
subatomicdoc,6/3/2014 8:49,4,2,@ ASCO Thank you for leading the way for 5 decades. An honor to participate and share with you and all that care about cancer # ASCO14,,@,#,4.73809E+17,https://twitter.com/subatomicdoc/status/473808736063328256,,,,
drcbsteer,6/3/2014 8:48,1,0,# ASCO14 # thingsIhavelearned # melanoma PD1 inhibitors - moderate RR (~30%) but responses durable.,,,# # #,4.73809E+17,https://twitter.com/drcbsteer/status/473808521171968001,,,,
BernieMD31,6/3/2014 8:47,0,2,MT @ DrAndyBaldwin # Obesity on its way to replacing # tobacco as number one preventable/modifiable cause of # cancer # ASCO14 # health,,@,# # # # #,4.73808E+17,https://twitter.com/BernieMD31/status/473808159048744960,,,,
jrgralow,6/3/2014 8:46,0,0,See slides frm G Coldtiz's ASCO-ACS award talk on cancer prevention- &many more of his talks! Great resource. # ASCO14 http://ow.ly/xzi6F,,,#,4.73808E+17,https://twitter.com/jrgralow/status/473808002991292418,,,,
UNC_Lineberger,6/3/2014 8:45,2,1,"Congrats to Dr. Aaron Falchook, winner of 2014 @ ASCO Merit Award! Dr. Falchook will present today @ # ASCO14, 9:45am pic.twitter.com/BpieI0Htlt",,@ @,#,4.73808E+17,https://twitter.com/UNC_Lineberger/status/473807791371853824,,,,
TransgeneSA,6/3/2014 8:45,1,1,L’immunothérapie : nouvelle arme thérapeutique contre les cancers. Confirmation à l’ # ASCO14 via @ lemonde.fr http://ow.ly/xzg15,,@,#,4.73808E+17,https://twitter.com/TransgeneSA/status/473807649621168128,,,,
nbferrara,6/3/2014 8:45,1,0,Tumor Size is Defining Factor to Response from Promising # Melanoma Drug: http://mayocl.in/1kCz7ZB # ASCO14,,,# #,4.73808E+17,https://twitter.com/nbferrara/status/473807639672258560,,,,
GlopesMd,6/3/2014 8:45,0,0,@ ASCO Thank you guys for retweeting! Looking forward to next year.,,@,,4.73808E+17,https://twitter.com/GlopesMd/status/473807591789703169,,,,
DMG_AICR,6/3/2014 8:44,0,0,"RT @ CardioOncology: Obesity is on way to replacing tobacco as the no. 1 preventable/modifiable cause of cancer.” @ CliffordHudis # ASCO14”""",,@ @,#,4.73808E+17,https://twitter.com/DMG_AICR/status/473807560144068608,,,,
CancerGeek,6/3/2014 8:44,1,0,"The New Cancer Detection System Using only a Cellphone, a Lens and an App http://flip.it/XzfnA # cancer # gyncsm # tech # ASCO14",,,# # # #,4.73807E+17,https://twitter.com/CancerGeek/status/473807429713793024,,,,
subatomicdoc,6/3/2014 8:43,0,0,"@ nickdawson Thanks for sharing Nick! I almost missed it, I was zoned in on # ASCO14 How are you?",,@,#,4.73807E+17,https://twitter.com/subatomicdoc/status/473807134506090496,,,,
OncEd,6/3/2014 8:42,1,0,# ASCO14 Hematology Video Update - SEXIE-R-CHOP-14 Trial - Dr. Michael Pfreundschuh http://bit.ly/RUxdwl,,,#,4.73807E+17,https://twitter.com/OncEd/status/473806991232872448,,,,
SWOG,6/3/2014 8:42,2,0,MT @ wallyjc: Proud to see 4 NCI-supported cooperative group trials at the # ASCO14 Plenary Session! @ NRGonc # SWOGonc @ ALLIANCE_org @ eaonc,,@ @ @ @,# #,4.73807E+17,https://twitter.com/SWOG/status/473806917689937920,,,,
jrgralow,6/3/2014 8:41,0,0,ASCO-ACS Award Winner Graham Colditz Highlights Primary Role of Prevention # ASCO14 Annual Meeting http://am.asco.org/asco-acs-award-winner-graham-colditz-highlights-primary-role-prevention#.U43Cgrl2Mgc.twitter …,,,# #,4.73807E+17,https://twitter.com/jrgralow/status/473806785715777536,,,,
jrgralow,6/3/2014 8:39,7,2,Interesting thoughts from @ LarryNortonMD on Questions Raised by ALTTO Trial # ASCO14 Annual Meeting http://am.asco.org/dr-larry-norton-questions-raised-altto-trial#.U43BwHBTnJo.twitter … # bcsm,,@,# # #,4.73806E+17,https://twitter.com/jrgralow/status/473806108864163840,,,,
ASCO,6/3/2014 8:39,0,0,@ DrJAshton @ GMA Thank you for sharing # ASCO14 news.,,@ @,#,4.73806E+17,https://twitter.com/ASCO/status/473806065789067264,,,,
GileadSciences,6/3/2014 8:38,3,3,Gilead announces Phase 2 results for investigational Syk inhibitor in relapsed # CLL at # ASCO14 http://bit.ly/1kEZXjz,,,# #,4.73806E+17,https://twitter.com/GileadSciences/status/473805919919157248,,,,
AnjeeDavis,6/3/2014 8:38,0,0,@ MaverickNY so great to see you at # ASCO14,,@,#,4.73806E+17,https://twitter.com/AnjeeDavis/status/473805909568028673,,,,
CureMelanoma,6/3/2014 8:38,0,0,"MT @ sloan_kettering: Welcome to Twitter, Dr. Wolchok @ wolchokj! Here he is giving @ medpagetoday an interview@ # asco14 pic.twitter.com/HKYGKHVYSu",,@ @ @ @,#,4.73806E+17,https://twitter.com/CureMelanoma/status/473805883647209472,,,,
ASCO,6/3/2014 8:38,0,0,@ DrNancyNBCNEWS @ TODAYshow @ NBCNews Thank you for sharing news from # ASCO14.,,@ @ @,#,4.73806E+17,https://twitter.com/ASCO/status/473805873417289728,,,,
_SEOM,6/3/2014 8:38,4,0,"Resumen para prensa de estudios presentados en # ASCO2014 en pulmón, cabeza y cuello y melanoma http://www.seom.org/onconexion-highlights-asco-2014 …",,,#,4.73806E+17,https://twitter.com/_SEOM/status/473805857314988033,,,,
Alice_Aitch,6/3/2014 8:37,0,0,@ subatomicdoc Another cost compare: test cost equiv to 2 months of 'smokers' surcharge' on Ins premiums permitted by PPACA @ ASCO,,@ @,,4.73806E+17,https://twitter.com/Alice_Aitch/status/473805648614797313,,,,
spargo_inc,6/3/2014 8:37,0,0,Our expo team taking a well deserved break during # ASCO14 pic.twitter.com/LnKZHfIzLE,,,#,4.73806E+17,https://twitter.com/spargo_inc/status/473805641715576832,,,,
CancerMedMDA,6/3/2014 8:35,0,1,"Efficacy, correl w/ tumor PDL-1 expression in melanoma patients on anti-PD-1 therapy. Dr. Wen-Jen Hwu study. Tues 11 AM. # ASCO14 # endcancer",,,# #,4.73805E+17,https://twitter.com/CancerMedMDA/status/473805106031636480,,,,
MGHCancerCenter,6/3/2014 8:35,0,1,"9:45-12:45, E Hall D1: Dr. Isakoff talk: biomarker IDs to predict single-agent platinum chemo response in mTNBC # bcsm # ASCO14",,,# #,4.73805E+17,https://twitter.com/MGHCancerCenter/status/473805095499730944,,,,
IMFsupport,6/3/2014 8:33,0,0,"At the @ ASCO meetings in Chicago: Mike @ baysidemk receives 2014 Partners In Progress Award"" CONGRATULATIONS MIKE!pic.twitter.com/WtNUA49XJ0""",,@ @,,4.73805E+17,https://twitter.com/IMFsupport/status/473804713339912192,,,,
syutoken_sanka,6/3/2014 8:33,1,1,HPV感染が問題になるんですか？そうするとワクチンが少しは有効と言うことでしょうか @ narumita @ teamoncology オーラルセックスは、咽頭がんのリスクである。 # ASCO14,,@ @,#,4.73805E+17,https://twitter.com/syutoken_sanka/status/473804682100367360,,,,
MaverickNY,6/3/2014 8:33,0,3,Am going to need more coffee to get through 2 hours of systems biology # asco14,,,#,4.73805E+17,https://twitter.com/MaverickNY/status/473804602257989632,,,,
rsm2800,6/3/2014 8:33,7,10,"The day I give my # ASCO14 talk on # hcsm, apps, clinical trials, THIS-->Apple Enters the Healthcare Software Ecosystem http://geekdoctor.blogspot.com/2014/06/apple-enters-healthcare-software.html …",,,# #,4.73805E+17,https://twitter.com/rsm2800/status/473804564861165570,,,,
nbferrara,6/3/2014 8:31,0,1,"ALTTO Test of Dual HER2 Blockade Finds Single Agent, Trastuzumab, Remains Gold Standard: http://mayocl.in/1jNvvnh # ASCO14 # BreastCancer",,,# #,4.73804E+17,https://twitter.com/nbferrara/status/473804089126830080,,,,
eMPR,6/3/2014 8:31,0,0,Combo Tx promising for recurrent ovarian cancer: http://ow.ly/xxPxt # ASCO14 # oncology,,,# #,4.73804E+17,https://twitter.com/eMPR/status/473804072437694464,,,,
ASCO,6/3/2014 8:30,0,3,@ subatomicdoc Thank you so much for joining us for # ASCO14 & for your contributions during the meeting.,,@,#,4.73804E+17,https://twitter.com/ASCO/status/473803993010155520,,,,
Alice_Aitch,6/3/2014 8:30,0,0,@ subatomicdoc Test runs about $200-300 and Highest risk = 20-30pk/yr smokers yes? Means ind test costs ~10%-15% annual spend on cigs. @ ASCO,,@ @,,4.73804E+17,https://twitter.com/Alice_Aitch/status/473803967818784769,,,,
CancerMedMDA,6/3/2014 8:30,0,1,Dr. Srdan Verstovsek on RESPONSE trial results for ruxolitinib in polycythemia vera patients resistant to hydroxyurea. Tues 9:45 AM. # ASCO14,,,#,4.73804E+17,https://twitter.com/CancerMedMDA/status/473803967231950848,,,,
narumita,6/3/2014 8:30,4,2,"_φ(･_･  @ teamoncology: オーラルセックスは、咽頭がんのリスクである。 # ASCO14""""",,@,#,4.73804E+17,https://twitter.com/narumita/status/473803902320529408,,,,
chiva_morena,6/3/2014 8:30,0,0,Gracias ASCO nos vemos el próximo Año!!!grandes cambios!! # ASCO14,,,#,4.73804E+17,https://twitter.com/chiva_morena/status/473803833416896512,,,,
DrDeborahFisher,6/3/2014 8:30,0,1,# ASCO14 Vitamin D not linked to # Breast # Cancer outcomes http://www.medpagetoday.com/HematologyOncology/BreastCancer/46116?xid=nl_mpt_DHE_2014-06-03 …,,,# # #,4.73804E+17,https://twitter.com/DrDeborahFisher/status/473803793813880832,,,,
subatomicdoc,6/3/2014 8:29,0,0,@ marykge @ uicc @ GTFRCC My pleasure to help. Thank you all for your leadership on a critical global cancer need # ASCO14,,@ @ @,#,4.73804E+17,https://twitter.com/subatomicdoc/status/473803768581324800,,,,
DrDeborahFisher,6/3/2014 8:29,0,1,# ASCO14 abstract: Immune treatment for # cervical # cancer http://www.medpagetoday.com/MeetingCoverage/ASCO/46118?xid=nl_mpt_DHE_2014-06-03 …,,,# # #,4.73804E+17,https://twitter.com/DrDeborahFisher/status/473803594781569024,,,,
chiva_morena,6/3/2014 8:29,0,0,"@ ASCO gracias ASCO!!! Grandes cambios!!, nos vemos próximo año!!",,@,,4.73804E+17,https://twitter.com/chiva_morena/status/473803554885734400,,,,
BairdAM,6/3/2014 8:28,0,0,"# lcsm MT  @ Boehringer: LUX-Lung5 afatinib # lungcancer results at # ASCO14 Dr Schuler at E354b from08:00 CDT Read more http://bit.ly/1kAu0ZP """"",,@,# # #,4.73803E+17,https://twitter.com/BairdAM/status/473803484740206592,,,,
DrMarkham,6/3/2014 8:27,0,0,"Heading home from # ASCO14 today. Flight delayed out of O'Hare, but just gives me more time to reflect on the weekend.",,,#,4.73803E+17,https://twitter.com/DrMarkham/status/473803280179806208,,,,
TedOkonCOA,6/3/2014 8:27,2,2,"Insured young # cancer patients fare better, live longer: # asco14 study, http://ow.ly/xzfC2",,,# #,4.73803E+17,https://twitter.com/TedOkonCOA/status/473803121668661248,,,,
nerifede,6/3/2014 8:26,0,0,@ nerifede # ASCO14 Posters presentation available at $ CLDX web site accessing http://www.celldex.com/science/publications.php …,,@,#,4.73803E+17,https://twitter.com/nerifede/status/473802950218113024,,,,
Alice_Aitch,6/3/2014 8:26,0,1,"@ subatomicdoc I'm objecting to language that conflates 'available' with 'paid by insurance and/or taxes'. It's already available"". @ ASCO""",,@ @,,4.73803E+17,https://twitter.com/Alice_Aitch/status/473802829576933376,,,,
2healthguru,6/3/2014 8:25,0,0,Per @ DwayneSpradlin ‘more docs tweeted # hdpalooza than # asco14’ @ ASCO annual meeting in Chicago # hcdradar,,@ @,# # #,4.73803E+17,https://twitter.com/2healthguru/status/473802746324602880,,,,
MaverickNY,6/3/2014 8:25,1,1,Waking up slowly on bus with a double espresso and a head cold # asco14,,,#,4.73803E+17,https://twitter.com/MaverickNY/status/473802607375683584,,,,
Chiltern_CRO,6/3/2014 8:25,0,2,Last day at # ASCO14. What will you take away from the conference? # Chiltern # Oncology # Quality # Innovation,,,# # # # #,4.73803E+17,https://twitter.com/Chiltern_CRO/status/473802559245664256,,,,
nerifede,6/3/2014 8:24,0,0,@ nerifede # ASCO14 Posters presentation available at $ CLDX web site accessing http://www.celldex.com/science/publications.php …,,@,#,4.73803E+17,https://twitter.com/nerifede/status/473802519605686272,,,,
Lymphoma_Doc,6/3/2014 8:24,1,1,". @ ASCO Thanks and congrats to ASCO, and all cancer researchers who made # ASCO14 such a great meeting. @ CliffordHudis address was excellent",,@ @,#,4.73802E+17,https://twitter.com/Lymphoma_Doc/status/473802428698357760,,,,
jrgralow,6/3/2014 8:24,9,4,Back to the Future: Family History is Still Key in the Genomic Era # ASCO14 Annual Meeting http://am.asco.org/back-future-family-history-still-key-genomic-era#.U42-YXa4AH4.twitter …,,,# #,4.73802E+17,https://twitter.com/jrgralow/status/473802354257453056,,,,
ExperisLifeSci,6/3/2014 8:24,0,0,Immune therapy # clinicaltrials for treating # Cancer gaining momentum. 4 companies starting 78 trials. # ASCO14 http://buswk.co/U8T1GQ,,,# # #,4.73802E+17,https://twitter.com/ExperisLifeSci/status/473802288721833984,,,,
EthanBasch1,6/3/2014 8:22,6,4,ASCO session on patient engagement in research starts at 8am CST # ASCO14 http://tinyurl.com/ojrvo8d,,,#,4.73802E+17,https://twitter.com/EthanBasch1/status/473801829185519616,,,,
MartinStockler,6/3/2014 8:21,1,0,Beautiful start to last day in # Chicago # ASCO14 http://runmeter.com/929452044c0356f8/Run-20140603-0601 …pic.twitter.com/N15zZSLhOZ,,,# #,4.73802E+17,https://twitter.com/MartinStockler/status/473801667826434048,,,,
CancerMedMDA,6/3/2014 8:20,2,0,Dr. Susan O'Brien evaluates ibrutinib efficacy 3 yrs after initiation in CLL & small lymphocytic leukemia patients. Tues 11:30 AM. # ASCO14,,,#,4.73801E+17,https://twitter.com/CancerMedMDA/status/473801382345342976,,,,
SynergyVision,6/3/2014 8:20,0,0,More impressive data coming out of # ASCO14 http://bit.ly/1h30yRk # pharma # MedComms,,,# # #,4.73801E+17,https://twitter.com/SynergyVision/status/473801270311284736,,,,
DebPhD,6/3/2014 8:19,0,0,Thanks # ACHA2014 and # ASCO14! I learned a ton but now it's time to go home to # NYC # health # science # peaceout # chicago,,,# # # # # # #,4.73801E+17,https://twitter.com/DebPhD/status/473801172227063808,,,,
mtmdphd,6/3/2014 8:19,6,6,"The numbers: >48K Tweets. 10,313 Participants. >160M Impressions. More # ASCO14 analytics: via @ symplur http://ow.ly/xzeF5 [5/1-6/3]",,@,#,4.73801E+17,https://twitter.com/mtmdphd/status/473801122806005760,,,,
DrDeborahFisher,6/3/2014 8:18,0,1,# ASCO14 Adjuvant FOLFOX Improves disease free survival in # rectal # cancer Patients http://www.cancernetwork.com/asco-2014-colorectal-cancer/adjuvant-folfox-improves-dfs-rectal-cancer-patients …,,,# # #,4.73801E+17,https://twitter.com/DrDeborahFisher/status/473800921898844161,,,,
Dominic_Tyer,6/3/2014 8:17,0,0,Merck’s anti-PD1 impresses in skin and lung cancer http://buff.ly/S2aDSz # pharma # ASCO14,,,# #,4.73801E+17,https://twitter.com/Dominic_Tyer/status/473800633137758208,,,,
drdonsdizon,6/3/2014 8:17,1,0,"von Minckwitz, Abstr 1005: GeparSixto: NACT impr pCR in brca w +FH or +mBRCA: std chemo +/- carbo. http://bit.ly/1tBcEmS # bcsm # ASCO14",,,# #,4.73801E+17,https://twitter.com/drdonsdizon/status/473800516414099456,,,,
subatomicdoc,6/3/2014 8:16,0,1,"@ stales @ DrAttai @ jodyms @ obogler You're welcome, well deserved! # ASCO14 # bcsm",,@ @ @ @,# #,4.738E+17,https://twitter.com/subatomicdoc/status/473800414253834240,,,,
DebConference,6/3/2014 8:15,0,0,Thanks # ACHA2014 and # ASCO14! I learned a ton but now it's time to go home to # NYC # health and # science yay!,,,# # # # #,4.738E+17,https://twitter.com/DebConference/status/473800217049849856,,,,
MartaMarteo,6/3/2014 8:15,0,0,El oncólogo conocido como el héroe del vinagre Surendra Shastri http://ow.ly/xzbzv congrats # ASCO14,,,#,4.738E+17,https://twitter.com/MartaMarteo/status/473800087400116224,,,,
nbferrara,6/3/2014 8:15,3,1,"Immunotherapy may be an option in challenging # BreastCancer, @ MayoClinic study finds: http://mayocl.in/1n6i5rq # ASCO14",,@,# #,4.738E+17,https://twitter.com/nbferrara/status/473800069624651776,,,,
GustaveRoussy,6/3/2014 8:14,4,0,RT @ ITCC_eu (Innovative Therapies for Children with Cancer consortium) studies at # ASCO14 http://bit.ly/1k8MP63 # ChildhoodCancer,,@,# #,4.738E+17,https://twitter.com/GustaveRoussy/status/473799864456077312,,,,
JeffreyMOtto,6/3/2014 8:14,0,1,A big TY to @ asco and # chicago for a great conference. See you next year! # ASCO14,,@,# #,4.738E+17,https://twitter.com/JeffreyMOtto/status/473799820445220864,,,,
ABumRap,6/3/2014 8:12,2,0,“ @ OncEd: ADORE trial addition of Oxaliplatin to 5fu for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63 # crcsm # ASCO14”,,@,# #,4.73799E+17,https://twitter.com/ABumRap/status/473799400486354944,,,,
AbbottNews,6/3/2014 8:11,0,2,"Abbott is committed to personalized medicine & companion diagnostics, especially in oncology. http://bit.ly/1hGVuwV # ASCO14",,,#,4.73799E+17,https://twitter.com/AbbottNews/status/473799009472372737,,,,
ShannonWestin,6/3/2014 8:10,0,3,@ ASCO thanks for an exciting meeting! Can't wait for next year. # ASCO14,,@,#,4.73799E+17,https://twitter.com/ShannonWestin/status/473798763887468544,,,,
x_bouchet,6/3/2014 8:08,0,0,@ vainchtock et @ HEVAWEB spécialiste données de santé publient à l' # asco14 # healthdata # heor # Cancer http://bit.ly/1onXWwd,,@ @,# # # #,4.73798E+17,https://twitter.com/x_bouchet/status/473798489059901440,,,,
LGG1,6/3/2014 8:07,0,0,RT @ BreastDocUK: So can I ask the # ASCO14 tweeps what one thing they are going to change in their practice post mtng?,,@,#,4.73798E+17,https://twitter.com/LGG1/status/473798049375223808,,,,
teamoncology,6/3/2014 8:06,2,1,It is important to provide the fertility information regardless of cancer type or stage of the disease. # ASCO14,,,#,4.73798E+17,https://twitter.com/teamoncology/status/473797890209357824,,,,
theNHSN,6/3/2014 8:05,0,0,@ HopkinsMedicine: Job alert: @ HopkinsMedicine is hiring for Senior Media Relations Positions: http://ow.ly/xtHPe # prjobs # ASCO14,,@ @,# #,4.73798E+17,https://twitter.com/theNHSN/status/473797584684081152,,,,
JacobPlieth,6/3/2014 8:05,9,5,"Understanding of PD-L1 expression bodes well for $ BMY, but post # ASCO14 slump looms. My take, via @ EPVantage http://ow.ly/xzcKG $ MRK",,@,#,4.73798E+17,https://twitter.com/JacobPlieth/status/473797568867340288,,,,
subatomicdoc,6/3/2014 8:03,0,0,@ BreastDocUK @ DrAttai @ rsm2800 Good question. I may temper my rec on PCI in ES-SCLC # ASCO14 # lcsm,,@ @ @,# #,4.73797E+17,https://twitter.com/subatomicdoc/status/473797095250735104,,,,
DrNancyMD,6/3/2014 8:03,0,1,New drug presented @ ASCO that can preserve fertility in women of childbearing age with hormone negative breast cancer @ TODAYshow @ NBCNews,,@ @ @,,4.73797E+17,https://twitter.com/DrNancyMD/status/473797010986770433,,,,
ASCO,6/3/2014 8:01,1,2,Going to the # ASCO14 Palliative Care session? Read about international efforts: http://bit.ly/1k6eucq via # ASCOConnection,,,# #,4.73797E+17,https://twitter.com/ASCO/status/473796665565270016,,,,
betht0002,6/3/2014 8:01,0,0,"Powerful words: Obesity is on its way to replacing tobacco as number one preventable/modifiable cause of cancer.” @ CliffordHudis # ASCO14""",,@,#,4.73797E+17,https://twitter.com/betht0002/status/473796511382245377,,,,
ABenderRD,6/3/2014 8:00,0,0,"MT @ KarenCollinsRD: Yes; diet/exer choices 4 more than # cancer outcome. MT @ rsm2800: Meyerhardt: # Survivors at risk for CVD, DM etc. # ASCO14",,@ @,# # #,4.73796E+17,https://twitter.com/ABenderRD/status/473796479677902848,,,,
Boehringer,6/3/2014 8:00,1,3,PRESS: Poster LUX-Lung 5 afatinib # lungcancer results at # ASCO14 by Dr Schuler at room E354b from08:00 CDT Read more http://bit.ly/1kAu0ZP,,,# #,4.73796E+17,https://twitter.com/Boehringer/status/473796348412973056,,,,
subatomicdoc,6/3/2014 8:00,0,0,"@ Alice_Aitch @ ASCO Thanks Alice. I think it's valuable, but costly & carries some risk. But want to see it available to highest risk # lcsm",,@ @,#,4.73796E+17,https://twitter.com/subatomicdoc/status/473796314296500226,,,,
Xcenda,6/3/2014 8:00,1,0,# Xcenda market research opportunities for # ASCO14 attendees. Register today: http://bit.ly/nocr1,,,# #,4.73796E+17,https://twitter.com/Xcenda/status/473796294566096896,,,,
teamoncology,6/3/2014 8:00,0,1,LHRH agonist is used in transplant sometime to prevent bleeding due to menstruation. # ASCO14,,,#,4.73796E+17,https://twitter.com/teamoncology/status/473796256611844096,,,,
MedscapeOnc,6/3/2014 8:00,3,1,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73796E+17,https://twitter.com/MedscapeOnc/status/473796250270040064,,,,
Medscape,6/3/2014 8:00,1,0,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73796E+17,https://twitter.com/Medscape/status/473796247904452608,,,,
ABenderRD,6/3/2014 7:59,0,0,MT @ KarenCollinsRD: # CancerSurvivor LEAN stdy: min 5% wt loss (diet+exer) best 2 decr insulin; inflam biomarkrs. M Irwin @ YaleCancer # ASCO14,,@ @,# #,4.73796E+17,https://twitter.com/ABenderRD/status/473796194737864704,,,,
teamoncology,6/3/2014 7:59,0,1,"In transplant (high-dose chemotherapy), LHRH agonist has been used but there are no evidence that fertility will be preserved. # ASCO14",,,#,4.73796E+17,https://twitter.com/teamoncology/status/473796113779003392,,,,
CancerSupportHQ,6/3/2014 7:59,1,1,Thanks @ ASCO for a great # ASCO14! See you next year! pic.twitter.com/ZZ7Ii402Ys,,@,#,4.73796E+17,https://twitter.com/CancerSupportHQ/status/473796003993501696,,,,
TapKadia,6/3/2014 7:59,0,1,@ ERPlimackMD - Had a quick # ASCO14 trip this year. Will try to catch up next year. Keep tweeting ...,,@,#,4.73796E+17,https://twitter.com/TapKadia/status/473796003590447104,,,,
mvsiguiendo,6/3/2014 7:57,1,1,Un placer haber podido desvirtualizar a @ mrsahuquillo y @ Beamglezubeda en # ASCO14.,,@ @,#,4.73796E+17,https://twitter.com/mvsiguiendo/status/473795655593631744,,,,
CancerDotNet,6/3/2014 7:57,1,1,Final day - Adv Lounge open 7:30-10:30 AM CT today - Feel free to stop by to say farewell to # ASCO14,,,#,4.73796E+17,https://twitter.com/CancerDotNet/status/473795599960379392,,,,
JacobPlieth,6/3/2014 7:57,4,0,"$ LLY's damp squibs, and what to do next. My take from # ASCO14 http://ow.ly/xzbVP",,,#,4.73796E+17,https://twitter.com/JacobPlieth/status/473795596017754112,,,,
conkers3,6/3/2014 7:57,0,0,# AZN at £43.66p MT . @ AstraZeneca updates on the rapid progress of its # oncology pipeline at # ASCO2014 http://www.astrazeneca.com/Media/Press-releases/Article/20140603--AstraZeneca-updates-on-the-rapid-progress-of-oncology-pipeline-at-ASCO-2014#.U422-vcsmkM.twitter … $ AZN,,@,# # # #,4.73796E+17,https://twitter.com/conkers3/status/473795564384321536,,,,
mtmdphd,6/3/2014 7:56,0,0,# ASCO14 Tweet Stats - 6-3-14 06:55a - via @ Symplur http://ow.ly/i/5MeSU,,@,#,4.73795E+17,https://twitter.com/mtmdphd/status/473795440874631168,,,,
teamoncology,6/3/2014 7:54,2,3,"【 # ASCO14 Important Update】Ipilimumab, targeting CTLA-4, is an effective treatment even in stage III melanoma. http://abstracts.asco.org/144/AbstView_144_130118.html …",,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794945891827712,,,,
teamoncology,6/3/2014 7:54,6,5,【 # ASCO14 Important Update】There are no association of Vitamin D level and prognosis in breast cancer. http://abstracts.asco.org/144/AbstView_144_128900.html …,,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794905664258050,,,,
teamoncology,6/3/2014 7:54,0,1,【 # ASCO14 Important Update】Combination immunotherapy may work in metastatic melanoma. http://abstracts.asco.org/144/AbstView_1 …,,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794866606907392,,,,
teamoncology,6/3/2014 7:54,0,1,【 # ASCO14 Important Update】combi mTOR & Akt inhibitors work in metastatic breast cancer with low RAS gene signature. http://meetinglibrary.asco.org/content/131939 …,,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794829063692288,,,,
giasison,6/3/2014 7:54,0,0,@ subatomicdoc No worries Matthew! See you on the next! :) Take care! Great job at # ASCO14,,@,#,4.73795E+17,https://twitter.com/giasison/status/473794814970822656,,,,
RegardingCancer,6/3/2014 7:54,0,0,Is there a potential new alternative for treating early breast cancer? # breastcancer # cancer # asco14... http://fb.me/2X6B7vKlP,,,# # #,4.73795E+17,https://twitter.com/RegardingCancer/status/473794784122138624,,,,
MarekTrnenyDr,6/3/2014 7:54,1,0,"# ASCO14 abst8502 PET driven therapy in hIgh risk DLBCL, more comments later on # lymphomahubpic.twitter.com/i2zCds8u23",,,# #,4.73795E+17,https://twitter.com/MarekTrnenyDr/status/473794757203095552,,,,
teamoncology,6/3/2014 7:54,2,0,オーラルセックスは、咽頭がんのリスクである。 # ASCO14,,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794744028393473,,,,
teamoncology,6/3/2014 7:53,2,0,【 # ASCO14 Important Update】 We can lower the dose of radiation HPV-positive oropharyngeal cancer. Safe & effective. http://abstracts.asco.org/144/AbstView_144_133616.html …,,,#,4.73795E+17,https://twitter.com/teamoncology/status/473794555674783744,,,,
teamoncology,6/3/2014 7:53,1,0,【 # ASCO14 Important Update】Adjuvant AI+ovarian Fx suppression is better than TAM in premenopausal HR+ BC. http://abstracts.asco.org/144/AbstView_144_129398.html … # BCSM,,,# #,4.73795E+17,https://twitter.com/teamoncology/status/473794502470008832,,,,
melmehdi,6/3/2014 7:52,0,0,Enfin un scoop à l' # ASCO14 # LRT,,,# #,4.73794E+17,https://twitter.com/melmehdi/status/473794302574088194,,,,
drol007,6/3/2014 7:51,0,0,Further immunotherapy for melanoma from # asco14 and early phase trials http://www.bbc.co.uk/news/health-27674658 …,,,#,4.73794E+17,https://twitter.com/drol007/status/473794184596697089,,,,
sdaryanani,6/3/2014 7:51,0,0,"# ASCO14 I propose a worldwide ban on tax free cigarettes, no more tax-free cigarettes, tax ought to go towards reseach or cancer treatment",,,#,4.73794E+17,https://twitter.com/sdaryanani/status/473794152493105153,,,,
Tony_Calles,6/3/2014 7:51,0,2,"Join me at lung cancer poster highlights session in E354b at 8-11, LKB1, PD-L1, PD-L2, PD-1 in KRAS mut NSCLC # ASCO14 # LCSM",,,# #,4.73794E+17,https://twitter.com/Tony_Calles/status/473794020129259520,,,,
teamoncology,6/3/2014 7:50,1,1,【 # ASCO14 Important Update】Early support to caregivers improve their QOL. http://abstracts.asco.org/144/AbstView_144_131678.html … # BCSM',,,# #,4.73794E+17,https://twitter.com/teamoncology/status/473793960222003200,,,,
OHmedcomms,6/3/2014 7:50,0,0,"The # succinct team are on their way back from a very successful @ ASCO meeting. 7 people, 6 days, 5 projects, 4 happy clients. # medcomms",,@,# #,4.73794E+17,https://twitter.com/OHmedcomms/status/473793933886361600,,,,
teamoncology,6/3/2014 7:50,3,1,【 # ASCO14 Important Update】U can give Zometa w/less frequent interval to breast cancer bone met. http://abstracts.asco.org/144/AbstView_144_129791.html … # BCSM,,,# #,4.73794E+17,https://twitter.com/teamoncology/status/473793899995996161,,,,
Prof_Nick_James,6/3/2014 7:50,0,1,"The not Pfizer"" stand at # ASCO14 ! pic.twitter.com/yARvVExUkj""",,,#,4.73794E+17,https://twitter.com/Prof_Nick_James/status/473793806572453888,,,,
teamoncology,6/3/2014 7:49,0,1,Do not know whether patients who preserved the ovarian function by LHRH agonist can get pregnant. http://abstracts.asco.org/144/AbstView_144_129172.html … # BCSM # ASCO14,,,# #,4.73794E+17,https://twitter.com/teamoncology/status/473793700598796288,,,,
evaluatevantage,6/3/2014 7:49,0,0,# ASCO14 - Damp squibs mean Lilly has it all to do: $ LLY http://ow.ly/xzaY1 # ramucirumab # necitumumab,,,# # #,4.73793E+17,https://twitter.com/evaluatevantage/status/473793471019769857,,,,
teamoncology,6/3/2014 7:48,0,0,【 # ASCO14 Important Update】LHRH agonist has a modest effect to prevent ovarian failure in ER- breast cancer. http://abstracts.asco.org/144/AbstView_144_129172.html … # BCSM,,,# #,4.73793E+17,https://twitter.com/teamoncology/status/473793243826491392,,,,
drdonsdizon,6/3/2014 7:47,0,0,@ ASCO loved it. Chat soon!,,@,,4.73793E+17,https://twitter.com/drdonsdizon/status/473793173287092224,,,,
_TheUrologist_,6/3/2014 7:47,5,3,# ePatient dark side? MT @ ArmstrongDrew: a risk of SoMe in clinical trials: pt self-unblinding # asco14 https://twitter.com/ArmstrongDrew/status/473537424627617793/photo/1pic.twitter.com/NQnq2rnw86 HT @ nickbrookMD,,@ @,# #,4.73793E+17,https://twitter.com/_TheUrologist_/status/473793103435149312,,,,
MayurKherdikar,6/3/2014 7:47,0,0,$ AZ shares updates on its oncology pipleline at # ASCO2014 http://www.astrazeneca.com/About-Us/Features/Article/20140530--demonstrating-AstraZeneca-oncology-science-ASCO-2014 … …,,,#,4.73793E+17,https://twitter.com/MayurKherdikar/status/473792966675296256,,,,
3NT,6/3/2014 7:46,4,2,More Immuno-Oncology on final day of # ASCO14 - final live blog from @ MaverickNY. Safe travels! http://3nt.co/Pembrolizumab,,@,#,4.73793E+17,https://twitter.com/3NT/status/473792797288693760,,,,
teamoncology,6/3/2014 7:45,3,4,【 # ASCO14 Update】進行がんにおいて、がんと直接関連しない薬（コレステロール抑制剤）をやめることが患者のQOLを改善することが証明された。死に直面しているひとへ無駄な薬を辞める必要あり。 http://abstracts.asco.org/144/AbstView_144_135132.html …,,,#,4.73793E+17,https://twitter.com/teamoncology/status/473792514508333056,,,,
MarekTrnenyDr,6/3/2014 7:45,1,0,"PET driven approach for high risk DLBCL, interesting data, abst 8503 # ASCO14, more appears on # lymphomahubpic.twitter.com/1wX3e51F8C",,,# #,4.73792E+17,https://twitter.com/MarekTrnenyDr/status/473792489330311168,,,,
BiotechStrategy,6/3/2014 7:44,0,0,ASCO 2014 Day 5 Live Blog - safe travels for all leaving Chicago today # ASCO14 http://biotechstrategyblog.com/2014/06/asco-2014-day-5-live-blog-asco14.html/ …,,,#,4.73792E+17,https://twitter.com/BiotechStrategy/status/473792276037005312,,,,
teamoncology,6/3/2014 7:44,0,4,【 # ASCO14 Update】 50年におよぶ乳がんの治療の発展がわかりやすくまとめてあります（英語）→ http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pG9xRCeIQ.twitter …,,,# #,4.73792E+17,https://twitter.com/teamoncology/status/473792266100670465,,,,
teamoncology,6/3/2014 7:43,0,1,【 # ASCO14 Update】閉経前ホルモン陽性乳がんにおいて、アロマテース阻害剤と卵巣機能抑制剤の組み合わせはタモキシフェンよりも再発をより下げる。,,,#,4.73792E+17,https://twitter.com/teamoncology/status/473792057555689472,,,,
damien_maillard,6/3/2014 7:40,0,0,“ @ LeemFrance: Une nouvelle avancée pour les enfants atteints de # tumeurs cérébrales http://buff.ly/1nYGT5J # ASCO14 # oncologie”,,@,# # #,4.73791E+17,https://twitter.com/damien_maillard/status/473791290598227968,,,,
LeemFrance,6/3/2014 7:40,7,1,Une nouvelle avancée pour les enfants atteints de # tumeurs cérébrales http://buff.ly/1nYGT5J # ASCO14 # oncologie,,,# # #,4.73791E+17,https://twitter.com/LeemFrance/status/473791244737732608,,,,
christinemphmd,6/3/2014 7:39,0,0,Last day of # ASCO14! It's been an exciting and exhausting few days!,,,#,4.73791E+17,https://twitter.com/christinemphmd/status/473791011941277696,,,,
DrJAshton,6/3/2014 7:38,1,4,Exciting immune therapy for advanced # CervicalCancer - news out of @ ASCO I discuss today on @ GMA # smalltrialbutpromisingresults,,@ @,# #,4.73791E+17,https://twitter.com/DrJAshton/status/473790894861455361,,,,
mtmdphd,6/3/2014 7:37,1,0,"MT @ fischmd: # Breastcancer: past, present, future challenges. Sledge et al, # JCO @ ASCO http://ow.ly/xz9QT # ASCO14 # bcsm",,@ @,# # # #,4.73791E+17,https://twitter.com/mtmdphd/status/473790507626541057,,,,
BioStocks,6/3/2014 7:35,4,3,New skin cancer drug hailed 'paradigm shift' in treatment $ MRK http://fw.to/46hjjag # ASCO14,,,#,4.7379E+17,https://twitter.com/BioStocks/status/473790062518206465,,,,
dhjutsw1,6/3/2014 7:34,3,0,@ ASCO Ramucirumab 'hailed' for marginal benefit in lung cancer at # ASCO14; emphasis on 'marginal'. http://www.medscape.com/viewarticle/826014?src=wnl_edit_cfna?src=sttwit …,,@,#,4.7379E+17,https://twitter.com/dhjutsw1/status/473789823325462530,,,,
teamoncology,6/3/2014 7:33,1,0,【 # ASCO14 Update】LHRH agonistを化学療法中に使用して、卵巣機能を温存を多少できる事が証明。ただ、妊娠できるかとは別問題。 http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.7379E+17,https://twitter.com/teamoncology/status/473789678378680322,,,,
teamoncology,6/3/2014 7:32,0,0,【 # ASCO14 Update】 低いビタミンDレベル、乳がんの生存率とは関連がない。つまり、ビタミンDを飲むことにより生存率の改善の根拠は無い。 http://abstracts.asco.org/144/AbstView_144_128900.html …,,,#,4.73789E+17,https://twitter.com/teamoncology/status/473789411549646850,,,,
LGG1,6/3/2014 7:30,0,0,Back to the Future: Family History is Still Key in the Genomic Era # ASCO14 # genetics http://ow.ly/3ljp98,,,# #,4.73789E+17,https://twitter.com/LGG1/status/473788882971271168,,,,
DebMaskens,6/3/2014 7:30,1,1,Important role for cancer patient orgs: Social Media in Clinical Trials http://meetinglibrary.asco.org/content/11400101-144#.U42w72SKbrc.twitter … # hcsm # asco14,,,# # #,4.73789E+17,https://twitter.com/DebMaskens/status/473788818999369729,,,,
teamoncology,6/3/2014 7:30,0,0,【 # ASCO14 Important Update】Anti-PD-1 monoclonal antibody MK-3475 is effective in melanoma. http://abstracts.asco.org/144/AbstView_144_133842.html …,,,#,4.73789E+17,https://twitter.com/teamoncology/status/473788801706229761,,,,
OpenAccessGov,6/3/2014 7:29,2,1,# skincancer research results released at @ ASCO are ‘exciting’... http://bit.ly/1pCfGb4 # melanoma # cancer # research,,@,# # # #,4.73789E+17,https://twitter.com/OpenAccessGov/status/473788547334692864,,,,
Joe_Hedden,6/3/2014 7:28,4,1,"@ Datamonitor_HC's take on key themes at # ASCO14, speaking on @ CNBCWEX with @ RossWestgate http://cnb.cx/1p3NOKD # pharma # cancer",,@ @ @,# # #,4.73788E+17,https://twitter.com/Joe_Hedden/status/473788240642981888,,,,
Sports_bios,6/3/2014 7:27,0,1,# ASCO14 almost done.. and the most fun story is this nonsense of who is better - $ CLVS vs $ AZN... EHA next.. and then the big V-I-G evts.,,,#,4.73788E+17,https://twitter.com/Sports_bios/status/473788032731336704,,,,
SitemanCenter,6/3/2014 7:25,3,0,"Matthew Ellis, MD, BChir, PhD, and others discuss strategies for picking combination therapy regimens: 8-9:15 am, Rm S100a # ASCO14",,,#,4.73787E+17,https://twitter.com/SitemanCenter/status/473787465384599552,,,,
TargetedOnc,6/3/2014 7:20,1,0,Dr. Janku: Sirolimus and vorinostat in heavily pretreated patients with refractory Hodgkin lymphoma http://www.targetedonc.com/conference/asco-2014/Sirolimus-and-Vorinostat-in-Heavily-Pretreated-Refractory-Hodgkin-Lymphoma … # ASCO14,,,#,4.73786E+17,https://twitter.com/TargetedOnc/status/473786257504743426,,,,
StephanThomeMD,6/3/2014 7:20,5,1,HPV-lymphocyte infusion cures !metastatic cervix cancer in 2 women in National Cancer Institute trial # ASCO14 Watch http://m.youtube.com/watch?v=Yx4xNNtak24 …,,,#,4.73786E+17,https://twitter.com/StephanThomeMD/status/473786214697664513,,,,
CureMelanoma,6/3/2014 7:18,0,1,RT @ JeffGershenwald: Let's begin a global dialog to achieve superlative value in # melanoma cancer care now # endcancer # asco14,,@,# # #,4.73786E+17,https://twitter.com/CureMelanoma/status/473785859985391616,,,,
dhjutsw1,6/3/2014 7:18,4,2,Enzalutamide in metastatic prostate cancer before chemotherapy; decreased risk of death; data presented at # ASCO14. http://nej.md/1oRqwKc,,,#,4.73786E+17,https://twitter.com/dhjutsw1/status/473785811943436289,,,,
subatomicdoc,6/3/2014 7:18,2,1,You too! RT @ LGG1: Wonderful to see @ fischmd @ drattai and @ subatomicdoc IRL. Great people who do great work! # ASCO14 pic.twitter.com/dYliaN2loO,,@ @ @ @,#,4.73786E+17,https://twitter.com/subatomicdoc/status/473785732956708864,,,,
tinypasscontent,6/3/2014 7:17,0,0,"ASCO 2014 Day 5 Live Blog # ASCO14"" http://ift.tt/1klIrXq # BiotechStrategy # tinypass # paidcontent ""Chicago – it’s the last day of the ...""",,,# # # #,4.73786E+17,https://twitter.com/tinypasscontent/status/473785565952106497,,,,
iBIOPROPEL,6/3/2014 7:16,1,0,Should the cost of # cancer # drugs factor into # FDA approval? # ASCO14 http://medcitynews.com/2014/06/fda-cancer-chief-insurers-patients-doctors-lawmakers-must-work-together-cut-drug-costs/ …,,,# # # #,4.73785E+17,https://twitter.com/iBIOPROPEL/status/473785385592434688,,,,
CancerSupportHQ,6/3/2014 7:15,3,2,Thanks @ OCNA @ ACSCAN @ ACCCBuzz @ GSK for a great panel on personalized medicine. # ASCO14 pic.twitter.com/xYgJizK4gg,,@ @ @ @,#,4.73785E+17,https://twitter.com/CancerSupportHQ/status/473784976362991616,,,,
ChristianGrdnr,6/3/2014 7:14,0,0,Skin cancer trial results 'exciting' # ASCO2014 http://bbc.in/1hTfHj8,,,#,4.73785E+17,https://twitter.com/ChristianGrdnr/status/473784690973753344,,,,
drdonsdizon,6/3/2014 7:11,2,3,Shout out and hearty congratulations 2 @ CliffordHudis Ur talk brought tweeting from podium 2 a whole new level- effective engagement # ASCO14,,@,#,4.73784E+17,https://twitter.com/drdonsdizon/status/473783965866668032,,,,
ecancer,6/3/2014 7:09,0,0,Is discontinuing statins near the end of life safe? Watch the interview with Prof Abernethy here http://ecancer.org/conference/514-asco-2014/video/2883/discontinuing-statins-near-the-end-of-life-is-safe--improves-patient-quality-of-life.php … # ASCO14,,,#,4.73784E+17,https://twitter.com/ecancer/status/473783638086389760,,,,
dytcmd,6/3/2014 7:09,0,0,"+1 “ @ iConquerCancer: Congrats to the 2014 @ iConquerCancer YIA, CDA, & ACRA recipients! http://bit.ly/1gBtM9R # ASCO14” cc@simon_p_kim",,@ @ @simon_p_kim,#,4.73784E+17,https://twitter.com/dytcmd/status/473783597544271872,,,,
drdonsdizon,6/3/2014 7:08,1,5,Leaving # ASCO14 A whirlwind but amazing. Hope those new 2 twitter stay w it. Keep calm and stay engaged!,,,#,4.73783E+17,https://twitter.com/drdonsdizon/status/473783308006854656,,,,
rschilsky,6/3/2014 7:08,1,0,Progress in prostate cancer treatment. # ASCO14. http://www.nejm.org/doi/full/10.1056/NEJMoa1405095?query=oncology-hematology …,,,#,4.73783E+17,https://twitter.com/rschilsky/status/473783168815104000,,,,
RickDomann,6/3/2014 7:07,1,1,"New System for Treating # Melanoma Seen as Hopeful @ ASCO, via @ nytimes http://nyti.ms/1jLZ74z",,@ @,#,4.73783E+17,https://twitter.com/RickDomann/status/473783112980500480,,,,
kevinatgrogan,6/3/2014 7:07,0,2,"@ JacobEPVantage @ JonEPVantage Marvellous # ASCO14 coverage, chapeau as they say in Lyon where I am off for # Biovision2014",,@ @,# #,4.73783E+17,https://twitter.com/kevinatgrogan/status/473782918780039168,,,,
drdonsdizon,6/3/2014 7:06,0,1,@ GlopesMd safe travels home. Meeting F2F was a highlight of # ASCO14 # FF,,@,# #,4.73783E+17,https://twitter.com/drdonsdizon/status/473782722914033665,,,,
StephanThomeMD,6/3/2014 7:05,0,0,"HPV discoverer, HPV vaccine inventor, Noble laureate finds virus in raw beef, explores links to human disease esp. colon cancer # ASCO14",,,#,4.73783E+17,https://twitter.com/StephanThomeMD/status/473782582317158400,,,,
evaluatepharma,6/3/2014 7:05,2,0,# ASCO14 - Academia gives # Erbitux another chance to gain share in colorectal cancer http://ow.ly/xz4YR $ LLY,,,# #,4.73782E+17,https://twitter.com/evaluatepharma/status/473782451987562496,,,,
rschilsky,6/3/2014 7:05,7,3,Breakthrough in CLL treatment. # ASCO14 http://www.nejm.org/doi/full/10.1056/NEJMoa1400376?query=oncology-hematology …,,,#,4.73782E+17,https://twitter.com/rschilsky/status/473782402813526016,,,,
MelanomaMom,6/3/2014 7:04,1,0,RT @ CancerDotNet: Dr. Antoni Ribas @ UCLAHealth discusses new anti-PD1 immunotherapy for met # melanoma # ASCO14 # melsm http://bit.ly/1m5jjQo,,@ @,# # #,4.73782E+17,https://twitter.com/MelanomaMom/status/473782172306771968,,,,
CureMelanoma,6/3/2014 7:02,0,0,RT @ timturnham: . @ CureMelanoma Every talk about clinical trial results ends with thanks to patients for being part of the study. # ASCO14,,@ @,#,4.73782E+17,https://twitter.com/CureMelanoma/status/473781657917730816,,,,
StephanThomeMD,6/3/2014 6:57,2,0,"HPV discover, HPV vaccine inventor, Nobel laureate Harald Zur Hausen won # ASCO14 Science prize. http://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html …",,,#,4.7378E+17,https://twitter.com/StephanThomeMD/status/473780386297020416,,,,
frosa_farma,6/3/2014 6:55,0,0,"@ bmsnews muestra en # ASCO14 su potencial en inmuno-oncología, alimentado con algunos acuerdos # pharma # cancer http://www.elglobal.net/noticias-medicamento/2014-06-02/industria-farmaceutica/bms-muestra-avances-con-dos-moleculas-en-asco-y-constata-su-apuesta-por-la-inmuno-oncologia/pagina.aspx?idart=841679 …",,@,# # #,4.7378E+17,https://twitter.com/frosa_farma/status/473780123008008192,,,,
subatomicdoc,6/3/2014 6:55,0,4,"I may miss my flight, but I can't leave Chicago without Garrett's popcorn for the kids. # ASCO14 # homewardboundpic.twitter.com/bpEePuerid",,,# #,4.7378E+17,https://twitter.com/subatomicdoc/status/473779909207556096,,,,
fischmd,6/3/2014 6:44,8,7,"How Progress Happens: An Industry Perspective on Innovation in Oncology"""," by @ MaceRothenberg http://bit.ly/RH2mDC # ASCO14""",,@,#,4.73777E+17,https://twitter.com/fischmd/status/473777259426639872,,,
HUPERTAN,6/3/2014 6:41,0,0,"News # ASCO14: The incidence of advanced stages # prostatecancer escalated in parallel with early stages = the # PSA N…http://lnkd.in/dwT3HYv""",,,# # #,4.73777E+17,https://twitter.com/HUPERTAN/status/473776583803547648,,,,
ggatyas,6/3/2014 6:41,0,0,"Reading now: @ newyorktimes Andrew Pollack, # immunotherapy gives # cancer patients hope, # ASCO14, http://nyti.ms/1oRjhlC",,@,# # #,4.73776E+17,https://twitter.com/ggatyas/status/473776449049341952,,,,
campaign4cancer,6/3/2014 6:39,1,2,"The journey never ends ur a survivor always  @ NETKanker: Long term side effects of # cancer treatment Info # ASCO14 http://www.cancer.net/survivorship/long-term-side-effects-cancer-treatment …”""",,@,# #,4.73776E+17,https://twitter.com/campaign4cancer/status/473775956822618112,,,,
fischmd,6/3/2014 6:39,6,6,"# Breastcancer: past, present, future challenges. Sledge et al, @ ASCO # JCO http://ow.ly/xz2jq # ASCO14",,@,# # #,4.73776E+17,https://twitter.com/fischmd/status/473775862652080128,,,,
GlopesMd,6/3/2014 6:35,2,11,"Good morning and goodbye, Chicago. We'll be back next year! # ASCO14 pic.twitter.com/nRZShATuel",,,#,4.73775E+17,https://twitter.com/GlopesMd/status/473775030350790656,,,,
HallandPartners,6/3/2014 6:35,0,0,# ASCO14 is well under way - take a look at what we've discovered so far http://bit.ly/1huW2LQ @ ASCO # oncology # healthresearch,,@,# # #,4.73775E+17,https://twitter.com/HallandPartners/status/473774995345510400,,,,
Medzineapp,6/3/2014 6:31,6,2,Strong Bond Between Young Adult Cancer Patients and Their Oncologists Reduces Thoughts of Suicide http://bit.ly/SpSY7O # ASCO14 # hcsm,,,# #,4.73774E+17,https://twitter.com/Medzineapp/status/473774007108775936,,,,
hjhope,6/3/2014 6:29,0,1,Cancer immunotherapy gets boost with release of nivolumab & pembrolizumab (PD-1 blockade) results @ # ASCO2014 http://goo.gl/TFNnhA,,@,#,4.73774E+17,https://twitter.com/hjhope/status/473773559710765056,,,,
ColinPWhite,6/3/2014 6:26,5,0,@Datamonitor_JH discussing # ASCO14 on CNBC's Worldwide Exchange http://cnb.cx/1rGyvfg,,@Datamonitor_JH,#,4.73773E+17,https://twitter.com/ColinPWhite/status/473772675173982208,,,,
darrenfergus,6/3/2014 6:25,0,0,A world class meeting very briefly summarised by Why Health - jet lagged but really buzzed up after # ASCO14. http://lnkd.in/dC62KGV,,,#,4.73772E+17,https://twitter.com/darrenfergus/status/473772483263225856,,,,
HUPERTAN,6/3/2014 6:24,0,0,"@DrVHUPERTAN: News # ASCO14: The LOW risk of death for men diagnosed with screen-detected localized prostate cancer.…http://meetinglibrary.asco.org/content/128075-144 …""",,@DrVHUPERTAN,#,4.73772E+17,https://twitter.com/HUPERTAN/status/473772161451036672,,,,
HUPERTAN,6/3/2014 6:19,0,0,"News # ASCO14: The LOW risk of death for men diagnosed with screen-detected localized prostate cancer."" http://meetinglibrary.asco.org/content/128075-144 …""",,,#,4.73771E+17,https://twitter.com/HUPERTAN/status/473771059599409152,,,,
AtriumHealth,6/3/2014 6:10,2,2,What's hot at ASCO 2014—Day 2 Coverage http://bit.ly/1rDIVw0 # ASCO14,,,#,4.73769E+17,https://twitter.com/AtriumHealth/status/473768555121352705,,,,
AIMS_Spain,6/3/2014 6:07,0,0,RT @ LuisTruchado: @ el_pais en @ ASCO invitado por @boehringer_esp en edición papel http://tinyurl.com/p4zbzqc Admirable # transparencia @ anisalud,,@ @ @ @boehringer_esp @,#,4.73768E+17,https://twitter.com/AIMS_Spain/status/473768044402339841,,,,
GustaveRoussy,6/3/2014 6:06,5,0,Thérapies ciblées seules ou combinées : un des thèmes de l' # ASCO14. Lire l'article http://bit.ly/1wZD3NV,,,#,4.73768E+17,https://twitter.com/GustaveRoussy/status/473767704734990336,,,,
titznglitz,6/3/2014 6:02,0,0,NCI News & Media @ NCIMedia Announced at # ASCO14: Treatment helps young women preserve their fertility during... http://fb.me/7qleQGi2y,,@,#,4.73767E+17,https://twitter.com/titznglitz/status/473766687863746560,,,,
HealthDeskNews,6/3/2014 5:59,0,0,Il palloncino che scova il # cancro al polmone. La novità da # ASCO2014 | @ ASCO | HealthDesk http://www.healthdesk.it/scienza/il_palloncino_che_scova_il_cancro_al_polmone/1401648360 …,,@,# #,4.73766E+17,https://twitter.com/HealthDeskNews/status/473765814365995008,,,,
PMLiVEcom,6/3/2014 5:56,0,3,Merck’s anti-PD1 impresses in skin and lung cancer http://bit.ly/1h30yRk # pharma # ASCO14 # oncology,,,# # #,4.73765E+17,https://twitter.com/PMLiVEcom/status/473765170142281728,,,,
Roche,6/3/2014 5:55,6,5,What's the difference between overall and progression-free survival? Test your # ClinicalTrials IQ: http://ow.ly/xwysZ # ASCO14,,,# #,4.73765E+17,https://twitter.com/Roche/status/473764807204958208,,,,
FightCRC,6/3/2014 5:47,0,2,"MT Our pleasure! @ subatomicdoc // @ AnjeeDavis @ CCAlliance @ chris4cure TY for your work to empower,assist my patients & others # ASCO14 # crcsm",,@ @ @ @,# #,4.73763E+17,https://twitter.com/FightCRC/status/473762860401950720,,,,
Boehringer,6/3/2014 5:45,0,1,BLOG POST: Read our round up of day 3 at ASCO by Julia Knebel # lungcancer # ASCO14 http://bit.ly/1onvYkl,,,# #,4.73763E+17,https://twitter.com/Boehringer/status/473762510307590144,,,,
PILAR_PJ,6/3/2014 5:45,1,2,Inmunoterapia contra el cáncer de vejiga metastasico d @ Beamglezubeda en @ larazon_es # ASCO2014 # nuevaarmavscancer http://www.larazon.es/detalle_normal/noticias/6547947/inmunoterapia-contra-el-cancer-de-vejiga-metastasico#.U42YeRmognw.twitter …,,@ @,# # #,4.73762E+17,https://twitter.com/PILAR_PJ/status/473762281525108736,,,,
subatomicdoc,6/3/2014 5:40,1,4,"@ AnjeeDavis @ FightCRC @ CCAlliance @ chris4cure Thank you all for your work to empower, assist my patients and others # ASCO14 # crcsm",,@ @ @ @,# #,4.73761E+17,https://twitter.com/subatomicdoc/status/473761213017767936,,,,
Medzineapp,6/3/2014 5:39,0,0,Adding # Chemotherapy to Hormone Therapy Improved Survival in Men with Newly Metastatic # ProstateCancer http://bit.ly/1nKbbLT # ASCO14 # PCSM,,,# # # #,4.73761E+17,https://twitter.com/Medzineapp/status/473761001528393728,,,,
Medzineapp,6/3/2014 5:34,0,1,Doubling Down on Next-Gen Cancer Drugs http://bit.ly/1n7SjmI # ASCO14 # hcsm,,,# #,4.7376E+17,https://twitter.com/Medzineapp/status/473759529436708864,,,,
redaccionmedica,6/3/2014 5:31,0,0,Industria | @ Roche_spain propone bevacizumab como terapia estándar en # Cancer colorrectal metastásico en @ ASCO http://www.redaccionmedica.com/secciones/industria/-7957 …,,@ @,#,4.73759E+17,https://twitter.com/redaccionmedica/status/473758809111142400,,,,
ByJoFagg,6/3/2014 5:30,0,1,ICYMI RT @ EPVantage Clovis impresses then disappoints with early lung cancer data: $ CLVS $ AZN http://ow.ly/xyV0y # ASCO14 # CO1686,,@,# #,4.73759E+17,https://twitter.com/ByJoFagg/status/473758542613463040,,,,
LeemFrance,6/3/2014 5:20,2,0,"# immunothérapie, la nouvelle arme anti-cancer http://buff.ly/1kxWqIX # oncologie # ASCO14",,,# # #,4.73756E+17,https://twitter.com/LeemFrance/status/473756052195127296,,,,
FAMESante,6/3/2014 5:16,0,0,Congrès de l' @ Asco 2014 : la # lutte contre le # cancer continue http://news.doctissimo.fr/Sante/Congres-de-l-Asco-2014-la-lutte-contre-le-cancer-continue-35002?utm_source=twitterfeed&utm_medium=twitter … @ famesante # sante,,@ @,# # #,4.73755E+17,https://twitter.com/FAMESante/status/473755038108499970,,,,
OncLive,6/3/2014 5:15,1,1,OncLive TV: Dr. Johanna Bendell Discusses Two Studies in BRAF-Mutated CRC http://ow.ly/xwGnW # ASCO14,,,#,4.73755E+17,https://twitter.com/OncLive/status/473754788874956801,,,,
GustaveRoussy,6/3/2014 5:06,5,2,"Le Quotidien du Médecin 2/06 : Un test génétique pour prévoir le risque de récidive du # cancer du rein"" http://bit.ly/1h2PsvE # ASCO14""",,,# #,4.73753E+17,https://twitter.com/GustaveRoussy/status/473752576509628416,,,,
Bispecific,6/3/2014 5:05,1,0,HT @ themotleyfool Potential of bispecific antibodies highlighted at # ASCO14 http://ow.ly/xySor $ AMGN $ AZN $ RHHBY,,@,#,4.73752E+17,https://twitter.com/Bispecific/status/473752219771490304,,,,
seniorhomes,6/3/2014 5:04,1,1,RT @ CancerDotNet: New study on caregivers: Benefits of a palliative care support program post-diagnosis... # ASCO14 http://bit.ly/1nB2Z0r,,@,#,4.73752E+17,https://twitter.com/seniorhomes/status/473751985930252288,,,,
hgazay,6/3/2014 5:02,0,0,Very good summary of this year's # Asco14 impact on # onclogy market http://lnkd.in/b6jT2KK,,,# #,4.73752E+17,https://twitter.com/hgazay/status/473751555179425793,,,,
Iamsaltafosso,6/3/2014 5:02,0,0,http://www.molmed.com/sites/default/files/uploads/press-releases/2531-new_data_presented_at_asco_on_ngr-htnf_significantly_extended_survival_in_mesothelioma_and_in_sarcomas/2531_1401761593.pdf … $ MLM.BIT # ASCO14,,,#,4.73752E+17,https://twitter.com/Iamsaltafosso/status/473751553426595841,,,,
Alimentomica,6/3/2014 4:54,1,0,Jeffrey Mayerhardt en @ ASCO realidades y mitos de # dietas milagrosas contra # cáncer No # alimentos malditos o geniales http://www.elmundo.es/salud/2014/06/02/538c4000e2704e95098b4578.html …,,@,# # #,4.73749E+17,https://twitter.com/Alimentomica/status/473749446468308992,,,,
ThePharmaLetter,6/3/2014 4:50,1,0,# ASCO14: @ AstraZeneca showcases much awaited # oncology pipeline http://bit.ly/1o2HN18 # pharma @ ASCO,,@ @,# # #,4.73748E+17,https://twitter.com/ThePharmaLetter/status/473748425629249536,,,,
ecancer,6/3/2014 4:43,1,0,Adjuvant ipilimumab improves recurrence-free survival in high-risk # melanoma http://ecancer.org/news/5748-asco-2014--adjuvant-ipilimumab-improves-recurrence-free-survival-in-high-risk-melanoma.php … # ASCO14,,,# #,4.73747E+17,https://twitter.com/ecancer/status/473746733319876608,,,,
ArcagyGineco,6/3/2014 4:43,0,0,Une nouvelle thérapie inédite contre le cancer de l'ovaire # ASCO14 @ ArcagyGineco http://videos.tf1.fr/jt-20h/2014/une-nouvelle-therapie-inedite-contre-le-cancer-de-l-ovaire-8426769.html …,,@,#,4.73747E+17,https://twitter.com/ArcagyGineco/status/473746684196184064,,,,
MBLoberg,6/3/2014 4:42,0,0,Prof Steinar Aamdal @ Oslounivsykehus forteller @ DagensMedisin om nye behandlinger av føflekkreft fra @ ASCO # ASCO2014 http://bit.ly/1nHpgcZ,,@ @ @,#,4.73746E+17,https://twitter.com/MBLoberg/status/473746477320519680,,,,
LuisTruchado,6/3/2014 4:29,1,0,@ el_pais acude a @ ASCO invitado por @boehringer_esp reportado en edición papel http://tinyurl.com/p4zbzqc via @ el_pais Admirable # transparencia,,@ @ @boehringer_esp @,#,4.73743E+17,https://twitter.com/LuisTruchado/status/473743325200011264,,,,
mtoynesewell,6/3/2014 4:29,0,0,@ ASCO @ScripMikeWard No wonder there are no journalists in London - they're all with you.,,@ @ScripMikeWard,,4.73743E+17,https://twitter.com/mtoynesewell/status/473743138050568192,,,,
CDRLifeSciences,6/3/2014 4:25,0,0,# immatics: # Cancer immunotherapy finally coming of age? High hopes # ASCO14 http://on.ft.com/1o2BxX5 via @ FT,,@,# # #,4.73742E+17,https://twitter.com/CDRLifeSciences/status/473742132298383360,,,,
TCD_Pharma,6/3/2014 4:23,0,0,La inmunoterapia contra el # cáncer amplía su campo de acción. # ASCO14 . http://bit.ly/1n7zhwH,,,# #,4.73742E+17,https://twitter.com/TCD_Pharma/status/473741847924576256,,,,
harrlan99,6/3/2014 4:21,0,0,@ ASCO World class,,@,,4.73741E+17,https://twitter.com/harrlan99/status/473741183496122368,,,,
Morrison_Pharma,6/3/2014 4:21,0,0,@ Merck and @ bmsnews present promising results for their anti PD-1s at @ ASCO via @ bbchealth http://www.bbc.co.uk/news/health-27674658 …,,@ @ @ @,,4.73741E+17,https://twitter.com/Morrison_Pharma/status/473741129825783809,,,,
pelletieramelie,6/3/2014 4:14,1,0,Congrès de l'Asco 2014 : la lutte contre le # cancer continue - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Congres-de-l-Asco-2014-la-lutte-contre-le-cancer-continue-35002 … # ASCO14,,@,# #,4.73739E+17,https://twitter.com/pelletieramelie/status/473739397481783296,,,,
mihoroscopoxdia,6/3/2014 4:03,0,0,hoy concluye # ASCO14 con la participación de más de 25.000 profesionales de todo el mundo que comparten un objetivo común: vencer al # LEO,,,# #,4.73737E+17,https://twitter.com/mihoroscopoxdia/status/473736600946343936,,,,
EKFdiagnostics,6/3/2014 4:02,0,1,"We are at ASCO, stop by and hear about EKF's PointMan Technology, find us at stand 4109 # ASCO14 pic.twitter.com/J0EOtgq3Lt",,,#,4.73737E+17,https://twitter.com/EKFdiagnostics/status/473736579710996480,,,,
LorellaSalce,6/3/2014 3:59,0,0,Prevenire i tumori fa risparmiare miliardi # ASCO14 @ ASCO # AIOM http://www.healthdesk.it/scienza/prevenire_i_tumori_fa_risparmiare_miliardi/1401544971 …,,@,# #,4.73736E+17,https://twitter.com/LorellaSalce/status/473735760244244481,,,,
StuartMayell,6/3/2014 3:54,0,1,Give a shout out to @ Merck and @ bmsnews for the melanoma breakthroughs hitting the headlines today. # pharma ain't all bad. # ASCO14,,@ @,# #,4.73734E+17,https://twitter.com/StuartMayell/status/473734480004665344,,,,
fwpharma,6/3/2014 3:52,1,1,ViewPoints: New data indicates key role for biomarkers in immuno-oncology development race http://bit.ly/1kE3hvl # ASCO14,,,#,4.73734E+17,https://twitter.com/fwpharma/status/473734011236651008,,,,
PortaleMedyczne,6/3/2014 3:51,0,0,Dziś kończy się Doroczny Zjazd @ ASCO - ciekawi najnowszych doniesień w dziedzinie onkologii ? Już wkrótce na stronie @ PortaleMedyczne,,@ @,,4.73734E+17,https://twitter.com/PortaleMedyczne/status/473733624173694976,,,,
LorellaSalce,6/3/2014 3:44,0,0,"Cancro ovaio, speranze da terapia combinata # ASCO14 @ ASCO http://www.repubblica.it/salute/medicina/2014/06/01/news/da_terapia_combinata_nuove_speranze_contro_cancro_ovaio-87810432/ … via @repubblicait",,@ @repubblicait,#,4.73732E+17,https://twitter.com/LorellaSalce/status/473732033496096769,,,,
_SEOM,6/3/2014 3:26,7,1,"Escucha un resumen de # ASCO2014: cáncer d mama&obesidad, pulmon, inmunoterapia, gástrico avanzado y neuroncologia en: http://bit.ly/1m50wVi",,,#,4.73727E+17,https://twitter.com/_SEOM/status/473727307320811520,,,,
pelletieramelie,6/3/2014 3:24,2,0,Cancer de la vessie : nouvel espoir face pour les formes métastatiques - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Cancer-de-la-vessie-nouvel-espoir-face-pour-les-formes-metastatiques-34995 … # ASCO14,,@,#,4.73727E+17,https://twitter.com/pelletieramelie/status/473726965623439360,,,,
Pharmafocus,6/3/2014 3:19,0,1,Boehringer lung cancer drug shows survival benefit: http://bit.ly/1o2mgpg # asco2014 # pharma # health # cancer,,,# # # #,4.73726E+17,https://twitter.com/Pharmafocus/status/473725561450557440,,,,
brettwells,6/3/2014 3:19,0,0,Boehringer lung cancer drug shows survival benefit: http://bit.ly/1o2mgpg # asco2014 # pharma # health # cancer,,,# # # #,4.73726E+17,https://twitter.com/brettwells/status/473725560859131905,,,,
Biostrata,6/3/2014 3:10,0,1,Fascinating data is already being served up at # ASCO14. Our US partner @ Chempetitive has the highlights thus far: http://chempetitive.com/chemunity/cancer-care-progress-asco-2014-highlights-chicago …,,@,#,4.73723E+17,https://twitter.com/Biostrata/status/473723397835608064,,,,
exerciseworks,6/3/2014 3:10,2,3,Importance of exercise for postmenopausal # breast # cancer risk reduction http://meetinglibrary.asco.org/content/133888-144#.U410weJ9zmo.twitter … # ASCO14,,,# # # #,4.73723E+17,https://twitter.com/exerciseworks/status/473723395423490048,,,,
pelletieramelie,6/3/2014 3:07,3,0,Cancer de la prostate : avancée majeure pour les formes métastatiques - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Cancer-de-la-prostate-avancee-majeure-pour-les-formes-metastatiques-34996 … # ASCO14,,@,#,4.73723E+17,https://twitter.com/pelletieramelie/status/473722516427386880,,,,
pelletieramelie,6/3/2014 3:06,6,3,"L’immunothérapie, nouvel espoir contre le # cancer - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/L-immunotherapie-nouvel-espoir-contre-le-cancer-34998 … # ASCO14",,@,# #,4.73722E+17,https://twitter.com/pelletieramelie/status/473722305881706496,,,,
pelletieramelie,6/3/2014 3:05,1,1,Cancer de l’ovaire avancé : vers une association de thérapies ciblées ? - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Cancer-de-l-ovaire-avance-vers-une-association-de-therapies-ciblees-34999 … # ASCO14,,@,#,4.73722E+17,https://twitter.com/pelletieramelie/status/473722115359645696,,,,
DasLebenshaus,6/3/2014 3:00,0,0,# ASCO14: study on quality of life of mRCC patients in cooperation with das Lebenshaus http://bit.ly/daslebenshaus via @ daslebenshaus,,@,#,4.73721E+17,https://twitter.com/DasLebenshaus/status/473720928010924033,,,,
cure_talk,6/3/2014 3:00,1,0,# ASCO2014 winners and losers http://www.forbes.com/sites/matthewherper/2014/06/02/cancer-conference-winners-and-losers/ …,,,#,4.73721E+17,https://twitter.com/cure_talk/status/473720921895600129,,,,
x_bouchet,6/3/2014 3:00,0,0,@ HEVAWEB spécialiste données de santé publie à l' # asco14 # healthdata # heor # Cancer http://bit.ly/1onXWwd,,@,# # # #,4.73721E+17,https://twitter.com/x_bouchet/status/473720821362741248,,,,
BoehringerES,6/3/2014 3:00,2,0,Hoy concluye # ASCO14 con la participación de más de 25.000 profesionales de todo el mundo que comparten un objetivo común: vencer al # cancer,,,# #,4.73721E+17,https://twitter.com/BoehringerES/status/473720743822258177,,,,
osservasaluteaz,6/3/2014 2:56,0,0,"# Asco14, Stefano Cascinu, Presidente dell'Aiom: come ridisegnare l’assistenza oncologica in Italia: http://bit.ly/1on6Aeq via@QSanit.",,@QSanit,#,4.7372E+17,https://twitter.com/osservasaluteaz/status/473719737047056384,,,,
damien_maillard,6/3/2014 2:48,0,0,“ @ davidbeme:Cancer de l’ovaire à un stade avancé : vers une association de thérapies ciblées ? # ASCO2014 @ doctissimo http://ow.ly/xyFZk ”,,@ @,#,4.73718E+17,https://twitter.com/damien_maillard/status/473717771973722112,,,,
davidbeme,6/3/2014 2:47,0,0,Cancer de l’ovaire à un stade avancé : vers une association de thérapies ciblées ? # ASCO2014 @ doctissimo http://ow.ly/xyFZk,,@,#,4.73718E+17,https://twitter.com/davidbeme/status/473717547565867008,,,,
SABarclay,6/3/2014 2:34,0,0,@ ASCO & @ hdpalooza should either combine or not be at same time ;),,@ @,,4.73714E+17,https://twitter.com/SABarclay/status/473714260153876480,,,,
genentech,6/3/2014 2:25,4,1,"“Whatever the future will be, if it’s going to make an impact it happens at @ ASCO” – S. Valerio, Sci Comms # Next50 # ASCO14",,@,# #,4.73712E+17,https://twitter.com/genentech/status/473711959674994688,,,,
xavigranda,6/3/2014 2:21,0,0,"El héroe del vinagre reconocido en @ asco, puede reducir un tercio las muertes por cáncer cervical http://www.elmundo.es/salud/2014/06/03/538cc4d7268e3e537c8b456d.html?cid=SMBOSO25301&s_kw=twitter …",,@,,4.73711E+17,https://twitter.com/xavigranda/status/473711032913768449,,,,
OncLive,6/3/2014 2:15,4,5,ipilimumab reduced the relative risk of cancer recurrence in the adjuvant setting by 25% in melanoma http://ow.ly/xxV93 # ASCO14,,,#,4.73709E+17,https://twitter.com/OncLive/status/473709442404732928,,,,
BIGagainstBC,6/3/2014 2:08,1,0,Breast Cancer Field Leverages Unique Biomarkers to Enhance Personalized Medicine # ASCO14 - http://am.asco.org/breast-cancer-field-leverages-unique-biomarkers-enhance-personalized-medicine#.U41mIPU8SvA.twitter …,,,# #,4.73708E+17,https://twitter.com/BIGagainstBC/status/473707665579720704,,,,
elenaslaso,6/3/2014 1:57,0,0,"@ aparcalaoreja:Una combinación de dos fármacos, más eficaz para un tipo de # cáncer de pulmón http://www.efefuturo.com/noticia/una-combinacion-de-dos-farmacos-mas-eficaz-para-un-tipo-de-cancer-de-pulmon/ … # ASCO14 @ EFEciencia",,@ @,# #,4.73705E+17,https://twitter.com/elenaslaso/status/473704913244274688,,,,
dralvaropinto,6/3/2014 1:50,0,1,Before leaving Chicago... it's time for the blues! # ASCO14 pic.twitter.com/8KtqPuAMMd,,,#,4.73703E+17,https://twitter.com/dralvaropinto/status/473703365000843266,,,,
pharmaphorum,6/3/2014 1:49,0,0,"@ mtmdphd thanks for sharing Mike and hope # ASCO14 proving interesting, shame I'm not there!",,@,#,4.73703E+17,https://twitter.com/pharmaphorum/status/473702974733447169,,,,
MyelomaTeacher,6/3/2014 1:15,1,0,# Senesco Announces Update on # SNS01-T at # ASCO14 # mmsm # myeloma http://online.wsj.com/article/PR-CO-20140602-905997.html …,,,# # # # #,4.73694E+17,https://twitter.com/MyelomaTeacher/status/473694462380875776,,,,
lenstarnes,6/3/2014 1:12,0,2,Excellent study by @ MotherinMed MDs' use of Twitter HT @ christinemphmd MT @eB2B_Health http://bit.ly/17fMwpr # ASCO14 # ESCcongress # hcsmeu,,@ @ @eB2B_Health,# # #,4.73694E+17,https://twitter.com/lenstarnes/status/473693701848698880,,,,
MyelomaTeacher,6/3/2014 1:08,0,0,# Novartis data at # ASCO14 show # panobinostat significantly improved progression-free survival in patients w/ # myeloma http://on.mktw.net/1pLOBPS,,,# # # #,4.73693E+17,https://twitter.com/MyelomaTeacher/status/473692729013055490,,,,
TuftsB,6/3/2014 1:07,0,0,@ DrAttai @ jrgralow @ ASCO ' thanks Dr D,,@ @ @,,4.73692E+17,https://twitter.com/TuftsB/status/473692312858800128,,,,
MyelomaTeacher,6/3/2014 1:01,2,1,@ theMMRF Newsflash from # ASCO14 - Volume 2 # mmsm # myeloma http://www.themmrf.org/about-the-mmrf/powerful-news/mmrf-blogs/mmrf-newsflash-from-asco-2014-volume-2.html …,,@,# # #,4.73691E+17,https://twitter.com/MyelomaTeacher/status/473690936875450368,,,,
dermanewsok,6/3/2014 1:00,0,0,"Melanoma, ipilimumab mostra netto miglioramento della sopravvivenza libera da recidiva # asco2014 http://bit.ly/1hu6DXp",,,#,4.73691E+17,https://twitter.com/dermanewsok/status/473690545257066497,,,,
antoniocaperna,6/3/2014 1:00,0,0,"Melanoma, ipilimumab mostra netto miglioramento della sopravvivenza libera da recidiva # asco2014 http://bit.ly/1hu6DXp",,,#,4.73691E+17,https://twitter.com/antoniocaperna/status/473690544292372481,,,,
salutedomani,6/3/2014 1:00,0,0,"Melanoma, ipilimumab mostra netto miglioramento della sopravvivenza libera da recidiva # asco2014 http://bit.ly/1hu6DXp",,,#,4.73691E+17,https://twitter.com/salutedomani/status/473690544200105985,,,,
christinemphmd,6/3/2014 0:56,0,0,“@eB2B_Health: Physician use of Twitter: Examining the data http://bit.ly/17fMwpr ” Hoping this is capturing the boom in # ASCO14 tweets!,,@eB2B_Health,#,4.7369E+17,https://twitter.com/christinemphmd/status/473689618198847488,,,,
DrBridgetOBrien,6/3/2014 0:49,0,0," @ WilliamDale_MD: # ASCO14 Hurria: Challenges are just opportunities in disguise. (And they have to be financed. ) # oncology."" Free = 0worth""",,@,# #,4.73688E+17,https://twitter.com/DrBridgetOBrien/status/473687773757837312,,,,
yzafar,6/3/2014 0:40,2,1,Excited to collaborate with the innovative and energetic @ CancerSupportCm to help cancer patients with financial distress # ASCO14,,@,#,4.73686E+17,https://twitter.com/yzafar/status/473685644909510656,,,,
globalmcures,6/3/2014 0:36,0,0,OFS Plus Exemestane Improves DFS in Early # BreastCancer | ASCO Annual Meeting http://am.asco.org/ofs-plus-exemestane-improves-dfs-early-breast-cancer#.U41QzTPYu0Q.twitter … # ASCO14 # GlobalMedicalCures # Cancer,,,# # # # #,4.73685E+17,https://twitter.com/globalmcures/status/473684732312420355,,,,
darrenfergus,6/3/2014 0:36,0,0,"Why Health will share our top learnings and take home messages from # ASCO14, including 1 or 2 surprises this year.",,,#,4.73685E+17,https://twitter.com/darrenfergus/status/473684705192050688,,,,
darrenfergus,6/3/2014 0:35,1,0,"Did we see 'value' feature as promised? No, but health economics had more emphasis at # ASCO14. A sign of more to come at congress...",,,#,4.73684E+17,https://twitter.com/darrenfergus/status/473684303881060352,,,,
PamyCW,6/3/2014 0:23,0,0,Day 54 # 100happydays - beautiful Morning in Chicago # ASCO2014 pic.twitter.com/XvmX7EyixR,,,# #,4.73681E+17,https://twitter.com/PamyCW/status/473681293746896899,,,,
Curiolog,6/3/2014 0:22,0,0,"Demain, dernier jour de l' # ASCO14...",,,#,4.73681E+17,https://twitter.com/Curiolog/status/473681048941785089,,,,
Franco1Mary,6/3/2014 0:02,0,0,# ASCO14,,,#,4.73676E+17,https://twitter.com/Franco1Mary/status/473676184598097920,,,,
clarisssv,6/2/2014 23:47,0,0,Adiós windy city!!! Como siempre un placer. Esta vez con una buena anfitriona # ASCO14 pic.twitter.com/BvPhh3Kyjt,,,#,4.73672E+17,https://twitter.com/clarisssv/status/473672192606359552,,,,
IngeDiepman,6/2/2014 23:40,1,0,# ASCO14 oncojournaal met prof Smit prof Gelderblom over ASCO nieuws longkanker en sarcomen. http://Www.oncologietv.nl pic.twitter.com/25ihPg1WrE,,,#,4.73671E+17,https://twitter.com/IngeDiepman/status/473670629657280512,,,,
BRCAresponder,6/2/2014 23:31,0,0,"@ rsm2800 also price (cost) of cancer previvorship""-- w/preventative Bilateral Salpingo-Oophorectomy OR hysterectomy @ NickiDurlester # ASCO14""",,@ @,#,4.73668E+17,https://twitter.com/BRCAresponder/status/473668287390556160,,,,
CancerSupportHQ,6/2/2014 23:27,2,2,@ CChangetogether @Payal_CChange @Kristen_CChange @LindaSueHouse LOVED seeing you @ ASCO # ASCO14 pic.twitter.com/ezLHao6Qc5,,@ @Payal_CChange @Kristen_CChange @LindaSueHouse @,#,4.73667E+17,https://twitter.com/CancerSupportHQ/status/473667360919154688,,,,
BRCAresponder,6/2/2014 23:20,0,1,@ JeamesSailor # ASCO14 on social media and # bcsm http://wp.me/p3daDY-ij via @ obogler @ pinkandbluedoc @ hisbreastcancer @ DrAttai @ jodyms,,@ @ @ @ @ @,# #,4.73665E+17,https://twitter.com/BRCAresponder/status/473665432285884416,,,,
NateDahlPharmD,6/2/2014 23:13,0,0,"RT @ MayoCancerCare: In treating some cancer patients, less is more: http://reut.rs/1kCELL2 # ASCO14",,@,#,4.73664E+17,https://twitter.com/NateDahlPharmD/status/473663703510814721,,,,
PublicHealthRTs,6/2/2014 23:10,0,0,RT @ JNCI_Now: Adoptive T cell therapy is being offered at an increasing number of major medical centers in the US & other countries. # ASCO14,,@,#,4.73663E+17,https://twitter.com/PublicHealthRTs/status/473662883768053760,,,,
DrMiguelPerales,6/2/2014 23:09,2,1,Skin cancer trial results 'exciting' # ASCO14 # melanoma http://www.bbc.co.uk/news/health-27674658 …,,,# #,4.73663E+17,https://twitter.com/DrMiguelPerales/status/473662831360245760,,,,
davidbeme,6/2/2014 22:59,3,0,L'immunothérapie : nouvel espoir contre de nombreux types de cancer # ASCO2014 @ doctissimo http://ow.ly/xyrHm,,@,#,4.7366E+17,https://twitter.com/davidbeme/status/473660217625169920,,,,
yglin,6/2/2014 22:59,0,0,"@ gyncsm @ ASCO @ drdonsdizon 3 tax funded immune therapy cervical ca clinical trials open now: GOG9929, GOG265, & NCT01693783",,@ @ @,,4.7366E+17,https://twitter.com/yglin/status/473660177439535104,,,,
DianeEMeier,6/2/2014 22:59,5,4," @ GeriPalBlog: The Business of Selling Hope Part II: Direct-to-Consumer Cancer Ctr Ads http://goo.gl/fb/U0sdR # asco14"" $=root of all evil""",,@,#,4.7366E+17,https://twitter.com/DianeEMeier/status/473660175245922304,,,,
TheCuckoosNest,6/2/2014 22:58,4,4,@ CancerDotNet @ ASCO Disappointed that lung cancer is #1 cancerkiller yet received less # ASCO14 attention than others.,,@ @,#1 #,4.7366E+17,https://twitter.com/TheCuckoosNest/status/473660021252055040,,,,
intervalolibre,6/2/2014 22:57,1,0,Publicado hoy 2/6/2014 en @ NEJM: Exemestane + supresión ovárica en cáncer de mama en premenopaúsicas. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1404037 … # ASCO2014,,@,#,4.7366E+17,https://twitter.com/intervalolibre/status/473659693832093696,,,,
FrauPinina,6/2/2014 22:51,1,0,He noTado un plagio tan cabrón de parte de ustedes que lo que dan es # ASCO14,,,#,4.73658E+17,https://twitter.com/FrauPinina/status/473658147413164033,,,,
DrMisialek,6/2/2014 22:46,0,0,Philadelphia Chromosome to Survivorship Issues: 50 Years of Progress in Hematologic Cancer Research @ ASCO # ASCO14 http://am.asco.org/philadelphia-chromosome-survivorship-issues-50-years-progress-hematologic-cancer-research#.U402tutYrg0.twitter …,,@,# #,4.73657E+17,https://twitter.com/DrMisialek/status/473656820624420864,,,,
intervalolibre,6/2/2014 22:44,0,0,El congreso del 50 aniversario de # ASCO2014 es hoy un gigantesco evento científico. @ ASCO pic.twitter.com/DZAhn6CN51,,@,#,4.73656E+17,https://twitter.com/intervalolibre/status/473656494400217088,,,,
DrMisialek,6/2/2014 22:44,0,0,Great Review: The History of Genitourinary Cancers: Past Progress and Future Promise http://am.asco.org/history-genitourinary-cancers-past-progress-and-future-promise#.U402L1GhqTk.twitter … @ ASCO # ASCO14,,@,# #,4.73656E+17,https://twitter.com/DrMisialek/status/473656413940908032,,,,
DrMisialek,6/2/2014 22:40,1,2,Adding Chemo to Hormone Therapy Improved Survival in Men with Metastatic Prostate Cancer http://am.asco.org/adding-chemotherapy-hormone-therapy-improved-survival-men-newly-metastatic-prostate-cancer#.U401Npo2N6s.twitter … @ ASCO @ DanaFarber # ASCO14,,@ @,# #,4.73655E+17,https://twitter.com/DrMisialek/status/473655466078527489,,,,
aicrtweets,6/2/2014 22:39,0,1,"RT @ drmisialek: Cancer Survivorship Program Models in Academic, Community, National Setting http://am.asco.org/cancer-survivorship-program-models-academic-community-national-settings#.U400iqH8ol8.twitter … @ ASCO @ DanaFarber # ASCO14",,@ @ @,# #,4.73655E+17,https://twitter.com/aicrtweets/status/473655089941708800,,,,
DrMisialek,6/2/2014 22:37,0,0,"Cancer Survivorship Program Models in Academic, Community, National Settings http://am.asco.org/cancer-survivorship-program-models-academic-community-national-settings#.U400iqH8ol8.twitter … @ ASCO @ DanaFarber # ASCO14",,@ @,# #,4.73655E+17,https://twitter.com/DrMisialek/status/473654568971423745,,,,
DavidCookeMD,6/2/2014 22:34,0,1,Must read > MT @ BrendonStilesMD: Many medically inoperable patients AREN'T. eval surgery vs. SBRT. # asco2014 http://abstracts.asco.org/144/AbstView_144_130194.html …” # lcsm,,@,# #,4.73654E+17,https://twitter.com/DavidCookeMD/status/473653988915560448,,,,
NinaBeri,6/2/2014 22:32,2,0,# asco14 is way more exciting than the # acr # acp # ADA or other national medical meetings! # meetingjunkie,,,# # # # #,4.73654E+17,https://twitter.com/NinaBeri/status/473653525743161344,,,,
mastologiaHLF,6/2/2014 22:31,2,2,"4mil mujeres/año mueren en USA debido a Ca Cuello Uterino @ JNCI_Now: Over 4,000 women die of cervical cancer each year in the U.S. # ASCO14.",,@,#,4.73653E+17,https://twitter.com/mastologiaHLF/status/473653129440161792,,,,
mastologiaHLF,6/2/2014 22:25,1,0,Las publicaciones en # ASCO14 nos han dado de nuevo un buen motivo para pensar que la investigación va muy bien encaminada.,,,#,4.73652E+17,https://twitter.com/mastologiaHLF/status/473651722188238849,,,,
adamfeuerstein,6/2/2014 22:23,1,2,". @ megtirrell Can I get a fireball shot? Something cinnamon-y!"" @ CNBC # drumj # ASCO14""",,@ @,# #,4.73651E+17,https://twitter.com/adamfeuerstein/status/473651249121075200,,,,
TargetedOnc,6/2/2014 22:20,1,0,Presented at # ASCO14: Sirolimus and Vorinostat in Heavily Pretreated Refractory Hodgkin Lymphoma http://www.targetedonc.com/conference/asco-2014/Sirolimus-and-Vorinostat-in-Heavily-Pretreated-Refractory-Hodgkin-Lymphoma …,,,#,4.7365E+17,https://twitter.com/TargetedOnc/status/473650306447081472,,,,
OncLive,6/2/2014 22:20,1,0,"Lawrence Fong, MD, discusses a phase II trial of intratumoral electroporation of plasmid IL-12 in melanoma http://ow.ly/xxokd # ASCO14",,,#,4.7365E+17,https://twitter.com/OncLive/status/473650301590052864,,,,
DrGlenWeiss,6/2/2014 22:18,0,2,Tuesday: last day for med onc fellows to come check out @ CancerCenter career booth: CF-1. # clinical # research # trials # ASCO14 @ ASCO @ AACR,,@ @ @,# # # #,4.7365E+17,https://twitter.com/DrGlenWeiss/status/473649838165622784,,,,
adamfeuerstein,6/2/2014 22:15,0,0,@ echo_nyc yup. Post # asco14 drunj,,@,#,4.73649E+17,https://twitter.com/adamfeuerstein/status/473649143811178496,,,,
AneesChagpar,6/2/2014 22:12,0,0,@ NagiSaghir Congrats on your year as chair of IAC @ ASCO! Was great to see everyone at World Oncology Leaders Reception tonight. # ASCO14,,@ @,#,4.73648E+17,https://twitter.com/AneesChagpar/status/473648321303969792,,,,
rdhoble,6/2/2014 22:12,1,0,Confidential app supports # breastcancer patients taking generic Arimidex (Anastrozole) # ASCO2014 # adherence # safety http://mhlib.com/i/e/539/en/,,,# # # #,4.73648E+17,https://twitter.com/rdhoble/status/473648296280354817,,,,
MayoCancerCare,6/2/2014 22:11,0,0,"In treating some cancer patients, less is more: http://reut.rs/1kCELL2 # ASCO14",,,#,4.73648E+17,https://twitter.com/MayoCancerCare/status/473648132580851713,,,,
bioinfosm,6/2/2014 22:10,1,3,"nice summary! RT @ ClinSeqNews At ASCO, Growing Data from NGS-guided Cancer Therapy Programs http://bit.ly/1o08OSM # ASCO14 # NGS # cancer",,@,# # #,4.73648E+17,https://twitter.com/bioinfosm/status/473647973759344640,,,,
rdhoble,6/2/2014 22:06,1,0,Confidential app supports # breastcancer patients taking generic Femara (Letrozole) # ASCO2014 http://mhlib.com/i/e/2820/en/ http://mhlib.com/i/e/2862/en/,,,# #,4.73647E+17,https://twitter.com/rdhoble/status/473646876924080129,,,,
OncoPlexDx,6/2/2014 22:04,0,0,# ASCO14 poster demonstrating clinical utility of mass spec # proteomics in breast cancer. # bcsm # HER2 http://goo.gl/ssy7V3,,,# # # #,4.73646E+17,https://twitter.com/OncoPlexDx/status/473646425545252864,,,,
socflyny,6/2/2014 22:03,0,1,Special thanks to our tireless @ drattai -- Doing double duty with her fabulous # ASCO14 coverage (and still having energy for us!) # bcsm,,@,# #,4.73646E+17,https://twitter.com/socflyny/status/473646120376475648,,,,
DrAttai,6/2/2014 22:01,3,8,"Next week - @ jrgralow and I will cover some of the interesting findings from # ASCO14. And yes, there will be blog posts and links!! # bcsm",,@,# #,4.73646E+17,https://twitter.com/DrAttai/status/473645623947063296,,,,
nbferrara,6/2/2014 22:00,1,6,Immune therapies improve treatment of cancers http://usat.ly/1mIXEix via @ usatoday # ASCO14,,@,#,4.73645E+17,https://twitter.com/nbferrara/status/473645277946347520,,,,
CDC_Genomics,6/2/2014 21:57,3,3,Lynch Syndrome 101 (years later) http://meetinglibrary.asco.org/sites/meetinglibrary.asco.org/files/edbook/144/pdf/zds00114000027.pdf … # asco14 @ MayoClinic @ KintalkUCSF @ LynchCancers,,@ @ @,#,4.73645E+17,https://twitter.com/CDC_Genomics/status/473644727645257728,,,,
urotoday,6/2/2014 21:55,0,1,# ASCO14 - Poster: Predicting response to abiraterone acetate: mRNA biomarker analysis of study ... http://dlvr.it/5sG9Zc,,,#,4.73644E+17,https://twitter.com/urotoday/status/473644160885342208,,,,
urotoday,6/2/2014 21:55,0,0,# ASCO14 - Poster: Regional differences observed in the phase 3 trial (ELM-PC 5) with orteronel ... http://dlvr.it/5sG9Cx,,,#,4.73644E+17,https://twitter.com/urotoday/status/473644126542385153,,,,
nbferrara,6/2/2014 21:50,0,0,MT @ ASCOPost 2nd-Line Treatment w/Ramucirumab + Docetaxel Extends Survival in Advanced Lung Cancer http://ow.ly/xyf8u # ASCO14 # lcsm,,@,# #,4.73643E+17,https://twitter.com/nbferrara/status/473642765910548481,,,,
timturnham,6/2/2014 21:49,0,1,"PD1 from @ Merck shows good results, will likely be approved this year. Will require prior treatment w/ ipi. Is this right approach? # ASCO14",,@,#,4.73643E+17,https://twitter.com/timturnham/status/473642588142977024,,,,
brandonmancini,6/2/2014 21:48,0,0,"“ @ OncLive: Johanna Bendell, MD, discusses two studies in BRAF-mutated CRC http://ow.ly/xwG4G # ASCO14”",,@,#,4.73642E+17,https://twitter.com/brandonmancini/status/473642302070865921,,,,
jonathanagin,6/2/2014 21:46,3,0,@ carisls # ASCO14 abstract 10037 showing promise for the use of molecular profiling to select therapies upon recurrence,,@,#,4.73642E+17,https://twitter.com/jonathanagin/status/473641851120263169,,,,
BioDueDiligence,6/2/2014 21:45,0,0,"Surprised at how few have followed BSR"" David to new handle @ AlpineBV_Miller - must # FF for # ASCO14 plus AUA and other meetings""",,@,# #,4.73641E+17,https://twitter.com/BioDueDiligence/status/473641479613599744,,,,
nbferrara,6/2/2014 21:40,0,0,RT @ ASCOPost Addition of Chemotherapy to Radiotherapy Improves Survival in Low-Grade Glioma http://ow.ly/xwYSq # ASCO14 # btsm,,@,# #,4.7364E+17,https://twitter.com/nbferrara/status/473640223243796480,,,,
DrBeckerSchutte,6/2/2014 21:39,0,1,Educating a different community. Yay! RT @ DrAttai @ ABHuret I tweeted a TON of # BCSM vocab at # ASCO14,,@ @,# #,4.7364E+17,https://twitter.com/DrBeckerSchutte/status/473640103865491456,,,,
jonathanagin,6/2/2014 21:39,3,1,@ carisls is pushing the envelope w/ an amazing poster at # ASCO14 on molecular profiling of 267 childhood cancers seeking targeted therapies,,@,#,4.7364E+17,https://twitter.com/jonathanagin/status/473640097863069696,,,,
stales,6/2/2014 21:39,1,0,RT @ DrAttai @ obogler gave a grt talk about # BCSM at # ASCO14 today - he was on a panel with @ mtmdphd and @ rsm2800.,,@ @ @ @,# #,4.7364E+17,https://twitter.com/stales/status/473640057627082755,,,,
chemobrainfog,6/2/2014 21:39,0,0,I saw that! RT @ DrAttai: @ ABHuret I tweeted a TON of # BCSM vocab at # ASCO14,,@ @,# #,4.7364E+17,https://twitter.com/chemobrainfog/status/473640013008486400,,,,
DrAttai,6/2/2014 21:38,0,4,@ ABHuret I tweeted a TON of # BCSM vocab at # ASCO14,,@,# #,4.7364E+17,https://twitter.com/DrAttai/status/473639930875637760,,,,
DianeRadfordMD,6/2/2014 21:37,0,0,Spreading the word @ DrAttai @ obogler gave a grt talk about # BCSM at # ASCO14 today - he was on a panel with @ mtmdphd and @ rsm2800.,,@ @ @ @,# #,4.7364E+17,https://twitter.com/DianeRadfordMD/status/473639660296499200,,,,
DrAttai,6/2/2014 21:36,0,2,@ obogler gave a great talk about # BCSM at # ASCO14 today - he was on a panel with @ mtmdphd and @ rsm2800. Spoke about our lurkers,,@ @ @,# #,4.73639E+17,https://twitter.com/DrAttai/status/473639408999354369,,,,
COSACPG,6/2/2014 21:32,0,0,“ @ JackWestMD: Dr. Spigel on MET antibody onartuzumab w/erlotinib in high MET-expressing NSCLC # ASCO14 # lcsm pic.twitter.com/MqClXNMf0E”,,@,# #,4.73638E+17,https://twitter.com/COSACPG/status/473638237261410304,,,,
COSACPG,6/2/2014 21:31,0,0,“ @ ASCO: RTOG 9802 first prospective study to ever demonstrate OS increase for patients w/ grade 2 glioma http://bit.ly/1l0JlHE # ASCO14”,,@,#,4.73638E+17,https://twitter.com/COSACPG/status/473638088301113344,,,,
nbferrara,6/2/2014 21:30,0,0,"In treating some cancer patients, less is more: http://reut.rs/1kCELL2 # ASCO14",,,#,4.73638E+17,https://twitter.com/nbferrara/status/473637794003562496,,,,
FreemanCo,6/2/2014 21:30,1,1,Seen at # ASCO14 in Chicago! cc @ ASCO pic.twitter.com/LwEc460dvn,,@,#,4.73638E+17,https://twitter.com/FreemanCo/status/473637733131235328,,,,
OphiraG,6/2/2014 21:27,2,1,@ ASCO thanks 4 your efforts to reduce global cancer disparities! @ uicc @ ncdalliance @ NCIGlobalHealth,,@ @ @ @,,4.73637E+17,https://twitter.com/OphiraG/status/473637076597227523,,,,
urotoday,6/2/2014 21:24,0,0,"# ASCO14 Analysis of Rad-223 Dichloride Evaluating Pain Relief ALSYMPCA Study. Listen to interview w/ Sten Nilsson, MD http://bit.ly/1rEYcN9",,,#,4.73636E+17,https://twitter.com/urotoday/status/473636302261215232,,,,
urotoday,6/2/2014 21:21,0,0,"# ASCO14 Final Analysis of Early Access Protocol w/ AA in mCRPC Patients. Listen to interview w/ Cora Sternberg, MD http://bit.ly/1jNBKaU",,,#,4.73636E+17,https://twitter.com/urotoday/status/473635627536101376,,,,
gyncsm,6/2/2014 21:20,6,4,# gycsm's @ drdonsdizon reporting on the results a cervical cancer trial with HPV targeted lymphcytes at # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/595?xid=nl_mpt_ASCO_2014-06-02&utm_source=%20ASCO_&utm_medium=email&utm_content=mpt&utm_campaign=06%7C02%7C2014&userid=323472&eun=g5317600d17r&email=womenofteal@gmail.com&mu_id=5317600 …,,@ @gmail,# #,4.73635E+17,https://twitter.com/gyncsm/status/473635260778151936,,,,
nbferrara,6/2/2014 21:20,0,0,New System For Treating Cancer Seen As Hopeful http://nyti.ms/1nXvwLa # ASCO14,,,#,4.73635E+17,https://twitter.com/nbferrara/status/473635246244888576,,,,
ASCO,6/2/2014 21:19,1,0,@ rsm2800 Thank you so much for your many contributions during # ASCO14.,,@,#,4.73635E+17,https://twitter.com/ASCO/status/473635150694449154,,,,
GeoffreyCurtis,6/2/2014 21:19,2,5,I miss @ MikeHuckman bow tie at the # ASCO14 annual dinner w/ @ adamfeuerstein @ scooperpr @ jodigralnick @ megtirrell @ Loftus @ ArmstrongDrew,,@ @ @ @ @ @ @,#,4.73635E+17,https://twitter.com/GeoffreyCurtis/status/473635090913034240,,,,
DrPaulyDeSantis,6/2/2014 21:16,0,0,"@ Pharmacyclics very helpful at # asco14 as well, @ AstraZenecaUS great team too",,@ @,#,4.73634E+17,https://twitter.com/DrPaulyDeSantis/status/473634346658570240,,,,
DrPaulyDeSantis,6/2/2014 21:15,1,1,"Also, just saying @ GileadSciences had the most helpful employees of all the biotech companies at # asco14 $ NLNK $ CLDX also were great",,@,#,4.73634E+17,https://twitter.com/DrPaulyDeSantis/status/473634006097854464,,,,
FoodieHC,6/2/2014 21:14,0,0,"even at Eataly, I can't quite escape my day job ties to # ASCO14; wonder if it's a conflict of interest… http://instagram.com/p/ow1hPQnMKk/",,,#,4.73634E+17,https://twitter.com/FoodieHC/status/473633668288634880,,,,
socflyny,6/2/2014 21:13,0,1,"@ DrAttai @ thecancergeek Yes, all those # ASCO14 photo opps are tiring! Good thing for # BedPolice. ; ) # BCSM (Outstanding job, Dr. A!)",,@ @,# # #,4.73634E+17,https://twitter.com/socflyny/status/473633639545446400,,,,
socflyny,6/2/2014 21:11,0,0,It's all about SLEEP! ; ) MT @ DrBeckerSchutte MT @ thecancergeek @ DrAttai w lots of stamina to do this after 3 busy days of # ASCO14 # bcsm,,@ @ @,# #,4.73633E+17,https://twitter.com/socflyny/status/473633083678539776,,,,
ASCO,6/2/2014 21:10,15,13,Images from today's # ASCO14 http://on.fb.me/1krGcki pic.twitter.com/ZRtLGLeNk4,,,#,4.73633E+17,https://twitter.com/ASCO/status/473632860076007425,,,,
nbferrara,6/2/2014 21:10,0,0,MT @ MMarchioneAP From riddled w/ tumors & less than year to live to no sign of cancer: http://tinyurl.com/ptsb5uz # ASCO14 # immunotherapy,,@,# #,4.73633E+17,https://twitter.com/nbferrara/status/473632737711390720,,,,
socflyny,6/2/2014 21:10,0,0,+1000! Rock Star! RT @ jodyms: @ drattai thanks for all your great # ASCO14 tweet coverage! # bcsm,,@ @,# #,4.73633E+17,https://twitter.com/socflyny/status/473632722448293888,,,,
OncLive,6/2/2014 21:10,0,0,"Johanna Bendell, MD, discusses two studies in BRAF-mutated CRC http://ow.ly/xwG4G # ASCO14",,,#,4.73633E+17,https://twitter.com/OncLive/status/473632709206876161,,,,
TargetedOnc,6/2/2014 21:09,0,3,Joint Analysis of Phase III Trials Will Change Practice in Premenopausal HR+ Breast Cancer http://www.targetedonc.com/conference/asco-2014/Joint-Analysis-of-Phase-III-Trials-Will-Change-Practice-in-Premenopausal-HR-Breast-Cancer … # ASCO14,,,#,4.73633E+17,https://twitter.com/TargetedOnc/status/473632628781109249,,,,
rsm2800,6/2/2014 21:08,1,1,"ORD>MSN on the way to training for the Apple, er, Epic EHR. Great # asco14 all! Must digest & read. Safe travels all! pic.twitter.com/m2nh4WATju",,,#,4.73632E+17,https://twitter.com/rsm2800/status/473632403064238081,,,,
KintalkUCSF,6/2/2014 21:06,3,1,# Lynchsyndrome 101 years- review- # ASCO14 meeting summary by @ MayoClinic's Dr.Noralane Lindor http://bit.ly/1kkfyed,,@,# #,4.73632E+17,https://twitter.com/KintalkUCSF/status/473631887278084097,,,,
gg_schwind,6/2/2014 21:06,0,1,Help me spread the word that # cancer # innovation matters. # mliwi # asco14 http://mylifeisworthit.org?kid=3A8BXmylifeisworthit.org/?kid=3A8BX,,,# # # #,4.73632E+17,https://twitter.com/gg_schwind/status/473631862162608128,,,,
megtirrell,6/2/2014 21:06,0,6,This is what is on TV pre-4am. # asco14 pic.twitter.com/40iGAEQl2j,,,#,4.73632E+17,https://twitter.com/megtirrell/status/473631838209343488,,,,
jodyms,6/2/2014 21:06,1,8,@ drattai thanks for all your great # ASCO14 tweet coverage! # bcsm,,@,# #,4.73632E+17,https://twitter.com/jodyms/status/473631787420516353,,,,
TargetedOnc,6/2/2014 21:05,4,2,Dual HER2-Blockade Strategy (Lapatinib + Trastuzumab) Fails in ALTTO Trial http://www.targetedonc.com/conference/asco-2014/Dual-HER2-Blockade-Strategy-With-Lapatinib-Fails-in-ALTTO-Trial … # ASCO14,,,#,4.73631E+17,https://twitter.com/TargetedOnc/status/473631492867125248,,,,
JasperCapital,6/2/2014 21:05,0,0,A Changing Practice: The Controversy Over Obligations to Return Incidental Findings in Genomic Sequencing http://ow.ly/xxSZ8 # ASCO14,,,#,4.73631E+17,https://twitter.com/JasperCapital/status/473631488194654208,,,,
DrAttai,6/2/2014 21:03,0,2,"Deanna Attai, breast surgeon based in LA; I've been tweeting from # ASCO14 in Chicago since Friday; co-moderator w/ @ jodyms and @ stales # bcsm",,@ @,# #,4.73631E+17,https://twitter.com/DrAttai/status/473631034417094657,,,,
GenesisIVFBC,6/2/2014 21:01,0,0,An @ ASCO study has found a drug that may help # women preserve # fertility after # chemo http://ow.ly/xxty7 via @ CTVNews,,@ @,# # #,4.7363E+17,https://twitter.com/GenesisIVFBC/status/473630435789271041,,,,
OphiraG,6/2/2014 21:00,0,0,Back home after great conferences: # cugh2014 @ NCIGlobalHealth @ GTFRCC @ ASCO !,,@ @ @,#,4.7363E+17,https://twitter.com/OphiraG/status/473630192079241216,,,,
nbferrara,6/2/2014 21:00,0,0,"RT @ ASCO Aging population could overwhelm resources for cancer care delivery, 65% increase expected by 2030 http://bit.ly/1u5asEk # ASCO14",,@,#,4.7363E+17,https://twitter.com/nbferrara/status/473630178183499777,,,,
TomVargheseJr,6/2/2014 20:59,0,1,@ subatomicdoc @ ASCO Great insights. Valuable read.,,@ @,,4.7363E+17,https://twitter.com/TomVargheseJr/status/473629979968679936,,,,
urotoday,6/2/2014 20:54,0,0,"# ASCO14 - Poster: Final analysis of a large, open-label global early access protocol with ... http://dlvr.it/5sFJr9",,,#,4.73629E+17,https://twitter.com/urotoday/status/473628689150644225,,,,
urotoday,6/2/2014 20:53,0,1,"# ASCO14 - Poster: A randomized double-blind, comparative study of ARN-509 plus androgen ... http://dlvr.it/5sFJQ8",,,#,4.73628E+17,https://twitter.com/urotoday/status/473628401400434688,,,,
fgrazz,6/2/2014 20:50,0,1,"@ chemobrainfog @ AdamsLisa @ shmget @ BarbBristow ♡ goes out 2 # BCSM comUnity. Hard 2 balance w/ occ SucCS @ ASCO feed, http://on.fb.me/1m6WI5R",,@ @ @ @ @,#,4.73628E+17,https://twitter.com/fgrazz/status/473627764852285440,,,,
nbferrara,6/2/2014 20:50,0,0,RT @ ASCO AVATAXHER shows increased pCR w/ bevacizumab in HER2+ breast cancer stratified by early PET change http://bit.ly/1p0RgW6 # ASCO14,,@,#,4.73628E+17,https://twitter.com/nbferrara/status/473627677145182208,,,,
Lymphoma_Doc,6/2/2014 20:47,4,8,Beautiful view to end an exciting & productive # ASCO14 ! See you next year for an even better # ASCO15pic.twitter.com/vTWJausUBY,,,# #,4.73627E+17,https://twitter.com/Lymphoma_Doc/status/473627040751812610,,,,
EFEciencia,6/2/2014 20:47,4,2,"Una combinación de dos fármacos, más eficaz para un tipo de # cáncer de pulmón http://www.efefuturo.com/noticia/una-combinacion-de-dos-farmacos-mas-eficaz-para-un-tipo-de-cancer-de-pulmon/ … # ASCO14",,,# #,4.73627E+17,https://twitter.com/EFEciencia/status/473627025429635073,,,,
chimoose,6/2/2014 20:47,0,0,RT @ brianreid: # ASCO14 soc media/clinical trials presentation by @ rsm2800. Why should you listen to him? Because eve… http://bit.ly/1oOGRzd,,@ @,#,4.73627E+17,https://twitter.com/chimoose/status/473626935084728320,,,,
subatomicdoc,6/2/2014 20:47,0,0,Illumination to Innovation: Transforming Data into Learning http://bit.ly/1kClWYq via @ Yuponc @ ASCO # ASCO14,,@ @,#,4.73627E+17,https://twitter.com/subatomicdoc/status/473626884782444545,,,,
MayoCancerCare,6/2/2014 20:44,0,1,New System For Treating Cancer Seen As Hopeful http://nyti.ms/1nXvwLa # ASCO14 # Immunotherapy,,,# #,4.73626E+17,https://twitter.com/MayoCancerCare/status/473626229300424704,,,,
Merck,6/2/2014 20:40,0,1,Thank you to the investors & journalists who joined our # ASCO14 Investor Briefing. $ MRK,,,#,4.73625E+17,https://twitter.com/Merck/status/473625201943773184,,,,
nbferrara,6/2/2014 20:40,0,0,RT @ ASCO SHAPE-2 & LEAN studies emphasize importance of weight loss in breast cancer survivors http://bit.ly/1tBHbPJ # ASCO14,,@,#,4.73625E+17,https://twitter.com/nbferrara/status/473625119861243904,,,,
AndytweetM,6/2/2014 20:39,0,0,@ ASCO is there any way to access them ?,,@,,4.73625E+17,https://twitter.com/AndytweetM/status/473624911337246720,,,,
HemOncToday,6/2/2014 20:39,2,3,# ASCO14 # Ruxolitinib plus # capecitabine extended survival in metastatic pancreatic cancer @ DukeU http://goo.gl/RQ8FX0,,@,# # #,4.73625E+17,https://twitter.com/HemOncToday/status/473624862012235776,,,,
GoHealio,6/2/2014 20:39,0,0,# ASCO14 # Ruxolitinib plus # capecitabine extended survival in metastatic pancreatic cancer @ DukeUhttp://goo.gl/RQ8FX0,,@,# # #,4.73625E+17,https://twitter.com/GoHealio/status/473624861240492032,,,,
subatomicdoc,6/2/2014 20:38,0,0,@ YinkaVidal Hi Yinka @ nxtstop1 thanks for sharing so much new coming from # ASCO14 # bioethx,,@ @,# #,4.73625E+17,https://twitter.com/subatomicdoc/status/473624796702711809,,,,
DrBobGoldberg,6/2/2014 20:38,2,0,According to @ asco calculator 20% chance survival for someone w less than yr to live not worth it http://yottafire.com/2014/06/immunotherapy-for-cancer-new-hopes-for-curing-using-patients-immune-cells/ …,,@,,4.73625E+17,https://twitter.com/DrBobGoldberg/status/473624692570722305,,,,
giasison,6/2/2014 20:37,0,1,@ subatomicdoc So far good Matthew. Pretty sure you had a blast at # ASCO14 ! Hope to see you soon!,,@,#,4.73625E+17,https://twitter.com/giasison/status/473624580506918912,,,,
Cortellis,6/2/2014 20:36,0,0,"Phase I data: Merck's PD1 MAb pembrolizumab response rate 40% in ipi-naive metastatic melanoma, estimated survival at 12 months 69% # ASCO14",,,#,4.73624E+17,https://twitter.com/Cortellis/status/473624322427195392,,,,
subatomicdoc,6/2/2014 20:35,0,0,Dinner after # ASCO14 (@Bandera Restaurant w/ 3 others) http://4sq.com/1oPKB3r pic.twitter.com/PA6CCWEHRI,,@Bandera,#,4.73624E+17,https://twitter.com/subatomicdoc/status/473624065006391296,,,,
giasison,6/2/2014 20:34,0,0,@ subatomicdoc Great to see you Matthew! # bioethx # ASCO14,,@,# #,4.73624E+17,https://twitter.com/giasison/status/473623711073832960,,,,
subatomicdoc,6/2/2014 20:32,1,5,"Hello # bioethx friends. Matt Katz, radiation oncologist, tweeting from Chicago at # ASCO14",,,# #,4.73623E+17,https://twitter.com/subatomicdoc/status/473623281330049024,,,,
RamalingamMD,6/2/2014 20:31,2,1,"Ramucirumab and necitumumab bottom line- improved survival, modest benefit, no bio marker. LCSM # ASCO14",,,#,4.73623E+17,https://twitter.com/RamalingamMD/status/473623055894589440,,,,
MontefioreNYC,6/2/2014 20:31,2,2,Marina Shcherba received a Conquer Cancer Foundation of # ASCO14 Merit Award.Learn more: http://mmcny.org/SoOlLf pic.twitter.com/bN4v9X8wgE,,,#,4.73623E+17,https://twitter.com/MontefioreNYC/status/473623040744366080,,,,
nbferrara,6/2/2014 20:30,0,0,MT @ ASCO Bevacizumab + chemo = no benefit in HER2- breast cancer http://bit.ly/1wUvPLb # ASCO14,,@,#,4.73623E+17,https://twitter.com/nbferrara/status/473622785965948929,,,,
DrAttai,6/2/2014 20:30,2,4,congrats! RT @ Melanoma_doctor Thanks to # asco14 have now passed 1k tweet bar # soproud,,@,# #,4.73623E+17,https://twitter.com/DrAttai/status/473622712468774912,,,,
medpagetoday,6/2/2014 20:30,2,0,"Mark G. Kris, MD, on the REVEL study. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1rCC2Lv",,@,#,4.73623E+17,https://twitter.com/medpagetoday/status/473622595695149056,,,,
FightCRC,6/2/2014 20:29,1,1,Here's a picture of our advocates showing their strong arm pose at # ASCO14 this weekend! Lots of great… http://instagram.com/p/owwcBFlrBT/,,,#,4.73622E+17,https://twitter.com/FightCRC/status/473622493861662720,,,,
RMiksad,6/2/2014 20:28,4,2,Inflammation story gets interesting in pancreatic cancer. Ruxolitinib + capecitabe improves 2nd line treatment for pts w/ high CRP # ASCO14,,,#,4.73622E+17,https://twitter.com/RMiksad/status/473622111152799745,,,,
deborahmorosini,6/2/2014 20:26,0,1,“ @ heidisa: This. # ASCO14 pic.twitter.com/PQnbu3gzY4”love love love,,@,#,4.73622E+17,https://twitter.com/deborahmorosini/status/473621777068072960,,,,
MaverickNY,6/2/2014 20:25,0,0,@ ASCO @ AlpineBV_Miller I was being very tongue in cheek on the breast cancer room change as @ rsm2800 will confirm!,,@ @ @,,4.73621E+17,https://twitter.com/MaverickNY/status/473621489561141248,,,,
NeoplasicasPeru,6/2/2014 20:21,7,6,@ valiabarak RT: Presentan nuevo tratamiento para cáncer de mama a nivel mundial con aportes de médicos # INEN # ASCO14 http://www.inen.sld.pe/portal/prensa/notas/626-np-020-14.html …,,@,# #,4.73621E+17,https://twitter.com/NeoplasicasPeru/status/473620516440666112,,,,
clarisssv,6/2/2014 20:21,0,0,Adiós Chicago. Buen congreso # ASCO14 pic.twitter.com/ZzzlQ0okE7,,,#,4.7362E+17,https://twitter.com/clarisssv/status/473620490989219842,,,,
clarisssv,6/2/2014 20:20,0,0,Descansando de # ASCO14. En Millenium Park. Mañana de vuelta. pic.twitter.com/vP1NW6syvr,,,#,4.7362E+17,https://twitter.com/clarisssv/status/473620231785431040,,,,
DrBobGoldberg,6/2/2014 20:19,0,0,"@ SprengelJ @ ASCO could use hibernation, not just sleep !!",,@ @,,4.7362E+17,https://twitter.com/DrBobGoldberg/status/473619926302076928,,,,
NeoplasicasPeru,6/2/2014 20:18,0,0,@ alvarezrodrich RT Presentan nuevo tratamiento contra el cáncer de mama con aportes de especialistas del # INEN # ASCO14,,@,# #,4.7362E+17,https://twitter.com/NeoplasicasPeru/status/473619707925647360,,,,
NeoplasicasPeru,6/2/2014 20:16,0,0,Presentan nuevo tratamiento para cáncer de mama a nivel mundial con aportes de especialistas del # INEN. http://www.inen.sld.pe/portal/prensa/notas/626-np-020-14.html …. # ASCO14,,,# #,4.73619E+17,https://twitter.com/NeoplasicasPeru/status/473619149860921344,,,,
OncNursingNews,6/2/2014 20:15,0,0,"Practice-changing: Dr. Pagani: I will combine ovarian function suppression with an AI rather than tamoxifen"" http://ow.ly/xxtCD # ASCO14""",,,#,4.73619E+17,https://twitter.com/OncNursingNews/status/473618877642199041,,,,
michelerhee,6/2/2014 20:14,1,0,HT @ orphandruganau: # ASCO # Cancer Conference Winners & Losers by @ matthewherper http://onforb.es/1p0kXqr via @ forbes # ASCO14,,@ @ @,# # #,4.73619E+17,https://twitter.com/michelerhee/status/473618618660315136,,,,
Lachelle_Dawn,6/2/2014 20:13,0,0,In other news...totally jealous of all the peeps that got to go to # ASCO2014,,,#,4.73618E+17,https://twitter.com/Lachelle_Dawn/status/473618419712266241,,,,
EdPalMal,6/2/2014 20:12,0,1,"Presentan nuevo tratamiento contra el cáncer de mama. # INEN, # ASCO14 http://www.inen.sld.pe/portal/prensa/notas/626-np-020-14.html …",,,# #,4.73618E+17,https://twitter.com/EdPalMal/status/473618163629051905,,,,
mtmdphd,6/2/2014 20:10,1,1,Not clear if ctDNA testing could be done for brain tumors due to BBB. # btsm # ASCO14,,,# #,4.73618E+17,https://twitter.com/mtmdphd/status/473617735285760000,,,,
MaverickNY,6/2/2014 20:10,0,0,Update for subs has posted on today's interesting data: http://icar.us/T6v0zk # asco14,,,#,4.73618E+17,https://twitter.com/MaverickNY/status/473617579412815872,,,,
mtmdphd,6/2/2014 20:09,0,0,ctDNA - from single/oligo molecular marker testing to broader next generation sequencing (NGS) w/ easy sequential access. # ASCO14,,,#,4.73617E+17,https://twitter.com/mtmdphd/status/473617413742010369,,,,
hmhyltonpac,6/2/2014 20:07,3,0,Balancing Our Values on Value | ASCO Connection http://connection.asco.org/Commentary/Article/ID/3895/Balancing-Our-Values-on-Value.aspx … via @ ASCO,,@,,4.73617E+17,https://twitter.com/hmhyltonpac/status/473616909603065857,,,,
zpoonja,6/2/2014 20:07,0,0,# ASCO14,,,#,4.73617E+17,https://twitter.com/zpoonja/status/473616840208699392,,,,
griffoncanisius,6/2/2014 20:04,0,1,@ AlpineBV_Miller best part of my poster: Oncologists treat post sip-T with chemo almost 4 months sooner then avg urology practice # ASCO14,,@,#,4.73616E+17,https://twitter.com/griffoncanisius/status/473616127244115968,,,,
subatomicdoc,6/2/2014 20:04,1,2,Racial differences in radiation-induced toxicity and cytokine expression levels http://bit.ly/1wwgXlR > @ HopkinsMedicine # bcsm # ASCO14,,@,# #,4.73616E+17,https://twitter.com/subatomicdoc/status/473616080905469952,,,,
Rad_Nation,6/2/2014 20:04,0,0,Racial differences in radiation-induced toxicity and cytokine expression levels http://buff.ly/1wwgXlW > @ HopkinsMedicine # bcsm # ASCO14,,@,# #,4.73616E+17,https://twitter.com/Rad_Nation/status/473616065969537025,,,,
DrAttai,6/2/2014 20:03,1,0,@ obogler absolutely rocked it at # ASCO14 http://malebreastcancerblog.org/2014/06/02/speaking-at-asco14-on-social-media-and-bcsm/ … # bcsm,,@,# #,4.73616E+17,https://twitter.com/DrAttai/status/473616025326338048,,,,
AndytweetM,6/2/2014 20:01,0,0,"@ Ludwig_Cancer @ ASCO ASCO team - will the recordings of meet the profeessor"" sessions be available through Virtual meeting / recordings ?""",,@ @,,4.73615E+17,https://twitter.com/AndytweetM/status/473615438182895616,,,,
ASCO,6/2/2014 20:00,3,7,"Sample select presentations from our 50th Annual Meeting via Virtual Meeting on Demand"" http://bit.ly/1oKjSW0 # ASCO14""",,,#,4.73615E+17,https://twitter.com/ASCO/status/473615224709607424,,,,
mtmdphd,6/2/2014 20:00,1,0,ctDNA helped rescue a drug in development by evaluating the blood of exceptional responders # ASCO14,,,#,4.73615E+17,https://twitter.com/mtmdphd/status/473615134502305792,,,,
BairdAM,6/2/2014 19:59,0,0,# lcsm MT  @ drcbsteer: # ASCO14 Rizvi - Pembrolizumab 1st line NSCLC," PD-L1+ >/=1% (78% of tot samples)n=45 median age 70! Realworld patients""""",,@,# #,4.73615E+17,https://twitter.com/BairdAM/status/473614932588507136,,,
brunomartinezmd,6/2/2014 19:58,1,0,“ @ ASCO: New treatment algorithm for patients with childhood nonrhabdomyosarcoma soft tissue sarcoma http://bit.ly/RY2PkS # ASCO14”,,@,#,4.73615E+17,https://twitter.com/brunomartinezmd/status/473614699733327872,,,,
GenomeBiomarker,6/2/2014 19:58,0,2,Mass cytometry: combining mass spec with flow cytometry. New tool for immuno-onc biomarker analysis. # asco14 pic.twitter.com/UV6aMKyZqy,,,#,4.73615E+17,https://twitter.com/GenomeBiomarker/status/473614596973273089,,,,
BairdAM,6/2/2014 19:57,1,1,"# lcsm  @ Boehringer: lungcancer is driven by an increasing no. of driver mutations” Frank Hilberg http://bit.ly/1tz9det # ASCO14""""",,@,# #,4.73614E+17,https://twitter.com/BairdAM/status/473614478760636416,,,,
nycdoc29,6/2/2014 19:57,0,0,"@ Merck: Dr. Seiwert presenting head & neck data at # ASCO14 Investor Briefing."" with ACOs & MCOs challenges are far more than clinical.""",,@,#,4.73614E+17,https://twitter.com/nycdoc29/status/473614454136266753,,,,
CancerSupportHQ,6/2/2014 19:53,1,0,The quality of diagnostic tests should be considered. Patients should talk freely with physicians about this. # ASCO14 pic.twitter.com/EL4W46lcud,,,#,4.73613E+17,https://twitter.com/CancerSupportHQ/status/473613419414036480,,,,
urotoday,6/2/2014 19:50,0,0,# ASCO14 - Poster: Patient-reported quality of life analysis of radium-223 dichloride ... http://dlvr.it/5sDPvm,,,#,4.73613E+17,https://twitter.com/urotoday/status/473612571321188352,,,,
TargetedOnc,6/2/2014 19:50,0,3,Frontline Tx with bevacizumab/cetuximab + FOLFOX/FOLFIRI yielded a comparable OS benefit of ~29 mos in mCRC http://www.targetedonc.com/conference/asco-2014/Bevacizumab-Cetuximab-Equally-Effective-in-KRAS-Wild-Type-mCRC … # ASCO14,,,#,4.73613E+17,https://twitter.com/TargetedOnc/status/473612566787551234,,,,
urotoday,6/2/2014 19:50,0,0,# ASCO14 - Poster: Symptomatic skeletal events in patients with advanced prostate cancer: ... http://dlvr.it/5sDPpk,,,#,4.73613E+17,https://twitter.com/urotoday/status/473612554090991618,,,,
CancerSupportHQ,6/2/2014 19:49,4,1,Panel speaks on the value of personalized medicine. # ASCO14 @ AmericanCancer @ ACCCBuzz @ OCNA @ GSKpic.twitter.com/ldv2arWuZH,,@ @ @ @,#,4.73612E+17,https://twitter.com/CancerSupportHQ/status/473612493000937472,,,,
UAZCancer,6/2/2014 19:49,1,0,"We contributed to this study, highlighted at # ASCO14 http://www.cancer.net/research-and-advocacy/research-summaries/new-immunotherapy-mk-3475-shows-promise-metastatic-melanoma?et_cid=33859001&et_rid=635210465&linkid=New+Immunotherapy%2c+MK-3475%2c+Shows+Promise+for+Metastatic+Melanoma …",,,#,4.73612E+17,https://twitter.com/UAZCancer/status/473612320271106048,,,,
Merck,6/2/2014 19:47,1,3,Dr. Seiwert w/ Merck's R. Perlmutter before presenting head & neck cancer data at our # ASCO14 Investor Briefing. pic.twitter.com/pFSaKNcNqT,,,#,4.73612E+17,https://twitter.com/Merck/status/473611875096481792,,,,
jodigralnick,6/2/2014 19:47,1,1,"ICYMI: $ CLVS CEO to # CNBC: we do not cause diabetes"" Part of EXCLUSIVE interview w/ @ megtirrell at # ASCO14 here: http://cnb.cx/T862Q8""",,@,# #,4.73612E+17,https://twitter.com/jodigralnick/status/473611827297800192,,,,
AndyBiotech,6/2/2014 19:46,2,2,$ AZN to aggressively push PD-L1+CTLA4 combo into P3 3L # NSCLC in 3Q14; P3 for add'l tumor type in 2014. $ BMY # ASCO14 pic.twitter.com/uCwRYVcrwu,,,# #,4.73612E+17,https://twitter.com/AndyBiotech/status/473611764018728960,,,,
OCNA,6/2/2014 19:44,2,4,Standing room only at our event on personalized medicine at # ASCO14. Our Laura Koontz will address… http://instagram.com/p/owrPWCn02g/,,,#,4.73611E+17,https://twitter.com/OCNA/status/473611062021869568,,,,
jburzawa,6/2/2014 19:40,0,0,“ @ ASCO: Neoadjuvant chemo as initial treatment in advanced ovarian cancer may decrease complications http://bit.ly/1m5L3V5 # ASCO14”,,@,#,4.7361E+17,https://twitter.com/jburzawa/status/473610217599430656,,,,
BairdAM,6/2/2014 19:39,1,0," @ CancerDotNet: Want a recap of # cancer research headlines since the start of # ASCO14? Find them here: http://bit.ly/1mRL4iv """"",,@,# #,4.7361E+17,https://twitter.com/BairdAM/status/473609975990730753,,,,
megtirrell,6/2/2014 19:39,6,2,"We're in the Wild West of immunotherapy"" -- Tanguy Seiwert at $ MRK investor event # ASCO14""",,,#,4.7361E+17,https://twitter.com/megtirrell/status/473609822508961792,,,,
brianreid,6/2/2014 19:39,0,1,"Truth: RT @ Merck: 'It's a brave new world and an important moment for oncology.' -R. Perlmutter # ASCO14 # client""",,@,# #,4.7361E+17,https://twitter.com/brianreid/status/473609760684507136,,,,
brendanweiss,6/2/2014 19:37,4,0,From @ Phari 3d G+plerixafor results in excellent SC yield with less weight gain in # amyloidosis # ASCO14 # mmsm,,@,# # #,4.73609E+17,https://twitter.com/brendanweiss/status/473609462784065536,,,,
DavidCookeMD,6/2/2014 19:37,8,4,Interesting > MT @ TheALCF: What happens when a smoker quits? A 15 year timeline. # BeatLungCancer # LCSM # ASCO14 https://twitter.com/TheALCF/status/473124603356004353/photo/1pic.twitter.com/5qE63Ik7IO ”,,@,# # #,4.73609E+17,https://twitter.com/DavidCookeMD/status/473609375987150848,,,,
peaces38,6/2/2014 19:37,0,0,“ @ Merck: 'It's a brave new world and an important moment for oncology.' -R. Perlmutter # ASCO14” I sure hope so.,,@,#,4.73609E+17,https://twitter.com/peaces38/status/473609305045073920,,,,
JacobPlieth,6/2/2014 19:37,0,2,@ dhovekamp42 fame! MT @nextprinciples: Key influencers driving # ASCO14 conversation: https://twitter.com/nextprinciples/status/473600284908732416/photo/1pic.twitter.com/92apl2j8F4,,@ @nextprinciples,#,4.73609E+17,https://twitter.com/JacobPlieth/status/473609258257633280,,,,
TheDura01,6/2/2014 19:35,0,0,“ @ CancerDotNet: Want a recap of # cancer research headlines since the start of # ASCO14? Find them here: http://bit.ly/1mRL4iv ”,,@,# #,4.73609E+17,https://twitter.com/TheDura01/status/473608789175054337,,,,
LillyDiabetes,6/2/2014 19:35,1,2,Thanks to everyone at # ASCO14 who picked up a brush and painted the @LlyOncOnCanvas mural for hope! # hopeforward http://ow.ly/i/5LWkL,,@LlyOncOnCanvas,# #,4.73609E+17,https://twitter.com/LillyDiabetes/status/473608761769480192,,,,
AndyBiotech,6/2/2014 19:33,2,3,$ AZN First early data from MEDI4736 (Anti-PD-L1) + Tremelimumab (Anti-CTLA4) in # NSCLC $ BMY $ MRK $ RHHBY # LCSM # ASCO14 pic.twitter.com/kHCJm9qpXs,,,# # #,4.73608E+17,https://twitter.com/AndyBiotech/status/473608497322790914,,,,
Perthera,6/2/2014 19:32,0,0,RT @ bmsnews: # Cancer research doesn’t take just one doctor or patient—it takes all of us http://ow.ly/xvjhl # ImmunoOncologyNow # ASCO14,,@,# # #,4.73608E+17,https://twitter.com/Perthera/status/473608149405274112,,,,
RyhMd,6/2/2014 19:31,0,0,# asco14 pic.twitter.com/8A31qHOhSB,,,#,4.73608E+17,https://twitter.com/RyhMd/status/473607907867508736,,,,
CancerDotNet,6/2/2014 19:30,12,8,Want a recap of # cancer research headlines since the start of # ASCO14? Find them here: http://bit.ly/1mRL4iv,,,# #,4.73608E+17,https://twitter.com/CancerDotNet/status/473607590065090561,,,,
Merck,6/2/2014 19:29,3,5,'It's a brave new world and an important moment for oncology.' -R. Perlmutter # ASCO14,,,#,4.73607E+17,https://twitter.com/Merck/status/473607457764552704,,,,
NDeVitoMD,6/2/2014 19:29,2,1,"“ @ CancerResearch: Discussing new cancer vaccine research, Charles Drake of JHU predicts, Vaccines will rise again."" # ASCO14"" good line""",,@,#,4.73607E+17,https://twitter.com/NDeVitoMD/status/473607241992769536,,,,
marykge,6/2/2014 19:28,3,2,"@ uicc  @ CancerRT: Check out our film with the amazing @ NCDFREE and @ SandroDemaio and learn about cancer care in Peru! @ GTFRCC # ASCO14”""",,@ @ @ @ @,#,4.73607E+17,https://twitter.com/marykge/status/473607107263352833,,,,
NDeVitoMD,6/2/2014 19:26,0,0,"Leaving @ asco now, great conference with a lot of new developments, especially in immunotherapy. # ASCO14",,@,#,4.73607E+17,https://twitter.com/NDeVitoMD/status/473606615783202816,,,,
JacobPlieth,6/2/2014 19:25,0,0,. @ JackWestMD Thx! My piece on this and other $ LLY damp squibs coming out shortly # ASCO14,,@,#,4.73606E+17,https://twitter.com/JacobPlieth/status/473606326372024320,,,,
nycdoc29,6/2/2014 19:24,1,1,"“@Kantar_Health: in from # ASCO14: Pembrolizumab and nivolumab face off in metastatic melanoma. - Far more needed to make clinical call...""",,@Kantar_Health,#,4.73606E+17,https://twitter.com/nycdoc29/status/473606158801207297,,,,
nycdoc29,6/2/2014 19:20,1,1,"@ DrHedrick: What was answer @ yzafar: ? from audience: ramucirumab doesnt meet ASCO value std in LC # asco14 but Tarceva in pancreatic did?""",,@ @,#,4.73605E+17,https://twitter.com/nycdoc29/status/473605214000656386,,,,
TommyJohn00,6/2/2014 19:17,0,0,Like brahmers glass half full analogy. Good to see the discussants in this session not being obsequious # ASCO14,,,#,4.73604E+17,https://twitter.com/TommyJohn00/status/473604407519887360,,,,
Tony_Calles,6/2/2014 19:17,1,0,Dr. Brahmer discussion on anti-EGFR MoAb in lung cancer (FLEX & SQUIRE): Put H-score to rest! # ASCO14 # LCSM,,,# #,4.73604E+17,https://twitter.com/Tony_Calles/status/473604379183157248,,,,
DebMaskens,6/2/2014 19:17,0,0,Risk/benefit RT @ MaverickNY: Experts clearly liking unprecedented efficacy of Nivo + ipi but not thrilled by 60% grade 3-4 AEs # asco14,,@,#,4.73604E+17,https://twitter.com/DebMaskens/status/473604282709602304,,,,
Merck,6/2/2014 19:16,0,1,Merck's Roger Perlmutter & Roy Baynes getting ready to kick off our @ ASCO Investor Briefing. # ASCO14 pic.twitter.com/fwI3b6PmLu,,@,#,4.73604E+17,https://twitter.com/Merck/status/473604070893428736,,,,
ASCO,6/2/2014 19:15,7,5,Androgen receptor splice variant-7 linked to enzalutamide and abiraterone resistance in pts w/mCRPC http://bit.ly/RY35QI # ASCO2014,,,#,4.73604E+17,https://twitter.com/ASCO/status/473603791187873792,,,,
jagasquet,6/2/2014 19:14,0,0,14-Month Survival Benefit Demonstrated With Upfront Chemo in # ProstateCancer http://www.targetedonc.com/conference/asco-2014/14-month-survival-benefit-demonstrated-with-upfront-chemo-in-prostate-cancer … # ASCO14 @ TargetedOnc,,@,# #,4.73604E+17,https://twitter.com/jagasquet/status/473603660799152128,,,,
JeffGershenwald,6/2/2014 19:12,10,6,Let's begin a global dialog to achieve superlative value in # melanoma cancer care now # endcancer # asco14,,,# # #,4.73603E+17,https://twitter.com/JeffGershenwald/status/473603006853050368,,,,
DCarrizosaMD,6/2/2014 19:11,0,0,# ASCO14 -again debate on necitumumab's clinical vs statistical benefit: important point said - 1.6 months is important to patients!!,,,#,4.73603E+17,https://twitter.com/DCarrizosaMD/status/473602779655585792,,,,
DrHedrick,6/2/2014 19:11,0,2,What was answer? MT @ yzafar: ? from audience: ramucirumab in lung cancer doesn't meet ASCO value standards. What do we do? # asco14 # lcsm,,@,# #,4.73603E+17,https://twitter.com/DrHedrick/status/473602729105833985,,,,
Tony_Calles,6/2/2014 19:10,0,1,This is what we are talking about today during the oral lung cancer presentations: Raising the bar # ASCO14 # LCSM http://jco.ascopubs.org/content/early/2014/03/14/JCO.2013.53.8009.full.pdf …,,,# #,4.73603E+17,https://twitter.com/Tony_Calles/status/473602561531207681,,,,
CancerMedMDA,6/2/2014 19:10,0,0,MD Anderson experience w/ first-in-human trials in aggressive bone cancers. Dr. John Livingston poster highlight Tues. 8 &11:30 AM. # ASCO14,,,#,4.73603E+17,https://twitter.com/CancerMedMDA/status/473602546431717376,,,,
corp_UNC,6/2/2014 19:10,1,0,Attn # hsronc fans: @ UrologyHSR Symposium http://ow.ly/xxksv Stellar mtg this fall hosted by @ UMichUrology # asco14 # ISPORMontreal,,@ @,# # #,4.73603E+17,https://twitter.com/corp_UNC/status/473602543189520385,,,,
TargetedOnc,6/2/2014 19:10,0,0,14-Month Survival Benefit Demonstrated With Upfront Chemo in Prostate Cancer http://www.targetedonc.com/conference/asco-2014/14-month-survival-benefit-demonstrated-with-upfront-chemo-in-prostate-cancer … # ASCO14,,,#,4.73603E+17,https://twitter.com/TargetedOnc/status/473602533383208960,,,,
DCarrizosaMD,6/2/2014 19:09,0,0,# ASCO14 - adding necitumumab (antiEGFR) to gem/cis in squamous improves 1year OS from 9.9 months to 11.5 (HR .84 p.012)- positive but small,,,#,4.73602E+17,https://twitter.com/DCarrizosaMD/status/473602222711119873,,,,
DrHedrick,6/2/2014 19:05,0,0,"YES! MT @ tomleblancMD: RT @ BekRx: They may be disappointing, but # ASCO14 has me thinking about how important negative trials really are.",,@ @,#,4.73601E+17,https://twitter.com/DrHedrick/status/473601313377640449,,,,
AaronCohenGadol,6/2/2014 19:05,5,6,Researchers to report on promising ICT-107 vaccine to treat glioblastoma multiforme at # ASCO14 http://ow.ly/xxvN1 # GBM # BTSM,,,# # #,4.73601E+17,https://twitter.com/AaronCohenGadol/status/473601250119147521,,,,
cure_magazine,6/2/2014 19:04,7,4,"A short video blog from CURE editor-in-chief, Dr. Debu Tripathy, on why ASCO matters to all of us. # asco14 http://fb.me/19ahg7h4z",,,#,4.73601E+17,https://twitter.com/cure_magazine/status/473601158926569473,,,,
n8pennell,6/2/2014 19:04,1,1,What is it about anti- EGFR antibodies and discrepancy between OS and PFS (or lack thereof) benefits? Same pattern as FLEX! # ASCO14 # LCSM,,,# #,4.73601E+17,https://twitter.com/n8pennell/status/473601114106236928,,,,
Tony_Calles,6/2/2014 19:04,3,1,On SQUIRE trial: Necitumumab (anti-EGFR) added to front line chemo. New standard of care for Squamous lung cancer? My view: ? # ASCO14 # LCSM,,,# #,4.73601E+17,https://twitter.com/Tony_Calles/status/473601095672279040,,,,
superpiran,6/2/2014 19:03,0,0,@ _anuca_ Hear you're at # ASCO14! Keep me updated! And watch out for awesome chocolate pretzels!,,@,#,4.73601E+17,https://twitter.com/superpiran/status/473600944048181248,,,,
JackWestMD,6/2/2014 19:02,4,5,"Necitumumab highlights distinction betw statistical & clinical significance. Vy large trial can make even minimal diffs positive"" # ASCO14""",,,#,4.73601E+17,https://twitter.com/JackWestMD/status/473600620721483776,,,,
ONAcom,6/2/2014 19:01,0,0,# ASCO14: Expanding # NCI Community Cancer Centers Program in a rural community can up clinical trial enrollment - http://ow.ly/xweSd,,,# #,4.736E+17,https://twitter.com/ONAcom/status/473600279615897600,,,,
tomleblancMD,6/2/2014 19:00,1,0,"RT @ BekRx: Dwelling on the negative - they may be disappointing, but # ASCO14 has me thinking about how important negative trials really are.",,@,#,4.736E+17,https://twitter.com/tomleblancMD/status/473600078264152064,,,,
JackWestMD,6/2/2014 19:00,7,5,"Thatcher, SQUIRE trial: no improvemt in med PFS; med OS benefit 1.4 mo, HR 0.84. IMHO, least impressive positive"" trial since FLEX # ASCO14""",,,#,4.736E+17,https://twitter.com/JackWestMD/status/473600052653731840,,,,
Xcenda,6/2/2014 19:00,1,0,How will the data presented at # ASCO14 impact your treatment? Share here: http://bit.ly/ascox,,,#,4.736E+17,https://twitter.com/Xcenda/status/473599981169815553,,,,
myriadgenetics,6/2/2014 19:00,2,1,"Myriad's BRACAnalysis CDx showed ability to predict platinum response in metastatic # breastcancer patients: # ASCO14, 6/3/14 9:45am E Hall D1",,,# #,4.736E+17,https://twitter.com/myriadgenetics/status/473599946361286658,,,,
DanBudwick,6/2/2014 18:59,0,1,Great to see @ MikeHuckman @ GeoffreyCurtis @ adamfeuerstein @ ronwinslow @ megtirrell @ ArmstrongDrew @ matthewherper @ RobertLangreth + @ # ASCO14,,@ @ @ @ @ @ @ @ @,#,4.736E+17,https://twitter.com/DanBudwick/status/473599822134788096,,,,
Alice_Aitch,6/2/2014 18:58,0,0,@ subatomicdoc @ ASCO I get a bit annoyed by If insurance doesn't pay," it isn't possible"". If my PCP recommended"," I'd find the $.""",,@ @,,4.736E+17,https://twitter.com/Alice_Aitch/status/473599629271896064,,
DrHedrick,6/2/2014 18:58,1,2,". @ JackWestMD @ MaverickNY @ TommyJohn00 Think we're reaching Little ado about nothing"" with some diseases. New paradigm needed. # ASCO14""",,@ @ @,#,4.736E+17,https://twitter.com/DrHedrick/status/473599547327778816,,,,
KoontzOncology,6/2/2014 18:58,0,0,The future of pediatric oncology. # ASCO14 pic.twitter.com/1IYKiWsDyr,,,#,4.736E+17,https://twitter.com/KoontzOncology/status/473599536322326528,,,,
Melanoma_MRV,6/2/2014 18:56,0,0,Future bright to prevent melanoma relapse with immune checkpoint antibodies- top priority is anti PD1 trials # ASCO2014 # melanoma,,,# #,4.73599E+17,https://twitter.com/Melanoma_MRV/status/473599030636064769,,,,
AlpineBV_Miller,6/2/2014 18:56,0,1,"My guess is $ AMGN seeks a front-line, Stage III B/C and Stage IVm1a disease. # ASCO14",,,#,4.73599E+17,https://twitter.com/AlpineBV_Miller/status/473598977771069440,,,,
bpowersphoto,6/2/2014 18:56,0,0,# conversations at # asco14 in # chicago @McCormick Place http://instagram.com/p/owlvVYrH2e/,,@McCormick,# # #,4.73599E+17,https://twitter.com/bpowersphoto/status/473598967356207105,,,,
ktsugawa,6/2/2014 18:55,0,1,"# ASCO14 http://tinyurl.com/krbjhqq Hara F, et al: SELECT-BC elegant study!!pic.twitter.com/hD3MHmcaGZ",,,#,4.73599E+17,https://twitter.com/ktsugawa/status/473598837135638529,,,,
Sorena997,6/2/2014 18:55,4,0,# ASCO14 WHI racial ethnic analysis study by Patel et al further showcases the impact of Ethnicity and Race on Lung Cancer world wide,,,#,4.73599E+17,https://twitter.com/Sorena997/status/473598713332781057,,,,
AlpineBV_Miller,6/2/2014 18:54,2,0,T-VEC is going to be an interesting CTGT FDA panel. Going to be interesting to see how much Pazdur interferes. # ASCO14 $ amgn,,,#,4.73599E+17,https://twitter.com/AlpineBV_Miller/status/473598535095824385,,,,
Melanoma_doctor,6/2/2014 18:54,0,1,Thanks to # asco14 have now passed 1k tweet bar # soproud,,,# #,4.73598E+17,https://twitter.com/Melanoma_doctor/status/473598454758146048,,,,
JackWestMD,6/2/2014 18:53,1,1,Thatcher presenting SQUIRE trial of EGFR antibody necitumumab in squamous NSCLC: 1st line cis/gem chemo +/- neci # ASCO14 # lcsm,,,# #,4.73598E+17,https://twitter.com/JackWestMD/status/473598424408129536,,,,
HenryJOncology,6/2/2014 18:53,0,0,1 day left. Looking forward to highlights of # sarcoma poster session @ ASCO # ASCO14 tomorrow!,,@,# #,4.73598E+17,https://twitter.com/HenryJOncology/status/473598289472802820,,,,
Melanoma_MRV,6/2/2014 18:53,0,0,# ASCO14 http://tinyurl.com/pz93u8l New immune therapies (Ipilimumab) prevents relapse in some patients with stage 3 Melpic.twitter.com/x6X7JLe4UN,,,#,4.73598E+17,https://twitter.com/Melanoma_MRV/status/473598288672088064,,,,
Ludwig_Cancer,6/2/2014 18:52,0,1,@ AndytweetM Thank you for your interest in George Coukos’ Meet the Professor Session! Please connect with @ ASCO in regards to your inquiry.,,@ @,,4.73598E+17,https://twitter.com/Ludwig_Cancer/status/473598022786752512,,,,
Melanoma_doctor,6/2/2014 18:52,0,1,W 41.5% serious+ complic. MT @ HipgraveGeoff: Dr. Eggermont discusses adjuvant treatment for # melanoma # ASCO14 http://bit.ly/1kphaSQ,,@,# #,4.73598E+17,https://twitter.com/Melanoma_doctor/status/473597984937361408,,,,
Sorena997,6/2/2014 18:51,0,1,# ASCO14 # EGFR Screening Results in Brazil show very interesting outcomes based on population... Look for poster,,,# #,4.73598E+17,https://twitter.com/Sorena997/status/473597788081893376,,,,
scientre,6/2/2014 18:51,1,1,In immunooncology Q&A: how do you personalize immunotherapy? Answers...we're working on it # ASCO14,,,#,4.73598E+17,https://twitter.com/scientre/status/473597683085873152,,,,
AlpineBV_Miller,6/2/2014 18:50,2,0,"Impressive that T-VEC can clear both injected and non-injected lesions, even in viscera. CRs in data are true RECIST $ AMGN # ASCO14",,,#,4.73598E+17,https://twitter.com/AlpineBV_Miller/status/473597637946793984,,,,
JackWestMD,6/2/2014 18:50,2,1,Agree. We need to shoot for more. RT @ TommyJohn00: @ JackWestMD makes ramicirumab even more meh when you see pd1 in action! # ASCO14,,@ @,#,4.73598E+17,https://twitter.com/JackWestMD/status/473597606744948738,,,,
OncLive,6/2/2014 18:50,0,0,"T-VEC Combinations, Monotherapy Intriguing in Unresectable Melanoma http://ow.ly/xy27B # ASCO14",,,#,4.73597E+17,https://twitter.com/OncLive/status/473597496904941568,,,,
CancerMedMDA,6/2/2014 18:50,0,0,Dr. Scott Kopetz on mutation and copy number discordance in primary vs metastatic colorectal cancer: not same disease. Tues 9:45 AM. # ASCO14,,,#,4.73597E+17,https://twitter.com/CancerMedMDA/status/473597475979534336,,,,
JBBC,6/2/2014 18:50,0,1,"Yes! RT @ subatomicdoc: +100 RT @ DrMarkham: What I love about Twitter is that it creates community, makes our world a smaller place. # ASCO14",,@ @,#,4.73597E+17,https://twitter.com/JBBC/status/473597475774038017,,,,
JediPD,6/2/2014 18:50,0,0,@ JackWestMD Wonder if all PD1 Ligand Abs will have similar binding capacity and checkpoint arrest to liberate CTL activity? # ASCO14,,@,#,4.73597E+17,https://twitter.com/JediPD/status/473597449819660289,,,,
drseisenberg,6/2/2014 18:49,0,2,RT @ subatomicdoc via @ KoontzOncology: The concept of therapeutic index in cancer therapy. # ASCO14 pic.twitter.com/981pCYJghY,,@ @,#,4.73597E+17,https://twitter.com/drseisenberg/status/473597388905795585,,,,
CancerResearch,6/2/2014 18:49,3,1,"Discussing new cancer vaccine research, Charles Drake of JHU predicts, Vaccines will rise again."" # ASCO14 # LloydOld""",,,# #,4.73597E+17,https://twitter.com/CancerResearch/status/473597284136280064,,,,
scientre,6/2/2014 18:49,2,0,"Welcoming another tx developer MT @ rsm2800 MT @ MaceRothenberg At great personal risk, I have entered # twittersphere # whatamidoing # ASCO14",,@ @,# # #,4.73597E+17,https://twitter.com/scientre/status/473597278696251392,,,,
HemOncToday,6/2/2014 18:49,2,1,# ASCO14 Adjuvant # sorafenib failed to extend RFS in hepatocellular carcinoma: http://goo.gl/NX5y4I,,,# #,4.73597E+17,https://twitter.com/HemOncToday/status/473597189579882496,,,,
GoHealio,6/2/2014 18:49,0,0,# ASCO14 Adjuvant # sorafenib failed to extend RFS in hepatocellular carcinoma: http://goo.gl/NX5y4I,,,# #,4.73597E+17,https://twitter.com/GoHealio/status/473597188845895681,,,,
UdderlySmooth,6/2/2014 18:48,0,2,Time to fly home. Safe travels to all attending # asco14 # UdderlySmooth http://ift.tt/1m6Mt1m pic.twitter.com/m0hGpRBbva,,,# #,4.73597E+17,https://twitter.com/UdderlySmooth/status/473597159292809216,,,,
Gazulides,6/2/2014 18:48,3,1,Concurrent use of ipilimumab and nivolumab has produced the os rates for metastatic melanoma of 85% at 1 year and 79% at 2 years # ASCO14,,,#,4.73597E+17,https://twitter.com/Gazulides/status/473597151511986178,,,,
subatomicdoc,6/2/2014 18:48,18,11,Six Critical Factors to # LungCancer Screening Becoming a Reality http://connection.asco.org/Commentary/Article/ID/3898/Six-Critical-Factors-to-Lung-Cancer-Screening-Becoming-a-Reality.aspx … via @ ASCO # ASCO14 # lcsm,,@,# # #,4.73597E+17,https://twitter.com/subatomicdoc/status/473597102094692353,,,,
drcbsteer,6/2/2014 18:48,2,1,# ASCO14 Rizvi- Pembro 1st line in NSCLC- Waterfall plot. RR 26% by recist. 47% by irRC. Almost all remain in response pic.twitter.com/sKY7tmKQNr,,,#,4.73597E+17,https://twitter.com/drcbsteer/status/473597019979010048,,,,
TommyJohn00,6/2/2014 18:48,1,0,@ JackWestMD makes ramicirumab even more meh when you see pd1 in action! # ASCO14,,@,#,4.73597E+17,https://twitter.com/TommyJohn00/status/473596964177989632,,,,
rsm2800,6/2/2014 18:47,1,1,Ganz: Need additional non-daily topical strategies. Also sez consider tam+low dose vag estrogen (not everyone would agree w/ this) # ASCO14,,,#,4.73597E+17,https://twitter.com/rsm2800/status/473596746900459520,,,,
DoctorEdny,6/2/2014 18:47,1,3,$ MRK MK-3475 PD1 in 1st line NSCLC interim mPFS 27.0 weeks # ASCO14 pic.twitter.com/StAfAL0gcz,,,#,4.73597E+17,https://twitter.com/DoctorEdny/status/473596744228691968,,,,
urotoday,6/2/2014 18:47,0,0,"# ASCO14 - Poster: A randomized, open-label phase 2a study evaluating quantified bone scan ... http://dlvr.it/5sCLBS",,,#,4.73597E+17,https://twitter.com/urotoday/status/473596700104216578,,,,
Sorena997,6/2/2014 18:46,0,1,# ASCO14 Acquired mutations and bio markers in lung cancer : Dr. David Carbone poster review session,,,#,4.73597E+17,https://twitter.com/Sorena997/status/473596625202708481,,,,
TommyJohn00,6/2/2014 18:45,1,1,"Pembro 2 vs 3 weekly n=45, impressive waterfall plot, 22 still on treatment, only 7 progressed! # ASCO14 pdl1+ in 70% most respond by week 9",,,#,4.73596E+17,https://twitter.com/TommyJohn00/status/473596343999811586,,,,
AlpineBV_Miller,6/2/2014 18:45,0,0,tah-lim-oh-gene la-her-pah-rep-vec. Just so you know. T-VEC $ AMGN # ASCO14,,,#,4.73596E+17,https://twitter.com/AlpineBV_Miller/status/473596253675458560,,,,
UCCancerCenter,6/2/2014 18:45,0,0,Ken Onel wraps up our day at # ASCO14 by presenting his compelling data about PRDM1 and risk for secondary cancers after radiation exposure,,,#,4.73596E+17,https://twitter.com/UCCancerCenter/status/473596253105057793,,,,
JackWestMD,6/2/2014 18:45,2,3,"Rizvi on anti-PD1 pembrolizumab for 1st line Rx in adv NSCLC, >1% PDL1+ 57 w/PDL1+. Well tol, 35 evaluable, 83% some shrinkage. # ASCO14",,,#,4.73596E+17,https://twitter.com/JackWestMD/status/473596214567763968,,,,
KoontzOncology,6/2/2014 18:44,0,0,With targeted therapy need to identify the target first then develop the drugs! # ASCO14 pic.twitter.com/7LQiSpgVu8,,,#,4.73596E+17,https://twitter.com/KoontzOncology/status/473596124914532353,,,,
rsm2800,6/2/2014 18:44,0,1,"Ganz: DHEA trial used daily dosing. Unfortunately primary outcome showed not effective 4 sx relief, tho’ sexual function was better # asco14",,,#,4.73596E+17,https://twitter.com/rsm2800/status/473596061039460352,,,,
Melanoma_doctor,6/2/2014 18:44,1,1,"Eggermont shows IFN adjuvant vs Ipi adjuvant trial curves side by side, unfortunately very similar. Needle not moving # asco14 # melanoma",,,# #,4.73596E+17,https://twitter.com/Melanoma_doctor/status/473595986410217472,,,,
timturnham,6/2/2014 18:43,3,1,. @ CureMelanoma Every talk about clinical trial results ends with thanks to patients for being part of the study. # ASCO14,,@,#,4.73596E+17,https://twitter.com/timturnham/status/473595803215605761,,,,
heidisa,6/2/2014 18:43,3,5,This. # ASCO14 pic.twitter.com/wmA9arcn79,,,#,4.73596E+17,https://twitter.com/heidisa/status/473595734554849280,,,,
drcbsteer,6/2/2014 18:43,1,2,"# ASCO14 Rizvi - Pembrolizumab 1st line NSCLC, PD-L1+ >/=1% (78% of total samples) n=45 median age 70!! Real world patients",,,#,4.73596E+17,https://twitter.com/drcbsteer/status/473595728011726848,,,,
Adam_Weiner535,6/2/2014 18:42,1,1,Incidence of testicular cancer increasing in US and Europe # ASCO14 http://goo.gl/NmmzFs @ UCCancerCenter,,@,#,4.73596E+17,https://twitter.com/Adam_Weiner535/status/473595562160553984,,,,
rsm2800,6/2/2014 18:42,4,2,"Ganz: Vaginal symptoms esp dryness clearly get worse w/ AI’s (less so w/ tamoxifen), so clinicians have to ask about this # bcsm # ASCO14",,,# #,4.73596E+17,https://twitter.com/rsm2800/status/473595545324621824,,,,
mtmdphd,6/2/2014 18:41,3,0,# AllianceNCTN N10C2 - DBRCT magnesium supplement to reduce menopausal hot flashes - Park # ASCO14 http://ow.ly/xy3sN -> use not supported,,,# #,4.73595E+17,https://twitter.com/mtmdphd/status/473595388193427457,,,,
KoontzOncology,6/2/2014 18:41,6,2,The concept of therapeutic index in cancer therapy. # ASCO14 pic.twitter.com/oiMw781SEh,,,#,4.73595E+17,https://twitter.com/KoontzOncology/status/473595297894256640,,,,
rsm2800,6/2/2014 18:41,2,0,Ganz: Park trial-Mg oxide ineffective for hot flashes; alternative/natural remedies have low efficacy in other randomized trials # asco14,,,#,4.73595E+17,https://twitter.com/rsm2800/status/473595273454026752,,,,
heidisa,6/2/2014 18:41,3,1,"Application of genomic analysis to AYA tumors may offer novel therapeutic options."" That's OPTIONS FOR TREATMENT"," people. # ASCO14""",,,#,4.73595E+17,https://twitter.com/heidisa/status/473595254776799232,,,
MDigitalLife,6/2/2014 18:41,0,1,RT @ brianreid: # ASCO14 soc media/clinical trials presentation by @ rsm2800. Why should you listen to him? Because ev…pic.twitter.com/mDCVd4j9PI,,@ @,#,4.73595E+17,https://twitter.com/MDigitalLife/status/473595165882736640,,,,
FoundationATCG,6/2/2014 18:40,1,1,Important data in # yacancer presented by @ hayeslat at # asco14 # ayacsmpic.twitter.com/TmFt32jIED,,@,# # #,4.73595E+17,https://twitter.com/FoundationATCG/status/473595062694453248,,,,
AndyBiotech,6/2/2014 18:40,0,2,# ASCO14 Crowdsourcing Did $ INCY mess up SD/PD w/ irRC criteria? Where is that 1 SD in 50mg arm? @ zbiotech @Sport234apic.twitter.com/3fursEfDX4,,@ @Sport234apic,#,4.73595E+17,https://twitter.com/AndyBiotech/status/473595034802339840,,,,
CancerMedMDA,6/2/2014 18:40,0,0,Learn how Dr. Alyssa Rieber's own experience having cancer changed her oncology practice. Tues. 8 AM. # ASCO14 # endcancer,,,# #,4.73595E+17,https://twitter.com/CancerMedMDA/status/473594972705660928,,,,
scientre,6/2/2014 18:39,0,0,"Drake: discussing abstract 3028 (MEDI551), says has a secret microRNA biomarker # ASCO14 immunooncology",,,#,4.73595E+17,https://twitter.com/scientre/status/473594904091041792,,,,
NPforNinos,6/2/2014 18:38,1,1,"Way Cool! RT @ heidisa: For the first time, comprehensive # genomic profiling of # aya solid tumors. Distinctive biology revealed. # ASCO14",,@,# # #,4.73595E+17,https://twitter.com/NPforNinos/status/473594600314396672,,,,
TommyJohn00,6/2/2014 18:38,1,0,Pdl1 neg tumours still have responses in 7-15% # ASCO14,,,#,4.73595E+17,https://twitter.com/TommyJohn00/status/473594576587223040,,,,
CI4CC,6/2/2014 18:38,0,1,# ASCO14 attendees: do not forget to look into Cancer Genomics Workshop Nov 10-13 San Francisco Bay Area. Go 2 http://www.ci4cc.org,,,#,4.73595E+17,https://twitter.com/CI4CC/status/473594536611315712,,,,
FoundationATCG,6/2/2014 18:38,3,1,@ heidisa: Excited to hear @ hayeslat present this important AYA data from @ FoundationATCG at # ASCO14 ! # gamechanger # yacancer # ayacsm,,@ @ @,# # # #,4.73595E+17,https://twitter.com/FoundationATCG/status/473594506399715330,,,,
rsm2800,6/2/2014 18:38,0,0,Ganz: Mind Body Study (MBS) standardized way of reporting vasomotor sx # ASCO14,,,#,4.73594E+17,https://twitter.com/rsm2800/status/473594480516665344,,,,
KoontzOncology,6/2/2014 18:38,0,0,How far have we come since nitrogen mustard in treating cancer patients? # ASCO14 pic.twitter.com/zKrkQdpw2c,,,#,4.73594E+17,https://twitter.com/KoontzOncology/status/473594471364710400,,,,
BekRx,6/2/2014 18:38,0,1,The tough call: how do you justify a primary outcome of less than 4 months increased overall survival? Is the answer desperation? # ASCO14,,,#,4.73594E+17,https://twitter.com/BekRx/status/473594426015899648,,,,
echo_nyc,6/2/2014 18:37,0,0,Just a small shout out to @ scientre who is crushing it on Twitter at # ASCO14,,@,#,4.73594E+17,https://twitter.com/echo_nyc/status/473594395506511872,,,,
AlpineBV_Miller,6/2/2014 18:37,1,2,@ JanssenUS Going to answer the ? About how you can promote OS when your study was neg for survival and it's not on your label? # ASCO14,,@,#,4.73594E+17,https://twitter.com/AlpineBV_Miller/status/473594328645111809,,,,
heidisa,6/2/2014 18:37,1,0,"For the first time, comprehensive # genomic profiling of # aya solid tumors. Distinctive biology revealed. # ASCO14",,,# # #,4.73594E+17,https://twitter.com/heidisa/status/473594317018529794,,,,
scientre,6/2/2014 18:37,2,1,Drake: how immunooncology # asco14 abstracts 3028 and 3032 fit into landscape pic.twitter.com/qjHX0ZnWla,,,#,4.73594E+17,https://twitter.com/scientre/status/473594312018903040,,,,
DCarrizosaMD,6/2/2014 18:37,0,1,# ASCO14 - debate on ramucirumab + docetaxel OS benefit of 1.4 months not enough benefit but it is best seen up to now in 2nd line,,,#,4.73594E+17,https://twitter.com/DCarrizosaMD/status/473594224018194434,,,,
scientre,6/2/2014 18:36,0,0,Drake: how immunooncology # asco14 abstract 3030 fits into landscape pic.twitter.com/jDc2k9bhgT,,,#,4.73594E+17,https://twitter.com/scientre/status/473594099694858240,,,,
drcbsteer,6/2/2014 18:36,1,0,"“ @ BairdAM: # lcsm RT  @ mnewtonPharmD: Ceritinib responses in Alk+ nonsmall cell lung cancer # ASCO14 pic.twitter.com/8oFRHcwhux""” Niagara Falls""",,@ @,# #,4.73594E+17,https://twitter.com/drcbsteer/status/473594027280187392,,,,
rsm2800,6/2/2014 18:36,0,1,"Ganz: Notes in healthy women who were in NSABP P1, 60% of healthy women had joint pain at baseline (similar to IBIS2) # asco14",,,#,4.73594E+17,https://twitter.com/rsm2800/status/473593979360264192,,,,
scientre,6/2/2014 18:36,0,2,Drake: how immunooncology # asco14 abstract 3033 fits into landscape pic.twitter.com/ssgUOsYtEC,,,#,4.73594E+17,https://twitter.com/scientre/status/473593912620515328,,,,
Sorena997,6/2/2014 18:35,0,0,# ASCO14 Monday winding down significantly. Headed to Cancer Epi and Prevention talk by David Carbone,,,#,4.73594E+17,https://twitter.com/Sorena997/status/473593733515321345,,,,
scientre,6/2/2014 18:34,3,1,Drake: how immunooncology # asco14 abstracts 3031 and 3029 fit into landscape pic.twitter.com/GYz82fuLEQ,,,#,4.73594E+17,https://twitter.com/scientre/status/473593646080884738,,,,
DCarrizosaMD,6/2/2014 18:34,0,1,# ASCO14 ramucirumab+docetaxel improved OS but small (1.4 months) in all histologies and w/ prior bev,,,#,4.73594E+17,https://twitter.com/DCarrizosaMD/status/473593617265610752,,,,
LguzzardiM,6/2/2014 18:34,3,3,"# BRCA Gene Can Be A Cancer Triple Whammy, Study Finds. @ aliceparkny @ TIMEHealth @ DartmouthHitch @ ASCO http://time.com/2810864/brca-gene-can-be-a-cancer-triple-whammy-study-finds/ …",,@ @ @ @,#,4.73594E+17,https://twitter.com/LguzzardiM/status/473593570273034241,,,,
AlpineBV_Miller,6/2/2014 18:34,0,0,42% grade 3/4 events in EORTC-18071 # ASCO14 Almost 50% of people left ipi arm due to AEs.,,,#,4.73594E+17,https://twitter.com/AlpineBV_Miller/status/473593516397195264,,,,
timturnham,6/2/2014 18:33,0,0,Study of ipi in melanoma pts at high risk of recurrence: average time to recurrence was 23 months vs. 13 months for pts not on ipi. # ASCO14,,,#,4.73593E+17,https://twitter.com/timturnham/status/473593268442505216,,,,
PAscierto,6/2/2014 18:33,0,0,@ Oncoinfo_it Positive results about the EORTC ipilimumab adjuvant trial it was just showed by Lex Eggermont # ASCO14 pic.twitter.com/ch8w95RRfj,,@,#,4.73593E+17,https://twitter.com/PAscierto/status/473593266706059264,,,,
JacobPlieth,6/2/2014 18:33,0,0,. @ JackWestMD What about effect solely in squames - possibly more impressive given difficulty of treating? $ LLY # ASCO14,,@,#,4.73593E+17,https://twitter.com/JacobPlieth/status/473593231414808576,,,,
scientre,6/2/2014 18:32,6,0,Drake discussing # ASCO14 Dev Thera immunooncology abstracts 3028-3033. Says you may think later that you saw it here first,,,#,4.73593E+17,https://twitter.com/scientre/status/473592950644285440,,,,
rsm2800,6/2/2014 18:32,5,2,Ganz: “Menopausal symptoms are the price (cost) of cancer survivorship.” # ASCO14,,,#,4.73593E+17,https://twitter.com/rsm2800/status/473592924463435776,,,,
yzafar,6/2/2014 18:31,4,3,? from audience: ramucirumab in lung cancer doesn't meet standards set by ASCO in terms of value. What do we do with that? # asco14 # lcsm,,,# #,4.73593E+17,https://twitter.com/yzafar/status/473592840795463683,,,,
AlpineBV_Miller,6/2/2014 18:31,0,0,EORTC-18071 9mo median RFS ipi v placebo Stage III melanoma post resection. # ASCO14,,,#,4.73593E+17,https://twitter.com/AlpineBV_Miller/status/473592825838567424,,,,
ASCO,6/2/2014 18:30,0,0,Read Educational Book articles on topics in Professional Development from # ASCO14 Education Session Speakers: http://bit.ly/1jqD7vL,,,#,4.73593E+17,https://twitter.com/ASCO/status/473592566764818432,,,,
JackWestMD,6/2/2014 18:30,3,3,"Perol on docetaxel +/- antiangiogenic ramucirumab as 2d line Rx for adv NSCLC # ASCO14 # lcsm my take: meh""pic.twitter.com/oQUhTyXHa0""",,,# #,4.73593E+17,https://twitter.com/JackWestMD/status/473592546765979648,,,,
ASCO,6/2/2014 18:30,9,7,Menopausal status may predict risk of breast cancer mortality among obese women with ER+ breast CA http://bit.ly/1nYxY4d # ASCO14,,,#,4.73593E+17,https://twitter.com/ASCO/status/473592544472100864,,,,
urotoday,6/2/2014 18:30,0,0,"# ASCO14 Chemohormonal vs Hormonal Therapy for Hormone-sensitive mPrCa. Listen to interview w/ Christopher Sweeney, MD http://bit.ly/1n61hAW",,,#,4.73593E+17,https://twitter.com/urotoday/status/473592527304392704,,,,
CancerDotNet,6/2/2014 18:30,5,1,"Dr. Alexander Eggermont discusses promising treatment"" for highrisk # melanoma recur reduction # ASCO14 http://bit.ly/1kphaSQ""",,,# #,4.73592E+17,https://twitter.com/CancerDotNet/status/473592476964757504,,,,
AlpineBV_Miller,6/2/2014 18:30,0,0,"With approved, though marginal, drugs for this indication is it fair to use a placebo control? EORTC-18071 # ASCO14",,,#,4.73592E+17,https://twitter.com/AlpineBV_Miller/status/473592418697510912,,,,
rsm2800,6/2/2014 18:29,3,0,"Bigger peril is NOT doing it! Welcome RT @ MaceRothenberg: At great personal risk, I have entered the # twittersphere # whatamidoing # asco14",,@,# # #,4.73592E+17,https://twitter.com/rsm2800/status/473592386028068865,,,,
Melanoma_doctor,6/2/2014 18:29,0,0,"Depends but prob Ph1 trial MT @ odonoghue80: @ Melanoma_doctor @ ASCO what to do after failing MageA3, Ipi, Zelboraf and Anti-PD1/KIR trial?",,@ @ @,,4.73592E+17,https://twitter.com/Melanoma_doctor/status/473592193526288385,,,,
jtenconi,6/2/2014 18:28,0,0,Thanks @ ASCO - see you next year pic.twitter.com/Ay1lpsH0cx,,@,,4.73592E+17,https://twitter.com/jtenconi/status/473592055646928896,,,,
AlpineBV_Miller,6/2/2014 18:28,2,0,Data on how ipi is 2-4x more expensive than vemura and other drugs followed by EORTC-18071 post-resection ipi data. # ASCO14,,,#,4.73592E+17,https://twitter.com/AlpineBV_Miller/status/473591904295456768,,,,
rsm2800,6/2/2014 18:27,4,0,Park: Mg oxide showed no statistically sig decrease in hot flashes # asco14,,,#,4.73592E+17,https://twitter.com/rsm2800/status/473591854966272000,,,,
DCarrizosaMD,6/2/2014 18:27,0,1,# ASCO14 ramucirumab+docetaxel increases OS from 9.1 months to 10.5 (HR.857 p0.0235) -no increased bleeding but small up in feb neutropenia,,,#,4.73592E+17,https://twitter.com/DCarrizosaMD/status/473591846158221312,,,,
PermIMedJobs,6/2/2014 18:27,0,0,RT @ ASCO: Dr. Ed Balaban on why ASCO members should consider joining the http://bit.ly/1mKSNxn,,@,,4.73592E+17,https://twitter.com/PermIMedJobs/status/473591824406179840,,,,
KUhlendorf,6/2/2014 18:27,3,1,How Progress Happens: An Industry Perspective on Innovation in # Oncology - by @ Pfizer's @ MaceRothenberg http://am.asco.org/how-progress-happens-industry-perspective-innovation-oncology#.U4z57JbEOWI.twitter … # ASCO14,,@ @,# # #,4.73592E+17,https://twitter.com/KUhlendorf/status/473591712250486784,,,,
kevin2kane,6/2/2014 18:27,1,1,"Bit easy? “ @ Roche: Are you a Statistical supremo""? Test your clinical trials IQ: http://ow.ly/xwxWW # ASCO14 # research”""",,@,# #,4.73592E+17,https://twitter.com/kevin2kane/status/473591703346360322,,,,
rsm2800,6/2/2014 18:26,1,0,"Park: 45% on AI, 45% on tam; 30-50 had 10+ hot flashes # ASCO14",,,#,4.73592E+17,https://twitter.com/rsm2800/status/473591563638284288,,,,
AneesChagpar,6/2/2014 18:26,0,1,@ WhitworthMD @ beitsch @ MDAndersonNews @ ASCO Indeed! Catch you guys next time!,,@ @ @ @,,4.73591E+17,https://twitter.com/AneesChagpar/status/473591480045821952,,,,
MelPalMD,6/2/2014 18:26,0,0,Greg Armstrong # ASCO14: staggering risk of second neoplasms in childhood cancer survivors pic.twitter.com/v87CKtyklv,,,#,4.73591E+17,https://twitter.com/MelPalMD/status/473591466644615168,,,,
rsm2800,6/2/2014 18:25,1,0,Park: Randomized placebo-controlled trial in pts with h/o breast ca randomized to 800 mg vs 1200 mg of mag oxide vs. placebo # asco14,,,#,4.73591E+17,https://twitter.com/rsm2800/status/473591242404925440,,,,
ADAPTKdnyCancer,6/2/2014 18:25,0,0,Today Dr. Figlin @ CedarsSinai presented an update on the ongoing ADAPT Phase 3 clinical trial for AGS-003 http://ow.ly/xxlOW # ASCO14,,@,#,4.73591E+17,https://twitter.com/ADAPTKdnyCancer/status/473591181654622208,,,,
OncLive,6/2/2014 18:24,0,1,HPV-Targeting Immunotherapy Shows Early Promise in Cervical Cancer http://ow.ly/xy1Tb # ASCO14,,,#,4.73591E+17,https://twitter.com/OncLive/status/473591123525787648,,,,
scientre,6/2/2014 18:23,1,4,Wargo: discussing abstracts 3015-3021. Nice visual of how fit in Dev Thera immunooncology landscape # asco14 pic.twitter.com/cRtcqKUfNh,,,#,4.73591E+17,https://twitter.com/scientre/status/473590774953943040,,,,
DavidGimenez12,6/2/2014 18:23,1,0,@DavidGimenez12preliminary safety and efficacy TH-302 looks promising for patients R/R multiple myeloma http://ow.ly/xvoR7 # ASCO14.$thld,,@DavidGimenez12preliminary,#,4.73591E+17,https://twitter.com/DavidGimenez12/status/473590732524355584,,,,
KoontzOncology,6/2/2014 18:22,3,0,Where we stand today with genetic abnormalities in pediatric ALL. # ASCO14 pic.twitter.com/nt3jE9TJ3F,,,#,4.7359E+17,https://twitter.com/KoontzOncology/status/473590432652623873,,,,
drcbsteer,6/2/2014 18:21,4,1,"MT@ASCO Boosting rituximab dose by one-third in elderly men with DLBCL improves PFS OS http://bit.ly/1kxUCQ6 # ASCO14 where elderly"" = >60y""",,@ASCO,#,4.7359E+17,https://twitter.com/drcbsteer/status/473590348846227456,,,,
WhitworthMD,6/2/2014 18:21,0,1,Anees we were looking for you. An action packed mtg. Great strides in breast care now! # ASCO14 @ AneesChagpar @ beitsch @ MDAndersonNews @ ASCO,,@ @ @ @,#,4.7359E+17,https://twitter.com/WhitworthMD/status/473590348061478912,,,,
rsm2800,6/2/2014 18:21,0,0,Park: Study or oral Mg to reduce hot flashes in breast cancer survivors # bcsm # ASCO14,,,# #,4.7359E+17,https://twitter.com/rsm2800/status/473590324414394368,,,,
UCCancerCenter,6/2/2014 18:20,4,2,Another day wraps up at the # ASCO14 Annual Meeting. Lots of great clinical research presented on latest cancer care. pic.twitter.com/zepkDGPyTm,,,#,4.7359E+17,https://twitter.com/UCCancerCenter/status/473590043010150400,,,,
dramarivirg,6/2/2014 18:20,0,0,Bevacizumab añadido a Erlotinib en ADC pulmón Mt EGFR mutado 1ra línea mejora la SLP y tasa d respuesta objetiva. Data SG inmadura # ASCO14,,,#,4.7359E+17,https://twitter.com/dramarivirg/status/473589885870559233,,,,
drseisenberg,6/2/2014 18:19,0,1,"> 155 Million Impressions & > 10,000 Participants. More analytics here: http://ow.ly/xy1hD via @ symplur # ASCO14",,@,#,4.7359E+17,https://twitter.com/drseisenberg/status/473589828689600512,,,,
KoontzOncology,6/2/2014 18:19,2,1,How genomic studies have provided insight into the characterization of pediatric ALL. # ASCO14 pic.twitter.com/LuCQP657OZ,,,#,4.7359E+17,https://twitter.com/KoontzOncology/status/473589789225385984,,,,
rsm2800,6/2/2014 18:19,0,1,Barton: DHEA & testosterone serum levels went up; not estradiol. No diff in bone biomarkers # ASCO14,,,#,4.7359E+17,https://twitter.com/rsm2800/status/473589706199142400,,,,
mtmdphd,6/2/2014 18:18,1,0,"> 155 Million Impressions & > 10,000 Participants. More # ASCO14 analytics here: http://ow.ly/xy1hD via @ symplur",,@,#,4.7359E+17,https://twitter.com/mtmdphd/status/473589576632905728,,,,
AstellasUS,6/2/2014 18:17,0,0,Thanks to all who attended our advocacy event at # ASCO14. Rep. Patti Bellock spoke on the ability unified patients have in effecting change.,,,#,4.73589E+17,https://twitter.com/AstellasUS/status/473589268192165889,,,,
rsm2800,6/2/2014 18:17,0,0,"Barton: At 12 wks diff btwn DHEA and control p=NS but was trend favoring DHEA, but pts reported better sexual function w/ DHEA # ASCO14",,,#,4.73589E+17,https://twitter.com/rsm2800/status/473589219739586563,,,,
montypal,6/2/2014 18:16,0,0,Proud of my student who did a great job representing out poster on conditional survival in bladder cancer # ASCO14 pic.twitter.com/mzoVWYFubQ,,,#,4.73589E+17,https://twitter.com/montypal/status/473589102345191424,,,,
subatomicdoc,6/2/2014 18:16,0,0,"@ DrAttai @ beitsch @ WhitworthMD Whoa, y'all were here? Wish I had known. Congrats! # ASCO14",,@ @ @,#,4.73589E+17,https://twitter.com/subatomicdoc/status/473588980173524992,,,,
Ludwig_Cancer,6/2/2014 18:15,0,1,"Candidate antibody drug derived from a Ludwig discovery shows promise against GBM, the deadliest # braincancer # ASCO14 http://bit.ly/1iA4CDK",,,# #,4.73589E+17,https://twitter.com/Ludwig_Cancer/status/473588710043561985,,,,
ASCO,6/2/2014 18:15,4,9,"Boosting rituximab dose by one-third in elderly men with DLBCL improves PFS, OS http://bit.ly/1kxUCQ6 # ASCO14",,,#,4.73589E+17,https://twitter.com/ASCO/status/473588700086272000,,,,
CancerTherAdvsr,6/2/2014 18:15,0,0,# ASCO14: Safe to Postpone ADT in Men with Asymptomatic # ProstateCancer and Rising PSA Levels http://ow.ly/xvsa9,,,# #,4.73589E+17,https://twitter.com/CancerTherAdvsr/status/473588686165385216,,,,
rsm2800,6/2/2014 18:15,0,0,"Barton: Measured most bothersome sx (dryness or dyspaurenia), women self-reported; 464 pts accrued # ASCO14",,,#,4.73589E+17,https://twitter.com/rsm2800/status/473588684462497792,,,,
appistry,6/2/2014 18:15,1,0,. @ BioITWorld covers our recently released # CloudDx and # PGDx partnership! http://ow.ly/xx81z # ASCO14 # genomics,,@,# # # #,4.73589E+17,https://twitter.com/appistry/status/473588678577897472,,,,
OncLive,6/2/2014 18:15,1,0,Adjuvant Ipilimumab Reduces Risk of Recurrence in Stage III Melanoma http://ow.ly/xxUTZ # ASCO14,,,#,4.73589E+17,https://twitter.com/OncLive/status/473588677978103808,,,,
nxtstop1,6/2/2014 18:15,1,0,MEET PTS WHERE THEY LIVE~ @ mtmdphd A lot of interest in social media in oncology at # ASCO14 @ ASCO pic.twitter.com/lskJ0yWOb4”,,@ @,#,4.73589E+17,https://twitter.com/nxtstop1/status/473588664463675392,,,,
heidisa,6/2/2014 18:14,3,2,Excited to hear @ hayeslat present this important AYA data from @ FoundationATCG at # ASCO14 ! # gamechanger # yacancer # ayacsm,,@ @,# # # #,4.73588E+17,https://twitter.com/heidisa/status/473588483525967872,,,,
TommyJohn00,6/2/2014 18:14,1,0,"@ n8pennell what doesn't make sense is in cappuzzos jco paper, met fish was positive and bad prog in 30%. Now we hear it's pos in 1% # ASCO14",,@,#,4.73588E+17,https://twitter.com/TommyJohn00/status/473588482708103168,,,,
rsm2800,6/2/2014 18:13,0,0,Barton: BCRF funding to look at biomarkers # ASCO14,,,#,4.73588E+17,https://twitter.com/rsm2800/status/473588347622137858,,,,
ERPlimackMD,6/2/2014 18:13,1,1, @ RyanNipp Financial distress, emotional symptoms," & overall distress in insured cancer pts http://bit.ly/1jZTrZ9 # ASCO14 @ FoxChaseCancer""",,@ @,#,4.73588E+17,https://twitter.com/ERPlimackMD/status/473588316382982144,,
subatomicdoc,6/2/2014 18:13,0,3,@ ConsanoMolly A true pleasure for me to meet you and @ ConsanoScott - keep inspiring others and helping us docs help others # ASCO14 # mitzvah,,@ @,# #,4.73588E+17,https://twitter.com/subatomicdoc/status/473588234896048128,,,,
rsm2800,6/2/2014 18:13,0,0,"Barton: Randomized to DHEA 2 doses or control moisturizer; all postmenop, all had mod severe vag sx, most breast or gyn ca # ASCO14",,,#,4.73588E+17,https://twitter.com/rsm2800/status/473588216130732032,,,,
RMiksad,6/2/2014 18:13,1,0,"STORM adjuvant HCC Sorafenib trial negative. When av time on drug 1yr, is it too much to ask cytostatic drug to work like cytotoxic? # ASCO14",,,#,4.73588E+17,https://twitter.com/RMiksad/status/473588211164651520,,,,
skylinedx,6/2/2014 18:13,0,1,"Great Day at ASCO and the multiple myeloma sessions. A lot of progress, still much work to be done. # ASCO14 # GEP",,,# #,4.73588E+17,https://twitter.com/skylinedx/status/473588152893202432,,,,
DMG_AICR,6/2/2014 18:13,0,0,RT @ ClevelandClinic: More than 1/3 of all US adults and 17% of US children and adolescents are obese. - Dr. Ligibel # ASCO14,,@,#,4.73588E+17,https://twitter.com/DMG_AICR/status/473588151894941696,,,,
KoontzOncology,6/2/2014 18:12,0,1,Recognizing Janet Rowley and her discoveries in identifying chromosomal translocations in leukemia. # ASCO14 pic.twitter.com/IDZwkyNApr,,,#,4.73588E+17,https://twitter.com/KoontzOncology/status/473588093069819904,,,,
PearlF,6/2/2014 18:12,2,1,Sad photo from @ YaleCancer: Seen outside the largest cancer conference in the US. # asco14 pic.twitter.com/Qdq00itZAN via @ drseisenberg,,@ @,#,4.73588E+17,https://twitter.com/PearlF/status/473588040427143168,,,,
rsm2800,6/2/2014 18:12,0,0,"Barton: Labrie trial, lowest DHEA slightly increased E2 serum levels but still in postmenop range # ASCO14",,,#,4.73588E+17,https://twitter.com/rsm2800/status/473587961985269760,,,,
timturnham,6/2/2014 18:12,0,0,"In BRAF therapy, size & number of tumors and high LDH levels suggest poorer outcomes, but not always. More studies are critical. # ASCO14",,,#,4.73588E+17,https://twitter.com/timturnham/status/473587901033226240,,,,
drsteventucker,6/2/2014 18:12,0,0,MT @ nxtstop1: YOUNG FAT NATION: More than 1/3 of all US adults and 17% of US children and adolescents are obese- Dr. Ligibel # ASCO14,,@,#,4.73588E+17,https://twitter.com/drsteventucker/status/473587895375118337,,,,
ohsuaya,6/2/2014 18:11,0,0,"MT @ hayeslat: Excited to present results of comprehensive genetic profiling of AYA tumors. Distinctive, targetable. # ASCO14 @ FoundationATCG",,@ @,#,4.73588E+17,https://twitter.com/ohsuaya/status/473587852685885440,,,,
HemOncToday,6/2/2014 18:11,2,1,. @ sloan_kettering doctor says # ASCO14 data forecasts 'bright future' in treatment of chronic myeloid # leukemia http://goo.gl/5glQB1,,@,# #,4.73588E+17,https://twitter.com/HemOncToday/status/473587820632997888,,,,
GoHealio,6/2/2014 18:11,0,0,. @ sloan_kettering doctor says # ASCO14 data forecasts 'bright future' in treatment of chronic myeloid # leukemia http://goo.gl/5glQB1,,@,# #,4.73588E+17,https://twitter.com/GoHealio/status/473587819861245952,,,,
DrAttai,6/2/2014 18:11,2,2,@ beitsch and @ WhitworthMD congrats on # ASCO14 posters!,,@ @,#,4.73588E+17,https://twitter.com/DrAttai/status/473587770003566593,,,,
GoHealio,6/2/2014 18:11,0,0,. @ sloan_memorial doctor says # ASCO14 data forecasts 'bright future' in treatment of chronic myeloid # leukemia http://goo.gl/5glQB1,,@,# #,4.73588E+17,https://twitter.com/GoHealio/status/473587629909626880,,,,
drseisenberg,6/2/2014 18:11,0,0,The SCAR Project: Male Breast Cancer http://wp.me/P3daDY-2l # ASCO14,,,#,4.73588E+17,https://twitter.com/drseisenberg/status/473587611315892224,,,,
rsm2800,6/2/2014 18:10,0,1,"Barton: DHEA is pro-hormone excreted from adrenal, thought not to be systemically active # ASCO14",,,#,4.73588E+17,https://twitter.com/rsm2800/status/473587594518093825,,,,
KoontzOncology,6/2/2014 18:10,0,0,Why cure is not enough in pediatric oncology. # ASCO14 pic.twitter.com/OtkIIMsU2W,,,#,4.73588E+17,https://twitter.com/KoontzOncology/status/473587580144189440,,,,
DrZackaryBerger,6/2/2014 18:10,0,0,"MT @ Marie_GruGru “Early Chemo Extends Lives of Men With Prostate Cancer, Study Finds http://ow.ly/xv05M # ASCO14 # pcsm” # metastaticonly",,@,# # #,4.73588E+17,https://twitter.com/DrZackaryBerger/status/473587578848161792,,,,
DMG_AICR,6/2/2014 18:10,0,0,RT @ DrKateWolin:LEAN study finds weight maintenance w @ aicrtweets print materials in breast cancer survivors # ASCO14 http://ow.ly/xxKic,,@ @,#,4.73588E+17,https://twitter.com/DMG_AICR/status/473587522732572672,,,,
mtmdphd,6/2/2014 18:10,4,2,# ASCO14 Tweet Statistics - 06-02-14 17:05 pic.twitter.com/S0PTqjGukQ,,,#,4.73588E+17,https://twitter.com/mtmdphd/status/473587508257628161,,,,
afreshchapter,6/2/2014 18:10,0,0,The view above. Small things amuse tired minds. Home stretch of # asco14 with 2 meetings left before… http://instagram.com/p/owghpGsgXx/,,,#,4.73588E+17,https://twitter.com/afreshchapter/status/473587501693558785,,,,
PublicHealthRTs,6/2/2014 18:10,0,0,RT @ JNCI_Now: Women with metastatic cervical cancer – caused by the human papillomavirus (HPV) – have limited treatment options. # ASCO14,,@,#,4.73587E+17,https://twitter.com/PublicHealthRTs/status/473587445880340480,,,,
DrAttai,6/2/2014 18:09,0,0,"Speaking at # ASCO14 on social media and # bcsm http://wp.me/p3daDY-ij via @ obogler - Oliver, they couldn't have picked better for that talk!",,@,# #,4.73587E+17,https://twitter.com/DrAttai/status/473587212051681280,,,,
Merck,6/2/2014 18:09,1,4,Merck's Mike Rosenblatt catching up w/ colleagues following Merck's melanoma data presentation. # ASCO14 pic.twitter.com/fqSZ4LfVlp,,,#,4.73587E+17,https://twitter.com/Merck/status/473587112747753472,,,,
MelPalMD,6/2/2014 18:09,4,0,"Morton at # ASCO14 on risk factor categories for second cancers, relationship with age pic.twitter.com/SOwlwfzFc6",,,#,4.73587E+17,https://twitter.com/MelPalMD/status/473587110880894976,,,,
Cancer_Genetics,6/2/2014 18:08,2,0,Lots of great information today at # ASCO14 Looking forward to tomorrow!,,,#,4.73587E+17,https://twitter.com/Cancer_Genetics/status/473587106087198721,,,,
TommyJohn00,6/2/2014 18:08,3,2,@ JackWestMD loved the financial toxicity slide btw! Won't be an option in Australia without Caucasian data is suspect. # ASCO14,,@,#,4.73587E+17,https://twitter.com/TommyJohn00/status/473586935479681024,,,,
nxtstop1,6/2/2014 18:08,0,0,YOUNG FAT NATION: @ ClevelandClinic: More than 1/3 of all US adults and 17% of US children and adolescents are obese. - Dr. Ligibel # ASCO14”,,@,#,4.73587E+17,https://twitter.com/nxtstop1/status/473586887811035136,,,,
rsm2800,6/2/2014 18:07,0,0,Barton: Alliance trial on vaginal DHEA in female cancer survivors # asco14,,,#,4.73587E+17,https://twitter.com/rsm2800/status/473586811575738368,,,,
Marie_GruGru,6/2/2014 18:06,4,0,"# BuzzOfTheYear # practicechanging “Early Chemo Extends Lives of Men With Prostate Cancer, Study Finds http://ow.ly/xv05M # ASCO14 # pcsm”",,,# # # #,4.73586E+17,https://twitter.com/Marie_GruGru/status/473586427062530048,,,,
scientre,6/2/2014 18:05,0,0,Ariyan: discussing Dev Thera Immunooncology abstracts with the goal of... # asco14 pic.twitter.com/6gG1fI91Ww,,,#,4.73586E+17,https://twitter.com/scientre/status/473586244216446976,,,,
TheLizArmy,6/2/2014 18:05,6,1,Options! RT @ ASCOPost: Addition of Chemotherapy to Radiotherapy Improves Survival in Low-Grade Glioma http://ow.ly/xwYSq # ASCO14 # btsm,,@,# #,4.73586E+17,https://twitter.com/TheLizArmy/status/473586159411822592,,,,
myriadgenetics,6/2/2014 18:05,1,0,"Physicians, visit MyriadPro for information that can help you serve your patients! http://bit.ly/1dgJ7EA # ASCO14 # ASCOConnecton",,,# #,4.73586E+17,https://twitter.com/myriadgenetics/status/473586104910622720,,,,
UCCancerCenter,6/2/2014 18:04,0,0,"Promising interim analysis of TEM/LEN combination in relapsed/refractory Hodgkin Lymphoma from Drs Smith, Stadler, Nabhan & Karrison # ASCO14",,,#,4.73586E+17,https://twitter.com/UCCancerCenter/status/473585986589716480,,,,
JoanneWeidhaas,6/2/2014 18:04,2,3,"Great head and neck oral session today at # ASCO14! We need predictive biomarkers in head and neck cancer"" and the KRAS-variant might be one""",,,#,4.73586E+17,https://twitter.com/JoanneWeidhaas/status/473585949600153600,,,,
odonoghue80,6/2/2014 18:04,0,0,"@ Melanoma_doctor @ ASCO what do patients do when they fail MageA3 trial vaccine, Ipi, Zelboraf, and now Anti-PD1/KIR trial?",,@ @,,4.73586E+17,https://twitter.com/odonoghue80/status/473585900094361600,,,,
DrBobGoldberg,6/2/2014 18:04,0,0,We survived @ ASCO # asco14 pic.twitter.com/0b9xRS4Aln,,@,#,4.73586E+17,https://twitter.com/DrBobGoldberg/status/473585877827190785,,,,
caseofdees,6/2/2014 18:03,0,0,@ cordekroon Neoadjuvant chemo as initial treatment in advanced ovarian cancer may decrease complications http://bit.ly/1m5L3V5 # ASCO14,,@,#,4.73586E+17,https://twitter.com/caseofdees/status/473585802921132032,,,,
scientre,6/2/2014 18:03,0,0,Melanoma trial of autologous monocyte-derived mRNA electroporated dendritic cells (TriMixDC-MEL) # asco14 http://abstracts.asco.org/144/AbstView_144_125491.html …,,,#,4.73586E+17,https://twitter.com/scientre/status/473585745740185601,,,,
MediTech_Media,6/2/2014 18:03,1,1,The # NSCLC session demonstrates the importance of identifying patient populations that benefit from specific agents # ASCO14 # individualized,,,# # #,4.73586E+17,https://twitter.com/MediTech_Media/status/473585741613002752,,,,
ConquerCancerFd,6/2/2014 18:03,1,2,A few pics from our Grants & Awards Ceremony yesterday are now up on FB. Congrats to all our recipients! http://on.fb.me/1iMTAuW # ASCO14,,,#,4.73586E+17,https://twitter.com/ConquerCancerFd/status/473585631105671169,,,,
ASCO,6/2/2014 18:01,6,0,Dr. Ed Balaban on why ASCO members should consider joining the @ AmerMedicalAssn http://bit.ly/1mMcHJL # ASCO14,,@,#,4.73585E+17,https://twitter.com/ASCO/status/473585291132141568,,,,
KoontzOncology,6/2/2014 18:01,1,0,Terrific strides have been made in the management of Wilms tumor as a result of cooperative group research. # ASCO14 pic.twitter.com/X4xqjBo310,,,#,4.73585E+17,https://twitter.com/KoontzOncology/status/473585288934330368,,,,
ASCO,6/2/2014 18:01,1,0,"Read the # ASCOConnection tribute to Dr. Donald Morton, melanoma expert: http://bit.ly/1jA2DPb # melsm # ASCO14",,,# # #,4.73585E+17,https://twitter.com/ASCO/status/473585252519378945,,,,
knwachter,6/2/2014 18:01,0,0,RT @ RamalingamMD: Radiation in extensive small cell lung ca- no role for PCI and questionable role for thoracic RT. # ASCO14 # LCSM,,@,# #,4.73585E+17,https://twitter.com/knwachter/status/473585222299422720,,,,
ASCO,6/2/2014 18:01,1,2,Read Educational Book articles on topics in Tumor Biology from # ASCO14 Education Session Speakers: http://bit.ly/RxBExb,,,#,4.73585E+17,https://twitter.com/ASCO/status/473585194348580864,,,,
ASCO,6/2/2014 18:01,12,5,Neoadjuvant chemo as initial treatment in advanced ovarian cancer may decrease complications http://bit.ly/1m5L3V5 # ASCO14,,,#,4.73585E+17,https://twitter.com/ASCO/status/473585170499792896,,,,
TheCKelsey,6/2/2014 18:00,0,1,@ PunitDhillon Excellent # ASCO14 for $ ONCS! Let's find some anti-PD1 now and press ahead!,,@,#,4.73585E+17,https://twitter.com/TheCKelsey/status/473584869743005696,,,,
JackWestMD,6/2/2014 17:59,1,0,"TY: It just gets more granular over time RT TommyJohn00: @ JackWestMD nice discussion # ASCO14. More subgroups within subgroups, more options!",,@,#,4.73585E+17,https://twitter.com/JackWestMD/status/473584703900241920,,,,
TargetedOnc,6/2/2014 17:59,0,1,. @ jrgralow on toxicities and pt-stated preference for oral vs IV delivery of bisphosphonates in SWOG S0307 http://www.targetedonc.com/conference/asco-2014/Comparing-Toxicities-and-Patient-Stated-Preference-in-the-SWOG-S0307-Trial … # ASCO14,,@,#,4.73585E+17,https://twitter.com/TargetedOnc/status/473584614540599298,,,,
TommyJohn00,6/2/2014 17:58,4,2,“ @ n8pennell: combined OS analysis from LUX trials of afatinib vs chemo in ex19d. # ASCO14 # LCSM” This is unprecedented and hard to ignore,,@,# #,4.73585E+17,https://twitter.com/TommyJohn00/status/473584527416520705,,,,
obogler,6/2/2014 17:58,6,3,speaking at # ASCO14 on social media and # bcsmhttp://wp.me/p3daDY-ij,,,# #,4.73584E+17,https://twitter.com/obogler/status/473584447929847808,,,,
JackWestMD,6/2/2014 17:58,0,1,"This, really appreciate your kind words. RT DrGregMasters: @ JackWestMD gave a great summary of lung ca data # asco2014",,@,#,4.73584E+17,https://twitter.com/JackWestMD/status/473584438136565762,,,,
mdahpbaloia,6/2/2014 17:57,1,2,"Surgonc resistant to change practice even w/ published randomized trial data, Medonc willing to change with # ASCO14 poster. Combo= # endcancer",,,# #,4.73584E+17,https://twitter.com/mdahpbaloia/status/473584110754340864,,,,
pablove,6/2/2014 17:56,0,0,Our Scientific Chair Dr. Leo Mascarenhas made headlines at # ASCO2014! http://ow.ly/xxYBV @ ASCO @ ChildrensLA # fightchildhoodcancer,,@ @,# #,4.73584E+17,https://twitter.com/pablove/status/473584046355021824,,,,
KoontzOncology,6/2/2014 17:56,0,0,Notable US pediatric oncology leaders. # ASCO14 pic.twitter.com/p9hrFOsdvJ,,,#,4.73584E+17,https://twitter.com/KoontzOncology/status/473584042106191873,,,,
brianreid,6/2/2014 17:56,0,1,"# ASCO14 selfie, 5 p.m. Man, the days get long. pic.twitter.com/d71dNpnwCI",,,#,4.73584E+17,https://twitter.com/brianreid/status/473583892348538881,,,,
mattshomepage,6/2/2014 17:56,0,0,Hodgkin lymphoma survivors develop second cancers because (1) affects youth (2) high dosage treatments # ASCO14 pic.twitter.com/HtgfLeZEoM,,,#,4.73584E+17,https://twitter.com/mattshomepage/status/473583876682821633,,,,
KoontzOncology,6/2/2014 17:56,0,0,InternationAl leaders in pediatric oncology. # ASCO14 pic.twitter.com/ONVGuMslj6,,,#,4.73584E+17,https://twitter.com/KoontzOncology/status/473583845317832704,,,,
griffoncanisius,6/2/2014 17:55,0,1,My poster session at # ASCO14. Time to chemo from PROCEED. More interesting next year when data is more mature. http://www.urotoday.com/Prostate-Cancer-Immunotherapy/asco14-poster-time-to-chemotherapy-following-treatment-with-sipuleucel-t-data-from-proceed.html …,,,#,4.73584E+17,https://twitter.com/griffoncanisius/status/473583753731014657,,,,
Roche,6/2/2014 17:55,0,4,Almost there - last day of # ASCO14 tomorrow. How many of you are in for the full haul?,,,#,4.73584E+17,https://twitter.com/Roche/status/473583647342493696,,,,
Rad_Nation,6/2/2014 17:54,0,0,Thank you everyone for the retweets and shares at # ASCO14,,,#,4.73584E+17,https://twitter.com/Rad_Nation/status/473583566153351169,,,,
AlpineBV_Miller,6/2/2014 17:54,6,7,"This vemura+cobi combo is really, really impressive. 100% FDG-PET metabolic response in P1 n=46. $ EXEL $ RHHBY # ASCO14",,,#,4.73584E+17,https://twitter.com/AlpineBV_Miller/status/473583561606717440,,,,
MelanomaReAlli,6/2/2014 17:54,3,4,"# ASCO14 quote from our CSO Oh my! Results show over 3/4 of metastatic # melanoma patients alive at 2 years if treated w/ Ipi & Nivo combo!""""",,,# #,4.73584E+17,https://twitter.com/MelanomaReAlli/status/473583550294290432,,,,
jdflaysakier,6/2/2014 17:54,7,1,"Cancer : immunothérapie, l'espoir d'un permis de tuert. Sur le blog http://www.docteurjd.com/?p=3223 # ASCO14",,,#,4.73583E+17,https://twitter.com/jdflaysakier/status/473583476956884992,,,,
CoreLIMS,6/2/2014 17:54,0,1,". @ illumina If we could only harness all of that brain-power for good... Oh, wait... that's already happening at # ASCO14",,@,#,4.73583E+17,https://twitter.com/CoreLIMS/status/473583471102021633,,,,
KoontzOncology,6/2/2014 17:54,0,0,Edith Patterson - a leader in the field of pediatric oncology. # ASCO14 pic.twitter.com/H8xV4CSjrH,,,#,4.73583E+17,https://twitter.com/KoontzOncology/status/473583367112630272,,,,
TommyJohn00,6/2/2014 17:54,0,0,"@ JackWestMD nice discussion # ASCO14. More subgroups within subgroups, more options!",,@,#,4.73583E+17,https://twitter.com/TommyJohn00/status/473583340969549825,,,,
annaazvolinsky,6/2/2014 17:53,0,0,"Neg, HER2+ adjuvant # breastcancer trial questions use of surrogate endpoint in neoadjuvant BC trials # ASCO14 http://www.cancernetwork.com/asco-2014-breast-cancer/anti-her2-combo-fails-improve-outcomes-early-breast-cancer …",,,# #,4.73583E+17,https://twitter.com/annaazvolinsky/status/473583301362323458,,,,
DrGregMasters,6/2/2014 17:53,0,1,@ JackWestMD gave a great summary of lung ca data # asco2014,,@,#,4.73583E+17,https://twitter.com/DrGregMasters/status/473583267976065024,,,,
dramarivirg,6/2/2014 17:53,0,0,LUX lung 3 y 6: Afatinib debe ser considerado 1ra línea en ADC pulmón metastasico EGFR mutado sólo en Del19 # ASCO14,,,#,4.73583E+17,https://twitter.com/dramarivirg/status/473583115613777920,,,,
KoontzOncology,6/2/2014 17:52,0,0,Some remarkable firsts in pediatric oncology. # ASCO14 pic.twitter.com/XoGm3GNf7h,,,#,4.73583E+17,https://twitter.com/KoontzOncology/status/473582972902588416,,,,
Cortellis,6/2/2014 17:51,0,1,MEDI3617 administered as single agent showed promising antitumor activity in ovarian cancer in phase I/II trial # ASCO14,,,#,4.73583E+17,https://twitter.com/Cortellis/status/473582646853779457,,,,
appistry,6/2/2014 17:50,0,0,. @ Medpagetoday outlines some headlines from # ASCO14. Check it out! http://ow.ly/xx3zi,,@,#,4.73582E+17,https://twitter.com/appistry/status/473582361897345024,,,,
duemed,6/2/2014 17:50,1,6,@ JackWestMD discussing costs of new lung cancer drugs and value in cancer tratment. # ASCO14 pic.twitter.com/rw6Xd8fKiv,,@,#,4.73582E+17,https://twitter.com/duemed/status/473582359875682304,,,,
DoctorJoette,6/2/2014 17:49,2,1,@ DeniseWhiteTV Be your own advocate. Clinical trials may help you or someone else http://ow.ly/3lhYUk http://ow.ly/3lhZbd @ ASCO,,@ @,,4.73582E+17,https://twitter.com/DoctorJoette/status/473582266388873217,,,,
CBPartners,6/2/2014 17:49,0,0,"Jack west on costs of Ceritinib at $13,500 - will make us look longingly back on the days of $10k / month therapy # ASCO14",,,#,4.73582E+17,https://twitter.com/CBPartners/status/473582117231030272,,,,
FairmontChicago,6/2/2014 17:49,1,0,Congratulations to @ ASCO on their 50th Anniversary and the success of # ASCO14! Here's to many more years in Chicago! pic.twitter.com/0mfOXpw9XH,,@,#,4.73582E+17,https://twitter.com/FairmontChicago/status/473582096829927424,,,,
vickiben,6/2/2014 17:49,0,0,RT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 # hcsm http://bit.ly/1kyrh87,,@ @,# #,4.73582E+17,https://twitter.com/vickiben/status/473582079125364736,,,,
LynneOmar,6/2/2014 17:49,0,0,"@ SCoRMembers MT Syst Rev & Analysis of Apps for Prevention, Detection, & Management of Cancer http://www.jmir.org/2013/12/e287 # ASCO14 @rms2800",,@ @rms2800,#,4.73582E+17,https://twitter.com/LynneOmar/status/473582075887747073,,,,
Rad_Nation,6/2/2014 17:48,0,0,Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma http://buff.ly/1kIZBwI # ASCO14 # hncsm # radonc,,,# # #,4.73582E+17,https://twitter.com/Rad_Nation/status/473581860384423936,,,,
subatomicdoc,6/2/2014 17:48,4,0,Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma http://bit.ly/1kIZyBl # ASCO14 # hncsm # radonc,,,# # #,4.73582E+17,https://twitter.com/subatomicdoc/status/473581839119286273,,,,
teamoncology,6/2/2014 17:47,0,0,@ WhitneyEpi I would like to see all the care/treatment to be seamless for our cancer patients and personalized. # BCSM # ASCO14,,@,# #,4.73582E+17,https://twitter.com/teamoncology/status/473581736706584576,,,,
rsm2800,6/2/2014 17:47,0,0,Oettinger: Reminds us that prognosis assoc w/ Stage C or D CHF is very poor # asco14,,,#,4.73582E+17,https://twitter.com/rsm2800/status/473581704058531843,,,,
DoctorJoette,6/2/2014 17:47,2,0,"If you've got cancer, be your own advocate. Clinical trials may help you or someone else http://ow.ly/3lhYUk http://ow.ly/3lhZbd @ ASCO",,@,,4.73582E+17,https://twitter.com/DoctorJoette/status/473581677290479617,,,,
m0370,6/2/2014 17:47,1,0,Twitterは勉強になるし、遊びじゃなくて仕事だよっていうのは、 # ASCO14 でも発表されているようです。やはりみんなどんどんTwitterすべき。 https://twitter.com/subatomicdoc/status/473220943113101312 …,,,#,4.73582E+17,https://twitter.com/m0370/status/473581574915506176,,,,
Progeny,6/2/2014 17:46,0,0,"The most common request from healthcare providers at # ESHG14 and # ASCO14 How can we store pedigrees in our EMR."" http://youtu.be/wgqHLBuyvkE""",,,# #,4.73582E+17,https://twitter.com/Progeny/status/473581560038719488,,,,
LGG1,6/2/2014 17:46,2,0,@ obogler is right: # bcsm is a great online community! # asco14 @ stales @ jodyms @ drattaipic.twitter.com/OQk1jNH1GY,,@ @ @ @,# #,4.73581E+17,https://twitter.com/LGG1/status/473581441679642624,,,,
knwachter,6/2/2014 17:46,0,1,"RT @ CBPartners: Jack west also states erlo+ bev is his preferred regimen moving forward"" assuming insur cvg # ASCO14 pic.twitter.com/glJK5fDfHC""",,@,#,4.73581E+17,https://twitter.com/knwachter/status/473581428144603137,,,,
mlsief,6/2/2014 17:46,1,1,Exciting news out of # ASCO2014 RT @ BosBizDon Metamark touts study showing prostate diagnostic is 90 percenthttp://tinyurl.com/pcjg75u,,@,#,4.73581E+17,https://twitter.com/mlsief/status/473581370191929345,,,,
n8pennell,6/2/2014 17:46,9,1,Dr. West: erlotinib plus bevacizumab will be my preferred regimen NOW for EGFR mut+ pts. Insurance coverage and cost big issue # ASCO14 # LCSM,,,# #,4.73581E+17,https://twitter.com/n8pennell/status/473581331054465026,,,,
CBPartners,6/2/2014 17:45,0,0,"Jack west also states erlo+ bev is his preferred regimen moving forward"" assuming insurance coverage # ASCO14 pic.twitter.com/f5zqb4oeQf""",,,#,4.73581E+17,https://twitter.com/CBPartners/status/473581239094755329,,,,
ASCO,6/2/2014 17:45,1,2,Read Educational Book articles on topics in Gynecologic Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1oq2MfY,,,#,4.73581E+17,https://twitter.com/ASCO/status/473581165128196096,,,,
RielyMD,6/2/2014 17:45,3,1,"@ JackWestMD: erlotinib + bev in EGFR mutant lung cancer my preferred regimen going forward"" based on Kato data. # ASCO14""",,@,#,4.73581E+17,https://twitter.com/RielyMD/status/473581102201053184,,,,
urotoday,6/2/2014 17:45,1,0,# ASCO14 - Impact on overall survival with chemohormonal therapy versus hormonal therapy for ... http://dlvr.it/5sBNFG,,,#,4.73581E+17,https://twitter.com/urotoday/status/473581093979824128,,,,
hollyejacobs,6/2/2014 17:44,0,1,Me too! @ IVF_IRMS We are also glad to hear about hopeful news! Great to hear news that helps with # infertility # breastcancer @ ASCO # ASCO14,,@ @,# # #,4.73581E+17,https://twitter.com/hollyejacobs/status/473580885170610176,,,,
CBPartners,6/2/2014 17:43,0,0,"Jack west asks about financial toxicity"" of bevacizumab + erlotinib data. # ASCO14 pic.twitter.com/WXYU5UmDPL""",,,#,4.73581E+17,https://twitter.com/CBPartners/status/473580813024768000,,,,
Melanoma_doctor,6/2/2014 17:43,2,2,"My Summary: Nivo + Ipi very impressive in Ph1, Ph3 trial accrued but results pend # finalanswer # melanoma # ASCO14 @ ASCO",,@,# # #,4.73581E+17,https://twitter.com/Melanoma_doctor/status/473580757580255234,,,,
rsm2800,6/2/2014 17:43,0,0,Hudson: SCP+APN more stated concerns about ins coverage vs ACP alone # asco14,,,#,4.73581E+17,https://twitter.com/rsm2800/status/473580726303358976,,,,
rsm2800,6/2/2014 17:42,0,0,"Hudson: 234 control (22% completed screening), 238 to APN intervention (52% completed screening) # asco14",,,#,4.7358E+17,https://twitter.com/rsm2800/status/473580457440051201,,,,
LerougeJolie,6/2/2014 17:42,0,0,Ojalá en Colombia los tratamientos oncológicos fueran de libre acceso y subvencionados por el estado. # ASCO14,,,#,4.7358E+17,https://twitter.com/LerougeJolie/status/473580442944569344,,,,
UROncDoc,6/2/2014 17:42,0,0,@ simon_p_kim @ cpgYALE @bubadg @ iConquerCancer @ ASCO @ YaleCancer @ YaleCOPPER strong work man. Congrats,,@ @ @bubadg @ @ @ @,,4.7358E+17,https://twitter.com/UROncDoc/status/473580376443846657,,,,
OncLive,6/2/2014 17:40,1,0,New Study Findings Confirm Pembrolizumab’s Durable Responses in Metastatic Melanoma http://ow.ly/xxWsj # ASCO14,,,#,4.7358E+17,https://twitter.com/OncLive/status/473579948515803136,,,,
SequentaInc,6/2/2014 17:40,0,1,L. Fong ( @ UCSFMedicine) presenting # ASCO14 data now using LymphoSIGHT platform in evaluation of # immunotherapy http://ow.ly/xxtaZ,,@,# #,4.7358E+17,https://twitter.com/SequentaInc/status/473579871881674752,,,,
Xcenda,6/2/2014 17:40,0,0,We’re honored to present 2 posters at # ASCO14 learn more: http://bit.ly/1jXRsje # xcenda # oncology # hematology,,,# # # #,4.7358E+17,https://twitter.com/Xcenda/status/473579825710391296,,,,
rsm2800,6/2/2014 17:39,0,0,Hudson: Survivor randomized to written surv care plan (SCP) or SCP+ adv pract nurse phone counseling wk 1&3 (20 min tailored script) # asco14,,,#,4.7358E+17,https://twitter.com/rsm2800/status/473579761600823296,,,,
ElizBlanchardMD,6/2/2014 17:39,0,1,Heading out from # ASCO14 Have patients to care for tomorrow AM-will tell them there is progress in cancer medicine. Safe travels everyone!,,,#,4.7358E+17,https://twitter.com/ElizBlanchardMD/status/473579720853176320,,,,
timturnham,6/2/2014 17:38,0,0,Some pts w/ BRAF mutation & MEK mutation don't do as well on BRAF inhibitors. Helps decide what drug to give to which pt. # ASCO14,,,#,4.7358E+17,https://twitter.com/timturnham/status/473579548681199616,,,,
Melanoma_doctor,6/2/2014 17:37,0,0,"Chief adjective for ASCO = EXHAUSTING MT @ DrMarkham: Had wonderful time at # ASCO14, but life must go on. Time for rest before heading home",,@,#,4.73579E+17,https://twitter.com/Melanoma_doctor/status/473579282334502912,,,,
rsm2800,6/2/2014 17:37,0,0,Hudson: Did addition of APN+phone screening incr CV risk screening rate in children treated w/ anthracyclines or chest RT # asco14,,,#,4.73579E+17,https://twitter.com/rsm2800/status/473579260901605377,,,,
Melanoma_doctor,6/2/2014 17:36,0,0,Sad but true RT @ JenniferViera: People are smoking right outside the door near our # CNBC set. Wearing badges for # ASCO14,,@,# #,4.73579E+17,https://twitter.com/Melanoma_doctor/status/473578954562220032,,,,
Cortellis,6/2/2014 17:35,0,0,Phase III results demonstrate survival benefit in patients with advanced gastric cancer receiving apatinib monotherapy # ASCO14,,,#,4.73579E+17,https://twitter.com/Cortellis/status/473578772633882625,,,,
CureMelanoma,6/2/2014 17:35,0,0,RT @ timturnham: CureTexh PD1 study looked at pts who had not done well on previous drugs.1 year out 66% were still alive. # ASCO14,,@,#,4.73579E+17,https://twitter.com/CureMelanoma/status/473578710067871744,,,,
WNYOCP,6/2/2014 17:35,0,2,"@ KathleenMaxian President of @ WNYOCP met up with @ drdonsdizon at # ASCO14 # GYNCSM pic.twitter.com/Fq10OleE0n"",,@ @ @,# #,473578636982116353""",https://twitter.com/WNYOCP/status/473578636982116353,,,,,,,,
CureMelanoma,6/2/2014 17:35,0,0,RT @ timturnham: Data on ipi going back over 5 years shows about 22% of pts w/ long term durable response. @ CureMelanoma # ASCO14,,@ @,#,4.73579E+17,https://twitter.com/CureMelanoma/status/473578616434229248,,,,
winemomjill,6/2/2014 17:35,1,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73579E+17,https://twitter.com/winemomjill/status/473578597157203968,,,,
CureMelanoma,6/2/2014 17:35,1,1,RT @ timturnham: Ipi + PD1 = more side effects but 79% of pts still alive after 2 years. One group had 88% still alive after 2 years! # ASCO14,,@,#,4.73579E+17,https://twitter.com/CureMelanoma/status/473578592702828545,,,,
DrMarkham,6/2/2014 17:34,0,0,"Had a wonderful time at # ASCO14, but life must go on. Time for some rest before heading home in the morning.",,,#,4.73578E+17,https://twitter.com/DrMarkham/status/473578365765812224,,,,
RielyMD,6/2/2014 17:34,2,4,@ JackWestMD made my day by citing data I reported in 2006 of different outcomes for 19 del vs l858r EGFR http://clincancerres.aacrjournals.org/content/12/3/839.long … # ASCO14,,@,#,4.73578E+17,https://twitter.com/RielyMD/status/473578335612993536,,,,
drseisenberg,6/2/2014 17:33,8,2,"7C's for the docs, patients & nurses of @ ASCO: Compassion, Communication, Creativity, Community, Care, Collaboration & Connection # ASCO14",,@,#,4.73578E+17,https://twitter.com/drseisenberg/status/473578273201352704,,,,
Melanoma_MRV,6/2/2014 17:33,0,0,Vale Don Morton A true pioneer & inspiring leader # asco14 pic.twitter.com/MQxzUfmmdt,,,#,4.73578E+17,https://twitter.com/Melanoma_MRV/status/473578110945091584,,,,
Melanoma_doctor,6/2/2014 17:33,0,0,Off topic but the person coughing constantly in front of me is making me feel ill # asco14 (not @ OmidHamidMD),,@,#,4.73578E+17,https://twitter.com/Melanoma_doctor/status/473578109049241600,,,,
KathleenMaxian,6/2/2014 17:32,1,0,Met up with @ drdonsdizon at # ASCO14 # GYNCSMpic.twitter.com/CTSBAzSwGz,,@,# #,4.73578E+17,https://twitter.com/KathleenMaxian/status/473578010956689409,,,,
MedscapePharm,6/2/2014 17:32,0,0,# ASCO2014 This drug combo is rewriting the record book for efficacy in melanoma---but eventually be eclipsed http://bit.ly/1uaqcWQ,,,#,4.73578E+17,https://twitter.com/MedscapePharm/status/473578001905381376,,,,
MedscapeOnc,6/2/2014 17:32,2,2,# ASCO2014 This drug combo is rewriting the record book for efficacy in melanoma---but eventually be eclipsed http://bit.ly/1uaqcWQ,,,#,4.73578E+17,https://twitter.com/MedscapeOnc/status/473578001775333376,,,,
MedscapeNurses,6/2/2014 17:32,0,0,# ASCO2014 This drug combo is rewriting the record book for efficacy in melanoma---but eventually be eclipsed http://bit.ly/1uaqcWQ,,,#,4.73578E+17,https://twitter.com/MedscapeNurses/status/473578001150394368,,,,
Medscape,6/2/2014 17:32,6,1,# ASCO2014 This drug combo is rewriting the record book for efficacy in melanoma---but eventually be eclipsed http://bit.ly/1uaqcWQ,,,#,4.73578E+17,https://twitter.com/Medscape/status/473578001146200064,,,,
Lymphoma_Doc,6/2/2014 17:32,1,0,"Primary mediastinal NHL outcomes from MD Anderson @LymphomaMyeloma. R-chemo is good, R-EPOCH may be better # ASCO14 pic.twitter.com/dDwrH6Lz61",,@LymphomaMyeloma,#,4.73578E+17,https://twitter.com/Lymphoma_Doc/status/473577915750559744,,,,
RielyMD,6/2/2014 17:31,0,0,@ JackWestMD giving interpretation of 3 excellent presentations # ASCO14,,@,#,4.73578E+17,https://twitter.com/RielyMD/status/473577703082573824,,,,
Melanoma_doctor,6/2/2014 17:30,1,3,Picture blurry because they were running so fast RT mass and unfortunate exodus after PD-1 presentations over # asco14 pic.twitter.com/OO1uUxjPWR,,,#,4.73578E+17,https://twitter.com/Melanoma_doctor/status/473577512824737792,,,,
ASCO,6/2/2014 17:30,1,0,Read Educational Book articles on topics in Geriatic Oncology from # ASCO14 Education Session Speakers: http://bit.ly/1lPb2Qq,,,#,4.73577E+17,https://twitter.com/ASCO/status/473577495762305024,,,,
ASCO,6/2/2014 17:30,8,2,Potential driver genes id'd using NGS in paired tumor samples of ovarian cancer http://bit.ly/1oNTL0l # ASCO14 # gyncsm,,,# #,4.73577E+17,https://twitter.com/ASCO/status/473577464485404672,,,,
GustaveRoussy,6/2/2014 17:30,2,0,# ASCO14 # video Pr Gilles Vassal @ GustaveRoussy Nouvelle étape pour la médecine personnalisée en cancérologie https://vimeo.com/97164562,,@,# #,4.73577E+17,https://twitter.com/GustaveRoussy/status/473577343496507392,,,,
Novartis,6/2/2014 17:30,3,3,Are you a reporter who missed our media briefing this morning? Find more info about data in ALK+ NSCLC http://bit.ly/1ua6fiZ # ASCO14,,,#,4.73577E+17,https://twitter.com/Novartis/status/473577332499042304,,,,
survivornetca,6/2/2014 17:30,0,0,RT @ obogler: Only 3% of # Cancer patients advance cancer knowledge by participating in # clinicaltrials according to @ mtmdphd # ASCO14,,@ @,# # #,4.73577E+17,https://twitter.com/survivornetca/status/473577327893307392,,,,
UChicagoMed,6/2/2014 17:29,0,0,"Plenty of cancer breakthroughs at # ASCO14, but much of the chatter this year will be on who’s picking up the tab http://buzz.mw/b0w8k_f",,,#,4.73577E+17,https://twitter.com/UChicagoMed/status/473577239540678656,,,,
CBPartners,6/2/2014 17:29,0,1,Erlotinib + bevacizumab in NSCLC EGFR mut+ summary slide # ASCO14 pic.twitter.com/styH157dHW,,,#,4.73577E+17,https://twitter.com/CBPartners/status/473577227259748352,,,,
DCarrizosaMD,6/2/2014 17:29,0,0,# ASCO14 - erlotinib + bevacizumab prolonged PFS vs erlotinib alone in del19/L858R Pts (16v9.7months p0.0015) in Phase II study in Japan,,,#,4.73577E+17,https://twitter.com/DCarrizosaMD/status/473577220263669760,,,,
scientre,6/2/2014 17:28,1,2,"Ok, just noticing the slides between sessions are scrolling through tweets, encouraging ppl to explore # asco14 pic.twitter.com/nvtQhbiOWB",,,#,4.73577E+17,https://twitter.com/scientre/status/473576900657684480,,,,
Melanoma_doctor,6/2/2014 17:28,8,4,Thinking back to 2013 almost funny how blasé we now are about the unbelievable outcomes w anti-PD-1 # melanoma # ASCO14 @ ASCO @ OmidHamidMD,,@ @,# #,4.73577E+17,https://twitter.com/Melanoma_doctor/status/473576876611743745,,,,
RyhMd,6/2/2014 17:27,0,0,99% DCR w Erlotinib+Bev in EGFR mut NSCLC # ASCO14,,,#,4.73577E+17,https://twitter.com/RyhMd/status/473576773188587520,,,,
OmidHamidMD,6/2/2014 17:27,1,0,"Dear # pharma & # investors @ ASCO # ASCO2014, Please stay for full session. # respectthework",,@,# # # #,4.73577E+17,https://twitter.com/OmidHamidMD/status/473576707665199104,,,,
Melanoma_doctor,6/2/2014 17:27,1,0,Mass and unfortunate exodus of Pharma and investor types after PD-1 presentations over. @ ASCO # melanoma # asco14 pic.twitter.com/OO1uUxjPWR,,@,# #,4.73577E+17,https://twitter.com/Melanoma_doctor/status/473576678477021184,,,,
NormandBlais,6/2/2014 17:27,0,1,"In EGFR MUT NSCLC, erlo + becacizumab almost doubles PFS: 9.7 mts to 16 mts (vs erlo alone). OS not presented. # LCCatASCO # ASCO14",,,# #,4.73577E+17,https://twitter.com/NormandBlais/status/473576672080699392,,,,
fischmd,6/2/2014 17:27,2,1,Herceptin-related CHF in adj # breastcancer: incr risk confined to the first 1.5 yrs only http://abstracts.asco.org/144/index.html # CardioOnc # ASCO14,,,# # #,4.73577E+17,https://twitter.com/fischmd/status/473576543814295552,,,,
Sports_bios,6/2/2014 17:26,0,1,No beef in this $ CLVS vs $ AZN convos.. sure interesting viewpts across the spectrum.. more exciting than many other # ASCO14 stories..,,,#,4.73577E+17,https://twitter.com/Sports_bios/status/473576507529785344,,,,
NEDmovie,6/2/2014 17:26,0,0,RT @CoCancerCenter # ASCO14 advice for oncologists - make sure your patients tested properly for targeted therapies http://bit.ly/RU8kkq,,@CoCancerCenter,#,4.73576E+17,https://twitter.com/NEDmovie/status/473576354840342528,,,,
Merck,6/2/2014 17:26,2,0,Investors and journalists are encouraged to join our investor briefing via webcast at 7:15EST @ ASCO. http://bit.ly/1oP2jnO,,@,,4.73576E+17,https://twitter.com/Merck/status/473576294094233601,,,,
RielyMD,6/2/2014 17:25,6,1,"Kato on erlotinib+/-bev in pts with EGFR mut lung,154 pts, pfs HR 0.54 favors bev + erlot median 16 vs 10 mo, p=0.0015, stunning! # ASCO14",,,#,4.73576E+17,https://twitter.com/RielyMD/status/473576160002326529,,,,
ByJonGardner,6/2/2014 17:25,0,0,@ avidresearch *and* the # ASCO14 presentation never mentioned insulin. @ MaverickNY @ jq1234t,,@ @ @,#,4.73576E+17,https://twitter.com/ByJonGardner/status/473576145204809728,,,,
evaluatepharma,6/2/2014 17:25,0,0,# ASCO14 – Clovis Oncology impresses then disappoints with early lung cancer data http://ow.ly/xwJ5Q $ CLVS $ AZN,,,#,4.73576E+17,https://twitter.com/evaluatepharma/status/473576091882622976,,,,
CBPartners,6/2/2014 17:25,0,0,Oncologists' choices for 1L EGFR mut+ NSCLC keep getting more interesting with ~6 mo mPFs benefit beva. + erlo. over erlotinib alone # ASCO14,,,#,4.73576E+17,https://twitter.com/CBPartners/status/473576074543398912,,,,
stephaniemlee,6/2/2014 17:24,0,0,Genentech's bladder cancer drug sees promising early results: http://blog.sfgate.com/techchron/2014/06/02/genentechs-bladder-cancer-drug-sees-promising-early-results/ … # ASCO14,,,#,4.73576E+17,https://twitter.com/stephaniemlee/status/473575851133394944,,,,
ElizBlanchardMD,6/2/2014 17:24,0,0,"Abs 9504: Authors: since CHF is less common after 1.5 years, do women need routine surveillance after that time period? # ASCO14",,,#,4.73576E+17,https://twitter.com/ElizBlanchardMD/status/473575807244574721,,,,
rsm2800,6/2/2014 17:22,0,0,"Goldhar: Risk of CHF assoc w/ trastuz not affected by anthracycline use, only seen in Rx phase. ?No need for echo post Rx phase # asco14",,,#,4.73576E+17,https://twitter.com/rsm2800/status/473575507062427648,,,,
OmidHamidMD,6/2/2014 17:22,0,0,"@ melanoma_doctor @ asco please see Powderly # ASCO13 with @ genentech data # PDL1. Need to query changes over time in tissue, T cell activation",,@ @ @,# #,4.73575E+17,https://twitter.com/OmidHamidMD/status/473575343790784512,,,,
Onconet_NL,6/2/2014 17:22,0,0,“ @ groen_w @MartijnMStuiver Snappen jullie dit?: Exercise program may result in prostate cancer progression # ASCO14 http://bit.ly/1rD6ODX ”,,@ @MartijnMStuiver,#,4.73575E+17,https://twitter.com/Onconet_NL/status/473575323351937024,,,,
PearlF,6/2/2014 17:22,4,3,< 15% of patients learn abt # clinicaltrials from their MDs. How 2 address awareness: http://ow.ly/xwKnl # ASCO14 HT @ genentech,,@,# #,4.73575E+17,https://twitter.com/PearlF/status/473575284948881408,,,,
ElizBlanchardMD,6/2/2014 17:20,1,0,"After 1.5 yrs have passed, risk of CHF much lower in women tx with trastuzumab. # ASCO14 # supponc",,,# #,4.73575E+17,https://twitter.com/ElizBlanchardMD/status/473575001174835202,,,,
YSCBuzz,6/2/2014 17:20,1,1,# ASCO14 highlights from today http://bit.ly/1rzEGBR,,,#,4.73575E+17,https://twitter.com/YSCBuzz/status/473574955553017856,,,,
3dsBIOVIA,6/2/2014 17:20,1,0,RT @ bmsnews: # Cancer research doesn’t take just one doctor or patient—it takes all of us http://ow.ly/xvjhl # ImmunoOncologyNow # ASCO14,,@,# # #,4.73575E+17,https://twitter.com/3dsBIOVIA/status/473574938482597888,,,,
MaverickNY,6/2/2014 17:20,2,0,Experts clearly liking unprecedented efficacy of Nivo + ipi but not thrilled by 60% grade 3-4 AEs # asco14,,,#,4.73575E+17,https://twitter.com/MaverickNY/status/473574919453048832,,,,
ElizBlanchardMD,6/2/2014 17:19,0,0,Abs 9504: trastuzumab assoc w incr risk of CHF 3% at one year 5.3% at 5 yrs in pts also getting chemo. # ASCO14 # supponc,,,# #,4.73575E+17,https://twitter.com/ElizBlanchardMD/status/473574766029574144,,,,
rsm2800,6/2/2014 17:19,0,0,"Goldhar: Risk of new onset of CHF after 1.5 yrs same for chemo+trastuz as chemo alone, so it is confined to time of adjuvant Rx # asco14",,,#,4.73575E+17,https://twitter.com/rsm2800/status/473574676208582656,,,,
scientre,6/2/2014 17:19,3,1,"Not 1st time I've heard this but said on panel during Q&A in HER2+ breast session a bad biomarker is as bad as a bad drug."" # ASCO14""",,,#,4.73575E+17,https://twitter.com/scientre/status/473574654196858880,,,,
Melanoma_doctor,6/2/2014 17:19,0,0,What does @ OmidHamidMD think of PD-L1 expression and anti PD-1 response? # melanoma # ASCO14 @ ASCO,,@ @,# #,4.73575E+17,https://twitter.com/Melanoma_doctor/status/473574615420510208,,,,
MelanomaReAlli,6/2/2014 17:18,1,2,More # ASCO14 news: Antipd1 antibodies keep looking great in # melanoma. Combo of Ipi and Nivo may have even longer benefit for patients!,,,# #,4.73574E+17,https://twitter.com/MelanomaReAlli/status/473574451196346368,,,,
rsm2800,6/2/2014 17:18,1,0,"Goldhar: N=15703 chemo alone, 3371 chemo+trastuz; median f/u 5.9 yrs; 5 yrs CHF=2.6% chemo alone, 5.3% chemo+trastuz (HR=0.87) # asco14",,,#,4.73574E+17,https://twitter.com/rsm2800/status/473574296527597568,,,,
Melanoma_doctor,6/2/2014 17:17,0,0,Associated not predictive RT @ Melanoma_doctor: Weber (discussing): PD -L1 expression and response to anti PD-1 # melanoma # ASCO14 @ ASCO,,@ @,# #,4.73574E+17,https://twitter.com/Melanoma_doctor/status/473574125546786816,,,,
obogler,6/2/2014 17:17,2,4,thanks friends for kind words - an honor to speak alongside @ rsm2800 & @ mtmdphd w/ @ DrAttai @ subatomicdoc @ fischmd & others there # ASCO14,,@ @ @ @ @,#,4.73574E+17,https://twitter.com/obogler/status/473574039869751296,,,,
LGG1,6/2/2014 17:16,0,0,@ subatomicdoc @ amyfries Great to meet you too! May have some ideas to bounce in the near future: will be in touch! # ASCO14,,@ @,#,4.73574E+17,https://twitter.com/LGG1/status/473573963835400192,,,,
CBPartners,6/2/2014 17:16,0,0,How personal is personalized medicine?Del19 results for afatinib thought provoking # ASCO14,,,#,4.73574E+17,https://twitter.com/CBPartners/status/473573840577380352,,,,
rsm2800,6/2/2014 17:16,0,0,Goldhar: Collected long term data from Toronto registries (3 diff sources); defined CHF=1 hosp admission or 1 amb visit+a 2nd event # asco14,,,#,4.73574E+17,https://twitter.com/rsm2800/status/473573771748843521,,,,
barbarastowe,6/2/2014 17:15,0,0,“ @ Roche: What will the future bring for cancer # immunotherapy? http://ow.ly/xp7F7 # ASCO14” @ MedsearchR @ medsearch_sa,,@ @ @,# #,4.73574E+17,https://twitter.com/barbarastowe/status/473573667818188800,,,,
amy_cully,6/2/2014 17:15,0,1,"So long Chicago, humidity, deep dish pizza, blisters, truly impressive social media onco professionals at # ASCO14! pic.twitter.com/2IYqWE3y8d",,,#,4.73574E+17,https://twitter.com/amy_cully/status/473573658397798401,,,,
OncLive,6/2/2014 17:15,0,2,"Robert Andtbacka, MD, CM, discusses phase III OS findings for T-VEC in unresectable melanoma http://ow.ly/xvy62 # ASCO14",,,#,4.73574E+17,https://twitter.com/OncLive/status/473573634876116992,,,,
ASCO,6/2/2014 17:15,0,2,Read Educational Book articles on topics in Genitourinary Cancer from # ASCO14 Education Session Speakers: http://bit.ly/Sc9MPG,,,#,4.73574E+17,https://twitter.com/ASCO/status/473573621869604864,,,,
Novartis,6/2/2014 17:15,0,1,Thank you to Dr. Dong-wan Kim for doing a great job presenting ALK+ NSCLC data at # ASCO14.,,,#,4.73574E+17,https://twitter.com/Novartis/status/473573618103091200,,,,
ASCO,6/2/2014 17:15,10,2,RTOG 9802 first prospective study to ever demonstrate OS increase for patients w/ grade 2 glioma http://bit.ly/1l0JlHE # ASCO14,,,#,4.73574E+17,https://twitter.com/ASCO/status/473573616471539713,,,,
scientre,6/2/2014 17:15,0,1,Q&A session in HER2+ breast session: why 5 new drugs and still only one assay? # ASCO14,,,#,4.73574E+17,https://twitter.com/scientre/status/473573568073441281,,,,
Melanoma_doctor,6/2/2014 17:15,1,0,Weber (discussing): PD -L1 expression NOT helpful in predicting response to anti PD-1. AGREE # melanoma # ASCO14 @ ASCO,,@,# #,4.73574E+17,https://twitter.com/Melanoma_doctor/status/473573527535505409,,,,
DoctorJoette,6/2/2014 17:15,0,1,New cancer treatment described as 'revolutionary' for advanced cervical /HPV related cancers http://ow.ly/3lhWbW @ myfoxtampabay @ ASCO,,@ @,,4.73574E+17,https://twitter.com/DoctorJoette/status/473573521889951744,,,,
ElizBlanchardMD,6/2/2014 17:14,0,0,Abs 9504: population based study from Canada in women with curable breast ca and no chf hx # ASCO14,,,#,4.73573E+17,https://twitter.com/ElizBlanchardMD/status/473573473311535104,,,,
rsm2800,6/2/2014 17:14,0,0,Goldhar: B31: anthracyclines+taxane+trastuz incr risk of cardiac event HR=3.3 c/w same chemo alone (short term results) # asco14,,,#,4.73573E+17,https://twitter.com/rsm2800/status/473573374275239936,,,,
DCarrizosaMD,6/2/2014 17:14,0,0,# ASCO14 - data from pooled lux lung 3/6 shows afatinib has overall OS improvement but ? Raised that it is better in del19 vs L858R,,,#,4.73573E+17,https://twitter.com/DCarrizosaMD/status/473573279857639425,,,,
ElizBlanchardMD,6/2/2014 17:13,1,0,Abs 9504: trastuzumab and heart failure--significant survivorship issue # ASCO14 # supponc,,,# #,4.73573E+17,https://twitter.com/ElizBlanchardMD/status/473573079529308161,,,,
rogersro,6/2/2014 17:13,0,0,$ mygn Dr. Michael Brawer explains # Prolaris data to attendees at # asco14 # prostatecancer # menshealth # cancer # menpic.twitter.com/mSgcg0yl0n,,,# # # # # #,4.73573E+17,https://twitter.com/rogersro/status/473573058779684864,,,,
rsm2800,6/2/2014 17:12,0,0,Goldhar: Discussing long term cardiotoxicity of trastuzumab # ASCO14,,,#,4.73573E+17,https://twitter.com/rsm2800/status/473572856413323265,,,,
RyhMd,6/2/2014 17:12,0,0,LUX3 & LUX6 conclusions # ASCO14 pic.twitter.com/UZTQJBekuM,,,#,4.73573E+17,https://twitter.com/RyhMd/status/473572785420521472,,,,
CBPartners,6/2/2014 17:11,0,0,Interesting to see James Chih-Hsin Yang try to correlate afatinib lux-lung 3/6 results with reimbursement policies in countries # ASCO14,,,#,4.73573E+17,https://twitter.com/CBPartners/status/473572695985381376,,,,
DCarrizosaMD,6/2/2014 17:11,0,1,# ASCO14 - subset analysis of pooled lux lung 3 and 6 shows shows significant OS improvement with Pts w/ del19 and L858R mutations,,,#,4.73573E+17,https://twitter.com/DCarrizosaMD/status/473572675676561409,,,,
DrMisialek,6/2/2014 17:10,6,5,"# ASCO14 thanks for all the Tweets, great way for other specialists to follow along and share with their colleagues @ ASCO @ Pathologists",,@ @,#,4.73572E+17,https://twitter.com/DrMisialek/status/473572374865281024,,,,
Novartis,6/2/2014 17:10,5,7,"As we present new ALK+ NSCLC data at # ASCO14, we’re so grateful to everyone who has supported our milestones # LCSMpic.twitter.com/SFZKyxxRtZ",,,# #,4.73572E+17,https://twitter.com/Novartis/status/473572337263329280,,,,
rsm2800,6/2/2014 17:10,1,0,Uncanny timing for my slide on PGHD today-->Apple worked w/ Mayo Clinic & Epic to build HealthKit platform http://medcitynews.com/2014/06/apple-worked-mayo-clinic-epic-build-heathkit-platform/#.U4znj_QDlNc.twitter … # asco14,,,# #,4.73572E+17,https://twitter.com/rsm2800/status/473572289724706816,,,,
NormandBlais,6/2/2014 17:09,0,0,Afatinib first TKI to show improved OS in del 19 mut NSCLC. Less convincing for L858R. # LCCatASCO # ASCO14. pic.twitter.com/7n8Q2g7jAX,,,# #,4.73572E+17,https://twitter.com/NormandBlais/status/473572204501008384,,,,
Melanoma_MRV,6/2/2014 17:09,0,2,# ASCO14 # melanoma http://tinyurl.com/l3nvhor 79% 2 year survival for nivolumab & Ipilimumab - last years data holding uppic.twitter.com/aIeAOFzUWI,,,# #,4.73572E+17,https://twitter.com/Melanoma_MRV/status/473572194472435712,,,,
ElizBlanchardMD,6/2/2014 17:09,0,0,"Q&A: do you switch bone agents after an SRE. Answer from author: Yes, if it's not denosumab to start. May be fair-- # ASCO14 # supponc",,,# #,4.73572E+17,https://twitter.com/ElizBlanchardMD/status/473572057461313536,,,,
josebouzacal,6/2/2014 17:07,0,0,RT @ Amgen: Look for # Amgen data on symptomatic skeletal events in patients with advanced # prostatecancer at # ASCO2014,,@,# # #,4.73572E+17,https://twitter.com/josebouzacal/status/473571608754675714,,,,
ElizBlanchardMD,6/2/2014 17:07,0,0,Q&A: question about compliance with metoclopramide QID for delayed emesis--a grt point. May be a real issue. # ASCO14 # supponc,,,# #,4.73572E+17,https://twitter.com/ElizBlanchardMD/status/473571557370245121,,,,
myESMO,6/2/2014 17:06,0,0,@ CareAcross We look forward to welcoming you to # ESMO14 in Madrid :-) # ASCO14,,@,# #,4.73571E+17,https://twitter.com/myESMO/status/473571307091931137,,,,
arifkamalmd,6/2/2014 17:06,0,0,"What do Seinfeld, Black Eyed Peas, and # Palliative Care have in common? Come find out at PC symposium Tue AM at # ASCO14",,,# #,4.73571E+17,https://twitter.com/arifkamalmd/status/473571290654449665,,,,
genentech,6/2/2014 17:05,2,3,"MET may be impt to cancer, but maybe it enlists other proteins that make tumors grow - A. Sandler # ASCO14 http://ow.ly/xwq4K",,,#,4.73571E+17,https://twitter.com/genentech/status/473571051075821568,,,,
arifkamalmd,6/2/2014 17:05,0,0,"Join  # Palliative Care: Interventions that Matter"" Tue AM at # ASCO14 to hear about innovations in early PC", caregiving," and statin d/c""",,,# #,4.73571E+17,https://twitter.com/arifkamalmd/status/473571012395958272,,
scientre,6/2/2014 17:04,1,0,Carey: concepts and trials to watch for in HER2+ breast cancer neoadjuvant setting # asco14 pic.twitter.com/ns3pxFYgkr,,,#,4.73571E+17,https://twitter.com/scientre/status/473570926312062977,,,,
ElizBlanchardMD,6/2/2014 17:04,0,0,Q&A: does bone agent need to be present to work? How important is half life? # ASCO14 # supponc,,,# #,4.73571E+17,https://twitter.com/ElizBlanchardMD/status/473570877767172096,,,,
jodigralnick,6/2/2014 17:04,2,4,People are smoking right outside the door near our # CNBC set. Wearing badges for # ASCO14 -a CANCER RESEARCH MEETING. Ummmm...,,,# #,4.73571E+17,https://twitter.com/jodigralnick/status/473570841209626625,,,,
BayerPharma,6/2/2014 17:03,0,0,# DYK about 1 in 20 men will be advanced at # prostatecancer diagnosis # ASCO14 http://bit.ly/Rv49fO,,,# # #,4.73571E+17,https://twitter.com/BayerPharma/status/473570645696348161,,,,
timturnham,6/2/2014 17:03,2,1,Ipi + PD1 = more side effects but 79% of pts still alive after 2 years. One group had 88% still alive after 2 years! @ CureMelanoma # ASCO14,,@,#,4.73571E+17,https://twitter.com/timturnham/status/473570578390347777,,,,
Melanoma_doctor,6/2/2014 17:02,0,0,"Nivo+ Ipi 1 yr OS 85%, median OS 40%, 2yr OS 79%. Most responses > 80% disease reduction # melanoma # ASCO14 @ ASCO",,@,# #,4.7357E+17,https://twitter.com/Melanoma_doctor/status/473570494009323520,,,,
DrDonaldHarvey,6/2/2014 17:02,0,0,"Ceritinib performed well in alk + patients with brain metastasis, regardless of prior alk inhibitor # ASCO14 pic.twitter.com/JYiTo0QZI7",,,#,4.7357E+17,https://twitter.com/DrDonaldHarvey/status/473570434752188416,,,,
arifkamalmd,6/2/2014 17:02,3,0,"The science of appropriateness"" - how zoledronic acid q12w", metoclopramide," and palonosotron are related # ASCO14""",,,#,4.7357E+17,https://twitter.com/arifkamalmd/status/473570358717870081,,
MaverickNY,6/2/2014 17:02,5,1,Sznol: unprecedented OS 79% at 2 years but high incidence of grade 3-4 events with nivo + ipi combo in melanoma # asco14,,,#,4.7357E+17,https://twitter.com/MaverickNY/status/473570349779812352,,,,
BioWorld,6/2/2014 17:02,1,0,"Don’t forget pancreatic; Newlink’s phase III patient picks, antibody levels IMPRESS # ASCO14 http://bit.ly/1wWsafI",,,#,4.7357E+17,https://twitter.com/BioWorld/status/473570260734705664,,,,
CareAcross,6/2/2014 17:01,0,0,A vibrant advocacy square is winding down as the # ASCO14 exhibition wraps up. See you at @ myESMO!pic.twitter.com/FzVcP6kCva,,@,#,4.7357E+17,https://twitter.com/CareAcross/status/473570228656300032,,,,
ASCO,6/2/2014 17:01,2,0,Experts discuss the experience of obtaining # QOPI Certification in a large practice http://bit.ly/1krhVLm CC @ MoffittNews # ASCO14,,@,# #,4.7357E+17,https://twitter.com/ASCO/status/473570209161547776,,,,
ONAcom,6/2/2014 17:01,0,0,# ASCO14: Expanding # NCI Community Cancer Centers Program in a rural community can up clinical trial enrollment - http://ow.ly/xweQw,,,# #,4.7357E+17,https://twitter.com/ONAcom/status/473570158653763585,,,,
ElizBlanchardMD,6/2/2014 17:01,0,0,Q&A: denosumab also being studied in other intervals/scheduling # ASCO14 # supponc,,,# #,4.7357E+17,https://twitter.com/ElizBlanchardMD/status/473570142648283136,,,,
ASCO,6/2/2014 17:01,0,1,Want a demo of # CancerLinQ? Please visit the Institute for Quality booth at # ASCO14 http://bit.ly/1kIto90 # ascoaction,,,# # #,4.7357E+17,https://twitter.com/ASCO/status/473570136717537280,,,,
Novartis,6/2/2014 17:01,0,1,Don’t miss new Phase III results in # polycythemiavera at # ASCO14 tomorrow at 9:57 AM CDT in E354a http://bit.ly/1i93rtE,,,# #,4.7357E+17,https://twitter.com/Novartis/status/473570117113380865,,,,
aftimosp,6/2/2014 17:01,0,0,Very flattering comments on the rationale and design of Zephir. Congratulations Dr Gebhart! # BreastCancer # ASCO14,,,# #,4.7357E+17,https://twitter.com/aftimosp/status/473570113698807808,,,,
ASCO,6/2/2014 17:01,2,0,"AREN0533: In SIR, 3-year EFS 88% and 3-year OS 92% when chemo was added to std treatment http://bit.ly/1mJCj8J # ASCO14",,,#,4.7357E+17,https://twitter.com/ASCO/status/473570038818287616,,,,
n8pennell,6/2/2014 17:01,0,0,Dr. Yang presenting combined OS analysis from LUX Lung trials of afatinib vs chemo for common mutations. # ASCO14 # LCSM,,,# #,4.7357E+17,https://twitter.com/n8pennell/status/473570003502247936,,,,
mayocliniclabs,6/2/2014 17:00,0,0,Check out our comprehensive # oncology offering at our dedicated microsite. # ASCO14 http://mayocl.in/1mAnSU8,,,# #,4.7357E+17,https://twitter.com/mayocliniclabs/status/473569988880904192,,,,
scientre,6/2/2014 17:00,2,0,Carey: so when considering HER2+ neo adjuvant trial results... # asco14 pic.twitter.com/h0YjIk3hl5,,,#,4.7357E+17,https://twitter.com/scientre/status/473569882458820608,,,,
DrAttai,6/2/2014 17:00,1,1,Very full day at # ASCO14 meeting up with so may online friends. Now off to see @ beitsch at the poster session!,,@,#,4.7357E+17,https://twitter.com/DrAttai/status/473569877392097280,,,,
myriadgenetics,6/2/2014 17:00,0,0,Attending # ASCO14? Visit us at Booth 2039 to find out about our # companiondiagnostic BRACAnalysis with # PARP inhibitors! # ASCOConnection,,,# # # #,4.7357E+17,https://twitter.com/myriadgenetics/status/473569766871810048,,,,
arifkamalmd,6/2/2014 17:00,0,0,Uh oh! Sitting in HSR orals. People are discussing costs at # ASCO14 ...are we reaching a tipping point? # quality,,,# #,4.7357E+17,https://twitter.com/arifkamalmd/status/473569756340318208,,,,
fischmd,6/2/2014 16:59,2,1,"Dr. Smith at # ASCO14: Asks pts: “Are you having trouble paying for your medicines?” Shared decisions based on efficacy, convenience, cost.",,,#,4.7357E+17,https://twitter.com/fischmd/status/473569704557432833,,,,
Melanoma_doctor,6/2/2014 16:59,0,0,Sznol: “I almost forgot I was presenting...” # melanoma # ASCO14 @ ASCO,,@,# #,4.7357E+17,https://twitter.com/Melanoma_doctor/status/473569631995985920,,,,
subatomicdoc,6/2/2014 16:59,0,1,"@ amyfries @ LGG1 Thanks for all your help, please give Claire my thanks too. So glad to have the chance to meet you in person at # ASCO14",,@ @,#,4.7357E+17,https://twitter.com/subatomicdoc/status/473569630137901056,,,,
WECAN_Seattle,6/2/2014 16:59,0,0,Georgian colleagues join Dr. Julie Gralow at # ASCO14 http://fb.me/2rMwMi6eY,,,#,4.7357E+17,https://twitter.com/WECAN_Seattle/status/473569580104052736,,,,
Larvol,6/2/2014 16:59,0,0,"# ASCO14 is winding down, but we're still going strong. Thanks to everyone who took the time to meet with us. See you next year!",,,#,4.7357E+17,https://twitter.com/Larvol/status/473569540610465792,,,,
Melanoma_MRV,6/2/2014 16:58,0,1,# ASCO14 http://tinyurl.com/l3nvhor Nivolumab + Ipilimumab 17% complete response rate - best ever in melanoma!pic.twitter.com/mcLo0S03Vb,,,#,4.73569E+17,https://twitter.com/Melanoma_MRV/status/473569468103544832,,,,
OVACInfo,6/2/2014 16:58,0,1,# ASCO14: Two drug combo boosts # ovarian # cancer survival @ cityofhope Breakthroughs Blog http://breakthroughs.cityofhope.org/asco-2014-drug-ovarian-cancer …,,@,# # #,4.73569E+17,https://twitter.com/OVACInfo/status/473569344744472576,,,,
ElizBlanchardMD,6/2/2014 16:58,1,0,Commentary: Alliance continuing to study olanzapine as a low cost alternative for both tx and prevention of chemo n/v # ASCO14 # supponc,,,# #,4.73569E+17,https://twitter.com/ElizBlanchardMD/status/473569275031334913,,,,
DCarrizosaMD,6/2/2014 16:58,2,0,# ASCO14 - in subset analysis: Ceritinib had response in 10/14 Pts with measurable brain mets,,,#,4.73569E+17,https://twitter.com/DCarrizosaMD/status/473569270669279233,,,,
scientre,6/2/2014 16:57,2,1,Carey: thought exercise in how to gauge possible survival benefit from pCR # asco14 HER2+ breast cancer pic.twitter.com/LuEQLt5oOY,,,#,4.73569E+17,https://twitter.com/scientre/status/473569223143604224,,,,
rsm2800,6/2/2014 16:57,1,2,"Tom Smith: Aprepitant vs metoclopramide=excellent acute & delayed results, no clinical difference btwn the two (but $300 vs $3.60) # asco14",,,#,4.73569E+17,https://twitter.com/rsm2800/status/473569088615493632,,,,
jodigralnick,6/2/2014 16:56,5,5,"ICYMI: $ CLVS CEO to # CNBC: we do not cause diabetes"" Full EXCLUSIVE interview w/ @ megtirrell at # ASCO14 here: http://cnb.cx/T862Q8""",,@,# #,4.73569E+17,https://twitter.com/jodigralnick/status/473568979983011840,,,,
tsayers77,6/2/2014 16:56,0,0,"Leaving # ASCO14, it is all about the power of the immune system @ ASCO glad to be part of it @ PorzioLaw",,@ @,#,4.73569E+17,https://twitter.com/tsayers77/status/473568968964591616,,,,
DCarrizosaMD,6/2/2014 16:56,0,0,# ASCO14 Ceritinib shows response in ALK + crizotinib naive/pretreated patients - watch for transaminitis and rare interstitial lung disease,,,#,4.73569E+17,https://twitter.com/DCarrizosaMD/status/473568845207470081,,,,
nycdoc29,6/2/2014 16:56,0,0,"“ @ IcahnMountSinai: landmark studies that our researchers presenting at # ASCO14: http://bit.ly/1iMfxuh  as former fulltime MSSM happy 2 see!""",,@,#,4.73569E+17,https://twitter.com/nycdoc29/status/473568786449059840,,,,
BairdAM,6/2/2014 16:56,0,0,"# lcsm RT  @ Novartis: Learn more about the data in # lungcancer that Dr. Dong-Wan Kim is presenting: http://bit.ly/1ua6fiZ # ASCO14""""",,@,# # #,4.73569E+17,https://twitter.com/BairdAM/status/473568784867794944,,,,
Emory_R,6/2/2014 16:56,1,0,Incyte's 'IDO' Cancer Immunotherapy Causes Investor Scrum at # ASCO14 - RR of 75% http://buff.ly/1nICwy7 $ INCY,,,#,4.73569E+17,https://twitter.com/Emory_R/status/473568765486333952,,,,
OVACInfo,6/2/2014 16:55,1,1,. @ theIOM: # Congress can help enroll # elderly # cancer patients in # clinicaltrials http://bit.ly/1op4Z80 # ASCO14,,@,# # # # #,4.73569E+17,https://twitter.com/OVACInfo/status/473568689380261888,,,,
scientre,6/2/2014 16:55,0,0,Carey: how so we interpret pCR data pooled between trials? # asco14 HER2+ breast cancer pic.twitter.com/vZCuzggPi2,,,#,4.73569E+17,https://twitter.com/scientre/status/473568685836468224,,,,
WhitneyEpi,6/2/2014 16:55,2,2,. @ UNC_Lineberger's Cancer Outcomes Research Program well represented at # ASCO14 See @ corp_UNC @ m_e_nielsen @dollhouse815 @ EthanBasch1 et al.,,@ @ @ @dollhouse815 @,#,4.73569E+17,https://twitter.com/WhitneyEpi/status/473568681013030912,,,,
BairdAM,6/2/2014 16:55,0,0,# lcsm MT  @ JackWestMD: Cappuzzo on MET as target in # LungCancer: estimates it could be useful target in 3-4%," including smokers # ASCO14""""",,@,# # #,4.73569E+17,https://twitter.com/BairdAM/status/473568657096720384,,,
WeickhardtOnc,6/2/2014 16:55,0,0,2/3rd ceritinib Rx ALK+ patients required dose reduction. Impressive activity but that does seem a little high to replace criz # ASCO14,,,#,4.73569E+17,https://twitter.com/WeickhardtOnc/status/473568647760588800,,,,
cmartindedios,6/2/2014 16:55,0,0,@ ASCO#ASCO14 http://www.asco.org/advocacy/asco-provides-input-us-house-committee-white-paper-accelerating-progress-care-0 …,,@,#ASCO14,4.73569E+17,https://twitter.com/cmartindedios/status/473568549085380608,,,,
ImegenTw,6/2/2014 16:55,1,1,@ efesalud: Dos nuevas moléculas logra frenar mejor # cáncer # ovario. http://www.efesalud.com/noticias/combinacion-moleculas-logra-frenar-mejor-cancer-ovario/ … @ ASCO pic.twitter.com/tqwfj5bq3o,,@ @,# #,4.73569E+17,https://twitter.com/ImegenTw/status/473568509159829504,,,,
ElizBlanchardMD,6/2/2014 16:54,0,0,Commentary:cost a factor using denosumab.Advises waiting for guidelines.I'm not sure-8 month to SRE difference meaningful # ASCO14 # supponc,,,# #,4.73568E+17,https://twitter.com/ElizBlanchardMD/status/473568465614548993,,,,
scientre,6/2/2014 16:54,0,0,Carey: 4 of the larger neoadjuvant HER2 trials # asco14 pic.twitter.com/UxwPKRYOxb,,,#,4.73568E+17,https://twitter.com/scientre/status/473568241596776448,,,,
HemOncToday,6/2/2014 16:53,2,0,"# ASCO14 @ WeillCornell treatment increased radiologic PFS, did not improve OS in castration-resistant # ProstateCancer http://goo.gl/5RHGPE",,@,# #,4.73568E+17,https://twitter.com/HemOncToday/status/473568212958072833,,,,
GoHealio,6/2/2014 16:53,0,0,"# ASCO14 @ WeillCornell treatment increased radiologic PFS, did not improve OS in castration-resistant # ProstateCancer http://goo.gl/5RHGPE",,@,# #,4.73568E+17,https://twitter.com/GoHealio/status/473568212232445953,,,,
fischmd,6/2/2014 16:53,4,1,"Denosumab is more effective than zometa at preventing skeletal events, but Dr. Smith asks: is it worth $1000 extra per month? # ASCO14",,,#,4.73568E+17,https://twitter.com/fischmd/status/473568185284046848,,,,
BairdAM,6/2/2014 16:53,5,3,"# lcsm RT  @ mnewtonPharmD: Ceritinib responses in Alk+ nonsmall cell lung cancer # ASCO14 pic.twitter.com/cWoblj0TXk""""",,@,# #,4.73568E+17,https://twitter.com/BairdAM/status/473568095710097408,,,,
DrAttai,6/2/2014 16:53,0,0,@ rsm2800 that's all?? btw - awesome combo of live and loaded tweets # asco14,,@,#,4.73568E+17,https://twitter.com/DrAttai/status/473568077830160384,,,,
rsm2800,6/2/2014 16:53,0,0,Tom Smith: Denosumab is a little better than ZA and pts prefer subq. But is it “worth” it for $1000s more? # asco14,,,#,4.73568E+17,https://twitter.com/rsm2800/status/473568054564380673,,,,
susanscutti,6/2/2014 16:53,0,0,Tweaking Standard # ProstateCancer Treatment To Extend Lives http://www.medicaldaily.com/docetaxel-added-standard-prostate-cancer-treatment-prolongs-survival-more-year-285944 … @ ASCO pic.twitter.com/8I81YzLMkt,,@,#,4.73568E+17,https://twitter.com/susanscutti/status/473568024260509696,,,,
CBPartners,6/2/2014 16:53,0,0,"New studies with anti-MET agents should be conducted ONLY in properly selected patients"" # NSCLC # ASCO14 pic.twitter.com/FGrmeG5zZ0""",,,# #,4.73568E+17,https://twitter.com/CBPartners/status/473568000315244546,,,,
NormandBlais,6/2/2014 16:52,0,0,"Ceritinib a new, FDA approved option in Alk rearranged NSCLC. 50% RR In brain mets! # LCCatASCO # ASCO14 pic.twitter.com/LpUjutUzu7",,,# #,4.73568E+17,https://twitter.com/NormandBlais/status/473567972200837120,,,,
Senology,6/2/2014 16:52,0,0,# ASCO2014 - Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer — NEJM http://nej.md/1iMHi5V # cancer # breast,,,# # #,4.73568E+17,https://twitter.com/Senology/status/473567925392007168,,,,
scientre,6/2/2014 16:52,0,0,Carey: NCCN guidelines neoadjuvant regimens in HER2+ breast cancer. Pertuzamab inclusion a bit controversial # asco14 pic.twitter.com/PosilJZhfO,,,#,4.73568E+17,https://twitter.com/scientre/status/473567910313885697,,,,
n8pennell,6/2/2014 16:52,1,1,"More than half of ALK+ pts had brain mets, very common! ORR very high in pts with brain mets with ceritinib. # ASCO14 # LCSM",,,# #,4.73568E+17,https://twitter.com/n8pennell/status/473567886397546496,,,,
MaverickNY,6/2/2014 16:52,1,2,"@ jq1234t @ avidresearch @ JonEPVantage hyperglycemia is common with IGF1R, mTOR and PI3K inhibitors. Feedback loops with IR # asco14",,@ @ @,#,4.73568E+17,https://twitter.com/MaverickNY/status/473567833268690944,,,,
drseisenberg,6/2/2014 16:52,1,0,RT @ rsm2800: # trial: clinical research in the age of social media (Lancet Oncology editorial) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)70206-2/fulltext … # ASCO14,,@,# #,4.73568E+17,https://twitter.com/drseisenberg/status/473567819003478016,,,,
BairdAM,6/2/2014 16:52,0,1," @ n8pennell: Dr . Kim presenting phase 3 ASCENT trial of ceritinib in ALK+ NSCLC pts. Led to approval of the drug last month! # ASCO14 # LCSM""""",,@,# #,4.73568E+17,https://twitter.com/BairdAM/status/473567786946408448,,,,
mnewtonPharmD,6/2/2014 16:52,0,0,Ceritinib also active in patients with brain mets. # LCSM # ASCO14,,,# #,4.73568E+17,https://twitter.com/mnewtonPharmD/status/473567783658483712,,,,
CliffordHudis,6/2/2014 16:51,0,0,@ dhjutsw1 @ ASCO thanks!!,,@ @,,4.73568E+17,https://twitter.com/CliffordHudis/status/473567695271493632,,,,
DrHedrick,6/2/2014 16:51,0,3,Dr. Nabil Adra of @ iumedschool presenting on the IU experience with Poor Risk Germ Cell Tumor # ASCO14 pic.twitter.com/5A1Cr7ZL51,,@,#,4.73568E+17,https://twitter.com/DrHedrick/status/473567653882527744,,,,
rsm2800,6/2/2014 16:51,0,0,"Tom Smith: Stopeck study Denosumab sl better than ZA in reducing SRE in multiple subgroups, but much more costly; no data on OS/QOL # asco14",,,#,4.73568E+17,https://twitter.com/rsm2800/status/473567581107142656,,,,
ElizBlanchardMD,6/2/2014 16:51,0,0,Commentary: Alliance studying Q12 vs Q4 week Zometa as initial therapy # ASCO14 # supponc,,,# #,4.73568E+17,https://twitter.com/ElizBlanchardMD/status/473567577768476672,,,,
n8pennell,6/2/2014 16:51,0,0,Dr . Kim presenting phase 3 ASCENT trial of ceritinib in ALK+ NSCLC pts. Led to approval of the drug last month! # ASCO14 # LCSM,,,# #,4.73568E+17,https://twitter.com/n8pennell/status/473567565504327680,,,,
jsperber,6/2/2014 16:50,0,0,RT @ stales: RT @ subatomicdoc: 60% of activity in # bcsm is retweets over period @ obogler studied # ASCO14 Power of resonation,,@ @ @,# #,4.73567E+17,https://twitter.com/jsperber/status/473567388261429248,,,,
OVACInfo,6/2/2014 16:50,0,1,"New Therapies Harness Power of the Immune System Against Cancer, from @ asco http://www.asco.org/press-center/new-therapies-harness-power-immune-system-against-cancer#.U4zjcO5PPss.twitter … # melanoma # cervicalcancer # asco14",,@,# # # #,4.73567E+17,https://twitter.com/OVACInfo/status/473567382951051264,,,,
scientre,6/2/2014 16:50,0,2,Carey: cons to neo adjuvant therapy in HER2+ breast cancer # asco14 pic.twitter.com/aph8bhh5i8,,,#,4.73567E+17,https://twitter.com/scientre/status/473567291767263232,,,,
IcahnMountSinai,6/2/2014 16:50,0,2,Check out these landmark studies that our researchers are presenting at # ASCO14: http://bit.ly/1iMfxuh # Cancer # HPV @ ASCO,,@,# # #,4.73567E+17,https://twitter.com/IcahnMountSinai/status/473567247966162944,,,,
rsm2800,6/2/2014 16:49,3,1,Tom Smith: OPTIMIZE2 No diff in SRE or ONJ w/ ZA q12 wk vs q4 (after yr 1) - all costs would be $7000/yr vs $2500/yr # asco14,,,#,4.73567E+17,https://twitter.com/rsm2800/status/473567015933079552,,,,
Melanoma_doctor,6/2/2014 16:49,2,0,Hodi: Nivo 1-2-3 yr OS = 63/48/41%. Dose going forward is 3mg/kg. med PFS on chosen dose is 9.7 months # melanoma # ASCO14 @ ASCO,,@,# #,4.73567E+17,https://twitter.com/Melanoma_doctor/status/473567014540554241,,,,
DrAttai,6/2/2014 16:48,0,0,@ obogler raising awareness for male breast cancer via http://thescarproject.org/ # bcsm # ASCO14,,@,# #,4.73567E+17,https://twitter.com/DrAttai/status/473566904045821953,,,,
mnewtonPharmD,6/2/2014 16:48,0,0,Ceritinib responses in Alk+ nonsmall cell lung cancer # ASCO14 pic.twitter.com/dDy5jMr3rR,,,#,4.73567E+17,https://twitter.com/mnewtonPharmD/status/473566865802162176,,,,
CancerAdvocacy,6/2/2014 16:48,0,1,Nina Wendling and @ sfuldnasso of NCCS painting a portion of the Hope Murals Project at # ASCO14 @LlyONcOnCanvas http://ow.ly/i/5LQBF,,@ @LlyONcOnCanvas,#,4.73567E+17,https://twitter.com/CancerAdvocacy/status/473566814212202497,,,,
timturnham,6/2/2014 16:48,0,0,Data on ipi going back over 5 years shows about 22% of pts w/ long term durable response. @ curemelanoma # ASCO14,,@,#,4.73567E+17,https://twitter.com/timturnham/status/473566755936534528,,,,
scientre,6/2/2014 16:48,0,0,Casey: Pros of neo adjuvant therapy in HER2+ breast cancer # asco14 pic.twitter.com/nn3yp4Mpnt,,,#,4.73567E+17,https://twitter.com/scientre/status/473566746792964096,,,,
NBTStweets,6/2/2014 16:47,1,2,"Thank you, Dr @ ben_ellingson, for the mention in your presentation at # ASCO14! pic.twitter.com/dZxc3ASgYj",,@,#,4.73567E+17,https://twitter.com/NBTStweets/status/473566646280286209,,,,
ElizBlanchardMD,6/2/2014 16:47,0,0,Commentary: cost if care skyrocketing--cost of premiums for pts are as well # ASCO14,,,#,4.73567E+17,https://twitter.com/ElizBlanchardMD/status/473566634356244480,,,,
fischmd,6/2/2014 16:47,0,1,"Dr. Tom Smith at # ASCO14: PET and CT scans, supportive care and maintainence chemo are driving up # costsofcare for # cancer",,,# # #,4.73567E+17,https://twitter.com/fischmd/status/473566607013605377,,,,
OVACInfo,6/2/2014 16:47,1,0,"Top # tweets from # ASCO14: https://storify.com/brianreid/asco14-sunday-s-top-tweets …. # Cancer # research is trending across the country, will # Congress listen?",,,# # # # #,4.73567E+17,https://twitter.com/OVACInfo/status/473566549555437570,,,,
DrAttai,6/2/2014 16:47,0,0,"@ obogler great graphics on the pulse of # bcsm"" # ASCO14""",,@,# #,4.73567E+17,https://twitter.com/DrAttai/status/473566543159111682,,,,
TeamTJSharpe,6/2/2014 16:46,0,1,"Adios Chicago, # asco14 time to digest, make sense of all the # melanoma info in my head! http://fb.me/19TAhqbqD",,,# #,4.73566E+17,https://twitter.com/TeamTJSharpe/status/473566462687199233,,,,
rsm2800,6/2/2014 16:46,2,0,Tom Smith: Biologics and targeted molecules have doubled the cost of cancer drug Rx in 5 yrs # asco14,,,#,4.73566E+17,https://twitter.com/rsm2800/status/473566439518265344,,,,
ShannonWestin,6/2/2014 16:46,0,0,@ leitaomd test for BRAF and CKIT in vulvovaginal melanomas. Consider clinical trials in this pop'n. # ASCO14 # gyncsm,,@,# #,4.73566E+17,https://twitter.com/ShannonWestin/status/473566292817883137,,,,
rsm2800,6/2/2014 16:45,1,0,"Tom Smith: IOM 2013 report Medicare system in crisis, no incentive to reduce costs # asco14",,,#,4.73566E+17,https://twitter.com/rsm2800/status/473566130842648576,,,,
corp_UNC,6/2/2014 16:45,0,0,"Racial/ethnic var'ns in lung ca incidence & mortality, adjusted for smoking: Women's Health Initiative # asco14 # lcsm http://ow.ly/xqDin",,,# #,4.73566E+17,https://twitter.com/corp_UNC/status/473566058121797632,,,,
appistry,6/2/2014 16:45,0,0,# ASCO14 attendees: participate in our # genomics testing survey for a chance to win the @ MisFit Shine! http://ow.ly/xjjQA # GEM,,@,# # #,4.73566E+17,https://twitter.com/appistry/status/473566056871915521,,,,
Melanoma_MRV,6/2/2014 16:45,0,1,# ASCO14 http://tinyurl.com/lqx3cyj Nivolumab (anti PD1) 3y overall survival over 40% in patients with advanced melanomapic.twitter.com/mwXPiFHrbo,,,#,4.73566E+17,https://twitter.com/Melanoma_MRV/status/473566048625504256,,,,
CancerDotNet,6/2/2014 16:45,6,5,"Search our full collection of # ASCO14 research summaries for patients, by disease/topic: http://bit.ly/1hrzWtP",,,#,4.73566E+17,https://twitter.com/CancerDotNet/status/473566045987696640,,,,
JackWestMD,6/2/2014 16:45,4,3,"Cappuzzo giving commentary on MET as target in # LungCancer: estimates it could be useful target in 3-4%, including smokers # ASCO14",,,# #,4.73566E+17,https://twitter.com/JackWestMD/status/473566044309975040,,,,
Novartis,6/2/2014 16:45,0,0,Learn more about the data in # lungcancer that Dr. Dong-Wan Kim is presenting: http://bit.ly/1ua6fiZ # ASCO14,,,# #,4.73566E+17,https://twitter.com/Novartis/status/473566016652709888,,,,
CoreLIMS,6/2/2014 16:45,0,1,". @ illumina are you trying to start a fight? MT: Great session today. Oncologists are social rock stars, scientists take note! # ASCO14",,@,#,4.73566E+17,https://twitter.com/CoreLIMS/status/473565987661705217,,,,
DrMarkham,6/2/2014 16:44,9,5,A survival curve showing progress in multiple myeloma in recent years. # ASCO14 # mmsmpic.twitter.com/MxSEtoXgM2,,,# #,4.73566E+17,https://twitter.com/DrMarkham/status/473565944825270273,,,,
MaverickNY,6/2/2014 16:44,1,1,Just saw @ RichardWJoseph at his awesome poster - findings worthy of an oral session - look forward to paper # asco14 pic.twitter.com/UTe0yBJRPT,,@,#,4.73566E+17,https://twitter.com/MaverickNY/status/473565899463868416,,,,
DrAttai,6/2/2014 16:44,0,2,"+1000!! RT @ DrMarkham Loved the social media talk by @ rsm2800 @ mtmdphd & @ obogler. Great work, speakers! # ASCO14",,@ @ @ @,#,4.73566E+17,https://twitter.com/DrAttai/status/473565897509314562,,,,
rsm2800,6/2/2014 16:44,0,0,Tom Smith on making dollars and $ ense from antiemetics & bone strengthening agents # asco14,,,#,4.73566E+17,https://twitter.com/rsm2800/status/473565724842422273,,,,
ElizBlanchardMD,6/2/2014 16:43,0,0,Abs 9503: other issue--cost. Metoclopramide much less. Tho many are using single dose fosprep # ASCO14 # supponc,,,# #,4.73566E+17,https://twitter.com/ElizBlanchardMD/status/473565701480124420,,,,
cmartindedios,6/2/2014 16:43,4,3,@ ASCO # asco14 @ obogler elements for effective # socialmediapic.twitter.com/ZYmq2A7zaa,,@ @,# #,4.73566E+17,https://twitter.com/cmartindedios/status/473565627408728064,,,,
OmidHamidMD,6/2/2014 16:43,3,3,"# melanoma @ ASCO # ASCO14 Nivolumab 1yr 63% 2yr 48%, yr 41% survival! historical 1 yr survi 25% pre # CTLA4 and # PD1. we've come long way fast!",,@,# # # #,4.73565E+17,https://twitter.com/OmidHamidMD/status/473565484705931264,,,,
CancerAdvocacy,6/2/2014 16:42,0,0,Lilly Oncology On Canvas: Expressions of a Cancer Journey at # ASCO14 @LlyOncOnCanvas http://ow.ly/i/5LQhK,,@LlyOncOnCanvas,#,4.73565E+17,https://twitter.com/CancerAdvocacy/status/473565389725900800,,,,
ElizBlanchardMD,6/2/2014 16:42,0,0,Abs 9503:Problems: can you separate acute vs delayed emesis? Was effect due to initial aprepitant? # ASCO14 # supponc,,,# #,4.73565E+17,https://twitter.com/ElizBlanchardMD/status/473565271777890304,,,,
OVACInfo,6/2/2014 16:42,0,0,. @ CliffordHudis: Big drop in federally funded study abstracts submitted to @ ASCO ann mtgs - in 2008: 575 abstracts vs 169 this yr # ASCO14,,@ @,#,4.73565E+17,https://twitter.com/OVACInfo/status/473565247882936322,,,,
n8pennell,6/2/2014 16:41,2,1,So did MET Lung trial fail because they used the wrong biomarker (IHC) to define MET+? Should have used FISH for copy number. # ASCO14 # LCSM,,,# #,4.73565E+17,https://twitter.com/n8pennell/status/473565201061908480,,,,
cmartindedios,6/2/2014 16:41,0,0,@ ASCO # asco14 @ obogler elements for effective # socialmediapic.twitter.com/kZTaPV9Ixi,,@ @,# #,4.73565E+17,https://twitter.com/cmartindedios/status/473565175141134336,,,,
tracyrode,6/2/2014 16:41,0,0,"Amazing # ASCO14 - lots on my to do"" list!""",,,#,4.73565E+17,https://twitter.com/tracyrode/status/473565131914231808,,,,
DavidGimenez12,6/2/2014 16:41,0,0,@ OncLive:preliminary safety and efficacy of TH-302 looks promising for patients R/R multiple myeloma http://ow.ly/xvoR7 # ASCO14.$thld,,@,#,4.73565E+17,https://twitter.com/DavidGimenez12/status/473565115556823040,,,,
ElizBlanchardMD,6/2/2014 16:41,0,0,Abs 9503:no diff in complete response (usually no vomiting or use of rescue antiemetics).No difference in AEs (with stats) # ASCO14 # supponc,,,# #,4.73565E+17,https://twitter.com/ElizBlanchardMD/status/473565071466303488,,,,
biologypartners,6/2/2014 16:41,1,0,". @ sloan_kettering plans to sequence 10,000 patient tumors a year and group/Rx the patients based on evolving mutation data # genomics # ASCO14",,@,# #,4.73565E+17,https://twitter.com/biologypartners/status/473565059600625664,,,,
scientre,6/2/2014 16:40,2,0,"Winer: NCCN adjuvant breast cancer study VazLuis, JCO, 2014 # asco14 pic3 pic.twitter.com/62xyEK7KAL",,,#,4.73565E+17,https://twitter.com/scientre/status/473564953287618562,,,,
scientre,6/2/2014 16:40,0,0,"Winer: NCCN adjuvant breast cancer study VazLuis, JCO, 2014 # asco14 pic2 pic.twitter.com/xe0qfgkR1u",,,#,4.73565E+17,https://twitter.com/scientre/status/473564828578365440,,,,
DrAttai,6/2/2014 16:40,0,0,"+1! RT @ LGG1 Thanks @ obogler for the informative, engaging, and delightful presentation at # ASCO14",,@ @,#,4.73565E+17,https://twitter.com/DrAttai/status/473564818570752000,,,,
Roche,6/2/2014 16:40,5,4,What will the future bring for cancer # immunotherapy? http://ow.ly/xp7F7 # ASCO14,,,# #,4.73565E+17,https://twitter.com/Roche/status/473564806214344704,,,,
jodigralnick,6/2/2014 16:40,0,0,ICYMI: # ASCO14: # FDA cancer czar talks to @ CNBC @ megtirrell abt breakthru designations & if chemo close to obsolete: http://cnb.cx/1m61RLs,,@ @,# #,4.73565E+17,https://twitter.com/jodigralnick/status/473564768985292800,,,,
scientre,6/2/2014 16:40,2,0,"Winer: also just published NCCN adjuvant breast cancer study VazLuis, JCO, 2014 # asco14 pic1 pic.twitter.com/H8CmhvF4q2",,,#,4.73565E+17,https://twitter.com/scientre/status/473564758797713408,,,,
CancerDotNet,6/2/2014 16:40,5,3,Ipi + investig drug proves to help with adv # melanoma. More from Dr. Mario Sznol @ YaleCancer # ASCO14 http://bit.ly/RXB5Ni,,@,# #,4.73565E+17,https://twitter.com/CancerDotNet/status/473564746189656065,,,,
DCarrizosaMD,6/2/2014 16:39,0,0,# ASCO14 - studies show intermediate/high MET amplification only in about 3% of patients - another rare target but great potential 4 future,,,#,4.73565E+17,https://twitter.com/DCarrizosaMD/status/473564703642648576,,,,
ElizBlanchardMD,6/2/2014 16:39,0,0,Abs 9503: closed early--recruitment issues. 137/147 pts in each arm # ASCO14 # supponc,,,# #,4.73564E+17,https://twitter.com/ElizBlanchardMD/status/473564495756136448,,,,
drsam,6/2/2014 16:39,0,2,Most creative # pediatric oncology poster at # asco14 - Grinch Syndrome - heart size after doxorubicin for ALL pic.twitter.com/RQNf8qPpYe,,,# #,4.73564E+17,https://twitter.com/drsam/status/473564477569261568,,,,
GenentechJobs,6/2/2014 16:39,0,0,"# ASCO14 Talent Hunt: Sr. Medical Director, Hemophilia: http://click2apply.net/429905f",,,#,4.73564E+17,https://twitter.com/GenentechJobs/status/473564477019783169,,,,
jwbelmon,6/2/2014 16:39,0,0,Cardiovascular complications in survivors of childhood cancer http://www.genomeweb.com/asco-talk-highlights-genetic-contributors-later-life-complications-pediatric-can … # ASCO14,,,#,4.73564E+17,https://twitter.com/jwbelmon/status/473564468824113153,,,,
scientre,6/2/2014 16:39,2,0,"Winer: Kaiser Permanante study adjuvant breast cancer study 2nd pic Fehrenbacher, JCO, 2014 # asco14 pic.twitter.com/GjcqSDxlbS",,,#,4.73564E+17,https://twitter.com/scientre/status/473564468677328896,,,,
DrAttai,6/2/2014 16:38,0,0,he did gr8 job! RT @ MaverickNY Congrats to @ rsm2800 to boldly go where no tweeter has gone before and live tweet from the podium # asco14,,@ @,#,4.73564E+17,https://twitter.com/DrAttai/status/473564395466133506,,,,
Tony_Calles,6/2/2014 16:38,2,1,Genetic dependence on MET but not the mere presence of MET determines responses to anti-MET therapies # ASCO14 # LCSMpic.twitter.com/74exVkRwCw,,,# #,4.73564E+17,https://twitter.com/Tony_Calles/status/473564257368702976,,,,
jodigralnick,6/2/2014 16:38,0,0,# ASCO14: @ megtirrell interviewing $ CLVS CEO Patrick Mahaffy on @ cnbcclosingbellpic.twitter.com/cqe0a2j3mP,,@ @,#,4.73564E+17,https://twitter.com/jodigralnick/status/473564229199757313,,,,
CovanceCareers,6/2/2014 16:38,0,0,"# Oncology career opportunities available! Lead Scientist, Sr Res Asst, Clinical Proj Mgr, CRA & more http://bit.ly/U7AOte # ASCO2014",,,# #,4.73564E+17,https://twitter.com/CovanceCareers/status/473564216742641664,,,,
DrHedrick,6/2/2014 16:37,0,1,Dr. Rizwan Khawaja of @ iumedschool presents Fludarabine/Cyclophosphamide for non-myeloablative transplant. # ASCO14 pic.twitter.com/edAUyyqxIx,,@,#,4.73564E+17,https://twitter.com/DrHedrick/status/473564156650455040,,,,
Melanoma_doctor,6/2/2014 16:37,1,1,Pidilizumab-- something must be going on that is “good” to have 65% 1 yr OS but more work to be done # melanoma # ASCO14 @ ASCO,,@,# #,4.73564E+17,https://twitter.com/Melanoma_doctor/status/473564125323620352,,,,
scientre,6/2/2014 16:37,2,1,Winer: Kaiser Permanente study on adjuvant therapy for BC just published JCO (had to wait till 3 PM) # asco14 pic.twitter.com/JS0uY4gGLq,,,#,4.73564E+17,https://twitter.com/scientre/status/473564124094689280,,,,
Cara_PR_Comms,6/2/2014 16:37,0,0,The shifting landscape of pancreatic cancer research funding # ASCO14 # cancerresearch http://bit.ly/1p1L7cg,,,# #,4.73564E+17,https://twitter.com/Cara_PR_Comms/status/473564101302435840,,,,
n8pennell,6/2/2014 16:37,1,0,"Capuzzo: very high MET copy number maybe less than 1% of patients, intermediate MET in about 3%. So quite rare. # ASCO14 # LCSM",,,# #,4.73564E+17,https://twitter.com/n8pennell/status/473564100568813569,,,,
SamuelLz,6/2/2014 16:37,0,0,@ CM_Hake Det känns ju helt klart som dagens hetaste ämne på mötet # dmasco # asco14,,@,# #,4.73564E+17,https://twitter.com/SamuelLz/status/473564021032235008,,,,
lucadf,6/2/2014 16:37,1,1,# ASCO14@Have a look to tweetsbfeed from the conference @ seen.co @ Oncoinfo_it @ la_stampapic.twitter.com/o2jken5qKx,,@Have @ @ @,#,4.73564E+17,https://twitter.com/lucadf/status/473563974974595072,,,,
martha,6/2/2014 16:36,0,1,@ twittmanda @ OmidHamidMD @ Melanoma_doctor @ ASCO Yes!!! Thank you for all of us following at home!,,@ @ @ @,,4.73564E+17,https://twitter.com/martha/status/473563931936849920,,,,
rsm2800,6/2/2014 16:36,0,4,"This is my 10,000th tweet since joining Twitter. Now back to your regularly scheduled programming # asco14",,,#,4.73564E+17,https://twitter.com/rsm2800/status/473563831793647616,,,,
MatthewHSimmons,6/2/2014 16:36,0,0,Interesting discussion on bus back to ORD re how to make molecular profiling & linked trials more accessible; cost & location... # ASCO14,,,#,4.73564E+17,https://twitter.com/MatthewHSimmons/status/473563817113178113,,,,
GenentechJobs,6/2/2014 16:36,1,2,Our PD group is recruiting during # ASCO14. Product Development group represents # MissionFocusedMedicine. More: http://bit.ly/1oeGOZV,,,# #,4.73564E+17,https://twitter.com/GenentechJobs/status/473563732480499713,,,,
OmidHamidMD,6/2/2014 16:35,0,0,@ MichaelAtkins @ Curetech - great information @ ASCO # ASCO14. Time to respect the benefit of # stabledisease in # Immunotherapy,,@ @ @,# # #,4.73564E+17,https://twitter.com/OmidHamidMD/status/473563573894283266,,,,
djsampson,6/2/2014 16:35,0,0,Well said RT @ drlen: Big progress in melanoma rx at # ASCO14. Time and history teaches us to tread carefully http://tinyurl.com/ok2wdbc,,@,#,4.73564E+17,https://twitter.com/djsampson/status/473563532546826241,,,,
carisls,6/2/2014 16:35,1,1,"...bringing molecular profiling to the [pediatric] patient now"" -- @ leonardSender # ASCO14 http://goo.gl/GRDd5I""",,@,#,4.73563E+17,https://twitter.com/carisls/status/473563499638296576,,,,
mnewtonPharmD,6/2/2014 16:34,0,0,"MET amplification more common is pts with smoking history, can be squamous or non-squamous histology # ASCO14",,,#,4.73563E+17,https://twitter.com/mnewtonPharmD/status/473563387914633217,,,,
CBPartners,6/2/2014 16:34,0,0,"Ramucirumab and apatinib, both targeting VEGFR2, provide similar survival benefit to late stage GC patients. # ASCO14 pic.twitter.com/Jcd2O6TvIr",,,#,4.73563E+17,https://twitter.com/CBPartners/status/473563254351200256,,,,
UCCancerCenter,6/2/2014 16:34,2,0,Immune therapy Pidilizumab in metastatic melanoma by Tom Gajewski and others shows inferior response rate but comparable survival # ASCO14,,,#,4.73563E+17,https://twitter.com/UCCancerCenter/status/473563235745275904,,,,
RielyMD,6/2/2014 16:33,7,1,"While small numbers, given high RR & sensible hypothesis, i would treat a pt w/ met amplified ( >5) lung cancer with crizotinib. # ASCO14",,,#,4.73563E+17,https://twitter.com/RielyMD/status/473563179436748800,,,,
DrMarkham,6/2/2014 16:33,0,1,Interesting. MT @ kellykcotton: Scientific validation couldn't be assessed for 63% of ca-related mobile apps: http://bit.ly/1pMYJIc # ASCO14,,@,#,4.73563E+17,https://twitter.com/DrMarkham/status/473563115335200768,,,,
ElizBlanchardMD,6/2/2014 16:33,0,0,Abs 9503: aprepitant vs metoclopramide for delayed emesis (an undertreated problem) # ASCO14 # supponc,,,# #,4.73563E+17,https://twitter.com/ElizBlanchardMD/status/473563103754747904,,,,
CNBCClosingBell,6/2/2014 16:32,0,0,"On now: @ clovisoncology CEO Patrick Mahaffy with @ megtirrell & @ Kelly_Evans, live from # ASCO14. Tune in! # exclusive",,@ @ @,# #,4.73563E+17,https://twitter.com/CNBCClosingBell/status/473562948301242368,,,,
MaverickNY,6/2/2014 16:32,0,0,@ AlpineBV_Miller @ ASCO that would be too easy - need to replicate what Dev Ther and tumour biology have to do ;),,@ @,,4.73563E+17,https://twitter.com/MaverickNY/status/473562848778784768,,,,
mnewtonPharmD,6/2/2014 16:32,0,0,Interesting how long this data took to develop considering crizotinib originally developed as MET inhibitor # ASCO14,,,#,4.73563E+17,https://twitter.com/mnewtonPharmD/status/473562846375464960,,,,
aicrtweets,6/2/2014 16:32,0,0,RT @ DrKateWolin: LEAN study finds weight maintenance w @ aicrtweets print materials in breast cancer survivors # ASCO14 http://ow.ly/xxKic,,@ @,#,4.73563E+17,https://twitter.com/aicrtweets/status/473562832056119298,,,,
twittmanda,6/2/2014 16:32,1,1,@ OmidHamidMD @ Melanoma_doctor @ ASCO Thank you for your perspectives on the sessions! It is a win-win!,,@ @ @,,4.73563E+17,https://twitter.com/twittmanda/status/473562800858873856,,,,
Melanoma_doctor,6/2/2014 16:32,0,0,Pidilizumab (CureTech) has one yr OS of 65% but only 6% ORR despite heavy pre-treatment. ?reason # melanoma # ASCO14 @ ASCO,,@,# #,4.73563E+17,https://twitter.com/Melanoma_doctor/status/473562780793311232,,,,
eMPR,6/2/2014 16:32,0,0,Chemotherapy plus goserelin can preserve ovarian function in women with # breastcancer: http://ow.ly/xxKSJ # ASCO14 # oncology,,,# # #,4.73563E+17,https://twitter.com/eMPR/status/473562764913676289,,,,
kellykcotton,6/2/2014 16:32,3,3,Scientific validation couldn't be assessed for 63% of 539 cancer-related mobile apps: http://bit.ly/1pMYJIc # ASCO14 # mhealth,,,# #,4.73563E+17,https://twitter.com/kellykcotton/status/473562711604076545,,,,
MaverickNY,6/2/2014 16:31,5,1,Pidlituzumab missed primary endpoint (6% ORR) but met 12 mon OS at 64.5% (less than pembrolizumab at 82%) # asco14,,,#,4.73563E+17,https://twitter.com/MaverickNY/status/473562620298264576,,,,
ElizBlanchardMD,6/2/2014 16:31,0,1,Abs 9502: No difference in AEs addressing concern of metabolism of cyclophosphamide w NK1 antagonists # ASCO14 # supponc,,,# #,4.73563E+17,https://twitter.com/ElizBlanchardMD/status/473562610521350144,,,,
BreastDocUK,6/2/2014 16:31,0,0,So can I ask the # ASCO14 tweeps what one thing they are going to change in their practice post mtng? @ drattai @ subatomicdoc @ rsm2800,,@ @ @,#,4.73562E+17,https://twitter.com/BreastDocUK/status/473562491331833856,,,,
ASTechFDN,6/2/2014 16:31,0,0,"RT @ Roche: Check out our latest Drawn to # Science"" movie about # ClinicalTrials! http://ow.ly/xp70m # ASCO14""",,@,# # #,4.73562E+17,https://twitter.com/ASTechFDN/status/473562473371402240,,,,
PublicHealthRTs,6/2/2014 16:31,0,0,"RT @ JNCI_Now: Over 4,000 women die of cervical cancer each year in the U.S. # ASCO14. # publichealth # women # cancer # chronic # illness",,@,# # # # # #,4.73562E+17,https://twitter.com/PublicHealthRTs/status/473562458482032641,,,,
ASCO,6/2/2014 16:31,4,0,Celebrate 50 yrs of progress & help make another 50 possible by donating to @ iconquercancer http://bit.ly/1jkhgWt # ASCO14,,@,#,4.73562E+17,https://twitter.com/ASCO/status/473562458024869888,,,,
michelerhee,6/2/2014 16:30,1,2,@ obogler @ rsm2800 I'm definitely a re-tweeter since I can't be at # ASCO14 myself! :),,@ @,#,4.73562E+17,https://twitter.com/michelerhee/status/473562434549350401,,,,
RaisBahrami,6/2/2014 16:30,0,0,MET signaling in bladder UCC esp adv stage. # NCIUOB # ASCO14 pic.twitter.com/DEMm6Oz9KD,,,# #,4.73562E+17,https://twitter.com/RaisBahrami/status/473562424801779712,,,,
Novartis,6/2/2014 16:30,1,1,"About 10,000 NSCLC patients in the US have ALK+ tumors. Learn more http://bit.ly/1jKwFFX # ASCO14",,,#,4.73562E+17,https://twitter.com/Novartis/status/473562403779928066,,,,
ASCO,6/2/2014 16:30,1,2,Wrap-up of the Community Oncology Town Hall on physician payment reform http://bit.ly/1gZdBmM # ASCO14,,,#,4.73562E+17,https://twitter.com/ASCO/status/473562388315123713,,,,
evaluatepharma,6/2/2014 16:30,0,0,# ASCO14 – Altto gives @ GSK and @ Novartis nothing to sing about http://ow.ly/xwHLk $ GSK $ NVS,,@ @,#,4.73562E+17,https://twitter.com/evaluatepharma/status/473562366102499328,,,,
DCarrizosaMD,6/2/2014 16:30,0,0,# ASCO14 - ? MET amplification may be new biomarker to look at but still low % (~7%) and seen in smokers/prev smokers - stay tuned! # LCI,,,# #,4.73562E+17,https://twitter.com/DCarrizosaMD/status/473562302286168064,,,,
ElizBlanchardMD,6/2/2014 16:30,0,0,Abs 9502: NEPA arm better in no vomiting and no significant nausea. AEs similar. No stats given. # ASCO14 # supponc,,,# #,4.73562E+17,https://twitter.com/ElizBlanchardMD/status/473562290839912448,,,,
Advaxis,6/2/2014 16:30,0,0,The # ASCO2014 poster included results from the Ph 2 clinical study of ADXS-HPV for # cervicalcancer. Learn more: http://bit.ly/1tZWhAr $ ADXS,,,# #,4.73562E+17,https://twitter.com/Advaxis/status/473562197650460672,,,,
drsam,6/2/2014 16:29,1,2,"Note to self: between now and # ASCO15, go out and make T-cell # cufflinks to either sell myself (DTC) or to # merck as a promo (B2B). # ASCO14",,,# # # #,4.73562E+17,https://twitter.com/drsam/status/473562116880732161,,,,
DrPaulyDeSantis,6/2/2014 16:29,1,0,$ INFI hedgehog in MF # ASCO14 pic.twitter.com/XXaDJlbilM,,,#,4.73562E+17,https://twitter.com/DrPaulyDeSantis/status/473562070987079681,,,,
Tony_Calles,6/2/2014 16:29,1,1,MET-amplified NSCLC: low incidence but another subgroup of patients that benefits from crizotinib # asco14 # lcsmpic.twitter.com/0hZAC6SSHo,,,# #,4.73562E+17,https://twitter.com/Tony_Calles/status/473562059561795586,,,,
n8pennell,6/2/2014 16:29,2,1,"Dr. Camidge on crizotinib in MET amplified NSCLC: 67% ORR in very high MET amplified. More common in smokers, but prob rare. # ASCO14 # LCSM",,,# #,4.73562E+17,https://twitter.com/n8pennell/status/473561989487529985,,,,
mnewtonPharmD,6/2/2014 16:28,0,0,Compelling but Is this enough to consider adding screening for MET amplification via FISH in NSCLC? # ASCO14 # LCSM,,,# #,4.73562E+17,https://twitter.com/mnewtonPharmD/status/473561881568092160,,,,
timturnham,6/2/2014 16:28,0,1,CureTexh PD1 study looked at pts who had not done well on previous drugs.1 year out 66% were still alive. Updates: @ curemelanoma. # ASCO14,,@,#,4.73562E+17,https://twitter.com/timturnham/status/473561857748635648,,,,
ElizBlanchardMD,6/2/2014 16:28,1,1,"Abs 9502: NEPA study. Problem is, now NK 1 antagonist is std in Adria based chemo (unlike this control arm) # ASCO14 # supponc",,,# #,4.73562E+17,https://twitter.com/ElizBlanchardMD/status/473561848932208641,,,,
AlpineBV_Miller,6/2/2014 16:28,0,0,@ MaverickNY Should move them to S401 and S402 as well. @ ASCO,,@ @,,4.73562E+17,https://twitter.com/AlpineBV_Miller/status/473561794162987008,,,,
JackWestMD,6/2/2014 16:28,3,5,Dr. Camidge on crizotinib for MET-amplified (by gene copy number) advanced NSCLC # ASCO14 # lcsmpic.twitter.com/isgWUQV4M7,,,# #,4.73562E+17,https://twitter.com/JackWestMD/status/473561731612962816,,,,
theMMRF,6/2/2014 16:27,3,1,The 2nd @ theMMRF blog from our onsite coverage of # ASCO14 with the latest # myeloma news is now posted! http://www.themmrf.org/asco # MMRFASCO,,@,# # #,4.73562E+17,https://twitter.com/theMMRF/status/473561553049223168,,,,
JohnCendpts,6/2/2014 16:27,10,5,"Trending today, all day - GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact - $ GSK # ASCO14 http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …",,,#,4.73562E+17,https://twitter.com/JohnCendpts/status/473561521495093248,,,,
DCarrizosaMD,6/2/2014 16:27,0,0,# ASCO14 - crizotinib showing responses in MET intermediate/high Pts,,,#,4.73562E+17,https://twitter.com/DCarrizosaMD/status/473561514545532928,,,,
OmidHamidMD,6/2/2014 16:27,2,2,@ OncologyTimes: . @ CliffordHudis: Drop in federally funded abstracts @ ASCO mtg 575 2008 vs 169 in2014 # ASCO14” Thank goodness pharma collabos,,@ @ @,#,4.73562E+17,https://twitter.com/OmidHamidMD/status/473561504508555264,,,,
ElizBlanchardMD,6/2/2014 16:27,0,0,Abs 9502: NEPA+dex vs palo +dex in (correction!) Adria based chemo # ASCO14 # supponc,,,# #,4.73561E+17,https://twitter.com/ElizBlanchardMD/status/473561445394042881,,,,
scarlett_0hara,6/2/2014 16:26,2,0,H.R.2090 - Patient Choice Act of 2013 To allow patients early access 2 new drugs http://www.opencongress.org/bill/hr2090-113/show … # ASCO14 # moms # CancerSurvivorsDay,,,# # #,4.73561E+17,https://twitter.com/scarlett_0hara/status/473561371498774530,,,,
DrKateWolin,6/2/2014 16:26,0,1,LEAN study finds weight maintenance with @ aicrtweets print materials in breast cancer survivors # ASCO14 http://ow.ly/xxKic,,@,#,4.73561E+17,https://twitter.com/DrKateWolin/status/473561290548723712,,,,
mnewtonPharmD,6/2/2014 16:26,1,1,Signal that crizotinib potentially quite effective in MET amplified (via FISH) lung ca. # ASCO14 # LCSMpic.twitter.com/XnDo9SK87m,,,# #,4.73561E+17,https://twitter.com/mnewtonPharmD/status/473561260144209920,,,,
NBTStweets,6/2/2014 16:26,1,1,Dr. Rousseau of @ Genentech talks about the hurdles and possible solutions in # pediatriconcology http://www.gene.com/stories/pediatric-oncology … # ASCO2014,,@,# #,4.73561E+17,https://twitter.com/NBTStweets/status/473561189746610176,,,,
scientre,6/2/2014 16:25,0,0,Modi references recent ASCO guidelines for HER2+ breast cancer treatment in JCO 2014 # asco14 http://m.jco.ascopubs.org/content/early/2014/05/15/JCO.2013.54.0948 …,,,#,4.73561E+17,https://twitter.com/scientre/status/473561118905233409,,,,
RielyMD,6/2/2014 16:25,0,1,"Camidge crizotinib treatment of met amplified, just 14 patients and 6 with high level amplification (4/6 partial response) # ASCO14",,,#,4.73561E+17,https://twitter.com/RielyMD/status/473561071111131136,,,,
DrKateWolin,6/2/2014 16:25,1,0,LEAN study finds weight maintenance with @ aicrtweets print materials in breast cancer survivors http://bit.ly/1tBHbPJ # ASCO14,,@,#,4.73561E+17,https://twitter.com/DrKateWolin/status/473561014500618241,,,,
OncLive,6/2/2014 16:25,1,1,The preliminary safety and efficacy of TH-302 looks promising for patients with R/R multiple myeloma http://ow.ly/xvoR7 # ASCO14,,,#,4.73561E+17,https://twitter.com/OncLive/status/473560982116384768,,,,
ElizBlanchardMD,6/2/2014 16:24,0,0,Abs 9502: Author reminds us that palo acts differently than others in the class # ASCO14 # supponc,,,# #,4.73561E+17,https://twitter.com/ElizBlanchardMD/status/473560902760153088,,,,
bfloannie,6/2/2014 16:24,1,0,Dr. Khushalani on new immunotherapy options for treating advanced melanoma: http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/610 … # ASCO14 @ medpagetoday,,@,#,4.73561E+17,https://twitter.com/bfloannie/status/473560842127286272,,,,
drecroach,6/2/2014 16:24,2,0,@ kellykcotton @ rsm2800 not all meetings allow pics. So nice of # ASCO14,,@ @,#,4.73561E+17,https://twitter.com/drecroach/status/473560747034034176,,,,
ElizBlanchardMD,6/2/2014 16:23,0,0,"Abs 9502: NEPA-a new, combo anti emetic (an NK1 antagonist like aprepitant plus palonosetron) in cisplatin tx pts # ASCO14 # supponc",,,# #,4.73561E+17,https://twitter.com/ElizBlanchardMD/status/473560567467491328,,,,
nxtstop1,6/2/2014 16:23,0,0,AGING & CANCER @ UChicagoCancer: Video:Our @ WilliamDale_MD talks tools 4 caring 4 older cancer patients # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/575 … # aging,,@ @,# #,4.73561E+17,https://twitter.com/nxtstop1/status/473560563641884672,,,,
RielyMD,6/2/2014 16:23,0,0,"Camidge on met amplified lung cancers, 0.8% >5 copies (high level) # ASCO14",,,#,4.73561E+17,https://twitter.com/RielyMD/status/473560551151661056,,,,
scientre,6/2/2014 16:23,0,0,"Modi: 2014 clinical pathways for HER2+ breast cancer, distinguishes ER+/- # asco14 pic.twitter.com/otjqfB9iok",,,#,4.73561E+17,https://twitter.com/scientre/status/473560508394905600,,,,
ECMC_UK,6/2/2014 16:23,0,0,MedImmune show interest in joining the ECMC combination Alliance at # ASCO14,,,#,4.7356E+17,https://twitter.com/ECMC_UK/status/473560481681387520,,,,
DrKateWolin,6/2/2014 16:22,2,2,RT @ ASCO: SHAPE-2 & LEAN studies emphasize importance of weight loss in breast cancer survivors http://bit.ly/1tBHbPJ # ASCO14,,@,#,4.7356E+17,https://twitter.com/DrKateWolin/status/473560346876477440,,,,
ShannonWestin,6/2/2014 16:22,6,0,J. Ledermann - no prospect of conducting RCT in rare tumors - how can we move the needle in this group? Registries! # ASCO14 # gyncsm,,,# #,4.7356E+17,https://twitter.com/ShannonWestin/status/473560323757051904,,,,
Melanoma_doctor,6/2/2014 16:21,0,1,Trying to be nice RT @ OmidHamidMD: @ melanoma_doctor We all win when physicians educate patients on the ongoings @ ASCO # ASCO14,,@ @ @,#,4.7356E+17,https://twitter.com/Melanoma_doctor/status/473560164420026368,,,,
RoswellPark,6/2/2014 16:21,2,0,Dr. Khushalani shares insights on combination # immunotherapy approaches for # melanoma # ASCO14 @ medpagetoday http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/610 …,,@,# # #,4.7356E+17,https://twitter.com/RoswellPark/status/473560082450743296,,,,
ElizBlanchardMD,6/2/2014 16:21,5,0,Abs 9501: denosumab beats Zometa in skeletal events; urine N telo peptide may be an important bio marker # ASCO14 # supponc,,,# #,4.7356E+17,https://twitter.com/ElizBlanchardMD/status/473559985956618241,,,,
WhitworthMD,6/2/2014 16:21,1,1,“ @ beitsch: # ASCO14 # agendia Congrats our friend - Debu Tripathy new Chief of # breast # Oncology @ MDAndersonNews pic.twitter.com/8Mnr4IDqlg”,,@ @,# # # #,4.7356E+17,https://twitter.com/WhitworthMD/status/473559941706702848,,,,
myPathMelanoma,6/2/2014 16:21,2,0,Stay in the loop! Sign up to receive more info on Myriad myPath # Melanoma NOW! http://bit.ly/myPathinfo # ASCO14,,,# #,4.7356E+17,https://twitter.com/myPathMelanoma/status/473559932927623168,,,,
JediPD,6/2/2014 16:20,0,1,Neg data RT @ JackWestMD: Dr.Spigel on MET antibody onartuzumab w/erlotinib in high MET-expressing NSCLC # ASCO14 # lcsmpic.twitter.com/dfgFCLo7vV,,@,# #,4.7356E+17,https://twitter.com/JediPD/status/473559928578535424,,,,
DrPaulyDeSantis,6/2/2014 16:20,0,1,$ GILD idelalisib/rituximab vs mono ritux trx # asco14 pic.twitter.com/IsHTsXd61L,,,#,4.7356E+17,https://twitter.com/DrPaulyDeSantis/status/473559818113150976,,,,
Melanoma_doctor,6/2/2014 16:20,5,0,"MK-3475 has ORR 34%, med PFS 5.5 month, med OS not reached (69% at 1 yr, 62% at 18 months) # melanoma # ASCO14 @ ASCO",,@,# #,4.7356E+17,https://twitter.com/Melanoma_doctor/status/473559814044663809,,,,
appistry,6/2/2014 16:20,1,0,How affordable is the modern crusade against cancer? Discover surprising facts at booth 16152 # ASCO14 Day 4! http://ow.ly/xajHr @ Forbes,,@,#,4.7356E+17,https://twitter.com/appistry/status/473559801356881921,,,,
AneesChagpar,6/2/2014 16:20,0,0,"@ beitsch @ MDAndersonNews Congrats Debu! Nice pic, Peter... And is that @ WhitworthMD I see? Sorry I missed you guys @ ASCO! # ASCO14",,@ @ @ @,#,4.7356E+17,https://twitter.com/AneesChagpar/status/473559797628141568,,,,
TurnaRay,6/2/2014 16:20,1,0,"Melanoma pts with BRAF mutations who relapse do a little bit better"" on Tafinlar/Mekinist combo vs Tafinlar http://bit.ly/RZ2Chb # asco14""",,,#,4.7356E+17,https://twitter.com/TurnaRay/status/473559794113314816,,,,
scientre,6/2/2014 16:20,0,0,Modi: clinical pathways 2013 for HER2+ breast cancer # asco14 pic.twitter.com/smgqtMbxUD,,,#,4.7356E+17,https://twitter.com/scientre/status/473559756595298304,,,,
Join_ImIn,6/2/2014 16:20,0,0,Breakthroughs in prostate cancer treatment via @ DavidAgus & @ cbsnews. # ASCO14 # clinicaltrials http://www.cbsnews.com/videos/breakthroughs-in-prostate-cancer-treatment …,,@ @,# #,4.7356E+17,https://twitter.com/Join_ImIn/status/473559689461235712,,,,
ElizBlanchardMD,6/2/2014 16:19,0,0,"Abs 9501 denosumab arm:longer time to first skeletal event(by months)regardless of loc, PS, other mets, bone tnver mkers # ASCO14 # supponc",,,# #,4.7356E+17,https://twitter.com/ElizBlanchardMD/status/473559590718951424,,,,
OmidHamidMD,6/2/2014 16:19,6,6,@ melanoma_doctor We all win when physicians educate patients on the ongoings @ ASCO # ASCO14,,@ @,#,4.7356E+17,https://twitter.com/OmidHamidMD/status/473559577045499904,,,,
BayerPharma,6/2/2014 16:19,0,1,# DYK bone mets are present in more than 90% of patients w/ # prostatecancer. Find out more http://bit.ly/Rv49fO # ASCO14,,,# # #,4.7356E+17,https://twitter.com/BayerPharma/status/473559576881942528,,,,
UCCancerCenter,6/2/2014 16:19,1,0,Two great posters by Tanguy Seiwert's lab in head & neck cancer - 1) describing three distinct molecular subtypes; 2) Hras mutations # ASCO14,,,#,4.73559E+17,https://twitter.com/UCCancerCenter/status/473559436439859201,,,,
lucadf,6/2/2014 16:18,0,1,"“ @ fischmd: A conference larger than the conference center: # socialmedia interactions from people not at mtg, @ rsm2800 # ASCO14” @ Oncoinfo_it",,@ @ @,# #,4.73559E+17,https://twitter.com/lucadf/status/473559286212481025,,,,
timturnham,6/2/2014 16:18,2,0,"317 pts on study of Merck PD1 drug had 34% response rate, w/ 62% still alive after 18 months. Great results in a big study. # ASCO14",,,#,4.73559E+17,https://twitter.com/timturnham/status/473559255446863872,,,,
carisls,6/2/2014 16:18,1,3,"Caris' Sherri Millis, PhD presents # MolecularIntel data on metaplastic breast cancer at # ASCO14 pic.twitter.com/xv3QWUlbFp",,,# #,4.73559E+17,https://twitter.com/carisls/status/473559250367549440,,,,
jodigralnick,6/2/2014 16:18,0,0,MINUTES AWAY: $ CLVS CEO Mahaffy joins @ megtirrell for an EXCLUSIVE LIVE interview on @ CNBCClosingBell at 4:25pm ET from # ASCO14,,@ @,#,4.73559E+17,https://twitter.com/jodigralnick/status/473559226355179520,,,,
Melanoma_MRV,6/2/2014 16:18,0,0,# ASCO14 http://tinyurl.com/phhjven 40% Response Rate to MK-3475 in Ipilimumab naive patients 88% responses ongoing!pic.twitter.com/NbF3HffyS5,,,#,4.73559E+17,https://twitter.com/Melanoma_MRV/status/473559218759671808,,,,
FoundationATCG,6/2/2014 16:17,0,1,Understand the difference between comprehensive and “hot-spot” # Nextgensequencing. Video: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# # #,4.73559E+17,https://twitter.com/FoundationATCG/status/473559161528401920,,,,
n8pennell,6/2/2014 16:17,5,3,MET Lung negative study great example of why pos subgroup analyses in phase 2 trials need to be tested in phase 3 trials. # ASCO14 # LCSM,,,# #,4.73559E+17,https://twitter.com/n8pennell/status/473558991273201664,,,,
beitsch,6/2/2014 16:16,2,4,# ASCO14 # agendia Congrats to good friend - Debu Tripathy named new Chief of # breastcancer # Oncology @ MDAndersonNewspic.twitter.com/2ESaXx6ALk,,@,# # # #,4.73559E+17,https://twitter.com/beitsch/status/473558912772624384,,,,
SarahCannonDocs,6/2/2014 16:16,3,4,# SCRI Dr. Spigel answering questions on biomarker data after presenting on # NSCLC trial # ASCO14 pic.twitter.com/cfyZHKOJTO,,,# # #,4.73559E+17,https://twitter.com/SarahCannonDocs/status/473558863946723328,,,,
Melanoma_doctor,6/2/2014 16:16,1,4,Sitting next to @ OmidHamidMD having Tweet-off. Which I will WIN # melanoma # ASCO14,,@,# #,4.73559E+17,https://twitter.com/Melanoma_doctor/status/473558767385452545,,,,
hkrupka,6/2/2014 16:15,0,0,"Ribas on immunotherapy pembro MK-3475 $ MRK: durable responses, good safety in 411 # melanoma pts regardless of prior ipilimumab $ BMS # ASCO14",,,# #,4.73559E+17,https://twitter.com/hkrupka/status/473558637651443712,,,,
RyanNipp,6/2/2014 16:15,2,1,"Financial distress, emotional symptoms, & overall distress in insured cancer patients http://bit.ly/1jZTrZ9 # ASCO14 # hpm @leahbrosenberg",,@leahbrosenberg,# #,4.73559E+17,https://twitter.com/RyanNipp/status/473558622635823105,,,,
Novartis,6/2/2014 16:15,1,4,New data in ALK+ NSCLC just announced. http://bit.ly/1ua6fiZ # ASCO14,,,#,4.73559E+17,https://twitter.com/Novartis/status/473558577844858881,,,,
genentech,6/2/2014 16:15,3,1,Med Dir Dr. Alan Sander talks abt ways we are carrying the lessons of METLung forward. # ASCO14 http://ow.ly/xwpSJ,,,#,4.73559E+17,https://twitter.com/genentech/status/473558516264095744,,,,
Amgen,6/2/2014 16:15,1,1,Look for # Amgen data on symptomatic skeletal events in patients with advanced # prostatecancer at # ASCO2014,,,# # #,4.73559E+17,https://twitter.com/Amgen/status/473558513328074752,,,,
ASCO,6/2/2014 16:15,5,8,New treatment algorithm for patients with childhood nonrhabdomyosarcoma soft tissue sarcoma http://bit.ly/RY2PkS # ASCO14,,,#,4.73559E+17,https://twitter.com/ASCO/status/473558511142842369,,,,
myriadgenetics,6/2/2014 16:15,2,0,Fndings at # ASCO14 show importance of testing patients for # hereditarycancer syndromes after 1st # cancer to avoid 2ndhttp://bit.ly/1u88lQ8,,,# # #,4.73558E+17,https://twitter.com/myriadgenetics/status/473558421422092289,,,,
OmidHamidMD,6/2/2014 16:14,0,0,@ ASCO # MK3475 # pembrolizumab response in # melanoma depend at on baseline tumor size,,@,# # #,4.73558E+17,https://twitter.com/OmidHamidMD/status/473558351457304576,,,,
JackWestMD,6/2/2014 16:14,10,3,Dr. Spigel on MET antibody onartuzumab w/erlotinib in high MET-expressing NSCLC # ASCO14 # lcsmpic.twitter.com/a6oUejwPKI,,,# #,4.73558E+17,https://twitter.com/JackWestMD/status/473558322927243264,,,,
ElizBlanchardMD,6/2/2014 16:14,0,0,Abs 9501: Zometa vs denosumab in solid tumor pts w bone mets. # ASCO14 # supponc,,,# #,4.73558E+17,https://twitter.com/ElizBlanchardMD/status/473558286252662784,,,,
DrMarkham,6/2/2014 16:14,0,0,Dreyling: Minimal residual disease in MCL is a powerful predictor but its use should be limited to clinical trials. # ASCO14 # lymsm,,,# #,4.73558E+17,https://twitter.com/DrMarkham/status/473558260109553666,,,,
DCarrizosaMD,6/2/2014 16:14,1,0,# ASCO14 -onartuzumab trial stopped due to futility: OS for onartuz+erlotinib 6.8 months vs 9.1 mo with erlotinib alone-reverses prior data,,,#,4.73558E+17,https://twitter.com/DCarrizosaMD/status/473558200227086336,,,,
DrPaulyDeSantis,6/2/2014 16:14,0,1,$ PCYC # asco14 pic.twitter.com/8K9FyyDjzM,,,#,4.73558E+17,https://twitter.com/DrPaulyDeSantis/status/473558190022332416,,,,
aftimosp,6/2/2014 16:13,0,0,S100bc: Dr Gebhart presenting Zephir: looking for a nuclear imaging biomarker predicting benefit with T-DM1 # ASCO14 pic.twitter.com/XyEXLD6hJL,,,#,4.73558E+17,https://twitter.com/aftimosp/status/473558148347752448,,,,
mnewtonPharmD,6/2/2014 16:13,0,0,Metastatic lung cancer session kicks off with final data for the disappointing MetMab phase 3 study # ASCO14 # LCSMpic.twitter.com/1z5wFXHVNJ,,,# #,4.73558E+17,https://twitter.com/mnewtonPharmD/status/473558060750110720,,,,
MaverickNY,6/2/2014 16:13,1,4,Congrats to @ rsm2800 to boldly go where no tweeter has gone before and live tweet from the podium # asco14,,@,#,4.73558E+17,https://twitter.com/MaverickNY/status/473558047118602240,,,,
CBPartners,6/2/2014 16:13,0,0,Interesting poster on # costsavings of # pathways # ASCO2014 pic.twitter.com/lEb1RrzTbK,,,# # #,4.73558E+17,https://twitter.com/CBPartners/status/473558037702410241,,,,
DrMarkham,6/2/2014 16:13,0,0,Dr. M.H. Dreyling: Characterization of indolent forms of mantle cell lymphoma requires further studies. # ASCO14 # lymsm,,,# #,4.73558E+17,https://twitter.com/DrMarkham/status/473558008598122496,,,,
ElizBlanchardMD,6/2/2014 16:13,0,0,"Abs LBA 9500:Optimize 2 trial:caution by the author, numbers small.Many have adopted this already, good to have some data. # ASCO14 # supponc",,,# #,4.73558E+17,https://twitter.com/ElizBlanchardMD/status/473558003774676992,,,,
DoctorEdny,6/2/2014 16:13,0,0,Onartuzumab and erlotinib CDs erlotinib in NSCLC in PIII METLung 1.27 HR OS data # ASCO14 pic.twitter.com/lFZoCqBMap,,,#,4.73558E+17,https://twitter.com/DoctorEdny/status/473557957213700098,,,,
BurrisSkip,6/2/2014 16:13,2,2,Great job by SCRI's Dr Spigel discussing the disappointing ph3 results of MetMAb in NSCLC. # ASCO2014 @ SarahCannonDocspic.twitter.com/kFLguAj3EJ,,@,#,4.73558E+17,https://twitter.com/BurrisSkip/status/473557923440766976,,,,
FlorianSlimano,6/2/2014 16:12,0,1,L'association de deux immunothpies dans le # mélanome (antiCTLA4 & antiPD1-PDL1) confirme donc son intérêt! # ipilimumab # nivolumab # ASCO14,,,# # # #,4.73558E+17,https://twitter.com/FlorianSlimano/status/473557786232901633,,,,
DrPaulyDeSantis,6/2/2014 16:12,0,0,$ PCYC $ GILD # ASCO14 pic.twitter.com/mAquRdA37M,,,#,4.73558E+17,https://twitter.com/DrPaulyDeSantis/status/473557749737857025,,,,
RielyMD,6/2/2014 16:12,0,1,"Spigel on erlotinib+/-onartuzumab: OS HR1.27 p=0.07 9% vs 6% resp rate favoring erlotinib +placebo, no hints of beneficial subgroups # ASCO14",,,#,4.73558E+17,https://twitter.com/RielyMD/status/473557727193866241,,,,
ElizBlanchardMD,6/2/2014 16:11,0,0,"Abs LBA 9500: Optimize 2: dose adjustments higher in Q4w, increased renal dysfunction higher in Q4wks (9.6 vs 7.9 %) # ASCO14 # supponc",,,# #,4.73558E+17,https://twitter.com/ElizBlanchardMD/status/473557659699134464,,,,
davidgrahammd,6/2/2014 16:11,0,0,Onartuzumab fails when added to erlotinib in MET + NSCLC. # lcsm # ASCO14,,,# #,4.73558E+17,https://twitter.com/davidgrahammd/status/473557640564707330,,,,
NatRevClinOncol,6/2/2014 16:10,0,0,Heated debate about cost and value of cancer care in ASCO/ECCO Joint session; some suggestions for way forward but no easy solution # ASCO14,,,#,4.73557E+17,https://twitter.com/NatRevClinOncol/status/473557320170233856,,,,
n8pennell,6/2/2014 16:10,1,1,"Spigel: Overall survival was not better in the onartuzumab arm than placebo. No subgroup did better, EGFR mut pts maybe worse? # ASCO14 # LCSM",,,# #,4.73557E+17,https://twitter.com/n8pennell/status/473557311055986689,,,,
NL4LiveSTRONG,6/2/2014 16:10,1,0,Artikel via # ASCO14 over de langetermijn bijwerkingen van kankerbehandelingen: http://www.cancer.net/survivorship/long-term-side-effects-cancer-treatment … # kanker,,,# #,4.73557E+17,https://twitter.com/NL4LiveSTRONG/status/473557262771167232,,,,
CancerDotNet,6/2/2014 16:10,1,0,Dr. Antoni Ribas @ UCLAHealth discusses new anti-PD1 immunotherapy for met # melanoma # ASCO14 # melsmhttp://bit.ly/1m5jjQo,,@,# # #,4.73557E+17,https://twitter.com/CancerDotNet/status/473557235579490304,,,,
AaronCohenGadol,6/2/2014 16:10,5,3,Researchers to report on promising ICT-107 vaccine to treat glioblastoma multiforme at # ASCO14 http://ow.ly/xxvDI # GBM # BTSM,,,# # #,4.73557E+17,https://twitter.com/AaronCohenGadol/status/473557233264238593,,,,
DrPaulyDeSantis,6/2/2014 16:10,0,0,$ GILD Syk inhibitor implicatioba # asco14 pic.twitter.com/dZgQnWONMT,,,#,4.73557E+17,https://twitter.com/DrPaulyDeSantis/status/473557202226388993,,,,
DrMarkham,6/2/2014 16:09,0,0,"Now attending: Lymphoma education session, focusing on mantle cell lymphoma first. http://ow.ly/xxGQN # asco14 # lymsm",,,# #,4.73557E+17,https://twitter.com/DrMarkham/status/473557057422233601,,,,
melanoma_Drs,6/2/2014 16:09,1,0,Rivas: >400 (!!) pts treated on variety of MK-3475 ph 1 trials for # melanoma # ASCO14,,,# #,4.73557E+17,https://twitter.com/melanoma_Drs/status/473557041857187840,,,,
Melanoma_doctor,6/2/2014 16:09,1,0,Rivas: >400 (!!) pts treated on variety of MK-3475 ph 1 trials for # melanoma # ASCO14,,,# #,4.73557E+17,https://twitter.com/Melanoma_doctor/status/473557041165107201,,,,
ConsanoMolly,6/2/2014 16:09,1,2,Love following @ subatomicdoc on Twitter and even more fun to chat in person! # ASCO14 pic.twitter.com/UTfeUm9B0i,,@,#,4.73557E+17,https://twitter.com/ConsanoMolly/status/473557010487586817,,,,
FlorianSlimano,6/2/2014 16:09,0,0,Beva+chemo = no benefit in HER2- breast K; may signal end of bevacizumab in this setting http://bit.ly/1wUvPLb # ASCO14 (via @ ASCO ),,@,#,4.73557E+17,https://twitter.com/FlorianSlimano/status/473556923196112896,,,,
MarcoLDavila,6/2/2014 16:08,0,0,CD27 appears to be a valid target for hematologic malignancies. # ASCO14 http://tinyurl.com/p9qdsmn,,,#,4.73557E+17,https://twitter.com/MarcoLDavila/status/473556791695925248,,,,
ElizBlanchardMD,6/2/2014 16:08,0,0,Abs LBA 9500:Optimize 2 trial:no difference in skeletal events between Q12w vs Q4. SREs 22vs 23% as was time to first SRE # ASCO14 # supponc,,,# #,4.73557E+17,https://twitter.com/ElizBlanchardMD/status/473556775229472769,,,,
n8pennell,6/2/2014 16:08,1,1,Spigel: 2/3 pts had 2+ MET positivity. # ASCO14 # LCSM,,,# #,4.73557E+17,https://twitter.com/n8pennell/status/473556774793273346,,,,
drseisenberg,6/2/2014 16:08,1,1,"RT @ subatomicdoc Financial distress, emotional symptoms & overall distress in insured cancer patients http://bit.ly/1jZTrZ9 # hsronc # ASCO14",,@,# #,4.73557E+17,https://twitter.com/drseisenberg/status/473556739644985344,,,,
AlpineBV_Miller,6/2/2014 16:08,2,0,@ scientre @ fischmd @ rsm2800 Moral is treat pts with respect in your trial. Or risk their online wrath and endanger your trial # ASCO14,,@ @ @,#,4.73557E+17,https://twitter.com/AlpineBV_Miller/status/473556661152808960,,,,
her2friends,6/2/2014 16:07,0,0,# Her2+ treatment history # asco14 pic.twitter.com/9RyrkRgRy2,,,# #,4.73557E+17,https://twitter.com/her2friends/status/473556520370978816,,,,
n8pennell,6/2/2014 16:07,1,1,Spigel: Metmab study stopped early for futility. # ASCO14 # LCSM,,,# #,4.73557E+17,https://twitter.com/n8pennell/status/473556514104696833,,,,
AlpineBV_Miller,6/2/2014 16:07,1,2,@ scientre @ fischmd @ rsm2800 RCC advocates warned they wouldn't stay quiet if they were subjected to placebo controls again # ASCO14,,@ @ @,#,4.73556E+17,https://twitter.com/AlpineBV_Miller/status/473556442369503232,,,,
scientre,6/2/2014 16:07,0,1,Modi: provides another timeline review of progress in HER2+ breast cancer # asco14 pic.twitter.com/A6MDRVzWPL,,,#,4.73556E+17,https://twitter.com/scientre/status/473556428134051841,,,,
n8pennell,6/2/2014 16:06,0,0,Dr. Spiegel presenting the erlotinib +\- Metmab in MET+ NSCLC phase 3 trial. press release said this neg but haven't seen data # ASCO14 # LCSM,,,# #,4.73556E+17,https://twitter.com/n8pennell/status/473556273649442817,,,,
OAkkerman_ERG,6/2/2014 16:06,18,11,Is Twitter becoming the communications tool of choice for med professionals? # ASCO14 # EnvironicsPharma http://www.environics.ca/environics-health--pharma-blog/post/67/Is-Twitter-the-New-Communication-Tool-for-Medical- …,,,# #,4.73556E+17,https://twitter.com/OAkkerman_ERG/status/473556241516474368,,,,
lymphoma,6/2/2014 16:06,3,0,"RT @ HemOncToday: # ASCO14 # Bortezomib, rituximab cyclophosphamide, # doxorubicin combo improved outcomes in mantle-cell # lymphoma",,@,# # # #,4.73556E+17,https://twitter.com/lymphoma/status/473556232301969408,,,,
ElizBlanchardMD,6/2/2014 16:06,0,0,"Abs LBA 9500: Optimize 2 trial: endpoints skeletal events, bone turnover markers. Non inferiority study # ASCO14 # supponc",,,# #,4.73556E+17,https://twitter.com/ElizBlanchardMD/status/473556207886946304,,,,
OncoGenexPharma,6/2/2014 16:06,1,0,Borealis-2 Trial in Progress Poster presented by # DrChoueiri more here: http://bit.ly/1lPIkPq # gucsm # asco14 # bladdercancer,,,# # # #,4.73556E+17,https://twitter.com/OncoGenexPharma/status/473556199380889601,,,,
BRCAresponder,6/2/2014 16:06,2,1,@ CancerDotNet @ ASCO Do you have a # hereditarycancer resource such as this? Would be great! # knowledgeispowerpic.twitter.com/OmJIH7et1a,,@ @,# #,4.73556E+17,https://twitter.com/BRCAresponder/status/473556173132554240,,,,
AlpineBV_Miller,6/2/2014 16:05,2,0,@ scientre @ fischmd @ rsm2800 RCC advocates realized 1mo into study placebos were different inside but stayed quiet to protect trial # ASCO14,,@ @ @,#,4.73556E+17,https://twitter.com/AlpineBV_Miller/status/473556116887318528,,,,
PaoloNuciforo,6/2/2014 16:05,0,0,The importance of HER2 quantitative determination # ASCO14 http://vhio.net/news/155/quantitative-determination-of-her2-levels-predictive-of-better-response-to-anti-her2-therapy …,,,#,4.73556E+17,https://twitter.com/PaoloNuciforo/status/473556088609308672,,,,
scientre,6/2/2014 16:05,0,0,Winer: sees these challenges remaining in HER2+ breast cancer # asco14 pic.twitter.com/Aujrm0SqWx,,,#,4.73556E+17,https://twitter.com/scientre/status/473556063661596672,,,,
TargetedOnc,6/2/2014 16:05,2,1,Presented at # ASCO14 | A Phase I Study of the CSF1R Kinase Inhibitor PLX3397 for PVNS http://www.targetedonc.com/conference/asco-2014/A-Phase-I-Study-of-the-CSF1R-Kinase-Inhibitor-PLX3397-for-PVNS …,,,#,4.73556E+17,https://twitter.com/TargetedOnc/status/473556029985533953,,,,
LSVCo,6/2/2014 16:05,0,0,Upfront Chemo Confers Dramatic Survival Gains in Prostate Cancer http://ow.ly/xvusZ # ASCO14,,,#,4.73556E+17,https://twitter.com/LSVCo/status/473556014311440384,,,,
US_CCS,6/2/2014 16:05,0,0,Upfront Chemo Confers Dramatic Survival Gains in Prostate Cancer http://ow.ly/xvut1 # ASCO14,,,#,4.73556E+17,https://twitter.com/US_CCS/status/473556014231736320,,,,
ElizBlanchardMD,6/2/2014 16:05,0,0,Abs LBA 9500: Optimize 2 trial: Zometa Q12 weeksvsQ4 weeks after a year of therapy in pts with breast ca and mets to bone. # ASCO14 # supponc,,,# #,4.73556E+17,https://twitter.com/ElizBlanchardMD/status/473555945021538305,,,,
subatomicdoc,6/2/2014 16:05,3,3,"Financial distress, emotional symptoms, & overall distress in insured cancer patients http://bit.ly/1jZTrZ9 # ASCO14 # hsronc",,,# #,4.73556E+17,https://twitter.com/subatomicdoc/status/473555925648015360,,,,
SamuelLz,6/2/2014 16:04,0,0,Och en snapshot från den generella postersessionen # dmasco # asco14 pic.twitter.com/VKpNObRUvT,,,# #,4.73556E+17,https://twitter.com/SamuelLz/status/473555885886033920,,,,
aftimosp,6/2/2014 16:04,0,0,G. Gebhart from Institut Bordet will present in a few minutes the 1st interim results of Zephir: T-DM1 in # BreastCancer (abs 11001) # ASCO14,,,# #,4.73556E+17,https://twitter.com/aftimosp/status/473555879027941376,,,,
WIOvarianCancer,6/2/2014 16:04,1,1,Drug therapy study gives promising results for ovarian cancer treatment from pills. http://bit.ly/1jN59BQ # ASCO14 # WOCA # ovariancancer,,,# # #,4.73556E+17,https://twitter.com/WIOvarianCancer/status/473555854306725888,,,,
brouardbenoit01,6/2/2014 16:04,1,1,Mobile applications in # oncology: Need for assessing scientific contents more precisely. # ASCO14 # mhealth http://abstracts.asco.org/144/AbstView_144_129069.html …,,,# # #,4.73556E+17,https://twitter.com/brouardbenoit01/status/473555839610269696,,,,
ByJonGardner,6/2/2014 16:04,0,0,"Everybody! Stop what you're doing! # ASCO14 break! # sgenball bowling in the parking garage, 15 minutes! Go! # fromtheannalsofbadideas $ SGEN",,,# # #,4.73556E+17,https://twitter.com/ByJonGardner/status/473555834069590016,,,,
scientre,6/2/2014 16:04,2,1,"HER2+ breast cancer session, lots of progress since trastuzumab approval in 1998 # asco14 pic.twitter.com/sdTzeSYUnN",,,#,4.73556E+17,https://twitter.com/scientre/status/473555755468345344,,,,
OAkkerman_ERG,6/2/2014 16:04,1,0,The # Melanoma Twitter sales force comes to life at # ASCO14 - blog by # EnvironicsPharma http://lnkd.in/dsji7cV,,,# # #,4.73556E+17,https://twitter.com/OAkkerman_ERG/status/473555725373800450,,,,
AlpineBV_Miller,6/2/2014 16:04,0,0,@ scientre @ fischmd @ rsm2800 Remember the RCC patient advocates who stood up and took Pazdur and Oynx to task for placebo controls # ASCO14,,@ @ @,#,4.73556E+17,https://twitter.com/AlpineBV_Miller/status/473555671557083136,,,,
Tony_Calles,6/2/2014 16:03,0,0,Next 3h for mNSCLC abstracts oral presentations. Getting started. # ASCO14 # lcsm,,,# #,4.73556E+17,https://twitter.com/Tony_Calles/status/473555555106439168,,,,
MontefioreNYC,6/2/2014 16:03,0,0,Thank you to everyone who attended our # ASCO14 Alumni Cocktail Reception this past Saturday!,,,#,4.73556E+17,https://twitter.com/MontefioreNYC/status/473555516007133184,,,,
BurrisSkip,6/2/2014 16:02,3,1,SCRI's David Spigel presents MetMAB lung results. # ASCO2014 @ SarahCannonDocspic.twitter.com/taZLYXZtKz,,@,#,4.73555E+17,https://twitter.com/BurrisSkip/status/473555255683461120,,,,
Novartis,6/2/2014 16:02,2,3,New Ph. III study results underline # Novartis commitment to finding potential ways to treat # multiplemyeloma: http://bit.ly/1tBkUBo # ASCO14,,,# # #,4.73555E+17,https://twitter.com/Novartis/status/473555176172044288,,,,
GenomicHealth,6/2/2014 16:02,0,0,Pilot lab study comparing 21-gene assay and PAM50 ROR taking place in S100bc at 4-4:12pm # Oncotype # ASCO14,,,# #,4.73555E+17,https://twitter.com/GenomicHealth/status/473555169813487616,,,,
ASCO,6/2/2014 16:02,7,7,# ASCO14 studies released today focus on immunotherapy. Learn more: http://bit.ly/1f4tUhm,,,#,4.73555E+17,https://twitter.com/ASCO/status/473555155334754304,,,,
ASCO,6/2/2014 16:01,1,0,ASCO Members: Visit a # ASCO14 Member Services Desk & refer a new member. You'll qualify for the chance of 1 year of comped membership dues,,,#,4.73555E+17,https://twitter.com/ASCO/status/473555106638888960,,,,
ASCO,6/2/2014 16:01,39,13,Bevacizumab + chemo = no benefit in HER2- breast cancer; may signal end of bevacizumab in this setting http://bit.ly/1wUvPLb # ASCO14,,,#,4.73555E+17,https://twitter.com/ASCO/status/473555009112907776,,,,
BRCAresponder,6/2/2014 16:01,1,1,@ drseisenberg @ DrAttai @ obogler correct link for @ thescarproject http://thescarproject.org # ASCO14,,@ @ @ @,#,4.73555E+17,https://twitter.com/BRCAresponder/status/473554984123265025,,,,
CancerDotNet,6/2/2014 16:01,1,1,Advocates: Find all sorts of @ ASCO resources at the # ASCO14 bookstore - booth #7004 http://bit.ly/1hQLfGm,,@,# #7004,4.73555E+17,https://twitter.com/CancerDotNet/status/473554955220291585,,,,
mayocliniclabs,6/2/2014 16:01,1,0,"Dr. Bergsagel discussing “Lymphoma and Myeloma: Where We Were, Where We Are, Where We Are Going.” # ASCO14",,,#,4.73555E+17,https://twitter.com/mayocliniclabs/status/473554951634157569,,,,
ASCO,6/2/2014 16:01,1,2,Dr. Monica Malik discusses the state of cancer care in India http://bit.ly/1rlsMeA # ASCO14,,,#,4.73555E+17,https://twitter.com/ASCO/status/473554949843218432,,,,
ASCO,6/2/2014 16:01,0,1,"Considering purchasing an # ASCO14 Virtual Meeting subscription? Preview content w/Virtual Meeting on Demand"": http://bit.ly/1oKjSW0""",,,#,4.73555E+17,https://twitter.com/ASCO/status/473554948274544640,,,,
ONAcom,6/2/2014 16:00,0,0,# ASCO14: Combination ridaforolimus + MK-2206 AKT inhibitor therapy yield modest efficacy for low-RAS # breastcancer - http://ow.ly/xwer0,,,# #,4.73555E+17,https://twitter.com/ONAcom/status/473554857186844672,,,,
Merck,6/2/2014 16:00,7,3,Lots of melanoma talk at # ASCO14. Getting ready to present our melanoma data. # MerckOncology.pic.twitter.com/eqCYst486i,,,# #,4.73555E+17,https://twitter.com/Merck/status/473554814581088258,,,,
nycdoc29,6/2/2014 16:00,0,0,“ @ Ann_Nonymous_MD: Am I the only anonymous oncologist at # ASCO14? I wouldn't be if not for few unethical oncologists.” Your Not alone!,,@,#,4.73555E+17,https://twitter.com/nycdoc29/status/473554762693369856,,,,
DrZackaryBerger,6/2/2014 16:00,0,0,# ASCO14 attendees: what do you think about the stock prices ($) as part of the twitter feed? Quite something. # justasimplecountryinternist,,,# #,4.73555E+17,https://twitter.com/DrZackaryBerger/status/473554751989485568,,,,
diablovalleyonc,6/2/2014 16:00,0,0,"another fantastic update from # asco2014: Dr. Chen from @ diablovalleyonc says The Prostate trial in plenary session for early...""",,@,#,4.73555E+17,https://twitter.com/diablovalleyonc/status/473554728446865408,,,,
PacificUrology,6/2/2014 16:00,0,0,"another fantastic update from # asco2014: Dr. Chen from @ diablovalleyonc says The Prostate trial in plenary session for early...""",,@,#,4.73555E+17,https://twitter.com/PacificUrology/status/473554723162042371,,,,
DrHedrick,6/2/2014 15:59,2,5,Dr. Laura Tenner of @ iumedschool (soon of @ UTSWNews) on Oncologist Communication of cost under @ obamacare # ASCO14 pic.twitter.com/uyo7CP588R,,@ @ @,#,4.73555E+17,https://twitter.com/DrHedrick/status/473554534812233728,,,,
Ann_Nonymous_MD,6/2/2014 15:58,0,0,Amazing to see such an active twitter community for # ASCO14.,,,#,4.73554E+17,https://twitter.com/Ann_Nonymous_MD/status/473554383175966720,,,,
cureLauncher,6/2/2014 15:58,2,0,We get it. Trial info needs to be simplified. How do we make sure # patients gain access to trials? # ASCO14 pic.twitter.com/KtDFewT0zT,,,# #,4.73554E+17,https://twitter.com/cureLauncher/status/473554364900986880,,,,
eMPR,6/2/2014 15:58,0,0,. @ NEJM study: new drug slows metastatic prostate cancer http://ow.ly/xxE5u # ASCO14 # oncology,,@,# #,4.73554E+17,https://twitter.com/eMPR/status/473554262765867008,,,,
aicrtweets,6/2/2014 15:57,1,2,MT @ KarenCollinsRD: # CancerSurvivor >5% weight loss (diet+exercise) best to decr insulin & inflam biomarkers. M Irwin @ YaleCancer # ASCO14,,@ @,# #,4.73554E+17,https://twitter.com/aicrtweets/status/473554115763920896,,,,
jodigralnick,6/2/2014 15:56,0,0,Big move in $ CLVS stock today. CEO Mahaffy joins @ megtirrell for an EXCLUSIVE LIVE interview on @ CNBCClosingBell at 4:25pm ET from # ASCO14,,@ @,#,4.73554E+17,https://twitter.com/jodigralnick/status/473553874754994176,,,,
hollyejacobs,6/2/2014 15:55,0,0,"YES! @ rsm2800: Tweetchats are a blur with the number of tweets flying per hour, BUT…important information is still shared # bcsm # asco14",,@,# #,4.73554E+17,https://twitter.com/hollyejacobs/status/473553528904884224,,,,
RyhMd,6/2/2014 15:55,0,0,Double Hit DLBCL # ASCO14 pic.twitter.com/KbnzMYI4li,,,#,4.73553E+17,https://twitter.com/RyhMd/status/473553499880718336,,,,
Cortellis,6/2/2014 15:55,1,0,Live from # ASCO14. Ph3 trial results shows that vinflunine plus capecitabine significantly improve PFS (30%) compared with CAPE alone,,,#,4.73553E+17,https://twitter.com/Cortellis/status/473553432075198464,,,,
myriadgenetics,6/2/2014 15:55,1,1,Dr. Michael Brawer explains data on Myriad's Prolaris test for # prostatecancer aggressiveness at # ASCO14. Poster 5059 pic.twitter.com/hYvuibuRWh,,,# #,4.73553E+17,https://twitter.com/myriadgenetics/status/473553391960875008,,,,
Ann_Nonymous_MD,6/2/2014 15:55,0,0,Am I the only anonymous oncologist at # ASCO14? I wouldn't be if not for few unethical oncologists.,,,#,4.73553E+17,https://twitter.com/Ann_Nonymous_MD/status/473553388161208320,,,,
VincentRK,6/2/2014 15:54,3,2,I like the data so far on Daratumumab RT “ @ mtmdphd: # mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 PFS pic.twitter.com/a71GlS69Am”,,@,# #,4.73553E+17,https://twitter.com/VincentRK/status/473553359262072832,,,,
YaleMed,6/2/2014 15:54,2,1,"Nice @ WSJ coverage of immunotherapy data, from @ YaleCancer doc Mario Sznol and colleageus http://ht.ly/xxCWP # asco14",,@ @,#,4.73553E+17,https://twitter.com/YaleMed/status/473553197299412992,,,,
CancerRT,6/2/2014 15:53,3,2,Check out our collaborative film project with the amazing @ NCDFREE and @ SandroDemaio and learn about cancer care in Peru! @ GTFRCC # ASCO14,,@ @ @,#,4.73553E+17,https://twitter.com/CancerRT/status/473553092756398080,,,,
SarahCannonDocs,6/2/2014 15:53,0,0,VIDEO: # SCRI Dr. Bendell on 2 BRAF-mutated # colorectal # cancer studies at # ASCO14 @ OncLive http://bit.ly/1m5EwcP,,@,# # # #,4.73553E+17,https://twitter.com/SarahCannonDocs/status/473553068366520320,,,,
govind_babu,6/2/2014 15:52,0,1,At the greatest oncology show on earth # ASCO14,,,#,4.73553E+17,https://twitter.com/govind_babu/status/473552847687401472,,,,
myPathMelanoma,6/2/2014 15:52,1,0,Have questions about Myriad myPath # Melanoma? Read our publications at http://www.IsThisMelanoma.com # ASCO14,,,# #,4.73553E+17,https://twitter.com/myPathMelanoma/status/473552633022517250,,,,
AdjaDjan,6/2/2014 15:51,1,0,# Germany # Hamburg # Goodlifehamburg # Street # ASCO14 # Cool # Happy # Sénégalaise # Skullapop # TeamDancehall # ChrisBrownIspic.twitter.com/VNYEUQgCiy,,,# # # # # # # # # # #,4.73552E+17,https://twitter.com/AdjaDjan/status/473552491121221632,,,,
BioBoomer,6/2/2014 15:51,0,0,$ IBB $ BIB great recovery. Lot's of innovation coming out of @ ASCO,,@,,4.73552E+17,https://twitter.com/BioBoomer/status/473552483298869248,,,,
appistry,6/2/2014 15:50,0,0,Discuss genomically enhanced medicine # GEM with us today at Booth 16152 at # ASCO14. # CloudDx,,,# # #,4.73552E+17,https://twitter.com/appistry/status/473552145795792896,,,,
RielyMD,6/2/2014 15:50,0,0,"Rajaram et al: national cancer db, from 2002-2011, use of chemo for stage 2-3 NSCLC went from 29% to 58% # ASCO14",,,#,4.73552E+17,https://twitter.com/RielyMD/status/473552131182452736,,,,
hkrupka,6/2/2014 15:49,0,0,# ASCO14,,,#,4.73552E+17,https://twitter.com/hkrupka/status/473552082860273664,,,,
DrPaulyDeSantis,6/2/2014 15:49,1,1,$ CLDX # ASCO14 pic.twitter.com/eYQsqvEHij,,,#,4.73552E+17,https://twitter.com/DrPaulyDeSantis/status/473551878589284352,,,,
ElizBlanchardMD,6/2/2014 15:48,0,0,Patient and survivor care oral abstracts in E253 in 15 minutes! # ASCO14 # supponc,,,# #,4.73552E+17,https://twitter.com/ElizBlanchardMD/status/473551860843180033,,,,
EWidera,6/2/2014 15:47,7,5,Most clinical advertisements by cancer centers use emotional appeals that evoke hope and fear http://www.geripal.org/2014/06/cancer-center-advertising-selling-hope.html … # ASCO14 # hpm,,,# #,4.73551E+17,https://twitter.com/EWidera/status/473551473759240193,,,,
MaverickNY,6/2/2014 15:47,0,0,Bumped into the lovely @ rsm2800 on the Ohio walk # asco14,,@,#,4.73551E+17,https://twitter.com/MaverickNY/status/473551417568165888,,,,
ncbennevis,6/2/2014 15:47,0,0,Clinically Meaningful Outcomes in # Research: An Important Step Toward Achieving High-Value # Cancer Care # ASCO2014 http://am.asco.org/clinically-meaningful-outcomes-research-important-step-toward-achieving-high-value-cancer-care#.U4zUmlvQ6Z8.twitter …,,,# # # #,4.73551E+17,https://twitter.com/ncbennevis/status/473551403613315072,,,,
LGG1,6/2/2014 15:47,0,1,"Thanks @ obogler for the informative, engaging, and delightful presentation at # ASCO14",,@,#,4.73551E+17,https://twitter.com/LGG1/status/473551390254854145,,,,
HemOncToday,6/2/2014 15:46,1,0,"# ASCO14 # Bortezomib, rituximab cyclophosphamide, # doxorubicin combo improved outcomes in mantle-cell # lymphoma: http://goo.gl/wcbsP6",,,# # # #,4.73551E+17,https://twitter.com/HemOncToday/status/473551287888666625,,,,
GoHealio,6/2/2014 15:46,0,0,"# ASCO14 # Bortezomib, rituximab cyclophosphamide, # doxorubicin combo improved outcomes in mantle-cell # lymphoma: http://goo.gl/wcbsP6",,,# # # #,4.73551E+17,https://twitter.com/GoHealio/status/473551287150448640,,,,
scientre,6/2/2014 15:46,0,1,Congrats! MT @ juliacowens Atterocor 1st ever poster up at # ASCO14 Phase 1 study ongoing in adrenocortical carcinoma pic.twitter.com/481abgeI5o,,@,#,4.73551E+17,https://twitter.com/scientre/status/473551285267230720,,,,
SitemanCenter,6/2/2014 15:45,0,0,"Elaine Mardis, PhD, of Siteman and @ WUSTLmed discusses the impact & applications of next-gen sequencing: 5:30 pm, Rm S100bc # ASCO14",,@,#,4.73551E+17,https://twitter.com/SitemanCenter/status/473551022150135810,,,,
aakonc,6/2/2014 15:45,0,0," @ DrAttai: next year questions via twitter? RT @ Preslaura Text qs to the panels is really cool. # ASCO14""twitter qs would be even cooler""",,@ @,#,4.73551E+17,https://twitter.com/aakonc/status/473550879493083136,,,,
HemOncToday,6/2/2014 15:44,1,0,# ASCO14 Another great # melanoma session http://ow.ly/i/5LNev,,,# #,4.73551E+17,https://twitter.com/HemOncToday/status/473550655886749696,,,,
GoHealio,6/2/2014 15:44,0,0,# ASCO14 Another great # melanoma session http://ow.ly/i/5LNev,,,# #,4.73551E+17,https://twitter.com/GoHealio/status/473550655236624384,,,,
YaleMed,6/2/2014 15:44,2,3,MT @ YaleCancer: Dr. Mario Sznol delivers new findings on immune therapy for adv. melanoma. # ASCO14 pic.twitter.com/cbfrLte6rc,,@,#,4.73551E+17,https://twitter.com/YaleMed/status/473550643995901952,,,,
BioDueDiligence,6/2/2014 15:43,0,0,Seeing inappropriate promotion of approved or investigational drugs at # ASCO14 or elsewhere? Report to FDA via BadAd@FDA.gov,,@FDA,#,4.73551E+17,https://twitter.com/BioDueDiligence/status/473550591990312960,,,,
DoctorEdny,6/2/2014 15:42,0,0,Targeted nanotherapeutics for cancer # asco14 pic.twitter.com/FW08Cma7sd,,,#,4.7355E+17,https://twitter.com/DoctorEdny/status/473550362105118720,,,,
myCME,6/2/2014 15:42,0,0,Trametinib + Dabrafenib Improves Survival in BRAFV600E/K Mutant Metastatic # Melanoma http://ow.ly/xxAcQ # ASCO14 # Dermatology,,,# # #,4.7355E+17,https://twitter.com/myCME/status/473550141929295874,,,,
Awesomics,6/2/2014 15:41,0,3,"Clinical Analysis and Interpretation of Cancer Genome Data (Van Allen et al. J Clin Oncology, 2013) http://jco.ascopubs.org/content/31/15/1825 … # ASCO14",,,#,4.7355E+17,https://twitter.com/Awesomics/status/473550099537068032,,,,
juliacowens,6/2/2014 15:41,0,1,Atterocor's first ever poster is now up at # ASCO14 describing Phase 1 study ongoing in adrenocortical carcinoma. pic.twitter.com/0TWWFw9N7C,,,#,4.7355E+17,https://twitter.com/juliacowens/status/473550018977492992,,,,
BayerPharma,6/2/2014 15:40,0,1,We discuss # mCRPC @ # ASCO14. # DYK more than half of all # prostatecancers are diagnosed in men over 65,,@,# # # #,4.7355E+17,https://twitter.com/BayerPharma/status/473549772700536832,,,,
nycdoc29,6/2/2014 15:40,0,0,"# ASCO14 - CLL Update - parting comment from OBrien  would use ibrutinib for all first relapsed CLL"" $$$ proposition that few MDs do today""",,,#,4.7355E+17,https://twitter.com/nycdoc29/status/473549667704520704,,,,
Palestine_onco,6/2/2014 15:40,0,0,@ CancerDotNet @ ASCO @ USCHealthNews Grest podcast !! Loved it,,@ @ @,,4.7355E+17,https://twitter.com/Palestine_onco/status/473549659676221441,,,,
AndytweetM,6/2/2014 15:39,0,1,"@ DrMarkham @ ShannonWestin @ ASCO @ mtmdphd @ drdonsdizon extended community following asco on twitter- sharing, asking Qs! Thanks 2 u all !",,@ @ @ @ @,,4.73549E+17,https://twitter.com/AndytweetM/status/473549491296301056,,,,
MaverickNY,6/2/2014 15:39,0,0,Trying to get put of E450 and run to another session is not easy with just one elevator down # asco14 pic.twitter.com/jcVK6poq2E,,,#,4.73549E+17,https://twitter.com/MaverickNY/status/473549490092519424,,,,
beitsch,6/2/2014 15:38,1,0,"# ASCO14 Poster Discussion Session TheraPrint # agendia mRNA related to complete path response - pTEN, hormone negativity & Her2 activation",,,# #,4.73549E+17,https://twitter.com/beitsch/status/473549299268481024,,,,
CancerNetwrk,6/2/2014 15:38,0,0,BLOG: Personalized Care vs Precise Care: The Geriatric Oncology Model http://bit.ly/1n5o8fX # ASCO14,,,#,4.73549E+17,https://twitter.com/CancerNetwrk/status/473549256146829312,,,,
LGG1,6/2/2014 15:37,5,12,Wonderful to see @ fischmd @ drattai and @ subatomicdoc IRL. Great people who do great work! # ASCO14 pic.twitter.com/bPbcQlfEIs,,@ @ @,#,4.73549E+17,https://twitter.com/LGG1/status/473549033655767040,,,,
urotoday,6/2/2014 15:37,1,1,# ASCO14 - Poster: 15-year survival outcomes following primary androgen deprivation therapy for ... http://dlvr.it/5s8Gw7,,,#,4.73549E+17,https://twitter.com/urotoday/status/473549004832124928,,,,
Merck,6/2/2014 15:37,1,0,Our lung cancer data is being presented during the 5PM (CDT) session in E Hall D2. Hope you'll join. # ASCO14 # lcsm,,,# #,4.73549E+17,https://twitter.com/Merck/status/473548927669903360,,,,
DrPaulyDeSantis,6/2/2014 15:36,0,1,$ IMMU SN-38ADC # ASCO14 pic.twitter.com/h8lTmjRs5E,,,#,4.73549E+17,https://twitter.com/DrPaulyDeSantis/status/473548652808372225,,,,
SequentaInc,6/2/2014 15:35,0,1,# ASCO2014 data now MT @ roelverhaak Great sci; Improved Survival w T Cell Clonotype Stability aftr # Immunotherapy Trmt http://ow.ly/xxwEH,,@,# #,4.73548E+17,https://twitter.com/SequentaInc/status/473548466665185280,,,,
drseisenberg,6/2/2014 15:35,2,2,"YES RT @ subatomicdoc: +100 RT @ DrMarkham: What I love about Twitter is that it creates community, makes our world a smaller place. # ASCO14",,@ @,#,4.73548E+17,https://twitter.com/drseisenberg/status/473548406380449792,,,,
Roche,6/2/2014 15:35,2,2,"Are you a Statistical supremo""? Test your clinical trials IQ: http://ow.ly/xwxWW # ASCO14 # research""",,,# #,4.73548E+17,https://twitter.com/Roche/status/473548405986562048,,,,
RS_Flinn,6/2/2014 15:34,0,0,"Funniest line overheard at # ASCO14: We already cured our cancer -- what are you working on?""""",,,#,4.73548E+17,https://twitter.com/RS_Flinn/status/473548183235489792,,,,
drseisenberg,6/2/2014 15:33,1,0,RT @ bmsnews: # Cancer research doesn’t take just one doctor or patient—it takes all of us http://ow.ly/xvjhl # ASCO14,,@,# #,4.73548E+17,https://twitter.com/drseisenberg/status/473548076385177600,,,,
TheChrisGale,6/2/2014 15:33,0,1,"Other news, Meg's no longer sideways on Twitter RT @ ArmstrongDrew Getting grilled on @ cnbc set by @ megtirrell # asco14 http://instagram.com/p/owOIttDovO/",,@ @ @,#,4.73548E+17,https://twitter.com/TheChrisGale/status/473548016352514049,,,,
drseisenberg,6/2/2014 15:32,1,3,# BCSM = Because Compassion Surely Matters # epatient # ASCO14,,,# # #,4.73548E+17,https://twitter.com/drseisenberg/status/473547769261477888,,,,
DrPaulyDeSantis,6/2/2014 15:32,2,1,$ AZN MEDI-551 # asco14 pic.twitter.com/lnZL5gL2Oo,,,#,4.73548E+17,https://twitter.com/DrPaulyDeSantis/status/473547758281179136,,,,
salutedomani,6/2/2014 15:32,1,0,Metastatic bladder cancer: Investigational immunotherapy anti-PDL1 (MPDL3280A) # ASCO2014 http://lnkd.in/dws8gei,,,#,4.73548E+17,https://twitter.com/salutedomani/status/473547734712995841,,,,
HenryJOncology,6/2/2014 15:31,0,0,We can value a drug asset by modeling it as a z-bond. We can buy CDS to hedge the bond. We can increase R&D financing! # ASCO14 poster 21,,,#,4.73548E+17,https://twitter.com/HenryJOncology/status/473547584137486336,,,,
NextGenClinical,6/2/2014 15:31,0,0,"A light"" departure from oncology for a moment. # ASCO14 pic.twitter.com/Q12oB3hC9Q""",,,#,4.73547E+17,https://twitter.com/NextGenClinical/status/473547478512730112,,,,
drseisenberg,6/2/2014 15:31,0,1,RT @ ASCO SHAPE-2 & LEAN studies emphasize importance of weight loss in breast cancer survivors http://bit.ly/1tBHbPJ # bcsm # ASCO14,,@,# #,4.73547E+17,https://twitter.com/drseisenberg/status/473547420488712194,,,,
ASCO,6/2/2014 15:31,5,3,Dr. Grant A. McArthur reviews the RAS/RAF/MEK/ERK pathway in # cancer: http://bit.ly/1gF8h83 # ASCO14,,,# #,4.73547E+17,https://twitter.com/ASCO/status/473547400095989760,,,,
drseisenberg,6/2/2014 15:30,0,0,"MT @ fischmd: Charming, riveting, informative: @ obogler is killing it here @ ASCO talking about # breastcancer & # bcsm # ASCO14",,@ @ @,# # #,4.73547E+17,https://twitter.com/drseisenberg/status/473547328314699776,,,,
ASCO,6/2/2014 15:30,4,4,SHAPE-2 & LEAN studies emphasize importance of weight loss in breast cancer survivors http://bit.ly/1tBHbPJ # ASCO14,,,#,4.73547E+17,https://twitter.com/ASCO/status/473547314662219776,,,,
Pharmaspectra,6/2/2014 15:30,0,0,RT @ CancerDotNet: # ASCO14 study: ipilimumab post-surgery reduces recurrence of high-risk stg 3 # melanoma # melsm http://bit.ly/1kphaSQ,,@,# # #,4.73547E+17,https://twitter.com/Pharmaspectra/status/473547268109639680,,,,
TargetedOnc,6/2/2014 15:30,0,1,Promise Seen With CO-1686 in Treatment-Resistant NSCLC http://www.targetedonc.com/conference/asco-2014/Promise-Seen-With-EGFR-Inhibitor-CO-1686-in-Treatment-Resistant-NSCLC … # ASCO14,,,#,4.73547E+17,https://twitter.com/TargetedOnc/status/473547240485969921,,,,
BioDueDiligence,6/2/2014 15:30,0,1,"If you missed it over the weekend, a new # ASCO14 themed journal watch: http://www.clinicaloncologytargets.com/blog.html",,,#,4.73547E+17,https://twitter.com/BioDueDiligence/status/473547210635083778,,,,
FoundationATCG,6/2/2014 15:30,1,2,Not all molecular testing is created equal. Learn about the differences here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73547E+17,https://twitter.com/FoundationATCG/status/473547180184444928,,,,
CBPartners,6/2/2014 15:30,0,0,"Immunotherapy (e.g. target CD19), something beyond BCR pathway inhibitors for relapsed CLL? # ASCO2014",,,#,4.73547E+17,https://twitter.com/CBPartners/status/473547124471496704,,,,
LivingBeyondBC,6/2/2014 15:29,2,2,Read our coverage of # breastcancer findings presented at # ASCO14 & register for 6/24 webinar on this annual meeting https://www.facebook.com/livingbeyondbreastcancer/photos/a.312271111316.147087.30427641316/10152224379051317/?type=1&relevant_count=1 …,,,# #,4.73547E+17,https://twitter.com/LivingBeyondBC/status/473547050446237696,,,,
drseisenberg,6/2/2014 15:29,1,1,The Dr. Susan Love Research Foundation’s Army of Women: http://www.armyofwomen.org/aboutus # ASCO14 # epatient,,,# #,4.73547E+17,https://twitter.com/drseisenberg/status/473546957193895936,,,,
nycdoc29,6/2/2014 15:28,0,0,# ASCO14 - CLL Update OBrien using her crystal ball to predict winner in novel agents in CLL....,,,#,4.73547E+17,https://twitter.com/nycdoc29/status/473546816638955520,,,,
Ludwig_Cancer,6/2/2014 15:27,0,0,Ludwig's Stephen Hodi presenting data on long-term survival of certain advanced # melanoma patients on experimental # immunotherapy # ASCO14,,,# # #,4.73547E+17,https://twitter.com/Ludwig_Cancer/status/473546561558183936,,,,
JacobPlieth,6/2/2014 15:27,2,1,Back then... # ASCO14 pic.twitter.com/Oh5bTgp8qx,,,#,4.73547E+17,https://twitter.com/JacobPlieth/status/473546534555254784,,,,
drseisenberg,6/2/2014 15:27,0,0,great tweetologists MT @TT_MDAnderson Learning frm the BEST they're here @ subatomicdoc @ fischmd @ DrAttai @ mtmdphd @ obogler @ rsm2800 # ASCO14,,@TT_MDAnderson @ @ @ @ @ @,#,4.73546E+17,https://twitter.com/drseisenberg/status/473546488690135041,,,,
hollyejacobs,6/2/2014 15:27,1,2,Which is why @ DrSusanLove 's @ArmyofWomen is so important @ obogler @ mtmdphd # ASCO14 # cancer,,@ @ArmyofWomen @ @,# #,4.73546E+17,https://twitter.com/hollyejacobs/status/473546361913102337,,,,
CancerGeek,6/2/2014 15:26,0,0,"ASCO Showdown: AstraZeneca vs. Clovis Oncology (AZN, CLVS): http://www.fool.com/investing/general/2014/06/02/asco-showdown-astrazenica-vs-clovis-oncology.aspx#.U4zPrUyCP64.twitter … via @ themotleyfool # ASCO14",,@,# #,4.73546E+17,https://twitter.com/CancerGeek/status/473546149039587328,,,,
DoctorEdny,6/2/2014 15:26,1,0,$ CERU Early RCC RR is very encouraging multiple indications underway; 1 dose inhibits HIF1a for a week # ASCO14 pic.twitter.com/54eNNfxB2Q,,,#,4.73546E+17,https://twitter.com/DoctorEdny/status/473546130102702083,,,,
DrDonaldHarvey,6/2/2014 15:25,0,1,One-stop drug delivery - it's possible to link moabs to nanoparticles. Dr. Mark Davis # ASCO14,,,#,4.73546E+17,https://twitter.com/DrDonaldHarvey/status/473546068626374656,,,,
kellykcotton,6/2/2014 15:25,3,2,@ rsm2800 Non-flash photography of slides for personal/non-commercial use is OK - you're safe Tweeting your pics! # ASCO14,,@,#,4.73546E+17,https://twitter.com/kellykcotton/status/473546060602671104,,,,
alantanmd,6/2/2014 15:25,0,0,Apatinib small molecule VEGF inhibitor improves OS in advanced gastric # ASCO14 pic.twitter.com/nTiNKKDavG,,,#,4.73546E+17,https://twitter.com/alantanmd/status/473546035218743296,,,,
strategicTy,6/2/2014 15:25,0,1,My 1st # livetweet at # asco14 !!! Learning frm the BEST- theyre all here @ subatomicdoc @ fischmd @ DrAttai @ mtmdphd @ obogler @ rsm2800 # THANKYOU,,@ @ @ @ @ @,# # #,4.73546E+17,https://twitter.com/strategicTy/status/473545932966199296,,,,
CancerGeek,6/2/2014 15:25,0,0,One rare cancer leads to another: Cancer registry saves baby’s life http://www.today.com/health/one-rare-cancer-leads-another-cancer-registry-saves-babys-life-2D79738991 … via @ todayshowhealth # cancer # ASCO14 # gyncsm,,@,# # #,4.73546E+17,https://twitter.com/CancerGeek/status/473545842431782913,,,,
drseisenberg,6/2/2014 15:24,5,0,@ s4pm is a 501(c)(3) not-for-profit organization devoted to promoting the concept of # participatorymedicine # epatient # ASCO14,,@,# # #,4.73546E+17,https://twitter.com/drseisenberg/status/473545811167440896,,,,
subatomicdoc,6/2/2014 15:24,1,1,"@ mtmdphd correctly points out # pharma can make # socmed regulations transparent, open source and adapt # ASCO14",,@,# # #,4.73546E+17,https://twitter.com/subatomicdoc/status/473545772743811073,,,,
fischmd,6/2/2014 15:23,4,2,"“The bigger the pharma, the more lawyers...the more rigid. They’re not going to want to do things.” @ mtmdphd # ASCO14",,@,#,4.73545E+17,https://twitter.com/fischmd/status/473545365866946560,,,,
adamfeuerstein,6/2/2014 15:23,3,9,$ INCY 'IDO' Cancer Immunotherapy Causes Investor Scrum at # ASCO14 -> http://www.thestreet.com/story/12730378/1/incytes-ido-cancer-immunotherapy-causes-investor-scrum-at-asco-14.html …,,,#,4.73545E+17,https://twitter.com/adamfeuerstein/status/473545341233799168,,,,
RaisBahrami,6/2/2014 15:23,0,0,@ sambrancatomd poster for Ph2 vaccine trial for BCG failures now open and accruing patients. # NCIUOB # ASCO14 pic.twitter.com/6ePxkp9GgS,,@,# #,4.73545E+17,https://twitter.com/RaisBahrami/status/473545339946147840,,,,
Preslaura,6/2/2014 15:23,0,0,@ DrAttai even cooler is that I just got RT by # ASCO14 Rockstar! :),,@,#,4.73545E+17,https://twitter.com/Preslaura/status/473545336792027137,,,,
drseisenberg,6/2/2014 15:22,5,1,"RT @ ArmstrongDrew: Re health IT: Standards are like toothbrushes. Everyone has one but nobody wants to use yours."" # ASCO14""",,@,#,4.73545E+17,https://twitter.com/drseisenberg/status/473545302008659968,,,,
kellykcotton,6/2/2014 15:22,5,1,"Little data on social media creating bias in clinical trials, but several cautionary tales. Important discussion to have @ rsm2800 # ASCO14",,@,#,4.73545E+17,https://twitter.com/kellykcotton/status/473545221012066305,,,,
DrPaulyDeSantis,6/2/2014 15:21,0,1,$ MRK mk-3475 # asco14 pic.twitter.com/cMteRq4mJL,,,#,4.73545E+17,https://twitter.com/DrPaulyDeSantis/status/473545020788989953,,,,
NextGenClinical,6/2/2014 15:20,0,0,Facebook versus twitter in relaying cancer discussion. What's best? Its ever changing. Maybe more Pintrest says Thompson. # ASCO14,,,#,4.73545E+17,https://twitter.com/NextGenClinical/status/473544781659144192,,,,
DrAttai,6/2/2014 15:20,2,4,@ rsm2800 twitter most helpful when tweets have an embedded link # ASCO14,,@,#,4.73545E+17,https://twitter.com/DrAttai/status/473544779339661312,,,,
ProjectInno,6/2/2014 15:20,2,0,20% drop in govt funded basic cancer research poses a challenge to finding new cures: http://ow.ly/xs1Sh # innovatenow # ASCO14,,,# #,4.73545E+17,https://twitter.com/ProjectInno/status/473544695411642369,,,,
BarringtonJNC,6/2/2014 15:20,1,0,@ BarringtonJames to top this off our USA team are working hard in Chicago and Montreal for the # ASCO14 and # ISPORMontreal conferences.,,@,# #,4.73545E+17,https://twitter.com/BarringtonJNC/status/473544633705037824,,,,
subatomicdoc,6/2/2014 15:20,1,2,Oy. I burned out my laptop # ASCO14 Time to recharge,,,#,4.73545E+17,https://twitter.com/subatomicdoc/status/473544631343669248,,,,
DrMarkham,6/2/2014 15:20,6,3,"Another monthly tweetchat worth mentioning: # gyncsm, focused on gyn cancers. @ gyncsm # ASCO14",,@,# #,4.73545E+17,https://twitter.com/DrMarkham/status/473544583318888449,,,,
AlpineBV_Miller,6/2/2014 15:19,0,0,There are some interesting Provenge posters here. Too bad $ DNDN didn't present them at # AUA14 instead of # ASCO14,,,# #,4.73545E+17,https://twitter.com/AlpineBV_Miller/status/473544556840235009,,,,
JPAHealthComm,6/2/2014 15:19,0,0,"RT @ imfmyeloma: One more shot from # ASCO14: Mike Katz with his award. Congrats, Mike!! pic.twitter.com/UrJCQTuqFK",,@,#,4.73545E+17,https://twitter.com/JPAHealthComm/status/473544550217445377,,,,
DrAttai,6/2/2014 15:19,1,3,next year questions via twitter? RT @ Preslaura The Text questions feature to the presentation panels is really cool. # ASCO14,,@,#,4.73545E+17,https://twitter.com/DrAttai/status/473544525672366080,,,,
SamBrownInc,6/2/2014 15:19,0,0,Incyte ($INCY) CEO Hervé Hoppenot in a @ StreetSignsCNBC interview today @ # ASCO14. http://ow.ly/i/5LLYi # oncology # cancer # pharma # biotech,,@ @,# # # # #,4.73544E+17,https://twitter.com/SamBrownInc/status/473544457296838656,,,,
FoundationATCG,6/2/2014 15:19,1,0,"How are # AYACSM cancers biologically distinct? Find out during the Oral Abstract Session TODAY: 5:24-5:36, S100bc, Ab11008 # ASCO14",,,# #,4.73544E+17,https://twitter.com/FoundationATCG/status/473544419283841024,,,,
clareburias,6/2/2014 15:19,0,1,"In the room with - @ obogler referencing the social media rock stars"" in the audience - incl @ subatomicdoc @ fischmd @ drattai et alia # ASCO14”""",,@ @ @ @,#,4.73544E+17,https://twitter.com/clareburias/status/473544346491305984,,,,
BayerPharma,6/2/2014 15:18,1,0,# DYK bone mets in # prostatecancer patients increased risk of death by 6.6 fold. Learn more about # mCRPC on http://bit.ly/Rv49fO # ASCO14,,,# # # #,4.73544E+17,https://twitter.com/BayerPharma/status/473544219479789568,,,,
cureLauncher,6/2/2014 15:18,1,1,@ mtmdphd @ smart_patients Part 1 - Simplify trial language 4 patients Part 2 - Get clinical trial sites to actually answer the phone # ASCO14,,@ @,#,4.73544E+17,https://twitter.com/cureLauncher/status/473544215818158082,,,,
DrAttai,6/2/2014 15:18,1,2,@ obogler tweetchats do have real person to person interaction - most start off with meet and great - warm and inviting # ASCO14 # bcsm,,@,# #,4.73544E+17,https://twitter.com/DrAttai/status/473544196042027009,,,,
myCME,6/2/2014 15:17,0,0,"Baseline hypertension & BMI affects hypertension, survival during VEGF inhibitor therapy http://ow.ly/xxwbw # ASCO14 # oncology",,,# #,4.73544E+17,https://twitter.com/myCME/status/473543976453431296,,,,
DrAttai,6/2/2014 15:17,2,2,"@ rsm2800 twitter is easy to get started, maybe more so than a blog # ASCO14",,@,#,4.73544E+17,https://twitter.com/DrAttai/status/473543943796563968,,,,
UNC_Lineberger,6/2/2014 15:17,2,2,"Congratulations Dr. Michael Eblan, recipient of 2014 @ ASCO & @ iConquerCancer Oncology Trainee Travel Award! # ASCO14 pic.twitter.com/fdYWQgl9pq",,@ @,#,4.73544E+17,https://twitter.com/UNC_Lineberger/status/473543904265273344,,,,
nycdoc29,6/2/2014 15:17,0,0,"# ASCO14 - OBrien FCR most common 1st line regimen today in US"" - I'd comment that BR is most common in out practice & gaining rapidly""",,,#,4.73544E+17,https://twitter.com/nycdoc29/status/473543884631724034,,,,
brendanweiss,6/2/2014 15:16,6,3,Come see our poster on a novel model for risk of progression in smoldering # myeloma # ASCO14 # mmsmpic.twitter.com/5gvM6Xiw0f,,,# # #,4.73544E+17,https://twitter.com/brendanweiss/status/473543784232275968,,,,
KoontzOncology,6/2/2014 15:16,0,0,Barriers to CAM research in children. # ASCO14 pic.twitter.com/JleN0duwEX,,,#,4.73544E+17,https://twitter.com/KoontzOncology/status/473543722840629249,,,,
Preslaura,6/2/2014 15:16,0,0,The Text questions feature to the presentation panels is really cool. # ASCO14,,,#,4.73544E+17,https://twitter.com/Preslaura/status/473543676245729281,,,,
clareburias,6/2/2014 15:16,0,0,Tweeting live from # ASCO14,,,#,4.73544E+17,https://twitter.com/clareburias/status/473543646428413953,,,,
Amgen,6/2/2014 15:15,1,1,# Amgen to present data on delay in SREs in patients with metastatic disease @3:12pm CDT in E253 # ASCO14,,@3,# #,4.73543E+17,https://twitter.com/Amgen/status/473543455453753344,,,,
ASCO,6/2/2014 15:15,3,2,AVATAXHER shows increased pCR with bevacizumab in HER2+ breast cancer stratified by early PET change http://bit.ly/1p0RgW6 # ASCO14,,,#,4.73543E+17,https://twitter.com/ASCO/status/473543449413967872,,,,
scientre,6/2/2014 15:15,2,0,"Pts 1st! But to support pts v valuable contribution to trials, privacy on blinding should be high on list @ DrAttai @ mtmdphd @ rsm2800 # ASCO14",,@ @ @,#,4.73543E+17,https://twitter.com/scientre/status/473543433525952514,,,,
DrAttai,6/2/2014 15:15,0,0,TY! RT @ DrMarkham Well-deserved. RT @ DrAttai: thanks @ obogler for the # bcsm shoutout including @ jodyms and @ stales # ASCO14,,@ @ @ @ @,# #,4.73543E+17,https://twitter.com/DrAttai/status/473543403527872512,,,,
Carpowich,6/2/2014 15:15,0,0,"Get out your score sheets: @ matthewherper tallies drug co. winners & losers from # ASCO14 annual meeting, via @ Forbes http://ow.ly/xxtJz",,@ @,#,4.73543E+17,https://twitter.com/Carpowich/status/473543378907721728,,,,
drdonsdizon,6/2/2014 15:15,0,1,"@ DrAttai @ mtmdphd @ rsm2800 @ obogler Missed it! Argh! But, survivorship near and dear to me. # ASCO14",,@ @ @ @,#,4.73543E+17,https://twitter.com/drdonsdizon/status/473543358355632128,,,,
a_silverstein,6/2/2014 15:14,0,0,". @ brianreid good point, just hard to fathom drop when we've made so many other positive advances in cancer. # asco14",,@,#,4.73543E+17,https://twitter.com/a_silverstein/status/473543250968444928,,,,
Mira_Kind,6/2/2014 15:13,0,1,. @ ASCO Poster by @ JoanneWeidhaas on # KRASvariant and NSCLC treatment response now posted: http://goo.gl/E094aZ # ASCO14,,@ @,# #,4.73543E+17,https://twitter.com/Mira_Kind/status/473542996760072192,,,,
LurieCancer,6/2/2014 15:13,1,1,Why it's so compelling... Don't neglect the social in social media: it's more conversation than presentation, says @ obogler # ASCO14,,@,#,4.73543E+17,https://twitter.com/LurieCancer/status/473542931727777795,,,
DrMarkham,6/2/2014 15:13,2,4,"Loved the social media talk by @ rsm2800 @ mtmdphd & @ obogler. Great work, speakers! # ASCO14",,@ @ @,#,4.73543E+17,https://twitter.com/DrMarkham/status/473542930767294465,,,,
WilmotCancer,6/2/2014 15:13,0,0,WCI's Karen Mustian shares her findings on the impact of exercise in older # prostatecancer patients at # ASCO14. pic.twitter.com/zNnqY5lMYq,,,# #,4.73543E+17,https://twitter.com/WilmotCancer/status/473542927059525632,,,,
drcbsteer,6/2/2014 15:13,0,0,# ASCO14 CLL session. Porter - CAR T Cell therapy. No evidence of GVHD as a SFX.,,,#,4.73543E+17,https://twitter.com/drcbsteer/status/473542910466883584,,,,
DrAttai,6/2/2014 15:13,2,3,"btw - the room for @ mtmdphd @ rsm2800 @ obogler is packed. Nice to see all the docs interested in SM, learning from the pros # ASCO14",,@ @ @,#,4.73543E+17,https://twitter.com/DrAttai/status/473542898492137472,,,,
gorskon,6/2/2014 15:13,0,5,"I note that I live my blogging life by Dr. Bruce Johnson's quote. I piss people off, but I piss people off who need it. @ JackWestMD # ASCO14",,@,#,4.73543E+17,https://twitter.com/gorskon/status/473542883098632193,,,,
DrPaulyDeSantis,6/2/2014 15:13,1,1,PD-1/PDL-1 expression broad implications for EMT shift # ASCO14 pic.twitter.com/e8Ak80eWYh,,,#,4.73543E+17,https://twitter.com/DrPaulyDeSantis/status/473542869178155008,,,,
drdonsdizon,6/2/2014 15:13,0,1,"If you are in the session on survivorship after a gyn cancer, or are following on twitter. OK to s/o a question # ASCO14.",,,#,4.73543E+17,https://twitter.com/drdonsdizon/status/473542855387254786,,,,
subatomicdoc,6/2/2014 15:12,1,0,RT @ mtmdphd: Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://bit.ly/T7Qb3W,,@ @,#,4.73543E+17,https://twitter.com/subatomicdoc/status/473542702584582144,,,,
MaverickNY,6/2/2014 15:12,1,2,@ djsampson @ obogler RT in a low volume # hashtag convo is one thing but for # asco14 lose signal to noise ratio in firehose,,@ @,# #,4.73543E+17,https://twitter.com/MaverickNY/status/473542659643310081,,,,
tabASCOsauce3,6/2/2014 15:12,0,1,Then this happened # ASCO14 pic.twitter.com/Zv2Y9LHrti,,,#,4.73543E+17,https://twitter.com/tabASCOsauce3/status/473542618593624064,,,,
nycdoc29,6/2/2014 15:12,0,0,“ @ drcbsteer: # ASCO14 Porter - CAR T cell therapy SFX include hypogammaglobulinemia from B cell aplasia.” Possible update on this tomorrow.,,@,#,4.73543E+17,https://twitter.com/nycdoc29/status/473542605259931650,,,,
subatomicdoc,6/2/2014 15:11,0,0,@ gorskon What have you found worthwhile? # ASCO14,,@,#,4.73543E+17,https://twitter.com/subatomicdoc/status/473542528180822016,,,,
subatomicdoc,6/2/2014 15:11,0,0,"@ gorskon I don't think it's the only platform, but currently the most popular. I've tinkered with others, too # ASCO14",,@,#,4.73542E+17,https://twitter.com/subatomicdoc/status/473542496656445442,,,,
NextGenClinical,6/2/2014 15:11,0,0,"Bolger- Don't neglect the social"" in social media. It's a conversation. # ASCO14""",,,#,4.73542E+17,https://twitter.com/NextGenClinical/status/473542490960588800,,,,
SurvivorRunner,6/2/2014 15:11,1,0,"“ @ DrAttai: @ obogler patients like to have their doctors, or at least some doctors, on SM # ASCO14” <----I know I do!",,@ @,#,4.73542E+17,https://twitter.com/SurvivorRunner/status/473542466940178432,,,,
scientre,6/2/2014 15:11,0,0,MT @ DrAttai: @ rsm2800 bottom line: need to be careful w use of SM & clinical trials - patient privacy utmost importance # ASCO14,,@ @,#,4.73542E+17,https://twitter.com/scientre/status/473542451060539393,,,,
drcbsteer,6/2/2014 15:11,2,1,# ASCO14 Porter - CAR T cell therapy at UPENN. Oldest patient 76YRS. No upper age limit but need to tolerate cytokine release syndrome,,,#,4.73542E+17,https://twitter.com/drcbsteer/status/473542431615774721,,,,
djsampson,6/2/2014 15:11,1,3,Don't neglect the social in social media. It's a conversation not a presentation @ obogler # asco14,,@,#,4.73542E+17,https://twitter.com/djsampson/status/473542418654973952,,,,
Emory_R,6/2/2014 15:11,0,0,"If You Build It, They Will Chuckle: Northwest Bio's Super-Sized # ASCO14 Booth - Adam's Biotech Beat - TheStreet http://buff.ly/1tBZkg7 $ NWBO",,,#,4.73542E+17,https://twitter.com/Emory_R/status/473542346811121664,,,,
ICONplc,6/2/2014 15:11,0,0,@ obogler great presentation @ ASCO # socialmedia. Thanks for sharing your personal # Brest cancer story,,@ @,# #,4.73542E+17,https://twitter.com/ICONplc/status/473542338560929792,,,,
DrAttai,6/2/2014 15:11,1,1,@ obogler you rock!! # ASCO14,,@,#,4.73542E+17,https://twitter.com/DrAttai/status/473542322769379328,,,,
strategicTy,6/2/2014 15:10,2,1,Social is Education @ obogler # asco14 # endcancer @PhysRelations @ oncolex,,@ @PhysRelations @,# #,4.73542E+17,https://twitter.com/strategicTy/status/473542275709296640,,,,
DrMarkham,6/2/2014 15:10,0,0,". @ obogler: don't neglect the social"" in social media. # ASCO14""",,@,#,4.73542E+17,https://twitter.com/DrMarkham/status/473542266955378688,,,,
subatomicdoc,6/2/2014 15:10,2,1,"@ obogler Social media is media, but it's also social. About conversation and human touch # ASCO14",,@,#,4.73542E+17,https://twitter.com/subatomicdoc/status/473542241282052097,,,,
nycdoc29,6/2/2014 15:10,1,0,“ @ drcbsteer: # ASCO14 Porter - CAR T cell therapy SFX include hypogammaglobulinemia from B cell aplasia.” also in some BTK inhibitor Rx pts,,@,#,4.73542E+17,https://twitter.com/nycdoc29/status/473542234718347265,,,,
mtmdphd,6/2/2014 15:10,1,1,"“ @ IMFmyeloma: One more shot from # ASCO14: Mike Katz with his award. Congrats, Mike!! pic.twitter.com/eRenPqgWsY” # mmsm <- congrats",,@,# #,4.73542E+17,https://twitter.com/mtmdphd/status/473542200404750336,,,,
Roche,6/2/2014 15:10,12,4,"Though treatment is improving, longer lifespans mean more cancer: incidence has doubled in the past 25 years. http://ow.ly/xp7sz # ASCO14",,,#,4.73542E+17,https://twitter.com/Roche/status/473542175138283520,,,,
trialcard,6/2/2014 15:10,0,0,GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact - $ GSK # ASCO14 http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 … RT via @ JohnCFierce,,@,#,4.73542E+17,https://twitter.com/trialcard/status/473542159468339200,,,,
WorldCongress,6/2/2014 15:10,0,0,R. Hauser @ ASCO about Efforts for Outcomes Driven Models - Integrate Support for Federal Quality Initiatives http://bit.ly/1lou1pR # EHR14,,@,#,4.73542E+17,https://twitter.com/WorldCongress/status/473542155794137088,,,,
MedMeeting,6/2/2014 15:10,2,0,R. Hauser @ ASCO about Efforts for Outcomes Driven Models - Integrate Support for Federal Quality Initiatives http://bit.ly/1lou1pR # EHR14,,@,#,4.73542E+17,https://twitter.com/MedMeeting/status/473542123288264704,,,,
DrPaulyDeSantis,6/2/2014 15:10,0,2,$ INCY IDO+ Ipilimumab # asco14 pic.twitter.com/aUX6Nxn6nH,,,#,4.73542E+17,https://twitter.com/DrPaulyDeSantis/status/473542118326411264,,,,
DrAttai,6/2/2014 15:09,1,0,"@ obogler patients like to have their doctors, or at least some doctors, on SM # ASCO14",,@,#,4.73542E+17,https://twitter.com/DrAttai/status/473542019823194112,,,,
LurieCancer,6/2/2014 15:09,1,3,". @ obogler: Social is Education--connect & learn!"" @ NMladicNU @ NUFeinbergMed # bcsm # ASCO14""",,@ @ @,# #,4.73542E+17,https://twitter.com/LurieCancer/status/473541972381433856,,,,
amandad_dc,6/2/2014 15:09,0,0,How I spent the last three days: staffing our booth at # ASCO14 http://instagram.com/p/owL0WAC_ca/,,,#,4.73542E+17,https://twitter.com/amandad_dc/status/473541965946949632,,,,
drqili,6/2/2014 15:09,0,0,Prospective registry of multiplex testing PROMPT is a great effort to share information on multi cancer genes. Several prezo on this # ASCO14,,,#,4.73542E+17,https://twitter.com/drqili/status/473541960104300544,,,,
subatomicdoc,6/2/2014 15:09,7,10,"+100 RT @ DrMarkham: What I love about Twitter is that it creates community, makes our world a smaller place. # ASCO14",,@,#,4.73542E+17,https://twitter.com/subatomicdoc/status/473541925015130113,,,,
GuneetWalia,6/2/2014 15:09,4,3,Adv # NSCLC with MET amplification responds to crizotinib: @ TheALCF funded researcher Ross Camidge at # ASCO14 # LCSM http://www.sciencedaily.com/releases/2014/05/140531154907.htm …,,@,# # #,4.73542E+17,https://twitter.com/GuneetWalia/status/473541924536602624,,,,
tabASCOsauce3,6/2/2014 15:08,0,0,Our docs talking! # ASCO14 pic.twitter.com/fn4zPCM4Fh,,,#,4.73542E+17,https://twitter.com/tabASCOsauce3/status/473541769402277888,,,,
DrMarkham,6/2/2014 15:08,4,3,"What I love about Twitter is that it creates community, makes our world a smaller place. # ASCO14",,,#,4.73542E+17,https://twitter.com/DrMarkham/status/473541741229133824,,,,
stales,6/2/2014 15:08,0,1,RT @ DrMarkham: Analysis of tweets from # bcsm chat by @ obogler is fascinating. # ASCO14,,@ @,# #,4.73542E+17,https://twitter.com/stales/status/473541735763943424,,,,
drcbsteer,6/2/2014 15:08,0,0,# ASCO14 Porter - CAR T cell therapy SFX include hypogammaglobulinemia from B cell aplasia.,,,#,4.73542E+17,https://twitter.com/drcbsteer/status/473541727937392640,,,,
rsm2800,6/2/2014 15:08,5,7,"Tweetchats are a blur with the number of tweets flying per hour, BUT…important information is still shared # bcsm # asco14",,,# #,4.73542E+17,https://twitter.com/rsm2800/status/473541691501080576,,,,
ecancer,6/2/2014 15:08,2,2,Met @ cancereu this morning at # ASCO14 to discuss improving access for patients to the latest cancer information through @ ecancer_patient,,@ @,#,4.73542E+17,https://twitter.com/ecancer/status/473541662942048256,,,,
stales,6/2/2014 15:08,1,0,RT @ subatomicdoc: 60% of activity in # bcsm is retweets over period @ obogler studied # ASCO14 Power of resonation,,@ @,# #,4.73542E+17,https://twitter.com/stales/status/473541651529744384,,,,
mtmdphd,6/2/2014 15:08,0,0,“@wingofzock: Apple enters the health care app market with tracking app Healthbook: http://ti.me/U7gMPt ” # ASCO14,,@wingofzock,#,4.73542E+17,https://twitter.com/mtmdphd/status/473541646685310976,,,,
stales,6/2/2014 15:08,1,0,"RT @ subatomicdoc: Cites # bcsm tweet chat on male breast cancer 10/7/2013. @ obogler Social is education."" # ASCO14""",,@ @,# #,4.73542E+17,https://twitter.com/stales/status/473541634681229313,,,,
nycdoc29,6/2/2014 15:08,0,0,# ASCO14 - nice review of data and basic science of CAR-T in CLL. Highlighted differences between diff groups.,,,#,4.73542E+17,https://twitter.com/nycdoc29/status/473541563248041984,,,,
a_silverstein,6/2/2014 15:07,0,0,@ brianreid @ OncologyTimes @ CliffordHudis @ ASCO @ mtmdphd I imagine people smart than me (you all) would see pros & cons in this,,@ @ @ @ @,,4.73542E+17,https://twitter.com/a_silverstein/status/473541554569609216,,,,
echo_nyc,6/2/2014 15:07,0,0,"As an aside - have been stuck outside for a while, but the BBQ smells fantastic. # ASCO14",,,#,4.73542E+17,https://twitter.com/echo_nyc/status/473541550606417920,,,,
djsampson,6/2/2014 15:07,1,0,"Ive always had trouble with RTs in a hashtagged chat. @ obogler tho points out their value as a sort of like"" # asco14""",,@,#,4.73542E+17,https://twitter.com/djsampson/status/473541542917853184,,,,
JacobPlieth,6/2/2014 15:07,2,0,Why govt-funded CALGB study might pique industry interest. Via @ EPVantage # ASCO14 $ LLY $ BMY http://ow.ly/xxuBG,,@,#,4.73542E+17,https://twitter.com/JacobPlieth/status/473541539122393088,,,,
subatomicdoc,6/2/2014 15:07,1,0,"Cites # bcsm tweet chat on male breast cancer 10/7/2013. @ obogler Social is education."" # ASCO14""",,@,# #,4.73542E+17,https://twitter.com/subatomicdoc/status/473541513226379266,,,,
DrAttai,6/2/2014 15:07,2,1,@ obogler discussing 10/2013 # bcsm tweetchat on male breast cancer # ASCO14 - describing the flurry of activity,,@,# #,4.73541E+17,https://twitter.com/DrAttai/status/473541429533618177,,,,
gorskon,6/2/2014 15:07,0,1,"@ rjblaskiewicz Social media at # ASCO14, that's all.",,@,#,4.73541E+17,https://twitter.com/gorskon/status/473541401834057728,,,,
jackiefox12,6/2/2014 15:07,2,0,"RT @ stales: RT @ rsm2800: “Amazing community” # bcsm tweetchat, acknowledges the seminal work by founders @ stales @ jodyms & @ DrAttai # ASCO14",,@ @ @ @ @,# #,4.73541E+17,https://twitter.com/jackiefox12/status/473541311371698176,,,,
LurieCancer,6/2/2014 15:07,0,1,. @ obogler: # bcsm community is much bigger than analytics may indicate. Many more are listening & learning. # ASCO14,,@,# #,4.73541E+17,https://twitter.com/LurieCancer/status/473541308146278401,,,,
fischmd,6/2/2014 15:06,3,3,"Looking under the # bcsm hood, via @ obogler # ASCO14: many participants, a very long “tail”, RT is key for ripple effect in twitter pond",,@,# #,4.73541E+17,https://twitter.com/fischmd/status/473541275929829376,,,,
gorskon,6/2/2014 15:06,0,0,@ drattai @ obogler The same is true of blog comment threads. The vast majority of blog readers never actually comment. # ASCO14,,@ @,#,4.73541E+17,https://twitter.com/gorskon/status/473541260808962048,,,,
DrMarkham,6/2/2014 15:06,0,1,Analysis of tweets from # bcsm chat by @ obogler is fascinating. # ASCO14,,@,# #,4.73541E+17,https://twitter.com/DrMarkham/status/473541257252179968,,,,
RielyMD,6/2/2014 15:06,0,0,"Abstract 6566, Gerber: 80% of ECOG lung ca trials excluded pts with other cancers <5yrs. ~ 10% in SEER w/lung ca w/ other ca <5yrs # ASCO14",,,#,4.73541E+17,https://twitter.com/RielyMD/status/473541234301341697,,,,
DrAttai,6/2/2014 15:06,1,2,@ obogler I want your slides!! # ASCO14 - fascinating research on # bcsm,,@,# #,4.73541E+17,https://twitter.com/DrAttai/status/473541203779411968,,,,
Melanoma_doctor,6/2/2014 15:06,0,1,"Clarification, injectable= intratumoral injectable MT @ Melanoma_doctor: Combo Rx for injectables should be w Ipi/PD1 Ab # melanoma # ASCO14",,@,# #,4.73541E+17,https://twitter.com/Melanoma_doctor/status/473541177791504385,,,,
subatomicdoc,6/2/2014 15:06,1,0,60% of activity in # bcsm is retweets over period @ obogler studied # ASCO14 Power of resonation,,@,# #,4.73541E+17,https://twitter.com/subatomicdoc/status/473541143787892737,,,,
rsm2800,6/2/2014 15:06,2,1,". @ obogler did analytics of # bcsm tweetchat, showed a long tail on the participant curve (so many lurkers) # asco14",,@,# #,4.73541E+17,https://twitter.com/rsm2800/status/473541117665755136,,,,
KoontzOncology,6/2/2014 15:06,0,0,Concerns with research studies of CAM therapies in pediatric cancer patients summarized by Dr. Kelly. # ASCO14 pic.twitter.com/DfITMjVnUo,,,#,4.73541E+17,https://twitter.com/KoontzOncology/status/473541095222411265,,,,
BCRFcure,6/2/2014 15:06,3,3,Women with # breastcancer urged to continue taking Tamoxifen for 10 years after receiving treatment http://ow.ly/xxqiu # ASCO2014,,,# #,4.73541E+17,https://twitter.com/BCRFcure/status/473541065589673984,,,,
echo_nyc,6/2/2014 15:06,0,0,My twitter stream is filled with useful data from # ASCO14 and people breathlessly talking about $ AAPL's new OS...,,,#,4.73541E+17,https://twitter.com/echo_nyc/status/473541065589657600,,,,
stales,6/2/2014 15:06,0,0,"RT @ rsm2800: “Amazing community” # bcsm tweetchat, acknowledges the seminal work by founders @ stales @ jodyms & @ DrAttai # ASCO14",,@ @ @ @,# #,4.73541E+17,https://twitter.com/stales/status/473541060762013700,,,,
subatomicdoc,6/2/2014 15:05,1,0,MT @ KoontzOncology: Pediatric cancer patients use CAM at rate of 30-40% as per Dr. Kara Kelly. # ASCO14 http://bit.ly/1pMLWFJ / # pedcsm,,@,# #,4.73541E+17,https://twitter.com/subatomicdoc/status/473540995951632384,,,,
DrAttai,6/2/2014 15:05,1,2,@ obogler many who participate in the # bcsm tweetchats are lurkers - reach is bigger than the #'s suggest # ASCO14,,@,# # #,4.73541E+17,https://twitter.com/DrAttai/status/473540990704578560,,,,
stales,6/2/2014 15:05,0,0,RT @ DrMarkham: Well-deserved. RT @ DrAttai: thanks @ obogler for the # bcsm shoutout including @ jodyms and @ stales # ASCO14,,@ @ @ @ @,# #,4.73541E+17,https://twitter.com/stales/status/473540960945971200,,,,
ChrisHeery,6/2/2014 15:05,0,0,“ @ subatomicdoc: 60% of patients discouraged by oncologist to participate in trials # ASCO14 @ mtmdphd” That's awful.,,@ @,#,4.73541E+17,https://twitter.com/ChrisHeery/status/473540903760834560,,,,
GenentechJobs,6/2/2014 15:05,1,0,# DYK Tweeting during # ASCO14 may help you have a better conference experience. http://bit.ly/TReGD8,,,# #,4.73541E+17,https://twitter.com/GenentechJobs/status/473540890409979904,,,,
stales,6/2/2014 15:05,0,0,RT @GSK_conferences: O Bogler @ MDAndersonNews: gr8t speaker: male # breastcancer pt & # Cancer researcher http://malebreastcancerblog.org # ASCO14 # bcsm,,@GSK_conferences @,# # # #,4.73541E+17,https://twitter.com/stales/status/473540887856025600,,,,
Boehringer,6/2/2014 15:05,3,1," # lungcancer is driven by an increasing number of driver mutations” Frank Hilberg http://bit.ly/1tz9det # notjustonedisease # ASCO14""",,,# # #,4.73541E+17,https://twitter.com/Boehringer/status/473540868700639233,,,,
SyLapostolle,6/2/2014 15:05,0,0,L'immunothérapie partout ici # ASCO14 demain dans @ APMinfos,,@,#,4.73541E+17,https://twitter.com/SyLapostolle/status/473540863688069120,,,,
Rad_Nation,6/2/2014 15:05,1,0,Omission of radiation in elderly women w/early # breastcancer receiving hormonal therapy http://abstracts.asco.org/144/AbstView_144_130366.html … # ASCO14 # bcsm # radonc,,,# # # #,4.73541E+17,https://twitter.com/Rad_Nation/status/473540834609344512,,,,
nycdoc29,6/2/2014 15:05,1,0,“ @ drcbsteer: # ASCO14 Porter - Cytokine release syndrome from CAR T cell therapy reversed with tocilizumab” we have siltuximab now as well.,,@,#,4.73541E+17,https://twitter.com/nycdoc29/status/473540808285904896,,,,
DrMarkham,6/2/2014 15:04,0,0,Well-deserved. RT @ DrAttai: thanks @ obogler for the # bcsm shoutout including @ jodyms and @ stales # ASCO14,,@ @ @ @,# #,4.73541E+17,https://twitter.com/DrMarkham/status/473540719786065920,,,,
jodyms,6/2/2014 15:04,0,2,TY! RT @ subatomicdoc: Shout out to # bcsm and @ DrAttai @ stales @ jodyms et al by @ obogler # ASCO14,,@ @ @ @ @,# #,4.73541E+17,https://twitter.com/jodyms/status/473540704308719616,,,,
SyLapostolle,6/2/2014 15:04,0,2,Des phases I à plus de 400 patients en onco # ASCO14,,,#,4.73541E+17,https://twitter.com/SyLapostolle/status/473540686088650752,,,,
rsm2800,6/2/2014 15:04,3,2,"“Amazing community” # bcsm tweetchat, acknowledges the seminal work by founders @ stales @ jodyms & @ DrAttai (who is in the audience) # ASCO14",,@ @ @,# #,4.73541E+17,https://twitter.com/rsm2800/status/473540676030701568,,,,
aftimosp,6/2/2014 15:04,0,1,Room S405: preliminary activity of the anti-CD70 monoclonal antibody in CTCL and RCC # ASCO14 pic.twitter.com/Ku95p9mV8H,,,#,4.73541E+17,https://twitter.com/aftimosp/status/473540657001144322,,,,
stales,6/2/2014 15:04,0,0,RT @ subatomicdoc: Shout out to # bcsm and @ DrAttai @ stales @ jodyms et al by @ obogler # ASCO14,,@ @ @ @ @,# #,4.73541E+17,https://twitter.com/stales/status/473540626290868224,,,,
NextGenClinical,6/2/2014 15:04,0,0,"Bolger's relays his personal breast cancer journey. Entering the world of pink"". His wife also dx with breast cancer. # ASCO14""",,,#,4.73541E+17,https://twitter.com/NextGenClinical/status/473540615645724672,,,,
Melanoma_doctor,6/2/2014 15:04,0,0,The World Series of # melanoma at # ASCO14: oral abstract session at 4 pm ET (one hr),,,# #,4.73541E+17,https://twitter.com/Melanoma_doctor/status/473540605734580224,,,,
KoontzOncology,6/2/2014 15:04,0,0,Pediatric cancer patients use CAM at rate of 30-40% as per Dr. Kara Kelly. # ASCO14 pic.twitter.com/YHIE4OSjYh,,,#,4.73541E+17,https://twitter.com/KoontzOncology/status/473540554027192320,,,,
drcbsteer,6/2/2014 15:03,0,0,# ASCO14 Porter - Cytokine release syndrome from CAR T cell therapy reversed with tocilizumab,,,#,4.7354E+17,https://twitter.com/drcbsteer/status/473540452017516545,,,,
DrAttai,6/2/2014 15:03,1,1,thanks @ obogler for the # bcsm shoutout including @ jodyms and @ stales # ASCO14,,@ @ @,# #,4.7354E+17,https://twitter.com/DrAttai/status/473540444685885440,,,,
fischmd,6/2/2014 15:03,9,2,"Charming, riveting, informative: @ obogler is killing it here at # ASCO14 talking about # breastcancer # bcsm and his # patientexperience",,@,# # # #,4.7354E+17,https://twitter.com/fischmd/status/473540413933223936,,,,
subatomicdoc,6/2/2014 15:03,2,1,Shout out to # bcsm and @ DrAttai @ stales @ jodyms et al by @ obogler # ASCO14,,@ @ @ @,# #,4.7354E+17,https://twitter.com/subatomicdoc/status/473540399974612992,,,,
jalopezg70,6/2/2014 15:03,0,1,"Uno de los mejores momentos con la buena compañía de los Drs. C. Fernández-Martos, J. Martin y A. Poveda en # ASCO14 pic.twitter.com/LOQVjUHHw5",,,#,4.7354E+17,https://twitter.com/jalopezg70/status/473540398158061570,,,,
drqili,6/2/2014 15:03,0,0,"Pt genetic panel test results,10% confirmed w/ interptn, 20% are variants of unkwn signifce, 70%neg. Need data sharing for VUS. # ASCO14",,,#,4.7354E+17,https://twitter.com/drqili/status/473540397298237440,,,,
echo_nyc,6/2/2014 15:03,0,0,Ran into @ adamfeuerstein at # ASCO14 Always nice to meet tweeps in person,,@,#,4.7354E+17,https://twitter.com/echo_nyc/status/473540329447374848,,,,
IMFmyeloma,6/2/2014 15:02,4,4,"One more shot from # ASCO14: Mike Katz with his award. Congrats, Mike!! pic.twitter.com/CODwOPWHMl",,,#,4.7354E+17,https://twitter.com/IMFmyeloma/status/473540218986180608,,,,
ASCO,6/2/2014 15:02,1,1,"Experts discuss patterns, # genomics of second cancers in today's Ed Session (4:45-6PM, S404) http://bit.ly/1iwrXX5 # ASCO14",,,# #,4.7354E+17,https://twitter.com/ASCO/status/473540209406406656,,,,
ElizBlanchardMD,6/2/2014 15:02,0,0,"The ostentatious-ness of the exhibits makes me a bit queezy, but Lilly art by pts,caregivers is exceptional # ASCO14 pic.twitter.com/4h6KeUdCXy",,,#,4.7354E+17,https://twitter.com/ElizBlanchardMD/status/473540188564508672,,,,
aftimosp,6/2/2014 15:02,0,0,Immunotherapy room 405: Our poster on an anti-CD70 monoclonal antibody in solid & hematological malignancies # ASCO14 pic.twitter.com/sGs5I51fqU,,,#,4.7354E+17,https://twitter.com/aftimosp/status/473540183783006210,,,,
mtmdphd,6/2/2014 15:02,2,0,"Here I am, topless in the @ nytimes -- @ obogler on being a guy with breast cancer - # ASCO14 # bcsm",,@ @,# #,4.7354E+17,https://twitter.com/mtmdphd/status/473540175562543105,,,,
scientre,6/2/2014 15:02,1,2,Big risk MT @ ArmstrongDrew So here's some of risk of social media in clinical trials-patients self-unblinding # asco14 https://twitter.com/ArmstrongDrew/status/473537424627617793/photo/1pic.twitter.com/HvJknsM9hH,,@,#,4.7354E+17,https://twitter.com/scientre/status/473540152628113409,,,,
DoctorEdny,6/2/2014 15:02,1,0,Cancer nanotechnology session: MR-guided US for BBB permeability through microbubbles - my # ASCO14 happy place pic.twitter.com/8qDCZrdwsw,,,#,4.7354E+17,https://twitter.com/DoctorEdny/status/473540148094042112,,,,
strategicTy,6/2/2014 15:02,5,0,@ obogler Describes what its like to be a patient and what the science is in his blog # asco14 # endcancer http://ow.ly/i/5LLgh,,@,# #,4.7354E+17,https://twitter.com/strategicTy/status/473540107455451136,,,,
mayocliniclabs,6/2/2014 15:02,0,0,Are you attending # ASCO14 in Chicago? Check out our blog to learn about our latest advancements in cancer testing. http://mayocl.in/T1r6rl,,,#,4.7354E+17,https://twitter.com/mayocliniclabs/status/473540079248736256,,,,
ethanjweiss,6/2/2014 15:02,0,1,I am totally overwhelmed...RT @ MaverickNY: My stream is totally dominated by # wwdc and # asco14 mind blowing mashup...,,@,# #,4.7354E+17,https://twitter.com/ethanjweiss/status/473540074328453120,,,,
AbbottNews,6/2/2014 15:02,6,3,Abbott develops tests to help physicians provide cancer patients with personalized treatment options # ASCO2014 http://bit.ly/1hGVuwV,,,#,4.7354E+17,https://twitter.com/AbbottNews/status/473540058788945920,,,,
ASCO,6/2/2014 15:02,6,5,Breast cancer field leverages unique biomarkers to enhance personalized medicine http://bit.ly/1gZd2tj # ASCO14,,,#,4.7354E+17,https://twitter.com/ASCO/status/473540055341232128,,,,
rsm2800,6/2/2014 15:02,2,2,Per @ obogler his experience as a male breast cancer patient led to advocacy for more research for male breast ca # asco14 # bcsm,,@,# #,4.7354E+17,https://twitter.com/rsm2800/status/473540049103888384,,,,
Novartis,6/2/2014 15:01,1,1,One hour to go before oral presentation on ALK+ NSCLC in S Hall A1. # ASCO14. The presentation starts at 3:48pm CDT,,,#,4.7354E+17,https://twitter.com/Novartis/status/473540042015916032,,,,
subatomicdoc,6/2/2014 15:01,1,0,Only 1/3 of # clinicaltrials allow men with # breastcancer to accrue. # ASCO14 # lackofaccess @ obogler,,@,# # # #,4.7354E+17,https://twitter.com/subatomicdoc/status/473540032024702976,,,,
DrAttai,6/2/2014 15:01,0,0,@ obogler only 1/3 of clinical trials for breast cancer even allow men to accrue # ASCO14,,@,#,4.7354E+17,https://twitter.com/DrAttai/status/473540011535917056,,,,
DanBudwick,6/2/2014 15:01,0,2,Celldex plans multiple Phase 1/2 combo studies - CD27 antibody & checkpoints like BMS' nivo/Yervoy & chemos http://ir.celldex.com/releasedetail.cfm?ReleaseID=851870 … # ASCO14,,,#,4.7354E+17,https://twitter.com/DanBudwick/status/473539995262025729,,,,
DrPaulyDeSantis,6/2/2014 15:01,0,3,I dont think theres any hype surrounding immuno/onc drugs $ BMY $ MRK $ ROG $ PFE # ASCO14 pic.twitter.com/PSPGRPoGgM,,,#,4.7354E+17,https://twitter.com/DrPaulyDeSantis/status/473539959253504000,,,,
mtmdphd,6/2/2014 15:01,0,1,Complaining is hard for a middle aged white guy... @ obogler male breast cancer survivor speaking at # ASCO14 # bcsm,,@,# #,4.7354E+17,https://twitter.com/mtmdphd/status/473539930380312577,,,,
subatomicdoc,6/2/2014 15:01,1,0,@ obogler looked and...$200M for breast cancer above others. But...what about male breast cancer? # bcsm # ASCO14,,@,# #,4.7354E+17,https://twitter.com/subatomicdoc/status/473539904668848128,,,,
Jesus_A_Olmos,6/2/2014 15:01,0,0,iOs 8 deja fuera al iphone 4 # iOS8 # AppleWWDC14 # ASCO14 # LoSabia,,,# # # #,4.7354E+17,https://twitter.com/Jesus_A_Olmos/status/473539877867618305,,,,
gorskon,6/2/2014 15:01,0,0,"But middle aged white guys do run the world, at least right now. # ASCO14",,,#,4.7354E+17,https://twitter.com/gorskon/status/473539865783451648,,,,
ONAcom,6/2/2014 15:01,0,0,# ASCO14: Fewer than 5% of adults with cancer enroll in clinical trials - read more http://ow.ly/xwdWh,,,#,4.7354E+17,https://twitter.com/ONAcom/status/473539832904699904,,,,
CancerDotNet,6/2/2014 15:00,0,0,Seen artwork throughout the # ASCO14 exhibit hall? Keep a lookout for the inspiring pieces by survivors/caregivers http://bit.ly/1rC1v7V,,,#,4.7354E+17,https://twitter.com/CancerDotNet/status/473539775476293633,,,,
subatomicdoc,6/2/2014 15:00,1,0,@ BekRx Did you know there is a journal for negative results? Knowing what not to do is very important too. Great to see at # ASCO14,,@,#,4.7354E+17,https://twitter.com/subatomicdoc/status/473539723651055616,,,,
FoundationATCG,6/2/2014 15:00,3,1,Celebrating 50 years of Science and Society # ASCO14. Read about the possibilities ahead: http://bit.ly/1kmrISN,,,#,4.7354E+17,https://twitter.com/FoundationATCG/status/473539632744128512,,,,
cure_magazine,6/2/2014 15:00,1,2,"Largest # asco14 yet? Attendance tops 34,600 for its 50th annual meeting.",,,#,4.7354E+17,https://twitter.com/cure_magazine/status/473539632408571904,,,,
DrAttai,6/2/2014 15:00,0,0,@ obogler docs have given him feedback that they use his blog to help educate their patients # ASCO14,,@,#,4.7354E+17,https://twitter.com/DrAttai/status/473539631078977536,,,,
CancerResearch,6/2/2014 15:00,0,0,5. SMILE! Shop with # Amazonsmile # ASCO14 http://ow.ly/xwkev,,,# #,4.7354E+17,https://twitter.com/CancerResearch/status/473539605812510720,,,,
myriadgenetics,6/2/2014 15:00,0,0,Myriad's myRisk # genepanel test detects significantly more deleterious mutations than single cancer tests. # ASCO14 http://bit.ly/1u88lQ8,,,# #,4.7354E+17,https://twitter.com/myriadgenetics/status/473539568814137344,,,,
Agendia,6/2/2014 15:00,0,0,@ whitworthmd BluePrint molecular subtyping + MammaPrint reclassified up to 25% of breast cancers. # ASCO14 # bcsm # hcsm http://hub.am/1kBveE5,,@,# # #,4.7354E+17,https://twitter.com/Agendia/status/473539563714248704,,,,
subatomicdoc,6/2/2014 15:00,2,0,@ obogler Written for mainstream but found helpful by other physicians # ASCO14,,@,#,4.7354E+17,https://twitter.com/subatomicdoc/status/473539563093114881,,,,
Agendia,6/2/2014 15:00,0,0,@ beitsch BluePrint molecular subtyping + MammaPrint reclassified up to 25% of breast cancers. # ASCO14 # bcsm # hcsm http://hub.am/1hRRrhn,,@,# # #,4.7354E+17,https://twitter.com/Agendia/status/473539554717466626,,,,
christinemphmd,6/2/2014 14:59,1,3,"AWESOME!!!! @ mtmdphd: @ obogler referencing social media rock stars"" in the audience - incl @ subatomicdoc @ fischmd @ drattai et alia # ASCO14""",,@ @ @ @ @,#,4.7354E+17,https://twitter.com/christinemphmd/status/473539540406505474,,,,
socflyny,6/2/2014 14:59,0,0,@ chemobrainfog Interesting @ sloan_kettering study - Late axillary recurrence after negative SLNB: http://abstracts.asco.org/144/AbstView_144_128936.html … (DM me) # ASCO14,,@ @,#,4.7354E+17,https://twitter.com/socflyny/status/473539537210454016,,,,
peterschoonheim,6/2/2014 14:59,0,0,Beautiful new # Elsevier booth at ASCO. Come over and learn about our Journals and educational initiatives. # ASCO14 pic.twitter.com/3k9Dlo6Ehj,,,# #,4.73539E+17,https://twitter.com/peterschoonheim/status/473539493254139905,,,,
Melanoma_doctor,6/2/2014 14:59,0,0,@ NJresearch RT @ twittmanda: So here’s some risk of social media in clinical trials--patients self-unblinding: # asco14 https://twitter.com/ArmstrongDrew/status/473537424627617793/photo/1pic.twitter.com/mIshnEsnWv,,@ @,#,4.73539E+17,https://twitter.com/Melanoma_doctor/status/473539484068630528,,,,
BekRx,6/2/2014 14:59,7,4,"Dwelling on the negative - they may be disappointing, but # ASCO14 has me thinking about how important negative trials really are.",,,#,4.73539E+17,https://twitter.com/BekRx/status/473539474413346817,,,,
oracknows,6/2/2014 14:59,0,1,Here's something for Orac's Tweeps to check out. # ASCO14 http://malebreastcancerblog.org,,,#,4.73539E+17,https://twitter.com/oracknows/status/473539455211433984,,,,
CathyWindels,6/2/2014 14:59,0,0,Sally Pipes: How a drug discount program backfired for cancer patients: http://onforb.es/1p0bMGD via @ forbes # cancer # ASCO14,,@,# #,4.73539E+17,https://twitter.com/CathyWindels/status/473539446361448450,,,,
subatomicdoc,6/2/2014 14:59,1,0,"@ obogler goal was to raise awareness, has transformed into advocacy # ASCO14 # bcsm",,@,# #,4.73539E+17,https://twitter.com/subatomicdoc/status/473539427168305152,,,,
DrAttai,6/2/2014 14:59,2,0,@ obogler started blogging about his cancer - figured I should make something of it - http://malebreastcancerblog.org/ # ASCO14,,@,#,4.73539E+17,https://twitter.com/DrAttai/status/473539426560528385,,,,
scientre,6/2/2014 14:59,2,0,BIG issue! MT @ fischmd Nervous laughter as @ rsm2800 describes online pt behaviors that might disrupt # clinicaltrials or bias data # ASCO14,,@ @,# #,4.73539E+17,https://twitter.com/scientre/status/473539402560724992,,,,
gorskon,6/2/2014 14:59,1,2,Here's something for my Tweeps to check out. # ASCO14 http://malebreastcancerblog.org,,,#,4.73539E+17,https://twitter.com/gorskon/status/473539400945512449,,,,
mtmdphd,6/2/2014 14:59,0,1,Entering a world of pink -- male breast cancer - via @ obogler # bcsm # ASCO14 # hcsm,,@,# # #,4.73539E+17,https://twitter.com/mtmdphd/status/473539347825045504,,,,
adamfeuerstein,6/2/2014 14:59,2,5,Enough activity in $ INCY IDO poster update at 50mg dose to justify combos with PD-1s. $ MRK $ BMY # ASCO14 Next data # ASCO15?,,,# #,4.73539E+17,https://twitter.com/adamfeuerstein/status/473539320595628032,,,,
strategicTy,6/2/2014 14:58,0,0,@ rsm2800 Data ≠ information ≠ knowledge | Can tools like @ oncolex help MD’s & researchers bridge divide w/ patients? # asco14 @PhysRelations,,@ @ @PhysRelations,#,4.73539E+17,https://twitter.com/strategicTy/status/473539246666821632,,,,
subatomicdoc,6/2/2014 14:58,1,0,@ obogler chose to blog about it on http://malbreastcancerblog.org # ASCO14,,@,#,4.73539E+17,https://twitter.com/subatomicdoc/status/473539232460718081,,,,
gorskon,6/2/2014 14:58,2,1,. @ subatomicdoc @ rsm2800 @ mtmdphd Of course it potentially could bias outcomes. Anyone who's been in social media a decade knows that # ASCO14,,@ @ @,#,4.73539E+17,https://twitter.com/gorskon/status/473539185744171008,,,,
ZaidAbdelsattar,6/2/2014 14:58,0,0,With my great mentor Dr. Hendren at # ASCO14 and our mixed-methods project,,,#,4.73539E+17,https://twitter.com/ZaidAbdelsattar/status/473539135412924417,,,,
ConquerCancerFd,6/2/2014 14:58,1,1,There's still time to honor @ ASCO's 50th w/ a gift to @ iConquerCancer. Your donation will be matched! http://ccf.asco.org # ASCO2014,,@ @,#,4.73539E+17,https://twitter.com/ConquerCancerFd/status/473539122314113024,,,,
SRGIDIBELL,6/2/2014 14:57,0,0," @ jalopezg70: Drs. Garcia del Muro and OM Tirado from # GEIS with a Ph-II trial:GEM +/- SIR in # STS # ASCO14 Great job team!""",,@,# # #,4.73539E+17,https://twitter.com/SRGIDIBELL/status/473539029213147139,,,,
DrAttai,6/2/2014 14:57,2,0,"@ obogler sharing his breast cancer story, and contrasting that w/ his wife # ASCO14",,@,#,4.73539E+17,https://twitter.com/DrAttai/status/473539018719002625,,,,
MediTech_Media,6/2/2014 14:57,0,1,@ obogler discussing social media from both the physician and # cancer patient perspective. # ASCO14 Very unique!,,@,# #,4.73539E+17,https://twitter.com/MediTech_Media/status/473538983478439936,,,,
carisls,6/2/2014 14:57,0,0,"Caris' technology says what can we do today"" to target treatments in pediatric cancers. // HT @ leonardSender # ASCO14 http://goo.gl/GRDd5I""",,@,#,4.73539E+17,https://twitter.com/carisls/status/473538947436408832,,,,
drcbsteer,6/2/2014 14:57,0,0,# ASCO14 Porter UPenn. CAR T cells as therapy in CLL. Best cartoon of what CAR is that I have seen. Impressive results but a lot of caveats.,,,#,4.73539E+17,https://twitter.com/drcbsteer/status/473538913630699520,,,,
subatomicdoc,6/2/2014 14:57,1,0,"@ obogler Multiple interactions between patients, providers in variety of ways # ASCO14",,@,#,4.73539E+17,https://twitter.com/subatomicdoc/status/473538815949152256,,,,
DrAttai,6/2/2014 14:57,2,0,@ obogler social media provides tremendous opportunity for doc-pt and pt-pt communication as well as social advocacy # ASCO14,,@,#,4.73539E+17,https://twitter.com/DrAttai/status/473538811688132608,,,,
knwachter,6/2/2014 14:56,0,0,RT @ NCIMedia: NCI at # ASCO14: A brief overview on research in women's # cancers: http://1.usa.gov/1pLOoMG pic.twitter.com/99ng4lgnO0,,@,# #,4.73539E+17,https://twitter.com/knwachter/status/473538767295639552,,,,
mtmdphd,6/2/2014 14:56,1,3,". @ obogler referencing the social media rock stars"" in the audience - incl @ subatomicdoc @ fischmd @ drattai et alia # ASCO14""",,@ @ @ @,#,4.73539E+17,https://twitter.com/mtmdphd/status/473538638492749825,,,,
DrMarkham,6/2/2014 14:56,0,2,". @ obogler: a lot of social media rock stars are in the audience"" # ASCO14""",,@,#,4.73539E+17,https://twitter.com/DrMarkham/status/473538628816490496,,,,
carisls,6/2/2014 14:56,0,0,"First time extensive comprehensive molecular profiling has been done in pediatric cancers"" -- @ leonardSender # ASCO14 http://goo.gl/GRDd5I""",,@,#,4.73539E+17,https://twitter.com/carisls/status/473538612416364545,,,,
ConsanoScott,6/2/2014 14:56,0,1,@ HopkinsMedicine Dr. Fader - Lack of weight loss action plan = huge barrier to weight management after cancer tx # ASCO14,,@,#,4.73539E+17,https://twitter.com/ConsanoScott/status/473538568766640128,,,,
CourtneyKagan,6/2/2014 14:55,0,0,Just painted the hope mural! Can't wait to see it in Chicago @LlyOncOnCanvas # HopeForward # ASCO14 pic.twitter.com/5V7idh4jnN,,@LlyOncOnCanvas,# #,4.73539E+17,https://twitter.com/CourtneyKagan/status/473538514764578816,,,,
subatomicdoc,6/2/2014 14:55,1,1,"@ obogler Badge and Bracelet"" - personal talk but can't separate from professional @ MDAndersonNews # ASCO14""",,@ @,#,4.73538E+17,https://twitter.com/subatomicdoc/status/473538476852260864,,,,
socflyny,6/2/2014 14:55,0,0,"@ subatomicdoc Great for firms, but who is educating patients? Common sense isn't common; self-disclosure on # social easily exploited # ASCO14",,@,# #,4.73538E+17,https://twitter.com/socflyny/status/473538358787211264,,,,
DrAttai,6/2/2014 14:55,2,0,@ obogler up next - Badge and Bracelet - The use of Social Media from an Academic and Personal Perspective # ASCO14,,@,#,4.73538E+17,https://twitter.com/DrAttai/status/473538335601078272,,,,
CancerTherAdvsr,6/2/2014 14:55,0,0,# ASCO14: Molecular Predictors May ID Patients with # Glioblastoma Likely to Benefit from Bevacizumab http://ow.ly/xvs3D,,,# #,4.73538E+17,https://twitter.com/CancerTherAdvsr/status/473538335261351937,,,,
subatomicdoc,6/2/2014 14:55,0,1,Last of the triad: @ obogler # ASCO14,,@,#,4.73538E+17,https://twitter.com/subatomicdoc/status/473538288544784385,,,,
QMBCI,6/2/2014 14:54,0,0," @ gorskon: ""Standards are like toothbrushes. Everybody has one"," but nobody wants to use yours."" # ASCO14""""",,@,#,4.73538E+17,https://twitter.com/QMBCI/status/473538264243392513,,,
InvestorHar,6/2/2014 14:54,0,0,@DamianFierce @ FierceBiotech Is there any coverage on $ STML # ASCO14 ?,,@DamianFierce @,#,4.73538E+17,https://twitter.com/InvestorHar/status/473538222002540544,,,,
DrAttai,6/2/2014 14:54,4,2,@ rsm2800 bottom line - you need to be careful w/ the use of SM and clinical trials - patient privacy of utmost importance # ASCO14,,@,#,4.73538E+17,https://twitter.com/DrAttai/status/473538202696187906,,,,
knwachter,6/2/2014 14:54,0,0,@ gorskon Thanks. I'll look for it. There's too much to process in the # ASCO now and a lot of good commentary is getting lost. # ASCO2014,,@,# #,4.73538E+17,https://twitter.com/knwachter/status/473538189790302208,,,,
OncNursingNews,6/2/2014 14:54,0,0,Key Role for Exemestane in Preventing Breast Cancer Recurrence in Premenopausal Women http://ow.ly/xxrJL # ASCO14,,,#,4.73538E+17,https://twitter.com/OncNursingNews/status/473538182362185730,,,,
cureLauncher,6/2/2014 14:54,2,1,@ rsm2800 What patients really need is a human being to be their healthcare navigator. We do this by phone.One by one.One on one. # ASCO14,,@,#,4.73538E+17,https://twitter.com/cureLauncher/status/473538138015404032,,,,
mattshomepage,6/2/2014 14:54,0,0,"# ASCO14 Any attendees interested in clinical/biomedical text mining, the bioNLP 2014 workshop is coming up! http://aclweb.org/aclwiki/index.php?title=BioNLP_Workshop …",,,#,4.73538E+17,https://twitter.com/mattshomepage/status/473538059800047617,,,,
subatomicdoc,6/2/2014 14:54,1,2,@ rsm2800 Data ≠ information ≠ knowledge. Caveat researcher # clinicaltrials # ASCO14,,@,# #,4.73538E+17,https://twitter.com/subatomicdoc/status/473538053546311680,,,,
subatomicdoc,6/2/2014 14:54,0,0,Fatigue & gonadal function in 796 testicular cancer survivors 12 and 19 years after treatment http://bit.ly/1ksZ7qd # ASCO14 # tscsm # ayacsm,,,# # #,4.73538E+17,https://twitter.com/subatomicdoc/status/473538043308421120,,,,
Rad_Nation,6/2/2014 14:54,0,0,Fatigue & gonadal function in 796 testicular cancer survivors 12 and 19 years after treatment http://buff.ly/1ksZ4L6 # ASCO14 # tscsm # ayacsm,,,# # #,4.73538E+17,https://twitter.com/Rad_Nation/status/473538040561156097,,,,
jalopezg70,6/2/2014 14:53,2,1,Drs. Garcia del Muro and OM Tirado from # GEIS with a Ph-II trial:GEM +/- SIR in # STS # ASCO14 http://tinyurl.com/ofsv4gs pic.twitter.com/E9wqeTSAUM,,,# # #,4.73538E+17,https://twitter.com/jalopezg70/status/473538014375710722,,,,
fischmd,6/2/2014 14:53,1,0,"Nervous laughter as @ rsm2800 describes online # epatient behaviors that might disrupt # clinicaltrials or bias the data {gulp], # ASCO14",,@,# # #,4.73538E+17,https://twitter.com/fischmd/status/473538001428295680,,,,
ncbennevis,6/2/2014 14:53,2,0,Philadelphia Chromosome to Survivorship Issues: 50 Years of Progress in # Hematologic # Cancer Research # ASCO2014 http://am.asco.org/philadelphia-chromosome-survivorship-issues-50-years-progress-hematologic-cancer-research#.U4zIFvJxB2c.twitter …,,,# # # #,4.73538E+17,https://twitter.com/ncbennevis/status/473537968234176512,,,,
chicagocapman,6/2/2014 14:53,0,0,The lines are still long... # ASCO14 Come find us for a # pickmeup.pic.twitter.com/WfZcVbHenk,,,# #,4.73538E+17,https://twitter.com/chicagocapman/status/473537910428667904,,,,
mtmdphd,6/2/2014 14:53,16,13,Patients are experts on themselves. Need to blend with MD expertise about the disease. Collaboration. # ASCO14,,,#,4.73538E+17,https://twitter.com/mtmdphd/status/473537906506997760,,,,
gorskon,6/2/2014 14:53,1,0,Data ≠ Information ≠ knowledge. You can't blend these things. # ASCO14,,,#,4.73538E+17,https://twitter.com/gorskon/status/473537883358244864,,,,
rsm2800,6/2/2014 14:53,12,2,# trial: clinical research in the age of social media (Lancet Oncology editorial) http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)70206-2/fulltext … # ASCO14,,,# #,4.73538E+17,https://twitter.com/rsm2800/status/473537868754067456,,,,
BoysenMeb,6/2/2014 14:53,0,0,Thank you for the interview @ CliffordHudis # ASCO14 # selfie @DagMedicinpic.twitter.com/OaKNlvpkn3,,@ @DagMedicinpic,# #,4.73538E+17,https://twitter.com/BoysenMeb/status/473537858590892032,,,,
brianbrewer,6/2/2014 14:53,0,2,$4.41. Convention center cafeteria extortion. # asco14 pic.twitter.com/3tzJNxIutg,,,#,4.73538E+17,https://twitter.com/brianbrewer/status/473537821815607296,,,,
ShannonWestin,6/2/2014 14:52,0,0,Cancer is a teachable moment - use to discuss and address obesity. # ASCO14 @ SGO_org has a great resource for this- the obesity toolkit.,,@,#,4.73538E+17,https://twitter.com/ShannonWestin/status/473537708737167360,,,,
JacobPlieth,6/2/2014 14:52,1,0,"$ INCY IDO + ipi adverse events, including 50mg dose # ASCO14 pic.twitter.com/QHCctxepR1",,,#,4.73538E+17,https://twitter.com/JacobPlieth/status/473537646812094464,,,,
subatomicdoc,6/2/2014 14:52,2,0,Great point by @ rsm2800 - can social media/networking bias outcomes? I've referred to as psychologic amplification # ASCO14 # clinicaltrials,,@,# #,4.73538E+17,https://twitter.com/subatomicdoc/status/473537542784954368,,,,
djsampson,6/2/2014 14:51,0,0,"Pts may falsify eligibility for trials, guess arm status, etc. using social media to chat with other pts on study # asco14",,,#,4.73538E+17,https://twitter.com/djsampson/status/473537529191223296,,,,
UCCancerCenter,6/2/2014 14:51,0,3,"Informative session on using social media for sharing cancer data, patient education, providing info on clinical trials # ASCO14",,,#,4.73538E+17,https://twitter.com/UCCancerCenter/status/473537523906408448,,,,
gorskon,6/2/2014 14:51,2,0,"Also, social media results in increased sensitization and perhaps over- or under-reporting of symptoms. # ASCO14",,,#,4.73538E+17,https://twitter.com/gorskon/status/473537521909899264,,,,
RielyMD,6/2/2014 14:51,1,0,"Abstract 6544, Tarazona: OS=DSS in pts with GI cancers, so should not exclude pts with history of other cancers from clin trials # ASCO14",,,#,4.73537E+17,https://twitter.com/RielyMD/status/473537497083830273,,,,
mtmdphd,6/2/2014 14:51,4,2,"We're all kind of nervously laughing..."" - @ rsm2800 about patients on trial online discussions - many issues. # ASCO14""",,@,#,4.73537E+17,https://twitter.com/mtmdphd/status/473537468818784257,,,,
drseisenberg,6/2/2014 14:51,0,0,RT @ rsm2800 Practical Guidance: The Use of Social Media In Oncology Practice (JOP 2012) http://jop.ascopubs.org/content/8/5/e114.full … # ASCO14,,@,#,4.73537E+17,https://twitter.com/drseisenberg/status/473537421498281984,,,,
strategicTy,6/2/2014 14:51,1,0,“Cancer apps (are) a great space to do research in” - @ rsm2800 . Great chance beginning today for @ ppisters @PhysRelations # asco14 # pilot,,@ @ @PhysRelations,# #,4.73537E+17,https://twitter.com/strategicTy/status/473537410073370624,,,,
rsm2800,6/2/2014 14:51,5,2,Practical Guidance: The Use of Social Media In Oncology Practice (JOP 2012) http://jop.ascopubs.org/content/8/5/e114.full … # ASCO14,,,#,4.73537E+17,https://twitter.com/rsm2800/status/473537365286612993,,,,
gorskon,6/2/2014 14:51,3,1,Encouraging falsification of eligibility status by social media - it's happening. # ASCO14,,,#,4.73537E+17,https://twitter.com/gorskon/status/473537346248261633,,,,
obogler,6/2/2014 14:51,2,0,@ rsm2800 talks about dark side of social media - how patients sometimes try and game the system to get on trials # ASCO2014,,@,#,4.73537E+17,https://twitter.com/obogler/status/473537338321420288,,,,
subatomicdoc,6/2/2014 14:51,1,0,Advice on how to game the system. Is it bad or good? But it's happening @ rsm2800 # clinicaltrials # ASCO14,,@,# #,4.73537E+17,https://twitter.com/subatomicdoc/status/473537337377296384,,,,
DrAttai,6/2/2014 14:50,1,1,"@ rsm2800 there's a darkside"" to clinical trial participants being online - unblinding", non-adherence," etc # ASCO14""",,@,#,4.73537E+17,https://twitter.com/DrAttai/status/473537272869322753,,
mignogna,6/2/2014 14:50,0,0,Major news for Cholangiocarcinoma research! Stop by booth 3029 now for more info on our upcoming Patient Registry! # ASCO14,,,#,4.73537E+17,https://twitter.com/mignogna/status/473537270629531649,,,,
FierceBiotech,6/2/2014 14:50,0,0,Tune in Thurs 2:00pm ET for 3rd # ASCO14 chat w @ FiercePharma's @ EricPFierce & @ EPVantage's @ JonEPVantage. http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … # FierceASCO,,@ @ @ @,# #,4.73537E+17,https://twitter.com/FierceBiotech/status/473537236479533056,,,,
ShannonWestin,6/2/2014 14:50,1,0,A. Nickles-Fader- review of interventions for obesity in endometrial ca survivors. What are the barriers? Lack of awareness! # ASCO14,,,#,4.73537E+17,https://twitter.com/ShannonWestin/status/473537210201825280,,,,
gorskon,6/2/2014 14:50,0,0,"@ knwachter Yesterday's Tweets from me and, of course, there will be a planned future blog post. # ASCO14",,@,#,4.73537E+17,https://twitter.com/gorskon/status/473537185426075648,,,,
DrLen,6/2/2014 14:50,0,0,Big progress in melanoma rx at # ASCO14. Time and history teaches us to tread carefully http://tinyurl.com/ok2wdbc,,,#,4.73537E+17,https://twitter.com/DrLen/status/473537176131469312,,,,
adamfeuerstein,6/2/2014 14:50,1,1,"OH at # ASCO14: Hedge fund traders helped"" $ INCY IDO investigator put up his poster.""",,,#,4.73537E+17,https://twitter.com/adamfeuerstein/status/473537166908211203,,,,
TedOkonCOA,6/2/2014 14:50,0,0,FDA cancer chief says ‘escalating’ drug prices can’t continue. http://ow.ly/xwrH2 # cancer # asco14,,,# #,4.73537E+17,https://twitter.com/TedOkonCOA/status/473537160961085440,,,,
Roche,6/2/2014 14:50,4,4,"Check out our latest Drawn to # Science"" movie about # ClinicalTrials! http://ow.ly/xp70m # ASCO14""",,,# # #,4.73537E+17,https://twitter.com/Roche/status/473537120427315201,,,,
rsm2800,6/2/2014 14:50,9,3,Potential for bias in clinical research by patient use of social networking by Glickman et al http://www.ncbi.nlm.nih.gov/pubmed/22378136 # ASCO14,,,#,4.73537E+17,https://twitter.com/rsm2800/status/473537113489944576,,,,
MaverickNY,6/2/2014 14:50,0,1,My stream is totally dominated by # wwdc and # asco14 mind blowing mashup...,,,# #,4.73537E+17,https://twitter.com/MaverickNY/status/473537105814368256,,,,
rsm2800,6/2/2014 14:50,2,7,Notable for 2 reasons: Amazing engagement at # ASCO14. And this is the 1st time I’ve ever # tweetedlivewhilespeakingpic.twitter.com/R1DUgyabt1,,,# #,4.73537E+17,https://twitter.com/rsm2800/status/473537099690291201,,,,
subatomicdoc,6/2/2014 14:50,1,0,Omission of radiation for elderly women w/early # breastcancer receiving hormonal therapy http://abstracts.asco.org/144/AbstView_144_130366.html … # ASCO14 # bcsm # radonc,,,# # # #,4.73537E+17,https://twitter.com/subatomicdoc/status/473537080308817921,,,,
subatomicdoc,6/2/2014 14:50,2,1,"Chemoradiation delays time to treatment, better local control in locally adv pancreatic CA vs chemo http://abstracts.asco.org/144/AbstView_144_132620.html … # ASCO14 # pancsm",,,# #,4.73537E+17,https://twitter.com/subatomicdoc/status/473537060167749632,,,,
RoswellPark,6/2/2014 14:50,0,0,"# RPCI Drs. Czuczman, Pili, Wang and Wetzler now presenting their latest research on lymphoma, leukemia and prostate cancer at # ASCO14",,,# #,4.73537E+17,https://twitter.com/RoswellPark/status/473537056959127552,,,,
drseisenberg,6/2/2014 14:49,0,0,RT @ DrAttai @ rsm2800 approx 380K people have signed up for @ oneoldsage - remarkable power of SM to help with clinical trials # ASCO14,,@ @ @,#,4.73537E+17,https://twitter.com/drseisenberg/status/473537026990821376,,,,
subatomicdoc,6/2/2014 14:49,0,1,@ LurieCancer Never doubt what @ rsm2800 can accomplish! :) # ASCO14,,@ @,#,4.73537E+17,https://twitter.com/subatomicdoc/status/473537008917159937,,,,
JeremyMooreFCCC,6/2/2014 14:49,0,0,@ ivanoransky no embargo breaks at # ASCO14?,,@,#,4.73537E+17,https://twitter.com/JeremyMooreFCCC/status/473536983407788032,,,,
DrDonaldHarvey,6/2/2014 14:49,0,1,How nano does nano have to be? 100 nm can cross blood brain barrier and diffuse. Dr. Justin Hanes at nanotechnology ed session # ASCO14,,,#,4.73537E+17,https://twitter.com/DrDonaldHarvey/status/473536917225897984,,,,
rsm2800,6/2/2014 14:49,1,0,Example of web-based platform matching patients to clinical trials - http://TrialX.com http://appliedinformaticsinc.com/portfolio/products-2 … # ASCO14,,,#,4.73537E+17,https://twitter.com/rsm2800/status/473536861819121665,,,,
drseisenberg,6/2/2014 14:49,0,1,# epatient is the central part of the # team. MT @ LurieCancer Patient access to information- @ rsm2800 shout out to @ ePatientDave # ASCO14,,@ @ @,# # #,4.73537E+17,https://twitter.com/drseisenberg/status/473536853706952704,,,,
gorskon,6/2/2014 14:49,1,0,Not likin' the crowd-sourced PatientsLikeMe trial. # ASCO14 http://www.sciencebasedmedicine.org/the-perils-of-patient-driven-clinical-research/ …,,,#,4.73537E+17,https://twitter.com/gorskon/status/473536839895105536,,,,
cureLauncher,6/2/2014 14:49,0,0,@ Novartis Thank you to the Novartis team for the leading the way in orphan drug development. # ASCO14,,@,#,4.73537E+17,https://twitter.com/cureLauncher/status/473536839174094848,,,,
AndyBiotech,6/2/2014 14:49,0,3,$ INCY # ASCO14 Slides/Posters Jakafi Ph2 in # PancreaticCancer http://www.incyte.com/sites/default/files/Hurwitz_ASCO%202014_RECAP%205.31.2014_FINAL.pdf … IDO+Yervoy Combo in Melanoma http://www.incyte.com/sites/default/files/ASCO2014_Gibney_INCB024360-201%20study_FINAL%205.28.2014.pdf …,,,# #,4.73537E+17,https://twitter.com/AndyBiotech/status/473536819213377536,,,,
subatomicdoc,6/2/2014 14:49,1,0,@ rsm2800 points out how @ patientslikeme engages users for # quantifiedhealth # clinicaltrials # ASCO14,,@ @,# # #,4.73537E+17,https://twitter.com/subatomicdoc/status/473536794298822656,,,,
HenryJOncology,6/2/2014 14:49,0,0,Great financial discussions on R&D in oncology. Come to poster 21 to talk # ASCO14,,,#,4.73537E+17,https://twitter.com/HenryJOncology/status/473536778721173504,,,,
JacobPlieth,6/2/2014 14:48,3,3,"$ INCY IDO + ipi poster, including 50mg dose # ASCO14 pic.twitter.com/Jk4kVutLv7",,,#,4.73537E+17,https://twitter.com/JacobPlieth/status/473536734764879874,,,,
kellykcotton,6/2/2014 14:48,0,1,"Lots of # mhealth apps out there... but of 300 unique cancer apps, few actually support disease management/prevention - @ rsm2800 # ASCO14",,@,# #,4.73537E+17,https://twitter.com/kellykcotton/status/473536653093392385,,,,
LurieCancer,6/2/2014 14:48,0,1,And they said it couldn't be done! RT @ subatomicdoc: @ rsm2800 doing the verboten - live tweet at the talk # powermove # ASCO14,,@ @,# #,4.73537E+17,https://twitter.com/LurieCancer/status/473536564501696513,,,,
mtmdphd,6/2/2014 14:48,0,0,Open ground to evaluate cancer apps for fellows etc - @ rsm2800 # ASCO14,,@,#,4.73537E+17,https://twitter.com/mtmdphd/status/473536532176195584,,,,
subatomicdoc,6/2/2014 14:47,1,1,Ripe research opportunity - what are cancer patients doing with all the apps out there? @ rsm2800 # ASCO14,,@,#,4.73537E+17,https://twitter.com/subatomicdoc/status/473536503809732608,,,,
gorskon,6/2/2014 14:47,1,0,"Bender et al: Most of the cancer apps are fairly lame."" I'd agree. Not a single evaluation of a cancer app # ASCO14""",,,#,4.73536E+17,https://twitter.com/gorskon/status/473536441213939714,,,,
JFreemanDaily,6/2/2014 14:47,0,0,Coukos: More tumor-infiltrating lymphocytes (TILs) in # cancer tumors correlates with better response to cancer treatments. # ASCO14,,,# #,4.73536E+17,https://twitter.com/JFreemanDaily/status/473536381269323777,,,,
subatomicdoc,6/2/2014 14:47,0,2,@ djsampson @ MaverickNY Ah! # selfie with me a # photobomb. No HIPAA issue. Doctors totally legal to datamine ;-) # ASCO14,,@ @,# # #,4.73536E+17,https://twitter.com/subatomicdoc/status/473536380312621056,,,,
mtmdphd,6/2/2014 14:47,1,3,Most cancer apps are fairly lame.. - @ rsm2800 # ASCO14,,@,#,4.73536E+17,https://twitter.com/mtmdphd/status/473536377867751427,,,,
jalopezg70,6/2/2014 14:47,0,0,"Drs. Cruz, Martin and Valverde from presenting a Ph-I trial with # Nilotinib in # STS # ASCO14 http://tinyurl.com/krqq366 pic.twitter.com/nfEcYuKOC6",,,# # #,4.73536E+17,https://twitter.com/jalopezg70/status/473536377452101632,,,,
rsm2800,6/2/2014 14:47,4,3,“Social Media Offers New Recruitment Strategy for Clinical Trials” via @iHealthBeat http://www.ihealthbeat.org/insight/2012/social-media-offers-new-recruitment-strategy-for-clinical-trials … # ASCO14,,@iHealthBeat,#,4.73536E+17,https://twitter.com/rsm2800/status/473536358649442304,,,,
socflyny,6/2/2014 14:46,0,0,*Any* medical self-disclosure on # social is a risk. But # cancer patients have most to lose from non-medical perspective. # ASCO14,,,# # #,4.73536E+17,https://twitter.com/socflyny/status/473536268744138752,,,,
knwachter,6/2/2014 14:46,0,0,"Been true for a long time. RT @ brianreid: A conference is no longer restricted to the walls in which you have your talks."" # ASCO14""",,@,#,4.73536E+17,https://twitter.com/knwachter/status/473536246707683330,,,,
n8pennell,6/2/2014 14:46,0,1,Tweeting from the podium: they said it couldn't be done but one man didn't accept that. Congratulations @ rsm2800! Strong work. # ASCO14 # Hcsm,,@,# #,4.73536E+17,https://twitter.com/n8pennell/status/473536227841675265,,,,
gorskon,6/2/2014 14:46,0,0,"Many people who Tweet about a conference aren't even there. Which is why I posted what I did about integrative oncology"" yesterday. # ASCO14""",,,#,4.73536E+17,https://twitter.com/gorskon/status/473536196098789377,,,,
AlpineBV_Miller,6/2/2014 14:46,0,0,Sadelain's CAR-T poster not up at # ASCO14 session.,,,#,4.73536E+17,https://twitter.com/AlpineBV_Miller/status/473536183184945152,,,,
nycdoc29,6/2/2014 14:46,0,0,# ASCO2014 - D Porter on CAR-T update in CLL,,,#,4.73536E+17,https://twitter.com/nycdoc29/status/473536167343042561,,,,
LGG1,6/2/2014 14:46,0,0,Woo hoo! @ rsm2800 live tweets from the podium at # ASCO14,,@,#,4.73536E+17,https://twitter.com/LGG1/status/473536144530210816,,,,
fischmd,6/2/2014 14:46,3,3,"A conference is now larger than the conference center: many # socialmedia interactions from people not at mtg, @ rsm2800 # ASCO14",,@,# #,4.73536E+17,https://twitter.com/fischmd/status/473536130407989248,,,,
DrMarkham,6/2/2014 14:46,3,1,"# ASCO14 is beyond the walls of McCormick Center, thanks to Twitter. @ ASCO",,@,#,4.73536E+17,https://twitter.com/DrMarkham/status/473536113051963392,,,,
Melanoma_doctor,6/2/2014 14:46,3,1,"The rise of the e-patient: informed, inquisitive, ? More likely to travel, ? More likely to enroll in clinical trials # ASCO14",,,#,4.73536E+17,https://twitter.com/Melanoma_doctor/status/473536108283039745,,,,
rsm2800,6/2/2014 14:46,4,5,"Systematic Review & Content Analysis of Smartphone Apps for Prevention, Detection, & Management of Cancer http://www.jmir.org/2013/12/e287 # ASCO14",,,#,4.73536E+17,https://twitter.com/rsm2800/status/473536107079274496,,,,
NextGenClinical,6/2/2014 14:46,2,1,# ASCO14 you have been very exciting this year! So many new innovations in cancer research! pic.twitter.com/a3vxflTtBR,,,#,4.73536E+17,https://twitter.com/NextGenClinical/status/473536062560563200,,,,
jodigralnick,6/2/2014 14:46,0,0,$ INCY CEO and @ megtirrell about to go live on # CNBC from # ASCO14 pic.twitter.com/5qfjCafjCf,,@,# #,4.73536E+17,https://twitter.com/jodigralnick/status/473536056672153600,,,,
obogler,6/2/2014 14:46,0,0,Many people who tweet about a conference aren't there - the conference is larger than before says @ rsm2800 at # ASCO14,,@,#,4.73536E+17,https://twitter.com/obogler/status/473536022102298624,,,,
gorskon,6/2/2014 14:45,2,1,Check out @ theNCI @ NCICancerCtrl @ NCIMedia @ NCIprevention @ NCI_NCIP @ NCIBiospecimens @ NCISymptomMgmt @ NCIGlobalHealth # ASCO14,,@ @ @ @ @ @ @ @,#,4.73536E+17,https://twitter.com/gorskon/status/473536007061532672,,,,
subatomicdoc,6/2/2014 14:45,0,0,@ rsm2800 doing the verboten - live tweet at the talk # powermove # ASCO14,,@,# #,4.73536E+17,https://twitter.com/subatomicdoc/status/473536001751515136,,,,
mtmdphd,6/2/2014 14:45,5,1,I and @ rsm2800 both mentioned @ symplur @ healthhashtags analytics. Great resource for medicine and oncology. # ASCO14 # tweetingfromthepodium,,@ @ @,# #,4.73536E+17,https://twitter.com/mtmdphd/status/473535995171057665,,,,
brianreid,6/2/2014 14:45,1,0,"A conference is no longer restricted to the walls in which you have your talks."" -- @ rsm2800 at # ASCO14""",,@,#,4.73536E+17,https://twitter.com/brianreid/status/473535959867592704,,,,
ePatientDave,6/2/2014 14:45,3,3,"@ DrAttai @ rsm2800 @ mtmdphd @ subatomicdoc Well hi to all at # ASCO14! Remember, I didn't start e-patient"" - I talk about what OTHERS do""",,@ @ @ @,#,4.73536E+17,https://twitter.com/ePatientDave/status/473535938371780608,,,,
DrAttai,6/2/2014 14:45,0,0,@ rsm2800 almost 6000 tweets from # SABCS; of 900+ tweeters - many were not at the conference # ASCO14,,@,# #,4.73536E+17,https://twitter.com/DrAttai/status/473535937809756160,,,,
BekRx,6/2/2014 14:45,0,1,The # ASCO14 buzzword: immunotherapy,,,#,4.73536E+17,https://twitter.com/BekRx/status/473535937805578240,,,,
drcbsteer,6/2/2014 14:45,0,0,# ASCO14 CLL Q about flu vaccination and Ibrutinib.CLL patients have decreased immunity anyway so probably can just give vaccine & cont drug,,,#,4.73536E+17,https://twitter.com/drcbsteer/status/473535916351700992,,,,
subatomicdoc,6/2/2014 14:45,2,0,@ rsm2800 highlights # SABCS13 analytics from @ symplur. Points out that the conference is no longer just on site - global # ASCO14,,@ @,# #,4.73536E+17,https://twitter.com/subatomicdoc/status/473535874123063296,,,,
Roche,6/2/2014 14:45,2,1,Thinking of # ClinicalTrials when you hear PRO? Test your clinical trials IQ: http://ow.ly/xwzCg # ASCO14,,,# #,4.73536E+17,https://twitter.com/Roche/status/473535870340186112,,,,
MaverickNY,6/2/2014 14:45,0,1,CLL session is jam packed. Needed a bigger room. # asco14,,,#,4.73536E+17,https://twitter.com/MaverickNY/status/473535866888278016,,,,
rsm2800,6/2/2014 14:45,2,0,Providers’ inevitable acceptance of patient generated health data (PGHD) http://mobihealthnews.com/31268/in-depth-providers-inevitable-acceptance-of-patient-generated-health-data … # ASCO14,,,#,4.73536E+17,https://twitter.com/rsm2800/status/473535855186165761,,,,
drseisenberg,6/2/2014 14:45,0,0,RT @ subatomicdoc: One key issue with social media (my take) will be issue with concerns re: solicitation for # clinicaltrials # ASCO14,,@,# #,4.73536E+17,https://twitter.com/drseisenberg/status/473535809866330112,,,,
socflyny,6/2/2014 14:45,0,0,@ mtmdphd SEC regs is one reason finance industry has been slow to embrace # social. What agency educates patients re self-disclosure? # ASCO14,,@,# #,4.73536E+17,https://twitter.com/socflyny/status/473535807807311873,,,,
DrAttai,6/2/2014 14:44,1,0,@ rsm2800 google and you tube most common search engines for medical information; also pubmed and other forms of social media # ASCO14,,@,#,4.73536E+17,https://twitter.com/DrAttai/status/473535713104121857,,,,
drseisenberg,6/2/2014 14:44,0,0,"RT @ subatomicdoc Key portals for information access: YouTube, PubMed, social media. # infooverload # ASCO14",,@,# #,4.73536E+17,https://twitter.com/drseisenberg/status/473535682439180289,,,,
scientre,6/2/2014 14:44,1,2,More PRO-perfO convergence? # asco14 MT @ SkipFleshman Apple introduced HealthKit with @ mayoclinic http://on.recode.net/1n1sPHy,,@ @,#,4.73536E+17,https://twitter.com/scientre/status/473535678652104704,,,,
drseisenberg,6/2/2014 14:44,0,0,"RT @ DrMarkham The epatient is equipped, empowered, enabled, and engaged. @ rsm2800 # ASCO14",,@ @,#,4.73536E+17,https://twitter.com/drseisenberg/status/473535618623209472,,,,
subatomicdoc,6/2/2014 14:44,1,1,"Key portals for information access: YouTube, PubMed, social media. # ASCO14 # infooverload",,,# #,4.73536E+17,https://twitter.com/subatomicdoc/status/473535607755378688,,,,
rsm2800,6/2/2014 14:44,0,1,The Healthcare Hashtag Project http://www.symplur.com/healthcare-hashtags … Follow meetings & communities of interest # ASCO14,,,#,4.73536E+17,https://twitter.com/rsm2800/status/473535603636973569,,,,
mtmdphd,6/2/2014 14:44,0,1,Shout out to @ ePatientDave from @ rsm2800 at # ASCO14,,@ @,#,4.73536E+17,https://twitter.com/mtmdphd/status/473535594816352256,,,,
ConsanoScott,6/2/2014 14:44,0,0,Increasing BMI correlates with # cancer mortality across all cancer types. # ASCO14,,,# #,4.73536E+17,https://twitter.com/ConsanoScott/status/473535573735768065,,,,
kellykcotton,6/2/2014 14:43,0,0,"Broadband internet, wireless internet, & social networking have led to the rise of the engaged & empowered e-patient"" - @ rsm2800 # ASCO14""",,@,#,4.73535E+17,https://twitter.com/kellykcotton/status/473535497159991296,,,,
DrAttai,6/2/2014 14:43,1,1,@ rsm2800 shout out to @ ePatientDave # ASCO14,,@ @,#,4.73535E+17,https://twitter.com/DrAttai/status/473535486481682432,,,,
subatomicdoc,6/2/2014 14:43,0,0,# Epatient emergence discussed. @ ePatientDave highlighted by @ rsm2800 # ASCO14,,@ @,# #,4.73535E+17,https://twitter.com/subatomicdoc/status/473535442600484864,,,,
DrAttai,6/2/2014 14:43,1,0,"@ rsm2800 defining e-patient - equipped, enabled, empowered, engaged; ?electronic, ?equal, ?eParticipant in clinical trials # ASCO14",,@,#,4.73535E+17,https://twitter.com/DrAttai/status/473535399777034241,,,,
obogler,6/2/2014 14:43,2,0,"The e-patient is equipped, empowered and works in partnership with physician says @ rsm2800 # ASCO14",,@,#,4.73535E+17,https://twitter.com/obogler/status/473535356134887424,,,,
rsm2800,6/2/2014 14:43,5,2,What is an e-patient? http://participatorymedicine.org/about # ASCO14,,,#,4.73535E+17,https://twitter.com/rsm2800/status/473535352108756993,,,,
Physns1stWatch,6/2/2014 14:43,1,3,Here are a few of the major news-makers presented at # ASCO14: http://jwat.ch/T7IXgr,,,#,4.73535E+17,https://twitter.com/Physns1stWatch/status/473535344961679360,,,,
DrMarkham,6/2/2014 14:43,1,1,"The epatient is equipped, empowered, enabled, and engaged. @ rsm2800 # ASCO14",,@,#,4.73535E+17,https://twitter.com/DrMarkham/status/473535328037650432,,,,
gorskon,6/2/2014 14:43,0,0,"E-patient""? Ugh. Hate to say it"," but I hate that term. There's got to be a better one. # ASCO14""",,,#,4.73535E+17,https://twitter.com/gorskon/status/473535299243372546,,,
fischmd,6/2/2014 14:43,1,2,“One of the great things about standards is that there are so many of them..” [Tongue in cheek] via @ rsm2800: # ASCO14 # hcsm # healthIT,,@,# # #,4.73535E+17,https://twitter.com/fischmd/status/473535270063968257,,,,
subatomicdoc,6/2/2014 14:42,1,1,Agree with @ rsm2800 but caveat is may not play out same in developing countries. # mhealth likely a bigger role # ASCO14,,@,# #,4.73535E+17,https://twitter.com/subatomicdoc/status/473535232528748544,,,,
ConsanoScott,6/2/2014 14:42,0,0,Obesity now surpasses smoking as #1 cause of death in the U.S. Obesity is a major threat to general health in cancer patients # ASCO14,,,#1 #,4.73535E+17,https://twitter.com/ConsanoScott/status/473535194046398464,,,,
LurieCancer,6/2/2014 14:42,0,1,". @ rsm2800: Important to remember digital divide & other consumer level barriers & # healthliteracy issues."" # ASCO14 # hchlitss""",,@,# # #,4.73535E+17,https://twitter.com/LurieCancer/status/473535162853371904,,,,
subatomicdoc,6/2/2014 14:42,1,0,@ rsm2800 3 digital revolutions: 1. Broadband access. 2. Wireless. 3. Social networking. # ASCO14,,@,#,4.73535E+17,https://twitter.com/subatomicdoc/status/473535108612247553,,,,
drdonsdizon,6/2/2014 14:42,0,0,@ ShannonWestin u r doing great on twitter! # impressed # ASCO14,,@,# #,4.73535E+17,https://twitter.com/drdonsdizon/status/473535104464461824,,,,
rsm2800,6/2/2014 14:42,0,0,Three digital revolutions leading to patient engagement and empowerment http://www.pewinternet.org/2013/07/26/e-patients-and-their-hunt-for-health-information … # ASCO14,,,#,4.73535E+17,https://twitter.com/rsm2800/status/473535100567949312,,,,
DrAttai,6/2/2014 14:42,0,1,"@ rsm2800 many barriers to access info - digital divide, health literacy, disabilities that limit access # ASCO14",,@,#,4.73535E+17,https://twitter.com/DrAttai/status/473535059266650112,,,,
djsampson,6/2/2014 14:41,3,4,"Half us us looking down, tweeting. “ @ mtmdphd: A lot of interest in social media in oncology at # ASCO14 @ ASCO pic.twitter.com/wYNkiMNDuA”",,@ @,#,4.73535E+17,https://twitter.com/djsampson/status/473534968992239616,,,,
drdonsdizon,6/2/2014 14:41,0,1,@ ConsanoScott always nice to see a friend in the audience! # ASCO14,,@,#,4.73535E+17,https://twitter.com/drdonsdizon/status/473534922133880832,,,,
dytcmd,6/2/2014 14:41,0,0,+1 “ @ DrAttai: @ mtmdphd oncologists need to be online because patients are online # ASCO14”,,@ @,#,4.73535E+17,https://twitter.com/dytcmd/status/473534880920264704,,,,
melanoma_Drs,6/2/2014 14:41,0,0,!!! RT @ obogler: @ rsm2800 “standards are like toothbrushes - everybody has one but no one wants to use yours”... # ASCO14,,@ @,#,4.73535E+17,https://twitter.com/melanoma_Drs/status/473534851921215489,,,,
Melanoma_doctor,6/2/2014 14:41,1,0,!!! RT @ obogler: @ rsm2800 “standards are like toothbrushes - everybody has one but no one wants to use yours”... # ASCO14,,@ @,#,4.73535E+17,https://twitter.com/Melanoma_doctor/status/473534851094966272,,,,
rsm2800,6/2/2014 14:41,0,0,Barriers limiting the impact of consumer health informatics applications http://www.ncbi.nlm.nih.gov/books/NBK32634 # ASCO14,,,#,4.73535E+17,https://twitter.com/rsm2800/status/473534848637083648,,,,
subatomicdoc,6/2/2014 14:41,1,0,What are the barriers? 1. Literacy/numeracy. 2. Application usability/UI. 3. Commercial influence. # ASCO14,,,#,4.73535E+17,https://twitter.com/subatomicdoc/status/473534765585285120,,,,
_Phenomenome,6/2/2014 14:40,0,2,It would be in everyone's best interest ... RT @ subatomicdoc: Can we build a @ kickstarter for cancer? ... @ Consano # ASCO14 # KnowYourRisk,,@ @ @,# #,4.73535E+17,https://twitter.com/_Phenomenome/status/473534754055524352,,,,
nuria_paladio,6/2/2014 14:40,0,0,@ JMercadeFarma i els resultats d' # ASCO2014 a quina hora?,,@,#,4.73535E+17,https://twitter.com/nuria_paladio/status/473534724619894784,,,,
adamfeuerstein,6/2/2014 14:40,1,1,$ INCY IDO poster scrum. # ASCO14 pic.twitter.com/yAk04mYGJ5,,,#,4.73535E+17,https://twitter.com/adamfeuerstein/status/473534705514459136,,,,
carisls,6/2/2014 14:40,1,0,"Our booth, 12096 has a guide to # ASCO14 # personalizedmedicine topics. Come by and talk molecular profiling with us!",,,# #,4.73535E+17,https://twitter.com/carisls/status/473534702771384320,,,,
drcbsteer,6/2/2014 14:40,0,0,"# ASCO14 Relapsed refractory CLL - ABT-199 very active drug, watch for tumour lysis syndrome. Recent update median duration response 20months",,,#,4.73535E+17,https://twitter.com/drcbsteer/status/473534666243596288,,,,
LurieCancer,6/2/2014 14:40,0,1,". @ rsm2800: Standards are like toothbrushes. Everybody has one but no one wants to use yours."" # ASCO14""",,@,#,4.73535E+17,https://twitter.com/LurieCancer/status/473534663760576512,,,,
Roche,6/2/2014 14:40,2,4,Keeping cancer # immunotherapy personal: # biomarkers lead the way to better therapy. http://ow.ly/xp6Qf # ASCO14,,,# # #,4.73535E+17,https://twitter.com/Roche/status/473534601793916928,,,,
rsm2800,6/2/2014 14:40,0,0,Principles of consumer health informatics (G Eysenbach BMJ 2000) http://www.bmj.com/content/320/7251/1713 … # ASCO14,,,#,4.73535E+17,https://twitter.com/rsm2800/status/473534597247270912,,,,
subatomicdoc,6/2/2014 14:40,0,0,"@ rsm2800 Increasingly patient portals, mobile apps and social media are emerging players in consumer health informatics # ASCO14",,@,#,4.73535E+17,https://twitter.com/subatomicdoc/status/473534590200451073,,,,
knwachter,6/2/2014 14:40,3,4,Twitter ASCO 2009: @ MaverickNY @ PharmacistScott @ MedReporter @ drsteventucker @ djsampson @ amarantoblook http://egmnblog.wordpress.com/2009/06/01/cancer-as-chronic-disease/ … # ASCO2014,,@ @ @ @ @ @,#,4.73535E+17,https://twitter.com/knwachter/status/473534586128191488,,,,
brianreid,6/2/2014 14:39,0,2,# ASCO14 soc media/clinical trials presentation by @ rsm2800. Why should you listen to him? Because everyone else is:pic.twitter.com/5rbiayNtnO,,@,#,4.73534E+17,https://twitter.com/brianreid/status/473534492380909568,,,,
mtmdphd,6/2/2014 14:39,8,10,A lot of interest in social media in oncology at # ASCO14 @ ASCO pic.twitter.com/X6RJQSniLY,,@,#,4.73534E+17,https://twitter.com/mtmdphd/status/473534482155180032,,,,
socflyny,6/2/2014 14:39,0,1,"@ fischmd @ mtmdphd Goes for patients, too. # HIPAA doesn't protect self-disclosure (think about job search, getting a loan, etc) # ASCO14",,@ @,# #,4.73534E+17,https://twitter.com/socflyny/status/473534426820132864,,,,
CancerNetwrk,6/2/2014 14:39,2,3,Early Trial of Cabozantinib and Abiraterone Shows Promise in Prostate Cancer http://bit.ly/1oowQFt # ASCO14,,,#,4.73534E+17,https://twitter.com/CancerNetwrk/status/473534372440973312,,,,
rsm2800,6/2/2014 14:39,0,0,“The best thing about standards is that there are so many of them.” http://xkcd.com/927 # informaticshumor # ASCO14,,,# #,4.73534E+17,https://twitter.com/rsm2800/status/473534346973171713,,,,
nycdoc29,6/2/2014 14:39,0,0,# ASCO14 - Great review of data of novel agents in CLL.,,,#,4.73534E+17,https://twitter.com/nycdoc29/status/473534296444383232,,,,
jalopezg70,6/2/2014 14:38,4,3,Dr. Gavilá from # FIVO presenting the preliminary results of the # TRASTYVERE study # ASCO14 http://tinyurl.com/poogv4m pic.twitter.com/0mcWj5bEzv,,,# # #,4.73534E+17,https://twitter.com/jalopezg70/status/473534255591473152,,,,
gorskon,6/2/2014 14:38,28,13,Standards are like toothbrushes. Everybody has one," but nobody wants to use yours."" # ASCO14""",,,#,4.73534E+17,https://twitter.com/gorskon/status/473534214415978496,,,
subatomicdoc,6/2/2014 14:38,1,0,Information retrieval is intersection of informatics and computer science @ rsm2800 # ASCO14,,@,#,4.73534E+17,https://twitter.com/subatomicdoc/status/473534171361456129,,,,
ShannonWestin,6/2/2014 14:38,1,0,“ @ rsm2800: Per @ mtmdphd unfortunate some patients are discouraged from participating in trials by their physicians # asco14” concerning stats,,@ @,#,4.73534E+17,https://twitter.com/ShannonWestin/status/473534121588064256,,,,
rsm2800,6/2/2014 14:38,3,0,Data vs information vs knowledge http://www.slideshare.net/EinsteinX2/data-vs-information … # ASCO14,,,#,4.73534E+17,https://twitter.com/rsm2800/status/473534093456834560,,,,
NormandBlais,6/2/2014 14:38,2,1,Seen at ASCO 2014. Stopping smoking works... Underutilized! # LCCatASCO # ASCO14 pic.twitter.com/4la8Kpt1ty,,,# #,4.73534E+17,https://twitter.com/NormandBlais/status/473534049537884160,,,,
DrAttai,6/2/2014 14:37,11,5,"@ rsm2800 standards are like toothbrushes - everybody has one but no one wants to use yours""... # ASCO14""",,@,#,4.73534E+17,https://twitter.com/DrAttai/status/473534003388379136,,,,
KathleenMaxian,6/2/2014 14:37,0,0,# ovariancancer redefining # sexual health 'education is key' Thanks @ drdonsdizon for the great # ASCO14,,@,# # #,4.73534E+17,https://twitter.com/KathleenMaxian/status/473533952066469888,,,,
rsm2800,6/2/2014 14:37,2,2,"Biomedical informatics is the field at the intersection of people, information, and technology http://www.biomedcentral.com/1472-6947/9/24 # ASCO14",,,#,4.73534E+17,https://twitter.com/rsm2800/status/473533842104791041,,,,
fischmd,6/2/2014 14:36,6,1,Flipping the classroom at # ASCO14: @ mtmdphd @ rsm2800 @ obogler schedule tweets and provide other online info to enhance their talks,,@ @ @,#,4.73534E+17,https://twitter.com/fischmd/status/473533666405392384,,,,
gorskon,6/2/2014 14:36,0,0,". @ subatomicdoc @ oracknows I don't know if attendees of # ASCO14 are ready for http://scienceblogs.com/insolence , so I plug http://www.sciencebasedmedicine.org",,@ @,#,4.73534E+17,https://twitter.com/gorskon/status/473533662063890432,,,,
subatomicdoc,6/2/2014 14:36,3,1,Data = knowledge with context @ rsm2800 # ASCO14,,@,#,4.73534E+17,https://twitter.com/subatomicdoc/status/473533656573566976,,,,
carisls,6/2/2014 14:36,0,0,Dr Sujana Movva presenting in clinical science symposium (right now!). CMI research for # sarcoma patients. pic.twitter.com/1VsbUbkjja # ASCO14,,,# #,4.73534E+17,https://twitter.com/carisls/status/473533629558042624,,,,
CancerResearch,6/2/2014 14:36,0,0,What do wedding season and CRI donations have in common? More than you'd think… # CIM2014 # ASCO14 http://owl.li/xxpPQ,,,# #,4.73534E+17,https://twitter.com/CancerResearch/status/473533621606035456,,,,
DrAttai,6/2/2014 14:36,1,0,"@ rsm2800 bioinformatics - intersection of people, information and technology. Technology isjust the tool # ASCO14",,@,#,4.73534E+17,https://twitter.com/DrAttai/status/473533516442251264,,,,
LurieCancer,6/2/2014 14:35,1,0,". @ rsm2800: A Bioinformatician's View of the Use of Social Media in Clinical Trials Re opportunities & risks for pts & researchers # ASCO14""",,@,#,4.73533E+17,https://twitter.com/LurieCancer/status/473533425346162688,,,,
obogler,6/2/2014 14:35,2,0,Now @ rsm2800 continues the discussion on how the digital revolution has enhanced patient engagement # ASCO14 S504,,@,#,4.73533E+17,https://twitter.com/obogler/status/473533345448484864,,,,
Melanoma_doctor,6/2/2014 14:35,1,0,MT @ Melanoma_doctor: Fascinating presentation on use of social media to enhance clinical trial accrual and info @ rsm2800 @ mtmdphd # ASCO14,,@ @ @,#,4.73533E+17,https://twitter.com/Melanoma_doctor/status/473533345390145536,,,,
socflyny,6/2/2014 14:35,2,1,"@ kellykcotton @ mtmdphd @ patientslikeme Very true, but also a dark side of # social self-disclosure: job discrimination, loans, etc. # ASCO14",,@ @ @,# #,4.73533E+17,https://twitter.com/socflyny/status/473533337676828672,,,,
Roche,6/2/2014 14:35,4,1,How can we tackle the imminent shortage of scientists and clinicians in oncology? http://ow.ly/xp6HR # ASCO14 # lifesciences,,,# #,4.73533E+17,https://twitter.com/Roche/status/473533316835340288,,,,
ITHS_UW,6/2/2014 14:35,0,0,Social Media in Clinical Trials: http://ow.ly/xpJkc via @ ASCO # SocialMedia # ClinicalTrials,,@,# #,4.73533E+17,https://twitter.com/ITHS_UW/status/473533312586510337,,,,
mtmdphd,6/2/2014 14:35,2,3,"Can We Build A Kickstarter For Cancer? - Forbes http://ow.ly/nB8Ho HT @ ASCO funding a “virtual biotech” for a single patient""""",,@,,4.73533E+17,https://twitter.com/mtmdphd/status/473533312011874305,,,,
PMedcn,6/2/2014 14:35,0,1,Nivolumab plus erlotinib demonstrated a response rate of 19% and was well-tolerated in EGFR-mutant NSCLC http://ow.ly/xvupg # ASCO14,,,#,4.73533E+17,https://twitter.com/PMedcn/status/473533294437728256,,,,
boehringerus,6/2/2014 14:35,1,1,Overall survival data from two Phase 3 studies for non-small cell # lungcancer presented today at # ASCO14 http://bit.ly/1mVhhsp,,,# #,4.73533E+17,https://twitter.com/boehringerus/status/473533292755845120,,,,
LSVCo,6/2/2014 14:35,0,0,Nivolumab plus erlotinib demonstrated a response rate of 19% and was well-tolerated in EGFR-mutant NSCLC http://ow.ly/xvupe # ASCO14,,,#,4.73533E+17,https://twitter.com/LSVCo/status/473533288276320256,,,,
US_CCS,6/2/2014 14:35,0,0,Nivolumab plus erlotinib demonstrated a response rate of 19% and was well-tolerated in EGFR-mutant NSCLC http://ow.ly/xvupj # ASCO14,,,#,4.73533E+17,https://twitter.com/US_CCS/status/473533288234364928,,,,
myriadgenetics,6/2/2014 14:35,2,0,Myriad myPath # Melanoma data are being featured at an # ASCO14 melanoma presentation. http://bit.ly/1rBXXT4 $ mygnpic.twitter.com/eVdUCdFnuY,,,# #,4.73533E+17,https://twitter.com/myriadgenetics/status/473533258462793728,,,,
DrAttai,6/2/2014 14:34,0,0,@ rsm2800 bioinformatics view of SM # ASCO14,,@,#,4.73533E+17,https://twitter.com/DrAttai/status/473533195473133568,,,,
MediTech_Media,6/2/2014 14:34,0,0,Oncologists need to be online because patients are online. Key thought from social media session at # ASCO14,,,#,4.73533E+17,https://twitter.com/MediTech_Media/status/473533187214163968,,,,
subatomicdoc,6/2/2014 14:34,1,0,Plug away! # FF @ oracknows while you're at it ;)RT @ gorskon: That's right. I also can't resist a plug whenever I can. # ASCO14,,@ @,# #,4.73533E+17,https://twitter.com/subatomicdoc/status/473533186015002625,,,,
DrMarkham,6/2/2014 14:34,4,3,We (oncologists) must be online because our patients are. @ mtmdphd # ASCO14,,@,#,4.73533E+17,https://twitter.com/DrMarkham/status/473533182609195008,,,,
urotoday,6/2/2014 14:34,1,1,# ASCO14 - Impact on overall survival with chemohormonal therapy versus hormonal therapy for ... http://dlvr.it/5s7ChL,,,#,4.73533E+17,https://twitter.com/urotoday/status/473533179953823744,,,,
urotoday,6/2/2014 14:34,0,0,# ASCO14 - Poster: Time to chemotherapy following treatment with sipuleucel-T: Data from PROCEED http://dlvr.it/5s7CcJ,,,#,4.73533E+17,https://twitter.com/urotoday/status/473533171686854657,,,,
mtmdphd,6/2/2014 14:34,0,0,"Part of my day job is in bioinformatics..."" @ rsm2800 # ASCO14""",,@,#,4.73533E+17,https://twitter.com/mtmdphd/status/473533129467396097,,,,
kellykcotton,6/2/2014 14:34,2,1,Social media can play a role in educating & engaging the public to improve clinical trials infrastructure - @ mtmdphd # ASCO14,,@,#,4.73533E+17,https://twitter.com/kellykcotton/status/473533127227228160,,,,
IcahnMountSinai,6/2/2014 14:34,0,2,Jami Fukui PhD presents on 'Comparison of weight loss among early-stage # BreastCancer patients post chemo' at # ASCO14 pic.twitter.com/dbxuawSvD7,,,# #,4.73533E+17,https://twitter.com/IcahnMountSinai/status/473533077218922497,,,,
cureLauncher,6/2/2014 14:34,1,1,@ mtmdphd @ btrfly12 @ smart_patients Thank U 4 the support. Glad to be mentioned at # ASCO14,,@ @ @,#,4.73533E+17,https://twitter.com/cureLauncher/status/473533048466571265,,,,
ShannonWestin,6/2/2014 14:33,0,1,@ drdonsdizon discusses management of female sexuality issues after GYN cancer treatment. Great review!!! # ASCO14 # gyncsm,,@,# #,4.73533E+17,https://twitter.com/ShannonWestin/status/473533000035364864,,,,
drcbsteer,6/2/2014 14:33,0,0,# ASCO14 Ibrutinib in CLL - novel toxicity - slight increase bleeding risk. Need to be careful re timing of surgery.,,,#,4.73533E+17,https://twitter.com/drcbsteer/status/473532995278999552,,,,
subatomicdoc,6/2/2014 14:33,1,0,Next up to bat: @ rsm2800 on bioinformatics perspective on # socmed # ASCO14 # hcsm,,@,# # #,4.73533E+17,https://twitter.com/subatomicdoc/status/473532956921692162,,,,
OncEd,6/2/2014 14:33,0,2,# ASCO14 Immunomodulatory activity of nivolumab in previously treated and untreated mRCC Dr. Toni Choueiri http://bit.ly/1u5Rm19,,,#,4.73533E+17,https://twitter.com/OncEd/status/473532945744289794,,,,
DrAttai,6/2/2014 14:33,4,7,@ mtmdphd oncologists need to be online because patients are online # ASCO14,,@,#,4.73533E+17,https://twitter.com/DrAttai/status/473532860469886976,,,,
LGG1,6/2/2014 14:33,0,2,Social media power panel with @ mtmdphd @ obogler @ rsm2800 at # ASCO14 pic.twitter.com/yM1UHA1nUI,,@ @ @,#,4.73533E+17,https://twitter.com/LGG1/status/473532838084898816,,,,
subatomicdoc,6/2/2014 14:33,1,0,"@ mtmdphd Fusion of ideas from researchers, clinicians patienst, others and then get the $ via crowdsourcing # ASCO14",,@,#,4.73533E+17,https://twitter.com/subatomicdoc/status/473532793536802816,,,,
ThisIsHillarie,6/2/2014 14:33,0,1,“ @ WinshipAtEmory: Melanoma expert Dr David Lawson at # ASCO14 pic.twitter.com/N0aHqC11uI” fantastic doctor!,,@,#,4.73533E+17,https://twitter.com/ThisIsHillarie/status/473532793394569216,,,,
socflyny,6/2/2014 14:33,0,0,"@ djsampson 1000% -- however, many would be well served to reconsider self-disclosure on Twitter & # social channels: much datamining # ASCO14",,@,# #,4.73533E+17,https://twitter.com/socflyny/status/473532755620671489,,,,
gorskon,6/2/2014 14:32,0,1,That's right. I also can't resist a plug whenever I can. # ASCO14,,,#,4.73533E+17,https://twitter.com/gorskon/status/473532620274286592,,,,
fischmd,6/2/2014 14:32,5,3,"Educated, engaged public is needed to sustain a national # clinicaltrials infrastructure.. # socialmedia is part of this. via @ mtmdphd # ASCO14",,@,# # #,4.73533E+17,https://twitter.com/fischmd/status/473532615296024576,,,,
knwachter,6/2/2014 14:32,2,2,"@ MaverickNY and @ drsteventucker were there too RT @ mattshomepage: In 2010, only 14 people were tweeting at ASCO. # ASCO14",,@ @ @,#,4.73533E+17,https://twitter.com/knwachter/status/473532595012395008,,,,
subatomicdoc,6/2/2014 14:32,2,1,"@ mtmdphd You can...crowdsource, crowdvote, crowdfund # clinicatrials # ASCO14",,@,# #,4.73533E+17,https://twitter.com/subatomicdoc/status/473532591413268480,,,,
ConsanoScott,6/2/2014 14:32,1,0,Role for testosterone to improve sexual health among female cancer patients? Only as last resort. Little to no benefit # asco14 @ drdonsdizon,,@,#,4.73533E+17,https://twitter.com/ConsanoScott/status/473532535113523200,,,,
Ludwig_Cancer,6/2/2014 14:32,0,0,Check out the Science of Oncology Award lecture by former Ludwig advisor & Nobel laureate Harald zur Hausen http://bit.ly/1hNj0Ze # ASCO14,,,#,4.73533E+17,https://twitter.com/Ludwig_Cancer/status/473532507649212417,,,,
jalopezg70,6/2/2014 14:31,0,0,Drs. Guerrero and Climent from # FIVO presenting their results on AR in # breastcancer # ASCO14 http://tinyurl.com/nkkgxjg pic.twitter.com/gx0cVPKZGy,,,# # #,4.73532E+17,https://twitter.com/jalopezg70/status/473532467119259649,,,,
gorskon,6/2/2014 14:31,0,0,@ obogler @ drattai Check out http://www.sciencebasedmedicine.org if you don't believe me. # ASCO14,,@ @,#,4.73532E+17,https://twitter.com/gorskon/status/473532418599563264,,,,
ASCO,6/2/2014 14:31,0,0,"Experts discuss the challenges and benefits of implementing EHRs, meaningful use, in editorial: http://bit.ly/1iwsLuR # ASCO14",,,#,4.73532E+17,https://twitter.com/ASCO/status/473532313562009601,,,,
gorskon,6/2/2014 14:31,1,0,". @ obogler @ drattai I almost *always* have something to say, but I tend to like to go into more detail. # ASCO14",,@ @,#,4.73532E+17,https://twitter.com/gorskon/status/473532311007272960,,,,
SitemanCenter,6/2/2014 14:31,1,0,"# ASCO14 A phase 2 trial of the PI3K-δ,γ inhibitor IPI-145 in patients w/refractory indolent non-Hodgkin lymphoma: http://goo.gl/9zlwXR",,,#,4.73532E+17,https://twitter.com/SitemanCenter/status/473532280129208320,,,,
mtmdphd,6/2/2014 14:31,2,2,Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlYdG,,@,#,4.73532E+17,https://twitter.com/mtmdphd/status/473532262999678976,,,,
DrAttai,6/2/2014 14:31,4,1,"@ mtmdphd can we build kickstarter for cancer using SM? # ASCO14. Crowdfund research, open access, simplifying trial enrollment # ASCO14",,@,# #,4.73532E+17,https://twitter.com/DrAttai/status/473532262638964737,,,,
corp_UNC,6/2/2014 14:31,1,0,Interoperable oncology treatment plan and summary implementation guide Deb Mayer @ UNC_Lineberger et al # asco14 http://ow.ly/xqCJn,,@,#,4.73532E+17,https://twitter.com/corp_UNC/status/473532262148235264,,,,
ConsanoMolly,6/2/2014 14:31,1,1,"More first time in real life"" meetings here at # ASCO14! @ JonnyImerman in the flesh!pic.twitter.com/A13HsO5an8""",,@,#,4.73532E+17,https://twitter.com/ConsanoMolly/status/473532252371296256,,,,
ASCO,6/2/2014 14:30,3,2,Extended Ed Session highlights how tumor genomic profiling can impact clinical practice & investigation http://bit.ly/1p0Q7ht # ASCO14,,,#,4.73532E+17,https://twitter.com/ASCO/status/473532214689689600,,,,
bmsnews,6/2/2014 14:30,3,2,"# Melanoma data from our pipeline across lines of therapy & stages of disease presented today at 3pm CDT, E Arie Crown Theater # ASCO14",,,# #,4.73532E+17,https://twitter.com/bmsnews/status/473532208192712704,,,,
subatomicdoc,6/2/2014 14:30,6,1,Can we build a @ kickstarter for cancer? Psst. look at @ Consano as a possible model. Others out there too # ASCO14,,@ @,#,4.73532E+17,https://twitter.com/subatomicdoc/status/473532199233269760,,,,
ASCO,6/2/2014 14:30,0,1,Virtual Meeting on Demand provides samples of # ASCO14 presentations: http://bit.ly/1oKjSW0,,,#,4.73532E+17,https://twitter.com/ASCO/status/473532167797354496,,,,
socflyny,6/2/2014 14:30,0,0,@ rsm2800 @ gorskon Why Twitter? (1) It's real time info (2) generally sophisticated user base. # ASCO14 # SocialMedia,,@ @,# #,4.73532E+17,https://twitter.com/socflyny/status/473532132963676160,,,,
kellykcotton,6/2/2014 14:30,7,1,"We must crowdsource the change we wish to see in the world"" - @ FarrisTimimi via @ mtmdphd social media talk at # ASCO14""",,@ @,#,4.73532E+17,https://twitter.com/kellykcotton/status/473532081600212992,,,,
rsm2800,6/2/2014 14:30,3,1,"My talk: A Bioinformatician's View of the Use of Social Media in Clinical Trials.” Re opportunities & risks for pts & researchers # ASCO14""",,,#,4.73532E+17,https://twitter.com/rsm2800/status/473532080677466112,,,,
AndyBiotech,6/2/2014 14:30,3,2,$ AZN Interesting Study on Biomarker Response of Anti-PD1 in Blood Samples From Solid Tumors Pts Undergoing RT http://clinicaltrials.gov/ct2/show/NCT02153151 … # ASCO14,,,#,4.73532E+17,https://twitter.com/AndyBiotech/status/473532080459378688,,,,
rsm2800,6/2/2014 14:30,0,0,Per @ mtmdphd interesting to note how a conservative org like Mayo Clinic has so engaged in Twitter and # hcsm # asco14,,@,# #,4.73532E+17,https://twitter.com/rsm2800/status/473532074381430785,,,,
nanostringtech,6/2/2014 14:30,2,1,"The NanoString nCounter Dx Analysis System delivers direct, multiplexed measurements of gene expression. See more @Booth 5019. # ASCO14",,@Booth,#,4.73532E+17,https://twitter.com/nanostringtech/status/473532051203690496,,,,
SanofiUS,6/2/2014 14:30,2,2,Be sure to follow along with all the relevant conversations in # prostate # cancer and # colorectal from # ASCO14!,,,# # # #,4.73532E+17,https://twitter.com/SanofiUS/status/473532044816158720,,,,
eMPR,6/2/2014 14:30,0,0,Combo Tx promising for recurrent ovarian cancer: http://ow.ly/xxico # ASCO14 # oncology,,,# #,4.73532E+17,https://twitter.com/eMPR/status/473532033751601152,,,,
GenomicHealth,6/2/2014 14:30,1,1,We are at booth 20007 at # ASCO14 - come visit! http://ow.ly/i/5LJAT,,,#,4.73532E+17,https://twitter.com/GenomicHealth/status/473532022892544000,,,,
medpagetoday,6/2/2014 14:30,1,0,ASCO: Cyramza boosts survival in NSCLC. @ atscommunity # ASCO14 http://bit.ly/1u9jQqB,,@,#,4.73532E+17,https://twitter.com/medpagetoday/status/473532005833916416,,,,
Melanoma_doctor,6/2/2014 14:29,3,2,Fascinating presentation on use of social media to enhance clinical trial accrual and info @ mtmdphd # ASCO14,,@,#,4.73532E+17,https://twitter.com/Melanoma_doctor/status/473531968383377408,,,,
subatomicdoc,6/2/2014 14:29,0,0,"@ FarrisTimimi We must crowdsource the change we want to see in the world"" per @ mtmdphd # ASCO14 # MCCSM""",,@ @,# #,4.73532E+17,https://twitter.com/subatomicdoc/status/473531924888440832,,,,
DrPaulyDeSantis,6/2/2014 14:29,2,0,"$ Incy conclusions # asco14 support role@of inflamm and jakstat pathway on pancr cancer"" pic.twitter.com/BBSBVDiGW1""",,@of,#,4.73532E+17,https://twitter.com/DrPaulyDeSantis/status/473531881342783488,,,,
fischmd,6/2/2014 14:29,1,2,"# socialmedia is a form of media...if you can’t put it on TV or some other media, don’t tweet it, via @ mtmdphd # ASCO14",,@,# #,4.73532E+17,https://twitter.com/fischmd/status/473531809385680896,,,,
brianreid,6/2/2014 14:29,1,0,i.e. less risky than you think. RT @ DrAttai: @ mtmdphd social media is a form of media re: risk of content # ASCO14,,@ @,#,4.73532E+17,https://twitter.com/brianreid/status/473531809150402560,,,,
subatomicdoc,6/2/2014 14:29,3,0,"@ mtmdphd makes excellent point. Twitter, any social media is just a diff comm tool. If you wouldn't make an ad, don't tweet it # ASCO14",,@,#,4.73532E+17,https://twitter.com/subatomicdoc/status/473531771943137280,,,,
kellykcotton,6/2/2014 14:29,1,1,Some barriers to clin trial recruitment can be overcome thru education - ditto barriers to MD social media participation # ASCO14 # hcsm,,,# #,4.73532E+17,https://twitter.com/kellykcotton/status/473531749729714176,,,,
LGG1,6/2/2014 14:28,1,1,@ mtmdphd Social media is a form of media # ASCO14,,@,#,4.73532E+17,https://twitter.com/LGG1/status/473531693832609792,,,,
yzafar,6/2/2014 14:28,14,6,"2nd-line # pancreaticcancer pts w/high CRP, ruxolitinib+cape improves OS & clinical benefit response over cape # asco14 pic.twitter.com/nZ5sVg3V7Z",,,# #,4.73532E+17,https://twitter.com/yzafar/status/473531687327256576,,,,
ConsanoScott,6/2/2014 14:28,1,1,Great talk about sexual health in female cancer patients by @ drdonsdizon # ASCO14 pic.twitter.com/NQUFLlQ5vS,,@,#,4.73532E+17,https://twitter.com/ConsanoScott/status/473531686454845441,,,,
ICONplc,6/2/2014 14:28,1,2,"Check out @ ICONSanAntonio, using social media to recruit patients # ASCO14. Great social media talk @ ASCO",,@ @,#,4.73532E+17,https://twitter.com/ICONplc/status/473531660118806528,,,,
DrAttai,6/2/2014 14:28,3,0,@ mtmdphd social media is a form of media re: risk of content # ASCO14,,@,#,4.73532E+17,https://twitter.com/DrAttai/status/473531585074315264,,,,
DarshanTalks,6/2/2014 14:28,1,1,RT @ Roche: Clinical trials - explained in an easy digestible way: http://ow.ly/xp5KN # ASCO14 # research,,@,# #,4.73532E+17,https://twitter.com/DarshanTalks/status/473531583329488896,,,,
DrPaulyDeSantis,6/2/2014 14:28,4,0,$ INCY ruxolitinib improved weight gain in all groups anti-cachexic improves survivability in pancr cancer # asco14 pic.twitter.com/sbMz3ePZxi,,,#,4.73532E+17,https://twitter.com/DrPaulyDeSantis/status/473531509966508032,,,,
gorskon,6/2/2014 14:27,0,0,"The reason I asked about Twitter and # ASCO14 is because a number of people told me today I don't Twitter.""""",,,#,4.73531E+17,https://twitter.com/gorskon/status/473531436285169664,,,,
MikeFranks753,6/2/2014 14:27,0,0,@ rschilsky @ ASCO Do you have informations about Nanobiotix ? It's a french company.,,@ @,,4.73531E+17,https://twitter.com/MikeFranks753/status/473531435425730560,,,,
subatomicdoc,6/2/2014 14:27,1,0,"FDA Guidance on social media - firm is responsible for site if: owned, controlled, created influenced, operated by firm/ # pharma # ASCO14",,,# #,4.73531E+17,https://twitter.com/subatomicdoc/status/473531434565922817,,,,
rsm2800,6/2/2014 14:27,1,1,"Ease? RT @ gorskon: Of course, the question is: Why is Twitter the platform of choice for # ASCO14? Why not blogs, Pinterest, Facebook, etc.?",,@,#,4.73531E+17,https://twitter.com/rsm2800/status/473531384636522496,,,,
LGG1,6/2/2014 14:27,0,0,"RT @ DrAttai: @ mtmdphd “can I get a RT, please” - social media for trial recruitment # ASCO14",,@ @,#,4.73531E+17,https://twitter.com/LGG1/status/473531355994025984,,,,
CBPartners,6/2/2014 14:27,0,0,Precision medicine has led to less disparities in breast cancer than in other tumor types- Dr. Steve Katz # disparitiesincancercare # ASCO14,,,# #,4.73531E+17,https://twitter.com/CBPartners/status/473531336935096321,,,,
obogler,6/2/2014 14:27,3,2,Social media: educating patients and public via twitter can be effective says @ mtmdphd # ASCO14 - need FDA guidance for industry,,@,#,4.73531E+17,https://twitter.com/obogler/status/473531318731415552,,,,
duemed,6/2/2014 14:27,1,0,100% LMS/LS/chondrosarcoma express PD1-L according to results presented by Dr Movva. Immunotherapy rules! # ASCO14,,,#,4.73531E+17,https://twitter.com/duemed/status/473531303384457216,,,,
DrPaulyDeSantis,6/2/2014 14:27,0,1,Disease control and response rates in all groups favored ruxolitinib $ INCY # ASCO14 pic.twitter.com/yUmvl8NF8w,,,#,4.73531E+17,https://twitter.com/DrPaulyDeSantis/status/473531254160515072,,,,
gorskon,6/2/2014 14:26,1,1,"Looky who's on Twitter: @ theNCI, @ US_FDA, etc.? # ASCO14",,@ @,#,4.73531E+17,https://twitter.com/gorskon/status/473531228373536769,,,,
subatomicdoc,6/2/2014 14:26,0,0,@ theNCI @ US_FDA have multiple channels involved on social media # ASCO14,,@ @,#,4.73531E+17,https://twitter.com/subatomicdoc/status/473531168089206784,,,,
KathleenMaxian,6/2/2014 14:26,0,0,"@ drdonsdizon What am I hearing in my clinic...from my patients after cancer about having sex?"" ""It hurts"" # ASCO14""",,@,#,4.73531E+17,https://twitter.com/KathleenMaxian/status/473531121503059968,,,,
rsm2800,6/2/2014 14:26,6,4,Per @ mtmdphd “Matt Katz is all over the place” but real props to @ subatomicdoc for creating a workable ontology # ASCO14,,@ @,#,4.73531E+17,https://twitter.com/rsm2800/status/473531113286029312,,,,
DrAttai,6/2/2014 14:26,1,0,"@ mtmdphd SM for education - NCTN cooperative groups, FDA, NCI, Institutions, cancer-specific groups # ASCO14",,@,#,4.73531E+17,https://twitter.com/DrAttai/status/473531068306718721,,,,
subatomicdoc,6/2/2014 14:26,4,2,One key issue with social media (my take) will be issue with concerns re: solicitation for # clinicaltrials # ASCO14,,,# #,4.73531E+17,https://twitter.com/subatomicdoc/status/473531019975741440,,,,
gorskon,6/2/2014 14:26,1,3,"Of course, the question is: Why is Twitter the platform of choice for # ASCO14? Why not blogs, Pinterest, Facebook, etc.?",,,#,4.73531E+17,https://twitter.com/gorskon/status/473531005484015617,,,,
DrPaulyDeSantis,6/2/2014 14:25,0,0,$ incy # asco2014 pic.twitter.com/LXItY9F7Af,,,#,4.73531E+17,https://twitter.com/DrPaulyDeSantis/status/473530984759951360,,,,
MediTech_Media,6/2/2014 14:25,0,1,Twitter is a cost effective means of # cancer # clinicaltrial recruitment. # ASCO14,,,# # #,4.73531E+17,https://twitter.com/MediTech_Media/status/473530978389225473,,,,
DrAttai,6/2/2014 14:25,7,0,@ mtmdphd can I get a RT," please"" - social media for trial recruitment # ASCO14""",,@,#,4.73531E+17,https://twitter.com/DrAttai/status/473530839352242178,,,
subatomicdoc,6/2/2014 14:25,0,0,@ mtmdphd citing study on recruitment via Twitter. May have value. # ASCO14,,@,#,4.73531E+17,https://twitter.com/subatomicdoc/status/473530823908786176,,,,
obogler,6/2/2014 14:25,3,3,trial accrual an area where social media can help reach pts at good price point and for hard to reach people @ mtmdphd # ASCO14,,@,#,4.73531E+17,https://twitter.com/obogler/status/473530816669052928,,,,
DrPaulyDeSantis,6/2/2014 14:25,0,0,$ INCY # ASCO2014 pic.twitter.com/WytxLTXPMB,,,#,4.73531E+17,https://twitter.com/DrPaulyDeSantis/status/473530763384586241,,,,
djsampson,6/2/2014 14:25,0,1,Social media participants display les concern about privacy; more need for research into *them* # asco14,,,#,4.73531E+17,https://twitter.com/djsampson/status/473530758913478656,,,,
winemomjill,6/2/2014 14:25,3,1,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73531E+17,https://twitter.com/winemomjill/status/473530751196364802,,,,
kellykcotton,6/2/2014 14:25,3,3,@ mtmdphd: Many patients are willing to share their info publicly to further research - see sites like @ patientslikeme and others # ASCO14,,@ @,#,4.73531E+17,https://twitter.com/kellykcotton/status/473530737228935168,,,,
AlpineBV_Miller,6/2/2014 14:24,0,1,Why $ incy says CRP is a real prognostic factor # ASCO14 pic.twitter.com/MxfCG9buLo,,,#,4.73531E+17,https://twitter.com/AlpineBV_Miller/status/473530672515391488,,,,
DrAttai,6/2/2014 14:24,5,0,@ mtmdphd online pt communities are on various SM platforms - many have approached scientific groups asking to be studied # ASCO14,,@,#,4.73531E+17,https://twitter.com/DrAttai/status/473530668350468096,,,,
HenryJOncology,6/2/2014 14:24,0,0,# ASCO14 Come poster 21. Pricing R&D and investing in pharma,,,#,4.73531E+17,https://twitter.com/HenryJOncology/status/473530605829750784,,,,
LurieCancer,6/2/2014 14:24,7,2,60% of patients discouraged by oncologist to participate in # clinicaltrials. @ mtmdphd reminds education can bypass obstacles # ASCO14,,@,# #,4.73531E+17,https://twitter.com/LurieCancer/status/473530529229586433,,,,
subatomicdoc,6/2/2014 14:24,2,3,"Physician led, patient centered RT @ DrAttai: @ mtmdphd multiple myeloma social media - describing monthly tweetchat # mmsm # ASCO14",,@ @,# #,4.7353E+17,https://twitter.com/subatomicdoc/status/473530494022615040,,,,
fischmd,6/2/2014 14:23,0,1,"Great evolving story about engagement of pts, experts, and community physicians regarding # myeloma via # mmsm, @ mtmdphd # ASCO14",,@,# # #,4.7353E+17,https://twitter.com/fischmd/status/473530400040812544,,,,
Progeny,6/2/2014 14:23,1,0,Not too late to stop by Booth 4028 and discuss how to integrate family history data into your EMR! # ASCO14,,,#,4.7353E+17,https://twitter.com/Progeny/status/473530398568226816,,,,
subatomicdoc,6/2/2014 14:23,0,1,"@ DrMarkham @ mtmdphd Thanks to @ ASCO for embracing it, and for all the patients, caregivers and providers who make them valuable! # ASCO14",,@ @ @,#,4.7353E+17,https://twitter.com/subatomicdoc/status/473530370303213568,,,,
urotoday,6/2/2014 14:23,1,0,"# ASCO14 Time to Chemo After Treatment w/ Sipuleucel-T: PROCEED Data. Listen to interview w/ Christopher Pieczonka, MD http://bit.ly/1hsplyC",,,#,4.7353E+17,https://twitter.com/urotoday/status/473530279072505856,,,,
AlpineBV_Miller,6/2/2014 14:23,0,0,"Cape +/- ruxo P2 has prespecified alpha of p=0.20. Huzzah! (Seriously). Didn't meet it, but I like the design. # ASCO14",,,#,4.7353E+17,https://twitter.com/AlpineBV_Miller/status/473530234139312128,,,,
DrAttai,6/2/2014 14:22,1,1,@ mtmdphd multiple myeloma social media - describing monthly tweetchat # mmsm # ASCO14,,@,# #,4.7353E+17,https://twitter.com/DrAttai/status/473530214484815873,,,,
gorskon,6/2/2014 14:22,0,0,@ drattai Can't help it. I'm a bit of a pedant at times. # ASCO14.,,@,#,4.7353E+17,https://twitter.com/gorskon/status/473530194397904896,,,,
subatomicdoc,6/2/2014 14:22,9,3,@ mtmdphd Hashtag fever! http://www.symplur.com/healthcare-hashtags/ontology/cancer/ … tag ontology embraced by @ ASCO # ASCO14,,@ @,#,4.7353E+17,https://twitter.com/subatomicdoc/status/473530193618145280,,,,
knwachter,6/2/2014 14:22,0,2,"Proud to say I was one of them! RT @ mattshomepage: In 2010, only 14 people were tweeting at ASCO. Now, it's over 4,000 # ASCO14",,@,#,4.7353E+17,https://twitter.com/knwachter/status/473530167575715840,,,,
DrMarkham,6/2/2014 14:22,0,1,Thanks to @ subatomicdoc for our cancer hashtags. @ mtmdphd # ASCO14,,@ @,#,4.7353E+17,https://twitter.com/DrMarkham/status/473530050848260097,,,,
MyelomaTeacher,6/2/2014 14:21,0,1,“ @ szusmani: # ASCO14 come ck out this TIP 1:15 pm to 5 pm Hall A pic.twitter.com/Jz5ZyrOOXY” # mmsm # myeloma Continuous Therapy vs observation,,@,# # #,4.7353E+17,https://twitter.com/MyelomaTeacher/status/473529978567811072,,,,
gorskon,6/2/2014 14:21,0,1,# ASCO14 Tweets: nearly 40K from 9000+ Twitter users. Not bad.,,,#,4.7353E+17,https://twitter.com/gorskon/status/473529977351065600,,,,
nycdoc29,6/2/2014 14:21,0,0,"# ASCO14 - 4 Novel agents, 4 diff MOAs. Gazyva, Imbruvica, Idealisib, ABT-199",,,#,4.7353E+17,https://twitter.com/nycdoc29/status/473529913677721600,,,,
fischmd,6/2/2014 14:21,3,2,There were over 131 million impressions on social media thus far from # ASCO14 via @ mtmdphd,,@,#,4.7353E+17,https://twitter.com/fischmd/status/473529887878557696,,,,
kellykcotton,6/2/2014 14:21,0,1,"# ASCO13 saw over 4,000 participants Tweeting. # ASCO14 has seen over 9,000! @ mtmdphd",,@,# #,4.7353E+17,https://twitter.com/kellykcotton/status/473529871004495872,,,,
djsampson,6/2/2014 14:21,0,0,"About 10,000 # asco14 tweets each day Saturday and Sunday (social media clinical trials sesh)",,,#,4.7353E+17,https://twitter.com/djsampson/status/473529841979912194,,,,
OncLive,6/2/2014 14:21,0,0,Dr. Lawrence Fong Discusses Intratumoral Electroporation of Plasmid IL-12 in Melanoma http://ow.ly/xwS9d # ASCO14,,,#,4.7353E+17,https://twitter.com/OncLive/status/473529802641899520,,,,
subatomicdoc,6/2/2014 14:21,0,1,9K participants in tweets for # ASCO14 per @ symplur --> shown by @ mtmdphd,,@ @,#,4.7353E+17,https://twitter.com/subatomicdoc/status/473529752373178368,,,,
DrAttai,6/2/2014 14:21,1,2,"@ mtmdphd tweets at # ASCO14 - so far approx 40K tweets, 9000+ participants, ~130M impressions",,@,#,4.7353E+17,https://twitter.com/DrAttai/status/473529732487999489,,,,
rsm2800,6/2/2014 14:20,3,3,Per @ mtmdphd unfortunate that some patients are discouraged from participating in trials by their physicians # asco14,,@,#,4.7353E+17,https://twitter.com/rsm2800/status/473529714879889408,,,,
obogler,6/2/2014 14:20,1,1,# ASCO14 tweets at about 10k a day says @ mtmdphd at our social media education session - now in S504,,@,#,4.7353E+17,https://twitter.com/obogler/status/473529712434618368,,,,
mattshomepage,6/2/2014 14:20,0,0,"In 2010, only 14 people were tweeting at ASCO. Now, it's over 4,000 # ASCO14",,,#,4.7353E+17,https://twitter.com/mattshomepage/status/473529614044639232,,,,
strategicTy,6/2/2014 14:20,0,0,Biomedical Informatics and Social Media talk with @ obogler presenting in S504 now # asco14 # mdanderson # endcancer,,@,# # #,4.7353E+17,https://twitter.com/strategicTy/status/473529609351606273,,,,
subatomicdoc,6/2/2014 14:20,0,1,Still growing. # ASCO14 has had 10K daily tweets @ mtmdphd,,@,#,4.7353E+17,https://twitter.com/subatomicdoc/status/473529605564162048,,,,
KathleenMaxian,6/2/2014 14:20,0,0,# ASCO14 # GYNCSM @ drdonsdizon presentation now ! E354a Sexual Health & Cancerpic.twitter.com/3BTe22oQCU,,@,# #,4.7353E+17,https://twitter.com/KathleenMaxian/status/473529586203242497,,,,
mtmdphd,6/2/2014 14:20,0,0,Hashtag Folksonomy for Cancer Communities on Twitter http://ow.ly/t6LXp Updated w/ Cancer Tag Ontology http://ow.ly/t6M9Y # ASCO14,,,#,4.7353E+17,https://twitter.com/mtmdphd/status/473529576195633152,,,,
accessnantucket,6/2/2014 14:20,0,0,"RT @ usatodayhealth: Immune therapies improve treatment of some cancers; at least six promising studies at # ASCO14, http://usat.ly/1kpMv7W ...",,@,#,4.7353E+17,https://twitter.com/accessnantucket/status/473529554334908416,,,,
knwachter,6/2/2014 14:20,0,0,about time RT @ rschilsky: # ASCO14: ASCO focusing on palliative care; launching new Palliative Care Symposium in Oct 2014 in Boston.,,@,#,4.7353E+17,https://twitter.com/knwachter/status/473529538069397504,,,,
PunitDhillon,6/2/2014 14:20,0,0,"Increases in IL-12, IFNy inducible genes and NK cells are consistent with pharmacodynamic effect of IL-12 # asco14 # oncs",,,# #,4.7353E+17,https://twitter.com/PunitDhillon/status/473529529085198336,,,,
subatomicdoc,6/2/2014 14:20,0,0,Growth in tweets via # ASCO meetings over time. # ASCO14,,,# #,4.7353E+17,https://twitter.com/subatomicdoc/status/473529501230845953,,,,
KirstenGoldberg,6/2/2014 14:19,0,0,RT @ obogler: Only 3% of cancer patients advance cancer knowledge by participating in clinical trials according to @ mtmdphd # ASCO14,,@ @,#,4.73529E+17,https://twitter.com/KirstenGoldberg/status/473529461343027200,,,,
obogler,6/2/2014 14:19,2,1,Many barriers to clinical trials - can physicians use social media to overcome? asks @ mtmdphd # ASCO14,,@,#,4.73529E+17,https://twitter.com/obogler/status/473529368736579584,,,,
nycdoc29,6/2/2014 14:19,0,0,# ASCO14 - J Brown on Novel Agents in CLL,,,#,4.73529E+17,https://twitter.com/nycdoc29/status/473529322821910528,,,,
subatomicdoc,6/2/2014 14:19,1,0,"Other issues include $, discouragement from PCP (50%). # ASCO14 @ mtmdphd",,@,#,4.73529E+17,https://twitter.com/subatomicdoc/status/473529246355570688,,,,
subatomicdoc,6/2/2014 14:18,5,0,60% of patients discouraged by oncologist to participate in trials # ASCO14 @ mtmdphd,,@,#,4.73529E+17,https://twitter.com/subatomicdoc/status/473529101568212992,,,,
CancerResearch,6/2/2014 14:18,0,0,"Overheard at # ASCO14: Doc 1: Can you believe the explosion of immunotherapy?"" Doc 2: ""I know"," it's incredible. Thank CRI.""""",,,#,4.73529E+17,https://twitter.com/CancerResearch/status/473529069372731392,,,
DrMarkham,6/2/2014 14:18,0,1,Social media in clinical trials. @ mtmdphd starts the session off. # ASCO14,,@,#,4.73529E+17,https://twitter.com/DrMarkham/status/473529043149918208,,,,
nycdoc29,6/2/2014 14:18,0,0,# ASCO14 - CLL session starting in e450. packed room,,,#,4.73529E+17,https://twitter.com/nycdoc29/status/473529040406839296,,,,
obogler,6/2/2014 14:18,5,3,Only 3% of cancer patients advance cancer knowledge by participating in clinical trials according to @ mtmdphd # ASCO14,,@,#,4.73529E+17,https://twitter.com/obogler/status/473529014112362497,,,,
MyelomaTeacher,6/2/2014 14:18,0,0,“ @ szusmani: Come check out my TIP poster # mmsm # ASCO14 Optimal induction for HRMM # myeloma pic.twitter.com/BnOzWkZ8y1”,,@,# # #,4.73529E+17,https://twitter.com/MyelomaTeacher/status/473529004621070336,,,,
subatomicdoc,6/2/2014 14:17,1,0,Only 3% in clinical trials are helping advance knowledge @ mtmdphd # ASCO14,,@,#,4.73529E+17,https://twitter.com/subatomicdoc/status/473528965534330881,,,,
DrAttai,6/2/2014 14:17,1,2,@ mtmdphd w/o clinical trials," cancer treatment would always be the same @ TomBeer"" # ASCO14""",,@ @,#,4.73529E+17,https://twitter.com/DrAttai/status/473528946865094656,,,
subatomicdoc,6/2/2014 14:17,3,2,Without clinical trials," cancer treatment would always remain the same."" @ TomBeer per @ mtmdphd # ASCO14""",,@ @,#,4.73529E+17,https://twitter.com/subatomicdoc/status/473528832142880768,,,
GeriPalBlog,6/2/2014 14:17,2,2,The Business of Selling Hope Part II: Direct-to-Consumer Cancer Center Advertising http://goo.gl/fb/U0sdR # asco14,,,#,4.73529E+17,https://twitter.com/GeriPalBlog/status/473528751804784640,,,,
subatomicdoc,6/2/2014 14:16,1,0,"@ mtmdphd objectives: Barriers; use of hashtags, and more! # ASCO14",,@,#,4.73529E+17,https://twitter.com/subatomicdoc/status/473528710663274498,,,,
obogler,6/2/2014 14:16,1,1,@ mtmdphd kicks off our # ASCO14 session on clinical trials and social media - join us in S504,,@,#,4.73529E+17,https://twitter.com/obogler/status/473528688491778048,,,,
DrAttai,6/2/2014 14:16,0,0,@ mtmdphd discussing SM in clinical trials # ASCO14,,@,#,4.73529E+17,https://twitter.com/DrAttai/status/473528633882312704,,,,
socflyny,6/2/2014 14:16,0,0,". @ ASCO If researchers want to know y women choose one surgical option vs another, ASK vs providing A, B, C that support their theory # ASCO14",,@,#,4.73529E+17,https://twitter.com/socflyny/status/473528613539946496,,,,
LurieCancer,6/2/2014 14:16,0,0,"Read to learn about Internet, Social Media, # Privacy Regulations, & # ClinicalTrials from the pros: @ rsm2800 @ mtmdphd @ obogler # ASCO14",,@ @ @,# # #,4.73529E+17,https://twitter.com/LurieCancer/status/473528596330737664,,,,
subatomicdoc,6/2/2014 14:15,0,0,@ rsm2800 @ mtmdphd @ obogler Next step will be tweeting questions? # ASCO14,,@ @ @,#,4.73528E+17,https://twitter.com/subatomicdoc/status/473528455712497665,,,,
drallysonocean,6/2/2014 14:15,3,1,# ASCO14 Cancer patients without psychiatric comorbidity had survival advantage of 2.24 months @ ASCO @ MMfightsCRCpic.twitter.com/PC8qnFxBE5,,@ @,#,4.73528E+17,https://twitter.com/drallysonocean/status/473528392802115585,,,,
SitemanCenter,6/2/2014 14:15,2,0,# ASCO14 Impact of CD34+ cell dose & comorbidities on engraftment following ASCT http://goo.gl/XaGMXR # leukemia # myelodysplasia,,,# # #,4.73528E+17,https://twitter.com/SitemanCenter/status/473528344643141633,,,,
rsm2800,6/2/2014 14:15,1,1,The pressure’s on…RT @ DrAttai: the anticipation is growing... @ mtmdphd @ rsm2800 @ obogler SM Session at # ASCO14,,@ @ @ @,#,4.73528E+17,https://twitter.com/rsm2800/status/473528344512696321,,,,
Roche,6/2/2014 14:15,5,3,What's the difference between overall and progression-free survival? Test your # ClinicalTrials IQ: http://ow.ly/xwxmZ # ASCO14,,,# #,4.73528E+17,https://twitter.com/Roche/status/473528344408256513,,,,
mayocliniclabs,6/2/2014 14:15,0,1,Dr. Dispenzieri discussing “Clinical Conundrums in Lymphoid Malignancies.” # ASCO14,,,#,4.73528E+17,https://twitter.com/mayocliniclabs/status/473528333196886016,,,,
subatomicdoc,6/2/2014 14:15,0,0,Apparently you can text questions to the speakers! # ASCO14,,,#,4.73528E+17,https://twitter.com/subatomicdoc/status/473528330013405186,,,,
fischmd,6/2/2014 14:15,1,2,"Excited to hear @ mtmdphd @ obogler @ rsm2800 discuss # socialmedia, privacy, and # clinicaltrials at # ASCO14",,@ @ @,# # #,4.73528E+17,https://twitter.com/fischmd/status/473528319649275904,,,,
Amgen,6/2/2014 14:15,1,0,Watch for # Amgen data on febrile # neutropenia in pts with # breastcancer # lungcancer and # nonhodgkinslymphoma @1:15PM CDT/S Hall A2 # ASCO14,,@1,# # # # # #,4.73528E+17,https://twitter.com/Amgen/status/473528304398778370,,,,
CancerDotNet,6/2/2014 14:15,3,2,Podcast for pts: Dr. Steven O'Day @ USCHealthNews on new immunotherapies from # ASCO14 # cancer researchhttp://bit.ly/1kv30Qn,,@,# #,4.73528E+17,https://twitter.com/CancerDotNet/status/473528274208178176,,,,
subatomicdoc,6/2/2014 14:15,0,0,Starting with @ mtmdphd on Social Media in # clinicaltrials # ASCO14 cc @ crgonzalez,,@ @,# #,4.73528E+17,https://twitter.com/subatomicdoc/status/473528259037376512,,,,
DrMarkham,6/2/2014 14:15,1,0,"From @ NPRHealth, a nice post about @ ASCO and # ASCO14 http://www.npr.org/blogs/health/2014/06/01/317402871/once-a-year-cancer-research-news-comes-in-a-flood-not-a-trickle …",,@ @,#,4.73528E+17,https://twitter.com/DrMarkham/status/473528250669744128,,,,
ASCO,6/2/2014 14:15,5,4,"Toxicities associated with new targeted agents requiring new thinking about AE detection, mgmt http://bit.ly/1kq2i6C # ASCO14",,,#,4.73528E+17,https://twitter.com/ASCO/status/473528245015822336,,,,
myriadgenetics,6/2/2014 14:15,1,0,Myriad my Path Melanoma validation data are being presented at # ASCO14 by Katherine Nathanson. http://bit.ly/1rBXXT4 pic.twitter.com/aMG3fg10PE,,,#,4.73528E+17,https://twitter.com/myriadgenetics/status/473528225767776257,,,,
Galenia_cat,6/2/2014 14:14,0,0,RT @ NEJM: From # ASCO14: Benefit of Enzalutamide in Chemotherapy-Naïve Metastatic Prostate Cancer http://goo.gl/sp14kO,,@,#,4.73528E+17,https://twitter.com/Galenia_cat/status/473528211532677120,,,,
LungCancerFaces,6/2/2014 14:14,1,0,“ @ Novartis: Approximately 2-7% of patients with NSCLC have the ALK gene rearrangement. http://bit.ly/1jKwFFX # ASCO14” # LCSM,,@,# #,4.73528E+17,https://twitter.com/LungCancerFaces/status/473528106343362560,,,,
SJNaggiar,6/2/2014 14:14,0,0,Heading home … that's a wrap from # ASCO2014,,,#,4.73528E+17,https://twitter.com/SJNaggiar/status/473528012592644097,,,,
subatomicdoc,6/2/2014 14:14,0,0,@ AneesChagpar @ jrgralow Thanks for sharing! # ASCO14,,@ @,#,4.73528E+17,https://twitter.com/subatomicdoc/status/473528007840509954,,,,
socflyny,6/2/2014 14:13,0,1,". @ drattai Too many of these studies force respondents to select A, B or C when answer may be D or none of above. # designflaw # ASCO14",,@,# #,4.73528E+17,https://twitter.com/socflyny/status/473527922716708864,,,,
MMarchioneAP,6/2/2014 14:13,0,2,“ @ ronwinslow: The Checkpoints are uninhibited. # ASCO14 h/t @ loftus pic.twitter.com/ocgQ42a0oM” it was a great te!,,@ @,#,4.73528E+17,https://twitter.com/MMarchioneAP/status/473527889737285632,,,,
DrAttai,6/2/2014 14:13,0,2,the anticipation is growing... @ mtmdphd @ rsm2800 @ obogler SM Session at # ASCO14,,@ @ @,#,4.73528E+17,https://twitter.com/DrAttai/status/473527839825076224,,,,
CatalyticRxn,6/2/2014 14:13,1,1,"Hells, yeah! # Immunotherapy for the win! According to @ CRiverLabs,  # Cancer immunotherapy is stealing the show at # ASCO14"" # health""",,@,# # # #,4.73528E+17,https://twitter.com/CatalyticRxn/status/473527780450111489,,,,
Oncpall,6/2/2014 14:12,0,0,"Survival Comparable With Bevacizumab, Cetuximab in mCRC http://shar.es/VTSOH via # ASCO14",,,#,4.73528E+17,https://twitter.com/Oncpall/status/473527683540713472,,,,
GlopesMd,6/2/2014 14:12,1,5,# ASCO14 - one of our international efforts to improve cancer care in # LMIC: Myanmar task forcepic.twitter.com/S3MCPgOKRq,,,# #,4.73528E+17,https://twitter.com/GlopesMd/status/473527596093673472,,,,
Oncpall,6/2/2014 14:11,1,1,"Delaying ADT Until Symptoms Appear Does Not Impact Survival, Study Suggests # ASCO14",,,#,4.73527E+17,https://twitter.com/Oncpall/status/473527360155709440,,,,
innovpartners,6/2/2014 14:11,0,0,NEW BioBlog Weekly: Highlights from # ASCO2014 http://buff.ly/U6qr94,,,#,4.73527E+17,https://twitter.com/innovpartners/status/473527238059892737,,,,
Novartis,6/2/2014 14:10,0,4,Starting now at # ASCO14: presentations on 5-year ENESTnd data & treatment-free remission data in S Hall A2 http://bit.ly/1n4oXWP,,,#,4.73527E+17,https://twitter.com/Novartis/status/473527048703836160,,,,
ASCO,6/2/2014 14:10,2,6,Today's 'Brave New World' Ed Session to address clinical mgmt of HER2+ breast cancer http://bit.ly/SVtqjH # bcsm # ASCO14,,,# #,4.73527E+17,https://twitter.com/ASCO/status/473527035466637312,,,,
sharon_hf,6/2/2014 14:10,0,0,"MT @ USATODAYhealth: Immune therapies improve cancer treatment; at least 6 promising studies at # ASCO14, http://usat.ly/1kpMv7W via @ usatoday",,@ @,#,4.73527E+17,https://twitter.com/sharon_hf/status/473526998233387009,,,,
drdonsdizon,6/2/2014 14:10,11,5,"In # survivorship, remember cancer is a social disease. It impacts the person with cancer and her partner/loved ones. # ASCO14",,,# #,4.73527E+17,https://twitter.com/drdonsdizon/status/473526964683145216,,,,
christinemphmd,6/2/2014 14:09,0,0,ADT+docetaxel had med OS of 57.6 mths versus 44.0 mths with ADT alone. 40% reduction in survival hazard! # ASCO14 # prostatecancer,,,# #,4.73527E+17,https://twitter.com/christinemphmd/status/473526870169120768,,,,
jrgralow,6/2/2014 14:09,0,0,No data on alendronate/low dose ibandronate MT @ corp_UNC Cost-eff of adj bisphos in postmen pts w br ca # bcsm # asco14 http://ow.ly/xxkYM,,@,# #,4.73527E+17,https://twitter.com/jrgralow/status/473526853542883328,,,,
subatomicdoc,6/2/2014 14:09,1,1,"Getting ready for a talk on privacy, clinical trials with @ rsm2800 @ mtmdphd @ obogler # ASCO14",,@ @ @,#,4.73527E+17,https://twitter.com/subatomicdoc/status/473526758294433792,,,,
TargetedOnc,6/2/2014 14:09,0,0,"Filip Janku, MD, PhD, from @ MDAndersonNews on sirolimus and vorinostat in heavily pretreated Hodgkin lymphoma http://www.targetedonc.com/conference/asco-2014/Sirolimus-and-Vorinostat-in-Heavily-Pretreated-Refractory-Hodgkin-Lymphoma … # ASCO14",,@,#,4.73527E+17,https://twitter.com/TargetedOnc/status/473526743979282432,,,,
Immutep,6/2/2014 14:09,0,0,Dr. Monk and Dr. Gray to Discuss Abstract Presented at ASCO At Call TODAY 9 PM EST/ 11AM AEST $ PBMD $ PRR # ASCO14 http://buff.ly/1u9BB9h,,,#,4.73527E+17,https://twitter.com/Immutep/status/473526718394015744,,,,
Oncpall,6/2/2014 14:08,0,0,Upfront Chemo Confers Dramatic Survival Gains in Prostate Cancer http://shar.es/VTTL1 via @ OncLive # ASCO14,,@,#,4.73527E+17,https://twitter.com/Oncpall/status/473526622050480128,,,,
szusmani,6/2/2014 14:08,0,1,@szusmani@Carolinas # ASCO14 location Hall A from 1:15 pm to 5 pm today,,@szusmani @Carolinas,#,4.73527E+17,https://twitter.com/szusmani/status/473526519768551424,,,,
subatomicdoc,6/2/2014 14:08,0,0,Physician communication on cost of cancer care under the Affordable Care Act http://bit.ly/1kPtZps # ASCO14 # hcsm,,,# #,4.73526E+17,https://twitter.com/subatomicdoc/status/473526482661552128,,,,
adamfeuerstein,6/2/2014 14:08,0,2,"Of course, $ PVCT poster today disclosed ph3 plans for PV-10 which don’t include PD-1 combination. DERP… # ASCO14",,,#,4.73526E+17,https://twitter.com/adamfeuerstein/status/473526464001110016,,,,
CUCancerCenter,6/2/2014 14:08,1,2,Dr. Karl Lewis at today's # ASCO14 poster session. pic.twitter.com/l9ShkNz2k7,,,#,4.73526E+17,https://twitter.com/CUCancerCenter/status/473526459273719808,,,,
adamfeuerstein,6/2/2014 14:07,5,1,Discussant of intra-lesional melanoma therapy posters said future studies must combine w/ PD-1s to be relevant. $ AMGN $ PVCT # ASCO14,,,#,4.73526E+17,https://twitter.com/adamfeuerstein/status/473526217736724480,,,,
CellSieve,6/2/2014 14:06,0,1,Stop by and see us! Booth no. 20135 # ASCO14 pic.twitter.com/ZUwNID3B3S,,,#,4.73526E+17,https://twitter.com/CellSieve/status/473526202318462976,,,,
jodigralnick,6/2/2014 14:06,2,0,$ INCY CEO will join # CNBC's @ megtirrell LIVE at 2:50pmET from # ASCO14 for an EXCLUSIVE interview on @ StreetSignsCNBC,,@ @,# #,4.73526E+17,https://twitter.com/jodigralnick/status/473526168294285312,,,,
szusmani,6/2/2014 14:06,1,1,# ASCO2014 come check out this TIP as well 1:15 pm to 5 pm Hall A pic.twitter.com/Ii2fhLny1R,,,#,4.73526E+17,https://twitter.com/szusmani/status/473526167287660544,,,,
DrLisaCurcio,6/2/2014 14:06,2,0,"Amen @ ASCO: Collecting family history is still key in the # genomic era http://bit.ly/1klFRL6 # ASCO14”""",,@,# #,4.73526E+17,https://twitter.com/DrLisaCurcio/status/473526154570125312,,,,
DrLCohen,6/2/2014 14:06,0,0,Nobel prize winner Dr. Hausen speaks at # ASCO14 connecting virus in undercooked red meat to colon cancer http://onlinelibrary.wiley.com/doi/10.1002/ijc.27413/abstract …,,,#,4.73526E+17,https://twitter.com/DrLCohen/status/473526108726767616,,,,
OrionCorpIR,6/2/2014 14:06,0,0,A new study poster on # ODM201 published today at # ASCO14. The poster is available here http://www.orion.fi/en/Research-and-developement/Congress-publications/ …,,,# #,4.73526E+17,https://twitter.com/OrionCorpIR/status/473526102376583169,,,,
DrAttai,6/2/2014 14:05,2,1,great SM presence represented here - @ subatomicdoc @ LurieCancer @ djsampson waiting to hear @ mtmdphd @ rsm2800 and @ obogler # ASCO14,,@ @ @ @ @ @,#,4.73526E+17,https://twitter.com/DrAttai/status/473525899741372417,,,,
LillyDiabetes,6/2/2014 14:05,1,1,It's great to see so many advances in # cancer treatment at # ASCO2014!,,,# #,4.73526E+17,https://twitter.com/LillyDiabetes/status/473525777108303872,,,,
ASCO,6/2/2014 14:05,3,3,"Get # ASCO14 slides for use in your presentations. No limit to #of slides you can DL, 3 yrs access http://bit.ly/1k5KSbo",,,# #of,4.73526E+17,https://twitter.com/ASCO/status/473525773052436481,,,,
SequentaInc,6/2/2014 14:05,0,0,"# ASCO14 # immunotherapy data w/ LymphoSIGHT pltfm (4:45 pm CT, S406) & visit bth 18152 before to learn more http://ow.ly/xvBcV",,,# #,4.73526E+17,https://twitter.com/SequentaInc/status/473525753213370368,,,,
ventana,6/2/2014 14:05,1,2,RT @ genentech: P. Bishop: Big data will be a huge part of revolutionizing cancer care in the # Next50 # ASCO14 http://ow.ly/xrAOs ...,,@,# #,4.73526E+17,https://twitter.com/ventana/status/473525724595621888,,,,
DrAttai,6/2/2014 14:04,0,0,the big question for this session on social media - is @ rsm2800 tweeting live or preloaded... # ASCO14,,@,#,4.73526E+17,https://twitter.com/DrAttai/status/473525639350218752,,,,
CUCancerCenter,6/2/2014 14:04,1,0,# ASCO14 Multi-institutional multiplexed genetic analysis in # lungcancer # LCSMpic.twitter.com/1F3CsKgHyN,,,# # #,4.73526E+17,https://twitter.com/CUCancerCenter/status/473525588364247040,,,,
obogler,6/2/2014 14:04,2,1,"In 10 min join @ rsm2800 @ mtmdphd and me for # ASCO14 social media, clinical trials and discussion S504",,@ @,#,4.73526E+17,https://twitter.com/obogler/status/473525548090535936,,,,
DMG_AICR,6/2/2014 14:03,0,0,RT @ KarenCollinsRD:LEAN stdy: at lst 5% weight loss (by diet+exercise) best to decr insulin & inflam biomarkers. M Irwin @ YaleCancer # ASCO14,,@ @,#,4.73525E+17,https://twitter.com/DMG_AICR/status/473525245174091776,,,,
TheSamfund,6/2/2014 14:03,0,1,"Thank you, @ ASCO, for developing these guidelines. # cancerisntfree # ASCO2014 http://www.financialexpress.com/news/cancer-doctors-urged-to-consider-value-when-treating-patients/1255902/1 …",,@,# #,4.73525E+17,https://twitter.com/TheSamfund/status/473525205055598592,,,,
miepsja,6/2/2014 14:02,0,0,“ @ LIVESTRONG_NL: Immune therapies improve treatment of # cancers - http://ow.ly/xx5cw # ASCO14 (via USAToday )”,,@,# #,4.73525E+17,https://twitter.com/miepsja/status/473525162890244096,,,,
DMG_AICR,6/2/2014 14:02,1,0,"RT @ ASCO: Aging population could overwhelm resources for cancer care delivery, 65% increase expected by 2030 http://bit.ly/1u5asEk # ASCO14",,@,#,4.73525E+17,https://twitter.com/DMG_AICR/status/473525151003578368,,,,
genentech,6/2/2014 14:02,0,0,# ASCO14: Learn a lot abt immunotherapies this wkend? Test your knowledge w/ our immunotherapy challenge: http://ow.ly/xwqG0,,,#,4.73525E+17,https://twitter.com/genentech/status/473525005515771904,,,,
mattshomepage,6/2/2014 14:02,0,0,Busy busy busy... # ASCO14 pic.twitter.com/arLCB9N06W,,,#,4.73525E+17,https://twitter.com/mattshomepage/status/473524980589031424,,,,
ASCO,6/2/2014 14:02,1,1,Heading to GU sessions at # ASCO14? Review 2014 GU Symposium highlights on # ASCOConnection http://bit.ly/1vbGe46 # pcsm # blcsm # kcsm,,,# # # # #,4.73525E+17,https://twitter.com/ASCO/status/473524954747904001,,,,
Merck,6/2/2014 14:02,5,0,Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer. # oncofacts # ASCO14 # lcsm,,,# # #,4.73525E+17,https://twitter.com/Merck/status/473524952994680832,,,,
SarahCannonDocs,6/2/2014 14:01,0,0,Interested in DUO: Ph. 3 trial IPI-145 vs. ofatumumab in pts w/ relapsed or refractory CLL/SLL? Chat w/ # SCRI's Dr. Flinn No.405B # ASCO14,,,# #,4.73525E+17,https://twitter.com/SarahCannonDocs/status/473524947663720448,,,,
Boehringer,6/2/2014 14:01,0,1,BLOG POST: On day 1 “the most popular time for tweets using # ASCO14 was 11.15am PST” http://bit.ly/1m1cLSF,,,#,4.73525E+17,https://twitter.com/Boehringer/status/473524883566391296,,,,
MartaMarteo,6/2/2014 14:01,2,0,Mitos de las dietas. Evitar la obesidad y realizar ejercicio físico reducen el riesgo de cáncer http://ow.ly/xvTK7 conclusiones en @ ASCO,,@,,4.73525E+17,https://twitter.com/MartaMarteo/status/473524858782224384,,,,
mtmdphd,6/2/2014 14:01,0,0,"There Is No Little Blue Pill for This: Female Sexuality after Gynecologic CA - @ DrDonSDizon - Mon, Jun 2 - 1:15-2:30p E354a # ASCO14 # gyncsm",,@,# #,4.73525E+17,https://twitter.com/mtmdphd/status/473524854558564352,,,,
ASCO,6/2/2014 14:01,16,2,"Aging population could overwhelm resources for cancer care delivery, 65% increase expected by 2030 http://bit.ly/1u5asEk # ASCO14",,,#,4.73525E+17,https://twitter.com/ASCO/status/473524829795418112,,,,
DrAttai,6/2/2014 14:01,1,1,Getting ready for what should be a great social media session with @ mtmdphd @ rsm2800 @ obogler # ASCO14,,@ @ @,#,4.73525E+17,https://twitter.com/DrAttai/status/473524806638243840,,,,
KarenCollinsRD,6/2/2014 14:01,0,0,# CancerSurvivor LEAN stdy: at lst 5% weight loss (by diet+exercise) best to decr insulin & inflam biomarkers. M Irwin @ YaleCancer # ASCO14,,@,# #,4.73525E+17,https://twitter.com/KarenCollinsRD/status/473524733334409217,,,,
brandeeplott,6/2/2014 14:00,0,0,'Excellent' survival in biology-based pediatric # neuroblastoma treatment reduction http://ow.ly/xvgHW # oncology # ASCO14,,,# # #,4.73525E+17,https://twitter.com/brandeeplott/status/473524675486957568,,,,
DrAttai,6/2/2014 14:00,0,0,just met @ obogler!! # ASCO14,,@,#,4.73525E+17,https://twitter.com/DrAttai/status/473524674861621248,,,,
PunitDhillon,6/2/2014 14:00,4,4,$ ONCS safety data continues to demonstrate an unprecedented profile for an immunotherapy drug. # ASCO14,,,#,4.73525E+17,https://twitter.com/PunitDhillon/status/473524645422182400,,,,
BayerPharma,6/2/2014 14:00,0,0,Bayer HealthCare shares data today at # ASCO14. View poster session on Genitourinary (Prostate) # Cancer to learn more http://am.asco.org/,,,# #,4.73525E+17,https://twitter.com/BayerPharma/status/473524629269917696,,,,
Boehringer,6/2/2014 14:00,3,1,# PRESS & # HCPs at # ASCO14 we're presenting new # lungcancer data for afatinib. Background info here: http://bit.ly/1b6mlnK,,,# # # #,4.73525E+17,https://twitter.com/Boehringer/status/473524603940507648,,,,
FayCortez,6/2/2014 14:00,0,1,"Wow, slow # ASCO14? @ MarkSchoenebaum cancels his follow-on webinar (to today's weekend take). I would have thought Mark could talk for days..",,@,#,4.73525E+17,https://twitter.com/FayCortez/status/473524581890670593,,,,
CancerResearch,6/2/2014 14:00,0,0,4.Inspire others by telling your # Cancer story # CIM2014 # ASCO14 http://ow.ly/xwk5R,,,# # #,4.73525E+17,https://twitter.com/CancerResearch/status/473524575838670849,,,,
DMG_AICR,6/2/2014 14:00,0,0,RT @MyPearlPoint: It is our last day exhibiting at # ASCO14. Come visit us at booth 3005 in the patient advocacy area! https://twitter.com/MyPearlPoint/status/473489403323875328/photo/1pic.twitter.com/eX5M36tNbk,,@MyPearlPoint,#,4.73525E+17,https://twitter.com/DMG_AICR/status/473524527016968192,,,,
medpagetoday,6/2/2014 14:00,6,2,Exercise program cuts cytokine production impacting prostate cancer progression # ASCO14 http://bit.ly/1rD6ODX,,,#,4.73524E+17,https://twitter.com/medpagetoday/status/473524476370358273,,,,
MedscapeOnc,6/2/2014 14:00,0,0,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.73524E+17,https://twitter.com/MedscapeOnc/status/473524465893003264,,,,
myriadgenetics,6/2/2014 14:00,1,1,Myriad will present data validating the # Prolaris test score in predicting # prostatecancer death TODAY at # ASCO14 1:15-5pm. Poster 5059,,,# # #,4.73524E+17,https://twitter.com/myriadgenetics/status/473524456619397121,,,,
Medscape,6/2/2014 14:00,0,1,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.73524E+17,https://twitter.com/Medscape/status/473524455579209728,,,,
drdonsdizon,6/2/2014 14:00,0,0,"Topical lidocaine effective 4 pain with penetration, if localized to vulvar vestibule. http://1.usa.gov/1tBqghU # bcsm # survivorship # ASCO14",,,# # #,4.73524E+17,https://twitter.com/drdonsdizon/status/473524455159779329,,,,
CancerTherAdvsr,6/2/2014 13:57,0,0,"Common theme of # ASCO14: Potentially practice-changing research, but results must be interpreted carefully & w/individual patient in mind.",,,#,4.73524E+17,https://twitter.com/CancerTherAdvsr/status/473523835304947712,,,,
KathleenMaxian,6/2/2014 13:57,0,0,Ovarian cancer molecular subtypes may predict response to bevacizumab # ASCO14 # GYNCSM # ovariancancerawareness http://www.sciencecodex.com/mayo_clinic_ovarian_cancer_subtypes_may_predict_response_to_bevacizumab-134715#.U4y6vF7EJ7I.twitter …,,,# # # #,4.73524E+17,https://twitter.com/KathleenMaxian/status/473523832737648640,,,,
HemOncToday,6/2/2014 13:57,2,0,# ASCO14 Prophylactic cranial irradiation increased DFS in patients with stage III non small cell # LungCancer http://goo.gl/fd2Hbq,,,# #,4.73524E+17,https://twitter.com/HemOncToday/status/473523703201161216,,,,
GoHealio,6/2/2014 13:57,0,0,# ASCO14 Prophylactic cranial irradiation increased DFS in patients with stage III non small cell # LungCancer http://goo.gl/fd2Hbq,,,# #,4.73524E+17,https://twitter.com/GoHealio/status/473523702483922944,,,,
hollyejacobs,6/2/2014 13:56,0,1,"Big, hopeful news for # fertility after # chemotherapy in ppl who have had # breastcancer http://bit.ly/U7pddF @ ASCO # ASCO14 # TheSilverLining",,@,# # # # #,4.73524E+17,https://twitter.com/hollyejacobs/status/473523610506645504,,,,
SkinMelanoma,6/2/2014 13:56,0,0,GEP test accurately id’d very low risk # melanoma tumors in patients receiving SLNB procedure # ASCO14 http://tinyurl.com/mra3zcx,,,# #,4.73524E+17,https://twitter.com/SkinMelanoma/status/473523519029268480,,,,
JackWestMD,6/2/2014 13:55,9,6,"Re: my # ASCO14 talk this PM, Dr. Bruce Johnson advises, If you're not pissing someone off"," you're not saying anything interesting"".""",,,#,4.73523E+17,https://twitter.com/JackWestMD/status/473523330545242112,,,
ChicagoInno,6/2/2014 13:55,0,1,"Yes, the WWDC is cool. But the news coming out of @ ASCO will literally save lives: http://chicagoinno.streetwise.co/2014/06/01/the-asco-annual-meeting-and-not-the-wwdc-is-the-conference-you-should-be-talking-about/ …",,@,,4.73523E+17,https://twitter.com/ChicagoInno/status/473523315953664000,,,,
NETKanker,6/2/2014 13:55,1,0,Long term side effects of # cancer treatment Info # ASCO14 http://www.cancer.net/survivorship/long-term-side-effects-cancer-treatment …,,,# #,4.73523E+17,https://twitter.com/NETKanker/status/473523273075261441,,,,
DrDonaldHarvey,6/2/2014 13:55,0,0,"As an organization we must be open to criticism"" - incoming ASCO president Dr. Peter Yu # ASCO14""",,,#,4.73523E+17,https://twitter.com/DrDonaldHarvey/status/473523246223327232,,,,
myCME,6/2/2014 13:55,0,0,Cediranib Plus Olaparib Increases PFS in Recurrent Ovarian Cancer http://ow.ly/xvhgn # ASCO14 # obgyn # oncology,,,# # #,4.73523E+17,https://twitter.com/myCME/status/473523239206285312,,,,
ProjectInno,6/2/2014 13:55,0,1,"From @ cure_magazine, a great post on our mission to get innovative cancer therapies to patients sooner: http://ow.ly/xuWog # ASCO14",,@,#,4.73523E+17,https://twitter.com/ProjectInno/status/473523229521633280,,,,
JoleneScience,6/2/2014 13:54,2,1,Market for new TKIs for chronic CLL Tx: comparison w/ CML epi # ASCO14 $ ABBV $ PCYC $ GILDpic.twitter.com/svv88v8mA2,,,#,4.73523E+17,https://twitter.com/JoleneScience/status/473522969265070080,,,,
RichardWJoseph,6/2/2014 13:53,0,0,@ Melanoma_doctor @ MaverickNY Agree. Cobrim results might change our perspective on BRAF/Mek. # melsm # ASCO14 @ genentech,,@ @ @,# #,4.73523E+17,https://twitter.com/RichardWJoseph/status/473522883738607616,,,,
drdonsdizon,6/2/2014 13:53,0,0,The experience of sexual dysfunction differs between men and women. # ASCO14 # survivorship,,,# #,4.73523E+17,https://twitter.com/drdonsdizon/status/473522686790864896,,,,
AndytweetM,6/2/2014 13:52,0,0,@ Ludwig_Cancer @ asco will the recording of this be available on virtual meeting / any other way ?,,@ @,,4.73523E+17,https://twitter.com/AndytweetM/status/473522528087183361,,,,
jrgralow,6/2/2014 13:52,2,1,"Via @ nprnews: Once A Year, Cancer Research News Comes In A Flood, Not A Trickle # ASCO14 http://n.pr/RLFaE7",,@,#,4.73522E+17,https://twitter.com/jrgralow/status/473522458415210497,,,,
wordbistro,6/2/2014 13:52,0,1,Cool! RT @ JFreemanDaily My peak # ASCO14 pt adv exp: meeting chemist who designed targeted # lungcancer drug Xalkori (which made me NED). # LCSM,,@,# # #,4.73522E+17,https://twitter.com/wordbistro/status/473522450245124096,,,,
MikeFranks753,6/2/2014 13:51,0,0,@ ASCO What about Nanobiotix ? Do you have news concerning this company ?,,@,,4.73522E+17,https://twitter.com/MikeFranks753/status/473522225136803840,,,,
MelPalMD,6/2/2014 13:50,0,0,"Couch at on future of BRCA: Risk modifying SNPs, VUS fxnl testing, Next-gen panels, Large public databases, Personalized screening # ASCO14",,,#,4.73522E+17,https://twitter.com/MelPalMD/status/473522086766321664,,,,
subatomicdoc,6/2/2014 13:50,7,5,A physician's guide to interpreting cancer statistics http://bit.ly/1pM4TZc via @ kevinmd # hcsm # ASCO14,,@,# #,4.73522E+17,https://twitter.com/subatomicdoc/status/473521992977895424,,,,
PunitDhillon,6/2/2014 13:50,2,4,"Even more confidence, because we have clear mechanism of action and gene expression data supporting the correlation. $ ONCS # ASCO14",,,#,4.73522E+17,https://twitter.com/PunitDhillon/status/473521970475454464,,,,
LIVESTRONG_NL,6/2/2014 13:50,0,0,Immune therapies improve treatment of # cancers - http://ow.ly/xx5cw # ASCO14 (via USAToday ),,,# #,4.73522E+17,https://twitter.com/LIVESTRONG_NL/status/473521955619233792,,,,
drdonsdizon,6/2/2014 13:50,4,0,For women: there really is no little blue pill. No data PDE5 inhibitors help sexual interest- cancer or no cancer. # survivorship # ASCO14,,,# #,4.73522E+17,https://twitter.com/drdonsdizon/status/473521930964697088,,,,
PHCbiomed,6/2/2014 13:49,0,0,How viable are your drugs or vaccines? Learn how proper refrigeration can preserve your supplies for a longer period at booth 17163 # ASCO14,,,#,4.73522E+17,https://twitter.com/PHCbiomed/status/473521889391161346,,,,
CUCancerCenter,6/2/2014 13:48,1,1,"# ASCO14 Tale of Two Prognoses in Pediatric Brain Tumor, Pilocytic Astrocytoma http://bit.ly/1oOm1QE pic.twitter.com/KdchxRKgug",,,#,4.73522E+17,https://twitter.com/CUCancerCenter/status/473521672947912704,,,,
Medicalfacts,6/2/2014 13:48,0,0,# ASCO14: Biologicals en chemotherapie geven gelijke resultaten in overleving bij patient met uitgezaaide... http://is.gd/7rqCoU,,,#,4.73522E+17,https://twitter.com/Medicalfacts/status/473521502512754688,,,,
MSuppli,6/2/2014 13:48,0,0,Free choice in first line mCRC but which combination after # coin and # EPOC ? # ASCO14 # mCRC,,,# # # #,4.73521E+17,https://twitter.com/MSuppli/status/473521475149103105,,,,
OncoSec,6/2/2014 13:47,1,2,Higher res version of today's poster presentation is available at the following link: http://ow.ly/xxhyk $ ONCS # ASCO14 @ asco,,@,#,4.73521E+17,https://twitter.com/OncoSec/status/473521322220617728,,,,
jrgralow,6/2/2014 13:46,9,3,. @ theNCI at # ASCO14 - A brief overview on research in womens cancers http://www.cancer.gov/newscenter/newsfromnci/2014/ASCOWomensCancerPerspective#.U4y4bGoe1VI.twitter …,,@,# #,4.73521E+17,https://twitter.com/jrgralow/status/473521160865325056,,,,
corp_UNC,6/2/2014 13:46,0,0,thx @dollhouse815 for tip! Link for Wright on limit'ns of publicly reported # quality measures: http://ow.ly/xxbFh # asco14 @ SGO_org,,@dollhouse815 @,# #,4.73521E+17,https://twitter.com/corp_UNC/status/473521036714336256,,,,
ECMC_UK,6/2/2014 13:46,0,0,Talking to pharma partners about ECMC Combination Alliance # ASCO14 pic.twitter.com/G5toL4uVGK,,,#,4.73521E+17,https://twitter.com/ECMC_UK/status/473521008368832512,,,,
corp_UNC,6/2/2014 13:45,1,0,Changes in ADT overuse: Reimb response and char. of persistent overusers S.Ellis @ m_e_nielsen et al # ASCO14 http://ow.ly/xulPd # pcsm,,@,# #,4.73521E+17,https://twitter.com/corp_UNC/status/473520826911047680,,,,
MGHCancerCenter,6/2/2014 13:45,0,0,"1:15-5, S Hall A2: Dr. Movassaghian poster: Outcomes among patients with isolated myeloid sarcoma: A SEER database analysis. # ASCO14",,,#,4.73521E+17,https://twitter.com/MGHCancerCenter/status/473520784921886720,,,,
FoundationATCG,6/2/2014 13:45,0,0,"# TargetedTherapy guided by # FoundationOne lead to higher response rates in # angiosarcoma Oral Pres: 2:03-2:15, S405, Ab 10512 # ASCO14",,,# # # #,4.73521E+17,https://twitter.com/FoundationATCG/status/473520755356213248,,,,
OncoSec,6/2/2014 13:44,7,3,"For those interested, a JPG of the $ ONCS poster image presented at today's # ASCO14 meeting: @ asco pic.twitter.com/V2TPcUFIeW",,@,#,4.73521E+17,https://twitter.com/OncoSec/status/473520636925861890,,,,
kbnewport,6/2/2014 13:44,0,1,@ fischmd What's the appropriate goal for QOPI measure of tx @EOL: need to collect data on this but goal is not zero. # ASCO14 # hpm,,@ @EOL,# #,4.73521E+17,https://twitter.com/kbnewport/status/473520584584736770,,,,
jrgralow,6/2/2014 13:44,0,0,Study Shows Potential of a New Personalized Strategy for Advanced Cervical Cancer # ASCO14 http://www.cancer.net/research-and-advocacy/research-summaries/study-shows-potential-new-personalized-strategy-advanced-cervical-cancer#.U4y3uiy8MPk.twitter …,,,# #,4.7352E+17,https://twitter.com/jrgralow/status/473520470847787008,,,,
melanoma_Drs,6/2/2014 13:44,0,0,MT @ Melanoma_doctor: Combo Rx for injectables should be w Ipi/PD1 Ab. Puzanov et al (Ph1 Ipi/TVec) suggests bright future # melanoma # ASCO14,,@,# #,4.7352E+17,https://twitter.com/melanoma_Drs/status/473520448454791168,,,,
mlazqui,6/2/2014 13:43,0,0,Abstr4500: adjuvant chemo better than tretament for relapse in pT3-T4 or N+M0 bladder cancer. http://abstracts.asco.org/144/AbstView_144_130351.html … # gucsm # ASCO14,,,# #,4.7352E+17,https://twitter.com/mlazqui/status/473520374689595392,,,,
AneesChagpar,6/2/2014 13:43,2,1,Great to be working with @ GTFRCC @ ASCO @ jrgralow @ subatomicdoc & others to address how we can improve cancer care globally. # ASCO14,,@ @ @ @,#,4.7352E+17,https://twitter.com/AneesChagpar/status/473520350572318720,,,,
MelPalMD,6/2/2014 13:43,0,0,"Lindor on future of Lynch: universal screen, pheno-geno, polygenic penetrance, new genes, prevention, less invasive testing. # ASCO14",,,#,4.7352E+17,https://twitter.com/MelPalMD/status/473520342338523136,,,,
Melanoma_doctor,6/2/2014 13:43,2,1,Combo Rx for injectables should be w Ipi/PD1 Ab. Poster by Puzanov et al (Ph1 Ipi/TVec) suggests bright future # melanoma # ASCO14,,,# #,4.7352E+17,https://twitter.com/Melanoma_doctor/status/473520282498772993,,,,
JFreemanDaily,6/2/2014 13:43,6,10,My peak # ASCO14 patient advocate experience: meeting chemist who designed my targeted # lungcancer drug Xalkori (which made me NED). # LCSM,,,# # #,4.7352E+17,https://twitter.com/JFreemanDaily/status/473520224612786179,,,,
PunitDhillon,6/2/2014 13:42,3,3,Regression of non-treated tumors suggests successful induction of systemic anti-tumor response in 60% of patients # ASCO14 $ ONCS,,,#,4.7352E+17,https://twitter.com/PunitDhillon/status/473519987089747968,,,,
obogler,6/2/2014 13:41,3,0,At # ASCO14 saw Dr. Mittendorf's poster about immunology trial which I'm a part of # malebreastcancerpic.twitter.com/xQtFXQgEwr,,,# #,4.7352E+17,https://twitter.com/obogler/status/473519915102920704,,,,
UCD_Cancer,6/2/2014 13:41,0,0,This weekend we celebrated survivors at our Cancer Survivors Day Picnic.Learn more about survivorship HERE: http://goo.gl/JDmJ01 @ ASCO,,@,,4.7352E+17,https://twitter.com/UCD_Cancer/status/473519767991492611,,,,
mlazqui,6/2/2014 13:41,3,1,Abstr 4505: ESPN trial- no advantage to everolimus vs sunitinib for non-clear cell # RCC. # gucsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_134866.html …,,,# # #,4.7352E+17,https://twitter.com/mlazqui/status/473519700924956672,,,,
MMarchioneAP,6/2/2014 13:40,16,7,from riddled with tumors and less than a year to live to no sign of cancer. the promise of # immunotheraphy http://tinyurl.com/ptsb5uz # ASCO14,,,# #,4.7352E+17,https://twitter.com/MMarchioneAP/status/473519646176706561,,,,
djsampson,6/2/2014 13:40,1,1,Good news! MT @ rschilsky: # ASCO14 annual biz mtg: ASCO ... launching new Palliative Care Symposium in October 2014 in Boston.,,@,#,4.73519E+17,https://twitter.com/djsampson/status/473519465318326272,,,,
mtmdphd,6/2/2014 13:40,0,0,Lymphoma and plasma cell disorder posters - 6/2 1:15-5:00 p # lymsm # mmsm # ASCO14 pic.twitter.com/hT1u7chOd2,,,# # #,4.73519E+17,https://twitter.com/mtmdphd/status/473519439829544960,,,,
melanoma_Drs,6/2/2014 13:40,0,0,"RT @ Melanoma_doctor: All injectable therapies can be lumped together--dim future as monoRx, key is combo as priming agent # melanoma # ASCO14",,@,# #,4.73519E+17,https://twitter.com/melanoma_Drs/status/473519427154345985,,,,
Melanoma_doctor,6/2/2014 13:39,1,2,"All injectable therapies can be lumped together--dim future as monoRx, key is combo as priming agent # melanoma # ASCO14",,,# #,4.73519E+17,https://twitter.com/Melanoma_doctor/status/473519312435941377,,,,
drdonsdizon,6/2/2014 13:39,1,0,"N Tanner, Abstr 4505: ESPN trial- no advantage to everolimus vs sunitinib for non-clear cell # RCC. # gucsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_134866.html …",,,# # #,4.73519E+17,https://twitter.com/drdonsdizon/status/473519172777820160,,,,
BioWorld,6/2/2014 13:38,4,2,"Live longer and prosper, with melanoma http://bit.ly/1p1dsPW # ASCO14",,,#,4.73519E+17,https://twitter.com/BioWorld/status/473519158857302016,,,,
jodigralnick,6/2/2014 13:38,6,6,# ASCO14: # FDA cancer czar talks to @ CNBC's @ megtirrell abt breakthru designations & if chemo will soon be obsolete: http://cnb.cx/1m61RLs,,@ @,# #,4.73519E+17,https://twitter.com/jodigralnick/status/473519142167801856,,,,
carisls,6/2/2014 13:38,0,0,Dr. Michael Friedlander of Australia'sPrince of Wales Hospital presenting molecular profiling of clear cell # ovarian carcinoma at # ASCO14,,,# #,4.73519E+17,https://twitter.com/carisls/status/473518948462239744,,,,
mikemejiamd,6/2/2014 13:36,0,0,Excellent summary on oesophgeal cancer # ASCO14 http://am.asco.org/experts-review-clinical-management-upper-gastrointestinal-cancers …,,,#,4.73519E+17,https://twitter.com/mikemejiamd/status/473518637429440513,,,,
GenomeGrl,6/2/2014 13:36,0,0,PALB2 gene: important contributor to hereditary # breastcancer and # pancreaticcancer. # ASCO14,,,# # #,4.73519E+17,https://twitter.com/GenomeGrl/status/473518534266748928,,,,
Merck,6/2/2014 13:36,1,0,Attending @ ASCO? Please join us at 3pm as we present our melanoma data at the E. Arie Crown Theater. # MerckOncology # ASCO14,,@,# #,4.73519E+17,https://twitter.com/Merck/status/473518503249461248,,,,
PunitDhillon,6/2/2014 13:36,3,3,"To the best of our knowledge, 1st time intratumoral therapy is showing correlation with local response leading to systemic response. # ASCO14",,,#,4.73518E+17,https://twitter.com/PunitDhillon/status/473518445070667776,,,,
ERPlimackMD,6/2/2014 13:35,2,2,Kudos to Quinn et al for quickly completing a RPhIII adrenocortical ca trial proving it can be done. Now just need a drug that works # ASCO14,,,#,4.73518E+17,https://twitter.com/ERPlimackMD/status/473518394889613314,,,,
ECMC_UK,6/2/2014 13:35,0,0,"Great dicussion about progress in the ECMC Combination Alliance with our partner, Astex at # ASCO14",,,#,4.73518E+17,https://twitter.com/ECMC_UK/status/473518318364536832,,,,
Melanoma_doctor,6/2/2014 13:35,1,1,Ipilimumab not effective in met uveal # melanoma # ASCO14,,,# #,4.73518E+17,https://twitter.com/Melanoma_doctor/status/473518302695014400,,,,
canceranswerman,6/2/2014 13:35,0,0,The latest RT @ theNCI: Learn about this # immunotherapy approach being tested against numerous solid tumors http://1.usa.gov/1mJcPs3 # ASCO14,,@,# #,4.73518E+17,https://twitter.com/canceranswerman/status/473518292981010432,,,,
Xcenda,6/2/2014 13:35,0,0,# Xcenda presents 2 posters on NSCLC & chronic myelogenous leukemia at # ASCO14 learn more: http://bit.ly/1jXRsje # oncology # hematology,,,# # # #,4.73518E+17,https://twitter.com/Xcenda/status/473518215914463232,,,,
melanoma_Drs,6/2/2014 13:35,0,0,"Poster highlight session underway, studies address testing, injectables and a pot pouri of Rx trials # melanoma # ASCO14",,,# #,4.73518E+17,https://twitter.com/melanoma_Drs/status/473518162622042113,,,,
Melanoma_doctor,6/2/2014 13:35,0,0,"Poster highlight session underway, studies address testing, injectables and a pot pouri of Rx trials # melanoma # ASCO14",,,# #,4.73518E+17,https://twitter.com/Melanoma_doctor/status/473518161888051201,,,,
ShannonWestin,6/2/2014 13:34,0,0,"“ @ KathleenMaxian: outliers"" should be analyzed as a tool for predicting response to treatment # ASCO14 # GYNCSM @ drdonsdizon"" well said!!""",,@ @,# #,4.73518E+17,https://twitter.com/ShannonWestin/status/473518125812822017,,,,
drdonsdizon,6/2/2014 13:34,0,0,C Sternberg @ EORTC Abstr 4500: Immediate vs delayed CT for high-risk bladder ca- 5yPFS 46.8 vs 29.5%. 5y OS 54 vs 48% # gucsm # ASCO14,,@,# #,4.73518E+17,https://twitter.com/drdonsdizon/status/473517904277676033,,,,
CancerFrontline,6/2/2014 13:33,2,2,American Society of Clinical Oncology recognizes MD Anderson leaders for impact on cancer care: http://www.mdanderson.org/newsroom/news-releases/2014/asco-recognizes-md-anderson-leaders.html#.U4y1ReNk_G4.twitter … # endcancer # ASCO14,,,# # #,4.73518E+17,https://twitter.com/CancerFrontline/status/473517894391701505,,,,
daphnezohar,6/2/2014 13:33,6,0,"If you want to get a sense for news at biggest cancer conference ( # ASCO14), Sunday's most RTed tweets: http://bit.ly/1hRy0Fs @ brianreid",,@,#,4.73518E+17,https://twitter.com/daphnezohar/status/473517846514118656,,,,
ESchattner,6/2/2014 13:33,8,2,"Indeed! via @ OncTimes_AsstEd: Patient education can no longer be an afterthought."" Nice column by @ RSM2800"," @ ASCO - http://bit.ly/1tBYJuW""",,@ @ @,,4.73518E+17,https://twitter.com/ESchattner/status/473517810371817472,,,
FreeBRCA,6/2/2014 13:33,0,0,@ JonathanHirsch @ MayoClinicCIM thx for the mention! Seen our latest project? www.free-the-data/sign # ASCO14,,@ @,#,4.73518E+17,https://twitter.com/FreeBRCA/status/473517744135368704,,,,
MelPalMD,6/2/2014 13:33,0,0,"Dark Matter"" - Jim Ford on the future of hereditary cancers # ASCO14 pic.twitter.com/mYmwsO6VN6""",,,#,4.73518E+17,https://twitter.com/MelPalMD/status/473517703076904960,,,,
ASCO,6/2/2014 13:33,0,0,@ dhjutsw1 Thank you so much for your presence & for your meaningful # ASCO14 tweets.,,@,#,4.73518E+17,https://twitter.com/ASCO/status/473517662925246466,,,,
KathleenMaxian,6/2/2014 13:33,2,3,"outliers"" should be analyzed as a tool for predicting who will respond to treatment # ASCO14 # GYNCSM @ drdonsdizon @ OCNA @ WNYOCP @ RoswellPark""",,@ @ @ @,# #,4.73518E+17,https://twitter.com/KathleenMaxian/status/473517651688300544,,,,
CancerFrontline,6/2/2014 13:32,1,0,Adding BRAF inhibition to chemo helps metastatic colon cancer patients http://www.mdanderson.org/newsroom/news-releases/2014/patients-metastatic-colon-cancer-respond-to-therapy.html#.U4y0r1FoNeo.twitter … # endcancer # ASCO14 # coloncancer,,,# # # #,4.73518E+17,https://twitter.com/CancerFrontline/status/473517593915949057,,,,
ZimJay,6/2/2014 13:32,0,0,@ gorskon Good luck with the PTSD. You deserve help getting @ EricMerola & # Burzynski out of your head. # ASCO14,,@ @,# #,4.73518E+17,https://twitter.com/ZimJay/status/473517556666740736,,,,
ECMC_UK,6/2/2014 13:32,0,0,Hazel Jones with Clare Shaw supporting UK combinations trials at the NIHR CRN:Cancer stand (4127) # ASCO14,,,#,4.73517E+17,https://twitter.com/ECMC_UK/status/473517430375849984,,,,
DrMisialek,6/2/2014 13:31,2,2,"MT @ aftimosp Other emerging targets in NSCLC: RET, NTRK1, CD74-NRG1, FGFR. @ Pathologists lead the way in profiling tumors # lcsm # ASCO14",,@ @,# #,4.73517E+17,https://twitter.com/DrMisialek/status/473517364836040705,,,,
CancerDotNet,6/2/2014 13:31,1,1,Video: Dr. Clifford Hudis @ CliffordHudis talks abt study on # cervicalcancer & immunotherapy approach # ASCO14 http://bit.ly/1wTxf8H,,@,# #,4.73517E+17,https://twitter.com/CancerDotNet/status/473517240995053568,,,,
corp_UNC,6/2/2014 13:31,0,0,"National survey of breast cancer screening in rural America Peppercorn,S.Wheeler @ UNC_Lineberger et al # bcsm # asco14 http://ow.ly/xplNk",,@,# #,4.73517E+17,https://twitter.com/corp_UNC/status/473517238210002944,,,,
CancerFrontline,6/2/2014 13:31,0,0,Metastatic colon cancer patients respond to new combination therapy | MD Anderson Cancer Center: http://www.mdanderson.org/newsroom/news-releases/2014/patients-metastatic-colon-cancer-respond-to-therapy.html#.U4y0r1FoNeo.twitter … # endcancer # ASCO14,,,# # #,4.73517E+17,https://twitter.com/CancerFrontline/status/473517204344807424,,,,
ASCO,6/2/2014 13:31,1,2,Clinical management of esophagogastric cancer: Consensus moving away from the evidence? http://bit.ly/1iLKgYc # ASCO14,,,#,4.73517E+17,https://twitter.com/ASCO/status/473517169100464128,,,,
drdonsdizon,6/2/2014 13:31,1,0,"C Sternberg @ EORTC, Abstr4500: adjuv chemo better than rx 4 relapse in pT3-T4 or N+M0 bladder cancer. http://abstracts.asco.org/144/AbstView_144_130351.html … # gucsm # ASCO14",,@,# #,4.73517E+17,https://twitter.com/drdonsdizon/status/473517150448013313,,,,
Novartis,6/2/2014 13:30,1,2,Approximately 2-7% of patients with NSCLC have the ALK gene rearrangement. http://bit.ly/1jKwFFX # ASCO14,,,#,4.73517E+17,https://twitter.com/Novartis/status/473517124456312832,,,,
SarahCannonDocs,6/2/2014 13:30,0,1,Lung Cancer # NCSLC Oral Abstract with SCRI today: Dr. Spigel share results from # SCRI clinical trial at # ASCO14 3pm E Hall D2,,,# # #,4.73517E+17,https://twitter.com/SarahCannonDocs/status/473517080760057856,,,,
SarahCannonDocs,6/2/2014 13:30,0,0,TWO GI (noncolorectral) abstracts supported by # SCRI's Dr.Bendell today at 1:15 E Hall D1 # ASCO14,,,# #,4.73517E+17,https://twitter.com/SarahCannonDocs/status/473517064238669824,,,,
KoontzOncology,6/2/2014 13:30,0,0,Availability of resources affects classification of neuroblastoma. # ASCO14 pic.twitter.com/pROQgTxbov,,,#,4.73517E+17,https://twitter.com/KoontzOncology/status/473516997586989056,,,,
YaleCancer,6/2/2014 13:30,4,2,@ sloan_kettering @ wolchokj @ medpagetoday @ ASCO Yale Cancer Center welcomes Dr. Wolchok to Twitter,,@ @ @ @,,4.73517E+17,https://twitter.com/YaleCancer/status/473516993606615040,,,,
Boehringer,6/2/2014 13:30,1,1,# PRESS: Today Prof Yang discusses latest afatinib # lungcancer results at 16:00 CDT in E hall D2 http://bit.ly/1kxE5f3 # ASCO14,,,# # #,4.73517E+17,https://twitter.com/Boehringer/status/473516993069715456,,,,
eMPR,6/2/2014 13:30,0,0,Exemestane vs tamoxifen in early breast cancer: http://ow.ly/xx4xH # ASCO14 # oncology,,,# #,4.73517E+17,https://twitter.com/eMPR/status/473516946781396992,,,,
myPathMelanoma,6/2/2014 13:30,0,0,If you haven't stopped by our poster presentation yet you have 15 minutes left! # ASCO14,,,#,4.73517E+17,https://twitter.com/myPathMelanoma/status/473516898961743872,,,,
ShannonWestin,6/2/2014 13:30,0,0,Exciting results using SPECT imaging to identify potential sensitivity to targeted therapy w vintafolide. Abst#5534 # ASCO14 # gyncsm,,,#5534 # #,4.73517E+17,https://twitter.com/ShannonWestin/status/473516897636716544,,,,
kbnewport,6/2/2014 13:29,0,0,# ASCO14 more poster sessions taking place between 1:15-5pm in S Hall A2. Be sure to stop by. # ASCO14,,,# #,4.73517E+17,https://twitter.com/kbnewport/status/473516888907984898,,,,
ImedexCME,6/2/2014 13:29,0,1,"Drs. R. O'Regan, K. Anderson, and A. Grothey are taping Best of the Day at our booth no.15085 @ oncologytube # oncology # CME # ASCO14 # Chicago",,@,# # # #,4.73517E+17,https://twitter.com/ImedexCME/status/473516883505721346,,,,
FullStopPress,6/2/2014 13:29,0,0,Tim Cook reminds me of Ashton Kutcher brutalizing the Legacy # ASCO14,,,#,4.73517E+17,https://twitter.com/FullStopPress/status/473516883128221697,,,,
Ludwig_Cancer,6/2/2014 13:29,0,2,"Check out: Ludwig's George Coukos is delivering a lecture now at # ASCO14 titled, The Historical Role of Targeting the Immune Environment”""",,,#,4.73517E+17,https://twitter.com/Ludwig_Cancer/status/473516785120333825,,,,
nxtstop1,6/2/2014 13:29,1,2,"MAGIC ELIXOR! @ kbnewport: # ASCO14 mult studies show exercise improves outcomes in cancer survivors:hematologic prostate, colorectal & breast",,@,#,4.73517E+17,https://twitter.com/nxtstop1/status/473516753549402113,,,,
KoontzOncology,6/2/2014 13:29,0,1,Nice summary of the treatment of HR neuroblastoma by Dr. Julia Glade Bender. # ASCO14 pic.twitter.com/rg8BmR0ffw,,,#,4.73517E+17,https://twitter.com/KoontzOncology/status/473516664823492608,,,,
tomleblancMD,6/2/2014 13:29,5,2,"Oncologists rarely say death"" in # endoflife discussions; euphemisms often not understood by patients: http://ow.ly/xxbGz # ASCO14 # hpm""",,,# # #,4.73517E+17,https://twitter.com/tomleblancMD/status/473516646456627201,,,,
CancerResearch,6/2/2014 13:28,0,1,@ nytimes 30 days 30 stories. Cancer immunotherapy is revolutionizing treatment today. # CIM2014 # ASCO14 http://owl.li/xuE03,,@,# #,4.73517E+17,https://twitter.com/CancerResearch/status/473516567662051328,,,,
DrRobertGlatter,6/2/2014 13:28,0,1,@ medmeme @ DrRobertGlatter @ Forbes thanks for RT and follow # ASCO14,,@ @ @,#,4.73517E+17,https://twitter.com/DrRobertGlatter/status/473516507864256512,,,,
JonathanHirsch,6/2/2014 13:27,1,1,# FreeTheData shout out by Fergus Couch @ MayoClinicCIM http://free-the-data.org @ FreeBRCA # ASCO14,,@ @,# #,4.73516E+17,https://twitter.com/JonathanHirsch/status/473516329115193344,,,,
BigTenCRC,6/2/2014 13:26,0,1,See photo highlights from the @ BigTenCRC meeting at # ASCO14 http://on.fb.me/U7l35i,,@,#,4.73516E+17,https://twitter.com/BigTenCRC/status/473516008549134336,,,,
damiangarde,6/2/2014 13:26,2,1,You can find all of @ FierceBiotech's # ASCO14 coverage right here: http://www.fiercebiotech.com/tags/asco-2014,,@,#,4.73516E+17,https://twitter.com/damiangarde/status/473515978144620544,,,,
AstellasUS,6/2/2014 13:26,5,5,"The value of cancer meds extend beyond treatment, also representing a substantial amount of economic relief. # ASCO14 pic.twitter.com/HVekpRjdll",,,#,4.73516E+17,https://twitter.com/AstellasUS/status/473515946330832896,,,,
RyanNipp,6/2/2014 13:25,2,2,@ DrHedrick @ ElizBlanchardMD - totally agree! We presented this last year... http://meetinglibrary.asco.org/content/110659-132 … # ASCO14,,@ @,#,4.73516E+17,https://twitter.com/RyanNipp/status/473515861085814785,,,,
EthanBasch1,6/2/2014 13:25,2,4,Excellent overview of impact of exercise interventions on cancer outcomes by Jennifer Ligabel: # ASCO14 http://tinyurl.com/odq55fq,,,#,4.73516E+17,https://twitter.com/EthanBasch1/status/473515776667025408,,,,
kbnewport,6/2/2014 13:25,0,0,RCTs needed to examine exercise effects in cancer survivors to clarify findings from small studies # ASCO14,,,#,4.73516E+17,https://twitter.com/kbnewport/status/473515715274625024,,,,
SarahCannonDocs,6/2/2014 13:25,0,0,Onartuzumab + erlotinib vs. erlotinib for # NSCLC: Results from # SCRI's pivotal phase III trial presented by Dr. Spigel 3pm EHall D2 # ASCO14,,,# # #,4.73516E+17,https://twitter.com/SarahCannonDocs/status/473515688687337472,,,,
ShannonWestin,6/2/2014 13:24,0,0,"Long term response (LTR) to PARP linked to BRCA mutations. However, 1/3 of LTR are BRCA wild type. Room for discovery! # ASCO14 # gyncsm",,,# #,4.73516E+17,https://twitter.com/ShannonWestin/status/473515571573956610,,,,
DrBobGoldberg,6/2/2014 13:24,1,0,Friend of mine who's daughter w cancer dying a home: who knew a week could mean so much ? # asco14 # mliwi,,,# #,4.73516E+17,https://twitter.com/DrBobGoldberg/status/473515501810118656,,,,
EIannelli,6/2/2014 13:23,5,4,Proud cancer patient advocate! # ASCO14 @ favo_it @ InsControCancro @ cancereu @ ACSNews @ acsglobal @ kgapo @ marghiadnsalpic.twitter.com/gJGn3qiTLW,,@ @ @ @ @ @ @,#,4.73515E+17,https://twitter.com/EIannelli/status/473515257194110976,,,,
EIannelli,6/2/2014 13:23,4,4,Grandi speranze dall'immunologia x cura # cancro # ASCO14 http://tinyurl.com/obgmger @ favo_it @ InsControCancro @ mritamon @ ManuelaPerrone,,@ @ @ @,# #,4.73515E+17,https://twitter.com/EIannelli/status/473515247148732416,,,,
MGHCancerCenter,6/2/2014 13:23,3,2,T-Cell therapy for cervical cancer treatments? Dr. Michael Birrer helps understand how in # ASCO14 press room,,,#,4.73515E+17,https://twitter.com/MGHCancerCenter/status/473515139128651776,,,,
rschilsky,6/2/2014 13:22,0,1,# ASCO14 Biz mtg: Dr. Lichter advocating support for coop groups and describing ASCO payment reform model.,,,#,4.73515E+17,https://twitter.com/rschilsky/status/473515071642271744,,,,
KoontzOncology,6/2/2014 13:22,0,0,Highlights of abstract 10026 at # ASCO14 pic.twitter.com/VwoFVwwv3z,,,#,4.73515E+17,https://twitter.com/KoontzOncology/status/473515019846844417,,,,
DrHedrick,6/2/2014 13:22,0,0,Basic important question. Why was topotecan control arms so good. Selection? Population (Japanese v. Western)? # ASCO14,,,#,4.73515E+17,https://twitter.com/DrHedrick/status/473514911797374978,,,,
TuftsB,6/2/2014 13:22,0,0,ASCO AHIP joined at hip rationing medically justifiable cancer care. Bureaucrats never added value or saved lives like mine # mliwi # asco14,,,# #,4.73515E+17,https://twitter.com/TuftsB/status/473514886988038144,,,,
aftimosp,6/2/2014 13:21,0,1,"Other emerging targets in NSCLC: RET, NTRK1, CD74-NRG1, FGFR. A big subset without any identified target. # lcsm # ASCO14",,,# #,4.73515E+17,https://twitter.com/aftimosp/status/473514807761444864,,,,
chemobrainfog,6/2/2014 13:21,0,0,Seems like building isn't as busy as normal. Wonder how many folks are at # ASCO14,,,#,4.73515E+17,https://twitter.com/chemobrainfog/status/473514770688393216,,,,
kbnewport,6/2/2014 13:21,0,0,"# ASCO14 numerous studies show that exercise improves outcomes in cancer survivors: hematologist, prostate, colorectal and breast",,,#,4.73515E+17,https://twitter.com/kbnewport/status/473514751822020608,,,,
LguzzardiM,6/2/2014 13:21,0,1,Back to the Future: Family History is Still Key in the Genomic Era. @ ASCO # BRCA http://am.asco.org/back-future-family-history-still-key-genomic-era …,,@,#,4.73515E+17,https://twitter.com/LguzzardiM/status/473514689591128066,,,,
JenPageWall,6/2/2014 13:21,2,0,LA Clippers Sell for $2 billion - about the same cost to develop just two innovative medicines # contextmatters # ASCO14,,,# #,4.73515E+17,https://twitter.com/JenPageWall/status/473514658218135553,,,,
HemOncToday,6/2/2014 13:20,0,0,# ASCO14 @ ClevelandClinic doc discusses combination therapy lowered ovarian failure risk in HR-negative # BreastCancer http://goo.gl/mIMmep,,@,# #,4.73515E+17,https://twitter.com/HemOncToday/status/473514575774904323,,,,
GoHealio,6/2/2014 13:20,0,0,# ASCO14 @ ClevelandClinic doc discusses combination therapy lowered ovarian failure risk in HR-negative # BreastCancer http://goo.gl/mIMmep,,@,# #,4.73515E+17,https://twitter.com/GoHealio/status/473514574998949888,,,,
nanostringtech,6/2/2014 13:20,1,1,Check out Booth 5019 at # ASCO14 this year! pic.twitter.com/EGCVBsDbeU,,,#,4.73515E+17,https://twitter.com/nanostringtech/status/473514536939442176,,,,
BayerPharma,6/2/2014 13:20,1,2,@ FightCRC @ CCAlliance @europacolon @ oncoguia thanks for being part of the lively discussion on # patient support! # ASCO2014,,@ @ @europacolon @,# #,4.73515E+17,https://twitter.com/BayerPharma/status/473514528718999552,,,,
LungCancerFaces,6/2/2014 13:20,2,1,"Media discriminates MT @ Boehringer: # Lungcancer not just smoker's disease, other risk factors, too: http://bit.ly/1oX5LdG # ASCO14 # LCSM",,@,# # #,4.73514E+17,https://twitter.com/LungCancerFaces/status/473514453095313408,,,,
GenomicHealth,6/2/2014 13:20,0,1,We have a few more poster sessions taking place between 1:15-5pm in S Hall A2. Be sure to stop by. # ASCO14,,,#,4.73514E+17,https://twitter.com/GenomicHealth/status/473514438231072768,,,,
GenentechJobs,6/2/2014 13:20,0,0,"# ASCO14 Talent Hunt: Medical Director, Pi3Kinase: http://click2apply.net/430228f",,,#,4.73514E+17,https://twitter.com/GenentechJobs/status/473514398946836480,,,,
myriadgenetics,6/2/2014 13:20,0,0,Are you attending # ASCO14? Visit us at Booth 2039 to learn about our extensive patient advocacy efforts! # personalmed # hereditarycancer,,,# # #,4.73514E+17,https://twitter.com/myriadgenetics/status/473514390050705409,,,,
YaleCancer,6/2/2014 13:19,2,5,Dr. Mario Sznol delivers new findings on immune therapy for adv. melanoma. @ sloan_kettering @ysm @ YNHH @ asco # ASCO14 pic.twitter.com/SfaQlHuap3,,@ @ysm @ @,#,4.73514E+17,https://twitter.com/YaleCancer/status/473514205380112385,,,,
CancerResearch,6/2/2014 13:19,8,4,30 days 30 stories. Cancer immunotherapy is revolutionizing treatment today. # CIM2014 # ASCO14 http://owl.li/xuE03,,,# #,4.73514E+17,https://twitter.com/CancerResearch/status/473514192323248128,,,,
CancerResearch,6/2/2014 13:18,1,0,Five things you can do to help CRI right now--and for free! # CIM2014 # ASCO14 http://ow.ly/xwjxE,,,# #,4.73514E+17,https://twitter.com/CancerResearch/status/473514099708796928,,,,
DrHedrick,6/2/2014 13:18,0,0,In arginine trial. No responses but 50% stable disease. Small benefit in PFS. Is it clinically meaningful? # ASCO14,,,#,4.73514E+17,https://twitter.com/DrHedrick/status/473514088556158977,,,,
KoontzOncology,6/2/2014 13:18,0,0,Highlights from abstract 10028 at # ASCO14 pic.twitter.com/WvL8E1zA1u,,,#,4.73514E+17,https://twitter.com/KoontzOncology/status/473514061981032448,,,,
CancerResearch,6/2/2014 13:18,1,0,http://TheAnswerToCancer.org is here! # CIM2014 # Immunotherapy # ASCO14 http://owl.li/xwL0p,,,# # #,4.73514E+17,https://twitter.com/CancerResearch/status/473514035221393408,,,,
ElizBlanchardMD,6/2/2014 13:18,1,1,Small cell: trial of chemo w or w/o ipilumimab ongoing. Hopeful that an immune based approach may work. # lcsm # ASCO14,,,# #,4.73514E+17,https://twitter.com/ElizBlanchardMD/status/473514020293861378,,,,
ERPlimackMD,6/2/2014 13:18,0,0,"Dr. Lara discusses: ncc RCC - different biology than clear cell. We need dedicated trials for these subsets, must be group effort. # ASCO14",,,#,4.73514E+17,https://twitter.com/ERPlimackMD/status/473513894393417728,,,,
tomleblancMD,6/2/2014 13:17,1,0,Do older men with non-Hodgkin # lymphoma need a higher dose of # rituximab? Interesting study! http://ow.ly/xx9iC # ASCO14,,,# # #,4.73514E+17,https://twitter.com/tomleblancMD/status/473513823509680128,,,,
NPforNinos,6/2/2014 13:17,0,0,RT @ ASCO: Improved fertility preservation after tx with goserelin+chemo in ER-/PR- breast cancer http://bit.ly/1tBHJoz # ASCO14,,@,#,4.73514E+17,https://twitter.com/NPforNinos/status/473513756694421505,,,,
aftimosp,6/2/2014 13:16,3,1,"A subset on NSCLC has features of BRCAness"" and may respond to PARPinh # lcsm # ASCO14""",,,# #,4.73514E+17,https://twitter.com/aftimosp/status/473513560094420992,,,,
NPforNinos,6/2/2014 13:16,0,0,@ Profphipps Try this link RT @ FoundationATCG: New insights into # genomic patterns unique to young adults. # ASCO14 http://ow.ly/3lhbFL,,@ @,# #,4.73513E+17,https://twitter.com/NPforNinos/status/473513443161419776,,,,
NextGenClinical,6/2/2014 13:16,0,0,Well conducted trials with disappointing results still provide us an opportunity to learn. # ASCO14,,,#,4.73513E+17,https://twitter.com/NextGenClinical/status/473513398206869507,,,,
biologypartners,6/2/2014 13:16,0,0,"If anybody is going to the poster session (1:15/S405) for the abstract I just mentioned, please tweet it # ASCO14 cc @ JPZaragoza1 @ MaverickNY",,@ @,#,4.73513E+17,https://twitter.com/biologypartners/status/473513392423305216,,,,
rschilsky,6/2/2014 13:15,2,1,# ASCO14 Biz mtg: CancerLinQ on track for launch in Q3 2015.,,,#,4.73513E+17,https://twitter.com/rschilsky/status/473513368373166080,,,,
DrHedrick,6/2/2014 13:15,0,0,Discussion: VEGF inhibitors are not effective in SCLC. # ASCO14,,,#,4.73513E+17,https://twitter.com/DrHedrick/status/473513329689112576,,,,
AlpineBV_Miller,6/2/2014 13:15,0,0,"@ JonEPVantage Until, of course, you get the inevitable urge to go pee. # ASCO14",,@,#,4.73513E+17,https://twitter.com/AlpineBV_Miller/status/473513297648820224,,,,
DrHedrick,6/2/2014 13:15,0,0,Meant in SCLC. Does it apply elsewhere? RT @ DrHedrick Have we reached a chemotherapy therapeutic plateau. Certainly seems so. # ASCO14,,@,#,4.73513E+17,https://twitter.com/DrHedrick/status/473513233052368897,,,,
ASCO,6/2/2014 13:15,3,5,Improved fertility preservation after tx with goserelin+chemo in ER-/PR- breast cancer http://bit.ly/1tBHJoz # ASCO14,,,#,4.73513E+17,https://twitter.com/ASCO/status/473513230611275776,,,,
corp_UNC,6/2/2014 13:15,0,0,Clinical oncology Rx plan & summary implement'n guide: An interoperable standard to improve Ca care quality # asco14 http://ow.ly/xqCoH,,,#,4.73513E+17,https://twitter.com/corp_UNC/status/473513230128930816,,,,
rsm2800,6/2/2014 13:15,7,1,Starts in 1 hr in S504 Internet, Social Media, Privacy Regulations," and Clinical Trials.” Pls join @ mtmdphd @ obogler & me # ASCO14""",,@ @,#,4.73513E+17,https://twitter.com/rsm2800/status/473513205508354050,
aftimosp,6/2/2014 13:15,0,0,"@ aftimosp: Other new potential targets in NSCLC: ARAF/CRAF (sorafenib), LASEP1 # lcsm # ASCO14",,@,# #,4.73513E+17,https://twitter.com/aftimosp/status/473513204018995201,,,,
DrHedrick,6/2/2014 13:14,0,0,So we have an additional larger trial that was neg for OS and small benefit for PFS. Yet another trial was done. # ASCO14,,,#,4.73513E+17,https://twitter.com/DrHedrick/status/473512964193255424,,,,
rschilsky,6/2/2014 13:14,0,1,# ASCO14 QOPI transitioning to electronic platform in Fall 2014; QOPI deemed as a qualified clinical data registry for PQRS reporting.,,,#,4.73513E+17,https://twitter.com/rschilsky/status/473512947508322304,,,,
dramarivirg,6/2/2014 13:13,3,1,"Sunitinib y everolimus eficaces en CCR otras histologías no celulas claras, aparente ventaja d sunitinib en SLP según estudio ESPN # ASCO14",,,#,4.73513E+17,https://twitter.com/dramarivirg/status/473512868202434560,,,,
ByJonGardner,6/2/2014 13:13,0,1,Can't. Take. Eyes. Off. Fountains. On. Concourse. # ASCO14 # mesmerising,,,# #,4.73513E+17,https://twitter.com/ByJonGardner/status/473512766553071618,,,,
ElizBlanchardMD,6/2/2014 13:13,0,1,Commentary: abs 7504: why not just re challenge w original regimen? Second line tx for small cell needs a new paradigm. # ASCO14 # lcsm,,,# #,4.73513E+17,https://twitter.com/ElizBlanchardMD/status/473512758374592512,,,,
ShannonWestin,6/2/2014 13:13,0,0,Neoadjuvant chemo + rad hyst may provide benefit - ? a fertility sparing option for women with locally adv cervix ca. # ASCO14 # gyncsm,,,# #,4.73513E+17,https://twitter.com/ShannonWestin/status/473512708881788928,,,,
myPathMelanoma,6/2/2014 13:12,1,0,"Which of these AREN'T subjective? # Myriad my Path Melanoma is an objective tool, increases dx confidence. # ASCO14 pic.twitter.com/gTHvufjDIy",,,# #,4.73513E+17,https://twitter.com/myPathMelanoma/status/473512538328424448,,,,
BayerPharma,6/2/2014 13:12,2,3,Thanks to @ preventcancer @ liferaftgroup @ ustoohq and others for attending our # advocacy summit today! # ASCO14,,@ @ @,# #,4.73513E+17,https://twitter.com/BayerPharma/status/473512505328041984,,,,
DrHedrick,6/2/2014 13:12,0,1,Have we reached a therapeutic chemotherapy plateau? Certainly seems like it. # ASCO14,,,#,4.73512E+17,https://twitter.com/DrHedrick/status/473512478757105664,,,,
rschilsky,6/2/2014 13:12,9,6,# ASCO14 annual biz mtg: ASCO focusing on palliative care; launching new Palliative Care Symposium in October 2014 in Boston.,,,#,4.73512E+17,https://twitter.com/rschilsky/status/473512459572363264,,,,
LungCancerFaces,6/2/2014 13:12,0,0,“ @ DrHedrick: Why is SCLC and Mesothelioma so hard? As opposed to advances in NSCLC there are no known driver mutations. # ASCO14” # LCSM,,@,# #,4.73512E+17,https://twitter.com/LungCancerFaces/status/473512425791037441,,,,
ERPlimackMD,6/2/2014 13:12,0,1,"Dr. Lara discusses ipi + nivo in RCC: activity additive, response rates among highest w many ongoing, ipi dose drives tox # ASCO14 # gucsm",,,# #,4.73512E+17,https://twitter.com/ERPlimackMD/status/473512418027782144,,,,
GenomeGrl,6/2/2014 13:12,0,0,This GC is happy to see that the hereditary breast and CRC session at # ASCO14 is completely full! @ GeneticCouns,,@,#,4.73512E+17,https://twitter.com/GenomeGrl/status/473512378681020416,,,,
LungCancerFaces,6/2/2014 13:11,1,1,"# LCSM=Lung Cancer Social Media, a community with one thing in common: # LungCancer. Docs, patients, caregivers, advocates. United. # ASCO14",,,# # #,4.73512E+17,https://twitter.com/LungCancerFaces/status/473512175860871168,,,,
DrHedrick,6/2/2014 13:11,0,0,"In topotecan v. PEI trial, Control arm OS was very long (selection?). Rechallenge was not done apparently. Very toxic. # ASCO14",,,#,4.73512E+17,https://twitter.com/DrHedrick/status/473512140541001728,,,,
robert_jeng,6/2/2014 13:10,2,0,"Dr Lara: nivo + ipi phase 3 gutsy. Phase 1 tox tends to be magnified in P3. # ASCO14""",,,#,4.73512E+17,https://twitter.com/robert_jeng/status/473512000887455744,,,,
MGHCancerCenter,6/2/2014 13:10,0,0,"1:15-5, S Hall A2: Aahra poster: Outcomes of in-hospital cardiopulmonary resuscitation in patients with metastatic cancer. # ASCO14",,,#,4.73512E+17,https://twitter.com/MGHCancerCenter/status/473511993882996736,,,,
rsm2800,6/2/2014 13:10,2,0,Insomnia-per Dr. Ford need to be screening for this more in cancer survivors. Also need more studies on pharmacologic interventions # asco14,,,#,4.73512E+17,https://twitter.com/rsm2800/status/473511992783679489,,,,
ElizBlanchardMD,6/2/2014 13:10,0,0,Abs7507:some hope for mesothelioma.Depriving arginine may help in tumors w/o arg specific enzyme(needs better marketing tho!) # ASCO14 # lcsm,,,# #,4.73512E+17,https://twitter.com/ElizBlanchardMD/status/473511970575224832,,,,
rschilsky,6/2/2014 13:10,2,3,# ASCO14 annual biz mtg: Dr. Lichter discussing global reach of ASCO to meet global cancer burden.,,,#,4.73512E+17,https://twitter.com/rschilsky/status/473511969220485120,,,,
SophiaCeulemans,6/2/2014 13:10,0,0,"Noralane Lindor: CAPP3 aspirin dosage-finding trial about to launch, reduction of # coloncancer risk in people with # lynch # ASCO14",,,# # #,4.73512E+17,https://twitter.com/SophiaCeulemans/status/473511924907638785,,,,
ONAcom,6/2/2014 13:10,0,2,"RT @ cure_magazine: Study shows Yervoy reduces risk of recurrence in patients with stage 3 melanoma, survival to be reported later # asco14",,@,#,4.73512E+17,https://twitter.com/ONAcom/status/473511918104506369,,,,
CRiverLabs,6/2/2014 13:10,0,1,"At # ASCO14, the red-hot field of cancer immunotherapy is stealing the show. Read: A Shot Against Cancer http://ow.ly/xs6oU . @ ASCO",,@,#,4.73512E+17,https://twitter.com/CRiverLabs/status/473511903109865473,,,,
sdaryanani,6/2/2014 13:10,0,0,# ASCO14 I propose a worldwide ban of tax free cigarettes!,,,#,4.73512E+17,https://twitter.com/sdaryanani/status/473511888639119360,,,,
Senesco,6/2/2014 13:10,1,0,"$ SNTI to announce update on # SNS01-T @ # ASCO14, June 2nd, 1:15PM CT during session Lymphoma & Plasma Cell Disorders"" http://bit.ly/1u8Toxi""",,@,# #,4.73512E+17,https://twitter.com/Senesco/status/473511865994076160,,,,
DrHedrick,6/2/2014 13:09,0,0,Why is SCLC and Mesothelioma so hard? As opposed to advances in NSCLC there are no known driver mutations. # ASCO14,,,#,4.73512E+17,https://twitter.com/DrHedrick/status/473511850987229184,,,,
bizrpt,6/2/2014 13:09,0,0,Takeaways from the weekend at # ASCO14 from @ megtirrell READ: http://bit.ly/1nYWX7y,,@,#,4.73512E+17,https://twitter.com/bizrpt/status/473511837762215936,,,,
ShannonWestin,6/2/2014 13:09,0,0,Chemotherapy improves outcomes in combination with XRT for vaginal cancer in a large registry study. # ASCO14 # gyncsm,,,# #,4.73512E+17,https://twitter.com/ShannonWestin/status/473511827964715009,,,,
aftimosp,6/2/2014 13:09,1,0,KRAS mutations as a mechanism of resistance to cizotinib in NSCLC with ROS1 fusions? # lcsm # ASCO14,,,# #,4.73512E+17,https://twitter.com/aftimosp/status/473511825540018176,,,,
dramarivirg,6/2/2014 13:09,0,1,"Nivolumab + ipilimumab probada en estudio fase I con eficacia y toxicidad aceptable, por lo q arranca fase III en 1ra línea CCRcc mt # ASCO14",,,#,4.73512E+17,https://twitter.com/dramarivirg/status/473511823187390464,,,,
ConsanoScott,6/2/2014 13:09,0,0,Only 5 hours left to get your orange pen! Come visit team @ Consano & talk # crowdfunding # cancer research at # ASCO14! pic.twitter.com/nQcknroXTO,,@,# # #,4.73512E+17,https://twitter.com/ConsanoScott/status/473511809429671937,,,,
diablovalleyonc,6/2/2014 13:09,0,1,# asco2014 is happening now! Dr. Karamlou of @diablovalleyoncology is at the meeting and is excited about break through news for # cll...,,@diablovalleyoncology,# #,4.73512E+17,https://twitter.com/diablovalleyonc/status/473511802060701697,,,,
rsm2800,6/2/2014 13:09,0,3,"Very interesting! RT @ brianreid: What's hot at # ASCO14? Sunday's most RTed tweets, in rank-order: http://bit.ly/1hRy0Fs",,@,#,4.73512E+17,https://twitter.com/rsm2800/status/473511752064172032,,,,
myelomacinderel,6/2/2014 13:09,0,0,"@ smerv @BloombergNews Yes,let's give a BIG shout-out 2 'all the 'fathers' who labored 2 discover immune checkpoints!! # ASCO14 # myeloma # mmsm",,@ @BloombergNews,# # #,4.73512E+17,https://twitter.com/myelomacinderel/status/473511749266980864,,,,
DrHedrick,6/2/2014 13:09,1,0,"Nice preliminary study in complex, difficult to treat disease. Will progress into Phase II study and another Phase I study in NSCLC. # ASCO14",,,#,4.73512E+17,https://twitter.com/DrHedrick/status/473511655956291585,,,,
ChrisHeery,6/2/2014 13:08,0,0,“ @ JNCI_Now: HPV-targeted adoptive T cell therapy may provide a new personalized strategy for advanced cervical cancer. # ASCO14” Hinrichs NCI,,@,#,4.73512E+17,https://twitter.com/ChrisHeery/status/473511559981850624,,,,
bradloncar,6/2/2014 13:08,10,11,Why biotech is the best: # ASCO14 where they are using the immune system to fight cancer is way more exciting than some $ AAPL conference.,,,#,4.73512E+17,https://twitter.com/bradloncar/status/473511536485732352,,,,
aftimosp,6/2/2014 13:08,2,0,ORR 77% with crizotinib in 26 evaluable patients with NSCLC and ROS1 fusions # lcsm # ASCO14,,,# #,4.73512E+17,https://twitter.com/aftimosp/status/473511529485066240,,,,
sommerjo,6/2/2014 13:08,7,3,"Oncologists, pharma co's & @ US_FDA convened by @ ChordomaFDN chart a path to approved drugs for chordoma at # asco14 pic.twitter.com/WqryZXbObB",,@ @,#,4.73512E+17,https://twitter.com/sommerjo/status/473511514062594048,,,,
osservasaluteaz,6/2/2014 13:08,0,1,"# Asco14, cure personalizzate contro il # tumore e nuova attenzione al “valore” della # terapia: http://bit.ly/1pJ3vGE via @ Agenzia_Italia.",,@,# # #,4.73511E+17,https://twitter.com/osservasaluteaz/status/473511420265775104,,,,
myPathMelanoma,6/2/2014 13:08,1,0,What makes a test clinically useful? # Myriad myPath Melanoma is reliable/reproducible across mult cohorts. # ASCO14 pic.twitter.com/ISdu19gS0f,,,# #,4.73511E+17,https://twitter.com/myPathMelanoma/status/473511390859501570,,,,
aftimosp,6/2/2014 13:07,1,0,ROS1 fusions are present in 1% of NScLC # lcsm # ASCO14,,,# #,4.73511E+17,https://twitter.com/aftimosp/status/473511357518594049,,,,
rsm2800,6/2/2014 13:07,2,1,Professional-cognitive behavioral therapy (CBT) more effective than video CBT in treating insomnia in breast ca pts # ASCO14,,,#,4.73511E+17,https://twitter.com/rsm2800/status/473511217185574912,,,,
medcitynews,6/2/2014 13:07,1,0,RT @PACENetworkUSA Patients can't wait for innovative # cancer meds @ ProjectInno makes sure they don't have to http://ow.ly/xuUAd # ASCO14,,@PACENetworkUSA @,# #,4.73511E+17,https://twitter.com/medcitynews/status/473511161108103168,,,,
DrHedrick,6/2/2014 13:07,1,0,Arginine interestingly may potentate pemetrexed function. Looking at it in NSCLC. # ASCO14,,,#,4.73511E+17,https://twitter.com/DrHedrick/status/473511145232687104,,,,
PNHP,6/2/2014 13:07,7,2,"We're at the @ asco annual meeting in Chicago. If you're here, stop by booth number 14152. # ASCO14 # SinglePayerpic.twitter.com/T0wLjKCah5",,@,# #,4.73511E+17,https://twitter.com/PNHP/status/473511133782245376,,,,
DrMisialek,6/2/2014 13:06,5,1,New US therapy wipes out cervical cancer in two women http://news.yahoo.com/us-therapy-wipes-cervical-cancer-two-women-005449170.html?soc_src=mediacontentsharebuttons … via @ YahooNews @ ASCO # ASCO14 # HPV,,@ @,# #,4.73511E+17,https://twitter.com/DrMisialek/status/473511073195507712,,,,
fwpharma,6/2/2014 13:06,1,1,"ICYMI: Bristol-Myers Squibb's nivolumab, Yervoy combination improves survival in melanoma study http://bit.ly/U6TER0 # pharma # ASCO14",,,# #,4.73511E+17,https://twitter.com/fwpharma/status/473511013422493696,,,,
KoontzOncology,6/2/2014 13:06,0,0,Concluding remarks on cardiopulmonary toxicities in pediatric cancer patients. # ASCO14 pic.twitter.com/fc4S94t63Y,,,#,4.73511E+17,https://twitter.com/KoontzOncology/status/473510994623619073,,,,
smerv,6/2/2014 13:06,3,1,"“I don’t think there is a tumor type that is not going to respond to some form of immune therapy,” http://bloom.bg/1kAckxz # ASCO14 # endcancer",,,# #,4.73511E+17,https://twitter.com/smerv/status/473510965762215936,,,,
rsm2800,6/2/2014 13:06,0,1,"Cognitive-behavioral therapy is preferred Rx for insomnia, but costly and not widely available # ASCO14",,,#,4.73511E+17,https://twitter.com/rsm2800/status/473510961655971843,,,,
fwpharma,6/2/2014 13:06,1,0,"ICYMI: Merck & Co. reports promising early-stage data for pembrolizumab in melanoma, lung cancer http://bit.ly/U6QJb3 # ASCO14 # pharma",,,# #,4.73511E+17,https://twitter.com/fwpharma/status/473510935022542849,,,,
journalclubapp,6/2/2014 13:06,0,0,Interested in oncology journal club? Visit http://wikijournalclub.org and participate in Wiki Journal Club. # ASCO14,,,#,4.73511E+17,https://twitter.com/journalclubapp/status/473510876931424256,,,,
DrHedrick,6/2/2014 13:06,0,0,"Significantly improved PFS, Not powered for OS. Also correlative re-biopsy results. # ASCO14",,,#,4.73511E+17,https://twitter.com/DrHedrick/status/473510856291278849,,,,
heidisa,6/2/2014 13:05,7,3,"Three AYA posters at # ASCO14, but all buried in pediatric onc. Majority of the population treated on the adult side. # MAJORDISCONNECT",,,# #,4.73511E+17,https://twitter.com/heidisa/status/473510853585936384,,,,
smerv,6/2/2014 13:05,0,1,"1) Bristol-Myers, Merck Immune Therapy Promising for Cancer http://bloom.bg/1kAckxz via @BloombergNews # ASCO14 # endcancer",,@BloombergNews,# #,4.73511E+17,https://twitter.com/smerv/status/473510737789202432,,,,
KoontzOncology,6/2/2014 13:05,0,0,Data to suggest dexrazoxane is safe as a cardio protectant in pediatric cancer pts. # ASCO14 pic.twitter.com/oTbdG94IRP,,,#,4.73511E+17,https://twitter.com/KoontzOncology/status/473510719213015040,,,,
thecancergeek,6/2/2014 13:05,0,0,Glad to see decent combination outcome from good preclinical science on PARPi-PI3Ki combination! # ASCO14,,,#,4.73511E+17,https://twitter.com/thecancergeek/status/473510701370048512,,,,
myCME,6/2/2014 13:05,0,0,Patients Positive for # NSCLC Mutation Benefit from Second-Line Novel EGFR Inhibitor http://ow.ly/xvh1N # lcsm # ASCO14,,,# # #,4.73511E+17,https://twitter.com/myCME/status/473510653089816576,,,,
genentech,6/2/2014 13:05,1,1,@ NextGenClinical We see the trend too - an improved understanding of biology leads to increased selectivity: http://ow.ly/xx5lj # ASCO14,,@,#,4.73511E+17,https://twitter.com/genentech/status/473510619896090624,,,,
SophiaCeulemans,6/2/2014 13:05,0,0,Noralane Lindor: 1/3 of Lynch-like families do not have an identifiable MMR mutation # ASCO14 # lynch # cancergenetics,,,# # #,4.73511E+17,https://twitter.com/SophiaCeulemans/status/473510618742681600,,,,
KarenCollinsRD,6/2/2014 13:05,0,1,"Yes; diet/exercise choices for more than # cancer outcome. MT @ rsm2800: Meyerhardt: # Survivors at risk for CVD, DM etc. # ASCO14",,@,# # #,4.73511E+17,https://twitter.com/KarenCollinsRD/status/473510610269769728,,,,
BiostatGirl,6/2/2014 13:04,0,0,My poster - quality of life of patients on the ALTTO trial. # asco2014 # asco14 http://instagram.com/p/ov9jdpAzHb/,,,# #,4.73511E+17,https://twitter.com/BiostatGirl/status/473510599175856128,,,,
HenryJOncology,6/2/2014 13:04,0,0,Interested in financing clinical research? Come to poster 21 # ASCO14! Together we can help patients!,,,#,4.73511E+17,https://twitter.com/HenryJOncology/status/473510540614983680,,,,
DrHedrick,6/2/2014 13:04,1,0,Control arm is Best Supportive Care not placebo. Should we be using Palliative Care as control arm based on Temel study? # ASCO14,,,#,4.7351E+17,https://twitter.com/DrHedrick/status/473510495497252864,,,,
smerv,6/2/2014 13:04,3,1,2)“It’s hard to believe that a single checkpoint is going to be important in every cancer.” New targets. http://nyti.ms/1jLZ74z # ASCO14,,,#,4.7351E+17,https://twitter.com/smerv/status/473510432217391104,,,,
DrMEisenberg,6/2/2014 13:04,0,0,Exciting progress to help cancer survivors maintain fertility. Drug Saves Fertility for Women With Cancer http://nyti.ms/1gJcure @ asco,,@,,4.7351E+17,https://twitter.com/DrMEisenberg/status/473510405466116096,,,,
brianreid,6/2/2014 13:04,7,1,"What's hot at # ASCO14? Sunday's most RTed tweets, in rank-order: http://bit.ly/1hRy0Fs",,,#,4.7351E+17,https://twitter.com/brianreid/status/473510399938408449,,,,
ERPlimackMD,6/2/2014 13:03,1,0,Kudos to MDACC DFCI BID for completing a trial in nccRCC Unfortunately results show minimal efficacy w mTOR/TKI xcept in chromophobe # ASCO14,,,#,4.7351E+17,https://twitter.com/ERPlimackMD/status/473510262977601536,,,,
teamoncology,6/2/2014 13:03,3,0,【 # ASCO14 Update】mTOR & Akt inhbs may work together in metastatic breast cancer with low RAS gene signature. http://meetinglibrary.asco.org/content/131939-144 … # BCSM,,,# #,4.7351E+17,https://twitter.com/teamoncology/status/473510229963857920,,,,
KoontzOncology,6/2/2014 13:03,0,0,We still have some challenges to the management of cancer survivors of pediatric tumors. # ASCO14 pic.twitter.com/Y3nHMm79HE,,,#,4.7351E+17,https://twitter.com/KoontzOncology/status/473510211589009408,,,,
smerv,6/2/2014 13:03,0,0,1) Cancer Researchers Report Longer Survival Rates With # Immunotherapy http://nyti.ms/1jLZ74z # ASCO14 # endcancer,,,# # #,4.7351E+17,https://twitter.com/smerv/status/473510149626134528,,,,
rsm2800,6/2/2014 13:02,1,1,Bradbury: Looked at 320 girls age 11-19 (208 were BRCA+ or parents+): no diff in anxiety/depression but no diff in health behaviors # ASCO14,,,#,4.7351E+17,https://twitter.com/rsm2800/status/473510064192372737,,,,
ASCO,6/2/2014 13:02,8,3,Editorial from @ RSM2800 discusses the evolution of our patient education efforts http://bit.ly/1hCY07n # ASCO14,,@,#,4.7351E+17,https://twitter.com/ASCO/status/473509970282287104,,,,
mtmdphd,6/2/2014 13:02,0,0,The Social Oncology Project 2014 - @ BrianReid @ KaylaRodrigue11 @ W2OGroup @ MDigitalLife http://ow.ly/xsh1j # SocOncology # ASCO14,,@ @ @ @,# #,4.7351E+17,https://twitter.com/mtmdphd/status/473509968000585728,,,,
TuftsB,6/2/2014 13:02,0,0,Damn bean counters that talk about financial toxicity. Real toxicity is fighting melphalan effects. Insulting & insensitive. # mliwi # asco14,,,# #,4.7351E+17,https://twitter.com/TuftsB/status/473509921741631488,,,,
davidbeme,6/2/2014 13:01,1,0,Cancer de la prostate : avancée majeure pour les formes métastatiques les plus avancées # ASCO2014 @ doctissimo http://ow.ly/xx65w,,@,#,4.7351E+17,https://twitter.com/davidbeme/status/473509840757993473,,,,
HenryJOncology,6/2/2014 13:01,0,0,IBM Watson to replace MD Anderson docs? Very exciting and provocative work http://abstracts.asco.org/144/AbstView_144_134497.html …. Congratulations Koichi! # ASCO14,,,#,4.7351E+17,https://twitter.com/HenryJOncology/status/473509815621136384,,,,
UNCurology,6/2/2014 13:01,1,0,"Molec.subtypes of ccRCC: Impact of DM, metformin & immunoRx on pt outcomes Haake, @NC_KidneyCancer et al # ASCO14 http://ow.ly/xpi6y",,@NC_KidneyCancer,#,4.7351E+17,https://twitter.com/UNCurology/status/473509761741516800,,,,
evaluatepharma,6/2/2014 13:01,0,0,# ASCO14 – Clovis Oncology impresses then disappoints with early lung cancer data http://ow.ly/xwIIs $ CLVS $ AZN,,,#,4.7351E+17,https://twitter.com/evaluatepharma/status/473509748432990208,,,,
Roche,6/2/2014 13:01,0,2,The # oncology treatment environment has changed substantially over the last couple of years. http://ow.ly/xp6wV # ASCO14,,,# #,4.7351E+17,https://twitter.com/Roche/status/473509744251256834,,,,
corp_UNC,6/2/2014 13:01,1,1,Cost-eff of adj bisphos regimens in postmeno.women w early breast ca Reeder-Hayes et al @ UNC_Lineberger # bcsm # asco14 http://ow.ly/xpkTE,,@,# #,4.7351E+17,https://twitter.com/corp_UNC/status/473509733240803328,,,,
mayocliniclabs,6/2/2014 13:01,0,0,Targeted testing and next generation sequencing for hereditary colon # cancer. # ASCO14 http://mayocl.in/T1r6rl,,,# #,4.7351E+17,https://twitter.com/mayocliniclabs/status/473509653109014528,,,,
teamoncology,6/2/2014 13:00,1,0,【 # ASCO14 Update】 Oral PI3 kinase and PARP inhibitor may work well together in BRCA germline mutated TNBC. http://meetinglibrary.asco.org/content/130302-144 …,,,#,4.7351E+17,https://twitter.com/teamoncology/status/473509526260289536,,,,
ONAcom,6/2/2014 13:00,1,1,# ASCO14: Combination ridaforolimus + MK-2206 AKT inhibitor therapy yield modest efficacy for low-RAS # breastcancer - http://ow.ly/xwepC,,,# #,4.7351E+17,https://twitter.com/ONAcom/status/473509508527190016,,,,
LIVESTRONG_NL,6/2/2014 13:00,1,0,Drs. Lange & Lin reflect on history of genitourinary # cancers. Past Progress & Future Promise http://bit.ly/1tUCiDn # ASCO14 (via @ ASCO ),,@,# #,4.7351E+17,https://twitter.com/LIVESTRONG_NL/status/473509503426895872,,,,
myelomacinderel,6/2/2014 13:00,2,2,"@ mtmdphd Hot Diggity!! YAY!!! # myeloma # ASCO14, # mmsm # MMRFASCO # ASCO14myeloma..myeloma therapy getting better QOL!!.",,@,# # # # #,4.73509E+17,https://twitter.com/myelomacinderel/status/473509433285152768,,,,
FoundationATCG,6/2/2014 13:00,1,1,"# NextGenSequencing identifies new alterations associated with complete responses to # chemo Poster Pres: 1:15-5, S Hall A2, Ab 4538 # ASCO14",,,# # #,4.73509E+17,https://twitter.com/FoundationATCG/status/473509431259725824,,,,
cardinalhealth,6/2/2014 13:00,2,1,Learn how our Clinical Pathways program positively impacts cancer treatment at our 1:15 pm poster session today. # ASCO14,,,#,4.73509E+17,https://twitter.com/cardinalhealth/status/473509405556604928,,,,
rsm2800,6/2/2014 13:00,0,0,". @ fischmd EPIPHANY study re PEs at home-45% asymptomatic, 82% were multiple, risk of death 6% (1% risk of death in a low-risk pop) # asco14",,@,#,4.73509E+17,https://twitter.com/rsm2800/status/473509391480524801,,,,
Senesco,6/2/2014 13:00,0,1,"Dr. Alice Bexon, $ SNTI VP of Clinical Development to present a poster at # ASCO14 June 2nd 1:15pm CT http://bit.ly/1u8Toxi",,,#,4.73509E+17,https://twitter.com/Senesco/status/473509387714056193,,,,
SiliconBio,6/2/2014 13:00,0,1,Last day to visit us at # ASCO14! Visit us at booth 24101 to hear about the benefits of our automated rare cell recovery technology # DEPArray,,,# #,4.73509E+17,https://twitter.com/SiliconBio/status/473509356093595648,,,,
pfizer,6/2/2014 13:00,5,8,Biomarker testing at lung cancer diagnosis can help inform treatment decisions http://LungCancerProfiles.com # ASCO14,,,#,4.73509E+17,https://twitter.com/pfizer/status/473509354076123136,,,,
NextGenClinical,6/2/2014 12:59,0,0,"Schilder-Drosophlia offering a novel, cost effective approach in the path to personalized medicine. # ASCO14",,,#,4.73509E+17,https://twitter.com/NextGenClinical/status/473509292054945792,,,,
DrHedrick,6/2/2014 12:59,0,0,Malignant pleural mesothelioma. Using arginine deprivation. # ASCO14,,,#,4.73509E+17,https://twitter.com/DrHedrick/status/473509272845058048,,,,
myPathMelanoma,6/2/2014 12:59,1,0,Myriad my Path Melanoma validation data is being presented now at # ASCO14 by Katherine Nathanson pic.twitter.com/sJTe6AGUxm,,,#,4.73509E+17,https://twitter.com/myPathMelanoma/status/473509232386781184,,,,
davidgrahammd,6/2/2014 12:59,0,0,Did inclusion of sarcomatoid RCC path in already small numbers of ESPN trial mask results? # gusm # ASCO14,,,# #,4.73509E+17,https://twitter.com/davidgrahammd/status/473509213130752000,,,,
GenomeGrl,6/2/2014 12:59,1,0,MLH1 methylation and BRAF tumor testing can help further screen MSI+ patients with CRC for Lynch syndrome. # ASCO14,,,#,4.73509E+17,https://twitter.com/GenomeGrl/status/473509203467051008,,,,
KoontzOncology,6/2/2014 12:58,0,0,Cardiac outcomes I'm aging survivors of pediatric cancers. # ASCO14 pic.twitter.com/aejRRIW2OS,,,#,4.73509E+17,https://twitter.com/KoontzOncology/status/473509050400124930,,,,
DCarrizosaMD,6/2/2014 12:58,3,1,# ASCO14 - no benefit to vandetinib added to chemo for first line ES-small cell lung cancer # LCI,,,# #,4.73509E+17,https://twitter.com/DCarrizosaMD/status/473509019693621248,,,,
VincentRK,6/2/2014 12:58,2,3,Can # myeloma colleagues who are as # ASCO14 who heard the panobinostat presentation tweet their bottomline view? @ mtmdphd @ Myeloma_Doc # mmsm,,@ @,# # #,4.73509E+17,https://twitter.com/VincentRK/status/473509004862566401,,,,
JoleneScience,6/2/2014 12:58,1,1,Most CML responses maintained after ponatinib dose-reduction; MDs must weigh risk/benefit in CV-risk pts $ ARIA # ASCO14,,,#,4.73509E+17,https://twitter.com/JoleneScience/status/473508992975900672,,,,
rsm2800,6/2/2014 12:58,0,0,. @ fischmd Ab 9523 palliative RT and death - 14% in last month of life esp lung and GI pts (surprising since usu done for bone mets) # ASCO14,,@,#,4.73509E+17,https://twitter.com/rsm2800/status/473508881570623488,,,,
AbbottNews,6/2/2014 12:58,6,2,Cancer represents nearly 70% of the field of personalized medicine. Learn more here: http://shout.lt/vgkd # ASCO2014 # ASCO2014,,,# #,4.73509E+17,https://twitter.com/AbbottNews/status/473508865368416256,,,,
DrHedrick,6/2/2014 12:57,0,0,"Toxicity increased, no improvement in time to progression, Not a drug to be further studied in unselected patients. # ASCO14",,,#,4.73509E+17,https://twitter.com/DrHedrick/status/473508784758095872,,,,
MaurerStats,6/2/2014 12:57,0,0,MT @ ASCO At Lymphoma/Plasma Cell Disorders # ASCO14 track? Recent EFS24 in DLBCL research via # ASCOConnection http://bit.ly/QO7SUp # lymsm,,@,# # #,4.73509E+17,https://twitter.com/MaurerStats/status/473508610673098752,,,,
rsm2800,6/2/2014 12:57,0,0,". @ fischmd Ab 9524 looked at EOL chemo patterns, little change 2007-2012 despite Dartmouth Atlas data # asco14",,@,#,4.73509E+17,https://twitter.com/rsm2800/status/473508598329274369,,,,
davidbeme,6/2/2014 12:56,0,0,Cancer de la vessie métastatique: résultats intéressants avec un anti-PDL1 (immunothérapie) # ASCO2014 @ doctissimo http://ow.ly/xx4Ux,,@,#,4.73509E+17,https://twitter.com/davidbeme/status/473508545665957888,,,,
DrHedrick,6/2/2014 12:56,0,0,Response rates not good for vandetinib. Time to progression no different. Neither is OS. # ASCO14,,,#,4.73509E+17,https://twitter.com/DrHedrick/status/473508508479266816,,,,
dhjutsw1,6/2/2014 12:56,2,1,@ ASCO # asco14 Terrific annual meeting as usual. Kudos to Jean Colvard & her awesome staff. Gr8 program @ CliffordHudispic.twitter.com/iP8noPlY2r,,@ @,#,4.73508E+17,https://twitter.com/dhjutsw1/status/473508484290727936,,,,
JoleneScience,6/2/2014 12:56,0,1,2nd line ramucirumab+docetaxel extends OS in NSCLC; modest but statistically sig effect (10.5 vs 9.1 mos) # ASCO14 $ LLY,,,#,4.73508E+17,https://twitter.com/JoleneScience/status/473508387666550784,,,,
ElizBlanchardMD,6/2/2014 12:56,0,0,Abs 7506:chemo w or w/o vandetanib in ext small cell.Toxicity (w/o any stats) incr in neutropenia thrombocytopenia) # ASCO14 # lcsm # supponc,,,# # #,4.73508E+17,https://twitter.com/ElizBlanchardMD/status/473508381932912641,,,,
LungCancerFaces,6/2/2014 12:56,1,0,"MT @ JLErsek: Roth: w/in 5yrs, # LungCancer LDCT in high risk pts could ID add'l ~55,000 LC of which ~17% would be stage 1/2 # ASCO14 # LCSM",,@,# # #,4.73508E+17,https://twitter.com/LungCancerFaces/status/473508360415739904,,,,
ryanwillumson,6/2/2014 12:55,0,0,"New bio pharma pub launch today! RT @ biopharmadive: ASCO looking at value, price to create cancer scorecard: http://ow.ly/xwzN8 # ASCO14",,@,#,4.73508E+17,https://twitter.com/ryanwillumson/status/473508304174723072,,,,
KoontzOncology,6/2/2014 12:55,0,0,"Learn more about Grinch Syndrome"" in pediatric cancer patients. # ASCO14 pic.twitter.com/GQj3S6WP65""",,,#,4.73508E+17,https://twitter.com/KoontzOncology/status/473508294506860545,,,,
QIAGENscience,6/2/2014 12:55,0,1,"Don't be shy. If you have questions to pose to our Medical & Scientific Affairs team, the exhibit hall's open until 5. Booth 5013, # ASCO14",,,#,4.73508E+17,https://twitter.com/QIAGENscience/status/473508246725345280,,,,
davidgrahammd,6/2/2014 12:55,0,0,ESPN trial in met RCC. Included x-over at prog. 68 pts? No diff in PFS 1st line or 2nd line. No OS diff. # gusm # ASCO14,,,# #,4.73508E+17,https://twitter.com/davidgrahammd/status/473508238529658881,,,,
winemomjill,6/2/2014 12:55,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73508E+17,https://twitter.com/winemomjill/status/473508123358294017,,,,
DrHedrick,6/2/2014 12:54,0,0,Arm balanced. Equal CIS/Carbon. Higher rates in Neutropenia/thrombocytopenia/hemolysis/HTN/Hyperglycemia/Pain? # ASCO14,,,#,4.73508E+17,https://twitter.com/DrHedrick/status/473508069373394944,,,,
rsm2800,6/2/2014 12:54,0,0,"Ab 9525 looked at interdisciplinary rehab interventions (8 wk program PT 2x/wk), need composite interventions to improve QOL, mood # asco14",,,#,4.73508E+17,https://twitter.com/rsm2800/status/473508042864996352,,,,
diberri,6/2/2014 12:54,1,0,Lots of people citing Wikipedia at ASCO. # ASCO14 pic.twitter.com/qLvyo4T5ow,,,#,4.73508E+17,https://twitter.com/diberri/status/473507930680348672,,,,
ElizBlanchardMD,6/2/2014 12:54,0,0,Abs 7506: chemo w or w/o vandetanib in ext small cell. 74 patients...not an easy disease to study on many levels # ASCO14 # lcsm,,,# #,4.73508E+17,https://twitter.com/ElizBlanchardMD/status/473507915987697665,,,,
kerrsheridan,6/2/2014 12:54,12,4,"Pioneering US study shows immunotherapy can wipe out cervical cancer, with success in 2 of 9 patients # ASCO14 @ AFP http://news.yahoo.com/us-therapy-wipes-cervical-cancer-two-women-005449170.html …",,@,#,4.73508E+17,https://twitter.com/kerrsheridan/status/473507870282354688,,,,
Progeny,6/2/2014 12:53,0,0,Collect patient family history online and assess # cancer risk BEFORE the clinic visit - Learn how at Booth 4028. # ASCO14,,,# #,4.73508E+17,https://twitter.com/Progeny/status/473507805039575040,,,,
NextGenClinical,6/2/2014 12:53,1,0,"Schildler- New mantra in early clinical triais Smaller and Smarter"" # ASCO14 pic.twitter.com/5NTqEfA9Nx""",,,#,4.73508E+17,https://twitter.com/NextGenClinical/status/473507713553424384,,,,
DrHedrick,6/2/2014 12:53,0,0,"Primary: Time to prog, Secondary: Safety, response rate, disease control rate, OS. Correlative data assessed (awaiting this data) # ASCO14",,,#,4.73508E+17,https://twitter.com/DrHedrick/status/473507686609596416,,,,
rsm2800,6/2/2014 12:53,0,0,"Ab 9522 UPMC CaSSy was web-based intervention in liver ca pts focused on pain, other sx # ASCO14",,,#,4.73508E+17,https://twitter.com/rsm2800/status/473507657907572738,,,,
ottohoffmann,6/2/2014 12:52,0,0, @ EFEciencia: Estudios en # cáncer de mama," próstata y colorrectal afinan la práctica clínica. http://www.efefuturo.com/noticia/nuevos-estudios-en-cancer-de-mama-prostata-y-colorrectal-afinan-la-practica-clinica/ … # ASCO14""""",,@,# #,4.73508E+17,https://twitter.com/ottohoffmann/status/473507557940940800,,,
KoontzOncology,6/2/2014 12:52,0,0,Summary comments from Dr. Killburn on phase I data being presented on pediatric patients at # ASCO14 pic.twitter.com/4VVhHp1PHc,,,#,4.73508E+17,https://twitter.com/KoontzOncology/status/473507551838208000,,,,
wendyselig,6/2/2014 12:52,1,2,So much progress once again for # melanoma patients at # asco14. @ MelanomaReAlli energized to accelerate pace toward cures.,,@,# #,4.73507E+17,https://twitter.com/wendyselig/status/473507442957905920,,,,
SkinMelanoma,6/2/2014 12:52,0,0,# ASCO14 presentation: Gene test DecisionDx-Melanoma identified “high risk” # melanoma patients who had negative SLNB http://tinyurl.com/mra3zcx,,,# #,4.73507E+17,https://twitter.com/SkinMelanoma/status/473507435635044352,,,,
rsm2800,6/2/2014 12:52,0,0,Ab 9521 questionnaire from Coping W/ Cancer Study recruited 2002-6: Caregivers more likely to recall prognostic discussions # asco14,,,#,4.73507E+17,https://twitter.com/rsm2800/status/473507390474567680,,,,
LungCancerFaces,6/2/2014 12:52,0,0,"Much >10% will do it MT @ arifkamalmd: If 10% eligible do lung cancer screening, 2750 add'l lives saved expense of $9 billion # ASCO14 # LCSM",,@,# #,4.73507E+17,https://twitter.com/LungCancerFaces/status/473507381725237248,,,,
bob_libbey,6/2/2014 12:52,0,0,50 years of biopharma industry # cancer research: better treatments = more survivors # asco14 http://ow.ly/i/5LEgy,,,# #,4.73507E+17,https://twitter.com/bob_libbey/status/473507376474386432,,,,
TuftsB,6/2/2014 12:51,0,0,ASCO execs lament drug costs. I get my pill based regimen and have a 0$ Co pay. # mliwi # asco14,,,# #,4.73507E+17,https://twitter.com/TuftsB/status/473507326365011968,,,,
OphiraG,6/2/2014 12:51,0,0,@ CancerAfrica great 2 meet you @ ASCO @ GTFRCC !! Keep in touch!,,@ @ @,,4.73507E+17,https://twitter.com/OphiraG/status/473507321445122048,,,,
DrMisialek,6/2/2014 12:51,6,1,"In treating some cancer patients, less is more: U.S. studies http://reut.rs/1jBn1zG @ reuters @ ASCO @ VUMChealth # ASCO14",,@ @ @,#,4.73507E+17,https://twitter.com/DrMisialek/status/473507307683577856,,,,
duemed,6/2/2014 12:51,0,0,"No effect of beva+platinum-etoposide in ED-SCLC. Better OS/PFS of PEirinotecan than topotecan in 2nd line mSCLC, but worth the AEs? # ASCO14",,,#,4.73507E+17,https://twitter.com/duemed/status/473507253979721728,,,,
connect2canada,6/2/2014 12:51,12,1,Canada supports 13 innovations to fight cancer in developing countries http://bit.ly/1k7Mo1b via @ PeterASinger @ gchallenges # ASCO14,,@ @,#,4.73507E+17,https://twitter.com/connect2canada/status/473507193392611328,,,,
oncologytube,6/2/2014 12:51,1,2,"Watch live tapings at # ASCO14 booth 15085 @ ImedexCME featured doctors Robert Drecier, Ken Anderson, and Ruth O'Regan",,@,#,4.73507E+17,https://twitter.com/oncologytube/status/473507148962754561,,,,
ERPlimackMD,6/2/2014 12:50,1,1,"Ipi + nivo in RCC: encouraging responses, many durable both before and after Tx discontinuation. Ph III 1st line trial is planned. # asco14",,,#,4.73507E+17,https://twitter.com/ERPlimackMD/status/473507056473743362,,,,
aftimosp,6/2/2014 12:50,0,0,Tumor biology poster highlights room S406 # ASCO14,,,#,4.73507E+17,https://twitter.com/aftimosp/status/473507003453538304,,,,
amylmurphy10,6/2/2014 12:50,0,1,@Carolinas @ EdKimMDLCI weighs in here MT @ LizSzabo: Immune therapies improve treatment of cancers # ASCO14 http://usat.ly/1mIXEix @ USATODAY,,@Carolinas @ @ @,#,4.73507E+17,https://twitter.com/amylmurphy10/status/473506906557124610,,,,
DebiopharmNews,6/2/2014 12:50,0,0,# ASCO14 How do we develop drug today? With the future # patient in mind! http://ow.ly/xwqLk,,,# #,4.73507E+17,https://twitter.com/DebiopharmNews/status/473506874147749888,,,,
rsm2800,6/2/2014 12:50,0,0,Review of Pt/survivor posters by @ fischmd notes 2013 IOM report on patient-centered quality cancer care # ASCO14,,@,#,4.73507E+17,https://twitter.com/rsm2800/status/473506837451399169,,,,
szusmani,6/2/2014 12:49,4,1,# ASCO2014 @ VincentRK @ Myeloma_Doc @ DrOlaLandgren Pano-1 data presented - 4 month PFS for Pano-Vel-Dex but ~26% GI Toxicities!,,@ @ @,#,4.73507E+17,https://twitter.com/szusmani/status/473506793847799808,,,,
markaorourke,6/2/2014 12:49,0,0,"# ASCO14 Dr. David Ryan on pseudomyxoma peritonei: good talk, bad disease.",,,#,4.73507E+17,https://twitter.com/markaorourke/status/473506777414504448,,,,
scienega,6/2/2014 12:49,1,2,Summary of David Porter & @ JohnCFierce tweet chat about Car-T Cell therapy at # ASCO14 http://bit.ly/U7gQyN,,@,#,4.73507E+17,https://twitter.com/scienega/status/473506694287224832,,,,
HealthcareGlbl,6/2/2014 12:49,0,0,"RT @ myriadgenetics: Dr. Loren Clarke and Mark Capone, President of MGL, talk to the media at # ASCO14 about Myriad's myPath # Melanoma.",,@,# #,4.73507E+17,https://twitter.com/HealthcareGlbl/status/473506651387875328,,,,
KarenTeber,6/2/2014 12:48,1,1,My Chicago taxi charges a $50 vomit clean up fee. Does that predict how he'll drive?? # asco14 pic.twitter.com/FczyZqroUG,,,#,4.73506E+17,https://twitter.com/KarenTeber/status/473506497335664640,,,,
ComputerJustin,6/2/2014 12:48,0,0,"“ @ bmsnews: Phase 1 combination data from our pipeline in # kidney cancer presented today at 9:45am CDT, E Hall D1 # ASCO14” Can we have a pdf?",,@,# #,4.73506E+17,https://twitter.com/ComputerJustin/status/473506446278414338,,,,
DoctorEdny,6/2/2014 12:48,7,3,$ BMY PDL-1 expression did not predict response to ipi/nivolumab in PI mRCC trial # ASCO14 pic.twitter.com/TNetEt3Yvr,,,#,4.73506E+17,https://twitter.com/DoctorEdny/status/473506410731700225,,,,
DrHedrick,6/2/2014 12:48,0,0,Big negative. Tough but necessary. A lot of this meeting is necessary negative trials. # ASCO14,,,#,4.73506E+17,https://twitter.com/DrHedrick/status/473506351440605184,,,,
thecancergeek,6/2/2014 12:48,2,1,"Nice # ASCO14 poster from @ teamoncology's group on RPPA profiling of TNBC- 2 subsets, basal and stromal w/ prog value https://www.dropbox.com/s/yahkjzr6tqu71md/ASCO2014_TNBC_RPPA.pdf …",,@,#,4.73506E+17,https://twitter.com/thecancergeek/status/473506328162234368,,,,
VonKlotMD,6/2/2014 12:47,0,0,The freezing experience # ASCO14,,,#,4.73506E+17,https://twitter.com/VonKlotMD/status/473506308310585344,,,,
NBTStweets,6/2/2014 12:47,1,1,Molecular Predictors May ID Patients with Glioblastoma Likely to Benefit from Bevacizumab http://bit.ly/1rD4pZT # ASCO2014,,,#,4.73506E+17,https://twitter.com/NBTStweets/status/473506272549949443,,,,
ElizBlanchardMD,6/2/2014 12:47,0,0,Abs 7505: bev in ext small cell. Serum VEGF or VEGFR not helpful bio markers for bev response. # ASCO14 # lcsm,,,# #,4.73506E+17,https://twitter.com/ElizBlanchardMD/status/473506267307466753,,,,
montypal,6/2/2014 12:47,3,0,Ipi/nivo moving into phase 3 for mRCC - So excited given what I saw from my participation in the phase I # ASCO14,,,#,4.73506E+17,https://twitter.com/montypal/status/473506190488399873,,,,
ElizBlanchardMD,6/2/2014 12:46,1,0,Abs 7505: bev in ext small cell. Htn most prominent increased toxicity with one grade 5 event. No OS or PFS benefit # ASCO14 # lcsm # supponc,,,# # #,4.73506E+17,https://twitter.com/ElizBlanchardMD/status/473505892319911938,,,,
theMMRF,6/2/2014 12:45,3,2,High responses in early # myeloma study presented at # ASCO14: # SAR650984+Revlimid-dex. MMRC sponsoring more SAR650984 studies! # MMRFASCO,,,# # # #,4.73506E+17,https://twitter.com/theMMRF/status/473505805581701120,,,,
JasonBardi,6/2/2014 12:45,0,0,IMMUNOTHERAPY v. # Cancer A.Pollack reporting from @ ASCO meeting on yin/yang of $10 billion market that may save lives http://www.nytimes.com/2014/06/03/business/cancer-researchers-report-longer-survival-rates-with-immunotherapy.html …,,@,#,4.73506E+17,https://twitter.com/JasonBardi/status/473505789899198464,,,,
DoctorEdny,6/2/2014 12:45,2,1,Nivolumab PD-L1 and ipilumumab CTLA-4 in mRCC PI data pos activity # ASCO14 PIII planned pic.twitter.com/P7wCIFnJWs,,,#,4.73506E+17,https://twitter.com/DoctorEdny/status/473505781414113280,,,,
drcbsteer,6/2/2014 12:45,0,1,"@ drcbsteer: # ASCO14 # gucsm activity of ipilimumab and nivolumab in renal cell carcinoma phase 1. 48% RR. Expected and acceptable"" toxicity""",,@,# #,4.73506E+17,https://twitter.com/drcbsteer/status/473505751877828608,,,,
scientre,6/2/2014 12:45,2,0,Anonymity vs. privacy: patient prefs sharing health data online http://ht.ly/xwpXL But is it anonymity or pseudonymity?? # hcsm # asco14,,,# #,4.73506E+17,https://twitter.com/scientre/status/473505718218547203,,,,
ASCO,6/2/2014 12:45,7,2,"Encouraging results from phase 1 studies of drug combinations in breast cancer, melanoma http://bit.ly/1oNSsi2 # ASCO14",,,#,4.73506E+17,https://twitter.com/ASCO/status/473505660391653377,,,,
winemomjill,6/2/2014 12:45,0,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73506E+17,https://twitter.com/winemomjill/status/473505620902309889,,,,
DrHedrick,6/2/2014 12:44,0,0,"No PFS benefit for addition of Bev to CT in ES-SCLC. TREND to OS benefit to control arm (I know, I know, trends...) # ASCO14",,,#,4.73506E+17,https://twitter.com/DrHedrick/status/473505507173728256,,,,
n8pennell,6/2/2014 12:44,1,0,No diff in PFS or OS for addition of bev to chemo in eSCLC. # ASCO14 # LCSM,,,# #,4.73506E+17,https://twitter.com/n8pennell/status/473505502245429249,,,,
cancerassassin1,6/2/2014 12:44,0,0,GI oral session 1:15 in E hall D1: one theme in particular: are we using correct approach to studying VEGF inhibitors/TKIs # Cancer # ASCO14,,,# #,4.73505E+17,https://twitter.com/cancerassassin1/status/473505411522260992,,,,
DocLHenry,6/2/2014 12:43,0,0,Biggest winner at # ASCO14? Swimmer's Plots. Those things are everywhere this year.,,,#,4.73505E+17,https://twitter.com/DocLHenry/status/473505300281323520,,,,
DanRx,6/2/2014 12:43,0,0,The real @ PharmaLive Daily Advantage returns w/ ASCO cancer news. http://ow.ly/xwVY1 # epharma # asco14,,@,# #,4.73505E+17,https://twitter.com/DanRx/status/473505137353555968,,,,
immunomix,6/2/2014 12:43,0,0,"In renal cancer, excellent response rate seen in Ipi- + Nivo- therapy # ASCO14",,,#,4.73505E+17,https://twitter.com/immunomix/status/473505075038810112,,,,
myelomacinderel,6/2/2014 12:42,0,0,"@ mtmdphd Awesome! # mmsm Celgene is happy 2!! # ASCO14. Hopefully, this puts an end2 phrase 'inevitable relapse' 2. # ASCO14myeloma..Thxs!!",,@,# # #,4.73505E+17,https://twitter.com/myelomacinderel/status/473504943295696897,,,,
n8pennell,6/2/2014 12:42,0,0,"IFCT0802 half of all pts excluded from the randomization, only 34-35 pts per arm. # ASCO14",,,#,4.73505E+17,https://twitter.com/n8pennell/status/473504927319613440,,,,
AnneBooms,6/2/2014 12:42,0,0,“ @ drcbsteer: # ASCO14 felt like something was missing on twitter this morning;-),,@,#,4.73505E+17,https://twitter.com/AnneBooms/status/473504925599535104,,,,
UCCancerCenter,6/2/2014 12:42,0,0,Collaborative project by Susan Cohn & International Neuroblastoma Risk Group shows value of clinical factors for risk stratification # ASCO14,,,#,4.73505E+17,https://twitter.com/UCCancerCenter/status/473504920935858176,,,,
drcbsteer,6/2/2014 12:42,0,0,@ DKarikios and the melanoma ovals are there later today. # asco14 # melanoma tweets will be limited.,,@,# #,4.73505E+17,https://twitter.com/drcbsteer/status/473504832176005121,,,,
DrHedrick,6/2/2014 12:42,0,0,"Hmmm primary endpoint: proportion patients who maintained a response to therapy after cycle 4 of chemotherapy"" (Why not survival?) # ASCO14""",,,#,4.73505E+17,https://twitter.com/DrHedrick/status/473504824013885440,,,,
UCSFCancer,6/2/2014 12:41,2,1,"# ASCO14 Dr. Tom Martin of @ UCSF impressive early # myeloma study of # SAR650984, monoclonal antibody targeting CD38. # MMRFASCO via @ theMMRF",,@ @,# # # #,4.73505E+17,https://twitter.com/UCSFCancer/status/473504792203894784,,,,
cancerassassin1,6/2/2014 12:41,0,0,GI oral session 1:15 in E hall D1: I am especially looking forward to discussant views + audience questions # stirthepot # ASCO14,,,# #,4.73505E+17,https://twitter.com/cancerassassin1/status/473504654198730753,,,,
davidgrahammd,6/2/2014 12:40,0,2,Nivo + Ipi in RCC. Ipi 3 arm more toxic but no more effective. 40+ % response with long duration # gusm # ASCO14,,,# #,4.73505E+17,https://twitter.com/davidgrahammd/status/473504555582627840,,,,
DrLisaCurcio,6/2/2014 12:40,0,1,"how long have I been saying this? @ DrAttai: Size doesn't always matter! Tumor biology important (3/3) # asco14 pic.twitter.com/VJ4e586lRJ”""",,@,#,4.73505E+17,https://twitter.com/DrLisaCurcio/status/473504553803849728,,,,
CancerNetwrk,6/2/2014 12:40,3,0,Site of Visceral Metastases Can Dictate Prognosis in Prostate Cancer http://bit.ly/1u9egob # ASCO14,,,#,4.73504E+17,https://twitter.com/CancerNetwrk/status/473504438444105728,,,,
Boehringer,6/2/2014 12:40,1,1,“Your human emotion is to reassure” Read Matthew Peters’ take on # lungcancer diagnosis # notjustonedisease http://bit.ly/1gPw7xL # ASCO14,,,# # #,4.73504E+17,https://twitter.com/Boehringer/status/473504430160367616,,,,
MGHCancerCenter,6/2/2014 12:40,0,0,"1:15-5, S Hall A2: Dr. Smith poster: SPARTAN trial: randomized study of ARN-509 + androgen deprivation therapy vs ADT in M0-CRPC # ASCO14",,,#,4.73504E+17,https://twitter.com/MGHCancerCenter/status/473504394575884288,,,,
finchtalk,6/2/2014 12:40,0,0,"Travel day. Enjoying tweets from # ASCO14 and fast and furious, nothing's happened yet # WWDC14",,,# #,4.73504E+17,https://twitter.com/finchtalk/status/473504384752427008,,,,
ElizBlanchardMD,6/2/2014 12:40,1,0,Abs 7505: bev in ext stage small cell. Note to bevacizumab developers--need to figure out who benefits from this drug! # ASCO14,,,#,4.73504E+17,https://twitter.com/ElizBlanchardMD/status/473504376947212288,,,,
DebiopharmNews,6/2/2014 12:40,0,0,# ASCO14 We are convinced that developing for # patients will shape the # future of # medicine http://ow.ly/xwqEx,,,# # # #,4.73504E+17,https://twitter.com/DebiopharmNews/status/473504344336531456,,,,
myriadgenetics,6/2/2014 12:40,1,0,Do you have 30 seconds? Take this simple quiz to find out if you're at # risk of # hereditarycancer: http://bit.ly/17zeRbJ # ASCO14 # KnowBRCA,,,# # # #,4.73504E+17,https://twitter.com/myriadgenetics/status/473504318952198145,,,,
KoontzOncology,6/2/2014 12:39,0,0,Evaluating new agents in pediatric cancer patients. # ASCO14 pic.twitter.com/m0JuwIvPrM,,,#,4.73504E+17,https://twitter.com/KoontzOncology/status/473504272584556546,,,,
DrHedrick,6/2/2014 12:39,0,0,First time I have heard biomarkers today in SCLC... Finally. # ASCO14,,,#,4.73504E+17,https://twitter.com/DrHedrick/status/473504197464584193,,,,
cancerassassin1,6/2/2014 12:39,0,0,"GI oral session 1:15 in E hall D1: reports of results of trials in met # pancreaticcancer (RECAP), adjuvant rx # liver # Cancer & more # ASCO14",,,# # # #,4.73504E+17,https://twitter.com/cancerassassin1/status/473504175486009344,,,,
PAscierto,6/2/2014 12:39,1,1,# asco2014 BREAK-2 study OS update: 31% of melanoma patients treated with dabrafenib still alive after 30 months @ Oncoinfo_it,,@,#,4.73504E+17,https://twitter.com/PAscierto/status/473504125611937793,,,,
n8pennell,6/2/2014 12:39,0,0,@ n8pennell: IFCT0802 randomized trial of chemo w or wo bevacizumab in eSCLC now being presented. # ASCO14 # LCSM,,@,# #,4.73504E+17,https://twitter.com/n8pennell/status/473504084423872512,,,,
DrHedrick,6/2/2014 12:38,0,0,Spell check is killing me. Trial is adding Bev to CIS/ETOP in ES-SCLC. Bev is 7.5mg/kg Q3week until progressing. 4 cycles of chemo. # ASCO14,,,#,4.73504E+17,https://twitter.com/DrHedrick/status/473504044578000896,,,,
MMarchioneAP,6/2/2014 12:38,1,0,"Lots of # ASCO14 news over the wknd. ICYMI, a big win against # prostatecancer; drug gives +1 year survival http://tinyurl.com/mdth33r",,,# #,4.73504E+17,https://twitter.com/MMarchioneAP/status/473503988449816576,,,,
n8pennell,6/2/2014 12:38,0,0,IFCT0802 randomized trial of chemo w or wo bevacizumab now being presented. # ASCO14 # LCSM,,,# #,4.73504E+17,https://twitter.com/n8pennell/status/473503960897445888,,,,
HEVAWEB,6/2/2014 12:37,2,1,The cost of thromboembolic events in French hospitalized patients with breast/prostate # cancer # asco14 # healthdata http://bit.ly/1onXWwd,,,# # #,4.73504E+17,https://twitter.com/HEVAWEB/status/473503806039543808,,,,
brady_urology,6/2/2014 12:37,0,1,Antonarakis presents Androgen Receptor Splice Variant-7 Linked to Enzalutamide & Abiraterone Resistance @ ASCO # ASCO14 http://am.asco.org/androgen-receptor-splice-variant-7-linked-enzalutamide-and-abiraterone-resistance#.U4yoGuQC0Tw.twitter …,,@,# #,4.73504E+17,https://twitter.com/brady_urology/status/473503804227600384,,,,
DCarrizosaMD,6/2/2014 12:37,0,0,# ASCO14 -PEI had 31% febrile neutropenia vs 7% in topotecan. Does toxicity balance OS improvement in palliative TX of ES-Small cell? # LCI,,,# #,4.73504E+17,https://twitter.com/DCarrizosaMD/status/473503732450480128,,,,
Merck,6/2/2014 12:37,0,0,@ matthewherper Thanks for a great interview this morning with Merck's Roger Perlmutter. # ASCO14 pic.twitter.com/3noggStmHn,,@,#,4.73504E+17,https://twitter.com/Merck/status/473503711252455424,,,,
ECMC_UK,6/2/2014 12:37,0,0,Talking to Galena Biopharma about possibilities of vaccines combinations in the ECMC Combination Alliance at # ASCO2014,,,#,4.73504E+17,https://twitter.com/ECMC_UK/status/473503671464914945,,,,
theMMRF,6/2/2014 12:37,0,2,"# ASCO14 Dr. Tom Martin of @ UCSFCancer presented impressive early # myeloma study of # SAR650984, monoclonal antibody targeting CD38. # MMRFASCO",,@,# # # #,4.73504E+17,https://twitter.com/theMMRF/status/473503640637157376,,,,
finchtalk,6/2/2014 12:37,0,0,“ @ NatRevClinOncol: Main message of # ASCO14 is cost and value of cancer care and how this fits with personalised medicine” | the message is?,,@,#,4.73504E+17,https://twitter.com/finchtalk/status/473503635125465088,,,,
n8pennell,6/2/2014 12:37,1,2,6 month improve in OS with cis/etp/irino compared to topotecan in sens relapse SCLC. Dr. Goto argues this should now be SOC. # ASCO14 # LCSM,,,# #,4.73504E+17,https://twitter.com/n8pennell/status/473503628943437824,,,,
VUMChealth,6/2/2014 12:37,3,1,"Sometimes with # cancer treatment, less can be more, as several # ASCO14 studies show. http://ow.ly/xx1Jg",,,# #,4.73504E+17,https://twitter.com/VUMChealth/status/473503622773637120,,,,
CynthiaManley,6/2/2014 12:37,0,0,"Sometimes with # cancer treatment, less can be more, as several # ASCO14 studies show. http://ow.ly/xwZjV",,,# #,4.73504E+17,https://twitter.com/CynthiaManley/status/473503621846695936,,,,
n8pennell,6/2/2014 12:37,1,1,"JCOG0605 trial of triplet chemo v topotecan 2nd line SCLC: higher ORR, more toxicity, longer PFS, longer OS 18 v 12m. # ASCO14 # LCSM",,,# #,4.73504E+17,https://twitter.com/n8pennell/status/473503604092207104,,,,
drcbsteer,6/2/2014 12:37,1,1,# ASCO14 # crcsm Colorectal cancer also becoming a collection of rare diseases as more RAS mutations shown to have effect on efficacy of EGFRi,,,# #,4.73504E+17,https://twitter.com/drcbsteer/status/473503594923446272,,,,
DrHedrick,6/2/2014 12:36,0,0,Next trial. Adding Bevacizumab to CIS/Stop. (Bev has had a bad weekend.) # ASCO14,,,#,4.73503E+17,https://twitter.com/DrHedrick/status/473503471258587137,,,,
brady_urology,6/2/2014 12:36,0,0,RT @ drphil_urology: grt summary 4 those who prefer 2 read. History of Genitourinary Cancers... @ ASCO # ASCO14 http://am.asco.org/history-genitourinary-cancers-past-progress-and-future-promise#.U4yjzQvPMmU.twitter …,,@ @,# #,4.73503E+17,https://twitter.com/brady_urology/status/473503464434462720,,,,
DrHedrick,6/2/2014 12:35,0,0,"FYI PEI is cisplatin, etoposide, IRINOTECAN. (PEI sometimes means ifosphamide) # ASCO14",,,#,4.73503E+17,https://twitter.com/DrHedrick/status/473503137157120000,,,,
ElizBlanchardMD,6/2/2014 12:35,1,0,Abs 7504: 6m improvement in OS with PEI vs topotecan. Wonder what result of PEI vs just cis/irinotecan would be. # ASCO14 # lcsm,,,# #,4.73503E+17,https://twitter.com/ElizBlanchardMD/status/473503076784279552,,,,
DCarrizosaMD,6/2/2014 12:35,0,0,"# ASCO14 - In japan, PEI(cis/vp16/irinotecan) vs topotecan showed significant improvement in OS (18.2 vs 12.5 months) p0.0079 but toxic # LCI",,,# #,4.73503E+17,https://twitter.com/DCarrizosaMD/status/473503062993424385,,,,
DrHedrick,6/2/2014 12:34,0,0,PEI longer PFS and OS than topo. Almost all patients received 3rd line therapy (hearing the words selection bias in my head) # ASCO14,,,#,4.73503E+17,https://twitter.com/DrHedrick/status/473502965765271552,,,,
BioWorld,6/2/2014 12:34,3,0,"Scant therapeutic options in HPV-linked cervical cancer, ‘TIL’ now http://bit.ly/RYgecy # ASCO14",,,#,4.73503E+17,https://twitter.com/BioWorld/status/473502932215033856,,,,
CitelineGailP,6/2/2014 12:33,1,0,@ CitelineRachelM @ Citeline looks at # oncology # immunotherapies beyond PD1 & PDL1 at # ASCO2014 A few show stealers? http://bit.ly/SVNyCm,,@ @,# # #,4.73503E+17,https://twitter.com/CitelineGailP/status/473502786983034880,,,,
LungCancerFaces,6/2/2014 12:33,0,1,More folks to follow for # ASCO14 updates: @ RamalingamMD @ RielyMD @ JFreemanDaily # LCSM,,@ @ @,# #,4.73503E+17,https://twitter.com/LungCancerFaces/status/473502717151682560,,,,
EDDFoundation,6/2/2014 12:33,0,0,“ @ ASCO: Read Educational Book articles on topics in Sarcoma from # ASCO14 Education Session Speakers: http://bit.ly/SLw0IW ”,,@,#,4.73503E+17,https://twitter.com/EDDFoundation/status/473502636936036353,,,,
AlpineBV_Miller,6/2/2014 12:33,0,1,Still no prison stripes or orange jumpsuits at the $ INSY # ASCO14 booth. Just FYI.,,,#,4.73503E+17,https://twitter.com/AlpineBV_Miller/status/473502619038908416,,,,
montypal,6/2/2014 12:33,0,0,So amazing to see lots of our @ cityofhope RCC studies highlighted at # ASCO14,,@,#,4.73503E+17,https://twitter.com/montypal/status/473502610197319681,,,,
JonathanHirsch,6/2/2014 12:33,2,0,Packed house for @ Syapse customer Jim Ford @ SUMedicine talk on cancer genomics # ASCO14,,@ @,#,4.73503E+17,https://twitter.com/JonathanHirsch/status/473502607302873088,,,,
ElizBlanchardMD,6/2/2014 12:33,1,0,Abs7504:cis/VP/irino (PEI) vs topotecan. That's a lot of chemo.ORR much better for PEI but more toxic: 31%febrile neutropenia # ASCO14 # lcsm,,,# #,4.73503E+17,https://twitter.com/ElizBlanchardMD/status/473502566157148160,,,,
myPathMelanoma,6/2/2014 12:32,1,0,At the Highlighted poster session waiting for our data to be presented! Get here soon or miss it! # melanoma # ASCO14 pic.twitter.com/hmRjgO81Y9,,,# #,4.73502E+17,https://twitter.com/myPathMelanoma/status/473502421927604224,,,,
jagasquet,6/2/2014 12:32,0,0,# ASCO14 50th Annual Meeting @ ASCO pic.twitter.com/LnhDrj3W7u,,@,#,4.73502E+17,https://twitter.com/jagasquet/status/473502406358360064,,,,
fainfosalute,6/2/2014 12:32,0,0,"TUMORE, AIOM: RISPARMI DALLA PREVENZIONE, 6 MILIARDI DI EURO IN 5 ANNI # asco2014 http://bit.ly/1hs5cJ2",,,#,4.73502E+17,https://twitter.com/fainfosalute/status/473502382505349121,,,,
AlpineBV_Miller,6/2/2014 12:32,0,1,"Hey, if you got a # sgenball make sure to bring it by $ SGEN # ASCO14 booth. They'll scan your badge and make a donation to cancer research.",,,# #,4.73502E+17,https://twitter.com/AlpineBV_Miller/status/473502354353192960,,,,
drcbsteer,6/2/2014 12:32,2,0,# ASCO14 Very interesting (but twitter free) morning thus far at colorectal oral presentations in wifi-free Arie Crown Theatre.,,,#,4.73502E+17,https://twitter.com/drcbsteer/status/473502301462999041,,,,
LungCancerFaces,6/2/2014 12:31,1,1,"$3 a month MT @ NTConnell: JA Roth: LDCT screen will dx more lung cancer at early stage, increase Medicare spending by $9.3B. # ASCO14 # lcsm",,@,# #,4.73502E+17,https://twitter.com/LungCancerFaces/status/473502235372965889,,,,
DrHedrick,6/2/2014 12:31,0,0,Trial is second line agent Topotecan versus PEI. Higher response in PEI arm. Much higher toxicity. # ASCO14,,,#,4.73502E+17,https://twitter.com/DrHedrick/status/473502208332677121,,,,
NTConnell,6/2/2014 12:31,0,1,"MJ Hassett @ DanaFarber Same structured data element can have different meaning depending and how and where it is used."" # ASCO14""",,@,#,4.73502E+17,https://twitter.com/NTConnell/status/473502158353358848,,,,
RamalingamMD,6/2/2014 12:31,3,0,Radiation in extensive small cell lung ca- no role for PCI and questionable role for thoracic RT. # ASCO14 # LCSM,,,# #,4.73502E+17,https://twitter.com/RamalingamMD/status/473502127168708609,,,,
ASCO,6/2/2014 12:31,4,4,Drs. Lange and Lin reflect on the history of genitourinary cancers http://bit.ly/1tUCiDn # ASCO14,,,#,4.73502E+17,https://twitter.com/ASCO/status/473502126283706368,,,,
CancerDotNet,6/2/2014 12:30,0,1,Summary for pts: Early study indicates 2-drug combo helps ppl w/ adv # melanoma live longer. # ASCO14 http://bit.ly/U6OaWx,,,# #,4.73502E+17,https://twitter.com/CancerDotNet/status/473502025549103104,,,,
DebiopharmNews,6/2/2014 12:30,0,0,"# ASCO14 The more the # patient benefits from our drug, the more accomplished we feel http://ow.ly/xwqvT",,,# #,4.73502E+17,https://twitter.com/DebiopharmNews/status/473502019333156864,,,,
SarahCannonDocs,6/2/2014 12:30,1,0,Immunologic activity of an activating anti-CD27 antibody. Join # SCRI Dr.Infante & Dr. Burris this afternoon in S405 # ASCO14,,,# #,4.73502E+17,https://twitter.com/SarahCannonDocs/status/473502018204860416,,,,
mayocliniclabs,6/2/2014 12:30,0,0,"Dr. Couch discussing “Hereditary Breast and Colon Cancer, and Clinical Oncology: Past, Present, and Future.” # ASCO14",,,#,4.73502E+17,https://twitter.com/mayocliniclabs/status/473502002954383360,,,,
MoffittResearch,6/2/2014 12:30,0,1,A poster highlight session about new therapies for melanoma featuring Drs. Jeffrey Weber & Geoffrey Gibney begins at 1:15 p.m. # ASCO14,,,#,4.73502E+17,https://twitter.com/MoffittResearch/status/473501990736379904,,,,
Novartis,6/2/2014 12:30,1,2,# Polycythemiavera by the Numbers-get the statistics about this incurable # bloodcancer # ASCO14 http://bit.ly/1ipAxGQ,,,# # #,4.73502E+17,https://twitter.com/Novartis/status/473501968372346880,,,,
OSUCCC_James,6/2/2014 12:30,0,1,Dr. Dave O'Malley gives perspective on HPV-adapted immune therapy for cervical cancer with @ Medscape at # ASCO14 pic.twitter.com/bQ1cbCT1Nd,,@,#,4.73502E+17,https://twitter.com/OSUCCC_James/status/473501929243308032,,,,
FoundationATCG,6/2/2014 12:30,0,0,"# FoundationOne finds actionable alts in # TNBC with patient response from matched therapy Poster HiLi: 1:15-4:15, E354b, Ab 1028 # ASCO14",,,# # #,4.73502E+17,https://twitter.com/FoundationATCG/status/473501881034354690,,,,
NatRevClinOncol,6/2/2014 12:30,5,1,Main message of # ASCO14 is cost and value of cancer care and how this fits with personalised medicine,,,#,4.73502E+17,https://twitter.com/NatRevClinOncol/status/473501824045969408,,,,
LungCancerFaces,6/2/2014 12:30,1,1,"And save lives MT @ DrMarkham: Roth #6501: Lung Cancer LDCT screening will have a large budget impact"" # asco14 # lcsm http://ow.ly/xwIgF""",,@,#6501 # #,4.73502E+17,https://twitter.com/LungCancerFaces/status/473501806824136704,,,,
TuftsB,6/2/2014 12:29,1,0,When novel medically justifiable regimens arise how many lives will be lost caused by ASCO admin slowing access to treatment? # mliwi # ASCO14,,,# #,4.73502E+17,https://twitter.com/TuftsB/status/473501781293400064,,,,
myriadgenetics,6/2/2014 12:29,2,0,"Dr. Loren Clarke and Mark Capone, President of MGL, talk to the media at # ASCO14 about Myriad's myPath # Melanoma.pic.twitter.com/JqbRTZogeu",,,# #,4.73502E+17,https://twitter.com/myriadgenetics/status/473501765006929920,,,,
nanostringtech,6/2/2014 12:29,0,0,"Learn more about the nCounter Dx Analysis System and our Prosigna assay during # ASCO14 at Booth 5019, located near @ ASCO Central.",,@,#,4.73502E+17,https://twitter.com/nanostringtech/status/473501753472606210,,,,
BetsyMunnell,6/2/2014 12:29,0,1,Excellent post. # VC RT @ galenmoore: Why Isn't Chicago the Silicon Valley of Life Sciences? http://chicagoinno.streetwise.co/2014/05/27/why-isnt-chicago-the-silicon-valley-of-life-sciences/ … via @ ChicagoInno # ASCO14,,@ @,# #,4.73502E+17,https://twitter.com/BetsyMunnell/status/473501699295158272,,,,
lenstarnes,6/2/2014 12:29,0,0,"@ andrewspong ...my final word on this. I now clock 11 participating # pharma s on # ASCO14. No question, a med soc conf world record @ ASCO",,@ @,# #,4.73502E+17,https://twitter.com/lenstarnes/status/473501668433084416,,,,
Neil_Iyengar,6/2/2014 12:29,0,0,Dose dense paclitaxel + lapatinib + trastuzumab is not tolerable. (S hall board 97). This & ALTTO = Adjuvant lapat doesn't work. # ASCO14,,,#,4.73502E+17,https://twitter.com/Neil_Iyengar/status/473501580931915777,,,,
aakonc,6/2/2014 12:28,1,2,Abs 6505 Nice work by Cheung et al showing admin data overestimate noncompliance with outpt Onc meds # hsronc # ASCO14,,,# #,4.73501E+17,https://twitter.com/aakonc/status/473501482692902912,,,,
subatomicdoc,6/2/2014 12:28,0,0,"Conversation continuing, wish I could stay for entire # ASCO14 @ GTFRCC presentation. But off to next meeting. Thanks @ marykge @ daniellerodin",,@ @ @,#,4.73501E+17,https://twitter.com/subatomicdoc/status/473501422265589761,,,,
gorskon,6/2/2014 12:28,0,0,. @ subatomicdoc And I have ear buds with me as well… # ASCO14,,@,#,4.73501E+17,https://twitter.com/gorskon/status/473501356137779200,,,,
jagasquet,6/2/2014 12:27,0,0,# ASCO14: Cancer Conference Winners And Losers http://www.forbes.com/sites/matthewherper/2014/06/02/cancer-conference-winners-and-losers/?partner=yahootix …,,,#,4.73501E+17,https://twitter.com/jagasquet/status/473501053896634369,,,,
Tony_Calles,6/2/2014 12:26,2,0,Today's oral presentations in lung cancer struggle with stats. Important results but careful interpretation should be taken. # ASCO14 # LCSM,,,# #,4.73501E+17,https://twitter.com/Tony_Calles/status/473500879916904448,,,,
ICONplc,6/2/2014 12:26,0,0,Did you know @ iconplc recently acquired @AptivSolutions?Stop by our booth 3119 # ASCO14 to find out more,,@ @AptivSolutions,#,4.73501E+17,https://twitter.com/ICONplc/status/473500850577739779,,,,
SusanLaufer,6/2/2014 12:26,0,0,Line for free crepes is shorter at @ NorthwestBio than @ tevapharm at # ASCO14,,@ @,#,4.73501E+17,https://twitter.com/SusanLaufer/status/473500795749425152,,,,
subatomicdoc,6/2/2014 12:25,1,0,"Radiation oncology may have issues in Turkey, a middle income country, because of prioritization # ASCO14 # radonc @ GTFRCC",,@,# #,4.73501E+17,https://twitter.com/subatomicdoc/status/473500774937665537,,,,
ASCOPost,6/2/2014 12:25,9,1,Addition of Chemotherapy to Radiotherapy Improves Survival in Low-Grade Glioma http://ow.ly/xwYSq # ASCO14 # btsm,,,# #,4.73501E+17,https://twitter.com/ASCOPost/status/473500676916793345,,,,
DrHedrick,6/2/2014 12:25,1,2,"Relapsed SCLC, topotecan only drug approved for disease. (some call it topotecan't) # ASCO14",,,#,4.73501E+17,https://twitter.com/DrHedrick/status/473500615734067200,,,,
Roche,6/2/2014 12:25,1,3,Investing in future talent to overcome lack of clinicians & scientists in the area of oncology. http://ow.ly/xp6ox # ASCO14 # lifescience,,,# #,4.73501E+17,https://twitter.com/Roche/status/473500604867026945,,,,
jborton1641,6/2/2014 12:25,0,0,@ scientre on patient-reported outcomes (PROs) which comes directly from the pt w/o clinician interpretation (per FDA) # asco14 # hcsm,,@,# #,4.73501E+17,https://twitter.com/jborton1641/status/473500591462027265,,,,
myriadgenetics,6/2/2014 12:25,1,0,Myriad myPath Melanoma helps physicians make a prompt and accurate diagnosis of potentially fatal # melanoma. http://bit.ly/1rBXXT4 # ASCO14,,,# #,4.73501E+17,https://twitter.com/myriadgenetics/status/473500583391809536,,,,
ONAcom,6/2/2014 12:25,0,0,RT @ thenci: In the news: Adoptive # immunotherapy approach shows promise in advanced # cervicalcancer http://yhoo.it/1mJbJMJ # ASCO14,,@,# # #,4.73501E+17,https://twitter.com/ONAcom/status/473500577427505152,,,,
HenryJOncology,6/2/2014 12:24,0,0,# hcldr http://abstracts.asco.org/144/AbstView_144_130438.html … highlighting that if the definition is flawed a database study will be flawed. Need to try harder # ASCO14,,,# #,4.735E+17,https://twitter.com/HenryJOncology/status/473500467972960256,,,,
AlpineBV_Miller,6/2/2014 12:24,0,0,"I agree. We sparred over the years at his nimotuzumab posters, but it was crystal clear he loved these kids # ASCO14 pic.twitter.com/ZWP7nV1jkK",,,#,4.735E+17,https://twitter.com/AlpineBV_Miller/status/473500462470025217,,,,
BayerPharma,6/2/2014 12:24,2,1,We are glad for having 20 leading # cancer patient # advocacy groups from across the world. Thanks all for attending! # ASCO14,,,# # #,4.735E+17,https://twitter.com/BayerPharma/status/473500423966711809,,,,
ASCOPost,6/2/2014 12:24,6,4,2nd-Line Treatment w/Ramucirumab + Standard Docetaxel Extends Overall Survival in Advanced Lung Cancer http://ow.ly/xwYwy # ASCO14 # lcsm,,,# #,4.735E+17,https://twitter.com/ASCOPost/status/473500419147448321,,,,
RichardWJoseph,6/2/2014 12:24,0,0,@ montypal Also need to find out if pbrm1 or bap1 associate with treatment outcomes in RCC. # asco14,,@,#,4.735E+17,https://twitter.com/RichardWJoseph/status/473500405565882369,,,,
nerifede,6/2/2014 12:24,0,0,@ Lucy3370 $ CLDX tree shaking before # ASCO14 presentation,,@,#,4.735E+17,https://twitter.com/nerifede/status/473500289337921536,,,,
SanofiCanada,6/2/2014 12:24,2,1,"MT @ SanofiUS At # ASCO14, we recognize the strength & resilience of patients and continue to support ongoing research pic.twitter.com/fRs2xGx1ur",,@,#,4.735E+17,https://twitter.com/SanofiCanada/status/473500286632624128,,,,
DrHedrick,6/2/2014 12:23,1,1,BIG LIMITATION: If we do therapy prophylactically we MUST have data on QOL/sx. We are likely treating patients who don't need it. # ASCO14,,,#,4.735E+17,https://twitter.com/DrHedrick/status/473500257306030080,,,,
subatomicdoc,6/2/2014 12:23,1,1,Proton therapy raised. Why should we spend $100M+ on a single system when you can use that better globally? # ASCO14 # radonc,,,# #,4.735E+17,https://twitter.com/subatomicdoc/status/473500253950586880,,,,
subatomicdoc,6/2/2014 12:23,1,0,Suggestion made to focus on curative radiation indications in underserved areas globally # ASCO14 # radonc,,,# #,4.735E+17,https://twitter.com/subatomicdoc/status/473500094369898496,,,,
ElizBlanchardMD,6/2/2014 12:22,0,1,Q&A: Dr Curran reiterates importance of QOL data--how did this not get included?? # ASCO14 # lcsm # supponc,,,# # #,4.735E+17,https://twitter.com/ElizBlanchardMD/status/473500014824931328,,,,
PeterHall001,6/2/2014 12:22,0,0," @ PECjournal: Coverage with evidence development sends chills down US payers # ISPORMontreal"" # ASCO14""",,@,# #,4.735E+17,https://twitter.com/PeterHall001/status/473499997334294528,,,,
subatomicdoc,6/2/2014 12:22,0,0,"Discussant: You may not need an uber-training, but some still necessary for quality care @ GTFRCC # ASCO14 # radonc",,@,# #,4.735E+17,https://twitter.com/subatomicdoc/status/473499867281895424,,,,
abcdiagnosis,6/2/2014 12:22,0,2,“ @ DrAttai: Size doesn't always matter! Tumor biology important (3/3) # asco14 pic.twitter.com/9TrDTIW6mb” # breastcancer,,@,# #,4.735E+17,https://twitter.com/abcdiagnosis/status/473499789129416704,,,,
jodigralnick,6/2/2014 12:21,0,0,# ASCO14 # CNBC coverage still going strong: @ megtirrell w/ Pres of $ MRK Research Labs: http://cnb.cx/1kiI3Jp . Next up: $ ARIA CEO @1235PMET,,@ @1235PMET,# #,4.735E+17,https://twitter.com/jodigralnick/status/473499646309203968,,,,
EllenLicking,6/2/2014 12:21,0,0,MT @ PinkSheetMaryJo @ CliffordHudis: dependent on industry for innovation. ask 4 relationship btwn cost and what patients get # ASCO14,,@ @,#,4.735E+17,https://twitter.com/EllenLicking/status/473499610107768833,,,,
RichardWJoseph,6/2/2014 12:21,0,1,@ montypal Thanks! Even more excited our next project with PBRM1 and BAP1. Those two markers identify 4 unique clinical subsets. # ASCO14,,@,#,4.735E+17,https://twitter.com/RichardWJoseph/status/473499555531485184,,,,
subatomicdoc,6/2/2014 12:20,0,0,"Discussant: In S. Africa, more awareness but need to improve further. @ GTFRCC # ASCO14",,@,#,4.735E+17,https://twitter.com/subatomicdoc/status/473499528067563521,,,,
RoswellPark,6/2/2014 12:20,1,0,"Dr. Monica Muppidi, one of our clinical fellows, sharing research on rare vascular tumors at # ASCO14 # CancerResearchpic.twitter.com/HuBJnhA5RK",,,# #,4.735E+17,https://twitter.com/RoswellPark/status/473499516021538816,,,,
DrHedrick,6/2/2014 12:20,1,0,". @ JackWestMD Question. Based on Seto, does logical scheme of screening MRI, Rx of mets presents, delaying RT for Sx or evident mets. # ASCO14",,@,#,4.73499E+17,https://twitter.com/DrHedrick/status/473499420320088064,,,,
ASCO,6/2/2014 12:20,2,1,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.73499E+17,https://twitter.com/ASCO/status/473499412090851328,,,,
DebiopharmNews,6/2/2014 12:20,0,0,"# ASCO14 The # patients are at the core of our business, we care for them! http://ow.ly/xwqpo",,,# #,4.73499E+17,https://twitter.com/DebiopharmNews/status/473499411746918400,,,,
LillyDiabetes,6/2/2014 12:20,1,2,Last day of @LlyOncOnCanvas mural painting at # ASCO14! By end of day we'll have our completed hope mural # hopeforward http://ow.ly/i/5LBJ4,,@LlyOncOnCanvas,# #,4.73499E+17,https://twitter.com/LillyDiabetes/status/473499410157305856,,,,
drseisenberg,6/2/2014 12:20,0,0,# ImmuneTherapies improve treatment of # cancers http://usat.ly/1mIXEix # ASCO14 # immunotherapy # cancer,,,# # # # #,4.73499E+17,https://twitter.com/drseisenberg/status/473499393459376129,,,,
fwmedtech,6/2/2014 12:20,0,0,"ALM AADx identifies ovarian cancer patients with good prognosis after standard of care chemotherapy, # ASCO2014 http://bit.ly/1wUKyFM",,,#,4.73499E+17,https://twitter.com/fwmedtech/status/473499389148016641,,,,
corp_UNC,6/2/2014 12:20,0,0,"Molec.subtypes of ccRCC: Impact of DM, metformin & immunoRx on pt outcomes Haake, @NC_KidneyCancer et al # ASCO14 http://ow.ly/xphM2",,@NC_KidneyCancer,#,4.73499E+17,https://twitter.com/corp_UNC/status/473499381350825985,,,,
subatomicdoc,6/2/2014 12:20,0,0,Discussant: We need a strategy and participation of society @ GTFRCC # ASCO14 / globally I believe,,@,#,4.73499E+17,https://twitter.com/subatomicdoc/status/473499372932857857,,,,
ElizBlanchardMD,6/2/2014 12:20,0,0,Grt Q&A: the difficulty of imaging post XRT-response vs XRT change? What was rate of brain mets picked up at pre-PCI scan? # ASCO14 # lcsm,,,# #,4.73499E+17,https://twitter.com/ElizBlanchardMD/status/473499348173873153,,,,
MoffittResearch,6/2/2014 12:19,1,0,"Thank you, @ Medpagetoday for speaking with our Dr. Robert Wenham today at # ASCO14. http://ow.ly/i/5LCpc",,@,#,4.73499E+17,https://twitter.com/MoffittResearch/status/473499277957005313,,,,
drphil_urology,6/2/2014 12:19,0,1,grt summary 4 those who prefer 2 read... History of Genitourinary Cancers: Past Progress & Future Promise | # ASCO14 http://am.asco.org/history-genitourinary-cancers-past-progress-and-future-promise#.U4yjzQvPMmU.twitter …,,,# #,4.73499E+17,https://twitter.com/drphil_urology/status/473499142443253761,,,,
ShabbirHossain,6/2/2014 12:19,0,1,Enjoyed following all the tweets from # asco14! Learned a lot! thanks everyone! # hcsm # healthcare # medicine # oncology,,,# # # # #,4.73499E+17,https://twitter.com/ShabbirHossain/status/473499043768057856,,,,
FolioBio,6/2/2014 12:18,0,0,Attending # ASCO14? Stop by booth 4122 & give the Folio team a high 5!,,,#,4.73499E+17,https://twitter.com/FolioBio/status/473498969822486528,,,,
drseisenberg,6/2/2014 12:18,0,0,RT @ subatomicdoc: Why women are choosing # mastectomy: Influences beyond the surgeon http://bit.ly/1hiAphJ # bcsm # ASCO14,,@,# # #,4.73499E+17,https://twitter.com/drseisenberg/status/473498940231651328,,,,
finchtalk,6/2/2014 12:18,0,0,"MT @ illumina: NGS, fast moving field, tech and bioinfx, how seq info clinically used far from standard # ASCO14 | Standardly non-standard",,@,#,4.73499E+17,https://twitter.com/finchtalk/status/473498909361184768,,,,
EllenLicking,6/2/2014 12:18,0,0,RT @ CliffordHudis “Price is what you pay. Value is what you get.” @ ASCO must define # value in # cancer care & pursue it. # ASCO14,,@ @,# # #,4.73499E+17,https://twitter.com/EllenLicking/status/473498904885878784,,,,
daniellerodin,6/2/2014 12:18,2,0,"“ @ subatomicdoc @ daniellerodin The story of Veronica is example of why we need universal, global access to radiotherapy @ UICC @ GTFRCC # ASCO14",,@ @ @ @,#,4.73499E+17,https://twitter.com/daniellerodin/status/473498869850853376,,,,
CheckOrphan,6/2/2014 12:18,0,0,@ Celgene presents updated results of # ClinicalTrials at # ASCO14 on # pancreaticcancer # OrphanDrugs # RareDisease http://ow.ly/xwXcN,,@,# # # # #,4.73499E+17,https://twitter.com/CheckOrphan/status/473498865396903936,,,,
drphil_urology,6/2/2014 12:18,0,0,Progress in # prostatecancer Research | # ASCO14 ... the longest GU cancer history! http://am.asco.org/progress-prostate-cancer-research#.U4yjlQ3Mszw.twitter …,,,# # #,4.73499E+17,https://twitter.com/drphil_urology/status/473498775974338561,,,,
BladderCancerUS,6/2/2014 12:17,0,1,"Exciting research in immune therapy for adv # bladdercancer yields promising results @ ScienceDaily, @ ASCO # ASCO14 http://www.sciencedaily.com/releases/2014/05/140531090724.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fbladder_cancer+%28Bladder+Cancer+News+--+ScienceDaily%29#.U4yix9oB2x4.twitter …",,@ @,# # #,4.73499E+17,https://twitter.com/BladderCancerUS/status/473498662744903680,,,,
drseisenberg,6/2/2014 12:17,0,1,RT @ genentech: < 15% of patients learn abt # clinicaltrials from their MDs. How to address awareness: http://ow.ly/xwKnl # ASCO14,,@,# #,4.73499E+17,https://twitter.com/drseisenberg/status/473498583132422144,,,,
WinshipAtEmory,6/2/2014 12:17,3,0,Huge crowd on hand at # ASCO14 listening to @ wallyjc take part in a panel discussion on radiation therapy.pic.twitter.com/q4xDyThNbO,,@,#,4.73499E+17,https://twitter.com/WinshipAtEmory/status/473498528057417729,,,,
PBLsciupdate,6/2/2014 12:16,0,0,"Growing use of Twitter at ASCO # ASCO13 featured 13,000 times during the two-week meeting period last year # ASCO14 - 25,000 since May 30",,,# #,4.73498E+17,https://twitter.com/PBLsciupdate/status/473498389879877632,,,,
chemie_bw,6/2/2014 12:16,0,1,Weiter so! Go on! RT @ pfizer Infographic: 50 years of cancer research and counting # asco14 pic.twitter.com/7F5AUbu6p4 ^AF,,@,#,4.73498E+17,https://twitter.com/chemie_bw/status/473498388462583809,,,,
SeanKhozin,6/2/2014 12:16,1,2,Great presentation by FDA colleague on our group's meta-analysis strongly correlating ORR with PFS in NSCLC # ASCO14 http://meetinglibrary.asco.org/content/124927-144 …,,,#,4.73498E+17,https://twitter.com/SeanKhozin/status/473498385933406209,,,,
galenmoore,6/2/2014 12:16,0,2,Why Isn't Chicago the Silicon Valley of Life Sciences? http://chicagoinno.streetwise.co/2014/05/27/why-isnt-chicago-the-silicon-valley-of-life-sciences/ … via @ ChicagoInno # ASCO14,,@,#,4.73498E+17,https://twitter.com/galenmoore/status/473498362851762176,,,,
subatomicdoc,6/2/2014 12:16,0,0,@ WHO @ UICC @ ASCO leadership all represented at meeting for @ GTFRCC # ASCO14 # radonc,,@ @ @ @,# #,4.73498E+17,https://twitter.com/subatomicdoc/status/473498346469208064,,,,
drphil_urology,6/2/2014 12:16,0,0,Progress in # UrothelialCancer Research | # ASCO14 .... shortest timeline!! http://am.asco.org/progress-urothelial-cancer-research#.U4yjJdGKmMU.twitter …,,,# # #,4.73498E+17,https://twitter.com/drphil_urology/status/473498311748759552,,,,
Transplant_Doc,6/2/2014 12:15,3,1,Daratumumab (anti-CD38 antibody) as single agent had 46% overall response in relapsed/refractory myeloma at 16 mg/kg dose # ASCO14 # mmsm,,,# #,4.73498E+17,https://twitter.com/Transplant_Doc/status/473498259051134976,,,,
TargetedOnc,6/2/2014 12:15,4,1,"Bevacizumab, Cetuximab Equally Effective in KRAS Wild-Type mCRC http://www.targetedonc.com/conference/asco-2014/Bevacizumab-Cetuximab-Equally-Effective-in-KRAS-Wild-Type-mCRC … # ASCO14",,,#,4.73498E+17,https://twitter.com/TargetedOnc/status/473498181431721984,,,,
dramarivirg,6/2/2014 12:15,0,0,Dres. Escudier y Motzer hablan de biomarcadores genéticos para predecir riesgo de recaída luego d nefrectomía en CCRcc st I- III # ASCO14,,,#,4.73498E+17,https://twitter.com/dramarivirg/status/473498171428339712,,,,
DrHedrick,6/2/2014 12:15,0,0,@ ElizBlanchardMD Agree. See no evidence that you can't wait for symptoms and clear evidence should screen with brain MRI in ES-SCLC # ASCO14,,@,#,4.73498E+17,https://twitter.com/DrHedrick/status/473498167926079488,,,,
lenstarnes,6/2/2014 12:15,0,0,"@ andrewspong ...and @ LillyPad # ASCO14 That sums to at least 7 participating pharmas, another record",,@ @,#,4.73498E+17,https://twitter.com/lenstarnes/status/473498166432890881,,,,
genentech,6/2/2014 12:15,12,7,"Cancers in children, w/ few exceptions, are distinct diseases & require a unique approach to # research: http://ow.ly/xwL1y # ASCO14",,,# #,4.73498E+17,https://twitter.com/genentech/status/473498097407238144,,,,
subatomicdoc,6/2/2014 12:15,0,0,@ gorskon True! # ASCO14 makes broadband multitasking easy :),,@,#,4.73498E+17,https://twitter.com/subatomicdoc/status/473498089920409602,,,,
decojeanne,6/2/2014 12:15,0,0,RT @ subatomicdoc: Why women are choosing mastectomy: Influences beyond the surgeon http://bit.ly/1hiAphJ # ASCO14 # bcsm,,@,# #,4.73498E+17,https://twitter.com/decojeanne/status/473498077576187904,,,,
smerv,6/2/2014 12:14,0,1,"2) With # immunotherapy, you're treating the patient, and the patient is treating the cancer. http://on.wsj.com/1jLZmN9 # ASCO14 # endcancer""",,,# # #,4.73498E+17,https://twitter.com/smerv/status/473497977319731201,,,,
mcmrhona,6/2/2014 12:14,2,2,Loved these portaloos on the McCormick place site ! # ASCO14 pic.twitter.com/6qmgzC3uvv,,,#,4.73498E+17,https://twitter.com/mcmrhona/status/473497973494935552,,,,
drseisenberg,6/2/2014 12:14,0,0,@ ASCO Conference Coverage from @ medpagetoday: http://www.medpagetoday.com/MeetingCoverage/ASCO/ … # ASCO14,,@ @,#,4.73498E+17,https://twitter.com/drseisenberg/status/473497939000582144,,,,
KemiDoll,6/2/2014 12:14,1,0,# ASCO14 Wright etal: publicly reported hosp quality indicators don't predict outcome for cancer surgery. @ SGO_org @ corp_UNC need 4 our work!,,@ @,#,4.73498E+17,https://twitter.com/KemiDoll/status/473497920822857728,,,,
drphil_urology,6/2/2014 12:14,0,0,Progress in # RCC # kidneycancer Research | # ASCO14 ... relatively short timeline compared to other organs! http://am.asco.org/progress-renal-cell-carcinoma-research#.U4yihHWpgiM.twitter …,,,# # # #,4.73498E+17,https://twitter.com/drphil_urology/status/473497816485330944,,,,
subatomicdoc,6/2/2014 12:13,1,0,"Dr. Trimble: We have vaccines for HPV, hepatitis @ GTFRCC # ASCO14",,@,#,4.73498E+17,https://twitter.com/subatomicdoc/status/473497701804670976,,,,
gorskon,6/2/2014 12:13,0,0,". @ subatomicdoc Of course, if I sit in the back I can listen to both, switching back and forth. Fortunately, the # ASCO14 wifi is excellent:-)",,@,#,4.73498E+17,https://twitter.com/gorskon/status/473497686000156672,,,,
subatomicdoc,6/2/2014 12:13,0,0,Dr. Trimble: Radiation is an essential part of a cancer control plan...that needs to include prevention @ GTFRCC # ASCO14,,@,#,4.73498E+17,https://twitter.com/subatomicdoc/status/473497611627155456,,,,
teamoncology,6/2/2014 12:13,1,0,RT @ ChrisHeery: @ teamoncology EMD-Serono IgG1 induces adcc anti-pd-l1. Genentech IgG1 modified for no adcc anti-pd-l. # ASCO14,,@ @,#,4.73498E+17,https://twitter.com/teamoncology/status/473497602307018753,,,,
knwachter,6/2/2014 12:13,0,0,RT @ JackWestMD: Robinson: Retro review of dB shows NSCLC st IIIA N2 pts who rec'd post-op chest RT had mod superior overall surv. # ASCO14,,@,#,4.73498E+17,https://twitter.com/knwachter/status/473497594547953664,,,,
ElizBlanchardMD,6/2/2014 12:13,0,0,"Abs 7502/3: Much less apt to rec PCI in ext stage, but will cont to consider XRT consolidation. Will discuss w my RadOncs tom # ASCO14 # LCSM",,,# #,4.73498E+17,https://twitter.com/ElizBlanchardMD/status/473497556170072064,,,,
jodigralnick,6/2/2014 12:13,0,1,# ASCO14 LIVE coverage continues at 1235pm ET on @ CNBCFastMoney w/ @ megtirrell's EXCLUSIVE @ CNBC interview with $ ARIA CEO @ harveyberger,,@ @ @ @,#,4.73498E+17,https://twitter.com/jodigralnick/status/473497550851678208,,,,
smerv,6/2/2014 12:12,0,0,"1) # Immunotherapy cancer drugs show promise http://on.wsj.com/1jLZmN9 Key thing is high frequency of durable responses."" # endcancer # ASCO14""",,,# # #,4.73497E+17,https://twitter.com/smerv/status/473497453983842304,,,,
subatomicdoc,6/2/2014 12:12,0,0,"Dr Lichter: Applies to doctor, physicist, therapist. Plans could be done remotely. Some maintenance too @ GTFRCC # ASCO14",,@,#,4.73497E+17,https://twitter.com/subatomicdoc/status/473497362829430785,,,,
LeemFrance,6/2/2014 12:12,5,1,Des progrès importants dans la lutte contre le # cancer de la # prostate # ASCO14 # hcsmeuFR http://buff.ly/1kq8LhT,,,# # # #,4.73497E+17,https://twitter.com/LeemFrance/status/473497318566924288,,,,
DrHedrick,6/2/2014 12:11,1,0,@ n8pennell Tough as trial stopped early. Prolonged trial may very well have shown this but may put participants at harm. What to do? # ASCO14,,@,#,4.73497E+17,https://twitter.com/DrHedrick/status/473497174106701824,,,,
subatomicdoc,6/2/2014 12:11,0,0,Dr. Lichter: Rules-based care may help permit training less specialized personnel for care delivery @ GTFRCC # ASCO14 # radonc,,@,# #,4.73497E+17,https://twitter.com/subatomicdoc/status/473497144939544576,,,,
dhjutsw1,6/2/2014 12:11,0,0,@ ASCO # ASCO14 # lcsm Abst #7502 Discussant Dr. Wally Curran correctly notes erroneous conclusion by PI - TRT did not improve OS per design.,,@,# # #7502,4.73497E+17,https://twitter.com/dhjutsw1/status/473497085568753664,,,,
knwachter,6/2/2014 12:11,0,0,"RT @ JackWestMD: Eberhardt: No diff in survival between chemo/RT, then lung surg, vs. chemo/RT to higher dose for stage III NSCLC # ASCO14",,@,#,4.73497E+17,https://twitter.com/knwachter/status/473497083220340736,,,,
ShannonWestin,6/2/2014 12:10,1,0,Personalized therapy for endometrial cancer and clear cell ovarian cancer- how do we do it? Come hear in E354a. # ASCO14 # gyncsm,,,# #,4.73497E+17,https://twitter.com/ShannonWestin/status/473496970125135873,,,,
subatomicdoc,6/2/2014 12:10,0,0,Dr. Lichter: The Western paradigm won't work @ GTFRCC # ASCO14 / Agree. That's why biosimilars emerge for drugs. What about for radiation?,,@,#,4.73497E+17,https://twitter.com/subatomicdoc/status/473496938831446018,,,,
EquicareHealth,6/2/2014 12:10,0,1,Last day to catch us at # ASCO14 - hope to see you at booth 4026!,,,#,4.73497E+17,https://twitter.com/EquicareHealth/status/473496929981460481,,,,
SamBrownInc,6/2/2014 12:10,0,0,RT @ asco: Missed today's # ASCO14 press briefing? View the recording for the latest in immunotherapy: http://bit.ly/QF4Thk,,@,#,4.73497E+17,https://twitter.com/SamBrownInc/status/473496927737495552,,,,
SitemanCenter,6/2/2014 12:10,0,1,"# ASCO14 Siteman's Matthew Powell, MD, co-chairs a session and panel Q&A on gynecologic cancer: 11:30 am-12:45 pm, Rm E354a",,,#,4.73497E+17,https://twitter.com/SitemanCenter/status/473496920716230656,,,,
teamoncology,6/2/2014 12:10,2,1,"Not sure. “In 10 y, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,,# #,4.73497E+17,https://twitter.com/teamoncology/status/473496915296800768,,,,
QIAGENscience,6/2/2014 12:10,1,0,QIAamp Circulating Nucleic Acid Kit permits fetal DNA extraction from blood/plasma in smpl vols low as 5 ml http://bit.ly/1nRo56w # ASCO14,,,#,4.73497E+17,https://twitter.com/QIAGENscience/status/473496893268717569,,,,
DebiopharmNews,6/2/2014 12:10,0,0,# ASCO14 # Innovation is precious and we take care of it by transforming it into a drug for the # patients http://ow.ly/xwqhP,,,# # #,4.73497E+17,https://twitter.com/DebiopharmNews/status/473496887543496705,,,,
ProjectInno,6/2/2014 12:10,0,1,Our goal: to find solutions to overcome the obstacles slowing down cancer # innovation http://ow.ly/xuWk2 # ASCO14,,,# #,4.73497E+17,https://twitter.com/ProjectInno/status/473496836544954368,,,,
PinkSheetMaryJo,6/2/2014 12:10,1,0,"Schnipper notes debate over # Sovaldi price when that gives a cure, and oncology at times offering just few months of PFS # ASCO14",,,# #,4.73497E+17,https://twitter.com/PinkSheetMaryJo/status/473496828009119744,,,,
genentech,6/2/2014 12:10,2,4,Stop by booth no. 10005 for a larger-than-life look at our pipeline. # ASCO14 pic.twitter.com/2NmWeD0AqU,,,#,4.73497E+17,https://twitter.com/genentech/status/473496819117621248,,,,
knwachter,6/2/2014 12:10,1,0,RT @ JackWestMD: K. Park on consolidation chemo after chemo/RT for stage III NSCLC # ASCO14 # lcsmpic.twitter.com/Zm5pPO0FRC,,@,# #,4.73497E+17,https://twitter.com/knwachter/status/473496766604914688,,,,
montypal,6/2/2014 12:09,1,0,@ RichardWJoseph Glad that Martin brought up your excellent work in his discussion # ASCO14 pic.twitter.com/uciv3Aaoa7,,@,#,4.73497E+17,https://twitter.com/montypal/status/473496727904067586,,,,
subatomicdoc,6/2/2014 12:09,1,0,Dr. Lichter: The presence and stature of radiation oncology differs by institution @ GTFRCC # ASCO14 # radonc,,@,# #,4.73497E+17,https://twitter.com/subatomicdoc/status/473496719586758656,,,,
scientre,6/2/2014 12:09,1,1,"If you are interested in value/cost of cancer care, this AM session was way more lively than Fri PM. Audience participation FTW! # ASCO14",,,#,4.73497E+17,https://twitter.com/scientre/status/473496719398019072,,,,
knwachter,6/2/2014 12:09,0,1,RT @ JackWestMD: Dr. Kelly on RADIANT trial of adj erlotinib as adjuvant Rx after surg for early stage NSCLC # ASCO14 pic.twitter.com/YVconFclFo,,@,#,4.73497E+17,https://twitter.com/knwachter/status/473496705514889216,,,,
DrHedrick,6/2/2014 12:09,0,0,I suspect this panel discussion will be good. # ASCO14,,,#,4.73497E+17,https://twitter.com/DrHedrick/status/473496688221777920,,,,
n8pennell,6/2/2014 12:08,1,0,Curran: Important finding is lack of OS benefit from PCI in eSCLC. Need to find better ways to give PCI and select right pts. # ASCO14 # LCSM,,,# #,4.73496E+17,https://twitter.com/n8pennell/status/473496457677635584,,,,
knwachter,6/2/2014 12:08,0,0,RT @ JackWestMD: Hanna on SELECT trial: 91% dzs-free surv for st III NSCLC EGFR mutn-pos pts who rec'd adj erlotinib is impressive # ASCO14,,@,#,4.73496E+17,https://twitter.com/knwachter/status/473496416841904128,,,,
ElizBlanchardMD,6/2/2014 12:08,2,0,Abs 7503: Dr Curran comments: does sparing the hippocampus improve risk/benefit ratio in PCI? Trials ongoing # ASCO14 # lcsm # supponc,,,# # #,4.73496E+17,https://twitter.com/ElizBlanchardMD/status/473496386055725056,,,,
teamoncology,6/2/2014 12:08,3,2,Need data. :) RT @ CancerResearch: Triple-negative breast cancer: possible target for immunotherapy? Scientists say Yes! # ASCO14,,@,#,4.73496E+17,https://twitter.com/teamoncology/status/473496361053081602,,,,
drseisenberg,6/2/2014 12:08,1,1,RT @ NEJM: Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia http://nej.md/1hvgQ05 # cll # ASCO14,,@,# #,4.73496E+17,https://twitter.com/drseisenberg/status/473496322541379585,,,,
subatomicdoc,6/2/2014 12:08,0,0,@ marykge How do we achieve greater equity --> Allen Lichter to @ ASCO @ GTFRCC # ASCO14,,@ @ @,#,4.73496E+17,https://twitter.com/subatomicdoc/status/473496279457480704,,,,
subatomicdoc,6/2/2014 12:07,0,0,"@ jrgralow Unfortunately, sticker shock"" issue with cost of equipment is a barrier @ GTFRCC # ASCO14 / paraphrase""",,@ @,#,4.73496E+17,https://twitter.com/subatomicdoc/status/473496169503801345,,,,
scientre,6/2/2014 12:07,1,3,Liking @ JackWestMD method of extended # ASCO14 tweets for items that require >140 characters.,,@,#,4.73496E+17,https://twitter.com/scientre/status/473496151539589120,,,,
teamoncology,6/2/2014 12:07,7,3,"Bottom line anti-PD-1, PD-L1, & CTLA-4, they all work in melanoma regardless of the company. anti-PD-L1 may work in bladder. # ASCO14",,,#,4.73496E+17,https://twitter.com/teamoncology/status/473496140369772545,,,,
kbmsu87,6/2/2014 12:07,1,0,"Our abstract, Improved access to tobacco cessation services for cancer patients using a statewide approach"" is presented today. # ASCO14""",,,#,4.73496E+17,https://twitter.com/kbmsu87/status/473496102076182528,,,,
DrHedrick,6/2/2014 12:07,0,0,"Emphasis should be on the LACK of effect on Survival: which is a perfectly plausible result."" # ASCO14""",,,#,4.73496E+17,https://twitter.com/DrHedrick/status/473496051073445888,,,,
subatomicdoc,6/2/2014 12:07,2,1,@ jrgralow Need patient engagement. Empower patient advocates. @ GTFRCC # ASCO14 like @ breastlessAfrik @ CancerAfrica,,@ @ @ @,#,4.73496E+17,https://twitter.com/subatomicdoc/status/473496049609609216,,,,
ElizBlanchardMD,6/2/2014 12:07,2,0,Abs 7503: Dr Curran comments: very little data on neurotoxicity # asco14 # lcsm,,,# #,4.73496E+17,https://twitter.com/ElizBlanchardMD/status/473496027719548928,,,,
drseisenberg,6/2/2014 12:06,4,4,RT @ DrAttai: Size doesn't always matter! Tumor biology important (3/3) # bcsm pic.twitter.com/0Tlc31ZYsO # ASCO14,,@,# #,4.73496E+17,https://twitter.com/drseisenberg/status/473495923809861632,,,,
subatomicdoc,6/2/2014 12:06,0,0,@ jrgralow No chance at postmastectomy radiation in Uganda. Almost all palliative only on 1 machine @ GTFRCC # ASCO14 # bcsm,,@ @,# #,4.73496E+17,https://twitter.com/subatomicdoc/status/473495907707912192,,,,
DrHedrick,6/2/2014 12:06,0,0,"EORTC study supporting PCI had variable design, no required imaging, variably RT dosing. # ASCO14",,,#,4.73496E+17,https://twitter.com/DrHedrick/status/473495850766065665,,,,
winemomjill,6/2/2014 12:06,1,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.73496E+17,https://twitter.com/winemomjill/status/473495829656113153,,,,
subatomicdoc,6/2/2014 12:05,0,0,@ jrgralow Need to have a multidisciplinary team. Mentions 1 cobalt unit in Uganda. @ GTFRCC # ASCO14,,@ @,#,4.73496E+17,https://twitter.com/subatomicdoc/status/473495717978591233,,,,
myESMO,6/2/2014 12:05,0,0,Today is our last day @ # ASCO14. We'd love to see you at our booth nr 3053 if you'd like to learn more about ESMO!,,@,#,4.73496E+17,https://twitter.com/myESMO/status/473495659719692288,,,,
UASDFCS,6/2/2014 12:05,0,0,Combinación de dos nuevas moléculas logra frenar mejor cáncer de ovario http://z101digital.com/app/article.aspx?id=128106 … @ DanaFarber @ ASCO @ z101digital,,@ @ @,,4.73496E+17,https://twitter.com/UASDFCS/status/473495657882210305,,,,
n8pennell,6/2/2014 12:05,1,0,"Curran: Despite title of talk, no statistical evidence of harm for PCI in eSCLC. # ASCO14 # LCSM",,,# #,4.73496E+17,https://twitter.com/n8pennell/status/473495655743488001,,,,
genentech,6/2/2014 12:05,9,9,< 15% of patients learn abt # clinicaltrials from their MDs. How to address awareness: http://ow.ly/xwKnl # ASCO14,,,# #,4.73496E+17,https://twitter.com/genentech/status/473495622197452800,,,,
myCME,6/2/2014 12:05,0,0,Metastatic Tumor Sites Predict Overall Survival in Castration Resistant # ProstateCancer http://ow.ly/xvgyb # ASCO14 # urology,,,# # #,4.73496E+17,https://twitter.com/myCME/status/473495613951451136,,,,
subatomicdoc,6/2/2014 12:05,1,0,@ jrgralow Highlights need to train/educate local surgeons to understand benefits of radiotherapy for cancer control @ GTFRCC # ASCO14,,@ @,#,4.73496E+17,https://twitter.com/subatomicdoc/status/473495584784277504,,,,
genentech,6/2/2014 12:05,12,7,"@ lymphoma predicts in the next decade we will see personalized, targeted therapies for lymphoma patients. # next50 # ASCO14",,@,# #,4.73496E+17,https://twitter.com/genentech/status/473495582951358468,,,,
lenstarnes,6/2/2014 12:05,0,0,@ andrewspong Forgot to add @ Novartis # ASCO14,,@ @,#,4.73496E+17,https://twitter.com/lenstarnes/status/473495578673168385,,,,
DrHedrick,6/2/2014 12:05,0,0,"Important that time to Brain Met was reduced. No difference in progressive free survival, no difference in overall survival. # ASCO14",,,#,4.73496E+17,https://twitter.com/DrHedrick/status/473495574843785216,,,,
LillyPad,6/2/2014 12:05,0,1,MT @ PhRMA: # Patients must be partners in assessing value & cost says @ leukemiamda @ LillyPad @ myUHC. http://bit.ly/1tv1yxW # ASCO14,,@ @ @ @,# #,4.73496E+17,https://twitter.com/LillyPad/status/473495544527331328,,,,
knwachter,6/2/2014 12:05,0,1,That's my dad's doc! RT @ WinshipAtEmory: Winship Exec Dir and ASCO Board member @ wallyjc on the big screen at # ASCO14 pic.twitter.com/pRcDe20KVY,,@ @,#,4.73496E+17,https://twitter.com/knwachter/status/473495540786016256,,,,
NOCC_Illinois,6/2/2014 12:04,0,0,CEO David Barley and Monica Doyle discussing progress at @ ASCO pic.twitter.com/VLpJdcnjfL,,@,,4.73495E+17,https://twitter.com/NOCC_Illinois/status/473495475988234240,,,,
subatomicdoc,6/2/2014 12:04,0,0,@ jrgralow We as a cancer community have to get together to be sure we have what we need @ GTFRCC # ASCO14,,@ @,#,4.73495E+17,https://twitter.com/subatomicdoc/status/473495420011020288,,,,
GlopesMd,6/2/2014 12:04,0,0,@ daniellerodin For more information on global radiation check http://www.globalrt.org http://gtfrcc.org/ # ASCO14 @ uicc @ GTFRCC,,@ @ @,#,4.73495E+17,https://twitter.com/GlopesMd/status/473495407322861571,,,,
giomarsi,6/2/2014 12:04,0,0,# Asco2014 : les thérapies ciblées et les combinaisons de médicaments http://www.gustaveroussy.fr/index.php?p_m=igrinter&p_id=5773 …,,,#,4.73495E+17,https://twitter.com/giomarsi/status/473495348640763904,,,,
PinkSheetMaryJo,6/2/2014 12:04,1,0,"Hudis: dependent on industry for innovation - know how real world works, just ask for relationship btwn cost and what patients get # ASCO14",,,#,4.73495E+17,https://twitter.com/PinkSheetMaryJo/status/473495334081933312,,,,
subatomicdoc,6/2/2014 12:04,0,0,@ jrgralow Thinks @ WHO's turning more attention to non-communicable diseases has been helpful for cancer control issue @ GTFRCC # ASCO14,,@ @ @,#,4.73495E+17,https://twitter.com/subatomicdoc/status/473495307255566336,,,,
knwachter,6/2/2014 12:04,0,0,Definitely agree from personal exp RT @ ASCO: Collecting family history is still key in the # genomic era http://bit.ly/1klFRL6 # ASCO14,,@,# #,4.73495E+17,https://twitter.com/knwachter/status/473495278956601344,,,,
ElizBlanchardMD,6/2/2014 12:04,0,0,Abs 7502: Dr Curran comments: also--very little presented on toxicity and QOL # ASCO14 # lcsm # supponc,,,# # #,4.73495E+17,https://twitter.com/ElizBlanchardMD/status/473495267866853376,,,,
DrHedrick,6/2/2014 12:04,1,0,"Conclusion that Thoracic RT prolongs OS"" not supported by data as 18/24 month timepoints not part of original study. # ASCO14""",,,#,4.73495E+17,https://twitter.com/DrHedrick/status/473495265924890624,,,,
n8pennell,6/2/2014 12:04,0,0,"Dr. Curran on CREST trial: thoracic RT for eSCLC debulking"" chemo res dz. Reinforces prim endpoint negative so not yet SOC. # ASCO14 # LCSM""",,,# #,4.73495E+17,https://twitter.com/n8pennell/status/473495253455241216,,,,
MyelomaTeacher,6/2/2014 12:03,0,2,"No blister walk"""," but still getting # ASCO14 # mmsm news via fellow tweeters @ mtmdphd @ maverickny # SoMed at its best!pic.twitter.com/i6ZDhLrCTf""",,@ @,# # #,4.73495E+17,https://twitter.com/MyelomaTeacher/status/473495193040089088,,,
GustaveRoussy,6/2/2014 12:03,4,0,# ASCO14 PrEggermont: 3 clinical trials on innovative therapies for # melanoma # immunotherapy http://bit.ly/1m5MRgG pic.twitter.com/sUfCXS46PC,,,# # #,4.73495E+17,https://twitter.com/GustaveRoussy/status/473495182303064064,,,,
SyneosHealth,6/2/2014 12:03,0,0,"Meet with our # oncology leaders at # ASCO14 booth 1115, including Nicholas Kenny, Susan Akers-Smith & Davide Fuller http://ow.ly/i/5LBpL",,,# #,4.73495E+17,https://twitter.com/SyneosHealth/status/473495152297017344,,,,
ElizBlanchardMD,6/2/2014 12:03,2,0,Abs 7502: Dr Curran comments: OS benefit seen at time pts 18 and 24 m not preplanned-he feels that XRT can improve DFS not OS # asco14 # lcsm,,,# #,4.73495E+17,https://twitter.com/ElizBlanchardMD/status/473495147645120514,,,,
teamoncology,6/2/2014 12:03,2,0,【 # ASCO14 Update】 Combination immunotherapy may work in metastatic melanoma. http://abstracts.asco.org/144/AbstView_144_126008.html …,,,#,4.73495E+17,https://twitter.com/teamoncology/status/473495081303822337,,,,
subatomicdoc,6/2/2014 12:03,0,0,"Question to the panel: How do we get the necessary resources?"" @ marykge @ GTFRCC # ASCO14""",,@ @,#,4.73495E+17,https://twitter.com/subatomicdoc/status/473495065378439168,,,,
lenstarnes,6/2/2014 12:03,0,1,@ andrewspong Indeed!Interesting 2 see which pharmas R participating: @ Pfizer @ Boehringer @GSK_conferences @ Roche @bayerhealthcare # ASCO14,,@ @ @ @GSK_conferences @ @bayerhealthcare,#,4.73495E+17,https://twitter.com/lenstarnes/status/473495036811042816,,,,
DrHedrick,6/2/2014 12:03,0,0,Purpose of consolidative Thoracic RT is to debulk chemo resistant dz. Has a good mechanistic rationale. # ASCO14,,,#,4.73495E+17,https://twitter.com/DrHedrick/status/473495024895033344,,,,
PSUCHICA,6/2/2014 12:03,0,0,What is the DIA Annual Mtg Everyone Buzzes Abt in # lifesciences? Stop by booth #8042 to hear more # dia2014 at # asco14,,,# #8042 # #,4.73495E+17,https://twitter.com/PSUCHICA/status/473495023905173505,,,,
pfizer,6/2/2014 12:03,30,13,Infographic: 50 years of cancer research and counting # asco14 pic.twitter.com/e8ppwyjBkf,,,#,4.73495E+17,https://twitter.com/pfizer/status/473495012127559681,,,,
Instinctif_HLS,6/2/2014 12:02,2,0,Nanobiotix Presents Successful Phase I Results for its Lead # nanomedicine Product NBTXR3 at # ASCO14 : http://tiny.cc/y33tgx,,,# #,4.73495E+17,https://twitter.com/Instinctif_HLS/status/473494969542803456,,,,
dmooneymd,6/2/2014 12:02,0,0,"Duran: why would seq chemo then rt work for ext stage? Non curative setting where you are debulking"" chemo resistant disease. # lcsm # ASCO14""",,,# #,4.73495E+17,https://twitter.com/dmooneymd/status/473494944485609472,,,,
GenentechJobs,6/2/2014 12:02,0,1,"# ASCO14 Talent Hunt: Sr. Medical Director, Zelboraf #00429263 http://click2apply.net/0429263f",,,# #00429263,4.73495E+17,https://twitter.com/GenentechJobs/status/473494939548925952,,,,
practiceupdate,6/2/2014 12:02,1,0,Heading out from # ASCO14? Be sure to visit PracticeUpdate's booth 21113 and learn how to enhance your clinical practice! @ ASCO,,@,#,4.73495E+17,https://twitter.com/practiceupdate/status/473494916321247232,,,,
subatomicdoc,6/2/2014 12:02,0,0,Next up @ jrgralow Edward Trimble and Allen Lichter CEO of @ ASCO @ GTFRCC # ASCO14,,@ @ @,#,4.73495E+17,https://twitter.com/subatomicdoc/status/473494914882629632,,,,
evaluatepharma,6/2/2014 12:02,0,1,# ASCO14 – Altto gives @ GSK and @ Novartis nothing to sing about http://ow.ly/xwGVk $ GSK $ NVS,,@ @,#,4.73495E+17,https://twitter.com/evaluatepharma/status/473494849271128065,,,,
Novartis,6/2/2014 12:02,1,2,# DYK about 50% of patients with a certain type of NSCLC have a genetic mutation driving their # cancer? http://bit.ly/1jKwFFX # ASCO14,,,# # #,4.73495E+17,https://twitter.com/Novartis/status/473494776118247424,,,,
CancerDotNet,6/2/2014 12:02,0,0,Video: Study on ipi after surg for reducing recurr of highrisk # melanoma w/ ASCO Pres Dr. Cliff Hudis # ASCO14 http://bit.ly/1jMbnlC,,,# #,4.73495E+17,https://twitter.com/CancerDotNet/status/473494769646444546,,,,
DrHedrick,6/2/2014 12:01,0,0,"No QOL data presented, no sx reporting, no CNS specific QA reported. (How are we still not doing this?) # ASCO14",,,#,4.73495E+17,https://twitter.com/DrHedrick/status/473494704450199552,,,,
SequentaInc,6/2/2014 12:01,0,0,Last day to visit us at # ASCO14 (booth 18152); come talk to the team abt the ClonoSIGHT test for # MRD http://ow.ly/xvB9c,,,# #,4.73495E+17,https://twitter.com/SequentaInc/status/473494681964531712,,,,
subatomicdoc,6/2/2014 12:01,0,0,"@ gorskon Apple wins that one. Still, on site attendance will be excellent based upon the two other # socmed sessions so far # ASCO14",,@,# #,4.73495E+17,https://twitter.com/subatomicdoc/status/473494678495838208,,,,
ASCO,6/2/2014 12:01,12,6,Collecting family history is still key in the # genomic era http://bit.ly/1klFRL6 # ASCO14,,,# #,4.73495E+17,https://twitter.com/ASCO/status/473494670887358464,,,,
UNCurology,6/2/2014 12:01,0,1,"MT @ m_e_nielsen: @ MattMilowsky &Billy Kim @ UNC_Lineberger 1:15-2:30 # asco14 session: From Genetics to Geriatric Medicine in Bladder Cancer""""",,@ @ @,#,4.73495E+17,https://twitter.com/UNCurology/status/473494658845540352,,,,
EIannelli,6/2/2014 12:00,1,1,what would a world free from the fear of cancer would like? # ASCO14 @ cancereu @ kgapo @ ASCOPostpic.twitter.com/aL7Gp89I2O,,@ @ @,#,4.73494E+17,https://twitter.com/EIannelli/status/473494493748932608,,,,
Amgen,6/2/2014 12:00,0,1,# Amgen announces new survival data from metastatic # melanoma trial at # ASCO14 http://bit.ly/1oN9ay9,,,# # #,4.73494E+17,https://twitter.com/Amgen/status/473494443639996417,,,,
ONAcom,6/2/2014 12:00,0,0,# ASCO14: Expanding # NCI Community Cancer Centers Program in a rural community can up clinical trial enrollment - http://ow.ly/xweHq,,,# #,4.73494E+17,https://twitter.com/ONAcom/status/473494437755355136,,,,
DebiopharmNews,6/2/2014 12:00,0,0,# ASCO14 Convert your molecule into a successful drug http://ow.ly/xwqdc,,,#,4.73494E+17,https://twitter.com/DebiopharmNews/status/473494434857115649,,,,
EncoreBioMed,6/2/2014 12:00,1,0,Success with adoptive T cell therapy in # cervicalcancer # ASCO14 http://reut.rs/U6ZuSC,,,# #,4.73494E+17,https://twitter.com/EncoreBioMed/status/473494422056108035,,,,
zorgnieu_ws,6/2/2014 12:00,0,0,# ASCO14: Biologicals en chemotherapie geven gelijke resultaten in overleving bij patient met uitgezaaide… http://wp.me/p2ZL1H-6rY,,,#,4.73494E+17,https://twitter.com/zorgnieu_ws/status/473494338131853312,,,,
FoundationATCG,6/2/2014 12:00,5,4,"# AYACSM is radically unique on a social, emotional, biologic and # genomic level http://bit.ly/1vsF6t5 http://on.wsj.com/1j2hAcE # ASCO14",,,# # #,4.73494E+17,https://twitter.com/FoundationATCG/status/473494330762887168,,,,
Xcenda,6/2/2014 12:00,0,0,View the new # Xcenda Challenging Cases video and schedule. Register to participate: http://bit.ly/1iv8GoQ # ASCO14,,,# #,4.73494E+17,https://twitter.com/Xcenda/status/473494302685814785,,,,
medpagetoday,6/2/2014 12:00,1,1,"For premenopausal women, Aromasin cut breast cancer recurrence compared when given atop ovarian suppression # ASCO14 http://bit.ly/1u8TMfc",,,#,4.73494E+17,https://twitter.com/medpagetoday/status/473494295366758401,,,,
Senesco,6/2/2014 12:00,0,0,"Senesco to present poster at # ASCO14 June 2nd, 1:15PM CT during session Lymphoma and Plasma Cell Disorders"" http://bit.ly/1u8Toxi $ SNTI""",,,#,4.73494E+17,https://twitter.com/Senesco/status/473494291675746304,,,,
CatseqBiotech,6/2/2014 12:00,0,0,RT @ AdaptiveBiotech # ASCO14 an optimistic but more balanced view of # immunotherapy emerges this year http://nyti.ms/1nXvwLa,,@,# #,4.73494E+17,https://twitter.com/CatseqBiotech/status/473494254543593474,,,,
subatomicdoc,6/2/2014 12:00,2,0,We have to include everybody in international community to realize importance of cancer control @ GTFRCC # ASCO14 / paraphrase,,@,#,4.73494E+17,https://twitter.com/subatomicdoc/status/473494253050400768,,,,
WinshipAtEmory,6/2/2014 11:59,1,0,Winship Exec Dir and ASCO Board member @ wallyjc on the big screen at # ASCO14 pic.twitter.com/kSTXdUYIjH,,@,#,4.73494E+17,https://twitter.com/WinshipAtEmory/status/473494124822151168,,,,
subatomicdoc,6/2/2014 11:59,3,0,Radiotherapy is one of the most important treatments in cancer care. But not easily available in Peru @ GTFRCC # ASCO14 # access,,@,# #,4.73494E+17,https://twitter.com/subatomicdoc/status/473494089799712768,,,,
PinkSheetMaryJo,6/2/2014 11:59,1,0,"Value model needs to be adaptable for early stage disease, where greatest potential for benefit - Schnipper # ASCO14",,,#,4.73494E+17,https://twitter.com/PinkSheetMaryJo/status/473494068815601664,,,,
DrMiguelPerales,6/2/2014 11:59,2,1,Novartis bone marrow drug LBH589 improves progression-free survival in # meyloma http://reut.rs/1kpNkh6 via @ reuters # ASCO14 # mmsm,,@,# # #,4.73494E+17,https://twitter.com/DrMiguelPerales/status/473494060502487041,,,,
scientre,6/2/2014 11:59,0,1,MT @ davidmcnierney: @ scientre PROs hottest topic last Friday @ theIOM mtg on bridging healthcare & research data. Focus on outcomes # ASCO14,,@ @ @,#,4.73494E+17,https://twitter.com/scientre/status/473494054249201664,,,,
TuftsB,6/2/2014 11:59,0,0,Experts & admins far removed from actual patients & out of touch. Do not lecture patients & call us toxic cost centers. # mliwi # asco14,,,# #,4.73494E+17,https://twitter.com/TuftsB/status/473494007323316224,,,,
CathyEngMD,6/2/2014 11:59,4,1,"Disagree w/Meropol: ANY rare RAS MT should now result in deferral of antiEGFR rx in mCRC. # crcsm, # endcancer, # ASCO2014. The data is there!",,,# # #,4.73494E+17,https://twitter.com/CathyEngMD/status/473493997717946368,,,,
gorskon,6/2/2014 11:58,0,0,Dang. The social media session at # ASCO14 will overlap with this. http://www.wxyz.com/news/science-tech/apple-worldwide-developers-conference-keynote-expected-to-unveil-ios-8-and-next-gen-mac-os …,,,#,4.73494E+17,https://twitter.com/gorskon/status/473493979883765761,,,,
PDRennert,6/2/2014 11:58,0,3,"Celebrating many oncology successes # ASCO14 reminds me of progress in autoimmunity- MS, RA, IBD But not yet # lupus http://simpletasks.org/lupus-look-like/ …",,,# #,4.73494E+17,https://twitter.com/PDRennert/status/473493840209252352,,,,
subatomicdoc,6/2/2014 11:58,6,3,"When a woman gets cancer, it's not a person but a family. Because the woman support family and society @ GTFRCC # ASCO14 # gyncsm # bcsm",,@,# # #,4.73494E+17,https://twitter.com/subatomicdoc/status/473493753244577792,,,,
PinkSheetMaryJo,6/2/2014 11:57,2,2,"PFS too unreliable a surrogate overall to include in ASCO value calculations, Schnipper says # ASCO14",,,#,4.73494E+17,https://twitter.com/PinkSheetMaryJo/status/473493675033362432,,,,
JackWestMD,6/2/2014 11:57,3,2,Dr. Seto on prophylactic cranial irradiat'n for ext st SCLC after 1st line chemo # ASCO14 # lcsmpic.twitter.com/dUIIGTn4OT,,,# #,4.73494E+17,https://twitter.com/JackWestMD/status/473493633292046336,,,,
DrHedrick,6/2/2014 11:57,0,0,Dr. William Duran Discussing: What is role of consolidative RT? # ASCO14,,,#,4.73494E+17,https://twitter.com/DrHedrick/status/473493585380519936,,,,
dmooneymd,6/2/2014 11:57,0,0,"A7503: pts receiving prophylactic pci had less lines of chemo on progression, may explain suggestion of poorer survival. # lcsm # ASCO14",,,# #,4.73494E+17,https://twitter.com/dmooneymd/status/473493573887729666,,,,
DCarrizosaMD,6/2/2014 11:57,0,1,"# ASCO14 - in Japan, PCI does not improve PFS or OS in ES-Small Cell # LCI",,,# #,4.73494E+17,https://twitter.com/DCarrizosaMD/status/473493518477185025,,,,
djsampson,6/2/2014 11:57,0,1,MT @ DrLen: With all the new treatments at # ASCO14 an old drug shows real benefit for advanced prostate cancer http://tinyurl.com/n9jdzjd,,@,#,4.73494E+17,https://twitter.com/djsampson/status/473493510965170176,,,,
BIOARRAYMDx,6/2/2014 11:56,0,0,Focus on precision medicine. Predictive diagnostic tests are becoming integral part of the standard of care @ ASCO @BloombergNews,,@ @BloombergNews,,4.73493E+17,https://twitter.com/BIOARRAYMDx/status/473493489041563648,,,,
DrHedrick,6/2/2014 11:56,2,0,PCI did not show benefit with CONFIRMED lack of brain mets post initial therapy. This seems very relevant. # ASCO14,,,#,4.73493E+17,https://twitter.com/DrHedrick/status/473493486961180672,,,,
subatomicdoc,6/2/2014 11:56,0,0,"@ daniellerodin The story of Veronica is example of why we need universal, global access to radiotherapy @ UICC @ GTFRCC # ASCO14",,@ @ @,#,4.73493E+17,https://twitter.com/subatomicdoc/status/473493390101721088,,,,
n8pennell,6/2/2014 11:56,2,0,"PCI significantly reduced brain mets in eSCLC, PFS not stat different. HR for OS 1.38, median 10m with PCI & 15m w/o not sig. # ASCO14 # LCSM",,,# #,4.73493E+17,https://twitter.com/n8pennell/status/473493343172055040,,,,
davidmcnierney,6/2/2014 11:56,1,1,. @ scientre PROs were the hottest topic at last Friday's @ theIOM meeting on bridging healthcare & research data. Focus on # outcomes. # ASCO14,,@ @,# #,4.73493E+17,https://twitter.com/davidmcnierney/status/473493286410153984,,,,
DrHedrick,6/2/2014 11:55,0,0,Surprisingly OS was not better in PCI arm. Possibly worse. HR for death 1.38 (NS). Curve for control arm continuously on top of PCI. # ASCO14,,,#,4.73493E+17,https://twitter.com/DrHedrick/status/473493193162780673,,,,
leryslaura,6/2/2014 11:55,0,0,“ @ genentech: 100 ppl w/ cancer will give 100 different definitions of 'quality.' redefining QoC: http://ow.ly/xwMcw # ASCO14”food4thought,,@,#,4.73493E+17,https://twitter.com/leryslaura/status/473493117794934784,,,,
subatomicdoc,6/2/2014 11:55,1,2,"@ cancerrt has powerful story videoed to share, highlight the need @ GTFRCC # ASCO14",,@ @,#,4.73493E+17,https://twitter.com/subatomicdoc/status/473493110954012672,,,,
genentech,6/2/2014 11:55,4,4,It takes courage to join a clinical trial - we owe it to pts to learn as much as we can from METLung http://ow.ly/xwptX # ASCO14,,,#,4.73493E+17,https://twitter.com/genentech/status/473493103614377985,,,,
OncLive,6/2/2014 11:55,1,1,ABT-199 plus rituximab demonstrated impressive activity with manageable toxicity for patients with CLL http://ow.ly/xvatI # ASCO14,,,#,4.73493E+17,https://twitter.com/OncLive/status/473493047070953473,,,,
myCME,6/2/2014 11:55,0,0,"Ginger extract improves chemotherapy-induced nausea, vomiting http://ow.ly/xvgnS # ASCO14 # oncology",,,# #,4.73493E+17,https://twitter.com/myCME/status/473493028192399361,,,,
EuNGSeqConf,6/2/2014 11:55,0,0,"“In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,,# #,4.73493E+17,https://twitter.com/EuNGSeqConf/status/473493025537425408,,,,
LSVCo,6/2/2014 11:55,0,0,"“In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,,# #,4.73493E+17,https://twitter.com/LSVCo/status/473493024023269377,,,,
ECMC_UK,6/2/2014 11:55,0,0,Great discussion on preclinical models during the early session at # ASCO14. It's critical to understand their disease relevance.,,,#,4.73493E+17,https://twitter.com/ECMC_UK/status/473492990518755329,,,,
subatomicdoc,6/2/2014 11:54,2,1,@ CancerRT Will provide a lot of information from young leaders. Website has >100 join before launch already @ GTFRCC # ASCO14,,@ @,#,4.73493E+17,https://twitter.com/subatomicdoc/status/473492952031850496,,,,
EIannelli,6/2/2014 11:54,2,2,# ASCO14 patient advocacy pavillion at asco congress @ InsControCancro @ favo_itpic.twitter.com/gXsWJM1f8e,,@ @,#,4.73493E+17,https://twitter.com/EIannelli/status/473492944209469440,,,,
Rndubois,6/2/2014 11:54,2,1,ASCO 2014 Annual Meeting Live Blog Day 4 # ASCO14 http://biotechstrategyblog.com/2014/06/asco-2014-annual-meeting-live-blog-day-4-asco14.html/ …,,,#,4.73493E+17,https://twitter.com/Rndubois/status/473492935686639617,,,,
DrMiguelPerales,6/2/2014 11:54,0,2,Cancer Researchers Report Longer Survival Rates With # Immunotherapy http://nyti.ms/1nXvwLa # ASCO14,,,# #,4.73493E+17,https://twitter.com/DrMiguelPerales/status/473492899154239488,,,,
rsm2800,6/2/2014 11:54,0,0,Toppmeyer: Need to await results of SOFT to determine if tam/OA better than tam alone # ASCO14,,,#,4.73493E+17,https://twitter.com/rsm2800/status/473492886902673408,,,,
DrLen,6/2/2014 11:54,0,1,With all the new treatments at # ASCO14 an old drug shows real benefit for men with advanced prostate cancer http://tinyurl.com/n9jdzjd,,,#,4.73493E+17,https://twitter.com/DrLen/status/473492847526961152,,,,
DoctorEdny,6/2/2014 11:54,1,0,$ ESALY Colevas w/lenvatinib mPFS is impressive; is lack of advantage do to x-over? Better than sorafenib # ASCO14 pic.twitter.com/MIGxDlzpZH,,,#,4.73493E+17,https://twitter.com/DoctorEdny/status/473492775233933313,,,,
scientre,6/2/2014 11:54,6,1,So much data MT @ DrAttai So sad - the abandoned posters bin # asco14 pic.twitter.com/2kDAeQP9tp,,@,#,4.73493E+17,https://twitter.com/scientre/status/473492774772551680,,,,
subatomicdoc,6/2/2014 11:54,0,1,@ daniellerodin @ GTFRCC has developed a platform launching this week: @ CancerRT # radonc # ASCO14,,@ @ @,# #,4.73493E+17,https://twitter.com/subatomicdoc/status/473492753540595712,,,,
rsm2800,6/2/2014 11:53,1,0,Toppmeyer: Compare QOL in BRCA pts undergoing ooph. Domchek data at # asco14 showed lots of toxicity w/ ooph,,,#,4.73493E+17,https://twitter.com/rsm2800/status/473492717981270016,,,,
DrHedrick,6/2/2014 11:53,0,0,Time to brain mets reduced in PCI. 80% patients in control arm received RT. 30% of patients in treatment arm received additional RT. # ASCO14,,,#,4.73493E+17,https://twitter.com/DrHedrick/status/473492713745416192,,,,
MightyCasey,6/2/2014 11:53,0,0,RT @ OpenCancer: Hope next year # asco14 and # hdpalooza will not overlap :),,@,# #,4.73493E+17,https://twitter.com/MightyCasey/status/473492681872932864,,,,
HenryJOncology,6/2/2014 11:53,0,1,Dr Patel delivers great talk summarizing # sarcoma progress. A great mentor and # hcldr. Great work! # ASCO14,,,# # #,4.73493E+17,https://twitter.com/HenryJOncology/status/473492579200163840,,,,
MartinStockler,6/2/2014 11:53,1,0,EORTC RCT of adj chemo in MI bladder ca supports proposed @ ANZUPtrials OPTIMUM RCT @ AnneLong888 @ shomik_s # ASCO14 http://tinyurl.com/oqa64dv,,@ @ @,#,4.73493E+17,https://twitter.com/MartinStockler/status/473492529489666049,,,,
DrHedrick,6/2/2014 11:52,0,0,Final analysis had 84 in PCI arm and 79 in No-PCI arm. Treatments were identical in all patients getting PCI. # ASCO14,,,#,4.73492E+17,https://twitter.com/DrHedrick/status/473492405891891200,,,,
subatomicdoc,6/2/2014 11:52,0,0,@ GTFRCC recognized that engaging young leaders is essential to success # ASCO14 # radonc,,@,# #,4.73492E+17,https://twitter.com/subatomicdoc/status/473492354926534657,,,,
rsm2800,6/2/2014 11:52,3,1,"Toppmeyer: SOFT/TEXT at # asco14 showed 4% improvement in DFS for AI c/w tam, no diff OS; definite toxicity w/ premature menopause # asco14",,,# #,4.73492E+17,https://twitter.com/rsm2800/status/473492290871107585,,,,
OpenCancer,6/2/2014 11:51,1,0,Hope next year # asco14 and # hdpalooza will not overlap :),,,# #,4.73492E+17,https://twitter.com/OpenCancer/status/473492226069504000,,,,
CliffordHudis,6/2/2014 11:51,7,4,Value is far more than cost. MT “ @ TuftsB: @ CliffordHudis @ ASCO - misguided focus on cost ignores medical & personal value. # mliwi # asco14”,,@ @ @,# #,4.73492E+17,https://twitter.com/CliffordHudis/status/473492224185880576,,,,
DrHedrick,6/2/2014 11:51,0,0,Interim analysis once 50% enrollment achieved. 37% of patients enrolled had died. IDMC halted trial due to futility. # ASCO14,,,#,4.73492E+17,https://twitter.com/DrHedrick/status/473492078199320577,,,,
Lymphoma_Doc,6/2/2014 11:51,2,0,"Most common phrase overheard @ # ASCO14 is we need combinations"". Busting Robustness editorial on why combos are key http://bit.ly/1l7EUtj""",,@,#,4.73492E+17,https://twitter.com/Lymphoma_Doc/status/473492074302418945,,,,
TuftsB,6/2/2014 11:51,0,0,@ ASCO - in UK i would have been denied the pill based regimen that saved my life. I am a patient not a data point or $ sign # mliwi # ASCO14,,@,# #,4.73492E+17,https://twitter.com/TuftsB/status/473492040924139521,,,,
subatomicdoc,6/2/2014 11:51,0,1,Next up: @ daniellerodin regarding @ CancerRT from @ UofTDRO @ GTFRCC # ASCO14,,@ @ @ @,#,4.73492E+17,https://twitter.com/subatomicdoc/status/473492039456157698,,,,
OncEd,6/2/2014 11:51,0,0,Sargent : stage 2 patients with dMMR do not need adjutant tx # crcsm # ASCO14,,,# #,4.73492E+17,https://twitter.com/OncEd/status/473492000466305025,,,,
subatomicdoc,6/2/2014 11:50,0,0,Key sounds like engaging African governments ? via @ UICC @ GTFRCC # ASCO14 to effect change,,@ @,#,4.73492E+17,https://twitter.com/subatomicdoc/status/473491891200065536,,,,
rsm2800,6/2/2014 11:50,0,1,Toppmeyer: Compare SOFT/TEXT at # asco14 w/ ABCSG12 (smaller trial than SOFT but no diff btwn AI & tam and maybe disadvantage to AI),,,#,4.73492E+17,https://twitter.com/rsm2800/status/473491884900233217,,,,
genentech,6/2/2014 11:50,3,4,100 ppl w/ cancer will give 100 different definitions of 'quality.' We need to redefine QoC: http://ow.ly/xwMcw # ASCO14,,,#,4.73492E+17,https://twitter.com/genentech/status/473491804055433216,,,,
DebiopharmNews,6/2/2014 11:50,1,0,# ASCO14 Successful in- and out-licensing for breakthrough drugs benefiting the # patient http://ow.ly/xwq66,,,# #,4.73492E+17,https://twitter.com/DebiopharmNews/status/473491784384151552,,,,
OncEd,6/2/2014 11:50,0,0,"Sargent : for stage 2 patients with dMMR 5 yr OS 90%, no benefit / detriment in OS for 5FU treated patients # crcsm # ASCO14",,,# #,4.73492E+17,https://twitter.com/OncEd/status/473491758580760576,,,,
Transplant_Doc,6/2/2014 11:50,3,0,SAR (anti-CD38 antibody) + LEN/Dex in relpased/refractory myeloma; median 6 prior lines of Rx: overall RR 58%. No DLT # ASCO14 # mmsm,,,# #,4.73492E+17,https://twitter.com/Transplant_Doc/status/473491754214109186,,,,
UASDFCS,6/2/2014 11:50,0,0,"Estudios en cáncer de mama, próstata y colorrectal afinan la práctica clínica http://z101digital.com/app/article.aspx?id=128136 … @ ASCO @ z101digital",,@ @,,4.73492E+17,https://twitter.com/UASDFCS/status/473491741006659585,,,,
drsteventucker,6/2/2014 11:49,3,2,Aerobics for the brain? Fitness experts praise mindfulness meditation # asco14 # health http://www.reuters.com/article/idUSKBN0ED1DZ20140602 …,,,# #,4.73492E+17,https://twitter.com/drsteventucker/status/473491698278858752,,,,
OncEd,6/2/2014 11:49,0,0,Sargent ACCENT database: dMMR data available on 7803 pts in 17 adjuvant trials # crcsm # ASCO14,,,# #,4.73492E+17,https://twitter.com/OncEd/status/473491671507025920,,,,
DrHedrick,6/2/2014 11:49,0,0,"Current trial mandated brain MRI for patients, to remove asymptomatic brain mets. All patients had NO mets by MRI # ASCO14",,,#,4.73492E+17,https://twitter.com/DrHedrick/status/473491665282674688,,,,
AdaptiveBiotech,6/2/2014 11:49,0,0,# ASCO14 . @ MSKCC_BreastCA using immunoSEQ to study TILs in breast cancer after ipilimumab # immunotherapy http://bit.ly/U1BiAX booth 2097,,@,# #,4.73492E+17,https://twitter.com/AdaptiveBiotech/status/473491623197048832,,,,
OncEd,6/2/2014 11:49,0,1,Sargent ACCENT database Impact of deficient mismatch repair (dMMR) in Stage 2/3 colon cancer # crcsm # ASCO14,,,# #,4.73492E+17,https://twitter.com/OncEd/status/473491552166113280,,,,
ConsanoScott,6/2/2014 11:49,0,1,Best part of # asco14. Posters! Innovative ideas. Endless enthusiasm. pic.twitter.com/jw4zqzo7Id,,,#,4.73492E+17,https://twitter.com/ConsanoScott/status/473491523447713793,,,,
DCarrizosaMD,6/2/2014 11:48,1,0,# ASCO14 - 2 yr OS in ES-Small cell after post chemo intrathoracic radiation (+PCI) improved to 13% from 3% (p0.004) - interesting # LCI,,,# #,4.73491E+17,https://twitter.com/DCarrizosaMD/status/473491431248920576,,,,
rsm2800,6/2/2014 11:48,0,1,Toppmeyer: ABCSG8: Benefit of adding ov suppression seen in women <40; note 2011 ASCO/Ontario guideline sez don’t add OA “routinely” # ASCO14,,,#,4.73491E+17,https://twitter.com/rsm2800/status/473491409090015233,,,,
ElizBlanchardMD,6/2/2014 11:48,1,0,Abs 7503: phase III trial in Japan shows that PCI has a detrimental effect in ext stage small cell # ASCO14 # lcsm,,,# #,4.73491E+17,https://twitter.com/ElizBlanchardMD/status/473491391021334528,,,,
LungCancerFaces,6/2/2014 11:48,2,2,Follow these Docs live tweeting from # ASCO14: @ dhjutsw1 @ dmooneymd @ JackWestMD @ ElizBlanchardMD @ n8pennell # LungCancer # LCSM,,@ @ @ @ @,# # #,4.73491E+17,https://twitter.com/LungCancerFaces/status/473491315720601600,,,,
scientre,6/2/2014 11:48,1,1,If u can't be in S504 at 1:15 MT @ mtmdphd Social Media in Clinical Trials @ mtmdphd # ASCO14 Educational Book http://ow.ly/xlEE8,,@ @,#,4.73491E+17,https://twitter.com/scientre/status/473491290337071104,,,,
NatRevClinOncol,6/2/2014 11:48,1,1,Chemotherapy makes a difference combined with bevacizumab or cetuximab in KRAS WT metstatic # colorectalcancer # ASCO14 http://am.asco.org/bevacizumab-or-cetuximab-two-chemotherapy-regimens-offer-similar-extended-survival-metastatic …,,,# #,4.73491E+17,https://twitter.com/NatRevClinOncol/status/473491256912261120,,,,
OncEd,6/2/2014 11:48,0,0,Sargent : data for oxali/irinotecan based regimens maturing # crcsm # ASCO14,,,# #,4.73491E+17,https://twitter.com/OncEd/status/473491234213097472,,,,
MediTech_Media,6/2/2014 11:47,0,0,"Continuous tx in multiple # myeloma extends PFS1, PFS2, and overall survival vs fixed duration tx. # ASCO14",,,# #,4.73491E+17,https://twitter.com/MediTech_Media/status/473491195717771264,,,,
OncEd,6/2/2014 11:47,0,0,Sargent dMMR does not impact on post recurrence survival # crcsm # ASCO14 # crcsm # ASCO14,,,# # # #,4.73491E+17,https://twitter.com/OncEd/status/473491113815576576,,,,
GlopesMd,6/2/2014 11:47,4,1,# ASCO14 - The global task force on radiotherapy for cancer control aims to address difficulties faced by low and middle income countries,,,#,4.73491E+17,https://twitter.com/GlopesMd/status/473491097973293056,,,,
CancerSupportHQ,6/2/2014 11:47,8,7,@ ASCO @ CliffordHudis Thanks for hearing our comment - look forward to working w/ you on this important issue! # ASCO14 pic.twitter.com/LQYdmrN8r0,,@ @,#,4.73491E+17,https://twitter.com/CancerSupportHQ/status/473491077396058112,,,,
DrHedrick,6/2/2014 11:47,0,0,Japanese trial of possible worsening of OS with prophylactic cranial irradiation in ES-SCLC. Intriguing. # ASCO14,,,#,4.73491E+17,https://twitter.com/DrHedrick/status/473491041887465474,,,,
OncEd,6/2/2014 11:47,0,0,Sargent : stage 2 patients with dMMR do not need adjutant tx # crcsm # ASCO14 # crcsm # ASCO14,,,# # # #,4.73491E+17,https://twitter.com/OncEd/status/473491028474089474,,,,
IUPCCM,6/2/2014 11:46,1,2,. @ DrHedrick is killing the live-tweeting of the # ASCO14 conference this week.,,@,#,4.73491E+17,https://twitter.com/IUPCCM/status/473490970869506049,,,,
gbosslet,6/2/2014 11:46,1,1,. @ DrHedrick is killing the live-tweeting of the # ASCO14 conference this week. @ IUPCCM,,@ @,#,4.73491E+17,https://twitter.com/gbosslet/status/473490964036993026,,,,
PinkSheetMaryJo,6/2/2014 11:46,0,0,"Schnipper points out outside US, assessments focus on clinical aspects first, then apply conclusions to pricing negotiations # ASCO14",,,#,4.73491E+17,https://twitter.com/PinkSheetMaryJo/status/473490960421515264,,,,
OncEd,6/2/2014 11:46,0,0,"Sargent : for stage 2 patients with dMMR 5 yr OS 90%, no benefit / detriment in OS for 5FU treated patients # crcsm # ASCO14 # crcsm # ASCO14",,,# # # #,4.73491E+17,https://twitter.com/OncEd/status/473490923935244288,,,,
RielyMD,6/2/2014 11:46,3,0,Slotman: radiation for extensive stage small cell lung cancer improves progression free and overall survival # ASCO14,,,#,4.73491E+17,https://twitter.com/RielyMD/status/473490896806486016,,,,
n8pennell,6/2/2014 11:46,0,0,Dr. Seto presenting Japanese randomized trial of PCI in eSCLC. # ASCO14 # LCSM,,,# #,4.73491E+17,https://twitter.com/n8pennell/status/473490886543048704,,,,
TuftsB,6/2/2014 11:46,0,0,@ CliffordHudis @ ASCO -I trust a doctor with my life when they wear a white coat but not when they wear a green eye shade # mliwi # ASCO14,,@ @,# #,4.73491E+17,https://twitter.com/TuftsB/status/473490856293703680,,,,
alantanmd,6/2/2014 11:46,1,1,Thoracic RT in extensive stage small cell lung cancer improves OS and PFS # ASCO14 pic.twitter.com/50TEflMk8o,,,#,4.73491E+17,https://twitter.com/alantanmd/status/473490840120459264,,,,
JackWestMD,6/2/2014 11:46,0,1,Slotman on consolidation chest RT after response to first line chemo for extensive stage SCLC # ASCO14 # lcsmpic.twitter.com/PxeczMGDL1,,,# #,4.73491E+17,https://twitter.com/JackWestMD/status/473490799309504512,,,,
theMMRF,6/2/2014 11:46,1,1,# ASCO14 # Panobinostat+Velcade-dex increases time without progression in relapsed/refractory # myeloma. http://www.themmrf.org/asco - # MMRFASCO,,,# # # #,4.73491E+17,https://twitter.com/theMMRF/status/473490779202404352,,,,
LaurenWallner,6/2/2014 11:46,0,0,Early chemo extends survival ~14 months in some men w/ metastatic prostate cancer # ASCO14 http://mobile.nytimes.com/2014/06/02/health/early-chemotherapy-extends-lives-of-men-with-prostate-cancer-study-finds.html?emc=eta1&_r=0&referrer= …,,,#,4.73491E+17,https://twitter.com/LaurenWallner/status/473490762131595264,,,,
rsm2800,6/2/2014 11:46,0,0,Toppmeyer: INT0101 ER+N+ randomized to CAF vs CAF/goserelin vs CAF/gos/tam=>no OS advantage at 9 yrs; maybe b/c pts were >40 # asco14,,,#,4.73491E+17,https://twitter.com/rsm2800/status/473490734893383681,,,,
MyelomaTeacher,6/2/2014 11:45,0,0,@ VincentRK @ mtmdphd What's being studied in # Endurance ? # mmsm # ASCO14,,@ @,# # #,4.73491E+17,https://twitter.com/MyelomaTeacher/status/473490682842480641,,,,
ElizBlanchardMD,6/2/2014 11:45,3,0,Abs 7502:consolidation XRT to chest in ext stage small cell improves OS on pts responding to initial tx.Note: all pts got PCI # asco14 # lcsm,,,# #,4.73491E+17,https://twitter.com/ElizBlanchardMD/status/473490658964287488,,,,
OncEd,6/2/2014 11:45,0,0,Van Cutsem CRYSTAL OS in FOLFIRI cetux 28.4 mos vs 20.2 mos in FOLFIRI alone in extended ras WT group # crcsm # ASCO14,,,# #,4.73491E+17,https://twitter.com/OncEd/status/473490657202700289,,,,
HenryJOncology,6/2/2014 11:45,0,0,@ ASCO A difference between a drug that keeps 1000 alive in perfect health for 1 day and one that keeps 1 alive for 1000 days? # ASCO14 # hcldr,,@,# #,4.73491E+17,https://twitter.com/HenryJOncology/status/473490648440401920,,,,
DrHedrick,6/2/2014 11:45,0,0,Addition thoracic RT in addition to PCI seems to significantly improve OS (particularly in those patients who live out to 2 years.) # ASCO14,,,#,4.73491E+17,https://twitter.com/DrHedrick/status/473490619512655873,,,,
maggiemfox,6/2/2014 11:45,1,0,Don't miss @ megtirrell @ CNBC from # ASCO2014 http://www.cnbc.com/id/101721186,,@ @,#,4.73491E+17,https://twitter.com/maggiemfox/status/473490618333675520,,,,
dmooneymd,6/2/2014 11:45,0,0,"Extensive small cell after chemo. Thoracic rt improves overall survival, progression free survival and thoracic control. # lcsm # ASCO14",,,# #,4.73491E+17,https://twitter.com/dmooneymd/status/473490615658115072,,,,
n8pennell,6/2/2014 11:45,0,0,Almost 50% reduction in intrathoracic progression with RT to chest for eSCLC. Dr. Slotman says this should be added to PCI. # ASCO14 # LCSM,,,# #,4.73491E+17,https://twitter.com/n8pennell/status/473490592908214272,,,,
OncEd,6/2/2014 11:45,0,0,Van Cutsem CRYSTAL Extended Ras Analysis found 15% KRAS/NRAS mutations beyond KRAS exon 2 # crcsm # ASCO14,,,# #,4.73491E+17,https://twitter.com/OncEd/status/473490590370648064,,,,
JeffreyMOtto,6/2/2014 11:45,3,1,KO: # ASCO14 going to need next generation genetic counseling to go with next generation sequencing,,,#,4.73491E+17,https://twitter.com/JeffreyMOtto/status/473490549349965826,,,,
Consalud_es,6/2/2014 11:45,5,2,Un medicamento de @ Novartis muestra una reducción del tamaño del carcinoma de células basales http://ow.ly/xwNij # Medicamentos cc: @ ASCO,,@ @,#,4.73491E+17,https://twitter.com/Consalud_es/status/473490547970433024,,,,
CancerTherAdvsr,6/2/2014 11:45,0,1,# ASCO14: # Nivolumab Safe in Platinum-resistant # OvarianCancer http://ow.ly/xvs22,,,# # #,4.73491E+17,https://twitter.com/CancerTherAdvsr/status/473490545516744705,,,,
OncEd,6/2/2014 11:45,1,0,"Tejpar OPUS Extended Ras Analysis selects population that has improved RR, PFS compared to KRAS WT exon 2 pop’n # crcsm # ASCO14",,,# #,4.73491E+17,https://twitter.com/OncEd/status/473490542396190720,,,,
FightCRC,6/2/2014 11:45,1,1,Did you follow # ASCO14 over the weekend? What new data did you find most interesting?,,,#,4.73491E+17,https://twitter.com/FightCRC/status/473490539732807680,,,,
harriseve,6/2/2014 11:45,0,0,RT @ DrAttai: Key component of a successful survivorship program - a true multidisciplinary team approach # ASCO14,,@,#,4.73491E+17,https://twitter.com/harriseve/status/473490516798357504,,,,
myriadgenetics,6/2/2014 11:45,0,0,At # ASCO14? Visit Booth 2039 to learn about Myriad’s superior accuracy in # genetictesting & variant classification program! # ASCOConnection,,,# # #,4.7349E+17,https://twitter.com/myriadgenetics/status/473490479430901760,,,,
gorskon,6/2/2014 11:44,0,0,Can doctor be sued for failing duty to warn about incidental findings on NextGen sequencing that portend health problems or death? # ASCO14,,,#,4.7349E+17,https://twitter.com/gorskon/status/473490430659538944,,,,
knwachter,6/2/2014 11:44,0,0,Shameless plug: Awesome medical writer looking for fulltime oncology gig. http://www.sci-scribe.net # ASCO2014,,,#,4.7349E+17,https://twitter.com/knwachter/status/473490425291223040,,,,
DrHedrick,6/2/2014 11:44,0,0,PFS was improved. Intrathoracic relapse was significantly reduced. (helpful for patients with sig lung dz). # ASCO14,,,#,4.7349E+17,https://twitter.com/DrHedrick/status/473490373512544257,,,,
OncEd,6/2/2014 11:44,0,0,Tejpar OPUS Extended Ras Analysis Ras evaluable population similar to overall pop’n # crcsm # ASCO14,,,# #,4.7349E+17,https://twitter.com/OncEd/status/473490362938691586,,,,
JeffreyMOtto,6/2/2014 11:44,0,0,KO: # ASCO14 lots of potential ethical issues with incidental findings. Child sequenced for break tumor also had mutations. For longQT,,,#,4.7349E+17,https://twitter.com/JeffreyMOtto/status/473490339047559172,,,,
zorgnl,6/2/2014 11:44,0,0,# ASCO14 Onderzoeksresultaten van de CALGB / SWOG 80405 studie werden op 1 juni 2014 gepresenteerd… http://goo.gl/fb/u0p4H via @ medicalfacts,,@,#,4.7349E+17,https://twitter.com/zorgnl/status/473490309062459393,,,,
Pharmaspectra,6/2/2014 11:44,1,1,Great piece by @ DrRobertGlatter: # ASCO2014: how scientific collaboration can help fight # cancer http://onforb.es/1tyeOSw # pharma # oncology,,@,# # # #,4.7349E+17,https://twitter.com/Pharmaspectra/status/473490241852960768,,,,
Emory_R,6/2/2014 11:44,1,0,Bristol's Immunotherapy Duo Doubles Survival in Melanoma Patients - TheStreet http://buff.ly/RXOpBg $ BMY $ MRK $ AZN # ASCO14,,,#,4.7349E+17,https://twitter.com/Emory_R/status/473490231627616256,,,,
n8pennell,6/2/2014 11:43,0,0,Slotman: PFS was significantly better for thoracic RT arm. # ASCO14 # LCSM,,,# #,4.7349E+17,https://twitter.com/n8pennell/status/473490204901535744,,,,
FightCRC,6/2/2014 11:43,0,1,New panel genetic tests means those w/ lynch and other crc syndromes 3.5-7% chance test positive for other cancer syndromes. # ASCO14 # crcsm,,,# #,4.7349E+17,https://twitter.com/FightCRC/status/473490199444750336,,,,
TuftsB,6/2/2014 11:43,0,0,@ CliffordHudis @ ASCO - misguided focus on cost ignores medical & personal value & would have denied me care in 09 & killed me # mliwi # asco14,,@ @,# #,4.7349E+17,https://twitter.com/TuftsB/status/473490176312737792,,,,
n8pennell,6/2/2014 11:43,0,0,"Slotman: OS HR 0.84 p=0.06 in favor of thoracic RT, not sig, but significantly more eSCOC pts alive at 2 years. # ASCO14 # LCSM",,,# #,4.7349E+17,https://twitter.com/n8pennell/status/473490018552774657,,,,
MyelomaTeacher,6/2/2014 11:43,0,0,@ theMMRF @ SanofiUS What time is the presentation? I'll watch for tweets! # mmsm # ASCO14,,@ @,# #,4.7349E+17,https://twitter.com/MyelomaTeacher/status/473489980829216769,,,,
dmooneymd,6/2/2014 11:43,0,0,"# lcsm Crest trial: thoracic rt vs obs after chemo for extensive small cell. Hr 1 yr os = 0.84, p=0.066. 2 yr os was significant. # ASCO14",,,# #,4.7349E+17,https://twitter.com/dmooneymd/status/473489974252568576,,,,
DrHedrick,6/2/2014 11:42,1,0,Patients receiving Thoracic RT did not show OS benefit at 12 months but curve split showed benefit at 18 and 24 months. # ASCO14,,,#,4.7349E+17,https://twitter.com/DrHedrick/status/473489945920016384,,,,
CancerResearch,6/2/2014 11:42,0,0,"Genentech's anti-PD-L1 antibody MPDL3280A shows promise in metastatic bladder cancer, earns FDA Breakthrough"" designation # ASCO14""",,,#,4.7349E+17,https://twitter.com/CancerResearch/status/473489943856418816,,,,
RichardWJoseph,6/2/2014 11:42,0,0,@ montypal Agree. Will continue to recommend neo-adjuvant though. I'm sure adjuvant PDL1 trials are looming in bladder. # blcsm # ASCO14,,@,# #,4.7349E+17,https://twitter.com/RichardWJoseph/status/473489938022150144,,,,
OncEd,6/2/2014 11:42,0,0,Tejpar OPUS Extended Ras Analysis found 26% KRAS/NRAS mutations beyond KRAS exon 2 # crcsm # ASCO14,,,# #,4.7349E+17,https://twitter.com/OncEd/status/473489866731585536,,,,
rsm2800,6/2/2014 11:42,1,1,"Toppmeyer: Caveats about ovarian ablation trials-they rarely included tamoxifen, chemo usu was CMF, not all were ER+ # asco14",,,#,4.7349E+17,https://twitter.com/rsm2800/status/473489856488689664,,,,
davidgrahammd,6/2/2014 11:42,0,0,Escudier presents pros. confirmation of 16 gene test to id increased risk of recurrence in RCC. Now if we only had an adj Rx. # gusm # ASCO14,,,# #,4.7349E+17,https://twitter.com/davidgrahammd/status/473489723693203456,,,,
drdonsdizon,6/2/2014 11:41,0,1,Gr8 stat to have. RT @ rsm2800 Toppmeyer: Only 15% of women < 40 had permanent amenorrhea after anthracycline + taxane chemo # asco14,,@,#,4.7349E+17,https://twitter.com/drdonsdizon/status/473489714138193923,,,,
exchequerpub,6/2/2014 11:41,0,2,A big thanks to everyone that came in for the @ ASCO convention this weekend. We hope to see you soon! @ McCormick_Place # ASCO14,,@ @,#,4.7349E+17,https://twitter.com/exchequerpub/status/473489682698088449,,,,
PeterHall001,6/2/2014 11:41,0,0,Can cost per QALY help patients decide which treatments to pay for themselves? I'm not convinced. # ASCO14,,,#,4.7349E+17,https://twitter.com/PeterHall001/status/473489673885478912,,,,
Transplant_Doc,6/2/2014 11:41,1,1,"MPT vs MPR in elderly newly diagnosed myeloma. Similar response rates, PFS and OS; better QOL at 12m, lower toxicity with MPR. # ASCO14 # mmsm",,,# #,4.7349E+17,https://twitter.com/Transplant_Doc/status/473489657699647488,,,,
timgerszewski,6/2/2014 11:41,1,0,Results from HPV/cancer study involving # SanfordResearch & @ ChronixBio to be presented at @ ASCO annual conference http://ow.ly/xs0Sb,,@ @,#,4.7349E+17,https://twitter.com/timgerszewski/status/473489649059770368,,,,
DrHedrick,6/2/2014 11:41,1,1,Study appears well balanced between arms. ?All pts with symptoms received MRI. About 50% had brain MRI if asymptomatic. # ASCO14,,,#,4.7349E+17,https://twitter.com/DrHedrick/status/473489569426702336,,,,
subatomicdoc,6/2/2014 11:41,0,0,"So...now that the machines are coming, how does Brazil staff them? @ GTFRCC # ASCO14 # radonc",,@,# #,4.7349E+17,https://twitter.com/subatomicdoc/status/473489551537610753,,,,
DoctorEdny,6/2/2014 11:41,2,0,$ ESALY lenvatinib increases PFS by 14.7 months vs placebo # ASCO14 pic.twitter.com/E8zGp8a1Rq,,,#,4.7349E+17,https://twitter.com/DoctorEdny/status/473489522370838528,,,,
Prof_Nick_James,6/2/2014 11:41,0,0,"@ Prof_Nick_James: Dawn of immuno-oncology"" for bladder cancer - Bajorin # ASCO14 pic.twitter.com/jcX9YArVZu""",,@,#,4.73489E+17,https://twitter.com/Prof_Nick_James/status/473489489185501184,,,,
daniellerodin,6/2/2014 11:41,4,2,Brazil to buy 80 Linacs in under-serviced regions - @ GlopesMd @ GTFRCC @ uicc @ CancerRT # ASCO14,,@ @ @ @,#,4.73489E+17,https://twitter.com/daniellerodin/status/473489483795406848,,,,
PCGAdvisory,6/2/2014 11:41,0,0,. @ ImmunoCellular Presents ICT-107 Phase II Data in Glioblastoma Patients at 2014 @ ASCO Annual Meeting $ IMUC # ASCO14 http://buff.ly/1nYxsmH,,@ @,#,4.73489E+17,https://twitter.com/PCGAdvisory/status/473489466909536256,,,,
subatomicdoc,6/2/2014 11:40,2,0,Brazil has just announced it's buying 80 linear accelerators to improve access @ GTFRCC # ASCO14 # radonc Getting bulk discount!,,@,# #,4.73489E+17,https://twitter.com/subatomicdoc/status/473489391629783040,,,,
AdaptiveBiotech,6/2/2014 11:40,3,0,# ASCO14 an optimistic but more balanced view of # immunotherapy emerges this year http://nyti.ms/1nXvwLa,,,# #,4.73489E+17,https://twitter.com/AdaptiveBiotech/status/473489363049795584,,,,
scientre,6/2/2014 11:40,1,0,"MT @ rsm2800 Come tweet w/ us later today! Mon 6/2 1:15p S504 Internet, Social Media, Privacy Regulations, & Clinical Trials # hcsm # ASCO14",,@,# #,4.73489E+17,https://twitter.com/scientre/status/473489328128405504,,,,
DebiopharmNews,6/2/2014 11:40,0,0,# ASCO14 Our unique # patientcentric business model for # success: Debiopharm Group http://ow.ly/xwpW3,,,# # #,4.73489E+17,https://twitter.com/DebiopharmNews/status/473489326589087745,,,,
MGHCancerCenter,6/2/2014 11:40,0,0,"1:15-5, S Hall A2: Dr. Raje poster: randomized trial of denosumab w/ zoledronic acid bone disease, adults w/ multiple myeloma # mmsm # ASCO14",,,# #,4.73489E+17,https://twitter.com/MGHCancerCenter/status/473489325917995009,,,,
JeffreyMOtto,6/2/2014 11:40,1,0,"KO: # ASCO14 lots of challenges with gene panels - somatic vs germline, to subtract or not to subtract - not easy to answer",,,#,4.73489E+17,https://twitter.com/JeffreyMOtto/status/473489288391184384,,,,
rsm2800,6/2/2014 11:40,0,0,Toppmeyer: Overview of LHRH agonists as adj Rx in premenop pt ER+ (Cuzick Lancet 2007): chemo+LHRH HR=0.88 vs chemo but mostly CMF # asco14,,,#,4.73489E+17,https://twitter.com/rsm2800/status/473489283978784768,,,,
drdonsdizon,6/2/2014 11:40,1,0,C Hinrichs @NCIBulletin LBA3008: 3/6 HPV+ metast # cervca had response to T-cell immunotx. Two with durable CR (11 and 18m). # gyncsm # ASCO14,,@NCIBulletin,# # #,4.73489E+17,https://twitter.com/drdonsdizon/status/473489219596193793,,,,
VincentRK,6/2/2014 11:39,0,3,I am attending # ASCO14 without attending # ASCO14 thanks to @ mtmdphd twitter feeds.,,@,# #,4.73489E+17,https://twitter.com/VincentRK/status/473489197999742977,,,,
daniellerodin,6/2/2014 11:39,5,0,In Rwanda," radiation is the #1 gap in cancer service delivery"" - Dr. Lawrence Shulman @ GTFRCC @ uicc @ CancerRT # ASCO14""",,@ @ @,#1 #,4.73489E+17,https://twitter.com/daniellerodin/status/473489115862683648,,,
DrHedrick,6/2/2014 11:39,0,0,"Primary endpoint Overall Survival. Must have proven ES-SCLC, response to therapy, no evidence of mets. Nearly 500pts # ASCO14",,,#,4.73489E+17,https://twitter.com/DrHedrick/status/473489082509959168,,,,
DrHedrick,6/2/2014 11:39,0,0,Prophylactic cranial irradiation in Extensive Stage Small Cell Carcinoma of lung. # ASCO14,,,#,4.73489E+17,https://twitter.com/DrHedrick/status/473489061563621376,,,,
HenryJOncology,6/2/2014 11:39,0,0,"Changing chemo post sx in osteo # sarcoma from AP to I andor mtx improves survival. MTP, not in US, may help. What can @ ASCO do to get mtp?",,@,#,4.73489E+17,https://twitter.com/HenryJOncology/status/473489013563613184,,,,
subatomicdoc,6/2/2014 11:39,3,0,Dr. Shulman: Providing a basis for care is critical...Having a program to sustain it is nontrivial. @ GTFRCC # ASCO14 # radonc,,@,# #,4.73489E+17,https://twitter.com/subatomicdoc/status/473488997197438976,,,,
MedscapeOnc,6/2/2014 11:39,3,3,# ASCO14 Medscape genetics coverage featured in Dr Ken Offit's next generation sequencing lecture pic.twitter.com/yVqLn5Kvi0,,,#,4.73489E+17,https://twitter.com/MedscapeOnc/status/473488987655393281,,,,
daniellerodin,6/2/2014 11:38,1,0,Paul Ruff speaking about challenges of human resources in providing radiotherapy in South Africa @ GTFRCC @ CancerRT @ uicc # ASCO14,,@ @ @,#,4.73489E+17,https://twitter.com/daniellerodin/status/473488889089646592,,,,
drsteventucker,6/2/2014 11:38,3,3,Data is King! AI now telling docs how to treat. http://www.wired.com/2014/06/ai-healthcare/ … # hdpalooza # ASCO14 HT @ EricTopol via @ WIRED,,@ @,# #,4.73489E+17,https://twitter.com/drsteventucker/status/473488806503407617,,,,
n8pennell,6/2/2014 11:38,0,0,Dr. Slotman presenting CREST trial of thoracic radiation in extensive small cell lung cancer. # ASCO14 # LCSM,,,# #,4.73489E+17,https://twitter.com/n8pennell/status/473488739508174848,,,,
knwachter,6/2/2014 11:38,0,0,@ MaverickNY Thanks. Foots not fractured. Hopefully the inflammation will calm down soon. Wish I was at # ASCO2014,,@,#,4.73489E+17,https://twitter.com/knwachter/status/473488718352097280,,,,
JeffreyMOtto,6/2/2014 11:37,0,0,KO: # ASCO14 prospective registry of multiplex testing - PROMPT for patients who have had gene panel testing,,,#,4.73489E+17,https://twitter.com/JeffreyMOtto/status/473488688047861760,,,,
subatomicdoc,6/2/2014 11:37,0,0,Discussants correctly recognizing it's a human capital / systems issue more than equipment issue @ GTFRCC # ASCO14 # radonc,,@,# #,4.73489E+17,https://twitter.com/subatomicdoc/status/473488655525224448,,,,
rsm2800,6/2/2014 11:37,1,1,Toppmeyer: Only 15% of women < 40 had permanent amenorrhea after anthracycline + taxane chemo # asco14,,,#,4.73489E+17,https://twitter.com/rsm2800/status/473488552483762176,,,,
gorskon,6/2/2014 11:37,1,1,"Ken Offit: Pandora's box"": Something is found. For instance"," mutation that predisposes to stomach cancer. Do we do gastrectromy? # ASCO14""",,,#,4.73489E+17,https://twitter.com/gorskon/status/473488516827971584,,,
Transplant_Doc,6/2/2014 11:37,4,2,"Panobinostat + velcade + dexamethasone significantly improves PFS in patients with relapsed myeloma, with manageable toxicity. # ASCO14 # mmsm",,,# #,4.73488E+17,https://twitter.com/Transplant_Doc/status/473488488391004162,,,,
DoctorEdny,6/2/2014 11:36,3,0,$ ESALY PIII trial of lenvatinib for iodine- refractory thyroid cancer sig positive PFS 65% ORR # ASCO14 pic.twitter.com/jm5KLuiCQv,,,#,4.73488E+17,https://twitter.com/DoctorEdny/status/473488391984930817,,,,
BayerPharma,6/2/2014 11:36,0,0,We present data on # GIST at 50th annual # ASCO14. Meeting abstracts are now available online http://am.asco.org/,,,# #,4.73488E+17,https://twitter.com/BayerPharma/status/473488369214042112,,,,
DCarrizosaMD,6/2/2014 11:36,0,0,# ASCO14 - appears that adjuvant erlotinib may only delay recurrence not prevent it but will need to await more data # LCI,,,# #,4.73488E+17,https://twitter.com/DCarrizosaMD/status/473488328684490753,,,,
HollmerMark,6/2/2014 11:36,1,0,Almac revealed that its new Dx spots ovarian cancer patients for whom @ Roche's Avastin would hurt. http://www.fiercediagnostics.com/story/almac-asco-dx-spots-ovarian-cancer-patients-whom-roches-avastin-would-hurt/2014-06-02 … # ASCO14,,@,#,4.73488E+17,https://twitter.com/HollmerMark/status/473488274905133056,,,,
FierceMedTech,6/2/2014 11:36,0,1,Almac revealed that its new Dx spots ovarian cancer patients for whom @ Roche's Avastin would hurt. http://www.fiercediagnostics.com/story/almac-asco-dx-spots-ovarian-cancer-patients-whom-roches-avastin-would-hurt/2014-06-02 … # ASCO14,,@,#,4.73488E+17,https://twitter.com/FierceMedTech/status/473488274900910080,,,,
rsm2800,6/2/2014 11:36,0,1,"Toppmeyer: Tamoxifen controversies - is there less benefit in ER+PR-, HER2+, and high Oncotype? Not known # asco14",,,#,4.73488E+17,https://twitter.com/rsm2800/status/473488229732085760,,,,
ElizBlanchardMD,6/2/2014 11:35,2,0,Comment:don't rec erlotinib p op w/o more data. Panel agrees. Clin trials best. But--it is done in practice (right or wrong)! # ASCO14 # lcsm,,,# #,4.73488E+17,https://twitter.com/ElizBlanchardMD/status/473488171465199617,,,,
subatomicdoc,6/2/2014 11:35,1,0,Dr. Loehrer: Lead with care. Create a platform on which patients are cared for. @ GTFRCC # ASCO14 # globalhealth,,@,# #,4.73488E+17,https://twitter.com/subatomicdoc/status/473488161515905024,,,,
myCME,6/2/2014 11:35,0,0,Exercise Beats Diet Alone for Reducing # BreastCancer Risk http://ow.ly/xvh8h # ASCO14 # bcsm,,,# # #,4.73488E+17,https://twitter.com/myCME/status/473488068151115777,,,,
DCarrizosaMD,6/2/2014 11:35,0,1,# ASCO14 - strong discussion that we cannot recommend adjuvant erlotinib - must wait for Alchemist Trial as radiant is negative # LCI,,,# #,4.73488E+17,https://twitter.com/DCarrizosaMD/status/473488045669613568,,,,
JeffreyMOtto,6/2/2014 11:35,0,1,KO: # ASCO14 Medscape has decided to NOT permit oncologists to order gene panel tests - in direct conflict with @ asco guidelines,,@,#,4.73488E+17,https://twitter.com/JeffreyMOtto/status/473488030569730048,,,,
DrBenParsons,6/2/2014 11:35,0,0,"@ ASCO ASCT in MM > 65yrs still cost effective at 72,000$ / life yr # ASCO",,@,#,4.73488E+17,https://twitter.com/DrBenParsons/status/473488017890353154,,,,
rsm2800,6/2/2014 11:35,0,1,"Toppmeyer: Was a long period of time in the 80s,90s when tam thought ineffective for premenop women. ATLAS=no diff btwn pre/post # asco14",,,#,4.73488E+17,https://twitter.com/rsm2800/status/473488012546801664,,,,
knwachter,6/2/2014 11:35,0,0,I need a good roundup of # lungcancer results. A trip to the ED interrupted my weekend. Don't drop heavy cans on your foot. # ASCO14,,,# #,4.73488E+17,https://twitter.com/knwachter/status/473487973041053696,,,,
dhjutsw1,6/2/2014 11:35,0,1,@ ASCO # ASCO14 # LCSM Dr. Govindan from Wash U urges caution in interpreting RADIANT trial results. I would agree.,,@,# #,4.73488E+17,https://twitter.com/dhjutsw1/status/473487964505661441,,,,
MyelomaTeacher,6/2/2014 11:34,0,1,@ MaverickNY @ mtmdphd Hi you two! I'm following your tweets It's # myeloma Monday ! # ASCO14 # mmsm,,@ @,# # #,4.73488E+17,https://twitter.com/MyelomaTeacher/status/473487843026034688,,,,
subatomicdoc,6/2/2014 11:34,2,0,Bringing radiation to rural Kenya doesn't solve the problem," it requires multidisciplinary care"" @ GTFRCC # ASCO14""",,@,#,4.73488E+17,https://twitter.com/subatomicdoc/status/473487831789076481,,,
davidgrahammd,6/2/2014 11:34,1,0,Dr. Raghavan poses tough question. Should we try for an international adjuvant trial in bladder ca? # gusm @carolinas # LCI # ASCO14,,@carolinas,# # #,4.73488E+17,https://twitter.com/davidgrahammd/status/473487721110192128,,,,
arifkamalmd,6/2/2014 11:34,0,1,"If 10% eligible get CT for lung cancer screening, 2750 additional lives saved per model at expense of $9 billion # ASCO14",,,#,4.73488E+17,https://twitter.com/arifkamalmd/status/473487714671935488,,,,
n8pennell,6/2/2014 11:33,0,3,"Dr. Govindan makes point of not recommending adj erlotinib of trial, put pts on ALCHEMIST trial! # ASCO14 # LCSM",,,# #,4.73488E+17,https://twitter.com/n8pennell/status/473487625371004928,,,,
subatomicdoc,6/2/2014 11:33,1,1,"Dr. Loehrer struck by the experience in terms of very advanced, untreated disease. @ GTFRCC # ASCO14",,@,#,4.73488E+17,https://twitter.com/subatomicdoc/status/473487612527652866,,,,
ByJonGardner,6/2/2014 11:33,4,0,Can CO-1686 overcome its hypoglycaemia side effect? $ CLVS investors don't appear to believe so: http://ow.ly/xwNyU # ASCO14,,,#,4.73488E+17,https://twitter.com/ByJonGardner/status/473487608560242689,,,,
gorskon,6/2/2014 11:33,0,0,". @ AmandaAthena @ brianreid Oh, I don't know. Twitter ain't my medium. Too constraining. # ASCO14",,@ @,#,4.73488E+17,https://twitter.com/gorskon/status/473487604759814145,,,,
rsm2800,6/2/2014 11:33,0,1,Toppmeyer: Notes many questions remain despite 120 yrs of using endocrine rx for breast ca! # asco14,,,#,4.73488E+17,https://twitter.com/rsm2800/status/473487588385239041,,,,
KatherineFrankC,6/2/2014 11:33,0,0,Part of the @ HarborsidePress booth at the @ ASCOPost 50th Annual Meeting this weekend in # Chicago! # ASCO2014 # ASCOpic.twitter.com/Ncu0smLDXz,,@ @,# # #,4.73488E+17,https://twitter.com/KatherineFrankC/status/473487550309740544,,,,
dhjutsw1,6/2/2014 11:33,0,0,@ ASCO # ASCO14 # LCSM Dr. David Stewart notes problem w using impressive DFS from subset analysis to make a potential Rx recommendation. Kudos,,@,# #,4.73488E+17,https://twitter.com/dhjutsw1/status/473487522723409920,,,,
RielyMD,6/2/2014 11:33,0,0,Govindan highlights the upcoming ALCHEMIST trial which will evaluate targeted therapies in the adjuvant setting. # ASCO14,,,#,4.73488E+17,https://twitter.com/RielyMD/status/473487522560241664,,,,
drsteventucker,6/2/2014 11:33,4,3,How will # Healthbook change # cancer care? Moscone's all dressed up for # WWDC pic.twitter.com/L3fI9iNZ7t” HT @ alicetruong # ASCO14,,@,# # # #,4.73488E+17,https://twitter.com/drsteventucker/status/473487515446300674,,,,
SKarlsberg,6/2/2014 11:33,0,1,"Cancer Researchers Report Longer Survival Rates With Immunotherapy, via @ nytimes-nice summary of # ASCO14 immuno data http://nyti.ms/1jLZ74z",,@,#,4.73488E+17,https://twitter.com/SKarlsberg/status/473487513802526720,,,,
arifkamalmd,6/2/2014 11:32,1,1,States with lower Medicaid reimbursement have longer delays for for breast cancer surgery # ASCO14,,,#,4.73487E+17,https://twitter.com/arifkamalmd/status/473487345753546753,,,,
rsm2800,6/2/2014 11:32,0,1,Toppmeyer: Impt topic of ovarian suppression in premenop woman as part of adjuvant endocrine therapy # asco14,,,#,4.73487E+17,https://twitter.com/rsm2800/status/473487327335940096,,,,
SKarlsberg,6/2/2014 11:32,0,1,"Cancer Researchers Report Longer Survival Rates With Immunotherapy, via @ nytimes-nice summary of # ASCO14 immuno data http://nyti.ms/1jLZ74z",,@,#,4.73487E+17,https://twitter.com/SKarlsberg/status/473487312370683904,,,,
brouardbenoit01,6/2/2014 11:32,0,0,Mobile applications in # oncology: Need for assessing # scientific contents more precisely. # asco14 # cancer # mhealth http://abstracts.asco.org/144/index.html,,,# # # # #,4.73487E+17,https://twitter.com/brouardbenoit01/status/473487285636169729,,,,
subatomicdoc,6/2/2014 11:32,0,0,Dr. Loehrer: discussing his experience with # globalhealth @ GTFRCC # ASCO14,,@,# #,4.73487E+17,https://twitter.com/subatomicdoc/status/473487268443734016,,,,
LinicalAmericas,6/2/2014 11:31,0,0,Loving the multiple Powerstrip tables @ ASCO - great addition to # ASCO14,,@,#,4.73487E+17,https://twitter.com/LinicalAmericas/status/473487192267165696,,,,
ASCO,6/2/2014 11:31,4,5,"Experts discuss how the UK measures benefit, assesses cost, determines funding for cancer care http://bit.ly/1k8ZQBf # ASCO14",,,#,4.73487E+17,https://twitter.com/ASCO/status/473487056669507585,,,,
gorskon,6/2/2014 11:31,0,0,Kenneth Offit: NextGen sequencing finding all sorts of stuff whose significance is as yet unknown. # ASCO14,,,#,4.73487E+17,https://twitter.com/gorskon/status/473487046560841728,,,,
corp_UNC,6/2/2014 11:31,0,0,Adoption of hypofractionated RT for early-stage inv.breast after RCT public'n R.Chen @ UNC_Lineberger # asco14 http://ow.ly/xprfj # bcsm,,@,# #,4.73487E+17,https://twitter.com/corp_UNC/status/473487022049738752,,,,
physicianswkly,6/2/2014 11:31,0,0,# ASCO14: # oncologists desire > cost & comparative effectiveness # data & more education on how to discuss costs w/ Pts http://www.physiciansweekly.com/asco-2014-discussing-costs-cancer-care-under-aca/ …,,,# # #,4.73487E+17,https://twitter.com/physicianswkly/status/473487021294768128,,,,
subatomicdoc,6/2/2014 11:31,2,0,Dr. Vanderpuye: An exchange program would be a huge asset to help training providers in # radiation @ GTFRCC # ASCO14 cc @ aapmHQ @ ASRT,,@ @ @,# #,4.73487E+17,https://twitter.com/subatomicdoc/status/473487017062326272,,,,
PeterHall001,6/2/2014 11:31,3,0,"CEA is hugely challenging in the US. Multiple payers, providers and policy makers Does this make universal goalposts impossible? # ASCO14",,,#,4.73487E+17,https://twitter.com/PeterHall001/status/473486998284414977,,,,
DebiopharmNews,6/2/2014 11:31,0,0,# ASCO14 # DYK US market accounts for 41% of total # oncology drug sales http://ow.ly/xwpQY,,,# # #,4.73487E+17,https://twitter.com/DebiopharmNews/status/473486984187772930,,,,
GustaveRoussy,6/2/2014 11:31,2,1,"# ASCO14 Dr Dufour @ GustaveRoussy / Etude sur les tumeurs cérébrales chez les enfants, # PNET explications en vidéo : https://vimeo.com/97130514",,@,# #,4.73487E+17,https://twitter.com/GustaveRoussy/status/473486979565649920,,,,
JeffreyMOtto,6/2/2014 11:31,0,0,KO: # ASCO14 many of these syndromes involve mutations in xcription factor mutations - penetrance is highly variable,,,#,4.73487E+17,https://twitter.com/JeffreyMOtto/status/473486967561154560,,,,
Novartis,6/2/2014 11:31,1,4,Dr. Fatima Cardoso explains why knowing your subtype of # advancedBC helps optimize treatment: http://bit.ly/1jqyj9S # ASCO14,,,# #,4.73487E+17,https://twitter.com/Novartis/status/473486957482610688,,,,
DrBobGoldberg,6/2/2014 11:30,1,1,@ ASCO richard Sullivan from uk: health care spending 'unsustainable' & eliminate a lot of innovation so bureaucrats can keep up. # ASCO14,,@,#,4.73487E+17,https://twitter.com/DrBobGoldberg/status/473486925991772160,,,,
Ludwig_Cancer,6/2/2014 11:30,0,0,Check out this story by @ ronwinslow and @ loftus from # ASCO14 on promise of # immunotherapies for # Cancer http://on.wsj.com/1jLZmN9,,@ @,# # #,4.73487E+17,https://twitter.com/Ludwig_Cancer/status/473486921864597504,,,,
brouardbenoit01,6/2/2014 11:30,0,0,My first abstract at ASCO 2014 Annual Meeting ! # mobile # app # cancer # asco14 # ehealth # mhealth http://abstracts.asco.org/144/AbstView_144_129069.html …,,,# # # # # #,4.73487E+17,https://twitter.com/brouardbenoit01/status/473486896245768192,,,,
ChipLanden,6/2/2014 11:30,0,0,@ ASCO Thanks for the clarification!,,@,,4.73487E+17,https://twitter.com/ChipLanden/status/473486884413243392,,,,
ONAcom,6/2/2014 11:30,0,0,RT @ drsapnapatel: Combination dabrafenib/trametinib increased PFS in BRAF-positive melanoma http://goo.gl/fhprx9 # ASCO14 # melanoma # melsm,,@,# # #,4.73487E+17,https://twitter.com/ONAcom/status/473486879250448384,,,,
dhjutsw1,6/2/2014 11:30,0,0,@ ASCO # ASCO14 # LCSM Comparing prolonged tamoxifen w prolonged erlotinib is not an apples to apples comparison. E >expensive & toxic.,,@,# #,4.73487E+17,https://twitter.com/dhjutsw1/status/473486849970036736,,,,
CancerDotNet,6/2/2014 11:30,0,0,"O'Day: Immunotherapy has exploded in the last decade, more & more patients are benefiting # ASCO14 http://bit.ly/U6OaWx",,,#,4.73487E+17,https://twitter.com/CancerDotNet/status/473486789190381568,,,,
FoundationATCG,6/2/2014 11:30,0,1,Take the molecular testing challenge: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73487E+17,https://twitter.com/FoundationATCG/status/473486780470415360,,,,
subatomicdoc,6/2/2014 11:30,0,0,Dr. Vanderpuye: HCP aren't educated about the potential value of # radiation for cancer control @ GTFRCC # ASCO14,,@,# #,4.73487E+17,https://twitter.com/subatomicdoc/status/473486745422405633,,,,
medpagetoday,6/2/2014 11:30,2,1,"Marie A. Bakitas, DNSc, on ENABLE III randomized clinical trial. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1rCBlBV",,@,#,4.73487E+17,https://twitter.com/medpagetoday/status/473486735041499137,,,,
JeffreyMOtto,6/2/2014 11:29,0,0,KO: # ASCO14 # NGS has identified a number of new cancer syndromes in the past few years,,,# #,4.73487E+17,https://twitter.com/JeffreyMOtto/status/473486676602261504,,,,
ElizBlanchardMD,6/2/2014 11:29,0,1,Dr Camidge question: are we giving erlotinib long enough after surgery? Answer: probably not # ASCO14 # LCSM,,,# #,4.73487E+17,https://twitter.com/ElizBlanchardMD/status/473486670336376832,,,,
rsm2800,6/2/2014 11:29,2,0,"Henry: HOPE study-exercise reduces AIMSS. May help many, not all esp those debilitated from recent chemo. Consider rehab referral # asco14",,,#,4.73487E+17,https://twitter.com/rsm2800/status/473486659757936640,,,,
DrMarkham,6/2/2014 11:29,0,0,"I find health services research to be fascinating, and so important in the quest for value in oncology care. # ASCO14",,,#,4.73487E+17,https://twitter.com/DrMarkham/status/473486612874407937,,,,
subatomicdoc,6/2/2014 11:29,0,1,Getting cobalt machine is enormous due to transportation radioactive materials issues @ GTFRCC # ASCO14,,@,#,4.73487E+17,https://twitter.com/subatomicdoc/status/473486515046084610,,,,
HemOncToday,6/2/2014 11:29,0,0,"# ASCO14 First-line # bevacizumab, # cetuximab equally effective for metastatic colorectal cancer @ CliffordHudis @ USC http://goo.gl/vQyjEG",,@ @,# # #,4.73487E+17,https://twitter.com/HemOncToday/status/473486509463838720,,,,
HealioAdolMed,6/2/2014 11:29,0,0,"# ASCO14 First-line # bevacizumab, # cetuximab equally effective for metastatic colorectal cancer @ CliffordHudis @ USC http://goo.gl/vQyjEG",,@ @,# # #,4.73487E+17,https://twitter.com/HealioAdolMed/status/473486508671127552,,,,
GoHealio,6/2/2014 11:29,0,0,"# ASCO14 First-line # bevacizumab, # cetuximab equally effective for metastatic colorectal cancer @ CliffordHudis @ USC http://goo.gl/vQyjEG",,@ @,# # #,4.73487E+17,https://twitter.com/GoHealio/status/473486507500896256,,,,
subatomicdoc,6/2/2014 11:28,0,0,Dr. Vanderpuye: Communicable diseases are bigger focus in Africa vs. chronic disease like cancer @ GTFRCC # ASCO14,,@,#,4.73486E+17,https://twitter.com/subatomicdoc/status/473486422985281536,,,,
DCarrizosaMD,6/2/2014 11:28,0,1,"# ASCO14 N Hanna feels too early to give up on adjuv erlotinib in mut + as results are clinically meaningful"" - maybe longer therapy? # LCI""",,,# #,4.73486E+17,https://twitter.com/DCarrizosaMD/status/473486411652661249,,,,
JeffreyMOtto,6/2/2014 11:28,0,0,KO: # ASCO14 cancer genetics program at @ asco university - first time something like this done,,@,#,4.73486E+17,https://twitter.com/JeffreyMOtto/status/473486374549475328,,,,
dmooneymd,6/2/2014 11:28,0,1,"Longer duration of erlotinib will likely be needed, but weigh toxicity and cost in face of no overall survival data yet. # lcsm # ASCO14",,,# #,4.73486E+17,https://twitter.com/dmooneymd/status/473486353938673664,,,,
amylmurphy10,6/2/2014 11:28,0,0,Hey Gabi @ GHannafantastic have you seen my friends @ JSchneide12 & @ betht0002 at # ASCO14 ? Wish I were there with you all this year!,,@ @ @,#,4.73486E+17,https://twitter.com/amylmurphy10/status/473486328450256896,,,,
TargetedOnc,6/2/2014 11:28,0,1,Dual HER2-Blockade Strategy With Lapatinib Fails in ALTTO Trial http://www.targetedonc.com/conference/asco-2014/Dual-HER2-Blockade-Strategy-With-Lapatinib-Fails-in-ALTTO-Trial … # ASCO14,,,#,4.73486E+17,https://twitter.com/TargetedOnc/status/473486320724361217,,,,
n8pennell,6/2/2014 11:28,0,2,Kelly: Longer duration of therapy with erlotinib in adj tx of EGFR mut pts is needed. Dr. Hanna agrees. # ASCO14 # LCSM,,,# #,4.73486E+17,https://twitter.com/n8pennell/status/473486300172267520,,,,
PhRMA,6/2/2014 11:28,1,0,"Despite cutting-edge meds, # patients are stuck w/ inadequate insurance model that must change says # PhRMA CEO http://bit.ly/1nDaGmT # ASCO14",,,# # #,4.73486E+17,https://twitter.com/PhRMA/status/473486257968791552,,,,
OncoGenexPharma,6/2/2014 11:28,0,0,Last day to visit $ OGXI at # ASCO14 and learn more about Treatment Resistance in # Cancer. We are at Booth #23085.,,,# # #23085,4.73486E+17,https://twitter.com/OncoGenexPharma/status/473486216906559488,,,,
UCCancerCenter,6/2/2014 11:28,1,0,Everett Vokes chaired a session on the multi-modality management of NSCLC and discussed chemotherapy as a part of chemoradiotherapy # ASCO14,,,#,4.73486E+17,https://twitter.com/UCCancerCenter/status/473486201329295360,,,,
subatomicdoc,6/2/2014 11:27,1,0,Dr. Vanderpuye: Very few in Ghana can travel to another country for treatment @ GTFRCC # ASCO14,,@,#,4.73486E+17,https://twitter.com/subatomicdoc/status/473486184551677952,,,,
COI_salud,6/2/2014 11:27,0,1,"Los investigadores dicen que el # cáncer triple negativo, uno de los más agresivos, es un posible objetivo de la inmunoterapia # ASCO2014",,,# #,4.73486E+17,https://twitter.com/COI_salud/status/473486149902553088,,,,
evaluatevantage,6/2/2014 11:27,0,0,Clovis impresses then disappoints with early lung cancer data: $ CLVS $ AZN http://ow.ly/xwLVc # ASCO14 # CO1686 # AZD9291,,,# # #,4.73486E+17,https://twitter.com/evaluatevantage/status/473486111571197952,,,,
WilmotCancer,6/2/2014 11:27,1,1,WCI's Michelle Janelsins presents findings on cognitive function before chemo in # breastcancer patients at # ASCO14. pic.twitter.com/PMprppxs2q,,,# #,4.73486E+17,https://twitter.com/WilmotCancer/status/473486105527205889,,,,
Biomedtracker,6/2/2014 11:27,6,3,20 oncologists surveyed at # ASCO14 to gauge interest in new data presented on experimental drugs: http://goo.gl/vlpDQP (subs) $ AZN # Cancer,,,# #,4.73486E+17,https://twitter.com/Biomedtracker/status/473486080822751233,,,,
MyelomaTeacher,6/2/2014 11:27,1,0,@ mtmdphd If I am interpreting Palumbo correctly is the study suggesting # maintenance until progression in # myeloma? # mmsm # ASCO14,,@,# # # #,4.73486E+17,https://twitter.com/MyelomaTeacher/status/473486079560286208,,,,
subatomicdoc,6/2/2014 11:27,1,0,"Getting a machine isn't the limitation. It's the internal politics, human capital needs are bigger issues @ GTFRCC # ASCO14",,@,#,4.73486E+17,https://twitter.com/subatomicdoc/status/473485957040046080,,,,
physicianswkly,6/2/2014 11:26,0,0,# ASCO14: EBRT for localized # prostatecancer significantly increases risk of 2nd cancers than no # Radiation therapy http://www.physiciansweekly.com/asco-2014-second-malignancies-prostate-cancer-treatment/ …,,,# # #,4.73486E+17,https://twitter.com/physicianswkly/status/473485899851132928,,,,
BistroBen,6/2/2014 11:26,0,0,Make the most of your lunch: eat a well-balanced meal at # ASCO14 and book your dinner reservations at the same time! @ ASCO,,@,#,4.73486E+17,https://twitter.com/BistroBen/status/473485874601013249,,,,
afreshchapter,6/2/2014 11:26,1,0,The final day if the # asco14. I will leave # inspired by all the exciting developments that will mean… http://instagram.com/p/ovyTeIsgfi/,,,# #,4.73486E+17,https://twitter.com/afreshchapter/status/473485860021624832,,,,
rsm2800,6/2/2014 11:26,0,1,"Henry: How to manage AIMSS? ELPh showed switching to 2nd AI showed 40% of pts able to tolerate; unclear why, since mech AIs same # asco14",,,#,4.73486E+17,https://twitter.com/rsm2800/status/473485826320384000,,,,
subatomicdoc,6/2/2014 11:26,0,0,"Radiation therapy is #1 gap in Rwanda --> key for breast, cervical cancer cure @ GTFRCC # ASCO14 cc @ breastlessAfrik @ CancerAfrica # bcsm",,@ @ @,#1 # #,4.73486E+17,https://twitter.com/subatomicdoc/status/473485727540338688,,,,
JeffreyMOtto,6/2/2014 11:26,0,0,Next up: Kenneth Offit - New syndromes and new conundrums posed by # ngs # ASCO14,,,# #,4.73486E+17,https://twitter.com/JeffreyMOtto/status/473485727263891456,,,,
DrMarkham,6/2/2014 11:26,0,0,RT @ ASCO: R2CHOP may overcome negative prognosis of non-GBC phenotype in DLBCL http://bit.ly/1oXL7dl # ASCO14 # lymsm,,@,# #,4.73486E+17,https://twitter.com/DrMarkham/status/473485710465716224,,,,
dhjutsw1,6/2/2014 11:25,0,0,@ ASCO # ASCO14 # LCSM Dr. Hanna discusses abst 7501 RADIANT. His conclusion: MAYBE adjuvant erlotinib works in EGFRmut NSCLC. Personally IDK.,,@,# #,4.73486E+17,https://twitter.com/dhjutsw1/status/473485677532037121,,,,
Senesco,6/2/2014 11:25,0,0,$ SNTI's VP of Clinical Development to present a poster at # ASCO14 discussing update on SNS01-T http://bit.ly/1u8Toxi # multiplemyeloma,,,# #,4.73486E+17,https://twitter.com/Senesco/status/473485664374124545,,,,
alantanmd,6/2/2014 11:25,1,1,"Adjuvant erlotinib stage III adjuvant EGFR mutant NSCLC improved DFS, no OS # ASCO14 pic.twitter.com/WQ5SIhJ0zk",,,#,4.73486E+17,https://twitter.com/alantanmd/status/473485630497124352,,,,
dmooneymd,6/2/2014 11:25,0,0,"Hannah: Although not significant, radiant, select, mskcc has clinical meaningful gain"" of dfs on erlotinib. Os data pending. # lcsm # ASCO14""",,,# #,4.73486E+17,https://twitter.com/dmooneymd/status/473485589317423105,,,,
genentech,6/2/2014 11:25,4,2,"> 70% of patients do not live near trial sites. Telemed, # hcsm & mHealth may be able to help: http://ow.ly/xwJRc # ASCO14",,,# #,4.73485E+17,https://twitter.com/genentech/status/473485496120016896,,,,
rsm2800,6/2/2014 11:25,0,1,"Henry: Data mixed as to whether low Vit D at baseline predicts for AIMSS (no in IBISII, yes in VITAL) # asco14. I usually measure 25OH levels",,,#,4.73485E+17,https://twitter.com/rsm2800/status/473485490100764673,,,,
genentech,6/2/2014 11:25,2,1,Immunotherapies: what it means to decode cellular camouflage & why it's tricky to strike a balance http://ow.ly/xwDBY # ASCO14,,,#,4.73485E+17,https://twitter.com/genentech/status/473485479858696192,,,,
subatomicdoc,6/2/2014 11:24,1,0,"Dr. Shulman: No real infrastructure makes it difficult, and each country has unique challenges @ GTFRCC # ASCO14",,@,#,4.73485E+17,https://twitter.com/subatomicdoc/status/473485427467636736,,,,
WinshipAtEmory,6/2/2014 11:24,2,0,"Dr Dan Goldstein, Winship Hem&Med Onc fellow, presents in an oral abstract session at # ASCO14 pic.twitter.com/vgOAkT3g3G",,,#,4.73485E+17,https://twitter.com/WinshipAtEmory/status/473485420198891520,,,,
CathyEngMD,6/2/2014 11:24,6,2,"# ASCO14:ACCENT database from Sargent indicates regardless of MSI status, stage 3 pts should still receive adjuvant chemo, # endcancer, # crcsm",,,# # #,4.73485E+17,https://twitter.com/CathyEngMD/status/473485412657561600,,,,
evaluatevantage,6/2/2014 11:24,5,2,Altto gives Glaxo and Novartis nothing to sing about: $ GSK $ NVS $ PBYI http://ow.ly/xwLsj # ASCO14 # Tykerb,,,# #,4.73485E+17,https://twitter.com/evaluatevantage/status/473485405845979137,,,,
n8pennell,6/2/2014 11:24,0,2,Hanna: clinically meaningful gain in DFS for adj erlotinib in mut+ pts! but jury out on OS. # ASCO14 # LCSM,,,# #,4.73485E+17,https://twitter.com/n8pennell/status/473485372383825920,,,,
JackWestMD,6/2/2014 11:24,0,1,Hanna on SELECT trial: 91% dzs-free surv for st III NSCLC EGFR mutn-pos pts who rec'd adjuvant erlotinib is impressive # ASCO14 # lcsm,,,# #,4.73485E+17,https://twitter.com/JackWestMD/status/473485353769119744,,,,
BayerPharma,6/2/2014 11:24,2,0,10-25% of # GIST cases have already spread at diagnosis. Learn about early detection http://bit.ly/1lKNhKY # ASCO14 http://twitpic.com/e5b2li,,,# #,4.73485E+17,https://twitter.com/BayerPharma/status/473485329392230400,,,,
emilygest,6/2/2014 11:24,0,1,# ASCO14 is gr8 oppty 2 share current # cancer research. @ StJudeResearch docs freely share discoveries every day.pic.twitter.com/S3WNAtxXBG,,@,# #,4.73485E+17,https://twitter.com/emilygest/status/473485251826941952,,,,
Cascadia,6/2/2014 11:24,0,1,@ dsgold no kidding # ASCO14 up as well (largest conf for oncology docs) I wish the silos would cross pollinate with # hdpalooza,,@,# #,4.73485E+17,https://twitter.com/Cascadia/status/473485222084767744,,,,
BistroBen,6/2/2014 11:24,0,0,Looking for a great place to grab dinner? The Bistro concierge desk can book your reservations while you're in town for # ASCO14! @ ASCO,,@,#,4.73485E+17,https://twitter.com/BistroBen/status/473485220126011393,,,,
Emory_R,6/2/2014 11:24,1,3,Merck Immunotherapy Posts Striking Results Against Advanced Melanoma - TheStreet http://buff.ly/1nHNdRw $ MRK $ AZN $ BMY $ RHHBY # ASCO14,,,#,4.73485E+17,https://twitter.com/Emory_R/status/473485212970909696,,,,
WilmotCancer,6/2/2014 11:24,3,2,WCI's Luke Peppone presents findings on symptom burden & side effects of # cancer treatment at # ASCO14. pic.twitter.com/Fej2Yhq5UD,,,# #,4.73485E+17,https://twitter.com/WilmotCancer/status/473485202342174722,,,,
rsm2800,6/2/2014 11:23,0,1,Henry: AIMSS (arthralgias from AIs); mechanism not fully known # asco14,,,#,4.73485E+17,https://twitter.com/rsm2800/status/473485180905066496,,,,
Lymphoma_Doc,6/2/2014 11:23,3,0,Myeloma oral session: $72k/life year gained with autoSCT in >65y MM patients. # ASCO14,,,#,4.73485E+17,https://twitter.com/Lymphoma_Doc/status/473485156905676800,,,,
CliffordHudis,6/2/2014 11:23,5,2,Disagreed that only drugs factor in value discussion. Much more included + 1 talk does not define policy. @ CliffordHudis disagreed # ASCO14”,,@,#,4.73485E+17,https://twitter.com/CliffordHudis/status/473485141759635456,,,,
subatomicdoc,6/2/2014 11:23,1,0,Dr. Shluman: focus on Rwanda and Haiti for his efforts. No radiation facilities at all. @ GTFRCC # ASCO14,,@,#,4.73485E+17,https://twitter.com/subatomicdoc/status/473485084318638080,,,,
n8pennell,6/2/2014 11:23,0,2,Hanna: magnitude of DFS gain is SUBSTANTIAL and SIGNIFICANT for adj erlotinib in EGFR mut pts. More than chemo. But... # ASCO14 # LCSM,,,# #,4.73485E+17,https://twitter.com/n8pennell/status/473485081726963712,,,,
rsm2800,6/2/2014 11:23,0,2,"Henry: However, most patients preferred venlafaxine over gabapentin (V is what I usually use in clinic). Lower doses better # asco14 # bcsm",,,# #,4.73485E+17,https://twitter.com/rsm2800/status/473484962344095745,,,,
subatomicdoc,6/2/2014 11:22,0,0,First panel with Dr. Larry Shulman from @ DanaFarber Dr. Loehrer from @ iumedschool and Verna Vanderpuye from Ghana @ GTFRCC # ASCO14,,@ @ @,#,4.73485E+17,https://twitter.com/subatomicdoc/status/473484920824672256,,,,
dramarivirg,6/2/2014 11:22,0,1,Cabozantinib y anti PD1 con resultados prometedores en cáncer de vejiga músculo invasor # ASCO14,,,#,4.73485E+17,https://twitter.com/dramarivirg/status/473484883999092736,,,,
GillisClaire,6/2/2014 11:22,1,0,"# ASCO14 challenging validity of NICE, CDF and reviewing how Washington influences Wigan for reimbursement new cancer drugs @ WG_Consulting",,@,#,4.73485E+17,https://twitter.com/GillisClaire/status/473484869625200640,,,,
TuftsB,6/2/2014 11:22,0,2,@ JenAtPhRMA @ washingtonpost - what is value? Not just care per $ but experiencing life events that are priceless. # mliwi # ASCO14,,@ @,# #,4.73485E+17,https://twitter.com/TuftsB/status/473484724623511552,,,,
subatomicdoc,6/2/2014 11:22,1,0,Immediate versus deferred chemo after radical cystectomy in pT3T4 and/or N+ M0 bladder cancer http://bit.ly/SdJDA5 > @ EORTC # ASCO14 # blcsm,,@,# #,4.73485E+17,https://twitter.com/subatomicdoc/status/473484715115438081,,,,
rsm2800,6/2/2014 11:22,0,1,"Henry: Vasomotor sx best managed w/ antidepressants, anticonvulsants. Venlafaxine & gabapentin best studied, seem equally effective # asco14",,,#,4.73485E+17,https://twitter.com/rsm2800/status/473484708106346497,,,,
PinkSheetMaryJo,6/2/2014 11:21,0,0,"Pharma sales are big part of economy overall, and oncology fastest growth area, Sullivan tells # ASCO14. System is addicted to cash flow.""""",,,#,4.73485E+17,https://twitter.com/PinkSheetMaryJo/status/473484682739200001,,,,
conkers3,6/2/2014 11:21,0,0,$ AZN up 1% to $73.30 MT . @ adamfeuerstein Biggest investor controversy at # ASCO14? $ CLVS vs # AZN My take http://www.thestreet.com/story/12728916/1/clovis-lung-cancer-bravado-falls-flat-with-new-diabetes-revelation.html … . @ AstraZeneca,,@ @,# #,4.73485E+17,https://twitter.com/conkers3/status/473484607661563905,,,,
jrgralow,6/2/2014 11:21,3,0,At @ uicc meeting of global task force on radiotherapy - led by @ marykge. 29 of 52 African countries have no XRT facilities! # ASCO14,,@ @,#,4.73485E+17,https://twitter.com/jrgralow/status/473484580687978496,,,,
fredhutch,6/2/2014 11:21,0,0,"MT @ CancerDotNet: Research from Joshua A. Roth, PhD abt lung cancer screening - patient summary: # lcsm # ASCO14 http://bit.ly/1nsfueC",,@,# #,4.73484E+17,https://twitter.com/fredhutch/status/473484494683766784,,,,
NTConnell,6/2/2014 11:21,0,0,"DA Goldstein @ WinshipAtEmory Bevacizumab incremental cost-effectiveness ratio $240,195/QALY in metastatic colorectal cancer # ASCO14 # crcsm",,@,# #,4.73484E+17,https://twitter.com/NTConnell/status/473484468209324032,,,,
GustaveRoussy,6/2/2014 11:20,2,0,"# ASCO2014 Dr A. Leary @ GustaveRoussy : cancer de l'endomètre et profilage génétique, explications en vidéo https://vimeo.com/97124584",,@,#,4.73484E+17,https://twitter.com/GustaveRoussy/status/473484354615001088,,,,
dramarivirg,6/2/2014 11:20,0,0,"Cambiando paradigmas # ASCO14 la era d trabajos en adyuvancia en cáncer de vejiga termino, el nuevo estándar es quimioterapia neoadyuvante",,,#,4.73484E+17,https://twitter.com/dramarivirg/status/473484300089044992,,,,
Prof_Nick_James,6/2/2014 11:20,1,1,Adjuvant chemo a bust in bladder cancer - poor accrual reflects poor fitness post-Cx. Neoad is standard of care - Bajorin. # ASCO14,,,#,4.73484E+17,https://twitter.com/Prof_Nick_James/status/473484298398744577,,,,
DrNancyZou,6/2/2014 11:20,0,0,# ASCO14 Dr Norah Lynn Henry presenting at the breast cancer management session. # GoBluepic.twitter.com/LVMbTzOW7n,,,# #,4.73484E+17,https://twitter.com/DrNancyZou/status/473484288554315776,,,,
DebiopharmNews,6/2/2014 11:20,0,0,# ASCO14 # DYK High pharma investments & cancer therapies account for > 30% preclinical & phase I clinical developments http://ow.ly/xwpHD,,,# #,4.73484E+17,https://twitter.com/DebiopharmNews/status/473484287854247936,,,,
WinshipAtEmory,6/2/2014 11:20,0,0,"# ASCO14 attendees, visit E Hall D2 at 10:55am CST for presentation Revisiting Radiation in Small Cell Lung Cancer"" with @ Wallyjc.""",,@,#,4.73484E+17,https://twitter.com/WinshipAtEmory/status/473484282087096320,,,,
subatomicdoc,6/2/2014 11:20,0,0,"Ambitious timetable to be ready for presenting more by World Cancer Congress in Melbourne, December 2014 @ GTFRCC # ASCO14",,@,#,4.73484E+17,https://twitter.com/subatomicdoc/status/473484280220241920,,,,
christinemphmd,6/2/2014 11:20,1,1,@ nick_faris @ ShabbirHossain I love all the great abstracts on prevention and lifestyle modifications in cancer! # ASCO14 # publichealth,,@ @,# #,4.73484E+17,https://twitter.com/christinemphmd/status/473484269298651136,,,,
myCME,6/2/2014 11:20,0,1,Molecular Predictors May ID Patients with # Glioblastoma Likely to Benefit from Bevacizumab http://ow.ly/xvhm4 # ASCO14 # oncology,,,# # #,4.73484E+17,https://twitter.com/myCME/status/473484268354961408,,,,
Boehringer,6/2/2014 11:20,3,4,POLL: In the last 50 yrs what has been the most significant development in # lungcancer? http://bit.ly/1iIp05G # ASCO14,,,# #,4.73484E+17,https://twitter.com/Boehringer/status/473484259270082560,,,,
rsm2800,6/2/2014 11:20,0,0,"Henry: Vaginal dryness-vag estrogens can lead to systemic absorption, could negate effect of AIs but more data needed. # asco14",,,#,4.73484E+17,https://twitter.com/rsm2800/status/473484257088638976,,,,
JoleneScience,6/2/2014 11:20,0,0,"Helsinn's NEPA (NK1+HT3 FDC), # TSRO's rolapitant both PO, long-acting; if approved, how will they be used vs fosaprepitant/Emend IV? # ASCO14",,,# #,4.73484E+17,https://twitter.com/JoleneScience/status/473484197726679042,,,,
physicianswkly,6/2/2014 11:20,0,0,"# ASCO14: majority of # oncologists believe addressing # tobacco use is important, but few provide cessation support http://www.physiciansweekly.com/asco-2014-tobacco-cessation-cancer-patients/ …",,,# # #,4.73484E+17,https://twitter.com/physicianswkly/status/473484190705782784,,,,
KinzieHotel,6/2/2014 11:19,0,0,We hope everyone staying w/ us for # ASCO14 is enjoying their # Chicago stay! We're happy you're here! :) @ ASCO @ ChooseChicago,,@ @,# #,4.73484E+17,https://twitter.com/KinzieHotel/status/473484169800978432,,,,
CancerResearch,6/2/2014 11:19,1,0,Triple-negative breast cancer: possible target for immunotherapy? Scientists say Yes! # ASCO14,,,#,4.73484E+17,https://twitter.com/CancerResearch/status/473484035143270400,,,,
rsm2800,6/2/2014 11:19,0,0,Data mixed RT @ DrAttai: @ rsm2800 so SE's mean treatment is working? # ASCO14,,@ @,#,4.73484E+17,https://twitter.com/rsm2800/status/473483994353246208,,,,
subatomicdoc,6/2/2014 11:18,4,0,Radiation is an element of a broader cancer care delivery system. Not part of formal calculation @ GTFRCC # ASCO14 # radonc,,@,# #,4.73484E+17,https://twitter.com/subatomicdoc/status/473483912472039424,,,,
rsm2800,6/2/2014 11:18,1,0,"Henry: Caution-most trials reporting AI-assoc sx used physician reported toxicity grading, not PROs. Sx measurement not standardized # ASCO14",,,#,4.73484E+17,https://twitter.com/rsm2800/status/473483871627927552,,,,
subatomicdoc,6/2/2014 11:18,0,0,What is the cost for the machine relative to the total cost for maintaining/sustaining radiation centers? @ GTFRCC # ASCO14,,@,#,4.73484E+17,https://twitter.com/subatomicdoc/status/473483783467851777,,,,
drsteventucker,6/2/2014 11:18,7,4,Most retweeted at # hdpalooza - @ Rock_Health @ MightyCasey @ Cascadia @ ManeeshJuneja @ SusannahFox # hdcradar pic.twitter.com/paXul8y60j # ASCO14,,@ @ @ @ @,# # #,4.73484E+17,https://twitter.com/drsteventucker/status/473483759950389248,,,,
davidgrahammd,6/2/2014 11:18,0,0,Bladder ca: the standard of care is neoadjuvant chemo. Used in <20% # gusm # ASCO14,,,# #,4.73484E+17,https://twitter.com/davidgrahammd/status/473483720033599488,,,,
DrBobGoldberg,6/2/2014 11:17,0,0,. @ ASCO event s100 on value &cancer care. rationing new drugs only thing discussed tho .5 pct of spending @ CliffordHudis disagreed # ASCO14,,@ @,#,4.73484E+17,https://twitter.com/DrBobGoldberg/status/473483665897697280,,,,
JeffreyMOtto,6/2/2014 11:17,0,0,AK: # ASCO14 50% of genetics in breast/ovarian cancers are currently unexplained,,,#,4.73484E+17,https://twitter.com/JeffreyMOtto/status/473483658100088832,,,,
JackWestMD,6/2/2014 11:17,1,0,Dr. Nasser Hanna commentary on consol chemo after chemo/RT: data do not support our practice of often giving consol chemo # ASCO14 # lcsm,,,# #,4.73484E+17,https://twitter.com/JackWestMD/status/473483656174923776,,,,
JoleneScience,6/2/2014 11:17,0,0,# chemo nausea & vomiting NK1 race: Ph3 NEPA results today @ # ASCO14; $ TSRO's rolapitant data over weekend,,@,# #,4.73484E+17,https://twitter.com/JoleneScience/status/473483651129155584,,,,
DCarrizosaMD,6/2/2014 11:17,0,1,# ASCO14 - N Hanna clearly states he disagrees w: NCCN -no consolidation chemo should be given even if weekly carbo/taxol used - change? # LCI,,,# #,4.73484E+17,https://twitter.com/DCarrizosaMD/status/473483643550060544,,,,
HotelMelanoma,6/2/2014 11:17,0,1,"@ CureMelanoma @ ASCO Great news, I did biochemo as an adjuvant treatment for Stage 3c and I'd love to see effective & less toxic options.",,@ @,,4.73484E+17,https://twitter.com/HotelMelanoma/status/473483612630032384,,,,
christinemphmd,6/2/2014 11:17,1,1,RT @thecancerian1: Absolutely LOVE to see all the MDs tweeting at # ASCO14 Gratitude for passion and dedication! # docsrock,,@thecancerian1,# #,4.73484E+17,https://twitter.com/christinemphmd/status/473483595701837824,,,,
ElizBlanchardMD,6/2/2014 11:17,0,1,Dr Hanna: no rand trial has shown improved outcomes w consolidation (or induction) p chemo/RT. Rct analysis: Tsujino JTO 2013 # ASCO14 # LCSM,,,# #,4.73484E+17,https://twitter.com/ElizBlanchardMD/status/473483539485577216,,,,
drdonsdizon,6/2/2014 11:17,1,2,"With my asco Connection editor, amyfries # ASCO14 http://instagram.com/p/ovxOh1pw42/",,,#,4.73483E+17,https://twitter.com/drdonsdizon/status/473483491556880384,,,,
subatomicdoc,6/2/2014 11:17,0,0,"Dr. Jaffray reviewing how @ GTFRCC is structured for burden/demand, health systems readiness, outputs # ASCO14",,@,#,4.73483E+17,https://twitter.com/subatomicdoc/status/473483476482547712,,,,
rsm2800,6/2/2014 11:17,0,2,Henry: TEAM trial of exem and tam seemed to show that pts w/ arthralgias+vasomotor sx+vulvovaginal sx had the best outcomes # asco14,,,#,4.73483E+17,https://twitter.com/rsm2800/status/473483446883323905,,,,
GustaveRoussy,6/2/2014 11:16,6,1,# ASCO14 Dr Georger @ gustaveroussy : 1ère étude de faisabilité sur la médecine personnalisée des cancers pédiatriques https://vimeo.com/97128256,,@,#,4.73483E+17,https://twitter.com/GustaveRoussy/status/473483399899123712,,,,
Pharmafocus,6/2/2014 11:16,0,0,ESMO outlines its developing 'magnitude of clinical benefit scale' at # ASCO14 - more details expected later this year # value # access,,,# # #,4.73483E+17,https://twitter.com/Pharmafocus/status/473483351383220224,,,,
GenentechJobs,6/2/2014 11:16,0,0,"Tweet: # ASCO14 Talent Hunt: Sr. Medical Director, Hemophilia: http://click2apply.net/429905f",,,#,4.73483E+17,https://twitter.com/GenentechJobs/status/473483334970916865,,,,
dhjutsw1,6/2/2014 11:16,0,1,@ ASCO # ASCO14 # LCSM Dr. Nasser Hanna discusses abst 7500. His conclusion: Stop it (consolidation CT). Agree.,,@,# #,4.73483E+17,https://twitter.com/dhjutsw1/status/473483324317790209,,,,
subatomicdoc,6/2/2014 11:16,2,0,What is appropriate economic investment in radiotherapy that is worthwhile? @ GTFRCC # ASCO14,,@,#,4.73483E+17,https://twitter.com/subatomicdoc/status/473483268134694913,,,,
Cascadia,6/2/2014 11:16,1,0,"# ASCO14 on Mon 1:15pm - Internet, Social Media, Privacy Regulations & Clinical Trials @ rsm2800 @ obogler @ mtmdphd",,@ @ @,#,4.73483E+17,https://twitter.com/Cascadia/status/473483257552830464,,,,
cancernurseEU,6/2/2014 11:15,1,0,"Elizabeth DeVries at # ASCO14 speaks of importance of partnership between nurses, doctors, patients. (thanks @GSK_conferences).",,@GSK_conferences,#,4.73483E+17,https://twitter.com/cancernurseEU/status/473483128494120960,,,,
rsm2800,6/2/2014 11:15,0,0,Henry: Greatest decr risk of recurrence in ATAC seen in women who developed either/both arthralgias or vasomotor sx # asco14,,,#,4.73483E+17,https://twitter.com/rsm2800/status/473483111078973440,,,,
n8pennell,6/2/2014 11:15,0,1,Message is don't give consolidation chemo in stage 3 patients getting concurrent CRT! # ASCO14 # LCSM,,,# #,4.73483E+17,https://twitter.com/n8pennell/status/473483105706471424,,,,
QIAGENBiox,6/2/2014 11:15,1,0,"Ingenuity Pathway Analysis helps to discover causal connections in complex ‘omics data http://bit.ly/1oGzYgN . Get addl info, #5013 # ASCO14",,,#5013 #,4.73483E+17,https://twitter.com/QIAGENBiox/status/473482945504616450,,,,
myriadgenetics,6/2/2014 11:15,2,0,Myriad's myRisk test identifies 63% more mutations related to # ovariancancer than BRCA1 & 2 testing alone. # ASCO14 http://bit.ly/1u88lQ8,,,# #,4.73483E+17,https://twitter.com/myriadgenetics/status/473482924138827776,,,,
CliffordHudis,6/2/2014 11:15,7,5,"Didn't include. But can in the future. MT: “ @ EthanBasch1: ASCO promotes value"" but trials don't include quality-adjusted survival. # ASCO14”""",,@,#,4.73483E+17,https://twitter.com/CliffordHudis/status/473482923232874496,,,,
Kenzibit,6/2/2014 11:14,0,0, @ NatRevClinOncol: A world free from the fear of cancer," Cliff Hudis intention # ASCO14 http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …""""",,@,#,4.73483E+17,https://twitter.com/Kenzibit/status/473482874742923265,,,
subatomicdoc,6/2/2014 11:14,2,0,"A plan of action to ensure global access to radiotherapy is long overdue."" @ GTFRCC published in Lancet Oncology 2014 # ASCO14""",,@,#,4.73483E+17,https://twitter.com/subatomicdoc/status/473482855905898496,,,,
rsm2800,6/2/2014 11:14,0,0,"Henry: MAP3 & IBISII prevention trials of AIs showed little diff in arthralgias btwn placebo/AI. Puzzling, due to no prior chemo? # asco14",,,#,4.73483E+17,https://twitter.com/rsm2800/status/473482812826214401,,,,
PinkSheetMaryJo,6/2/2014 11:14,0,0,Heated exchange w Hudis at value session. Commenter says pathways need to do better at accounting for patient feelings on value # ASCO14,,,#,4.73483E+17,https://twitter.com/PinkSheetMaryJo/status/473482800671490048,,,,
Lymphoma_Doc,6/2/2014 11:14,0,1,"@ ShannonWestin will discuss personalized therapy for endometrial and clear cell GYN cancers at 1130 today, E354b at # ASCO14",,@,#,4.73483E+17,https://twitter.com/Lymphoma_Doc/status/473482786385301506,,,,
NTConnell,6/2/2014 11:14,0,1,JA Roth: Low-dose CT screen will diagnose more lung cancer at early stage but increases Medicare spending by $9.3B over 5yrs. # ASCO14 # lcsm,,,# #,4.73483E+17,https://twitter.com/NTConnell/status/473482750012706816,,,,
WayneKoberstein,6/2/2014 11:14,1,0,"# ASCO14 Even non-immuno Tx researchers are looking at combos w immunoTxs, measuring PD-1, CTLA-4 expression as biomarkers. @ RfwrightLSL",,@,#,4.73483E+17,https://twitter.com/WayneKoberstein/status/473482737165565952,,,,
JeffreyMOtto,6/2/2014 11:14,0,0,AK: # ASCO14 most available gene panels consist of both clinically actionable genes - and ones where clinical sig. is uncertain,,,#,4.73483E+17,https://twitter.com/JeffreyMOtto/status/473482719909781504,,,,
gorskon,6/2/2014 11:13,0,0,I hadn't quite realized how great the @ RealAngelina_J effect has been in genetic testing. # ASCO14,,@,#,4.73483E+17,https://twitter.com/gorskon/status/473482658068983808,,,,
subatomicdoc,6/2/2014 11:13,2,3,Global engagement underway for @ GTFRCC with you leaders @ CancerRT highlighted by @ daniellerodin later on. # ASCO14,,@ @ @,#,4.73483E+17,https://twitter.com/subatomicdoc/status/473482519166205952,,,,
n8pennell,6/2/2014 11:13,0,1,Hanna: All randomized trials testing induction or consolidation chemo in stage 3 pts have been negative. # ASCO14 # LCSM,,,# #,4.73483E+17,https://twitter.com/n8pennell/status/473482506877304832,,,,
dramarivirg,6/2/2014 11:13,0,0,Anti PD1/PDL1 (inmunoterapia) el boom de # ASCO14 están siendo probados en estudios fase IIyIII en varias patologías con altas expectativas,,,#,4.73482E+17,https://twitter.com/dramarivirg/status/473482491375132672,,,,
ElizBlanchardMD,6/2/2014 11:13,0,0,"Abs 7501: DFS looked better numerically for pts w mutation, but not statistically significant. # ASCO14 # lcsm",,,# #,4.73482E+17,https://twitter.com/ElizBlanchardMD/status/473482472018423808,,,,
mattshomepage,6/2/2014 11:13,0,0,What's a way to convert clinical notes into structured data for research? Come see at S Hall A2 Poster 386 # ASCO14 pic.twitter.com/VjU9ZY7E2e,,,#,4.73482E+17,https://twitter.com/mattshomepage/status/473482427416182785,,,,
rsm2800,6/2/2014 11:12,0,0,Henry: AI-assoc arthralgias on treatment trials 18-35%. Is this variability due to diff in definitions? MA27 showed >50% incidence # asco14,,,#,4.73482E+17,https://twitter.com/rsm2800/status/473482415067758592,,,,
subatomicdoc,6/2/2014 11:12,0,0,"@ UICC What does it cost to close the gap between what exists today and resonable access to radiotherapy globally?"" # ASCO14 @ GTFRCC""",,@ @,#,4.73482E+17,https://twitter.com/subatomicdoc/status/473482280581595139,,,,
JackWestMD,6/2/2014 11:12,0,2,Dr. Kelly on RADIANT trial of adjuvant erlotinib as adjuvant Rx after surgery for early stage NSCLC # ASCO14 # lcsmpic.twitter.com/MNyZVmMUwn,,,# #,4.73482E+17,https://twitter.com/JackWestMD/status/473482262512943106,,,,
JeffreyMOtto,6/2/2014 11:11,0,0,"AK: # ASCO14 because most panels developed in Caucasians, more frequent reports of unknown significant mutations in other ethnicities",,,#,4.73482E+17,https://twitter.com/JeffreyMOtto/status/473482094325157888,,,,
ChipLanden,6/2/2014 11:11,0,0,@ yzafar @ ASCO Is it now OK to take pictures of presentations and distribute them?,,@ @,,4.73482E+17,https://twitter.com/ChipLanden/status/473482039778611200,,,,
teamoncology,6/2/2014 11:11,0,4,The most important for me is to create high quality clinical & translational investigators who care about advanced breast cancer. # ASCO14,,,#,4.73482E+17,https://twitter.com/teamoncology/status/473482014775984128,,,,
gorskon,6/2/2014 11:11,0,0,". @ medscapeonc And, of course, we do not know what to do with all this sequencing data. # ASCO14",,@,#,4.73482E+17,https://twitter.com/gorskon/status/473481996891467778,,,,
DCarrizosaMD,6/2/2014 11:11,0,1,# ASCO14 oral lung locoregional - RADIANT adjuvant erlotinib did not improve DFS (even in mutation + Pts) # LCI,,,# #,4.73482E+17,https://twitter.com/DCarrizosaMD/status/473481995960733696,,,,
mtkutluk,6/2/2014 11:11,1,0,Global Task Force on Radiotherapy for Cancer Control session at ASCO has challenges on the agenda. # ASCO14,,,#,4.73482E+17,https://twitter.com/mtkutluk/status/473481993502879744,,,,
subatomicdoc,6/2/2014 11:11,0,0,@ breastlessAfrik @ CancerAfrica We're discussing # radiation access for # Cancer at # ASCO14 - follow @ GTFRCC for more. Tweeting talks now,,@ @ @,# # #,4.73482E+17,https://twitter.com/subatomicdoc/status/473481986720292864,,,,
n8pennell,6/2/2014 11:11,0,0,Nassar Hanna discussing Park and Kelly studies now. # ASCO14 # LCSM,,,# #,4.73482E+17,https://twitter.com/n8pennell/status/473481944039428096,,,,
Elekta,6/2/2014 11:11,2,0,Visit # ASCO14 booth 4019 to discover how single-day treatment for # GammaKnife can work within your treatment protocolpic.twitter.com/bC7V5MTauU,,,# #,4.73482E+17,https://twitter.com/Elekta/status/473481934635425792,,,,
ElizBlanchardMD,6/2/2014 11:10,0,1,Abs7501:Radiant trial: erlotinib did not improve DFS or OS after surgery for lung cancer in pts with EGFR expression. # ASCO14 # LCSM,,,# #,4.73482E+17,https://twitter.com/ElizBlanchardMD/status/473481842419843072,,,,
DrMarkham,6/2/2014 11:10,0,0,RT @ mtmdphd: Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://ow.ly/xlEE8,,@ @,#,4.73482E+17,https://twitter.com/DrMarkham/status/473481821544800256,,,,
subatomicdoc,6/2/2014 11:10,0,0,13.2 Million deaths globally by 2030 per @ WHO. Incidence will grow in multilple nations without resources for dealing with it. # ASCO14,,@,#,4.73482E+17,https://twitter.com/subatomicdoc/status/473481798245027840,,,,
physicianswkly,6/2/2014 11:10,0,0,# ASCO14: more active participation in treatment decisions by # Cancer # patients = better reported quality of care. http://www.physiciansweekly.com/asco-2014-patients-decision-making/ …,,,# # #,4.73482E+17,https://twitter.com/physicianswkly/status/473481790116859904,,,,
DrMarkham,6/2/2014 11:10,0,0,"Roth, #6501: Low dose CT screening for lung cancer will have a large budget impact"" # asco14 # lcsm http://ow.ly/xwIgF""",,,#6501 # #,4.73482E+17,https://twitter.com/DrMarkham/status/473481766020603904,,,,
mtmdphd,6/2/2014 11:10,3,1,Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://ow.ly/xlEE8,,@,#,4.73482E+17,https://twitter.com/mtmdphd/status/473481761486548992,,,,
n8pennell,6/2/2014 11:10,1,1,HR 0.61 in favor of adjuvant erlotinib for DFS (p=0.03) but dr. Kelly reinforcing that this was not statistically sig. # ASCO14 # LCSM,,,# #,4.73482E+17,https://twitter.com/n8pennell/status/473481753764851713,,,,
EMDSerono,6/2/2014 11:10,0,0,We’re committed to furthering innovation in oncology care. Stop by booth 14087 at # ASCO14 to learn more.,,,#,4.73482E+17,https://twitter.com/EMDSerono/status/473481750749126659,,,,
Cancer_Genetics,6/2/2014 11:10,1,0,Come discuss biomarker discovery and CGI's Select One # clinicaltrial services - Booth 22134 # ASCO14 http://www.cancergenetics.com/cgi-select-one/,,,# #,4.73482E+17,https://twitter.com/Cancer_Genetics/status/473481700614627328,,,,
applemacbookpro,6/2/2014 11:10,0,1,RT @ subatomicdoc: Impact of p16 status on cetuximab+radiotherapy in H+N cancer http://bit.ly/RI7xmy > @ NRGOnc # ASCO14 # hncsm,,@ @,# #,4.73482E+17,https://twitter.com/applemacbookpro/status/473481700123504642,,,,
DebiopharmNews,6/2/2014 11:10,0,0,"# ASCO14 Phase I basket study Debio1347, # FGFR inhibitor in solid # tumors (abstract/poster # TPS2629) Find out more http://ow.ly/xwpyT",,,# # # #,4.73482E+17,https://twitter.com/DebiopharmNews/status/473481698131587072,,,,
RielyMD,6/2/2014 11:09,0,1,"Karen Kelly on RADIANT, DFS favors erlotinib vs placebo in adjuvant treatment of EGFR mut lung cancers, HR 0.6. OS immature. # ASCO14",,,#,4.73482E+17,https://twitter.com/RielyMD/status/473481656679272448,,,,
teamoncology,6/2/2014 11:09,0,0,TY !! RT @ Brooksx2: Really helpful!!!! “ @ teamoncology: @ Brooksx2 Appreciate your acknowledgment. I can not tell if my # ASCO14”,,@ @ @,#,4.73482E+17,https://twitter.com/teamoncology/status/473481622453379072,,,,
subatomicdoc,6/2/2014 11:09,0,0,@ WHO released cancer report on World Cancer Day 2/4/14 # ASCO14 Up to 25 million cases annually by 2025,,@,#,4.73482E+17,https://twitter.com/subatomicdoc/status/473481613112659970,,,,
HeliotropeRNA,6/2/2014 11:09,0,0,$ ARWR being pummeled....biotech interest being drawn out of # rnai space by # ASCO14?,,,# #,4.73482E+17,https://twitter.com/HeliotropeRNA/status/473481597237219328,,,,
JeffreyMOtto,6/2/2014 11:09,0,0,AK: # ASCO14 1990s-2013 - the single gene testing era. This where our processes were developed,,,#,4.73482E+17,https://twitter.com/JeffreyMOtto/status/473481588110397441,,,,
rsm2800,6/2/2014 11:09,1,0,Henry UMich now talking about highly relevant topic: Side effects of endocrine therapy # asco14 # bcsm,,,# #,4.73482E+17,https://twitter.com/rsm2800/status/473481563921842177,,,,
UNC_Lineberger,6/2/2014 11:09,4,2,Dr. Lisa Carey at # ASCO14 - Dual HER2 Targeting Benefits Subset of Breast Cancer Patients http://bit.ly/1m5ErWz,,,#,4.73482E+17,https://twitter.com/UNC_Lineberger/status/473481502408585216,,,,
AlpineBV_Miller,6/2/2014 11:09,1,1,Presenter of $ EXEL data blows thru efficacy to spend most of talk on cabo's effect on checkpoint targets and Tregs. # ASCO14,,,#,4.73481E+17,https://twitter.com/AlpineBV_Miller/status/473481484586999808,,,,
dhjutsw1,6/2/2014 11:09,3,2,"@ ASCO # ASCO14 # LCSM RADIANT abst 7501, no DFS or OS benefit w erlotinib. Trial is negative. Subset w EGFRmut better DFS but NOT significant.",,@,# #,4.73481E+17,https://twitter.com/dhjutsw1/status/473481466287251456,,,,
DrMarkham,6/2/2014 11:08,2,0,"Roth, #6501: low dose CT screening for lung ca will dx more cases of early stage lung cancer, increase Medicare expenditure. # lcsm # asco14",,,#6501 # #,4.73481E+17,https://twitter.com/DrMarkham/status/473481381872672768,,,,
rsm2800,6/2/2014 11:08,0,1,Smith: Can you use PAM50 to predict prognostic outcome using “ROR” score? Works well for yrs 0-10. RS performs less well yr 6-10 # asco14,,,#,4.73481E+17,https://twitter.com/rsm2800/status/473481374125420544,,,,
subatomicdoc,6/2/2014 11:08,0,0,David Jaffray up next to discuss @ GTFRCC - # ASCO14 # radonc,,@,# #,4.73481E+17,https://twitter.com/subatomicdoc/status/473481323244298240,,,,
IQVIA_Biotech,6/2/2014 11:08,0,0,Visit Novella at booth 24097 to learn how our team is uniquely positioned to help plan your next # oncology # clinicaltrials. # ASCO14,,,# # #,4.73481E+17,https://twitter.com/IQVIA_Biotech/status/473481281859514368,,,,
n8pennell,6/2/2014 11:08,0,1,Kelly: 51% of EGFR mut pts on trials stage 1. Arms not well balanced in this subgroup. Compliance was good. # ASCO14 # LCSM,,,# #,4.73481E+17,https://twitter.com/n8pennell/status/473481257083748354,,,,
rsm2800,6/2/2014 11:08,1,1,Smith: Conclusion slide re duration endocrine therapy # asco14 pic.twitter.com/oLzWpbQ6MN,,,#,4.73481E+17,https://twitter.com/rsm2800/status/473481168273551360,,,,
Oncoinfo_it,6/2/2014 11:07,0,0,"Bloody T9! Induce regression"""," of course... Thank u @ lucadf # ASCO14""",,@,#,4.73481E+17,https://twitter.com/Oncoinfo_it/status/473481105468063744,,,
gorskon,6/2/2014 11:07,0,0,. @ MedscapeOnc Chanock @ NIH reminds me why we haven't cured cancer yet. # ASCO14 http://www.sciencebasedmedicine.org/why-havent-we-cured-cancer-yet/ …,,@ @,#,4.73481E+17,https://twitter.com/gorskon/status/473481066284855296,,,,
JeffreyMOtto,6/2/2014 11:07,0,0,"Next up: Allison Kurlan application of panel tests in practice"" # ASCO14""",,,#,4.73481E+17,https://twitter.com/JeffreyMOtto/status/473481053798014976,,,,
subatomicdoc,6/2/2014 11:07,0,0,@ marykge Goal is to promote greater health equity globally in cancer care @ UICC --> @ GTFRCC. Global leaders can make a difference # ASCO14,,@ @ @,#,4.73481E+17,https://twitter.com/subatomicdoc/status/473481025083830272,,,,
z_phd,6/2/2014 11:07,0,0,"OK, @ bmsnews wins the award for coolest booth toy, with its MakerBot T-cells! # ASCO14 pic.twitter.com/8vyrrRPwMO",,@,#,4.73481E+17,https://twitter.com/z_phd/status/473480934424334336,,,,
ecancer,6/2/2014 11:07,1,1,Dr Steven O'Day updates ecancer on the latest in immunotherapy - video to follow # ASCO14 pic.twitter.com/6N9bqsJ1Qq,,,#,4.73481E+17,https://twitter.com/ecancer/status/473480931760549888,,,,
n8pennell,6/2/2014 11:06,1,1,Kelly: Importantly there were no treatment related deaths from 2 years of adjuvant erlotinib. # ASCO14 # LCSM,,,# #,4.73481E+17,https://twitter.com/n8pennell/status/473480907584974848,,,,
PeterHall001,6/2/2014 11:06,0,0,Numerous cost-effectiveness analyses as oral presentations at # ASCO14. Previously unheard of! Long may it continue.,,,#,4.73481E+17,https://twitter.com/PeterHall001/status/473480900508790784,,,,
CliffordHudis,6/2/2014 11:06,9,0,Value in Cancer Care will improve patient outcomes. # ASCO14,,,#,4.73481E+17,https://twitter.com/CliffordHudis/status/473480892929691649,,,,
OncEd,6/2/2014 11:06,0,1,Tejpar OPUS (FOLFOX +/- Cetuximab for mCRC) update: Extended Ras Analysis # crcsm # ASCO14,,,# #,4.73481E+17,https://twitter.com/OncEd/status/473480840090230784,,,,
subatomicdoc,6/2/2014 11:06,0,0,@ marykge In last year @ UICC has defined its role. Purpose is to unite cancer community globally # ASCO14,,@ @,#,4.73481E+17,https://twitter.com/subatomicdoc/status/473480786109136896,,,,
JSchneide12,6/2/2014 11:06,2,0,Important questions from @Carolinas Dr. Raghavan for some very important and exciting # ASCO14 news. # LCI http://on.wsj.com/1jLZmN9,,@Carolinas,# #,4.73481E+17,https://twitter.com/JSchneide12/status/473480774990053378,,,,
JeffreyMOtto,6/2/2014 11:06,0,0,"SC: # ASCO14 The incidentelome"" a very big and difficult challenge""",,,#,4.73481E+17,https://twitter.com/JeffreyMOtto/status/473480774369280000,,,,
n8pennell,6/2/2014 11:06,0,0,Kelly: no difference in DFS between arms in RADIANT. Looks very negative. OS data immature as few pts have died. # ASCO14 # LCSM,,,# #,4.73481E+17,https://twitter.com/n8pennell/status/473480687694409728,,,,
subatomicdoc,6/2/2014 11:05,0,0,@ maryge discusses @ UICC has largest cancer NGO in the world # ASCO14,,@ @,#,4.73481E+17,https://twitter.com/subatomicdoc/status/473480649366462464,,,,
physicianswkly,6/2/2014 11:05,0,0,# ASCO14: significant increased in incidence of # prostatecancer in last 10 yrs not fully explained by PSA # screening http://www.physiciansweekly.com/prostate-cancer-incidence/ …,,,# # #,4.73481E+17,https://twitter.com/physicianswkly/status/473480618870046720,,,,
teamoncology,6/2/2014 11:05,0,0,Yeah!! Proud of my mentees. RT @ DrAttai: Another @ teamoncology mentee! They are representing you well # asco14 pic.twitter.com/VL60ZtMylN,,@ @,#,4.73481E+17,https://twitter.com/teamoncology/status/473480601433952256,,,,
genentech,6/2/2014 11:05,4,3,"We should look to biomarkers for immunotherapy to help us find who is eligible for combo trials..."" D. Chen # ASCO14 http://ow.ly/xwD4i""",,,#,4.73481E+17,https://twitter.com/genentech/status/473480544429563904,,,,
NEJMGroup,6/2/2014 11:05,0,0,"Last opportunity # ASCO14 Visit the @ NEJMGroup at booth 20127, get a 15% @ NEJM subscription discount.",,@ @,#,4.73481E+17,https://twitter.com/NEJMGroup/status/473480543913639936,,,,
MGHCancerCenter,6/2/2014 11:05,0,0,11:30-12:45 E354A: Dr. Birrer & meta-analysis of databases for prognostic & predictive gene signatures of late-stage ovarian cancer # ASCO14,,,#,4.73481E+17,https://twitter.com/MGHCancerCenter/status/473480534581321728,,,,
Roche,6/2/2014 11:05,2,3,"How William Pao, Global Head of # Oncology, # Roche pRED, defines a “failed” study: http://ow.ly/xp6fR # ASCO14",,,# # #,4.73481E+17,https://twitter.com/Roche/status/473480529426513920,,,,
WayneKoberstein,6/2/2014 11:05,1,1,"If I admit my ignorance and lack of ability to understand all the science # ASCO14, I find I understand more than I know. @ RfwrightLSL",,@,#,4.73481E+17,https://twitter.com/WayneKoberstein/status/473480528445071360,,,,
DrMarkham,6/2/2014 11:05,0,1,Dr. Halpern's abstract #6500 on disparities in breast cancer surgeries in Medicaid population: http://ow.ly/xwH3W # bcsm # asco14,,,#6500 # #,4.73481E+17,https://twitter.com/DrMarkham/status/473480523327995905,,,,
WinshipAtEmory,6/2/2014 11:05,1,1,Abstract: Cost-effectiveness analysis of bevacizumab in first- and second-line treatment of mCRC: http://ow.ly/xsWYN # ASCO14,,,#,4.73481E+17,https://twitter.com/WinshipAtEmory/status/473480519918047232,,,,
myCME,6/2/2014 11:05,1,0,Dr. Hudis Becomes First @ ASCO President to Tweet Presidential Address http://ow.ly/xvgTp # ASCO14 # hcsm,,@,# #,4.7348E+17,https://twitter.com/myCME/status/473480478910320640,,,,
teamoncology,6/2/2014 11:05,0,1,@ Brooksx2 Appreciate your acknowledgment. I can not tell if my tweets are helpful. Negative or positive comments are welcome. # ASCO14,,@,#,4.7348E+17,https://twitter.com/teamoncology/status/473480460249477122,,,,
dhjutsw1,6/2/2014 11:05,0,0,"@ ASCO # ASCO14 # LCSM RADIANT, a RCT initiated before it's time? EGFRmut status NOT an eligibility criteria - added later. >70% wt.",,@,# #,4.7348E+17,https://twitter.com/dhjutsw1/status/473480423260303362,,,,
n8pennell,6/2/2014 11:05,0,0,"Kelly: 623 pts on erlotinib, 350 on placebo. # ASCO14 # LCSM",,,# #,4.7348E+17,https://twitter.com/n8pennell/status/473480406126563328,,,,
DrAttai,6/2/2014 11:04,2,3,Another @ teamoncology mentee! They are representing you well # asco14 pic.twitter.com/ClRs2tUoZX,,@,#,4.7348E+17,https://twitter.com/DrAttai/status/473480391886921728,,,,
LungCancerFaces,6/2/2014 11:04,2,1,“ @ ONAcom: # ASCO14: Fewer than 5% of adults with cancer enroll in clinical trials - read more http://ow.ly/xwdSU ” # lcsm,,@,# #,4.7348E+17,https://twitter.com/LungCancerFaces/status/473480351159812096,,,,
SiemensHealth,6/2/2014 11:04,1,0,"Attendees at # ASCO14, have you stopped by Booth 6141 to pass the Baton yet? # TheBatonPass",,,# #,4.7348E+17,https://twitter.com/SiemensHealth/status/473480344235421696,,,,
n8pennell,6/2/2014 11:04,0,1,Dr. Kelly explains why results in EGFR mut pts not significant. Still don't get it myself. Has to with prim endpt failing. # ASCO14 # LCSM,,,# #,4.7348E+17,https://twitter.com/n8pennell/status/473480242187620352,,,,
EthanBasch1,6/2/2014 11:04,3,3,Halpern: Increased Medicaid reimbursement decreases time to mastectomy. # ASCO14 http://tinyurl.com/ky4z6je pic.twitter.com/FYDpFHEH03,,,#,4.7348E+17,https://twitter.com/EthanBasch1/status/473480211896340480,,,,
JeffreyMOtto,6/2/2014 11:04,0,0,SC: # ASCO14 moving from discovery to clinically actionable is both expensive and dangerous.,,,#,4.7348E+17,https://twitter.com/JeffreyMOtto/status/473480206338899968,,,,
TransgeneSA,6/2/2014 11:04,0,0,Immune therapies improve treatment of cancers http://usat.ly/1mIXEix via @ usatoday # ASCO14,,@,#,4.7348E+17,https://twitter.com/TransgeneSA/status/473480187221254144,,,,
subatomicdoc,6/2/2014 11:04,0,0,"Dr. Mike Milosevic introducing meeting for @ GTFRCC for challenges, systematic approach to cancer control with # radiation # ASCO14 # radonc",,@,# # #,4.7348E+17,https://twitter.com/subatomicdoc/status/473480179281453056,,,,
TGeorgeMD,6/2/2014 11:03,0,0,MT @ wallyjc: All 4 NCI-supported cooperative group trials at the # ASCO14 Plenary Session yesterday! @ SWOG @ ALLIANCE_org @ eaonc @ NRGonc,,@ @ @ @ @,#,4.7348E+17,https://twitter.com/TGeorgeMD/status/473479964260839424,,,,
NickDunnCNBC,6/2/2014 11:02,0,2,Merck wants to be the leader in cancer treatment - @ megtirrell talks to $ MRK Pres at # ASCO14. http://video.cnbc.com/gallery/?video=3000280593 …,,@,#,4.7348E+17,https://twitter.com/NickDunnCNBC/status/473479868928512002,,,,
OncologySurgery,6/2/2014 11:02,0,0,RT @ ASCO: Editorial examines controversy over obligations to return incidental findings in sequencing http://bit.ly/T76zBH,,@,,4.7348E+17,https://twitter.com/OncologySurgery/status/473479862754111488,,,,
ASCO,6/2/2014 11:02,5,1,Editorial examines controversy over obligations to return incidental findings in # genomic sequencing http://bit.ly/1nyil5Z # ASCO14,,,# #,4.7348E+17,https://twitter.com/ASCO/status/473479794374770688,,,,
JeffreyMOtto,6/2/2014 11:02,0,1,SC: # ASCO14 looking at the genetic continuum: low freq/high effect to high freq/low effect. Me: this is why GWAS studies are not clin. Sig.,,,#,4.7348E+17,https://twitter.com/JeffreyMOtto/status/473479756281683968,,,,
eaonc,6/2/2014 11:02,1,0,# Medscape on E3805 # ASCO14 Practice-Changing Results for Metastatic Prostate Cancer # eaonc http://www.medscape.com/viewarticle/826018?src=sttwit …,,,# # #,4.7348E+17,https://twitter.com/eaonc/status/473479748371247105,,,,
cancernurseEU,6/2/2014 11:02,0,0,Follow # ASCO14 for the American Society of Clinical Oncology's annual meeting. Large conference = busy hashtag!,,,#,4.7348E+17,https://twitter.com/cancernurseEU/status/473479732412313600,,,,
ONAcom,6/2/2014 11:02,4,2,# ASCO14: Fewer than 5% of adults with cancer enroll in clinical trials - read more http://ow.ly/xwdSU,,,#,4.7348E+17,https://twitter.com/ONAcom/status/473479678196723712,,,,
ProjectInno,6/2/2014 11:02,0,0,We’ve made strides against cancer--but there is progress to make. Here’s how to achieve it: http://ow.ly/xrNpH # innovatenow # ASCO14,,,# #,4.7348E+17,https://twitter.com/ProjectInno/status/473479669338361857,,,,
n8pennell,6/2/2014 11:01,0,1,Dr. Kelly reviewing data supporting biomarkers EGFR protein or copy #by FISH now known to not be predictive but basis for RADIANT. # ASCO14,,,#by #,4.7348E+17,https://twitter.com/n8pennell/status/473479622374723584,,,,
CancerDotNet,6/2/2014 11:01,0,0,"Research from Joshua A. Roth, PhD @ HutchinsonCtr abt lung cancer screening - patient summary: # lcsm # ASCO14 http://bit.ly/1nsfueC",,@,# #,4.7348E+17,https://twitter.com/CancerDotNet/status/473479618746679296,,,,
TuftsCancerCtr,6/2/2014 11:01,0,0,AutoBMT for myeloma in age >65: better survival AND cost effective -Gunjan Shah # ASCO14 # mmsm # bmtsm http://bit.ly/1kp7wQl,,,# # #,4.7348E+17,https://twitter.com/TuftsCancerCtr/status/473479615034691586,,,,
DebiopharmNews,6/2/2014 11:01,0,0,"# ASCO14 Clinical PK/PD model for Debio 1143, antagonist of IAPs in # cancer (abstract/poster #2585) Find out more http://ow.ly/xwpsW",,,# # #2585,4.7348E+17,https://twitter.com/DebiopharmNews/status/473479574521917440,,,,
AstraZenecaUS,6/2/2014 11:01,2,0,AZ is committed to # oncology solutions. Stop by booth #16005 to learn more. # ASCO14,,,# #16005 #,4.7348E+17,https://twitter.com/AstraZenecaUS/status/473479563444756480,,,,
JanssenUS,6/2/2014 11:01,0,0,New data published in @ NEJM will be presented at # ASCO14 on Tuesday at 11:33 am CT (E354a) http://prn.to/1mCk8BP,,@,#,4.7348E+17,https://twitter.com/JanssenUS/status/473479518678966272,,,,
physicianswkly,6/2/2014 11:01,0,0,# ASCO14: Many # Oncology -focused # mobile # apps don't appear to be scientifically validated. http://www.physiciansweekly.com/asco-2014-mobile-apps-oncology/ …,,,# # # #,4.73479E+17,https://twitter.com/physicianswkly/status/473479494456868864,,,,
teamoncology,6/2/2014 11:01,1,1,Yes. Nice to see my mentee. :) RT @ DrAttai: @ teamoncology wish you were here! # asco14 pic.twitter.com/BKE9Gnn27F,,@ @,#,4.73479E+17,https://twitter.com/teamoncology/status/473479405608529920,,,,
gorskon,6/2/2014 11:00,0,0,". @ jonathanhirsch @ asco Yeah, I'm glad I got here a bit early. It should have been held in a bigger room. # ASCO14",,@ @,#,4.73479E+17,https://twitter.com/gorskon/status/473479300503449600,,,,
rsm2800,6/2/2014 11:00,1,2,Smith: Don’t have any data yet on > 5 yrs of AI but several studies should be coming out soon # asco14,,,#,4.73479E+17,https://twitter.com/rsm2800/status/473479248544428032,,,,
NTConnell,6/2/2014 11:00,0,0,Women who live in states with higher Medicaid reimbursement have shorter times to breast conserving surgery for breast cancer # bcsm # ASCO14,,,# #,4.73479E+17,https://twitter.com/NTConnell/status/473479242131714048,,,,
NatRevClinOncol,6/2/2014 11:00,1,0,Mixed results at ASCO plenary: great survival in prostate cancer but disappointing ALTTO trial data in breast cancer # ASCO14 plenary,,,#,4.73479E+17,https://twitter.com/NatRevClinOncol/status/473479228785057792,,,,
AlpineBV_Miller,6/2/2014 11:00,0,0,"Cora Sternberg doing an honest portrayal of data. Big PFS benefit. OS only a trend. See the node +/- trends, too. # ASCO14",,,#,4.73479E+17,https://twitter.com/AlpineBV_Miller/status/473479219679621121,,,,
JackWestMD,6/2/2014 11:00,4,2,K. Park on consolidation chemo after chemo/RT for stage III NSCLC # ASCO14 # lcsmpic.twitter.com/IfMcb2Le7q,,,# #,4.73479E+17,https://twitter.com/JackWestMD/status/473479216215126016,,,,
TGeorgeMD,6/2/2014 11:00,0,0,Dr. Tejpar: Extended RAS MUT profiling finds larger % of pts w/ mCRC who FAIL to benefit (& may HARM) w/ Cmab tx. Highly relevant! # ASCO14,,,#,4.73479E+17,https://twitter.com/TGeorgeMD/status/473479213648183296,,,,
FiercePharma,6/2/2014 11:00,1,0,# ICYMI: Our special # ASCO14 edition http://bit.ly/1oNraIF # pharma,,,# # #,4.73479E+17,https://twitter.com/FiercePharma/status/473479195566174208,,,,
CarlyHFierce,6/2/2014 11:00,1,0,# ICYMI: Our special # ASCO14 edition http://bit.ly/1oNraIF # pharma,,,# # #,4.73479E+17,https://twitter.com/CarlyHFierce/status/473479195452903424,,,,
Prof_Nick_James,6/2/2014 11:00,1,2,Adjuvant chemo improves pfs but not OS in post cystectomy setting but underpowered due to poor accrual # Asco14 pic.twitter.com/nqoTQtOQ91,,,#,4.73479E+17,https://twitter.com/Prof_Nick_James/status/473479187458977792,,,,
myriadgenetics,6/2/2014 11:00,3,0,Myriad will collaborate with leading experts in an innovative study to accelerate # hereditarycancer research. http://bit.ly/1u8KlfU # ASCO14,,,# #,4.73479E+17,https://twitter.com/myriadgenetics/status/473479184656764928,,,,
eaonc,6/2/2014 11:00,1,0,E3805 Docetaxel With ADT Improves Survival for Metastatic Prostate Cancer Patients # ASCO14 # eaonc http://shar.es/VTtMN via @ sharethis,,@,# #,4.73479E+17,https://twitter.com/eaonc/status/473479168702046208,,,,
DrMarkham,6/2/2014 11:00,0,0,Halpern: Black Medicaid beneficiaries were more likely than white beneficiaries to have longer delays to breast ca surgery # bcsm # ASCO14,,,# #,4.73479E+17,https://twitter.com/DrMarkham/status/473479161613680640,,,,
aakonc,6/2/2014 10:59,1,0,Opus confirms Extended Ras mutants have worse survival w anti EFGR Overdue mandate ext RAS in all. # ASCO14 # crcsmpic.twitter.com/oDYAgcHapW,,,# #,4.73479E+17,https://twitter.com/aakonc/status/473479128629645312,,,,
mtmdphd,6/2/2014 10:59,2,1,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Concl: CT major improvement over FDT. Include PFS2 in studies pic.twitter.com/dIWN1T75jk,,,# #,4.73479E+17,https://twitter.com/mtmdphd/status/473479120203309056,,,,
DrAttai,6/2/2014 10:59,1,2,@ teamoncology wish you were here! # asco14 pic.twitter.com/FM7iMGPZUW,,@,#,4.73479E+17,https://twitter.com/DrAttai/status/473479086049095681,,,,
montypal,6/2/2014 10:59,0,0,Data getting me to think twice about adjuvant bladder cancer treatment # ASCO14 pic.twitter.com/1sjtXH6luX,,,#,4.73479E+17,https://twitter.com/montypal/status/473479058873786368,,,,
JeffreyMOtto,6/2/2014 10:59,0,0,SC: # ASCO14 NGS discovery projects often uncover unexpected relationships.,,,#,4.73479E+17,https://twitter.com/JeffreyMOtto/status/473478973293596673,,,,
n8pennell,6/2/2014 10:59,0,0,Dr. Kelly presenting results of the RADIANT trial of adjuvant erlotinib. # ASCO14 # LCSM,,,# #,4.73479E+17,https://twitter.com/n8pennell/status/473478955178397696,,,,
DCarrizosaMD,6/2/2014 10:59,0,1,# ASCO14 oral lung locoregional - CCheIN study now second neg study looking at chemo (cis/doc) consolidation after chemoxrt # LCI,,,# #,4.73479E+17,https://twitter.com/DCarrizosaMD/status/473478951977754625,,,,
DrAttai,6/2/2014 10:59,6,3,Molecular subtypes for TNBC via @ teamoncology @ MDAndersonNews # asco14 pic.twitter.com/6fBLd2HCep,,@ @,#,4.73479E+17,https://twitter.com/DrAttai/status/473478921330393088,,,,
mtmdphd,6/2/2014 10:58,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - 60 vs 69% OS 4 yr pic.twitter.com/QII50fq14R,,,# #,4.73479E+17,https://twitter.com/mtmdphd/status/473478884210790400,,,,
rsm2800,6/2/2014 10:58,0,1,Smith: MA17 showed greater benefit for women who were premenopausal at dx then became postmenop vs those that started postmenop # asco14,,,#,4.73479E+17,https://twitter.com/rsm2800/status/473478850114887680,,,,
janinegug,6/2/2014 10:58,0,0,Check out @ LivingBeyondBC coverage from # ASCO14 yesterday: Targeted Therapies Heat up Oncology Meeting http://shar.es/VTtDM via @ sharethis,,@ @,#,4.73479E+17,https://twitter.com/janinegug/status/473478812077129728,,,,
AlpineBV_Miller,6/2/2014 10:58,0,0,Congrats to EORTC for finally enrolling deferred vs immediate chemo in adv post-cys bladder ca. Immediate adjuvant looks best # ASCO14,,,#,4.73479E+17,https://twitter.com/AlpineBV_Miller/status/473478776136159233,,,,
n8pennell,6/2/2014 10:58,0,0,Park: Many pts too sick from CRT to get assigned consolidation chemo. Tough tx so good that we can stop and let pts recover. # ASCO14 # LCSM,,,# #,4.73479E+17,https://twitter.com/n8pennell/status/473478757286957056,,,,
ecancer,6/2/2014 10:58,0,0,How has the # prostatecancer landscape changed over the last decade? See the discussion here at # ASCO14 http://ecancer.org/video/2851/asco-2014--advances-in-prostate-cancer-discussion.php …,,,# #,4.73479E+17,https://twitter.com/ecancer/status/473478755600855040,,,,
JonathanHirsch,6/2/2014 10:58,1,3,Germline genetics in clinical care session at # ASCO14 is totally packed. Awesome to see! @ ASCO,,@,#,4.73479E+17,https://twitter.com/JonathanHirsch/status/473478745295056898,,,,
mtmdphd,6/2/2014 10:58,2,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Subset of Pts who experienced 1st progresion - no diff med PFS pic.twitter.com/CNxfm6e33B,,,# #,4.73479E+17,https://twitter.com/mtmdphd/status/473478744838270976,,,,
JeffreyMOtto,6/2/2014 10:58,0,0,SC: # ASCO14 - NGS - incidental findings represent a big challenge.,,,#,4.73479E+17,https://twitter.com/JeffreyMOtto/status/473478698276904960,,,,
dramarivirg,6/2/2014 10:58,0,0,Mantenimiento con Bevacizumab solo en CCRM luego d inducción con CapeOx+bev controversial # ASCO14,,,#,4.73479E+17,https://twitter.com/dramarivirg/status/473478649736626177,,,,
teamoncology,6/2/2014 10:57,1,0,"@ ElaineSchattner Unfortunately, too many trials for advanced disease can only be done at large cancer centers. # ASCO14 # BCSM",,@,# #,4.73479E+17,https://twitter.com/teamoncology/status/473478608145510400,,,,
mtmdphd,6/2/2014 10:57,0,1,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - 2nd PFS - lost 50% of study population pic.twitter.com/nJzemj7ExF,,,# #,4.73479E+17,https://twitter.com/mtmdphd/status/473478558825062402,,,,
MedscapeOnc,6/2/2014 10:57,3,0,"Chanock/NIH: the issue of tumor genomes -- plural -- is really critical when we think about tumor heterogeneity."" # ASCO14 @ NIH""",,@,#,4.73479E+17,https://twitter.com/MedscapeOnc/status/473478554714247168,,,,
dmooneymd,6/2/2014 10:57,0,0,# lcsm Cchein trial: role of consol chemo after crt in inop stg iii nsclc. 9 wks Cis-taxotere with pfs 9.1 vs 8 mos for obs. P=0.4. # ASCO14,,,# #,4.73479E+17,https://twitter.com/dmooneymd/status/473478524947681280,,,,
dhjutsw1,6/2/2014 10:57,0,2,"@ asco # ASCO14 # LCSM abst #7500 No PFS or OS benefit with consolidation CT in stage III NSCLC. Have we finally proved"" this strategy failed?""",,@,# # #7500,4.73478E+17,https://twitter.com/dhjutsw1/status/473478498410299392,,,,
rsm2800,6/2/2014 10:57,2,0,"Smith: MA17, NSABP B-33, ABCSG-6a all showed improv DFS w/ adding AI post 5 yrs tam # ASCO14",,,#,4.73478E+17,https://twitter.com/rsm2800/status/473478443305168896,,,,
DrMarkham,6/2/2014 10:57,1,0,"Dr. Halpern: In states with lower Medicaid reimbursement for mastectomy, longer wait for curative breast cancer surgery. # bcsm # ASCO14",,,# #,4.73478E+17,https://twitter.com/DrMarkham/status/473478417787400192,,,,
JeffreyMOtto,6/2/2014 10:57,0,0,"SC: # ASCO14 big, big difference in approach when using NGS for discovery or for # clia",,,# #,4.73478E+17,https://twitter.com/JeffreyMOtto/status/473478415543046144,,,,
CancerNetwrk,6/2/2014 10:57,0,0,# ASCO14 Blog: A Huge Value Question REGARDless of the RAINBOW http://bit.ly/1l0CX34,,,#,4.73478E+17,https://twitter.com/CancerNetwrk/status/473478401064701952,,,,
davidgrahammd,6/2/2014 10:57,0,0,EORTC immed vs delayed chemo in bladder after cystectomy. Poor accrual. Better PFS No diff in OS. Neoadj Rx remains underused # ASCO14 # gusm,,,# #,4.73478E+17,https://twitter.com/davidgrahammd/status/473478397843472384,,,,
mtmdphd,6/2/2014 10:56,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - improve 15 mo with CT vs FDT for med PFS2 - 1y landmark analysis pic.twitter.com/mXYLK3n6vI,,,# #,4.73478E+17,https://twitter.com/mtmdphd/status/473478383993909249,,,,
twittmanda,6/2/2014 10:56,0,0,@ subatomicdoc @ GTFRCC @ ASCO @ marykge @ daniellerodin You give multitasking a great name :),,@ @ @ @ @,,4.73478E+17,https://twitter.com/twittmanda/status/473478340599246849,,,,
GenentechJobs,6/2/2014 10:56,0,0,"# ASCO14 Talent Hunt: Medical Director, Hematology GDC: http://click2apply.net/413854f",,,#,4.73478E+17,https://twitter.com/GenentechJobs/status/473478340242714625,,,,
physicianswkly,6/2/2014 10:56,0,0,# ASCO14: # Physicians w/ novel # prostatecancer # technology influenced about perceived clinical benefits http://www.physiciansweekly.com/asco-2014-novel-prostate-cancer-technology/ …,,,# # # #,4.73478E+17,https://twitter.com/physicianswkly/status/473478331246346243,,,,
BayerPharma,6/2/2014 10:56,0,0,# ASCO14 presentations discuss # GIST. # DYK more than 50% of patients will develop progressive disease by 2 years. http://bit.ly/1lKNhKY,,,# # #,4.73478E+17,https://twitter.com/BayerPharma/status/473478319288377345,,,,
dramarivirg,6/2/2014 10:56,0,0,CAIRO 3: beneficio d mantenimiento con Capecitabina+Bevacizumab luego de CepeOX+bev inducción en CCRM en SLE pero no en SG # ASCO14,,,#,4.73478E+17,https://twitter.com/dramarivirg/status/473478269174812672,,,,
n8pennell,6/2/2014 10:56,1,1,No improvement in PFS or OS for consolidation chemo. This reinforces message that con tx not needed after CRT for stage 3. # ASCO14 # LCSM,,,# #,4.73478E+17,https://twitter.com/n8pennell/status/473478191823478784,,,,
mtmdphd,6/2/2014 10:56,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - PFS2 pic.twitter.com/XUEwiSfifL,,,# #,4.73478E+17,https://twitter.com/mtmdphd/status/473478155899244545,,,,
rsm2800,6/2/2014 10:55,1,1,Smith: ATLAS further incr risk of uterine ca 3.1% at 10 yrs vs 1.6% for 5 yrs but no increase in deaths # asco14,,,#,4.73478E+17,https://twitter.com/rsm2800/status/473478111011418113,,,,
GuardantHealth,6/2/2014 10:55,1,1,"David Hoon, who presented this morning, and the # Guardant360 poster for # melanoma patients. # ASCO14 cc: @ ASCO pic.twitter.com/lcZYdE5emI",,@,# # #,4.73478E+17,https://twitter.com/GuardantHealth/status/473478110751776768,,,,
JeffreyMOtto,6/2/2014 10:55,0,0,"SC: # ASCO14 Me: tech moves fast, data generation is the trivial piece - analysis is difficult. Need to be aware of inherent platform bias",,,#,4.73478E+17,https://twitter.com/JeffreyMOtto/status/473478086608973824,,,,
mtmdphd,6/2/2014 10:55,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Subgroup analysis favors CT pic.twitter.com/qF6XOnNG47,,,# #,4.73478E+17,https://twitter.com/mtmdphd/status/473477989502828544,,,,
MetaplasticBC,6/2/2014 10:55,1,0,More on PD-L1 and PD-1. Immune cancer improves in treatment of cancers # ASCO14 http://usat.ly/1mIXEix,,,#,4.73478E+17,https://twitter.com/MetaplasticBC/status/473477929360687104,,,,
myCME,6/2/2014 10:55,0,0,Ridaforolimus + AKT Inhibitor Phase 1 Trial: Tolerable but Modest Efficacy for # BreastCancer http://ow.ly/xvgEg # bcsm # ASCO14,,,# # #,4.73478E+17,https://twitter.com/myCME/status/473477918346457088,,,,
PinkSheetMaryJo,6/2/2014 10:54,0,0,"Hudis to politicians calling out # ASCO14 for focus on value over care: False dichotomy, proper thinking on value puts patients center",,,#,4.73478E+17,https://twitter.com/PinkSheetMaryJo/status/473477866030526465,,,,
CNBCClosingBell,6/2/2014 10:54,4,3,# WWDC14 + @ REITs_NAREIT + # ASCO14 + # NYUhospitality conf. Adding up to a # MustWatch show. Don't miss @ CNBCClosingBell!!,,@ @,# # # #,4.73478E+17,https://twitter.com/CNBCClosingBell/status/473477778336395265,,,,
mtmdphd,6/2/2014 10:54,0,2,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Double remission duration pic.twitter.com/osgliUJgO0,,,# #,4.73478E+17,https://twitter.com/mtmdphd/status/473477765317296130,,,,
aakonc,6/2/2014 10:54,0,0,OPUS 26% of WT KRAS have other RAS mutations. Should not be treated- save pts toxicity and cost # crcsm # ASCO14,,,# #,4.73478E+17,https://twitter.com/aakonc/status/473477757662679040,,,,
n8pennell,6/2/2014 10:54,0,0,"Park: 1/3 of pts on consolidation arm never received chemo, about 50% got 2 cycles. # ASCO14 # LCSM",,,# #,4.73478E+17,https://twitter.com/n8pennell/status/473477747294339072,,,,
rsm2800,6/2/2014 10:54,0,0,Smith: ATLAS had no increase in non-breast cancer deaths w 10 yrs tam (so no incr death due to clot or uterine ca) # bcsm # ASCO14,,,# #,4.73478E+17,https://twitter.com/rsm2800/status/473477719749967872,,,,
AnneBooms,6/2/2014 10:54,1,1,# ASCO14 Devries on cost disparities of cancer drugs pic.twitter.com/ATj5HE96ZT,,,#,4.73478E+17,https://twitter.com/AnneBooms/status/473477705841664000,,,,
DrAttai,6/2/2014 10:54,5,4,Impact of 21 gene assay on therapy for stage I breast ca via @ teamoncology @ MDAndersonNews # asco14 pic.twitter.com/uYBtNCsHWU,,@ @,#,4.73478E+17,https://twitter.com/DrAttai/status/473477649453842432,,,,
mtmdphd,6/2/2014 10:53,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - ITT analysis PFS1 pic.twitter.com/QopVayGTNz,,,# #,4.73478E+17,https://twitter.com/mtmdphd/status/473477624082477056,,,,
KimmelCancerCtr,6/2/2014 10:53,2,4,"Great poster on liquid biopsies!  @ GuardantHealth: Laura Austin poster # ASCO14 # Guardant360 cc: @ ASCO # cancer pic.twitter.com/APFwcplhxq""""",,@ @,# # #,4.73478E+17,https://twitter.com/KimmelCancerCtr/status/473477616113315840,,,,
lenstarnes,6/2/2014 10:53,0,0,Just going up and up... # ASCO14 Twitter participant/physical attendee % = 33.> 140m impressions! # hcsm # hcsmeu # epatient @ symplur,,@,# # # #,4.73478E+17,https://twitter.com/lenstarnes/status/473477527625691136,,,,
n8pennell,6/2/2014 10:53,0,0,Park: Trial started enrollment in 2005. That is a long time! # ASCO14 # LCSM,,,# #,4.73477E+17,https://twitter.com/n8pennell/status/473477486517698560,,,,
hansenmedical,6/2/2014 10:53,0,0,RT @ ASCO Read Educational Book articles on topics in Cancer Prevention/Epidemiology from # ASCO14 speakers: http://bit.ly/1kHXtW1,,@,#,4.73477E+17,https://twitter.com/hansenmedical/status/473477481559633920,,,,
mtmdphd,6/2/2014 10:53,0,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Table 1 pic.twitter.com/Jrqn0Ej80Q,,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473477463595823104,,,,
rsm2800,6/2/2014 10:53,3,1,"Smith: ATLAS 10 v 5 yr tam. For 10 yr RR=0.75 for recurrence, only seen yr 10+, RR=0.71 for OS yr 10+ # bcsm # ASCO14",,,# #,4.73477E+17,https://twitter.com/rsm2800/status/473477447732563968,,,,
chuslamas,6/2/2014 10:53,0,0,"any data from EORTC 18071, ipilimumap complementary to surgery in melanoma III? Photos? # ASCO14",,,#,4.73477E+17,https://twitter.com/chuslamas/status/473477423598948352,,,,
DrMisialek,6/2/2014 10:53,0,1,Drug Saves Fertility for Women With Cancer http://nyti.ms/1gJcure @ nytimes @ ClevelandClinic @ ASCO # ASCO14,,@ @ @,#,4.73477E+17,https://twitter.com/DrMisialek/status/473477407610273792,,,,
JenaidMRees,6/2/2014 10:52,0,0,Does trial enrollment prohibit objective evaluation of whole # cancer cell immunotherapy? Read More: http://bit.ly/wccancervac # ASCO14,,,# #,4.73477E+17,https://twitter.com/JenaidMRees/status/473477377327394817,,,,
mtmdphd,6/2/2014 10:52,3,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Study Design - 3 phase III trials comparing CT vs FD n=1218 pic.twitter.com/6A7PtPl4o3,,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473477347350675456,,,,
subatomicdoc,6/2/2014 10:52,1,1,I'm now at the @ GTFRCC - @ ASCO meeting for # globalhealth issues in # radonc # ASCO14 w/ @ marykge @ daniellerodin,,@ @ @ @,# # #,4.73477E+17,https://twitter.com/subatomicdoc/status/473477302953590784,,,,
sloan_kettering,6/2/2014 10:52,3,3,"Welcome to Twitter, Dr. Jedd Wolchok @ wolchokj! Here he is giving @ medpagetoday an interview at # asco14 @ asco pic.twitter.com/StjjzZrNox",,@ @ @,#,4.73477E+17,https://twitter.com/sloan_kettering/status/473477284767469569,,,,
CRC_Medical,6/2/2014 10:52,0,0,# ASCO14 - Visit # CRCPress Booth #23128 for discounts on amazing new # medicine + # oncology titles. @ ASCO pic.twitter.com/eMU2N1I7cw,,@,# # #23128 # #,4.73477E+17,https://twitter.com/CRC_Medical/status/473477238768537600,,,,
SarahKarlin,6/2/2014 10:52,2,0,Third-Generation EGFR Inhibitors’ Safety Profiles Under Scrutiny At # ASCO14 http://www.pharmamedtechbi.com/publications/the-pink-sheet-daily/2014/6/1/thirdgeneration-egfr-inhibitors-safety-profiles-under-scrutiny-at-asco …,,,#,4.73477E+17,https://twitter.com/SarahKarlin/status/473477221999734784,,,,
physicianswkly,6/2/2014 10:52,0,0,# ASCO14: <1/6 of patients w/ # lungcancer or colorectal # Cancer discuss clinical trial participation w/ # physicians. http://www.physiciansweekly.com/asco-2014-discussing-clinical-trials-lung-colorectal-cancer/ …,,,# # # #,4.73477E+17,https://twitter.com/physicianswkly/status/473477155436105728,,,,
JeffreyMOtto,6/2/2014 10:52,1,0,SC: # ASCO14 but only around 25 of these findings are clinically actionable,,,#,4.73477E+17,https://twitter.com/JeffreyMOtto/status/473477145751076864,,,,
AJMC_Journal,6/2/2014 10:52,0,0,Overdiagnosis and Overtreatment: The Cancer Paradigm # ASCO14 http://bit.ly/1jMot2a,,,#,4.73477E+17,https://twitter.com/AJMC_Journal/status/473477136821792769,,,,
PresCancerPanel,6/2/2014 10:51,1,0,"RT @ CancerGeek: ASCO: Once A Year, Cancer Research News Comes In A Flood, Not A Trickle http://n.pr/1kAKPE7 # ASCO14 # cancer",,@,# #,4.73477E+17,https://twitter.com/PresCancerPanel/status/473477129058123776,,,,
mtmdphd,6/2/2014 10:51,1,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - Second PFS - from 1st prog to 2nd... pic.twitter.com/ou4GIYSSSt,,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473477094669029376,,,,
JeffreyMOtto,6/2/2014 10:51,0,0,"SC: # ASCO14 110 identified cancer syndromes, more than 25 highly penetrant, and more than 450 GWAS loci",,,#,4.73477E+17,https://twitter.com/JeffreyMOtto/status/473476977152630784,,,,
Curiolog,6/2/2014 10:51,0,0,"- I'm not a statistician but..."" - ""BUT YOUR RESULTS ARE NOT SIGNIFICATIVE"," DUDE !!!"" # ASCO14""",,,#,4.73477E+17,https://twitter.com/Curiolog/status/473476974254362625,,,
rsm2800,6/2/2014 10:51,1,1,Ian Smith on optimal duration of endocrine rx for breast ca. Notes that long term that ER+ do less well than ER- due to late relapse # ASCO14,,,#,4.73477E+17,https://twitter.com/rsm2800/status/473476959356219392,,,,
chicagocapman,6/2/2014 10:51,0,0,"Over 3000 mango, strawberry & carrot/kale smoothies served. Come get yours @ booths 10123 and 19135 # ASCO14 pic.twitter.com/J2b55RxhqV",,@,#,4.73477E+17,https://twitter.com/chicagocapman/status/473476942482534401,,,,
womenofteal,6/2/2014 10:51,0,0,# gyncsm @ ASCO Potential of a New Personalized Strategy for Advanced Cervical Cancer | http://Cancer.Net http://www.cancer.net/research-and-advocacy/research-summaries/study-shows-potential-new-personalized-strategy-advanced-cervical-cancer#.U4yPPhut4YM.twitter …,,@,# #,4.73477E+17,https://twitter.com/womenofteal/status/473476925160038401,,,,
wallyjc,6/2/2014 10:50,7,2,Proud to see 4 NCI-supported cooperative group trials at the # ASCO14 Plenary Session yesterday! @ WinshipAtEmory @ SWOG @ ALLIANCE_org @ eaonc,,@ @ @ @,#,4.73477E+17,https://twitter.com/wallyjc/status/473476856545439744,,,,
mtmdphd,6/2/2014 10:50,1,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - PFS2 gives a surrogate of outcome with a much shorter f/u,,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473476824425857025,,,,
chuslamas,6/2/2014 10:50,1,2,“ @ urbano_anido: BAC+docetaxel en ca próstata sensible a castración enf avanzada.Aumento en superviv de 17 meses # ASCO14” El viejo docetaxel!,,@,#,4.73477E+17,https://twitter.com/chuslamas/status/473476744868270080,,,,
ProjectInno,6/2/2014 10:50,0,0,How can we address the barriers impeding innovations that fight cancer? Find out: http://ow.ly/xrNjn # innovatenow # ASCO14,,,# #,4.73477E+17,https://twitter.com/ProjectInno/status/473476743798730752,,,,
mtmdphd,6/2/2014 10:50,1,0,"Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - OS is ultimate endpoint, but OS impacted by multiple lines of therapy",,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473476728887590912,,,,
DebiopharmNews,6/2/2014 10:50,0,0,# ASCO14 Phase I/II Debio 1143 combo with CCRT in # patients with # HNSCN (abstract/poster # TPS6097) Find out more http://ow.ly/xwpmm,,,# # # #,4.73477E+17,https://twitter.com/DebiopharmNews/status/473476726237200384,,,,
subatomicdoc,6/2/2014 10:50,1,2,"@ twittmanda @ XRT4U @ Rad_Nation Not sure, I was giving my talk while this abstract was being presented. I can ask the lead author # ASCO14",,@ @ @,#,4.73477E+17,https://twitter.com/subatomicdoc/status/473476672184795136,,,,
JeffreyMOtto,6/2/2014 10:50,0,0,"SC: # ASCO14 # cancer # genomics can be divided into 4 spaces: germline, somatic, discovery and clinically actionable.",,,# # #,4.73477E+17,https://twitter.com/JeffreyMOtto/status/473476663120912384,,,,
JoleneScience,6/2/2014 10:49,4,0,Many ramucirumab presentations Monday: how will new anti-VEGF(R) agents compare in solid tumors? (hit & miss so far) $ LLY # ASCO14,,,#,4.73477E+17,https://twitter.com/JoleneScience/status/473476555134345218,,,,
mtmdphd,6/2/2014 10:49,1,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - How can we evaluate the efficacy of our Tx? pic.twitter.com/76hByTN1iZ,,,# #,4.73477E+17,https://twitter.com/mtmdphd/status/473476543290040320,,,,
RXMedDyn,6/2/2014 10:49,0,0,Cancer Research is always changing! # ASCO14 provides a flood of new information for everyone to look at. http://on.fb.me/1jqS9Sq,,,#,4.73477E+17,https://twitter.com/RXMedDyn/status/473476531642449920,,,,
n8pennell,6/2/2014 10:49,2,0,Dr. Park presenting CChelN trial testing consolidation chemo for unresect stage 3 NSCLC # ASCO14 # LCSM,,,# #,4.73477E+17,https://twitter.com/n8pennell/status/473476500441006081,,,,
CancerResearch,6/2/2014 10:49,0,1,@ ASCO its # CancerImmunotherapyMonth and we are excited about all of the news coming out of this years conference!,,@,#,4.73476E+17,https://twitter.com/CancerResearch/status/473476497144299520,,,,
christinemphmd,6/2/2014 10:49,0,0,Rt @ yzafar: Saltz: What is the price of stability with bevacizumab? # ASCO14 # crcsm # financialtoxicity pic.twitter.com/TX9IUit5T8 # cancervalue,,@,# # # #,4.73476E+17,https://twitter.com/christinemphmd/status/473476402676006912,,,,
mtmdphd,6/2/2014 10:49,1,0,Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur - A shift in paradigm from fixed to continuous Tx b/c have residual dis pic.twitter.com/ap8McAZIX3,,,# #,4.73476E+17,https://twitter.com/mtmdphd/status/473476386142035968,,,,
DoctorEdny,6/2/2014 10:48,3,0,$ CLVS down 10% on incr hyperglycemia w/CO-1686 in NSCLC see 20 oncologists impressions # ASCO14 data: http://bit.ly/U6Adrw ($ or subs) $ AZN,,,#,4.73476E+17,https://twitter.com/DoctorEdny/status/473476365623504896,,,,
mtmdphd,6/2/2014 10:48,1,0,"Palumbo # mmsm # ASCO14 - Cont Tx vs Fixed Dur of Rx in New MM - PFS1, PFS2, OS Endpoints pic.twitter.com/KgNYvch0rm",,,# #,4.73476E+17,https://twitter.com/mtmdphd/status/473476198660837376,,,,
Emory_R,6/2/2014 10:48,0,3,CAR-Ts: Remissions now stretch toward 4 years - FierceBiotech http://buff.ly/1nHIdME # ASCO14,,,#,4.73476E+17,https://twitter.com/Emory_R/status/473476182001090561,,,,
JeffreyMOtto,6/2/2014 10:48,0,0,SC: # ASCO14 long history of evidence of heritability of cancer - first noted by Broca in 1866,,,#,4.73476E+17,https://twitter.com/JeffreyMOtto/status/473476152896389121,,,,
drdonsdizon,6/2/2014 10:48,1,1,C Hinrichs @NCIBulletin LBA3008: Adoptive T-cell immunotx 4 HPV+ ca: Exciting results 4 prior Rx # cervca. Wave of future? # ASCO14 # gyncsm,,@NCIBulletin,# # #,4.73476E+17,https://twitter.com/drdonsdizon/status/473476130993750016,,,,
vincepalermo,6/2/2014 10:47,0,0,@ ASCO @ DKFZ @ 1 Change diet habits ASAP ! # bovinemeat # Cancerpic.twitter.com/7Kzav2DMVq,,@ @ @,# #,4.73476E+17,https://twitter.com/vincepalermo/status/473475962017824768,,,,
OncLive,6/2/2014 10:47,1,2,Dr. Johanna Bendell from @ SarahCannonDocs Discusses Two Studies in BRAF-Mutated CRC http://ow.ly/xwCSz # ASCO14,,@,#,4.73476E+17,https://twitter.com/OncLive/status/473475938177777664,,,,
Sports_bios,6/2/2014 10:47,0,1,Looks like $ ARIA winner for the # ASCO14 ball this morning (but fading).. and $ PBYI being Cinderella's step sister - Drizella,,,#,4.73476E+17,https://twitter.com/Sports_bios/status/473475931701800961,,,,
physicianswkly,6/2/2014 10:47,1,1,# ASCO14: Patients in # Pillars4Life online group intervention have statistically & clinically significant improvements http://www.physiciansweekly.com/asco-2014-pillars4life/ …,,,# #,4.73476E+17,https://twitter.com/physicianswkly/status/473475904942137344,,,,
CancerSupportHQ,6/2/2014 10:46,2,1,How do we really add the patient voice to the conversation?? How do you define value? # ASCO14 http://www.cancerexperienceregistry.org pic.twitter.com/attLrW1zy2,,,#,4.73476E+17,https://twitter.com/CancerSupportHQ/status/473475825740697600,,,,
GustaveRoussy,6/2/2014 10:46,4,0,# ASCO14 Le Dr Dufour : étude sur les tumeurs cérébrales chez les enfants. Bientôt la vidéo : http://bit.ly/RQbjdC pic.twitter.com/7Q8HFMLEGK,,,#,4.73476E+17,https://twitter.com/GustaveRoussy/status/473475657440444417,,,,
DrHedrick,6/2/2014 10:46,0,2,"Agree. Lot of research dollars, sweat, and tears. RT @ DrAttai: So sad - the abandoned posters bin # asco14 pic.twitter.com/Ypshlr2oeU",,@,#,4.73476E+17,https://twitter.com/DrHedrick/status/473475630223589376,,,,
heidisa,6/2/2014 10:45,2,4,"Surprising & important! @ FoundationATCG: How are # AYACSM cancers biologically distinct? Oral Session: 5:24-5:36, S100bc, Ab11008 # ASCO14”",,@,# #,4.73476E+17,https://twitter.com/heidisa/status/473475616730513409,,,,
ASCO,6/2/2014 10:45,16,0,Clinically meaningful outcomes in research an important step toward achieving high-value cancer care http://bit.ly/1k8ZIBR # ASCO14,,,#,4.73476E+17,https://twitter.com/ASCO/status/473475514850881536,,,,
Boehringer,6/2/2014 10:45,0,1,# HCPs: What’s the biggest barrier to better # lungcancer care for patients? # notjustonedisease # ASCO14,,,# # # #,4.73475E+17,https://twitter.com/Boehringer/status/473475495791984640,,,,
Roche,6/2/2014 10:45,13,5,# PersonalizedMedicine means we can target precisely those patients most likely to be helped. http://ow.ly/xp68y # ASCO14,,,# #,4.73475E+17,https://twitter.com/Roche/status/473475493711601665,,,,
JackWestMD,6/2/2014 10:45,1,1,SCLC & stage I-III NSCLC # ASCO14 oral abstract session starting. Look forward to time when it's in same time zone as rest of mtg. # 2MileWalk,,,# #,4.73475E+17,https://twitter.com/JackWestMD/status/473475487092998144,,,,
CRC_Medical,6/2/2014 10:45,0,0,"Great photo of our # author, John F. Smyth, at the American Society of Clinical Oncology Conference # ASCO14! He's... http://fb.me/6BwF6wGxS",,,# #,4.73475E+17,https://twitter.com/CRC_Medical/status/473475480180375552,,,,
nanostringtech,6/2/2014 10:45,0,1,"Chapman et al present Competing risks of mortality by PAM50 intrinsic subtype…"" at # ASCO14 (Abstract 562) http://abstracts.asco.org/144/AbstView_144_129910.html …""",,,#,4.73475E+17,https://twitter.com/nanostringtech/status/473475383816249345,,,,
giomarsi,6/2/2014 10:44,0,0,Nouvelle déception pour le lapatinib dans le cancer du sein: en adjuvant # ASCO14 @ APMinfos via @ SyLapostolle,,@ @,#,4.73475E+17,https://twitter.com/giomarsi/status/473475297443336194,,,,
BayerPharma,6/2/2014 10:44,0,0,# DYK 40-70% of # GIST occurs in the stomach. Find out more on http://bit.ly/1gDuhjy # ASCO14 http://twitpic.com/e5ayb4,,,# # #,4.73475E+17,https://twitter.com/BayerPharma/status/473475259417759744,,,,
teamoncology,6/2/2014 10:44,0,0,RT @ Timothyfarley16: @ teamoncology monotherapy in prostate? Ph1 no activity. # ASCO14,,@ @,#,4.73475E+17,https://twitter.com/teamoncology/status/473475218208350209,,,,
mtmdphd,6/2/2014 10:43,1,0,# mmsm # ASCO14 - Infusion - incr dose = incr time to deliver (SAR),,,# #,4.73475E+17,https://twitter.com/mtmdphd/status/473475069885562881,,,,
JLErsek,6/2/2014 10:43,0,0,"Greetings from health services research session @ # ASCO14 more to come on low dose lung ct, cost effect of bev in mCRC, health policy # LCI",,@,# #,4.73475E+17,https://twitter.com/JLErsek/status/473474968354033664,,,,
teamoncology,6/2/2014 10:42,0,2,I hope that anti-PD-1 and anti-PD-L1 will work in breast cancer. We plan to have a study in metastatic breast cancer. # ASCO14 # BCSM,,,# #,4.73475E+17,https://twitter.com/teamoncology/status/473474799692308480,,,,
WinshipAtEmory,6/2/2014 10:42,2,0,Sheela Hanasoge investigated the role of radiotherapy in sleep disturbances in breast cancer patients # ASCO14 pic.twitter.com/RWU6iKPZEa,,,#,4.73475E+17,https://twitter.com/WinshipAtEmory/status/473474754599329792,,,,
CancerGeek,6/2/2014 10:41,2,0,Cancer: Scientists Prime The Immune System As A Powerful Cancer Weapon http://flip.it/WMcnP # cancer # ASCO14,,,# #,4.73475E+17,https://twitter.com/CancerGeek/status/473474536005197824,,,,
teamoncology,6/2/2014 10:41,0,0,You wonder is there any cancer types that anti-PD-1 and anti-PD-L1 will not work. # ASCO14,,,#,4.73475E+17,https://twitter.com/teamoncology/status/473474524621447168,,,,
physicianswkly,6/2/2014 10:41,0,1,# ASCO14: Measuring 4 kallikrein markers improves specificity of # prostatecancer cancer screening compared w/ PSA only http://www.physiciansweekly.com/asco-2014-prostate-cancer-screening/ …,,,# #,4.73474E+17,https://twitter.com/physicianswkly/status/473474485317025792,,,,
OncEd,6/2/2014 10:40,0,0,Saltz treatments need to be individualized but chemo breaks should still be part of treatment of mCRC # crcsm # ASCO14,,,# #,4.73474E+17,https://twitter.com/OncEd/status/473474194744020992,,,,
TargetedOnc,6/2/2014 10:40,0,1,An interview at # ASCO14 with Dr. William D. Tap: PLX3397 for PVNS http://www.targetedonc.com/conference/asco-2014/A-Phase-I-Study-of-the-CSF1R-Kinase-Inhibitor-PLX3397-for-PVNS …,,,#,4.73474E+17,https://twitter.com/TargetedOnc/status/473474184660926464,,,,
DebiopharmNews,6/2/2014 10:40,0,0,# ASCO14 Phase I study Debio 1143 combo in # patients # leukemia # bloodcancer (abstract/poster #7029) Find out more http://ow.ly/xwlG3,,,# # # # #7029,4.73474E+17,https://twitter.com/DebiopharmNews/status/473474150632538112,,,,
genentech,6/2/2014 10:40,4,2,Med Dir Dr. A. Sandler explains why a negtrial isn't always a failed trial. Let's talk about MET. # ASCO14 http://ow.ly/xwpbD,,,#,4.73474E+17,https://twitter.com/genentech/status/473474129535172608,,,,
ShannonWestin,6/2/2014 10:40,2,1,Encouraging activity of defactinib (FAKi) in combo w paclitaxel in ovarian cancer. # ASCO14 # gyncsm,,,# #,4.73474E+17,https://twitter.com/ShannonWestin/status/473474126993440768,,,,
FoundationATCG,6/2/2014 10:39,2,1,"How are # AYACSM cancers biologically distinct? Find out during the Oral Abstract Session TODAY: 5:24-5:36, S100bc, Ab11008 # ASCO14",,,# #,4.73474E+17,https://twitter.com/FoundationATCG/status/473474098287636480,,,,
Boehringer,6/2/2014 10:39,0,2,"# PRESS: Learn more on LUX-Lung 3 & 6 trials via our interactive infographic, pooled results presented # ASCO14 http://bit.ly/ZjI3gs",,,# #,4.73474E+17,https://twitter.com/Boehringer/status/473474073423798272,,,,
mtmdphd,6/2/2014 10:39,2,0,# mmsm # ASCO14 - How to integrate multiple mAbs in Myeloma therapy? [Need more % Pts on trials] cc: @ VincentRKpic.twitter.com/NlCUzeAbq3,,@,# #,4.73474E+17,https://twitter.com/mtmdphd/status/473474068482887680,,,,
USATODAYhealth,6/2/2014 10:39,10,5,"Immune therapies improve treatment of some cancers; at least six promising studies at # ASCO14, http://usat.ly/1kpMv7W via @ usatoday",,@,#,4.73474E+17,https://twitter.com/USATODAYhealth/status/473474032642588672,,,,
JeffreyMOtto,6/2/2014 10:39,0,0,First up: Stephen Chanock - NGS: basic principles and interplay of tumor and germ-line genomes. # ASCO14,,,#,4.73474E+17,https://twitter.com/JeffreyMOtto/status/473474009611259904,,,,
LizSzabo,6/2/2014 10:39,23,7,"Immune therapies improve treatment of some cancers; at least six promising studies at # ASCO14, http://usat.ly/1mIXEix via @ usatoday",,@,#,4.73474E+17,https://twitter.com/LizSzabo/status/473473989151432704,,,,
NatRevClinOncol,6/2/2014 10:39,0,1,"A world free from the fear of cancer, Cliff Hudis intention # ASCO14 http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …",,,#,4.73474E+17,https://twitter.com/NatRevClinOncol/status/473473932344176640,,,,
chicagocapman,6/2/2014 10:38,0,0,Come say bonjour to Todd @ ASCO booth #4097 pic.twitter.com/phMwAdkAu9,,@,#4097,4.73474E+17,https://twitter.com/chicagocapman/status/473473852974981120,,,,
JeffreyMOtto,6/2/2014 10:38,0,0,Next session: Cancer genomics and inherited risk: recent advances and current challenges # ASCO14,,,#,4.73474E+17,https://twitter.com/JeffreyMOtto/status/473473677242011648,,,,
mtmdphd,6/2/2014 10:38,3,1,# mmsm # ASCO14 - Siltuximab impressive pic.twitter.com/QF8VjgyoD2,,,# #,4.73474E+17,https://twitter.com/mtmdphd/status/473473635035123712,,,,
Cortellis,6/2/2014 10:37,1,0,"P2 results of GDC0980 in patients with advanced endometrial carcinoma shows a PFS at 6 months of 20%, with a median OS of 17 months # ASCO14",,,#,4.73474E+17,https://twitter.com/Cortellis/status/473473571793031170,,,,
ShannonWestin,6/2/2014 10:37,0,0,Detectable level of heregulin mRNA corr w MM121 activity in subset of ovarian ca-future direction for this ErbB3 ab? # ASCO14 # gyncsm,,,# #,4.73474E+17,https://twitter.com/ShannonWestin/status/473473557155315713,,,,
MaurerStats,6/2/2014 10:37,0,0,MT @ DrMarkham Cardiovascular disease persists in Hodgkin # lymphoma survivors >35 yrs out from trtmnt. http://ow.ly/xwAvq # ASCO14 # lymsm,,@,# # #,4.73474E+17,https://twitter.com/MaurerStats/status/473473514360414208,,,,
PrDavidKhayat,6/2/2014 10:37,3,1,"# ASCO14, # Chicago : Finalement, avec moins de # traitements, on fait parfois mieux : métastases osseuses, # cancer orl...",,,# # # #,4.73474E+17,https://twitter.com/PrDavidKhayat/status/473473513672957952,,,,
aakonc,6/2/2014 10:37,0,0,Dr Saltz vital slide on cost of Bev maintenance #financialtoxicity#crc # ASCO14 pic.twitter.com/Tx5820xSJj,,,#financialtoxicity #crc #,4.73473E+17,https://twitter.com/aakonc/status/473473481347063810,,,,
DrMarkham,6/2/2014 10:37,0,0,@ ASCOPost @ asco Glad to be of service. :),,@ @,,4.73473E+17,https://twitter.com/DrMarkham/status/473473462527602688,,,,
TGeorgeMD,6/2/2014 10:37,2,1,"Dr. Saltz: single most impt variable in benefit/cost analysis for pts w/ mCRC is not Rx $$, but rather pt TIME. TIME alive. # ASCO14 # crcsm",,,# #,4.73473E+17,https://twitter.com/TGeorgeMD/status/473473388292616192,,,,
brendanweiss,6/2/2014 10:37,2,0,Dhodapkar of @ YaleCancer - need to understand long term effects of ant-CD38 mAbs - they impact diverse immune cells # ASCO14 # mmsm,,@,# #,4.73473E+17,https://twitter.com/brendanweiss/status/473473374950547456,,,,
caponew1,6/2/2014 10:36,6,3,New monotherapy Dara data by Lokhorst shows promising 35% response in pan-refractory pts at max 16mg dose # MMRFASCO with 2 reaching CR @ ASCO,,@,#,4.73473E+17,https://twitter.com/caponew1/status/473473353689628672,,,,
yzafar,6/2/2014 10:36,11,2,Saltz: What is the price of stability with bevacizumab? # ASCO14 # crcsm # financialtoxicitypic.twitter.com/fPdqZVU17v,,,# # #,4.73473E+17,https://twitter.com/yzafar/status/473473306868592641,,,,
mtmdphd,6/2/2014 10:36,1,1,# mmsm # ASCO14 - Need CD38 combo trials --> I have an idea if companies are interested. # EAOnc @ VincentRK,,@,# # #,4.73473E+17,https://twitter.com/mtmdphd/status/473473290959597568,,,,
CRC_Medical,6/2/2014 10:36,0,0,# ASCO14 Attendees! Have you entered our $200 AMEX gift card # Giveaway yet? Stop by # CRCPress booth #23128 for your last chance today! @ ASCO,,@,# # # #23128,4.73473E+17,https://twitter.com/CRC_Medical/status/473473240263065600,,,,
mtmdphd,6/2/2014 10:36,2,1,# mmsm # ASCO14 - CD38 as a Target for mAbs in MM pic.twitter.com/lrYg8X4i18,,,# #,4.73473E+17,https://twitter.com/mtmdphd/status/473473156469235714,,,,
SamuelLz,6/2/2014 10:36,0,1,Här kommer min intervju med Håkan Mellstedt # dmasco # asco14 http://www.dagensmedicin.se/asco/kongress-nestor-tror-pa-framgangar-inom-leukemi/ …,,,# #,4.73473E+17,https://twitter.com/SamuelLz/status/473473113796001792,,,,
ASCOPost,6/2/2014 10:36,0,0,"@ DrMarkham @ ASCO Thx for that heads-up! (working off an old folksonomy cheat sheet, I guess)",,@ @,,4.73473E+17,https://twitter.com/ASCOPost/status/473473107853082625,,,,
inkkr,6/2/2014 10:35,0,1,@ GCIHealth Great to meet at the networking tables at # ASCO14,,@,#,4.73473E+17,https://twitter.com/inkkr/status/473472989112336384,,,,
DrMarkham,6/2/2014 10:35,16,2,Cardiovascular disease persists in Hodgkin lymphoma survivors at least 35 years out from treatment. http://ow.ly/xwAvq # ASCO14 # lymsm,,,# #,4.73473E+17,https://twitter.com/DrMarkham/status/473472860624003072,,,,
GustaveRoussy,6/2/2014 10:34,3,0,# ASCO2014 Dr A. Leary : cancer de l'endomètre et profilage génétique. Bientôt la vidéo sur : http://bit.ly/RQbjdC pic.twitter.com/ifejxriIyU,,,#,4.73473E+17,https://twitter.com/GustaveRoussy/status/473472834980040706,,,,
DrAttai,6/2/2014 10:34,5,1,Mastectomy decision http://abstracts.asco.org/144/AbstView_144_130276.html?utm_content=buffer94a37&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer … # ASCO14 # bcsm,,,# #,4.73473E+17,https://twitter.com/DrAttai/status/473472769523720192,,,,
aakonc,6/2/2014 10:34,0,0,Len Saltz has alternative take on maintenance chemo asking for superiority of tx vs no tx#avoidgroupthink # ASCO14,,,#avoidgroupthink #,4.73473E+17,https://twitter.com/aakonc/status/473472752909680640,,,,
mtmdphd,6/2/2014 10:34,0,0,# mmsm # ASCO14 Dhodapkar Disc - impressive responses even in early phase trials (therapeutic intent even in Ph 1) pic.twitter.com/QpsCwQDH1f,,,# #,4.73473E+17,https://twitter.com/mtmdphd/status/473472731108089856,,,,
OncEd,6/2/2014 10:34,0,0,Saltz Dicsussing AIO 0207 and CAIRO3 induction maintenance studies # crcsm # ASCO14,,,# #,4.73473E+17,https://twitter.com/OncEd/status/473472698916806657,,,,
brendanweiss,6/2/2014 10:34,1,0,Dara infusion reactions may depend on tumor burden and drug dilution during administration # ASCO14 # mmsm,,,# #,4.73473E+17,https://twitter.com/brendanweiss/status/473472684052197376,,,,
shariqalavi,6/2/2014 10:34,1,1,@ cytel Benefits of social media - see you in 2015 - adaptive enrichment designs in oncology. # ASCO14 pic.twitter.com/FtC8CjK0O1,,@,#,4.73473E+17,https://twitter.com/shariqalavi/status/473472644801515520,,,,
PMLiVEcom,6/2/2014 10:33,1,0,"Drug discovery and development is a team sport"" - @ AstraZeneca's Susan Galbraith http://bit.ly/1oQEM3p # ASCO14""",,@,#,4.73472E+17,https://twitter.com/PMLiVEcom/status/473472447753486336,,,,
WinshipAtEmory,6/2/2014 10:33,3,0,Dr Elisavet Paplomata looked at the response to pre-op chemo in triple negative breast cancer # ASCO14 pic.twitter.com/A6nQwdlQPV,,,#,4.73472E+17,https://twitter.com/WinshipAtEmory/status/473472353994018816,,,,
yzafar,6/2/2014 10:33,0,0,"Saltz: should we treat to prolong treatment response, especially when OS is not improved? # ASCO14 # crcsm",,,# #,4.73472E+17,https://twitter.com/yzafar/status/473472352047886336,,,,
DrAttai,6/2/2014 10:32,9,9,Why women are choosing mastectomy - influences beyond the surgeon # asco14 # bcsmpic.twitter.com/73sJ20ezQA,,,# #,4.73472E+17,https://twitter.com/DrAttai/status/473472342015102976,,,,
MidAmPrint,6/2/2014 10:32,0,0,We know it's not the windy weather of the Windy City that's blowing the attendees of # ASCO14 away! # HCSM Tweeters: http://bit.ly/1lBa5hq,,,# #,4.73472E+17,https://twitter.com/MidAmPrint/status/473472283823341568,,,,
TGeorgeMD,6/2/2014 10:32,4,0,Dr. Saltz: Treatment break strategies for pts w/ mCRC need to be individualized but not abandoned. Impt for QOL. # ASCO14 # crcsm CAIRO3/AIO,,,# #,4.73472E+17,https://twitter.com/TGeorgeMD/status/473472264454021120,,,,
JSweetenhamMD,6/2/2014 10:32,0,0,http://abstracts.asco.org/144/index.html Important data from HCI and the U of Utah College of Pharmacy at # ASCO14 @ huntsmancancer,,@,#,4.73472E+17,https://twitter.com/JSweetenhamMD/status/473472162838220800,,,,
brendanweiss,6/2/2014 10:32,5,1,"Dhodapkar of @ YaleCancer: mAbs have strong preclinical synergy with len, only anti-CD38 mAbs have single agent activity # ASCO14 # mmsm",,@,# #,4.73472E+17,https://twitter.com/brendanweiss/status/473472109700583427,,,,
fwpharma,6/2/2014 10:31,1,0,FirstWord Lists: A revolution in # cancer – a launch calendar for key immuno-oncology indications http://bit.ly/SnTtPL # ASCO14,,,# #,4.73472E+17,https://twitter.com/fwpharma/status/473472050787794944,,,,
corp_UNC,6/2/2014 10:31,0,0,Return of individual research results: Policies & experiences of cancer genomic researchers A.Deal et al # asco14 http://ow.ly/xqBn6,,,#,4.73472E+17,https://twitter.com/corp_UNC/status/473471909305516032,,,,
ASCO,6/2/2014 10:31,0,1,Looking for yesterday's Daily News? Did you spill coffee in your session? Email amhelp@asco.org for assistance. # ASCO14,,@asco,#,4.73472E+17,https://twitter.com/ASCO/status/473471903555149824,,,,
CancerDotNet,6/2/2014 10:31,9,0,# ASCO14 research on metastatic # melanoma: New PD-1 immunotherapy MK-3475 shows promisehttp://bit.ly/1m5jjQo,,,# #,4.73472E+17,https://twitter.com/CancerDotNet/status/473471857921114112,,,,
ASCOPost,6/2/2014 10:31,8,1,"Merck immune system-booster effective in skin, lung cancer (via @ Reuters) http://ow.ly/xwzv4 # ASCO14 # lcsm # melnm",,@,# # #,4.73472E+17,https://twitter.com/ASCOPost/status/473471853122846720,,,,
drdonsdizon,6/2/2014 10:31,1,1,"Ribas, et al. LBA9000- PEmbrolimumab in adv # melanoma, durable responses with 88% continuing. G3-4 tox 12%. Med OS 71% at 1y. # ASCO14",,,# #,4.73472E+17,https://twitter.com/drdonsdizon/status/473471850949775360,,,,
adamfeuerstein,6/2/2014 10:30,0,0,"What are # ASCO14 stocks doing this morning? Someone give me a rundown, pls.",,,#,4.73472E+17,https://twitter.com/adamfeuerstein/status/473471842674827265,,,,
naveen101,6/2/2014 10:30,0,2,"@ ConsanoMolly My pleasure, as always. Sounds like you're having a ball at # ASCO14 . Keep up the good work :)",,@,#,4.73472E+17,https://twitter.com/naveen101/status/473471826400530434,,,,
SarahCannonDocs,6/2/2014 10:30,0,0,Oral Presentation with # SCRI: Genitourinary (Nonprostate) Cancer - 9:45 am E Hall D1 # ASCO14,,,# #,4.73472E+17,https://twitter.com/SarahCannonDocs/status/473471811007811584,,,,
MontefioreNYC,6/2/2014 10:30,2,0,Want to learn about a new lung # cancer discovery? Read details here: http://bit.ly/1lV3aNs # ASCO14,,,# #,4.73472E+17,https://twitter.com/MontefioreNYC/status/473471807908229120,,,,
ONAcom,6/2/2014 10:30,0,2,"MT @ asco: # ASCO14 Nivolumab/ipilimumab combo produced unprecedented 2-yr overall survival rates: 79%, ‘very impressive’ – Dr Sznol",,@,#,4.73472E+17,https://twitter.com/ONAcom/status/473471786123001857,,,,
SequentaInc,6/2/2014 10:30,0,1,"# ASCO14 abst. 3016: Improved OS associated w/ maintenance of pre-exist hi-freq memory T-cells during immunotherapy trtmt (4:45pm CT, S406)",,,#,4.73472E+17,https://twitter.com/SequentaInc/status/473471743202689024,,,,
mtmdphd,6/2/2014 10:30,1,0,# mmsm # ASCO14 Dhodapkar Disc - mAbs in Advanced Phase Testing in MM pic.twitter.com/yZK71HyoKK,,,# #,4.73472E+17,https://twitter.com/mtmdphd/status/473471724395036672,,,,
SamuelLz,6/2/2014 10:30,1,0,-> men @ magnusfovaeus slår här ett slag för att kongressen även är viktig för kirurger och urologer # dmasco # asco14 http://www.dagensmedicin.se/asco/nyheter-ocksa-for-oss-som-opererar/ …,,@,# #,4.73472E+17,https://twitter.com/SamuelLz/status/473471724311171073,,,,
DebiopharmNews,6/2/2014 10:30,0,0,# ASCO14 Final PK/PD phase I Debio 1143 (AT406) # patients # cancer (abstract/poster #2532). Find out more https://www.debiopharm.com/our-business/pipeline.html …,,,# # # #2532,4.73472E+17,https://twitter.com/DebiopharmNews/status/473471668313411585,,,,
FierceBiotech,6/2/2014 10:30,5,2,# ASCO14: Bristol-Myers immuno-oncology combo extends lives of patients in melanoma study. http://www.fiercebiotech.com/story/bristol-myers-immuno-oncology-combo-extends-lives-patients-melanoma-study/2014-06-01 … by @ JohnCFierce $ BMY,,@,#,4.73472E+17,https://twitter.com/FierceBiotech/status/473471630337781760,,,,
mtmdphd,6/2/2014 10:29,2,0,# mmsm # ASCO14 Dhodapkar Disc - Targets... pic.twitter.com/gdDeZc7CNw,,,# #,4.73472E+17,https://twitter.com/mtmdphd/status/473471559458631680,,,,
tomleblancMD,6/2/2014 10:29,0,1,Amazing!!! RT @ ASCO: # ASCO14 Press brief: Nivolumab/ipilimumab combo produced unprecedented 2-yr overall survival rates: 79%,,@,#,4.73472E+17,https://twitter.com/tomleblancMD/status/473471530459234304,,,,
teamoncology,6/2/2014 10:29,0,0,Can somebody teach me what is the difference of all the different anti-PD-1 antibodies under development? # ASCO14,,,#,4.73471E+17,https://twitter.com/teamoncology/status/473471495050502144,,,,
ShannonWestin,6/2/2014 10:29,0,0,J. Liu- MM-121 (ErbB3 MAB) did not offer additional benefit to wkly taxol in an unselected ovarian ca pop'n. # ASCO14 # gyncsm,,,# #,4.73471E+17,https://twitter.com/ShannonWestin/status/473471458535305216,,,,
SamuelLz,6/2/2014 10:29,0,0,Asco handlar väldigt mycket om läkemedel i år # dmasco # asco14 ->,,,# #,4.73471E+17,https://twitter.com/SamuelLz/status/473471452914528256,,,,
bmsnews,6/2/2014 10:29,6,5,A behind the scenes look at Michael Giordano’s interview with @ SquawkCNBC at # ASCO14 pic.twitter.com/9EszunIjQC,,@,#,4.73471E+17,https://twitter.com/bmsnews/status/473471419766947841,,,,
WayneKoberstein,6/2/2014 10:29,1,0,"Random thoughts # ASCO14: Chemo & targeted-drug folks feeling eclipsed by immunoTx buzz here, but still rule in practice. @ RfwrightLSL",,@,#,4.73471E+17,https://twitter.com/WayneKoberstein/status/473471346513420288,,,,
SanofiUS,6/2/2014 10:28,0,0,RT @ SanofiCanada: Fostering communication among oncology-related subspecialties at # ASCO2014,,@,#,4.73471E+17,https://twitter.com/SanofiUS/status/473471284790460417,,,,
mtmdphd,6/2/2014 10:28,0,1,# mmsm # ASCO14 Dhodapkar Disc - mAb - More than one way to kill a tumor pic.twitter.com/1lLxVNRu2J,,,# #,4.73471E+17,https://twitter.com/mtmdphd/status/473471275105796096,,,,
teamoncology,6/2/2014 10:28,0,0,【 # ASCO14 Update】Anti-PD-1 monoclonal antibody MK-3475 effective in melanoma. http://abstracts.asco.org/144/AbstView_144_133842.html …,,,#,4.73471E+17,https://twitter.com/teamoncology/status/473471265995358208,,,,
caponew1,6/2/2014 10:28,10,4,Exciting data from Dr. Tom Martin @ ucsf SAR combination study # MMRFASCO @ asco with ORR of 63% and >40% in pan Imid/PI refractory patients.,,@ @,#,4.73471E+17,https://twitter.com/caponew1/status/473471184160714752,,,,
laurentingels,6/2/2014 10:28,0,1,# ASCO14 interviews à la chaîne # cancer # onconlogypic.twitter.com/FbgtgklraN,,,# # #,4.73471E+17,https://twitter.com/laurentingels/status/473471137717166080,,,,
mtmdphd,6/2/2014 10:28,0,0,# mmsm # ASCO14 Dhodapkar Disc - Improving Therapeutic Landscape in Myeloma pic.twitter.com/PwIu6vBDwN,,,# #,4.73471E+17,https://twitter.com/mtmdphd/status/473471134001004544,,,,
MGHCancerCenter,6/2/2014 10:27,0,1,"Ryan Sullivan, MD in the # ASCO14 press room putting two promising melanoma studies in perspective for members of the media",,,#,4.73471E+17,https://twitter.com/MGHCancerCenter/status/473470991763783680,,,,
MedscapeOnc,6/2/2014 10:27,2,1,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73471E+17,https://twitter.com/MedscapeOnc/status/473470941045854208,,,,
Medscape,6/2/2014 10:27,3,0,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73471E+17,https://twitter.com/Medscape/status/473470940563533824,,,,
OncEd,6/2/2014 10:26,0,0,Koopman CAIRO3 QOL : no clinically relevant difference between maintenance and no tx arm # crcsm # ASCO14,,,# #,4.73471E+17,https://twitter.com/OncEd/status/473470826898280448,,,,
CathyEngMD,6/2/2014 10:26,1,1,# ASCO14: CAIRO3 update. Interesting results of the role of metachronous vs synchronous disease in met # colorectal # Cancer,,,# # #,4.73471E+17,https://twitter.com/CathyEngMD/status/473470826319474688,,,,
DrMarkham,6/2/2014 10:26,0,2,"@ ASCOPost @ asco Just FYI, but most of use # gyncsm rather than # gynca for gyn cancers info. # ASCO14",,@ @,# # #,4.73471E+17,https://twitter.com/DrMarkham/status/473470815137439745,,,,
tomleblancMD,6/2/2014 10:26,0,0,MT @ drecroach: Dr. Sweetenham reflects on 50 years of progress against blood # cancers http://bit.ly/1pBLWbD # ASCO14 # leukemia # lymphoma,,@,# # # #,4.73471E+17,https://twitter.com/tomleblancMD/status/473470805826093057,,,,
DoctorEdny,6/2/2014 10:26,1,0,Oncologists need to improve upon their genomic literacy as panel testing advances # ASCO14 pic.twitter.com/PI0LCiT8JB,,,#,4.73471E+17,https://twitter.com/DoctorEdny/status/473470782514135040,,,,
brendanweiss,6/2/2014 10:26,2,1,anti-CD38 MoAbs continue to impress in RRMM # ASCO14 # mmsm,,,# #,4.73471E+17,https://twitter.com/brendanweiss/status/473470768182218752,,,,
teamoncology,6/2/2014 10:26,0,0,I am going to guess that Anti-PD1 or Anti-PD-L1 will be effective in Stage III melanoma. # ASCO14,,,#,4.73471E+17,https://twitter.com/teamoncology/status/473470760707571713,,,,
ErinZwirnPR,6/2/2014 10:26,0,0,RT @ ProjectInno:We must commit as a nation to hasten the pace of medical discovery in order to save more lives http://ow.ly/xwoMj # ASCO14,,@,#,4.73471E+17,https://twitter.com/ErinZwirnPR/status/473470743721037824,,,,
DoctorEdny,6/2/2014 10:26,3,0,$ MYRD 67% increase in detection of del muts w/ 25 panel gene assay in ovarian cancer over BRCA1/2 alone # ASCO14 pic.twitter.com/0Xg7t7B74P,,,#,4.73471E+17,https://twitter.com/DoctorEdny/status/473470721059221506,,,,
mtmdphd,6/2/2014 10:26,1,0,# mmsm # ASCO14 Castleman's - Van Rhee - New Tx options for a rare disease - global effort pic.twitter.com/7i98sYWThO,,,# #,4.73471E+17,https://twitter.com/mtmdphd/status/473470691275452416,,,,
DoctorEdny,6/2/2014 10:26,2,0,25 gene panel testing details $ MYRD # ASCO14 pic.twitter.com/RlAJ1T4WrZ,,,#,4.73471E+17,https://twitter.com/DoctorEdny/status/473470688674975744,,,,
UMR4NIH,6/2/2014 10:26,0,1,". @ ASCO's 50th reveals major progress against cancer, but funding is short and many challenges remain."" # ASCO14 # NIH http://www.standardmedia.co.ke/health/article/2000123325/breathtaking-progress-in-fight-against-cancer …""",,@,# #,4.73471E+17,https://twitter.com/UMR4NIH/status/473470659562319872,,,,
DoctorEdny,6/2/2014 10:26,2,0,Clinical multiplex panel for Lynch syndrome # ASCO14 $ MYRD discussant says 5.6% is actual endptpic.twitter.com/FfxNrwrHgD,,,#,4.73471E+17,https://twitter.com/DoctorEdny/status/473470655548391424,,,,
DoctorEdny,6/2/2014 10:26,2,0,Finding BRCA1 is important and finding these pts is valuable finding $ MYRD # ASCO14 pic.twitter.com/AeFz2T7f9u,,,#,4.73471E+17,https://twitter.com/DoctorEdny/status/473470604780507136,,,,
Xcenda,6/2/2014 10:26,0,1,# Xcenda presents 2 posters on NSCLC & chronic myelogenous leukemia at # ASCO2014. Learn more: http://bit.ly/1jXRsje # ASCO14,,,# # #,4.73471E+17,https://twitter.com/Xcenda/status/473470594973851649,,,,
teamoncology,6/2/2014 10:26,0,0,"【 # ASCO14 Update】Ipilimumab, targeting CTLA-4, is an effective treatment in stage III melanoma. http://abstracts.asco.org/144/AbstView_144_130118.html …",,,#,4.73471E+17,https://twitter.com/teamoncology/status/473470590683062272,,,,
LifeSciAdvisors,6/2/2014 10:25,0,0,DelMar Pharmaceuticals $ DMPI Presents Promising VAL-083 Interim Data from GBM Clinical Trial at # ASCO2014 http://ow.ly/xwyqg,,,#,4.73471E+17,https://twitter.com/LifeSciAdvisors/status/473470572773789696,,,,
BioWorld,6/2/2014 10:25,2,0,"Happy Immuno- oncology Day, # ASCO14 . Melanoma in the crosshairs.",,,#,4.73471E+17,https://twitter.com/BioWorld/status/473470512757497856,,,,
DrMarkham,6/2/2014 10:25,0,0,# gyncsm RT @ ASCOPost: Doctors use immune therapy against cervical cancer (via @ washingtonpost) http://ow.ly/xwxYH # ASCO14,,@ @,# #,4.7347E+17,https://twitter.com/DrMarkham/status/473470471439388673,,,,
BeaconHC,6/2/2014 10:25,0,1,A tremendous amount of positive information coming out of # ASCO14 Here's hoping for more!,,,#,4.7347E+17,https://twitter.com/BeaconHC/status/473470466683076609,,,,
WinshipAtEmory,6/2/2014 10:25,2,1,Breast cancer expert Dr Amelia Zelnak presented a study funded in part by the Glenn Family Foundation # ASCO14 pic.twitter.com/tzimmzsqNX,,,#,4.7347E+17,https://twitter.com/WinshipAtEmory/status/473470462891024384,,,,
mtmdphd,6/2/2014 10:25,1,0,# mmsm # ASCO14 Castleman's - Van Rhee - Siltuximab Conclusions pic.twitter.com/58DhmUAS31,,,# #,4.7347E+17,https://twitter.com/mtmdphd/status/473470440237961217,,,,
ASCOPost,6/2/2014 10:24,4,0,Doctors use immune therapy against cervical cancer (via @ washingtonpost) http://ow.ly/xwxYH # ASCO14 # gynca # cxca,,@,# # #,4.7347E+17,https://twitter.com/ASCOPost/status/473470186570645504,,,,
mtmdphd,6/2/2014 10:24,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Safety Summary pic.twitter.com/3HriLXHN04,,,# #,4.7347E+17,https://twitter.com/mtmdphd/status/473470138566864896,,,,
OncEd,6/2/2014 10:24,1,0,Koopman CAIRO3 Maintenace Cape Bev improves time to 2nd progression but not OS compared to no treatment # crcsm # ASCO14,,,# #,4.7347E+17,https://twitter.com/OncEd/status/473470116286722048,,,,
teamoncology,6/2/2014 10:23,0,0,@ DrAttai You wonder if there is a better way to use less papers for poster production. # ASCO14 # BCSM,,@,# #,4.7347E+17,https://twitter.com/teamoncology/status/473470000787775488,,,,
LifeSciAdvisors,6/2/2014 10:23,0,0,Adherex $ ADHXF Announces Results from Two Sodium Thiosulfate Phase 3 Studies @ # ASCO2014. http://ow.ly/xwxUW,,@,#,4.7347E+17,https://twitter.com/LifeSciAdvisors/status/473469973114142720,,,,
mtmdphd,6/2/2014 10:23,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Secondary Endpoints pic.twitter.com/29ywv4oyHf,,,# #,4.7347E+17,https://twitter.com/mtmdphd/status/473469862468390913,,,,
DrMarkham,6/2/2014 10:23,1,1,MT @ tgeorgemd: Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer. Confirms clinical practice. # ASCO14 # crcsm @ UFHealth,,@ @,# #,4.7347E+17,https://twitter.com/DrMarkham/status/473469857603022849,,,,
bpowersphoto,6/2/2014 10:22,0,0,Skyline reflection at # asco14. # chicago # skyline # reflection # itwillalwaysbesearstome @McCormick Place http://instagram.com/p/ovrAH_rH55/,,@McCormick,# # # # #,4.7347E+17,https://twitter.com/bpowersphoto/status/473469802627874818,,,,
CancerTherAdvsr,6/2/2014 10:22,0,0,"@ ASCO has come a long way! More than 33,000 attendees at # ASCO14! pic.twitter.com/Umn1py4BSK",,@,#,4.7347E+17,https://twitter.com/CancerTherAdvsr/status/473469788681805824,,,,
pbcancerdoc,6/2/2014 10:22,1,0,@ OHSUKnight CCE OHSU poster on impact of genomic testing. http://abstracts.asco.org/144/AbstView_144_128879.html …. # ASCO14 # genomics # NextGenpic.twitter.com/m8xe3tUwEL,,@,# # #,4.7347E+17,https://twitter.com/pbcancerdoc/status/473469766456590336,,,,
yzafar,6/2/2014 10:22,4,0,"Met colorectal: after 6 cycles of capox-bev, maint cap-bev improves PFS over obs, but no OS benefit. # ASCO14 # crcsmpic.twitter.com/lxiBCcKIf9",,,# #,4.7347E+17,https://twitter.com/yzafar/status/473469756943896576,,,,
mtmdphd,6/2/2014 10:22,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Time to Treatment Failure (TTF) - Tx naive and prior Tx pic.twitter.com/FNEVaiJ4Ca,,,# #,4.7347E+17,https://twitter.com/mtmdphd/status/473469733426429952,,,,
teamoncology,6/2/2014 10:22,3,2,Do they recycle? # ASCO14 # BCSM RT @ DrAttai: So sad - the abandoned posters bin # asco14 pic.twitter.com/XMaL2ZfM4h,,@,# # #,4.7347E+17,https://twitter.com/teamoncology/status/473469602509242368,,,,
ShannonWestin,6/2/2014 10:22,1,0,MK2206 (AKTi) w disappointing activity in uterine serous ca. But- one PR x 12 mo. Need to clarify why she had benefit. # ASCO14 # gyncsm,,,# #,4.7347E+17,https://twitter.com/ShannonWestin/status/473469590140620800,,,,
drdonsdizon,6/2/2014 10:22,2,0,LBA9008 Must consider toxicity of Rx: both physical & financial. In study- 5 Rx-related deaths is not trivial. # ASCO14 # melanoma,,,# #,4.7347E+17,https://twitter.com/drdonsdizon/status/473469587510800384,,,,
mtmdphd,6/2/2014 10:21,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - TTF pic.twitter.com/i3wECr1HXI,,,# #,4.7347E+17,https://twitter.com/mtmdphd/status/473469556653314048,,,,
ASCOPost,6/2/2014 10:21,9,2,Cancer Researchers Report Longer Survival Rates With Immunotherapy (via @ NYTimes) http://ow.ly/xwxh0 # ASCO14 # melnm,,@,# #,4.73469E+17,https://twitter.com/ASCOPost/status/473469464588349443,,,,
mtmdphd,6/2/2014 10:21,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Response pic.twitter.com/bJmWZiV8LW,,,# #,4.73469E+17,https://twitter.com/mtmdphd/status/473469441129603072,,,,
strategicTy,6/2/2014 10:21,0,0,Thank you @ asco for such a wonderful/informative week and please thank your great city @ chicagosmayor for hosting all of us here # asco14,,@ @,#,4.73469E+17,https://twitter.com/strategicTy/status/473469361030971392,,,,
TGeorgeMD,6/2/2014 10:21,4,3,"Dr. Allegra- FOLFOX improves survival in adjuvant rectal cancer, similar to colon. Confirms our clinical practice. # ASCO14 # crcsm @ UFHealth",,@,# #,4.73469E+17,https://twitter.com/TGeorgeMD/status/473469360590585856,,,,
drdonsdizon,6/2/2014 10:21,1,0,A Eggermont @ EORTC LBA9008: Adjuvant Ipi vs placebo: 3yRFS 46.5 v 34.8%. Median RFS 26.1 vs 17.1m. OS?? # melanoma # ASCO14,,@,# #,4.73469E+17,https://twitter.com/drdonsdizon/status/473469334300282881,,,,
mtmdphd,6/2/2014 10:20,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Prior Regimens pic.twitter.com/tXn0ZV97gf,,,# #,4.73469E+17,https://twitter.com/mtmdphd/status/473469325098381313,,,,
preventcancer,6/2/2014 10:20,1,2,Oncologist friends from Italy in @ preventcancer lime green shades at # ASCO14 pic.twitter.com/ToZDTIvyjX,,@,#,4.73469E+17,https://twitter.com/preventcancer/status/473469255619727360,,,,
boehringerus,6/2/2014 10:20,0,2,There’s lots to learn about # lungcancer and # ASCO14 has the latest in R&D. Check out these disease fast facts: http://bit.ly/1ch4Qyx,,,# #,4.73469E+17,https://twitter.com/boehringerus/status/473469211340447745,,,,
DasLebenshaus,6/2/2014 10:20,0,1,"# ASCO14: Come see me and my poster, at 1:15 pm, abstract#4602, board 163B, to discuss about quality of life for mRCC patients.",,,# #4602,4.73469E+17,https://twitter.com/DasLebenshaus/status/473469179828633601,,,,
mtmdphd,6/2/2014 10:20,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Table 1 pic.twitter.com/Pk9bzVuFgc,,,# #,4.73469E+17,https://twitter.com/mtmdphd/status/473469154604105728,,,,
genentech,6/2/2014 10:20,3,0,Why adv melanoma may be a 'proving ground' for cutting edge tx approaches: http://ow.ly/xwtqf - J. Low - Med Dir. # ASCO14 # melsm,,,# #,4.73469E+17,https://twitter.com/genentech/status/473469143711502336,,,,
DebiopharmNews,6/2/2014 10:20,0,0,# ASCO14 Debio1143 results in # HNCSM Find out more http://ow.ly/xwlov,,,# #,4.73469E+17,https://twitter.com/DebiopharmNews/status/473469114837897217,,,,
FierceBiotech,6/2/2014 10:20,6,2,"# ASCO14: Amgen is gunning for approval of viral cancer vaccine, adds positive combo data. http://www.fiercebiotech.com/story/amgen-gunning-approval-viral-cancer-vaccine-adds-positive-combo-data/2014-06-01 … by @ JohnCFierce $ AMGN",,@,#,4.73469E+17,https://twitter.com/FierceBiotech/status/473469114543915008,,,,
drdonsdizon,6/2/2014 10:20,0,0,A Eggermont @ EORTC LBA9008: Adjuvant ipi signif improves recurrence-free surv (RFS) vs placebo. # melanoma # ASCO14,,@,# #,4.73469E+17,https://twitter.com/drdonsdizon/status/473469084936331264,,,,
jdflaysakier,6/2/2014 10:19,10,1,L'histoire du test respiratoire pour le cancer du poumon dont on parle en France est passée totalement inaperçue ici à Chicago ! # ASCO14,,,#,4.73469E+17,https://twitter.com/jdflaysakier/status/473469073984999424,,,,
mtmdphd,6/2/2014 10:19,0,1,# mmsm # ASCO14 Castleman's - Van Rhee - Study Design pic.twitter.com/YLA9bez9J1,,,# #,4.73469E+17,https://twitter.com/mtmdphd/status/473468932356321280,,,,
DrAttai,6/2/2014 10:19,3,4,So sad - the abandoned posters bin # asco14 pic.twitter.com/rXwkq1k3hU,,,#,4.73469E+17,https://twitter.com/DrAttai/status/473468861602230273,,,,
charleneson,6/2/2014 10:18,0,4,"We have massively parallel sequencing but not massively parallel genetic counseling"" # ASCO14""",,,#,4.73469E+17,https://twitter.com/charleneson/status/473468709156057088,,,,
ExperisLifeSci,6/2/2014 10:18,0,1,MD Anderson studies show that scaling back medications is safe in some instances saving strain on body & $$. http://reut.rs/1kxK6ID # ASCO14,,,#,4.73469E+17,https://twitter.com/ExperisLifeSci/status/473468681934995457,,,,
mtmdphd,6/2/2014 10:18,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Central Role of IL-6 in Pathogenesis of MCD pic.twitter.com/qiUH8vq05S,,,# #,4.73469E+17,https://twitter.com/mtmdphd/status/473468672032645121,,,,
mnewtonPharmD,6/2/2014 10:18,1,0,Wow! # melanoma RT @ ASCO: # ASCO14 Press brief: Nivolumab/ipilimumab combo produced unprecedented 2-yr overall survival rates: 79%,,@,# #,4.73469E+17,https://twitter.com/mnewtonPharmD/status/473468664474501120,,,,
Cognicum,6/2/2014 10:18,0,0,“ @ ASCO: Not an ASCO Member? Join at # ASCO14: Visit a Member Services Desk to receive a membership https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,#,4.73469E+17,https://twitter.com/Cognicum/status/473468599378935809,,,,
ByJonGardner,6/2/2014 10:17,0,1,"For the record on the $ CLVS insulin reveal: No data in the CO-1686 # ASCO14 presentation, news came 40-some minutes into 1-hour analyst mtg.",,,#,4.73469E+17,https://twitter.com/ByJonGardner/status/473468575806914560,,,,
drecroach,6/2/2014 10:17,0,0,Dr. Sweetenham reflects on 50 years of progress against hematologic cancers http://bit.ly/1pBLWbD # ASCO14,,,#,4.73469E+17,https://twitter.com/drecroach/status/473468555024142336,,,,
WayneKoberstein,6/2/2014 10:17,1,1,Random thoughts # ASCO14 Many oncs would be happy fine-tuning the status quo forever; others dream of miracles. @ RfwrightLSL @ kevingopal,,@ @,#,4.73468E+17,https://twitter.com/WayneKoberstein/status/473468487747121152,,,,
Rfonsi1,6/2/2014 10:17,4,2,It was obvious and now great we have daratumumab and SAR650984. Why did it take so long to have monoclonals for myeloma??? # ASCO14,,,#,4.73468E+17,https://twitter.com/Rfonsi1/status/473468474657087488,,,,
wendyselig,6/2/2014 10:17,0,1,More big news from # asco14 for # melanoma patients: 88 percent 2 year survival on immunology combo! @ MelanomaReAlli,,@,# #,4.73468E+17,https://twitter.com/wendyselig/status/473468384844460032,,,,
Roche,6/2/2014 10:17,1,5,So you think you know your hazard ratio from your success rate? Test your # ClinicalTtrials IQ: http://ow.ly/xwwct # ASCO14,,,# #,4.73468E+17,https://twitter.com/Roche/status/473468327701266432,,,,
mtmdphd,6/2/2014 10:16,0,0,# mmsm # ASCO14 Castleman's - Van Rhee - Background MCD pic.twitter.com/hkhSreJUdZ,,,# #,4.73468E+17,https://twitter.com/mtmdphd/status/473468318846689282,,,,
YaleMed,6/2/2014 10:16,3,1,"Dr. Sznol: Hard to believe single checkpoint is going to be important for every cancer"" @ YaleCancer @ nytimes # asco14 http://nyti.ms/1gYcEev""",,@ @,#,4.73468E+17,https://twitter.com/YaleMed/status/473468290111901696,,,,
DrAttai,6/2/2014 10:16,10,6,Size doesn't always matter! Tumor biology important (3/3) # asco14 pic.twitter.com/m37fLf8lO6,,,#,4.73468E+17,https://twitter.com/DrAttai/status/473468226794717186,,,,
Consano,6/2/2014 10:16,1,1,"If you haven't yet, come on by our # ASCO14 http://consano.org table to talk # crowdfunding # research… and to get a complimentary pen!",,,# # #,4.73468E+17,https://twitter.com/Consano/status/473468196788240384,,,,
DrAttai,6/2/2014 10:16,4,4,Size doesn't always matter! Tumor biology important (2/3) # asco14 pic.twitter.com/LXGqLF8zvx,,,#,4.73468E+17,https://twitter.com/DrAttai/status/473468164723195904,,,,
mtmdphd,6/2/2014 10:16,1,0,# mmsm # ASCO14 Castleman's - Van Rhee - Siltuximab in Prev Tx Multicentric Castleman's Disease (MCD) pic.twitter.com/hz1wSacCFL,,,# #,4.73468E+17,https://twitter.com/mtmdphd/status/473468136834879489,,,,
teamoncology,6/2/2014 10:16,0,0,"T1b BC and intermediate RS, pts who received HT alone had the similar DFS as those who received CH-T. # ASCO14 # BCSM http://abstracts.asco.org/144/AbstView_144_133769.html …",,,# #,4.73468E+17,https://twitter.com/teamoncology/status/473468102881988609,,,,
DrAttai,6/2/2014 10:16,3,2,Size doesn't always matter! Tumor biology important (1/3) # asco14 pic.twitter.com/iToMsS8f2L,,,#,4.73468E+17,https://twitter.com/DrAttai/status/473468089011806208,,,,
big4bio,6/2/2014 10:15,0,0,ASCO 2014 Annual Meeting Live Blog Day 4 # ASCO14 http://biotechstrategyblog.com/2014/06/asco-2014-annual-meeting-live-blog-day-4-asco14.html/ …,,,#,4.73468E+17,https://twitter.com/big4bio/status/473468066597052418,,,,
teamoncology,6/2/2014 10:15,0,1,Less than 10% of patients with stage I had high RS. http://abstracts.asco.org/144/AbstView_144_133769.html … # ASCO14 # BCSM,,,# #,4.73468E+17,https://twitter.com/teamoncology/status/473467967372414977,,,,
yzafar,6/2/2014 10:15,1,0,"Met CRC: To prolong time to progression, more maintenance is better, but no OS imrpvmt http://bit.ly/1m2UoNh # ASCO14 pic.twitter.com/3EwaqZBh2C",,,#,4.73468E+17,https://twitter.com/yzafar/status/473467957721305088,,,,
Novartis,6/2/2014 10:15,0,1,Lots of discussions about # lungcancer at # ASCO14. Learn more about ALK+ NSCLC # LCSM http://bit.ly/1nVnWz2,,,# # #,4.73468E+17,https://twitter.com/Novartis/status/473467954194313216,,,,
JacobPlieth,6/2/2014 10:15,2,1,"$ MRK INN puzzle explained by Dr Ribas: lambro"" was approved by US naming body"," but international one didn't like it; hence ""pembro"" # ASCO14""",,,#,4.73468E+17,https://twitter.com/JacobPlieth/status/473467954084851712,,,
realdealneiman,6/2/2014 10:15,0,0,Anyone at # ASCO14 know what's going on with the $ GTXI presentation and data?,,,#,4.73468E+17,https://twitter.com/realdealneiman/status/473467867246383105,,,,
subatomicdoc,6/2/2014 10:15,2,2,"Treatment, prognosis of # breastcancer patients w/ brain mets according to subtype http://abstracts.asco.org/144/AbstView_144_127629.html … # ASCO14 # bcsm # btsm # radonc",,,# # # # #,4.73468E+17,https://twitter.com/subatomicdoc/status/473467856848687106,,,,
FiercePharma,6/2/2014 10:15,0,0,# ASCO14: $ AZN's # Zoladex could stave off early menopause in breast cancer patients http://www.fiercepharma.com/story/azs-zoladex-could-stave-early-menopause-breast-cancer-patients/2014-06-02 … # pharma by @ CarlyHFierce,,@,# # #,4.73468E+17,https://twitter.com/FiercePharma/status/473467855476752384,,,,
genentech,6/2/2014 10:15,5,2,"As little as 5 yrs ago, there were no approved targeted tx for # skincancer. Today = options. http://ow.ly/xwrz4 # ASCO14 What's next?",,,# #,4.73468E+17,https://twitter.com/genentech/status/473467847642214401,,,,
myPathMelanoma,6/2/2014 10:15,0,0,Data at # ASCO14 show Myriad myPath Melanoma helps physicians make a prompt and accurate diagnosis of potentially fatal # melanoma.,,,# #,4.73468E+17,https://twitter.com/myPathMelanoma/status/473467827446222848,,,,
myriadgenetics,6/2/2014 10:15,0,0,Data at # ASCO14 show Myriad myPath Melanoma helps physicians make a prompt and accurate diagnosis of potentially fatal # melanoma.,,,# #,4.73468E+17,https://twitter.com/myriadgenetics/status/473467826619953152,,,,
MediTech_Media,6/2/2014 10:14,0,0,"Poster 186, sites w high volume # breastcancer surgeons or written tx plans more likely to follow tx guidelines # ASCO14 Weldon et al",,,# #,4.73468E+17,https://twitter.com/MediTech_Media/status/473467813441835008,,,,
RubenNiesvizky,6/2/2014 10:14,0,0,@ ASCO @ MyelomaCenter daratumumab monotherapy in RRMM; ORR 35% > VGPR and CR seen about 10% 23 m pfs,,@ @,,4.73468E+17,https://twitter.com/RubenNiesvizky/status/473467732348792832,,,,
mtmdphd,6/2/2014 10:14,3,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 Conclusions (2/2) pic.twitter.com/HjDsKOSYEB,,,# #,4.73468E+17,https://twitter.com/mtmdphd/status/473467670508347393,,,,
OncEd,6/2/2014 10:14,0,0,Arnold AIO 0207 interim analysis of OS: 3 arms the same # crcsm # ASCO14,,,# #,4.73468E+17,https://twitter.com/OncEd/status/473467591181488128,,,,
MelanomaReAlli,6/2/2014 10:14,0,0,Merck steps up with more positive data on immuno-oncology treatment via @ FierceBiotech http://www.fiercebiotech.com/story/merck-steps-more-positive-data-immuno-oncology-star-pembrolizumab/2014-06-01 … # ASCO14,,@,#,4.73468E+17,https://twitter.com/MelanomaReAlli/status/473467582234624000,,,,
JosephDMcCarthy,6/2/2014 10:14,1,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73468E+17,https://twitter.com/JosephDMcCarthy/status/473467574907576320,,,,
mtmdphd,6/2/2014 10:13,3,2,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 Conclusions 1/2 pic.twitter.com/gl8FWcR53l,,,# #,4.73468E+17,https://twitter.com/mtmdphd/status/473467563801083904,,,,
Gazulides,6/2/2014 10:13,1,0,Combination of cediranib and olaparib significantly more active in ovarian cancer than olaparib alone # ASCO14,,,#,4.73468E+17,https://twitter.com/Gazulides/status/473467543491858433,,,,
mtmdphd,6/2/2014 10:13,2,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 PFS pic.twitter.com/m9tyrhsF3Q,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473467444124979201,,,,
strategicTy,6/2/2014 10:13,1,0,Final day of exhibition at # asco14 come to booth 4054 for info on # phaseItrials @ mdanderson International programs & # physrels,,@,# # #,4.73467E+17,https://twitter.com/strategicTy/status/473467419663794176,,,,
MaverickNY,6/2/2014 10:13,10,6,Ooh RT @ carisls: PD-L1 expression in 2 # sarcoma subtypes suggests immunotherapy treatment options. http://icar.us/1kADfZV # ASCO14,,@,# #,4.73467E+17,https://twitter.com/MaverickNY/status/473467394640601089,,,,
nycdoc29,6/2/2014 10:13,0,0,# ASCO14 - impressive waterfall with ORR 35% with single agent Daratumumab in heavily pretreated MM at 16 mg/kg,,,#,4.73467E+17,https://twitter.com/nycdoc29/status/473467360310202368,,,,
mtmdphd,6/2/2014 10:13,0,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 BM PC pic.twitter.com/uBFGg7dOJe,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473467338931847168,,,,
DrAttai,6/2/2014 10:12,2,1,BC subtypes according to BMI and insulin resistance (3/3) # asco14 pic.twitter.com/RnRK09SI3t,,,#,4.73467E+17,https://twitter.com/DrAttai/status/473467219050237953,,,,
mtmdphd,6/2/2014 10:12,0,2,"# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - Response, some CRs pic.twitter.com/r5SztBWN9d",,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473467214323257344,,,,
ShannonWestin,6/2/2014 10:12,0,0,V. Makker- a group of pts w PI3K aberrations appeared to gain benefit from GDC-0980. # ASCO14 # gyncsm,,,# #,4.73467E+17,https://twitter.com/ShannonWestin/status/473467175781801984,,,,
DrAttai,6/2/2014 10:12,1,1,BC subtypes according to BMI and insulin resistance (2/3) # asco14 pic.twitter.com/zevopU0Vbe,,,#,4.73467E+17,https://twitter.com/DrAttai/status/473467159457566720,,,,
DrAttai,6/2/2014 10:12,1,1,BC subtypes according to BMI and insulin resistance (1/3) # asco14 pic.twitter.com/yHnhQDSSZu,,,#,4.73467E+17,https://twitter.com/DrAttai/status/473467081036677120,,,,
mtmdphd,6/2/2014 10:12,0,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - Best Change in Response waterfall plot pic.twitter.com/zIOzu9pJMA,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473467078692057088,,,,
Gazulides,6/2/2014 10:11,1,0,"RESONATE: compared ibrutinib with ofatumumab. With ibrutinib, 80% of patients were still in remission at 1 year # ASCO14",,,#,4.73467E+17,https://twitter.com/Gazulides/status/473466964921159680,,,,
mtmdphd,6/2/2014 10:11,1,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - less infusion related reaction with dilution of drug pic.twitter.com/MZTacXmyYk,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473466909703561217,,,,
Mills_I,6/2/2014 10:11,0,1,A little shuttle bus courtesy could go a long way. He could have said there is a person right behind me wait a moment. # asco14,,,#,4.73467E+17,https://twitter.com/Mills_I/status/473466893891014656,,,,
mtmdphd,6/2/2014 10:10,0,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - AEs -> infection (heavy pre-Tx Pts) pic.twitter.com/Hw47wnI3t9,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473466765889273856,,,,
ByJonGardner,6/2/2014 10:10,0,0,Eggs in the # ASCO14 press room this morning. They are all mine.,,,#,4.73467E+17,https://twitter.com/ByJonGardner/status/473466748617105408,,,,
aakonc,6/2/2014 10:10,0,0,"AIO 207 metCRC randomized to maintenance w 5fu, Bev or no Rx - some tx better than none (non inf analysis) # ASCO14 # crcsm",,,# #,4.73467E+17,https://twitter.com/aakonc/status/473466682036342785,,,,
ASCO,6/2/2014 10:10,1,2,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.73467E+17,https://twitter.com/ASCO/status/473466671446114304,,,,
ProjectInno,6/2/2014 10:10,0,2,We must commit as a nation to hasten the pace of medical discovery in order to save more lives http://ow.ly/xwoMj # ASCO14 # innovatenow,,,# #,4.73467E+17,https://twitter.com/ProjectInno/status/473466664500330496,,,,
genentech,6/2/2014 10:10,2,1,"# ASCO14 highlights QoL for cancer patients, caregivers. Read our take: http://ow.ly/xserK",,,#,4.73467E+17,https://twitter.com/genentech/status/473466660830339073,,,,
Roche,6/2/2014 10:10,20,13,Clinical trials - explained in an easy digestible way: http://ow.ly/xp5KN # ASCO14 # research,,,# #,4.73467E+17,https://twitter.com/Roche/status/473466649618944000,,,,
DebiopharmNews,6/2/2014 10:10,0,0,"# ASCO14 Phase I-II Debio0932, oral # HSP90 inhibitor, 1st & 2nd line # NSCLC (abstract/poster # TPS2632) Find out more http://ow.ly/xwl9v",,,# # # #,4.73467E+17,https://twitter.com/DebiopharmNews/status/473466649363116033,,,,
heidisa,6/2/2014 10:10,5,8,Different--even molecularly. MT @ FoundationATCG: New insights into # genomic patterns unique to young adults. # ASCO14 http://ow.ly/3lhbFL,,@,# #,4.73467E+17,https://twitter.com/heidisa/status/473466635064717313,,,,
carisls,6/2/2014 10:10,0,2,PD-L1 expression in 2 # sarcoma subtypes suggests immunotherapy treatment options. http://goo.gl/KxK2tG # ASCO14,,,# #,4.73467E+17,https://twitter.com/carisls/status/473466603431284737,,,,
FierceBiotech,6/2/2014 10:10,5,0,# ASCO14 coverage: Merck steps up with more positive data on immuno-oncology star pembrolizumab. http://www.fiercebiotech.com/story/merck-steps-more-positive-data-immuno-oncology-star-pembrolizumab/2014-06-01 … by @ JohnCFierce $ MRK,,@,#,4.73467E+17,https://twitter.com/FierceBiotech/status/473466586959859714,,,,
n8pennell,6/2/2014 10:10,1,1,"Lung cancer oral sessions both on tap for today, first in 30 minutes. Better late than never but about time! # ASCO14 # LCSM",,,# #,4.73467E+17,https://twitter.com/n8pennell/status/473466582903967745,,,,
OncEd,6/2/2014 10:09,0,0,Arnold AIO 0207 Cannot conclude that no treatment arm non-inferior for TFS # crcsm # ASCO14,,,# #,4.73467E+17,https://twitter.com/OncEd/status/473466551417712640,,,,
BayerPharma,6/2/2014 10:09,0,2,"Tune into # ASCO14 for presentations on # GIST. 4,500 – 5,000K new cases are diagnosed in the U.S. each year.pic.twitter.com/w4DIYegdTp",,,# #,4.73467E+17,https://twitter.com/BayerPharma/status/473466525274632192,,,,
sjaakvink,6/2/2014 10:09,1,0,French oncologists @ ASCO very positive about further treatment options for their patients in need @ myTomorrows patient advocates support,,@ @,,4.73467E+17,https://twitter.com/sjaakvink/status/473466521457393667,,,,
mtmdphd,6/2/2014 10:09,1,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - Pt characteristics pic.twitter.com/bHdTfVpjME,,,# #,4.73467E+17,https://twitter.com/mtmdphd/status/473466507574648832,,,,
JWatch,6/2/2014 10:09,0,0,# ASCO14: Visit our booth 20127 for a 15% subscription discount.,,,#,4.73466E+17,https://twitter.com/JWatch/status/473466399789424640,,,,
dukeleuk,6/2/2014 10:09,0,2,50 years of progress against hematologic cancers http://bit.ly/1pBLWbD # ASCO14 # nostalgia my first ASCO as a fellow in 2000,,,# #,4.73466E+17,https://twitter.com/dukeleuk/status/473466373763788800,,,,
JSweetenhamMD,6/2/2014 10:09,0,0,With our amazing HCI/U of Utah Pharmacy team at # ASCO14 @ huntsmancancerpic.twitter.com/Inj6TxE4h8,,@,#,4.73466E+17,https://twitter.com/JSweetenhamMD/status/473466336514179073,,,,
mtmdphd,6/2/2014 10:09,1,1,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - Trial Design pic.twitter.com/ZqQ1PzmA7T,,,# #,4.73466E+17,https://twitter.com/mtmdphd/status/473466313093156864,,,,
Gazulides,6/2/2014 10:08,1,0,REVEL: Ramucirumab marginally improved survival (1.4 months) in the second-line treatment of non-small cell lung cancer # ASCO14,,,#,4.73466E+17,https://twitter.com/Gazulides/status/473466233338068992,,,,
ShannonWestin,6/2/2014 10:08,0,0,GDC-0980 (PI3K/mTORCi) has modest activity in Endo cancer but was limited by tolerability. # ASCO14 # gyncsm,,,# #,4.73466E+17,https://twitter.com/ShannonWestin/status/473466190770495488,,,,
mtmdphd,6/2/2014 10:08,0,2,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 - GEN501 - Monotherapy pic.twitter.com/QgKTfWDpTZ,,,# #,4.73466E+17,https://twitter.com/mtmdphd/status/473466105957453824,,,,
myPathMelanoma,6/2/2014 10:08,1,0,Myriad myPath # Melanoma objectively differentiates # malignant melanoma from # benign nevi # melanomadiagnostic # ASCO14,,,# # # # #,4.73466E+17,https://twitter.com/myPathMelanoma/status/473466063762374657,,,,
teamoncology,6/2/2014 10:07,0,1,Our group will present today the impact of Oncotype DX on adjuvant therapy in stage I breast cancer. http://abstracts.asco.org/144/AbstView_1 … # ASCO14 # asco14,,,# #,4.73466E+17,https://twitter.com/teamoncology/status/473465961597530114,,,,
GuardantHealth,6/2/2014 10:07,1,1,Great turnout at Dr Hoon's poster at # ASCO14 in E354b on broad panel circulating tumor DNA monitoring in melanoma pic.twitter.com/mgnfyXn1r4,,,#,4.73466E+17,https://twitter.com/GuardantHealth/status/473465950302633984,,,,
mtmdphd,6/2/2014 10:07,0,3,# mmsm # ASCO14 - Lokhorst - Daratumumab - anti-CD38 pic.twitter.com/iRsa1wQRgr,,,# #,4.73466E+17,https://twitter.com/mtmdphd/status/473465935882645505,,,,
OncEd,6/2/2014 10:07,0,0,Arnold AIO 0207 primary endpoint Time to failure of strategy # crcsm # ASCO14,,,# #,4.73466E+17,https://twitter.com/OncEd/status/473465824905560064,,,,
SarahKarlin,6/2/2014 10:06,1,0,looking for # ASCO14 updates? @ PinkSheetMaryJo & @ ThePinkSheet1 have you covered. # cancer. # pharma,,@ @,# # #,4.73466E+17,https://twitter.com/SarahKarlin/status/473465794752684032,,,,
mtmdphd,6/2/2014 10:06,1,1,Sometimes the best part of # ASCO14 are the distractions on the way to sessions (you know who you are...),,,#,4.73466E+17,https://twitter.com/mtmdphd/status/473465725395673088,,,,
teamoncology,6/2/2014 10:06,1,0,Nice. RT @ DrAttai: Breast cancer poster session # asco14 pic.twitter.com/u5bY0XD3MV,,@,#,4.73466E+17,https://twitter.com/teamoncology/status/473465723986006018,,,,
OncEd,6/2/2014 10:06,0,0,Arnold AIO 0207 Non-Inferiority trial of post induction maintenance: FP+bev vs bev vs no treatment # crcsm # ASCO14,,,# #,4.73466E+17,https://twitter.com/OncEd/status/473465661998792704,,,,
mtmdphd,6/2/2014 10:06,0,0,"# mmsm # ASCO14 - SAR - MMRC, Sanofi, Celgene, Pts - thanks pic.twitter.com/k7BJcppWOq",,,# #,4.73466E+17,https://twitter.com/mtmdphd/status/473465622303899648,,,,
Gazulides,6/2/2014 10:06,1,0,Use of the LHRH agonist goserelin during chemotherapy for breast cancer protected against infertility and early menopause # ASCO14,,,#,4.73466E+17,https://twitter.com/Gazulides/status/473465599520030720,,,,
nycdoc29,6/2/2014 10:06,0,0,# ASCO14 - SAR650984 + Rev/Dex looks good in relapsed MM,,,#,4.73466E+17,https://twitter.com/nycdoc29/status/473465577244491776,,,,
RubenNiesvizky,6/2/2014 10:06,0,0,@ ASCO @ MyelomaCenter SAR 650984 hum-aCD38 in ph 1 in RRMM plus rev dex: no MTD at 10 mg/kg- 74% Len refr 52% vel refr ORR 63-58% 7 pt VGPR,,@ @,,4.73466E+17,https://twitter.com/RubenNiesvizky/status/473465566226026496,,,,
DrAttai,6/2/2014 10:06,1,3,Breast cancer poster session # asco14 pic.twitter.com/kn5zQA91a0,,,#,4.73466E+17,https://twitter.com/DrAttai/status/473465562564411392,,,,
DrMiguelPerales,6/2/2014 10:05,7,3,Cancer Hospitals incl @ sloan_kettering Make Gene Tests a New Standard for Care http://bloom.bg/1gWpBWh via @BloombergNews # ASCO14 # genomics,,@ @BloombergNews,# #,4.73465E+17,https://twitter.com/DrMiguelPerales/status/473465479315472385,,,,
janinegug,6/2/2014 10:05,0,0,@ ASCO appreciate that. It's hard 2get 2 meetings & sessions when sent so far away. Clarity before the mtg also helpful.,,@,,4.73465E+17,https://twitter.com/janinegug/status/473465468431634432,,,,
mtmdphd,6/2/2014 10:05,0,0,# mmsm # ASCO14 - SAR Len Dex MTD not reached - 33% ORR in pom refr Pts (n=9),,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473465460663783424,,,,
mtmdphd,6/2/2014 10:05,0,0,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnZg5 # ASCO14,,@,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473465390824456192,,,,
ALLIANCE_org,6/2/2014 10:05,0,1,Alliance for Clinical Trials in Oncology is a @ theNCI Nat'l Clinical Trials Network grp. http://www.AlliancNCTN.org # ASCO14,,@,#,4.73465E+17,https://twitter.com/ALLIANCE_org/status/473465376253440001,,,,
heidisa,6/2/2014 10:05,0,0,"RT @ hayeslat: Excited to present results of comprehensive genetic profiling of AYA tumors. Distinctive, targetable. # ASCO14 @ FoundationATCG",,@ @,#,4.73465E+17,https://twitter.com/heidisa/status/473465367617372160,,,,
scientre,6/2/2014 10:05,0,3,MT @ adamfeuerstein # ASCO14 press conferences: Nerdy oncologists are treated like rock stars. pic.twitter.com/pDp2qeyAmt,,@,#,4.73465E+17,https://twitter.com/scientre/status/473465353889411074,,,,
nanostringtech,6/2/2014 10:05,0,0,Gelmon et al present “Prognostic and predictive significance of PAM50 intrinsic subtypes…” # ASCO14 (Abstract 11019) http://abstracts.asco.org/144/AbstView_144_131686.html …,,,#,4.73465E+17,https://twitter.com/nanostringtech/status/473465352135794688,,,,
Rad_Nation,6/2/2014 10:05,2,0,Randomized trial of thoracic radiation in extensive small cell # lungcancer http://buff.ly/1jZdmZq # ASCO14 # lcsm # radonc,,,# # # #,4.73465E+17,https://twitter.com/Rad_Nation/status/473465347690229760,,,,
mtmdphd,6/2/2014 10:05,7,2,# mmsm # ASCO14 - SAR650984 w/ len/Dex - Conclusions pic.twitter.com/Q56NY6Kvfh,,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473465347035922432,,,,
subatomicdoc,6/2/2014 10:05,4,2,Randomized trial of thoracic radiation in extensive small cell # lungcancer http://bit.ly/1jZdoRh # ASCO14 # lcsm # radonc,,,# # # #,4.73465E+17,https://twitter.com/subatomicdoc/status/473465346742292480,,,,
OncEd,6/2/2014 10:04,0,0,"Allegra imbalances in arms in dropout rates, intended tx rates and cape dose may explain lack of benefit seen in PETACC 6 # crcsm # ASCO14",,,# #,4.73465E+17,https://twitter.com/OncEd/status/473465264978538496,,,,
mtmdphd,6/2/2014 10:04,0,1,# mmsm # ASCO14 - SAR Response Rate by prior CA Tx pic.twitter.com/IOxbXGq3Pa,,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473465191108079616,,,,
TriageCancer,6/2/2014 10:04,0,0,Day 3 @ # ASCO14: Are you here? Come by the Patient Advocacy Pavilion & learn about orgs helping patients & caregivers pic.twitter.com/oazVXoBkYb,,@,#,4.73465E+17,https://twitter.com/TriageCancer/status/473465187144859650,,,,
JSweetenhamMD,6/2/2014 10:04,6,1,In the supportive care poster session at # ASCO14. Evidence for benefit of exercise during and after treatment is growing @ huntsmancancer,,@,#,4.73465E+17,https://twitter.com/JSweetenhamMD/status/473465161844396032,,,,
mtmdphd,6/2/2014 10:04,1,1,# mmsm # ASCO14 - Time on Tx by best response - SAR pic.twitter.com/tiZJZlmAdF,,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473465059864104960,,,,
markaorourke,6/2/2014 10:04,0,0,# ASCO14 England primary care doctors feel left out of loop of information about cancer therapy. Same challenges in USA.,,,#,4.73465E+17,https://twitter.com/markaorourke/status/473465059230773248,,,,
mtmdphd,6/2/2014 10:03,1,1,# mmsm # ASCO14 - Max change M-spike - waterfall pic.twitter.com/B3RTOgUumS,,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473464929916555265,,,,
OncEd,6/2/2014 10:03,2,0,ADORE trial addition of Oxaliplatin to 5fu for adjuvant tx of rectal cancer improved 3yr DFS: 72 vs 63% HR=0.63 # crcsm # ASCO14,,,# #,4.73465E+17,https://twitter.com/OncEd/status/473464859800375297,,,,
mtmdphd,6/2/2014 10:02,2,0,"# mmsm # ASCO14 - SAR ORR 58%, highest dose ORR 63%, CBR 67% pic.twitter.com/NL0qkAdaPa",,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473464792649592834,,,,
RedEmpressC,6/2/2014 10:02,0,0,@ ASCO: Dr. Sweetenham reflects on 50 years of progress against hematologic cancers http://bit.ly/1pBLWbD # ASCO14 # haematology,,@,# #,4.73465E+17,https://twitter.com/RedEmpressC/status/473464757169975298,,,,
SassyCell,6/2/2014 10:02,2,2,@ TheA2C @ CancerResearch @ ASCO Thank you for your hard work getting the word out about # immunotherapy !! # WhiteOutCancer # CIM,,@ @ @,# # #,4.73465E+17,https://twitter.com/SassyCell/status/473464717185675264,,,,
ASCO,6/2/2014 10:02,1,2,Catch the Highlights of the Day session streaming live at all Networking Cafes on ASCO LIVE. # ASCO14,,,#,4.73465E+17,https://twitter.com/ASCO/status/473464710139248640,,,,
oncofertility,6/2/2014 10:02,1,1,A drug during chemo may preserve fertility in breast cancer patients http://cnn.it/1jMhG8N # oncofertility # yacancer # ayacsm # asco14,,,# # # #,4.73465E+17,https://twitter.com/oncofertility/status/473464705970081792,,,,
ASCO,6/2/2014 10:02,1,0,Not an ASCO Member? Join at # ASCO14: Visit a Member Services Desk to receive a membership dues credit & thank you gift.,,,#,4.73465E+17,https://twitter.com/ASCO/status/473464682427473921,,,,
MaverickNY,6/2/2014 10:02,7,2,"True RT @ wendyselig: # ASCO14 speaker: 5 years ago you could hold the # melanoma meeting in a cafeteria. Today the largest rooms are packed.""""",,@,# #,4.73465E+17,https://twitter.com/MaverickNY/status/473464657530085376,,,,
Novartis,6/2/2014 10:02,3,5,Not at # ASCO14? Learn how the US # Novartis Signature Program brings the protocol to the patient: http://bit.ly/1n5sdPS,,,# #,4.73465E+17,https://twitter.com/Novartis/status/473464655802007552,,,,
WinshipAtEmory,6/2/2014 10:02,2,0,Melanoma expert Dr David Lawson presented his study on sentinel lymph node biopsies at # ASCO14 pic.twitter.com/E4Ied2J0gh,,,#,4.73465E+17,https://twitter.com/WinshipAtEmory/status/473464597341806592,,,,
mtmdphd,6/2/2014 10:02,0,1,# mmsm # ASCO14 - PK SAR650984 pic.twitter.com/hX8C9Zn05i,,,# #,4.73465E+17,https://twitter.com/mtmdphd/status/473464595785326592,,,,
Roche,6/2/2014 10:02,0,0,Day 4 of # ASCO14 – looking forward to a day full of data presentations!,,,#,4.73465E+17,https://twitter.com/Roche/status/473464575195901953,,,,
matthewherper,6/2/2014 10:02,3,7,"$ PFE oncology booth at # ASCO14: Pfizer: Focused On What Truly Matters."" There's the setup"," give me the punchline...""",,,#,4.73465E+17,https://twitter.com/matthewherper/status/473464574935842816,,,
bmsnews,6/2/2014 10:02,1,0,"Phase 1 combination data from our pipeline in # kidney cancer presented today at 9:45am CDT, E Hall D1 # ASCO14",,,# #,4.73465E+17,https://twitter.com/bmsnews/status/473464560582922240,,,,
TuftsCancerCtr,6/2/2014 10:02,0,0,Congratulations # Tufts fellow Gunjan Shah @ iConquerCancer merit award & # ASCO14 travel award recipient # bmtsm # mmsm http://ow.ly/xuD4C,,@,# # # #,4.73465E+17,https://twitter.com/TuftsCancerCtr/status/473464554824167424,,,,
OncEd,6/2/2014 10:01,0,0,ADORE Trial 320 patient trial of Adjuvant FOLFOX vs 5FU for resected rectal ca after preop chemorads # crcsm # ASCO14,,,# #,4.73465E+17,https://twitter.com/OncEd/status/473464536872534016,,,,
EncoreBioMed,6/2/2014 10:01,0,0,Early chemotherapy appears to extend survival in men with advanced # prostatecancer # ASCO14 http://bit.ly/1pLRznH,,,# #,4.73464E+17,https://twitter.com/EncoreBioMed/status/473464475707002881,,,,
Gazulides,6/2/2014 10:01,1,0,Bevacizumab and cetuximab have similar survival benefits in metastatic colorectal cancer # ASCO14,,,#,4.73464E+17,https://twitter.com/Gazulides/status/473464465447350272,,,,
mayocliniclabs,6/2/2014 10:01,0,1,Day 4 at # ASCO14. Visit us at booth #2054. http://mayocl.in/T1r6rl,,,# #2054,4.73464E+17,https://twitter.com/mayocliniclabs/status/473464450654416896,,,,
ASCO,6/2/2014 10:01,2,1,Dr. Sweetenham reflects on 50 years of progress against hematologic cancers http://bit.ly/1pBLWbD # ASCO14,,,#,4.73464E+17,https://twitter.com/ASCO/status/473464432971231232,,,,
Boehringer,6/2/2014 10:01,1,4,"Tomorrow promises to be another exciting day at ASCO"" Julia Knebel # lungcancer # ASCO14 http://bit.ly/1mE8Htf""",,,# #,4.73464E+17,https://twitter.com/Boehringer/status/473464403296550913,,,,
RedEmpressC,6/2/2014 10:01,0,0,J&J's # Imbruvica thumps GSK's Arzerra in head-to-head leukemia trial http://www.fiercepharma.com/story/jjs-imbruvica-thumps-gsks-arzerra-head-head-leukemia-trial/2014-06-02 … $ JNJ $ GSK # pharma # oncology # ASCO14,,,# # # #,4.73464E+17,https://twitter.com/RedEmpressC/status/473464363475804160,,,,
CRC_Medical,6/2/2014 10:01,0,0,Stop by Booth #23128 for specials on # medicalbooks + don't forget to enter our # giveaway. Mention this post for an extra discount # ASCO14,,,#23128 # # #,4.73464E+17,https://twitter.com/CRC_Medical/status/473464358887243776,,,,
theMMRF,6/2/2014 10:01,2,1,Data from a # myeloma study funded by @ theMMRF & conducted w/ partner @ SanofiUS presented today at # ASCO14: http://www.themmrf.org/about-the-mmrf/powerful-news/press-releases/mmrc-asco-2014.html … - # MMRFASCO,,@ @,# # #,4.73464E+17,https://twitter.com/theMMRF/status/473464308547215360,,,,
ONAcom,6/2/2014 10:00,0,0,# ASCO14: Combination ridaforolimus + MK-2206 AKT inhibitor therapy yield modest efficacy for low-RAS # breastcancer - http://ow.ly/xwelD,,,# #,4.73464E+17,https://twitter.com/ONAcom/status/473464245762686976,,,,
braincancer_AU,6/2/2014 10:00,2,0,Trial of a potential drug for # glioblastoma shows encouraging results http://buff.ly/1kh3x9k # asco14 # braincancer,,,# # #,4.73464E+17,https://twitter.com/braincancer_AU/status/473464229199351809,,,,
markaorourke,6/2/2014 10:00,2,3,# ASCO14 # Survivorship education session: excellent slides on differential needs of survivors of different types of cancers.,,,# #,4.73464E+17,https://twitter.com/markaorourke/status/473464222987202562,,,,
DebiopharmNews,6/2/2014 10:00,0,0,"# ASCO14 Final Phase I Debio 0932, oral # HSP90 inhibitor, # oncology (abstract/poster #2550) Find out more http://ow.ly/xwkWC",,,# # # #2550,4.73464E+17,https://twitter.com/DebiopharmNews/status/473464189135388672,,,,
bioclinica,6/2/2014 10:00,0,0,RT @ FierceBiotech: # ASCO14 coverage: Lilly's ramucirumab scores marginal gain for lung cancer patients. http://www.fiercebiotech.com/story/lillys-ramucirumab-scores-marginal-positive-gain-lung-cancer-patients/2014-05-31 … @ JohnCFierce,,@ @,#,4.73464E+17,https://twitter.com/bioclinica/status/473464185796706304,,,,
CGTCatapult,6/2/2014 10:00,1,0,RT @ FierceBiotech: # ASCO14 coverage: GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact. http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …...,,@,#,4.73464E+17,https://twitter.com/CGTCatapult/status/473464164040835072,,,,
ejpc_emma,6/2/2014 10:00,0,0,RT @ FierceBiotech: # ASCO14 coverage: GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact. http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …...,,@,#,4.73464E+17,https://twitter.com/ejpc_emma/status/473464163256532992,,,,
FiercePharma,6/2/2014 10:00,2,1,# ASCO14: $ GSK misses survival endpoint with # Tykerb-Herceptin pairing http://www.fiercepharma.com/story/gsk-misses-survival-endpoint-tykerb-herceptin-pairing/2014-06-01 … # pharma by @ CarlyHFierce,,@,# # #,4.73464E+17,https://twitter.com/FiercePharma/status/473464128791515137,,,,
FoxChaseCancer,6/2/2014 10:00,1,0,Fox Chase's Yu-Ning Wong is among authors whose findings may help some prostate cancer patients live longer http://mobile.nytimes.com/2014/06/02/health/early-chemotherapy-extends-lives-of-men-with-prostate-cancer-study-finds.html?referrer= … # ASCO14,,,#,4.73464E+17,https://twitter.com/FoxChaseCancer/status/473464105072730112,,,,
medpagetoday,6/2/2014 10:00,1,0,Ovarian failure occurred 70% less in women w/ hormone receptor-negative breast cancer treated w/ goserelin # ASCO14 http://bit.ly/1rBLy1y,,,#,4.73464E+17,https://twitter.com/medpagetoday/status/473464097862721536,,,,
cardinalhealth,6/2/2014 10:00,0,1,The latest abstracts on how Clinical Pathways improve cancer care http://bit.ly/1k8DPUo # ASCO14 # essentialtooncology,,,# #,4.73464E+17,https://twitter.com/cardinalhealth/status/473464095945916416,,,,
FierceBiotech,6/2/2014 10:00,3,1,# ASCO14 coverage: GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact. http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 … by @ JohnCFierce $ GSK,,@,#,4.73464E+17,https://twitter.com/FierceBiotech/status/473464086756200451,,,,
SanofiCanada,6/2/2014 10:00,0,0,Fostering communication among oncology-related subspecialties at # ASCO2014,,,#,4.73464E+17,https://twitter.com/SanofiCanada/status/473464057283239936,,,,
TylerWhisman,6/2/2014 9:59,0,0,Yervoy significant but small OS adv at $120k+ : Nivo + Yervoy and Pem big OS trend but at what cost? # ASCO14,,,#,4.73464E+17,https://twitter.com/TylerWhisman/status/473464016921456640,,,,
WayneKoberstein,6/2/2014 9:59,2,0,"Ipi tox real but manageable, reversible, says Mario Sznol # ASCO14 press conf. Combos more promising, esp. w/ patient selection @ RfwrightLSL",,@,#,4.73464E+17,https://twitter.com/WayneKoberstein/status/473464012412551168,,,,
big4bioBOS,6/2/2014 9:59,0,1,Karyopharm Provides Data Update for Selinexor in Non-Hodgkin's # Lymphoma and Acute Myeloid # Leukemia - http://investors.karyopharm.com/releasedetail.cfm?ReleaseID=851593 … # ASCO14,,,# # #,4.73464E+17,https://twitter.com/big4bioBOS/status/473463910553485312,,,,
sharkbiotech,6/2/2014 9:59,0,0,As usual the # ASCO14 gaps gets filled $ PCYC $ MRK $ ABBV etc,,,#,4.73464E+17,https://twitter.com/sharkbiotech/status/473463804236292096,,,,
nycdoc29,6/2/2014 9:58,0,0,"“ @ Faisalk_Can: So much for # ASCO14 , good data points in $ pcyc and $ mrk and both down” RESONATE data isn't clinically shifting in real world",,@,#,4.73464E+17,https://twitter.com/nycdoc29/status/473463666332164097,,,,
KUhlendorf,6/2/2014 9:57,0,1,. @ matthewherper: Scientists Prime The Immune System As A Powerful # Cancer Weapon http://onforb.es/1p09TJO via @ forbes # ASCO14,,@ @,# #,4.73464E+17,https://twitter.com/KUhlendorf/status/473463542473961473,,,,
jodigralnick,6/2/2014 9:57,2,1,# ASCO14 LIVE coverage continues @10:15amET on @ SquawkStreet w/ @ megtirrell's EXCLUSIVE @ CNBC interview w/ $ BMY SVP Oncology/Immunosciences,,@10 @ @ @,#,4.73463E+17,https://twitter.com/jodigralnick/status/473463449440120832,,,,
adenacb,6/2/2014 9:57,0,0,TRUTH RT “ @ SeporahRaizer: Don't write off people with metastatic cancer # bcsm # ASCO14 # mbcsm http://www.huffingtonpost.com/seporah-raizer/hey-hey-were-the-metsters_b_5398475.html …”,,@,# # #,4.73463E+17,https://twitter.com/adenacb/status/473463401545740288,,,,
Wiley_Health,6/2/2014 9:57,0,1,"Celebrate # ASCO14 with a selection of articles related to clinical oncology. Read, cite, and share! @ ASCO @ ASCOPost http://ow.ly/xwrUn",,@ @,#,4.73463E+17,https://twitter.com/Wiley_Health/status/473463344708743169,,,,
MedscapeOnc,6/2/2014 9:57,1,2,Follow Medscape today for breaking news on immunotherapies in melanoma at # ASCO2014 http://bit.ly/1oNwT0Z,,,#,4.73463E+17,https://twitter.com/MedscapeOnc/status/473463337301594112,,,,
JacobPlieth,6/2/2014 9:57,0,1,Dr Eggermont says has separate slide on 5 deaths in ipi stage III melanoma trial. Not shown in presser $ BMY # ASCO14,,,#,4.73463E+17,https://twitter.com/JacobPlieth/status/473463295002021889,,,,
ByJonGardner,6/2/2014 9:56,0,0,Hinrichs: 2 CRs in HPV-targeting TIL in metastatic cervical cancer now up to 22 and 15 mos. # ASCO14,,,#,4.73463E+17,https://twitter.com/ByJonGardner/status/473463282460676097,,,,
WayneKoberstein,6/2/2014 9:56,1,0,# ASCO14 @ RfwrightLSL met analysis shows clear survival benefit of Ipi over interferon.,,@,#,4.73463E+17,https://twitter.com/WayneKoberstein/status/473463247350530048,,,,
billykaos,6/2/2014 9:56,0,0,stunning-->MT: @ brendanweiss # Obesity may account for up to 50% of risk of some # cancers @ gcolditz # ASCO14 cc @DrFriedenCDC @ CMichaelGibson,,@ @ @DrFriedenCDC @,# # #,4.73463E+17,https://twitter.com/billykaos/status/473463239259738113,,,,
SarahCannonDocs,6/2/2014 9:56,1,0,If you want to discuss NSCLC RADIANT details being presented 9:45 am E Hall D2 @ # ASCO14 - get in touch with # SCRI's Dr. Spigel,,@,# #,4.73463E+17,https://twitter.com/SarahCannonDocs/status/473463226165116929,,,,
markaorourke,6/2/2014 9:56,0,0,# ASCO14 # Survivorship is a distinct phase of the cancer control continuum in England as well as U.S. There is special expertise!,,,# #,4.73463E+17,https://twitter.com/markaorourke/status/473463183135350784,,,,
CancerAdvocacy,6/2/2014 9:56,0,0,Argenbright: great example of community-based survivorship care using Journey Forward for care plans # journeyforward # ASCO14,,,# #,4.73463E+17,https://twitter.com/CancerAdvocacy/status/473463161962516481,,,,
SarahCannonDocs,6/2/2014 9:56,0,1,Interested in Ph.I study: nivolumab combo w/ ipilimumab in mRCC? 9:45am E Hall D1. Tweet to connect w/ coauthor # SCRI's Dr. Infante # ASCO14,,,# #,4.73463E+17,https://twitter.com/SarahCannonDocs/status/473463089527271424,,,,
jaterceno,6/2/2014 9:56,0,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73463E+17,https://twitter.com/jaterceno/status/473463055469531137,,,,
drdmaz,6/2/2014 9:55,0,0,Is exemestane the future for PREmenopausal hormone receptor + # breastcancer : @ NEJM @ ASCO http://www.nejm.org/doi/full/10.1056/NEJMoa1404037#.U4yBqjWihOE.twitter …,,@ @,# #,4.73463E+17,https://twitter.com/drdmaz/status/473463020530974720,,,,
ByJonGardner,6/2/2014 9:55,0,0,"Hinrichs: HPV-targeting TIL in metastatic cervical cancer will be expanded to 35 patients, and to HPV+ solid tumours. # ASCO14",,,#,4.73463E+17,https://twitter.com/ByJonGardner/status/473463019213578240,,,,
MediTech_Media,6/2/2014 9:55,0,0,"Poster 215, study of over 500 TNBC pts: lobular most aggressive histological subtype of triple negative # breastcancer Pogoda et al. # ASCO14",,,# #,4.73463E+17,https://twitter.com/MediTech_Media/status/473462993918115840,,,,
GenentechJobs,6/2/2014 9:55,0,0,Our PD group is recruiting during # ASCO14. Product Development group represents # MissionFocusedMedicine. More: http://bit.ly/1oeGOZV,,,# #,4.73463E+17,https://twitter.com/GenentechJobs/status/473462990780370945,,,,
DrMarkham,6/2/2014 9:55,2,0,Very promising research on immunotherapy for advanced cervical cancer. http://bit.ly/1m5dqCE # ASCO14 # gyncsm,,,# #,4.73463E+17,https://twitter.com/DrMarkham/status/473462911533608960,,,,
GustaveRoussy,6/2/2014 9:55,3,1,# ASCO2014 Pr Michel Ducreux interrogé sur l'étude Axus # cancer colorectal métastasé. Itw : https://vimeo.com/97071826 pic.twitter.com/XVxaXgxquC,,,# #,4.73463E+17,https://twitter.com/GustaveRoussy/status/473462904671322112,,,,
DrBobGoldberg,6/2/2014 9:55,1,0,. @ ASCO @ AHIPCoverage Karen Ignagni sing from same songbook: restrict access to save $) # asco14 # mliwi http://youtu.be/VbY0dFNRzFU,,@ @,# #,4.73463E+17,https://twitter.com/DrBobGoldberg/status/473462900439646209,,,,
JeffreyMOtto,6/2/2014 9:55,0,0,"LL: # ASCO14 ATM was the most frequently non-BRCA, non-Lynch related genes",,,#,4.73463E+17,https://twitter.com/JeffreyMOtto/status/473462877597089792,,,,
SophiaCeulemans,6/2/2014 9:55,0,0,"O'Donnell: necessary for onc germline # pharmacogenomic findings to pass high bar, would you withhold or change tx based on results # ASCO14",,,# #,4.73463E+17,https://twitter.com/SophiaCeulemans/status/473462847654338561,,,,
subatomicdoc,6/2/2014 9:55,0,0,Balancing Our Values on Value http://bit.ly/1kzBKew via @ hmhyltonpac # ASCO14 # hsronc,,@,# #,4.73463E+17,https://twitter.com/subatomicdoc/status/473462795959545856,,,,
chicagocapman,6/2/2014 9:55,0,1,Last day @ ASCO. Another great show! # ASCO14 pic.twitter.com/3YuZnJdRwJ,,@,#,4.73463E+17,https://twitter.com/chicagocapman/status/473462792901914625,,,,
ByJonGardner,6/2/2014 9:55,0,0,"Hinrichs: HPV-targeting TIL in metastatic cervical cancer is one time treatment, pt tolerance for tox higher. # ASCO14",,,#,4.73463E+17,https://twitter.com/ByJonGardner/status/473462792541196288,,,,
jodigralnick,6/2/2014 9:54,1,0,"Biggest takeaways from # ASCO14 from @ CNBC's @ megtirrell: http://cnb.cx/1m5uIzH $ AZN, $ CLVS, $ PCYC, $ ARIA, $ MRK, $ BMY, $ NVS, $ FMI, $ ABBV",,@ @,#,4.73463E+17,https://twitter.com/jodigralnick/status/473462759271960576,,,,
twittmanda,6/2/2014 9:54,0,0,@ DrAttai Feel your pain! # ASCO14,,@,#,4.73463E+17,https://twitter.com/twittmanda/status/473462691336843264,,,,
heidisa,6/2/2014 9:54,1,0,RT @ heycriticalmass: ICYMI: Drug during chemo helps preserve # fertility in # breastcancer patients. http://ow.ly/3lh9ZZ # ayacsm # asco14,,@,# # # #,4.73463E+17,https://twitter.com/heidisa/status/473462687931060224,,,,
jtriestm,6/2/2014 9:54,0,0,Highlights of the Day | http://Cancer.Net http://www.cancer.net/research-and-advocacy/asco-annual-meetings/highlights-day#.U4yB_wHBkG4.twitter … # asco14 melanoma cervical ca,,,# #,4.73463E+17,https://twitter.com/jtriestm/status/473462681798594560,,,,
JacobPlieth,6/2/2014 9:54,0,0,"Fed-funded HPV-TIL RT @ matthewherper: These cells aren't modified. They're cultured from tumor fragments, expanded, and re-infused. # ASCO14",,@,#,4.73463E+17,https://twitter.com/JacobPlieth/status/473462613226307584,,,,
ByJonGardner,6/2/2014 9:54,0,0,"Hinrichs: neutropaenia, infections with suppressed bone marrow counts main AEs from HPV-targeting TIL in metastatic cervical cancer. # ASCO14",,,#,4.73463E+17,https://twitter.com/ByJonGardner/status/473462612772925440,,,,
UCCancerCenter,6/2/2014 9:54,0,0,Peter O'Donnell describes 1200 Patients Project to translate pharmacogenomics into the clinic preemptively at # ASCO14 http://bit.ly/1wTNwdD,,,#,4.73463E+17,https://twitter.com/UCCancerCenter/status/473462588265988096,,,,
JeffreyMOtto,6/2/2014 9:53,0,0,LL: # ASCO14 40% of patients had mutations of unknown significance,,,#,4.73463E+17,https://twitter.com/JeffreyMOtto/status/473462506451517440,,,,
CureCancerNow,6/2/2014 9:52,0,0,"While a lot of exciting news is coming out of @ ASCO, we are reminded that cancer therapy rarely improves in... http://fb.me/3RC8MJnXa""",,@,,4.73462E+17,https://twitter.com/CureCancerNow/status/473462260787318786,,,,
JeffreyMOtto,6/2/2014 9:52,0,0,LL: # ASCO14 100/648 had deleterious or suspected deleterious mutations,,,#,4.73462E+17,https://twitter.com/JeffreyMOtto/status/473462259822243841,,,,
GustaveRoussy,6/2/2014 9:52,4,0,# ASCO14 Endometrial cancer: co-occurring mutations and combined targeted therapies- Drs Lhomme & Leary @ GustaveRoussy http://bit.ly/1wTJcuT,,@,#,4.73462E+17,https://twitter.com/GustaveRoussy/status/473462253661208576,,,,
GastricCancerFD,6/2/2014 9:52,1,0,Check out this interview with UCSD's Andrew Lowy on the latest in # gastriccancer research @ CancerNetwrk # ASCO14 http://ow.ly/xwqSY,,@,# #,4.73462E+17,https://twitter.com/GastricCancerFD/status/473462201068822529,,,,
SusanLaufer,6/2/2014 9:52,1,0,"Hedvig Hricak of @ MSKCC_OncoNotes on imaging as companion diagnostics - imho, best session of # ASCO14 !",,@,#,4.73462E+17,https://twitter.com/SusanLaufer/status/473462084844683264,,,,
DrAttai,6/2/2014 9:51,1,6,I love the fact that I can be in one session and follow multiple others via twitter. However it's contributing to brain overload... # ASCO14,,,#,4.73462E+17,https://twitter.com/DrAttai/status/473461959711817728,,,,
subatomicdoc,6/2/2014 9:51,0,0,"@ davidgrahammd Consider an All-in-one"""," then add @ Epocrates if need be. Medibabble a + # ASCO14""",,@ @,#,4.73462E+17,https://twitter.com/subatomicdoc/status/473461957144879104,,,
jaterceno,6/2/2014 9:51,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73462E+17,https://twitter.com/jaterceno/status/473461813385113600,,,,
JeffreyMOtto,6/2/2014 9:51,0,0,LL: # ASCO14 looked at 648 ovarian pts,,,#,4.73462E+17,https://twitter.com/JeffreyMOtto/status/473461806250205184,,,,
DrAttai,6/2/2014 9:50,0,0,"cool! MT @ subatomicdoc @ davidgrahammd Medibabble helps with taking medical history, speaks in multiple languages # ASCO14",,@ @,#,4.73462E+17,https://twitter.com/DrAttai/status/473461773715386369,,,,
DrBobGoldberg,6/2/2014 9:50,0,0,@ SprengelJ @ ASCO thanks Jeanie !!,,@ @,,4.73462E+17,https://twitter.com/DrBobGoldberg/status/473461768657068032,,,,
scientre,6/2/2014 9:50,0,1,Confident! MT @ mtmdphd: @ scientre More # mmsm & myeloma trials 1:15p S504 # ASCO14 SoMe in Clinical Trials (if I get slides uploaded that is),,@ @,# #,4.73462E+17,https://twitter.com/scientre/status/473461736226713600,,,,
EinsteinMed,6/2/2014 9:50,2,1,"RT @ rsm2800: Come tweet w/ us later today! Mon 1:15p S504 for Internet, Social Media, Privacy Regulations, & Clinical Trials # hcsm # ASCO14",,@,# #,4.73462E+17,https://twitter.com/EinsteinMed/status/473461733840146432,,,,
OncoSec,6/2/2014 9:50,5,6,$ ONCS presented positive phase 2 interim data today at # ASCO14 evaluating ImmunoPulse in melanoma: http://ow.ly/3lh9mU,,,#,4.73462E+17,https://twitter.com/OncoSec/status/473461711618715648,,,,
OncLive,6/2/2014 9:50,0,0,Viewing melanoma and endometrial cancer posters in E354b at # ASCO14 - QR codes should become standard pic.twitter.com/6XDU27TF2n,,,#,4.73462E+17,https://twitter.com/OncLive/status/473461704475828224,,,,
matthewherper,6/2/2014 9:50,1,2,How is this different form CART cells? not genetically modified. They don't see cytokine storm as the CARTs do. # ASCO14,,,#,4.73462E+17,https://twitter.com/matthewherper/status/473461629750083584,,,,
gumedcenter,6/2/2014 9:50,1,0,. @ LombardiCancer director optimistic re: T cell therapy concept in # HPV # cervicalcancer study via @ HealthDay http://bit.ly/1u8qz45 # asco14,,@ @,# # #,4.73462E+17,https://twitter.com/gumedcenter/status/473461621575401473,,,,
subatomicdoc,6/2/2014 9:50,1,2,@ davidgrahammd @ Doximity has nice function for setting up fax#HIPAA compliant # ASCO14,,@ @,#HIPAA #,4.73462E+17,https://twitter.com/subatomicdoc/status/473461538050039808,,,,
JeffreyMOtto,6/2/2014 9:49,0,1,# ASCO14 Lucy Langer - a study of ovarian cancer pts tested with a 25 gene panel of heredity,,,#,4.73462E+17,https://twitter.com/JeffreyMOtto/status/473461529627471873,,,,
JacobPlieth,6/2/2014 9:49,0,1,Dr Hinrichs on fed-funded HPV-TIL study: plan to expand and treat 35 patients # ASCO14,,,#,4.73462E+17,https://twitter.com/JacobPlieth/status/473461516235464704,,,,
MedscapeOnc,6/2/2014 9:49,3,0,Medscape's # ASCO2014 Live Blog coverage outlines breaking news coming today http://bit.ly/1kvlmkg,,,#,4.73461E+17,https://twitter.com/MedscapeOnc/status/473461456529539072,,,,
aakonc,6/2/2014 9:49,0,0,ADORE excluded pCR rectal ca so benefit of adj folfox in that population still incompletely understood # crcsm # ASCO14,,,# #,4.73461E+17,https://twitter.com/aakonc/status/473461371103760386,,,,
ASCO,6/2/2014 9:49,1,2,"# ASCO14 Press brief: “Durable, complete tumor regression can occur following single infusion w/ HPV-targeted T cells” – Dr Hinrichs",,,#,4.73461E+17,https://twitter.com/ASCO/status/473461315311501312,,,,
GustaveRoussy,6/2/2014 9:49,2,0,# ASCO14 Le Pr Karim Fizazi interrogé sur l'étude GETUG 12 # prostatecancer). Voir l'itw : https://vimeo.com/97063718 pic.twitter.com/dEv1OaEkxy,,,# #,4.73461E+17,https://twitter.com/GustaveRoussy/status/473461295128510465,,,,
DrAttai,6/2/2014 9:48,0,0,Argenbright - funding for survivorship care programs v. difficult. Need to get creative looking for sources. # ASCO14,,,#,4.73461E+17,https://twitter.com/DrAttai/status/473461278439387138,,,,
AdamsLisa,6/2/2014 9:48,6,3,I think many w/MBC would take risks on drugs outside tight limits of trials they can't qualify for (too many prior chemos etc) # ASCO14 # bcsm,,,# #,4.73461E+17,https://twitter.com/AdamsLisa/status/473461270239543297,,,,
LGG1,6/2/2014 9:48,0,0,"@ davidgrahammd QxMD app has 150 calculators, decision support # ASCO14",,@,#,4.73461E+17,https://twitter.com/LGG1/status/473461263792496640,,,,
subatomicdoc,6/2/2014 9:48,0,0,"@ davidgrahammd Medibabble helps with taking medical history, speaks in multiple languages - inc f/u questions. Mostly Y/N, # s # ASCO14",,@,# #,4.73461E+17,https://twitter.com/subatomicdoc/status/473461247623831552,,,,
ASCO,6/2/2014 9:48,5,4,# ASCO14 Press brief: Dr Hinrichs to discuss HPV-targeted lymphocytes for metastatic cervical cancer http://bit.ly/1m5dqCE # gynca # cxca,,,# # #,4.73461E+17,https://twitter.com/ASCO/status/473461188308008960,,,,
DrAttai,6/2/2014 9:48,1,1,"Argenbright discussing mobile survivorship care units - awesome! Videoconference capability, exercise equipment, etc # ASCO14",,,#,4.73461E+17,https://twitter.com/DrAttai/status/473461145387683840,,,,
markaorourke,6/2/2014 9:48,0,1,# ASCO14 Community # survivorship program received grant support and saw underserved population. Then went mobile.,,,# #,4.73461E+17,https://twitter.com/markaorourke/status/473461051359391745,,,,
MelanomaMom,6/2/2014 9:47,1,1,RT @ ASCO: # ASCO14 Dr Sznol presents update on 1st trial to address nivolumab/ipilimumab combo in adv. # melanoma http://bit.ly/1l0hA26,,@,# #,4.73461E+17,https://twitter.com/MelanomaMom/status/473460982463741952,,,,
WayneKoberstein,6/2/2014 9:47,1,0,"# ASCO14 press Conf. QA: adaptive t-cell Tx show suppressed marrow, infection effects, but reversible. @ RfwrightLSL Study was 9 patients.",,@,#,4.73461E+17,https://twitter.com/WayneKoberstein/status/473460968006356992,,,,
WHOPressUS,6/2/2014 9:47,0,0,Today’s is our last day exhibiting at # ASCO14. Visit the WHO Press booth 20119 by 5pm to receive 15% off all titles.,,,#,4.73461E+17,https://twitter.com/WHOPressUS/status/473460959038947328,,,,
kellykcotton,6/2/2014 9:47,0,0,". @ davidgrahammd suggests Omnio, Medscape Mobile, Epocrates, QxMD Calculate, Medibabble as useful clinical practice apps # ASCO14 # mhealth",,@,# #,4.73461E+17,https://twitter.com/kellykcotton/status/473460862746107904,,,,
MediTech_Media,6/2/2014 9:47,0,0,"Poster 200, nearly 1/3 of triple negative # breastcancer patients had a BRCA pathway mutation. # ASCO14 De Greve et al.",,,# #,4.73461E+17,https://twitter.com/MediTech_Media/status/473460820182302721,,,,
CureMelanoma,6/2/2014 9:47,0,2,RT @ ASCO: # ASCO14 Press brief: Adjuvant therapy w/ipilimumab for pts w/earlier-stage melanoma decreased relative risk of recurrence by ~25%,,@,#,4.73461E+17,https://twitter.com/CureMelanoma/status/473460816222904320,,,,
c_cerrado,6/2/2014 9:47,0,0,“ @ theNCI: In the news: Adoptive # immunotherapy approach shows promise in advanced # cervicalcancer http://yhoo.it/1mJbJMJ # ASCO14”,,@,# # #,4.73461E+17,https://twitter.com/c_cerrado/status/473460781552779264,,,,
subatomicdoc,6/2/2014 9:46,0,0,@ davidgrahammd Printer Pro great for iOS printing # ASCO14,,@,#,4.73461E+17,https://twitter.com/subatomicdoc/status/473460754377871360,,,,
Oncoinfo_it,6/2/2014 9:46,1,1,An immunotherapy can reduce regression of cervical cancer. C.S.Hinrichs # ASCO14 pic.twitter.com/I3lwwhOal3,,,#,4.73461E+17,https://twitter.com/Oncoinfo_it/status/473460719640645632,,,,
AdamsLisa,6/2/2014 9:46,8,3,"1 yr or 2 or 5 may seem soon"" to most. In scheme of drug pipeline it is. But clinical trials & ACCESS to them=key for MBC. # ASCO14 # bcsm""",,,# #,4.73461E+17,https://twitter.com/AdamsLisa/status/473460689055780865,,,,
matthewherper,6/2/2014 9:46,0,1,Most common adverse events with cell therapy were hematological: suppressed bone marrow and blood counts. Also neutropenia. # ASCO14,,,#,4.73461E+17,https://twitter.com/matthewherper/status/473460660723273728,,,,
subatomicdoc,6/2/2014 9:46,0,1,"@ davidgrahammd Utilities QxMD calculator = decision support, many calculators by specialty. can pick faves # ASCO14",,@,#,4.73461E+17,https://twitter.com/subatomicdoc/status/473460568901558276,,,,
TurnaRay,6/2/2014 9:46,0,0,"early data on next-gen EGFR inhibitors hit mutant cells, sparing wild-type # ASCO14 http://bit.ly/T6ScgK",,,#,4.73461E+17,https://twitter.com/TurnaRay/status/473460537565913088,,,,
MelanomaMom,6/2/2014 9:46,0,0,RT @ ASCO: # ASCO14 Press brief: Next up - Dr Ribas to discuss PD-1-targeting antibody MK-3475 for # melanoma http://bit.ly/1gXPO6G,,@,# #,4.73461E+17,https://twitter.com/MelanomaMom/status/473460525888598016,,,,
cure_magazine,6/2/2014 9:45,2,3,Early trial shows immunotherapy might also help HPV-related cervical cancer. # asco14,,,#,4.7346E+17,https://twitter.com/cure_magazine/status/473460473094873088,,,,
Novartis,6/2/2014 9:45,3,0,For HCPs: NET Talk is being showcased at # ASCO14. Visit the # Novartis booth to submit your questions about # NETCancer.,,,# # #,4.7346E+17,https://twitter.com/Novartis/status/473460385962799104,,,,
SarahCannonDocs,6/2/2014 9:45,1,0,Lung cancer news with # SCRI this morning: 9:45 am E Hall D2 at # ASCO14,,,# #,4.7346E+17,https://twitter.com/SarahCannonDocs/status/473460381768515584,,,,
JenPageWall,6/2/2014 9:45,1,0,Castellani Op-Ed in The Hill: Health insurance model must evolve # ASCO14 http://onphr.ma/1nDh4dL#sthash.OCJRbF6D.uxfs … via @ PhRMA,,@,# #sthash,4.7346E+17,https://twitter.com/JenPageWall/status/473460375652802560,,,,
carisls,6/2/2014 9:45,1,2,Loss or alteration to PTEN found in 80% of # sarcoma subtypes http://goo.gl/KxK2tG # ASCO14 # MolecularIntel,,,# # #,4.7346E+17,https://twitter.com/carisls/status/473460355625418753,,,,
krnmsw,6/2/2014 9:45,0,0,"@ DrLochChandler Integrative oncology adds to, should not replace traditional cancer care http://bit.ly/1pJyNNL # ASCO14”",,@,#,4.7346E+17,https://twitter.com/krnmsw/status/473460345776787456,,,,
FiercePharma,6/2/2014 9:45,2,3,# ASCO14: J&J's # Imbruvica thumps GSK's Arzerra in head-to-head leukemia trial http://www.fiercepharma.com/story/jjs-imbruvica-thumps-gsks-arzerra-head-head-leukemia-trial/2014-06-02 … $ JNJ $ GSK # pharma by @ CarlyHFierce,,@,# # #,4.7346E+17,https://twitter.com/FiercePharma/status/473460327674163200,,,,
FierceBiotech,6/2/2014 9:45,6,1,# ASCO14 coverage: Lilly's ramucirumab scores a marginal gain for lung cancer patients. http://www.fiercebiotech.com/story/lillys-ramucirumab-scores-marginal-positive-gain-lung-cancer-patients/2014-05-31 … by @ JohnCFierce $ LLY,,@,#,4.7346E+17,https://twitter.com/FierceBiotech/status/473460325346324481,,,,
theNCI,6/2/2014 9:45,17,12,Learn more about this # immunotherapy approach being tested against numerous solid tumors http://1.usa.gov/1mJcPs3 # ASCO14,,,# #,4.7346E+17,https://twitter.com/theNCI/status/473460301623746560,,,,
CarlyHFierce,6/2/2014 9:45,0,1,# ASCO14: $ GSK misses survival endpoint with # Tykerb-Herceptin pairing http://bit.ly/1oNtq2J # pharma,,,# # #,4.7346E+17,https://twitter.com/CarlyHFierce/status/473460292639137792,,,,
subatomicdoc,6/2/2014 9:44,0,0,@ davidgrahammd NCCN has free version but not as intuitive as @ Epocrates premium version # ASCO14,,@ @,#,4.7346E+17,https://twitter.com/subatomicdoc/status/473460250067369984,,,,
MelanomaMom,6/2/2014 9:44,1,0,RT @ adamfeuerstein: $ BMY nivo+Yervoy # melanoma survival curves. # ASCO14 presser pic.twitter.com/o7VRGXQHhx,,@,# #,4.7346E+17,https://twitter.com/MelanomaMom/status/473460235999277057,,,,
TuftsB,6/2/2014 9:44,1,0,@ DrAttai @ NirajGusani - yes. There is no average cancer patient or recovery. Thanks for bringing this up. # mliwi # asco14,,@ @,# #,4.7346E+17,https://twitter.com/TuftsB/status/473460197764399105,,,,
LGG1,6/2/2014 9:44,0,0,Graham: Free all-in-one apps for smart phones worth exploring include Omnio and Medscape Mobile. # ASCO14 @ davidgrahammd,,@,#,4.7346E+17,https://twitter.com/LGG1/status/473460161625866242,,,,
teamoncology,6/2/2014 9:44,1,2,Very understandable as a cancer patient. RT @ AmazzoneFuriosa: @ AdamsLisa @ Groz_P we all can be metastatic. we all are scared. # ASCO14 # BCSM,,@ @ @,# #,4.7346E+17,https://twitter.com/teamoncology/status/473460088930185216,,,,
markaorourke,6/2/2014 9:44,2,0,# ASCO14 Dr. Argenbreit started with Journey Forward for treatment summary. Exercise program popular with survivors. # bcsm # pcsm,,,# # #,4.7346E+17,https://twitter.com/markaorourke/status/473460087273451520,,,,
WayneKoberstein,6/2/2014 9:44,1,0,Side effects of PD-1 inhibs include 1 death by colitis in study of 50 melanoma patients. But proof in pudding is OS. # ASCO14 @ RfwrightLSL,,@,#,4.7346E+17,https://twitter.com/WayneKoberstein/status/473460086690816000,,,,
WayneKoberstein,6/2/2014 9:44,0,0,NCI study (about 20 patients) Adoptive T-cell Tx in cerv. cancer > complete response in 2 patients. # ASCO14 @ RfwrightLSL @ kevingopal,,@ @,#,4.7346E+17,https://twitter.com/WayneKoberstein/status/473460086686642176,,,,
WayneKoberstein,6/2/2014 9:44,0,0,Other study of Ipi/Nivi combo (Yale) showed only 40% durable response; update 2yr OS 79%. Complete response 17% # ASCO14 @ RfwrightLSL,,@,#,4.7346E+17,https://twitter.com/WayneKoberstein/status/473460086674046976,,,,
JacobPlieth,6/2/2014 9:44,0,0,O'Day on nivo+ipi study: not clear that combining is optional vs sequencing $ BMY # ASCO14,,,#,4.7346E+17,https://twitter.com/JacobPlieth/status/473460078881030144,,,,
jdflaysakier,6/2/2014 9:44,10,2,Les traitements basés sur l'immunotherapie donnent des premiers resultats trés encourageants dans le melanome metastatique # ASCO14,,,#,4.7346E+17,https://twitter.com/jdflaysakier/status/473460052117192704,,,,
DRGinsights,6/2/2014 9:43,1,0,50 Years of Fighting Cancer - a look at the changing oncology landscape and ASCO's role in shaping it http://decisionresources.com/The-Decision-Resources-Blog/June-2014/ASCO-6-2-2014 … # ASCO14,,,#,4.7346E+17,https://twitter.com/DRGinsights/status/473460012292259840,,,,
DrAttai,6/2/2014 9:43,0,1,"Argenbright - getting info for survivorship treatment summary often a hunting and gathering"" exercise # ASCO14""",,,#,4.7346E+17,https://twitter.com/DrAttai/status/473459992021196800,,,,
LesamisdeMikhy,6/2/2014 9:43,0,1,"“ @ GustaveRoussy:dans @ lemondefr Avancée pr les enfants atteint de tumeurs cérébrales"" # TNEP http://bit.ly/1mIEuct # ASCO14” Bravo et Merci!""",,@ @,# #,4.7346E+17,https://twitter.com/LesamisdeMikhy/status/473459976464498688,,,,
subatomicdoc,6/2/2014 9:43,0,0,"@ davidgrahammd Can get good medication interactions, with 'walk your way' interface for NCCN guidelines @ Epocrates # ASCO14",,@ @,#,4.7346E+17,https://twitter.com/subatomicdoc/status/473459965458665472,,,,
AdamsLisa,6/2/2014 9:43,15,22,Not trying to pick fight here. But if people in the field do not understand the urgency of those with stage 4 BC it saddens me # ASCO14 # bcsm,,,# #,4.7346E+17,https://twitter.com/AdamsLisa/status/473459937042264064,,,,
CathyEngMD,6/2/2014 9:43,1,1,"Abs #3502: # ASCO14 adjuvant FOLFOX may be best for ypT3-4, N+ locally adv rectal # cancer and may not be needed in ypT0-2 pts, # endcancer",,,#3502 # # #,4.7346E+17,https://twitter.com/CathyEngMD/status/473459913004707840,,,,
InstitutoRoche,6/2/2014 9:43,4,1,Algunas consideraciones sobre nuevas # inmunoterapias contra # cáncer de las q tanto se está hablando en # ASCO14 (ing) http://goo.gl/cpMzbM,,,# # #,4.7346E+17,https://twitter.com/InstitutoRoche/status/473459844423639040,,,,
Miles4Melanoma,6/2/2014 9:42,0,0,RT @ CureMelanoma: BSM announces Yervoy in adjuvant setting prolongs recurrence in advanced # melanoma patients http://ow.ly/xwkk0 # ASCO14,,@,# #,4.7346E+17,https://twitter.com/Miles4Melanoma/status/473459719643090944,,,,
AdamsLisa,6/2/2014 9:42,3,5,Um: incurable diag seems a good reason RT @ teamoncology: sorry misstated.Just do not want met breast cancer patients to panic # ASCO14 # BCSM,,@,# #,4.7346E+17,https://twitter.com/AdamsLisa/status/473459683765018625,,,,
subatomicdoc,6/2/2014 9:42,0,0,@ davidgrahammd More refined options @ Epocrates - free and premium options including NCCN Guidelines # ASCO14,,@ @,#,4.7346E+17,https://twitter.com/subatomicdoc/status/473459617293676544,,,,
Oncoinfo_it,6/2/2014 9:42,2,1,Combination immunotherapy ipilimumab + nivolumab: long- term survival in advanced melanoma. Sznol # ASCO14 @ PAsciertopic.twitter.com/IK6RpQbdg2,,@,#,4.7346E+17,https://twitter.com/Oncoinfo_it/status/473459614454124545,,,,
brendanweiss,6/2/2014 9:42,2,0,Pano is worthy of FDA approval @ Myeloma_Doc # ASCO14 # mmsm,,@,# #,4.7346E+17,https://twitter.com/brendanweiss/status/473459581474316288,,,,
aakonc,6/2/2014 9:42,0,0,ADORE establishes postoperative benefit of folfox over 5fu very clearly # crcsm # ASCO14,,,# #,4.7346E+17,https://twitter.com/aakonc/status/473459545805561856,,,,
maestrocjm,6/2/2014 9:41,0,0,In the news: Adoptive # immunotherapy approach shows promise in advanced # cervicalcancer http://yhoo.it/1mJbJMJ # ASCO14,,,# # #,4.73459E+17,https://twitter.com/maestrocjm/status/473459471919116288,,,,
MTomasson,6/2/2014 9:41,0,0,Following # ASCO14 on the twits..stunned at how far cancer treatments have come in the past decade.,,,#,4.73459E+17,https://twitter.com/MTomasson/status/473459428893540352,,,,
matthewherper,6/2/2014 9:41,2,4,"Clinical responses in three patients. Two CRs, was 18 and 11 months, now 22 months 15 months. Durable. # ASCO14",,,#,4.73459E+17,https://twitter.com/matthewherper/status/473459396069326848,,,,
PullanConsult,6/2/2014 9:41,0,0,"Only 10% of accelerated approvals later withdrawn for non confirmed efficacy. Paul Kluetz, FDA # ASCO14",,,#,4.73459E+17,https://twitter.com/PullanConsult/status/473459384371396608,,,,
UROncDoc,6/2/2014 9:41,0,0,# ASCO14 chemo+ADT in men with newly diagnosed hormone-sensitive # PC improves OS by >13 mospic.twitter.com/oBtMugZIIe,,,# #,4.73459E+17,https://twitter.com/UROncDoc/status/473459381653479424,,,,
rsm2800,6/2/2014 9:41,0,1,"Counting on it RT @ DrAttai: hi # bcsm - in case you haven't noticed, I'm tweeting yet again from # ASCO14 today",,@,# #,4.73459E+17,https://twitter.com/rsm2800/status/473459368315600896,,,,
DrTaraSmith,6/2/2014 9:41,0,0,“ @ NOCC_National: Two drug combo boosts ovarian cancer survival... ‐ @ cityofhope Breakthroughs Blog http://breakthroughs.cityofhope.org/asco-2014-drug-ovarian-cancer … # ASCO2014” AMAZING,,@ @,#,4.73459E+17,https://twitter.com/DrTaraSmith/status/473459359742038016,,,,
CancerNetwrk,6/2/2014 9:41,0,1,Exemestane Trumps Tamoxifen in Early Breast Cancer http://bit.ly/1p0uii0 # ASCO14,,,#,4.73459E+17,https://twitter.com/CancerNetwrk/status/473459313277534210,,,,
DShaywitz,6/2/2014 9:41,0,0,"Re: # ASCO14 excited to hear about progress, but not fan of horse race reporting",,,#,4.73459E+17,https://twitter.com/DShaywitz/status/473459313231409152,,,,
AlwaysBeWrite,6/2/2014 9:41,0,0,What dat mouf do? RT @ Alterwired: Most Oral HPV Infections Are in Men http://shar.es/VT1m7 via @ LiveScience @ ASCO,,@ @ @,,4.73459E+17,https://twitter.com/AlwaysBeWrite/status/473459290876162048,,,,
subatomicdoc,6/2/2014 9:41,3,0,Reduced-dose IMRT in HPV+ resectable oropharyngeal CA after cCR to induction chemo http://bit.ly/1mIhSJc > @ eaonc # ASCO14 # hncsm # radonc,,@,# # #,4.73459E+17,https://twitter.com/subatomicdoc/status/473459268176576512,,,,
Rad_Nation,6/2/2014 9:41,1,0,Reduced-dose IMRT in HPV+ resectable oropharyngeal CA after cCR to induction chemo http://buff.ly/1mIhSsB > @ eaonc # ASCO14 # hncsm # radonc,,@,# # #,4.73459E+17,https://twitter.com/Rad_Nation/status/473459267773947904,,,,
med_and_more,6/2/2014 9:40,0,0,“Some moderate wins and real setbacks“: RT @ CMichaelGibson: Cancer Conference Winners And Losers # ASCO2014 http://www.forbes.com/sites/matthewherper/2014/06/02/cancer-conference-winners-and-losers/ …,,@,#,4.73459E+17,https://twitter.com/med_and_more/status/473459249621004288,,,,
CancerDotNet,6/2/2014 9:40,3,1,Interactive PDF of # ASCO14 research & what it all means for pts: http://bit.ly/1jM9eGo pic.twitter.com/IWnwsktNaM,,,#,4.73459E+17,https://twitter.com/CancerDotNet/status/473459245833539584,,,,
aakonc,6/2/2014 9:40,0,0,Interesting conflicting data in rectal ca # ASCO14 # crcsm,,,# #,4.73459E+17,https://twitter.com/aakonc/status/473459239143604224,,,,
mlazqui,6/2/2014 9:40,3,2,"# ASCO14 Nivolumab/ipilimumab combo produced unprecedented 2-yr overall survival rates: 79%, ‘very impressive’ – Dr Sznol",,,#,4.73459E+17,https://twitter.com/mlazqui/status/473459182004629504,,,,
KarlaRivershaw,6/2/2014 9:40,0,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73459E+17,https://twitter.com/KarlaRivershaw/status/473459163662934017,,,,
BoysenMeb,6/2/2014 9:40,0,1,Ready for yet another good day # ASCO14 @DagMedicin pic.twitter.com/HLRcfG1D4u,,@DagMedicin,#,4.73459E+17,https://twitter.com/BoysenMeb/status/473459150253330432,,,,
genentech,6/2/2014 9:40,2,0,Conversations about skin cancer have evolved over last 50 yrs. Where do we go from here? # Next50 # ASCO14 http://ow.ly/xrh38,,,# #,4.73459E+17,https://twitter.com/genentech/status/473459126702727168,,,,
subatomicdoc,6/2/2014 9:40,0,0,@ medscape mobile can give you CME too # ASCO14 @ davidgrahammd,,@ @,#,4.73459E+17,https://twitter.com/subatomicdoc/status/473459090438778881,,,,
ProjectInno,6/2/2014 9:40,0,0,MT @ fdalawyers: National Patient Advocate Foundation Launches Project at # ASCO14: http://bit.ly/1kQVrTJ,,@,#,4.73459E+17,https://twitter.com/ProjectInno/status/473459087708286976,,,,
machfowlerBC,6/2/2014 9:40,0,0,More on PD-L1 and PD-1. Immune cancer improves in treatment of cancers # ASCO14 http://usat.ly/1mIXEix,,,#,4.73459E+17,https://twitter.com/machfowlerBC/status/473459084260556800,,,,
matthewherper,6/2/2014 9:40,0,0,"These cells aren't modified. They're cultured from tumor fragments, expanded, and re-infused. # ASCO14",,,#,4.73459E+17,https://twitter.com/matthewherper/status/473459058041962496,,,,
theNCI,6/2/2014 9:40,6,3,In the news: Adoptive # immunotherapy approach shows promise in advanced # cervicalcancer http://yhoo.it/1mJbJMJ # ASCO14,,,# # #,4.73459E+17,https://twitter.com/theNCI/status/473459045672976385,,,,
markaorourke,6/2/2014 9:40,0,0,# ASCO14 Dr. Argenbreit describes adult # survivorship program in a community setting. Started small and grew. Emphasize psychosocial.,,,# #,4.73459E+17,https://twitter.com/markaorourke/status/473459038106054656,,,,
ALLIANCE_org,6/2/2014 9:39,0,0,# ASCO14 poster: NCCTG N0733 http://bit.ly/1tBnxmT,,,#,4.73459E+17,https://twitter.com/ALLIANCE_org/status/473459001753993218,,,,
brendanweiss,6/2/2014 9:39,1,0,Pano-Bortez-Dex schedule needs optimization for even better benefit @ Myeloma_Doc # ASCO14,,@,#,4.73459E+17,https://twitter.com/brendanweiss/status/473458972557852672,,,,
DrAttai,6/2/2014 9:39,0,5,"hi # bcsm - in case you haven't noticed, I'm tweeting yet again from # ASCO14 today",,,# #,4.73459E+17,https://twitter.com/DrAttai/status/473458969470836736,,,,
timturnham,6/2/2014 9:39,10,4,RT @ curemelanoma: BSM announces Yervoy in adjuvant setting prolongs recurrence in advanced # melanoma patients http://ow.ly/xwkk0 # ASCO14,,@,# #,4.73459E+17,https://twitter.com/timturnham/status/473458919759945728,,,,
matthewherper,6/2/2014 9:39,0,0,"But so far they haven't worked, says Hinrichs. So they tried this cell therapy. # ASCO14",,,#,4.73459E+17,https://twitter.com/matthewherper/status/473458912692539393,,,,
mlazqui,6/2/2014 9:39,3,0,Splice variant RA-V7 asociada a resistencia a enzalutamida y abiraterona en CPRCm # ASCO14,,,#,4.73459E+17,https://twitter.com/mlazqui/status/473458900726214657,,,,
subatomicdoc,6/2/2014 9:39,0,0,"@ davidgrahammd talking about Omnio as all-one app. @ medscape another. Both iOS, Android but medscape also Kindle app # ASCO14",,@ @,#,4.73459E+17,https://twitter.com/subatomicdoc/status/473458893050617857,,,,
TuftsB,6/2/2014 9:39,0,0,All ASCO cost controllers should first read The Patient as Person & Ethics at the Edges of Life by Paul Ramsey & reconsider # mliwi # asco14,,,# #,4.73459E+17,https://twitter.com/TuftsB/status/473458863833120768,,,,
SeporahRaizer,6/2/2014 9:39,7,8,Don't write off people with metastatic cancer # bcsm # ASCO14 # mbcsmhttp://www.huffingtonpost.com/seporah-raizer/hey-hey-were-the-metsters_b_5398475.html …,,,# # #,4.73459E+17,https://twitter.com/SeporahRaizer/status/473458839166414848,,,,
teamoncology,6/2/2014 9:39,1,2,"@ AdamsLisa We need to increase more options for metastatic breast cancer by trials, supportive care, and standard of care. # ASCO14 # BCSM",,@,# #,4.73459E+17,https://twitter.com/teamoncology/status/473458810846060545,,,,
ASCO,6/2/2014 9:39,20,6,"# ASCO14 Press brief: Nivolumab/ipilimumab combo produced unprecedented 2-yr overall survival rates: 79%, ‘very impressive’ – Dr Sznol",,,#,4.73459E+17,https://twitter.com/ASCO/status/473458797089153024,,,,
matthewherper,6/2/2014 9:38,6,1,"Cervical cancer kills 4,000 women in the U.S. each year. HPV proteins are appealing targets for immunotherapy... # ASCO14",,,#,4.73459E+17,https://twitter.com/matthewherper/status/473458713161125888,,,,
GustaveRoussy,6/2/2014 9:38,2,0,# ASCO14 Cancer endomètre : coexistence de mutations et intérêt de thérapies ciblées combinées - Drs Leary et Lhomme http://bit.ly/1m5rCeQ,,,#,4.73459E+17,https://twitter.com/GustaveRoussy/status/473458675596939264,,,,
teamoncology,6/2/2014 9:38,0,1,@ AdamsLisa Practice changing and efforts to run many good clinical trials are two separate things. # ASCO14 # BCSM,,@,# #,4.73459E+17,https://twitter.com/teamoncology/status/473458665861558272,,,,
CarlyHFierce,6/2/2014 9:38,1,0,# ASCO14: J&J's # Imbruvica thumps GSK's Arzerra in head-to-head leukemia trial http://bit.ly/1rCl3ZR $ JNJ $ GSK # pharma,,,# # #,4.73459E+17,https://twitter.com/CarlyHFierce/status/473458634421465088,,,,
ASCO,6/2/2014 9:38,4,3,# ASCO14 Press brief: Dr Sznol presents update on 1st trial to address nivolumab/ipilimumab combo in adv. melanoma http://bit.ly/1l0hA26,,,#,4.73459E+17,https://twitter.com/ASCO/status/473458614003589120,,,,
DrSapnaPatel,6/2/2014 9:38,0,0,Combination dabrafenib/trametinib increased PFS in BRAF-positive melanoma http://goo.gl/fhprx9 # ASCO14 # melanoma # melsm,,,# # #,4.73459E+17,https://twitter.com/DrSapnaPatel/status/473458591173574658,,,,
mtmdphd,6/2/2014 9:38,0,0,@ scientre More on # mmsm and myeloma trials at 1:15p in S504 # ASCO14 - Social Media in Clinical Trials...(if I get slides uploaded that is),,@,# #,4.73459E+17,https://twitter.com/mtmdphd/status/473458538430595072,,,,
ATHOSMONT,6/2/2014 9:37,0,0," @ Alterwired: Exercise Beats Diet in Reducing Breast Cancer Risk http://shar.es/VTncg via @ LiveScience @ ASCO""""",,@ @ @,,4.73458E+17,https://twitter.com/ATHOSMONT/status/473458493949612033,,,,
PennMedNews,6/2/2014 9:37,0,1,More questions than answer: Penn presenting # ASCO14 abstract (1510) this morning on large panel genetic testing http://www.uphs.upenn.edu/news/News_Releases/2014/05/maxwell/ …,,,#,4.73458E+17,https://twitter.com/PennMedNews/status/473458484353454080,,,,
brendanweiss,6/2/2014 9:37,4,0,"For nonSCT candidates with NDMM Rd, Vd and MPV are all standard inductions with low risk of sec prim malig @ Myeloma_Doc # ASCO14 # mmsm",,@,# #,4.73458E+17,https://twitter.com/brendanweiss/status/473458361389051904,,,,
adamfeuerstein,6/2/2014 9:37,2,1,O’Day on nivo+Yervoy melanoma: Cautions small #of patients. ORR not much different combo vs mono. Needs to win on OS. $ BMY # ASCO14 presser,,,#of #,4.73458E+17,https://twitter.com/adamfeuerstein/status/473458331101962241,,,,
PullanConsult,6/2/2014 9:37,0,1,Immune gene signature better OS but worse with Avastin in ovarian. # ASCO14 abstract 5502,,,#,4.73458E+17,https://twitter.com/PullanConsult/status/473458322851385344,,,,
matthewherper,6/2/2014 9:37,0,0,But O'Day cautions that the treatment is going to have to win based on survival. # ASCO14,,,#,4.73458E+17,https://twitter.com/matthewherper/status/473458320716877824,,,,
teamoncology,6/2/2014 9:37,1,1,@ AdamsLisa sorry misstated. I just do not want metastatic breast cancer patients to panic. It is a tough situation. # ASCO14 # BCSM,,@,# #,4.73458E+17,https://twitter.com/teamoncology/status/473458260725362689,,,,
SeporahRaizer,6/2/2014 9:36,5,1,@ AdamsLisa @ teamoncology Needs 2 b balance in focus on making life better 4 those in remission & making life longer 4 those w/mets # ASCO14,,@ @,#,4.73458E+17,https://twitter.com/SeporahRaizer/status/473458221337038849,,,,
matthewherper,6/2/2014 9:36,0,4,Steven O'Day: I almost feel like I'm looking at child leukemia survival cures when looking at $ BMY combo data. # ASCO14,,,#,4.73458E+17,https://twitter.com/matthewherper/status/473458187199602688,,,,
cure_magazine,6/2/2014 9:36,2,2,RT @ teamoncology: @ AdamsLisa Agree. We need to do a better job for metastatic breast cancer. # ASCO14 # BCSM @ CarrieMCorey,,@ @ @,# #,4.73458E+17,https://twitter.com/cure_magazine/status/473458172481769472,,,,
DrAttai,6/2/2014 9:36,1,0,Dr. Argenbright discussing successful models for community based survivorship programs # ASCO14,,,#,4.73458E+17,https://twitter.com/DrAttai/status/473458096334200833,,,,
teamoncology,6/2/2014 9:36,0,0,@ AdamsLisa Agree. We need to do a better job for metastatic breast cancer. # ASCO14 # BCSM,,@,# #,4.73458E+17,https://twitter.com/teamoncology/status/473458046148935680,,,,
julestwits,6/2/2014 9:36,0,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.73458E+17,https://twitter.com/julestwits/status/473458038587023360,,,,
Progeny,6/2/2014 9:36,0,1,See how top healthcare providers are currently using our online FHQ to assess risk and integrate with their EMR - Booth 4028 # ASCO14,,,#,4.73458E+17,https://twitter.com/Progeny/status/473458009671077890,,,,
LGG1,6/2/2014 9:35,0,0,Now up: @ davidgrahammd addressing how to use smart phone apps to enhance practice # ASCO14,,@,#,4.73458E+17,https://twitter.com/LGG1/status/473457997549944832,,,,
MaverickNY,6/2/2014 9:35,2,1,@ Myeloma_Doc giving an excellent overview and context in discussing the myeloma trials. Nice job! # asco14,,@,#,4.73458E+17,https://twitter.com/MaverickNY/status/473457991484989440,,,,
AhidegDr,6/2/2014 9:35,0,0,@ DrAttai Need better communication during and post tx so PCP better prepared & can support/be involved during this time # ASCO14 # survivor,,@,# #,4.73458E+17,https://twitter.com/AhidegDr/status/473457958328991744,,,,
NirajGusani,6/2/2014 9:35,1,0,need more dissemination of models and best practices “ @ DrAttai: Acad. vs community based survivorship programs face diff challenges # ASCO14”,,@,#,4.73458E+17,https://twitter.com/NirajGusani/status/473457951802679296,,,,
myCME,6/2/2014 9:35,0,0,MT @ LifeEmpower: Cancer Conference Winners And Losers http://ow.ly/3lh81D # ASCO14 # biotech # pharma,,@,# # #,4.73458E+17,https://twitter.com/myCME/status/473457921930846208,,,,
CureMelanoma,6/2/2014 9:35,0,0,RT @ ASCO: # ASCO14 Press brief: Next up - Dr Ribas to discuss PD-1-targeting antibody MK-3475 for melanoma http://bit.ly/1gXPO6G,,@,#,4.73458E+17,https://twitter.com/CureMelanoma/status/473457894164541440,,,,
KLCampbellPhD,6/2/2014 9:35,0,0,Looking forward to Patient and Survivorship Care highlighted poster session discussion in S102 at 11:30 am today # ASCO14,,,#,4.73458E+17,https://twitter.com/KLCampbellPhD/status/473457829899014145,,,,
julestwits,6/2/2014 9:35,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73458E+17,https://twitter.com/julestwits/status/473457784387026944,,,,
myriadgenetics,6/2/2014 9:35,2,2,Myriad myRisk # genepanel found 63% more positive results in # ovariancancer patients than BRCA1 & 2 testing alone. 8:48am in S100a at # ASCO14,,,# # #,4.73458E+17,https://twitter.com/myriadgenetics/status/473457758168035329,,,,
JenniferEPayne,6/2/2014 9:35,0,0,“ @ NEJM: From # ASCO14: Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia http://nej.md/1hvgQ05 ”,,@,#,4.73458E+17,https://twitter.com/JenniferEPayne/status/473457756402626561,,,,
BioPharmaJosh,6/2/2014 9:34,0,0,RT @ JohnCFierce: GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact - $ GSK # ASCO14 http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …,,@,#,4.73458E+17,https://twitter.com/BioPharmaJosh/status/473457732360888320,,,,
adamfeuerstein,6/2/2014 9:34,1,3,$ BMY nivo+Yervoy melanoma safety. 1 treatment related death. # ASCO14 presser pic.twitter.com/Co7QPTDwF2,,,#,4.73458E+17,https://twitter.com/adamfeuerstein/status/473457691319607296,,,,
teamoncology,6/2/2014 9:34,0,0,"True. RT @ AdamsLisa: If you have it, it's scary # ASCO14 # BCSM",,@,# #,4.73458E+17,https://twitter.com/teamoncology/status/473457683211644929,,,,
OncEd,6/2/2014 9:34,0,0,Schmoll PETACC6 2 more years follow up needed for final evaluation # crcsm # ASCO14,,,# #,4.73458E+17,https://twitter.com/OncEd/status/473457599820886016,,,,
maggiemfox,6/2/2014 9:34,0,0,Harnessing your own immune system to fight cancer # ASCO2014 http://www.nbcnews.com/health/cancer/fighting-back-patients-own-immune-cells-tackle-cervical-cancer-n119286 …,,,#,4.73458E+17,https://twitter.com/maggiemfox/status/473457598646071296,,,,
AdamsLisa,6/2/2014 9:34,8,5,This is tough to hear when clock is ticking RT @ teamoncology: Nothing for practice changing for metastatic breast cancer. :( # ASCO14 # BCSM,,@,# #,4.73458E+17,https://twitter.com/AdamsLisa/status/473457566673272833,,,,
StreamingWell,6/2/2014 9:34,0,0,Filming at # ASCO2014 2 days down and 2 to go! pic.twitter.com/0x9pTm2JFN,,,#,4.73458E+17,https://twitter.com/StreamingWell/status/473457515284672513,,,,
jrgralow,6/2/2014 9:33,2,1,"At my S0307 poster on toxicity, ONJ, fracture & pt pref for IV vs oral - trial of 3 bisphosphonates in adj breast cancer. # ASCO14 # SWOGonc",,,# #,4.73457E+17,https://twitter.com/jrgralow/status/473457480018980864,,,,
OncologyCentral,6/2/2014 9:33,0,0,# News from # ASCO14 - Three # genes may predict benefit of early # chemotherapy in # bladder # cancer http://bit.ly/19MA7os,,,# # # # # #,4.73457E+17,https://twitter.com/OncologyCentral/status/473457465838018561,,,,
megtirrell,6/2/2014 9:33,1,0,Great story from @ NBCNews colleague @ maggiemfox from # ASCO14: http://www.today.com/health/one-rare-cancer-leads-another-cancer-registry-saves-babys-life-2D79738991 …,,@ @,#,4.73457E+17,https://twitter.com/megtirrell/status/473457390369914881,,,,
AdamsLisa,6/2/2014 9:33,2,5,"If you have it, it's scary MT @ teamoncology:Lots of investigators making efforts to fight met breast cancer.So not to be scary # ASCO14 # BCSM",,@,# #,4.73457E+17,https://twitter.com/AdamsLisa/status/473457335172874240,,,,
LGG1,6/2/2014 9:33,3,0,One important value of social media: provides opportunities to better understand patients’ experiences. @ subatomicdoc # ASCO14,,@,#,4.73457E+17,https://twitter.com/LGG1/status/473457317430956032,,,,
DrAttai,6/2/2014 9:33,4,1,Academic vs community based survivorship programs face different challenges but both sites can be successful # ASCO14,,,#,4.73457E+17,https://twitter.com/DrAttai/status/473457315308662784,,,,
ASCO,6/2/2014 9:33,7,4,# ASCO14 Press brief: Next up - Dr Ribas to discuss PD-1-targeting antibody MK-3475 for melanoma http://bit.ly/1gXPO6G,,,#,4.73457E+17,https://twitter.com/ASCO/status/473457280722415616,,,,
eatevilpenguins,6/2/2014 9:33,0,0,"# ASCO14 Losers: $ PBYI, $ CLVS, $ LLY; # ASCO14 Winners: $ AZN, cell therapy, PD-1, and $ GSK http://onforb.es/1p0kXqr @ twittmanda Rocks with Info",,@,# #,4.73457E+17,https://twitter.com/eatevilpenguins/status/473457272728092672,,,,
SWOG,6/2/2014 9:32,2,0,"# ASCO14 today # SWOGonc Trials-in-Prog: S1211 # myeloma http://abstracts.asco.org/144/AbstView_144_126521.html …, S1216 # prostate http://abstracts.asco.org/144/AbstView_144_130445.html … 1:15-5, S Hall A2",,,# # # #,4.73457E+17,https://twitter.com/SWOG/status/473457204704845825,,,,
brendanweiss,6/2/2014 9:32,2,1,"MPT-T v mPR-R in elderly NDMM probably equivalent outcomes, but MPT-T more toxic - Mel rarely used in NDMM in US # mmsm # ASCO14",,,# #,4.73457E+17,https://twitter.com/brendanweiss/status/473457162396913664,,,,
ASCO,6/2/2014 9:32,7,5,"# ASCO14 Press brief: 34% response rate to MK-3475 for melanoma, regardless of prior treatment with ipilimumab. 88% responses ongoing",,,#,4.73457E+17,https://twitter.com/ASCO/status/473457087264337920,,,,
n8pennell,6/2/2014 9:32,0,0,"Nothing but good things, both could well be winners for pts @ SherryAStoll: @ n8pennell What does Clovis vs Astra mean for patients? # ASCO14",,@ @,#,4.73457E+17,https://twitter.com/n8pennell/status/473457052094709760,,,,
brianreid,6/2/2014 9:32,2,0,"Today is # ASCO14 all-immunotherapy-all-the-time day. For good background on the approach, follow @ TheA2C ... ( # client)",,@,# #,4.73457E+17,https://twitter.com/brianreid/status/473457044964782081,,,,
AdamsLisa,6/2/2014 9:32,5,3,@ teamoncology the advances in metastatic breast cancer treatment are lagging. # ASCO14 is showing it now. It is very scary to those with MBC.,,@,#,4.73457E+17,https://twitter.com/AdamsLisa/status/473457019706671104,,,,
LMSatWCG,6/2/2014 9:32,0,0,# SocOncology report from @ W2OGroup looked at 15 million online conversations about cancer. What we saw: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.73457E+17,https://twitter.com/LMSatWCG/status/473457003814064128,,,,
DrAttai,6/2/2014 9:31,0,0,Prospective survivorship plan starting at the time of diagnosis is important # ASCO14,,,#,4.73457E+17,https://twitter.com/DrAttai/status/473456942678310912,,,,
adamfeuerstein,6/2/2014 9:31,4,3,$ BMY nivo+Yervoy melanoma survival curves. # ASCO14 presser pic.twitter.com/ZHhulasorT,,,#,4.73457E+17,https://twitter.com/adamfeuerstein/status/473456942363725824,,,,
DrAttai,6/2/2014 9:31,4,2,Key component of a successful survivorship program - a true multidisciplinary team approach # ASCO14,,,#,4.73457E+17,https://twitter.com/DrAttai/status/473456814764589057,,,,
JosephDMcCarthy,6/2/2014 9:31,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73457E+17,https://twitter.com/JosephDMcCarthy/status/473456781537329153,,,,
subatomicdoc,6/2/2014 9:31,0,0,Preoperative chemoRT & postop 5-FUoxali vs 5-FU in locally advanced # rectalcancer http://abstracts.asco.org/144/AbstView_144_133115.html … # ASCO14 # crcsm # hcsm # radonc,,,# # # # #,4.73457E+17,https://twitter.com/subatomicdoc/status/473456775354908672,,,,
ASCO,6/2/2014 9:31,2,2,Prep for # ASCO14 social media talks w/ @ mtmdphd & @ davidgrahammd's # ASCOConnection articles http://bit.ly/1gJQerW http://bit.ly/1fFAS5V,,@ @,# #,4.73457E+17,https://twitter.com/ASCO/status/473456758166667264,,,,
dmooneymd,6/2/2014 9:31,0,0,"Upon occurrence of sunitinib resistance rcc, dose escalation has been effective in both xenograft and patient models. # ASCO14 # rccsm",,,# #,4.73457E+17,https://twitter.com/dmooneymd/status/473456754286542849,,,,
Rad_Nation,6/2/2014 9:31,1,0,Preoperative chemoRT & postop 5-FUoxali vs 5-FU in locally advanced # rectalcancer http://abstracts.asco.org/144/AbstView_144_133115.html … # ASCO14 # crcsm # hcsm # radonc,,,# # # # #,4.73457E+17,https://twitter.com/Rad_Nation/status/473456751925530624,,,,
brianreid,6/2/2014 9:30,0,1,Must-read. RT @ maggiemfox: You can't make this stuff up # ASCO2014 http://www.today.com/health/one-rare-cancer-leads-another-cancer-registry-saves-babys-life-2D79738991 …,,@,#,4.73457E+17,https://twitter.com/brianreid/status/473456727787307008,,,,
Novartis,6/2/2014 9:30,2,2,# Novartis findings show potential treatment option for patients with relapsed/refractory # multiplemyeloma http://bit.ly/1tBkUBo # ASCO14,,,# # #,4.73457E+17,https://twitter.com/Novartis/status/473456698641096704,,,,
GenomicHealth,6/2/2014 9:30,0,1,Oral abstract at 10:33am in E Hall D1: Validation of 16-gene signature for prediction of recurrence after nephrectomy # ASCO14,,,#,4.73457E+17,https://twitter.com/GenomicHealth/status/473456670686052352,,,,
aakonc,6/2/2014 9:30,0,0,# ASCO14 http://tinyurl.com/n5flg3v lkng fwd to discussion Is Future Here? Novel Tech in DecsnMkg E 253 at noon todaypic.twitter.com/tZagpaH7VT,,,#,4.73457E+17,https://twitter.com/aakonc/status/473456658044039168,,,,
LillyPad,6/2/2014 9:30,0,0,Is there a common ground to cut the costs of cancer care? # ASCO14 http://ow.ly/xsehS,,,#,4.73457E+17,https://twitter.com/LillyPad/status/473456656790331393,,,,
brendanweiss,6/2/2014 9:30,5,0,Panobinostat encouraging PFS benefit - a new class of drugs for MM? # ASCO14 # mmsm,,,# #,4.73457E+17,https://twitter.com/brendanweiss/status/473456631649673216,,,,
JanssenUS,6/2/2014 9:30,0,1,New data on siltuximab featured in oral presentation today at 9:12am CT in E354a # ASCO14 – learn more here: http://bit.ly/1n21k3R,,,#,4.73457E+17,https://twitter.com/JanssenUS/status/473456629846114304,,,,
MaurerStats,6/2/2014 9:30,0,0,Lenalidomide Plus R-CHOP in DLBCL | # ASCO14 Daily News summary @ GregNowakowski @MayoClinicLymph http://am.asco.org/lenalidomide-plus-r-chop-may-reduce-negative-prognostic-impact-non-germinal-center-b-cell-diffuse#.U4x76tuyrs8.twitter … # lymsm,,@ @MayoClinicLymph,# # #,4.73457E+17,https://twitter.com/MaurerStats/status/473456621989797888,,,,
subatomicdoc,6/2/2014 9:30,4,4,Late axillary recurrence after negative sentinel node biopsy in # breastcancer http://abstracts.asco.org/144/AbstView_144_128936.html … > @ sloan_kettering # ASCO14 # bcsm,,@,# # #,4.73457E+17,https://twitter.com/subatomicdoc/status/473456621340078081,,,,
nycdoc29,6/2/2014 9:30,0,0,Leaving Day 2 Updates Session in D1 and ran into Wall St. # ASCO14 1st Ins Cos and now Wall St trying to predict Rx pic.twitter.com/b2pGtLKSkh,,,#,4.73457E+17,https://twitter.com/nycdoc29/status/473456586082762752,,,,
CancerDotNet,6/2/2014 9:30,1,0,Patient summary on potential of new personalized treatment for met # cervicalcancer # ASCO14 study: http://bit.ly/1mJ1GY8,,,# #,4.73457E+17,https://twitter.com/CancerDotNet/status/473456581498404864,,,,
FierceBiotech,6/2/2014 9:30,1,1,# ASCO14 coverage: AbbVie's leukemia drug program continues to wow analysts in early study. http://www.fiercebiotech.com/story/abbvies-leukemia-drug-program-continues-wow-analysts-early-study/2014-05-31 … by @ JohnCFierce $ ABBV,,@,#,4.73457E+17,https://twitter.com/FierceBiotech/status/473456544617467906,,,,
DrAttai,6/2/2014 9:30,2,1,Many challenges in cancer survivorship care - ideal time / method to transition back to primary care doc - some pts don't want # ASCO14,,,#,4.73457E+17,https://twitter.com/DrAttai/status/473456502586740738,,,,
FierceBiotech,6/2/2014 9:29,4,2,"Our special # ASCO14 issue: Merck, Bristol and Roche advance immuno-oncology drugs; GSK opens new cancer R&D chapter http://bit.ly/SockKP",,,#,4.73456E+17,https://twitter.com/FierceBiotech/status/473456439361802241,,,,
ByJonGardner,6/2/2014 9:29,0,0,Clinical response to HPV-targeting TIL in metastatic cervical cancer. # ASCO14 pic.twitter.com/HzUhYo1pc9,,,#,4.73456E+17,https://twitter.com/ByJonGardner/status/473456429861728256,,,,
FiercePharma,6/2/2014 9:29,2,0,"Check out our special issue devoted to # ASCO14, with coverage from @ JohnCFierce and @ CarlyHFierce: http://bit.ly/1oNraIF",,@ @,#,4.73456E+17,https://twitter.com/FiercePharma/status/473456380926783488,,,,
AshleySumrallMD,6/2/2014 9:29,0,0,Sneak peek this am on new way to type & grade brain tumors based on histopath + molec signature. Can't wait to hear more! # ASCO14 # btsm,,,# #,4.73456E+17,https://twitter.com/AshleySumrallMD/status/473456344046268417,,,,
AnneGStorvik,6/2/2014 9:29,0,1,Tettpakket på pressekonferansen om nye immunterapier denne morgenen. # ASCO14 pic.twitter.com/ySJOdL0jvW,,,#,4.73456E+17,https://twitter.com/AnneGStorvik/status/473456329739083777,,,,
RubenNiesvizky,6/2/2014 9:29,0,0,@ ASCO @ MyelomaCenter MPR-r MPT-T proves MPR OFFERS NO PROGRESS,,@ @,,4.73456E+17,https://twitter.com/RubenNiesvizky/status/473456317412044800,,,,
SWOG,6/2/2014 9:29,0,0,"# ASCO14: # SWOGonc S0927 Omega-3s for AI-induced pain in brca pts: Mon 8-11 A.M., S102; Mon 11:30-12:45 S100bc http://abstracts.asco.org/144/AbstView_144_130965.html … # bcsm",,,# # #,4.73456E+17,https://twitter.com/SWOG/status/473456294595416065,,,,
AhidegDr,6/2/2014 9:29,0,0,FYI @ SeattleMamaDoc : # ASCO14 Adjuvant therapy w/ipilimumab for pts w/earlier-stage melanoma decreased relative risk of recurrence by ~25%”,,@,#,4.73456E+17,https://twitter.com/AhidegDr/status/473456285393100800,,,,
DrPaulyDeSantis,6/2/2014 9:29,0,0,@ Pharming_Eric Pharmacogenomics # ASCO14 pic.twitter.com/QPkGPTuMt4,,@,#,4.73456E+17,https://twitter.com/DrPaulyDeSantis/status/473456268053872641,,,,
PaulineBernfeld,6/2/2014 9:28,0,0,Last day of # ASCO14 come pick up some journals at the @ nature @ NatureOutlook standpic.twitter.com/Gq07WpW9Vq,,@ @,#,4.73456E+17,https://twitter.com/PaulineBernfeld/status/473456234859745280,,,,
EdwardLangJr,6/2/2014 9:28,0,0,RT: @ genentech: Here are a few things to consider (& re-consider) about immunotherapies: http://ow.ly/xn0QA # ASCO14,,@,#,4.73456E+17,https://twitter.com/EdwardLangJr/status/473456234419744768,,,,
MelanomaMom,6/2/2014 9:28,0,0,RT @ adamfeuerstein: O’Day: 2/3 # melanoma patients from $ MRK pembro benefit. Combos or sequences may be better. Tox benign. # ASCO14 presser,,@,# #,4.73456E+17,https://twitter.com/MelanomaMom/status/473456201133723649,,,,
WayneKoberstein,6/2/2014 9:28,1,0,"Ipi/Nivi combo more that 90% durable response, amazing safety profile in study! (! Warranted. # ASCO14 @ RfwrightLSL @ kevingopal",,@ @,#,4.73456E+17,https://twitter.com/WayneKoberstein/status/473456190567886848,,,,
CMichaelGibson,6/2/2014 9:28,7,3,Cancer Conference Winners And Losers # ASCO2014 http://www.forbes.com/sites/matthewherper/2014/06/02/cancer-conference-winners-and-losers/ …,,,#,4.73456E+17,https://twitter.com/CMichaelGibson/status/473456102172930048,,,,
BIGagainstBC,6/2/2014 9:28,2,0,# ASCO14 Special session at 9:45am - Dr Martine Piccart and Dr Clifford Hudis present a Joint Session: Value and Cancer Care,,,#,4.73456E+17,https://twitter.com/BIGagainstBC/status/473456075161616385,,,,
MaverickNY,6/2/2014 9:28,2,3,"Panobinostat data in RR MM impressive, MPT-T vs MPR-R not so much. # asco14 end of road for melphalan in US",,,#,4.73456E+17,https://twitter.com/MaverickNY/status/473456057491410944,,,,
DrPaulyDeSantis,6/2/2014 9:27,0,0,@ Pharming_Eric # ASCO14 Pharmacogenomics pic.twitter.com/NjBmJYBBWY,,@,#,4.73456E+17,https://twitter.com/DrPaulyDeSantis/status/473455977778642944,,,,
danielebanfi83,6/2/2014 9:27,1,0,Il # tumore del triangolo maledetto. Nuove speranze per il # cancro dello stomaco. Lo spiego su @ la_stampa http://www.lastampa.it/2014/06/02/scienza/una-nuova-arma-per-il-tumore-del-triangolo-maledetto-yKxgyqRW2Os8M0j2b041RN/pagina.html … # ASCO14,,@,# # #,4.73456E+17,https://twitter.com/danielebanfi83/status/473455954004938752,,,,
dmooneymd,6/2/2014 9:27,0,0,"A4520: can we observe as front line therapy for metastatic rcc? Median time before treatment 14 months. No tx, no adverse events. # ASCO14",,,#,4.73456E+17,https://twitter.com/dmooneymd/status/473455945293393921,,,,
RubenNiesvizky,6/2/2014 9:27,0,0,@ ASCO @ MyelomaCenter ECOG: MPT-t vs MPR-r; pfs 306 pts. ORR 75 vs 70--pfs 21 vs 18 all in favor MPT OS 52 vs 47 more heme spm in MPT,,@ @,,4.73456E+17,https://twitter.com/RubenNiesvizky/status/473455929800024064,,,,
HallandPartners,6/2/2014 9:27,0,1,Seeing the shift from 'treating with drugs' to 'treating our patients' at # ASCO14 http://bit.ly/1kAuIpY # oncology # healthcare,,,# # #,4.73456E+17,https://twitter.com/HallandPartners/status/473455890243526656,,,,
tehfem,6/2/2014 9:27,0,0,# ASCO14 addition of oxalip no benefit for Sx outcome no DFS no OS advantage,,,#,4.73456E+17,https://twitter.com/tehfem/status/473455886065623040,,,,
cure_magazine,6/2/2014 9:27,3,2,"Results from melanoma mets trial w MK-3457 shows 69% 1-yr survival, low toxicity. One of the most benign therapies I've seen"" # ASCO14""",,,#,4.73456E+17,https://twitter.com/cure_magazine/status/473455878008741888,,,,
JacobPlieth,6/2/2014 9:27,5,2,Rivas: Pembro in melanoma - one of the most benign therapies I've ever used $ MRK # ASCO14,,,#,4.73456E+17,https://twitter.com/JacobPlieth/status/473455861151846401,,,,
Oncoinfo_it,6/2/2014 9:27,2,1,Ribas PD-1 Targeting Immunotherapy MK-3475 has high & long-lasting activity metastatic melanoma # ASCO14 @ PAsciertopic.twitter.com/ZPKrseHnnq,,@,#,4.73456E+17,https://twitter.com/Oncoinfo_it/status/473455852083769344,,,,
adamfeuerstein,6/2/2014 9:27,2,4,O’Day: 2/3 melanoma patients from $ MRK pembro study getting benefit. Combos or sequences may be better. Tox benign. # ASCO14 presser,,,#,4.73456E+17,https://twitter.com/adamfeuerstein/status/473455763407773696,,,,
WayneKoberstein,6/2/2014 9:26,1,0,"Combo of Ipi & nivolumimab shows much clearer, durable response. Most benign"" Tx advanced melanoma presenter seen. # ASCO14 @ RfwrightLSL""",,@,#,4.73456E+17,https://twitter.com/WayneKoberstein/status/473455695107731456,,,,
matthewherper,6/2/2014 9:26,1,0,"Steven O'Day on $ MRK vs. $ BMY in melanoma: remarkably similar."" # ASCO14""",,,#,4.73456E+17,https://twitter.com/matthewherper/status/473455624236564480,,,,
MontefioreNYC,6/2/2014 9:26,0,1,"Our docs including @ slibutti are at # ASCO14 in Chicago. If you're there, visit us at booth 20112. pic.twitter.com/UhLIxkVlHg",,@,#,4.73456E+17,https://twitter.com/MontefioreNYC/status/473455607673286656,,,,
SynergyVision,6/2/2014 9:26,0,1,Lots of news coming out of # ASCO14 AZ with exciting data for their ovarian cancer combo http://bit.ly/1mIEklB # pharma via @ PMLiVEcom,,@,# #,4.73456E+17,https://twitter.com/SynergyVision/status/473455573829423104,,,,
BaharGholipour,6/2/2014 9:26,7,3,Most Oral HPV Infections Are in Men http://shar.es/VT1m7 via @ LiveScience @ ASCO,,@ @,,4.73456E+17,https://twitter.com/BaharGholipour/status/473455540425588736,,,,
KarlaRivershaw,6/2/2014 9:26,0,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73455E+17,https://twitter.com/KarlaRivershaw/status/473455495903444993,,,,
JosephDMcCarthy,6/2/2014 9:26,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73455E+17,https://twitter.com/JosephDMcCarthy/status/473455494859096065,,,,
gumedcenter,6/2/2014 9:25,1,0,"Immunotherapy brings “remarkable change” in some # cancers, @ LombardiCancer director tells @ loftus @ WSJ http://on.wsj.com/1u8lWHb # asco14",,@ @ @,# #,4.73455E+17,https://twitter.com/gumedcenter/status/473455447429496832,,,,
adamfeuerstein,6/2/2014 9:25,6,5,$ MRK pembro melanoma swimmer's plot. Michael Phelps esque. # ASCO14 presser pic.twitter.com/TrU4c1PNOW,,,#,4.73455E+17,https://twitter.com/adamfeuerstein/status/473455326017359872,,,,
OncEd,6/2/2014 9:25,0,0,Schmoll PETACC6 no differences seen in Stage 2 or 3 subgroups # crcsm # ASCO14,,,# #,4.73455E+17,https://twitter.com/OncEd/status/473455304286666752,,,,
LGG1,6/2/2014 9:23,1,0,@ subatomicdoc discussing # bcsm as an online community that works. Also # lcsm. # ASCO14,,@,# # #,4.73455E+17,https://twitter.com/LGG1/status/473454978636709888,,,,
BayerPharma,6/2/2014 9:23,2,2,Today we sit down with # advocates at # ASCO14 roundtable discussion about # patient support.,,,# # #,4.73455E+17,https://twitter.com/BayerPharma/status/473454937125687296,,,,
OncEd,6/2/2014 9:23,0,0,Schmoll PETACC6 3 yr DFS same in CapeOx and Cape arms HR 1.04 # crcsm # ASCO14,,,# #,4.73455E+17,https://twitter.com/OncEd/status/473454901750939649,,,,
AstellasUS,6/2/2014 9:23,2,1,Astellas is a proud supporter of the Young Investigator Award being presented by @ iConquerCancer. http://Bit.ly/1jI4qHY # ASCO14,,@,#,4.73455E+17,https://twitter.com/AstellasUS/status/473454885661605888,,,,
adamfeuerstein,6/2/2014 9:23,6,3,$ MRK pembro melanoma waterfall plot. # ASCO14 presser pic.twitter.com/QnlUo93vbd,,,#,4.73455E+17,https://twitter.com/adamfeuerstein/status/473454885544153089,,,,
CureMelanoma,6/2/2014 9:23,4,3,BSM announces Yervoy in adjuvant setting prolongs recurrence in advanced # melanoma patients. Our statement: http://ow.ly/xwkk0 # ASCO14,,,# #,4.73455E+17,https://twitter.com/CureMelanoma/status/473454883321176064,,,,
maggiemfox,6/2/2014 9:23,1,0,You can't make this stuff up # ASCO2014 http://www.today.com/health/one-rare-cancer-leads-another-cancer-registry-saves-babys-life-2D79738991 …,,,#,4.73455E+17,https://twitter.com/maggiemfox/status/473454877109018624,,,,
DrAttai,6/2/2014 9:23,0,1,Sitting in session on survivorship - discussing various care plans # ASCO14,,,#,4.73455E+17,https://twitter.com/DrAttai/status/473454808612225024,,,,
n8pennell,6/2/2014 9:23,1,0,Cancer Conference Winners And Losers http://flip.it/aUg7w # asco14,,,#,4.73455E+17,https://twitter.com/n8pennell/status/473454783278612480,,,,
MelanomaMom,6/2/2014 9:23,0,0,RT @ adamfeuerstein: O’Day at # ASCO14 presser says jury still out on Yervoy adjuvant # melanoma - Need to see OS data next year. $ BMY,,@,# #,4.73455E+17,https://twitter.com/MelanomaMom/status/473454772058464257,,,,
BaharGholipour,6/2/2014 9:23,7,3,Exercise Beats Diet in Reducing Breast Cancer Risk http://shar.es/VTncg via @ LiveScience @ ASCO,,@ @,,4.73455E+17,https://twitter.com/BaharGholipour/status/473454755956547584,,,,
KLCampbellPhD,6/2/2014 9:23,2,0,Oeffinger - survivorship programs need a champion at the institution to ensure survivorship is a priority # ASCO14,,,#,4.73455E+17,https://twitter.com/KLCampbellPhD/status/473454755327393793,,,,
FondationSBO,6/2/2014 9:22,0,0,Nous vos proposerons chaque jour les principales conclusions des rencontres # ASCO14 car il s'y passe et s'y dit beaucoup de choses ! # cancer,,,# #,4.73455E+17,https://twitter.com/FondationSBO/status/473454683148005377,,,,
ASCO,6/2/2014 9:22,2,1,"# ASCO14 Press brief: 5-yr relapse rates for these pts vary from 40% to almost 90%, at very high risk – Dr Eggermont # melnm",,,# #,4.73455E+17,https://twitter.com/ASCO/status/473454657675997185,,,,
DetiffeOncoDNA,6/2/2014 9:22,0,0,"# ASCO14 stop by booth 5044 and discover our special offer for OncoDEEP service, the most comprehensive molecular profiling of tumor.",,,#,4.73455E+17,https://twitter.com/DetiffeOncoDNA/status/473454631214125057,,,,
cure_magazine,6/2/2014 9:22,0,0,"Largest phase 1 trial in metastatic melanoma testing MK-3457 (pembrolizumab), a PD-1 inhibitor. Updated results announced at # ASCO14",,,#,4.73455E+17,https://twitter.com/cure_magazine/status/473454547323478016,,,,
GustaveRoussy,6/2/2014 9:22,3,1,# ASCO14 Pediatric cancer: feasibility results of molecular screening for childhood # Cancer DrGeoerger @ gustaveroussy http://bit.ly/U6WS7c,,@,# #,4.73455E+17,https://twitter.com/GustaveRoussy/status/473454518781624320,,,,
KarlaRivershaw,6/2/2014 9:22,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73455E+17,https://twitter.com/KarlaRivershaw/status/473454513484230656,,,,
RoswellPark,6/2/2014 9:22,1,1,"Dozens of # RPCI researchers are at # ASCO14, presenting findings on new therapies & novel treatments: http://goo.gl/BjzptY # RPCINews",,,# # #,4.73455E+17,https://twitter.com/RoswellPark/status/473454505242402817,,,,
ASCO,6/2/2014 9:22,8,2,# ASCO14 Press brief: Adjuvant therapy w/ipilimumab for pts w/earlier-stage melanoma decreased relative risk of recurrence by ~25%,,,#,4.73454E+17,https://twitter.com/ASCO/status/473454496967065600,,,,
osservasaluteaz,6/2/2014 9:22,1,0,"# Asco14, come è cambiata in 50 anni la lotta al # tumore e il ruolo della # prevenzione: http://bit.ly/1ohzxIX via @ la_stampa.",,@,# # #,4.73454E+17,https://twitter.com/osservasaluteaz/status/473454493208944640,,,,
WayneKoberstein,6/2/2014 9:21,0,0,"ImmunoTx was mysterious, anecdotal approach until checkpoint inhibitors produced clear, durable responses. # ASCO14 @ RfwrightLSL @ kevingopal",,@ @,#,4.73454E+17,https://twitter.com/WayneKoberstein/status/473454454163795968,,,,
ASCO,6/2/2014 9:21,7,0,# ASCO14 press brief: 1st study to show ipilimumab is also effective in an adjuvant setting for earlier-stage disease http://bit.ly/1oN63Gx,,,#,4.73454E+17,https://twitter.com/ASCO/status/473454294243737600,,,,
LillianErdahlMD,6/2/2014 9:21,1,0,"# BCSM highlighted in MTP Social Media session # ASCO14, way to go advocate survivors!!",,,# #,4.73454E+17,https://twitter.com/LillianErdahlMD/status/473454232600072192,,,,
Chris_Ciaccia,6/2/2014 9:20,0,0,"If you care about # ASCO14, @ adamfeuerstein is helping make sense of it all",,@,#,4.73454E+17,https://twitter.com/Chris_Ciaccia/status/473454187976880128,,,,
CathyEngMD,6/2/2014 9:20,1,2,"Abs#3500, # ASCO14: There may be a role for oxali- still as a XRT sensitizer in loc adv rectal # cancer, improved DFS vs control. # endcancer",,,#3500 # # #,4.73454E+17,https://twitter.com/CathyEngMD/status/473454110734557185,,,,
GustaveRoussy,6/2/2014 9:19,4,0,"# ASCO14 Major @ GustaveRoussy presentations today # genitourinary (non prostate) cancer, # ImmunoOncology # melanoma and # pediatric patients",,@,# # # # #,4.73454E+17,https://twitter.com/GustaveRoussy/status/473453978093912064,,,,
adamfeuerstein,6/2/2014 9:19,1,1,O’Day at # ASCO14 presser says jury still out on Yervoy adjuvant melanoma. Need to see OS data next year. $ BMY,,,#,4.73454E+17,https://twitter.com/adamfeuerstein/status/473453917347774464,,,,
MaverickNY,6/2/2014 9:19,4,1,"@ teamoncology no doubt politics plays a big part of plenary selections but there are cancers beyond breast, lung, early prostate # asco14",,@,#,4.73454E+17,https://twitter.com/MaverickNY/status/473453908913049600,,,,
carisls,6/2/2014 9:19,0,0,"Predictive biomarker profiling of 1,900+ # sarcomas: potential novel treatments 1:15p S406 # ASCO14 http://goo.gl/UcM087 // @ FoxChaseCancer",,@,# #,4.73454E+17,https://twitter.com/carisls/status/473453878449827840,,,,
robert_jeng,6/2/2014 9:19,2,2,$ NVS LBH589 first quant data show 4 month PFS benefit in myeloma. 12 mo vs 8 mo placebo. # ASCO14,,,#,4.73454E+17,https://twitter.com/robert_jeng/status/473453847688380418,,,,
JacobPlieth,6/2/2014 9:19,2,1,"Pembro ph I melanoma trial, 411 pts $ MRK # ASCO14 pic.twitter.com/SJ52Q3FOfk",,,#,4.73454E+17,https://twitter.com/JacobPlieth/status/473453812251131905,,,,
cure_magazine,6/2/2014 9:19,1,1,One additional trial ongoing - phase 3 trial evaluating two different doses of Yervoy in melanoma. Results to be reported later. # asco14,,,#,4.73454E+17,https://twitter.com/cure_magazine/status/473453794798612481,,,,
UCCancerCenter,6/2/2014 9:19,0,0,"Sonali Smith recaps lymphoma clinical trial highlights from # ASCO14, including promising DLBCL improvement on RCHOP pic.twitter.com/5tflaPVU13",,,#,4.73454E+17,https://twitter.com/UCCancerCenter/status/473453790927286272,,,,
Sciences_Avenir,6/2/2014 9:19,7,2,ASCO 2014 : Nouvelle solution contre une maladie rare des articulations > http://bit.ly/1hQEx3g - # ASCO2014 pic.twitter.com/GPJFKGGtkg,,,#,4.73454E+17,https://twitter.com/Sciences_Avenir/status/473453766931648512,,,,
DrAttai,6/2/2014 9:19,0,1,The people handing out # ASCO14 daily news are so friendly this morning - nice to start a long day of meetings with a smile,,,#,4.73454E+17,https://twitter.com/DrAttai/status/473453749487558656,,,,
NCIMedia,6/2/2014 9:18,6,2,NCI at # ASCO14: A brief overview on research in women's # cancers: http://1.usa.gov/1pLOoMG pic.twitter.com/AQ8Y6BIae3,,,# #,4.73454E+17,https://twitter.com/NCIMedia/status/473453725772972032,,,,
AdoorAmanullah,6/2/2014 9:18,0,0,# ASCO14 Alarm on Declining Federally Funded Research http://www.medscape.com/viewarticle/826019 ….,,,#,4.73454E+17,https://twitter.com/AdoorAmanullah/status/473453666608107520,,,,
megtirrell,6/2/2014 9:18,4,2,"Early movers from the wknd at # ASCO14: $ PCYC up 7.2%, $ ARIA up 13%, $ CLVS down 4.5%. @ARIADPharm & Clovis CEOs join us live today on @ cnbc",,@ARIADPharm @,#,4.73454E+17,https://twitter.com/megtirrell/status/473453629664690176,,,,
kellykcotton,6/2/2014 9:18,0,1,"Getting started on social media: Lurk first, then comment & post - each network has its own etiquette rules"" @ subatomicdoc # ASCO14 # hcsm""",,@,# #,4.73454E+17,https://twitter.com/kellykcotton/status/473453546403553280,,,,
ShannonWestin,6/2/2014 9:18,0,0,Join me at the gyn ca poster highlights. E354b. Discussion starts at 11:30 in E354a. # ASCO14 # gyncsm,,,# #,4.73454E+17,https://twitter.com/ShannonWestin/status/473453516527509504,,,,
MaverickNY,6/2/2014 9:18,3,0,"@ teamoncology PREVAIL in CRPC, PANORAMA1 in MM, anti PD-L1 in bladder cancer. All practice changing # asco14",,@,#,4.73454E+17,https://twitter.com/MaverickNY/status/473453501910360064,,,,
GustaveRoussy,6/2/2014 9:17,3,0,"# ASCO14 Welcome to day 4 @ ASCO. Today, a big presentations program for @ GustaveRoussy delegatespic.twitter.com/KTtlURtdQC",,@ @,#,4.73453E+17,https://twitter.com/GustaveRoussy/status/473453476077654016,,,,
OncEd,6/2/2014 9:17,0,0,Schmoll PETACC6 1094 patients randomized # crcsm # ASCO14,,,# #,4.73453E+17,https://twitter.com/OncEd/status/473453433094430720,,,,
Oncoinfo_it,6/2/2014 9:17,1,1,Eggermont: Adjuvant Ipilimumab Improves Recurrence-Free Survival in High-Risk Stage 3 Melanoma @ PAscierto # ASCO14 pic.twitter.com/us6NozzvaF,,@,#,4.73453E+17,https://twitter.com/Oncoinfo_it/status/473453367965274112,,,,
Rfonsi1,6/2/2014 9:17,7,3,Great job by Paul Richardson presenting PANORAMA data on panobinostat as treatment for myeloma # ASCO14,,,#,4.73453E+17,https://twitter.com/Rfonsi1/status/473453357844410368,,,,
cure_magazine,6/2/2014 9:17,1,1,"Study shows Yervoy reduces risk of recurrence in patients with stage 3 melanoma, survival to be reported later # asco14",,,#,4.73453E+17,https://twitter.com/cure_magazine/status/473453240894636034,,,,
OncEd,6/2/2014 9:16,0,0,Schmoll PETACC6 Adjuvant CapeOx vs Capecitabine - Oxali added to pre and post op tx for rectal cancer # crcsm # ASCO14,,,# #,4.73453E+17,https://twitter.com/OncEd/status/473453225098891264,,,,
carisls,6/2/2014 9:16,0,0,"Molecular profiling of 267 # pediatriccancers to identify potential clinically relevant targets, poster 8am S, A2; pres. 11:30 S504 # ASCO14",,,# #,4.73453E+17,https://twitter.com/carisls/status/473453192290648064,,,,
GustaveRoussy,6/2/2014 9:16,4,0,# ASCO14 Etude sur l'application de la médecine personnalisée aux enfants atteints de cancer DrGeoerger @ GustaveRoussy http://bit.ly/1p0oODZ,,@,#,4.73453E+17,https://twitter.com/GustaveRoussy/status/473453186943303680,,,,
NickVRamos,6/2/2014 9:16,0,0,$ ONCS # ASCO14 results http://www.heraldonline.com/2014/06/02/6016839/oncosec-medical-presents-positive.html?sp=/100/773/385/ …,,,#,4.73453E+17,https://twitter.com/NickVRamos/status/473453164570877952,,,,
LGG1,6/2/2014 9:16,0,1,Katz: 80% of world leaders have a Twitter account # ASCO14 @ subatomicdoc,,@,#,4.73453E+17,https://twitter.com/LGG1/status/473453108656619520,,,,
caseofdees,6/2/2014 9:16,1,0,@ teamoncology Yes... I agree. Hopefully we can propose treatment to those who need it and skip it for those who don't need it # ASCO14,,@,#,4.73453E+17,https://twitter.com/caseofdees/status/473453076368863232,,,,
kellykcotton,6/2/2014 9:16,0,0,"About 50% of folks at Smartly Using Smartphones + Social Media"" session have a Twitter account # ASCO14 # hcsm""",,,# #,4.73453E+17,https://twitter.com/kellykcotton/status/473453071981617153,,,,
AdoorAmanullah,6/2/2014 9:15,0,0,# ASCO14 Practice-Changing Results for Metastatic Prostate Cancer http://www.medscape.com/viewarticle/826018 …,,,#,4.73453E+17,https://twitter.com/AdoorAmanullah/status/473452944009216001,,,,
Medzineapp,6/2/2014 9:15,0,0,Anti–PD-L1 Antibody Demonstrates Promising Activity in Patients With Metastatic # BladderCancer # ASCO14 http://bit.ly/1nXRWMs,,,# #,4.73453E+17,https://twitter.com/Medzineapp/status/473452941681389568,,,,
MelanomaMom,6/2/2014 9:15,0,0,RT @ adamfeuerstein: $ BMY Yervoy adjuvant # melanoma safety data. Not easy to tolerate. # ASCO14 presser pic.twitter.com/USNaA9d5vX,,@,# #,4.73453E+17,https://twitter.com/MelanomaMom/status/473452904368852993,,,,
JanssenUS,6/2/2014 9:15,0,1,Learn more about new data from investigational compound daratumumab in oral presentation at # ASCO14 at 9 am CT in E354a,,,#,4.73453E+17,https://twitter.com/JanssenUS/status/473452883024023553,,,,
kellykcotton,6/2/2014 9:15,1,0,"Caveat: When you join SM networks, physician-specific included, your data is being aggregated & sold - @ subatomicdoc # ASCO14 # hcsm",,@,# #,4.73453E+17,https://twitter.com/kellykcotton/status/473452879723122688,,,,
OncLive,6/2/2014 9:15,0,0,Dr. Robert Andtbacka from @ huntsmancancer Discusses OS With T-VEC in Melanoma http://ow.ly/xvy62 # ASCO14,,@,#,4.73453E+17,https://twitter.com/OncLive/status/473452838480519168,,,,
markaorourke,6/2/2014 9:15,0,0,"# ASCO14 # Survivorship follow up clinics use shared care"" with oncologist. A great idea!""",,,# #,4.73453E+17,https://twitter.com/markaorourke/status/473452831278501888,,,,
WileyOnc_Hem,6/2/2014 9:15,2,5,"Celebrate # ASCO14 with a selection of articles related to clinical oncology. Read, cite, and share! http://ow.ly/xoHfH @ ASCO @ ASCOPost",,@ @,#,4.73453E+17,https://twitter.com/WileyOnc_Hem/status/473452829643112448,,,,
subatomicdoc,6/2/2014 9:15,1,1,Local therapy & survival for stage IV # breastcancer: SEER 1988-2010. http://abstracts.asco.org/144/AbstView_144_128956.html … > @ uihealthcare # ASCO14 # bcsm # radonc,,@,# # # #,4.73453E+17,https://twitter.com/subatomicdoc/status/473452780884340736,,,,
JohnstonDon,6/2/2014 9:15,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73453E+17,https://twitter.com/JohnstonDon/status/473452769287077888,,,,
RubenNiesvizky,6/2/2014 9:15,0,0,@ ASCO @ MyelomaCenter PANORAMA 1; pano + bortezomib dex vs bortez dex RRMM: 768 pt pfs 12 vs 8 -- increase CR RATE an GI TOX fatigue,,@ @,,4.73453E+17,https://twitter.com/RubenNiesvizky/status/473452753415835648,,,,
adamfeuerstein,6/2/2014 9:15,3,2,$ BMY Yervoy adjuvant melanoma safety data. Not easy to tolerate. # ASCO14 presser pic.twitter.com/mFyTZUZ4cG,,,#,4.73453E+17,https://twitter.com/adamfeuerstein/status/473452746902081536,,,,
FierceBiotech,6/2/2014 9:15,2,0,# ASCO14 coverage: Clovis preps for a blockbuster showdown with AstraZeneca. http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31 … by @ JohnCFierce $ CLVS $ AZN,,@,#,4.73453E+17,https://twitter.com/FierceBiotech/status/473452739918184448,,,,
SherryNothingam,6/2/2014 9:14,0,0,RT @ subatomicdoc: Why women are choosing mastectomy: Influences beyond the surgeon http://bit.ly/1hiAphJ # ASCO14 # bcsm,,@,# #,4.73453E+17,https://twitter.com/SherryNothingam/status/473452704090828800,,,,
WayneKoberstein,6/2/2014 9:14,1,0,"1st study presented: EORTC 18071/CA 184-029, melanoma, ENDPOINT RECURRENCE-free survival, 60 pts., 2yr 8%; 3yr, 12% # ASCO14 @ RfwrightLSL",,@,#,4.73453E+17,https://twitter.com/WayneKoberstein/status/473452638047334400,,,,
RubenNiesvizky,6/2/2014 9:14,0,0,@ ASCO @ MyelomaCenter PANORAMA 1; pano + bortezomib dex vs bortez dex RRMM: 768 pt pfs 12 vs 8 m ?benefit high risk no OS benefit yet,,@ @,,4.73453E+17,https://twitter.com/RubenNiesvizky/status/473452535223955457,,,,
ALLIANCE_org,6/2/2014 9:14,2,0,# ASCO14 poster: @ Alliance_org Multictr phs 2 study of angiopoietin-1 & -2 peptibody trebananib for tx of angiosarcoma http://bit.ly/1hruRli,,@,#,4.73453E+17,https://twitter.com/ALLIANCE_org/status/473452526751477760,,,,
mtmdphd,6/2/2014 9:14,1,0,MT @ carisls: Genomic & protein alte in 126 triple-negative (TN) metaplastic Br CA Pts poster 1p E354b # ASCO14 http://goo.gl/UcM087 # bcsm,,@,# #,4.73453E+17,https://twitter.com/mtmdphd/status/473452518597742592,,,,
carisls,6/2/2014 9:13,1,1,"Molecular profiling of clear cell # ovarian carcinoma, poster 8-11a, E354b; presentation 11:30a, E354a # gyncsm # ASCO14 http://goo.gl/UcM087",,,# # #,4.73452E+17,https://twitter.com/carisls/status/473452440818171905,,,,
DrMiguelPerales,6/2/2014 9:13,0,1,"Bristol's Yervoy, alone or in combo, improves # melanoma results: studies http://reut.rs/1jLZNa5 via @ reuters # ASCO14 # melsm",,@,# # #,4.73452E+17,https://twitter.com/DrMiguelPerales/status/473452412980568065,,,,
jtriestm,6/2/2014 9:13,1,2,Ovarian cancer subtypes may predict response to bevacizumab | Science Codex http://www.sciencecodex.com/mayo_clinic_ovarian_cancer_subtypes_may_predict_response_to_bevacizumab-134715 … # asco14,,,#,4.73452E+17,https://twitter.com/jtriestm/status/473452410426253312,,,,
ebeckjord,6/2/2014 9:13,0,1,Poster w @ LIVESTRONGHQ at # ASCO14 on how treatment summaries promote # QOL & empowerment for # cancer # survivorspic.twitter.com/kS7YSxNecO,,@,# # # #,4.73452E+17,https://twitter.com/ebeckjord/status/473452404092841984,,,,
MelanomaMom,6/2/2014 9:13,0,0,RT @ adamfeuerstein: $ BMY Yervoy adjuvant # melanoma efficacy results. # ASCO14 presser pic.twitter.com/gpj51ONdDe,,@,# #,4.73452E+17,https://twitter.com/MelanomaMom/status/473452391308992512,,,,
OncEd,6/2/2014 9:13,0,0,Rodel AIO-04 Longterm grade 3/4 neuropathy 5% # crcsm # ASCO14,,,# #,4.73452E+17,https://twitter.com/OncEd/status/473452363886637056,,,,
adamfeuerstein,6/2/2014 9:12,4,3,$ BMY Yervoy adjuvant melanoma efficacy results. # ASCO14 presser pic.twitter.com/jiAg29jhrw,,,#,4.73452E+17,https://twitter.com/adamfeuerstein/status/473452112769482752,,,,
GenentechJobs,6/2/2014 9:12,1,1,Day 4 has begun. Team Genentech has been busy presenting new data on 27 different medicines during # ASCO14,,,#,4.73452E+17,https://twitter.com/GenentechJobs/status/473452080099651584,,,,
markaorourke,6/2/2014 9:12,0,0,# ASCO14 # Survivorship education session starts with new ASCO guidelines. Next is pediatric with emphasis on comprehensive assessment.,,,# #,4.73452E+17,https://twitter.com/markaorourke/status/473452049846108161,,,,
OncEd,6/2/2014 9:12,0,0,Rodel AIO-04 Oxaliplatin improved 3 yr DFS from 71.2 to 75.9 % HR=0.79 p=0.03 # crcsm # ASCO14,,,# #,4.73452E+17,https://twitter.com/OncEd/status/473452036034674689,,,,
carisls,6/2/2014 9:12,0,0,"Genomic & protein alterations, 126 triple-negative (TN) metaplastic # breastcancer patients, pres 4:45, E, D1 # ASCO14 http://goo.gl/UcM087",,,# #,4.73452E+17,https://twitter.com/carisls/status/473451976244465665,,,,
kahmed198,6/2/2014 9:11,1,0,RT “ @ NEJM: From # ASCO14: Benefit of Enzalutamide in Chemotherapy-Naïve Metastatic Prostate Cancer http://nej.md/1ioUi1d ”,,@,#,4.73452E+17,https://twitter.com/kahmed198/status/473451894330118144,,,,
eaonc,6/2/2014 9:11,0,1,K Stewart # ASCO14 about to present E1A06 # eaonc results E354a,,,# #,4.73452E+17,https://twitter.com/eaonc/status/473451812062625792,,,,
vbarsan,6/2/2014 9:11,0,0,"ponatinib (94%, n=109) vs. imatinib (68%, n=114) patients achieved <10% BCR-ABL transcript level @3 mo (P<0.001) # ASCO14",,@3,#,4.73452E+17,https://twitter.com/vbarsan/status/473451790063513600,,,,
ASCO,6/2/2014 9:11,5,4,# ASCO14 Press brief: “It is truly a brave new world these days for immunotherapy” –Dr. O’Day,,,#,4.73452E+17,https://twitter.com/ASCO/status/473451729263280128,,,,
carisls,6/2/2014 9:10,0,0,"Genomic & protein alterations in 126 triple-negative (TN) metaplastic # breastcancer patients, poster 1p E354b # ASCO14 http://goo.gl/UcM087",,,# #,4.73452E+17,https://twitter.com/carisls/status/473451695846879233,,,,
AhidegDr,6/2/2014 9:10,0,0,Reconsider the conclusion - what about the desire to not have mammograms...or breasts Ask women! # ASCO14 # survivor http://abstracts.asco.org/144/AbstView_144_130276.html?utm_content=buffer94a37&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer …,,,# #,4.73452E+17,https://twitter.com/AhidegDr/status/473451683738320896,,,,
ASCO,6/2/2014 9:10,5,3,# ASCO14 Press brief: Dr Eggermont presenting phase III study on ipilimumab for high-risk stage III melanoma http://bit.ly/1oN63Gx,,,#,4.73452E+17,https://twitter.com/ASCO/status/473451615492771840,,,,
genentech,6/2/2014 9:10,10,1,Here are a few things to consider (& re-consider) about immunotherapies: http://ow.ly/xn0QA # ASCO14,,,#,4.73452E+17,https://twitter.com/genentech/status/473451602872123392,,,,
Oncoinfo_it,6/2/2014 9:10,2,0,"@ ODayMD Immunotherapy: great and long lasting progresses against # melanoma"" @ PAscierto @ MandalaMario # ASCO14 pic.twitter.com/YptZtPY6OK""",,@ @ @,# #,4.73452E+17,https://twitter.com/Oncoinfo_it/status/473451586346573824,,,,
mtmdphd,6/2/2014 9:10,0,0,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.73452E+17,https://twitter.com/mtmdphd/status/473451552221724672,,,,
fredhoot,6/2/2014 9:10,0,0,RT @ subatomicdoc: Impact of p16 status on cetuximab+radiotherapy in H+N cancer http://bit.ly/RI7xmy > @ NRGOnc # ASCO14 # hncsm,,@ @,# #,4.73451E+17,https://twitter.com/fredhoot/status/473451474262192128,,,,
myriadgenetics,6/2/2014 9:10,0,0,Data at # ASCO14 show Myriad myPath Melanoma helps physicians be more confident in diagnosing # melanoma Poster 9021 http://bit.ly/1rBXXT4,,,# #,4.73451E+17,https://twitter.com/myriadgenetics/status/473451471166390272,,,,
SherryNothingam,6/2/2014 9:09,0,0,RT @ subatomicdoc: Impact of p16 status on cetuximab+radiotherapy in H+N cancer http://bit.ly/RI7xmy > @ NRGOnc # ASCO14 # hncsm,,@ @,# #,4.73451E+17,https://twitter.com/SherryNothingam/status/473451431073439744,,,,
Elekta,6/2/2014 9:09,0,1,"Before leaving Chicago, don't forget to visit booth Elekta 4019 at # ASCO14 today! http://ow.ly/i/5Lr9t",,,#,4.73451E+17,https://twitter.com/Elekta/status/473451419736223744,,,,
LGG1,6/2/2014 9:09,4,2,"Katz on social media: communities are defined by interest, not location # ASCO14 @ subatomicdoc",,@,#,4.73451E+17,https://twitter.com/LGG1/status/473451374760296448,,,,
sesiegler,6/2/2014 9:09,0,0,. @ ASCO It is nice to see Dr. Ribas is presenting! *waves*,,@,,4.73451E+17,https://twitter.com/sesiegler/status/473451370478329856,,,,
HRWhealthcare,6/2/2014 9:09,0,0,News from # ASCO14 about progress in Immunotherapy # ASCO # Oncology,,,# # #,4.73451E+17,https://twitter.com/HRWhealthcare/status/473451342439411712,,,,
docrohan,6/2/2014 9:09,0,1," @ subatomicdoc: Why women are choosing mastectomy: Influences beyond the surgeon http://bit.ly/1hiAphJ # ASCO14 # bcsm @ BreastCaIndia # cancer""",,@ @,# # #,4.73451E+17,https://twitter.com/docrohan/status/473451334679543809,,,,
drdonsdizon,6/2/2014 9:09,4,1,Honored to be at the @ ASCO presscast on immunotherapy. Amazing but early data in # cervca part of program. # gyncsm # ASCO14,,@,# # #,4.73451E+17,https://twitter.com/drdonsdizon/status/473451215062564864,,,,
NickDunnCNBC,6/2/2014 9:08,1,3,Big movers out of big cancer conference # ASCO14. @ megtirrell reports on the # WarOnCancer. http://www.cnbc.com/id/101721186 $ AZN $ ARIA $ PCYC $ CLVS,,@,# #,4.73451E+17,https://twitter.com/NickDunnCNBC/status/473451049093980160,,,,
subatomicdoc,6/2/2014 9:08,1,1,"Great group, go visit! MT @ chris4cure: The CHRIS4LIFE booth at # ASCO14 http://on.fb.me/1gWVz4I via @ COLONTOWN / # crcsm",,@ @,# #,4.73451E+17,https://twitter.com/subatomicdoc/status/473450964301905920,,,,
DrBobGoldberg,6/2/2014 9:07,0,0,. @ asco ad for their new value initiative # costcontainment http://youtu.be/Sh8mNjeuyV4,,@,#,4.73451E+17,https://twitter.com/DrBobGoldberg/status/473450950410371073,,,,
MelanomaMom,6/2/2014 9:07,0,0,Recent Progress in # Melanoma Management Catalyst for Change in Future Directions for Research | # ASCO14 - http://am.asco.org/recent-explosion-progress-melanoma-management-catalyst-change-future-directions-research#.U4x214owXxE.twitter …,,,# # #,4.73451E+17,https://twitter.com/MelanomaMom/status/473450914603204608,,,,
LillianErdahlMD,6/2/2014 9:07,1,1,@ subatomicdoc giving a great MTP session on social media E451a # ASCO14,,@,#,4.73451E+17,https://twitter.com/LillianErdahlMD/status/473450884257828865,,,,
OncEd,6/2/2014 9:07,0,0,Rodel AIO-04 German Rectal Cancer Study Group 1200 pt adjuvant trial FOLFOX vs 5FU rectal cancer # crcsm # ASCO14,,,# #,4.73451E+17,https://twitter.com/OncEd/status/473450859305910272,,,,
Perthera,6/2/2014 9:06,0,0,"What a great Breakfast Meeting! Thanks to everyone that joined us to hear Michael Pishvaian, MD, PhD discuss molecular analysis # ASCO14",,,#,4.73451E+17,https://twitter.com/Perthera/status/473450681186402304,,,,
carisls,6/2/2014 9:06,1,1,Visit booth 12096 to discuss any of our 34 # ASCO14 molecular profiling studies # breastcancer # sarcoma # colorectal # gastrointestinal # ovarian,,,# # # # # #,4.73451E+17,https://twitter.com/carisls/status/473450662999519233,,,,
lanisia,6/2/2014 9:06,0,1,@ DrAttai the headlines are intriguing nonetheless! # ASCO14,,@,#,4.73451E+17,https://twitter.com/lanisia/status/473450643597053952,,,,
TedOkonCOA,6/2/2014 9:06,1,1,Last few grueling days at # asco14. @ 60minutes there doing a story but not sure they really understand the real cancer crisis.,,@,#,4.73451E+17,https://twitter.com/TedOkonCOA/status/473450568271560704,,,,
ASCO,6/2/2014 9:06,8,3,ASCO Expert Dr Steven O'Day moderating today's # ASCO14 press briefing. Topic: Progress in Immunotherapy pic.twitter.com/6GLuJisgS6,,,#,4.73451E+17,https://twitter.com/ASCO/status/473450552492576768,,,,
rsm2800,6/2/2014 9:06,1,3,"Come tweet w/ us later today! Mon 6/2 1:15p S504 for Internet, Social Media, Privacy Regulations, and Clinical Trials # hcsm # ASCO14",,,# #,4.73451E+17,https://twitter.com/rsm2800/status/473450541528653825,,,,
YaleCancer,6/2/2014 9:06,1,1,"Dr. Steven O'Day @ ASCO says immune therapy a series of revolutions. Some therapies are cruise missiles.""""",,@,,4.73451E+17,https://twitter.com/YaleCancer/status/473450515972771840,,,,
jstnchsbrwn,6/2/2014 9:06,0,0,"Everything is discoverable; anonymity is a myth."" @ asco on social media use: identify yourself. Agreed!""",,@,,4.7345E+17,https://twitter.com/jstnchsbrwn/status/473450459861385216,,,,
Rad_Nation,6/2/2014 9:05,1,0,Impact of p16 status on cetuximab+radiotherapy in H+N cancer http://buff.ly/RI7zea > @ NRGOnc # ASCO14 # hncsm,,@,# #,4.7345E+17,https://twitter.com/Rad_Nation/status/473450313106866176,,,,
TuftsCancerCtr,6/2/2014 9:05,0,0,Susan Parsons # Tufts: stress of child with HSCT affects whole family - broader family support needed # ASCO14 # survivorship # bmtsm...,,,# # # #,4.7345E+17,https://twitter.com/TuftsCancerCtr/status/473450271126073345,,,,
subatomicdoc,6/2/2014 9:05,2,0,Impact of p16 status on cetuximab+radiotherapy in H+N cancer http://bit.ly/RI7xmy > @ NRGOnc # ASCO14 # hncsm,,@,# #,4.7345E+17,https://twitter.com/subatomicdoc/status/473450266164219904,,,,
teamoncology,6/2/2014 9:05,0,1,@ Groz_P Lots of investigators are making efforts to fight metastatic breast cancer. So not to be scary. # ASCO14 # BCSM,,@,# #,4.7345E+17,https://twitter.com/teamoncology/status/473450231334309889,,,,
Sermo,6/2/2014 9:04,1,2,"What's wrong with MOCs today, a great piece from @ DrLindaMD http://blog.sermo.com/2014/06/02/doctors-push-back-against-moc-requirements/ … # ASCO14",,@,#,4.7345E+17,https://twitter.com/Sermo/status/473450165550841856,,,,
QIAGENscience,6/2/2014 9:04,1,0,We’ve 2 liquid biopsy technologies 4 cancer diag & newborn screening; allow easier sample access & limit risk assoc w trad methods. # ASCO14,,,#,4.7345E+17,https://twitter.com/QIAGENscience/status/473450127265644544,,,,
DrMiguelPerales,6/2/2014 9:04,0,0,"Merck immune system-booster MK3475 anti-PD1 effective in skin, lung cancer http://reut.rs/So5dlw via @ reuters # ASCO14 # immunotherapy",,@,# #,4.7345E+17,https://twitter.com/DrMiguelPerales/status/473450090925813762,,,,
Groz_P,6/2/2014 9:04,0,0,“ @ teamoncology: @ ElaineSchattner Nothing for practice changing for metastatic breast cancer. :( # ASCO14 # BCSM” Very Frustrating and scary,,@ @,# #,4.7345E+17,https://twitter.com/Groz_P/status/473449991143714817,,,,
WayneKoberstein,6/2/2014 9:03,1,0,"# ASCO14 PR Conf focus on big results in melanoma, cervical, breast cancers for ipi & PD1 blockers. @ RfwrightLSL @ kevingopal",,@ @,#,4.7345E+17,https://twitter.com/WayneKoberstein/status/473449891000098816,,,,
davidgrahammd,6/2/2014 9:03,1,0,@ subatomicdoc starting our ticketed session at # ASCO14 pic.twitter.com/cEtU7qOsWx,,@,#,4.7345E+17,https://twitter.com/davidgrahammd/status/473449889167208448,,,,
jagasquet,6/2/2014 9:03,0,0,New data from study combining # immunotherapies in metastatic melanoma T-VEC http://bit.ly/1oN9ay9 @ Amgen # ASCO14,,@,# #,4.7345E+17,https://twitter.com/jagasquet/status/473449860163592192,,,,
SJNaggiar,6/2/2014 9:02,0,1,# ASCO2014 Monday press briefing on progress in immunotherapy,,,#,4.7345E+17,https://twitter.com/SJNaggiar/status/473449684338757632,,,,
AdoorAmanullah,6/2/2014 9:02,0,0,# ASCO14 study led by @ theNCI: Adding docetaxel to hormone therapy lengthens lives in met prostate ca # pcsmhttp://bit.ly/1kwY8Fw,,@,# #,4.7345E+17,https://twitter.com/AdoorAmanullah/status/473449671533539328,,,,
ASCO,6/2/2014 9:02,7,2,Missed today's # ASCO14 press briefing? View the recording for the latest in immunotherapy: http://bit.ly/QF4Thk,,,#,4.7345E+17,https://twitter.com/ASCO/status/473449545113034753,,,,
CancerMedMDA,6/2/2014 9:02,0,0,Visit Dr. Muhamed Baljevic's poster on CNS relapse in adult ALL. Mon. 1:15 PM. # ASCO14 # endcancer,,,# #,4.73449E+17,https://twitter.com/CancerMedMDA/status/473449488041136129,,,,
teamoncology,6/2/2014 9:01,0,0,@ Groz_P @ ElaineSchattner Nothing for practice changing for metastatic breast cancer. :( # ASCO14 # BCSM,,@ @,# #,4.73449E+17,https://twitter.com/teamoncology/status/473449447326621696,,,,
CancerDotNet,6/2/2014 9:01,9,2,# ASCO14 study: ipilimumab post-surgery reduces recurrence of high-risk stg 3 # melanoma # melsm http://bit.ly/1kphaSQ,,,# # #,4.73449E+17,https://twitter.com/CancerDotNet/status/473449344017129473,,,,
WinshipAtEmory,6/2/2014 9:01,0,0,Abstract: GEP test prediction and overall survival in cutaneous melanoma patients undergoing SLNB: http://ow.ly/xsWE8 # ASCO14,,,#,4.73449E+17,https://twitter.com/WinshipAtEmory/status/473449300132102144,,,,
jagasquet,6/2/2014 9:01,0,0,# Yervoy ( # ipilimumab) improves recurrence-free survival in Phase III StageIII # melanoma trial http://bit.ly/U6USM9 $ BMY # ASCO14 “ @ fwpharma,,@,# # # #,4.73449E+17,https://twitter.com/jagasquet/status/473449285690748928,,,,
CRC_Medical,6/2/2014 9:01,0,2,Check out this star title from # ASCO14! Atlas of Procedures in # Gynecologic # Oncology 3rd Ed. Save 20% w/ promo EMN13 http://ow.ly/xr8pu,,,# # #,4.73449E+17,https://twitter.com/CRC_Medical/status/473449280972533760,,,,
adamfeuerstein,6/2/2014 9:01,1,4,# ASCO14 press conferences: Nerdy oncologists are treated like rock stars. pic.twitter.com/mntQYyELuI,,,#,4.73449E+17,https://twitter.com/adamfeuerstein/status/473449272126746624,,,,
ONAcom,6/2/2014 9:01,0,0,# ASCO14: Fewer than 5% of adults with cancer enroll in clinical trials - read more http://ow.ly/xwdNN,,,#,4.73449E+17,https://twitter.com/ONAcom/status/473449258520428544,,,,
NCIMedia,6/2/2014 9:00,3,0,Interested in # cancer genomics? Read about that and other sessions with NCI participants at # ASCO14 happening today: http://1.usa.gov/1omUQZo,,,# #,4.73449E+17,https://twitter.com/NCIMedia/status/473449170041573376,,,,
Novartis,6/2/2014 9:00,4,3,Starting now in E354a: New # Novartis phase III data for patients with # multiplemyeloma # ASCO14 http://bit.ly/1i93rtE,,,# # #,4.73449E+17,https://twitter.com/Novartis/status/473449164001792001,,,,
DrMiguelPerales,6/2/2014 9:00,0,1,Personalized therapy with T cells against # HPV helped women w advanced cervical cancer http://reut.rs/1rBVo3t via @ reuters # ASCO14 # gyncsm,,@,# # #,4.73449E+17,https://twitter.com/DrMiguelPerales/status/473449098280853506,,,,
Pharmacyclics,6/2/2014 9:00,0,1,We are always excited about # innovation! Visit booth 18097 to see ibrutinib through # GoogleGlass # ASCO14,,,# # #,4.73449E+17,https://twitter.com/Pharmacyclics/status/473449019864141824,,,,
carisls,6/2/2014 9:00,2,0,"Sarcoma is a heterogenous group of tumors with more than 50 subtypes."" http://goo.gl/KxK2tG # ASCO14 # MolecularIntel""",,,# #,4.73449E+17,https://twitter.com/carisls/status/473449010028900352,,,,
pamstutz2,6/2/2014 8:59,0,0,@ megtirrell take a look at booth 20135 at # ASCO14. The company called Creatv MicroTech has a tech to discover CTCs in the blood.,,@,#,4.73449E+17,https://twitter.com/pamstutz2/status/473448867564765184,,,,
Groz_P,6/2/2014 8:59,0,0,@ teamoncology @ ElaineSchattner Many of us are still looking for practice changing news for bc mets (zometa aside). Anything?? # asco14,,@ @,#,4.73449E+17,https://twitter.com/Groz_P/status/473448772622909440,,,,
WayneKoberstein,6/2/2014 8:59,1,0,Tweeting live from immunoTx press conference # ASCO14 @ RfwrightLSL @ kevingopal,,@ @,#,4.73449E+17,https://twitter.com/WayneKoberstein/status/473448757166866432,,,,
carisls,6/2/2014 8:58,0,0,"Research w/ Caris # MolecularIntel provides treatment direction for 2,047 # Sarcoma patients http://goo.gl/KxK2tG # ASCO14 HT @ FoxChaseCancer",,@,# # #,4.73449E+17,https://twitter.com/carisls/status/473448666921848832,,,,
JeremyMooreFCCC,6/2/2014 8:58,2,0,"Too many shout outs, so congrats to all on a successful # ASCO14 http://tinyurl.com/qgz7bme",,,#,4.73449E+17,https://twitter.com/JeremyMooreFCCC/status/473448530905169920,,,,
julestwits,6/2/2014 8:58,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73448E+17,https://twitter.com/julestwits/status/473448470318444544,,,,
DrMiguelPerales,6/2/2014 8:58,1,0,"@ mtmdphd @ symplur Mike, I get 5,659 Participants from 5/30 - 6/2. More # ASCO14 analytics here: http://www.symplur.com/healthcare-hashtags/ASCO14/analytics/?hashtag=ASCO14&fdate=05%2F30%2F2014&shour=0&smin=0&tdate=06%2F02%2F2014&thour=10&tmin=0&ssec=00&tsec=00&img=1 … via @ symplur",,@ @ @,#,4.73448E+17,https://twitter.com/DrMiguelPerales/status/473448459992064000,,,,
teamoncology,6/2/2014 8:57,0,0,@NishantBelugali Here is our work. Please download. # ASCO14 # BCSM https://www.dropbox.com/s/yahkjzr6tqu71md/ASCO2014_TNBC_RPPA.pdf …,,@NishantBelugali,# #,4.73448E+17,https://twitter.com/teamoncology/status/473448430593777664,,,,
FierceBiotech,6/2/2014 8:57,1,0,# ASCO14 coverage: Roche partners with Roche on 'breakthrough' PD-L1 cancer program. http://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 … by @ JohnCFierce,,@,#,4.73448E+17,https://twitter.com/FierceBiotech/status/473448404639821825,,,,
jaterceno,6/2/2014 8:56,0,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73448E+17,https://twitter.com/jaterceno/status/473448087546265600,,,,
QIAGENscience,6/2/2014 8:56,0,0,iLibrary app allows iPad users to view @ ASCO multimedia inc. JCO issues & @ ASCO Uni videos. http://bit.ly/So9Zzf pic.twitter.com/OvgceSijLq,,@ @,,4.73448E+17,https://twitter.com/QIAGENscience/status/473447999973380096,,,,
fwpharma,6/2/2014 8:55,0,0,Bristol-Myers Squibb's Yervoy improves recurrence-free survival in Phase III melanoma trial http://bit.ly/U6USM9 $ BMY # ASCO14,,,#,4.73448E+17,https://twitter.com/fwpharma/status/473447810403414016,,,,
TargetedOnc,6/2/2014 8:55,0,1,CO-1686 continues to show activity in pts with NSCLC who developed resistance after prior Tx with an EGFR TKI http://www.targetedonc.com/conference/asco-2014/Promise-Seen-With-EGFR-Inhibitor-CO-1686-in-Treatment-Resistant-NSCLC … # ASCO14,,,#,4.73448E+17,https://twitter.com/TargetedOnc/status/473447772465942529,,,,
SitemanCenter,6/2/2014 8:55,2,1,"Miss the # ASCO14 debate on follow-up imaging in # lymphoma? Ken Carson, MD, & @ CancerNetwrk review the pros & cons: http://goo.gl/bdD6zF",,@,# #,4.73448E+17,https://twitter.com/SitemanCenter/status/473447760981917696,,,,
mtmdphd,6/2/2014 8:55,0,0,. @ ASCO Social Media Info http://ow.ly/xt4Ov # ASCO14 Tweeps: http://ow.ly/xt4Ow Ten Tips: http://ow.ly/xt4Ox,,@,#,4.73448E+17,https://twitter.com/mtmdphd/status/473447736466231297,,,,
JohnstonDon,6/2/2014 8:55,0,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73448E+17,https://twitter.com/JohnstonDon/status/473447701657706496,,,,
jaterceno,6/2/2014 8:55,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.73448E+17,https://twitter.com/jaterceno/status/473447701393444864,,,,
nanostringtech,6/2/2014 8:55,0,0,"O'Shaughnessy et al: Low cytolytic T-cell CD8 expression in mesenchymal triple negative breast cancers…"" at # ASCO14 http://abstracts.asco.org/144/AbstView_144_133619.html …""",,,#,4.73448E+17,https://twitter.com/nanostringtech/status/473447699916677124,,,,
myPathMelanoma,6/2/2014 8:55,1,0,Check out our poster TODAY 8am-12:45am Myriad myPath # Melanoma: Influence of Gene Sign. on Treatment of Melanocytic # Tumors # ASCO14,,,# # #,4.73448E+17,https://twitter.com/myPathMelanoma/status/473447691905540096,,,,
myriadgenetics,6/2/2014 8:55,0,0,Data at # ASCO14 show Myriad's myRisk test helps solve the overlap dilemma among # hereditarycancer syndromes. TODAYhttp://bit.ly/1u88lQ8,,,# #,4.73448E+17,https://twitter.com/myriadgenetics/status/473447691720998912,,,,
lanisia,6/2/2014 8:54,0,1,So many tweets from # ASCO14 ...,,,#,4.73448E+17,https://twitter.com/lanisia/status/473447562049892353,,,,
DrMiguelPerales,6/2/2014 8:54,2,0,# ASCO14 # immunotherapy RT @ WoodBD Scientists Prime The Immune System As A Powerful Cancer Weapon http://onforb.es/1p09TJO via @ forbes,,@ @,# #,4.73448E+17,https://twitter.com/DrMiguelPerales/status/473447537811419136,,,,
AlpineBV_Miller,6/2/2014 8:53,0,0,Feeling bad for denizens of our # ASCO14 host city. Tough game 7 OT loss last night.,,,#,4.73447E+17,https://twitter.com/AlpineBV_Miller/status/473447308928253952,,,,
UdderlySmooth,6/2/2014 8:52,0,0,Rise and shine! Happy Monday last day at # ASCO14 then heading home http://ift.tt/1omSR7C pic.twitter.com/njlT79v5Gl,,,#,4.73447E+17,https://twitter.com/UdderlySmooth/status/473447165826957312,,,,
OncologyRehab,6/2/2014 8:52,0,0,Last day at @ ASCO in Chicago! Visit our booth #17159! # ASCO14,,@,#17159 #,4.73447E+17,https://twitter.com/OncologyRehab/status/473447081600745473,,,,
NOCC_National,6/2/2014 8:52,7,5,Two drug combo boosts ovarian cancer survival... ‐ @ cityofhope Breakthroughs Blog http://breakthroughs.cityofhope.org/asco-2014-drug-ovarian-cancer … # ASCO2014,,@,#,4.73447E+17,https://twitter.com/NOCC_National/status/473446976990617600,,,,
The_HFoundation,6/2/2014 8:51,2,4,RT @sharonscottm: Reflecting on Cancer Survivors Day! # luriewalk @ ASCO @ LurieCancer @ LIVESTRONGCEO @ NMHnewspic.twitter.com/Zl7ZZRH2sE,,@sharonscottm @ @ @ @,#,4.73447E+17,https://twitter.com/The_HFoundation/status/473446807175831553,,,,
teamoncology,6/2/2014 8:51,3,2,Top Breast Cancer Findings from # ASCO14 Part II: effectiveness of Zometa is no difference between every 4 week or 12 weeks. # BCSM,,,# #,4.73447E+17,https://twitter.com/teamoncology/status/473446793942814720,,,,
Melanoma_MRV,6/2/2014 8:51,1,1,Combined Dabrafenib&Trametinib improves survival in advanced BRAF mutant melanoma compared to Dabrafenib. # ASCO14 pic.twitter.com/U0SNvVXpzB,,,#,4.73447E+17,https://twitter.com/Melanoma_MRV/status/473446730202365952,,,,
JanssenUS,6/2/2014 8:51,0,1,Janssen presents new IMAAGEN data in prostate cancer at # ASCO14 Stop by S Hall A2 at 1:15 pm to learn more http://jan4.me/1nXKoJD,,,#,4.73447E+17,https://twitter.com/JanssenUS/status/473446723797647360,,,,
davidkroll,6/2/2014 8:51,3,0,Nice @ matthewherper # ASCO14 report on adoptive transfer of HPV- primed T cells to treat cervical cancer. http://www.forbes.com/sites/matthewherper/2014/06/02/scientists-prime-the-immune-system-as-a-powerful-cancer-weapon/?utm_source=followingimmediate&utm_medium=email&utm_campaign=20140602 … # HeLa,,@,# #,4.73447E+17,https://twitter.com/davidkroll/status/473446716646367232,,,,
CancerTherAdvsr,6/2/2014 8:50,0,1,# ASCO14: # Radiation Plus Combination # Chemotherapy Prolong OS in Low-Grade # Glioma http://ow.ly/xvrYY,,,# # # #,4.73446E+17,https://twitter.com/CancerTherAdvsr/status/473446491114459136,,,,
teamoncology,6/2/2014 8:50,3,2,Top Negative Breast Cancer Findings from # ASCO14: Adding lapatinib to trastuzumab makes no difference. Bevacizumab does not work. # BCSM,,,# #,4.73446E+17,https://twitter.com/teamoncology/status/473446489323098112,,,,
WrigleyTom,6/2/2014 8:50,0,0,"Merrimack Pharmaceuticals Identifies Heregulin as Patient Response Biomarker for MM-121 ..."" | via $ MACK pr http://bit.ly/T6I4Vs # ASCO14""",,,#,4.73446E+17,https://twitter.com/WrigleyTom/status/473446455215026177,,,,
OncoPlexDx,6/2/2014 8:49,0,1,POSTER 113 - Mass Spec reveals subgroup of 3+ patients expressing very high levels of HER2 respond much better to # herceptin. # ASCO14 # bcsm,,,# # #,4.73446E+17,https://twitter.com/OncoPlexDx/status/473446380259008512,,,,
ESchattner,6/2/2014 8:49,4,4,"Big news, # ASCO14: (Old) Drug Saves Fertility for Women With Breast Cancer - http://nyti.ms/1gJcure",,,#,4.73446E+17,https://twitter.com/ESchattner/status/473446368950747136,,,,
teamoncology,6/2/2014 8:49,6,2,"Top Breast Cancer Findings from # ASCO14: goserelin saves fertility, ovarian Fx suppression and AI improves HR+ primary BREAST CANCER. # BCSM",,,# #,4.73446E+17,https://twitter.com/teamoncology/status/473446208103407616,,,,
KarlaRivershaw,6/2/2014 8:49,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73446E+17,https://twitter.com/KarlaRivershaw/status/473446206941954048,,,,
Rfonsi1,6/2/2014 8:49,1,0,Where are myeloma oral sessions this am # ASCO14 # mmsm,,,# #,4.73446E+17,https://twitter.com/Rfonsi1/status/473446179263750147,,,,
Groz_P,6/2/2014 8:48,0,0,"Tweet pic plz.A2: Dr. Isakoff's poster: 1st in human study, MM-141, novel tetravalent monoclonal antibody targeting IGF-1R & ErbB3 # ASCO14”",,,#,4.73446E+17,https://twitter.com/Groz_P/status/473446085542039552,,,,
SyLapostolle,6/2/2014 8:48,8,0,Un médicament de plus pour le cancer de la thyroïde réfractaire # ASCO14 @ APMinfos,,@,#,4.73446E+17,https://twitter.com/SyLapostolle/status/473446053132255232,,,,
matthewherper,6/2/2014 8:48,14,9,"# ASCO14 Losers: $ PBYI, $ CLVS, $ LLY; # ASCO14 Winners: $ AZN, cell therapy, PD-1, and $ GSKhttp://onforb.es/1p0kXqr",,,# #,4.73446E+17,https://twitter.com/matthewherper/status/473445994609541120,,,,
matthewherper,6/2/2014 8:47,9,6,# ASCO14 Winners And Losers. http://onforb.es/1p0kXqr,,,#,4.73446E+17,https://twitter.com/matthewherper/status/473445875730382848,,,,
NBTStweets,6/2/2014 8:47,2,3,We are attending # ASCO14! Stop by the booth and learn the latest on @ nbtstweets research and initiatives.pic.twitter.com/YAActIES8g,,@,#,4.73446E+17,https://twitter.com/NBTStweets/status/473445713662054401,,,,
Merck,6/2/2014 8:46,10,7,Check out our very own Roger Perlmutter as he preps for an interview w/ @ SquawkCNBC from # ASCO14 this morning. pic.twitter.com/lKtj6GDTJY,,@,#,4.73446E+17,https://twitter.com/Merck/status/473445645072994304,,,,
vicoterp,6/2/2014 8:46,1,0,Drug found to prolong life after prostate cancer http://wapo.st/1rAnHiD @ asco,,@,,4.73446E+17,https://twitter.com/vicoterp/status/473445637259014144,,,,
CancerAdvocacy,6/2/2014 8:46,2,3,"Refreshed and ready for another day at # ASCO14. First stop: survivorship programs discussion, moderated by NCCS advisor Kevin Oeffinger.",,,#,4.73446E+17,https://twitter.com/CancerAdvocacy/status/473445573950177282,,,,
SyLapostolle,6/2/2014 8:46,1,0,Nouvelle déception pour le lapatinib dans le cancer du sein: en adjuvant # ASCO14 @ APMinfos,,@,#,4.73446E+17,https://twitter.com/SyLapostolle/status/473445549819973632,,,,
DrMisialek,6/2/2014 8:45,4,0,New Therapies Harness Power of the Immune System Against Cancer @ ASCO # ASCO14 http://www.asco.org/press-center/new-therapies-harness-power-immune-system-against-cancer#.U4xx1qLp9GJ.twitter …,,@,# #,4.73445E+17,https://twitter.com/DrMisialek/status/473445332982833152,,,,
SyLapostolle,6/2/2014 8:45,3,0,Avastin et Erbitux équivalents en 1e ligne dans le cancer colorectal # ASCO14 @ APMinfos,,@,#,4.73445E+17,https://twitter.com/SyLapostolle/status/473445257879642112,,,,
WinshipAtEmory,6/2/2014 8:45,1,0,View schedule of abstract presentations at # ASCO14 by Winship members to start at 8:00am CST this morning: http://ow.ly/xiLpV # ASCO14,,,# #,4.73445E+17,https://twitter.com/WinshipAtEmory/status/473445257292808193,,,,
CancerMedMDA,6/2/2014 8:45,0,1,OPTIMIZE-2 trial results:Safety & efficacy every 4 wk vs 12 wk zoledronic acid in women w/ bone mets from breast cancer. Mon. 3 PM # ASCO14,,,#,4.73445E+17,https://twitter.com/CancerMedMDA/status/473445253752848384,,,,
Accucoms,6/2/2014 8:45,0,0,Experts hope advances in next-generation sequencing will unravel breast cancer complexity http://bit.ly/1m3su3G # ASCO14 RT @ ASCO,,@,#,4.73445E+17,https://twitter.com/Accucoms/status/473445225353216000,,,,
Rad_Nation,6/2/2014 8:45,0,0,Why women are choosing mastectomy: Influences beyond the surgeon http://buff.ly/1hiAphK # ASCO14 # bcsm,,,# #,4.73445E+17,https://twitter.com/Rad_Nation/status/473445211386167296,,,,
subatomicdoc,6/2/2014 8:45,9,3,Why women are choosing mastectomy: Influences beyond the surgeon http://bit.ly/1hiAphJ # ASCO14 # bcsm,,,# #,4.73445E+17,https://twitter.com/subatomicdoc/status/473445182508371968,,,,
GustaveRoussy,6/2/2014 8:44,9,1,"Article @ lemondefr Avancée pour les enfants atteint de tumeurs cérébrales"" # TNEP http://bit.ly/1mIEuct # ASCO14""",,@,# #,4.73445E+17,https://twitter.com/GustaveRoussy/status/473445141634883584,,,,
ecancer,6/2/2014 8:44,5,1,Dr Pagani discusses her landmark phase III trials in preventing # breastcancer recurrences at # ASCO14 http://ecancer.org/video/2875/adjuvant-exemestane-is-more-effective-than-tamoxifen-when-combined-with-ovarian-function-suppression-in-young-women-with-hormone-sensitive--early-stage-breast-cancer.php …,,,# #,4.73445E+17,https://twitter.com/ecancer/status/473445018511106048,,,,
QIAGENscience,6/2/2014 8:43,0,0,Fun fact: Most JAK2 tests performed in the USA are quantitative. What can you learn from # allele burden? Visit us in booth #5013. # ASCO14,,,# #5013 #,4.73445E+17,https://twitter.com/QIAGENscience/status/473444804186370048,,,,
ducrest,6/2/2014 8:43,0,0,RT @ bmsnews: BMS Announcing advanced melanoma data from our pipeline # ASCO14 # melnm http://ow.ly/xw5jS # skincancer,,@,# # #,4.73445E+17,https://twitter.com/ducrest/status/473444741838045185,,,,
SyLapostolle,6/2/2014 8:43,0,0,Progrès dans trois cancers fréquents en plénière # ASCO14 lire sur @ APMinfos,,@,#,4.73445E+17,https://twitter.com/SyLapostolle/status/473444728995086336,,,,
ccheddarberk,6/2/2014 8:42,1,0,# ASCO14 cheat sheet: Why $ CLVS $ ARIA $ PCYC are on the move http://cnb.cx/1pysoaU,,,#,4.73445E+17,https://twitter.com/ccheddarberk/status/473444647390703616,,,,
westr,6/2/2014 8:42,0,3,Yup! RT @ kerfors: Will be a busy day in my Twitter feed # hdpalooza # WWDC14 # iccs2014 # ASCO2014 # dmasco,,@,# # # # #,4.73445E+17,https://twitter.com/westr/status/473444568265142272,,,,
drallysonocean,6/2/2014 8:41,0,0,# ASCO14 @ MMfightsCRC Drug Saves Fertility for Women With Cancer http://nyti.ms/1jBaNXT,,@,#,4.73444E+17,https://twitter.com/drallysonocean/status/473444368397783040,,,,
fwpharma,6/2/2014 8:40,0,2,"Bristol-Myers Squibb's nivolumab, Yervoy combination improves survival in melanoma study http://bit.ly/U6TER0 @ bmsnews # pharma # ASCO14",,@,# #,4.73444E+17,https://twitter.com/fwpharma/status/473444015388774400,,,,
CancerMedMDA,6/2/2014 8:40,1,0,Dr. Koichi Takahashi compares induction w/ intermediate intensity vs intensive chemo in elderly patients w AML. Poster Mon. 1:15 PM. # ASCO14,,,#,4.73444E+17,https://twitter.com/CancerMedMDA/status/473443982056628224,,,,
SarahCannonDocs,6/2/2014 8:40,0,1,Gynecologic Cancer news at # ASCO14 - join # SCRI this morning E 354 b,,,# #,4.73444E+17,https://twitter.com/SarahCannonDocs/status/473443969993805824,,,,
teamoncology,6/2/2014 8:40,2,3,今日はポスター発表。蛋白レベルでは、トリプル・ネガティブ乳がんは２つのタイプにしか分類できない。http://abstracts.asco.org/144/AbstView_144_132516.html … # ASCO14 # BCSM,,,# #,4.73444E+17,https://twitter.com/teamoncology/status/473443947771990016,,,,
Frank_S_David,6/2/2014 8:40,0,1,"AdaptImmune deal shows novelty of GSK's evolving approach to cancer R&D. My prior piece, for context: http://www.pharmagellan.com/should-pharma-rd-and-commercial-just-be-friends/ … # ASCO14",,,#,4.73444E+17,https://twitter.com/Frank_S_David/status/473443935499874304,,,,
myriadgenetics,6/2/2014 8:40,0,0,Myriad's myRisk test helps solve the overlap dilemma among # hereditarycancer syndromes. TODAY at 8 in S100a! # ASCO14,,,# #,4.73444E+17,https://twitter.com/myriadgenetics/status/473443916847394817,,,,
teamoncology,6/2/2014 8:38,0,1,"Please visit our poster this AM. We can only divide the TNBC into 2 subtypes by protein assay (RPPA), basal and stromal types. # ASCO14 # BCSM",,,# #,4.73444E+17,https://twitter.com/teamoncology/status/473443614308069377,,,,
yzafar,6/2/2014 8:37,3,0,The paths to lower cost in cancer: 1) define value; 2) reform research; 3) prioritize learning systems http://bit.ly/1kpjfOL # ASCO14,,,#,4.73443E+17,https://twitter.com/yzafar/status/473443162502234112,,,,
DonnaYoungDC,6/2/2014 8:36,3,1,Genentech/Roche anti-PDL1 cancer immunotherapy wins 'breakthrough' status http://bit.ly/1mIYpIj $ RHHBY # pharma # ASCO14 # breakthrough # FDA,,,# # # #,4.73443E+17,https://twitter.com/DonnaYoungDC/status/473442951017029632,,,,
adamfeuerstein,6/2/2014 8:36,0,0,"@HessMessInc Sorry to disappoint you, but no one is talking about $ ONCS or electroporation at # ASCO14.",,@HessMessInc,#,4.73443E+17,https://twitter.com/adamfeuerstein/status/473442917940723712,,,,
bewellwithsami,6/2/2014 8:35,0,0,“ @ ClevelandClinic: “Obesity is on its way to replacing tobacco as the number one preventable/modifiable cause of cancer.” # ASCO14”,,@,#,4.73443E+17,https://twitter.com/bewellwithsami/status/473442824805838848,,,,
ckonto,6/2/2014 8:35,0,2,Ipilimumab vs placebo after complete resection of stage III melanoma: EORTC 18071 phase III trial results # Asco14 http://abstracts.asco.org/144/AbstView_144_130118.html …,,,#,4.73443E+17,https://twitter.com/ckonto/status/473442777254985729,,,,
CancerMedMDA,6/2/2014 8:35,0,0,Dr. Shreyaskumar Patel to chair session on advances in sarcoma. Discusses move to targeted therapy. Mon. 9:45 AM. # ASCO14 # endcancer,,,# #,4.73443E+17,https://twitter.com/CancerMedMDA/status/473442716060512257,,,,
Xcenda,6/2/2014 8:35,0,0,We’re honored to present 2 posters at # ASCO14 ~ Learn more: http://bit.ly/1jXRsje # oncology # hematology,,,# # #,4.73443E+17,https://twitter.com/Xcenda/status/473442692383272960,,,,
JohnstonDon,6/2/2014 8:35,0,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73443E+17,https://twitter.com/JohnstonDon/status/473442671017877504,,,,
betht0002,6/2/2014 8:34,0,1,@Carolinas # LCI expert Dr. Asim Amin is PI on nivolumab research; could be 'game-changing' # immunotherapy drug. DM me for more info. # ASCO14,,@Carolinas,# # #,4.73443E+17,https://twitter.com/betht0002/status/473442553367257088,,,,
teamoncology,6/2/2014 8:34,0,0,【 # ASCO14 Update】 The protein and gene array discordance observed in TNBC. http://abstracts.asco.org/144/AbstView_144_133585.html … # BCSM,,,# #,4.73442E+17,https://twitter.com/teamoncology/status/473442425856225280,,,,
Marckemil,6/2/2014 8:32,0,0,to confuse us even + “ @ NEJM: From # ASCO14: Benefit of Enzalutamide in Chemotherapy-Naïve Metastatic Prostate Cancer http://nej.md/1ioUi1d ”,,@,#,4.73442E+17,https://twitter.com/Marckemil/status/473442089003659264,,,,
PrDavidKhayat,6/2/2014 8:32,1,0,"# ASCO14, # Chicago : Résultats tres intéressants d'une association de thérapeutiques ciblées dans les # cancers de l' # ovaire en rechute",,,# # # #,4.73442E+17,https://twitter.com/PrDavidKhayat/status/473442048323108864,,,,
teamoncology,6/2/2014 8:31,0,0,"【 # ASCO14 Update】Tivantinib (METi) is well-tolerated, but is inactive as monotherapy to treat metastatic TNBC. http://abstracts.asco.org/144/AbstView_144_128048.html … # BCSM",,,# #,4.73442E+17,https://twitter.com/teamoncology/status/473441899420712960,,,,
SkinMelanoma,6/2/2014 8:31,1,0,‘Poster Highlights’ presentation on prognostic gene test for Stage1&2 # melanoma (Abst 9022) starts today @11:30a CDT # ASCO14,,@11,# #,4.73442E+17,https://twitter.com/SkinMelanoma/status/473441714309304320,,,,
DasLebenshaus,6/2/2014 8:31,0,1,# ASCO14 Nivo plus Sunitinib or Pazopanib showed encouraging antitumor activity - Abstract 5010 http://tinyurl.com/k6ynqeo # Kidneycancer # IKCC,,,# # #,4.73442E+17,https://twitter.com/DasLebenshaus/status/473441703350001664,,,,
salutedomani,6/2/2014 8:31,0,0,Metastatic bladder cancer: Investigational immunotherapy anti-PDL1 (MPDL3280A) # ASCO2014 http://www.salutedomani.com/il_weblog_di_antonio/2014/06/metastatic-bladder-cancer-investigational-immunotherapy-anti-pdl1-mpdl3280a-asco2014.html …,,,#,4.73442E+17,https://twitter.com/salutedomani/status/473441681505656832,,,,
dermanewsok,6/2/2014 8:31,0,0,Metastatic bladder cancer: Investigational immunotherapy anti-PDL1 (MPDL3280A) # ASCO2014 http://www.salutedomani.com/il_weblog_di_antonio/2014/06/metastatic-bladder-cancer-investigational-immunotherapy-anti-pdl1-mpdl3280a-asco2014.html …,,,#,4.73442E+17,https://twitter.com/dermanewsok/status/473441681086631937,,,,
antoniocaperna,6/2/2014 8:31,0,0,Metastatic bladder cancer: Investigational immunotherapy anti-PDL1 (MPDL3280A) # ASCO2014 http://www.salutedomani.com/il_weblog_di_antonio/2014/06/metastatic-bladder-cancer-investigational-immunotherapy-anti-pdl1-mpdl3280a-asco2014.html …,,,#,4.73442E+17,https://twitter.com/antoniocaperna/status/473441680923037697,,,,
Immutep,6/2/2014 8:30,1,1,We Are Hosting a Conference Call Today at 11AM AEST (9 PM EST) to Discuss Abstract Presented at ASCO $ PBMD # ASCO14 http://yhoo.it/1hFrnWI,,,#,4.73442E+17,https://twitter.com/Immutep/status/473441644436803584,,,,
ASCO,6/2/2014 8:30,2,0,Learn more about patient engagement before the # ASCO14 session: http://bit.ly/1fFAS5V via # ASCOConnection CC @ drdonsdizon,,@,# #,4.73442E+17,https://twitter.com/ASCO/status/473441636316626945,,,,
CancerMedMDA,6/2/2014 8:30,1,0,Dr. Koichi Takahashi presents value MD Anderson Oncology Expert Advisor powered by IBM Watson cliniclal decision tool. # ASCO14 Mon. 11:45 AM,,,#,4.73442E+17,https://twitter.com/CancerMedMDA/status/473441632281698305,,,,
CancerDotNet,6/2/2014 8:30,0,0,At # ASCO14? Be sure to visit our http://Cancer.Net booth @ASCO Central in the Onc Prof Hall from 9AM-5PM today http://bit.ly/1iADfcN,,@ASCO,#,4.73441E+17,https://twitter.com/CancerDotNet/status/473441494100357120,,,,
CDC_Genomics,6/2/2014 8:30,3,1,Cancer precision medicine: are we there yet? @ washingtonpost # genomics # pm101 # ASCO14 http://www.washingtonpost.com/national/health-science/2014/06/01/40127d1c-e107-11e3-8dcc-d6b7fede081a_story.html?hpid=z4 …,,@,# # #,4.73441E+17,https://twitter.com/CDC_Genomics/status/473441486852599808,,,,
OncLive,6/2/2014 8:30,0,0,TH-302 demonstrated activity and a manageable toxicity profile in relapsed/refractory multiple myeloma http://ow.ly/xvoKn # ASCO14,,,#,4.73441E+17,https://twitter.com/OncLive/status/473441476190670848,,,,
BayerPharma,6/2/2014 8:30,1,2,# DYK what # GIST is? It’s a type of # cancer located in the # digestive tract. # ASCO14 http://bit.ly/1gDuhjy pic.twitter.com/AQ9GKQEG3N,,,# # # # #,4.73441E+17,https://twitter.com/BayerPharma/status/473441456238383105,,,,
JohnCendpts,6/2/2014 8:30,2,1,Like a good David vs. Goliath story? Added Goliath -Clovis preps for a blockbuster showdown with AstraZeneca # ASCO14 http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31 …,,,#,4.73441E+17,https://twitter.com/JohnCendpts/status/473441418053046272,,,,
teamoncology,6/2/2014 8:28,0,0,【 # ASCO14 Update】 12 Month favored than 6 M adjuvant Herceptin treatment for HER2+ breast cancer. http://www.onclive.com/conference-coverage/asco-2014/Dr-Yardley-on-Enzalutamide-Plus-Exemestane-in-Hormone-Positive-Breast-Cancer …,,,#,4.73441E+17,https://twitter.com/teamoncology/status/473441047909908481,,,,
julestwits,6/2/2014 8:28,0,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73441E+17,https://twitter.com/julestwits/status/473441045066579968,,,,
MikeHuckman,6/2/2014 8:28,0,0,Here's COO Dan O'Day of client Roche/Genentech w/ @ megtirrell on @ SquawkCNBC this morning from # ASCO14 : http://tinyurl.com/ozh8gr4,,@ @,#,4.73441E+17,https://twitter.com/MikeHuckman/status/473441041081589760,,,,
BioCurious1,6/2/2014 8:27,0,0,Novartis sonidegib pivotal PII data at # ASCO14 $ CRIS relevant. http://www.novartis.com/newsroom/media-releases/en/2014/1789711.shtml …,,,#,4.73441E+17,https://twitter.com/BioCurious1/status/473440802178232320,,,,
brandingscience,6/2/2014 8:27,0,0,# ASCO14 closed by how best to use 'old drugs.' What does this say about pharma industry pipeline as well as the healthcare system? # health,,,# #,4.73441E+17,https://twitter.com/brandingscience/status/473440761682599936,,,,
Groz_P,6/2/2014 8:26,0,0,"My doc!Diff trial:A2: Dr. Isakoff's poster: 1st in human study,MM-141, novel tetravalent monoclonal antibody targeting IGF-1R&ErbB3 # ASCO14”",,,#,4.73441E+17,https://twitter.com/Groz_P/status/473440616610033664,,,,
mtmdphd,6/2/2014 8:26,2,1,"The numbers: 3,029 Twitter Participants at # ASCO14 (May 1 - June 2). @ Symplur analytics here: http://www.symplur.com/healthcare-hashtags/ASCO14/analytics/?hashtag=ASCO14&fdate=06%2F01%2F2014&shour=0&smin=0&tdate=06%2F02%2F2014&thour=10&tmin=0&ssec=00&tsec=00&img=1 …",,@,#,4.73441E+17,https://twitter.com/mtmdphd/status/473440584145698817,,,,
Aiims1742,6/2/2014 8:26,0,1,# immunotherapy juggernaut continues via @ matthewherper @ forbes Adaptive T cell transfer in # cervical # cancer # ASCO14 http://www.forbes.com/sites/matthewherper/2014/06/02/scientists-prime-the-immune-system-as-a-powerful-cancer-weapon/?utm_source=followingimmediate&utm_medium=email&utm_campaign=20140602&ss=pharma …,,@ @,# # # #,4.7344E+17,https://twitter.com/Aiims1742/status/473440451911876609,,,,
Dharding76,6/2/2014 8:26,0,0,@ BioWorld Tumor genome profiling: the way of the future or TMI? # ASCO14 http://gag.gl/5Lmws,,@,#,4.7344E+17,https://twitter.com/Dharding76/status/473440448468758528,,,,
stefaniei,6/2/2014 8:26,11,3,"Immunotherapy Cancer Drugs Show Promise at # ASCO14, but some serious side effects worry. @ Loftus @ ronwinslow http://online.wsj.com/articles/immunotherapy-cancer-drug-data-show-promise-in-prolonging-lives-1401679269 …",,@ @,#,4.7344E+17,https://twitter.com/stefaniei/status/473440436871520256,,,,
theNCI,6/2/2014 8:25,8,4,"Today at # ASCO14 NCI presenters will be in sessions on # genomics, nanotechnology, and more http://1.usa.gov/1oNfoOo",,,# #,4.7344E+17,https://twitter.com/theNCI/status/473440377513705472,,,,
JosephDMcCarthy,6/2/2014 8:25,0,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.7344E+17,https://twitter.com/JosephDMcCarthy/status/473440193601880064,,,,
CancerMedMDA,6/2/2014 8:25,0,0,Poster highlight: Assoc. EMT w/ PD1/PDL1 expression & immunophenotype in NSCLC. Biomarkers for Tx? Dr. Yanyan Lou. Mon. 1:15 & 4:45. # ASCO14,,,#,4.7344E+17,https://twitter.com/CancerMedMDA/status/473440178397544448,,,,
annwax,6/2/2014 8:24,0,1,"Just to let everyone know that my book Op-ED on Cancer"" is on # Amazon . Looking 4ward to ur feedback # books # cancer # BCSm # LCSM # ASCO14""",,,# # # # # #,4.7344E+17,https://twitter.com/annwax/status/473440074752073728,,,,
JediPD,6/2/2014 8:24,0,0,The push for PFS as a surrogate end point in cancer medicine is fraught with short-sightedness. # ASCO14,,,#,4.7344E+17,https://twitter.com/JediPD/status/473439899425976320,,,,
jodigralnick,6/2/2014 8:22,2,0,"ICYMI: @ megtirrell EXCLUSIVE @ CNBC intvw w/ $ AZN CMO Briggs Morrison, about why # ASCO14 is so important to company: http://cnb.cx/1hQqI4N",,@ @,#,4.7344E+17,https://twitter.com/jodigralnick/status/473439582034595840,,,,
OrianaSpagnolo,6/2/2014 8:21,2,0,A. Goldhirsch honored by # ASCO14 Gianni Bonadonna Award 4 his distinguished career advancing the field of BC research http://www.asco.org/about-asco/aron-goldhirsch-md-2014-award#.U4xrXhUqw40.twitter …,,,# #,4.73439E+17,https://twitter.com/OrianaSpagnolo/status/473439361120235520,,,,
megtirrell,6/2/2014 8:21,6,1,$ MRK's Roger Perlmutter joins us live on @ SquawkCNBC from # ASCO14 at 8:40am ET. Thanks to $ AZN's Briggs Morrison for great intvw earlier!,,@,#,4.73439E+17,https://twitter.com/megtirrell/status/473439306821140480,,,,
mtmdphd,6/2/2014 8:21,1,1,Become a @ iConquerCancer donor -- http://ow.ly/xwaw2 # ASCO14,,@,#,4.73439E+17,https://twitter.com/mtmdphd/status/473439219881619456,,,,
bmsnews,6/2/2014 8:21,8,4,One way cancers evade the body’s immune response is by exploiting the PD-1 checkpoint pathway. Learn more: http://ow.ly/xw8SN # ASCO14,,,#,4.73439E+17,https://twitter.com/bmsnews/status/473439147039158272,,,,
Chiltern_CRO,6/2/2014 8:20,0,1,"Day 4 of # ASCO14 - are you there? Meet # Chiltern Dr. Newel, Kathy S. and Denise E. on site.",,,# #,4.73439E+17,https://twitter.com/Chiltern_CRO/status/473439109801734144,,,,
Sciences_Avenir,6/2/2014 8:20,6,1,Plusieurs études présentées à l'Asco 2014 font état de progrès importants dans la lutte contre le cancer > http://bit.ly/1pLkecq # ASCO2014,,,#,4.73439E+17,https://twitter.com/Sciences_Avenir/status/473439037530046464,,,,
teamoncology,6/2/2014 8:19,0,0,@ MaverickNY What do you think should have been selected for the plenary talks? # ASCO14,,@,#,4.73439E+17,https://twitter.com/teamoncology/status/473438791688916994,,,,
OSUCCC_James,6/2/2014 8:19,1,1,Congrats to @ emacrae01 for receiving a Conquer Cancer Foundation Career Development Award at # ASCO14! pic.twitter.com/LKjgvwxeND,,@,#,4.73439E+17,https://twitter.com/OSUCCC_James/status/473438721350860801,,,,
AneesChagpar,6/2/2014 8:18,0,1,@ mtmdphd @ ASCO @ iConquerCancer Yes; growing all the time! This year marks inaugural # ASCO14 innovation grants to help LMCs reduce ca burden,,@ @ @,#,4.73438E+17,https://twitter.com/AneesChagpar/status/473438395763785729,,,,
JediPD,6/2/2014 8:17,0,0,Exemestane+Ovarian Suppression=better DFS by 4% but no OS. AND higher toxicity & non-adherence Game change=No # asco14 http://www.nejm.org/doi/full/10.1056/NEJMoa1404037 …,,,#,4.73438E+17,https://twitter.com/JediPD/status/473438360611348480,,,,
teamoncology,6/2/2014 8:17,0,0,Interesting. RT @ jrgralow: Cool drug MT@OncLive: M Pegram discusses trial w/margetuximab in HER2 “low” MBC http://ow.ly/xuAg6 # ASCO14,,@ @OncLive,#,4.73438E+17,https://twitter.com/teamoncology/status/473438315065008128,,,,
NIHRCRN_nwcoast,6/2/2014 8:17,2,1,Beneficial role social media can play in # ClinicalTrials http://meetinglibrary.asco.org/content/11400101-144#.U4xpe_FGVJB.twitter … # crnurse via @ JJLarsonkeller @ ASCO,,@ @,# # #,4.73438E+17,https://twitter.com/NIHRCRN_nwcoast/status/473438276159029248,,,,
inkkr,6/2/2014 8:17,0,1,Watch out, cancer cells, indeed. by @ matthewherper at @ Forbes on cancer & immune system http://www.forbes.com/sites/matthewherper/2014/06/02/scientists-prime-the-immune-system-as-a-powerful-cancer-weapon/?utm_source=followingimmediate&utm_medium=email&utm_campaign=20140602&ss=pharma … # ASCO14,,@ @,#,4.73438E+17,https://twitter.com/inkkr/status/473438204352135169,,
davidgrahammd,6/2/2014 8:17,0,3,Coffee in hand and ready to present with @ subatomicdoc on social media and smartphones @Carolinas # LCI # ASCO14,,@ @Carolinas,# #,4.73438E+17,https://twitter.com/davidgrahammd/status/473438154792636416,,,,
redaccionmedica,6/2/2014 8:16,1,0,Industria | Una inmunoterapia de @ Roche_spain demuestra potencial en cáncer de vejiga metastásico http://www.redaccionmedica.com/secciones/industria/pm01183-de-pharmamar-mejora-la-supervivencia-de-pacientes-con-cancer-de-ovario-resistente-5040 … @ ASCO,,@ @,,4.73438E+17,https://twitter.com/redaccionmedica/status/473438018041573376,,,,
BioWorld,6/2/2014 8:15,1,1,"Cab driver just asked which"" McCormick Place. Is the other one this big? # ASCO14""",,,#,4.73438E+17,https://twitter.com/BioWorld/status/473437794002825217,,,,
Asuragen,6/2/2014 8:15,0,1,Today is the LAST day to see us at # ASCO14! Stop by booth #24089 and hear about our best in class clinical solutions.,,,# #24089,4.73438E+17,https://twitter.com/Asuragen/status/473437738549514241,,,,
m_e_nielsen,6/2/2014 8:15,2,0,"Matt Milowsky & Billy Kim @ UNC_Lineberger 1:15-2:30 # asco14 session: From Genetics to Geriatric Medicine in Bladder Cancer"" cc @ B_C_A_N""",,@ @,#,4.73438E+17,https://twitter.com/m_e_nielsen/status/473437704366333952,,,,
imv_inc,6/2/2014 8:14,4,2,IMV’s # CancerVaccine Shrinks Ovarian Cancer Patient’s Tumor By 43%; New Data Presented at # ASCO14 https://www.facebook.com/pages/Immunovaccine-Inc/224346854247738 …,,,# #,4.73437E+17,https://twitter.com/imv_inc/status/473437469602377729,,,,
GustaveRoussy,6/2/2014 8:13,4,0,# ASCO14 # mélanome 3 essais cliniques sur des thérapies innovantes annoncés par @ Gustaveroussy # immunothérapie http://bit.ly/1wTcDNC,,@,# # #,4.73437E+17,https://twitter.com/GustaveRoussy/status/473437294322810880,,,,
Danbigman,6/2/2014 8:12,0,0,Scientists prime the immune system as a powerful cancer weapon http://onforb.es/1p09TJO @ matthewherper via @ forbes # ASCO14,,@ @,#,4.73437E+17,https://twitter.com/Danbigman/status/473436970283040768,,,,
JohnCendpts,6/2/2014 8:12,1,3,Posted last night - GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact - $ GSK # ASCO14 http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …,,,#,4.73437E+17,https://twitter.com/JohnCendpts/status/473436917061935104,,,,
DanBudwick,6/2/2014 8:11,0,0,ICYMI ImmunoGen/Sanofi announced yesterday positive # ASCO14 data from SAR3419's STARLYTE Phase II trial in DLBCL http://investor.immunogen.com/releasedetail.cfm?ReleaseID=851614 …,,,#,4.73437E+17,https://twitter.com/DanBudwick/status/473436812871213056,,,,
adamfeuerstein,6/2/2014 8:11,1,3,# ASCO14 press conference at 9 am ET focused on this morning's $ BMY $ MRK PD-1 melanoma data. I'll live tweet.,,,#,4.73437E+17,https://twitter.com/adamfeuerstein/status/473436713352974336,,,,
NIHRCRN_nwcoast,6/2/2014 8:11,0,0,Improving # clinicaltrials through patient reporting http://www.conquercancerfoundation.org/video-improving-clinical-trials-through-patient-reporting … via @ ethanbasch1 @ asco # research # crnurse # health,,@ @,# # # #,4.73437E+17,https://twitter.com/NIHRCRN_nwcoast/status/473436672877940736,,,,
Aiims1742,6/2/2014 8:10,0,1,Striking phase 1 in advanced # melanoma combining $ BMY # immunotherapy # ipilimumab # nivolumab # ASCO14 @ adamfeuerstein http://www.thestreet.mobi/story/12725476/1/bristols-immunotherapy-duo-doubles-survival-in-melanoma-patients.html …,,@,# # # # #,4.73437E+17,https://twitter.com/Aiims1742/status/473436612727021568,,,,
Gil_Bashe,6/2/2014 8:10,1,0,@ ASCO Impressed by the tremendous/promising biopharma innovation presented at # ASCO14,,@,#,4.73437E+17,https://twitter.com/Gil_Bashe/status/473436577092222976,,,,
CancerMedMDA,6/2/2014 8:10,1,0,Dr. Susan O'Brien to chair education session: update on frontline & novel therapy for CLL. Mon. 1:15 PM. # ASCO14 # endcancer,,,# #,4.73436E+17,https://twitter.com/CancerMedMDA/status/473436461694738434,,,,
BayerPharma,6/2/2014 8:10,1,0,Talking about # cancer: what’s behind the abbreviation # GIST? # ASCO14 pic.twitter.com/TmWWJPzXik,,,# # #,4.73436E+17,https://twitter.com/BayerPharma/status/473436449095036928,,,,
ASCP_Chicago,6/2/2014 8:10,0,1,Today is the last day to visit ASCP at the @ ASCO Annual Meeting! Stop by booth 16163 from 9am-5pm # ASCO14 http://am.asco.org/,,@,#,4.73436E+17,https://twitter.com/ASCP_Chicago/status/473436446779768832,,,,
CancerDotNet,6/2/2014 8:10,3,0,Advocate Lounge hours today from 7:30am-5:30pm CT. Visit to connect and regroup before more # ASCO14 sessions!,,,#,4.73436E+17,https://twitter.com/CancerDotNet/status/473436418229166080,,,,
barleychironda,6/2/2014 8:10,0,0,Excellent idea # tweetups RT @ ASCO: Joining us for our # ASCO14 Tweetup in 30 minutes? Here's a map of the location: pic.twitter.com/YlBN7AkmI7,,@,# #,4.73436E+17,https://twitter.com/barleychironda/status/473436383076700160,,,,
mtmdphd,6/2/2014 8:09,0,0,@ AneesChagpar I hadn't really known about how much @ ASCO and @ iConquerCancer are doing to help around the world http://ow.ly/xw910,,@ @ @,,4.73436E+17,https://twitter.com/mtmdphd/status/473436342513594368,,,,
WCGClinical,6/2/2014 8:08,0,1,"http://Pharmabiz.com : WIRB-Copernicus forms new # Cancer-focused institutional review board, WCG # Oncology http://bit.ly/1wTaxNT # ASCO14",,,# # #,4.73436E+17,https://twitter.com/WCGClinical/status/473436064485765120,,,,
Boehringer,6/2/2014 8:08,3,2,# PressRelease: New data on LUX-Lung 3/6 overall survival presented at # ASCO14. Read more here: http://bit.ly/1pLqHEa,,,# #,4.73436E+17,https://twitter.com/Boehringer/status/473436046005665792,,,,
AlpineBV_Miller,6/2/2014 8:07,0,0,@ CNBC crew set up at # ASCO14. pic.twitter.com/hPgEqOD7ou,,@,#,4.73436E+17,https://twitter.com/AlpineBV_Miller/status/473435844188340225,,,,
jodigralnick,6/2/2014 8:07,3,1,"ICYMI: @ megtirrell's EXCLUSIVE # ASCO14 interview with Roche COO of Pharma Daniel O'Day, talking # ImmunoOncology -http://cnb.cx/1hrlMJ8",,@,# #,4.73436E+17,https://twitter.com/jodigralnick/status/473435795224010752,,,,
Pharmafocus,6/2/2014 8:07,1,1,"ASCO 2014: old dogs, new tricks top the bill: http://bit.ly/1u8bq2I # asco2014 # cancer # pharma # health",,,# # # #,4.73436E+17,https://twitter.com/Pharmafocus/status/473435684804775937,,,,
brettwells,6/2/2014 8:07,0,0,"ASCO 2014: old dogs, new tricks top the bill: http://bit.ly/1u8bq2I # asco2014 # cancer # pharma # health",,,# # # #,4.73436E+17,https://twitter.com/brettwells/status/473435684104318976,,,,
Aiims1742,6/2/2014 8:06,0,1,Some remarkable # immunotherapy data coming out of # ASCO14 via @ adamfeuerstein http://www.thestreet.mobi/story/12725321/1/merck-immunotherapy-posts-striking-results-against-advanced-melanoma.html …,,@,# #,4.73436E+17,https://twitter.com/Aiims1742/status/473435580119134209,,,,
fwpharma,6/2/2014 8:06,5,0,"Merck & Co. reports promising early-stage data for pembrolizumab in melanoma, lung cancer http://bit.ly/U6QJb3 # ASCO14 # pharma @ Merck",,@,# #,4.73435E+17,https://twitter.com/fwpharma/status/473435434245447680,,,,
jseguritan,6/2/2014 8:06,0,1,RT @ nytimesbusiness: # Cancer Researchers Report Longer Survival Rates With # Immunotherapy http://nyti.ms/1gXTl4R # ASCO14 # pharma,,@,# # # #,4.73435E+17,https://twitter.com/jseguritan/status/473435358324359168,,,,
JNCI_Now,6/2/2014 8:05,1,0,Adoptive immunotherapy is a promising approach for these patients because of association between cervical cancer & HPV. # ASCO14,,,#,4.73435E+17,https://twitter.com/JNCI_Now/status/473435125741416448,,,,
JNCI_Now,6/2/2014 8:05,0,1,"Along with screening and preventative vaccines, better treatments are needed to reduce cervical cancer deaths in the future. # ASCO14",,,#,4.73435E+17,https://twitter.com/JNCI_Now/status/473435123916877825,,,,
JNCI_Now,6/2/2014 8:05,0,0,Disease disproportionately affects underserved populations -- who are less likely to undergo cervical cancer screenings. # ASCO14,,,#,4.73435E+17,https://twitter.com/JNCI_Now/status/473435122981556225,,,,
JNCI_Now,6/2/2014 8:05,1,0,"Over 4,000 women die of cervical cancer each year in the U.S. # ASCO14.",,,#,4.73435E+17,https://twitter.com/JNCI_Now/status/473435122100756481,,,,
JNCI_Now,6/2/2014 8:05,1,0,Adoptive T cell therapy is being offered at an increasing number of major medical centers in the United States and other countries. # ASCO14,,,#,4.73435E+17,https://twitter.com/JNCI_Now/status/473435121068961792,,,,
mattshomepage,6/2/2014 8:04,1,0,Come see @ ICBI_Georgetown poster on text mining childhood cancer late effects! Hope to have live demo. S Hall A2 Poster No. 386 # ASCO14,,@,#,4.73435E+17,https://twitter.com/mattshomepage/status/473435078467801088,,,,
Dominic_Tyer,6/2/2014 8:04,0,0,AZ’s ovarian cancer combination aces trial http://buff.ly/1nXlRV6 # pharma # ASCO14,,,# #,4.73435E+17,https://twitter.com/Dominic_Tyer/status/473434910699839488,,,,
DrAttai,6/2/2014 8:03,9,3,what everyone needs to know RT @ ASCO Genomics: What a Fellow Needs to Know http://bit.ly/1iZh2J4 # ASCO14,,@,#,4.73435E+17,https://twitter.com/DrAttai/status/473434842978586624,,,,
DagensMedicinDK,6/2/2014 8:03,0,0,Prostatakræft-læger havde svært ved at få armene ned efter søndagens ‘plenary session’ ved # ASCO14 http://www.dagensmedicin.dk/asco/interview/uventet-gennembrud-for-prostatakraft/ …,,,#,4.73435E+17,https://twitter.com/DagensMedicinDK/status/473434837161086976,,,,
jodigralnick,6/2/2014 8:03,1,0,# ASCO14 LIVE coverage continues at 8:40am ET on @ SquawkCNBC with @ megtirrell's First on @ CNBC interview with President of $ MRK Research Labs,,@ @ @,#,4.73435E+17,https://twitter.com/jodigralnick/status/473434784736501761,,,,
jrgralow,6/2/2014 8:03,1,2,ALTTO: important to thank GSK for role in this important trial - willing to trust & work w/ coop grps. We will still learn a lot! # ASCO14,,,#,4.73435E+17,https://twitter.com/jrgralow/status/473434656063623169,,,,
AneesChagpar,6/2/2014 8:02,1,1,"@ mtmdphd Thx! I've been fortunate to have had @ ASCO mentees from India, Nigeria and Pakistan @ YaleCancer . The world is shrinking! # ASCO14",,@ @ @,#,4.73435E+17,https://twitter.com/AneesChagpar/status/473434553173155840,,,,
m0370,6/2/2014 8:02,0,1,抄録や # ASCO14 ツイートを見て肺がん情報を検索しても、（さすがに書いてある内容は血液腫瘍よりわかりやすいが）どれくらいインパクトのある研究なのかイマイチ要領を掴みにくいので、やはり肺がん情報をつぶやく人をフォローするのがてっとりばやい。,,,#,4.73434E+17,https://twitter.com/m0370/status/473434480376434690,,,,
DanBudwick,6/2/2014 8:02,1,0,Amazing melanoma data out at # ASCO14 today - @ adamfeuerstein covers news from BMS http://www.thestreet.com/story/12725476/1/bristols-immunotherapy-duo-doubles-survival-in-melanoma-patients.html … and Merck http://www.thestreet.com/story/12725321/1/merck-immunotherapy-posts-striking-results-against-advanced-melanoma.html …,,@,#,4.73434E+17,https://twitter.com/DanBudwick/status/473434404287561728,,,,
ASCO,6/2/2014 8:01,10,3,Genomics: What a Fellow Needs to Know http://bit.ly/1iZh2J4 # ASCO14 # ASCOConnection,,,# #,4.73434E+17,https://twitter.com/ASCO/status/473434349539713025,,,,
stede07,6/2/2014 8:01,0,0, @ ClevelandClinic: “In 10 years," we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14""""",,@,# #,4.73434E+17,https://twitter.com/stede07/status/473434280367251457,,,
NEJM,6/2/2014 8:01,14,8,From # ASCO14: Benefit of Enzalutamide in Chemotherapy-Naïve Metastatic Prostate Cancer http://nej.md/1ioUi1d,,,#,4.73434E+17,https://twitter.com/NEJM/status/473434234074697729,,,,
ECMC_UK,6/2/2014 8:01,0,1,Apparently PPI is the next revolution but hasn't that already started @ SDenegri? via @ rschilsky& @ MedscapeOnc # ASCO14 pic.twitter.com/bV6oQOre2p,,@ @ @,#,4.73434E+17,https://twitter.com/ECMC_UK/status/473434174846939137,,,,
nbferrara,6/2/2014 8:00,1,0,"RT @ ASCOPost Early Chemotherapy Extends Lives of Men With Prostate Cancer, Study Finds (via @ NYTimes) http://ow.ly/xv05M # ASCO14 # pcsm",,@ @,# #,4.73434E+17,https://twitter.com/nbferrara/status/473434023587749888,,,,
FoundationATCG,6/2/2014 8:00,1,2,"# FoundationOne IDs alterations associated w/extraordinary response to # Capecitabine in # BCSM Poster Pres: 8-11:45, S Hall A2, Ab 555 # ASCO14",,,# # # #,4.73434E+17,https://twitter.com/FoundationATCG/status/473433897707900928,,,,
Medscape,6/2/2014 8:00,5,0,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73434E+17,https://twitter.com/Medscape/status/473433887905808385,,,,
JNCI_Now,6/2/2014 8:00,0,0,HPV-targeted adoptive T cell therapy essentially augments the natural immune response to HPV in the tumor. # ASCO14,,,#,4.73434E+17,https://twitter.com/JNCI_Now/status/473433874681180162,,,,
JNCI_Now,6/2/2014 8:00,0,0,"2 standard 1st-line therapies -- chemotherapy & combination of chemo & bevacizumab, There is no 2nd-line treatment available for OS. # ASCO14",,,#,4.73434E+17,https://twitter.com/JNCI_Now/status/473433869207629824,,,,
JNCI_Now,6/2/2014 8:00,0,0,Women with metastatic cervical cancer – caused by the human papillomavirus (HPV) – have limited treatment options. # ASCO14,,,#,4.73434E+17,https://twitter.com/JNCI_Now/status/473433868414889985,,,,
JNCI_Now,6/2/2014 8:00,2,0,"This treatment is still considered experimental and is associated with significant side effects."" -Christian Hinrichs"," MD # ASCO14""",,,#,4.73434E+17,https://twitter.com/JNCI_Now/status/473433867244679168,,,
JNCI_Now,6/2/2014 8:00,0,0,The stud implies that cellular therapy might have application to broader range of tumor types than previously recognized. # ASCO14,,,#,4.73434E+17,https://twitter.com/JNCI_Now/status/473433866309337088,,,,
MedscapeOnc,6/2/2014 8:00,0,0,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73434E+17,https://twitter.com/MedscapeOnc/status/473433861930512384,,,,
matthewherper,6/2/2014 7:59,3,5,"Yeah, re: the 8-person study, it's weird for me too. But I really think this cell therapy stuff is very exciting. # ASCO14",,,#,4.73434E+17,https://twitter.com/matthewherper/status/473433796839477248,,,,
JosephDMcCarthy,6/2/2014 7:58,0,0,"@ BioWorld Next step in success with cancer therapy: Quality of life, by 'giving & taking away' # ASCO14 http://gag.gl/Y5ClB",,@,#,4.73433E+17,https://twitter.com/JosephDMcCarthy/status/473433486167388160,,,,
matthewherper,6/2/2014 7:56,22,18,So I think an 8-patient cervical cancer study is more important than all the much bigger studies at # ASCO14 http://www.forbes.com/sites/matthewherper/2014/06/02/scientists-prime-the-immune-system-as-a-powerful-cancer-weapon/ …,,,#,4.73433E+17,https://twitter.com/matthewherper/status/473433003058679808,,,,
kbnewport,6/2/2014 7:56,0,0,"# ASCO14 presenting data on quality of solid tumor RCT abstracts this afternoon, visit me at poster #47",,,# #47,4.73433E+17,https://twitter.com/kbnewport/status/473432942153576449,,,,
AneesChagpar,6/2/2014 7:55,3,3,"If you've ever won an @ ASCO @ iConquerCancer award (Merit, YIA, CDO, IDEA, etc), retweet! Let's be conquerors # ASCO14!",,@ @,#,4.73433E+17,https://twitter.com/AneesChagpar/status/473432733176590336,,,,
pamstutz2,6/2/2014 7:55,3,0,Creatv MicroTech is @ ASCO. Check out their booth for images of CTCs captured in the blood stream. @ CellSieve booth 20135,,@ @,,4.73433E+17,https://twitter.com/pamstutz2/status/473432655195688960,,,,
FoundationATCG,6/2/2014 7:55,1,1,"Targetable alterations found in # HER2-positive # BCSM w/residual disease after treatment Poster Pres: 8-11:45, S Hall A2, Ab 625 # ASCO14",,,# # #,4.73433E+17,https://twitter.com/FoundationATCG/status/473432638414282753,,,,
NEJM,6/2/2014 7:55,7,4,From # ASCO14: Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia http://nej.md/1hvgQ05,,,#,4.73433E+17,https://twitter.com/NEJM/status/473432634111320064,,,,
JNCI_Now,6/2/2014 7:55,0,0,"In study, two patients with widespread metastases had complete remissions after a single treatment with the HPV-targeted T cells. # ASCO14",,,#,4.73433E+17,https://twitter.com/JNCI_Now/status/473432601957388288,,,,
JNCI_Now,6/2/2014 7:55,0,0,HPV-targeted adoptive T cell therapy may provide a new personalized strategy for advanced cervical cancer. # ASCO14,,,#,4.73433E+17,https://twitter.com/JNCI_Now/status/473432601135288320,,,,
JNCI_Now,6/2/2014 7:55,0,0,“Anti CTLA-4 & anti PD1 single-agent therapies for metastatic MEL have made signif contributions in recent years.- Steven O’Day," MD # ASCO14""",,,#,4.73433E+17,https://twitter.com/JNCI_Now/status/473432600388722688,,,
JNCI_Now,6/2/2014 7:55,1,1,Lasting antitumor effects have been observed with nivolumab as a single-agent therapy. # ASCO14,,,#,4.73433E+17,https://twitter.com/JNCI_Now/status/473432599637929985,,,,
JNCI_Now,6/2/2014 7:55,1,1,Ipilimumab is FDA-approved for the treatment of metastatic melanoma. # ASCO14,,,#,4.73433E+17,https://twitter.com/JNCI_Now/status/473432598937493504,,,,
OrianaSpagnolo,6/2/2014 7:54,0,0,Breast Cancer Field Leverages Unique Biomarkers to Enhance Personalized Medicine # breastcancer # ASCO14 http://am.asco.org/breast-cancer-field-leverages-unique-biomarkers-enhance-personalized-medicine#.U4xl5M177ok.twitter …,,,# # #,4.73433E+17,https://twitter.com/OrianaSpagnolo/status/473432539537756161,,,,
BCourtieu,6/2/2014 7:54,0,0,@ Integragen # ASCO14 study results on New EPOC shows mir 31-3p is predictive of response to anti EGFR therapy in mCRC http://tinyurl.com/ppft6ew,,@,#,4.73432E+17,https://twitter.com/BCourtieu/status/473432412748546048,,,,
subatomicdoc,6/2/2014 7:52,0,5,My talk is in the hinterlands but I get an awesome Lake Michigan view. I love Chicago! # ASCO14 pic.twitter.com/iO1yTfwycb,,,#,4.73432E+17,https://twitter.com/subatomicdoc/status/473432062574485504,,,,
AndyBiotech,6/2/2014 7:52,5,4,# ASCO14 PD-1/L1 New Tumor Roche Bladder https://twitter.com/AndyBiotech/status/473076358596550657 … $ MRK H&N https://twitter.com/AndyBiotech/status/473172658579075072 … $ BMY Ovarianhttps://twitter.com/AndyBiotech/status/473132419219206144 …,,,#,4.73432E+17,https://twitter.com/AndyBiotech/status/473431887541960704,,,,
NEJM,6/2/2014 7:50,10,5,From # ASCO14: Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer http://nej.md/1hadOUs,,,#,4.73431E+17,https://twitter.com/NEJM/status/473431400444858368,,,,
FoundationATCG,6/2/2014 7:50,2,1,"Even w/o # BRCA alts, newly IDed alts may predict sensitivity to platinum-based ther & PARP inhib Poster HiLi: 8-11, E354b, Ab 5536 # ASCO14",,,# #,4.73431E+17,https://twitter.com/FoundationATCG/status/473431394664714240,,,,
JNCI_Now,6/2/2014 7:50,0,1,Nivolumab and ipilimumab are antibody drugs that target and block two different “gatekeepers” or checkpoints on T cells. # ASCO14,,,#,4.73431E+17,https://twitter.com/JNCI_Now/status/473431351064936451,,,,
JNCI_Now,6/2/2014 7:50,0,0,Median survival for patients diagnosed w/ advanced MEL used to be less than a year & only approx 20-25% survived 2 years. # ASCO14,,,#,4.73431E+17,https://twitter.com/JNCI_Now/status/473431349391417344,,,,
JNCI_Now,6/2/2014 7:50,0,0,"In the study, the combination treatment nearly doubled the median overall survival found in previous studies of either agent alone. # ASCO14",,,#,4.73431E+17,https://twitter.com/JNCI_Now/status/473431348439285760,,,,
JNCI_Now,6/2/2014 7:50,3,3,Combination immunotherapy w/ ipilimumab & nivolumab achieves long-term survival for patients w/ advanced melanoma. # ASCO14,,,#,4.73431E+17,https://twitter.com/JNCI_Now/status/473431347617218560,,,,
JNCI_Now,6/2/2014 7:50,0,1,"Anti PD-1 as a single agent is a major breakthrough and improves on the initial success of ipilimumab in metastatic melanoma."" # ASCO14""",,,#,4.73431E+17,https://twitter.com/JNCI_Now/status/473431346757386241,,,,
BairdAM,6/2/2014 7:49,0,0,# lcsm MT  @ genentech: Alan Sandler, Med Dir," discusses learnings from a negative Phase 3 # lungcancer trial. # ASCO14 http://ow.ly/xrgKc """"",,@,# # #,4.73431E+17,https://twitter.com/BairdAM/status/473431133741281282,,
SeverinePicault,6/2/2014 7:48,0,0,# ASCO2014. L'espoir goséréline # cancer http://www.sciencesetavenir.fr/sante/20140531.OBS9075/la-gosereline-une-hormone-pour-lutter-contre-l-infertilite-des-femmes-sous-chimiotherapie.html … via @ sciences_avenir,,@,# #,4.73431E+17,https://twitter.com/SeverinePicault/status/473430911791288320,,,,
Siti_Rokhma13,6/2/2014 7:47,0,0,gery please .... # ASCO14 # Kkeapseong,,,# #,4.73431E+17,https://twitter.com/Siti_Rokhma13/status/473430677224837120,,,,
BairdAM,6/2/2014 7:47,0,0,"# lcsm RT  @ Merck: Check out the non-small cell lung cancer data being presented today @ ASCO: http://bit.ly/1kAbAIx # ASCO14""""",,@ @,# #,4.73431E+17,https://twitter.com/BairdAM/status/473430579807928320,,,,
daniellerodin,6/2/2014 7:46,0,1,Excited to be @ ASCO in Chicago today for @ GTFRCC session and to launch @ CancerRT.,,@ @ @,,4.73431E+17,https://twitter.com/daniellerodin/status/473430563131756544,,,,
AneesChagpar,6/2/2014 7:46,2,1,"@ mtmdphd @ ASCO As a 3x mentor @ YaleCancer, I can tell you this is a great program! Support @ iConquerCancer",,@ @ @ @,,4.7343E+17,https://twitter.com/AneesChagpar/status/473430469028347904,,,,
FoundationATCG,6/2/2014 7:45,1,1,"Novel, potentially targetable # BRAF fusion found in rare # pancsm by # FoundationOne Poster Highlights: 8-11, S405, Ab 11029 # ASCO14",,,# # # #,4.7343E+17,https://twitter.com/FoundationATCG/status/473430141599629312,,,,
JNCI_Now,6/2/2014 7:45,1,1,Research is showing that MK-3475 results in long-lasting clinical responses in most patients & has impressive OS w/ low toxicity. # ASCO14,,,#,4.7343E+17,https://twitter.com/JNCI_Now/status/473430090236170240,,,,
JNCI_Now,6/2/2014 7:45,0,0,Expanded access program for MK-3475 is available for some patients w/ advanced MEL who have been previously treated wi/ ipilimumab. # ASCO14,,,#,4.7343E+17,https://twitter.com/JNCI_Now/status/473430089338585088,,,,
JNCI_Now,6/2/2014 7:45,1,1,"In May 2014, the FDA granted MK-3475 a priority review designation under its Accelerated Approval program. # ASCO14",,,#,4.7343E+17,https://twitter.com/JNCI_Now/status/473430088495538177,,,,
JNCI_Now,6/2/2014 7:45,0,0,"The FDA had previously granted a breakthrough therapy designation to MK-3475 for unresectable, or metastatic, melanoma. # ASCO14",,,#,4.7343E+17,https://twitter.com/JNCI_Now/status/473430087505698816,,,,
JNCI_Now,6/2/2014 7:45,0,0,"“These are early data, but they tell us we are on to something really important.”-Antoni Ribas, MD, PhD # ASCO14",,,#,4.7343E+17,https://twitter.com/JNCI_Now/status/473430086691979264,,,,
JohnstonDon,6/2/2014 7:45,0,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.7343E+17,https://twitter.com/JohnstonDon/status/473430085031452673,,,,
cancerassassin1,6/2/2014 7:44,0,0,Great lineup of presenters & discussants for GI oral session this afternoon--1:45. # ASCO14 http://tinyurl.com/kkges3d pic.twitter.com/HXVO9nJb3y,,,#,4.7343E+17,https://twitter.com/cancerassassin1/status/473430045051351040,,,,
conkers3,6/2/2014 7:44,0,1,# AZN up 1% to £43.41p MT . @ JacobEPVantage # Cedirinib + # olaparib combo in ovarian cancer $ AZN # ASCO14 pic.twitter.com/wyO1sQou8q . @ AstraZeneca,,@ @,# # # #,4.7343E+17,https://twitter.com/conkers3/status/473430018430083072,,,,
mtmdphd,6/2/2014 7:43,1,1,"Improving # ClinicalTrials through patient reporting - Ethan M. Basch, MD @ EthanBasch1 (2007 @ ASCO CDA) http://ow.ly/xw57I",,@ @,#,4.7343E+17,https://twitter.com/mtmdphd/status/473429737550123008,,,,
bmsnews,6/2/2014 7:43,13,6,BMS Announcing advanced melanoma data from our pipeline # ASCO14 # melnm http://ow.ly/xw5jS,,,# #,4.7343E+17,https://twitter.com/bmsnews/status/473429579043176449,,,,
cancerassassin1,6/2/2014 7:42,1,1,Fitness Ctr at Hyatt Regency McC *packed* by 6am w/ oncologists/fitness enthusiasts. # energy # practicingwhattheypreach # ASCO14 @ HyattTweets,,@,# # #,4.73429E+17,https://twitter.com/cancerassassin1/status/473429467432382464,,,,
BairdAM,6/2/2014 7:42,0,0,# IHavePVNS MT  @ TargetedOnc: William D.Tap from @ sloan_kettering," phase I study of PLX3397 treatment of PVNS http://www.targetedonc.com/conference/asco-2014/A-Phase-I-Study-of-the-CSF1R-Kinase-Inhibitor-PLX3397-for-PVNS … # ASCO14""""",,@ @,# #,4.73429E+17,https://twitter.com/BairdAM/status/473429422695923712,,,
GantosJ,6/2/2014 7:42,0,1,"$ MRK 1st Presentation of Data for Pembrolizumab MK-3475 Anti-PD-1 Antibody, in Patients with Previously-Untreated, Advanced NSCLC at # ASCO14",,,#,4.73429E+17,https://twitter.com/GantosJ/status/473429349560233985,,,,
drdonsdizon,6/2/2014 7:40,5,0,Posting a new blog from # ASCO14 re: research 4 # survivorswithcancer; link 2 @ Consano http://connection.asco.org/Commentary/Article/ID/3896/Seeking-Answers-Preventive-Care-for-Patients-with-Metastatic-Cancer.aspx … @MBNCbuzz @ MGHCancerCenter,,@ @MBNCbuzz @,# #,4.73429E+17,https://twitter.com/drdonsdizon/status/473428937495048192,,,,
MGHCancerCenter,6/2/2014 7:40,0,1,"8-11:45 S Hall A2: Dr. Isakoff's poster: 1st in human study, MM-141, novel tetravalent monoclonal antibody targeting IGF-1R & ErbB3 # ASCO14",,,#,4.73429E+17,https://twitter.com/MGHCancerCenter/status/473428882864222208,,,,
FoundationATCG,6/2/2014 7:40,2,0,"Comprehensive # genomic profiling may identify targetable alts in >50% of # PediatricCancer Poster HiLi: 8-11:45, S Hall A2, Ab 10035 # ASCO14",,,# # #,4.73429E+17,https://twitter.com/FoundationATCG/status/473428839649914880,,,,
JNCI_Now,6/2/2014 7:40,1,1,“This is probably the biggest phase I trial ever conducted in oncology.-Antoni Ribas, MD," PhD # ASCO14""",,,#,4.73429E+17,https://twitter.com/JNCI_Now/status/473428831932395520,,
JNCI_Now,6/2/2014 7:40,2,0,PD-1 targeting immunotherapy MK-3475 has high & long-lasting activity against metastatic melanoma. # ASCO14,,,#,4.73429E+17,https://twitter.com/JNCI_Now/status/473428831072550913,,,,
JNCI_Now,6/2/2014 7:40,0,0,This is the first study to demonstrate its clinical benefit in stage III melanoma,”- Steven O’Day," MD # ASCO14""",,,#,4.73429E+17,https://twitter.com/JNCI_Now/status/473428830254682113,,
JNCI_Now,6/2/2014 7:40,0,0,“The results of this study are promising. Ipilimumab is an effective treatment in stage IV melanoma.-Steven O’Day," MD # ASCO14""",,,#,4.73429E+17,https://twitter.com/JNCI_Now/status/473428829445165056,,,
JNCI_Now,6/2/2014 7:40,0,0,This is the first study to show that ipilimumab is also effective in an adjuvant setting for earlier-stage disease. # ASCO14,,,#,4.73429E+17,https://twitter.com/JNCI_Now/status/473428828409180160,,,,
Curiolog,6/2/2014 7:39,0,0,Cancers de l'enfant : un boulevard ouvert à plus de thérapies ciblées http://www.allodocteurs.fr/actualite-sante-cancers-de-l-enfant-les-therapies-ciblees-ont-de-l-avenir-13570.asp?1=1 … # cancer # ASCO14,,,# #,4.73429E+17,https://twitter.com/Curiolog/status/473428606060736513,,,,
bmsnews,6/2/2014 7:38,14,7,Phase 3 study in adjuvant melanoma meets primary endpoint # ASCO14 http://ow.ly/xw4JX,,,#,4.73429E+17,https://twitter.com/bmsnews/status/473428553628151808,,,,
Merck,6/2/2014 7:38,8,2,Check out the melanoma data being presented today @ ASCO: http://bit.ly/1wT1CMi # ASCO14,,@,#,4.73429E+17,https://twitter.com/Merck/status/473428506446405632,,,,
adamfeuerstein,6/2/2014 7:38,13,8,$ MRK Immunotherapy Posts Striking Results Against Advanced Melanoma —> http://www.thestreet.com/story/12725321/1/merck-immunotherapy-posts-striking-results-against-advanced-melanoma.html … # ASCO14,,,#,4.73428E+17,https://twitter.com/adamfeuerstein/status/473428409050083328,,,,
jaterceno,6/2/2014 7:38,0,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.73428E+17,https://twitter.com/jaterceno/status/473428349399072768,,,,
Merck,6/2/2014 7:37,8,1,Check out the non-small cell lung cancer data being presented today @ ASCO: http://bit.ly/1kAbAIx # ASCO14,,@,#,4.73428E+17,https://twitter.com/Merck/status/473428210404040704,,,,
KarlaRivershaw,6/2/2014 7:37,0,0,@ BioWorld Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://gag.gl/viEQ9,,@,#,4.73428E+17,https://twitter.com/KarlaRivershaw/status/473428094871949312,,,,
adamfeuerstein,6/2/2014 7:36,7,7,$ BMY Immunotherapy Duo Doubles Survival in Melanoma Patients —> http://www.thestreet.com/story/12725476/1/bristols-immunotherapy-duo-doubles-survival-in-melanoma-patients.html … # ASCO14,,,#,4.73428E+17,https://twitter.com/adamfeuerstein/status/473427996213522432,,,,
ASCO,6/2/2014 7:36,10,2,"# ASCO14 features immunotherapy advances in melanoma, cervical cancer http://bit.ly/1rBV30I # melnm # gynca",,,# # #,4.73428E+17,https://twitter.com/ASCO/status/473427918908321792,,,,
CancerDotNet,6/2/2014 7:35,3,1,New research from # ASCO14 on # melanoma & cervical cancer # melsm # gyncsm - What it means for patients: http://bit.ly/U6OaWx,,,# # # #,4.73428E+17,https://twitter.com/CancerDotNet/status/473427762251063296,,,,
aftimosp,6/2/2014 7:35,0,0,"Join us starting 1h15 pm, room S405 for abstract 3023: a first in human phase 1 trial of an anti-CD70 monoclonal antibody # ASCO14",,,#,4.73428E+17,https://twitter.com/aftimosp/status/473427603882123265,,,,
julestwits,6/2/2014 7:35,0,0,"@ BioWorld Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC # ASCO14 http://gag.gl/Z5mar",,@,#,4.73428E+17,https://twitter.com/julestwits/status/473427585120997376,,,,
JNCI_Now,6/2/2014 7:35,2,0,The immunotherapy drug ipilimumab is FDA-approved for the treatment of inoperable stage IV (metastatic) melanoma. # ASCO14,,,#,4.73428E+17,https://twitter.com/JNCI_Now/status/473427572257480705,,,,
JNCI_Now,6/2/2014 7:35,0,0,“We’ve seen many impressive new treatments for advanced melanoma in recent years.-Alexander Eggermont, MD," PhD # ASCO14""",,,#,4.73428E+17,https://twitter.com/JNCI_Now/status/473427571536064512,,
JNCI_Now,6/2/2014 7:35,0,0,Researchers saw substantially fewer recurrences among patients who are at high risk of relapse. # ASCO14,,,#,4.73428E+17,https://twitter.com/JNCI_Now/status/473427570663649281,,,,
JNCI_Now,6/2/2014 7:35,5,2,ipilimumab for patients w/ high-risk stage 3 melanoma decreases relative risk of cancer recurrence by 25% compared to placebo. # ASCO14,,,#,4.73428E+17,https://twitter.com/JNCI_Now/status/473427569610874880,,,,
JNCI_Now,6/2/2014 7:35,1,0,Adjuvant ipilimumab improves recurrence-free survival in patients w/ high-risk stage III Melanoma. # ASCO14,,,#,4.73428E+17,https://twitter.com/JNCI_Now/status/473427568872652800,,,,
HemOncToday,6/2/2014 7:33,1,1,# ASCO14 Combination dabrafenib/trametinib increased PFS in BRAF-positive # melanoma @ Sydney_Uni http://goo.gl/fhprx9,,@,# #,4.73427E+17,https://twitter.com/HemOncToday/status/473427271626551296,,,,
GoHealio,6/2/2014 7:33,0,1,# ASCO14 Combination dabrafenib/trametinib increased PFS in BRAF-positive # melanoma @ Sydney_Uni http://goo.gl/fhprx9,,@,# #,4.73427E+17,https://twitter.com/GoHealio/status/473427270821228544,,,,
tinypasscontent,6/2/2014 7:33,0,0,"ASCO 2014 Annual Meeting Live Blog Day 4 # ASCO14"" http://ift.tt/1wSZYuk # BiotechStrategy # tinypass # paidcontent ""Chicago – it’s day 4...""",,,# # # #,4.73427E+17,https://twitter.com/tinypasscontent/status/473427180954071040,,,,
aftimosp,6/2/2014 7:33,0,0,"Join us at 3 pm, room S100bc for abstract 11001: the Zephir trial is a nuclear imaging biomarker for T-DM1 in # BreastCancer # bcsm # ASCO14",,,# # #,4.73427E+17,https://twitter.com/aftimosp/status/473427162075119616,,,,
mtmdphd,6/2/2014 7:33,0,0,. @ ASCO International Development and Education Award (IDEA) http://ow.ly/xw43b,,@,,4.73427E+17,https://twitter.com/mtmdphd/status/473427127820640256,,,,
JohnstonDon,6/2/2014 7:31,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others # ASCO14 http://gag.gl/CQrUp",,,#,4.73427E+17,https://twitter.com/JohnstonDon/status/473426737188327424,,,,
FoundationATCG,6/2/2014 7:31,1,0,New treatment options may be available to # PediatricCancer patients as identified by # FoundationOne. http://bit.ly/1gXOWPp # ASCO14,,,# # #,4.73427E+17,https://twitter.com/FoundationATCG/status/473426615796371456,,,,
hayeslat,6/2/2014 7:30,5,6,"Excited to present results of comprehensive genetic profiling of AYA tumors later today. Distinctive, targetable. # ASCO14 @ FoundationATCG",,@,#,4.73426E+17,https://twitter.com/hayeslat/status/473426425731899392,,,,
genentech,6/2/2014 7:30,4,0,"Dr. Alan Sandler, Med Dir, discusses learnings from a negative Phase III # lungcancer trial. # ASCO14 http://ow.ly/xrgKc",,,# #,4.73426E+17,https://twitter.com/genentech/status/473426419297816576,,,,
ACInvestorBlog,6/2/2014 7:30,1,4,$ ARIA $ AVEO strong PM action # ASCO14,,,#,4.73426E+17,https://twitter.com/ACInvestorBlog/status/473426396711501824,,,,
AneesChagpar,6/2/2014 7:30,0,0,@ subatomicdoc @ wallyjc @ DrMarkham @ TGeorgeMD @ marykge @ jrgralow @ JackWestMD @ n8pennell I too missed many but am glad I got to connect @ ASCO,,@ @ @ @ @ @ @ @ @,,4.73426E+17,https://twitter.com/AneesChagpar/status/473426305447645184,,,,
FoundationATCG,6/2/2014 7:29,0,0,New insights into the # genomic patterns unique to # AYACSM identified by # FoundationOne presented at # ASCO14 http://bit.ly/1hQfjlu,,,# # # #,4.73426E+17,https://twitter.com/FoundationATCG/status/473426171321802752,,,,
3NT,6/2/2014 7:28,1,1,ASCO 2014 Annual Meeting Day 4 blog is live - updates for subs during the day # ASCO14 http://3nt.co/Oncochat,,,#,4.73426E+17,https://twitter.com/3NT/status/473426016212619265,,,,
CowenResearch,6/2/2014 7:26,0,0,Steve Scala publishes large # Pharma highlights from # ASCO14 $ RHHBY $ MRK $ LLY $ GSK,,,# #,4.73425E+17,https://twitter.com/CowenResearch/status/473425431492706304,,,,
AndyBiotech,6/2/2014 7:26,4,0,Bayer in-licenses Orion's ODM201 (androgen receptor inhibitor) for mCRPC http://www.investor.bayer.de/index.php?id=145&L=1&tx_news_pi1%5Bnews%5D=1696 … $ MDVN $ JNJ # ASCO14 http://abstracts.asco.org/144/AbstView_144_133200.html …,,,#,4.73425E+17,https://twitter.com/AndyBiotech/status/473425380792352768,,,,
subatomicdoc,6/2/2014 7:26,0,0,@ DrMarkham @ TGeorgeMD @ marykge @ jrgralow @ JackWestMD @ n8pennell Still hoping to connect at # ASCO14 - DM me!,,@ @ @ @ @ @,#,4.73425E+17,https://twitter.com/subatomicdoc/status/473425297778688001,,,,
DanBudwick,6/2/2014 7:24,0,0,ICYMI @ CNBC @ megtirrell summarizes key takeaways from a busy weekend at # ASCO14 http://www.cnbc.com/id/101721186,,@ @,#,4.73425E+17,https://twitter.com/DanBudwick/status/473424852284485632,,,,
MRCCTU,6/2/2014 7:22,0,0,"PATCH Trial in progress poster http://bit.ly/1jLYuYQ 1.15-5pm, abstract ID TPS5099, S Hall A2; Board 225B # ASCO2014",,,#,4.73424E+17,https://twitter.com/MRCCTU/status/473424476072574976,,,,
MRCCTU,6/2/2014 7:20,0,0,"PATCH poster http://bit.ly/1pzmqqc 1.15-5pm, Genitourinary Prostate Cancer poster session, abstract ID 5067, S Hall A2; Board 196 # ASCO2014",,,#,4.73424E+17,https://twitter.com/MRCCTU/status/473423948093616128,,,,
RedEmpressC,6/2/2014 7:20,0,1,AZ’s ovarian # cancer combination aces trial http://bit.ly/1mIEklB # pharma # ASCO14 # Oncology,,,# # # #,4.73424E+17,https://twitter.com/RedEmpressC/status/473423912815312896,,,,
OncLive,6/2/2014 7:20,5,2,"Ibrutinib monotherapy tripled PFS, doubled OS, and substantially improved ORR compared with ofatumumab in CLL http://ow.ly/xvp09 # ASCO14",,,#,4.73424E+17,https://twitter.com/OncLive/status/473423812932161538,,,,
sharon_markman,6/2/2014 7:18,0,4,Reflecting on Cancer Survivors Day! # luriewalk @ASCO@LurieCancer @ LIVESTRONGCEO @ The_HFoundation @ NMHnewspic.twitter.com/4E1tRgGu2b,,@ASCO @LurieCancer @ @ @,#,4.73424E+17,https://twitter.com/sharon_markman/status/473423516101259264,,,,
DanBudwick,6/2/2014 7:18,0,0,. @ FoundationATCG - Distinct alterations seen in commonly overlooked patient pop. of adolescents/young adults http://investors.foundationmedicine.com/releasedetail.cfm?ReleaseID=851674 … # ASCO14,,@,#,4.73423E+17,https://twitter.com/DanBudwick/status/473423495129346050,,,,
BioMadrid_org,6/2/2014 7:18,1,0,# Merck colaborará con Sysmex Inostics en un análisis de sangre para determinar los biomarcadores RAS http://bit.ly/1tygYl5 # ASCO14,,,# #,4.73423E+17,https://twitter.com/BioMadrid_org/status/473423403891040256,,,,
GenomicHealth,6/2/2014 7:15,1,0,It's the last day to stop by booth 20007! Come say hi & check out the enhanced # Oncotype # breastcancer report http://bit.ly/1wE95ia # ASCO14,,,# # #,4.73423E+17,https://twitter.com/GenomicHealth/status/473422579643199488,,,,
DanBudwick,6/2/2014 7:14,0,0,2 # ASCO14 PRs from @ FoundationATCG today - 1st on use of FoundationOne in IDing targeted Rx options for ped cases http://investors.foundationmedicine.com/releasedetail.cfm?ReleaseID=851667 … …,,@,#,4.73422E+17,https://twitter.com/DanBudwick/status/473422415679471616,,,,
BairdAM,6/2/2014 7:14,0,1,"# lcsm MT  @ OncLive: Naiyer A. Rizvi discusses nivolumab plus erlotinib in patients with EGFR MT adv NSCLC http://ow.ly/xux6t # ASCO14""""",,@,# #,4.73422E+17,https://twitter.com/BairdAM/status/473422294119763968,,,,
NGCorbi1,6/2/2014 7:12,0,0,"Just completed a 6.11 mi run - Michigan Ave, Chicago River and Lakeshore Trail . # ASCO2014 http://rnkpr.com/a61sueu # RunKeeper",,,# #,4.73422E+17,https://twitter.com/NGCorbi1/status/473421979274338304,,,,
Atip4,6/2/2014 7:12,0,0,@ adamfeuerstein What happened to $ exel at # ASCO14 ? From what I see nothing ... Not even one press release!,,@,#,4.73422E+17,https://twitter.com/Atip4/status/473421838379679744,,,,
Frank_S_David,6/2/2014 7:12,1,0,Zero: number of # ASCO14 attendees I've seen wearing Google Glass.,,,#,4.73422E+17,https://twitter.com/Frank_S_David/status/473421825813520384,,,,
damiangarde,6/2/2014 7:10,0,1,"If you missed @ FierceBiotech's # ASCO14 mid-conference chat with @ MarkSchoenebaum yesterday, you can find it here: https://storify.com/DamianFierce/fiercebiotech-s-asco14-chat-with-markschoenebaum …",,@ @,#,4.73421E+17,https://twitter.com/damiangarde/status/473421420333387776,,,,
adamfeuerstein,6/2/2014 7:10,5,7,Biggest investor “controversy” at # ASCO14? $ CLVS vs $ AZN. My take —> http://www.thestreet.com/story/12728916/1/clovis-lung-cancer-bravado-falls-flat-with-new-diabetes-revelation.html …,,,#,4.73421E+17,https://twitter.com/adamfeuerstein/status/473421295917355008,,,,
ThePharmaLetter,6/2/2014 7:09,0,1,Have you read our coverage of @ ASCO 2014? http://bit.ly/1wSRHq6 # oncology # pharma,,@,# #,4.73421E+17,https://twitter.com/ThePharmaLetter/status/473421205220118528,,,,
ia_mamahkejogja,6/2/2014 7:09,0,0,# AsianDreamCupINA # ASCO14 ^^,,,# #,4.73421E+17,https://twitter.com/ia_mamahkejogja/status/473421096604028929,,,,
krystadawn,6/2/2014 7:08,0,0,With CNBC and @ megtirrell bright and early this morning! # ASCO14 pic.twitter.com/f7CggTx24T,,@,#,4.73421E+17,https://twitter.com/krystadawn/status/473420800587223040,,,,
fwpharma,6/2/2014 7:08,1,1,"Interested in revenue expectations, launch calendar for key immuno-oncology assets? Check out our latest list http://bit.ly/SnTtPL # ASCO14",,,#,4.73421E+17,https://twitter.com/fwpharma/status/473420775488495617,,,,
adamfeuerstein,6/2/2014 7:07,2,8,This morning’s sell-side buzz over # ASCO14 immuno-oncology data from the weekend —> http://www.thestreet.com/story/12729142/1/asco-14-sell-side-buzz-over-big-pharma-immuno-oncology-pipelines.html …,,,#,4.73421E+17,https://twitter.com/adamfeuerstein/status/473420534685114368,,,,
drdonsdizon,6/2/2014 7:06,4,3,"Loved this: Avoid misapprehension of risk (by MD & patient) & resultant misapplication of therapy."" Dr. M. Morris @ sloan_kettering # ASCO14""",,@,#,4.7342E+17,https://twitter.com/drdonsdizon/status/473420379651047424,,,,
megtirrell,6/2/2014 7:06,0,1,Great interview with @ Roche's Dan O'Day to kick off @ cnbc's # ASCO14 coverage. Next up: $ AZN's Dr. Briggs Morrison @7:30am ET on @ SquawkCNBC,,@ @ @7 @,#,4.7342E+17,https://twitter.com/megtirrell/status/473420295878238208,,,,
Alofs,6/2/2014 7:04,1,1,"Big pharma talk cancer research at Chicago gathering http://fw.to/2z6eZ6D Immunotherapy #1 topic at # ASCO14, @ thepmcf # toronto @ bnn",,@ @,#1 # #,4.7342E+17,https://twitter.com/Alofs/status/473419924732276739,,,,
cristina_djsj,6/2/2014 7:01,0,1,"AZ’s ovarian cancer combo demonstrates progression-free survival of 17.7, great news. # ASCO14 # astrazeneca",,,# #,4.73419E+17,https://twitter.com/cristina_djsj/status/473419112937308160,,,,
jodigralnick,6/2/2014 7:01,0,0,Another # ASCO14 @ CNBC exclusive coming up on @ SquawkCNBC at 730amET: $ AZN CMO joins @ megtirrell LIVE,,@ @ @,#,4.73419E+17,https://twitter.com/jodigralnick/status/473419080846684160,,,,
bioclinica,6/2/2014 7:00,0,0,RT @ drattai # ASCO14 - Science and Society - reflections by @ ASCO President @ CliffordHudis http://ow.ly/xr2lC,,@ @ @,#,4.73419E+17,https://twitter.com/bioclinica/status/473418932142239744,,,,
Synthon,6/2/2014 7:00,4,0,Today we’ll talk on why it’s warranted to include HER2 1+ and 2+ breast & gastric cancer patients in PhI trials with our # ADC SYD985 # ASCO14,,,# #,4.73419E+17,https://twitter.com/Synthon/status/473418827301003264,,,,
subatomicdoc,6/2/2014 6:58,0,0,@ drattai Going to @ rsm2800 @ obogler @ mtmdphd too - see you there! # ASCO14,,@ @ @ @,#,4.73418E+17,https://twitter.com/subatomicdoc/status/473418420726534144,,,,
subatomicdoc,6/2/2014 6:57,1,3,Nice morning on Michigan Avenue # ASCO14 pic.twitter.com/eZ1yoNqmi4,,,#,4.73418E+17,https://twitter.com/subatomicdoc/status/473418032367558656,,,,
nxtstop1,6/2/2014 6:57,0,1,VALUE TWEETS MT @ subatomicdoc: @ yayayarndiva @ scientre @ rsm2800 @ CliffordHudis Thx Mimi If what I say>worth repeating will B tweeted! # ASCO14,,@ @ @ @ @,#,4.73418E+17,https://twitter.com/nxtstop1/status/473417996099014656,,,,
Alofs,6/2/2014 6:56,2,4,"# ASCO14 featured on # cnbc this morning. Immuno Therapy the big story. # roche right therapy +right patient + right time. @ thePMCF @ marykge""",,@ @,# # #,4.73418E+17,https://twitter.com/Alofs/status/473417899676540928,,,,
socflyny,6/2/2014 6:50,0,0,"@ drattai Yes : ) But costs I'm referring to are intangibles, beyond insur co-pays, etc. Can't list them all in 140, but compelling. # ASCO14",,@,#,4.73416E+17,https://twitter.com/socflyny/status/473416333053673473,,,,
CowenResearch,6/2/2014 6:49,0,0,Eric Schmidt publishes takeaways from his meeting at # ASCO14 w/ $ PBYI mgmt,,,#,4.73416E+17,https://twitter.com/CowenResearch/status/473416011580833793,,,,
osservasaluteaz,6/2/2014 6:47,0,1,"# Asco14, # Tumore e # qualità della # vita, la nuova # sfida dell’ # oncologia contemporanea: http://bit.ly/1ohymJr via @ QSanit.",,@,# # # # # #,4.73415E+17,https://twitter.com/osservasaluteaz/status/473415481366683648,,,,
PMLiVEcom,6/2/2014 6:46,0,1,AZ’s ovarian # cancer combination aces trial http://bit.ly/1mIEklB # pharma # ASCO14,,,# # #,4.73415E+17,https://twitter.com/PMLiVEcom/status/473415327653830657,,,,
merck_es,6/2/2014 6:45,0,0,Nueva alternativa para preservar la # fertilidad en mujeres con cáncer # ASCO14 @ mvsiguiendo via @ elmundo_es http://ow.ly/xuXKP,,@ @,# #,4.73415E+17,https://twitter.com/merck_es/status/473414994412204032,,,,
KUhlendorf,6/2/2014 6:42,0,0,". @ brady_dennis nicely outlines patient benefits, value dialogue of specialty # medicines. http://wapo.st/1kZBWZ9 @ washingtonpost # ASCO14",,@ @,# #,4.73414E+17,https://twitter.com/KUhlendorf/status/473414402163875840,,,,
subatomicdoc,6/2/2014 6:35,1,3,"@ yayayarndiva @ scientre @ rsm2800 @ CliffordHudis Thanks, Mimi. If what I say is worth repeating, there will be tweeting. # ASCO14 # hcsm",,@ @ @ @,# #,4.73413E+17,https://twitter.com/subatomicdoc/status/473412566887460865,,,,
GenentechJobs,6/2/2014 6:34,1,0,"# ASCO14 poster presentation at 8 am today: Breast Cancer/HER2/ER with our own Lisa Wang, Laura Chu, Marjorie Green and Chunyan Song.",,,#,4.73412E+17,https://twitter.com/GenentechJobs/status/473412339807424512,,,,
hblodget,6/2/2014 6:31,0,0,"RT @ DavidAgus: On way to @ CBSThisMorning to discuss exciting new treatments for cancer from @ ASCO meetings. No cures, but slow progress.",,@ @ @,,4.73412E+17,https://twitter.com/hblodget/status/473411690571501568,,,,
DavidAgus,6/2/2014 6:31,0,1,"On the way to @ CBSThisMorning to discuss exciting new treatments for cancer from @ ASCO meetings. No cures, but slow progress.",,@ @,,4.73411E+17,https://twitter.com/DavidAgus/status/473411477492092931,,,,
eBeeHealth,6/2/2014 6:28,0,0,The 2014 MDigitalLIfe Social Oncology Project Report by @ w2ogroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report?ref=http://mdigitallife.com/socialoncology/ …,,@,# #,4.73411E+17,https://twitter.com/eBeeHealth/status/473410808441876481,,,,
davisa20,6/2/2014 6:26,2,2,Lights on the bridge to the East Bldg look even better in the early morning light. # ASCO14 pic.twitter.com/EgDtHK9Quf,,,#,4.7341E+17,https://twitter.com/davisa20/status/473410227371769856,,,,
OncLive,6/2/2014 6:20,1,2,Lenvatinib improved PFS by 14.7 months in patients with RAI-resistant differentiated thyroid cancer http://ow.ly/xvp6Q # ASCO14,,,#,4.73409E+17,https://twitter.com/OncLive/status/473408735248121857,,,,
Prof_Nick_James,6/2/2014 6:19,0,0,Congratulations to Chris Sweeney on CHAARTED results - very important news for prostate cancer pts # ASCO14 http://www.cancer.gov/newscenter/newsfromnci/2013/E3805 …,,,#,4.73408E+17,https://twitter.com/Prof_Nick_James/status/473408497195814912,,,,
CureMelanoma,6/2/2014 6:18,0,1,RT @ timturnham: In mtg w/ @ US_FDA Price is not a factor in drug approval; ask if drug is improvement and if is safe. @ CureMelanoma # ASCO14,,@ @ @,#,4.73408E+17,https://twitter.com/CureMelanoma/status/473408308737765376,,,,
CureMelanoma,6/2/2014 6:18,0,1,RT @ timturnham: Some drugs approved by @ US_FDA before Europe. Means disparity of care based on where you live. @ CureMelanoma # ASCO14,,@ @ @,#,4.73408E+17,https://twitter.com/CureMelanoma/status/473408251737153537,,,,
ecancer,6/2/2014 6:10,1,0,Exemestane better prevents recurring # breastcancer than tamoxifen in some younger women http://ecancer.org/news/5731-asco-2014--adjuvant-exemestane-is-more-effective-than-tamoxifen-when-combined-with-ovarian-function-suppression-in-young-women-with-hormone-sensitive--early-stage-breast-cancer.php … # ASCO14,,,# #,4.73406E+17,https://twitter.com/ecancer/status/473406241734393856,,,,
PrDavidKhayat,6/2/2014 6:10,0,0,"# ASCO14, # Chicago : un nouvel espoir incroyable pour les # cancers de la # thyroïde résistants à l'iode radioactif",,,# # # #,4.73406E+17,https://twitter.com/PrDavidKhayat/status/473406189909581824,,,,
adamfeuerstein,6/2/2014 6:10,1,2,Early morning here at # ASCO14. A slug of $ BMY $ MRK PD-1 melanoma data emerges from embargo at 7:30 am ET.,,,#,4.73406E+17,https://twitter.com/adamfeuerstein/status/473406169503895552,,,,
WEHI_research,6/2/2014 6:09,0,0,A blood test to measure risk of # bowelcancer recurring - Dr Jeanne Tie is speaking at # ASCO14 tumour biology poster highlights today # crcsm,,,# # #,4.73406E+17,https://twitter.com/WEHI_research/status/473406031041531905,,,,
JonnyJPatience,6/2/2014 6:02,0,0,Ibrutinib in CLL: more positive results are emerging at # ASCO14 http://bit.ly/1od9SRp,,,#,4.73404E+17,https://twitter.com/JonnyJPatience/status/473404246197825536,,,,
GRUPOARAN,6/2/2014 6:00,0,0,"RT @ _SEOM: Escucha un resumen de # ASCO2014: cáncer d mama&obesidad, pulmon, inmunoterapia, gástrico avanzado y neuroncologia en:...",,@,#,4.73404E+17,https://twitter.com/GRUPOARAN/status/473403695745740800,,,,
redaccionmedica,6/2/2014 5:56,2,2,"Industria | PM01183, de PharmaMar, mejora la supervivencia en cáncer de ovario resistente http://www.redaccionmedica.com/secciones/industria/pm01183-de-pharmamar-mejora-la-supervivencia-de-pacientes-con-cancer-de-ovario-resistente-5040 … En el Congreso de @ ASCO",,@,,4.73403E+17,https://twitter.com/redaccionmedica/status/473402816548335617,,,,
salutedomani,6/2/2014 5:55,0,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://lnkd.in/d9dxgjA,,,#,4.73403E+17,https://twitter.com/salutedomani/status/473402581981462528,,,,
salutedomani,6/2/2014 5:55,0,0,Tumore prostata: i risultati dello studio PREVAIL con Enzalutamide su NEJM # asco2014 http://lnkd.in/dc6UnFx,,,#,4.73403E+17,https://twitter.com/salutedomani/status/473402501627015168,,,,
Boehringer,6/2/2014 5:55,1,1,"There was a buzz of excitement in the air & we were welcomed “Good morning doctors” Julia Knebel # lungcancer # ASCO14 http://bit.ly/1mE8Htf""",,,# #,4.73402E+17,https://twitter.com/Boehringer/status/473402424812920832,,,,
Accucoms,6/2/2014 5:55,0,0,RT @ ASCO: How has ASCO helped you in your oncology career? Give back in honor of our 50th Anniversary http://bit.ly/1jTn8uy @ iConquerCancer,,@ @,,4.73402E+17,https://twitter.com/Accucoms/status/473402418852802560,,,,
ITCC_eu,6/2/2014 5:49,0,0,@ ITCC_eu studies at # ASCO14 today from 8:00 AM to 11:45 AM in S Hall A2 http://bit.ly/1k8MP63 # ChildhoodCancerpic.twitter.com/sa40KeIq1k,,@,# #,4.73401E+17,https://twitter.com/ITCC_eu/status/473401093075259392,,,,
MyelomaUK,6/2/2014 5:48,1,0,Read our Monday round-up of # myeloma highlights from # ASCO14 - the largest int'l cancer conference in the calendar http://bit.ly/1rBALUX,,,# #,4.73401E+17,https://twitter.com/MyelomaUK/status/473400726572380161,,,,
drdonsdizon,6/2/2014 5:40,0,2,"MT  @ chimoose: And here are the accounts most RT by EX-US docs at # ASCO14 pic.twitter.com/08DX1rB3tG"" @ MGHCancerCenter""",,@ @,#,4.73399E+17,https://twitter.com/drdonsdizon/status/473398749016768514,,,,
_SEOM,6/2/2014 5:38,3,1,"Escucha un resumen de # ASCO2014: cáncer d mama&obesidad, pulmon, inmunoterapia, gástrico avanzado y neuroncologia en: http://bit.ly/1m50wVi",,,#,4.73398E+17,https://twitter.com/_SEOM/status/473398175466668032,,,,
subatomicdoc,6/2/2014 5:23,0,3,@ drattai @ stales @ jodyms @ chemobrainfog @ ABHuret OK. Now claiming EST - up and at 'em! Talk this morning # ASCO14 # hcsm,,@ @ @ @ @,# #,4.73395E+17,https://twitter.com/subatomicdoc/status/473394585410867202,,,,
olascar,6/2/2014 5:21,4,0,# ASCO2014 Une nouvelle stratégie efficace contre le cancer de la prostate présentée au congrès @ ASCO de Chicago http://sciav.fr/1n39jKS,,@,#,4.73394E+17,https://twitter.com/olascar/status/473393884496953344,,,,
subatomicdoc,6/2/2014 5:20,0,5,I have no idea how to tweet my AM talk while giving it. I need to learn from @ rsm2800 @ CliffordHudis @ scientre # ASCO14 # hcsm,,@ @ @,# #,4.73394E+17,https://twitter.com/subatomicdoc/status/473393672432930816,,,,
GroupeUNICANCER,6/2/2014 5:16,3,0,# ASCO14 : 1 étude pour utiliser les résultats précoces de l’imagerie TEP et orienter vers un traitement + efficace http://bit.ly/asco14tepscan,,,#,4.73393E+17,https://twitter.com/GroupeUNICANCER/status/473392708779003904,,,,
OncLive,6/2/2014 5:15,0,0,Dr Pegram discusses a novel HER2-targeted agent that he describes as a “super trastuzumab” http://ow.ly/xuAmm # ASCO14,,,#,4.73392E+17,https://twitter.com/OncLive/status/473392353810841600,,,,
oncobretagne,6/2/2014 5:10,1,0,# ASCO14 des avancées importantes pour les cancers du sein et de la prostate. http://www.docteurjd.com/,,,#,4.73391E+17,https://twitter.com/oncobretagne/status/473391098619244545,,,,
BoehringerES,6/2/2014 5:05,5,1,Hoy en # ASCO14 presentamos importantes resultados en supervivencia global para # cancerpulmon # NSCLC # EGFR http://bit.ly/S8CGQC,,,# # # #,4.7339E+17,https://twitter.com/BoehringerES/status/473389890458361858,,,,
nxtstop1,6/2/2014 5:04,0,0,HEALTH SOCIAL MEDIA CREED: MT @ DrMisialek:MT @ subatomicdoc: Benefits of SM need pathologists 2 tweet @ fischmd # ASCO14 pic.twitter.com/Rgsymu9PdW,,@ @ @,#,4.7339E+17,https://twitter.com/nxtstop1/status/473389661188931584,,,,
GroupeUNICANCER,6/2/2014 5:02,7,2,Congrès # ASCO14 : 2 études françaises pour améliorer la prise en charge des personnes âgées atteintes d’un cancer http://bit.ly/asco14oncogeriatrie …,,,#,4.73389E+17,https://twitter.com/GroupeUNICANCER/status/473389099475562496,,,,
WBvanDijk,6/2/2014 4:59,0,0,RT @ caseofdees: Morrow over waarom weglaten van behandeling moeilijk is # ASCO14 pic.twitter.com/S8K3CXF7Rk,,@,#,4.73388E+17,https://twitter.com/WBvanDijk/status/473388351689871360,,,,
ELDERCAREADVOCA,6/2/2014 4:57,0,0,“ @ Roche: Keeping cancer # immunotherapy personal http://ow.ly/xp2c1 # ASCO14” Each Individual Requires Personal Care with Cancer!,,@,# #,4.73388E+17,https://twitter.com/ELDERCAREADVOCA/status/473387981911650304,,,,
World_ADC,6/2/2014 4:53,0,0,Lots of $ SGEN ADC tech on show at # ASCO14 http://ow.ly/xvIXE,,,#,4.73387E+17,https://twitter.com/World_ADC/status/473386990520766464,,,,
ADC_drugs,6/2/2014 4:53,2,0,Lots of $ SGEN ADC tech on show at # ASCO14 http://ow.ly/xvIXj,,,#,4.73387E+17,https://twitter.com/ADC_drugs/status/473386989929369600,,,,
ADC_drugs,6/2/2014 4:51,2,0,RT @ MilesHarleyHW: Clinical updates of # ADC programs covered at # ASCO14 - exclusive summary ebook available at http://adc-summit.com/content-library,,@,# #,4.73386E+17,https://twitter.com/ADC_drugs/status/473386377590366210,,,,
caseofdees,6/2/2014 4:50,0,0,@ DeAmazones Dat is NIET de conclusie van die studie. In beide armen nl eierstokonderdrukking. ... # ASCO14 @ NL4LiveSTRONG,,@ @,#,4.73386E+17,https://twitter.com/caseofdees/status/473386177874370560,,,,
ecancer,6/2/2014 4:50,2,0,"Early, phone-based # palliativecare support gives better quality of life to caregivers http://ecancer.org/news/5746-asco-2014--early--phone-based--palliative-care-support-improves-caregiver-quality-of-life.php … # ASCO14",,,# #,4.73386E+17,https://twitter.com/ecancer/status/473386059624370176,,,,
ELDERCAREADVOCA,6/2/2014 4:48,0,0,“ @ LillyPad:How do we determine and reward value in cancer care and develop new treatments? # ASCO14 http://ow.ly/xsenO ”SuccessfulOutcomes!,,@,#,4.73386E+17,https://twitter.com/ELDERCAREADVOCA/status/473385674289459200,,,,
marvel_matt,6/2/2014 4:41,1,1,"Some v interesting interviews from # ASCO2014 by @ ecancer (for blood cancers, mantle cell lymphoma and CLL feature) http://ecancer.org/conference/514-asco-2014.php#.U4w4eQFPThY.twitter …",,@,# #,4.73384E+17,https://twitter.com/marvel_matt/status/473383970629906432,,,,
MBLoberg,6/2/2014 4:39,1,0,Utprøvningsenhetens Paal Brunsvig @ Oslounivsykehus og OCC-medlem # Lytix presenterer tidligfase data på # ASCO14 @ ASCO http://bit.ly/1pz5hNs,,@ @,# #,4.73383E+17,https://twitter.com/MBLoberg/status/473383473349419008,,,,
psicro,6/2/2014 4:36,1,0,How do you stay in control of your global # oncology study? @ ASCO stop by PSI's booth 12117 to discuss. pic.twitter.com/gh9g1vEIM6,,@,#,4.73383E+17,https://twitter.com/psicro/status/473382627358281728,,,,
DeAmazones,6/2/2014 4:30,2,0,Amerikaans oncologiecongres: uitschakeling eierstokfunctie geeft langere ziektevrije overleving http://ow.ly/xuWC8 # borstkanker # asco14,,,# #,4.73381E+17,https://twitter.com/DeAmazones/status/473381067479867392,,,,
InnatePharma,6/2/2014 4:30,2,3,Trials in progress poster of Phase I trial of lirilumab and nivolumab in advanced solid tumors presented at # ASCO14 http://innate-pharma.com/sites/default/files/45679_asco_poster_tips_segal_v4c_final.pdf …,,,#,4.73381E+17,https://twitter.com/InnatePharma/status/473381024286932992,,,,
OncLive,6/2/2014 4:20,0,1,Idelalisib plus rituximab demonstrated impressive activity with manageable toxicity for patients with CLL http://ow.ly/xvasr # ASCO14,,,#,4.73379E+17,https://twitter.com/OncLive/status/473378522938241024,,,,
Wim_Schellekens,6/2/2014 4:20,4,2,“Passende Zorg” @ OMSmedspec # Overuse RT @ caseofdees: Morrow: waarom weglaten v behandeling moeilijk is! # ASCO14 pic.twitter.com/anG9lmFjK4,,@ @,# #,4.73379E+17,https://twitter.com/Wim_Schellekens/status/473378522900492288,,,,
Biomedtracker,6/2/2014 4:17,5,2,Check out what 20 US oncologists think about # ASCO14 $ CLVS $ AZN data and PD-1 diagnostics $ MRK $ BMY: http://bit.ly/U6Adrw ($ or subs),,,#,4.73378E+17,https://twitter.com/Biomedtracker/status/473377803287527424,,,,
Medzineapp,6/2/2014 4:15,0,0,"ASCO 2014: old dogs, new tricks top the bill http://bit.ly/1iKwPrx # Asco14",,,#,4.73377E+17,https://twitter.com/Medzineapp/status/473377361497694208,,,,
Biomedtracker,6/2/2014 4:14,5,0,Download @ BioMedTracker # ASCO14 Weekend Update w/new survey of 20 US oncologists @ MedDeviceTrackr companion Dx: http://bit.ly/1rBfTwZ (sub),,@ @,#,4.73377E+17,https://twitter.com/Biomedtracker/status/473377046807060482,,,,
felixjackson,6/2/2014 4:11,0,0,# ASCO14 Annual Meeting Tweeters: http://www.pinterest.com/pin/283867582737519520/ … via @ andrewspong,,@,#,4.73376E+17,https://twitter.com/felixjackson/status/473376227131400193,,,,
nxtstop1,6/2/2014 4:01,3,2,GREAT SERVICE. @ lenstarnes:Kudos to @ Roche Lung cancer healthcare blog http://ow.ly/xuKMN # lcsm # hcldr # ASCO14 # hcsmeu # epatient # hcsm,,@ @,# # # # # #,4.73374E+17,https://twitter.com/nxtstop1/status/473373787325341696,,,,
DuseLu,6/2/2014 4:01,0,0,"Trials101: RT @ Roche: OS, PFS, QoL?We help you to understand # ClinicalTrial endpoints http://buff.ly/1oKw0qc (*.pdf) # ASCO14 # CancerResearch",,@,# # #,4.73374E+17,https://twitter.com/DuseLu/status/473373724503470080,,,,
CureTalks,6/2/2014 3:56,0,0,To explain mixed multigene panels new counseling models are needed # ASCO2014 http://am.asco.org/new-approaches-needed-deal-data-generated-germline-sequencing#.U4wtK9KuPT4.twitter …,,,# #,4.73373E+17,https://twitter.com/CureTalks/status/473372609241837569,,,,
lenstarnes,6/2/2014 3:55,4,5,Kudos to @ Roche Lung cancer healthcare blog http://ow.ly/xuKMN # lcsm # hcldr # ASCO14 # hcsmeu # epatient # hcsm,,@,# # # # # #,4.73372E+17,https://twitter.com/lenstarnes/status/473372429935321088,,,,
nxtstop1,6/2/2014 3:53,0,1,PRECIOUS PRIVACY. @ rsm2800:Fr. talk Mon. re social media & clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/ieompLid9S,,@,#,4.73372E+17,https://twitter.com/nxtstop1/status/473371813183909888,,,,
BIGagainstBC,6/2/2014 3:49,0,0,ALTTO Reveals Lapatinib Fails to Add Benefit of Trastuzumab in Adjuvant Setting # ASCO14 http://am.asco.org/altto-reveals-lapatinib-fails-add-benefit-trastuzumab-adjuvant-setting#.U4wse4EwSvg.twitter …,,,# #,4.73371E+17,https://twitter.com/BIGagainstBC/status/473370862691692544,,,,
pelletieramelie,6/2/2014 3:49,0,0,L’ # obésité augmente le risque de mortalité du # cancerdusein - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/L-obesite-augmente-le-risque-de-mortalite-du-cancer-du-sein-34956 … # ASCO14,,@,# # #,4.73371E+17,https://twitter.com/pelletieramelie/status/473370720160858113,,,,
pelletieramelie,6/2/2014 3:48,0,0,Cancer : le rôle des proches mérite une meilleure reconnaissance - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Cancer-le-role-des-proches-merite-une-meilleure-reconnaissance-34957 … # ASCO14,,@,#,4.73371E+17,https://twitter.com/pelletieramelie/status/473370559200251904,,,,
pelletieramelie,6/2/2014 3:47,2,0,Des thérapies ciblées de 2e génération s'attaquent aux cancers du poumon résistants - cc @ Doctissimo http://news.doctissimo.fr/Sante/Des-therapies-ciblees-de-2e-generation-s-attaquent-aux-cancers-du-poumon-resistants-34959 … # ASCO14,,@,#,4.7337E+17,https://twitter.com/pelletieramelie/status/473370398952665089,,,,
fwpharma,6/2/2014 3:46,2,1,From # ASCO14: @ Roche's anti-PDL1 therapy MPDL3280A shrinks tumours in early-stage bladder cancer study http://bit.ly/1ryB03b $ RHHBY,,@,#,4.7337E+17,https://twitter.com/fwpharma/status/473369992290136064,,,,
pelletieramelie,6/2/2014 3:46,0,0,Cancer : Faut-il alléger l’ordonnance des patients en fin de vie ? - News Médicaments - cc @ Doctissimo http://news.doctissimo.fr/Medicaments/Cancer-Faut-il-alleger-l-ordonnance-des-patients-en-fin-de-vie-34960 … # ASCO14,,@,#,4.7337E+17,https://twitter.com/pelletieramelie/status/473369992180682752,,,,
pelletieramelie,6/2/2014 3:45,2,0,Nouvelle thérapie ciblée contre des cancers de la thyroïde très agressifs - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Nouvelle-therapie-ciblee-contre-des-cancers-de-la-thyroide-tres-agressifs-34961 … # ASCO14,,@,#,4.7337E+17,https://twitter.com/pelletieramelie/status/473369919950569472,,,,
pelletieramelie,6/2/2014 3:45,0,0,Cancer du sein : mieux préserver la fertilité des femmes sous chimiothérapie - News Santé - cc @ Doctissimo http://news.doctissimo.fr/Sante/Cancer-du-sein-mieux-preserver-la-fertilite-des-femmes-sous-chimiotherapie-34970 … # ASCO14,,@,#,4.7337E+17,https://twitter.com/pelletieramelie/status/473369829592662016,,,,
fwpharma,6/2/2014 3:45,0,0,"From # ASCO14: Combination of @ AstraZeneca's olaparib, cediranib nearly doubles PFS in ovarian cancer studyhttp://bit.ly/1hoXi38",,@,#,4.7337E+17,https://twitter.com/fwpharma/status/473369800501391360,,,,
fwpharma,6/2/2014 3:43,0,0,From # ASCO14: Study finds addition of GlaxoSmithKline's Tykerb to Herceptin does not improve disease-free survival http://bit.ly/T3SpBl,,,#,4.73369E+17,https://twitter.com/fwpharma/status/473369326062694400,,,,
fwpharma,6/2/2014 3:42,1,1,FirstWord Lists: A revolution in cancer – a launch calendar for key immuno-oncology indications http://bit.ly/SnTtPL # pharma # ASCO14,,,# #,4.73369E+17,https://twitter.com/fwpharma/status/473369067097972736,,,,
AlmacGroup,6/2/2014 3:31,3,3,# Almac announces validation of novel test for # OvarianCancer patients at # ASCO14 @ ASCO http://ow.ly/xvB6A,,@,# # #,4.73366E+17,https://twitter.com/AlmacGroup/status/473366176689815552,,,,
OncLive,6/2/2014 3:15,1,1,MPDL3280A receives a breakthrough therapy designation for PD-L1-positive metastatic bladder cancer http://ow.ly/xuMRW # ASCO14,,,#,4.73362E+17,https://twitter.com/OncLive/status/473362191773876225,,,,
darrenfergus,6/2/2014 3:14,0,0,Why Health is interviewing experts from 7am # ASCO14 time. What do they think of how trusted combinations can be us…http://lnkd.in/dJpmgYQ,,,#,4.73362E+17,https://twitter.com/darrenfergus/status/473361900839768064,,,,
osservasaluteaz,6/2/2014 2:56,0,0,"# Asco14, Scienza e società: i prossimi 50 anni"": il tema della 50a edizione: http://bit.ly/1ohwfFq via @ adnk_salute # tumore # ricerca""",,@,# # #,4.73357E+17,https://twitter.com/osservasaluteaz/status/473357402444926976,,,,
GustaveRoussy,6/2/2014 2:49,11,1,"Reportage sur @ France2tv hier pour comprendre l'immunothérapie, qui sera à l'honneur aujourd´hui à # ASCO14 http://bit.ly/1pyUumm",,@,#,4.73356E+17,https://twitter.com/GustaveRoussy/status/473355605382819840,,,,
catherinemboyle,6/2/2014 2:47,0,0,"Roche immunotherapy ninja:"" Citi take on # ASCO14 results so far""",,,#,4.73355E+17,https://twitter.com/catherinemboyle/status/473355095124746240,,,,
AbigailTFox,6/2/2014 2:37,1,1,Shinseki & VA Crisis: A Scandal?Prototype? Is Cancer Treatment Next..to Get the Treatment? http://bit.ly/1olp7rL @ JamesPPinkerton # ASCO14,,@,#,4.73353E+17,https://twitter.com/AbigailTFox/status/473352720829530112,,,,
socflyny,6/2/2014 2:35,0,0,. @ drattai Still waiting for the study that measures full patient economic costs (incl value of time) in surgical choices. # ASCO14,,@,#,4.73352E+17,https://twitter.com/socflyny/status/473352229437845504,,,,
JFreemanDaily,6/2/2014 2:31,2,4,One last Sunday # LCSM TweetUp at # ASCO14: @ dhicks444 of @ TheALCF and me.pic.twitter.com/Mh7JyCd7sK,,@ @,# #,4.73351E+17,https://twitter.com/JFreemanDaily/status/473351099244883968,,,,
darrenfergus,6/2/2014 2:25,0,0,"Why Health is watching how the UK views CLL. If value can be shown, data from RESONATE will surely shake up expert opinions. # ASCO14",,,#,4.7335E+17,https://twitter.com/darrenfergus/status/473349684539293696,,,,
OncLive,6/2/2014 2:20,0,1,"Naiyer A. Rizvi, MD, discusses nivolumab plus erlotinib in patients with EGFR MT advanced NSCLC http://ow.ly/xux6t # ASCO14",,,#,4.73348E+17,https://twitter.com/OncLive/status/473348307461619713,,,,
Roche,6/2/2014 2:10,4,6,Pioneering Healthcare blog: Reaching out to others with the help of social media - http://ow.ly/xuKMN # lcsm # hcldr # ASCO14,,,# # #,4.73346E+17,https://twitter.com/Roche/status/473345791869067264,,,,
globalmcures,6/2/2014 1:59,0,1,The Combination of # Olaparib and # Cediranib Significantly Improves PFS in Recurrent # OvarianCancer | http://am.asco.org/combination-olaparib-and-cediranib-significantly-improves-progression-free-survival-recurrent#.U4wSn5HUMgc.twitter … # ASCO14 # Women,,,# # # # # #,4.73343E+17,https://twitter.com/globalmcures/status/473343175218581504,,,,
darrenfergus,6/2/2014 1:55,0,1,"Cancer costs are rising and it's hard to put society before your patient when a drug gives OS benefit, even if its value is ??? # ASCO14",,,#,4.73342E+17,https://twitter.com/darrenfergus/status/473342005049696257,,,,
ACInvestorBlog,6/2/2014 1:50,0,3,$ AVEO could be the perfect start to the week ;) # ASCO14 news !!,,,#,4.73341E+17,https://twitter.com/ACInvestorBlog/status/473340816896045056,,,,
DATATRAKinc,6/2/2014 1:50,0,0,"RT @ ClevelandClinic: “In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,@,# #,4.73341E+17,https://twitter.com/DATATRAKinc/status/473340768019808256,,,,
swelldiabetes,6/2/2014 1:44,1,1,MT “ @ subatomicdoc: The best of us can be 'outed' with *Kryptonite* tagging. Even Superman! # ASCO14 # privacyfail pic.twitter.com/JNA7mHVl4U”,,@,# #,4.73339E+17,https://twitter.com/swelldiabetes/status/473339441063677952,,,,
liemeij,6/2/2014 1:35,1,3,@ CPescott @ CongressCare Hierbij de link naar mijn presentatie http://bit.ly/SocialMediaASCO14 … # ASCO14 # socialmedia,,@ @,# #,4.73337E+17,https://twitter.com/liemeij/status/473337193495154688,,,,
kerfors,6/2/2014 1:34,1,1,Will be a busy day in my Twitter feed # hdpalooza # WWDC14 # iccs2014 # ASCO2014 # dmasco,,,# # # # #,4.73337E+17,https://twitter.com/kerfors/status/473336848354648064,,,,
liemeij,6/2/2014 1:31,0,0,@MCvanStaveren Hierbij de link naar mijn presentatie http://bit.ly/SocialMediaASCO14 … # ASCO14 # socialmedia,,@MCvanStaveren,# #,4.73336E+17,https://twitter.com/liemeij/status/473336137927233536,,,,
cure_talk,6/2/2014 1:26,1,0,"Success of Molecular Testing Depends on Dialogue Between Oncologist, Pathologist # ASCO2014 http://am.asco.org/success-molecular-testing-depends-dialogue-between-oncologist-pathologist#.U4wK8uO2mMw.twitter …",,,# #,4.73335E+17,https://twitter.com/cure_talk/status/473334815333175296,,,,
cure_talk,6/2/2014 1:25,1,1,"Across Phases, Trial Design Remains an Evolving Art | # ASCO2014 http://am.asco.org/across-phases-trial-design-remains-evolving-art#.U4wKrA3yeKk.twitter …",,,# #,4.73335E+17,https://twitter.com/cure_talk/status/473334542497894400,,,,
dralvaropinto,6/2/2014 1:21,0,1,Enjoying the jazz at Chicago! Because there's more to life than # ASCO14 ... pic.twitter.com/3ZlV9AR130,,,#,4.73334E+17,https://twitter.com/dralvaropinto/status/473333518735785984,,,,
braincancer_AU,6/2/2014 1:18,2,6,Trial of a potential drug for # glioblastoma shows encouraging results http://bit.ly/1gWin4C # asco14 # braincancer,,,# # #,4.73333E+17,https://twitter.com/braincancer_AU/status/473332852734431232,,,,
OncLive,6/2/2014 1:15,2,1,Adjuvant lapatinib plus trastuzumab did not significantly improve DFS in early breast cancer http://ow.ly/xuZsp # ASCO14,,,#,4.73332E+17,https://twitter.com/OncLive/status/473331950779133952,,,,
PamyCW,6/2/2014 1:13,0,1,Day 52 # 100happydays - need alert! Picked up a 3D-printed T-cell at # ASCO14 pic.twitter.com/GxVLgf34nO,,,# #,4.73332E+17,https://twitter.com/PamyCW/status/473331602412806144,,,,
maxinesun,6/2/2014 1:13,0,0,@ simon_p_kim @ cpgYALE @bubadg @ iConquerCancer @ ASCO @ YaleCancer @ YaleCOPPER Big congrats!,,@ @ @bubadg @ @ @ @,,4.73332E+17,https://twitter.com/maxinesun/status/473331548344041472,,,,
drecroach,6/2/2014 1:04,0,0,Does anyone have experience with this circulating tumor cell isolation system? very promising. http://goo.gl/V8RQXw # ASCO14,,,#,4.73329E+17,https://twitter.com/drecroach/status/473329246321274880,,,,
Onconet_NL,6/2/2014 0:58,0,0,Nieuwe behandelmogelijkheden voor patienten met # prostaatkanker tijdens # asco2014 http://am.asco.org/adding-chemotherapy-hormone-therapy-men-newly-metastatic-prostate-cancer-leads-%E2%80%98unprecedented …,,,# #,4.73328E+17,https://twitter.com/Onconet_NL/status/473327885047328768,,,,
JFreemanDaily,6/2/2014 0:56,2,7,# ASCO14 is good source of exercise--I've walked 12 miles in 3 days. As for a source of sleep? Not so much ... # LCSM,,,# #,4.73327E+17,https://twitter.com/JFreemanDaily/status/473327208660873217,,,,
S_Amani,6/2/2014 0:44,2,0,Navigating the Brave New World of Social Media in Medicine: Getting the Most Out of Technology via @ Asco # nhssm http://zite.to/1oYnAci,,@,#,4.73324E+17,https://twitter.com/S_Amani/status/473324135494746112,,,,
HistoWiz,6/2/2014 0:41,0,0,Day 2 of the exhibit @ ASCO @ HistoWiz @ technology and Practice Management Pavillion booth #4046pic.twitter.com/0y9JVmftpk,,@ @ @,#4046pic,4.73324E+17,https://twitter.com/HistoWiz/status/473323526515326977,,,,
eulota,6/2/2014 0:37,0,0,RT @ TargetedOnc: Olaparib/Cediranib Combo Nearly Doubled PFS in Recurrent Ovarian Cancer http://www.targetedonc.com/conference/asco-2014/OlaparibCediranib-Combo-Nearly-Doubled-PFS-in-Recurrent-Ovarian-Cancer … # ASCO14,,@,#,4.73323E+17,https://twitter.com/eulota/status/473322611292651520,,,,
TuftsB,6/2/2014 0:36,0,0,"@PACENetworkUSA: Continuous innovation changed @ TuftsB’s cancer diagnosis from fatal to manageable. http://ow.ly/xtCym # mliwi # ASCO14""",,@PACENetworkUSA @,# #,4.73322E+17,https://twitter.com/TuftsB/status/473322262578626560,,,,
DrAnasYounes,6/2/2014 0:31,0,0,@ mtmdphd Thanks Mike for all the tweets. Was good seeing you at the President reception # ASCO14,,@,#,4.73321E+17,https://twitter.com/DrAnasYounes/status/473321028626952193,,,,
CureTalks,6/2/2014 0:17,1,1,"In 50 yrs, 7 drugs were approved by FDA for melanoma 4 being approved in last 3 yrs # ASCO2014 http://am.asco.org/recent-explosion-progress-melanoma-management-catalyst-change-future-directions-research#.U4v6AktUipY.twitter …",,,# #,4.73317E+17,https://twitter.com/CureTalks/status/473317480283111424,,,,
Rob_Hager,6/2/2014 0:14,0,0,@ MegTirrell: Takeaways from weekend at # ASCO2014 http://fw.to/2z6eZ6D @ CNBC $ XPH $ IBB,,@ @,#,4.73317E+17,https://twitter.com/Rob_Hager/status/473316684208431104,,,,
wandering_gu,6/2/2014 0:10,16,6,Pretty interesting. 2.5x breast ca tweets vs. prostate ca. Similar dif in funding. . . MT @ dr_coops: # ASCO14 http://flip.it/yXAJ3 # PCSM,,@,# #,4.73316E+17,https://twitter.com/wandering_gu/status/473315698975186945,,,,
GScheiber,6/2/2014 0:05,0,0,“ @ Boehringer: What are the most common # lungcancer symptoms? Watch this video to find out: http://bit.ly/1gApTvY > # ASCO14”,,@,# #,4.73314E+17,https://twitter.com/GScheiber/status/473314476872441856,,,,
intopic,6/2/2014 0:01,0,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://dlvr.it/5rj50c,,,#,4.73313E+17,https://twitter.com/intopic/status/473313349774487552,,,,
KanghoKo,6/1/2014 23:47,0,0,“ @ TargetedOnc: Results from the phase III CALGB/SWOG 80405 trial were presented today at # ASCO14 http://www.targetedonc.com/conference/asco-2014/Results-from-the-Phase-III-CALGBSWOG-80405-Trial …”,,@,#,4.7331E+17,https://twitter.com/KanghoKo/status/473309940799397888,,,,
timturnham,6/1/2014 23:47,0,1,"Jim Allison, inventor of IPI, plays harmonica at event for @ sitcancer. @curemelanima # ASCO14 pic.twitter.com/eBgwR51fJu",,@ @curemelanima,#,4.7331E+17,https://twitter.com/timturnham/status/473309911057965056,,,,
DaveDolton,6/1/2014 23:46,0,0,@ subatomicdoc @ MyelomaTeacher @ theNCI Thanks! @ mtmdphd please let me know more....could not make it to # ASCO14,,@ @ @ @,#,4.7331E+17,https://twitter.com/DaveDolton/status/473309771387633667,,,,
BiostatGirl,6/1/2014 23:44,0,0,Celebratory comedy! # chicago # asco2014 # asco14 http://instagram.com/p/ouh8EhgzMg/,,,# # #,4.73309E+17,https://twitter.com/BiostatGirl/status/473309134193172480,,,,
mastologiaHLF,6/1/2014 23:43,2,0,Ejercicio como parte importante de tto RT @ drattai: Dr. Cassileth - a crucial component of integrative oncology is EXERCISE # ASCO14 # bcsm,,@,# #,4.73309E+17,https://twitter.com/mastologiaHLF/status/473308938054938624,,,,
NDeVitoMD,6/1/2014 23:43,1,1,@ sitcancer fundraiser @ asco yep that's Jim Allison on harmonica! pic.twitter.com/Yi8qMqlNp5,,@ @,,4.73309E+17,https://twitter.com/NDeVitoMD/status/473308811764441088,,,,
JFreemanDaily,6/1/2014 23:42,0,2,"@ IanJohnPereira No planned tweetups, but you never know who you'll find roaming the halls of # ASCO14. # LCSM",,@,# #,4.73309E+17,https://twitter.com/JFreemanDaily/status/473308707309117441,,,,
JFreemanDaily,6/1/2014 23:40,4,7,Another # LCSM TweetUp at # ASCO14: @ subatomicdoc Dr. Matt Katz and me. RL connectivity is kinda cool!pic.twitter.com/I0CVVZ4TIs,,@,# #,4.73308E+17,https://twitter.com/JFreemanDaily/status/473308208837443584,,,,
subatomicdoc,6/1/2014 23:31,0,0,@ DaveDolton @ MyelomaTeacher @ theNCI I'd refer you to @ mtmdphd for link/contacts - I was tweeting his talk at # ASCO14,,@ @ @ @,#,4.73306E+17,https://twitter.com/subatomicdoc/status/473305833334263808,,,,
MyelomaTeacher,6/1/2014 23:27,1,0,Social Media Is a Form of Media | @ ASCO Connection http://connection.asco.org/Commentary/Article/ID/3543/Social-Media-Is-a-Form-of-Media.aspx … via @ ASCO,,@ @,,4.73305E+17,https://twitter.com/MyelomaTeacher/status/473304919311544320,,,,
DATATRAKinc,6/1/2014 23:25,0,0,RT @ ASCO: Scenes from today's # ASCO14 http://on.fb.me/1gVOHoa pic.twitter.com/mAieRxSn5g,,@,#,4.73304E+17,https://twitter.com/DATATRAKinc/status/473304264505577473,,,,
jrgralow,6/1/2014 23:24,6,1,Cool drug MT@OncLive: M Pegramndiscusses trial exploring margetuximab in HER2 “low” metastatic breast cancer http://ow.ly/xuAg6 # ASCO14,,@OncLive,#,4.73304E+17,https://twitter.com/jrgralow/status/473304040496193536,,,,
DrSherifMorgan,6/1/2014 23:17,0,0,House of Blues in # chicago - this is # asco14 after hours! http://instagram.com/p/ouezvliHgT/,,,# #,4.73302E+17,https://twitter.com/DrSherifMorgan/status/473302250505633792,,,,
danettekrberry,6/1/2014 23:15,0,0,@ ASCO,,@,,4.73302E+17,https://twitter.com/danettekrberry/status/473301871571267585,,,,
krystadawn,6/1/2014 23:15,0,0,Sorry about your Blackhawks loss # ASCO14 host city @ ChicagosMayor,,@,#,4.73302E+17,https://twitter.com/krystadawn/status/473301837924532224,,,,
megtirrell,6/1/2014 23:14,5,3,Takeaways from the weekend at # asco14. Still more to come! Tune to @ cnbc tomorrow for our live coverage. http://www.cnbc.com/id/101721186,,@,#,4.73302E+17,https://twitter.com/megtirrell/status/473301567622639616,,,,
MyelomaTeacher,6/1/2014 23:14,0,0,Can't wait for # Myeloma Monday at # ASCO14 ! # MMSM I will be following remotely thru my fellow twerps tweet!,,,# # #,4.73302E+17,https://twitter.com/MyelomaTeacher/status/473301519719469056,,,,
MyelomaTeacher,6/1/2014 23:11,0,0,Panorama I: # Panobinostat # ASCO14 @ myelomacinderel http://myelomacinderella.net/2014/06/panorama-i-panobinostat-asco-2014/ … # MMSM # myeloma,,@,# # # #,4.73301E+17,https://twitter.com/MyelomaTeacher/status/473300891840552960,,,,
DrAttai,6/1/2014 23:09,2,3,Honored to attend the @ ASCO Presidential Reception in honor of @ CliffordHudis # ASCO14,,@ @,#,4.733E+17,https://twitter.com/DrAttai/status/473300283662270464,,,,
gotoPER,6/1/2014 23:04,1,1,Great faculty and lots of interactive discussion at tonight's PER Lung Symp at ASCO @ gotoper # asco14 # lcsmpic.twitter.com/poiMug6qRp,,@,# #,4.73299E+17,https://twitter.com/gotoPER/status/473299134879780864,,,,
subatomicdoc,6/1/2014 22:55,0,0,@ CBlotner_ A little overwhelming # ASCO14 is bigger than rad onc meetings. Fun though # btsm,,@,# #,4.73297E+17,https://twitter.com/subatomicdoc/status/473296880076873729,,,,
ZHeatherChamp,6/1/2014 22:54,0,0,RT @ subatomicdoc @ ZHeatherChamp If @ ASCO is cool with it I'll post talk to Slideshare; not sure re: video # ASCO14 # btsm,,@ @ @,# #,4.73297E+17,https://twitter.com/ZHeatherChamp/status/473296636928851968,,,,
subatomicdoc,6/1/2014 22:54,0,2,@ ZHeatherChamp If @ ASCO is cool with it I'll post talk to Slideshare; not sure re: video # ASCO14 # btsm,,@ @,# #,4.73297E+17,https://twitter.com/subatomicdoc/status/473296536819224577,,,,
krystadawn,6/1/2014 22:52,1,0,ASCO humor RT @ ronwinslow: The Checkpoints are uninhibited. # ASCO14 h/t @ loftuspic.twitter.com/OEQfW9Qfdt,,@ @,#,4.73296E+17,https://twitter.com/krystadawn/status/473296132253437952,,,,
CBlotner_,6/1/2014 22:52,0,1,"@ subatomicdoc It's always a pleasure to have you with us Matt. How are you finding # ASCO14 so far, and will your talk be recorded? # btsm",,@,# #,4.73296E+17,https://twitter.com/CBlotner_/status/473296028452786176,,,,
PulmaoSA,6/1/2014 22:52,0,0,What are the most common # lungcancer symptoms? Watch this # video to find out: http://bit.ly/1gApTvY > # ASCO14 # quitsmoking,,,# # # #,4.73296E+17,https://twitter.com/PulmaoSA/status/473295939445080064,,,,
subatomicdoc,6/1/2014 22:51,0,2,"@ TheLizArmy My pleasure, Liz. I'm mentioning # btsm in my # ASCO14 talk tomorrow AM",,@,# #,4.73296E+17,https://twitter.com/subatomicdoc/status/473295921456115712,,,,
subatomicdoc,6/1/2014 22:50,0,0,"@ CBlotner_ Sorry to jump in late, listening in. Matt Katz here, doc in MA. Currently @ # ASCO14 # btsm",,@ @,# #,4.73296E+17,https://twitter.com/subatomicdoc/status/473295679918731265,,,,
BioStocks,6/1/2014 22:47,0,0,AstraZeneca’s Cancer News Boosts CEO Soriot’s $45 Billion Case http://bloom.bg/1rzXXmv $ AZN $ PFE # ASCO14,,,#,4.73295E+17,https://twitter.com/BioStocks/status/473294805011681280,,,,
ASCO,6/1/2014 22:41,7,8,Scenes from today's # ASCO14 http://on.fb.me/1gVOHoa pic.twitter.com/tr5pCAn7de,,,#,4.73293E+17,https://twitter.com/ASCO/status/473293370001850368,,,,
GailOnasch,6/1/2014 22:40,0,2,# OAS meeting daily in DC in the MALL when you can get to DC join them as your finances allow. http://ln.is/www.youtube.com/embe/d7Vp6 …? # tcot # ASCO14 @ AP,,@,# # #,4.73293E+17,https://twitter.com/GailOnasch/status/473293033791045632,,,,
hwitteman,6/1/2014 22:31,0,1,"MT @ subatomicdoc: Communication is at the core of interacting with patients"" @ mtmdphd # ASCO14""",,@ @,#,4.73291E+17,https://twitter.com/hwitteman/status/473290724478562305,,,,
sjaakvink,6/1/2014 22:30,0,0,@ ASCO president: we oncologists need to be part of solving the problem of cancer by empowering patients and be humble towstds these patients,,@,,4.73291E+17,https://twitter.com/sjaakvink/status/473290547789307904,,,,
wandering_gu,6/1/2014 22:28,0,1,@ simon_p_kim @ cpgYALE @bubadg @ iConquerCancer @ asco @ YaleCancer @ YaleCOPPER CONGRATS!!! Awesome news.,,@ @ @bubadg @ @ @ @,,4.7329E+17,https://twitter.com/wandering_gu/status/473289976252096512,,,,
OncLive,6/1/2014 22:25,3,1,"Mark Pegram, MD, discusses a trial exploring margetuximab in HER2 “low” metastatic breast cancer http://ow.ly/xuAg6 # ASCO14",,,#,4.73289E+17,https://twitter.com/OncLive/status/473289160766545922,,,,
borjasas,6/1/2014 22:23,0,0,. @ JAMAInternalMed | @ ASCO | The Role of Testing for BRCA1 and BRCA2 in Cancer Prevention | http://goo.gl/vrFBF8 |pic.twitter.com/UDc1I55IPk,,@ @,,4.73289E+17,https://twitter.com/borjasas/status/473288826350485504,,,,
DrSherifMorgan,6/1/2014 22:22,0,0,"RT @ ClevelandClinic: “In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,@,# #,4.73288E+17,https://twitter.com/DrSherifMorgan/status/473288453153513474,,,,
Vaneciendo,6/1/2014 22:21,0,0,Boudou sos una mancha y no la de Rolando. # ASCO14 # OcasoK @ Lanataenel13,,@,# #,4.73288E+17,https://twitter.com/Vaneciendo/status/473288388150558721,,,,
ronwinslow,6/1/2014 22:21,4,6,The Checkpoints are uninhibited. # ASCO14 h/t @ loftuspic.twitter.com/8dsLn8Oadb,,@,#,4.73288E+17,https://twitter.com/ronwinslow/status/473288293308579841,,,,
jeffblackradio,6/1/2014 22:21,0,2,"Thanks everyone! Celebrate everyday! promo code domino"" at http://jeffblack.com National Cancer Survivors Day # ncsd2014 # MLIWI # asco2014""",,,# # #,4.73288E+17,https://twitter.com/jeffblackradio/status/473288281430704129,,,,
DanTheCancerMan,6/1/2014 22:21,0,0,Check points are planning now. Who knew Jim Allison could shred harmonica. @ ASCO pic.twitter.com/ZmPwFZDYWY,,@,,4.73288E+17,https://twitter.com/DanTheCancerMan/status/473288143320645632,,,,
CBlotner_,6/1/2014 22:16,0,0,@ ZHeatherChamp # ASCO14 is the hashtag used for 2014's American Society of Clinical Oncology's meeting: http://am.asco.org/ # btsm,,@,# #,4.73287E+17,https://twitter.com/CBlotner_/status/473286999844347904,,,,
NirajGusani,6/1/2014 22:15,0,1,". @ chimoose I'm sure you are busy this week w # ASCO14, but would love to talk soon after when you are free - please DM me to arrange.",,@,#,4.73287E+17,https://twitter.com/NirajGusani/status/473286814183067648,,,,
TheLizArmy,6/1/2014 22:15,0,0,@ CBlotner_ Not following # ASCO14 as much as I'd like. Still getting used to Pacific Coast Time after Japan (16 hr time difference). # btsm,,@,# #,4.73287E+17,https://twitter.com/TheLizArmy/status/473286728493830145,,,,
wendyashmen,6/1/2014 22:15,0,0,Great faculty and lots of interactive discussion at tonight's PER Lung Symp at ASCO @ gotoper # asco14 # lcsmpic.twitter.com/MnbO2FmXWo,,@,# #,4.73287E+17,https://twitter.com/wendyashmen/status/473286705890742272,,,,
Gene_Antibody,6/1/2014 22:15,0,1,Check out this cool article about using technology to bring clin trials to patients. http://ow.ly/xn1xz # ASCO14,,,#,4.73287E+17,https://twitter.com/Gene_Antibody/status/473286667047280642,,,,
MontefioreNYC,6/1/2014 22:14,2,2,Dr. Rafi Kabarriti received a Young Investigator Grant for new therapeutic approaches for prostate # cancer. # ASCO14 pic.twitter.com/Soc1IVQphn,,,# #,4.73287E+17,https://twitter.com/MontefioreNYC/status/473286564961726464,,,,
OAkkerman_ERG,6/1/2014 22:14,1,1,BI's Focus on # Lungcancer is a top 10 tweeted site at # ASCO14 Here are 3 retweeters driving the volume. pic.twitter.com/TzfOgnIwxN,,,# #,4.73287E+17,https://twitter.com/OAkkerman_ERG/status/473286561602482176,,,,
Cangela25,6/1/2014 22:14,0,1,@ CBlotner_ I would say I've been following # ASCO14 through organizations I've already been following. # btsm,,@,# #,4.73287E+17,https://twitter.com/Cangela25/status/473286547111178240,,,,
CBlotner_,6/1/2014 22:12,0,0,Has anyone else in tonight's chat been following # ASCO14 updates this weekend? # btsm,,,# #,4.73286E+17,https://twitter.com/CBlotner_/status/473286091886587904,,,,
AguusssGimenez,6/1/2014 22:12,0,0,Mañana al cole qw # ASCO14,,,#,4.73286E+17,https://twitter.com/AguusssGimenez/status/473285894284517377,,,,
Frank_S_David,6/1/2014 22:11,0,1,Pharma marketing Q: Are big drug billboards on street outside clinical conferences really good use of $? # ASCO14 pic.twitter.com/A9HHsdWlFO,,,#,4.73286E+17,https://twitter.com/Frank_S_David/status/473285826978529280,,,,
RP_RP_RP,6/1/2014 22:06,0,0,“ @ bradloncar: Roche's immunotherapy pipeline. # ASCO14 pic.twitter.com/7isozuMLv2” @ NinaBeri,,@ @,#,4.73285E+17,https://twitter.com/RP_RP_RP/status/473284550026874880,,,,
UrologyMatch,6/1/2014 22:05,1,0,# ASCO14 A 'Home Run' in Prostate Cancer Tx -http://www.medpagetoday.com/HematologyOncology/ProstateCancer/46090 … @ ccottriau,,@,#,4.73284E+17,https://twitter.com/UrologyMatch/status/473284283487236096,,,,
CBlotner_,6/1/2014 22:05,1,0,"Hey everyone! In case you all haven't heard, # btsm was the 2nd most used cancer-hashtag via @ ASCO's # SOCOncology http://mdigitallife.com/socialoncology/",,@,# #,4.73284E+17,https://twitter.com/CBlotner_/status/473284136183275520,,,,
TargetedOnc,6/1/2014 22:05,0,2,Results from the phase III CALGB/SWOG 80405 trial were presented today at # ASCO14 http://www.targetedonc.com/conference/asco-2014/Results-from-the-Phase-III-CALGBSWOG-80405-Trial …,,,#,4.73284E+17,https://twitter.com/TargetedOnc/status/473284126129545216,,,,
teamoncology,6/1/2014 21:52,1,5,【 # ASCO14 Update】ゾメタの効果と安全性は、乳がん骨転移患者では、毎４週でも毎12週でも、同じ。画期的。 http://abstracts.asco.org/144/AbstView_144_129791.html …,,,#,4.73281E+17,https://twitter.com/teamoncology/status/473280899673366528,,,,
teamoncology,6/1/2014 21:51,2,1,【 # ASCO14 Update】 ビタミンDの低いレベル、乳がんの生存率とは関連がない。つまり、ビタミンDを飲むことにより生存率の改善の根拠は無い。 http://abstracts.asco.org/144/AbstView_144_128900.html …,,,#,4.73281E+17,https://twitter.com/teamoncology/status/473280834682621952,,,,
Emory_R,6/1/2014 21:51,0,0,"Once A Year, Cancer Research News Comes In A Flood, Not A Trickle : Shots - Health News : NPR http://buff.ly/1mHnByV # ASCO14",,,#,4.73281E+17,https://twitter.com/Emory_R/status/473280805104787456,,,,
teamoncology,6/1/2014 21:51,0,1,【 # ASCO14 Update】卵巣がんにおいて、VEGFR とPARP 阻害剤の相乗効果が確認。 http://abstracts.asco.org/144/AbstView_144_130933.html …,,,#,4.73281E+17,https://twitter.com/teamoncology/status/473280717216964608,,,,
teamoncology,6/1/2014 21:51,1,1,【 # ASCO14 Update】LHRH agonistを化学療法中に使用して、卵巣機能を温存を多少できることが証明。ただ、今後も研究が必要、妊娠できるかとは別問題。 http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.73281E+17,https://twitter.com/teamoncology/status/473280645867646976,,,,
teamoncology,6/1/2014 21:50,0,1,【 # ASCO14 Update】 転移性大腸がんにおいて、抗EGFR抗体あるいは、血管新生血管阻害剤をどちらからスタートしても効果は同じ。 http://abstracts.asco.org/144/AbstView_144_127755.html …,,,#,4.7328E+17,https://twitter.com/teamoncology/status/473280480175857664,,,,
OAkkerman_ERG,6/1/2014 21:50,2,2,Go Figure: Katz’s @ subatomicdoc Tweeted link “Benefits of Social Media” now a top link at # ASCO14 http://www.environics.ca/environics-health--pharma-blog/post/65/ASCO-2014-Shows-Benefits-of-Social-Media … # environicspharma,,@,# #,4.7328E+17,https://twitter.com/OAkkerman_ERG/status/473280368238280704,,,,
teamoncology,6/1/2014 21:49,0,0,【 # ASCO14 Update】閉経前ホルモン陽性の乳がんにおいて、アロマテース阻害剤と卵巣機能抑制剤の組み合わせは再発をより下げる。,,,#,4.7328E+17,https://twitter.com/teamoncology/status/473280313141886978,,,,
teamoncology,6/1/2014 21:49,1,3,【 # ASCO14 Update】 50年間の乳がんの治療の発展がわかりやすくまとめてあります（英語）→ http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pG9xRCeIQ.twitter … # bcsm,,,# # #,4.7328E+17,https://twitter.com/teamoncology/status/473280107201576960,,,,
gotoPER,6/1/2014 21:47,3,1,Dr Soria discusses which disease settings will be impacted by immune checkpoint inhibitors @ GoToPER # asco14 # lcsmpic.twitter.com/EIuGkbYxnU,,@,# #,4.7328E+17,https://twitter.com/gotoPER/status/473279740116480000,,,,
KoontzOncology,6/1/2014 21:47,0,0,Enjoying the @ HOPARX networking dinner at Fogo de Chao during the # ASCO14 meeting here in Chicago. Ready for dessert! pic.twitter.com/zEVPiQfRzt,,@,#,4.7328E+17,https://twitter.com/KoontzOncology/status/473279655928406016,,,,
gotoPER,6/1/2014 21:46,1,2,Dr. Lynch personally answering clinician questions on EGFR inhibition in NSCLC. @ GoToPER # asco2014 # lcsmpic.twitter.com/tLfiESPswI,,@,# #,4.73279E+17,https://twitter.com/gotoPER/status/473279335974326272,,,,
drecroach,6/1/2014 21:44,0,1,"GSK invests 350 million $, to develop CAR-T cells for cancer with Adaptimmune # ASCO14 http://goo.gl/VB4G6H",,,#,4.73279E+17,https://twitter.com/drecroach/status/473279070814617600,,,,
gotoPER,6/1/2014 21:44,1,1,Full house at Personalization of NSCLC Therapy symposium at Hyatt Regency @ GoToPER # asco14 # lcsmpic.twitter.com/xKewnzrvxh,,@,# #,4.73279E+17,https://twitter.com/gotoPER/status/473278974294904832,,,,
KUhlendorf,6/1/2014 21:44,0,0,Continuous # Innovation Leads to Longer Lives https://pacenetworkusa.com/entry.php?id=91 # ASCO14,,,# #,4.73279E+17,https://twitter.com/KUhlendorf/status/473278964220178434,,,,
AneesChagpar,6/1/2014 21:44,0,1,So great seeing friends & colleagues @ ASCO president's reception in honor of @ CliffordHudis -- thanks so much for a great # ASCO14,,@ @,#,4.73279E+17,https://twitter.com/AneesChagpar/status/473278960588304384,,,,
wendyashmen,6/1/2014 21:44,0,0,Dr Soria discusses which disease settings will be impacted by immune checkpoint inhibitors @ GoToPER # asco14 # lcsmpic.twitter.com/ZoqbhtMwlC,,@,# #,4.73279E+17,https://twitter.com/wendyashmen/status/473278958004211712,,,,
gotoPER,6/1/2014 21:43,1,1,Dr Gandara presents 2nd Gen ALK-Inhibitor Master Protocol Proposal from NCI at lung symp @ GoToPER # asco14 # lcsmpic.twitter.com/LAeOH2dXqk,,@,# #,4.73279E+17,https://twitter.com/gotoPER/status/473278698465284096,,,,
gotoPER,6/1/2014 21:42,1,1,Dr Brahmer presenting the latest on predictive markers for PD-(L)1 antibodies at PER lung symp # asco14 # lcsmpic.twitter.com/TPQZ8qiWSn,,,# #,4.73278E+17,https://twitter.com/gotoPER/status/473278436203823105,,,,
KarenTeber,6/1/2014 21:41,0,0,Looking forward to seeing my @ lombardicancer colleagues tonight! # asco2014,,@,#,4.73278E+17,https://twitter.com/KarenTeber/status/473278119067910144,,,,
ndrewColburn,6/1/2014 21:37,0,1,I apparently I need to research more oncology related terms and information. I understood about 1/2 the tweets I saw this weekend :P # ASCO14,,,#,4.73277E+17,https://twitter.com/ndrewColburn/status/473277125748092928,,,,
dr_alhashem,6/1/2014 21:37,1,0,Late-Braking abs:hormon Rx+Docetaxel improves OS over Hormonal alone in men w High Volume mets Prostate Ca # ASCO14 http://abstracts.asco.org/144/AbstView_144_127755.html …,,,#,4.73277E+17,https://twitter.com/dr_alhashem/status/473277097558159361,,,,
jrzalcberg,6/1/2014 21:36,3,1,# ASCO14 Obesity is the new tobacco- this rolling stone is headed towards us. We have to find a way to head it off at the pass!,,,#,4.73277E+17,https://twitter.com/jrzalcberg/status/473276939210620928,,,,
jrzalcberg,6/1/2014 21:35,4,1,# ASCO14 No major breakthrough in GI oncology at ASCO meeting yet- lots of trials being done though to try and improve results for patients,,,#,4.73277E+17,https://twitter.com/jrzalcberg/status/473276732569845760,,,,
OncLive,6/1/2014 21:35,0,0,‘Smart’ Alkylator TH-302 Shows Clinical Benefit in Early Multiple Myeloma Trial http://ow.ly/xvbaf # ASCO14,,,#,4.73277E+17,https://twitter.com/OncLive/status/473276601296519168,,,,
brentgendleman,6/1/2014 21:34,2,0,# asco14 framing the situation well http://m.washingtonpost.com/national/health-science/2014/06/01/40127d1c-e107-11e3-8dcc-d6b7fede081a_story.html?wprss=rss_national …,,,#,4.73276E+17,https://twitter.com/brentgendleman/status/473276421457330176,,,,
montrose52,6/1/2014 21:31,0,1,Great job SPK! Congratulations. Well-deserved. Making @ UMichUrology proud. @ simon_p_kim @ cpgYALE @ iConquerCancer @ ASCO @ YaleCancer,,@ @ @ @ @ @,,4.73276E+17,https://twitter.com/montrose52/status/473275555501338624,,,,
wendyashmen,6/1/2014 21:29,0,0,Dr Brahmer presenting the latest on predictive markers for PD-(L)1 antibodies at PER lung symp # asco14 # lcsmpic.twitter.com/hxICOoAMKX,,,# #,4.73275E+17,https://twitter.com/wendyashmen/status/473275161048014848,,,,
JohnCendpts,6/1/2014 21:29,17,14,GlaxoSmithKline opens a new chapter in cancer R&D with pioneering TCR pact - $ GSK # ASCO14 http://www.fiercebiotech.com/story/glaxosmithkline-opens-new-chapter-cancer-rd-pioneering-tcr-pact/2014-06-01 …,,,#,4.73275E+17,https://twitter.com/JohnCendpts/status/473275106941468673,,,,
PharmaPinkSheet,6/1/2014 21:28,1,0,Look to @ pinksheetmaryjo for the key info coming out of # ASCO14,,@,#,4.73275E+17,https://twitter.com/PharmaPinkSheet/status/473275024468893696,,,,
Groz_P,6/1/2014 21:28,0,0,@ annieg917 Thought it was just me. Not finding any good news from # asco14 for women w/bc mets.,,@,#,4.73275E+17,https://twitter.com/Groz_P/status/473274820294356992,,,,
davidbeme,6/1/2014 21:26,0,0,Leucémie lymphoïde chronique : les bons résultats de l'ibrutinib en cas de rechutes # ASCO2014 @ doctissimo http://ow.ly/xvdIs,,@,#,4.73274E+17,https://twitter.com/davidbeme/status/473274465787588609,,,,
gotoPER,6/1/2014 21:25,1,2,@ GoToPER lung cancer dinner symposium is underway # ASCO14 # LCSMpic.twitter.com/MTZHKmPbG2,,@,# #,4.73274E+17,https://twitter.com/gotoPER/status/473274095258591232,,,,
davidbeme,6/1/2014 21:24,0,0,Cancer de la prostate : faut-il traiter en cas de récidive biologique (PSA+ sans symptômes) ? # ASCO2014 @ doctissimo http://ow.ly/xv4bj,,@,#,4.73274E+17,https://twitter.com/davidbeme/status/473273978656935937,,,,
aicrtweets,6/1/2014 21:20,0,0,RT @ djsampson: G Colditz: pop over 65 expected to reach 20% by 2050. Risk and opportunity to prevent cx # asco14,,@,#,4.73273E+17,https://twitter.com/aicrtweets/status/473272841673388033,,,,
OncEd,6/1/2014 21:19,0,0,@ subatomicdoc Thanks for stopping by our booth at # ASCO14! Head&Neck Rad Onc learning module available online http://www.oncologyeducation.com/information/head-and-neck/ …,,@,#,4.73273E+17,https://twitter.com/OncEd/status/473272568750018561,,,,
NateDahlPharmD,6/1/2014 21:17,0,0,RT @ subatomicdoc: Brain metastases in patients with testicular germ cell tumors http://abstracts.asco.org/144/AbstView_144_130878.html … # ASCO14 # tscsm,,@,# #,4.73272E+17,https://twitter.com/NateDahlPharmD/status/473272264226390016,,,,
Frank_S_David,6/1/2014 21:13,1,3,MT @ MaverickNY: These shld be essential rdg4 # ASCO14 presenters -> YES! Full deck of PPT tips: http://www.khoslaventures.com/wp-content/uploads/Vinod-Khosla-2014.5.20_Pitch-the-Way-VCs-think_KVSummit_alt.pdf …pic.twitter.com/7zNisRqgYl,,@,#,4.73271E+17,https://twitter.com/Frank_S_David/status/473271231861764096,,,,
drapaolaceledon,6/1/2014 21:12,0,1,REVEL: Ramucirumab aumenta sobrevida en SEGUNDA línea de cáncer de pulmón!!!!!! # ASCO14,,,#,4.73271E+17,https://twitter.com/drapaolaceledon/status/473270964105785344,,,,
wendyashmen,6/1/2014 21:12,0,0,Dr Gandara presents 2nd Gen ALK-Inhibitor Master Protocol Proposal from NCI at lung symp @ GoToPER # asco14 # lcsmpic.twitter.com/wfYs6qZI6S,,@,# #,4.73271E+17,https://twitter.com/wendyashmen/status/473270814817918976,,,,
ConsanoMolly,6/1/2014 21:09,2,2,Dr. @ CliffordHudis knows how to throw a party! Great time with @ ConsanoScott at the # ASCO14 President's Reception. pic.twitter.com/f6R0LkkOmN,,@ @,#,4.7327E+17,https://twitter.com/ConsanoMolly/status/473270250772119552,,,,
DrGlenWeiss,6/1/2014 21:09,0,0,". @ mtmdphd: What if we had metrics on the # ASCO14 Virtual Meeting downloads and 'likes to help figure out what's important - @ fischmd” like!""",,@ @,#,4.7327E+17,https://twitter.com/DrGlenWeiss/status/473270080856674305,,,,
coolchatter,6/1/2014 21:08,0,1,"Tried # googleglass at the # imbruvica booth at # ASCO14. Cool technology, but definitely not for me. pic.twitter.com/k2JGPBpqq0",,,# # #,4.7327E+17,https://twitter.com/coolchatter/status/473269906012913664,,,,
MaverickNY,6/1/2014 21:08,0,1,@ Frank_S_David should be essential reading for many presenters at # asco14,,@,#,4.7327E+17,https://twitter.com/MaverickNY/status/473269808491143168,,,,
mvillaseca,6/1/2014 21:06,0,0,RT @ CancerNetwrk: Insulin Resistant Metastatic Breast Cancer Patients Fare Worse http://flip.it/em2xU # ASCO14,,@,#,4.73269E+17,https://twitter.com/mvillaseca/status/473269490458038272,,,,
nbferrara,6/1/2014 21:05,0,0,"RT @ OncLive Negative ALTTO Results Reverberate for Lapatinib, Novel Clinical Trials http://ow.ly/xuZ9J # ASCO14",,@,#,4.73269E+17,https://twitter.com/nbferrara/status/473269056402120704,,,,
wendyashmen,6/1/2014 21:05,0,0,Full house at Personalization of NSCLC Therapy symposium at Hyatt Regency @ GoToPER # asco14 # lcsmpic.twitter.com/JSs7t0jha4,,@,# #,4.73269E+17,https://twitter.com/wendyashmen/status/473269018254516224,,,,
CancerConnector,6/1/2014 21:03,0,0,"I'm looking forward to my return to # clinicaloncology next year, and excited to see skipper of @ ASCO active here on @ twitter # bravenewworld",,@ @,# #,4.73269E+17,https://twitter.com/CancerConnector/status/473268623965192192,,,,
scientre,6/1/2014 20:59,2,5,Really appreciate all the engagement on # ASCO14 stream around our talks this evening! Taking the @ mtmdphd @ fischmd show on the road?!?,,@ @,#,4.73268E+17,https://twitter.com/scientre/status/473267679328239616,,,,
DrVGimino,6/1/2014 20:57,0,0,@ MedscapeOnc @ TomVargheseJr seems that # ASCO14 is proud that pt engagement is the 4th revolution in # cancer care?,,@ @,# #,4.73267E+17,https://twitter.com/DrVGimino/status/473267116267687937,,,,
echo_nyc,6/1/2014 20:55,0,0,Where are # ASCO14 folks watching the game???,,,#,4.73267E+17,https://twitter.com/echo_nyc/status/473266558957932545,,,,
OncLive,6/1/2014 20:55,1,1,Novel Rituximab Combinations Highly Effective in CLL http://ow.ly/xvamF # ASCO14,,,#,4.73267E+17,https://twitter.com/OncLive/status/473266522044235776,,,,
nbferrara,6/1/2014 20:55,0,0,RT @ medpagetoday ASCO: Lung cancer tests would cost Medicare billions. @ atscommunity # ASCO14 http://bit.ly/1sRd3Bm,,@ @,#,4.73267E+17,https://twitter.com/nbferrara/status/473266515895418881,,,,
CancerNetwrk,6/1/2014 20:54,2,0,Insulin Resistant Metastatic Breast Cancer Patients Fare Worse http://bit.ly/1nVrC5v # ASCO14,,,#,4.73266E+17,https://twitter.com/CancerNetwrk/status/473266446848761856,,,,
carisls,6/1/2014 20:49,0,0,@ leonardSender discusses key insights from the # MolecularIntel study on pediatric cancers at # ASCO14 http://goo.gl/GRDd5I,,@,# #,4.73265E+17,https://twitter.com/carisls/status/473265122387836929,,,,
ralucatopor,6/1/2014 20:48,0,0,Trabajando por una junta Latino Americana # trilingual # asco2014 @The JW Chicago Marriott http://instagram.com/p/ouNzs7Evny/,,@The,# #,4.73265E+17,https://twitter.com/ralucatopor/status/473264866577240065,,,,
TheseAreMyScars,6/1/2014 20:47,1,1,"If you are following the 50th # ASCO14 meeting, you can also follow # LCCatASCO and @ NormandBlais he will be posting on all the happenings.",,@,# #,4.73265E+17,https://twitter.com/TheseAreMyScars/status/473264602802040832,,,,
wendyashmen,6/1/2014 20:46,0,0,Dr. Lynch personally answering clinician questions on EGFR inhibition in NSCLC. @ GoToPER # asco2014 # lcsmpic.twitter.com/j3JclNf4lH,,@,# #,4.73264E+17,https://twitter.com/wendyashmen/status/473264388531449856,,,,
drdonsdizon,6/1/2014 20:45,0,2,@ rsm2800 A large trial has lessons for all of us. Even if the trial is negative. Think of the 8000+ pts who participated! # ASCO14,,@,#,4.73264E+17,https://twitter.com/drdonsdizon/status/473264145396404224,,,,
nbferrara,6/1/2014 20:45,1,0,"RT @ ASCO Integrative oncology adds to, should not replace traditional cancer care http://bit.ly/1pJyNNL # ASCO14",,@,#,4.73264E+17,https://twitter.com/nbferrara/status/473264028731838464,,,,
ProjectInno,6/1/2014 20:45,0,0,Read these cancer survivors' inspiring stories & share your story today! http://ow.ly/xuVPJ # NCSD14 # ASCO14,,,# #,4.73264E+17,https://twitter.com/ProjectInno/status/473264010125930496,,,,
dmavicente,6/1/2014 20:44,0,0,# ASCO14. Si usted tiene un cáncer de próstata metástasico pregúntele a su urólogo por la quimio. Puede estar perdiendo oportunidades !!!!,,,#,4.73264E+17,https://twitter.com/dmavicente/status/473263806228226048,,,,
IngeDiepman,6/1/2014 20:44,1,0,"# ASCO14 http://www.oncologietv.nl journaal 2 ;JohnHaanen en WinaldGerritsen over immuuntherapie, en docetaxel bij hormoongevoel. prost.carc.",,,#,4.73264E+17,https://twitter.com/IngeDiepman/status/473263746790334464,,,,
dmavicente,6/1/2014 20:43,0,0,# ASCO14. 4 plenaria. Estudio ALTTO. Lapatinib no aporta nada a trastu en adyuvancia. Los resultados del brazo de lapa solo??? Infratratadas,,,#,4.73263E+17,https://twitter.com/dmavicente/status/473263494088122368,,,,
OphiraG,6/1/2014 20:42,0,0,@ colleen_young @ PeterASinger @ ASCO thx 4 MT! So much can be done 2 close the # cancerdivide @ gchallenges,,@ @ @ @,#,4.73263E+17,https://twitter.com/OphiraG/status/473263456854884352,,,,
maggiedinomemd,6/1/2014 20:42,0,1,Finally our national breast cancer conferences focusing on cancer prevention! # ASCO14 # cancerprevention # nutritional making progress!,,,# # #,4.73263E+17,https://twitter.com/maggiedinomemd/status/473263435656884225,,,,
saveyourskinfdn,6/1/2014 20:37,1,1,We are so thrilled to be at @ ASCO this year! # ASCO14 pic.twitter.com/OUMAiNI3x9,,@,#,4.73262E+17,https://twitter.com/saveyourskinfdn/status/473262159594799104,,,,
antoniocaperna,6/1/2014 20:37,0,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://ow.ly/2HmpsC,,,#,4.73262E+17,https://twitter.com/antoniocaperna/status/473261985019482112,,,,
declangmurphy,6/1/2014 20:36,2,5,# asco14 producing lots of top uro-oncology data. Would go some year but I hear it's all KM curves and no videos! No good for dumb surgeons,,,#,4.73262E+17,https://twitter.com/declangmurphy/status/473261828202446848,,,,
LungCancerFaces,6/1/2014 20:35,0,0,Another # LCSM Tweetup at # ASCO14: @ JFreemanDaily and @ Tony_Calles!pic.twitter.com/prMYgFQjd1,,@ @,# #,4.73262E+17,https://twitter.com/LungCancerFaces/status/473261518037868545,,,,
nbferrara,6/1/2014 20:35,0,0,RT @ ASCO Experts discuss consensus standards for multiplex # cancer genomic testing http://bit.ly/RTL1XZ # ASCO14,,@,# #,4.73261E+17,https://twitter.com/nbferrara/status/473261481933668352,,,,
Drchik23,6/1/2014 20:33,0,1,Did anyone post $ mack's poster info? Just curious. Perhaps I missed it? TIA. # ASCO14,,,#,4.73261E+17,https://twitter.com/Drchik23/status/473260992533913600,,,,
Jehennessy3,6/1/2014 20:32,0,0,# ASCO2014 Purple Pig makes it all worthwhile. pic.twitter.com/VF9XQWicnW,,,#,4.73261E+17,https://twitter.com/Jehennessy3/status/473260952067272705,,,,
OncologyTimes,6/1/2014 20:32,3,1,"Correcting this: FYI, for George Sledge fans, here's link to his Musings of a Cancer Doctor"" blog: http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/list.aspx?listType=blogs&listId=11&ContextualNavigationType=blogs&ContextualNavigationId=11 … # ASCO14""",,,#,4.73261E+17,https://twitter.com/OncologyTimes/status/473260850200195072,,,,
SurvivorRunner,6/1/2014 20:32,0,0," @ scientre: . @ mtmdphd with a great roundup of hashtags!! # asco14 pic.twitter.com/Ad0cLUAMsC” # LCSM” <-----I see some # BCSM up there!! :)""",,@ @,# # #,4.73261E+17,https://twitter.com/SurvivorRunner/status/473260836367400960,,,,
OncLive,6/1/2014 20:30,3,2,Practice-Changing Data Revealed for Premenopausal HR+ Breast Cancer http://ow.ly/xv9QA # ASCO14,,,#,4.7326E+17,https://twitter.com/OncLive/status/473260313887113216,,,,
m_e_nielsen,6/1/2014 20:29,0,0,@ simon_p_kim congrats to you & yr whole crew @ cpgYALE @bubadg @ iConquerCancer @ ASCO @ YaleCancer @ YaleCOPPER,,@ @ @bubadg @ @ @ @,,4.7326E+17,https://twitter.com/m_e_nielsen/status/473260145120915456,,,,
jagasquet,6/1/2014 20:28,1,1,"Negative ALTTO Results Reverberate for # Lapatinib, Novel Clinical Trials # breastcancer http://ow.ly/xuZ9J # ASCO14 @ OncLive",,@,# # #,4.7326E+17,https://twitter.com/jagasquet/status/473259751497662464,,,,
BeckyCanvin,6/1/2014 20:27,0,0,Anyone at # ASCO14 want to know what's happening on social media for # ASCO14 - take a look here: http://asco-2014.boehringer-ingelheim.com/daily-social-media-picks-%C2%AD-asco-day-1/ …,,,# #,4.7326E+17,https://twitter.com/BeckyCanvin/status/473259698545000449,,,,
colleen_young,6/1/2014 20:27,1,0,Great work @ OphiraG RT @ PeterASinger: Bridging the Digital Divide to Close the Cancer Divide by @ OphiraG http://www.grandchallenges.ca/2014/bridging-the-digital-divide-to-close-the-cancer-divide/ … # ASCO14,,@ @ @,#,4.7326E+17,https://twitter.com/colleen_young/status/473259632501071872,,,,
PropellerHealth,6/1/2014 20:26,0,0,MT @ scientre: Are wearables FDA approval? Could think @ PropellerHealth sensor as a wearable for the inhaler http://ht.ly/xuBJO # ASCO14,,@ @,#,4.73259E+17,https://twitter.com/PropellerHealth/status/473259428054310912,,,,
ecancer,6/1/2014 20:26,2,0,# ecancer is currently filming at a satellite symposium on licensed treatments for melanoma at # ASCO14 pic.twitter.com/6y4EhrLqvr,,,# #,4.73259E+17,https://twitter.com/ecancer/status/473259240476246016,,,,
nbferrara,6/1/2014 20:25,0,0,MT @ ASCOPost Bortezomib Combo Significantly Improves PFS in Newly Diagnosed Mantle Cell Lymphoma http://ow.ly/xv87P # ASCO14 # lylsm,,@,# #,4.73259E+17,https://twitter.com/nbferrara/status/473258960259399680,,,,
MedPedsDoctor,6/1/2014 20:23,0,1,"Double RT RT @ subatomicdoc: Communicationg is at the core of interacting with patients"" @ mtmdphd # ASCO14""",,@ @,#,4.73259E+17,https://twitter.com/MedPedsDoctor/status/473258667714674688,,,,
TuftsB,6/1/2014 20:23,0,0,"@eRaceCancer - Economics are wrong & it is morally questionable, why is ASCO doing this disservice to patients and doctots? # mliwi # ASCO14",,@eRaceCancer,# #,4.73258E+17,https://twitter.com/TuftsB/status/473258468174880768,,,,
bradloncar,6/1/2014 20:22,2,2,Roche's immunotherapy pipeline. # ASCO14 pic.twitter.com/EhNI5P9Wvf,,,#,4.73258E+17,https://twitter.com/bradloncar/status/473258404211748864,,,,
OncLive,6/1/2014 20:20,3,1,REVEL is the first study in nearly a decade to show an improvement in OS for second-line advanced NSCLC http://ow.ly/xu5hX # ASCO14,,,#,4.73258E+17,https://twitter.com/OncLive/status/473257715540971520,,,,
LungCancerFaces,6/1/2014 20:16,0,4,Recognize any of them? @ scientre: . @ mtmdphd finishes with a great roundup of hashtags!! # asco14 pic.twitter.com/QQXn7Plaex” # LCSM,,@ @,# #,4.73257E+17,https://twitter.com/LungCancerFaces/status/473256894362947585,,,,
jfowlerpharmd,6/1/2014 20:15,0,1,"# ASCO14 # chicago 35,000 oncologists and scientists fighting cancer and winning!pic.twitter.com/lnZoD9MHEr",,,# #,4.73257E+17,https://twitter.com/jfowlerpharmd/status/473256575411290113,,,,
nbferrara,6/1/2014 20:15,0,0,MT @ ASCOPost Study: Overall Survival Benefit for Patients w/Stage III Soft Tissue Sarcomas ( @ FoxChaseCancer) http://ow.ly/xv83F # ASCO14,,@ @,#,4.73256E+17,https://twitter.com/nbferrara/status/473256479819317248,,,,
timfenske,6/1/2014 20:14,1,1,Len + Ritux for 1st line FL. >90% ORR and 2 yr PFS but almost all were low or int FLIPI. Martin et al # ASCO14 http://www.healio.com/hematology-oncology/highlights-from-asco-2014/lenalidomide-rituximab-achieved-responses-in-treatment-naive-patients-with-follicular-lymphoma …,,,#,4.73256E+17,https://twitter.com/timfenske/status/473256306233835520,,,,
sarah_blagden,6/1/2014 20:13,1,1,Combined targeted therapies (without chemo) shows success in platinum-sensitive recurrent ca ovary@ASCO: http://bit.ly/1kxhL0f # ASCO14”,,@ASCO,#,4.73256E+17,https://twitter.com/sarah_blagden/status/473256168530251777,,,,
marcodoc,6/1/2014 20:12,0,0,High volume disease mProstste Ca.: ADT+docetaxel improves OS! That's good! # ASCO14 pic.twitter.com/UCyT5qvRjX,,,#,4.73256E+17,https://twitter.com/marcodoc/status/473255717542297600,,,,
dbsable,6/1/2014 20:09,1,3,Not being at # ASCO14 and seeing all of the twitter activity I feel like I'm away at boarding school.,,,#,4.73255E+17,https://twitter.com/dbsable/status/473254989645623296,,,,
ASCO,6/1/2014 20:05,1,1,Review our new Survivorship Compendium @the ASCO booth in Exhibit Hall today-June 2 (Monday) http://bit.ly/1k7zHOO # ASCO14,,@the,#,4.73254E+17,https://twitter.com/ASCO/status/473253953787158528,,,,
SRPT_Fan,6/1/2014 20:05,0,3,"Usually only the dumbest shit trends on twitter, but I see that # ASCO14 is trending right now. Impressive.",,,#,4.73254E+17,https://twitter.com/SRPT_Fan/status/473253945327235072,,,,
Disruptivestock,6/1/2014 20:05,0,0,$ thld data on trial treating glioblastoma w th302 looks very promising! # ASCO2014,,,#,4.73254E+17,https://twitter.com/Disruptivestock/status/473253933277020160,,,,
nbferrara,6/1/2014 20:05,0,0,MT @ MMarchioneAP One of biggest wins in met. cancer ever; drug boosts # prostatecancer survival 1 year+: http://tinyurl.com/mdth33r # ASCO14,,@,# #,4.73254E+17,https://twitter.com/nbferrara/status/473253929023963136,,,,
carisls,6/1/2014 20:04,0,0,@ weldeiry from @ PennStHershey discusses key tumor profiling data on # CRC at # ASCO14 pic.twitter.com/LiQxpVHNTU,,@ @,# #,4.73254E+17,https://twitter.com/carisls/status/473253783644798976,,,,
DrAttai,6/1/2014 20:03,1,0,“ @ JackWestMD: Heading to # ASCO14 President's Reception at Chicago's Union Station. Should be fun. First time there.” Me too see you soon!,,@,#,4.73254E+17,https://twitter.com/DrAttai/status/473253573539950592,,,,
EFEciencia,6/1/2014 20:02,5,2,"Estudios en # cáncer de mama, próstata y colorrectal afinan la práctica clínica. http://www.efefuturo.com/noticia/nuevos-estudios-en-cancer-de-mama-prostata-y-colorrectal-afinan-la-practica-clinica/ … # ASCO14",,,# #,4.73253E+17,https://twitter.com/EFEciencia/status/473253224300834816,,,,
coloncancermike,6/1/2014 20:00,3,5,Talking CRC advances at # ASCO14 with our friends at @ FightCRC @ CCAlliance @ chris4cure @ genentech,,@ @ @ @,#,4.73253E+17,https://twitter.com/coloncancermike/status/473252816899670016,,,,
hmhyltonpac,6/1/2014 19:58,0,0,"Via @ nprnews: Once A Year, Cancer Research News Comes In A Flood, Not A Trickle http://n.pr/RLFaE7 . # ASCO14",,@,#,4.73252E+17,https://twitter.com/hmhyltonpac/status/473252394084487169,,,,
JacobPlieth,6/1/2014 19:55,0,1,Safety of Merck KGaA's anti-PD-L1 MSB0010718C # ASCO14 pic.twitter.com/zW1VjFddQx,,,#,4.73251E+17,https://twitter.com/JacobPlieth/status/473251477423939584,,,,
nbferrara,6/1/2014 19:55,0,0,"MT @ NCIMedia # ASCO14 : Overhaul to Fed. Sponsored Trials & Enriched Support for Community-Based Research"" http://tinyurl.com/py3ulao # NCTN""",,@,# #,4.73251E+17,https://twitter.com/nbferrara/status/473251419471220736,,,,
mtmdphd,6/1/2014 19:55,1,1,. @ ASCO Social Media Info http://ow.ly/xt4NN # ASCO14 Tweeps: http://ow.ly/xt4NO Ten Tips: http://ow.ly/xt4NP,,@,#,4.73251E+17,https://twitter.com/mtmdphd/status/473251415838982145,,,,
DavidBerthold,6/1/2014 19:54,0,0,"@ SummersAnne in Conversation with # CateBlanchett June 26, Sydney. Book here: http://bit.ly/1py6Dbh # ASCO14",,@,# #,4.73251E+17,https://twitter.com/DavidBerthold/status/473251369453752321,,,,
JacobPlieth,6/1/2014 19:54,0,2,Early data: 1 PR in 28-patient ph I dose-esc study of Merck KGaA's anti-PD-L1 MSB0010718C # ASCO14 pic.twitter.com/nUwdyyiaYx,,,#,4.73251E+17,https://twitter.com/JacobPlieth/status/473251236461182976,,,,
AlpineBV_Miller,6/1/2014 19:52,0,2,Tough room at $ RHHBY event. Speaker on IO programs cracking all sorts of funny immunotherapy jokes and I'm the only one laughing # ASCO14,,,#,4.73251E+17,https://twitter.com/AlpineBV_Miller/status/473250790451445761,,,,
BoysenMeb,6/1/2014 19:50,0,0,Nyt kæmpestudie sparer det danske samfund for mere end 150 mio kr # breastcancer # ASCO14 @DagMedicin,,@DagMedicin,# #,4.7325E+17,https://twitter.com/BoysenMeb/status/473250335029731328,,,,
theNCI,6/1/2014 19:50,22,14,"In case you missed, here's a comprehensive overview of our revamped clinical trials program http://1.usa.gov/1kyrsLD # NCTN # ASCO14",,,# #,4.7325E+17,https://twitter.com/theNCI/status/473250159548444672,,,,
CureCancerAu,6/1/2014 19:47,0,0,Thanks for the re-tweets Ashley! @ drng So many interesting updates from # ASCO14 Have not seen any rhymes from you recently?,,@,#,4.7325E+17,https://twitter.com/CureCancerAu/status/473249560479821824,,,,
drdonsdizon,6/1/2014 19:47,0,1,Mini-reunion of the MSKCC medical oncology fellows from 2002 # ASCO14 http://instagram.com/p/ouGzjJpw9g/,,,#,4.73249E+17,https://twitter.com/drdonsdizon/status/473249467357868033,,,,
DrMisialek,6/1/2014 19:45,4,1,Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing http://www.coloradocancerblogs.org/oncologists-talk-pathologist-cancer-molecular-testing/ … @CoCancerCenter @ Pathologists # ASCO14,,@CoCancerCenter @,#,4.73249E+17,https://twitter.com/DrMisialek/status/473248957490270208,,,,
JackWestMD,6/1/2014 19:45,0,1,Heading to # ASCO14 President's Reception at Chicago's Union Station. Should be fun. First time there.,,,#,4.73249E+17,https://twitter.com/JackWestMD/status/473248900804268032,,,,
DrMisialek,6/1/2014 19:42,5,3,"ALK, ROS1 and now NTRK1: Prevalence of New Genetic Driver in Lung Cancer http://www.coloradocancerblogs.org/alk-ros1-now-ntrk1-study-shows-prevalence-new-genetic-driver-lung-cancer/ … @CoCancerCenter @ ASCO # ASCO14 # LCSM",,@CoCancerCenter @,# #,4.73248E+17,https://twitter.com/DrMisialek/status/473248366437343232,,,,
JoleneScience,6/1/2014 19:41,0,1,I'm interested in the cancer # nanotechnology session @ # ASCO14 tomorrow: maybe it's my background showing,,@,# #,4.73248E+17,https://twitter.com/JoleneScience/status/473247882133651457,,,,
annaazvolinsky,6/1/2014 19:40,0,0,Exemestane better than tamoxifen when combined w/ ovarian fcn suppression in early # breastcancer # ASCO14 http://www.cancernetwork.com/asco-2014-breast-cancer/exemestane-trumps-tamoxifen-early-breast-cancer …,,,# #,4.73248E+17,https://twitter.com/annaazvolinsky/status/473247800994828288,,,,
PeterHall001,6/1/2014 19:40,3,4,Busy day at # ASCO14 all about obesity and red meat increasing cancer risk. Time to sample the local cuisine. pic.twitter.com/EzZUDVJFyG,,,#,4.73248E+17,https://twitter.com/PeterHall001/status/473247719708839936,,,,
ProjectInno,6/1/2014 19:40,0,1,4 year gain in cancer survival rates between 1988-2000 produced $1.9 trillion in societal value http://ow.ly/xuVGo # NCSD14 # ASCO14,,,# #,4.73248E+17,https://twitter.com/ProjectInno/status/473247671164362753,,,,
annaazvolinsky,6/1/2014 19:39,2,4,Small study shows # breastcancer pts with insulin resistance have worse outcomes # ASCO14 http://www.cancernetwork.com/asco-2014-breast-cancer/insulin-resistant-metastatic-breast-cancer-patients-fare-worse …,,,# #,4.73248E+17,https://twitter.com/annaazvolinsky/status/473247550452297729,,,,
Sorena997,6/1/2014 19:39,1,1,"# ASCO14 Nice Session: The future is now: Incorporating EHRs, Cloud Decision Tools, & Social Media into Clinical Practice : INTEROPERABILITY",,,#,4.73247E+17,https://twitter.com/Sorena997/status/473247461104836608,,,,
Giacomettetti,6/1/2014 19:39,0,0,@ dhjutsw1 @ ASCO zur Hausen - not Zurich! He gave a fascinating lecture this afternoon!,,@ @,,4.73247E+17,https://twitter.com/Giacomettetti/status/473247392859688960,,,,
annaazvolinsky,6/1/2014 19:37,4,1,Adding chemo to hormone therapy boosts survival by >13 mo in # prostate cancer! & this is a generic drug... # ASCO14 http://www.cancernetwork.com/asco-2014-prostate-cancer/docetaxel-adt-improves-survival-metastatic-prostate-cancer-patients …,,,# #,4.73247E+17,https://twitter.com/annaazvolinsky/status/473247053095907329,,,,
twiterney,6/1/2014 19:37,0,1,"Just been invited to a prostate dinner"" - think I'll pass"," thanks # ASCO14""",,,#,4.73247E+17,https://twitter.com/twiterney/status/473246993502855168,,,
MediTech_Media,6/1/2014 19:36,1,1,"It is inspiring to see so many focused on improving # cancer research, patient outcomes, and patient quality of life @ ASCO # ASCO14.",,@,# #,4.73247E+17,https://twitter.com/MediTech_Media/status/473246850913677312,,,,
nycdoc29,6/1/2014 19:35,0,0,@ jodigralnick # ASCO14 coverage coming your way tomorrow @ CNBC! @ megtirrell @ SquawkCNBC” - not in ivory academic towers or clinical trial,,@ @ @ @,#,4.73247E+17,https://twitter.com/nycdoc29/status/473246567361568768,,,,
galja02,6/1/2014 19:35,0,0,# ASCO14 http://tinyurl.com/n3ct8hm pic.twitter.com/Lnw3YPWWHz,,,#,4.73246E+17,https://twitter.com/galja02/status/473246425334050816,,,,
nycdoc29,6/1/2014 19:35,0,0,@ jodigralnick # ASCO14 coverage coming your way tomorrow @ CNBC! @ megtirrell @ SquawkCNBC” - 65% of cancer patients in US treated in community,,@ @ @ @,#,4.73246E+17,https://twitter.com/nycdoc29/status/473246390420652034,,,,
OncNursingNews,6/1/2014 19:35,2,0,Goserelin during chemo for early-stage breast cancer led to better preservation of ovarian function http://ow.ly/xuOSP # ASCO14,,,#,4.73246E+17,https://twitter.com/OncNursingNews/status/473246386050568193,,,,
ShannonWestin,6/1/2014 19:34,1,0,"“ @ Lymphoma_Doc: With so much exciting data at # ASCO14, hard to believe that <5% of US cancer patients go on clinical trials.” Huge issue",,@,#,4.73246E+17,https://twitter.com/ShannonWestin/status/473246358342623232,,,,
jseguritan,6/1/2014 19:34,0,0,Re-thinking use of older drugs can trump new ones RT Early # Chemotherapy Extends Lives in Prostate # Cancer http://nyti.ms/1nT2cpn # ASCO2014,,,# # #,4.73246E+17,https://twitter.com/jseguritan/status/473246283243606016,,,,
AmbryGenetics,6/1/2014 19:34,6,5,Thank you @ mylifelineorg for your continued efforts in spreading # cancerawareness! # Ribboning at # ASCO14! # NCSD2014pic.twitter.com/1GMhQW6Bp7,,@,# # # #,4.73246E+17,https://twitter.com/AmbryGenetics/status/473246258518556672,,,,
galja02,6/1/2014 19:34,0,0,# ASCO14 http://tinyurl.com/n3ct8hm pic.twitter.com/KE9CigTQo8,,,#,4.73246E+17,https://twitter.com/galja02/status/473246202688188417,,,,
nycdoc29,6/1/2014 19:34,0,0,@ jodigralnick # ASCO14 coverage coming your way tomorrow @ CNBC! @ megtirrell @ SquawkCNBC” - Don't forget community Onc prespective,,@ @ @ @,#,4.73246E+17,https://twitter.com/nycdoc29/status/473246171155034112,,,,
Cortellis,6/1/2014 19:33,1,1,Combination of LEE011 and binimetinib shows promising preliminary antitumor activity in patients with advanced NRAS-mutant melanoma # ASCO14,,,#,4.73246E+17,https://twitter.com/Cortellis/status/473246038388916225,,,,
galja02,6/1/2014 19:33,0,0,# ASCO14 http://tinyurl.com/n3ct8hm pic.twitter.com/oo9gFaOWB9,,,#,4.73246E+17,https://twitter.com/galja02/status/473245958726119425,,,,
galja02,6/1/2014 19:32,1,0,# ASCO14 http://tinyurl.com/n3ct8hm pic.twitter.com/RcDvsQdUph,,,#,4.73246E+17,https://twitter.com/galja02/status/473245759622492160,,,,
backowen,6/1/2014 19:31,1,0,truly disappointed : Sledge at # ASCO14 on ALLTO trial: “this is a negative trial...a serious disappointment for the entire field.”,,,#,4.73245E+17,https://twitter.com/backowen/status/473245497348476929,,,,
CancerDotNet,6/1/2014 19:30,1,1,The # ASCO14 Onc Prof Hall is open from 9AM - 5PM local time tomorrow. Be sure to visit the http://Cancer.Net booth @ASCO Central!...,,@ASCO,#,4.73245E+17,https://twitter.com/CancerDotNet/status/473245247188004865,,,,
AneesChagpar,6/1/2014 19:30,1,1,Congrats Abu-Bakar on your @ ASCO IDEA Award! Looking forward to hosting you @ YaleCancer @ Yale # ASCO14 pic.twitter.com/HOC5ymCtFo,,@ @ @,#,4.73245E+17,https://twitter.com/AneesChagpar/status/473245149578153985,,,,
medpagetoday,6/1/2014 19:30,1,0,"Gabriel N. Hortobagyi, MD, on OPTIMIZE-2 Trial. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1u2PbLA",,@,#,4.73245E+17,https://twitter.com/medpagetoday/status/473245107102052352,,,,
urbano_anido,6/1/2014 19:29,3,4,BAC+docetaxel en cáncer de próstata sensible a castración enfermedad avanzada Aumento en supervivencia de 17 meses # ASCO14,,,#,4.73245E+17,https://twitter.com/urbano_anido/status/473244916609728512,,,,
subatomicdoc,6/1/2014 19:29,0,1,"@ Sermo Nice! # ASCO14 has been very active, great meeting",,@,#,4.73245E+17,https://twitter.com/subatomicdoc/status/473244909449654272,,,,
garyleethompson,6/1/2014 19:28,2,6,Just finished 100 miles at Lake Tahoe fundraising for @ LLSUSA so the folks at # ASCO14 have best possible to fight # cancer,,@,# #,4.73245E+17,https://twitter.com/garyleethompson/status/473244799844102144,,,,
subatomicdoc,6/1/2014 19:28,0,0,"@ DrMarkham my pleasure! Great session, couldn't keep up w/all the great ideas from @ mtmdphd @ fischmd @ scientre # ASCO14",,@ @ @ @,#,4.73245E+17,https://twitter.com/subatomicdoc/status/473244657338810368,,,,
soufyane85,6/1/2014 19:27,0,0,# ASCO14 http://tinyurl.com/pv4ectv,,,#,4.73244E+17,https://twitter.com/soufyane85/status/473244494713090048,,,,
soufyane85,6/1/2014 19:27,0,0,# ASCO14 http://tinyurl.com/l8d6elv,,,#,4.73244E+17,https://twitter.com/soufyane85/status/473244373665456128,,,,
urotoday,6/1/2014 19:26,1,1,"# ASCO14 SWOG S0925: ADT with Cixutumumab vs ADT Alone. Listen to interview w/ Evan Y. Yu, MD http://bit.ly/1m46INr",,,#,4.73244E+17,https://twitter.com/urotoday/status/473244229071011840,,,,
Sorena997,6/1/2014 19:25,1,1,"# ASCO14 # IOM Report on Delivering Quality Cancer Care and what needs to happen: CANCER INFORMATICS"" is key in the success of this roadmap""",,,# #,4.73244E+17,https://twitter.com/Sorena997/status/473243972291141632,,,,
harriseve,6/1/2014 19:25,1,1,RT @ Mills_I: @ drdonsdizon on value of social media in global patient advocacy. Need 2engage &build relationships. # ASCO14 @ CancerSupportCm,,@ @ @,#,4.73244E+17,https://twitter.com/harriseve/status/473243874761379840,,,,
urotoday,6/1/2014 19:24,1,0,"# ASCO14 Primary, Secondary, & Quality-of-life Results from PREVAIL. Listen to interview w/ Andrew J. Armstrong, MD http://bit.ly/1tA34yJ",,,#,4.73244E+17,https://twitter.com/urotoday/status/473243664802529280,,,,
megtirrell,6/1/2014 19:23,6,6,ASCOpalooza kicks off tomorrow at 6:50am ET on @ SquawkCNBC. We'll be bringing you live intvws with top newsmakers from # ASCO14 Tune in!,,@,#,4.73244E+17,https://twitter.com/megtirrell/status/473243558192087040,,,,
IBCResearch,6/1/2014 19:21,2,0,"Biology is Messy and Science is Hard"" George Sledge", MD," providing plenary discussion ALTTO results # ASCO14. # whatsnext? # BC""",,,# # #,4.73243E+17,https://twitter.com/IBCResearch/status/473243047698776066,,
OncLive,6/1/2014 19:20,1,0,"Survival Comparable With Bevacizumab, Cetuximab in mCRC http://ow.ly/xv6qw # ASCO14",,,#,4.73243E+17,https://twitter.com/OncLive/status/473242750146871296,,,,
PDRennert,6/1/2014 19:20,0,0,Every onc-vax co wants to waltz with Nivo or Ipi. I ask: is the adjuvant setting the right one for a promiscuous T cell response? # ASCO14,,,#,4.73243E+17,https://twitter.com/PDRennert/status/473242694056423424,,,,
BrisaVegaa22,6/1/2014 19:20,1,2,# Fea # horrible # nodable # inviolable # ASCO14 pic.twitter.com/pPyYxPJoRe,,,# # # # #,4.73243E+17,https://twitter.com/BrisaVegaa22/status/473242623298523136,,,,
DrMisialek,6/1/2014 19:20,19,19,"MT @ subatomicdoc: Benefits of social media, let's get more pathologists Tweeting @ fischmd # ASCO14 pic.twitter.com/60xncB4vRF @ Pathologists",,@ @ @,#,4.73243E+17,https://twitter.com/DrMisialek/status/473242609553788929,,,,
CancerDotNet,6/1/2014 19:20,8,1,Patients/Caregivers: Want today's # cancer research headlines from # ASCO14? Find them here: http://bit.ly/1mRL4iv,,,# #,4.73243E+17,https://twitter.com/CancerDotNet/status/473242609197264896,,,,
kbnewport,6/1/2014 19:18,0,0,"# ASCO14 Dr. Ganz response to ? re: advocating for better patient information: Organizations can lobby for, create & validate decision aids",,,#,4.73242E+17,https://twitter.com/kbnewport/status/473242226253123584,,,,
jodigralnick,6/1/2014 19:18,1,2,Tons of EXCLUSIVE # ASCO14 coverage coming your way tomorrow on @ CNBC! First up: @ megtirrell intvws Roche Pharma COO @650amET on @ SquawkCNBC,,@ @ @650amET @,#,4.73242E+17,https://twitter.com/jodigralnick/status/473242177577836544,,,,
wpvinc,6/1/2014 19:16,0,0,“ @ ClevelandClinic: More than 1/3 of all US adults and 17% of US children and adolescents are obese. - Dr. Ligibel # ASCO14”,,@,#,4.73242E+17,https://twitter.com/wpvinc/status/473241729743585281,,,,
PaoloFoggi,6/1/2014 19:16,0,0,"Can we routinely use pCR as a reliable surrogate for DFS and OS? From ALTTO right now...maybe not""- Dr Hudis # ASCO14 http://am.asco.org/altto-reveals-lapatinib-fails-add-benefit-trastuzumab-adjuvant-setting …""",,,#,4.73242E+17,https://twitter.com/PaoloFoggi/status/473241627897909249,,,,
OncLive,6/1/2014 19:15,3,1,MPDL3280A reduced tumors in 43% of patients with previously treated PD-L1-positive metastatic bladder cancer http://ow.ly/xuMHy # ASCO14,,,#,4.73241E+17,https://twitter.com/OncLive/status/473241391397879808,,,,
DrFloresAyala,6/1/2014 19:13,0,0," @ subatomicdoc: ""Don't use Facebook for followup"" lol but true @ fischmd # ASCO14"" // :0""",,@ @,#,4.73241E+17,https://twitter.com/DrFloresAyala/status/473240917638676480,,,,
Ribbonfist,6/1/2014 19:11,0,3,"Come visit us at # ASCO14! Honored to have a small presence in the massive booth of our friends, Northwest Bio # NWBOpic.twitter.com/axkV63sZks",,,# #,4.73241E+17,https://twitter.com/Ribbonfist/status/473240504172560384,,,,
ipaulmampilly,6/1/2014 19:10,0,0,# ASCO14 odd sat through cns pres that did not mention biggest gbl trial ongoing 222 patient nci sponsor,,,#,4.7324E+17,https://twitter.com/ipaulmampilly/status/473240239474237440,,,,
RegardingCancer,6/1/2014 19:10,2,1,Chemotherapy induced nausea and vomiting might be improved by using ginger extract # asco2014 # chemotherapy... http://fb.me/3vfaLLqNa,,,# #,4.7324E+17,https://twitter.com/RegardingCancer/status/473240221510008833,,,,
Xcenda,6/1/2014 19:10,0,0,We’re honored to present 2 posters at # ASCO14 - Learn more: http://bit.ly/1jXRsje # xcenda # oncology # hematology,,,# # # #,4.7324E+17,https://twitter.com/Xcenda/status/473240096808771584,,,,
MRansomBooks,6/1/2014 19:09,0,1,Have a good talk Mario I'm sure you will.. keep up the great work at MSKCC my friend! @ leitaomd @ asco,,@ @,,4.7324E+17,https://twitter.com/MRansomBooks/status/473239965657477120,,,,
GustaveRoussy,6/1/2014 19:09,3,1,# ASCO14 # video Pr Ducreux @ GustaveRoussy présente l'étude Axus (anti-angiogénique sur # cancer colorectal métastasé) https://vimeo.com/97071826,,@,# # #,4.7324E+17,https://twitter.com/GustaveRoussy/status/473239856085479424,,,,
clarisssv,6/1/2014 19:05,0,1,Me lo he encontrado en Chicago...de paseo después de un día agotador en # ASCO14. Mañana más y mejor pic.twitter.com/chCrEWNuRF,,,#,4.73239E+17,https://twitter.com/clarisssv/status/473238952359780352,,,,
mmameg,6/1/2014 19:05,2,0,# ASCO14 a great success pic.twitter.com/fR6LPbMLuJ,,,#,4.73239E+17,https://twitter.com/mmameg/status/473238850614349824,,,,
ProjectInno,6/1/2014 19:05,1,0,Our blueprint to reduce barriers to cancer innovation: http://ow.ly/xtyVW # ASCO14 # innovatenow # NCSD14,,,# # #,4.73239E+17,https://twitter.com/ProjectInno/status/473238847351189504,,,,
mvillaseca,6/1/2014 19:04,1,0,RT @ ASCO: Dr. Jason A. Dubovsky: Exploring the B-cell receptor pathway http://flip.it/3b2Qs # ASCO14,,@,#,4.73239E+17,https://twitter.com/mvillaseca/status/473238746281050113,,,,
kellykcotton,6/1/2014 19:03,2,0,"For patients, reliable & curated sites like @ CancerDotNet are good for info; social media provides community & support # ASCO14 # hcsm",,@,# #,4.73238E+17,https://twitter.com/kellykcotton/status/473238386946617344,,,,
subatomicdoc,6/1/2014 19:03,1,1,@ fischmd directs patients to @ AmericanCancer @ theNCI @ CancerDotNet as reliable sources of information # ASCO14 not all over the internet,,@ @ @ @,#,4.73238E+17,https://twitter.com/subatomicdoc/status/473238379640139776,,,,
CI4CC,6/1/2014 19:02,1,2,# ASCO14 ALL @ ci4cc'ers attending ASCO JOIN us at the TAVERN ON RUSH tonight at 9 PM!!! Mixing it up with social media,,@,#,4.73238E+17,https://twitter.com/CI4CC/status/473238209582096384,,,,
kellykcotton,6/1/2014 19:00,1,0,"Social data can be used to generate hypotheses, but aren't necessarily clinically actionable - @ scientre # ASCO14 # hcsm",,@,# #,4.73238E+17,https://twitter.com/kellykcotton/status/473237604306280448,,,,
subatomicdoc,6/1/2014 19:00,1,1,"@ scientre We should be able to count on measurements are accurate, secure, appropriate # ASCO14 Agree",,@,#,4.73238E+17,https://twitter.com/subatomicdoc/status/473237583074697216,,,,
myriadgenetics,6/1/2014 19:00,2,0,"Myriad's BRACAnalysis CDx showed ability to predict platinum response in metastatic # breastcancer patients: # ASCO14, 6/3/14 9:45am E Hall D1",,,# #,4.73238E+17,https://twitter.com/myriadgenetics/status/473237578137624576,,,,
CBPartners,6/1/2014 18:59,0,0,EGFRvIII," the first candidate for glioma vaccine"""," shows promising benefit in PFS and OS - now in phase III clinical trial # ASCO14""",,,#,4.73238E+17,https://twitter.com/CBPartners/status/473237512581038081,,
subatomicdoc,6/1/2014 18:59,0,0,@ rsm2800 Who do we trust about how well a health data tool works? # asco14,,@,#,4.73237E+17,https://twitter.com/subatomicdoc/status/473237303570481154,,,,
motorrecilla,6/1/2014 18:58,1,0,Impressive attendance in the plennary session at # ASCO14 and the lecture about animal-food and cancer. pic.twitter.com/JP6VOr3lrw,,,#,4.73237E+17,https://twitter.com/motorrecilla/status/473237226533310464,,,,
DrMarkham,6/1/2014 18:58,3,1,"Truth. RT @ kellykcotton: On social media, your network is as strong as you build it to be - @ mtmdphd # ASCO14 # hcsm",,@ @,# #,4.73237E+17,https://twitter.com/DrMarkham/status/473237225271209984,,,,
Sorena997,6/1/2014 18:58,1,1,# ASCO14 Thank you Dan and Sarah for all the @ CI4CC re-tweets! KEEP IT UP :),,@,#,4.73237E+17,https://twitter.com/Sorena997/status/473237170141278210,,,,
kellykcotton,6/1/2014 18:57,1,1,"On social media, your network is as strong as you build it to be - @ mtmdphd # ASCO14 # hcsm",,@,# #,4.73237E+17,https://twitter.com/kellykcotton/status/473236824341491712,,,,
kellykcotton,6/1/2014 18:55,6,3,Twitter searches can provide more recent & relevant conversations than Google searches might - @ fischmd on social media # ASCO14,,@,#,4.73237E+17,https://twitter.com/kellykcotton/status/473236547005722624,,,,
kbnewport,6/1/2014 18:55,2,4,# ASCO14 # hpm Dr. Neuss: Illustration of personalized care:pic.twitter.com/yGSPQxiJUv,,,# #,4.73237E+17,https://twitter.com/kbnewport/status/473236537576943616,,,,
Sorena997,6/1/2014 18:55,1,1,Positive data today for JAK2 inhibition in metastatic # pancreatic # ASCO14 Neil Love symposium,,,# #,4.73236E+17,https://twitter.com/Sorena997/status/473236351887101952,,,,
DrMarkham,6/1/2014 18:54,1,0,@ subatomicdoc thanks for tweeting the session by @ mtmdphd @ fischmd & @ scientre - felt like I was there! # asco14,,@ @ @ @,#,4.73236E+17,https://twitter.com/DrMarkham/status/473236289467482112,,,,
ElizBlanchardMD,6/1/2014 18:54,1,0,Great session on social media applications in clinical practice and research by @ mtmdphd @ fischmd @ scientre # ASCO14,,@ @ @,#,4.73236E+17,https://twitter.com/ElizBlanchardMD/status/473236238577577985,,,,
scientre,6/1/2014 18:54,4,2,. @ mtmdphd finishes with a great roundup of hashtags!! # asco14 pic.twitter.com/5FsWDwJtfF,,@,#,4.73236E+17,https://twitter.com/scientre/status/473236125658914816,,,,
DrAttai,6/1/2014 18:54,0,1,Ok - sessions over for me for the day - back tomorrow morning! # ASCO14,,,#,4.73236E+17,https://twitter.com/DrAttai/status/473236049179594752,,,,
subhamadhavan,6/1/2014 18:53,2,2,# ASCO14 DrNeuss: 21% of oncologists' revenue is from chemotherapy and 19% is from chemo administration.,,,#,4.73236E+17,https://twitter.com/subhamadhavan/status/473236029416030208,,,,
DrAttai,6/1/2014 18:53,1,0,"Very clear and pertinent session by Drs. Morrow, Lee and Hassett # ASCO14",,,#,4.73236E+17,https://twitter.com/DrAttai/status/473235916862263296,,,,
DrAttai,6/1/2014 18:53,1,0,"Hassett when clinical benefits are similar, it's very appropriate to consider costs # ASCO14 # bcsm",,,# #,4.73236E+17,https://twitter.com/DrAttai/status/473235812914847745,,,,
kellykcotton,6/1/2014 18:53,1,0,"Social media can extend conversations, but IRL meetings will remain core to oncology field - @ mtmdphd # ASCO14 # hcsm",,@,# #,4.73236E+17,https://twitter.com/kellykcotton/status/473235809743962113,,,,
urotoday,6/1/2014 18:52,1,0,"# ASCO14 - Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and ... http://dlvr.it/5rcNYV",,,#,4.73236E+17,https://twitter.com/urotoday/status/473235688427499520,,,,
urotoday,6/1/2014 18:52,0,0,# ASCO14 - Poster: Galeterone in men with CRPC: Results in four distinct patient populations ... http://dlvr.it/5rcNTl,,,#,4.73236E+17,https://twitter.com/urotoday/status/473235685139546112,,,,
subatomicdoc,6/1/2014 18:52,3,2,@ mtmdphd Expect more from # pharma contributing to cancer conversations # ASCO14 # hcsm,,@,# # #,4.73236E+17,https://twitter.com/subatomicdoc/status/473235647486894080,,,,
kbnewport,6/1/2014 18:52,2,0,"# ASCO14 Dr. Neuss: The term palliative"" remains controversial and it shouldn't. Palliative does not equal hospice. # hpm""",,,# #,4.73236E+17,https://twitter.com/kbnewport/status/473235554667356160,,,,
subatomicdoc,6/1/2014 18:51,0,0,@ mtmdphd IRL will remain a core component of @ ASCO and other oncology org success. Social media may complement # ASCO14,,@ @,#,4.73236E+17,https://twitter.com/subatomicdoc/status/473235528720973824,,,,
mvillaseca,6/1/2014 18:51,1,0,RT @ ASCO: Reduced risk of progression with cediranib/olaparib in patients w/recurrent ovarian CA http://flip.it/h8p2V # ASCO14,,@,#,4.73235E+17,https://twitter.com/mvillaseca/status/473235472756776960,,,,
scientre,6/1/2014 18:51,1,1,. @ mtmdphd asks if this is a new way for docs to collaborate # asco14 pic.twitter.com/uSmPfDk3lz,,@,#,4.73235E+17,https://twitter.com/scientre/status/473235430683729921,,,,
mvillaseca,6/1/2014 18:51,1,0,Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer http://flip.it/tMiIp # ASCO14,,,#,4.73235E+17,https://twitter.com/mvillaseca/status/473235361238646784,,,,
carobianchiM,6/1/2014 18:51,1,0,Hace el favorcito y deja de pasar q me haces mal al estomago # ASCO14,,,#,4.73235E+17,https://twitter.com/carobianchiM/status/473235351675609088,,,,
OncologyTimes,6/1/2014 18:51,1,0,"Dilemma for post-plenaries if attending all: nice that rms next to each other, but no time in b/w so have to miss 1st 5 min or so # ASCO14",,,#,4.73235E+17,https://twitter.com/OncologyTimes/status/473235294792056832,,,,
subatomicdoc,6/1/2014 18:50,2,0,Are there ways to do meetings and collaborate online? @ mtmdphd # ASCO14 Where should @ ASCO go int the NEXT 50 years?,,@ @,#,4.73235E+17,https://twitter.com/subatomicdoc/status/473235246314295297,,,,
yzafar,6/1/2014 18:50,3,2,Sledge: Can we still keep politics out of the clinic? Patients believe what their MDs say about the # ACA # ASCO14 pic.twitter.com/UioKPlIW9r,,,# #,4.73235E+17,https://twitter.com/yzafar/status/473235228186918912,,,,
mattshomepage,6/1/2014 18:50,0,0,FYI for those interested in twitter mining - http://www.ark.cs.cmu.edu/TweetNLP/ is a great tool to use for parts-of-speech tagging in Twitter. # ASCO14,,,#,4.73235E+17,https://twitter.com/mattshomepage/status/473235151527223296,,,,
Sermo,6/1/2014 18:50,1,0,@ subatomicdoc We have four MDs covering # ASCO14 they're giving great updates to the community.,,@,#,4.73235E+17,https://twitter.com/Sermo/status/473235139112493056,,,,
ProjectInno,6/1/2014 18:50,2,2,Without innovation, we don't find cancer cures, says cancer survivor Nancy Davenport-Ennis http://ow.ly/xuVXH # ASCO14 # NCSD14,,,# #,4.73235E+17,https://twitter.com/ProjectInno/status/473235071559020544,,
Gene_Antibody,6/1/2014 18:50,1,1,"N. Valente, VP - Hem Dev: taught me so much abt progress in # bloodcancer tx. # ASCO14 http://ow.ly/xv0zG pic.twitter.com/PL5Ar0ltc5",,,# #,4.73235E+17,https://twitter.com/Gene_Antibody/status/473235055033479168,,,,
scientre,6/1/2014 18:49,2,1,. @ mtmdphd sharing recent Analytics around # asco14 hashtag http://www.environics.ca/environics-health--pharma-blog …,,@,#,4.73235E+17,https://twitter.com/scientre/status/473234987811344384,,,,
DrAttai,6/1/2014 18:49,1,5,I think I'm about to get into twitter jail... # ASCO14,,,#,4.73235E+17,https://twitter.com/DrAttai/status/473234871897575424,,,,
subatomicdoc,6/1/2014 18:49,0,1,@ doximity @ QuantiaMD @ sermo @ healthtap mentioned by @ mtmdphd - many others # ASCO14,,@ @ @ @ @,#,4.73235E+17,https://twitter.com/subatomicdoc/status/473234848283250688,,,,
CI4CC,6/1/2014 18:49,0,0,# ASCO14 Prostate Cancer Headlines: http://www.medscape.com/viewarticle/826018?src=wnl_edit_cfna&uac=151913BT?src=sttwit …,,,#,4.73235E+17,https://twitter.com/CI4CC/status/473234803941466112,,,,
mattshomepage,6/1/2014 18:48,1,0,"Examples of online MD Communities: ASCO, Doximity, HealthTap, QuantiaMD, Sermo, ... # ASCO14",,,#,4.73235E+17,https://twitter.com/mattshomepage/status/473234761972871168,,,,
m0370,6/1/2014 18:48,0,0,# ASCO14 見てると、字数が限られるツイートでもセツキシマブはcetuxと略すらしい。,,,#,4.73235E+17,https://twitter.com/m0370/status/473234732696616960,,,,
DrAttai,6/1/2014 18:48,3,0,"Hassett - costs of chemo also include unexpected hospitalization,etc , not just the cost of the drugs # ASCO14 # bcsm",,,# #,4.73235E+17,https://twitter.com/DrAttai/status/473234663000244224,,,,
subatomicdoc,6/1/2014 18:48,0,1,@ mtmdphd Lots of online MD communities - not open like Twitter # ASCO14,,@,#,4.73235E+17,https://twitter.com/subatomicdoc/status/473234631819403264,,,,
learnhospice,6/1/2014 18:48,0,0,@ rsm2800 @ mtmdphd # ASCO14 what a fab initiative wld love 2 know more,,@ @,#,4.73235E+17,https://twitter.com/learnhospice/status/473234630477619201,,,,
kellykcotton,6/1/2014 18:47,3,4,Google may not be best for reliable health info; @ subatomicdoc's cancer hashtags make Twitter a great source - @ mtmdphd # ASCO14,,@ @,#,4.73235E+17,https://twitter.com/kellykcotton/status/473234528597966848,,,,
subatomicdoc,6/1/2014 18:47,0,0,"@ mtmphd mentions company Environics and changes in tweet volume are # ASCO14 meeting, how it affects industry etc",,@,#,4.73235E+17,https://twitter.com/subatomicdoc/status/473234512206254080,,,,
scientre,6/1/2014 18:47,0,1,. @ mtmdphd shares recent update from W2O on social media engagement on cancer community # asco14 http://www.businesswire.com/news/home/20140514006754/en/MDigitalLife-Analysis-Shows-Breast-Cancer-Dominates-Physician#.U4utNIm9LCQ …,,@,# #,4.73234E+17,https://twitter.com/scientre/status/473234439926190081,,,,
LanghamChicago,6/1/2014 18:47,0,3,@ aphsstuart @ ASCO @ cathiereid Thank you both very much—we're delighted to have you in residence and hope to welcome you back for # ASCO15.,,@ @ @,#,4.73234E+17,https://twitter.com/LanghamChicago/status/473234430593482754,,,,
MKnoll_MD,6/1/2014 18:47,2,1,@ drattai could this be because many women > 70 have a long life expectancy? So they choose therapy despite low LRR risk? # ASCO14 # bcsm,,@,# #,4.73234E+17,https://twitter.com/MKnoll_MD/status/473234359416139776,,,,
mattshomepage,6/1/2014 18:47,2,2,Might be able to use this when text mining... # ASCO14 pic.twitter.com/MEUvIC02ZA,,,#,4.73234E+17,https://twitter.com/mattshomepage/status/473234357399064576,,,,
DrAttai,6/1/2014 18:47,2,1,Hassett - benefit of treatment depends on the setting - curative vs palliative intent # ASCO14 # bcsm,,,# #,4.73234E+17,https://twitter.com/DrAttai/status/473234329142050818,,,,
subhamadhavan,6/1/2014 18:46,4,1,# ASCO14 Dr. Neuss: Top 1% of patients responsible for 1/5th of healthcare costs - these are mostly cancer patients.,,,#,4.73234E+17,https://twitter.com/subhamadhavan/status/473234274657652736,,,,
kbnewport,6/1/2014 18:46,1,1,# ASCO14 Lost of references to Choosing Wisely | American Society of Clinical Oncology http://www.choosingwisely.org/doctor-patient-lists/american-society-of-clinical-oncology/#.U4utMP9XabU.twitter …,,,# #,4.73234E+17,https://twitter.com/kbnewport/status/473234247646314496,,,,
CBPartners,6/1/2014 18:46,0,0,Comment from podium too early to tell the difference in safety [for NSCLC immunotherapy]," but pneumonitis appears higher for PD1"" # ASCO14""",,,#,4.73234E+17,https://twitter.com/CBPartners/status/473234241397207040,,,
subatomicdoc,6/1/2014 18:46,0,0,@ mtmphd You are too kind! # ASCO14 # HLTHTOP,,@,# #,4.73234E+17,https://twitter.com/subatomicdoc/status/473234236598521857,,,,
learnhospice,6/1/2014 18:46,0,0,# ASCO14 what fab tweets are coming - learning & enjoying lots here in the UK,,,#,4.73234E+17,https://twitter.com/learnhospice/status/473234203807850499,,,,
Sorena997,6/1/2014 18:46,1,1,# ASCO14 BIG Data is everywhere ! Especially at ASCO pic.twitter.com/ElkT3iRtY8,,,#,4.73234E+17,https://twitter.com/Sorena997/status/473234190780350464,,,,
arifkamalmd,6/1/2014 18:46,1,2,"High quality # cancer care requires focus on spiritual and caregiver needs. 2 impt conclusions, 1 abstract # asco2014 pic.twitter.com/72RvHoET0v",,,# #,4.73234E+17,https://twitter.com/arifkamalmd/status/473234189127405568,,,,
rsm2800,6/1/2014 18:46,6,3,". @ mtmdphd set up tweetchat for myeloma patients & online conversation quadrupled. Great engagement, and helps patients! # hcsm # asco14",,@,# #,4.73234E+17,https://twitter.com/rsm2800/status/473234104738013184,,,,
subatomicdoc,6/1/2014 18:46,1,0,@ mtmdphd Commenting on hashtag folksonomy post for @ ASCO - evolved into Cancer Tag Ontology on @ symplur http://www.symplur.com/healthcare-hashtags/ontology/cancer/ … # ASCO14,,@ @ @,#,4.73234E+17,https://twitter.com/subatomicdoc/status/473234080507502592,,,,
MLGoodacre,6/1/2014 18:45,1,0,“ @ subhamadhavan: # ASCO14 Dr Ganz:cancer patients at highr risk 4 bankruptcy v ppl w/o cancer diagnosis. As if we don't have enough concerns!,,@,#,4.73234E+17,https://twitter.com/MLGoodacre/status/473233996919623680,,,,
FightCRC,6/1/2014 18:45,1,1,Standing room only on new data at # ASCO14! # crcadvocacy # crcawareness # coloncancer # colorectalcancer… http://instagram.com/p/ot_u5sFrDQ/,,,# # # # #,4.73234E+17,https://twitter.com/FightCRC/status/473233915998515200,,,,
SamuelLz,6/1/2014 18:45,0,0,"Intervjuade just onkologi-gurun Håkan Mellstedt. Artikel på sajten imorgon, men här ett foto redan nu # dmasco # asco14 pic.twitter.com/iheM7RifYD",,,# #,4.73234E+17,https://twitter.com/SamuelLz/status/473233891047006208,,,,
ElizBlanchardMD,6/1/2014 18:45,0,1,Fascinating slide by @ mtmdphd re: tweets on a cancer type vs deaths from that cancer. Lung cancer loses again. :( # ASCO14 # lcsm,,@,# #,4.73234E+17,https://twitter.com/ElizBlanchardMD/status/473233855755714560,,,,
DrAttai,6/1/2014 18:45,5,2,Hassett - cost effective does not necessarily mean cost savings # ASCO14 # bcsm,,,# #,4.73234E+17,https://twitter.com/DrAttai/status/473233836877574144,,,,
theNCI,6/1/2014 18:45,31,16,Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer http://1.usa.gov/1nV2V9m # ASCO14,,,#,4.73234E+17,https://twitter.com/theNCI/status/473233828589600768,,,,
CancerMedMDA,6/1/2014 18:45,1,0,Dr. William William presents results of randomized placebo-controlled trial of erlotinib for prevention of oral cancer. Mon. 10 AM. # ASCO14,,,#,4.73234E+17,https://twitter.com/CancerMedMDA/status/473233825825558530,,,,
scientre,6/1/2014 18:45,3,1,Great data from @ mtmdphd on impact of # mmsm hashtag # asco14 pic.twitter.com/8OY7UUh5Q8,,@,# #,4.73234E+17,https://twitter.com/scientre/status/473233825104158720,,,,
ASCO,6/1/2014 18:45,19,12,Reduced risk of progression with cediranib/olaparib in patients w/recurrent ovarian CA http://bit.ly/1kxhL0f # ASCO14,,,#,4.73234E+17,https://twitter.com/ASCO/status/473233819320193024,,,,
Gene_Antibody,6/1/2014 18:45,4,4,The # blisterwalk can be fun when you run into your buddy @ MaverickNY # ASCO14 pic.twitter.com/dq0mx3PF5t,,@,# #,4.73234E+17,https://twitter.com/Gene_Antibody/status/473233800882040833,,,,
subatomicdoc,6/1/2014 18:44,0,0,@ mtmdphd Discussed how # mmsm has evolved with quadrupling of MD conversations about myeloma # ASCO14 # hcsm,,@,# # #,4.73234E+17,https://twitter.com/subatomicdoc/status/473233752789749760,,,,
Rubagumyaf,6/1/2014 18:44,0,0,Following # ASCO14 online....great topics being tackled..,,,#,4.73234E+17,https://twitter.com/Rubagumyaf/status/473233738663346178,,,,
DrAttai,6/1/2014 18:44,1,0,Hassettt some drugs with similar actions have very different costs / prices # ASCO14 # bcsm,,,# #,4.73234E+17,https://twitter.com/DrAttai/status/473233612662661120,,,,
mattshomepage,6/1/2014 18:44,0,0,20% increase conversations about cancer from physicians 2012-2013 # ASCO14,,,#,4.73234E+17,https://twitter.com/mattshomepage/status/473233593636904962,,,,
subatomicdoc,6/1/2014 18:44,7,1,Patient online communities - @ theNCI has working group looking to education patients and providers # hcsm # ASCO14 # mmsm,,@,# # #,4.73234E+17,https://twitter.com/subatomicdoc/status/473233544500621312,,,,
scientre,6/1/2014 18:43,2,3,. @ mtmdphd sharing @ subatomicdoc top twitter resources # asco14 pic.twitter.com/UvWuKRY8MV,,@ @,#,4.73234E+17,https://twitter.com/scientre/status/473233511986765824,,,,
RareAdvocate,6/1/2014 18:43,0,0,"@ DrLen Nice news for the worldwide pop, less so for U.S. Men. We need to look at novels +/- ADT but need better predictive markers. # ASCO14",,@,#,4.73234E+17,https://twitter.com/RareAdvocate/status/473233503841443841,,,,
DrAttai,6/1/2014 18:43,1,0,Hassett costs of common breast cancer treatments (chemo) - all I can say is wow... range $31 - $7200 per dose # ASCO14 # bcsm,,,# #,4.73234E+17,https://twitter.com/DrAttai/status/473233502079811584,,,,
MKnoll_MD,6/1/2014 18:43,2,1,And for all pts! MT: @ fischmd value of physical exam in advanced # cancer pts?Pts perceive it positively! http://ow.ly/xuJzh # hpm # ASCO14,,@,# # #,4.73234E+17,https://twitter.com/MKnoll_MD/status/473233500582072321,,,,
kellykcotton,6/1/2014 18:43,2,2,"Go where the people are"" - if the people you want to reach are on Twitter"," start Tweeting! - @ mtmdphd on social media # ASCO14 # hcsm""",,@,# #,4.73233E+17,https://twitter.com/kellykcotton/status/473233425906675712,,,
OncologyTimes,6/1/2014 18:43,2,0,"In post-plenary for the breast cancer studies, w Eric Winer, Chair; & Lowell Schnipper, M Piccart-Gebhart, O Pagani, & N Davidson # ASCO14",,,#,4.73233E+17,https://twitter.com/OncologyTimes/status/473233334546341888,,,,
subatomicdoc,6/1/2014 18:43,1,1,@ brianreid research w/ @ mtmdphd cited 20% increase in cancer related tweets from 2012 to 2013. # ASCO14 # hcsm,,@ @,# #,4.73233E+17,https://twitter.com/subatomicdoc/status/473233331199287296,,,,
davidbeme,6/1/2014 18:42,2,0,Cancer du sein: la goséréline permet de mieux préserver la fertilité des femmes sous chimio # ASCO2014 @ doctissimo http://ow.ly/xv42Z,,@,#,4.73233E+17,https://twitter.com/davidbeme/status/473233206259752960,,,,
MaceyLHenderson,6/1/2014 18:42,3,3,@ EndoGoddess: RT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 pic.twitter.com/JtVMR8E416 @ jchevinsky @mkuczew @ patrickdherron,,@ @ @ @ @mkuczew @,#,4.73233E+17,https://twitter.com/MaceyLHenderson/status/473233152308023296,,,,
subatomicdoc,6/1/2014 18:42,0,0,"@ Doctor_V discussed 4 types of doctors on social media. @ mtmphd # ASCO14 - link, Bryan?",,@ @,#,4.73233E+17,https://twitter.com/subatomicdoc/status/473233087879327744,,,,
subhamadhavan,6/1/2014 18:42,2,0,# ASCO14 Dr Neuss: age adjusted death rates in African American women with breast cancer higher in comparison to white women.,,,#,4.73233E+17,https://twitter.com/subhamadhavan/status/473233081906647040,,,,
DrAttai,6/1/2014 18:41,3,2,"Hassett in looking at value, need to assess survival, recurrence benefits but also toxicity / QOL factors # ASCO14 # bcsm",,,# #,4.73233E+17,https://twitter.com/DrAttai/status/473232849190260743,,,,
subatomicdoc,6/1/2014 18:41,0,0,"Go where the people are"" > @ mtmdphd - The Jesse James principle! # ASCO14""",,@,#,4.73233E+17,https://twitter.com/subatomicdoc/status/473232776951369728,,,,
rsm2800,6/1/2014 18:40,2,2,". @ mtmdphd How is # hcsm diff from reg media? It’s faster, archivable, can be amplified, anyone can do it # hcsm # asco14",,@,# # #,4.73233E+17,https://twitter.com/rsm2800/status/473232719367770113,,,,
RareAdvocate,6/1/2014 18:40,0,0,"@ DrLen Data presented show 70% percent with no prior therapy and only 20% having had an RP. That sounds more like Europe, not U.S. # ASCO14",,@,#,4.73233E+17,https://twitter.com/RareAdvocate/status/473232684983263236,,,,
DrWinkfield,6/1/2014 18:40,0,0,"Mentee, Taaj Shelton, receiving her award @ iConquerCancer Foundation Awards # ASCO14 # ProudMentor http://fb.me/33VPYF5T0",,@,# #,4.73233E+17,https://twitter.com/DrWinkfield/status/473232611469692932,,,,
dhjutsw1,6/1/2014 18:40,1,0,@ ASCO # asco14 Amy Abernathy from Duke speaking oncologist burnout & tools to cope. See Ed Book. pic.twitter.com/V7E1bAksWV,,@,#,4.73233E+17,https://twitter.com/dhjutsw1/status/473232608978272257,,,,
CancerMedMDA,6/1/2014 18:40,3,3,Dr. Vali Papadimitrakopoulou presents predictive & prognostic markers to therapy in head and neck cancer. Mon. 8 AM. # ASCO14 # endcancer,,,# #,4.73233E+17,https://twitter.com/CancerMedMDA/status/473232568725561347,,,,
subatomicdoc,6/1/2014 18:40,2,1,"Social media: faster, permanent, interactive, amplification # ASCO14 > @ mtmdphd",,@,#,4.73233E+17,https://twitter.com/subatomicdoc/status/473232550433804288,,,,
DrAttai,6/1/2014 18:39,3,0,"Hassett - tamox for DCIS - many using for selected, not all cases # ASCO14 # bcsm (2/2)",,,# #,4.73233E+17,https://twitter.com/DrAttai/status/473232503290216448,,,,
DrAttai,6/1/2014 18:39,3,1,"Hassettt - should we use tamox for DCIS? Reduces recurrence, invasive cancer, but no improved survival (1/2) # ASCO14 # bcsm",,,# #,4.73232E+17,https://twitter.com/DrAttai/status/473232397933506562,,,,
rsm2800,6/1/2014 18:39,3,0,. @ mtmdphd Context intelligence - what channel to use (social media vs journal vs other) # asco14 # hcsm,,@,# #,4.73232E+17,https://twitter.com/rsm2800/status/473232349237231616,,,,
dramarivirg,6/1/2014 18:37,0,0,"Discusión post plenaria # CancerDeMama dra Pagani, dra Piccart # ASCO14 pic.twitter.com/ufQNIgM2rl",,,# #,4.73232E+17,https://twitter.com/dramarivirg/status/473231926724009984,,,,
subatomicdoc,6/1/2014 18:37,6,2,"Communicationg is at the core of interacting with patients"" @ mtmdphd # ASCO14""",,@,#,4.73232E+17,https://twitter.com/subatomicdoc/status/473231897946898432,,,,
AAmberjay,6/1/2014 18:37,0,0,"So many tweets on great talks, so little time to read them from # ASCO14. Keep them coming, Aus is a long way from the windy city..",,,#,4.73232E+17,https://twitter.com/AAmberjay/status/473231886483861505,,,,
subatomicdoc,6/1/2014 18:37,0,1,Next up: @ mtmdphd on modern communications methods # ASCO14,,@,#,4.73232E+17,https://twitter.com/subatomicdoc/status/473231783937310720,,,,
OncologyTimes,6/1/2014 18:36,0,0,"Post-plenaries def v interesting, lively, & spirited, but not very tweetable"" # ASCO14""",,,#,4.73232E+17,https://twitter.com/OncologyTimes/status/473231759547437056,,,,
HenryJOncology,6/1/2014 18:36,0,0,Lack of ASS1 expression in # sarcoma predict poor survival. By eliminating extracellular arginine may tx CA. Preclinical drug tested # ASCO14,,,# #,4.73232E+17,https://twitter.com/HenryJOncology/status/473231748281552896,,,,
MehrazinMD,6/1/2014 18:36,1,3,Neoadj dense-dose GC # bladdercancer: 32% pCR+13% to NMIBC. ~ T. to surg. 9.2 wks http://dlvr.it/5rbX1K @ ERPlimackMD @ FCUroOnc # ASCO14,,@ @,# #,4.73232E+17,https://twitter.com/MehrazinMD/status/473231741441019907,,,,
WilliamDale_MD,6/1/2014 18:35,0,1,"We go on tour in the fall.  @ mtmdphd: @ chimoose Are these the David Hasselhoffs of # ASCO14? @ WilliamDale_MD @ ASCO @ drdonsdizon @ JNCI_Now""""",,@ @ @ @ @ @,#,4.73232E+17,https://twitter.com/WilliamDale_MD/status/473231502126628864,,,,
michelerhee,6/1/2014 18:35,6,12,I love that National Cancer Survivors Day falls during # ASCO14. Perfectly appropriate. # cancerpatients,,,# #,4.73231E+17,https://twitter.com/michelerhee/status/473231451278684160,,,,
subatomicdoc,6/1/2014 18:35,0,0,@ scientre Can we use smartphones for 'passive tracking' with sensors? # ASCO14,,@,#,4.73231E+17,https://twitter.com/subatomicdoc/status/473231325483122688,,,,
TargetedOnc,6/1/2014 18:35,3,2,"William D. Tap, MD, from @ sloan_kettering, discusses a phase I study of PLX3397 for the treatment of PVNS http://www.targetedonc.com/conference/asco-2014/A-Phase-I-Study-of-the-CSF1R-Kinase-Inhibitor-PLX3397-for-PVNS … # ASCO14",,@,#,4.73231E+17,https://twitter.com/TargetedOnc/status/473231296584773637,,,,
CancerMedMDA,6/1/2014 18:35,1,1,Dr. Jianjun Zhang poster highlights on multiregion whole exome sequencing & lung cancer intratumor heterogeneity. # ASCO14 Mon. 8 AM.,,,#,4.73231E+17,https://twitter.com/CancerMedMDA/status/473231290180067328,,,,
subatomicdoc,6/1/2014 18:34,0,0,@ scientre Wearable tech currently a very small minority of devices. New apps coming out # ASCO14,,@,#,4.73231E+17,https://twitter.com/subatomicdoc/status/473231121899978752,,,,
subatomicdoc,6/1/2014 18:33,1,1,Privacy mentioned only briefly. IMHO it's a fundamental ethical issue making # dataming a potential disaster http://network.socialmedia.mayoclinic.org/discussion/are-some-patients-joining-tuskegee-2-0 … # ASCO14,,,# #,4.73231E+17,https://twitter.com/subatomicdoc/status/473230900713385984,,,,
rsm2800,6/1/2014 18:32,1,0,. @ scientre Online pt communities have a business model where they sell patient data. The good companies are transparent about this # asco14,,@,#,4.73231E+17,https://twitter.com/rsm2800/status/473230726754619392,,,,
pharmagossip,6/1/2014 18:32,0,1,"# asco14 please sign up to http://alltrials.net - all trials registered, all reported. Thanks",,,#,4.73231E+17,https://twitter.com/pharmagossip/status/473230697210314752,,,,
davidgrahammd,6/1/2014 18:32,0,1,Great discussion on ASCO serving the community oncologist better at ClinPrac Cmte. They are very open to discussion. Contact them! # ASCO14,,,#,4.73231E+17,https://twitter.com/davidgrahammd/status/473230568264835078,,,,
subatomicdoc,6/1/2014 18:31,0,0,"Patient privacy - social media companies make money by selling people's data"" @ scientre # ASCO14""",,@,#,4.7323E+17,https://twitter.com/subatomicdoc/status/473230496550248448,,,,
subhamadhavan,6/1/2014 18:31,1,0,# ASCO14 Dr Sledge: CMS shd incentivize oncologists to use the digital infrastructure being created to report cancer data.,,,#,4.7323E+17,https://twitter.com/subhamadhavan/status/473230437376991232,,,,
DrAttai,6/1/2014 18:31,4,2,Hassett no significantly better breast cancer outcomes in US considering $$ spent # ASCO14 # bcsm,,,# #,4.7323E+17,https://twitter.com/DrAttai/status/473230421732626435,,,,
WilliamDale_MD,6/1/2014 18:31,0,1,"Cool! MT. @ chimoose: The accounts most RT by EX-US MDs # ASCO14 @ williamdale_md @ asco @ mtmdphd @ drdonsdizon @ JNCI_Now pic.twitter.com/G1yI04YMbV"",,@ @ @ @ @ @,#,473230406196924423""",https://twitter.com/WilliamDale_MD/status/473230406196924423,,,,,,,,
OncologyTimes,6/1/2014 18:31,1,1,"Alan Venook: LBA3 was real world study, all kinds of things happened in yrs of the study such as shortages of 5FU & folinic acid # ASCO14",,,#,4.7323E+17,https://twitter.com/OncologyTimes/status/473230359505534976,,,,
subhamadhavan,6/1/2014 18:31,1,0,"# ASCO14 Dr Sledge: QOPI certified by CMS as quality registry; this might result in funding to report to QOPI, currently a voluntary activity",,,#,4.7323E+17,https://twitter.com/subhamadhavan/status/473230269646790657,,,,
subatomicdoc,6/1/2014 18:30,0,0,"@ scientre Data from social media isn't verifiable, adequate for patient care, can't link to EHR # ASCO14 # hcsm # HITsm",,@,# # #,4.7323E+17,https://twitter.com/subatomicdoc/status/473230225552076800,,,,
DrAttai,6/1/2014 18:30,1,1,Hassett spending on chemo very much related to spending on surgery and radiation therapy # ASCO14 # bcsm,,,# #,4.7323E+17,https://twitter.com/DrAttai/status/473230169621426179,,,,
ASCO,6/1/2014 18:30,3,6,Read Educational Book articles on topics in Sarcoma from # ASCO14 Education Session Speakers: http://bit.ly/SLw0IW,,,#,4.7323E+17,https://twitter.com/ASCO/status/473230110049722371,,,,
CancerMedMDA,6/1/2014 18:30,0,0,Dr. Sausan Abouharb evaluates response of synovial sarcoma to Tx w/ gemcitabine & docetaxel. Poster Mon. 8 AM. # ASCO14,,,#,4.7323E+17,https://twitter.com/CancerMedMDA/status/473230102046994432,,,,
ASCO,6/1/2014 18:30,15,13,CNS metastases are common in patients with HER2-positive or triple negative breast cancer http://bit.ly/T49Ul3 # ASCO14 # bcsm,,,# #,4.7323E+17,https://twitter.com/ASCO/status/473230083281666049,,,,
subatomicdoc,6/1/2014 18:30,0,0,"@ scientre Social media provides community, can't get that with a provider. # ASCO14 # s4pm # hcsm",,@,# # #,4.7323E+17,https://twitter.com/subatomicdoc/status/473230044727230464,,,,
myriadgenetics,6/1/2014 18:30,3,0,Myriad will present data validating the # Prolaris test score in predicting # prostatecancer death TOMORROW at # ASCO14 1:15-5pm. Poster 5059,,,# # #,4.7323E+17,https://twitter.com/myriadgenetics/status/473230016730243072,,,,
HenryJOncology,6/1/2014 18:29,0,0,"SDH germline mutation ?vandetinib, braf tx, ?NF1 targets. @ sloan_kettering @ NCICancerCtrl what standards tx for WT gist? More Qs # ASCO14",,@ @,#,4.7323E+17,https://twitter.com/HenryJOncology/status/473229899847565312,,,,
montypal,6/1/2014 18:29,0,0,Amazing data for docetaxel in hormone sensitive MPC ... Will be changing my practice immediately # ASCO14,,,#,4.7323E+17,https://twitter.com/montypal/status/473229819116023811,,,,
Sorena997,6/1/2014 18:28,0,0,# ASCO14 Slowing down after long productive day pic.twitter.com/70OQk58afE,,,#,4.7323E+17,https://twitter.com/Sorena997/status/473229724224081922,,,,
subatomicdoc,6/1/2014 18:28,3,0,"My concern is that story is overly powerful, skews reality for readers. May be selection bias in experience vs nontweeters # ASCO14 @ scientre",,@,#,4.7323E+17,https://twitter.com/subatomicdoc/status/473229707257737216,,,,
subatomicdoc,6/1/2014 18:27,0,0,"@ scientre makes point that is important. Story - can be compelling, fascinating. # ASCO14 # whenpatientstweet",,@,# #,4.73229E+17,https://twitter.com/subatomicdoc/status/473229440730660864,,,,
DrAttai,6/1/2014 18:27,0,0,Hassett - value based approach to systemic therapy # ASCO14 # bcsm,,,# #,4.73229E+17,https://twitter.com/DrAttai/status/473229430685696000,,,,
drapaolaceledon,6/1/2014 18:27,1,1,Cubriendo las incidencias de # ASCO14 desde Venezuela! por Virtual Meeting!,,,#,4.73229E+17,https://twitter.com/drapaolaceledon/status/473229379229978624,,,,
nycdoc29,6/1/2014 18:27,0,1,@ cancerassassin1 - NP the exact # s vary widely due to quarterly volumes and use but erbitux is more $$$ than Avastin. # ASCO14,,@,# #,4.73229E+17,https://twitter.com/nycdoc29/status/473229311110299649,,,,
subatomicdoc,6/1/2014 18:27,0,0,@ scientre fascinated by patient blog information related to clinical trial experience and side effects # ASCO14,,@,#,4.73229E+17,https://twitter.com/subatomicdoc/status/473229310535294976,,,,
joseluis_pa,6/1/2014 18:26,0,0,"RT “ @ genentech: Standardization, guidance & multiplex test may help solve the issue w/ tissue. More: http://ow.ly/xuDvi # ASCO14”",,@,#,4.73229E+17,https://twitter.com/joseluis_pa/status/473229205174747139,,,,
rsm2800,6/1/2014 18:26,0,1,". @ scientre Searching social media to find adverse event reports from pts-blogs, Twitter, FB, web-search histories “creepy” # asco14 # hcsm",,@,# #,4.73229E+17,https://twitter.com/rsm2800/status/473229145149698049,,,,
DrAttai,6/1/2014 18:25,1,0,"Lee - concerns of tomo - longer follow up needed, concerns about overdiagnosis / overtreatment # ASCO14 # bcsm",,,# #,4.73229E+17,https://twitter.com/DrAttai/status/473228980179714050,,,,
AdnanNagrial,6/1/2014 18:25,0,2,# ASCO14 Clapping from audience for criticism of conclusion that Cetux is = Bev in TRUE KRAS WT # CALGB80405,,,# #,4.73229E+17,https://twitter.com/AdnanNagrial/status/473228980049285121,,,,
drdonsdizon,6/1/2014 18:25,1,0,@ chimoose @ WilliamDale_MD @ ASCO @ mtmdphd @ JNCI_Now very nice,,@ @ @ @ @,,4.73229E+17,https://twitter.com/drdonsdizon/status/473228908897128448,,,,
DrAttai,6/1/2014 18:25,1,0,Lee - benefits of breast tomo - decreased recall rate and false positives; increased rate of cancer detection # ASCO14 # bcsm,,,# #,4.73229E+17,https://twitter.com/DrAttai/status/473228840857526276,,,,
RosettaGenomics,6/1/2014 18:25,2,1,# CancerOriginTest is helping to enable a personalized approach to cancer. Learn more at http://www.RosettaGenomics.com or visit # ASCO14 booth #12120,,,# # #12120,4.73229E+17,https://twitter.com/RosettaGenomics/status/473228813317705728,,,,
OphiraG,6/1/2014 18:25,0,0,@ PeterASinger # ASCO14 thx 4MT! And @ gchallenges 4 supporting our # mHealth # breastcancer project! @ uicc @ NCIGlobalHealth,,@ @ @ @,# # #,4.73229E+17,https://twitter.com/OphiraG/status/473228793092771840,,,,
subatomicdoc,6/1/2014 18:25,2,2,@ scientre mentions how health datamining can be done. @ Twitter is now opening database for health # ASCO14 # datagrants,,@ @,# #,4.73229E+17,https://twitter.com/subatomicdoc/status/473228786557669376,,,,
CancerMedMDA,6/1/2014 18:25,1,1,Dr. Robert Orlowski reviews decade of progress in multiple myeloma. Mon. 8 AM. # ASCO14 # endcancer,,,# #,4.73229E+17,https://twitter.com/CancerMedMDA/status/473228782179196931,,,,
CBankheadMPT,6/1/2014 18:25,1,0,Survival benefit in metastatic prostate cancer with two cheap drugs a home run. # ASCO14 http://www.medpagetoday.com/HematologyOncology/ProstateCancer/46090 …,,,#,4.73229E+17,https://twitter.com/CBankheadMPT/status/473228774763663368,,,,
mtmdphd,6/1/2014 18:25,1,2,@ chimoose Are these the David Hasselhoffs of ASCO? @ WilliamDale_MD @ ASCO @ drdonsdizon @ JNCI_Now,,@ @ @ @ @,,4.73229E+17,https://twitter.com/mtmdphd/status/473228769377804288,,,,
rsm2800,6/1/2014 18:25,2,0,. @ scientre Table on several ePROs in use today incl Patient Viewpoint from @ HopkinsMedicine & Patient Care Monitor from Duke # asco14 # hcsm,,@ @,# #,4.73229E+17,https://twitter.com/rsm2800/status/473228769352630272,,,,
scientre,6/1/2014 18:25,0,1,Passive tracking adds to convergence of patient reported outcomes # PRO and performance outcomes # PerfO # ASCO14,,,# # #,4.73229E+17,https://twitter.com/scientre/status/473228762155204609,,,,
mattshomepage,6/1/2014 18:24,0,0,# ASCO14 pic.twitter.com/TGWWUAqhWn,,,#,4.73229E+17,https://twitter.com/mattshomepage/status/473228738709053440,,,,
DrAttai,6/1/2014 18:24,6,2,Lee - many believe breast tomosynthesis will become standard for breast imaging # ASCO14 # bcsm,,,# #,4.73229E+17,https://twitter.com/DrAttai/status/473228613924716547,,,,
subatomicdoc,6/1/2014 18:24,3,1,"@ scientre Facebook has more users, but tends to be more private than Twitter # ASCO14 > @ scientre",,@ @,#,4.73229E+17,https://twitter.com/subatomicdoc/status/473228609474162688,,,,
AneesChagpar,6/1/2014 18:24,2,1,Particularly pleased that Simon King @ YaleCancer @ Yale won a career development award @ ASCO @ YaleCOPPER @ iConquerCancer @ cpgYALE # ASCO14,,@ @ @ @ @ @,#,4.73229E+17,https://twitter.com/AneesChagpar/status/473228594723188737,,,,
scientre,6/1/2014 18:24,2,0,Phones turning to wearables: iPhone5s(2013): 5sensors. GalaxyS5(2014) 10sensors http://ht.ly/xuBXX # ASCO14 @KPCB 2014InternetTrends,,@KPCB,#,4.73229E+17,https://twitter.com/scientre/status/473228515098099713,,,,
subatomicdoc,6/1/2014 18:23,6,3,@ sloan_kettering lets patients see how they compare to other patients (de-identified) to know what to expect for recovery # ASCO14 # hcsm,,@,# #,4.73228E+17,https://twitter.com/subatomicdoc/status/473228412698374144,,,,
cmartindedios,6/1/2014 18:23,1,1,@ ASCO # asco14 # patient centered Carepic.twitter.com/PW4mxgxiHh,,@,# #,4.73228E+17,https://twitter.com/cmartindedios/status/473228405043769344,,,,
CI4CC,6/1/2014 18:23,0,2,# ASCO14 Do not forget to Hold November 10-13 for NCI Cancer Genomics Workshop in San Francisco Bay Area. Go to http://ci4cc.org,,,#,4.73228E+17,https://twitter.com/CI4CC/status/473228379454709760,,,,
ElizBlanchardMD,6/1/2014 18:23,0,0,Dr Strong: electronic PRO systems available (JOP 2013). More tools in Ca J Clin 2012. Some with open patient access. # ASCO14 # supponc,,,# #,4.73228E+17,https://twitter.com/ElizBlanchardMD/status/473228343655944192,,,,
DrAttai,6/1/2014 18:23,0,1,Lee - unclear who will do well w/ mammographic surveillance alone; who will benefit from supplemental surveillance # ASCO14 # bcsm,,,# #,4.73228E+17,https://twitter.com/DrAttai/status/473228282708901891,,,,
scientre,6/1/2014 18:23,0,1,"Phones rule! App 4 that? FDA appr app 4 diabetes pts. Real-time coach, ed content & support + link 2 provider http://ht.ly/xuBtC # ASCO14",,,#,4.73228E+17,https://twitter.com/scientre/status/473228256292769792,,,,
_Phenomenome,6/1/2014 18:22,0,1,How can we increase the way we capture pre prostateCA patients B4 diagnosis @ YupOnc? # ASCO14 pic.twitter.com/PHvZFfqd0K # KnowYourRisk # ASCO14,,@,# # #,4.73228E+17,https://twitter.com/_Phenomenome/status/473228215633575939,,,,
RosettaGenomics,6/1/2014 18:22,0,0,Did you get a chance to stop by the @ RosettaGenomics booth #12120 at # ASCO14? Still one day left to come learn about our # CancerOriginTest,,@,#12120 # #,4.73228E+17,https://twitter.com/RosettaGenomics/status/473228207991574531,,,,
subatomicdoc,6/1/2014 18:22,0,1,ePRO Systems from @ HopkinsMedicine @ DukeCancer @ sloan_kettering given as examples # ASCO14 # hcsm,,@ @ @,# #,4.73228E+17,https://twitter.com/subatomicdoc/status/473228207106179072,,,,
joseluis_pa,6/1/2014 18:22,0,0,“RT @ PhRMA: Research and # innovation has led to increased survival rates for # cancer patients http://bit.ly/1nAxDqP # ASCO14”,,@,# # #,4.73228E+17,https://twitter.com/joseluis_pa/status/473228162315587586,,,,
mtmdphd,6/1/2014 18:22,0,0,". @ scientre # ASCO14 - gives examples of ePRO feeding into EMR - Johns Hopkins, Duke CCC, MSKCC",,@,#,4.73228E+17,https://twitter.com/mtmdphd/status/473228075027546112,,,,
mattshomepage,6/1/2014 18:22,0,0,# ASCO14 pic.twitter.com/EnOpvxXcBI,,,#,4.73228E+17,https://twitter.com/mattshomepage/status/473228053896642560,,,,
scientre,6/1/2014 18:22,0,0,"But phones dominate market, esp vs wearables # ASCO14 http://ht.ly/xuDVs @KPCB 2014InternetTrendsReport",,@KPCB,#,4.73228E+17,https://twitter.com/scientre/status/473228003984433152,,,,
DrAttai,6/1/2014 18:21,2,2,Lee - molecular subtypes predict local relapse and distant mets # # ASCO14 # bcsm,,,# # #,4.73228E+17,https://twitter.com/DrAttai/status/473227924519522309,,,,
PinkSheetMaryJo,6/1/2014 18:21,0,0,"Sledge: sponsors aim 4 best possible pop, but means trials less relevant. IoM proposes 6m patent ext for testing older pat/comorbid # ASCO14",,,#,4.73228E+17,https://twitter.com/PinkSheetMaryJo/status/473227863110742019,,,,
subatomicdoc,6/1/2014 18:21,1,0,Many systems have PRO systems for oncology - megalist. How do we use in mainstream? @ scientre # ASCO14,,@,#,4.73228E+17,https://twitter.com/subatomicdoc/status/473227834240937984,,,,
scientre,6/1/2014 18:21,1,1,Are wearables FDA approval? Could think of @PropellorHealth inhaler sensor as a wearable for the inhaler http://ht.ly/xuBJO # ASCO14,,@PropellorHealth,#,4.73228E+17,https://twitter.com/scientre/status/473227811419729921,,,,
PhRMA,6/1/2014 18:21,1,0,DYK? <5% of # cancer patients currently participate in # clinicaltrials. Learn more from @ thehill opinion: http://bit.ly/1tv1yxW # ASCO14,,@,# # #,4.73228E+17,https://twitter.com/PhRMA/status/473227752208748545,,,,
nycdoc29,6/1/2014 18:21,0,1,"“ @ cancerassassin1: is Avastin ($5000) really half the price of Cetuximab ($10,000)? # ASCO14”- though with rebates from GPO the $$$ is less",,@,#,4.73228E+17,https://twitter.com/nycdoc29/status/473227741635301379,,,,
twittmanda,6/1/2014 18:20,0,0,@ drattai @ ASCO Interesting!,,@ @,,4.73228E+17,https://twitter.com/twittmanda/status/473227727869583360,,,,
mattshomepage,6/1/2014 18:20,0,0,Example PRO Instruments: MD Anderson Symptom Inventory PROMIS PRO-CTCAE EuroQoL - EG-5D Products EORTC QLQ-C30 # ASCO14,,,#,4.73228E+17,https://twitter.com/mattshomepage/status/473227693954039809,,,,
subatomicdoc,6/1/2014 18:20,1,0,"PROMIS looks at physical, mental and social health # ASCO14 @ scientre",,@,#,4.73228E+17,https://twitter.com/subatomicdoc/status/473227669027303424,,,,
subhamadhavan,6/1/2014 18:20,3,0,# ASCO14 Dr Sledge: data collected from NCI on RCTs and observational studies shd be harmonized for data elements collected on CMS studies.,,,#,4.73228E+17,https://twitter.com/subhamadhavan/status/473227647984492548,,,,
DrAttai,6/1/2014 18:20,4,2,"Lee - surveillance mammography is less sensitive than screening mammography # ASCO14 # bcsm; more likely age <40, extremely dense are factors",,,# #,4.73228E+17,https://twitter.com/DrAttai/status/473227628443611139,,,,
kbnewport,6/1/2014 18:20,5,3,"# ASCO14 Dr. Sledge: It is a tragedy for cancer patients to spend their final days in an ICU"" http://www.dartmouthatlas.org/data/map.aspx?ind=173 … # hpm""",,,# #,4.73228E+17,https://twitter.com/kbnewport/status/473227605605625857,,,,
nycdoc29,6/1/2014 18:20,0,0,"“ @ cancerassassin1: is Avastin ($5000) really half the price of Cetuximab ($10,000)? # ASCO14” - as a private practice MD - YES though with",,@,#,4.73228E+17,https://twitter.com/nycdoc29/status/473227580498522113,,,,
subatomicdoc,6/1/2014 18:20,0,0,"@ scientre Gives a list of several PRO modules: MDASI, EQ-5D, @ EORTC C-30, PROMIS, PRO-CTCAE # ASCO14",,@ @,#,4.73228E+17,https://twitter.com/subatomicdoc/status/473227543089131520,,,,
chimoose,6/1/2014 18:20,2,3,And here are the accounts most RT by EX-US docs at # ASCO14 @ williamdale_md @ asco @ mtmdphd @ drdonsdizon @ JNCI_Nowpic.twitter.com/oMrPd950J0,,@ @ @ @ @,#,4.73228E+17,https://twitter.com/chimoose/status/473227515352207361,,,,
OncLive,6/1/2014 18:20,2,1,Nivolumab plus erlotinib demonstrated a response rate of 19% and was well-tolerated in EGFR-mutant NSCLC http://ow.ly/xuxbY # ASCO14,,,#,4.73228E+17,https://twitter.com/OncLive/status/473227513297371139,,,,
ElizBlanchardMD,6/1/2014 18:20,1,0,Dr Strong: of 70 FDA labels (in 2000's) 6 used PROs to help labeling. Important to develop PROs as tools. # ASCO14 # supponc,,,# #,4.73228E+17,https://twitter.com/ElizBlanchardMD/status/473227507940880384,,,,
scientre,6/1/2014 18:20,0,0,Where do/can we wear “wearables”? http://ht.ly/xuC3X # ASCO14 via @ venturebeat,,@,#,4.73227E+17,https://twitter.com/scientre/status/473227499392868352,,,,
scientre,6/1/2014 18:20,1,0,"Ex: Jawbone: 100MM nights sleep, 50B activity pts crunched/week, 1M personalized insights/week http://ht.ly/xuBMo # ASCO14 @KPCB",,@KPCB,#,4.73227E+17,https://twitter.com/scientre/status/473227499023769601,,,,
DrAttai,6/1/2014 18:18,0,3,"Lee - breast MRI for surveillance - evidence to support is sparse, but often there is a pro-intervention bias, so it gets done # ASCO14 # bcsm",,,# #,4.73227E+17,https://twitter.com/DrAttai/status/473227144232173571,,,,
rsm2800,6/1/2014 18:18,1,0,". @ scientre notes that 4 drugs approved on tumor sx alone from 1990-2002 eg, mitoxantrone/pdn in prostate ca # asco14 # hcsm",,@,# #,4.73227E+17,https://twitter.com/rsm2800/status/473227081778593792,,,,
subatomicdoc,6/1/2014 18:18,2,1,"PRO assessments for gemcitabine, imatinib, abarelix, and a few others @ scientre # ASCO14",,@,#,4.73227E+17,https://twitter.com/subatomicdoc/status/473227072744083456,,,,
scientre,6/1/2014 18:18,1,1,"SoMe & PROs: lit ex: What pts say about their adverse events on Twitter # ASCO14 http://ht.ly/xuCTK Drug Safety, 2014, 37, 343-350",,,#,4.73227E+17,https://twitter.com/scientre/status/473227055711014912,,,,
scientre,6/1/2014 18:18,0,2,Open Research Exchange advisors incl notable onc PRO: Basch @sloan_kettering & @ Gnanasakthy @ novartis http://ht.ly/xuC9l # ASCO14,,@sloan_kettering @ @,#,4.73227E+17,https://twitter.com/scientre/status/473227051952898048,,,,
scientre,6/1/2014 18:18,0,2,SoMe & PROs: Adverse event examples from literature: Facebookhttp://ht.ly/xuCLm Web search histories http://ht.ly/xuCM5 # ASCO14,,,#,4.73227E+17,https://twitter.com/scientre/status/473227051608993792,,,,
scientre,6/1/2014 18:18,0,2,Formal PRO instruments on web @ Bristol_Myers rheumatoid arthritis http://ht.ly/xuCEk & @ GSKUS asthma http://ht.ly/xuCC2 # ASCO14,,@ @,#,4.73227E+17,https://twitter.com/scientre/status/473227037344153600,,,,
scientre,6/1/2014 18:18,2,3,. @ PatientsLikeMe has Open Research Exchange: 1st open res platform 4 creating health outcome measurements # ASCO14 http://ht.ly/xuCqW,,@,#,4.73227E+17,https://twitter.com/scientre/status/473227037339959296,,,,
NickZdenkowski,6/1/2014 18:18,0,1,"@ theMJA not only palliation, but improving survival in high risk metastatic prostate cancer, # ASCO14 today",,@,#,4.73227E+17,https://twitter.com/NickZdenkowski/status/473227028489977856,,,,
caseofdees,6/1/2014 18:17,0,2,Morrow over verbeteren v behandeling van vroege stadiumborstkanker- waarom weglaten v behandeling moeilijk is # ASCO14 pic.twitter.com/G4kyIMEhdf,,,#,4.73227E+17,https://twitter.com/caseofdees/status/473226953672388612,,,,
Sorena997,6/1/2014 18:17,1,1,"Variety in Cancer data serves very specific purposes, yet much data not ready for clinical action! Let's not forget that. # ASCO14",,,#,4.73227E+17,https://twitter.com/Sorena997/status/473226904636751874,,,,
subatomicdoc,6/1/2014 18:17,2,1,"@ scientre When looking at oncology, PROs contributed to some drug approval by @ US_FDA # ASCO14",,@ @,#,4.73227E+17,https://twitter.com/subatomicdoc/status/473226897271181312,,,,
HuntRhona,6/1/2014 18:17,1,1,"Obesity is on its way to replacing tobacco as the number one preventable/modifiable cause of cancer.” - @ CliffordHudis # ASCO14”""""",,@,#,4.73227E+17,https://twitter.com/HuntRhona/status/473226867827560449,,,,
DrAttai,6/1/2014 18:17,3,2,"Lee - post-treatment surveillance; physical exam and mammogram; AVOID PET/CT per @ ASCO Choosing Wisely Campaign, NCCN # ASCO14 # bcsm",,@,# #,4.73227E+17,https://twitter.com/DrAttai/status/473226812466933761,,,,
scientre,6/1/2014 18:17,1,1,SoMe&PROs: Adverse event: Pt blogs: @adamslisa has Stage IV breast cancer. Can read her exps on std tx http://ht.ly/xuD8l # ASCO14,,@adamslisa,#,4.73227E+17,https://twitter.com/scientre/status/473226802790277120,,,,
scientre,6/1/2014 18:17,2,3,SoMe&PROs: Adverse events: Pt blogs: @ lil_lytnin has Stage IV lung cancer. Read her exps incl side effects # ASCO14 http://ht.ly/xuDbC,,@,#,4.73227E+17,https://twitter.com/scientre/status/473226789443993600,,,,
scientre,6/1/2014 18:17,1,1,SoMe&PROs: Adverse event: Pt blogs: @adamslisa has Stage IV breast cancer. Can read her exps on clin trial http://ht.ly/xuD3f # ASCO14,,@adamslisa,#,4.73227E+17,https://twitter.com/scientre/status/473226784465358848,,,,
scientre,6/1/2014 18:16,0,0,. @ MSFTResearch Postpartum Mood Study: Analyze SoMe posts 4 linguistic markers suggest postpartum depression # ASCO14 http://ht.ly/xuDoB,,@,#,4.73227E+17,https://twitter.com/scientre/status/473226532165390336,,,,
scientre,6/1/2014 18:16,1,1,Twitter # DataGrants 1st rd incl @ harvardmed & @ BostonChildrens Foodborne GI Illness Surveillance # ASCO14 http://ht.ly/xuDfo,,@ @,# #,4.73226E+17,https://twitter.com/scientre/status/473226493225480194,,,,
strategicTy,6/1/2014 18:16,1,0,Thanks for stopping by @ShewithLynch Lets chat soon! # asco14 # endcancer http://ow.ly/i/5L61s,,@ShewithLynch,# #,4.73226E+17,https://twitter.com/strategicTy/status/473226491275522048,,,,
westonmagazines,6/1/2014 18:16,0,0,RT “ @ bmsnews: Ever wonder what a T cell looks like? Check out this 3D image from our # ImmunoOncology booth # ASCO14 pic.twitter.com/CxBfrpJLf3”,,@,# #,4.73226E+17,https://twitter.com/westonmagazines/status/473226487399600128,,,,
DrAttai,6/1/2014 18:16,0,0,@ chimoose @ brianreid you guys are list-making machines! # ASCO14,,@ @,#,4.73226E+17,https://twitter.com/DrAttai/status/473226483826434051,,,,
cancerassassin1,6/1/2014 18:15,0,1,"I may have misheard Dr Saltz earlier in session: is Avastin ($5000) really half the price of Cetuximab ($10,000)? # ASCO14",,,#,4.73226E+17,https://twitter.com/cancerassassin1/status/473226337709072384,,,,
scientre,6/1/2014 18:15,4,2,73% internet users use social networking sites. 71% online adults @ Facebook 18% @ Twitter # ASCO14 http://ht.ly/xuDwv PewIntrnt&AmLifeProj,,@ @,#,4.73226E+17,https://twitter.com/scientre/status/473226299205365760,,,,
scientre,6/1/2014 18:15,0,1,62% happy to communicate by email for healthcare concerns http://ht.ly/xuDKA # ASCO14 @KPCB 2014InternetTrendsReport,,@KPCB,#,4.73226E+17,https://twitter.com/scientre/status/473226284961513474,,,,
ASCO,6/1/2014 18:15,7,6,Dr. Lynn M. Schuchter on 50 years of progress in melanoma research http://bit.ly/1gTJaOS # ASCO14,,,#,4.73226E+17,https://twitter.com/ASCO/status/473226268264374273,,,,
ASCO,6/1/2014 18:15,1,1,Read Educational Book articles on topics in Practice Management & Information Tech from # ASCO14 speakers: http://bit.ly/1lPb7nj,,,#,4.73226E+17,https://twitter.com/ASCO/status/473226265110253572,,,,
scientre,6/1/2014 18:15,0,2,But! ~25% @ Facebook accounts public vs. ~90% for @ Twitter # ASCO14 http://ht.ly/xuDtm PewInternet&AmericanLifeProject,,@ @,#,4.73226E+17,https://twitter.com/scientre/status/473226239814037504,,,,
HenryJOncology,6/1/2014 18:14,0,0,Aurora A inhibitors in lipo # sarcoma? # ASCO14 highlighting difficulty and importance of hitting the target. Medical chemists have hard job.,,,# #,4.73226E+17,https://twitter.com/HenryJOncology/status/473226178359083008,,,,
CaraAnselmo,6/1/2014 18:14,0,1,"Yes, I feel sad I'm not at # ASCO14, but a really great run by the water today + time spent with an amazing friend helped make up for it.",,,#,4.73226E+17,https://twitter.com/CaraAnselmo/status/473226146759581698,,,,
DrAttai,6/1/2014 18:14,2,1,Lee - can MRI be used to better select patients for specific treatments? # ASCO14 # bcsm,,,# #,4.73226E+17,https://twitter.com/DrAttai/status/473226083333337090,,,,
subatomicdoc,6/1/2014 18:14,1,1,"What is purpose of PROs? Individual patient, patient groups, providers have different benefits @ scientre # ASCO14",,@,#,4.73226E+17,https://twitter.com/subatomicdoc/status/473226071014273026,,,,
AdnanNagrial,6/1/2014 18:14,0,0,"# ASCO14 Post discussion plenary on GI: lots of patients changed treatment before progression, why so much surprise about maintenance?",,,#,4.73226E+17,https://twitter.com/AdnanNagrial/status/473226060348149760,,,,
scientre,6/1/2014 18:14,0,2,Rvw of ePRO Systems Used in Cancer Clinical Care: TableA1 # ASCO14 http://ht.ly/xuRY6 JOP.2013.001067,,,#,4.73226E+17,https://twitter.com/scientre/status/473226042987913216,,,,
scientre,6/1/2014 18:14,0,1,84% hospital/acad/inst HC practices use fully function EHR. 51% (&inc) office-based practices # ASCO14 http://ht.ly/xuRNu @KPCB 2014Rprt,,@KPCB,#,4.73226E+17,https://twitter.com/scientre/status/473226039678603264,,,,
scientre,6/1/2014 18:14,1,1,ePROs can go direct to EHR. Ex: ePRO systems in onc clin practice Table2 # ASCO14 http://ht.ly/xuRSt CACancerJClin_2012_62_336,,,#,4.73226E+17,https://twitter.com/scientre/status/473226025409593345,,,,
ScheryllAlken,6/1/2014 18:13,0,0,@ ProfJohnCrown do you think its the way forward for these patients?!Would be great to get the ipi/anti PD1 trial for @ICORG_Ireland # ASCO14,,@ @ICORG_Ireland,#,4.73226E+17,https://twitter.com/ScheryllAlken/status/473225924255555585,,,,
mtmdphd,6/1/2014 18:13,0,0,. @ scientre # ASCO14 - PRO and MD reported outcomes can be divergent,,@,#,4.73226E+17,https://twitter.com/mtmdphd/status/473225918081556480,,,,
subatomicdoc,6/1/2014 18:13,2,2,@ JNCI_Now 2009 article: Patients better than clinicians at symptom assessment # sp4m # ASCO14,,@,# #,4.73226E+17,https://twitter.com/subatomicdoc/status/473225913518141440,,,,
YSCBuzz,6/1/2014 18:13,6,6,ASCO Breaking News for young women with breast cancer! # ASCO14 @ ASCO # bcsm Read YSC blog here: http://bit.ly/1rzG8E0,,@,# #,4.73226E+17,https://twitter.com/YSCBuzz/status/473225840457555969,,,,
PeterASinger,6/1/2014 18:13,1,0,Bridging the Digital Divide to Close the Cancer Divide by @ OphiraG http://www.grandchallenges.ca/2014/bridging-the-digital-divide-to-close-the-cancer-divide/ … # ASCO14,,@,#,4.73226E+17,https://twitter.com/PeterASinger/status/473225839392616448,,,,
scientre,6/1/2014 18:13,1,2,2 of 2 Exs onc PRO instruments: EQ-5D Products http://ht.ly/xuS3L EORTC QLQ-C30 http://ht.ly/xuS5y # ASCO14,,,#,4.73226E+17,https://twitter.com/scientre/status/473225787407990786,,,,
rsm2800,6/1/2014 18:13,5,0,. @ scientre on patient-reported outcomes (PROs) which comes directly from the pt w/o clinician interpretation (per FDA) # asco14 # hcsm,,@,# #,4.73226E+17,https://twitter.com/rsm2800/status/473225753698369536,,,,
NickZdenkowski,6/1/2014 18:13,0,0,# ASCO14 SOFT/TEXT shows DFS benefit to adjuvant exemestane and ovarian suppression in premenopausal women compared with tamoxifen and OFS,,,#,4.73226E+17,https://twitter.com/NickZdenkowski/status/473225741849460736,,,,
scientre,6/1/2014 18:13,1,2,1of2 Exs onc PRO instruments: PROMIS http://ht.ly/xuS2s PRO-CTCAE http://ht.ly/xuS4v MDASI http://ht.ly/xuS59 # ASCO14,,,#,4.73226E+17,https://twitter.com/scientre/status/473225741207744512,,,,
DrJenShineDyer,6/1/2014 18:13,3,1,RT @ mtmdphd: Datamining from social media is not driving clinical action. It is hypothesis generating - @ scientre # ASCO14,,@ @,#,4.73226E+17,https://twitter.com/DrJenShineDyer/status/473225729027874816,,,,
subatomicdoc,6/1/2014 18:12,0,0,"Clinical outcome assessments: patient-reported, clinican reported and others # ASCO14 > @ scientre",,@,#,4.73226E+17,https://twitter.com/subatomicdoc/status/473225675805966336,,,,
cancerassassin1,6/1/2014 18:12,0,1,Discussion re CALGB 08405: Dr Wolff # MDAnderson notes 20-30% had primary tumor intact. Does this affect data interpretation? # ASCO14,,,# #,4.73226E+17,https://twitter.com/cancerassassin1/status/473225666129711104,,,,
PeterASinger,6/1/2014 18:12,3,1,Canada supports 13 innovations to fight cancer in developing countries http://www.grandchallenges.ca/2014/canada-supports-13-innovations-to-fight-cancer-in-developing-countries/ … # ASCO14,,,#,4.73226E+17,https://twitter.com/PeterASinger/status/473225607300808704,,,,
mtmdphd,6/1/2014 18:12,1,0,Datamining from social media is not driving clinical action. It is hypothesis generating - @ scientre # ASCO14,,@,#,4.73226E+17,https://twitter.com/mtmdphd/status/473225603043188736,,,,
RosettaGenomics,6/1/2014 18:12,0,0,# ROSG is at # ASCO14 so be sure you come check us out at booth #12120. We want to answer your questions on # microRNA & our # cancerorigintest,,,# # #12120 # #,4.73226E+17,https://twitter.com/RosettaGenomics/status/473225593967087616,,,,
mattshomepage,6/1/2014 18:12,0,0,# ASCO14 agreed pic.twitter.com/jN0vrBPIHK,,,#,4.73226E+17,https://twitter.com/mattshomepage/status/473225592918540289,,,,
scientre,6/1/2014 18:12,2,1,A Review of Patient-Reported Outcome Labels in the United States: 2006 to 2010 http://ht.ly/xuTeA ValueHealth_2012_15_437 # ASCO14,,,#,4.73226E+17,https://twitter.com/scientre/status/473225544343879680,,,,
scientre,6/1/2014 18:12,0,0,'02-'06: 6of70 new/rev FDAappr onc pdts w PRO assess incl Leuprolideacetate Interferonalfa-2b Palifermin http://ht.ly/xuSRj # ASCO14,,,#,4.73226E+17,https://twitter.com/scientre/status/473225540657115136,,,,
scientre,6/1/2014 18:12,2,0,1/02-9/06: 6 of 70 new/revised FDA appr oncology pdt labels w PRO assess incl Gemcitabine Imatinib Abarelix http://ht.ly/xuSZ8 # ASCO14,,,#,4.73226E+17,https://twitter.com/scientre/status/473225534789271552,,,,
rsm2800,6/1/2014 18:12,1,0,. @ scientre Dr. Laura Strong (biotech leader) on social media; has prescheduled tweets w/ references # asco14 # hcsm,,@,# #,4.73225E+17,https://twitter.com/rsm2800/status/473225494918213632,,,,
DrAttai,6/1/2014 18:12,0,0,"Lee - up till now, mgm and US standard to define extent of disease for breast cancer; MRI optional per NCCN # ASCO14 # bcsm",,,# #,4.73225E+17,https://twitter.com/DrAttai/status/473225493324767235,,,,
mtmdphd,6/1/2014 18:11,0,0,. @ scientre covering Patient Reported Outcomes (PRO) - # ASCO14,,@,#,4.73225E+17,https://twitter.com/mtmdphd/status/473225376815005696,,,,
subatomicdoc,6/1/2014 18:11,4,1,PROs (patient reported outcomes) have real value # ASCO14 per @ scientre,,@,#,4.73225E+17,https://twitter.com/subatomicdoc/status/473225368246050817,,,,
scientre,6/1/2014 18:11,0,0,1/90-11/02: 57 apps w reg FDA appr. 4 on tumor-specific sympt alone incl mitoxantrone http://ht.ly/xuTrM # ASCO14 JClinOncol21_1404,,,#,4.73225E+17,https://twitter.com/scientre/status/473225288327774208,,,,
scientre,6/1/2014 18:11,0,0,"1/90-11/02: 57 apps reg FDA appr. 9 support w tumorspecfic symptoms, incl cutaneous manifestations malignancy http://ht.ly/xuTnp # ASCO14",,,#,4.73225E+17,https://twitter.com/scientre/status/473225286155128832,,,,
scientre,6/1/2014 18:11,1,0,1/90-11/02: 57 apps w reg FDA appr. 2 w composite clin benefit: pamidronate&zoledronate http://ht.ly/xuTh9 # ASCO14 JClinOncol_21_1404,,,#,4.73225E+17,https://twitter.com/scientre/status/473225267293327361,,,,
drsteventucker,6/1/2014 18:11,1,1,Seems everyone at # asco14 is getting the message - # Obesity trumps smoking for cancer risk CC @ robertlustig,,@,# #,4.73225E+17,https://twitter.com/drsteventucker/status/473225238939832320,,,,
scientre,6/1/2014 18:11,1,0,1/90-11/02: 57 appl w reg FDA approval. Zero w quality of life. FDA & EMA are diff http://ht.ly/xuT4f # ASCO14 JClinOncol_2003_21_1404,,,#,4.73225E+17,https://twitter.com/scientre/status/473225236632965121,,,,
cure_magazine,6/1/2014 18:10,2,3,"Ganz: Cancer is the poster child for the challenges in managing a healthcare team. Working to make communication easier, effective # asco14",,,#,4.73225E+17,https://twitter.com/cure_magazine/status/473225171105767426,,,,
LaurenWallner,6/1/2014 18:10,1,1,Monica Morrow on improving the value of tx for early-stage breast cancer- why eliminating treatment is hard # ASCO14 pic.twitter.com/7bVYpdQlnk,,,#,4.73225E+17,https://twitter.com/LaurenWallner/status/473225164868837377,,,,
ArcagyGineco,6/1/2014 18:10,0,1,# ASCO14 : Résultats de l’étude Olaparib + cediranib dans les cancers de l’ovaire en rechute sensible : 80% de taux de réponse !,,,#,4.73225E+17,https://twitter.com/ArcagyGineco/status/473225139057082368,,,,
mtmdphd,6/1/2014 18:10,0,0,I'm the non-oncologist -- @ scientre # ASCO14 at talk...,,@,#,4.73225E+17,https://twitter.com/mtmdphd/status/473225111911165952,,,,
DrAttai,6/1/2014 18:10,0,1,"Lee - we need to measure outcomes better; condition specific, multidimensional, no single outcome captures results of care. # ASCO14 # bcsm",,,# #,4.73225E+17,https://twitter.com/DrAttai/status/473225071268757504,,,,
subatomicdoc,6/1/2014 18:10,0,0,"Next up: @ scientre on Tools for Collecting Patient Reported Outcomes"" # ASCO14""",,@,#,4.73225E+17,https://twitter.com/subatomicdoc/status/473225069569646592,,,,
scientre,6/1/2014 18:10,0,0,NME&BLA (all indic) w PRO claims: 2006-2010=24% (28of116). 20 PRO as primary endpt http://ht.ly/xuTGQ # ASCO14 ValueHealth15_437,,,#,4.73225E+17,https://twitter.com/scientre/status/473225029614706689,,,,
scientre,6/1/2014 18:10,0,0,NME&BLA (all indic) w PRO claims: 1997-2002=30% (64 of 215). 23 appr on PRO alone http://ht.ly/xuTMb # ASCO14 ValueHealth15_437,,,#,4.73225E+17,https://twitter.com/scientre/status/473225014674587650,,,,
OncologyTimes,6/1/2014 18:10,1,0,On panel for LBA3 post-plenary in addition to A Venook & J Tabernero are Leonard Saltz & Georgioas Lypas (Chair) # ASCO14,,,#,4.73225E+17,https://twitter.com/OncologyTimes/status/473225014049648640,,,,
CancerTherAdvsr,6/1/2014 18:10,0,0,# ASCO14: Enzalutamide + Abiraterone Acetate Safe for Bone-metastatic Castration Resistant # ProstateCancer http://ow.ly/xuT4P,,,# #,4.73225E+17,https://twitter.com/CancerTherAdvsr/status/473224984413110276,,,,
scientre,6/1/2014 18:10,0,0,"FDA PRO guidance: Draft in 2006, Final in 2009 # ASCO14 http://ht.ly/xuU73",,,#,4.73225E+17,https://twitter.com/scientre/status/473224982521053184,,,,
AdnanNagrial,6/1/2014 18:09,0,0,# ASCO14 Post Plenary Discussion on GI: 80405 is not ready for interpretation until full RAS data is available,,,#,4.73225E+17,https://twitter.com/AdnanNagrial/status/473224948543025155,,,,
CBPartners,6/1/2014 18:09,0,0,The future of precision medicine from # ASCO14 http://bit.ly/1kwZ7uq,,,#,4.73225E+17,https://twitter.com/CBPartners/status/473224945888411648,,,,
rsm2800,6/1/2014 18:09,0,1,". @ fischmd Importance of using lists to filter and parse accounts on Twitter. I’ll confess, I’ve never really set up lists; must try # ASCO14",,@,#,4.73225E+17,https://twitter.com/rsm2800/status/473224927923814400,,,,
PithyWoman,6/1/2014 18:09,0,0,@ prompters MT “ @ drdonsdizon: My take on Prof zur Hausen talk: Major implication--potential for prevention--is reason enough 2 study # ASCO14”,,@ @,#,4.73225E+17,https://twitter.com/PithyWoman/status/473224795031478272,,,,
scientre,6/1/2014 18:09,0,1,Pt reported adverse events more strongly assoc w measures of daily health status than clinicians http://ht.ly/xuUa5 # ASCO14 JNCI101_1624,,,#,4.73225E+17,https://twitter.com/scientre/status/473224781517438977,,,,
brianreid,6/1/2014 18:09,0,0,"The meat of # ASCO14: handles with the most RTs from U.S. physicians. You go, @ rsm2800! (Via @ chimoose)pic.twitter.com/OQeUZiuTbI",,@ @,#,4.73225E+17,https://twitter.com/brianreid/status/473224779999084545,,,,
NickZdenkowski,6/1/2014 18:09,0,0,Impressive prostate cancer results - docetaxel and ADT at diagnosis of metastatic disease OS 49 vs 32months c/w ADT alone # ASCO14,,,#,4.73225E+17,https://twitter.com/NickZdenkowski/status/473224771652448257,,,,
subatomicdoc,6/1/2014 18:09,0,1,"How to avoid overload: filter with lists, hashtags. # ASCO14",,,#,4.73225E+17,https://twitter.com/subatomicdoc/status/473224756360015872,,,,
Awesomics,6/1/2014 18:09,2,1,"Track the flood ➙ # ASCO14 RT @ nprscience Once A Year, Cancer Research News Comes In A Flood, Not A Trickle http://n.pr/1mZuVI2",,@,#,4.73225E+17,https://twitter.com/Awesomics/status/473224720444182529,,,,
DrAttai,6/1/2014 18:08,0,0,Dr. Lee - value based imaging in breast cancer patients # ASCO14 # bcsm,,,# #,4.73225E+17,https://twitter.com/DrAttai/status/473224703830933504,,,,
Drcchabert,6/1/2014 18:08,1,0,@ declangmurphy @ m_e_nielsen @ twitter nice Delan!!! Glad to c u r taking # ASCO14 seriously,,@ @ @,#,4.73225E+17,https://twitter.com/Drcchabert/status/473224688882028544,,,,
kbnewport,6/1/2014 18:08,3,0,"# ASCO14 Dr. Gast quoting Dr. T Smith: consider a get to know you"" hospice visit early in advanced cancer care # hpm""",,,# #,4.73225E+17,https://twitter.com/kbnewport/status/473224665272680448,,,,
SWOG,6/1/2014 18:08,1,3,MT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 pic.twitter.com/1nvi7Asg8d # SWOGonc # EAonc,,@ @,# # #,4.73225E+17,https://twitter.com/SWOG/status/473224652542976004,,,,
DrJenShineDyer,6/1/2014 18:08,2,4,RT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 pic.twitter.com/qh3XoWykCM,,@ @,#,4.73225E+17,https://twitter.com/DrJenShineDyer/status/473224637980377088,,,,
drdonsdizon,6/1/2014 18:08,1,2,"@ genentech @ fischmd more individualized, more personalized, less toxic, financially and physically. # ASCO14",,@ @,#,4.73225E+17,https://twitter.com/drdonsdizon/status/473224592077508609,,,,
chimoose,6/1/2014 18:08,8,6,"We love our lists, yes? Here are the 10 accounts most retweeted by docs at # ASCO14 @ subatomicdoc @ rsm2800 @ brianreidpic.twitter.com/BUrQrbDzMX",,@ @ @,#,4.73225E+17,https://twitter.com/chimoose/status/473224565779210240,,,,
DoctorNatasha,6/1/2014 18:08,4,3,RT @ subatomicdoc: Benefits of social media @ fischmd # ASCO14 pic.twitter.com/Iosgkwtg7L,,@ @,#,4.73225E+17,https://twitter.com/DoctorNatasha/status/473224558263427072,,,,
scientre,6/1/2014 18:08,1,0,". @ US_FDA Tx Dvlpmt Tools: 4 types Clin Outcome Assessments: Patient (PRO), Clinician, Observer, Performance http://ht.ly/xuSr8 # ASCO14",,@,#,4.73225E+17,https://twitter.com/scientre/status/473224529406201857,,,,
cancerassassin1,6/1/2014 18:08,1,0,Discussion w/ distinguished panel re: CALGB 08405. Dr Saltz @ sloan_kettering added insight re: costs of drugs used in that study. # ASCO14,,@,#,4.73225E+17,https://twitter.com/cancerassassin1/status/473224524754714624,,,,
scientre,6/1/2014 18:08,1,1,. @ US_FDA PRO: any report of status of pt health cond dir from pt wo interpretation by clinician or other http://ht.ly/xuSwf # ASCO14,,@,#,4.73225E+17,https://twitter.com/scientre/status/473224508736688128,,,,
LillianErdahlMD,6/1/2014 18:08,1,1,@ fischmd Great overview of social media use and opportunities for physicians # ASCO14,,@,#,4.73224E+17,https://twitter.com/LillianErdahlMD/status/473224499089793024,,,,
subatomicdoc,6/1/2014 18:08,2,1,Know what the social media policy is for: your state; professional society; hospital; medical practice # ASCO14 > @ fischmd,,@,#,4.73224E+17,https://twitter.com/subatomicdoc/status/473224491691040768,,,,
DrAttai,6/1/2014 18:07,5,2,Morrow - utilizing treatments with low value will leave us no $$ to provide proven treatments in the future # ASCO14 # bcsm,,,# #,4.73224E+17,https://twitter.com/DrAttai/status/473224456065007616,,,,
subhamadhavan,6/1/2014 18:07,7,1,# ASCO14 Dr Ganz:cancer patients are at a higher risk for bankruptcy compared to people without a cancer diagnosis.,,,#,4.73224E+17,https://twitter.com/subhamadhavan/status/473224425639124992,,,,
PithyWoman,6/1/2014 18:07,0,0,@ prompters MT “ @ DrLen: Gr8 logic: Zur Hausen re infectious agent & CRC risk fm red meat Grilled chicken/fish don't have same effect # ASCO14”,,@ @,#,4.73224E+17,https://twitter.com/PithyWoman/status/473224284303675392,,,,
scientre,6/1/2014 18:07,0,0,Different data can serve distinct purposes. Some sets sufficient for hypothesis generation but not clinical decision. Both important # ASCO14,,,#,4.73224E+17,https://twitter.com/scientre/status/473224276862984192,,,,
drdonsdizon,6/1/2014 18:06,0,1,@ AneesChagpar @ CliffordHudis @ ASCO @FITWEEK52 according to my@Fitbit I'm doing about 5 miles a day # ASCO14,,@ @ @ @FITWEEK52 @Fitbit,#,4.73224E+17,https://twitter.com/drdonsdizon/status/473224163688456192,,,,
DrAttai,6/1/2014 18:06,3,1,Morrow - why aren't we eliminating treatment despite data? Many factors - # ASCO14 # bcsm,,,# #,4.73224E+17,https://twitter.com/DrAttai/status/473224155463430145,,,,
subatomicdoc,6/1/2014 18:06,2,2,Think before you link! - advice re: malware @ fischmd # ASCO14 # hcsm,,@,# #,4.73224E+17,https://twitter.com/subatomicdoc/status/473224140380307457,,,,
chimoose,6/1/2014 18:06,0,1,"@ drsteventucker Hey, if you're tweeting # ASCO14, you're there in spirit!! ;-) @ ProfJohnCrown",,@ @,#,4.73224E+17,https://twitter.com/chimoose/status/473224136127709184,,,,
AneesChagpar,6/1/2014 18:06,1,0,Awesome to see so many award winners. @ ASCO @ iConquerCancer # ASCO14,,@ @,#,4.73224E+17,https://twitter.com/AneesChagpar/status/473224115332337664,,,,
rsm2800,6/1/2014 18:06,3,2,. @ fischmd notes much less spam on # asco14 c/w prior yrs. Props to the # hcsm crew from @ ASCO,,@ @,# #,4.73224E+17,https://twitter.com/rsm2800/status/473224057299562496,,,,
scientre,6/1/2014 18:06,0,1,"Before we get to PROs, simply collecting data not useful http://ht.ly/xuBgq Need to convert in something…. # ASCO14",,,#,4.73224E+17,https://twitter.com/scientre/status/473224019416580096,,,,
kbnewport,6/1/2014 18:06,1,1,"# ASCO14 Dr Gast: CA care teams should collaborate with pt to create a care plan including prognosis, treatments, goals, expectations # hpm",,,# #,4.73224E+17,https://twitter.com/kbnewport/status/473223994960015360,,,,
DrAttai,6/1/2014 18:05,4,2,"Morrow - CALGB 9343 - despite revision of NCCN guidelines and long term follow up, XRT use in women > 70 still at high rate # ASCO14 # bcsm",,,# #,4.73224E+17,https://twitter.com/DrAttai/status/473223922130092032,,,,
kellykcotton,6/1/2014 18:05,3,1,"You should expect debate on social media, but show reserve & respect in your responses - @ fischmd # ASCO14 # hcsm",,@,# #,4.73224E+17,https://twitter.com/kellykcotton/status/473223907663548416,,,,
drsteventucker,6/1/2014 18:05,1,1,And I'm still in Singapore MT @ chimoose: Most active Ex-US docs at # ASCO14 are @ profjohncrown and @ drsteventucker,,@ @ @,#,4.73224E+17,https://twitter.com/drsteventucker/status/473223875480662017,,,,
scientre,6/1/2014 18:05,0,1,"In # ASCO14 Ed Session this PM, I’ll share data & ideas about Emerging Tools for Collecting Patient-Reported Outcomes # PRO",,,# #,4.73224E+17,https://twitter.com/scientre/status/473223784560742400,,,,
ASCO,6/1/2014 18:05,8,5,How Progress Happens: An Industry Perspective on Innovation in Oncology from @ macerothenberg http://bit.ly/RH2mDC # ASCO14,,@,#,4.73224E+17,https://twitter.com/ASCO/status/473223737874333696,,,,
dramarivirg,6/1/2014 18:05,0,0,"Morrow MRI to detect contralateral breast cancer?For average woman, incidence is 2-3% at 10 yrs for ER+,5-6% for ER- # ASCO14 ” @ jcragostini",,@,#,4.73224E+17,https://twitter.com/dramarivirg/status/473223732031258625,,,,
OncLive,6/1/2014 18:05,4,1,Upfront Chemo Confers Dramatic Survival Gains in Prostate Cancer http://ow.ly/xv1si # ASCO14,,,#,4.73224E+17,https://twitter.com/OncLive/status/473223728231620608,,,,
DrAttai,6/1/2014 18:04,1,1,Morrow - another area of overutilization / decreased value - XRT after lumpectomy in women > age 70. CALGB 9343 # ASCO14 # bcsm,,,# #,4.73224E+17,https://twitter.com/DrAttai/status/473223708983971840,,,,
subatomicdoc,6/1/2014 18:04,2,3,"Problematic issues with online interactions, learn how to share w/ reserve", respect," humility"" per @ fischmd # ASCO14""",,@,#,4.73224E+17,https://twitter.com/subatomicdoc/status/473223705988853760,,
scientre,6/1/2014 18:04,0,0,Laughing too much about @ fischmd story about googling that can't figure out how to do justice!! # ASCO14,,@,#,4.73224E+17,https://twitter.com/scientre/status/473223578595622913,,,,
GustaveRoussy,6/1/2014 18:04,6,0,# ASCO14 # video Pr Fizazi @ GustaveRoussy sur les résultats de l'étude GETUG12 @ GroupeUNICANCER cancer de la prostate https://vimeo.com/97063718,,@ @,# #,4.73224E+17,https://twitter.com/GustaveRoussy/status/473223572585193473,,,,
rsm2800,6/1/2014 18:04,1,1,". @ fischmd re patient-targeted googling, may threaten the doctor-patient relationship # hcsm # asco14",,@,# #,4.73224E+17,https://twitter.com/rsm2800/status/473223542775881728,,,,
jufu_0,6/1/2014 18:04,0,1,Irony of # ASCO14 session on appropriate social media use: audible buzzes from texts and notifications from a phone on the presenters' table,,,#,4.73223E+17,https://twitter.com/jufu_0/status/473223495615545346,,,,
TuftsB,6/1/2014 18:04,0,0,"To paraphrase Rep. Grayson in health care debate, new ASCO plan is if you get cancer just die already - & do not be a burden # mliwi # ASCO14",,,# #,4.73223E+17,https://twitter.com/TuftsB/status/473223479815589888,,,,
weldeiry,6/1/2014 18:04,0,1,"Congratulations to Mala Talekar, recipient of a Conquer Cancer Foundation 2014 Young Investigator Awardee # ASCO14 pic.twitter.com/fu8duCkAQj",,,#,4.73223E+17,https://twitter.com/weldeiry/status/473223468247285760,,,,
PithyWoman,6/1/2014 18:03,0,0,@ prompters MT “ @ dmooneymd: Talk a/b value of cancer care. Off patent drug w/ 17 month extension of survival in high risk population # ASCO14”,,@ @,#,4.73223E+17,https://twitter.com/PithyWoman/status/473223452485107712,,,,
EIannelli,6/1/2014 18:03,2,2,# ASCO14 30.000 doctors more or less & a lot of patient advocates & # cancer # survivors all together against cancerpic.twitter.com/UBxA9lgYiq,,,# # #,4.73223E+17,https://twitter.com/EIannelli/status/473223432805437440,,,,
DrAttai,6/1/2014 18:03,3,1,"Morrow - no difference in local, regional or distant recurrence w/axillary dissection compared to SN biopsy for node micromets # ASCO14 # bcsm",,,# #,4.73223E+17,https://twitter.com/DrAttai/status/473223410739593216,,,,
DrBobGoldberg,6/1/2014 18:03,3,0,. @ asco value guidelines will discriminate against women and minorities # ascorationing https://pacenetworkusa.com/entry.php?id=91,,@,#,4.73223E+17,https://twitter.com/DrBobGoldberg/status/473223393144479744,,,,
subatomicdoc,6/1/2014 18:03,3,2,"Don't use Facebook for followup"" lol but true @ fischmd # ASCO14""",,@,#,4.73223E+17,https://twitter.com/subatomicdoc/status/473223362584408064,,,,
cmartindedios,6/1/2014 18:03,0,0,@ ASCO # asco14 # patient centered Care sessionpic.twitter.com/XcuBNJfwV7,,@,# #,4.73223E+17,https://twitter.com/cmartindedios/status/473223247282962432,,,,
DrHedrick,6/1/2014 18:03,0,0,Morrow: Do you need to do Ax Dissection for micrometasteses. N benefit to local or distant mets. # ASCO14,,,#,4.73223E+17,https://twitter.com/DrHedrick/status/473223243571032064,,,,
subatomicdoc,6/1/2014 18:03,3,3,Google your patients? @ fischmd correctly points out that it is an ethical issue. # ASCO14,,@,#,4.73223E+17,https://twitter.com/subatomicdoc/status/473223221949378560,,,,
YSCBuzz,6/1/2014 18:03,1,1,Check out highlights from the day at # ASCO14 http://bit.ly/1rzEGBR,,,#,4.73223E+17,https://twitter.com/YSCBuzz/status/473223214420590592,,,,
scientre,6/1/2014 18:02,0,0,. @ fischmd tries to avoid reflective tweets from clinical settings. # ASCO14,,@,#,4.73223E+17,https://twitter.com/scientre/status/473223176970047489,,,,
yzafar,6/1/2014 18:02,15,6,Ganz: palliative care does not equal end of life care # asco14 pic.twitter.com/I6jWriTEbw,,,#,4.73223E+17,https://twitter.com/yzafar/status/473223112712929280,,,,
aftimosp,6/1/2014 18:02,0,0,# ASCO14 # Chicago http://instagram.com/p/ot60BLDVnR/,,,# #,4.73223E+17,https://twitter.com/aftimosp/status/473223095646289920,,,,
subatomicdoc,6/1/2014 18:02,3,1,"Confidentiality issues are real ones. @ fischmd: Pause before posting."" Reflective tweets on clinical stuff should be avoided # ASCO14""",,@,#,4.73223E+17,https://twitter.com/subatomicdoc/status/473223069105127424,,,,
PithyWoman,6/1/2014 18:02,0,0,"@ neomaione MT “ @ rsm2800 Amazing: Dr. Venook shows median OS of met colorectal ca of 9 mos in 1992 vs 29+ mos in this trial # ASCO14"",,@ @,#,473223006961950721""",https://twitter.com/PithyWoman/status/473223006961950721,,,,,,,,
DrAttai,6/1/2014 18:01,3,2,Morrow: re: sentinel nodes - the time has come to stop looking for and treating micrometastases in the axillary nodes # ASCO14 # bcsm,,,# #,4.73223E+17,https://twitter.com/DrAttai/status/473222956978806785,,,,
DrGlenWeiss,6/1/2014 18:01,0,0,Medical oncology fellows check out @ CancerCenter career booth: CF-1. # clinical # research # trials # ASCO14 @ ASCO @ AACR # lcsm # bcsm # gucsm,,@ @ @,# # # # # # #,4.73223E+17,https://twitter.com/DrGlenWeiss/status/473222863034802178,,,,
hmhyltonpac,6/1/2014 18:01,1,0,"@ fischmd at # ASCO14: Your SoMe presence should reflect that you are honest, helpful, responsible, and compassionate.",,@,#,4.73223E+17,https://twitter.com/hmhyltonpac/status/473222809225666560,,,,
rsm2800,6/1/2014 18:01,3,2,"At the . @ fischmd talk right now, @ mtmdphd is # tweetingfromthepodium # asco14 # hcsm",,@ @,# # #,4.73223E+17,https://twitter.com/rsm2800/status/473222801113894912,,,,
scientre,6/1/2014 18:01,0,0,. @ fischmd pn maintaining sep professional & personal persons online. Getting familiar w privacy settings. Never assume anonymous # ASCO14,,@,#,4.73223E+17,https://twitter.com/scientre/status/473222756054884353,,,,
KMFDallas,6/1/2014 18:01,0,0,@ ASCO Remember there are over 10 million exposed to DES # TheDESTragedy,,@,#,4.73223E+17,https://twitter.com/KMFDallas/status/473222727588122624,,,,
ASCO,6/1/2014 18:00,3,3,Going to the breast cancer track at # ASCO14? Catch up on some reading on # ASCOConnection http://bit.ly/1jD8y5T # bcsm,,,# # #,4.73223E+17,https://twitter.com/ASCO/status/473222699897327617,,,,
PrevGenetics,6/1/2014 18:00,0,0,We're at # ASCO14 booth 2042! Stop by to learn about our newest panel tests.,,,#,4.73223E+17,https://twitter.com/PrevGenetics/status/473222678019833856,,,,
subatomicdoc,6/1/2014 18:00,3,6,Even the best of us can be 'outed' with tagging. Even Superman! # ASCO14 # privacyfailpic.twitter.com/k7S153B2EZ,,,# #,4.73223E+17,https://twitter.com/subatomicdoc/status/473222666888155137,,,,
kbnewport,6/1/2014 18:00,0,0,# ASCO14 Dr. Gast: pts want to know about their diagnoses and want to be involved in decision-making which = patient centered care # hpm,,,# #,4.73223E+17,https://twitter.com/kbnewport/status/473222653172776962,,,,
_Phenomenome,6/1/2014 18:00,0,1,"Great tweet shares from @ fischmd's presentation, @ subatomicdoc. Thank you. # ASCO14 # KnowYourRisk cc: @ DrTaraSmith @ e_bingham @ shawn_ritchie",,@ @ @ @ @,# #,4.73223E+17,https://twitter.com/_Phenomenome/status/473222623506468864,,,,
DrAttai,6/1/2014 18:00,1,1,"Morrow - while negative margins optimize local control, wider margins do not improve local control # ASCO14 # bcsm",,,# #,4.73223E+17,https://twitter.com/DrAttai/status/473222599888367616,,,,
dramarivirg,6/1/2014 18:00,0,0,Morrow -MRI does not help predict extent of surgery;no improvement in local recurrence for either invasive CA or DCIS # ASCO14” @ jcragostini,,@,#,4.73223E+17,https://twitter.com/dramarivirg/status/473222573220581376,,,,
rsm2800,6/1/2014 18:00,0,1,. @ fischmd Blurring the professional & personal-maintain separate personas (I respect that view; don’t totally agree). # asco14,,@,#,4.73223E+17,https://twitter.com/rsm2800/status/473222501531516929,,,,
AZBreast,6/1/2014 18:00,0,0, @ drattai: Morrow: CPM no improvement in survival," double the surgery -> double the complication rate. # ASCO14 Patients need to hear this!""",,@,#,4.73222E+17,https://twitter.com/AZBreast/status/473222498671419392,,,
DrAttai,6/1/2014 17:59,2,2,@ SocSurgOnc margin statement http://www.surgonc.org/margins-study # ASCO14 # bcsm,,@,# #,4.73222E+17,https://twitter.com/DrAttai/status/473222436700172289,,,,
DrHedrick,6/1/2014 17:59,0,0,"Morrow: Margin creep - Sense that bigger margin is better. 1/2 of re-excision are of clear margins that Need"" to be bigger. # ASCO14""",,,#,4.73222E+17,https://twitter.com/DrHedrick/status/473222427871158272,,,,
subatomicdoc,6/1/2014 17:59,3,2,"Private vs. public, personal vs professional. @ fischmd you're fooling yourself re: anonymity. # ASCO14""",,@,#,4.73222E+17,https://twitter.com/subatomicdoc/status/473222375660453888,,,,
davidgrahammd,6/1/2014 17:59,0,0,In Clin Practice Cmte who want to hear how better to coordinate activities and services to practicing Oncs. @ YupOnc showing support # ASCO14,,@,#,4.73222E+17,https://twitter.com/davidgrahammd/status/473222352084676609,,,,
Neil_Iyengar,6/1/2014 17:59,0,0,"@ DamianFog @ dr_ashwitt Good point, believe slide is just crude rate. Thought provoking. # ASCO14",,@ @,#,4.73222E+17,https://twitter.com/Neil_Iyengar/status/473222340789420032,,,,
RyhMd,6/1/2014 17:59,0,0,PDL-1 up regulation mechanism on tumor cells # ASCO14 pic.twitter.com/ie0m3oUFGP,,,#,4.73222E+17,https://twitter.com/RyhMd/status/473222334443433984,,,,
declangmurphy,6/1/2014 17:59,0,1,MT @ m_e_nielsen does virtual ASCO: Another grt day at # asco14; # ViewFromMySeat even better than yest thx to @ Twitter https://vine.co/v/MpM0dwxBEmJ,,@ @,# #,4.73222E+17,https://twitter.com/declangmurphy/status/473222317984604160,,,,
DrAttai,6/1/2014 17:59,0,2,@ ASBrS margin statement: https://www.breastsurgeons.org/new_layout/about/statements/PDF_Statements/Lumpectomy_Margins.pdf … # ASCO14 # bcsm,,@,# #,4.73222E+17,https://twitter.com/DrAttai/status/473222282069155840,,,,
dramarivirg,6/1/2014 17:58,0,1,“ @ drattai: Morrow - use of MRI to detect contralateral breast cancer not the best use of resources # ASCO14 # bcsm” RT,,@,# #,4.73222E+17,https://twitter.com/dramarivirg/status/473222172907810816,,,,
subatomicdoc,6/1/2014 17:58,2,3,Twitter addiction. @ fischmd kindly not pointing ME out as a case study # ASCO14,,@,#,4.73222E+17,https://twitter.com/subatomicdoc/status/473222158882066433,,,,
WayneKoberstein,6/1/2014 17:58,2,1,# ASCO14 A key question & answer to affect immunoTx. @ RfwrightLSLpic.twitter.com/2ln7pP6jIM,,@,#,4.73222E+17,https://twitter.com/WayneKoberstein/status/473222155187290112,,,,
ElizBlanchardMD,6/1/2014 17:58,4,1,Using tweet #1000 at # ASCO14 to debut a new hashtag: # supponc,,,#1000 # #,4.73222E+17,https://twitter.com/ElizBlanchardMD/status/473222121921867776,,,,
rsm2800,6/1/2014 17:58,2,0,". @ fischmd We can manage the barriers to # hcsm! Not enamored of status quo, experience w/ managing toxicity, not afraid to fail # asco14",,@,# #,4.73222E+17,https://twitter.com/rsm2800/status/473222105954152448,,,,
declangmurphy,6/1/2014 17:58,0,0,@ charlesryanmd Agree Chuck. This one will change practice with almost immediate effect. And it's cheap!!! # asco14 http://prostatecancerinfolink.net/2013/12/06/early-docetxel-chemotherapy-adt-extends-survival-of-men-with-metastatic-prostate-cancer/ …,,@,#,4.73222E+17,https://twitter.com/declangmurphy/status/473222044809580544,,,,
AdnanNagrial,6/1/2014 17:58,0,0,# ASCO14 Maha Hussain: Docetaxel plus ADT is the new standard of care for this population,,,#,4.73222E+17,https://twitter.com/AdnanNagrial/status/473222039973527552,,,,
DrAttai,6/1/2014 17:58,1,1,Morrow - another area where we are not getting value - re-excision for larger margins after lumpectomy # ASCO14 # bcsm,,,# #,4.73222E+17,https://twitter.com/DrAttai/status/473222033623752704,,,,
subatomicdoc,6/1/2014 17:58,0,0,@ XRT4U @ fischmd Cavernous room but great attendance at this session # ASCO14,,@ @,#,4.73222E+17,https://twitter.com/subatomicdoc/status/473221994092048384,,,,
DrHedrick,6/1/2014 17:58,0,0,"Morrow: Who is getting CPM? White, young, low risk, unlike to have second primary, good insurance, in high volume centers. # ASCO14",,,#,4.73222E+17,https://twitter.com/DrHedrick/status/473221967823122433,,,,
scientre,6/1/2014 17:57,0,0,. @ fischmd uses great figure from Finding the missing link for big biomedical data # ASCO14 http://jama.jamanetwork.com/Mobile/article.aspx?articleID=1875648 …,,@,#,4.73222E+17,https://twitter.com/scientre/status/473221912391606272,,,,
timturnham,6/1/2014 17:57,1,1,Some drugs approved by @ US_FDA before Europe. Means disparity of care based on where you live. @ CureMelanoma # ASCO14,,@ @,#,4.73222E+17,https://twitter.com/timturnham/status/473221856242454529,,,,
DrAttai,6/1/2014 17:57,1,1,"Morrow: CPM more likely in younger, Caucasian women, insured, hospitals that do high-volume surgery # ASCO14 # bcsm",,,# #,4.73222E+17,https://twitter.com/DrAttai/status/473221854740881409,,,,
mattshomepage,6/1/2014 17:57,0,0,@ fischmd points out some physicians might not tweet because it seems like a narcissistic indulgence # ASCO14,,@,#,4.73222E+17,https://twitter.com/mattshomepage/status/473221843168407553,,,,
dramarivirg,6/1/2014 17:57,1,1,@ doctormatias @ drapaolaceledon esta plenaria estuvo genial!! Interesante en extremo! Valió la pena este # ASCO14,,@ @,#,4.73222E+17,https://twitter.com/dramarivirg/status/473221829134274560,,,,
subatomicdoc,6/1/2014 17:57,2,2,"Yes! # ASCO14 RT @ chimoose: @ brianreid You know I'm not a graphics guy, but is this worth sharing? http://bit.ly/RUGXH2",,@ @,#,4.73222E+17,https://twitter.com/subatomicdoc/status/473221788064043008,,,,
DrHedrick,6/1/2014 17:57,0,0,"Morrow: Contralateral Prophylactic Mastectomy: Increasing rates, no survival benefit. # ASCO14",,,#,4.73222E+17,https://twitter.com/DrHedrick/status/473221754144313344,,,,
rsm2800,6/1/2014 17:57,0,0,". @ fischmd Barriers to # hcsm for docs-too busy, seems narcissistic, seen bad things happen, haven’t seen anything great, no mentors # ASCO14",,@,# #,4.73222E+17,https://twitter.com/rsm2800/status/473221736280780801,,,,
DrAttai,6/1/2014 17:57,3,1,"Morrow: CPM no improvement in survival, double the surgery -> double the complication rate. # ASCO14 # bcsm",,,# #,4.73222E+17,https://twitter.com/DrAttai/status/473221709844455424,,,,
DrAttai,6/1/2014 17:56,2,0,Morrow - rates of CMP are increasing. Contralateral prophylactic mastectomy - removal of opposite normal breast # ASCO14 # bcsm,,,# #,4.73222E+17,https://twitter.com/DrAttai/status/473221571361136640,,,,
LillianErdahlMD,6/1/2014 17:56,2,0,"Michael Fisch highlights the importance of teaching social media use to medical trainees, preparing them for the future # ASCO14",,,#,4.73222E+17,https://twitter.com/LillianErdahlMD/status/473221512514662400,,,,
favo_it,6/1/2014 17:56,4,2,"We're in Chicago to represent italian # cancer patients at # ASCO14,working together patients advocates from all over the world! @ EIannelli",,@,# #,4.73221E+17,https://twitter.com/favo_it/status/473221475844227073,,,,
DrHedrick,6/1/2014 17:56,0,0,"Morrow: Prior study suggest MRI detect hidden contralateral breast cancer. SEER database demonstrate same rate No extra"" detection. # ASCO14""",,,#,4.73221E+17,https://twitter.com/DrHedrick/status/473221454285139969,,,,
subatomicdoc,6/1/2014 17:55,1,1,"My caveat on # bigdata - incorporation requires patient protections for privacy, how data used # ASCO14",,,# #,4.73221E+17,https://twitter.com/subatomicdoc/status/473221438355173376,,,,
DrAttai,6/1/2014 17:55,3,0,Morrow - use of MRI to detect contralateral breast cancer not the best use of resources # ASCO14 # bcsm,,,# #,4.73221E+17,https://twitter.com/DrAttai/status/473221430847750144,,,,
rsm2800,6/1/2014 17:55,1,1,". @ fischmd As teachers we have obligation to guide trainees about # hcsm, emphasize professionalism. So we have to use/understand it # asco14",,@,# #,4.73221E+17,https://twitter.com/rsm2800/status/473221356092268544,,,,
subatomicdoc,6/1/2014 17:55,9,4,"Social media is part of tapestry of potentially high value information for big data"" @ fischmd # ASCO14""",,@,#,4.73221E+17,https://twitter.com/subatomicdoc/status/473221284407427072,,,,
_Phenomenome,6/1/2014 17:55,0,0,. @ DrTaraSmith @ e_bingham @ shawn_ritchie @ alixhay -> Article on CRC screening rates: http://ow.ly/xv1bM . We can improve this. # ASCO14,,@ @ @ @,#,4.73221E+17,https://twitter.com/_Phenomenome/status/473221265030127616,,,,
genentech,6/1/2014 17:55,0,0,"Hey @ fischmd @ drdonsdizon, How will # CancerResearch progress in # Next50 yrs? # ASCO14",,@ @,# # #,4.73221E+17,https://twitter.com/genentech/status/473221226551578626,,,,
Roche,6/1/2014 17:55,1,0,Halfway through # ASCO14. What are your highlights so far?,,,#,4.73221E+17,https://twitter.com/Roche/status/473221225221996546,,,,
TargetedOnc,6/1/2014 17:55,1,2,FDA Grants Breakthrough Therapy Designation to MPDL3280A for Bladder Cancer http://www.targetedonc.com/conference/immunotherapy-news-asco-2014/FDA-Grants-Breakthrough-Therapy-Designation-to-MPDL3280A-for-Bladder-Cancer … # ASCO14,,,#,4.73221E+17,https://twitter.com/TargetedOnc/status/473221208109248513,,,,
kellykcotton,6/1/2014 17:54,1,0,"Benefits of # hcsm: shared note taking, crowdsourcing ideas & resources, staying up to date w/research - @ fischmd # ASCO14",,@,# #,4.73221E+17,https://twitter.com/kellykcotton/status/473221157642960896,,,,
ProfJohnCrown,6/1/2014 17:54,0,2,Came to CNS immunotherapy session by accident! It's great! I'm staying! # ASCO14,,,#,4.73221E+17,https://twitter.com/ProfJohnCrown/status/473221128258080768,,,,
DrAttai,6/1/2014 17:54,0,2,"Morrow MRI to detect contralateral breast cancer? For average woman, incidence is 2-3% at 10 yrs for ER+, 5-6% for ER- # ASCO14 # bcsm",,,# #,4.73221E+17,https://twitter.com/DrAttai/status/473221106347032577,,,,
richardsross33,6/1/2014 17:54,0,0,Interesting to hear perspectives on benefits of social media for clinical practitioners # ASCO14,,,#,4.73221E+17,https://twitter.com/richardsross33/status/473221092723924994,,,,
Nelson_Carreras,6/1/2014 17:54,0,1,"@ JoFuste  @ genentech: Immunotherapy is going to be big tmrw. Start thinking differently today: http://ow.ly/xuE2c # ASCO14""""",,@ @,#,4.73221E+17,https://twitter.com/Nelson_Carreras/status/473221051401633793,,,,
ipaulmampilly,6/1/2014 17:54,0,0,# ASCO14 a informal study at 1998 asco meeting..74% of responding said broke bad news 5 times per month..some 20 per month..ed and prep impt,,,#,4.73221E+17,https://twitter.com/ipaulmampilly/status/473220978747518976,,,,
hmhyltonpac,6/1/2014 17:54,0,0,@ fischmd at # ASCO14: benefits of SoMe include bringing together disparate stakeholders,,@,#,4.73221E+17,https://twitter.com/hmhyltonpac/status/473220962637602817,,,,
mtmdphd,6/1/2014 17:54,1,6,"What if we had metrics on the # ASCO14 Virtual Meeting downloads and 'likes to help figure out what is important - @ fischmd""",,@,#,4.73221E+17,https://twitter.com/mtmdphd/status/473220957482401793,,,,
subatomicdoc,6/1/2014 17:53,81,49,Benefits of social media @ fischmd # ASCO14 pic.twitter.com/pjsdiHFnb2,,@,#,4.73221E+17,https://twitter.com/subatomicdoc/status/473220943113101312,,,,
rsm2800,6/1/2014 17:53,4,2,". @ fischmd “Flipping the classroom” Get content via YouTube, Virtual Meeting etc in advance, then coming together to discuss # hcsm # ASCO14",,@,# #,4.73221E+17,https://twitter.com/rsm2800/status/473220866428264448,,,,
OncologyTimes,6/1/2014 17:53,1,2,"SO wish wasn't same time as post-plenaries! MT @ subatomicdoc: Now getting ready 4 The Future is Now"" w/ @ mtmdphd @ scientre @ fischmd # ASCO14""",,@ @ @ @,#,4.73221E+17,https://twitter.com/OncologyTimes/status/473220865429995520,,,,
DrHedrick,6/1/2014 17:53,0,0,Morrow: MRI does not reduce rates of local recurrence over patients who do not get MRI. Appears makes no difference then convention. # ASCO14,,,#,4.73221E+17,https://twitter.com/DrHedrick/status/473220753731485697,,,,
DrAttai,6/1/2014 17:53,2,2,Morrow - MRI does not help predict extent of surgery; no improvement in local recurrence for either invasive CA or DCIS # ASCO14 # bcsm,,,# #,4.73221E+17,https://twitter.com/DrAttai/status/473220726515048452,,,,
scientre,6/1/2014 17:52,0,1,. @ fischmd 1 of benefits of social media is flipping classroom & the clinic # ASCO14,,@,#,4.7322E+17,https://twitter.com/scientre/status/473220496595877888,,,,
rsm2800,6/1/2014 17:51,3,0,". @ fischmd talking about benefits of # hcsm - keeping up with new ideas, research & engaging with patients/public on key topics # asco14",,@,# #,4.7322E+17,https://twitter.com/rsm2800/status/473220426550620160,,,,
DrAttai,6/1/2014 17:51,1,2,Morrow - several treatments do not provide value in terms of improving outcomes - 5 to be discussed # ASCO14 # bcsm,,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473220422151192577,,,,
dramarivirg,6/1/2014 17:51,0,0,@ OncologyTimes very interesting.. Here we are! # ASCO14,,@,#,4.7322E+17,https://twitter.com/dramarivirg/status/473220334523400192,,,,
UCCancerCenter,6/1/2014 17:51,0,0,Fay Hlubocky's poster looked at marital distress among advanced cancer patients and their spouses # ASCO14,,,#,4.7322E+17,https://twitter.com/UCCancerCenter/status/473220312780521474,,,,
subatomicdoc,6/1/2014 17:51,19,8,Social media amplifies what you can share on a logarithmic scale http://www.ncbi.nlm.nih.gov/pubmed/?term=23630451 … # ASCO14 via @ fischmdpic.twitter.com/wAV7LgFGJY,,@,#,4.7322E+17,https://twitter.com/subatomicdoc/status/473220307986030592,,,,
DrAttai,6/1/2014 17:50,2,0,"Morrow: Need to take into account local control, quality of life, and outcome to define value # ASCO14 # bcsm",,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473220185969917952,,,,
scientre,6/1/2014 17:50,2,0,. @ fischmd social media is a Bayesian way of sharing information # ASCO14,,@,#,4.7322E+17,https://twitter.com/scientre/status/473220170681700353,,,,
DrHedrick,6/1/2014 17:50,0,0,"Morrow: Value = OS, DFS, local control, or quality of life as return of investment. # ASCO14",,,#,4.7322E+17,https://twitter.com/DrHedrick/status/473220162590494720,,,,
OncologyTimes,6/1/2014 17:50,2,2,+1! RT @ scientre: @ fischmd likes Twitter handles on # ASCO14 badges...but hopes they'll be in bigger print in future!,,@ @,#,4.7322E+17,https://twitter.com/OncologyTimes/status/473220137663737856,,,,
LinicalAmericas,6/1/2014 17:50,0,0,@ LesleyRStahl sighting - wonder if there is a @ 60Minutes story tied to # ASCO14 ?,,@ @,#,4.7322E+17,https://twitter.com/LinicalAmericas/status/473220096295702529,,,,
kellykcotton,6/1/2014 17:50,0,0,"The power of social media to influence science & patient care is dramatically different than it was a few years ago"" - @ fischmd # ASCO14""",,@,#,4.7322E+17,https://twitter.com/kellykcotton/status/473220088057696256,,,,
DrAttai,6/1/2014 17:50,2,1,Morrow - true cost effectiveness has to take into pt experience given no difference in outcomes # ASCO14 # bcsm,,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473220039475482624,,,,
datacision,6/1/2014 17:50,1,0,Listening to @ fischmd talking about use of social media in medical practice # ASCO14 - new communication method! pic.twitter.com/i0arJziLQq,,@,#,4.7322E+17,https://twitter.com/datacision/status/473219974949924864,,,,
OncNursingNews,6/1/2014 17:50,1,0,MT@ClevelandClinic “Obesity on its way to replacing tobacco as the number 1 preventable/modifiable cause of cancer.” @ CliffordHudis # ASCO14,,@ClevelandClinic @,#,4.7322E+17,https://twitter.com/OncNursingNews/status/473219956688314369,,,,
cancersupport,6/1/2014 17:49,0,1,OS over 29months with 10% surviving >5 years in stage IV colorectal cancer # asco2014,,,#,4.7322E+17,https://twitter.com/cancersupport/status/473219936869822464,,,,
mattshomepage,6/1/2014 17:49,0,0,"In 2013, 82,383 cancer-related tweets from 4,155 unique U.S. physicians # ASCO14",,,#,4.7322E+17,https://twitter.com/mattshomepage/status/473219846818115584,,,,
DrAttai,6/1/2014 17:49,6,3,Morrow - most cost effective actually mastectomy; lumpectomy + XRT more expensive. But survival + so we move beyond cost # ASCO14 # bcsm,,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473219824982982656,,,,
urotoday,6/1/2014 17:49,2,0,# ASCO14 - Neoadjuvant dose-dense gemcitabine and cisplatin (DDGC) in patients with ... http://dlvr.it/5rbX1K,,,#,4.7322E+17,https://twitter.com/urotoday/status/473219716866007040,,,,
urotoday,6/1/2014 17:49,0,0,# ASCO14 - Inhibition of PD-L1 by MPDL3280A and clinical activity in patients with metastatic ... http://dlvr.it/5rbX07,,,#,4.7322E+17,https://twitter.com/urotoday/status/473219713216966656,,,,
DamianFog,6/1/2014 17:49,0,0,@ Neil_Iyengar @ dr_ashwitt Wonder if age adjusted colorectal rates? India shorter life expect & no screening will 'lower' CRC rates. # ASCO14,,@ @,#,4.7322E+17,https://twitter.com/DamianFog/status/473219708884631552,,,,
urotoday,6/1/2014 17:49,0,0,# ASCO14 - Association of somatic ERCC2 mutations with cisplatin sensitivity in muscle-invasive ... http://dlvr.it/5rbWwr,,,#,4.7322E+17,https://twitter.com/urotoday/status/473219705864339456,,,,
chadinabhan,6/1/2014 17:49,1,1,Enzalutamide (Xtandi) improved all outcome measures in mCRPC in chemotherapy-naive patients. Beer et al. # ASCO14 http://www.nejm.org/doi/full/10.1056/NEJMoa1405095?query=OF …,,,#,4.7322E+17,https://twitter.com/chadinabhan/status/473219697950064640,,,,
subatomicdoc,6/1/2014 17:49,3,2,"@ fischmd: In 2013, 82K cancer related tweets from 4K doctors --> research from @ mtmdphd @ brianreid # ASCO14",,@ @ @,#,4.7322E+17,https://twitter.com/subatomicdoc/status/473219694749446144,,,,
jrgralow,6/1/2014 17:49,1,0,Can't read mine w/out glasses! MT @ scientre: . @ fischmd likes Twitter handles on # ASCO14 badges- hopes they'll be in bigger print in future!,,@ @,#,4.7322E+17,https://twitter.com/jrgralow/status/473219693059526657,,,,
DrHedrick,6/1/2014 17:48,0,0,"Morrow: Proportion of surgery costs 25% in 2002. Likely less today, more costly drugs, outpt surgery, etc. # ASCO14",,,#,4.7322E+17,https://twitter.com/DrHedrick/status/473219660947537920,,,,
scientre,6/1/2014 17:48,2,1,". @ fischmd hashtags on TV, at events & # ASCO14 of course helps connect people around common interests",,@,#,4.7322E+17,https://twitter.com/scientre/status/473219646762786816,,,,
DrAttai,6/1/2014 17:48,2,0,"Morrow costs probably lower today due to sentinel node biopsy, other factors # ASCO14 # bcsm",,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473219639301128194,,,,
DrAttai,6/1/2014 17:48,1,2,Morrow: surgery accounts for 25% of year 1 costs of breast cancer care based on 2002 Medicare data. Good value for $ # ASCO14 # bcsm,,,# #,4.7322E+17,https://twitter.com/DrAttai/status/473219522686894081,,,,
OncologyTimes,6/1/2014 17:48,0,0,"In post-plenary discussion for LBA2, in addition to C Sweeney & M Morris, on panel are Ian Tannock and Maha Hussain # ASCO14",,,#,4.73219E+17,https://twitter.com/OncologyTimes/status/473219498745405442,,,,
DrBobGoldberg,6/1/2014 17:48,1,0,@ MMarchioneAP how will @ asco value app address all innovation. Will never keep up unless it becomes NICE # ascorationing,,@ @,#,4.73219E+17,https://twitter.com/DrBobGoldberg/status/473219449529851904,,,,
myPathMelanoma,6/1/2014 17:48,2,1,"Don't forget to stop by our poster presentation tomorrow, Monday, June 2 from 8am-12:45pm! # ASCO14",,,#,4.73219E+17,https://twitter.com/myPathMelanoma/status/473219438607491072,,,,
subatomicdoc,6/1/2014 17:47,1,0,"@ fischmd: Facebook: 1.28B, Twitter 255 million monthly users as of 4/2014 # ASCO14",,@,#,4.73219E+17,https://twitter.com/subatomicdoc/status/473219425466712065,,,,
JSweetenhamMD,6/1/2014 17:47,0,0,Debate on surveillance imaging in lymphoma about to start at # ASCO14 - time for a change to NCCN guidelines? @ huntsmancancer,,@,#,4.73219E+17,https://twitter.com/JSweetenhamMD/status/473219415660826625,,,,
cancersupport,6/1/2014 17:47,0,1,Early chemo in hormone sensitive prostate cancer shows impressive survival data # asco2014,,,#,4.73219E+17,https://twitter.com/cancersupport/status/473219380105338880,,,,
Medicalfacts,6/1/2014 17:47,1,0,# ASCO14 Toevoeging docetaxel aan hormoontherapie verlengt leven van mannen met uitgezaaide hormoongevoelige... http://is.gd/eotvGI,,,#,4.73219E+17,https://twitter.com/Medicalfacts/status/473219368583974912,,,,
DrAttai,6/1/2014 17:47,1,1,Morrow - Local Therapy for patients with DCIS and early-stage disease - balancing value and outcome # ASCO14 # bcsm,,,# #,4.73219E+17,https://twitter.com/DrAttai/status/473219272345673728,,,,
jrgralow,6/1/2014 17:47,0,1,Works better if given w/ chemo- 1/2 in ALTTO got it after! MT @ ProfJohnCrown: Underestimated effect of trastuzumab in early studies. # ASCO14,,@,#,4.73219E+17,https://twitter.com/jrgralow/status/473219270802153473,,,,
premal2000,6/1/2014 17:47,0,0,@ DrLCohen @ fischmd @ ASCO @ CliffordHudis Only if healthier products are price effective. Easier said than done.,,@ @ @ @,,4.73219E+17,https://twitter.com/premal2000/status/473219250308411393,,,,
carisls,6/1/2014 17:46,1,1,Dr. Spetzler discusses groundbreaking Caris Molecular Intelligence data for recurrent # ovarian cancer http://goo.gl/uMLpdm # ASCO14,,,# #,4.73219E+17,https://twitter.com/carisls/status/473219160806543360,,,,
scientre,6/1/2014 17:46,0,2,. @ fischmd likes Twitter handles on # ASCO14 badges...but hopes they'll be in bigger print in future!,,@,#,4.73219E+17,https://twitter.com/scientre/status/473219154808700928,,,,
subatomicdoc,6/1/2014 17:46,1,1,"@ fischmd: 5 types of social media: networking, microblogging, blogging, media sharing, bookmarking # ASCO14",,@,#,4.73219E+17,https://twitter.com/subatomicdoc/status/473219118519177216,,,,
sesaz,6/1/2014 17:46,0,0,“ @ mtmdphd: Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlYmw ” # MedEd # hcsm,,@ @,# # #,4.73219E+17,https://twitter.com/sesaz/status/473219078035734528,,,,
RyanJWitt,6/1/2014 17:45,0,1,It's only fitting to tweet shout out @ fischmd and @ mtmdphd when you're seeing them in person. # ASCO14 pic.twitter.com/2Ipntbsj23,,@ @,#,4.73219E+17,https://twitter.com/RyanJWitt/status/473218906820055040,,,,
WileyOnc_Hem,6/1/2014 17:45,0,0,More than 14.5 mil cancer survivors in US based on @ ACSNews release for # NationalCancerSurvivorsDay at # ASCO14 @ ASCO http://ow.ly/3lfAxu,,@ @,# #,4.73219E+17,https://twitter.com/WileyOnc_Hem/status/473218898058551296,,,,
subatomicdoc,6/1/2014 17:45,2,2,@ fischmd will start with guidelines on social media and social networking # ASCO14,,@,#,4.73219E+17,https://twitter.com/subatomicdoc/status/473218851677548545,,,,
Boehringer,6/1/2014 17:45,2,3,What are the most common # lungcancer symptoms? Watch this # video to find out: http://bit.ly/1gApTvY > # ASCO14,,,# # #,4.73219E+17,https://twitter.com/Boehringer/status/473218750574239745,,,,
ASCO,6/1/2014 17:45,3,0,"CRC screening rates still low, but improved among black patients w/a tailored navigation system http://bit.ly/1pxrrzq # ASCO14",,,#,4.73219E+17,https://twitter.com/ASCO/status/473218723755864064,,,,
PhRMA,6/1/2014 17:45,2,0,Personalized treatment and care that comes from research and # innovation is crucial for # cancer patients http://bit.ly/1nAxDqP # ASCO14,,,# # #,4.73219E+17,https://twitter.com/PhRMA/status/473218711663296512,,,,
favo_it,6/1/2014 17:45,2,2,Anche in # ASCO14 si parla di preservazione della # fertilità per i malati di # cancro come nella nostra Giornata! http://ep70.eventpilotadmin.com/web/page.php?page=Session&project=ASCOAM14&id=P0S8632 …,,,# # #,4.73219E+17,https://twitter.com/favo_it/status/473218704663412736,,,,
timturnham,6/1/2014 17:45,0,0,"Pt asks @ US_FDA why do trials w/control arm when control is an old, weak drug. FDA says they are open to stopping this practice. # ASCO14",,@,#,4.73219E+17,https://twitter.com/timturnham/status/473218702175768576,,,,
subatomicdoc,6/1/2014 17:44,5,1,"Now getting ready for The Future is Now"" with @ mtmdphd @ scientre @ fischmd at # ASCO14""",,@ @ @,#,4.73219E+17,https://twitter.com/subatomicdoc/status/473218680067588096,,,,
DrAttai,6/1/2014 17:44,2,1,next session - Streamlining Breast Cancer Care - Opportunities and Challenges # ASCO14 # bcsm moderated by Dr. Monica Morrow,,,# #,4.73219E+17,https://twitter.com/DrAttai/status/473218529509244928,,,,
TuftsB,6/1/2014 17:44,0,0,@ rschilsky - Due to ASCO cost rationing approach & truth in advertising 60 minutes will be only 30 minutes long that week. # mliwi # asco14,,@,# #,4.73219E+17,https://twitter.com/TuftsB/status/473218512157417472,,,,
strategicTy,6/1/2014 17:43,0,1,Great surprise visit from Dr Mendelsohn at # asco14 @PhysRelations @ MDAndersonNews http://ow.ly/i/5L5pj,,@PhysRelations @,#,4.73218E+17,https://twitter.com/strategicTy/status/473218343856779266,,,,
ipaulmampilly,6/1/2014 17:43,0,0,# ASCO14 breaking bad news badly adds to upset..only 46.2% of patients in study satisfied with bad news communication..,,,#,4.73218E+17,https://twitter.com/ipaulmampilly/status/473218263778746368,,,,
salutedomani,6/1/2014 17:42,1,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://bit.ly/1ky7aSK,,,#,4.73218E+17,https://twitter.com/salutedomani/status/473217931631796224,,,,
dermanewsok,6/1/2014 17:42,0,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://bit.ly/1ky7aSK,,,#,4.73218E+17,https://twitter.com/dermanewsok/status/473217931493404673,,,,
antoniocaperna,6/1/2014 17:42,0,0,Tumore al seno HER2 positivo: 30 anni di ricerca e terapia # ASCO2014 http://bit.ly/1ky7aSK,,,#,4.73218E+17,https://twitter.com/antoniocaperna/status/473217931191386113,,,,
lilianacast,6/1/2014 17:41,1,0, @ drapaolaceledon: Con solo los resultados del CALGB 80405, el ALTTO y el SOFT," este # ASCO14 está súper interesante!"" De acuerdo!!""",,@,#,4.73218E+17,https://twitter.com/lilianacast/status/473217853500715008,,
AstellasUS,6/1/2014 17:41,3,2,The resources invested into # cancer R&D will continue to produce life-saving results that far exceed cost: http://onphr.ma/SbIUQd # ASCO14,,,# #,4.73218E+17,https://twitter.com/AstellasUS/status/473217778665947136,,,,
DanaHolmes911,6/1/2014 17:40,0,1,"So much data coming out of # ASCO14 , so grateful to those who are behind it. @ VincentRK @ mtmdphd @ brendanweiss @ MayoMyeloma @ szusmani",,@ @ @ @ @,#,4.73218E+17,https://twitter.com/DanaHolmes911/status/473217618607091712,,,,
tomleblancMD,6/1/2014 17:40,1,1,MT @ cancerassassin1: many # crc # cancer # patients will prefer Bev over EGFR-I's due to QOL # ASCO14,,@,# # # #,4.73218E+17,https://twitter.com/tomleblancMD/status/473217568908775424,,,,
AneesChagpar,6/1/2014 17:40,0,0,@ mtmdphd @ Lymphoma_Doc Looking good Mike! @ ASCO # ASCO14,,@ @ @,#,4.73217E+17,https://twitter.com/AneesChagpar/status/473217493302259712,,,,
ASCOPost,6/1/2014 17:39,12,6,"Early Chemotherapy Extends Lives of Men With Prostate Cancer, Study Finds (via @ NYTimes) http://ow.ly/xv05M # ASCO14 # pcsm",,@,# #,4.73217E+17,https://twitter.com/ASCOPost/status/473217379712110592,,,,
OncologyTimes,6/1/2014 17:39,0,0,". @ jrgralow @ MaverickNY @ teamoncology Also, we had been told the results +/- were actually not known until just B4 the presentation # ASCO14",,@ @ @,#,4.73217E+17,https://twitter.com/OncologyTimes/status/473217332567736320,,,,
CareAcross,6/1/2014 17:39,0,0,Targeted lung adenocarcinoma therapies based on genetics:Our article on a # ASCO14 day2 highlight http://ow.ly/xuZYL # LCSM,,,# #,4.73217E+17,https://twitter.com/CareAcross/status/473217322044653569,,,,
nycdoc29,6/1/2014 17:39,0,0,"# ASCO14 -lots of lapatinib bashing post ALTTO data which is unfortunate, good drug in right setting for right patient. Whole reason 4 trial",,,#,4.73217E+17,https://twitter.com/nycdoc29/status/473217255711322112,,,,
jrgralow,6/1/2014 17:39,1,2,Most critical aspect of national cancer control plans succeeding: PATIENT INVOLVEMENT. R Sullivan @Poland-US Cancer mtg # ASCO14,,@Poland,#,4.73217E+17,https://twitter.com/jrgralow/status/473217178276487168,,,,
HemOncToday,6/1/2014 17:38,0,4,# ASCO14 @ CliffordHudis discusses results showing # exemestane superior to tamoxifen for early-stage # BreastCancer http://goo.gl/zmma56,,@,# # #,4.73217E+17,https://twitter.com/HemOncToday/status/473217148794724353,,,,
GoHealio,6/1/2014 17:38,3,0,# ASCO14 @ CliffordHudis discusses results showing # exemestane superior to tamoxifen for early-stage # BreastCancer http://goo.gl/zmma56,,@,# # #,4.73217E+17,https://twitter.com/GoHealio/status/473217147586760704,,,,
heidisa,6/1/2014 17:37,0,1,I shoulda photobombed! ;-) MT @ drdonsdizon: @ ConsanoMolly: And I finally meet @ drdonsdizon in person! # ASCO14 # selfiepic.twitter.com/1ts2C5RDiq,,@ @ @,# #,4.73217E+17,https://twitter.com/heidisa/status/473216903272755201,,,,
_Phenomenome,6/1/2014 17:37,0,0,"Align w/ entities who have resources 2 help stave off the cancer epidemic in the aging, @ ASCO. http://ow.ly/xuZCL # KnowYourRisk # ASCO14",,@,# #,4.73217E+17,https://twitter.com/_Phenomenome/status/473216895060295680,,,,
declangmurphy,6/1/2014 17:37,4,3,Busy start to week with # ASCO14 data streaming on twitter and now enza PREVAIL study in @ nejm today http://www.nejm.org/doi/full/10.1056/NEJMoa1405095?query=featured_home#abstract …,,@,# #abstract,4.73217E+17,https://twitter.com/declangmurphy/status/473216773756436480,,,,
_TheUrologist_,6/1/2014 17:37,0,2,@ AlpineBV_Miller ahh thanks - tweetstream & media blurbs missing a few points & p's ;) # asco14 pic.twitter.com/Vos9V8zR6j,,@,#,4.73217E+17,https://twitter.com/_TheUrologist_/status/473216745508196352,,,,
MalcolmBarrattJ,6/1/2014 17:35,0,1,A history of # lung # cancer # research 1933 to the present # ASCO14 http://am.asco.org/sites/am.asco.org/files/AM14daily-anniv.lung-timeline.pdf …,,,# # # #,4.73216E+17,https://twitter.com/MalcolmBarrattJ/status/473216366972264448,,,,
heidisa,6/1/2014 17:35,0,0,& a better experience. MT @ mtmdphd: Love the science at # ASCO14 but constantly reminded abt Pts watching 4 it 2 translate 2 better medicine,,@,#,4.73216E+17,https://twitter.com/heidisa/status/473216288119328768,,,,
mtmdphd,6/1/2014 17:35,3,2,Hashtag Folksonomy for Cancer Communities on Twitter http://ow.ly/t6LXp Updated w/ Cancer Tag Ontology http://ow.ly/t6M9Y # ASCO14,,,#,4.73216E+17,https://twitter.com/mtmdphd/status/473216198336086016,,,,
Xcenda,6/1/2014 17:35,0,0,# Xcenda presents 2 posters on NSCLC & chronic myelogenous leukemia at # ASCO14 learn more: http://bit.ly/1jXRsje # oncology # hematology,,,# # # #,4.73216E+17,https://twitter.com/Xcenda/status/473216171357904896,,,,
Pat2Munoz,6/1/2014 17:34,1,0,"Feliz Dia, Sobrevivientes! # ASCO14 @ ASCO pic.twitter.com/Tf9YABUEhB",,@,#,4.73216E+17,https://twitter.com/Pat2Munoz/status/473216134645575680,,,,
jrgralow,6/1/2014 17:32,1,1,Or climb a mtn w/ cancer survivors this summer! MT @ drattai: MD recommendations 4 exercise not enough. Combine w/ info & tools # asco14 # bcsm,,@,# #,4.73216E+17,https://twitter.com/jrgralow/status/473215637347905536,,,,
Neil_Iyengar,6/1/2014 17:31,0,1,ALTTO: Adding lapatinib not better. Visit our poster tomorrow re poor tolerability. Add'l nail in coffin. # ASCO14 pic.twitter.com/kzFNCbnGdt,,,#,4.73215E+17,https://twitter.com/Neil_Iyengar/status/473215392329252864,,,,
ASCOPost,6/1/2014 17:31,6,1,Two drug combo boosts ovarian cancer survival (via @ CityOfHope) http://ow.ly/xuZyT # ASCO14 # gynca # ovca,,@,# # #,4.73215E+17,https://twitter.com/ASCOPost/status/473215387786825728,,,,
AneesChagpar,6/1/2014 17:31,0,0,@ ASCO Presenting clinical trials to ALL eligible pts improves care for ALL. Minorities participate when offered trials. @ YaleCancer # ASCO14,,@ @,#,4.73215E+17,https://twitter.com/AneesChagpar/status/473215384578166786,,,,
z_phd,6/1/2014 17:31,0,0,I was there in the room during the first kickoff meeting for ALTTO in 2007. Very excited to see the first report here at # ASCO14!,,,#,4.73215E+17,https://twitter.com/z_phd/status/473215320245940224,,,,
BarringtonJames,6/1/2014 17:31,0,0,"Also, find one of our team at the # ASCO14 conference, take their card and come to the Hyatt bar this evening and we'll buy you a drink!",,,#,4.73215E+17,https://twitter.com/BarringtonJames/status/473215256337338368,,,,
drapaolaceledon,6/1/2014 17:30,0,0,"Con solo los resultados del CALGB 80405, el ALTTO y el SOFT, este # ASCO14 está súper interesante!",,,#,4.73215E+17,https://twitter.com/drapaolaceledon/status/473215140687802368,,,,
SequentaInc,6/1/2014 17:30,0,0,# ASCO14 Tmrw: L. Fong to discuss NGS w/ LymphoSIGHT platform to assess impact of anti-CTLA4 antibody http://ow.ly/xmb1C # immunotherapy,,,# #,4.73215E+17,https://twitter.com/SequentaInc/status/473215010177810432,,,,
ASCO,6/1/2014 17:30,19,2,Preparing for an Epidemic: Cancer Care in an Aging Population http://bit.ly/1u5asEk # ASCO14 # gerionc,,,# #,4.73215E+17,https://twitter.com/ASCO/status/473214981492973568,,,,
ASCO,6/1/2014 17:30,9,7,Dr. Jason A. Dubovsky: Exploring the B-cell receptor pathway http://bit.ly/1lV1FPl # ASCO14,,,#,4.73215E+17,https://twitter.com/ASCO/status/473214979496505344,,,,
ecancer,6/1/2014 17:30,0,1,"Dr Pérol: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC, watch now http://bit.ly/T4I8ow # ASCO14",,,#,4.73215E+17,https://twitter.com/ecancer/status/473214951356919808,,,,
Xcenda,6/1/2014 17:30,1,0,Great sessions at # ASCO14! How do your treatment decisions compare to your colleagues? Share here: http://bit.ly/ascox # oncology,,,# #,4.73215E+17,https://twitter.com/Xcenda/status/473214947275440130,,,,
BarringtonJames,6/1/2014 17:29,0,0,"If you want to learn how to play spoof, our team will be in red ties teaching it in the bar of the Hyatt soon # ASCO14 # GameOn",,,# #,4.73215E+17,https://twitter.com/BarringtonJames/status/473214868787855361,,,,
DrLen,6/1/2014 17:29,0,0,@ ScottRiccioLLS Obviously there are pts RX for cure who develop met disease. The ? is going to be how many are hi vs lo volume # ASCO14,,@,#,4.73215E+17,https://twitter.com/DrLen/status/473214814337368065,,,,
AlpineBV_Miller,6/1/2014 17:29,0,0,@ _TheUrologist_ The data were negative except in very high risk men with big disease burden. 70% had no local therapy. # ASCO14,,@,#,4.73215E+17,https://twitter.com/AlpineBV_Miller/status/473214681440862209,,,,
djsampson,6/1/2014 17:28,1,1,Why did # asco14 plenary feature neg trial? Read on: https://twitter.com/maverickny/status/473209343455035392 …,,,#,4.73215E+17,https://twitter.com/djsampson/status/473214612981424128,,,,
jrgralow,6/1/2014 17:28,1,1,Slide at # ASCO14 Polish-US Cooperation on Cancer Rsrch mtg: Think big, act small, dare to fail, stop talking," start acting now"" - L Engelen""",,,#,4.73215E+17,https://twitter.com/jrgralow/status/473214551715225600
NickZdenkowski,6/1/2014 17:28,0,0,"# ALTTO results disappointing at # ASCO14, does this mean that neoadjuvant can only drop the loser, not pick the winner?",,,# #,4.73214E+17,https://twitter.com/NickZdenkowski/status/473214473461710848,,,,
OphiraG,6/1/2014 17:27,0,1,@ IanJohnPereira @ DrJoshuaTepper omg funny! Good @ ASCO year. Greatly enjoyed @ AORTIC_AFRICA events. Others with hands-on experience # cancer,,@ @ @ @,#,4.73214E+17,https://twitter.com/OphiraG/status/473214253931827208,,,,
timturnham,6/1/2014 17:27,0,0,In mtg w/ @ US_FDA Price is not a factor in drug approval; ask if drug is improvement and if is safe. @ CureMelanoma # ASCO14,,@ @,#,4.73214E+17,https://twitter.com/timturnham/status/473214208276852737,,,,
Allan_Zimet,6/1/2014 17:26,0,0,# asco14 Sledge. Success in metastatic disease does not predict success in the adjuvant setting. An old lesson learnt in many diseases.,,,#,4.73214E+17,https://twitter.com/Allan_Zimet/status/473214114891046912,,,,
jrgralow,6/1/2014 17:26,1,1,Great mtg today @ # ASCO14 discussing project 4 improving cancer pathology & ER/other biomarker testing in low/mid income countries. # ASCO14,,@,# #,4.73214E+17,https://twitter.com/jrgralow/status/473214032795930624,,,,
OncLive,6/1/2014 17:25,4,2,"Negative ALTTO Results Reverberate for Lapatinib, Novel Clinical Trials http://ow.ly/xuZ9J # ASCO14",,,#,4.73214E+17,https://twitter.com/OncLive/status/473213671565705216,,,,
CancerTherAdvsr,6/1/2014 17:25,0,0,# ASCO14: Metastatic Tumor Sites Predict OS in Castration Resistant # ProstateCancer http://ow.ly/xuT2j,,,# #,4.73214E+17,https://twitter.com/CancerTherAdvsr/status/473213668516462592,,,,
OncEd,6/1/2014 17:24,1,2,# ASCO14 GI Cancer Video Update - CALGB/SWOG 80405 - Dr. Alan Venook http://bit.ly/1pJXYjd # MedOnc,,,# #,4.73214E+17,https://twitter.com/OncEd/status/473213586303504384,,,,
leitaomd,6/1/2014 17:24,0,0,On way to @ ASCO. Giving talk on vulvovaginal melanoma Monday afternoon. Hope to catch up with colleagues also!,,@,,4.73214E+17,https://twitter.com/leitaomd/status/473213585850900481,,,,
DrZackaryBerger,6/1/2014 17:23,0,1," @ PhRMA: Melanoma R&D nearly doubled survival last 50 yr from 50% to 93.1% http://bit.ly/1nAxDqP # ASCO14"" non-Pharma sources 4 this stat?""",,@,#,4.73213E+17,https://twitter.com/DrZackaryBerger/status/473213159788929025,,,,
drapaolaceledon,6/1/2014 17:22,0,0,Docetaxel + deprivación androgénica mejora sobrevida en cáncer de próstata MT: Abstract LBA2 # ASCO14,,,#,4.73213E+17,https://twitter.com/drapaolaceledon/status/473213046710865920,,,,
ipaulmampilly,6/1/2014 17:21,0,1,# ASCO14 Harvard/MIT Broad Inst study of 5000 tumors across 21 cancer types identified 33 new cancer genes..25% incr..how any more out there?,,,#,4.73213E+17,https://twitter.com/ipaulmampilly/status/473212855190175749,,,,
_TheUrologist_,6/1/2014 17:21,1,2,"Much knuckle-cracking & calisthenics by uros prepping to use abi/enza in pre-chemo mCRPC, now docetaxel leapfrogs again w/ E3805? # asco14",,,#,4.73213E+17,https://twitter.com/_TheUrologist_/status/473212760524722180,,,,
_Phenomenome,6/1/2014 17:21,0,0,. @ chimoose you're in a great place w/ @ ASCO @ RSM2800 @ DrAttai @ CliffordHudis @ DrDonSDizon @ brianreid # ASCO14. We love docs that tweet!,,@ @ @ @ @ @ @,#,4.73213E+17,https://twitter.com/_Phenomenome/status/473212737750044673,,,,
brianreid,6/1/2014 17:20,0,1,# ASCO14: Headed to the @ mtmdphd session on social media use? You may want to check out # SocOncology report: http://bit.ly/SYoydz,,@,# #,4.73213E+17,https://twitter.com/brianreid/status/473212639838208000,,,,
RoswellPark,6/1/2014 17:20,0,0,"Dr. James Marshall, at # ASCO14, reflects on # chemoprevention: successes (like aspirin) few and far between; beta blockers warrant more study",,,# #,4.73212E+17,https://twitter.com/RoswellPark/status/473212467930464256,,,,
genentech,6/1/2014 17:20,8,5,Immunotherapy is going to be big tmrw. Start thinking differently today: http://ow.ly/xuE2c # ASCO14,,,#,4.73212E+17,https://twitter.com/genentech/status/473212454353514496,,,,
Boehringer,6/1/2014 17:20,2,3,"...there was a buzz of excitement in the air and we were welcomed “Good morning doctors”."" # ASCO14 - http://bit.ly/1mE8Htf - # hcsm # hcsmeu""",,,# # #,4.73212E+17,https://twitter.com/Boehringer/status/473212454085099520,,,,
mtmdphd,6/1/2014 17:20,1,3,Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://ow.ly/xlFyu,,@,#,4.73212E+17,https://twitter.com/mtmdphd/status/473212449957900289,,,,
Roche,6/1/2014 17:20,2,2,Image of an investigational 4-plex diagnostic test: http://ow.ly/xp4CO # lcsm # ASCO14 # meded,,,# # #,4.73212E+17,https://twitter.com/Roche/status/473212437714702338,,,,
jrgralow,6/1/2014 17:20,3,3,"Publication of SOFT/TEXT MT @ NEJM In premen br ca, adj tx w/ exemestane & ovarian suppress reduces recurrence # ASCO14 http://nej.md/1hadOUs",,@,#,4.73212E+17,https://twitter.com/jrgralow/status/473212413576495104,,,,
drapaolaceledon,6/1/2014 17:19,0,0,Cubriendo las incidencias de uno de los congresos más importantes en oncología: Congreso Americano de Oncología # ASCO14,,,#,4.73212E+17,https://twitter.com/drapaolaceledon/status/473212200304529409,,,,
CancerNetwrk,6/1/2014 17:19,5,3,Docetaxel With ADT Improves Survival for Metastatic Prostate Cancer Patients http://bit.ly/1tzRRON # ASCO14,,,#,4.73212E+17,https://twitter.com/CancerNetwrk/status/473212139805884416,,,,
Onconet_NL,6/1/2014 17:18,1,1,# obesitas is grootste risicofactor is voor terugkeer van # kanker dus steken oncologen er nog 1 op tijdens # asco14 :( pic.twitter.com/GdehxJd0RS”,,,# # #,4.73212E+17,https://twitter.com/Onconet_NL/status/473211913552551936,,,,
CancerNetwrk,6/1/2014 17:18,0,0,What It Costs to Be an Oncologist http://bit.ly/1tzRN1A # ASCO14,,,#,4.73212E+17,https://twitter.com/CancerNetwrk/status/473211902198579201,,,,
AlpineBV_Miller,6/1/2014 17:18,0,0,"@ EthanBasch1 @ ASCO has no business adjudicating value"". Oncologists should adjudicate efficacy and QoL. # ASCO14""",,@ @,#,4.73212E+17,https://twitter.com/AlpineBV_Miller/status/473211889145905153,,,,
drsam,6/1/2014 17:17,0,0,Annual ASCO # DanaFarber Peds heme-onc ex-pat fellows reunion tonight! For those who left the mother ship and survived! # ASCO14,,,# #,4.73212E+17,https://twitter.com/drsam/status/473211679962955780,,,,
PhRMA,6/1/2014 17:17,11,2,Melanoma R&D has led to # patient survival rates nearly doubling in the last 50 years from 50% to 93.1% http://bit.ly/1nAxDqP # ASCO14,,,# #,4.73212E+17,https://twitter.com/PhRMA/status/473211642210050050,,,,
_Phenomenome,6/1/2014 17:16,0,1,Investigators exploring innovative chemoprevention/cancer prevention avenues http://bit.ly/1n0vy3V via @ ASCO # ASCO14,,@,#,4.73212E+17,https://twitter.com/_Phenomenome/status/473211538795671552,,,,
subatomicdoc,6/1/2014 17:16,4,7,@ iurojc I'll be mentioning # urojc in my social media talk tomorrow at # ASCO14 - other specialties should see what you're doing # kudos,,@,# # #,4.73211E+17,https://twitter.com/subatomicdoc/status/473211415424421888,,,,
teamoncology,6/1/2014 17:15,2,1,@ rsm2800 @ jrgralow Any good hypothesis driven clinical trials should be considered for plenary regardless of the outcome. # ASCO14 # BCSM,,@ @,# #,4.73211E+17,https://twitter.com/teamoncology/status/473211294955208709,,,,
AdnanNagrial,6/1/2014 17:15,1,0,# ASCO14 CALGB 80405 Cetux/Chemo as first-line tx in CRC is not superior to current standard of Bev/Chemo # conflict # FIRE3,,,# # #,4.73211E+17,https://twitter.com/AdnanNagrial/status/473211209030713346,,,,
genentech,6/1/2014 17:15,8,6,Thx! MT @ mtmdphd: Very cool @ genentech - Pipeline Explorer - we need for @ theNCI http://ClinicalTrials.Gov # ASCO14 pic.twitter.com/52VKIHxMVD,,@ @ @,#,4.73211E+17,https://twitter.com/genentech/status/473211156065447937,,,,
AlpineBV_Miller,6/1/2014 17:14,0,0,"@ Pharmafocus Only in very high rissk men, though # ASCO14",,@,#,4.73211E+17,https://twitter.com/AlpineBV_Miller/status/473210969091764225,,,,
jrgralow,6/1/2014 17:14,0,0,LBAs usually accepted before results known. MT @ MaverickNY @ rsm2800 @ teamoncology plenary should be about WOW data! # asco14,,@ @ @,#,4.73211E+17,https://twitter.com/jrgralow/status/473210942101417984,,,,
mjterborg,6/1/2014 17:14,1,2,"Prachtig duidelijke dia!  @ marco_scheller: # ASCO14 - ALTTO...ouch https://twitter.com/marco_scheller/status/473203341187878912/photo/1pic.twitter.com/GxpeiK8lpw "" @ caseofdees # borstkanker""",,@ @,# #,4.73211E+17,https://twitter.com/mjterborg/status/473210901009821698,,,,
teamoncology,6/1/2014 17:14,0,0,The question is whether anti-PD1 or anti-PD-L1 antibody has activity in breast cancer. # ASCO14 # BCSM,,,# #,4.73211E+17,https://twitter.com/teamoncology/status/473210897360379907,,,,
Pharmafocus,6/1/2014 17:14,2,0,Exemestane more effective than standard tamoxifen at preventing breast # cancer recurrence in young women # ASCO14,,,# #,4.73211E+17,https://twitter.com/Pharmafocus/status/473210892432470016,,,,
teamoncology,6/1/2014 17:12,1,1,"@ MaverickNY @ rsm2800 As George has stated, it really makes me think how to formulate the study of the future HER2+ primary BC. # ASCO14 # BCSM",,@ @,# #,4.73211E+17,https://twitter.com/teamoncology/status/473210595437576192,,,,
evaglezhaba,6/1/2014 17:12,2,3,# ASCO14 CALGB/SWOG 80405: Bev and cetuximab equivalent given with standard chemo.” Lo dice un oncólogo!! Equivalentes!!,,,#,4.73211E+17,https://twitter.com/evaglezhaba/status/473210528148754433,,,,
AdnanNagrial,6/1/2014 17:12,0,0,# ASCO14 Docetaxel early in treatment for high volume hormone sens prostate ca improves survival by over a year! Huge result,,,#,4.7321E+17,https://twitter.com/AdnanNagrial/status/473210456845213697,,,,
KathleenMaxian,6/1/2014 17:11,1,1,Dr. Leighton & Dr. Maxian @ LilySue49 @ WNYOCP @ OCNA # ASCO14 # ovariancancerawarenesspic.twitter.com/7WRyMT4cfn,,@ @ @,# #,4.7321E+17,https://twitter.com/KathleenMaxian/status/473210323374059521,,,,
ipaulmampilly,6/1/2014 17:11,0,0,# ASCO14 observation cancer docs love $ sbuxpic.twitter.com/fBvjgxjCet,,,#,4.7321E+17,https://twitter.com/ipaulmampilly/status/473210314641514498,,,,
teamoncology,6/1/2014 17:11,1,1,@ MaverickNY @ rsm2800 To me this neg ALTTO study is a WOW. Hitting my brain so hard. Having dizziness. # ASCO14 # BCSM,,@ @,# #,4.7321E+17,https://twitter.com/teamoncology/status/473210256114208771,,,,
gotoPER,6/1/2014 17:11,3,1,Join @ GoToPER tonight for NSCLC dinner symposium @6pm @Hyatt Regency Chicago-Regency Ballroom # ASCO14 # lcsmpic.twitter.com/BiigRvXm54,,@ @6pm @Hyatt,# #,4.7321E+17,https://twitter.com/gotoPER/status/473210161524670464,,,,
AlpineBV_Miller,6/1/2014 17:10,0,0,"@ rsm2800 He addressed that. This neg trial makes us rethink combos, trial design, and pCR as a surrogate endpoint. # ASCO14",,@,#,4.7321E+17,https://twitter.com/AlpineBV_Miller/status/473210114821066752,,,,
Pharmafocus,6/1/2014 17:10,1,0,Adding docetaxel to first-line hormone therapy in prostate cancer extends overall survival by around 13 months # ASCO14,,,#,4.7321E+17,https://twitter.com/Pharmafocus/status/473210039633997825,,,,
oncodocsydney,6/1/2014 17:10,0,0,Enjoying catching up with fellow ACCORDians outside the main plenary hall. Come say hi! # ASCO14 # ACORD,,,# #,4.7321E+17,https://twitter.com/oncodocsydney/status/473209964849156098,,,,
declangmurphy,6/1/2014 17:10,0,2,@ mdallera @ daviesbj Agree Marc. Just when I thought med-onc was dispensable! # ASCO14,,@ @,#,4.7321E+17,https://twitter.com/declangmurphy/status/473209950504628226,,,,
SitemanCenter,6/1/2014 17:10,0,0,"Siteman's Dr Brian Van Tine chairs a session on the role of novel molecular and metabolic pathways in # sarcoma: 4:45-6 pm, Rm S406 # ASCO14",,,# #,4.7321E+17,https://twitter.com/SitemanCenter/status/473209917030277120,,,,
teamoncology,6/1/2014 17:09,0,2,【 # ASCO14 Update】 Anti–PD-L1 Ab demonstrates activity in certain patients with metastatic Bladder Cancer http://www.ascopost.com/ViewNews.aspx?nid=16275 …,,,#,4.7321E+17,https://twitter.com/teamoncology/status/473209788944236552,,,,
ipaulmampilly,6/1/2014 17:09,1,0,# ASCO14 only 28% oncologists in study felt comfortable discussing costs..even though 83% felt NCCN guidelines should have cost info,,,#,4.7321E+17,https://twitter.com/ipaulmampilly/status/473209683377786880,,,,
MaverickNY,6/1/2014 17:07,0,0,@ rsm2800 @ teamoncology that's why we're not there - plenary should be about WOW data! # asco14,,@ @,#,4.73209E+17,https://twitter.com/MaverickNY/status/473209343455035392,,,,
DrAnasYounes,6/1/2014 17:07,1,0,A break at # ASCO14 pic.twitter.com/TeYYB7nB7G,,,#,4.73209E+17,https://twitter.com/DrAnasYounes/status/473209307572355073,,,,
ipaulmampilly,6/1/2014 17:06,2,1,# ASCO14 72% of patients in study that no health care professional has ever discussed costs with them,,,#,4.73209E+17,https://twitter.com/ipaulmampilly/status/473209059420561411,,,,
NTConnell,6/1/2014 17:06,0,0,My twitter handle @ NTConnell made it onto the main screen during the # ASCO14 plenary pre-show. @ drdonsdizon would be proud...,,@ @,#,4.73209E+17,https://twitter.com/NTConnell/status/473209054266155008,,,,
Pharmafocus,6/1/2014 17:05,1,0,Effectiveness of established # cancer drugs in new settings highlighted at # ASCO14 highlights session,,,# #,4.73209E+17,https://twitter.com/Pharmafocus/status/473208853983543296,,,,
Roche,6/1/2014 17:05,5,6,"Enjoy our latest Drawn to # Science"" video explaining clinical trials! http://ow.ly/xp4vX # ASCO14""",,,# #,4.73209E+17,https://twitter.com/Roche/status/473208649943642112,,,,
corp_UNC,6/1/2014 17:05,0,1,# CER: contemporary adjuvant chemo among older rectal cancer patients @ lundjenny @ hannasanoff et al # hsronc # asco14 http://ow.ly/xulZI,,@ @,# # #,4.73209E+17,https://twitter.com/corp_UNC/status/473208636425396224,,,,
Cognicum,6/1/2014 17:04,0,0,"“ @ ipaulmampilly: # ASCO14 stats 25,500 attendees.feels more like over 30,000 and 400 exhibitors.Browse the attendees! https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …",,@,#,4.73209E+17,https://twitter.com/Cognicum/status/473208600517947393,,,,
khnguyen,6/1/2014 17:04,0,0,"Completely agree. “ @ mtmdphd: Social media is democratising healthcare meetings - eg # ASCO14"",,@,#,473208556230299648""",https://twitter.com/khnguyen/status/473208556230299648,,,,,,,,
gotoPER,6/1/2014 17:04,2,1,"Join @ GoToPER Hear @ YaleTomLynch discuss EGFR, ALK & targeted therapies dinner symposium @6 pm @Hyatt Regency Chicago # lcsm # ASCO14",,@ @ @6 @Hyatt,# #,4.73209E+17,https://twitter.com/gotoPER/status/473208500324417537,,,,
ASCOPost,6/1/2014 17:04,5,2,Investigational Anti–PD-L1 Antibody Shows Promising Activity in Some Pts w/Metastatic Bladder Cancer http://ow.ly/xuXHX # ASCO14 # blcsm,,,# #,4.73208E+17,https://twitter.com/ASCOPost/status/473208377083187200,,,,
DrFloresAyala,6/1/2014 17:03,0,2,Qué tal # ASCO14 Dr @ jeanp27 ?,,@,#,4.73208E+17,https://twitter.com/DrFloresAyala/status/473208302549991426,,,,
teamoncology,6/1/2014 17:03,7,6,MetMab study was not a failure in lung cancer. What did they learn? A nice article to read. http://www.gene.com/asco/lets-talk-about-met … # ASCO14,,,#,4.73208E+17,https://twitter.com/teamoncology/status/473208252713283590,,,,
MedscapePharm,6/1/2014 17:03,0,0,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/MedscapePharm/status/473208236640718850,,,,
MedscapePath,6/1/2014 17:03,1,1,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/MedscapePath/status/473208236602949634,,,,
MedscapeOnc,6/1/2014 17:03,0,0,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/MedscapeOnc/status/473208236565229568,,,,
MedscapeNurses,6/1/2014 17:03,0,0,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/MedscapeNurses/status/473208236535840771,,,,
MedscapeStudent,6/1/2014 17:03,0,0,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/MedscapeStudent/status/473208235885744135,,,,
Medscape,6/1/2014 17:03,0,0,"# ASCO2014 Odds? Medscape's Nick Mulcahy sits down at in the plenary (5K people). Next to Robert Morgan, City of Hope, former interviewee...",,,#,4.73208E+17,https://twitter.com/Medscape/status/473208235843805192,,,,
lynnhanessian,6/1/2014 17:03,0,0,Celebrated memory of Selma Schimmel today. Courage. Inspiration. Passion. Unrelenting drive. Truly remarkable. @ VitalOptions # ASCO2014,,@,#,4.73208E+17,https://twitter.com/lynnhanessian/status/473208227186761731,,,,
ipaulmampilly,6/1/2014 17:03,0,0,# ASCO14 by 2030 cancer incidence going to rise 45% due to aging..Dr. Ronald dePinho MD Anderson cancer center Univ TX,,,#,4.73208E+17,https://twitter.com/ipaulmampilly/status/473208217753772035,,,,
mnewtonPharmD,6/1/2014 17:02,0,0,"ALTTO trial RT @ rsm2800: Sledge: Even though p=0.48, it’s a negative trial. Subgroups similarly uninformative # ASCO14",,@,#,4.73208E+17,https://twitter.com/mnewtonPharmD/status/473208085805543424,,,,
Lymphoma_Doc,6/1/2014 17:02,0,1,"Another beautiful day at # ASCO14, exciting data presented, even more exciting studies in the works. # throughglasspic.twitter.com/RspyCFHtZ4",,,# #,4.73208E+17,https://twitter.com/Lymphoma_Doc/status/473207991005900801,,,,
gotoPER,6/1/2014 17:02,2,1,Join @ GoToPER to hear Dr Soria discuss immunotherapies at lung cancer CME dinner symposium @6pm @Hyatt Regency Chicago # ASCO14 # lcsm,,@ @6pm @Hyatt,# #,4.73208E+17,https://twitter.com/gotoPER/status/473207990515167232,,,,
janinegug,6/1/2014 17:01,0,0,@ ASCO Thank you for the help!,,@,,4.73208E+17,https://twitter.com/janinegug/status/473207853504012290,,,,
robertwalker10,6/1/2014 17:01,0,0,Join @ GoToPER to hear Dr Soria discuss immunotherapies at lung cancer CME dinner symposium @6pm @Hyatt Regency Chicago # ASCO14 # lcsm,,@ @6pm @Hyatt,# #,4.73208E+17,https://twitter.com/robertwalker10/status/473207819492421632,,,,
mtmdphd,6/1/2014 17:01,3,7,Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlYmw,,@,#,4.73208E+17,https://twitter.com/mtmdphd/status/473207609643008001,,,,
ASCO,6/1/2014 17:00,3,4,Read Educational Book articles on topics in GI (Noncolorectal) Cancer from # ASCO14 speakers: http://bit.ly/1mlFDXt,,,#,4.73208E+17,https://twitter.com/ASCO/status/473207585206968321,,,,
Boehringer,6/1/2014 17:00,0,0,PRESS: Refresh your memory on the results of the LUME-LUNG 1 trial http://bit.ly/18EdzYx # lungcancer # ASCO14,,,# #,4.73208E+17,https://twitter.com/Boehringer/status/473207510732926976,,,,
appistry,6/1/2014 17:00,0,0,Do you know about our new On Ramp Program for # NGS analysis? http://ow.ly/xrZin Learn more at our # ASCO14 booth!,,,# #,4.73207E+17,https://twitter.com/appistry/status/473207497705414656,,,,
zorgnieu_ws,6/1/2014 17:00,0,0,# ASCO14 Toevoeging docetaxel aan hormoontherapie verlengt leven van mannen met uitgezaaide hormoongevoelige… http://wp.me/p2ZL1H-6qV,,,#,4.73207E+17,https://twitter.com/zorgnieu_ws/status/473207479124250624,,,,
ProjectInno,6/1/2014 17:00,1,0,"In last 15 years, 50 million life years have been saved due to innovative cancer treatments http://ow.ly/xuVaP # ASCO14 # NCSD14",,,# #,4.73207E+17,https://twitter.com/ProjectInno/status/473207452994129920,,,,
DrGlenWeiss,6/1/2014 17:00,1,0,"True MT @ DrHedrick: Lot of deflation in the room, but >95% 4yr OS Her2+ # bcsm >29 month OS in met CRC seems pretty successful # ASCO14”",,@,# #,4.73207E+17,https://twitter.com/DrGlenWeiss/status/473207436950896642,,,,
GenentechJobs,6/1/2014 17:00,0,0,"Day 3 of # ASCO14. McCormick Place in # Chicago is the place to be on June 1, 2014... http://talent.gene.com/go/1nv6e_ # Genentech",,,# # #,4.73207E+17,https://twitter.com/GenentechJobs/status/473207373994016771,,,,
myriadgenetics,6/1/2014 17:00,1,0,Data at # ASCO14 show Myriad's myRisk test helps solve the overlap dilemma among # hereditarycancer syndromes. TOMORROW at 8:00am in S100a,,,# #,4.73207E+17,https://twitter.com/myriadgenetics/status/473207365580242949,,,,
Advaxis,6/1/2014 17:00,0,1,ADXS-HPV Ph 2 data results were presented during the # Gynecologic # Cancer poster at # ASCO2014 http://bit.ly/1tZWhAr $ ADXS # immunotherapy,,,# # # #,4.73207E+17,https://twitter.com/Advaxis/status/473207365349552128,,,,
DetiffeOncoDNA,6/1/2014 16:59,0,0,# ASCO14 visit us at our booth 5044 and discover our specail offer for OncoDEEP product line pic.twitter.com/Klp1VZ10ND,,,#,4.73207E+17,https://twitter.com/DetiffeOncoDNA/status/473207353115168769,,,,
wordbistro,6/1/2014 16:59,0,0,"YES “ @ LGG1: George Sledge: Biology is messy and science is hard."" # ASCO14”""",,@,#,4.73207E+17,https://twitter.com/wordbistro/status/473207327173382144,,,,
mtmdphd,6/1/2014 16:59,6,7,Very cool @ Genentech - Pipeline Explorer - we need for @ theNCI http://ClinicalTrials.Gov # clinicaltrials # ASCO14 pic.twitter.com/qAi7i1p8Cj,,@ @,# #,4.73207E+17,https://twitter.com/mtmdphd/status/473207184923193344,,,,
harriseve,6/1/2014 16:59,0,1,WORD. MT @ drdonsdizon: NOTE Sexual health suffers on exemestane: 45% libido decrease; this can't B ignored. # BCSM # ASCO14,,@,# #,4.73207E+17,https://twitter.com/harriseve/status/473207166816768000,,,,
teamoncology,6/1/2014 16:59,3,4,HER2 is a good predictor for anti-HER2 drug but not good enough. Need a marker that predict the benefit only to trastuzumab. # ASCO14 # BCSM,,,# #,4.73207E+17,https://twitter.com/teamoncology/status/473207113842315266,,,,
Katsumata_Nori,6/1/2014 16:58,0,1,"Biology is messy, Science is hard. By Dr. Sledge. # ASCO14",,,#,4.73207E+17,https://twitter.com/Katsumata_Nori/status/473207018140889088,,,,
MedscapePharm,6/1/2014 16:58,0,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/MedscapePharm/status/473206942429478914,,,,
MedscapePath,6/1/2014 16:58,0,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/MedscapePath/status/473206942404313088,,,,
MedscapeOnc,6/1/2014 16:58,3,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/MedscapeOnc/status/473206942328823811,,,,
MedscapeNurses,6/1/2014 16:58,0,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/MedscapeNurses/status/473206942286901258,,,,
MedscapeStudent,6/1/2014 16:58,0,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/MedscapeStudent/status/473206942253338625,,,,
Medscape,6/1/2014 16:58,1,0,# ASCO2014 Rise and shine! Medscape has top news every morning at 6:30 am. Visit us and be the first to know the data http://bit.ly/1tQLhFs,,,#,4.73207E+17,https://twitter.com/Medscape/status/473206942186209281,,,,
bproulx,6/1/2014 16:58,0,0,@ SiliconBio showing @ ASCO the only sure way to get 100% pure tumor cells from FFPE tissue preps for genomic analysis - booth 24101,,@ @,,4.73207E+17,https://twitter.com/bproulx/status/473206863413395456,,,,
ArmandOrlandi,6/1/2014 16:57,0,0,TEXT/SOFT Practice changing in breast cancer!!! # ASCO2014,,,#,4.73207E+17,https://twitter.com/ArmandOrlandi/status/473206848728748033,,,,
khnguyen,6/1/2014 16:57,0,0,"We win some battles; we lose many. But we will move on. For all past, current, and future cancer patients. # refusingtobeSisyphus # ASCO14",,,# #,4.73207E+17,https://twitter.com/khnguyen/status/473206711894151168,,,,
teamoncology,6/1/2014 16:57,1,1,"The pCR & long-term outcome impact is not all the same. The large difference comes out in TNBC, not ER or HER2. # ASCO14 # BCSM",,,# #,4.73207E+17,https://twitter.com/teamoncology/status/473206691865972740,,,,
nxtstop1,6/1/2014 16:56,0,0,BREAST CA GENOMICS. @ DrKhouryCDC: Impact of Advances in Genomics on Breast Cancer Precision Medicine http://am.asco.org/unravelling-complexities-breast-cancer-genomics … # ASCO14 @ ASCO”,,@ @,#,4.73207E+17,https://twitter.com/nxtstop1/status/473206596411985921,,,,
jrgralow,6/1/2014 16:56,0,0,"@ AdamsLisa Maybe you wld prefer need to stop enrolling pts who won't recur."" But that means cured. Trouble is knowing who they are! # ASCO14""",,@,#,4.73207E+17,https://twitter.com/jrgralow/status/473206585360404480,,,,
anukPDX,6/1/2014 16:55,0,0,"@ ASCO # ASCO14 Words of wisdom by Dr. George Sledge at Plenary Session conclusion Biology is messy. Science is hard.""""",,@,#,4.73206E+17,https://twitter.com/anukPDX/status/473206309878513665,,,,
ecancer,6/1/2014 16:55,1,0,Catch up on the latest from ASCO 2014 http://bit.ly/U5Zl1C # ASCO14,,,#,4.73206E+17,https://twitter.com/ecancer/status/473206262490877953,,,,
SitemanCenter,6/1/2014 16:55,1,0,Should routine post-treatment imaging for # lymphoma patients end? Join the # ASCO14 debate http://goo.gl/2VBqyX 4:45pm E Arie Crown Theater,,,# #,4.73206E+17,https://twitter.com/SitemanCenter/status/473206156241149952,,,,
LIVESTRONG_NL,6/1/2014 16:55,0,0,Data shows continued long-term effectiveness of immunotherapy in advanced # melanoma http://ow.ly/xuWxX @ DanaFarber @ ASCO via @ DrMisialek,,@ @ @,#,4.73206E+17,https://twitter.com/LIVESTRONG_NL/status/473206145600221184,,,,
teamoncology,6/1/2014 16:55,0,0,"@ rsm2800 Agree a great concern of this ALLTO being negative, it even shakes up neosphere approach. # ASCO14 # BCSM",,@,# #,4.73206E+17,https://twitter.com/teamoncology/status/473206137412530177,,,,
JenniferCKing,6/1/2014 16:54,0,0,Biology is messy and science is hard. - George Sledge # ASCO14,,,#,4.73206E+17,https://twitter.com/JenniferCKing/status/473206008882688000,,,,
mnewtonPharmD,6/1/2014 16:54,1,0,"ALTTO trial disappointing. Adding lapatinib to adjuvant trastuzumab - no benefit, only added toxicity # ASCO14",,,#,4.73206E+17,https://twitter.com/mnewtonPharmD/status/473205918574735360,,,,
mariaviniegra,6/1/2014 16:53,0,0,Estamos muy depres con sledge # asco2014 pic.twitter.com/R1SL0gMUno,,,#,4.73206E+17,https://twitter.com/mariaviniegra/status/473205803600871424,,,,
khnguyen,6/1/2014 16:53,1,0,"Proud of my division chief, Dr. George Sledge. Great talk! # ASCO14",,,#,4.73206E+17,https://twitter.com/khnguyen/status/473205754967506945,,,,
MelPalMD,6/1/2014 16:53,3,0,Sledge on disappointing ALTTO results # ASCO14 pic.twitter.com/oqagnx8bFo,,,#,4.73206E+17,https://twitter.com/MelPalMD/status/473205731433275398,,,,
DrHedrick,6/1/2014 16:53,0,2,"Lot of deflation in the room, but >95% survival Her2+ disease, >29 month OS in metastatic CRC seem an awful lot like success to me. # ASCO14",,,#,4.73206E+17,https://twitter.com/DrHedrick/status/473205724689211392,,,,
rg_oncodoc,6/1/2014 16:53,0,0," @ OncEd: ALTTO Trial - 4 yr OS analysis >95% is all arms - no difference # ASCO14"" dissappointing ALTTO results""",,@,#,4.73206E+17,https://twitter.com/rg_oncodoc/status/473205704648454144,,,,
BioWorld,6/1/2014 16:53,2,2,Sledge at # ASCO14: Hopes and beliefs are no substitutes for the hard work of well-conducted clinical trials,,,#,4.73206E+17,https://twitter.com/BioWorld/status/473205668934332418,,,,
LGG1,6/1/2014 16:53,4,1,"George Sledge: Biology is messy and science is hard."" # ASCO14""",,,#,4.73206E+17,https://twitter.com/LGG1/status/473205645437853696,,,,
fischmd,6/1/2014 16:53,6,6,"“If we cannot trust neoadj and metastatic results to predict the adjuv setting, how will we move forward?...biology is messy” Sledge # ASCO14",,,#,4.73206E+17,https://twitter.com/fischmd/status/473205599145328640,,,,
SiliconBio,6/1/2014 16:52,0,0,@ siliconbio showing the only sure way to get 100% pure tumor cells from FFPE tissue preps for genomic analysis. # ASCO14 booth 24101,,@,#,4.73206E+17,https://twitter.com/SiliconBio/status/473205582334156800,,,,
rsm2800,6/1/2014 16:51,1,1,"Sledge: How to move forward in adjuvant Rx, if we can’t trust neoadj or metastatic results? # ASCO14",,,#,4.73205E+17,https://twitter.com/rsm2800/status/473205330248081412,,,,
mfrimawi,6/1/2014 16:51,0,0,# ALTTO results highlight the importance of selecting the right treatment for each patient based on clinical and molecular features # ASCO14,,,# #,4.73205E+17,https://twitter.com/mfrimawi/status/473205310648512513,,,,
MelPalMD,6/1/2014 16:51,1,0,Sledge at # ASCO14: Are we in an adjuvant crisis with targeted biologics? We need to understand our failures to cure this problem.,,,#,4.73205E+17,https://twitter.com/MelPalMD/status/473205281145368577,,,,
teamoncology,6/1/2014 16:51,3,4,Agree. RT @ DrHedrick: I would argue more important. Negative trials often never even see publication. Avoids repeating failures! # ASCO14,,@,#,4.73205E+17,https://twitter.com/teamoncology/status/473205161691607042,,,,
dramarivirg,6/1/2014 16:51,0,1,Plenaria # ASCO14 ALTTO trial:primer análisis: curvas de SG # cancerdemama HER2+pic.twitter.com/TgLF3g5GpR,,,# #,4.73205E+17,https://twitter.com/dramarivirg/status/473205104779489280,,,,
JoanneWeidhaas,6/1/2014 16:50,0,0,I'm getting depressed. Talking about all of our failures. # ASCO14,,,#,4.73205E+17,https://twitter.com/JoanneWeidhaas/status/473205059250307072,,,,
cancerassassin1,6/1/2014 16:50,1,0,negative trial of anti-VeGF in hepatomas: come to tomorrow's GI non-colorectal oral presentation in PM for details # ASCO14,,,#,4.73205E+17,https://twitter.com/cancerassassin1/status/473205058385887233,,,,
ProfJohnCrown,6/1/2014 16:50,1,0,We consistently underestimated the effect of trastuzumab from early studies. # ASCO14,,,#,4.73205E+17,https://twitter.com/ProfJohnCrown/status/473204988320444416,,,,
jrgralow,6/1/2014 16:50,0,0,Questions FDA preop regist strategy? MT @ fischmd: Sledge # ASCO14 on ALTTO: “negative trial- serious disappointment for entire field” # bcsm,,@,# #,4.73205E+17,https://twitter.com/jrgralow/status/473204973715873792,,,,
rsm2800,6/1/2014 16:50,3,1,"Sledge: Why does targeted Rx fail in the adjuvant setting (not just breast ca)? Wrong drugs, wrong duration, wrong pts? # ASCO14",,,#,4.73205E+17,https://twitter.com/rsm2800/status/473204903783825408,,,,
Medicalfacts,6/1/2014 16:50,0,0,# ASCO14 Toevoeging docetaxel aan hormoontherapie verlengt leven van mannen met uitgezaaide hormoongevoelige prostaatk http://www.medicalfacts.nl/?p=206905,,,#,4.73205E+17,https://twitter.com/Medicalfacts/status/473204866203271168,,,,
ipaulmampilly,6/1/2014 16:49,0,0,# ASCO14 project data sphere..big data for cancer research http://ceo-lsc.org/projectdatasphere …,,,#,4.73205E+17,https://twitter.com/ipaulmampilly/status/473204791242264579,,,,
dramarivirg,6/1/2014 16:49,5,2,Plenaria # ASCO14 ALTTO trial:primer análisis: discusión:no beneficio de combinar lapatinib con Trastuzumab en adyuvancia # cancerdemama HER2+,,,# #,4.73205E+17,https://twitter.com/dramarivirg/status/473204723034894336,,,,
BioWorld,6/1/2014 16:49,7,2,"Given the serious consequences of publication bias, it's heartening to see a negative result in the plenary at # ASCO14.",,,#,4.73205E+17,https://twitter.com/BioWorld/status/473204668164997120,,,,
teamoncology,6/1/2014 16:49,3,6,"Do not agree w/ a failure."" No failure in a hypothesis-drive clinical trials. The hypothesis is rejected but not ""a failure. # ASCO14 # BCSM""",,,# #,4.73205E+17,https://twitter.com/teamoncology/status/473204591954116609,,,,
DrMisialek,6/1/2014 16:48,6,3,"MT @ fischmd # ASCO14 median US income $51,371 one cancer drug wipes it out, testing also expensive http://www.costsofcare.org/the-cost-of-laboratory-testing/ … @ CostsofCare",,@ @,#,4.73205E+17,https://twitter.com/DrMisialek/status/473204557863198720,,,,
drdonsdizon,6/1/2014 16:48,2,1,G. Sledge re ALLTO: This is a negative trial. Implication: Neoadj dual HER2 incr pCR but no survival benefit. # bcsm # ASCO14,,,# #,4.73205E+17,https://twitter.com/drdonsdizon/status/473204552414822403,,,,
DrHedrick,6/1/2014 16:48,2,1,@ teamoncology @ rsm2800 I would argue more important. Negative trials often never even see publication. Avoids repeating failures! # ASCO14,,@ @,#,4.73205E+17,https://twitter.com/DrHedrick/status/473204510983086082,,,,
rsm2800,6/1/2014 16:48,1,1,"Sledge: Neosphere-impressive pCR w/ dual blockade, but so did L+T in neoALTTO “not a confidence booster for this approach” # ASCO14",,,#,4.73204E+17,https://twitter.com/rsm2800/status/473204449041584129,,,,
caseofdees,6/1/2014 16:48,3,4,Héél goed. Ook trials waar géén positief resultaat uit komt worden gepresenteerd op # ASCO14. Dat is een stap voorwaarts !! # borstkanker,,,# #,4.73204E+17,https://twitter.com/caseofdees/status/473204420487151616,,,,
BreastDocUK,6/1/2014 16:48,0,0,@ rsm2800 Because negative trials force us to lick wounds inflicted by our hubris. Pausing to reflect on failure is so important # ASCO14,,@,#,4.73204E+17,https://twitter.com/BreastDocUK/status/473204404422987776,,,,
salutedomani,6/1/2014 16:48,0,0,"Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at # ASCO2014 http://lnkd.in/dA7DBM5",,,#,4.73204E+17,https://twitter.com/salutedomani/status/473204377881034752,,,,
TuftsB,6/1/2014 16:48,0,0,Suggested ASCO panel. What value do administrators add to patient cancer care? Trick question - answer is 0. # MLIWI # ASCO14,,,# #,4.73204E+17,https://twitter.com/TuftsB/status/473204374056206337,,,,
ProfJohnCrown,6/1/2014 16:48,1,0,One reason we are so disappointed with failure of lap-as we were with Bev at SABCC- is that trastuzumab is better than we thought! # ASCO14,,,#,4.73204E+17,https://twitter.com/ProfJohnCrown/status/473204362010177536,,,,
DrFloresAyala,6/1/2014 16:48,0,1," @ anelcabrera: Taxotere en combinación con ADT primera línea en próstata"" // # ASCO14""",,@,#,4.73204E+17,https://twitter.com/DrFloresAyala/status/473204341932052480,,,,
halawani_hafez,6/1/2014 16:47,0,0,@ drallysonocean dr ocean Iike to get together if you have time @ asco. I am@convention ctr,,@ @ @convention,,4.73204E+17,https://twitter.com/halawani_hafez/status/473204140529561601,,,,
stuartgiles01,6/1/2014 16:47,3,3,Absolutely wonderful stay @ LanghamChicago - will be back @ ASCO with @ cathiereid for sure # langhamlovepic.twitter.com/83mMJBs53m,,@ @ @,#,4.73204E+17,https://twitter.com/stuartgiles01/status/473204120770191361,,,,
teamoncology,6/1/2014 16:47,4,1,Important to present. RT @ rsm2800: Sledge re ALTTO: “Disappointing.” So why is a negative trial being presented at a plenary? # ASCO14,,@,#,4.73204E+17,https://twitter.com/teamoncology/status/473204111316230146,,,,
OncEd,6/1/2014 16:47,1,2,Dr. Sledge - We need to re-think our approach to development of new drugs in EBC. Questions the role of pCR in drug development. # ASCO14,,,#,4.73204E+17,https://twitter.com/OncEd/status/473204095159767040,,,,
jrgralow,6/1/2014 16:47,0,0,"@ myelomacinderel @ Rfonsi1 Patient's choice, but w/ full discussion of REALISTIC expectation of benefit & toxicity (incl financial). # ASCO14",,@ @,#,4.73204E+17,https://twitter.com/jrgralow/status/473204085685231616,,,,
JoanneWeidhaas,6/1/2014 16:46,0,0,Hopes dashed that pCR predicts better outcome. Sigh. # ASCO14,,,#,4.73204E+17,https://twitter.com/JoanneWeidhaas/status/473204034837291009,,,,
rsm2800,6/1/2014 16:46,1,1,Sledge: “The null hypothesis won.” # asco14,,,#,4.73204E+17,https://twitter.com/rsm2800/status/473204024326373376,,,,
dramarivirg,6/1/2014 16:46,0,0,Plenaria # ASCO14 curvas SG Exemestane+SO vs Tamoxifeno+ SO # cancerdemama RH positivos premenopausicaspic.twitter.com/D8Jr0iYkeu,,,# #,4.73204E+17,https://twitter.com/dramarivirg/status/473203985164537856,,,,
dramarivirg,6/1/2014 16:46,0,0,Plenaria # ASCO14 curvas SLE Exemestane+SO vs Tamoxifeno+ SO # cancerdemama RH positivos premenopausicaspic.twitter.com/Glyx8H9dlY,,,# #,4.73204E+17,https://twitter.com/dramarivirg/status/473203898938040322,,,,
charlesryanmd,6/1/2014 16:45,0,0,kudos to Chris Sweeney and ECOG for taking 3805 to finish line. Change in SOC for those at high risk. Let's keep pushing envelope # asco2014,,,#,4.73204E+17,https://twitter.com/charlesryanmd/status/473203821989351424,,,,
dhjutsw1,6/1/2014 16:45,0,0,"@ ASCO Former ASCO Pres. George Sledge: the results of ALTTO not a Great Leap Forward"". A negative trial. pic.twitter.com/NCcK7QY00H""",,@,,4.73204E+17,https://twitter.com/dhjutsw1/status/473203784508641280,,,,
fischmd,6/1/2014 16:45,8,3,Sledge at # ASCO14 on ALLTO trial: “this is a negative trial...a serious disappointment for the entire field.” # bcsm,,,# #,4.73204E+17,https://twitter.com/fischmd/status/473203712970997760,,,,
teamoncology,6/1/2014 16:45,0,0,@ ChrisHeery Most patients do not want to get chemo for hormone receptor positive breast cancer. # ASCO14,,@,#,4.73204E+17,https://twitter.com/teamoncology/status/473203673216991233,,,,
nxtstop1,6/1/2014 16:45,0,0,"@ MunTheLoon @ ASCO And Add Social Media: Those Few Are A Tour de Force"" ! # ASCO14""",,@ @,#,4.73204E+17,https://twitter.com/nxtstop1/status/473203657253457922,,,,
caseofdees,6/1/2014 16:45,0,0,@ rsm2800 ALTTO: Geen verschil in overleving tussen 2 armen maar overleving was 95% (TOP voor HER2+ ziekte; zagen we nóóit voor 2005) # asco14,,@,#,4.73204E+17,https://twitter.com/caseofdees/status/473203628980056065,,,,
ASCO,6/1/2014 16:45,6,4,"Minorities, older pts less likely to hear about clin trials, but as likely as others to enroll when aware http://bit.ly/1hNabP9 # ASCO14",,,#,4.73204E+17,https://twitter.com/ASCO/status/473203619144429568,,,,
CancerTherAdvsr,6/1/2014 16:45,0,0,'Excellent' Survival in Biology-based Pediatric # Neuroblastoma Treatment Reduction # ASCO14 http://ow.ly/xuQxl,,,# #,4.73204E+17,https://twitter.com/CancerTherAdvsr/status/473203598630068224,,,,
FollowHeidi,6/1/2014 16:44,0,0,"George Sledge is speaking at # ASCO14 right now. I have a rock star/superhero oncologist, ladies and gentlemen. # savedmylife # and mybaby",,,# # #,4.73204E+17,https://twitter.com/FollowHeidi/status/473203513892544513,,,,
VincentRK,6/1/2014 16:44,1,1,We need to have value based pricing. Wake up @ Rfonsi1: it is a monopoly out there. See http://bit.ly/1hMVcEK @ jrgralow @ ASCOPost # ASCO14”,,@ @ @,#,4.73203E+17,https://twitter.com/VincentRK/status/473203471806504961,,,,
rsm2800,6/1/2014 16:44,0,1,Sledge: Referencing colleague’s Tatiana Prowell’s NEJM paper about pCR & accelerated drug approval in early breast ca # asco14,,,#,4.73203E+17,https://twitter.com/rsm2800/status/473203446120587265,,,,
corp_UNC,6/1/2014 16:44,0,0,MT @raphaelyechieli: @ ASCO @ CancerNetwrk Noam Vanderwalde @ UNC_Lineberger on geriatric oncology http://www.cancernetwork.com/asco-2014/blogs/personalized-care-vs-precise-care-geriatric-oncology-model … # asco14 # gerionc,,@raphaelyechieli @ @ @,# #,4.73203E+17,https://twitter.com/corp_UNC/status/473203426139308032,,,,
ConsanoMolly,6/1/2014 16:44,2,3,Photo op with my friend @ heidisa -- # ASCO14: Bringing friends from around the country together! pic.twitter.com/wz8zAmjQaF,,@,#,4.73203E+17,https://twitter.com/ConsanoMolly/status/473203333889818624,,,,
chadinabhan,6/1/2014 16:43,0,1,Officially published. Ibrutinib improved all outcome measures compared with ofatumumab in relapsed CLL. # ASCO14 http://www.nejm.org/doi/full/10.1056/NEJMoa1400376?query=OF …,,,#,4.73203E+17,https://twitter.com/chadinabhan/status/473203286427049986,,,,
MTomasson,6/1/2014 16:43,0,0,+1 RT @ VincentRK: Have to disagree with you on this MT “ @ Rfonsi1: @ jrgralow yes for me? - price controls - will kill innovation # ASCO14,,@ @ @,#,4.73203E+17,https://twitter.com/MTomasson/status/473203271939944448,,,,
DrGlenWeiss,6/1/2014 16:43,0,0,MT @ fischmd: New benchmarks for 1st line treatment of met # colorectal cancer: >29 month median surv # ASCO14 # crcsm progress over hx 9month!,,@,# # #,4.73203E+17,https://twitter.com/DrGlenWeiss/status/473203196585074688,,,,
CardioOncology,6/1/2014 16:43,0,1,"“ @ drattai: Same RFs as for heart dz: obesity, exercise, alcohol, smoking because these factors so important # asco14 # bcsm”",,@,# #,4.73203E+17,https://twitter.com/CardioOncology/status/473203184748756994,,,,
rsm2800,6/1/2014 16:43,3,3,Sledge re ALTTO: “Disappointing.” “A failure.” So why is a negative trial being presented at a plenary? # ASCO14,,,#,4.73203E+17,https://twitter.com/rsm2800/status/473203144004878336,,,,
OncEd,6/1/2014 16:42,0,0,ASCO Discussant Dr. George Sledge - ALTTO - 'A Serious Disappointment' # ASCO14,,,#,4.73203E+17,https://twitter.com/OncEd/status/473202974034890752,,,,
VincentRK,6/1/2014 16:42,0,1,Have to disagree with you on this MT “ @ Rfonsi1: @ jrgralow yes for me? - price controls - will kill innovation # ASCO14”,,@ @,#,4.73203E+17,https://twitter.com/VincentRK/status/473202946276999169,,,,
rsm2800,6/1/2014 16:42,0,0,"Sledge: Even though p=0.48, it’s a negative trial. Subgroups similarly uninformative # ASCO14",,,#,4.73203E+17,https://twitter.com/rsm2800/status/473202918045147137,,,,
MunTheLoon,6/1/2014 16:41,2,4,Never believe that a few caring people can't change the world. For, indeed," that's all who ever have."" - Margaret Mead @ ASCO # ASCO14""",,@,#,4.73203E+17,https://twitter.com/MunTheLoon/status/473202755109412864,,
grhyasen,6/1/2014 16:41,4,1,IO biomarker discussion $ AZN $ MRK $ BMY $ RHHBY RT @ JacobEPVantage: Dr Sharma conclusion slide from yesterday # ASCO14 pic.twitter.com/pGzDoRyDYF,,@,#,4.73203E+17,https://twitter.com/grhyasen/status/473202738126663680,,,,
teamoncology,6/1/2014 16:41,0,0,@ jrgralow @ rsm2800 Agree that we can not lump ER+ HER2+ and ER- HER2+ diseases. # ASCO14 # bcsm,,@ @,# #,4.73203E+17,https://twitter.com/teamoncology/status/473202737169956865,,,,
subatomicdoc,6/1/2014 16:41,2,2,@ djsampson I have suggestions tomorrow on lung cancer screening. Posting on @ ASCO Connection blog # lcsm # ASCO14,,@ @,# #,4.73203E+17,https://twitter.com/subatomicdoc/status/473202732766347264,,,,
jrgralow,6/1/2014 16:41,1,1,Many Avenues Being Explored for Cancer Prevention # ASCO14 Annual Meeting http://am.asco.org/many-avenues-being-explored-cancer-prevention#.U4uP6r9W1K8.twitter …,,,# #,4.73203E+17,https://twitter.com/jrgralow/status/473202690067927040,,,,
CardioOncology,6/1/2014 16:41,11,5,"Obesity is on its way to replacing tobacco as the number one preventable/modifiable cause of cancer.” - @ CliffordHudis # ASCO14”""",,@,#,4.73203E+17,https://twitter.com/CardioOncology/status/473202672951390208,,,,
rsm2800,6/1/2014 16:41,0,0,"Sledge: Event rate lower than expected, so result is ALTTO is underpowered # sobering # asco14",,,# #,4.73203E+17,https://twitter.com/rsm2800/status/473202667942985730,,,,
cancerassassin1,6/1/2014 16:40,0,0,Neuro-Onc perspective on ALTTO: I'd be interested in subset analyses for brain mets considering Lapatinib crossing BBB better # ASCO14,,,#,4.73203E+17,https://twitter.com/cancerassassin1/status/473202505715691521,,,,
Boehringer,6/1/2014 16:40,2,3,"An investment in knowledge pays the best interest"" - Benjamin Franklin. Share what you have learned @ ASCO today? # TIL # ASCO14 # quote""",,@,# # #,4.73202E+17,https://twitter.com/Boehringer/status/473202403060514816,,,,
dermanewsok,6/1/2014 16:40,1,0,Tumore prostata: i risultati dello studio PREVAIL con Enzalutamide su NEJM # asco2014 http://bit.ly/1hprL18,,,#,4.73202E+17,https://twitter.com/dermanewsok/status/473202391659982850,,,,
salutedomani,6/1/2014 16:40,0,0,Tumore prostata: i risultati dello studio PREVAIL con Enzalutamide su NEJM # asco2014 http://bit.ly/1hprL18,,,#,4.73202E+17,https://twitter.com/salutedomani/status/473202390288453635,,,,
antoniocaperna,6/1/2014 16:40,1,1,Tumore prostata: i risultati dello studio PREVAIL con Enzalutamide su NEJM # asco2014 http://bit.ly/1hprL18,,,#,4.73202E+17,https://twitter.com/antoniocaperna/status/473202389407629314,,,,
rsm2800,6/1/2014 16:40,0,0,Sledge: Notes that the 8300+ pts in ALLTTO were accrued pretty quickly (< 4yrs) # asco14,,,#,4.73202E+17,https://twitter.com/rsm2800/status/473202363914665984,,,,
jrgralow,6/1/2014 16:40,4,1,. @ teamoncology @ rsm2800: I think HER2+ disease that is ER+ is different than ER-. Can't even lump all HER2+ together anymore! # ASCO14 # bcsm,,@ @,# #,4.73202E+17,https://twitter.com/jrgralow/status/473202363642417152,,,,
myelomacinderel,6/1/2014 16:39,0,0,@ jrgralow @ WilliamDale_MD Yes. Happy wives take care of husband's health make sure of check-up. Call it the Couric effect. # ASCO14,,@ @,#,4.73202E+17,https://twitter.com/myelomacinderel/status/473202284844027904,,,,
subatomicdoc,6/1/2014 16:39,0,0,"@TT_MDAnderson Thanks, Ty! Great meeting you, let me know how I can help # radonc efforts # ASCO14",,@TT_MDAnderson,# #,4.73202E+17,https://twitter.com/subatomicdoc/status/473202268503027712,,,,
rsm2800,6/1/2014 16:39,0,0,"Sledge: Why lapatinib? Blocks EGFR and HER2, and L+T combo clearly had activity # asco14",,,#,4.73202E+17,https://twitter.com/rsm2800/status/473202122964471809,,,,
CardioOncology,6/1/2014 16:39,0,0,"“ @ rsm2800: ALTTO: In retrospect, low cardiotoxicity may have meant min her2 acticity # CardioOnc # asco14”",,@,# #,4.73202E+17,https://twitter.com/CardioOncology/status/473202119588470785,,,,
drdonsdizon,6/1/2014 16:39,0,0,@ ChrisHeery perhaps it should be in men with high risk disease. These data seem to support its value. # ASCO14,,@,#,4.73202E+17,https://twitter.com/drdonsdizon/status/473202079998443520,,,,
z_phd,6/1/2014 16:39,4,5,I don't think I will ever get tired of listening to George Sledge talk about clinical research. # ASCO14,,,#,4.73202E+17,https://twitter.com/z_phd/status/473202072650002434,,,,
DrMiguelPerales,6/1/2014 16:38,0,0,MT @ mtmdphd . @ DrAnasYounes # lymsm # ASCO14 - MSKCC 11-142 @ sloan_kettering - Results for first 33 evaluable Ptspic.twitter.com/pRN50STy9I,,@ @ @,# #,4.73202E+17,https://twitter.com/DrMiguelPerales/status/473202046577803265,,,,
DrBobGoldberg,6/1/2014 16:38,1,0,. @ rschilsky @ DrBobGoldberg: every discussion @ asco on value begins & ends w denying meds to dying patients. Can we say bias lawsuit ?,,@ @ @,,4.73202E+17,https://twitter.com/DrBobGoldberg/status/473201965586210816,,,,
TargetedOnc,6/1/2014 16:38,0,3,Promise Seen With EGFR Inhibitor CO-1686 in Treatment-Resistant NSCLC http://www.targetedonc.com/conference/asco-2014/Promise-Seen-With-EGFR-Inhibitor-CO-1686-in-Treatment-Resistant-NSCLC … # ASCO14,,,#,4.73202E+17,https://twitter.com/TargetedOnc/status/473201962134302720,,,,
ConsanoMolly,6/1/2014 16:38,0,0,Can't resist the bling - so great to see you Heidi! RT @ heidisa Winner of Best Lanyard Award: @ ConsanoMolly ! # ASCO14 pic.twitter.com/LzfgBCPOEL,,@ @,#,4.73202E+17,https://twitter.com/ConsanoMolly/status/473201899982684161,,,,
cancerassassin1,6/1/2014 16:38,0,1,"Technology over past decade has been useful for large meetings like # ASCO14 Mtg apps, tablets, etc Anyone using # google Glass? @ googledevs",,@,# #,4.73202E+17,https://twitter.com/cancerassassin1/status/473201888377049088,,,,
jrgralow,6/1/2014 16:38,1,3,YES & ovary supp needed MT @ drdonsdizon Sexual hlth suffers on exemestane: 52% vag dryness 45% libido decrease 31% dyspareunia # BCSM # ASCO14,,@,# #,4.73202E+17,https://twitter.com/jrgralow/status/473201874947297280,,,,
dramarivirg,6/1/2014 16:38,1,1,Plenaria # ASCO14 dra Picart: # cancerdemama ALTTO trial: no beneficio en SLE la combinación del lapatinib+ Trastuzumab en pacientes HER2+,,,# #,4.73202E+17,https://twitter.com/dramarivirg/status/473201858698547201,,,,
drsam,6/1/2014 16:38,0,1,"Tried # googleglass at the # imbruvica booth at # ASCO14. Cool technology, but definitely not for me. pic.twitter.com/AQsZwEYIbx",,,# # #,4.73202E+17,https://twitter.com/drsam/status/473201830303129600,,,,
rsm2800,6/1/2014 16:37,1,0,Sledge: Can’t think of a more obvious discussant for ALTTO than Dr. Sledge # ASCO14,,,#,4.73202E+17,https://twitter.com/rsm2800/status/473201758722740225,,,,
BioWorld,6/1/2014 16:37,0,0,"The echoing, accented voice. The multiple screens. Darkness. Plenary session # ASCO14 # bladerunner",,,# #,4.73202E+17,https://twitter.com/BioWorld/status/473201689496145921,,,,
salutedomani,6/1/2014 16:37,0,0,"TUMORE, AIOM: RISPARMI DALLA PREVENZIONE, 6 MILIARDI DI EURO IN 5 ANNI # asco2014 http://lnkd.in/dh9Px6z",,,#,4.73202E+17,https://twitter.com/salutedomani/status/473201681623044096,,,,
drdonsdizon,6/1/2014 16:37,0,0,@ rsm2800 and only answered in a randomized clinical trial # ASCO14 # bcsm,,@,# #,4.73202E+17,https://twitter.com/drdonsdizon/status/473201656327585792,,,,
JacobPlieth,6/1/2014 16:37,0,1,Dr Sharma said would not like to deprive PD-L1-negative patient of an anti-PD-L1 treatment # ASCO14 pic.twitter.com/INRcv4PKri,,,#,4.73202E+17,https://twitter.com/JacobPlieth/status/473201614749048833,,,,
dralvaropinto,6/1/2014 16:36,0,1,Changing the standard for metastatic hormone sensitive prostate cancer with docetaxel chemotherapy # ASCO14,,,#,4.73201E+17,https://twitter.com/dralvaropinto/status/473201483211481089,,,,
rjleonardmd,6/1/2014 16:36,0,0,# ASCO14,,,#,4.73201E+17,https://twitter.com/rjleonardmd/status/473201386545770496,,,,
PhRMA,6/1/2014 16:36,4,3,Our goal should be to address chronic disease & bring down costs while keeping the focus on # patients http://onphr.ma/TRMIal # ASCO14,,,# #,4.73201E+17,https://twitter.com/PhRMA/status/473201349476106240,,,,
scientre,6/1/2014 16:36,2,0,& my newest social media expt: many interesting tidbits (+refs) will auto-tweet out during my talk in case you miss or want to share # asco14,,,#,4.73201E+17,https://twitter.com/scientre/status/473201339372404737,,,,
drdonsdizon,6/1/2014 16:36,0,1,ALLTO did not meet its endpoint of disease free survival. Patients w HER2+ disease do extremely well. # bcsm # ASCO14,,,# #,4.73201E+17,https://twitter.com/drdonsdizon/status/473201318430265344,,,,
rsm2800,6/1/2014 16:35,2,0,ALTTO: Doubling in pCR w/ L+T in neoALLTTO did _not_ translate into a survival advantage in ALTTO # ASCO14,,,#,4.73201E+17,https://twitter.com/rsm2800/status/473201313388302336,,,,
GillisClaire,6/1/2014 16:35,1,0,# ASCO14 QOPI CancerLinQ helps move to quality based reimbursement system with big data to audit and reinforce best practice @ WG_Consulting,,@,#,4.73201E+17,https://twitter.com/GillisClaire/status/473201309102129152,,,,
CardioOncology,6/1/2014 16:35,0,0,“ @ rsm2800: ALTTO: No diff in OS between arms but 4 yr OS was 95% (that’s super for HER2+ disease; we never saw that before 2005!) # asco14”,,@,#,4.73201E+17,https://twitter.com/CardioOncology/status/473201239056871424,,,,
JacobPlieth,6/1/2014 16:35,0,3,Dr Sharma conclusion slide from yesterday # ASCO14 pic.twitter.com/coKSoqGOd4,,,#,4.73201E+17,https://twitter.com/JacobPlieth/status/473201232404701186,,,,
YupOnc,6/1/2014 16:35,29,15,# asco2014 ALTTO addition of lapatinib to trastuzumab adjuvant therapy did not improve overall survival pic.twitter.com/VVA5P82uub,,,#,4.73201E+17,https://twitter.com/YupOnc/status/473201192559214592,,,,
GustaveRoussy,6/1/2014 16:35,3,0,"# ASCO14 Plenary session: Christopher Sweeney, MBBS, presents significant results for prostate cancer # Cancer",,,# #,4.73201E+17,https://twitter.com/GustaveRoussy/status/473201191447719936,,,,
Palestine_onco,6/1/2014 16:35,0,1,@ ASCO @ iConquerCancer Just reading the tweets enormously expanded my knowledge !!!,,@ @,,4.73201E+17,https://twitter.com/Palestine_onco/status/473201085859897344,,,,
LIVESTRONG_NL,6/1/2014 16:35,0,0,Experts hope advances next-generation sequencing will unravel breast cancer complexity http://bit.ly/1m3su3G # ASCO14 # borstkanker ( @ ASCO ),,@,# #,4.73201E+17,https://twitter.com/LIVESTRONG_NL/status/473201075563282432,,,,
JacobPlieth,6/1/2014 16:34,1,1,"Dr Sharma: instead of focusing on PD-L1 expression, shouldn't we just measure T-cell infiltration into tumours as prognostic marker? # ASCO14",,,#,4.73201E+17,https://twitter.com/JacobPlieth/status/473200967648026624,,,,
hepcentro,6/1/2014 16:34,0,0,"@ MOCBrasil , quando teremos novidades sobre hepatocarcinoma ? # ASCO2014 # MOCnaASCO # liver",,@,# # #,4.73201E+17,https://twitter.com/hepcentro/status/473200916506902528,,,,
scientre,6/1/2014 16:34,7,2,"Today @5:05PM (S504) I'll be talking abt Emerging Tools for Collecting Patient-Reported Outcomes # asco14 Gd progress, cool stuff on horizon",,@5,#,4.73201E+17,https://twitter.com/scientre/status/473200895917035522,,,,
OncEd,6/1/2014 16:34,0,0,ALTTO - More Grade 3/4 toxicity seen in combination arm. No difference in cardiac toxicity. # ASCO14,,,#,4.73201E+17,https://twitter.com/OncEd/status/473200867722555392,,,,
wendyashmen,6/1/2014 16:34,0,0,@ GoToPER is preparing for tonight's lung symp at Hyatt on E Wacker at 6 pm. # asco14 # lcsmpic.twitter.com/p1xz0MoRse,,@,# #,4.73201E+17,https://twitter.com/wendyashmen/status/473200860697464832,,,,
DrHedrick,6/1/2014 16:34,0,1,"@ Tony_Calles Agree, though I suspect FOLFOX Bev in US remains preferred regimen. Would be practice changing if alternate finding. # ASCO14",,@,#,4.73201E+17,https://twitter.com/DrHedrick/status/473200839088427009,,,,
sesaz,6/1/2014 16:34,0,0,“ @ ASCO: 'Brave new world' of social media in medicine: sessions of interest Sun & Mon http://bit.ly/1mLfbYY # ASCO14” # hcsm,,@,# #,4.73201E+17,https://twitter.com/sesaz/status/473200835862601728,,,,
drdonsdizon,6/1/2014 16:33,1,2,An un-official # ASCO14 selfie. These are some who represent the heart and soul of asco http://instagram.com/p/otwrMNpw3K/,,,#,4.73201E+17,https://twitter.com/drdonsdizon/status/473200802895388674,,,,
teamoncology,6/1/2014 16:33,0,0,@ rsm2800 Does this mean that long-term follow up is needed or you just can not improve the OS any more in HER2+ breast cancer? # ASCO14,,@,#,4.73201E+17,https://twitter.com/teamoncology/status/473200652244357121,,,,
Rfonsi1,6/1/2014 16:33,0,1,@ jrgralow yes for me? But it all depends. Hypothetical. Party-line of prices too high - price controls - will kill innovation # ASCO14,,@,#,4.73201E+17,https://twitter.com/Rfonsi1/status/473200626881798144,,,,
nycdoc29,6/1/2014 16:33,0,0,"# ASCO14 - ALTTO - I guess more isn't always better. Single agent Herceptin wins efficacy, safety, and cost!",,,#,4.73201E+17,https://twitter.com/nycdoc29/status/473200625799278592,,,,
BioWorld,6/1/2014 16:32,0,0,3penny opera style stats:Go make yourself a plan/And be a shining light/Then make yourself a second plan/For neither will come right # ASCO14,,,#,4.732E+17,https://twitter.com/BioWorld/status/473200465979899904,,,,
nmunozm,6/1/2014 16:32,0,0,“ @ dmavicente: # ASCO14. Beva y cetu en primera línea de colon mts son iguales. 29 meses de superviv. Equivalentes.” Politicam. incorrecto,,@,#,4.732E+17,https://twitter.com/nmunozm/status/473200463232634880,,,,
OncEd,6/1/2014 16:32,1,0,ALTTO Trial - 4 yr OS analysis >95% is all arms - no difference # ASCO14,,,#,4.732E+17,https://twitter.com/OncEd/status/473200325440962560,,,,
rsm2800,6/1/2014 16:32,4,0,ALTTO: No diff in OS between arms but 4 yr OS was 95% (that’s super for HER2+ disease; we never saw that before 2005!) # asco14,,,#,4.732E+17,https://twitter.com/rsm2800/status/473200318298071040,,,,
GenentechJobs,6/1/2014 16:31,0,0,Updates from the # ASCO14 meeting via ASCO Daily News all week. http://bit.ly/1u5Kz7o,,,#,4.732E+17,https://twitter.com/GenentechJobs/status/473200285653807104,,,,
drallysonocean,6/1/2014 16:31,2,2,@ FightCRC @ MMfightsCRC So excited to be collaborating with you to improve treatments and quality of life for # crcsm # ASCO14 # CRC2014,,@ @,# # #,4.732E+17,https://twitter.com/drallysonocean/status/473200274283462656,,,,
JacobPlieth,6/1/2014 16:31,0,1,"Thus, PD-L1 expression at a single time point might not reflect an evolving immune response in tumour microenvironment (Dr Sharma) # ASCO14",,,#,4.732E+17,https://twitter.com/JacobPlieth/status/473200200828194816,,,,
jrgralow,6/1/2014 16:31,1,2,"Need to stop enrolling pts already cured! RT @ rsm2800: ALTTO: 8381 pts randomized (compare w/ E5103, another “negative” trial) # asco14 # bcsm",,@,# #,4.732E+17,https://twitter.com/jrgralow/status/473200197951311872,,,,
PAN_Foundation,6/1/2014 16:31,0,2,2nd day exhibiting at # ASCO14 come by & find out more about PAN! pic.twitter.com/FmGQyxe5PQ,,,#,4.732E+17,https://twitter.com/PAN_Foundation/status/473200127633403904,,,,
dmooneymd,6/1/2014 16:31,0,0,Allto: disease free survival of three arms not significant. Very high 4 yr dfs 86-88%. Small ns benefit to T+ L in Hr neg pts. # bcsm # ASCO14,,,# #,4.732E+17,https://twitter.com/dmooneymd/status/473200097912954881,,,,
teamoncology,6/1/2014 16:30,2,1,So far no major advances outside of hormonal receptor positive # breastcancer. # ASCO14 # BCSM,,,# # #,4.732E+17,https://twitter.com/teamoncology/status/473200010658476033,,,,
Curiolog,6/1/2014 16:30,0,0,Cancer : réviser les standards de traitements http://www.allodocteurs.fr/actualite-sante-cancer-reviser-les-standards-de-traitements-13568.asp?1=1 … # ASCO14,,,#,4.732E+17,https://twitter.com/Curiolog/status/473200001149964288,,,,
jrgralow,6/1/2014 16:30,0,1,"No OS benefit, OFS adds QOL issues MT @ ecancer: Adj exemestane + ovarian supp preferable 2 tamoxifen in br ca # ASCO14 pic.twitter.com/QDRlDiYYPP",,@,#,4.732E+17,https://twitter.com/jrgralow/status/473199992778526720,,,,
kgapo,6/1/2014 16:30,1,2,worth reading authors roster at blog about lung cancer at # ASCO14 http://asco-2014.boehringer-ingelheim.com/authors/ @ pharmaphorum Stefania Vallone!,,@,#,4.732E+17,https://twitter.com/kgapo/status/473199915913723904,,,,
MontefioreNYC,6/1/2014 16:30,1,0,Follow us as our # oncology team will be presenting new discoveries at # ASCO14 (see http://bit.ly/1nArBX4 ) & celebrating Cancer Survivor Day,,,# #,4.732E+17,https://twitter.com/MontefioreNYC/status/473199914194042880,,,,
mayocliniclabs,6/1/2014 16:30,0,0,50-gene next generation sequencing panel helps tailor therapies to the individual patient. # ASCO14 http://mayocl.in/T1r6rl,,,#,4.732E+17,https://twitter.com/mayocliniclabs/status/473199910465339392,,,,
rsm2800,6/1/2014 16:30,0,0,ALTTO: HR=0.84 for concurrent L + T for DFS but not statistically significant # asco14,,,#,4.732E+17,https://twitter.com/rsm2800/status/473199907197571072,,,,
ASCO,6/1/2014 16:30,8,2,Investigators exploring innovative chemoprevention/cancer prevention avenues http://bit.ly/1n0vy3V # ASCO14,,,#,4.732E+17,https://twitter.com/ASCO/status/473199884653584384,,,,
ALLIANCE_org,6/1/2014 16:30,1,0,Well said RT @ SWOGChair: CALGB/SWOG 80405 Biological equivalent but both arms did spectacularly. Glad for NCTN & research sponsors # ASCO2014,,@,#,4.732E+17,https://twitter.com/ALLIANCE_org/status/473199848595136514,,,,
OncEd,6/1/2014 16:30,5,0,ALTTO Results - DFS : L+T 88% T->L 87% T alone 86% The L+T vs T superiority required a p value of 0.025 - was not met. # ASCO14,,,#,4.732E+17,https://twitter.com/OncEd/status/473199843054059520,,,,
FoundationATCG,6/1/2014 16:30,0,0,Celebrating 50 years of Science and Society # ASCO14. Read about the possibilities ahead: http://bit.ly/1kmrISN @ ASCO,,@,#,4.732E+17,https://twitter.com/FoundationATCG/status/473199837433700352,,,,
ProjectInno,6/1/2014 16:30,1,0,"As we celebrate # NCSD14, here's a blueprint to help even more people survive cancer http://ow.ly/xuUU8 # ASCO14",,,# #,4.732E+17,https://twitter.com/ProjectInno/status/473199833235607552,,,,
NadiaSahali,6/1/2014 16:30,0,0,# ASCO14 2 avancées impt. pour les # cancers du sein et de la prostate à lire sur blog de @ jdflaysakier http://www.docteurjd.com/ # gucsm # bcsm,,@,# # # #,4.732E+17,https://twitter.com/NadiaSahali/status/473199831499165696,,,,
JacobPlieth,6/1/2014 16:30,3,5,Dr Sharma slide from yesterday # ASCO14 pic.twitter.com/A0JdBajueD,,,#,4.732E+17,https://twitter.com/JacobPlieth/status/473199823433134080,,,,
medpagetoday,6/1/2014 16:30,4,2,ASCO: Lung cancer tests would cost Medicare billions. @ atscommunity # ASCO14 http://bit.ly/1sRd3Bm,,@,#,4.732E+17,https://twitter.com/medpagetoday/status/473199813895278592,,,,
neilbaxter85,6/1/2014 16:29,0,0,Any new data from Scancell regarding their SCIB1 8mg trial? # ASCO14,,,#,4.732E+17,https://twitter.com/neilbaxter85/status/473199801174360064,,,,
FightCRC,6/1/2014 16:29,1,1,@ drallysonocean nice meeting you at # ASCO14! Thanks for all that you're doing in # CRC!,,@,# #,4.732E+17,https://twitter.com/FightCRC/status/473199772476522496,,,,
JacobPlieth,6/1/2014 16:29,0,2,"Dr Sharma said immune response changes over time, so initially PD-L1-negative tumours might end up expressing PD-L1 later # ASCO14",,,#,4.732E+17,https://twitter.com/JacobPlieth/status/473199656453668864,,,,
TuftsB,6/1/2014 16:29,1,0,@ rschilsky @ ASCO -I'd love to. If we followed your advice I would have been denied care in spring 2009 and dead by the fall # mliwi # ASCO14,,@ @,# #,4.732E+17,https://twitter.com/TuftsB/status/473199628591300609,,,,
ArcagyGineco,6/1/2014 16:29,0,1,Cancer ovaire en rechute sensible en direct de l’ # ASCO14 : l’association olaparib + cediranib double la survie sans progression,,,#,4.732E+17,https://twitter.com/ArcagyGineco/status/473199590737715200,,,,
rsm2800,6/1/2014 16:29,1,0,ALTTO: 40% pts randomized were N0; many had T<2cm # asco14,,,#,4.732E+17,https://twitter.com/rsm2800/status/473199585930665984,,,,
BayerPharma,6/1/2014 16:28,1,0,Have you visited the Bayer HealthCare booth at # ASCO14? We welcome you at booth #10097. pic.twitter.com/rMRZwWVA2r,,,# #10097,4.732E+17,https://twitter.com/BayerPharma/status/473199534416605185,,,,
rsm2800,6/1/2014 16:28,2,0,"ALTTO: 8381 pts randomized (compare w/ E5103, another “negative” trial) # asco14 # bcsm",,,# #,4.73199E+17,https://twitter.com/rsm2800/status/473199427973181440,,,,
heidisa,6/1/2014 16:28,1,1,Winner of Best Lanyard Award: @ ConsanoMolly ! # ASCO14 pic.twitter.com/K3Niw4RLT0,,@,#,4.73199E+17,https://twitter.com/heidisa/status/473199415268622336,,,,
jrgralow,6/1/2014 16:28,1,0,Compliance will be better MT @ aftimosp @ teamoncology tox profile lapatinib unfav compared to pertuzumab. Will APHINITY be +? # bcsm # ASCO14,,@ @,# #,4.73199E+17,https://twitter.com/jrgralow/status/473199354120269825,,,,
m_e_nielsen,6/1/2014 16:28,0,2,Another great day at # asco14; # ViewFromMySeat even better than yest thx to @ Twitter https://vine.co/v/MpM0dwxBEmJ,,@,# #,4.73199E+17,https://twitter.com/m_e_nielsen/status/473199324877557760,,,,
teamoncology,6/1/2014 16:27,0,0,@ jrgralow So the question is where will the lapatinib survive? Lapatinib + Trastuzumab for MBC? # ASCO14,,@,#,4.73199E+17,https://twitter.com/teamoncology/status/473199300793479170,,,,
dmooneymd,6/1/2014 16:27,0,0,Allto: overall survival endpoint. Lapatinib only arm closed early due to futility. 8300 pts recruited. # ASCO14 # bcsm,,,# #,4.73199E+17,https://twitter.com/dmooneymd/status/473199296582402048,,,,
janinegug,6/1/2014 16:27,0,0,"@ ASCO I went there and they sent me to Room 106a. There were 2 spaces, already taken by nursing moms. I used first aid yesterday,no problems",,@,,4.73199E+17,https://twitter.com/janinegug/status/473199213904265216,,,,
FightCRC,6/1/2014 16:27,4,1,"20 years ago, # CRC survival averaged 8 months. That's a 21-month leap in survivorship in 20 years! # CRCResearch # ASCO14",,,# # #,4.73199E+17,https://twitter.com/FightCRC/status/473199170778431488,,,,
rsm2800,6/1/2014 16:27,0,0,ALTTO: Event rate was lower than anticipated (we’ve heard that a lot this mtg) # asco14 # respectyourstatistician,,,# #,4.73199E+17,https://twitter.com/rsm2800/status/473199146711523329,,,,
ipaulmampilly,6/1/2014 16:26,0,0,"# ASCO14 Tweet-network with your fellow tweeters at 7.30 pm..The Office 955 W Fulton Market, Chicago, IL 60607..wear your badge.. # RSVP",,,# #,4.73199E+17,https://twitter.com/ipaulmampilly/status/473198992889614336,,,,
IanGertler,6/1/2014 16:26,2,1,@ chimoose @ rsm2800 @ ASCO @ drattai @ CliffordHudis @ drdonsdizon @ brianreid Social Oncology leaders; thank you all for your expertise! # ASCO14,,@ @ @ @ @ @ @,#,4.73199E+17,https://twitter.com/IanGertler/status/473198845086949376,,,,
JacobPlieth,6/1/2014 16:25,1,2,I was v impressed with Padmanee Sharma's discussion yesterday about relevance (or not) of using PD-L1 as a biomarker # ASCO14,,,#,4.73199E+17,https://twitter.com/JacobPlieth/status/473198769656197120,,,,
FightCRC,6/1/2014 16:25,2,1,Our founder Nancy Roach sat In a session at # ASCO14 and found out that the new benchmark for overall survival is 29 months for # CRC...,,,# #,4.73199E+17,https://twitter.com/FightCRC/status/473198681009950721,,,,
teamoncology,6/1/2014 16:25,0,1,We need to know the cost for all these new great drugs. We know that it is expensive but we have to do our reality check by number. # ASCO14,,,#,4.73199E+17,https://twitter.com/teamoncology/status/473198654660939776,,,,
genentech,6/1/2014 16:25,1,2,# ASCO14: Prep for Monday's sessions on advances in melanoma - http://ow.ly/xtrSq,,,#,4.73199E+17,https://twitter.com/genentech/status/473198603465670657,,,,
jrgralow,6/1/2014 16:25,1,0,"Yes, espec since pertuz approved preop MT @ teamoncology Is use of lapatinib in dual HER2 setting dead despite NeoALLTO hi pCR? # ASCO14 # BCSM",,@,# #,4.73199E+17,https://twitter.com/jrgralow/status/473198589041471488,,,,
dmooneymd,6/1/2014 16:25,0,0,"Altto: adj her2 breast ca trial. Randomized to one year her 2 tx with either Traztuzumab (T), Lapatinib (L), T --> L, T + L. # bcsm # ASCO14",,,# #,4.73199E+17,https://twitter.com/dmooneymd/status/473198577549074432,,,,
CancerDotNet,6/1/2014 16:25,6,3,# ASCO14 pt summary: Adding drug to standard combo treatment not beneficial for early HER2+ br ca # bcsm http://bit.ly/1kYARRk,,,# #,4.73199E+17,https://twitter.com/CancerDotNet/status/473198565939216384,,,,
drdonsdizon,6/1/2014 16:24,0,0,@ chimoose @ rsm2800 @ ASCO @ drattai @ CliffordHudis @ brianreid very cool,,@ @ @ @ @ @,,4.73199E+17,https://twitter.com/drdonsdizon/status/473198527997550593,,,,
rsm2800,6/1/2014 16:24,1,0,ALTTO: 3 “pragmatic” designs: 1. Sequential antiHER2 AFTER all chemo (n=4613); 2. Concurrent antiHER2 after anthracyclines (n=3337) # asco14,,,#,4.73198E+17,https://twitter.com/rsm2800/status/473198463220322304,,,,
bpowersphoto,6/1/2014 16:24,0,0,"# ASCO14 # chicago @Mccormick Place, Illinois http://instagram.com/p/otvkX7rH91/",,@Mccormick,# #,4.73198E+17,https://twitter.com/bpowersphoto/status/473198368865259521,,,,
teamoncology,6/1/2014 16:23,0,0,Does pathological CR a truly a good read out for HER2 positive primary breast cancer? # ASCO2014,,,#,4.73198E+17,https://twitter.com/teamoncology/status/473198245154275328,,,,
chimoose,6/1/2014 16:23,4,1,The handles US docs are Retweeting most at # ASCO14? @ RSM2800 @ ASCO @ DrAttai @ CliffordHudis @ DrDonSDizon http://bit.ly/SOCONC @ brianreid,,@ @ @ @ @ @,#,4.73198E+17,https://twitter.com/chimoose/status/473198182999261185,,,,
GenentechJobs,6/1/2014 16:23,0,1,"# ASCO14 Breast Cancer/HER2/ER/Poster Session - 6/2, 8:00 - 11:45 am featuring our own: Lisa Wang, Laura Chu, Marjorie Green & Chunyan Song.",,,#,4.73198E+17,https://twitter.com/GenentechJobs/status/473198155631042560,,,,
t_andreiu,6/1/2014 16:23,0,0,# ASCO14 = a steady diet of coffee and bananas...,,,#,4.73198E+17,https://twitter.com/t_andreiu/status/473198126648807424,,,,
rsm2800,6/1/2014 16:22,1,0,ALTTO: Will dual HER2 blockade improve DFS and OS in adjuvant setting? # asco14,,,#,4.73198E+17,https://twitter.com/rsm2800/status/473197958083518464,,,,
cancerassassin1,6/1/2014 16:22,4,1,I hope many # crc # cancer # patients will be encouraged by OS of CALGB 80405...But know they will prefer Bev over EGFR-I's due to QOL # ASCO14,,,# # # #,4.73198E+17,https://twitter.com/cancerassassin1/status/473197910411071488,,,,
JediPD,6/1/2014 16:22,0,0,"Studies, Stats, Report & Discussions MT @ chimoose: # ASCO14! Watch http://MDigitalLife.com/SocialOncology for details! # MDigitalLife pic.twitter.com/wvu6OnSVB8”",,@,# #,4.73198E+17,https://twitter.com/JediPD/status/473197818099040256,,,,
mariaviniegra,6/1/2014 16:21,0,0,Cuanto pastiche es aceptable para aumentar el poder estadistico de un estudio? # asco2014.,,,#,4.73198E+17,https://twitter.com/mariaviniegra/status/473197789007319040,,,,
jrgralow,6/1/2014 16:21,0,0,". @ Rfonsi1 Is a drug that extends survival for 2-3 mos w/ signif toxicity worth it (especially if $10,000/month but even if less)? # ASCO14",,@,#,4.73198E+17,https://twitter.com/jrgralow/status/473197721210597376,,,,
teamoncology,6/1/2014 16:21,1,1,"Pertuzumab is $5,900 a month, or about $71,000 a year stated in 2012. # ASCO14. One-year course of Herceptin treatment costs about $70,000.",,,#,4.73198E+17,https://twitter.com/teamoncology/status/473197711525548032,,,,
rsm2800,6/1/2014 16:21,1,0,"ALTTO: Why was lapatinib attractive for adj Rx in 2006? Oral drug, low cardiotoxicity, some activity against brain mets # asco14",,,#,4.73198E+17,https://twitter.com/rsm2800/status/473197704294563840,,,,
AneesChagpar,6/1/2014 16:21,0,0,Hangin' out with Salimah @ YaleCancer booth @ ASCO # ASCO14 -- her first tweet! Spreading the love for twitter... pic.twitter.com/UQhgAixdhq,,@ @,#,4.73198E+17,https://twitter.com/AneesChagpar/status/473197576007991297,,,,
odub75,6/1/2014 16:20,0,0,Finally a draw... # ASCO14 pic.twitter.com/LY3h43ERcd,,,#,4.73197E+17,https://twitter.com/odub75/status/473197447674859522,,,,
sayrizvi,6/1/2014 16:20,0,0,“ @ mtmdphd: MT @ alantanmd: No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab # ASCO14 pic.twitter.com/Vub6PLX55D # crcsm”,,@ @,# #,4.73197E+17,https://twitter.com/sayrizvi/status/473197421087178752,,,,
CancerDotNet,6/1/2014 16:20,0,0,Advocates at # ASCO14: Check out the Attendee Resource Center. Key for all your meeting info: http://bit.ly/1iIbOO4,,,#,4.73197E+17,https://twitter.com/CancerDotNet/status/473197360114581505,,,,
LillyDiabetes,6/1/2014 16:20,1,0,Check out the @LlyOncOnCanvas hope mural with one day of painting to go! http://ow.ly/i/5L3r8 # hopeforward # ASCO14,,@LlyOncOnCanvas,# #,4.73197E+17,https://twitter.com/LillyDiabetes/status/473197337725390848,,,,
ipaulmampilly,6/1/2014 16:19,0,0,# ASCO14 thats 1 cancer med pro per every 101 sq feet of McCormick place which is 2.6 mill sq feet in total..,,,#,4.73197E+17,https://twitter.com/ipaulmampilly/status/473197279612903424,,,,
chimoose,6/1/2014 16:19,3,1,Most active Ex-US docs at # ASCO14 are @ profjohncrown and @ drsteventucker! Follow the action at http://bit.ly/SOCONC pic.twitter.com/Wg36qq3Tsd,,@ @,#,4.73197E+17,https://twitter.com/chimoose/status/473197218405441536,,,,
Mills_I,6/1/2014 16:19,0,0,Learn about Global Resource for Advancing Cancer Education GRACE. Stop by Pt Advocacy booth + I'll explain. http://Cancergrace.org # ASCO14,,,#,4.73197E+17,https://twitter.com/Mills_I/status/473197208314322944,,,,
melanoma_mama,6/1/2014 16:19,0,0,@ martha @ ASCO Me too!,,@ @,,4.73197E+17,https://twitter.com/melanoma_mama/status/473197090060111872,,,,
OncEd,6/1/2014 16:18,0,0,Results of ALTTO by Dr. Martine Piccart Trastuzumab + Lap vs T->L vs. L alone vs. H alone # ASCO14 Plenary,,,#,4.73197E+17,https://twitter.com/OncEd/status/473196965996396544,,,,
cancerassassin1,6/1/2014 16:17,1,0,CALGB 80405: This study = good starting point for subset analyses and expanded testing of banked # colon # cancer tumors. I want in! # ASCO14,,,# # #,4.73197E+17,https://twitter.com/cancerassassin1/status/473196757065928704,,,,
DrLCohen,6/1/2014 16:17,2,2,“ @ premal2000: @ fischmd @ ASCO @ CliffordHudis You can’t ban foods and limit minors from consuming them.” We can change fast/processed food,,@ @ @ @,,4.73197E+17,https://twitter.com/DrLCohen/status/473196747733618688,,,,
CI4CC,6/1/2014 16:17,1,0,Download the # ASCO14 smart phone App and search for # Informatics!,,,# #,4.73197E+17,https://twitter.com/CI4CC/status/473196692524003331,,,,
dmavicente,6/1/2014 16:17,0,0,# ASCO14 tercera. Beva y cetu en primera línea de colon mts son iguales. 29 meses de superviv. Equivalentes.,,,#,4.73197E+17,https://twitter.com/dmavicente/status/473196684500291584,,,,
ALLIANCE_org,6/1/2014 16:16,1,1,"# ASCO14 ALTTO comparing 1 yr anti-HER2 ther w/ L alone, T alone, T→L or T+L in adj tx of HER2+ early breast ca http://bit.ly/1tzuNjc",,,#,4.73197E+17,https://twitter.com/ALLIANCE_org/status/473196511913058304,,,,
cancerassassin1,6/1/2014 16:16,0,0,"CALGB 80405: wise to expand outlook to multiple forms of Ras, but I missed if this included H-Ras? # ASCO14",,,#,4.73196E+17,https://twitter.com/cancerassassin1/status/473196477519380480,,,,
mattshomepage,6/1/2014 16:16,1,1,Excited to present a poster at # ASCO14. Poster is on text mining childhood cancer late effects. Heading over now!,,,#,4.73196E+17,https://twitter.com/mattshomepage/status/473196354362019840,,,,
dmavicente,6/1/2014 16:16,1,0,# ASCO14. Plenaria. Docetaxel en próstata no resistente aumenta supervivencia más de 1 año. Algún urólogo aficionado a la Onco por ahí?,,,#,4.73196E+17,https://twitter.com/dmavicente/status/473196333348958208,,,,
teamoncology,6/1/2014 16:15,0,0,@ PSUMaryDom But then the question is should we change the type of the food sold at the convention center that promote obesity? # ASCO14,,@,#,4.73196E+17,https://twitter.com/teamoncology/status/473196280106467328,,,,
aakonc,6/1/2014 16:15,0,0,@ yzafar could median age 59 have something to do with it ? # ASCO14,,@,#,4.73196E+17,https://twitter.com/aakonc/status/473196261760573440,,,,
nycdoc29,6/1/2014 16:15,0,0,@ DrHedrick @ Tony_Calles @ drattai - in CRC maybe will shift overwhelming US use of FOLFOX + Avastin in 1st line. # ASCO14,,@ @ @,#,4.73196E+17,https://twitter.com/nycdoc29/status/473196256412844032,,,,
oncodocsydney,6/1/2014 16:15,1,2,Tabernero: extended RAS analysis in 080405 may change HR for OS and alter conclusions based on projections from other trials # ASCO14,,,#,4.73196E+17,https://twitter.com/oncodocsydney/status/473196247105683456,,,,
chimoose,6/1/2014 16:15,3,2,For the 1st time we're tracking doc tweets outside the US - 123 are actively tweeting # ASCO14! http://bit.ly/SOCONC pic.twitter.com/UAy0E5QKv6,,,#,4.73196E+17,https://twitter.com/chimoose/status/473196209973121024,,,,
teamoncology,6/1/2014 16:15,0,0,@ PSUMaryDom @ YaleCancer Agree. Why you can we not ban smoking outside of the ASCO conference? # ASCO14,,@ @,#,4.73196E+17,https://twitter.com/teamoncology/status/473196114183593984,,,,
ASCO,6/1/2014 16:15,0,1,Pre-Annual Meeting Seminar discusses new approaches to deal w/germline sequencing data http://bit.ly/1mGdxGp # ASCO14,,,#,4.73196E+17,https://twitter.com/ASCO/status/473196080864460800,,,,
chimoose,6/1/2014 16:14,7,4,There are 198 US physicians actively tweeting at # ASCO14! Watch http://MDigitalLife.com/SocialOncology for details! # MDigitalLifepic.twitter.com/obXKj5gIPC,,,# #,4.73196E+17,https://twitter.com/chimoose/status/473195947451629570,,,,
teamoncology,6/1/2014 16:14,0,0,@ aftimosp Agree. Pertuzumab is clearly less toxic that pertuzumab. Pertuzumab is more expensive than lapatinib. # ASCO14,,@,#,4.73196E+17,https://twitter.com/teamoncology/status/473195854094794752,,,,
oncodocsydney,6/1/2014 16:13,1,1,"Tabernero:poss explanations 4 improved mOS in 080405 cf FIRE3; more use of 2nd+line Rx in former, ?depth of response, ?extended RAS # ASCO14",,,#,4.73196E+17,https://twitter.com/oncodocsydney/status/473195756372119553,,,,
yzafar,6/1/2014 16:13,1,1,CALGB 80405: Why do we see a 29mo OS in this study? # ASCO14 # crcsmpic.twitter.com/IiYUF2tSd2,,,# #,4.73196E+17,https://twitter.com/yzafar/status/473195726420574208,,,,
ipaulmampilly,6/1/2014 16:13,1,1,"# ASCO14 stats 25,500 attendees..feels more like over 30,000 and 400 exhibitors..http://trade-shows.findthebest.com/q/430/3284/How-many-people-attend-the-American-Society-of-Clinical-Oncology-ASCO …",,,#,4.73196E+17,https://twitter.com/ipaulmampilly/status/473195719130484736,,,,
ClinOncologist,6/1/2014 16:12,0,0,"@ ASCO @ yzafar Wow, a discussion of chemotherapy causing financial bankruptcy to pts in the USA. I am thankful for the # NHS",,@ @,#,4.73195E+17,https://twitter.com/ClinOncologist/status/473195478478516224,,,,
INVIVOcom,6/1/2014 16:12,1,5,INVIVO knows biosimilars # hospira # asco2014 pic.twitter.com/b6oBnlAgED,,,# #,4.73195E+17,https://twitter.com/INVIVOcom/status/473195476981149696,,,,
AbbottNews,6/1/2014 16:12,8,2,Abbott’s breast cancer companion diagnostic was the first gene-based test aimed to detect the HER-2 gene in breast cancer patients # ASCO14,,,#,4.73195E+17,https://twitter.com/AbbottNews/status/473195300849741826,,,,
DrHedrick,6/1/2014 16:11,0,0,@ Tony_Calles @ drattai Add results in colorectal cancer that will not change practice. # ASCO14,,@ @,#,4.73195E+17,https://twitter.com/DrHedrick/status/473195133089755136,,,,
dmooneymd,6/1/2014 16:11,0,2,"A negative study"" that shows how far we have come in # crcsm extending overall survival to median of 29 mos! # ASCO14 pic.twitter.com/9zkJp2h8W9""",,,# #,4.73195E+17,https://twitter.com/dmooneymd/status/473195091520024577,,,,
aftimosp,6/1/2014 16:10,3,1,# ASCO14 plenary session: huge survival gains in prostate cancer and colorectal cancer!,,,#,4.73195E+17,https://twitter.com/aftimosp/status/473194949018918912,,,,
thinkalot,6/1/2014 16:10,0,1,"Truth # healthcare @ yzafar:We (ie, I) spend a lot of time arguing we spend too much. Really, we need to spend better # ASCO14",,@,# #,4.73195E+17,https://twitter.com/thinkalot/status/473194901190877184,,,,
teamoncology,6/1/2014 16:10,15,8,Yep. RT @ YaleCancer: Seen outside the largest cancer conf. Must do better helping people with this addiction. # asco14 pic.twitter.com/vZjnJeFQbq,,@,#,4.73195E+17,https://twitter.com/teamoncology/status/473194897919315968,,,,
UNCurology,6/1/2014 16:10,4,1,Join us in welcoming our stellar # KOL GU med onc colleagues @ EthanBasch1 & @ MattMilowsky to twitter # asco14 cc @ UrologyMatch,,@ @ @,# #,4.73195E+17,https://twitter.com/UNCurology/status/473194877371838464,,,,
ASCO,6/1/2014 16:10,1,1,Dr. Randall F. Holcombe: Applying lessons learned from QOPI participation http://bit.ly/1trCS9q # ASCO14,,,#,4.73195E+17,https://twitter.com/ASCO/status/473194809042411520,,,,
CancerTherAdvsr,6/1/2014 16:10,0,0,# ASCO14: PET ΔSUV 'Useful Tool' to Optimize Neoadjuvant Therapy for HER2-positive # BreastCancer http://ow.ly/xuQtR,,,# #,4.73195E+17,https://twitter.com/CancerTherAdvsr/status/473194788301574144,,,,
GenomeBiomarker,6/1/2014 16:10,0,1,FOLFOX +bev vs +cet. # ASCO14 pic.twitter.com/mUrm5fcbfD,,,#,4.73195E+17,https://twitter.com/GenomeBiomarker/status/473194775836098560,,,,
aftimosp,6/1/2014 16:09,3,0,@ teamoncology tox profile of lapatinib unfavorable when compared to pertuzumab... Will APHINITY be positive? # bcsm # ASCO14,,@,# #,4.73195E+17,https://twitter.com/aftimosp/status/473194735705022464,,,,
oncodocsydney,6/1/2014 16:09,0,1,Tabernero: skin dissatisfaction w/cetux did not result in worse overal QoL ?due to understanding of assoc btw skin tox & outcome # ASCO14,,,#,4.73195E+17,https://twitter.com/oncodocsydney/status/473194639076630528,,,,
urotoday,6/1/2014 16:08,0,0,Dr. Sweeney is presenting the ECOG-3805 data in front of a packed plenary hall! # ASCO14 http://bit.ly/SnieM1 pic.twitter.com/3ssTONNg60,,,#,4.73194E+17,https://twitter.com/urotoday/status/473194495639818240,,,,
TGeorgeMD,6/1/2014 16:08,2,2,CALGB 80405 tissue biorepository is a national cancer rsch treasure; $$ by the @ theNCI; will provide major return on that investment # ASCO14,,@,#,4.73194E+17,https://twitter.com/TGeorgeMD/status/473194406145982466,,,,
teamoncology,6/1/2014 16:07,0,0,So is the use of lapatinib in double HER2 setting dead despite of NeoALLTO showed high pCR rate? # ASCO14 # BCSM,,,# #,4.73194E+17,https://twitter.com/teamoncology/status/473194235332526080,,,,
dramarivirg,6/1/2014 16:07,0,0,"Plenaria # ASCO14 CALGB/SWOG 80405: cetuximab es equivalente a bevacizumab combinado con qt FOLFOX o FOLFIRI en SG, media de SG de 29 meses",,,#,4.73194E+17,https://twitter.com/dramarivirg/status/473194136615813120,,,,
ALLIANCE_org,6/1/2014 16:07,2,1,RT @ ASCO: Plenary brief # ASCO14: @ EdithPerezMD discussing results of large phase III ALTTO trial for pts w/early HER2+ breast cancer. # bcsm,,@ @,# #,4.73194E+17,https://twitter.com/ALLIANCE_org/status/473194046483996672,,,,
KellyColligan,6/1/2014 16:07,0,0,RT @ ASCO: Plenary brief # ASCO14: @ EdithPerezMD discussing results of large phase III ALTTO trial for pts w/early HER2+ breast cancer. # bcsm,,@ @,# #,4.73194E+17,https://twitter.com/KellyColligan/status/473194044789514240,,,,
oncodocsydney,6/1/2014 16:06,4,2,"Tabernero: putting CALGB/WOG 80405 in context. A negative superiority study, not a non-inferiority/equivalence trial # ASCO14",,,#,4.73194E+17,https://twitter.com/oncodocsydney/status/473194006483324929,,,,
fischmd,6/1/2014 16:06,23,12,"New benchmarks for 1st line treatment of met # colorectal cancer: >29 month median survival, about 10% live 5 or more years, # ASCO14 # crcsm",,,# # #,4.73194E+17,https://twitter.com/fischmd/status/473193944608940032,,,,
RN2teach,6/1/2014 16:06,1,1,Good read! “ @ ASCO: Experts hope advances in next-generation sequencing will unravel breast cancer complexity http://bit.ly/1m3su3G # ASCO14”,,@,#,4.73194E+17,https://twitter.com/RN2teach/status/473193908495605761,,,,
GenomeBiomarker,6/1/2014 16:06,0,1,Expanded RAS panel # ASCO14 pic.twitter.com/FPu0ZN918r,,,#,4.73194E+17,https://twitter.com/GenomeBiomarker/status/473193807065145345,,,,
SitemanCenter,6/1/2014 16:05,2,0,Did you miss @ GColditz's @ ASCO- @ AmericanCancer Society Award lecture at # ASCO14? Here are his slides: http://goo.gl/vPyAjH,,@ @ @,#,4.73194E+17,https://twitter.com/SitemanCenter/status/473193694669971456,,,,
DrMiguelPerales,6/1/2014 16:05,0,3,Ths @ mtmdphd for comprehensive tweeting during # ASCO14 # lymphoma session today. Almost like being there except that I was rounding on in-pts,,@,# #,4.73194E+17,https://twitter.com/DrMiguelPerales/status/473193657999585281,,,,
RMiksad,6/1/2014 16:05,1,0,@ asco CALGB 80405 Cetux DSQoL skin satisfaction decline not reflected in global EORTC QoL. ? Instrument effect vs belief skin tox=efficacy,,@,,4.73194E+17,https://twitter.com/RMiksad/status/473193626546491392,,,,
mtmdphd,6/1/2014 16:05,2,0,"# ASCO14 Pharma: You will likely be interested in what biotech president @ Scientre has to say about PRO, AEs & social media - 6/1 4:45p S504",,@,#,4.73194E+17,https://twitter.com/mtmdphd/status/473193584666345472,,,,
rsm2800,6/1/2014 16:04,30,17,Most amazing slide of the day: Dr. Venook showing median OS of met colorectal ca of 9 mos in 1992 vs 29+ mos in this trial # ASCO14 # research,,,# #,4.73193E+17,https://twitter.com/rsm2800/status/473193498930204672,,,,
mtmdphd,6/1/2014 16:04,1,1,MT @ alantanmd: No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab # ASCO14 pic.twitter.com/Pb5yRPLwPQ # crcsm,,@,# #,4.73193E+17,https://twitter.com/mtmdphd/status/473193294030454784,,,,
coffeydc,6/1/2014 16:03,0,0,"In metastatic CRC RT @ ASCO: # ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival.",,@,#,4.73193E+17,https://twitter.com/coffeydc/status/473193229454934016,,,,
dramarivirg,6/1/2014 16:03,1,1,Plenaria # ASCO14 docetaxel+ BAT mejora SG en comparación a BAT solo en # cancerDeProstata hormono sensible con gran volumen de enfermedad,,,# #,4.73193E+17,https://twitter.com/dramarivirg/status/473193146353213440,,,,
oncodocsydney,6/1/2014 16:03,0,1,Venook: QoL (incl skin tox) & patient preferences important considerations for Rx decisions in KRAS WT CRC commencing 1st line Rx # ASCO14,,,#,4.73193E+17,https://twitter.com/oncodocsydney/status/473193122105917440,,,,
PCFnews,6/1/2014 16:03,2,2,PCF investigator Dr Sweeney: significant survival benefit for Docetaxel + ADT in hormone therapy-naive metastatic # prostatecancer # ASCO14,,,# #,4.73193E+17,https://twitter.com/PCFnews/status/473193099779645441,,,,
dramarivirg,6/1/2014 16:03,0,0,Plenaria # ASCO14 dra Pagani: Exemestane +supresión ovárica mejora SLP en mujeres premenopausicas con RH +comparado con TMX+supresión ovarica,,,#,4.73193E+17,https://twitter.com/dramarivirg/status/473193042577735680,,,,
tomleblancMD,6/1/2014 16:03,0,0,Combination # chemo + biologic therapy yielded enormous survival improvements in metastatic # colorectal # cancer in last 20 yrs! # ASCO14,,,# # # #,4.73193E+17,https://twitter.com/tomleblancMD/status/473193036265320448,,,,
dramarivirg,6/1/2014 16:02,0,0,Plenaria # ASCO14 # cancerdemama dra Pagani: nueva opción de tratamiento Exemestane + supresión ovárica en premenopausicas RH positivos,,,# #,4.73193E+17,https://twitter.com/dramarivirg/status/473192988081156097,,,,
yzafar,6/1/2014 16:02,7,2,CALGB 80405: new benchmark in survival for metastatic # colorectalcancer: >29 months. Thanks to @ theNCI for funding this trial # ASCO14 @ ASCO,,@ @,# #,4.73193E+17,https://twitter.com/yzafar/status/473192972767727617,,,,
Ferheca12,6/1/2014 16:02,0,0,Cetu y Beva como la Pepsi y la CocaCola... al final to es lo mismo # ASCO2014,,,#,4.73193E+17,https://twitter.com/Ferheca12/status/473192971807248384,,,,
janinegug,6/1/2014 16:02,1,0,"Thx a lot, # ASCO14, 4 moving # Breastfeeding moms 2 farthest reaches to pump, adding 20 mins to job & no water 2 clean & dump. Disappointing.",,,# #,4.73193E+17,https://twitter.com/janinegug/status/473192927599284224,,,,
TGeorgeMD,6/1/2014 16:02,13,5,"For mCRC (KRAS WT), initial treatment should be driven by shared decision making between MD & pt | Venook: http://bit.ly/T3TuJB # ASCO14",,,#,4.73193E+17,https://twitter.com/TGeorgeMD/status/473192883269693440,,,,
BairdAM,6/1/2014 16:02,0,0,# lcsm RT  @ n8pennell: Mok: 35% of squam cell+adeno early stage have PDL-1 exp,"no diff by histology.Need to determine best dec of +. # ASCO14""""",,@,# #,4.73193E+17,https://twitter.com/BairdAM/status/473192861278564352,,,
luisgamd,6/1/2014 16:02,0,0,@ CancerDotNet @ ASCO,,@ @,,4.73193E+17,https://twitter.com/luisgamd/status/473192808111943680,,,,
OncEd,6/1/2014 16:01,1,2,CALGB 80405 Chemo Bev and Chemo Cetux - no difference in OS Global QOL favours Bev but not statistically significant p=0.054 # crcsm # ASCO14,,,# #,4.73193E+17,https://twitter.com/OncEd/status/473192750427684864,,,,
DrHedrick,6/1/2014 16:01,1,1,"80405: Across the board, OS is 29 months! Amazing improvement. 20 years of improvement. # ASCO14",,,#,4.73193E+17,https://twitter.com/DrHedrick/status/473192742018117632,,,,
mtmdphd,6/1/2014 16:01,1,0,The Social Oncology Project 2014 - @ BrianReid @ KaylaRodrigue11 @ W2OGroup @ MDigitalLife http://ow.ly/xsh2R # SocOncology # ASCO14,,@ @ @ @,# #,4.73193E+17,https://twitter.com/mtmdphd/status/473192538527252482,,,,
aakonc,6/1/2014 16:00,0,1,Results inconclusive until extended ras analysis available IMO # crcsm # ASCO14,,,# #,4.73192E+17,https://twitter.com/aakonc/status/473192476900360193,,,,
oncodocsydney,6/1/2014 16:00,0,1,Venook: RAS mutations exon 12 &13 used to define inclusion in this trial. Expanded RAS to be undertaken in conjunction with others # ASCO14,,,#,4.73192E+17,https://twitter.com/oncodocsydney/status/473192451231191041,,,,
Roche,6/1/2014 16:00,4,5,"We are starting to enter a new level of how we're approaching treatment opportunities for # CancerPatients."" http://ow.ly/xp4k5 # ASCO14""",,,# #,4.73192E+17,https://twitter.com/Roche/status/473192428661641216,,,,
Roche,6/1/2014 16:00,1,2,How we at # Roche are investing in tomorrow's leading scientists: http://ow.ly/xp1Ha # ASCO14,,,# #,4.73192E+17,https://twitter.com/Roche/status/473192408940019713,,,,
Boehringer,6/1/2014 16:00,1,1,# PRESS & # HCPs: # DidYouKnow Acute Myeloid # Leukaemia is one of the most common blood cancers in adults? http://bit.ly/1edV8Lj - # ASCO14,,,# # # # #,4.73192E+17,https://twitter.com/Boehringer/status/473192404217233408,,,,
DKarikios,6/1/2014 16:00,0,1,@ oncodocsydney As will extended RAS! # ASCO14,,@,#,4.73192E+17,https://twitter.com/DKarikios/status/473192378053173248,,,,
amedinacol,6/1/2014 16:00,0,1,High volume disease definition # ASCO14 pic.twitter.com/FqQQPqb965,,,#,4.73192E+17,https://twitter.com/amedinacol/status/473192366275166208,,,,
DCarrizosaMD,6/1/2014 16:00,0,1,# ASCO14 plenary - remember accruing Pts to CALGB 80405 in fellowship -no diff in chemo+bev or cetux OS in 1st line tx of colorectal CA # LCI,,,# #,4.73192E+17,https://twitter.com/DCarrizosaMD/status/473192341767868416,,,,
xavigranda,6/1/2014 16:00,2,0,'Superhormonas' contra el cáncer de próstata @ asco http://www.elmundo.es/salud/2014/06/01/5388ab72268e3ee2648b4579.html?cid=SMBOSO25301&s_kw=twitter …,,@,,4.73192E+17,https://twitter.com/xavigranda/status/473192301531893761,,,,
TuftsCancerCtr,6/1/2014 16:00,2,0,"Among pts with NSC # LungCancer, metformin use assoc w better survival # ASCO14 @ TuftsCTSI @ DukeCancer http://ow.ly/xuEW9",,@ @,# #,4.73192E+17,https://twitter.com/TuftsCancerCtr/status/473192297191178240,,,,
davidgrahammd,6/1/2014 16:00,0,0,Statisticians will love to talk about 80405 not being designed as a non-inferiority trial # ASCO14,,,#,4.73192E+17,https://twitter.com/davidgrahammd/status/473192287963742209,,,,
FoundationATCG,6/1/2014 16:00,1,1,A lot to celebrate and more to look forward to at # ASCO14. Read about Foundation Medicine’s beginning at http://bit.ly/1u5p8n8,,,#,4.73192E+17,https://twitter.com/FoundationATCG/status/473192285396410371,,,,
abcdiagnosis,6/1/2014 16:00,0,2,RT @ drattai “ @ ipaulmampilly: # ASCO14 lower # breastcancer risk for women following life style recommendations pic.twitter.com/6VWvWpP9LN”,,@ @,# #,4.73192E+17,https://twitter.com/abcdiagnosis/status/473192258486149121,,,,
ElizBlanchardMD,6/1/2014 15:59,0,1,"Folfiri or Folfox with either cetux or bev similar outcomes: what about QOL? Similar, though skin a major issue. # ASCO14",,,#,4.73192E+17,https://twitter.com/ElizBlanchardMD/status/473192211002036224,,,,
BairdAM,6/1/2014 15:59,0,0,# lcsm RT  @ n8pennell: Kong: PCI for stage 3 NSCLC improved DFS and decreased brain metastases," trend towards OS benefit. # ASCO14""""",,@,# #,4.73192E+17,https://twitter.com/BairdAM/status/473192188835147776,,,
KellyColligan,6/1/2014 15:59,0,0,AGREE! RT @ lisap1999: CALGB/SWOG 80405 show equivalence in arms. More importantly shows the tenacity of the investigators. Bravo! # ASCO14,,@,#,4.73192E+17,https://twitter.com/KellyColligan/status/473192165628473344,,,,
DrHealeyBird,6/1/2014 15:59,0,0,“ @ ASCO: “Do Some Human Cancers Originate from Infections Transmitted from Domestic Animals?”—Harald zur Hausen - buy yaks now!,,@,,4.73192E+17,https://twitter.com/DrHealeyBird/status/473192137593745408,,,,
OncEd,6/1/2014 15:59,0,1,CALGB 80405 data on extended Ras and subsequent therapies pending # crcsm # ASCO14,,,# #,4.73192E+17,https://twitter.com/OncEd/status/473192102927798272,,,,
BairdAM,6/1/2014 15:59,0,0,"# lcsm RT  @ n8pennell: Kong: PORT for resected N2 disease in National Cancer Database improved OS by 4.5% at 5 years. # ASCO14""""",,@,# #,4.73192E+17,https://twitter.com/BairdAM/status/473192071860219904,,,,
lisap1999,6/1/2014 15:58,0,0,CALGB/SWOG 80405 show equivalence in arms. More importantly they show the tenacity of the investigators. Bravo! # ASCO14,,,#,4.73192E+17,https://twitter.com/lisap1999/status/473191956139757568,,,,
samreess,6/1/2014 15:58,0,0,"A very exciting approach to cancer therapy  @ Roche: Keeping cancer # immunotherapy personal http://ow.ly/xp2c1 # ASCO14""""",,@,# #,4.73192E+17,https://twitter.com/samreess/status/473191935369547776,,,,
oncodocsydney,6/1/2014 15:58,0,1,Details of second and subsequent treatments in CALGB 80405 not yet available; will be important to interpretation and cf FIRE3 # ASCO14,,,#,4.73192E+17,https://twitter.com/oncodocsydney/status/473191930298654720,,,,
nycdoc29,6/1/2014 15:58,0,0,# asco14 - will SWOG data change the US favoritism for FOLFOX + Avastin? in mCRC,,,#,4.73192E+17,https://twitter.com/nycdoc29/status/473191918978224128,,,,
tehfem,6/1/2014 15:58,0,0,# ASCO14 Bev=Cetux in first line. Time for grp analysis according to RAS status?,,,#,4.73192E+17,https://twitter.com/tehfem/status/473191912233373696,,,,
dandunlop,6/1/2014 15:58,1,1,Awesome? RT @tt_mdanderson: Got to meet @ subatomicdoc ! Great chat about # radonc collaboration. Looking forward to more # physrels # asco14,,@tt_mdanderson @,# # #,4.73192E+17,https://twitter.com/dandunlop/status/473191894936473600,,,,
declangmurphy,6/1/2014 15:58,0,1,@ AlpineBV_Miller It is a game-changer for high-volume and will become standard of care I expect. The OS is v impressive # asco14,,@,#,4.73192E+17,https://twitter.com/declangmurphy/status/473191768742047744,,,,
RMiksad,6/1/2014 15:58,1,0,@ ASCO Dr Venook. First line treatment for CRC. Choice of biologic (Bev vs cetux) to chemo does not affect outcome in CALGB/SWOG 80405.,,@,,4.73192E+17,https://twitter.com/RMiksad/status/473191759494008832,,,,
CDerleth,6/1/2014 15:57,2,2,CHAARTED: Docetaxel + ADT prolongs med OS 17 mos in men w/ high volume met CSPC! Guess you CAN teach an old dog new tricks! # ASCO14,,,#,4.73192E+17,https://twitter.com/CDerleth/status/473191706612203520,,,,
aakonc,6/1/2014 15:57,0,0,11% disease free is awesome in met dz#crcsm # asco2014,,,#crcsm #,4.73192E+17,https://twitter.com/aakonc/status/473191692309626880,,,,
mlazqui,6/1/2014 15:57,3,1,Sweeney: 28% had grade 3/4 adverse event in ADT + docetaxel arm # ASCO14,,,#,4.73192E+17,https://twitter.com/mlazqui/status/473191685502296066,,,,
Medicalfacts,6/1/2014 15:57,0,0,No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab # ASCO14,,,#,4.73192E+17,https://twitter.com/Medicalfacts/status/473191672478986240,,,,
MedicalFactsEU,6/1/2014 15:57,0,0,No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab # ASCO14,,,#,4.73192E+17,https://twitter.com/MedicalFactsEU/status/473191672458014720,,,,
OncEd,6/1/2014 15:57,2,2,"CALGB 80405 FOLFOX subset 30 mos (cetux) vs 27 mos (bev) p-0.09, FOLFIRI arms no difference # crcsm # ASCO14",,,# #,4.73192E+17,https://twitter.com/OncEd/status/473191643060142081,,,,
dandunlop,6/1/2014 15:57,0,0,RT @tt_mdanderson: RT @nextprinciples: Top tweeters for day 3 so far # ASCO14 @ mtmdphd @ teamoncology @ShewithLynch @ drattai @ CI4CC,,@tt_mdanderson @nextprinciples @ @ @ShewithLynch @ @,#,4.73192E+17,https://twitter.com/dandunlop/status/473191625473413120,,,,
oncodocsydney,6/1/2014 15:57,0,1,Venook: comparison of chemotx backbone (FOLFOX/FOLFIRI) limited by small numbers utilising the latter. # ASCO14,,,#,4.73192E+17,https://twitter.com/oncodocsydney/status/473191571849240576,,,,
DrHedrick,6/1/2014 15:57,0,0,80405: Remember! Metastatic colorectal cancer can be a curable disease if low volume and respectable. # ASCO14,,,#,4.73192E+17,https://twitter.com/DrHedrick/status/473191547518074880,,,,
dmooneymd,6/1/2014 15:57,0,1,Swog 80405: overall survival the same... pfs the same...folfiri-bev and folfox-cet suggest hint of specific subgroup synergy. # ASCO14,,,#,4.73192E+17,https://twitter.com/dmooneymd/status/473191526252544000,,,,
alantanmd,6/1/2014 15:56,0,1,No difference OS and PFS in 1st line mCRC bevacizumab vs cetuximab # ASCO14 pic.twitter.com/x4MDGAejWv,,,#,4.73191E+17,https://twitter.com/alantanmd/status/473191485433982976,,,,
HenryJOncology,6/1/2014 15:56,0,0,# gucsm Docetaxel in high-volume disease improve OS more than any other treatment since castration! # ASCO14 clarifies http://abstracts.asco.org/144/AbstView_144_127755.html …,,,# #,4.73191E+17,https://twitter.com/HenryJOncology/status/473191478869504000,,,,
mlazqui,6/1/2014 15:56,2,0,In high volume disease OS improved from 32 to 49 mos with docetaxel # pcsm # ASCO14,,,# #,4.73191E+17,https://twitter.com/mlazqui/status/473191432975831040,,,,
BreastDocUK,6/1/2014 15:56,0,0,So not practice changing at all then? MT: @ dhjutsw1 discussion of conclusions TEXT and SOFT trials # ASCO14 pic.twitter.com/lzcbJTsjom,,@,#,4.73191E+17,https://twitter.com/BreastDocUK/status/473191355200839681,,,,
Medicalfacts,6/1/2014 15:56,0,0,RT: @jorgeramos800 Cost per Qaly “Financial efficacy” of docetaxel in one great slide! # ASCO14 https://twitter.com/JorgeRamos800/status/473187498127278080/photo/1pic.twitter.com/vS0aYYQfEI,,@jorgeramos800,#,4.73191E+17,https://twitter.com/Medicalfacts/status/473191350872322048,,,,
tomleblancMD,6/1/2014 15:56,7,0,Patients with metastatic colorectal # cancer lived median of 29 months on CALGB/SWOG 80405 study. Now that's progress! # ASCO14,,,# #,4.73191E+17,https://twitter.com/tomleblancMD/status/473191336699772928,,,,
yzafar,6/1/2014 15:56,5,2,"CALGB 80405: 10 years & 1200 patients later, we learn that bev=cetux in the first line, but the biomarker data might enlighten # ASCO14 @ ASCO",,@,#,4.73191E+17,https://twitter.com/yzafar/status/473191326310494208,,,,
SWOGChair,6/1/2014 15:56,0,1,"CALGB/SWOG 80405. Biological equivalent, but both arms did spectacularly. Glad for the NCTN and research it sponsors! # ASCO2014",,,#,4.73191E+17,https://twitter.com/SWOGChair/status/473191297415516160,,,,
YupOnc,6/1/2014 15:56,35,15,# ASCO14 no survival advantage for bev or cetux in mets colon cancer with standard chemo pic.twitter.com/ZkDT0dwbgh,,,#,4.73191E+17,https://twitter.com/YupOnc/status/473191292722483200,,,,
gorskon,6/1/2014 15:56,3,2,". @ drattai @ asco Sadly for me, @ markcrislip gets most of them. He also refers to CAM as the beer goggles of medicine."" He's right. # ASCO14""",,@ @ @,#,4.73191E+17,https://twitter.com/gorskon/status/473191257007587329,,,,
amedinacol,6/1/2014 15:55,0,1,Thinking how urologists are going to receive these brand new news!! # ASCO14 pic.twitter.com/o43fT2hfcz,,,#,4.73191E+17,https://twitter.com/amedinacol/status/473191244919603200,,,,
stuartgiles01,6/1/2014 15:55,1,0,Time for one last run and that will be an # ASCO14 wrap for me. Wheels up for the West Coast and # pebblebeach pic.twitter.com/tA0maA7vSQ,,,# #,4.73191E+17,https://twitter.com/stuartgiles01/status/473191207628447744,,,,
oncodocsydney,6/1/2014 15:55,0,0,Venook: CALGB/SWOG 80405: primary hypothesis of superior survival for one arm (difference in median 5.5) not met # ASCO14,,,#,4.73191E+17,https://twitter.com/oncodocsydney/status/473191149654786049,,,,
LillyDiabetes,6/1/2014 15:55,0,0,Look at how people are bringing art to life during day 2 of @LlyOncOnCanvas hope mural painting at # ASCO14! http://ow.ly/i/5L3mv,,@LlyOncOnCanvas,#,4.73191E+17,https://twitter.com/LillyDiabetes/status/473191114384871425,,,,
gorskon,6/1/2014 15:55,0,0,I can 99.9% guarantee that @ asco will never invite me to be part of this elite crowd of Twitter fiends. http://am.asco.org/2014-asco-annual-meeting-tweeters … # ASCO14,,@,#,4.73191E+17,https://twitter.com/gorskon/status/473191102489456640,,,,
nycdoc29,6/1/2014 15:55,0,0,# asco14 SWOG 80405 - OS no diff between chemo + avastin v chemo + erbitux.,,,#,4.73191E+17,https://twitter.com/nycdoc29/status/473191082680147968,,,,
andygaya,6/1/2014 15:54,0,1,CALGB 80405 OS - chemo/BEv v. chemo/Cetux = 29 v. 29.9 mos; HR = 0.92 (p=0.34). # crcsm # ASCO14,,,# #,4.73191E+17,https://twitter.com/andygaya/status/473190982733664256,,,,
DomenickBertell,6/1/2014 15:54,0,0,"# ASCO2014 takeaway: A handful of tumor-site-specific diagnostic panels, or NGS PCR focused on hot spots, could cover most cancers",,,#,4.73191E+17,https://twitter.com/DomenickBertell/status/473190935657209856,,,,
DrAttai,6/1/2014 15:54,0,0,@ gorskon @ ASCO @ MarkCrislip I'm sure of that. You can't have all the good one-liners tho,,@ @ @,,4.73191E+17,https://twitter.com/DrAttai/status/473190921421328384,,,,
DrHedrick,6/1/2014 15:54,1,0,80405: Chemo + Bev v. Chemo + Cetux. Essentially the same. One not better than the other. Negative study? Wouldn't put it that way. # ASCO14,,,#,4.73191E+17,https://twitter.com/DrHedrick/status/473190912840175616,,,,
mlazqui,6/1/2014 15:54,1,0,No financial toxicity! @JorgeRamos800: “Financial efficacy” of docetaxel in one great slide! # ASCO14 https://twitter.com/JorgeRamos800/status/473187498127278080/photo/1pic.twitter.com/yoYhv3ER0S,,@JorgeRamos800,#,4.73191E+17,https://twitter.com/mlazqui/status/473190871924756480,,,,
OncEd,6/1/2014 15:54,0,1,CALGB 80405 PFS (by investigator): chemo/BV v. chemo/CET: 10.84 v. 10.45 mos. # crcsm # ASCO14,,,# #,4.73191E+17,https://twitter.com/OncEd/status/473190821458898945,,,,
tehfem,6/1/2014 15:54,0,0,# ASCO14 CALGB/SWOG 80405 trial Bev-chemo vs Cetux-chemo OS HR O.925 p 0.32 same mOS 29 mo,,,#,4.73191E+17,https://twitter.com/tehfem/status/473190799123828736,,,,
DomenickBertell,6/1/2014 15:54,0,0,# ASCO2014 takeaway: Approach that might balance best treatment and cost – run standard Dx panel (20-60 mutations) on all new patients,,,#,4.73191E+17,https://twitter.com/DomenickBertell/status/473190786528739328,,,,
DKarikios,6/1/2014 15:53,2,0,# ASCO14 Bev + chemo = Cetux + chemo in met CRC 1st line treatment in terms of OS,,,#,4.73191E+17,https://twitter.com/DKarikios/status/473190711261548544,,,,
aakonc,6/1/2014 15:53,0,2,Median age in c80405 only 59! Remember that when interpreting high OS # crcsm # ASCO14,,,# #,4.73191E+17,https://twitter.com/aakonc/status/473190703431155712,,,,
jdflaysakier,6/1/2014 15:53,20,4,Cancer : deux avancées importantes dans le traitement des cancers du sein et de la prostate. Sur le blog http://www.docteurjd.com/?p=3218 # ASCO14,,,#,4.73191E+17,https://twitter.com/jdflaysakier/status/473190698163134465,,,,
gorskon,6/1/2014 15:53,0,0,. @ drattai @ asco My good bud @ markcrislip has a way with words. I wish I'd said that. # ASCO14,,@ @ @,#,4.73191E+17,https://twitter.com/gorskon/status/473190695864254464,,,,
teamoncology,6/1/2014 15:53,2,0,"ALLTO & other double anti-HER2 trials teach us that we need predictive biomarkers, who will benefit to trastuzumab alone. # ASCO14 # BCSM",,,# #,4.73191E+17,https://twitter.com/teamoncology/status/473190695117676544,,,,
OncEd,6/1/2014 15:53,0,1,CALGB 80405 OS - chemo/BV v. chemo/CET = 29 v. 29.9 mos; HR = 0.92 (p=0.34). # crcsm # ASCO14,,,# #,4.73191E+17,https://twitter.com/OncEd/status/473190672401723392,,,,
PCFnews,6/1/2014 15:53,2,2,PCF Young Investigator Dr Antonarakis: ARV7 is predictive biomarker for # prostatecancer resistance to Abiraterone & Enzalutamide # ASCO14,,,# #,4.73191E+17,https://twitter.com/PCFnews/status/473190661219692544,,,,
Oncpall,6/1/2014 15:53,1,0,Investigational Immunotherapy Granted First Breakthrough Therapy Designation in Bladder Cancer http://shar.es/VFV52 via @ OncLive # ASCO14,,@,#,4.73191E+17,https://twitter.com/Oncpall/status/473190625165078528,,,,
Emory_R,6/1/2014 15:53,0,1,GSK misses survival endpoint with Tykerb-Herceptin pairing http://buff.ly/1oY6KKx # ASCO14,,,#,4.73191E+17,https://twitter.com/Emory_R/status/473190552364941312,,,,
DrHedrick,6/1/2014 15:53,0,1,80405: More patients got FOLFOX than FOLFIRI. Almost all were palliative intent. # ASCO14,,,#,4.73191E+17,https://twitter.com/DrHedrick/status/473190510811947008,,,,
andygaya,6/1/2014 15:52,0,0,SWOG 80405: K-ras wt met colorectal cancer: physician choice FOLFIRI or FOLFOX then randomized to cetuximab or bevacizumab. # ASCO14 # crcsm,,,# #,4.7319E+17,https://twitter.com/andygaya/status/473190462460030976,,,,
OncEd,6/1/2014 15:52,0,1,"CALGB 80405 N=1137 FOLFIRI 27%, mFOLFOX6 73% primary endpt OS # crcsm # ASCO14",,,# #,4.7319E+17,https://twitter.com/OncEd/status/473190400669536257,,,,
Medicalfacts,6/1/2014 15:52,0,0,Plenary session 80405: K-ras + met colorectal cancer: Dr's choice folfiri or folfox...then randomized to cetuximab or bevacizumab. # ASCO14,,,#,4.7319E+17,https://twitter.com/Medicalfacts/status/473190355618529281,,,,
zorgnl,6/1/2014 15:52,0,0,Plenary session 80405: K-ras + met colorectal cancer: Dr's choice folfiri or folfox...then randomized to cetuximab or bevacizumab. # ASCO14,,,#,4.7319E+17,https://twitter.com/zorgnl/status/473190355614306306,,,,
DrAttai,6/1/2014 15:52,0,0,@ gorskon @ ASCO @ MarkCrislip ok that was good,,@ @ @,,4.7319E+17,https://twitter.com/DrAttai/status/473190355584548864,,,,
oncodocsydney,6/1/2014 15:52,1,0,Venook: CALGB80405 1st line Rx with chemotx (physicians choice FOLFOX or FOLFIRI) plus cetuximab or bev in KRAS WT # ASCO14,,,#,4.7319E+17,https://twitter.com/oncodocsydney/status/473190349817802753,,,,
ByJonGardner,6/1/2014 15:52,0,0,"My motto for # ASCO14: Metformin is NOT insulin."" $ CLVS""",,,#,4.7319E+17,https://twitter.com/ByJonGardner/status/473190348924407808,,,,
PhRMA,6/1/2014 15:52,0,1,# PhRMA is dedicated to finding solutions that ensure life-saving meds reach those who need them most http://onphr.ma/1nP9oV4 # ASCO14,,,# #,4.7319E+17,https://twitter.com/PhRMA/status/473190303965261824,,,,
DrHedrick,6/1/2014 15:52,0,0,80405: Overall survival is primary outgoing. Looking for best arm. Null hypothesis is that they are the same. # ASCO14,,,#,4.7319E+17,https://twitter.com/DrHedrick/status/473190248290459648,,,,
PeterHall001,6/1/2014 15:51,0,0,CHAARTED trial. Chemohormonal tx in hormone naive adv prostate ca. Looks like we'll need more urological oncologists! # ASCO14,,,#,4.7319E+17,https://twitter.com/PeterHall001/status/473190240878747648,,,,
mlazqui,6/1/2014 15:51,4,1,Docetaxel + BAC: mejoría de 17 meses en supervivencia global en pacientes con cáncer de próstata mets y más volumen tumoral # ASCO14,,,#,4.7319E+17,https://twitter.com/mlazqui/status/473190237058134016,,,,
davidgrahammd,6/1/2014 15:51,0,0,RT @ Tony_Calles: So far at the Plenary Session at # ASCO14 Prostate cancer results will change the standard of care-for only a small number,,@,#,4.7319E+17,https://twitter.com/davidgrahammd/status/473190227889377282,,,,
PeterHall001,6/1/2014 15:51,1,0,# ASCO14 has finally woken up to cost- effectiveness!,,,#,4.7319E+17,https://twitter.com/PeterHall001/status/473190225435303937,,,,
gorskon,6/1/2014 15:50,3,2,". @ asco Integrative"" oncology adds nothing to cancer care other than pseudoscience. # ASCO14""",,@,#,4.7319E+17,https://twitter.com/gorskon/status/473189916168708096,,,,
teamoncology,6/1/2014 15:50,3,1,【 # ASCO14 Update】 No association of vit D and outcome of breast cancer in MA.21 study. http://abstracts.asco.org/144/AbstView_144_128900.html … # BCSM,,,# #,4.7319E+17,https://twitter.com/teamoncology/status/473189836673662976,,,,
dmooneymd,6/1/2014 15:50,1,0,Swog 80405: K-ras wt met colorectal cancer: physician choice folfiri or folfox...then randomized to cetuximab or bevacizumab. # ASCO14 # crcsm,,,# #,4.7319E+17,https://twitter.com/dmooneymd/status/473189816390021120,,,,
CancerDotNet,6/1/2014 15:50,2,0,Ongoing study indicates 2 targeted therapies equally effctve for met colorectal cancer # ASCO14 summary: # crcsm http://bit.ly/1oK8x8n,,,# #,4.7319E+17,https://twitter.com/CancerDotNet/status/473189792227008512,,,,
rachescat,6/1/2014 15:50,0,0,Desenredando las complejidades de la genómica del cáncer de mama http://am.asco.org/unravelling-complexities-breast-cancer-genomics … # ASCO14,,,#,4.7319E+17,https://twitter.com/rachescat/status/473189791811772416,,,,
gyori6,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/gyori6/status/473189791077396480,,,,
gyori77,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/gyori77/status/473189790574456832,,,,
emma1974emma,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/emma1974emma/status/473189790498971648,,,,
ateszter2,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/ateszter2/status/473189790469599232,,,,
emma2anna,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/emma2anna/status/473189790465421312,,,,
danidani1974,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/danidani1974/status/473189790427660289,,,,
arthur11974,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/arthur11974/status/473189790423470081,,,,
AteszterKreatv,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/AteszterKreatv/status/473189790419271680,,,,
andreeartur1,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/andreeartur1/status/473189790410878976,,,,
diana2emma,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/diana2emma/status/473189790402490369,,,,
artur11974,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/artur11974/status/473189790368944128,,,,
andreetunde,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/andreetunde/status/473189790364762112,,,,
Artur1Artur6,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/Artur1Artur6/status/473189790364729345,,,,
ateszter1,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/ateszter1/status/473189790360551424,,,,
adianaemma,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/adianaemma/status/473189790326984704,,,,
aartur4,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/aartur4/status/473189790322790400,,,,
aarturartur2,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/aarturartur2/status/473189790322786304,,,,
GyoriTunde,6/1/2014 15:50,0,0,http://etsy.me/1nHPatq http://etsy.me/17EFB9W http://etsy.me/1fB4Yda http://etsy.me/14wTZQ5 # ASCO14,,,#,4.7319E+17,https://twitter.com/GyoriTunde/status/473189790280851456,,,,
gorskon,6/1/2014 15:50,1,1,". @ asco Integrative oncology"": ""Integrating"" pseudoscience-based oncology with science-based oncology. How can this be a good idea? # ASCO14""",,@,#,4.7319E+17,https://twitter.com/gorskon/status/473189778578735105,,,,
teamoncology,6/1/2014 15:50,0,0,【 # ASCO14 Update】 A higher pCR rate among BRCA germline mutation who received anthra/taxane based chemo in TNBC. # bcsm,,,# #,4.7319E+17,https://twitter.com/teamoncology/status/473189752582045696,,,,
teamoncology,6/1/2014 15:49,0,0,【 # ASCO14 Update】 Medullary & apocrine histology of TNBC has better prognosis. http://abstracts.asco.org/144/AbstView_144_132579.html … # ASCO14 # bcsm,,,# # #,4.7319E+17,https://twitter.com/teamoncology/status/473189655857201152,,,,
teamoncology,6/1/2014 15:49,0,1,【 # ASCO14 Update】Cetuximab combined with Ixa provides high pCR rate in TNBC. http://abstracts.asco.org/144/AbstView_144_135110.html … # bcsm,,,# #,4.7319E+17,https://twitter.com/teamoncology/status/473189606028890112,,,,
teamoncology,6/1/2014 15:48,0,0,【 # ASCO14 Update】 Cediranib+Olaparib significantly increases progression-free survival in women w/recurrent ovarian cancer. # BCSM,,,# #,4.73189E+17,https://twitter.com/teamoncology/status/473189481558724608,,,,
gorskon,6/1/2014 15:48,2,5,". @ asco Integrative oncology"": ""Integrating"" cow pie with apple pie does not make the apple pie taste better. Hat tip @ MarkCrislip # ASCO14""",,@ @,#,4.73189E+17,https://twitter.com/gorskon/status/473189387463700480,,,,
OncEd,6/1/2014 15:48,0,0,CALGB 80405 KRAS WT codon 12/13 - FOLFIRI or FOLFOX at investigator's discretion # crcsm # ASCO14,,,# #,4.73189E+17,https://twitter.com/OncEd/status/473189349149114369,,,,
DKarikios,6/1/2014 15:48,0,0,# ASCO14 Waiting with very baited breath for Bev vs Cetux in 1st line met CRC,,,#,4.73189E+17,https://twitter.com/DKarikios/status/473189322875625472,,,,
MjosemvI,6/1/2014 15:48,1,0,# asco14 Revisiting docetaxel in prostate cancer. Chaarted study. Also improves survival in metastatic hormone sensitive disease.,,,#,4.73189E+17,https://twitter.com/MjosemvI/status/473189271470624768,,,,
ABhealer108,6/1/2014 15:47,0,0,New option for premenopausal breast ca: Exemestane+Ovarian suppression.SOFT/TEXT trials. Excellent discussion by Dr. Davidson. # ASCO14,,,#,4.73189E+17,https://twitter.com/ABhealer108/status/473189231108444162,,,,
IanJPereira,6/1/2014 15:47,0,0,Tried my best @ OphiraG. Support stringy. Will be an interesting time ahead for Canada's global step at # SavingLives. @ ASCO @ NCIGlobalHealth,,@ @ @,#,4.73189E+17,https://twitter.com/IanJPereira/status/473189229338431488,,,,
nycdoc29,6/1/2014 15:47,0,0,"@ drdonsdizon: Sweeney ECOG -Docetaxel remarkably improves OS 4 men w mets. # ASCO14 # gucsm” - practice changing starting Wed for me.""",,@,# #,4.73189E+17,https://twitter.com/nycdoc29/status/473189209562701825,,,,
TGeorgeMD,6/1/2014 15:47,0,0,Venook: 1st line mCRC chemo+bev or chemo+CMab OS no diff | @ ALLIANCE_org: CALGB/ @ SWOG 80405 http://bit.ly/T3TuJB # ASCO14 @ NRGonc # crcsm,,@ @ @,# #,4.73189E+17,https://twitter.com/TGeorgeMD/status/473189190596050945,,,,
odub75,6/1/2014 15:47,0,2,@ Asco # ASCO14 just before the long-waited results.... pic.twitter.com/7jwr2vsGj7,,@,#,4.73189E+17,https://twitter.com/odub75/status/473189082902716417,,,,
GenentechJobs,6/1/2014 15:47,0,0,# ASCO14 Talent Hunt for Assoc. Medical Directors (2): PD-L1 -http://click2apply.net/431199f & TDM1 - http://click2apply.net/416279 Retweet # job.,,,# #,4.73189E+17,https://twitter.com/GenentechJobs/status/473188995644416000,,,,
rsm2800,6/1/2014 15:46,3,1,Bottom line: ADT+docetaxel improves OS substantially in pts w/ high volume dz (variably defined); preferrable to chemo at relapse # ASCO14,,,#,4.73189E+17,https://twitter.com/rsm2800/status/473188966435270656,,,,
Tony_Calles,6/1/2014 15:46,11,1,"So far at the Plenary Session at # ASCO14 Prostate cancer results will change the standard of care, Breast cancer results will not.",,,#,4.73189E+17,https://twitter.com/Tony_Calles/status/473188947993309184,,,,
abcdiagnosis,6/1/2014 15:46,0,2,“ @ drattai: More on obesity via @ HopkinsMedicine # asco14 # bcsm (3/3) pic.twitter.com/ZAXRlNERg9”,,@ @,# #,4.73189E+17,https://twitter.com/abcdiagnosis/status/473188872202248192,,,,
OncEd,6/1/2014 15:46,0,0,CALGB 80405 Venook Chemo+Bev vs Chemo+Cetux first line mCRC # crcsm # ASCO14,,,# #,4.73189E+17,https://twitter.com/OncEd/status/473188849041276928,,,,
ALLIANCE_org,6/1/2014 15:46,4,0,# ASCO14 Plenary: CALGB/SWOG 80405 results comparing 4 common 1st-line tx for colorectal cancer @ ALLIANCE_org @ SWOG http://bit.ly/RTClAT,,@ @,#,4.73189E+17,https://twitter.com/ALLIANCE_org/status/473188813070946304,,,,
teamoncology,6/1/2014 15:46,0,0,See the # ASCO14 trend map. We have some major issues that it is not well represented from certain part of the world. http://trendsmap.com/topic/%23asco14,,,#,4.73189E+17,https://twitter.com/teamoncology/status/473188807546638336,,,,
AlpineBV_Miller,6/1/2014 15:46,0,1,Why this doesn't affect the vast majority of US patients. # ASCO14. pic.twitter.com/JdeK8sAw5K,,,#,4.73189E+17,https://twitter.com/AlpineBV_Miller/status/473188784230891520,,,,
abcdiagnosis,6/1/2014 15:46,1,2,RT @ drattai: More on obesity via @ HopkinsMedicine # asco14 # bcsm (2/3)pic.twitter.com/ZXvqax4qEY,,@ @,# #,4.73189E+17,https://twitter.com/abcdiagnosis/status/473188741478350848,,,,
EthanBasch1,6/1/2014 15:45,12,6,"ASCO is promoting importance of value"" but phase III trials reported at ASCO meeting aren't including quality-adjusted survival. # ASCO14""",,,#,4.73189E+17,https://twitter.com/EthanBasch1/status/473188723296071680,,,,
OtisBrawley,6/1/2014 15:45,2,2,"# ASCO14 Sweeney and Charted gang. Congrats OS incr 13m, finally a clear real benefit to chemo in PCA",,,#,4.73189E+17,https://twitter.com/OtisBrawley/status/473188700474843137,,,,
OncEd,6/1/2014 15:45,0,0,ECOG Sweeney results for Low Volume disease patients - need further follow up # pcsm # ASCO14,,,# #,4.73189E+17,https://twitter.com/OncEd/status/473188686281310209,,,,
yzafar,6/1/2014 15:45,2,1,"We (ie, I) spend a lot of time arguing we spend too much. Really, we need to spend better # ASCO14",,,#,4.73189E+17,https://twitter.com/yzafar/status/473188661438447616,,,,
ERPlimackMD,6/1/2014 15:45,1,1,"In newly Dx'd high vol PCa, early docetaxel + ADT increased OS 17 mo despite crossover to docetaxel later. New SOC. # asco14 # pcsm # gusm",,,# # #,4.73189E+17,https://twitter.com/ERPlimackMD/status/473188547126915072,,,,
andygaya,6/1/2014 15:45,0,0,1st line ADT / docetaxel vs ADT improves survival in met prostate cancer by 13 months (44m to 57m). # ASCO14 # prostatecancer,,,# #,4.73189E+17,https://twitter.com/andygaya/status/473188540298194944,,,,
ASCO,6/1/2014 15:45,9,2,"Integrative oncology adds to, should not replace traditional cancer care http://bit.ly/1pJyNNL # ASCO14",,,#,4.73189E+17,https://twitter.com/ASCO/status/473188532602015744,,,,
arifkamalmd,6/1/2014 15:44,1,1,"Advance care planning in three, straightforward steps. # asco2014 pic.twitter.com/rm72ShWQMw",,,#,4.73188E+17,https://twitter.com/arifkamalmd/status/473188435407405058,,,,
CDC_Genomics,6/1/2014 15:44,17,7,Impact of Advances in Genomics on Breast Cancer Precision Medicine http://am.asco.org/unravelling-complexities-breast-cancer-genomics … # ASCO14 @ ASCO,,@,#,4.73188E+17,https://twitter.com/CDC_Genomics/status/473188433423122433,,,,
drcbsteer,6/1/2014 15:43,1,0,@ DKarikios @ Gazulides hard to believe $1500 per dose of docetaxel. More like $150? # whatiswithUSdrugprices # ASCO14,,@ @,# #,4.73188E+17,https://twitter.com/drcbsteer/status/473188227105705984,,,,
ERPlimackMD,6/1/2014 15:43,5,5,"A generic drug (docetaxel), given early, prolongs OS > 1 year in mPCa. Federal funding was critical for this major advance. # asco14 @ theNCI",,@,#,4.73188E+17,https://twitter.com/ERPlimackMD/status/473188122872643584,,,,
DrLen,6/1/2014 15:43,0,1,@ daviesbj good point. As noted by commenter we need to pay attention to implications for the appropriate prostate cancer pts. # ASCO14,,@,#,4.73188E+17,https://twitter.com/DrLen/status/473188116971659264,,,,
drdonsdizon,6/1/2014 15:43,5,2,"Avoid the misapprehension of risk (by both physician and patient) and the resultant misapplication of therapy."" Dr. M. Morris # ASCO14""",,,#,4.73188E+17,https://twitter.com/drdonsdizon/status/473188008355966976,,,,
BioWorld,6/1/2014 15:43,1,1,"The cardinal sin of prostate cancer care at every stage is the misapprehension of risk leading to the misapplication of therapy"" # ASCO14""",,,#,4.73188E+17,https://twitter.com/BioWorld/status/473188002387476480,,,,
nxtstop1,6/1/2014 15:43,0,1,"THE TWITTER SPHERE: # ASCO14 @ Boehringer: BLOG POST: “Over 3,900 tweets were generated on day 1 of ASCO using # ASCO14” http://bit.ly/1m1cLSF ”",,@,# #,4.73188E+17,https://twitter.com/nxtstop1/status/473187985765040128,,,,
TargetedOnc,6/1/2014 15:42,0,1,"OH at # ASCO14: The plenary session is totally irrelevant to my life.""""",,,#,4.73188E+17,https://twitter.com/TargetedOnc/status/473187959123218432,,,,
FightCRC,6/1/2014 15:42,0,0,Dr. Christopher Lieu at poster presentation # ASCO14 # coloncancer anti-EGFR antibodies http://bit.ly/1gK1Kcd,,,# #,4.73188E+17,https://twitter.com/FightCRC/status/473187812481589248,,,,
TuftsB,6/1/2014 15:42,1,3,@ Celgene_Myeloma - thanks for incremental innovation in medicines that saved my life and kicked cancers ass for 5 years # mliwi # ASCO14,,@,# #,4.73188E+17,https://twitter.com/TuftsB/status/473187794647793664,,,,
YourDiseaseRisk,6/1/2014 15:41,0,0,RT @ ASCO: 'Brave new world' of social media in medicine: sessions of interest Sun & Mon http://bit.ly/1mLfbYY # ASCO14,,@,#,4.73188E+17,https://twitter.com/YourDiseaseRisk/status/473187710115799040,,,,
dmooneymd,6/1/2014 15:41,0,0,Definitely should be practice changing in high volume pts. Brings back docetaxel when I had stopped using c/t sipuleucel or zytiga. # ASCO14,,,#,4.73188E+17,https://twitter.com/dmooneymd/status/473187671947214848,,,,
ecancer,6/1/2014 15:41,4,0,"Prof Abernethy: Discontinuing statins near the end of life improves patient quality of life, vid coming soon # ASCO14 pic.twitter.com/ghvuXa4iFz",,,#,4.73188E+17,https://twitter.com/ecancer/status/473187635314163713,,,,
teamoncology,6/1/2014 15:41,0,0,@ yzafar I must say the NIH review system for clinical trials are not stellar. Some of the reviewers lack clinical sense. # ASCO14,,@,#,4.73188E+17,https://twitter.com/teamoncology/status/473187601508073473,,,,
DrHedrick,6/1/2014 15:41,0,0,"Discussion: Does not seem to be a control arm"" effect. Similar to previous recent studies. # ASCO14""",,,#,4.73188E+17,https://twitter.com/DrHedrick/status/473187593589235712,,,,
mfrimawi,6/1/2014 15:41,0,0,Value in cancer care needs to be not only promoted but also incentivized. # ASCO14,,,#,4.73188E+17,https://twitter.com/mfrimawi/status/473187546965757952,,,,
DKarikios,6/1/2014 15:41,0,0,Love how value keeps on coming up at # ASCO14 - hugely important to discuss - # timesarechanging,,,# #,4.73188E+17,https://twitter.com/DKarikios/status/473187530364301312,,,,
IanJPereira,6/1/2014 15:41,0,0,Sorry to have missed the # ASCO14 tweetups. How did they go and will there be more? :) @ subatomicdoc @ JFreemanDaily @ mtmdphd @ brianreid,,@ @ @ @,#,4.73188E+17,https://twitter.com/IanJPereira/status/473187529358061568,,,,
drdonsdizon,6/1/2014 15:40,0,0,"TY Dr Morris: Need conversation of results in terms of value- efficacy, toxicity, and cost. Great work. # gucsm # ASCO14",,,# #,4.73187E+17,https://twitter.com/drdonsdizon/status/473187459162185728,,,,
uwaliraye,6/1/2014 15:40,0,0,"In premenopausal breast cancer, adjuvant treatment with exemestane & ovarian suppress reduces recurrence. # ASCO14 http://nej.md/1hadOUs "",,,#,473187455899017216""",https://twitter.com/uwaliraye/status/473187455899017216,,,,,,,,
CathyEngMD,6/1/2014 15:40,1,0,"Great comment from Drs. Sweeney and Wolchok # ASCO14 re: the imp contribution of the cooperative groups to the Plenary, # SWOG, # endcancer",,,# # #,4.73187E+17,https://twitter.com/CathyEngMD/status/473187431312019456,,,,
KaylaRodrigue11,6/1/2014 15:40,1,1,Cancer communities are using twitter to discuss care. What role do MDs play. The social oncology project. http://bit.ly/SOCONC # asco14,,,#,4.73187E+17,https://twitter.com/KaylaRodrigue11/status/473187398407311360,,,,
ShepardDale,6/1/2014 15:40,0,0,At the # ASCO14 plenary session showing a 13.6 month increase in OS by adding docetaxel to ADT for hormone sensitive met # prostatecancer,,,# #,4.73187E+17,https://twitter.com/ShepardDale/status/473187373405470720,,,,
BreakthroCancer,6/1/2014 15:40,2,0,We have a new # Blog available on our site from @ DrHealeyBird who's attending @ ASCO read it here http://www.hopeliveshere.ie # CancerResearch,,@ @,# #,4.73187E+17,https://twitter.com/BreakthroCancer/status/473187316430024704,,,,
miepsja,6/1/2014 15:40,1,0,“ @ MedscapeOnc: Schilsky: patient engagement will be fourth revolution affecting future of cancer care # ASCO14 pic.twitter.com/jOD3FTPzRX”,,@,#,4.73187E+17,https://twitter.com/miepsja/status/473187310407024640,,,,
teamoncology,6/1/2014 15:40,1,1,@ yzafar The issue is that we do not spend too much funding for early phase studies in cancer to find the potential winners. # ASCO14,,@,#,4.73187E+17,https://twitter.com/teamoncology/status/473187309131554818,,,,
OtisBrawley,6/1/2014 15:40,4,2,# ASCO14 ECOG 3805 is a great achievement for us who remember estramustine,,,#,4.73187E+17,https://twitter.com/OtisBrawley/status/473187306258460672,,,,
CancerAfrica,6/1/2014 15:40,0,0,# ASCO14 Dr zur Hausen on a future where cattle could be vaccinated to prevent transmission of cancer causing agents from cattle...perhaps?,,,#,4.73187E+17,https://twitter.com/CancerAfrica/status/473187276982587394,,,,
myriadgenetics,6/1/2014 15:40,0,0,Myriad's # Prolaris tests provides personalized # risk assessment for men with # prostatecancer. http://bit.ly/1sNsVEZ # ASCO14 Poster 5059,,,# # # #,4.73187E+17,https://twitter.com/myriadgenetics/status/473187226663141376,,,,
Memphisprays,6/1/2014 15:39,0,0,# askmac # AskJohnGreen # ASCO14 # BattleOfTheFandoms # BaileyForWildcard # BGT # Comrades2014 # celebrityencounter # DerekSays # WWDC14,,,# # # # # # # # # #,4.73187E+17,https://twitter.com/Memphisprays/status/473187126847479809,,,,
teamoncology,6/1/2014 15:39,0,0,@ yzafar Interesting questions. The questions is how many more large phase III studies can we do with the current accrual rate? # ASCO14,,@,#,4.73187E+17,https://twitter.com/teamoncology/status/473187080768466944,,,,
dmooneymd,6/1/2014 15:38,4,1,Talk about value of cancer care. Off patent drug with 17 month extension of survival in high risk population. # ASCO14,,,#,4.73187E+17,https://twitter.com/dmooneymd/status/473186952129175552,,,,
Ferheca12,6/1/2014 15:38,0,0,Al carajo Uro y Rt en cancer de próstata con enfermedad diseminada. Docetaxel + ADT aumenta 13m OS y 17m en high volume # ASCO2014,,,#,4.73187E+17,https://twitter.com/Ferheca12/status/473186902590644225,,,,
rsm2800,6/1/2014 15:38,2,0,Morris on ADT/docetaxel: Generic docetaxel fairly inexpensive; cost savings plus efficacy in improving OS when used earlier=a win # asco14,,,#,4.73187E+17,https://twitter.com/rsm2800/status/473186893182423040,,,,
marykge,6/1/2014 15:38,1,1,"Provocative talk. Promising future. # ASCO2014 Science of Oncology award lecture Prof Harald Zur Hausen MD pic.twitter.com/GaDWmrpoyp @ uicc""",,@,#,4.73187E+17,https://twitter.com/marykge/status/473186840191586304,,,,
RaisBahrami,6/1/2014 15:38,0,0,Plenary: docetaxel to accompany ADT in met PCa pts when starting tx esp in high vol met pts - start when still castration sensitive # ASCO14,,,#,4.73187E+17,https://twitter.com/RaisBahrami/status/473186802275454976,,,,
CancerAfrica,6/1/2014 15:37,0,0,# ASCO14 butchers/slaughter house worker exposed 2 aerosols from handling slaughter animals= possible airborne infection cause 4 cancer?,,,#,4.73187E+17,https://twitter.com/CancerAfrica/status/473186540039208960,,,,
yzafar,6/1/2014 15:37,9,0,"All abstracts at plenary were funded by federal funds. Yet today, cancer comprises 0.1% of federal budget. Are we spending enough? # ASCO14",,,#,4.73186E+17,https://twitter.com/yzafar/status/473186490793869313,,,,
AlpineBV_Miller,6/1/2014 15:37,3,2,KM comparing high-risk vs low-risk pts. Note the low risk are not stat sig. # ASCO14. pic.twitter.com/q7QXjHfJ3V,,,#,4.73186E+17,https://twitter.com/AlpineBV_Miller/status/473186476394831872,,,,
Medicalfacts,6/1/2014 15:37,0,0,"Sweeney: Early docetaxel in hormone naive metastatic prostate cancer improves OS - HR = 0.61, median improvement of 13.6 months # asco14",,,#,4.73186E+17,https://twitter.com/Medicalfacts/status/473186471307128832,,,,
DrHedrick,6/1/2014 15:37,0,0,Discussion: MUCH bigger effects than newer agents in the castrate resistant setting. # ASCO14 pic.twitter.com/VyHXLWFTPv,,,#,4.73186E+17,https://twitter.com/DrHedrick/status/473186470438518784,,,,
nxtstop1,6/1/2014 15:36,0,0,FINANCIAL TOXICITY of CHEMO. @ rsm2800: RT @ rsm2800: Davidson: Consider financial toxicity: goserelin almost $6000/yr # ASCO14 is addressing.,,@ @,#,4.73186E+17,https://twitter.com/nxtstop1/status/473186466235817985,,,,
lenstarnes,6/1/2014 15:36,1,2,"# ASCO14 Twitter participant/physical attendee % = 29, up 7% last 24 hours > mind- boggling 121m impressions # hcsm # hcsmeu # FOAMed @ symplur",,@,# # # #,4.73186E+17,https://twitter.com/lenstarnes/status/473186425555664896,,,,
Juanfran_jf,6/1/2014 15:36,2,0,Chemotherapy raise again in prostate cancer # ASCO14 pic.twitter.com/ZQQMALfnex,,,#,4.73186E+17,https://twitter.com/Juanfran_jf/status/473186425035165696,,,,
SWOGChair,6/1/2014 15:36,2,0,Biggest finding # ASCO2014? Coop group study shows adding docetaxel improves OS early met prostate cancer. Bravo Dr Sweeney! # swogonc,,,# #,4.73186E+17,https://twitter.com/SWOGChair/status/473186280344666112,,,,
drdonsdizon,6/1/2014 15:36,2,0,I don't treat prostate ca but results by Sweeney et al are so important. Docetaxel remarkably improves OS 4 men w mets. # ASCO14 # gucsm,,,# #,4.73186E+17,https://twitter.com/drdonsdizon/status/473186270555144193,,,,
teamoncology,6/1/2014 15:36,1,0,Interesting to know that hormonal Rx+chemo work in prostate cancer but this concept has not worked well in # BreastCancer # BCSM # ASCO14,,,# # #,4.73186E+17,https://twitter.com/teamoncology/status/473186266045878273,,,,
Medicalfacts,6/1/2014 15:35,0,0,10 years ago docetaxel data was first presented in prostate cancer. # ASCO14,,,#,4.73186E+17,https://twitter.com/Medicalfacts/status/473186007282900993,,,,
ASCO,6/1/2014 15:35,14,10,'Brave new world' of social media in medicine: sessions of interest Sun & Mon http://bit.ly/1mLfbYY # ASCO14,,,#,4.73186E+17,https://twitter.com/ASCO/status/473185994943262720,,,,
DrHedrick,6/1/2014 15:34,0,0,Discussion: Introduction of docetaxel improved OS by few months. Effect appears bigger with moving ADT up to castrate sensitive. # ASCO14,,,#,4.73186E+17,https://twitter.com/DrHedrick/status/473185920938541056,,,,
arifkamalmd,6/1/2014 15:34,6,4,Defining the # palliative care need in BMT # asco2014 pic.twitter.com/1DlaUogsFr,,,# #,4.73186E+17,https://twitter.com/arifkamalmd/status/473185830388121600,,,,
MOCBrasil,6/1/2014 15:34,0,0,Acabou de terminar a primeira apresentação na plenaria da # asco2014 e o # MOC2014 já trouxe os resultados para vcs. http://mocbrasil.com/blog/2014/06/01/asco-2014-domingo-0106-sessao-plenaria-no-1-cancer-de-mama/ …,,,# #,4.73186E+17,https://twitter.com/MOCBrasil/status/473185811601842176,,,,
AskDrSuzanne,6/1/2014 15:34,0,1,"Huge issue- needs Attn “ @ drdonsdizon: Baumgart, et Al. Sexual health toxicity of aromatase inhibitors. # bcsm # ASCO14 http://www.ncbi.nlm.nih.gov/pubmed/22990756 ”",,@,# #,4.73186E+17,https://twitter.com/AskDrSuzanne/status/473185764281290752,,,,
drcbsteer,6/1/2014 15:33,1,0,# ASCO14 Sweeney. Patients with mCSPC both younger and older than 70 years benefited from ADT + docetaxel,,,#,4.73186E+17,https://twitter.com/drcbsteer/status/473185700893188096,,,,
teamoncology,6/1/2014 15:33,1,2,"【 # ASCO14 Update】wow RT @ AndrewCowanMD: ADT+docetaxel vs ADT alone in hormone sensitive met PCa, 13 M OS improvement. https://twitter.com/AndrewCowanMD/status/473184110538932224/photo/1pic.twitter.com/Uy0DgMlhAE",,@,#,4.73186E+17,https://twitter.com/teamoncology/status/473185647176327168,,,,
DrHedrick,6/1/2014 15:33,0,0,Discussion: 10 years ago docetaxel data was first presented in prostate cancer. # ASCO14 # ASCO04,,,# #,4.73186E+17,https://twitter.com/DrHedrick/status/473185631305084928,,,,
DCarrizosaMD,6/1/2014 15:33,1,0,# ASCO14 plenary- >1yr improvement in OS if adding docetaxel to androgen deprivation in new prostate CA with high volume dz -wow! # LCI,,,# #,4.73186E+17,https://twitter.com/DCarrizosaMD/status/473185613215068162,,,,
tpjmd,6/1/2014 15:32,0,1,"CHAARTED is quite impressive at first blush, especially as 75% of those in hormonal suppression alone arm eventually got docetaxel. # ASCO14",,,#,4.73185E+17,https://twitter.com/tpjmd/status/473185455815786496,,,,
CancerAfrica,6/1/2014 15:32,0,0,# ASCO14 >20 epidemologic surveys show increase risk of butchers/slaughter house workers for lung+oropharyngeal cancer -Dr zur Hausen,,,#,4.73185E+17,https://twitter.com/CancerAfrica/status/473185438258442240,,,,
DrLen,6/1/2014 15:32,0,2,So the question for me is why did it take us so long to discover the benefit of early use of docetaxel in prostate cancer? # ASCO14,,,#,4.73185E+17,https://twitter.com/DrLen/status/473185402938228736,,,,
Cortellis,6/1/2014 15:32,2,0,Joint analysis TEXT & SOFT trials: improved DFS with exemestane + ovarian suppression vs tamoxifen in premenopausal breast cancer # asco14,,,#,4.73185E+17,https://twitter.com/Cortellis/status/473185380226039809,,,,
OncEd,6/1/2014 15:32,0,0,ECOG Sweeney practice changing presentation: major benefit for docetaxel in metastatic hormone sensitive prostate ca # pcsm # ASCO14,,,# #,4.73185E+17,https://twitter.com/OncEd/status/473185373129306112,,,,
YupOnc,6/1/2014 15:32,23,9,# ASCO14 prostate patients with high volume disease 1 year improved survival with early use of docetaxel with ADT pic.twitter.com/3WhgOW7AvJ,,,#,4.73185E+17,https://twitter.com/YupOnc/status/473185313817628674,,,,
BurrisSkip,6/1/2014 15:32,3,0,Dr Sweeney reports 1st line ADT / docetaxel vs ADT improves survival in prostate cancer by 13 months (44m to 57m). # ASCO14 @ SarahCannonDocs,,@,#,4.73185E+17,https://twitter.com/BurrisSkip/status/473185296188968960,,,,
robert_jeng,6/1/2014 15:31,0,0,Does chemo hormonal data at plenary open door to explore other therapies with ADT? # asco14,,,#,4.73185E+17,https://twitter.com/robert_jeng/status/473185199682248704,,,,
teamoncology,6/1/2014 15:31,0,0,@ thecancergeek ER+ Primary inflammatory breast cancer is very different from non-IBC. See this paper. http://annonc.oxfordjournals.org/content/early/2013/12/17/annonc.mdt525.short?rss=1 … # ASCO14,,@,#,4.73185E+17,https://twitter.com/teamoncology/status/473185197890879488,,,,
d2merino,6/1/2014 15:31,0,0,"Congratulations Dr. Les Robison, winner of the # ASCO14 Ped Oncology award! # childhoodcancersurvivor @ StJudeResearch http://www.forbes.com/sites/robertglatter/2014/05/31/asco-2014-how-scientific-collaboration-can-improve-our-approach-to-fighting-cancer/ …",,@,# #,4.73185E+17,https://twitter.com/d2merino/status/473185196968529921,,,,
lka_,6/1/2014 15:31,0,0,# ASCO14 pic.twitter.com/mQMi3jFKVf,,,#,4.73185E+17,https://twitter.com/lka_/status/473185159299080192,,,,
DrStelling,6/1/2014 15:31,0,0,@ gorskon @ juliomayol @ KoontzOncology @ rschilsky if we *do* shell out the cash & Upgrade our hospitals; that wld change everything # ASCO14”,,@ @ @ @,#,4.73185E+17,https://twitter.com/DrStelling/status/473185102739296256,,,,
Tony_Calles,6/1/2014 15:31,1,0,Plenary session at # ASCO14 Survival benefit when chemo is added to ADT upfront in prostate cancer pic.twitter.com/CzkhChfLA4,,,#,4.73185E+17,https://twitter.com/Tony_Calles/status/473185076256440320,,,,
KowalyszynMD,6/1/2014 15:30,0,0,Bloqueo hormonal + docetaxel mejor que bloqueo solo. Plenaria # ASCO2014 pic.twitter.com/m2rcnV5Mmy,,,#,4.73185E+17,https://twitter.com/KowalyszynMD/status/473184951022919681,,,,
SanofiUS,6/1/2014 15:30,0,0,RT @ ASCO: . @ CliffordHudis talks # ASCO14 plenary papers w/ @ CBSEveningNews. Airs tonite @6 pm EST http://bit.ly/1pJNAYy,,@ @ @ @6,#,4.73185E+17,https://twitter.com/SanofiUS/status/473184947168354305,,,,
rsm2800,6/1/2014 15:30,1,1,Sweeney: 28% had grade 3/4 adverse event in ADT + docetaxel arm # ASCO14,,,#,4.73185E+17,https://twitter.com/rsm2800/status/473184914699874305,,,,
Novartis,6/1/2014 15:30,3,2,Posters on the future of # CML treatment will be featured at # ASCO14. Learn more here: http://bit.ly/1n4oXWP,,,# #,4.73185E+17,https://twitter.com/Novartis/status/473184888515207168,,,,
BayerPharma,6/1/2014 15:30,1,1,"We present # livercancer data at # ASCO14. # DYK there are 748,300 new cases annually http://bit.ly/1rprB8H http://twitpic.com/e58zq9",,,# # #,4.73185E+17,https://twitter.com/BayerPharma/status/473184888322269184,,,,
NEJM,6/1/2014 15:30,13,1,# ASCO14 Copies of TEXT/SOFT study on exemestane/breast cancer available at booth 20127.,,,#,4.73185E+17,https://twitter.com/NEJM/status/473184866520293376,,,,
DrStelling,6/1/2014 15:30,0,0,@ gorskon @ juliomayol @ KoontzOncology @ rschilsky Dunno-can be like building a house w/o laying foundation 1st # ASCO14,,@ @ @ @,#,4.73185E+17,https://twitter.com/DrStelling/status/473184864582508544,,,,
LillyPad,6/1/2014 15:30,2,1,How do we determine and reward value in cancer care and develop new treatments? # ASCO14 http://ow.ly/xsenO,,,#,4.73185E+17,https://twitter.com/LillyPad/status/473184832567394304,,,,
ASCO,6/1/2014 15:30,6,3,Experts hope advances in next-generation sequencing will unravel breast cancer complexity http://bit.ly/1m3su3G # ASCO14,,,#,4.73185E+17,https://twitter.com/ASCO/status/473184821079187457,,,,
teamoncology,6/1/2014 15:30,0,0,"@ thecancergeek Yes for ER+ premenopausal Inflammatory Breast Cancer, I will recommend OSF and AI combo. The risk is just too high. # ASCO14",,@,#,4.73185E+17,https://twitter.com/teamoncology/status/473184773821571072,,,,
TargetedOnc,6/1/2014 15:30,0,2,Dr. Hoff on the Effect of Ziv-Aflibercept in the BEV Pre-Treated Subgroup of Patients in the VELOUR Trial http://www.targetedonc.com/conference/asco-2014/The-Effect-of-Ziv-Aflibercept-in-the-Bevacizumab-Pre-Treated-Subgroup-of-Patients-in-the-VELOUR-Trial … # ASCO14,,,#,4.73185E+17,https://twitter.com/TargetedOnc/status/473184768885264384,,,,
CancerTherAdvsr,6/1/2014 15:30,0,0,Molecular Subtyping Pinpoints Optimal # BreastCancer Treatment # ASCO14 http://ow.ly/xuQpq,,,# #,4.73185E+17,https://twitter.com/CancerTherAdvsr/status/473184744193421312,,,,
ChiariTracy,6/1/2014 15:30,0,0,RT @ Cascadia Where are patient voices at largest cancer conf? # ASCO14 # S4PM @least 1 session on Tue http://am.asco.org/tuesday-june-3-2014 … … @ PatientsFCR,,@ @least @,# #,4.73185E+17,https://twitter.com/ChiariTracy/status/473184743488782336,,,,
genentech,6/1/2014 15:30,0,0,"@ alfayezmo great questions. If we have enough data, does the phase matter? http://ow.ly/3lfoo4 # ASCO14",,@,#,4.73185E+17,https://twitter.com/genentech/status/473184738422042624,,,,
CancerAfrica,6/1/2014 15:29,2,0,# ASCO14 financial toxicity= cost burden of cancer drugs,,,#,4.73185E+17,https://twitter.com/CancerAfrica/status/473184662706462720,,,,
dmooneymd,6/1/2014 15:29,1,0,Chaarted: 3/4 of Adt alone patients eventually got docetaxel. Makes overall survival effect of docetaxel upfront very impressive. # ASCO14,,,#,4.73185E+17,https://twitter.com/dmooneymd/status/473184631005540352,,,,
DrHedrick,6/1/2014 15:29,0,0,Sweeney: Patients getting docetaxel were able to get further therapy at higher rate. Most control patients eventually got docetaxel. # ASCO14,,,#,4.73185E+17,https://twitter.com/DrHedrick/status/473184616065413120,,,,
oncodocsydney,6/1/2014 15:29,0,0,"Sweeney: 75% pts in ADT alone arm received docetaxel at progression, smaller % other Rx # ASCO14",,,#,4.73185E+17,https://twitter.com/oncodocsydney/status/473184614463574016,,,,
nxtstop1,6/1/2014 15:29,0,0,"ON RISK SIDE LEDGER:COST. @ juliomayol @ jrgralow:Cancer doctors urged to consider value when treating patients # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-health-cancer-value-20140530,0,4872696.story …",,@ @,#,4.73185E+17,https://twitter.com/nxtstop1/status/473184604891799552,,,,
drdonsdizon,6/1/2014 15:29,2,2,@ KDamokles @pedrazosfroilan @ duemed agree w Dr Davidson- these data shouldn't impact care. Await SOFT data. OFS is no picnic. # bcsm # ASCO14,,@ @pedrazosfroilan @,# #,4.73185E+17,https://twitter.com/drdonsdizon/status/473184533748019200,,,,
DrLen,6/1/2014 15:29,0,0,@ gorskon Understood and I am not convinced either. It is the hypothesis generation that I found interesting. # ASCO14,,@,#,4.73185E+17,https://twitter.com/DrLen/status/473184520657981440,,,,
MaverickNY,6/1/2014 15:29,0,0,What's with the horribly cramped poster sections in S Hall A2 this year? Two posters to a small board? Nuts. # asco14,,,#,4.73184E+17,https://twitter.com/MaverickNY/status/473184499699056642,,,,
rsm2800,6/1/2014 15:29,1,0,Sweeney: 75% pts progressing on ADT alone ultimately got docetaxel # ASCO14,,,#,4.73184E+17,https://twitter.com/rsm2800/status/473184497618259969,,,,
robert_jeng,6/1/2014 15:28,1,0,More than one year increased survival with docetaxel + ADT vs ADT alone. # asco2014,,,#,4.73184E+17,https://twitter.com/robert_jeng/status/473184440206647296,,,,
OncEd,6/1/2014 15:28,0,0,ECOG Sweeney therapy beyond progression : 3/4 of those who progressed on ADT received docetaxel # pcsm # ASCO14,,,# #,4.73184E+17,https://twitter.com/OncEd/status/473184371231707136,,,,
AlpineBV_Miller,6/1/2014 15:28,1,2,Chemohormonal data OS benefit all in high volume disease at entry. Pts with low volume did not benefit # ASCO14,,,#,4.73184E+17,https://twitter.com/AlpineBV_Miller/status/473184322959454208,,,,
djsampson,6/1/2014 15:28,0,0,"OH during infections transmitted from domestic animals plenary: I was with him 'til he started citing Wikipedia."" # ASCO14""",,,#,4.73184E+17,https://twitter.com/djsampson/status/473184320447062016,,,,
ChrisHeery,6/1/2014 15:27,0,0,The major problem with early docetaxel study: confounded by new agents since the study occurred. # ASCO14,,,#,4.73184E+17,https://twitter.com/ChrisHeery/status/473184190910197761,,,,
cordekroon,6/1/2014 15:27,1,0,Needs to be studied! “ @ teamoncology: @ cordekroon We ado not know the long-term impact of OFS in young BC patients. # ASCO14 # BCSM”,,@ @,# #,4.73184E+17,https://twitter.com/cordekroon/status/473184155321524225,,,,
gorskon,6/1/2014 15:27,2,1,". @ drstelling @ juliomayol @ koontzoncology @ rschilsky Oh, I don't know if it's *worse* than useless. :-) # ASCO14",,@ @ @ @,#,4.73184E+17,https://twitter.com/gorskon/status/473184123922567168,,,,
rsm2800,6/1/2014 15:27,0,0,Sweeney: ADT+docetaxel benefitted all subgroups including +/- visceral mets # ASCO14,,,#,4.73184E+17,https://twitter.com/rsm2800/status/473184119162011649,,,,
oncodocsydney,6/1/2014 15:27,1,0,"Sweeney: improvement in mOS w/early chemotx seen in all subgroups, but greatest in high volume disease (CHAARTED) # ASCO14",,,#,4.73184E+17,https://twitter.com/oncodocsydney/status/473184077164843008,,,,
DrHedrick,6/1/2014 15:27,0,0,"Sweeney: Benefits across all subsets other than those with very low numbers. Best if harder to treat! Older, high volume. # ASCO14",,,#,4.73184E+17,https://twitter.com/DrHedrick/status/473184077013467137,,,,
RaisBahrami,6/1/2014 15:27,0,0,"Dr. Sweeney: CHAARTED study shows ADT+docetaxel had higher OS compared to ADT alone, driven by pts with high volume met dz. # ASCO14",,,#,4.73184E+17,https://twitter.com/RaisBahrami/status/473184034852724736,,,,
PhRMA,6/1/2014 15:27,0,2,Castellani: Value of meds means more time w/ family for # patients & breakthroughs add ~$3T/yr to natl wealth http://bit.ly/1nDaGmT # ASCO14,,,# #,4.73184E+17,https://twitter.com/PhRMA/status/473183983316893697,,,,
AlpineBV_Miller,6/1/2014 15:26,1,2,These chemohormonal data are not representative of the typical US patient. Over 70% had no local therapy. Only 20% had RP. # ASCO14,,,#,4.73184E+17,https://twitter.com/AlpineBV_Miller/status/473183934524973056,,,,
dytcmd,6/1/2014 15:26,0,0,"Sadly, comments apply broadly MT @ DrHedrick: Large trial, good stats, small but real effect. Relevant? Good use of lim research $? # ASCO14”",,@,#,4.73184E+17,https://twitter.com/dytcmd/status/473183917357682688,,,,
rsm2800,6/1/2014 15:26,1,1,"Sweeney: Improvement in OS clearly attributed to decrease in prostate cancer deaths, w/ greater benefit seen in high volume pts # ASCO14",,,#,4.73184E+17,https://twitter.com/rsm2800/status/473183883333083137,,,,
OncEd,6/1/2014 15:26,1,1,ECOG Sweeney In high volume disease OS improved from 32 to 49 mos with docetaxel # pcsm # ASCO14,,,# #,4.73184E+17,https://twitter.com/OncEd/status/473183870528270337,,,,
tehfem,6/1/2014 15:26,0,0,# ASCO14 chemo+ADT > ADT in m prostate ca hormone naive,,,#,4.73184E+17,https://twitter.com/tehfem/status/473183865746382848,,,,
DrHedrick,6/1/2014 15:26,0,0,Sweeney: Deaths largely related to prostate cancer. One possible treatment related death. Biggest effect is in high volume disease. # ASCO14,,,#,4.73184E+17,https://twitter.com/DrHedrick/status/473183864362262528,,,,
dmooneymd,6/1/2014 15:26,1,1,"Chaarted: median os 57.6 vs 44.0 months. P=0.0003. 13 month improvement! In patients with high volume disease, 17 months! # ASCO14",,,#,4.73184E+17,https://twitter.com/dmooneymd/status/473183851112431616,,,,
drapaolaceledon,6/1/2014 15:26,0,0,Metaanálisis: Trastuzumab beneficia sustancialmente tumores menores de 2cms # ASCO14,,,#,4.73184E+17,https://twitter.com/drapaolaceledon/status/473183848910835713,,,,
oncodocsydney,6/1/2014 15:26,1,0,"Sweeney: RPh3 CHAARTED-early docetaxel chemo +ADT improved OS in 1st line Rx of HRProstateCa cf ADT alone (HR 0.61,p=0.0003) # ASCO14",,,#,4.73184E+17,https://twitter.com/oncodocsydney/status/473183766920560640,,,,
Medicalfacts,6/1/2014 15:26,0,0,RT @ DrHedrick: Sweeney: Overall Survival increased from 44 months to 57.6 months with addition of docetaxel. # ASCO14,,@,#,4.73184E+17,https://twitter.com/Medicalfacts/status/473183725455675392,,,,
OncEd,6/1/2014 15:25,0,0,ECOG Sweeney Docetaxl improved OS 44 to 57 mos - major improvement! # pcsm # ASCO14,,,# #,4.73184E+17,https://twitter.com/OncEd/status/473183650310520832,,,,
miepsja,6/1/2014 15:25,0,0,“ @ LIVESTRONG_NL: 50 years of progress in lung # cancer research - http://bit.ly/TXJxxV # ASCO14 (via @ ASCO )”,,@ @,# #,4.73184E+17,https://twitter.com/miepsja/status/473183639774445568,,,,
DKarikios,6/1/2014 15:25,2,0,"# ASCO14 Sweeney et al: Early docetaxel in hormone naive metastatic prostate cancer improves OS - HR = 0.61, median improvement of 13.6 mths",,,#,4.73184E+17,https://twitter.com/DKarikios/status/473183639128129536,,,,
DrHedrick,6/1/2014 15:25,0,0,Sweeney: Overall Survival increased from 44 months to 57.6 months with addition of docetaxel. # ASCO14,,,#,4.73184E+17,https://twitter.com/DrHedrick/status/473183578482679808,,,,
CancerAfrica,6/1/2014 15:25,1,0,# ASCO14 Science of Oncology award and lecture nobel laurete Prof Harald Zur Hausen MD @ ASCO @ iConquerCancerpic.twitter.com/Qkc4cw6YYP,,@ @,#,4.73184E+17,https://twitter.com/CancerAfrica/status/473183561160617984,,,,
rsm2800,6/1/2014 15:25,1,0,Sweeney: Androgen deprivation +/- docetaxel chemo for metastatic prostate cancer # ASCO14,,,#,4.73184E+17,https://twitter.com/rsm2800/status/473183501131333632,,,,
CancerAfrica,6/1/2014 15:25,0,0,# ASCO14 21% of human cancers linked to infections Dr zur Hausen,,,#,4.73183E+17,https://twitter.com/CancerAfrica/status/473183470689480704,,,,
Boehringer,6/1/2014 15:25,1,1,"BLOG POST: “Over 3,900 tweets were generated on day 1 of ASCO using # ASCO14” http://bit.ly/1m1cLSF",,,#,4.73183E+17,https://twitter.com/Boehringer/status/473183460627345408,,,,
EMDSerono,6/1/2014 15:25,0,0,50 years’ strong and just as impactful. # ASCO14 still driving cutting-edge scientific discussion on oncology.,,,#,4.73183E+17,https://twitter.com/EMDSerono/status/473183460375683075,,,,
BioWorld,6/1/2014 15:24,0,0,"Phase III ALTTO disappointing, but may set new tenor for pCR in breast cancer, others http://bit.ly/1iIRv33 # ASCO14",,,#,4.73183E+17,https://twitter.com/BioWorld/status/473183441849430017,,,,
Medicalfacts,6/1/2014 15:24,0,0,# ASCO14 Firstline bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastati... http://ow.ly/2HlOip,,,#,4.73183E+17,https://twitter.com/Medicalfacts/status/473183438741463040,,,,
DrStelling,6/1/2014 15:24,1,0,@ gorskon @ juliomayol @ KoontzOncology @ rschilsky Big Data in medicine=worse than useless unless we fund proper Infrastructure # ASCO14”,,@ @ @ @,#,4.73183E+17,https://twitter.com/DrStelling/status/473183423633190912,,,,
nycdoc29,6/1/2014 15:24,0,0,“ @ teamoncology: So how many of you are going to start giving OSF and AI in the clinic? # ASCO14” high risk 4 endometrial Ca would consider.,,@,#,4.73183E+17,https://twitter.com/nycdoc29/status/473183403966480384,,,,
OncEd,6/1/2014 15:24,1,0,"ECOG Sweeney Median age: 63 years (range: 36 to 91); 70% ECOG 0 24% prior radiotherapy, 24% prior prostatectomy; HV 67% # pcsm # ASCO14",,,# #,4.73183E+17,https://twitter.com/OncEd/status/473183363646627840,,,,
SaraZwicker,6/1/2014 15:24,0,0,Hosting a meeting outside is glorious! # chicago # ASCO14,,,# #,4.73183E+17,https://twitter.com/SaraZwicker/status/473183309468405760,,,,
DrHedrick,6/1/2014 15:24,0,0,Sweeney: Characteristics are largely similar. Matched in terms of disease characteristics. # ASCO14,,,#,4.73183E+17,https://twitter.com/DrHedrick/status/473183294654124033,,,,
teamoncology,6/1/2014 15:24,0,1,You wonder how the sexuality issue is going to explode by giving AI and ovarian suppression function in such a young age. # ASCO14,,,#,4.73183E+17,https://twitter.com/teamoncology/status/473183246885199872,,,,
gorskon,6/1/2014 15:23,0,0,. @ drlen 'Fraid I gotta say: Prof. zur Hausen didn't convince me. Lots of speculation based on correlation. Almost no hard data. # ASCO14.,,@,#,4.73183E+17,https://twitter.com/gorskon/status/473183160226684928,,,,
DrHedrick,6/1/2014 15:23,0,0,Sweeney: 3 amendments additional of low volume mets due to slow accrual. Change in projected OS due to newer agents/stage migration. # ASCO14,,,#,4.73183E+17,https://twitter.com/DrHedrick/status/473183144560975872,,,,
OncEd,6/1/2014 15:23,0,0,"ECOG Sweeney 790 men accrued , median follow up 29 mos # pcsm # ASCO14",,,# #,4.73183E+17,https://twitter.com/OncEd/status/473183056258662400,,,,
HemOncToday,6/1/2014 15:23,3,2,# ASCO14 @ sloan_kettering doc highlights how # temsirolimus combination improved survival in # rhabdomyosarcoma http://goo.gl/HnHCDf,,@,# # #,4.73183E+17,https://twitter.com/HemOncToday/status/473183029381570562,,,,
GoHealio,6/1/2014 15:23,0,0,# ASCO14 @ sloan_kettering doc highlights how # temsirolimus combination improved survival in # rhabdomyosarcoma http://goo.gl/HnHCDf,,@,# # #,4.73183E+17,https://twitter.com/GoHealio/status/473183028546912256,,,,
teamoncology,6/1/2014 15:23,0,0,So how many of you are going to start giving OSF and AI in the clinic from this week? # ASCO14,,,#,4.73183E+17,https://twitter.com/teamoncology/status/473182994543292416,,,,
dmooneymd,6/1/2014 15:22,0,0,Chaarted: New metastatic prostate cancer. Adt +/- docetaxel. Primary endpoint: detect 33% improvement in overall survival. # ASCO14,,,#,4.73183E+17,https://twitter.com/dmooneymd/status/473182943503196160,,,,
tpjmd,6/1/2014 15:22,0,0,There is something stirring in watching answers revealed to questions whose answers have never been known before. # ASCO14,,,#,4.73183E+17,https://twitter.com/tpjmd/status/473182941754171393,,,,
OncEd,6/1/2014 15:22,0,0,ECOG Sweeney ....(HV: visceral metastases and/or 4 or more bone mets) # pcsm # ASCO14,,,# #,4.73183E+17,https://twitter.com/OncEd/status/473182783364669440,,,,
OncLive,6/1/2014 15:21,0,3,Grab the latest issue of Oncology & Biotech News and OncologyLive at our # ASCO14 booth #18127 pic.twitter.com/48q6E2vDkI,,,# #18127,4.73183E+17,https://twitter.com/OncLive/status/473182688942125056,,,,
DrHedrick,6/1/2014 15:21,0,0,"Sweeney: Primary endpoint Overall Survival. Secondary - PSA Decline, time to progression, QOL. # ASCO14",,,#,4.73183E+17,https://twitter.com/DrHedrick/status/473182653386993664,,,,
OncEd,6/1/2014 15:21,0,0,ECOG Sweeney Stratification factors include high volume (HV) vs. low volume (LV) disease ..... # pcsm # ASCO14,,,# #,4.73183E+17,https://twitter.com/OncEd/status/473182645997031425,,,,
gorskon,6/1/2014 15:21,1,0,I am skeptical “ @ juliomayol: “ @ KoontzOncology:Big data in the field of precision medicine as per @ rschilsky # ASCO14 pic.twitter.com/Vd2IR0grjj””,,@ @ @,#,4.73182E+17,https://twitter.com/gorskon/status/473182473547837441,,,,
DrHedrick,6/1/2014 15:20,0,0,Sweeney: Randomized to ADT v. ADT + Docetaxel. Several stratification schemes. # ASCO14,,,#,4.73182E+17,https://twitter.com/DrHedrick/status/473182414781440000,,,,
thecancergeek,6/1/2014 15:20,0,0,Why wasn't histologic type of BC analyzed in the SOFT/TEXT studies given prev studies suggesting lobular is more tamox-resistant? # ASCO14,,,#,4.73182E+17,https://twitter.com/thecancergeek/status/473182381860331521,,,,
teamoncology,6/1/2014 15:20,3,1,@ rsm2800 People forget that U can not self inject goserelin. Lost of time from work. So the loss is more substantial than we think. # ASCO14,,@,#,4.73182E+17,https://twitter.com/teamoncology/status/473182371362009088,,,,
rsm2800,6/1/2014 15:20,1,1,NEJM link to SOFT/TEXT = http://www.nejm.org/doi/full/10.1056/NEJMoa1404037 … # ASCO14,,,#,4.73182E+17,https://twitter.com/rsm2800/status/473182338440916993,,,,
CancerDotNet,6/1/2014 15:20,6,5,# ASCO14 study led by @ theNCI: Adding docetaxel to hormone therapy lengthens lives in met prostate ca # pcsm http://bit.ly/1kwY8Fw,,@,# #,4.73182E+17,https://twitter.com/CancerDotNet/status/473182255410872321,,,,
genentech,6/1/2014 15:20,3,2,# rev2014 RT @ jrgralow: Yes! RT @ MedscapeOnc: Schilsky: patient engagement will be 4th revolution affecting future of cancer care # ASCO14,,@ @,# #,4.73182E+17,https://twitter.com/genentech/status/473182202373865473,,,,
OncEd,6/1/2014 15:19,0,0,ECOG Sweeney randomized to ADT alone or ADT + D dosed 75mg/m2 every 3 weeks for 6 cycles within 4 mos of starting ADT # pcsm # ASCO14,,,# #,4.73182E+17,https://twitter.com/OncEd/status/473182172984401921,,,,
DrHedrick,6/1/2014 15:19,0,0,Dr. Christopher Sweeney: CHAARTED trial. I had patients on this trial. Excited. # ASCO14,,,#,4.73182E+17,https://twitter.com/DrHedrick/status/473182121830264832,,,,
teamoncology,6/1/2014 15:19,0,0,And lost of time to get this. RT @ rsm2800: RT @ rsm2800: Davidson: Consider financial toxicity: goserelin almost $6000/yr # asco14,,@ @,#,4.73182E+17,https://twitter.com/teamoncology/status/473182088200351745,,,,
juliomayol,6/1/2014 15:19,3,2,“ @ KoontzOncology: Big data in the field of precision medicine as per @ rschilsky # ASCO14 pic.twitter.com/GlER88568O”,,@ @,#,4.73182E+17,https://twitter.com/juliomayol/status/473181982395224064,,,,
drapaolaceledon,6/1/2014 15:19,0,0,Nueva opción en adyuvancia para premenopáusicas con cáncer de mama hormonosensible EXE + SO ( aunque más tóxica) # ASCO14,,,#,4.73182E+17,https://twitter.com/drapaolaceledon/status/473181975776616448,,,,
DrStelling,6/1/2014 15:18,1,1,@ juliomayol @ jrgralow Cancer MDs shld focus on treating their patients. Stop trying 2 make them do jobs of 5 ppl. Hire them help. # ASCO14”,,@ @,#,4.73182E+17,https://twitter.com/DrStelling/status/473181932101312512,,,,
drdonsdizon,6/1/2014 15:18,0,3,"Baumgart, et Al. Sexual health toxicity of aromatase inhibitors. # bcsm # ASCO14 http://www.ncbi.nlm.nih.gov/pubmed/22990756",,,# #,4.73182E+17,https://twitter.com/drdonsdizon/status/473181929261772801,,,,
teamoncology,6/1/2014 15:18,0,1,Very true. RT @ rsm2800: ABCSG12 vs SOFT/TEXT: Does AI matter (exemestane vs anastrozole)? # bcsm # ASCO14,,@,# #,4.73182E+17,https://twitter.com/teamoncology/status/473181923712331777,,,,
caseofdees,6/1/2014 15:18,2,1,Bij jonge vrouwen # borstkanker behandeling met exemestane & eierstokonderdrukking vermindert terugkeer. # ASCO14 http://nej.md/1hadOUs,,,# #,4.73182E+17,https://twitter.com/caseofdees/status/473181918591459328,,,,
RMiksad,6/1/2014 15:18,0,0,@ YupOnc @ ASCO Dr Hausen Plenary: Is link btwn colorectal cancer & red meat due to virus interacting w/ carcinogens formed during cooking?,,@ @,,4.73182E+17,https://twitter.com/RMiksad/status/473181856708718593,,,,
gorskon,6/1/2014 15:17,1,1,# ASCO14: Thoughts on clinical trial design showing oncologists aren't as dogmatic as # Burzynski & @ EricMerola claim. http://am.asco.org/across-phases-trial-design-remains-evolving-art …,,@,# #,4.73182E+17,https://twitter.com/gorskon/status/473181641913823233,,,,
teamoncology,6/1/2014 15:17,0,2,【 # ASCO14 Update】 The original paper of SOFT/TEXT study in @ NEJM. Read the original data and make your own decision. http://www.nejm.org/doi/full/10.1056/NEJMoa1404037 …,,@,#,4.73182E+17,https://twitter.com/teamoncology/status/473181629179916288,,,,
rsm2800,6/1/2014 15:17,1,1,http://abstracts.asco.org/144/AbstView_144_129398.html … RT @ AskDrSuzanne: Anyone have a link? Thx for texting during ASCO!! “ @ rsm2800: SOFT/TEXT: # ASCO14,,@ @,#,4.73182E+17,https://twitter.com/rsm2800/status/473181577967435777,,,,
BJRimelMD,6/1/2014 15:17,1,0,@ drdonsdizon An example of how low/slow accrual to # clinicaltrials affects the ability to answer important clinical questions. # ASCO14,,@,# #,4.73182E+17,https://twitter.com/BJRimelMD/status/473181521143431168,,,,
aftimosp,6/1/2014 15:17,1,0,Davidson on SOFT/TEXT: Not all pre-menopausal women with early # BreastCancer need chemo # bcsm # ASCO14,,,# # #,4.73182E+17,https://twitter.com/aftimosp/status/473181520367476736,,,,
OncEd,6/1/2014 15:16,1,0,ECOG Sweeney Androgen Deprivation Therapy (ADT) +/- Docetaxel (D) for hormone sensitive prostate ca # pcsm # ASCO14,,,# #,4.73181E+17,https://twitter.com/OncEd/status/473181409512001536,,,,
angel189,6/1/2014 15:16,0,0,RT @ lenstarnes: Virtual # pharma conf booth has arrived: @ pfizer virtual PFE Oncology booth at # ASCO14 http://shrd.by/SR0cPa # hcsm # hcsmeu…,,@ @,# # # #,4.73181E+17,https://twitter.com/angel189/status/473181366243586048,,,,
mnewtonPharmD,6/1/2014 15:16,1,1,Great points on TEXT/ SOFT trial results from Dr. Nancy Davidson. Results now in @ NEJM # ASCO14 pic.twitter.com/o6uV5jvdi4,,@,#,4.73181E+17,https://twitter.com/mnewtonPharmD/status/473181323579101185,,,,
AJMC_Journal,6/1/2014 15:16,0,0,Read our day 2 # ASCO14 coverage here: http://www.ajmc.com/conferences/asco-2014 …,,,#,4.73181E+17,https://twitter.com/AJMC_Journal/status/473181298404904961,,,,
AJMC_Journal,6/1/2014 15:16,0,0,Read our day 2 # ASCO14 coverage here: http://www.ajmc.com/conferences/asco-2014 …,,,#,4.73181E+17,https://twitter.com/AJMC_Journal/status/473181280662605824,,,,
DrAttai,6/1/2014 15:16,0,0,Great plenary session # ASCO14,,,#,4.73181E+17,https://twitter.com/DrAttai/status/473181268587606016,,,,
FierceBiotech,6/1/2014 15:16,11,7,"If you missed our # ASCO14 Twitter chat with @ MarkSchoenebaum, catch it here or http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … or on Storify https://storify.com/DamianFierce/fiercebiotech-s-asco14-chat-with-markschoenebaum …",,@,#,4.73181E+17,https://twitter.com/FierceBiotech/status/473181250333585408,,,,
teamoncology,6/1/2014 15:15,0,0,"Issue. RT @ rsm2800: Davidson rev: Limit of SOFT/TEXT: short f/u of 5.7 y, heterog pop w/ regards to chemo; long period of accrual # ASCO14",,@,#,4.73181E+17,https://twitter.com/teamoncology/status/473181180783624192,,,,
Perthera,6/1/2014 15:15,0,0,Not too late to register! Breakfast mtg at # ASCO14 on Turning Molecular Analyses into Actionable Treatment Decisions http://ow.ly/wNot9,,,#,4.73181E+17,https://twitter.com/Perthera/status/473181141286273024,,,,
drdonsdizon,6/1/2014 15:15,0,0,@ jrgralow @ ASCO @ CancerDotNet SO GLAD YOU MET!,,@ @ @,,4.73181E+17,https://twitter.com/drdonsdizon/status/473181085573341185,,,,
rsm2800,6/1/2014 15:15,1,0,Davidson: “Remember the power of endocrine therapy-not every premenop woman needs chemo” # ASCO14,,,#,4.73181E+17,https://twitter.com/rsm2800/status/473181060025421824,,,,
juliomayol,6/1/2014 15:15,0,0,"“ @ jrgralow: Cancer doctors urged to consider value when treating patients # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-health-cancer-value-20140530,0,4872696.story …”",,@,#,4.73181E+17,https://twitter.com/juliomayol/status/473181054401257472,,,,
dhjutsw1,6/1/2014 15:15,11,3,@ ASCO # asco14. Dr. Nancy Davidson discusses her conclusions vis-a-vis TEXT & SOFT Trials. pic.twitter.com/xfiSldLm2y,,@,#,4.73181E+17,https://twitter.com/dhjutsw1/status/473181027834138625,,,,
ALLIANCE_org,6/1/2014 15:15,0,0,# ASCO14 Plenary: Impact on OS w/ chemohormonal ther vs hormonal ther for hormone-sensitive newly mPrCa cc: @ eaonc http://bit.ly/1oXYjit,,@,#,4.73181E+17,https://twitter.com/ALLIANCE_org/status/473181010776317953,,,,
DCarrizosaMD,6/1/2014 15:15,0,0,# ASCO14 plenary - TEXT/SOFT show exemestane+ovarian suppression is a real option in premenopausal women but ? Is if/when to use OFS # LCI,,,# #,4.73181E+17,https://twitter.com/DCarrizosaMD/status/473180998210183168,,,,
LIVESTRONG_NL,6/1/2014 15:15,0,0,Studies released: focus on targeted therapies - http://bit.ly/1kdpLch # cancer # ASCO14,,,# #,4.73181E+17,https://twitter.com/LIVESTRONG_NL/status/473180996385669120,,,,
Roche,6/1/2014 15:15,7,6,Keeping cancer # immunotherapy personal http://ow.ly/xp2c1 # ASCO14,,,# #,4.73181E+17,https://twitter.com/Roche/status/473180985484673024,,,,
RyhMd,6/1/2014 15:15,0,0,Do we need specific FDA approval for Exemestane in premenausal women? # ASCO14,,,#,4.73181E+17,https://twitter.com/RyhMd/status/473180980355010560,,,,
oncodocsydney,6/1/2014 15:15,0,0,“ @ rsm2800: Davidson: Consider financial toxicity: goserelin almost $6000/yr”yes! Net clinical benefit has 2 consider all toxicities # ASCO14,,@,#,4.73181E+17,https://twitter.com/oncodocsydney/status/473180979654582272,,,,
ASCO,6/1/2014 15:15,13,10,Is classic phase I obsolete? Is phase III always necessary? Discussions on trial design at Pre- # ASCO14 seminar http://bit.ly/1nTZiAD,,,#,4.73181E+17,https://twitter.com/ASCO/status/473180976072646656,,,,
teamoncology,6/1/2014 15:14,0,0,TY for recognizing. RT @nextprinciples: Top tweeters for day 3 so far # ASCO14 @ mtmdphd @ teamoncology @ShewithLynch @ drattai @ CI4CC,,@nextprinciples @ @ @ShewithLynch @ @,#,4.73181E+17,https://twitter.com/teamoncology/status/473180909860958208,,,,
OncEd,6/1/2014 15:14,1,0,Davidson Conclusion on LBA1. Exemestane + OFS is a new tx option for premenopausal HR +ve EBC. # ASCO14,,,#,4.73181E+17,https://twitter.com/OncEd/status/473180899979182080,,,,
teamoncology,6/1/2014 15:14,3,0,Is all women w/hormone receptor+ premenopausal breast cancer want to receive ovarian function suppression with exemestane? No. # ASCO14,,,#,4.73181E+17,https://twitter.com/teamoncology/status/473180839451189248,,,,
rsm2800,6/1/2014 15:14,1,0,Davidson:AI+OS is “Evidence-based approach” for premenop women; but still awaiting SOFT # ASCO14,,,#,4.73181E+17,https://twitter.com/rsm2800/status/473180834556436480,,,,
DrHedrick,6/1/2014 15:14,0,0,"Discussion: Costs of drugs including AI, OFS, and poss bisphosphonate needed are high. Good use of resources given low cost of Tam? # ASCO14",,,#,4.73181E+17,https://twitter.com/DrHedrick/status/473180796329553920,,,,
IndustryNightIn,6/1/2014 15:14,0,0,@ MsShanBo @ SPDoubleYou # industry list coming soon! Still at work # ASCO14,,@ @,# #,4.73181E+17,https://twitter.com/IndustryNightIn/status/473180774594646016,,,,
DCarrizosaMD,6/1/2014 15:14,0,0,Poster discuss # ASCO14 - need more effective agents for second line small cell. Still nothing great yet... # LCI,,,# #,4.73181E+17,https://twitter.com/DCarrizosaMD/status/473180747000332288,,,,
JamesPPinkerton,6/1/2014 15:13,3,1,...they are a choice," a matter of priorities."" http://bit.ly/1oKHfi9 # ASCO14 VA policy of less is Obama admin. policy of less. 2/2""",,,#,4.73181E+17,https://twitter.com/JamesPPinkerton/status/473180677483941889,,,
dmooneymd,6/1/2014 15:13,0,0,"Wholesale cost: $7300 per month for exemestane...$1300 per month for tamoxifen. Not the paying cost, though. # bcsm # ASCO14",,,# #,4.73181E+17,https://twitter.com/dmooneymd/status/473180658316345344,,,,
JoanneWeidhaas,6/1/2014 15:13,0,0,Davidson's take- need longer follow up- cost should be considered- # ASCO14,,,#,4.73181E+17,https://twitter.com/JoanneWeidhaas/status/473180566435930112,,,,
ElizBlanchardMD,6/1/2014 15:13,2,2,"Dr Davidson calls cost of tx financial toxicity"". Great term. # ASCO14""",,,#,4.73181E+17,https://twitter.com/ElizBlanchardMD/status/473180539068112897,,,,
rsm2800,6/1/2014 15:13,3,0,RT @ rsm2800: Davidson: Consider financial toxicity: goserelin almost $6000/yr # asco14,,@,#,4.73181E+17,https://twitter.com/rsm2800/status/473180530226126849,,,,
mjsanchezperez,6/1/2014 15:13,0,0,"“ @ NEJM: In premenopausal breast cancer, adjuvant tx w/ exemestane & ovarian suppress reduces recurrence. # ASCO14 http://nej.md/1hadOUs ”",,@,#,4.7318E+17,https://twitter.com/mjsanchezperez/status/473180471258796032,,,,
DrHedrick,6/1/2014 15:12,0,0,"My thought: Large trial, good statistics, small but real effect. Clinically relevant? Is this good use of limited research dollars? # ASCO14",,,#,4.7318E+17,https://twitter.com/DrHedrick/status/473180383765229569,,,,
Berkowitzm,6/1/2014 15:12,0,0,"Potential new standard for women w breast cancer. Exciting times. # breastcancer, # ASCO14 http://www.nejm.org/doi/full/10.1056/NEJMoa1404037?&utm_content=buffer96416&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer& …",,,# #,4.7318E+17,https://twitter.com/Berkowitzm/status/473180336596058112,,,,
GustaveRoussy,6/1/2014 15:12,3,0,# ASCO2014 The plenary session: large audience to discover significant results in care # breastcancer .pic.twitter.com/SfAIyb8RDU,,,# #,4.7318E+17,https://twitter.com/GustaveRoussy/status/473180225741029376,,,,
drapaolaceledon,6/1/2014 15:12,0,1,Recomiendo la disertación de la Dra. Mónica Morrow: Cómo trataremos el cáncer de mama en 5 años? # ASCO14 Me encantó! en Virtual Meeting,,,#,4.7318E+17,https://twitter.com/drapaolaceledon/status/473180204278747137,,,,
favalous1,6/1/2014 15:11,0,0,@ Merck Booth looks great! Congrats and enjoy # ASCO14,,@,#,4.7318E+17,https://twitter.com/favalous1/status/473180091414245376,,,,
teamoncology,6/1/2014 15:11,1,0,Agree- nice TEDx! MT @ teamoncology: values come from mutual empowerment btwn Drs & pts. My TEDx about this. https://www.youtube.com/watch?v=Cqe5cKhgFFc … # ASCO14,,@,#,4.7318E+17,https://twitter.com/teamoncology/status/473179982168981505,,,,
rsm2800,6/1/2014 15:10,0,0,ABCSG12 vs SOFT/TEXT: Does AI matter (exemestane vs anastrozole)? # bcsm # ASCO14,,,# #,4.7318E+17,https://twitter.com/rsm2800/status/473179818213650433,,,,
NEJM,6/1/2014 15:10,57,32,"TEXT/SOFT: In premenopausal breast cancer, adjuvant tx w/ exemestane & ovarian suppress reduces recurrence. # ASCO14 http://nej.md/1hadOUs",,,#,4.7318E+17,https://twitter.com/NEJM/status/473179742699814912,,,,
davidgrahammd,6/1/2014 15:10,0,0,Just a thought...shouldn’t we publish plenary session papers in JCO? # ASCO14,,,#,4.7318E+17,https://twitter.com/davidgrahammd/status/473179734835478529,,,,
nycdoc29,6/1/2014 15:10,0,1,“ @ AskDrSuzanne: Anyone have a link? SOFT/TEXT: # ASCO14”” NEJMhttp://www.nejm.org/doi/full/10.1056/NEJMoa1404037 - here you go!,,@,#,4.7318E+17,https://twitter.com/nycdoc29/status/473179727310901250,,,,
ASCO,6/1/2014 15:10,0,1,"Dr. Roselle De Guzman: Cancer care in the Philippines, when typhoons strike http://bit.ly/1mwfmpq # ASCO14",,,#,4.7318E+17,https://twitter.com/ASCO/status/473179706834317313,,,,
miepsja,6/1/2014 15:09,0,0,“ @ LIVESTRONG_NL: Veelbelovende behandeling tegen agressieve # huidkanker http://ow.ly/xuH0S # ASCO14”,,@,# #,4.7318E+17,https://twitter.com/miepsja/status/473179666183122944,,,,
rsm2800,6/1/2014 15:09,3,1,Davidson: SOFT/TEXT largest trial but don’t forget ABCSG12 also studied same treatments (and showed worse OS w/ AI+OS) # ASCO14,,,#,4.7318E+17,https://twitter.com/rsm2800/status/473179597568090112,,,,
DrHedrick,6/1/2014 15:09,1,0,Discussion: Prior study did not find this benefit. Used different AI. Why this discrepancy? Methods? Obesity? # ASCO14,,,#,4.7318E+17,https://twitter.com/DrHedrick/status/473179521756049408,,,,
teamoncology,6/1/2014 15:09,0,2,Everything is about moderation. I would not stop taking red meat because I have cancer. # ASCO14,,,#,4.73179E+17,https://twitter.com/teamoncology/status/473179493075406848,,,,
PhRMA,6/1/2014 15:09,1,0,# Cancer mortality rates fell 14% from 2000-09 thanks to new treatment options in the US. More from @ Celgene: http://bit.ly/1lXRIjY # ASCO14,,@,# #,4.73179E+17,https://twitter.com/PhRMA/status/473179446644449280,,,,
nightinrapture,6/1/2014 15:08,0,0,"Three more hours of people coming up to ask me where's the (super specific cancer drug/organization/support group)'s table?"" # ASCO2014""",,,#,4.73179E+17,https://twitter.com/nightinrapture/status/473179337936883713,,,,
OrmondOncDoc,6/1/2014 15:08,1,2,I am arriving late for the plenary sessions because I was eating a juicy rare steak for lunch. What did I miss? # asco14,,,#,4.73179E+17,https://twitter.com/OrmondOncDoc/status/473179328302555136,,,,
cmartindedios,6/1/2014 15:08,7,3,Día del # superviviente # cancer # chicago @ ASCO # asco14 @ GEPAC_ @ asociacionASACO @ AsociacionAsate @ FECMA1pic.twitter.com/O2aYVeV1TV,,@ @ @ @ @,# # # #,4.73179E+17,https://twitter.com/cmartindedios/status/473179317636038656,,,,
michelerhee,6/1/2014 15:08,1,0,"RT @ CancerNetwrk: Dendritic Cell Vaccine Improved PFS, Not OS in Glioblastoma http://bit.ly/1gUa5dn # ASCO14 # btsm",,@,# #,4.73179E+17,https://twitter.com/michelerhee/status/473179289051860992,,,,
drdonsdizon,6/1/2014 15:08,2,0,"Thank you Dr Nancy Davidson: really balanced review of SOFT and TEXT. The landscape has changed between 2003 & 2014."" # BCSM # ASCO14""",,,# #,4.73179E+17,https://twitter.com/drdonsdizon/status/473179266654679040,,,,
teamoncology,6/1/2014 15:08,0,0,RT @ rsm2800: Zur Hausen: Other studies showing association of red meat consumption and lung &amp; breast ca (not saying causative) # ASCO14,,@,#,4.73179E+17,https://twitter.com/teamoncology/status/473179248883015681,,,,
drapaolaceledon,6/1/2014 15:07,1,0,Inmunoterapia no mejoro la sobrevida en Glioblastoma # ASCO14 Que lástima!!!!,,,#,4.73179E+17,https://twitter.com/drapaolaceledon/status/473179098676994048,,,,
RyhMd,6/1/2014 15:07,0,1,# ASCO14 OS of 32m in CholangioCA/GB after adjuvant C-CRT. First Phase 2 prospective study in North America (GI non colorectal posters),,,#,4.73179E+17,https://twitter.com/RyhMd/status/473179097720713216,,,,
Ferheca12,6/1/2014 15:07,0,1,Cual es el papel de los IA en pacientes premeno con Supresión ovárica sin saber el papel de la SO en estas pacientes? Esto q es? # ASCO14,,,#,4.73179E+17,https://twitter.com/Ferheca12/status/473179062501117952,,,,
rsm2800,6/1/2014 15:07,0,0,"Davidson review: Limitations of SOFT/TEXT: short f/u of 5.7 yrs, heterogeneous pop w/ regards to chemo; long period of accrual 2003+ # ASCO14",,,#,4.73179E+17,https://twitter.com/rsm2800/status/473178989721174019,,,,
lenstarnes,6/1/2014 15:07,1,1,Virtual # pharma conf booth has arrived: @ pfizer virtual PFE Oncology booth at # ASCO14 http://bit.ly/1nFRGE6 # hcsm # hcsmeu # ESCcongress,,@,# # # # #,4.73179E+17,https://twitter.com/lenstarnes/status/473178963955949568,,,,
AlpineBV_Miller,6/1/2014 15:06,0,1,No room in North B1 for plenary. Head to overfow in E Hall D1 # ASCO14,,,#,4.73179E+17,https://twitter.com/AlpineBV_Miller/status/473178901930573824,,,,
HenkJanOut,6/1/2014 15:06,0,0,"Ook med tijdschriften doen aan marketing “ @ NEJM: # ASCO14 Visit the @ NEJMGroup at booth 20127, get a 15% @ NEJM subscription discount.”",,@ @ @,#,4.73179E+17,https://twitter.com/HenkJanOut/status/473178898617098242,,,,
teamoncology,6/1/2014 15:06,4,0,"【 # ASCO14 Update】 RT @ DrHedrick: Hansen: 21% of human cancers are linked to infections, H. pylori, Hep B, HPV, EBV, HIV, HTLV.",,@,#,4.73179E+17,https://twitter.com/teamoncology/status/473178878676987905,,,,
drdonsdizon,6/1/2014 15:06,1,0,SOFT/TEXT trials enrolled over 8 years- a lot can change in that time in oncology. # BCSM # ASCO14,,,# #,4.73179E+17,https://twitter.com/drdonsdizon/status/473178832707809280,,,,
AskDrSuzanne,6/1/2014 15:06,0,0,Anyone have a link? Thx for texting during ASCO!! “ @ rsm2800: SOFT/TEXT: Results published online in NEJM today # ASCO14”,,@,#,4.73179E+17,https://twitter.com/AskDrSuzanne/status/473178770908528641,,,,
ElizBlanchardMD,6/1/2014 15:06,0,0,Exemestane better DFS not OS (may be too early). Grade3+ AEs similar. QOL similar--details see poster of abstract 557 tomorrow # ASCO14,,,#,4.73179E+17,https://twitter.com/ElizBlanchardMD/status/473178756606341121,,,,
DrHedrick,6/1/2014 15:06,0,0,"Pagani: Trial amended due to fewer than expected events. (Great for patients, common in recent trials. What to do for trial design) # ASCO14",,,#,4.73179E+17,https://twitter.com/DrHedrick/status/473178740504399872,,,,
teamoncology,6/1/2014 15:06,0,0,# ASCO14 Dr. Clifford Hudis 今年の会長からの乳がん情報。ビデオでどうぞ。 https://www.youtube.com/watch?v=-vtVLTH-D48&feature=youtu.be …,,,#,4.73179E+17,https://twitter.com/teamoncology/status/473178733050744833,,,,
JamesPPinkerton,6/1/2014 15:05,0,0,"...that’s a different story. http://bit.ly/1oKHfi9 2/2 # ASCO14""",,,#,4.73179E+17,https://twitter.com/JamesPPinkerton/status/473178561772126208,,,,
teamoncology,6/1/2014 15:05,2,0,Breast Cancer Research News from # ASCO14 with Dr. Clifford Hudis. Watch the video. https://www.youtube.com/watch?v=-vtVLTH-D48&feature=youtu.be …,,,#,4.73179E+17,https://twitter.com/teamoncology/status/473178512539385856,,,,
Boehringer,6/1/2014 15:05,2,3,BLOG POST: How I work - Hear an investigator’s perspective on # lungcancer research http://bit.ly/1tz9det # ASCO14 # notjustonedisease,,,# # #,4.73178E+17,https://twitter.com/Boehringer/status/473178464787628034,,,,
thecancergeek,6/1/2014 15:04,4,0,NEJM paper online today on the AI+ovarian suppression story being presented in the plenary at # ASCO14 -> http://buff.ly/1pJKO5B,,,#,4.73178E+17,https://twitter.com/thecancergeek/status/473178405828296704,,,,
odub75,6/1/2014 15:04,0,0,So many people attending the plenary session!!! # Asco14 pic.twitter.com/Xt5IrOuoUf,,,#,4.73178E+17,https://twitter.com/odub75/status/473178403000963072,,,,
WayneKoberstein,6/1/2014 15:04,1,2,"Don't look at PD-1 or PDL-1 as biomarkers to manage patients, says Pam Sharma. # ASCO14 Dynamic not static targets.",,,#,4.73178E+17,https://twitter.com/WayneKoberstein/status/473178356108644352,,,,
mnewtonPharmD,6/1/2014 15:04,0,0,Perhaps Opens door to using AI + ovarian suppression as reasonable alternative adjuvant endocrine tx in premenopausal women. # ASCO14,,,#,4.73178E+17,https://twitter.com/mnewtonPharmD/status/473178350136344577,,,,
CancerNetwrk,6/1/2014 15:04,1,2,"Dendritic Cell Vaccine Improved PFS, Not OS in Glioblastoma http://bit.ly/1gUa5dn # ASCO14",,,#,4.73178E+17,https://twitter.com/CancerNetwrk/status/473178255974211586,,,,
martha,6/1/2014 15:04,0,2,Wishing I was @ ASCO today. # patient # advocate # geek # melanoma # lifelonglearner,,@,# # # # #,4.73178E+17,https://twitter.com/martha/status/473178231877951490,,,,
FierceBiotech,6/1/2014 15:04,7,2,# FierceASCO will return Thursday when @ FiercePharma's @ EricPFierce and @ EPVantage's @ JonEPVantage team up to recap # ASCO14. See you then.,,@ @ @ @,# #,4.73178E+17,https://twitter.com/FierceBiotech/status/473178197773651968,,,,
DrHedrick,6/1/2014 15:04,1,0,Discussion: Consistent increased benefit from maximizing estrogen inhibition over time. # ASCO14,,,#,4.73178E+17,https://twitter.com/DrHedrick/status/473178165641089024,,,,
OncEd,6/1/2014 15:03,0,0,Discussion by Dr. Nancy Davidson - Role of OFS in addition to Tam will be presented likely at SABCS 14 . # ASCO14,,,#,4.73178E+17,https://twitter.com/OncEd/status/473178113052901377,,,,
QIAGENscience,6/1/2014 15:03,1,1,Ingenuity Pathway Analysis helps researchers to understand upstream reg mechanisms & connections to downstream functional effects. # ASCO14,,,#,4.73178E+17,https://twitter.com/QIAGENscience/status/473178093776285696,,,,
oncodocsydney,6/1/2014 15:03,1,0,"“ @ rsm2800: SOFT/TEXT: Tam vs tam/OS results from SOFT available end of 2014 # ASCO14” yes, these results +QoL will be important 4 Rx context",,@,#,4.73178E+17,https://twitter.com/oncodocsydney/status/473178092748701696,,,,
MarkSchoenebaum,6/1/2014 15:02,43,8,"new tumors w/ activity: ovarian ($BMY), H&N ($MRK), and bladder ($Roche). I can't wait to see blood tumors at ASH2014!! # fierceasco # asco14",,,# #,4.73178E+17,https://twitter.com/MarkSchoenebaum/status/473177694880821248,,,,
nxtstop1,6/1/2014 15:01,0,0,CIGS R ADDICTIVE.NO 2 STIGMA. @ Boehringer:Stigma re # lungcancer affects media interest.Stefania from WALCE http://bit.ly/1oX5LdG # ASCO14”,,@,# #,4.73178E+17,https://twitter.com/nxtstop1/status/473177526756327424,,,,
TuftsCancerCtr,6/1/2014 15:01,0,0,"In diabetics w # coloncancer, metformin assoc with better outcome: J Paulus @ TuftsCTSI & MJ Kelley @ DukeCancer # ASCO14 http://ow.ly/xuHd1",,@ @,# #,4.73177E+17,https://twitter.com/TuftsCancerCtr/status/473177434674966532,,,,
mnewtonPharmD,6/1/2014 15:01,0,0,Adjuvant Exemestane + ovarian suppression better DFS than tamoxifen + ov supp in premenopausal women # ASCO14 pic.twitter.com/xT3ZOOeu47,,,#,4.73177E+17,https://twitter.com/mnewtonPharmD/status/473177419437068288,,,,
MarkSchoenebaum,6/1/2014 15:00,20,8,"for me, the big picture pd-1/pdl-1 take away is we now have REAL data suggesting activity in MORE & MORE tumors. # asco14 # fierceasco",,,# #,4.73177E+17,https://twitter.com/MarkSchoenebaum/status/473177354848567296,,,,
mayocliniclabs,6/1/2014 15:00,0,0,Are you attending # ASCO14 in Chicago? Check out our blog to learn about our latest advancements in cancer testing. http://mayocl.in/T1r6rl,,,#,4.73177E+17,https://twitter.com/mayocliniclabs/status/473177335152513024,,,,
rsm2800,6/1/2014 15:00,2,1,SOFT/TEXT: Results published online in NEJM today # ASCO14,,,#,4.73177E+17,https://twitter.com/rsm2800/status/473177310460260352,,,,
ASCO,6/1/2014 15:00,1,2,"Get a sneak peek of the # ASCO14 Virtual Meeting via Virtual Meeting on Demand"" http://bit.ly/1oKjSW0""",,,#,4.73177E+17,https://twitter.com/ASCO/status/473177295751225344,,,,
alantanmd,6/1/2014 15:00,1,0,Exemestane and OFS superior to Tamoxifen and OFS in premenopausal early breast cancer # ASCO14 pic.twitter.com/cS2oUIRNCV,,,#,4.73177E+17,https://twitter.com/alantanmd/status/473177214750834688,,,,
WayneKoberstein,6/1/2014 15:00,1,1,"But immunoTx buzz at # ASCO14 can deceive; bulk still about chemo, the workhorse. @ RfwrightLSL",,@,#,4.73177E+17,https://twitter.com/WayneKoberstein/status/473177192008925184,,,,
FoundationATCG,6/1/2014 15:00,3,4,We are excited to be at # ASCO14 and announcing the launch of our blog: Foundation Forward! Check it out here: http://bit.ly/SnbVZ3,,,#,4.73177E+17,https://twitter.com/FoundationATCG/status/473177174468349955,,,,
rsm2800,6/1/2014 15:00,4,0,SOFT/TEXT: Tam vs tam/OS results from SOFT available end of 2014 # ASCO14,,,#,4.73177E+17,https://twitter.com/rsm2800/status/473177168826994688,,,,
Keith_Terry,6/1/2014 15:00,0,0,"Day 3 of # ASCO14. McCormick Place in # Chicago is the place to be on June 1, 2014... http://talent.gene.com/go/vev_9m # Genentech",,,# # #,4.73177E+17,https://twitter.com/Keith_Terry/status/473177166683705344,,,,
DrHedrick,6/1/2014 14:59,0,0,Pagani: OFS question on addition to Tam coming late 2014. # ASCO14,,,#,4.73177E+17,https://twitter.com/DrHedrick/status/473177140025131009,,,,
MarkSchoenebaum,6/1/2014 14:59,9,3,"so far, i haven't seen anything that really changes pd-1/pdl-1 race. and most docs don't seem to see a clear difference # fierceasco # asco14",,,# #,4.73177E+17,https://twitter.com/MarkSchoenebaum/status/473177134966390784,,,,
aftimosp,6/1/2014 14:59,0,0,SOFT/TEXT: Treatment cessation more frequent in the exemestane arm vs tamoxifen: 16% vs 11% # BreastCancer # bcsm # ASCO14,,,# # #,4.73177E+17,https://twitter.com/aftimosp/status/473177133188411392,,,,
drdonsdizon,6/1/2014 14:59,13,7,NOTE Sexual health suffers on exemestane: 52%% vag dryness 45% libido decrease 31% dyspareunia. These effects can't B ignored. # BCSM # ASCO14,,,# #,4.73177E+17,https://twitter.com/drdonsdizon/status/473177041886793728,,,,
OncEd,6/1/2014 14:59,0,0,Perspective - SOFT/TEXT Analysis - Is 3.8% clinically meaningful? Why results are different from previous ABCSG trial? # ASCO14,,,#,4.73177E+17,https://twitter.com/OncEd/status/473176960286224384,,,,
rsm2800,6/1/2014 14:59,1,0,SOFT/TEXT: Early cessation of assigned treatment more common in exemestane group = 16% (c/w 11% for tam) # ASCO14,,,#,4.73177E+17,https://twitter.com/rsm2800/status/473176954145755136,,,,
lka_,6/1/2014 14:59,0,0,# ASCO14 pic.twitter.com/GYaCaLpwGe,,,#,4.73177E+17,https://twitter.com/lka_/status/473176934952615936,,,,
GustaveRoussy,6/1/2014 14:58,3,0,# ASCO14 # video Dr E.Angevin @ GustaveRoussy explique les résultats en phase I d'un nouvel inhibiteur de la voie MET https://vimeo.com/97055202,,@,# #,4.73177E+17,https://twitter.com/GustaveRoussy/status/473176858960592896,,,,
DrHedrick,6/1/2014 14:58,0,1,@ drattai What is grade 1-2 depression? Is it clinically relevant? Did it require treatment. Very important issues! # ASCO14,,@,#,4.73177E+17,https://twitter.com/DrHedrick/status/473176826596970496,,,,
CathyEngMD,6/1/2014 14:58,0,0,"Joint analysis of TEXT and SOFT trial showed improved DFS with exemestane + OFS vs Tam in HR+ early breast # cancer, # ASCO14",,,# #,4.73177E+17,https://twitter.com/CathyEngMD/status/473176759647887360,,,,
dmooneymd,6/1/2014 14:58,0,0,"Pagani: grade 3/4 toxicity similar but msk, osteoporosis more in exemestane and thrombosis more in tamoxifen. Qol similar. # bcsm # ASCO14",,,# #,4.73177E+17,https://twitter.com/dmooneymd/status/473176725874933760,,,,
MLIWI,6/1/2014 14:58,1,0,Join the Movement to support the Value of Medical Innovation. Sign the petition. # ASCO14 # MLIWI http://buff.ly/1wN8TgJ,,,# #,4.73177E+17,https://twitter.com/MLIWI/status/473176665213140992,,,,
rsm2800,6/1/2014 14:57,4,0,SOFT/TEXT: 13% of women had osteoporosis in exemestane group (about 2x as much as in tam group) # ASCO14,,,#,4.73177E+17,https://twitter.com/rsm2800/status/473176650503299072,,,,
DrHedrick,6/1/2014 14:57,0,0,Pagani: Grade 3 events appear similar to prior studies of AI / Tam / OFS. More osteoporosis in this young population! # ASCO14,,,#,4.73177E+17,https://twitter.com/DrHedrick/status/473176616613326848,,,,
FierceBiotech,6/1/2014 14:57,1,0,Do you think # ASCO14 has altered the PD-1/PDL-1 race in any meaningful way? # FierceASCO,,,# #,4.73177E+17,https://twitter.com/FierceBiotech/status/473176607658496001,,,,
DrAttai,6/1/2014 14:57,2,1,Pagani - depression reported in 50% - yikes! # ASCO14,,,#,4.73177E+17,https://twitter.com/DrAttai/status/473176528361381888,,,,
aftimosp,6/1/2014 14:57,3,1,SOFT/TEXT results are reassuring when treating pre-menopausal women with ER+ # BreastCancer and contra-indications to tamoxifen # ASCO14 # bcsm,,,# # #,4.73176E+17,https://twitter.com/aftimosp/status/473176444668227585,,,,
lka_,6/1/2014 14:56,0,0,4% improvement in 5 yr OS in exemestane +OFS arm vs tamoxifen +OFS in premenopausal women with early breast cancer # ASCO14,,,#,4.73176E+17,https://twitter.com/lka_/status/473176367232598016,,,,
VincentRK,6/1/2014 14:56,2,1,There is a poster by Jeremy Larsen from @ MayoClinic on how criteria for # myeloma can vary based on underlying cytogenetic subtype # ASCO14,,@,# #,4.73176E+17,https://twitter.com/VincentRK/status/473176333501997056,,,,
DrAttai,6/1/2014 14:56,0,0,“ @ rsm2800: SOFT/TEXT: 60% of first events involved distant sites # ASCO14” we still dont have an answer for those pts,,@,#,4.73176E+17,https://twitter.com/DrAttai/status/473176229093187584,,,,
DrStelling,6/1/2014 14:56,1,1,@ nxtstop1 @ ElizBlanchardMD Now let's start getting mechs of action for all those membrane proteins! Shld only take ~20 yrs! # ASCO14,,@ @,#,4.73176E+17,https://twitter.com/DrStelling/status/473176163012337665,,,,
CUCancerCenter,6/1/2014 14:55,0,1,# ASCO14 Dr. Dara Aisner advice for oncologists - make sure your patients tested properly for targeted therapies http://bit.ly/RU8kkq,,,#,4.73176E+17,https://twitter.com/CUCancerCenter/status/473176083521478656,,,,
rsm2800,6/1/2014 14:55,2,2,"SOFT/TEXT: Of 43% of women who received no chemo, 97% getting exem+OS were disease free at yr 5 (reassuring it’s that high) # ASCO14",,,#,4.73176E+17,https://twitter.com/rsm2800/status/473176054949888000,,,,
MarkSchoenebaum,6/1/2014 14:55,0,2,"The big wall street trade"" into # asco14 was long $ AZN b/c some think they can leapfrog $ BMY in CTLA-4 combo trials # fierceasco""",,,# #,4.73176E+17,https://twitter.com/MarkSchoenebaum/status/473176022213328896,,,,
DrCESimmons,6/1/2014 14:55,0,0,TEXT SOFT joint analysis at # ASCO14 reminds me of ATAC,,,#,4.73176E+17,https://twitter.com/DrCESimmons/status/473176008246689792,,,,
nxtstop1,6/1/2014 14:55,1,0,LETS DISCUSS THIS! @OncoVip: Marchetti:For onc pts still smoking:risk of inefficacy incr. up to 72%. @ Oncoinfo_it @ WalceOnlus2006 # ASCO14”,,@OncoVip @ @,#,4.73176E+17,https://twitter.com/nxtstop1/status/473175976566743040,,,,
DrAttai,6/1/2014 14:55,3,0,Pagani no difference overall survival but need longer follow up # ASCO14,,,#,4.73176E+17,https://twitter.com/DrAttai/status/473175932354580481,,,,
aftimosp,6/1/2014 14:55,0,0,SOFT/TEXT: Endometrial cancer: 5 in tamoxifen arm versus 2 in exemestane arm # BreastCancer # bcsm # ASCO14,,,# # #,4.73176E+17,https://twitter.com/aftimosp/status/473175927305039872,,,,
drdonsdizon,6/1/2014 14:55,7,2,"Diff betwn exemestane/OS v tampxifen/OS in disease free survival was 3.8%. Statistically sig, but is it clinically meaningful? # BCSM # ASCO14",,,# #,4.73176E+17,https://twitter.com/drdonsdizon/status/473175921940516864,,,,
mlazqui,6/1/2014 14:55,0,0,SOFT/TEXT: Exem + OS (compared w/ tam+OS) DFS HR=0.72; abs difference was 3.8% at 5 yrs # ASCO14,,,#,4.73176E+17,https://twitter.com/mlazqui/status/473175920527020032,,,,
EuNGSeqConf,6/1/2014 14:55,1,0,3 out of 5 # oncology treatments expected to launch by 2017 will be # targetedtherapies. # ASCO14 https://twitter.com/Quintiles/status/473154531661201411/photo/1pic.twitter.com/yd4naBDrYd,,,# # #,4.73176E+17,https://twitter.com/EuNGSeqConf/status/473175917410664448,,,,
PMedcn,6/1/2014 14:55,0,0,3 out of 5 # oncology treatments expected to launch by 2017 will be # targetedtherapies. # ASCO14 https://twitter.com/Quintiles/status/473154531661201411/photo/1pic.twitter.com/KZcAsseOd8,,,# # #,4.73176E+17,https://twitter.com/PMedcn/status/473175917263859712,,,,
dmooneymd,6/1/2014 14:54,0,0,"5 yr dfs 91.1 vs 87.3%, p=0.0002, in favor of exemestane + ofs. Overall survival the same at 5 yrs...not mature data. # bcsm # ASCO14",,,# #,4.73176E+17,https://twitter.com/dmooneymd/status/473175897416036352,,,,
tehfem,6/1/2014 14:54,0,0,# ASCO14 exem/OS SHOWED IMPROVED breast ca free surv and DFS,,,#,4.73176E+17,https://twitter.com/tehfem/status/473175895415336961,,,,
OncEd,6/1/2014 14:54,1,0,Exe+OFS vs. Tam + OFS - No difference in OS. Distance recurrence free interval HR 0.78 # ASCO14,,,#,4.73176E+17,https://twitter.com/OncEd/status/473175867535798273,,,,
TimBrady42,6/1/2014 14:54,0,0,Beautiful weekend in Chicago. # ASCO14,,,#,4.73176E+17,https://twitter.com/TimBrady42/status/473175851895255040,,,,
DrMarkham,6/1/2014 14:54,0,0,+1 MT @ drdonsdizon: My take on talk by zur Hausen: Hmm.... Major implication- potential for prevention is reason enough to study. # ASCO14,,@,#,4.73176E+17,https://twitter.com/DrMarkham/status/473175804805787650,,,,
rsm2800,6/1/2014 14:54,1,1,SOFT/TEXT: 60% of first events involved distant sites # ASCO14,,,#,4.73176E+17,https://twitter.com/rsm2800/status/473175695858737152,,,,
kgapo,6/1/2014 14:53,3,2,@ EIannelli yes!this shld B the message on # cancersurvivorsday 2day!we need # cancersurvivorship careplan! # ASCO14 @ favo_it @ ACSNews @ cancereu,,@ @ @ @,# # #,4.73176E+17,https://twitter.com/kgapo/status/473175581518229504,,,,
OncNursingNews,6/1/2014 14:53,4,5,"One of the most exciting things...is we're talking about # survivorship in lung cancer.""-Dr. Khuri # ASCO14 # lcsmpic.twitter.com/nfPJKMsnVe""",,,# # #,4.73175E+17,https://twitter.com/OncNursingNews/status/473175489566089216,,,,
DrMisialek,6/1/2014 14:53,0,0,New data shows continued long-term effectiveness of immunotherapy in advanced melanoma http://www.dana-farber.org/Newsroom/News-Releases/New-data-shows-continued-long-term-effectiveness-of-immunotherapy-in-advanced-melanoma.aspx#.U4t2U7YBHU4.twitter … @ DanaFarber @ ASCO # ASCO14,,@ @,# #,4.73175E+17,https://twitter.com/DrMisialek/status/473175438718951424,,,,
rsm2800,6/1/2014 14:53,9,2,"SOFT/TEXT: Exem + OS (compared w/ tam+OS) DFS HR=0.72, p=0.0002; abs difference was 3.8% at 5 yrs # ASCO14",,,#,4.73175E+17,https://twitter.com/rsm2800/status/473175432053792769,,,,
pfizer,6/1/2014 14:52,4,6,Can’t attend # ASCO14? Visit our Virtual Booth for PFE Oncology http://www.PfizerOncologyDevelopment.com,,,#,4.73175E+17,https://twitter.com/pfizer/status/473175372373426176,,,,
tehfem,6/1/2014 14:52,0,0,# ASCO14 tam+OS vs Exem+OS :benefit for Exem/OS HR0.72 p=0.0002,,,#,4.73175E+17,https://twitter.com/tehfem/status/473175369797754883,,,,
OncEd,6/1/2014 14:52,1,1,SOFT and TEXT combined analysis - TAM +OFS vs. Exemestane + OFS Results - 5 yr DFS - Tam arm 87.3% vs. Exe arm - 91.1% P=0.0002 # ASCO14,,,#,4.73175E+17,https://twitter.com/OncEd/status/473175346993319936,,,,
oncodocsydney,6/1/2014 14:52,0,0,SOFT/TEXT: ovarian suppression+exemestane improved DFS (incl recurrence) cf ov supp+Tamoxifen HR0.72 (P=0.0002) accross subgroups # ASCO14,,,#,4.73175E+17,https://twitter.com/oncodocsydney/status/473175334691827712,,,,
DKarikios,6/1/2014 14:52,0,0,"# ASCO14 Pagani et al: Exemestane + OFS better than Tamoxifen + OFS in terms of disease free survival, HR = 0.72, ARR = 3.8%",,,#,4.73175E+17,https://twitter.com/DKarikios/status/473175309315866625,,,,
ConquerCancerFd,6/1/2014 14:52,3,1,It's @ ASCO's 50th Anniversary & we're giving out 50 Young Investigator Awards today! Full list here: http://bit.ly/1gBtM9R # ASCO14,,@,#,4.73175E+17,https://twitter.com/ConquerCancerFd/status/473175190294528000,,,,
JoanneWeidhaas,6/1/2014 14:52,0,0,"Pagani reporting on tam versus AIs and ovarian suppression, or tam alone. TEXT and SOFT trials- significant!! AIs better! # ASCO14",,,#,4.73175E+17,https://twitter.com/JoanneWeidhaas/status/473175151820156928,,,,
nxtstop1,6/1/2014 14:51,0,0,"WikIMedica"" @ davidgrahammd: 1st use of Wikipedia as a reference in an ASCO plenary session? # ASCO14”""",,@,#,4.73175E+17,https://twitter.com/nxtstop1/status/473175137668198400,,,,
drdonsdizon,6/1/2014 14:51,1,0,Pagani: Over half treated with chemotherapy. # BCSM # ASCO14,,,# #,4.73175E+17,https://twitter.com/drdonsdizon/status/473175097638154240,,,,
rsm2800,6/1/2014 14:51,0,1,SOFT/TEXT: Median age was 43; 42% N+; 12% HER2+; 50% received chemo # ASCO14,,,#,4.73175E+17,https://twitter.com/rsm2800/status/473175086317322240,,,,
NirajGusani,6/1/2014 14:51,0,2,w refreshments! Nice... RT @ ASCO: # ASCO14 Tweetup. Thanks to all for attending. We're grateful. http://ow.ly/i/5KLDk,,@,#,4.73175E+17,https://twitter.com/NirajGusani/status/473175084455452673,,,,
tomleblancMD,6/1/2014 14:51,1,1,MT @ ASCO: @ arifkamalmd & Abernethy: Improving Quality of # Palliative Care w/Virtual Learning Collaborative http://bit.ly/1nxNlD0 # ASCO14,,@ @,# #,4.73175E+17,https://twitter.com/tomleblancMD/status/473175078474366976,,,,
AlanCoss,6/1/2014 14:51,0,0,@ conlethmurphy Microbiome & GI disease is huge area at the moment. Good review of link with cancer here: http://www.gastrojournal.org/article/S0016-5085(14)00003-1/abstract … # ASCO14,,@,#,4.73175E+17,https://twitter.com/AlanCoss/status/473175069775384578,,,,
gorskon,6/1/2014 14:51,0,0,# ASCO14: “ @ davidgrahammd: @ gorskon @ drdonsdizon so unspecific that it could have been written by the Ancient Aliens writers”,,@ @ @,#,4.73175E+17,https://twitter.com/gorskon/status/473175021641535489,,,,
MarkSchoenebaum,6/1/2014 14:51,3,4,"Bladder pts live only ~7 mos, so big unmet need. # asco14 room was packed-been long time since docs have seen innovation here # fierceasco",,,# #,4.73175E+17,https://twitter.com/MarkSchoenebaum/status/473175015085457408,,,,
subhamadhavan,6/1/2014 14:51,1,0,# ASCO14 Dr Hausen: infectious agents in beef and types of beef linked to cancer risk.,,,#,4.73175E+17,https://twitter.com/subhamadhavan/status/473174949113655296,,,,
dmooneymd,6/1/2014 14:51,0,0,Pagani: Primary endpoint: disease-free survival. Planned joint analysis of TEXT and SOFT trials. Intent to treat. # bcsm # ASCO14,,,# #,4.73175E+17,https://twitter.com/dmooneymd/status/473174942796636162,,,,
Rfonsi1,6/1/2014 14:51,0,0,@ jrgralow @ mtmdphd what does that mean? # ASCO14,,@ @,#,4.73175E+17,https://twitter.com/Rfonsi1/status/473174923276746753,,,,
drdonsdizon,6/1/2014 14:50,1,1,Pagan- trial amended due to lower than expected accrual. This analysis changed to primary objective. # BCSM # ASCO14,,,# #,4.73175E+17,https://twitter.com/drdonsdizon/status/473174883820900354,,,,
dhicks444,6/1/2014 14:50,5,6,# ASCO2014 @ TheALCF # beatlungcancer # LCSM @ UpstageLungCancpic.twitter.com/YEovpUbLbE,,@ @,# # #,4.73175E+17,https://twitter.com/dhicks444/status/473174881073639424,,,,
DrAttai,6/1/2014 14:50,1,1,Pagani TEXT and SOFT treatments # asco14 # bcsmpic.twitter.com/Tw0el0hmxv,,,# #,4.73175E+17,https://twitter.com/DrAttai/status/473174809182871552,,,,
drugwonks,6/1/2014 14:50,4,7,. @ DrBobGoldberg schools @ ASCO on the REALITY of # healthcare costs. FACT: # Innovation has reduced # costofcare. LISTEN: http://buff.ly/1wOwgXk,,@ @,# # #,4.73175E+17,https://twitter.com/drugwonks/status/473174788308234240,,,,
NEJM,6/1/2014 14:50,0,2,"# ASCO14 Visit the @ NEJMGroup at booth 20127, get a 15% @ NEJM subscription discount.",,@ @,#,4.73175E+17,https://twitter.com/NEJM/status/473174733023105024,,,,
rsm2800,6/1/2014 14:50,2,1,SOFT/TEXT: DFS was primary endpoint; overall survival was secondary endpoint (important to keep this in mind) # asco14,,,#,4.73175E+17,https://twitter.com/rsm2800/status/473174710771924992,,,,
nxtstop1,6/1/2014 14:49,0,0,“ @ ElizBlanchardMD: Science of oncology lecture--one take home--role of immunology in cancer is so much larger than we realize # ASCO14”,,@,#,4.73175E+17,https://twitter.com/nxtstop1/status/473174621756211200,,,,
MarkSchoenebaum,6/1/2014 14:49,7,6,$ roche data in bladder were really pretty striking. 40-50% response rate in high expressers. seemed durable too. # asco14 # fierceasco,,,# #,4.73175E+17,https://twitter.com/MarkSchoenebaum/status/473174566873751552,,,,
vickyyyf,6/1/2014 14:49,0,0,Then again this might be dependent on whether Daily Mail have a reporter at # ASCO14...im thinking not.,,,#,4.73175E+17,https://twitter.com/vickyyyf/status/473174566584741888,,,,
clarisssv,6/1/2014 14:49,0,0,Seguimos en # ASCO14. Sigue todas las novedades en @ diariomedico,,@,#,4.73175E+17,https://twitter.com/clarisssv/status/473174533910712320,,,,
DrHedrick,6/1/2014 14:49,0,0,Pagani: Ovarian Function Suppressing (OFS) TEXT gave triptorelin or option of oophorectomy or irradiation. SOFT allow choice of OFS. # ASCO14,,,#,4.73175E+17,https://twitter.com/DrHedrick/status/473174530303987713,,,,
CancerTherAdvsr,6/1/2014 14:49,0,0,RT @ drdonsdizon: SOFT trial- tamoxifen vs tamoxifen+OS vs Exemestane + OS. Data re tamoxifen alone not presented. # bcsm # ASCO14,,@,# #,4.73175E+17,https://twitter.com/CancerTherAdvsr/status/473174512125878274,,,,
rsm2800,6/1/2014 14:49,0,1,SOFT/TEXT: TEXT used triptorelin for ovarian suppresion (OS); SOFT used any method of OS # ASCO14,,,#,4.73175E+17,https://twitter.com/rsm2800/status/473174501698465793,,,,
drdonsdizon,6/1/2014 14:49,0,0,# BCSM # ASCO14 SOFT/TEXT results also uses tamoxifen for five years. We've moved on since this study was planned.,,,# #,4.73175E+17,https://twitter.com/drdonsdizon/status/473174500012720128,,,,
ipaulmampilly,6/1/2014 14:49,0,0,# ASCO14 not sure how I missed this yesterday $ azn booth..what is this? Brain transference?pic.twitter.com/y5cXO5nXth,,,#,4.73174E+17,https://twitter.com/ipaulmampilly/status/473174474372972544,,,,
aftimosp,6/1/2014 14:49,0,0,SOFT trial: too bad the comparison between tamoxifen alone and tampxifen + OFS is not reported # BreastCancer # bcsm # ASCO14,,,# # #,4.73174E+17,https://twitter.com/aftimosp/status/473174398552510465,,,,
vickyyyf,6/1/2014 14:48,0,0,Oh my. Zur Hausen plenary lecture at # ASCO14 practically guarantees a 'cows cause cancer!' Daily Mail headline tomorrow. Im calling it.,,,#,4.73174E+17,https://twitter.com/vickyyyf/status/473174364037586944,,,,
dmooneymd,6/1/2014 14:48,0,0,Adjuvant therapy x 5 years of ai (exemestane) vs tamoxifen-both with ovarian function suppression-in premenopausal women. # ASCO14 # bcsm,,,# #,4.73174E+17,https://twitter.com/dmooneymd/status/473174284584910849,,,,
tomleblancMD,6/1/2014 14:48,1,0,RT @ ASCO: R2CHOP may overcome negative prognosis of non-GBC phenotype in DLBCL http://bit.ly/1oXL7dl # ASCO14 # lymphoma,,@,# #,4.73174E+17,https://twitter.com/tomleblancMD/status/473174262673854464,,,,
rsm2800,6/1/2014 14:48,0,1,"SOFT/TEXT: Study pop: premenop women, ER/PR>10%, N- or N+; therapy continued for 5 yrs; chemo permitted, not specified # ASCO14",,,#,4.73174E+17,https://twitter.com/rsm2800/status/473174244709253120,,,,
drdonsdizon,6/1/2014 14:47,0,1,SOFT trial- tamoxifen vs tamoxifen+OS vs Exemestane + OS. Data re tamoxifen alone not presented. # bcsm # ASCO14,,,# #,4.73174E+17,https://twitter.com/drdonsdizon/status/473174095937695744,,,,
DrHedrick,6/1/2014 14:47,1,0,Pagani: Disease Free Survival is the primary outcome. 4690 randomized to either Tam+OFS or Exem+OFS. # ASCO14,,,#,4.73174E+17,https://twitter.com/DrHedrick/status/473173976123199488,,,,
josico99,6/1/2014 14:47,0,0,@ DrMisialek @ DanaFarber @ ASCO Great news! Thank you for tweeting.,,@ @ @,,4.73174E+17,https://twitter.com/josico99/status/473173929235062785,,,,
rsm2800,6/1/2014 14:46,2,1,SOFT/TEXT: TEXT was Tam or exemestane plus ov suppression; SOFT was tam vs tam/ov suppr vs exem/ov suppr # asco14,,,#,4.73174E+17,https://twitter.com/rsm2800/status/473173877770575873,,,,
DrStelling,6/1/2014 14:46,0,2,"@ MarkSchoenebaum Are the sick and dying"" really the same thing as a true ""free market""? Capitalism will only get us so far w health # ASCO14""",,@,#,4.73174E+17,https://twitter.com/DrStelling/status/473173873634988032,,,,
JamesPPinkerton,6/1/2014 14:46,0,0,Crisis at Dept. of Veterans Affairs: Scandal? Prototype? And Is Cancer Treatment Next…to Get the Treatment? http://shar.es/VFDba # ASCO14,,,#,4.73174E+17,https://twitter.com/JamesPPinkerton/status/473173850864107520,,,,
DrAttai,6/1/2014 14:46,1,0,Pagani TEXT and SOFT results apply to premenopausal ER+ breast CA # ASCO14 # bcsm,,,# #,4.73174E+17,https://twitter.com/DrAttai/status/473173769922830336,,,,
drdonsdizon,6/1/2014 14:46,1,2,LBA1 SOFT/TEXT analysis of ov suppression w tamoxifen or exemestane. Not presenting ov suppression VS endocrine therapy alone. # bcsm # ASCO14,,,# #,4.73174E+17,https://twitter.com/drdonsdizon/status/473173676821856256,,,,
oncodocsydney,6/1/2014 14:46,0,0,need regulatory reform 2 facilitate this“ @ genentech: >70%pts don’t live nr clin trial sites.Telemed may b key 2 overcoming barriers # ASCO14”,,@,#,4.73174E+17,https://twitter.com/oncodocsydney/status/473173636216782848,,,,
rsm2800,6/1/2014 14:45,1,1,SOFT/TEXT: Trial designed to accommodate international differences in treatment; this presentation focuses on AI question # asco14,,,#,4.73174E+17,https://twitter.com/rsm2800/status/473173626053615616,,,,
BioWorld,6/1/2014 14:45,0,0,"Fed funding’s fruits appear just as money is going away; ‘old dog, new tricks’ in PC http://bit.ly/1iIMLKW # ASCO14",,,#,4.73174E+17,https://twitter.com/BioWorld/status/473173586006773761,,,,
OncEd,6/1/2014 14:45,0,0,Plenary Presentation LBA 1. IBCSG designed TEXT and SOFT trial - optimal endocrine therapy for premenopausal women # ASCO14 # BCsm,,,# #,4.73174E+17,https://twitter.com/OncEd/status/473173576745381888,,,,
KellyColligan,6/1/2014 14:45,1,1,RT @ DrHedrick: Anyone else worried the beef industry is going to come after them? I am a little. # ASCO14 >> Lessons learned from Oprah.,,@,#,4.73173E+17,https://twitter.com/KellyColligan/status/473173469601878016,,,,
DrHedrick,6/1/2014 14:45,2,0,Pagani: Exemestane + Ovarian Suppression v. Tamoxifen + Ovarian Suppression in pre-menopausal hormone positive patients. # ASCO14,,,#,4.73173E+17,https://twitter.com/DrHedrick/status/473173463960924161,,,,
LIVESTRONG_NL,6/1/2014 14:45,0,0,Veelbelovende behandeling tegen agressieve # huidkanker http://ow.ly/xuH0S # ASCO14,,,# #,4.73173E+17,https://twitter.com/LIVESTRONG_NL/status/473173463000444929,,,,
genentech,6/1/2014 14:45,0,2,> 100 yrs before @ asco & Dr. Ehrlich’s vision is still inspiring research today http://ow.ly/3lfiec,,@,,4.73173E+17,https://twitter.com/genentech/status/473173459477213185,,,,
ASCO,6/1/2014 14:45,1,0,At the Lymphoma/Plasma Cell Disorders track at # ASCO14? Catch up on recent research via # ASCOConnection http://bit.ly/QO7SUp # lymsm,,,# # #,4.73173E+17,https://twitter.com/ASCO/status/473173456088231938,,,,
ASCO,6/1/2014 14:45,0,1,"Ed Session highlights NCIs restructured clinical research programs, & ASCOs Community Rsrch Forum http://bit.ly/1oKoL1m # ASCO14",,,#,4.73173E+17,https://twitter.com/ASCO/status/473173418553393152,,,,
rsm2800,6/1/2014 14:45,1,0,"SOFT/TEXT: Coordinated by IBCSG, subjects from 27 countries # ASCO14",,,#,4.73173E+17,https://twitter.com/rsm2800/status/473173400836255746,,,,
DrMisialek,6/1/2014 14:44,3,1,Blood test shows promise for identifying genetic abnormalities in tumors http://www.dana-farber.org/Newsroom/News-Releases/Blood-test-shows-promise-for-identifying-genetic-abnormalities-in-tumors.aspx#.U4t0G9fZt_E.twitter … @ DanaFarber @ ASCO # ASCO14,,@ @,# #,4.73173E+17,https://twitter.com/DrMisialek/status/473173252169547776,,,,
DrAttai,6/1/2014 14:44,0,0,Pagani joint analysis of SOFT and TEXT trials # ASCO14,,,#,4.73173E+17,https://twitter.com/DrAttai/status/473173213623906304,,,,
MarkSchoenebaum,6/1/2014 14:44,1,0,"sales for $ MRK pd-1 only into h&n hyper-expressers"" would shrink the market. only ~20% of patients would be eligible # asco14 # fierceasco""",,,# #,4.73173E+17,https://twitter.com/MarkSchoenebaum/status/473173209374674944,,,,
Oncoinfo_it,6/1/2014 14:44,0,0,"F.De Braud: Questo # ASCO14 invita i ricercatori a reimmaginare le sequenze nelle nuove terapie"" @ procopio_g""",,@,#,4.73173E+17,https://twitter.com/Oncoinfo_it/status/473173195768754178,,,,
drallysonocean,6/1/2014 14:44,2,1,# ASCO14 BEV=CETUX with FOLFOX or FOLFIRI both acceptable and similarly efficacious. @ MMfightsCRC # crcsm,,@,# #,4.73173E+17,https://twitter.com/drallysonocean/status/473173175392817155,,,,
DrHedrick,6/1/2014 14:44,0,0,Anyone else worried the beef industry is going to come after them? I am a little. # ASCO14,,,#,4.73173E+17,https://twitter.com/DrHedrick/status/473173163590037505,,,,
shlomo1961,6/1/2014 14:43,0,0,"@ MarkSchoenebaum In lung, tox in combo with chemo looks fine, but combo with Yervoy looks rough. $ BMY # fierceasco # ASCO14",,@,# #,4.73173E+17,https://twitter.com/shlomo1961/status/473173037471133696,,,,
nxtstop1,6/1/2014 14:43,1,1,IN THE KNOW:ASCO2014! THX! @Carolinas : # ASCO14 Coverage - Day 1 - What's hot from the 2014 ASCO Converence - http://bit.ly/1rz33zy ”,,@Carolinas,#,4.73173E+17,https://twitter.com/nxtstop1/status/473173036665815040,,,,
DrStelling,6/1/2014 14:43,2,1,"@ drdonsdizon @ vickyyyf Life mostly consists of confounding variables, heh, it's not a physical science. Yet. # ASCO14",,@ @,#,4.73173E+17,https://twitter.com/DrStelling/status/473173015233306624,,,,
DrHedrick,6/1/2014 14:42,0,0,"Hausen: Counterintuitive. Immune suppression (BMT pts, AIDS pts) Have decreased BrCa incidence. Is a pathogen coopting immune system # ASCO14",,,#,4.73173E+17,https://twitter.com/DrHedrick/status/473172872241119234,,,,
DomenickBertell,6/1/2014 14:42,1,2,"# ASCO2014 takeaway: In near term, the advent of cheaper IHC ALK testing should help more lung cancer patients get tested for ALK",,,#,4.73173E+17,https://twitter.com/DomenickBertell/status/473172871200927745,,,,
drdonsdizon,6/1/2014 14:42,5,3,My take on the talk by Prof zur Hausen: Hmmm.... Major implication- potential for prevention is reason enough to study. # ASCO14,,,#,4.73173E+17,https://twitter.com/drdonsdizon/status/473172831774449665,,,,
DrLen,6/1/2014 14:42,2,0,Great logic of Zur Hausen re infectious agent and CRC risk from red meat. Also grilled chicken/fish don't have same effect # ASCO14,,,#,4.73173E+17,https://twitter.com/DrLen/status/473172790435405824,,,,
Neil_Iyengar,6/1/2014 14:42,4,2,Fascinating. Dr zur Hausen: infectious agents in beef linked to cancer (even in cow milk). # ASCO14 pic.twitter.com/xLAjzDpHfF,,,#,4.73173E+17,https://twitter.com/Neil_Iyengar/status/473172781056942081,,,,
conlethmurphy,6/1/2014 14:42,2,1,# ASCO14 fascinating talk by professor zur hausen on possible infectious causes of breast and colon cancer. Food for thought indeed..,,,#,4.73173E+17,https://twitter.com/conlethmurphy/status/473172775406809089,,,,
vickyyyf,6/1/2014 14:42,0,1,@ drdonsdizon will definitely look up any relevant publications. Sadly not at # asco14. Enjoying following your updates!,,@,#,4.73173E+17,https://twitter.com/vickyyyf/status/473172703042883586,,,,
afinley,6/1/2014 14:42,0,0,"Nice try, zur Hausen, but I'm not regretting my steak! # ASCO14",,,#,4.73173E+17,https://twitter.com/afinley/status/473172696013209600,,,,
DomenickBertell,6/1/2014 14:42,0,0,"# ASCO2014 takeaway: Dx for lung cancer (e.g., FISH for EGFR, ALK, etc.) run to ~$5,000 – NGS PCR shd be able to compete with that cost soon",,,#,4.73173E+17,https://twitter.com/DomenickBertell/status/473172677134671874,,,,
AndyBiotech,6/1/2014 14:42,3,2,$ MRK MK-3475 (Anti-PD1) in Head and Neck Cancer: 20% ORR http://www.mercknewsroom.com/news-release/oncology-newsroom/first-presentation-early-data-pembrolizumab-mk-3475-mercks-investigat … # ASCO14 # HNCSM via @ MarkSchoenebaumpic.twitter.com/0yKMF6PbFU,,@,# #,4.73173E+17,https://twitter.com/AndyBiotech/status/473172658579075072,,,,
MarkSchoenebaum,6/1/2014 14:41,7,1,"now for $ MRK. new H&N data looked good. Looked awesome in PDL-1 hyper"" expressers. No PFS/OS data though"," so caveats. # asco14 # fierceasco""",,,# #,4.73173E+17,https://twitter.com/MarkSchoenebaum/status/473172621740105728,,,
shlomo1961,6/1/2014 14:41,0,1,@ MarkSchoenebaum Excited to start my # fierceasco twitter chat! # asco14,,@,# #,4.73173E+17,https://twitter.com/shlomo1961/status/473172595940945920,,,,
DomenickBertell,6/1/2014 14:41,0,0,# ASCO2014 takeaway: A PCR-based Dx approach targeting exomes or hot spots could be a plausible standard of care in cancers like lung soon,,,#,4.73173E+17,https://twitter.com/DomenickBertell/status/473172523769954304,,,,
Oncoinfo_it,6/1/2014 14:41,0,0,@ CliffordHudis: importanza ribadita degli studi finanziati dal governo federale. E noi? # ASCO14 @ lucadf,,@ @,#,4.73172E+17,https://twitter.com/Oncoinfo_it/status/473172464651223041,,,,
CourtneyKagan,6/1/2014 14:41,0,0,"# ASCO14 plenary - red meat linked to colon cancer, could it be from a virus in cattle?",,,#,4.73172E+17,https://twitter.com/CourtneyKagan/status/473172455184662529,,,,
drdonsdizon,6/1/2014 14:41,2,1,"@ vickyyyf I admit, seems 2B ton of confounding variables that need to be figured in to the story of a potential infectious agent # ASCO14",,@,#,4.73172E+17,https://twitter.com/drdonsdizon/status/473172410599227392,,,,
RenataMGlebocki,6/1/2014 14:41,0,0,disgusting RT“ @ ClevelandClinic: More than 1/3 of all US adults and 17% of US children and adolescents are obese. - Dr. Ligibel # ASCO14”,,@,#,4.73172E+17,https://twitter.com/RenataMGlebocki/status/473172398460915713,,,,
CareAcross,6/1/2014 14:40,1,0,"The # ASCO14 plennary is in session. Focus: breast, prostate, colon cancer pic.twitter.com/wl4qz7KQdk",,,#,4.73172E+17,https://twitter.com/CareAcross/status/473172349458468864,,,,
DrMisialek,6/1/2014 14:40,2,1,Combo therapy shows promise against forms of breast & ovarian cancer in early trial http://www.dana-farber.org/Newsroom/News-Releases/combination-therapy-shows-promise-against-forms-of-breast-and-ovarian-cancer-in-early-clinical-trial.aspx#.U4tzTIpnBec.twitter … @ ASCO @ DanaFarber # ASCO14 # bcsm,,@ @,# # #,4.73172E+17,https://twitter.com/DrMisialek/status/473172345423933442,,,,
ecancer,6/1/2014 14:40,3,1,Dr Liu: Cediranib plus olaparib significantly increases progression-free survival in recurrent ovarian cancer http://bit.ly/1gU4WlA # ASCO14,,,#,4.73172E+17,https://twitter.com/ecancer/status/473172339337613312,,,,
Fakman1971,6/1/2014 14:40,1,0,Plenary overflow room is almost full. Awaiting Dr Sweeny. # ASCO14,,,#,4.73172E+17,https://twitter.com/Fakman1971/status/473172283994157057,,,,
Melanoma_doctor,6/1/2014 14:40,0,0,"Thanks, and yet cost was never brought up MT @ MaverickNY: @ Melanoma_doctor well said! Cost vs value debate important # asco14 # melanoma",,@ @,# #,4.73172E+17,https://twitter.com/Melanoma_doctor/status/473172277136474113,,,,
gorskon,6/1/2014 14:40,0,0,. @ drattai @ drdonsdizon Sure. I just wish there were more direct evidence presented. # ASCO14,,@ @,#,4.73172E+17,https://twitter.com/gorskon/status/473172250204856320,,,,
jrgralow,6/1/2014 14:40,12,7,Yes! RT @ MedscapeOnc: Schilsky: patient engagement will be fourth revolution affecting future of cancer care # ASCO14 pic.twitter.com/fWR9k0mFLG,,@,#,4.73172E+17,https://twitter.com/jrgralow/status/473172222430154753,,,,
Boehringer,6/1/2014 14:40,2,3,"Unfortunately the stigma surrounding # lungcancer affects media interest in the topic"" Stefania from WALCE http://bit.ly/1oX5LdG # ASCO14""",,,# #,4.73172E+17,https://twitter.com/Boehringer/status/473172180881391618,,,,
PhRMA,6/1/2014 14:40,0,0,. @ leukemiamda @ LillyPad @ myUHC: We’re evidence that agreement is possible in cost of # cancer discussions http://bit.ly/1tv1yxW # ASCO14,,@ @ @,# #,4.73172E+17,https://twitter.com/PhRMA/status/473172134861078530,,,,
mnewtonPharmD,6/1/2014 14:39,2,0,Are we consuming carcinogenic viral particles by eating red meat from bos taurus? - Dr zur Hausen # ASCO14 pic.twitter.com/zZJlvljhlI,,,#,4.73172E+17,https://twitter.com/mnewtonPharmD/status/473171998567583746,,,,
ALLIANCE_org,6/1/2014 14:39,0,0,Coming up soon at # ASCO14 Plenary: A Joint analysis of IBCSG TEXT and SOFT trials. http://abstracts.asco.org/144/index.html,,,#,4.73172E+17,https://twitter.com/ALLIANCE_org/status/473171984973459457,,,,
davidgrahammd,6/1/2014 14:39,0,0,1st use of Wikipedia as a reference in an ASCO plenary session? # ASCO14,,,#,4.73172E+17,https://twitter.com/davidgrahammd/status/473171913939099650,,,,
rsm2800,6/1/2014 14:39,5,0,Zur Hausen: Beef consumption low in India but India is largest consumer of milk (& incidence of breast ca>colon ca rising in India) # asco14,,,#,4.73172E+17,https://twitter.com/rsm2800/status/473171902022701057,,,,
ElizBlanchardMD,6/1/2014 14:38,4,1,Science of onc lecture--one take home--role if immunology in cancer is so much larger than we realize # ASCO14,,,#,4.73172E+17,https://twitter.com/ElizBlanchardMD/status/473171797110575104,,,,
michelerhee,6/1/2014 14:38,0,1,Probs ditto 4 brain. MT @ MarkSchoenebaum: $ BMY nivo tox in ovarian a bit high but desperate pts so would b used # asco14 # fierceasco,,@,# #,4.73172E+17,https://twitter.com/michelerhee/status/473171789242068993,,,,
JoanneWeidhaas,6/1/2014 14:38,0,1,Can't say I've seen Wikipedia as a reference in a plenary before... # ASCO14,,,#,4.73172E+17,https://twitter.com/JoanneWeidhaas/status/473171788705173504,,,,
hectorherrerac,6/1/2014 14:38,1,0," @ ClevelandClinic: 21% of all cancers can be linked to infections - Prof. zur Hausen # ASCO14""""",,@,#,4.73172E+17,https://twitter.com/hectorherrerac/status/473171757797748736,,,,
AtriumHealth,6/1/2014 14:38,0,0,# ASCO14 Coverage - Day 1 - What's hot from the 2014 ASCO Converence - http://bit.ly/1rz33zy,,,#,4.73172E+17,https://twitter.com/AtriumHealth/status/473171731377446912,,,,
C_DeSantis,6/1/2014 14:38,0,0,"I'm wearing flats tomorrow!  @ MaverickNY: Doing the # blisterwalk... Sung to the tune of ""Doing the Lambeth Walk"" # asco14”""",,@,# #,4.73172E+17,https://twitter.com/C_DeSantis/status/473171721093402626,,,,
OncEd,6/1/2014 14:38,0,0,# ASCO14 Effect of lenalidomide w/ R-CHOP on -ve prognostic impact of nongerminal center phenotype Dr. Nowakowski http://bit.ly/1u5pbPS,,,#,4.73172E+17,https://twitter.com/OncEd/status/473171719155228673,,,,
DrAttai,6/1/2014 14:38,0,0,Feeling better about the quinoa kale salad I had for lunch # ASCO14,,,#,4.73172E+17,https://twitter.com/DrAttai/status/473171716554760194,,,,
MarkSchoenebaum,6/1/2014 14:38,1,2,"In lung, tox in combo with chemo looks fine, but combo with Yervoy looks rough. $ BMY # fierceasco # ASCO14",,,# #,4.73172E+17,https://twitter.com/MarkSchoenebaum/status/473171714893811713,,,,
AdoorAmanullah,6/1/2014 14:38,0,1,# ASCO14 Sunday at ASCO: Hot News From Plenary Session http://www.medscape.com/viewarticle/825811 …,,,#,4.73172E+17,https://twitter.com/AdoorAmanullah/status/473171694711242752,,,,
drapaolaceledon,6/1/2014 14:38,0,1,Cubriendo todas las incidencias del Congreso Americano de Oncología Clínica # ASCO14 a través de Virtual Meeting,,,#,4.73172E+17,https://twitter.com/drapaolaceledon/status/473171654101979137,,,,
JediPD,6/1/2014 14:38,0,0,Less Moooing and more Mowing the grass will save your brimstone encrusted Crypts! # ASCO14 (Had to...),,,#,4.73172E+17,https://twitter.com/JediPD/status/473171630597111809,,,,
nycdoc29,6/1/2014 14:37,0,1,"# ASCO14 - if CMS is listening to Plenary consider paying for red meat"" consumption & cooking counseling along with smoking cessation.""",,,#,4.73172E+17,https://twitter.com/nycdoc29/status/473171517967441920,,,,
MarkSchoenebaum,6/1/2014 14:37,0,1,"For example, $ BMY nivo tox in ovarian was a bit high.but these are absolutely desperate patients.so would be used # fierceasco # asco14",,,# #,4.73171E+17,https://twitter.com/MarkSchoenebaum/status/473171402560774144,,,,
ElizBlanchardMD,6/1/2014 14:36,0,1,Science of Onc: May be a link of red meat consumption and breast cancer and lung cancer ( in non smokers) along with colon ca. # ASCO14,,,#,4.73171E+17,https://twitter.com/ElizBlanchardMD/status/473171304435023872,,,,
ClevelandClinic,6/1/2014 14:36,53,22,21% of all cancers can be linked to infections - Prof. zur Hausen # ASCO14,,,#,4.73171E+17,https://twitter.com/ClevelandClinic/status/473171291072376832,,,,
drdonsdizon,6/1/2014 14:36,0,0,@ DrMarkham Does make me reconsider dry-aged beef. Wonder if marbling is an issue? # ASCO14,,@,#,4.73171E+17,https://twitter.com/drdonsdizon/status/473171270155370496,,,,
jrgralow,6/1/2014 14:36,1,0,Sadly another negative bevacizumab study MT @ eaonc: Coming up # ASCO14: E5103- breast oral session # eaonc # ALLIANCE_org # SWOGonc # nrgoncology,,@,# # # # #,4.73171E+17,https://twitter.com/jrgralow/status/473171188219658241,,,,
tgunninkEBD,6/1/2014 14:36,0,0,“ @ DrMarkham: I'm rethinking tonight's steak dinner. # ASCO14” That makes 2 of us.,,@,#,4.73171E+17,https://twitter.com/tgunninkEBD/status/473171171442450434,,,,
MarkSchoenebaum,6/1/2014 14:36,0,1,"For example, $ BMY nivo tox in ovarian was a bit high...but these are absolutely desperate patients...so would be used # asco14 # fierceasco",,,# #,4.73171E+17,https://twitter.com/MarkSchoenebaum/status/473171125921275904,,,,
brianreid,6/1/2014 14:35,2,3,Best part of # ASCO14: the fact that @ gorskon is tweeting.,,@,#,4.73171E+17,https://twitter.com/brianreid/status/473171103024939008,,,,
ipaulmampilly,6/1/2014 14:35,0,0,# ASCO14 lunch fun sweet tooth junk pic.twitter.com/2MGyskrFxq,,,#,4.73171E+17,https://twitter.com/ipaulmampilly/status/473171080392507392,,,,
DrAttai,6/1/2014 14:35,1,0,“ @ drdonsdizon: very preliminary I agree @ gorskon @ drattai # ASCO14” but a very entertaining and provocative talk,,@ @ @,#,4.73171E+17,https://twitter.com/DrAttai/status/473171029700132864,,,,
ZskiTexas,6/1/2014 14:35,0,0,“ @ ThislsDeep: 7 Pics of people who survived Cancer # CancerSurvivorsDay http://fascpics.com/1kwxLo5 . https://twitter.com/ThislsDeep/status/473166343425261568/photo/1pic.twitter.com/X60eFHRIOU ” # ASCO14,,@,# #,4.73171E+17,https://twitter.com/ZskiTexas/status/473171015531380736,,,,
DrHedrick,6/1/2014 14:35,0,0,Hausen: Reports association of red meat consumption in lung and breast cancers. Is this marker of western lifestyle or mechanistic. # ASCO14,,,#,4.73171E+17,https://twitter.com/DrHedrick/status/473170995998519298,,,,
MarkSchoenebaum,6/1/2014 14:35,0,1,$ BMY's nivo tox varies by setting & combo agent. always a risk/benefit balance. so tolerance for tox depends on efficacy # fierceasco # asco14,,,# #,4.73171E+17,https://twitter.com/MarkSchoenebaum/status/473170910380187648,,,,
DrMarkham,6/1/2014 14:35,0,2,I'm rethinking tonight's steak dinner. # ASCO14,,,#,4.73171E+17,https://twitter.com/DrMarkham/status/473170903720013825,,,,
djsampson,6/1/2014 14:35,0,0,Need to figure out password to get onto # bigsweaty. Ideas? # asco14,,,# #,4.73171E+17,https://twitter.com/djsampson/status/473170902117781505,,,,
EMDSerono,6/1/2014 14:35,0,0,Are you at # ASCO14? Visit us at booth 14087,,,#,4.73171E+17,https://twitter.com/EMDSerono/status/473170887840378882,,,,
drapaolaceledon,6/1/2014 14:35,0,0,Consenso para estandarizar Next Generation Sequencing en oncología # ASCO14,,,#,4.73171E+17,https://twitter.com/drapaolaceledon/status/473170884841463809,,,,
rsm2800,6/1/2014 14:35,1,0,Zur Hausen: Mentioning other studies showing association of red meat consumption and lung & breast ca (not saying causative) # ASCO14,,,#,4.73171E+17,https://twitter.com/rsm2800/status/473170876821540864,,,,
gotoPER,6/1/2014 14:34,2,4,Join @ GoToPER for Personalization of NSCLC Therapy CME-certified symposium 7pm @Hyatt Regency Chicago # ASCO14 # lcsmpic.twitter.com/NFjaEymwio,,@ @Hyatt,# #,4.73171E+17,https://twitter.com/gotoPER/status/473170857762623488,,,,
MaverickNY,6/1/2014 14:34,1,0,"Doing the # blisterwalk... Sung to the tune of Doing the Lambeth Walk"" # asco14""",,,# #,4.73171E+17,https://twitter.com/MaverickNY/status/473170841367486465,,,,
drdonsdizon,6/1/2014 14:34,0,0,very preliminary I agree @ gorskon @ drattai # ASCO14,,@ @,#,4.73171E+17,https://twitter.com/drdonsdizon/status/473170813278244864,,,,
tehfem,6/1/2014 14:34,0,0,# ASCO14 recent studies showed increased risk after red meat consumption for breast and lung cancer,,,#,4.73171E+17,https://twitter.com/tehfem/status/473170801445699585,,,,
WhitworthMD,6/1/2014 14:34,0,0,Starting point. “ @ ASCO: Experts discuss consensus standards for multiplex # cancer genomic testing http://bit.ly/RTL1XZ # ASCO14”,,@,# #,4.73171E+17,https://twitter.com/WhitworthMD/status/473170648370782209,,,,
jrgralow,6/1/2014 14:34,1,0,"SWOG S0230 study rumored to be #1 newsworthy (news covered) presentation at # ASCO14 - Congrats, H Moore! # SWOGonc",,,#1 # #,4.73171E+17,https://twitter.com/jrgralow/status/473170637658525696,,,,
myelomabeacon,6/1/2014 14:33,1,1,ICYMI - Our detailed coverage of the # myeloma posters presented on Day 1 of # ASCO14 (Friday) http://www.myelomabeacon.com/news/2014/05/31/asco-2014-multiple-myeloma-update-day-one/ …,,,# #,4.73171E+17,https://twitter.com/myelomabeacon/status/473170609443463168,,,,
FightCRC,6/1/2014 14:33,0,1,Our # advocates at the # ASCO14 meeting in # Chicago this weekend! # CRCAdvocacy # CRCAwareness… http://instagram.com/p/oti8FylrM5/,,,# # # # #,4.73171E+17,https://twitter.com/FightCRC/status/473170597988814849,,,,
dmooneymd,6/1/2014 14:33,0,0,RT @ DrHedrick: As a total aside... I just love red meat and I feel my heart (and colon) sinking continually during this talk. # ASCO14,,@,#,4.73171E+17,https://twitter.com/dmooneymd/status/473170570767396864,,,,
tshein,6/1/2014 14:33,1,1,Yoga helps! RT @ teamoncology: Role of integrative medicine in the traditional cancer care. Read this. http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter … # ASCO14 # BCSM,,@,# # #,4.73171E+17,https://twitter.com/tshein/status/473170514102329344,,,,
DrHedrick,6/1/2014 14:33,0,0,Hausen: A virus located... not present in colon cancer cell lines. WAS found in a chronic neurologic disorder. Being investigated. # ASCO14,,,#,4.7317E+17,https://twitter.com/DrHedrick/status/473170487900504064,,,,
drapaolaceledon,6/1/2014 14:32,2,0,Obesidad disminuye sobrevida en pacientes premenopáusicas con cáncerdemama temprano hormonosensible # ASCO14 Estudio EBCTCG,,,#,4.7317E+17,https://twitter.com/drapaolaceledon/status/473170352215191552,,,,
JLErsek,6/1/2014 14:32,0,0,MT @ rsm2800 probably the 1st ASCO plenary session that featured pictures of yaks and sashimi if you’re following along # ASCO14 # LCI haha,,@,# #,4.7317E+17,https://twitter.com/JLErsek/status/473170345021947904,,,,
DrStelling,6/1/2014 14:32,0,0,"@ ASCO I wld not really call mere genetic info molecular""; we need the Active Biochemistry on the phenotype level 4 diagnostics # ASCO14""",,@,#,4.7317E+17,https://twitter.com/DrStelling/status/473170272225206272,,,,
ipaulmampilly,6/1/2014 14:32,0,0,# ASCO14 lunch junk pic.twitter.com/qTaqDqCixI,,,#,4.7317E+17,https://twitter.com/ipaulmampilly/status/473170239015092224,,,,
thecancergeek,6/1/2014 14:31,3,3,Cool - my new favorite pathway has been linked to endocrine resistance via down-regulating ER http://abstracts.asco.org/144/AbstView_144_134749.html … # ASCO14 abstract,,,#,4.7317E+17,https://twitter.com/thecancergeek/status/473170082625880064,,,,
Cortellis,6/1/2014 14:31,1,0,Pilot study of PLX3397 demonstrates early and sustained tumor mass reductions with 79% ORR by TVS in patients with PVNS # ASCO14,,,#,4.7317E+17,https://twitter.com/Cortellis/status/473170059141996544,,,,
oncodocsydney,6/1/2014 14:31,1,0,Looking forward to catching up with # ACORD alumni at # ASCO14 after the plenary session. See you outside hall B1!,,,# #,4.7317E+17,https://twitter.com/oncodocsydney/status/473170055287799809,,,,
urotoday,6/1/2014 14:31,0,0,A huge and busy exhibit hall at # ASCO14 pic.twitter.com/kg1YTcOqPh,,,#,4.7317E+17,https://twitter.com/urotoday/status/473170022823514113,,,,
christinemphmd,6/1/2014 14:31,0,0,Thanks to all who visited the poster! Great to discuss in person & develop new research ?s & collaborations for future projects! # ASCO14,,,#,4.7317E+17,https://twitter.com/christinemphmd/status/473169966016253953,,,,
DrHedrick,6/1/2014 14:31,1,1,"Hausen: 2 possible pathways, transmission of latent virus. Chronic inflammatory process triggered by consumed pathogens. # ASCO14",,,#,4.7317E+17,https://twitter.com/DrHedrick/status/473169925075660800,,,,
iman_elhariry,6/1/2014 14:31,0,0,# ASCO14 is this end of era for beef meat rare or medium rare!,,,#,4.7317E+17,https://twitter.com/iman_elhariry/status/473169918637395969,,,,
gotoPER,6/1/2014 14:31,2,2,"Hear @ YaleTomLynch discuss EGFR, ALK & targeted therapies @6/1 7pm @Hyatt Regency Chicago info @ GoToPER booth 5099 # lcsm # ASCO14",,@ @6 @Hyatt @,# #,4.7317E+17,https://twitter.com/gotoPER/status/473169894327197697,,,,
SanofiUS,6/1/2014 14:30,0,0,FYI: RT @ ASCO: Low battery? Charge your devices at Networking Cafes and Charging Stations located throughout McCormick Place # ASCO14,,@,#,4.7317E+17,https://twitter.com/SanofiUS/status/473169751146237954,,,,
MarkSchoenebaum,6/1/2014 14:30,0,1,Excited to start my # fierceasco twitter chat! # asco14,,,# #,4.7317E+17,https://twitter.com/MarkSchoenebaum/status/473169739418574850,,,,
AdoorAmanullah,6/1/2014 14:30,0,1,"ASCO meeting in Chicago, over 30,000 oncologist attending. # ASCO14 pic.twitter.com/izJnaXIsfm",,,#,4.7317E+17,https://twitter.com/AdoorAmanullah/status/473169704907862016,,,,
ASCO,6/1/2014 14:30,9,2,Experts discuss consensus standards for multiplex # cancer genomic testing http://bit.ly/RTL1XZ # ASCO14,,,# #,4.7317E+17,https://twitter.com/ASCO/status/473169700919476224,,,,
FierceBiotech,6/1/2014 14:30,0,0,"Hello, everyone, and welcome to our # ASCO14 chat with @ MarkSchoenebaum, head of ISI’s healthcare research team. # FierceASCO",,@,# #,4.7317E+17,https://twitter.com/FierceBiotech/status/473169694531125248,,,,
DoctorEdny,6/1/2014 14:30,1,0,This plenary talk is making me feel worse about my McDonald's cheeseburgers for lunch # ASCO14 pic.twitter.com/YRYeCKtnij,,,#,4.7317E+17,https://twitter.com/DoctorEdny/status/473169673958473729,,,,
tehfem,6/1/2014 14:30,1,0,# ASCO14 Risk is higher due a thermo-resistant virus in raw and undercooked meat,,,#,4.7317E+17,https://twitter.com/tehfem/status/473169672624287744,,,,
jrgralow,6/1/2014 14:30,2,1,Really!? MT @ WilliamDale_MD: # ASCO14 Finding #2 Wives marital happiness leads to more husbands colonoscopies. Really. pic.twitter.com/hXvvjiK03w,,@,# #2,4.7317E+17,https://twitter.com/jrgralow/status/473169664236093440,,,,
myriadgenetics,6/1/2014 14:30,1,1,"If you’re attending # ASCO14, visit us at Booth 2039 to find out about our # companiondiagnostic BRACAnalysis with # PARP inhibitors!",,,# # #,4.7317E+17,https://twitter.com/myriadgenetics/status/473169612213719040,,,,
Tony_Calles,6/1/2014 14:29,0,0,Have you ever realized this painting was at McCormick place? It's always good to take a break # ASCO14 pic.twitter.com/fphTSMqIpZ,,,#,4.7317E+17,https://twitter.com/Tony_Calles/status/473169569813921792,,,,
rsm2800,6/1/2014 14:29,5,2,Zur Hausen: Hypothesis: A specific bovine factor is causally involved in human colorectal cancer? # asco14,,,#,4.7317E+17,https://twitter.com/rsm2800/status/473169527857889280,,,,
SKarlsberg,6/1/2014 14:29,0,0,"Plenary session at # ASCO14 - cooked beef has carcinogens, undercooked beef may be pathogenic. Damned if you, damned if you don't.",,,#,4.7317E+17,https://twitter.com/SKarlsberg/status/473169525727592448,,,,
DrHedrick,6/1/2014 14:29,0,1,Hausen: Possible that a thermo-resistant virus? Latent infections passed though colon that is suppressed with tumor suppressors. # ASCO14,,,#,4.73169E+17,https://twitter.com/DrHedrick/status/473169461457870849,,,,
ipaulmampilly,6/1/2014 14:29,0,0,# ASCO14 lunch healthy pic.twitter.com/oy8r0330q4,,,#,4.73169E+17,https://twitter.com/ipaulmampilly/status/473169436418252801,,,,
david_colquhoun,6/1/2014 14:28,1,1,@ gorskon @ rjblaskiewicz @ drattai @ rsm2800 @ obogler @ mtmdphd The @ ASCO site asks for feedback. I gave them some (uncomplimentary(,,@ @ @ @ @ @ @,,4.73169E+17,https://twitter.com/david_colquhoun/status/473169338292535297,,,,
RoswellPark,6/1/2014 14:28,1,0,Dr. Opyrchal presented new research today on how # breastcancer comes to resist hormonal therapy http://goo.gl/HJP1nx # ASCO14,,,# #,4.73169E+17,https://twitter.com/RoswellPark/status/473169296244625409,,,,
DrAttai,6/1/2014 14:28,0,1,"“ @ gorskon: . @ drattai @ drdonsdizon Or maybe oversold"" is a better word. # ASCO14” I'll go with that""",,@ @ @,#,4.73169E+17,https://twitter.com/DrAttai/status/473169205224034304,,,,
DKarikios,6/1/2014 14:28,3,1,"Dont need to get rid of my cat, just my cow # ASCO14",,,#,4.73169E+17,https://twitter.com/DKarikios/status/473169177944281088,,,,
dmooneymd,6/1/2014 14:28,0,0,Why increasing crc incidence in Japan? Rare meat and air dried meat popular. Both of these preps let infectious organisms thrive. # ASCO14,,,#,4.73169E+17,https://twitter.com/dmooneymd/status/473169164161409024,,,,
maggiemfox,6/1/2014 14:28,1,1,"I dare you RT @ djsampson: WiFi down in plenary, forcing agonizing choice: whether to join network labeled big sweaty"" # asco14""",,@,#,4.73169E+17,https://twitter.com/maggiemfox/status/473169160927993856,,,,
christinemphmd,6/1/2014 14:28,1,0,21% of # cancers linked to # infections # HPV # EBV # Hpylori # HIV # HTLV # HepB # ASCO14,,,# # # # # # # # #,4.73169E+17,https://twitter.com/christinemphmd/status/473169109589692417,,,,
DrHedrick,6/1/2014 14:28,2,2,As a total aside... I just love red meat and I feel my heart (and colon) sinking continually during this talk. # itswhatsfordinner # ASCO14,,,# #,4.73169E+17,https://twitter.com/DrHedrick/status/473169107970322434,,,,
DrHedrick,6/1/2014 14:27,1,0,"Hausen: Preparation may have an influence. Raw, air dried, medium/rare. # ASCO14",,,#,4.73169E+17,https://twitter.com/DrHedrick/status/473168884745256960,,,,
thecancergeek,6/1/2014 14:26,0,1,"Don't do it!!! RT @ djsampson: WiFi down in plenary, forcing agonizing choice: whether to join network labeled big sweaty"" # asco14""",,@,#,4.73169E+17,https://twitter.com/thecancergeek/status/473168832278704128,,,,
gorskon,6/1/2014 14:26,0,0,". @ drattai @ drdonsdizon Or maybe oversold"" is a better word. # ASCO14""",,@ @,#,4.73169E+17,https://twitter.com/gorskon/status/473168782262026240,,,,
jrgralow,6/1/2014 14:26,2,0,Tobacco still tobacco- smoking cessation remains critical MT @ CliffordHudis Obesity is new tobacco: resources http://bit.ly/1puQK2p # ASCO14,,@,#,4.73169E+17,https://twitter.com/jrgralow/status/473168768798314496,,,,
Cortellis,6/1/2014 14:26,0,0,Initial analysis of phase II results shows promising activity of ponatinib in patients with advanced GIST # ASCO14,,,#,4.73169E+17,https://twitter.com/Cortellis/status/473168680914677760,,,,
rsm2800,6/1/2014 14:26,3,6,I believe this is probably the first ASCO plenary session that featured pictures of yaks and sashimi if you’re following along # ASCO14,,,#,4.73169E+17,https://twitter.com/rsm2800/status/473168657661440000,,,,
drapaolaceledon,6/1/2014 14:25,0,1,Avastin y Erbitux eficacia similar en primera línea para cáncer de colon y recto: Estudio CALB/SWOG 80405 # ASCO14 @ vitoconet01,,@,#,4.73168E+17,https://twitter.com/drapaolaceledon/status/473168386424573952,,,,
CancerDotNet,6/1/2014 14:25,0,0,"Find @ RedCross in the back of # ASCO14 Onc Prof Hall & give blood! 9am-3pm CDT. For appts, use sponsor code ASCO: http://rdcrss.org/1iIbW05",,@,#,4.73168E+17,https://twitter.com/CancerDotNet/status/473168375947223040,,,,
CancerAdvocacy,6/1/2014 14:25,3,1,"Cancer Policy Matters blog: http://ow.ly/xuEr2 How can we make survivorship care planning a reality?"" # NCSD2014 # ASCO14 # journeyforward""",,,# # #,4.73168E+17,https://twitter.com/CancerAdvocacy/status/473168371522236418,,,,
gorskon,6/1/2014 14:25,1,0,"@ drattai @ drdonsdizon Interesting, but highly speculative and, to me, less than convincing. # ASCO14",,@ @,#,4.73168E+17,https://twitter.com/gorskon/status/473168366589710341,,,,
SanofiUS,6/1/2014 14:24,1,0,RT @ ASCO: Use Virtual Meeting on Demand to preview select # ASCO14 presentations http://bit.ly/1pJI6gH,,@,#,4.73168E+17,https://twitter.com/SanofiUS/status/473168301309591552,,,,
djsampson,6/1/2014 14:24,0,0,"WiFi down in plenary, forcing agonizing choice: whether to join network labeled big sweaty"" # asco14""",,,#,4.73168E+17,https://twitter.com/djsampson/status/473168231562477569,,,,
OncNursingNews,6/1/2014 14:24,0,1,Study Finds Survival and Fertility Benefit When Goserelin Augments Breast Cancer Chemo http://ow.ly/xuN1K # ASCO14 # bcsm,,,# #,4.73168E+17,https://twitter.com/OncNursingNews/status/473168196053532672,,,,
gotoPER,6/1/2014 14:24,2,2,Hear Dr Soria discuss immunotherapies at lung cancer CME symposium @6/1 7pm @Hyatt Regency Chicago info @ GoToPER booth 5099 # lcsm # ASCO14,,@6 @Hyatt @,# #,4.73168E+17,https://twitter.com/gotoPER/status/473168192849051650,,,,
Cortellis,6/1/2014 14:24,0,0,"SGN-CD19A (Seattle Genetics), a humanised anti-CD19 mAb: ORR 30%, CR 16% & manageable tox seen in interim C1 data in B-cell NHL # ASCO14",,,#,4.73168E+17,https://twitter.com/Cortellis/status/473168126075748353,,,,
neulpt,6/1/2014 14:24,0,0,New MR enhancement predicts high-grade histology in patients with progressive low-grade gliomas only 80% of the time! # ASCO14 Always biopsy!,,,#,4.73168E+17,https://twitter.com/neulpt/status/473168122606657536,,,,
DrMarkham,6/1/2014 14:24,3,1,"Fascinating. MT @ drattai: Zur Hausen increased CA risk w/ beef. Not yak, goat, camel (reviewing consumption from worldwide cultures) # ASCO14",,@,#,4.73168E+17,https://twitter.com/DrMarkham/status/473168105729196032,,,,
gorskon,6/1/2014 14:23,0,0,. @ rjblaskiewicz @ drattai @ rsm2800 @ obogler @ mtmdphd @ ASCO After my Tweets about quackademic oncology presented at # ASCO14? I'm not so sure.,,@ @ @ @ @ @,#,4.73168E+17,https://twitter.com/gorskon/status/473168060015456258,,,,
annaazvolinsky,6/1/2014 14:23,0,0,Certain HER2-positive early-stage # breastcancer ptsmay not benefit from more aggressive chemo # ASCO14 http://www.cancernetwork.com/asco-2014-breast-cancer/dual-her2-targeting-benefits-subset-breast-cancer-patients …,,,# #,4.73168E+17,https://twitter.com/annaazvolinsky/status/473167989919850496,,,,
DrHedrick,6/1/2014 14:23,1,0,"Hausen: A number of human viruses (BK, JC) are not permissive to replication in animal cells but are carcinogenic. Is inverse true? # ASCO14",,,#,4.73168E+17,https://twitter.com/DrHedrick/status/473167966100418560,,,,
OCRF,6/1/2014 14:23,2,0,In Chicago for the American Society of Clinical Oncology's 50th Annual Meeting - stay tuned for highlights! # ASCO14 pic.twitter.com/MsV022ktsc,,,#,4.73168E+17,https://twitter.com/OCRF/status/473167910698250242,,,,
RoswellPark,6/1/2014 14:23,0,0,"Dr. George, co-author on research presented yesterday at # ASCO14: a brighter outlook for # kidneycancer patients"" http://goo.gl/zrJo3T""",,,# #,4.73168E+17,https://twitter.com/RoswellPark/status/473167850560307200,,,,
dmooneymd,6/1/2014 14:22,0,0,Why is red meat associated with colorectal cancer? Mongolia is disapproving carcinogenic theory one grilled yak at a time. # ASCO14,,,#,4.73168E+17,https://twitter.com/dmooneymd/status/473167767676256256,,,,
jrgralow,6/1/2014 14:22,1,0,# ASCO14 plenary: AI + Ovarian Suppression Effective Alternative for Premenopausal Early-Stage ER+ Breast CA # bcsm http://www.cancer.net/research-and-advocacy/research-summaries/exemestane-plus-ovarian-function-suppression-may-be-more-effective-alternative-premenopausal-women#.U4tu_1KRsBQ.twitter …,,,# # #,4.73168E+17,https://twitter.com/jrgralow/status/473167761732956160,,,,
DrAttai,6/1/2014 14:22,4,1,"Zur Hausen increased CA risk with beef. Not yak, goat, camel - reviewing consumption from worldwide cultures # ASCO14",,,#,4.73168E+17,https://twitter.com/DrAttai/status/473167735481200641,,,,
DrHedrick,6/1/2014 14:22,0,0,"Hausen: Other red meat (camel, yak, water buffalo) do now seem to confer this risk. Possibly only beef? # ASCO14",,,#,4.73168E+17,https://twitter.com/DrHedrick/status/473167651968016384,,,,
Xcenda,6/1/2014 14:22,1,0,# Xcenda presents 2 posters on NSCLC & chronic myelogenous leukemia at # ASCO14. Learn more: http://bit.ly/1jXRsje # oncology,,,# # #,4.73168E+17,https://twitter.com/Xcenda/status/473167618216452096,,,,
JacobPlieth,6/1/2014 14:22,0,0,"So, 45 minutes into yesterday's 58-min meeting $ CLVS mentions insulin"" # ASCO14 $ AZN""",,,#,4.73168E+17,https://twitter.com/JacobPlieth/status/473167603779641344,,,,
Oncoinfo_it,6/1/2014 14:21,0,0,"What types of information do you tweet and Who? Attend The future si now"""," today 4:45 pm Room S504. # ASCO14 @ mtmdphd @ fischmd @ lucadf""",,@ @ @,#,4.73168E+17,https://twitter.com/Oncoinfo_it/status/473167588944793600,,,
AshleySumrallMD,6/1/2014 14:21,0,0,MT @ jrgralow: Optimizing Therapies for Breast Cancer CNS Mets. Problem that is only growing! # ASCO14 # bcsm http://am.asco.org/optimizing-therapies-breast-cancer-central-nervous-system-metastases#.U4tTNzmhMZ8.twitter …”,,@,# # #,4.73168E+17,https://twitter.com/AshleySumrallMD/status/473167532808232960,,,,
rsm2800,6/1/2014 14:21,1,0,"Zur Hausen: Mongolia-meat consumption high incl beef (yak), mutton, camel, horse & usually grilled; so why colon ca rates low there? # asco14",,,#,4.73167E+17,https://twitter.com/rsm2800/status/473167494111174657,,,,
rdhoble,6/1/2014 14:21,2,1,Confidential app supports # breastcancer patients taking generic Aromasin (Exemestane) # ASCO2014 # safety # adherence http://mhlib.com/i/e/2820/en/,,,# # # #,4.73167E+17,https://twitter.com/rdhoble/status/473167458459582464,,,,
dhjutsw1,6/1/2014 14:21,1,0,@ ASCO # ASCO14 ~21% of human cancers related to infections - Dr. Harald Zur Hausen.,,@,#,4.73167E+17,https://twitter.com/dhjutsw1/status/473167372467986432,,,,
DrHedrick,6/1/2014 14:20,0,0,Hausen: Other high red meat consumption countries have low incidence of cancer. How can it be Red Meat with these discrepancies. # ASCO14,,,#,4.73167E+17,https://twitter.com/DrHedrick/status/473167317933621249,,,,
JSweetenhamMD,6/1/2014 14:20,1,0,Chicago is such a great city for # ASCO14. Even the dogs look cooler here #@huntsmancancer pic.twitter.com/xNmBoyI0JP,,@huntsmancancer,# #,4.73167E+17,https://twitter.com/JSweetenhamMD/status/473167289785671680,,,,
ASCO,6/1/2014 14:20,5,1,Interested in the debate on cost of care at # ASCO14? Read @ yzafar 's take: http://bit.ly/1oUH5Sm via # ASCOConnection,,@,# #,4.73167E+17,https://twitter.com/ASCO/status/473167172039360513,,,,
gorskon,6/1/2014 14:20,1,1,. @ drdonsdizon Saw Prof. zur Hausen's talk at a Grand Rounds. Lots of speculation based on correlation. Not much convincing evidence. # ASCO14,,@,#,4.73167E+17,https://twitter.com/gorskon/status/473167129815318528,,,,
drapaolaceledon,6/1/2014 14:19,0,0,Estudios IBCSG-TEXT y SOFT: Exemestane + supresión ovárica es superior a tamoxifeno en adyuvancia para premenopáusicas # ASCO14,,,#,4.73167E+17,https://twitter.com/drapaolaceledon/status/473167067869229056,,,,
rsm2800,6/1/2014 14:19,2,0,Zur Hausen: Why is red meat assoc w/ colon ca but grilled chicken and fish are relatively safe? # asco14,,,#,4.73167E+17,https://twitter.com/rsm2800/status/473166912235401216,,,,
DrHedrick,6/1/2014 14:19,0,0,"Hausen: White meat (fish, chicken) considered safe? Concerns of aromatic compounds in cooking. However compounds in white meat too. # ASCO14",,,#,4.73167E+17,https://twitter.com/DrHedrick/status/473166909060313088,,,,
ECMC_UK,6/1/2014 14:18,0,0,"Handy:  @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm""""",,@,# #,4.73167E+17,https://twitter.com/ECMC_UK/status/473166746783080448,,,,
JoanneWeidhaas,6/1/2014 14:18,1,0,Good news- smoked white meat is fine! No colon cancer risk! # ASCO14,,,#,4.73167E+17,https://twitter.com/JoanneWeidhaas/status/473166668156248065,,,,
drdonsdizon,6/1/2014 14:18,0,0,# ASCO14 Prof zur Hausen- discussing environmental associations for cancer risk,,,#,4.73167E+17,https://twitter.com/drdonsdizon/status/473166589534035970,,,,
DrHedrick,6/1/2014 14:17,0,0,Hausen: Differences in colon cancer rates world wide. Epidemiologically (not mechanistically) associated with eating red meat. # ASCO14,,,#,4.73166E+17,https://twitter.com/DrHedrick/status/473166471753764864,,,,
DKarikios,6/1/2014 14:17,0,0,Time to get rid of my cat? Are some cancers linked to infections transmitted by domestic animals # ASCO14 # poorharry,,,# #,4.73166E+17,https://twitter.com/DKarikios/status/473166465945042944,,,,
aftimosp,6/1/2014 14:17,0,0,View from the convention center # ASCO14 # Chicago http://instagram.com/p/othBZLjVku/,,,# #,4.73166E+17,https://twitter.com/aftimosp/status/473166380435398656,,,,
myPathMelanoma,6/1/2014 14:17,1,0,Learn how we're enhancing patient care thru more definitive diagnosis of melanocytic lesions at booth 2039 # melanoma # isthismelanoma # ASCO14,,,# # #,4.73166E+17,https://twitter.com/myPathMelanoma/status/473166339394121728,,,,
DrAttai,6/1/2014 14:16,0,0,zur Hausen what is mechanism of increase in colorectal cancer w/ red meat consumption? # ASCO14,,,#,4.73166E+17,https://twitter.com/DrAttai/status/473166299242463232,,,,
MOCBrasil,6/1/2014 14:16,0,0,A Plenaria começa agora! # ASCO2014 # MOCnaASCO # ONCOLOGY # CANCERpic.twitter.com/CD56tEDok3,,,# # # #,4.73166E+17,https://twitter.com/MOCBrasil/status/473166281039179778,,,,
drallysonocean,6/1/2014 14:16,1,2,@ShewithLynch @ ASCO @ CCAlliance @ ColonCancerCDA @ TheColonClub @ GYRIG @ MMfightsCRC # ASCO14 looking forward to plenary session and # crcsm data,,@ShewithLynch @ @ @ @ @ @,# #,4.73166E+17,https://twitter.com/drallysonocean/status/473166225091334146,,,,
bfloannie,6/1/2014 14:16,0,0,@ RoswellPark's J. Marshall: Structure of clinical practice makes it hard to intervene when # cancer pts smoke # ASCO14 http://goo.gl/sGV2Xd,,@,# #,4.73166E+17,https://twitter.com/bfloannie/status/473166194221268992,,,,
Roche,6/1/2014 14:15,3,2,What does great # science look like? http://ow.ly/xoTM7 # ASCO14,,,# #,4.73166E+17,https://twitter.com/Roche/status/473165910141071361,,,,
LIVESTRONG_NL,6/1/2014 14:15,1,0,50 Yrs in Breast Cancer: Progress in Treatment Based On Improved Understanding of Biology http://ow.ly/xuHTP # ASCO14 # borstkanker / @ ASCO,,@,# #,4.73166E+17,https://twitter.com/LIVESTRONG_NL/status/473165889253441536,,,,
drdonsdizon,6/1/2014 14:15,2,1,# ASCO14 Prof zur Hausen: provocative lecture- do some cancers come from infections transmitted by domestic animals?,,,#,4.73166E+17,https://twitter.com/drdonsdizon/status/473165874552377345,,,,
ASCO,6/1/2014 14:15,4,0,Drs. Natraj Ammakkanavar & Nasser Hanna: The oncologist's role in tobacco cessation http://bit.ly/1k59YfP # ASCO14,,,#,4.73166E+17,https://twitter.com/ASCO/status/473165869892530176,,,,
ASCO,6/1/2014 14:15,6,2,R2CHOP may overcome negative prognosis of non-GBC phenotype in DLBCL http://bit.ly/1oXL7dl # ASCO14,,,#,4.73166E+17,https://twitter.com/ASCO/status/473165869884133377,,,,
drdonsdizon,6/1/2014 14:15,0,0,# ASCO14 always amazed at how many come to plenary! # standingroomonly,,,# #,4.73166E+17,https://twitter.com/drdonsdizon/status/473165868390957056,,,,
drdonsdizon,6/1/2014 14:15,0,0,# ASCO14 important if true bc may open new paths for prevention- Prof zur Hausen,,,#,4.73166E+17,https://twitter.com/drdonsdizon/status/473165862615412736,,,,
TargetedOnc,6/1/2014 14:15,2,3,Results from the Phase III CALGB/SWOG 80405 Trial | Dr. Richard Goldberg comments: http://www.targetedonc.com/conference/asco-2014/Results-from-the-Phase-III-CALGBSWOG-80405-Trial … # ASCO14,,,#,4.73166E+17,https://twitter.com/TargetedOnc/status/473165847545249796,,,,
rsm2800,6/1/2014 14:14,1,0,"Zur Hausen: Also consider cancers assoc w/ +/- immunosuppression, non-tumorigenic cancers, and nutritional events # asco14",,,#,4.73166E+17,https://twitter.com/rsm2800/status/473165786236743680,,,,
ME_Fleury,6/1/2014 14:14,0,0,# ASCO14 Plenary- Provocative talk for pet owners--Do some cancers arise from infections from domestic animals?,,,#,4.73166E+17,https://twitter.com/ME_Fleury/status/473165737302167552,,,,
drapaolaceledon,6/1/2014 14:14,8,2,Estudio ALTTO: Añadir Lapatinib a Herceptin no mejoró SLE en adyuvancia # ASCO14 # cancerdemama,,,# #,4.73166E+17,https://twitter.com/drapaolaceledon/status/473165696730689538,,,,
DrHedrick,6/1/2014 14:14,0,0,Hausen: Cancer occur at increased frequency under immune suppression. # ASCO14,,,#,4.73166E+17,https://twitter.com/DrHedrick/status/473165673565126656,,,,
JLErsek,6/1/2014 14:13,0,0,zur Hausen lecture: Approx 21% of human cancers linked to infections # LCI @Carolinas # ASCO14,,@Carolinas,# #,4.73165E+17,https://twitter.com/JLErsek/status/473165483123171328,,,,
DrAttai,6/1/2014 14:13,0,1,zur Hausen nutritional cancer risk factors possibly linked to infections # ASCO14,,,#,4.73165E+17,https://twitter.com/DrAttai/status/473165460775927808,,,,
davidgrahammd,6/1/2014 14:13,0,0,@ morningmika RT @ dmooneymd: Obesity is the new tobacco. See @ ASCO resources http://bit.ly/1puQK2p # ASCO14,,@ @ @,#,4.73165E+17,https://twitter.com/davidgrahammd/status/473165398603743233,,,,
PhRMA,6/1/2014 14:13,5,3,Prostate # cancer had 5 yr survival rate of 43% in '64 but after 50 yrs of research the rate is now 100% http://bit.ly/1nAxDqP # ASCO14,,,# #,4.73165E+17,https://twitter.com/PhRMA/status/473165373349457920,,,,
Mills_I,6/1/2014 14:13,0,0,"Young adult movement will improve cancer care-science,technology, personal issues with the YAs making the contributions+changes. # ASCO14",,,#,4.73165E+17,https://twitter.com/Mills_I/status/473165354429321216,,,,
SusanLaufer,6/1/2014 14:13,1,0,"~21% of human cancers are linked to infections"" - Nobel Laureate Harald zur Hausen # Plenary # ASCO14""",,,# #,4.73165E+17,https://twitter.com/SusanLaufer/status/473165347458011138,,,,
jrgralow,6/1/2014 14:12,1,0,Fertility Preservation and Breast Cancer Research News with @ CliffordHudis # asco14 # bcsm http://youtu.be/LG0ogtCd7mw,,@,# #,4.73165E+17,https://twitter.com/jrgralow/status/473165254390603777,,,,
intervalolibre,6/1/2014 14:12,1,0,"Exemestane + supresión ovárica en cåncer de mama en premenopáusicas, la noticia del día en # ASCO2014 http://globovision.com/articulo/descubren-nuevo-tratamiento-eficaz-para-combatir-el-cancer-de-seno …",,,#,4.73165E+17,https://twitter.com/intervalolibre/status/473165198023729152,,,,
DrHedrick,6/1/2014 14:12,13,7,"Hansen: 21% of human cancers are linked to infections, H. pylori, Hep B, HPV, EBV, HIV, HTLV. # ASCO14",,,#,4.73165E+17,https://twitter.com/DrHedrick/status/473165122639106048,,,,
DrAttai,6/1/2014 14:12,0,0,zur Hausen approx 21% of cancers related to infections # ASCO14,,,#,4.73165E+17,https://twitter.com/DrAttai/status/473165104591015936,,,,
rsm2800,6/1/2014 14:11,15,4,"Zur Hausen: 21% of global cancers linked to infections. 35% bacterial , almost all others are viral e.g. hep B, EBV, HPV, HHV8 # ASCO14",,,#,4.73165E+17,https://twitter.com/rsm2800/status/473165056960503810,,,,
NickiDurlester,6/1/2014 14:11,0,1,MRT Multiple Studies Presented # ASCO14 Practice-Changing Impact of Oncotype DX® to Optimize # BreastCancer Care @ LguzzardiM @ GenomicHealth,,@ @,# #,4.73165E+17,https://twitter.com/NickiDurlester/status/473164969567989760,,,,
RoswellPark,6/1/2014 14:11,1,0,"Marshall: The structure & demands of clin. practice make it difficult to take more than superficial action"" when cancer pts. smoke # ASCO14""",,,#,4.73165E+17,https://twitter.com/RoswellPark/status/473164922848034817,,,,
Cortellis,6/1/2014 14:10,1,0,COMBI-d study results presented in # ASCO14: first melanoma trial in phase III shows that dabrafenib + trametinib reduced risk of progression,,,#,4.73165E+17,https://twitter.com/Cortellis/status/473164697064448000,,,,
DrHedrick,6/1/2014 14:10,0,0,Dr. Harald zur Hansen- Do some cancers originate from infections transmitted from domestic animals? # ASCO14,,,#,4.73165E+17,https://twitter.com/DrHedrick/status/473164630848573440,,,,
Boehringer,6/1/2014 14:10,1,2,“I didn't let my diagnosis define me but allowed me to be the person I was meant to be” @ thesearemyscars http://bit.ly/1kdfBHE # ASCO14,,@,#,4.73165E+17,https://twitter.com/Boehringer/status/473164608229105664,,,,
DrAttai,6/1/2014 14:09,1,0,Interesting - Do some human cancers originate from infections transmitted from domestic animals Dr. Harald zur Hausen # ASCO14,,,#,4.73165E+17,https://twitter.com/DrAttai/status/473164507603161089,,,,
jrgralow,6/1/2014 14:09,7,2,"# ASCO14 Breast Cancer Research News, 5 min video with @ CliffordHudis http://youtu.be/-vtVLTH-D48 # bcsm",,@,# #,4.73164E+17,https://twitter.com/jrgralow/status/473164456571469825,,,,
dhjutsw1,6/1/2014 14:09,7,4,@ ASCO honors Dr Harald Zurich Hausen with Science of Oncology Award 2014. # asco14 pic.twitter.com/pNCvCL1uME,,@,#,4.73164E+17,https://twitter.com/dhjutsw1/status/473164401575342080,,,,
Agendia,6/1/2014 14:09,2,1,RT @ Agendia: BluePrint molecular subtyping + MP reclassified up to 25% of breast cancers. # bettertogether # ASCO14 # bcsm # hcsm http://t.c…,,@,# # # #,4.73164E+17,https://twitter.com/Agendia/status/473164330385809408,,,,
BiostatGirl,6/1/2014 14:09,0,0,Plenary selfie. # asco2014 # asco14 http://instagram.com/p/otgFrFgzDv/,,,# #,4.73164E+17,https://twitter.com/BiostatGirl/status/473164329240371203,,,,
RoswellPark,6/1/2014 14:08,1,0,Dr. James Marshall: What's preventing many oncologists from referring patients who smoke for quit counseling? # ASCO14 http://goo.gl/sGV2Xd,,,#,4.73164E+17,https://twitter.com/RoswellPark/status/473164304754429952,,,,
jrgralow,6/1/2014 14:08,11,10,"# ASCO14 Breast Cancer Research News, 5 min video with @ cliffordhudis http://youtu.be/-vtVLTH-D48",,@,#,4.73164E+17,https://twitter.com/jrgralow/status/473164204342386689,,,,
StephanThomeMD,6/1/2014 14:08,0,1,Harold zur Hausen receives scientific lifetime achievement award # ASCO14 for HPV and EBV research,,,#,4.73164E+17,https://twitter.com/StephanThomeMD/status/473164084620578816,,,,
FightCRC,6/1/2014 14:07,1,0,Here's a pic overlooking the booths at # ASCO14. Follow us to see the latest pictures and happenings… http://instagram.com/p/otf-DLlrG2/,,,#,4.73164E+17,https://twitter.com/FightCRC/status/473164067176062976,,,,
mtmdphd,6/1/2014 14:07,1,0,Celebrate ASCO's 50th Anniv w a donation to Conquer Cancer Fnd of ASCO Mission Endowment http://ow.ly/xuLWs # ASCO14 @ iConquerCancer,,@,#,4.73164E+17,https://twitter.com/mtmdphd/status/473164038361612288,,,,
intervalolibre,6/1/2014 14:07,1,1,"Exemestane + supresión ovárica reduce recurrencia en premenopáusicas. Alternativa al tamoxifeno"" Dra Pagani. Vía @ dramarivirg # ASCO14""",,@,#,4.73164E+17,https://twitter.com/intervalolibre/status/473163991750311936,,,,
JLErsek,6/1/2014 14:07,0,0,Plenary session @ # ASCO14! @Carolinas # LCI,,@ @Carolinas,# #,4.73164E+17,https://twitter.com/JLErsek/status/473163850549051392,,,,
LGBTCancer,6/1/2014 14:05,1,1,Excellent prostate cancer sessions @ASCO massive sea change in pharma understanding of lgbt cancer survivorship. # asco14,,@ASCO,#,4.73164E+17,https://twitter.com/LGBTCancer/status/473163535389057024,,,,
DrAttai,6/1/2014 14:05,0,0,Wifi has slowed to a crawl in plenary session # ASCO14,,,#,4.73164E+17,https://twitter.com/DrAttai/status/473163512165199872,,,,
Roche,6/1/2014 14:05,3,4,Pioneering Healthcare blog: Reaching out to others with the help of social media - http://ow.ly/xuKER # lcsm # hcldr # ASCO14,,,# # #,4.73163E+17,https://twitter.com/Roche/status/473163361728090112,,,,
carisls,6/1/2014 14:05,0,0,"“...cancers from different # gastrointestinal cancers may share the same molecular pathway. http://goo.gl/oG0B17 # ASCO14 # MolecularIntel""",,,# # #,4.73163E+17,https://twitter.com/carisls/status/473163348797059073,,,,
ASCO,6/1/2014 14:05,0,1,For # ASCO14 media interviews: email mediateam@asco.org or stop by the Interview Request Booth at the front of the Press Room,,@asco,#,4.73163E+17,https://twitter.com/ASCO/status/473163335413006336,,,,
CancerNetwrk,6/1/2014 14:04,5,2,Overview of the ASCO Gynecologic Oncology Poster Session http://bit.ly/1m3AVfq # ASCO14,,,#,4.73163E+17,https://twitter.com/CancerNetwrk/status/473163307206316032,,,,
Bergeronmf,6/1/2014 14:04,0,0,"Indeed MT @ NormandBlais: Since last two decades, still no breakthrough for small cell lung cancer… Better not to smoke # tabac # ASCO14",,@,# #,4.73163E+17,https://twitter.com/Bergeronmf/status/473163271613448193,,,,
dhjutsw1,6/1/2014 14:04,0,0,@ CliffordHudis opening @ ASCO # asco14 plenary session. pic.twitter.com/oujI3zz8XR,,@ @,#,4.73163E+17,https://twitter.com/dhjutsw1/status/473163240118034433,,,,
MKChan_RCPSC,6/1/2014 14:03,1,1,RT  @ PhRMA: Assessment of value must reflect needs & preferences of individual # patients," says @ KUhlendorf @ # ASCO14 http://onphr.ma/1wGFpkH ”""",,@ @ @,# #,4.73163E+17,https://twitter.com/MKChan_RCPSC/status/473163051194015744,,,
westr,6/1/2014 14:02,7,2,HUGE: RT @ genentech: >70% of pts don’t live near clin trial sites. Telemed may be key to overcoming barrier. http://ow.ly/xk7oq # ASCO14,,@,#,4.73163E+17,https://twitter.com/westr/status/473162707462799360,,,,
Novartis,6/1/2014 14:01,1,5,Tomorrow at 8AM CDT: new Phase III # multiplemyeloma data will be presented in E354a # ASCO14 http://bit.ly/1i93rtE,,,# #,4.73162E+17,https://twitter.com/Novartis/status/473162429221072896,,,,
ASCO,6/1/2014 14:01,0,4,Low battery? Charge your devices at Networking Cafes and Charging Stations located throughout McCormick Place # ASCO14,,,#,4.73162E+17,https://twitter.com/ASCO/status/473162408631209985,,,,
mayocliniclabs,6/1/2014 14:01,0,0,# FISH testing aids in differentiation of malignant from benign melanocytic lesions. Learn more at booth 2054. # ASCO14 http://mayocl.in/T1r6rl,,,# #,4.73162E+17,https://twitter.com/mayocliniclabs/status/473162326393491456,,,,
ConsanoScott,6/1/2014 14:00,0,1,Meeting people from all over the world today at # ASCO14. So cool!,,,#,4.73162E+17,https://twitter.com/ConsanoScott/status/473162259984678912,,,,
iman_elhariry,6/1/2014 14:00,0,0,# ASCO14 wow. A very nice video celebrating asco 50 years,,,#,4.73162E+17,https://twitter.com/iman_elhariry/status/473162239852433408,,,,
dramarivirg,6/1/2014 14:00,1,1,"“Plenary brief # ASCO14: Exemestane+OFS sig. reduced risk of recurrence, results confirm tx as valid alternative to tamoxifen - Dr Pagani”",,,#,4.73162E+17,https://twitter.com/dramarivirg/status/473162190355046400,,,,
corp_UNC,6/1/2014 14:00,2,2,Consenus conference: Key components of survivorship care plans Deb Mayer @ UNC_Lineberger et al # asco14 http://ow.ly/xqzPS,,@,#,4.73162E+17,https://twitter.com/corp_UNC/status/473162173678899200,,,,
MedscapeOnc,6/1/2014 14:00,1,1,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.73162E+17,https://twitter.com/MedscapeOnc/status/473162072646111233,,,,
FoundationATCG,6/1/2014 14:00,1,1,Think differently about Molecular testing: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73162E+17,https://twitter.com/FoundationATCG/status/473162070494433280,,,,
Medscape,6/1/2014 14:00,0,0,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.73162E+17,https://twitter.com/Medscape/status/473162062533644288,,,,
dramarivirg,6/1/2014 13:59,0,0,“ @ ASCO: Plenary brief # ASCO14: Adding lapatinib to adjuvant trastuzumab does not improve outcomes; no signif. difference in 4-yr survival”,,@,#,4.73162E+17,https://twitter.com/dramarivirg/status/473162044321976320,,,,
dramarivirg,6/1/2014 13:59,0,1,"“Plenary abstract, LBA4 - Phase III ALTTO trial for pts w/early HER2+ breast cancer: http://bit.ly/1n050jo # ASCO14 # bcsm”",,,# #,4.73162E+17,https://twitter.com/dramarivirg/status/473161854508748800,,,,
rsm2800,6/1/2014 13:58,4,2,"Plenary hall fills, video plays, buzz builds…& 1000s grab every last wifi packet (save some for us tweeting) # ASCO14 pic.twitter.com/xtYaD9dESY",,,#,4.73162E+17,https://twitter.com/rsm2800/status/473161776410796032,,,,
iman_elhariry,6/1/2014 13:58,0,0,# ASCO14 i wish i brought my cashmere pashmina. This really cold at Hall B plenary session,,,#,4.73162E+17,https://twitter.com/iman_elhariry/status/473161658207330304,,,,
mLdoctor,6/1/2014 13:57,0,0,"it's kind of hard to sumurize # ASCO214 @ ASCO # lungcancer in a presentation, when i have no slides yet besides the tweeted"" once","i'm stuck!""",,@,# #,4.73162E+17,https://twitter.com/mLdoctor/status/473161516578271232,,,
OncEd,6/1/2014 13:57,0,1,# ASCO14 Video Update: The Future of Targeting EGFR – Dr. Ron Burkes # LCSM http://bit.ly/T4iQH3,,,# #,4.73161E+17,https://twitter.com/OncEd/status/473161460764274688,,,,
DomenickBertell,6/1/2014 13:57,0,0,"# ASCO2014 takeaway: Whole Genome Sequencing (WGS) for dxing tumors is a long way off, and maybe never broadly affordable for early workups",,,#,4.73161E+17,https://twitter.com/DomenickBertell/status/473161432788635648,,,,
subatomicdoc,6/1/2014 13:57,1,2,"@ShewithLynch Great to meet you too, Georgia! And the staff @ AmbryGenetics - thanks for all the information! # ASCO14",,@ShewithLynch @,#,4.73161E+17,https://twitter.com/subatomicdoc/status/473161349514919936,,,,
dramarivirg,6/1/2014 13:57,0,0,"“Adding Goserelin to Chemotherapy Helps to Preserve Fertility, Prolong Survival in Women With Breast Cancer http://www.targetedonc.com/conference/asco-2014/Adding-Goserelin-to-Chemotherapy-Helps-to-Preserve-Fertility-Prolong-Survival … # ASCO14”",,,#,4.73161E+17,https://twitter.com/dramarivirg/status/473161322331258881,,,,
DomenickBertell,6/1/2014 13:56,0,0,"# ASCO2014 takeaway: vis using advanced diagnostics to identify mutations --> targeted therapies, reimbursement remains a significant barrier",,,#,4.73161E+17,https://twitter.com/DomenickBertell/status/473161160238583809,,,,
AreYouDenseInc,6/1/2014 13:55,0,2,"“ @ LguzzardiM: 10 Years of Hormones for Breast Cancer, # ASCO14 Says http://www.medpagetoday.com/HematologyOncology/BreastCancer/46007 …” I'm on 10 yrs +",,@,#,4.73161E+17,https://twitter.com/AreYouDenseInc/status/473161013437956097,,,,
genentech,6/1/2014 13:55,4,1,>70% of pts don’t live near clin trial sites. Telemed may be key to overcoming this enrollment barrier. http://ow.ly/xk7oq # ASCO14,,,#,4.73161E+17,https://twitter.com/genentech/status/473160827051466752,,,,
BIOARRAYMDx,6/1/2014 13:54,0,1,Celebrating the impact of science on society # ASCO2014 http://fb.me/150raLpPP,,,#,4.73161E+17,https://twitter.com/BIOARRAYMDx/status/473160797271891968,,,,
davidgrahammd,6/1/2014 13:54,0,2,Love seeing & hearing the history of our organization # ASCO14,,,#,4.73161E+17,https://twitter.com/davidgrahammd/status/473160751780491264,,,,
jrgralow,6/1/2014 13:54,1,1,"# ASCO14: latest news on lapatinib and trastuzumab, and ibrutinib http://www.thepharmaletter.com/article/asco-2014-latest-news-on-lapatinib-and-trastuzumab-and-ibrutinib …",,,#,4.73161E+17,https://twitter.com/jrgralow/status/473160735992713217,,,,
theABTA,6/1/2014 13:54,0,0,"The ABTA's Senior Program Manager, Jillann, and Project Specialist, Antoinette, at # ASCO14. Stop by and say hi! pic.twitter.com/REZbvebZca",,,#,4.73161E+17,https://twitter.com/theABTA/status/473160678849515520,,,,
dramarivirg,6/1/2014 13:54,0,0,Plenary sesion in a few minutes # ASCO14,,,#,4.73161E+17,https://twitter.com/dramarivirg/status/473160649971752960,,,,
Juanfran_jf,6/1/2014 13:53,2,1,# ASCO14 PD-L1 key in bladder cancer. Surprising results!,,,#,4.7316E+17,https://twitter.com/Juanfran_jf/status/473160353132453889,,,,
LguzzardiM,6/1/2014 13:52,2,1,"10 Years of Hormones for Breast Cancer, # ASCO14 Says http://www.medpagetoday.com/HematologyOncology/BreastCancer/46007 …",,,#,4.7316E+17,https://twitter.com/LguzzardiM/status/473160280873390082,,,,
gorskon,6/1/2014 13:52,0,0,Can't say I find this unexpected. http://medicalxpress.com/news/2014-06-altto-dual-her2-blockade-agent.html … # ASCO14,,,#,4.7316E+17,https://twitter.com/gorskon/status/473160193489268736,,,,
PinkSheetMaryJo,6/1/2014 13:51,1,0,"Ferris: if inflamed tumor phenotype is predictive of immunotherapeutic response, can it be a prognostic marker? Panel Q&A. # ASCO14",,,#,4.7316E+17,https://twitter.com/PinkSheetMaryJo/status/473159999129387008,,,,
HemOncToday,6/1/2014 13:51,0,0,# ASCO14 Risk-based strategy outlines new standard of care in pediatric soft tissue # sarcoma at Lucile Salter Packard: http://goo.gl/t7K6Do,,,# #,4.7316E+17,https://twitter.com/HemOncToday/status/473159983396573184,,,,
GoHealio,6/1/2014 13:51,0,0,# ASCO14 Risk-based strategy outlines new standard of care in pediatric soft tissue # sarcoma at Lucile Salter Packard: http://goo.gl/t7K6Do,,,# #,4.7316E+17,https://twitter.com/GoHealio/status/473159982603845632,,,,
GillisClaire,6/1/2014 13:51,1,0,# ASCO14 time to review across all phases of oncology trials to ensure evolution to meet approval and reimbursement hurdles @ FDA,,@,#,4.7316E+17,https://twitter.com/GillisClaire/status/473159947677876224,,,,
GrupoGTG,6/1/2014 13:51,0,0,Plenária na # ASCO14. Aguardando as novidades. pic.twitter.com/1N8cq4oAP5,,,#,4.7316E+17,https://twitter.com/GrupoGTG/status/473159873954185217,,,,
iman_elhariry,6/1/2014 13:51,0,0,"# ASCO14 disappointed not to access posters at S hall A2, supposed to be up to http://1.45.pm . session closed early",,,#,4.7316E+17,https://twitter.com/iman_elhariry/status/473159833945120768,,,,
jrgralow,6/1/2014 13:50,3,0,Embargo lifted: ALTTO test of dual HER2 blockade finds single agent remains gold standard-plenary today http://medx.cc/320822678 # ASCO14 # bcsm,,,# #,4.7316E+17,https://twitter.com/jrgralow/status/473159759848153088,,,,
BayerPharma,6/1/2014 13:50,1,0,"HCC accounts for 70-85% of the total # livercancer burden, it’s one of the major subtypes in liver cancer. # ASCO14 http://bit.ly/1rprB8H",,,# #,4.7316E+17,https://twitter.com/BayerPharma/status/473159695633747968,,,,
ProjectInno,6/1/2014 13:50,0,0,Check out our interactive white paper on # innovation against cancer! http://ow.ly/xrNBy # ASCO14,,,# #,4.7316E+17,https://twitter.com/ProjectInno/status/473159582106546176,,,,
mnewtonPharmD,6/1/2014 13:49,4,1,Time for the # ASCO14 Plenary session! pic.twitter.com/ILRCclSH4b,,,#,4.73159E+17,https://twitter.com/mnewtonPharmD/status/473159392893075456,,,,
SheldonLHolder,6/1/2014 13:49,0,0,What happened at the ASCO meeting Saturday http://wp.me/pdkiw-58A via @ NewPCaInfoLink # ASCO14,,@,#,4.73159E+17,https://twitter.com/SheldonLHolder/status/473159359304708100,,,,
gorskon,6/1/2014 13:48,0,0,". @ drattai @ rsm2800 @ obogler @ mtmdphd Of course, @ asco will *never* invite me to be on such a panel. I'm too disruptive & critical. # ASCO14",,@ @ @ @ @,#,4.73159E+17,https://twitter.com/gorskon/status/473159281521745921,,,,
ASCOPost,6/1/2014 13:48,10,2,Drug combination extends survival by more than a year in metastatic prostate cancer (via @ DanaFarber) http://ow.ly/xuKFg # ASCO14 # pcsm,,@,# #,4.73159E+17,https://twitter.com/ASCOPost/status/473159264610320384,,,,
Mills_I,6/1/2014 13:48,0,0,Tribute panel-Selma Schimmel originated pt centered care getting patients and HCPs talking together. Improving communication+care. # ASCO14,,,#,4.73159E+17,https://twitter.com/Mills_I/status/473159195769188354,,,,
ChiariTracy,6/1/2014 13:48,0,0,Researchers Provide Update on Phase II Trial of Vaccine for Malignant Brain Tumors http://www.newswise.com/articles/researchers-to-provide-update-on-phase-ii-trial-of-vaccine-for-malignant-brain-tumors#.U4tmymkX5nU.twitter … @ PatientsFCR @ ASCO @ smartpatients,,@ @ @,#,4.73159E+17,https://twitter.com/ChiariTracy/status/473159121563181057,,,,
jdflaysakier,6/1/2014 13:47,7,3,En ligne à 20h 30 un article sur 2 avancées importantes qui concernent les cancers du sein et de la prostate # ASCO14 http://docteurjd.com,,,#,4.73159E+17,https://twitter.com/jdflaysakier/status/473158816629264384,,,,
PinkSheetMaryJo,6/1/2014 13:46,1,0,"Need to stimulate inflammation and immunity in tumor micro environment, Ferris says, not just inhibit checkpoints # ASCO14",,,#,4.73159E+17,https://twitter.com/PinkSheetMaryJo/status/473158769296162817,,,,
susanhosbach,6/1/2014 13:46,0,0,Fertility preservation is still not offered to the majority of young adult cancer survivors. @ vitaloptions # ASCO14,,@,#,4.73159E+17,https://twitter.com/susanhosbach/status/473158708965699584,,,,
tgunninkEBD,6/1/2014 13:46,0,0,Blurry but fascinating. Life expectancy decreases as you travel east on London's tube by neighborhood # ASCO14 pic.twitter.com/bAVIJBZ9DH,,,#,4.73159E+17,https://twitter.com/tgunninkEBD/status/473158681635209217,,,,
ASCOPost,6/1/2014 13:46,7,2,Bortezomib Combination Significantly Improves PFS in Newly Diagnosed Mantle Cell Lymphoma http://ow.ly/xuKsS # ASCO14 # lylsm,,,# #,4.73159E+17,https://twitter.com/ASCOPost/status/473158605441888256,,,,
jrgralow,6/1/2014 13:46,5,4,"With Gertrude, Philippa, Betty, & Olajumoke from Rwanda, Uganda, & Nigeria at @ ASCO patient advocate lounge # ASCO14 pic.twitter.com/RLA5zGTT7C",,@,#,4.73159E+17,https://twitter.com/jrgralow/status/473158575150624768,,,,
chris1mcb,6/1/2014 13:45,1,0,# ASCO14 - How Scientific Collaboration Can Improve Our Approach To Fighting # Cancer http://ow.ly/xuH9S via @ Forbes,,@,# #,4.73158E+17,https://twitter.com/chris1mcb/status/473158362784620544,,,,
SamBrownInc,6/1/2014 13:45,0,0,RT @ ASCO: . @ CliffordHudis talks # ASCO14 plenary papers w/ @ CBSEveningNews. Airs tonight at 6pm EST.pic.twitter.com/8smbP4IdiJ,,@ @ @,#,4.73158E+17,https://twitter.com/SamBrownInc/status/473158357453242368,,,,
GenomicHealth,6/1/2014 13:45,0,1,Decision impact study in # DCIS shows # Oncotype DX DCIS Score changes recommendations in 1 out of 3 pts: http://bit.ly/1n0AkhX # ASCO14 $ GHDX,,,# # #,4.73158E+17,https://twitter.com/GenomicHealth/status/473158328777211904,,,,
ASCO,6/1/2014 13:45,10,2,Nobel Laureate Harald zur Hausen to speak on oncoviruses at today's Plenary Session http://bit.ly/1pxpPpj # ASCO14,,,#,4.73158E+17,https://twitter.com/ASCO/status/473158327632162817,,,,
ALLIANCE_org,6/1/2014 13:45,0,0,1st results of phase 3 ALTTO trial (BIG 2-06; NCCTG N063D) to be presented in # ASCO14 plenary session http://bit.ly/1tzuNjc # AllianceNCTN,,,# #,4.73158E+17,https://twitter.com/ALLIANCE_org/status/473158301296103424,,,,
myriadgenetics,6/1/2014 13:45,1,1,Watch this video to find out more about # BRCA1 and # BRCA2 # genetictesting! http://bit.ly/1dgAjP9 # hereditarycancer # ASCO14 # ovariancancer,,,# # # # # #,4.73158E+17,https://twitter.com/myriadgenetics/status/473158285193797633,,,,
ecancer,6/1/2014 13:44,5,1,Prof Pagani: Adjuvant exemestane plus ovarian function suppression preferable to tamoxifen in breast cancer # ASCO14 pic.twitter.com/JU2Q8lUU3N,,,#,4.73158E+17,https://twitter.com/ecancer/status/473158272287911937,,,,
PinkSheetMaryJo,6/1/2014 13:43,0,0,"Need to resolve cut-points for PD-L1 expression, Ferris tells # ASCO14",,,#,4.73158E+17,https://twitter.com/PinkSheetMaryJo/status/473158015877935104,,,,
SheldonLHolder,6/1/2014 13:43,0,1,# ASCO14 - Poster: ARN-509 in patients with metastatic castration-resistant # prostatecancer http://www.urotoday.com/mCRPC-Treatment/asco14-poster-arn-509-in-patients-with-metastatic-castration-resistant-prostate-cancer-with-and-without-prior-abiraterone-acetate-treatment.html … via @ urotoday,,@,# #,4.73158E+17,https://twitter.com/SheldonLHolder/status/473157987859582977,,,,
salutedomani,6/1/2014 13:43,0,0,"Tumore al polmone, la combinazione bevacizumab-erlotinib prolunga la sopravvivenza # asco2014 http://lnkd.in/d5bH6mX",,,#,4.73158E+17,https://twitter.com/salutedomani/status/473157956498771969,,,,
BIOTECH888,6/1/2014 13:43,1,1,Olaparib + Cediranib combo Significantly Improves Progression-Free Survival in Recurrent Ovarian Cancer # ASCO14 http://am.asco.org/combination-olaparib-and-cediranib-significantly-improves-progression-free-survival-recurrent …,,,#,4.73158E+17,https://twitter.com/BIOTECH888/status/473157954724573186,,,,
EIannelli,6/1/2014 13:43,2,2,# ASCO14 conclusioni e suggerimenti x gestione invecchiamento precoce ex malati # cancro @ favo_it @ InsControCancropic.twitter.com/4dVTg6W0Jb,,@ @,# #,4.73158E+17,https://twitter.com/EIannelli/status/473157938178060289,,,,
SamBrownInc,6/1/2014 13:43,0,0,RT @ Boehringer BLOG POST: Our social media summary of # ASCO14 day 2 # lungcancer http://bit.ly/1m1cLSF,,@,# #,4.73158E+17,https://twitter.com/SamBrownInc/status/473157911741751296,,,,
OphiraG,6/1/2014 13:43,0,0,"Importance of public discourse 2 foster honest debate re: HTAs, perceptions re: (false) promise of new cancer Rx , can we say NO? @ ASCO",,@,,4.73158E+17,https://twitter.com/OphiraG/status/473157865243680768,,,,
ConquerCancerFd,6/1/2014 13:43,1,2,"Big news, # ASCO14 – Raj Mantena, RPh has agreed to match all gifts to @ iConquerCancer up to $1mm! Donate here: http://bit.ly/1ryX3GR",,@,#,4.73158E+17,https://twitter.com/ConquerCancerFd/status/473157836319760385,,,,
sammyuill,6/1/2014 13:43,0,0,I am in this video! “ @ Gene_Antibody: Phew! Amazing first day at # asco14 I'm exhausted. # blisterwalk http://Instagram.com/p/orbOj1w9zn/ ”,,@,# #,4.73158E+17,https://twitter.com/sammyuill/status/473157834809815041,,,,
davidgrahammd,6/1/2014 13:42,0,1,Practice changing studies starting soon in Plenary Session # ASCO14,,,#,4.73158E+17,https://twitter.com/davidgrahammd/status/473157718887264258,,,,
PhRMA,6/1/2014 13:42,1,0,Most # HIX plans are increasing out of pocket costs & limiting access to prescription meds for patients http://onphr.ma/TRMIal # ASCO14,,,# #,4.73158E+17,https://twitter.com/PhRMA/status/473157589715255296,,,,
CareAcross,6/1/2014 13:42,0,0,Emotional celebration of Selma Schimmel's contribution to Advocacy In Action @ vitaloptions at # ASCO14 pic.twitter.com/g2XkrCsZ2f,,@,#,4.73158E+17,https://twitter.com/CareAcross/status/473157557876719616,,,,
megtirrell,6/1/2014 13:42,3,2,@ FoundationATCG has its own golf cart at # asco14. Obviously a selfie w @ danbudwick had to happenpic.twitter.com/U5VNV18Wa3,,@ @,#,4.73158E+17,https://twitter.com/megtirrell/status/473157537366147072,,,,
Tony_Calles,6/1/2014 13:41,0,0,Anti-mesothelin vaccine shows preliminary impressive responses in mesothelioma # ASCO14 # lcsmpic.twitter.com/affBFEnqOn,,,# #,4.73157E+17,https://twitter.com/Tony_Calles/status/473157329656238080,,,,
AneesChagpar,6/1/2014 13:40,2,3,"My selfie tweet w/ @ YaleTomLynch @ YaleCancer in @ AACR brochure @ ASCO -- retweet in print""? @ JeffreyLMolter # ASCO14 pic.twitter.com/vYugNpFvqP""",,@ @ @ @ @,#,4.73157E+17,https://twitter.com/AneesChagpar/status/473157253395415040,,,,
JanssenUS,6/1/2014 13:40,4,3,Visit booth 18097 at # ASCO2014 and take a # selfie on the moon with # GoogleGlass,,,# # #,4.73157E+17,https://twitter.com/JanssenUS/status/473157085996535808,,,,
TargetedOnc,6/1/2014 13:40,1,1,"Adding Goserelin to Chemotherapy Helps to Preserve Fertility, Prolong Survival in Women With Breast Cancer http://www.targetedonc.com/conference/asco-2014/Adding-Goserelin-to-Chemotherapy-Helps-to-Preserve-Fertility-Prolong-Survival … # ASCO14",,,#,4.73157E+17,https://twitter.com/TargetedOnc/status/473157075074580481,,,,
lexphibi,6/1/2014 13:39,2,1,“ @ bmsnews: Ever wonder what a T cell looks like? Check out this 3D image from our # ImmunoOncology booth 7081 # ASCO14 pic.twitter.com/Z2QBQFCzNN”,,@,# #,4.73157E+17,https://twitter.com/lexphibi/status/473156925430198273,,,,
Cancer_Genetics,6/1/2014 13:39,2,1,CGI is celebrating National # Cancer # Survivor month. Lonnie talks about the survivors who inspire her. # ASCO2014 https://www.youtube.com/watch?v=Hbd0d-un3Wk …,,,# # #,4.73157E+17,https://twitter.com/Cancer_Genetics/status/473156917444231168,,,,
WinshipAtEmory,6/1/2014 13:39,0,1,Winship Deputy Director @ DrFadloKhuri talked with @ OncLive about lung cancer survivorship. # ASCO14 pic.twitter.com/aAFqZLHyo6,,@ @,#,4.73157E+17,https://twitter.com/WinshipAtEmory/status/473156845839073280,,,,
OphiraG,6/1/2014 13:38,1,0,"Lively panel discussion @ asco session on health systems, affordability & sustainability # cancer carepic.twitter.com/wyebIagVke",,@,#,4.73157E+17,https://twitter.com/OphiraG/status/473156689852911617,,,,
DrLisaCurcio,6/1/2014 13:38,1,1,“ @ drattai: Genetic counseling for young women at risk for HBOC via @ LurieCancer # asco14 # bcsm (1/3) pic.twitter.com/Jn4W7K9tjb”,,@ @,# #,4.73157E+17,https://twitter.com/DrLisaCurcio/status/473156604859150336,,,,
GillesThoni,6/1/2014 13:38,1,0,2 étud au congrès de @ ASCO sur l'effet de l'exercice ds les récidives du cancer du sein http://meetinglibrary.asco.org/content/128774-144 … & http://medicine.yale.edu/cancer/news/article.aspx?id=7483 …,,@,,4.73157E+17,https://twitter.com/GillesThoni/status/473156550270648321,,,,
RD_Catherine,6/1/2014 13:38,0,0,"Fatigue after cancer treatment http://bit.ly/1kmm0jF Possible causes, assessment and treatment options from @ ASCO",,@,,4.73157E+17,https://twitter.com/RD_Catherine/status/473156543685591040,,,,
ASCOPost,6/1/2014 13:37,7,3,Research Shows Overall Survival Benefit for Patients w/Stage III Soft Tissue Sarcomas (via @ FoxChaseCancer) http://ow.ly/xuJYM # ASCO14,,@,#,4.73156E+17,https://twitter.com/ASCOPost/status/473156477717594112,,,,
EIannelli,6/1/2014 13:36,2,2,# ASCO14 accelerated ageing risk 4 cancer survivors! Collaboration between oncologist & family doctor @ cancereupic.twitter.com/DX286Rjexm,,@,#,4.73156E+17,https://twitter.com/EIannelli/status/473156154952933378,,,,
NormandBlais,6/1/2014 13:36,0,1,26% PR and 39% minor resp in 2nd-line Rx for recurrent thymic CA with sunitinib. 20% PR with everolimus. # LCCatASCO # ASCO14 # defirespire,,,# # #,4.73156E+17,https://twitter.com/NormandBlais/status/473156072874594304,,,,
UCCancerCenter,6/1/2014 13:35,2,1,Impressive early phase Ib data HPV- and HPV+ HNSCC patients with Pembrolizumab (MK-3475) immunotherapy presented by Tanguy Seiwert # ASCO14,,,#,4.73156E+17,https://twitter.com/UCCancerCenter/status/473155821485191168,,,,
Boehringer,6/1/2014 13:35,1,0,POLL: Take part in our poll and tell us what are the biggest challenges faced by # lungcancer patients http://bit.ly/1iI0ly9 # ASCO14,,,# #,4.73156E+17,https://twitter.com/Boehringer/status/473155816338771968,,,,
ASCO,6/1/2014 13:35,3,0,Use Virtual Meeting on Demand to preview select # ASCO14 presentations http://bit.ly/1oKjSW0,,,#,4.73156E+17,https://twitter.com/ASCO/status/473155796709441536,,,,
genentech,6/1/2014 13:35,2,1,Need a break? Watch a video of day 1! RT @ Gene_Antibody: Phew! Amazing day at # asco14. I'm exhausted. http://instagram.com/p/orbOj1w9zn/ # blisterwalk,,@,# #,4.73156E+17,https://twitter.com/genentech/status/473155791118422016,,,,
GustaveRoussy,6/1/2014 13:34,2,0,# ASCO14 # video : le Pr Soria @ gustaveroussy explique les résultats prometteurs d'un essai précoce sur le lucitanib https://vimeo.com/97050502,,@,# #,4.73156E+17,https://twitter.com/GustaveRoussy/status/473155730368102400,,,,
Tony_Calles,6/1/2014 13:34,0,2,Riely on thymic cancer poster discussion: nice promising therapies. # ASCO14 # lcsmpic.twitter.com/cwvpxk1Nau,,,# #,4.73156E+17,https://twitter.com/Tony_Calles/status/473155534737375233,,,,
DrStelling,6/1/2014 13:34,0,0,@ NTConnell Talk is cheap in health. Resources- both qualified staff and equipment- are not. # ASCO14,,@,#,4.73156E+17,https://twitter.com/DrStelling/status/473155525648322561,,,,
aftimosp,6/1/2014 13:33,2,1,Prelinical data suggest that polo-like kinase 1 (PLK1)might be a target to reverse endocrine resistance in # BreastCancer # ASCO14,,,# #,4.73156E+17,https://twitter.com/aftimosp/status/473155508870709249,,,,
JackWestMD,6/1/2014 13:33,0,1,Thomas: sunitinib leads to 26% response rate & median PFS of 7 months in previously treated thymic carcinoma. # ASCO14,,,#,4.73155E+17,https://twitter.com/JackWestMD/status/473155470467665921,,,,
PinkSheetMaryJo,6/1/2014 13:33,2,1,MK-3475 in head & neck conclusions; Ph III starting soon # ASCO14 pic.twitter.com/86xIVkF6Is,,,#,4.73155E+17,https://twitter.com/PinkSheetMaryJo/status/473155441338621953,,,,
gorskon,6/1/2014 13:32,0,1,"Follow me, # ASCO14. I command you. (How can you resist an invitation like that? :-) )",,,#,4.73155E+17,https://twitter.com/gorskon/status/473155247381426176,,,,
fischmd,6/1/2014 13:32,6,2,What value is the physical exam in advanced # cancer patients? Pts perceive it positively! http://ow.ly/xuJzh # hpm # ASCO14,,,# # #,4.73155E+17,https://twitter.com/fischmd/status/473155078493581313,,,,
NTConnell,6/1/2014 13:32,1,1,Global oncology session at # ASCO14 discusses theories about disparities but very little in practical applied solutions/measurable outcomes.,,,#,4.73155E+17,https://twitter.com/NTConnell/status/473155074337042432,,,,
DrAttai,6/1/2014 13:32,1,0,“ @ TomVargheseJr: Impressive RT @ ASCO: # ASCO14 Tweetup. Thanks to all for attending. We're grateful. http://ow.ly/i/5KLDk ” it was also fun!,,@ @,#,4.73155E+17,https://twitter.com/DrAttai/status/473155047619301376,,,,
Progeny,6/1/2014 13:31,0,0,"Cancer family history vital in assessing need for # GeneticCounseling, but documentation often incomplete. # ASCO14 http://am.asco.org/cancer-family-history-vital-assessing-need-genetic-counseling …",,,# #,4.73155E+17,https://twitter.com/Progeny/status/473154962646528000,,,,
KUhlendorf,6/1/2014 13:31,2,0,Collaborative progress against # cancer on display at # ASCO14 underscores need for pro-innovation policies/regs pic.twitter.com/IG8Iy5ZcPj,,,# #,4.73155E+17,https://twitter.com/KUhlendorf/status/473154792252903424,,,,
genentech,6/1/2014 13:30,4,2,Take a break from sessions & target some tumors. Play our immunotherapy game & learn abt what's next: http://ow.ly/xuIWG # ASCO14,,,#,4.73155E+17,https://twitter.com/genentech/status/473154721688342530,,,,
OncLive,6/1/2014 13:30,0,1,"John C. Byrd, MD, discusses the comparison of ofatumumab to ibrutinib in patients with relapsed CLL http://ow.ly/xub61 # ASCO14",,,#,4.73155E+17,https://twitter.com/OncLive/status/473154676918325248,,,,
ASCO,6/1/2014 13:30,6,1,“Do Some Human Cancers Originate from Infections Transmitted from Domestic Animals?”—Harald zur Hausen MD of @ DKFZ @ 1 pm N Hall B1 # ASCO14,,@ @,#,4.73155E+17,https://twitter.com/ASCO/status/473154667044933632,,,,
TomVargheseJr,6/1/2014 13:30,0,0,Impressive RT @ ASCO: # ASCO14 Tweetup. Thanks to all for attending. We're grateful. http://ow.ly/i/5KLDk,,@,#,4.73155E+17,https://twitter.com/TomVargheseJr/status/473154653484351489,,,,
SanofiUS,6/1/2014 13:30,0,2,"For the latest in # oncology news and research this week, be sure to follow # ASCO14 pic.twitter.com/wAHgNV3WD7",,,# #,4.73155E+17,https://twitter.com/SanofiUS/status/473154649831530497,,,,
PDRennert,6/1/2014 13:30,0,0,"MK-3475 moving to phase 3 in head and neck cancer, a notoriously difficult tumor. Early data encouraging. Anti-PD-L1. # ASCO14",,,#,4.73155E+17,https://twitter.com/PDRennert/status/473154648866836481,,,,
LguzzardiM,6/1/2014 13:29,0,1,"Multiple Studies Presented # ASCO14 Unique, Practice-Changing Impact of Oncotype DX® to Optimize BC Care http://investor.genomichealth.com/releaseDetail.cfm?releaseID=851610 …",,,#,4.73154E+17,https://twitter.com/LguzzardiM/status/473154447921930240,,,,
JackWestMD,6/1/2014 13:29,0,1,"The always excellent @ RielyMD speaking on novel treatments for thymoma , thymic carcinoma, & mesothelioma. Tough job. # ASCO14",,@,#,4.73154E+17,https://twitter.com/JackWestMD/status/473154443123253248,,,,
ipaulmampilly,6/1/2014 13:29,0,0,# ASCO14 cancer journey through poetry and art pic.twitter.com/cTVTH53J2o,,,#,4.73154E+17,https://twitter.com/ipaulmampilly/status/473154336726716416,,,,
dmooneymd,6/1/2014 13:29,0,0,Multiple randomized studies show prophylactic anticonvulsant not effective in preventing first seizure. Not recommended. # ASCO14,,,#,4.73154E+17,https://twitter.com/dmooneymd/status/473154328807886848,,,,
DrAttai,6/1/2014 13:29,0,0,@ gorskon @ rsm2800 @ obogler @ mtmdphd @ ASCO great - looking forward to meeting,,@ @ @ @ @,,4.73154E+17,https://twitter.com/DrAttai/status/473154308742340609,,,,
mcbennett6,6/1/2014 13:28,0,1,RT @ SU2C: Happy National Cancer Survivors Day! Who do you stand up for? # ASCO14,,@,#,4.73154E+17,https://twitter.com/mcbennett6/status/473154146913492992,,,,
gorskon,6/1/2014 13:28,0,0,@ drattai @ rsm2800 @ obogler @ mtmdphd @ asco Sounds like a plan.,,@ @ @ @ @,,4.73154E+17,https://twitter.com/gorskon/status/473154095587790850,,,,
rdoebele,6/1/2014 13:28,1,0,"@ ConsanoScott Significant because this is me & Charlie Rudin, who sparked my interest in lung cancer in back in 2001. # ASCO2014",,@,#,4.73154E+17,https://twitter.com/rdoebele/status/473154080408625152,,,,
EIannelli,6/1/2014 13:28,2,3,# ASCO14 rischio invecchiamento precoce x ex malati di # cancro necessaria collaborazione medico di famiglia e oncologopic.twitter.com/M0AJsjStBC,,,# #,4.73154E+17,https://twitter.com/EIannelli/status/473154044492390402,,,,
ipaulmampilly,6/1/2014 13:27,0,0,# ASCO14 cancer journey through art pic.twitter.com/0xCycnm5CO,,,#,4.73154E+17,https://twitter.com/ipaulmampilly/status/473153981880213506,,,,
BIOARRAYMDx,6/1/2014 13:27,0,1,New targets show promised for ER-positive metastatic breast cancer # ASCO2014,,,#,4.73154E+17,https://twitter.com/BIOARRAYMDx/status/473153928599592960,,,,
djsampson,6/1/2014 13:27,2,0,Drug prices in the spotlight. @ LesleyRStahl of @ 60Minutes visits # ASCO14 pic.twitter.com/REVMaGF9dV,,@ @,#,4.73154E+17,https://twitter.com/djsampson/status/473153770365276160,,,,
ipaulmampilly,6/1/2014 13:27,0,0,# ASCO14 cancer journey through art pic.twitter.com/GwttNvWfc7,,,#,4.73154E+17,https://twitter.com/ipaulmampilly/status/473153769107357696,,,,
gorskon,6/1/2014 13:27,1,1,". @ drattai Like # ASCO14 discussion on obesity, diet, & cancer because so many attack conventional"" medicine for not addressing these issues.""",,@,#,4.73154E+17,https://twitter.com/gorskon/status/473153757703045120,,,,
ipaulmampilly,6/1/2014 13:26,0,0,# ASCO14 cancer journey through art pic.twitter.com/90SOWU6WA5,,,#,4.73154E+17,https://twitter.com/ipaulmampilly/status/473153538441609216,,,,
DrBobGoldberg,6/1/2014 13:25,1,1,. @ CliffordHudis Income inequality& disparities in cancer care getting worse in UK & Europe!! Yet @ asco wants to adopt this 'social justice',,@ @,,4.73153E+17,https://twitter.com/DrBobGoldberg/status/473153499879182336,,,,
TriageCancer,6/1/2014 13:25,1,0,Day 2 of # ASCO14 well underway! Enjoyed catching up with @ YSCBuzz @ kirklsp @ DiplomatRx @SURVIVORVILLE @ ThePinkFundpic.twitter.com/j3T9yDWMlC,,@ @ @ @SURVIVORVILLE @,#,4.73153E+17,https://twitter.com/TriageCancer/status/473153479306137600,,,,
CBPartners,6/1/2014 13:25,1,1,US ranks highest on cost related access problems in cancer among European countries- Richard Sullivan # ASCO14 pic.twitter.com/5MwmEu7Rif,,,#,4.73153E+17,https://twitter.com/CBPartners/status/473153443373522945,,,,
teamoncology,6/1/2014 13:25,0,0,Thanks. RT @nextprinciples: @ teamoncology Your dog looks a cutie &amp; well trained. You shouldn't have a problem. # ASCO14,,@nextprinciples @,#,4.73153E+17,https://twitter.com/teamoncology/status/473153425505394688,,,,
DrAttai,6/1/2014 13:25,0,0,@ gorskon @ rsm2800 @ obogler @ mtmdphd @ ASCO I will be at that session too - make sure we meet!,,@ @ @ @ @,,4.73153E+17,https://twitter.com/DrAttai/status/473153397403557889,,,,
joseluis_pa,6/1/2014 13:25,1,0,MT “ @ djsampson: Colditz: chart: cancers attributed to obesity # asco14 pic.twitter.com/3rusfplSck”. 17% breast cancers attributed to obesity,,@,#,4.73153E+17,https://twitter.com/joseluis_pa/status/473153339258318848,,,,
SanofiUS,6/1/2014 13:25,0,0,"RT @ ASCO: Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1pJDiYs",,@,#,4.73153E+17,https://twitter.com/SanofiUS/status/473153268626255872,,,,
Mills_I,6/1/2014 13:25,2,2,Remembering Selma Schimmel-Vital Options founder+started movement for young adults with cancer in the early 80's. # ASCO14 @ CancerSupportCm,,@,#,4.73153E+17,https://twitter.com/Mills_I/status/473153265430171648,,,,
PAscierto,6/1/2014 13:25,1,1,New opportunity for NRAS mutated melanoma patients from the results of phase 1/2 study of binimetinub plus LEE011 # ASCO14 @ Oncoinfo_it,,@,#,4.73153E+17,https://twitter.com/PAscierto/status/473153264494837761,,,,
TGeorgeMD,6/1/2014 13:24,0,3,Long awaited for practice MT @ ALLIANCE_org: CALGB/ @ SWOG 80405 results today Plenary Session http://bit.ly/T3TuJB # ASCO14 @ NRGonc # crcsm,,@ @ @,# #,4.73153E+17,https://twitter.com/TGeorgeMD/status/473153236317528064,,,,
HenkJanOut,6/1/2014 13:24,7,1,Ondertussen gebeurt er erg veel op # ASCO14 Veel nieuws op gebied nieuwe kankergeneesmiddelen,,,#,4.73153E+17,https://twitter.com/HenkJanOut/status/473152999964299264,,,,
dmooneymd,6/1/2014 13:23,0,0,20% of pts with cns disease have vte's. Intracranial hemorrhage rate very low with anticoagulant. No data for new oral drugs. # ASCO14,,,#,4.73153E+17,https://twitter.com/dmooneymd/status/473152931865563136,,,,
ERPlimackMD,6/1/2014 13:23,0,0,Dr. Siewert: 78% of screened head and neck patients had 1-100% PDL1 IHC staining in tumor or stroma. # hncsm # ASCO14,,,# #,4.73153E+17,https://twitter.com/ERPlimackMD/status/473152908502921216,,,,
ipaulmampilly,6/1/2014 13:23,0,0,# ASCO14 back to cost vs benefit debate pic.twitter.com/RvXEDlHQYh,,,#,4.73153E+17,https://twitter.com/ipaulmampilly/status/473152862345003009,,,,
DrMiguelPerales,6/1/2014 13:22,0,0,@ mtmdphd any insight (no pun intended) why SGN-CD19a causes eye tox? # ASCO14,,@,#,4.73153E+17,https://twitter.com/DrMiguelPerales/status/473152686599442432,,,,
EIannelli,6/1/2014 13:22,2,1,Da # ASCO14 necessario piano oncologico x i lungosopravviventi! @ favo_it @ InsControCancro @ ailar_it @ SCinieri @ CesareFassari @ fiorellatosoni,,@ @ @ @ @ @,#,4.73153E+17,https://twitter.com/EIannelli/status/473152668873928705,,,,
Merck,6/1/2014 13:22,4,3,“Data at @ ASCO underscores why Merck is advancing a broad development program including late-stage studies in 4 tumor types.” -Dr. Baynes,,@,,4.73153E+17,https://twitter.com/Merck/status/473152629606842369,,,,
jmboyce,6/1/2014 13:22,0,0,Fantastic recap on the latest in melanoma research and treatment from # ASCO2014 http://am.asco.org/recent-explosion-progress-melanoma-management-catalyst-change-future-directions-research …,,,#,4.73153E+17,https://twitter.com/jmboyce/status/473152552343973890,,,,
gorskon,6/1/2014 13:22,0,0,@ rsm2800 I have to leave early today to visit my new nephew. ( # ASCO14 vs. new baby: Baby wins every time.) I'll be around all day tomorrow.,,@,#,4.73153E+17,https://twitter.com/gorskon/status/473152512653279233,,,,
nycdoc29,6/1/2014 13:22,0,0,“@GSK_conferences: Dr Sullivan: Economics is 1 aspect of cancer access # ASCO14” - increasingly & unfortuantely it's a gate keeper too often,,@GSK_conferences,#,4.73153E+17,https://twitter.com/nycdoc29/status/473152511432728576,,,,
dhjutsw1,6/1/2014 13:21,2,2,"# ASCO14 abst#7523 PARPi w Cis+E in SCLC called promising"". Numbers small", OR not better," OS 9.7 mo & >toxicity. Not that exciting.""",,,# #7523,4.73152E+17,https://twitter.com/dhjutsw1/status/473152401679982592,,
PhRMA,6/1/2014 13:21,0,0,# Patients must be partners in assessing value & cost.says @ leukemiamda @ LillyPad @ myUHC via @ TheHill http://bit.ly/1tv1yxW # ASCO14,,@ @ @ @,# #,4.73152E+17,https://twitter.com/PhRMA/status/473152290539327489,,,,
RamalingamMD,6/1/2014 13:20,1,2,Adjuvant EGFR TKI for early stage NSCLC pts with mutation? Not so fast..... # lcsm # ASCO14,,,# #,4.73152E+17,https://twitter.com/RamalingamMD/status/473152166744821760,,,,
gorskon,6/1/2014 13:20,0,1,". @ mparish243 Well, it has to be more benign. It's a report of a session at # ASCO14. Unfortunately, the thinking isn't sufficiently different",,@,#,4.73152E+17,https://twitter.com/gorskon/status/473152131399430145,,,,
CancerDotNet,6/1/2014 13:20,4,2,Videos: @ ASCO President Dr. Clifford Hudis @ CliffordHudis on today's scientific headlines from # ASCO14 http://bit.ly/1mW8p2w,,@ @,#,4.73152E+17,https://twitter.com/CancerDotNet/status/473152068262584320,,,,
DCarrizosaMD,6/1/2014 13:20,0,0,Poster discuss # ASCO14 - small cell: encouraging phase I study of PARP +Chemo showing safety and + signal - ? Future directions # LCI,,,# #,4.73152E+17,https://twitter.com/DCarrizosaMD/status/473152012163366914,,,,
LiveStrongCat7,6/1/2014 13:20,0,1,@ LIVESTRONGCEO MT @ MedscapeOnc Schilsky patient engagement'll b 4th revolution affectin future of cancer care # ASCO14 pic.twitter.com/7z8UH35AHU,,@ @,#,4.73152E+17,https://twitter.com/LiveStrongCat7/status/473152004412276737,,,,
JRFess05,6/1/2014 13:19,0,0,Great 3D image of a T Cell MT: # ImmunoOncology # ASCO14 pic.twitter.com/UwglivAJ6s,,,# #,4.73152E+17,https://twitter.com/JRFess05/status/473151925056471042,,,,
EIannelli,6/1/2014 13:19,3,4,# ASCO14 we need # cancer suvivorship care plan! @ favo_it @ ACSNews @ InsControCancro @ cancereu @ kgapo @ ManuelaPerrone @ marghiadnsal @ mritamon,,@ @ @ @ @ @ @ @,# #,4.73152E+17,https://twitter.com/EIannelli/status/473151768910495746,,,,
oncologyTVfeed,6/1/2014 13:19,0,0,Conducting interviews with poster presenters at Booth #20126 at # ASCO14--Come by the booth to say hi to Oncology.TV! pic.twitter.com/Td6PKYopnv,,,#20126 #,4.73152E+17,https://twitter.com/oncologyTVfeed/status/473151764934295552,,,,
gorskon,6/1/2014 13:19,0,0,"@ drattai It is always about me, you know. :-) Anyway I find the concept of mouse avatars interesting, but a long run for short slide # ASCO14",,@,#,4.73152E+17,https://twitter.com/gorskon/status/473151744898502656,,,,
Cancer_Cell,6/1/2014 13:18,2,1,The clinical results were also presented this morning # ASCO14.,,,#,4.73152E+17,https://twitter.com/Cancer_Cell/status/473151586890301441,,,,
MOCBrasil,6/1/2014 13:17,0,0,Somos os primeiros da fila para a plenária! Acompanhe MOCnaASCO e fique sabendo em tempo real os result da # ASCO2014 pic.twitter.com/4WbNjxsB3N,,,#,4.73151E+17,https://twitter.com/MOCBrasil/status/473151363942449152,,,,
QIAGENscience,6/1/2014 13:17,1,1,BCR-ABL1 Mbc: Avoid intra and inter lab variations. Visit our booth #5013 to learn more. # ASCO14,,,#5013 #,4.73151E+17,https://twitter.com/QIAGENscience/status/473151321571594240,,,,
politikaterina,6/1/2014 13:16,0,0,Half-marathon done! Now off to # ASCO14 # Exercise+researchtobeatcancer @ YaleCancer @ ASCO,,@ @,# #,4.73151E+17,https://twitter.com/politikaterina/status/473151164230680576,,,,
dmooneymd,6/1/2014 13:16,0,0,Steroids may not be needed for small lesion mets (less edema). Dosing dex 4-8 mg daily. Improvement within 24 hrs. # ASCO14,,,#,4.73151E+17,https://twitter.com/dmooneymd/status/473151147096940544,,,,
gorskon,6/1/2014 13:16,0,0,"This one's for you, @ david_colquhoun. Quackademic acupuncture session at # ASCO14: http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter … @ drattai",,@ @,# #,4.73151E+17,https://twitter.com/gorskon/status/473150997318340608,,,,
urotoday,6/1/2014 13:15,1,0,"# ASCO14 Androgen Receptor Amplification mCRPC Patients Refractory to AA or Enz. Listen to interview w/ Eric Small, MD http://bit.ly/1mGeHS8",,,#,4.73151E+17,https://twitter.com/urotoday/status/473150974782357504,,,,
mcbennett6,6/1/2014 13:15,3,2,"For those tracking # ASCO14, you should follow @ TheSAMFund to find out why # cancerisntfree",,@,# #,4.73151E+17,https://twitter.com/mcbennett6/status/473150951696912385,,,,
DrMiguelPerales,6/1/2014 13:15,0,0,Cancer Survivors: More Than 14.5 Million in US # ASCO14 http://abcnews.go.com/Health/wireStory/cancer-survivors-number-14-million-us-23946226 …,,,#,4.73151E+17,https://twitter.com/DrMiguelPerales/status/473150932725669888,,,,
DrNeilLove,6/1/2014 13:15,0,0,Join us for the 3rd of 4 RTP programs in Chicago tonight as we take a closer look at # NHL and # myeloma. http://bit.ly/15FM0Rr # ASCO14,,,# # #,4.73151E+17,https://twitter.com/DrNeilLove/status/473150869404663809,,,,
ipaulmampilly,6/1/2014 13:15,7,3,# ASCO14 lower breast cancer risk for women following life style recommendations pic.twitter.com/UjJ2yjWqzt,,,#,4.73151E+17,https://twitter.com/ipaulmampilly/status/473150824215228418,,,,
OphiraG,6/1/2014 13:15,3,0,"Can't achieve mort targets 4 # cancer just via prevention/behav change. Need early detection, Rx capacity! @ asco pic.twitter.com/Y24YtdC9h5",,@,#,4.73151E+17,https://twitter.com/OphiraG/status/473150819966402560,,,,
TomVargheseJr,6/1/2014 13:14,1,0,"Amen RT @ genentech: Standardization, guidance & multiplex test may help solve the issue w/ tissue. More: http://ow.ly/xuDvi # ASCO14",,@,#,4.73151E+17,https://twitter.com/TomVargheseJr/status/473150648628699136,,,,
ConsanoMolly,6/1/2014 13:14,4,4,Grateful to celebrate # NationalCancerSurvivorsDay at # ASCO14 sharing how @ consano came out of my # breastcancer dx.pic.twitter.com/t5BfOczVrS,,@,# # #,4.73151E+17,https://twitter.com/ConsanoMolly/status/473150619822612480,,,,
dhjutsw1,6/1/2014 13:14,0,0,@ ASCO # ASCO14 abst#7519 CbE va. CDDP + topotecan in SCLC. Interesting results but recommend sticking w current preferred Rx = CDDP/CBDCA+E.,,@,# #7519,4.73151E+17,https://twitter.com/dhjutsw1/status/473150553724186625,,,,
StormyVNV,6/1/2014 13:14,0,0,@ DrMisialek @ ASCO @ DanaFarber Is # LungCancer really all from Smoking? Burning Shit Canspic.twitter.com/WLUd59FgI6,,@ @ @,#,4.73151E+17,https://twitter.com/StormyVNV/status/473150548594536448,,,,
GustaveRoussy,6/1/2014 13:14,3,0,# ASCO2014 Pr Ducreux @ GustaveRoussy itw: dynamic contrast enhances ultrasonography of the response # colorectal cancerpic.twitter.com/RlxPdNw1ui,,@,# #,4.7315E+17,https://twitter.com/GustaveRoussy/status/473150480932040704,,,,
urotoday,6/1/2014 13:13,1,0,"# ASCO14 Galeterone in Men with CRPC: Results from ARMOR2 Study. Listen to interview w/ Robert Bruce Montgomery, MD http://bit.ly/1mGeiz8",,,#,4.7315E+17,https://twitter.com/urotoday/status/473150447503831040,,,,
RD_Catherine,6/1/2014 13:13,0,0,One for @ thecsp via @ gorskon and @ drattai Check out my bud Steve Novella's article with @ david_colquhoun: http://www.sciencebasedmedicine.org/acupuncture-doesnt-work … … # ASCO14,,@ @ @ @,#,4.7315E+17,https://twitter.com/RD_Catherine/status/473150362489458689,,,,
LoMann7,6/1/2014 13:13,1,0,@rosswmann MT“ @ TheALCF: Ditch the Cancer Stick!! What happens when a smoker quits? # BeatLungCancer # LCSM # ASCO14 https://twitter.com/TheALCF/status/473124603356004353/photo/1pic.twitter.com/ewojMwdhT0 ”,,@rosswmann @,# # #,4.7315E+17,https://twitter.com/LoMann7/status/473150283401265152,,,,
cure_magazine,6/1/2014 13:12,0,0,Celebrating the life of @ vitaloptions Selma Schimmel at # ASCO14,,@,#,4.7315E+17,https://twitter.com/cure_magazine/status/473150180674396161,,,,
PascalMaurel,6/1/2014 13:12,1,0,"Pr A Buzyn:points sur # cancer avant # ASCO14: recherche, th.ciblées, tabac, prévention... # RCFR14 @ Institut_cancer http://bit.ly/1k43wEk",,@,# # #,4.7315E+17,https://twitter.com/PascalMaurel/status/473150063104258048,,,,
_SEOM,6/1/2014 13:12,9,2,# OncoNexion permite a periodistas y oncólogos consultar los resultados dl congreso mundial de Oncología # ASCO14 http://www.onconexion2014.com/,,,# #,4.7315E+17,https://twitter.com/_SEOM/status/473150014647050240,,,,
urotoday,6/1/2014 13:12,0,0,"# ASCO14 Study of Abiraterone Acetate and Docetaxel in Patients with mCRPC. Listen to interview w/ Scott T. Tagawa, MD http://bit.ly/1m3wHo0",,,#,4.7315E+17,https://twitter.com/urotoday/status/473149986109014016,,,,
dmooneymd,6/1/2014 13:12,1,0,"Symptomatic cns disease: the role of steroids, anticoagulant, and anticonvulsant. # ASCO14",,,#,4.7315E+17,https://twitter.com/dmooneymd/status/473149985408962560,,,,
dytcmd,6/1/2014 13:11,3,2,". @ ERPlimackMD @ Lymphoma_Doc Clin trial participt'n needs culture change. Peds onc does it, adults shd too # asco14 http://goo.gl/r89YK3",,@ @,#,4.7315E+17,https://twitter.com/dytcmd/status/473149940710264833,,,,
ipaulmampilly,6/1/2014 13:11,1,1,# ASCO14 genetic testing pitfalls pic.twitter.com/yjOlr78oAR,,,#,4.7315E+17,https://twitter.com/ipaulmampilly/status/473149835944947713,,,,
teamoncology,6/1/2014 13:11,1,2,The question is whether # breastcancer has a targetable gene mutation like melanoma or lung cancer. # BCSM # ASCO14,,,# # #,4.7315E+17,https://twitter.com/teamoncology/status/473149793686937600,,,,
salutedomani,6/1/2014 13:11,0,0,"Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at # ASCO2014 http://bit.ly/1kYM7xc",,,#,4.7315E+17,https://twitter.com/salutedomani/status/473149731665760256,,,,
dermanewsok,6/1/2014 13:11,0,0,"Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at # ASCO2014 http://bit.ly/1mGe2A8",,,#,4.7315E+17,https://twitter.com/dermanewsok/status/473149731581853696,,,,
antoniocaperna,6/1/2014 13:11,0,0,"Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at # ASCO2014 http://bit.ly/1mGe2A8",,,#,4.7315E+17,https://twitter.com/antoniocaperna/status/473149731464433664,,,,
CBPartners,6/1/2014 13:11,0,1,@ WHO 9 targets to reduce the risk of cancer by 2025 # ASCO14 pic.twitter.com/tKyaKIO3Ae,,@,#,4.7315E+17,https://twitter.com/CBPartners/status/473149727618641921,,,,
NormandBlais,6/1/2014 13:10,1,1,"Since last two decades, still no breakthrough for small cell lung cancer… Better not to smoke # LCCatASCO # ASCO14 # defirespire",,,# # #,4.7315E+17,https://twitter.com/NormandBlais/status/473149723730120704,,,,
MMarchioneAP,6/1/2014 13:10,15,5,One of the biggest wins in metastatic cancer ever; drug boosts # prostatecancer survival more than a year. http://tinyurl.com/mdth33r # ASCO14,,,# #,4.7315E+17,https://twitter.com/MMarchioneAP/status/473149719766900736,,,,
urotoday,6/1/2014 13:10,0,0,"# ASCO14 Genomic Analysis of ctDNA in Plasma of mCRPC Patients. Listen to interview w/ Kim Chi, MD http://bit.ly/Sn7CNp",,,#,4.7315E+17,https://twitter.com/urotoday/status/473149652720947200,,,,
DrMisialek,6/1/2014 13:10,1,1,From Smoking Cessation to Targeted Therapy:Progress in LungCancer Research Continues http://am.asco.org/smoking-cessation-targeted-therapy-progress-lung-cancer-research-continues#.U4teOJZn_hk.twitter … @ ASCO @ DanaFarber # ASCO14 # lcsm,,@ @,# # #,4.7315E+17,https://twitter.com/DrMisialek/status/473149616943558656,,,,
teamoncology,6/1/2014 13:10,0,0,【 # ASCO14 101】The other mutations in # BreastCancer is less than 5%. We have not yet found a single gene mutation drive for breast cancer.,,,# #,4.7315E+17,https://twitter.com/teamoncology/status/473149595132776448,,,,
RichardWJoseph,6/1/2014 13:10,0,0,@ ERPlimackMD @ Lymphoma_Doc I expect big increases in trial participants as drugs are more effective and patients are more informed. # ASCO14,,@ @,#,4.7315E+17,https://twitter.com/RichardWJoseph/status/473149545933975552,,,,
LungCancerFaces,6/1/2014 13:10,2,1,“ @ adamfeuerstein: $ CLVS Lung Cancer Bravado Falls Flat With New Diabetes Revelation —> http://www.thestreet.com/story/12728916/1/clovis-lung-cancer-bravado-falls-flat-with-new-diabetes-revelation.html … $ AZN # ASCO14” # LCSM,,@,# #,4.7315E+17,https://twitter.com/LungCancerFaces/status/473149520550064128,,,,
SpringerClinMed,6/1/2014 13:10,1,0,"Interesting abstract from # ASCO14: An analysis of cancer-specific Twitter conversations among physicians in 2013"" http://ow.ly/xr4TB""",,,#,4.7315E+17,https://twitter.com/SpringerClinMed/status/473149512085962753,,,,
ProjectInno,6/1/2014 13:10,0,1,Video: the need to accelerate cancer # innovation: http://ow.ly/xtyQj # ASCO14 # innovatenow,,,# # #,4.7315E+17,https://twitter.com/ProjectInno/status/473149509913288704,,,,
KellyColligan,6/1/2014 13:10,2,1,. @ YaleCancer @ josico99 Decline in federal funding for cancer research is more than disturbing. It's irresponsible. # ASCO14,,@ @,#,4.7315E+17,https://twitter.com/KellyColligan/status/473149504258977792,,,,
Novartis,6/1/2014 13:10,3,3,First presentation of pivotal data for # Novartis # basalcellcarcinoma investigational compound; abstr No.9009a # ASCO14 http://bit.ly/SmSQ9c,,,# # #,4.73149E+17,https://twitter.com/Novartis/status/473149496751575041,,,,
emilygest,6/1/2014 13:10,1,0,". @ StJudeResearch studies health history, physical function & memory issues in # childcancer survivors. # ASCO2014",,@,# #,4.73149E+17,https://twitter.com/emilygest/status/473149487742205952,,,,
CancerTherAdvsr,6/1/2014 13:10,0,0,"RT @ drdonsdizon: # bcsm # ASCO14 Based on POEMS, Goserelin makes sense for women<50y, ER/PR- dz. Should we extrapolate to those w ER/PR+?",,@,# #,4.73149E+17,https://twitter.com/CancerTherAdvsr/status/473149487494750208,,,,
gorskon,6/1/2014 13:09,0,0,. @ drattai Check out my bud Steve Novella's article with @ david_colquhoun: http://www.sciencebasedmedicine.org/acupuncture-doesnt-work … # ASCO14,,@ @,#,4.73149E+17,https://twitter.com/gorskon/status/473149430359523329,,,,
DrMarkham,6/1/2014 13:09,3,0,"Patient-Derived Xenograft Models in Gynecologic Cancers, @ ASCO Ed Book: http://meetinglibrary.asco.org/content/11400258-144 … # gyncsm # ASCO14",,@,# #,4.73149E+17,https://twitter.com/DrMarkham/status/473149419798679553,,,,
teamoncology,6/1/2014 13:09,1,0,【 # ASCO14 101】 PIK3 is the 2nd most common mutation but we do not know the meaning of targeting by PIK3/mTOR inhibitors in # BreastCancer,,,# #,4.73149E+17,https://twitter.com/teamoncology/status/473149384863916033,,,,
dhjutsw1,6/1/2014 13:09,1,0,Gr8 summary of RADIANT & SELECT trials in Kung cancer by Tony Mok. @ ASCO # asco14 pic.twitter.com/pYy7KzzTC6,,@,#,4.73149E+17,https://twitter.com/dhjutsw1/status/473149377444192256,,,,
urotoday,6/1/2014 13:08,1,0,"# ASCO14 15-year Survival Outcomes Following Primary ADT for Localized PCa. Listen to interview w/ Siu-Long Yao, MD http://bit.ly/U5K9BN",,,#,4.73149E+17,https://twitter.com/urotoday/status/473149160862920704,,,,
JeffreyMOtto,6/1/2014 13:08,0,0,LM: # ASCO14 need to be concerned about assay bias - as it may mislead confidence in results...r-squared tests will not reveal assay bias,,,#,4.73149E+17,https://twitter.com/JeffreyMOtto/status/473149069347401729,,,,
DCarrizosaMD,6/1/2014 13:08,1,0,Poster discuss at # ASCO14 :Tony Mok - no OS benefit from adjuvant erlotinib but maybe due to insufficient exposure to drug (+DFS benefit),,,#,4.73149E+17,https://twitter.com/DCarrizosaMD/status/473149059721879552,,,,
n8pennell,6/1/2014 13:07,2,1,Mok: adjuvant erlotinib in EGFR mut+ may improve DFS but no evid of OS benefit yet. Duration (2yrs) of tx prob too short. # ASCO14,,,#,4.73149E+17,https://twitter.com/n8pennell/status/473148963164811264,,,,
gorskon,6/1/2014 13:07,1,2,. @ drattai Not convinced yet? I could provide more. So much more. :-) Acupuncture does not work—for anything. # ASCO14,,@,#,4.73149E+17,https://twitter.com/gorskon/status/473148957745770496,,,,
OphiraG,6/1/2014 13:07,0,0,Global # NoTobaccoDay & other # ncd commitments should be highlighted @ ASCO ! Dr Ullrich @ WHO @ ncdalliance @ uicc,,@ @ @ @,# #,4.73149E+17,https://twitter.com/OphiraG/status/473148938934296576,,,,
ALLIANCE_org,6/1/2014 13:07,2,1,CALGB/SWOG 80405 results will be presented in today's Plenary Session http://bit.ly/T3TuJB # ASCO14 @ ALLIANCE_org @ SWOG,,@ @,#,4.73149E+17,https://twitter.com/ALLIANCE_org/status/473148904410607616,,,,
teamoncology,6/1/2014 13:07,0,1,【 # ASCO14 101】 p53 is the most common mutation but it is still not a clinically relevant target in # breastcancer. # BCSM,,,# # #,4.73149E+17,https://twitter.com/teamoncology/status/473148855379185664,,,,
cancerassassin1,6/1/2014 13:07,0,0,One of my goals today: to finally sort out Apatinib from Afatinib. # medicalterminology # ASCO14,,,# #,4.73149E+17,https://twitter.com/cancerassassin1/status/473148808453685248,,,,
ipaulmampilly,6/1/2014 13:07,0,0,"# ASCO14 organizers need to standardize posters so that abstract nos, study method, conclusion in same place for all posters",,,#,4.73149E+17,https://twitter.com/ipaulmampilly/status/473148774593101824,,,,
maherjend,6/1/2014 13:07,0,0,From Smoking Cessation to Targeted Therapy: Progress in Lung Cancer Research Continues # ASCO14 http://sco.lt/4qLLQP,,,#,4.73149E+17,https://twitter.com/maherjend/status/473148768054181889,,,,
SarahCannon_UK,6/1/2014 13:07,1,0,10 # ASCO14 abstracts with contributions from authors affiliated with us @SCRI UK: http://sarahcannonresearch.co.uk/news/scri-at-2014-asco-annual-meeting/ …pic.twitter.com/WEmi0WyYyZ,,@SCRI,#,4.73149E+17,https://twitter.com/SarahCannon_UK/status/473148747149344768,,,,
nanostringtech,6/1/2014 13:07,0,0,Mayor Rahm Emanuel officially declares June 2014 as “Oncology Month in # Chicago in honor of @ ASCO 50th annual meeting http://bit.ly/TLmJl4,,@,#,4.73149E+17,https://twitter.com/nanostringtech/status/473148741155692546,,,,
gorskon,6/1/2014 13:06,0,0,Attending the # ASCO14 session on mouse avatars. It's an interesting concept. Not yet sure I'm sold—yet. (1/2). http://www.sciencebasedmedicine.org/mouse-avatars-new-predictors-of-response-to-chemotherapy/ …,,,#,4.73149E+17,https://twitter.com/gorskon/status/473148662500306944,,,,
dhjutsw1,6/1/2014 13:06,0,1,# ASCO14 abst#7513 RADIANT Trial EGFRMUT subanalysis group; more ? than answers. Adjuvant EGFR TKI Rx not ready 4 prime time. @ ASCO,,@,# #7513,4.73149E+17,https://twitter.com/dhjutsw1/status/473148598163476480,,,,
AGMednet,6/1/2014 13:06,0,0,AG Mednet is here! # ASCO14 pic.twitter.com/pTIuX8QZbO,,,#,4.73149E+17,https://twitter.com/AGMednet/status/473148592505782272,,,,
FCUroOnc,6/1/2014 13:06,1,1,"Huge paradigm shift MT @ ERPlimackMD: NYTimes: Early Chemo Benefits Men W/Prostate Cancer, OS > 1 year # gusm # asco14 http://nyti.ms/1kllhze",,@,# #,4.73149E+17,https://twitter.com/FCUroOnc/status/473148537078038528,,,,
aftimosp,6/1/2014 13:06,3,0,B. Henessey: We do not understand yet the role of the PI3K pathway in endocrine resistance. # BreastCancer # ASCO14,,,# #,4.73148E+17,https://twitter.com/aftimosp/status/473148479985176576,,,,
GenomicHealth,6/1/2014 13:05,0,3,Studies demonstrate practice-changing impact of # Oncotype to optimize # cancer care http://bit.ly/1n0AkhX # ASCO14 # DCIS # bcsm $ GHDX,,,# # # # #,4.73148E+17,https://twitter.com/GenomicHealth/status/473148399626518528,,,,
OphiraG,6/1/2014 13:05,0,1,Global # NoTobaccoDay & other # ncd commitments should be highlighted @ ASCO ! Dr Ullrich @ WHO @ ncdalliance @ NCDFREE,,@ @ @ @,# #,4.73148E+17,https://twitter.com/OphiraG/status/473148269082976256,,,,
Boehringer,6/1/2014 13:05,2,1,"“Patients can only be harmed by speculative, irrelevant reassurance” Matthew Peters # notjustonedisease http://bit.ly/1gPw7xL # ASCO14",,,# #,4.73148E+17,https://twitter.com/Boehringer/status/473148264049807360,,,,
genentech,6/1/2014 13:05,3,3,"Standardization, guidance & multiplex test may help solve the issue w/ tissue. More: http://ow.ly/xuDvi # ASCO14",,,#,4.73148E+17,https://twitter.com/genentech/status/473148260753100800,,,,
emilygest,6/1/2014 13:05,3,0,# childcancer cure has a cost says @ StJudeResearch doc. Survivors must take care of themselves bc they r vulnerable to early aging. # ASCO2014,,@,# #,4.73148E+17,https://twitter.com/emilygest/status/473148251747938305,,,,
erythrosine,6/1/2014 13:05,0,0,any news on $ MACK's poster # ASCO2014 ?,,,#,4.73148E+17,https://twitter.com/erythrosine/status/473148241073426432,,,,
JackWestMD,6/1/2014 13:04,5,2,"Mok, commentary on adjuvant erlotinib in EGFR mutn-pos pts.: TKI Rx may delay recurrence, but no evidence of surv benefit # ASCO14",,,#,4.73148E+17,https://twitter.com/JackWestMD/status/473148137222459392,,,,
JeffreyMOtto,6/1/2014 13:03,0,0,LM: # ASCO14 - need to specify specimen handling requirements for any assay to be used in a clinical trial,,,#,4.73148E+17,https://twitter.com/JeffreyMOtto/status/473147951208878080,,,,
ipaulmampilly,6/1/2014 13:03,0,1,# ASCO14 this is a hot combo in concept pic.twitter.com/MYEgG5zb0E,,,#,4.73148E+17,https://twitter.com/ipaulmampilly/status/473147947346309120,,,,
PascalMaurel,6/1/2014 13:03,2,1,# ASCO14:Espoirs dans la lutte contre # cancer poumon. Un point fait depuis 50ans http://bit.ly/1gTHogH,,,# #,4.73148E+17,https://twitter.com/PascalMaurel/status/473147916925026305,,,,
mnewtonPharmD,6/1/2014 13:03,0,1,Wow @ ASCO has come a long way in 50 years! # ASCO14 pic.twitter.com/WHnF5nUOhW,,@,#,4.73148E+17,https://twitter.com/mnewtonPharmD/status/473147901221142528,,,,
DrLen,6/1/2014 13:03,0,0,Mouse vs machine: juxtaposition of genomics and mouse avatars in cancer rx/resistance. What will make the most difference? # ASCO14,,,#,4.73148E+17,https://twitter.com/DrLen/status/473147811249541120,,,,
OphiraG,6/1/2014 13:03,0,0,Did I hear right? @ WHO cancer lead Dr Ullrich had never been invited @ ASCO ? Huge gap btw # cancer world & # globalhealth,,@ @,# #,4.73148E+17,https://twitter.com/OphiraG/status/473147743016591360,,,,
JeffreyMOtto,6/1/2014 13:03,0,0,LM: # ASCO14 specific reporting requirements if it is intended to return results to physicians and or patients,,,#,4.73148E+17,https://twitter.com/JeffreyMOtto/status/473147726125748225,,,,
teamoncology,6/1/2014 13:02,0,0,@nextprinciples Thanks. I just have to be careful that my dog will be with me why I am focus on # ASCO14. LOL,,@nextprinciples,#,4.73148E+17,https://twitter.com/teamoncology/status/473147614959919105,,,,
JackWestMD,6/1/2014 13:02,2,1,Shepherd: 161 EGFR mutn-pos early stage NS pts on RADIANT trial show better med dzs-free surv 46.4 vs. 28.5 mo. w/adjuvant erlotinib # ASCO14,,,#,4.73148E+17,https://twitter.com/JackWestMD/status/473147590125441025,,,,
GustaveRoussy,6/1/2014 13:02,3,1,# ASCO2014 Dr Dufour @ GustaveRoussy. Phase-II trial presented 31/05: new therapeutic strategy for chilhood brain tumorpic.twitter.com/XeEWJIdrKe,,@,#,4.73148E+17,https://twitter.com/GustaveRoussy/status/473147578469449728,,,,
JacobPlieth,6/1/2014 13:02,0,0,Great to talk to you! Enjoy the rest of # ASCO14 @ JPZaragoza1,,@,#,4.73148E+17,https://twitter.com/JacobPlieth/status/473147505257873408,,,,
sjaakvink,6/1/2014 13:02,2,1,attitude of pharma and health care prof is changing @ ASCO reaching out for a tipping point @ CliffordHudis with honest broker @ myTomorrows ?,,@ @ @,,4.73148E+17,https://twitter.com/sjaakvink/status/473147504456790016,,,,
FranklinHuang,6/1/2014 13:01,0,0,@ globalonc # asco2014 WHO 1st time at ASCO on global cancer control # convergence @ asco pic.twitter.com/SOEvOi2PND,,@ @,# #,4.73147E+17,https://twitter.com/FranklinHuang/status/473147420403314689,,,,
JeffreyMOtto,6/1/2014 13:01,0,0,"LM: # ASCO14 oftentimes people are using research grade assays, but clinical grade assays are needed for clinical trials.",,,#,4.73147E+17,https://twitter.com/JeffreyMOtto/status/473147398852575232,,,,
dmooneymd,6/1/2014 13:01,0,1,"Breast cancer chemo with cns activity: xeloda, hd mtx, cis-etoposide. Targeted drugs w/cns activity includes tykerb. # bcsm # ASCO14",,,# #,4.73147E+17,https://twitter.com/dmooneymd/status/473147281391501312,,,,
RichardWJoseph,6/1/2014 13:01,0,1,"@ OncLive Very excited to open this trial, as are my patients. First time for long term hope for these patients. # blcsm # ASCO14 @ genentech",,@ @,# #,4.73147E+17,https://twitter.com/RichardWJoseph/status/473147251565817856,,,,
cancerassassin1,6/1/2014 13:01,0,0,Great lineup of discussants discussing # gi # cancer posters in Hall D2. Focus on genome-focused selective markers and treatments. # ASCO14,,,# # #,4.73147E+17,https://twitter.com/cancerassassin1/status/473147225577893889,,,,
NovartisScience,6/1/2014 13:01,2,0,Dr. Bill Sellers shares a # cancer moonshot: http://bit.ly/1loEC41 # asco14 # NIBResearch,,,# # #,4.73147E+17,https://twitter.com/NovartisScience/status/473147214097690624,,,,
Roche,6/1/2014 13:00,4,4,"OS, PFS, QoL? We help you to understand # ClinicalTrial endpoints http://ow.ly/xoTBL (*.pdf) # ASCO14 # CancerResearch",,,# # #,4.73147E+17,https://twitter.com/Roche/status/473147200336572416,,,,
strategicTy,6/1/2014 13:00,0,2,Got to meet @ subatomicdoc !!! Great chat about # radonc collaboration. Looking forward to more # physrels # asco14 http://ow.ly/i/5L02r,,@,# # #,4.73147E+17,https://twitter.com/strategicTy/status/473147147660304384,,,,
OphiraG,6/1/2014 13:00,0,0,Andreas Ullrich speaking now! Global response 2 cancer burden @ WHO approach @ ASCO # ASCO14 pic.twitter.com/YBysdvluio,,@ @,#,4.73147E+17,https://twitter.com/OphiraG/status/473147147622567937,,,,
teamoncology,6/1/2014 13:00,0,0,Mmm too small. RT @ TargetedOnc: Ramucirumab Improves Survival by 1.4 Months in NSCLC http://www.targetedonc.com/conference/asco-2014/Ramucirumab-Improves-Survival-by-14-Months-in-NSCLC … # ASCO14,,@,#,4.73147E+17,https://twitter.com/teamoncology/status/473147142031171584,,,,
ASCO,6/1/2014 13:00,3,5,Drs. Hatoon Bakhribah & Alex A. Adjei: Exploring MET Inhibitors in Cancer Therapy http://bit.ly/1k8Qdmj # ASCO14,,,#,4.73147E+17,https://twitter.com/ASCO/status/473147095218913280,,,,
GenentechJobs,6/1/2014 13:00,0,1,"# ASCO14 VP, Clinical Dev. Talent Hunt: HER Signaling: http://click2apply.net/431863t & Signaling: http://click2apply.net/431946t pic.twitter.com/Mel13ItQqW",,,#,4.73147E+17,https://twitter.com/GenentechJobs/status/473147090386694144,,,,
emilygest,6/1/2014 13:00,4,1,"18 million Americans with history of cancer will be alive in 2022, says @ StJudeResearch doc at # ASCO2014. Ped survivors at risk of...",,@,#,4.73147E+17,https://twitter.com/emilygest/status/473147017750134784,,,,
FoundationATCG,6/1/2014 13:00,2,2,Understand the difference between comprehensive and “hot-spot” # Nextgensequencing. Video: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# # #,4.73147E+17,https://twitter.com/FoundationATCG/status/473146998757928961,,,,
Fifino9,6/1/2014 13:00,0,0,« @ drattai Underutilization of physical therapy in older patients with cancer # asco14 (1/2) pic.twitter.com/QMb1PPPJWc» OT needed too @ BAOTCOT,,@ @,#,4.73147E+17,https://twitter.com/Fifino9/status/473146989769945088,,,,
myriadgenetics,6/1/2014 13:00,0,0,Myriad's findings at # ASCO14 show importance of testing patients for # hereditarycancer syndromes after 1st cancer to avoid 2nd. Pstr 1542,,,# #,4.73147E+17,https://twitter.com/myriadgenetics/status/473146965371281408,,,,
DrMarkham,6/1/2014 12:58,1,2,Nice post. RT @ subatomicdoc: Approachable Researchers: Take This Opportunity to Connect http://bit.ly/1gREYPF via @ davidgrahammd # ASCO14,,@ @,#,4.73147E+17,https://twitter.com/DrMarkham/status/473146674626723840,,,,
Fifino9,6/1/2014 12:58,0,0,HT@drattai Underutilization of PT and OT in older patients with cancer # asco14 pic.twitter.com/B6USzQMDPl» @ BAOTCOT,,@drattai @,#,4.73147E+17,https://twitter.com/Fifino9/status/473146656725401600,,,,
dmooneymd,6/1/2014 12:58,0,0,Small cell cns orr for frontline chemo: 27-50%. Controversial whether chemo can replace local tx as first treatment option. # lcsm # ASCO14,,,# #,4.73147E+17,https://twitter.com/dmooneymd/status/473146640027885568,,,,
WilliamDale_MD,6/1/2014 12:58,1,1,"Its a blast! Great # social media atmosphere. RT  @ ASCO: @ WilliamDale_MD Thank you for attending & thank you for your # ASCO14 engagement.""""",,@ @,# #,4.73147E+17,https://twitter.com/WilliamDale_MD/status/473146615604060160,,,,
MLIWI,6/1/2014 12:58,0,0,Doctors should choose patients over cheaper drugs: http://buff.ly/1klG8Cs . Sign the petition. # ASCO14 # MLIWI http://buff.ly/1klG8Cv,,,# #,4.73147E+17,https://twitter.com/MLIWI/status/473146518950936576,,,,
drugwonks,6/1/2014 12:58,2,0,Doctors should choose patients over cheaper drugs: http://buff.ly/1klG8CE . Sign the petition. # ASCO14 # costofcanceI http://buff.ly/1klG8CH,,,# #,4.73147E+17,https://twitter.com/drugwonks/status/473146515398340608,,,,
n8pennell,6/1/2014 12:57,0,1,"Mok: 35% of both squamous cell and adenocarcinoma early stage have PDL-1 exp, no diff by histology. Need to determine best dec of +. # ASCO14",,,#,4.73146E+17,https://twitter.com/n8pennell/status/473146451066097664,,,,
GustaveRoussy,6/1/2014 12:57,4,2,# ASCO14 Pr Fizazi @ GustaveRoussy @ GroupeUNICANCER interviewed for GETUG 12. Press release: http://bit.ly/1oXz4wI pic.twitter.com/wJEV9j778m,,@ @,#,4.73146E+17,https://twitter.com/GustaveRoussy/status/473146412935311360,,,,
markhdavis,6/1/2014 12:57,0,0,RT @ blendoh: Stop by booth 18097 to walk on the moon at # ASCO14 # lunarselfie,,@,# #,4.73146E+17,https://twitter.com/markhdavis/status/473146331423592448,,,,
JeffreyMOtto,6/1/2014 12:57,0,0,LM: # ASCO14 for predictive # biomarkers treatment effect varies by biomarker status,,,# #,4.73146E+17,https://twitter.com/JeffreyMOtto/status/473146296862142464,,,,
gorskon,6/1/2014 12:57,1,1,". @ mparish243 We don’t associate with that riff-raff. They’re fundamentalist loons. We’re scientists!"" :-) # ASCO14 http://www.sciencebasedmedicine.org/the-central-dogma-of-alternativecomplementaryintegrative-medicine/ …""",,@,#,4.73146E+17,https://twitter.com/gorskon/status/473146235957051393,,,,
JFreemanDaily,6/1/2014 12:56,1,5,"# Lungcancer community connections at # ASCO14-- @ dustywater and I attended Talking to You Pathologist."" # lcsmpic.twitter.com/3ZUX4X59CE""",,@,# # #,4.73146E+17,https://twitter.com/JFreemanDaily/status/473146145485897728,,,,
CancerTherAdvsr,6/1/2014 12:56,0,0,RT @ drdonsdizon: # bcsm # ASCO14 MAJOR FINDING of POEMS: Goserelin signific reduced OF at 2 years (5 women [8%] vs 15 women [22%]. OR 0.30...,,@,# #,4.73146E+17,https://twitter.com/CancerTherAdvsr/status/473146127358132224,,,,
ipaulmampilly,6/1/2014 12:56,0,0,# ASCO14 too many good immunotherapy abstracts only saw half of them session now closed,,,#,4.73146E+17,https://twitter.com/ipaulmampilly/status/473146106881507329,,,,
ICONplc,6/1/2014 12:56,0,0,"@MedImmune We just missed your poster. Please stop by booth 3119, ICON would like to find out more # ASCO14",,@MedImmune,#,4.73146E+17,https://twitter.com/ICONplc/status/473146025180266496,,,,
dmooneymd,6/1/2014 12:56,0,0,"Initial systemic tx for cns dx: chemosensitive tumors, asymptomatic brain Mets with effective options"""," contraindications to rt. # ASCO14""",,,#,4.73146E+17,https://twitter.com/dmooneymd/status/473146020097191936,,,
ERPlimackMD,6/1/2014 12:56,3,0, @ Lymphoma_Doc: With so much exciting data at # ASCO14 ," it's hard to believe that <5% of US cancer patients go on clinical trials.""""",,@,#,4.73146E+17,https://twitter.com/ERPlimackMD/status/473145972508598272,,,
gorskon,6/1/2014 12:56,0,1,. @ mparish243 You might be interested in this. # ASCO14 (2/2) http://www.sciencebasedmedicine.org/the-central-dogma-of-alternativecomplementaryintegrative-medicine/ …,,@,#,4.73146E+17,https://twitter.com/gorskon/status/473145958084382722,,,,
ASCO,6/1/2014 12:55,8,4,. @ CliffordHudis talks # ASCO14 plenary papers w/ @ CBSEveningNews. Airs tonite @6 pm ESTpic.twitter.com/cCKt83HEwx,,@ @ @6,#,4.73146E+17,https://twitter.com/ASCO/status/473145853683982336,,,,
PhRMA,6/1/2014 12:55,1,0,Lack of coverage along w/high deductibles leave patients w/o proper care & paying more out of pocket http://onphr.ma/1nP9oV4 # ASCO14,,,#,4.73146E+17,https://twitter.com/PhRMA/status/473145749937467392,,,,
carisls,6/1/2014 12:55,0,0,# MolecularIntel study shows agents targeting PI3K pathway may treat # gastrointestinal cancer types http://goo.gl/oG0B17 # ASCO14,,,# # #,4.73146E+17,https://twitter.com/carisls/status/473145745806462977,,,,
OncLive,6/1/2014 12:55,1,1,Investigational Immunotherapy Granted First Breakthrough Therapy Designation in Bladder Cancer http://ow.ly/xuFAZ # ASCO14,,,#,4.73146E+17,https://twitter.com/OncLive/status/473145725367627776,,,,
ASCO,6/1/2014 12:54,0,0,@ WilliamDale_MD Thank you for attending & thank you for your # ASCO14 engagement.,,@,#,4.73146E+17,https://twitter.com/ASCO/status/473145667431698432,,,,
JeffreyMOtto,6/1/2014 12:54,0,0,LM: # ASCO14 predictive # biomarkers are generally more useful because they do guide Tx selection,,,# #,4.73146E+17,https://twitter.com/JeffreyMOtto/status/473145608778153985,,,,
cancerassassin1,6/1/2014 12:54,2,3,We celebrate @ SurvivorsDay to commemorate life but acknowledge we have so much work left to do... *together*. @ ASCO @ AmericanCancer # ASCO14,,@ @ @,#,4.73146E+17,https://twitter.com/cancerassassin1/status/473145599857266689,,,,
KUhlendorf,6/1/2014 12:54,1,0,Packed house for session on # immunotherapy research for head and neck # cancer # ASCO14 pic.twitter.com/6BeMlZthGP,,,# # #,4.73146E+17,https://twitter.com/KUhlendorf/status/473145590474223616,,,,
ipaulmampilly,6/1/2014 12:54,0,1,# ASCO14 solid tumor pembroluzimab pic.twitter.com/TiQ8fUxVAV,,,#,4.73146E+17,https://twitter.com/ipaulmampilly/status/473145569981239296,,,,
gorskon,6/1/2014 12:54,0,1,". @ mparish243 Yes & no. Alternative treatments called quackery"" but ""complementary"" treatments are often the same treatments! # ASCO14 (1/2)""",,@,#,4.73146E+17,https://twitter.com/gorskon/status/473145560858640385,,,,
CBPartners,6/1/2014 12:54,0,0,"Coverage,Communication, and Culture- The three Cs of differences in treating # oncology in the US and Europe- Lawrence Brown # ASCO14",,,# #,4.73146E+17,https://twitter.com/CBPartners/status/473145552004448256,,,,
WilliamDale_MD,6/1/2014 12:53,0,1,# ASCO14 Thanks for all the visits and retweets! I learned a lot to improve for publication. Home to my wife... pic.twitter.com/8naF6JnRSU,,,#,4.73145E+17,https://twitter.com/WilliamDale_MD/status/473145397141975040,,,,
ipaulmampilly,6/1/2014 12:53,0,0,# ASCO14 more pembroluzimab pic.twitter.com/Zmun6GKzb0,,,#,4.73145E+17,https://twitter.com/ipaulmampilly/status/473145393195524096,,,,
JeffreyMOtto,6/1/2014 12:53,0,0,LM: # ASCO14 prognostic # biomarkers are not always relevant for Tx decisions.,,,# #,4.73145E+17,https://twitter.com/JeffreyMOtto/status/473145333250129920,,,,
OSUCCC_James,6/1/2014 12:53,0,2,"Dr. Jennifer Woyach details mechanisms of resistance behind ibrutinib, published in NEJM/presented at # ASCO14 pic.twitter.com/keFEufH0ad",,,#,4.73145E+17,https://twitter.com/OSUCCC_James/status/473145318310047744,,,,
DrMarkham,6/1/2014 12:53,2,0,PDX models also being used in cervical cancer. Dr. Mackay now discussing. # gyncsm # ASCO14,,,# #,4.73145E+17,https://twitter.com/DrMarkham/status/473145264715608065,,,,
JeffreyMOtto,6/1/2014 12:52,0,0,LM: # ASCO14 - need to specify intended clinical use,,,#,4.73145E+17,https://twitter.com/JeffreyMOtto/status/473145058531618816,,,,
gorskon,6/1/2014 12:52,0,0,. @ rsm2800 @ obogler @ mtmdphd @ asco Oooh. I'll have to attend that one. # ASCO14,,@ @ @ @,#,4.73145E+17,https://twitter.com/gorskon/status/473145042501390337,,,,
cancerassassin1,6/1/2014 12:52,0,0,"Specialness"" of today: spending # cancer Survivors Day @ asco Annual Mtg to honor friends", family," and patients lost to # cancer # ASCO14""",,@,# # #,4.73145E+17,https://twitter.com/cancerassassin1/status/473145004840718336,,
ipaulmampilly,6/1/2014 12:52,0,0,# ASCO14 excitement for pembroluzimab and not just in hematology pic.twitter.com/T0tSRVgS1Y,,,#,4.73145E+17,https://twitter.com/ipaulmampilly/status/473145004165443585,,,,
n8pennell,6/1/2014 12:51,0,2,Dr. Tony Mok discussing early stage NSCLC and molecular therapy. # ASCO14,,,#,4.73145E+17,https://twitter.com/n8pennell/status/473144930660265984,,,,
JeffreyMOtto,6/1/2014 12:51,0,0,LS: # ASCO14 what role will the # biomarker play in the trial? Eligibility? Tx? Risk stratification?,,,# #,4.73145E+17,https://twitter.com/JeffreyMOtto/status/473144850808721409,,,,
efratdotan,6/1/2014 12:51,1,5,Thanks to all the ASCO14 tweeters who make it easy to experience the meeting from afar. Great job! # ASCO14 # FirstTweet.,,,# #,4.73145E+17,https://twitter.com/efratdotan/status/473144788318171136,,,,
Merck,6/1/2014 12:51,3,1,'Recurrent & metastatic head & neck cancer carries a poor prognosis. Addt'l treatment options are urgently needed.' -Dr. Seiwert. # ASCO14,,,#,4.73145E+17,https://twitter.com/Merck/status/473144775114489856,,,,
JFreemanDaily,6/1/2014 12:51,2,2,@ Tony_Calles Nice to meet # LCSM tweeps IRL--so glad you introduced yourself to me at # ASCO14!,,@,# #,4.73145E+17,https://twitter.com/JFreemanDaily/status/473144719745499136,,,,
nitinroper,6/1/2014 12:51,0,0,Percentage of precision cancer medicine trials in the U.S. has increased from 3% in 2006 to 16% in 2013. # ASCO14 pic.twitter.com/QUtyXvT9Hy,,,#,4.73145E+17,https://twitter.com/nitinroper/status/473144710362853377,,,,
OphiraG,6/1/2014 12:50,0,0,@ ASCO @ NCIGlobalHealth @ ncdalliance @ AORTIC_AFRICA spoke too soon. US vs EU mostly discussed but imp 2 compare N-N systems too.,,@ @ @ @,,4.73145E+17,https://twitter.com/OphiraG/status/473144631761571840,,,,
DebiopharmNews,6/1/2014 12:50,0,0,# ASCO14 How do we develop drug today? With the future # patient in mind ! http://ow.ly/x96Zn,,,# #,4.73144E+17,https://twitter.com/DebiopharmNews/status/473144496700813312,,,,
CancerAdvocacy,6/1/2014 12:50,0,0,"ICYMI from the Cancer Policy Matters blog: Why we care about physician payment"" http://ow.ly/xuEim # qualitycare # NCDS2014 # ASCO14""",,,# # #,4.73144E+17,https://twitter.com/CancerAdvocacy/status/473144496549806080,,,,
RichardWJoseph,6/1/2014 12:49,0,0,@ Genentech BRAF/Mek combo very impressive PFS of >13 months. Promising news for melanoma patients. # ASCO14 # melsm,,@,# #,4.73144E+17,https://twitter.com/RichardWJoseph/status/473144381214838784,,,,
QIAGENscience,6/1/2014 12:49,0,1,"Ingenuity Pathway Analysis helps to discover causal connections in complex ‘omics data http://bit.ly/1oGzYgN . Get addl info, #5013 # ASCO14",,,#5013 #,4.73144E+17,https://twitter.com/QIAGENscience/status/473144193276444672,,,,
intervalolibre,6/1/2014 12:48,2,0,50 años de avances contra el cáncer de pulmón artículo de Bruce Johnson # ASCO14 http://am.asco.org/smoking-cessation-targeted-therapy-progress-lung-cancer-research-continues …,,,#,4.73144E+17,https://twitter.com/intervalolibre/status/473144123357396992,,,,
tehfem,6/1/2014 12:48,0,0,"# ASCO14 Epitubicin or no Epi in neoadj trt for gastric cancer. Comparable resection rate and time to Sx, less toxicity in CF vs ECX",,,#,4.73144E+17,https://twitter.com/tehfem/status/473143990796439552,,,,
n8pennell,6/1/2014 12:47,0,1,"Kong: Should we give up on cetuximab for chemo radiation in lung cancer? I think I would."" # ASCO14""",,,#,4.73144E+17,https://twitter.com/n8pennell/status/473143903944998912,,,,
PaoloFoggi,6/1/2014 12:47,0,0,@ ASCO How much can we trust pCR? @ US_FDA @ EMA_News,,@ @ @,,4.73144E+17,https://twitter.com/PaoloFoggi/status/473143804539973632,,,,
DrSherifMorgan,6/1/2014 12:47,0,0,Poster presentation for the phase 1 clinical trial of Alimta and Taxotere at # ASCO14 http://instagram.com/p/otWvVkiHnS/,,,#,4.73144E+17,https://twitter.com/DrSherifMorgan/status/473143770662187008,,,,
JeffreyMOtto,6/1/2014 12:47,0,0,QL: # ASCO14 # fda also required lots of tests to prove that assay had no cross reactivity w/ other viruses,,,# #,4.73144E+17,https://twitter.com/JeffreyMOtto/status/473143725065924610,,,,
gorskon,6/1/2014 12:46,0,0,. @ drattai Haha. The eternal problem of doing social media at meetings! That's why I bring my laptop & iPad. Much longer battery life # ASCO14,,@,#,4.73144E+17,https://twitter.com/gorskon/status/473143552814637056,,,,
TargetedOnc,6/1/2014 12:46,1,2,Ramucirumab Improves Survival by 1.4 Months in NSCLC http://www.targetedonc.com/conference/asco-2014/Ramucirumab-Improves-Survival-by-14-Months-in-NSCLC … # ASCO14,,,#,4.73143E+17,https://twitter.com/TargetedOnc/status/473143455917817856,,,,
JeffreyMOtto,6/1/2014 12:45,0,0,QL: # ASCO14 # fDA said that IDE required to launch clinical trial,,,# #,4.73143E+17,https://twitter.com/JeffreyMOtto/status/473143427626835968,,,,
PascalMaurel,6/1/2014 12:45,0,0,"# ASCO14:des succès(1ère fois en 10 ans"")bénéfices dans K avancés Poumon""",,,#,4.73143E+17,https://twitter.com/PascalMaurel/status/473143335381893120,,,,
EIannelli,6/1/2014 12:45,2,2,Please ask me about # cancer news at # ASCO14 @ favo_it @ InsControCancro @ cancereu @ kgapo @ ailar_it @ Cancer_Buzzpic.twitter.com/RaZ0WfKeZ9,,@ @ @ @ @ @,# #,4.73143E+17,https://twitter.com/EIannelli/status/473143311864455169,,,,
genentech,6/1/2014 12:45,3,3,"# HCSM is giving us an unprecedented oppty to redefine quality of care, w/ patient insights: http://ow.ly/xuDWJ # ASCO14",,,# #,4.73143E+17,https://twitter.com/genentech/status/473143226631999488,,,,
LIVESTRONG_NL,6/1/2014 12:45,5,2,50 years of progress in lung # cancer research - http://bit.ly/TXJxxV # ASCO14 (via @ ASCO ),,@,# #,4.73143E+17,https://twitter.com/LIVESTRONG_NL/status/473143200790904832,,,,
JackWestMD,6/1/2014 12:44,2,0,"Eberhardt: No diff in survival between chemo/RT, then lung surg, vs. chemo/RT to higher dose for stage III NSCLC # ASCO14",,,#,4.73143E+17,https://twitter.com/JackWestMD/status/473143067495923712,,,,
Progeny,6/1/2014 12:44,0,0,Extended family history is better at identifying candidates for high risk screening and # GeneticCounseling. http://abstracts.asco.org/144/AbstView_144_126052.html … # ASCO14,,,# #,4.73143E+17,https://twitter.com/Progeny/status/473143009916121089,,,,
DrMarkham,6/1/2014 12:44,1,0,Had my very first @ ASCO committee meeting today. So proud to be a volunteer for this organization. # ASCO14,,@,#,4.73143E+17,https://twitter.com/DrMarkham/status/473143002274492416,,,,
RaphaelRousseau,6/1/2014 12:44,0,0,Still too soon to use gene profiling to direct targeted rx in children w/cancer # ASCO14 http://tinyurl.com/p8awdl5 pic.twitter.com/fIreHSAaLL,,,#,4.73143E+17,https://twitter.com/RaphaelRousseau/status/473142983823339520,,,,
UCCancerCenter,6/1/2014 12:44,4,4,Study from Funmi Olopade and Brazilian colleagues analyzed genetic anticipation in BRCA1/2 families # ASCO14 pic.twitter.com/QnHG85jeWP,,,#,4.73143E+17,https://twitter.com/UCCancerCenter/status/473142958108467202,,,,
JeffreyMOtto,6/1/2014 12:44,0,0,"QL: # ASCO14 after standardization of pcr mm and calibrators, reproducibility between labs dramatically improved",,,#,4.73143E+17,https://twitter.com/JeffreyMOtto/status/473142956669403136,,,,
CancerGeek,6/1/2014 12:44,0,0,"@ djsampson IME when we build programs starting w end users first, it becomes more impactful & drives compliance. # ASCO14",,@,#,4.73143E+17,https://twitter.com/CancerGeek/status/473142955491225600,,,,
Consano,6/1/2014 12:43,3,1,"Photo op w/Steven from ALCMI @ TheALCF, our newest partner. Love collaborating w/other innovative orgs! # asco14 # lcsmpic.twitter.com/LKZPN3foch",,@,# #,4.73143E+17,https://twitter.com/Consano/status/473142919940276224,,,,
ipaulmampilly,6/1/2014 12:43,0,0,# ASCO14 PROSTVAC challenge $ dndn Provenge if approvedpic.twitter.com/vR987mBavZ,,,#,4.73143E+17,https://twitter.com/ipaulmampilly/status/473142913955004416,,,,
PascalMaurel,6/1/2014 12:43,0,0,"# ASCO14:news voies pour améliorer soins malades # cancers sein:Moins est plus "" (""less is more""):préserver fertilité"," moins radiations ..""",,,# #,4.73143E+17,https://twitter.com/PascalMaurel/status/473142859949170688,,,
n8pennell,6/1/2014 12:43,0,0,"Kong: Trial in stage 3 NSCLC chemo radiation then surgery versus boost RT showed no difference in OS between arms, same as INT0839. # ASCO14",,,#,4.73143E+17,https://twitter.com/n8pennell/status/473142850759446528,,,,
JoleneScience,6/1/2014 12:43,1,0,ALTTO: Tykerb+Herceptin no better than H alone in adjuvant setting (HER2+ eBC); no chance for label expansion there # ASCO14 $ GSK $ NVS,,,#,4.73143E+17,https://twitter.com/JoleneScience/status/473142723948457984,,,,
JeffreyMOtto,6/1/2014 12:43,0,0,QL: # ASCO14 found variability in # pcr mastermix. Roche reagents performed better.,,,# #,4.73143E+17,https://twitter.com/JeffreyMOtto/status/473142718328090625,,,,
carisls,6/1/2014 12:42,0,1,KRAS mutations found in lower # gastrointestinal cancers indicate lack of benefit for EGFR antibody therapy http://goo.gl/oG0B17 # ASCO14,,,# #,4.73143E+17,https://twitter.com/carisls/status/473142653803311104,,,,
JeffreyMOtto,6/1/2014 12:42,0,0,QL: # ASCO14 initial results showed poor consistency between different labs,,,#,4.73142E+17,https://twitter.com/JeffreyMOtto/status/473142480167116801,,,,
CancerGeek,6/1/2014 12:42,0,0,"@ djsampson So question to be asked, what can we do to drive pt compliance? # ASCO14 # PX",,@,# #,4.73142E+17,https://twitter.com/CancerGeek/status/473142477072138240,,,,
Neil_Iyengar,6/1/2014 12:42,0,0,Thrilled Dr. Morris is chairing discussion session including our work re obesity & breast ca # ASCO14 @ PatrickGMorrispic.twitter.com/sKYFGh2NyO,,@,#,4.73142E+17,https://twitter.com/Neil_Iyengar/status/473142441894494208,,,,
JackWestMD,6/1/2014 12:41,3,2,Wang: Chinese trial of prophylactic cranial irradiat'n for st III NSCLC: major decr in brain mets & strong trend toward better surv # ASCO14,,,#,4.73142E+17,https://twitter.com/JackWestMD/status/473142288039038976,,,,
GenentechJobs,6/1/2014 12:40,0,0,@ ASCO thanks for the info. # ASCO14 Plenary - can be watched via LIVE simulcast in Hall D1.,,@,#,4.73142E+17,https://twitter.com/GenentechJobs/status/473142150582910976,,,,
JeffreyMOtto,6/1/2014 12:40,0,0,QL: # ASCO14 develop standardized processes and equipment for different labs globally,,,#,4.73142E+17,https://twitter.com/JeffreyMOtto/status/473142149651771393,,,,
DrMarkham,6/1/2014 12:40,8,3,Love that Dr. Haluska's ovarian avatar project has it's own twitter account: @ ovatars # gyncsm # ASCO14,,@,# #,4.73142E+17,https://twitter.com/DrMarkham/status/473142077338177536,,,,
magnusfovaeus,6/1/2014 12:40,0,0,"Inhibition of PD-L1 by MPDL3280A , activity in pts with metastatic bladdercancer # ASCO14 http://abstracts.asco.org/144/AbstView_144_128960.html …",,,#,4.73142E+17,https://twitter.com/magnusfovaeus/status/473142057133826049,,,,
PascalMaurel,6/1/2014 12:40,0,0,Une belle et intéressante histoire des succès in # ASCO14 dans le Cancer sein http://bit.ly/1mG8O7F,,,#,4.73142E+17,https://twitter.com/PascalMaurel/status/473142022459891713,,,,
Boehringer,6/1/2014 12:40,47,122,"# HCPs: How are patient outcomes improving in # NSCLC, for patients with and without actionable mutations? http://bit.ly/1stP7Ug > # ASCO14",,,# # #,4.73142E+17,https://twitter.com/Boehringer/status/473141994446127105,,,,
DebiopharmNews,6/1/2014 12:40,0,0,# ASCO14 We are convinced that developing for # patients will shape the # future of # medicine http://ow.ly/x96VW,,,# # # #,4.73142E+17,https://twitter.com/DebiopharmNews/status/473141987924008960,,,,
Roche,6/1/2014 12:40,10,3,There are diagnostic tests in development that can investigate tumour tissue for multiple # biomarkers. http://ow.ly/xp2yn # ASCO14,,,# #,4.73142E+17,https://twitter.com/Roche/status/473141970530205696,,,,
dhjutsw1,6/1/2014 12:40,0,0,"@ ASCO # ASCO14 abst#7508 PCI improves"" OS in N2. Again highly questionable conclusions. Fewer CNS mets.""",,@,# #7508,4.73142E+17,https://twitter.com/dhjutsw1/status/473141948048359424,,,,
n8pennell,6/1/2014 12:39,1,0,"Kong: PCI for stage 3 NSCLC improved DFS and decreased brain metastases, trend towards OS benefit. # ASCO14",,,#,4.73142E+17,https://twitter.com/n8pennell/status/473141895070482432,,,,
JeffreyMOtto,6/1/2014 12:39,0,0,"QL: # ASCO14 Me: Holy cow! Costs $1,000 to ship plasma from Taiwan to Hong Kong. How is that possible?????",,,#,4.73142E+17,https://twitter.com/JeffreyMOtto/status/473141727436353536,,,,
Cognicum,6/1/2014 12:38,0,0,“ @ Merck: Head and neck cancer is the 6th most common cancer worldwide. # ASCO14”https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,#,4.73142E+17,https://twitter.com/Cognicum/status/473141622059065344,,,,
adamfeuerstein,6/1/2014 12:38,7,9,$ CLVS Lung Cancer Bravado Falls Flat With New Diabetes Revelation —> http://www.thestreet.com/story/12728916/1/clovis-lung-cancer-bravado-falls-flat-with-new-diabetes-revelation.html … $ AZN # ASCO14,,,#,4.73142E+17,https://twitter.com/adamfeuerstein/status/473141543428042753,,,,
JackWestMD,6/1/2014 12:38,5,1,Robinson: Retrospective review of database shows NSCLC st IIIA N2 pts who rec'd post-op chest RT had mod superior overall surv. # ASCO14,,,#,4.73141E+17,https://twitter.com/JackWestMD/status/473141480107036672,,,,
tehfem,6/1/2014 12:38,0,0,# ASCO14 induction chemo could improve dyspagia prior to preop chemo/rad,,,#,4.73141E+17,https://twitter.com/tehfem/status/473141440068210688,,,,
dhjutsw1,6/1/2014 12:38,2,1,"# ASCO14 @ ASCO Abst#7509 PORT in respected N2 NSCLC. PORT improves"" OS. Highly questionable conclusions. More ? than answers!""",,@,# #7509,4.73141E+17,https://twitter.com/dhjutsw1/status/473141434736861185,,,,
Merck,6/1/2014 12:37,14,2,Head and neck cancer is the 6th most common cancer worldwide. # ASCO14,,,#,4.73141E+17,https://twitter.com/Merck/status/473141369369014273,,,,
kissyblack,6/1/2014 12:37,0,1,# ncsd2014 Today we recognize survivors! Help give our loved ones a more powerful voice & together we can save more lives # MLIWI # ASCO14,,,# # #,4.73141E+17,https://twitter.com/kissyblack/status/473141365103394817,,,,
HemOncToday,6/1/2014 12:37,2,1,"# ASCO14 # Lenalidomide, rituximab achieved responses in patients with follicular # lymphoma @ WeillCornell http://goo.gl/7Heh2v",,@,# # #,4.73141E+17,https://twitter.com/HemOncToday/status/473141347596394497,,,,
GoHealio,6/1/2014 12:37,0,0,"# ASCO14 # Lenalidomide, rituximab achieved responses in patients with follicular # lymphoma @ WeillCornell http://goo.gl/7Heh2v",,@,# # #,4.73141E+17,https://twitter.com/GoHealio/status/473141346929475584,,,,
FightCRC,6/1/2014 12:37,0,0,"Enjoying ASCO with this awesome crew of survivors, caregivers and staff of Fight CRC! # asco14 http://fb.me/3084q28nx",,,#,4.73141E+17,https://twitter.com/FightCRC/status/473141311286284288,,,,
teamoncology,6/1/2014 12:37,3,0,【 # ASCO14 Update】 E5103 臨床試験において、初期乳がんにおけるアバスチンの補助療法の効果は否定される。,,,#,4.73141E+17,https://twitter.com/teamoncology/status/473141256126615553,,,,
n8pennell,6/1/2014 12:37,0,0,Kong: PORT data reinforces approach of using PORT for resected N2 NSCLC. # ASCO14,,,#,4.73141E+17,https://twitter.com/n8pennell/status/473141254826774528,,,,
JeffreyMOtto,6/1/2014 12:37,0,0,QL: # ASCO14 cell-free EBV # dna detectable in plasma. Detection inversely related to outcomes,,,# #,4.73141E+17,https://twitter.com/JeffreyMOtto/status/473141238493745153,,,,
QIAGENscience,6/1/2014 12:36,2,1,Discover our FDA-approved therascreen® solid tumor biomarker product line. We have KRAS PCR test & EGFR one. # ASCO14 pic.twitter.com/lJZaTdQr0M,,,#,4.73141E+17,https://twitter.com/QIAGENscience/status/473141123104669697,,,,
CI4CC,6/1/2014 12:36,1,0,All # ASCO14 academic attendees get FREE MEMBERSHIP to CI4CC during conference. Go 2 membership login at http://www.ci4cc.org and sign up!,,,#,4.73141E+17,https://twitter.com/CI4CC/status/473140979277766656,,,,
teamoncology,6/1/2014 12:36,0,2,【 # ASCO14 Update】 ５０年間の乳がんの治療の発展がわかりやすくまとめてあります（英語）→ http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pG9xRCeIQ.twitter … # bcsm,,,# # #,4.73141E+17,https://twitter.com/teamoncology/status/473140952928751616,,,,
n8pennell,6/1/2014 12:36,0,0,Kong: PORT for resected N2 disease in National Cancer Database improved OS by 4.5% at 5 years. # ASCO14,,,#,4.73141E+17,https://twitter.com/n8pennell/status/473140952480354305,,,,
DrMarkham,6/1/2014 12:36,1,1,"Dr. Haluska discussing ovarian avatar project, using patient-derived xenografts (PDX) to study responses to therapy. # gyncsm # ASCO14",,,# #,4.73141E+17,https://twitter.com/DrMarkham/status/473140935061434368,,,,
LivingBeyondBC,6/1/2014 12:36,4,0,Read our coverage of # breastcancer findings presented at # ASCO14 on Saturday http://ow.ly/xuGaH,,,# #,4.73141E+17,https://twitter.com/LivingBeyondBC/status/473140928732213248,,,,
OlgaKubassova,6/1/2014 12:36,2,0,"The race for # Roche, # BMS and # Merck in est. $35b # immuno- # oncology market is on. # pharma # business # drugs # ASCO14 http://www.trefis.com/stock/mrk/articles/241372/marywhat-merck-bristol-myers-squibb-and-roche-are-doing-to-win-the-immuno-oncology-drugs-market/2014-05-30 …",,,# # # # # # # # #,4.73141E+17,https://twitter.com/OlgaKubassova/status/473140922520453120,,,,
tehfem,6/1/2014 12:36,0,0,# ASCO14 Radiotherapy alone is an effective tool for dysphagia palliation. No advantage for chemo/rad,,,#,4.73141E+17,https://twitter.com/tehfem/status/473140921090191360,,,,
JeffreyMOtto,6/1/2014 12:35,0,0,QL: # ASCO14 important to find # biomarker for adjuvant chemo tolerance in NPC - focus on EBV DNA,,,# #,4.73141E+17,https://twitter.com/JeffreyMOtto/status/473140915461054464,,,,
ImedexCME,6/1/2014 12:35,1,0,Come to our # ASCO14 booth 15085 to see Dr. Myron Czuczman discuss # lymphoma # CLL today at 12:45 @ oncologytube # oncology # CME,,@,# # # # #,4.73141E+17,https://twitter.com/ImedexCME/status/473140825468456960,,,,
Boehringer,6/1/2014 12:35,2,0,POLL: What has been the most significant development in # lungcancer in the last 50 years? http://bit.ly/1iIp05G # ASCO14,,,# #,4.73141E+17,https://twitter.com/Boehringer/status/473140716974399488,,,,
Amgen,6/1/2014 12:35,1,0,Curious about investigational BiTE® antibodies? Visit # Amgen booth #19042& learn about BiTE molecules at # ASCO14,,,# #19042 #,4.73141E+17,https://twitter.com/Amgen/status/473140711731494912,,,,
JeffreyMOtto,6/1/2014 12:34,0,0,QL: # ASCO14 prob with adjuvant chemotherapy is difficulty of delivery with greater than 60% unable to complete all 3 cycles,,,#,4.73141E+17,https://twitter.com/JeffreyMOtto/status/473140637429030912,,,,
TuftsCancerCtr,6/1/2014 12:34,0,0,Fc-optimized anti-HER2 Ab MGAH22 in # BreastCancer: updated phase II results in S Hall A2 - Jack Erban # Tufts # ASCO14 http://ow.ly/xuFQx,,,# # #,4.73141E+17,https://twitter.com/TuftsCancerCtr/status/473140582484029441,,,,
WinshipAtEmory,6/1/2014 12:34,2,1,. @ SagarLonialMD being interviewed by @ medpagetoday at # ASCO14 pic.twitter.com/gmFOgZmoao,,@ @,#,4.73141E+17,https://twitter.com/WinshipAtEmory/status/473140555695022081,,,,
JeffreyMOtto,6/1/2014 12:33,0,0,QL: # ASCO14 NPC is much more prevalent in southeast Asia,,,#,4.7314E+17,https://twitter.com/JeffreyMOtto/status/473140303587602432,,,,
ipaulmampilly,6/1/2014 12:33,0,0,# ASCO14 next gen immunotherapy tumor specific CTL pic.twitter.com/QXFlEelscw,,,#,4.7314E+17,https://twitter.com/ipaulmampilly/status/473140195249102848,,,,
TheBossTrader,6/1/2014 12:33,1,2,Sign up for June 2014 - Stock Picking Challenge. Winner gets a Free StockTwits Shirt. http://forum.withwingslikeeagles.net/showthread.php?509-June-2014-1-Month-Stock-Picking-Challenge … # stocks # stockmarket # ASCO14,,,# # #,4.7314E+17,https://twitter.com/TheBossTrader/status/473140182959792128,,,,
OlgaKubassova,6/1/2014 12:33,2,0,"Tweets, stories and opinions on # breastcancer # cancer # ASCO14 http://paper.li/myndemayfield/1360477201 …",,,# # #,4.7314E+17,https://twitter.com/OlgaKubassova/status/473140179520466944,,,,
jorge_rozette,6/1/2014 12:32,0,0,# ASCO14 http://tinyurl.com/pj8rhd5 pic.twitter.com/wvROS3iXrD,,,#,4.7314E+17,https://twitter.com/jorge_rozette/status/473140118120042497,,,,
Doctor_V,6/1/2014 12:32,1,2,"Via @ mcbennett6: According to @ symplur, there have been over 15k # ASCO14 tweets since Friday - still 2.5 days to go! @ brianreid",,@ @ @,#,4.7314E+17,https://twitter.com/Doctor_V/status/473140118014787585,,,,
n8pennell,6/1/2014 12:32,0,0,Dr. Kong discussing locally advanced NSCLC abstracts. # ASCO14,,,#,4.7314E+17,https://twitter.com/n8pennell/status/473140103251247104,,,,
OphiraG,6/1/2014 12:32,0,0,"Learning from intl health care systems"" imp @ asco session relevant 2 # globalhealth @ NCIGlobalHealth @ ncdalliance @ AORTIC_AFRICA""",,@ @ @ @,#,4.7314E+17,https://twitter.com/OphiraG/status/473140012889145344,,,,
n8pennell,6/1/2014 12:32,0,0,Starting the discussion now for adjuvant/locally advanced/small cell/other lung cancer poster highlights session # ASCO14,,,#,4.7314E+17,https://twitter.com/n8pennell/status/473139928369758208,,,,
mcbennett6,6/1/2014 12:31,1,1,"According to @ symplur, there have been over 15k # ASCO14 tweets since Friday - and there's still 2.5 days to go! cc: @ brianreid",,@ @,#,4.7314E+17,https://twitter.com/mcbennett6/status/473139867174445056,,,,
UCCancerCenter,6/1/2014 12:31,4,4,". @ WilliamDale_MD - married men are more likely to get their colonoscopies, especially if wives are happy and highly educated # ASCO14",,@,#,4.7314E+17,https://twitter.com/UCCancerCenter/status/473139777131524096,,,,
DebiopharmNews,6/1/2014 12:30,0,0,"# ASCO14 The more the # patient benefits from our drug, the more accomplished we feel",,,# #,4.7314E+17,https://twitter.com/DebiopharmNews/status/473139570159411200,,,,
Novartis,6/1/2014 12:30,2,2,"HCPs, Do you have a question about # NETCancer? Ask an expert. Visit booth 7023 at # ASCO14.",,,# #,4.7314E+17,https://twitter.com/Novartis/status/473139567491821568,,,,
practiceupdate,6/1/2014 12:30,0,0,"What sessions will you attend before # ASCO14 ends? Here are picks from our # Oncology Associate Editor, Axel Grothey http://ow.ly/xtUzX",,,# #,4.73139E+17,https://twitter.com/practiceupdate/status/473139488018157568,,,,
TuftsB,6/1/2014 12:30,1,0,@ DrBobGoldberg @ ASCO - Tough enough being oncologist. Now good doctors forced to be accountants & lawyers against their will # mliwi # asco14,,@ @,# #,4.73139E+17,https://twitter.com/TuftsB/status/473139434154917888,,,,
myPathMelanoma,6/1/2014 12:30,4,1,"Myriad myPath # Melanoma impacts changes in dx, mgmt recommendations & pathologist confidence # melanomadiagnostic # isthismelanoma # ASCO14",,,# # # #,4.73139E+17,https://twitter.com/myPathMelanoma/status/473139410863546368,,,,
TuftsCancerCtr,6/1/2014 12:29,1,0,Metformin can be safely added to std chemo regimens in phase I - Congrats Athena Kritharis # Tufts fellow # ASCO14 http://ow.ly/xuFEZ,,,# #,4.73139E+17,https://twitter.com/TuftsCancerCtr/status/473139197583560705,,,,
WayneKoberstein,6/1/2014 12:28,2,1,"Sorry, too busy speaking with people at # ASCO14 to tweet blow-by-blow. Never seen such excitement here, mostly about immunoTx. @ RfwrightLSL",,@,#,4.73139E+17,https://twitter.com/WayneKoberstein/status/473139146995691520,,,,
NickVRamos,6/1/2014 12:28,0,0,"$ IMUC Currently owned by 30% institutions and 70% retail, look for the institution to rise post # asco14 positive results, phase 3 soon!",,,#,4.73139E+17,https://twitter.com/NickVRamos/status/473139071477612545,,,,
ipaulmampilly,6/1/2014 12:28,3,1,# ASCO14 going by the qty and quality of posters it's official..we are in the immunotherapy era,,,#,4.73139E+17,https://twitter.com/ipaulmampilly/status/473139052007677952,,,,
Sorena997,6/1/2014 12:28,2,1,Significant challenges in rolling out lung cancer CT screening to wider community. # ASCO14 ... This needs a deep look,,,#,4.73139E+17,https://twitter.com/Sorena997/status/473139012002004993,,,,
gorskon,6/1/2014 12:28,0,0,". @ teamoncology Yes, brain mets are horrible. Mother-in-law died of brain mets (& other mets) from BC. She wasn't herself at the end. # ASCO14",,@,#,4.73139E+17,https://twitter.com/gorskon/status/473138959120596994,,,,
oncologytube,6/1/2014 12:27,1,1,If you are at # ASCO14 see a live taping with Ken Anderson at 12:45pm booth 15085 @ ImedexCME,,@,#,4.73139E+17,https://twitter.com/oncologytube/status/473138897929912322,,,,
KUhlendorf,6/1/2014 12:27,0,0,Palatable excitement on lung # cancer progress at # ASCO14 pic.twitter.com/wYjuhNUY4c,,,# #,4.73139E+17,https://twitter.com/KUhlendorf/status/473138801569562625,,,,
gorskon,6/1/2014 12:27,1,0,The reason so many physicians fall for acupuncture is probably because it involves sticking needles into people (2/2). # ASCO14,,,#,4.73139E+17,https://twitter.com/gorskon/status/473138681361219585,,,,
Cognicum,6/1/2014 12:26,1,0,“ @ ASCO: congratulations to Summa Health System on their Clinical Trials part Award. TBP 7:30 am in E Hall D1 # ASCO14”https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,#,4.73139E+17,https://twitter.com/Cognicum/status/473138568601554944,,,,
teamoncology,6/1/2014 12:26,4,2,Brain met in breast cancer is a big issue. Read this. # ASCO14 # BCSM http://am.asco.org/optimizing-therapies-breast-cancer-central-nervous-system-metastases#.U4tTNzmhMZ8.twitter …,,,# # #,4.73139E+17,https://twitter.com/teamoncology/status/473138513701904384,,,,
DrGlenWeiss,6/1/2014 12:26,0,0,MT @ OncLive: Adding ramucirumab to docetaxel improved OS by 1.4 months in pts w/ advanced NSCLC http://ow.ly/xu5fn # ASCO14” unimpressive,,@,#,4.73138E+17,https://twitter.com/DrGlenWeiss/status/473138457150500864,,,,
KellyColligan,6/1/2014 12:25,0,1,Agree >> # shouldneverhappen RT @ drdonsdizon: # bcsm # ASCO14 POEMS closed prior to full accrual after loss of funding http://meetinglibrary.asco.org/content/129172-144 …,,@,# # #,4.73138E+17,https://twitter.com/KellyColligan/status/473138342456877057,,,,
MarcoWu1,6/1/2014 12:25,0,0,http://am.asco.org/smoking-cessation-targeted-therapy-progress-lung-cancer-research-continues … # ASCO14 # lungcancer,,,# #,4.73138E+17,https://twitter.com/MarcoWu1/status/473138270142865408,,,,
gorskon,6/1/2014 12:25,3,3,It pains me deeply to see quackademic medicine presented at # ASCO14 without skepticism. http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter …,,,# #,4.73138E+17,https://twitter.com/gorskon/status/473138212320608256,,,,
ABumRap,6/1/2014 12:24,0,0,“ @ yzafar: Anal cancer: outcomes are similar with 5FU v capecitabine http://bit.ly/1m2UoNh # acsm @ ABumRap # ASCO14 pic.twitter.com/G1HNy1NAsK”,,@ @,# #,4.73138E+17,https://twitter.com/ABumRap/status/473138143378817025,,,,
djsampson,6/1/2014 12:24,1,1,Vincent Lam: there are significant challenges in rolling out lung cancer CT screening to wider community. # ASCO14 pic.twitter.com/KNtqDKtNAS,,,#,4.73138E+17,https://twitter.com/djsampson/status/473138059899592704,,,,
gorskon,6/1/2014 12:24,0,0,". @ markmcan @ teamoncology @ drattai I should, however, be able to watch the video later. # ASCO14",,@ @ @,#,4.73138E+17,https://twitter.com/gorskon/status/473138011811897344,,,,
Agendia,6/1/2014 12:24,1,0,Multiple Studies on Agendia’s MammaPrint and BluePrint Tests to Be Featured at # ASCO2014 Tomorrow... http://owl.li/xuFdj,,,#,4.73138E+17,https://twitter.com/Agendia/status/473137935374905344,,,,
CI4CC,6/1/2014 12:24,0,1,Looking for Cancer Genomics and Cancer Bioinformatics Speakers for Fall # CI4CC in San Francisco: Go to http://www.ci4cc.org # ASCO14,,,# #,4.73138E+17,https://twitter.com/CI4CC/status/473137926969102338,,,,
DrGlenWeiss,6/1/2014 12:24,1,0,MT @ ipaulmampilly: # ASCO14 upto 25% pts die within 90 days pic.twitter.com/UU8FGFgGMG” others have published similar risk calc for ph1,,@,#,4.73138E+17,https://twitter.com/DrGlenWeiss/status/473137903477223425,,,,
gorskon,6/1/2014 12:23,0,0,". @ markmcan @ teamoncology @ drattai Damn. It's a shame that, due to circumstances beyond my control, I couldn't attend that # ASCO14 session.",,@ @ @,#,4.73138E+17,https://twitter.com/gorskon/status/473137848330510337,,,,
teamoncology,6/1/2014 12:23,2,5,Role of integrative medicine in the traditional cancer care. Read this. http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter … # ASCO14 # BCSM,,,# # #,4.73138E+17,https://twitter.com/teamoncology/status/473137845238919169,,,,
jrgralow,6/1/2014 12:23,3,5,Optimizing Therapies for Breast Cancer Central Nervous System Metastases # ASCO14 # bcsm Annual Meeting http://am.asco.org/optimizing-therapies-breast-cancer-central-nervous-system-metastases#.U4tTNzmhMZ8.twitter …,,,# # #,4.73138E+17,https://twitter.com/jrgralow/status/473137728964407296,,,,
ipaulmampilly,6/1/2014 12:22,1,0,# ASCO14 pretty impressive if this can be replicated in clinic pic.twitter.com/2y5WCDbByf,,,#,4.73138E+17,https://twitter.com/ipaulmampilly/status/473137603202777089,,,,
carisls,6/1/2014 12:22,1,0,Dr. David Arguello from Caris presenting our serous ovarian cancer study at # ASCO14 pic.twitter.com/crLXBrgInr,,,#,4.73138E+17,https://twitter.com/carisls/status/473137579479810048,,,,
WilliamDale_MD,6/1/2014 12:22,18,10,"# ASCO14 Key findings: Happy, educated wives lead to more colonoscopies for husbands. Consider a joint MD visit. pic.twitter.com/rEnOqMvve7",,,#,4.73138E+17,https://twitter.com/WilliamDale_MD/status/473137557299949569,,,,
djsampson,6/1/2014 12:22,0,0,Abstract 1566: 154 high risk pts scanned; poor compliance; 0 cancers found; 1 undetected death # asco14 (undetected) pic.twitter.com/qHAMlSuYrF,,,#,4.73138E+17,https://twitter.com/djsampson/status/473137519320506368,,,,
drdonsdizon,6/1/2014 12:22,0,0,"# bcsm # ASCO14 Based on POEMS, Goserelin makes sense for women<50y, ER/PR- dz. Should we extrapolate to those w ER/PR+?",,,# #,4.73137E+17,https://twitter.com/drdonsdizon/status/473137497665331201,,,,
Frank_S_David,6/1/2014 12:21,0,1,"The plural of anecdotes is not evidence"": great @ mjmauboussin line to remember during # ASCO14. Book excerpt: http://michaelmauboussin.com/excerpts/TTexcerpt.pdf …""",,@,#,4.73137E+17,https://twitter.com/Frank_S_David/status/473137336260509697,,,,
KoontzOncology,6/1/2014 12:20,0,0,# ASCO14 http://tinyurl.com/ppsvla6 Excellent talk @ rschilsky! Just don't forget impt role of onc pharmacists -> @ HOPARXpic.twitter.com/6T61f7XS26,,@ @,#,4.73137E+17,https://twitter.com/KoontzOncology/status/473137083633385472,,,,
jrgralow,6/1/2014 12:20,3,0,"The Challenges of the Aging Population: More Patients with Cancer, Fewer Physicians, Costlier Therapies # ASCO14 http://am.asco.org/challenges-aging-population-more-patients-cancer-fewer-physicians-costlier-therapies#.U4tSn1Voem8.twitter …",,,# #,4.73137E+17,https://twitter.com/jrgralow/status/473137012099141632,,,,
ASCO,6/1/2014 12:20,1,1,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.73137E+17,https://twitter.com/ASCO/status/473136977009979392,,,,
OncLive,6/1/2014 12:20,1,0,Adding ramucirumab to docectaxel improved OS by 1.4 months in patients with advanced NSCLC http://ow.ly/xu5fn # ASCO14,,,#,4.73137E+17,https://twitter.com/OncLive/status/473136976426967041,,,,
gorskon,6/1/2014 12:20,0,0,. @ jrgralow What is this stuff doing at ASCO? # ASCO14 http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter …,,@,# #,4.73137E+17,https://twitter.com/gorskon/status/473136972064886784,,,,
DebiopharmNews,6/1/2014 12:20,0,0,"# ASCO14 The # patients are at the core of our business, we care for them! http://ow.ly/x96ON",,,# #,4.73137E+17,https://twitter.com/DebiopharmNews/status/473136964515168256,,,,
Progeny,6/1/2014 12:19,1,1,"Hear how to capture a patient's family history online, assess cancer risk and integrate the pedigree with your EMR at Booth 4028. # ASCO14",,,#,4.73137E+17,https://twitter.com/Progeny/status/473136881689825280,,,,
QuiverVoice,6/1/2014 12:19,1,1,HARD DATA FROM SOFT (& TEXT): Exemestane + OS > tamoxifen + OS in premenopausal women w/ER+ # breastcancer # ASCO14 http://www.cancer.gov/newscenter/newsfromnci/2014/ASCOSOFTandTEXT …,,,# #,4.73137E+17,https://twitter.com/QuiverVoice/status/473136826715103232,,,,
JeffreyMOtto,6/1/2014 12:19,0,0,"First up: Quynh-Thu Le from an international collaboration to harmonization in # biomarker use"" # ASCO14""",,,# #,4.73137E+17,https://twitter.com/JeffreyMOtto/status/473136678563885056,,,,
ecancer,6/1/2014 12:19,4,0,Posters of interest # ASCO2014 pic.twitter.com/5o7w0fdT4p,,,#,4.73137E+17,https://twitter.com/ecancer/status/473136650466631680,,,,
gorskon,6/1/2014 12:18,2,2,. @ drattai The data for acupuncture is more like nonexistent. It's placebo. # ASCO14 http://www.sciencebasedmedicine.org/a-trilogy-of-acupuncture-terror/ …,,@,#,4.73137E+17,https://twitter.com/gorskon/status/473136598696333312,,,,
jrgralow,6/1/2014 12:18,1,1,Integrative Oncology Can Add Benefit to Traditional Cancer Treatments # ASCO14 Annual Meeting http://am.asco.org/integrative-oncology-can-add-benefit-traditional-cancer-treatments#.U4tSRWj20NY.twitter …,,,# #,4.73137E+17,https://twitter.com/jrgralow/status/473136511907418112,,,,
DrGlenWeiss,6/1/2014 12:18,0,0,MT jrgralow: FDA chief- 'escalating' drug prices can't go on # ASCO14 http://reut.rs/1rwNIQ2 @ reuters faster approval w/breakthru wont drop $,,@,#,4.73136E+17,https://twitter.com/DrGlenWeiss/status/473136470115766274,,,,
vgargMD,6/1/2014 12:18,1,0,@ KoontzOncology @ ASCO @ rschilsky nice visual codification of # oncology # HIT enabled 'learning system' CancerLinQpic.twitter.com/Oi8FtKMyzU,,@ @ @,# #,4.73136E+17,https://twitter.com/vgargMD/status/473136457457348609,,,,
drdonsdizon,6/1/2014 12:18,3,0,"# bcsm # ASCO14 Survival on POEMS better w Goserelin: 4yDFS 89v78% (HR 0.40, 95%CI 0.24-0.97) 4yOS 92v82% (HR 0.43,95%CI 0.18-1.0)",,,# #,4.73136E+17,https://twitter.com/drdonsdizon/status/473136454093139968,,,,
DasLebenshaus,6/1/2014 12:17,1,1,Neues vom ASCO 2014: Nivolumab bei metastasierendem Nierenzellkarzinom - Newsroom - das Lebenshaus http://tinyurl.com/ndmyfhn # ASCO14 # IKCC,,,# #,4.73136E+17,https://twitter.com/DasLebenshaus/status/473136323973226496,,,,
JeffreyMOtto,6/1/2014 12:17,1,0,Next session: Dev. of usable # biomarker: odyssey of plasma EBV DNA in nasopharyngeal carcinoma: from journal to clin trial # ASCO14,,,# #,4.73136E+17,https://twitter.com/JeffreyMOtto/status/473136272190369792,,,,
gmannrph,6/1/2014 12:17,1,1,# ASCO14 Obesity is the New tabacco in the fight for cancer prevention.,,,#,4.73136E+17,https://twitter.com/gmannrph/status/473136270290743296,,,,
WilliamDale_MD,6/1/2014 12:16,2,0,"# ASCO14 Finding #4 - If you get screened for any cancer, your spouse is more likely to get screened for # cancer.pic.twitter.com/gb19HCt2D9",,,# #4 #,4.73136E+17,https://twitter.com/WilliamDale_MD/status/473136041138733056,,,,
gmannrph,6/1/2014 12:16,0,0,# ASCO14 Interesting talk on the value of cancer care. What amount is society willing to pay to extend 1 life for 1 month. Who decides?,,,#,4.73136E+17,https://twitter.com/gmannrph/status/473135950676381696,,,,
subatomicdoc,6/1/2014 12:16,3,0,Brain metastases in patients with testicular germ cell tumors http://abstracts.asco.org/144/AbstView_144_130878.html … # ASCO14 # tscsm,,,# #,4.73136E+17,https://twitter.com/subatomicdoc/status/473135887539527682,,,,
gorskon,6/1/2014 12:15,3,3,". @ teamoncology @ drattai Sorry, but I'm afraid acupuncture is nothing more than a theatrical placebo. http://www.sciencebasedmedicine.org/acupuncture-doesnt-work/ … # ASCO14",,@ @,#,4.73136E+17,https://twitter.com/gorskon/status/473135826466271232,,,,
wallyjc,6/1/2014 12:15,2,5,Winship's Dr Rathi Pillai presenting update of ECOG's selenium chemo prevention trial! # ASCO14 pic.twitter.com/Su4u1z9w7V,,,#,4.73136E+17,https://twitter.com/wallyjc/status/473135817255174144,,,,
teamoncology,6/1/2014 12:15,0,0,RT @ drdonsdizon: MAJOR FINDING of POEMS: Goserelin reduced OF at 2 years (5 women [8%] vs 15 women [22%]. OR 0.30 (95%CI 0.09-0.97) # ASCO14,,@,#,4.73136E+17,https://twitter.com/teamoncology/status/473135801627185153,,,,
GuneetWalia,6/1/2014 12:15,1,0,Personalizing cancer care: Therapeutic treatment of # LungCancer based on cancer genomics # ASCO14 # LCSM http://am.asco.org/present-and-future-genomic-profiling-personalizing-cancer-care …,,,# # #,4.73136E+17,https://twitter.com/GuneetWalia/status/473135767326560256,,,,
drdonsdizon,6/1/2014 12:15,3,2,"# bcsm # ASCO14 POEMS: Rx w Goserelin assoc w higher rate of attempted, achieved, & ongoing pregnancy, and higher delivery rates.",,,# #,4.73136E+17,https://twitter.com/drdonsdizon/status/473135719037153282,,,,
SequentaInc,6/1/2014 12:15,1,1,How are you using # MRD testing in # bloodcancers? Stop by booth 18152 to talk NGS-based MRD testing ClonoSIGHT http://ow.ly/xmaUT # ASCO14,,,# # #,4.73136E+17,https://twitter.com/SequentaInc/status/473135698686799872,,,,
TargetedOnc,6/1/2014 12:15,3,2,Dr. Ramalingam on New Data for EGFR Inhibitors for Lung Cancer http://www.targetedonc.com/conference/asco-2014/New-Data-for-EGFR-Inhibitors-for-Lung-Cancer … # ASCO14,,,#,4.73136E+17,https://twitter.com/TargetedOnc/status/473135671411228673,,,,
Boehringer,6/1/2014 12:15,1,1,"...I headed straight to the 1st session - Targeting # EGFR: The Next 10 Years.""... - Read more at: http://bit.ly/1mE8Htf # ASCO14""",,,# #,4.73136E+17,https://twitter.com/Boehringer/status/473135661927895040,,,,
myriadgenetics,6/1/2014 12:15,1,0,Did you know that # genepanel testing identifies more clinically actionable mutations? Visit us at Booth 2039 to find out more! # ASCO14,,,# #,4.73136E+17,https://twitter.com/myriadgenetics/status/473135636891725824,,,,
teamoncology,6/1/2014 12:14,0,0,@ cordekroon We ado not know the long-term impact of OFS in young BC patients. # ASCO14 # BCSM,,@,# #,4.73136E+17,https://twitter.com/teamoncology/status/473135577118687235,,,,
ipaulmampilly,6/1/2014 12:14,1,0,# ASCO14 tox driven mortality in phase 1 less than 0.5% but upto 25% patients die within 90 days pic.twitter.com/t9x59Yn6vn,,,#,4.73135E+17,https://twitter.com/ipaulmampilly/status/473135477500149760,,,,
WilliamDale_MD,6/1/2014 12:13,3,0,# ASCO14 Finding #3 - Another asymmetry. Wives' with more education lead to husbands getting more colonoscopies. pic.twitter.com/hcM5YKgQAk,,,# #3,4.73135E+17,https://twitter.com/WilliamDale_MD/status/473135261035945984,,,,
drdonsdizon,6/1/2014 12:13,5,1,# bcsm # ASCO14 MAJOR FINDING of POEMS: Goserelin signific reduced OF at 2 years (5 women [8%] vs 15 women [22%]. OR 0.30 (95%CI 0.09-0.97),,,# #,4.73135E+17,https://twitter.com/drdonsdizon/status/473135169109364737,,,,
liutprando,6/1/2014 12:12,1,1,“ @ KoontzOncology: Big data in the field of precision medicine as per @ rschilsky # ASCO14 pic.twitter.com/7ge2UDwoXK”,,@ @,#,4.73135E+17,https://twitter.com/liutprando/status/473135102609088512,,,,
ImedexCME,6/1/2014 12:12,2,0,We are giving away free ISB drives at # ASCO14 booth 15085. Stop by to get one. pic.twitter.com/7JIFFWQg7P,,,#,4.73135E+17,https://twitter.com/ImedexCME/status/473135064599916544,,,,
ThisIsHillarie,6/1/2014 12:12,1,2,“ @ WinshipAtEmory: Dr Rathi Pillai in front of her poster # ASCO14 pic.twitter.com/7Xr7KJgJdN” love Dr Pillai!,,@,#,4.73135E+17,https://twitter.com/ThisIsHillarie/status/473135034422272001,,,,
_TheUrologist_,6/1/2014 12:11,1,1,Effect of met location on OS in CRPC ( # asco14 abs 5002): pic.twitter.com/53SksrPTei,,,#,4.73135E+17,https://twitter.com/_TheUrologist_/status/473134875680448512,,,,
doctoreebs,6/1/2014 12:11,1,0,Excellent poster presentation on high incidence of HPV+ H&N lung metastasis by UTSW heme/onc fellow Dr. Law # ASCO14 pic.twitter.com/h4o2w4d7dV,,,#,4.73135E+17,https://twitter.com/doctoreebs/status/473134865748336640,,,,
GenentechJobs,6/1/2014 12:11,1,0,"Catching up with Genentech team members today during # ASCO14 Immunobiology/Immunotherapy, 11:30 am to 1:00 pm, - S100bc.",,,#,4.73135E+17,https://twitter.com/GenentechJobs/status/473134776958713856,,,,
dansbarrington,6/1/2014 12:11,1,0,@ dansbarrington or come to our booth 2066 to get a card for a drink in the bar later. # ASCO14,,@,#,4.73135E+17,https://twitter.com/dansbarrington/status/473134763721912320,,,,
Lymphoma_Doc,6/1/2014 12:11,0,0,@ genentech my opinion: all patients should be offered a trial until we have +++effective & tolerable therapies for their disease. # ASCO14,,@,#,4.73135E+17,https://twitter.com/Lymphoma_Doc/status/473134739998912512,,,,
DrMisialek,6/1/2014 12:11,1,0,ASCO Annual Meeting 2014: Highlights from Dana Farber Research http://www.dana-farber.org/Research/ASCO-Annual-Meeting-2014.aspx#.U4tQG5tR_yM.twitter … @ DanaFarber @ ASCO # ASCO14,,@ @,# #,4.73135E+17,https://twitter.com/DrMisialek/status/473134720449257472,,,,
DrAttai,6/1/2014 12:11,18,9,"For those watching at home you're hearing so much about obesity, exercise, alcohol, smoking because these factors so important # asco14 # bcsm",,,# #,4.73135E+17,https://twitter.com/DrAttai/status/473134714039967744,,,,
teamoncology,6/1/2014 12:10,0,0,【 # ASCO14 Update】 RT @ aftimosp: 36% reduction in the death risk w/ dabrafenib + trametinib vs dabrafenib + placebo in BRAF-mutated melanoma,,@,#,4.73135E+17,https://twitter.com/teamoncology/status/473134541951877120,,,,
drdonsdizon,6/1/2014 12:10,4,0,"# bcsm # ASCO14 POEMS- Goserelin assoc with higher g2-4 toxicity (48% vs 24% without G). However, g3-4 toxicity rare. http://meetinglibrary.asco.org/content/129172-144 …",,,# #,4.73134E+17,https://twitter.com/drdonsdizon/status/473134475199524864,,,,
DebiopharmNews,6/1/2014 12:10,0,0,# ASCO14 # Innovation is precious and we take care of it by transforming it into a drug for the # patients http://ow.ly/x96M3,,,# # #,4.73134E+17,https://twitter.com/DebiopharmNews/status/473134438927589377,,,,
Novartis,6/1/2014 12:10,3,3,Don't miss the oral presentation on ALK+ NSCLC on 6/2 from 3:48-4pm CDT in S Hall A1. # ASCO14,,,#,4.73134E+17,https://twitter.com/Novartis/status/473134428227928065,,,,
Roche,6/1/2014 12:10,3,4,Scouting for talents in # oncology # research - http://ow.ly/xp30G # ASCO14,,,# # #,4.73134E+17,https://twitter.com/Roche/status/473134418195152896,,,,
mariaviniegra,6/1/2014 12:09,0,0,# bigdata tenés los datos a mano," pero no te dejan usar por esa burocracia de la ética"" llora estadistica noruega"," muy rubia ella # asco2014""",,,# #,4.73134E+17,https://twitter.com/mariaviniegra/status/473134249215029248,,
GustaveRoussy,6/1/2014 12:09,1,0,# ASCO14 Etude GETUG12: impact positif de la chimio associée au traitement de référence sur le # cancer de la prostate http://bit.ly/1nFyKW3,,,# #,4.73134E+17,https://twitter.com/GustaveRoussy/status/473134241174519808,,,,
JasmineGruiaGr,6/1/2014 12:09,0,0,New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies # ASCO2014 http://www.news-medical.net/news/20140531/New-data-highlights-molecular-profiling-in-guiding-treatment-of-patients-with-gynecologic-malignancies.aspx …,,,#,4.73134E+17,https://twitter.com/JasmineGruiaGr/status/473134132394860544,,,,
DrAttai,6/1/2014 12:08,0,1,@ JeamesSailor @ PenrynPam surprised that was the only mention I've seen so far. Hopefully more tomorrow # ASCO14,,@ @,#,4.73134E+17,https://twitter.com/DrAttai/status/473134093140385792,,,,
drdonsdizon,6/1/2014 12:08,0,0,"# bcsm # ASCO14 218 evaluable patients were enrolled (note; originally, accrual was for >400p) http://meetinglibrary.asco.org/content/129172-144 …",,,# #,4.73134E+17,https://twitter.com/drdonsdizon/status/473134087373201411,,,,
Acedotor,6/1/2014 12:08,0,1,@ Merck to Collaborate with Sysmex Inostics on a Blood-Based RAS Biomarker Test @ ASCO: http://noticiadesalud.blogspot.com.es/2014/06/merck-to-collaborate-with-sysmex.html …,,@ @,,4.73134E+17,https://twitter.com/Acedotor/status/473133965541646336,,,,
drdonsdizon,6/1/2014 12:08,0,0,# bcsm # ASCO14 POEMS was closed prior to full accrual after loss of funding. # shouldneverhappen http://meetinglibrary.asco.org/content/129172-144 …,,,# # #,4.73134E+17,https://twitter.com/drdonsdizon/status/473133916262371328,,,,
BioPharmaJosh,6/1/2014 12:07,1,0,Novartis has hired a Merck executive as its oncology chief http://on.wsj.com/1kYyjmi # ASCO14 $ NVS $ MRK via @ WSJ,,@,#,4.73134E+17,https://twitter.com/BioPharmaJosh/status/473133819004858369,,,,
drol007,6/1/2014 12:07,1,2,“ @ ASCO: # Openaccess during month of June to JOP's May issue which covers Quality Care Symposium http://bit.ly/1gABNLY # meded # ASCOQLTY”,,@,# # #,4.73134E+17,https://twitter.com/drol007/status/473133816866172930,,,,
drdonsdizon,6/1/2014 12:06,0,0,"# bcsm # ASCO14 Primary endpt of POEMS: Ov failure at 2 years (amenorrhea for prior 6m, FSH postmenop range). Exploratory endpts=DFS and OS.",,,# #,4.73134E+17,https://twitter.com/drdonsdizon/status/473133595427475456,,,,
LinicalAmericas,6/1/2014 12:06,0,0,Looking for something fun tonight in Chicago for # ASCO14? Check out the ASCO Work/Play Guide by @Accelovance. http://accelovance.com/workplay.php,,@Accelovance,#,4.73134E+17,https://twitter.com/LinicalAmericas/status/473133590193008640,,,,
Tony_Calles,6/1/2014 12:06,0,0,@ JFreemanDaily I think that I've met you. Brave!! # asco14 # lcsmpic.twitter.com/ZvkSD79clm,,@,# #,4.73134E+17,https://twitter.com/Tony_Calles/status/473133505174843392,,,,
bpowersphoto,6/1/2014 12:06,0,0,"# rusty # benches at # ASCO14 in # chicago. @Mccormick Place, Illinois http://instagram.com/p/otSCiALH9F/",,@Mccormick,# # # #,4.73133E+17,https://twitter.com/bpowersphoto/status/473133444285747200,,,,
jrgralow,6/1/2014 12:06,2,4,FDA cancer chief says 'escalating' drug prices can't continue # ASCO14 http://reut.rs/1rwNIQ2 via @ reuters,,@,#,4.73133E+17,https://twitter.com/jrgralow/status/473133439680385024,,,,
nitinroper,6/1/2014 12:06,1,0,"Future of precision cancer medicine will be large clinical registries such as Cancer LinQ, not randomized trials. - Dr. Schilsky # ASCO14",,,#,4.73133E+17,https://twitter.com/nitinroper/status/473133388002758656,,,,
GustaveRoussy,6/1/2014 12:05,2,0,# ASCO14 GETUG12 trial's results: benefits of chemotherapy on survival in advanced prostate # cancer Press release: http://bit.ly/1oXz4wI,,,# #,4.73133E+17,https://twitter.com/GustaveRoussy/status/473133251453001728,,,,
ipaulmampilly,6/1/2014 12:05,0,0,# ASCO14 revolution needed only 6% of phase 1 trials done on the basis of target expression 94% on dose escalation pic.twitter.com/TgnAMuvoSj,,,#,4.73133E+17,https://twitter.com/ipaulmampilly/status/473133232201150465,,,,
genentech,6/1/2014 12:05,4,0,"# DYK? Cancer is one of the leading causes of death in children, 2nd only to accidents. More on Ped Onc: http://ow.ly/xuDcs # ASCO14",,,# #,4.73133E+17,https://twitter.com/genentech/status/473133190656589824,,,,
DasLebenshaus,6/1/2014 12:04,0,1,#5009 - Nivo for RCC - encouraging OS and ORR data with little side effects - http://www.daslebenshaus.org/index.php/nier/aktuelles/entry/neues-vom-asco-2014-nivolumab-bei-metastasierendem-nierenzellkarzinom-mrcc-ergebnisse-einer-randomisierten-dosisfindungs-phase-ii-studie … # kidneycancer # ASCO14 # IKCC,,,#5009 # # #,4.73133E+17,https://twitter.com/DasLebenshaus/status/473133018224144384,,,,
JediPD,6/1/2014 12:04,1,0,"About time! RT @ jrgralow: Cancer doctors urged to consider value when treating patients # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-health-cancer-value-20140530,0,4872696.story …",,@,#,4.73133E+17,https://twitter.com/JediPD/status/473133014407712768,,,,
drdonsdizon,6/1/2014 12:04,2,1,"More about POEMS study (Moore, LBA505)- Prevention Of Early Menopause Study # bcsm # ASCO14 http://meetinglibrary.asco.org/content/129172-144 …",,,# #,4.73133E+17,https://twitter.com/drdonsdizon/status/473132893456171009,,,,
PhRMA,6/1/2014 12:04,2,2,Targeted lung # cancer therapies have helped increase survival rates by 300% & leukemia survival rates to >90% http://bit.ly/1nAxDqP # ASCO14,,,# #,4.73133E+17,https://twitter.com/PhRMA/status/473132885977735168,,,,
KoontzOncology,6/1/2014 12:03,18,7,@ rschilsky concludes his talk on precision medicine with a nice summary slide. # ASCO14 pic.twitter.com/06m1Hxeb6a,,@,#,4.73133E+17,https://twitter.com/KoontzOncology/status/473132820861550594,,,,
motorrecilla,6/1/2014 12:03,0,0,"Molecular testing: the way to individualized theraphy, through the engadment between oncologist and pathologist. Great session at # ASCO14!",,,#,4.73133E+17,https://twitter.com/motorrecilla/status/473132805783044096,,,,
PCFnews,6/1/2014 12:03,2,2,Four PCF-funded young investigators present exciting clinical trial results at # prostatecancer session at # ASCO14 ! So proud!,,,# #,4.73133E+17,https://twitter.com/PCFnews/status/473132805380403202,,,,
PinkSheetMaryJo,6/1/2014 12:02,0,0,"Big data holds promise of rapidly accelerating learning while helping manage omics"" and value issues -Schilsky # ASCO14""",,,#,4.73132E+17,https://twitter.com/PinkSheetMaryJo/status/473132476731498496,,,,
KoontzOncology,6/1/2014 12:02,0,0,@ rschilsky describes the future of precision medicine. # ASCO14 pic.twitter.com/2h0hLw34Xc,,@,#,4.73132E+17,https://twitter.com/KoontzOncology/status/473132434712977408,,,,
AndyBiotech,6/1/2014 12:02,0,1,$ BMY Nivolumab ORR & AEs in platinum resistant # OvarianCancer via @ JPZaragoza1 # ASCO14 # gyncsm pic.twitter.com/rXLURwQvlWpic.twitter.com/1LDENoRfLw,,@,# # #,4.73132E+17,https://twitter.com/AndyBiotech/status/473132419219206144,,,,
nocopas,6/1/2014 12:02,3,6,"Since 1980, 83% of life expectancy gains for cancer patients attributable to new treatment, including # medicalinnovation. # asco14 # NCSD2014",,,# # #,4.73132E+17,https://twitter.com/nocopas/status/473132417377517570,,,,
DrMisialek,6/1/2014 12:02,2,0,Early Chemotherapy Extends Lives of Men With Prostate Cancer http://nyti.ms/1nT2cpn @ nytimes @ ASCO # ASCO14 @ CCCNevada,,@ @ @,#,4.73132E+17,https://twitter.com/DrMisialek/status/473132403264065536,,,,
jrgralow,6/1/2014 12:01,1,3,# ASCO14: Early Palliation in Ca Patients Eases Caregiver Burden http://www.medpagetoday.com/MeetingCoverage/ASCO/46077 …,,,#,4.73132E+17,https://twitter.com/jrgralow/status/473132323404128259,,,,
jrgralow,6/1/2014 12:01,1,1,Agree- nice TEDx! MT @ teamoncology: values come from mutual empowerment btwn Drs & pts. My TEDx about this. https://www.youtube.com/watch?v=Cqe5cKhgFFc … # ASCO14,,@,#,4.73132E+17,https://twitter.com/jrgralow/status/473132285974556672,,,,
ASCO,6/1/2014 12:01,2,1,In the East building and don't want to cross the bridge for Plenary? Stay and watch the LIVE simulcast in Hall D1. # ASCO14,,,#,4.73132E+17,https://twitter.com/ASCO/status/473132276856143872,,,,
rogersro,6/1/2014 12:01,0,0,Myriad will present abstract 1509 on hereditary cancer syndrome overlap tomorrow at 8 am. Shows benefit of cancer panel tests # ASCO14,,,#,4.73132E+17,https://twitter.com/rogersro/status/473132276541181952,,,,
WHOPressUS,6/1/2014 12:01,0,0,Yesterday’s # ASCO14 best seller: The World Cancer Report 2014. http://ow.ly/3leTFI http://ow.ly/i/5KW6V,,,#,4.73132E+17,https://twitter.com/WHOPressUS/status/473132252122324992,,,,
DebiopharmNews,6/1/2014 12:01,0,0,# ASCO14 Convert your molecule into a successful drug http://ow.ly/x96It,,,#,4.73132E+17,https://twitter.com/DebiopharmNews/status/473132236683083776,,,,
Novartis,6/1/2014 12:01,1,2,Discussing barriers in # clinicaltrials & how US # Novartis Signature Program brings the protocol to patients # ASCO14 http://bit.ly/1n5sdPS,,,# # #,4.73132E+17,https://twitter.com/Novartis/status/473132207482351617,,,,
Roche,6/1/2014 12:01,4,3,Decision making in an increasingly complex treatment environment: http://ow.ly/xoTqX # ASCO14 # healthcare,,,# #,4.73132E+17,https://twitter.com/Roche/status/473132143955435520,,,,
mtmdphd,6/1/2014 12:01,0,1,I agree MT @ JSweetenhamMD: Anas Younes is doing a great job reviewing HL therapy at # ASCO14 # lymsm,,@,# #,4.73132E+17,https://twitter.com/mtmdphd/status/473132138112757760,,,,
CancerAdvocacy,6/1/2014 12:01,2,3,42-year survivor Ellen Stovall talks about what good # cancer care should look like http://ow.ly/xuDm1 # NCSD2014 # ASCO14 # PACTAct,,,# # # #,4.73132E+17,https://twitter.com/CancerAdvocacy/status/473132130927910912,,,,
appistry,6/1/2014 12:01,0,0,Receive an official # Appistry # GEM & a chance at the @ MisFit Shine once you complete our survey: http://ow.ly/xjjQA # ASCO14,,@,# # #,4.73132E+17,https://twitter.com/appistry/status/473132117271248897,,,,
mayocliniclabs,6/1/2014 12:00,0,0,Visit booth #2054 to learn about testing for bone and soft tissue # tumors. # ASCO14 http://mayocl.in/T1r6rl,,,#2054 # #,4.73132E+17,https://twitter.com/mayocliniclabs/status/473132108425474048,,,,
ASCO,6/1/2014 12:00,2,1,Dr. Blase Polite: Oncology Leadership in Health System Reform: http://bit.ly/1klAnAb # ASCO14,,,#,4.73132E+17,https://twitter.com/ASCO/status/473132024078024704,,,,
OncoPlexDx,6/1/2014 12:00,0,0,Stop by #18119 at 12PM today to meet # oncology expert Jedd Levine MD & to learn a better way to measure # proteins than # IHC. # ASCO14 # hcldr,,,#18119 # # # # #,4.73132E+17,https://twitter.com/OncoPlexDx/status/473132011985833984,,,,
PinkSheetMaryJo,6/1/2014 12:00,0,0,"Can embed clinical trials in registries, Schilsky says. Get real time randomization, comparative results. # ASCO14",,,#,4.73132E+17,https://twitter.com/PinkSheetMaryJo/status/473131962048479232,,,,
FoundationATCG,6/1/2014 12:00,1,2,How can you be sure that no stone is left unturned for your patients? Find out here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73132E+17,https://twitter.com/FoundationATCG/status/473131916707639297,,,,
cardinalhealth,6/1/2014 12:00,0,0,We can help! Stop by # ASCO14 booth 5027 to see innovative solutions and services for your oncology practice. # essentialtooncology,,,# #,4.73132E+17,https://twitter.com/cardinalhealth/status/473131877193097220,,,,
DanaFarber,6/1/2014 12:00,2,3,Researchers report patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy: http://bit.ly/1k7SE9Q # ASCO14,,,#,4.73132E+17,https://twitter.com/DanaFarber/status/473131870327418881,,,,
BoehringerES,6/1/2014 12:00,3,0,# angiogenesis es esencial en el crecimiento del tumor.Su inhibición puede dar nuevas opciones a los pacientes http://bit.ly/1hqDSoS # ASCO14,,,# #,4.73132E+17,https://twitter.com/BoehringerES/status/473131870251520002,,,,
Medscape,6/1/2014 12:00,2,0,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73132E+17,https://twitter.com/Medscape/status/473131867852394496,,,,
SiliconBio,6/1/2014 12:00,0,0,"Visit booth 24101 at # ASCO14 to hear how @ SiliconBio can help isolate and recover single, rare cells for your translational research.",,@,#,4.73132E+17,https://twitter.com/SiliconBio/status/473131867311718400,,,,
MedscapeOnc,6/1/2014 12:00,1,1,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.73132E+17,https://twitter.com/MedscapeOnc/status/473131865759424515,,,,
mtmdphd,6/1/2014 11:59,1,1,". @ DrAnasYounes # lymsm # ASCO14 - HL Conclusions & Future Directions - BV at center - HDACi, PD1, PI3K/mTORi, chemo pic.twitter.com/dgAweXzNwJ",,@,# #,4.73132E+17,https://twitter.com/mtmdphd/status/473131687090876417,,,,
Rad_Nation,6/1/2014 11:59,2,1,Capecitabine/mitomycin (CM) in combination with radiation for anal cancer http://abstracts.asco.org/144/AbstView_144_130168.html … # ASCO14 # ancsm # radonc,,,# # #,4.73132E+17,https://twitter.com/Rad_Nation/status/473131623798816768,,,,
subatomicdoc,6/1/2014 11:59,1,1,Capecitabine/mitomycin (CM) in combination with radiation for anal cancer http://abstracts.asco.org/144/AbstView_144_130168.html … # ASCO14 # ancsm # radonc,,,# # #,4.73132E+17,https://twitter.com/subatomicdoc/status/473131608523173888,,,,
EdwinPosadasMD,6/1/2014 11:58,0,0,# enzalutamide is highly active in # prostatecancer even before chemotherapy # ASCO14,,,# # #,4.73132E+17,https://twitter.com/EdwinPosadasMD/status/473131593339781120,,,,
ASCO,6/1/2014 11:58,6,3,"Plenary abstract, LBA4 - Phase III ALTTO trial for pts w/early HER2+ breast cancer: http://bit.ly/1n050jo # ASCO14 # bcsm",,,# #,4.73132E+17,https://twitter.com/ASCO/status/473131546254532608,,,,
PennMedNews,6/1/2014 11:58,1,1,Marcia Brose gives update on sorafenib's effect on overall survival in meta. # thyroidcancer # DECISIONTrial # ASCO14 http://abstracts.asco.org/144/AbstView_144_130451.html …,,,# # #,4.73131E+17,https://twitter.com/PennMedNews/status/473131477387866113,,,,
ASCO,6/1/2014 11:58,6,5,Abstract LBA3 now online: CALGB/SWOG 80405 results will be presented in today's Plenary Session http://bit.ly/T3TuJB # ASCO14,,,#,4.73131E+17,https://twitter.com/ASCO/status/473131420295368705,,,,
PinkSheetMaryJo,6/1/2014 11:58,0,1,"NIH approps roughly same as 1995, coop groups withering, Schilsky tells # ASCO14. Need to embed research in practice, national registries",,,#,4.73131E+17,https://twitter.com/PinkSheetMaryJo/status/473131417900433408,,,,
ERPlimackMD,6/1/2014 11:58,0,0,Dr. Armstrong re PREVAIL: need to understand Hazard ratio vs landmark/median PFS to characterize benefit of enzalutamide vs placebo # ASCO14,,,#,4.73131E+17,https://twitter.com/ERPlimackMD/status/473131372903538688,,,,
ASCO,6/1/2014 11:57,5,3,Abstract LBA2 now available: Phase III E3805 prostate cancer study http://bit.ly/T3TdWT # ASCO14 # pcsm,,,# #,4.73131E+17,https://twitter.com/ASCO/status/473131346022662145,,,,
mtmdphd,6/1/2014 11:57,2,2,. @ DrAnasYounes # lymsm # ASCO14 - Activity of PI3K/mTOR inhibitors in lymphoma pic.twitter.com/b8FAQN7NiA,,@,# #,4.73131E+17,https://twitter.com/mtmdphd/status/473131247448129537,,,,
ipaulmampilly,6/1/2014 11:57,0,1,# ASCO14 molecular profile how you'll be assigned cancer therapy in the future pic.twitter.com/RpZdb7GAkh,,,#,4.73131E+17,https://twitter.com/ipaulmampilly/status/473131232587698176,,,,
JSweetenhamMD,6/1/2014 11:57,0,0,Anas Younes is doing a great job reviewing HL therapy at # ASCO14,,,#,4.73131E+17,https://twitter.com/JSweetenhamMD/status/473131219941855232,,,,
cancersupport,6/1/2014 11:57,0,1,http://www.cancer.gov/newscenter/newsfromnci/2014/ASCOSOFTandTEXT … # ASCO14,,,#,4.73131E+17,https://twitter.com/cancersupport/status/473131219165921281,,,,
KoontzOncology,6/1/2014 11:57,3,3,The role of @ ASCO CancerLinQ in caring for pts in the time of precision medicine as explained by @ rschilsky # ASCO14 pic.twitter.com/PkERdhFWDM,,@ @,#,4.73131E+17,https://twitter.com/KoontzOncology/status/473131134508081153,,,,
StJudeResearch,6/1/2014 11:57,2,6,. @ StJude Drs. Les Robison and Melissa Hudson talk with @ DrRobertGlatter about collaboration in science # ASCO14 http://onforb.es/1m3mCaJ,,@ @,#,4.73131E+17,https://twitter.com/StJudeResearch/status/473131131802378241,,,,
robertwalker10,6/1/2014 11:57,0,0,Join @ GoToPER for Personalization of NSCLC Therapy CME-certified dinner symposium 7pm @Hyatt Regency Chicago # ASCO14 pic.twitter.com/pRCbLJtQod,,@ @Hyatt,#,4.73131E+17,https://twitter.com/robertwalker10/status/473131128506036225,,,,
ASCO,6/1/2014 11:56,11,7,"Abstract LBA1 - Exemestane+OFS vs tamoxifen+OFS in HR+ early breast ca, TEXT and SOFT trials: http://bit.ly/RTkIkU # ASCO14 # bcsm",,,# #,4.73131E+17,https://twitter.com/ASCO/status/473131094616047616,,,,
mtmdphd,6/1/2014 11:56,0,1,. @ DrAnasYounes # lymsm # ASCO14 - Mocetinostat in rel HL - Waterfall plot of clinical responses pic.twitter.com/7S2Tg7VCmj,,@,# #,4.73131E+17,https://twitter.com/mtmdphd/status/473131079629828097,,,,
WilliamDale_MD,6/1/2014 11:56,2,1,# ASCO14 Finding #2: Wives' marital happiness leads to more husbands' colonoscopyies. Really. pic.twitter.com/Ce2GbbBY8a,,,# #2,4.73131E+17,https://twitter.com/WilliamDale_MD/status/473131058976677888,,,,
SarahCannonDocs,6/1/2014 11:56,1,0,Poster 83 @SCRI_UK Dr. Arkenau: well tolerated FGFR inhibitor in pts w/ GC & GOJ. Now answering: is there a target phosphate level? # ASCO14,,@SCRI_UK,#,4.73131E+17,https://twitter.com/SarahCannonDocs/status/473131004233015296,,,,
AstraZenecaUS,6/1/2014 11:56,3,4,RT @MedImmune: MedImmune and @ AstraZeneca are demonstrating our oncology science at # ASCO14 http://bit.ly/1gPXhVq https://twitter.com/MedImmune/status/472759387585380352/photo/1pic.twitter.com/vL8aNZQJjG,,@MedImmune @,#,4.73131E+17,https://twitter.com/AstraZenecaUS/status/473130970854735873,,,,
dmooneymd,6/1/2014 11:55,0,0,Younes: can we eliminate chemotherapy in frontline setting from Hodgkin disease in lieu of Brentuximab? # lymsm # ASCO14,,,# #,4.73131E+17,https://twitter.com/dmooneymd/status/473130851400572930,,,,
mtmdphd,6/1/2014 11:55,0,1,. @ DrAnasYounes # lymsm # ASCO14 - Single agent activity of new agents in post SCT relapsed cHL pic.twitter.com/UlxWE0vGlJ,,@,# #,4.73131E+17,https://twitter.com/mtmdphd/status/473130826813952000,,,,
marykge,6/1/2014 11:55,1,0,@ DrAnasYounes - brentuximab alone in early stage Hodgkin; interesting possibility but will it work? # ASCO14 pic.twitter.com/LXrcBIoO7w,,@,#,4.73131E+17,https://twitter.com/marykge/status/473130824309940224,,,,
MediTech_Media,6/1/2014 11:55,1,1,# Patient and # Survivor care posters were very interesting this year at # ASCO14. Shined light on # cancer patient and caregiver issues.,,,# # # #,4.73131E+17,https://twitter.com/MediTech_Media/status/473130800079044608,,,,
teamoncology,6/1/2014 11:55,0,0,@ ASCO I am going to delete my comments.,,@,,4.73131E+17,https://twitter.com/teamoncology/status/473130715098251265,,,,
mtmdphd,6/1/2014 11:55,2,0,. @ DrAnasYounes # lymsm # ASCO14 - Relapse after ASCT - OS by Era of Transplant # bmtsmpic.twitter.com/HYU6QzXBcN,,@,# # #,4.73131E+17,https://twitter.com/mtmdphd/status/473130643518652416,,,,
joseluis_pa,6/1/2014 11:55,0,0,“RT @ yzafar: Continue the cancer drug cost and value discussion after @ ASCO at @ theIOM next week http://ow.ly/x5W5b # ASCO14”,,@ @ @,#,4.73131E+17,https://twitter.com/joseluis_pa/status/473130642281349120,,,,
JeffreyMOtto,6/1/2014 11:55,0,0,TY Charles Swanton for an outstanding talk!!! # ASCO14,,,#,4.73131E+17,https://twitter.com/JeffreyMOtto/status/473130618151530496,,,,
Boehringer,6/1/2014 11:55,2,1,BLOG POST: A summary of our 2nd day at # ASCO14. http://bit.ly/1mE8Htf # NotJustOneDisease # EGFR # hcsm # hcsmeu,,,# # # # #,4.73131E+17,https://twitter.com/Boehringer/status/473130617316835329,,,,
teamoncology,6/1/2014 11:55,0,0,@ ASCO I see. Thank you.,,@,,4.73131E+17,https://twitter.com/teamoncology/status/473130612694319105,,,,
kj_hashi,6/1/2014 11:54,3,2,カペシタビンの手足症候群に対するピリドキシンの効果。 以前他の論文で効果が否定されていた気もするが、この研究もあまり芳しくない結果。 # ASCO14 http://abstracts.asco.org/144/AbstView_144_126160.html …,,,#,4.73131E+17,https://twitter.com/kj_hashi/status/473130590938468352,,,,
DrMisialek,6/1/2014 11:54,1,3,New Report Estimates Nearly 19 Million Cancer Survivors in the U.S. by 2024 @ AmericanCancer @ ASCO # ASCO14 http://pressroom.cancer.org/Survivorship2014 …,,@ @,#,4.73131E+17,https://twitter.com/DrMisialek/status/473130552141565952,,,,
cancerassassin1,6/1/2014 11:54,0,0,Genome doubling --> higher relapse early stage colon cancer. Tetraploidy fosters Intratumor evolution and selection pressures. # ASCO14,,,#,4.73131E+17,https://twitter.com/cancerassassin1/status/473130507526750208,,,,
SusanLaufer,6/1/2014 11:54,1,0,"Freshly deep-fried mini-donuts at the @ Bayer booth at # ASCO14 . Add powdered sugar or not, your choice.",,@,#,4.7313E+17,https://twitter.com/SusanLaufer/status/473130389658021888,,,,
WCGClinical,6/1/2014 11:54,0,0,"Hosting webinar on 6/10 about unique ethical issues in # oncology research. Details: # ASCO14, booth 3097 or register http://bit.ly/1kg6IrS",,,# #,4.7313E+17,https://twitter.com/WCGClinical/status/473130354426277888,,,,
teamoncology,6/1/2014 11:54,0,0,:( RT @ ClevelandClinic: 0.1% - That is the approximate proportion of US federal funds allocated to # cancer research - @ cliffordhudis # ASCO14,,@ @,# #,4.7313E+17,https://twitter.com/teamoncology/status/473130351963807745,,,,
AbbottNews,6/1/2014 11:54,1,0,Abbott’s companion diagnostics can help physicians when making life-changing treatment decisions. http://bit.ly/1hGVuwV # ASCO2014,,,#,4.7313E+17,https://twitter.com/AbbottNews/status/473130351712559104,,,,
GuneetWalia,6/1/2014 11:53,0,0,Pasi Jaane: Clinical activity of EGFR inhibitor AZD9291 in pts with EGFR inhibitor–resistant # NSCLC http://am.asco.org/clinical-activity-mutant-selective-egfr-inhibitor-azd9291-patients-pts-egfr-inhibitor%E2%80%93resistant-non … # LCSM # ASCO14,,,# # #,4.7313E+17,https://twitter.com/GuneetWalia/status/473130250767839232,,,,
JeffreyMOtto,6/1/2014 11:53,0,0,CS: # ASCO14 genome doubling is significant precursor of onset of tumor heterogeneity,,,#,4.7313E+17,https://twitter.com/JeffreyMOtto/status/473130224906170368,,,,
ipaulmampilly,6/1/2014 11:53,0,0,# ASCO14 testing drugs by class I-spy2 testing graduates med agents by class based mech action pic.twitter.com/7ub8xsCFWG,,,#,4.7313E+17,https://twitter.com/ipaulmampilly/status/473130198050021376,,,,
GustaveRoussy,6/1/2014 11:53,4,0,# ASCO14 PrFizazi for GETUG 12: chemo effects in addition to radio/hormonotherapy (prostate # cancer) @ GroupeUNICANCERpic.twitter.com/hywKWloBfY,,@,# #,4.7313E+17,https://twitter.com/GustaveRoussy/status/473130196284235776,,,,
mtmdphd,6/1/2014 11:53,0,0,. @ DrAnasYounes # lymsm # ASCO14 - MSKCC 11-142 - Results for first 33 evaluable Pts pic.twitter.com/Zl8uCxP2IX,,@,# #,4.7313E+17,https://twitter.com/mtmdphd/status/473130177653125120,,,,
teamoncology,6/1/2014 11:53,1,0,Not bad. I think it is 10% from Ph1 to Ph3? RT @ ipaulmampilly: # ASCO14 only 39% of drugs transition from ph2 to ph3 pic.twitter.com/CMDZ5fCFp4,,@,#,4.7313E+17,https://twitter.com/teamoncology/status/473130154600849411,,,,
DrMisialek,6/1/2014 11:53,4,3,Oncologists: How to talk with your pathologist about cancer molecular testing @ ASCO @ Pathologists # ASCO14 http://www.eurekalert.org/pub_releases/2014-06/uocd-oht052814.php#.U4tMLhh-C5E.twitter …,,@ @,# #,4.7313E+17,https://twitter.com/DrMisialek/status/473130137912094720,,,,
JeffreyMOtto,6/1/2014 11:52,0,0,"CS: # ASCO14 ..thus due to tolerance of doubled genomes, enhances ability to generate variation.",,,#,4.7313E+17,https://twitter.com/JeffreyMOtto/status/473130007964172288,,,,
JamesPPinkerton,6/1/2014 11:52,0,0,The debate here at # ASCO14 is a true conflict of visions. Some say that we should invent our way out. Others say more regulation. 3/3,,,#,4.7313E+17,https://twitter.com/JamesPPinkerton/status/473129931946598401,,,,
mtmdphd,6/1/2014 11:52,0,0,. @ DrAnasYounes # lymsm # ASCO14 - PFS in randomized Pet -ve population -> at one point elim XRT and chemo pic.twitter.com/49Ol4Nnmnm,,@,# #,4.7313E+17,https://twitter.com/mtmdphd/status/473129876959285248,,,,
cancersupport,6/1/2014 11:52,0,1,Ovarian suppression with exemesatane better then Tam in premenopausal woman with ER +ve breast dancer # ASCO14,,,#,4.7313E+17,https://twitter.com/cancersupport/status/473129849310416896,,,,
ALLIANCE_org,6/1/2014 11:51,1,1,# ASCO14 Happening now | S Hall A2 brd 262 | GWAS of docetaxel-induced neutropenia in # CALGB90401/60404 http://bit.ly/1m3mXu6,,,# #,4.7313E+17,https://twitter.com/ALLIANCE_org/status/473129815684288513,,,,
DrMisialek,6/1/2014 11:51,6,3,"Major Advances in Breast, Prostate and Colorectal Cancer Treatment Featured at # ASCO14 @ ASCO http://www.asco.org/press-center/major-advances-breast-prostate-and-colorectal-cancer-treatment-featured-asco%E2%80%99s-annual#.U4tL_6lvB7o.twitter …",,@,# #,4.7313E+17,https://twitter.com/DrMisialek/status/473129807748689922,,,,
KoontzOncology,6/1/2014 11:51,5,4,Big data in the field of precision medicine as per @ rschilsky # ASCO14 pic.twitter.com/wGtLTULV7X,,@,#,4.7313E+17,https://twitter.com/KoontzOncology/status/473129804234256384,,,,
Amyloid_Planet,6/1/2014 11:51,3,1,s**t desperate onc docs will undoubtedly try after # ASCO14: vorinostat + sirolimus in RR HD. 57% ORR (phase 1 trial) pic.twitter.com/D17tmvDKzY,,,#,4.7313E+17,https://twitter.com/Amyloid_Planet/status/473129758919000065,,,,
JSwatercooler,6/1/2014 11:51,0,0,Hi @ AlpineBV_Miller -caught a glimpse of you rushing to the poster session just now! Hardest working fund mgr at # ASCO14 ?,,@,#,4.7313E+17,https://twitter.com/JSwatercooler/status/473129749905428480,,,,
teamoncology,6/1/2014 11:51,0,0,"Agree. RT @nextprinciples: @ teamoncology We see a vibrant, trusted and engaged community sharing great insights # ASCO14",,@nextprinciples @,#,4.7313E+17,https://twitter.com/teamoncology/status/473129745635213312,,,,
JeffreyMOtto,6/1/2014 11:51,0,0,CS: # ASCO14 genome doubled cells tend to tolerate chromosomal instability better,,,#,4.7313E+17,https://twitter.com/JeffreyMOtto/status/473129721472233472,,,,
DrHedrick,6/1/2014 11:51,0,0,Hoch: Cost effectiveness in cancer care. Consider incentive. Need to reassess value. Oncologists must PUSH field or be PULLED by it. # ASCO14,,,#,4.7313E+17,https://twitter.com/DrHedrick/status/473129705961684992,,,,
emiialauie,6/1/2014 11:51,1,0,Me parece tan desagradable esas personas que en el face se ponen de nombre ponicornio o pitufo # ASCO14,,,#,4.7313E+17,https://twitter.com/emiialauie/status/473129695626924033,,,,
teamoncology,6/1/2014 11:51,0,1,"@ jrgralow Also, the values come from the mutual empowerment between Drs and pts. My TEDx Talk about this. https://www.youtube.com/watch?v=Cqe5cKhgFFc … # ASCO14",,@,#,4.7313E+17,https://twitter.com/teamoncology/status/473129674617266176,,,,
ipaulmampilly,6/1/2014 11:50,0,0,# ASCO14 only 39% of drugs transition from ph2 to ph3 pic.twitter.com/lKDyS1aEQu,,,#,4.7313E+17,https://twitter.com/ipaulmampilly/status/473129536335667200,,,,
BoysenMeb,6/1/2014 11:50,2,0,Morgenmad og interview med knivskarpe aktieanalytiker Michael Novod. Senere venter store resultater. Dag 3 på # ASCO14 blir god @DagMedicin,,@DagMedicin,#,4.73129E+17,https://twitter.com/BoysenMeb/status/473129470531219457,,,,
mtmdphd,6/1/2014 11:50,0,0,". @ DrAnasYounes # lymsm # ASCO14 - HD13 Early-stage favorable HL (now use 20 Gy IF-RT), elim arms 2 & 4 pic.twitter.com/uYjj1rna4Z",,@,# #,4.73129E+17,https://twitter.com/mtmdphd/status/473129436293128193,,,,
DebiopharmNews,6/1/2014 11:50,0,0,# ASCO14 Successful in- and out-licensing for breakthrough drugs benefiting the # patient http://ow.ly/x96mn,,,# #,4.73129E+17,https://twitter.com/DebiopharmNews/status/473129412716933121,,,,
jrgralow,6/1/2014 11:50,3,4,Embargo lifted: results of SOFT/TEXT combined analysis to be presented at plenary this pm - OFS + tamox vs AI # ASCO14 http://www.cancer.gov/newscenter/newsfromnci/2014/ASCOSOFTandTEXT …,,,#,4.73129E+17,https://twitter.com/jrgralow/status/473129398543986688,,,,
OncLive,6/1/2014 11:50,0,0,Dr. Mark Pegram from @ SUMedicine on a Phase II Trial of MGAH22 in Breast Cancer http://ow.ly/xuA6t # ASCO14,,@,#,4.73129E+17,https://twitter.com/OncLive/status/473129378885689345,,,,
CancerTherAdvsr,6/1/2014 11:50,3,1,# ASCO14: Goserelin Helps Preserve Fertility Among Women Undergoing # Chemo for HR-Negative # BreastCancer http://ow.ly/xuyWY,,,# # #,4.73129E+17,https://twitter.com/CancerTherAdvsr/status/473129357243056128,,,,
KoontzOncology,6/1/2014 11:49,8,6,@ rschilsky explains a new model on obtaining drugs in the era of precision medicine. # ASCO14 pic.twitter.com/ENgdN7fKE8,,@,#,4.73129E+17,https://twitter.com/KoontzOncology/status/473129305560465408,,,,
teamoncology,6/1/2014 11:49,0,0,"True. RT @ jrgralow: Cancer doctors urged to consider value when treating patients # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-health-cancer-value-20140530,0,4872696.story …",,@,#,4.73129E+17,https://twitter.com/teamoncology/status/473129264548560896,,,,
fwpharma,6/1/2014 11:49,3,0,Roche's anti-PDL1 therapy MPDL3280A shrinks tumours in early-stage bladder cancer study http://bit.ly/1ryB03b # ASCO14 # pharma,,,# #,4.73129E+17,https://twitter.com/fwpharma/status/473129256076460033,,,,
JeffreyMOtto,6/1/2014 11:49,0,0,"CS: # asco14 doubled genomes in CRC are more unstable, and tend to drift towards trlploidy",,,#,4.73129E+17,https://twitter.com/JeffreyMOtto/status/473129133049151488,,,,
ipaulmampilly,6/1/2014 11:48,0,0,# ASCO14 $2 bill to dev successful drug pic.twitter.com/AscljW61Nv,,,#,4.73129E+17,https://twitter.com/ipaulmampilly/status/473129076891594753,,,,
JSweetenhamMD,6/1/2014 11:48,0,0,Dr Garrido-Laguna from HCI gets a shout out at # ASCO14 lymphoma session for contributions to sirolimus/vorinostat study. @ huntsmancancer,,@,#,4.73129E+17,https://twitter.com/JSweetenhamMD/status/473129073976549376,,,,
ArcagyGineco,6/1/2014 11:48,0,0,En direct de l‘ # ASCO14 : pazopanib + taxol hebdomaire améliore la survie sans progression dans le cancer de l’ovaire en rechute précoce,,,#,4.73129E+17,https://twitter.com/ArcagyGineco/status/473129059388375040,,,,
JamesPPinkerton,6/1/2014 11:48,1,0,"Every cancer patient, and every family concerned about cancer, should mindful of what is happening at # ASCO14--policy debate brewing... 1/3",,,#,4.73129E+17,https://twitter.com/JamesPPinkerton/status/473128953222537216,,,,
mtmdphd,6/1/2014 11:48,0,0,. @ DrAnasYounes of @ MSKCC_OncoNotes # lymsm # ASCO14 - Tx in Early Stage HL pic.twitter.com/9cUgxe6lR8,,@ @,# #,4.73129E+17,https://twitter.com/mtmdphd/status/473128943068123136,,,,
NateDahlPharmD,6/1/2014 11:48,0,0,RT @ ASCOPost: FDA cancer chief says 'escalating' drug prices can't continue (via @ Reuters) http://ow.ly/xuyGQ # ASCO14,,@ @,#,4.73129E+17,https://twitter.com/NateDahlPharmD/status/473128933144023042,,,,
teamoncology,6/1/2014 11:48,0,0,RT @ jrgralow: Targeted therapies in breast cancer tutorial from @ theNCI # ASCO14 # bcsm http://ow.ly/xuCqj,,@ @,# #,4.73129E+17,https://twitter.com/teamoncology/status/473128921110552578,,,,
JeffreyMOtto,6/1/2014 11:47,0,0,"CS: # asco14 replication stress leads to chromosomal instability, and 18q loss contributes replication stress",,,#,4.73129E+17,https://twitter.com/JeffreyMOtto/status/473128794673655808,,,,
PinkSheetMaryJo,6/1/2014 11:47,1,0,"Schilsky: need to screen 154 to enroll one patient in study of multiple kinase inhibitors. Need alternate ways, esp in rare cancers # ASCO14",,,#,4.73129E+17,https://twitter.com/PinkSheetMaryJo/status/473128773102342144,,,,
KoontzOncology,6/1/2014 11:47,1,0,Some ways patients can gain access to medications # ASCO14 pic.twitter.com/7SFbYLVbjO,,,#,4.73129E+17,https://twitter.com/KoontzOncology/status/473128759215017984,,,,
teamoncology,6/1/2014 11:47,4,1,Nice to read. RT @ jrgralow: Overview of PARP inhibitors in breast cancer from @ theNCI http://www.cancer.gov/cancertopics/understandingcancer/targetedtherapies/breastcancer_htmlcourse/page5 … # ASCO14 # bcsm,,@ @,# #,4.73129E+17,https://twitter.com/teamoncology/status/473128645297336321,,,,
DrHedrick,6/1/2014 11:47,0,0,"My thoughts: Combine targeted agents, overcome mutation, multiple pathways in colorectal cancer. Where's the chemo? Its a new era. # ASCO14",,,#,4.73129E+17,https://twitter.com/DrHedrick/status/473128622182920193,,,,
TuftsB,6/1/2014 11:47,0,0,"@ DrBobGoldberg @ ASCO - are we individual human beings , lab rats or economic playthings for PHDs?",,@ @,,4.73129E+17,https://twitter.com/TuftsB/status/473128612925681664,,,,
cancersupport,6/1/2014 11:47,1,1,Binimetinib (NRAS inh) with LEE011(CDK4 inh) shows promise 33% response 33 shrink 20-30% >80% clinical benefit # ASCO14,,,#,4.73129E+17,https://twitter.com/cancersupport/status/473128598313123840,,,,
jrgralow,6/1/2014 11:47,4,2,"Cancer doctors urged to consider value when treating patients # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-health-cancer-value-20140530,0,4872696.story …",,,#,4.73129E+17,https://twitter.com/jrgralow/status/473128592633651201,,,,
mnewtonPharmD,6/1/2014 11:46,0,0,Orterinel improved rPFS but not OS in mCRPC. (CYP 17 inhibitor) # ASCO14 pic.twitter.com/65XXYclpQt,,,#,4.73129E+17,https://twitter.com/mnewtonPharmD/status/473128546043715584,,,,
DrAttai,6/1/2014 11:46,0,0,CPM effects on QOL (2/2) # asco14 # bcsmpic.twitter.com/sGeBn4ULtQ,,,# #,4.73128E+17,https://twitter.com/DrAttai/status/473128473243164672,,,,
mtmdphd,6/1/2014 11:46,0,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Shout out to @ DrAnasYounes and @LymphomaMyeloma Deptpic.twitter.com/G3T1TBcWur,,@ @LymphomaMyeloma,# #,4.73128E+17,https://twitter.com/mtmdphd/status/473128412027289600,,,,
JeffreyMOtto,6/1/2014 11:46,0,0,"CS: # ASCO14 found three genes at 18q when knocked out lead to CIN: png, rkhd2 znf516",,,#,4.73128E+17,https://twitter.com/JeffreyMOtto/status/473128378825211905,,,,
DrAttai,6/1/2014 11:46,0,0,CPM effects on QOL (1/2) # asco14 # bcsmpic.twitter.com/eRVMdOxfKw,,,# #,4.73128E+17,https://twitter.com/DrAttai/status/473128365785100288,,,,
JediPD,6/1/2014 11:45,0,1,@ teamoncology @ nxtstop1 Maybe CT scanned visceral obesity is the cause for inflammation! (The irony in that tongue in cheek) # ASCO14,,@ @,#,4.73128E+17,https://twitter.com/JediPD/status/473128309149421568,,,,
DKarikios,6/1/2014 11:45,0,0,# ASCO2014 Tagawa: Orteronel - do we really need another CYP17 inhibitor in prostate cancer? (unlikely to get approval in Australia),,,#,4.73128E+17,https://twitter.com/DKarikios/status/473128265868005377,,,,
EDVISSERAFIM,6/1/2014 11:45,0,0,# ASCO14,,,#,4.73128E+17,https://twitter.com/EDVISSERAFIM/status/473128254895710208,,,,
cancersupport,6/1/2014 11:45,1,0,"“ @ rschilsky: # ASCO14 CALGB/SWOG 80405 shows 29 mo. median OS in both arms,best ever reported. Bev and cetuximab given with standard chemo",,@,#,4.73128E+17,https://twitter.com/cancersupport/status/473128224420294656,,,,
mtmdphd,6/1/2014 11:45,0,2,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Conclusions - new alternative mTORi + HDACi considered pic.twitter.com/IbcBYjS45b,,,# #,4.73128E+17,https://twitter.com/mtmdphd/status/473128210675564544,,,,
teamoncology,6/1/2014 11:45,3,1,【 # ASCO14 Update】Pazopanib plus paclitaxel may be effective in pts w/platinum-res or refractory advanced ovarian. http://abstracts.asco.org/144/AbstView_144_131237.html …,,,#,4.73128E+17,https://twitter.com/teamoncology/status/473128181902233601,,,,
cancerassassin1,6/1/2014 11:45,1,0,My burning question x 3 yrs: why is sound of seagulls so loud during talks in Hall D1?as with Tootsie Pops we may never know # ASCO14 @ ASCO,,@,#,4.73128E+17,https://twitter.com/cancerassassin1/status/473128164198461440,,,,
Cascadia,6/1/2014 11:45,0,0,@ genentech + Collaboration is Game Changer in Cancer Research http://onforb.es/1tyeOSw @ DrRobertGlatter # ASCO14 # HDPalozza via @ Forbes,,@ @ @,# #,4.73128E+17,https://twitter.com/Cascadia/status/473128161958694912,,,,
jrgralow,6/1/2014 11:45,3,3,Targeted therapies in breast cancer tutorial from @ theNCI # ASCO14 # bcsm http://ow.ly/xuCqj,,@,# #,4.73128E+17,https://twitter.com/jrgralow/status/473128160260030464,,,,
CureMelanoma,6/1/2014 11:45,0,0,Following # melanoma # cancer updates from # ASCO14? Follow our Exec Director @ TimTurnham who is live-tweeting updates. # oncology # ASCO,,@,# # # # #,4.73128E+17,https://twitter.com/CureMelanoma/status/473128127439581185,,,,
MRFCureOM,6/1/2014 11:45,0,0,Following # melanoma # cancer updates from # ASCO14? Follow our Exec Director @ TimTurnham who is live-tweeting updates. # oncology # ASCO,,@,# # # # #,4.73128E+17,https://twitter.com/MRFCureOM/status/473128127049523200,,,,
jtriestm,6/1/2014 11:45,0,1,"ASCO 2014: New combo, cediranib plus olaparib, increases pfs recurrent ovarian cancer. ecancer - News http://ecancer.org/news/5742-asco-2014--new-combo--cediranib-plus-olaparib--significantly-increases-progression-free-survival-in-recurrent-ovarian-cancer.php#.U4tKUWfijJ8.twitter … # asco14",,,# #,4.73128E+17,https://twitter.com/jtriestm/status/473128095885430784,,,,
NTConnell,6/1/2014 11:45,2,1,"Oncologists' practice patterns seem to be associated with financial incentives (and other stuff)"" - Jeffrey Hoch # ASCO14""",,,#,4.73128E+17,https://twitter.com/NTConnell/status/473128084787699712,,,,
kj_hashi,6/1/2014 11:44,1,0,徐放性グラニセトロン（そんなものがあるのか！）とパロノセトロンの非劣性を見たPhaseIII。効果に差は無しの結果で今後この製剤も夜に出てくるのかも。 # ASCO14 http://abstracts.asco.org/144/AbstView_144_134088.html …,,,#,4.73128E+17,https://twitter.com/kj_hashi/status/473128082878902272,,,,
ERPlimackMD,6/1/2014 11:44,3,0,"Enzalutamide in mCRPC pre-chemo shows OS, PFS, and QOL benefit over placebo. Results @ ASCO14 @ NEJM # ASCO14 # gusm http://www.nejm.org/doi/full/10.1056/NEJMoa1405095 …",,@ @,# #,4.73128E+17,https://twitter.com/ERPlimackMD/status/473128079242440705,,,,
JeffreyMOtto,6/1/2014 11:44,0,0,CS: # ASCO14 deletion of section of 18q seems to be associated w/ chromosomal instability,,,#,4.73128E+17,https://twitter.com/JeffreyMOtto/status/473128047634575360,,,,
mtmdphd,6/1/2014 11:44,0,1,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Case pic.twitter.com/jkO6G1N3Qd,,,# #,4.73128E+17,https://twitter.com/mtmdphd/status/473128010057809920,,,,
drdonsdizon,6/1/2014 11:44,2,1,"Truth! MT  @ teamoncology: Agree. You just can never simplify the biology of cancer. # ASCO14""""",,@,#,4.73128E+17,https://twitter.com/drdonsdizon/status/473127990042591232,,,,
jtriestm,6/1/2014 11:43,0,0,Clinical trial analysis suggests drug combination effective in recurrent ovarian cancer - http://www.dana-farber.org/Newsroom/News-Releases/clinical-trial-analysis-suggests-drug-combination-may-be-highly-effective-in-recurrent-ovarian-cancer.aspx#.U4tKBc4U_rE.twitter … # asco14,,,# #,4.73128E+17,https://twitter.com/jtriestm/status/473127800170221568,,,,
MaverickNY,6/1/2014 11:43,3,5,Whoa en route to posters past exhibits - $ AZN is like something from Star Trek # asco14 pic.twitter.com/aeN5wO7XC3,,,#,4.73128E+17,https://twitter.com/MaverickNY/status/473127765701828608,,,,
carisls,6/1/2014 11:43,0,0,"Study suggests # esophageal, GEJ, gastric & # gallbladder cancers could benefit from HER2 targeted therapies http://goo.gl/oG0B17 # ASCO14",,,# # #,4.73128E+17,https://twitter.com/carisls/status/473127671141249024,,,,
nxtstop1,6/1/2014 11:43,0,0,"Follow @ drattai for her tweets of her excellent slides on Obesity & Breast Ca., Genetic Screening Breast Ca & Male Breast Ca. # ASCO14",,@,#,4.73128E+17,https://twitter.com/nxtstop1/status/473127640967024640,,,,
jrgralow,6/1/2014 11:43,1,0,Overview of PARP inhibitors in breast cancer from @ theNCI http://www.cancer.gov/cancertopics/understandingcancer/targetedtherapies/breastcancer_htmlcourse/page5 … # ASCO14 # bcsm,,@,# #,4.73128E+17,https://twitter.com/jrgralow/status/473127584704630784,,,,
mtmdphd,6/1/2014 11:43,1,1,"Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Case refractory to 9 prior Rx including Auto, Allo, BV pic.twitter.com/JhcxbvVBGs",,,# #,4.73128E+17,https://twitter.com/mtmdphd/status/473127584151400448,,,,
KoontzOncology,6/1/2014 11:42,0,0,Basket trials allow us to see how drugs interact with selected targets. # ASCO14 pic.twitter.com/zeJ5ZW8aNL,,,#,4.73127E+17,https://twitter.com/KoontzOncology/status/473127455172345857,,,,
DrBobGoldberg,6/1/2014 11:42,1,0,. @ ASCO app says society determines how much life worth # costshiftingpic.twitter.com/8K5LCcvMhs,,@,#,4.73127E+17,https://twitter.com/DrBobGoldberg/status/473127401657208833,,,,
PhRMA,6/1/2014 11:42,1,0,Incremental advances are mostly likely to lead to breakthroughs says @ Celgene. Read more: http://bit.ly/1hFWamh # ASCO14,,@,#,4.73127E+17,https://twitter.com/PhRMA/status/473127377023692803,,,,
MedscapeOnc,6/1/2014 11:41,17,13,Schilsky: patient engagement will be fourth revolution affecting future of cancer care # ASCO14 pic.twitter.com/AYOxkEoQIM,,,#,4.73127E+17,https://twitter.com/MedscapeOnc/status/473127304118296577,,,,
JeffreyMOtto,6/1/2014 11:41,1,0,CS: # ASCO14 mechanisms that trigger chromosomal instability is incompletely understood.,,,#,4.73127E+17,https://twitter.com/JeffreyMOtto/status/473127296275345408,,,,
DrAttai,6/1/2014 11:41,3,0,Alcohol consumption after cancer diagnosis (2/2) # asco14 # bcsmpic.twitter.com/dnWrdKivCY,,,# #,4.73127E+17,https://twitter.com/DrAttai/status/473127238523973632,,,,
mtmdphd,6/1/2014 11:41,0,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Toxicity pic.twitter.com/99iCVzsXob,,,# #,4.73127E+17,https://twitter.com/mtmdphd/status/473127215694364672,,,,
JamesPPinkerton,6/1/2014 11:41,0,0,"# ASCO14 -- The long run is a series of short runs. Science can be slow, but happily, it's cumulative. A cure will not be built in a day.",,,#,4.73127E+17,https://twitter.com/JamesPPinkerton/status/473127200242565120,,,,
djsampson,6/1/2014 11:41,0,1,Real challenge implementing in real life MT @ subatomicdoc: Low-dose CT lung cancer screening in the community http://bit.ly/1kROx0p # ASCO14,,@,#,4.73127E+17,https://twitter.com/djsampson/status/473127182509043712,,,,
DrAttai,6/1/2014 11:41,3,0,Alcohol consumption after cancer diagnosis (1/2) # asco14 # bcsmpic.twitter.com/F7pxinySW5,,,# #,4.73127E+17,https://twitter.com/DrAttai/status/473127180231528448,,,,
FightCRC,6/1/2014 11:41,0,0,"Jeff Allen, ED of Friends of Cancer Research, on Lung Master Protocol & impact on clinical trials # ASCO14 # crcsmpic.twitter.com/G7UFfvRTYH",,,# #,4.73127E+17,https://twitter.com/FightCRC/status/473127103836078080,,,,
PinkSheetMaryJo,6/1/2014 11:41,0,1,"Will clinically cure major fraction of melanoma in 5-10 yrs, Eggermont tells # ASCO14. Breaking tolerance will get Nobel prize.",,,#,4.73127E+17,https://twitter.com/PinkSheetMaryJo/status/473127081564717056,,,,
dmooneymd,6/1/2014 11:40,0,0,"Phase I study of vorinostat and sirolimus in refractory Hodgkin dz. Orr 57%, median fu 5.4 mos with median ttf not reached. # lymsm # ASCO14",,,# #,4.73127E+17,https://twitter.com/dmooneymd/status/473127073054076928,,,,
mtmdphd,6/1/2014 11:40,1,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Efficacy Summary pic.twitter.com/dvRYRnxph1,,,# #,4.73127E+17,https://twitter.com/mtmdphd/status/473127014069972993,,,,
Lhcamacho,6/1/2014 11:40,0,1,"# ASCO14 Annual Mtg remains a playground where dreams of regulators, investigators, clinicians, patient advocates and pts become true!",,,#,4.73127E+17,https://twitter.com/Lhcamacho/status/473126957451055105,,,,
DrBobGoldberg,6/1/2014 11:40,2,0,. @ ASCO app will be financially toxic to patients expose docs to lawsuits # costofcarepic.twitter.com/2Iq7IUqPvm,,@,#,4.73127E+17,https://twitter.com/DrBobGoldberg/status/473126941118439425,,,,
EthanBasch1,6/1/2014 11:40,0,0,Prostate: modest 8.8 week OS benefit w enzalutamide pre-chemotherapy w QOL benefit # ASCO14 http://tinyurl.com/mk9dhwy pic.twitter.com/uHSrQ2YuQ9,,,#,4.73127E+17,https://twitter.com/EthanBasch1/status/473126939465900032,,,,
DebiopharmNews,6/1/2014 11:40,0,0,# ASCO14 Our unique # patientcentric business model for # success: Debiopharm Group http://ow.ly/x96i0,,,# # #,4.73127E+17,https://twitter.com/DebiopharmNews/status/473126898852438017,,,,
markaorourke,6/1/2014 11:40,0,0,# ASCO14 Cancer health services: scant literature re oncologist $ incentives. Are oncologists susceptible to $ incentives? Yes!,,,#,4.73127E+17,https://twitter.com/markaorourke/status/473126880368132096,,,,
ClevelandClinic,6/1/2014 11:40,37,12,More than 1/3 of all US adults and 17% of US children and adolescents are obese. - Dr. Ligibel # ASCO14,,,#,4.73127E+17,https://twitter.com/ClevelandClinic/status/473126867181240320,,,,
genentech,6/1/2014 11:40,0,0,@ Lymphoma_Doc Unfortunate & true. More on the main barriers & what we can do to overcome them here: http://ow.ly/xuBjR # ASCO14,,@,#,4.73127E+17,https://twitter.com/genentech/status/473126863829999616,,,,
mtmdphd,6/1/2014 11:40,2,1,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Waterfall plot (maximum reduction) pic.twitter.com/4YpAHJa9YG,,,# #,4.73127E+17,https://twitter.com/mtmdphd/status/473126855793725440,,,,
teamoncology,6/1/2014 11:40,0,0,@nextprinciples thanks. This looks like a horse race. LOL # ASCO14 https://twitter.com/nextprinciples/status/473125934833229826/photo/1pic.twitter.com/xaCZTDZzhh,,@nextprinciples,#,4.73127E+17,https://twitter.com/teamoncology/status/473126829859946497,,,,
JeffreyMOtto,6/1/2014 11:39,0,0,CS: # asco14 need to understand biological mechanisms for genomic instability - and target it,,,#,4.73127E+17,https://twitter.com/JeffreyMOtto/status/473126820943249409,,,,
MaverickNY,6/1/2014 11:39,0,1,Bumped into @ PDRennert and @ aftimosp this am separately. To delightful gentleman! # asco14 pic.twitter.com/GgH6KMJK0G,,@ @,#,4.73127E+17,https://twitter.com/MaverickNY/status/473126796272340993,,,,
gorskon,6/1/2014 11:39,4,1,"For the haters who keep claiming that cancer treatment hasn't improved in 40 years, try this on for size. # ASCO14 http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology …",,,#,4.73127E+17,https://twitter.com/gorskon/status/473126753406554113,,,,
jrgralow,6/1/2014 11:39,0,1,". @ drdonsdizon with his # ASCO14 IDEA award mentee, Iryna from Ukraine. pic.twitter.com/qqI6UI0iGA",,@,#,4.73127E+17,https://twitter.com/jrgralow/status/473126726990856192,,,,
mtmdphd,6/1/2014 11:39,0,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Pt characteristics (notes amended protocol) pic.twitter.com/pFY57N1Bon,,,# #,4.73127E+17,https://twitter.com/mtmdphd/status/473126644136558592,,,,
JeffreyMOtto,6/1/2014 11:39,1,0,CS: # ASCO14 - in CRC drug resistance is almost inevitable and polyclonality is likely very complex.,,,#,4.73127E+17,https://twitter.com/JeffreyMOtto/status/473126634946842624,,,,
jtriestm,6/1/2014 11:38,0,0,Paclitaxel plus pazopanib improved survival in advanced ovarian cancer http://goo.gl/tqqKof # asco14,,,#,4.73127E+17,https://twitter.com/jtriestm/status/473126516432179200,,,,
gorskon,6/1/2014 11:38,0,0,Something about meetings gets me Tweeting again. I hadn't Tweeted much at all for a few weeks before I arrived at # ASCO14. Weird.,,,#,4.73127E+17,https://twitter.com/gorskon/status/473126511114215424,,,,
mtmdphd,6/1/2014 11:38,0,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - TCP DLT pic.twitter.com/d29sP3fJPO,,,# #,4.73126E+17,https://twitter.com/mtmdphd/status/473126476158877697,,,,
DrAttai,6/1/2014 11:38,4,2,Cardiac fitness in pts with chemo-induced heart failure via @ MDAndersonNews @ k_basenengquist # asco14 # bcsm (2/2)pic.twitter.com/J7xEQZF7qg,,@ @,# #,4.73126E+17,https://twitter.com/DrAttai/status/473126445448167425,,,,
jtriestm,6/1/2014 11:38,0,0,Novel agent bested topotecan in platinum-resistant ovarian cancer http://goo.gl/y6gjLP # asco14,,,#,4.73126E+17,https://twitter.com/jtriestm/status/473126373968461824,,,,
DrAttai,6/1/2014 11:38,3,4,Cardiac fitness in pts with chemo-induced heart failure via @ MDAndersonNews @ k_basenengquist # asco14 # bcsm (1/2)pic.twitter.com/v9Kl6f8n3g,,@ @,# #,4.73126E+17,https://twitter.com/DrAttai/status/473126372726951937,,,,
JeffreyMOtto,6/1/2014 11:37,0,0,CS: # ASCO14 - diversity means that # biomarkers tested at different sites may give different results. Me - opportunity for liq. biopsies,,,# #,4.73126E+17,https://twitter.com/JeffreyMOtto/status/473126315915509760,,,,
mtmdphd,6/1/2014 11:37,0,0,Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - schedule pic.twitter.com/vfgGXwoKAu,,,# #,4.73126E+17,https://twitter.com/mtmdphd/status/473126279861272576,,,,
KoontzOncology,6/1/2014 11:37,0,0,The future of immunology combinations in melanoma as part of precision medicine. # ASCO14 pic.twitter.com/Whzn7WUmLZ,,,#,4.73126E+17,https://twitter.com/KoontzOncology/status/473126252300484608,,,,
WCGClinical,6/1/2014 11:37,0,0,"WCG Academy online courses designed 2 max adult learner’s attention/retention, assignments 2 meet individual’s knowledge gaps # ASCO14 demos",,,#,4.73126E+17,https://twitter.com/WCGClinical/status/473126249339322368,,,,
SkinMelanoma,6/1/2014 11:37,1,1,Results from study of DecisionDx-Melanoma predictive gene test selected as ‘Poster Highlights’ presentation at # ASCO14 (Abst 9022),,,#,4.73126E+17,https://twitter.com/SkinMelanoma/status/473126236328570880,,,,
jtriestm,6/1/2014 11:37,0,0,"New drugs may make a dent in lung, ovarian cancer http://wapo.st/1kWIyHG via @ jtriestm # asco14",,@,#,4.73126E+17,https://twitter.com/jtriestm/status/473126173682061312,,,,
mtmdphd,6/1/2014 11:37,0,0,"Janku # lymsm # ASCO14 mTORi (sirolimus) + HDACi (vorinostat) - Phase 1, 3+3 with MTD/RP2D exp cohorts pic.twitter.com/qPkP3igmPe",,,# #,4.73126E+17,https://twitter.com/mtmdphd/status/473126148583723008,,,,
StefanoLuminari,6/1/2014 11:37,2,1,# ASCO14. Federico on Brentuximab Vedotin before ABVD in HL. 12 pts complete metabolic responses in 92% with BV. @ lymphomahub,,@,#,4.73126E+17,https://twitter.com/StefanoLuminari/status/473126108720680960,,,,
SkinMelanoma,6/1/2014 11:37,4,1,New data being presented tmrw at # ASCO14 by @ EmoryUniversity’s Dr. David Lawson on gene test to predict survival in # melanoma patients,,@,# #,4.73126E+17,https://twitter.com/SkinMelanoma/status/473126103200976896,,,,
mnewtonPharmD,6/1/2014 11:37,0,0,PREVAIL results live at @ NEJM # ASCO14,,@,#,4.73126E+17,https://twitter.com/mnewtonPharmD/status/473126096276561920,,,,
DrLen,6/1/2014 11:36,0,0,Eggermont: we are very bad predicting toxicites of combo immune/target rx. You will kill patients so need clinical trials. # ASCO14,,,#,4.73126E+17,https://twitter.com/DrLen/status/473126024725540864,,,,
fwpharma,6/1/2014 11:36,0,0,Study: Exemestane reduces hormone-sensitive breast cancer recurrence # ASCO2014 http://bit.ly/1mFZ7Gi,,,#,4.73126E+17,https://twitter.com/fwpharma/status/473125978513080320,,,,
carisls,6/1/2014 11:36,2,1,Biomarker distribution in # gastrointestinal cancers showed 3 distinct tumor type clusters. http://goo.gl/oG0B17 # ASCO14 # MolecularIntel,,,# # #,4.73126E+17,https://twitter.com/carisls/status/473125892970270720,,,,
dramanfredi,6/1/2014 11:36,0,1," @ drattai: Genetic counseling for young women at risk for HBOC via @ LurieCancer # asco14 # bcsm (2/3) pic.twitter.com/T1tuQWU21N"" @ nunezlina""",,@ @ @,# #,4.73126E+17,https://twitter.com/dramanfredi/status/473125859797520385,,,,
JeffreyMOtto,6/1/2014 11:36,0,0,CS: # asco14 genomic instability fosters the diversity necessary to develop treatment resistance.,,,#,4.73126E+17,https://twitter.com/JeffreyMOtto/status/473125850955911168,,,,
mnewtonPharmD,6/1/2014 11:36,1,0,Enzalutamide also improved QOL via FACT-P scale. Important given indolent nature of disease. # ASCO14 pic.twitter.com/Lil6L5CgK5,,,#,4.73126E+17,https://twitter.com/mnewtonPharmD/status/473125832610037760,,,,
PinkSheetMaryJo,6/1/2014 11:35,0,2,"Immunotherapy combos will need to go thru trials. We are v bad at predicting toxicity, Eggermont warns. Will kill patients. # ASCO14",,,#,4.73126E+17,https://twitter.com/PinkSheetMaryJo/status/473125791237431296,,,,
dramanfredi,6/1/2014 11:35,0,0," @ drattai: Genetic counseling for young women at risk for HBOC via # asco14 # bcsm (3/3) pic.twitter.com/0nKzvg4jDf"" @ nunezlina @ mariaviniegra""",,@ @ @,# #,4.73126E+17,https://twitter.com/dramanfredi/status/473125784002232321,,,,
mtmdphd,6/1/2014 11:35,0,0,Janku # lymsm # ASCO14 - Younes background... pic.twitter.com/sRd8mdFEKV,,,# #,4.73126E+17,https://twitter.com/mtmdphd/status/473125780550352896,,,,
CancerNetwrk,6/1/2014 11:35,0,0,BLOG: Planning Your ASCO Meeting http://bit.ly/1n0io6Z # ASCO14,,,#,4.73126E+17,https://twitter.com/CancerNetwrk/status/473125655975329792,,,,
genentech,6/1/2014 11:35,1,1,@ z_phd We agree. Here's how we're learning from one negative trial: http://ow.ly/xuB7W # ASCO14,,@,#,4.73126E+17,https://twitter.com/genentech/status/473125621363900417,,,,
jtriestm,6/1/2014 11:35,0,0,Pair of Pills Shows Promise for Recurrent Ovarian Cancer http://po.st/PcrPYr via @ jtriestm # asco14,,@,#,4.73126E+17,https://twitter.com/jtriestm/status/473125589163851778,,,,
AlpineBV_Miller,6/1/2014 11:35,4,5,"Not sure how many had 8506 on their sched, but these data are really intriguing for Adcetris $ SGEN # ASCO14 pic.twitter.com/nmDcmEh1KO",,,#,4.73126E+17,https://twitter.com/AlpineBV_Miller/status/473125588476375040,,,,
PDRennert,6/1/2014 11:34,3,1,"bretuximab vedotin in rrNHL: 83% CR 10% PR, ORR > 90%, DOR > 4mo after followup 11/12 CR one w/PD (had been PR). v nice # ASCO14",,,#,4.73126E+17,https://twitter.com/PDRennert/status/473125548726968320,,,,
nxtstop1,6/1/2014 11:34,76,26,INFOGRAPHIC:LIFE AFTER CIGS. @ TheALCF:What happens after smoker quits>15 year timeline. # BeatLungCancer # LCSM # ASCO14 https://twitter.com/TheALCF/status/473124603356004353/photo/1pic.twitter.com/UJwu2qTWee,,@,# # #,4.73126E+17,https://twitter.com/nxtstop1/status/473125548437168129,,,,
JeffreyMOtto,6/1/2014 11:34,1,0,CS: # ASCO14 part of the challenge in Tx of CRC is that we are trying to target unstable genomes.,,,#,4.73126E+17,https://twitter.com/JeffreyMOtto/status/473125546021642240,,,,
jtriestm,6/1/2014 11:34,0,0,http://www.huffingtonpost.com/huff-wires/20140531/us-med-cancer-drugs/?utm_hp_ref=sports&ir=sports … New drugs Ovarian lung cancer # asco14 # ovarian # gynscm # lcsm,,,# # # #,4.73125E+17,https://twitter.com/jtriestm/status/473125436084334592,,,,
mtmdphd,6/1/2014 11:34,5,2,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Conclusion - 2c BV well tolerated w/ 92% metabolic resp pic.twitter.com/41ETO2VAJn,,,# #,4.73125E+17,https://twitter.com/mtmdphd/status/473125381017702400,,,,
JeffreyMOtto,6/1/2014 11:34,0,0,"CS: # ASCO14 heterogeneity at 3 levels: inter tumor, intratumor, and intercellular. All have implications for Tx",,,#,4.73125E+17,https://twitter.com/JeffreyMOtto/status/473125347660414976,,,,
teamoncology,6/1/2014 11:34,0,0,"@ nxtstop1 @ JediPD We need to fight obesity is a nice slogan but the question is what is obesity, it does not fit to everybody. # ASCO14",,@ @,#,4.73125E+17,https://twitter.com/teamoncology/status/473125325258227712,,,,
mikeczub,6/1/2014 11:33,0,0,These numbers don't give me that warm fuzzy feeling inside # ASCO14 pic.twitter.com/IjYj3pqMup,,,#,4.73125E+17,https://twitter.com/mikeczub/status/473125259621969921,,,,
mnewtonPharmD,6/1/2014 11:33,0,0,"Enzalutamide benefit in radiographic PFS, OS vs placebo. Not shown: updated OS benefit continues, less SREs. # ASCO14 pic.twitter.com/jwAXUjRnUF",,,#,4.73125E+17,https://twitter.com/mnewtonPharmD/status/473125255159250944,,,,
theMMRF,6/1/2014 11:33,2,1,# ASCO14 Early study in relapsed/refractory myeloma: High response rates with daratumumab+Revlimid-dex. http://www.themmrf.org/asco - # MMRFASCO,,,# #,4.73125E+17,https://twitter.com/theMMRF/status/473125249509507075,,,,
DrLen,6/1/2014 11:33,0,0,"Eggermont: Innovative immunomodulation"" produces long term benefit unlike short term effect of BRAF inhibitors in melanoma # ASCO14""",,,#,4.73125E+17,https://twitter.com/DrLen/status/473125222812372994,,,,
DrAttai,6/1/2014 11:33,5,2,MD recommendations for exercise not enough. Combine with info and tools # asco14 # bcsm (2/2)pic.twitter.com/58rd2aprx0,,,# #,4.73125E+17,https://twitter.com/DrAttai/status/473125206857248768,,,,
NTConnell,6/1/2014 11:33,0,1,"Out of pocket costs (co-pays, time off work, parking) should be considered part of cancer treatment toxicity evaluation. -C. Earle # ASCO14",,,#,4.73125E+17,https://twitter.com/NTConnell/status/473125141174824960,,,,
DrAttai,6/1/2014 11:33,3,1,MD recommendations for exercise not enough. Combine with info and tools # asco14 # bcsm (1/2)pic.twitter.com/Oofv341WcB,,,# #,4.73125E+17,https://twitter.com/DrAttai/status/473125096803291136,,,,
mtmdphd,6/1/2014 11:33,0,2,"Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Case 010, DS3 pic.twitter.com/6YJNXLf4wP",,,# #,4.73125E+17,https://twitter.com/mtmdphd/status/473125087999426561,,,,
ipaulmampilly,6/1/2014 11:32,0,0,# ASCO14 heart patients pay attention Tki class effect QTC prolongation pic.twitter.com/K2z24Vhf6X,,,#,4.73125E+17,https://twitter.com/ipaulmampilly/status/473125038343073792,,,,
ecancer,6/1/2014 11:32,1,0,"Prof Sweeney: Benefits of docetaxel plus hormone therapy in hormone-sensitive prostate cancer, vid to follow # ASCO14 pic.twitter.com/o9Tm8RXk59",,,#,4.73125E+17,https://twitter.com/ecancer/status/473125025994637314,,,,
Boehringer,6/1/2014 11:32,1,1,Do you have some down time during the next days at # ASCO14? Discover # Chicago - http://bit.ly/18mn8ea pic.twitter.com/4vxCLpjEL7,,,# #,4.73125E+17,https://twitter.com/Boehringer/status/473125014758510594,,,,
JeffreyMOtto,6/1/2014 11:32,0,0,"Next up: Charles Swanton what is tumor heterogeneity and how will that play a role in development of agents to treat CRC # ASCO14""",,,#,4.73125E+17,https://twitter.com/JeffreyMOtto/status/473124980071628800,,,,
HenryJOncology,6/1/2014 11:32,0,0,IGF1R target for # sarcoma? Not in WTGIST according to collaborative trial @ # ASCO14. But a model for adult-pediatric collaboration.,,@,# #,4.73125E+17,https://twitter.com/HenryJOncology/status/473124963298193408,,,,
mtmdphd,6/1/2014 11:32,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Case 001 pic.twitter.com/So3BrHEx0Z,,,# #,4.73125E+17,https://twitter.com/mtmdphd/status/473124962229039104,,,,
cancerassassin1,6/1/2014 11:32,0,0,"Dr Habernero: Importance of stratifying patients on trials using expanded mutation profiling (KRas, NRas, BRAF, pik3ca, also MSI). # ASCO14",,,#,4.73125E+17,https://twitter.com/cancerassassin1/status/473124944654909440,,,,
AndreaHooper15,6/1/2014 11:32,0,1,# ASCO14 is a reminder that cancer therapy rarely improves in leaps and bounds," but ... in small increments"" @ nprnews http://n.pr/RLFaE7""",,@,#,4.73125E+17,https://twitter.com/AndreaHooper15/status/473124912836923393,,,
mtmdphd,6/1/2014 11:31,3,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Final Response pic.twitter.com/uIngf72Iwm,,,# #,4.73125E+17,https://twitter.com/mtmdphd/status/473124692354945024,,,,
CancerGeek,6/1/2014 11:31,3,4,"ASCO: Once A Year, Cancer Research News Comes In A Flood, Not A Trickle http://flip.it/eW7pL # ASCO14 # cancer",,,# #,4.73125E+17,https://twitter.com/CancerGeek/status/473124564655161345,,,,
mtmdphd,6/1/2014 11:30,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - PET Response by Risk Stratification pic.twitter.com/ABCR9vEAQs,,,# #,4.73125E+17,https://twitter.com/mtmdphd/status/473124549324992512,,,,
TargetedOnc,6/1/2014 11:30,2,0,Dr. Abernethy: Consider whether a pt with late-stage cancer should continue on statins http://www.targetedonc.com/conference/asco-2014/Considering-the-Discontinuation-of-Statins-in-Late-Stage-Cancer-Patients … # ASCO14,,,#,4.73125E+17,https://twitter.com/TargetedOnc/status/473124524205297664,,,,
cancerassassin1,6/1/2014 11:30,5,1,# colorectal # cancer subtyping consortium to present data on molecular profiling at Clinical Science Symposium 9:45 Tuesday @ asco # ASCO14,,@,# # #,4.73125E+17,https://twitter.com/cancerassassin1/status/473124518954016768,,,,
SanofiUS,6/1/2014 11:30,0,0,Enjoying your 3rd day at # ASCO14? Swing by booth 7047. and tell us how your conference is going!,,,#,4.73125E+17,https://twitter.com/SanofiUS/status/473124504785657856,,,,
Amgen,6/1/2014 11:30,1,1,Virtually resect # melanoma lesions and learn about the immune system at # Amgen booth #19042 at # ASCO14,,,# # #19042 #,4.73124E+17,https://twitter.com/Amgen/status/473124494413168640,,,,
corp_UNC,6/1/2014 11:30,0,0,"NCDB: LN yield & survival in gastric carcinoma J.Samples,K.Stitzenberg,M.Meyers @ UNC_Lineberger # asco14 http://ow.ly/xplo2",,@,#,4.73124E+17,https://twitter.com/corp_UNC/status/473124492844498944,,,,
DebiopharmNews,6/1/2014 11:30,0,0,# ASCO14 # DYK US market accounts for 41% of total # oncology drug sales http://ow.ly/x96bQ,,,# # #,4.73124E+17,https://twitter.com/DebiopharmNews/status/473124482279014400,,,,
PRKena,6/1/2014 11:30,0,0,http://lnkd.in/bF-HM7p Biodesix has banner year # asco14,,,#,4.73124E+17,https://twitter.com/PRKena/status/473124463114870786,,,,
mtmdphd,6/1/2014 11:30,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Tx (n=12) pic.twitter.com/PMCtN5FBK9,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473124412544532480,,,,
genentech,6/1/2014 11:30,3,3,@ markaorourke Agreed. Quality needs to be at the center of future trial design. More on that: http://ow.ly/xuAGI # ASCO14,,@,#,4.73124E+17,https://twitter.com/genentech/status/473124392961323008,,,,
WCGClinical,6/1/2014 11:30,0,0,"We encourage you to visit #3097 & request a demo of WCG Academy, our online learning solution for # clinical # research professionals. # ASCO14",,,#3097 # # #,4.73124E+17,https://twitter.com/WCGClinical/status/473124389450690562,,,,
Xcenda,6/1/2014 11:30,1,0,# Xcenda presents 2 posters at # ASCO2014 ~ Learn more: http://bit.ly/1jXRsje # ASCO14 # oncology # hematology,,,# # # # #,4.73124E+17,https://twitter.com/Xcenda/status/473124375713959937,,,,
mtmdphd,6/1/2014 11:30,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - PET - local vs. central pic.twitter.com/hq5A9Oeax7,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473124371499089920,,,,
medpagetoday,6/1/2014 11:30,4,3,"Amy P. Abernethy, PhD, on continuing vs discontinuing statins in life-limiting illness. # ASCO14 Watch the video: http://bit.ly/1rvObBQ",,,#,4.73124E+17,https://twitter.com/medpagetoday/status/473124316972740609,,,,
SophiaCeulemans,6/1/2014 11:29,0,0,"Cliby: application of current std of care is one of most cost-effective quality strategies available"" # ASCO14 # healthcarereform # gyncancer""",,,# # #,4.73124E+17,https://twitter.com/SophiaCeulemans/status/473124294000914433,,,,
BrendonStilesMD,6/1/2014 11:29,2,3,Turns out many medically inoperable patients AREN'T. Need multidisciplinary eval of surgery vs. SBRT. # asco2014 http://abstracts.asco.org/144/AbstView_144_130194.html …,,,#,4.73124E+17,https://twitter.com/BrendonStilesMD/status/473124257158156288,,,,
Cascadia,6/1/2014 11:29,1,2,Enriched Support for Community-Based Research # ASCO14 http://am.asco.org/education-session-details-overhaul-federally-sponsored-trials-and-enriched-support-community-based#.U4tGiphLLbY.twitter … ^model forpic.twitter.com/Q790wFLnvp,,,# #,4.73124E+17,https://twitter.com/Cascadia/status/473124247632879617,,,,
teamoncology,6/1/2014 11:29,0,0,"@ gorskon I agree. Compare to US, Japan, and EU. US sure has a major issue in the cost. # ASCO14",,@,#,4.73124E+17,https://twitter.com/teamoncology/status/473124224836448258,,,,
mtmdphd,6/1/2014 11:29,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Toxicity pic.twitter.com/xvChWnJMYY,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473124223234621440,,,,
DrAttai,6/1/2014 11:29,3,0,More on obesity via @ HopkinsMedicine # asco14 # bcsm (3/3)pic.twitter.com/Fxt6OlxMjY,,@,# #,4.73124E+17,https://twitter.com/DrAttai/status/473124193425694721,,,,
CeprecOaxaca,6/1/2014 11:29,0,0,"Cervical Cancer Screening in Mexico at # ASCO14 Sunday, June 1,2014",,,#,4.73124E+17,https://twitter.com/CeprecOaxaca/status/473124165168291840,,,,
DrAttai,6/1/2014 11:29,3,1,More on obesity via @ HopkinsMedicine # asco14 # bcsm (2/3)pic.twitter.com/ZwgyMvGlKk,,@,# #,4.73124E+17,https://twitter.com/DrAttai/status/473124144100687872,,,,
teamoncology,6/1/2014 11:29,0,0,"RT @ gorskon: Not sure I agree that high quality care will always be less costly, not more costly. Sometimes yes, sometimes no. # ASCO14",,@,#,4.73124E+17,https://twitter.com/teamoncology/status/473124056783278080,,,,
mtmdphd,6/1/2014 11:28,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Risk Strat by EORTC Criteria pic.twitter.com/zD8ZQp8BHw,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473123968900427776,,,,
gorskon,6/1/2014 11:28,0,1,"Not sure I agree that high quality care will always be less costly, not more costly. Sometimes yes, sometimes no. # ASCO14",,,#,4.73124E+17,https://twitter.com/gorskon/status/473123960985767937,,,,
survive_conquer,6/1/2014 11:28,0,2,Great conversation with IL Rep. Patti Bellock and @ AstellasUS about the importance of patient advocacy in affecting public policy # ASCO14,,@,#,4.73124E+17,https://twitter.com/survive_conquer/status/473123908569157632,,,,
DrAttai,6/1/2014 11:28,2,0,More in obesity via @ HopkinsMedicine # asco14 # bcsm (1/3)pic.twitter.com/dYeJ2NigR8,,@,# #,4.73124E+17,https://twitter.com/DrAttai/status/473123894082023426,,,,
teamoncology,6/1/2014 11:28,0,0,【 # ASCO14 Update】 RT @ AndrewCowanMD: Orteronel + pred did not meet 1' endpoint of OS in mCRPC. # ASCO14 https://twitter.com/AndrewCowanMD/status/473123395786539008/photo/1pic.twitter.com/jJW86PV6yy,,@,# #,4.73124E+17,https://twitter.com/teamoncology/status/473123856417169409,,,,
EthanBasch1,6/1/2014 11:28,0,0,Prostate: rPFS response did not translate to OS benefit w TAK700 pre-chemotherapy. # ASCO14 http://tinyurl.com/mk9dhwy pic.twitter.com/JgbIXlr3py,,,#,4.73124E+17,https://twitter.com/EthanBasch1/status/473123853242490880,,,,
mtmdphd,6/1/2014 11:28,0,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Table 1 pic.twitter.com/H7l7AKL8Ep,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473123842270191616,,,,
markaorourke,6/1/2014 11:28,0,0,"“ @ Lymphoma_Doc: With so much exciting data at # ASCO14 , it's hard to believe that <5% of US cancer patients go on clinical trials.”",,@,#,4.73124E+17,https://twitter.com/markaorourke/status/473123839875223552,,,,
mnewtonPharmD,6/1/2014 11:27,0,0,PREVAIL trial of enzalutamide in prostate cancer patients after progression on ADT being presented now # asco14 pic.twitter.com/aN1sPXYtHT,,,#,4.73124E+17,https://twitter.com/mnewtonPharmD/status/473123758778368001,,,,
teamoncology,6/1/2014 11:27,0,0,True. I am on this border. :) RT @ JediPD: @ teamoncology The hard edge between BMI 24.9 and 25 is worth a look. Wouldn't you say? # ASCO14,,@ @,#,4.73124E+17,https://twitter.com/teamoncology/status/473123751026896896,,,,
mtmdphd,6/1/2014 11:27,1,1,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Study Flow Chart pic.twitter.com/folFQeMTD8,,,# #,4.73124E+17,https://twitter.com/mtmdphd/status/473123735646765056,,,,
ipaulmampilly,6/1/2014 11:27,0,0,# ASCO14 predicting success from phase 1 results pic.twitter.com/6Iuy4RdKyd,,,#,4.73124E+17,https://twitter.com/ipaulmampilly/status/473123730013835264,,,,
DrBobGoldberg,6/1/2014 11:27,2,0,. @ LungCancerFaces @ ASCO value leader: “I don’t think a six-week increment is that impressive” for lung cancer http://www.spokesman.com/stories/2014/jun/01/new-cancer-drugs-working-but-at-steep-cost/ …,,@ @,,4.73124E+17,https://twitter.com/DrBobGoldberg/status/473123699730567169,,,,
teamoncology,6/1/2014 11:27,0,0,RT @ drattai: Male breast cancer disparities # asco14 # bcsm (1/3)pic.twitter.com/iRvsRe7STe,,@,# #,4.73124E+17,https://twitter.com/teamoncology/status/473123645204623360,,,,
markaorourke,6/1/2014 11:26,0,0,# ASCO14 Cancer health services research: need more pragmatic trials. Back to the problem of informed consent? Call it QI? Hopefully not.,,,#,4.73124E+17,https://twitter.com/markaorourke/status/473123532000739328,,,,
mtmdphd,6/1/2014 11:26,0,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Review methodology pic.twitter.com/5kltoUKJ2z,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473123424685289472,,,,
Lymphoma_Doc,6/1/2014 11:26,10,4,"With so much exciting data at # ASCO14 , it's hard to believe that <5% of US cancer patients go on clinical trials.",,,#,4.73123E+17,https://twitter.com/Lymphoma_Doc/status/473123404933906434,,,,
PRKena,6/1/2014 11:26,1,0,Immunotherapy is revolutionizing oncology & combo therapy is the way to pioneer the frontier of treatment: @ Psioxus # ASCO2014,,@,#,4.73123E+17,https://twitter.com/PRKena/status/473123352182145026,,,,
mtmdphd,6/1/2014 11:26,0,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Methods - Deauville Score (DS) included pic.twitter.com/5uFTJ7MLCc,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473123308972826624,,,,
BrendonStilesMD,6/1/2014 11:25,0,0,"Comprehensive genomics-Clearly the future, but must address cost & determine clinical utility in lungCA. # asco2014 http://abstracts.asco.org/144/AbstView_144_130519.html …",,,#,4.73123E+17,https://twitter.com/BrendonStilesMD/status/473123267771760640,,,,
Merck,6/1/2014 11:25,2,3,We hope you join us at 11:30 in room S100bc as we present new data in head & neck cancer @ ASCO. # MerckOncology,,@,#,4.73123E+17,https://twitter.com/Merck/status/473123251510870016,,,,
CancerDotNet,6/1/2014 11:25,2,3,"William D. Tap, MD of @ sloan_kettering on PLX3397 study for # PVNS neoplastic joint disorder # ASCO14 http://bit.ly/1jqnuok",,@,# #,4.73123E+17,https://twitter.com/CancerDotNet/status/473123106316623873,,,,
mtmdphd,6/1/2014 11:25,0,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - 2c BV bvf standard chemo w/ ABVD +/- RT in Pts w/ limited/int stage HL,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473123100348121088,,,,
genentech,6/1/2014 11:25,0,0,"@ cancerassassin1 We've seen cancer targets evolving not only in the body, but also the lab. More here: http://ow.ly/xuAo6 # ASCO14",,@,#,4.73123E+17,https://twitter.com/genentech/status/473123099102412800,,,,
PDRennert,6/1/2014 11:25,2,0,"SAR3419-DM4 in rrDLBCL: ORR 44%, CR 15%, PR 30%, 17% SD, 39% PD mDOR 15 mo, mPFS 4.4 mo, mOS 9.2 mo. Low tox, nice responses # ASCO14 $ IMGN",,,#,4.73123E+17,https://twitter.com/PDRennert/status/473123054089158656,,,,
myPathMelanoma,6/1/2014 11:25,1,0,See our poster June 2nd 8am-12:45pm! Myriad myPath # Melanoma Influence of Gene Sign. On Treatment of Melanocytic Tumors # ASCO14,,,# #,4.73123E+17,https://twitter.com/myPathMelanoma/status/473123053694509056,,,,
nxtstop1,6/1/2014 11:24,0,0,Follow @ mtmdphd: 4 detailed tweets re Forero-Torres # lymsm # ASCO14 - Ph1 SGN-CD19A in rel/ref NHL - interim analysis pic.twitter.com/7OteZbYgJD”,,@,# #,4.73123E+17,https://twitter.com/nxtstop1/status/473123038313979905,,,,
gorskon,6/1/2014 11:24,1,1,For the @ ChicagoSkeptics who asked me about this last night. “ @ drattai: Male breast cancer disparities # asco14 … pic.twitter.com/avDcsO9nvl”,,@ @,#,4.73123E+17,https://twitter.com/gorskon/status/473122967518711808,,,,
dmooneymd,6/1/2014 11:24,0,0,Federico: can we modify Hodgkin tx to reduce late complications while maintaining high cure rate? Brentuximab the answer? # lymsm # ASCO14,,,# #,4.73123E+17,https://twitter.com/dmooneymd/status/473122907502022656,,,,
mtmdphd,6/1/2014 11:24,0,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - CD30 target on HL RS cells w/ limited exp on nl cells,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473122902909657088,,,,
AlpineBV_Miller,6/1/2014 11:24,1,3,Presenter is spinning hard to rationalize these clinically unimpressive $ GSK data. # ASCO14 pic.twitter.com/yy4Sg66Io1,,,#,4.73123E+17,https://twitter.com/AlpineBV_Miller/status/473122869824987136,,,,
mtmdphd,6/1/2014 11:24,0,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - Background pic.twitter.com/4D5QNYwC0W,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473122821632425985,,,,
JediPD,6/1/2014 11:24,0,0,@ teamoncology The hard edge between BMI 24.9 and 25 is worth a look. Wouldn't you say? # ASCO14,,@,#,4.73123E+17,https://twitter.com/JediPD/status/473122801361379328,,,,
DrBenParsons,6/1/2014 11:23,0,0,Starlyte phase II trial very promising ADC for Bcell lymphoma # ASCO14,,,#,4.73123E+17,https://twitter.com/DrBenParsons/status/473122768603860992,,,,
mtmdphd,6/1/2014 11:23,1,0,Federico # lymsm # ASCO14 - Ph2 Brentuximab ABVD in unTx HL - pic.twitter.com/1PNpaHPqZ7,,,# #,4.73123E+17,https://twitter.com/mtmdphd/status/473122611757858816,,,,
maggiemfox,6/1/2014 11:22,3,1,"In prostate cancer, more chemo can be better # asco14 http://www.nbcnews.com/health/cancer/more-chemo-equals-longer-life-some-prostate-cancer-patients-n119566 …",,,#,4.73123E+17,https://twitter.com/maggiemfox/status/473122516282523649,,,,
DrAttai,6/1/2014 11:22,2,0,Male breast cancer disparities # asco14 # bcsm (3/3)pic.twitter.com/CKR3nwLgmO,,,# #,4.73122E+17,https://twitter.com/DrAttai/status/473122392668389377,,,,
BrendonStilesMD,6/1/2014 11:22,1,1,Early growth may not be indicative of treatment failure with immunotherapy. Important concept. # asco2014 http://abstracts.asco.org/144/AbstView_144_130631.html …,,,#,4.73122E+17,https://twitter.com/BrendonStilesMD/status/473122339312664576,,,,
HenryJOncology,6/1/2014 11:22,0,0,"Ponatinib in GIST # sarcoma? Vascular occlusive disease not seen in phase 2 # ASCO14 , but a concern. Perhaps for good PS if no choice.",,,# #,4.73122E+17,https://twitter.com/HenryJOncology/status/473122318231691264,,,,
DrAttai,6/1/2014 11:22,2,0,Male breast cancer disparities # asco14 # bcsm (2/3)pic.twitter.com/repN7heTkw,,,# #,4.73122E+17,https://twitter.com/DrAttai/status/473122312515256321,,,,
PinkSheetMaryJo,6/1/2014 11:22,0,0,"Eggermont on learning abt combo in melanoma: mono-dimensional thinking about pathways is a problem, need to think about cross-talk # ASCO14",,,#,4.73122E+17,https://twitter.com/PinkSheetMaryJo/status/473122303853985794,,,,
DrAttai,6/1/2014 11:21,4,1,Male breast cancer disparities # asco14 # bcsm (1/3)pic.twitter.com/0GpwE5V2ie,,,# #,4.73122E+17,https://twitter.com/DrAttai/status/473122236447354880,,,,
mtmdphd,6/1/2014 11:21,1,2,"Blanc # lymsm # ASCO14 - SAR3419 - Conclusions - ORR 43.9%, favorable AE, biomarkers pic.twitter.com/HgHUAAtEW5",,,# #,4.73122E+17,https://twitter.com/mtmdphd/status/473122226120953856,,,,
kj_hashi,6/1/2014 11:21,3,7,どのくらい早期から緩和ケアを導入するのが良いか、診断直後と３ヶ月後からで比較した試験。 １年生存率で差がでたが、長期の治療効果では差がでなかった。 結果の解釈を何方かにお聞きしたい研究。 # ASCO14 http://abstracts.asco.org/144/AbstView_144_130067.html …,,,#,4.73122E+17,https://twitter.com/kj_hashi/status/473122125746683906,,,,
djsampson,6/1/2014 11:21,0,0,"TY! RT @ MaryHartleyRD: Actually overweight""- there's a difference. RT @ djsampson ""Colditz: chart: cancers attributed to obesity # asco14...""",,@ @,#,4.73122E+17,https://twitter.com/djsampson/status/473122059955236864,,,,
JSweetenhamMD,6/1/2014 11:21,0,0,CD19 starting to look like an interesting therapeutic target in lymphoma at # ASCO14 ORRs of 30 -40% @ huntsmancancer,,@,#,4.73122E+17,https://twitter.com/JSweetenhamMD/status/473122057937764352,,,,
mtmdphd,6/1/2014 11:20,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Biomarker analysis by MYC/BCL2 expression pic.twitter.com/hlTWKM4ucU,,,# #,4.73122E+17,https://twitter.com/mtmdphd/status/473121933316620288,,,,
DebiopharmNews,6/1/2014 11:20,0,0,# ASCO14 # DYK High pharma investments & cancer therapies account for > 30% preclinical & phase I clinical developments http://ow.ly/x967u,,,# #,4.73122E+17,https://twitter.com/DebiopharmNews/status/473121853637394433,,,,
genentech,6/1/2014 11:20,0,0,@ KoontzOncology Here's more on what we can do to bring these innovative trials to patients: http://ow.ly/xuzNS # asco14,,@,#,4.73122E+17,https://twitter.com/genentech/status/473121807646879744,,,,
mtmdphd,6/1/2014 11:20,0,1,Blanc # lymsm # ASCO14 - Biomarker analysis - STARLYTE pic.twitter.com/Xz1RMvGSws,,,# #,4.73122E+17,https://twitter.com/mtmdphd/status/473121796842332160,,,,
DrLen,6/1/2014 11:19,0,0,"A Eggermont on BRAF inhibitors: a story of success and failure."" A reminder that enthusiasm must be balanced w/ caution # ASCO14""",,,#,4.73122E+17,https://twitter.com/DrLen/status/473121772942786561,,,,
JeffreyMOtto,6/1/2014 11:19,0,1,JT: # ASCO14 - starting to use liquid biopsies - this will be very important in determine when a pt. will be come resistant to therapy.,,,#,4.73122E+17,https://twitter.com/JeffreyMOtto/status/473121742958129152,,,,
dmooneymd,6/1/2014 11:19,0,0,Ocular toxicities with cd19 antibody drug conjugates seen to be class effect. Unclear reason. # lymsm # ASCO14,,,# #,4.73122E+17,https://twitter.com/dmooneymd/status/473121721910689794,,,,
cancerassassin1,6/1/2014 11:19,0,1,"Key point: acquired resistance to anti-EGFR abs colorectal @ cancer, 40% acquire KRas mutation; 30% acquire mutations in KRas + NRas # ASCO14",,@,#,4.73122E+17,https://twitter.com/cancerassassin1/status/473121675140419585,,,,
mtmdphd,6/1/2014 11:19,0,1,Blanc # lymsm # ASCO14 - SAR3419 - CD19+ biomarker pic.twitter.com/h3npZxEPpN,,,# #,4.73122E+17,https://twitter.com/mtmdphd/status/473121609340182528,,,,
wendyselig,6/1/2014 11:19,2,1,"@ MelanomaReAlli leading researcher: everything of real value I ever did was the result of philanthropic funding support."" # asco14""",,@,#,4.73122E+17,https://twitter.com/wendyselig/status/473121605971750912,,,,
CathyEngMD,6/1/2014 11:19,5,1,"# ASCO14 Plenary session will include pivotal # prostate # cancer trial as well as results of CALGB/ @ SWOG 80405 for met # crcsm, # endcancer",,@,# # # # #,4.73122E+17,https://twitter.com/CathyEngMD/status/473121603383857152,,,,
teamoncology,6/1/2014 11:19,0,1,"If you are wining and dining too much at # ASCO14, you may be pushing your BMI toward obesity. :)",,,#,4.73122E+17,https://twitter.com/teamoncology/status/473121578507456515,,,,
DrHedrick,6/1/2014 11:18,0,0,"Tabernero: Resistance to EGFR: RAS family, HER2 amp, MET amp, PIK2CA mute, BRAF mutation. Redefines what is meant by Wildtype. # ASCO14",,,#,4.73121E+17,https://twitter.com/DrHedrick/status/473121406226792449,,,,
markaorourke,6/1/2014 11:18,1,0,# ASCO14 Future of cancer health services research: big data is key. I hope we can get patient-reported outcome and quality measures. # hcsm,,,# #,4.73121E+17,https://twitter.com/markaorourke/status/473121376577257472,,,,
mtmdphd,6/1/2014 11:18,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Most frequent TEAEs pic.twitter.com/qWCiwWlOxz,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473121370734620672,,,,
teamoncology,6/1/2014 11:18,1,3,"【 # ASCO14 101】BMI, Normal weight = 18.5–24.9, Overweight = 25–29.9. Overweight is also consider a move toward the risk of cancer by some PIs.",,,#,4.73121E+17,https://twitter.com/teamoncology/status/473121317567201281,,,,
StephanThomeMD,6/1/2014 11:18,0,0,# ASCO14 Attending Chicago meeting: Happy 50 birthday to American Society of Clinical Oncology,,,#,4.73121E+17,https://twitter.com/StephanThomeMD/status/473121312597377024,,,,
DoctorEdny,6/1/2014 11:18,0,0,$ SNY SAR3419 single agent OS 9.2 mths in STARLIGHT PII for RR DLBCL # ASCO14 pic.twitter.com/QdfvvZVPRm,,,#,4.73121E+17,https://twitter.com/DoctorEdny/status/473121295195205632,,,,
dmooneymd,6/1/2014 11:18,0,0,"Trneny: cd19 adc, CoR, phase ii study in refr DLBCL. Orr 44%, achieved primary endpoint. Median DoR 5.5 mo. 38% g3/4 tox. # ASCO14 # lymsm",,,# #,4.73121E+17,https://twitter.com/dmooneymd/status/473121292745723905,,,,
mayocliniclabs,6/1/2014 11:17,4,1,"MT @ Ovatars (Mayo Clinc’s Dr. Paul Haluska) See how Ovarian Avatars will help improve ovarian cancer treatment! At # ASCO14, 11:30, rm E354",,@,#,4.73121E+17,https://twitter.com/mayocliniclabs/status/473121209811341312,,,,
JeffreyMOtto,6/1/2014 11:17,0,0,"JT: # ASCO14 based on Mol profiling, can generally predict which pts will be refractory to targeted therapy",,,#,4.73121E+17,https://twitter.com/JeffreyMOtto/status/473121177813389312,,,,
cancerassassin1,6/1/2014 11:17,0,0,Discussion of upfront resistance to anti-EGFR mAbs in colorectal # cancer: eg in BRAF mutants. Dr Habernero Gall D1 # ASCO14,,,# #,4.73121E+17,https://twitter.com/cancerassassin1/status/473121173547794432,,,,
mtmdphd,6/1/2014 11:17,0,1,Blanc # lymsm # ASCO14 - SAR3419 - AEs pic.twitter.com/V624aG2aJw,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473121134721138689,,,,
ipaulmampilly,6/1/2014 11:17,0,0,# ASCO14 phase 2 outcome the only significant predictor of phase 3 trials pic.twitter.com/W7imqCKESI,,,#,4.73121E+17,https://twitter.com/ipaulmampilly/status/473121042891034626,,,,
mtmdphd,6/1/2014 11:16,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Overall Survival pic.twitter.com/Z41ns6SX8u,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473121024234782720,,,,
StefanoLuminari,6/1/2014 11:16,1,0,"# ASCO14 Trnerny on SAR3419 PHII study rel/ref DLBCL (STARLYTE). N=61. ORR 44%, CR 14.6%. med DoR 5.5 months",,,#,4.73121E+17,https://twitter.com/StefanoLuminari/status/473121007843037185,,,,
teamoncology,6/1/2014 11:16,0,0,【 # ASCO14 101】 Obesity is defined as BMI >= 30. Calculate your BMI → http://www.nhlbi.nih.gov/guidelines/obesity/BMI/bmicalc.htm … Are you at high risk of cancer?,,,#,4.73121E+17,https://twitter.com/teamoncology/status/473120994324803586,,,,
mtmdphd,6/1/2014 11:16,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Swimmer plot pic.twitter.com/ql37GuBFFZ,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473120925643456512,,,,
OncEd,6/1/2014 11:16,2,0,@ ophirag interviewing Nazik Hammad for the upcoming Global Cancer Control group at http://OncologyEducation.com # ASCO14 pic.twitter.com/MXJWr2krrB,,@,#,4.73121E+17,https://twitter.com/OncEd/status/473120857007484929,,,,
Amyloid_Planet,6/1/2014 11:16,0,0,"# ASCO14 SGN-CD19A 30% ORR (16%CR) in RR NHL w blurred vision in 1/2 of pts, reversible keratopathy in 1/3.",,,#,4.73121E+17,https://twitter.com/Amyloid_Planet/status/473120799965315072,,,,
AshleySumrallMD,6/1/2014 11:15,1,0,"ICT-107 data from ph 2 DCVax in GBM early, but +PFS & QOL. # ASCO14 # braintumor # LCI # immunotherapy",,,# # # #,4.73121E+17,https://twitter.com/AshleySumrallMD/status/473120776250732545,,,,
dhjutsw1,6/1/2014 11:15,0,0,Oncology Leadership in Health System Reform: Seizing the Opportunity for Change; # ASCO14. http://am.asco.org/oncology-leadership-health-system-reform-seizing-opportunity-change#.U4tDjh_jQJo.twitter …,,,# #,4.73121E+17,https://twitter.com/dhjutsw1/status/473120775558291456,,,,
mtmdphd,6/1/2014 11:15,1,1,Blanc # lymsm # ASCO14 - SAR3419 - ORR 43.9% pic.twitter.com/RCHfh6TvPH,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473120710601474048,,,,
anukPDX,6/1/2014 11:15,0,0,@ ASCO Journal of Oncology Practice # JOP editors at # ASCO14 Dr. Jeff Ward & Dr. John Cox pic.twitter.com/m7IZ7HUige,,@,# #,4.73121E+17,https://twitter.com/anukPDX/status/473120662827974656,,,,
cancerassassin1,6/1/2014 11:15,0,0,"Dr Tabernero of Vall d'Hebron: molecular profiling primary vs metastatic sites-- notable differences BRAF, PI3K etc are seen. # ASCO14",,,#,4.73121E+17,https://twitter.com/cancerassassin1/status/473120659191922688,,,,
genentech,6/1/2014 11:15,0,0,@ Cascadia Agreed! Need to id what the # bigdata flood can & can't do in cancer: http://ow.ly/xuzvj # asco14,,@,# #,4.73121E+17,https://twitter.com/genentech/status/473120605353803776,,,,
CancerDotNet,6/1/2014 11:15,2,0,Podcast: @ ASCO President Dr. Clifford Hudis @ CliffordHudis on today's # ASCO14 research # brsm # crcsm # pcsmhttp://bit.ly/1kv30Qn,,@ @,# # # #,4.73121E+17,https://twitter.com/CancerDotNet/status/473120605248946177,,,,
PhRMA,6/1/2014 11:15,2,0,Gains from # cancer research to society far outweigh the costs to US # healthcare system http://onphr.ma/SbIUQd # ASCO14,,,# # #,4.73121E+17,https://twitter.com/PhRMA/status/473120590040010753,,,,
nanostringtech,6/1/2014 11:15,0,0,"Learn more about our Prosigna Breast Cancer Prognostic Gene Signature Assay, based on the PAM50 molecular profile at Booth 5019. # ASCO14",,,#,4.73121E+17,https://twitter.com/nanostringtech/status/473120590035816448,,,,
mtmdphd,6/1/2014 11:15,0,1,Blanc # lymsm # ASCO14 - SAR3419 - STARLYTE Study status on May 2014 pic.twitter.com/xBZ64Poj1g,,,# #,4.73121E+17,https://twitter.com/mtmdphd/status/473120567458291712,,,,
dhjutsw1,6/1/2014 11:15,3,1,The Oncologists Role in Tobacco Cessation | @ ASCO Annual Meeting. # ASCO14. http://am.asco.org/oncologists-role-tobacco-cessation#.U4tDZaXh994.twitter …,,@,# #,4.73121E+17,https://twitter.com/dhjutsw1/status/473120554673635328,,,,
JeffreyMOtto,6/1/2014 11:14,0,0,JT: # ASCO14 mutational status seems to be conserved between primary tumor and metastatic sites,,,#,4.73121E+17,https://twitter.com/JeffreyMOtto/status/473120530766503937,,,,
VincentRK,6/1/2014 11:14,0,1,Yes! See: http://bit.ly/1hMVcEK MT “ @ ASCOPost: FDA cancer chief says 'escalating' drug prices cant continue http://ow.ly/xuyGQ # ASCO14”,,@,#,4.73121E+17,https://twitter.com/VincentRK/status/473120522335555585,,,,
CancerDotNet,6/1/2014 11:14,0,1,Advocates: Research Review Session today 5:30pm CT w/ Dr. Minetta Liu sharing abt news from # ASCO14 in S402,,,#,4.73121E+17,https://twitter.com/CancerDotNet/status/473120521857806340,,,,
mtmdphd,6/1/2014 11:14,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Disease Characteristics pic.twitter.com/kcgegGLsR5,,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473120425120378880,,,,
dhjutsw1,6/1/2014 11:14,1,0,Consensus Standards for Multiplex Cancer Genomic Testing from # ASCO14. http://am.asco.org/consensus-standards-multiplex-cancer-genomic-testing-joint-roundtable-fosters-awareness-expectations#.U4tDOlx5h3o.twitter …,,,# #,4.7312E+17,https://twitter.com/dhjutsw1/status/473120385718681600,,,,
Paperboy2009,6/1/2014 11:14,0,0,"@ adamfeuerstein So for the laymen out there, who's 'winning' # ASCO14, in your eyes, Adam?",,@,#,4.7312E+17,https://twitter.com/Paperboy2009/status/473120345273401344,,,,
mtmdphd,6/1/2014 11:14,0,0,Blanc # lymsm # ASCO14 - SAR3419 - Pt Characteristics (1) pic.twitter.com/UQuVzu8BlY,,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473120314910846977,,,,
WilliamDale_MD,6/1/2014 11:13,1,1,# ASCO14 Finding#1: Married men have higher colonoscopy rates vs unmarried men. No differences for women. pic.twitter.com/Z2ldTDkfSH,,,# #1,4.7312E+17,https://twitter.com/WilliamDale_MD/status/473120269133811714,,,,
mtmdphd,6/1/2014 11:13,0,1,Blanc # lymsm # ASCO14 - SAR3419 - Pt recruitment pic.twitter.com/eVNV0hMbps,,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473120189354348544,,,,
DrAttai,6/1/2014 11:13,9,6,Genetic counseling for young women at risk for HBOC via @ LurieCancer # asco14 # bcsm (3/3)pic.twitter.com/VlQusulFB9,,@,# #,4.7312E+17,https://twitter.com/DrAttai/status/473120157335060481,,,,
dhjutsw1,6/1/2014 11:13,1,0,# ASCO14 Big changes are afoot for federally sponsored # cancer # trials. Read more. http://am.asco.org/education-session-details-overhaul-federally-sponsored-trials-and-enriched-support-community-based#.U4tCt5j9pvI.twitter …,,,# # # #,4.7312E+17,https://twitter.com/dhjutsw1/status/473120088661323777,,,,
DrAttai,6/1/2014 11:13,3,2,Genetic counseling for young women at risk for HBOC via @ LurieCancer # asco14 # bcsm (2/3)pic.twitter.com/f8GSJYDwED,,@,# #,4.7312E+17,https://twitter.com/DrAttai/status/473120056314843138,,,,
mtmdphd,6/1/2014 11:12,0,1,Blanc # lymsm # ASCO14 - SAR3419 - STARLYTE Study Design pic.twitter.com/rL93m3jpKx,,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473120021091463169,,,,
SophiaCeulemans,6/1/2014 11:12,0,0,"Cliby from @ MayoClinic answers how do I know my gyn cancer surgeon is providing quality care?"" # ASCO14 # gyncancer""",,@,# #,4.7312E+17,https://twitter.com/SophiaCeulemans/status/473119996181508096,,,,
GuneetWalia,6/1/2014 11:12,2,1,"New, clinically actionable subset of # NSCLC: driven by mutations & fusions of NTRK1 http://www.sciencedaily.com/releases/2014/05/140531090645.htm … # ASCO14 # LCSM",,,# # #,4.7312E+17,https://twitter.com/GuneetWalia/status/473119974530105344,,,,
DrAttai,6/1/2014 11:12,9,4,Genetic counseling for young women at risk for HBOC via @ LurieCancer # asco14 # bcsm (1/3)pic.twitter.com/4cJdSzbotg,,@,# #,4.7312E+17,https://twitter.com/DrAttai/status/473119958755725312,,,,
JeffreyMOtto,6/1/2014 11:12,0,0,"JT: # ASCO14 some CRC tumors are hyper-mutated, others are not",,,#,4.7312E+17,https://twitter.com/JeffreyMOtto/status/473119930997805057,,,,
DrRobertGlatter,6/1/2014 11:12,0,0,@ emilygest @ Forbes @ DrRobertGlatter # ASCO14 thanks for Follow and RT!,,@ @ @,#,4.7312E+17,https://twitter.com/DrRobertGlatter/status/473119877365256192,,,,
mtmdphd,6/1/2014 11:12,0,1,Blanc # lymsm # ASCO14 - SAR3419 - STARLYTE Study Objectives pic.twitter.com/ji10hI30ks,,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473119830334509056,,,,
Paperboy2009,6/1/2014 11:12,0,0,@ AlpineBV_Miller So who's 'winning' # ASCO14?,,@,#,4.7312E+17,https://twitter.com/Paperboy2009/status/473119819416739840,,,,
teamoncology,6/1/2014 11:12,1,1,"【 # ASCO14 Update】 RT @ cells_nnm: Results of clinical trial, targeting cancer stem cells by Wnt-inhibitor at # ASCO14 http://esciencenews.com/articles/2014/06/01/results.phase.i.trial.omp.54f28.a.wnt.inhibitor.targeting.cancer.stem.cells …",,@,# #,4.7312E+17,https://twitter.com/teamoncology/status/473119778723221505,,,,
FightCRC,6/1/2014 11:11,2,1,Research trends toward gene expression profiles of different sub types of CRC- what we're hearing at # ASCO14 # crcsm,,,# #,4.7312E+17,https://twitter.com/FightCRC/status/473119749858418689,,,,
DrRobertGlatter,6/1/2014 11:11,0,0,@ Forbes @ StJudeResearch # ASCO14 @ DrRobertGlatter thanks for RT!,,@ @ @,#,4.7312E+17,https://twitter.com/DrRobertGlatter/status/473119729205673984,,,,
mtmdphd,6/1/2014 11:11,0,1,"Blanc # lymsm # ASCO14 - SAR3419 - Background - TED 6828, TED 6829 pic.twitter.com/nqisn9D6JH",,,# #,4.7312E+17,https://twitter.com/mtmdphd/status/473119683974270976,,,,
JediPD,6/1/2014 11:11,0,0,@ mtmdphd Implied selective (molecular?) sensitivity to SGN-CD19A in rel/ref NHL pic.twitter.com/E7mpwPJQyY CR (Lo dose) PR&SD(Hi Dose)? # ASCO14,,@,#,4.7312E+17,https://twitter.com/JediPD/status/473119661593485313,,,,
robertwalker10,6/1/2014 11:11,0,0,Setting up for @ GoToPER # ASCO14 NSCLC satellite @7 tonight @Hyatt Regency Chicago. See us at @ GoToPER booth 5099pic.twitter.com/BInaTDUnS5,,@ @7 @Hyatt @,#,4.7312E+17,https://twitter.com/robertwalker10/status/473119601380052992,,,,
Paperboy2009,6/1/2014 11:11,0,0,@ AndyBiotech so who's 'winning' # ASCO14?,,@,#,4.7312E+17,https://twitter.com/Paperboy2009/status/473119599672975360,,,,
dermanewsok,6/1/2014 11:11,0,0,"TUMORE, AIOM: RISPARMI DALLA PREVENZIONE, 6 MILIARDI DI EURO IN 5 ANNI # asco2014 http://bit.ly/1hoZFmD",,,#,4.7312E+17,https://twitter.com/dermanewsok/status/473119540897800192,,,,
antoniocaperna,6/1/2014 11:11,0,0,"TUMORE, AIOM: RISPARMI DALLA PREVENZIONE, 6 MILIARDI DI EURO IN 5 ANNI # asco2014 http://bit.ly/1hoZFmD",,,#,4.7312E+17,https://twitter.com/antoniocaperna/status/473119540612575234,,,,
salutedomani,6/1/2014 11:11,1,0,"TUMORE, AIOM: RISPARMI DALLA PREVENZIONE, 6 MILIARDI DI EURO IN 5 ANNI # asco2014 http://bit.ly/1hoZFmD",,,#,4.7312E+17,https://twitter.com/salutedomani/status/473119537064206338,,,,
mtmdphd,6/1/2014 11:10,0,1,Blanc # lymsm # ASCO14 - SAR3419 - pic.twitter.com/xzRfizZXwp,,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473119489459232768,,,,
teamoncology,6/1/2014 11:10,1,0,@ gorskon @ drdonsdizon We have tendency to forget our past. There is no quick fix in cancer. # ASCO14,,@ @,#,4.73119E+17,https://twitter.com/teamoncology/status/473119475319857152,,,,
JeffreyMOtto,6/1/2014 11:10,0,0,JT: # ASCO14 chromosomal instability vs MSI as classification tools for CRC,,,#,4.73119E+17,https://twitter.com/JeffreyMOtto/status/473119470438088704,,,,
gorskon,6/1/2014 11:10,0,0,Appropriate for # ASCO14: “ @ TheRealNimoy: Congratulations to quitters. Stay strong…Smoking doesn't make anything better. LLAP”,,@,#,4.73119E+17,https://twitter.com/gorskon/status/473119454382288896,,,,
Lymphoma_Doc,6/1/2014 11:10,1,3,"Abs 8505: SGN-CD19A in relapsed aggressive NHL ORR of 30%. My patients +/- response but not durable, needs further eval in combos. # ASCO14",,,#,4.73119E+17,https://twitter.com/Lymphoma_Doc/status/473119406911148032,,,,
FightCRC,6/1/2014 11:10,0,1,"Were at # asco14 again today! If you're here, stop by and say hello! http://fb.me/3rwYDA0Jg",,,#,4.73119E+17,https://twitter.com/FightCRC/status/473119381648867330,,,,
z_phd,6/1/2014 11:10,0,0,Let's hear it for the negative trial data presented at # ASCO14! Results don't have to be practice-changing to be important!,,,#,4.73119E+17,https://twitter.com/z_phd/status/473119368973664256,,,,
mtmdphd,6/1/2014 11:10,1,0,Blanc # lymsm # ASCO14 - pic.twitter.com/Vjn6YpcVBn,,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473119354234896384,,,,
PDRennert,6/1/2014 11:10,2,1,"SGN-CD19a in DLBCL: ORR 30%, 16% CR, 14% PR, 35% SD, 35% progressive disease; DOR is good in the CR/PR group. Eye tox reversible # ASCO14",,,#,4.73119E+17,https://twitter.com/PDRennert/status/473119353530245121,,,,
DebiopharmNews,6/1/2014 11:10,0,0,"# ASCO14 Phase I basket study Debio1347, # FGFR inhibitor in solid # tumors (abstract/poster # TPS2629) Find out more http://ow.ly/x95Vd",,,# # # #,4.73119E+17,https://twitter.com/DebiopharmNews/status/473119342981566465,,,,
DoctorEdny,6/1/2014 11:10,1,1,"$ SGEN SGN-CD19A PI conclusions, keratopathy AE reversible # ASCO14 pic.twitter.com/08Vykync3b",,,#,4.73119E+17,https://twitter.com/DoctorEdny/status/473119307313205248,,,,
myriadgenetics,6/1/2014 11:10,1,0,Myriad myRisk test uses NGS technology to evaluate 25 clinically important # genes linked to 8 # hereditarycancers. # ASCO14 Poster 1548,,,# # #,4.73119E+17,https://twitter.com/myriadgenetics/status/473119277654867970,,,,
DrAttai,6/1/2014 11:09,2,1,Last poster on obesity markers via @ LurieCancer # asco14,,@,#,4.73119E+17,https://twitter.com/DrAttai/status/473119234890141696,,,,
JeffreyMOtto,6/1/2014 11:09,0,0,JT: # ASCO14 CRC is one of the first solid tumors to be classified on the basis of molecular profiling,,,#,4.73119E+17,https://twitter.com/JeffreyMOtto/status/473119182490726400,,,,
mtmdphd,6/1/2014 11:09,0,0,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Time to ramp up the # OphthoOncology clinics...pic.twitter.com/Fz8ibjAQyl,,,# # #,4.73119E+17,https://twitter.com/mtmdphd/status/473119175997923328,,,,
VincentRK,6/1/2014 11:09,4,1,Very impressive. MT “ @ mtmdphd: Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL (about 1/4 of PR still on Tx) pic.twitter.com/Yaf46uLaiI”,,@,# #,4.73119E+17,https://twitter.com/VincentRK/status/473119156368207872,,,,
subatomicdoc,6/1/2014 11:09,0,4,Huzzah! Made it # ASCO14 pic.twitter.com/D5hEZtK7ia,,,#,4.73119E+17,https://twitter.com/subatomicdoc/status/473119048855990272,,,,
JacobPlieth,6/1/2014 11:09,3,4,CALGB study mPFS curves Erbitux/Avastin in mCRC KRAS wild type # ASCO14 $ LLY $ RHHBY @ ootomo1979pic.twitter.com/A2GTX51IiI,,@,#,4.73119E+17,https://twitter.com/JacobPlieth/status/473119027577880578,,,,
mtmdphd,6/1/2014 11:08,3,1,"Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Conclusions - ORR 30% (11/37), CR 16%, eye gtt, encouraging pic.twitter.com/sJLPjAGNd2",,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473119010457137152,,,,
Merck,6/1/2014 11:08,4,2,Learn more about recruitment in our clinical trials when you visit our exhibit booth #19077 @ ASCO. # ASCO14 pic.twitter.com/sBfhXNxKZv,,@,#19077 #,4.73119E+17,https://twitter.com/Merck/status/473119009194639360,,,,
FightCRC,6/1/2014 11:08,1,1,A new consensus group (CRCSC) will help advance a biologic understanding of # coloncancer! # ASCO14 # crcsm,,,# # #,4.73119E+17,https://twitter.com/FightCRC/status/473118961794838529,,,,
cancerassassin1,6/1/2014 11:08,1,0,Dr Tejpar @ LeuvenU: understanding molecular biology of colorectal cancer will incorporate systems biology and networking in tumors. # ASCO14,,@,#,4.73119E+17,https://twitter.com/cancerassassin1/status/473118878156218369,,,,
JeffreyMOtto,6/1/2014 11:08,0,0,"Next up: Josep Tabernero molecular BioMarker characterization and sub typing of CRC - next generation of matched targeted Tx # ASCO14""",,,#,4.73119E+17,https://twitter.com/JeffreyMOtto/status/473118869947957248,,,,
mtmdphd,6/1/2014 11:08,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - pic.twitter.com/aPjSru3IIN,,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473118776234622976,,,,
gorskon,6/1/2014 11:07,1,0,@ teamoncology @ drdonsdizon So true. I remember the complaints at War on Cancer's 40th Anniversary well. # ASCO14 http://www.sciencebasedmedicine.org/why-havent-we-cured-cancer-yet/ …,,@ @,#,4.73119E+17,https://twitter.com/gorskon/status/473118754361323521,,,,
dmooneymd,6/1/2014 11:07,0,0,"Forero: Phase I sgn-cd19a (antibody drug conjugate) in refractory nhl. Ae of keratopathy. 16% cr, 14%pr. 24% still tx. # lymsm # ASCO14 # uab",,,# # #,4.73119E+17,https://twitter.com/dmooneymd/status/473118700321529857,,,,
mtmdphd,6/1/2014 11:07,2,2,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Waterfall plot (about 1/4 of PR still on Tx) pic.twitter.com/3IhttyTo5H,,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473118674581463040,,,,
Jessicutz,6/1/2014 11:07,0,0," @ CancerDotNet: Guide to # breastcancer from @ ASCO's pt education site for patients/caregivers # ASCO14 http://bit.ly/U5unXE "" excelente""",,@ @,# #,4.73119E+17,https://twitter.com/Jessicutz/status/473118659733639168,,,,
DoctorEdny,6/1/2014 11:07,0,0,$ SGEN SGN-CD19A ADC in PI study of Relapsed/Refractory Lymphoma # ASCO14 pic.twitter.com/j6a8mphdKS,,,#,4.73119E+17,https://twitter.com/DoctorEdny/status/473118638594355200,,,,
DrAttai,6/1/2014 11:07,3,0,More on weight gain after treatment. Some genetic markers being evaluated to determine who is at risk # asco14 # bcsmpic.twitter.com/US42Af412t,,,# #,4.73119E+17,https://twitter.com/DrAttai/status/473118554087514112,,,,
mtmdphd,6/1/2014 11:07,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Best Clinical Response (per Investigator) pic.twitter.com/eqlS0KAY6z,,,# #,4.73119E+17,https://twitter.com/mtmdphd/status/473118542112755712,,,,
KoontzOncology,6/1/2014 11:06,0,0,Dr. Tsimberidou just gave an overview of precision medicine in clinical trials. # ASCO14 pic.twitter.com/ROAUPL9iqH,,,#,4.73119E+17,https://twitter.com/KoontzOncology/status/473118501037940736,,,,
dansbarrington,6/1/2014 11:06,1,0,Get a Barrington James business card from the English guys in the red ties show is at the Hyatt bar later and we'll buy you a drink # ASCO14,,,#,4.73118E+17,https://twitter.com/dansbarrington/status/473118487691681792,,,,
reinheimerpr,6/1/2014 11:06,0,0,RT @ ClevelandClinic: “Obesity is on its way to replacing tobacco as the #1 preventable/modifiable cause of cancer.” @ CliffordHudis # ASCO14,,@ @,#1 #,4.73118E+17,https://twitter.com/reinheimerpr/status/473118428476092416,,,,
cells_nnm,6/1/2014 11:06,4,1,"OncoMed presented results of clinical trial, targeting cancer stem cells by Wnt-inhibitor at # ASCO14 http://esciencenews.com/articles/2014/06/01/results.phase.i.trial.omp.54f28.a.wnt.inhibitor.targeting.cancer.stem.cells … # cancerSC",,,# #,4.73118E+17,https://twitter.com/cells_nnm/status/473118407437479937,,,,
mtmdphd,6/1/2014 11:06,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Pharmocokinetics (PK) - ~2 week half-life pic.twitter.com/6IO2qbMM1u,,,# #,4.73118E+17,https://twitter.com/mtmdphd/status/473118406410260481,,,,
cancerassassin1,6/1/2014 11:06,0,0,Dr Tejpar on molecular targeting colorectal cancer: novel targets to include understanding Intratumor & intrapatient heterogeneity # ASCO14,,,#,4.73118E+17,https://twitter.com/cancerassassin1/status/473118345706106881,,,,
WilliamDale_MD,6/1/2014 11:06,0,0,"# ASCO14 (interlude) Nice! Where are you going to publish it?"". Suggestions welcome. Stop by to give me your thoughts on journals.""",,,#,4.73118E+17,https://twitter.com/WilliamDale_MD/status/473118300872785920,,,,
mtmdphd,6/1/2014 11:05,1,0,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - prophylactic steroids is under evaluation - SMK,,,# #,4.73118E+17,https://twitter.com/mtmdphd/status/473118204534214656,,,,
YourDiseaseRisk,6/1/2014 11:05,0,0,MT @ ASCO: “Carpe Diem: Time to Seize the Opportunity for Cancer Prevention” Graham Colditz MD @8 am @ AmericanCancer Award&Lecture # ASCO14,,@ @8 @,#,4.73118E+17,https://twitter.com/YourDiseaseRisk/status/473118175379615744,,,,
harriseve,6/1/2014 11:05,0,0,b/c Tamox made me KRAYKRAY: shut ovaries down; use AIs 4young women w/ hormone-resp # breastcancer http://1.usa.gov/1hMJfz0 # bcsm # ASCO14,,,# # #,4.73118E+17,https://twitter.com/harriseve/status/473118159978119169,,,,
mtmdphd,6/1/2014 11:05,0,0,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - steroids and dose mods help for eye sx. # OphthOncology,,,# # #,4.73118E+17,https://twitter.com/mtmdphd/status/473118123550584832,,,,
Cascadia,6/1/2014 11:05,19,9,Missing Link for Big Biomedical Data @ jama_current http://ow.ly/xtEdb via @ fischmd # ASCO14 # HDPaloozapic.twitter.com/zyM7ROBzyT,,@ @,# #,4.73118E+17,https://twitter.com/Cascadia/status/473118120278642688,,,,
mtmdphd,6/1/2014 11:05,2,2,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - 84% eye toxicity - most grade 1/2. Symptoms reversible pic.twitter.com/lwH3DmMVh6,,,# #,4.73118E+17,https://twitter.com/mtmdphd/status/473118047721750528,,,,
genentech,6/1/2014 11:05,2,1,# DYK? A mustard gas-based tx was the first chemo to achieve durable remissions in lymphoma. http://ow.ly/xuyCJ # ASCO14,,,# #,4.73118E+17,https://twitter.com/genentech/status/473118041145114624,,,,
JeffreyMOtto,6/1/2014 11:05,0,0,TS: # ASCO14 need to use polyomics for functional validation of new targets,,,#,4.73118E+17,https://twitter.com/JeffreyMOtto/status/473118040255905793,,,,
genentech,6/1/2014 11:05,5,3,Infographic: Evolution of Ph1#clinicaltrials & how they are speeding drug development # ASCO14 http://ow.ly/xuy2o,,,#clinicaltrials #,4.73118E+17,https://twitter.com/genentech/status/473118036686172161,,,,
NTConnell,6/1/2014 11:04,0,2,Novel linkage data between cancer registries and bankruptcy records demonstrate the effect that policy changes have on cancer pts. # ASCO14,,,#,4.73118E+17,https://twitter.com/NTConnell/status/473117947075244034,,,,
SophiaCeulemans,6/1/2014 11:04,0,0,Powell: main approach to measuring quality care is consistency in process # ASCO14 # healthcarereform # qualitymeasures # gynonc # gyncancer,,,# # # # #,4.73118E+17,https://twitter.com/SophiaCeulemans/status/473117939772948480,,,,
fwpharma,6/1/2014 11:04,2,0,Early use of docetaxel with hormone therapy prolongs survival in prostate cancer trial http://bit.ly/1hoYHXv # ASCO14,,,#,4.73118E+17,https://twitter.com/fwpharma/status/473117867635146752,,,,
mtmdphd,6/1/2014 11:03,0,0,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Superficial Microcystic Keratopathy # OphthoOncologypic.twitter.com/3YIQYniAiJ,,,# # #,4.73118E+17,https://twitter.com/mtmdphd/status/473117729890000896,,,,
QIAGENscience,6/1/2014 11:03,0,0,JAK2 testing: Get more than a # mutation status! Stop by 5013 to discuss what you can learn from JAK2 testing # ASCO14 pic.twitter.com/wjcJYFj2N4,,,# #,4.73118E+17,https://twitter.com/QIAGENscience/status/473117682536312834,,,,
NickVRamos,6/1/2014 11:03,0,0,Anyone currently at IMUC presentation of updated results on GBM? # ASCO14,,,#,4.73118E+17,https://twitter.com/NickVRamos/status/473117670901313537,,,,
JeffreyMOtto,6/1/2014 11:03,0,0,TS: # ASCO14 keep your biospecimens for future use!,,,#,4.73118E+17,https://twitter.com/JeffreyMOtto/status/473117655105552384,,,,
YourDiseaseRisk,6/1/2014 11:03,0,0,"RT @ djsampson: Colditz: we must deliver br ca prevention with policy, providers, and communities # asco14",,@,#,4.73118E+17,https://twitter.com/YourDiseaseRisk/status/473117639863443457,,,,
rsm2800,6/1/2014 11:03,9,6,Honored to be on panel w/ @ obogler @ mtmdphd Mon 6/2 1:15p S504 for Internet, Social Media, Privacy Regulations," & Clinical Trials"" # ASCO14""",,@ @,#,4.73118E+17,https://twitter.com/rsm2800/status/473117592690110464,
cancerassassin1,6/1/2014 11:03,0,0,Session on # colorectal cancer tumor heterogeneity and pathology in Hall D1-- # ASCO14 http://tinyurl.com/nsv2d3e pic.twitter.com/xY3lw2w8MA,,,# #,4.73118E+17,https://twitter.com/cancerassassin1/status/473117574713315328,,,,
teamoncology,6/1/2014 11:03,0,0,Agree. You just can never simplify the biology of cancer. RT @ drdonsdizon: @ teamoncology SO much more work to do! # ASCO14,,@ @,#,4.73118E+17,https://twitter.com/teamoncology/status/473117530496581635,,,,
JeffreyMOtto,6/1/2014 11:02,0,0,"TS: # asco14 as biological knowledge increases, need to consider implications for stratification.",,,#,4.73118E+17,https://twitter.com/JeffreyMOtto/status/473117504622309376,,,,
mtmdphd,6/1/2014 11:02,0,0,"Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - blurred vision, keratopathy, TCP, anemia - gr >= 3 AEs in >= 2 pts",,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473117482048577536,,,,
mtmdphd,6/1/2014 11:02,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - AE in >= 15% Pts pic.twitter.com/CjRutcCmj4,,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473117386493939712,,,,
Cascadia,6/1/2014 11:02,4,4,Wish I could get the flood of pure data pouring out of # ASCO14 into the hands of data geeks and innovators # HDPalooza,,,# #,4.73117E+17,https://twitter.com/Cascadia/status/473117340406915072,,,,
JeffreyMOtto,6/1/2014 11:02,0,0,TS: # ASCO14 need to consider disease heterogeneity when designing clinical trials,,,#,4.73117E+17,https://twitter.com/JeffreyMOtto/status/473117280101208064,,,,
jagasquet,6/1/2014 11:01,1,0,Pivotal data for @ Novartis # LDE225 # sonidegib show marked tumor responses in advanced basal cell carcinoma https://uk.finance.yahoo.com/news/pivotal-data-novartis-investigational-compound-130202068.html … # ASCO14,,@,# # #,4.73117E+17,https://twitter.com/jagasquet/status/473117201839312896,,,,
mtmdphd,6/1/2014 11:01,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - (so far) Pt and disease characteristics pic.twitter.com/CJ4jLUuFrb,,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473117148207124480,,,,
DebiopharmNews,6/1/2014 11:01,0,0,"# ASCO14 Clinical PK/PD model for Debio 1143, antagonist of IAPs in # cancer (abstract/poster #2585) Find out more http://ow.ly/x95Pz",,,# # #2585,4.73117E+17,https://twitter.com/DebiopharmNews/status/473117121455857664,,,,
appistry,6/1/2014 11:01,0,0,What is genomically enhanced medicine and what does it tell us about the future of # oncology? # genomics # GEM # ASCO14,,,# # # #,4.73117E+17,https://twitter.com/appistry/status/473117108344487938,,,,
bmsnews,6/1/2014 11:01,1,1,We are committed to researching # cancer with our # clinicaltrials.Learn more on Study Connect http://ow.ly/xmpbe # ASCO14,,,# # #,4.73117E+17,https://twitter.com/bmsnews/status/473117044586872832,,,,
UrologyMatch,6/1/2014 11:01,1,0,“ @ CBPartners: Spending more without getting better results. Talks on # value and # quality at # ASCO14 pic.twitter.com/pkHl9snE8R”,,@,# # #,4.73117E+17,https://twitter.com/UrologyMatch/status/473117021358817280,,,,
mtmdphd,6/1/2014 11:00,0,0,"Forero-Torres # lymsm # ASCO14 - SGN-CD19A rel/ref NHL - Study Status - no DLT in cycle 1. Doses 3, 4, 5 mg/kg expanded pic.twitter.com/l8gEMrPQlY",,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473116996801150976,,,,
drdonsdizon,6/1/2014 11:00,0,0,@ teamoncology SO much more work to do! # ASCO14,,@,#,4.73117E+17,https://twitter.com/drdonsdizon/status/473116983630635008,,,,
Roche,6/1/2014 11:00,1,2,Tonight at 6.30pm # Roche # ASCO14 Analyst Event at Marriott Downtown Chicago $ ROG $ RHHBYhttp://ow.ly/xp3gb,,,# #,4.73117E+17,https://twitter.com/Roche/status/473116950688964608,,,,
practiceupdate,6/1/2014 11:00,0,0,"Check out upcoming # ASCO14 sessions recommended by our # Oncology Editor in Chief, Dr. Lee S. Schwartzberg @ OncSTATdoc http://ow.ly/xtU9w",,@,# #,4.73117E+17,https://twitter.com/practiceupdate/status/473116934809354240,,,,
JeffreyMOtto,6/1/2014 11:00,0,0,TS: # ASCO14 presentation on Tuesday will be on consensus molecular subtypes of CRC - new paradigm of working together,,,#,4.73117E+17,https://twitter.com/JeffreyMOtto/status/473116914227871745,,,,
CRC_Medical,6/1/2014 11:00,0,0,Not attending # ASCO14? Don't worry! You can still SAVE 20% on # oncology # books. Enter promo EMN13 at checkout here at http://ow.ly/xr7J6,,,# # #,4.73117E+17,https://twitter.com/CRC_Medical/status/473116911459663873,,,,
ASCO,6/1/2014 11:00,4,2,"Dr. Jennifer A. Ligibel on Obesity & Cancer, ASCO Initiatives: http://bit.ly/1nyfny4 # ASCO14",,,#,4.73117E+17,https://twitter.com/ASCO/status/473116904950079488,,,,
ConsanoScott,6/1/2014 11:00,0,0,@ genentech And hopefully the # Next50 treatments will have fewer and less severe side effects! # ASCO14,,@,# #,4.73117E+17,https://twitter.com/ConsanoScott/status/473116877636399106,,,,
CBPartners,6/1/2014 11:00,0,0,Spending more without getting better results. Talks on # value and # quality at # ASCO14 pic.twitter.com/7WNEsjlK04,,,# # #,4.73117E+17,https://twitter.com/CBPartners/status/473116826151694336,,,,
CancerTherAdvsr,6/1/2014 11:00,4,2,# ASCO14: # Exercise Beats Diet Alone for Reducing # BreastCancer Risk http://ow.ly/xuwjb,,,# # #,4.73117E+17,https://twitter.com/CancerTherAdvsr/status/473116825119883266,,,,
FoundationATCG,6/1/2014 11:00,0,1,Not all molecular testing is created equal. Learn about the differences here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73117E+17,https://twitter.com/FoundationATCG/status/473116802579304448,,,,
drdonsdizon,6/1/2014 11:00,0,0,Gourley: 63-gene immune sig: worse PFS (19 vs 36m wo Bev) & inf OS if Bev given. Need validatn ASAP. # gyncsm # ASCO14 pic.twitter.com/JISVyzsYZa,,,# #,4.73117E+17,https://twitter.com/drdonsdizon/status/473116799093841921,,,,
mtmdphd,6/1/2014 11:00,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Study Design pic.twitter.com/ZtbUQYLTtJ,,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473116787220156416,,,,
Neil_Iyengar,6/1/2014 10:59,0,0,Join us at our poster highlights today. Post-menopause is assoc w breast inflammation independent of obesity. E354b Poster board 1. # ASCO14,,,#,4.73117E+17,https://twitter.com/Neil_Iyengar/status/473116701782183936,,,,
mtmdphd,6/1/2014 10:59,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Objectives and Eligibility Criteria pic.twitter.com/DnM9vhTY19,,,# #,4.73117E+17,https://twitter.com/mtmdphd/status/473116607951413248,,,,
UrologyMatch,6/1/2014 10:59,1,1,“ @ 3NT: Just updated # ASCO14 live blog with quick note from prostate cancer session. (for subs) http://3nt.co/Nivolumab ” # gusm,,@,# #,4.73117E+17,https://twitter.com/UrologyMatch/status/473116594931896320,,,,
DrAttai,6/1/2014 10:59,0,1,Underutilization of physical therapy in older patients with cancer # asco14 (2/2) pic.twitter.com/JnqR9E4VZb,,,#,4.73117E+17,https://twitter.com/DrAttai/status/473116592692527104,,,,
JeffreyMOtto,6/1/2014 10:59,0,0,"TS: # ASCO14 CRC can segregate into hyper mutant"" and ""non-hyper mutant"" types""",,,#,4.73117E+17,https://twitter.com/JeffreyMOtto/status/473116547792527360,,,,
BRCAresponder,6/1/2014 10:59,1,2,BOOK LIST http://tinyurl.com/moy7hv6 # BRCA # breast # ovariancancer # pancreatic # prostate # melanoma # malebreastcancer # gyncsm # ASCO # ASCO14,,,# # # # # # # # # #,4.73117E+17,https://twitter.com/BRCAresponder/status/473116515802169344,,,,
DrAttai,6/1/2014 10:58,0,1,Underutilization of physical therapy in older patients with cancer # asco14 (1/2) pic.twitter.com/Bbv8Urb1Vb,,,#,4.73117E+17,https://twitter.com/DrAttai/status/473116505484169216,,,,
mtmdphd,6/1/2014 10:58,0,0,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - humanized anti-CD19 monoclonal Ab,,,# #,4.73116E+17,https://twitter.com/mtmdphd/status/473116357203333120,,,,
teamoncology,6/1/2014 10:58,0,0,Need training. :) RT @ MaverickNY: Another beef for # asco14 presenters - a busy 7x5 table is NOT going to work for the majority of audience,,@,#,4.73116E+17,https://twitter.com/teamoncology/status/473116313221472256,,,,
mtmdphd,6/1/2014 10:58,0,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A in rel/ref NHL - Proposed Mechanism of Action pic.twitter.com/MNveUd4E78,,,# #,4.73116E+17,https://twitter.com/mtmdphd/status/473116284356677632,,,,
Frank_S_David,6/1/2014 10:57,0,0,"Just2 clarify, problem starts w/pathologist"" was audience comment", not mine. As ex-pathologist myself," I was a bit miffed. # ASCO14""",,,#,4.73116E+17,https://twitter.com/Frank_S_David/status/473116142387871744,,
JeffreyMOtto,6/1/2014 10:57,0,0,TS: # ASCO14 CRC - many diseases hitting the same organ,,,#,4.73116E+17,https://twitter.com/JeffreyMOtto/status/473116127540023298,,,,
ERPlimackMD,6/1/2014 10:57,0,0," @ ASCOPost: FDA cancer chief says 'escalating' drug prices can't continue (via @ Reuters) http://ow.ly/xuyGQ # ASCO14""""",,@ @,#,4.73116E+17,https://twitter.com/ERPlimackMD/status/473116122884374528,,,,
mtmdphd,6/1/2014 10:57,1,1,Forero-Torres # lymsm # ASCO14 - SGN-CD19A Targeted to B-cell Malignancies - CD19 is most expressed Ag in B-cell CA pic.twitter.com/B5knKlvAEj,,,# #,4.73116E+17,https://twitter.com/mtmdphd/status/473116099366887425,,,,
MaryHartleyRD,6/1/2014 10:57,0,0,"Actually overweight""- there's a difference. RT @ djsampson ""Colditz: chart: cancers attributed to obesity # asco14...""",,@,#,4.73116E+17,https://twitter.com/MaryHartleyRD/status/473116097311694848,,,,
NCIMedia,6/1/2014 10:56,1,2,"From # ASCO14 : Overhaul to Federally Sponsored Trials and Enriched Support for Community-Based Research"" http://tinyurl.com/py3ulao # NCTN""",,,# #,4.73116E+17,https://twitter.com/NCIMedia/status/473115963274297344,,,,
UrologyMatch,6/1/2014 10:56,0,0,“ @ ASCOPost: FDA cancer chief says 'escalating' drug prices can't continue (via @ Reuters) http://ow.ly/xuyGQ # ASCO14”,,@ @,#,4.73116E+17,https://twitter.com/UrologyMatch/status/473115944667987968,,,,
JeffreyMOtto,6/1/2014 10:56,0,1,"TS: # ASCO14 all MSI tumors are not created equal, but prognosis tends to be good",,,#,4.73116E+17,https://twitter.com/JeffreyMOtto/status/473115936401395712,,,,
AshleySumrallMD,6/1/2014 10:56,0,0,Dr JClarke: GBM is not homogeneous dz. We neep to stop thinking of it that way. # ASCO14 # braintumor,,,# #,4.73116E+17,https://twitter.com/AshleySumrallMD/status/473115914079330305,,,,
jagasquet,6/1/2014 10:56,0,0,First Presentation of # Pembrolizumab (MK-3475) in Advanced Head and Neck Cancer at # ASCO14 http://po.st/4dilns via @ po_st # immunotherapy,,@,# # #,4.73116E+17,https://twitter.com/jagasquet/status/473115912208261120,,,,
mtmdphd,6/1/2014 10:56,1,0,Forero-Torres # lymsm # ASCO14 - Ph1 SGN-CD19A in rel/ref NHL - interim analysis pic.twitter.com/ZkDegSRvMu,,,# #,4.73116E+17,https://twitter.com/mtmdphd/status/473115905309016065,,,,
scooperpr,6/1/2014 10:56,0,0,Special thanks to @ adamfeuerstein for the banquet plate of fudge brownies outside the press room that served as my lunch yesterday. # ASCO14,,@,#,4.73116E+17,https://twitter.com/scooperpr/status/473115764929478656,,,,
UrologyMatch,6/1/2014 10:55,1,0,“ @ AlpineBV_Miller: This slide strongly suggests using enza first since it creates less AR-V7+ pts. # ASCO14 $ MDVN pic.twitter.com/I0O4fgsR5Q”,,@,#,4.73116E+17,https://twitter.com/UrologyMatch/status/473115675376893953,,,,
NTConnell,6/1/2014 10:55,0,1,Cost of national oncologic expenditures expected to increase from $124B in 2010 to $157B in 2020 just due to population increase. # ASCO2014,,,#,4.73116E+17,https://twitter.com/NTConnell/status/473115669614309376,,,,
DoctorGlobal,6/1/2014 10:55,0,0,". @ NTConnell White blood cells/differential. Since there are no second line options, only 3 possible imatinib doses, its suffices. # ASCO14",,@,#,4.73116E+17,https://twitter.com/DoctorGlobal/status/473115552832315392,,,,
WilliamDale_MD,6/1/2014 10:55,1,0,"# ASCO14 Cancer screening outcomes studied: # PSA. for men, # mammograms for women, colonoscopy for both.",,,# # #,4.73116E+17,https://twitter.com/WilliamDale_MD/status/473115547832291328,,,,
genentech,6/1/2014 10:55,20,13,"Goal for the # Next50: “We will replace chemo w/ individualized, targeted treatment approaches.” D. Berger # ASCO14 pic.twitter.com/GpGWUbxNg7",,,# #,4.73116E+17,https://twitter.com/genentech/status/473115526278152192,,,,
genentech,6/1/2014 10:55,0,2,"Now could be a turning pt in making MRD a reliable & meaningful endpoint in # clinicaltrials."" - N. Valente http://ow.ly/xuync # ASCO14""",,,# #,4.73116E+17,https://twitter.com/genentech/status/473115518359322624,,,,
JeffreyMOtto,6/1/2014 10:55,0,0,TS: # asco14 don't underestimate heterogeneity within response and effect of chemotherapy,,,#,4.73116E+17,https://twitter.com/JeffreyMOtto/status/473115510847332352,,,,
Tony_Calles,6/1/2014 10:55,0,0,Dr. Jänne talking about genotyping in lung cancer. Comprehensive lecture every one can follow. # ASCO14 # lcsmpic.twitter.com/uIsIkEzWEr,,,# #,4.73116E+17,https://twitter.com/Tony_Calles/status/473115509563871233,,,,
MaverickNY,6/1/2014 10:54,2,0,Another beef for # asco14 presenters - a busy 7x5 table is NOT going to work for the majority of audience unless close up,,,#,4.73115E+17,https://twitter.com/MaverickNY/status/473115453934813184,,,,
UrologyMatch,6/1/2014 10:54,0,0,“ @ dr_coops: Analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid # ASCO14 http://ow.ly/xcxgz # PCSM”,,@ @,# #,4.73115E+17,https://twitter.com/UrologyMatch/status/473115453100134401,,,,
JeffreyMOtto,6/1/2014 10:54,0,0,TS: # ASCO14 drugs and # biomarkers will find that CRC heterogeneity will drive effect,,,# #,4.73115E+17,https://twitter.com/JeffreyMOtto/status/473115363790815232,,,,
AlpineBV_Miller,6/1/2014 10:54,1,2,The $ GSK COMBId data are unimpressive. Leaves the field wide open for $ RHHBY $ EXEL coBRIM combo # ASCO14,,,#,4.73115E+17,https://twitter.com/AlpineBV_Miller/status/473115361668509698,,,,
SanofiUS,6/1/2014 10:53,1,0,RT @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1pJk997 Want to follow all? Subscribe to our list http://bit.ly/1pJkaKk # hcsm,,@,# #,4.73115E+17,https://twitter.com/SanofiUS/status/473115231909318656,,,,
gumedcenter,6/1/2014 10:53,2,0,"Effects of # breastcancer therapy w/ ovary shut down “not negligible,” @ LombardiCancer doc tells @ reuters http://reut.rs/1hMC9uk # asco14",,@ @,# #,4.73115E+17,https://twitter.com/gumedcenter/status/473115076728471552,,,,
chigrl13,6/1/2014 10:53,0,0,@ drattai # ASCO14 # bcsm thankU for accupuncture tip. Had my 1st # chemo on 27May2014,,@,# # #,4.73115E+17,https://twitter.com/chigrl13/status/473115066972110848,,,,
theABTA,6/1/2014 10:53,1,2,Brain tumor researchers share findings during the # ASCO14 research poster session. We're ready for another great day. pic.twitter.com/b1AyKVKL9y,,,#,4.73115E+17,https://twitter.com/theABTA/status/473115021170331648,,,,
ASCOPost,6/1/2014 10:52,10,2,FDA cancer chief says 'escalating' drug prices can't continue (via @ Reuters) http://ow.ly/xuyGQ # ASCO14,,@,#,4.73115E+17,https://twitter.com/ASCOPost/status/473114991730905088,,,,
fwpharma,6/1/2014 10:52,4,2,"Combination of AstraZeneca's olaparib, cediranib nearly doubles PFS in ovarian cancer study http://bit.ly/1hoXi38 $ AZN # ASCO14",,,#,4.73115E+17,https://twitter.com/fwpharma/status/473114986714509312,,,,
WilliamDale_MD,6/1/2014 10:52,1,0,"# ASCO14 Unique feature of NSHAP is matched spousal data, which is unique for nationally- representative sample.",,,#,4.73115E+17,https://twitter.com/WilliamDale_MD/status/473114918309216256,,,,
MediTech_Media,6/1/2014 10:52,0,0,"Risk of developing pancreatic cancer 2x higher in diabetics vs non-diabetics. # ASCO14 poster 386, Schmidt et al",,,#,4.73115E+17,https://twitter.com/MediTech_Media/status/473114915226796032,,,,
JeffreyMOtto,6/1/2014 10:52,0,0,TS: # ASCO14 it is imperative to recognize biological heterogeneity within CRC,,,#,4.73115E+17,https://twitter.com/JeffreyMOtto/status/473114915109339136,,,,
drdonsdizon,6/1/2014 10:52,1,1,"Gourley data: Immune subgroup had WORSE outcome on Bev vs control. Non-immune, benefit w Bev. # gyncsm # ASCO14 pic.twitter.com/ptcBbJoIMY",,,# #,4.73115E+17,https://twitter.com/drdonsdizon/status/473114904258281473,,,,
jagasquet,6/1/2014 10:52,1,0,@ NEJM # Enzalutamide in Metastatic # ProstateCancer before Chemotherapy — NEJM http://nej.md/1iIk4xL # ASCO14,,@,# # #,4.73115E+17,https://twitter.com/jagasquet/status/473114833810759681,,,,
Tony_Calles,6/1/2014 10:52,0,0,"Moving to What are we talking about NGS, Sanger sequencing in lung cancer # ASCO14 # lcsmpic.twitter.com/Pc3LV0xnfe",,,# #,4.73115E+17,https://twitter.com/Tony_Calles/status/473114749765709824,,,,
aakonc,6/1/2014 10:51,0,0,“ @ rschilsky: # ASCO14 CALGB/SWOG 80405 shows 29 mo. median OS in both arms. Bev and cetux equivalent.” OS results best news from study#crcsm,,@,# #crcsm,4.73115E+17,https://twitter.com/aakonc/status/473114726117822465,,,,
coaster_riding,6/1/2014 10:51,0,1,Newer Anti-Estrogen Treatment May Benefit Younger # BreastCancer # Survivors. # Health via @ DoctorsLounge http://bit.ly/1wNqsNK # ASCO14,,@,# # # #,4.73115E+17,https://twitter.com/coaster_riding/status/473114638947598337,,,,
mtmdphd,6/1/2014 10:51,0,0,# lymsm # ASCO14 commenter - try using CT texture analysis as another imaging modality,,,# #,4.73115E+17,https://twitter.com/mtmdphd/status/473114579518906368,,,,
JeffreyMOtto,6/1/2014 10:51,2,1,TS: # ASCO14 - gone are the times when we wait for robust and exhaustive clinical data to use # biomarkers to change clinical practice,,,# #,4.73115E+17,https://twitter.com/JeffreyMOtto/status/473114554449539072,,,,
WileyOnc_Hem,6/1/2014 10:50,0,0,Circumcision linked to reduced risk of prostate cancer in some men. Read the article here http://ow.ly/3leXyP # ASCO14 @ ASCO @ BJUIjournal,,@ @,#,4.73114E+17,https://twitter.com/WileyOnc_Hem/status/473114469024153600,,,,
jagasquet,6/1/2014 10:50,2,1,# ASCO14 Study finds addition of # Tykerb to # Herceptin does not improve disease-free survival # breastcancer http://www.firstwordpharma.com/node/1214191 @ fwpharma,,@,# # # #,4.73114E+17,https://twitter.com/jagasquet/status/473114326610362368,,,,
OncLive,6/1/2014 10:50,5,3,Dr. Naiyer Rizvi from @ sloan_kettering on Nivolumab Plus Erlotinib in Patients with EGFR mutated NSCLC http://ow.ly/xutO1 # ASCO14,,@,#,4.73114E+17,https://twitter.com/OncLive/status/473114303009419264,,,,
DebiopharmNews,6/1/2014 10:50,0,0,# ASCO14 Phase I/II Debio 1143 combo with CCRT in # patients with # HNSCN (abstract/poster # TPS6097) Find out more http://ow.ly/x95Fq,,,# # # #,4.73114E+17,https://twitter.com/DebiopharmNews/status/473114296361418752,,,,
teamoncology,6/1/2014 10:50,0,0,"@ drdonsdizon HGSOC and TNBC have similar gene signature per TCGA data. But, one the bev works, and the other no impact. # ASCO14 # BCSM",,@,# #,4.73114E+17,https://twitter.com/teamoncology/status/473114296222629888,,,,
RickDomann,6/1/2014 10:50,0,0,“ @ ASCO: Dr. Bruce E. Johnson: 50 years of progress in lung cancer research http://bit.ly/TXJxxV # ASCO14”,,@,#,4.73114E+17,https://twitter.com/RickDomann/status/473114289792745472,,,,
Roche,6/1/2014 10:50,6,5,The PHC approach to therapy has significant implications for all stakeholders within the # healthcare system http://ow.ly/xoZme # ASCO14,,,# #,4.73114E+17,https://twitter.com/Roche/status/473114287792463872,,,,
JeffreyMOtto,6/1/2014 10:50,0,0,ST: # asco14 lots of trials have shown impact of KRAS and NRAS on anti-EGFR therapies,,,#,4.73114E+17,https://twitter.com/JeffreyMOtto/status/473114244901502976,,,,
JediPD,6/1/2014 10:49,0,0,@ fischmd @ mtmdphd Emanuel uses correlation between pricing & income with implied causality of bankruptcy>evoking emotion not answers # ASCO14,,@ @,#,4.73114E+17,https://twitter.com/JediPD/status/473114167189450752,,,,
VOInnovation,6/1/2014 10:49,0,1,"RT @ DrBobGoldberg: Increasing life expectancy most powerful driver of social equality. # asco14"" # MLIWI @ MLIWI""",,@ @,# #,4.73114E+17,https://twitter.com/VOInnovation/status/473114137782788096,,,,
daviesbj,6/1/2014 10:49,1,0,@ AlpineBV_Miller @ ChapinMD if you can tell me who is who then I'm all for sequencing appropriately. We are not there tho... # ASCO14,,@ @,#,4.73114E+17,https://twitter.com/daviesbj/status/473114035148587008,,,,
WilliamDale_MD,6/1/2014 10:49,2,0,"# ASCO14 Data Set- National Social life , Health. & Aging (NSHAP). NIA funded. 2010. Nationally- representative. pic.twitter.com/YE2RMBm2Nx",,,#,4.73114E+17,https://twitter.com/WilliamDale_MD/status/473114010435325953,,,,
aakonc,6/1/2014 10:49,0,0,Now we can finally talk about it @ ASCO: Plenary brief # ASCO14: FOLFOX and FOLFIRI acceptable w/either” – Dr Venook” # c80405,,@,# #,4.73114E+17,https://twitter.com/aakonc/status/473113997504704512,,,,
drdonsdizon,6/1/2014 10:48,1,0,Gurley: 63-gene immune signature (absent of angiogenic biology). ICON7 data (n=284 high grade serous) # gyncsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_133112.html …,,,# #,4.73114E+17,https://twitter.com/drdonsdizon/status/473113906458542081,,,,
teamoncology,6/1/2014 10:48,0,0,"RT @ drdonsdizon: Really interesting findings, C. Gourley re: mol subtype of hi-grade serous # ovca &amp; bev # ASCO14 http://abstracts.asco.org/144/AbstView_144_133112.html …",,@,# #,4.73114E+17,https://twitter.com/teamoncology/status/473113856319823872,,,,
jfclearywisc,6/1/2014 10:48,2,0,RT @ PalliativeMedJ: FREE trial access to # Palliative Medicine til 30th june for @EAPCOnlus congress # ASCO14 # Hpm https://online.sagepub.com/cgi/register?registration=FTPMJEAPCCON14 …,,@ @EAPCOnlus,# # #,4.73114E+17,https://twitter.com/jfclearywisc/status/473113790221799425,,,,
SanofiCanada,6/1/2014 10:48,1,0,# SanofiCA is proud to take part in cutting-edge scientific presentations # ASCO2014 Annual Meeting,,,# #,4.73114E+17,https://twitter.com/SanofiCanada/status/473113762955001856,,,,
PHCbiomed,6/1/2014 10:48,0,0,Did you know that improper refrigeration of sensitive drugs or biologicals can decrease their efficacy? Learn more at 17163 # ASCO14,,,#,4.73114E+17,https://twitter.com/PHCbiomed/status/473113754545434625,,,,
JeffreyMOtto,6/1/2014 10:47,0,0,ST: # asco14 - only two currently validated markers for CRC - RAS and MSI,,,#,4.73114E+17,https://twitter.com/JeffreyMOtto/status/473113725546033152,,,,
CBPartners,6/1/2014 10:47,0,0,Oncology has the power to lead payment reform http://bit.ly/1m3fsU3 # ASCO14,,,#,4.73113E+17,https://twitter.com/CBPartners/status/473113499703738368,,,,
Wiley_Health,6/1/2014 10:46,2,1,Circumcision linked to reduced risk of prostate cancer in some men. Read the article here http://ow.ly/3leXyP # ASCO14 @ ASCO @ BJUIjournal,,@ @,#,4.73113E+17,https://twitter.com/Wiley_Health/status/473113454786912256,,,,
aakonc,6/1/2014 10:46,0,0,Difficult to fully comprehend C80405 results until extended ras analysis available # ASCO14 # colorectalcancer,,,# #,4.73113E+17,https://twitter.com/aakonc/status/473113425502277632,,,,
drdonsdizon,6/1/2014 10:46,3,3,"Really interesting findings, Abstr 5502- C. Gourley re: mol subtype of hi-grade serous # ovca & bev # gyncsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_133112.html …",,,# # #,4.73113E+17,https://twitter.com/drdonsdizon/status/473113368966864899,,,,
ilaberna,6/1/2014 10:46,0,0,“ @ mimar2000 11Studi del prof # Crinó @ ospedaleperugia al convegno mondiale di # ASCO14 Sconfiggere il cancro mantenendo alta qualità di vita!,,@ @,# #,4.73113E+17,https://twitter.com/ilaberna/status/473113364689072128,,,,
MyelomaTeacher,6/1/2014 10:46,3,2,New drug on the block... # TH302 Initial data. Poster PDF via @ myelomabeacon http://www.myelomabeacon.com/docs/asco2014/8534.pdf … # ASCO14 # mmsm # myeloma,,@,# # # #,4.73113E+17,https://twitter.com/MyelomaTeacher/status/473113290739294208,,,,
teamoncology,6/1/2014 10:45,1,0,RT @ TargetedOnc: Dr R Goldberg from @ OSUCCC_James discusses results from the phase III CALGB/SWOG 80405 trial http://www.targetedonc.com/conference/asco-2014/Results-from-the-Phase-III-CALGBSWOG-80405-Trial … # ASCO14,,@ @,#,4.73113E+17,https://twitter.com/teamoncology/status/473113183356338176,,,,
GustaveRoussy,6/1/2014 10:45,3,1,# ASCO14 How chemotherapy has significant impact on surviving prostate cancer without recurrence @ GroupeUNICANCERpic.twitter.com/QY7kMSmj4M,,@,#,4.73113E+17,https://twitter.com/GustaveRoussy/status/473113137344835584,,,,
WilliamDale_MD,6/1/2014 10:45,2,0,# ASCO14 Are cancer screening rates for married vs unmarried? What relationship features important to rates? pic.twitter.com/PxwxnK2fhC,,,#,4.73113E+17,https://twitter.com/WilliamDale_MD/status/473113135948120064,,,,
ASCOPost,6/1/2014 10:45,4,2,"Once A Year, Cancer Research News Comes In A Flood, Not A Trickle (via @ NPR) http://ow.ly/xuy7k # ASCO14",,@,#,4.73113E+17,https://twitter.com/ASCOPost/status/473113135424233472,,,,
Lymphoma_Doc,6/1/2014 10:45,3,1,"Abst 8504: Blood based minimal residual disease detection in DLBCL = feasible & predictive, exciting data from @ SequentaInc team # ASCO14",,@,#,4.73113E+17,https://twitter.com/Lymphoma_Doc/status/473113072820060160,,,,
igormorr,6/1/2014 10:45,0,0,“ @ ClevelandClinic: “Obesity is replacing tobacco as the number one preventable/modifiable cause of cancer.” - @ CliffordHudis # ASCO14”,,@ @,#,4.73113E+17,https://twitter.com/igormorr/status/473113045540278272,,,,
mayocliniclabs,6/1/2014 10:45,0,0,Dr. Cliby is discussing “Quality and Value in Gynecologic Cancer Care: Do We Get What We Pay For?” # ASCO14,,,#,4.73113E+17,https://twitter.com/mayocliniclabs/status/473113024828821504,,,,
3NT,6/1/2014 10:44,0,1,Just updated # ASCO14 live blog with quick note from prostate cancer session. (for subs) http://3nt.co/Nivolumab,,,#,4.73113E+17,https://twitter.com/3NT/status/473112955362750465,,,,
TargetedOnc,6/1/2014 10:44,0,2,"Richard Goldberg, MD, from @ OSUCCC_James discusses results from the phase III CALGB/SWOG 80405 trial http://www.targetedonc.com/conference/asco-2014/Results-from-the-Phase-III-CALGBSWOG-80405-Trial … # ASCO14",,@,#,4.73113E+17,https://twitter.com/TargetedOnc/status/473112952418336768,,,,
Dra_Guaripete,6/1/2014 10:44,0,0,"Ya los medios rebotan lo publicado en # ASCO14, hay mucha información rompiendo el celofán @ ASCO",,@,#,4.73113E+17,https://twitter.com/Dra_Guaripete/status/473112928359817217,,,,
christinemphmd,6/1/2014 10:44,1,0,Drs. Christine Garcia and Robert Hendler representing @ StonyBrookMed at # ASCO14 @ stonybrooku @ sbuim c,,@ @ @,#,4.73113E+17,https://twitter.com/christinemphmd/status/473112919094611968,,,,
teamoncology,6/1/2014 10:44,0,0,"【 # ASCO14 101】 Ramucirumab, targeting VEGFR2, now has positive results in lung and gastric cancer. But, not in # BreastCancer. # BCSM",,,# # #,4.73113E+17,https://twitter.com/teamoncology/status/473112876425543682,,,,
myPathMelanoma,6/1/2014 10:44,0,0,Myriad myPath # Melanoma is a clinically validated assay for difficult-to-diagnose # melanocytic lesions # isthismelanoma # ASCO14,,,# # # #,4.73113E+17,https://twitter.com/myPathMelanoma/status/473112734322552833,,,,
IMFmyeloma,6/1/2014 10:43,2,2,Check out the IMF's booth at # ASCO14! pic.twitter.com/RhhhLakUW0,,,#,4.73113E+17,https://twitter.com/IMFmyeloma/status/473112584325849088,,,,
DrHedrick,6/1/2014 10:43,0,2,Dr. Trent Miller of @ iumedschool presenting trial in progress on testosterone replacement in testis cancer. # ASCO14 pic.twitter.com/L3zw8kHGxU,,@,#,4.73113E+17,https://twitter.com/DrHedrick/status/473112573592608770,,,,
teamoncology,6/1/2014 10:42,0,1,Yes. RT @ HenryJOncology: Does involvement in the trial represent a COI for discussants in # meded? Who should critique # ASCO14 abstracts?,,@,# #,4.73112E+17,https://twitter.com/teamoncology/status/473112459364950016,,,,
WilliamDale_MD,6/1/2014 10:42,0,0,# ASCO14 Virtual tour on # cancer screening behavior influence of spouses from poster 359. Stay tuned.,,,# #,4.73112E+17,https://twitter.com/WilliamDale_MD/status/473112426263494658,,,,
mtmdphd,6/1/2014 10:42,1,1,Flower # lymsm # ASCO14 - Disc - Kurtz et al 8504 - IgHTS - provocative. Future studies to establish clin utility pic.twitter.com/9AWGvAVUxC,,,# #,4.73112E+17,https://twitter.com/mtmdphd/status/473112416449220608,,,,
gumedcenter,6/1/2014 10:42,2,0,. @ LombardiCancer @ RueschCenter doc shares ideas on controlling # cancer drug costs with @ reuters http://reut.rs/1kwB4eV # ASCO2014,,@ @ @,# #,4.73112E+17,https://twitter.com/gumedcenter/status/473112296974458880,,,,
VOInnovation,6/1/2014 10:42,0,1,The cost of new medicines may be balanced by savings in other health care expenses: http://bit.ly/1iIiwUj via @ Celgene. # ASCO14 # MLIWI,,@,# #,4.73112E+17,https://twitter.com/VOInnovation/status/473112278552682496,,,,
teamoncology,6/1/2014 10:42,0,1,【 # ASCO14 Update】閉経前ホルモン陽性の乳がんにおいて、アロマテース阻害剤と卵巣機能抑制剤の組み合わせは再発を下げる。,,,#,4.73112E+17,https://twitter.com/teamoncology/status/473112255676948480,,,,
gumedcenter,6/1/2014 10:41,1,0,"New # breastcancer therapy involving ovary shut down “is not negligible,” @ LombardiCancer doc tells @ reuters http://reut.rs/1hMC9uk # asco14",,@ @,# #,4.73112E+17,https://twitter.com/gumedcenter/status/473112189885485056,,,,
MyelomaTeacher,6/1/2014 10:41,0,0,"Poster PDF of Safety & Efficacy of # daratumumab , Len, Dex in RRMM # mmsm # ASCO14 # myeloma http://www.myelomabeacon.com/docs/asco2014/8533.pdf … @ myelomabeacon",,@,# # # #,4.73112E+17,https://twitter.com/MyelomaTeacher/status/473112182784528386,,,,
mtmdphd,6/1/2014 10:41,1,0,Flower # lymsm # ASCO14 - Disc - Alternatives to Surveillance Imaging pic.twitter.com/KnvIdBFZjl,,,# #,4.73112E+17,https://twitter.com/mtmdphd/status/473112072046510080,,,,
Boehringer,6/1/2014 10:41,2,0,BLOG POST: Why is # lungcancer so under-reported? Food for thought on # notjustonedisease http://bit.ly/1oX5LdG # ASCO14,,,# # #,4.73112E+17,https://twitter.com/Boehringer/status/473112033702187008,,,,
dmooneymd,6/1/2014 10:41,1,0,Flowers: Surveillance imaging in nhl-Scan only relapse detection is rare (1-3%) with low potential of secondary malignancies. # lymsm # ASCO14,,,# #,4.73112E+17,https://twitter.com/dmooneymd/status/473111994963197952,,,,
DrLisaCurcio,6/1/2014 10:40,0,1,“ @ drattai: Metcalfe: those who had oophorectomy have mortality reduction. Primarily in pts w/ BRCA1 vs 2 # asco14 # bcsm”,,@,# #,4.73112E+17,https://twitter.com/DrLisaCurcio/status/473111957902729217,,,,
BRCAresponder,6/1/2014 10:40,0,1,Have you read the WEEKLY? @ BRCAresponder WEEKLY news # BRCA # hereditarycancer # research # Debate # mastectomy https://storify.com/BRCAresponder/5-30-14-brcaresponder-weekly … # ASCO14,,@,# # # # # #,4.73112E+17,https://twitter.com/BRCAresponder/status/473111942739935233,,,,
teamoncology,6/1/2014 10:40,0,0,【 # ASCO14 Update】 転移性大腸がんにおいて、抗EGFR抗体あるいは、血管新生血管阻害剤を化学療法どちらからスタートしても効果は同じ。 http://abstracts.asco.org/144/AbstView_144_127755.html …,,,#,4.73112E+17,https://twitter.com/teamoncology/status/473111853497741312,,,,
DebiopharmNews,6/1/2014 10:40,0,0,# ASCO14 Phase I study Debio 1143 combo in # patients # leukemia # bloodcancer (abstract/poster #7029) Find out more http://ow.ly/x95Ab,,,# # # # #7029,4.73112E+17,https://twitter.com/DebiopharmNews/status/473111805565607936,,,,
HenryJOncology,6/1/2014 10:40,0,1,@ fischmd Does involvement in the trial represent a conflict of interest for discussants in # meded? Who should critique # ASCO14 abstracts?,,@,# #,4.73112E+17,https://twitter.com/HenryJOncology/status/473111802100711425,,,,
HallandPartners,6/1/2014 10:40,0,0,At @ ASCO & would love to share insights from a recent study conducted with specialists & patients- k.zapert@hallandpartners.com # ASCO14,,@ @hallandpartners,#,4.73112E+17,https://twitter.com/HallandPartners/status/473111731770638336,,,,
DrAttai,6/1/2014 10:39,1,3,I would be completely lost without the # asco14 meeting planner app. Just saying.,,,#,4.73112E+17,https://twitter.com/DrAttai/status/473111696190758912,,,,
subatomicdoc,6/1/2014 10:39,0,0,"@ dr_coops I'll check it out, send photo. Just leaving Miracle Mile. For the convention center. # ASCO14",,@,#,4.73112E+17,https://twitter.com/subatomicdoc/status/473111552380645377,,,,
dr_coops,6/1/2014 10:38,3,2,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 http://ow.ly/xcxgz # PCSM,,@,# #,4.73111E+17,https://twitter.com/dr_coops/status/473111465730113536,,,,
AlpineBV_Miller,6/1/2014 10:38,0,0,@ ChapinMD @ daviesbj Exactly. Irresponsible to expose guy to chemo AEs if he's a next-gen AR tx responder. # ASCO14,,@ @,#,4.73111E+17,https://twitter.com/AlpineBV_Miller/status/473111426366988288,,,,
teamoncology,6/1/2014 10:38,1,0,【 # ASCO14 101】 I do not recall any prospectively validated immune signature in # breastcancer that can be used in the clinic. # BCSM,,,# # #,4.73111E+17,https://twitter.com/teamoncology/status/473111309647499265,,,,
myelomacinderel,6/1/2014 10:38,1,0,Riveting preview upcoming PBS 6 hr 3 documentary. # myeloma # ASCO14 @ MyelomaTeacher http://am.asco.org/asco ’s-role-upcoming-pbs-documentary,,@,# #,4.73111E+17,https://twitter.com/myelomacinderel/status/473111301905195008,,,,
MyelomaTeacher,6/1/2014 10:38,0,1,"Thanks @ myelomabeacon 4 poster PDF of Phase 1 # SAR650984, a # CD38 monoclonal antibody in RRMM # mmsm # ASCO14 # myeloma http://www.myelomabeacon.com/docs/asco2014/8532.pdf …",,@,# # # # #,4.73111E+17,https://twitter.com/MyelomaTeacher/status/473111296578453505,,,,
drsreform,6/1/2014 10:38,1,0,@ _connectedcare @ Cyclenut66 and @ ASCO this week calling obesity the new tobacco,,@ @ @,,4.73111E+17,https://twitter.com/drsreform/status/473111257482940416,,,,
elmundosalud,6/1/2014 10:38,27,12,Sin duda lo más novedoso y esperanzador de # ASCO14 es que se consolida el concepto de inmunoterapia antitumoral. pic.twitter.com/U2KAbDYbJe,,,#,4.73111E+17,https://twitter.com/elmundosalud/status/473111230094118914,,,,
_TheUrologist_,6/1/2014 10:37,3,2,(ADT + 18wk docetaxel) v ADT in hormone-sensitive CaPr: OS↑44→58 months (more if high-stage) # asco14 http://www.urotoday.com/mCRPC-Treatment/addition-of-docetaxel-to-initial-hormone-therapy-substantially-improves-survival-in-men-with-metastatic-hormone-sensitive-prostate-cancer.html?utm_source=dlvr.it&utm_medium=twitter … HT @ LoebStacy,,@,#,4.73111E+17,https://twitter.com/_TheUrologist_/status/473111214730797056,,,,
ClevelandClinic,6/1/2014 10:37,196,51,“Obesity is on its way to replacing tobacco as the number one preventable/modifiable cause of cancer.” - @ CliffordHudis # ASCO14,,@,#,4.73111E+17,https://twitter.com/ClevelandClinic/status/473111164348821505,,,,
dmooneymd,6/1/2014 10:37,0,0,"Pet-directed therapy for high risk DLBCL is feasible, per cassanovas. Don't know if this led to improved outcomes, though. # lymsm # ASCO14",,,# #,4.73111E+17,https://twitter.com/dmooneymd/status/473111144824311808,,,,
jorge_rozette,6/1/2014 10:37,0,0,# ASCO14 http://tinyurl.com/pj8rhd5 pic.twitter.com/WHiVFqcMau,,,#,4.73111E+17,https://twitter.com/jorge_rozette/status/473111110019604480,,,,
PabloOldfield,6/1/2014 10:37,3,1,Find myself or @ dansbarrington at the # ASCO14 conference. Take a card and come to the Hyatt bar this evening and we will buy you a drink!,,@,#,4.73111E+17,https://twitter.com/PabloOldfield/status/473111033117433856,,,,
teamoncology,6/1/2014 10:37,0,0,RT @ drattai: Immune signature (3/3) # asco14 # bcsmpic.twitter.com/PpmVmQDi55,,@,# #,4.73111E+17,https://twitter.com/teamoncology/status/473111001747845120,,,,
OncoPlexDx,6/1/2014 10:37,0,0,Stop by #18119 at 12PM today to meet # oncology expert Jedd Levine MD & to learn a better way to measure # proteins than # IHC. # ASCO14 # esocsm,,,#18119 # # # # #,4.73111E+17,https://twitter.com/OncoPlexDx/status/473110981837860865,,,,
teamoncology,6/1/2014 10:36,1,1,"【 # ASCO14 101】 There are many immune signature: from the tumor, non-tumor, tumor infiltrating lymphocytes in breast cancer. # bcsm",,,# #,4.73111E+17,https://twitter.com/teamoncology/status/473110948522119168,,,,
QIAGENscience,6/1/2014 10:36,0,0,Targeted therapy depends on reliable test results. Don’t fall behind. Be sure 2 request FDA-approved test. http://bit.ly/1mkJGD6 # ASCO14,,,#,4.73111E+17,https://twitter.com/QIAGENscience/status/473110884228026368,,,,
yzafar,6/1/2014 10:36,4,0,Continue the cancer drug cost and value discussion after @ ASCO at @ theIOM next week http://ow.ly/x5W5b # ASCO14,,@ @,#,4.73111E+17,https://twitter.com/yzafar/status/473110781329178624,,,,
Cascadia,6/1/2014 10:36,0,0,How Progress Happens Innovation in Oncology @ pfizer @ MaceRothenberg: # ASCO14 http://bit.ly/1oX8Nys pic.twitter.com/Wj1OceDixc,,@ @,#,4.73111E+17,https://twitter.com/Cascadia/status/473110759682363393,,,,
MelanomaReAlli,6/1/2014 10:36,1,1,Exciting session this morning on combination strategies for # melanoma - many possibilities to explore for greater benefit for pts # ASCO14,,,# #,4.73111E+17,https://twitter.com/MelanomaReAlli/status/473110744029200386,,,,
DrAttai,6/1/2014 10:36,4,1,Immune signature (3/3) # asco14 # bcsmpic.twitter.com/kaWcSqHWha,,,# #,4.73111E+17,https://twitter.com/DrAttai/status/473110733576994817,,,,
subatomicdoc,6/1/2014 10:35,0,1,@ djsampson @ gcolditz @ CassSunstein Cool! Key seems to be in part astute 'framing' and heuristics. # ASCO14 # hcsm,,@ @ @,# #,4.73111E+17,https://twitter.com/subatomicdoc/status/473110660000530433,,,,
JohnCendpts,6/1/2014 10:35,0,0,RT @ ACROhealth: TODAY @ FierceBiotech # TwitterChat. Hear top industry minds @DamianFierce @ MarkSchoenebaum # fierceasco # ASCO2014,,@ @ @DamianFierce @,# # #,4.73111E+17,https://twitter.com/JohnCendpts/status/473110628866203648,,,,
SitemanCenter,6/1/2014 10:35,1,1,MT “ @ djsampson: Great chart from @ gcolditz: opportunities for cancer prevention by the numbers # asco14 pic.twitter.com/PPJJ88JDej”,,@ @,#,4.73111E+17,https://twitter.com/SitemanCenter/status/473110624453419009,,,,
teamoncology,6/1/2014 10:35,0,0,RT @ drattai: Using immune signature to predict relapse (1/3) # asco14 # bcsmpic.twitter.com/eeJNmUEFkl,,@,# #,4.73111E+17,https://twitter.com/teamoncology/status/473110619067924480,,,,
DrAttai,6/1/2014 10:35,1,1,Immune signature (2/3) # asco14 # bcsmpic.twitter.com/UNlmqvGCeq,,,# #,4.73111E+17,https://twitter.com/DrAttai/status/473110586147209216,,,,
theABTA,6/1/2014 10:35,0,0,We're ready for another great day of learning and sharing at # ASCO14. Stop by our exhibit booth and say hello!,,,#,4.73111E+17,https://twitter.com/theABTA/status/473110517536804864,,,,
gumedcenter,6/1/2014 10:34,1,0,. @ LombardiCancer @ RueschCenter doc shares ideas on controlling drug costs with @ reuters http://reut.rs/1kwB4eV # ASCO2014,,@ @ @,#,4.7311E+17,https://twitter.com/gumedcenter/status/473110455490461696,,,,
DrAttai,6/1/2014 10:34,3,3,Using immune signature to predict relapse (1/3) # asco14 # bcsmpic.twitter.com/YcvGbI6ETx,,,# #,4.7311E+17,https://twitter.com/DrAttai/status/473110436842594304,,,,
mtmdphd,6/1/2014 10:34,3,1,MT @ mnewtonPharmD: Cedirinib/olaparib PFS curve in ovarian cancer # ASCO14 pic.twitter.com/JIsqqLmLsw # gyncsm,,@,# #,4.7311E+17,https://twitter.com/mtmdphd/status/473110371298205696,,,,
teamoncology,6/1/2014 10:34,3,1,Nice. RT @ subatomicdoc: Low-dose CT # lungcancer screening in the community: A prospective cohort study http://bit.ly/1kROx0p # ASCO14 # lcsm,,@,# # #,4.7311E+17,https://twitter.com/teamoncology/status/473110340960411650,,,,
jlserna,6/1/2014 10:34,7,2,Sin duda lo más novedoso y esperanzador de # ASCO14 es que el concepto de inmunoterapia antitumoral se está consolidando.,,,#,4.7311E+17,https://twitter.com/jlserna/status/473110316763471872,,,,
JeffreyMOtto,6/1/2014 10:34,0,0,Hearing the seagulls adds an ambiance that you just don't get at other conference venues # chicago # ASCO14,,,# #,4.7311E+17,https://twitter.com/JeffreyMOtto/status/473110238980493312,,,,
sitcancer,6/1/2014 10:34,1,2,Happy # ASCO14 day 2! Join us at booth 2047 for some neat swag! pic.twitter.com/hQxrFAZKCN,,,#,4.7311E+17,https://twitter.com/sitcancer/status/473110221313687552,,,,
mlazqui,6/1/2014 10:33,1,0,Cierto! @ duemed Becas @ _SEOM en # ASCO14 gracias al trabajo de Xabier G de Albéniz sobre “inmediate vs delayed ADT” pic.twitter.com/GXjhNq9V2r,,@ @,#,4.7311E+17,https://twitter.com/mlazqui/status/473110166079303680,,,,
nig_onco,6/1/2014 10:33,3,0,"Presented by INT Milan & H Niguarda Milan anti-ROS1, -TRKA, -ALK RXDX101 results of phase I precision oncology trial # ASCO14",,,#,4.7311E+17,https://twitter.com/nig_onco/status/473110129534308352,,,,
emilygest,6/1/2014 10:33,0,0,@ DrRobertGlatter @ Forbes Great story on # ASCO14,,@ @,#,4.7311E+17,https://twitter.com/emilygest/status/473110098743926784,,,,
subatomicdoc,6/1/2014 10:33,1,2,Low-dose CT # lungcancer screening in the community: A prospective cohort study http://bit.ly/1kROx0p # ASCO14 # lcsm,,,# # #,4.7311E+17,https://twitter.com/subatomicdoc/status/473109995941556224,,,,
drsteventucker,6/1/2014 10:32,9,2,MT @ djsampson: Great chart: opportunities for cancer prevention by the numbers # asco14 pic.twitter.com/BICO2HhWhm # health # lifestyle,,@,# # #,4.7311E+17,https://twitter.com/drsteventucker/status/473109934981136384,,,,
kellykcotton,6/1/2014 10:32,0,0,"Another Plenary abstract, LBA4 - Phase III ALTTO trial for pts w/early HER2+ breast cancer: http://bit.ly/1n050jo # ASCO14 # bcsm",,,# #,4.7311E+17,https://twitter.com/kellykcotton/status/473109933610008576,,,,
drdonsdizon,6/1/2014 10:32,2,1,Great work @ yscbuzz. Available at # ASCO14. Grab a copy! cc @ jenmerschdorf http://instagram.com/p/otHWR7pwyg/,,@ @,#,4.7311E+17,https://twitter.com/drdonsdizon/status/473109924596027392,,,,
teamoncology,6/1/2014 10:32,0,1,TY again. RT @ chimoose: @ teamoncology U video was really good - it's helpful to hear from the pros. http://mdigitallife.com/socialoncology/2014-2/videos/ … # ASCO14 @ nxtstop1,,@ @ @,#,4.7311E+17,https://twitter.com/teamoncology/status/473109904849260544,,,,
MediTech_Media,6/1/2014 10:32,0,0,"Caregivers underestimate cancer patient QOL compared with patient self-assessment # ASCO14. Poster 210, Lam et al.",,,#,4.7311E+17,https://twitter.com/MediTech_Media/status/473109892866117632,,,,
yzafar,6/1/2014 10:32,11,5,Anal cancer: outcomes are similar with 5FU v capecitabine http://bit.ly/1m2UoNh # acsm @ ABumRap # ASCO14 pic.twitter.com/IyQsxVaB2q,,@,# #,4.7311E+17,https://twitter.com/yzafar/status/473109774830436352,,,,
ASCOPost,6/1/2014 10:32,12,9,Oncologists: How to Talk w/Your Pathologist About Cancer Molecular Testing (via Colorado Cancer Blogs) http://ow.ly/xuxim # ASCO14,,,#,4.7311E+17,https://twitter.com/ASCOPost/status/473109739589865472,,,,
MaverickNY,6/1/2014 10:32,1,0,@ Melanoma_doctor well said! Cost vs value debate is very much to the fore this year # asco14,,@,#,4.7311E+17,https://twitter.com/MaverickNY/status/473109727522865152,,,,
strategicTy,6/1/2014 10:31,0,0,Day 3 of # asco14 Come visit booth 4054 to visit with an investigator w/ our # phaseItrials group # MDAnderson,,,# # #,4.7311E+17,https://twitter.com/strategicTy/status/473109643699687425,,,,
gorskon,6/1/2014 10:31,0,0,"If you see me at # ASCO14, say hi. I'll be here much of the day today and all day tomorrow looking for blog fodder—I mean, learning oncology.",,,#,4.7311E+17,https://twitter.com/gorskon/status/473109636757745664,,,,
GuneetWalia,6/1/2014 10:31,1,1,Eli Lily's Ramucirumab (Cyramza) only modestly extends survival in adv squamous cell # LungCancer pts # ASCO14 # LCSM http://www.thestreet.mobi/story/12725161/1/lilly-drug-extends-survival-in-advanced-lung-cancer-patients.html …,,,# # #,4.7311E+17,https://twitter.com/GuneetWalia/status/473109584421216256,,,,
chimoose,6/1/2014 10:30,3,2,@ teamoncology You're welcome! Your video was really good - it's helpful to hear from the pros. http://mdigitallife.com/socialoncology/2014-2/videos/ … # ASCO14 @ nxtstop1,,@ @,#,4.73109E+17,https://twitter.com/chimoose/status/473109436413009920,,,,
kellykcotton,6/1/2014 10:30,1,0,Abstract LBA3 now online: CALGB/SWOG 80405 results will be presented in today's Plenary Session http://bit.ly/T3TuJB # ASCO14,,,#,4.73109E+17,https://twitter.com/kellykcotton/status/473109422307545089,,,,
DrAnasYounes,6/1/2014 10:30,5,2,interesting study from Stanford on detecting MRD in DLBL using Sequents sequencing platform.needs to be confirmed prospectively # ASCO14,,,#,4.73109E+17,https://twitter.com/DrAnasYounes/status/473109401910661121,,,,
ERPlimackMD,6/1/2014 10:30,1,2,"Thank you to the CaPSURE pts, investigators and sites. Longitudinal collection of PCa data is a powerful tool. @ UCSFCancer. # ASCO14 # gusm",,@,# #,4.73109E+17,https://twitter.com/ERPlimackMD/status/473109387792617472,,,,
DebiopharmNews,6/1/2014 10:30,0,0,# ASCO14 Final PK/PD phase I Debio 1143 (AT406) # patients # cancer (abstract/poster #2532). Find out more http://ow.ly/x95sN,,,# # # #2532,4.73109E+17,https://twitter.com/DebiopharmNews/status/473109379420798976,,,,
SarahCannonDocs,6/1/2014 10:30,2,0,Breast Cancer: from HER2/ER to Triple-Negative/Cytotoxics/Local Therapy. Join # SCRI at # ASCO14 today S Hall A2,,,# #,4.73109E+17,https://twitter.com/SarahCannonDocs/status/473109351797129218,,,,
jorge_rozette,6/1/2014 10:30,0,0,# ASCO14 http://tinyurl.com/k6ns39p pic.twitter.com/HnKWQaL9Sl,,,#,4.73109E+17,https://twitter.com/jorge_rozette/status/473109339813588993,,,,
genentech,6/1/2014 10:30,2,4,"via # REV2014: In 10 yrs we won't say # breastcancer or # coloncancer. We'll ID cancer types by genetics"" - J. Vose @ ASCO # Next50 # ASCO14""",,@,# # # # #,4.73109E+17,https://twitter.com/genentech/status/473109314849497089,,,,
MyelomaTeacher,6/1/2014 10:30,0,0,MT “ @ myelomacinderel: The genomified learning curve. Wondering what the terms mean? # myeloma # ASCO14 http://am.asco.org/next-generation-genomic-testing-understanding-semantics-helps-guide-assay-use-selection …” # genomics @ asco,,@ @,# # #,4.73109E+17,https://twitter.com/MyelomaTeacher/status/473109307471716352,,,,
ASCO,6/1/2014 10:30,11,3,Dr. Bruce E. Johnson: 50 years of progress in lung cancer research http://bit.ly/TXJxxV # ASCO14,,,#,4.73109E+17,https://twitter.com/ASCO/status/473109303503908864,,,,
gorskon,6/1/2014 10:30,0,0,"Finally, after much difficulty, I'm at # ASCO14. Nice, speedy wifi for a change. Now, off to see some science.",,,#,4.73109E+17,https://twitter.com/gorskon/status/473109301037240320,,,,
teamoncology,6/1/2014 10:30,0,0,"I see those tweets. :( RT @ nycdoc29: @ teamoncology - finance guys to pushing their stock, etc. # asco14",,@ @,#,4.73109E+17,https://twitter.com/teamoncology/status/473109288173334529,,,,
mtmdphd,6/1/2014 10:29,0,0,Flower # lymsm # ASCO14 - Disc - Note need quality PET scans for 5 Point Score (5PS) pic.twitter.com/RwSP2qdl2p,,,# #,4.73109E+17,https://twitter.com/mtmdphd/status/473109121982406657,,,,
hinrick,6/1/2014 10:29,1,0,Therapeutic cancer vaccine based on strictly allogeneic cells from healty blood donors. Immunicum present at # ASCO14,,,#,4.73109E+17,https://twitter.com/hinrick/status/473109085655949312,,,,
DrGlenWeiss,6/1/2014 10:29,1,0,Medical oncology fellows come check out @ CancerCenter career booth: CF-1. # clinical # research # trials # ASCO14 @ ASCO @ AACR # lcsm,,@ @ @,# # # # #,4.73109E+17,https://twitter.com/DrGlenWeiss/status/473109056937533440,,,,
Melanoma_doctor,6/1/2014 10:29,3,2,"The more you try and explain away a K-M curve, the more it looks squirrely-why must it be wrong if it’s unexpected? # melanoma # ASCO14",,,# #,4.73109E+17,https://twitter.com/Melanoma_doctor/status/473109051052937216,,,,
MelanomaReAlli,6/1/2014 10:29,0,0,MRA Young Investigator Georgina Long presents encouraging data for dabrafenib + trametinib combo compared to dabrafenib alone at # ASCO14,,,#,4.73109E+17,https://twitter.com/MelanomaReAlli/status/473109045671649280,,,,
dmooneymd,6/1/2014 10:29,0,0,IgHTS can detect molecular residual disease in DLBCL noninvasive through plasma and lymphocyte analysis. # lymsm # ASCO14,,,# #,4.73109E+17,https://twitter.com/dmooneymd/status/473108989711241217,,,,
teamoncology,6/1/2014 10:29,2,2,"【 # ASCO14 Update】 RT @ drattai: Dr. Cassileth benefits from acupuncture - joint pains, chemo-induced nausea, hot flashes, dry mouth # bcsm",,@,# #,4.73109E+17,https://twitter.com/teamoncology/status/473108982840565760,,,,
aftimosp,6/1/2014 10:29,0,0,Combi-D advantage for dabrafenib + trametinib: Median PFS 9.3 vs 8.8 months. PFS at 6 months 70% vs 57%. HR = 0.75. ORR: 67% vs 51%. # ASCO14,,,#,4.73109E+17,https://twitter.com/aftimosp/status/473108966944571392,,,,
PDRennert,6/1/2014 10:28,0,0,]waiting for the antibody drug data @lymphoma session. Didn't realize there would be imaging talks first # rightplacewrongtime at # ASCO14,,@lymphoma,# #,4.73109E+17,https://twitter.com/PDRennert/status/473108950859395072,,,,
DrAttai,6/1/2014 10:28,2,0,Harsh!  @ Frank_S_David: Comment on low-grade," indolent ""cancers"" in overDx session # ASCO14: ""problem starts with the pathologist."" Ouch!”""",,@,#,4.73109E+17,https://twitter.com/DrAttai/status/473108929585893376,,,
kellykcotton,6/1/2014 10:28,0,1,Abstract LBA2 now available: Phase III E3805 prostate cancer study http://bit.ly/T3TdWT # ASCO14 # pcsm,,,# #,4.73109E+17,https://twitter.com/kellykcotton/status/473108923638366208,,,,
duemed,6/1/2014 10:28,3,1,"Becas @ _SEOM en # ASCO14 gracias al trabajo de Xabier García de Albéniz sobre inmediate vs delayed ADT"" pic.twitter.com/ZXYgAVRA9P""",,@,#,4.73109E+17,https://twitter.com/duemed/status/473108818583236609,,,,
jdflaysakier,6/1/2014 10:28,7,0,Cancer de la prostate évolué: une chimio associée d'emblée à la castration chimique réduit la mortalité de 39% # ASCO14,,,#,4.73109E+17,https://twitter.com/jdflaysakier/status/473108741693247488,,,,
mtmdphd,6/1/2014 10:28,2,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Conclusions pic.twitter.com/IY32SslMtI,,,# #,4.73109E+17,https://twitter.com/mtmdphd/status/473108733246308352,,,,
_TheUrologist_,6/1/2014 10:27,0,0,@ ERPlimackMD were there specific triggers to initiate Tx? # asco14,,@,#,4.73109E+17,https://twitter.com/_TheUrologist_/status/473108680167415809,,,,
mtmdphd,6/1/2014 10:27,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Advantages and Disadvantages pic.twitter.com/gMqNGJMQmf,,,# #,4.73109E+17,https://twitter.com/mtmdphd/status/473108621468135424,,,,
teamoncology,6/1/2014 10:27,1,0,【 # ASCO14 Update】 RT @ ASCOPost: Ibrutinib shown to improve leukemia survival (via Reuters) http://ow.ly/xuwzz # lylsm,,@,# #,4.73109E+17,https://twitter.com/teamoncology/status/473108593856626689,,,,
mnewtonPharmD,6/1/2014 10:27,0,4,Cedirinib/olaparib PFS curve in ovarian cancer # ASCO14 pic.twitter.com/tifk3nTSjA,,,#,4.73109E+17,https://twitter.com/mnewtonPharmD/status/473108591034269697,,,,
HenryJOncology,6/1/2014 10:27,0,0,"CSF1 target by TKI or mab for PVNS in 2 expansion phase I studies, -70% RR. Phase 3 next. Competing trials or teamwork? # hcldr # ASCO14",,,# #,4.73109E+17,https://twitter.com/HenryJOncology/status/473108550399430656,,,,
DrAttai,6/1/2014 10:27,0,2,Back at # ASCO14 - tweeting on topics that may be of interest to the # bcsm community. Poster sessions this morning,,,# #,4.73109E+17,https://twitter.com/DrAttai/status/473108549976227840,,,,
kdgrace007,6/1/2014 10:27,0,1,Spending my # NationalCancerSurvivorsDay reviewing all of the research from our @ SarahCannonDocs that are presenting at # ASCO14.,,@,# #,4.73109E+17,https://twitter.com/kdgrace007/status/473108516228833281,,,,
Xcenda,6/1/2014 10:27,1,0,# ASCO14 Attendees: Find out the dates for our upcoming Challenging Cases events. Learn more: http://bit.ly/1a54Owd # oncology,,,# #,4.73108E+17,https://twitter.com/Xcenda/status/473108498150998016,,,,
mtmdphd,6/1/2014 10:27,0,0,"Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - MRD Dynamics - Pt1 granuloma, Pt2 recurrent NHL - limitations pic.twitter.com/2qI0CO5a6O",,,# #,4.73108E+17,https://twitter.com/mtmdphd/status/473108487913111552,,,,
hinrick,6/1/2014 10:26,1,0,"Initiating a strong immune response through bystander cell activation. At poster board 152B, Immunicum present Ph I/II data in mRCC. # ASCO14",,,#,4.73108E+17,https://twitter.com/hinrick/status/473108433835929600,,,,
drdonsdizon,6/1/2014 10:26,3,2,# ASCO14 RT @ twittmanda Agree completely! It's great to have these innovations but when they don't get to those that need its a lose-lose!,,@,#,4.73108E+17,https://twitter.com/drdonsdizon/status/473108417582612480,,,,
teamoncology,6/1/2014 10:26,0,0,【 # ASCO14 101】 Enzalutamide is an androgen receptor (AR) inhibitor. There is an ongoing clinical trial in AR positive breast cancer.,,,#,4.73108E+17,https://twitter.com/teamoncology/status/473108404890632192,,,,
jfclearywisc,6/1/2014 10:26,3,0,No # hpmglobal chat Monday June 2nd! Suggest monitor # ASCO14 for significant cancer # Palliativecare tweets from @ ASCO in chicago # Hpm,,@,# # # #,4.73108E+17,https://twitter.com/jfclearywisc/status/473108289132052480,,,,
PhRMA,6/1/2014 10:26,5,2,50 years of R&D has yielded incredible results for # cancer # patients. Imagine what the next 50 will bring http://bit.ly/1nAxDqP # ASCO14,,,# # #,4.73108E+17,https://twitter.com/PhRMA/status/473108264444366848,,,,
WinshipAtEmory,6/1/2014 10:26,1,0,Dr Jun Zhang is one of several Winship researchers looking at potential new therapies for # NSCLC # ASCO14 pic.twitter.com/ORItVASsYb,,,# #,4.73108E+17,https://twitter.com/WinshipAtEmory/status/473108262498598912,,,,
nycdoc29,6/1/2014 10:26,0,0,"@ teamoncology - finance guys to pushing their stock, etc. # asco14",,@,#,4.73108E+17,https://twitter.com/nycdoc29/status/473108246623186944,,,,
teamoncology,6/1/2014 10:26,1,0,Enzalutamide significantly decreased the risk of progression and death with metastatic prostate cancer. http://www.nejm.org/doi/full/10.1056/NEJMoa1405095 … # ASCO14,,,#,4.73108E+17,https://twitter.com/teamoncology/status/473108213391323136,,,,
Frank_S_David,6/1/2014 10:25,0,1,"Comment on low-grade, indolent cancers"" in overDx session at # ASCO14: ""The problem all starts with the pathologist."" Ouch!""",,,#,4.73108E+17,https://twitter.com/Frank_S_David/status/473108165308194816,,,,
LoebStacy,6/1/2014 10:25,3,3,Docetaxel plus hormone therapy improves survival in newly diagnosed metastatic # prostatecancer http://dlvr.it/5rPWFV via @ urotoday # ASCO14,,@,# #,4.73108E+17,https://twitter.com/LoebStacy/status/473108116058677248,,,,
DrAttai,6/1/2014 10:25,1,1,Comparison of BC recurrence patterns 1986-1992 vs 2004-2008 # asco14 # bcsmpic.twitter.com/OPMyDz6T08,,,# #,4.73108E+17,https://twitter.com/DrAttai/status/473108103681298432,,,,
DCarrizosaMD,6/1/2014 10:25,1,1,At # ASCO14 and excited about possibility of fellow education at # LCI @Carolinas!,,@Carolinas,# #,4.73108E+17,https://twitter.com/DCarrizosaMD/status/473108069992239104,,,,
CancerDotNet,6/1/2014 10:25,0,0,When you visit http://Cancer.Net @ASCO Central (7004) check out our redesigned print materials for pts! # ASCO14 pic.twitter.com/Z4BYh6Io2f,,@ASCO,#,4.73108E+17,https://twitter.com/CancerDotNet/status/473107983883567104,,,,
myelomacinderel,6/1/2014 10:25,1,2,Get on the genomified learning curve. Wondering what the terms mean? # myeloma # ASCO14 @ MyelomaTeacher http://am.asco.org/next-generation-genomic-testing-understanding-semantics-helps-guide-assay-use-selection …,,@,# #,4.73108E+17,https://twitter.com/myelomacinderel/status/473107982214242304,,,,
Melanoma_doctor,6/1/2014 10:25,1,1,"# CombiD good news is that BRAFi/MEKi reduces complications except fevers, med OS > 2 yrs in first study # melanoma # ASCO14",,,# # #,4.73108E+17,https://twitter.com/Melanoma_doctor/status/473107975897636864,,,,
dmooneymd,6/1/2014 10:25,0,0,"R-acvbp and r-chop14 with equivalent survival data, although R-acvbp had better pet response --> fewer pts requiring salvage. # lymsm # ASCO14",,,# #,4.73108E+17,https://twitter.com/dmooneymd/status/473107965709266944,,,,
ERPlimackMD,6/1/2014 10:25,5,3,"M0 PSA recurrent PCa pts don't like watching PSA rise but need to educate that bringing it down w ADT has risks/SEs, unclear benefit # ASCO14",,,#,4.73108E+17,https://twitter.com/ERPlimackMD/status/473107965122457600,,,,
mtmdphd,6/1/2014 10:24,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Sensitivity of MRD improves closer to relapse pic.twitter.com/WhBITeFhzM,,,# #,4.73108E+17,https://twitter.com/mtmdphd/status/473107949100208128,,,,
kellykcotton,6/1/2014 10:24,0,0,"Abstract LBA1 - Exemestane+OFS vs tamoxifen+OFS in HR+ early breast ca, TEXT and SOFT trials: http://bit.ly/RTkIkU # ASCO14 # bcsm",,,# #,4.73108E+17,https://twitter.com/kellykcotton/status/473107931832266752,,,,
MaverickNY,6/1/2014 10:24,1,2,Thawing out at the back of Chiberia (Arie Crown). Love the tables with charging points! # asco14,,,#,4.73108E+17,https://twitter.com/MaverickNY/status/473107893320179712,,,,
wendyselig,6/1/2014 10:24,3,5,"Median survival for some groups of # melanoma patients increase is impressive"": @ MelanomaReAlli MAP member Toni Ribas at # asco14""",,@,# #,4.73108E+17,https://twitter.com/wendyselig/status/473107859426000896,,,,
teamoncology,6/1/2014 10:24,1,0,【 # ASCO14 Update】 No outcome differnce by starting anti-EGFR Ab or angiogenesis inh w/chemo in met colorectal cancer. http://abstracts.asco.org/144/AbstView_144_127755.html …,,,#,4.73108E+17,https://twitter.com/teamoncology/status/473107845559250944,,,,
CancerNetwrk,6/1/2014 10:24,1,0,Dual HER2 Targeting Benefits Subset of Breast Cancer Patients http://bit.ly/SmXrYX # ASCO14,,,#,4.73108E+17,https://twitter.com/CancerNetwrk/status/473107818607038466,,,,
mtmdphd,6/1/2014 10:24,1,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - (this is very cool),,,# #,4.73108E+17,https://twitter.com/mtmdphd/status/473107761333411840,,,,
ChapinMD,6/1/2014 10:24,0,0,@ daviesbj @ AlpineBV_Miller nice talk on AR splice variants as a possible predictive markers for tx selection today # ASCO14,,@ @,#,4.73108E+17,https://twitter.com/ChapinMD/status/473107747320631296,,,,
mtmdphd,6/1/2014 10:24,0,1,"Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - MRD vs. PET-CT during Surveillance - 100% Spec, 100% PPV !! pic.twitter.com/6ZF60EFjIs",,,# #,4.73108E+17,https://twitter.com/mtmdphd/status/473107726667493377,,,,
msmithMPT,6/1/2014 10:24,0,0,ASCO: Cyramza Boosts Survival in NSCLC http://www.medpagetoday.com/MeetingCoverage/ASCO/46083 … # asco14,,,#,4.73108E+17,https://twitter.com/msmithMPT/status/473107714818580480,,,,
NCIadvocacy,6/1/2014 10:23,2,0,"Advocates at ASCO: Come meet @ theNCI OAR Acting Director Kelley Landy in the Patient Advocate Lounge, S402, from 11 AM to 12 PM. # ASCO14",,@,#,4.73108E+17,https://twitter.com/NCIadvocacy/status/473107673987424256,,,,
JediPD,6/1/2014 10:23,2,1,@ teamoncology Conflicts of Interest statements in most cases will have passion & fury. Reasoned comments will be muted & Logical! # ASCO14,,@,#,4.73108E+17,https://twitter.com/JediPD/status/473107656446861312,,,,
mtmdphd,6/1/2014 10:23,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - pic.twitter.com/zSKqgQSNdj,,,# #,4.73108E+17,https://twitter.com/mtmdphd/status/473107519645429760,,,,
DrAttai,6/1/2014 10:22,4,2,more on the obesity connection - insulin resistance may represent adverse prognostic factor in metastatic BC # asco14 pic.twitter.com/j4xeILkQqE,,,#,4.73107E+17,https://twitter.com/DrAttai/status/473107404151074816,,,,
RickDomann,6/1/2014 10:22,0,0,"New Results presented @ ASCO show Early Chemotherapy Extends Lives of Men With Prostate Cancer, via @ nytimes http://nyti.ms/1kllhze",,@ @,,4.73107E+17,https://twitter.com/RickDomann/status/473107380843327488,,,,
ASCOPost,6/1/2014 10:22,5,2,Ibrutinib shown to improve leukemia survival (via Reuters) http://ow.ly/xuwzz # ASCO14 # lylsm,,,# #,4.73107E+17,https://twitter.com/ASCOPost/status/473107380113510400,,,,
GuneetWalia,6/1/2014 10:22,0,0,Does # ClinicalTrial data at # ASCO14 adhere to @ ASCO's defn of clinically meaningful outcomes of 20%improvements inOS? http://m.jco.ascopubs.org/content/32/12/1277.long …,,@,# #,4.73107E+17,https://twitter.com/GuneetWalia/status/473107273032544257,,,,
jfclearywisc,6/1/2014 10:22,1,1,RT @ ASCO: @ arifkamalmd & Amy Abernathy : Improve Qual of # Palliativecare w/Virtual Learning Collab http://bit.ly/1nxNlD0 # ASCO14 # hpmglobal,,@ @,# # #,4.73107E+17,https://twitter.com/jfclearywisc/status/473107227369172992,,,,
EdwinPosadasMD,6/1/2014 10:22,0,0,Immediate ADT for PSA relapse after surgery does not better than delaying for a while. # ASCO14,,,#,4.73107E+17,https://twitter.com/EdwinPosadasMD/status/473107225704423424,,,,
JeffreyMOtto,6/1/2014 10:21,0,0,"First up: Sabine Tejpar what is the current status of # biomarkers in use for treatment of pts with CRC? # ASCO14""",,,# #,4.73107E+17,https://twitter.com/JeffreyMOtto/status/473107174986481664,,,,
anukPDX,6/1/2014 10:21,0,0,@ ASCO At Journal of Oncology Practice editors meeting # JOP has grown and showcases excellence in content!pic.twitter.com/dYTJYzk0RA,,@,#,4.73107E+17,https://twitter.com/anukPDX/status/473107137452068864,,,,
wendyselig,6/1/2014 10:21,2,1,". @ melanomarealli researcher Toni Ribas summarizing progress in drug combinations for # melanoma at # asco14: Exciting advances""""",,@,# #,4.73107E+17,https://twitter.com/wendyselig/status/473107125124603906,,,,
BioWorld,6/1/2014 10:21,4,1,worries about patients’ privacy eclipse worries about protecting them from an inefficient research system: food for thought at # ASCO14,,,#,4.73107E+17,https://twitter.com/BioWorld/status/473107073232670722,,,,
melanoma_Drs,6/1/2014 10:21,0,0,MT @ Melanoma_doctor: # CombiD also PFS curves crossing. OS interim/premature. I worry re cost of combo for (median) 2 wks # melanoma # ASCO14,,@,# # #,4.73107E+17,https://twitter.com/melanoma_Drs/status/473107072322924544,,,,
nxtstop1,6/1/2014 10:21,0,0,"@ AlpineBV_Miller @ ASCO Arie Crown"" Massive~Hard 2B timely w/ large crowds.In past found best to just roll w/it~~Gr8 sharing""",,@ @,,4.73107E+17,https://twitter.com/nxtstop1/status/473107009466675200,,,,
Frank_S_David,6/1/2014 10:21,1,1,Need2 change cancer rhetoric: for decades we insisted screening saves lives; reality is more nuanced. Gr8 talk by @ DrLauraEsserman # ASCO14,,@,#,4.73107E+17,https://twitter.com/Frank_S_David/status/473106992425619456,,,,
mtmdphd,6/1/2014 10:21,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - IgHTS Clonotype Identification pic.twitter.com/2rujfpA27j,,,# #,4.73107E+17,https://twitter.com/mtmdphd/status/473106985601085442,,,,
3NT,6/1/2014 10:21,0,0,Enzalutamide in metastatic CRPC pre-chemo data published today. MT @ NEJM copies at # ASCO14 booth 20127 # PREVAIL http://3nt.co/Medivation,,@,# #,4.73107E+17,https://twitter.com/3NT/status/473106983768178689,,,,
fwpharma,6/1/2014 10:21,6,1,Study finds addition of GlaxoSmithKline's Tykerb to Herceptin does not improve disease-free survival http://bit.ly/T3SpBl $ GSK # ASCO14,,,#,4.73107E+17,https://twitter.com/fwpharma/status/473106949308178433,,,,
teamoncology,6/1/2014 10:20,0,0,I wish that there is a way to show conflict of interest of those tweets at # ASCO14. I can't tell who has what kind of conflict.,,,#,4.73107E+17,https://twitter.com/teamoncology/status/473106892361707523,,,,
Melanoma_doctor,6/1/2014 10:20,2,2,# CombiD also PFS curves crossing. OS interim/premature. I worry about cost of combo drugs for (median) 2 wks # melanoma # ASCO14,,,# # #,4.73107E+17,https://twitter.com/Melanoma_doctor/status/473106855359938560,,,,
mtmdphd,6/1/2014 10:20,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Pt Characteristics pic.twitter.com/zQ632bHrgB,,,# #,4.73107E+17,https://twitter.com/mtmdphd/status/473106802222329856,,,,
DebiopharmNews,6/1/2014 10:20,0,0,# ASCO14 Debio1143 results in # HNCSM Find out more http://ow.ly/x95nL,,,# #,4.73107E+17,https://twitter.com/DebiopharmNews/status/473106764150632448,,,,
daviesbj,6/1/2014 10:20,0,0,@ ChapinMD agreed. But if the gain is so great with early chemo why spend so much $ on abi/enza & when to give? CC @ AlpineBV_Miller # ASCO14,,@ @,#,4.73107E+17,https://twitter.com/daviesbj/status/473106754596003841,,,,
OncLive,6/1/2014 10:20,10,4,The dosing for zoledronic acid can be lowered in women with breast cancer and bone metastases http://ow.ly/xtzsQ # ASCO14,,,#,4.73107E+17,https://twitter.com/OncLive/status/473106753383833600,,,,
PDRennert,6/1/2014 10:20,0,2,@ AndyBiotech @ ShannonWestin the Nivo tox drumbeat is loud and sustained. One of the bigger themes at # ASCO14,,@ @,#,4.73107E+17,https://twitter.com/PDRennert/status/473106751295066112,,,,
JeffreyMOtto,6/1/2014 10:20,0,0,"Looking fwd to a great session: the evol. of mol. understanding of CRC: what we are doing now, what future holds & how tumor prof.. # ASCO14",,,#,4.73107E+17,https://twitter.com/JeffreyMOtto/status/473106716180377600,,,,
mtmdphd,6/1/2014 10:19,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Methods - Stanford & Australia pic.twitter.com/F4r1mQRfZt,,,# #,4.73107E+17,https://twitter.com/mtmdphd/status/473106629043318785,,,,
dmooneymd,6/1/2014 10:19,0,0,Should already stressed patients have added burden of knowing relative cost vs outcome of treatment when deciding on tx with doc? # ASCO14,,,#,4.73107E+17,https://twitter.com/dmooneymd/status/473106571674009601,,,,
DrAttai,6/1/2014 10:19,0,0,@ MDAndersonNews poster conclusions # asco14 pic.twitter.com/G1zvxEDOOF,,@,#,4.73107E+17,https://twitter.com/DrAttai/status/473106559992864768,,,,
BioWorld,6/1/2014 10:19,0,0,"Companies have justifiable competitive worries re sharing, Dilts at # ASCO14 argues electronics industry has made billions by sharing well",,,#,4.73107E+17,https://twitter.com/BioWorld/status/473106538987397121,,,,
OrianaSpagnolo,6/1/2014 10:19,0,0,New Treatmt Option for Young Women w/ Hormone-Sensitive # breastcancer-Joint analysis TEXT & SOFT trials # ASCO14 @ 1PM http://abstracts.asco.org/144/index.html,,@,# #,4.73107E+17,https://twitter.com/OrianaSpagnolo/status/473106538601529344,,,,
aftimosp,6/1/2014 10:19,0,0,"Dose interruption to manage dabrafenib-induced pyrexia, not dose reduction # ASCO14",,,#,4.73107E+17,https://twitter.com/aftimosp/status/473106514518233088,,,,
mtmdphd,6/1/2014 10:19,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - MRD - Molecular Residual Disease pic.twitter.com/t35hzOz6bB,,,# #,4.73106E+17,https://twitter.com/mtmdphd/status/473106482716635136,,,,
WilliamDale_MD,6/1/2014 10:18,1,1,"# ASCO14 Nice of James Marshall, Alliance Prevention Chair and lapsed sociologist"" to discuss poster on spousal effects on cancer screening.""",,,#,4.73106E+17,https://twitter.com/WilliamDale_MD/status/473106386474110976,,,,
DrAttai,6/1/2014 10:18,1,0,"Interesting poster looking at visceral adiposity, BMI and clinical BC outcomes from @ MDAndersonNews # asco14 pic.twitter.com/mN8LPyIXmx",,@,#,4.73106E+17,https://twitter.com/DrAttai/status/473106383080914944,,,,
Frank_S_David,6/1/2014 10:18,0,0,"Thoughtful, nuanced disc of overDx in cancer by @ DrLauraEsserman # ASCO14: need better selection of screening pop & mgmt of lo-risk lesions",,@,#,4.73106E+17,https://twitter.com/Frank_S_David/status/473106365289070593,,,,
ERPlimackMD,6/1/2014 10:18,0,1,"M0 PSA recurrent PCa: despite retrospective limitations of CaPSURE database analysis, many pts can defer ADT safely. # ASCO14 # GUSM",,,# #,4.73106E+17,https://twitter.com/ERPlimackMD/status/473106357571575808,,,,
mtmdphd,6/1/2014 10:18,0,1,Kurtz # lymsm # ASCO14 - ctDNA monitoring in DLBCL - Ig genes detected by High Throughput Sequencing (IgHTS) pic.twitter.com/l5Jugdt9aW,,,# #,4.73106E+17,https://twitter.com/mtmdphd/status/473106325363101696,,,,
teamoncology,6/1/2014 10:18,0,0,Our data at # SABCS13 showed that increased BMI helped the outcome of tumor response of neoadj Rx. # BCSM # ASCO14,,,# # #,4.73106E+17,https://twitter.com/teamoncology/status/473106310750142465,,,,
brianreid,6/1/2014 10:18,2,0,"More on what's hot at # ASCO14. Saturday's most RTed tweets, rank-ordered (via @ Spotify) http://bit.ly/1klKgCz",,@,#,4.73106E+17,https://twitter.com/brianreid/status/473106310259806208,,,,
TawnyaBowles,6/1/2014 10:18,0,1,Dr. Long: Dabrafenib + trametinib in Stage IV # melanoma = better PFS vs. dabrafenib alone. # ASCO14,,,# #,4.73106E+17,https://twitter.com/TawnyaBowles/status/473106294941835264,,,,
markaorourke,6/1/2014 10:18,0,0,Healthy eating: The case for eating steak and cream | The Economist http://econ.st/1k1B9YX # ASCO14 Data still supports avoiding animal fat.,,,#,4.73106E+17,https://twitter.com/markaorourke/status/473106250826121218,,,,
ByJonGardner,6/1/2014 10:17,1,0,Panorama of the # ASCO14 press room. pic.twitter.com/vrG771jmhK,,,#,4.73106E+17,https://twitter.com/ByJonGardner/status/473106158475948034,,,,
teamoncology,6/1/2014 10:17,0,0,【 # ASCO14 101】 We do not know improving BMI will help breast cancer outcome. # BCSM # ASCO14,,,# # #,4.73106E+17,https://twitter.com/teamoncology/status/473106126649556992,,,,
WinshipAtEmory,6/1/2014 10:17,1,1,Winship's Dr Olatunji Alese presents during the # ASCO14 Developmental Therapeutics poster session. pic.twitter.com/yAUfRM4QMf,,,#,4.73106E+17,https://twitter.com/WinshipAtEmory/status/473106110480941056,,,,
aftimosp,6/1/2014 10:17,0,0,36% reduction in the risk of death with the combo of dabrafenib + trametinib versus dabrafenib + placebo in BRAF-mutated melanoma # ASCO14,,,#,4.73106E+17,https://twitter.com/aftimosp/status/473106080223199232,,,,
urotoday,6/1/2014 10:17,0,0,Packed hall listening to PCa oral abstract session at # ASCO14 pic.twitter.com/fwVuLtWOKs,,,#,4.73106E+17,https://twitter.com/urotoday/status/473106077563617281,,,,
MediTech_Media,6/1/2014 10:17,0,1,"Poster 12, study shows only 41% of phase 2 trials contributing to phase 3 trials were positive, Hay et al. # ASCO14",,,#,4.73106E+17,https://twitter.com/MediTech_Media/status/473106056546373632,,,,
mtmdphd,6/1/2014 10:17,1,0,Kurtz # lymsm # ASCO14 - monitoring in DLBCL - Rationale & Objective - circulating tumor DNA (ctDNA) pic.twitter.com/MtCE0lixMe,,,# #,4.73106E+17,https://twitter.com/mtmdphd/status/473105963193733122,,,,
timturnham,6/1/2014 10:17,1,1,In a BRAF + MEK trial from @ genentech pts w/ high LDH did better than others. Overall good results for most pts. # ASCO14,,@,#,4.73106E+17,https://twitter.com/timturnham/status/473105959968313344,,,,
Melanoma_doctor,6/1/2014 10:17,1,1,"# CombiD primary endpt was PFS, was significant but median values 8.8 vs 9.3 months ie TWO WEEKS ????value of therapy # melanoma # ASCO14",,,# # #,4.73106E+17,https://twitter.com/Melanoma_doctor/status/473105943572803584,,,,
JacobPlieth,6/1/2014 10:16,0,1,"@PTKevinGrogan You are definitely missed. Lots of social events around # ASCO14, as ever...",,@PTKevinGrogan,#,4.73106E+17,https://twitter.com/JacobPlieth/status/473105923964022784,,,,
teamoncology,6/1/2014 10:16,0,0,Obesity and Breast Cancer was part of poster discussion of # SABCS13. There is more questions than we answered at this stage. # ASCO14,,,# #,4.73106E+17,https://twitter.com/teamoncology/status/473105904519217152,,,,
ChapinMD,6/1/2014 10:16,0,0,@ daviesbj what we need is better predictive markers for response to tx. Applying an all or none may miss possibilities of benefit. # ASCO14,,@,#,4.73106E+17,https://twitter.com/ChapinMD/status/473105743537643521,,,,
QIAGENscience,6/1/2014 10:16,0,1,"All tests are not created equal. QIAGEN has the only FDA-approved KRAS test, the therascreen KRAS test. # ASCO14 5013 pic.twitter.com/cVQG4Fp7Xo",,,#,4.73106E+17,https://twitter.com/QIAGENscience/status/473105739683495936,,,,
JFreemanDaily,6/1/2014 10:16,3,2,Author and friend @ jay_lake died of colon cancer this AM. I renew my patient advocacy work in his honor. http://www.jlake.com/2014/06/01/cancer-the-end-has-come/ … # ASCO14,,@,#,4.73106E+17,https://twitter.com/JFreemanDaily/status/473105736793219072,,,,
ConsanoScott,6/1/2014 10:15,3,3,In need of an orange pen? Curious about # crowdfunding medical # research? Stop by the @ Consano booth at # ASCO14. pic.twitter.com/W6hFIqYzfu,,@,# # #,4.73106E+17,https://twitter.com/ConsanoScott/status/473105665066405888,,,,
BioWorld,6/1/2014 10:15,0,0,"GREAT session on datasharing at # ASCO14. Many challenges, but great opportunities, too.",,,#,4.73106E+17,https://twitter.com/BioWorld/status/473105662994440193,,,,
nxtstop1,6/1/2014 10:15,0,0,PALLIATIVE.MT @ ASCO:Drs. Kamal & Abernethy: Improving Quality of Palliative Care w/Virtual Learning Collab. http://bit.ly/1nxNlD0 # ASCO14,,@,#,4.73106E+17,https://twitter.com/nxtstop1/status/473105590898536449,,,,
theNCI,6/1/2014 10:15,26,5,Study of targeted therapies for breast cancer established model for global clinical trials (updated) http://1.usa.gov/1px9MIa # ALTTO # ASCO14,,,# #,4.73106E+17,https://twitter.com/theNCI/status/473105589686763520,,,,
ERPlimackMD,6/1/2014 10:15,2,1,"M0 PSA recurrent PCa, equivalent 10 yr OS w immediate vs Deferred ADT. Caution: not randomized, retrospective, selection bias. # asco14 # gusm",,,# #,4.73106E+17,https://twitter.com/ERPlimackMD/status/473105587413471232,,,,
AlpineBV_Miller,6/1/2014 10:15,0,0,"Arie Crown Theater is 15 MINUTES behind. C'mon folks, respect the time of attendees and other presenters. # ASCO14 @ ASCO",,@,#,4.73106E+17,https://twitter.com/AlpineBV_Miller/status/473105580232806400,,,,
DrAttai,6/1/2014 10:15,1,0,@ Neil_Iyengar @ MSKCC_BreastCA poster on obesity and breast cancer # asco14 pic.twitter.com/Mv5XsiC9Er,,@ @,#,4.73106E+17,https://twitter.com/DrAttai/status/473105531196825601,,,,
Novartis,6/1/2014 10:15,0,1,Sneak peek of updates to http://advancedbreastcancercommunity.org right now on our YouTube channel: http://bit.ly/1jqyj9S # advancedBC # ASCO14,,,# #,4.73106E+17,https://twitter.com/Novartis/status/473105509365874688,,,,
Melanoma_doctor,6/1/2014 10:15,0,2,# CombiD trial is dabrafenib w trametinib vs dabrafenib w placebo ( BRAFi/MEKi vs BRAFi/placebo) in BRAF mutant # melanoma # ASCO14,,,# # #,4.73105E+17,https://twitter.com/Melanoma_doctor/status/473105478726471680,,,,
SanofiUS,6/1/2014 10:15,0,0,"MT @ KUhlendorf: # ASCO14:33k scientists, students, patients, co's, advocates, academics, gov researchers, reporters determined 2 beat # cancer",,@,# #,4.73105E+17,https://twitter.com/SanofiUS/status/473105459634012160,,,,
myriadgenetics,6/1/2014 10:15,2,0,Myriad myRisk test & personalized # cancer risk management tool influenced physicians’ treatment decisions in 91% of cases. Pstr 1553 # ASCO14,,,# #,4.73105E+17,https://twitter.com/myriadgenetics/status/473105437345071104,,,,
mtmdphd,6/1/2014 10:14,0,0,Casasnovas # lymsm # ASCO14 - GAINED - GA In NEwly Diagnosed DLBCL <- new trial pic.twitter.com/2WaqPSzNhU,,,# #,4.73105E+17,https://twitter.com/mtmdphd/status/473105414654275584,,,,
teamoncology,6/1/2014 10:14,0,0,@ chimoose Many people spend too much time to tweet. :) # ASCO14,,@,#,4.73105E+17,https://twitter.com/teamoncology/status/473105373914603521,,,,
julearwood,6/1/2014 10:14,0,0,Taking in all the great research @ # ASCO14 wonderful to see the advances in cancer treatments,,@,#,4.73105E+17,https://twitter.com/julearwood/status/473105341530775552,,,,
DKarikios,6/1/2014 10:14,0,0,Delaying ADT in PSA only relapsed prostate cancer may be reasonable but Australian study should provide clearer answer # ASCO14,,,#,4.73105E+17,https://twitter.com/DKarikios/status/473105334127456256,,,,
teamoncology,6/1/2014 10:14,1,0,@ chimoose You do not want waste time in tweeting while you attend the meeting or sacrifice your work. # ASCO14,,@,#,4.73105E+17,https://twitter.com/teamoncology/status/473105309267812352,,,,
jmmrad,6/1/2014 10:14,0,0,"# ASCO14 Garcia-Albeniz, early vs delayed ADT for PSA only relapse. No difference BUT selection may these outcomes. Phase III ongoing.",,,#,4.73105E+17,https://twitter.com/jmmrad/status/473105279723520003,,,,
ritrattosalute,6/1/2014 10:14,3,3,@ InsControCancro @NonFareAutogol @ EIannelli @ aimac_it @ ASCO siamo in prima linea per diffondere il 'verbo' della # prevenzione!,,@ @NonFareAutogol @ @ @,#,4.73105E+17,https://twitter.com/ritrattosalute/status/473105277886431232,,,,
DrHedrick,6/1/2014 10:14,0,0,Garcia: Ongoing randomized study in Australia should answer question. # ASCO14,,,#,4.73105E+17,https://twitter.com/DrHedrick/status/473105226090942464,,,,
teamoncology,6/1/2014 10:14,1,1,@ chimoose Thanks for RT. My favorite tool is YoruFukurou and Twittelator. Very efficient to tweets than any other stuff. # ASCO14,,@,#,4.73105E+17,https://twitter.com/teamoncology/status/473105201176379392,,,,
mtmdphd,6/1/2014 10:14,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - Outcomes pic.twitter.com/NUeOnXKhOa,,,# #,4.73105E+17,https://twitter.com/mtmdphd/status/473105184030466048,,,,
DrAttai,6/1/2014 10:13,5,1,More on obesity and breast cancer @ neil_iyengar # asco14 pic.twitter.com/bIS6CBKM1t,,@,#,4.73105E+17,https://twitter.com/DrAttai/status/473105123065868291,,,,
BarringtonJNC,6/1/2014 10:13,1,0,Barrington James are out in force today.See a red tie & get a business card and we'll buy your first drink this evening in the bar # ASCO14,,,#,4.73105E+17,https://twitter.com/BarringtonJNC/status/473105114257821696,,,,
DrHedrick,6/1/2014 10:13,1,0,Garcia: Conclusion: Patients undergoing immediate v. delayed ADT are similar in terms of survival. # ASCO14,,,#,4.73105E+17,https://twitter.com/DrHedrick/status/473105109866807296,,,,
mtmdphd,6/1/2014 10:13,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - primary objective not reached. PET guided may equalize Tx's,,,# #,4.73105E+17,https://twitter.com/mtmdphd/status/473105014953869312,,,,
MelanomaMom,6/1/2014 10:13,1,3,25% reduction of risk in of progression with BRAFi and MEKi combo in # melanoma. # ASCO14,,,# #,4.73105E+17,https://twitter.com/MelanomaMom/status/473104963066155008,,,,
aly_vdl,6/1/2014 10:12,0,0,@ mau_rs Gracias! Mas informacion productos # innovadores @ 360Medlink desarrollados para # industria # farma :) # technologia en # ASCO2014,,@ @,# # # # #,4.73105E+17,https://twitter.com/aly_vdl/status/473104884691398657,,,,
ShannonWestin,6/1/2014 10:12,0,0,"@ AndytweetM Majority were HG serous, 2 clear cells (1 with CR) # ASCO14 # gyncsm",,@,# #,4.73105E+17,https://twitter.com/ShannonWestin/status/473104874998362112,,,,
mtmdphd,6/1/2014 10:12,1,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - LNH 2007-3B Conclusions pic.twitter.com/4bBQR2rYUF,,,# #,4.73105E+17,https://twitter.com/mtmdphd/status/473104818899529728,,,,
WinshipAtEmory,6/1/2014 10:12,3,2,The # ASCO14 Poster session started early and we ran in to @ DrDonaldHarvey and Dr Taofeek Owonikokopic.twitter.com/oyR1uIyxwZ,,@,#,4.73105E+17,https://twitter.com/WinshipAtEmory/status/473104730688737280,,,,
JediPD,6/1/2014 10:12,0,1,"@ subatomicdoc The expressed epitope on the visceral homed"" mets would have molecular switches that we need to address # ASCO14""",,@,#,4.73105E+17,https://twitter.com/JediPD/status/473104684568559616,,,,
mtmdphd,6/1/2014 10:11,1,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - PFS/OS similar pic.twitter.com/wUwxUV8Bjk,,,# #,4.73105E+17,https://twitter.com/mtmdphd/status/473104653035790336,,,,
DrHedrick,6/1/2014 10:11,0,0,Garcia: Baseline characteristics are very similar. 5 and 10 year survival are broadly similar in both immediate and deferred groups # ASCO14,,,#,4.73105E+17,https://twitter.com/DrHedrick/status/473104586828697600,,,,
mtmdphd,6/1/2014 10:11,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - Actual Consolidation Tx pic.twitter.com/JPIdIMjqJU,,,# #,4.73104E+17,https://twitter.com/mtmdphd/status/473104494025510912,,,,
ShannonWestin,6/1/2014 10:11,0,0,"O. Dorigo -is immune therapy relevant in ovarian ca"" YES # ASCO14 # gyncsm""",,,# #,4.73104E+17,https://twitter.com/ShannonWestin/status/473104470327689217,,,,
ZachPharmD,6/1/2014 10:11,0,0,@ ASCO Gracias!,,@,,4.73104E+17,https://twitter.com/ZachPharmD/status/473104464837345281,,,,
AnneBooms,6/1/2014 10:10,2,1,“ @ m_e_nielsen: # asco14 Early Palliative Care=good http://ow.ly/xurcZ ?more opportunities even *earlier*? I agree!,,@,#,4.73104E+17,https://twitter.com/AnneBooms/status/473104370847207424,,,,
ABumRap,6/1/2014 10:10,0,0,“ @ subatomicdoc: Tumor HPV status and invasive squamous cell carcinoma of the anus http://abstracts.asco.org/144/AbstView_144_129693.html … > @ umassmemorial # ASCO14 # ancsm”,,@ @,# #,4.73104E+17,https://twitter.com/ABumRap/status/473104369815404544,,,,
mtmdphd,6/1/2014 10:10,2,1,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - PET2 and PET4 results pic.twitter.com/zE7tSAavmK,,,# #,4.73104E+17,https://twitter.com/mtmdphd/status/473104329818537984,,,,
DonnaYoungDC,6/1/2014 10:10,1,2,Cost/high drug prices hot topic at # ASCO14 Read my report on last week's # AtlanticMedicine panel http://bit.ly/1mxEvBH # pharma # biotech,,,# # # #,4.73104E+17,https://twitter.com/DonnaYoungDC/status/473104316925243392,,,,
daviesbj,6/1/2014 10:10,0,1,How meaningful is the PREVAIL data if we move up chemo? ? for MDs smarter than I...IMO muddles the future of $ mdvn and abi # ASCO14,,,#,4.73104E+17,https://twitter.com/daviesbj/status/473104293562552320,,,,
aly_vdl,6/1/2014 10:10,0,2,@ noordinaryco Thank you! Know more about @ 360Medlink # innovative products developed for the # pharma industry :) # technology in # ASCO2014,,@ @,# # # #,4.73104E+17,https://twitter.com/aly_vdl/status/473104258280488960,,,,
teamoncology,6/1/2014 10:10,0,2,Indeed. RT @Matt_SCRI_UK: Nice summary of evolution of cancer drug development paradigm from @ Quintiles... # ASCO14 pic.twitter.com/UWwj75FmlE,,@Matt_SCRI_UK @,#,4.73104E+17,https://twitter.com/teamoncology/status/473104248855474176,,,,
DebiopharmNews,6/1/2014 10:10,0,1,"# ASCO14 Phase I-II Debio0932, oral # HSP90 inhibitor, 1st & 2nd line # NSCLC (abstract/poster # TPS2632) Find out more http://ow.ly/x95hT",,,# # # #,4.73104E+17,https://twitter.com/DebiopharmNews/status/473104245152317440,,,,
ASCO,6/1/2014 10:10,9,6,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.73104E+17,https://twitter.com/ASCO/status/473104243910791169,,,,
Roche,6/1/2014 10:10,5,1,What's the prognosis for diagnostic testing in # lungcancer? http://ow.ly/xoTe9 # ASCO14 # lcsm,,,# # #,4.73104E+17,https://twitter.com/Roche/status/473104227544604672,,,,
SitemanCenter,6/1/2014 10:10,1,1,"How will the # ACA affect gynecologic cancer care? Siteman's Matthew Powell, MD, chairs a discussion: 9:45 am, Rm E354a # ASCO14",,,# #,4.73104E+17,https://twitter.com/SitemanCenter/status/473104223740391424,,,,
genentech,6/1/2014 10:10,4,3,Goal for # Next50: “Immunotherapy will change approach to cancer tx & improve survival.” – D. Berger # ASCO14 http://ow.ly/xutWr,,,# #,4.73104E+17,https://twitter.com/genentech/status/473104207198060544,,,,
markaorourke,6/1/2014 10:10,0,0,"# ASCO14 The MTP session for neuroendocrine tumors is outstanding. Well balanced, clear, manageable flux of information with. # hbcsm",,,# #,4.73104E+17,https://twitter.com/markaorourke/status/473104186469789696,,,,
mtmdphd,6/1/2014 10:09,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - Response after 4 cycles pic.twitter.com/E4OacSnLs4,,,# #,4.73104E+17,https://twitter.com/mtmdphd/status/473104160020525056,,,,
DrHedrick,6/1/2014 10:09,0,0,"Garcia: Outcomes are PrCa mortality and all cause mortality. Study population is from CaPSURE database. Started in '95, 43 sites. # ASCO14",,,#,4.73104E+17,https://twitter.com/DrHedrick/status/473104000402075648,,,,
teamoncology,6/1/2014 10:09,0,1,@ ASCO Lots of good tweets but still we can make improvement to make it understandable to those who are not there. :),,@,,4.73104E+17,https://twitter.com/teamoncology/status/473103994642903040,,,,
hkrupka,6/1/2014 10:08,1,1,Georgina Long on $ NVS $ GSK dabr/tram Ph3 COMBI-D # ASCO14 poor PFS data: censoring 18 pts & plateauing led to high PFS in dabrafenib mono arm,,,#,4.73104E+17,https://twitter.com/hkrupka/status/473103909557268481,,,,
nxtstop1,6/1/2014 10:08,0,0,THE ABCs of WOMEN'S WELLNESS. @ AHRQNews: Stay healthy at any age—screenings and tips for women’s health http://1.usa.gov/1in6XVU # ASCO14,,@,#,4.73104E+17,https://twitter.com/nxtstop1/status/473103907061649410,,,,
cmartindedios,6/1/2014 10:08,0,0,"@ ASCO # asco14 change is hard...much less # innovation "" # clinicaltrials transparency sessionpic.twitter.com/5QD4e56dc2""",,@,# # #,4.73104E+17,https://twitter.com/cmartindedios/status/473103867757211648,,,,
InsControCancro,6/1/2014 10:08,2,2,"prof.Cascinu ( # AIOM): Italia sia capitale europea # prevenzione e stili di vita sani"" # ASCO14 @NonFareAutogol @ EIannelli @ ASCO""",,@NonFareAutogol @ @,# # #,4.73104E+17,https://twitter.com/InsControCancro/status/473103866507313152,,,,
Ludwig_Cancer,6/1/2014 10:08,1,1,Ludwig's George Demetri sharing data at # ASCO14 on long-term control of advanced gastrointestinal stromal # tumors w/ targeted drug imatinib,,,# #,4.73104E+17,https://twitter.com/Ludwig_Cancer/status/473103842369077248,,,,
artfranken,6/1/2014 10:08,0,0,@ GildeHealthcare @ ASCO I hope we can continue to benefit from Bob Pinedo as Operational Partner in the Gilde team for many years,,@ @,,4.73104E+17,https://twitter.com/artfranken/status/473103684709388288,,,,
InsControCancro,6/1/2014 10:08,4,4,# tumori: risparmio 6 miliardi in 5 anni da # prevenzione @NonFareAutogol @ ritrattosalute @ EIannelli @ aimac_it @ ASCO # ASCO2014,,@NonFareAutogol @ @ @ @,# # #,4.73104E+17,https://twitter.com/InsControCancro/status/473103678292123649,,,,
aftimosp,6/1/2014 10:07,0,0,Many many explanations for the similar median PFS between dabrafenib + placebo and dabrafenib + trametinib # ASCO14,,,#,4.73104E+17,https://twitter.com/aftimosp/status/473103626886725632,,,,
mtmdphd,6/1/2014 10:07,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - Study design... pic.twitter.com/8bkuvidoKX,,,# #,4.73104E+17,https://twitter.com/mtmdphd/status/473103617449541633,,,,
teamoncology,6/1/2014 10:07,1,0,"@ ASCO You are welcome. If there is anything that I can help social media, let me know. I am heavily involved with AACR social media.",,@,,4.73104E+17,https://twitter.com/teamoncology/status/473103609328975872,,,,
subatomicdoc,6/1/2014 10:07,1,1,@ djsampson @ gcolditz Have you read @ CassSunstein's book Nudge? http://www.amazon.com/gp/aw/d/014311526X/ref=mp_s_a_1_1?qid=1401631571&sr=8-1&pi=SY200_QL40 … # ASCO14 # healthydefault,,@ @ @,# #,4.73104E+17,https://twitter.com/subatomicdoc/status/473103569856761856,,,,
MatthewHSimmons,6/1/2014 10:07,3,0,Nice summary of evolution of cancer drug development paradigm from @ Quintiles... # ASCO14 pic.twitter.com/fu6Uf11YRz,,@,#,4.73103E+17,https://twitter.com/MatthewHSimmons/status/473103437010194432,,,,
BioWorld,6/1/2014 10:07,2,0,"All 4 plenary studies at # ASCO14 fed funded, but they began long ago, the $ drying up. Prez Hudis: Disturbing."" pic.twitter.com/Fgcus2n8Eo""",,,#,4.73103E+17,https://twitter.com/BioWorld/status/473103434950774784,,,,
DrHedrick,6/1/2014 10:06,0,0,"Garcia: Exclusion: evidence of mets, orchiectomy, symptomatic relapse, ADT in past 12 months. # ASCO14",,,#,4.73103E+17,https://twitter.com/DrHedrick/status/473103405658144768,,,,
BioWorld,6/1/2014 10:06,0,0,"Use/don't use? Hard to give yes/no answer when you're dealing with someone who's going to die in the next 12 months."" # ASCO14 Greg Masters""",,,#,4.73103E+17,https://twitter.com/BioWorld/status/473103398342905856,,,,
drcbsteer,6/1/2014 10:06,0,0,# ASCO14 Trotman - PET in follicular NHL. 246 scans. Median 4.6 yrs FU. Postinduction PET positivity strongly predictive of PFS/OS,,,#,4.73103E+17,https://twitter.com/drcbsteer/status/473103396703326208,,,,
ASCO,6/1/2014 10:06,0,1,@ teamoncology Thank you for the acknowledgement & for your ongoing participation in the # ASCO14 conversation.,,@,#,4.73103E+17,https://twitter.com/ASCO/status/473103340839378944,,,,
mtmdphd,6/1/2014 10:06,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - aaIPI 2-3 - RCHOP14 similar to R-MegaCHOP inductions,,,# #,4.73103E+17,https://twitter.com/mtmdphd/status/473103304721825792,,,,
ZachPharmD,6/1/2014 10:06,0,0,@ ASCO What room are lymphoma orals this morning?,,@,,4.73103E+17,https://twitter.com/ZachPharmD/status/473103230864330752,,,,
DrHedrick,6/1/2014 10:06,0,0,"Garcia: Inclusion: PrCa treated with curative intent, PSA only relapse (0.2ng/mL or 3 rising levels one month apart) # ASCO14",,,#,4.73103E+17,https://twitter.com/DrHedrick/status/473103222224453633,,,,
nxtstop1,6/1/2014 10:06,0,0,@ healthhashtags And # ASCO14 ongoing~~~ :),,@,#,4.73103E+17,https://twitter.com/nxtstop1/status/473103202141757440,,,,
mtmdphd,6/1/2014 10:06,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - aaIPI 1 - R-ACVBP sup to RCHOP21 pic.twitter.com/gATOWag36g,,,# #,4.73103E+17,https://twitter.com/mtmdphd/status/473103189500518400,,,,
mtmdphd,6/1/2014 10:05,0,0,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnZaq # ASCO14,,@,# #,4.73103E+17,https://twitter.com/mtmdphd/status/473102968217427968,,,,
corp_UNC,6/1/2014 10:05,2,1,MT @ m_e_nielsen: Tension btwn emerging payer guidelines/incentives vs.personalized cancer care http://online.wsj.com/news/articles/SB10001424052702304587704579588170876612100?mod=trending_now_3 … @ EthanBasch1 # asco14,,@ @,#,4.73103E+17,https://twitter.com/corp_UNC/status/473102958994153472,,,,
genentech,6/1/2014 10:05,2,3,"Nearly 20 yrs ago, 1st data on our angiogenesis program was presented at ASCO. # ASCO14 # ASCOmemory",,,# #,4.73103E+17,https://twitter.com/genentech/status/473102954787250176,,,,
mtmdphd,6/1/2014 10:05,1,0,Casasnovas Abstr 8503 # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL - Vitolo Lugano Abs 072 pic.twitter.com/LV2RTZ2vSs,,,# #,4.73103E+17,https://twitter.com/mtmdphd/status/473102945182318592,,,,
CancerDotNet,6/1/2014 10:05,0,1,"Xabier Garcia-Albeniz, MD @ HSPHCancerEpi on study abt hormone therapy for men w/ rising PSA # pcsm # ASCO14 http://bit.ly/1p06woo",,@,# #,4.73103E+17,https://twitter.com/CancerDotNet/status/473102933958344705,,,,
EdwinPosadasMD,6/1/2014 10:04,0,0,Johns Hopkins: AR splice variants predict resistance to AR therapy- an evolving paradigm? # ASCO14,,,#,4.73103E+17,https://twitter.com/EdwinPosadasMD/status/473102826793893888,,,,
ByJonGardner,6/1/2014 10:04,0,0,Couldn't tweet the ALTTO OS or DFS curves because the slide wasn't exactly photogenic. $ GSK # asco14,,,#,4.73103E+17,https://twitter.com/ByJonGardner/status/473102793742757889,,,,
BIGagainstBC,6/1/2014 10:04,1,0,Today 1st results of ph.3 ALTTO trial -adjuvant treatment of HER2-positive early # breastcancer # ASCO14 - @ 1PM Hall B1 http://abstracts.asco.org/144/index.html,,@,# #,4.73103E+17,https://twitter.com/BIGagainstBC/status/473102786478235648,,,,
AnneBooms,6/1/2014 10:04,0,0,# ASCO14- Identifying low risk disease http://jnci.oxfordjournals.org/cgi/content/long/102/9/582 …,,,#,4.73103E+17,https://twitter.com/AnneBooms/status/473102780165406720,,,,
teamoncology,6/1/2014 10:04,1,0,. @ ASCO is a great organization to join if you are involved in # cancer.,,@,#,4.73103E+17,https://twitter.com/teamoncology/status/473102769176338432,,,,
carisls,6/1/2014 10:04,1,2,Our friends at @ FightCRC at # ASCO14! pic.twitter.com/KHgIsKt2kM,,@,#,4.73103E+17,https://twitter.com/carisls/status/473102732270645248,,,,
AndyBiotech,6/1/2014 10:04,2,3,"$ BMY -> RT @ ShannonWestin: PD-1 inhibitor nivolumab in recurrent ovarian cancer 17% RR, high toxicity (11/18 w G3/4 AE) # ASCO14 # gyncsm",,@,# #,4.73103E+17,https://twitter.com/AndyBiotech/status/473102683860385792,,,,
aftimosp,6/1/2014 10:03,0,0,Here it comes: results of Combi-D: phase 3 trial of dabrafenib + trametinib versus dabrafenib + placebo in BRAF-mutated melanoma # ASCO14,,,#,4.73103E+17,https://twitter.com/aftimosp/status/473102622011191297,,,,
Melanoma_doctor,6/1/2014 10:03,0,1,Subgroup analysis of Dab/Tram--men do better! (Every other study shows opposite)???? # melanoma # ASCO14,,,# #,4.73103E+17,https://twitter.com/Melanoma_doctor/status/473102568475095040,,,,
EdwinPosadasMD,6/1/2014 10:03,0,0,MDACC shows that # abiraterone and # enzalutamide can be combined. Question: is it better? # ASCO14,,,# # #,4.73103E+17,https://twitter.com/EdwinPosadasMD/status/473102566226948096,,,,
teamoncology,6/1/2014 10:03,0,0,"@ dmooneymd Being a patient, I do not want to live 4-6 weeks more by spending lots of money for my medical bill. # ASCO14",,@,#,4.73103E+17,https://twitter.com/teamoncology/status/473102562510372864,,,,
mtmdphd,6/1/2014 10:03,0,0,Casasnovas # lymsm # ASCO14 - Ph2 RCT R-ACVBP + BEAM/ASCT in high risk DLBCL pic.twitter.com/meA1vmMJv7,,,# #,4.73103E+17,https://twitter.com/mtmdphd/status/473102512354902016,,,,
DrHedrick,6/1/2014 10:03,0,0,Garcia: Immediate vs deferred initiation of ADT in patients with PSA only relapse. # ASCO14,,,#,4.73102E+17,https://twitter.com/DrHedrick/status/473102449109397504,,,,
myPathMelanoma,6/1/2014 10:03,0,0,How can Myriad myPath # Melanoma help your diagnosis? Learn more at http://www.IsThisMelanoma.com and at boot 2039 # ASCO14,,,# #,4.73102E+17,https://twitter.com/myPathMelanoma/status/473102416544403457,,,,
ASCO,6/1/2014 10:02,3,1,Advances “only possible thanks to nation’s longstanding commitment to funding clinical cancer research”- @ CliffordHudis # ASCO14 press conf,,@,#,4.73102E+17,https://twitter.com/ASCO/status/473102365898584064,,,,
christinemphmd,6/1/2014 10:02,0,1,Please also visit Dr. Robert Hendler's poster on severe # diarrhea with # ipilimumab in # cancer # ASCO14 @ StonyBrookMedpic.twitter.com/KI1u3GnySp,,@,# # # #,4.73102E+17,https://twitter.com/christinemphmd/status/473102330171510784,,,,
ShannonWestin,6/1/2014 10:02,0,3,2 sustained CR in nivolumab study. Need to explore biomarkers of response. # ASCO14 # gyncsm,,,# #,4.73102E+17,https://twitter.com/ShannonWestin/status/473102320184852480,,,,
djsampson,6/1/2014 10:02,1,0,Colditz: we need regulatory strategy that reinforces healthy choices # asco14,,,#,4.73102E+17,https://twitter.com/djsampson/status/473102264937086976,,,,
teamoncology,6/1/2014 10:02,1,0,"@ dr_FPetracci Some good news. Fertility preservation, use of AI in premenopausal, zometa use of 12w, lots of good QOL stuff. # ASCO14",,@,#,4.73102E+17,https://twitter.com/teamoncology/status/473102233244938241,,,,
carisls,6/1/2014 10:02,2,0,"# MolecularIntel data on GI Cancers announced at # ASCO14, showing importance of comprehensive tumor profiling http://goo.gl/Rp9CWh",,,# #,4.73102E+17,https://twitter.com/carisls/status/473102207387054081,,,,
timturnham,6/1/2014 10:02,2,1,"Combining BRAF + MEK from GSK works, but has biggest impact on pts w/ low tumor burden and low LDH. # ASCO14",,,#,4.73102E+17,https://twitter.com/timturnham/status/473102200747859968,,,,
ASCO,6/1/2014 10:02,10,1,"All 4 # ASCO14 Plenary studies supported in part by @ NIH, but huge drop in fed’lly funded submissions this yr comp’d to 2008",,@,#,4.73102E+17,https://twitter.com/ASCO/status/473102184922750977,,,,
StefanoLuminari,6/1/2014 10:02,2,0,# asco14 Trotman on PET in Follicular Lymphoma. pooled analysis of three studies with 246pts. high PFS and OS advantage for PET negative pts,,,#,4.73102E+17,https://twitter.com/StefanoLuminari/status/473102182229635072,,,,
MaimonidesMC,6/1/2014 10:02,0,0,What to Expect: # Chemotherapy Infusion http://maimo.md/1nX7Ll7 # chemo # ASCO14,,,# # #,4.73102E+17,https://twitter.com/MaimonidesMC/status/473102176672575489,,,,
mtmdphd,6/1/2014 10:02,0,0,Trotman # lymsm # ASCO14 - PET in FL - Postinduction PET-CT a platform to study response-adapted therapy. pic.twitter.com/0SiBRS77wO,,,# #,4.73102E+17,https://twitter.com/mtmdphd/status/473102165805121536,,,,
Melanoma_doctor,6/1/2014 10:02,1,0,Updated Ph2 results from init Dabrafenib/trametinib study- 25 month med OS # melanoma # ASCO14,,,# #,4.73102E+17,https://twitter.com/Melanoma_doctor/status/473102163724734465,,,,
AnneBooms,6/1/2014 10:01,0,0,# ASCO14 Esserman on Idle tumors pic.twitter.com/1D04oHO9NT,,,#,4.73102E+17,https://twitter.com/AnneBooms/status/473102105176449024,,,,
ONAcom,6/1/2014 10:01,0,0,Attending ASCO 2014? Come visit us at the Haymarket Oncology booth (#15081)! # ASCO14,,,#15081 #,4.73102E+17,https://twitter.com/ONAcom/status/473102045789290497,,,,
AstraZenecaUS,6/1/2014 10:01,2,0,AstraZeneca presentations continue today at # ASCO14 http://ow.ly/xs1Nh,,,#,4.73102E+17,https://twitter.com/AstraZenecaUS/status/473102044841381888,,,,
ASCO,6/1/2014 10:01,4,2,Not an ASCO Member? Join at # ASCO14: Visit a Member Services Desk to receive a membership dues credit & thank you gift,,,#,4.73102E+17,https://twitter.com/ASCO/status/473101997953261569,,,,
ASCO,6/1/2014 10:01,1,1,"Before the Colorectal Cancer session at # ASCO14, read up on the GI Symposium: http://bit.ly/1sTlDzq # crcsm # ASCOConnection",,,# # #,4.73102E+17,https://twitter.com/ASCO/status/473101997911330816,,,,
mtmdphd,6/1/2014 10:01,1,0,"Trotman # lymsm # ASCO14 - PET in FL - With PET/CT, CT assessment limited value. 5PS new SOC",,,# #,4.73102E+17,https://twitter.com/mtmdphd/status/473101973550424064,,,,
DebiopharmNews,6/1/2014 10:01,0,0,"# ASCO14 Final Phase I Debio 0932, oral # HSP90 inhibitor, # oncology (abstract/poster #2550) Find out more http://ow.ly/x95dS",,,# # # #2550,4.73102E+17,https://twitter.com/DebiopharmNews/status/473101961131479040,,,,
mayocliniclabs,6/1/2014 10:01,0,0,Ready for day 3 at # ASCO14. Bring your # cancer testing questions to booth #2054.,,,# # #2054,4.73102E+17,https://twitter.com/mayocliniclabs/status/473101930605334529,,,,
MelanomaReAlli,6/1/2014 10:01,0,0,Be sure to follow MRA's CEO @ WendySelig for # melanoma updates from # ASCO14! We will be tweeting the meeting as well!,,@,# #,4.73102E+17,https://twitter.com/MelanomaReAlli/status/473101923437252609,,,,
ByJonGardner,6/1/2014 10:00,0,0,"Re the big drop in @ ASCO submissions from fed-backed studies: Actions have consequences, elected officials. # ASCO14",,@,#,4.73102E+17,https://twitter.com/ByJonGardner/status/473101899411906560,,,,
mtmdphd,6/1/2014 10:00,1,1,Trotman # lymsm # ASCO14 - PET in FL - Conclusions - med f/u 4.6 yrs in 246 Pts - PET-CT pred PFS/OS pic.twitter.com/yeH3A2IfUt,,,# #,4.73102E+17,https://twitter.com/mtmdphd/status/473101884266254337,,,,
AstellasUS,6/1/2014 10:00,2,2,"Today at # ASCO14, Andrew Armstrong of @ Duke_Medicine presents expanded results of Phase 3 trial in prostate cancer. http://bit.ly/1pEQ9Lv",,@,#,4.73102E+17,https://twitter.com/AstellasUS/status/473101863139938304,,,,
teamoncology,6/1/2014 10:00,0,0,@ aftimosp If the outcome is going to improve by long-term follow up that will be interesting. # ASCO14,,@,#,4.73102E+17,https://twitter.com/teamoncology/status/473101816771530753,,,,
ShannonWestin,6/1/2014 10:00,0,3,"PD-1 inhibitor nivolumab in recurrent ovarian cancer 17% RR, high toxicity (11/18 w G3/4 AE) # ASCO14 # gyncsm",,,# #,4.73102E+17,https://twitter.com/ShannonWestin/status/473101810518220800,,,,
ASCO,6/1/2014 10:00,6,5,Drs. Kamal & Abernethy: Improving Quality of Palliative Care w/Virtual Learning Collaborative http://bit.ly/1nxNlD0 # ASCO14 CC @ arifkamalmd,,@,#,4.73102E+17,https://twitter.com/ASCO/status/473101801399779328,,,,
medtechy,6/1/2014 10:00,0,0,Any reps at # ASCO14 - Join the discussion and share how it is from a reps perspective |http://bit.ly/1tz52PR @ novartis @ pfizer @ sanofius,,@ @ @,#,4.73102E+17,https://twitter.com/medtechy/status/473101757971984384,,,,
TargetedOnc,6/1/2014 10:00,3,0,The dosing frequency of zoledronic acid can be reduced by 33% w/o compromising efficacy and safety http://www.targetedonc.com/conference/asco-2014/Dosing-Frequency-of-Zoledronic-Acid-Can-Be-Reduced-Without-Compromising-Efficacy-in-Breast-Cancer … # ASCO14,,,#,4.73102E+17,https://twitter.com/TargetedOnc/status/473101741484146688,,,,
FoundationATCG,6/1/2014 10:00,0,2,Take the molecular testing challenge and learn about the comprehensive approach: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.73102E+17,https://twitter.com/FoundationATCG/status/473101732126285825,,,,
cardinalhealth,6/1/2014 10:00,0,0,Did you know 60.4% of surveyed oncologists reported increase in personal workloads? – [Oncology Trend Report 2013]. # ASCO14,,,#,4.73102E+17,https://twitter.com/cardinalhealth/status/473101723402137600,,,,
CancerDotNet,6/1/2014 10:00,0,1,"Hongchao Pan, PhD of @ UniofOxford on study abt obesity & premenopausal ER+ breast cancer # bcsm # ASCO14 http://bit.ly/1mKwitP",,@,# #,4.73102E+17,https://twitter.com/CancerDotNet/status/473101705228607488,,,,
SanofiUS,6/1/2014 10:00,3,1,"At # ASCO14, we recognize the strength & resilience of every patient and continue to support ongoing research pic.twitter.com/Uq1eZ12d8G",,,#,4.73102E+17,https://twitter.com/SanofiUS/status/473101700224806912,,,,
teamoncology,6/1/2014 10:00,0,0,Possible. RT @ aftimosp: @ teamoncology another ALLTO question: was the analysis performed too early? # ASCO14,,@ @,#,4.73102E+17,https://twitter.com/teamoncology/status/473101690036436992,,,,
NCIMedia,6/1/2014 10:00,8,3,Announced at # ASCO14: New treatment option for young women with hormone-sensitive breast # cancer: http://1.usa.gov/1hMJfz0 # bcsm,,,# # #,4.73102E+17,https://twitter.com/NCIMedia/status/473101682419961856,,,,
DanaFarber,6/1/2014 10:00,1,6,Blood test shows promise for identifying genetic abnormalities in tumors: http://bit.ly/1k7SE9Q # ASCO14,,,#,4.73102E+17,https://twitter.com/DanaFarber/status/473101669790916608,,,,
mtmdphd,6/1/2014 10:00,1,0,Trotman # lymsm # ASCO14 - PET in FL - HR 6.7 for OS based on postinduction PET status pic.twitter.com/DVRqEEYk4c,,,# #,4.73102E+17,https://twitter.com/mtmdphd/status/473101667953422336,,,,
KLCampbellPhD,6/1/2014 9:59,1,1,"Colditz: plan A should be prevention and early detection; Plan B therapy only when Plan A fails"" -Vogelstein Science 2013 # ASCO14""",,,#,4.73102E+17,https://twitter.com/KLCampbellPhD/status/473101619358203904,,,,
teamoncology,6/1/2014 9:59,0,0,"So, there are three two double anti-HER2 therapy as neoadjuvant therapy, will they all translate to improved overall survival. # ASCO14",,,#,4.73102E+17,https://twitter.com/teamoncology/status/473101586915291136,,,,
aftimosp,6/1/2014 9:59,0,0,@ teamoncology another ALLTO question: was the analysis performed too early? # ASCO14,,@,#,4.73102E+17,https://twitter.com/aftimosp/status/473101555571650560,,,,
staciawag,6/1/2014 9:59,0,0,Oncologist at # ASCO14 smoking outside - assuring job security.,,,#,4.73102E+17,https://twitter.com/staciawag/status/473101554463936513,,,,
mtmdphd,6/1/2014 9:59,1,0,Trotman # lymsm # ASCO14 - PET in FL - Both PET cut-offs predictive of PFS - HR 3.9 pic.twitter.com/hCSeZ2hMpF,,,# #,4.73101E+17,https://twitter.com/mtmdphd/status/473101498495148034,,,,
CancerTherAdvsr,6/1/2014 9:59,0,0,Panel now fielding questions from reporters on the plenary session studies # ASCO14 # CTAatASCopic.twitter.com/0r5w8IkpV6,,,# #,4.73101E+17,https://twitter.com/CancerTherAdvsr/status/473101459119034368,,,,
teamoncology,6/1/2014 9:58,0,0,"For TNBC, pCR reflects the long-term outcome. Fur, for androgen enriched population, they do well even w/o pCR. # ASCO14",,,#,4.73101E+17,https://twitter.com/teamoncology/status/473101384963743744,,,,
MelanomaMom,6/1/2014 9:58,0,1,Updated data on combined braf and mek at higher doses results in median overall survival of 25 months. # melanoma # ASCO14,,,# #,4.73101E+17,https://twitter.com/MelanomaMom/status/473101361169858560,,,,
Cascadia,6/1/2014 9:58,0,1,Just added two more patient centered groups @ CANcerviver @PACENetworkUSA the rapidly growing # ASCO14 list https://twitter.com/Cascadia/lists/asco14 …,,@ @PACENetworkUSA,#,4.73101E+17,https://twitter.com/Cascadia/status/473101360859058176,,,,
mtmdphd,6/1/2014 9:58,0,0,Trotman # lymsm # ASCO14 - PET in FL - PET Review Results pic.twitter.com/1eiRkdT62l,,,# #,4.73101E+17,https://twitter.com/mtmdphd/status/473101249345515520,,,,
teamoncology,6/1/2014 9:57,0,1,You wonder by ALLTO study being negative. Does pCR really translate to an improved long-term outcome in HER2+ primary breast cancer? # ASCO14,,,#,4.73101E+17,https://twitter.com/teamoncology/status/473101062581129216,,,,
mtmdphd,6/1/2014 9:57,1,0,Trotman # lymsm # ASCO14 - PET in FL - Postinduction PET review concordance - 3 indep reviewers pic.twitter.com/jOU28p6dp3,,,# #,4.73101E+17,https://twitter.com/mtmdphd/status/473101059670691840,,,,
laurentingels,6/1/2014 9:57,0,0,"Nombreuses questions sur les avancées dans le traitement du cancer prostatique, du sein. # ASCO14 # Cancer # onconlogypic.twitter.com/VWTXTmN8En",,,# # #,4.73101E+17,https://twitter.com/laurentingels/status/473101038405558273,,,,
djsampson,6/1/2014 9:57,0,0,Colditz: simply taxing SSBs isn't going to enough. Need to address entire food environment # asco14,,,#,4.73101E+17,https://twitter.com/djsampson/status/473101024341684225,,,,
AnneBooms,6/1/2014 9:57,3,1,# ASCO14 Esserman on new paradigms tumor progression and screening pic.twitter.com/ko7wvouJbX,,,#,4.73101E+17,https://twitter.com/AnneBooms/status/473101009523601408,,,,
CancerDotNet,6/1/2014 9:57,10,3,Guide to # breastcancer from @ ASCO's pt education site for patients/caregivers # bcsm # ASCO14 http://bit.ly/U5unXE,,@,# # #,4.73101E+17,https://twitter.com/CancerDotNet/status/473100982440980480,,,,
BrendonStilesMD,6/1/2014 9:57,0,0,From NCDB database. Neoadj vs adj chemo for N2 lungCA. But I feel like chemo better tolerated up front. # asco2014 http://abstracts.asco.org/144/AbstView_144_128621.html …,,,#,4.73101E+17,https://twitter.com/BrendonStilesMD/status/473100960697708544,,,,
aftimosp,6/1/2014 9:57,0,0,Updated phase 1 trial results: Median overall survival 25 months for dabrafenib + trametinib versus 20 months for dabrafenib # ASCO14,,,#,4.73101E+17,https://twitter.com/aftimosp/status/473100916313559040,,,,
UCCancerCenter,6/1/2014 9:56,1,1,Mark Ratain on valid design and conduct of pharmacogenomics studies to identify variants to guide drug dosing and supportive care # ASCO14,,,#,4.73101E+17,https://twitter.com/UCCancerCenter/status/473100872323694592,,,,
mtmdphd,6/1/2014 9:56,1,0,Trotman # lymsm # ASCO14 - PET in FL - PFS according to CT response pic.twitter.com/q93Qqq6Rym,,,# #,4.73101E+17,https://twitter.com/mtmdphd/status/473100861041016832,,,,
CancerSupportHQ,6/1/2014 9:56,0,3,Kim T & Kim J - # ASCO14 not just about science - it's about what the science does for PEOPLE! @ ASCO @ CancerSupportCmpic.twitter.com/Ty51EDP4Js,,@ @,#,4.73101E+17,https://twitter.com/CancerSupportHQ/status/473100825855025152,,,,
AlpineBV_Miller,6/1/2014 9:56,0,1,That # fail moment when you run-walk to the other end of the building only to realize you are in the wrong room # ASCO14,,,# #,4.73101E+17,https://twitter.com/AlpineBV_Miller/status/473100822558281730,,,,
djsampson,6/1/2014 9:56,0,0,Colditz: tweaking diets and changing ingredients isn't going to turn us around # asco14,,,#,4.73101E+17,https://twitter.com/djsampson/status/473100790232391680,,,,
AJMC_Journal,6/1/2014 9:56,0,0,Make sure to follow our # ASCO14 coverage -- http://www.ajmc.com/conferences/asco-2014 …,,,#,4.73101E+17,https://twitter.com/AJMC_Journal/status/473100727767031809,,,,
djsampson,6/1/2014 9:55,3,0,We to Colditz: we identified villain in tobacco. Who is villain in obesity? A: physical activity # asco14,,,#,4.73101E+17,https://twitter.com/djsampson/status/473100616684675072,,,,
fwpharma,6/1/2014 9:55,1,0,AstraZeneca's Zoladex may help prevent early menopause in patients with breast cancer: study http://bit.ly/T3Pgl0 $ AZN # ASCO14,,,#,4.73101E+17,https://twitter.com/fwpharma/status/473100593016627200,,,,
brianreid,6/1/2014 9:55,26,5,Whoa. MT @ OncologyTimes: . @ CliffordHudis: Big drop in federally funded abstracts submitted to @ ASCO mtgs: 575 in 2008 vs 169 this yr # ASCO14,,@ @ @,#,4.73101E+17,https://twitter.com/brianreid/status/473100580064202752,,,,
ShinyBlackShoe,6/1/2014 9:55,0,0," # ASCO14: Adding lap to adjuv tras does not improve outcome; no signif. dif in 4yr surv"" I think I just heard the NHS give a sigh of relief""",,,#,4.73101E+17,https://twitter.com/ShinyBlackShoe/status/473100576793038849,,,,
SamuelLz,6/1/2014 9:55,0,0,Nu kan du läsa om floppen med Tyverb på @ dagensmedicin # dmasco # asco14 http://www.dagensmedicin.se/asco/jatteflopp-for-lakemedel-mot-brostcancer/ …,,@,# #,4.73101E+17,https://twitter.com/SamuelLz/status/473100526885036033,,,,
ERPlimackMD,6/1/2014 9:55,0,1,"NYTimes: Early Chemotherapy Extends Lives of Men With Prostate Cancer, Study Finds. OS benefit > 1 year # gusm # asco14 http://nyti.ms/1kllhze",,,# #,4.73101E+17,https://twitter.com/ERPlimackMD/status/473100521616977921,,,,
drcbsteer,6/1/2014 9:55,3,1,Ah ha .... @ mtmdphd has arrived in the # lymsm Lymphoma/plasma cell oral presentations - I can relax and read his tweets and photos. # ASCO14,,@,# #,4.731E+17,https://twitter.com/drcbsteer/status/473100489769635841,,,,
mtmdphd,6/1/2014 9:55,0,0,Trotman # lymsm # ASCO14 - PET in FL - Study Population - n=246 Pts reviewed pic.twitter.com/29la8OYVan,,,# #,4.731E+17,https://twitter.com/mtmdphd/status/473100474556481536,,,,
teamoncology,6/1/2014 9:55,1,0,【 # ASCO14 101】We do not know the cut off of positive androgen receptor in breast cancer yet.,,,#,4.731E+17,https://twitter.com/teamoncology/status/473100473986084864,,,,
drugwonks,6/1/2014 9:55,4,0,"For every 15% drop in # cancer deaths, $127.2 billion in productivity is gained. Join Us. # ASCO14 # MLIWI http://buff.ly/1wN7DKF",,,# # #,4.731E+17,https://twitter.com/drugwonks/status/473100467267190784,,,,
PublicHealthRTs,6/1/2014 9:55,0,0,RT @ hmhyltonpac: Cancer patients are more than 2.5 times more likely to struggle with bankruptcy-Dr. Leah Zullig at # ASCO14 # cancer # health,,@,# # #,4.731E+17,https://twitter.com/PublicHealthRTs/status/473100446157242368,,,,
damien_maillard,6/1/2014 9:54,0,0,“ @ jdflaysakier: En 20 ans l'esperance de vie d'un patient avec un cancer du colon métastatique est passée de 8 mois à 29 mois # ASCO14”,,@,#,4.731E+17,https://twitter.com/damien_maillard/status/473100399835357184,,,,
CANcerviver,6/1/2014 9:54,0,0,RT @ theNCI: New treatment option for young women with hormone-sensitive breast cancer http://1.usa.gov/1px1Jey # exemestane # ASCO14 # BCSM,,@,# # #,4.731E+17,https://twitter.com/CANcerviver/status/473100376863166464,,,,
teamoncology,6/1/2014 9:54,1,0,【 # ASCO14 101】Androgen receptor positive breast cancer has better prognosis per JNCI meta-analysis this year.,,,#,4.731E+17,https://twitter.com/teamoncology/status/473100348446359552,,,,
dmooneymd,6/1/2014 9:54,3,0,"Do pts understand meaningful clinical effect"" or do they assume benefit higher than reality. Cancer cure vs live for 6 more wks. # ASCO14""",,,#,4.731E+17,https://twitter.com/dmooneymd/status/473100342486241280,,,,
AnneBooms,6/1/2014 9:54,0,0,# ASCO14 NLST trial shows fact on lung cancer screening- Esserman http://www.cancer.gov/newscenter/newsfromnci/2011/NLSTFastFacts …,,,#,4.731E+17,https://twitter.com/AnneBooms/status/473100337898074112,,,,
mtmdphd,6/1/2014 9:54,0,0,"Trotman # lymsm # ASCO14 - PET in FL - 5 Point Scale (5PS) - Meignan M, 2009 pic.twitter.com/MwRspzoVoi",,,# #,4.731E+17,https://twitter.com/mtmdphd/status/473100311708827650,,,,
aftimosp,6/1/2014 9:54,0,0,BRAF-mutated melanoma patients with a complete response on dabrafenib + trametinib have a significantly prolonged overall survival # ASCO14,,,#,4.731E+17,https://twitter.com/aftimosp/status/473100278754197504,,,,
d__darocha,6/1/2014 9:54,0,0,Espero que tenhamos logo os dados atualizados com a mutação ampliada de RAS. # asco14,,,#,4.731E+17,https://twitter.com/d__darocha/status/473100196608356352,,,,
aakonc,6/1/2014 9:54,0,0,Objective confirmation loss of resrchrs @OncologyTimes@CliffordHudis: Big drop in federally funded abstracts @ ASCO2008: 575 vs 169 # ASCO14,,@OncologyTimes @CliffordHudis @,#,4.731E+17,https://twitter.com/aakonc/status/473100177063284736,,,,
teamoncology,6/1/2014 9:54,0,0,"【 # ASCO14 101】Androgen receptor expression is the highest among ER, followed by HER2, and then TNBC.",,,#,4.731E+17,https://twitter.com/teamoncology/status/473100165922824193,,,,
rsm2800,6/1/2014 9:53,0,0,"Malin: Noting that E5103, a neg trial of bev in breast ca, involved 5000 pts # asco14",,,#,4.731E+17,https://twitter.com/rsm2800/status/473100123921477632,,,,
mtmdphd,6/1/2014 9:53,1,0,Trotman # lymsm # ASCO14 - PET in FL - Aim pic.twitter.com/LR7n2nnfgE,,,# #,4.731E+17,https://twitter.com/mtmdphd/status/473100121593225217,,,,
brianreid,6/1/2014 9:53,1,0,Want to keep up with the cancer immunotherapy buzz? Follow the Answer to Cancer: @ TheA2C # ASCO14,,@,#,4.731E+17,https://twitter.com/brianreid/status/473100100470714368,,,,
CancerTherAdvsr,6/1/2014 9:53,0,0,RT @ ASCO: Plenary brief # ASCO14: ALTTO results have “tremendous potential implications…for drug development” - @ CliffordHudis,,@ @,#,4.731E+17,https://twitter.com/CancerTherAdvsr/status/473100098332020736,,,,
teamoncology,6/1/2014 9:53,0,0,【 # ASCO14 101】 Androgen receptor targeted treatment is aggressively pursed to determine if there is any signal in breast cancer.,,,#,4.731E+17,https://twitter.com/teamoncology/status/473100060230569985,,,,
myelomacinderel,6/1/2014 9:53,1,1,"Teamwork & dialogue needed 4 docs to become 'genomified # myeloma # ASCO14 # ASCO14myeloma. Let the path talk begin!! http://am.asco.org/success-molecular-testing-depends-dialogue-between-oncologist-pathologist …""",,,# # #,4.731E+17,https://twitter.com/myelomacinderel/status/473100010268405760,,,,
mtmdphd,6/1/2014 9:53,1,0,Trotman Abstr 8502 # lymsm # ASCO14 - PET in FL - 3 studies pic.twitter.com/3VVQbVs5Tn,,,# #,4.731E+17,https://twitter.com/mtmdphd/status/473100007080722432,,,,
djsampson,6/1/2014 9:53,0,0,"Colditz: we must deliver br ca prevention with policy, providers, and communities # asco14",,,#,4.731E+17,https://twitter.com/djsampson/status/473099989426511874,,,,
ConsanoScott,6/1/2014 9:53,1,0,New technology bringing researchers closer to finding accurate and predictive marker of prostate cancer prognosis? # ASCO14,,,#,4.731E+17,https://twitter.com/ConsanoScott/status/473099921336582144,,,,
ShinyBlackShoe,6/1/2014 9:52,0,0,"MT @ ASCO Plenary brief # ASCO14: Adding docetaxel to std hormone therapy in HRPC provides substantial survival benefit, ~13 mos # dealChanger",,@,# #,4.731E+17,https://twitter.com/ShinyBlackShoe/status/473099849764995072,,,,
JacobPlieth,6/1/2014 9:52,0,0,Key for $ LLY and $ RHHBY from CALGB study is further RAS analyses - like in Fire-3 study # ASCO14,,,#,4.731E+17,https://twitter.com/JacobPlieth/status/473099824938893312,,,,
teamoncology,6/1/2014 9:52,0,1,Important topic. RT @ OncLive: Dr Denise Yardley discusses targeting the androgen receptor in breast cancer http://ow.ly/xtF4K # ASCO14,,@,#,4.731E+17,https://twitter.com/teamoncology/status/473099812854702080,,,,
OrianaSpagnolo,6/1/2014 9:52,0,0,Today 1st results of ph.3 ALTTO trial -adjuvant treatment of HER2-positive early # breastcancer # ASCO14 - @ 1PM Hall B1 http://abstracts.asco.org/144/index.html,,@,# #,4.731E+17,https://twitter.com/OrianaSpagnolo/status/473099810614951936,,,,
ShannonWestin,6/1/2014 9:52,1,0,Metformin under evaluation for early stage and recurrent endometrial cancer. # ASCO14 # gyncsm,,,# #,4.731E+17,https://twitter.com/ShannonWestin/status/473099647771504640,,,,
teamoncology,6/1/2014 9:51,2,0,【 # ASCO14 Update】 E5103 study. Adjuvant bevacizumab in early breast cancer did not improve disease-free survival. The end of bevacizumab.,,,#,4.731E+17,https://twitter.com/teamoncology/status/473099636840738816,,,,
BrendonStilesMD,6/1/2014 9:51,2,0,Interesting abstract yesterday. Surgery in carefully selected N3 lungCA patients improves outcome. # ASCO2014 # lcsm http://abstracts.asco.org/144/AbstView_144_134935.html …,,,# #,4.731E+17,https://twitter.com/BrendonStilesMD/status/473099635171819521,,,,
KowalyszynMD,6/1/2014 9:51,0,0,# ASCO2014. Trabajemos para ello pic.twitter.com/5f4e5w1RGT,,,#,4.731E+17,https://twitter.com/KowalyszynMD/status/473099580796854272,,,,
mtmdphd,6/1/2014 9:51,1,0,Trotman # lymsm # ASCO14 - PET in FL - Response assessment - FLIPI fail to ID all Px pic.twitter.com/ImeTa1POJm,,,# #,4.731E+17,https://twitter.com/mtmdphd/status/473099551084388353,,,,
rsm2800,6/1/2014 9:51,0,0,Malin: Ellis JCO 2014; 32:1277 Sev ASCO workgroups tried to define clinically meaningful outcomes in diff tumor types (background) # ASCO14,,,#,4.731E+17,https://twitter.com/rsm2800/status/473099538878955522,,,,
drcbsteer,6/1/2014 9:51,0,0,# ASCO14 # lymsm Judith Trotman from Sydney presenting utility of PET-CT in follicular NHL - Go Judith!,,,# #,4.731E+17,https://twitter.com/drcbsteer/status/473099537268371456,,,,
ACROhealth,6/1/2014 9:51,0,2,Tune in TODAY to Pt.2 of @ FierceBiotech # TwitterChat. Hear top industry minds @DamianFierce @ MarkSchoenebaum # innovation # oncology # ASCO2014,,@ @DamianFierce @,# # # #,4.73099E+17,https://twitter.com/ACROhealth/status/473099397996097536,,,,
Melanoma_doctor,6/1/2014 9:51,0,1,Disagree-key is understand resist. mech NOT combining drugs MT@timturnham BRAF+ # melanoma respond to BRAFi briefly Combos key # ASCO14,,@timturnham,# #,4.73099E+17,https://twitter.com/Melanoma_doctor/status/473099396788531200,,,,
MelanomaMom,6/1/2014 9:50,4,2,Combined LEE011 and binimelnib promising in NRAS # melanoma. # ASCO14 pic.twitter.com/klOWKxDw86,,,# #,4.73099E+17,https://twitter.com/MelanomaMom/status/473099370934857729,,,,
jmmrad,6/1/2014 9:50,0,0,# ASCO14 E. Efstathiou shows combo of Abi and Enza has more fatigue. PSA response and time on therapy not better than monotherapy,,,#,4.73099E+17,https://twitter.com/jmmrad/status/473099356770291712,,,,
aftimosp,6/1/2014 9:50,0,0,Updated survival data of the dabrafenib + trametinib phase 1 trial show lower benefit for patients BRAFi pretreated # ASCO14,,,#,4.73099E+17,https://twitter.com/aftimosp/status/473099329562238976,,,,
UNC_Lineberger,6/1/2014 9:50,3,0,"Eval. of falls in older adults: How are we doing? | Guerard, Muss et al @ corp_UNC # gerionc # ASCO14 pic.twitter.com/aZyr0TyvOu",,@,# #,4.73099E+17,https://twitter.com/UNC_Lineberger/status/473099295605157888,,,,
JacobPlieth,6/1/2014 9:50,1,0,"Ironic that answer from fed-funded study like CALGB could be v relevant for companies, though it's too risky for them to ask the q # ASCO14",,,#,4.73099E+17,https://twitter.com/JacobPlieth/status/473099253825687552,,,,
DKarikios,6/1/2014 9:50,1,0,Taplin: combination AR inhibition (enz + abi) is probably worth pursuing - trial is underway # ASCO14,,,#,4.73099E+17,https://twitter.com/DKarikios/status/473099233520652288,,,,
ShannonWestin,6/1/2014 9:50,0,0,"P. Soliman- phase 0 studies are feasible in newly dx endometrial cancer"". A novel way to assess agent effect. # ASCO14 # gyncsm""",,,# #,4.73099E+17,https://twitter.com/ShannonWestin/status/473099211383128064,,,,
mtmdphd,6/1/2014 9:50,5,0,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.73099E+17,https://twitter.com/mtmdphd/status/473099203204644864,,,,
subatomicdoc,6/1/2014 9:50,1,1,Randomized phase II trial of dendritic cell (DC) vaccination w/ ICT-107 in newly diagnosed glioblastoma http://abstracts.asco.org/144/AbstView_144_129630.html … # ASCO14 # btsm,,,# #,4.73099E+17,https://twitter.com/subatomicdoc/status/473099160275939328,,,,
subatomicdoc,6/1/2014 9:50,2,3,A 6-gene signature for outcome prediction of grade II/III glioma http://bit.ly/1jZMTK9 # ASCO14 # btsm,,,# #,4.73099E+17,https://twitter.com/subatomicdoc/status/473099152147365888,,,,
djsampson,6/1/2014 9:49,1,0,Colditz: how much can we reduce br ca risk (bad shot of chart) # asco14 pic.twitter.com/uy3KLxUQZo,,,#,4.73099E+17,https://twitter.com/djsampson/status/473099080109801472,,,,
ASCO,6/1/2014 9:49,0,1,# ASCO14 press briefing now wrapping up with Q&A session. All Plenary presentations later today.,,,#,4.73099E+17,https://twitter.com/ASCO/status/473098990247243776,,,,
ASCO,6/1/2014 9:49,4,1,Plenary brief # ASCO14: ALTTO results have “tremendous potential implications…for drug development” - @ CliffordHudis,,@,#,4.73099E+17,https://twitter.com/ASCO/status/473098904754720768,,,,
WilliamDale_MD,6/1/2014 9:49,2,3,"Poster ready, Board 359! Come talk with me about how wives improve husband's cancer screening. # ASCO14 pic.twitter.com/bCGRbsCTW9",,,#,4.73099E+17,https://twitter.com/WilliamDale_MD/status/473098902665973760,,,,
rsm2800,6/1/2014 9:48,0,2,Gnant: Goserelin “kind of worked” to preserve fertility in premenop breast ca pts getting adj chemo (not a ringing endorsement?) # asco14,,,#,4.73099E+17,https://twitter.com/rsm2800/status/473098817567731712,,,,
jdflaysakier,6/1/2014 9:48,5,1,En 20 ans l'esperance de vie d'un patient avec un cancer du colon métastatique est passée de 8 mois à 29 mois # ASCO14,,,#,4.73099E+17,https://twitter.com/jdflaysakier/status/473098811225550848,,,,
HemOncToday,6/1/2014 9:48,3,3,# ASCO14 # Paclitaxel plus # pazopanib improved survival in advanced # OvarianCancer - http://goo.gl/Ik1MKc,,,# # # #,4.73099E+17,https://twitter.com/HemOncToday/status/473098776996216833,,,,
GoHealio,6/1/2014 9:48,0,1,# ASCO14 # Paclitaxel plus # pazopanib improved survival in advanced # OvarianCancer - http://goo.gl/Ik1MKc,,,# # # #,4.73099E+17,https://twitter.com/GoHealio/status/473098776044113920,,,,
EthanBasch1,6/1/2014 9:48,1,0,Colorectal: looking forward to Venook CALGB 80405 in Plenary 2:45pm # ASCO14 http://tinyurl.com/lxlmu5f,,,#,4.73099E+17,https://twitter.com/EthanBasch1/status/473098725225951232,,,,
teamoncology,6/1/2014 9:48,1,1,A big issue. RT @ dianeradfordmd: 17% breast cancers attributed to obesity MT @ djsampson Colditz: cancers attributed to obesity # asco14,,@ @,#,4.73099E+17,https://twitter.com/teamoncology/status/473098719802318849,,,,
ConsanoScott,6/1/2014 9:48,0,0,@ DanaFarber Dr. Taplin states prostate cancer pts with liver mets are underserved - need new therapies. # ASCO14,,@,#,4.73099E+17,https://twitter.com/ConsanoScott/status/473098701398085632,,,,
drcbsteer,6/1/2014 9:48,0,0,# ASCO14 Question time - Pfreundschuh - 375mg/m2 rituximab may not be the standard dose in females either. We just don't know # lymsm,,,# #,4.73099E+17,https://twitter.com/drcbsteer/status/473098685883371520,,,,
WHOPressUS,6/1/2014 9:48,0,0,"The # ASCO14 WHO Press booth is open today from 9-5pm. All titles are 15% off. Publisher’s Pavilion, booth 20119.",,,#,4.73099E+17,https://twitter.com/WHOPressUS/status/473098648738615296,,,,
subatomicdoc,6/1/2014 9:48,2,3,Biopsychosocial predictors of pain among women recovering from surgery for gynecologic cancer http://bit.ly/1kWw4zP # ASCO14 # gyncsm,,,# #,4.73099E+17,https://twitter.com/subatomicdoc/status/473098646754701312,,,,
takashtoy,6/1/2014 9:48,0,0,TCD_Haplo+CBとdoubleCBを比べるとHaplo+CBの方が生着も生存もよかったと。抄録にはキメリズムが書いてないけど、ただのHaploでよかった（臍帯血いらなかった）のではと思ってしまう… # ASCO14 http://abstracts.asco.org/144/index.html,,,#,4.73099E+17,https://twitter.com/takashtoy/status/473098646301315072,,,,
SJNaggiar,6/1/2014 9:47,0,0,@ CliffordHudis ALTTO study long-term implications: we can't use pre-op setting + improvement in PCR as surrogate for DFS and OS # ASCO2014,,@,#,4.73099E+17,https://twitter.com/SJNaggiar/status/473098600160194560,,,,
nxtstop1,6/1/2014 9:47,0,0,"Immunotherapy, Interaction of # aging & cancer, Diet & Cancer, Regenerative Medicine, Genetics >>> ALL At Forefront CA! # ASCO14",,,# #,4.73099E+17,https://twitter.com/nxtstop1/status/473098521696948224,,,,
dmooneymd,6/1/2014 9:47,0,0,"Baseline obesity has negative impact in survival on premenopausal er+ cancer. Also, vitamin d data still lacking. # bcsm # ASCO14",,,# #,4.73098E+17,https://twitter.com/dmooneymd/status/473098420140244992,,,,
teamoncology,6/1/2014 9:46,0,0,"@ cordekroon Clearly, OSF could be inconvenient because it is not a self injection now. Also, it would make the clinic busier. # ASCO14",,@,#,4.73098E+17,https://twitter.com/teamoncology/status/473098362049150977,,,,
ByJonGardner,6/1/2014 9:46,0,0,Hudis on ALTTO trial: May not be able to use pathological complete response as surrogate for survival. $ GSK # ASCO14,,,#,4.73098E+17,https://twitter.com/ByJonGardner/status/473098361802063872,,,,
DKarikios,6/1/2014 9:46,1,0,Taplin: new therapies needed for men with CRPC who have liver metastases # ASCO14,,,#,4.73098E+17,https://twitter.com/DKarikios/status/473098300132831233,,,,
wallyjc,6/1/2014 9:46,0,0,Pts with proneural IDH-defined glioblastoma may benefit from anti-angiogenic tx?. Data from Avaglio trial # ASCO14 @ WinshipAtEmory,,@,#,4.73098E+17,https://twitter.com/wallyjc/status/473098267308601344,,,,
duemed,6/1/2014 9:46,1,0,Time to search ways to overcome AR-V7 resistance? Niclosamide may have a role... http://www.ncbi.nlm.nih.gov/pubmed/24740322 # ASCO14,,,#,4.73098E+17,https://twitter.com/duemed/status/473098262790942720,,,,
rsm2800,6/1/2014 9:46,0,0,"Gnant review: Turner Royal Marsden showed serum circulating tumor DNA predictive of relapse, up to 13 mos prior to clinical relapse # ASCO14",,,#,4.73098E+17,https://twitter.com/rsm2800/status/473098149570310144,,,,
ByJonGardner,6/1/2014 9:46,3,1,"ALTTO trial finding: DFS HR of 0.84 concurrent Tykerb/Herceptin, 0.96 sequential. Not significant. $ GSK # ASCO14",,,#,4.73098E+17,https://twitter.com/ByJonGardner/status/473098138585415680,,,,
bfloannie,6/1/2014 9:45,0,0,"In Chicago for # ASCO14, just heard about modest but important advances in treating breast, colorectal and metastatic prostate cancer",,,#,4.73098E+17,https://twitter.com/bfloannie/status/473098082297856000,,,,
Melanoma_MRV,6/1/2014 9:45,0,0,# ASCO14 http://tinyurl.com/kaezxtn NRAS mutant melanomapic.twitter.com/OFkTWaLSMx,,,#,4.73098E+17,https://twitter.com/Melanoma_MRV/status/473098068976734208,,,,
cinghio81,6/1/2014 9:45,1,0,Already commin practice in # EoL care # hpm MT @ JAMA_current: # Statin Use Can Stop When Illnes Is Terminal @ ASCO http://wp.me/p13lz7-389,,@ @,# # #,4.73098E+17,https://twitter.com/cinghio81/status/473098060999188480,,,,
jmmrad,6/1/2014 9:45,0,0,# ASCO14 Halabi confirms that liver worse than lung worse than bone metastasis in prostate cancer,,,#,4.73098E+17,https://twitter.com/jmmrad/status/473098023476547584,,,,
DrAnasYounes,6/1/2014 9:45,0,0,Cavalli and Pfreundschuh presentation are now being discussed # ASCO14 pic.twitter.com/vtLBegsLWw,,,#,4.73098E+17,https://twitter.com/DrAnasYounes/status/473097971811102720,,,,
ConsanoScott,6/1/2014 9:45,0,0,@ YaleCancer Completely agree. Time to start investing in our country's health by supporting research! # ASCO14,,@,#,4.73098E+17,https://twitter.com/ConsanoScott/status/473097966098857984,,,,
teamoncology,6/1/2014 9:45,0,0,@ cordekroon Agree with you. How does this practice of giving AI And OFS in clinic means? I myself have lots of questions. # ASCO14,,@,#,4.73098E+17,https://twitter.com/teamoncology/status/473097947479957505,,,,
subatomicdoc,6/1/2014 9:45,3,1,Site of visceral metastases predict overall survival in castration-resistant prostate cancer (CRPC) http://bit.ly/1kJ1E46 # ASCO14 # pcsm,,,# #,4.73098E+17,https://twitter.com/subatomicdoc/status/473097932829642752,,,,
TakedaOncology,6/1/2014 9:45,1,1,Thrilled to be at # ASCO14 on National Cancer @ SurvivorsDay. # NCSD2014,,@,# #,4.73098E+17,https://twitter.com/TakedaOncology/status/473097925414121472,,,,
CancerTherAdvsr,6/1/2014 9:44,0,0,"In ALTTO, disease-free survival didn't differ significantly between treatment arms, showing lapatinib didn't provide further benefit # ASCO14",,,#,4.73098E+17,https://twitter.com/CancerTherAdvsr/status/473097788444524544,,,,
teamoncology,6/1/2014 9:44,0,0,RT @ cordekroon: Q is whether OFS+E is 'worthwhile' w/respect to # QofL & more important: explanation non-sign increase OS HR 1.14 # ASCO14,,@,# #,4.73098E+17,https://twitter.com/teamoncology/status/473097679631699968,,,,
mlazqui,6/1/2014 9:43,0,0,OS lung mets vs bone mets in mRCPC; HR 1.2 # ASCO14 pic.twitter.com/hyGhnRK6pW,,,#,4.73098E+17,https://twitter.com/mlazqui/status/473097631951245313,,,,
jeffblackradio,6/1/2014 9:43,2,1,"Promo code domino"" at http://www.jeffblack.com National Cancer Survivors Day # ncsd2014 # MLIWI # asco2014 Share to celebrate! free download""",,,# # #,4.73098E+17,https://twitter.com/jeffblackradio/status/473097600347156480,,,,
DianeRadfordMD,6/1/2014 9:43,24,9,17% breast cancers attributed to obesity MT @ djsampson Colditz: chart: cancers attributed to obesity # asco14 pic.twitter.com/pEzmJutVdK,,@,#,4.73098E+17,https://twitter.com/DianeRadfordMD/status/473097576170795008,,,,
djsampson,6/1/2014 9:43,1,0,"Colditz making case that lower parity, delayed childbearing, dietary changes fueling br ca rise in Asia # asco14",,,#,4.73098E+17,https://twitter.com/djsampson/status/473097568834953216,,,,
DrAnasYounes,6/1/2014 9:43,0,0,Michael Williams did a nice job discussing the first 2 presentations # ASCO14,,,#,4.73098E+17,https://twitter.com/DrAnasYounes/status/473097562359365633,,,,
AndyBiotech,6/1/2014 9:43,7,5,$ MRK MK-3475 (Anti-PD1) in Advanced Head and Neck Cancer: 20% ORR; Ph3 initiating. http://www.mercknewsroom.com/news-release/oncology-newsroom/first-presentation-early-data-pembrolizumab-mk-3475-mercks-investigat … # ASCO14 pic.twitter.com/EFfAtfrF6t,,,#,4.73098E+17,https://twitter.com/AndyBiotech/status/473097535633231872,,,,
timturnham,6/1/2014 9:43,1,1,"Combo study in pts w/ NRAS mutation: benefit in most cases, but a lot of side effects. Good news, but need more work. # ASCO14",,,#,4.73097E+17,https://twitter.com/timturnham/status/473097484567580673,,,,
markaorourke,6/1/2014 9:43,0,0,@ amdevane # ASCO14 What is the role for Ga68 DOTATOC PT-CT in the diagnosis of neuroendocrine tumor? Do we have this at our hospital? # hbcsm,,@,# #,4.73097E+17,https://twitter.com/markaorourke/status/473097462115491841,,,,
Melanoma_MRV,6/1/2014 9:43,0,0,New findings for NRAS mutant melanoma - MEK + CDK4 inhibition shows activity in advanced melanoma # ASCO14 Early but promising,,,#,4.73097E+17,https://twitter.com/Melanoma_MRV/status/473097449964580864,,,,
drallysonocean,6/1/2014 9:43,0,1,# ASCO14 @ MMfightsCRC # CancerSurvivor National Cancer Survivor Day. Who are you celebrating?,,@,# #,4.73097E+17,https://twitter.com/drallysonocean/status/473097412547211264,,,,
aly_vdl,6/1/2014 9:43,0,1,Desarrollo para # iPad creado para labs. q presentan su pipeline. Disponible para # ASCO2014. Mas info? Preguntame! # innovacion # tecnologia,,,# # # #,4.73097E+17,https://twitter.com/aly_vdl/status/473097393286946816,,,,
teamoncology,6/1/2014 9:43,0,0,"@ cordekroon 【TEXT/SOFT study】No surprise with the results. But, we needed this prospective study. # ASCO14",,@,#,4.73097E+17,https://twitter.com/teamoncology/status/473097389369077761,,,,
brendanweiss,6/1/2014 9:42,1,0,@ MTomasson listening to your colleague @ gcolditz at # ASCO14 and I think I would agree,,@ @,#,4.73097E+17,https://twitter.com/brendanweiss/status/473097373645033472,,,,
melanoma_Drs,6/1/2014 9:42,0,1,IDO/MEK inhib Ph1 results 5/21 PR--2/21 CR--7/21 “almost” response but sig DLT so dosing sched unclear moving forward # melanoma # ASCO14,,,# #,4.73097E+17,https://twitter.com/melanoma_Drs/status/473097372818751488,,,,
Melanoma_doctor,6/1/2014 9:42,0,1,IDO/MEK inhib Ph1 results 5/21 PR--2/21 CR--7/21 “almost” response but sig DLT so dosing sched unclear moving forward # melanoma # ASCO14,,,# #,4.73097E+17,https://twitter.com/Melanoma_doctor/status/473097372244144128,,,,
rsm2800,6/1/2014 9:42,0,0,Gnant: Perez N9831 showed adaptive immunity important for HER2 efficacy; per Gnant not practice changing yet # asco14,,,#,4.73097E+17,https://twitter.com/rsm2800/status/473097344616239104,,,,
sloan_kettering,6/1/2014 9:42,16,1,MSK's Michael J. Morris discusses new findings about benefits of early chemo on prostate cancer with NYTimes http://nyti.ms/1hMF4Df # ASCO14,,,#,4.73097E+17,https://twitter.com/sloan_kettering/status/473097316325265410,,,,
cinghio81,6/1/2014 9:42,2,0,MT @ OncLive: In # EoL care discontinuation of statins may increase the median time-to-death & improve QoL http://ow.ly/xtg0q # ASCO14 # hpm,,@,# # #,4.73097E+17,https://twitter.com/cinghio81/status/473097178375012352,,,,
ASCO,6/1/2014 9:42,17,3,Plenary brief # ASCO14: Adding lapatinib to adjuvant trastuzumab does not improve outcomes; no signif. difference in 4-yr survival,,,#,4.73097E+17,https://twitter.com/ASCO/status/473097152437440512,,,,
ybarton,6/1/2014 9:41,0,0,RT @ ASCO: Innovation in cancer care therapy may improve patient care and the # value of the care received http://bit.ly/1hgGtYj # ASCO14,,@,# #,4.73097E+17,https://twitter.com/ybarton/status/473097064973623296,,,,
ASCO,6/1/2014 9:41,6,4,Plenary brief # ASCO14: Dr Perez discussing results of large phase III ALTTO trial for pts w/early HER2+ breast cancer. # bcsm,,,# #,4.73097E+17,https://twitter.com/ASCO/status/473097042374688769,,,,
MaverickNY,6/1/2014 9:41,3,1,LEE011 (CDK4/6) plus binimetinib (MEK) looks promising in NRAS-mutant melanomas # asco14,,,#,4.73097E+17,https://twitter.com/MaverickNY/status/473097008593780736,,,,
drcbsteer,6/1/2014 9:41,0,0,# ASCO14 # lymsm Pfreundschuh trial addressed the fact that rituximab dosing has been empiric until now and refining this can improve outcomes,,,# #,4.73097E+17,https://twitter.com/drcbsteer/status/473096940977418240,,,,
DKarikios,6/1/2014 9:41,2,0,"# asco14 Halabi et al confirm in men with CRPC, site of metastases predicts OS - liver and lung mets confer worse survival",,,#,4.73097E+17,https://twitter.com/DKarikios/status/473096929493000194,,,,
Preslaura,6/1/2014 9:41,1,0,Grateful both my parents are cancer survivors. Let's learn to save more. # ASCO14 # NationalCancerSurvivorsDay,,,# #,4.73097E+17,https://twitter.com/Preslaura/status/473096915899281408,,,,
mtmdphd,6/1/2014 9:41,0,2,MT @ RichardWJoseph: MEKi plus CDK4i showing promise for difficult to treat NRAS mutant melanoma. # ASCO14 # melsm,,@,# #,4.73097E+17,https://twitter.com/mtmdphd/status/473096913496334336,,,,
drsteventucker,6/1/2014 9:41,1,0,Awesome tweets coming from @ djsampson on # cancer prevention talk. # ASCO14 # health # bcsm # hcsm @ drseisenberg,,@ @,# # # # #,4.73097E+17,https://twitter.com/drsteventucker/status/473096903043723264,,,,
ASCO,6/1/2014 9:41,9,4,"Plenary brief # ASCO14: FOLFOX and FOLFIRI both acceptable in combo w/either targeted drug, all “perfectly reasonable options” – Dr Venook",,,#,4.73097E+17,https://twitter.com/ASCO/status/473096896886865921,,,,
SarahCannonDocs,6/1/2014 9:40,3,3,Dr.Bendell post interview on value of testing for BRAF mutations in colon cancer w/ @ OncLive # ASCO14 # SCRIpic.twitter.com/SUxHFH2O1k,,@,# #,4.73097E+17,https://twitter.com/SarahCannonDocs/status/473096830449094656,,,,
aftimosp,6/1/2014 9:40,0,0,LEE011 + binimetinib: 10 out of 15 patients (67%) showed concurrent mutation/loss of NRAS and CDKN2A # ASCO14,,,#,4.73097E+17,https://twitter.com/aftimosp/status/473096793002360832,,,,
mtmdphd,6/1/2014 9:40,0,0,"Sosman # melsm # ASCO14 - Conclusions - LEE011 + binimetinib - promising, common AEs, explore intermittent dosing... pic.twitter.com/ocWUrf1br2",,,# #,4.73097E+17,https://twitter.com/mtmdphd/status/473096789474951168,,,,
RichardWJoseph,6/1/2014 9:40,0,0,MEKi plus CDK4i showing promise for difficult to treat NRAS mutant melanoma. # ASCO14,,,#,4.73097E+17,https://twitter.com/RichardWJoseph/status/473096785494544384,,,,
dmooneymd,6/1/2014 9:40,0,0,Her 2 data: even tumors < 2 cm benefited from her 2 treatment. Increased pcr not necessarily predictive of survival benefit. # bcsm # ASCO14,,,# #,4.73097E+17,https://twitter.com/dmooneymd/status/473096716741115905,,,,
rsm2800,6/1/2014 9:40,2,0,Gnant: O’Sullivan small HER2+ tumors benefited from adj trastuz but most were T1c & N+; still some question re T1a/b # bcsm # ASCO14,,,# #,4.73097E+17,https://twitter.com/rsm2800/status/473096684600565760,,,,
Boehringer,6/1/2014 9:40,0,0,Have some down time? Discover # Chicago during # ASCO14 http://bit.ly/18mn8ea,,,# #,4.73097E+17,https://twitter.com/Boehringer/status/473096677155676160,,,,
mlazqui,6/1/2014 9:40,1,0,OS lung mets vs bone mets in mRCPC; HR 1.2 # ASCO14 http://tinyurl.com/k89l9wf pic.twitter.com/UP7Vfc6cr3,,,#,4.73097E+17,https://twitter.com/mlazqui/status/473096646377877504,,,,
Melanoma_doctor,6/1/2014 9:39,2,3,IDO inhib plus MEK inhib combo may have activity in NRAS mutated # melanoma # ASCO14,,,# #,4.73097E+17,https://twitter.com/Melanoma_doctor/status/473096545681039360,,,,
mtmdphd,6/1/2014 9:39,0,2,Sosman # melsm # ASCO14 - Results: Foundation Medicine pic.twitter.com/RPqJlQCeZG,,,# #,4.73097E+17,https://twitter.com/mtmdphd/status/473096531311353856,,,,
JacobPlieth,6/1/2014 9:39,0,1,"Dr Venook, on CALGB mCRC KRAS w/t study: it answers q companies might not want to ask # ASCO14 $ LLY $ RHHBY",,,#,4.73096E+17,https://twitter.com/JacobPlieth/status/473096485090115585,,,,
djsampson,6/1/2014 9:39,0,0,Colditz age of first menarche plummeting in Asia # asco14,,,#,4.73096E+17,https://twitter.com/djsampson/status/473096437115256832,,,,
CureMelanoma,6/1/2014 9:39,1,1,MT @ timturnham: Half of melanoma have BRAF but only respond 2 BRAF drugs for mos. 3-4 ways tumors resist the drug. Combos are key # ASCO14,,@,#,4.73096E+17,https://twitter.com/CureMelanoma/status/473096399434043393,,,,
daviesbj,6/1/2014 9:38,0,0,@ ChapinMD @ ASCO Brian take pics,,@ @,,4.73096E+17,https://twitter.com/daviesbj/status/473096356249079808,,,,
mtmdphd,6/1/2014 9:38,0,2,Sosman # melsm # ASCO14 - Swimmers plot (Dur of Tx Exposure) pic.twitter.com/R4bjifzOZV,,,# #,4.73096E+17,https://twitter.com/mtmdphd/status/473096338050396161,,,,
Melanoma_doctor,6/1/2014 9:38,0,0,# ASCO14 day 3 is rolling,,,#,4.73096E+17,https://twitter.com/Melanoma_doctor/status/473096308610564096,,,,
mtmdphd,6/1/2014 9:38,1,0,Sosman # melsm # ASCO14 - Patient Case Studies - NRAS Q61R mutant melanoma Tx'd w/ LEE011 + Binimetinib pic.twitter.com/zY2Bv5dhyS,,,# #,4.73096E+17,https://twitter.com/mtmdphd/status/473096144420368384,,,,
aly_vdl,6/1/2014 9:38,0,2,A user friendly # iPad development to present labs. pipeline ready for # ASCO2014. More information? Ask me about it! # innovation # technology,,,# # # #,4.73096E+17,https://twitter.com/aly_vdl/status/473096141077094400,,,,
dmooneymd,6/1/2014 9:37,0,0,Early pet assessment in neoadjuvant # bcsm . Poor responders randomized to continue chemo +/- bev. Slightly higher pcr. # bcsm # ASCO14 $$$,,,# # #,4.73096E+17,https://twitter.com/dmooneymd/status/473096101310902272,,,,
aftimosp,6/1/2014 9:37,1,0,LEE011 + binimetinib: 7 out of 21 patients with NRAS-mutant melanoma responded. Another 7 had 20 to 30% regression # ASCO14,,,#,4.73096E+17,https://twitter.com/aftimosp/status/473096066146263041,,,,
JacobPlieth,6/1/2014 9:37,4,4,CALGB study mOS curves Erbitux/Avastin in mCRC # ASCO14 $ LLY $ RHHBYpic.twitter.com/6LKzALF183,,,#,4.73096E+17,https://twitter.com/JacobPlieth/status/473095966950957056,,,,
ChapinMD,6/1/2014 9:37,0,0,@ daviesbj @ ASCO not yet that I know of. Plenary is at 1pm. # ASCO14,,@ @,#,4.73096E+17,https://twitter.com/ChapinMD/status/473095965990084608,,,,
Prof_Nick_James,6/1/2014 9:37,0,0,Interesting data in prostate session on AR splice variants and resistance to abi/Enza - look predictive. Data on chemo now needed # asco14,,,#,4.73096E+17,https://twitter.com/Prof_Nick_James/status/473095938731696128,,,,
mtmdphd,6/1/2014 9:37,0,0,"Sosman # melsm # ASCO14 - Results: Response -- 33% PR, 52% SD, several with symptom improvement pic.twitter.com/vZXNA0sZKu",,,# #,4.73096E+17,https://twitter.com/mtmdphd/status/473095878119399424,,,,
daviesbj,6/1/2014 9:36,0,0,@ ASCO is there a link to the abstract for the early taxotere study in men with metastatic prostate cancer?,,@,,4.73096E+17,https://twitter.com/daviesbj/status/473095772984979456,,,,
CancerTherAdvsr,6/1/2014 9:35,0,0,. @ EdithPerezMD now speaking on ALTTO study # ASCO14,,@,#,4.73096E+17,https://twitter.com/CancerTherAdvsr/status/473095531653115904,,,,
aftimosp,6/1/2014 9:35,0,1,"Phase 1 LEE011 + binimetinib (MEK162): Rash, CPK elevation associated with MEKi Minimal leucopenia and neutropenia. # ASCO14",,,#,4.73096E+17,https://twitter.com/aftimosp/status/473095502335320064,,,,
ASCO,6/1/2014 9:35,18,6,"Plenary press brief # ASCO14: Bevacizumab + chemo and cetuximab + chemo were equally effective, no meaningful diff. in survival. # crcsm",,,# #,4.73095E+17,https://twitter.com/ASCO/status/473095451466797056,,,,
nick_faris,6/1/2014 9:35,6,1,"Not overweight, plant based diet, limited alcohol, exercise = 22% reduction in breast ca, 52% reduction in colon ca in women # ASCO14",,,#,4.73095E+17,https://twitter.com/nick_faris/status/473095436858056704,,,,
Rad_Nation,6/1/2014 9:35,3,3,Pre and postradiation lymphopenia predicts survival in management of bone metastases http://buff.ly/1mCdqxc > @ HopkinsMedicine # ASCO14 # hpm,,@,# #,4.73095E+17,https://twitter.com/Rad_Nation/status/473095426779148288,,,,
Roche,6/1/2014 9:35,3,5,"The focus # ASCO14 has brought to important societal questions, gives an opportunity to reflect upon patient access. http://ow.ly/xoYaM",,,#,4.73095E+17,https://twitter.com/Roche/status/473095401495871488,,,,
SitemanCenter,6/1/2014 9:35,0,0,# ASCO14 Multidisciplinary treatment for stage IIIA non-small cell lung cancer: Does institution matter? http://goo.gl/YEzjwK,,,#,4.73095E+17,https://twitter.com/SitemanCenter/status/473095400250163201,,,,
djsampson,6/1/2014 9:34,2,0,Colditz: Chart: what works in cancer prevention? # asco14 pic.twitter.com/fsol8sPZzA,,,#,4.73095E+17,https://twitter.com/djsampson/status/473095364698845184,,,,
rsm2800,6/1/2014 9:34,2,0,Gnant review: E5103 adjuvant bevacizumab in early breast ca did not improve DFS when added to chemo; “nail in coffin” in adj setting # asco14,,,#,4.73095E+17,https://twitter.com/rsm2800/status/473095337364561920,,,,
ASCO,6/1/2014 9:34,7,4,"Plenary brief # ASCO14: Dr. Venook presenting CALGB/SWOG 80405 results, comparing 4 common 1st-line treatments for colorectal cancer",,,#,4.73095E+17,https://twitter.com/ASCO/status/473095328301068288,,,,
AndytweetM,6/1/2014 9:34,0,1,PD-1 / Nivolumab (immunotherapy) in Ovarian Cancer (in E354a) this a.m. Anyone attending? # ASCO14,,,#,4.73095E+17,https://twitter.com/AndytweetM/status/473095319115550720,,,,
MaverickNY,6/1/2014 9:34,2,0,Too many presenters crowding too much tiny text on slides - less is more! # asco14,,,#,4.73095E+17,https://twitter.com/MaverickNY/status/473095310139740162,,,,
TracyW95,6/1/2014 9:34,1,2,Have a great day @tdhlf with @ LurieCancer at # ASCO14 @ adampetrich @ chadinabhan,,@tdhlf @ @ @,#,4.73095E+17,https://twitter.com/TracyW95/status/473095293794549761,,,,
mtmdphd,6/1/2014 9:34,0,0,Sosman # melsm # ASCO14 - DLT w/ LEE011 + binimetinib pic.twitter.com/XmWqft7Rw7,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473095291445727232,,,,
AndyBiotech,6/1/2014 9:34,9,8,$ MDVN Enzalutamide Ph3 PREVAIL Data in Pre-Chemo mCRPC Published in NEJM http://www.nejm.org/doi/full/10.1056/NEJMoa1405095?query=featured_home … # ASCO14 # PCSMpic.twitter.com/JA12AN6jjw,,,# #,4.73095E+17,https://twitter.com/AndyBiotech/status/473095253432762369,,,,
staciawag,6/1/2014 9:34,0,0,# ASCO14 National Cancer Survivor Day May all these brilliant minds find a cure and always remember to treat the whole patient,,,#,4.73095E+17,https://twitter.com/staciawag/status/473095231273844737,,,,
dmooneymd,6/1/2014 9:34,0,0,ACT +/- bevacizumab in adjuvant. No survival difference. Final nail in adjuvant bevacizumab coffin... probably. # bcsm # ASCO14,,,# #,4.73095E+17,https://twitter.com/dmooneymd/status/473095171639214081,,,,
mtmdphd,6/1/2014 9:34,0,0,Sosman # melsm # ASCO14 - elev CPK w/ MEKi (known tox) pic.twitter.com/kTxojZLoPb,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473095136214126592,,,,
CancerTherAdvsr,6/1/2014 9:33,0,0,"Venook: This is really the tip of the iceberg from what we stand to learn from this study"" # ASCO14""",,,#,4.73095E+17,https://twitter.com/CancerTherAdvsr/status/473095110255599618,,,,
aftimosp,6/1/2014 9:33,0,0,1 patient with KRAS-mutant pancreatic carcinoma was enrolled in the LEE011 + binimetinib phase1 trial # ASCO14,,,#,4.73095E+17,https://twitter.com/aftimosp/status/473095109735874561,,,,
mtmdphd,6/1/2014 9:33,0,0,Sosman # melsm # ASCO14 - poor Px Pts pic.twitter.com/Iv6Nh4uHHV,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473094974985089025,,,,
timturnham,6/1/2014 9:33,3,1,Half of melanomas have BRAF mutation; but only respond to BRAF drugs for months. 3-4 ways tumors resist the drug. Combos are key. # ASCO14,,,#,4.73095E+17,https://twitter.com/timturnham/status/473094900099985408,,,,
AbbottNews,6/1/2014 9:33,2,1,Learn about the impact of personalized medicine & companion diagnostics from patient perspectives at http://bit.ly/1hGVuwV # ASCO14,,,#,4.73095E+17,https://twitter.com/AbbottNews/status/473094887144173568,,,,
mtmdphd,6/1/2014 9:32,0,0,Sosman # melsm # ASCO14 - no RP2D / schedule yet,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473094840658702337,,,,
WCGClinical,6/1/2014 9:32,1,1,We are giving eConsent demos in our # ASCO14 booth #3097 today. Please stop by to discuss this important topic. pic.twitter.com/A0scplU9A6,,,# #3097,4.73095E+17,https://twitter.com/WCGClinical/status/473094813458644993,,,,
mtmdphd,6/1/2014 9:32,0,0,Sosman # melsm # ASCO14 - RP2D using a Bayesian logistic regression model with overdose control principle,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473094755887628288,,,,
OncologyTimes,6/1/2014 9:32,2,1,"MT @ djsampson: Graham Colditz, @ AmericanCancer Awd & Lecture: Chart: cancers attributed to obesity # asco14 pic.twitter.com/lVofsIH0vt",,@ @,#,4.73095E+17,https://twitter.com/OncologyTimes/status/473094707460210689,,,,
drcbsteer,6/1/2014 9:32,1,1,# ASCO14 SEXIERCHOP14 study # lymsm 500 vs 375mg/m2 rituximab eliminated poorer outcomes seen in males vs females inRICOVER trial Pfreundschuh,,,# #,4.73095E+17,https://twitter.com/drcbsteer/status/473094662010699776,,,,
rschilsky,6/1/2014 9:31,14,6,"# ASCO14 CALGB/SWOG 80405 shows 29 mo. median OS in both arms,best ever reported. Bev and cetuximab equivalent given with standard chemo.",,,#,4.73095E+17,https://twitter.com/rschilsky/status/473094599570124800,,,,
mtmdphd,6/1/2014 9:31,0,0,Sosman # melsm # ASCO14 - Study Design and Objectives - LEE011 + Binimetinib -> Bayesian modeling pic.twitter.com/4VEa743M3n,,,# #,4.73095E+17,https://twitter.com/mtmdphd/status/473094568343519232,,,,
ASCO,6/1/2014 9:31,1,1,Plenary # ASCO14: “This is an almost unprecedented improvement in median survival…this is transformative“ - @ cliffordhudis on E3805 study,,@,#,4.73095E+17,https://twitter.com/ASCO/status/473094511921758208,,,,
nick_faris,6/1/2014 9:31,1,1,Tobacco : last 50 years of cancer prevention :: Obesity : next 50 - cliff hurdis # ASCO14,,,#,4.73094E+17,https://twitter.com/nick_faris/status/473094487212699648,,,,
djsampson,6/1/2014 9:31,6,6,Great chart from Colditz: opportunities for cancer prevention by the numbers # asco14 pic.twitter.com/zj5y7oEdC9,,,#,4.73094E+17,https://twitter.com/djsampson/status/473094484440272897,,,,
CancerTherAdvsr,6/1/2014 9:31,0,0,Venook: Conclusion from this is there is no diff between these two therapies as starting pt for patients # ASCO14,,,#,4.73094E+17,https://twitter.com/CancerTherAdvsr/status/473094476370411521,,,,
brendanweiss,6/1/2014 9:31,3,0,Addressing lack of exercise may result in cancer reduction of 85% - time frame for prevention is long 20 years @ gcolditz # ASCO14,,@,#,4.73094E+17,https://twitter.com/brendanweiss/status/473094446914228224,,,,
HenryJOncology,6/1/2014 9:31,0,0,"Astounding results for aldoxorubicin! Improved pfs 3.7 months, hr=0.5. Definitely ready for phase 3. # sarcoma teams to mobilise! # ASCO14",,,# #,4.73094E+17,https://twitter.com/HenryJOncology/status/473094439062106112,,,,
CureMelanoma,6/1/2014 9:31,2,0,RT @ timturnham: Many of best treatments only avail in trials. Why do only 3% of cancer pts go in a trial? Need better info on trials # ASCO14,,@,#,4.73094E+17,https://twitter.com/CureMelanoma/status/473094421958115328,,,,
NEJM,6/1/2014 9:30,1,4,# ASCO14 Copies of PREVAIL study available at booth 20127.,,,#,4.73094E+17,https://twitter.com/NEJM/status/473094300902117377,,,,
dmooneymd,6/1/2014 9:30,0,0,Henderson: elevated risk of breast cancer in childhood cancer survivors even those not treated with chest xrt. # bcsm # ASCO14,,,# #,4.73094E+17,https://twitter.com/dmooneymd/status/473094286280384512,,,,
Amgen,6/1/2014 9:30,2,3,# Amgen discusses new data evaluating activity in giant cell tumor of bone @9:24am CDT in S406 # ASCO14,,@9,# #,4.73094E+17,https://twitter.com/Amgen/status/473094249773555712,,,,
CureMelanoma,6/1/2014 9:30,3,1,"MT @ timturnham: Study: BRAF + new MEK inhibitor shows 87% of pts respond, for a median of 13.7 mo. Best results 4 targeted therapy # ASCO14",,@,#,4.73094E+17,https://twitter.com/CureMelanoma/status/473094185802022914,,,,
SarahCannonDocs,6/1/2014 9:30,0,0,Immunology: a key approach in cancer care - Join # SCRI S Hall A2 # ASCO14,,,# #,4.73094E+17,https://twitter.com/SarahCannonDocs/status/473094148846010368,,,,
nxtstop1,6/1/2014 9:30,2,1,!!!! @ brendanweiss: Obesity may account for up to 50% of risk of some cancers @ gcolditz # ASCO14,,@ @,#,4.73094E+17,https://twitter.com/nxtstop1/status/473094135457402881,,,,
wendyselig,6/1/2014 9:30,0,0,# melanoma progress starting off the day # asco14 with @ MelanomaReAlli funded researchers discussing combinations for better results,,@,# #,4.73094E+17,https://twitter.com/wendyselig/status/473094130554261504,,,,
myriadgenetics,6/1/2014 9:30,2,0,Myriad's findings at # ASCO14 show importance of testing patients for # hereditarycancer syndromes after 1st # cancer to avoid 2nd. Pstr 1542,,,# # #,4.73094E+17,https://twitter.com/myriadgenetics/status/473094120416632832,,,,
mtmdphd,6/1/2014 9:30,0,0,Sosman # melsm # ASCO14 - Binimetinib & LEE011 pic.twitter.com/l2SHaIu6x5,,,# #,4.73094E+17,https://twitter.com/mtmdphd/status/473094111311183873,,,,
nick_faris,6/1/2014 9:29,0,0,Cliff Hurdis and Graham Colditz both sounding the alarm on obesity's role in the cause of cancer. # ASCO14,,,#,4.73094E+17,https://twitter.com/nick_faris/status/473094099923267584,,,,
dhjutsw1,6/1/2014 9:29,0,0,"MT:  @ OncologyTimes: Big drop in federally funded study abst submitted to @ ASCO ann mtgs - in 2008: 575 abstracts vs 169 # ASCO14”""",,@ @,#,4.73094E+17,https://twitter.com/dhjutsw1/status/473094082927935488,,,,
aftimosp,6/1/2014 9:29,0,0,Phase 1 trial of LEE011 (CDK4/6i) + binimetinib [MEK162] (MEKi) in NRS-mutant melanoma # ASCO14,,,#,4.73094E+17,https://twitter.com/aftimosp/status/473094041983524864,,,,
CureMelanoma,6/1/2014 9:29,8,0,RT @ timturnham: Melanoma most common cancer in pregnant women. A substance in blood of these women makes mel cells grow in the lab # ASCO14,,@,#,4.73094E+17,https://twitter.com/CureMelanoma/status/473093991345684480,,,,
nxtstop1,6/1/2014 9:29,0,0,"WE NEED GOV! @ rsm2800:So key RT @ cure_magazine: Hudis: All plenary studies presented received federal funding,such important point. # asco14",,@ @,#,4.73094E+17,https://twitter.com/nxtstop1/status/473093968000200705,,,,
AlpineBV_Miller,6/1/2014 9:29,6,4,This slide strongly suggests using enza first since it creates less AR-V7+ pts. # ASCO14 $ MDVNpic.twitter.com/UYfeaUZs2Q,,,#,4.73094E+17,https://twitter.com/AlpineBV_Miller/status/473093935683080193,,,,
oncotuits,6/1/2014 9:28,4,0,No se pierdan este estudio mexicano de # triplenegativo # asco14 realizado en el @ incanmx @ tomateloapecho @ cancermexpic.twitter.com/SAyE0Eghcf,,@ @ @,# #,4.73094E+17,https://twitter.com/oncotuits/status/473093840761790464,,,,
CancerTherAdvsr,6/1/2014 9:28,0,0,Venook: These two distinctly diff biological therapies didn't impart a significant difference in outcome for patients # ASCO14,,,#,4.73094E+17,https://twitter.com/CancerTherAdvsr/status/473093758804697091,,,,
GustaveRoussy,6/1/2014 9:28,3,0,Asco 2014 is setting records with + 5000 abstracts and + 30000 attendees. Welcome to day 3 of # ASCO2014 pic.twitter.com/FeoCtYpGqu,,,#,4.73094E+17,https://twitter.com/GustaveRoussy/status/473093740035604480,,,,
LisaVanHoosePT,6/1/2014 9:28,0,1,“ @ dhjutsw1: RT: @ CliffordHudis to @ asco members # ASCO14 pic.twitter.com/hO8pW20T3W”” @ WYCOBCT,,@ @ @ @,#,4.73094E+17,https://twitter.com/LisaVanHoosePT/status/473093728580939776,,,,
mtmdphd,6/1/2014 9:28,1,0,"Sosman - Dr. Davies has done such a great job, I could probably eliminate 2/3 of my talk... # ASCO14 # melsm",,,# #,4.73094E+17,https://twitter.com/mtmdphd/status/473093676214661120,,,,
Merck,6/1/2014 9:28,6,3,Check out the head and neck cancer data being presented today @ ASCO’s # ASCO14: http://bit.ly/1mFFDS2 # MerckOncology,,@,# #,4.73094E+17,https://twitter.com/Merck/status/473093638961266688,,,,
subatomicdoc,6/1/2014 9:28,6,1,MT @ djsampson: Colditz: chart: cancers attributed to obesity # asco14 pic.twitter.com/4NxHVviA4B # gyncsm # esocsm # pancsm,,@,# # # #,4.73094E+17,https://twitter.com/subatomicdoc/status/473093610607742976,,,,
nxtstop1,6/1/2014 9:27,0,0,"Comprehensive Cancer Ctr def:NCI Designation:Ctr w/Top Clinical Care,Active Basic Research & Population Science Outreach/Prevention # ASCO14",,,#,4.73094E+17,https://twitter.com/nxtstop1/status/473093598783631360,,,,
StefanoLuminari,6/1/2014 9:27,2,0,# ASCO14 SEXIECHOP14 in DLBCL: Rituximab at 500mg/m2 eliminates the increased risk of elderly males compared to females @ lymphomahub,,@,#,4.73093E+17,https://twitter.com/StefanoLuminari/status/473093497038196736,,,,
mtmdphd,6/1/2014 9:27,0,0,Great talk -> Davies @MDAMelanomaOnc - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma,,@MDAMelanomaOnc,# #,4.73093E+17,https://twitter.com/mtmdphd/status/473093447860367360,,,,
EthanBasch1,6/1/2014 9:27,0,0,Prostate cancer: AR-V7 splice variant predicts PFS with enzalutamide and abiraterone. # ASCO14 http://tinyurl.com/purd946 pic.twitter.com/xy76TpDgjc,,,#,4.73093E+17,https://twitter.com/EthanBasch1/status/473093447612923904,,,,
hkrupka,6/1/2014 9:27,0,0,Weird that 200mg dose more efficacious for $ NVS HHi sonidegib # ASCO14 with fewer AEs than 800mg dose. Probably not hitting target very hard.,,,#,4.73093E+17,https://twitter.com/hkrupka/status/473093425554673664,,,,
aftimosp,6/1/2014 9:27,0,0,Rationale to combine MEKi and CDK4i in NRAS-mutant melanoma # ASCO14,,,#,4.73093E+17,https://twitter.com/aftimosp/status/473093398086582272,,,,
DianeRadfordMD,6/1/2014 9:27,6,6,"50 Years in Breast Cancer: Dramatic Progress in Rx, Improved Understanding of Biology - Dr. Monica Morrow @ ASCO http://bit.ly/1pJ9bQX",,@,,4.73093E+17,https://twitter.com/DianeRadfordMD/status/473093364208766976,,,,
mtmdphd,6/1/2014 9:26,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - Key Concepts pic.twitter.com/Q6Tcww0N4c,,,# #,4.73093E+17,https://twitter.com/mtmdphd/status/473093326611435521,,,,
twittmanda,6/1/2014 9:26,1,1,@ drdonsdizon @ ASCO Agree completely! It's great to have these innovations but when they don't get to those that need its a lose-lose!,,@ @,,4.73093E+17,https://twitter.com/twittmanda/status/473093236861304832,,,,
brendanweiss,6/1/2014 9:26,4,1,Obesity may account for up to 50% of risk of some cancers @ gcolditz # ASCO14,,@,#,4.73093E+17,https://twitter.com/brendanweiss/status/473093152598147072,,,,
mtmdphd,6/1/2014 9:26,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - NRAS-mut mel - MEKi + CDK4i pic.twitter.com/XVRfjQBGoQ,,,# #,4.73093E+17,https://twitter.com/mtmdphd/status/473093103809593344,,,,
CancerTherAdvsr,6/1/2014 9:26,0,0,"Alan P. Venook, MD, now speaking # ASCO14",,,#,4.73093E+17,https://twitter.com/CancerTherAdvsr/status/473093103205638144,,,,
Oncoinfo_it,6/1/2014 9:25,1,0,C.Sweeney: Docetaxel + terapia ormonale iniziale migliora OV in cancro prostata ormoni sensibile LBA2 # ASCO14 pic.twitter.com/nLYBOrP3yi,,,#,4.73093E+17,https://twitter.com/Oncoinfo_it/status/473093079684349952,,,,
duemed,6/1/2014 9:25,0,0,Impact on OS with chemohorm therapy vs horm therapy for horm-sensitive newly mPrCa http://abstracts.asco.org/144/index.html # ASCO14 pic.twitter.com/gySunZel8j,,,#,4.73093E+17,https://twitter.com/duemed/status/473093040702103552,,,,
CancerNetwrk,6/1/2014 9:25,0,0,Thoughts on the Annual PLATO Fellows Forum in Breast Oncology http://bit.ly/1pJ90VG # ASCO14,,,#,4.73093E+17,https://twitter.com/CancerNetwrk/status/473093003268325376,,,,
drcbsteer,6/1/2014 9:25,0,0,"# ASCO14 SEXIE-R-CHOP14 study # lymsm elderly"" NHL. Higher dose rituximab given to male patients. 500mg/m2 No diff in rituximab rel toxicity""",,,# #,4.73093E+17,https://twitter.com/drcbsteer/status/473092991213907968,,,,
mtmdphd,6/1/2014 9:25,1,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - NRAS GEMM pic.twitter.com/CT46zYfOBH,,,# #,4.73093E+17,https://twitter.com/mtmdphd/status/473092970959224833,,,,
YaleCancer,6/1/2014 9:25,3,1,"Dr. Clifford Hudis said decline of federal funding for cancer research disturbing."" # ASCO14""",,,#,4.73093E+17,https://twitter.com/YaleCancer/status/473092928168935424,,,,
djsampson,6/1/2014 9:25,6,2,Colditz: chart: cancers attributed to obesity # asco14 pic.twitter.com/3zdR9Wv7K6,,,#,4.73093E+17,https://twitter.com/djsampson/status/473092905175760896,,,,
AlpineBV_Miller,6/1/2014 9:25,2,0,AR-V7 data this morning irrelevant for pre-chemo. Enza and abi suffer equally # ASCO14 $ MDVN $ JNJ,,,#,4.73093E+17,https://twitter.com/AlpineBV_Miller/status/473092904496676864,,,,
MelanomaReAlli,6/1/2014 9:25,1,1,MRA-funded investigator Michael Davies from @MDAMelanomaOnc currently discussing novel combination therapies for # melanoma at # ASCO14,,@MDAMelanomaOnc,# #,4.73093E+17,https://twitter.com/MelanomaReAlli/status/473092884535590912,,,,
MGHCancerCenter,6/1/2014 9:25,0,0,"8-11:45, S Hall A2: Dr. Guddati poster: outcomes of invasive mechanical ventilation in elderly patients with metastatic cancer # ASCO14",,,#,4.73093E+17,https://twitter.com/MGHCancerCenter/status/473092883705520128,,,,
WinshipAtEmory,6/1/2014 9:25,0,0,Abstract: Management approaches/outcomes of # lungcancer patients hospitalized - malignant pleural effusions: http://ow.ly/xsWqD # ASCO14,,,# #,4.73093E+17,https://twitter.com/WinshipAtEmory/status/473092882162016257,,,,
aftimosp,6/1/2014 9:24,6,1,Intra-patient heterogeneity and even intra-lesional heterogeneity with different mechanisms of resistance described in melanoma # ASCO14,,,#,4.73093E+17,https://twitter.com/aftimosp/status/473092786452180995,,,,
DrAnasYounes,6/1/2014 9:24,0,0,At the lymphoma session in Hall D2 # ASCO14 pic.twitter.com/WTgg8846Wo,,,#,4.73093E+17,https://twitter.com/DrAnasYounes/status/473092724468355072,,,,
CancerTherAdvsr,6/1/2014 9:24,1,0,Sweeney: Adding # chemo drug docetaxel to standard hormone therapy extends survival for men w/metastatic # prostatecancer # ASCO14,,,# # #,4.73093E+17,https://twitter.com/CancerTherAdvsr/status/473092679786827776,,,,
brendanweiss,6/1/2014 9:23,1,0,"@ gcolditz Tobacco will kill 1 billion by the end of this century"" # ASCO14""",,@,#,4.73093E+17,https://twitter.com/brendanweiss/status/473092567387893761,,,,
mtmdphd,6/1/2014 9:23,0,0,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - NRAS-Mutant Melanoma pic.twitter.com/ZHNim2KaaK,,,# #,4.73093E+17,https://twitter.com/mtmdphd/status/473092511171239936,,,,
Novartis,6/1/2014 9:23,4,4,Now at # ASCO14: Phase II study results for # basalcellcarcinoma investigational compound; abstract No. 9009a http://bit.ly/SmSQ9c,,,# #,4.73092E+17,https://twitter.com/Novartis/status/473092462878420992,,,,
Merck,6/1/2014 9:23,4,2,Kicking off day 3 @ ASCO. Proud to be a part of # ASCO14. pic.twitter.com/DV1wspCC4E,,@,#,4.73092E+17,https://twitter.com/Merck/status/473092444196970496,,,,
AnneBooms,6/1/2014 9:23,0,0,# ASCO14 Smith: Conflicting Guidelines and Medicolegal Risk http://jama.jamanetwork.com/article.aspx?articleid=1691914#.U4spCvt07Bo.twitter …,,,# #,4.73092E+17,https://twitter.com/AnneBooms/status/473092377100292098,,,,
mtmdphd,6/1/2014 9:23,0,0,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - Targeted Therapy - Beyond BRAF pic.twitter.com/egSRC4goDt,,,# #,4.73092E+17,https://twitter.com/mtmdphd/status/473092371526066178,,,,
teamoncology,6/1/2014 9:22,0,0,"If E3 Study, use of adjuvant aromatase inhibitor with mTOR inhibitor is positive, what will happen in the future. :) # ASCO14",,,#,4.73092E+17,https://twitter.com/teamoncology/status/473092284846579712,,,,
JanssenUS,6/1/2014 9:22,0,0,New bortezomib and trabectedin combo data in an oral presentation at # ASCO14 (E Hall D2 and S406),,,#,4.73092E+17,https://twitter.com/JanssenUS/status/473092228861394944,,,,
teamoncology,6/1/2014 9:22,0,0,"With positive SOFT/TEXT study, you wonder what if this positive result is because of tamoxifen CYP2D6 mutation has any impact. # ASCO14",,,#,4.73092E+17,https://twitter.com/teamoncology/status/473092224444399617,,,,
CancerTherAdvsr,6/1/2014 9:22,1,0,Sweeney: CHAARTED designed to assess benefit of upfront chemohormonal therapy for metastatic # prostatecancer # ASCO14,,,# #,4.73092E+17,https://twitter.com/CancerTherAdvsr/status/473092209600778242,,,,
subatomicdoc,6/1/2014 9:22,2,1,Radiation +PCV chemo for low grade glioma http://abstracts.asco.org/144/AbstView_144_127483.html … > @ NRGOnc @ eaonc @ SWOG @ ALLIANCE_org # btsm # ASCO14 # hcsm,,@ @ @ @,# # #,4.73092E+17,https://twitter.com/subatomicdoc/status/473092164109746177,,,,
AForman_CGC,6/1/2014 9:22,1,1,My poster at # ASCO14 today! The clinical experience: Hereditary cancer testing by a 25-gene panel. @ myriadgeneticshttp://bit.ly/1qFsz5H,,@,#,4.73092E+17,https://twitter.com/AForman_CGC/status/473092150201425920,,,,
PhRMA,6/1/2014 9:22,4,2,"# Innovative meds reduce costs like hospital, dr visits. More from @ Celgene: http://bit.ly/1ku6YbS # ASCO14",,@,# #,4.73092E+17,https://twitter.com/PhRMA/status/473092122359246849,,,,
mtmdphd,6/1/2014 9:22,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - Another Challenge: Heterogeneity pic.twitter.com/3dwdZeVKGx,,,# #,4.73092E+17,https://twitter.com/mtmdphd/status/473092119276838912,,,,
ASCO,6/1/2014 9:21,5,5,"Plenary brief # ASCO14: Adding docetaxel to std hormone therapy provides substantial survival benefit, ~13 mos – Dr Sweeney # pcsm",,,# #,4.73092E+17,https://twitter.com/ASCO/status/473092091875426304,,,,
teamoncology,6/1/2014 9:21,0,0,"【 # ASCO14 Update】In premenopausal HR+ breast CA, adj exemestane+ovarian function suppression (OFS) reduced the recurrence vs tamoxifen+ OFS.",,,#,4.73092E+17,https://twitter.com/teamoncology/status/473092066038140928,,,,
HenryJOncology,6/1/2014 9:21,0,0,"# sarcoma bevacizumab does not augment wPac for angiosarc? Small trial, but randomised. Great job by the French Sarcoma Group! # ASCO14",,,# #,4.73092E+17,https://twitter.com/HenryJOncology/status/473092007221415936,,,,
EthanBasch1,6/1/2014 9:21,1,0,"Prostate cancer: enzalutamide and abiraterone combination well tolerated, responses potentially predictable. # ASCO14 http://tinyurl.com/o2t6sst",,,#,4.73092E+17,https://twitter.com/EthanBasch1/status/473091952812888065,,,,
teamoncology,6/1/2014 9:21,5,3,【 # ASCO14 Update】 the abstract of the benefit of aromatase inhibitor plus ovarian function suppression. http://abstracts.asco.org/144/AbstView_144_129398.html …,,,#,4.73092E+17,https://twitter.com/teamoncology/status/473091943417659393,,,,
JacobPlieth,6/1/2014 9:21,1,0,"Dr Sweeney, presenting fed-funded CHAARTED study, says it's difficult for industry to support trials that go on for 5yrs+ # ASCO14",,,#,4.73092E+17,https://twitter.com/JacobPlieth/status/473091899105230848,,,,
ASCO,6/1/2014 9:21,1,2,Plenary briefing # ASCO14: Study evaluates hormone therapy w/ or w/o chemo for men w/ newly-diagnosed met. prostate cancer. # pcsm,,,# #,4.73092E+17,https://twitter.com/ASCO/status/473091892469858304,,,,
ConsanoScott,6/1/2014 9:21,0,0,Another beautiful day in Chicago at # ASCO14. pic.twitter.com/Z3MMiYqQgX,,,#,4.73092E+17,https://twitter.com/ConsanoScott/status/473091856684032000,,,,
mtmdphd,6/1/2014 9:20,0,0,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - Van Allen CA Disc 2014; Shi CA Disc 2014 ref'd,,,# #,4.73092E+17,https://twitter.com/mtmdphd/status/473091715977732096,,,,
wallyjc,6/1/2014 9:20,1,2,"Great talk by Jan Buckner on RTOG 9802, a practice-changing phase III trial for adults with low grade glioma! # ASCO14 @ WinshipAtEmory",,@,#,4.73092E+17,https://twitter.com/wallyjc/status/473091649951002625,,,,
SitemanCenter,6/1/2014 9:20,2,0,# ASCO14 Postoperative radiotherapy for pathologic N2 non-small cell lung cancer treated w/adjuvant chemotherapy: http://goo.gl/dl1hGB,,,#,4.73092E+17,https://twitter.com/SitemanCenter/status/473091634226544640,,,,
CancerDotNet,6/1/2014 9:20,4,1,# ASCO14 pt summary on exemestane w/ovarian funct suppression as hormone thpy for early br ca # bcsm http://bit.ly/1rxP39e,,,# #,4.73092E+17,https://twitter.com/CancerDotNet/status/473091630611038209,,,,
WinshipAtEmory,6/1/2014 9:20,1,0,"Abstract: Olatunji Alese, MD on Mortality from malignant bowel obstruction in hospitalized cancer patients: http://ow.ly/xsWlh # ASCO14",,,#,4.73092E+17,https://twitter.com/WinshipAtEmory/status/473091621282914304,,,,
myPathMelanoma,6/1/2014 9:20,0,0,Sign up today to receive educational information regarding Myriad myPath # Melanoma! http://bit.ly/myPathinfo # ASCO14,,,# #,4.73092E+17,https://twitter.com/myPathMelanoma/status/473091597299490816,,,,
mtmdphd,6/1/2014 9:19,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - Global Assessment of Res to BRAFi pic.twitter.com/TkXwABdh16,,,# #,4.73092E+17,https://twitter.com/mtmdphd/status/473091552269852672,,,,
m_e_nielsen,6/1/2014 9:19,5,1,# asco14 Early Palliative Care=good http://ow.ly/xurcZ ?more opportunities even *earlier*? eg prior to major surg onc proc? cc @ fischmd,,@,#,4.73092E+17,https://twitter.com/m_e_nielsen/status/473091551493890048,,,,
StefanoLuminari,6/1/2014 9:19,2,0,"# ASCO14 LYM3002 PhIII trial. VR-CAP with more thrombocytopenias, neutropenia and infections; 7.5% g3-4 neuropathies higher than R-CHOP",,,#,4.73091E+17,https://twitter.com/StefanoLuminari/status/473091496975933441,,,,
djsampson,6/1/2014 9:19,0,0,"G Colditz: when people benefit from prevention, they don't realize it # asco14",,,#,4.73091E+17,https://twitter.com/djsampson/status/473091435349032961,,,,
mlazqui,6/1/2014 9:19,0,0,Splice variant AR # ASCO14 http://tinyurl.com/k89l9wf pic.twitter.com/Rn4n8n8gdk,,,#,4.73091E+17,https://twitter.com/mlazqui/status/473091370731978752,,,,
mtmdphd,6/1/2014 9:19,0,0,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - rationale for combo MAPK pathway inhibition,,,# #,4.73091E+17,https://twitter.com/mtmdphd/status/473091369180078080,,,,
ASCO,6/1/2014 9:18,5,3,"Plenary brief # ASCO14: Exemestane+OFS sig. reduced risk of recurrence, results confirm tx as valid alternative to tamoxifen - Dr Pagani",,,#,4.73091E+17,https://twitter.com/ASCO/status/473091325328625664,,,,
OncologyTimes,6/1/2014 9:18,13,2,. @ CliffordHudis: Big drop in federally funded study abstracts submitted to @ ASCO ann mtgs - in 2008: 575 abstracts vs 169 this yr # ASCO14,,@ @,#,4.73091E+17,https://twitter.com/OncologyTimes/status/473091158416302080,,,,
sonialf,6/1/2014 9:18,1,0,what's new in # palliative world at # asco14? # hpmglobal,,,# # #,4.73091E+17,https://twitter.com/sonialf/status/473091145052864513,,,,
SiRHaPo,6/1/2014 9:18,0,0,Easy like a # Sundaymorning # goodmorningchicago # asco14 pic.twitter.com/IEbgblxZbd,,,# # #,4.73091E+17,https://twitter.com/SiRHaPo/status/473091123137609729,,,,
mtmdphd,6/1/2014 9:18,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combo Strategies in Melanoma - BRAFi Resist - react MAPK pathway signalling pic.twitter.com/2MTCaKFnp7,,,# #,4.73091E+17,https://twitter.com/mtmdphd/status/473091096474832896,,,,
trinejn,6/1/2014 9:17,0,0,- we're here to make more of these # ASCO2014 pic.twitter.com/HzWTUkTSvZ,,,#,4.73091E+17,https://twitter.com/trinejn/status/473091032884994048,,,,
drcbsteer,6/1/2014 9:17,0,0,# ASCO14 Cavalli Mantle cell - more bone marrow toxicity with bortezomib regimen vs RCHOP no difference in neuropathy,,,#,4.73091E+17,https://twitter.com/drcbsteer/status/473090933102510080,,,,
CancerTherAdvsr,6/1/2014 9:17,0,0,Sweeney: Known since 1950s that testosterone has been effective therapy for # prostatecancer # ASCO14,,,# #,4.73091E+17,https://twitter.com/CancerTherAdvsr/status/473090927058493440,,,,
jalopezg70,6/1/2014 9:17,1,0,# ASCO14 http://tinyurl.com/nrju2pk Great presrntation of Dr. Javier Martin from # GEIS of the results of the traslational study of GEIS-20.,,,# #,4.73091E+17,https://twitter.com/jalopezg70/status/473090904513732609,,,,
wallyjc,6/1/2014 9:17,0,0,Welcome to 3 outstanding physicians who will join Winship Cancer Institute faculty in 2014 & 2015! # ASCO14 pic.twitter.com/N6foGfAaLR,,,#,4.73091E+17,https://twitter.com/wallyjc/status/473090896062193664,,,,
mtmdphd,6/1/2014 9:16,1,1,Davies - # melsm # ASCO14 - Molec Basis for Combinatorial Strategies in Melanoma - BRAFi limited by transient responses - 5-6mo,,,# #,4.73091E+17,https://twitter.com/mtmdphd/status/473090808480931840,,,,
ASCO,6/1/2014 9:16,1,1,"Plenary press briefing # ASCO14: “This study answers a long-awaited question, with seeds more than a century ago” - @ CliffordHudis",,@,#,4.73091E+17,https://twitter.com/ASCO/status/473090729385136129,,,,
mtmdphd,6/1/2014 9:16,2,0,Davies - # melsm # ASCO14 - Molec Basis for Combinatorial Strategies in Melanoma - single agent BRAFi pic.twitter.com/vBqMX7YnSj,,,# #,4.73091E+17,https://twitter.com/mtmdphd/status/473090711953223681,,,,
FierceBiotech,6/1/2014 9:16,3,1,Follow # FierceASCO today at 2:30 ET for an # ASCO14 chat with @DamianFierce and @ MarkSchoenebaum. More here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …,,@DamianFierce @,# #,4.73091E+17,https://twitter.com/FierceBiotech/status/473090656764981248,,,,
StefanoLuminari,6/1/2014 9:16,1,1,# ASCO14 LYM3002 PhIII trial. median OS not reached with VR-CAP vs 56 months in R-CHOP. HR 0.80 (0.59 - 1.1) not enough events.,,,#,4.73091E+17,https://twitter.com/StefanoLuminari/status/473090642487160832,,,,
ASCO,6/1/2014 9:16,0,4,Plenary press briefing # ASCO14: Dr. Sweeney presents results of phase III E3805 prostate cancer study. # pcsm,,,# #,4.73091E+17,https://twitter.com/ASCO/status/473090597558177792,,,,
mtmdphd,6/1/2014 9:15,0,1,Davies - # melsm # ASCO14 - Molec Basis for Combinatorial Strategies in Melanoma - Landscape of Driver Mutations pic.twitter.com/ZDITQFlqvt,,,# #,4.7309E+17,https://twitter.com/mtmdphd/status/473090476355371009,,,,
CancerTherAdvsr,6/1/2014 9:15,0,0,"Christopher Sweeney, MBBS, now about to discuss CHAARTED study during # ASCO14 press conference",,,#,4.7309E+17,https://twitter.com/CancerTherAdvsr/status/473090473259986944,,,,
AnneBooms,6/1/2014 9:15,0,0,# ASCO14 Smith on cancer screening http://jama.jamanetwork.com/article.aspx?articleid=197942 …,,,#,4.7309E+17,https://twitter.com/AnneBooms/status/473090435498659841,,,,
WinshipAtEmory,6/1/2014 9:15,2,1,Abstract: Phenformin combines w/selumetinib in targeting KRAS mutant NSCLC cells w/alternative LKB1 status: http://ow.ly/xsWfw # ASCO14,,,#,4.7309E+17,https://twitter.com/WinshipAtEmory/status/473090403647127552,,,,
ASCO,6/1/2014 9:15,10,11,Advice on oncologist/pathologist communication re: molecular testing at session today http://bit.ly/1po4Rt9 # ASCO14,,,#,4.7309E+17,https://twitter.com/ASCO/status/473090390514761728,,,,
djsampson,6/1/2014 9:15,0,0,"G Colditz barriers include fights among scientists, skepticism that breast ca can be prevented # asco14",,,#,4.7309E+17,https://twitter.com/djsampson/status/473090360487313408,,,,
OncologyTimes,6/1/2014 9:15,2,2,". @ CliffordHudis: With less fed $$, who is going to launch & complete these kinds of imp l-t clin studies like the plenary studies? # ASCO14",,@,#,4.7309E+17,https://twitter.com/OncologyTimes/status/473090354800263168,,,,
teamoncology,6/1/2014 9:14,0,0,Participating # ASCO14 while I take my dog for a walk. Power of social media. :) http://moby.to/dj3tsa,,,#,4.7309E+17,https://twitter.com/teamoncology/status/473090329378189312,,,,
drcbsteer,6/1/2014 9:14,0,0,# ASCO14 Cavalli Mantle cell. PFS 24 vs 14 months with VR-CAP (V=bortezomib) HR 0.63 # lymsm,,,# #,4.7309E+17,https://twitter.com/drcbsteer/status/473090312005750784,,,,
MaverickNY,6/1/2014 9:13,0,0,@ aftimosp not sure if it's novel as following vismodegib. More of a me-too? # asco14,,@,#,4.7309E+17,https://twitter.com/MaverickNY/status/473090055305969664,,,,
mtmdphd,6/1/2014 9:13,0,1,"MT @ OncologyTimes: . @ CliffordHudis: Restructured clinical trials system is streamlined, but also smaller. # ASCO14",,@ @,#,4.7309E+17,https://twitter.com/mtmdphd/status/473090029129318400,,,,
djsampson,6/1/2014 9:13,1,0,"G Colditz: we have prevention strategies for other top cancers for women (lung, colon) but not breast # asco14",,,#,4.7309E+17,https://twitter.com/djsampson/status/473090006446125056,,,,
CancerTherAdvsr,6/1/2014 9:13,0,0,"Pagani: Findings indicate exemestane is better than tamoxifen when given w/ovarian function suppression, but longer follow-up needed # ASCO14",,,#,4.7309E+17,https://twitter.com/CancerTherAdvsr/status/473089924305268736,,,,
AlpineBV_Miller,6/1/2014 9:12,0,0,Main takeaway from enza+abi combo is don't get chemo first. Complicates the chemohormonal data coming later # ASCO14,,,#,4.7309E+17,https://twitter.com/AlpineBV_Miller/status/473089819980365824,,,,
StefanoLuminari,6/1/2014 9:12,1,0,Cavalli on LYM3002 PhIII trial R-CHOP vs VR-CAP (bortezomib) in MCL. N=486 med. pfs improved from 14.4 to 24.7 with bortez. HR 0.63 # asco14,,,#,4.7309E+17,https://twitter.com/StefanoLuminari/status/473089768520052736,,,,
aftimosp,6/1/2014 9:12,0,0,Sonidegib: 2 cardiac deaths at 800 mg versus 0 at 200 mg. comparable activity at 2 doses # ASCO14,,,#,4.7309E+17,https://twitter.com/aftimosp/status/473089751772565504,,,,
mtmdphd,6/1/2014 9:12,2,1,"Migden - BOLT - sonidegib BCC # ASCO14 - Summary - pos benefit-risk profile, more favorable safety 200 mg dose pic.twitter.com/POGjejRGYx",,,#,4.7309E+17,https://twitter.com/mtmdphd/status/473089686370787328,,,,
markaorourke,6/1/2014 9:12,1,1,"# ASCO14 Neuroendocrine cancer intermediate risk is mitosis per hpf 2 to 20, need tri-phasic imaging, need to review path grade. # hbcsm",,,# #,4.7309E+17,https://twitter.com/markaorourke/status/473089651394482176,,,,
mjsanchezperez,6/1/2014 9:12,0,1,“ @ theNCI: New treatment option for young women with hormone-sensitive breast cancer http://1.usa.gov/1px1Jey # exemestane # ASCO14 # BCSM”,,@,# # #,4.7309E+17,https://twitter.com/mjsanchezperez/status/473089608402878464,,,,
ASCO,6/1/2014 9:11,12,8,"Plenary brief # ASCO14: Adjuvant exemestane, when given w/ ovarian function suppression, was more effective than tamoxifen – Dr Pagani",,,#,4.7309E+17,https://twitter.com/ASCO/status/473089547853901824,,,,
TuftsB,6/1/2014 9:11,0,0,ASCO cost and care restrictions will be unqualified limit on patient & doctor choice.and pro Q A L Y # mliwi # ASCO14,,,# #,4.73089E+17,https://twitter.com/TuftsB/status/473089433177436160,,,,
mtmdphd,6/1/2014 9:11,2,1,Migden - BOLT - sonidegib BCC # ASCO14 - Serious AE and On-Tx Deaths pic.twitter.com/aHi8zsHOSv,,,#,4.73089E+17,https://twitter.com/mtmdphd/status/473089384963923968,,,,
ASCO,6/1/2014 9:10,4,4,# ASCO14 Plenary brief: Study evaluated premenopausal women w/ hormone-sensitive breast cancers: 5 yrs of tamoxifen is std care,,,#,4.73089E+17,https://twitter.com/ASCO/status/473089314440900608,,,,
bio_clouseau,6/1/2014 9:10,0,0,Early Chemotherapy Extends Lives of Men With Prostate Cancer via @nytimeshealth http://www.nytimes.com/2014/06/02/health/early-chemotherapy-extends-lives-of-men-with-prostate-cancer-study-finds.html … # ASCO14,,@nytimeshealth,#,4.73089E+17,https://twitter.com/bio_clouseau/status/473089308661141504,,,,
drcbsteer,6/1/2014 9:10,0,0,# ASCO14 Cavalli - Bortezomib replaced the vincristine in RCHOP. Called VR-CAP n= 487 median age 66,,,#,4.73089E+17,https://twitter.com/drcbsteer/status/473089271147266048,,,,
aftimosp,6/1/2014 9:10,0,0,Sonidegib is a novel Hedgehog pathway inh with promising activity in basal cell carcinoma (locally advanced and metastatic) # ASCO14,,,#,4.73089E+17,https://twitter.com/aftimosp/status/473089252788809729,,,,
CancerTherAdvsr,6/1/2014 9:10,0,0,Pagani: TEXT and SOFT compared exemestane w/ovarian function suppression to tamoxifen in women with hormone-sensitive cancers # ASCO14,,,#,4.73089E+17,https://twitter.com/CancerTherAdvsr/status/473089250289016832,,,,
dmooneymd,6/1/2014 9:10,0,0,Domchek: qol after bso for brca pts. Sign quality of life issues premenopausal. Sexual function and vasomotor as better w hrt. # ASCO14,,,#,4.73089E+17,https://twitter.com/dmooneymd/status/473089240893362176,,,,
mtmdphd,6/1/2014 9:10,0,0,Migden - BOLT - sonidegib BCC # ASCO14 - AEs pic.twitter.com/1USW68aIz3,,,#,4.73089E+17,https://twitter.com/mtmdphd/status/473089220182306817,,,,
ASCO,6/1/2014 9:10,1,3,"Plenary brief # ASCO14: First up, Dr. Pagani to discuss joint analysis of TEXT and SOFT phase III trials. # bcsm",,,# #,4.73089E+17,https://twitter.com/ASCO/status/473089207985262592,,,,
OncologyTimes,6/1/2014 9:10,2,0,". @ CliffordHudis: All 4 plenary studies federally funding, but launched yrs ago, B4 current smaller clin trials system # ASCO14",,@,#,4.73089E+17,https://twitter.com/OncologyTimes/status/473089189198970880,,,,
NEJMGroup,6/1/2014 9:10,3,0,"PREVAIL: Enzalutamide improves progression-free, overall survival in chemo-naïve prostate cancer. # ASCO14 http://nej.md/1ioUi1d",,,#,4.73089E+17,https://twitter.com/NEJMGroup/status/473089148400975873,,,,
ProjectInno,6/1/2014 9:10,1,0,Only continued investment in innovation can ensure future cancer treatment breakthroughs http://ow.ly/xrNZ8 # ASCO14,,,#,4.73089E+17,https://twitter.com/ProjectInno/status/473089144445739008,,,,
Roche,6/1/2014 9:10,8,5,What goes into the design of a clinical study? http://ow.ly/xoSyD # ASCO14 # drugdevelopment,,,# #,4.73089E+17,https://twitter.com/Roche/status/473089118902419456,,,,
WinshipAtEmory,6/1/2014 9:10,0,0,"Abstract: Taofeek Owonikoko, MD on phase 1 multicenter study of BMS-936561 (MDX-1203) in ccRCC and B-NHL: http://ow.ly/xsW9G # ASCO14",,,#,4.73089E+17,https://twitter.com/WinshipAtEmory/status/473089110027280384,,,,
LGG1,6/1/2014 9:10,1,0,CRC Screening Rates Improved Among Black Patients # ASCO14 http://am.asco.org/crc-screening-rates-improved-among-black-patients#.U4sl3YGxOTg.twitter …,,,# #,4.73089E+17,https://twitter.com/LGG1/status/473089076761858048,,,,
mtmdphd,6/1/2014 9:09,0,0,Migden - BOLT - sonidegib BCC # ASCO14 - Additional Efficacy Outcomes pic.twitter.com/NNOWWOI5r8,,,#,4.73089E+17,https://twitter.com/mtmdphd/status/473088976379973632,,,,
DoctorEdny,6/1/2014 9:09,0,0,Data presentations sparser than your usual # ASCO14 Sunday,,,#,4.73089E+17,https://twitter.com/DoctorEdny/status/473088971732692992,,,,
Oncoinfo_it,6/1/2014 9:09,0,0,@ CliffordHudis: Quattro studi aprono oggi nuove vie nella terapia di prostata," mammella e colon-retto"". # ASCO2014 pic.twitter.com/MFrm1n9Gkq""",,@,#,4.73089E+17,https://twitter.com/Oncoinfo_it/status/473088969341939712,,,
djsampson,6/1/2014 9:09,0,0,G Colditz: pop over 65 expected to reach 20% by 2050. Risk and opportunity to prevent cx # asco14,,,#,4.73089E+17,https://twitter.com/djsampson/status/473088961116516352,,,,
JacobPlieth,6/1/2014 9:09,0,0,"All 4 plenary abstracts received federal funding (blue badge), says Clifford Hudis # ASCO14",,,#,4.73089E+17,https://twitter.com/JacobPlieth/status/473088839842824192,,,,
SanofiUS,6/1/2014 9:08,0,0,RT @ ASCO: Plenary press briefing # ASCO14: our President @ CliffordHudis moderating http://bit.ly/1pJ7va1,,@ @,#,4.73089E+17,https://twitter.com/SanofiUS/status/473088809387560960,,,,
dmooneymd,6/1/2014 9:08,1,1,Metcalfe: oophorectomy in brca carriers. Hr for brca1 breast cancer specific mortality 0.34. All cause mortality also better. # bcsm # ASCO14,,,# #,4.73089E+17,https://twitter.com/dmooneymd/status/473088772708368385,,,,
raphael_ortiz,6/1/2014 9:08,1,1,Navigatiing treatment options in advanced # neuroendocrine tumors ticketed session starting now at # ASCO2014 # NETCANC…http://lnkd.in/dN6wAsB,,,# # #,4.73089E+17,https://twitter.com/raphael_ortiz/status/473088771546550273,,,,
mtmdphd,6/1/2014 9:08,1,1,Migden - BOLT - sonidegib BCC # ASCO14 - Waterfall Plots pic.twitter.com/VK6NpH10Ax,,,#,4.73089E+17,https://twitter.com/mtmdphd/status/473088685488242688,,,,
mtmdphd,6/1/2014 9:07,0,1,Migden - BOLT - sonidegib BCC # ASCO14 - ORR mBCC pic.twitter.com/hLrrXHnhL4,,,#,4.73089E+17,https://twitter.com/mtmdphd/status/473088532723269632,,,,
nxtstop1,6/1/2014 9:07,0,1,LETS TALK @IT. @ ArmstrongDrew:Half billboards in Chicago R4 cancer drug ads # ASCO14. Dallas w/nada. 4 heart meeting. Tells where $$$ R ....,,@IT @,#,4.73088E+17,https://twitter.com/nxtstop1/status/473088497780133889,,,,
JacobPlieth,6/1/2014 9:07,1,0,"Clifford Hudis highlighting federally funded studies (CALGB, ALTTO etc) that industry isn't particularly interested in funding # ASCO14",,,#,4.73088E+17,https://twitter.com/JacobPlieth/status/473088484241313793,,,,
markaorourke,6/1/2014 9:07,0,0,# ASCO14 Increasing incidence of neuroendocrine tumors do to incidental findings and use of EUS. # hpcsm,,,# #,4.73088E+17,https://twitter.com/markaorourke/status/473088458253418496,,,,
drcbsteer,6/1/2014 9:07,0,0,# ASCO14 Kickoff for day3 - Lymphoma oral presentations. #1 RCHOP vs bortezomib-containing regimen in mantle cell NHL - Cavalli,,,# #1,4.73088E+17,https://twitter.com/drcbsteer/status/473088439643308033,,,,
ASCO,6/1/2014 9:07,4,2,Plenary press briefing # ASCO14: our President @ CliffordHudis moderatingpic.twitter.com/qFjSjYMs7T,,@,#,4.73088E+17,https://twitter.com/ASCO/status/473088414288318465,,,,
mtmdphd,6/1/2014 9:07,0,1,Migden - BOLT - sonidegib BCC # ASCO14 - ORR LaBCC pic.twitter.com/ongayXPZC7,,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088371922067456,,,,
SeattleGenetics,6/1/2014 9:06,0,1,$ SGEN data from antibody-drug conjugate (ADC) SGN-CD19A phase 1 NHL clinical trial presented at # ASCO14 http://ow.ly/xuqEd,,,#,4.73088E+17,https://twitter.com/SeattleGenetics/status/473088282536853504,,,,
CancerTherAdvsr,6/1/2014 9:06,0,0,"Olivia Pagani, MD, to present on the joint analysis of BCSG TEXT and SOFT trials # breastcancer # ASCO14",,,# #,4.73088E+17,https://twitter.com/CancerTherAdvsr/status/473088240061530112,,,,
KP_SEDE,6/1/2014 9:06,0,0,Las pacientes con cáncer de mama y obesidad tienen beneficios a largo plazo ejercitandose para bajar de peso. # ASCO14,,,#,4.73088E+17,https://twitter.com/KP_SEDE/status/473088194083573760,,,,
mtmdphd,6/1/2014 9:06,0,1,Migden - BOLT - sonidegib BCC - # ASCO14 - Background pic.twitter.com/6u6blOso7Z,,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088092354510848,,,,
dmooneymd,6/1/2014 9:06,1,0,"Shape 2 trial: compared with diet, equivalent weight loss by exercise has more benefits with fitness and lean body mass. # ASCO14",,,#,4.73088E+17,https://twitter.com/dmooneymd/status/473088089582100480,,,,
ASCO,6/1/2014 9:06,0,1,Plenary brief # ASCO14: “These results answer critical questions that people w/ cancer & their doctors face every day” -- @ CliffordHudis,,@,#,4.73088E+17,https://twitter.com/ASCO/status/473088084561920001,,,,
mtmdphd,6/1/2014 9:06,0,0,# ASCO14 MiFi interferes with ASCO / MCC WiFi,,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088084460855296,,,,
mtmdphd,6/1/2014 9:06,3,1,"Love the Join the Conversation!"" display at sessions for # ASCO14 pic.twitter.com/AB34am2pFt""",,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088084439875584,,,,
mtmdphd,6/1/2014 9:05,0,1,Migden - BOLT - sonidegib BCC # ASCO14 - Endpoints and discussion of modified RECIST pic.twitter.com/IgQUCOKBTh,,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088049421643776,,,,
CancerTherAdvsr,6/1/2014 9:05,0,0,Hudis emphasizing importance of federal funding to support studies during press conference on today's plenary session at # ASCO14,,,#,4.73088E+17,https://twitter.com/CancerTherAdvsr/status/473088041922609152,,,,
mtmdphd,6/1/2014 9:05,0,1,Migden - BOLT - sonidegib BCC # ASCO14 - Stringent Response Criteria for ORR pic.twitter.com/nJmrlHGnoU,,,#,4.73088E+17,https://twitter.com/mtmdphd/status/473088025056907264,,,,
rsm2800,6/1/2014 9:05,1,1,"So key RT @ cure_magazine: Hudis: All plenary studies presented today received federal funding, critically important point. # asco14",,@,#,4.73088E+17,https://twitter.com/rsm2800/status/473087981251985408,,,,
Pharmacyclics,6/1/2014 9:05,0,0,Learn about our new findings in b-cell malignancies at # ASCO14 http://bit.ly/1p6oHGj,,,#,4.73088E+17,https://twitter.com/Pharmacyclics/status/473087874653356034,,,,
SitemanCenter,6/1/2014 9:05,0,0,# ASCO14 Phase 1 study supports further investigation of MLN8237 combined w/nab-paclitaxel in patients w/solid tumors http://goo.gl/lvp5XN,,,#,4.73088E+17,https://twitter.com/SitemanCenter/status/473087872757936128,,,,
Amgen,6/1/2014 9:05,0,0,# Amgen data examines how neutropenic complications in # cancer pts may affect (neo)adjuvant # chemo delivery @8:00 AM CDT/S Hall A2 # ASCO14,,@8,# # # #,4.73088E+17,https://twitter.com/Amgen/status/473087869163433985,,,,
WinshipAtEmory,6/1/2014 9:05,0,0,"Abstract: Taofeek Owonikoko, MD on study of veliparib in combo w/cisplatin and etoposide in SCLC patients: http://ow.ly/xsW0N # ASCO14",,,#,4.73088E+17,https://twitter.com/WinshipAtEmory/status/473087869012443136,,,,
genentech,6/1/2014 9:05,13,3,Today is National Cancer Survivor Day. How do you think # survivorship definition will change in # Next50 yrs? # ASCO14 # NCSD,,,# # # #,4.73088E+17,https://twitter.com/genentech/status/473087851379580929,,,,
TakedaOncology,6/1/2014 9:05,1,0,"Phase 3 international, randomized study of patients with previously untreated mantle cell # lymsm presented at # ASCO14 http://ow.ly/xuqfJ",,,# #,4.73088E+17,https://twitter.com/TakedaOncology/status/473087847361425408,,,,
ASCO,6/1/2014 9:05,0,1,Plenary press briefing # ASCO14: our President @ CliffordHudis moderating,,@,#,4.73088E+17,https://twitter.com/ASCO/status/473087839702622208,,,,
nxtstop1,6/1/2014 9:04,0,0,FASHION STYLE & COMFORT!@DanBudwick: The funky-colored button down seems to have replaced the tie at # ASCO14,,@DanBudwick,#,4.73088E+17,https://twitter.com/nxtstop1/status/473087798832930820,,,,
teamoncology,6/1/2014 9:04,2,0,"【ALTTO study】HR for DFS was 0.84 (97.5% CI, 0.70-1.02; P=0.048; 4-yr DFS%=88% vs. 86%) for L+T vs. T. # ASCO14",,,#,4.73088E+17,https://twitter.com/teamoncology/status/473087792700866560,,,,
ShabbirHossain,6/1/2014 9:04,0,0,@ ArmstrongDrew also noticed much of the twitter feed for # asco14 is # pharma stuff.,,@,# #,4.73088E+17,https://twitter.com/ShabbirHossain/status/473087643774119936,,,,
dmooneymd,6/1/2014 9:03,0,0,Chlebowski: hormone therapy risk not affected by obesity or ethnicity. E+p increases risk...maybe e alone better. # bcsm # ASCO14,,,# #,4.73088E+17,https://twitter.com/dmooneymd/status/473087515222487040,,,,
CancerTherAdvsr,6/1/2014 9:03,0,1,Press conference at # ASCO14 begins @ChemoAdvisor Ed Board member @ EdithPerezMD looks ready to speak! # CTAatASCOpic.twitter.com/4pCLxD41ZG,,@ChemoAdvisor @,# #,4.73087E+17,https://twitter.com/CancerTherAdvsr/status/473087455839940608,,,,
cure_magazine,6/1/2014 9:03,1,2,"Hudis: All plenary studies presented today received federal funding, critically important point. # asco14 # cancerresearch",,,# #,4.73087E+17,https://twitter.com/cure_magazine/status/473087449376108544,,,,
BairdAM,6/1/2014 9:03,0,0,# lcsm MT  @ n8pennell: Another driver oncogene in NSCLC, HER2 mutations," in 2.6% of adeno in LCMC # ASCO14 pic.twitter.com/UqKnYoan67""""",,@,# #,4.73087E+17,https://twitter.com/BairdAM/status/473087427221794817,,
DanBudwick,6/1/2014 9:03,1,0,The funky-colored button down seems to have replaced the tie at # ASCO14,,,#,4.73087E+17,https://twitter.com/DanBudwick/status/473087381118394368,,,,
PhRMA,6/1/2014 9:03,1,0,"# Patients pay up to 40% out of pocket for meds, which overlooks inherent value they provide says Castellani http://bit.ly/1nDaGmT # ASCO14",,,# #,4.73087E+17,https://twitter.com/PhRMA/status/473087355230752768,,,,
JacobPlieth,6/1/2014 9:02,0,0,No diff between Avastin and Erbitux in mOS or mPFS in CALGB mCRC study in KRAS wild types # ASCO14 $ LLY $ RHHBY,,,#,4.73087E+17,https://twitter.com/JacobPlieth/status/473087180882313216,,,,
dmooneymd,6/1/2014 9:01,0,1,"Cancer prev with Dr. Weitzel. Risks related to # bcsm is a mosaic. Focus on obesity, lack of exercise and hormonal therapy. # ASCO14",,,# #,4.73087E+17,https://twitter.com/dmooneymd/status/473087061977595904,,,,
krnmsw,6/1/2014 9:01,0,0,@ ASCO: Congratulations to Providence Portland Med Center on their Clinical Trials Participation Award @ ProvHealth # cancer # qualitycancercare,,@ @,# #,4.73087E+17,https://twitter.com/krnmsw/status/473087042273181696,,,,
SJNaggiar,6/1/2014 9:01,0,0,Day 3... Sunday morning # ASCO2014 press briefing pic.twitter.com/oDkk1umTxq,,,#,4.73087E+17,https://twitter.com/SJNaggiar/status/473086954058170368,,,,
Amgen,6/1/2014 9:01,0,0,# Amgen to compare HCP-assessed risk vs prediction-model risk of febrile or severe # neutropenia in pts with nonmyeloid malignancies # ASCO14,,,# # #,4.73087E+17,https://twitter.com/Amgen/status/473086916888653824,,,,
SequentaInc,6/1/2014 9:01,0,0,"Noninvasive monitoring of cellular vs. acellular tumor DNA from Ig genes for # DLBCL (9am CT, E Hall D2) http://ow.ly/xmamQ # ASCO14",,,# #,4.73087E+17,https://twitter.com/SequentaInc/status/473086886903545856,,,,
corp_UNC,6/1/2014 9:00,3,2,Underutiliz'n of OT & PT for older adults with cancer @mpergolotti et al @ UNC_Lineberger # ASCO14 http://ow.ly/xpjqs,,@mpergolotti @,#,4.73087E+17,https://twitter.com/corp_UNC/status/473086764790611970,,,,
WinshipAtEmory,6/1/2014 9:00,1,2,"Abstract: Rathi Pillai, MD on Second primary lung cancers: Analysis of E5597 selenium chemoprevention study: http://ow.ly/xsVSt # ASCO14",,,#,4.73087E+17,https://twitter.com/WinshipAtEmory/status/473086753520492544,,,,
BayerPharma,6/1/2014 9:00,4,0,Phase 1-2 pipeline Bayer presentations available at # ASCO14. Learn more about # oncology research at Bayer HealthCare http://bit.ly/Rv3Phd,,,# #,4.73087E+17,https://twitter.com/BayerPharma/status/473086742527221760,,,,
ASCO,6/1/2014 9:00,2,4,"Discuss 'Quality & Value in Gynecologic Cancer Care' at today's Education Session, (9:45-11AM, E354) http://bit.ly/1mLbSRy # ASCO14",,,#,4.73087E+17,https://twitter.com/ASCO/status/473086718502248448,,,,
CancerMedMDA,6/1/2014 9:00,2,2,Learn more about the role of chemotherapy in penile cancer management. Dr. Lance Pagliaro presents Sun. 11:30 # ASCO14. # endcancer,,,# #,4.73087E+17,https://twitter.com/CancerMedMDA/status/473086699267174400,,,,
theNCI,6/1/2014 9:00,14,11,New treatment option for young women with hormone-sensitive breast cancer http://1.usa.gov/1px1Jey # exemestane # ASCO14 # BCSM,,,# # #,4.73087E+17,https://twitter.com/theNCI/status/473086594883522560,,,,
NCIMedia,6/1/2014 9:00,5,2,Making your schedule at # ASCO14? Here's a list of sessions featuring NCI staff that will take place today: http://1.usa.gov/1wMQ5hJ,,,#,4.73087E+17,https://twitter.com/NCIMedia/status/473086584305483776,,,,
myriadgenetics,6/1/2014 9:00,1,2,"Attending # ASCO14? Check out Myriad Posters 1542, 1553, 1548 & 1541 TODAY at 8-11:45am in S Hall A! # hereditarycancerhttp://bit.ly/1qFsz5H",,,# #,4.73087E+17,https://twitter.com/myriadgenetics/status/473086577048969217,,,,
FoundationATCG,6/1/2014 9:00,2,3,"# Nextgensequencing is a technology, not a test. Learn more about the diff btwn hot spot"" & # FoundationOne: http://bit.ly/1hIAUfC # ASCO14""",,,# # #,4.73087E+17,https://twitter.com/FoundationATCG/status/473086572116463617,,,,
teamoncology,6/1/2014 8:59,0,1,【ALTTO study】Here is the final full abstract. http://abstracts.asco.org/144/AbstView_144_128258.html … # ASCO14,,,#,4.73087E+17,https://twitter.com/teamoncology/status/473086525157019648,,,,
dmooneymd,6/1/2014 8:59,0,0,Okamoto et al: carbo/taxol equiv to cis/iri in clear cell cancer. Toxicity different. # gyncsm # ASCO14,,,# #,4.73087E+17,https://twitter.com/dmooneymd/status/473086507385769984,,,,
ASCO,6/1/2014 8:59,2,3,"Live tweeting plenary brief in two minutes. Advances in breast, prostate, colorectal cancer treatment # ASCO14",,,#,4.73086E+17,https://twitter.com/ASCO/status/473086336866721792,,,,
teamoncology,6/1/2014 8:58,2,2,【 # ASCO14 Update】 ALTTO study shows no benefit of adding lapatinib to adjuvant trastuzumab. http://abstracts.asco.org/144/AbstView_144_128258.html …,,,#,4.73086E+17,https://twitter.com/teamoncology/status/473086289999196161,,,,
DrAttai,6/1/2014 8:58,1,0,Heading back to # ASCO14 LOTS of posters to review this morning,,,#,4.73086E+17,https://twitter.com/DrAttai/status/473086117945036800,,,,
dmooneymd,6/1/2014 8:57,0,0,Gourley et al: molecular subgroup of high grade serous ovarian cancer-reduced os with bevacizumab. # ASCO14 # gyncsm,,,# #,4.73086E+17,https://twitter.com/dmooneymd/status/473085937459552256,,,,
teamoncology,6/1/2014 8:57,0,0,【SOFT/TEXT study】No difference in toxicities rate. Grade 3-4 targeted AEs were reported in 31% E+OFS vs 29% T+OFS patients. # ASCO14,,,#,4.73086E+17,https://twitter.com/teamoncology/status/473085897848528898,,,,
teamoncology,6/1/2014 8:56,0,0,【SOFT/TEXT study】 E+OFS had reduced DFS hazard (HR=0.72; P=0.0002) vs T+OFS; 5y DFS was 91.1% vs 87.3%. # ASCO14 Impressive.,,,#,4.73086E+17,https://twitter.com/teamoncology/status/473085682953359360,,,,
christinemphmd,6/1/2014 8:55,0,0,# ASCO14 :OK to Cut Back on Bone Mets Therapy http://www.medpagetoday.com/HematologyOncology/BreastCancer/46079 …,,,#,4.73085E+17,https://twitter.com/christinemphmd/status/473085421745102848,,,,
Awesomics,6/1/2014 8:55,0,1,Detailed genetic charactzn of 1000 cell lines MT @ DaleYuzuki Cancer Cell Line Encyclopedia at Broad http://www.broadinstitute.org/software/cprg/?q=node/11 … # AACR14 # ASCO14,,@,# #,4.73085E+17,https://twitter.com/Awesomics/status/473085379604926464,,,,
TuftsB,6/1/2014 8:55,0,0,"Per Oscar Wilde, ASCO cost advocates know the price of everything and the value of nothing. Do not ration my cancer care. # mliwi # ASCO14",,,# #,4.73085E+17,https://twitter.com/TuftsB/status/473085358750846976,,,,
mtmdphd,6/1/2014 8:55,0,0,. @ ASCO Social Media Info http://ow.ly/xt4M0 # ASCO14 Tweeps: http://ow.ly/xt4M1 Ten Tips: http://ow.ly/xt4M2,,@,#,4.73085E+17,https://twitter.com/mtmdphd/status/473085317722148866,,,,
SarahCannonDocs,6/1/2014 8:55,1,0,STARTING SOON: Melanoma/Skin Cancer Oral Presentation with # SCRI's Dr. Infante - # ASCO14 E Arie Crown Theater,,,# #,4.73085E+17,https://twitter.com/SarahCannonDocs/status/473085313766920192,,,,
DanielVelaMD,6/1/2014 8:54,0,1,"“@nytimeshealth: Early Chemotherapy Extends Lives of Men With Prostate Cancer, Study Finds http://nyti.ms/1wMMTCG ” # ASCO14",,@nytimeshealth,#,4.73085E+17,https://twitter.com/DanielVelaMD/status/473085259240583168,,,,
teamoncology,6/1/2014 8:54,0,0,"With SOFT/TEXT study positive, you wonder what if this positive result is because of tamoxifen CYP2D6 mutation has any impact. # ASCO14",,,#,4.73085E+17,https://twitter.com/teamoncology/status/473085125844934657,,,,
bmsnews,6/1/2014 8:53,8,4,Ever wonder what a T cell looks like? Check out this 3D image from our # ImmunoOncology booth 7081 # ASCO14 pic.twitter.com/uE2OdLdoCu,,,# #,4.73085E+17,https://twitter.com/bmsnews/status/473084887659184129,,,,
teamoncology,6/1/2014 8:53,0,0,"Also if E3 Study, use of adjuvant aromatase inhibitor with mTOR inhibitor is positive, what will happen in the future. :) # ASCO14",,,#,4.73085E+17,https://twitter.com/teamoncology/status/473084821216833537,,,,
ASCOPost,6/1/2014 8:53,8,4,Anti-PD-L1 immunotherapy drug shrinks tumors in early bladder cancer study (via Chicago Tribune) http://ow.ly/xupPJ # ASCO14,,,#,4.73085E+17,https://twitter.com/ASCOPost/status/473084803760553984,,,,
dmooneymd,6/1/2014 8:52,0,1,"Lurbinectedin: novel transcription targeted tx. Promising pfs and os vs irinotecan, though toxic, in plat res # gyncsm . # ASCO14",,,# #,4.73085E+17,https://twitter.com/dmooneymd/status/473084560662482944,,,,
dhjutsw1,6/1/2014 8:50,15,4,RT: @ CliffordHudis to @ asco members # ASCO14 pic.twitter.com/m3ygpMnnv0”,,@ @,#,4.73084E+17,https://twitter.com/dhjutsw1/status/473084170730610688,,,,
dmooneymd,6/1/2014 8:49,0,0,"New molecular targeted therapy in # gyncsm : Liu et al- rand ph 2 olaparib and cediranib. pfs 17.9 months, esp brca - pts. No chemo! # ASCO14",,,# #,4.73084E+17,https://twitter.com/dmooneymd/status/473084028849901568,,,,
TuftsB,6/1/2014 8:49,3,2,Best treatment for average cancer patient? We are not average & each individual case can & should be addressed differently # mliwi # asco14,,,# #,4.73084E+17,https://twitter.com/TuftsB/status/473083958620856321,,,,
aftimosp,6/1/2014 8:49,0,0,It would be interesting to compare olaparib versis olaparib + cediranib only in patients with gBRCA mutations. Still positive? # ASCO14,,,#,4.73084E+17,https://twitter.com/aftimosp/status/473083902282579969,,,,
teamoncology,6/1/2014 8:49,1,1,【 # ASCO14 Update】 Here is the abstract of the benefit of aromatase inhibitor plus ovarian function suppression. http://abstracts.asco.org/144/AbstView_144_129398.html …,,,#,4.73084E+17,https://twitter.com/teamoncology/status/473083881600458752,,,,
nxtstop1,6/1/2014 8:49,0,0,THE MISSION: @ ProjectInno:Movement 2 accelerate innovation against cancer http://ow.ly/xtyiD # innovatenow # ASCO14 http://ow.ly/i/5KF3I,,@,# #,4.73084E+17,https://twitter.com/nxtstop1/status/473083822481756161,,,,
HemOncToday,6/1/2014 8:48,0,2,# ASCO14 @MayoClinc doc weighs in on novel agent bested # topotecan in platinum-resistant # OvarianCancerhttp://goo.gl/oWKDjU,,@MayoClinc,# # #,4.73084E+17,https://twitter.com/HemOncToday/status/473083771160633345,,,,
GoHealio,6/1/2014 8:48,0,1,# ASCO14 @MayoClinc doc weighs in on novel agent bested # topotecan in platinum-resistant # OvarianCancer http://goo.gl/oWKDjU,,@MayoClinc,# # #,4.73084E+17,https://twitter.com/GoHealio/status/473083770468564992,,,,
teamoncology,6/1/2014 8:47,0,1,"【 # ASCO14 Update】In premenopausal HR+ breast CA, adj exemestane+ovarian function suppression (OFS) reduced the recurrence vs tamoxifen+OFS.",,,#,4.73083E+17,https://twitter.com/teamoncology/status/473083485029031936,,,,
ConquerCancerFd,6/1/2014 8:46,0,0,Breakfast & Estate Planning starting in 15 min - join us in room S403a for this free session: http://bit.ly/1lFwtVc # ASCO14,,,#,4.73083E+17,https://twitter.com/ConquerCancerFd/status/473083075451424769,,,,
oncotuits,6/1/2014 8:45,0,1,Estudio # allto: lapatinib sin beneficio en adyuvancia # cancermama her2+. Herceptin es suficiente. @ eforgach @ robinshawdf # ASCO14,,@ @,# # #,4.73083E+17,https://twitter.com/oncotuits/status/473083032954765312,,,,
ecancer,6/1/2014 8:45,3,2,# ecancer is at # ASCO14 giving you the latest and greatest with lots more to come! Visit http://ecancer.org .pic.twitter.com/Bk5STKUH9u,,,# #,4.73083E+17,https://twitter.com/ecancer/status/473082843015299072,,,,
WinshipAtEmory,6/1/2014 8:45,1,0,View schedule of abstract presentations at # ASCO14 by Winship members to start at 8:00am CST today: http://ow.ly/xiLaH,,,#,4.73083E+17,https://twitter.com/WinshipAtEmory/status/473082825965846528,,,,
ProjectInno,6/1/2014 8:45,2,0,The movement to accelerate innovation against cancer starts now. Join us: http://ow.ly/xtyiD # innovatenow # ASCO14 http://ow.ly/i/5KF3I,,,# #,4.73083E+17,https://twitter.com/ProjectInno/status/473082825290551296,,,,
CancerMedMDA,6/1/2014 8:45,2,1,Dr. Christopher Logothetis to chair session on rare genitourinary cancers. Includes lethal prostate cancer variants. # ASCO14 Sun. 11:30 AM.,,,#,4.73083E+17,https://twitter.com/CancerMedMDA/status/473082813785579521,,,,
LivingBeyondBC,6/1/2014 8:44,0,1,Headed to meeting of the @ mbcalliance at # ASCO14 to see how we can collaborate to improve the lives of people with # metastaticbreastcancer!,,@,# #,4.73083E+17,https://twitter.com/LivingBeyondBC/status/473082753974431744,,,,
aftimosp,6/1/2014 8:44,0,2,Lake Michigan from the 47th floor # ASCO14 pic.twitter.com/isNrYCyDNU,,,#,4.73083E+17,https://twitter.com/aftimosp/status/473082625200885760,,,,
Tony_Calles,6/1/2014 8:44,0,2,Heading to lung cancer poster highlight session. Looks very interesting. # ASCO14 # LCSMpic.twitter.com/dYhW38GQXu,,,# #,4.73083E+17,https://twitter.com/Tony_Calles/status/473082620243615744,,,,
markaorourke,6/1/2014 8:44,1,1,# ASCO14 Delaware did a great job to increase colonoscopy screening. Way to go!,,,#,4.73083E+17,https://twitter.com/markaorourke/status/473082594335424512,,,,
aftimosp,6/1/2014 8:43,0,1,Join us this morning at Board 38 for our abstract (2575): phase 1 trial with a pan-histonedeacetylase inh in combo with doxorubicin # ASCO14,,,#,4.73082E+17,https://twitter.com/aftimosp/status/473082382007164928,,,,
danielebanfi83,6/1/2014 8:43,16,10,Lotta al # cancro: una partita che dura da 50 anni. Progressi e prospettive spiegate su @ la_stampa http://lastampa.it/2014/06/01/scienza/lotta-al-cancro-una-partita-che-si-gioca-da-cinquanta-anni-Qdnwd0Ec5ey2YcFcBeRV3I/pagina.html … # ASCO14,,@,# #,4.73082E+17,https://twitter.com/danielebanfi83/status/473082326667120642,,,,
wendyselig,6/1/2014 8:42,5,4,Headline in today's. # asco14 daily highlights # melanoma progress. By @ MelanomaReAlli YIA and MAP memberpic.twitter.com/Ekkvl2OZYq,,@,# #,4.73082E+17,https://twitter.com/wendyselig/status/473082226595229696,,,,
RS_Flinn,6/1/2014 8:42,2,1,"Once A Year, Cancer Research News Comes In A Flood, Not A Trickle via @ NPR # ASCO14 http://zite.to/1nFfk3D",,@,#,4.73082E+17,https://twitter.com/RS_Flinn/status/473082133838184448,,,,
CancerTherAdvsr,6/1/2014 8:42,0,1,Day 2 of # ASCO14 begins! # CTAatASCOpic.twitter.com/Bbz7c80fAh,,,# #,4.73082E+17,https://twitter.com/CancerTherAdvsr/status/473082100493467648,,,,
myPathMelanoma,6/1/2014 8:42,0,0,"Hey # ASCO14, have you visited our booth yet? Stop by booth 2039 today to learn more about Myriad myPath # Melanoma!",,,# #,4.73082E+17,https://twitter.com/myPathMelanoma/status/473082033170694145,,,,
YaleCancer,6/1/2014 8:41,59,29,Seen outside the largest cancer conference in the US. We must do better helping people with this addiction. # asco14 pic.twitter.com/jSnYgbV4Tj,,,#,4.73082E+17,https://twitter.com/YaleCancer/status/473082008403705856,,,,
jalopezg70,6/1/2014 8:40,0,0,# ASCO14 http://tinyurl.com/nze7scc The GREKO-II study from the # GETHI group. Very active in searching the best options for a rare pathology.,,,# #,4.73082E+17,https://twitter.com/jalopezg70/status/473081586456748032,,,,
CancerMedMDA,6/1/2014 8:40,10,4,Dr. Michael Fisch shares expertise on appropriate use of social media & networking in medical practice. # ASCO14 Sun. 4:45 PM.,,,#,4.73082E+17,https://twitter.com/CancerMedMDA/status/473081581603926016,,,,
aftimosp,6/1/2014 8:40,1,0,Advancing the Role of Biomarkers in Drug Development | # ASCO14 Annual Meeting http://am.asco.org/advancing-role-biomarkers-drug-development#.U4sfIt3C4IU.twitter …,,,# #,4.73082E+17,https://twitter.com/aftimosp/status/473081571004522496,,,,
jagasquet,6/1/2014 8:39,0,1,"# ASCO14 plenary session: abstracts published! Advances in breast, prostate, colorectal cancer treatment http://bit.ly/1kexrv1 @ ASCO",,@,#,4.73081E+17,https://twitter.com/jagasquet/status/473081431824953344,,,,
cure_magazine,6/1/2014 8:39,8,6,"Today is National Cancer Survivors Day. # ASCO14, a conf committed to increasing survivorship and increasing quality of life after cancer",,,#,4.73081E+17,https://twitter.com/cure_magazine/status/473081386975252481,,,,
aftimosp,6/1/2014 8:39,0,0,Recapturing the Momentum: Reversing the Decline in Federal Funding for Cancer Research | # ASCO14 Annual Meeting http://am.asco.org/recapturing-momentum-reversing-decline-federal-funding-cancer-research#.U4sexQfRB7g.twitter …,,,# #,4.73081E+17,https://twitter.com/aftimosp/status/473081386165751808,,,,
christinemphmd,6/1/2014 8:37,1,0,Another beautiful day in # Chicago for day 3 of # ASCO14. Stop by my poster this morning! # mtor # infection # cancerpic.twitter.com/FcSGbVTYRd,,,# # # # #,4.73081E+17,https://twitter.com/christinemphmd/status/473080894606303232,,,,
janinegug,6/1/2014 8:36,3,2,Great podcast on today's 2 oral abstracts in # BreastCancer at # ASCO14 http://www.cancer.net/blog/podcasts?et_cid=33855669&et_rid=463565525&linkid=In+this+podcast …,,,# #,4.73081E+17,https://twitter.com/janinegug/status/473080735751225344,,,,
jalopezg70,6/1/2014 8:35,0,0,# ASCO14 http://tinyurl.com/pew6rgq Poster presented by # GETHI group. The Greko-1 study. Congratulations for the great effort!,,,# #,4.73081E+17,https://twitter.com/jalopezg70/status/473080509527248896,,,,
aftimosp,6/1/2014 8:35,1,0,AbbVie's leukemia drug program continues to wow analysts in early study - FierceBiotech: http://www.fiercebiotech.com/story/abbvies-leukemia-drug-program-continues-wow-analysts-early-study/2014-05-31?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4sdsu5QFog.twitter … # ASCO14,,,# #,4.7308E+17,https://twitter.com/aftimosp/status/473080358481584128,,,,
Roche,6/1/2014 8:35,2,3,Welcome to day 3 of # ASCO14! We wish you an inspiring conference day!,,,#,4.7308E+17,https://twitter.com/Roche/status/473080304006348800,,,,
aftimosp,6/1/2014 8:34,2,0,# ASCO14 : OK to Cut Back on Bone Mets Therapy After a Year on treatment http://www.medpagetoday.com/HematologyOncology/BreastCancer/46079 … # BreastCancer # BCSM,,,# # #,4.7308E+17,https://twitter.com/aftimosp/status/473080228273610754,,,,
philtalamo,6/1/2014 8:34,0,0,Another day at # ASCO14 - don't forget tonight is our @ GoToPER Lung Cancer CME Satellite! At the Hyatt on Wacker # LCSM http://www.gotoper.com/conferences/ASC/meetings/personalization-NSCLC-therapy/ …,,@,# #,4.7308E+17,https://twitter.com/philtalamo/status/473080082093727744,,,,
nxtstop1,6/1/2014 8:34,0,1,ON THE THRESHOLD OF CHEMO? WATCH>>. @ MaimonidesMC:What to expect when undergoing # chemotherapy: http://www.youtube.com/watch?v=WSUBGOtva0I&feature=youtu.be …. # ASCO14,,@,# #,4.7308E+17,https://twitter.com/nxtstop1/status/473080033645309954,,,,
tehfem,6/1/2014 8:33,0,0,# ASCO14 Bev/chemo=Cetux/chemo details at plenary session,,,#,4.7308E+17,https://twitter.com/tehfem/status/473079981061718016,,,,
JediPD,6/1/2014 8:33,1,0,"Genomic Medicine with Impact: Ibrutinib, for CLL. Cediranib & Olaparib combination for Ovarian Cancer # ASCO14",,,#,4.7308E+17,https://twitter.com/JediPD/status/473079890724810752,,,,
aftimosp,6/1/2014 8:33,1,0,New generation anti-EGFR TKIs in NSCLC: Clovis Oncology preps for a blockbuster showdown with AstraZeneca # ASCO14 http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4sc2nFiNI0.twitter …,,,# #,4.7308E+17,https://twitter.com/aftimosp/status/473079889579364352,,,,
PhRMA,6/1/2014 8:33,5,2,"Assessment of value must reflect needs & preferences of individual # patients, says @ KUhlendorf at # ASCO14 http://onphr.ma/1wGFpkH",,@,# #,4.7308E+17,https://twitter.com/PhRMA/status/473079782469423104,,,,
aftimosp,6/1/2014 8:31,4,0,"Immunotherapy drug shrinks tumors in bladder cancer study: 43% response rate with the anti-PDL1 antibody # ASCO14 http://www.chicagotribune.com/health/sns-rt-us-roche-hldg-bladdercancer-20140531,0,3130870.story …",,,#,4.7308E+17,https://twitter.com/aftimosp/status/473079509982257152,,,,
Immutep,6/1/2014 8:30,0,0,A Conference Call on to Discuss Abstract Presented at ASCO Will Be Held June 3 11AM AEST (9 PM EST) $ PBMD # ASCO14 http://yhoo.it/1hFrnWI,,,#,4.73079E+17,https://twitter.com/Immutep/status/473079152573444096,,,,
BioWorld,6/1/2014 8:30,1,0,Life goes on behind # ASCO14 as day three begins pic.twitter.com/SynUpwTtDh,,,#,4.73079E+17,https://twitter.com/BioWorld/status/473079139130286081,,,,
GenomicHealth,6/1/2014 8:30,0,0,Come see poster 524 in E354b: # Oncotype &proliferation response to short-term pre-op endocrine tx for chemo decision in early bc. # ASCO14,,,# #,4.73079E+17,https://twitter.com/GenomicHealth/status/473079113633505280,,,,
GenomicHealth,6/1/2014 8:30,2,0,Still haven't seen the enhanced # Oncotype # breastcancer report? See what the excitement is abt @booth 20007! http://bit.ly/1wE95ia # ASCO14,,@booth,# # #,4.73079E+17,https://twitter.com/GenomicHealth/status/473079085229694976,,,,
CancerDotNet,6/1/2014 8:29,1,0,"Advocate Lounge hours today are 7:30am-6:30pm CT. Home base"" for advocates during # ASCO14 pic.twitter.com/0P16PjS6yM""",,,#,4.73079E+17,https://twitter.com/CancerDotNet/status/473078914232090624,,,,
Linda_Brock_PhD,6/1/2014 8:29,0,0,"Let's hope so RT @ genentech In 10 yrs we won't say # breastcancer or # coloncancer. We'll ID cancer types by genetics"" - J. Vose # ASCO14""",,@,# # #,4.73079E+17,https://twitter.com/Linda_Brock_PhD/status/473078781393911808,,,,
aftimosp,6/1/2014 8:28,0,1,"Saturday at ASCO: CLL and Lung, Thyroid, Ovarian Cancer News # ASCO14 http://www.medscape.com/viewarticle/825969?src=rss?src=sttwit …",,,#,4.73079E+17,https://twitter.com/aftimosp/status/473078625403535360,,,,
pfizer,6/1/2014 8:27,4,4,Pfizer’s Mace Rothenberg: Innovation is an investment in society’s health # ASCO14 http://bit.ly/1oX8Nys,,,#,4.73078E+17,https://twitter.com/pfizer/status/473078466787966976,,,,
salutedomani,6/1/2014 8:26,0,1,"Tumore al polmone, la combinazione bevacizumab-erlotinib prolunga la sopravvivenza # asco2014 http://bit.ly/1oX8uUw",,,#,4.73078E+17,https://twitter.com/salutedomani/status/473078007423188993,,,,
antoniocaperna,6/1/2014 8:26,1,0,"Tumore al polmone, la combinazione bevacizumab-erlotinib prolunga la sopravvivenza # asco2014 http://bit.ly/1oX8uUw",,,#,4.73078E+17,https://twitter.com/antoniocaperna/status/473078007347687424,,,,
dermanewsok,6/1/2014 8:26,0,0,"Tumore al polmone, la combinazione bevacizumab-erlotinib prolunga la sopravvivenza # asco2014 http://bit.ly/1oX8uUw",,,#,4.73078E+17,https://twitter.com/dermanewsok/status/473078007184125952,,,,
RarePOV,6/1/2014 8:25,0,0,"'Breathtaking progress,' against # cancer but challenges remain http://news.yahoo.com/breathtaking-progress-against-cancer-challenges-remain-063641044.html?soc_src=mediacontentstory … @ ASCO calls for increased funding for @ NIH research",,@ @,#,4.73078E+17,https://twitter.com/RarePOV/status/473077970945339392,,,,
BairdAM,6/1/2014 8:25,1,1,"# lcsm MT  @ drdonsdizon: 'Clinically meaningful' depends on clinical context. RE: Ramucirumab in # LungCancer http://www.medscape.com/viewarticle/826014?src=sttwit … # ASCO14""""",,@,# # #,4.73078E+17,https://twitter.com/BairdAM/status/473077911088414721,,,,
aftimosp,6/1/2014 8:25,0,0,Targeted Drug Highly Effective in Advanced Thyroid Cancer: numbers with Levantinib higher than with sorafenib http://www.medscape.com/viewarticle/826017?src=rss?src=sttwit … # ASCO14,,,#,4.73078E+17,https://twitter.com/aftimosp/status/473077858860937216,,,,
aftimosp,6/1/2014 8:23,0,0,Ramucirumab and Marginal Benefit in Lung Cancer >>> marginal because no biomarkers for anti-angiogenics http://www.medscape.com/viewarticle/826014?src=sttwit … # ASCO14 # lcsm,,,# #,4.73077E+17,https://twitter.com/aftimosp/status/473077313282641921,,,,
OrianaSpagnolo,6/1/2014 8:21,1,1,50 Years in Breast Cancer: Dramatic Progress in Treatment Based On an Improved Understanding of Biology | # ASCO14 http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4samA1Gz7Q.twitter …,,,# #,4.73077E+17,https://twitter.com/OrianaSpagnolo/status/473076761102540800,,,,
dmooneymd,6/1/2014 8:20,0,0,Heading Sunday morning to highlights of Saturday. Turns out I can't be everywhere at once. # ASCO14,,,#,4.73076E+17,https://twitter.com/dmooneymd/status/473076496001548288,,,,
teaminspire,6/1/2014 8:19,5,4,"'Breathtaking progress,' against cancer but challenges remain http://news.yahoo.com/breathtaking-progress-against-cancer-challenges-remain-063641044.html … via @ YahooNews # cancer # ASCO14",,@,# #,4.73076E+17,https://twitter.com/teaminspire/status/473076364997054465,,,,
AndyBiotech,6/1/2014 8:19,3,2,Roche MPDL3280A (Anti-PD-L1) Ph1 ORR & AEs in # BladderCancer via @ JacobEPVantage # ASCO14 # GUSM pic.twitter.com/uz9y3ecJW9pic.twitter.com/nJnEFKqNAN,,@,# # #,4.73076E+17,https://twitter.com/AndyBiotech/status/473076358596550657,,,,
BioWorld,6/1/2014 8:18,0,0,Don't try to get into the # ASCO14 press room before 7:30. I mean it. She means it.,,,#,4.73076E+17,https://twitter.com/BioWorld/status/473076147799220224,,,,
BayerPharma,6/1/2014 8:14,2,3,Bayer HealthCre presents 4 abstracts on pipeline data at # ASCO14. Find abstracts online: http://am.asco.org/,,,#,4.73075E+17,https://twitter.com/BayerPharma/status/473075125282439169,,,,
JLErsek,6/1/2014 8:14,0,0,MT from Dr. @ Ashleysumrallmd NovoTTF-100A therapy for recurr GBM: analysis of patient registry data http://bit.ly/1rpommU # ASCO14 # LCI,,@,# #,4.73075E+17,https://twitter.com/JLErsek/status/473075009704198144,,,,
KUhlendorf,6/1/2014 8:13,1,2,"Nice overview in http://medicalxpress.com of the progress, challenges in # cancer research # ASCO14 http://m.medicalxpress.com/news/2014-06-breathtaking-cancer.html …",,,# #,4.73075E+17,https://twitter.com/KUhlendorf/status/473074801331171329,,,,
GlopesMd,6/1/2014 8:11,4,1,# ASCO14 - early docetaxel with androgen deprivation improves overall survival for patients with high volume metastatic prostate cancer,,,#,4.73074E+17,https://twitter.com/GlopesMd/status/473074380302327809,,,,
OncNursingNews,6/1/2014 8:10,0,0,RT @ TargetedOnc: Dosing Frequency of Zoledronic Acid Can Be Reduced Without Compromising Efficacy http://www.targetedonc.com/conference/asco-2014/Dosing-Frequency-of-Zoledronic-Acid-Can-Be-Reduced-Without-Compromising-Efficacy-in-Breast-Cancer … # ASCO14,,@,#,4.73074E+17,https://twitter.com/OncNursingNews/status/473074046754902017,,,,
OncNursingNews,6/1/2014 8:10,0,0,"Early # Palliative Care for Caregivers Improves Their Wellbeing, Too http://ow.ly/xtEec # ASCO14",,,# #,4.73074E+17,https://twitter.com/OncNursingNews/status/473074030061563905,,,,
nxtstop1,6/1/2014 8:09,0,0,VIDEO. @ OncLive: Dr Denise Yardley discusses targeting the androgen receptor in breast cancer http://ow.ly/xtF4K # ASCO14”,,@,#,4.73074E+17,https://twitter.com/nxtstop1/status/473073807482052608,,,,
GlopesMd,6/1/2014 8:09,3,3,# ASCO14 ovarian suppression with exemestane leads to better DFS then with tamoxifen - SOFT and TEXT pic.twitter.com/aqyFRDK4qI,,,#,4.73074E+17,https://twitter.com/GlopesMd/status/473073741878931456,,,,
nxtstop1,6/1/2014 8:07,0,0,"CANCER NEWS U CAN USE. @ Medscape: For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs ”",,@,#,4.73073E+17,https://twitter.com/nxtstop1/status/473073379608498177,,,,
yzafar,6/1/2014 8:07,7,5,"Today's # colorectalcancer highlight: 80405 results. Bev=cetux, but devil is in the details. Need biomarkers! http://bit.ly/1m2UoNh # ASCO14",,,# #,4.73073E+17,https://twitter.com/yzafar/status/473073263187611648,,,,
nxtstop1,6/1/2014 8:06,0,0,"ITS ALL CANCER. @ DrMiguelPerales:Via @ nprnews:Once A Year, Cancer Research News Comes In A Flood,Not Trickle http://n.pr/RLFaE7 # ASCO14",,@ @,#,4.73073E+17,https://twitter.com/nxtstop1/status/473073073189449728,,,,
ecancer,6/1/2014 8:05,0,1,It's dawn in Chicago and the @ ecancer team head back to # ASCO2014 to bring you the key news in the world of oncology pic.twitter.com/R3RlMCFrND,,@,#,4.73073E+17,https://twitter.com/ecancer/status/473072792766668801,,,,
OncLive,6/1/2014 8:05,2,2,Dr Denise Yardley discusses targeting the androgen receptor in breast cancer http://ow.ly/xtF4K # ASCO14,,,#,4.73073E+17,https://twitter.com/OncLive/status/473072746554212352,,,,
JNCI_Now,6/1/2014 8:05,0,2,"In ALTTO, rate of congestive heart failure was less than 1%, even though 95% of women received anthracycline chemotherapy. # BCSM # ASCO14",,,# #,4.73073E+17,https://twitter.com/JNCI_Now/status/473072733060730881,,,,
JNCI_Now,6/1/2014 8:05,1,1,Many doctors have stopped using anthracycline chemotherapy due to concerns about heart toxicities and are using TCH regimen instead. # ASCO14,,,#,4.73073E+17,https://twitter.com/JNCI_Now/status/473072732242862080,,,,
JNCI_Now,6/1/2014 8:05,0,0,Another important finding from this trial was that the rates of serious heart-related side effects were very low. # BCSM # ASCO14,,,# #,4.73073E+17,https://twitter.com/JNCI_Now/status/473072729529139200,,,,
JNCI_Now,6/1/2014 8:05,0,0,"Combination treatment was linked w/ higher rates of certain side effects, such as diarrhea, skin rash, and liver problems. # ASCO14",,,#,4.73073E+17,https://twitter.com/JNCI_Now/status/473072728451190784,,,,
DrMiguelPerales,6/1/2014 8:03,8,6,# ASCO14: How Scientific Collaboration Can Improve Our Approach To Fighting Cancer http://onforb.es/1tyeOSw via @ forbes,,@,#,4.73072E+17,https://twitter.com/DrMiguelPerales/status/473072373676007424,,,,
VincentRK,6/1/2014 8:03,0,1,Hope it looks better than iOS7 “ @ WoodBD: Stay tuned for iOS8 and healthbook. @ mtmdphd # ASCO14 http://venturebeat.com/2014/05/31/apples-healthbook-will-finally-debut-as-part-of-ios-8-this-monday/ …,,@ @,#,4.73072E+17,https://twitter.com/VincentRK/status/473072267925000192,,,,
betht0002,6/1/2014 8:02,0,0,"How is it already June?! Getting my @ Starbucks fix, then heading to McCormick Place for # ASCO14 Day 3!",,@,#,4.73072E+17,https://twitter.com/betht0002/status/473072101654417408,,,,
DrMiguelPerales,6/1/2014 8:01,2,2,"Via @ nprnews: Once A Year, Cancer Research News Comes In A Flood, Not A Trickle http://n.pr/RLFaE7 # ASCO14",,@,#,4.73072E+17,https://twitter.com/DrMiguelPerales/status/473071857730457601,,,,
corp_UNC,6/1/2014 8:01,1,0,"Eval. of falls in older adults: How are we doing? | Guerard,Muss et al @ UNC_Lineberger # GeriatricOncology # ASCO14 http://ow.ly/xpdQ0",,@,# #,4.73072E+17,https://twitter.com/corp_UNC/status/473071798054297600,,,,
MGHCancerCenter,6/1/2014 8:01,0,1,"8-11:45, S Hall A2: Dr. Polubriaginof poster: Implications of guidelines for genetic testing & MRI use in breast cancer # bcsm # ASCO14",,,# #,4.73072E+17,https://twitter.com/MGHCancerCenter/status/473071754194472960,,,,
Elekta,6/1/2014 8:01,0,0,"At # ASCO14, learn how # MOSAIQ deploys tools to improve workflow and patient interactions, while facilitating a safe treatment experience.",,,# #,4.73072E+17,https://twitter.com/Elekta/status/473071736377065473,,,,
ASCO,6/1/2014 8:00,0,1,Our congratulations to Horizon BioAdvance on their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@7,#,4.73072E+17,https://twitter.com/ASCO/status/473071698779316224,,,,
ASCO,6/1/2014 8:00,2,2,"Help recognize Congressman @ JohnCarneyDE’s drug shortages & fees work, which impact pts fighting cancer @7:30 am in E Hall D1 # ASCO14",,@ @7,#,4.73072E+17,https://twitter.com/ASCO/status/473071686498410496,,,,
ASCO,6/1/2014 8:00,2,5,. @ IMFmyeloma’s Michael Katz 20+ survivor of myeloma & rectal cancer. Join us to present Partners in Progress Award @7:30 E Hall D1 # ASCO14,,@ @7,#,4.73072E+17,https://twitter.com/ASCO/status/473071679481323520,,,,
ASCO,6/1/2014 8:00,1,3,Congratulations to Northern Indiana Cancer Research Consortium on their Clinical Trials Participation Award TBP @7:30 am E Hall D1 # ASCO14,,@7,#,4.73072E+17,https://twitter.com/ASCO/status/473071679351316480,,,,
ProjectInno,6/1/2014 8:00,0,0,"Have you seen our white paper, Securing the Future of Innovation in # Cancer Treatment? http://ow.ly/xr9hf # ASCO14",,,# #,4.73072E+17,https://twitter.com/ProjectInno/status/473071590473994240,,,,
SarahCannonDocs,6/1/2014 8:00,1,0,Join # SCRI for # ASCO14 poster sessions today in S Hall A2 - Breakthrough Cancer Research meets Personalized Care with Sarah Cannon,,,# #,4.73072E+17,https://twitter.com/SarahCannonDocs/status/473071501093392384,,,,
JNCI_Now,6/1/2014 8:00,1,2,"Approx. 20% of patients experience a relapse within 10 years, w/ the cancer usually appearing in other parts of the body. # BCSM # ASCO14",,,# #,4.73071E+17,https://twitter.com/JNCI_Now/status/473071487960633345,,,,
JNCI_Now,6/1/2014 8:00,1,1,Treatment w/ trastuzumab & chemo significantly reduces risk of cancer recurrence & death for women w/ early-stage HER2+ BC. # ASCO14,,,#,4.73071E+17,https://twitter.com/JNCI_Now/status/473071481371361280,,,,
JNCI_Now,6/1/2014 8:00,1,0,"We were surprised that adding lapatinib did not provide further benefit.""- Edith A. Perez"," MD # BCSM # ASCO14""",,,# #,4.73071E+17,https://twitter.com/JNCI_Now/status/473071480234733569,,,
JNCI_Now,6/1/2014 8:00,0,1,"“We were encouraged to see that most patients w/ HER2+ early BC are doing well w/ standard trastuzumab therapy,” -Edith A. Perez, MD # ASCO14",,,#,4.73071E+17,https://twitter.com/JNCI_Now/status/473071479152574464,,,,
JNCI_Now,6/1/2014 8:00,1,0,"Researchers found no statistically significant differences in treatment arms in 4year disease-free survival, ranging form 86-88% # ASCO14",,,#,4.73071E+17,https://twitter.com/JNCI_Now/status/473071478108192769,,,,
MedscapeOnc,6/1/2014 8:00,0,0,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73071E+17,https://twitter.com/MedscapeOnc/status/473071473762914305,,,,
Medscape,6/1/2014 8:00,0,1,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.73071E+17,https://twitter.com/Medscape/status/473071473121173505,,,,
DanaFarber,6/1/2014 8:00,0,1,Study shows drug combo dramatically extends survival in advanced # prostatecancer: http://bit.ly/1k7SE9Q # ASCO14 # pcsm,,,# # #,4.73071E+17,https://twitter.com/DanaFarber/status/473071470206521345,,,,
ASCO,6/1/2014 7:59,9,4,"# ASCO14 plenary briefing features advances in breast, prostate, colorectal cancer treatment http://bit.ly/1kexrv1 # bcsm # pcsm # crcsm",,,# # # #,4.73071E+17,https://twitter.com/ASCO/status/473071452854681600,,,,
DrMiguelPerales,6/1/2014 7:59,0,0,# ASCO14 MT @ Reuters_Health Study of # aromasin may open new options for younger women with breast cancer http://reut.rs/1klfJVA # bcsm,,@,# # #,4.73071E+17,https://twitter.com/DrMiguelPerales/status/473071425176498176,,,,
SamuelLz,6/1/2014 7:57,0,0,Snart artikel om det på @ dagensmedicin # dmasco # asco14,,@,# #,4.73071E+17,https://twitter.com/SamuelLz/status/473070753752297472,,,,
SWOG,6/1/2014 7:56,0,0,"Bevacizumab, cetuximab equally effective when added to chemo 4 metastatic CRC w/o KRAS mutat # ASCO14 # SWOGonc http://swog.org/Members/Download/BulletinBoard/Article223.pdf … # CRCSM",,,# # #,4.73071E+17,https://twitter.com/SWOG/status/473070514165272576,,,,
nxtstop1,6/1/2014 7:56,1,0,MT @ DarrenHudach: Great organizations are made of great people. # leadership” # ASCO14,,@,# #,4.7307E+17,https://twitter.com/nxtstop1/status/473070476869120000,,,,
lucadf,6/1/2014 7:55,2,0,I want oncologists to think about value but also about changing their own practice. Zeke Emanuel # ASCO14 @ UPenn_MedEthics @ Oncoinfo_it,,@ @,#,4.7307E+17,https://twitter.com/lucadf/status/473070352344829952,,,,
SamuelLz,6/1/2014 7:55,1,0,Läkemedlet Tyverb floppar i jättestudie http://abstracts.asco.org/144/AbstView_144_128258.html … # dmasco # asco14,,,# #,4.7307E+17,https://twitter.com/SamuelLz/status/473070301581160448,,,,
ASCO,6/1/2014 7:55,6,3,Our congratulations to @ MountSinaiNYC on their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@ @7,#,4.7307E+17,https://twitter.com/ASCO/status/473070225769119744,,,,
JNCI_Now,6/1/2014 7:55,0,0,Adding lapatinib to adjuvant trastuzumab does not improve outcomes for women w/ early-stage HER2+ BC. # BCSM # ASCO14,,,# #,4.7307E+17,https://twitter.com/JNCI_Now/status/473070216922939393,,,,
JNCI_Now,6/1/2014 7:55,0,0,ALTTO (Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) # ASCO14,,,#,4.7307E+17,https://twitter.com/JNCI_Now/status/473070215534608384,,,,
JNCI_Now,6/1/2014 7:55,0,0,"“They can be reassured that two widely used regimens offer good and equivalent survival.” Clifford A. Hudis, MD, FACP # CRCSM # ASCO14",,,# #,4.7307E+17,https://twitter.com/JNCI_Now/status/473070214767067136,,,,
JNCI_Now,6/1/2014 7:55,0,0,"“With this finding, oncologists and patients have more ways to personalize cancer treatment,” -Clifford A. Hudis, MD, FACP # CRCSM # ASCO14",,,# #,4.7307E+17,https://twitter.com/JNCI_Now/status/473070213651767297,,,,
JNCI_Now,6/1/2014 7:55,0,2,Bevacizumab w/ FOLFOX is widely used in the U.S. while cetuximab-based regimens tend to be used more frequently in Europe. # CRCSM # ASCO14,,,# #,4.7307E+17,https://twitter.com/JNCI_Now/status/473070212334374914,,,,
PDRennert,6/1/2014 7:54,0,0,Good morning Chicago! Another beautiful day at # ASCO14,,,#,4.7307E+17,https://twitter.com/PDRennert/status/473070018746675200,,,,
robertwalker10,6/1/2014 7:53,0,0,Good morning Chicago great day for @ GoToPER NSCLC satellite @7pm @Hyatt Regency -info @booth 5099 # ASCO14 # LCSMpic.twitter.com/faSipDjnwK,,@ @7pm @Hyatt @booth,# #,4.7307E+17,https://twitter.com/robertwalker10/status/473069791058481152,,,,
CancerDotNet,6/1/2014 7:51,0,0,"Just released! Patient summaries on # ASCO14 highlights on breast, colorectal, & prostate ca # pcsm # crcsm # bcsm http://bit.ly/1oJGea4",,,# # # #,4.73069E+17,https://twitter.com/CancerDotNet/status/473069346777231360,,,,
Neil_Iyengar,6/1/2014 7:51,0,0,ALTTO: dual anti-HER2 after surgery is not better. Bigger issue: does not support pCR as surrogate endpoint. # ASCO14 http://m.medicalxpress.com/news/2014-06-altto-dual-her2-blockade-agent.html …,,,#,4.73069E+17,https://twitter.com/Neil_Iyengar/status/473069342616465408,,,,
LGG1,6/1/2014 7:50,0,0,Diane Blum on # value in # cancer care from the patient perspective # ASCO14 http://ow.ly/3leJl2,,,# # #,4.73069E+17,https://twitter.com/LGG1/status/473069090148741120,,,,
LungCancerFaces,6/1/2014 7:50,0,1,"MT @ drdonsdizon: Clinically meaningful"" depends on clinical context. Ramucirumab in Lung Cancer http://www.medscape.com/viewarticle/826014?src=sttwit … # ASCO14 # LCSM""",,@,# #,4.73069E+17,https://twitter.com/LungCancerFaces/status/473069075099181056,,,,
yzafar,6/1/2014 7:50,1,0,Today's poster highlight in # pancreaticcancer: Radioimmunotherapy in pretreated met panc http://bit.ly/1m2UoNh # ASCO14 # pancsm,,,# # #,4.73069E+17,https://twitter.com/yzafar/status/473068967113011200,,,,
JNCI_Now,6/1/2014 7:50,0,3,"Cetuximab targets EGFR, a protein involved in cancer growth and spread. # CRCSM # ASCO14",,,# #,4.73069E+17,https://twitter.com/JNCI_Now/status/473068959642562560,,,,
JNCI_Now,6/1/2014 7:50,0,1,"Bevacizumab targets VEGF, blocking the development of blood vessels that tumors need to grow. # CRCSM # ASCO14",,,# #,4.73069E+17,https://twitter.com/JNCI_Now/status/473068958765940736,,,,
JNCI_Now,6/1/2014 7:50,1,1,"Targeted therapies have played a key part in extending survival, from 10 months 20 years ago to nearly 2.5 years seen in this study. # ASCO14",,,#,4.73069E+17,https://twitter.com/JNCI_Now/status/473068957700599808,,,,
JNCI_Now,6/1/2014 7:50,0,0,"Approx. 50,000 Americans are diagnosed with MCRC each year. # CRCSM # ASCO14",,,# #,4.73069E+17,https://twitter.com/JNCI_Now/status/473068956907864065,,,,
JNCI_Now,6/1/2014 7:50,0,0,“About 75% of patients w/ MCRC in U.S initially receive bevacizumab-based therapy.-Alan P. Venook," MD # CRCSM # ASCO14""",,,# #,4.73069E+17,https://twitter.com/JNCI_Now/status/473068956073205760,,,
theNHSN,6/1/2014 7:49,0,0,@ HopkinsMedicine: Job alert: @ HopkinsMedicine is hiring for Senior Media Relations Positions: http://ow.ly/xtHPe # prjobs # ASCO14,,@ @,# #,4.73069E+17,https://twitter.com/theNHSN/status/473068909852389376,,,,
drdonsdizon,6/1/2014 7:49,2,0,"ALLTO LBA4: Bottom line, Trastuzumab alone as adjuvant therapy is sufficient- and excellent. # MoreNotNeeded for HER2+BC. # bcsm # ASCO14",,,# # #,4.73069E+17,https://twitter.com/drdonsdizon/status/473068694772273152,,,,
drdonsdizon,6/1/2014 7:48,4,3,ALLTO results LBA4: 4yDFS 86% Tras alone; 88% Tras+Lap; 87% Tras then Lap. Rate of CHF across trial <1%. # bcsm # ASCO14,,,# #,4.73068E+17,https://twitter.com/drdonsdizon/status/473068443667668993,,,,
drdonsdizon,6/1/2014 7:46,1,1,"O Pagani @ Alliance_org LBA1 results of TEXT/SOFT did not report result w drug alone (ie, no Ovar Supp). Need further FU. # bcsm # ASCO14",,@,# #,4.73068E+17,https://twitter.com/drdonsdizon/status/473067940963549184,,,,
SamuelLz,6/1/2014 7:45,0,0,En annan av plenarstudierna visar på möjliga fördelar med aromatashämmare http://www.dagensmedicin.se/asco/nya-ron-kan-andra-behandling-av-brostcancer-hos-yngre/ … # dmasco # asco14,,,# #,4.73068E+17,https://twitter.com/SamuelLz/status/473067928964059136,,,,
drdonsdizon,6/1/2014 7:45,3,2,"Clinically meaningful"" depends on clinical context. Excellent piece re Ramucirumab in Lung Cancer http://www.medscape.com/viewarticle/826014?src=sttwit … # ASCO14""",,,#,4.73068E+17,https://twitter.com/drdonsdizon/status/473067871753363457,,,,
FoundationATCG,6/1/2014 7:45,0,2,"Therapies matched by # FoundationOne show higher response rates in adv # BCSM Poster Pres: 8-11am, S Hall A2, Ab 2606 # ASCO14 @ MDAndersonNews",,@,# # #,4.73068E+17,https://twitter.com/FoundationATCG/status/473067748025585664,,,,
MoffittResearch,6/1/2014 7:45,0,0,Dr. Jeffrey Weber will discuss how to identify & manage toxicities from kinase inhibitors & immunotherapy today at 9:45 a.m. # ASCO14,,,#,4.73068E+17,https://twitter.com/MoffittResearch/status/473067733379457024,,,,
JNCI_Now,6/1/2014 7:45,2,1,Bevacizumab & chemotherapy & cetuximab plus chemotherapy – are equally effective for patients w/ MCRC and no KRAS mutations. # CRCSM # ASCO14,,,# #,4.73068E+17,https://twitter.com/JNCI_Now/status/473067700332154880,,,,
JNCI_Now,6/1/2014 7:45,0,0,Chemotherapy is typically initiated only after the disease progresses despite ADT. # ASCO14,,,#,4.73068E+17,https://twitter.com/JNCI_Now/status/473067699585552385,,,,
JNCI_Now,6/1/2014 7:45,0,0,"Approx. 30,000 patients die of hormone-resistant PRCA in U.S. # ASCO14",,,#,4.73068E+17,https://twitter.com/JNCI_Now/status/473067698784436224,,,,
JNCI_Now,6/1/2014 7:45,0,0,"Even though ADT is effective, the disease eventually becomes resistant to the therapy in most patients. # ASCO14",,,#,4.73068E+17,https://twitter.com/JNCI_Now/status/473067697790414849,,,,
JNCI_Now,6/1/2014 7:45,1,0,Hormonal therapy aka androgen deprivation therapy (ADT) is the standard first-line treatment for hormone-sensitive prostate cancer. # ASCO14,,,#,4.73068E+17,https://twitter.com/JNCI_Now/status/473067696712450050,,,,
drdonsdizon,6/1/2014 7:45,0,0,"O Pagani @ Alliance_org LBA1: Ovarian suppression w exemestane or tamoxifen- 5yDFS 91 v 87% (HR 0.72, 95%CI .60-.86). # bcsm # ASCO14",,@,# #,4.73068E+17,https://twitter.com/drdonsdizon/status/473067688030240769,,,,
CaeptnCook,6/1/2014 7:43,0,0,Early start for 2nd full day of # ASCO14 - another exciting meeting day!,,,#,4.73067E+17,https://twitter.com/CaeptnCook/status/473067278888882176,,,,
JNCI_Now,6/1/2014 7:40,0,0,"Benefit is substantial & warrants being a new standard treatment for men who have high-extent disease & are fit for chemotherapy.” # ASCO14""",,,#,4.73066E+17,https://twitter.com/JNCI_Now/status/473066443076956160,,,,
JNCI_Now,6/1/2014 7:40,0,0,“This is the first study to identify strategy that prolongs survival in newly diagnosed metastatic PRCA.-Christopher Sweeney," MBBS # ASCO14""",,,#,4.73066E+17,https://twitter.com/JNCI_Now/status/473066442238095360,,,
JNCI_Now,6/1/2014 7:40,0,0,The survival benefit is even greater for the subset of men with extensive disease spread (high-extent disease). # ASCO14,,,#,4.73066E+17,https://twitter.com/JNCI_Now/status/473066440778465280,,,,
JNCI_Now,6/1/2014 7:40,2,0,Adding docetaxel to standard hormone therapy extends survival for men w/ newly diagnosed hormone-sensitive PRCA by roughly 10 months. # ASCO14,,,#,4.73066E+17,https://twitter.com/JNCI_Now/status/473066439851536384,,,,
JNCI_Now,6/1/2014 7:40,2,0,Now, with ovarian suppression," aromatase inhibitors are an option offering a further reduction in the risk of recurrence.” # ASCO14""",,,#,4.73066E+17,https://twitter.com/JNCI_Now/status/473066438932959233,,
SamuelLz,6/1/2014 7:39,0,0,Vi skriver förstås om dem på @ dagensmedicin http://www.dagensmedicin.se/asco/ # dmasco # asco2014,,@,# #,4.73066E+17,https://twitter.com/SamuelLz/status/473066356204904448,,,,
SamuelLz,6/1/2014 7:38,0,0,Nu har abstract till studierna som presenteras på plenarsessionerna släppts http://abstsearch.asco.org/144_60057/search.php?zoom_query=plenary+session&op.x=32&op.y=11&op=Search … # dmasco # asco14,,,# #,4.73066E+17,https://twitter.com/SamuelLz/status/473066007683416064,,,,
rschilsky,6/1/2014 7:37,3,2,# ASCO14 Speaking today at 9:45 on precision cancer medicine in 50 years. Prediction is hard," especially about the future""!""",,,#,4.73066E+17,https://twitter.com/rschilsky/status/473065851131011073,,,
AlpineBV_Miller,6/1/2014 7:37,0,0,My # ASCO14 sched for the first half of today is improbable bordering on impossible. Really wish the posters were up longer.,,,#,4.73066E+17,https://twitter.com/AlpineBV_Miller/status/473065735217242112,,,,
lenstarnes,6/1/2014 7:37,0,1,Shld B no surprise @ Boehringer using SoMe 2 drive lung cancer convo at # ASCO14 http://bit.ly/1kesClt # hcsm # hcsmeu # pharma HT @ mtmdphd,,@ @,# # # #,4.73066E+17,https://twitter.com/lenstarnes/status/473065681315852288,,,,
teamoncology,6/1/2014 7:35,0,4,【 # ASCO14 Update】 A great review of # breastcancer by Dr. M Morrow. Read if you missed her talk. http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pG9xRCeIQ.twitter … # bcsm,,,# # # #,4.73065E+17,https://twitter.com/teamoncology/status/473065343275909121,,,,
yzafar,6/1/2014 7:35,0,0,Today's highlight in gastroesophageal cancer: role of periop chemoXRT vs chemo alone http://bit.ly/1m2UoNh # ASCO14 # esocsm,,,# #,4.73065E+17,https://twitter.com/yzafar/status/473065234480246784,,,,
ASCO,6/1/2014 7:35,0,1,Our congratulations to Summa Health System on their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@7,#,4.73065E+17,https://twitter.com/ASCO/status/473065204851679232,,,,
JNCI_Now,6/1/2014 7:35,2,0,"“Young women w/ BC have long needed additional treatment options after surgery & now they may have one” Clifford A. Hudis, MD, FACP. # ASCO14",,,#,4.73065E+17,https://twitter.com/JNCI_Now/status/473065186186649600,,,,
JNCI_Now,6/1/2014 7:35,2,0,The standard adjuvant endocrine (hormone) therapy for premenopausal women is currently five years of tamoxifen. # ASCO14,,,#,4.73065E+17,https://twitter.com/JNCI_Now/status/473065184399872001,,,,
JNCI_Now,6/1/2014 7:35,4,1,These results confirm that exemestane w/ ovarian function suppression (OFS) constitutes a valid alternative,” -Olivia Pagani," MD # ASCO14""",,,#,4.73065E+17,https://twitter.com/JNCI_Now/status/473065183581986816,,
JNCI_Now,6/1/2014 7:35,1,1,Tamoxifen has been the standard hormone therapy for preventing BC recurrences in young women w/ hormone-sensitive disease. # ASCO14,,,#,4.73065E+17,https://twitter.com/JNCI_Now/status/473065182592122880,,,,
JNCI_Now,6/1/2014 7:35,4,0,"Adjuvant exemestane is more effective than tamoxifen when combined w/ OF suppression in women w/ hormone-sensitive, early-stage BC. # ASCO14",,,#,4.73065E+17,https://twitter.com/JNCI_Now/status/473065181543555073,,,,
nxtstop1,6/1/2014 7:33,0,1,PAY 2 PLAY.(4 free AFTER conference?)MT @ lenstarnes:See how @ ASCO uses # ASCO14 Live Blog access as revenue stream: http://bit.ly/1kesClt,,@ @,#,4.73065E+17,https://twitter.com/nxtstop1/status/473064838147485697,,,,
dagensmedicin,6/1/2014 7:33,1,0,"Tidig cytostatika förlängde livet vid prostatacancer, # dmasco, dagens topp från # asco2014: http://www.dagensmedicin.se/asco/tidig-cytostatika-forlangde-livet-vid-prostatacancer/ …",,,# #,4.73065E+17,https://twitter.com/dagensmedicin/status/473064734762500096,,,,
teamoncology,6/1/2014 7:32,0,0,【 # ASCO14 Update】 Where is Oncology heading in USA? Read this article. http://am.asco.org/assessing-where-oncology-and-where-it-going …,,,#,4.73064E+17,https://twitter.com/teamoncology/status/473064422198362112,,,,
afaxon23,6/1/2014 7:31,0,0," @ BairdAM: # lcsm "" @ matthewherper: Eli Lilly Lung Cancer Drug May Succeed Where Avastin Failed # ASCO14 http://onforb.es/1kv2Fgy """"""",,@ @,# #,4.73064E+17,https://twitter.com/afaxon23/status/473064275502968832,,,,
Sara_22_tl,6/1/2014 7:30,1,0,10 días y selectividad... Qué ilusión :D! # selectividad2014 # ASCO14,,,# #,4.73064E+17,https://twitter.com/Sara_22_tl/status/473064050994475008,,,,
ASCO,6/1/2014 7:30,6,5,“Carpe Diem: Time to Seize the Opportunity for Cancer Prevention” Graham Colditz MD @8 am in S100a @ AmericanCancer Award&Lecture # ASCO14,,@8 @,#,4.73064E+17,https://twitter.com/ASCO/status/473064018232741888,,,,
teamoncology,6/1/2014 7:30,0,0,【 # ASCO14 Update】 Developing Hedgehog Signaling Pathway as a cancer target. A nice article to read. http://am.asco.org/hedgehog-signaling-pathway-therapeutic-abrogation-fundamental-developmental-molecular-pathway …,,,#,4.73064E+17,https://twitter.com/teamoncology/status/473064008879063040,,,,
SitemanCenter,6/1/2014 7:30,0,0,". @ GColditz to receive @ ASCO- @ AmericanCancer Award, discuss cancer prevention: 8 am, Rm S100a http://goo.gl/y9kCQV # ASCO14",,@ @ @,#,4.73064E+17,https://twitter.com/SitemanCenter/status/473064001816248320,,,,
Xcenda,6/1/2014 7:30,1,0,# Xcenda presents 2 posters at # ASCO2014 learn more: http://bit.ly/1jXRsje # oncology # ASCO14,,,# # # #,4.73064E+17,https://twitter.com/Xcenda/status/473063950360133633,,,,
bwoodmd,6/1/2014 7:27,4,3,"Stay tuned for iOS8 and healthbook. @ mtmdphd or others, any interesting PGHD data at # ASCO14? http://venturebeat.com/2014/05/31/apples-healthbook-will-finally-debut-as-part-of-ios-8-this-monday/ …",,@,#,4.73063E+17,https://twitter.com/bwoodmd/status/473063235957305344,,,,
n8pennell,6/1/2014 7:24,1,1,"Join me at lung cancer poster highlights session in S404 at 8-11, excited about 2 adjuvant erlotinib in EGFR mut+ trials! # ASCO14 # LCSM",,,# #,4.73063E+17,https://twitter.com/n8pennell/status/473062514222055424,,,,
lenstarnes,6/1/2014 7:24,0,0,Interesting 2C how @ ASCO using # ASCO14 Live Blog access as revenue stream: http://bit.ly/1kesClt Other med socs might take note @ escardio,,@ @,#,4.73062E+17,https://twitter.com/lenstarnes/status/473062450175434752,,,,
BioWorld,6/1/2014 7:22,3,4,Tumor genome profiling: the way of the future or TMI? http://bit.ly/1iHXtRK # ASCO14,,,#,4.73062E+17,https://twitter.com/BioWorld/status/473062000776712192,,,,
ASCO,6/1/2014 7:20,0,0,Our congratulations to Doctors Hospital of Laredo on their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@7,#,4.73061E+17,https://twitter.com/ASCO/status/473061450567929856,,,,
VincentRK,6/1/2014 7:18,4,4,Very interested to see what Panobinostat Phase III results are like. It was on my top 10 list for 2013 @ Myeloma_Doc # ASCO14 # myeloma,,@,# #,4.73061E+17,https://twitter.com/VincentRK/status/473061039630581762,,,,
DaleYuzuki,6/1/2014 7:17,0,0,. @ Clarksearch I think you should give # ESHG14 and # ASCO14 search panels on a tool like HootSuite a try.,,@,# #,4.73061E+17,https://twitter.com/DaleYuzuki/status/473060876808110080,,,,
eyoste,6/1/2014 7:13,1,1,First accomplishment of the day? Up and ready for a 6:30 breakfast meeting. # ASCO14,,,#,4.7306E+17,https://twitter.com/eyoste/status/473059717758328832,,,,
drdonsdizon,6/1/2014 7:12,0,0,@ TigerBlossom13 that would be great. # intimacy so important and often assumed 2B same as intercourse. DM me. I'm at # ASCO14 until Tuesday.,,@,# #,4.7306E+17,https://twitter.com/drdonsdizon/status/473059609544884224,,,,
Clarksearch,6/1/2014 7:11,0,0,I follow scientists & doctors so my stream is awash these days with # ESHG14 and # ASCO14 . A lot to take in but trying,,,# #,4.73059E+17,https://twitter.com/Clarksearch/status/473059374785892352,,,,
BiotechStrategy,6/1/2014 7:10,0,0,ASCO 2014 Meeting Day 3 Live Blog # ASCO14 http://biotechstrategyblog.com/2014/06/asco-2014-meeting-day-3-live-blog-asco14.html/ …,,,#,4.73059E+17,https://twitter.com/BiotechStrategy/status/473059070618783744,,,,
3NT,6/1/2014 7:09,0,1,ASCO 2014 Meeting Day 3 Live Blog - latest update from @ MaverickNY just posted # ASCO14 http://3nt.co/Nivolumab,,@,#,4.73059E+17,https://twitter.com/3NT/status/473058821368467456,,,,
mtmdphd,6/1/2014 7:07,0,0,Molecular Biological Basis for Rational Combination Strategies in Melanoma - Davies - E Arie Crown Theater - Sun 8:12-8:24a # melsm # ASCO14,,,# #,4.73058E+17,https://twitter.com/mtmdphd/status/473058369318977536,,,,
darrenfergus,6/1/2014 7:07,0,0,"'Financial burden, value to society...' As today starts at # ASCO14 Why Health will be communicating what this really means to clinicians?",,,#,4.73058E+17,https://twitter.com/darrenfergus/status/473058284740816896,,,,
CPbyCelloHealth,6/1/2014 7:02,0,0,# Vaccines A diversity of platforms & options for combinations with checkpoints and other targets gives hope. # ASCO2014 @ EmilyMFierce,,@,# #,4.73057E+17,https://twitter.com/CPbyCelloHealth/status/473056894572331008,,,,
mtmdphd,6/1/2014 7:01,1,0,BI's Social Media Play in Lung Cancer - @ OAkkerman_ERG http://ow.ly/xujYn # ASCO14 # lcsm,,@,# #,4.73057E+17,https://twitter.com/mtmdphd/status/473056828226822144,,,,
Xcenda,6/1/2014 7:00,1,0,# ASCO14 # Xcenda market research opportunities for practicing hematologist/oncologists. Learn more: http://bit.ly/nocr1 # oncology,,,# # #,4.73056E+17,https://twitter.com/Xcenda/status/473056421731254272,,,,
tinypasscontent,6/1/2014 6:59,0,0,"ASCO 2014 Meeting Day 3 Live Blog # ASCO14"" http://ift.tt/1iHV75D # BiotechStrategy # tinypass # paidcontent ""The ASCO 2014 conference he...""",,,# # # #,4.73056E+17,https://twitter.com/tinypasscontent/status/473056152591548416,,,,
efesalud,6/1/2014 6:53,28,10,Dos nuevas moléculas logra frenar mejor cáncer ovario. http://www.efesalud.com/noticias/combinacion-moleculas-logra-frenar-mejor-cancer-ovario/ … Estudio presentado en # ASCO14 @ ASCO pic.twitter.com/imgunLl977,,@,#,4.73055E+17,https://twitter.com/efesalud/status/473054812452696064,,,,
davisa20,6/1/2014 6:43,1,0,Welcome to Day 3 of # ASCO14. We start early this morning with Highlights of the Day in Hall D1. See you there!,,,#,4.73052E+17,https://twitter.com/davisa20/status/473052144291958784,,,,
socialego,6/1/2014 6:42,0,1,"개인 맞춤 타겟 암 치료를 위해 필요한 기술과 낮아진 비용과 충분한 지식들이 급속히 쌓여간다는 것을 보여주는 인포그래픽스 자료입니다. 그림 출처: @ quintiles (트위터), # ASCO2014 http://fb.me/6T0iIaeHu",,@,#,4.73052E+17,https://twitter.com/socialego/status/473052012868026369,,,,
drmikesevilla,6/1/2014 6:39,0,0,RT @ jrgralow: At TweetUp # asco14 pic.twitter.com/YJ1CP4NzGe,,@,#,4.73051E+17,https://twitter.com/drmikesevilla/status/473051241225129985,,,,
subatomicdoc,6/1/2014 6:36,0,3,Now boarding for # ASCO14 (@Gate B32) http://4sq.com/1gSB6Oi,,@Gate,#,4.73051E+17,https://twitter.com/subatomicdoc/status/473050543146164224,,,,
MedscapePharm,6/1/2014 6:36,0,0,# ASCO2014 Adding irinotecan to VAC did not significantly improve event free or overall survival compared to VAC alone for rhabdomyosarcoma,,,#,4.7305E+17,https://twitter.com/MedscapePharm/status/473050447712747520,,,,
MedscapePeds,6/1/2014 6:36,2,0,# ASCO2014 Adding irinotecan to VAC did not significantly improve event free or overall survival compared to VAC alone for rhabdomyosarcoma,,,#,4.7305E+17,https://twitter.com/MedscapePeds/status/473050447649837056,,,,
MedscapeOnc,6/1/2014 6:36,0,1,# ASCO2014 Adding irinotecan to VAC did not significantly improve event free or overall survival compared to VAC alone for rhabdomyosarcoma,,,#,4.7305E+17,https://twitter.com/MedscapeOnc/status/473050447620497408,,,,
MedscapeNurses,6/1/2014 6:36,0,0,# ASCO2014 Adding irinotecan to VAC did not significantly improve event free or overall survival compared to VAC alone for rhabdomyosarcoma,,,#,4.7305E+17,https://twitter.com/MedscapeNurses/status/473050447616286720,,,,
Medscape,6/1/2014 6:36,2,3,# ASCO2014 Adding irinotecan to VAC did not significantly improve event free or overall survival compared to VAC alone for rhabdomyosarcoma,,,#,4.7305E+17,https://twitter.com/Medscape/status/473050447519834112,,,,
MedscapePharm,6/1/2014 6:33,0,0,# ASCO2014 New targeted agent shows high response rates in pts with radioiodine-resistant advanced thyroid cancer. http://bit.ly/1u4cbdl,,,#,4.7305E+17,https://twitter.com/MedscapePharm/status/473049589121966080,,,,
MedscapeEndo,6/1/2014 6:33,0,0,# ASCO2014 New targeted agent shows high response rates in pts with radioiodine-resistant advanced thyroid cancer. http://bit.ly/1u4cbdl,,,#,4.7305E+17,https://twitter.com/MedscapeEndo/status/473049589075816448,,,,
MedscapeOnc,6/1/2014 6:33,1,0,# ASCO2014 New targeted agent shows high response rates in pts with radioiodine-resistant advanced thyroid cancer. http://bit.ly/1u4cbdl,,,#,4.7305E+17,https://twitter.com/MedscapeOnc/status/473049589042253824,,,,
Medscape,6/1/2014 6:33,7,1,# ASCO2014 New targeted agent shows high response rates in pts with radioiodine-resistant advanced thyroid cancer. http://bit.ly/1u4cbdl,,,#,4.7305E+17,https://twitter.com/Medscape/status/473049588450865152,,,,
MedscapeNurses,6/1/2014 6:33,0,0,# ASCO2014 New targeted agent shows high response rates in pts with radioiodine-resistant advanced thyroid cancer. http://bit.ly/1u4cbdl,,,#,4.7305E+17,https://twitter.com/MedscapeNurses/status/473049588392161280,,,,
UrologyMatch,6/1/2014 6:33,0,1,“ @ genentech: Check out our take on treating cancer today and tomorrow. Visit our # ASCO14 newsroom. https://cards.twitter.com/cards/18ce53uydr3/jin …”,,@,#,4.7305E+17,https://twitter.com/UrologyMatch/status/473049577013383168,,,,
ZamboninMarco,6/1/2014 6:32,0,0,I nodi vengono al pettine: una riflessione sulla spesa farmaceutica in # oncologia. # ASCO2014 http://mobile.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html …,,,# #,4.73049E+17,https://twitter.com/ZamboninMarco/status/473049333957689344,,,,
MedscapePharm,6/1/2014 6:29,1,0,"# ASCO2014 Olaparib + cediranib is significantly more active against recurrent, platinum sensitive ovarian cancer than olaparib alone",,,#,4.73049E+17,https://twitter.com/MedscapePharm/status/473048772218343424,,,,
MedscapeNurses,6/1/2014 6:29,0,0,"# ASCO2014 Olaparib + cediranib is significantly more active against recurrent, platinum sensitive ovarian cancer than olaparib alone",,,#,4.73049E+17,https://twitter.com/MedscapeNurses/status/473048772180578304,,,,
MedscapeObGyn,6/1/2014 6:29,0,0,"# ASCO2014 Olaparib + cediranib is significantly more active against recurrent, platinum sensitive ovarian cancer than olaparib alone",,,#,4.73049E+17,https://twitter.com/MedscapeObGyn/status/473048772176379904,,,,
Medscape,6/1/2014 6:29,3,0,"# ASCO2014 Olaparib + cediranib is significantly more active against recurrent, platinum sensitive ovarian cancer than olaparib alone",,,#,4.73049E+17,https://twitter.com/Medscape/status/473048772130271232,,,,
MedscapeOnc,6/1/2014 6:29,3,3,"# ASCO2014 Olaparib + cediranib is significantly more active against recurrent, platinum sensitive ovarian cancer than olaparib alone",,,#,4.73049E+17,https://twitter.com/MedscapeOnc/status/473048772105080832,,,,
Curiolog,6/1/2014 6:27,1,1,Cancers du sein : des mécanismes biologiques insoupçonnés jouent sur la survie à long terme http://allodocteurs.fr/actualite-sante--cancer-du-sein-des-facteurs-de-risque-insoupconnes-13567.asp?1=1 … # ASCO14 # cancer,,,# #,4.73048E+17,https://twitter.com/Curiolog/status/473048102631649280,,,,
MayurKherdikar,6/1/2014 6:27,1,1,FDA oncology chief says rising drug prices cannot continue http://reut.rs/1mYGFKS # ASCO14,,,#,4.73048E+17,https://twitter.com/MayurKherdikar/status/473048085061709824,,,,
nxtstop1,6/1/2014 6:24,2,1,"STOPPING STATINS. @newsatJAMA: Statin Use Can Stop When Illness Is Terminal, Study Reports http://wp.me/p13lz7-389 # ASCO14",,@newsatJAMA,#,4.73047E+17,https://twitter.com/nxtstop1/status/473047414287249408,,,,
nxtstop1,6/1/2014 6:21,0,1,"OBESITY=TOBACCO TODAY. @ Neil_Iyengar: In some ways obesity appears to be the tobacco of our generation"" Hudis presidential address # ASCO14”""",,@,#,4.73047E+17,https://twitter.com/nxtstop1/status/473046660482740225,,,,
OncLive,6/1/2014 6:15,1,0,ETS gene fusions could be a potential predictive biomarker in prostate cancer http://ow.ly/xtAUg # ASCO14,,,#,4.73045E+17,https://twitter.com/OncLive/status/473045085563936768,,,,
ASCO,6/1/2014 6:15,3,4,Our congratulations to Providence Portland Med Center on their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@7,#,4.73045E+17,https://twitter.com/ASCO/status/473045074407088128,,,,
ASCO,6/1/2014 6:00,0,1,Our congratulations to Ingalls Cancer Institute for their Clinical Trials Participation Award. TBP @7:30 am in E Hall D1 # ASCO14,,@7,#,4.73041E+17,https://twitter.com/ASCO/status/473041452055154688,,,,
alessiominuzzo,6/1/2014 5:59,0,1,Week-end of # ECM with the # storify of # ASCO14 e # EASMadrid # EASCongress # science2point0,,,# # # # # #,4.73041E+17,https://twitter.com/alessiominuzzo/status/473041052841308160,,,,
Primary_Immune,6/1/2014 5:59,0,0,@ ASCO: Unravelling the Complexities of # BreastCancer # Genomics http://am.asco.org/unravelling-complexities-breast-cancer-genomics … # genome # sequencing # cancer,,@,# # # # #,4.73041E+17,https://twitter.com/Primary_Immune/status/473041022658691072,,,,
NETKanker,6/1/2014 5:48,0,0,Science and Society: 50 years later Price is what you pay. Value is what you get # ASCO14 # mustread http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …,,,# #,4.73038E+17,https://twitter.com/NETKanker/status/473038246902235136,,,,
GildeHealthcare,6/1/2014 5:35,1,0,Gilde Healthcare congratulates Bob Pinedo who will be honored by the American Society of Clinical Oncology. @ ASCO Amehttp://on.fb.me/19N9Nle”,,@,,4.73035E+17,https://twitter.com/GildeHealthcare/status/473035002901725185,,,,
BoehringerES,6/1/2014 5:30,3,0,El bloqueo irreversible de la familia ErbB en pacientes con # cancerpulmon prolonga la supervivencia # ASCO14 # afatinib http://bit.ly/1noZ9HE,,,# # #,4.73034E+17,https://twitter.com/BoehringerES/status/473033714243354624,,,,
ACInvestorBlog,6/1/2014 5:28,2,3,$ AVEO Should take off next week after yesterday's news http://stks.co/s0Npt # ASCO14 http://stks.co/p0O32,,,#,4.73033E+17,https://twitter.com/ACInvestorBlog/status/473033305206849537,,,,
nxtstop1,6/1/2014 5:27,1,0,TWITTER: MY POST-IT /YOUR POST-IT!@MichaelaFinegan: Borrowed. Thanks @ JulieFenner1#socialmedia pic.twitter.com/9G5h2tQBI1 # twitter # ASCO14,,@MichaelaFinegan @,#socialmedia # #,4.73033E+17,https://twitter.com/nxtstop1/status/473033161346019328,,,,
mediplanetFR,6/1/2014 5:24,0,0,Belgian doctors are following # ASCO14 on http://www.mediplanet.be .,,,#,4.73032E+17,https://twitter.com/mediplanetFR/status/473032308707311616,,,,
OncLive,6/1/2014 5:15,1,0,Dr. John Byrd from @ OSUCCC_James Discusses Ofatumumab Versus Ibrutinib in CLL http://ow.ly/xub29 # ASCO14,,@,#,4.7303E+17,https://twitter.com/OncLive/status/473029955526598656,,,,
DocJarad,6/1/2014 4:50,2,1,Another @ TROGfightcancer RCT In the spotlight at # ASCO14 looking at RT or chemoRT palliation for esophageal cancer http://abstracts.asco.org/144/AbstView_144_135050.html …,,@,#,4.73024E+17,https://twitter.com/DocJarad/status/473023676107853825,,,,
abcdiagnosis,6/1/2014 4:46,2,1,RT @ jrgralow: Unravelling the Complexities of # BreastCancer Genomics # ASCO14 http://am.asco.org/unravelling-complexities-breast-cancer-genomics#.U4pWzfFJEK0.twitter …,,@,# # #,4.73023E+17,https://twitter.com/abcdiagnosis/status/473022765231243264,,,,
abcdiagnosis,6/1/2014 4:45,2,1,“ @ alantanmd: No proven association 25 OH vitamin D levels and # breastcancer survival # ASCO14 pic.twitter.com/ZxcjpW2zwY”,,@,# #,4.73023E+17,https://twitter.com/abcdiagnosis/status/473022582229585920,,,,
abcdiagnosis,6/1/2014 4:45,1,1,“ @ drattai: Giordano - high BMI associated with low vitamin D levels # ASCO14 # bcsm” # breastcancer,,@,# # #,4.73022E+17,https://twitter.com/abcdiagnosis/status/473022479859195906,,,,
abcdiagnosis,6/1/2014 4:44,0,1,"“ @ drattai:LEAN study wt loss had favorable effects on some inflammatory, metabolic biomarkers assoc w/ # breastcancer survival # ASCO14 # bcsm”",,@,# # #,4.73022E+17,https://twitter.com/abcdiagnosis/status/473022365211705344,,,,
abcdiagnosis,6/1/2014 4:44,1,1,“ @ drattai: Dr May exercise-induced weight loss stronger favorable effect on BC related hormones than diet-induced weight loss # ASCO14 # bcsm”,,@,# #,4.73022E+17,https://twitter.com/abcdiagnosis/status/473022302368829440,,,,
abcdiagnosis,6/1/2014 4:44,2,1,“ @ drattai: Dr. May - # exercise has a protective effect on development of postmenopausal # breastcancer # ASCO14 # bcsm”,,@,# # # #,4.73022E+17,https://twitter.com/abcdiagnosis/status/473022215278301185,,,,
pvanhouts,6/1/2014 4:32,0,1,"@ PinedoNRC RT @ rsm2800 Pinedo: “Each patient is a pearl.” We can learn a lot from each patient. Value each pt, doing translat. work # asco14",,@ @,#,4.73019E+17,https://twitter.com/pvanhouts/status/473019254410072064,,,,
DocJarad,6/1/2014 4:19,3,0,Best evidence yet supporting surveillance for low-risk stage one seminoma: <3% recurrence at 4yr # ASCO14 http://abstracts.asco.org/144/AbstView_144_126404.html …,,,#,4.73016E+17,https://twitter.com/DocJarad/status/473016069901135873,,,,
nxtstop1,6/1/2014 4:18,0,0,@ drattai @ ASCO MAJOR Tweetup! Congrats!,,@ @,,4.73016E+17,https://twitter.com/nxtstop1/status/473015772579512322,,,,
dagensmedicin,6/1/2014 4:01,4,0,"Fetman kan vara vår generations tobak"". Läs Dagens Medicins bevakning från Asco 2014", # dmasco," # asco2014: http://www.dagensmedicin.se/asco/fetman-kan-vara-var-generations-tobak/ …""",,,# #,4.73011E+17,https://twitter.com/dagensmedicin/status/473011487343382529,,
MartineCarret,6/1/2014 3:37,0,0,# Cancer du sein : ces facteurs de risque insoupçonnés # ASCO2014 http://bit.ly/1pIzZB1 via à @ Allodocteurs,,@,# #,4.73005E+17,https://twitter.com/MartineCarret/status/473005441430343681,,,,
Medtweet55,6/1/2014 3:31,0,0,"Nice article and infographic from Genentech... @ genentech: # ASCO14 - What do the # Next50 yrs hold for immunotherapy: http://ow.ly/xmVpu """"",,@,# #,4.73004E+17,https://twitter.com/Medtweet55/status/473004011583725568,,,,
OncLive,6/1/2014 3:15,3,2,Treatment with ibrutinib dramatically increased PFS and OS compared with ofatumumab in relapsed CLL http://ow.ly/xtNO7 # ASCO14,,,#,4.73E+17,https://twitter.com/OncLive/status/472999772773953536,,,,
hospicedoctor,6/1/2014 2:55,0,1,@ drdonsdizon and...early referral to palliative care ! # ASCO14,,@,#,4.72995E+17,https://twitter.com/hospicedoctor/status/472994743119777792,,,,
shirleyayres,6/1/2014 2:48,0,1,@ hospicedoctor: @ drdonsdizon Thanks Ros I agree great presentation on patient advocacy & # socialmedia at # ASCO14 @ learnhospice @ mjseres,,@ @ @ @,# #,4.72993E+17,https://twitter.com/shirleyayres/status/472993120876236800,,,,
Pedonc,6/1/2014 2:44,0,0,“ @ ASCO: Educational Book articles on CNS Tumors from # ASCO14 speakers: http://bit.ly/1kHWXax ”. Good review of adult medulloblastoma,,@,#,4.72992E+17,https://twitter.com/Pedonc/status/472992014444011520,,,,
AshleySumrallMD,6/1/2014 2:41,2,1,More data: NovoTTF-100A therapy for recurrent GBM: analysis of patient registry data. http://bit.ly/1rpommU # ASCO14 # LCI # TuneIn2GBM,,,# # #,4.72991E+17,https://twitter.com/AshleySumrallMD/status/472991300799963136,,,,
TheseAreMyScars,6/1/2014 2:33,0,0,“ @ ASCO: Diane Blum discusses value in cancer care from a patient perspective http://bit.ly/1mVJfRE # ASCO14” life = priceless,,@,#,4.72989E+17,https://twitter.com/TheseAreMyScars/status/472989219703373824,,,,
NL4LiveSTRONG,6/1/2014 2:30,0,0,# ASCO14: Bob Pinedo ontvangt internationale award voor zijn baanbrekende werk aan kanker http://www.medicalfacts.nl/2014/05/30/asco14-bob-pinedo-ontvangt-internationale-award-voor-zijn-baanbrekende-werk-aan-kanker/ …,,,#,4.72988E+17,https://twitter.com/NL4LiveSTRONG/status/472988489433497600,,,,
OncLive,6/1/2014 2:15,1,1,"In end of life care, the discontinuation of statins may increase the median time-to-death and improve QoL http://ow.ly/xtg0q # ASCO14",,,#,4.72985E+17,https://twitter.com/OncLive/status/472984680544108544,,,,
BairdAM,6/1/2014 2:10,3,2,"# lcsm  @ matthewherper: Eli Lilly Lung Cancer Drug May Succeed Where Avastin Failed # ASCO14 http://onforb.es/1kv2Fgy """"",,@,# #,4.72984E+17,https://twitter.com/BairdAM/status/472983623247740928,,,,
JustJosue,6/1/2014 2:09,0,0,Una pelea de novios te cague la fiesta de tu cumple lo peor es que ni tu novia # ASCO14,,,#,4.72983E+17,https://twitter.com/JustJosue/status/472983314375385088,,,,
genentech,6/1/2014 2:05,0,0,"@ maverickNY, 8 y/o Julissa wants to invent a mind-reading hat for dogs. Whose # ASCO14 mind would you like to read? http://ow.ly/xsmAZ",,@,#,4.72982E+17,https://twitter.com/genentech/status/472982147171893248,,,,
pick1998_2,6/1/2014 1:56,0,0,"# ASCO14 No breakthrough so far (PD inhibitors were last year), No earth-shaking buyout like last year either. Still lots of fun, attenders?",,,#,4.7298E+17,https://twitter.com/pick1998_2/status/472980010966724608,,,,
dottorTuri,6/1/2014 1:49,0,0,"“ @ Oncoinfo_it: C.Gridelli: Good news: keep growing among lung cancer patients the number of those benefiting of target therapies"" # ASCO14”""",,@,#,4.72978E+17,https://twitter.com/dottorTuri/status/472978304837124096,,,,
RahimAlyahya,6/1/2014 1:47,1,1,# ASCO14 في هذا المؤتمر تتسابق شركات الأدوية العالمية في عرض أحدث مالديها من دراسات لأدويتها التي لاتزال في مراحل البحث والتطوير,,,#,4.72978E+17,https://twitter.com/RahimAlyahya/status/472977781203402752,,,,
RahimAlyahya,6/1/2014 1:46,0,0,# ASCO14 لكل من يرغب في متابعة أحدث العلاجات والتوصيات في مجال السرطان عليه بهذا الهاشتاق,,,#,4.72977E+17,https://twitter.com/RahimAlyahya/status/472977363588763648,,,,
RahimAlyahya,6/1/2014 1:43,1,0,# ASCO14 هذا من أشهر المؤتمرات العالمية إن لم يكن أشهرها المتخصصة في أمراض السرطان ويقام حالياً في شيكاغو يشارك فيه أكثر من ٣٣ ألف مختص,,,#,4.72977E+17,https://twitter.com/RahimAlyahya/status/472976781230632960,,,,
JessicaVogel10,6/1/2014 1:16,2,0," @ IngeDiepman: # ASCO14 http://www.oncologietv.nl : oa combi parp- en angiogeneseremmer. pic.twitter.com/3ds0Xh0EjW"" @ radboudumc Nelleke Ottevanger""",,@ @,#,4.7297E+17,https://twitter.com/JessicaVogel10/status/472969928723951616,,,,
nilaymgandhi,6/1/2014 1:15,0,0,“ @ urotoday: # ASCO14 Similar OS and pCr rate w GC or MVAC for NAC in 25 center study http://dlvr.it/5r9Lgr ”,,@,#,4.7297E+17,https://twitter.com/nilaymgandhi/status/472969756732309504,,,,
OncLive,6/1/2014 1:15,3,0,Ramucirumab Modestly Improves Survival in Advanced NSCLC http://ow.ly/xu59z # ASCO14,,,#,4.7297E+17,https://twitter.com/OncLive/status/472969562959663104,,,,
DrGlenWeiss,6/1/2014 1:15,0,0,Medical oncology fellows come check out @ CancerCenter career booth: CF-1. # clinical # research # trials # ASCO14 @ ASCO @ AACR # lcsm # bcsm,,@ @ @,# # # # # #,4.7297E+17,https://twitter.com/DrGlenWeiss/status/472969555770613760,,,,
cancermex,6/1/2014 1:05,1,1,By 2020 over 70% of cancers will occur in low-/middle-income countries. Ho to overcome access hurdles? http://ow.ly/xoOhY # ASCO14...,,,#,4.72967E+17,https://twitter.com/cancermex/status/472967130666000384,,,,
carisls,6/1/2014 0:55,1,1,Multi-technology profiling of # gyncsm provide individualized biomarker-to-drug guidance http://goo.gl/UvuGDw # ASCO14 # MolecularIntel,,,# # #,4.72965E+17,https://twitter.com/carisls/status/472964521850839040,,,,
krnmsw,6/1/2014 0:52,1,2,“ @ drdonsdizon -theme at # ASCO14 in midst of amazing progress- Balance innovation w access. Oncology social workers will ensure this for pts,,@,#,4.72964E+17,https://twitter.com/krnmsw/status/472963854994243585,,,,
DasLebenshaus,6/1/2014 0:50,0,0,GDC-0980 (PI3K and mTOR (TORC1/2 Inhibitor)) fails against Everolimus - http://tinyurl.com/onlcwp9 # kidneycancer # ASCO14 # IKCC14,,,# # #,4.72963E+17,https://twitter.com/DasLebenshaus/status/472963376721956864,,,,
FierceBiotech,6/1/2014 0:48,11,2,AbbVie's leukemia drug program continues to wow analysts in early study http://www.fiercebiotech.com/story/abbvies-leukemia-drug-program-continues-wow-analysts-early-study/2014-05-31 … by @ JohnCFierce # ASCO14 $ ABBV,,@,#,4.72963E+17,https://twitter.com/FierceBiotech/status/472962910969671680,,,,
CBlotner_,6/1/2014 0:46,0,0,"@ audvin Hi Audun! Could you create a graphic for the month of May for the # btsm community, like Symplur did with # ASCO14 analytics?",,@,# #,4.72962E+17,https://twitter.com/CBlotner_/status/472962457372090368,,,,
mlazqui,6/1/2014 0:36,2,0,"RT @ Mills_I: NSCLC ALK+ tx post Criz include 2nd generation inhibitors-ceretinib, alectinib,AP26113; pemetrexed; HSP90. # ASCO14 # lcsm",,@,# #,4.7296E+17,https://twitter.com/mlazqui/status/472959813794938880,,,,
mlazqui,6/1/2014 0:35,4,0,@ JackWestMD: Langer: Brain major sanctuary site in ALK+ NSCLC pts: 46% develop brain mets as 1st/only site of progression on criz. # ASCO14,,@,#,4.7296E+17,https://twitter.com/mlazqui/status/472959662326054912,,,,
mlazqui,6/1/2014 0:34,5,3,# ASCO14 @prIME_Oncology: # NSCLC Tony Mok great presentation! Here are his take home messages https://twitter.com/prIME_Oncology/status/472904314944761856/photo/1pic.twitter.com/VEf6JqfzbY,,@prIME_Oncology,# #,4.72959E+17,https://twitter.com/mlazqui/status/472959306116395008,,,,
iman_elhariry,6/1/2014 0:27,1,2,@ ASCO Thank you ASCO for the great # ASCO14 App this year. syncing all devices is huge benefit. Love it,,@,#,4.72958E+17,https://twitter.com/iman_elhariry/status/472957595649466368,,,,
aparcalaoreja,6/1/2014 0:26,2,0,La combinación de dos nuevas moléculas logra frenar con más eficacia el cáncer de ovario http://www.efefuturo.com/noticia/la-combinacion-de-dos-nuevas-moleculas-logra-frenar-con-mas-eficacia-el-cancer-de-ovario/ … # ASCO14,,,#,4.72957E+17,https://twitter.com/aparcalaoreja/status/472957253507489795,,,,
OncLive,6/1/2014 0:20,2,1,Dr Denise Yardley on a pilot study that assessed enzalutamide plus exemestane in HR-positive breast cancer http://ow.ly/xtF39 # ASCO14,,,#,4.72956E+17,https://twitter.com/OncLive/status/472955728232464384,,,,
DrBobGoldberg,6/1/2014 0:19,0,0,. @ asco value app high tech rationing # costshifting,,@,#,4.72956E+17,https://twitter.com/DrBobGoldberg/status/472955643977297920,,,,
GoGoBio,6/1/2014 0:19,0,0,@ fezziwig2008 @ ASCO Safety?,,@ @,,4.72956E+17,https://twitter.com/GoGoBio/status/472955548535894017,,,,
fischmd,6/1/2014 0:18,0,2,Such fun! MT @ ElaineSchattner: Delighted to meet @ drattai @ rsm2800 @ mtmdphd @ JackWestMD @ DrMarkham @ brianreid @ jrgralow at # ASCO14!,,@ @ @ @ @ @ @ @,#,4.72955E+17,https://twitter.com/fischmd/status/472955396408479744,,,,
alantanmd,6/1/2014 0:07,1,1,Goserelin with chemo in ER negative breast cancer preserves fertility and prolongs survival # ASCO14 pic.twitter.com/rsElueGVje,,,#,4.72953E+17,https://twitter.com/alantanmd/status/472952660916965377,,,,
KMilehamMD,6/1/2014 0:04,3,1,Great pizza at Giordano's for our LCI team! # LCI # ASCO14 @Carolinas pic.twitter.com/KV1fwOjz1I,,@Carolinas,# #,4.72952E+17,https://twitter.com/KMilehamMD/status/472951779278479360,,,,
BairdAM,5/31/2014 23:59,0,0,"# lcsm MT  @ Lung_Cancer_: # ASCO14 Biothera to present phase2 sty data on predictive serum biomarker # NSCLC: Biothe... http://bit.ly/1mCQNXK """"",,@,# # #,4.7295E+17,https://twitter.com/BairdAM/status/472950492398501888,,,,
B_Appelquist,5/31/2014 23:55,0,0,This is the future of # cancer treatment “ @ ASCO: # ASCO14 studies released today focus on targeted therapies: http://bit.ly/1kdpLch ”,,@,# #,4.7295E+17,https://twitter.com/B_Appelquist/status/472949534247886848,,,,
womenofteal,5/31/2014 23:53,2,1,“ @ CancerDotNet: Infographic from @ ASCO guideline on # fertility preservation before cancer treatment # ASCO14 http://bit.ly/1ruc3FS ” # gyncsm,,@ @,# # #,4.72949E+17,https://twitter.com/womenofteal/status/472949040007897089,,,,
BairdAM,5/31/2014 23:50,0,1,"# lcsm  @ Boehringer: BLOG POST: Our social media summary of # ASCO14 day 2 # lungcancer http://bit.ly/1m1cLSF """"",,@,# # #,4.72948E+17,https://twitter.com/BairdAM/status/472948281463418881,,,,
LungCancerFaces,5/31/2014 23:48,0,0,Follow @ Tony_Calles @ BrendonStilesMD @ subatomicdoc for up-to-the-minute tweets from # ASCO14! # LCSM,,@ @ @,# #,4.72948E+17,https://twitter.com/LungCancerFaces/status/472947726439563265,,,,
scientre,5/31/2014 23:47,0,0,+1 MT @ JPZaragoza1 Meeting great tweeps like @ MaverickNY @ bradloncar @ dsobek @ binarypharmer @ scientre makes trip more than worth it! # ASCO14,,@ @ @ @ @ @,#,4.72947E+17,https://twitter.com/scientre/status/472947445744537600,,,,
premal2000,5/31/2014 23:46,0,0,Following # ASCO14 from afar this year but it seems once again that Dx has taken a backseat. Where’s the promise of # personalizedmedicine?,,,# #,4.72947E+17,https://twitter.com/premal2000/status/472947345085046784,,,,
SethBla,5/31/2014 23:44,4,4,"despite RCTs of # prostatecancer w adv features benefit w RT, many pts still not told. Can RTOG0621 Δmgmnt? # ASCO14 http://alturl.com/rfwu2",,,# #,4.72947E+17,https://twitter.com/SethBla/status/472946715293540352,,,,
FierceBiotech,5/31/2014 23:37,5,2,Lilly's ramucirumab scores a marginal gain for lung cancer patients http://www.fiercebiotech.com/story/lillys-ramucirumab-scores-marginal-positive-gain-lung-cancer-patients/2014-05-31 … by @ JohnCFierce # ASCO14 $ LLY,,@,#,4.72945E+17,https://twitter.com/FierceBiotech/status/472945121361932289,,,,
declangmurphy,5/31/2014 23:32,1,1,@ urotoday Nice to see Dr Gleave scrutinizing posters in your pic # ASCO14. Disappointing his OGX-011 SYNERGY phase III trial failed,,@,#,4.72944E+17,https://twitter.com/declangmurphy/status/472943792559890432,,,,
CancerAdvocacy,5/31/2014 23:27,6,1,"Early palliative care good for caregivers, too. Palliative care should start from diagnosis. # ASCO14 http://www.medpagetoday.com/MeetingCoverage/ASCO/46077 …",,,#,4.72943E+17,https://twitter.com/CancerAdvocacy/status/472942512798060545,,,,
DrMMurphy,5/31/2014 23:22,0,0,love keeping up with the # ASCO14 meeting from afar! thanks to all for sharing all the hilights!,,,#,4.72941E+17,https://twitter.com/DrMMurphy/status/472941221644881920,,,,
IBCResearch,5/31/2014 23:22,1,0,Not at # ASCO14? View the Presidential Address video/transcript here http://connection.asco.org/Magazine/Article/ID/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …. # Next50years # wecantaffordnotto,,,# # #,4.72941E+17,https://twitter.com/IBCResearch/status/472941205240971264,,,,
Loder5,5/31/2014 23:19,0,0,“ @ adamfeuerstein: Net worth of crowd at @ MarkSchoenebaum # ASCO14 party > folks at last night's unofficial tweetup. Ka-ching.”,,@ @,#,4.72941E+17,https://twitter.com/Loder5/status/472940523800788992,,,,
DrMiguelPerales,5/31/2014 23:11,2,1,Expensive Drugs Forcing Cancer Doctors to Weigh Price - Bloomberg via @BloombergNews http://bloom.bg/1jzvRhd # ASCO14,,@BloombergNews,#,4.72939E+17,https://twitter.com/DrMiguelPerales/status/472938512031813632,,,,
MKnoll_MD,5/31/2014 23:10,3,6,Amazing that # ASCO14 is trending. Kuos to @ ASCO leadership for being so engaged! # RadOnc # Cancer # Chemotherapy,,@,# # # #,4.72938E+17,https://twitter.com/MKnoll_MD/status/472938253361111040,,,,
TargetedOnc,5/31/2014 23:10,1,0,Adding goserelin to chemo in early-stage HR- disease helps both to preserve fertility and prolong survival http://www.targetedonc.com/conference/asco-2014/Adding-Goserelin-to-Chemotherapy-Helps-to-Preserve-Fertility-Prolong-Survival … # ASCO14,,,#,4.72938E+17,https://twitter.com/TargetedOnc/status/472938129331347456,,,,
ASCO,5/31/2014 23:10,4,2,Tune in at 8 AM CDT tomorrow for live coverage of # ASCO14 Plenary press briefing,,,#,4.72938E+17,https://twitter.com/ASCO/status/472938127058018304,,,,
hoperugo,5/31/2014 23:08,0,0,# asco14 poems study gives hope for young women with ER negative disease - the chance for improved fertility!,,,#,4.72938E+17,https://twitter.com/hoperugo/status/472937788116328448,,,,
FCUroOnc,5/31/2014 23:08,0,1,"Dear @ ASCO, may we suggest @ ERPlimackMD to be an # asco15 Tweeter? Would be great to see # pcsm # blcsm # krcc # testca # adcsm covered next year!",,@ @,# # # # # #,4.72938E+17,https://twitter.com/FCUroOnc/status/472937762543243264,,,,
drdonsdizon,5/31/2014 23:05,0,6,My pal @ DrAttai at # ASCO14 Twitter friends and colleagues! http://instagram.com/p/or4pu3JwxR/,,@,#,4.72937E+17,https://twitter.com/drdonsdizon/status/472936871685660672,,,,
ASCO,5/31/2014 23:04,5,2,Science and Society: Fifty Years Later http://bit.ly/1oVoGWh @ CliffordHudis # ASCO14 Presidential Address,,@,#,4.72937E+17,https://twitter.com/ASCO/status/472936798168297472,,,,
ASCO,5/31/2014 23:02,6,5,# ASCO14 studies released today focus on targeted therapies: http://bit.ly/1kdpLch,,,#,4.72936E+17,https://twitter.com/ASCO/status/472936262744436736,,,,
Oncoinfo_it,5/31/2014 23:00,0,1,"C.Gridelli: Good news: keep growing among lung cancer patients the number of those benefiting of target therapies"" # ASCO14""",,,#,4.72936E+17,https://twitter.com/Oncoinfo_it/status/472935667207766016,,,,
GenomicHealth,5/31/2014 22:57,3,2,"Very interesting read abt # breastcancer research, thanks for the heads up @ JenMerschdorf, Jenna, and Stacy! http://bit.ly/1r1002D # ASCO14",,@,# #,4.72935E+17,https://twitter.com/GenomicHealth/status/472934986786406401,,,,
premal2000,5/31/2014 22:57,0,0,@ DrLCohen @ fischmd @ ASCO @ CliffordHudis You can’t ban foods and limit minors from consuming them. Not the same.,,@ @ @ @,,4.72935E+17,https://twitter.com/premal2000/status/472934857526358016,,,,
MKnoll_MD,5/31/2014 22:51,1,1,"Long term follow up of # radiation therapy +/- PCV, but 1p19q co-deletion not yet examined http://abstracts.asco.org/144/AbstView_144_127483.html … # ASCO14 # RadOnc",,,# # #,4.72934E+17,https://twitter.com/MKnoll_MD/status/472933518209994752,,,,
DrAttai,5/31/2014 22:49,0,0,@ mzenilman @ Hawleysaraht @ JAMASurgery I agree! I just need to get thru # ASCO14 first...,,@ @ @,#,4.72933E+17,https://twitter.com/DrAttai/status/472932841190612992,,,,
OphiraG,5/31/2014 22:48,0,0,"Must celebrate & elevate # women leaders # cancer @ AORTIC_AFRICA Drs Funmi, Sulma, Nazik, Verna! @ CancerAfrica @ ASCO @ NCIGlobalHealth",,@ @ @ @,# #,4.72933E+17,https://twitter.com/OphiraG/status/472932722445676545,,,,
merck_de,5/31/2014 22:46,0,0,"# Merck und Sysmex arbeiten gemeinsam an Test, um Krebspatienten besser zu helfen # ASCO14 http://bit.ly/1iHd8AP pic.twitter.com/Dx1EnPQD0S",,,# #,4.72932E+17,https://twitter.com/merck_de/status/472932094860328960,,,,
subatomicdoc,5/31/2014 22:41,0,1,@ ABHuret @ drattai @ drdonsdizon I'll be there tomorrow :) # bcsm # ASCO14,,@ @ @,# #,4.72931E+17,https://twitter.com/subatomicdoc/status/472930886116470784,,,,
EWidera,5/31/2014 22:41,0,1,Keep up the good tweets on palliative care and oncology at # ASCO14. Good to see # hpm representing,,,# #,4.72931E+17,https://twitter.com/EWidera/status/472930817048465409,,,,
Oncoinfo_it,5/31/2014 22:40,0,0,“ @ lucadf: Eventually studying Twitter use among physicians @ Oncoinfo_it http://abstracts.asco.org/144/AbstView_144_132049.html …” # ASCO14,,@ @,#,4.72931E+17,https://twitter.com/Oncoinfo_it/status/472930658202181632,,,,
TargetedOnc,5/31/2014 22:40,2,1,Stopping Statins in Late-Stage Cancer Patients http://www.targetedonc.com/conference/asco-2014/Considering-the-Discontinuation-of-Statins-in-Late-Stage-Cancer-Patients … # ASCO14,,,#,4.72931E+17,https://twitter.com/TargetedOnc/status/472930563901644800,,,,
chris4cure,5/31/2014 22:39,0,1,The CHRIS4LIFE booth at # ASCO14 http://fb.me/6FQNxNjNB via @ COLONTOWN,,@,#,4.7293E+17,https://twitter.com/chris4cure/status/472930282275078144,,,,
merckgroup,5/31/2014 22:37,1,1,# Merck and Sysmex jointly work on a fast test to help cancer patients; signed at # ASCO14 http://bit.ly/1tygYl5 pic.twitter.com/9olxlZNmx5,,,# #,4.7293E+17,https://twitter.com/merckgroup/status/472929920629637121,,,,
OphiraG,5/31/2014 22:36,1,0,Amazing eve @ AORTIC_AFRICA @ ASCO @ NCIGlobalHealth mtg. Real leadership # cancer control- real experts- cancer care providers from # africa.,,@ @ @,# #,4.7293E+17,https://twitter.com/OphiraG/status/472929667419504640,,,,
Tony_Calles,5/31/2014 22:35,0,1,On nivolumab: is too early to say whether or not PD-L1 expression is a biomarker in NSCLC? # ASCO14 # LCSMpic.twitter.com/D97DX98foJ,,,# #,4.72929E+17,https://twitter.com/Tony_Calles/status/472929449370214400,,,,
MikeHuckman,5/31/2014 22:33,0,1,"Thx @ scooperpr!  @ megtirrell: @ Cnbc family reunion w @ mikehuckman at @ markschoenebaum # asco14 party! # bigshoestofill pic.twitter.com/GCFT7bO3Rx”""",,@ @ @ @ @,# #,4.72929E+17,https://twitter.com/MikeHuckman/status/472928829758271488,,,,
OphiraG,5/31/2014 22:31,0,0,From the fire into frying pan! My feeling @ asco on heels of # cugh2014 @ NCIGlobalHealth @ AORTIC_AFRICA !,,@ @ @,#,4.72928E+17,https://twitter.com/OphiraG/status/472928309450637312,,,,
teamoncology,5/31/2014 22:29,1,1,The University of Texas MD Anderson Cancer Center ＆ JTOP Ver. / AKB48[official] # ASCO14 Enjoy our dancing video. http://youtu.be/0XGnzYMoX3g,,,#,4.72928E+17,https://twitter.com/teamoncology/status/472927848366223360,,,,
DrAttai,5/31/2014 22:25,0,0,@ MaverickNY we haven't yet - hope to run into you over the next few days # ASCO14,,@,#,4.72927E+17,https://twitter.com/DrAttai/status/472926788881240064,,,,
Tony_Calles,5/31/2014 22:24,0,2,The mutational profile # lungcancer in Never-Smokers. The Princess Margaret experience. Don't miss KRAS # LCSM # ASCO14 pic.twitter.com/f6yhJS9tEF,,,# # #,4.72927E+17,https://twitter.com/Tony_Calles/status/472926673063927808,,,,
Boehringer,5/31/2014 22:20,2,0,BLOG POST: Our social media summary of # ASCO14 day 2 # lungcancer http://bit.ly/1m1cLSF,,,# #,4.72926E+17,https://twitter.com/Boehringer/status/472925613024497665,,,,
Tony_Calles,5/31/2014 22:17,0,2,I found this assay pretty smart. Testing for NTRK1 in # lungcancer. On @ rdoebele presentation. # ASCO14 # LCSMpic.twitter.com/WfH17RWwg5,,@,# # #,4.72925E+17,https://twitter.com/Tony_Calles/status/472924964371562496,,,,
IngeDiepman,5/31/2014 22:17,0,0,# ASCO14 http://www.oncologietv.nl journaal 1: oa combi parp- en angiogeneseremmer veelbelovend .pic.twitter.com/mzOWbWfmEb,,,#,4.72925E+17,https://twitter.com/IngeDiepman/status/472924901452423168,,,,
subatomicdoc,5/31/2014 22:17,0,1,@ MKnoll_MD My read is that all in cohort had WBRT/SIB. Reference was RTOG 9508 cohort as comparison. # radonc # ASCO14,,@,# #,4.72925E+17,https://twitter.com/subatomicdoc/status/472924840018849794,,,,
DanBudwick,5/31/2014 22:13,1,1,The most interesting man at # ASCO14 pic.twitter.com/bIYmlTKaF5,,,#,4.72924E+17,https://twitter.com/DanBudwick/status/472923925731500033,,,,
darrylwalter,5/31/2014 22:12,0,0,Great idea of using members who are subject experts. http://www.asco.org/press-center/ascos-expert-connect … # ASCO14 # associations # membership # mediaoutreach,,,# # # #,4.72924E+17,https://twitter.com/darrylwalter/status/472923639365378048,,,,
drdonsdizon,5/31/2014 22:09,0,1,@ drattai @ knit1pug2 @ ASCO and then some!,,@ @ @,,4.72923E+17,https://twitter.com/drdonsdizon/status/472922814207774720,,,,
wendyashmen,5/31/2014 22:07,0,2,PER Enjoying Chicago pizza # asco14 pic.twitter.com/0XYlvRlDRV,,,#,4.72922E+17,https://twitter.com/wendyashmen/status/472922270478786560,,,,
emilycfreeman,5/31/2014 22:06,0,0,RT @ Cascadia- @ CancerDotNet patient-friendly summaries of # cancer research presented here at # ASCO14: http://bit.ly/1kXfVu4,,@ @,# #,4.72922E+17,https://twitter.com/emilycfreeman/status/472922067147296768,,,,
Cascadia,5/31/2014 22:04,0,3,@ JackWestMD thanks for indepth tweets from # ASCO14 - I didn't realize you cofounded @ cancergrace and are from Seattle also!,,@ @,#,4.72922E+17,https://twitter.com/Cascadia/status/472921679350759424,,,,
scooperpr,5/31/2014 22:04,0,0,"@ brianreid @ mcbennett6 @ GeoffreyCurtis Where you at bro? Tour # ASCO14 Unofficial Tweet Up was on hit, but someone forgot to order food.",,@ @ @,#,4.72922E+17,https://twitter.com/scooperpr/status/472921641421635584,,,,
wendyashmen,5/31/2014 22:03,0,2,PER group enjoying Chicago deep dish pizza before tomorrow night's lung symposium @Hyatt on Wacker at # ASCO14 # LCSMpic.twitter.com/FZLYThdB2C,,@Hyatt,# #,4.72921E+17,https://twitter.com/wendyashmen/status/472921346440040448,,,,
Tony_Calles,5/31/2014 22:01,3,1,Not all ALK+ resistance mutations do the same with different ALK inhibitors. Check yours. # ASCO14 # LCSMpic.twitter.com/h6r6qr5umN,,,# #,4.72921E+17,https://twitter.com/Tony_Calles/status/472920765420281856,,,,
ASCO,5/31/2014 22:00,2,0,New resource for media: Let us connect you with an # ASCO14 expert http://bit.ly/1i9utpE http://ow.ly/i/5l3SY,,,#,4.72921E+17,https://twitter.com/ASCO/status/472920671274946560,,,,
MyelomaTeacher,5/31/2014 21:59,1,2,# Myeloma at # ASCO14: A Preview of the Highlights # MMSM @ BrianDurieMD @ IMFmyeloma http://myeloma.org/MtEntryPage.action?source=/imf_blogs/myeloma_voices/2014/05/myeloma-at-asco-2014-a-preview-of-the-highlights.html …,,@ @,# # #,4.7292E+17,https://twitter.com/MyelomaTeacher/status/472920362708381696,,,,
megtirrell,5/31/2014 21:59,3,6,@ Cnbc family reunion w @ mikehuckman at @ markschoenebaum # asco14 party! (Thanks @ brianreid!) # bigshoestofillpic.twitter.com/z7kyi3SG5s,,@ @ @ @,# #,4.7292E+17,https://twitter.com/megtirrell/status/472920331813134336,,,,
Cascadia,5/31/2014 21:58,2,2,Checking out . @ CancerDotNet patient-friendly summaries of # cancer research presented here at # ASCO14: http://bit.ly/1kXfVu4,,@,# #,4.7292E+17,https://twitter.com/Cascadia/status/472920043106213888,,,,
hsiegel,5/31/2014 21:54,0,0,RT @ kellykcotton: Today's Presidential Address from @ CliffordHudis - video + full transcript: http://bit.ly/1oVoGWh # ASCO14,,@ @,#,4.72919E+17,https://twitter.com/hsiegel/status/472919188181643264,,,,
Tony_Calles,5/31/2014 21:53,4,4,"For me, this is today's winner. AZD9291 ORR around 60% at all dose levels for EGFR T790M # lungcancer # lcsm # ASCO14 pic.twitter.com/WyWmBYXK2S",,,# # #,4.72919E+17,https://twitter.com/Tony_Calles/status/472918818860589056,,,,
AbbottNews,5/31/2014 21:52,1,2,Abbott developed an FDA-approved diagnostic designed 2 detect ALK gene alterations in lung cancer patients. http://bit.ly/1hGVuwV # ASCO14,,,#,4.72918E+17,https://twitter.com/AbbottNews/status/472918458574045184,,,,
Cascadia,5/31/2014 21:47,1,2,@ stales lots of opportunity to collaborate with so many # ASCO14 Docs in 1 place... perhaps invite to BCSM chat?,,@,#,4.72917E+17,https://twitter.com/Cascadia/status/472917294465966081,,,,
ShannonWestin,5/31/2014 21:45,3,1,“ @ teamoncology: We have too many clinical investigators who do not push for collecting samples from patients on clinical trials. # ASCO14”,,@,#,4.72917E+17,https://twitter.com/ShannonWestin/status/472916812146163713,,,,
MyelomaTeacher,5/31/2014 21:42,0,0,RT @ myelomabeacon: coverage of the # myeloma posters presented on Day 1 of # ASCO14 (with PDFs of key posters) http://www.myelomabeacon.com/news/2014/05/31/asco-2014-multiple-myeloma-update-day-one/ … # mmsm,,@,# # #,4.72916E+17,https://twitter.com/MyelomaTeacher/status/472915961092517888,,,,
hsiegel,5/31/2014 21:41,0,0,RT @ ASCO: Drs. Chien and Dawson review Wnt signaling pathways in cancer & Wnt-targeted therapy http://bit.ly/1lU2Dew # ASCO14. Great article,,@,#,4.72916E+17,https://twitter.com/hsiegel/status/472915747925393408,,,,
MyelomaTeacher,5/31/2014 21:40,4,2,@ theMMRF Newsflash from # ASCO14 - Volume 1 http://www.themmrf.org/about-the-mmrf/powerful-news/mmrf-blogs/mmrf-newsflash-from-asco-2014-volume-1.html … # MMRFASCO # SAR650984 # daratumumab # TH-302. # mmsm,,@,# # # # # #,4.72915E+17,https://twitter.com/MyelomaTeacher/status/472915449974636544,,,,
urotoday,5/31/2014 21:39,0,0,# ASCO14 - Poster: Circulating tumor cell count and lactate dehydrogenase levels are prognostic ... http://dlvr.it/5rBlKZ,,,#,4.72915E+17,https://twitter.com/urotoday/status/472915241685090304,,,,
Sorena997,5/31/2014 21:38,2,1,Responses with crizotinib in MET-amplified lung cancer show new targetable form of disease http://medicalxpress.com/news/2014-05-responses-crizotinib-met-amplified-lung-cancer.html … # ASCO14,,,#,4.72915E+17,https://twitter.com/Sorena997/status/472914984586854401,,,,
myelomabeacon,5/31/2014 21:31,1,2,Detailed coverage of the # myeloma posters presented on Day 1 of # ASCO14 (with PDFs of key posters) http://www.myelomabeacon.com/news/2014/05/31/asco-2014-multiple-myeloma-update-day-one/ …,,,# #,4.72913E+17,https://twitter.com/myelomabeacon/status/472913258673078272,,,,
TargetedOnc,5/31/2014 21:30,2,2,Dosing Frequency of Zoledronic Acid Can Be Reduced http://www.targetedonc.com/conference/asco-2014/Dosing-Frequency-of-Zoledronic-Acid-Can-Be-Reduced-Without-Compromising-Efficacy-in-Breast-Cancer … # ASCO14,,,#,4.72913E+17,https://twitter.com/TargetedOnc/status/472912936676380672,,,,
alantanmd,5/31/2014 21:28,20,7,Monday will present positive data for JAK2 inhibition in metastatic # pancreatic # Cancer # ASCO14 Neil Love symposium pic.twitter.com/vxVRj90DWF,,,# # #,4.72912E+17,https://twitter.com/alantanmd/status/472912415102107649,,,,
BairdAM,5/31/2014 21:27,0,0,"# lcsm MT @prIME_Oncology: 3rd gen TKI AZD9291 efficacy greater in T790M+ (ORR 64%) than in T790M- (ORR 22%) pts EGFR TKI-res NSCLC # ASCO14""""",,@prIME_Oncology,# #,4.72912E+17,https://twitter.com/BairdAM/status/472912258129866752,,,,
anukPDX,5/31/2014 21:26,1,1,# ProvidenceCancerCenter team relaxes for dinner after # ASCO14 @ ProvHealth @ ASCO pic.twitter.com/8WgVABvkUQ,,@ @,# #,4.72912E+17,https://twitter.com/anukPDX/status/472911958052970496,,,,
DrAttai,5/31/2014 21:25,0,1,Also great to meet the face behind @ LurieCancer! # ASCO14,,@,#,4.72912E+17,https://twitter.com/DrAttai/status/472911732071882754,,,,
BairdAM,5/31/2014 21:19,2,1,"# lcsm  @ ASCO: # ASCO14 press conf: 2nd-line addition of ramucirumab improves lung cancer survival in phase III study. # lcsm""""",,@,# # #,4.7291E+17,https://twitter.com/BairdAM/status/472910193399836672,,,,
BairdAM,5/31/2014 21:18,2,1,"# lcsm MT  @ YaleCancer:YCC Director Tom Lynch discusses next gen therapy for EGFR mut. lung cancer # asco14 @ysm @ YNHH pic.twitter.com/7669C98vq0""""",,@ @ysm @,# #,4.7291E+17,https://twitter.com/BairdAM/status/472910011899727872,,,,
stales,5/31/2014 21:13,0,0,RT @ cascadia: Where are patient voices at largest cancer conf? # ASCO14 # HCSM # S4PM # BCSM ^at least 1 session on Tue http://am.asco.org/tuesday-june-3-2014 …,,@,# # # #,4.72909E+17,https://twitter.com/stales/status/472908855236890624,,,,
stales,5/31/2014 21:13,1,0,Unfortunately @ cancereu @ jodyms @ Cascadia No -- I'm not at # ASCO14 Wish I was.,,@ @ @,#,4.72909E+17,https://twitter.com/stales/status/472908737230151680,,,,
BairdAM,5/31/2014 21:11,0,0,"RT  @ JackWestMD: Dr. Kim on HM61713 in T790M+ acquired resistance for EGFR mutn-pos # LungCancer # ASCO14 # lcsm pic.twitter.com/ZuZWj7kAU6""""",,@,# # #,4.72908E+17,https://twitter.com/BairdAM/status/472908340951908353,,,,
BairdAM,5/31/2014 21:11,0,0,"RT  @ JackWestMD: Dr. Sequist on CO1686 in EGFR mutn-pos # LungCancer # ASCO14 # lcsm pic.twitter.com/wOmE88h8ug""""",,@,# # #,4.72908E+17,https://twitter.com/BairdAM/status/472908246030622720,,,,
BairdAM,5/31/2014 21:11,1,0,"# lcsm  @ JackWestMD: Dr. Janne on AZD9291 for acquired EGFR mutn-pos # LungCancer # ASCO14 pic.twitter.com/SWAsO9t7Ze""""",,@,# # #,4.72908E+17,https://twitter.com/BairdAM/status/472908164162023424,,,,
DrAttai,5/31/2014 21:10,1,0,“ @ ASCO: # ASCO14 Tweetup. Thanks to all for attending. We're grateful. http://ow.ly/i/5KLDk ” thanks for hosting!,,@,#,4.72908E+17,https://twitter.com/DrAttai/status/472907965092347904,,,,
LguzzardiM,5/31/2014 21:09,1,0,Assessing Where Oncology Is and Where It Is Going. # ASCO14 @ CliffordHudis http://am.asco.org/assessing-where-oncology-and-where-it-going …,,@,#,4.72908E+17,https://twitter.com/LguzzardiM/status/472907766475284480,,,,
BioDueDiligence,5/31/2014 21:08,0,5,In honor of # ASCO14 a new Clinical Oncology Targets journal watch: http://stks.co/t0NqW With tons of open access articles plus $ FMI papers,,,#,4.72907E+17,https://twitter.com/BioDueDiligence/status/472907445971738624,,,,
DrAttai,5/31/2014 21:08,0,0,And it was also fantastic to meet the face behind @ ASCO! # ASCO14,,@,#,4.72907E+17,https://twitter.com/DrAttai/status/472907396344324096,,,,
ESchattner,5/31/2014 21:07,2,3,Delighted! to meet @ drattai @ rsm2800 @ mtmdphd @ fischmd @ JackWestMD @ DrMarkham @ brianreid @ jrgralow and others at # ASCO14!,,@ @ @ @ @ @ @ @,#,4.72907E+17,https://twitter.com/ESchattner/status/472907313498828801,,,,
BairdAM,5/31/2014 21:07,0,0,"# lcsm  @ IASLC: Its got that NEW BOOK smell! See it at # ASCO2014 http://ow.ly/i/5KgAk """"",,@,# #,4.72907E+17,https://twitter.com/BairdAM/status/472907217474043904,,,,
BairdAM,5/31/2014 21:02,0,0,RT  @ JFreemanDaily: Phase 1 trial shows RXDX-101 is potent inhibitor of ALK+ and ROS+ NSCLC," and gets into brain. # lcsm # ASCO14""""",,@,# #,4.72906E+17,https://twitter.com/BairdAM/status/472905921253744640,,,
knit1pug2,5/31/2014 20:59,0,1,@ drattai @ drdonsdizon @ ASCO <3 even more! 2 of my fave twidocs.,,@ @ @,,4.72905E+17,https://twitter.com/knit1pug2/status/472905266808504320,,,,
CancerSupportHQ,5/31/2014 20:56,3,0,Michelle J Fleece speaks in Chicago # cancerinsurancechecklist # ASCO14 @ ASCO @ ACCCBuzz @ CancerSupportCm @ Novartispic.twitter.com/99f7Fs19Zg,,@ @ @ @,# #,4.72904E+17,https://twitter.com/CancerSupportHQ/status/472904444279943168,,,,
TakedaOncology,5/31/2014 20:55,1,0,The # ASCO14 theme is “science and society”. Listen to # ASCO president @ CliffordHudis discuss it here: http://bit.ly/1hgFUxr,,@,# #,4.72904E+17,https://twitter.com/TakedaOncology/status/472904140600115200,,,,
myriadgenetics,5/31/2014 20:55,0,0,Data at # ASCO14 show Myriad's myRisk test helps solve the overlap dilemma among # hereditarycancer syndromes. MONDAY at 8:00am in S100a,,,# #,4.72904E+17,https://twitter.com/myriadgenetics/status/472904111411564545,,,,
DrAttai,5/31/2014 20:54,2,3,So great to meet @ rsm2800 @ mtmdphd @ fischmd @ JackWestMD @ DrMarkham @ brianreid @ ElaineSchattner and more for the first time at # ASCO14!,,@ @ @ @ @ @ @,#,4.72904E+17,https://twitter.com/DrAttai/status/472903991387369472,,,,
BairdAM,5/31/2014 20:53,2,1,"# lcsm  @ OncLive: CO-1686 Continues to Show Promising Results in Treatment-Resistant NSCLC http://ow.ly/xtVV4 # ASCO14""""",,@,# #,4.72904E+17,https://twitter.com/BairdAM/status/472903612591374336,,,,
jagasquet,5/31/2014 20:52,0,0,# ClovisOncology preps for a blockbuster showdown with # AstraZeneca - # ASCO14 http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4p40lyTCdI.twitter …,,,# # # #,4.72903E+17,https://twitter.com/jagasquet/status/472903439718957057,,,,
jagasquet,5/31/2014 20:50,2,2,"Saturday at # ASCO14: CLL and Lung, Thyroid, Ovarian Cancer. # Ibrutinib # Ramucirumab # Lenvatinib # cediranib/ # olaparib http://www.medscape.com/viewarticle/825969?src=rss?src=sttwit …",,,# # # # # #,4.72903E+17,https://twitter.com/jagasquet/status/472902892186136576,,,,
ProjectInno,5/31/2014 20:50,0,0,"Via @ CNBC, a look at our agenda-setting plan to # innovatenow: http://ow.ly/xtdqS # ASCO14",,@,# #,4.72903E+17,https://twitter.com/ProjectInno/status/472902890387169280,,,,
OncLive,5/31/2014 20:50,2,1,CO-1686 Continues to Show Promising Results in Treatment-Resistant NSCLC http://ow.ly/xtVV4 # ASCO14,,,#,4.72903E+17,https://twitter.com/OncLive/status/472902874520109057,,,,
timturnham,5/31/2014 20:49,6,1,Many of best treatments only available in trials. Why do only 3% of cancer patients go into a trial? Need better info on trials. # ASCO14,,,#,4.72903E+17,https://twitter.com/timturnham/status/472902668042518528,,,,
CancerSupportHQ,5/31/2014 20:49,2,0,Matt Farber speaks on the Affordable Care Act. @ ACCCBuzz @ Novartis @ ASCO # ASCO14 @ CancerSupportCmpic.twitter.com/57zRsdvob4,,@ @ @ @,#,4.72903E+17,https://twitter.com/CancerSupportHQ/status/472902608953548800,,,,
adamfeuerstein,5/31/2014 20:48,4,3,Net worth of crowd at @ MarkSchoenebaum # ASCO14 party > folks at last night's unofficial tweetup. Ka-ching.,,@,#,4.72903E+17,https://twitter.com/adamfeuerstein/status/472902580365185024,,,,
DrAttai,5/31/2014 20:47,0,0,@ knit1pug2 @ drdonsdizon we actually met at @ ASCO Breast Cancer meeting last September - we're old buddies!,,@ @ @,,4.72902E+17,https://twitter.com/DrAttai/status/472902195000913920,,,,
DrAttai,5/31/2014 20:45,0,0,"Great to meet you! MT  @ Loftus: Met new docs to follow at # asco14 tweetup @ mtmdphd @ rsm2800 @ drattai""",,@ @ @ @,#,4.72902E+17,https://twitter.com/DrAttai/status/472901827067793409,,,,
BioDueDiligence,5/31/2014 20:44,0,0,"Thanks in advance to anyone at # ASCO14 who might be able to send me $ FMI related posters as the clinical utility"" data start to emerge""",,,#,4.72902E+17,https://twitter.com/BioDueDiligence/status/472901583966326784,,,,
antoniocaperna,5/31/2014 20:37,0,1,Tumore: Boehringer Ingelheim presenta gli ultimi risultati di studi sui propri farmaci # ASCO14 http://ow.ly/2HkXLE,,,#,4.729E+17,https://twitter.com/antoniocaperna/status/472899762937921537,,,,
subatomicdoc,5/31/2014 20:37,0,0,@ mikemejiamd @ BrendonStilesMD True! But quality imaging w/low false+ can bring earlier diagnosis. # ASCO14 # lcsm,,@ @,# #,4.729E+17,https://twitter.com/subatomicdoc/status/472899636370632704,,,,
Boehringer,5/31/2014 20:35,3,3,BLOG POST: Day 2 @ ASCO – “Good morning Doctors!” http://shar.es/VUDbj # notjustonedisease # ASCO14 # EGFRpic.twitter.com/GgaB5GY4oQ,,@,# # #,4.72899E+17,https://twitter.com/Boehringer/status/472899146475524096,,,,
teamoncology,5/31/2014 20:33,0,1,RT @ theNCI PARP inhibitors studied as a treatment for ovarian & breast cancer. Here's how they may work http://1.usa.gov/1jItR6m # ASCO14,,@,#,4.72899E+17,https://twitter.com/teamoncology/status/472898626516049920,,,,
GeneDx,5/31/2014 20:31,0,1,"We have genetic counselors and biotech experts -- Jen, Erica & Harpreet, at our # ASCO14 booth. Come visit! pic.twitter.com/iyV9X07dmi",,,#,4.72898E+17,https://twitter.com/GeneDx/status/472898124923813888,,,,
myriadgenetics,5/31/2014 20:30,0,0,Myriad has demonstrated its commitment to # personalizedmed with its companion diagnostic tests. # ASCO14,,,# #,4.72898E+17,https://twitter.com/myriadgenetics/status/472897818919571457,,,,
timturnham,5/31/2014 20:26,2,5,"Study of BRAF + new MEK inhibitor shows 87% of pts respond, for a median of 13.7 months. Best results ever for targeted therapy. # ASCO14",,,#,4.72897E+17,https://twitter.com/timturnham/status/472896934475096064,,,,
OncLive,5/31/2014 20:25,5,5,The dosing frequency of zoledronic acid can be reduced by 33% without compromising efficacy and safety http://ow.ly/xty1h # ASCO14,,,#,4.72897E+17,https://twitter.com/OncLive/status/472896579595415552,,,,
AdamsLisa,5/31/2014 20:23,2,4,@ Groz_P @ NiklasSavander thank you for sharing that piece that quoted my blog. Following # ASCO14 from afar...,,@ @,#,4.72896E+17,https://twitter.com/AdamsLisa/status/472896302653898752,,,,
javspeedster,5/31/2014 20:23,0,0,@ jagasquet @67juananmayol @ ASCO sin duda la mejor ocasión para estar al día de de los nuevos avances contra el cáncer!,,@ @67juananmayol @,,4.72896E+17,https://twitter.com/javspeedster/status/472896262640267265,,,,
RamalingamMD,5/31/2014 20:23,0,1,Very proud of ECOG-ACRIN @ eaonc GU committee colleagues presenting a practice-changing prostate ca study # ASCO14 plenary session.,,@,#,4.72896E+17,https://twitter.com/RamalingamMD/status/472896151641788416,,,,
Boehringer,5/31/2014 20:22,2,2,POLL: What are the biggest challenges faced by # lungcancer patients? Take part in our poll http://bit.ly/1oVq8If # ASCO14,,,# #,4.72896E+17,https://twitter.com/Boehringer/status/472895828370026496,,,,
afreshchapter,5/31/2014 20:21,0,0,Saw this sign on my walk between meetings at # asco14. If only I had more time in # chicago # mykindofplace http://instagram.com/p/orl30PMgXk/,,,# # #,4.72896E+17,https://twitter.com/afreshchapter/status/472895571963834368,,,,
scientre,5/31/2014 20:20,0,1,"Thanks to @ GeoffreyCurtis for the ride to next # ASCO14 event. Learning a lot about corp comms""!!""",,@,#,4.72895E+17,https://twitter.com/scientre/status/472895484617822208,,,,
AmbryGenetics,5/31/2014 20:19,1,2,Great first day at # ASCO14! # Chicago # McCormickPlace # AmbryGenetics # bcsm # gyncsm # BreastCancer… http://instagram.com/p/orlpWlg-Sj/,,,# # # # # # #,4.72895E+17,https://twitter.com/AmbryGenetics/status/472895075773472770,,,,
BioDueDiligence,5/31/2014 20:18,0,1,"Thanks for all the # ASCO14 coverage so far, wish I was there!",,,#,4.72895E+17,https://twitter.com/BioDueDiligence/status/472894996044349441,,,,
BayerPharma,5/31/2014 20:16,1,1,# DYK RAI-refractory # thyroidcancer patients have an average survival of 3 - 5 years. Tune into # ASCO14 for more http://bit.ly/QJ7c2P,,,# # #,4.72894E+17,https://twitter.com/BayerPharma/status/472894485350068225,,,,
jaziehoncology,5/31/2014 20:16,0,1," @ drdonsdizon: Amazing time at asco IDEA award reception w @ jrgralow @ glopesMD and @ jaziehoncology # asco14 http://instagram.com/p/oo69byJw_W/ """"",,@ @ @ @,#,4.72894E+17,https://twitter.com/jaziehoncology/status/472894475912884224,,,,
DrMisialek,5/31/2014 20:14,6,2,"Studies Reveal New Strategies to Improve Quality of Life for Patients, Survivors and Caregivers @ ASCO # ASCO14 http://www.asco.org/press-center/studies-reveal-new-strategies-improve-quality-life-patients-survivors-and-caregivers#.U4pwTUM9qqQ.twitter …",,@,# #,4.72894E+17,https://twitter.com/DrMisialek/status/472894025410695168,,,,
ASCO,5/31/2014 20:14,0,7,# ASCO14 Tweetup. Thanks to all for attending. We're grateful. http://ow.ly/i/5KLDk,,,#,4.72894E+17,https://twitter.com/ASCO/status/472893915495165953,,,,
DrMisialek,5/31/2014 20:12,4,1,"Studies Reveal Potential New Targeted Therapies for Common, Hard-to-Treat Cancers @ asco # ASCO14 http://www.asco.org/press-center/studies-reveal-potential-new-targeted-therapies-common-hard-treat-cancers#.U4pvzw5_5OI.twitter …",,@,# #,4.72893E+17,https://twitter.com/DrMisialek/status/472893456793104384,,,,
GantosJ,5/31/2014 20:12,0,0,"@ demetrescuv just back home, have not seen any data yet, @ JPZaragoza1 & @ dsobek should have more info, they both are attending # ASCO14",,@ @ @,#,4.72893E+17,https://twitter.com/GantosJ/status/472893440838361088,,,,
timturnham,5/31/2014 20:11,0,1,"Half of mel pts have a BRAF mutation, most in a spot called V600e. New data: drug used for V600e also works on other V600 errors. # ASCO14",,,#,4.72893E+17,https://twitter.com/timturnham/status/472893206959370241,,,,
myriadgenetics,5/31/2014 20:10,0,0,Myriad will present data validating the # Prolaris test score in predicting # prostatecancer death MONDAY at # ASCO14 1:15-5pm. Poster 5059,,,# # #,4.72893E+17,https://twitter.com/myriadgenetics/status/472892785364697088,,,,
Loftus,5/31/2014 20:08,2,5,Met new docs to follow at # asco14 tweetup @ mtmdphd @ rsm2800 @ drattai sorry I missed @ DrMarkham,,@ @ @ @,#,4.72892E+17,https://twitter.com/Loftus/status/472892358489808896,,,,
BCourtieu,5/31/2014 20:07,0,0,@ ASCO # ALINT mi31-3p data presented at GI highlight sessionpic.twitter.com/iA0qERem6K,,@,#,4.72892E+17,https://twitter.com/BCourtieu/status/472892172115513344,,,,
AstellasUS,5/31/2014 20:07,0,1,We had an amazing time meeting everyone at the # ASCO14 TweetUp today! RT if you were there!,,,#,4.72892E+17,https://twitter.com/AstellasUS/status/472892164297744384,,,,
DocsForChangeTX,5/31/2014 20:04,0,0,@ DrLCohen @ fischmd @ ASCO @ CliffordHudis We address this and other issues through legislative # advocacy. New volunteers always welcome.,,@ @ @ @,#,4.72891E+17,https://twitter.com/DocsForChangeTX/status/472891297129189376,,,,
jrgralow,5/31/2014 20:03,2,7,# ASCO14 TweetUp!! pic.twitter.com/AMUMoNm9mD,,,#,4.72891E+17,https://twitter.com/jrgralow/status/472891190694936577,,,,
Sorena997,5/31/2014 20:03,1,1,Thank You @ OSUCCC_James for the gracious invite ! Great Party. # ASCO14,,@,#,4.72891E+17,https://twitter.com/Sorena997/status/472891144192675840,,,,
tomwatson83a,5/31/2014 20:03,0,1,@ AstellasUS @ PhRMA we go again for the next 50 # ASCO14,,@ @,#,4.72891E+17,https://twitter.com/tomwatson83a/status/472891132607623168,,,,
westr,5/31/2014 20:01,5,11,Seriously awesome crew: RT @ drattai: # asco14 tweetup with @ fischmd and @ mtmdphdpic.twitter.com/zf5422ULW4,,@ @ @,#,4.72891E+17,https://twitter.com/westr/status/472890651349360640,,,,
TakedaOncology,5/31/2014 20:01,1,1,Our visual communications and events teams did a great job on our booth for # ASCO14. http://ow.ly/i/5KLXD . And the cupcakes are # amazing.,,,# #,4.72891E+17,https://twitter.com/TakedaOncology/status/472890621741760512,,,,
juhuthukral,5/31/2014 20:01,1,0,Def agree! @ sfuldnasso: Palliative care begins at diagnosis and has to be included in any alternative payment model. # ASCO14 # cancercare,,@,# #,4.72891E+17,https://twitter.com/juhuthukral/status/472890555999858689,,,,
teamoncology,5/31/2014 20:01,8,13,【 # ASCO14 Update】ゾメタの効果と安全性は、乳がん骨転移患者では、毎４週でも毎１２週でも、同じ。画期的。 http://abstracts.asco.org/144/AbstView_144_129791.html …,,,#,4.72891E+17,https://twitter.com/teamoncology/status/472890544939483137,,,,
teamoncology,5/31/2014 20:00,19,20,【 # ASCO14 Update】進行がんにおいて、がんと関連ないような薬、コレステロール抑制剤をやめることが患者のQOLを改善されることが証明された。死に直面しているひとへ無駄な薬を辞める必要があるのかも。 http://abstracts.asco.org/144/AbstView_144_135132.html …,,,#,4.7289E+17,https://twitter.com/teamoncology/status/472890442040627200,,,,
mlazqui,5/31/2014 20:00,1,1,Llena la sesión de inmunoterapia en cáncer genitourinario # ASCO14 pic.twitter.com/TOMdxyJ35Q,,,#,4.7289E+17,https://twitter.com/mlazqui/status/472890434243788800,,,,
practiceupdate,5/31/2014 20:00,0,0,Take a look at some recommended # ASCO14 sessions to attend from our # Oncology Advisory Board: http://ow.ly/xtUoL,,,# #,4.7289E+17,https://twitter.com/practiceupdate/status/472890417844092928,,,,
teamoncology,5/31/2014 20:00,5,4,【 # ASCO14 Update】LHRH agonistを化学療法中に使用して、卵巣機能を温存を多少できることが証明された。ただ、今後も研究が必要、妊娠できるかとは別問題。 http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.7289E+17,https://twitter.com/teamoncology/status/472890399665553408,,,,
teamoncology,5/31/2014 19:59,6,3,乳がんにおける体重増加と生存率、治療効果に関しては未だに答えがない。 # ASCO14,,,#,4.7289E+17,https://twitter.com/teamoncology/status/472890165870862337,,,,
DrMarkham,5/31/2014 19:59,2,2,Great to meet you all! RT @ Celgene: At @ ASCO # tweetup w @ mtmdphd @ Celgene_Myeloma https://twitter.com/Celgene/status/472889401803288576/photo/1pic.twitter.com/dyLxrVuYxo,,@ @ @ @,#,4.7289E+17,https://twitter.com/DrMarkham/status/472890072241410048,,,,
mlazqui,5/31/2014 19:58,1,0,Abstract 500 Adjuvant bevacizumab does not improve disease outcomes in early breast cancer. # ASCO14,,,#,4.7289E+17,https://twitter.com/mlazqui/status/472889915135766528,,,,
teamoncology,5/31/2014 19:58,9,5,肥満対策が、がんを減らすことになる。 # ASCO14,,,#,4.7289E+17,https://twitter.com/teamoncology/status/472889827797372928,,,,
teamoncology,5/31/2014 19:57,17,5,肥満はタバコを吸うことと同じくらい大きな問題でがんに大きく貢献している。 # ASCO14,,,#,4.7289E+17,https://twitter.com/teamoncology/status/472889641125691392,,,,
Globeathon,5/31/2014 19:55,0,2,"RT @ DanaFarber: Life-prolonging # ovariancancer chemotherapy underused, study finds: http://bit.ly/1rvLmkp # ASCO14 # gyncsm",,@,# # #,4.72889E+17,https://twitter.com/Globeathon/status/472889259204952064,,,,
MyelomaTeacher,5/31/2014 19:55,0,0,@ JackWhelan Unfortunately no. I wasn't able to attend # ASCO14 I'm following remotely thru twitter.,,@,#,4.72889E+17,https://twitter.com/MyelomaTeacher/status/472889251735289856,,,,
teamoncology,5/31/2014 19:55,2,4,【 # ASCO14 Update】卵巣がんにおいて、VEGFR とPARP 阻害剤の相乗効果が確認された。 http://abstracts.asco.org/144/AbstView_144_130933.html …,,,#,4.72889E+17,https://twitter.com/teamoncology/status/472889238724161538,,,,
DrMarkham,5/31/2014 19:55,0,1,The @ ASCO Tweet-up was so much fun! # ASCO14,,@,#,4.72889E+17,https://twitter.com/DrMarkham/status/472889140309409792,,,,
teamoncology,5/31/2014 19:55,6,0,【 # ASCO14 Update】 ビタミンDのレベル、乳がんの生存率とは関連がない。つまり、ビタミンDを飲むことにより生存率の改善の根拠は無い。 http://abstracts.asco.org/144/AbstView_144_128900.html …,,,#,4.72889E+17,https://twitter.com/teamoncology/status/472889017592061952,,,,
2healthguru,5/31/2014 19:54,1,1,And the thoughtful & articulate @ healthmessaging Steve Wilkins http://www.blogtalkradio.com/justoncology/2014/05/09/meet-stephen-wilkins … c/o @ chemosabe1 # ASCO14,,@ @,#,4.72889E+17,https://twitter.com/2healthguru/status/472888843709194240,,,,
nycdoc29,5/31/2014 19:52,0,1,@ ERPlimackMD - Welcome to the Twitter Onc Family # ASCO14,,@,#,4.72888E+17,https://twitter.com/nycdoc29/status/472888489391181824,,,,
2healthguru,5/31/2014 19:51,0,0,The amazing James Mason MD @ ScrippsHealth http://www.blogtalkradio.com/justoncology/2014/04/09/meet-james-mason-md … # asco14 c/o @ chemosabe1,,@ @,#,4.72888E+17,https://twitter.com/2healthguru/status/472888229189128193,,,,
drdonsdizon,5/31/2014 19:51,0,0,@ kellykcotton such a great event! TYSM @ ASCO,,@ @,,4.72888E+17,https://twitter.com/drdonsdizon/status/472888080567787520,,,,
2healthguru,5/31/2014 19:49,0,0,Three great chats given # ASCO14 First @ drattai http://www.blogtalkradio.com/justoncology/2014/04/02/meet-deanna-attai-md-aka-drattai … c/o @ chemosabe1,,@ @,#,4.72888E+17,https://twitter.com/2healthguru/status/472887747297161217,,,,
JLErsek,5/31/2014 19:49,0,0,Look @that nice waterfall! Dr. Amin @Carolinas # LCI doc discussed Nivo+TKI. good anti-tumor activity seen # ASCO14 pic.twitter.com/eB3jfmb8MF,,@that @Carolinas,# #,4.72888E+17,https://twitter.com/JLErsek/status/472887626966786049,,,,
TapKadia,5/31/2014 19:49,1,2,@ ERPlimackMD welcome to twitter! # ASCO14,,@,#,4.72888E+17,https://twitter.com/TapKadia/status/472887580032516097,,,,
Urogill,5/31/2014 19:49,0,0,@ Prof_Nick_James seems to be rearing its head in all urol cancers. Interesting # ASCO14,,@,#,4.72888E+17,https://twitter.com/Urogill/status/472887532720357376,,,,
urotoday,5/31/2014 19:49,1,1,# ASCO14 - Poster: Phase 1b study of abiraterone acetate and docetaxel in patients with ... http://dlvr.it/5r9LlN,,,#,4.72888E+17,https://twitter.com/urotoday/status/472887532095422464,,,,
urotoday,5/31/2014 19:49,0,0,"# ASCO14 - Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, ... http://dlvr.it/5r9Lgr",,,#,4.72888E+17,https://twitter.com/urotoday/status/472887527641083904,,,,
urotoday,5/31/2014 19:49,1,1,# ASCO14 - Poster: ARN-509 in patients with metastatic castration-resistant prostate cancer with ... http://dlvr.it/5r9LZ4,,,#,4.72888E+17,https://twitter.com/urotoday/status/472887521039228928,,,,
KUhlendorf,5/31/2014 19:47,1,1,More # ASCO14 street art on the value of medical # innovation. @ CSPIpic.twitter.com/SzHe5sFJPA,,@,# #,4.72887E+17,https://twitter.com/KUhlendorf/status/472887047582416896,,,,
drsteventucker,5/31/2014 19:46,10,5,Data-led medicine is the future of medicine. # asco14 # genomics # digitalhealth via @ wired cc @ EricTopol http://www.wired.co.uk/magazine/archive/2014/06/ideas-bank/vinod-khosla …,,@ @,# # #,4.72887E+17,https://twitter.com/drsteventucker/status/472886984080252928,,,,
socflyny,5/31/2014 19:46,0,1,@ drattai @ drdonsdizon Okay ... NOW I'm officially jealous! ; ) We need a # BCSM class pic from # ASCO14,,@ @,# #,4.72887E+17,https://twitter.com/socflyny/status/472886821358424064,,,,
theNCI,5/31/2014 19:45,48,19,PARP inhibitors are being studied as a treatment for ovarian & breast cancer. Here's how they may work http://1.usa.gov/1jItR6m # ASCO14,,,#,4.72887E+17,https://twitter.com/theNCI/status/472886512821227520,,,,
CLOUDHealth,5/31/2014 19:44,0,0,"@PACENetworkUSA @ KUhlendorf @ BIDMChealth For that matter, what if there isn't one center but dynamic # digitalfabric that pivots? # ASCO14",,@PACENetworkUSA @ @,# #,4.72886E+17,https://twitter.com/CLOUDHealth/status/472886432856412161,,,,
socflyny,5/31/2014 19:44,2,2,"Disturbing: MT @ fischmd: Emanuel at # ASCO14 - Median US household income = $51,371; ONE of our cancer drugs wipes this out. # costsofcare",,@,# #,4.72886E+17,https://twitter.com/socflyny/status/472886426619506688,,,,
TargetedOnc,5/31/2014 19:44,7,3,Olaparib/Cediranib Combo Nearly Doubled PFS in Recurrent Ovarian Cancer http://www.targetedonc.com/conference/asco-2014/OlaparibCediranib-Combo-Nearly-Doubled-PFS-in-Recurrent-Ovarian-Cancer … # ASCO14,,,#,4.72886E+17,https://twitter.com/TargetedOnc/status/472886279328108545,,,,
CLOUDHealth,5/31/2014 19:43,0,0,@PACENetworkUSA @ KUhlendorf @ BIDMChealth What if systems were designed from # patient out rather than from # EHR to patient? # ASCO14,,@PACENetworkUSA @ @,# # #,4.72886E+17,https://twitter.com/CLOUDHealth/status/472886193709789184,,,,
hjsoch,5/31/2014 19:41,0,0,# ASCO14: Patients Should Be at the Center of the Value Proposition http://shar.es/VUihx via @ PhRMA,,@,#,4.72886E+17,https://twitter.com/hjsoch/status/472885726577586176,,,,
socflyny,5/31/2014 19:41,1,2,@ rsm2800 @ LurieCancer *waving* hope to meet you both soon! # ASCO14,,@ @,#,4.72886E+17,https://twitter.com/socflyny/status/472885699151011840,,,,
CLOUDHealth,5/31/2014 19:41,0,0,@ JackWestMD @ drattai Gr8 folks!! Bummed my annual bike ride with @ teamintraining for @ LLSusa in Tahoe is always same weekend as # ASCO14,,@ @ @ @,#,4.72886E+17,https://twitter.com/CLOUDHealth/status/472885652577480704,,,,
rsm2800,5/31/2014 19:40,0,2,With my pal @ LurieCancer at the # ASCO14 tweet up pic.twitter.com/fi0pZNnjG4,,@,#,4.72885E+17,https://twitter.com/rsm2800/status/472885239996764162,,,,
socflyny,5/31/2014 19:38,0,0,@ Cascadia Some of us are here in Twitter spirit! : ) # BCSM # ASCO14,,@,# #,4.72885E+17,https://twitter.com/socflyny/status/472884936937328640,,,,
DrAttai,5/31/2014 19:38,0,9,With my buddy @ drdonsdizon!! # asco14 pic.twitter.com/KoCjfTEcsN,,@,#,4.72885E+17,https://twitter.com/DrAttai/status/472884800161087488,,,,
JLErsek,5/31/2014 19:36,2,0,Drs. Burri & Sumrall and their poster @ # ASCO14. Superior OS 4 CRT+bev vs. CRT in UGBM. Abstract 2069 # LCI @Carolinaspic.twitter.com/b3zUCJOmYK,,@ @Carolinaspic,# #,4.72884E+17,https://twitter.com/JLErsek/status/472884402167762944,,,,
rogersro,5/31/2014 19:36,0,0,Myriad's Mark Capone and Dr. Loren Clarke discussing key research at ASCO 2014. # asco14 $ mygn # diagnostics.pic.twitter.com/DhC2Y8OSJD,,,# #,4.72884E+17,https://twitter.com/rogersro/status/472884347771449344,,,,
JoleneScience,5/31/2014 19:36,0,0,GEPARSIXTO neoadj carboplatin: read-through to veliparib PARP program; synergy in HR-deficient cancers? $ ABBV # ASCO14,,,#,4.72884E+17,https://twitter.com/JoleneScience/status/472884263818260480,,,,
AmbryGenetics,5/31/2014 19:35,0,1,Booth 8143 at # ASCO14 Stop By! Come learn about our latest advancements in # cancer testing!pic.twitter.com/SOZBa0iEx3,,,# #,4.72884E+17,https://twitter.com/AmbryGenetics/status/472884184005230592,,,,
socflyny,5/31/2014 19:35,0,1,@ kellykcotton @ drattai The Best! (As is @ LGG1) Wish I could be there! @ ASCO # ASCO14,,@ @ @ @,#,4.72884E+17,https://twitter.com/socflyny/status/472884101934886912,,,,
socflyny,5/31/2014 19:33,1,0,Wow! MT @ timturnham Melanoma is most common cancer in pregnant women. Substance in blood makes melanoma cells grow in lab. # asco14,,@,#,4.72884E+17,https://twitter.com/socflyny/status/472883527084965888,,,,
clairepope9,5/31/2014 19:32,0,0,“ @ Cascadia: Where are patient voices at largest cancer conf? # ASCO14 see @ jtvcancer get in touch for more info,,@ @,#,4.72883E+17,https://twitter.com/clairepope9/status/472883415101218817,,,,
globalmcures,5/31/2014 19:32,0,0,Dr. Amy Abernathy on the Use of # Statins in Patients at End-of-Life http://am.asco.org/dr-amy-abernathy-use-statins-patients-end-life … # ASCO14 # GlobalMedicalCures,,,# # #,4.72883E+17,https://twitter.com/globalmcures/status/472883302794543104,,,,
kellykcotton,5/31/2014 19:32,2,11,"Putting the social"" in social media at the # ASCO14 Tweetup! pic.twitter.com/21qI346MAB""",,,#,4.72883E+17,https://twitter.com/kellykcotton/status/472883290580328448,,,,
socflyny,5/31/2014 19:31,0,1,@ stales <--- # PartyCrasher # TakesOneToKnowOne # PartnerInCrime lol ; ) # asco14,,@,# # # #,4.72883E+17,https://twitter.com/socflyny/status/472883219529224192,,,,
EFEciencia,5/31/2014 19:31,3,2,La combinación de dos nuevas moléculas logra frenar con más eficacia el cáncer de ovario. http://www.efefuturo.com/noticia/la-combinacion-de-dos-nuevas-moleculas-logra-frenar-con-mas-eficacia-el-cancer-de-ovario/ … # ASCO14,,,#,4.72883E+17,https://twitter.com/EFEciencia/status/472883009301925888,,,,
globalmcures,5/31/2014 19:31,0,0,Wnt Signaling Pathways in # Cancer: A New Hope | # ASCO14 Annual Meeting http://am.asco.org/wnt-signaling-pathways-cancer-new-hope#.U4pmHYP5ZBg.twitter … # GlobalMedicalCures,,,# # # #,4.72883E+17,https://twitter.com/globalmcures/status/472882971024715776,,,,
socflyny,5/31/2014 19:30,0,0,@ urotoday # ASCOProblems ; ) # ASCO14,,@,# #,4.72883E+17,https://twitter.com/socflyny/status/472882948950085632,,,,
medpagetoday,5/31/2014 19:30,2,1,"Barbara Ann Burtness, MD, on Reduced-dose IMRT in HPV. # ASCO14 @ ASCOPost Watch the video here: http://bit.ly/1rv0fmX",,@,#,4.72883E+17,https://twitter.com/medpagetoday/status/472882723376218113,,,,
socflyny,5/31/2014 19:29,1,1,"@ drdonsdizon And hopefully, collaboration : ) (Wish I Was There!) ; ) # asco14",,@,#,4.72883E+17,https://twitter.com/socflyny/status/472882676043894785,,,,
globalmcures,5/31/2014 19:29,0,0,"State of # Cancer Care in America: 2014"" Hill Briefing Webcast http://www.asco.org/practice-research/state-cancer-care-america-2014-hill-briefing-webcast … # Asco14 # asco2014 # globalmedicalcures""",,,# # # #,4.72883E+17,https://twitter.com/globalmcures/status/472882665688145920,,,,
DrLCohen,5/31/2014 19:29,2,1,“ @ CliffordHudis: Obesity is the new tobacco. resources http://bit.ly/1puQK2p # ASCO14” @ BlueCure @ margaretcuomo @ DrDavidKatz @ katiecouric,,@ @ @ @ @,#,4.72883E+17,https://twitter.com/DrLCohen/status/472882603633434624,,,,
annaazvolinsky,5/31/2014 19:28,1,0,"Next year, # ASCO14 shuttles with windows that open, please. Is that too much to ask to at least partly enjoy the wonderful weather?",,,#,4.72882E+17,https://twitter.com/annaazvolinsky/status/472882461698183168,,,,
urotoday,5/31/2014 19:28,1,1,Long lines for the buses... 30 minutes waiting and still not boarded a bus yet! # ASCO14 pic.twitter.com/7tTBFkjeMo,,,#,4.72882E+17,https://twitter.com/urotoday/status/472882364146667520,,,,
stales,5/31/2014 19:28,0,1,@ caitlinjenkins Sorry! I'm not at # ASCO14 I wish I was!! I miss all my friends from @ genentech and # REV2014 How are you? Hope all is well!,,@ @,# #,4.72882E+17,https://twitter.com/stales/status/472882325978877952,,,,
globalmcures,5/31/2014 19:27,0,0,Progress in # BreastCancer Research | # ASCO2014 Annual Meeting http://am.asco.org/progress-breast-cancer-research#.U4plKLakfoA.twitter … # Cancer # GlobalMedicalCures # Breast # Women # Mom,,,# # # # # # # #,4.72882E+17,https://twitter.com/globalmcures/status/472881972201541632,,,,
VincentRK,5/31/2014 19:26,1,1,"Agree. Don't like casual use. MT “ @ mtmdphd: Standard(s) of care"" is tricky. Different meanings for practice", IRBs, insurance," etc # ASCO14”""",,@,#,4.72882E+17,https://twitter.com/VincentRK/status/472881869298487296,
globalmcures,5/31/2014 19:25,0,0,50 Years in # BreastCancer: Dramatic Progress in Treatment Based On an Improved Understanding of Biology | # ASCO2014 http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pk219g3jE.twitter …,,,# # #,4.72882E+17,https://twitter.com/globalmcures/status/472881597591453696,,,,
JayneJuvan,5/31/2014 19:25,2,0,"RT @ ClevelandClinic: “In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,@,# #,4.72881E+17,https://twitter.com/JayneJuvan/status/472881482244321280,,,,
LungCancerFaces,5/31/2014 19:23,0,4,I think I see @ JFreemanDaily! @ jrgralow: At TweetUp # asco14 pic.twitter.com/eHYA7k8KSc # LCSM,,@ @,# #,4.72881E+17,https://twitter.com/LungCancerFaces/status/472880970681819137,,,,
gastromom,5/31/2014 19:22,1,0,# ASCO14 what a lively feed. Soon we will need a tool to search within a hashtag,,,#,4.72881E+17,https://twitter.com/gastromom/status/472880936494059520,,,,
TargetedOnc,5/31/2014 19:22,1,3,Lenvatinib Highly Effective Against RAI-Resistant Differentiated Thyroid Cancer http://www.targetedonc.com/conference/asco-2014/Lenvatinib-Highly-Effective-Against-RAI-Resistant-Differentiated-Thyroid-Cancer … # ASCO14,,,#,4.72881E+17,https://twitter.com/TargetedOnc/status/472880857884024832,,,,
socflyny,5/31/2014 19:20,0,2,"THIS: MT @ ClevelandClinic: “The true value of healthcare isn't measured in dollars, but the dignity of the patient.” Dr. Salmasy # asco14",,@,#,4.7288E+17,https://twitter.com/socflyny/status/472880356484734977,,,,
Neil_Iyengar,5/31/2014 19:20,14,4,Great infographic re obesity & cancer risk from @ AICR thematic with # ASCO14 pic.twitter.com/xvFtoz5BKQ,,@,#,4.7288E+17,https://twitter.com/Neil_Iyengar/status/472880291070345216,,,,
myriadgenetics,5/31/2014 19:20,0,0,At # ASCO14? Visit Booth 2039 to learn about Myriad’s superior accuracy in # genetictesting & variant classification program! # cancer,,,# # #,4.7288E+17,https://twitter.com/myriadgenetics/status/472880207859154944,,,,
socflyny,5/31/2014 19:17,0,0,@ fischmd @ ASCO @ CliffordHudis SUGAR = New Tobacco. Challenge to find 'healthy' basics w/out it. Food Industry = No accountability # ASCO14,,@ @ @,#,4.7288E+17,https://twitter.com/socflyny/status/472879582761082880,,,,
jrgralow,5/31/2014 19:17,1,4,At TweetUp # asco14 pic.twitter.com/V56f9PrAl2,,,#,4.7288E+17,https://twitter.com/jrgralow/status/472879533234737153,,,,
PAN_Foundation,5/31/2014 19:16,0,2,Shout out to our great booth neighbors at # ASCO14 @ mylifelineorg!,,@,#,4.72879E+17,https://twitter.com/PAN_Foundation/status/472879390066757632,,,,
BoehringerES,5/31/2014 19:16,1,1,Empieza el blogging about lung cancer at # ASCO2014 siguelo en # notjustonedisease http://www.notjustonedisease.com @ boehringer,,@,# #,4.72879E+17,https://twitter.com/BoehringerES/status/472879386375770114,,,,
TargetedOnc,5/31/2014 19:15,2,3,"Suresh S. Ramalingam, MD, discusses data presented at # ASCO14 examining EGFR inhibitors for lung cancer http://www.targetedonc.com/conference/asco-2014/New-Data-for-EGFR-Inhibitors-for-Lung-Cancer …",,,#,4.72879E+17,https://twitter.com/TargetedOnc/status/472879002206871552,,,,
jagasquet,5/31/2014 19:15,1,0,Roche partners with Roche on 'breakthrough' PD-L1 cancer program http://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 … # immunotherapy # ASCO14 @ FierceBiotech,,@,# #,4.72879E+17,https://twitter.com/jagasquet/status/472878951204134913,,,,
jagasquet,5/31/2014 19:14,1,0,This infographic from @ PhRMA illustrates impact research & innovation on cancer survivor rates # ASCO14 pic.twitter.com/AV6k3ktW37 @ AstellasUS,,@ @,#,4.72879E+17,https://twitter.com/jagasquet/status/472878871373971457,,,,
Cortellis,5/31/2014 19:12,0,0,# ASCO14 pic.twitter.com/Rx1VYSZX28,,,#,4.72878E+17,https://twitter.com/Cortellis/status/472878435397038081,,,,
jaziehoncology,5/31/2014 19:12,2,6,ASCO Tweetup. It was quite a social meeting. No one was tweeting. Strangely! there was a network!! @ asco pic.twitter.com/9EVLHfQUGd,,@,,4.72878E+17,https://twitter.com/jaziehoncology/status/472878406053289984,,,,
El_Chapo219,5/31/2014 19:12,0,0,Got Dat Chopper With Monkey Nuts cause Wen I Shoot Tryna Knock A Nigga Face Off! # ASCO14,,,#,4.72878E+17,https://twitter.com/El_Chapo219/status/472878239417769984,,,,
DrLCohen,5/31/2014 19:10,9,5, @ fischmd: “In some ways," # obesity appears to be the new tobacco of our generation.” @ ASCO President @ CliffordHudis at # ASCO14 plenary.""""",,@ @ @,# #,4.72878E+17,https://twitter.com/DrLCohen/status/472877854062297088,,,
MaverickNY,5/31/2014 19:10,0,0,@ RichardWJoseph @ ERPlimackMD there were some presentations on that this afternoon by Dr Motzer and others. Some nice responses # asco14,,@ @,#,4.72878E+17,https://twitter.com/MaverickNY/status/472877698021601280,,,,
JoleneScience,5/31/2014 19:09,4,1,Nintedanib w/ chemo for ovarian cancer: modest mPFS increase (HR~0.85). Is this enough; how about OS? # gyncsm # ASCO14,,,# #,4.72878E+17,https://twitter.com/JoleneScience/status/472877561072988161,,,,
GlopesMd,5/31/2014 19:09,0,1,O uso de análogo de LHRH diminui falência ovariana e melhora a chance de mulheres com câncer de mama em quimioterapia engravidarem # ASCO14,,,#,4.72877E+17,https://twitter.com/GlopesMd/status/472877479472816128,,,,
DrAttai,5/31/2014 19:08,3,10,# asco14 tweetup with @ fischmd and @ mtmdphdpic.twitter.com/YlcGltEgx6,,@ @,#,4.72877E+17,https://twitter.com/DrAttai/status/472877384698310657,,,,
AndytweetM,5/31/2014 19:08,0,0,@ ASCO sorry for the quick follow-up. Any update ?,,@,,4.72877E+17,https://twitter.com/AndytweetM/status/472877283846684672,,,,
socflyny,5/31/2014 19:06,0,0,@ markaorourke Did they name any institutions? Many patients turned advocate w/ biz + marketing backgrounds that could do this well! # ASCO14,,@,#,4.72877E+17,https://twitter.com/socflyny/status/472876807021416448,,,,
PinkSheetMaryJo,5/31/2014 19:05,0,0,Schulman says need systemic fix so not confronting patients faced w life-threatening illness w cost issues. # ASCO14,,,#,4.72877E+17,https://twitter.com/PinkSheetMaryJo/status/472876503882276864,,,,
markaorourke,5/31/2014 19:03,0,2,# ASCO14 Cancer institutions are preparing educational materials to explain tumor profiling. How does one make it 5th grade reading level.,,,#,4.72876E+17,https://twitter.com/markaorourke/status/472876072573624321,,,,
PinkSheetMaryJo,5/31/2014 19:03,0,0,Conti dislikes suggestions to increase copays to make patients more sensitive to price. Regressive. # asco14,,,#,4.72876E+17,https://twitter.com/PinkSheetMaryJo/status/472876009986203648,,,,
JackWestMD,5/31/2014 19:02,0,3,Great time at # ASCO14 Tweetup! RT @ drattai: With @ JackWestMDpic.twitter.com/Xf3ekJkEb7,,@ @,#,4.72876E+17,https://twitter.com/JackWestMD/status/472875800769736704,,,,
DrAttai,5/31/2014 19:02,1,1,# asco14 tweetup with @ JackWestMD # bcsm # lcsmpic.twitter.com/nxiv22TYHl,,@,# # #,4.72876E+17,https://twitter.com/DrAttai/status/472875739680083968,,,,
SophiaCeulemans,5/31/2014 19:01,0,0,I met Dr Jack Cuzick today! I feel like I just met a celebrity at # ASCO14,,,#,4.72876E+17,https://twitter.com/SophiaCeulemans/status/472875580393005056,,,,
Cortellis,5/31/2014 19:01,1,0,Alectinib capsule (150 mg) shows high efficacy and favorable safety for ALK-rearranged NSCLC patients # ASCO14,,,#,4.72876E+17,https://twitter.com/Cortellis/status/472875534729216000,,,,
CancerDotNet,5/31/2014 19:01,1,1,ICYMI: Patient-friendly recap of today's # cancer research headlines from # ASCO14 here: http://bit.ly/1mRL4iv,,,# #,4.72875E+17,https://twitter.com/CancerDotNet/status/472875453355933696,,,,
socflyny,5/31/2014 19:00,1,0,"@ yzafar Many doctors & hospitals elected not to participate in # ACA plans; this is HUGE survivor issue, too. # ASCO14",,@,# #,4.72875E+17,https://twitter.com/socflyny/status/472875309831032832,,,,
scientre,5/31/2014 19:00,0,2,"Sun @5:05PM (S504) I'll be talking abt Emerging Tools for Collecting Patient-Reported Outcomes # asco14 Good progress, cool stuff on horizon",,@5,#,4.72875E+17,https://twitter.com/scientre/status/472875212661616640,,,,
myriadgenetics,5/31/2014 19:00,1,0,Multi-gene panel tests result in significant treatment changes for # cancer patients. Visit use at Booth 2039 to learn more! # ASCO14,,,# #,4.72875E+17,https://twitter.com/myriadgenetics/status/472875203031080960,,,,
PinkSheetMaryJo,5/31/2014 18:59,1,1,"Polite warns # ASCO14, danger of bundling is that it's difficult to unbundle",,,#,4.72875E+17,https://twitter.com/PinkSheetMaryJo/status/472875048202944512,,,,
socflyny,5/31/2014 18:57,1,0,@ ElizBlanchardMD Did it mention that many doctors & hospitals aren't accepting # ACA plans? This is a huge survivor issue ... # ASCO14,,@,# #,4.72875E+17,https://twitter.com/socflyny/status/472874651828621312,,,,
MaverickNY,5/31/2014 18:57,1,13,And joined by the really nice @ JPZaragoza1 love meeting bio tweeps in real life! # asco14 pic.twitter.com/bgTpw7OOCt,,@,#,4.72875E+17,https://twitter.com/MaverickNY/status/472874628764139520,,,,
IMFmyeloma,5/31/2014 18:57,5,4,Seen around # ASCO14: Mike Katz interviewing Angela Dispenzieri Mayo Clinic researcher involved in measles virotherapy pic.twitter.com/qX6KOdNUud,,,#,4.72875E+17,https://twitter.com/IMFmyeloma/status/472874626129743872,,,,
hospicedoctor,5/31/2014 18:57,0,1,@ drdonsdizon These are wonderful slides from my Twitter pal at # ASCO14 patient # advocacy & # SoMe for @ learnhospice @ shirleyayres @ mjseres,,@ @ @ @,# # #,4.72874E+17,https://twitter.com/hospicedoctor/status/472874479987982336,,,,
PinkSheetMaryJo,5/31/2014 18:56,1,0,"Conti: cost of development not = drug price, related to what market will bear. More bargaining could bring down, she tells # ASCO14",,,#,4.72874E+17,https://twitter.com/PinkSheetMaryJo/status/472874344474238976,,,,
GenomicHealth,5/31/2014 18:56,2,1,Having fun at # ASCO14 & looking forward to tweetup!,,,#,4.72874E+17,https://twitter.com/GenomicHealth/status/472874342729007104,,,,
MaverickNY,5/31/2014 18:56,2,17,"Great to meet @ bradloncar again! Super guy, v smart # asco14 pic.twitter.com/HkdIOx0a4Y",,@,#,4.72874E+17,https://twitter.com/MaverickNY/status/472874241013338112,,,,
PinkSheetMaryJo,5/31/2014 18:55,0,0,"@ KUhlendorf Conti now pointing out drastically cutting drug prices would deter innovation, citing vaccines and antibiotics. # ASCO14",,@,#,4.72874E+17,https://twitter.com/PinkSheetMaryJo/status/472874033185566721,,,,
CancerMedMDA,5/31/2014 18:55,3,1,Combining ENZA w/ abiraterone acetate in bone metastatic castration resistant prostate cancer. Learn more Sun. 8 AM. # ASCO14 # endcancer,,,# #,4.72874E+17,https://twitter.com/CancerMedMDA/status/472873933352763392,,,,
LizDowling2,5/31/2014 18:54,2,1,# ASCO14 Swain & Nunes analyze biology of bc in African American women using MammaPrint and BluePrint # bcsm http://bit.ly/SlaSZU,,,# #,4.72874E+17,https://twitter.com/LizDowling2/status/472873878012694528,,,,
socflyny,5/31/2014 18:54,0,1,@ drattai @ jrgralow @ rsm2800 Three of our # BCSM Rock Stars! : ) # ASCO14,,@ @ @,# #,4.72874E+17,https://twitter.com/socflyny/status/472873825894690816,,,,
caitlinjenkins,5/31/2014 18:54,2,0,RT @ Gene_Antibody: Phew! Amazing first day at # asco14 I'm exhausted. # blisterwalk http://goo.gl/ljz0BH,,@,# #,4.72874E+17,https://twitter.com/caitlinjenkins/status/472873704465367041,,,,
EthanBasch1,5/31/2014 18:53,1,1,"Prostate: once again, no benefits of hormones as primary therapy in localized prostate ca - Rutgers study # ASCO14 pic.twitter.com/vqpKj6F5B8",,,#,4.72874E+17,https://twitter.com/EthanBasch1/status/472873630955601920,,,,
ArulPerumal,5/31/2014 18:53,0,0,This infographic from @ PhRMA illustrates the impact research & innovation has had on cancer survivor rates # ASCO14 http://lnkd.in/b--KDdC,,@,#,4.72874E+17,https://twitter.com/ArulPerumal/status/472873615273123840,,,,
bpowersphoto,5/31/2014 18:53,0,0,Nice light as day two of # asco14 comes to an end in # chicago. @McCormick Place http://instagram.com/p/orb30rLH1S/,,@McCormick,# #,4.72874E+17,https://twitter.com/bpowersphoto/status/472873581722890240,,,,
minnesotadon,5/31/2014 18:53,0,0,@ ASCO I am at the tweetup. Is anybody saying anything?,,@,,4.72873E+17,https://twitter.com/minnesotadon/status/472873478291337216,,,,
GenentechJobs,5/31/2014 18:53,0,0,# ASCO14 Talent Hunt: Clinical Scientist Specialist: http://click2apply.net/0412468t,,,#,4.72873E+17,https://twitter.com/GenentechJobs/status/472873445802274816,,,,
LguzzardiM,5/31/2014 18:50,5,1,Genomic profiling of breast cancer in African American women. # ASCO14 http://abstracts.asco.org/144/AbstView_144_132631.html …,,,#,4.72873E+17,https://twitter.com/LguzzardiM/status/472872881358393344,,,,
yzafar,5/31/2014 18:50,1,0,"@ CancerGeek yes, complexity and also frequency of visits. # ASCO14",,@,#,4.72873E+17,https://twitter.com/yzafar/status/472872704291254272,,,,
SitemanCenter,5/31/2014 18:50,0,3,# ASCO14 Don't miss @ GColditz's cancer prevention talk & @ ASCO- @ AmericanCancer Award presentation 8 am Sun Rm S100a http://ow.ly/i/5KHWB,,@ @ @,#,4.72873E+17,https://twitter.com/SitemanCenter/status/472872695634591744,,,,
ProjectInno,5/31/2014 18:50,0,0,. @ projectinno is attending # ASCO14 to spread the word about securing the future of # Cancer innovation http://www.bit.ly/1k7HSAA # innovatenow,,@,# # #,4.72873E+17,https://twitter.com/ProjectInno/status/472872693168340992,,,,
RichardWJoseph,5/31/2014 18:50,0,1,@ ERPlimackMD Anti-VEGF leads to favorable immune microenvironment. Would love a sequential approach of anti-VEGF followed by pd1. # ASCO14,,@,#,4.72873E+17,https://twitter.com/RichardWJoseph/status/472872662319259649,,,,
AshleySumrallMD,5/31/2014 18:49,1,0,BEV helps some newly dx pts with GBM get through radiation. # btam # tunein2gbm # ASCO14 http://meetinglibrary.asco.org/content/133461-144 …,,,# # #,4.72873E+17,https://twitter.com/AshleySumrallMD/status/472872633512755201,,,,
DrAttai,5/31/2014 18:49,2,7,First # asco14 tweetup pic with @ jrgralow and @ rsm2800pic.twitter.com/MgCU5On1pS,,@ @,#,4.72873E+17,https://twitter.com/DrAttai/status/472872594601807873,,,,
krystadawn,5/31/2014 18:49,0,0,Pretty much sums it up in 10 secs RT @ Gene_Antibody: Phew! Amazing first day at # asco14 I'm exhausted. # blisterwalk http://Instagram.com/p/orbOj1w9zn/,,@,# #,4.72873E+17,https://twitter.com/krystadawn/status/472872590852509696,,,,
drdonsdizon,5/31/2014 18:48,0,0,@ hopeitkeepsup @ Consano Nora: Their's would be a great story! # ASCO14,,@ @,#,4.72872E+17,https://twitter.com/drdonsdizon/status/472872323909836800,,,,
Gene_Antibody,5/31/2014 18:48,6,2,Phew! Amazing first day at # asco14 I'm exhausted. # blisterwalk http://instagram.com/p/orbOj1w9zn/,,,# #,4.72872E+17,https://twitter.com/Gene_Antibody/status/472872163469701120,,,,
DrHealeyBird,5/31/2014 18:46,0,1,# ASCO14 http://tinyurl.com/mx6f8t2 excellent discussion - the immune system isn't a static target PD1 IHC not enoughpic.twitter.com/Au4SWLHx3V,,,#,4.72872E+17,https://twitter.com/DrHealeyBird/status/472871744433553408,,,,
Sorena997,5/31/2014 18:46,1,1,# ASCO14 new class of drugs for NHL! great presentation by Martin,,,#,4.72872E+17,https://twitter.com/Sorena997/status/472871673893765120,,,,
CancerGeek,5/31/2014 18:45,0,0,"@ yzafar Isn't it due to the fear in complexity of cancer care, both during & follow through on post care? # ASCO14",,@,#,4.72872E+17,https://twitter.com/CancerGeek/status/472871500333473792,,,,
LizDowling2,5/31/2014 18:45,2,1,"Nunes shares findings on African American women molecular subtypes # bcsm at # ASCO14, more at http://bit.ly/SlaSZU pic.twitter.com/lQluREDZM6",,,# #,4.72871E+17,https://twitter.com/LizDowling2/status/472871482515668992,,,,
CancerMedMDA,5/31/2014 18:45,2,2,Learn more about BRCA testing in male patients from Dr. Zahi Mitri's poster. # ASCO14 Sun. 8 AM. # endcancer,,,# #,4.72871E+17,https://twitter.com/CancerMedMDA/status/472871419635052544,,,,
SophiaCeulemans,5/31/2014 18:45,0,0,"Should there be an institutional level ongoing process re: ethics and results of WGS/WES?"" - McCormick from @ MayoClinic # ASCO14""",,@,#,4.72871E+17,https://twitter.com/SophiaCeulemans/status/472871417344978945,,,,
CancerGeek,5/31/2014 18:44,1,0,"@ Lymphoma_Doc Frameworks like I-SPY2 will be future & allow for rapid iterations, results, & outcomes. # ASCO14",,@,#,4.72871E+17,https://twitter.com/CancerGeek/status/472871255004426240,,,,
mlazqui,5/31/2014 18:43,0,0,Casi! @ jlserna: Casi todos los oncólogos del mundo se han venido a Chicago a # ASCO14. La ciudad llena de ellos. pic.twitter.com/Q8KHPAtwFx,,@,#,4.72871E+17,https://twitter.com/mlazqui/status/472871116298780672,,,,
DrHealeyBird,5/31/2014 18:43,1,0,# ASCO14 http://tinyurl.com/q8v36w8 new class of drugs for NHL and other cancers - great presentation Martinpic.twitter.com/6djZpKBkC7,,,#,4.72871E+17,https://twitter.com/DrHealeyBird/status/472871074066341891,,,,
nycdoc29,5/31/2014 18:43,0,0,@ ASCO # ASCO14 - Got a ton of marketing mail once I registered! Have to figure out a more environment friendly way! pic.twitter.com/3bzlVQbMGa,,@,#,4.72871E+17,https://twitter.com/nycdoc29/status/472871028486844416,,,,
BeckyCanvin,5/31/2014 18:43,1,0,@ nycdoc29 ok.....only a handful of people here # ASCO14,,@,#,4.72871E+17,https://twitter.com/BeckyCanvin/status/472870996387438592,,,,
AstellasUS,5/31/2014 18:43,6,4,This infographic from @ PhRMA illustrates the impact research & innovation has had on cancer survivor rates # ASCO14 pic.twitter.com/gxSXLtoUBd,,@,#,4.72871E+17,https://twitter.com/AstellasUS/status/472870970160844800,,,,
AnneBooms,5/31/2014 18:43,0,0, @ drcbsteer: # ASCO14 It's 5:30am in Australia, 2:30pm here in Chicago. Awww," Jetlag!""",,@,#,4.72871E+17,https://twitter.com/AnneBooms/status/472870916553052160,,
m0370,5/31/2014 18:42,10,8,たくさんの薬を飲み過ぎの人が多いけど進行癌で緩和ケア中心の病状になったときは薬を整理して減らした方が予後が良いかも。予後1年以内と予測される人のコレステロールの薬は本当に必要ですか？という話。／ RT @ OncLive http://ow.ly/xtfQZ # ASCO14,,@,#,4.72871E+17,https://twitter.com/m0370/status/472870817647194112,,,,
RCSHChicago,5/31/2014 18:41,0,1,The restaurant is full for # ASCO14 weekend so we are out catering an event! Try us for your next party! pic.twitter.com/SYQ26DQ3iD,,,#,4.7287E+17,https://twitter.com/RCSHChicago/status/472870423273930752,,,,
ElizBlanchardMD,5/31/2014 18:40,0,1,Excellent presentation on impact of ACA on cancer care by Dr Blase Polite. Of note: QOPI will be used for quality metric reporting # ASCO14,,,#,4.7287E+17,https://twitter.com/ElizBlanchardMD/status/472870316952145920,,,,
CBPartners,5/31/2014 18:40,0,0,"# ASCO14 buzzing with the question, how do we define value?"" http://bit.ly/1u2z3tE http://bit.ly/1oeCFoH""",,,#,4.7287E+17,https://twitter.com/CBPartners/status/472870300153962497,,,,
markaorourke,5/31/2014 18:40,0,0,# ASCO14 When is the evidence base sufficient for WES/WGS in an ongoing innovation space apart from research?,,,#,4.7287E+17,https://twitter.com/markaorourke/status/472870260493017088,,,,
ChapinMD,5/31/2014 18:40,0,2,Pleasure to have met @ ERPlimackMD at # ASCO14 Within minutes if following exchange. # coincidence,,@,# #,4.7287E+17,https://twitter.com/ChapinMD/status/472870196932132864,,,,
TGeorgeMD,5/31/2014 18:40,14,2,New surrogate for rectal cancer # clinicaltrials (NAR Score) better than pCR in predicting survival. Validated X 2. @ NRGonc # crcsm # ASCO14,,@,# # #,4.7287E+17,https://twitter.com/TGeorgeMD/status/472870185951838208,,,,
CancerDotNet,5/31/2014 18:40,2,4,Searchable collection of # ASCO14 patient research summaries so far - and more to come! http://bit.ly/1hc1eil,,,#,4.7287E+17,https://twitter.com/CancerDotNet/status/472870182701244416,,,,
scientre,5/31/2014 18:40,0,1,"# asco14 tweetup venue ready... If those folks to right were on Twitter, they'd be here now rather than on taxi line! pic.twitter.com/wjAwU23rNH",,,#,4.7287E+17,https://twitter.com/scientre/status/472870156977594368,,,,
PDRennert,5/31/2014 18:39,1,2,Oh this is nice. Ruxotinib + panobinistat showing synergy in myelofibrosis trials. No data on fibrotic status of the bone marrow # ASCO14,,,#,4.7287E+17,https://twitter.com/PDRennert/status/472870123796459520,,,,
CancerAdvocacy,5/31/2014 18:39,1,1,"Two productive and informative days at # ASCO14. Important discussions on value, quality in cancer care.",,,#,4.7287E+17,https://twitter.com/CancerAdvocacy/status/472870080729350144,,,,
minnesotadon,5/31/2014 18:39,1,1,@ ASCO Here for the tweetup. Is this working?,,@,,4.7287E+17,https://twitter.com/minnesotadon/status/472870009069654016,,,,
MediTech_Media,5/31/2014 18:38,0,0,"Today was jam-packed with exciting new research findings # ASCO14. Wish we could have tweeted them all! Genomics, biomarkers, etc. Hot topics",,,#,4.7287E+17,https://twitter.com/MediTech_Media/status/472869873929158658,,,,
myPathMelanoma,5/31/2014 18:38,0,0,Stop by the @ MyriadGenetics myPath # Melanoma booth 2039 to check out our new # melanomadiagostic assay. # ASCO14 # isthismelanoma,,@,# # # #,4.7287E+17,https://twitter.com/myPathMelanoma/status/472869632500449281,,,,
LurieCancer,5/31/2014 18:37,1,4,Getting Warm! # ASCO14 pic.twitter.com/bY5a6jsklw,,,#,4.7287E+17,https://twitter.com/LurieCancer/status/472869617623244800,,,,
nycdoc29,5/31/2014 18:37,0,0,“ @ BeckyCanvin: At # ASCO14 for the official tweet up. Who else is here?” Will be there shortly! Colorectal session ongoing in D2,,@,#,4.7287E+17,https://twitter.com/nycdoc29/status/472869565069025280,,,,
SAJansky,5/31/2014 18:37,0,0,View outside the # ASCO14 press room. I love Chicago in the summer. pic.twitter.com/u5Fj6kOhvW,,,#,4.72869E+17,https://twitter.com/SAJansky/status/472869417987346432,,,,
PatriciaMWinter,5/31/2014 18:37,1,1,@ ASCO is the # ASCO14 tweetup happening outside starbucks? pic.twitter.com/8wJrGrt8ve,,@,#,4.72869E+17,https://twitter.com/PatriciaMWinter/status/472869383270707200,,,,
MOCBrasil,5/31/2014 18:36,0,1,"Pts com CA MAMA HER2+, < 2 cm se beneficiam em SLP e SG apos o tto adjuvante com Transtuzumabe. # MOCnaASCO # ASCO2014",,,# #,4.72869E+17,https://twitter.com/MOCBrasil/status/472869329814708224,,,,
yzafar,5/31/2014 18:36,0,1,Polite: Out of network trials not covered under ACA. Critical for patients traveling to referral centers # ASCO14 pic.twitter.com/SE83TSWAAB,,,#,4.72869E+17,https://twitter.com/yzafar/status/472869309899747328,,,,
ERPlimackMD,5/31/2014 18:36,1,0,"Dr. Tanya Dorff discusses: endpoint selection in CRPC trials remains a challenge, need to choose carefully. # ASCO14 # gusm",,,# #,4.72869E+17,https://twitter.com/ERPlimackMD/status/472869293554954240,,,,
Mills_I,5/31/2014 18:36,2,1,"NSCLC ALK+ tx post Criz include 2nd generation inhibitors-ceretinib, alectinib,AP26113; pemetrexed; HSP90. # ASCO14 # lcsm @ cancerGRACE",,@,# #,4.72869E+17,https://twitter.com/Mills_I/status/472869284344238080,,,,
markaorourke,5/31/2014 18:36,0,0,"# ASCO14 Informed consent and research regulation is recurring theme in WES/WGS discussion. Need new models for pt protection"" in CER.""",,,#,4.72869E+17,https://twitter.com/markaorourke/status/472869254224965632,,,,
inkkr,5/31/2014 18:36,0,1,"Headed to @ MarkSchoenebaum's soirée at @ NoMIchicago. Certainly a highlight of # ASCO14, no doubt.",,@ @,#,4.72869E+17,https://twitter.com/inkkr/status/472869225242304512,,,,
SophiaCeulemans,5/31/2014 18:35,0,0,McCormick from @ MayoClinic: important to consider if WGS/WES is considered research or clinical when determining # ethics # ASCO14,,@,# #,4.72869E+17,https://twitter.com/SophiaCeulemans/status/472869109861216257,,,,
her2friends,5/31/2014 18:35,0,0,PGanz of ucla providing QOL for cancer patients discusses # ASCO14 pic.twitter.com/9CvUQyPZPE,,,#,4.72869E+17,https://twitter.com/her2friends/status/472869098654011393,,,,
OncLive,5/31/2014 18:34,2,3,Targeted Therapy Combination Improves PFS in Ovarian Cancer http://ow.ly/xtRmi # ASCO14,,,#,4.72869E+17,https://twitter.com/OncLive/status/472868824728231937,,,,
DrSabha,5/31/2014 18:34,0,0,"While screening is covered under the ACA, biopsies related to screening are not. # ASCO14",,,#,4.72869E+17,https://twitter.com/DrSabha/status/472868821670572032,,,,
jrgralow,5/31/2014 18:34,1,0,"Small HER2+ br ca - meta-analysis of trastuzumab benefit in randomized trials. Need to look specifically at T1N0 patients, not LN+ # ASCO14",,,#,4.72869E+17,https://twitter.com/jrgralow/status/472868806843699201,,,,
warrenhogarth,5/31/2014 18:33,2,3,MDanderson and @ GuardantHealth presenting results # ASCO14 pic.twitter.com/LTUP8XTdGj,,@,#,4.72869E+17,https://twitter.com/warrenhogarth/status/472868574705774593,,,,
ElizBlanchardMD,5/31/2014 18:33,0,1,Frequent issue RT @ OncLive: Is it safe to discontinue statins for a patient with less than a year to live? http://ow.ly/xtfQZ # ASCO14,,@,#,4.72869E+17,https://twitter.com/ElizBlanchardMD/status/472868519290220544,,,,
robynkarlage,5/31/2014 18:33,0,2,My department chair getting award for pediatric oncology research at # ASCO14 we're doing awesome things at # stjude!pic.twitter.com/UqWkW80OEK,,,# #,4.72869E+17,https://twitter.com/robynkarlage/status/472868507458105344,,,,
TGeorgeMD,5/31/2014 18:33,3,1,Dr. Baxter-Resecting lung mets in crc # cancer is safe w/ survival similar to liver. May be option for some # crcsm # ASCO14,,,# # #,4.72868E+17,https://twitter.com/TGeorgeMD/status/472868480048721920,,,,
scientre,5/31/2014 18:33,1,1,"Berry suggests @ NovartisScience TPS2646 6/1 8AM Signature Program: series of tissue-agnostic, mutn-specific signal finding trials # ASCO14",,@,#,4.72868E+17,https://twitter.com/scientre/status/472868435903676416,,,,
DrSabha,5/31/2014 18:32,0,0,@ ASCO will soon be coming out with a firm policy recommending all states to participate in Medicaid expansion # ASCO14 # cancer,,@,# #,4.72868E+17,https://twitter.com/DrSabha/status/472868358153441280,,,,
rsm2800,5/31/2014 18:32,0,0,"O’Sullivan: ER- 1957/4220 pts, most T1c; DFS difference in HERA vs NSABP B-31, might be due to cross-over? # asco14",,,#,4.72868E+17,https://twitter.com/rsm2800/status/472868193111789568,,,,
BeckyCanvin,5/31/2014 18:32,2,2,At # ASCO14 for the official tweet up. Who else is here?,,,#,4.72868E+17,https://twitter.com/BeckyCanvin/status/472868128209121280,,,,
davidbeme,5/31/2014 18:31,2,0,Cancer : Faut-il alléger l’ordonnance des patients en fin de vie ? # ASCO2014 @ doctissimo http://ow.ly/xtRhX,,@,#,4.72868E+17,https://twitter.com/davidbeme/status/472868115874070529,,,,
FirstReportMC,5/31/2014 18:31,1,1,Here's our story from the ASCO annual meeting on the combo of olaparib & cediranib to treat ovarian cancer - http://www.firstreportnow.com/first/olaparib-plus-cediranib-treat-ovarian-cancer … # ASCO14,,,#,4.72868E+17,https://twitter.com/FirstReportMC/status/472868108349104129,,,,
PhRMA,5/31/2014 18:31,2,2,. @ Celgene put the cost & value of # innovative meds in perspective. Read the story here: http://bit.ly/1ku6YbS # ASCO14,,@,# #,4.72868E+17,https://twitter.com/PhRMA/status/472867902496858112,,,,
davidbeme,5/31/2014 18:30,0,0,Cancer de la thyroïde résistants à l'iode 13: le lenvatinib efficace avec toxicité importante # ASCO2014 @ doctissimo http://ow.ly/xtR6x,,@,#,4.72868E+17,https://twitter.com/davidbeme/status/472867849338621953,,,,
Javier__gamez,5/31/2014 18:30,0,0,@ ASCO @ FightCRC cannabis can cure all!!!,,@ @,,4.72868E+17,https://twitter.com/Javier__gamez/status/472867800592048128,,,,
ProjectInno,5/31/2014 18:30,0,0,It's time to put cancer innovation on the national agenda! http://ow.ly/xtaL3 via @ dddmag # ASCO14,,@,#,4.72868E+17,https://twitter.com/ProjectInno/status/472867776550674432,,,,
OncLive,5/31/2014 18:30,2,1,Is it safe to discontinue statins for a patient with less than a year to live? http://ow.ly/xtfQZ # ASCO14,,,#,4.72868E+17,https://twitter.com/OncLive/status/472867768103370752,,,,
ASCO,5/31/2014 18:30,17,9,50 Years in Breast Cancer: Improved understanding of biology leads to progress in treatment http://bit.ly/1hmg0IH # ASCO14 # bcsm,,,# #,4.72868E+17,https://twitter.com/ASCO/status/472867753154867200,,,,
ASCO,5/31/2014 18:30,4,3,Read Educational Book articles on topics in Pediatric Oncology from # ASCO14 Education Session Speakers: http://bit.ly/1mzMSwC,,,#,4.72868E+17,https://twitter.com/ASCO/status/472867737417826304,,,,
CancerMedMDA,5/31/2014 18:30,3,2,Dr. Rodabe Amaria to co-chair session on novel combination therapies for melanoma. Dr. Michael Davies on molecular basis. Sun. 8 AM. # ASCO14,,,#,4.72868E+17,https://twitter.com/CancerMedMDA/status/472867709857050624,,,,
CareAcross,5/31/2014 18:30,0,0,"Unfortunately we'll miss it :( MT @ ASCO It's not too late to join us at today's # ASCO14 Tweetup, 5:45PM, Level 2.5 Food Court",,@,#,4.72868E+17,https://twitter.com/CareAcross/status/472867655612129280,,,,
myriadgenetics,5/31/2014 18:30,2,1,Did you know that # genepanel testing identifies more mutations and more # cancers? Visit us at Booth 2039 to find out more! # ASCO14,,,# # #,4.72868E+17,https://twitter.com/myriadgenetics/status/472867620144705536,,,,
MOCBrasil,5/31/2014 18:29,0,0,Trastuzumabe no tto adjuvante de CA Mama HER2+ < 2cm; meta-analise # MOCnaASCO # asco14,,,# #,4.72868E+17,https://twitter.com/MOCBrasil/status/472867516235390976,,,,
rsm2800,5/31/2014 18:29,0,0,"O’Sullivan: 2263/4220 were ER+, DFS HR=0.7 for trastuz vs none # asco14",,,#,4.72867E+17,https://twitter.com/rsm2800/status/472867449914683392,,,,
rsm2800,5/31/2014 18:27,0,0,"O’Sullivan: Trials included all of the big randomized trials, but not BCIRG006; final meta-analysis of 4220 pt # ASCO14",,,#,4.72867E+17,https://twitter.com/rsm2800/status/472867064982433792,,,,
RamalingamMD,5/31/2014 18:27,10,3,Excellent poster session on lung cancer # ASCO14 # Lcsm. Peripheral blood tests to detect mutations shows promise.,,,# #,4.72867E+17,https://twitter.com/RamalingamMD/status/472866998821859328,,,,
SophiaCeulemans,5/31/2014 18:27,0,0,Bradbury: we need best practices and standards on # genomic tumor profiling # ASCO14,,,# #,4.72867E+17,https://twitter.com/SophiaCeulemans/status/472866875966504961,,,,
cmartindedios,5/31/2014 18:27,0,0,@ ASCO What Oncologists wants? # ASCO14 # healthcare in America in 2014pic.twitter.com/tWHD8npPmr,,@,# #,4.72867E+17,https://twitter.com/cmartindedios/status/472866863517429760,,,,
brianbrewer,5/31/2014 18:26,0,0,Decompressing from an intensely good day of networking. # asco14 http://4sq.com/1jIl8kT,,,#,4.72867E+17,https://twitter.com/brianbrewer/status/472866842126843905,,,,
amylmurphy10,5/31/2014 18:26,3,2,MT @ stuxrt: Standing room only to see @Carolinas HealthCare System's Awesome Asim Amin at the podium # ASCO14 # LCIpic.twitter.com/i4yp6MUby7,,@ @Carolinas,# #,4.72867E+17,https://twitter.com/amylmurphy10/status/472866754352250881,,,,
warrenhogarth,5/31/2014 18:26,3,4,@ GuardantHealth 360 non-invasive tumor sequencing now available to all cancer patients # ASCO14 - http://bit.ly/1kjfdY2 cc: @ Sequoia_Capital,,@ @,#,4.72867E+17,https://twitter.com/warrenhogarth/status/472866705941999616,,,,
aftimosp,5/31/2014 18:26,0,0,AVATAXHER has an elegant design using SUV change after 1 cycle of neo-adjuvan chemo + trastuzumab to stratify patients # BreastCancer # ASCO14,,,# #,4.72867E+17,https://twitter.com/aftimosp/status/472866705295679488,,,,
EthanBasch1,5/31/2014 18:26,1,2,Prostate: limited benefits of abiraterone after enzalutamide and vice versa despite persistent AR activity # ASCO14 pic.twitter.com/2KYiGraw5R,,,#,4.72867E+17,https://twitter.com/EthanBasch1/status/472866665374707713,,,,
rsm2800,5/31/2014 18:26,1,0,O’Sullivan: Looked at sep analysis for ER+ vs ER_ in pts w/ small HER2+ tumors # ASCO14,,,#,4.72867E+17,https://twitter.com/rsm2800/status/472866660718637056,,,,
jrgralow,5/31/2014 18:25,2,4,Unravelling the Complexities of Breast Cancer Genomics # ASCO14 http://am.asco.org/unravelling-complexities-breast-cancer-genomics#.U4pWzfFJEK0.twitter …,,,# #,4.72867E+17,https://twitter.com/jrgralow/status/472866547673747456,,,,
mtmdphd,5/31/2014 18:25,6,1,"Standard(s) of care"" is tricky. Different meanings for clinical practice", IRBs, insurance," etc esp as related to clinical trials. # ASCO14""",,,#,4.72866E+17,https://twitter.com/mtmdphd/status/472866455089074176,
rsm2800,5/31/2014 18:25,1,0,O’Sullivan: Talking about trastuzumab (T) in HER2+ < 2cm; meta-analysis # asco14,,,#,4.72866E+17,https://twitter.com/rsm2800/status/472866434687582209,,,,
socflyny,5/31/2014 18:25,0,2,The tweet-up makes me feel like I'm there ... perhaps next year. Great info and insights. # asco14,,,#,4.72866E+17,https://twitter.com/socflyny/status/472866430065471488,,,,
oncotuits,5/31/2014 18:25,0,0,Toxicity requires experience # ASCO14 @ droncoped,,@,#,4.72866E+17,https://twitter.com/oncotuits/status/472866427272433664,,,,
DoctorEdny,5/31/2014 18:25,4,2,"Dr Berry @ MDAndersonNews no ? clinical trials will change dramatically"" # ASCO14 pic.twitter.com/OWqDsR9HH3""",,@,#,4.72866E+17,https://twitter.com/DoctorEdny/status/472866395752267776,,,,
CancerMedMDA,5/31/2014 18:25,1,0,Dr. Rashmi Murthy on genetic testing referral patterns & outcomes in high-risk breast cancer survivors. # ASCO14 Poster Sun. 8 AM. # endcancer,,,# #,4.72866E+17,https://twitter.com/CancerMedMDA/status/472866383727190016,,,,
alantanmd,5/31/2014 18:24,6,1,AP26113 ALK inhibitor for ALK+ NSCLC with responses in brain mets $ ARIA # ASCO14 pic.twitter.com/0m0be3JDtc,,,#,4.72866E+17,https://twitter.com/alantanmd/status/472866286905856001,,,,
wordsbyjess,5/31/2014 18:24,2,3,@ drcbsteer @ ddembe @ ProfFranBoyle @ AnneBooms Excellent. Thinking of doing an # ASCO14 summary for the next @ COSAoncology enews.,,@ @ @ @ @,#,4.72866E+17,https://twitter.com/wordsbyjess/status/472866196899893249,,,,
aftimosp,5/31/2014 18:24,0,0,AVATAXHER: adding bevacizumab increased the pCR rate in combination with trastuzumab in patients with an insufficient PET response # ASCO14,,,#,4.72866E+17,https://twitter.com/aftimosp/status/472866180126896128,,,,
MalakAbed,5/31/2014 18:23,5,4,Progress in # BreastCancer Research | ASCO Annual Meeting http://am.asco.org/progress-breast-cancer-research#.U4pWLIUzbLh.twitter …. # asco14,,,# # #,4.72866E+17,https://twitter.com/MalakAbed/status/472865888623153152,,,,
surgicalcaps,5/31/2014 18:22,0,0,@ ASCO # chicago,,@,#,4.72866E+17,https://twitter.com/surgicalcaps/status/472865734578958336,,,,
socflyny,5/31/2014 18:22,0,0,"@ drattai @ chemobrainfog Haha! Nothing a job wouldn't resolve, either. ; ) # ASCO14",,@ @,#,4.72866E+17,https://twitter.com/socflyny/status/472865729772261377,,,,
BioWorld,5/31/2014 18:22,2,1,"Bradbury at # ASCO14: The idea that tumor genomic profiling is broadly beneficial is for now a hypothesis, not a foregone conclusion",,,#,4.72866E+17,https://twitter.com/BioWorld/status/472865662692380672,,,,
brianbrewer,5/31/2014 18:21,0,0,Brian Reid is the Answer to Cancer. @ TheA2C @ brianreid # immunotherapy # asco14 pic.twitter.com/qG0vQQKLvn,,@ @,# #,4.72866E+17,https://twitter.com/brianbrewer/status/472865577435152384,,,,
urotoday,5/31/2014 18:21,3,0,Interesting prostate cancer poster session at # ASCO14. Interviews and summaries coming shortly! pic.twitter.com/sqT3QeoQwD,,,#,4.72866E+17,https://twitter.com/urotoday/status/472865503288258561,,,,
scientre,5/31/2014 18:21,2,1,Berry: comparing features of modern platform trials # asco14 pic.twitter.com/viqV4OKGsu,,,#,4.72866E+17,https://twitter.com/scientre/status/472865501199491072,,,,
ElizBlanchardMD,5/31/2014 18:21,2,1,Dr Shulman: need to be cautious that 'payment reform' is not simply a shift of cost from provider to patient. # ASCO14,,,#,4.72865E+17,https://twitter.com/ElizBlanchardMD/status/472865478809899008,,,,
SophiaCeulemans,5/31/2014 18:21,1,0,Bradbury: Clinical utility is more complicated to assess in the context of bundled # genetic tests # ASCO14,,,# #,4.72865E+17,https://twitter.com/SophiaCeulemans/status/472865464113451010,,,,
lisap1999,5/31/2014 18:21,0,1,@ ASCO too bad I can't make it. Should be great!,,@,,4.72865E+17,https://twitter.com/lisap1999/status/472865447810199552,,,,
cmartindedios,5/31/2014 18:20,0,0,What patients want? @ asco # asco14 # healthcare in America in 2014pic.twitter.com/2kuUFcuxT3,,@,# #,4.72865E+17,https://twitter.com/cmartindedios/status/472865260178014209,,,,
2xHelix,5/31/2014 18:20,1,2,Congratulations to @ GuardantHealth on the commercial launch of their free-cell DNA cancer blood test - http://www.bizjournals.com/sanfrancisco/prnewswire/press_releases/California/2014/05/30/SF38463 … # ASCO14,,@,#,4.72865E+17,https://twitter.com/2xHelix/status/472865190242185216,,,,
DrSabha,5/31/2014 18:19,2,1,"When there is variation in oncology practice in the absence of data, we should then be factoring in cost of each pathway. # ASCO14",,,#,4.72865E+17,https://twitter.com/DrSabha/status/472865083039956992,,,,
ShabbirHossain,5/31/2014 18:19,0,0,@ yzafar Every case different but gross generalization 2 say in onc pcp cedes control. Cost containment has 2 be tackled as a team # ASCO14,,@,#,4.72865E+17,https://twitter.com/ShabbirHossain/status/472864923740282880,,,,
rsm2800,5/31/2014 18:19,0,0,"RT @ scientre: In the Berry session, somebody has volume on...their phone chirps every time they tweet :D # ASCO14 # twittershaming",,@,# #,4.72865E+17,https://twitter.com/rsm2800/status/472864888595820544,,,,
dramarivirg,5/31/2014 18:18,0,0,“ @ drattai: Giordano baseline obesity negative impact on survival in pre-menopausal women with ER+ BC. (1/2) # ASCO14 # bcsm” RT,,@,# #,4.72865E+17,https://twitter.com/dramarivirg/status/472864842563735552,,,,
DrSabha,5/31/2014 18:18,0,0,"Oncologist B, in the absence of data, would not provide chemo to avoid possible toxicity. # ASCO14",,,#,4.72865E+17,https://twitter.com/DrSabha/status/472864727974936576,,,,
markaorourke,5/31/2014 18:18,3,0,# ASCO14 Genetic profiling of tumors raises ethical questions when germline mutations found. Good discussion by Angela Bradbury.,,,#,4.72865E+17,https://twitter.com/markaorourke/status/472864721688068096,,,,
strategicTy,5/31/2014 18:18,1,0,Great 1st day at # asco14 ! Visit booth 4054 and hear about MD Anderson # phaseItrials and # oncolex http://ow.ly/i/5KKva,,,# # #,4.72865E+17,https://twitter.com/strategicTy/status/472864647197237248,,,,
ERPlimackMD,5/31/2014 18:18,3,2," @ RichardWJoseph: Unleashing the immune system in GU cancers was a great session. Much needed hope for urothelial and RCC patients. # ASCO14""""",,@,#,4.72865E+17,https://twitter.com/ERPlimackMD/status/472864629698203648,,,,
jrgralow,5/31/2014 18:18,1,2,see you there! RT @ ASCO: Joining us for our # ASCO14 Tweetup in 30 minutes? Here's a map of the location: pic.twitter.com/QApplWn9YU,,@,#,4.72865E+17,https://twitter.com/jrgralow/status/472864597180186625,,,,
DrSabha,5/31/2014 18:17,0,0,"Oncologist A, in the absence of data, would provide chemo in the hope of a possible survival benefit. # ASCO14",,,#,4.72865E+17,https://twitter.com/DrSabha/status/472864516569825280,,,,
TGeorgeMD,5/31/2014 18:17,2,0,"Dr. Reid - Pts w/ KRAS G13D mutations, in prospective study, DO NOT benefit from CMab. # crcsm # ASCO14. Should not use this treatment",,,# #,4.72864E+17,https://twitter.com/TGeorgeMD/status/472864360659165184,,,,
DrBredlau,5/31/2014 18:16,0,0,Ran in to my fellowship mentor at ASCO. How cool is that! :-) # ASCO14 # PBTP,,,# #,4.72864E+17,https://twitter.com/DrBredlau/status/472864336029831168,,,,
FightCRC,5/31/2014 18:16,0,2,"RT @ ASCOPost: Patients Metastatic Colon Cancer Respond to New Combination Therapy, Phase IB Study Shows http://ow.ly/xtDKj # ASCO14",,@,#,4.72864E+17,https://twitter.com/FightCRC/status/472864121315024896,,,,
PinkSheetMaryJo,5/31/2014 18:15,0,0,Variation in practice is often in areas with weakest evidence. Need good," solid data"" - Schulman # ASCO14""",,,#,4.72864E+17,https://twitter.com/PinkSheetMaryJo/status/472864010556428288,,,
KlareOKeefe,5/31/2014 18:15,0,1,@ YaleTomLynch @ ASCO @ YaleCancer when will there be a KRAS: next 10 years conversation?? # lcsm,,@ @ @,#,4.72864E+17,https://twitter.com/KlareOKeefe/status/472863971989782531,,,,
ASCO,5/31/2014 18:15,0,0,"Ed Book Invited Article: Paul B. Chapman, MD, on treating metastatic melanoma, introduction by Jedd Wolchok, MD, PhD # ASCO14",,,#,4.72864E+17,https://twitter.com/ASCO/status/472863893761839104,,,,
CancerMedMDA,5/31/2014 18:15,0,0,Dr. Apostolia Tsimberidou discusses prospective clinical trials as advances in precision medicine. Education Session Sun. 9:45 AM. # ASCO14,,,#,4.72864E+17,https://twitter.com/CancerMedMDA/status/472863878712668162,,,,
JezCN,5/31/2014 18:14,1,1,# ASCO14 # Chicago # fightcancerpic.twitter.com/iT7fdzdSP5,,,# # #,4.72864E+17,https://twitter.com/JezCN/status/472863787016802304,,,,
scientre,5/31/2014 18:14,0,1,"In the Berry session, somebody has volume on...their phone chirps every time they tweet :D # ASCO14",,,#,4.72864E+17,https://twitter.com/scientre/status/472863685405581312,,,,
aftimosp,5/31/2014 18:14,0,0,Lisa Carey: Shift towards luminal A in residual disease of HER2+ # BreastCancer treated in the neoadjuvant C40601 trial # ASCO14,,,# #,4.72864E+17,https://twitter.com/aftimosp/status/472863676752334848,,,,
MedscapeOnc,5/31/2014 18:14,2,2,65% of radioiodine-resistant advanced differentiated thyroid cancer patients respond to lenvatinib http://bit.ly/1kvA9vb # ASCO14,,,#,4.72864E+17,https://twitter.com/MedscapeOnc/status/472863605709234176,,,,
sitcancer,5/31/2014 18:13,1,0,Thanks to everyone who stopped by our exhibit booth today! We'll be back at 9 am tomorrow in case you missed us at booth 2047! # ASCO14,,,#,4.72864E+17,https://twitter.com/sitcancer/status/472863577108647936,,,,
dsleeter,5/31/2014 18:13,0,0,# asco14,,,#,4.72864E+17,https://twitter.com/dsleeter/status/472863530291838976,,,,
ASCO,5/31/2014 18:13,6,2,Joining us for our # ASCO14 Tweetup in 30 minutes? Here's a map of the location: pic.twitter.com/nSXDCgbLaF,,,#,4.72863E+17,https://twitter.com/ASCO/status/472863473433866240,,,,
GenomeGrl,5/31/2014 18:13,0,1,@ GeneticCouns Great sessions so far here at # ASCO14!,,@,#,4.72863E+17,https://twitter.com/GenomeGrl/status/472863378906824704,,,,
dramarivirg,5/31/2014 18:12,0,1,"“ @ RichardWJoseph: Phase 2 nivolumab in RCC second line and beyond with PFS of -4 months,ORR of ~20%, OS>18 months, # ASCO14” RT",,@,#,4.72863E+17,https://twitter.com/dramarivirg/status/472863318156517376,,,,
KoontzOncology,5/31/2014 18:12,0,0,# ASCO14 http://tinyurl.com/mgmusm6 100% survival for pts with localized NB as treated on COG ANBL0531.pic.twitter.com/ASTMGt9EqO,,,#,4.72863E+17,https://twitter.com/KoontzOncology/status/472863307628818432,,,,
scientre,5/31/2014 18:12,4,2,"Berry: Don't blame FDA for lack of innovation in clinical trials, blame academics. Refs DeMets & Califf JAMA 2011 # ASCO14",,,#,4.72863E+17,https://twitter.com/scientre/status/472863295003979776,,,,
FightCRC,5/31/2014 18:12,0,0,RT @ genentech: # ASCO14 is in full swing. Visit our newsroom for perspectives on cancer advances. https://cards.twitter.com/cards/18ce53uydr3/jin …,,@,#,4.72863E+17,https://twitter.com/FightCRC/status/472863134923771904,,,,
Sorena997,5/31/2014 18:12,1,1,# ASCO14 has done a marvelous job incorporating Cancer # Informatics and associated # Genomics into their program. Ditto to the Vendors!,,,# # #,4.72863E+17,https://twitter.com/Sorena997/status/472863096432648193,,,,
GenomeGrl,5/31/2014 18:11,0,0,Twitter Roundup: Which GC's are at # ASCO14? @ GeneticCouns,,@,#,4.72863E+17,https://twitter.com/GenomeGrl/status/472863005353705472,,,,
PinkSheetMaryJo,5/31/2014 18:11,0,0,"ACOs mean oncologists could share in risk and benefit of ACO performance, Schulman tells # ASCO14",,,#,4.72863E+17,https://twitter.com/PinkSheetMaryJo/status/472862856049065984,,,,
DrBobGoldberg,5/31/2014 18:10,0,0,Almost ejected from @ ASCO event for challenging the systematic distribution of disinformation on cost and value of cancer # mliwi,,@,#,4.72863E+17,https://twitter.com/DrBobGoldberg/status/472862832254799872,,,,
yzafar,5/31/2014 18:10,5,2,Schumann: key point - why is cancer care unique in regards to ACOs? # ASCO14 pic.twitter.com/FemAZZrARo,,,#,4.72863E+17,https://twitter.com/yzafar/status/472862819772137473,,,,
Lymphoma_Doc,5/31/2014 18:10,11,6,"Dr. Berry: Clinical trials will change dramatically as we slice cancers"" into smaller and smaller pieces"," no more huge trials. # ASCO14""",,,#,4.72863E+17,https://twitter.com/Lymphoma_Doc/status/472862706404311040,,,
RichardWJoseph,5/31/2014 18:10,0,2,"Phase 2 nivolumab in RCC second line and beyond with PFS of -4 months,ORR of ~20%, OS>18 months, # ASCO14",,,#,4.72863E+17,https://twitter.com/RichardWJoseph/status/472862668655951872,,,,
narumita,5/31/2014 18:10,0,2,HPV感染のある頭頸部がんの治療_φ(･_･ # ASCO2014 low-dose radiation sometimes ok in HPV+ head/neck # vanderbilt-ingram http://ow.ly/xtF4Q,,,# #,4.72863E+17,https://twitter.com/narumita/status/472862665073639424,,,,
CancerMedMDA,5/31/2014 18:10,3,0,Dr. Filip Janku on mTOR inhibitor sirolimus + HDAC inhibitor vorinostat in refractory Hodgkin lymphoma patients. Sun. 8 AM. # ASCO14,,,#,4.72863E+17,https://twitter.com/CancerMedMDA/status/472862658094727168,,,,
CancerDotNet,5/31/2014 18:10,2,0,"Podcast for pts: new targeted therapies for cancer at # ASCO14, w/ Dr. Gregory Masters @ christianacarehttp://bit.ly/1kv30Qn",,@,#,4.72863E+17,https://twitter.com/CancerDotNet/status/472862639274885120,,,,
EthanBasch1,5/31/2014 18:10,1,0,Jen Malin on pathway to value/innovation in cancer care http://am.asco.org/pathway-value-and-innovation … # ASCO14,,,#,4.72863E+17,https://twitter.com/EthanBasch1/status/472862628461969408,,,,
PhRMA,5/31/2014 18:10,3,2,"To combat # cancer costs, how we determine & reward value in care are key says @ leukemiamda @ LillyPad @ myUHC http://bit.ly/1tv1yxW # ASCO14",,@ @ @,# #,4.72863E+17,https://twitter.com/PhRMA/status/472862614351925249,,,,
RichardWJoseph,5/31/2014 18:09,4,4,Unleashing the immune system in GU cancers was a great session. Much needed hope for urothelial and RCC patients. # ASCO14,,,#,4.72862E+17,https://twitter.com/RichardWJoseph/status/472862458819129345,,,,
drcbsteer,5/31/2014 18:09,2,0,@ jharris567 Great to be at # ASCO14 learning about the cutting edge oncology treatments @ COSAoncology folk @ ddembe @ ProfFranBoyle @ AnneBooms,,@ @ @ @ @,#,4.72862E+17,https://twitter.com/drcbsteer/status/472862431459684352,,,,
MGHCancerCenter,5/31/2014 18:09,0,0,Dr. Dejan Juric Chairing the Optimizing the Use of Targeted Therapies in the Face of Toxicity Session now # ASCO2014,,,#,4.72862E+17,https://twitter.com/MGHCancerCenter/status/472862355056246785,,,,
LJLichtman,5/31/2014 18:08,0,3,"Proud of dad, B.J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology @ JoelleLichtman # ASCO14 pic.twitter.com/HgcnyDvq2H",,@,#,4.72862E+17,https://twitter.com/LJLichtman/status/472862226110353408,,,,
rsm2800,5/31/2014 18:08,1,1,"Carey re CALGB 40601: Also looked at 5 immune signatures, trend with TILs; all significantly associated w/ pCR # ASCO14",,,#,4.72862E+17,https://twitter.com/rsm2800/status/472862166156967936,,,,
DrSabha,5/31/2014 18:07,0,0,ACOs are purported to improve cost savings by focusing on coordinating care more efficiently. # ASCO14,,,#,4.72862E+17,https://twitter.com/DrSabha/status/472862009067704320,,,,
NormandBlais,5/31/2014 18:07,0,1,"Dr Daniel Costa: AZD9291 and CO-1686 very active, too early to say which agent is better in T790M+ patients # LCCatASCO # ASCO14",,,# #,4.72862E+17,https://twitter.com/NormandBlais/status/472861897315086337,,,,
rsm2800,5/31/2014 18:07,0,0,Carey re CALGB 40601: HER2-enriched subtype most likely to have pCR c/w LumA or LumB # asco14,,,#,4.72862E+17,https://twitter.com/rsm2800/status/472861859884695552,,,,
BioWorld,5/31/2014 18:06,0,1,Following a different kind of value discussion at # ASCO14: promise and pitfalls of tumor genomic profiling,,,#,4.72862E+17,https://twitter.com/BioWorld/status/472861765098029056,,,,
Merck,5/31/2014 18:06,5,2,"Tomorrow, we're presenting new data in head & neck cancer. Join us at McCormick Place in room S100bc to learn more at 1130:AM. # ASCO14.",,,#,4.72862E+17,https://twitter.com/Merck/status/472861633153601537,,,,
rsm2800,5/31/2014 18:06,0,0,"Carey re CALGB 40601: Looked at PAM50 predictor + Claudin-low + others including p53; of n=265 pt, 90% are lumA, lumB, basal preRx # ASCO14",,,#,4.72862E+17,https://twitter.com/rsm2800/status/472861617047101440,,,,
hospicedoctor,5/31/2014 18:05,0,0,@ drdonsdizon Your # ASCO14 talk sounds great...any chance of seeing the slides...if there were any of course!,,@,#,4.72861E+17,https://twitter.com/hospicedoctor/status/472861473979781120,,,,
yzafar,5/31/2014 18:05,10,5,"Conti: providers, payers, and manufacturers have a role in healthcare cost and reform # ASCO14 pic.twitter.com/kmf0Zim8lp",,,#,4.72861E+17,https://twitter.com/yzafar/status/472861398574186496,,,,
CancerMedMDA,5/31/2014 18:05,1,1,Learn more about role of TP53 mutations in Phase I trial pazopanib + vorinostat. Dr. Ming-Mou Hou's poster Sun. 8 AM. # ASCO14 # endcancer,,,# #,4.72861E+17,https://twitter.com/CancerMedMDA/status/472861381776404481,,,,
mtmdphd,5/31/2014 18:05,1,0,". @ ASCO Community Research Forum Annual Meeting - Sep 28-29, 2014 # ASCO14 http://www.asco.org/practice-research/community-research-forum-annual-meetings … <- registration June 6",,@,#,4.72861E+17,https://twitter.com/mtmdphd/status/472861380761382912,,,,
genentech,5/31/2014 18:05,6,1,# ASCO14 - What do the # Next50 yrs hold for immunotherapy? Here's our take: http://ow.ly/xmVpu,,,# #,4.72861E+17,https://twitter.com/genentech/status/472861371865268224,,,,
rsm2800,5/31/2014 18:04,0,0,Carey re CALGB 40601: Taxol +/- Herc vs lap (pCR presented ASCO13 was highest in THL but p=NS); now presenting biomarker analysis # asco14,,,#,4.72861E+17,https://twitter.com/rsm2800/status/472861190184398849,,,,
GustaveRoussy,5/31/2014 18:03,2,0,# ASCO14 @ ericangevin itw on results of a phase-I first-in-humans clinical trial evaluating specific c-MET inhibitorpic.twitter.com/Fl1AB1XrQ8,,@,#,4.72861E+17,https://twitter.com/GustaveRoussy/status/472861054188650496,,,,
DrSabha,5/31/2014 18:03,0,0,Imatinib goes off patent in 6 months! # ASCO14,,,#,4.72861E+17,https://twitter.com/DrSabha/status/472860968918482944,,,,
PinkSheetMaryJo,5/31/2014 18:03,0,0,"Conti proposes base reimbursement w add'l reimb based on disease setting, level of evidence, advances # ASCO14",,,#,4.72861E+17,https://twitter.com/PinkSheetMaryJo/status/472860958524968960,,,,
jrgralow,5/31/2014 18:03,1,0,S0230 study will impact clinical care in premen ER- breast ca pts starting chemo. How much concern in trying to extrapolate to ER+? # ASCO14,,,#,4.72861E+17,https://twitter.com/jrgralow/status/472860932390268928,,,,
DrCESimmons,5/31/2014 18:03,0,0,Discussion wrt lifestyle factors & breast ca outcomes # ASCO2014 weight control and bone health can both be improved w exercise,,,#,4.72861E+17,https://twitter.com/DrCESimmons/status/472860857186402305,,,,
TGeorgeMD,5/31/2014 18:03,0,0,Triplet biologic therapy ($$$) for BRAF MUT crc surprisingly well tolerated. ?durable responses # crcsm # ASCO14 http://ow.ly/i/5KKfG,,,# #,4.72861E+17,https://twitter.com/TGeorgeMD/status/472860840102993920,,,,
drdonsdizon,5/31/2014 18:02,0,0,Markers in cancer- less prognostic. Need more predictive. Excellent intro by Robert Coleman @ MDAndersonNews # gyncsm # ASCO14,,@,# #,4.72861E+17,https://twitter.com/drdonsdizon/status/472860577631461376,,,,
drcbsteer,5/31/2014 18:01,0,0,# ASCO14 Dr Stuart Lichtman very worthy recipient of the BJ Kennedy award for service to # geriatriconcology. Go Stu!,,,# #,4.72861E+17,https://twitter.com/drcbsteer/status/472860565220900865,,,,
DrSabha,5/31/2014 18:01,0,0,Should drug reimbursement be linked with the level of evidence for the cancer disease subtype? # ASCO14,,,#,4.72861E+17,https://twitter.com/DrSabha/status/472860563500843008,,,,
birthlovedeath,5/31/2014 18:01,0,0,# palliativecare can be hidden/solitary. http://loveinourowntime.com pulls back the curtains & facilitates discussion. $5 off code ASCO14 # ASCO14,,,# #,4.72861E+17,https://twitter.com/birthlovedeath/status/472860508442222592,,,,
ASCO,5/31/2014 18:01,3,3,Headed to the GI track at # ASCO14? Catch up on GI Symposium highlights on # ASCOConnection http://bit.ly/1iQxGGj # crcsm # esocsm # stcsm,,,# # # # #,4.7286E+17,https://twitter.com/ASCO/status/472860327567450113,,,,
OncologyTimes,5/31/2014 18:00,0,1,"Love this interview opp"" I received from a company"," addressing me as ""Hi {{First Name}}"" # ASCO14 (I've made plenty of my own mistakes tho!)""",,,#,4.7286E+17,https://twitter.com/OncologyTimes/status/472860302950666240,,,
ASCO,5/31/2014 18:00,2,2,Drs. Chien and Dawson review Wnt signaling pathways in cancer & Wnt-targeted therapy http://bit.ly/1lU2Dew # ASCO14,,,#,4.7286E+17,https://twitter.com/ASCO/status/472860283304943618,,,,
ASCO,5/31/2014 18:00,1,1,Read Educational Book articles on topics in Patient & Survivor Care from # ASCO14 Education Session Speakers: http://bit.ly/1oFM89S,,,#,4.7286E+17,https://twitter.com/ASCO/status/472860252577484800,,,,
Roche,5/31/2014 18:00,2,1,That's it for day 2 of # ASCO14. Have a great Saturday night!,,,#,4.7286E+17,https://twitter.com/Roche/status/472860227961126913,,,,
jrgralow,5/31/2014 18:00,0,0,This analysis not powered MT @ drattai: Giordano - link between vit D & br ca outcomes inconclusive. Many confounding factors # ASCO14 # bcsm,,@,# #,4.7286E+17,https://twitter.com/jrgralow/status/472860212140195840,,,,
CancerDotNet,5/31/2014 18:00,2,0,Resource: Practical tips for reading & understanding medical research studies # ASCO14 http://bit.ly/1la6QiP,,,#,4.7286E+17,https://twitter.com/CancerDotNet/status/472860193009586176,,,,
DrSabha,5/31/2014 18:00,1,0,Pressure for providers to find discounts on acquisition of cancer drugs pushing hospital employment for oncologists. # ASCO14,,,#,4.7286E+17,https://twitter.com/DrSabha/status/472860129202040832,,,,
SaudiMedical,5/31/2014 17:59,2,0,RT @ alantanmd: No proven association 25 OH vitamin D levels and breast cancer survival # ASCO14 pic.twitter.com/cGjWIzEZty,,@,#,4.7286E+17,https://twitter.com/SaudiMedical/status/472860008502542336,,,,
birthlovedeath,5/31/2014 17:59,0,0,Film http://loveinourowntime.com bears witness to lives beginning & ending. # palliativecare # oncology # nursing # psych education/training # ASCO14,,,# # # # #,4.7286E+17,https://twitter.com/birthlovedeath/status/472859993494913024,,,,
natesadeghi,5/31/2014 17:59,1,0,Irony at # ASCO2014 http://instagram.com/p/orVo3Dl-cf/,,,#,4.7286E+17,https://twitter.com/natesadeghi/status/472859873315528706,,,,
MedscapeOnc,5/31/2014 17:58,2,0,Rena Conti: “Single biggest factor in the launch prices of cancer drugs this year is the launch prices of cancer drugs last year.” # ASCO2014,,,#,4.7286E+17,https://twitter.com/MedscapeOnc/status/472859772954636288,,,,
DKarikios,5/31/2014 17:58,0,0,EGFRi/MEKi/BRAFi Triplet therapy for BRAF mutant colorectal cancer??? Perhaps only way to get a decent response rate.... # ASCO14,,,#,4.7286E+17,https://twitter.com/DKarikios/status/472859746803150848,,,,
DrSabha,5/31/2014 17:58,0,0,Is there a conflict of interest of improving practice revenue compared to patient benefit from the cancer drug? # bioethics # ASCO14,,,# #,4.7286E+17,https://twitter.com/DrSabha/status/472859587381837824,,,,
ERPlimackMD,5/31/2014 17:57,2,1,Dr. Lauren Harshman discusses nivolumab: continuation of responses off therapy ?Immune memory? # gusm # ASCO14,,,# #,4.7286E+17,https://twitter.com/ERPlimackMD/status/472859549632708609,,,,
rjperez_phd,5/31/2014 17:57,0,0,"# ASCO14 Padmanee Sharma suggested PD-L1 should be used as prognostic marker in cancer immunotherapy, not as stratification marker",,,#,4.7286E+17,https://twitter.com/rjperez_phd/status/472859514828763136,,,,
PinkSheetMaryJo,5/31/2014 17:56,0,0,"$12B on top 10 cancer drugs, half of use off-label and half of that not compendia - Conti at # ASCO14",,,#,4.72859E+17,https://twitter.com/PinkSheetMaryJo/status/472859227758026753,,,,
UrologyMatch,5/31/2014 17:56,2,0,“ @ sloan_kettering: Five decades of @ ASCO - five opportunities # ASCO14 @ CliffordHudis pic.twitter.com/tseFLtEV8G”,,@ @ @,#,4.72859E+17,https://twitter.com/UrologyMatch/status/472859202571239424,,,,
RaisBahrami,5/31/2014 17:56,0,0,Feldman et al: 18F-FDHT PET as imaging of AR-driven met PCa...only false neg cases were dedifferentiated or neuroendocrine subtype # ASCO14,,,#,4.72859E+17,https://twitter.com/RaisBahrami/status/472859197538045952,,,,
anukPDX,5/31/2014 17:56,0,0,@ ASCO Great to be at # ASCO14! # QOPIpic.twitter.com/RBwxIwzZAv,,@,# #,4.72859E+17,https://twitter.com/anukPDX/status/472859195474452480,,,,
MedscapeOnc,5/31/2014 17:56,1,3,Ibrutinib's transformative impact on CLL survival highlighted in Medscape Oncology news coverage: http://bit.ly/U45YS0 # ASCO14,,,#,4.72859E+17,https://twitter.com/MedscapeOnc/status/472859135365877760,,,,
mtmdphd,5/31/2014 17:56,1,0,. @ ASCO Community Research Forum http://www.asco.org/practice-research/community-research-forum … # ASCO14,,@,#,4.72859E+17,https://twitter.com/mtmdphd/status/472859083926937601,,,,
gumedcenter,5/31/2014 17:56,2,1,# ASCO14 study: Ibrutinib improves # CLL survival. @ LombardiCancer doc tells @ medscape it’s a “game changer” http://bit.ly/1kXkCUM,,@ @,# #,4.72859E+17,https://twitter.com/gumedcenter/status/472859065987891200,,,,
DrSabha,5/31/2014 17:55,2,1,"$12B was spent on 10 cancer drugs, a majority of which were not FDA approved or within NCCN guidelines # ASCO14",,,#,4.72859E+17,https://twitter.com/DrSabha/status/472859023415721984,,,,
gumedcenter,5/31/2014 17:55,2,0,"Modest survival w/ ramucirumab for # lungcancer is “clinically relevant,” @ LombardiCancer doc tells @ medscape http://bit.ly/1mDKDqy # ASCO14",,@ @,# #,4.72859E+17,https://twitter.com/gumedcenter/status/472859004046426112,,,,
heidisa,5/31/2014 17:55,0,2,A herd of oncologists? A consolidation of oncologists? Whatever...this is what it looks like. # ASCO14 pic.twitter.com/DsBzIkcx0K,,,#,4.72859E+17,https://twitter.com/heidisa/status/472858862207250432,,,,
OncLive,5/31/2014 17:55,5,2,"Ibrutinib Triples PFS, Doubles OS in Phase III CLL Trial http://ow.ly/xtNty # ASCO14",,,#,4.72859E+17,https://twitter.com/OncLive/status/472858845631750144,,,,
genentech,5/31/2014 17:55,1,4,"Improving QoL for cancer patients, caregivers critical. We believe patient insights are key to do so: http://ow.ly/xsfMg # ASCO14",,,#,4.72859E+17,https://twitter.com/genentech/status/472858833598296066,,,,
hmhyltonpac,5/31/2014 17:54,0,0,US spent $37 billion on cancer drugs in 2013-Dr. Rena Conti-Current & Future Implications of Patient Protection & ACA session at # ASCO2014,,,#,4.72859E+17,https://twitter.com/hmhyltonpac/status/472858624378023936,,,,
TGeorgeMD,5/31/2014 17:54,5,1,Colorectal cancer BRAF mutation = bad. Inhibiting both BRAF + MEK/EGFR pathways very promising. # clinicaltrials ongoing # crcsm # ASCO14,,,# # #,4.72859E+17,https://twitter.com/TGeorgeMD/status/472858611115622401,,,,
PinkSheetMaryJo,5/31/2014 17:54,1,0,"Conti cites IMS at # ASCO14: US spent $37B on cancer drugs in 2013, growing faster than costs of overall cancer care and healthcare spending",,,#,4.72859E+17,https://twitter.com/PinkSheetMaryJo/status/472858599346405377,,,,
EthanBasch1,5/31/2014 17:53,0,0,"Prostate cancer poster discussion: multiple prognostic models presented in metastatic cancer, but clinical decision aids lacking. # ASCO14",,,#,4.72859E+17,https://twitter.com/EthanBasch1/status/472858532266917889,,,,
uk_oncologist,5/31/2014 17:53,0,0,Interesting @ ukaesthetic “ @ adamfeuerstein: $ AZN $ CLVS toxicity comparisons from Discussant Tom Lynch # ASCO14 pic.twitter.com/ZL7oad1LBt”,,@ @,#,4.72859E+17,https://twitter.com/uk_oncologist/status/472858510548803585,,,,
cnurys,5/31/2014 17:53,0,0,"RT @ StJudeResearch: Congratulations @ StJude researcher Dr. Les Robison, recipient of @ ASCO Pediatric ... (more) http://tm.to/eCmB4",,@ @ @,,4.72858E+17,https://twitter.com/cnurys/status/472858463996219394,,,,
SPDoubleYou,5/31/2014 17:53,0,1,"@ IndustryNightIn No doubt man! Great group, always happy to have # ASCO14 back to # Chicago, but everyone needs a taste after while...",,@,# #,4.72858E+17,https://twitter.com/SPDoubleYou/status/472858401404223488,,,,
RaisBahrami,5/31/2014 17:53,0,0,Dr. Gleave highlights biomarkers and risk indices predicting met PCa response to tx...goal to guide best therapy choice. # ASCO14,,,#,4.72858E+17,https://twitter.com/RaisBahrami/status/472858332722892800,,,,
DrSabha,5/31/2014 17:52,0,0,"$37B in 2013, or 30% of medical spending was spent on cancer drugs. # ASCO14",,,#,4.72858E+17,https://twitter.com/DrSabha/status/472858167408590848,,,,
IndustryNightIn,5/31/2014 17:52,0,1,@ SPDoubleYou gotcha. Working with # ASCO14 today since 4 am. Needed a drink!,,@,#,4.72858E+17,https://twitter.com/IndustryNightIn/status/472858158021742592,,,,
cmartindedios,5/31/2014 17:52,2,1,Value in # cancer Care from a # patient perspective @ ASCO # ASCO14 http://am.asco.org/patient-perspective-value …,,@,# # #,4.72858E+17,https://twitter.com/cmartindedios/status/472858108239163392,,,,
ERPlimackMD,5/31/2014 17:51,1,0,"Dr: Sharma: PDL1 expression is dynamic, baseline IHC does not tell the whole story. PDL1 neg can still respond. # blcsm # gusm # ASCO14",,,# # #,4.72858E+17,https://twitter.com/ERPlimackMD/status/472857815153782786,,,,
DrHedrick,5/31/2014 17:49,1,1,Goserelin. My ?. Shouldn't this be considered irrespective of desire for preservation. Perhaps women reconsider post treatment # ASCO14,,,#,4.72857E+17,https://twitter.com/DrHedrick/status/472857468364918785,,,,
peepeeDoctor,5/31/2014 17:49,0,0,RT @ fischmd: add Twitter handle to 2014 @ ASCO Badge: Here's how http://bit.ly/1k49xiQ # ASCO14” @ AmerUrological @ Uroweb r u listening?!,,@ @ @ @,#,4.72857E+17,https://twitter.com/peepeeDoctor/status/472857362458771456,,,,
DoctorGlobal,5/31/2014 17:49,0,0,@ NTConnell They're both overpriced. We pay $122 a month for generic imatinib from # India bcr-abl testing is unavailable currently. # ASCO14,,@,# #,4.72857E+17,https://twitter.com/DoctorGlobal/status/472857343819272193,,,,
OrderofTheDimen,5/31/2014 17:48,0,0,# ASCO14 is trending! Awesome - glad to have collaborated on some works that'll be presented there :D,,,#,4.72857E+17,https://twitter.com/OrderofTheDimen/status/472857112771457026,,,,
briankoffman,5/31/2014 17:48,0,0,"Check out  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.72857E+17,https://twitter.com/briankoffman/status/472857085156532225,,,,
MassimoDiMaio75,5/31/2014 17:47,0,2,Oncologi italiani # ASCO14 pic.twitter.com/A7IzgSC6qY,,,#,4.72857E+17,https://twitter.com/MassimoDiMaio75/status/472856933977030656,,,,
LeliaMartin,5/31/2014 17:47,0,0,# ASCO14,,,#,4.72857E+17,https://twitter.com/LeliaMartin/status/472856818763698178,,,,
rsm2800,5/31/2014 17:47,3,1,"Giordano commentary: POEMS study missing endpt data for 38% of participants, so results not definitive; but goserelin is an option # asco14",,,#,4.72857E+17,https://twitter.com/rsm2800/status/472856815491751936,,,,
KoontzOncology,5/31/2014 17:46,0,0,# ASCO14 http://tinyurl.com/lsbsrkb No net improvements in RMS for 20+ years. Local recurrence & XRT morbidity = concernspic.twitter.com/kOkCkjcPej,,,#,4.72857E+17,https://twitter.com/KoontzOncology/status/472856703156105217,,,,
YasirYousifE,5/31/2014 17:46,0,1,Poster highlights session-colorectal cancer # ASCO14 pic.twitter.com/VItqBAaZ0d,,,#,4.72857E+17,https://twitter.com/YasirYousifE/status/472856699632898049,,,,
OSUCCC_James,5/31/2014 17:46,0,1,# TheJames Dr. Luiz Araujo shares data on 80 gene mutation panel/ potential ethnic differences in lung cancer # ASCO14 pic.twitter.com/0QZaqpniL1,,,# #,4.72857E+17,https://twitter.com/OSUCCC_James/status/472856644591054848,,,,
peepeeDoctor,5/31/2014 17:46,0,0,@ AAmanullah you are at # ASCO14? Give us some updates!,,@,#,4.72857E+17,https://twitter.com/peepeeDoctor/status/472856596704673792,,,,
DrHedrick,5/31/2014 17:46,0,0,"Giordano: Goserelin associated with lower rates of ovarian failure, higher rate of pregnancy. # ASCO14",,,#,4.72857E+17,https://twitter.com/DrHedrick/status/472856582490177536,,,,
DrCESimmons,5/31/2014 17:46,0,0,@ jrgralow Yes bone health v important - Lohman study role of vit d not seen. Funny given cold Canada! # ASCO2014,,@,#,4.72857E+17,https://twitter.com/DrCESimmons/status/472856582293028864,,,,
SusanLaufer,5/31/2014 17:45,0,1,Next up at # ASCO14 : Companion Diagnostics and Biomarker Development in Oncology Drug Development,,,#,4.72857E+17,https://twitter.com/SusanLaufer/status/472856534058549249,,,,
Lionsdencomms,5/31/2014 17:45,0,0,Hosting cancer news conference at # ASCO14 in Chicago. Great views of city and lake! pic.twitter.com/l9BwlkIE0l,,,#,4.72856E+17,https://twitter.com/Lionsdencomms/status/472856440462258176,,,,
JoleneScience,5/31/2014 17:45,0,0,"All-oral chemo regimens: less inconvenient than getting pumped full of pre-meds+infused at the clinic; QoL, pt cost benefits? # ASCO14",,,#,4.72856E+17,https://twitter.com/JoleneScience/status/472856373802184704,,,,
CancerDotNet,5/31/2014 17:45,3,1,Infographic from @ ASCO guideline on # fertility preservation before cancer treatment # ASCO14 http://bit.ly/1ruc3FS,,@,# #,4.72856E+17,https://twitter.com/CancerDotNet/status/472856356421394432,,,,
GustaveRoussy,5/31/2014 17:45,4,0,# ASCO14 @ JCSoria itw on New Targeted Therapies in early trials: targeting FGFR path as a very promising approachpic.twitter.com/JaBbMx4ZBy,,@,#,4.72856E+17,https://twitter.com/GustaveRoussy/status/472856340889862145,,,,
ASCO,5/31/2014 17:45,0,2,Read Educational Book articles on topics in GI (Colorectal) Cancer from # ASCO14 speakers: http://bit.ly/1wg092g,,,#,4.72856E+17,https://twitter.com/ASCO/status/472856340185219072,,,,
mayocliniclabs,5/31/2014 17:45,0,0,Dr. McCormick is discussing “Tumor Genomic Profiling in Cancer Care: Field of Dreams or Ethical Minefield?” # ASCO14,,,#,4.72856E+17,https://twitter.com/mayocliniclabs/status/472856328239845376,,,,
myriadgenetics,5/31/2014 17:45,0,0,Are you attending # ASCO14? Visit us at Booth 2039 to find out about our industry leading # genetictests!http://bit.ly/1qFsz5H,,,# #,4.72856E+17,https://twitter.com/myriadgenetics/status/472856294974427136,,,,
mtmdphd,5/31/2014 17:44,0,0,ASCO Research Program Quality Assessment Tool - http://www.asco.org/practice-research/asco-research-program-quality-assessment-tool-contact-information … # ASCO14,,,#,4.72856E+17,https://twitter.com/mtmdphd/status/472856226523774976,,,,
JacobPlieth,5/31/2014 17:43,2,4,Response rate summary in MPDL3280A bladder cancer study $ RHHBY # ASCO14 pic.twitter.com/Lx0jFvQWAf,,,#,4.72856E+17,https://twitter.com/JacobPlieth/status/472855841784082432,,,,
drdonsdizon,5/31/2014 17:42,0,2,@ JLErsek absolutely. There are resource-rich and resource-poor areas within the US. # EveryoneDeservesOptions # ASCO14,,@,# #,4.72856E+17,https://twitter.com/drdonsdizon/status/472855785727209472,,,,
kgapo,5/31/2014 17:42,0,0,@ OncologyTimes Greek twting doctors at # ASCO14 wll love you for sharing this as accused of been careless about the rising cost of hc!,,@,#,4.72856E+17,https://twitter.com/kgapo/status/472855774512029696,,,,
DrAttai,5/31/2014 17:42,5,3,Giordano - link between vitamin D and breast cancer outcomes inconclusive. Many cofounding factors for observational studies # ASCO14 # bcsm,,,# #,4.72856E+17,https://twitter.com/DrAttai/status/472855712079835136,,,,
AshleySumrallMD,5/31/2014 17:42,0,1,“ @ stuxrt: Working to change course of unresectable GBM w Avastin at # LCI # ASCO14 @Carolinas pic.twitter.com/WEovwqQgo4” # btam # tunein2gbm,,@ @Carolinas,# # # #,4.72856E+17,https://twitter.com/AshleySumrallMD/status/472855686054170625,,,,
JacobPlieth,5/31/2014 17:42,0,1,Treatment-related AEs in MPDL3280A phI bladder cancer study $ RHHBY # ASCO14 pic.twitter.com/hTF4aEX6pt,,,#,4.72856E+17,https://twitter.com/JacobPlieth/status/472855570584596480,,,,
MGHCancerCenter,5/31/2014 17:42,1,0,Afternoon educational sessions are about to start at # ASCO2014 Dr. Jay Loeffler Chairs the Radiotherapy in Pediatric Oncology discussion,,,#,4.72856E+17,https://twitter.com/MGHCancerCenter/status/472855538506928128,,,,
DrAttai,5/31/2014 17:41,0,1,Giordano - high BMI associated with low vitamin D levels # ASCO14 # bcsm,,,# #,4.72856E+17,https://twitter.com/DrAttai/status/472855531984789504,,,,
jmboyce,5/31/2014 17:41,1,0,From # ASCO2014 Unravelling the Complexities of Breast Cancer Genomics http://bit.ly/U44JCn,,,#,4.72855E+17,https://twitter.com/jmboyce/status/472855492100751360,,,,
rsm2800,5/31/2014 17:41,1,2,"Giordano commentary: Vit D study (Abst 504)-limitations=single measurement of 25OH level, no data on subseq Vit d use, BMI # bcsm # asco14",,,# #,4.72855E+17,https://twitter.com/rsm2800/status/472855488707571713,,,,
HemOncToday,5/31/2014 17:41,1,4,"# ASCO14 Addition of cediranib to olaparib was highly active in recurrent # OvarianCancer, says @ DanaFarber doc: http://goo.gl/3trgM1",,@,# #,4.72855E+17,https://twitter.com/HemOncToday/status/472855432013578241,,,,
GoHealio,5/31/2014 17:41,1,1,"# ASCO14 Addition of cediranib to olaparib was highly active in recurrent # OvarianCancer, says @ DanaFarber doc: http://goo.gl/3trgM1",,@,# #,4.72855E+17,https://twitter.com/GoHealio/status/472855431300526081,,,,
drdonsdizon,5/31/2014 17:41,0,0,@ DrMarkham two words # tweetup # ASCO14,,@,# #,4.72855E+17,https://twitter.com/drdonsdizon/status/472855370809868288,,,,
ConsanoScott,5/31/2014 17:41,1,0,Just spotted @ rdoebele presenting his lung cancer research at # asco14 pic.twitter.com/AzZraG4oEd,,@,#,4.72855E+17,https://twitter.com/ConsanoScott/status/472855336253001728,,,,
YasirYousifE,5/31/2014 17:41,0,0,Live twitter updates # ASCO14 pic.twitter.com/y1xhzukGy5,,,#,4.72855E+17,https://twitter.com/YasirYousifE/status/472855330104545280,,,,
PhRMA,5/31/2014 17:41,3,1,"Understanding of # cancer is leading to medical discovery, resulting in better lives for # cancer patients http://onphr.ma/SbIUQd # ASCO14",,,# # #,4.72855E+17,https://twitter.com/PhRMA/status/472855305634586624,,,,
DrAttai,5/31/2014 17:40,0,1,Giordano Not clear if wt loss after diagnosis improves outcome (2/2) # ASCO14 # bcsm,,,# #,4.72855E+17,https://twitter.com/DrAttai/status/472855242334556161,,,,
KoontzOncology,5/31/2014 17:40,0,0,# ASCO14 http://tinyurl.com/nuohrbe Still need to investigate which RMS pts can receive lower doses of XRT.pic.twitter.com/BLEH1uH83k,,,#,4.72855E+17,https://twitter.com/KoontzOncology/status/472855204488949760,,,,
dralvaropinto,5/31/2014 17:40,1,0,"PD-L1 Inhibitor MPDL3280A, very promising results in bladder cancer #5011 # ASCO14",,,#5011 #,4.72855E+17,https://twitter.com/dralvaropinto/status/472855186382548992,,,,
DrAttai,5/31/2014 17:40,0,0,Giordano baseline obesity negative impact on survival in pre-menopausal women with ER+ BC. (1/2) # ASCO14 # bcsm,,,# #,4.72855E+17,https://twitter.com/DrAttai/status/472855160675659777,,,,
OncEd,5/31/2014 17:40,1,1,# ASCO14 video update:PFS in ovarian cancer pts 2nd remission w/mucin-1 autologous dendritic cell thrpy-Dr. Heidi Gray http://bit.ly/RQCeWX,,,#,4.72855E+17,https://twitter.com/OncEd/status/472855086226366464,,,,
ipaulmampilly,5/31/2014 17:40,0,0,# ASCO14 huge really huge buzz for $ bmy ipilimumab...so many presentations with it,,,#,4.72855E+17,https://twitter.com/ipaulmampilly/status/472855080627351554,,,,
rsm2800,5/31/2014 17:39,4,2,Giordano commentary: Biggest unanswered question re obesity is whether weight loss AFTER breast ca dx improves outcome # bscm # asco14,,,# #,4.72855E+17,https://twitter.com/rsm2800/status/472855025643823104,,,,
BiostatGirl,5/31/2014 17:39,0,0,Columbus Drive # chicago # asco2014 # asco2014 http://instagram.com/p/orTbczAzJj/,,,# # #,4.72855E+17,https://twitter.com/BiostatGirl/status/472855015061598208,,,,
TakedaOncology,5/31/2014 17:39,0,0,"# ASCO14 Thanks for a great first day. If you haven't stopped by yet, come see us tomorrow at Booth 14004. http://ow.ly/i/5KJVt",,,#,4.72855E+17,https://twitter.com/TakedaOncology/status/472854982547763200,,,,
JacobPlieth,5/31/2014 17:39,0,1,"Issue is key, as tox means PD-1 + VEGF combo should be approached with caution, said Dr Amin # ASCO14",,,#,4.72855E+17,https://twitter.com/JacobPlieth/status/472854862720294912,,,,
rsm2800,5/31/2014 17:39,0,1,"Giordano commentary: Obesity neg impact on prognosis in premenop women w/ ER+ breast ca, not in postmenop. Unexpected # bcsm # ASCO2014",,,# #,4.72855E+17,https://twitter.com/rsm2800/status/472854829790810112,,,,
Spares73,5/31/2014 17:39,0,0,# ASCO14 immunotherapy is hitting runs in ALL tumour types even Bladder Cancer! But why we do we treat indef. with PD-1 antibodies?,,,#,4.72855E+17,https://twitter.com/Spares73/status/472854818114244609,,,,
DrHedrick,5/31/2014 17:39,0,0,Giordano: Question left unanswered. Does intervention and weight loss make a difference? # ASCO14,,,#,4.72855E+17,https://twitter.com/DrHedrick/status/472854799512526848,,,,
wordsbyjess,5/31/2014 17:38,0,0,@ drcbsteer # ASCO14 Doing a great job. Any other @ COSAoncology members at the conference?,,@ @,#,4.72855E+17,https://twitter.com/wordsbyjess/status/472854710878085120,,,,
JacobPlieth,5/31/2014 17:38,0,1,And AEs in nivo + VEGF phase I mRCC trial $ BMY # ASCO14 pic.twitter.com/jlHOM7OQCG,,,#,4.72855E+17,https://twitter.com/JacobPlieth/status/472854678011527168,,,,
michelerhee,5/31/2014 17:38,0,0,MT @ CancerNetwrk: FLT-PET Fails to Distinguish True # Glioblastoma Progression http://bit.ly/1gQV3VR # ASCO14 # GBM # btsm,,@,# # # #,4.72855E+17,https://twitter.com/michelerhee/status/472854630284529664,,,,
DrHedrick,5/31/2014 17:38,0,0,Giordano: Happened to have lower rates of obesity. May have achieved better dosing of chemo given they were on a trial. # ASCO14,,,#,4.72855E+17,https://twitter.com/DrHedrick/status/472854587486253057,,,,
DrCESimmons,5/31/2014 17:38,0,1,Pan et al abs 503 higher risk for premen ER pos breast ca pts with BMI over 30 - but what if BMI changed after diagnosis? # ASCO2014,,,#,4.72855E+17,https://twitter.com/DrCESimmons/status/472854563956199426,,,,
myPathMelanoma,5/31/2014 17:38,0,0,Myriad myPath # Melanoma aids in the diagnosis of # melanoma # ASCO14 # isthismelanoma # melanomadiagnosis,,,# # # # #,4.72855E+17,https://twitter.com/myPathMelanoma/status/472854534121725952,,,,
rsm2800,5/31/2014 17:37,3,0,"Giordano commentary: Obesity meta-analysis limitations=no randomization, no detailed table on pt characteristics, no adjust for race # asco14",,,#,4.72855E+17,https://twitter.com/rsm2800/status/472854509236928512,,,,
BavarianNordic,5/31/2014 17:37,2,1,Join mgmt from BN and key opinion leaders discussing PROSTVAC # immunotherapy live today at 5pm CDT from # ASCO2014 http://bit.ly/1kuFaiF,,,# #,4.72854E+17,https://twitter.com/BavarianNordic/status/472854423954538496,,,,
DrHedrick,5/31/2014 17:37,0,0,"Giordano: Study showed premenopausal ER+ patients who were obese had worse outcome. Large study, though retrospective. # ASCO14",,,#,4.72854E+17,https://twitter.com/DrHedrick/status/472854360377282561,,,,
DrAttai,5/31/2014 17:37,3,0,Giordano - possible reduced efficacy of medications; many reasons that outcomes are worse in obese women with BC (2/2) # ASCO14 # bcsm,,,# #,4.72854E+17,https://twitter.com/DrAttai/status/472854349115564032,,,,
JacobPlieth,5/31/2014 17:37,1,1,Selected AEs in nivo phase II mRCC study $ BMY # ASCO14 pic.twitter.com/TNkOM9RlIS,,,#,4.72854E+17,https://twitter.com/JacobPlieth/status/472854311999778816,,,,
EBOncology,5/31/2014 17:36,0,0,"# ASCO14 Practicing oncologists are gatekeepers of chemotherapy/care and so in some way responsible for the cost.""- Beverly Moy", MD," MPH""",,,#,4.72854E+17,https://twitter.com/EBOncology/status/472854252528738304,,
DrAttai,5/31/2014 17:36,2,2,"Giordano - obesity and breast cancer. Increased estrogen, insulin pathways, inflammation (1/2) # ASCO14 # bcsm",,,# #,4.72854E+17,https://twitter.com/DrAttai/status/472854205645197313,,,,
RMiksad,5/31/2014 17:36,0,1,@ HannaSanoff @ yzafar @ ASCO the harder question is what do we do when those duties conflict. The heated debate here suggests no easy answer,,@ @ @,,4.72854E+17,https://twitter.com/RMiksad/status/472854186749485056,,,,
ERPlimackMD,5/31/2014 17:36,1,0,What endpoint to use for immunotherapy trials? Powles/Motzer: PFS doesn't tell whole story. Need to show tail of curve. # ASCO2014 # gusm,,,# #,4.72854E+17,https://twitter.com/ERPlimackMD/status/472854176738058241,,,,
nxtstop1,5/31/2014 17:36,0,0,ETHICS IN CA CARE @ ASCO: Read Educational Book articles on topics in Ethics from # ASCO14 Education Session Speakers: http://bit.ly/1lPb231,,@,#,4.72854E+17,https://twitter.com/nxtstop1/status/472854114322219008,,,,
rsm2800,5/31/2014 17:36,0,0,"Giordano commentary: Obesity and poorer outcomes: ?due to insulin papers, underdosing of chemo, cormorbidities # bcsm # asco14",,,# #,4.72854E+17,https://twitter.com/rsm2800/status/472854091014492160,,,,
DrHedrick,5/31/2014 17:36,0,0,"Giordano: Reasons obesity may be worse? Increased estrogens, aromatase differences, Comorbid conditions, underdosed chemotherapy? # ASCO14",,,#,4.72854E+17,https://twitter.com/DrHedrick/status/472854035545198592,,,,
PSUMaryDom,5/31/2014 17:35,0,0,Love the RCC docs...used to work with them a lot in a past life # asco14,,,#,4.72854E+17,https://twitter.com/PSUMaryDom/status/472853885350969344,,,,
NTConnell,5/31/2014 17:35,0,1,Michele Baccarani from Università di Bologna points out that cost of PCR for BCR-ABL is equivalent to one day of treatment for CML # ASCO14,,,#,4.72854E+17,https://twitter.com/NTConnell/status/472853841042759680,,,,
nxtstop1,5/31/2014 17:35,0,0,LET'S TALK COST. @ ASCO: Cancer care value from the provider's perspective http://bit.ly/RPf0As # ASCO14 # chemotherapy,,@,# #,4.72854E+17,https://twitter.com/nxtstop1/status/472853827947745280,,,,
NYDesignGuy,5/31/2014 17:35,0,0,“ @ MikeHuckman: And we wait. And wait. @ united flt arrived early at # ASCO14. Apparently our bags did not. pic.twitter.com/bXz7VXdJkm” Oy!,,@ @,#,4.72854E+17,https://twitter.com/NYDesignGuy/status/472853789964517378,,,,
DrHedrick,5/31/2014 17:35,2,0,Discussant Giordano: Obesity is risk factor for post menopausal breast cancer. # ASCO14,,,#,4.72854E+17,https://twitter.com/DrHedrick/status/472853789880643584,,,,
CancerDotNet,5/31/2014 17:35,7,5,Lead author Dr. Halle Moore @ ClevelandClinic outlines # fertility preservation research from # ASCO14 # bcsmhttp://bit.ly/1oScqpk,,@,# # #,4.72854E+17,https://twitter.com/CancerDotNet/status/472853787515047938,,,,
cancerGRACE,5/31/2014 17:34,0,0,Thank you! “ @ Celgene: # ASCO14:Visit Booth #3005 @ CancerSupportCm @ cancercare @ yscbuzz @ bebrightpink @ CancerGrace @ FreetoBreathe & more”,,@ @ @ @ @ @ @,# #3005,4.72854E+17,https://twitter.com/cancerGRACE/status/472853707114020864,,,,
FLneurology,5/31/2014 17:34,0,0,# ASCO14: Ibrutinib helps with certain cancer treatment ... Could this work for # MS eventually? - http://ow.ly/xtNdE,,,# #,4.72854E+17,https://twitter.com/FLneurology/status/472853599757021184,,,,
DrKantor,5/31/2014 17:34,0,0,# ASCO14: Ibrutinib helps with certain cancer treatment ... Could this work for # MS eventually? - http://ow.ly/xtNdC,,,# #,4.72854E+17,https://twitter.com/DrKantor/status/472853599094321153,,,,
DrDanielKantor,5/31/2014 17:34,0,0,# ASCO14: Ibrutinib helps with certain cancer treatment ... Could this work for # MS eventually? - http://ow.ly/3ldnwV,,,# #,4.72854E+17,https://twitter.com/DrDanielKantor/status/472853598460977152,,,,
CLOUDHealth,5/31/2014 17:34,1,0,"Imagine if we all had secure, private access to all # data & breakthroughs came from analytics, not silos # ASCO14",,,# #,4.72854E+17,https://twitter.com/CLOUDHealth/status/472853547264925696,,,,
jrgralow,5/31/2014 17:33,0,0,Hard to explain MT @ rsm2800 Moore: Exploratory analysis=better DFS in goserelin. Surprising in ER- pop; for OS HR also signif # bcsm # ASCO14,,@,# #,4.72853E+17,https://twitter.com/jrgralow/status/472853385314844672,,,,
ConsanoMolly,5/31/2014 17:33,0,0,"Thanks for sharing, Paul! RT @ ipaulmampilly # ASCO14 kickstarter for med research http://consano.org pic.twitter.com/j4zTL73BnQ",,@,#,4.72853E+17,https://twitter.com/ConsanoMolly/status/472853375306850304,,,,
DrAttai,5/31/2014 17:33,0,0,Dr. Giordano - lifestyle and survivorship in early breast cancer abstract discussion session # ASCO14 # bcsm,,,# #,4.72853E+17,https://twitter.com/DrAttai/status/472853331300581376,,,,
aimac_it,5/31/2014 17:33,3,2,# ASCO14: 1st report on state of # cancer care in US @ favo_it: 6th report on cancer care in Italy 2014. Italy v/ US 6-1pic.twitter.com/5lwU7f3DIP,,@,# #,4.72853E+17,https://twitter.com/aimac_it/status/472853327974105089,,,,
JLErsek,5/31/2014 17:33,0,0,All these great things about # PD1 at # ASCO14... @ 4Nathalie needs # compassionateuse won't someone give her a chance?,,@,# # #,4.72853E+17,https://twitter.com/JLErsek/status/472853311461535744,,,,
CANcerviver,5/31/2014 17:32,0,0,RT @ Sorena997: Preference-based screening materials improved colon cancer screening rates in African Americans # ASCO14.,,@,#,4.72853E+17,https://twitter.com/CANcerviver/status/472853238774239232,,,,
DrHedrick,5/31/2014 17:32,0,0,"Moore: Goserelin led to consistent improved ovarian function, pregnancy, and favorable DFS and OS (need more data) # ASCO14",,,#,4.72853E+17,https://twitter.com/DrHedrick/status/472853154359693312,,,,
TurnaRay,5/31/2014 17:32,0,0,# Asco2014 Back to writing... pic.twitter.com/WwGlPr4Y4O,,,#,4.72853E+17,https://twitter.com/TurnaRay/status/472853125167337472,,,,
rsm2800,5/31/2014 17:31,0,1,Moore: Exploratory analysis=better DFS HR=0.49 in goserelin. Surprising in this ER neg population; for OS HR also significant # bcsm # ASCO14,,,# #,4.72853E+17,https://twitter.com/rsm2800/status/472852939967451137,,,,
DrHedrick,5/31/2014 17:31,0,0,Moore: Improvement in disease free survival and overall survival. # ASCO14,,,#,4.72853E+17,https://twitter.com/DrHedrick/status/472852778193534976,,,,
teamoncology,5/31/2014 17:30,0,0,I am glad that POEMS study result came out. When this study started some docs were not enthusiastic. # bcsm # ASCO14,,,# #,4.72853E+17,https://twitter.com/teamoncology/status/472852764012183553,,,,
MikeHuckman,5/31/2014 17:30,0,0,And we wait. And wait. @ united flt arrived early at # ASCO14. Apparently our bags did not. pic.twitter.com/5fpTsJ8juy,,@,#,4.72853E+17,https://twitter.com/MikeHuckman/status/472852646806564864,,,,
ASCO,5/31/2014 17:30,2,4,Cancer care value from the provider's perspective http://bit.ly/RPf0As # ASCO14,,,#,4.72853E+17,https://twitter.com/ASCO/status/472852645456396288,,,,
ASCO,5/31/2014 17:30,1,1,Read Educational Book articles on topics in Ethics from # ASCO14 Education Session Speakers: http://bit.ly/1lPb231,,,#,4.72853E+17,https://twitter.com/ASCO/status/472852632647008256,,,,
DrHedrick,5/31/2014 17:30,0,0,Moore: 11% in control arm and 22% in goserelin arm achieved pregnancy p=0.03. No adverse events in goserelin arms for pregnancy # ASCO14,,,#,4.72853E+17,https://twitter.com/DrHedrick/status/472852600795463680,,,,
CancerDotNet,5/31/2014 17:30,4,2,Updated content from @ ASCO's pt education site on # fertility & cancer treatment for women: http://bit.ly/1j2kApS # ASCO14,,@,# #,4.72853E+17,https://twitter.com/CancerDotNet/status/472852591421173761,,,,
Gene_Antibody,5/31/2014 17:30,1,0,"@ medicalbots, 8 y/o Briana wants to invent robots. How might robots fight cancer in the # Next50 yrs? http://ow.ly/xsn5F # ASCO14",,@,# #,4.72853E+17,https://twitter.com/Gene_Antibody/status/472852583854669825,,,,
rsm2800,5/31/2014 17:29,4,2,Moore: Odds of getting pregnant w/in 5 yrs = 0.25 for goserelin vs chemo only arm; no evidence of increased adverse pregnancy events # asco14,,,#,4.72852E+17,https://twitter.com/rsm2800/status/472852484575068160,,,,
KoontzOncology,5/31/2014 17:29,0,0,"# ASCO14 http://tinyurl.com/ozlgcf8 although VI added to VAC for IRRMS didn't improve outcome, toxicity lesspic.twitter.com/SJ3j9lL3Mn",,,#,4.72852E+17,https://twitter.com/KoontzOncology/status/472852456456863744,,,,
teamoncology,5/31/2014 17:29,0,0,When Lupron was given for high-dose chemotherapy in hem cancer. It did not work. Glad to see new data. # bcsm # ASCO14,,,# #,4.72852E+17,https://twitter.com/teamoncology/status/472852442187444224,,,,
aftimosp,5/31/2014 17:29,0,0,Higher rate of achieved pregnancies in the goserelin arm # ASCO14,,,#,4.72852E+17,https://twitter.com/aftimosp/status/472852425414422528,,,,
yzafar,5/31/2014 17:29,0,0,@ HannaSanoff @ ASCO exactly!,,@ @,,4.72852E+17,https://twitter.com/yzafar/status/472852392405237762,,,,
subatomicdoc,5/31/2014 17:28,5,4,Hope in the mirror http://subatomicdoc.tumblr.com/post/11798473443/hope-in-the-mirror … # ASCO14 # pedcsmpic.twitter.com/oHa8iQyfRV,,,# #,4.72852E+17,https://twitter.com/subatomicdoc/status/472852261979561986,,,,
teamoncology,5/31/2014 17:28,1,0,"RT @ rsm2800: Moore: Goserelin pts 8% had ovarian failure vs 22% in chemo alone arm (odds ratio =0.3, p=0.02) # bcsm # ASCO14",,@,# #,4.72852E+17,https://twitter.com/teamoncology/status/472852203007258624,,,,
aftimosp,5/31/2014 17:28,1,0,POEMS ovarian failure: lower rate of ovarian failure in the LHRH agonist arm # ASCO14,,,#,4.72852E+17,https://twitter.com/aftimosp/status/472852124397604864,,,,
MaverickNY,5/31/2014 17:28,1,0,"Outside Arie Crown 5 bars, inside? Nothing all day except for the first 10 mins. Wifi & Att borked inside # asco14",,,#,4.72852E+17,https://twitter.com/MaverickNY/status/472852105926291456,,,,
rsm2800,5/31/2014 17:28,2,2,"Moore: Goserelin pts 8% had ovarian failure vs 22% in chemo alone arm (odds ratio =0.3, p=0.02) # bcsm # ASCO14",,,# #,4.72852E+17,https://twitter.com/rsm2800/status/472852103543533568,,,,
Cognicum,5/31/2014 17:27,0,0,“ @ Roche: Personalised therapy is like a jigsaw combining different treatments to fight different tumours # ASCO14 https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,#,4.72852E+17,https://twitter.com/Cognicum/status/472851993791578112,,,,
DrHedrick,5/31/2014 17:27,0,0,"Moore: Ovarian failure was just 1/3 as likely in goserelin patient as in those without. OR 0.30, p=0.02. # ASCO14",,,#,4.72852E+17,https://twitter.com/DrHedrick/status/472851989760856064,,,,
nycdoc29,5/31/2014 17:27,0,0,# ASCO14 - POEMS Phase 3 - chemo + goserelin decreased ovarian failure vs chemo. 22% v 8% only AEs were endocrine as expected,,,#,4.72852E+17,https://twitter.com/nycdoc29/status/472851976586158080,,,,
amy_cully,5/31/2014 17:27,0,1,Big. # ASCO14 pic.twitter.com/fmXvaU5gDO,,,#,4.72852E+17,https://twitter.com/amy_cully/status/472851938745528321,,,,
Cortellis,5/31/2014 17:27,1,0,MPDL3280A demonstrates promising safety & efficacy profile in heavily pretreated patients with metastatic urothelial bladder cancer # ASCO14,,,#,4.72852E+17,https://twitter.com/Cortellis/status/472851861121564672,,,,
MOCBrasil,5/31/2014 17:27,0,0,# MOCnaASCO # ASCO2014 # bcsmpic.twitter.com/gK2AMtpab7,,,# # #,4.72852E+17,https://twitter.com/MOCBrasil/status/472851839982252032,,,,
DrHedrick,5/31/2014 17:26,0,0,"Moore: 257 pts randomized. Some goserelin toxicity, hot flashes, mood changes, vaginal dryness. # ASCO14",,,#,4.72852E+17,https://twitter.com/DrHedrick/status/472851736995319809,,,,
jrgralow,5/31/2014 17:26,1,0,H Moore presenting on S0230 study of goserelin during chemo in TNBC to protect ovarian function. Lots of press on this. It works! # ASCO14,,,#,4.72852E+17,https://twitter.com/jrgralow/status/472851681693429761,,,,
HannaSanoff,5/31/2014 17:26,0,0,@ yzafar @ ASCO can't it be both?,,@ @,,4.72852E+17,https://twitter.com/HannaSanoff/status/472851599334055936,,,,
OncEd,5/31/2014 17:26,0,0,# ASCO14 live video update! Bevacizumab in the adjuvant treatment of HER2-negative breast cancer - Dr. Kathy Miller http://bit.ly/1oVA30n,,,#,4.72852E+17,https://twitter.com/OncEd/status/472851598205407232,,,,
rsm2800,5/31/2014 17:26,0,1,"Moore: POEMS trial 257 pts randomized, only 226 pts evaluable so some drop out for missing data # asco14",,,#,4.72852E+17,https://twitter.com/rsm2800/status/472851594820599808,,,,
AndreaMiyahira,5/31/2014 17:26,2,1,Sharma: PD-L1 expression may not be good biomarker for selecting pts for immunotherapy txt: expression not required for responses # ASCO14,,,#,4.72852E+17,https://twitter.com/AndreaMiyahira/status/472851548410621952,,,,
DrHedrick,5/31/2014 17:25,0,0,"Moore: Study closed prior to referral due to loss of funding. # ASCO14 (my comment, loss of funding is just awful for this good study)",,,#,4.72851E+17,https://twitter.com/DrHedrick/status/472851467200913408,,,,
CBPartners,5/31/2014 17:25,0,0,Interesting to hear more about ASCO’s physician payment reform at the community oncologist town hall http://bit.ly/1rvj7SI # ASCO14,,,#,4.72851E+17,https://twitter.com/CBPartners/status/472851362561011712,,,,
dytcmd,5/31/2014 17:25,0,1,@ ERPlimackMD use # asco14 (and great adapting to Twitter!),,@,#,4.72851E+17,https://twitter.com/dytcmd/status/472851340411293696,,,,
kgapo,5/31/2014 17:25,2,2,# Palliative care begins at diagnosis and has to be included in any alternative payment model. # ASCO14 v @ sfuldnasso cc @ esmart_eu,,@ @,# #,4.72851E+17,https://twitter.com/kgapo/status/472851330877644800,,,,
Cognicum,5/31/2014 17:24,0,0,“ @ Novartis: # ASCO14 always brings together top # Oncology experts to discuss # advancedBC advancements https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,# # #,4.72851E+17,https://twitter.com/Cognicum/status/472851223440531456,,,,
rsm2800,5/31/2014 17:24,0,1,"Moore: Early stage breast ca, randomized ER neg women to chemo vs chemo/goserelin; primary outcome ovarian failure at 2 yrs # bcsm # asco14",,,# #,4.72851E+17,https://twitter.com/rsm2800/status/472851096856043520,,,,
nycdoc29,5/31/2014 17:24,0,0,POEMS/S0230 phase 3 now...LBA # ASCO14 endpoints primary Ovarian Failure at 2 yrs,,,#,4.72851E+17,https://twitter.com/nycdoc29/status/472851010780930048,,,,
TylerWhisman,5/31/2014 17:23,0,0,While PD-1 may not be an acceptable biomarker for IT - we MUST figure out who will and will not benefit from tx. # ASCO14,,,#,4.72851E+17,https://twitter.com/TylerWhisman/status/472850944661925888,,,,
Lymphoma_Doc,5/31/2014 17:23,4,1,"Excellent review by Dr Sharma on anti-PD1 biomarkers in GU cancers, baseline pdl1 is not relevant as expression induced by therapy. # ASCO14",,,#,4.72851E+17,https://twitter.com/Lymphoma_Doc/status/472850907278114816,,,,
PeterHall001,5/31/2014 17:23,0,0,Evidence that vit D not prognostic for oncological breast cancer outcome in RCT populations. Again. Maybe only related to toxicity? # ASCO14,,,#,4.72851E+17,https://twitter.com/PeterHall001/status/472850900516884480,,,,
PDRennert,5/31/2014 17:23,3,2,love the Discussant on # immunotherapy # biomarkers: basic science tells us to forget about PD-L1 status as a biomarker! Well done # ASCO14,,,# # #,4.72851E+17,https://twitter.com/PDRennert/status/472850866131976192,,,,
OncEd,5/31/2014 17:23,1,1,# ASCO14 videos posted! http://bit.ly/1m1bRpg,,,#,4.72851E+17,https://twitter.com/OncEd/status/472850770350460929,,,,
DrHedrick,5/31/2014 17:22,0,0,"Moore: Prior studies looked at pregnancy outcomes, only at menses return. # ASCO14",,,#,4.72851E+17,https://twitter.com/DrHedrick/status/472850707000078336,,,,
rsm2800,5/31/2014 17:22,0,1,Moore: Goserelin trial POEMS (prevention of early menopause for premenop pts receiving chemo); to date randomized studies mixed # asco14,,,#,4.72851E+17,https://twitter.com/rsm2800/status/472850648904384512,,,,
OrmondOncDoc,5/31/2014 17:22,1,2,I recommend visiting josh @ JM_HealthIT at the CancerLinq exhibit sporting Google glass. # ASCO14,,@,#,4.72851E+17,https://twitter.com/OrmondOncDoc/status/472850638901374976,,,,
sfuldnasso,5/31/2014 17:22,6,4,Palliative care begins at diagnosis and has to be included in any alternative payment model. # ASCO14,,,#,4.72851E+17,https://twitter.com/sfuldnasso/status/472850597042221056,,,,
DrHedrick,5/31/2014 17:22,0,0,Moore: Phase III trial of LHRH analog to reduce ovarian failure in early stage breast cancer. Prevention of premature menopause. # ASCO14,,,#,4.72851E+17,https://twitter.com/DrHedrick/status/472850516813561857,,,,
dytcmd,5/31/2014 17:21,1,1,"+1 “ @ ERPlimackMD: Dr. Powles: Need more effective therapies for bladder cancer, no 2nd line std of care # gusm # blcsm # ASCO14 @ B_C_A_N”",,@ @,# # #,4.7285E+17,https://twitter.com/dytcmd/status/472850471636721664,,,,
alantanmd,5/31/2014 17:21,31,13,No proven association 25 OH vitamin D levels and breast cancer survival # ASCO14 pic.twitter.com/IMXl85Vxay,,,#,4.7285E+17,https://twitter.com/alantanmd/status/472850449645568000,,,,
rsm2800,5/31/2014 17:21,4,1,"Lohmann: Conclusion-Role of Vit D in breast cancer is unproven, no recommendation for Vit D supplementation (so level 20-30 prob ok) # asco14",,,#,4.7285E+17,https://twitter.com/rsm2800/status/472850300575830017,,,,
DrTerstriep,5/31/2014 17:20,0,0,Definitely see this in practice! @ drattai: predictor of emotional well being after CA= age. Younger pt -> more emotional distress # ASCO14.,,@,#,4.7285E+17,https://twitter.com/DrTerstriep/status/472850214811074560,,,,
jrgralow,5/31/2014 17:20,2,1,I use for bone health in cloudy Seattle! MT @ teamoncology: Please stop measuring vit D because patients have breast cancer. # ASCO14 # bcsm,,@,# #,4.7285E+17,https://twitter.com/jrgralow/status/472850194997202944,,,,
DrHedrick,5/31/2014 17:20,1,0,Lohmann: No support for Vitamin D supplementation as a means of improving breath cancer outcomes. # ASCO14,,,#,4.7285E+17,https://twitter.com/DrHedrick/status/472850194695192576,,,,
SCinieri,5/31/2014 17:20,2,2,# Asco14 obesity and breastcancerpremenopausalwomen A real problem,,,#,4.7285E+17,https://twitter.com/SCinieri/status/472850191461392384,,,,
OncLive,5/31/2014 17:20,0,0,Study Supports Dialing Back Radiation for Some Patients With HPV-Positive Oropharyngeal Cancer http://ow.ly/xtIbI # ASCO14,,,#,4.7285E+17,https://twitter.com/OncLive/status/472850109487931393,,,,
rsm2800,5/31/2014 17:20,0,0,"Lohmann: So why do prospective studies show no correlation w/ 25OH Vit D levels? Unclear, could be related to pt population # ASCO14",,,#,4.7285E+17,https://twitter.com/rsm2800/status/472850074699968513,,,,
dermanewsok,5/31/2014 17:20,1,0,Tumore: Boehringer Ingelheim presenta gli ultimi risultati di studi sui propri farmaci # ASCO14 http://bit.ly/1jIdwi1,,,#,4.7285E+17,https://twitter.com/dermanewsok/status/472850012200640512,,,,
salutedomani,5/31/2014 17:20,0,0,Tumore: Boehringer Ingelheim presenta gli ultimi risultati di studi sui propri farmaci # ASCO14 http://bit.ly/1jIdwi1,,,#,4.7285E+17,https://twitter.com/salutedomani/status/472850012020289536,,,,
antoniocaperna,5/31/2014 17:20,0,0,Tumore: Boehringer Ingelheim presenta gli ultimi risultati di studi sui propri farmaci # ASCO14 http://bit.ly/1jIdwi1,,,#,4.7285E+17,https://twitter.com/antoniocaperna/status/472850011793809408,,,,
DrHedrick,5/31/2014 17:19,0,0,"Lohmann: Significant limitations: No BMI, single level drawn, no data on supplementation of Vitamin D. # ASCO14",,,#,4.7285E+17,https://twitter.com/DrHedrick/status/472849947088674817,,,,
KoontzOncology,5/31/2014 17:19,0,0,"# ASCO14 http://tinyurl.com/pthvmvn When added to VC in pts w/ 1st relapse RMS, temsirolimus EFS > bevacizumab EFSpic.twitter.com/IS1Gy0jP63",,,#,4.7285E+17,https://twitter.com/KoontzOncology/status/472849933767151617,,,,
DrSabha,5/31/2014 17:19,8,5,Awesome review of Breast Cancer advances by Monica Morrow # bcsm # ASCO14 http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology#.U4pG9xRCeIQ.twitter …,,,# # #,4.7285E+17,https://twitter.com/DrSabha/status/472849920979107840,,,,
DrNancyZou,5/31/2014 17:19,0,0,Pre-menopausal women of BMI>30 with ER+ breast cancer are associated with higher mortality. # ASCO14,,,#,4.7285E+17,https://twitter.com/DrNancyZou/status/472849884148936705,,,,
rsm2800,5/31/2014 17:19,0,0,"Lohmann: Limitations-was post hoc analysis, no BMI info, no info about Vit D supplementation # ASCO14",,,#,4.7285E+17,https://twitter.com/rsm2800/status/472849837990617088,,,,
KUhlendorf,5/31/2014 17:19,0,1,Feisty # ASCO14 panel on payment reform reflects complexities/sensitivities. Short shrift on sustaining innovation. pic.twitter.com/J0FCflpK0C,,,#,4.7285E+17,https://twitter.com/KUhlendorf/status/472849827009556480,,,,
GregTucker21,5/31/2014 17:19,0,0,"@ JacobEPVantage Jacob, love to follow you, but these # ASCO14 tweets are useless. Just being honest. Keep up the good journalism.",,@,#,4.7285E+17,https://twitter.com/GregTucker21/status/472849807661600769,,,,
DrHedrick,5/31/2014 17:19,0,0,"Lohmann: Relapse free, breast cancer specific, and overall survival were not different regardless of Vitamin D level. # ASCO14",,,#,4.7285E+17,https://twitter.com/DrHedrick/status/472849755295744000,,,,
rsm2800,5/31/2014 17:18,1,1,"Lohmann: No diff in RFS, breast ca-specific survival, or OS for 25OH Vit D levels using pre-IOM and 2011 IOM classification # ASCO14",,,#,4.7285E+17,https://twitter.com/rsm2800/status/472849691537731586,,,,
mfrimawi,5/31/2014 17:18,0,0,Isn't it time to close the book on bevacizumab in breast cancer? # ASCO14,,,#,4.7285E+17,https://twitter.com/mfrimawi/status/472849635967393792,,,,
Neil_Iyengar,5/31/2014 17:18,0,0,From tissue-based talk to epidemiology: premenopausal women w breast ca have worse survival than nonobese # ASCO14 pic.twitter.com/wDMyNOl8TK,,,#,4.7285E+17,https://twitter.com/Neil_Iyengar/status/472849574483468288,,,,
teamoncology,5/31/2014 17:17,1,2,"Some docs, please stop measuring vitamin D level because patients have breast cancer. I do not know what to do. # ASCO14 # bcsm",,,# #,4.72849E+17,https://twitter.com/teamoncology/status/472849482745278464,,,,
EIannelli,5/31/2014 17:17,4,4,# ASCO14 1° rapporto assistenza oncolog USA. Osservat Favo 6° rapporto assistenza malato # cancro Italia vs USA 6 a 1pic.twitter.com/bzYqUBY7tO,,,# #,4.72849E+17,https://twitter.com/EIannelli/status/472849480346124288,,,,
BOPACommittee,5/31/2014 17:17,1,1,ASCO 14 is underway! For updates please use hashtag # asco14,,,#,4.72849E+17,https://twitter.com/BOPACommittee/status/472849436776083456,,,,
rsm2800,5/31/2014 17:17,0,0,Lohmann: Mean 25OH level was 69.7 (normal) for all pts # ASCO14,,,#,4.72849E+17,https://twitter.com/rsm2800/status/472849379779297280,,,,
sfuldnasso,5/31/2014 17:17,0,0,Monitoring and quality measurement are key to ensuring patient protections in alternative payment models. # ASCO14,,,#,4.72849E+17,https://twitter.com/sfuldnasso/status/472849311844556800,,,,
DrHedrick,5/31/2014 17:17,0,0,"Lohmann: Patients had to donate blood. Characteristics were somewhat different. More likely white, having mastectomy, etc. # ASCO14",,,#,4.72849E+17,https://twitter.com/DrHedrick/status/472849275601559553,,,,
jrgralow,5/31/2014 17:16,3,0,1st breast oral session # ASCO14: starting out w/ more anti-angiogenic trials with negative results. Can't figure out who benefits in br ca.,,,#,4.72849E+17,https://twitter.com/jrgralow/status/472849215048404993,,,,
rsm2800,5/31/2014 17:16,0,0,Lohmann: Women who gave blood samples for this study more likely to be white and ECOG 0 # ASCO14,,,#,4.72849E+17,https://twitter.com/rsm2800/status/472849208332939264,,,,
subatomicdoc,5/31/2014 17:16,2,1,"@ AnneBooms @ nxtstop1 Interesting point, good thing to consider as well. Thanks! # ASCO14",,@ @,#,4.72849E+17,https://twitter.com/subatomicdoc/status/472849193577775106,,,,
ERPlimackMD,5/31/2014 17:16,1,0,"Dr: Sharma: PDL1 expression is dynamic, baseline IHC does not tell the whole story. PDL1 neg can still respond. # blcsm # gusm # ASCO2014",,,# # #,4.72849E+17,https://twitter.com/ERPlimackMD/status/472849163449683968,,,,
teamoncology,5/31/2014 17:16,1,0,【 # ASCO14 Update】 No association of vitamin D and outcome of breast cancer in MA.21 study. http://abstracts.asco.org/144/AbstView_144_128900.html …,,,#,4.72849E+17,https://twitter.com/teamoncology/status/472849162896039937,,,,
DrHedrick,5/31/2014 17:15,0,0,"Lohmann: MA21 looked at 3 arms, CEF / EC+T / AC+T. This trial uses those patients and follows. Included baseline characteristics # ASCO14",,,#,4.72849E+17,https://twitter.com/DrHedrick/status/472848980892983296,,,,
rsm2800,5/31/2014 17:15,0,1,Lohmann: MA21 CEF vs EC/T vs AC/T; also studied 25OH Vit D levels; they used 2011 IOM standards as well as pre-IOM # ASCO14,,,#,4.72849E+17,https://twitter.com/rsm2800/status/472848945362644992,,,,
ASCO,5/31/2014 17:15,2,1,Read Educational Book articles on Developmental Therapeutics from # ASCO14 Education Session Speakers: http://bit.ly/1huRu2A,,,#,4.72849E+17,https://twitter.com/ASCO/status/472848826802642944,,,,
nanostringtech,5/31/2014 17:15,0,0,Prosigna simultaneously measures the expression levels of 50 genes used in the PAM50 classification algorithm. See more @Booth 5019 # ASCO14,,@Booth,#,4.72849E+17,https://twitter.com/nanostringtech/status/472848799149199360,,,,
twittmanda,5/31/2014 17:15,0,0,@ StJudeResearch @ ASCO @ StJude Congratulations Dr. Robison and St Judes! Well deserved!,,@ @ @,,4.72849E+17,https://twitter.com/twittmanda/status/472848749467680768,,,,
rsm2800,5/31/2014 17:14,5,2,"Lohmann: 2 trials 1 adjuvant, 1 neoadjuvant=no correlation of breast ca outcome w/ Vit D; observational studies suggest association # asco14",,,#,4.72849E+17,https://twitter.com/rsm2800/status/472848597273165824,,,,
CancerTherAdvsr,5/31/2014 17:14,1,0,# ASCO14: Cediranib Plus Olaparib Increases PFS in Recurrent # OvarianCancer # CTAatASCO http://ow.ly/xtLZN,,,# # #,4.72849E+17,https://twitter.com/CancerTherAdvsr/status/472848580525715457,,,,
RichardWJoseph,5/31/2014 17:14,3,0,Roche's Anti-pdl1 gets breakthrough designation for urothelial cancer. # ASCO14,,,#,4.72849E+17,https://twitter.com/RichardWJoseph/status/472848576604020738,,,,
earthangel711,5/31/2014 17:13,0,0,God Bless you Dr. Les for your great work helping to save Children with cancer :-) @ StJudeResearch @ StJude @ ASCO,,@ @ @,,4.72848E+17,https://twitter.com/earthangel711/status/472848419934203904,,,,
BurrisSkip,5/31/2014 17:13,2,0,Drs Hong and Falchook create enthusiasm around MET-inhibitors with great talks. # ASCO14 @ SarahCannonDocs,,@,#,4.72848E+17,https://twitter.com/BurrisSkip/status/472848407766130688,,,,
DrHedrick,5/31/2014 17:13,0,0,Lohmann: Low Vitamin D may lower disease free and overall survival. Unknown of causal. May be a surrogate maker of poorer health. # ASCO14,,,#,4.72848E+17,https://twitter.com/DrHedrick/status/472848404130037760,,,,
ChrisHeery,5/31/2014 17:13,0,0,Microbial invasion->barrier disruption->macrophage activation->nf-kb and stat3 activation->il-23->il-17 Katin # ASCO14,,,#,4.72848E+17,https://twitter.com/ChrisHeery/status/472848354590736384,,,,
teamoncology,5/31/2014 17:13,2,2,A great article by Dan Hayes. about biomarker. http://am.asco.org/next-generation-genomic-testing-understanding-semantics-helps-guide-assay-use-selection … # ASCO14,,,#,4.72848E+17,https://twitter.com/teamoncology/status/472848335028494336,,,,
dytcmd,5/31/2014 17:12,0,0,MT @ mtmdphd: Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 http://ow.ly/xmCr3 Great review- highlights clinical value of # hcsm,,@ @,# #,4.72848E+17,https://twitter.com/dytcmd/status/472848189901373440,,,,
GuardantHealth,5/31/2014 17:12,3,2,Laura Austin poster on # breastcancer # ASCO14 # GuardantHealth # Guardant360 cc: @ ASCO # cancerpic.twitter.com/7BKPn7f3hB,,@,# # # # #,4.72848E+17,https://twitter.com/GuardantHealth/status/472848137212928000,,,,
BayerPharma,5/31/2014 17:12,2,3,"According to the WHO, 298,102 people were diagnosed with # thyroidcancer in 2012. Learn more http://bit.ly/QJ7c2P # ASCO14",,,# #,4.72848E+17,https://twitter.com/BayerPharma/status/472848133492596736,,,,
dsobek,5/31/2014 17:12,0,0,Finally arrived at # ASCO14 Who is around?,,,#,4.72848E+17,https://twitter.com/dsobek/status/472848114517159936,,,,
MGHCancerCenter,5/31/2014 17:12,2,1,"Dr. Jennifer Temel discussing issues related to palliative care clinics at # ASCO14 in session now, an important research subject for her",,,#,4.72848E+17,https://twitter.com/MGHCancerCenter/status/472848114353979393,,,,
afreshchapter,5/31/2014 17:12,0,1,@ LurieCancer stopped by the # ASCO14 booth but couldn't make the tweet up. Hope to connect in the next couple of days!,,@,#,4.72848E+17,https://twitter.com/afreshchapter/status/472848113074733057,,,,
rsm2800,5/31/2014 17:12,1,0,Lohmann: Next up-research on Vit D blood levels and breast ca outcomes in NCIC trials; lots of interest in Vit D but data scant # asco14,,,#,4.72848E+17,https://twitter.com/rsm2800/status/472848005804990464,,,,
DrHedrick,5/31/2014 17:12,0,0,"Lohmann: Vitamin D may modulate apoptosis, proliferation, angiogenesis, and metastasis. # ASCO14",,,#,4.72848E+17,https://twitter.com/DrHedrick/status/472847995965554688,,,,
dansbarrington,5/31/2014 17:11,3,1,If you want to learn how to play spoof we will be in red ties teaching it in the bar in the Hyatt soon # ASCO14 you may even win a drink. ;),,,#,4.72848E+17,https://twitter.com/dansbarrington/status/472847933449461760,,,,
ScripMandy,5/31/2014 17:11,0,0,# ASCO14 Amgen biomarker data justify first-line Vectibix in colorectal cancer: http://bit.ly/1m1nKM0 (Scrip subscribers) $ AMGN,,,#,4.72848E+17,https://twitter.com/ScripMandy/status/472847910535585792,,,,
ChrisHeery,5/31/2014 17:11,0,0,Colorectal cancer cells lose adhesion and mucin (muc2) expression as IL-17 / 23 axis is upregulated. Katin # ASCO14,,,#,4.72848E+17,https://twitter.com/ChrisHeery/status/472847794022006785,,,,
PhRMA,5/31/2014 17:11,1,0,Discussion about cost needs to account for value of # innovative meds to # patients & # healthcare system http://onphr.ma/1kqAJKe # ASCO14,,,# # # #,4.72848E+17,https://twitter.com/PhRMA/status/472847756139044864,,,,
TylerWhisman,5/31/2014 17:10,1,1,Even more evident this year: MD -> Onc fellowship -> PhD in Immunology = ideal path for future Oncologists. # ASCO14,,,#,4.72848E+17,https://twitter.com/TylerWhisman/status/472847675881426944,,,,
ChestConsultant,5/31/2014 17:10,0,0,RT @ YaleTomLynch:Looking forward to talks on # EGFR: Next 10 Years-breaking barrier of acquired resistance @ YaleCancer # ASCO14 # RespEd # naclc,,@ @,# # # #,4.72848E+17,https://twitter.com/ChestConsultant/status/472847651474771968,,,,
ScripMandy,5/31/2014 17:10,5,0,"# ASCO14: Pharmacyclics, Janssen's Imbruvica shines in CLL: http://bit.ly/Sm4qSb (Scrip subscribers) $ PCYC $ JNJ",,,#,4.72848E+17,https://twitter.com/ScripMandy/status/472847595744661504,,,,
DrHedrick,5/31/2014 17:10,0,0,Lohmann: Prognostic association of 25-OH Vitamin D blood levels with breast cancer outcomes in clinical trial. # ASCO14,,,#,4.72848E+17,https://twitter.com/DrHedrick/status/472847589558480896,,,,
Prof_Nick_James,5/31/2014 17:10,0,0,Back to the future. Immunotherapy makes a comeback in RCC # ASCO14 pic.twitter.com/mnSQpltmUt,,,#,4.72848E+17,https://twitter.com/Prof_Nick_James/status/472847566355595266,,,,
CancerDotNet,5/31/2014 17:10,5,4,"Videos: Dr. Peter Yu, @ ASCO's President Elect, discusses today's targeted therapy research from # ASCO14: http://bit.ly/1mW8p2w",,@,#,4.72848E+17,https://twitter.com/CancerDotNet/status/472847546210340864,,,,
genentech,5/31/2014 17:10,4,3,"With ~250 investigational meds in dev for # bloodcancer, 1 size clearly doesn't fit all. Our approach: http://ow.ly/xtKZI # ASCO14",,,# #,4.72848E+17,https://twitter.com/genentech/status/472847513574453249,,,,
DrHedrick,5/31/2014 17:09,0,0,Pan: Tumors were slightly smaller in normal weight women. Analysis was planned for this. Obesity is independent factor despite this # ASCO14,,,#,4.72847E+17,https://twitter.com/DrHedrick/status/472847383152578560,,,,
motorrecilla,5/31/2014 17:09,0,1,"En el descans x dinar, ens refresquem"" amb les vistes de Chicago dd Palau de Congressos McCormick Place. # ASCO14 pic.twitter.com/K11brDRAro""",,,#,4.72847E+17,https://twitter.com/motorrecilla/status/472847283558432768,,,,
CancerNetwrk,5/31/2014 17:09,2,2,FLT-PET Fails to Distinguish True Glioblastoma Progression http://bit.ly/1gQV3VR # ASCO14,,,#,4.72847E+17,https://twitter.com/CancerNetwrk/status/472847245185146880,,,,
ScripMandy,5/31/2014 17:08,3,0,"# ASCO14: Clovis, AstraZeneca face off with EGFR, PARP inhibitors: http://bit.ly/1pHAxqO (Scrip subscribers) $ CLVS $ AZN",,,#,4.72847E+17,https://twitter.com/ScripMandy/status/472847203564666880,,,,
DrHedrick,5/31/2014 17:08,0,0,"Pan: Women >55, obese, with ER + disease did a little better than those under 55. # ASCO14",,,#,4.72847E+17,https://twitter.com/DrHedrick/status/472847048228995073,,,,
StJudeResearch,5/31/2014 17:08,61,79,"Congratulations @ StJude researcher Dr. Les Robison, recipient of @ ASCO Pediatric Oncology Award. # ASCO14 pic.twitter.com/gwQndJowLM",,@ @,#,4.72847E+17,https://twitter.com/StJudeResearch/status/472846988439207936,,,,
NextGenClinical,5/31/2014 17:07,0,1,"Excess monitoring of molecular tests affects pocket and causes anxiety"". Baccarani # ASCO14""",,,#,4.72847E+17,https://twitter.com/NextGenClinical/status/472846932889444352,,,,
CancerDotNet,5/31/2014 17:07,2,2,Scenes from @ ASCO’s Patient Advocate Program from Annual Meeting # ASCO14 http://on.fb.me/1nDY52P,,@,#,4.72847E+17,https://twitter.com/CancerDotNet/status/472846923020664832,,,,
teamoncology,5/31/2014 17:07,0,0,【 # ASCO14 Update】 RT @ alantanmd: PDL-1 therapy for PDL-1 positive urothelial bladder cancer impressive responses,,@,#,4.72847E+17,https://twitter.com/teamoncology/status/472846836059758592,,,,
dhjutsw1,5/31/2014 17:07,0,0,Gr8 MOC session @ ASCO # ASCO14. Gr8 questions & excellent feedback. >80% oncologists signed up as of May 1. Appreciate insights.,,@,#,4.72847E+17,https://twitter.com/dhjutsw1/status/472846739326529536,,,,
alantanmd,5/31/2014 17:06,4,5,PDL-1 therapy for PDL-1 positive urothelial bladder cancer impressive responses # ASCO14 pic.twitter.com/FvwALxk18l,,,#,4.72847E+17,https://twitter.com/alantanmd/status/472846628945010688,,,,
teamoncology,5/31/2014 17:06,1,0,【 # ASCO14 Update】Combi VEGFR & PARP inhibitors significantly extended PFS & ORR compared to PARPi in plat-sens OvCa. http://abstracts.asco.org/144/AbstView_144_130933.html …,,,#,4.72847E+17,https://twitter.com/teamoncology/status/472846606258032640,,,,
drdonsdizon,5/31/2014 17:06,3,0,With @ ConsanoMolly this afternoon at # ASCO14. Learn about our study for # survivorswithcancer… http://instagram.com/p/orPkflJw2h/,,@,# #,4.72847E+17,https://twitter.com/drdonsdizon/status/472846529623900161,,,,
NextGenClinical,5/31/2014 17:05,1,0,The landscape of mutated population is highly dynamic- Baccarani # ASCO14,,,#,4.72846E+17,https://twitter.com/NextGenClinical/status/472846413152280576,,,,
YaleCancer,5/31/2014 17:05,0,0,@ AneesChagpar @ ASCO How about gummy bears? Do they count?,,@ @,,4.72846E+17,https://twitter.com/YaleCancer/status/472846280180649984,,,,
ProjectInno,5/31/2014 17:05,0,0,Looking forward to meeting online friends at today's tweetup! # ASCO14,,,#,4.72846E+17,https://twitter.com/ProjectInno/status/472846275709509634,,,,
Roche,5/31/2014 17:05,3,7, # Patient-centric treatment is an enormous opportunity but also an enormous challenge, says Dr. Niko Andre http://ow.ly/xoREs # ASCO14,,,# #,4.72846E+17,https://twitter.com/Roche/status/472846267429965824,,,
ConsanoScott,5/31/2014 17:05,0,0,@ iConquerCancer @ CancerDotNet Excellent! It is so important to make research approachable to patients. # ASCO14,,@ @,#,4.72846E+17,https://twitter.com/ConsanoScott/status/472846260546711552,,,,
ipaulmampilly,5/31/2014 17:04,0,1,# ASCO14 hard to believe but today's most sophisticated cancer drugs begins with coley and his formula..http://www.peoplespharmacy.com/2012/02/25/780-cancer-and-the-immune-system/ …,,,#,4.72846E+17,https://twitter.com/ipaulmampilly/status/472846162328698880,,,,
ChrisHeery,5/31/2014 17:04,0,0,Blocking IL-17 or 23 reduces tumor ability to form (usually stays in adenine form without these signals). Katin # ASCO14,,,#,4.72846E+17,https://twitter.com/ChrisHeery/status/472846155055771649,,,,
RaisBahrami,5/31/2014 17:04,1,0,PD-1 and PD-L1 inhibition combined with TKIs in the tx of mRCC...combo therapy to avoid resistance and progression...added AEs # ASCO14,,,#,4.72846E+17,https://twitter.com/RaisBahrami/status/472846085774651392,,,,
MaverickNY,5/31/2014 17:04,5,4,"Based on Powles data, Gene's anti PD-L1 in UBC looks v encouraging considering how difficult these pats are to treat. Nice work! # asco14",,,#,4.72846E+17,https://twitter.com/MaverickNY/status/472846060013223936,,,,
DrHedrick,5/31/2014 17:04,0,0,"Pan: little effect of obesity in postmenopausal women with ER+ disease, no effect in ER- disease. # ASCO14",,,#,4.72846E+17,https://twitter.com/DrHedrick/status/472846006049308672,,,,
ShannonWestin,5/31/2014 17:04,0,0,@ dchimd look to the upcoming TRUST studies to answer primary cytoreduction/neoadjuvant question in adv ovarian ca. # ASCO14 # gyncsm,,@,# #,4.72846E+17,https://twitter.com/ShannonWestin/status/472845984959971328,,,,
drcbsteer,5/31/2014 17:03,0,0,"# ASCO14 Boulahssass Prospective study in over 500 pts mean age 82yrs. Adv Stage, MNA, gait speed predictive of death at 100days. # gerionc",,,# #,4.72846E+17,https://twitter.com/drcbsteer/status/472845897663918081,,,,
KUhlendorf,5/31/2014 17:03,0,0,"Call for panel etiquette: how about limiting audience members' questions"" to", say," a minute. Or even two. # ASCO14""",,,#,4.72846E+17,https://twitter.com/KUhlendorf/status/472845837974765568,,
PDRennert,5/31/2014 17:03,4,2,"MPDL3280A anti-PD-L1 in therapy-resistant bladder cohort shows very robust durable responses, low toxicity. impressive therapeutic # ASCO14",,,#,4.72846E+17,https://twitter.com/PDRennert/status/472845828210827264,,,,
ChrisHeery,5/31/2014 17:03,0,0,IL-23 promotes colorectal cancer tumor growth. Katin # ASCO14 pic.twitter.com/NckbC8YBoM,,,#,4.72846E+17,https://twitter.com/ChrisHeery/status/472845816021778432,,,,
NormandBlais,5/31/2014 17:02,3,1,Poster session: EGFR mut NSCLC developing brain metastases conserve the same mutation pattern as primary tumor # LCCatASCO # ASCO14,,,# #,4.72846E+17,https://twitter.com/NormandBlais/status/472845652310106112,,,,
ChrisHeery,5/31/2014 17:02,0,0,IL-23 / IL-17 axis upregulated in sporadic colorectal cancer. Karin # ASCO14 pic.twitter.com/ujgW9eOvgQ,,,#,4.72846E+17,https://twitter.com/ChrisHeery/status/472845563893792768,,,,
andygaya,5/31/2014 17:02,0,0,# ASCO14 Americans: Do you say goodbye on the phone or do you just pause and hang up like in the movies ?,,,#,4.72846E+17,https://twitter.com/andygaya/status/472845504318300160,,,,
DrHedrick,5/31/2014 17:02,0,0,Pan: Obesity increased the risk of death by 1/3 in ER+ premenppausal women. # ASCO14,,,#,4.72846E+17,https://twitter.com/DrHedrick/status/472845500782477313,,,,
DrHedrick,5/31/2014 17:01,0,0,Pan: independent adverse effect of obesity on premenopausal women with ER+ disease. # ASCO14,,,#,4.72845E+17,https://twitter.com/DrHedrick/status/472845290836611073,,,,
ASCO,5/31/2014 17:01,2,3,Want a demo of # CancerLinQ? Please visit the Institute for Quality booth at # ASCO14 http://bit.ly/1kIto90 # ascoaction,,,# # #,4.72845E+17,https://twitter.com/ASCO/status/472845283240706048,,,,
ASCO,5/31/2014 17:01,0,0,Review ACA before the # ASCO14 Health Care in America session: http://bit.ly/1iZjkI4 http://bit.ly/1n29vbO via # ASCOConnection,,,# #,4.72845E+17,https://twitter.com/ASCO/status/472845273325404160,,,,
QIAGENscience,5/31/2014 17:01,2,1,@ InsightGenetics # ASCO14 ALK fusions in NSCLC poster presentation TPS11136 today until 5:00pm S Hall A2,,@,#,4.72845E+17,https://twitter.com/QIAGENscience/status/472845262822842368,,,,
bmsnews,5/31/2014 17:01,6,1,Learn more about our # cancer # clinicaltrials on Study Connect http://ow.ly/xmoGd # ASCO14,,,# # #,4.72845E+17,https://twitter.com/bmsnews/status/472845256145518592,,,,
ASCO,5/31/2014 17:00,5,3,Read Educational Book articles on topics in Clinical Trials from # ASCO14 Education Session Speakers: http://bit.ly/1kHWXHP,,,#,4.72845E+17,https://twitter.com/ASCO/status/472845190567583744,,,,
harriseve,5/31/2014 17:00,0,0,3:45 PDT today : # ASCO14 Tweetup. Details here: http://bit.ly/NvNypj MT @ DrMarkham,,@,#,4.72845E+17,https://twitter.com/harriseve/status/472845050666569728,,,,
Xcenda,5/31/2014 17:00,2,1,# Xcenda market research opportunities for # ASCO14 attendees. Register today: http://bit.ly/nocr1,,,# #,4.72845E+17,https://twitter.com/Xcenda/status/472845012758052865,,,,
ConquerCancerFd,5/31/2014 17:00,5,2,. @ CancerDotNet has great patient-friendly summaries of the # cancer research presented here at # ASCO14: http://bit.ly/1kXfVu4,,@,# #,4.72845E+17,https://twitter.com/ConquerCancerFd/status/472845004436942848,,,,
CareAcross,5/31/2014 16:59,2,1,"Chicago: great weather today, but cancer research keeps delegated indoors, at # ASCO14 pic.twitter.com/CguvvTH6JW",,,#,4.72845E+17,https://twitter.com/CareAcross/status/472844883343204352,,,,
DrHedrick,5/31/2014 16:59,1,1,Pan: Effect of obesity on prognosis in pre-menopausal ER+ early stage breast cancer. # ASCO14,,,#,4.72845E+17,https://twitter.com/DrHedrick/status/472844863516721152,,,,
Sorena997,5/31/2014 16:58,1,1,# ASCO14 pic.twitter.com/GpSBL0sKls,,,#,4.72845E+17,https://twitter.com/Sorena997/status/472844684705157121,,,,
TuftsB,5/31/2014 16:58,0,0,Questioner almost ejected from cost panel 4 daring to disagree with prepackaged Asco conclusion. So much for honest debate # MLIWI. # asco14,,,# #,4.72845E+17,https://twitter.com/TuftsB/status/472844535576670208,,,,
Preslaura,5/31/2014 16:58,3,3,Almost every cancer study and presentation discusses genetics. Thinking in all new terms about treatment approaches. # ASCO14,,,#,4.72845E+17,https://twitter.com/Preslaura/status/472844518510063616,,,,
PennMedNews,5/31/2014 16:58,2,0,Susan Domchek reports on side effects experienced by # BRCA carriers following # cancer risk-reducing surgery # ASCO14 pic.twitter.com/lGwkmbFGDG,,,# # #,4.72844E+17,https://twitter.com/PennMedNews/status/472844499828621312,,,,
JoleneScience,5/31/2014 16:57,1,1,$ AZN submitted NDA for olaparib in ovarian cancer; would be 1st PARP inhibitor if approved by FDA # ASCO14 # gyncsmpic.twitter.com/pBzJa3VaZY,,,# #,4.72844E+17,https://twitter.com/JoleneScience/status/472844374900871168,,,,
QIAGENscience,5/31/2014 16:57,1,0,"@ InsightGenetics # ASCO14 poster: Plans to compare qPCR, w IHC & FISH to detect ALK fusions in NSCLC FFPE specimens; study to use our test",,@,#,4.72844E+17,https://twitter.com/QIAGENscience/status/472844318500483072,,,,
Prof_Nick_James,5/31/2014 16:56,7,2,Very exciting data presented by Tom Powles with PDL1 inhibition in 2nd line bladder cancer # ASCO14 pic.twitter.com/ztgnASkCO3,,,#,4.72844E+17,https://twitter.com/Prof_Nick_James/status/472844163533533184,,,,
Jerry_DurhamPT,5/31/2014 16:56,1,0,"RT @ ElizBlanchardMD: Dr Jeff Ward: if we don't participate in payment reform, someone will do it for us # ASCO14 THEY ALREADY DO!!",,@,#,4.72844E+17,https://twitter.com/Jerry_DurhamPT/status/472844131211812864,,,,
EIannelli,5/31/2014 16:56,2,3,http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=21814 … @ mritamon @ QSanit obiettivo centrato! # ASCO14 @ InsControCancro @ favo_it @ ailar_it @ fiorellatosoni @ ONcotwITting,,@ @ @ @ @ @ @,#,4.72844E+17,https://twitter.com/EIannelli/status/472844052530864128,,,,
JacobPlieth,5/31/2014 16:56,1,0,"Speed of responses in phI MPDL3280A bladder cancer study were a surprise, says Dr Powles $ RHHBY # ASCO14",,,#,4.72844E+17,https://twitter.com/JacobPlieth/status/472844030964142080,,,,
ERPlimackMD,5/31/2014 16:56,4,0,"Dr Powles: MPDL3280A in bladder cancer is well tolerated, 16/17 responses ongoing at time of data cutoff. # gusm # blcsm # ASCO2014.",,,# # #,4.72844E+17,https://twitter.com/ERPlimackMD/status/472844008159723520,,,,
AndytweetM,5/31/2014 16:55,0,0,@ ASCO is there a #where I can call them?,,@,#where,4.72844E+17,https://twitter.com/AndytweetM/status/472843864513187843,,,,
JoleneScience,5/31/2014 16:55,0,0,17.7 mos mPFS for olaparib+cediranib in recurrent Pt-sens ovarian ( @ theNCI-sponsored) # gyncsm # ASCO14,,@,# #,4.72844E+17,https://twitter.com/JoleneScience/status/472843826302685184,,,,
subatomicdoc,5/31/2014 16:54,9,5,“We build too many walls and not enough bridges.” - Sir Isaac Newton (via njoi) http://tmblr.co/ZzLuQy1HQxyZp # ASCO14 # hcsm,,,# #,4.72844E+17,https://twitter.com/subatomicdoc/status/472843663341809666,,,,
khnguyen,5/31/2014 16:54,0,0,Dr Mayer nicely summarized anti-angiogenesis data in breast ca. Bev has no role? More hope for other anti-angiogenic agents? # ASCO14,,,#,4.72844E+17,https://twitter.com/khnguyen/status/472843558534545409,,,,
theABTA,5/31/2014 16:54,0,0,"ABTA researcher, Andrew Chi, MD, PHD, shares his team's study results during poster session at # ASCO14 pic.twitter.com/vTSUKZsoje",,,#,4.72844E+17,https://twitter.com/theABTA/status/472843510198968320,,,,
drdonsdizon,5/31/2014 16:53,1,2,@LindaSueHouse @ advocacyleader @ CancerSupportCm TYSM. I thought it was a great session # ASCO14,,@LindaSueHouse @ @,#,4.72843E+17,https://twitter.com/drdonsdizon/status/472843457288212481,,,,
RS_Flinn,5/31/2014 16:53,0,0,@ brianreid are those your # ASCO14 pickup lines or prognostication for my Sunday night? @ ToddRingler,,@ @,#,4.72843E+17,https://twitter.com/RS_Flinn/status/472843425931624448,,,,
brianreid,5/31/2014 16:53,0,1,"@ djsampson @ DrLen Get that guy Google Glass. Seriously, I would pay cash money for a Len's-eye view of # ASCO14",,@ @,#,4.72843E+17,https://twitter.com/brianreid/status/472843409355321344,,,,
DrBenParsons,5/31/2014 16:53,0,0,# ASCO14 43% ORR in metastatic bladder cancer with PDL1 expressing tumor using PD1 therapy,,,#,4.72843E+17,https://twitter.com/DrBenParsons/status/472843266057330689,,,,
djsampson,5/31/2014 16:53,0,0,I think @ DrLen needs one more device # asco14 pic.twitter.com/R2qIdDJrm8,,@,#,4.72843E+17,https://twitter.com/djsampson/status/472843215612043264,,,,
RS_Flinn,5/31/2014 16:52,0,0,Guessing Game of Thrones pick up lines r NSFW RT @ ToddRingler: @ RS_Flinn @ GameOfThrones # ASCO14 are we doing # ASCO14 pick-up lines now??? ;),,@ @ @,# #,4.72843E+17,https://twitter.com/RS_Flinn/status/472843101351211009,,,,
JoleneScience,5/31/2014 16:52,0,0,"@BMTEdny Also lots of ADC talks in Sunday Lymphoma session @ # ASCO14; go bioconjugation! ($SGEN, $ IMGN) # lymsm",,@BMTEdny @,# #,4.72843E+17,https://twitter.com/JoleneScience/status/472843086909829120,,,,
EIannelli,5/31/2014 16:51,1,1,http://www.quotidianosanita.it/scienza-e-farmaci/articolo.php?articolo_id=21815 … ultime da # ASCO14 brava @ mritamon @ favo_it @ InsControCancro,,@ @ @,#,4.72843E+17,https://twitter.com/EIannelli/status/472842920081379330,,,,
ToddRingler,5/31/2014 16:51,0,0,@ RS_Flinn @ GameofThrones # ASCO14 are we doing # ASCO14 pick-up lines now??? ;),,@ @,# #,4.72843E+17,https://twitter.com/ToddRingler/status/472842855610724352,,,,
alantanmd,5/31/2014 16:51,1,3,"Nivolumab PD-1 has encouraging responses, also with sunitinib in mRCC # ASCO14 pic.twitter.com/E5AMMmuEvT",,,#,4.72843E+17,https://twitter.com/alantanmd/status/472842807548207104,,,,
ElizBlanchardMD,5/31/2014 16:51,1,0,"Dr Jeff Ward: if we don't participate in payment reform, someone will do it for us # ASCO14",,,#,4.72843E+17,https://twitter.com/ElizBlanchardMD/status/472842726640062464,,,,
myESMO,5/31/2014 16:51,0,1,"Attending # ASCO14? We'd love to see you @our booth nr 3053. Find out about membership, # OncologyPRO, # ESMO14, & more",,@our,# # #,4.72843E+17,https://twitter.com/myESMO/status/472842719266865152,,,,
MehrazinMD,5/31/2014 16:50,1,3,"Dr. Amin: nivolumab+VEGF, encouraging response rate in metastatic # kidneycancer # ASCO2014 via @ ERPlimackMDpic.twitter.com/BbFqKOq4em",,@,# #,4.72843E+17,https://twitter.com/MehrazinMD/status/472842539826171905,,,,
sfuldnasso,5/31/2014 16:50,1,0,"Ward: fee for service reimbursement is medicine's dark secret"" # ASCO14""",,,#,4.72843E+17,https://twitter.com/sfuldnasso/status/472842523098894337,,,,
ElizBlanchardMD,5/31/2014 16:50,1,0,Dr Jeff Ward:ASCO payment reform can influence practices to develop patent centered prgms that can improve quality and patient care # ASCO14,,,#,4.72843E+17,https://twitter.com/ElizBlanchardMD/status/472842516505432064,,,,
OncLive,5/31/2014 16:50,0,2,"Goserelin Preserves Fertility, Aids Survival During Breast Cancer Chemo http://ow.ly/xtHNH # ASCO14",,,#,4.72842E+17,https://twitter.com/OncLive/status/472842488072654848,,,,
NuCana_news,5/31/2014 16:50,0,0,"NuCana will be presenting at the American Society of Clinical Oncology # ASCO14 annual meeting on May 30-June 3, 2014 in Chicago, Illinois.",,,#,4.72842E+17,https://twitter.com/NuCana_news/status/472842451737391104,,,,
DrHedrick,5/31/2014 16:49,1,0,Is there a current role for bevacizumab in breast cancer? Answer - No. Even neoadj trials would have to be massively impressive. # ASCO14,,,#,4.72842E+17,https://twitter.com/DrHedrick/status/472842412445143040,,,,
NextGenClinical,5/31/2014 16:48,1,0,Significant clones can remain in CR after BMT in secondary AML- Ebert # ASCO14,,,#,4.72842E+17,https://twitter.com/NextGenClinical/status/472842047796178944,,,,
drugwonks,5/31/2014 16:48,2,0,"For every 15% drop in # cancer deaths, $127.2 billion in productivity is gained. Join Us. # ASCO14 # MLIWI http://buff.ly/1ktLDdO # mliwi",,,# # # #,4.72842E+17,https://twitter.com/drugwonks/status/472842028649578496,,,,
ERPlimackMD,5/31/2014 16:48,10,6,"Dr. Powles: Need more effective therapies for bladder cancer, no FDA approved second line standard of care # gusm # blcsm # ASCO2014 @ B_C_A_N",,@,# # #,4.72842E+17,https://twitter.com/ERPlimackMD/status/472842025034055682,,,,
aftimosp,5/31/2014 16:48,0,0,Erica Mayer putting the trebananib in HER2+ # BreastCancer into perspective... # ASCO14,,,# #,4.72842E+17,https://twitter.com/aftimosp/status/472841997955252224,,,,
ChrisHeery,5/31/2014 16:47,0,0,"Can now calculate immunoscore with standard pathology slide. Software does much of the work, pathologist verifies. Galon # ASCO14",,,#,4.72842E+17,https://twitter.com/ChrisHeery/status/472841924454256640,,,,
elaineleung,5/31/2014 16:47,0,0,Hashtags heatmap- groovy! RT @nextprinciples: Top 20 conversation at # ASCO14. @nextprinciples https://twitter.com/nextprinciples/status/472839195774296064/photo/1pic.twitter.com/JfHMisvRcn,,@nextprinciples @nextprinciples,#,4.72842E+17,https://twitter.com/elaineleung/status/472841779814072320,,,,
DrSabha,5/31/2014 16:47,0,0,"Studying angiogenesis inhibition is challenging when the biomarkers, timing, and endpoints aren't relevant # ASCO14",,,#,4.72842E+17,https://twitter.com/DrSabha/status/472841745206886401,,,,
DrHedrick,5/31/2014 16:47,0,0,Trebananib has similar response rates conceptually as pertuzumab did in CLEOPATRA (admission of limit comparing Phase I and III) # ASCO14,,,#,4.72842E+17,https://twitter.com/DrHedrick/status/472841732082896897,,,,
TuftsB,5/31/2014 16:47,0,1,"He who saves a single life saves the entire world."" Treat patients as individuals during cancer fight. Use all tools for us. # mliwi # asco14""",,,# #,4.72842E+17,https://twitter.com/TuftsB/status/472841729000103936,,,,
Ishmael_Gritli,5/31/2014 16:47,0,0,Attending now the Inflammatory Cell and Cancer session # AACR # ASCO14 http://tinyurl.com/pffmdrt pic.twitter.com/9o3An4pASd,,,# #,4.72842E+17,https://twitter.com/Ishmael_Gritli/status/472841720376221696,,,,
dr_alhashem,5/31/2014 16:47,0,0,Oral abstract session in breast cancer # ASCO14 pic.twitter.com/aLU46NlakI,,,#,4.72842E+17,https://twitter.com/dr_alhashem/status/472841707701026816,,,,
JackWestMD,5/31/2014 16:47,7,4,Langer: Brain major sanctuary site in ALK+ NSCLC pts: 46% develop brain mets as 1st/only site of progression on criz. # ASCO14 # LCSM,,,# #,4.72842E+17,https://twitter.com/JackWestMD/status/472841705113526272,,,,
n8pennell,5/31/2014 16:46,7,3,"Another driver oncogene in NSCLC, HER2 mutations, in 2.6% of adeno in LCMC. Higher than I thought! # ASCO14 pic.twitter.com/nSJaC3JvfD",,,#,4.72842E+17,https://twitter.com/n8pennell/status/472841631733805056,,,,
NextGenClinical,5/31/2014 16:45,0,0,Secondary AML has distinct genetics from de novo AML- Ebert # ASCO14,,,#,4.72841E+17,https://twitter.com/NextGenClinical/status/472841392763731968,,,,
NTConnell,5/31/2014 16:45,1,1,Great # ASCO14 talk by Ben Ebert from @ BrighamWomens and @ DanaFarber about the mutations in MDS how these data may guide therapy.,,@ @,#,4.72841E+17,https://twitter.com/NTConnell/status/472841288023556097,,,,
Novartis,5/31/2014 16:45,1,2,# ASCO14 always brings together top # Oncology experts to discuss # advancedBC advancements http://bit.ly/1ipAxGQ,,,# # #,4.72841E+17,https://twitter.com/Novartis/status/472841259804291072,,,,
JeffreyMOtto,5/31/2014 16:45,0,0,"Next up: Michele Baccarani molecular monitoring and mutations in cml: how to get the most out of your TKIs # ASCO14""",,,#,4.72841E+17,https://twitter.com/JeffreyMOtto/status/472841257891672064,,,,
DrAttai,5/31/2014 16:45,4,3,"Dr. Domckeck high impact on QOL from oophorectomy in BRCA pts - sexual, cognitive, other # ASCO14 # bcsm",,,# #,4.72841E+17,https://twitter.com/DrAttai/status/472841246612783104,,,,
Gene_Antibody,5/31/2014 16:45,0,0,“Care” isn’t just about meds – it’s abt the overall well-being of ppl w/ cancer http://ow.ly/xn27u # ASCO14,,,#,4.72841E+17,https://twitter.com/Gene_Antibody/status/472841238505594880,,,,
ChrisHeery,5/31/2014 16:45,0,0,High risk of death with poor (low) immunoscore even in stage 1 or 2 mCRC. Galon # ASCO14 pic.twitter.com/fcwepcKpyQ,,,#,4.72841E+17,https://twitter.com/ChrisHeery/status/472841196201463808,,,,
Mykalt45,5/31/2014 16:44,5,3,Be prepared to be blown away by bavituximab # ASCO14! $ PPHM,,,#,4.72841E+17,https://twitter.com/Mykalt45/status/472841175167029249,,,,
DrHedrick,5/31/2014 16:44,0,0,Is this end of the era of angiogenesis inhibition in breast cancer? Perhaps a different VEGF inhibitor is needed # ASCO14,,,#,4.72841E+17,https://twitter.com/DrHedrick/status/472841102807298048,,,,
ematich,5/31/2014 16:44,0,0,Dr. Antonio Jimeno # ASCO14 presenting results of clinical trial targeting cancer stem cells http://bit.ly/1nDVJAN pic.twitter.com/qVclRNu1XG,,,#,4.72841E+17,https://twitter.com/ematich/status/472841035056312320,,,,
teamoncology,5/31/2014 16:44,0,0,"We now need to look which breast cancer subtype are fatal. Triple Negative Breast Cancer, Metaplastic, and Inflammatory BC. # ASCO14 # bcsm",,,# #,4.72841E+17,https://twitter.com/teamoncology/status/472840976331833344,,,,
RS_Flinn,5/31/2014 16:43,0,1,Wondering if there's enough @ GameofThrones fans at # ASCO14 to get a viewing party together Sunday night. Any takers?,,@,#,4.72841E+17,https://twitter.com/RS_Flinn/status/472840937090318336,,,,
KoontzOncology,5/31/2014 16:43,0,0,# ASCO14 http://tinyurl.com/n8ngkf9 EFS improved with intensive chemo in BT-WT but OS improved only in stage I ptspic.twitter.com/a7KhMKjH9J,,,#,4.72841E+17,https://twitter.com/KoontzOncology/status/472840913765806080,,,,
Boehringer,5/31/2014 16:43,8,2,BLOG POST: Our social media summary of # ASCO14 day 1 http://bit.ly/1m1cLSF # lungcancer # notjustonediseasepic.twitter.com/YltGEHCREO,,,# # #,4.72841E+17,https://twitter.com/Boehringer/status/472840794408517632,,,,
markaorourke,5/31/2014 16:43,1,0,# ASCO14 abstract 9510 Decrease in distress associated with decrease in inflammatory cytokines in elderly prostate ca survivors. # pcsm,,,# #,4.72841E+17,https://twitter.com/markaorourke/status/472840717963108352,,,,
QIAGENscience,5/31/2014 16:43,0,1,"Ingenuity Clinical test indic inc hereditary cancer, somatic cancer, carrier screening, & cardiovascular. http://bit.ly/1tL25xH # ASCO14",,,#,4.72841E+17,https://twitter.com/QIAGENscience/status/472840716969050112,,,,
DrAttai,5/31/2014 16:42,4,1,"Dr. Domchek: less educated, early age at oophorectomy associated with poorer QOL scores # ASCO14 # bcsm",,,# #,4.72841E+17,https://twitter.com/DrAttai/status/472840620344492032,,,,
teamoncology,5/31/2014 16:42,2,1,Yep. RT @ pfizer: Did you know 30% of women diagnosed with early breast cancer will progress to advanced disease? # ASCO14 # bcsm,,@,# #,4.72841E+17,https://twitter.com/teamoncology/status/472840610378833920,,,,
PDRennert,5/31/2014 16:42,0,1,Discuss ant reluctantly waved the caution flag on Nivo combos. The checkered flag will have to wait. # ASCO14,,,#,4.72841E+17,https://twitter.com/PDRennert/status/472840581690179584,,,,
teamoncology,5/31/2014 16:42,0,1,@ drjeanpereira There are gene signature in TNBC that may be involved in angiogenesis. # ASCO14,,@,#,4.72841E+17,https://twitter.com/teamoncology/status/472840581006123008,,,,
PSUMaryDom,5/31/2014 16:42,1,0,wow! RT @lucasvsmd: Incredible response with pac herc trebananib in 1st line met # breastcancer . # ASCO14 88% ORR,,@lucasvsmd,# #,4.72841E+17,https://twitter.com/PSUMaryDom/status/472840567353638912,,,,
AtriumHealth,5/31/2014 16:42,6,1,"New drugs may make a dent in lung, ovarian cancer - http://yhoo.it/1rv9eEM # LCI # ASCO14",,,# #,4.72841E+17,https://twitter.com/AtriumHealth/status/472840505709977601,,,,
JeffreyMOtto,5/31/2014 16:42,0,0,BE: MDS pts often have AML clones in the original lesion - just go on to develop after cr to mds treatment. # ASCO14,,,#,4.72841E+17,https://twitter.com/JeffreyMOtto/status/472840501553819648,,,,
bradloncar,5/31/2014 16:42,3,5,How huge is # ASCO14? A view from the balcony seats where @ JPZaragoza1 and I are currently sitting.pic.twitter.com/D8t3GkCSB3,,@,#,4.7284E+17,https://twitter.com/bradloncar/status/472840483849637888,,,,
teamoncology,5/31/2014 16:42,0,0,Not sure. Need biomarkers. # ASCO14 RT @ drjeanpereira: # ASCO14 Bevacizumab must be erased from Breast Cancer book chapters?,,@,# #,4.7284E+17,https://twitter.com/teamoncology/status/472840444393426944,,,,
DrHedrick,5/31/2014 16:41,0,0,Concerning for discontinuation of adjuvant chemotherapy. E5103 has advantage of correlative analysis previous studies did not. # ASCO14,,,#,4.7284E+17,https://twitter.com/DrHedrick/status/472840430569402368,,,,
ChrisHeery,5/31/2014 16:41,0,0,Immunoscore now being tested prospectively in comparison to other staging techniques/prognostic markers. Galon # ASCO14,,,#,4.7284E+17,https://twitter.com/ChrisHeery/status/472840423421906944,,,,
sarah_blagden,5/31/2014 16:41,1,0,JCOG3017 results # ASCO14 no advantage treating clear cell ovarian cancer with ironotecan plus platinum over the usual carboplatin and taxol,,,#,4.7284E+17,https://twitter.com/sarah_blagden/status/472840407572045825,,,,
teamoncology,5/31/2014 16:41,0,0,@ ClevelandClinic Similar statement was made 20 years ago when interferon alpha came out. We will divide our pts by targets. # ASCO14,,@,#,4.7284E+17,https://twitter.com/teamoncology/status/472840337614839808,,,,
wendyselig,5/31/2014 16:41,3,3,"Lovely to have more tools in the toolbox"" for # melanoma patients. Pat Hwu from @MDAMelanomaOnc @ MelanomaReAlli # asco2014.""",,@MDAMelanomaOnc @,# #,4.7284E+17,https://twitter.com/wendyselig/status/472840239329734656,,,,
JeffreyMOtto,5/31/2014 16:41,0,0,BE: pts w/ mds often go on to develop aml. # ASCO14,,,#,4.7284E+17,https://twitter.com/JeffreyMOtto/status/472840204517388288,,,,
adamfeuerstein,5/31/2014 16:40,2,9,Discussant PD-1 scorecard in kidney cancer $ BMY # ASCO14 pic.twitter.com/5NuyhtoldN,,,#,4.7284E+17,https://twitter.com/adamfeuerstein/status/472840147050827777,,,,
GustaveRoussy,5/31/2014 16:40,6,0,# ASCO14 Targeted therapies and early trials: @ GustaveRoussy presented 3 clinical studies on new inhibitors @ ASCO http://bit.ly/1ku73wp,,@ @,#,4.7284E+17,https://twitter.com/GustaveRoussy/status/472840142659805184,,,,
teamoncology,5/31/2014 16:40,0,0,"Can you agree? RT @ ClevelandClinic: “In 10 y, we won’t say breast or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,@,# #,4.7284E+17,https://twitter.com/teamoncology/status/472840092604575744,,,,
ERPlimackMD,5/31/2014 16:40,0,1,Dr. Lauren Harshman discusses nivolumab: continuation of responses off therapy ?Immune memory? # gusm # asco2014,,,# #,4.7284E+17,https://twitter.com/ERPlimackMD/status/472840089559920640,,,,
DrAttai,5/31/2014 16:40,1,1,Dr. Domchek many pts enrolled thru @ FacingOurRisk website. various QOL measures evaluated. 7900 pts # ASCO14 # bcsm,,@,# #,4.7284E+17,https://twitter.com/DrAttai/status/472840033645240322,,,,
DrHedrick,5/31/2014 16:40,0,0,"Bevacizumab in adjuvant setting, BEATRICE and BETH, both without benefit. # ASCO14",,,#,4.7284E+17,https://twitter.com/DrHedrick/status/472840014494433280,,,,
JeffreyMOtto,5/31/2014 16:40,0,0,BE: pts w/ p53 mutations have very poor outcomes even with bone marrow Xplants (mds) # ASCO14,,,#,4.7284E+17,https://twitter.com/JeffreyMOtto/status/472840002586812417,,,,
wendyselig,5/31/2014 16:39,2,1,. @ melanomarealli Medical Advisory Panel mbr Pat Hwu: immune therapy is simple but powerful approach for progress in # melanoma. # asco14.,,@,# #,4.7284E+17,https://twitter.com/wendyselig/status/472839811112652801,,,,
ChrisHeery,5/31/2014 16:39,0,0,"Now working on the mechanism of how these cells are attracted, infiltrate, and proliferate. Galon # ASCO14",,,#,4.7284E+17,https://twitter.com/ChrisHeery/status/472839755223154688,,,,
betht0002,5/31/2014 16:39,0,0,Listening to @Carolinas Dr. Asim Amin discuss exciting # immunotherapy drug ; could improve OS in kidney cancer patients # ASCO14 # LCI,,@Carolinas,# # #,4.7284E+17,https://twitter.com/betht0002/status/472839725368102912,,,,
TylerWhisman,5/31/2014 16:37,0,0,PD-1 + VEGF TKI combo in RCC -- Proceed with caution. High ORR but Gr 3/4 toxicity concerns. # ASCO14,,,#,4.72839E+17,https://twitter.com/TylerWhisman/status/472839427556130816,,,,
stuartgiles01,5/31/2014 16:37,0,1,"@ cathiereid yes, 33,000+ # ASCO14 delegates take up a lot of room & logistics but provide an amazing snapshot of cancer care around the world",,@,#,4.72839E+17,https://twitter.com/stuartgiles01/status/472839358576218112,,,,
ChrisHeery,5/31/2014 16:37,0,0,"Immune landscape - 20 different immune subsets. The good guys"" are the adaptive immune subsets"," except T-IL17 cells. Galon # ASCO14""",,,#,4.72839E+17,https://twitter.com/ChrisHeery/status/472839321209167872,,,
markaorourke,5/31/2014 16:37,4,2,"# ASCO14 abstract 9510 Prostate ca survivors with high distress had high cytokines. With exercise program, distress down and cytokines down.",,,#,4.72839E+17,https://twitter.com/markaorourke/status/472839303983562752,,,,
DrMarkham,5/31/2014 16:37,3,1,Promising! RT @ journeycancer: Great news for ovarian cancer survivors. http://www.cancer.gov/newscenter/newsfromnci/2014/OvarianNCT01116648ASCO?cid=sf26798030 … # gyncsm # ASCO14,,@,# #,4.72839E+17,https://twitter.com/DrMarkham/status/472839295934668800,,,,
DrAttai,5/31/2014 16:37,1,1,Dr. Domchek QOL after oophorectomy in BRCA 1/2 pts # ASCO14 # bcsm,,,# #,4.72839E+17,https://twitter.com/DrAttai/status/472839252359647232,,,,
DoctorEdny,5/31/2014 16:36,1,0,"$ AMGN PIb study of trebananib (amg-386) in HER2+ mBC shows 30mg dose 18.7 months mPFS, 88% ORR # ASCO14 pic.twitter.com/bYYTIfOmUS",,,#,4.72839E+17,https://twitter.com/DoctorEdny/status/472839133690593281,,,,
GScheiber,5/31/2014 16:36,0,0,“ @ jdflaysakier: Cancer ovaire récidivant : la combinaison Olaparib-Cediranib freine la maladie pendant quasiment 18 mois # ASCO14”,,@,#,4.72839E+17,https://twitter.com/GScheiber/status/472839123427164160,,,,
DrMarkham,5/31/2014 16:36,3,1,JGOG3017: no difference in PFS between cis/cpt11 and carbo/paclitaxel in clear cell ovary ca. # gyncsm # ASCO14,,,# #,4.72839E+17,https://twitter.com/DrMarkham/status/472839091856609281,,,,
DrHedrick,5/31/2014 16:36,0,0,"Discussing: Much public interest in angiogenesis. Starving the tumor"" # ASCO14""",,,#,4.72839E+17,https://twitter.com/DrHedrick/status/472839076467703809,,,,
FattusBlokus,5/31/2014 16:36,0,1,To be fair... Simply bleach your hair. # hair # bleach # BLEACH版深夜の真剣お絵描き60分一本勝負 # lookingforyou # skyboxing # prom2k14 # cashtag # oomf # ASCO14,,,# # # # # # # # #,4.72839E+17,https://twitter.com/FattusBlokus/status/472839069912039424,,,,
bpowersphoto,5/31/2014 16:36,0,0,Beam me up. # asco14 # chicagopic.twitter.com/PejDK2JpLv,,,# #,4.72839E+17,https://twitter.com/bpowersphoto/status/472838972016586752,,,,
Rad_Nation,5/31/2014 16:36,2,0,Cisplatin- vs carboplatin-based concurrent chemoRT for limited-stage small cell # lungcancer http://buff.ly/1mx8iZx # ASCO14 # lcsm,,,# # #,4.72839E+17,https://twitter.com/Rad_Nation/status/472838963401859072,,,,
PhRMA,5/31/2014 16:36,2,0,.@JenniatPhRMA explains # HIX high deductibles & cost sharing put patient health at risk & increase costs http://onphr.ma/1nP9oV4 # ASCO14,,@JenniatPhRMA,# #,4.72839E+17,https://twitter.com/PhRMA/status/472838961560178689,,,,
ChrisHeery,5/31/2014 16:35,0,0,"Immunoscore makes TNM staging irrelevant. Galon # ASCO14 (he didn't actually say that, but that's what the data says)",,,#,4.72839E+17,https://twitter.com/ChrisHeery/status/472838871411994624,,,,
ME_Fleury,5/31/2014 16:35,0,0,"Jeffrey Ward at # ASCO14: Current FFS care doesn't reward good decision making, and incentivizes inefficiency",,,#,4.72839E+17,https://twitter.com/ME_Fleury/status/472838796988665857,,,,
adamfeuerstein,5/31/2014 16:35,1,2,Discussant slide on $ BMY nivo kidney cancer ph2 # ASCO14 pic.twitter.com/1VSp6p9Zej,,,#,4.72839E+17,https://twitter.com/adamfeuerstein/status/472838796384669697,,,,
OncLive,5/31/2014 16:35,0,0,Lenvatinib Likely to Become Standard in Resistant Differentiated Thyroid Cancer http://ow.ly/xtJjK # ASCO14,,,#,4.72839E+17,https://twitter.com/OncLive/status/472838698695151616,,,,
JeffreyMOtto,5/31/2014 16:35,0,0,BE: are pts with complex cytogenetic so just patients w/ p53 mutations? # ASCO14,,,#,4.72839E+17,https://twitter.com/JeffreyMOtto/status/472838683440459777,,,,
CancerGeek,5/31/2014 16:34,0,0,"@ chcosts It's not just pricing, but the value to patients that goes along with the price strategy. # PX # ASCO14",,@,# #,4.72839E+17,https://twitter.com/CancerGeek/status/472838661768511488,,,,
olascar,5/31/2014 16:34,4,0,À @ ASCO les résultats encourageants de la # goséréline contre l'infertilité après chimiothérapie cc @ carolechatelain http://bit.ly/Sm29WR,,@ @,#,4.72839E+17,https://twitter.com/olascar/status/472838579698552832,,,,
ChrisHeery,5/31/2014 16:34,0,1,High density invasive T cells (cd3 and cd45ro) corresponds with good outcome. Lack of both - very poor outcome. Science 2006 Galon # ASCO14,,,#,4.72839E+17,https://twitter.com/ChrisHeery/status/472838543283195904,,,,
OncEd,5/31/2014 16:34,0,0,"Impressive results from Phase Ib trial of Trebananib and Paclitaxel- ORR of 88%, PFS 18.7m (dose of 30mg/kg) ifirst line Her 2+ MBC # ASCO14",,,#,4.72839E+17,https://twitter.com/OncEd/status/472838511632973824,,,,
dhicks444,5/31/2014 16:34,2,5,# ASCO2014 # TheALCF # beatlungcancer great mtgs today with # merck # millenium # genentech # peregrin # grace # novartis # bmspic.twitter.com/6fwHjyfDUR,,,# # # # # # # # # #,4.72838E+17,https://twitter.com/dhicks444/status/472838462132199424,,,,
cancermd,5/31/2014 16:33,0,1,"Impressive results from Phase Ib trial of Trebananib and Paclitaxel- ORR of 88%, PFS 18.7m (dose of 30mg/kg) ifirst line Her 2+ MBC # ASCO14",,,#,4.72838E+17,https://twitter.com/cancermd/status/472838382188363776,,,,
CancerGeek,5/31/2014 16:33,1,1,"@ JoeBabaian Important discussions but still appears that # ASCO14 , United Health, & others have forgotten to include patients. MDC dialogue.",,@,#,4.72838E+17,https://twitter.com/CancerGeek/status/472838381756751873,,,,
JeffreyMOtto,5/31/2014 16:33,1,0,"BE: can simplify integration of genetic mutations into tests by lumping into good, intermediate and poor buckets # ASCO14",,,#,4.72838E+17,https://twitter.com/JeffreyMOtto/status/472838324022153217,,,,
adamfeuerstein,5/31/2014 16:33,0,6,Discussant slide on $ BMY nivo kidney cancer ph2 # ASCO14 pic.twitter.com/4SM2Z4wHGb,,,#,4.72838E+17,https://twitter.com/adamfeuerstein/status/472838308733530112,,,,
datacision,5/31/2014 16:33,1,0,A quieter moment at the @ SarahCannonDocs booth (2063) at # ASCO14 - come & meet Denise & Neil. pic.twitter.com/sz9bUCG774,,@,#,4.72838E+17,https://twitter.com/datacision/status/472838281760342016,,,,
ChrisHeery,5/31/2014 16:33,0,0,Tissue microarray provides the ability to get consistent data in this cohort. Galon # ASCO14,,,#,4.72838E+17,https://twitter.com/ChrisHeery/status/472838273711091712,,,,
GustaveRoussy,5/31/2014 16:33,4,0,"# ASCO14 Voir notre focus sur les essais précoces et le département dédié @ GustaveRoussy, le DITEP : http://bit.ly/1nDUO3l",,@,#,4.72838E+17,https://twitter.com/GustaveRoussy/status/472838270188261378,,,,
KoontzOncology,5/31/2014 16:32,0,0,# ASCO14 http://tinyurl.com/ogq9hg6 Stage IVFH WT had favorable outcomes when treated with regimen M compared to DD-4Apic.twitter.com/vQT9Cdmso0,,,#,4.72838E+17,https://twitter.com/KoontzOncology/status/472838129570041856,,,,
ERPlimackMD,5/31/2014 16:32,1,0,"Dr.Amin: nivolumab + VEGF TKI, encouraging response rate, caution: renal/hepatotoxicity. # gusm # ASCO2014 pic.twitter.com/FW3HSZZF1Q",,,# #,4.72838E+17,https://twitter.com/ERPlimackMD/status/472838087987302400,,,,
MarcoLDavila,5/31/2014 16:32,0,0,A brief history of immunotherapy leads to an exciting review of current studies of immunotherapy 4 cancer. # ASCO14 http://tinyurl.com/kkhxtry,,,#,4.72838E+17,https://twitter.com/MarcoLDavila/status/472837982861275136,,,,
GenentechJobs,5/31/2014 16:31,0,0,# ASCO14 Talent Hunt: Companion Diagnostic Leader: http://click2apply.net/419110t Retweet please.,,,#,4.72838E+17,https://twitter.com/GenentechJobs/status/472837895468752896,,,,
aftimosp,5/31/2014 16:31,1,0,"Trebananib in combo with paclitaxel + trastuzumab in HER2+ # BreastCancer: no need to wait for the results, treatment is too toxic! # ASCO14",,,# #,4.72838E+17,https://twitter.com/aftimosp/status/472837782541328384,,,,
Jehennessy3,5/31/2014 16:31,0,0,# ASCO2014 brush with greatness. pic.twitter.com/pfAhqjukKM,,,#,4.72838E+17,https://twitter.com/Jehennessy3/status/472837763839299584,,,,
DrAttai,5/31/2014 16:31,4,3,Metcalfe: improved survival benefit of oophorectomy in BRCA1 PT persists beyond age 50 # ASCO14 # bcsm,,,# #,4.72838E+17,https://twitter.com/DrAttai/status/472837746248011776,,,,
DrHedrick,5/31/2014 16:31,0,0,"Kaufman: High rate of edema, overall manageable. # ASCO14",,,#,4.72838E+17,https://twitter.com/DrHedrick/status/472837746164502528,,,,
JeffreyMOtto,5/31/2014 16:31,0,0,BE: identify mutations that add information and are independent of existing prognostic variables # ASCO14,,,#,4.72838E+17,https://twitter.com/JeffreyMOtto/status/472837719346118658,,,,
Oncoinfo_it,5/31/2014 16:31,0,0,“ @ kevinmd: Cancer care for international patients http://goo.gl/fb/LOKfs ” # ASCO14 @ ASCO14,,@ @,#,4.72838E+17,https://twitter.com/Oncoinfo_it/status/472837672273473536,,,,
ASCO,5/31/2014 16:30,13,4,Diane Blum discusses value in cancer care from a patient perspective http://bit.ly/1mVJfRE # ASCO14,,,#,4.72838E+17,https://twitter.com/ASCO/status/472837570423173121,,,,
DrHedrick,5/31/2014 16:30,0,0,"Kaufman: Treatment emergent Adverse Events, Edema, few thrombosis, hemorrhage, hypertension. Lower rate than other VEGF agents. # ASCO14",,,#,4.72838E+17,https://twitter.com/DrHedrick/status/472837554224771073,,,,
NextGenClinical,5/31/2014 16:30,0,0,Pathological assessment of dysplasia hematopoiesis can vary causing differences in diagnosis- Ebert # ASCO14,,,#,4.72838E+17,https://twitter.com/NextGenClinical/status/472837518744776704,,,,
Lymphoma_Doc,5/31/2014 16:30,2,4,"Nivolumab with TKI responses promising, interesting that no correlation with PDL1 expression in renal cell cancer # ASCO14",,,#,4.72838E+17,https://twitter.com/Lymphoma_Doc/status/472837515054153728,,,,
subatomicdoc,5/31/2014 16:30,1,2,"@ nxtstop1 @ AnneBooms Common in many areas of medicine, but a major issue in oncology for sure. # ASCO14 # compassionfatigue",,@ @,# #,4.72838E+17,https://twitter.com/subatomicdoc/status/472837509668675584,,,,
aftimosp,5/31/2014 16:30,0,0,Trebananib in combo with paclitaxel + trastuzumab in HER2+ # BreastCancer. Another anti-angiogenic tested without a biomarker # ASCO14,,,# #,4.72838E+17,https://twitter.com/aftimosp/status/472837504115040256,,,,
DrDonaldHarvey,5/31/2014 16:30,0,1,Phase Ib nivolumab + pazopanib or sunitinib in RCC - promising responses with increased hepatic AE rates. Secondary CYP concerns? # ASCO14,,,#,4.72837E+17,https://twitter.com/DrDonaldHarvey/status/472837490974285824,,,,
GustaveRoussy,5/31/2014 16:29,3,1,# ASCO14 3 présentations orales @ GustaveRoussy d'essais précoces sur des thérapies ciblées innovantes. Communiqué: http://bit.ly/1oe5HVC,,@,#,4.72837E+17,https://twitter.com/GustaveRoussy/status/472837341837819904,,,,
DrAttai,5/31/2014 16:29,6,7,Metcalfe: those who had oophorectomy have mortality reduction. Primarily in pts w/ BRCA1 vs 2 # asco14 # bcsm,,,# #,4.72837E+17,https://twitter.com/DrAttai/status/472837181510127616,,,,
nxtstop1,5/31/2014 16:29,0,0,COMPASSION FATIGUE: WE GOT HELP! @ AnneBooms: # ASCO14: Building resilience to combat C.F.amongst Oncology HCP. pic.twitter.com/Kv8vR4lGPD”,,@,#,4.72837E+17,https://twitter.com/nxtstop1/status/472837181439217664,,,,
DrMarkham,5/31/2014 16:29,5,1,"Incidence of clear cell ovarian cancer is 5% in western countries, but 20% in Japan. Interesting. # gyncsm # ASCO14",,,# #,4.72837E+17,https://twitter.com/DrMarkham/status/472837167245713408,,,,
PDRennert,5/31/2014 16:28,0,3,"Novo plus TKI for mRCC: difficult tox profile. Robust tumor burden drop, long duration. Sunitinib cohort esp. # ASCO14",,,#,4.72837E+17,https://twitter.com/PDRennert/status/472837121712336896,,,,
PinkSheetMaryJo,5/31/2014 16:28,0,0,McClellan # ASCO14 talk on physician payment reform is too much for 140 char. Worth checking out. pic.twitter.com/QlSalwYu5F,,,#,4.72837E+17,https://twitter.com/PinkSheetMaryJo/status/472837080067088386,,,,
CancerNetwrk,5/31/2014 16:28,0,2,Blog: Getting the Most Out of Posters http://bit.ly/1hn1FMe # ASCO14,,,#,4.72837E+17,https://twitter.com/CancerNetwrk/status/472837010739445760,,,,
markaorourke,5/31/2014 16:28,4,2,# ASCO14 abstract 9509 Elderly breast ca pts S/P RT&chemo. Half declined in cognitive test but no effect on ability to perform ADL's. # bcsm,,,# #,4.72837E+17,https://twitter.com/markaorourke/status/472837007098793984,,,,
TawnyaBowles,5/31/2014 16:28,3,1,Dr. Hodi: responses to anti-PD-1 antibody in metastatic # Melanoma can persist after treatment stops. # ASCO14,,,# #,4.72837E+17,https://twitter.com/TawnyaBowles/status/472836975519465472,,,,
DrHedrick,5/31/2014 16:28,0,0,"Kaufman: 2 cohorts, 2 doses 10mg/kg or 30mg/kg QW. With conventional PT dosing. # ASCO14",,,#,4.72837E+17,https://twitter.com/DrHedrick/status/472836927172149248,,,,
roseherring,5/31/2014 16:28,0,0,Dr. Amin presents phase 1 Nivolumab data to packed house. Proud to work for a program doing great work for science + patients # ASCO2014 # LCI,,,# #,4.72837E+17,https://twitter.com/roseherring/status/472836924517142528,,,,
ChrisHeery,5/31/2014 16:27,1,1,"Up next, one of my favorite topics by Jerome Galon. Immuno scoring for colorectal cancer. # ASCO14",,,#,4.72837E+17,https://twitter.com/ChrisHeery/status/472836834569908225,,,,
EdwinPosadasMD,5/31/2014 16:27,0,1,# Nivolumab is highly active in # kidneycancer # ASCO14 early improvement in survival!,,,# # #,4.72837E+17,https://twitter.com/EdwinPosadasMD/status/472836740882124801,,,,
MelanomaMom,5/31/2014 16:27,2,0,Spider plot of # melanoma tumor size after treatment with nivo (pd1) # ASCO14 pic.twitter.com/cOeqEoMfUP,,,# #,4.72837E+17,https://twitter.com/MelanomaMom/status/472836693876158464,,,,
nxtstop1,5/31/2014 16:26,0,0,@ millennium_US Time 4 Sailing. It's # ASCO14 !,,@,#,4.72837E+17,https://twitter.com/nxtstop1/status/472836623902588928,,,,
KUhlendorf,5/31/2014 16:26,2,2,McClellan suggests bringing competitive model in # Medicare Part D to Part B # ASCO14,,,# #,4.72837E+17,https://twitter.com/KUhlendorf/status/472836591086346240,,,,
JeffreyMOtto,5/31/2014 16:26,0,0,BE: MDS is very heterogeneous and this leads to big problems. Genetics should help improve Dx # ASCO14,,,#,4.72837E+17,https://twitter.com/JeffreyMOtto/status/472836563756646401,,,,
stuxrt,5/31/2014 16:26,2,3,"Standing room only to see Awesome Asim Amin. He's at the podium, hard to see since seat so far away # ASCO14 # LCIpic.twitter.com/ebzcP879G4",,,# #,4.72837E+17,https://twitter.com/stuxrt/status/472836554030067712,,,,
KMilehamMD,5/31/2014 16:26,2,2,Tumor burden reduction nivo presentation by Amin # LCI @Carolinas # ASCO14 pic.twitter.com/hvZDtSVdlp,,@Carolinas,# #,4.72837E+17,https://twitter.com/KMilehamMD/status/472836521171881985,,,,
QIAGENscience,5/31/2014 16:26,1,0,Do you have questions that you’d like to pose to our Medical Affairs team? Stop by booth 5013 # ASCO14 pic.twitter.com/bTPCHIx3PA,,,#,4.72836E+17,https://twitter.com/QIAGENscience/status/472836416712740865,,,,
HenryJOncology,5/31/2014 16:25,0,0,"Given trabectedin activity in STS-gyn sarcoma, lurbinectedin development? http://abstracts.asco.org/144/AbstView_144_131577.html … # gyncsm # ASCO14 leading the way, # sarcoma",,,# # #,4.72836E+17,https://twitter.com/HenryJOncology/status/472836396529352704,,,,
brianreid,5/31/2014 16:25,1,2,McClellan talking about bringing a Part D mentality to Part B approach to drugs/costs. # healthgeeking # ASCO14,,,# #,4.72836E+17,https://twitter.com/brianreid/status/472836372928028672,,,,
DrHedrick,5/31/2014 16:25,0,0,"Kaufman: Trebananib recombinant peptibody, inhibits tumor growth in preclinical data. # ASCO14",,,#,4.72836E+17,https://twitter.com/DrHedrick/status/472836365923938304,,,,
AnneBooms,5/31/2014 16:25,0,0,# ASCO14: Building resilience to combat C.F.amongst Oncology HCP. pic.twitter.com/ZJmLjYkk8c,,,#,4.72836E+17,https://twitter.com/AnneBooms/status/472836287548772352,,,,
Disruptivestock,5/31/2014 16:25,0,0,# asco14 any big winners?,,,#,4.72836E+17,https://twitter.com/Disruptivestock/status/472836284281409538,,,,
JeffreyMOtto,5/31/2014 16:25,0,0,"Next up: Benjamin Ebert  making sense of the mutations in myelodysplatic syndrome: can we improve outcomes # ASCO14""",,,#,4.72836E+17,https://twitter.com/JeffreyMOtto/status/472836235783077889,,,,
ChapinMD,5/31/2014 16:24,0,0,"Bruce JacobsI'm learning that pd1 inhibitors are different the PDE inhibitors"" # ASCO14""",,,#,4.72836E+17,https://twitter.com/ChapinMD/status/472836158267719680,,,,
davidgrahammd,5/31/2014 16:24,1,0,Nivo+sunitinib overall responsible by RECIST 59% @Carolinas # ASCO14 # LCI # gusm,,@Carolinas,# # #,4.72836E+17,https://twitter.com/davidgrahammd/status/472836144829579264,,,,
DrHedrick,5/31/2014 16:24,0,0,"Kaufman: Looking at VEGF pathway, as well as angiogoetin axis, ANG1/2 interact to induce endothelial proliferation. # ASCO14",,,#,4.72836E+17,https://twitter.com/DrHedrick/status/472836120498417664,,,,
Disruptivestock,5/31/2014 16:24,0,0,# asco14,,,#,4.72836E+17,https://twitter.com/Disruptivestock/status/472836086494801920,,,,
TakedaOncology,5/31/2014 16:24,4,2,What a day in Chicago! # ASCO14 Protip: the deck of the East building has amazing views! # breaktimepic.twitter.com/5sjmDrUW7z,,,# #,4.72836E+17,https://twitter.com/TakedaOncology/status/472836072482033664,,,,
DrAttai,5/31/2014 16:24,3,2,Dr Metcalfe effect of oophorectomy on long term mortality in BRCA+ PT with breast cancer # ASCO14 # bcsm,,,# #,4.72836E+17,https://twitter.com/DrAttai/status/472836038574866432,,,,
JeffreyMOtto,5/31/2014 16:24,0,0,RL: do genetic profiling and then assign to a trial. Now is not the time to be nihilistic. # ASCO14,,,#,4.72836E+17,https://twitter.com/JeffreyMOtto/status/472835921545814017,,,,
myPathMelanoma,5/31/2014 16:24,0,1,Need a refresher on # sunscreen myths v. facts? Our handy # infographic can help! http://bit.ly/sunscreenfacts # ASCO14,,,# # #,4.72836E+17,https://twitter.com/myPathMelanoma/status/472835912175329280,,,,
wmikenelson,5/31/2014 16:23,0,0,Outdoor yoga in Chicago! # reverseyourwarrior # ASCO14 pic.twitter.com/ElVrmRhYm2,,,# #,4.72836E+17,https://twitter.com/wmikenelson/status/472835830474870784,,,,
JackWestMD,5/31/2014 16:23,5,1,Lots of interest in focal radiation for oligomet dzs now that RT technology so good & many pts show very isolated progress'n. # ASCO14 # LCSM,,,# #,4.72836E+17,https://twitter.com/JackWestMD/status/472835818285838336,,,,
EIannelli,5/31/2014 16:23,1,1,# ASCO14 http://tinyurl.com/obgmger new discover in immunology: hope 4 # cancer care @ kgapo @ cancereu @ AmericanCancer @ CancerNetwrk @ CDC_Cancer,,@ @ @ @ @,# #,4.72836E+17,https://twitter.com/EIannelli/status/472835785628991489,,,,
DrHedrick,5/31/2014 16:23,0,0,Kaufman: Phase 1B Trebananib + Paclitaxel + Traztuzumab in metastatic setting. # ASCO14,,,#,4.72836E+17,https://twitter.com/DrHedrick/status/472835734043627520,,,,
KUhlendorf,5/31/2014 16:23,1,1,"My brain works at much slower speed than Dr McClellan's. But certainly agree choice, competition & beneficiary engagement are key # ASCO14",,,#,4.72836E+17,https://twitter.com/KUhlendorf/status/472835668133949440,,,,
Boehringer,5/31/2014 16:22,0,0,Uncertainty at the time of # lungcancer diagnosis: http://shar.es/VU7S8 - # notjustonedisease # ASCO14,,,# # #,4.72836E+17,https://twitter.com/Boehringer/status/472835611074641920,,,,
aftimosp,5/31/2014 16:22,0,0,The IDMC was right in stopping the AROBASE trial testing exemestane + bevacizumab maintenace after pacltaxel + bevacizumab # ASCO14,,,#,4.72836E+17,https://twitter.com/aftimosp/status/472835571383939073,,,,
BrendonStilesMD,5/31/2014 16:22,15,9,CT scans increasingly used to distinguish noninvasive / invasive lung cancers. # ImprovingCTscreening # lcsm # ASCO14 pic.twitter.com/z0ReS4iF9O,,,# # #,4.72835E+17,https://twitter.com/BrendonStilesMD/status/472835482632478720,,,,
MedscapeOnc,5/31/2014 16:22,2,2,Medscape blogger Dr. Brandon Smaglo highlights the best GI cancer posters and abstracts at # ASCO14 http://bit.ly/1kvlmkg,,,#,4.72835E+17,https://twitter.com/MedscapeOnc/status/472835452148264960,,,,
DrHedrick,5/31/2014 16:22,0,0,"Tredan: Subgroups with or without prior AI exposure showed no benefit, no difference in QOL. However Increased toxicity in Taxane # ASCO14",,,#,4.72835E+17,https://twitter.com/DrHedrick/status/472835421748334592,,,,
ShannonWestin,5/31/2014 16:21,1,1,More evidence for MEK inhibition in low grade ovarian cancer. # ASCO14 # gyncsm,,,# #,4.72835E+17,https://twitter.com/ShannonWestin/status/472835321613541376,,,,
cancermd,5/31/2014 16:21,1,0,Follow @ OncEd for latest # ASCO14 updates,,@,#,4.72835E+17,https://twitter.com/cancermd/status/472835204738871297,,,,
JackWestMD,5/31/2014 16:21,1,1,"Dr. Corey Langer from Penn is speaking at a sold-out # ASCO14 Meet the Professor"" session on management of oligometastatic dzs in NSCLC""",,,#,4.72835E+17,https://twitter.com/JackWestMD/status/472835197927718912,,,,
davidgrahammd,5/31/2014 16:20,1,0,Nivo + other TKI in phase I no DLT with sunitinib @Carolinas # LCI # ASCO14 # gusm,,@Carolinas,# # #,4.72835E+17,https://twitter.com/davidgrahammd/status/472835147117912064,,,,
jrgralow,5/31/2014 16:20,1,1,In meeting with @ asco & @ uicc discussing framework for additions to WHO essential medications list for oncology. # asco14,,@ @,#,4.72835E+17,https://twitter.com/jrgralow/status/472835071183839233,,,,
DrHedrick,5/31/2014 16:20,0,0,Tredan: No difference between the arms. More toxicity in the Taxane arm. # ASCO14,,,#,4.72835E+17,https://twitter.com/DrHedrick/status/472834940816850944,,,,
subatomicdoc,5/31/2014 16:20,3,1,Molecular profiling of low-grade gliomas (LGG) in Colombia http://bit.ly/1tkYdkQ # ASCO14 # btsm,,,# #,4.72835E+17,https://twitter.com/subatomicdoc/status/472834940686856192,,,,
OncEd,5/31/2014 16:19,0,0,AROBASE Trial - 117 patients IDMC recommended - stop enrollment. Med PFS 7.6m (endocrine + Bev arm) vs 8.1 m (maint chemo + Bev) # ASCO14,,,#,4.72835E+17,https://twitter.com/OncEd/status/472834824739110913,,,,
scientre,5/31/2014 16:19,0,0,MT @ rsm2800 Warner: Only 10% of patients in U.S. have tumor stage entered in structured format. Sad # ASCO14,,@,#,4.72835E+17,https://twitter.com/scientre/status/472834777914290176,,,,
GustaveRoussy,5/31/2014 16:19,3,0,# ASCO2014 @ ericangevin @ gustaveroussy presents results of clinical trial phase I evaluating specific inhibitor c-METpic.twitter.com/g2lf9uQL1K,,@ @,#,4.72835E+17,https://twitter.com/GustaveRoussy/status/472834774940532736,,,,
scientre,5/31/2014 16:19,2,2,"MT @ rsm2800 Warner: Big data iceberg- visible data structured; vast amt of data under water unstructured,incl PDFs, text documents # asco14",,@,#,4.72835E+17,https://twitter.com/scientre/status/472834725556809731,,,,
drcbsteer,5/31/2014 16:19,1,0,# bcsm # ASCO14 Joly Measurement of cognitive function shows decline in # elderly patients with adjuvant chemotherapy corr with fatigue not CGA,,,# # #,4.72835E+17,https://twitter.com/drcbsteer/status/472834664411844610,,,,
MMarchioneAP,5/31/2014 16:19,5,2,The cancer society brain trust at # ASCO2014 pic.twitter.com/lKf79Mhj2W,,,#,4.72835E+17,https://twitter.com/MMarchioneAP/status/472834661211971584,,,,
DrHedrick,5/31/2014 16:18,0,0,Tredan: High rate of discontinuation of taxane discontinuation. Only exposed on avg to 2.3 months in maintenance arm # ASCO14,,,#,4.72835E+17,https://twitter.com/DrHedrick/status/472834539640070144,,,,
KMilehamMD,5/31/2014 16:18,1,0,Asim Amin just started presentation on nivo + sunitinib or pazopanib # LCI @Carolinas # ASCO14,,@Carolinas,# #,4.72834E+17,https://twitter.com/KMilehamMD/status/472834422257905664,,,,
KoontzOncology,5/31/2014 16:18,0,0,# ASCO14 http://tinyurl.com/ogq9hg6 Real time review of pediatric renal tumor pathology feasible but discrepancies existpic.twitter.com/V2GPcaM5Pn,,,#,4.72834E+17,https://twitter.com/KoontzOncology/status/472834418785394688,,,,
ilatersa,5/31/2014 16:17,0,1,“ @ theNCI: Dr Abrams: The most recent milestones leading up to the National Clinical Trials Network. # ASCO14 # NCTN pic.twitter.com/7lm9XOpHi0”,,@,# #,4.72834E+17,https://twitter.com/ilatersa/status/472834382684639232,,,,
JeffreyMOtto,5/31/2014 16:17,0,0,RL: combination of DNA&RNA capture drastically improves power to identify gene rearrangements # ASCO14,,,#,4.72834E+17,https://twitter.com/JeffreyMOtto/status/472834360320995328,,,,
markaorourke,5/31/2014 16:17,1,0,"# ASCO14 abstract 9509 Elderly breast ca S/P RT+-chemo. Half with cognitive decline, indep of chemo and indep of pt subjective impression.",,,#,4.72834E+17,https://twitter.com/markaorourke/status/472834318256332801,,,,
Oncoinfo_it,5/31/2014 16:17,0,0,"# ASCO14 shows value of less is more"" treatment strategies #9500 @ lucadf""",,@,# #9500,4.72834E+17,https://twitter.com/Oncoinfo_it/status/472834257711558657,,,,
ERPlimackMD,5/31/2014 16:17,8,4,Motzer et al: nivolumab OS in pretreated RCC is promising. 20/35 responses ongoing @data cutoff. # gusm # ASCO14 pic.twitter.com/5UrP9a8K4L,,@data,# #,4.72834E+17,https://twitter.com/ERPlimackMD/status/472834236446408706,,,,
PhRMA,5/31/2014 16:17,1,0,"We know little about # patients’ preference for discussing costs, says @ KUhlendorf from # ASCO14 http://onphr.ma/1wGFpkH",,@,# #,4.72834E+17,https://twitter.com/PhRMA/status/472834190623248385,,,,
Rad_Nation,5/31/2014 16:17,0,0,Institutional clinical trial volume on survival in stage III # lungcancer chemoRT http://buff.ly/1reHWlV > @ NRGOnc # ASCO14 # radonc,,@,# # #,4.72834E+17,https://twitter.com/Rad_Nation/status/472834162672812032,,,,
subatomicdoc,5/31/2014 16:17,1,1,Institutional clinical trial volume on survival in stage III # lungcancer chemoRT http://bit.ly/1reHXWW > @ NRGOnc # ASCO14 # radonc,,@,# # #,4.72834E+17,https://twitter.com/subatomicdoc/status/472834148215062528,,,,
LurieCancer,5/31/2014 16:16,1,0,Stop by & visit the @ NMHnews / @ LurieCancer booth #2065 at # ASCO14,,@ @,#2065 #,4.72834E+17,https://twitter.com/LurieCancer/status/472834086835585024,,,,
nmunozm,5/31/2014 16:16,0,0,@cecilicp @ vbaosv New study suggests that it is safe to stop statin therapy in patients with a life expectancy of less than a year. # ASCO14,,@cecilicp @,#,4.72834E+17,https://twitter.com/nmunozm/status/472834063745970176,,,,
PortalOnconews,5/31/2014 16:16,0,0,"Ciência e Sociedade: Cinquenta anos depois – por Clifford Hudis, presidente da ASCO 2014 http://connection.asco.org/Magazine/Article/ID/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx … via @ ASCO",,@,,4.72834E+17,https://twitter.com/PortalOnconews/status/472834049665286144,,,,
drcbsteer,5/31/2014 16:16,2,1,# bcsm # ASCO14 Measurement of cognitive function showed decline in # elderly patients after adjuvant chemotherapy Q: transitory or permanent?,,,# # #,4.72834E+17,https://twitter.com/drcbsteer/status/472834034297339904,,,,
AneesChagpar,5/31/2014 16:16,0,0,Denmark encourages clinicians to take advantage of teachable moment of cancer to encourage healthier habits for pts. @ ASCO # ASCO14,,@,#,4.72834E+17,https://twitter.com/AneesChagpar/status/472833965163048960,,,,
Oncoinfo_it,5/31/2014 16:16,0,0,"# ASCO14 mostra il valore delle strategie di trattamento meno e' meglio"" #9500""",,,# #9500,4.72834E+17,https://twitter.com/Oncoinfo_it/status/472833955625185280,,,,
AlpineBV_Miller,5/31/2014 16:16,6,7,Dr. Small VERY careful to emphasize small n & other limitations. If this holds Xtandi will be used 1st $ MDVN # ASCO14 pic.twitter.com/8BIZj0I6zv,,,#,4.72834E+17,https://twitter.com/AlpineBV_Miller/status/472833941209382912,,,,
DrHedrick,5/31/2014 16:16,0,0,Tredan: AROBASE Randomized phase III Tax + Bev v. Exemestane + Bev in metastatic setting. # ASCO14,,,#,4.72834E+17,https://twitter.com/DrHedrick/status/472833926588026880,,,,
PinkSheetMaryJo,5/31/2014 16:16,0,0,"McClellan likes idea of shared savings/shared risk; dr share in reducing costs w improved quality, maybe share risks 4 higher costs # ASCO14",,,#,4.72834E+17,https://twitter.com/PinkSheetMaryJo/status/472833925199708160,,,,
KUhlendorf,5/31/2014 16:16,0,0,"Move to alt payment models led by # oncology for many reasons, including era of # personalized med, combo treatments - McClellan # ASCO14",,,# # #,4.72834E+17,https://twitter.com/KUhlendorf/status/472833903246311424,,,,
Jehennessy3,5/31/2014 16:15,0,0,# ASCO2014 payment reform discussion underway pic.twitter.com/YIDCaUBLFJ,,,#,4.72834E+17,https://twitter.com/Jehennessy3/status/472833864667512832,,,,
BrendonStilesMD,5/31/2014 16:15,1,1,With Sandra and Sara from Lung Cancer Research Foundation at # ASCO14. @ Lung_Fund thanks for support!pic.twitter.com/i1AUG2eHZR,,@,#,4.72834E+17,https://twitter.com/BrendonStilesMD/status/472833856152686592,,,,
MaurerStats,5/31/2014 16:15,0,0,MT @ DrMarkham Haluska: Platinum-resistance is the final common pathway for our ovary ca patients. # gyncsm # ASCO14,,@,# #,4.72834E+17,https://twitter.com/MaurerStats/status/472833838499258368,,,,
JeffreyMOtto,5/31/2014 16:15,0,0,RL: tests need to detect rearrangements as well as standard point mutations. # ASCO14,,,#,4.72834E+17,https://twitter.com/JeffreyMOtto/status/472833830139985920,,,,
OncLive,5/31/2014 16:15,4,1,Dr. Denise Yardley from @SarahCannonPR on Enzalutamide Plus Exemestane in HR-Positive Breast Cancer http://ow.ly/xtEQJ # ASCO14,,@SarahCannonPR,#,4.72834E+17,https://twitter.com/OncLive/status/472833749030543360,,,,
EIannelli,5/31/2014 16:15,1,1,Grandi speranze dall'immunologia x cura # cancro # ASCO14 http://tinyurl.com/obgmger @ favo_it @ InsControCancro @ mritamon @ ManuelaPerrone,,@ @ @ @,# #,4.72834E+17,https://twitter.com/EIannelli/status/472833730155786240,,,,
JacobPlieth,5/31/2014 16:15,2,2,Nivo PFS in phII mRCC study $ BMY # ASCO14 pic.twitter.com/4b2a7Bd3qT,,,#,4.72834E+17,https://twitter.com/JacobPlieth/status/472833702087901184,,,,
saminamea,5/31/2014 16:15,0,0,An analysis of # cancer-specific Twitter conversations among # physicians in 2013. @ ASCO @ BestofCancer http://abstracts.asco.org/144/AbstView_144_132049.html …,,@ @,# #,4.72834E+17,https://twitter.com/saminamea/status/472833687525285888,,,,
LillyPad,5/31/2014 16:15,3,2,An unlikely trio finds 3 solutions for cutting the cost of cancer # ASCO14 http://ow.ly/xseaE,,,#,4.72834E+17,https://twitter.com/LillyPad/status/472833686527025153,,,,
CUCancerCenter,5/31/2014 16:14,2,2,@ rdoebele shows prevalence of new driver in # lungcancer # lcsm at # ASCO14 http://bit.ly/1oVpOt4,,@,# # #,4.72834E+17,https://twitter.com/CUCancerCenter/status/472833592318390272,,,,
OncEd,5/31/2014 16:14,0,0,AROBASE Trial - Phase III trial of maintenance Bev and endocrine therapy in MBC # ASCO14 # Breastcancer,,,# #,4.72834E+17,https://twitter.com/OncEd/status/472833565906849792,,,,
MelanomaMom,5/31/2014 16:14,1,0,Summary of previous ipi data in # melanoma # ASCO14 pic.twitter.com/cQM2qCmdgl,,,# #,4.72834E+17,https://twitter.com/MelanomaMom/status/472833551168466944,,,,
Cancer_Matters,5/31/2014 16:14,0,0,Amazing to see how far we've come in such a short time - RT @ drattai: Progress in Breast Cancer Research - http://am.asco.org/progress-breast-cancer-research#.U4obIXQtE-g.twitter … # ASCO14,,@,# #,4.72834E+17,https://twitter.com/Cancer_Matters/status/472833540540100609,,,,
adamfeuerstein,5/31/2014 16:14,1,4,$ BMY nivo Kidney cancer ph2 OS compared to other studies. # ASCO14 pic.twitter.com/QknAxTD1pO,,,#,4.72833E+17,https://twitter.com/adamfeuerstein/status/472833456633040897,,,,
JeffreyMOtto,5/31/2014 16:13,1,0,Recurring theme in genomic profiling talks: generating data is the easy part - analysis of that data is the challenge # ASCO14,,,#,4.72833E+17,https://twitter.com/JeffreyMOtto/status/472833385925451778,,,,
TylerWhisman,5/31/2014 16:13,0,0,So response to nivo not impacted by dose but OS does appear to favor higher dose arms in rcc. # ASCO14,,,#,4.72833E+17,https://twitter.com/TylerWhisman/status/472833316681707520,,,,
Ludwig_Cancer,5/31/2014 16:13,0,0,MT @ OncLive: Awards given to 16 heroes in oncology. Incl. Ludwig's George Demetri & Jedd Wolchok! http://ow.ly/xsBz5 # giantsCC # ASCO14,,@,# #,4.72833E+17,https://twitter.com/Ludwig_Cancer/status/472833177338531840,,,,
AndytweetM,5/31/2014 16:13,0,0,@ ASCO emailed them but no response. If appreciate a prompt response . Thanks much,,@,,4.72833E+17,https://twitter.com/AndytweetM/status/472833176621289473,,,,
MedscapeOnc,5/31/2014 16:12,0,1,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.72833E+17,https://twitter.com/MedscapeOnc/status/472833134132609024,,,,
Mira_Kind,5/31/2014 16:12,0,0,Currently at # ASCO14: @ joanneweidhaas presenting poster about unique treatment response in # NSCLC for # KRASvariant http://goo.gl/yS9yHz,,@,# # #,4.72833E+17,https://twitter.com/Mira_Kind/status/472833078256091136,,,,
sfuldnasso,5/31/2014 16:12,2,0,"McClellan: Payment reform must not be too risky for payers, providers, likely to improve care for patients (e.g., care planning) # ASCO14",,,#,4.72833E+17,https://twitter.com/sfuldnasso/status/472833038507069441,,,,
JeffreyMOtto,5/31/2014 16:12,1,0,RL: sequencing needs to be at a much higher level in a clinical setting than in a research setting. # ASCO14,,,#,4.72833E+17,https://twitter.com/JeffreyMOtto/status/472833005728587776,,,,
chicagocapman,5/31/2014 16:12,0,0,Who else goes gaga for @ genetech cookies? # ASCO14? pic.twitter.com/OJbovtvERu,,@,#,4.72833E+17,https://twitter.com/chicagocapman/status/472832986908737536,,,,
DrMarkham,5/31/2014 16:12,0,0,"Factoid: Lurbinectedin is an ecteinascidin, derived from the sea squirt. (Abstract 5505) # gyncsm # ASCO14",,,# #,4.72833E+17,https://twitter.com/DrMarkham/status/472832944407859200,,,,
adamfeuerstein,5/31/2014 16:11,2,3,$ BMY nivo kidney cancer ph2 OS # ASCO14 pic.twitter.com/knSLhmYqyT,,,#,4.72833E+17,https://twitter.com/adamfeuerstein/status/472832865961406464,,,,
LotiJackson,5/31/2014 16:11,0,0,Come and play spoof with us at # ASCO14 to win prizes from @ Harrods or our very own spoof tokens. pic.twitter.com/3jjnVZ43xW” @ copyrightrepro,,@ @,#,4.72833E+17,https://twitter.com/LotiJackson/status/472832787515330560,,,,
PinkSheetMaryJo,5/31/2014 16:11,4,3,"Most important for payment reform, getting docs on board. No one trusts policy makers over physicians, McClellan tells # ASCO14",,,#,4.72833E+17,https://twitter.com/PinkSheetMaryJo/status/472832688228155392,,,,
aftimosp,5/31/2014 16:11,1,1,Bevacizumab in adjuvant # BreastCancer : no patient subtype benefited. Good luck while looking for biomarkers!!! # ASCO14,,,# #,4.72833E+17,https://twitter.com/aftimosp/status/472832686097055744,,,,
harriseve,5/31/2014 16:11,1,0,Validation! med protects fertility in study of young women w/cancer http://flip.it/LAPAP @ nytimes # ASCO14 Via @ CancerGeek # oncofertility,,@ @,# #,4.72833E+17,https://twitter.com/harriseve/status/472832677230673920,,,,
LotiJackson,5/31/2014 16:11,0,0,“ @ dansbarrington: Come and play spoof with us at # ASCO14 to win prizes from @ Harrods or our very own spoof tokens. pic.twitter.com/Ltv2eAApGD”,,@ @,#,4.72833E+17,https://twitter.com/LotiJackson/status/472832674273718272,,,,
EIannelli,5/31/2014 16:11,2,1,"# ASCO14 http://tinyurl.com/lmgefwq la lotta al # cancro è anche prevenzione primaria: alimentaz, movimento e stop fumo @ favo_it @ InsControCancro",,@ @,# #,4.72833E+17,https://twitter.com/EIannelli/status/472832638214881280,,,,
davidgrahammd,5/31/2014 16:10,0,2,"Similar to other immunotherapies... With Nivolumab, if you respond it lasts a good long time # ASCO14",,,#,4.72833E+17,https://twitter.com/davidgrahammd/status/472832635476398080,,,,
DrBridgetOBrien,5/31/2014 16:10,0,1,@ theNCI Dr Abrams: The most recent milestones leading up to the National Clinical Trials Network. # ASCO14 Clarifiy pic.twitter.com/hTI0pAumYY,,@,#,4.72833E+17,https://twitter.com/DrBridgetOBrien/status/472832584012267521,,,,
PeterHall001,5/31/2014 16:10,1,1,Follow-up strategies after early breast cancer remain devoid of evidence... But so many promising technologies! # ASCO14,,,#,4.72833E+17,https://twitter.com/PeterHall001/status/472832575027699712,,,,
MOCBrasil,5/31/2014 16:10,0,0,E5103 - Esta sendo apresentado AGORA na # ASCO2014 Não houve benefício na adjuvância. # MOCnaASCO,,,# #,4.72833E+17,https://twitter.com/MOCBrasil/status/472832569629999104,,,,
DrHedrick,5/31/2014 16:10,0,0,"Miller: BEV not improving DFS in adjuvant setting. No new toxicities. Have correlative data and biospecimen data, serial collection. # ASCO14",,,#,4.72833E+17,https://twitter.com/DrHedrick/status/472832558397685760,,,,
JeffreyMOtto,5/31/2014 16:10,0,0,RL: re sequencing of just 9 genes meaningfully changed classification of AML - when integrated into other tests # asco14,,,#,4.72833E+17,https://twitter.com/JeffreyMOtto/status/472832554287235073,,,,
OncNursingNews,5/31/2014 16:10,0,0,Discontinuing Statins in Late-Stage Cancer Patients via @ OncLive http://ow.ly/xtEuh # ASCO14,,@,#,4.72832E+17,https://twitter.com/OncNursingNews/status/472832470287921152,,,,
scientre,5/31/2014 16:10,0,0,"# ASCO14 Tweetup 5:45 PM today http://tweetvite.com/event/ASCO14 South Building, Level 2.5 Food Court. Looks like I'll meet many new tweeps IRL",,,#,4.72832E+17,https://twitter.com/scientre/status/472832435227742209,,,,
JMoLawre,5/31/2014 16:10,0,2,"@ xeni Following # ASCO14 as if my life depended on it. (Oh, wait...) Seriously-- important, amazing, hopeful stuff!!",,@,#,4.72832E+17,https://twitter.com/JMoLawre/status/472832402176212992,,,,
aftimosp,5/31/2014 16:10,0,0,Bevacizumab was toxic: small but significant increase in CHF and early discontinuation was common # BreastCancer # ASCO14,,,# #,4.72832E+17,https://twitter.com/aftimosp/status/472832391216504832,,,,
myriadgenetics,5/31/2014 16:10,1,1,"Attending # ASCO14? Check out Myriad Posters 1542, 1553, 1548 & 1541 TOMORROW 8-11:45am in S Hall A! # hereditarycancerhttp://bit.ly/1qFsz5H",,,# #,4.72832E+17,https://twitter.com/myriadgenetics/status/472832387361947650,,,,
PinkSheetMaryJo,5/31/2014 16:09,0,0,"McClellan's musts for physician payment reform - not too much risk for payers or phys, offer better care, not too hard to implement # ASCO14",,,#,4.72832E+17,https://twitter.com/PinkSheetMaryJo/status/472832369817161728,,,,
Sorena997,5/31/2014 16:09,1,1,Miller: Interesting hierarchical setup - multiple arms trial. Evaluating for efficacy for duration as well as increased safety data # ASCO14,,,#,4.72832E+17,https://twitter.com/Sorena997/status/472832239529914368,,,,
OncEd,5/31/2014 16:09,1,0,E5103 - No benefit in OS with adjuvant Bevacizumab in Breast Cancer # ASCO14,,,#,4.72832E+17,https://twitter.com/OncEd/status/472832160034869248,,,,
ClevelandClinic,5/31/2014 16:08,16,8,0.1% - That is the approximate proportion of US federal funds allocated to # cancer research - @ cliffordhudis # ASCO14,,@,# #,4.72832E+17,https://twitter.com/ClevelandClinic/status/472832100211900416,,,,
aftimosp,5/31/2014 16:08,1,0,Final results show no difference in IDFS nor overall survival for bevacizumab in the adjuvant treatment of # BreastCancer # ASCO14,,,# #,4.72832E+17,https://twitter.com/aftimosp/status/472831960880910336,,,,
davidgrahammd,5/31/2014 16:08,1,3,"Nivolumab in pre-Rx met RCC-no effect of dose on PFS, OR # asco14",,,#,4.72832E+17,https://twitter.com/davidgrahammd/status/472831945299460096,,,,
OncEd,5/31/2014 16:08,1,0,E5103 - Bevaciuzumab in Adjuvant Breast Cancer. Presented by Dr. Kathy Miller. No difference in IDFS with Adjuvant Bev # ASCO14,,,#,4.72832E+17,https://twitter.com/OncEd/status/472831898943639552,,,,
DrHedrick,5/31/2014 16:07,0,0,Miller: Results - No invasive disease free survival benefit. No subset benefitted. Small statistic significant increase in CHF. # ASCO14,,,#,4.72832E+17,https://twitter.com/DrHedrick/status/472831878794575873,,,,
JeffreyMOtto,5/31/2014 16:07,0,1,RL: how are we going to use these markers to change therapy. # ASCO14,,,#,4.72832E+17,https://twitter.com/JeffreyMOtto/status/472831842425769984,,,,
GillisClaire,5/31/2014 16:07,0,0,@ dianeblum outstanding view of patient centric value discussion # ASCO14,,@,#,4.72832E+17,https://twitter.com/GillisClaire/status/472831840840327169,,,,
DoctorEdny,5/31/2014 16:07,0,1,There is regulatory enthusiasm for adcs - Dr Abrams # ASCO14 pic.twitter.com/gKomctU8Wf,,,#,4.72832E+17,https://twitter.com/DoctorEdny/status/472831823538847745,,,,
AdvocateDebM,5/31/2014 16:07,0,1,"I'm relatively new to tweeting as a cancer research advocate and 2x cancer survivor, so I'm greatly... http://twvt.us/ASCO14 # ASCO14 # twvt",,,# #,4.72832E+17,https://twitter.com/AdvocateDebM/status/472831712313892864,,,,
Neil_Iyengar,5/31/2014 16:07,0,0,Andy Dannenberg: fat tissue inflammation is key link between obesity and breast cancer; occurs in a subset of lean women too (diet?) # ASCO14,,,#,4.72832E+17,https://twitter.com/Neil_Iyengar/status/472831706475814912,,,,
Viscira,5/31/2014 16:07,0,0,"# ASCO14 Viscira designed booth solutions for @ GileadSciences, touch screen programs, molecule gallerypic.twitter.com/3YMyAKgJnN",,@,#,4.72832E+17,https://twitter.com/Viscira/status/472831676817874944,,,,
JeffreyMOtto,5/31/2014 16:06,2,1,"RL: despite deluge"" of papers"," few biomarkers have made it to the clinic. # ASCO14""",,,#,4.72832E+17,https://twitter.com/JeffreyMOtto/status/472831607393775616,,,
cancermd,5/31/2014 16:06,1,0,E5103 - Bevaciuzumab in Adjuvant Breast Cancer. Presented by Dr. Kathy Miller. No difference in IDFS with Adjuvant Bev # ASCO14,,,#,4.72832E+17,https://twitter.com/cancermd/status/472831568034017282,,,,
DrMarkham,5/31/2014 16:06,3,0,Haulska: Platinum-resistance is the final common pathway for our ovary ca patients. # gyncsm # ASCO14,,,# #,4.72832E+17,https://twitter.com/DrMarkham/status/472831560497242112,,,,
JeffreyMOtto,5/31/2014 16:05,1,0,"RL: WGS has identified novel, but recurrent disease alleles in AML. # ASCO14",,,#,4.72831E+17,https://twitter.com/JeffreyMOtto/status/472831354900860928,,,,
DrHedrick,5/31/2014 16:05,0,0,Miller: Interesting hierarchical setup - multiple arms trial. Evaluating for efficacy for duration as well as increased safety data # ASCO14,,,#,4.72831E+17,https://twitter.com/DrHedrick/status/472831253658755072,,,,
LillyDiabetes,5/31/2014 16:05,1,1,Look at the progress we’ve made on Day 1 of the @LlyOncOnCanvas hope mural painting at # ASCO14! # hopeforward http://ow.ly/i/5KHw8,,@LlyOncOnCanvas,# #,4.72831E+17,https://twitter.com/LillyDiabetes/status/472831214626148352,,,,
genentech,5/31/2014 16:05,3,1,The hints Coley spoke about 100+ yrs ago are leading immunotherapy in new directions http://ow.ly/xmVhN # ASCO14,,,#,4.72831E+17,https://twitter.com/genentech/status/472831177595060224,,,,
OncEd,5/31/2014 16:05,0,0,"Now latest breast cancer updates by Dr. Sunil Verma, Sunnybrook Canada # ASCO14 # ASCO2014",,,# #,4.72831E+17,https://twitter.com/OncEd/status/472831150268751872,,,,
kellykcotton,5/31/2014 16:04,2,0,Today's Presidential Address from @ CliffordHudis - video + full transcript: http://bit.ly/1oVoGWh # ASCO14,,@,#,4.72831E+17,https://twitter.com/kellykcotton/status/472831125648588800,,,,
JeffreyMOtto,5/31/2014 16:04,0,0,RL: two hit model for aml pathogenesis - but does not apply to ~60% of patients. We need new models. # ASCO14,,,#,4.72831E+17,https://twitter.com/JeffreyMOtto/status/472831125367586816,,,,
GillisClaire,5/31/2014 16:04,0,0,"# ASCO14 reduce cost, providers advocate reduced use targeted therapies, optimize scans, communicate terminal prognosis. What about outcome?",,,#,4.72831E+17,https://twitter.com/GillisClaire/status/472831073798586368,,,,
LisaVanHoosePT,5/31/2014 16:04,1,0," @ UHhospitals:possible new method to predicting response to chemotherapy in triple- # breastcancer http://ow.ly/xnWVc # ASCO14 @ WYCOBCT""",,@ @,# #,4.72831E+17,https://twitter.com/LisaVanHoosePT/status/472830988163092480,,,,
pisanie7,5/31/2014 16:04,0,0,@ PhRMA: # HIV is example of how incremental innovation leads to medical breakthroughs. @ Celgene has more: http://bit.ly/1hFWamh # ASCO14,,@ @,# #,4.72831E+17,https://twitter.com/pisanie7/status/472830945213837312,,,,
MCharakidis,5/31/2014 16:03,0,0,@ ASCO 'in the next 5-10 years we will see changes in medicine/oncology that we haven't seen in the past 50 years' Leroy Hood ASCO 2014,,@,,4.72831E+17,https://twitter.com/MCharakidis/status/472830865068654592,,,,
OncEd,5/31/2014 16:03,0,0,Dr. H.Gray: PFS ovarian cancer pts 2nd remission w/mucin-1 autologous dendritic cell thrpy # ASCO14-stay tuned 4 video pic.twitter.com/FsPm9E78b1,,,#,4.72831E+17,https://twitter.com/OncEd/status/472830828129431552,,,,
DoctorEdny,5/31/2014 16:03,0,1,"$ OMED redundancy in wnt; add of notch, hedgehog, or pi3k inh in desmoids may be path fwd - Dr Abrams # ASCO14 pic.twitter.com/90BD2bLpQ6",,,#,4.72831E+17,https://twitter.com/DoctorEdny/status/472830704427225088,,,,
derodry,5/31/2014 16:03,0,0," @ theNCI: We are sharing slides from Jeffrey Abram's talk on precision medicine & NCI's new National Clinical Trials Network. # NCTN # ASCO14""""",,@,# #,4.72831E+17,https://twitter.com/derodry/status/472830697556557824,,,,
JeffreyMOtto,5/31/2014 16:03,0,0,RL: aml still associated with poor overall survival. # ASCO14,,,#,4.72831E+17,https://twitter.com/JeffreyMOtto/status/472830672977928192,,,,
Preslaura,5/31/2014 16:02,0,0,Walked the # blisterwalk 6 times today in 3 in sandals and still holding up. # ASCO14 pic.twitter.com/WHatpfNawI,,,# #,4.72831E+17,https://twitter.com/Preslaura/status/472830599044939776,,,,
DrHedrick,5/31/2014 16:02,0,0,Oral Abstracts. Dr. Kathy Miller from @ iumedschool presenting final results of E5103 Bevacizumab in the adjuvant setting. # ASCO14,,@,#,4.72831E+17,https://twitter.com/DrHedrick/status/472830501456470016,,,,
DrAttai,5/31/2014 16:02,0,0,“ @ ASCO: @ CliffordHudis # ASCO14 speech is posted here: http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …”,,@ @,#,4.7283E+17,https://twitter.com/DrAttai/status/472830463195631616,,,,
tracyrode,5/31/2014 16:02,1,1,"Wow. @ ClevelandClinic: “In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics # ASCO14""",,@,# #,4.7283E+17,https://twitter.com/tracyrode/status/472830420472856577,,,,
cam_arnold,5/31/2014 16:02,0,1,"@ genentech booth was out of cookies, but my good friend @ krystadawn had an extra one, so I got my fix # ASCO14 pic.twitter.com/ywBbZYtYkI",,@ @,#,4.7283E+17,https://twitter.com/cam_arnold/status/472830416458883072,,,,
JeffreyMOtto,5/31/2014 16:02,0,0,"First up: Ross Levine mutational profiling in the mgmt and prognosis of AML"" # ASCO14""",,,#,4.7283E+17,https://twitter.com/JeffreyMOtto/status/472830412591759360,,,,
HopkinsMedicine,5/31/2014 16:02,8,4,Job Alert: @ HopkinsMedicine is hiring for Senior Media Relations Positions. Learn more: http://ow.ly/xtHPe # prjobs # ASCO14,,@,# #,4.7283E+17,https://twitter.com/HopkinsMedicine/status/472830409991266304,,,,
LindaBohannonRN,5/31/2014 16:02,2,2,@ drdonsdizon thanks for joining me today - LOVED your talk! - # ASCO14 # advocacyleader @ advocacyleader @ CancerSupportCm,,@ @ @,# #,4.7283E+17,https://twitter.com/LindaBohannonRN/status/472830408904560640,,,,
Cascadia,5/31/2014 16:01,0,1,Recorded stream # ASCO14 Presidents address via @ CliffordHudis http://bcove.me/m908c6om hard copy http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …”,,@,#,4.7283E+17,https://twitter.com/Cascadia/status/472830279544238080,,,,
DrLiebknicht,5/31/2014 16:01,0,0,# ASCO14 A salute from a mad scientist to all you brilliant folks working in this important field! You are amazing! Cheerio & keep fighting!,,,#,4.7283E+17,https://twitter.com/DrLiebknicht/status/472830274896920576,,,,
ASCO,5/31/2014 16:01,3,2,Become an ASCO member at # ASCO14: Visit a Member Services Desk & receive a membership dues credit & thank you gift,,,#,4.7283E+17,https://twitter.com/ASCO/status/472830219481780224,,,,
Roche,5/31/2014 16:01,6,2,Personalised therapy is like a jigsaw combining different treatments to fight different tumours # ASCO14 http://ow.ly/xoPhg # health,,,# #,4.7283E+17,https://twitter.com/Roche/status/472830165895372800,,,,
genentech,5/31/2014 16:01,4,2,How can we get ahead of the growing #of biomarker tests req. to select from a growing #of tx options? # ASCO14 http://ow.ly/xr2bZ,,,#of #of #,4.7283E+17,https://twitter.com/genentech/status/472830163089371137,,,,
JeffreyMOtto,5/31/2014 16:00,0,0,This session: clinical utility of genetic profiling in myeloid malignancies # ASCO14,,,#,4.7283E+17,https://twitter.com/JeffreyMOtto/status/472830113038761984,,,,
TargetedOnc,5/31/2014 16:00,2,0,"Adding Goserelin to Chemotherapy Helps to Preserve Fertility, Prolong Survival http://www.targetedonc.com/conference/asco-2014/Adding-Goserelin-to-Chemotherapy-Helps-to-Preserve-Fertility-Prolong-Survival … # ASCO14",,,#,4.7283E+17,https://twitter.com/TargetedOnc/status/472830110790606848,,,,
mayocliniclabs,5/31/2014 16:00,0,0,Learn about our biomarker testing for targeted therapy in non-small cell lung carcinomas at booth #2054. # ASCO14 http://mayocl.in/T1r6rl,,,#2054 #,4.7283E+17,https://twitter.com/mayocliniclabs/status/472830090615996416,,,,
Roche,5/31/2014 16:00,16,19,A negative # clinicalstudy isn't a failed study. It’s a reminder that there’s more work to do. http://ow.ly/xoR4O # ASCO14 # ClinicalTrials,,,# # #,4.7283E+17,https://twitter.com/Roche/status/472830071208939520,,,,
ASCO,5/31/2014 16:00,5,2,"Unstable life circumstances continue to delay cancer care progress in Iraq, writes Dr. Mula-Hussain http://bit.ly/ShKKP4 # ASCO14",,,#,4.7283E+17,https://twitter.com/ASCO/status/472830064984612867,,,,
LisaVanHoosePT,5/31/2014 16:00,1,0, @ mtmdphd: # ASCO14 - Abrams - @ theNCI MATCH a partnership with pharmaceutical companies, academics," and community sites"" @ WYCOBCT""",,@ @ @,#,4.7283E+17,https://twitter.com/LisaVanHoosePT/status/472829999821500416,,
medtechy,5/31/2014 16:00,0,0,Any reps at # ASCO14 - Join the discussion and share how it is from a reps perspective |http://bit.ly/1ku8g1P @ novartis @ pfizer @ sanofius,,@ @ @,#,4.7283E+17,https://twitter.com/medtechy/status/472829964153552896,,,,
FoundationATCG,5/31/2014 16:00,2,2,How can you be sure that no stone is left unturned for your patients? Find out here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.7283E+17,https://twitter.com/FoundationATCG/status/472829945073250304,,,,
SanofiUS,5/31/2014 16:00,0,0,RT @ PhRMA: Research and # innovation has led to increased survival rates for # cancer patients http://bit.ly/1pHtgat # ASCO14,,@,# # #,4.7283E+17,https://twitter.com/SanofiUS/status/472829890237329410,,,,
pfizer,5/31/2014 16:00,13,3,Did you know 30% of women diagnosed with early breast cancer will progress to advanced disease? # ASCO14 # bcsm,,,# #,4.7283E+17,https://twitter.com/pfizer/status/472829879738957824,,,,
SJoelHastings,5/31/2014 15:59,0,0,Checking out the AZ/Medi booth at # ASCO14 pic.twitter.com/9bd6VwGrll,,,#,4.7283E+17,https://twitter.com/SJoelHastings/status/472829676759420928,,,,
GustaveRoussy,5/31/2014 15:59,4,2,# ASCO2014 @ BernardEscudier itw for the oral presentation on June 02 # gene signature # risk recurrence # renal cancerpic.twitter.com/tN0S47zguG,,@,# # # #,4.7283E+17,https://twitter.com/GustaveRoussy/status/472829653309464576,,,,
MediTech_Media,5/31/2014 15:58,0,0,Great points made by ASCO Pres @ CliffordHudis during this morning's opening ceremony. See his speech here http://goo.gl/qExzbv # asco14,,@,#,4.7283E+17,https://twitter.com/MediTech_Media/status/472829514708291585,,,,
Sorena997,5/31/2014 15:58,1,2,"# ASCO14 Dr Carbone pB304 A Ph3, Randomized, Open-Label Trial of Nivolumab as First-Line Therapy for Stage IV NACLC pic.twitter.com/tlAqJgix3n",,,#,4.72829E+17,https://twitter.com/Sorena997/status/472829442352746497,,,,
Rad_Nation,5/31/2014 15:58,2,0,Phase II study of whole brain RT w/ simultaneous integrated boost for 1-10 brain metastases http://abstracts.asco.org/144/AbstView_144_133149.html … # ASCO14 # btsm # radonc,,,# # #,4.72829E+17,https://twitter.com/Rad_Nation/status/472829394856443904,,,,
subatomicdoc,5/31/2014 15:58,5,0,Phase II study of whole brain RT w/ simultaneous integrated boost for 1-10 brain metastases http://abstracts.asco.org/144/AbstView_144_133149.html … # ASCO14 # btsm # radonc,,,# # #,4.72829E+17,https://twitter.com/subatomicdoc/status/472829371523547137,,,,
Cascadia,5/31/2014 15:57,1,1,"Long Tail of 150+ people # ASCO14 https://twitter.com/Cascadia/lists/asco14 … - if I missed you just tweet add me # ASCO14 list” - heading out sailing""",,,# #,4.72829E+17,https://twitter.com/Cascadia/status/472829156942548992,,,,
TapKadia,5/31/2014 15:57,0,1,"# ASCO14. Poster highlights, abstract 7031. pic.twitter.com/vYvhsf3xHz",,,#,4.72829E+17,https://twitter.com/TapKadia/status/472829133244735488,,,,
nxtstop1,5/31/2014 15:56,0,1,@ ASCO @ sloan_kettering @ CliffordHudis Thx So Much! <,,@ @ @,,4.72829E+17,https://twitter.com/nxtstop1/status/472829107127197696,,,,
DrMiguelPerales,5/31/2014 15:56,1,1,MT @ Reuters_Health Roche immunotherapy drug antiPDL1 shrinks tumors in early bladder cancer study http://reut.rs/1khFwh9 # ASCO14,,@,#,4.72829E+17,https://twitter.com/DrMiguelPerales/status/472829098541056000,,,,
davidgrahammd,5/31/2014 15:56,2,1,Arie Crown theater... The black hole of # asco14 wifi,,,#,4.72829E+17,https://twitter.com/davidgrahammd/status/472829064710213632,,,,
nxtstop1,5/31/2014 15:56,0,1,Clifford A Hudis' PRESIDENTIAL ADDRESS AT # ASCO14 MT @ ASCO: @ sloan_kettering @ CliffordHudis' # ASCO14 speech : http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …”,,@ @ @,# #,4.72829E+17,https://twitter.com/nxtstop1/status/472829033018044417,,,,
her2friends,5/31/2014 15:56,0,0,# ASCO14 http://tinyurl.com/mmot287 pic.twitter.com/abzdrZZQlX,,,#,4.72829E+17,https://twitter.com/her2friends/status/472829031868792833,,,,
Mills_I,5/31/2014 15:56,8,4,@ drdonsdizon speaks of value of social media in global patient advocacy. Need to engage and build relationships. # ASCO14 @ CancerSupportCm,,@ @,#,4.72829E+17,https://twitter.com/Mills_I/status/472828892470718464,,,,
KUhlendorf,5/31/2014 15:55,2,2,"At risk of redundancy, still can't believe how many people are smoking at # ASCO14 https://www.google.com/search?q=smokers+lungs&source=lnms&tbm=isch&sa=X&ei=BjKKU93jNsyEqgbNioDYDg&ved=0CAcQ_AUoAQ&biw=320&bih=460#facrc=_&imgrc=R2trTTUWfkFmcM%253A%3BoYxWePDAlieQEM%3Bhttp%253A%252F%252Fcfrankdavis.files.wordpress.com%252F2012%252F08%252Fsmokers-lungs1.jpg%3Bhttp%253A%252F%252Fcfrankdavis.wordpress.com%252F2012%252F08%252F06%252Fthe-black-lung-lie%252F%3B379%3B301 …",,,# #facrc,4.72829E+17,https://twitter.com/KUhlendorf/status/472828615269552128,,,,
TargetedOnc,5/31/2014 15:54,4,2,We spoke with Dr. Suresh S. Ramalingam from @ WinshipAtEmory earlier today about new data for EGFR inhibitors http://www.targetedonc.com/conference/asco-2014/New-Data-for-EGFR-Inhibitors-for-Lung-Cancer … # ASCO14,,@,#,4.72829E+17,https://twitter.com/TargetedOnc/status/472828519635251202,,,,
Neil_Iyengar,5/31/2014 15:54,1,0,"Americans are in fact meeting exercise goals but we're still as obese as ever, just in our jogging suits. Dr Denmark-Wahnefried # ASCO14",,,#,4.72828E+17,https://twitter.com/Neil_Iyengar/status/472828360801140736,,,,
AneesChagpar,5/31/2014 15:53,3,2,If you're gonna eat 6 jelly beans," be prepared to chop wood for 6 min"" says Wendy Denmark @ ASCO # ASCO14 ... Note to self: no jelly beans!""",,@,#,4.72828E+17,https://twitter.com/AneesChagpar/status/472828259315777537,,,
PRKena,5/31/2014 15:53,0,0,Hot topics at # ASCO14 : illumina and immunotherapy.,,,#,4.72828E+17,https://twitter.com/PRKena/status/472828247843934208,,,,
AndytweetM,5/31/2014 15:53,0,0,@ ASCO thanks much. I'd need the code for patients / caregivers.,,@,,4.72828E+17,https://twitter.com/AndytweetM/status/472828224683376640,,,,
Mills_I,5/31/2014 15:53,4,2,"Linda House @ CancerSupportCm speaks to global advocates. Must collaborate, create diverse partnerships, dialogue and be strategic. # ASCO14",,@,#,4.72828E+17,https://twitter.com/Mills_I/status/472828186947256321,,,,
HenryJOncology,5/31/2014 15:53,0,0,"# hcldr Can oncologists even assess the value of cancer care delivered to an individual? Great debate, but need formal definitions # ASCO14",,,# #,4.72828E+17,https://twitter.com/HenryJOncology/status/472828124598509568,,,,
mtmdphd,5/31/2014 15:52,2,0,MT @ DrMisialek: Ph 3 Strengthens Support of Ibrutinib as 2nd-line Therapy for CLL http://shar.es/V9c5v @ OSUCCC_James @ NEJM # ASCO14 # leusm,,@ @ @,# #,4.72828E+17,https://twitter.com/mtmdphd/status/472828022727639040,,,,
ProfJohnCrown,5/31/2014 15:52,1,3,Also attended interesting presentation from Dr Khanh Do on wee-1 inhibitor. Wee-1 inhibitor is not a contraceptive by the way. # ASCO14,,,#,4.72828E+17,https://twitter.com/ProfJohnCrown/status/472827980826554368,,,,
PRKena,5/31/2014 15:52,0,0,@ clovisoncology congrats on excellent data presentations. # ASCO14,,@,#,4.72828E+17,https://twitter.com/PRKena/status/472827950685896704,,,,
AJMC_Journal,5/31/2014 15:51,1,0,Encouraging Results in Leukemia from a BCL-2 Inhibitor # ASCO14 http://bit.ly/1kvgV98,,,#,4.72828E+17,https://twitter.com/AJMC_Journal/status/472827845262458881,,,,
KirstenGoldberg,5/31/2014 15:51,0,0,RT @ asco: Past President Bernard Fisher reflects on our mission to promote clinical # cancer research http://bit.ly/1mDnAMj,,@,#,4.72828E+17,https://twitter.com/KirstenGoldberg/status/472827630170165248,,,,
MelanomaReAlli,5/31/2014 15:49,0,1,Looking fwd to hearing from MRA investigators at # ASCO14 session From Coley to Cure? Past, Present," & Future of Immunotherapy for Melanoma""""",,,#,4.72827E+17,https://twitter.com/MelanomaReAlli/status/472827338715975681,,
DoctorEdny,5/31/2014 15:49,0,2,$ OMED OMP-54F28 targeting decoy receptor for wnt correct summary # ASCO14 pic.twitter.com/Jm8Hfy34xy,,,#,4.72827E+17,https://twitter.com/DoctorEdny/status/472827276900724736,,,,
ASCO,5/31/2014 15:49,5,3,@ sloan_kettering @ CliffordHudis @ nxtstop1 Hello. @ CliffordHudis' # ASCO14 speech is posted here: http://connection.asco.org/Magazine/Article/id/3893/Science-and-Society-Fifty-Years-LaterThe-2014-Presidential-Address-by-Clifford-A-Hudis-MD-FACP.aspx …,,@ @ @ @,#,4.72827E+17,https://twitter.com/ASCO/status/472827261063012354,,,,
SusanLaufer,5/31/2014 15:49,0,0,Walking around # ASCO14 I feel like my brain is constantly in facial recognition mode. Wonderful to run into so many old friends & colleagues,,,#,4.72827E+17,https://twitter.com/SusanLaufer/status/472827232088772608,,,,
jeccles69,5/31/2014 15:49,0,0,# subscribeshow to my @ YouTube channel for great up to date # news http://youtu.be/yB-U3mPtqww # AnthonyJoshua # babygill # ThankYouLiam # ASCO14,,@,# # # # # #,4.72827E+17,https://twitter.com/jeccles69/status/472827120398635008,,,,
BayerPharma,5/31/2014 15:48,1,1,RT “ @ ASCO: Dr. Shah reflects on 50 years of innovation and discovery in GI cancers: http://bit.ly/1rkqMmQ # ASCO14 # crcsm”,,@,# #,4.72827E+17,https://twitter.com/BayerPharma/status/472827048382464000,,,,
brendanweiss,5/31/2014 15:48,1,2,Suggestions for developing a compassion fatigue prevention plan # ASCO14 pic.twitter.com/rOdK1P2mQl,,,#,4.72827E+17,https://twitter.com/brendanweiss/status/472826871735148544,,,,
DrMarkham,5/31/2014 15:47,2,0,"A. Poveda, #5505 - lurbinectedin was active in plat-resistant/refractory ovary ca, with longer PFS/OS than topotecan. # gyncsm # ASCO14",,,#5505 # #,4.72827E+17,https://twitter.com/DrMarkham/status/472826812918419456,,,,
KirstenGoldberg,5/31/2014 15:47,1,0,RT @ asco: Our Past Presidents Remember: Dr Bernard Fisher reflects on our mission to promote clinical # cancer research...,,@,#,4.72827E+17,https://twitter.com/KirstenGoldberg/status/472826669301264385,,,,
ProfJohnCrown,5/31/2014 15:47,2,0,Really interesting presentation from Skip Burris on Napi2B immuno-conjugate. # ASCO14,,,#,4.72827E+17,https://twitter.com/ProfJohnCrown/status/472826660459659264,,,,
jackiefox12,5/31/2014 15:46,1,3,"“ @ ClevelandClinic: “In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14” @ UNMC",,@ @,# #,4.72826E+17,https://twitter.com/jackiefox12/status/472826361875562496,,,,
AndytweetM,5/31/2014 15:45,0,0,@ ASCO I could not attend hence requesting,,@,,4.72826E+17,https://twitter.com/AndytweetM/status/472826335464017920,,,,
GustaveRoussy,5/31/2014 15:45,0,0,# ASCO2014 @ BernardEscudier en itw pour l'étude présentée 020614 # signature génétique # risque de rechute # cancer reinpic.twitter.com/tN0S47zguG,,@,# # # #,4.72826E+17,https://twitter.com/GustaveRoussy/status/472826248310579200,,,,
drcbsteer,5/31/2014 15:45,0,1,"@ cathiereid Yes, no disrespect to the fabulous # ASCO14 presenters intended but the time difference does bring its challenges.",,@,#,4.72826E+17,https://twitter.com/drcbsteer/status/472826140046798848,,,,
myPathMelanoma,5/31/2014 15:45,1,0,Myriad myPath # Melanoma is a clinically validated assay for difficult-to-diagnose melanocytic lesions # isthismelanoma # ASCO14,,,# # #,4.72826E+17,https://twitter.com/myPathMelanoma/status/472826098099564544,,,,
nanostringtech,5/31/2014 15:45,0,0,"Carey et al: Gene expression signatures in pre- & post-therapy specimens from CALGB 40601 phase III trial.."" # ASCO14 http://abstracts.asco.org/144/AbstView_144_129700.html …""",,,#,4.72826E+17,https://twitter.com/nanostringtech/status/472826098019876864,,,,
OncEd,5/31/2014 15:44,0,0,Dr. Kathy Miller: Bevacizumab in Adjuvant Treatment of HER- Breast Cancer # ASCO14- stay tuned for video interview! pic.twitter.com/plcnZ4wZ5b,,,#,4.72826E+17,https://twitter.com/OncEd/status/472825898287104000,,,,
AneesChagpar,5/31/2014 15:43,8,5,"Melinda Irwin @ YaleCancer presents LEAN trial data @ ASCO Dose response effect of weight loss on biomarkers"" # ASCO14 pic.twitter.com/qyXVX9Be3a""",,@ @,#,4.72826E+17,https://twitter.com/AneesChagpar/status/472825772194144256,,,,
jalopezg70,5/31/2014 15:43,0,0,Dr. POVEDA presenting the results of the PM01183 trial in platinum resistant and refractory ovarian cancer at # ASCO14 pic.twitter.com/K2IVPg3yCf,,,#,4.72826E+17,https://twitter.com/jalopezg70/status/472825594590531584,,,,
KLCampbellPhD,5/31/2014 15:42,1,0,In-person and telephone-based intervention equivalent for weight loss in breast cancer survivors; 5‰ weight loss improved biomarkers # ASCO14,,,#,4.72825E+17,https://twitter.com/KLCampbellPhD/status/472825379711770624,,,,
docjavip,5/31/2014 15:41,1,1,Time to immunotherapy in renal cancer # ASCO14 pic.twitter.com/bfr56B7JYc,,,#,4.72825E+17,https://twitter.com/docjavip/status/472825301027028992,,,,
CareAcross,5/31/2014 15:41,0,0,Our article from # ASCO14 day 1: focus on fertility preservation. What options do cancer patients have? http://ow.ly/xtGY1,,,#,4.72825E+17,https://twitter.com/CareAcross/status/472825155480481792,,,,
DrAttai,5/31/2014 15:40,2,2,"Dr. Demark-Wahnefried discussing the studies on BMI, weight loss, and breast cancer # ASCO14 # bcsm",,,# #,4.72825E+17,https://twitter.com/DrAttai/status/472825076740792320,,,,
DrMarkham,5/31/2014 15:40,1,0,"H. Gray, CAN003 trial: mucin1 vaccine in ovarian cancer, PFS maybe longer in group in 2nd clinical remission. #5504 # gyncsm # ASCO14",,,#5504 # #,4.72825E+17,https://twitter.com/DrMarkham/status/472824949686927360,,,,
drcbsteer,5/31/2014 15:40,0,2,"# ASCO14 It's 5:30am in Australia, 2:30pm here in Chicago. Fatigue setting in. Only twitter keeping me awake at the moment. # hcsm",,,# #,4.72825E+17,https://twitter.com/drcbsteer/status/472824904471937024,,,,
genentech,5/31/2014 15:40,1,1,@ rsm2800 Absolutely. Here's more on putting patients at the center of drug development: http://ow.ly/xtGf5 # ASCO14,,@,#,4.72825E+17,https://twitter.com/genentech/status/472824876194361344,,,,
BayerPharma,5/31/2014 15:39,3,1,We are welcoming # ASCO14 visitors at our international booth. Stop by our booth! pic.twitter.com/75qNLY8fhM,,,#,4.72825E+17,https://twitter.com/BayerPharma/status/472824794036314113,,,,
danielebanfi83,5/31/2014 15:39,0,2,25 mila partecipanti. C'è traffico! # ASCO14 pic.twitter.com/Lii14IGPRy,,,#,4.72825E+17,https://twitter.com/danielebanfi83/status/472824784255201281,,,,
NateDahlPharmD,5/31/2014 15:39,0,0,RT @ CancerDotNet: The basics of targeted therapy for # cancer: http://bit.ly/U3HpVk # ASCO14,,@,# #,4.72825E+17,https://twitter.com/NateDahlPharmD/status/472824782623232000,,,,
K_BasenEngquist,5/31/2014 15:38,1,1,"Irwin, 11 session weight loss prog 4 breast cancer survivors -> similar wt loss (~6%) whether delivered by phone or in person. # ASCO14 # BCSM",,,# #,4.72825E+17,https://twitter.com/K_BasenEngquist/status/472824569217425408,,,,
DoctorEdny,5/31/2014 15:38,1,0,Correction DNIB0600A adc in lung and ovarian cancer led to discontinuation # ASCO14 time for more coffee...,,,#,4.72824E+17,https://twitter.com/DoctorEdny/status/472824473175867392,,,,
thecancergeek,5/31/2014 15:38,0,2,Good abstract on the prognostic value from the special histologic subtypes of TNBC from # ASCO14 http://buff.ly/1pHrhCX,,,#,4.72824E+17,https://twitter.com/thecancergeek/status/472824355073040385,,,,
DrHedrick,5/31/2014 15:37,2,1,Dr. Shadia Jalal of @ iumedschool and @ hoosiercancer presenting Phase I data on amrubicin in # SCLC # ASCO14 pic.twitter.com/nHSKxns1Pz,,@ @,# #,4.72824E+17,https://twitter.com/DrHedrick/status/472824314673524736,,,,
AlpineBV_Miller,5/31/2014 15:36,0,3,$ RHHBY ADC using $ SGEN tech. # ASCO14 pic.twitter.com/VWQ94AaLef,,,#,4.72824E+17,https://twitter.com/AlpineBV_Miller/status/472824033659330560,,,,
StefanoLuminari,5/31/2014 15:36,5,2,# asco14 Novakowsky conclusion slide on R2CHOP for DLBCL @ lymphomahubpic.twitter.com/fLe1DdK9d7,,@,#,4.72824E+17,https://twitter.com/StefanoLuminari/status/472823875198537729,,,,
ShannonWestin,5/31/2014 15:36,2,1,Mucin-1 autologous dendritic cell therapy improves PFS after 1st/2nd remission in ovarian ca # ASCO14 # gyncsm,,,# #,4.72824E+17,https://twitter.com/ShannonWestin/status/472823830013304832,,,,
danielebanfi83,5/31/2014 15:35,0,1,Piccola sala del congresso # ASCO14. pic.twitter.com/YqpRMDeYsP,,,#,4.72824E+17,https://twitter.com/danielebanfi83/status/472823783259385856,,,,
mcupps,5/31/2014 15:35,0,0,“@BayerHealthCare: 50% chance of someone with CRC passing it to children. http://bit.ly/STP4Vp # ASCO14 http://twitpic.com/e54sgb I hope not,,@BayerHealthCare,#,4.72824E+17,https://twitter.com/mcupps/status/472823723037192192,,,,
carisls,5/31/2014 15:35,3,0,Get our guide to # ASCO14 # personalizedmedicine topics is available at booth 12096,,,# #,4.72824E+17,https://twitter.com/carisls/status/472823720059211776,,,,
megtirrell,5/31/2014 15:35,3,8,Accidentally texted a wrong number. Person responded kindly and offered restaurant recommendations in Chicago. # ilovethemidwest # ASCO14,,,# #,4.72824E+17,https://twitter.com/megtirrell/status/472823622315163648,,,,
DMCMarketPlace,5/31/2014 15:35,0,0,“ @ ASCO:Review 2014 ASCO Educational Book articles in advance of # ASCO14 educational sessions: http://bit.ly/SLvfQa ” # MerckOncology,,@,# #,4.72824E+17,https://twitter.com/DMCMarketPlace/status/472823617726996481,,,,
MaurerStats,5/31/2014 15:34,0,0,MT @ Lymphoma_Doc @ GregNowakowski RCHOP + lenalidomide shows GCB=non-GCB DLBCL outcomes. Len+chemo trials planned at MDACC. # ASCO14 # lymsm,,@ @,# #,4.72824E+17,https://twitter.com/MaurerStats/status/472823573644853248,,,,
AlpineBV_Miller,5/31/2014 15:34,0,2,41% ORR (PRs) in ovarian cancer pts with target for this $ RHHBY drug using $ SGEN ADC # ASCO14,,,#,4.72824E+17,https://twitter.com/AlpineBV_Miller/status/472823544486064129,,,,
DrAttai,5/31/2014 15:34,2,1,"LEAN study: wt loss had favorable effects on some inflammatory, metabolic biomarkers assoc w/ BC survival # ASCO14 # bcsm",,,# #,4.72823E+17,https://twitter.com/DrAttai/status/472823493755932672,,,,
BioPharmaMike,5/31/2014 15:34,1,0,@ Roche - Breakthrough immunotherapy anti-PDL1 (MPDL3280A) shrank tumors in 43% of those w/ one type of metastatic bladder # cancer # ASCO14,,@,# #,4.72823E+17,https://twitter.com/BioPharmaMike/status/472823438432673792,,,,
Cascadia,5/31/2014 15:34,1,0,Intensity of end-of-life care # EOLC among adolescents and young adults with cancer. # ASCO14 http://abstracts.asco.org/144/index.html,,,# #,4.72823E+17,https://twitter.com/Cascadia/status/472823389220913152,,,,
SusanLaufer,5/31/2014 15:34,0,0,"Ooh... crepes at the @ tevapharm booth at # ASCO14 (nutella/banana, spinach/ricotta, strawberries/cream, & ironically, ham/gruyere) תודה רבה!",,@,#,4.72823E+17,https://twitter.com/SusanLaufer/status/472823360024772610,,,,
DMCMarketPlace,5/31/2014 15:34,0,0,“ @ ASCO:Review 2014 ASCO Educational Book articles in advance of # ASCO14 educational sessions: http://bit.ly/SLvfQa ” Artículos disponibles!,,@,#,4.72823E+17,https://twitter.com/DMCMarketPlace/status/472823331939708928,,,,
GenentechJobs,5/31/2014 15:33,0,0,Interested in working for us? Visit our website http://bit.ly/1d789aG . Learn about us as an employer. # ASCO14 pic.twitter.com/NnFdlUx4in,,,#,4.72823E+17,https://twitter.com/GenentechJobs/status/472823184845070336,,,,
sfuldnasso,5/31/2014 15:33,4,2,"Shared decision-making gives patients equal role. Not the same as taking into account"" the patient's circumstances. # ASCO14""",,,#,4.72823E+17,https://twitter.com/sfuldnasso/status/472823178335514624,,,,
Rad_Nation,5/31/2014 15:33,1,0,Phase II trial of atorvastatin with radiation+temozolomide for glioblastoma http://buff.ly/1hE1Htz # ASCO14 # btsm,,,# #,4.72823E+17,https://twitter.com/Rad_Nation/status/472823100552519680,,,,
subatomicdoc,5/31/2014 15:33,2,0,Phase II trial of atorvastatin with radiation+temozolomide for glioblastoma http://bit.ly/1hE1FSs # ASCO14 # btsm,,,# #,4.72823E+17,https://twitter.com/subatomicdoc/status/472823091526377472,,,,
DrLen,5/31/2014 15:32,2,3,"From # ASCO14: A focus on the cost, value and financial toxicity of cancer care http://tinyurl.com/l2ocg9u",,,#,4.72823E+17,https://twitter.com/DrLen/status/472822942368559105,,,,
subatomicdoc,5/31/2014 15:32,8,1,ROS1 mutation linked to worse survival in glioblastoma http://bit.ly/1orOKdI # ASCO14 # btsm,,,# #,4.72823E+17,https://twitter.com/subatomicdoc/status/472822841772355585,,,,
sfuldnasso,5/31/2014 15:31,1,0,"Good discussion, but not a lot of disagreement in the debate on oncologists' ethical obligations to patient or society. # ASCO14",,,#,4.72823E+17,https://twitter.com/sfuldnasso/status/472822743033860096,,,,
KLCampbellPhD,5/31/2014 15:31,3,2,SHAPE-2 results: Reduction in sex hormones with weight loss alone and weight loss with exercise but greater effects with exercise # ASCO14,,,#,4.72823E+17,https://twitter.com/KLCampbellPhD/status/472822715871551488,,,,
AndyBiotech,5/31/2014 15:31,1,0,"$ AZN paid $ MRK $50M u/f for this WEE1, meh -> @ JacobEPVantage: AEs of MK1775 - 1 death # ASCO14 pic.twitter.com/2OtVZMZblQpic.twitter.com/nmvkKyj9NI",,@,#,4.72823E+17,https://twitter.com/AndyBiotech/status/472822677158522880,,,,
teamoncology,5/31/2014 15:31,3,1,【 # ASCO14 Update】 A higher pCR rate among germline BRCA mutation who received anthra/taxane based chemo in TNBC. # bcsm,,,# #,4.72823E+17,https://twitter.com/teamoncology/status/472822605389373440,,,,
AndytweetM,5/31/2014 15:31,0,0,@ ASCO how does one get access to the virtual meetings ? Can someone help with the access today? Will very much appreciate it,,@,,4.72823E+17,https://twitter.com/AndytweetM/status/472822602772525058,,,,
CancerDotNet,5/31/2014 15:30,0,0,On the # ASCO14 exhibit floor? Check out the Patient Advocacy Booth (#3005) - full of nonprofits doing good work http://bit.ly/1iADfcN,,,# #3005,4.72822E+17,https://twitter.com/CancerDotNet/status/472822474888212481,,,,
Amgen,5/31/2014 15:30,4,0,Look for # Amgen first-in-human data for oral selective MET-inhibitor in advanced solid tumors at 3:39pm CDT in E Hall D2 # ASCO14,,,# #,4.72822E+17,https://twitter.com/Amgen/status/472822450401845248,,,,
MGHCancerCenter,5/31/2014 15:30,0,1,"4:45-6, E Hall D2: Dr. Corcoran talks about phase 1-2 trial of dabrafenib + trametinib in BRAF V600 mutant colorectal cancer # crcsm # ASCO14",,,# #,4.72822E+17,https://twitter.com/MGHCancerCenter/status/472822444202688512,,,,
cmartindedios,5/31/2014 15:30,0,0,@ ASCO # ASCO2014 http://www.asco.org/sites/www.asco.org/files/asco_socialmedia_card.pdf …,,@,#,4.72822E+17,https://twitter.com/cmartindedios/status/472822441258283010,,,,
TargetedOnc,5/31/2014 15:30,2,0,Considering the Discontinuation of Statins in Late-Stage Cancer Patients http://www.targetedonc.com/conference/asco-2014/Considering-the-Discontinuation-of-Statins-in-Late-Stage-Cancer-Patients … # ASCO14,,,#,4.72822E+17,https://twitter.com/TargetedOnc/status/472822410996375553,,,,
Lymphoma_Doc,5/31/2014 15:30,1,0,@ GregNowakowski: RCHOP + lenalidomide shows GCB = non-GCB DLBCL outcomes. We have Len + chemo trials planned in non-GCB at MDACC. # ASCO14,,@,#,4.72822E+17,https://twitter.com/Lymphoma_Doc/status/472822391652241408,,,,
genentech,5/31/2014 15:30,8,10,It's time to create endpoints that reflect the outcomes that are most meaningful to ppl w/ cancer. # ASCO14 # QoL http://ow.ly/xtF3E,,,# #,4.72822E+17,https://twitter.com/genentech/status/472822341417046016,,,,
myriadgenetics,5/31/2014 15:30,0,0,"It's still # Melanoma Awareness Month. Find out the facts, risks & how to protect yourself! http://bit.ly/1pSICwF # SPOTskincancer # ASCO14",,,# # #,4.72822E+17,https://twitter.com/myriadgenetics/status/472822327768399872,,,,
KoontzOncology,5/31/2014 15:29,0,0,# ASCO14 http://tinyurl.com/m2wcy2b Congratulations to Dr. Leslie Robison for receiving the Pediatric Oncology Award!pic.twitter.com/7OjKvxUvPf,,,#,4.72822E+17,https://twitter.com/KoontzOncology/status/472822287801282561,,,,
tomleblancMD,5/31/2014 15:29,3,0,Jagsi: responsible stewardship of resources possible WITHOUT reducing ability to help the individual patient before us # ASCO14 # costofcare,,,# #,4.72822E+17,https://twitter.com/tomleblancMD/status/472822246034395138,,,,
Melanoma_doctor,5/31/2014 15:29,0,2,"Great line from # ASCO14-physician told me he is more likely to give IL-2 to ice hockey players because they're tough"" # melanoma""",,,# #,4.72822E+17,https://twitter.com/Melanoma_doctor/status/472822162256982016,,,,
DoctorEdny,5/31/2014 15:28,1,0,$ AZN AZD1775 wee1 inhibitor had 2 DLTs at 300mg BID; 1 PR in BRCA1 mut head and neck cancer # ASCO14 pic.twitter.com/58S3nvGBkJ,,,#,4.72822E+17,https://twitter.com/DoctorEdny/status/472822000063631360,,,,
BreastDocUK,5/31/2014 15:28,1,0,The beauty of the virtual conference is that I have just mowed my lawn in between sessions # ASCO14,,,#,4.72822E+17,https://twitter.com/BreastDocUK/status/472821925556002818,,,,
DrAttai,5/31/2014 15:28,1,0,LEAN study asks is benefit of wt loss due to inflammatory bio marker effects? # ASCO14 # bcsm,,,# #,4.72822E+17,https://twitter.com/DrAttai/status/472821917078937600,,,,
eaonc,5/31/2014 15:28,0,0,"Witzig # MayoClinic on E1412-active/enrolling: could confirm lenalidomide improves outcome when + to RCHOP"" # ASCO2014 http://ow.ly/xtFRm""",,,# #,4.72822E+17,https://twitter.com/eaonc/status/472821823672188929,,,,
MGHCancerCenter,5/31/2014 15:28,0,0,Great job by Drs. Lori Wirth and Don Dizon in the # ASCO14 press room today. Look for MGH Cancer Center stories soon!,,,#,4.72822E+17,https://twitter.com/MGHCancerCenter/status/472821820572590080,,,,
heidisa,5/31/2014 15:28,0,0,RT @ markaorourke: # ASCO14 Sulmasy: Onc’s need to practice cost-responsible care and then teach it.,,@,#,4.72822E+17,https://twitter.com/heidisa/status/472821816034361345,,,,
juliacowens,5/31/2014 15:27,0,0,Awfully distracting to have seagulls calls in the background during the entire developmental therapeutics session at # ASCO14,,,#,4.72822E+17,https://twitter.com/juliacowens/status/472821642562134017,,,,
JacobPlieth,5/31/2014 15:27,0,3,Summary of phI study of MK1775 (wee1 kinase inh) $ AZN $ MRK # ASCO14 pic.twitter.com/FQR81BVAwc,,,#,4.72822E+17,https://twitter.com/JacobPlieth/status/472821624887320576,,,,
KoontzOncology,5/31/2014 15:27,0,0,# ASCO14 http://tinyurl.com/m2wcy2b There are more than 240 members of the CCSS research team now headed by Dr. Armstrongpic.twitter.com/8LN2oaD2p5,,,#,4.72822E+17,https://twitter.com/KoontzOncology/status/472821622320402432,,,,
drdonsdizon,5/31/2014 15:27,0,5," @ ConsanoMolly: And I finally meet @ drdonsdizon in person! Had to get an # ASCO14 # selfie to document the moment! pic.twitter.com/bRajABNlPb"" RT""",,@ @,# #,4.72822E+17,https://twitter.com/drdonsdizon/status/472821608617631745,,,,
danielebanfi83,5/31/2014 15:26,0,1,La dura vita dei partecipanti al congresso # ASCO14. pic.twitter.com/xuKHv97YKi,,,#,4.72822E+17,https://twitter.com/danielebanfi83/status/472821537629011968,,,,
StefanoLuminari,5/31/2014 15:26,1,0,"# Asco14 Nowakowski on R2CHOP for DLBCL. Ph2 on 64 pts. infrequent gr 3-4 AEs, ORR 98% with 80% CR, 2ys PFS 59, 2 yrOS 78%; GCB=nonGCB",,,#,4.72822E+17,https://twitter.com/StefanoLuminari/status/472821511959482368,,,,
AneesChagpar,5/31/2014 15:26,0,0,"Tough, but impt, conversations to be had re: palliative care. @ YaleTomLynch @ YaleCancer @ ASCO @ medpagetoday http://www.medpagetoday.com/MeetingCoverage/ASCO/46077 … # ASCO14",,@ @ @ @,#,4.72821E+17,https://twitter.com/AneesChagpar/status/472821400869568512,,,,
ImedexCME,5/31/2014 15:25,0,0,We'll be recording Best of the Day sessions with your favorite doctors Sunday and Monday. Visit us at booth 15085 and see. # ASCO14 # Oncology,,,# #,4.72821E+17,https://twitter.com/ImedexCME/status/472821213593890818,,,,
heidisa,5/31/2014 15:25,0,0,"Live and learn, learn and live. RT @ CancerDotNet: The basics of targeted therapy for # cancer: http://bit.ly/U3HpVk # ASCO14",,@,# #,4.72821E+17,https://twitter.com/heidisa/status/472821168777728001,,,,
KUhlendorf,5/31/2014 15:25,1,0,Me-too drugs=old news. We are in era of precision medicine. But what if only one company pursues pathway and falls short? # ASCO14,,,#,4.72821E+17,https://twitter.com/KUhlendorf/status/472821067308736512,,,,
ipaulmampilly,5/31/2014 15:24,0,0,# ASCO14 biggest hall I have been at this year pic.twitter.com/7MngM9R0Is,,,#,4.72821E+17,https://twitter.com/ipaulmampilly/status/472821001647308801,,,,
ChrisHeery,5/31/2014 15:24,0,0,Combinations are not simply A+ B. They may change biology. Synergy hard to model. Sznol # ASCO14,,,#,4.72821E+17,https://twitter.com/ChrisHeery/status/472820898072780801,,,,
aftimosp,5/31/2014 15:24,0,0,Turner: Patients with detectable mutations or rising abundance may be suitable for therapeutic trials of novel agents # BreastCancer # ASCO14,,,# #,4.72821E+17,https://twitter.com/aftimosp/status/472820888513937409,,,,
PhRMA,5/31/2014 15:24,0,0,Recent advances in treatment offer great long-term value to # patients and society http://onphr.ma/1kqAJKe # ASCO14,,,# #,4.72821E+17,https://twitter.com/PhRMA/status/472820874731474944,,,,
ipaulmampilly,5/31/2014 15:23,0,0,This pres is in a hall the size of Kansas # ASCO14 pic.twitter.com/IvBv4v3goK,,,#,4.72821E+17,https://twitter.com/ipaulmampilly/status/472820775301677056,,,,
markaorourke,5/31/2014 15:23,0,0,# ASCO14 Every dollar of innovation saves seven dollars? I don't think so.,,,#,4.72821E+17,https://twitter.com/markaorourke/status/472820774605422592,,,,
KoontzOncology,5/31/2014 15:23,2,1,# ASCO14 http://tinyurl.com/m2wcy2b There are gaps that remain in survivorship research. Need to continue studies.pic.twitter.com/7rSWaE7Y7t,,,#,4.72821E+17,https://twitter.com/KoontzOncology/status/472820689322647552,,,,
ImedexCME,5/31/2014 15:23,0,0,In Chicago? Come say hello and get a free USB drive! # ASCO14 booth 15085 # cme # education # Oncologypic.twitter.com/YgFSl4TjCi,,,# # # #,4.72821E+17,https://twitter.com/ImedexCME/status/472820665058615297,,,,
aftimosp,5/31/2014 15:23,1,0,N. Turner: Raising mutation abundance in the post-surgical period is a sensitive and specific predictor of relapse # BreastCancer # ASCO14,,,# #,4.72821E+17,https://twitter.com/aftimosp/status/472820649694490624,,,,
LillyDiabetes,5/31/2014 15:22,2,0,Day 1 of the @LlyOncOnCanvas hope mural painting at # ASCO14 making progress! # hopeforward http://ow.ly/i/5KHt5,,@LlyOncOnCanvas,# #,4.72821E+17,https://twitter.com/LillyDiabetes/status/472820519373651968,,,,
DrAttai,5/31/2014 15:22,9,6,Dr. May - exercise-induced weight loss stronger favorable effect on BC related hormones than diet-induced weight loss # ASCO14 # bcsm,,,# #,4.7282E+17,https://twitter.com/DrAttai/status/472820433335877632,,,,
JacobPlieth,5/31/2014 15:22,0,2,AEs of MK1775 (wee1 kinase inh) - one death $ AZN $ MRK # ASCO14 pic.twitter.com/MQPvaGTFoJ,,,#,4.7282E+17,https://twitter.com/JacobPlieth/status/472820426247512065,,,,
ChrisHeery,5/31/2014 15:22,0,0,"Biomarkers in immunotherapy are difficult. Good for stratification for activity, not perfectly predictive on a pt to pt basis. Sznol # ASCO14",,,#,4.7282E+17,https://twitter.com/ChrisHeery/status/472820382878035969,,,,
aftimosp,5/31/2014 15:22,0,0,N. Turner: Tracking tumor specific mutations in plasma can predict early relapse following the tratment of primary # BreastCancer # ASCO14,,,# #,4.7282E+17,https://twitter.com/aftimosp/status/472820314556993536,,,,
KoontzOncology,5/31/2014 15:22,0,1,"# ASCO14 http://tinyurl.com/m2wcy2b There are responsibilities that go with survivorship"" <-- so true for so many!!pic.twitter.com/77U8qxKY3A""",,,#,4.7282E+17,https://twitter.com/KoontzOncology/status/472820311189368833,,,,
dougulman,5/31/2014 15:21,0,1,@ Uber_CHI from midway airport is amazing! cc: @ uber # ASCO14,,@ @,#,4.7282E+17,https://twitter.com/dougulman/status/472820162102824961,,,,
JacobPlieth,5/31/2014 15:21,0,1,PhI IST of MK1775 (wee1 kinase inh) $ AZN $ MRK # ASCO14 pic.twitter.com/RQoLXWULJU,,,#,4.7282E+17,https://twitter.com/JacobPlieth/status/472820108562563072,,,,
conlethmurphy,5/31/2014 15:21,0,0,PARP inhibition plus antiVEGF therapy in ovarian cancer: combination oral therapy WITHOUT chemotherapy. promising early results # ASCO14,,,#,4.7282E+17,https://twitter.com/conlethmurphy/status/472820072143413250,,,,
OncologyTimes,5/31/2014 15:20,3,2,'The myth that physicians are innoc bystanders watching hc costs zoom out of control can't be sustained' -R Jagsi quoted H Brody # ASCO14,,,#,4.7282E+17,https://twitter.com/OncologyTimes/status/472819943550226432,,,,
Plaza_Bickle,5/31/2014 15:20,0,0,"Buena parte de mi TL habla del # ASCO14, varios in situ. Yo cubrí 2 en su día, Atlanta y San Diego. Gran experiencia. Me faltó Chicago...",,,#,4.7282E+17,https://twitter.com/Plaza_Bickle/status/472819909018546176,,,,
GenentechJobs,5/31/2014 15:20,2,2,# Chicago is a great city for # ASCO14. We look forward to forging new relationships & renewing old connections. pic.twitter.com/PLIMOaiPWw,,,# #,4.7282E+17,https://twitter.com/GenentechJobs/status/472819810795913217,,,,
teamoncology,5/31/2014 15:19,0,0,【 # ASCO14 Update】Anti-EGFR therapy combined with Ixa provides high pCR rate in TNBC. http://abstracts.asco.org/144/AbstView_144_135110.html … # bcsm,,,# #,4.7282E+17,https://twitter.com/teamoncology/status/472819766998990848,,,,
AneesChagpar,5/31/2014 15:19,1,0,"Awesome to read about @ ASCO's continued international efforts in today's Daily News"" -- esp the impact of new innovation grants. # ASCO14""",,@,#,4.7282E+17,https://twitter.com/AneesChagpar/status/472819680273793024,,,,
262withDonna,5/31/2014 15:19,0,1,"RT @ ALLIANCE_org  # ASCO14 Today: Assoc of genomic analysis of immune fcn genes & clinical outcome in adj H trial. # N9831 @ EdithPerezMD""...""",,@ @,# #,4.7282E+17,https://twitter.com/262withDonna/status/472819581669867520,,,,
markaorourke,5/31/2014 15:19,3,2,# ASCO14 Sulmasy: Onc's need to practice cost-responsible care and then teach it.,,,#,4.7282E+17,https://twitter.com/markaorourke/status/472819573906235393,,,,
aicrtweets,5/31/2014 15:19,4,2,RT @ drattai: Dr. May - exercise has a protective effect on development of postmenopausal breast cancer # ASCO14 # bcsm,,@,# #,4.7282E+17,https://twitter.com/aicrtweets/status/472819571498704896,,,,
garyleethompson,5/31/2014 15:19,1,1,"As # ASCO14 unfolds, a thx from our family to @ Genentech as my wife begins a protocol of both Perjeta & Herceptin for metastasis. # ItMatters",,@,# #,4.7282E+17,https://twitter.com/garyleethompson/status/472819565702180864,,,,
GustaveRoussy,5/31/2014 15:18,2,0,# ASCO14 Further discussions on targeted therapies in early trials with Pr Jean-Charles Soria @ gustaveroussypic.twitter.com/ArZquIKRWX,,@,#,4.7282E+17,https://twitter.com/GustaveRoussy/status/472819512832983043,,,,
ChrisHeery,5/31/2014 15:18,0,3,Not clear that prior autoimmune event with one checkpoint inhibitor predicts event with the next option. (Cite: Jeff Webber) Sznol # ASCO14,,,#,4.72819E+17,https://twitter.com/ChrisHeery/status/472819493840756738,,,,
TriageCancer,5/31/2014 15:18,2,2,Have you been by the Patient Advocacy booths? Come find us & our neighbors/friends @ YSCBuzz @ theABTA @ mylifelineorg @ ImermanAngels # ASCO14,,@ @ @ @,#,4.72819E+17,https://twitter.com/TriageCancer/status/472819457040322560,,,,
brianreid,5/31/2014 15:18,9,3,Everyone wants everything," No one wants to pay for anything. No one wants to say no to anyone."" -- Sulmasy on the US system # ASCO14""",,,#,4.72819E+17,https://twitter.com/brianreid/status/472819406515752961,,,
TawnyaBowles,5/31/2014 15:18,0,0,Dr. Sondak: selection important in surgery for Stage IV # Melanoma; lack of data on adjuvant rx. # ASCO14,,,# #,4.72819E+17,https://twitter.com/TawnyaBowles/status/472819299946487809,,,,
betht0002,5/31/2014 15:17,0,1,I think I could get used to working from here. # ASCO14 @McCormick Place Chicago Convention… http://instagram.com/p/orCw7dvyEd/,,@McCormick,#,4.72819E+17,https://twitter.com/betht0002/status/472819254119899137,,,,
Oncoinfo_it,5/31/2014 15:17,5,3,Twitter alla conquista di # ASCO14. Oncologiii...? @ Tecnoetica @ salvo_fedele @ lucadf @ helixpis @ PAsciertopic.twitter.com/GpeALIOF5Z,,@ @ @ @ @,#,4.72819E+17,https://twitter.com/Oncoinfo_it/status/472819245697736705,,,,
drcbsteer,5/31/2014 15:17,0,0,# ASCO14 # gyncsm Lederman discussing EOC oral papers. Room for a trial adding olaparib to cedirinib/chemo as per ICON6?,,,# #,4.72819E+17,https://twitter.com/drcbsteer/status/472819168190816256,,,,
jalopezg70,5/31/2014 15:17,0,0," @ illumina: NT: Using ctDNA as an early indicator of breast cancer relapse- dynamic mutation tracking is an accurate method. # ASCO14""""",,@,#,4.72819E+17,https://twitter.com/jalopezg70/status/472819094920912897,,,,
teamoncology,5/31/2014 15:17,0,0,【 # ASCO14 Update】Increased TILs with immunomodulatory TNBC and response to neoadjuvant platinum-based Rx. http://abstracts.asco.org/144/AbstView_144_131689.html … # bcsm,,,# #,4.72819E+17,https://twitter.com/teamoncology/status/472819082966757376,,,,
KoontzOncology,5/31/2014 15:16,0,0,# ASCO14 http://tinyurl.com/m2wcy2b 32% of pediatric cancer survivors have reported smoking by the age of 40 as per CCSSpic.twitter.com/sa6MlJwb8F,,,#,4.72819E+17,https://twitter.com/KoontzOncology/status/472819027136741376,,,,
ChrisHeery,5/31/2014 15:16,0,0,Dose response curve indicates increasing doses of checkpoint inhibitors does increase toxicity. Sznol # ASCO14,,,#,4.72819E+17,https://twitter.com/ChrisHeery/status/472819012196261888,,,,
mtmdphd,5/31/2014 15:16,2,1,If you've donated to CCF @ iConquerCancer stop by S401 lounge for a cold soda to help re-energize... If you aren't a donor - donate. # ASCO14,,@,#,4.72819E+17,https://twitter.com/mtmdphd/status/472819007205023745,,,,
DrAttai,5/31/2014 15:16,5,3,Dr. May - exercise has a protective effect on development of postmenopausal breast cancer # ASCO14 # bcsm,,,# #,4.72819E+17,https://twitter.com/DrAttai/status/472818969163096065,,,,
eaonc,5/31/2014 15:16,0,0,Medscape AJ Cmelak E1308 study chair # ASCO2014: low-dose radiation sometimes ok in HPV+ head/neck # vanderbilt-ingram http://ow.ly/xtF4Q,,,# #,4.72819E+17,https://twitter.com/eaonc/status/472818897939599360,,,,
ConsanoScott,5/31/2014 15:16,0,0,Rising cfDNA levels are predictive of poor outcome # asco14,,,#,4.72819E+17,https://twitter.com/ConsanoScott/status/472818863554711552,,,,
KUhlendorf,5/31/2014 15:16,4,1,"# ASCO14: 33k scientists, students, patients, companies, advocates, academics, govt researchers, reporters & more determined to beat # cancer",,,# #,4.72819E+17,https://twitter.com/KUhlendorf/status/472818832244228096,,,,
garyleethompson,5/31/2014 15:16,0,1,@ luriecancer Maureen started her new treatments this Thurs/Fri. Big thanks again to Dr. Gradishar for his insights. # ASCO14 # cancer,,@,# #,4.72819E+17,https://twitter.com/garyleethompson/status/472818809766940673,,,,
UmutDisel,5/31/2014 15:15,0,0,"Patients With Metastatic Colon Cancer Respond to New Combination Therapy, Phase IB Study Shows http://ow.ly/xtDKj # ASCO14 # crcsm"",,,# #,472818781287636992""",https://twitter.com/UmutDisel/status/472818781287636992,,,,,,,,
FVazMan,5/31/2014 15:15,0,0,# ASCO14 http://tinyurl.com/orwdvns good session is coming! Enjoy it!pic.twitter.com/nXHBqI9QQS,,,#,4.72819E+17,https://twitter.com/FVazMan/status/472818751961067520,,,,
DrAttai,5/31/2014 15:15,0,3,"Dr. May - effects of exercise, weight loss on postmenopausal breast cancer # ASCO14 # bcsm",,,# #,4.72819E+17,https://twitter.com/DrAttai/status/472818708893540353,,,,
ChrisHeery,5/31/2014 15:15,0,3,"Nivo + Ipi -->lowest dose combo less effective. Perhaps the higher concentration = tumor saturation, increasing effectiveness. Sznol # ASCO14",,,#,4.72819E+17,https://twitter.com/ChrisHeery/status/472818695358525441,,,,
JediPD,5/31/2014 15:15,0,0,@ teamoncology Microenvironment -Yup...EMT not withstanding and the cross-talk within. # ASCO14,,@,#,4.72819E+17,https://twitter.com/JediPD/status/472818662161002496,,,,
MediTech_Media,5/31/2014 15:15,0,0,Head and neck tumor biomarkers are differentially expressed by HIV status. Zhang et al # ASCO14,,,#,4.72819E+17,https://twitter.com/MediTech_Media/status/472818660352880641,,,,
genentech,5/31/2014 15:15,0,1,This vid abt Paul Ehrlich is for # histmed buffs in town for # AAHM14 or # ASCO14 http://ow.ly/xk6cd,,,# # #,4.72819E+17,https://twitter.com/genentech/status/472818642259046400,,,,
davidgrahammd,5/31/2014 15:15,0,2,Dr Amin to report on combination use of Nivolumab in metastatic RCC in 1 hour. @carolinas # LCI # ASCO14,,@carolinas,# #,4.72819E+17,https://twitter.com/davidgrahammd/status/472818641537609728,,,,
wallyjc,5/31/2014 15:15,0,1,"Winship's Bree Eaton, MD of @ Winship5K presenting an NRG Oncology poster on RTOG 0617 # ASCO14 pic.twitter.com/New6Gd38Hm",,@,#,4.72819E+17,https://twitter.com/wallyjc/status/472818639201402880,,,,
brianreid,5/31/2014 15:15,1,1,Jagsi's top 5 ways to improve value in cancer care. # ASCO14 pic.twitter.com/TE6lSW62jG,,,#,4.72819E+17,https://twitter.com/brianreid/status/472818631693594624,,,,
Lymphoma_Doc,5/31/2014 15:14,3,2,CD79b and CD22 antibody drug conjugate + rituximab both show ORR is ~55% and ~65% in relapsed DLBCL and FL. Neuropathy is an issue. # ASCO14,,,#,4.72819E+17,https://twitter.com/Lymphoma_Doc/status/472818530564730880,,,,
hmhyltonpac,5/31/2014 15:14,1,0,"Dr. Jagsi, quoting Mark Twain at # ASCO14-Always do right. It will astonish some and gratify the rest.",,,#,4.72819E+17,https://twitter.com/hmhyltonpac/status/472818509760962561,,,,
RfwrightLSL,5/31/2014 15:14,1,0,My daughter getting ready to Jam on her # PRS during # relayforlife # ASCO14 will like pic.twitter.com/5oF8lqdKPg,,,# # #,4.72819E+17,https://twitter.com/RfwrightLSL/status/472818500428656640,,,,
ShannonWestin,5/31/2014 15:14,0,0,Can olaparib/cediranib replace platinum? J. Ledermann # ASCO14 # gyncsm,,,# #,4.72818E+17,https://twitter.com/ShannonWestin/status/472818481902002176,,,,
teamoncology,5/31/2014 15:14,1,2,【 # ASCO14 Update】 Medullary and apocrine histology of TNBC has better prognosis. http://abstracts.asco.org/144/AbstView_144_132579.html … # ASCO14 # bcsm,,,# # #,4.72818E+17,https://twitter.com/teamoncology/status/472818423102066690,,,,
MaurerStats,5/31/2014 15:14,1,0,Rt @ lymphomahub @ StefanoLuminari: # ASCO14 dr.Levy conclusions on romulus trial @ lymphomahub pic.twitter.com/VlOgeMOuqz # lymsm,,@ @ @,# #,4.72818E+17,https://twitter.com/MaurerStats/status/472818355217657856,,,,
K_BasenEngquist,5/31/2014 15:14,0,1,"Chlebowski, From WHI - African-American women taking estrogen only (no progestin) HRT had decreased risk of breast cancer. # ASCO14",,,#,4.72818E+17,https://twitter.com/K_BasenEngquist/status/472818347101675521,,,,
SJNaggiar,5/31/2014 15:14,0,0,"Some final thoughts from Dr. Jagsi, physicians cannot pretend that their sole duty is to the patient before them # ASCO2014",,,#,4.72818E+17,https://twitter.com/SJNaggiar/status/472818334388719616,,,,
rkwilliams,5/31/2014 15:14,0,1,Awesome meeting some of the great conquerors at # ASCO14 @ mtmdphd @ iConquerCancerpic.twitter.com/lMrCHZ3zHh,,@ @,#,4.72818E+17,https://twitter.com/rkwilliams/status/472818292768636928,,,,
JFreemanDaily,5/31/2014 15:13,3,6,"Phase 1 trial shows RXDX-101 is potent inhibitor of ALK+ and ROS+ NSCLC, and gets into brain. # lcsm # ASCO14",,,# #,4.72818E+17,https://twitter.com/JFreemanDaily/status/472818278667415553,,,,
markaorourke,5/31/2014 15:13,0,0,# ASCO14 Need to educate and motivate ourselves to choose wisely in controlling the costs of cancer care.,,,#,4.72818E+17,https://twitter.com/markaorourke/status/472818220559532033,,,,
EthanBasch1,5/31/2014 15:13,0,0,How do we decide whether to recommend therapies with very small but real clinical benefits but very high cost? Value session # ASCO14,,,#,4.72818E+17,https://twitter.com/EthanBasch1/status/472818142066917376,,,,
CLOUDHealth,5/31/2014 15:13,1,0,"Biggest question in creating connections b/w patients, doctors & clinical trials is everybody trying to be THE platform or portal # ASCO14",,,#,4.72818E+17,https://twitter.com/CLOUDHealth/status/472818138153615360,,,,
ConsanoScott,5/31/2014 15:13,2,2,cfDNA gives earlier detection of breast cancer relapse # asco14 pic.twitter.com/76wys2UzcC,,,#,4.72818E+17,https://twitter.com/ConsanoScott/status/472818077701128192,,,,
LurieCancer,5/31/2014 15:12,0,1,"@ afreshchapter: Our # ASCO14 booth is #2065. I'm not at the booth, but will be at the Tweetup this afternoon. Will you?",,@,# #2065,4.72818E+17,https://twitter.com/LurieCancer/status/472817945031499776,,,,
teamoncology,5/31/2014 15:12,0,0,"@ JediPD As you said, this may be the reason why angiogenesis inhibitor works in SOC and not in TNBC. # ASCO14 # bcsm",,@,# #,4.72818E+17,https://twitter.com/teamoncology/status/472817896058413056,,,,
tomleblancMD,5/31/2014 15:12,0,0,Jagsi: responsible stewardship of resources is possible WITHOUT reducing our ability to help the individual patient before us # ASCO14,,,#,4.72818E+17,https://twitter.com/tomleblancMD/status/472817889540841472,,,,
theMMRF,5/31/2014 15:12,4,4,The 1st @ theMMRF blog from our onsite coverage of # ASCO14 with the latest # myeloma news is now posted! http://www.themmrf.org/asco # MMRFASCO,,@,# # #,4.72818E+17,https://twitter.com/theMMRF/status/472817877893275649,,,,
BioPharmaMike,5/31/2014 15:12,1,1,@ Roche - Breakthrough immunotherapy anti-PDL1 (MPDL3280A) shrank tumors in 43% of those w/ one type of metastatic bladder # cancer # ASCO2014,,@,# #,4.72818E+17,https://twitter.com/BioPharmaMike/status/472817875149787136,,,,
SJNaggiar,5/31/2014 15:11,0,0,Dr. Jagsi reminds that @ ASCO has issued 2 top five lists with opportunities to improve the quality of cancer care # choosingwisely # ASCO2014,,@,# #,4.72818E+17,https://twitter.com/SJNaggiar/status/472817754601697281,,,,
teamoncology,5/31/2014 15:11,0,0,"@ JediPD If the genetic is very smiler between SOC and TNBC, them the difference have to be in the microenvironment. # ASCO14 # bcsm",,@,# #,4.72818E+17,https://twitter.com/teamoncology/status/472817751820476416,,,,
Cognicum,5/31/2014 15:11,0,0,“ @ Novartis: Presentation on 3-year ENESTcmr data evaluating long-term # CML treatment starting now in S405 # ASCO14 https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,# #,4.72818E+17,https://twitter.com/Cognicum/status/472817726747316225,,,,
UdderlySmooth,5/31/2014 15:11,0,0,@ SeattleGenetics Do we need to be scanned? Loved this year's display @ iConquerCancer @ ASCO,,@ @ @,,4.72818E+17,https://twitter.com/UdderlySmooth/status/472817659478679552,,,,
RyanNipp,5/31/2014 15:11,2,1,MT @ tomleblancMD: Great piece by @ fischmd on # palliative care in # oncology: http://ow.ly/3lcR9J # hpm # ASCO14 # pallonc,,@ @,# # # # #,4.72818E+17,https://twitter.com/RyanNipp/status/472817640390811648,,,,
garyleethompson,5/31/2014 15:11,0,1,@ LBChavaree Thx Laura! 5th ride in 5 years. Always same weekend as # ASCO14 Great job on the # RevForum with @ Livestrong & @ iconquercancer,,@ @ @,# #,4.72818E+17,https://twitter.com/garyleethompson/status/472817616361627649,,,,
ChrisHeery,5/31/2014 15:11,0,1,"If you respond to immune therapy, your later progression may respond again to the same therapy. ~10% Sznol # ASCO14",,,#,4.72818E+17,https://twitter.com/ChrisHeery/status/472817605858697216,,,,
DoctorEdny,5/31/2014 15:11,0,3,$ RDRX PI study validates FGFR fusions as a drug target - Dr Solit # ASCO14 pic.twitter.com/BB4Fgu0uXZ,,,#,4.72818E+17,https://twitter.com/DoctorEdny/status/472817585151811584,,,,
tomleblancMD,5/31/2014 15:11,0,1,Jagsi: first step in curbing expenditures on unhelpful # cancer care = follow the # choosingwisely recommendations from @ ASCO # ASCO14,,@,# # #,4.72818E+17,https://twitter.com/tomleblancMD/status/472817537756180480,,,,
StefanoLuminari,5/31/2014 15:10,0,0,# ASCO14 dr.Levy conclusions on romulus trial @ lymphomahubpic.twitter.com/cnY1QuWByr,,@,#,4.72818E+17,https://twitter.com/StefanoLuminari/status/472817536619536385,,,,
MedkoHealth,5/31/2014 15:10,0,1,# ASCO14 # oncologist in # LatAm country? Check our fast growing doctor-patient portal: http://medkohealth.com/,,,# # #,4.72818E+17,https://twitter.com/MedkoHealth/status/472817501500227584,,,,
ASCO,5/31/2014 15:10,0,0,@ davidgrahammd offers # ASCO14 networking advice http://bit.ly/1u1Fb5t on # ASCOconnection,,@,# #,4.72817E+17,https://twitter.com/ASCO/status/472817387050639361,,,,
ProjectInno,5/31/2014 15:10,0,0,Losing half a million Americans to cancer each year demands our attention & relentless commitment http://ow.ly/xtz32 # ASCO14,,,#,4.72817E+17,https://twitter.com/ProjectInno/status/472817366318219264,,,,
JediPD,5/31/2014 15:10,1,0,@ teamoncology Might be the large capillary bed of the Omentum vs. The fibrosis in the breast tissue? # ASCO14,,@,#,4.72817E+17,https://twitter.com/JediPD/status/472817353601056768,,,,
CancerDotNet,5/31/2014 15:10,4,1,New drug combo proves helpful for recurrent ovarian cancer. More on this study from # ASCO14: # gyncsm http://bit.ly/1kuRvIL,,,# #,4.72817E+17,https://twitter.com/CancerDotNet/status/472817334290505729,,,,
ChrisHeery,5/31/2014 15:10,0,0,Unconventional responders may have received significant clinical benefit not recognized by standard RECIST. Sznol # ASCO14,,,#,4.72817E+17,https://twitter.com/ChrisHeery/status/472817291927617536,,,,
ConsanoMolly,5/31/2014 15:09,1,0,And I finally meet @ drdonsdizon in person! Had to get an # ASCO14 # selfie to document the moment!pic.twitter.com/eCxOmWTGRa,,@,# #,4.72817E+17,https://twitter.com/ConsanoMolly/status/472817188894945280,,,,
MOCBrasil,5/31/2014 15:09,0,0,Abstr500: ECOG5103 não mostrou benefício para bevacizumabe na adjuvância # MOCnaASCO # bcsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_130506.html … ...,,,# # #,4.72817E+17,https://twitter.com/MOCBrasil/status/472817179604156416,,,,
StefanoLuminari,5/31/2014 15:09,1,0,# asco14 AEs slide from romulus trial @ lymphomahubpic.twitter.com/cSwzahMKkK,,@,#,4.72817E+17,https://twitter.com/StefanoLuminari/status/472817157903233024,,,,
HemOncToday,5/31/2014 15:09,3,1,"# ASCO14 Gregory A. Masters, MD, discusses how # lenvatinib improved PFS in radioiodine-resistant differentiated ThyroidCancer:...",,,# #,4.72817E+17,https://twitter.com/HemOncToday/status/472817084532264960,,,,
GoHealio,5/31/2014 15:09,0,0,"# ASCO14 Gregory A. Masters, MD, discusses how # lenvatinib improved PFS in radioiodine-resistant differentiated ThyroidCancer:...",,,# #,4.72817E+17,https://twitter.com/GoHealio/status/472817083953446912,,,,
rsm2800,5/31/2014 15:09,0,0,Artz: Querying Darwin - users can create own cohort by specific marker; helpful for screening pts for a trial directed at a marker # asco14,,,#,4.72817E+17,https://twitter.com/rsm2800/status/472817070371921920,,,,
ipaulmampilly,5/31/2014 15:09,0,0,# ASCO14 the intersection of $ aapl $ fb $ goog and cancer...p4 medicine in today's asco daily newspic.twitter.com/Oyu19WL8bQ,,,#,4.72817E+17,https://twitter.com/ipaulmampilly/status/472817049069453312,,,,
tomleblancMD,5/31/2014 15:08,2,0,Jagsi: overuse of resources on low-value care; case where individually rational decisions lead to collectively inferior outcomes # ASCO14,,,#,4.72817E+17,https://twitter.com/tomleblancMD/status/472817027766554624,,,,
ShannonWestin,5/31/2014 15:08,0,0,"J. Ledermann- consider less chemo and more maintenance pazopanib to improve QOL"". # ASCO14 # gyncsm""",,,# #,4.72817E+17,https://twitter.com/ShannonWestin/status/472816991880097792,,,,
ChrisHeery,5/31/2014 15:08,0,1,Unconventional responses: difficult aspects of trial design and pt management on trial. Sznol # ASCO14 irRC better correlates w outcomes.,,,#,4.72817E+17,https://twitter.com/ChrisHeery/status/472816945809485824,,,,
markaorourke,5/31/2014 15:07,0,0,# ASCO14 Debate on oncologist's role serving both pt and society (for cost control). Let the onc serve the pt and let ASCO serve society.,,,#,4.72817E+17,https://twitter.com/markaorourke/status/472816763290525698,,,,
JediPD,5/31/2014 15:07,0,0,@ rsm2800 Does not include Inherent PCR error rates >= 20% in the cut and paste...More like Oy Vay # ASCO14,,@,#,4.72817E+17,https://twitter.com/JediPD/status/472816733750054913,,,,
teamoncology,5/31/2014 15:07,1,0,Why does angiogensis inhibitors work in ovarian cancer but not in breast cancer? # ASCO14 # bcsm,,,# #,4.72817E+17,https://twitter.com/teamoncology/status/472816716221673472,,,,
GenentechJobs,5/31/2014 15:07,0,2,"# ASCO14 exhibit hall is open today, tomorrow & Monday from 9:00 am - 5:00 pm. Head to Hall A, Level 3, South Building pic.twitter.com/rjzk5aQ9Sh",,,#,4.72817E+17,https://twitter.com/GenentechJobs/status/472816696072228864,,,,
AdvocateDebM,5/31/2014 15:07,0,0,"Check out  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.72817E+17,https://twitter.com/AdvocateDebM/status/472816630594953216,,,,
EBOncology,5/31/2014 15:07,0,0,"# ASCO14 To lead an evidence-based identification of value is the oncologists responsibility.""- Reshma Jagsi"," MD""",,,#,4.72817E+17,https://twitter.com/EBOncology/status/472816597493874689,,,
YaleCancer,5/31/2014 15:07,5,3,MT YCC's Dr. Tom Lynch: Palliative care is a careful conversation bt physicians and patients. # asco14 @ medpagetodayhttp://www.medpagetoday.com/MeetingCoverage/ASCO/46077 …,,@,#,4.72817E+17,https://twitter.com/YaleCancer/status/472816568918106112,,,,
SarahCannon_UK,5/31/2014 15:07,3,1,10 # ASCO14 abstracts with contributions from authors affiliated with us @SCRI UK: http://sarahcannonresearch.co.uk/news/scri-at-2014-asco-annual-meeting/ …pic.twitter.com/hQiS6Gm6YB,,@SCRI,#,4.72817E+17,https://twitter.com/SarahCannon_UK/status/472816563884523520,,,,
jdflaysakier,5/31/2014 15:07,0,0,Récidives des cancers de l'ovaire : l'espoir d'un nouveau traitement par voie orale. Sur le blog http://www.docteurjd.com/?p=3212 # ASCO14,,,#,4.72817E+17,https://twitter.com/jdflaysakier/status/472816540396421121,,,,
teamoncology,5/31/2014 15:06,1,0,RT @ ShannonWestin: Weekly paclitaxel and pazopanib in plat resist ovarian cancer sig improve PFS OS. # ASCO14 # bcsm,,@,# #,4.72817E+17,https://twitter.com/teamoncology/status/472816523162042368,,,,
DoctorEdny,5/31/2014 15:06,1,1,$ clvs $ rdrx $ jnj Phase I first in human studies extra effort to enroll the right patients to show activity - Dr Solit # ASCO14,,,#,4.72816E+17,https://twitter.com/DoctorEdny/status/472816497375846400,,,,
ChrisHeery,5/31/2014 15:06,0,0,Difficult aspects of radiographic assessment. Pseudo prog - real entity and hard to know when pt is truly unlikely to benefit. Sznol # ASCO14,,,#,4.72816E+17,https://twitter.com/ChrisHeery/status/472816477326680065,,,,
dmooneymd,5/31/2014 15:06,0,0,"Surgical candidates (10%?): oligometastatic, small disease. Maybe also oligopersistent dz"" after effective neoadjuvant tx. # melsm # ASCO14""",,,# #,4.72816E+17,https://twitter.com/dmooneymd/status/472816469269434368,,,,
MelanomaReAlli,5/31/2014 15:06,0,0,Excited for day 1 of # ASCO14! pic.twitter.com/XobCU4UDr2,,,#,4.72816E+17,https://twitter.com/MelanomaReAlli/status/472816453260148738,,,,
KoontzOncology,5/31/2014 15:06,0,0,# ASCO14 http://tinyurl.com/m2wcy2b St Jude lifetime cohort study finds frailty isn't just for older cancer survivorspic.twitter.com/8SHtq50i6V,,,#,4.72816E+17,https://twitter.com/KoontzOncology/status/472816363124572160,,,,
ecancer,5/31/2014 15:06,1,0,"Lenvatinib delays progression for radioiodine-resistant, advanced differentiated thyroid cancer http://bit.ly/1pv3mth # ASCO14",,,#,4.72816E+17,https://twitter.com/ecancer/status/472816344023719936,,,,
ConsanoScott,5/31/2014 15:06,0,0,Assessing detection of micromets in early breast cancer using cfDNA? # asco14,,,#,4.72816E+17,https://twitter.com/ConsanoScott/status/472816312490946560,,,,
suvikki12,5/31/2014 15:06,0,2,Clinical data supporting targeted therapy options for patients w/ metastatic BRAF-mutated melanomas. One word:hope. Lots of it. @ ASCO,,@,,4.72816E+17,https://twitter.com/suvikki12/status/472816290315251713,,,,
Sorena997,5/31/2014 15:05,1,0,Dr Gray presenting soon # ASCO14 Abstract 5504. PFS in # ovarian cancer,,,# #,4.72816E+17,https://twitter.com/Sorena997/status/472816248225800192,,,,
rsm2800,5/31/2014 15:05,0,0,"Artz: Use ICD-0 coding from tumor registry, not iCD-9. Problem is that it’s >6 months old by definition # asco14",,,#,4.72816E+17,https://twitter.com/rsm2800/status/472816187089227776,,,,
TylerWhisman,5/31/2014 15:05,0,0,Hauschild: Symptomatic disease and not BRAF status might be key to Melanoma to algorithm once PD-1s arrive. # ASCO14,,,#,4.72816E+17,https://twitter.com/TylerWhisman/status/472816157289091073,,,,
teamoncology,5/31/2014 15:05,2,0,Did the clinical trial enrollment increased by studying gene mutation of the tumors? Nope. What is wrong with this picture? # ASCO14,,,#,4.72816E+17,https://twitter.com/teamoncology/status/472816156462444544,,,,
CBPartners,5/31/2014 15:05,0,0,"@ CBPartners: Jagsi we are harming patients [eg bankruptcy] by ignoring costs"" @ ASCO""",,@ @,,4.72816E+17,https://twitter.com/CBPartners/status/472816139928895488,,,,
genentech,5/31/2014 15:05,2,2,"Goal for # Next50: “Advances in dx & meds lead to truly # personalized approach for 1 person's specific cancer” – J. Low, Med Dir # ASCO14",,,# # #,4.72816E+17,https://twitter.com/genentech/status/472816084081733632,,,,
MelanomaMom,5/31/2014 15:05,1,0,When to consider surgery vs. Systemic therapy for metastatic # melanoma. # ASCO14 pic.twitter.com/Ha1RTn5Mrz,,,# #,4.72816E+17,https://twitter.com/MelanomaMom/status/472816071809187841,,,,
ipaulmampilly,5/31/2014 15:04,0,0,# ASCO14 asco daily news shows this graph...funding crisis at NIH coming? pic.twitter.com/gdgSskj0g1,,,#,4.72816E+17,https://twitter.com/ipaulmampilly/status/472816014233980928,,,,
teamoncology,5/31/2014 15:04,0,1,Many docs order gene analysis of cancer but many docs do not have means to make this clinically relevant under standard of care. # ASCO14,,,#,4.72816E+17,https://twitter.com/teamoncology/status/472815955714662401,,,,
ChrisHeery,5/31/2014 15:04,1,2,The greatest value is at the end of the survival curve with immunotherapy. Even if median PFS does not improve much. Sznol # ASCO14,,,#,4.72816E+17,https://twitter.com/ChrisHeery/status/472815891176898560,,,,
SJNaggiar,5/31/2014 15:04,0,0,Dr. Jagsi says studies show that prescribing costly care can hurt the individual patient # ASCO2014,,,#,4.72816E+17,https://twitter.com/SJNaggiar/status/472815824903102464,,,,
heidisa,5/31/2014 15:03,2,3,So many conferences. So little time. # ASCO14 pic.twitter.com/claOtNUPEj,,,#,4.72816E+17,https://twitter.com/heidisa/status/472815758037483520,,,,
carisls,5/31/2014 15:03,2,0,"Molecular analysis of 17 types of # gastrointestinal cancer, international cohort of 11,324 patients: http://goo.gl/7TMLwr # ASCO14",,,# #,4.72816E+17,https://twitter.com/carisls/status/472815735153369090,,,,
christinemphmd,5/31/2014 15:03,2,0,"Sondak: What's the secret to surgery in metastatic melanoma? Selection, selection, selection. # ASCO14 # melanoma # surgery",,,# # #,4.72816E+17,https://twitter.com/christinemphmd/status/472815722557882368,,,,
dmooneymd,5/31/2014 15:03,0,0,Surgery for met # melanoma? Revisiting in light of effective tx. Surgical studies w/highly selected pop. Chemo studies all comers. # ASCO14,,,# #,4.72816E+17,https://twitter.com/dmooneymd/status/472815604617838592,,,,
ChrisHeery,5/31/2014 15:03,1,1,Hard to decide which agents to bring forward when obvious responses are not part of early stage trials. Sznol # ASCO14,,,#,4.72816E+17,https://twitter.com/ChrisHeery/status/472815581846982658,,,,
JLErsek,5/31/2014 15:03,0,0,"Dr. Symanowski, Biostatistician @Carolinas # LCI discussing poster @ # ASCO14. pic.twitter.com/Ti7VuVHTlj",,@Carolinas @,# #,4.72816E+17,https://twitter.com/JLErsek/status/472815533424148481,,,,
rsm2800,5/31/2014 15:02,0,0,Artz: Molecular diagnostic testing is usu put into anatomic path report by cutting and pasting text; digital—>analog—>digital oy # asco14,,,#,4.72816E+17,https://twitter.com/rsm2800/status/472815521272840192,,,,
BioPharmaMike,5/31/2014 15:02,0,0,# Ibrutinib three year follow-up of single-agent & combo study results in # CLL to be discussed at # ASCO2014 Tuesday http://www.prnewswire.co.uk/news-releases/261363351.html …,,,# # #,4.72815E+17,https://twitter.com/BioPharmaMike/status/472815442457669632,,,,
djsampson,5/31/2014 15:02,0,1,"We may not want to incentivize cost effectiveness, but we also don't want to skip it -Dr Jagsi # asco14",,,#,4.72815E+17,https://twitter.com/djsampson/status/472815408874274816,,,,
DoctorEdny,5/31/2014 15:02,1,3,"$ CLVS Lucitanib less potent FGFR agonist, leads to less side effects notably no hyperphosphatemia - Solit # ASCO14 pic.twitter.com/TUIB6G9Ogo",,,#,4.72815E+17,https://twitter.com/DoctorEdny/status/472815389140082689,,,,
ChrisHeery,5/31/2014 15:02,1,1,Prior therapies may influence outcome of subsequent agent. Hard to replicate in vivo effects. Sznol # ASCO14,,,#,4.72815E+17,https://twitter.com/ChrisHeery/status/472815355811729408,,,,
DrZahwa,5/31/2014 15:02,0,0,"RT Pathologists: RT hmhyltonpac: Dr. Emanuel @ # ASCO14: take solutions to Washington. IMHO, ASCO's payment reform model is a step in this...",,@,#,4.72815E+17,https://twitter.com/DrZahwa/status/472815300300521472,,,,
CI4CC,5/31/2014 15:02,0,0,NCI Cancer Genomics Workshop in November 2014 San Francisco Bay Area: Go To http://www.ci4cc.org for more information. # ASCO14,,,#,4.72815E+17,https://twitter.com/CI4CC/status/472815283313197056,,,,
janinegug,5/31/2014 15:02,4,3,0.1 percent of federal budget goes to # Cancer research. That is just morally wrong. It is time to wage a real war on cancer. # ASCO14,,,# #,4.72815E+17,https://twitter.com/janinegug/status/472815274245500928,,,,
mayocliniclabs,5/31/2014 15:01,0,0,Check out our comprehensive # oncology offering at our dedicated microsite. # ASCO14 http://mayocl.in/1mAnSU8,,,# #,4.72815E+17,https://twitter.com/mayocliniclabs/status/472815196562784256,,,,
ClevelandClinic,5/31/2014 15:01,70,31,"“The true value of healthcare is not measured in dollars, but in the dignity of the patient.” - Dr. Salmasy at # ASCO14",,,#,4.72815E+17,https://twitter.com/ClevelandClinic/status/472815123720318977,,,,
Roche,5/31/2014 15:01,14,5,By 2020 over 70% of cancers will occur in low-/middle-income countries. How to overcome access hurdles? http://ow.ly/xkTZn # ASCO14,,,#,4.72815E+17,https://twitter.com/Roche/status/472815094548942848,,,,
ASCO,5/31/2014 15:01,6,1,Designing & implementing a medical specialty society-based # quality improvement training program http://bit.ly/1kO4ncs # ASCO14,,,# #,4.72815E+17,https://twitter.com/ASCO/status/472815074651172864,,,,
carisls,5/31/2014 15:01,2,0,Molecular profiling of HPV-positive and negative # headandneck SCC: S Hall http://A2goo.gl/7TMLwr # ASCO14 # MolecularIntel,,,# # #,4.72815E+17,https://twitter.com/carisls/status/472815072428175360,,,,
rsm2800,5/31/2014 15:01,1,0,"Artz: Darwin system; web-based viewer takes input of all clinical data, goes to data warehouse; anyone can view, manipulate # ASCO14",,,#,4.72815E+17,https://twitter.com/rsm2800/status/472815022326808576,,,,
ConsanoScott,5/31/2014 15:00,0,0,Would love to know if @ ConsanoMolly had higher levels of TILs in her breast cancer. I sure hope so! # asco14,,@,#,4.72815E+17,https://twitter.com/ConsanoScott/status/472815015561789440,,,,
bmsnews,5/31/2014 15:00,5,5,"New Phase 1 & 2 data of investigational compound in # kidney cancer presented today @ 3pm CDT, E Arie Crown Theater # ASCO14",,@,# #,4.72815E+17,https://twitter.com/bmsnews/status/472814981709590528,,,,
ChrisHeery,5/31/2014 15:00,0,1,"Mario Sznol talk on endpoints in immunotherapy. Unique activity patterns, unique toxicity, complicated biology. Reassess the system. # ASCO14",,,#,4.72815E+17,https://twitter.com/ChrisHeery/status/472814968966873089,,,,
AndyBiotech,5/31/2014 15:00,1,3,$ RXDX Trk -> @BMTEdny: RXDX-101 next gen kinase inhibitor PI shows no DLT ; PRs in adv neuroblastoma and mCRC # ASCO14 pic.twitter.com/yjMt5QNeLU,,@BMTEdny,#,4.72815E+17,https://twitter.com/AndyBiotech/status/472814960087949312,,,,
fischmd,5/31/2014 15:00,5,4,"Dr. Hood's # ASCO14 talk on systems medicine, wellness, and # healthcare revolution resonates with this @ jama_current http://ow.ly/xtEdb",,@,# #,4.72815E+17,https://twitter.com/fischmd/status/472814950382321664,,,,
PPDCRO,5/31/2014 15:00,0,0,Hear about our progressive Phase I capabilities through novel study designs at booth 8115. # ASCO14 http://ht.ly/xrNB6,,,#,4.72815E+17,https://twitter.com/PPDCRO/status/472814947735703552,,,,
djsampson,5/31/2014 15:00,1,1,"This debate on Value is good, but last night's PSA throwdown b/w @ AlpineBV_Miller and @ OtisBrawley was livelier # asco14",,@ @,#,4.72815E+17,https://twitter.com/djsampson/status/472814852466278401,,,,
Rad_Nation,5/31/2014 15:00,0,0,"Adjuvant radiation, ADT+docetaxel for prostate cancer: Phase II trial http://buff.ly/1kdhEqm > @ NRGonc # ASCO14 # pcsm # radonc",,@,# # #,4.72815E+17,https://twitter.com/Rad_Nation/status/472814845570850816,,,,
FoundationATCG,5/31/2014 15:00,2,1,Take the molecular testing challenge and learn about the comprehensive approach: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.72815E+17,https://twitter.com/FoundationATCG/status/472814843406188544,,,,
subatomicdoc,5/31/2014 15:00,0,1,"Adjuvant radiation, ADT+docetaxel for prostate cancer: Phase II trial http://bit.ly/1kdhEqi > @ NRGonc # ASCO14 # pcsm # radonc",,@,# # #,4.72815E+17,https://twitter.com/subatomicdoc/status/472814840495767552,,,,
SGDESPREZ,5/31/2014 15:00,0,0,Impressive # cancer project by @ StJude with the St Jude Lifetime Cohort http://bit.ly/1ruKwUS # ASCO14,,@,# #,4.72815E+17,https://twitter.com/SGDESPREZ/status/472814816499752960,,,,
Pharmacyclics,5/31/2014 15:00,0,1,We are thrilled to be at # ASCO14! Stop by booth 18097 to learn more about our latest research and advances in # cancercare,,,# #,4.72815E+17,https://twitter.com/Pharmacyclics/status/472814809193254913,,,,
MedkoHealth,5/31/2014 15:00,0,1,Are you a top oncologist ? Become the member of the fastest growing doctor- patient portal in # LatAm: http://medkohealth.com # ASCO14,,,# #,4.72815E+17,https://twitter.com/MedkoHealth/status/472814790729940992,,,,
myriadgenetics,5/31/2014 15:00,1,1,Data from 2 clinical studies on Myriad myPath # Melanoma show it can differentiate melanoma from benign nevi. http://bit.ly/1qFsz5H # ASCO14,,,# #,4.72815E+17,https://twitter.com/myriadgenetics/status/472814786229444608,,,,
FrauPinina,5/31/2014 15:00,0,0,ConGrats to ASCO on his 50-year birthday. God bless you Asquito. # ASCO14,,,#,4.72815E+17,https://twitter.com/FrauPinina/status/472814782408839168,,,,
carisls,5/31/2014 15:00,2,0,Molecular profiling of non-small cell # lungcancer by histologic subtype. http://goo.gl/7TMLwr # ASCO14 # MolecularIntel,,,# # #,4.72815E+17,https://twitter.com/carisls/status/472814781624483840,,,,
mattlehman77,5/31/2014 14:59,1,2,Dr Gray presenting soon at 2:27pm # ASCO14 Abstract 5504. PFS in # ovarian cancer patients in second remission improved with # CVac,,,# # #,4.72815E+17,https://twitter.com/mattlehman77/status/472814767266992128,,,,
TawnyaBowles,5/31/2014 14:59,1,0,"Patient symptoms, tumor burden important considerations in choice of firstline rx for metastatic # Melanoma # ASCO14",,,# #,4.72815E+17,https://twitter.com/TawnyaBowles/status/472814701374496768,,,,
StefanoLuminari,5/31/2014 14:59,1,1,# ASCO14 romulus waterfall plots @ lymphomahubpic.twitter.com/oapByA6y2b,,@,#,4.72815E+17,https://twitter.com/StefanoLuminari/status/472814638900723713,,,,
rsm2800,5/31/2014 14:59,0,0,Artz: Have to report eCQMs from certified EHR technology; many of the measures are identical to primary care populations # asco14,,,#,4.72815E+17,https://twitter.com/rsm2800/status/472814618859950080,,,,
JacobPlieth,5/31/2014 14:59,0,2,JNJ-42756493 phI summary slide $ JNJ # ASCO14 pic.twitter.com/xcm3Ku0gXv,,,#,4.72815E+17,https://twitter.com/JacobPlieth/status/472814596332322816,,,,
carisls,5/31/2014 14:59,3,1,Further molecular profiling of tumors harboring therapeutic targets in non-small cell # lungcancer S Hall A2 http://goo.gl/7TMLwr # ASCO14,,,# #,4.72815E+17,https://twitter.com/carisls/status/472814584638996480,,,,
StefanoLuminari,5/31/2014 14:59,1,0,# ASCO14 results of ROMULUS ph IIRnd trial ORR 56% in DLBCL and 62 to70 % in FL,,,#,4.72815E+17,https://twitter.com/StefanoLuminari/status/472814579978756096,,,,
drcbsteer,5/31/2014 14:59,0,0,# ASCO14 # gyncsm Pignata MITO-11 - pazopanib + wkly paclitaxel improved PFS vs single agent by 3 months in plat res EOC patients.,,,# #,4.72815E+17,https://twitter.com/drcbsteer/status/472814540946563072,,,,
JacobPlieth,5/31/2014 14:58,1,2,Clinical activities of >6mg JNJ-42756493 (pan-FGFR inhibitor) in phase I $ JNJ # ASCO14 pic.twitter.com/HH75wUSbOb,,,#,4.72814E+17,https://twitter.com/JacobPlieth/status/472814451708534785,,,,
brendanweiss,5/31/2014 14:58,0,0,"Deignan, lessons from first responders: we all need a compassion fatigue prevention program, society and our patients need us # ASCO14",,,#,4.72814E+17,https://twitter.com/brendanweiss/status/472814443878162432,,,,
dmooneymd,5/31/2014 14:58,0,0,Possible new alg:Nonsymptomatic disease: anti pd1 ab. Symptomatic disease: anti pd1 + ipi. Only bring Braf tx on progression. # ASCO14 # melsm,,,# #,4.72814E+17,https://twitter.com/dmooneymd/status/472814413863350273,,,,
BioPharmaMike,5/31/2014 14:58,3,0,# Janssen presents RESONATE data on investigational compound # ibrutinib at # ASCO2014 # cancer # CLL # SLL # PFS # OS http://www.prnewswire.co.uk/news-releases/261363331.html …,,,# # # # # # # #,4.72814E+17,https://twitter.com/BioPharmaMike/status/472814407005663233,,,,
CLOUDHealth,5/31/2014 14:58,2,2,"As # ASCO14 attendees consider # data think about how our electric grid would work if it had separate power plants, like our databases. # hitsm",,,# # #,4.72814E+17,https://twitter.com/CLOUDHealth/status/472814382833876992,,,,
brianreid,5/31/2014 14:58,1,0,"Jagsi on value: We must call attention to general areas of waste. There's a lot of low-hanging fruit out there."" # ASCO14""",,,#,4.72814E+17,https://twitter.com/brianreid/status/472814351368593408,,,,
AlpineBV_Miller,5/31/2014 14:58,2,0,Polatuzumab going forward in P3 as late-Iine single agent. # ASCO14 $ RHHBY $ SGEN,,,#,4.72814E+17,https://twitter.com/AlpineBV_Miller/status/472814340215943169,,,,
OncoPlexDx,5/31/2014 14:58,1,0,"Come meet Dr. Dan Catenacci, MD - GI Medical Oncologist at U of Chicago - today at 4PM at #18119 re: Targeted Chemotherpy in GI. # ASCO14",,,#18119 #,4.72814E+17,https://twitter.com/OncoPlexDx/status/472814325124841472,,,,
JacobPlieth,5/31/2014 14:57,0,2,AE summary for JNJ-42756493 $ JNJ # ASCO14 pic.twitter.com/yUwbuLxYmV,,,#,4.72814E+17,https://twitter.com/JacobPlieth/status/472814259366137857,,,,
StefanoLuminari,5/31/2014 14:57,1,0,# ASCO14 conclusions from romulus study @ lymphomahubpic.twitter.com/gdK3bVLCFG,,@,#,4.72814E+17,https://twitter.com/StefanoLuminari/status/472814256808030208,,,,
ConsanoScott,5/31/2014 14:57,1,3,TIL and immunotherapies. Great slide # ASCO14 pic.twitter.com/sCjibf6FTy,,,#,4.72814E+17,https://twitter.com/ConsanoScott/status/472814180269957120,,,,
CareAcross,5/31/2014 14:57,1,0,Prof. Pinedo from @VUmcAmsterdam receives this year's prestigious Karnofsky award for cancer # ASCO14 pic.twitter.com/fSq3xwkpal,,@VUmcAmsterdam,#,4.72814E+17,https://twitter.com/CareAcross/status/472814164960739328,,,,
SarahCannonDocs,5/31/2014 14:57,0,0,Next up: @ BurrisSkip's talk on ADC targeting NaPi2b in pts w/ NSCLC and ovarian cancer EHall D2 at 2:27pm # ASCO14,,@,#,4.72814E+17,https://twitter.com/SarahCannonDocs/status/472814134191722498,,,,
rsm2800,5/31/2014 14:57,0,0,"Artz: Looked at Clinical Quality Measures eCQMs; don’t have min/max values, just have to report on them # asco14",,,#,4.72814E+17,https://twitter.com/rsm2800/status/472814125270446080,,,,
JacobPlieth,5/31/2014 14:57,0,2,PhI TEAEs of recommended phII dose of JNJ-42756493 (pan-FGFR inhibitor) $ JNJ # ASCO14 pic.twitter.com/CkOlc6ujGX,,,#,4.72814E+17,https://twitter.com/JacobPlieth/status/472814116436840448,,,,
TomomiArikawa,5/31/2014 14:57,0,0,@ BCRFcure @ CliffordHudis @ ASCO HE IS AWESOME!!! YEAH!!! YEAH!!! YEAH!!!,,@ @ @,,4.72814E+17,https://twitter.com/TomomiArikawa/status/472814084703158273,,,,
AnneBooms,5/31/2014 14:57,2,1,# ASCO14 Potter's talk on Compassion Fatigue amongst HCP http://www.ncbi.nlm.nih.gov/pubmed/23448743,,,#,4.72814E+17,https://twitter.com/AnneBooms/status/472814083126083584,,,,
MaverickNY,5/31/2014 14:57,0,1,@ AlpineBV_Miller looks good in FL # asco14,,@,#,4.72814E+17,https://twitter.com/MaverickNY/status/472814022954598401,,,,
ShannonWestin,5/31/2014 14:56,0,1,Weekly paclitaxel and pazopanib in plat resist ovarian cancer sig improve PFS OS. # ASCO14 # gyncsm,,,# #,4.72814E+17,https://twitter.com/ShannonWestin/status/472813989215227904,,,,
KUhlendorf,5/31/2014 14:56,0,0,". @ UMHealthSystem's Reshma Jagsi: physicians need to be responsible stewards of health resources to maximize value, reduce waste # ASCO14",,@,#,4.72814E+17,https://twitter.com/KUhlendorf/status/472813951596900352,,,,
SJNaggiar,5/31/2014 14:56,0,0,Dr. Reshma Jagsi on the oncologist duty to society: healthcare spending crowds out other spending essential to promote health # ASCO2014,,,#,4.72814E+17,https://twitter.com/SJNaggiar/status/472813828963848192,,,,
Lymphoma_Doc,5/31/2014 14:56,1,1,"@ MaverickNY I didn't think he meant that, this was phase I with response/stability at all doses. Waterfall is impressive. # ASCO14",,@,#,4.72814E+17,https://twitter.com/Lymphoma_Doc/status/472813819237257218,,,,
hmhyltonpac,5/31/2014 14:56,1,1,Healthcare spending crowds out other spending essential to promote health-Dr. Jagsi on value in cancer care debate at # ASCO14,,,#,4.72814E+17,https://twitter.com/hmhyltonpac/status/472813798139904000,,,,
drcbsteer,5/31/2014 14:56,0,0,# ASCO14 # gyncsm Pignata- pazopanib + wkly paclitaxel improved PFS vs single agent in plat resistant EOC.,,,# #,4.72814E+17,https://twitter.com/drcbsteer/status/472813775699980288,,,,
OncNursingNews,5/31/2014 14:56,1,0,Randomized Trial Finds Caregiver Quality of Life Improves With Early Palliative Care http://ow.ly/xtEc1 # ASCO14,,,#,4.72814E+17,https://twitter.com/OncNursingNews/status/472813773498376193,,,,
dmooneymd,5/31/2014 14:55,0,0,Ctla4 antibody + pd1 therapy moves time to response into few weeks comp paired to few months for ipilumumab. # melsm # ASCO14,,,# #,4.72814E+17,https://twitter.com/dmooneymd/status/472813749313626113,,,,
AlpineBV_Miller,5/31/2014 14:55,3,3,Wow. These true CR rates are impressive in pola/pina. $ RHHBY has winners on their hands $ SGEN # ASCO14,,,#,4.72814E+17,https://twitter.com/AlpineBV_Miller/status/472813726945796096,,,,
kissyblack,5/31/2014 14:55,0,0,Help me spread the word that # cancer # innovation matters. # mliwi # asco14 http://bit.ly/1ocX2Gv,,,# # # #,4.72814E+17,https://twitter.com/kissyblack/status/472813656460124160,,,,
rsm2800,5/31/2014 14:55,0,0,"Warner: Lack of data structure is not necessarily an impediment, if you use NLP, but all data can be noisy # ASCO14",,,#,4.72814E+17,https://twitter.com/rsm2800/status/472813648897781760,,,,
mtmdphd,5/31/2014 14:55,0,1,"Warner # ASCO14 EHR - Slicing"" the data to increase insight pic.twitter.com/ho91aLszqL""",,,#,4.72814E+17,https://twitter.com/mtmdphd/status/472813635891240960,,,,
BCRFcure,5/31/2014 14:55,2,3,Congrats to @ cliffordhudis for his wonderful @ asco address today! So proud of his leadership & vision in the # science community. # ASCO2014,,@ @,# #,4.72814E+17,https://twitter.com/BCRFcure/status/472813605982060544,,,,
EthanBasch1,5/31/2014 14:55,0,0,Rise in US health care costs as % GDP far exceeds other Western nations. Value session. # ASCO14,,,#,4.72814E+17,https://twitter.com/EthanBasch1/status/472813603829997568,,,,
KoontzOncology,5/31/2014 14:55,0,0,# ASCO14 http://tinyurl.com/m2wcy2b It's not just txs that affect outcomes of pedi cancer survivors - genes important toopic.twitter.com/eeBruLeKME,,,#,4.72814E+17,https://twitter.com/KoontzOncology/status/472813587090919424,,,,
eaonc,5/31/2014 14:55,2,1,Prep for 6/1 plenary # ASCO2014: Read early E3805 results-new treatment extends life in men w adv prostate ca # eaonc http://ow.ly/xtE61,,,# #,4.72814E+17,https://twitter.com/eaonc/status/472813568170409984,,,,
Roche,5/31/2014 14:55,2,2,We're committed to ensuring that data publications are of high-quality & meet the medical community's needs. # ASCO14 http://ow.ly/xoONe,,,#,4.72814E+17,https://twitter.com/Roche/status/472813551883931648,,,,
Sorena997,5/31/2014 14:54,1,1,Use natural language processing ( # NLP) to extract stage from unstructured sources # ASCO14,,,# #,4.72813E+17,https://twitter.com/Sorena997/status/472813448594997249,,,,
TawnyaBowles,5/31/2014 14:54,2,0,Dr. Hauschild: BRAFi + MEKi = high response rates in metastatic # Melanoma; overall survival data immature. # ASCO14,,,# #,4.72813E+17,https://twitter.com/TawnyaBowles/status/472813430139654145,,,,
StefanoLuminari,5/31/2014 14:54,1,0,"# ASCO14 results of ROMULUS ph IIRnd trial with anti CD22 or CD79b, and Rituximab in FL and DLBCL. p. neurop. gr >=2 observed at high rates",,,#,4.72813E+17,https://twitter.com/StefanoLuminari/status/472813405351329792,,,,
BeBrightPink,5/31/2014 14:53,2,1,Come visit us at the # PatientAdvocacyBooth if you are attending # ASCO14 # Outreach # BreastCancer # OvarianCancer,,,# # # # #,4.72813E+17,https://twitter.com/BeBrightPink/status/472813185083658240,,,,
AlpineBV_Miller,5/31/2014 14:53,0,0,Neutropenia in pina/polo was rarely (4%) febrile. Most pts had perip neuropathy at entry. Seems worse in FL than DLBCL. # ASCO14,,,#,4.72813E+17,https://twitter.com/AlpineBV_Miller/status/472813038543048704,,,,
DoctorEdny,5/31/2014 14:53,2,3,$ RDRX RDRX-101 next gen kinase inhibitor PI shows no DLT ; PRs in adv neuroblastoma and mCRC # ASCO14 pic.twitter.com/OSy5zfLG2K,,,#,4.72813E+17,https://twitter.com/DoctorEdny/status/472813035787419649,,,,
dmooneymd,5/31/2014 14:53,2,0,Key for decision of frontline therapy...time to response (favors Braf/mek) vs durability of response (favors immunotherapy) # melsm # ASCO14,,,# #,4.72813E+17,https://twitter.com/dmooneymd/status/472813025678725121,,,,
subatomicdoc,5/31/2014 14:53,4,1,Recurrent glioblastoma: Does the timing of bevacizumab treatment impact survival? http://abstracts.asco.org/144/AbstView_144_127593.html … # ASCO14 # btsm,,,# #,4.72813E+17,https://twitter.com/subatomicdoc/status/472813012920041473,,,,
rsm2800,5/31/2014 14:52,2,1,Warner: Use natural language processing (NLP) to extract stage from unstructured sources; they could calc stage in 96% at Vandy # asco14,,,#,4.72813E+17,https://twitter.com/rsm2800/status/472812881692471296,,,,
TylerWhisman,5/31/2014 14:52,5,0,Hauschild: BRAF+MEKi appear most effective when used as first line. My question is whether inc benefit justifies double cost? # ASCO14,,,#,4.72813E+17,https://twitter.com/TylerWhisman/status/472812875061686273,,,,
aftimosp,5/31/2014 14:52,1,0,C. Denkert: Immune mRNAs and H and E identification of TILs provide the same information # BreastCancer # ASCO14,,,# #,4.72813E+17,https://twitter.com/aftimosp/status/472812797634420736,,,,
nycdoc29,5/31/2014 14:51,1,0,# ASCO14 - Denkert PDL1 may not play same prognostic role in BC they way they maybe used in melanoma or NSCLC.,,,#,4.72813E+17,https://twitter.com/nycdoc29/status/472812729032798209,,,,
Sorena997,5/31/2014 14:51,1,1,Preference-based screening materials improved colon cancer screening rates in African Americans # ASCO14.,,,#,4.72813E+17,https://twitter.com/Sorena997/status/472812719570436096,,,,
MarcoLDavila,5/31/2014 14:51,0,0,Expression of immune suppressive markers correlated with pCR after neoadjuvant chemo for br cancer. # ASCO14 http://tinyurl.com/prk7dou,,,#,4.72813E+17,https://twitter.com/MarcoLDavila/status/472812671960891392,,,,
mtmdphd,5/31/2014 14:51,0,0,Artz # ASCO14 # EHR - How to make MU in EHRs more meaningful - Stage ambiguity in clinical documents - common issue...,,,# #,4.72813E+17,https://twitter.com/mtmdphd/status/472812650187870208,,,,
dmooneymd,5/31/2014 14:51,0,0,We already know frontline dabrafenib + trametinib with hr 0.75 c/t dabrafenib + placebo. Only 1 mo pfs. Combi d trial. # melsm # ASCO14,,,# #,4.72813E+17,https://twitter.com/dmooneymd/status/472812641769885697,,,,
KLCampbellPhD,5/31/2014 14:51,0,0,Young rural women in the US meeting what they think are mammography screening guidelines; going annually # ASCO14.,,,#,4.72813E+17,https://twitter.com/KLCampbellPhD/status/472812625621839872,,,,
DrSherifMorgan,5/31/2014 14:51,0,0,RT @ ipaulmampilly: # ASCO14 kickstarter for med research http://consano.org pic.twitter.com/0dBfY2gpwi,,@,#,4.72813E+17,https://twitter.com/DrSherifMorgan/status/472812577383514112,,,,
PhRMA,5/31/2014 14:51,5,2,Research and # innovation has led to increased survival rates for # cancer patients http://bit.ly/1nAxDqP # ASCO14,,,# # #,4.72813E+17,https://twitter.com/PhRMA/status/472812555585331201,,,,
KoontzOncology,5/31/2014 14:51,2,0,# ASCO14 http://tinyurl.com/m2wcy2b Childhood cancer survivors have significant risks for cardiac complicationspic.twitter.com/rhYhL7Y0M5,,,#,4.72813E+17,https://twitter.com/KoontzOncology/status/472812522064855041,,,,
mtmdphd,5/31/2014 14:51,0,1,Artz # ASCO14 # EHR - How to make MU in EHRs more meaningful - Staging the Vanderbilt Lung SNaPshot Cohort # lcsmpic.twitter.com/UMYYym4IOp,,,# # #,4.72813E+17,https://twitter.com/mtmdphd/status/472812520927809537,,,,
rsm2800,5/31/2014 14:51,2,0,Warner: Only 10% of patients in U.S. have tumor stage entered in structured format. Sad # ASCO14,,,#,4.72813E+17,https://twitter.com/rsm2800/status/472812516620259328,,,,
elaineleung,5/31/2014 14:51,0,0,Breaking the taboo of mife! RT @ subatomicdoc: Treatment of multiple IC # meningioma w/ mifepristone (RU486) http://bit.ly/SdJbBV # ASCO14,,@,# #,4.72813E+17,https://twitter.com/elaineleung/status/472812507628048384,,,,
aftimosp,5/31/2014 14:50,0,0,"C. Denkert: Paradoxically, immune suppressors expression also linked to higher rates of pCR in Geparsixto # BreastCancer # ASCO14",,,# #,4.72812E+17,https://twitter.com/aftimosp/status/472812452183154689,,,,
AlpineBV_Miller,5/31/2014 14:50,0,0,These pima/pomo pts are really refractory. # ASCO14 $ RHHBY $ SGEN,,,#,4.72812E+17,https://twitter.com/AlpineBV_Miller/status/472812438287835136,,,,
ShannonWestin,5/31/2014 14:50,1,1,Gourley- immune subgroup of ovarian cancer has inferior PFS when Rx with Bevacizumab. Developing a response signature. # ASCO14 # gyncsm,,,# #,4.72812E+17,https://twitter.com/ShannonWestin/status/472812358503374848,,,,
CancerDotNet,5/31/2014 14:50,4,2,The basics of targeted therapy for # cancer: http://bit.ly/U3HpVk # ASCO14,,,# #,4.72812E+17,https://twitter.com/CancerDotNet/status/472812342783537152,,,,
medbiomarketing,5/31/2014 14:50,0,0,"RT @ dmooneymd Oncogenic driver: can we identify? 10-20 actionable drivers, most are <10% of patients, clinical results suboptimal # ASCO14"",,@,#,472812305793945600""",https://twitter.com/medbiomarketing/status/472812305793945600,,,,,,,,
mtmdphd,5/31/2014 14:50,1,0,Artz # ASCO14 # EHR - How to make MU in EHRs more meaningful - Big Data iceberg - structured data is the tip / unstructured data below surface,,,# #,4.72812E+17,https://twitter.com/mtmdphd/status/472812294498304000,,,,
rsm2800,5/31/2014 14:50,0,1,"Warner: Big data iceberg- visible data are structured; vast amt of data under the water unstructured,includes PDFs, text documents # asco14",,,#,4.72812E+17,https://twitter.com/rsm2800/status/472812289876189184,,,,
drcbsteer,5/31/2014 14:50,0,0,"# ASCO14 # gyncsm non-immune"" genetic signature highgrade serous EOC patients-more angiogenesis genes activated; trend toward Bev sensitivity""",,,# #,4.72812E+17,https://twitter.com/drcbsteer/status/472812275490107392,,,,
subatomicdoc,5/31/2014 14:50,7,1,Successful treatment of multiple intracranial # meningioma with mifepristone (RU486) http://bit.ly/SdJbBV # ASCO14 # btsm,,,# # #,4.72812E+17,https://twitter.com/subatomicdoc/status/472812262588420097,,,,
Globeathon,5/31/2014 14:49,3,1,Ovarian cancer news from # ASCO14 RT @ CancerDotNet: study about new drug combo for recurrent ovarian cancer http://bit.ly/1u1zvYY,,@,#,4.72812E+17,https://twitter.com/Globeathon/status/472812221966213120,,,,
FierceBiotech,5/31/2014 14:49,6,1,Roche partners with Roche on 'breakthrough' PD-L1 cancer program http://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 … by @ JohnCFierce # ASCO14,,@,#,4.72812E+17,https://twitter.com/FierceBiotech/status/472812156610543616,,,,
mtmdphd,5/31/2014 14:49,2,0,Artz # ASCO14 # EHR - How to make MU in EHRs more meaningful - natural language processing (NLP) can help...,,,# #,4.72812E+17,https://twitter.com/mtmdphd/status/472812115699331072,,,,
christinemphmd,5/31/2014 14:49,0,0,"# BRAFi high response rates, but few confirmed lasting CRs. Only drugs with very quick responses & proven benefit in # QoL # melanoma # ASCO14",,,# # # #,4.72812E+17,https://twitter.com/christinemphmd/status/472812028328169472,,,,
aftimosp,5/31/2014 14:49,0,0,C. denkert: Immune markers were linked to increased pCR rates in GEPARSIXTO # ASCO14 # BreastCancer,,,# #,4.72812E+17,https://twitter.com/aftimosp/status/472812027597959168,,,,
neulpt,5/31/2014 14:49,2,0,Preoperative chemotherapy as a new strategy of treatment for low-grade gliomas in eloquent areas: # ASCO14 . Why didn't I think of that?,,,#,4.72812E+17,https://twitter.com/neulpt/status/472812019746234370,,,,
levinemd,5/31/2014 14:49,2,3,# ASCO14 Re-analysis of ICON-7 OV CA data suggests that bevacizumab is associated with a worse outcome among tumors with immunophenotype,,,#,4.72812E+17,https://twitter.com/levinemd/status/472812013518094336,,,,
BladderCancerUS,5/31/2014 14:48,1,1,Come visit BCAN's booth at # ASCO14 patient advocacy pavilion. Thanks Rosie & Cynthia for volunteering! pic.twitter.com/34q0En8Eqa,,,#,4.72812E+17,https://twitter.com/BladderCancerUS/status/472811917682425856,,,,
KLCampbellPhD,5/31/2014 14:48,1,0,Preference-based screening materials improved colon cancer screening rates in African Americans # ASCO14.,,,#,4.72812E+17,https://twitter.com/KLCampbellPhD/status/472811846445957121,,,,
dmooneymd,5/31/2014 14:48,1,0,"Brain Mets: break mb trial. Dabrafenib only with 40% orr, 80% cns control. Few confirmed long lasting cr. New standard of care. # ASCO14",,,#,4.72812E+17,https://twitter.com/dmooneymd/status/472811820726497280,,,,
ASCOPost,5/31/2014 14:48,13,7,"Patients With Metastatic Colon Cancer Respond to New Combination Therapy, Phase IB Study Shows http://ow.ly/xtDKj # ASCO14 # crcsm",,,# #,4.72812E+17,https://twitter.com/ASCOPost/status/472811799969292288,,,,
eaonc,5/31/2014 14:48,0,0,"Here's a helpful guide to ECOG-ACRIN and PrECOG, LLC presence at # ASCO2014. http://ow.ly/xtDKU",,,#,4.72812E+17,https://twitter.com/eaonc/status/472811796387360768,,,,
KUhlendorf,5/31/2014 14:47,0,0,We need to revisit the distinction of statistical significance and clinical importance in # cancer - @ UCCancerCenter's Sulmasy # ASCO14,,@,# #,4.72812E+17,https://twitter.com/KUhlendorf/status/472811686869889025,,,,
aftimosp,5/31/2014 14:47,1,0,LpBC = lymphocyte-predominant # BreastCancer # ASCO14,,,# #,4.72812E+17,https://twitter.com/aftimosp/status/472811669752537088,,,,
WinshipAtEmory,5/31/2014 14:47,3,1,Dr Rathi Pillai in front of her poster on HER2 mutations in lung adenocarcinoma # ASCO14 pic.twitter.com/3K2PdcpfCr,,,#,4.72812E+17,https://twitter.com/WinshipAtEmory/status/472811652664946688,,,,
KoontzOncology,5/31/2014 14:47,0,0,# ASCO14 http://tinyurl.com/m2wcy2b 21% risk of developing a secondary cancer at 30 years of survival after pedi cancerpic.twitter.com/hMS7AexzOK,,,#,4.72812E+17,https://twitter.com/KoontzOncology/status/472811504769974273,,,,
mtmdphd,5/31/2014 14:46,1,0,# EAOnc E1308 HPV+ head and neck cancer may benefit from lower dose of radiation. http://ow.ly/xtDls # hncsm # ASCO14 HT @ EAOnc,,@,# # #,4.72811E+17,https://twitter.com/mtmdphd/status/472811358866509824,,,,
eaonc,5/31/2014 14:46,1,1,Coming up 3PM # ASCO14: Breast Ca. K Miller E5103 results. Her2/ER oral abstract session @ eaonc # eaonc # ALLIANCE_org # SWOGonc # nrgoncology,,@,# # # # #,4.72811E+17,https://twitter.com/eaonc/status/472811246539264000,,,,
dmooneymd,5/31/2014 14:45,0,0,"Break3 trial...pt cross over to dabrafenib if progressed on the dtic. OS 18.2m vs 15.6m, ns. Braf active 1st and 2nd line. # melsm # ASCO14",,,# #,4.72811E+17,https://twitter.com/dmooneymd/status/472811225823182849,,,,
EthanBasch1,5/31/2014 14:45,1,0,Daniel Sulmasy in Value session: physician bedside rationing (considering cost in decisions for individual patients) is unethical # ASCO14,,,#,4.72811E+17,https://twitter.com/EthanBasch1/status/472811189810900992,,,,
rsm2800,5/31/2014 14:45,1,0,"At EHR session w/ Drs. Warner, Yu, Artz # asco14",,,#,4.72811E+17,https://twitter.com/rsm2800/status/472811164884156418,,,,
drcbsteer,5/31/2014 14:45,0,0,"# ASCO14 # gyncsm 1st line EOC immune"" genetic signature patients had worse PFS when given bevacizumab (in combination with chemo)""",,,# #,4.72811E+17,https://twitter.com/drcbsteer/status/472811138875682818,,,,
theABTA,5/31/2014 14:45,1,1,Quality of life & financial burden being positioned as important components of extending lives at # ASCO14. Big impact on patients & families,,,#,4.72811E+17,https://twitter.com/theABTA/status/472811129622650880,,,,
Groz_P,5/31/2014 14:45,0,0,@ AdamsLisa (you are in this):“ @ NiklasSavander: excellent viewpoint on patient perspective by Dr Blum http://bit.ly/1mVJfRE # ASCO14””,,@ @,#,4.72811E+17,https://twitter.com/Groz_P/status/472811071435440128,,,,
khnguyen,5/31/2014 14:45,0,0,"Promising phase I data on anti-FGFR drugs, but still very early. We need better drugs soon for squamous lung cancer. # ASCO14",,,#,4.72811E+17,https://twitter.com/khnguyen/status/472811025168097280,,,,
hgazay,5/31/2014 14:45,0,0,At # asco14 chicago - immunotherapies and the future of oncology,,,#,4.72811E+17,https://twitter.com/hgazay/status/472811021556408320,,,,
hmhyltonpac,5/31/2014 14:45,3,0,We should practice the art of medicine with therapeutic parsimony and diagnostic elegance-Dr. Sulmany at # ASCO14 cancer care value debate,,,#,4.72811E+17,https://twitter.com/hmhyltonpac/status/472811012140589056,,,,
jrgralow,5/31/2014 14:45,4,1,"National Cancer Survivor's Day is Sunday, June 1st. http://ow.ly/xtDxX # ASCO14",,,#,4.72811E+17,https://twitter.com/jrgralow/status/472811006528585728,,,,
GEORM_SEOR,5/31/2014 14:44,0,0,Practice Changing: Goserelin Preserves Fertility During Breast Cancer Chemo http://bit.ly/1hK7Xjr # ASCO14,,,#,4.72811E+17,https://twitter.com/GEORM_SEOR/status/472810943593086976,,,,
Monthy_A,5/31/2014 14:44,0,1,Practice Changing: Goserelin Preserves Fertility During Breast Cancer Chemo http://bit.ly/1hK7Xjr # ASCO14,,,#,4.72811E+17,https://twitter.com/Monthy_A/status/472810943572107265,,,,
SEOR3,5/31/2014 14:44,0,0,Practice Changing: Goserelin Preserves Fertility During Breast Cancer Chemo http://bit.ly/1hK7Xjr # ASCO14,,,#,4.72811E+17,https://twitter.com/SEOR3/status/472810943383347201,,,,
Oncoangel,5/31/2014 14:44,0,0,Practice Changing: Goserelin Preserves Fertility During Breast Cancer Chemo http://bit.ly/1hK7Xjr # ASCO14,,,#,4.72811E+17,https://twitter.com/Oncoangel/status/472810943295279104,,,,
KUhlendorf,5/31/2014 14:44,0,0,". @ UCCancerCenter' Sulmasy could get his point across without using the term bedside rationing"". Too politically charged. # ASCO14""",,@,#,4.72811E+17,https://twitter.com/KUhlendorf/status/472810919635218432,,,,
AlpineBV_Miller,5/31/2014 14:44,0,0,One thing about @ ASCO meetings was their ability to stay on time. Not so much for # ASCO14 Maybe the chairs & presenters need a reminder.,,@,#,4.72811E+17,https://twitter.com/AlpineBV_Miller/status/472810769667874817,,,,
Pathologists,5/31/2014 14:44,2,1,"RT @ hmhyltonpac: Dr. Emanuel @ # ASCO14: take solutions to Washington. IMHO, ASCO's payment reform model is a step in this direction.",,@ @,#,4.72811E+17,https://twitter.com/Pathologists/status/472810743734079488,,,,
mtmdphd,5/31/2014 14:43,0,1,A Rapid Learning System Prototype - YouTube http://ow.ly/uFdPW # CancerLinQ @ ASCO,,@,#,4.72811E+17,https://twitter.com/mtmdphd/status/472810529342234625,,,,
dmooneymd,5/31/2014 14:43,1,0,Compare to zelboraf....orr 57%. Fast acting...symptom relief in 1-2 weeks. Although not durable. # melsm # ASCO14,,,# #,4.72811E+17,https://twitter.com/dmooneymd/status/472810502037323776,,,,
myPathMelanoma,5/31/2014 14:43,2,0,Myriad myPath # Melanoma a 23-gene expression signature by qPCR for objective diagnostic info # melanomadiagnostic # isthismelanoma # ASCO14,,,# # # #,4.7281E+17,https://twitter.com/myPathMelanoma/status/472810492893749248,,,,
ConsanoScott,5/31/2014 14:42,1,1,Tumor-infiltrating lymphocyte presence in breast cancer = improved chemo response and improved prognosis # asco14,,,#,4.7281E+17,https://twitter.com/ConsanoScott/status/472810446287024129,,,,
SuruchiD,5/31/2014 14:42,0,0,“ @ Roche: What goes into the design of a clinical study? http://ow.ly/xoNUJ # ASCO14 # lifescience”,,@,# #,4.7281E+17,https://twitter.com/SuruchiD/status/472810434181857281,,,,
PCRCGroup,5/31/2014 14:42,1,0,Jean Kutner on medication discontinuation as new line of # research; improving QoL while reducing costs: http://ow.ly/xtcqM # ASCO14 # hpm,,,# # #,4.7281E+17,https://twitter.com/PCRCGroup/status/472810427337179136,,,,
KUhlendorf,5/31/2014 14:42,2,0,. @ UCCancerCenter's Sulmasy at # ASCO14: patients need to trust that # oncologists act in their best interests,,@,# #,4.7281E+17,https://twitter.com/KUhlendorf/status/472810399235338241,,,,
NiklasSavander,5/31/2014 14:42,1,0,excellent viewpoint on patient perspective by Dr Blum http://bit.ly/1mVJfRE # ASCO14”,,,#,4.7281E+17,https://twitter.com/NiklasSavander/status/472810376393162752,,,,
MarcoLDavila,5/31/2014 14:42,0,2,# ASCO14 http://tinyurl.com/ph88pxv . Can CAR T cells be used for Breast cancer patients not responsive to trastuzumab?pic.twitter.com/WlGXyvoSEL,,,#,4.7281E+17,https://twitter.com/MarcoLDavila/status/472810329676992512,,,,
mtmdphd,5/31/2014 14:42,2,1,"Shoppers have Amazon. Students have Google. Oncologists will have CancerLinQ"" - @ CNN http://ow.ly/uvol0 @ ASCO""",,@ @,,4.7281E+17,https://twitter.com/mtmdphd/status/472810305668411392,,,,
emilygest,5/31/2014 14:42,0,0,Congrats to Dr Robison from @ StJudeResearch for his award at # ASCO14! Thank you for your contributions to survivorship research.,,@,#,4.7281E+17,https://twitter.com/emilygest/status/472810248307093504,,,,
cityofhope,5/31/2014 14:42,5,6,"a two drug combo can boost # OvarianCancer survival, according to new research presented at # ASCO14 http://breakthroughs.cityofhope.org/asco-2014-drug-ovarian-cancer … @ ASCO",,@,# #,4.7281E+17,https://twitter.com/cityofhope/status/472810245907939328,,,,
ClevelandClinic,5/31/2014 14:42,150,52,"“In 10 years, we won’t say breast cancer or colon cancer. We’ll ID cancer types by # genetics” - J. Vose # ASCO14",,,# #,4.7281E+17,https://twitter.com/ClevelandClinic/status/472810240539635712,,,,
davidgrahammd,5/31/2014 14:41,0,0,Most impressive sign of ease and low cost of genome analysis? Walk the exhibit floor # ASCO14,,,#,4.7281E+17,https://twitter.com/davidgrahammd/status/472810196587536384,,,,
fischmd,5/31/2014 14:41,4,2,"Why does @ ASCO bother with Facebook, Twitter? FB has 1.28 billion monthly users, Twitter with 255 million http://ow.ly/xtDgp # ASCO14",,@,#,4.7281E+17,https://twitter.com/fischmd/status/472810186823184385,,,,
hmhyltonpac,5/31/2014 14:41,7,6,The true value of healthcare is not measured in dollars but in the dignity of the patient-Dr. Sulmany at # ASCO14 cancer care value debate,,,#,4.7281E+17,https://twitter.com/hmhyltonpac/status/472810161565106176,,,,
DoctorEdny,5/31/2014 14:41,0,1,$ JNJ JNJ-42756493 panFGFR inhibitor PI data in adv tumors # ASCO14 pic.twitter.com/3E5JLwzE3r,,,#,4.7281E+17,https://twitter.com/DoctorEdny/status/472810152635412480,,,,
UCCancerCenter,5/31/2014 14:41,0,1,Manish Sharma showed that UGT1A1 genotype determines sensitivity of advanced GI patients to mFOLFIRINOX # ASCO14 pic.twitter.com/eCOT4cuqsr,,,#,4.7281E+17,https://twitter.com/UCCancerCenter/status/472810129428332545,,,,
DrAttai,5/31/2014 14:41,1,2,Dr. Denkert - expression of immune genes in TNBC # ASCO14 # bcsm,,,# #,4.7281E+17,https://twitter.com/DrAttai/status/472810122478366720,,,,
PCRCGroup,5/31/2014 14:41,0,0,Media coverage of statin discontinuation trial results. Important implications for clinical practice! http://ow.ly/xtaaR # hpm # ASCO14,,,# #,4.7281E+17,https://twitter.com/PCRCGroup/status/472810033768841217,,,,
dmooneymd,5/31/2014 14:41,0,0,Interleukin 2 with orr 15% and durable cr 5%. Never tested prospectively. # melsm # ASCO14,,,# #,4.7281E+17,https://twitter.com/dmooneymd/status/472810017230311424,,,,
BarringtonJNC,5/31/2014 14:41,3,2,If you find the English accent terribly charming.Come and visit the Barrington James boys@PabloOldfield @ dansbarrington booth 2006 # ASCO14,,@PabloOldfield @,#,4.7281E+17,https://twitter.com/BarringtonJNC/status/472810003745632257,,,,
MaverickNY,5/31/2014 14:41,0,0,Owen O'Connor is scolding the selinexor researchers for treating with sub therapeutic and suboptimal doses # asco14 ouch,,,#,4.7281E+17,https://twitter.com/MaverickNY/status/472809993679695872,,,,
TawnyaBowles,5/31/2014 14:40,0,0,Dr. Chapman: Next generation tumor sequencing examines >1 billion DNA molecules. Costly. # Melanoma # ASCO14,,,# #,4.7281E+17,https://twitter.com/TawnyaBowles/status/472809984820920321,,,,
OncologyTimes,5/31/2014 14:40,7,5,"MT @ sfuldnasso: Daniel Sulmasy, in 1of few presentations w/o slides, bc believes Power corrupts","& PowerPoint corrupts absolutely"" # ASCO14""",,@,#,4.7281E+17,https://twitter.com/OncologyTimes/status/472809984636772352,,,
WinshipAtEmory,5/31/2014 14:40,1,2,"Madhusmita Behera, PhD, looked at trends in small cell lung cancer survival # ASCO14 pic.twitter.com/cBW0se4plK",,,#,4.7281E+17,https://twitter.com/WinshipAtEmory/status/472809913098711040,,,,
aftimosp,5/31/2014 14:40,0,2,Sherene Loi introducing the PANACeA trial with the combination of anti-PD1 therapy and trastuzumab in HER2 positive # BreastCancer # ASCO14,,,# #,4.7281E+17,https://twitter.com/aftimosp/status/472809842386542592,,,,
CancerDotNet,5/31/2014 14:40,2,2,Advocates: Research Review Session w/ Dr. Patricia Ganz today at 5:30pm CT in the Adv Lounge S402 # ASCO14,,,#,4.7281E+17,https://twitter.com/CancerDotNet/status/472809823713898497,,,,
ProjectInno,5/31/2014 14:40,0,1,"For cancer patients everywhere, we must commit to accelerating the pace of innovation http://ow.ly/xty8z http://ow.ly/i/5KF0G # ASCO14",,,#,4.7281E+17,https://twitter.com/ProjectInno/status/472809815795040256,,,,
Roche,5/31/2014 14:40,3,2,By 2020 over 70% of cancers will occur in low-/middle-income countries. Ho to overcome access hurdles? http://ow.ly/xoOhY # ASCO14...,,,#,4.7281E+17,https://twitter.com/Roche/status/472809790411145217,,,,
DrAttai,5/31/2014 14:40,1,1,"Loi - further research needed to determine clinical utility of biomarkers in breast cancer, and role immune modulation # ASCO14 # bcsm",,,# #,4.7281E+17,https://twitter.com/DrAttai/status/472809784870436864,,,,
nycdoc29,5/31/2014 14:40,0,1,"# ASCO14 - Herceptin plus anti PD-1 in Panacea Trial, wow still learning about Hereceptin and use in BC. # bcsm",,,# #,4.7281E+17,https://twitter.com/nycdoc29/status/472809764682878976,,,,
KoontzOncology,5/31/2014 14:40,0,0,# ASCO14 http://tinyurl.com/m2wcy2b Dr. Robison now reviewing the history of the Childhood Cancer Survivor Studypic.twitter.com/6NaUzawix9,,,#,4.7281E+17,https://twitter.com/KoontzOncology/status/472809743220633601,,,,
CBPartners,5/31/2014 14:39,0,0,"Packed house at the value and cancer care"" debate - physician duty to patient vs. duty to society @ ASCO""",,@,,4.7281E+17,https://twitter.com/CBPartners/status/472809673968877568,,,,
heidisa,5/31/2014 14:39,0,0,"How times have changed! # cool RT @ ASCO: Join us at today’s # ASCO14 Tweetup, 5:45PM, Level 2.5 Food Court. Details: http://bit.ly/NvNypj",,@,# #,4.7281E+17,https://twitter.com/heidisa/status/472809641337167873,,,,
BiostatGirl,5/31/2014 14:39,0,0,"And more importantly, my picture on the acknowledgement slide! # asco2014 # asco14 http://instagram.com/p/oq-vXOAzCH/",,,# #,4.7281E+17,https://twitter.com/BiostatGirl/status/472809625348493312,,,,
wendyselig,5/31/2014 14:39,1,6,"# ASCO14 speaker: 5 years ago you could hold the # melanoma meeting in a cafeteria. Today the largest rooms are packed."" @ MelanomaReAlli""",,@,# #,4.7281E+17,https://twitter.com/wendyselig/status/472809620247830528,,,,
yzafar,5/31/2014 14:39,0,0,Sulmasey: great question faced by society is how can we control costs without mitigating quality of cancer care! # ASCO14,,,#,4.7281E+17,https://twitter.com/yzafar/status/472809601499680768,,,,
mtmdphd,5/31/2014 14:39,0,1,"The Changing Face of Research in Community Practice - Zon, Bruinooge, Lyss # JOP http://ow.ly/x29SX # clinicaltrials # ASCO14",,,# # #,4.7281E+17,https://twitter.com/mtmdphd/status/472809597812498433,,,,
KUhlendorf,5/31/2014 14:39,1,0,Population # medicine cannot be practiced at bedside - @ UCCancerCenter' Sulmasy at # ASCO14 panel on value and ethics in # cancer care,,@,# # #,4.7281E+17,https://twitter.com/KUhlendorf/status/472809596885929985,,,,
PCRCGroup,5/31/2014 14:39,0,0,Video of Amy Abernethy discussing the exciting new statin discontinuation study results! http://ow.ly/xtfIq # ASCO14 # hpm # PCRCGroup,,,# # #,4.7281E+17,https://twitter.com/PCRCGroup/status/472809555785957376,,,,
aftimosp,5/31/2014 14:39,0,0,S. Loi: triple negative and HER2+ breast tumors have a higher mutational load than luminal # BreastCancer # ASCO14 # bcsm,,,# # #,4.7281E+17,https://twitter.com/aftimosp/status/472809546914594817,,,,
JohnCendpts,5/31/2014 14:38,1,0,Roche partners with Roche on 'breakthrough' PD-L1 cancer program - # ASCO14 # pharmahttp://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 …,,,# #,4.72809E+17,https://twitter.com/JohnCendpts/status/472809470780006401,,,,
davidgrahammd,5/31/2014 14:38,4,1,12 centers have volunteered to provide data for CancerLinQ...moving ahead @ YupOnc # ASCO14,,@,#,4.72809E+17,https://twitter.com/davidgrahammd/status/472809437703708676,,,,
DrAttai,5/31/2014 14:38,1,3,Loi - really cool video of tumor cells being attacked by Tcells # ASCO14 # bcsm,,,# #,4.72809E+17,https://twitter.com/DrAttai/status/472809425280172033,,,,
SethBla,5/31/2014 14:38,11,2,"@ ASCO RT The Patient Perspective on Value in # Cancer Care http://bit.ly/1mVJfRE # ASCO14"" great piece focusing on ""value"" of treatments""",,@,# #,4.72809E+17,https://twitter.com/SethBla/status/472809406556831744,,,,
dmooneymd,5/31/2014 14:38,0,0,Dr. Hauschild: frontline approaches to # melanoma. No cytotoxic chemotherapy! # ASCO14 # melsm,,,# # #,4.72809E+17,https://twitter.com/dmooneymd/status/472809366597283840,,,,
MediTech_Media,5/31/2014 14:38,0,0,Combining gene expression data w conventional histopathology improves accuracy of idenifying primary site. Mileshkin et al. # asco14,,,#,4.72809E+17,https://twitter.com/MediTech_Media/status/472809309013676032,,,,
StefanoLuminari,5/31/2014 14:38,0,1,# ASCO14 slide on SINEs pic.twitter.com/g600YsObah,,,#,4.72809E+17,https://twitter.com/StefanoLuminari/status/472809274725638144,,,,
mtmdphd,5/31/2014 14:37,4,1,"The use of social media has become an increasingly important topic among oncologists..."" http://ow.ly/wTsOU # ASCO14""",,,#,4.72809E+17,https://twitter.com/mtmdphd/status/472809222342594560,,,,
aftimosp,5/31/2014 14:37,0,0,S. Loi: Melanoma and NSCLC have a high mutational load and seem highly responsive to immunotherapy: mutations-antigens correlation? # ASCO14,,,#,4.72809E+17,https://twitter.com/aftimosp/status/472809097666887680,,,,
ConsanoScott,5/31/2014 14:37,0,0,High mutational load seen in melanoma and NSCLC ->More responsive to immune-mediated therapies. # ASCO14,,,#,4.72809E+17,https://twitter.com/ConsanoScott/status/472809087412207616,,,,
KUhlendorf,5/31/2014 14:36,0,0,"Art of # medicine involves application of scientific knowledge to care of individual # patient, @ UCCancerCenter's Daniel Sulmasy # ASCO14",,@,# # #,4.72809E+17,https://twitter.com/KUhlendorf/status/472808942553542656,,,,
DrAttai,5/31/2014 14:36,1,0,"Loi - tumors with high mutational load - mutations may act as neoAntigens"" to elicit immune response # ASCO14 # bcsm""",,,# #,4.72809E+17,https://twitter.com/DrAttai/status/472808938938060800,,,,
AndyBiotech,5/31/2014 14:36,2,6,"$ KPTI Provides Data Update for Selinexor # ASCO14 http://investors.karyopharm.com/releasedetail.cfm?ReleaseID=851593 … NHL: 28% ORR, 5% CR AML: 16% ORR, 11% CR/CRipic.twitter.com/aLcH4PHfBQ",,,#,4.72809E+17,https://twitter.com/AndyBiotech/status/472808809619288064,,,,
wendyselig,5/31/2014 14:36,0,0,. @ melanomarealli Medical Advisory Panel Chair Paul Chapman describing sequencing technologies for # melanoma at # ASCO14,,@,# #,4.72809E+17,https://twitter.com/wendyselig/status/472808774474821632,,,,
SJNaggiar,5/31/2014 14:36,0,0,Dr. Daniel Sulmasy: the art of medicine is the application of scientific knowledge to the individual patient # ASCO2014,,,#,4.72809E+17,https://twitter.com/SJNaggiar/status/472808760726278144,,,,
BiostatGirl,5/31/2014 14:35,0,0,14-gene predictive immune signature for trastuzumab... # asco2014 # asco14 @ EdithPerezMD http://instagram.com/p/oq-YLZgzBa/,,@,# #,4.72809E+17,https://twitter.com/BiostatGirl/status/472808722256117760,,,,
mtmdphd,5/31/2014 14:35,0,0,EHR CancerLinQ @ YupOnc # ASCO14 - CancerLinQ used to evaluate ESA use after FDA changes... rapid,,@,#,4.72809E+17,https://twitter.com/mtmdphd/status/472808689779220480,,,,
AnneBooms,5/31/2014 14:35,0,0,"# ASCO14: Anthony Back onPhysician Resilience: What It Means, Why It Matters, and Ho... : Academic Medicine http://journals.lww.com/academicmedicine/Fulltext/2013/03000/Physician_Resilience___What_It_Means,_Why_It.12.aspx …",,,#,4.72809E+17,https://twitter.com/AnneBooms/status/472808606824288256,,,,
DrBobGoldberg,5/31/2014 14:35,4,1,@ asco spreading lies about cost of cancer .. Here's the facts pic.twitter.com/SDnrdzynKF,,@,,4.72809E+17,https://twitter.com/DrBobGoldberg/status/472808589829353472,,,,
heidisa,5/31/2014 14:35,0,0,Discuss! RT @ yzafar: Debate in value session: is our responsibility to patient or society? Fascinating! # ASCO14 http://ow.ly/3ld9E1,,@,#,4.72809E+17,https://twitter.com/heidisa/status/472808584053788673,,,,
StefanoLuminari,5/31/2014 14:35,2,0,# ASCO14 o'connors summary slide about exportins @ lymphomahubpic.twitter.com/cj8HcpJc57,,@,#,4.72808E+17,https://twitter.com/StefanoLuminari/status/472808491091238915,,,,
mtmdphd,5/31/2014 14:35,0,0,EHR CancerLinQ @ YupOnc # ASCO14 - Prototype - 170K # bcsm datapic.twitter.com/aLtqH4PT13,,@,# #,4.72808E+17,https://twitter.com/mtmdphd/status/472808486460325888,,,,
WinshipAtEmory,5/31/2014 14:34,1,1,Dr Conor Steuer of Winship presents outcomes of a study on AC tumors of the lung at # ASCO14 pic.twitter.com/dXOPShGGFk,,,#,4.72808E+17,https://twitter.com/WinshipAtEmory/status/472808474897047553,,,,
FightCRC,5/31/2014 14:34,1,0,Love watching crowded poster sessions at # ASCO14 pic.twitter.com/NarBTxGzlP,,,#,4.72808E+17,https://twitter.com/FightCRC/status/472808454017396737,,,,
sfuldnasso,5/31/2014 14:34,0,1,"Dr. Sulmasy, in one of the few presentations without slides: Power corrupts, and PowerPoint corrupts absolutely. # ASCO14",,,#,4.72808E+17,https://twitter.com/sfuldnasso/status/472808321007644672,,,,
GustaveRoussy,5/31/2014 14:34,1,0,# ASCO2014 @rastilavbahleda @ gustaveroussy now presenting results of early clinical trial evaluating an FGFR inhibitorpic.twitter.com/P5Fa6d141n,,@rastilavbahleda @,#,4.72808E+17,https://twitter.com/GustaveRoussy/status/472808270345019392,,,,
DrAttai,5/31/2014 14:34,1,0,"Loi there are genes associated with relapse free survival. immune enrichment"" important in response to trastuzumab # ASCO14 # bcsm""",,,# #,4.72808E+17,https://twitter.com/DrAttai/status/472808266884739072,,,,
RemedyInformatx,5/31/2014 14:33,0,0,"Lots of great things happening in cancer research, devoted people, organizations, and companies all together at # ASCO2014",,,#,4.72808E+17,https://twitter.com/RemedyInformatx/status/472808206696448000,,,,
MedscapeOnc,5/31/2014 14:33,1,1,Dr Sulmasy from UChicago: Value is 'best directed at the bedside' # ASCO14,,,#,4.72808E+17,https://twitter.com/MedscapeOnc/status/472808188581253121,,,,
ConsanoScott,5/31/2014 14:33,0,0,Immunity is important for trastuzumab efficacy in preventing recurrence of breast cancer # asco14,,,#,4.72808E+17,https://twitter.com/ConsanoScott/status/472808154099879936,,,,
teamoncology,5/31/2014 14:33,1,1,RT @ jrgralow: Need 2 help MT @ ASCOPost: Women w/ BRCA Mutations Report Signif Side Effects after Oophorectomy http://ow.ly/xtCPP # ASCO14,,@ @,#,4.72808E+17,https://twitter.com/teamoncology/status/472808135405473792,,,,
DustinSmithPhD,5/31/2014 14:33,13,3,"So true: In 10 yrs we won't say # breastcancer or # coloncancer. We'll ID cancer types by genetics"" - J. Vose @ ASCO # Next50 # ASCO14”""",,@,# # # #,4.72808E+17,https://twitter.com/DustinSmithPhD/status/472808074999525376,,,,
jimbob_510,5/31/2014 14:33,0,0,Cool Rube Goldberg device @ SGen booth describes ADC MOA. # ASCO14 pic.twitter.com/YXyItL2CNI,,@,#,4.72808E+17,https://twitter.com/jimbob_510/status/472807978727665664,,,,
mtmdphd,5/31/2014 14:32,0,0,"EHR CancerLinQ @ YupOnc # ASCO14 - The Missing Link - shared data, learning, QI, Pts/MD, community oncology real world pic.twitter.com/NN37ms3J3U",,@,#,4.72808E+17,https://twitter.com/mtmdphd/status/472807888377765889,,,,
garyleethompson,5/31/2014 14:32,0,1,"Thrilled to know dear friend @ terriwingham in Chi at # ASCO14 Wish I was there, too. Riding 100 miles tomorrow in Tahoe for @ teamintraining",,@ @,#,4.72808E+17,https://twitter.com/garyleethompson/status/472807838168141826,,,,
jagasquet,5/31/2014 14:32,0,1,"# ASCO14 press brief: Combo of PARP inhibitor + anti-angiogenic improves # ovariancancer survival, independent of BRCA status @ ASCO",,@,# #,4.72808E+17,https://twitter.com/jagasquet/status/472807780706164736,,,,
jrgralow,5/31/2014 14:32,3,1,No surprise- need to help MT @ ASCOPost: Women w/ BRCA Mutations Report Signif Side Effects after Oophorectomy http://ow.ly/xtCPP # ASCO14,,@,#,4.72808E+17,https://twitter.com/jrgralow/status/472807777438822401,,,,
KUhlendorf,5/31/2014 14:32,0,0,. @ MassGeneral's Moy claims meds/tech acct for majority of cancer spend. Not so - meds are small portion http://onphr.ma/SbIUQd # ASCO14,,@,#,4.72808E+17,https://twitter.com/KUhlendorf/status/472807751266357248,,,,
subatomicdoc,5/31/2014 14:32,3,1,Preoperative chemo for low grade gliomas in eloquent areas: phase 2 study http://bit.ly/1mCmBxI # ASCO14 # btsm,,,# #,4.72808E+17,https://twitter.com/subatomicdoc/status/472807736095559680,,,,
jonodoc,5/31/2014 14:31,2,1,"Sulmasy: Power corrupts. PowerPoint corrupts absolutely."" Crowd chuckles and applauds. # ASCO14""",,,#,4.72808E+17,https://twitter.com/jonodoc/status/472807720404656128,,,,
MichalisLiontos,5/31/2014 14:31,0,0,Greetings to all Greek friends at # ASCO14,,,#,4.72808E+17,https://twitter.com/MichalisLiontos/status/472807700284579840,,,,
yzafar,5/31/2014 14:31,4,1,Debate in value session: is our responsibility to patient or society? Fascinating session! # ASCO14 @ ASCO pic.twitter.com/8KSvVZ1Q3Z,,@,#,4.72808E+17,https://twitter.com/yzafar/status/472807648023556097,,,,
SJNaggiar,5/31/2014 14:31,0,0,What is the value of cancer care? No consensus," depends on who you ask."" Dr. Beverly Moy on the oncologist ethical dilemma # ASCO2014""",,,#,4.72808E+17,https://twitter.com/SJNaggiar/status/472807501583613952,,,
EthanBasch1,5/31/2014 14:31,0,0,Bev Moy in Value session: do oncology providers have gatekeeper obligation to control cost? # ASCO14,,,#,4.72807E+17,https://twitter.com/EthanBasch1/status/472807499297341441,,,,
DrAttai,5/31/2014 14:31,0,0,Loi - immunity is important for trastuzumab efficacy # ASCO14 # bcsm,,,# #,4.72807E+17,https://twitter.com/DrAttai/status/472807480268161025,,,,
MR_Glick,5/31/2014 14:31,0,0,Power corrupts," and PowerPoint corrupts absolutely"" # nerdhumor # ASCO14""",,,# #,4.72807E+17,https://twitter.com/MR_Glick/status/472807473297252352,,,
mtmdphd,5/31/2014 14:30,0,1,EHR CancerLinQ @ YupOnc # ASCO14 - MU Detractors - data =/ knowledge =/ learning pic.twitter.com/yEadzPyGHV,,@,#,4.72807E+17,https://twitter.com/mtmdphd/status/472807406846496768,,,,
ASCO,5/31/2014 14:30,7,3,Dr. Shah reflects on 50 years of innovation and discovery in GI cancers: http://bit.ly/1rkqMmQ # ASCO14 # crcsm,,,# #,4.72807E+17,https://twitter.com/ASCO/status/472807403873124352,,,,
SarahCannonDocs,5/31/2014 14:30,1,1,# SCRI's @ AndyKennedyMD reviewing LINAC vs Implantation methods for liver therapies in EHall D1 right now # ASCO14 pic.twitter.com/ziFtOrr78H,,@,# #,4.72807E+17,https://twitter.com/SarahCannonDocs/status/472807395161554944,,,,
jimbob_510,5/31/2014 14:30,0,0,JC Soria discusses lucitanib Ph 1 data. Nice 3D waterfall plot that included swimlane DOT data. # ASCO14,,,#,4.72807E+17,https://twitter.com/jimbob_510/status/472807390698799105,,,,
teamoncology,5/31/2014 14:30,0,0,RT @ drattai: Dr. Loi - discussing the role of immune system in therapeutic response to Her2-directed therapy # ASCO14 # bcsm,,@,# #,4.72807E+17,https://twitter.com/teamoncology/status/472807386302787584,,,,
mayocliniclabs,5/31/2014 14:30,0,0,Visit E354b to check out our poster on gastrointestinal (colorectal) cancer. # ASCO14,,,#,4.72807E+17,https://twitter.com/mayocliniclabs/status/472807311330009088,,,,
DoctorEdny,5/31/2014 14:30,0,0,$ CLVS exploratory trial of lucitinib for fgfr1-amplified NSCLC is underway # ASCO14 pic.twitter.com/MCeaeutsCb,,,#,4.72807E+17,https://twitter.com/DoctorEdny/status/472807259480027136,,,,
pfizer,5/31/2014 14:30,6,1,Pfizer believes molecular testing for all clinically relevant biomarkers is important to patients w/ metastatic NSCLC # ASCO14,,,#,4.72807E+17,https://twitter.com/pfizer/status/472807223966851072,,,,
mtmdphd,5/31/2014 14:29,0,0,EHR CancerLinQ @ YupOnc # ASCO14 - MU stage 4 (? TBD?),,@,#,4.72807E+17,https://twitter.com/mtmdphd/status/472807182853881856,,,,
LungCancerFaces,5/31/2014 14:29,2,4,. @ ConsanoMolly @ ConsanoScott are great! @ ipaulmampilly: # ASCO14 kickstarter for med research http://consano.org pic.twitter.com/42BYC7F6h7,,@ @ @,#,4.72807E+17,https://twitter.com/LungCancerFaces/status/472807179519414272,,,,
StefanoLuminari,5/31/2014 14:29,0,0,"# asco14 Gutierrez on Selinexor, future development on richter S a DLBCL",,,#,4.72807E+17,https://twitter.com/StefanoLuminari/status/472807154026426369,,,,
DrAttai,5/31/2014 14:29,0,0,Dr. Loi - discussing the role of immune system in therapeutic response to Her2-directed therapy # ASCO14 # bcsm,,,# #,4.72807E+17,https://twitter.com/DrAttai/status/472807125945970688,,,,
NadiaSahali,5/31/2014 14:29,0,0,"@ GustaveRoussy : Chicago capitale mondiale de la cancerologie pendant 5 jours"" # ASCO14 # cancer # oncologie http://www.gustaveroussy.fr/index.php?p_m=igrinter&p_id=5764 …""",,@,# # #,4.72807E+17,https://twitter.com/NadiaSahali/status/472807096975908864,,,,
Lymphoma_Doc,5/31/2014 14:29,1,2,"Selinexor, kpt-330, inhibitor of xpo1/nuclear export, shows impressive durable activity in relapsed DLBCL, including double hit. # ASCO14",,,#,4.72807E+17,https://twitter.com/Lymphoma_Doc/status/472807096036380672,,,,
sitcancer,5/31/2014 14:29,1,0,Have you watched our NSCLC immunotherapy video? Head to booth 2047 and check it out! # ASCO14 pic.twitter.com/J5grgKsnYQ,,,#,4.72807E+17,https://twitter.com/sitcancer/status/472807067917774848,,,,
PhRMA,5/31/2014 14:29,3,1,Some said cost of # HIV/AIDS would break # healthcare system but opposite happened. It can be true for # cancer http://bit.ly/1nDaGmT # ASCO14,,,# # # #,4.72807E+17,https://twitter.com/PhRMA/status/472807034098708481,,,,
JacobPlieth,5/31/2014 14:29,1,0,"Lucitanib has indisputable clinical efficacy"""," says Dr Soria $ CLVS # ASCO14""",,,#,4.72807E+17,https://twitter.com/JacobPlieth/status/472806990709006336,,,
jrgralow,5/31/2014 14:29,0,1,Trial is such a great mode! MT @ theNCI: New Lung-MAP study relies on public-private partnerships - # ASCO14 pic.twitter.com/qfVxheieKZ,,@,#,4.72807E+17,https://twitter.com/jrgralow/status/472806983138279427,,,,
EthanBasch1,5/31/2014 14:29,0,0,Bev Moy in Value session: drug prices account for most cancer care cost (Wellpoint and United Health data) # ASCO14,,,#,4.72807E+17,https://twitter.com/EthanBasch1/status/472806969472851968,,,,
brendanweiss,5/31/2014 14:28,0,0,What does the high level of # burnout in oncologists yet high career satisfaction say about us? # ASCO14,,,# #,4.72807E+17,https://twitter.com/brendanweiss/status/472806915177979904,,,,
brianreid,5/31/2014 14:28,0,0,"Beverly Moy raising the key point on the whole value"" thing in oncology: how do you define it? # ASCO14""",,,#,4.72807E+17,https://twitter.com/brianreid/status/472806776614944768,,,,
aftimosp,5/31/2014 14:28,1,0,A 14-gene immune signature has been developed to predict the benefit of adjuvant trastuzumab # BreastCancer # ASCO14,,,# #,4.72807E+17,https://twitter.com/aftimosp/status/472806764488826880,,,,
mtmdphd,5/31/2014 14:28,0,0,EHR @ YupOnc EHR CancerLinQ # ASCO14 - Proposed delay in 2014 Meaningful Use (MU) 2 pic.twitter.com/bJnS2N2evM,,@,#,4.72807E+17,https://twitter.com/mtmdphd/status/472806726274531329,,,,
drcbsteer,5/31/2014 14:27,1,1,# ASCO14 Liu # gyncsm olaparib ORR 48% vs 80% olaparib + cedirinib in rec plat sens # ovariancancer,,,# # #,4.72807E+17,https://twitter.com/drcbsteer/status/472806698739335169,,,,
JacobPlieth,5/31/2014 14:27,1,3,Lucitanib summary $ CLVS # ASCO14 pic.twitter.com/xwsLXAlplq,,,#,4.72807E+17,https://twitter.com/JacobPlieth/status/472806666539651072,,,,
TargetedOnc,5/31/2014 14:27,2,0,Dosing Frequency of Zoledronic Acid Can Be Reduced Without Compromising Efficacy http://www.targetedonc.com/conference/asco-2014/Dosing-Frequency-of-Zoledronic-Acid-Can-Be-Reduced-Without-Compromising-Efficacy-in-Breast-Cancer … # ASCO14,,,#,4.72807E+17,https://twitter.com/TargetedOnc/status/472806662651510786,,,,
WinshipAtEmory,5/31/2014 14:27,1,0,Winship's Dr Bree Eaton lead a study looking at patient treatment at high vs low volume centers # ASCO14 pic.twitter.com/mBAW6xMqBD,,,#,4.72807E+17,https://twitter.com/WinshipAtEmory/status/472806660193656833,,,,
DoctorEdny,5/31/2014 14:27,0,1,$ CLVS Lucitinib MTD is 30mg. Expansion cohort 10-20mg. 50% PR in FGF amplified breast cancer. # ASCO14 pic.twitter.com/UHjjSpR3F8,,,#,4.72807E+17,https://twitter.com/DoctorEdny/status/472806652455170048,,,,
jrgralow,5/31/2014 14:27,0,1,Tobacco still a problem! MT @ fischmd: “In some ways obesity is tobacco of our generation.” @ ASCO President @ CliffordHudis at # ASCO14,,@ @ @,#,4.72807E+17,https://twitter.com/jrgralow/status/472806626844749824,,,,
nxtstop1,5/31/2014 14:27,0,0,@ ASCO @ sloan_kettering @ CliffordHudis Wonderful!,,@ @ @,,4.72807E+17,https://twitter.com/nxtstop1/status/472806500381913088,,,,
jagasquet,5/31/2014 14:27,2,0,Eli Lilly # LungCancer # Ramucirumab May Succeed Where # Avastin Failed. # asco14 http://www.forbes.com/sites/matthewherper/2014/05/31/eli-lilly-lung-cancer-drug-may-succeed-where-avastin-failed/ …,,,# # # #,4.72806E+17,https://twitter.com/jagasquet/status/472806492702515200,,,,
nxtstop1,5/31/2014 14:26,0,0,@ sloan_kettering @ ASCO @ CliffordHudis Thanks If You Can Get It~ Tweet Out fr. Sites~ I gather there is BiG Interest in Reading It! # ASCO14,,@ @ @,#,4.72806E+17,https://twitter.com/nxtstop1/status/472806412125351936,,,,
TawnyaBowles,5/31/2014 14:26,1,1,Dr. Chapman: Both PET and CT useful for melanoma pts. Precise tumor measurements better by CT. # ASCO14 # Melanoma,,,# #,4.72806E+17,https://twitter.com/TawnyaBowles/status/472806406639198208,,,,
yzafar,5/31/2014 14:26,2,0,Bev Moy: By 2018 50% of household budget will go towards healthcare - value of cancer care session # ASCO14,,,#,4.72806E+17,https://twitter.com/yzafar/status/472806332614340608,,,,
levinemd,5/31/2014 14:26,3,2,Joyce Liu presents at # ASCO14; a two fold benefit to olaparib/cediranib compared to olaparib alone in plainum sens recurrent OV CA,,,#,4.72806E+17,https://twitter.com/levinemd/status/472806295280824320,,,,
stuxrt,5/31/2014 14:26,1,0,Working to Change the course of the care of unresectable glioblastoma with Avastin at # LCI # ASCO14 @Carolinas pic.twitter.com/CsVxM8Fbyg,,@Carolinas,# #,4.72806E+17,https://twitter.com/stuxrt/status/472806230986354688,,,,
Lhcamacho,5/31/2014 14:25,0,0,# ASCO14 “Five-year survival rate was “49% for pts diagnosed between 1975 to 1977 and 68% for those between 2003 and 2009” @ ASCO @ ASCOPost,,@ @,#,4.72806E+17,https://twitter.com/Lhcamacho/status/472806210568470528,,,,
dmooneymd,5/31/2014 14:25,0,0,"If patient treated with braf inhibitor, ct more accurate. Braf inhibition falsely affects suv on pet. # melsm # ASCO14",,,# #,4.72806E+17,https://twitter.com/dmooneymd/status/472806101163851776,,,,
drcbsteer,5/31/2014 14:25,0,0,"# ASCO14 Liu # gyncsm olaparib + cedirinib toxicity appeared not insignificant, principally hypertension.",,,# #,4.72806E+17,https://twitter.com/drcbsteer/status/472806036546809856,,,,
JacobPlieth,5/31/2014 14:25,1,1,3D waterfall plot for lucitanib $ CLVS # ASCO14 pic.twitter.com/x79inPWzGF,,,#,4.72806E+17,https://twitter.com/JacobPlieth/status/472806026518220800,,,,
SJNaggiar,5/31/2014 14:25,0,0,Fact from # ASCO2014: Cancer therapy is the most rapidly growing segment of healthcare,,,#,4.72806E+17,https://twitter.com/SJNaggiar/status/472806000425435137,,,,
ShannonWestin,5/31/2014 14:25,3,1,Joyce Liu- Olaparib/Cediranib active regardless of BRCA status. # ASCO14 # gyncsm,,,# #,4.72806E+17,https://twitter.com/ShannonWestin/status/472805999058100224,,,,
jrgralow,5/31/2014 14:25,3,0,Cool idea! RT @ ipaulmampilly: # ASCO14 kickstarter for med research http://consano.org pic.twitter.com/9aQD45XrzD,,@,#,4.72806E+17,https://twitter.com/jrgralow/status/472805978602496002,,,,
Sorena997,5/31/2014 14:24,1,0,Dr. Joyce Liu @ DanaFarber on her study on new drug combo for recurrent ovarian cancer # ASCO14,,@,#,4.72806E+17,https://twitter.com/Sorena997/status/472805951784095744,,,,
StefanoLuminari,5/31/2014 14:24,1,0,"# asco14 Gutierrez on a PhI study with Selinexor on 51 rel/ref NHL most AEs grade 1-2, disease control 74%, ORR 28% with 5%CR",,,#,4.72806E+17,https://twitter.com/StefanoLuminari/status/472805933165199360,,,,
drcbsteer,5/31/2014 14:24,0,0,# ASCO14 Liu # gyncsm olaparib + cedirinib Difference in PFS more marked in BRCA WT or unknown,,,# #,4.72806E+17,https://twitter.com/drcbsteer/status/472805913070686208,,,,
dmooneymd,5/31/2014 14:24,0,0,Pet and ct give same answer for melanoma staging 84% of time. About equivalent. Pet not as good for specific tumor size. # melsm # ASCO14,,,# #,4.72806E+17,https://twitter.com/dmooneymd/status/472805835140108288,,,,
JacobPlieth,5/31/2014 14:24,2,1,Efficacy of lucitanib $ CLVS # ASCO14 pic.twitter.com/2cP1fMaE9n,,,#,4.72806E+17,https://twitter.com/JacobPlieth/status/472805781587628032,,,,
jrgralow,5/31/2014 14:24,1,0,"Dinner w/ physicians from Republic of Georgia at # ASCO14 - exploring collaborations in education, training, research. http://ow.ly/i/5KGf6",,,#,4.72806E+17,https://twitter.com/jrgralow/status/472805744006668288,,,,
JacobPlieth,5/31/2014 14:23,2,1,DL tox with lucitanib $ CLVS # ASCO14 pic.twitter.com/2nKqKmVAyE,,,#,4.72805E+17,https://twitter.com/JacobPlieth/status/472805498576986113,,,,
corp_UNC,5/31/2014 14:23,1,0,"Please help us welcome (& follow) our # FearlessLeader, @ EthanBasch1, to Twitter http://www.unclineberger.org/news/2012-news/basch-leads-cancer-outcomes-research-program … cc @ ASCO @ CliffordHudis # asco14",,@ @ @,# #,4.72805E+17,https://twitter.com/corp_UNC/status/472805484391825408,,,,
drcbsteer,5/31/2014 14:23,0,0,# ASCO14 Liu # gyncsm combination of cedirinib and olaparib prolonged PFS in plat sens ovarian cancer.,,,# #,4.72805E+17,https://twitter.com/drcbsteer/status/472805465991434240,,,,
ZskiTexas,5/31/2014 14:22,1,0,"# ASCO14 Progenics poster pres'n: A Phase 2 Trial of PSMA ADC in Taxane-Treated mCRPC"": http://files.shareholder.com/downloads/PGNX/3207744449x0x758637/efb8f02f-0921-4bf1-b148-b0b3528a5a45/PSMA_-_ASCO_Poster_2014_-_FINAL_5-27-2014.pdf … $ PGNX""",,,#,4.72805E+17,https://twitter.com/ZskiTexas/status/472805388362866688,,,,
aftimosp,5/31/2014 14:22,0,0,Genomics show that 4 out of 6 biological pathways associated with benefit to adjvant trastuzumab linked to immunological functions # ASCO14,,,#,4.72805E+17,https://twitter.com/aftimosp/status/472805333660753920,,,,
SeattleGenetics,5/31/2014 14:21,1,1,Data from multiple $ SGEN collaborator antibody-drug conjugate (ADC) programs highlighted at # ASCO14 http://ow.ly/xtBUt,,,#,4.72805E+17,https://twitter.com/SeattleGenetics/status/472805205634207744,,,,
yzafar,5/31/2014 14:21,3,2,"# ASCO14 tweeps welcome GU oncologist, health services rsrchr & fellow bass player @ EthanBasch1 to twitter @ fischmd @ corp_UNC @ UNC_Lineberger",,@ @ @ @,#,4.72805E+17,https://twitter.com/yzafar/status/472805114093510657,,,,
drcbsteer,5/31/2014 14:21,1,2,# ASCO14 Liu # gyncsm PARP inhib and VEGFR inhib (olaparib and cedirinib) synergistic in platinum sensitive relapsed ovarian cancer.,,,# #,4.72805E+17,https://twitter.com/drcbsteer/status/472805059559170048,,,,
ipaulmampilly,5/31/2014 14:21,0,0,# ASCO14 oncology professionals hall haha cancer drug bazaar pic.twitter.com/aiHGRhYgBX,,,#,4.72805E+17,https://twitter.com/ipaulmampilly/status/472804992379002880,,,,
dmooneymd,5/31/2014 14:21,0,0,"Nccn recommends ct scan to stage only stage iiib, possibly iiia. For earlier stage, false positive imaging delays treatment. # melsm # ASCO14",,,# #,4.72805E+17,https://twitter.com/dmooneymd/status/472804977463656448,,,,
alenvmd,5/31/2014 14:20,0,1,@ Medscape thanks for the pick me up # ASCO14,,@,#,4.72805E+17,https://twitter.com/alenvmd/status/472804921419386880,,,,
WinshipAtEmory,5/31/2014 14:20,2,0,Winship's Dr Nabil Saba presenting his poster at # ASCO14. pic.twitter.com/ujWsEvfKxm,,,#,4.72805E+17,https://twitter.com/WinshipAtEmory/status/472804842520727554,,,,
Roche,5/31/2014 14:20,5,4,What goes into the design of a clinical study? http://ow.ly/xoNUJ # ASCO14 # lifescience,,,# #,4.72805E+17,https://twitter.com/Roche/status/472804791249555456,,,,
ASCO,5/31/2014 14:20,2,0,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.72805E+17,https://twitter.com/ASCO/status/472804775395098624,,,,
brendanweiss,5/31/2014 14:20,0,1,Anthony Back of SCCA: Oncology is not for wimps # ASCO14,,,#,4.72805E+17,https://twitter.com/brendanweiss/status/472804758689153025,,,,
ShannonWestin,5/31/2014 14:20,2,1,Exciting data from J.Liu and colleagues. Olaparib and Cediranib yield PFS benefit in ovarian Shannon # ASCO14 # gyncsm,,,# #,4.72805E+17,https://twitter.com/ShannonWestin/status/472804738762018816,,,,
CancerDotNet,5/31/2014 14:20,2,4,Dr. Joyce Liu @ DanaFarber on her study abt new drug combo for recurrent ovarian cancer # ASCO14 # gyncsm http://bit.ly/1kuRvIL,,@,# #,4.72805E+17,https://twitter.com/CancerDotNet/status/472804722475540480,,,,
myriadgenetics,5/31/2014 14:20,3,1,"Did u know Myriad myRisk tests for 8 # hereditarycancers: breast, colon, ovarian, uterine, pancreatic, prostate, gastric & melanoma? # ASCO14",,,# #,4.72805E+17,https://twitter.com/myriadgenetics/status/472804706075435009,,,,
mcbennett6,5/31/2014 14:19,1,0,This is @ GeoffreyCurtis's desk during # ASCO14 pic.twitter.com/o7JOXh7fhb,,@,#,4.72805E+17,https://twitter.com/mcbennett6/status/472804683753730049,,,,
MedscapeOnc,5/31/2014 14:19,1,1,Should oncologists advocate for individual patients or society at large when determining value? Debate @ ASCO E253,,@,,4.72805E+17,https://twitter.com/MedscapeOnc/status/472804635372429312,,,,
ipaulmampilly,5/31/2014 14:19,3,1,# ASCO14 kudos to organizers for putting advocacy groups right up front pic.twitter.com/CdSbzlKv1b,,,#,4.72805E+17,https://twitter.com/ipaulmampilly/status/472804604691095552,,,,
YSCBuzz,5/31/2014 14:19,0,3,Excited to get our Research Agenda into the hands of # asco14 attendees! pic.twitter.com/VOFWla2MCp,,,#,4.72805E+17,https://twitter.com/YSCBuzz/status/472804556271665152,,,,
Oncoinfo_it,5/31/2014 14:18,1,0,"S. Cascinu: La biologia molecolare farà ridisegnare gli studi clinici in 5 anni"" # ASCO14""",,,#,4.72804E+17,https://twitter.com/Oncoinfo_it/status/472804328160632832,,,,
jagasquet,5/31/2014 14:17,2,0,# ASCO14 Ready for next session! @ asco pic.twitter.com/YlV6tl7UfO,,@,#,4.72804E+17,https://twitter.com/jagasquet/status/472804168844197888,,,,
z_phd,5/31/2014 14:17,0,0,Who watches the watchers? # ASCO14 pic.twitter.com/x2qQfDE4Rc,,,#,4.72804E+17,https://twitter.com/z_phd/status/472804118386712577,,,,
teamoncology,5/31/2014 14:17,0,0,@ AndytweetM No. I have not seen the presentation by virtual meeting. # ASCO14,,@,#,4.72804E+17,https://twitter.com/teamoncology/status/472804083930124288,,,,
ipaulmampilly,5/31/2014 14:17,0,1,# ASCO14 kickstarter for med research http://consano.org pic.twitter.com/AI95DhQQR6,,,#,4.72804E+17,https://twitter.com/ipaulmampilly/status/472804009393553408,,,,
ProjectInno,5/31/2014 14:17,0,0,"Between 2008 & 2012, Rx meds accounted for just 5% of overall health care expenditure growth # ASCO2014",,,#,4.72804E+17,https://twitter.com/ProjectInno/status/472804006956630016,,,,
teamoncology,5/31/2014 14:17,0,0,"@ AndytweetM However, in breast cancer, anti-angiogenesis has not been very effective. # ASCO14",,@,#,4.72804E+17,https://twitter.com/teamoncology/status/472803972818812928,,,,
DrAttai,5/31/2014 14:17,0,0,"I expect another intense, fascinating session # ASCO14 # bcsm",,,# #,4.72804E+17,https://twitter.com/DrAttai/status/472803950484525056,,,,
DrAttai,5/31/2014 14:16,2,0,back in session after lunch. Harnessing Biology and Immunology to Develop Novel Biomarkers # ASCO14 # bcsm,,,# #,4.72804E+17,https://twitter.com/DrAttai/status/472803878921326592,,,,
teamoncology,5/31/2014 14:16,0,1,"@ AndytweetM Agree. B/C serious epithelial ovarian cancer and TNBC has a very similar gene signature, PARPi and Angio may work. # ASCO14",,@,#,4.72804E+17,https://twitter.com/teamoncology/status/472803818908819456,,,,
SanofiUS,5/31/2014 14:16,1,0,"RT @ ASCO: It's not too late to join us at today's # ASCO14 Tweetup, 5:45PM, Level 2.5 Food Court. Details: http://bit.ly/1pHj5m7",,@,#,4.72804E+17,https://twitter.com/SanofiUS/status/472803744145735680,,,,
Novartis,5/31/2014 14:15,4,2,"Check out poster presentation on # myelofibrosis, an uncommon # bloodcancer, at # ASCO14 in S405 http://bit.ly/1i93rtE",,,# # #,4.72804E+17,https://twitter.com/Novartis/status/472803524594900993,,,,
PPDCRO,5/31/2014 14:15,1,0,Join us @booth 8115 to see why we are leading the industry in study start up. # ASCO14 http://ht.ly/xrNnJ,,@booth,#,4.72803E+17,https://twitter.com/PPDCRO/status/472803487798284288,,,,
SanofiUS,5/31/2014 14:15,1,0,"RT @ ASCO: Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1kcdLId",,@,#,4.72803E+17,https://twitter.com/SanofiUS/status/472803479510343680,,,,
DrMarkham,5/31/2014 14:15,1,0,Had a great reunion dinner with 2 of my former co-fellows (B. Boulmay & @Close2Chaos) last night. # ASCO14 http://twitpic.com/e55jk9,,@Close2Chaos,#,4.72803E+17,https://twitter.com/DrMarkham/status/472803478285606912,,,,
sloan_kettering,5/31/2014 14:14,1,2,Good Q - @ ASCO can you share the link to @ CliffordHudis' address if you have it? MT @ nxtstop1: can You Tweet Out A Link to His Transcript,,@ @ @,,4.72803E+17,https://twitter.com/sloan_kettering/status/472803395028647936,,,,
tomleblancMD,5/31/2014 14:14,1,0,RT @ Neil_Iyengar: Proportion of US federal funding allocated to # cancer research. Yikes. # ASCO14 pic.twitter.com/CDgSmnKbtO,,@,# #,4.72803E+17,https://twitter.com/tomleblancMD/status/472803240367890433,,,,
KadrinWilfong,5/31/2014 14:13,1,0,"Looking forward to the select-a-scenario"" mCRPC CME symposium with @ WilliamOhMD & @ TomBeer on 6/1: http://bit.ly/ASCOprostate # ASCO14 # gucsm""",,@ @,# #,4.72803E+17,https://twitter.com/KadrinWilfong/status/472803175750463488,,,,
Sorena997,5/31/2014 14:13,1,1,"RT @ DrMarkham: The accomplishments over the past 50 years, in the science of oncology & in the US, are astounding. # ASCO14",,@,#,4.72803E+17,https://twitter.com/Sorena997/status/472803006488932354,,,,
tomleblancMD,5/31/2014 14:12,0,1,MT @ Cascadia: Factors affecting communication between oncology staff and bereaved families: http://abstracts.asco.org/144/AbstView_144_133041.html … # ASCO14 # hpm # pallonc,,@,# # #,4.72803E+17,https://twitter.com/tomleblancMD/status/472802888461606913,,,,
teamoncology,5/31/2014 14:12,0,0,【 # ASCO14 Ueno Editorial】 You wonder if Cediranib plus Olaparib combo will work in triple negative # breastcancer,,,# #,4.72803E+17,https://twitter.com/teamoncology/status/472802852423729153,,,,
teamoncology,5/31/2014 14:12,1,0,【 # ASCO14 Update】 RT @ JNCI_Now: 1st time combi of a PARP inhibitor & an anti-angiogenic drug in clinical trial for ovarian cancer.,,@,#,4.72803E+17,https://twitter.com/teamoncology/status/472802709414760448,,,,
tomleblancMD,5/31/2014 14:11,0,0,"RT @ DrMarkham: The accomplishments over the past 50 years, in the science of oncology & in the US, are astounding. # ASCO14",,@,#,4.72803E+17,https://twitter.com/tomleblancMD/status/472802635595399168,,,,
teamoncology,5/31/2014 14:11,0,0,【 # ASCO14 Update】 RT @ JNCI_Now: Confirms preclinical research which suggested that olaparib and cediranib synergize. # ASCO14,,@,# #,4.72803E+17,https://twitter.com/teamoncology/status/472802522021646336,,,,
SarahCannonDocs,5/31/2014 14:11,2,1,Come see # SCRI's # DrKennedy talk about the nuts and bolts of liver directed therapies at 1:15pm EHall D1 # ASCO14 pic.twitter.com/d5fQyKz7V2,,,# # #,4.72803E+17,https://twitter.com/SarahCannonDocs/status/472802519773872128,,,,
PhRMA,5/31/2014 14:11,0,0,# HIV is an excellent example of how incremental innovation leads to medical breakthroughs. @ Celgene has more: http://bit.ly/1hFWamh # ASCO14,,@,# #,4.72802E+17,https://twitter.com/PhRMA/status/472802479550124034,,,,
DrAttai,5/31/2014 14:10,15,5,Progress in Breast Cancer Research | ASCO Annual Meeting http://am.asco.org/progress-breast-cancer-research#.U4obIXQtE-g.twitter … # ASCO14 # bcsm,,,# # #,4.72802E+17,https://twitter.com/DrAttai/status/472802421618401280,,,,
teamoncology,5/31/2014 14:10,0,0,【 # ASCO14 Update】 RT @ JNCI_Now: Cediranib + Olaparib significantly increases progression-free survival in women w/recurrent ovarian cancer.,,@,#,4.72802E+17,https://twitter.com/teamoncology/status/472802396012179456,,,,
aftimosp,5/31/2014 14:10,0,0,"Harnessing biology and immunology to develop novel biomarkers"" session about to start Hall B1 # ASCO14""",,,#,4.72802E+17,https://twitter.com/aftimosp/status/472802372528271360,,,,
SitemanCenter,5/31/2014 14:10,2,1,# ASCO14 Debio 1143 at doses ≤400 mg/day can be safely combined w/daunorubicin & cytarabine in certain AML patients: http://goo.gl/T7Vo0I,,,#,4.72802E+17,https://twitter.com/SitemanCenter/status/472802236868075520,,,,
Novartis,5/31/2014 14:10,1,2,Presentation on 3-year ENESTcmr data evaluating long-term # CML treatment starting now in S405 # ASCO14 http://bit.ly/1n4oXWP,,,# #,4.72802E+17,https://twitter.com/Novartis/status/472802234653474818,,,,
teamoncology,5/31/2014 14:09,0,0,RT @ JNCI_Now: Differentiated thyroid cancer is most common subtype of thyroid cancer. # ASCO14,,@,#,4.72802E+17,https://twitter.com/teamoncology/status/472802113840349184,,,,
UCSFCancer,5/31/2014 14:09,3,1,MT @ subatomicdoc: Statin use and risk of pancreatic cancer http://bit.ly/1kPxBaS > # UCSF # ASCO14 # pancsm,,@,# # #,4.72802E+17,https://twitter.com/UCSFCancer/status/472802058383290369,,,,
teamoncology,5/31/2014 14:09,0,0,【 # ASCO14 101】 Enobarsm is an investigational selective androgen receptor modulator.,,,#,4.72802E+17,https://twitter.com/teamoncology/status/472802051089379329,,,,
Sorena997,5/31/2014 14:09,1,1,P4 Medicine Presented by Dr. Leroy Hood of Institute for Systems Biology at # ASCO14 opening session http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4oYzXIM3wc.twitter …,,,# #,4.72802E+17,https://twitter.com/Sorena997/status/472802041425702913,,,,
BoysenMeb,5/31/2014 14:09,1,1,Dag 2 på # ASCO14 begyndte med en bunke post fra industrien foran hoteldøren. Det bliver endnu en god dag @DagMedicin pic.twitter.com/1pILML862F,,@DagMedicin,#,4.72802E+17,https://twitter.com/BoysenMeb/status/472802018311294976,,,,
glfceo,5/31/2014 14:08,1,0,Who from # ASCO14 is attending # hdpalooza ? @ OpenCancer will be doing demo - pls stop by!,,@,# #,4.72802E+17,https://twitter.com/glfceo/status/472801898635227137,,,,
christinemphmd,5/31/2014 14:08,1,0,Frontline approach to met BRAF-mutant melanoma starts in 7 min! # ASCO14 # melanoma,,,# #,4.72802E+17,https://twitter.com/christinemphmd/status/472801873200943105,,,,
ipaulmampilly,5/31/2014 14:08,0,0,# ASCO14 $ nvs pipeline also impressivepic.twitter.com/tXbrNNLUk9,,,#,4.72802E+17,https://twitter.com/ipaulmampilly/status/472801864539705344,,,,
QIAGENscience,5/31/2014 14:08,1,0,BCR-ABL1 Mbcr: Align on the International Scale with QIAGEN. # ASCO14; booth 5013 pic.twitter.com/07FaLAd4ek,,,#,4.72802E+17,https://twitter.com/QIAGENscience/status/472801787062140928,,,,
teamoncology,5/31/2014 14:08,1,0,【 # ASCO14 Update】 Androgen may be an important target in metastatic breast cancer. Enobosarm. http://abstracts.asco.org/144/AbstView_144_130932.html …,,,#,4.72802E+17,https://twitter.com/teamoncology/status/472801768447832064,,,,
SusanLaufer,5/31/2014 14:08,0,0,# ASCO14 Food court 1 - Avoid the red curry tofu. Horribly gross.,,,#,4.72802E+17,https://twitter.com/SusanLaufer/status/472801707655954432,,,,
wendyselig,5/31/2014 14:07,4,4,. @ melanomarealli at # ASCO14 to promote # melanoma progress. Yes we are wearing # sunscreen!pic.twitter.com/0IEy99iPWf,,@,# # #,4.72802E+17,https://twitter.com/wendyselig/status/472801679239565312,,,,
JLErsek,5/31/2014 14:07,1,1,Alot on the agenda this afternoon. 3 # LCI presentations and a stroll through the cancer epi posters. Results to come! @Carolinas # ASCO14,,@Carolinas,# #,4.72802E+17,https://twitter.com/JLErsek/status/472801660322869248,,,,
nxtstop1,5/31/2014 14:07,0,0,"CONGRESS, CUTS, & THE NIH @ jrgralow: Cancer Research Progress Threatened - Infographic from # ASCO14 http://am.asco.org/cancer-research-progress-threatened#.U4oZncbbMPg.twitter …”",,@,# #,4.72802E+17,https://twitter.com/nxtstop1/status/472801534112055296,,,,
ONcotwITting,5/31/2014 14:07,4,8,"Grande attesa per la plenary session di domani # ASCO14. I temi: carcinoma mammario, carcinoma prostatico, carcinoma colorettale.",,,#,4.72801E+17,https://twitter.com/ONcotwITting/status/472801459072143360,,,,
PRKena,5/31/2014 14:06,0,0,ASCO attire less formal this year. Comfy shoes still required. # ASCO14,,,#,4.72801E+17,https://twitter.com/PRKena/status/472801263323598848,,,,
ipaulmampilly,5/31/2014 14:06,0,0,# ASCO14 Hey $ pfe check out the $ bayry pipeline..impressivepic.twitter.com/6TvV2jkeST,,,#,4.72801E+17,https://twitter.com/ipaulmampilly/status/472801215617990656,,,,
BurrisSkip,5/31/2014 14:05,3,1,Dr Kennedy / SCRI updating on approaches to liver malignancies. # ASCO14,,,#,4.72801E+17,https://twitter.com/BurrisSkip/status/472801140682133504,,,,
Roche,5/31/2014 14:05,9,2,Global cancer burden is set to double before 2030. How does this affect doctors & scientists in # oncology http://ow.ly/xoNtZ # ASCO14,,,# #,4.72801E+17,https://twitter.com/Roche/status/472801010701045760,,,,
DrAttai,5/31/2014 14:05,2,0,"not same as being here, but also how I attended"" last year RT @ teamoncology Participating by # ASCO14 by twitter and teleconference. Not bad""",,@,#,4.72801E+17,https://twitter.com/DrAttai/status/472801002874089472,,,,
genentech,5/31/2014 14:05,15,13,"via # REV2014 In 10 yrs we won't say # breastcancer or # coloncancer. We'll ID cancer types by genetics"" - J. Vose @ ASCO # Next50 # ASCO14""",,@,# # # # #,4.72801E+17,https://twitter.com/genentech/status/472801002220191745,,,,
Pharmacyclics,5/31/2014 14:05,0,0,Dr. Samantha Jaglowski’s @ OSUCCC_James IMBRUVICA (ibrutinib) combination clinical data presented at 1:15 p.m. # ASCO14 http://bit.ly/1p6oHGj,,@,#,4.72801E+17,https://twitter.com/Pharmacyclics/status/472800952668270592,,,,
jrgralow,5/31/2014 14:04,9,8,Cancer Research Progress Threatened - Infographic from # ASCO14 http://am.asco.org/cancer-research-progress-threatened#.U4oZncbbMPg.twitter …,,,# #,4.72801E+17,https://twitter.com/jrgralow/status/472800880480104449,,,,
SAJansky,5/31/2014 14:03,2,1,Loved participating in the @LlyOncOnCanvas project at # ASCO14. It's coming to CLE during @ bikeVeloSano # hopeforwardpic.twitter.com/8xsEk8Ownh,,@LlyOncOnCanvas @,# #,4.72801E+17,https://twitter.com/SAJansky/status/472800666365493249,,,,
ipaulmampilly,5/31/2014 14:03,0,0,# ASCO14 afatinib Gilotrif booth disposes with the subtlety pic.twitter.com/72aqgRjNSP,,,#,4.72801E+17,https://twitter.com/ipaulmampilly/status/472800584027107329,,,,
PDRennert,5/31/2014 14:03,0,0,"About to peek in on the ongoing evolution of # lymphoma care, in the context of # immunotherapy and # ADC antibodies # ASCO14",,,# # # #,4.72801E+17,https://twitter.com/PDRennert/status/472800540712534021,,,,
JediPD,5/31/2014 14:02,1,0,@ JackWestMD @ ASCOPost Should be called Iatrogenic dysregulation of the normal/semi-normal (Knudsen) Genome! # ASCO14,,@ @,#,4.728E+17,https://twitter.com/JediPD/status/472800316707319809,,,,
dhjutsw1,5/31/2014 14:02,0,1,Will be speaking at an MOC session # ASCO14 later today. Gr8 amount of activity at @ ASCO MOC booth. Staff provides useful info.,,@,#,4.728E+17,https://twitter.com/dhjutsw1/status/472800295467376640,,,,
CI4CC,5/31/2014 14:02,0,0,"# ASCO14 Ibrutinib superior to ofatumumab for relapsed, refractory chronic lymphocytic # leukemia",,,# #,4.728E+17,https://twitter.com/CI4CC/status/472800269638459392,,,,
sfuldnasso,5/31/2014 14:02,0,0,"@ drdonsdizon If we follow your advice, there would be no tweeting at ASCO. Surely everyone is fatigued! # ASCO14",,@,#,4.728E+17,https://twitter.com/sfuldnasso/status/472800258247102465,,,,
subatomicdoc,5/31/2014 14:02,2,0,A population-based analysis of patterns of care in stage I testicular seminoma http://abstracts.asco.org/144/AbstView_144_128646.html … # ASCO14 # tscsm,,,# #,4.728E+17,https://twitter.com/subatomicdoc/status/472800220171239426,,,,
AyoksAJ,5/31/2014 14:02,0,0,@ Laura_Kickham Posters on the future of CML treatment will be featured at # ASCO14. Learn about the evolution of CML: http://bit.ly/CML101,,@,#,4.728E+17,https://twitter.com/AyoksAJ/status/472800194976038912,,,,
Novartis,5/31/2014 14:01,2,2,Incidence of advanced # basalcellcarcinoma varies by location & sun exposure & is about 0.003-0.55% wrldwide # ASCO14 http://bit.ly/1lYLaSk,,,# #,4.728E+17,https://twitter.com/Novartis/status/472800127028326400,,,,
teamoncology,5/31/2014 14:01,0,0,Participating by # ASCO14 by twitter and teleconference. Not bad.,,,#,4.728E+17,https://twitter.com/teamoncology/status/472800124020588544,,,,
mayocliniclabs,5/31/2014 14:01,1,0,Are you attending # ASCO14 in Chicago? Check out our blog to learn about our latest advancements in cancer testing. http://mayocl.in/T1r6rl,,,#,4.728E+17,https://twitter.com/mayocliniclabs/status/472800120699105280,,,,
jrgralow,5/31/2014 14:01,2,1,Concept of P4 Medicine Presented by Dr. Leroy Hood of Institute for Systems Biology at # ASCO14 opening session http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4oYzXIM3wc.twitter …,,,# #,4.728E+17,https://twitter.com/jrgralow/status/472800111815172097,,,,
ASCO,5/31/2014 14:01,0,1,"It's not too late to join us at today's # ASCO14 Tweetup, 5:45PM, Level 2.5 Food Court. Details: http://bit.ly/NvNypj",,,#,4.728E+17,https://twitter.com/ASCO/status/472800108564987904,,,,
ASCO,5/31/2014 14:01,18,2,# ASCO14 studies released today focus on targeted therapies. Learn more: http://bit.ly/1f6KFYZ,,,#,4.728E+17,https://twitter.com/ASCO/status/472800090097455104,,,,
BayerPharma,5/31/2014 14:01,1,2,Want to learn more about # thyroidcancer at # ASCO14? Visit poster session on Head and Neck Cancer,,,# #,4.728E+17,https://twitter.com/BayerPharma/status/472800088247762944,,,,
ASCO,5/31/2014 14:01,0,0,Enjoying the Head & Neck track at # ASCO14? Continue learning with # ASCOConnection & # ASCOU http://bit.ly/1sxAkpM # hncsm,,,# # # #,4.728E+17,https://twitter.com/ASCO/status/472800033222721536,,,,
CRC_Medical,5/31/2014 14:01,0,0,# ASCO14 Bestseller: # LungCancer Therapy Annual 7 by Rolf A. Stahel. SAVE 20% - Use promo EMN13 at checkout http://ow.ly/xr8Ud,,,# #,4.728E+17,https://twitter.com/CRC_Medical/status/472799995406852097,,,,
ipaulmampilly,5/31/2014 14:01,1,1,# ASCO14 $ immu could be exciting in 2015pic.twitter.com/fiIvicSLYZ,,,#,4.728E+17,https://twitter.com/ipaulmampilly/status/472799988591132672,,,,
ASCO,5/31/2014 14:01,2,3,Learn to prevent & manage CRC complications at todays Treatment of Elderly Patients session http://bit.ly/1hzPeHg # crcsm # ASCO14,,,# #,4.728E+17,https://twitter.com/ASCO/status/472799986506543104,,,,
ProjectInno,5/31/2014 14:00,0,1,Only continued investment in innovation can ensure future cancer treatment breakthroughs http://ow.ly/xs37B # ASCO14,,,#,4.728E+17,https://twitter.com/ProjectInno/status/472799873432301569,,,,
corp_UNC,5/31/2014 14:00,0,0,Patient eligibility & trial design for salvage of adv urothelial ca based on the impact of prognostic factors # asco14 http://ow.ly/xqEkK,,,#,4.728E+17,https://twitter.com/corp_UNC/status/472799829245313024,,,,
yzafar,5/31/2014 14:00,4,0,Waterfall plots from BRAF/MEK/EGFR data in mCRC http://abstracts.asco.org/144/index.html See at poster highlights now # ASCO14 # crcsmpic.twitter.com/po0mgiQZNz,,,# #,4.728E+17,https://twitter.com/yzafar/status/472799745417969664,,,,
FoundationATCG,5/31/2014 14:00,2,1,Think differently about Molecular testing: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.728E+17,https://twitter.com/FoundationATCG/status/472799725486239744,,,,
lucadf,5/31/2014 14:00,1,1,No guns needed: There're enough docs @ ASCO @ Oncoinfo_it: # ASCO14: BOOM! pic.twitter.com/swKOT2zOdv,,@ @,#,4.728E+17,https://twitter.com/lucadf/status/472799692372574209,,,,
cardinalhealth,5/31/2014 14:00,2,0,The latest abstracts on how Clinical Pathways improve cancer care http://bit.ly/1k8DPUo # ASCO14 # essentialtooncology,,,# #,4.728E+17,https://twitter.com/cardinalhealth/status/472799687108345856,,,,
MedscapeOnc,5/31/2014 14:00,2,1,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.728E+17,https://twitter.com/MedscapeOnc/status/472799684516270081,,,,
myPathMelanoma,5/31/2014 14:00,2,0,# IsThisMelanoma? The stakes are too high NOT to know! Visit http://www.IsThisMelanoma.com or stop by booth 2039 to learn more. # ASCO14 # Melanoma,,,# # #,4.728E+17,https://twitter.com/myPathMelanoma/status/472799682918236161,,,,
DanaFarber,5/31/2014 14:00,9,2,"New research shows potential targeted therapy for metastatic, androgen receptor +, breast cancer: http://bit.ly/1k7SE9Q # ASCO14 # SFSCWC",,,# #,4.728E+17,https://twitter.com/DanaFarber/status/472799678954995713,,,,
Medscape,5/31/2014 14:00,3,2,At # ASCO14 and need an afternoon pick me up? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.728E+17,https://twitter.com/Medscape/status/472799676459008000,,,,
ipaulmampilly,5/31/2014 13:59,0,0,# ASCO14 $ aria very lonely waiting for new pivotals before big sales push?pic.twitter.com/1BEBOLnd0u,,,#,4.72799E+17,https://twitter.com/ipaulmampilly/status/472799477695537152,,,,
PharmD_Onc,5/31/2014 13:58,0,0,# ASCO14 pic.twitter.com/RTs5F2UOBZ,,,#,4.72799E+17,https://twitter.com/PharmD_Onc/status/472799380584812544,,,,
nxtstop1,5/31/2014 13:58,0,0,"@ Oncoinfo_it @ ASCO @ lucadf Of Course, But So a Tragic We Need These Signs~~ oh dear, just so tragic. Will. We. Learn? # ASCO14",,@ @ @,#,4.72799E+17,https://twitter.com/nxtstop1/status/472799376729845761,,,,
Lymphoma_Doc,5/31/2014 13:58,1,0,Pre-session projector screens of # ASCO14 tweets is a great idea,,,#,4.72799E+17,https://twitter.com/Lymphoma_Doc/status/472799236581752832,,,,
drugwonks,5/31/2014 13:58,0,0,Myth: New cancer meds bankrupting USA. Fact: New # cancer Rx costs less than 1/2 of 1% of # healthcare spending . # CMPI # ASCO14,,,# # # #,4.72799E+17,https://twitter.com/drugwonks/status/472799177844723715,,,,
DrAttai,5/31/2014 13:57,0,1,wow RT @ rsm2800 Vogel: STAR trial cost >$100M to conduct. Whoa. “Need better trial design.” Absolutely. # bcsm # ASCO14,,@,# #,4.72799E+17,https://twitter.com/DrAttai/status/472799149285330946,,,,
ALLIANCE_org,5/31/2014 13:57,1,0,Don't miss the # ASCO14 | 3 pm | Breast Ca - Her2/ER Oral abstract session f/ research from @ theNCI # NCTN @ ALLIANCE_org @ eaonc @ SWOG,,@ @ @ @,# #,4.72799E+17,https://twitter.com/ALLIANCE_org/status/472799076992696320,,,,
DrAttai,5/31/2014 13:56,1,1,@ RobynKanter you're welcome! Trying to just throw out some highlights. So much good info presented here # ASCO14 # bcsm,,@,# #,4.72799E+17,https://twitter.com/DrAttai/status/472798828194590720,,,,
DrR_DUNNE,5/31/2014 13:55,0,0,Enjoying the view after a busy morning at # ASCO2014 pic.twitter.com/hRNnqOYuz2,,,#,4.72799E+17,https://twitter.com/DrR_DUNNE/status/472798578646450176,,,,
Oncoinfo_it,5/31/2014 13:55,0,0,# ASCO14: BOOM! @ ASCO @ lucadfpic.twitter.com/7ObjZ2pIYn,,@ @,#,4.72799E+17,https://twitter.com/Oncoinfo_it/status/472798521360674816,,,,
nxtstop1,5/31/2014 13:55,1,0,VALUE TO ME. @ KUhlendorf: # ASCO14: Patients Should Be at the Center of the Value Proposition http://shar.es/VU1oV via @ PhRMA”,,@ @,#,4.72799E+17,https://twitter.com/nxtstop1/status/472798514854895616,,,,
OpenCancer,5/31/2014 13:55,1,0,. @ drattai totally ! Our focus! # epidemiology # cancer # ASCO14,,@,# # #,4.72798E+17,https://twitter.com/OpenCancer/status/472798494735216640,,,,
SitemanCenter,5/31/2014 13:55,1,0,# ASCO14 Performing a 2nd alloHSCT on patients w/active disease has very poor outcomes: http://goo.gl/t4pJv9 See Poster #10 in Rm S405,,,# #10,4.72798E+17,https://twitter.com/SitemanCenter/status/472798446261649410,,,,
JackWestMD,5/31/2014 13:54,3,0,I see this. MT @ ASCOPost: Men Who Get RT 4 Prostate Cancer Have Higher Long-Term Risk of Bladder & Rectal Ca http://ow.ly/xtur8 # ASCO14,,@,#,4.72798E+17,https://twitter.com/JackWestMD/status/472798186479054848,,,,
Oncoinfo_it,5/31/2014 13:53,1,0,"S.Cascinu: Nel semestre europeo guidiamo la UE sulla strada della prevenzione e sostenibilità"" @ carmine_pinto # ASCO14""",,@,#,4.72798E+17,https://twitter.com/Oncoinfo_it/status/472798063183294464,,,,
jeccles69,5/31/2014 13:53,1,0,Todays episode of H*T$ On Twitter http://youtu.be/yB-U3mPtqww # AnthonyJoshua # babygill # ThankYouLiam # ASCO14 @ YouTube,,@,# # # #,4.72798E+17,https://twitter.com/jeccles69/status/472798015267561473,,,,
jrgralow,5/31/2014 13:52,1,0,Recapturing the Momentum: Reversing the Decline in Federal Funding for Cancer Research # ASCO14 http://am.asco.org/recapturing-momentum-reversing-decline-federal-funding-cancer-research#.U4oW22_Uj0o.twitter …,,,# #,4.72798E+17,https://twitter.com/jrgralow/status/472797845003579392,,,,
hemedoc,5/31/2014 13:52,5,4,Tom Martin et al @ UCSF MT @ theMMRF: # ASCO14 Impressive responses in relapsed/refractory myeloma w/ # SAR650984. http://www.themmrf.org/asco # mmsm,,@ @,# # #,4.72798E+17,https://twitter.com/hemedoc/status/472797753458688001,,,,
HemOncToday,5/31/2014 13:52,9,2,"# ASCO14 Ibrutinib superior to ofatumumab for relapsed, refractory chronic lymphocytic # leukemia and SLL @ OhioState http://goo.gl/xjpMv3",,@,# #,4.72798E+17,https://twitter.com/HemOncToday/status/472797713315426304,,,,
GoHealio,5/31/2014 13:52,0,0,"# ASCO14 Ibrutinib superior to ofatumumab for relapsed, refractory chronic lymphocytic # leukemia and SLL @ OhioState http://goo.gl/xjpMv3",,@,# #,4.72798E+17,https://twitter.com/GoHealio/status/472797712573026304,,,,
MaryAjango,5/31/2014 13:51,1,2,Patient advocacy at # ASCO14 @ YSCBuzzpic.twitter.com/CvMffbW4by,,@,#,4.72798E+17,https://twitter.com/MaryAjango/status/472797638388375552,,,,
jrgralow,5/31/2014 13:51,2,1,"Next-Generation Genomic Testing: An Understanding of Semantics Helps Guide Assay Use, Selection # ASCO14 http://am.asco.org/next-generation-genomic-testing-understanding-semantics-helps-guide-assay-use-selection#.U4oWlwrLXBs.twitter …",,,# #,4.72798E+17,https://twitter.com/jrgralow/status/472797570054385665,,,,
nxtstop1,5/31/2014 13:51,1,0,"PALLIATIVE PREFERRED. @ OncLive: Early Palliative Care for Caregivers Improves Their Wellbeing, Too http://ow.ly/xtytl # ASCO14”",,@,#,4.72798E+17,https://twitter.com/nxtstop1/status/472797507357900802,,,,
JimWeissW2O,5/31/2014 13:51,2,0,"Lung, colon cancer conversations rose last year, breast cancer fell, says @ W2OGroup’s # SocOncology: # ASCO14 http://bit.ly/SOCONC …",,@,# #,4.72797E+17,https://twitter.com/JimWeissW2O/status/472797479197360128,,,,
Oncoinfo_it,5/31/2014 13:51,2,0,A.Sobrero on @ ASCO: Rejection, wonder," metabolization: the usual sequence of italian oncologist reaction"" # ASCO14 @ PAscierto""",,@ @,#,4.72797E+17,https://twitter.com/Oncoinfo_it/status/472797424403357696,,
WinshipAtEmory,5/31/2014 13:50,0,0,Abstract: @ ramalingammd on ganetespib/docetaxel combo vs docetaxel alone in lung adenocarcinoma patients: http://ow.ly/xsVmo # ASCO14,,@,#,4.72797E+17,https://twitter.com/WinshipAtEmory/status/472797174926147584,,,,
jimbob_510,5/31/2014 13:50,0,0,Cool Rube Goldberg device @ SGen booth describes ADC MOA. # asco14 pic.twitter.com/YXyItL2CNI,,@,#,4.72797E+17,https://twitter.com/jimbob_510/status/472797174921953280,,,,
KUhlendorf,5/31/2014 13:49,3,0,# ASCO14: Patients Should Be at the Center of the Value Proposition http://shar.es/VU1oV via @ PhRMA,,@,#,4.72797E+17,https://twitter.com/KUhlendorf/status/472797070311452672,,,,
GillisClaire,5/31/2014 13:49,0,0,# ASCO14 TKI beats MAB in CLL winning on responses remissions and OS practice changing # nejm,,,# #,4.72797E+17,https://twitter.com/GillisClaire/status/472797033007296512,,,,
JackWestMD,5/31/2014 13:49,6,7,Happy to have met @ drattai at # ASCO14. Got to say how much # bcsm has shown power of social media to galvanize cancer communities. # lcsm,,@,# # #,4.72797E+17,https://twitter.com/JackWestMD/status/472797029186301952,,,,
Oncoinfo_it,5/31/2014 13:48,1,0,"A.Sobrero su @ ASCO: Rifiuto, stupore e metabolizzazione. La consueta reazione sequenziale degli oncologi italiani. # ASCO14",,@,#,4.72797E+17,https://twitter.com/Oncoinfo_it/status/472796651527368705,,,,
ipaulmampilly,5/31/2014 13:47,1,2,# ASCO14 Genentech booth gets the most circular booth award pic.twitter.com/j70q90ukpw,,,#,4.72797E+17,https://twitter.com/ipaulmampilly/status/472796596976246784,,,,
CI4CC,5/31/2014 13:47,0,0,Promise of MEK/BRAF/EGFR inhibition in patients with BRAF # ASCO14,,,#,4.72797E+17,https://twitter.com/CI4CC/status/472796500192292865,,,,
z_phd,5/31/2014 13:47,1,0,The crowd waiting to hang posters for the afternoon session... # ASCO14 pic.twitter.com/o96E5syvEf,,,#,4.72796E+17,https://twitter.com/z_phd/status/472796466919243776,,,,
MLIWI,5/31/2014 13:47,0,0,"Because of innovative research, the number of # cancer therapies has grown. Innovation matters. # ASCO14 # MLIWI http://buff.ly/1u117gP",,,# # #,4.72796E+17,https://twitter.com/MLIWI/status/472796402276663296,,,,
OncLive,5/31/2014 13:45,2,0,"Early Palliative Care for Caregivers Improves Their Wellbeing, Too http://ow.ly/xtytl # ASCO14",,,#,4.72796E+17,https://twitter.com/OncLive/status/472795965595086848,,,,
WinshipAtEmory,5/31/2014 13:45,1,0,"Abstract: Rathi Pillai, MD on HER2 mutations in lung adenocarcinoma: A report from the LCMC: http://ow.ly/xsV8w # ASCO14 # lcsm",,,# #,4.72796E+17,https://twitter.com/WinshipAtEmory/status/472795917335425024,,,,
genentech,5/31/2014 13:45,6,3,Immunotherapy requires targeting cancer but not healthy cells. Learn more & take the challenge: http://ow.ly/xtwFw # ASCO14,,,#,4.72796E+17,https://twitter.com/genentech/status/472795912679723008,,,,
hospicedoctor,5/31/2014 13:44,2,1,“ @ sloan_kettering: . @ CliffordHudis # ASCO14 pic.twitter.com/j88TfgvL0L” Noble intention from the ASCO President at the huge US cancer conference,,@ @,#,4.72796E+17,https://twitter.com/hospicedoctor/status/472795825043943424,,,,
BiostatGirl,5/31/2014 13:44,0,0,Another gorgeous day! View of downtown # chicago from the convention center. # asco2014 # asco14 http://instagram.com/p/oq4gdvgzFh/,,,# # #,4.72796E+17,https://twitter.com/BiostatGirl/status/472795813584715780,,,,
Stevenbeales,5/31/2014 13:43,1,0,“ @ Roche: What goes into the design of a clinical study? http://ow.ly/xkTMJ # ASCO14 # ClinicalTrials”,,@,# #,4.72796E+17,https://twitter.com/Stevenbeales/status/472795631233531904,,,,
krystadawn,5/31/2014 13:43,0,1,My # asco14 moment pic.twitter.com/5oZ9dtjomF,,,#,4.72796E+17,https://twitter.com/krystadawn/status/472795584538370049,,,,
OncLive,5/31/2014 13:43,7,4,Just finished a great talk with Dr Greenberger @ LLSusa & Dr Byrd @ OSUCCC_James at # ASCO14 - a lot happening in CLL! pic.twitter.com/2rrYYhm7A5,,@ @,#,4.72796E+17,https://twitter.com/OncLive/status/472795508357222401,,,,
sfuldnasso,5/31/2014 13:43,1,1,Shouldn't smoking be banned at a cancer conference? Time to find a new spot to eat lunch. # asco14,,,#,4.72795E+17,https://twitter.com/sfuldnasso/status/472795470230994944,,,,
FoundationATCG,5/31/2014 13:43,3,1,"# Genomic profiling may identify therapeutic tgts in tissue of unknown origin Poster Pres: 1:15-5, S Hall A2, Ab 11048 # ASCO14 @ ASCO",,@,# #,4.72795E+17,https://twitter.com/FoundationATCG/status/472795417261146112,,,,
Cortellis,5/31/2014 13:43,2,0,Phase 3 PENELOPE trial: pertuzumab along with standard chemotherapy for platinum-resistant ovarian cancer is well tolerated # ASCO14,,,#,4.72795E+17,https://twitter.com/Cortellis/status/472795398273114112,,,,
ipaulmampilly,5/31/2014 13:42,1,1,# ASCO14 $ dndn Provenge gets most orange and most artistic booth awardpic.twitter.com/OdG4SEJhXG,,,#,4.72795E+17,https://twitter.com/ipaulmampilly/status/472795343554617345,,,,
jrgralow,5/31/2014 13:42,2,1,OPTIMIZE 2 Study: Zoledronic Acid Can Be Administered Less Frequently in Breast Cancer pts with bone mets http://shar.es/VUnsw # ASCO14,,,#,4.72795E+17,https://twitter.com/jrgralow/status/472795292081741824,,,,
FoundationATCG,5/31/2014 13:42,5,0,"ALK rearrangements detected by # FoundationOne, but not FISH in # LCSM Poster Pres: 1:15-5, S Hall A2, Ab 8049 # ASCO14 @ ASCO",,@,# # #,4.72795E+17,https://twitter.com/FoundationATCG/status/472795208552546304,,,,
Medicalfacts,5/31/2014 13:42,1,1,"50 jaar ASCO # ASCO14 - In de erkenning van de evolutie en vooruitgang in de oncologische zorg , zal de American... http://is.gd/6t7fhn",,,#,4.72795E+17,https://twitter.com/Medicalfacts/status/472795180299722753,,,,
ALopipero,5/31/2014 13:41,1,0,$ PCYC setting the stage at # ASCO14 !!!,,,#,4.72795E+17,https://twitter.com/ALopipero/status/472794937952464896,,,,
StomachCancer_,5/31/2014 13:41,3,4,@ StupidCancerCEO stopping by for selfies at our booth at # ASCO14 @ StupidCancerpic.twitter.com/Ct69Srdcv7,,@ @,#,4.72795E+17,https://twitter.com/StomachCancer_/status/472794895984652289,,,,
jlserna,5/31/2014 13:40,10,6,Casi todos los oncólogos del mundo se han venido a Chicago a # ASCO14. La ciudad llena de ellos. pic.twitter.com/79c37rvanz,,,#,4.72795E+17,https://twitter.com/jlserna/status/472794844155244545,,,,
ipaulmampilly,5/31/2014 13:40,0,0,# ASCO14 $ amgn biggest booth award..much bigger than this picturepic.twitter.com/TO4TSV7hhu,,,#,4.72795E+17,https://twitter.com/ipaulmampilly/status/472794814443192320,,,,
SophiaCeulemans,5/31/2014 13:40,1,0,"Rare empty convention hall, straggler attendees looking for quiet # solace at # ASCO14 pic.twitter.com/JRm5TMrdmO",,,# #,4.72795E+17,https://twitter.com/SophiaCeulemans/status/472794752153178112,,,,
WinshipAtEmory,5/31/2014 13:40,1,0,Abstract: @ ramalingammd on Tecemotide in unresectable stage III NSCLC after first-line concurrent CRT: http://ow.ly/xsURg # ASCO14,,@,#,4.72795E+17,https://twitter.com/WinshipAtEmory/status/472794725695889408,,,,
Roche,5/31/2014 13:40,10,6,What goes into the design of a clinical study? http://ow.ly/xkTMJ # ASCO14 # ClinicalTrials,,,# #,4.72795E+17,https://twitter.com/Roche/status/472794694335090688,,,,
CANcerviver,5/31/2014 13:40,1,0,RT @ NCIMedia: From # ASCO14: Clinical trial analysis suggests drug combination may be highly effective ... http://tmi.me/1em9KR,,@,#,4.72795E+17,https://twitter.com/CANcerviver/status/472794666967248896,,,,
theNCI,5/31/2014 13:40,9,4,"Here's the rationale of the ALCHEMIST trial, part of NCI's Precision Cancer Medicine Effort # NCTN # ASCO14 pic.twitter.com/PtLVQj7bL6",,,# #,4.72795E+17,https://twitter.com/theNCI/status/472794656347287552,,,,
CANcerviver,5/31/2014 13:39,1,0,RT @ theNCI: Dr Abrams: The most recent milestones leading up to the National Clinical Trials Network. # ASCO14 # NCTNpic.twitter.com/QgBr44pNvA,,@,# #,4.72795E+17,https://twitter.com/CANcerviver/status/472794536369221632,,,,
dansbarrington,5/31/2014 13:38,3,0,"Unlike many booths at # ASCO14 we unfortunately haven't got beautiful women on our booth 2066. Come and see Neil, Paul and I anyway though...",,,#,4.72794E+17,https://twitter.com/dansbarrington/status/472794317602701312,,,,
laurentingels,5/31/2014 13:38,1,0,Journée d'interviews et de montage à l'ASCO. # ASCO14 # Chicago # USA # onconlogy .pic.twitter.com/GuJbVtGNMK,,,# # # #,4.72794E+17,https://twitter.com/laurentingels/status/472794294756323328,,,,
drcbsteer,5/31/2014 13:38,1,1,@nextprinciples @ mtmdphd @ drattai @ Stocks_Biotech @ShewithLynch # gerionc makes it on twitter at # ASCO14 https://twitter.com/nextprinciples/status/472787658381742080 …,,@nextprinciples @ @ @ @ShewithLynch,# #,4.72794E+17,https://twitter.com/drcbsteer/status/472794279983976449,,,,
ipaulmampilly,5/31/2014 13:38,0,0,# ASCO14 no food no ice cream no people pic.twitter.com/7SDXqcmqRh,,,#,4.72794E+17,https://twitter.com/ipaulmampilly/status/472794173264125952,,,,
SarahCannonDocs,5/31/2014 13:37,2,0,Unleashing the Immune System on Genointuary Cancers - Join # SCRI at 3pm today E Arie # ASCO14,,,# #,4.72794E+17,https://twitter.com/SarahCannonDocs/status/472794125180616704,,,,
dansbarrington,5/31/2014 13:37,2,3,"Unlike many booths at # ASCO14 we unfortunately haven't got beautiful women on our booth. Come and see Neil, Paul and I anyway though....",,,#,4.72794E+17,https://twitter.com/dansbarrington/status/472794118553620480,,,,
CancerTherAdvsr,5/31/2014 13:37,2,0,Don't forget to stop by Booth 15081 to learn more about Chemotherapy Advisor! # ASCO14,,,#,4.72794E+17,https://twitter.com/CancerTherAdvsr/status/472794083510198272,,,,
ipaulmampilly,5/31/2014 13:36,1,0,# ASCO14 unmanned too bad would have had my genome read. pic.twitter.com/xagq032JMF,,,#,4.72794E+17,https://twitter.com/ipaulmampilly/status/472793776638132224,,,,
yzafar,5/31/2014 13:36,1,0,Coming up # colorectalcancer poster highlight: Promise of MEK/BRAF/EGFR inhibition in pts with BRAF-MT CRC http://abstracts.asco.org/144/index.html # ASCO14,,,# #,4.72794E+17,https://twitter.com/yzafar/status/472793663106342912,,,,
slibutti,5/31/2014 13:35,3,2,Come visit us at booth 20112 # ASCO14 and hear about our new clinical trials and pick up a cool laser pointer!! pic.twitter.com/fvE9IgfVVh,,,#,4.72793E+17,https://twitter.com/slibutti/status/472793448329007104,,,,
theNCI,5/31/2014 13:35,10,4,Dr Abrams: The most recent milestones leading up to the National Clinical Trials Network. # ASCO14 # NCTNpic.twitter.com/PapJj0DGtf,,,# #,4.72793E+17,https://twitter.com/theNCI/status/472793414921363456,,,,
WinshipAtEmory,5/31/2014 13:35,3,1,"Abstract: Madhusmita Behera, PhD on trends in small cell lung cancer survival: http://ow.ly/xsUIz # ASCO14 # lcsm",,,# #,4.72793E+17,https://twitter.com/WinshipAtEmory/status/472793410630598657,,,,
genentech,5/31/2014 13:35,1,1,# ASCO14: Don’t miss our famous cookies - grab one at our booth (no. 10005) before your next session! http://ow.ly/xtu99,,,#,4.72793E+17,https://twitter.com/genentech/status/472793388597927936,,,,
tracyrode,5/31/2014 13:34,1,0,Day 2 at # ASCO14 - come see us!,,,#,4.72793E+17,https://twitter.com/tracyrode/status/472793242367307776,,,,
SarahCannonDocs,5/31/2014 13:34,2,0,"Ph I Study of DNIB0600A, Targeting NaPi2b, in pts w/ NSCLC or Platinum Oral Fri 2:15-2:45 Ehall D2 @ BurrisSkip # DrSpigel # ASCO14 # SCRI",,@,# # #,4.72793E+17,https://twitter.com/SarahCannonDocs/status/472793149119950848,,,,
SarahCannonDocs,5/31/2014 13:33,1,0,"Fact: Median survival for pts w/ recurrent GBM is < 6 months. Learn about TPS2109, exploring activity of VAL-083 for GBM treatment # ASCO14",,,#,4.72793E+17,https://twitter.com/SarahCannonDocs/status/472793028063932416,,,,
SarahCannonDocs,5/31/2014 13:33,2,1,Clinical Science Symp Ph II Randomized Study ROMULUS of PoV or PiV Plus RTX in Pts w/ R/R NHL Fri 1:15-2:45 E Arie Crown # DrFlinn # ASCO14,,,# #,4.72793E+17,https://twitter.com/SarahCannonDocs/status/472792925106360320,,,,
ipaulmampilly,5/31/2014 13:32,1,0,# ASCO14 at least 5 massage booths..these guys would not be here unless big use from cancer docs pic.twitter.com/GMwS3Fk5WP,,,#,4.72793E+17,https://twitter.com/ipaulmampilly/status/472792846412808193,,,,
SarahCannonDocs,5/31/2014 13:32,0,0,"Ph 1 study oral JNJ-42756493, a FGFR inhibitor, in pts w/ advanced solid tumors Oral Sat 1:30-1:40 Ehall D2 # DrInfante # ASCO14 # SCRI",,,# # #,4.72793E+17,https://twitter.com/SarahCannonDocs/status/472792788141359104,,,,
SarahCannonDocs,5/31/2014 13:31,1,0,Encouraging evidence of clinical activity seen in pts w/ BRAF V600E mutated colon cancer. See Phase I/11 study: Poster 3 Abs#3515 # ASCO14,,,#3515 #,4.72793E+17,https://twitter.com/SarahCannonDocs/status/472792605269692417,,,,
existent_io,5/31/2014 13:31,1,1,"Check out OncoTypeDX @ GenomicHealth booth # ASCO14, learning about advances in fight against # breastcancer # coloncancer # protatecancer",,@,# # # #,4.72793E+17,https://twitter.com/existent_io/status/472792592300912640,,,,
ZamboninMarco,5/31/2014 13:31,0,0,Qualche volta ridurre i farmaci fa bene... # ASCO14 http://in.mobile.reuters.com/article/idINKBN0EA1YH20140530?irpc=932 …,,,#,4.72793E+17,https://twitter.com/ZamboninMarco/status/472792546125832194,,,,
sciberomics,5/31/2014 13:31,0,0,1+ MT @ CliffordHudis: Information tech in medicine lags other fields @ ASCO developing # CancerLinQ to catch up http://bit.ly/1gxqfJy # ASCO14,,@ @,# #,4.72792E+17,https://twitter.com/sciberomics/status/472792401028067328,,,,
practiceupdate,5/31/2014 13:30,1,0,"While at # ASCO14, you may not have a chance to attend all the sessions. Be sure to check out our conference coverage http://ow.ly/xtwnx",,,#,4.72792E+17,https://twitter.com/practiceupdate/status/472792335605321730,,,,
CancerDotNet,5/31/2014 13:30,1,1,"To help sift through # ASCO14 data, look for disease-specific hashtags on our summaries - Common list on Symplur: http://bit.ly/1oGZo0p",,,#,4.72792E+17,https://twitter.com/CancerDotNet/status/472792323139846145,,,,
theNCI,5/31/2014 13:30,12,3,"In his talk, Dr Abrams shared some of the history of the National Clinical Trials Network. # ASCO14 # NCTNpic.twitter.com/dzXoK8z0zF",,,# #,4.72792E+17,https://twitter.com/theNCI/status/472792305997709314,,,,
Novartis,5/31/2014 13:30,0,3,Posters on the future of # CML treatment will be featured at # ASCO14. Learn about the evolution of # CML: http://bit.ly/CML101,,,# # #,4.72792E+17,https://twitter.com/Novartis/status/472792283755315201,,,,
WinshipAtEmory,5/31/2014 13:30,0,0,"Abstract: Nabil Saba, MD on receptors and correlations w/clinical characteristics in squamous cell carcinoma: http://ow.ly/xsUwQ # ASCO14",,,#,4.72792E+17,https://twitter.com/WinshipAtEmory/status/472792268290932736,,,,
TargetedOnc,5/31/2014 13:30,0,1,Just finished up an interview with Dr. Suresh Ramalingam at # ASCO14! pic.twitter.com/hKeF7s2NLi,,,#,4.72792E+17,https://twitter.com/TargetedOnc/status/472792267791818753,,,,
SanofiUS,5/31/2014 13:30,0,0,Be sure to follow along with all the relevant conversations on # oncology at # ASCO14 pic.twitter.com/KvM5B0NWCD,,,# #,4.72792E+17,https://twitter.com/SanofiUS/status/472792140746350592,,,,
Damarrero22,5/31/2014 13:30,0,1,Finally done working at the McCormick place! It was fun while it lasted but I'm super glad to go back home! Goodbye # ASCO14,,,#,4.72792E+17,https://twitter.com/Damarrero22/status/472792139282538497,,,,
myPathMelanoma,5/31/2014 13:30,1,0,Be the first to learn about important updates regarding Myriad myPath # Melanoma. Sign up here: http://bit.ly/myPathinfo # ASCO14,,,# #,4.72792E+17,https://twitter.com/myPathMelanoma/status/472792127131242496,,,,
sciberomics,5/31/2014 13:29,0,0,MT @ illumina: Come by booth 20147 to learn about next generation sequencing in oncology # ASCO14 # NGSpic.twitter.com/WipbV6zRzv,,@,# #,4.72792E+17,https://twitter.com/sciberomics/status/472792045116211200,,,,
wendyselig,5/31/2014 13:29,0,0,Great day at # ASCO14! Mtgs back to back with # melanoma researchers and allies with @ MelanomaReAlli. Buzz is strong for data coming Monday,,@,# #,4.72792E+17,https://twitter.com/wendyselig/status/472791986294886401,,,,
PhRMA,5/31/2014 13:29,2,2,. @ Celgene says focusing on # clinicaltrials w/ ambitious goals could slow progress in # cancer care http://bit.ly/1hFWa # ASCO14,,@,# # #,4.72792E+17,https://twitter.com/PhRMA/status/472791912919756800,,,,
ipaulmampilly,5/31/2014 13:27,0,0,# ASCO14 no food no ice cream no Star Wars..oh it's the us med info booth pic.twitter.com/JFnX7CRAI3,,,#,4.72792E+17,https://twitter.com/ipaulmampilly/status/472791553636040704,,,,
sciberomics,5/31/2014 13:27,0,0,MT @ drdonsdizon: Big theme at # ASCO14 even in midst of amazing progress- Balance innovation w access. Everyone w cancer deserves it. # ASCO14,,@,# #,4.72792E+17,https://twitter.com/sciberomics/status/472791543431311360,,,,
OncLive,5/31/2014 13:27,4,4,Zoledronic Acid Can Be Administered Less Frequently in Breast Cancer http://ow.ly/xtxRM # ASCO14,,,#,4.72792E+17,https://twitter.com/OncLive/status/472791532719050752,,,,
DrGlenWeiss,5/31/2014 13:27,1,1,. @ ipaulmampilly: # ASCO14 $ pcyc imbruvica gets the award for the most Star Wars like booth pic.twitter.com/I50oyVWyxI” I wonder who designs these,,@,#,4.72792E+17,https://twitter.com/DrGlenWeiss/status/472791525987217409,,,,
m_e_nielsen,5/31/2014 13:27,0,1,Would be great to be there at mtg but still: Loving my seats at # asco14 thx to Twitter https://vine.co/v/MpudAdMEAp6,,,#,4.72791E+17,https://twitter.com/m_e_nielsen/status/472791448304517120,,,,
ProjectInno,5/31/2014 13:27,12,12,Find out why we are committed to accelerating cancer innovation: http://ow.ly/xtxLo # ASCO14 # innovatenow,,,# #,4.72791E+17,https://twitter.com/ProjectInno/status/472791367803207680,,,,
LungCancerFaces,5/31/2014 13:26,2,0,“ @ picardonhealth: When is a novel # cancer drug worth it? http://tinyurl.com/khkyssw # ASCO14 $ LLY $ AZN $ JNJ via @ MMarchioneAP” # LCSM,,@ @,# # #,4.72791E+17,https://twitter.com/LungCancerFaces/status/472791339319304193,,,,
Groz_P,5/31/2014 13:26,0,0,This is my trial. Going well so far. : HER2/ER # BreastCancer session on LEE011 @ # ASCO14 TMRW. Details: http://bit.ly/1k8d8y6 ”,,@,# #,4.72791E+17,https://twitter.com/Groz_P/status/472791290237947904,,,,
ipaulmampilly,5/31/2014 13:25,1,0,# ASCO14 $ pcyc imbruvica gets the award for the most Star Wars like boothpic.twitter.com/Fd5A0T4EhO,,,#,4.72791E+17,https://twitter.com/ipaulmampilly/status/472791033982779392,,,,
KUhlendorf,5/31/2014 13:25,1,0,This doesn't come close to capturing amazing scope of progress against # cancer reflected in # ASCO14 exhibition pic.twitter.com/IAv7JKZ8To,,,# #,4.72791E+17,https://twitter.com/KUhlendorf/status/472790985756262401,,,,
Boehringer,5/31/2014 13:25,1,0,# PRESS: want to know more about the relevance of EGFR mutations to the treatment of # lungcancer? http://bit.ly/TTAgaf # ASCO14,,,# # #,4.72791E+17,https://twitter.com/Boehringer/status/472790902193545216,,,,
WinshipAtEmory,5/31/2014 13:25,0,0,View schedule of abstract presentations at # ASCO14 by Winship members to start at 1:15pm CST today: http://ow.ly/xiKHP,,,#,4.72791E+17,https://twitter.com/WinshipAtEmory/status/472790894748643329,,,,
theNCI,5/31/2014 13:25,8,2,New Lung-MAP study relies on public-private partnerships - National Clinical Trials Network # NCTN # ASCO14 pic.twitter.com/COFc6pvvJD,,,# #,4.72791E+17,https://twitter.com/theNCI/status/472790880542535680,,,,
GenomicHealth,5/31/2014 13:25,0,0,Heading to Hall A2 1:15-5pm? Check out abstract 11050 - Clinical utility of 12-gene DCIS score assay: Impact on treatment (Tx) recs # ASCO14,,,#,4.72791E+17,https://twitter.com/GenomicHealth/status/472790875945598977,,,,
SamBrownInc,5/31/2014 13:24,0,0,RT @nextprinciples: This top tweeted URL shows # ASCO14 experts to follow on Twitter. http://ow.ly/xtxz6,,@nextprinciples,#,4.72791E+17,https://twitter.com/SamBrownInc/status/472790748254191617,,,,
LizDowling2,5/31/2014 13:24,2,0,"Salazar's PARSC ColoPrint study will look at outcomes at 3 & 5 yrs # ASCO14, # crsm find out why http://bit.ly/1kc4yPX pic.twitter.com/LzpVQfByVn",,,# #,4.72791E+17,https://twitter.com/LizDowling2/status/472790728100151296,,,,
sciberomics,5/31/2014 13:24,0,0,Looking forward to the # ASCO14 Tweetup tonight! # twvt,,,# #,4.72791E+17,https://twitter.com/sciberomics/status/472790635460587520,,,,
LizDowling2,5/31/2014 13:23,2,0,# ASCO14 first prospective CC study to compare gene expression & clinical risk factors - intriguing results http://bit.ly/1kc4yPX,,,#,4.72791E+17,https://twitter.com/LizDowling2/status/472790517466398721,,,,
Frank_S_David,5/31/2014 13:23,0,1,Phoenix seems2b go-to # ASCO14 Chinatown eatery - many other blue blazers here besides mine! Worth every step of 15 min walk from conference.,,,#,4.72791E+17,https://twitter.com/Frank_S_David/status/472790510315520000,,,,
LizDowling2,5/31/2014 13:22,0,0,Salazar # ASCO14 prospective study # crsm shows marked diff in NCCN risk classification and and genomic ColoPrint http://bit.ly/1kc4yPX,,,# #,4.7279E+17,https://twitter.com/LizDowling2/status/472790357168513025,,,,
ASCOPost,5/31/2014 13:22,8,5,Women With BRCA Mutations Report Significant Side Effects Following Risk-Reducing Salpingo-Oophorectomy http://ow.ly/xtxkI # ASCO14,,,#,4.7279E+17,https://twitter.com/ASCOPost/status/472790304282902529,,,,
ipaulmampilly,5/31/2014 13:22,1,0,# ASCO14 biosimilars? Don't tell $ amgn these guys are back herepic.twitter.com/Z5h1wry4hv,,,#,4.7279E+17,https://twitter.com/ipaulmampilly/status/472790293608431617,,,,
BGI_Genomics,5/31/2014 13:22,2,1,Attending # ASCO14 ? Visit us at booth 19140 to learn more about the latest NGS strategies for # cancer research at BGIpic.twitter.com/0PxQoKETTJ,,,# #,4.7279E+17,https://twitter.com/BGI_Genomics/status/472790262377635840,,,,
ben_ellingson,5/31/2014 13:22,0,0,# asco2014 @McCormick Place Chicago Convention Center/Chicago ILL. http://instagram.com/p/oq1-inoHLM/,,@McCormick,#,4.7279E+17,https://twitter.com/ben_ellingson/status/472790248490283008,,,,
ShannonWestin,5/31/2014 13:21,0,0,Enjoying a lakeside lunch before the gyn cancer oral session # ASCO14 pic.twitter.com/mG9yzeInMS,,,#,4.7279E+17,https://twitter.com/ShannonWestin/status/472790060698329089,,,,
k8ethics,5/31/2014 13:21,0,0,RT @ Cascadia: Factors affecting communication patterns between oncology staff and bereaved families: http://abstracts.asco.org/144/AbstView_144_133041.html … # ASCO14 # EOLC,,@,# #,4.7279E+17,https://twitter.com/k8ethics/status/472790022270484481,,,,
nxtstop1,5/31/2014 13:21,1,0,"Mind 2 Mind,Heart 2 Heart @ drdonsdizon: @ LarryNortonMD @ ASCOPost @ DrAnasYounes Healers & those impacted directly must define value. # ASCO14”",,@ @ @ @,#,4.7279E+17,https://twitter.com/nxtstop1/status/472790020546256896,,,,
existent_io,5/31/2014 13:20,0,0,# ASCO14 is filling up. Learning the latest in the # fightagainstcancerpic.twitter.com/kOKL8dxRwU,,,# #,4.7279E+17,https://twitter.com/existent_io/status/472789718493839360,,,,
scarlett_0hara,5/31/2014 13:20,0,0,# moms MT @ CliffordHudis: Investmnt in # cancer research not commensurate 2 problem & @ theNCI has lost 23% of its 2003 purchasng power # ASCO14,,@ @,# # #,4.7279E+17,https://twitter.com/scarlett_0hara/status/472789713355804672,,,,
dougulman,5/31/2014 13:20,0,1,Catching up with @AbZtotheGail on the @ SouthwestAir flight to Chicago # ASCO14,,@AbZtotheGail @,#,4.7279E+17,https://twitter.com/dougulman/status/472789713187663875,,,,
LungCancerFaces,5/31/2014 13:20,2,1,Shocker MT @ VincentRK: Sad @ Neil_Iyengar: Proportion of US federal funding allocated to cancer research # ASCO14 pic.twitter.com/AIGtaXCFHX # LCSM,,@ @,# #,4.7279E+17,https://twitter.com/LungCancerFaces/status/472789690295132160,,,,
NovartisScience,5/31/2014 13:20,1,1,HER2/ER # BreastCancer session on LEE011 @ # ASCO14 TMRW. Details: http://bit.ly/1k8d8y6,,@,# #,4.7279E+17,https://twitter.com/NovartisScience/status/472789682322153472,,,,
JanBresch,5/31/2014 13:20,10,5,Another hit at # ASCO14 @ preventcancer newsletter w/ piece on @ jeffpulver Living With Intentionpic.twitter.com/cKvg0kNhD7,,@ @,#,4.7279E+17,https://twitter.com/JanBresch/status/472789670410342400,,,,
theNCI,5/31/2014 13:20,7,7,"Here's another slide from Dr Abrams: Developing a National Strategy for Precision Medicine"" # ASCO14 pic.twitter.com/B7fbvtdwOY""",,,#,4.7279E+17,https://twitter.com/theNCI/status/472789623736119297,,,,
nycdoc29,5/31/2014 13:19,0,1,How strange! Myriad Booth $ MYGN across the aisle from CAP booth. Guess it's ASCO's way of smoothing hard feelings. # ASCO14 # bcsm,,,# #,4.7279E+17,https://twitter.com/nycdoc29/status/472789595143565312,,,,
DrBobGoldberg,5/31/2014 13:19,1,0,@ drdonsdizon @ LarryNortonMD @ ASCOPost @ DrAnasYounes yes. We must strengthen the relationship between doctor and patient # asco14 # mliwi,,@ @ @ @,# #,4.7279E+17,https://twitter.com/DrBobGoldberg/status/472789545579466752,,,,
CancerNetwrk,5/31/2014 13:19,3,0,RT @CoCancerCenter One step closer to a breath test for # lungcancer # lcsm # ASCO14 http://bit.ly/1hJQXtJ,,@CoCancerCenter,# # #,4.7279E+17,https://twitter.com/CancerNetwrk/status/472789519289581568,,,,
PhRMA,5/31/2014 13:19,5,2,# PhRMA CEO: ‘60s insurance model discourages use of innovative meds & encourages more costly hospitalizations http://bit.ly/1nDaGmT # ASCO14,,,# #,4.72789E+17,https://twitter.com/PhRMA/status/472789381963456513,,,,
GlopesMd,5/31/2014 13:18,2,2,# ASCO14 - Obesity is the new tobacco! pic.twitter.com/TGDgUGIN1I,,,#,4.72789E+17,https://twitter.com/GlopesMd/status/472789263503745024,,,,
nxtstop1,5/31/2014 13:18,0,1,EACH PATIENT IS A PEARL. Pinedo. Tweet Of The Day~~~ # ASCO14,,,#,4.72789E+17,https://twitter.com/nxtstop1/status/472789148885995521,,,,
afreshchapter,5/31/2014 13:18,0,1,@ LurieCancer Do you have a booth at # asco14? Would be great to stop by and say hello.,,@,#,4.72789E+17,https://twitter.com/afreshchapter/status/472789148844437505,,,,
FirstReportMC,5/31/2014 13:18,0,0,Results of the RESONATE trial were published today in the NEJM - http://www.nejm.org/doi/full/10.1056/NEJMoa1400376?query=featured_home … ; Read our story at http://www.firstreportnow.com/first/ibrutinib-superior-ofatumumab-patients-previously-treated-chronic-lymphocytic-leukemia-or-smal … # ASCO14,,,#,4.72789E+17,https://twitter.com/FirstReportMC/status/472789122206011392,,,,
nanostringtech,5/31/2014 13:18,0,1,"We invite # ASCO14 attendees to visit us at booth 5019, located near @ ASCO Central.",,@,#,4.72789E+17,https://twitter.com/nanostringtech/status/472789121467834368,,,,
FierceBiotech,5/31/2014 13:17,1,1,Tune in Sunday @2:30 ET for an # ASCO14 chat w @DamianFierce & @ MarkSchoenebaum. Follow # FierceASCO. More info here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …,,@2 @DamianFierce @,# #,4.72789E+17,https://twitter.com/FierceBiotech/status/472789053910577152,,,,
ZamboninMarco,5/31/2014 13:17,0,1,# ASCO14 hashtag per seguire i tweet relativi al congresso americano di # oncologia in corso in questi giorni. # cancro # tumori # medicina,,,# # # # #,4.72789E+17,https://twitter.com/ZamboninMarco/status/472789032326680577,,,,
QIAGENscience,5/31/2014 13:17,1,2,Stop by our # ASCO14 booth #5013 to get your Blood # Cancer Biomarker Chart!pic.twitter.com/d90LXW0ZnZ,,,# #5013 #,4.72789E+17,https://twitter.com/QIAGENscience/status/472788950764257280,,,,
DrLen,5/31/2014 13:17,2,2,"Dr Pinedo talks of his daughter w/ ovarian ca. This was not planned.We all have pearls in our lives.This was my pearl. # ASCO14""",,,#,4.72789E+17,https://twitter.com/DrLen/status/472788908917665792,,,,
brandonmancini,5/31/2014 13:17,0,0,“ @ ASCO: # ASCO14 press briefing. Today's topic: What's new in targeted therapies http://ow.ly/i/5KyP8 ” # cancernews,,@,# #,4.72789E+17,https://twitter.com/brandonmancini/status/472788906803724288,,,,
BayerPharma,5/31/2014 13:15,5,1,42% of metastatic patients with differentiated # thyroidcancer will fail to respond to radioactive iodine # ASCO14 http://bit.ly/1nG3941,,,# #,4.72789E+17,https://twitter.com/BayerPharma/status/472788509481512960,,,,
ipaulmampilly,5/31/2014 13:15,0,0,# ASCO14 national institute of health lends money? pic.twitter.com/r1QmlPraMX,,,#,4.72788E+17,https://twitter.com/ipaulmampilly/status/472788497208991744,,,,
FirstReportMC,5/31/2014 13:15,0,0,Here's our story from the ASCO meeting on phase 3 trial of ibrutinib beating ofatumumab in CLL patients - http://www.firstreportnow.com/first/ibrutinib-superior-ofatumumab-patients-previously-treated-chronic-lymphocytic-leukemia-or-smal … # ASCO14,,,#,4.72788E+17,https://twitter.com/FirstReportMC/status/472788388991352832,,,,
myPathMelanoma,5/31/2014 13:15,2,0,Thank you to everyone who stopped by our poster presentation this morning! If you have more questions visit us at booth 2039 # ASCO14,,,#,4.72788E+17,https://twitter.com/myPathMelanoma/status/472788347497107456,,,,
LungCancerFaces,5/31/2014 13:14,0,1,THIS MT @ KUhlendorf: Measuring value in cancer care more complicated than just adding up costs of medicines per @ CliffordHudis # ASCO14 # LCSM,,@ @,# #,4.72788E+17,https://twitter.com/LungCancerFaces/status/472788331307081729,,,,
christinemphmd,5/31/2014 13:14,0,0,# networking extravaganza in the # ASCO14 cafe pic.twitter.com/EZKXxosjpB,,,# #,4.72788E+17,https://twitter.com/christinemphmd/status/472788287518949376,,,,
AlpineBV_Miller,5/31/2014 13:13,0,0,@ ASCO Any chance you could extend the poster display hours on 6/1 in S405/E345b to end at 11:45a instead of 11a?,,@,,4.72788E+17,https://twitter.com/AlpineBV_Miller/status/472788053191589888,,,,
afreshchapter,5/31/2014 13:13,0,0,Longest # Starbucks line of my life at # asco14 # conferences & # caffeine. # worththewait http://instagram.com/p/oq07vYsgeC/,,,# # # # #,4.72788E+17,https://twitter.com/afreshchapter/status/472787955573354497,,,,
ipaulmampilly,5/31/2014 13:13,3,0,# ASCO14 the other side says... pic.twitter.com/yMRPd14nWt,,,#,4.72788E+17,https://twitter.com/ipaulmampilly/status/472787874258358272,,,,
ancasa2000,5/31/2014 13:13,1,0,It can happen to all of us (Dr Pinedo) Certainly we all have a touching history near us about cancer # ASCO14,,,#,4.72788E+17,https://twitter.com/ancasa2000/status/472787843115253763,,,,
theNCI,5/31/2014 13:11,12,4,Dr. Abrams: The # NCTN will allow greater collaboration than ever before. Here's the structure. # ASCO14 pic.twitter.com/lIgilFsRLk,,,# #,4.72788E+17,https://twitter.com/theNCI/status/472787523794894848,,,,
ipaulmampilly,5/31/2014 13:11,1,0,# ASCO14 one of the more unusual booths mini breathing nose pic.twitter.com/csdchmi5DQ,,,#,4.72787E+17,https://twitter.com/ipaulmampilly/status/472787463459831808,,,,
NateDahlPharmD,5/31/2014 13:11,0,0,RT @ ASCOPost: Cancer doctors urged to consider value when treating patients (via Chicago Tribune) http://ow.ly/xtsp7 # ASCO14,,@,#,4.72787E+17,https://twitter.com/NateDahlPharmD/status/472787436104204288,,,,
DrMarkham,5/31/2014 13:10,1,0,"# lymsm MT @ NEJM: RESONATE: Ibrutinib improves PFS, overall survival, and RR, in prev treated CLL. # ASCO14 http://nej.md/1hvgQ05",,@,# #,4.72787E+17,https://twitter.com/DrMarkham/status/472787275944710144,,,,
Gene_Antibody,5/31/2014 13:10,0,0,Exploring our pipeline at # asco14 http://instagram.com/p/oq0m8-Q93i/,,,#,4.72787E+17,https://twitter.com/Gene_Antibody/status/472787240905474048,,,,
theNCI,5/31/2014 13:10,0,0,We are sharing some slides from Dr Jeffrey Abram's talk on precision medicine & NCI's new National Clinical Trials Network. # NCTN # ASCO14,,,# #,4.72787E+17,https://twitter.com/theNCI/status/472787113898147840,,,,
myriadgenetics,5/31/2014 13:10,2,1,Attending # ASCO14? Visit us at Booth 2039 to find out about our # BRACAnalysis # CDx with # PARP inhibitors! http://bit.ly/1tWn80k # cancer,,,# # # # #,4.72787E+17,https://twitter.com/myriadgenetics/status/472787090296418305,,,,
DrMarkham,5/31/2014 13:09,1,3,RT @ mtmdphd: Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://ow.ly/xmCr3,,@ @,#,4.72787E+17,https://twitter.com/DrMarkham/status/472786836994019328,,,,
sesiegler,5/31/2014 13:08,0,0,". @ CancerDotNet @ ASCO Finally, a non misleading headline. If it extends life", it is non curative.,,@ @,,4.72787E+17,https://twitter.com/sesiegler/status/472786812688424960,,,
SiemensHealth,5/31/2014 13:08,3,0,"Tomorrow at # ASCO14, we are offering a Symposium, Advanced Imaging for Oncological Therapy Stratification"". Register http://ow.ly/3ld0K6""",,,#,4.72787E+17,https://twitter.com/SiemensHealth/status/472786799048531968,,,,
MLIWI,5/31/2014 13:08,2,1,RT @ DrBobGoldberg: Increasing life expectancy the most powerful driver of social equality. # asco14.,,@,#,4.72787E+17,https://twitter.com/MLIWI/status/472786791603634177,,,,
ipaulmampilly,5/31/2014 13:08,0,0,# ASCO14 food ice cream even to get you to stop and listen.. pic.twitter.com/0TgOMricR9,,,#,4.72787E+17,https://twitter.com/ipaulmampilly/status/472786775422029824,,,,
VincentRK,5/31/2014 13:08,4,0,Sad “ @ Neil_Iyengar: Proportion of US federal funding allocated to cancer research. Yikes. # ASCO14 pic.twitter.com/4SQD2YQWBL”,,@,#,4.72787E+17,https://twitter.com/VincentRK/status/472786651198930945,,,,
WinshipAtEmory,5/31/2014 13:06,1,1,Winship # lungcancer expert @ RamalingamMD being interviewed by @ OncLive at # ASCO14 pic.twitter.com/4BBOTJgA5N,,@ @,# #,4.72786E+17,https://twitter.com/WinshipAtEmory/status/472786310378561536,,,,
CancerAfrica,5/31/2014 13:06,0,0,# ASCO14 @ iConquerCancer @ ASCO patient cancer advocates lunch meeting in S402 pic.twitter.com/eFGvM81PHz,,@ @,#,4.72786E+17,https://twitter.com/CancerAfrica/status/472786298965860352,,,,
CUCancerCenter,5/31/2014 13:06,8,7,One step closer to a breath test for # lungcancer # lcsm # ASCO14 http://bit.ly/1hJQXtJ,,,# # #,4.72786E+17,https://twitter.com/CUCancerCenter/status/472786273074049024,,,,
ipaulmampilly,5/31/2014 13:06,0,0,# ASCO14 most purple booth award Otsuka phama... pic.twitter.com/DDPaFvqQ33,,,#,4.72786E+17,https://twitter.com/ipaulmampilly/status/472786208566022144,,,,
TapKadia,5/31/2014 13:06,0,0,# Leukemia poster highlights session at # ASCO14 in room S405 and S406.,,,# #,4.72786E+17,https://twitter.com/TapKadia/status/472786161086525440,,,,
withyouDrWu,5/31/2014 13:06,1,1,"“ @ WilliamDale_MD: # ASCO14 Hurria: Challenges are just opportunities in disguise. Unless they happen to you""",,@,#,4.72786E+17,https://twitter.com/withyouDrWu/status/472786149178892288,,,,
ECMC_UK,5/31/2014 13:05,0,0,Vertex show interest in the ECMC Combinations Allaince at # ASCO14 with discussions with RaDCom for radiotherapy combinations,,,#,4.72786E+17,https://twitter.com/ECMC_UK/status/472785946220310528,,,,
mtmdphd,5/31/2014 13:05,1,2,Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://ow.ly/xmCr3,,@,#,4.72786E+17,https://twitter.com/mtmdphd/status/472785927098884097,,,,
genentech,5/31/2014 13:05,2,5,"In the # Next50 yrs: Role of surgical onc will evolve into quarterback of care..."" – M.E. Widmer # ASCO14 # REV2014pic.twitter.com/RGlgiJsujH""",,,# # #,4.72786E+17,https://twitter.com/genentech/status/472785893770932224,,,,
ipaulmampilly,5/31/2014 13:05,0,0,# ASCO14 murals by cancer docs... pic.twitter.com/WLDQbzrNKd,,,#,4.72786E+17,https://twitter.com/ipaulmampilly/status/472785847063162880,,,,
elmundosalud,5/31/2014 13:04,8,2,Además de hablar de nuevos fármacos en # ASCO14 también tratan la calidad de vida del paciente con estudios científico. Una buena iniciativa,,,#,4.72786E+17,https://twitter.com/elmundosalud/status/472785740410392577,,,,
hoosiercancer,5/31/2014 13:04,0,1,"Attending # ASCO14? Stop by the @ HoosierCancer booth 18164, near the food court.pic.twitter.com/DGv4Esls1I",,@,#,4.72786E+17,https://twitter.com/hoosiercancer/status/472785707032121344,,,,
nxtstop1,5/31/2014 13:03,0,0,@ withyouDrWu @ picardonhealth @ MMarchioneAP If Don't Have Money? If truly better -not just months- Shd B covered?Price Negotiation? # ASCO14,,@ @ @,#,4.72786E+17,https://twitter.com/nxtstop1/status/472785522897612800,,,,
amylmurphy10,5/31/2014 13:03,1,0,“ @ MMarchioneAP: When is a novel # cancer drug worth it? http://tinyurl.com/khkyssw # ASCO14 $ LLY $ AZN $JNJ” @Carolinas Dr Raghavan weighs in # LCI,,@ @Carolinas,# # #,4.72785E+17,https://twitter.com/amylmurphy10/status/472785418455617536,,,,
ipaulmampilly,5/31/2014 13:03,0,0,# ASCO14 free meals served by $ nwbo big hitpic.twitter.com/IhPf3EVRt9,,,#,4.72785E+17,https://twitter.com/ipaulmampilly/status/472785370858663936,,,,
JediPD,5/31/2014 13:02,1,0,+1 RT @ teamoncology: Our group to present impact of Oncotype DX on adjuvant therapy in stage I breast cancer. http://abstracts.asco.org/144/AbstView_144_133769.html … # ASCO14,,@,#,4.72785E+17,https://twitter.com/JediPD/status/472785115647864832,,,,
jdflaysakier,5/31/2014 13:02,18,2,Cancer de l'ovaire récidivant : la combinaison Olaparib-Cediranib freine la maladie pendant quasiment 18 mois # ASCO14,,,#,4.72785E+17,https://twitter.com/jdflaysakier/status/472785106826838016,,,,
Novartis,5/31/2014 13:01,0,1,# Novartis is committed to the # NETCancer community. Visit our booth at # ASCO14 to learn more.,,,# # #,4.72785E+17,https://twitter.com/Novartis/status/472785068663255040,,,,
ASCO,5/31/2014 13:01,0,0,Need technical assistance with an # ASCO14 product? Visit our experts at Technology & App Central in Concierge Services,,,#,4.72785E+17,https://twitter.com/ASCO/status/472785005950025728,,,,
DrMarkham,5/31/2014 13:01,8,5,"From the @ ASCO Ed Book - Ovarian Cancer: Targeting the Untargetable, by Dr. Michael Birrer, http://meetinglibrary.asco.org/content/114000013-144 … # gyncsm # ASCO14",,@,# #,4.72785E+17,https://twitter.com/DrMarkham/status/472785004712701953,,,,
EncoreBioMed,5/31/2014 13:01,0,0,Less frequent # bisphosphonate dosing okay for # breastcancer after the first year # ASCO14 http://bit.ly/1ktJ1wq,,,# # #,4.72785E+17,https://twitter.com/EncoreBioMed/status/472784965328207872,,,,
ASCO,5/31/2014 13:01,1,3,Drs. Kim & Rudin discuss the association between the Hedgehog pathway and various tumors http://bit.ly/1nxhh27 # ASCO14,,,#,4.72785E+17,https://twitter.com/ASCO/status/472784957124141058,,,,
ipaulmampilly,5/31/2014 13:01,0,0,# ASCO14 custom color stethoscopes pic.twitter.com/TSglndPSKl,,,#,4.72785E+17,https://twitter.com/ipaulmampilly/status/472784908524732416,,,,
Roche,5/31/2014 13:01,3,3,"Testing times for Personalised # Healthcare? Huge potential benefits, but a gap in understanding: http://ow.ly/xkPBO # ASCO14",,,# #,4.72785E+17,https://twitter.com/Roche/status/472784834843402242,,,,
ASCO,5/31/2014 13:00,4,2,"Your chance to discuss # cancer care w/ fellow Tweeters is today @ # ASCO14 Tweetup 5:45 in South Building, Level 2.5 Food Court",,@,# #,4.72785E+17,https://twitter.com/ASCO/status/472784811015565312,,,,
corp_UNC,5/31/2014 13:00,3,0,"Breast cancer screening in younger women N.Beri, Stephanie Wheeler @ unchpm @ UNC_Lineberger et al # asco14 http://ow.ly/xqAEm",,@ @,#,4.72785E+17,https://twitter.com/corp_UNC/status/472784779264688128,,,,
CancerDotNet,5/31/2014 13:00,4,4,# ASCO14 Research: Combining ramucirumab & chemo as 2nd line trtmt lengthens lives of pts w/ # NSCLC # lcsm http://bit.ly/1kv2sdr,,,# # #,4.72785E+17,https://twitter.com/CancerDotNet/status/472784752433692672,,,,
FoundationATCG,5/31/2014 13:00,6,2,"Physicians using # FoundationOne change treatment decisions for 28% of patients Poster Pres: 1:15-5pm, S Hall A2 # ASCO14, Ab 11109 @ CCCNevada",,@,# #,4.72785E+17,https://twitter.com/FoundationATCG/status/472784631452803073,,,,
ipaulmampilly,5/31/2014 13:00,0,0,# ASCO14 cancer geeks eat healthy pic.twitter.com/sA7boahcm7,,,#,4.72785E+17,https://twitter.com/ipaulmampilly/status/472784612503351296,,,,
maryguiden,5/31/2014 12:59,0,0,MT@ConsanoScott: # Cancer researchers looking to fund your innovative project? Stop by @ Consano booth at # ASCO14 to talk # crowdfunding!,,@ConsanoScott @,# # #,4.72785E+17,https://twitter.com/maryguiden/status/472784502134018049,,,,
amylmurphy10,5/31/2014 12:59,1,1,@Carolinas HealthCare System's Levine Cancer Institute President Derek Raghavan talks value of treatment @ AP # ASCO14 http://news.yahoo.com/drugs-may-dent-lung-ovarian-cancer-141658078.html;_ylt=AwrBJR5ECYpTfwcAGfiZmolQ …,,@Carolinas @,#,4.72784E+17,https://twitter.com/amylmurphy10/status/472784362153713664,,,,
jdflaysakier,5/31/2014 12:59,0,0,Salle de presse # ASCO14. Ça travaille dur mais en guettant d'un œil le buffet installé au fond de la salle ! pic.twitter.com/gxIVduQOjg,,,#,4.72784E+17,https://twitter.com/jdflaysakier/status/472784350480588800,,,,
Oncoinfo_it,5/31/2014 12:59,1,2,S.Cascinu: Attività fisica," dieta e screening per rendere sostenibile la spesa"" # ASCO14 pic.twitter.com/9AgxE59Xqg""",,,#,4.72784E+17,https://twitter.com/Oncoinfo_it/status/472784329333276672,,,
ASCO,5/31/2014 12:58,14,2,"The Patient Perspective on Value in Cancer Care by Diane Blum, MSW http://bit.ly/1mVJfRE # ASCO14",,,#,4.72784E+17,https://twitter.com/ASCO/status/472784273356128256,,,,
withyouDrWu,5/31/2014 12:58,1,1,“ @ picardonhealth: When is a novel # cancer drug worth it? # ASCO14 $ LLY $ AZN $ JNJ via @ MMarchioneAP” when it's you and you've got the $,,@ @,# #,4.72784E+17,https://twitter.com/withyouDrWu/status/472784097539264512,,,,
trutane,5/31/2014 12:57,0,1,"@ caitlin_hool try gesundheit"" next time ;) # ASCO14""",,@,#,4.72784E+17,https://twitter.com/trutane/status/472784063430815744,,,,
YaleCancer,5/31/2014 12:57,1,0,YCC Dir. Tom Lynch discusses emerging drugs for lung ca. mutations with Chinese Soc. for Clinical Oncology # asco14 pic.twitter.com/mM6RUqY4mK,,,#,4.72784E+17,https://twitter.com/YaleCancer/status/472784039032930305,,,,
ConsanoScott,5/31/2014 12:57,0,0,Help @ drdonsdizon answer important questions for women living with advanced # cancer https://www.youtube.com/watch?v=sgpLgXTDm4g … # SurvivorsWithCancer # ASCO14,,@,# # #,4.72784E+17,https://twitter.com/ConsanoScott/status/472784022737674240,,,,
PhRMA,5/31/2014 12:57,3,0,. @ Celgene explains why # patient interests & new treatment options shouldn’t be lost in the cost discussion http://bit.ly/1lXRIjY # ASCO14,,@,# #,4.72784E+17,https://twitter.com/PhRMA/status/472783820144377858,,,,
nxtstop1,5/31/2014 12:56,0,0,PALLIATION: YES WE CAN! @ lrn_brk: ASCO looks to improve medical education on palliative care # ASCO14 http://bit.ly/1nPGna8 ”,,@,#,4.72784E+17,https://twitter.com/nxtstop1/status/472783628322095105,,,,
ShabbirHossain,5/31/2014 12:55,1,1,“ @ christinemphmd: Each patient is a pearl, HM (Bob) Pinedo. # ASCO14 # patientcare” # meded,,@,# # #,4.72784E+17,https://twitter.com/ShabbirHossain/status/472783546541957120,,,
teamoncology,5/31/2014 12:55,0,0,Nonmetastatic IBC: Evolution of invasive disease-free (IDFS) and overall survival (OS) over a 21-year period. # ASCO14 http://abstracts.asco.org/144/index.html,,,#,4.72783E+17,https://twitter.com/teamoncology/status/472783440945762304,,,,
lrn_brk,5/31/2014 12:55,0,0,ASCO looks to improve medical education on palliative care # ASCO14 http://bit.ly/1nPGna8,,,#,4.72783E+17,https://twitter.com/lrn_brk/status/472783337317498880,,,,
theNCI,5/31/2014 12:55,10,2,"Here's a glimpse of round one"" of the new Lung-MAP clinical trial. # NCTN # ASCO14 pic.twitter.com/3sNEBiXgj1""",,,# #,4.72783E+17,https://twitter.com/theNCI/status/472783330510127104,,,,
theNCI,5/31/2014 12:55,7,1,Have you heard of NCI's Exceptional Responders initiative? Some details from Dr Abrams' talk at # ASCO14: pic.twitter.com/5ydRWMpbdv,,,#,4.72783E+17,https://twitter.com/theNCI/status/472783328916287488,,,,
teamoncology,5/31/2014 12:54,1,0,Prognostic power of molecular subtypes in inflammatory breast cancer: A multicentric study. # ASCO14 http://abstracts.asco.org/144/index.html,,,#,4.72783E+17,https://twitter.com/teamoncology/status/472783237412970496,,,,
bradloncar,5/31/2014 12:54,0,0,Saw Pascal Soriot on the exhibition floor. Always impressed with CEOs who get out there. $ AZN # ASCO14,,,#,4.72783E+17,https://twitter.com/bradloncar/status/472783220002795520,,,,
rsm2800,5/31/2014 12:54,1,1,RT @ teamoncology Our group will present impact of Oncotype DX on adjuvant therapy for stage I breast ca http://abstracts.asco.org/144/AbstView_144_133769.html … # ASCO14 # bcsm,,@,# #,4.72783E+17,https://twitter.com/rsm2800/status/472783211336982530,,,,
OncEd,5/31/2014 12:53,4,2,RCTs Examining CS vs IS of Delivering Systematic Tx for Untreated mCRC @ scottrberry # ASCO14 @ cancercare_onpic.twitter.com/Fkrmgenka6,,@ @,#,4.72783E+17,https://twitter.com/OncEd/status/472783047293550592,,,,
dukeleuk,5/31/2014 12:53,0,0,"Value if less is more"" treatment strategies in palliative care. # ASCO14""",,,#,4.72783E+17,https://twitter.com/dukeleuk/status/472782927760064512,,,,
teamoncology,5/31/2014 12:53,0,0,A retrospective review of clinical and pathologic aspects of inflammatory breast cancer: # ASCO14 http://abstracts.asco.org/144/index.html,,,#,4.72783E+17,https://twitter.com/teamoncology/status/472782887310204930,,,,
lrn_brk,5/31/2014 12:53,1,0,"The Patient Perspective on Value in Cancer Care by Diane Blum, MSW # ASCO14 # ASCODailyNews http://bit.ly/1iG50Rg",,,# #,4.72783E+17,https://twitter.com/lrn_brk/status/472782873070952448,,,,
staciawag,5/31/2014 12:53,1,1,At # ASCO14 sharing the great programs # cbtf. Come to booth 2035.pic.twitter.com/0x47KH2tmN,,,# #,4.72783E+17,https://twitter.com/staciawag/status/472782870457896960,,,,
jseguritan,5/31/2014 12:51,0,0,Clinical role in squamous NSCLC? RT @ matthewherper: Lilly Lung # Cancer Drug May Succeed Where Avastin Failed # ASCO14 http://onforb.es/1kv2Fgy,,@,# #,4.72783E+17,https://twitter.com/jseguritan/status/472782500742197248,,,,
Cascadia,5/31/2014 12:51,4,2,Factors affecting communication patterns between oncology staff and bereaved families: http://abstracts.asco.org/144/AbstView_144_133041.html … # ASCO14 # EOLC,,,# #,4.72782E+17,https://twitter.com/Cascadia/status/472782377627172864,,,,
lrn_brk,5/31/2014 12:51,0,0,"In her final year as Editor, Dr. Morrow reflects on # ASCODailyNews # ASCO14 http://bit.ly/RPFAcC",,,# #,4.72782E+17,https://twitter.com/lrn_brk/status/472782369154666497,,,,
DebMaskens,5/31/2014 12:51,1,1,RT @ DasLebenshaus: Neues vom # ASCO14 -- my international IKCC colleague Berit Eberhardt is live blogging # kidneycancer updates in German...,,@,# #,4.72782E+17,https://twitter.com/DebMaskens/status/472782358157213697,,,,
teamoncology,5/31/2014 12:51,3,1,Our group will present impact of Oncotype DX on adjuvant therapy for stage I breast cancer. http://abstracts.asco.org/144/AbstView_144_133769.html … # ASCO14,,,#,4.72782E+17,https://twitter.com/teamoncology/status/472782313793662976,,,,
DebiopharmNews,5/31/2014 12:50,0,0,# ASCO14 How do we develop drug today? With the future # patient in mind ! http://ow.ly/x93Fi,,,# #,4.72782E+17,https://twitter.com/DebiopharmNews/status/472782140405739521,,,,
rsm2800,5/31/2014 12:49,0,0,"Pinedo: Extracted 600 ml fluid from center of tumor in pt w/ LMS, found much higher levels of VEGF in tumor c/w plasma # asco14",,,#,4.72782E+17,https://twitter.com/rsm2800/status/472782024768368640,,,,
teamoncology,5/31/2014 12:49,0,0,"Congratulations. RT @ CliffordHudis: . @ ASCO is setting records with ≥ 5000 accepted abstracts, more than 33,000 attendees expected # ASCO14",,@ @,#,4.72782E+17,https://twitter.com/teamoncology/status/472781966287200257,,,,
Emory_R,5/31/2014 12:49,1,2,Clovis preps for a blockbuster showdown with AstraZeneca http://buff.ly/1nDwC17 $ CLVS # ASCO14,,,#,4.72782E+17,https://twitter.com/Emory_R/status/472781961116004352,,,,
DrAnasYounes,5/31/2014 12:49,3,3,"RT @ ASCOPost: New drugs may make a dent in lung, ovarian cancer (via Washington Post) http://bit.ly/1wHjeL1 # ASCO14 # lcsm # ovca",,@,# # #,4.72782E+17,https://twitter.com/DrAnasYounes/status/472781869251981312,,,,
teamoncology,5/31/2014 12:49,1,1,Our group is presenting new TNBC molecular classification using protein based technology (RPPA). http://abstracts.asco.org/144/AbstView_144_132516.html … # ASCO14,,,#,4.72782E+17,https://twitter.com/teamoncology/status/472781833306779649,,,,
SophiaCeulemans,5/31/2014 12:49,0,0,"Heading to # ASCO14 and ran into the pink-wearing crowd of # avonwalkCH for # breastcancer, interesting timing",,,# # #,4.72782E+17,https://twitter.com/SophiaCeulemans/status/472781803623706624,,,,
OncoGenexPharma,5/31/2014 12:48,1,0,$ OGXI has partnered with @ GildasClubCHI to raise awareness about Treatment Resistance. Learn more:Booth 23085 # ASCO14 pic.twitter.com/eUVfAlrEQ4,,@,#,4.72782E+17,https://twitter.com/OncoGenexPharma/status/472781747542065152,,,,
MarkSchoenebaum,5/31/2014 12:48,43,1,THIS IS IMPORTANT! GREAT WORK MATT!  @ matthewherper: Squam vs. non-squam HR for ramu: OS, non-squam 0.83," squam 0.88. $ LLY # ASCO14""""",,@,#,4.72782E+17,https://twitter.com/MarkSchoenebaum/status/472781698267373568,,
drdonsdizon,5/31/2014 12:48,1,0,@ LarryNortonMD @ ASCOPost @ DrAnasYounes Healers and those impacted directly must define value. # ASCO14,,@ @ @,#,4.72782E+17,https://twitter.com/drdonsdizon/status/472781692378181632,,,,
DrAnasYounes,5/31/2014 12:48,1,2,RT @ ProfJohnCrown: Yes great speech “ @ sloan_kettering: Amazing presidential address by @ CliffordHudis. We are so proud of him! # ASCO14”,,@ @ @,#,4.72782E+17,https://twitter.com/DrAnasYounes/status/472781651978637313,,,,
ConsanoScott,5/31/2014 12:48,3,2,Calling all # cancer researchers. Looking to fund your innovative project? Stop by the @ Consano booth at # ASCO14 to talk # crowdfunding!,,@,# # #,4.72782E+17,https://twitter.com/ConsanoScott/status/472781590674685952,,,,
CancerMedMDA,5/31/2014 12:45,0,0,"Dr. Pam Sharma, Genitourinary Medical Oncology, discusses PD-1 inhibition to # endcancer. Sat. 4 PM. # ASCO14",,,# #,4.72781E+17,https://twitter.com/CancerMedMDA/status/472780905942351872,,,,
ASCO,5/31/2014 12:45,2,3,. @ rschilsky discusses our continued call for renewed commitment to federal funding of cancer research http://bit.ly/1rtMHIr # ASCO14,,@,#,4.72781E+17,https://twitter.com/ASCO/status/472780880554258432,,,,
MoffittResearch,5/31/2014 12:45,0,1,Dr. Scott Antonia's poster presentation on Nivolumab in combo with chemo for non-small cell lung cancer is about to begin. # ASCO14,,,#,4.72781E+17,https://twitter.com/MoffittResearch/status/472780844680347648,,,,
katellington,5/31/2014 12:45,0,0,Knowing when not to tweet is important. See @ drdonsdizon: Follow simple guidance/stay safe out there. # ASCO14 pic.twitter.com/s06gQpPvsY MT,,@,#,4.72781E+17,https://twitter.com/katellington/status/472780800501366784,,,,
drdonsdizon,5/31/2014 12:44,0,1,@ nxtstop1 TYSM The tweets are certainly flying! # ASCO14,,@,#,4.72781E+17,https://twitter.com/drdonsdizon/status/472780749368610816,,,,
RiboGuy,5/31/2014 12:44,0,0,"Which he does every year & not wrong yet @ OncologyTimes Lee Hood, # ASCO14 predicts more change in medicine in next 5-10 yrs than the past 50",,@,#,4.72781E+17,https://twitter.com/RiboGuy/status/472780746034130945,,,,
m0370,5/31/2014 12:44,0,0,あちらの夜が明けた途端に # ASCO14 タグでの学会情報が怒涛の速さでツイートされている！ 彼の国はべらぼうにツイッタラー医学会員が多いらしい（違,,,#,4.72781E+17,https://twitter.com/m0370/status/472780715688357888,,,,
ecancer,5/31/2014 12:44,1,1,Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL http://bit.ly/1od9SRp # ASCO14,,,#,4.72781E+17,https://twitter.com/ecancer/status/472780588269989889,,,,
JoanneWeidhaas,5/31/2014 12:43,6,4,"Concept of P4 Medicine - predictive, personalized, preventive and participatory at # ASCO14. This is # MiraKind - join! http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4oGaaBFhYI.twitter …",,,# # #,4.72781E+17,https://twitter.com/JoanneWeidhaas/status/472780525287907328,,,,
nxtstop1,5/31/2014 12:43,0,0,"@ drdonsdizon Don, A Superb Social Outreach Happening at # ASCO14 ! Congrats To You All. All About Extending The Reach!"" ~Enjoy Sharing~B.""",,@,#,4.7278E+17,https://twitter.com/nxtstop1/status/472780368085409793,,,,
lrn_brk,5/31/2014 12:43,6,2,"It is our intention to create a world free from the fear of cancer."" @ CliffordHudis # ASCO14""",,@,#,4.7278E+17,https://twitter.com/lrn_brk/status/472780353753874432,,,,
FutureDocs,5/31/2014 12:42,2,3,Great to meet @ yzafar tackling important issue of @ CostsofCare for cancer patients # ASCO14 cc @ ChrisMoriates @ neel_shah,,@ @ @ @,#,4.7278E+17,https://twitter.com/FutureDocs/status/472780263777640448,,,,
mvillaseca,5/31/2014 12:42,3,0,RT @ ASCO: Dr. Daniel Hayes sorts through the semantics of next-generation # genomic testing http://flip.it/Cq8ks # ASCO14,,@,# #,4.7278E+17,https://twitter.com/mvillaseca/status/472780255292571648,,,,
MelPalMD,5/31/2014 12:42,1,1,Progress in Breast Cancer Research # ASCO14 http://am.asco.org/progress-breast-cancer-research#.U4oGUS0E4rM.twitter …,,,# #,4.7278E+17,https://twitter.com/MelPalMD/status/472780164632281088,,,,
efratdotan,5/31/2014 12:42,0,1,“ @ carisls: Dr. Igor Astsaturov MD of @ FoxChaseCancer presenting CMI data on 1300+ # neuroendocrine cancers # ASCO14 pic.twitter.com/LZHXwtbtLE”,,@ @,# #,4.7278E+17,https://twitter.com/efratdotan/status/472780121250996224,,,,
CI4CC,5/31/2014 12:42,0,0,# ASCO14,,,#,4.7278E+17,https://twitter.com/CI4CC/status/472780088459550720,,,,
drugwonks,5/31/2014 12:42,3,0,"In 2012, retail prescription medicines accounted for just $0.09 of every dollar spent on health care. http://buff.ly/1twYi56 # ASCO14 # mliwi",,,# #,4.7278E+17,https://twitter.com/drugwonks/status/472780058936225792,,,,
ASCOPost,5/31/2014 12:41,13,3,Men Who Get Radiotherapy for Prostate Cancer Have Increased Long-Term Risk of Bladder or Rectal Cancer http://ow.ly/xtur8 # ASCO14 # pcsm,,,# #,4.7278E+17,https://twitter.com/ASCOPost/status/472780035590746112,,,,
DrBobGoldberg,5/31/2014 12:41,1,0,@ CliffordHudis @ Cascadia @ ASCO longer life is greatest driver of social justice # mliwi,,@ @ @,#,4.7278E+17,https://twitter.com/DrBobGoldberg/status/472779950882578432,,,,
FightCRC,5/31/2014 12:41,1,1,"“ @ megeblad: Dr. Hudis, @ CliffordHudis, is 1st @ ASCO president to tweet # ASCO14 plenary talk - and does it very well.” Love it!",,@ @ @,#,4.7278E+17,https://twitter.com/FightCRC/status/472779915876511744,,,,
carisls,5/31/2014 12:41,1,0,"Dr. Maisse Al Bakir of Imperial College, # molecularIntel non-epithelial # ovarian cancer by histologic subtypehttp://goo.gl/YtkwxD # ASCO14",,,# # #,4.7278E+17,https://twitter.com/carisls/status/472779904749424640,,,,
AJMC_Journal,5/31/2014 12:40,0,0,The EGF Receptor Continues to be a Promising Target in # NSCLC # ASCO14 http://bit.ly/U3v6s8,,,# #,4.7278E+17,https://twitter.com/AJMC_Journal/status/472779739245985792,,,,
teamoncology,5/31/2014 12:40,0,0,【 # ASCO14 Update】Study shows that you can stop statin (anti-cholesterol drug) w/o harm in pts w/advanced cancer. http://abstracts.asco.org/144/AbstView_144_135132.html …,,,#,4.7278E+17,https://twitter.com/teamoncology/status/472779699593039872,,,,
scarlett_0hara,5/31/2014 12:40,1,0,# moms MT @ rsm2800: Hudis: Our nation’s investment in science is woeful; Fed investment in research on cancer is 0.1% of Fed budget # asco14,,@,# #,4.7278E+17,https://twitter.com/scarlett_0hara/status/472779657520349184,,,,
nxtstop1,5/31/2014 12:40,1,1,CONGRATS # ASCO14 ! @ rsm2800: Look what is trending worldwide on Twitter right now # asco14 pic.twitter.com/9a8GbIGUa2 All About Extending Reach!,,@,# #,4.7278E+17,https://twitter.com/nxtstop1/status/472779642927984640,,,,
CureMelanoma,5/31/2014 12:40,5,1,Looking for updates on # melanoma news from # ASCO14? Follow our Exec Dir @ TimTurnham who is live-tweeting from the conf.,,@,# #,4.7278E+17,https://twitter.com/CureMelanoma/status/472779623538098176,,,,
teamoncology,5/31/2014 12:40,1,0,【 # ASCO14 Update】ENABLE III study shows that importance of supporting the cancer caregiver as soon as possible. http://abstracts.asco.org/144/AbstView_144_131678.html …,,,#,4.7278E+17,https://twitter.com/teamoncology/status/472779619163049984,,,,
DebiopharmNews,5/31/2014 12:40,0,0,# ASCO14 We are convinced that developing for # patients will shape the # future of # medicine http://ow.ly/x93vn,,,# # # #,4.7278E+17,https://twitter.com/DebiopharmNews/status/472779609478819840,,,,
CancerMedMDA,5/31/2014 12:40,2,0,Dr. Eduardo Bruera to chair session on Tx of elderly patients w colorectal cancer complications. # ASCO14 Sat. 3 PM.,,,#,4.7278E+17,https://twitter.com/CancerMedMDA/status/472779585143463938,,,,
ConsanoScott,5/31/2014 12:40,1,0,@ UCCancerCenter We love supporting cutting edge research at @ Consano. Let's talk! # ASCO14,,@ @,#,4.7278E+17,https://twitter.com/ConsanoScott/status/472779582160904192,,,,
teamoncology,5/31/2014 12:39,0,0,【 # ASCO14 101】 Ramucirumab is anti-VEGFR2 monoclonal antibody. Effective in gastric cancer also. But not in breast cancer.,,,#,4.7278E+17,https://twitter.com/teamoncology/status/472779504637603840,,,,
drdonsdizon,5/31/2014 12:39,6,7,New to Twitter? Follow simple guidance and stay safe out there. # ASCO14 pic.twitter.com/bSHs9NIe6m,,,#,4.72779E+17,https://twitter.com/drdonsdizon/status/472779462959202304,,,,
teamoncology,5/31/2014 12:39,0,0,【 # ASCO14 Update】LHRH agonist have a slight edge to protect from an ovarian failure by chemo. http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.72779E+17,https://twitter.com/teamoncology/status/472779445179138048,,,,
rschilsky,5/31/2014 12:39,2,3,"# ASCO14 Pinedo Karnofsky address: Each patient is a pearl to be valued"".""",,,#,4.72779E+17,https://twitter.com/rschilsky/status/472779353622073344,,,,
HenkJanOut,5/31/2014 12:38,2,0,"Stop hiermee, farma! “ @ drsam: Merck Oncology is clearly back! They've got toppings for their Fro-Yo! # ASCO14 pic.twitter.com/k395Eb3DZR”",,@,#,4.72779E+17,https://twitter.com/HenkJanOut/status/472779228283691008,,,,
LizDowling2,5/31/2014 12:38,1,0,# ASCO14 first prospective CC study to compare gene expression & clinical risk factors - intriguing results http://bit.ly/RPuJiQ,,,#,4.72779E+17,https://twitter.com/LizDowling2/status/472779224072208385,,,,
DrAttai,5/31/2014 12:38,0,0,@ CliffordHudis very passionate and inspiring @ ASCO presidential address # ASCO14,,@ @,#,4.72779E+17,https://twitter.com/DrAttai/status/472779202434170880,,,,
teamoncology,5/31/2014 12:38,1,2,"May be we should abolish, the word “optional” collection of samples in clinical trials. # ASCO14",,,#,4.72779E+17,https://twitter.com/teamoncology/status/472779182506647553,,,,
cstratos,5/31/2014 12:38,2,0,“ @ melanoma_Drs: Upcoming: # dabrafenib + # trametinib + # ipilimumab for # melanoma at # ASCO14 # lookingfortoxicity” this is next,,@,# # # # # #,4.72779E+17,https://twitter.com/cstratos/status/472779063585943553,,,,
ipaulmampilly,5/31/2014 12:38,1,0,# ASCO14 164 patient study..found nearly 45 percent..skipping drugs..not filling cancer-related rx due to cost..http://bloom.bg/1jzvRhd,,,#,4.72779E+17,https://twitter.com/ipaulmampilly/status/472779056316833793,,,,
teamoncology,5/31/2014 12:38,2,0,We have too many clinical investigators who do not push for collecting samples from patients while on clinical trials. # ASCO14,,,#,4.72779E+17,https://twitter.com/teamoncology/status/472779035320123392,,,,
mtkutluk,5/31/2014 12:37,3,1,"Dr Pinedo says each patient is a pearl"". We learn a lot from them. We should treat them like a pearl. # ASCO14""",,,#,4.72779E+17,https://twitter.com/mtkutluk/status/472779032451616768,,,,
nxtstop1,5/31/2014 12:37,2,2,"@ lenstarnes @ symplur Agree! They have stand out SOCIAL"" acumen in medical world ~~ # ASCO14""",,@ @,#,4.72779E+17,https://twitter.com/nxtstop1/status/472778956215549952,,,,
UCCancerCenter,5/31/2014 12:37,1,3,Check out our booth at # ASCO14 and hear about all our patient services and cutting-edge research. See you at Booth 11160 in the exhibit hall,,,#,4.72779E+17,https://twitter.com/UCCancerCenter/status/472778887102230528,,,,
teamoncology,5/31/2014 12:37,0,0,I must say “optional biopsies in clinical trials” is like saying that we will not collect the samples. # ASCO14,,,#,4.72779E+17,https://twitter.com/teamoncology/status/472778838871531522,,,,
NickVRamos,5/31/2014 12:37,1,1,"Looks like $ CLVS is the best to hit # ASCO14 so far, for a 50 dollar stock their market cap is only 1.74b. Interesting Monday ahead!",,,#,4.72779E+17,https://twitter.com/NickVRamos/status/472778836137242626,,,,
NikolaidesLaura,5/31/2014 12:37,1,0,@ pwendl interviews Dr. Moore on the POEMS study re preservation of fertility in young women w # breastcancer # ASCO14 http://tinyurl.com/p6zvs42,,@,# #,4.72779E+17,https://twitter.com/NikolaidesLaura/status/472778817396678657,,,,
teamoncology,5/31/2014 12:37,2,0,"Without dedication of our patients providing samples (blood & tissue), we will not make a progress in improving cancer treatments. # ASCO14",,,#,4.72779E+17,https://twitter.com/teamoncology/status/472778808039182337,,,,
matthewherper,5/31/2014 12:37,6,5,"Squam vs. non-squam HR for ramu: OS, non-squam 0.83, squam 0.88. For PFSl non-squam 0.75, squam 0.76 http://onforb.es/1kv2Fgy $ LLY # ASCO14",,,#,4.72779E+17,https://twitter.com/matthewherper/status/472778807103856640,,,,
JackWhelan,5/31/2014 12:36,0,0,"Dr. Mike and friends, @ mtmdphd is there a scheduled Tweetup @ ASCO this year.",,@ @,,4.72779E+17,https://twitter.com/JackWhelan/status/472778762908868608,,,,
granitehead,5/31/2014 12:36,1,2,"Translational Genomics: Clues from the resilient, by SH Friend & EE Schadt. A paradigm hanging path to Rx # ASCO14 http://www.sciencemag.org/content/344/6187/970.full …",,,#,4.72779E+17,https://twitter.com/granitehead/status/472778606599737344,,,,
DrBobGoldberg,5/31/2014 12:35,5,2,Increasing life expectancy most powerful driver of social equality. # asco14,,,#,4.72778E+17,https://twitter.com/DrBobGoldberg/status/472778398381932544,,,,
fitstylebyshana,5/31/2014 12:35,0,1,@ AneesChagpar @ drdonsdizon @ CliffordHudis @ ASCO @FITWEEK52 you go Anees! Best fitness equip are ur own 2 feet.,,@ @ @ @ @FITWEEK52,,4.72778E+17,https://twitter.com/fitstylebyshana/status/472778387237654528,,,,
LinicalAmericas,5/31/2014 12:35,3,0,A potential setback for combo therapy in melanoma? Triplet combo of dabrafenib/ipilimumab/trametinib Ph1 life threatening GI tox # ASCO14,,,#,4.72778E+17,https://twitter.com/LinicalAmericas/status/472778380480634880,,,,
Roche,5/31/2014 12:35,6,5,The anatomy of # innovation: Find out how we make discoveries that lead to better lives for patients http://ow.ly/xkPsj (*.pdf) # ASCO14,,,# #,4.72778E+17,https://twitter.com/Roche/status/472778315003342849,,,,
Gene_Antibody,5/31/2014 12:35,1,0,Need a break at # ASCO14? Watch The Case of the Wild Kinase, - exploring BRAF & discovering a cancer paradox http://ow.ly/xtsE3,,,#,4.72778E+17,https://twitter.com/Gene_Antibody/status/472778307667509248,,,
ConsanoMolly,5/31/2014 12:34,3,2,"If you're at # ASCO14, find @ drdonsdizon and ask him about his # crowdfunding project! https://www.consano.org/projects/38-is-less-more-for-women-living-with-metastatic-cancer … # SurvivorsWithCancer",,@,# # #,4.72778E+17,https://twitter.com/ConsanoMolly/status/472778191405207552,,,,
m0370,5/31/2014 12:34,0,0,あら、今までASCOガイドラインでもLHRHaによる妊娠機能温存は根拠なしで有効性不明だったのに、今後は変わるのかもね？>RT 昨日のゾメタの話題ではないけど、UpToDateがどれくらいの速さで変わるか注目（今のところはASCOガイドラインと同じ記述）。 # ASCO14,,,#,4.72778E+17,https://twitter.com/m0370/status/472778111122038786,,,,
julian_hong,5/31/2014 12:34,2,0,All key. Into #5 of course. RT @ sloan_kettering: Five decades of @ ASCO - five opportunities # ASCO14 @ CliffordHudispic.twitter.com/1MdjWg84xW,,@ @ @,#5 #,4.72778E+17,https://twitter.com/julian_hong/status/472778079849308160,,,,
christinemphmd,5/31/2014 12:33,0,0,Each patient is a pearl, HM (Bob) Pinedo. # ASCO14 # patientcare,,,# #,4.72778E+17,https://twitter.com/christinemphmd/status/472777850500952064,,,
PhRMA,5/31/2014 12:33,1,0,Our own @ KUhlendorf provides insights from # ASCO14. Read his thoughts on value of meds: http://onphr.ma/1wGFpkH,,@,#,4.72778E+17,https://twitter.com/PhRMA/status/472777802681303041,,,,
rsm2800,5/31/2014 12:32,33,22,Pinedo: “Each patient is a pearl.” We can learn a lot from each patient. We should value each pt as we are doing translational work # asco14,,,#,4.72778E+17,https://twitter.com/rsm2800/status/472777607776182273,,,,
ipaulmampilly,5/31/2014 12:32,4,1,# ASCO14 2013 cancer patients..nearly 3 times more likely to go bankrupt than people without cancer...http://bloom.bg/1jzvRhd,,,#,4.72778E+17,https://twitter.com/ipaulmampilly/status/472777597269463041,,,,
christinemphmd,5/31/2014 12:31,4,2,Pinedo: Translational research is crossing the bridge. # ASCO14 pic.twitter.com/ILtgaDQruf,,,#,4.72777E+17,https://twitter.com/christinemphmd/status/472777474359959552,,,,
OphiraG,5/31/2014 12:31,0,0,"Prof Bob Pinedo- Karnofsky Award & gr8 lecture -quotes Spinoza def understanding"" re: bench 2 bedside @ ASCO""",,@,,4.72777E+17,https://twitter.com/OphiraG/status/472777472430206976,,,,
matthewherper,5/31/2014 12:31,9,2,Eli Lilly Lung Cancer Drug May Succeed Where Avastin Failed # ASCO14 http://onforb.es/1kv2Fgy,,,#,4.72777E+17,https://twitter.com/matthewherper/status/472777444601384960,,,,
drdonsdizon,5/31/2014 12:30,1,0,"@ AneesChagpar @ CliffordHudis @ ASCO @FITWEEK52 Run Anees, Run!! # ASCO14",,@ @ @ @FITWEEK52,#,4.72777E+17,https://twitter.com/drdonsdizon/status/472777245195784192,,,,
DebiopharmNews,5/31/2014 12:30,1,0,"# ASCO14 The more the # patient benefits from our drug, the more accomplished we feel http://ow.ly/x93rh",,,# #,4.72777E+17,https://twitter.com/DebiopharmNews/status/472777228829618176,,,,
ASCO,5/31/2014 12:30,4,3,Dr. Daniel Hayes sorts through the semantics of next-generation # genomic testing http://bit.ly/1tTBAWQ # ASCO14,,,# #,4.72777E+17,https://twitter.com/ASCO/status/472777214510235648,,,,
mayocliniclabs,5/31/2014 12:30,1,3,New # gene panel # cancer test helps tailor therapies to individual patient. Visit booth #2054 to learn more. # ASCO14 http://mayocl.in/T1r6rl,,,# # #2054 #,4.72777E+17,https://twitter.com/mayocliniclabs/status/472777172437188608,,,,
MGHCancerCenter,5/31/2014 12:30,1,0,"1:15-5, S Hall A2: Dr. Wakimoto poster: Targetable signaling pathway mutations and progression of IDH-mutant glioma. # ASCO14",,,#,4.72777E+17,https://twitter.com/MGHCancerCenter/status/472777152371625985,,,,
ProjectInno,5/31/2014 12:30,1,0,Capturing cancer drugs’ true value calls for clear thinking http://ow.ly/xs2La # ASCO14 via @ BioWorld,,@,#,4.72777E+17,https://twitter.com/ProjectInno/status/472777099598888961,,,,
teamoncology,5/31/2014 12:30,1,0,Nice. RT @ WayneKoberstein: Lake Michigan outside # ASCO14. Contrast to hubbub inside. @ RfwrightLSLpic.twitter.com/gWq5mmnZRl,,@ @,#,4.72777E+17,https://twitter.com/teamoncology/status/472777034330947584,,,,
teamoncology,5/31/2014 12:29,2,0,Dr @ CliffordHudis states a tremendous impact of science to the community. We can do a better job to explain science to lay person. # ASCO14,,@,#,4.72777E+17,https://twitter.com/teamoncology/status/472776981423996928,,,,
OncologyTimes,5/31/2014 12:29,1,0,". # ASCO14 Karnofsky Awd winner Herbert Bob"" Pinedo titles his talk ""Understanding""""",,,#,4.72777E+17,https://twitter.com/OncologyTimes/status/472776964344799233,,,,
mvillaseca,5/31/2014 12:29,1,0,RT @ ASCO: Innovation in cancer care therapy may improve patient care and the # value of the care received http://flip.it/vOhhq # ASCO14,,@,# #,4.72777E+17,https://twitter.com/mvillaseca/status/472776899081809921,,,,
rsm2800,5/31/2014 12:29,1,1,Pinedo: Karnofsky address entitled simply “Understanding” # parsimony # asco14,,,# #,4.72777E+17,https://twitter.com/rsm2800/status/472776857973030912,,,,
YasirYousifE,5/31/2014 12:29,1,0,Clifford Hudis: obesity is the new tobacco # ASCO14,,,#,4.72777E+17,https://twitter.com/YasirYousifE/status/472776813358247937,,,,
nxtstop1,5/31/2014 12:29,1,0,FATIGUE:WE GOT HELP! @Medzineapp: ASCO Expert Panel develops treatment guidelines for cancer-related fatigue http://bit.ly/1txjHeD # ASCO14,,@Medzineapp,#,4.72777E+17,https://twitter.com/nxtstop1/status/472776811772801024,,,,
betht0002,5/31/2014 12:28,1,0,“ @ JSchneide12: Making # cancer progress but at what cost? http://abcn.ws/1oUUxq0 With @Carolinas Dr. Raghavan # LCI # ASCO14”,,@ @Carolinas,# # #,4.72777E+17,https://twitter.com/betht0002/status/472776752742535168,,,,
Neil_Iyengar,5/31/2014 12:28,5,4,We are forever indebted to our mentors @ CliffordHudis # ASCO14 pic.twitter.com/5hWGAV1NZE,,@,#,4.72777E+17,https://twitter.com/Neil_Iyengar/status/472776692063543297,,,,
HemOncToday,5/31/2014 12:28,2,0,# ASCO14 Gregory Masters weighs in on # ramucirumab plus chemotherapy improved outcomes in non–small cell # LungCancer http://goo.gl/W8LTnn,,,# # #,4.72777E+17,https://twitter.com/HemOncToday/status/472776687147819008,,,,
GoHealio,5/31/2014 12:28,1,0,# ASCO14 Gregory Masters weighs in on # ramucirumab plus chemotherapy improved outcomes in non–small cell # LungCancer http://goo.gl/W8LTnn,,,# # #,4.72777E+17,https://twitter.com/GoHealio/status/472776686250258434,,,,
WayneKoberstein,5/31/2014 12:28,1,0,Lake Michigan outside # ASCO14. Contrast to hubbub inside. @ RfwrightLSLpic.twitter.com/xzPSXIj13k,,@,#,4.72777E+17,https://twitter.com/WayneKoberstein/status/472776641664806913,,,,
JSchneide12,5/31/2014 12:27,2,5,The scene outside McCormick Center at # ASCO14. Must not be melanoma specialists. pic.twitter.com/VTJH0D5UHi,,,#,4.72776E+17,https://twitter.com/JSchneide12/status/472776496822894592,,,,
MarkSchoenebaum,5/31/2014 12:27,36,11,Congrats to Rob Langreth for a good article on cancer drug prices. # ASCO14 --> http://mobile.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html …,,,#,4.72776E+17,https://twitter.com/MarkSchoenebaum/status/472776398751662080,,,,
TheseAreMyScars,5/31/2014 12:27,1,0,"“@kNOwLungCancer: Obesity appears to be the new tobacco of our age, increasing risk for cancer # ASCO14” wonder if it'll have the same stigma",,@kNOwLungCancer,#,4.72776E+17,https://twitter.com/TheseAreMyScars/status/472776382205165568,,,,
LinicalAmericas,5/31/2014 12:27,2,0,@ SeattleGenetics - great visual demo of your compound # ASCO14 pic.twitter.com/rNfLfBj9Dx,,@,#,4.72776E+17,https://twitter.com/LinicalAmericas/status/472776340832518145,,,,
teamoncology,5/31/2014 12:27,0,1,Which country have an universal health care and no limited access in developed countries? Japan is one of them # ASCO14,,,#,4.72776E+17,https://twitter.com/teamoncology/status/472776315066544128,,,,
LarryNortonMD,5/31/2014 12:26,6,4,“ @ ASCOPost: Cancer doctors to consider value (via Chicago Tribune) http://ow.ly/xtsp7 # ASCO14” Healers themselves must DEFINE value.,,@,#,4.72776E+17,https://twitter.com/LarryNortonMD/status/472776222637056000,,,,
JackWestMD,5/31/2014 12:26,1,0,Yes. @ ASCO support would help RT XRT4U: @ JackWestMD Try to have ASCO engage in climate change. Quiet about NLST and CMS.MEDPAC fiasco too.,,@ @,,4.72776E+17,https://twitter.com/JackWestMD/status/472776082840489985,,,,
PhRMA,5/31/2014 12:26,2,0,. @ robzirk illustrates how prescription meds only account for a small % of # healthcare spending & growth http://onphr.ma/TRMIal # ASCO14,,@,# #,4.72776E+17,https://twitter.com/PhRMA/status/472776069221597184,,,,
LizDowling2,5/31/2014 12:26,2,0,Salazar # ASCO14 prospective study # crsm shows marked diff in NCCN risk classification and and genomic ColoPrint http://bit.ly/RPuJiQ,,,# #,4.72776E+17,https://twitter.com/LizDowling2/status/472776053002207232,,,,
Cortellis,5/31/2014 12:25,2,0,"RP2D for MK0752 & gemcitabine combination in patients with pancreatic ductal adenocarcinoma was 1800mg and 1000mg/m2, respectively # ASCO14",,,#,4.72776E+17,https://twitter.com/Cortellis/status/472775833015554048,,,,
JackWestMD,5/31/2014 12:24,3,4,. @ ethan780 I'm quite hopeful abt both CO1686 & AZD9291 for acq'd resistance in EGFR mutn-pos NSCLC. Early but vy impressive work. # ASCO14,,@,#,4.72776E+17,https://twitter.com/JackWestMD/status/472775609442385920,,,,
YSCBuzz,5/31/2014 12:24,4,2,At # ASCO14 ? pick up YSC’s New Research Agenda @their advocacy booth answering ? 4 Young women w/ BC http://bit.ly/1r1002D,,@their,#,4.72776E+17,https://twitter.com/YSCBuzz/status/472775512528412673,,,,
teamoncology,5/31/2014 12:23,2,0,If obesity is the new tobacco. We should ban obesity. An extreme idea. But it is an important to think how we reduce obesity. # ASCO14,,,#,4.72775E+17,https://twitter.com/teamoncology/status/472775402931224576,,,,
ALLIANCE_org,5/31/2014 12:23,1,0,"# ASCO14 Poster bd 221 | Sunitinib switch maintnance in NSCLC: A rando, placebo-controlled phase 3 trial # CALGB30607 http://bit.ly/1m0KSu9",,,# #,4.72775E+17,https://twitter.com/ALLIANCE_org/status/472775380030332928,,,,
kellykcotton,5/31/2014 12:23,1,2,Very cool to see @ CliffordHudis live-tweeting his Presidential Address & the excited responses at # ASCO14,,@,#,4.72775E+17,https://twitter.com/kellykcotton/status/472775333692080130,,,,
AVAILABLELIGHT_,5/31/2014 12:23,2,0,The team leaving ASCO! Show floor opens today! # ASCO14 # team # workinghardpic.twitter.com/5sHkU3we78,,,# # #,4.72775E+17,https://twitter.com/AVAILABLELIGHT_/status/472775286753603584,,,,
CancerDotNet,5/31/2014 12:22,2,1,Study: lenvatinib may be option for thyroid cancer when RAI-resistant # thyca # thycsm # ASCO14 http://bit.ly/1pH5Y4l,,,# # #,4.72775E+17,https://twitter.com/CancerDotNet/status/472775253908017153,,,,
TeamTJSharpe,5/31/2014 12:22,1,2,"Checking in at @ Merck # ASCO14 booth. They had no Patient"" salutation I suppose pic.twitter.com/IjwY9znf0d""",,@,#,4.72775E+17,https://twitter.com/TeamTJSharpe/status/472775087461249024,,,,
ipaulmampilly,5/31/2014 12:22,1,0,# ASCO14 Global spending on cancer drugs alone rose 28 percent to $91 billion in 2013 from $71 billion in 2008.. http://bloom.bg/1jzvRhd,,,#,4.72775E+17,https://twitter.com/ipaulmampilly/status/472775066493542400,,,,
ASCOPost,5/31/2014 12:21,10,5,Cancer doctors urged to consider value when treating patients (via Chicago Tribune) http://ow.ly/xtsp7 # ASCO14,,,#,4.72775E+17,https://twitter.com/ASCOPost/status/472774998663651328,,,,
LurieCancer,5/31/2014 12:21,1,1,MT @ CliffordHudis: # ASCO14 may be the only mtg in Chicago where neither @ RahmEmanuel nor Ari are the most famous Emanuel HT @ OncologyTimes,,@ @ @,#,4.72775E+17,https://twitter.com/LurieCancer/status/472774858011856896,,,,
ASCO,5/31/2014 12:20,1,0,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.72775E+17,https://twitter.com/ASCO/status/472774591795200002,,,,
PRPCancerGuide,5/31/2014 12:20,1,1,"Congrats to Patient Resource board member James Armitage, MD, for his Special Recognition Award at # ASCO14.",,,#,4.72775E+17,https://twitter.com/PRPCancerGuide/status/472774591182819328,,,,
DebiopharmNews,5/31/2014 12:20,1,0,"# ASCO14 The # patients are at the core of our business, we care for them! http://ow.ly/x93kY",,,# #,4.72775E+17,https://twitter.com/DebiopharmNews/status/472774583188471808,,,,
CancerMedMDA,5/31/2014 12:20,1,0,Dr. Gerald Falchook discusses targeting the HGF/MET pathway to # endcancer. # ASCO14 Sat. 3:50 PM.,,,# #,4.72775E+17,https://twitter.com/CancerMedMDA/status/472774550514843648,,,,
genentech,5/31/2014 12:20,3,1,Lots of talk about # bloodcancer at # ASCO14 - here's more on the progress since 1969: http://ow.ly/xtqYZ,,,# #,4.72775E+17,https://twitter.com/genentech/status/472774520357781505,,,,
hectorherrerac,5/31/2014 12:19,1,0," @ ClevelandClinic: Fertility freeze helps women have babies after chemo http://www.nbcnews.com/health/cancer/fertility-freeze-helps-women-have-babies-after-chemo-n117616 … (via @ maggiemfox) # ASCO14""""",,@ @,#,4.72774E+17,https://twitter.com/hectorherrerac/status/472774353764220928,,,,
chemobrainfog,5/31/2014 12:18,0,0,. @ MaverickNY Well tolerated is a term that should be reserved SOLEY for use by patients taking any particular drug. # my2cents # ASCO14,,@,# #,4.72774E+17,https://twitter.com/chemobrainfog/status/472774223216521216,,,,
megeblad,5/31/2014 12:17,0,1,"Dr. Hudis, @ CliffordHudis, is 1st @ ASCO president to tweet # ASCO14 plenary talk - and does it very well.",,@ @,#,4.72774E+17,https://twitter.com/megeblad/status/472773946493120513,,,,
Medzineapp,5/31/2014 12:17,0,0,ASCO Expert Panel develops treatment guidelines for cancer-related fatigue http://bit.ly/1txjHeD # ASCO14,,,#,4.72774E+17,https://twitter.com/Medzineapp/status/472773938914013184,,,,
ProfJohnCrown,5/31/2014 12:17,2,1,Yes great speech “ @ sloan_kettering: Amazing presidential address by @ CliffordHudis. We are so proud of him! # ASCO14”,,@ @,#,4.72774E+17,https://twitter.com/ProfJohnCrown/status/472773880268877825,,,,
OphiraG,5/31/2014 12:17,0,0,@ asco humanitarian Dr Surendra Shastri well-deserved! Imagine what we could achieve globally w ++efforts like his! @ uicc @ NCIGlobalHealth,,@ @ @,,4.72774E+17,https://twitter.com/OphiraG/status/472773857246711808,,,,
sloan_kettering,5/31/2014 12:16,2,4,Amazing presidential address by @ CliffordHudis. We are so proud of him! # ASCO14,,@,#,4.72774E+17,https://twitter.com/sloan_kettering/status/472773657639403521,,,,
JoanneWeidhaas,5/31/2014 12:16,3,1,Beautiful day here in Chicago for # ASCO14! Exciting the masses of people trying to solve cancer! pic.twitter.com/VE4p9VwKBT,,,#,4.72774E+17,https://twitter.com/JoanneWeidhaas/status/472773653600288768,,,,
wordbistro,5/31/2014 12:16,0,0,MT yay!“ @ rsm2800: And look at what is trending worldwide on Twitter right now # asco14 pic.twitter.com/YsILQmmZJL”,,@,#,4.72774E+17,https://twitter.com/wordbistro/status/472773583119605760,,,,
ancasa2000,5/31/2014 12:16,0,0,@ ancasa2000: Well deserved humanitarian award. Last year presentation was impressive # ASCO14 pic.twitter.com/SZoQ08RnJV,,@,#,4.72774E+17,https://twitter.com/ancasa2000/status/472773554581540864,,,,
DrBobGoldberg,5/31/2014 12:16,0,0,@ Lymphoma_Doc @ CliffordHudis agree completely. We need payment to keep up w innovation # ASCO14 # mliwi,,@ @,# #,4.72774E+17,https://twitter.com/DrBobGoldberg/status/472773545710596097,,,,
myPathMelanoma,5/31/2014 12:16,0,0,The Myriad myPath # Melanoma poster presentation is happening NOW in room E354b! # ASCO14,,,# #,4.72774E+17,https://twitter.com/myPathMelanoma/status/472773501141540864,,,,
ElizBlanchardMD,5/31/2014 12:15,0,1,“ @ BeWellBoston: 5 simple ways to cut 500 calories from your # diet: http://bo.st/1nAl52z # EatWell” Apropos to # ASCO14,,@,# # #,4.72773E+17,https://twitter.com/ElizBlanchardMD/status/472773476575498240,,,,
rsm2800,5/31/2014 12:15,4,5,And look at what is trending worldwide on Twitter right now # asco14 pic.twitter.com/ecgV2pmcsz,,,#,4.72773E+17,https://twitter.com/rsm2800/status/472773459731181569,,,,
AneesChagpar,5/31/2014 12:15,1,0,"@ drdonsdizon @ CliffordHudis @ ASCO Treadmills instead of chairs at next meeting? Meanwhile, pedometer on and running at # ASCO14 @FITWEEK52",,@ @ @ @FITWEEK52,#,4.72773E+17,https://twitter.com/AneesChagpar/status/472773427997065216,,,,
hmhyltonpac,5/31/2014 12:15,2,0,"Enjoyed the President's address at # ASCO14, a tribute to ASCO's history and vision for the future to free the world of the fear of cancer.",,,#,4.72773E+17,https://twitter.com/hmhyltonpac/status/472773384640946176,,,,
ASCO,5/31/2014 12:15,11,3,Innovation in cancer care therapy may improve patient care and the # value of the care received http://bit.ly/1hgGtYj # ASCO14,,,# #,4.72773E+17,https://twitter.com/ASCO/status/472773362713124864,,,,
CancerMedMDA,5/31/2014 12:15,2,1,Dr. David Hong on first-in-human study of highly selective oral MET inhibitor. # ASCO14. Sat. 3:30 PM. # endcancer,,,# #,4.72773E+17,https://twitter.com/CancerMedMDA/status/472773343775842304,,,,
Amgen,5/31/2014 12:15,2,1,"Visit # Amgen @ # ASCO14 Industry Expert Theater to learn about Advanced Biomarkers in GI Malignancies, @12:15pm CDT [back of Onc Prof Hall]",,@ @12,# #,4.72773E+17,https://twitter.com/Amgen/status/472773341355708416,,,,
mfrimawi,5/31/2014 12:15,0,0,ASCO president @ CliffordHudis delivered a passionate speech about his vision & intent for a world free of the fear of cancer # ASCO14,,@,#,4.72773E+17,https://twitter.com/mfrimawi/status/472773335521460224,,,,
rschilsky,5/31/2014 12:15,17,8,"What a fabulous Prez Address by @ CliffordHudis # ASCO14. It is our intention to create a world free from the fear of cancer"".We can do this!""",,@,#,4.72773E+17,https://twitter.com/rschilsky/status/472773331012567040,,,,
FoundationATCG,5/31/2014 12:15,1,0,"# NSCLC patients who failed # chemo achieve better disease control w/combo # targetedtherapy Poster Pres: 1:15-5, S Hall A2, Ab 8042 # ASCO14",,,# # # #,4.72773E+17,https://twitter.com/FoundationATCG/status/472773320018907136,,,,
JanssenUS,5/31/2014 12:15,0,0,Head to E Hall D2 at 1:27 pm CT for oral presentation of solid tumor data for an investigational compound # ASCO14,,,#,4.72773E+17,https://twitter.com/JanssenUS/status/472773267800227840,,,,
OncologyTimes,5/31/2014 12:14,2,1,Agree! RT @ DrMarkham: @ CliffordHudis's address was inspiring and moving. # ASCO14,,@ @,#,4.72773E+17,https://twitter.com/OncologyTimes/status/472773117039767552,,,,
mnewtonPharmD,5/31/2014 12:14,0,0,"usually 1st drugs I recommend stopping RT @ ASCOPost: Statin Use Can Stop When Illness Is Terminal, http://ow.ly/xtiM5 # ASCO14",,@,#,4.72773E+17,https://twitter.com/mnewtonPharmD/status/472773100535578624,,,,
picardonhealth,5/31/2014 12:14,4,2,When is a novel # cancer drug worth it? http://tinyurl.com/khkyssw # ASCO14 $ LLY $ AZN $ JNJ via @ MMarchioneAP,,@,# #,4.72773E+17,https://twitter.com/picardonhealth/status/472773091043454976,,,,
ByJonGardner,5/31/2014 12:14,0,0,"Everybody! Stop what you're doing! It's time for an # ASCO14 break! # sgenball fight by the lake, 15 minutes! # fromtheAnnalsOfBadIdeas $ SGEN",,,# # #,4.72773E+17,https://twitter.com/ByJonGardner/status/472773083842220032,,,,
DrBobGoldberg,5/31/2014 12:14,1,0,@ cancerassassin1 value is code word for rationing. personalized medicine generates value # scraptheapp # ASCO14,,@,# #,4.72773E+17,https://twitter.com/DrBobGoldberg/status/472773070714048513,,,,
datacision,5/31/2014 12:14,0,0,Don't forget to visit the @ SarahCannonDocs booth 2063 @ ASCO # ASCO14 pic.twitter.com/lPj0j6DG5H,,@ @,#,4.72773E+17,https://twitter.com/datacision/status/472773023372947456,,,,
JoleneScience,5/31/2014 12:13,1,0,"Imbruvica RESONATE 9-mo results in @ NEJM: ORR 42%, 88% 6-mo PFS, outcome independent of del17p/purine analog failure $ PCYC # ASCO14",,@,#,4.72773E+17,https://twitter.com/JoleneScience/status/472772958746726401,,,,
OncologyTimes,5/31/2014 12:13,3,3,. @ CliffordHudis clearly emotional as he discusses his father who died of metastatic prostate cancer at age 64 # ASCO14,,@,#,4.72773E+17,https://twitter.com/OncologyTimes/status/472772821655891968,,,,
WayneKoberstein,5/31/2014 12:13,0,0,I am here at # ASCO14 to harvest input from KOLs for our virtual Combination Cancer Immunotherapy Roundtable. A rich field. @.RfwrightLSL,,@,#,4.72773E+17,https://twitter.com/WayneKoberstein/status/472772761136279552,,,,
christinemphmd,5/31/2014 12:12,1,0,Incredibly inspiring presidential address by @ CliffordHudis at # ASCO14 @ ASCO,,@ @,#,4.72773E+17,https://twitter.com/christinemphmd/status/472772739896737794,,,,
c_cerrado,5/31/2014 12:12,0,0,“ @ ClevelandClinic: Fertility freeze helps women have babies after chemo http://www.nbcnews.com/health/cancer/fertility-freeze-helps-women-have-babies-after-chemo-n117616 … (via @ maggiemfox) # ASCO14”,,@ @,#,4.72773E+17,https://twitter.com/c_cerrado/status/472772721202704384,,,,
DrMarkham,5/31/2014 12:12,1,0,. @ CliffordHudis's address was inspiring and moving. # ASCO14,,@,#,4.72773E+17,https://twitter.com/DrMarkham/status/472772657180839937,,,,
HenkJanOut,5/31/2014 12:12,0,0,"Big issue @ sloan_kettering: @ CliffordHudis:... Industry sees pricing problem, too @ matthewherper # ASCO14 pic.twitter.com/RrpEBBxalF”",,@ @ @,#,4.72773E+17,https://twitter.com/HenkJanOut/status/472772574066507777,,,,
ClevelandClinic,5/31/2014 12:12,12,8,Fertility freeze helps women have babies after chemo http://www.nbcnews.com/health/cancer/fertility-freeze-helps-women-have-babies-after-chemo-n117616 … (via @ maggiemfox) # ASCO14,,@,#,4.72773E+17,https://twitter.com/ClevelandClinic/status/472772546773798913,,,,
mljohnsonmd,5/31/2014 12:11,1,2,"“ @ RielyMD: blumenthal FDA: 12567 pts 80% outside us, near perfect correlation btn ORR and PFS r2 0.89 # ASCO14” great analysis @ LurieCancer",,@ @,#,4.72772E+17,https://twitter.com/mljohnsonmd/status/472772431745003520,,,,
ASCOPost,5/31/2014 12:11,9,7,"New drugs may make a dent in lung, ovarian cancer (via Washington Post) http://ow.ly/xtqN9 # ASCO14 # lcsm # ovca",,,# # #,4.72772E+17,https://twitter.com/ASCOPost/status/472772352011665409,,,,
KintalkUCSF,5/31/2014 12:11,0,1,long term # Statin use may reduce risk 4 # pancreas cancer- # ASCO14 @ UCSFCancer # pancsm # chemoprevention http://bit.ly/1ru48bT,,@,# # # # #,4.72772E+17,https://twitter.com/KintalkUCSF/status/472772277839593472,,,,
theMMRF,5/31/2014 12:10,5,2,# ASCO14 Early # myeloma study presented: Impressive responses in relapsed/refractory patients w/ # SAR650984. http://www.themmrf.org/asco # MMRFASCO,,,# # # #,4.72772E+17,https://twitter.com/theMMRF/status/472772168695422976,,,,
aftimosp,5/31/2014 12:10,0,1,In vivo in contrast with in vitro: mek inh did not impair the immune response. # ASCO14,,,#,4.72772E+17,https://twitter.com/aftimosp/status/472772152844771330,,,,
DrBobGoldberg,5/31/2014 12:10,0,0,@ DrHedrick who defines social justice ? And who decides who gets what? Who lives or dies? # ASCO14,,@,#,4.72772E+17,https://twitter.com/DrBobGoldberg/status/472772099241951232,,,,
DebiopharmNews,5/31/2014 12:10,1,0,# ASCO14 # Innovation is precious and we take care of it by transforming it into a drug for the # patients http://ow.ly/x93f3,,,# # #,4.72772E+17,https://twitter.com/DebiopharmNews/status/472772073514102785,,,,
rsm2800,5/31/2014 12:10,8,3,Hudis: Standing O for @ CliffordHudis pres address-vision of how science impacts society to free the world from the fear of cancer # asco14,,@,#,4.72772E+17,https://twitter.com/rsm2800/status/472772060260077568,,,,
TawnyaBowles,5/31/2014 12:10,0,0,"Busy # melanoma poster session at # ASCO14. New combo rx, insight into genetics/biology. # hopepic.twitter.com/dW3HFa3Qop",,,# # #,4.72772E+17,https://twitter.com/TawnyaBowles/status/472771992333344768,,,,
QIAGENscience,5/31/2014 12:09,0,0,New CAL-R biomarker for hemato-oncology application. Visit us at # ASCO14 booth #5013 to learn more about it!,,,# #5013,4.72772E+17,https://twitter.com/QIAGENscience/status/472771955830304768,,,,
NewCanvasAdv,5/31/2014 12:09,0,0,@ CliffordHudis @ ASCO Inspiring. Thank you for sharing.,,@ @,,4.72772E+17,https://twitter.com/NewCanvasAdv/status/472771933692776448,,,,
mnewtonPharmD,5/31/2014 12:09,0,0,A little late but finally headed to # ASCO14 ! Hope to see some familiar faces at Monday's poster session.,,,#,4.72772E+17,https://twitter.com/mnewtonPharmD/status/472771932371574784,,,,
TuftsB,5/31/2014 12:09,0,0,@ KUhlendorf @ CliffordHudis @ PhRMA - yes! We patients live longer and see family life events that cannot be quantified. # mliwi # asco14,,@ @ @,# #,4.72772E+17,https://twitter.com/TuftsB/status/472771801152770048,,,,
christinemphmd,5/31/2014 12:08,1,0,# ASCO14 Presidential Address @McCormick Place http://instagram.com/p/oqti-QCa4T/,,@McCormick,#,4.72772E+17,https://twitter.com/christinemphmd/status/472771709293309953,,,,
PetraMaertens,5/31/2014 12:08,2,1,# ASCO14 High demand for defining value requiring multi stakeholder input @Gfk_en,,@Gfk_en,#,4.72772E+17,https://twitter.com/PetraMaertens/status/472771632105156610,,,,
WilliamDale_MD,5/31/2014 12:08,3,2,# ASCO14 Hurria: Challenges are just opportunities in disguise. (And they have to be financed. ) # geriatrics # oncology.,,,# # #,4.72772E+17,https://twitter.com/WilliamDale_MD/status/472771609665630208,,,,
teamoncology,5/31/2014 12:08,0,1,Drug seem to save fertility. But the difference was very small. What do you think? http://www.nytimes.com/2014/05/31/business/drug-could-protect-fertility-in-breast-cancer-patients.html?_r=0 … # ASCO14,,,#,4.72772E+17,https://twitter.com/teamoncology/status/472771601503502336,,,,
aftimosp,5/31/2014 12:08,0,0,Combo of dabrafenib (BRAFi)+ trametinib (MEKi) + adoptive cell therapy in immune competent murine models with BRAF-mutated melanoma # ASCO14,,,#,4.72772E+17,https://twitter.com/aftimosp/status/472771579806367744,,,,
TawnyaBowles,5/31/2014 12:07,0,0,# melanoma not uncommon in # pregnancy. Nice poster at # ASCO14 exploring why. @ LudwigCancerpic.twitter.com/ZSjRpG4RGn,,@,# # #,4.72771E+17,https://twitter.com/TawnyaBowles/status/472771426798546944,,,,
premal2000,5/31/2014 12:07,0,0,Gross understatement! “ @ CliffordHudis: Information technology in medicine lags other fields. http://bit.ly/1gxqfJy # ASCO14”,,@,#,4.72771E+17,https://twitter.com/premal2000/status/472771353808879617,,,,
PhRMA,5/31/2014 12:07,8,0,# Medicare # PartD is great example of how increased access to meds reduces # healthcare costs says # PhRMA CEO http://bit.ly/1nDaGmT # ASCO14,,,# # # # #,4.72771E+17,https://twitter.com/PhRMA/status/472771251941826560,,,,
StomachCancer_,5/31/2014 12:06,0,1,Our booth is all set at # ASCO2014. Come by and say hello!!,,,#,4.72771E+17,https://twitter.com/StomachCancer_/status/472770999729917952,,,,
WilliamDale_MD,5/31/2014 12:06,3,0,"# ASCO14 Wrap up of Special Session on # gerionc models of care by the undisputed leader, Arti Hurria.",,,# #,4.72771E+17,https://twitter.com/WilliamDale_MD/status/472770993807585281,,,,
aftimosp,5/31/2014 12:05,1,0,The triplet combo of ipi + dabrafenib (BRAF i) + trametinib (MEK i) was stoppped after 2 patients developed colitis and perforation # ASCO14,,,#,4.72771E+17,https://twitter.com/aftimosp/status/472770976162140160,,,,
ProteinLounge,5/31/2014 12:05,2,3,For # ASCO14 in Chicago today: Dr. Monica Morrow's talk - 50 years in breast cancer. http://proteinlounge.com/Animation/Introduction%20to%20Breast%20Cancer …,,,#,4.72771E+17,https://twitter.com/ProteinLounge/status/472770945032417282,,,,
preventcancer,5/31/2014 12:05,3,0,The @ preventcancer booth at # ASCO14 features our brand new newsletter featuring Andrea Roane @ abuddy # cancerpic.twitter.com/7BAFGwDPjt,,@ @,# #,4.72771E+17,https://twitter.com/preventcancer/status/472770941701734400,,,,
mfrimawi,5/31/2014 12:05,0,0,ASCO president @ CliffordHudis about Fighting cancer: we can afford to win it. We can't afford to lose it. # ASCO14,,@,#,4.72771E+17,https://twitter.com/mfrimawi/status/472770860441686017,,,,
sloan_kettering,5/31/2014 12:05,16,5,Five decades of @ ASCO - five opportunities # ASCO14 @ CliffordHudispic.twitter.com/maMhhUkP5k,,@ @,#,4.72771E+17,https://twitter.com/sloan_kettering/status/472770814643666944,,,,
Roche,5/31/2014 12:05,6,6,How can # pharma help address the imminent shortage of scientists and clinicians in oncology? http://ow.ly/xkPgM # ASCO14,,,# #,4.72771E+17,https://twitter.com/Roche/status/472770786672246784,,,,
genentech,5/31/2014 12:05,2,1,@ DrMarkham Agree - even more so in the last 5 yrs in # skinccancer: http://ow.ly/xtoPv # ASCO14,,@,# #,4.72771E+17,https://twitter.com/genentech/status/472770776752742400,,,,
fischmd,5/31/2014 12:05,7,5,"# CancerLinQ by @ ASCO: Learning from every patient encounter with every patient with cancer from every practice site, @ rschilsky at # ASCO14",,@ @,# #,4.72771E+17,https://twitter.com/fischmd/status/472770771027517440,,,,
SanofiUS,5/31/2014 12:05,5,0,MT @ KUhlendorf: @ ASCO Pres. @ CliffordHudis emphasizes collective goal of ridding world frm fear of # cancer # ASCO14 http://bit.ly/1pH3Ppn,,@ @ @,# #,4.72771E+17,https://twitter.com/SanofiUS/status/472770749879832576,,,,
DrHedrick,5/31/2014 12:05,1,0,"Our intention is to use science to transform society by making a world free from the fear of cancer."" - @ CliffordHudis # ASCO14""",,@,#,4.72771E+17,https://twitter.com/DrHedrick/status/472770735732453377,,,,
aftimosp,5/31/2014 12:04,0,0,Full doses of ipilimumab and dabrafenib were administered with no DLTs # ASCO14,,,#,4.72771E+17,https://twitter.com/aftimosp/status/472770594107166720,,,,
aftimosp,5/31/2014 12:04,1,0,Phase 1 trial of dabrafenib and ipilimumab seems promising. The vemurafenib and ipi combo was stopped because of tox # ASCO14,,,#,4.7277E+17,https://twitter.com/aftimosp/status/472770486938525698,,,,
INVIVOcom,5/31/2014 12:03,3,1,# ASCO14 open for day 1! pic.twitter.com/26qyfWh2z2,,,#,4.7277E+17,https://twitter.com/INVIVOcom/status/472770472518897666,,,,
Cortellis,5/31/2014 12:03,3,0,"Sym004, 1st in class mix of 2 mAbs targeting non-overlapping EGFR epitopes; 40% CRC patients in C1 study show tumor shrinkage >10% # ASCO14",,,#,4.7277E+17,https://twitter.com/Cortellis/status/472770458056921088,,,,
ZosiaChustecka,5/31/2014 12:03,1,0,Check out Medscape coverage from # ASCO14 and new this year we have a live blog http://www.medscape.com/viewarticle/825818 …,,,#,4.7277E+17,https://twitter.com/ZosiaChustecka/status/472770329408851968,,,,
christinemphmd,5/31/2014 12:03,1,2,Awesome resources on genomics for practicing physicians @ ASCO University http://university.asco.org # ASCO14 # meded # lifelonglearning # genomics,,@,# # # #,4.7277E+17,https://twitter.com/christinemphmd/status/472770301139636224,,,,
aftimosp,5/31/2014 12:03,0,0,Olaparib and BKM120 phase 1: PI3K inh sensitizes BRCA-proficient # BreastCancer to PARP inh? # ASCO14,,,# #,4.7277E+17,https://twitter.com/aftimosp/status/472770283053789185,,,,
ancasa2000,5/31/2014 12:03,2,0,"Five decades, five opportunities # ASCO14 pic.twitter.com/3lFlj2qubc",,,#,4.7277E+17,https://twitter.com/ancasa2000/status/472770267979079680,,,,
NVCInfo,5/31/2014 12:03,1,1,# pharma # packaging # innovation project & LIVE tutor online # course inspired by @ ASCO # ASCO14 http://www.en.nvc.nl/pharmaceutical-packaging-innovation/ … * http://www.en.nvc.nl/opleidingen/nvc-e-course-pharmaceutical-packaging-online/ …,,@,# # # # #,4.7277E+17,https://twitter.com/NVCInfo/status/472770237558169601,,,,
mfrimawi,5/31/2014 12:02,1,1,ASCO president @ CliffordHudis says information technology can help expedite drug development. # ASCO14,,@,#,4.7277E+17,https://twitter.com/mfrimawi/status/472770134076313601,,,,
AlpineBV_Miller,5/31/2014 12:02,1,0,@ JonEPVantage @ bradloncar It's Adcetris mechanism of action. Didn't see anywhere in the booth for the # sgenball @ SeattleGenetics # ASCO14,,@ @ @,# #,4.7277E+17,https://twitter.com/AlpineBV_Miller/status/472770129902977024,,,,
CI4CC,5/31/2014 12:02,0,0,Older melanoma pts do worse than younger pts?! ... but only when treated with immunotherapies for Stage 3 disease. # ASCO14,,,#,4.7277E+17,https://twitter.com/CI4CC/status/472770111607021569,,,,
WilliamDale_MD,5/31/2014 12:02,3,0,# ASCO14 If you've seen one # gerionc clinic," you've seen one # gerionc program."" Harvey Cohen.""",,,# # #,4.7277E+17,https://twitter.com/WilliamDale_MD/status/472770040031219713,,,
Mike_Seeley,5/31/2014 12:02,0,0,RT “ @ hmhyltonpac: Dr. Ezekiel Emanuel at # ASCO14: Just one oncology drug can potentially wipe out the median income of the US household.”,,@,#,4.7277E+17,https://twitter.com/Mike_Seeley/status/472770032171110401,,,,
appistry,5/31/2014 12:02,1,2,"We just announced # CloudDx, a cloud-based service for ordering # genomics tests. http://ow.ly/xrTPU Learn more @ # ASCO14 @ SLU_Official",,@ @,# # #,4.7277E+17,https://twitter.com/appistry/status/472769996436037632,,,,
aftimosp,5/31/2014 12:01,1,0,Olaparib + BKM120 phase 1: Patient with TN # BreastCancer and WITHOUT BRCA mutation had CR. # ASCO14,,,# #,4.7277E+17,https://twitter.com/aftimosp/status/472769911748444161,,,,
DebiopharmNews,5/31/2014 12:01,2,0,# ASCO14 Convert your molecule into a successful drug http://ow.ly/x93ar,,,#,4.7277E+17,https://twitter.com/DebiopharmNews/status/472769890743754753,,,,
ASCO,5/31/2014 12:01,6,2,"'Front-Line Approach to Metastatic BRAF-Mutant Melanoma' session covers diagnostic, treatment options http://bit.ly/1toHjC5 # ASCO14",,,#,4.7277E+17,https://twitter.com/ASCO/status/472769875551993856,,,,
CI4CC,5/31/2014 12:01,0,0,# ASCO14 is in full swing. Follow the conversation & learn more about Cancer Informatics visit http://www.ci4cc.org,,,#,4.7277E+17,https://twitter.com/CI4CC/status/472769845386162176,,,,
WayneKoberstein,5/31/2014 12:01,2,0,"Unlike other Tx, immuno trials start in early patients. Also, takes weeks/months for response to develop. # ASCO14 @ RfwrightLSL",,@,#,4.7277E+17,https://twitter.com/WayneKoberstein/status/472769808933478400,,,,
MelPalMD,5/31/2014 12:01,1,1,"Practice what you preach? Some hospitals will not hire people who smoke. Should we not hire people with high BMI at cancer center? # ASCO14”""",,,#,4.7277E+17,https://twitter.com/MelPalMD/status/472769782845300736,,,,
bmsnews,5/31/2014 12:01,7,7,"Long-term follow-up from Phase 1 trial of investigational compound in # lung cancer presented today @ 1:15pm CDT, S Hall A2 # ASCO14",,@,# #,4.7277E+17,https://twitter.com/bmsnews/status/472769776599969792,,,,
PetraMaertens,5/31/2014 12:00,1,1,"# ASCO14 Highly contentious session with discussion on value of cancer care, where are the PROs? @Gfk_en",,@Gfk_en,#,4.7277E+17,https://twitter.com/PetraMaertens/status/472769682601033728,,,,
WHOPressUS,5/31/2014 12:00,1,1,"Also NEW for # ASCO14: The ICD-O Classification of Diseases for Oncology, 3rd Ed. Visit the WHO Press booth 20119. http://ow.ly/i/5KAsc",,,#,4.7277E+17,https://twitter.com/WHOPressUS/status/472769598602096644,,,,
aftimosp,5/31/2014 12:00,1,0,Olaparib and BKM120 phase1: 7 ovarian cancer patients had PR (ORR = 22%). 1 # BreastCancer had a CR (ORR = 30%) # ASCO14,,,# #,4.7277E+17,https://twitter.com/aftimosp/status/472769593899905024,,,,
teamoncology,5/31/2014 12:00,3,1,Obesity is an important issue in USA. Not every country is super obese like USA. Look your non-USA colleagues’ habitus. :) # ASCO14,,,#,4.7277E+17,https://twitter.com/teamoncology/status/472769573507194880,,,,
PhRMA,5/31/2014 12:00,1,0,# Patients should be at center of discussions around value & related methodologies observes @ KUhlendorf from # ASCO14 http://onphr.ma/1wGFpkH,,@,# #,4.7277E+17,https://twitter.com/PhRMA/status/472769538216321024,,,,
MedscapeOnc,5/31/2014 12:00,1,1,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.7277E+17,https://twitter.com/MedscapeOnc/status/472769513000153088,,,,
cancerassassin1,5/31/2014 12:00,0,1,On theme of Genomics & Genetics for Practicing Clinician: IMO we need more education as many MDs remain unaware of need & resources. # ASCO14,,,#,4.7277E+17,https://twitter.com/cancerassassin1/status/472769501012848641,,,,
myriadgenetics,5/31/2014 12:00,1,0,A 160-patient study found Myriad's HRD test predicted response to therapy in # TNBC patients. http://bit.ly/1tWn80k # ASCO14 Poster TPS1445,,,# #,4.72769E+17,https://twitter.com/myriadgenetics/status/472769497741287424,,,,
Medscape,5/31/2014 12:00,0,1,Check out our live blog from # ASCO14: http://bit.ly/1tQM9tQ,,,#,4.72769E+17,https://twitter.com/Medscape/status/472769488656412674,,,,
DanaFarber,5/31/2014 12:00,10,5,Palbociclib enters adjuvant testing for stage II-III # breastcancer: http://bit.ly/1k7SE9Q # ASCO14 # bcsm # SFSCWC,,,# # # #,4.72769E+17,https://twitter.com/DanaFarber/status/472769482193383424,,,,
MelPalMD,5/31/2014 12:00,3,3,"Why prevention is necessary - Dr. Ezekiel Emanuel at # ASCO14: Just one oncology drug can wipe out the median income of the US household""""",,,#,4.72769E+17,https://twitter.com/MelPalMD/status/472769474970402816,,,,
DrHedrick,5/31/2014 11:59,0,0,"Genetics and Genomics in cancer care. Is it safe, accurate, predictive, prognostic, actionable, and affordable. Lot of concerns. # ASCO14",,,#,4.72769E+17,https://twitter.com/DrHedrick/status/472769466900967425,,,,
JSchneide12,5/31/2014 11:59,0,2,Making # cancer progress but at what cost? http://abcn.ws/1oUUxq0 With @Carolinas Dr. Raghavan # LCI # ASCO14,,@Carolinas,# # #,4.72769E+17,https://twitter.com/JSchneide12/status/472769429671931905,,,,
mfrimawi,5/31/2014 11:59,0,0,ASCO president @ CliffordHudis : # obesity may reverse the the progress we made in cancer care in the last 50 years. # ASCO14,,@,# #,4.72769E+17,https://twitter.com/mfrimawi/status/472769317202038786,,,,
rsm2800,5/31/2014 11:59,1,1,Hudis: ASCO addressing privacy concerns about genomic information (see ASCO University course by Ken Offit) # ASCO14,,,#,4.72769E+17,https://twitter.com/rsm2800/status/472769277305434114,,,,
lenstarnes,5/31/2014 11:59,5,4,# ASCO14 Twitter participant/physical attendee % = 22. Must B one of the highest comparable medical society conference ratios @ symplur,,@,#,4.72769E+17,https://twitter.com/lenstarnes/status/472769257076711424,,,,
sloan_kettering,5/31/2014 11:59,4,2,. @ CliffordHudis: Health consequences of # obesity will confront us for decades. Can't let it reverse 50yrs of cancer research strides # ASCO14,,@,# #,4.72769E+17,https://twitter.com/sloan_kettering/status/472769251460120576,,,,
THsuMD,5/31/2014 11:59,0,0,Inspiring session involving the leaders of geriatric oncology about how to set up a geri-onc presence at your institution # ASCO14 # gerionc,,,# #,4.72769E+17,https://twitter.com/THsuMD/status/472769245961400320,,,,
KUhlendorf,5/31/2014 11:59,4,2,"Measuring value in # cancer care is more complicated than simply adding up costs of medicines, @ CliffordHudis says at # ASCO14",,@,# #,4.72769E+17,https://twitter.com/KUhlendorf/status/472769240299077633,,,,
aftimosp,5/31/2014 11:59,1,0,"Olaparib + BKM120 phase 1: DLTs: hyperglycemia, transaminitis ( safety signals: transaminitis and depression) # ASCO14",,,#,4.72769E+17,https://twitter.com/aftimosp/status/472769232627699712,,,,
IBCResearch,5/31/2014 11:59,3,0,Is obesity the new tobacco? Increased cancer risk with obesity focus of @ ASCO @ CliffordHudis # ASCO14 Stay tuned. # BC # IBC,,@ @,# # #,4.72769E+17,https://twitter.com/IBCResearch/status/472769225849716736,,,,
teamoncology,5/31/2014 11:58,1,0,"True, but more in USA. RT @ Pharmafocus: # ASCO14 president Clifford Hudis: Obesity appears to be the tobacco of our generation""""",,@,#,4.72769E+17,https://twitter.com/teamoncology/status/472769203699589120,,,,
RasuShrestha,5/31/2014 11:58,4,3,Interoperable data in cancer registries key to improving treatment http://searchhealthit.techtarget.com/feature/Interoperable-data-in-cancer-registries-key-to-improving-treatment … # ASCO14 # interoperability # Cancer,,,# # #,4.72769E+17,https://twitter.com/RasuShrestha/status/472769193059033089,,,,
chemobrainfog,5/31/2014 11:58,0,0,"To my friends in # Chicago-You are at center of TON of things this weekend: # ASCO2014 @ avonwalks and game 7 hockey. My kind of town""""",,@,# #,4.72769E+17,https://twitter.com/chemobrainfog/status/472769174910283776,,,,
dansbarrington,5/31/2014 11:58,3,0,# ASCO14 Visit us on booth 2066 to find out about some amazing candidates. Mention this tweet and we'll buy you a drink in the bar later!!,,,#,4.72769E+17,https://twitter.com/dansbarrington/status/472769172007837696,,,,
hawkdigital,5/31/2014 11:58,0,0,What’s big in # SocOncology? Annual @ W2OGroup report says cancer hashtags and doc tweets: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72769E+17,https://twitter.com/hawkdigital/status/472769151581175808,,,,
teamoncology,5/31/2014 11:58,1,2,The other issue is that the food that is provided at the convention center for # ASCO14 generally promotes obesity. :(,,,#,4.72769E+17,https://twitter.com/teamoncology/status/472769085869006848,,,,
2XBCSURVIVOR76,5/31/2014 11:58,2,0,@ SellersMPA so GREAT to see you as always! And a great way to start the day too. # ASCO14,,@,#,4.72769E+17,https://twitter.com/2XBCSURVIVOR76/status/472769079061671937,,,,
BioWorld,5/31/2014 11:58,4,0,Pharmacyclics’ Imbruvica beats GSK’s Arzerra in elderly CLL patients # ASCO14 http://bit.ly/1hJGi20,,,#,4.72769E+17,https://twitter.com/BioWorld/status/472769076180164608,,,,
dansbarrington,5/31/2014 11:58,2,0,# ASCO14 Visit us on booth 2066 to find out about some amazing vacancies. Mention this tweet and we'll buy you a drink in the bar later!!,,,#,4.72769E+17,https://twitter.com/dansbarrington/status/472769073953390594,,,,
UdderlySmooth,5/31/2014 11:58,1,3,# asco14 exhibit hall 24 hours later # UdderlySmooth http://ift.tt/1mCZfpX pic.twitter.com/0ooi7bSYcg,,,# #,4.72769E+17,https://twitter.com/UdderlySmooth/status/472769067322200064,,,,
CI4CC,5/31/2014 11:58,0,0,Obesity as the new tobacco in cancer # ASCO14,,,#,4.72769E+17,https://twitter.com/CI4CC/status/472769061353689088,,,,
aftimosp,5/31/2014 11:58,3,0,Olaparib + BKM120 phase 1: 70% of ovarian and 92% of # BreastCancer had germline BRCA mutations # ASCO14,,,# #,4.72769E+17,https://twitter.com/aftimosp/status/472769040721530880,,,,
Pharmafocus,5/31/2014 11:58,2,0,"# ASCO14 president Clifford Hudis: Obesity appears to be the tobacco of our generation""""",,,#,4.72769E+17,https://twitter.com/Pharmafocus/status/472769038850859008,,,,
skipbidder,5/31/2014 11:57,1,1,Thanks for # ASCO14 tweets. Many of us outside onc are following as well. Links are helpful if you can post em,,,#,4.72769E+17,https://twitter.com/skipbidder/status/472768964536578048,,,,
MelPalMD,5/31/2014 11:57,1,0,Concept of P4 Medicine by Dr. Leroy Hood may be the future # ASCO14 http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4n7w0zKRjc.twitter …,,,# #,4.72769E+17,https://twitter.com/MelPalMD/status/472768914481356800,,,,
teamoncology,5/31/2014 11:57,4,2,Some hospitals will not hire people who smokes. Should we not hire people with high BMI at cancer center? # ASCO14,,,#,4.72769E+17,https://twitter.com/teamoncology/status/472768850086203392,,,,
WayneKoberstein,5/31/2014 11:57,2,0,"Ed Bradley, head Medimmune's immunoTx program: (i.e.) patient response to checkpoint inhibitors will drive adoption. # ASCO14 @ RfwrightLSL",,@,#,4.72769E+17,https://twitter.com/WayneKoberstein/status/472768836408573952,,,,
DrHedrick,5/31/2014 11:57,2,1,Obesity as the new tobacco in cancer care. Coincides nicely with social justice concerns. A lot revolves around poverty. # ASCO14,,,#,4.72769E+17,https://twitter.com/DrHedrick/status/472768785171361792,,,,
christinemphmd,5/31/2014 11:57,1,0,On # value and # cost of # cancer care. Who said it? Not who you'd expect! A CEO of pharm # ASCO14 @ CliffordHudispic.twitter.com/B0dADWhZ1X,,@,# # # #,4.72769E+17,https://twitter.com/christinemphmd/status/472768748001062912,,,,
Lymphoma_Doc,5/31/2014 11:56,4,1,@ ASCO Obesity and Cancer resources for Oncologists http://bit.ly/1khVsjG # ASCO14,,@,#,4.72769E+17,https://twitter.com/Lymphoma_Doc/status/472768666077900801,,,,
MMarchioneAP,5/31/2014 11:56,3,1,When is a novel # cancer drug worth it? http://tinyurl.com/khkyssw # ASCO14 $ LLY $ AZN $ JNJ,,,# #,4.72769E+17,https://twitter.com/MMarchioneAP/status/472768617160138755,,,,
THsuMD,5/31/2014 11:56,0,0,National geri-onc programs in France and Belgium. Hoping Canada can learn from our colleagues! # ASCO14 # gerionc # wishfulthinking,,,# # #,4.72769E+17,https://twitter.com/THsuMD/status/472768612441153536,,,,
aftimosp,5/31/2014 11:56,1,0,Funding of the olaparib and BKM120 trial by @ SU2C # ASCO14,,@,#,4.72769E+17,https://twitter.com/aftimosp/status/472768596066578432,,,,
michael_gilman,5/31/2014 11:55,2,0,"As public service to my followers, providing an occasional break from the # ASCO14 deluge. Like this: http://mashable.com/2014/05/30/apple-iwatch-parody/ … # ascobreaktime",,,# #,4.72768E+17,https://twitter.com/michael_gilman/status/472768397068218368,,,,
aftimosp,5/31/2014 11:55,1,0,Phase 1 of olaparib and BKM120 (pan-PI3K inh) in TNBC and high grade serous ovarian cancer # ASCO14,,,#,4.72768E+17,https://twitter.com/aftimosp/status/472768380496121856,,,,
ProfJohnCrown,5/31/2014 11:55,3,3,"Call to arms from @ CliffordHudis Obesity is the smoking of our generation"" # ASCO14""",,@,#,4.72768E+17,https://twitter.com/ProfJohnCrown/status/472768333578661889,,,,
AlpineBV_Miller,5/31/2014 11:55,1,1,Dropped by $ INSY booth at # ASCO14 Nobody in prison stripes or orange jumpsuits. Just FYI.,,,#,4.72768E+17,https://twitter.com/AlpineBV_Miller/status/472768321650429953,,,,
ProjectInno,5/31/2014 11:55,1,0,Cancer cures are born of medical innovation http://ow.ly/xs32s # innovatenow # ASCO14 # innovatenow,,,# # #,4.72768E+17,https://twitter.com/ProjectInno/status/472768254772281344,,,,
ShabbirHossain,5/31/2014 11:55,1,0,“ @ mfrimawi: ASCO president @ CliffordHudis says: # Obesity may be as much a public health hazard as smoking. # ASCO14”,,@ @,# #,4.72768E+17,https://twitter.com/ShabbirHossain/status/472768230168477696,,,,
KUhlendorf,5/31/2014 11:55,3,0,". @ CliffordHudis at # ASCO14: we must work together to preserve # cancer # innovation while protecting access to, affordability of care",,@,# # #,4.72768E+17,https://twitter.com/KUhlendorf/status/472768218642518016,,,,
ME_Fleury,5/31/2014 11:54,3,1,Cliff Hudis at # ASCO14: Obesity is the new tobacco of our generation.,,,#,4.72768E+17,https://twitter.com/ME_Fleury/status/472768160454959104,,,,
fischmd,5/31/2014 11:54,17,8,"“In some ways, # obesity appears to be the new tobacco of our generation.” @ ASCO President @ CliffordHudis at # ASCO14 plenary.",,@ @,# #,4.72768E+17,https://twitter.com/fischmd/status/472768101965398016,,,,
hmhyltonpac,5/31/2014 11:54,2,1,"Interesting parallel by Dr. Hudis at # ASCO14, discussing obesity being the tobacco"" of this era.""",,,#,4.72768E+17,https://twitter.com/hmhyltonpac/status/472768087238770689,,,,
ABhealer108,5/31/2014 11:54,1,0,Barrier to trial accrual: MD discussion with pts. excellent talks by Drs.Schilsky & Worta McCaskill-Stevens. # ASCO14 @ rschilsky,,@,#,4.72768E+17,https://twitter.com/ABhealer108/status/472768086614216704,,,,
Merck,5/31/2014 11:54,3,2,"As we join # ASCO14, check out what we're doing to help make a difference in the fight against cancer: http://bit.ly/1puOU1w # MerckOncology",,,# #,4.72768E+17,https://twitter.com/Merck/status/472768053701124097,,,,
CancerNetwrk,5/31/2014 11:54,4,0,RT @ rsm2800 Hudis: Our nation’s investment in science is woeful; Federal investment in research on cancer is 0.1% of federal budget # asco14,,@,#,4.72768E+17,https://twitter.com/CancerNetwrk/status/472768039168258048,,,,
DrBobGoldberg,5/31/2014 11:54,0,0,@ fischmd @ CliffordHudis digitized consumers will make your cost models irrelevant by next year. Scrap the @ asco app!! # mliwi,,@ @ @,#,4.72768E+17,https://twitter.com/DrBobGoldberg/status/472768034479042560,,,,
MidAmPrint,5/31/2014 11:54,0,0,How is # ASCO14 going? So well that you ran out of your printed material? @ MidAmPrint can help! http://ow.ly/wiZIs,,@,#,4.72768E+17,https://twitter.com/MidAmPrint/status/472767984692252673,,,,
mfrimawi,5/31/2014 11:54,0,0,ASCO president @ CliffordHudis says: Obesity may be as much a public health hazard as smoking. # ASCO14,,@,#,4.72768E+17,https://twitter.com/mfrimawi/status/472767971408896000,,,,
teamoncology,5/31/2014 11:54,2,0,Dr . @ CliffordHudis discuss about addressing obesity. But how in USA? US has the highest obesity rate in the world. # ASCO14,,@,#,4.72768E+17,https://twitter.com/teamoncology/status/472767969215262720,,,,
aftimosp,5/31/2014 11:53,1,0,No PRs in prostate cancer with the mTOR and AKT combo # ASCO14,,,#,4.72768E+17,https://twitter.com/aftimosp/status/472767952928772096,,,,
sloan_kettering,5/31/2014 11:53,44,20,". @ CliffordHudis: who said in @ Forbes mag? A: pharma CEO. Industry sees pricing problem, too. @ matthewherper # ASCO14 pic.twitter.com/lUvwbzUbrJ",,@ @ @,#,4.72768E+17,https://twitter.com/sloan_kettering/status/472767890010431488,,,,
Neil_Iyengar,5/31/2014 11:53,2,0,"In some ways obesity appears to be the tobacco of our generation"" Hudis presidential address # ASCO14""",,,#,4.72768E+17,https://twitter.com/Neil_Iyengar/status/472767863825387520,,,,
Lhcamacho,5/31/2014 11:53,1,0,In some ways," obesity seems to be the new tobacco of our generation"" @ CliffordHudis # ASCO14 @ ASCO @ ASCOPost""",,@ @ @,#,4.72768E+17,https://twitter.com/Lhcamacho/status/472767847744434176,,,
martinnaley,5/31/2014 11:53,2,0,@ CliffordHudis Obesity is the new tobacco of this generation - a leading cause of cancer. # ASCO14,,@,#,4.72768E+17,https://twitter.com/martinnaley/status/472767797794451456,,,,
CliffordHudis,5/31/2014 11:53,7,3,LBJ pursued “Great Society”. “We can afford to win it. We cannot afford to lose it” His '64 SOTU speech http://bit.ly/1tiIh2u # ASCO14,,,#,4.72768E+17,https://twitter.com/CliffordHudis/status/472767781319237632,,,,
DrHollyHolmes,5/31/2014 11:53,4,0,# ASCO14 Harvey Cohen: let's create a grid to show the specific components of existing geri onc programs.,,,#,4.72768E+17,https://twitter.com/DrHollyHolmes/status/472767775631355906,,,,
sphatch,5/31/2014 11:53,1,1,An Overview of @ theNCI's National Clinical Trials Network (NCTN): http://www.cancer.gov/clinicaltrials/nctn …. # ASCO14,,@,#,4.72768E+17,https://twitter.com/sphatch/status/472767756501549056,,,,
Lymphoma_Doc,5/31/2014 11:53,1,0,@ CliffordHudis Obesity is the new tobacco for increased cancer risk societal issue # ASCO14,,@,#,4.72768E+17,https://twitter.com/Lymphoma_Doc/status/472767748418707456,,,,
KUhlendorf,5/31/2014 11:53,1,1,. @ CliffordHudis on high OOP costs: it makes no sense to disincentivize # compliance to meds that saves in other areas of care. # ASCO14,,@,# #,4.72768E+17,https://twitter.com/KUhlendorf/status/472767726185086976,,,,
chemobrainfog,5/31/2014 11:52,0,0,Via @ SHAREing: # ASCO2014 news @ drdonsdizon 2 talk abt tx options 4 people living w/ # metastatic BC 6/12 12:30ET http://ow.ly/xto0L # bcsm,,@ @,# # #,4.72768E+17,https://twitter.com/chemobrainfog/status/472767707495288833,,,,
DrBobGoldberg,5/31/2014 11:52,1,0,@ fischmd @ CliffordHudis we need tools to achieve @ ISBLeeHood vision of medicine. Want to save $. Support such innovations # ASCO14 # mliwi,,@ @ @,# #,4.72768E+17,https://twitter.com/DrBobGoldberg/status/472767688708980737,,,,
XRT4U,5/31/2014 11:52,0,0,@ CliffordHudis @ ASCO Oscar Wilde: a cynic knows the price of everything and the value of nothing.,,@ @,,4.72768E+17,https://twitter.com/XRT4U/status/472767636103655424,,,,
DrHedrick,5/31/2014 11:52,1,1,# ASCO14 Related to @ CliffordHudis talk - Why Oncologists Should Support Single-Payer National Health Insurance http://jop.ascopubs.org/content/10/1/7.full?sid=493c5a90-ae72-4836-aecc-3d2ff5320829#.U4n6WwVA4Zk.twitter …,,@,# #,4.72768E+17,https://twitter.com/DrHedrick/status/472767546664706048,,,,
aftimosp,5/31/2014 11:52,0,0,2 patients with breast cancer had PR. DIsease control rate was seen on 47% of patients. One patient on trial for 415 days # ASCO14,,,#,4.72768E+17,https://twitter.com/aftimosp/status/472767528800768000,,,,
cancerassassin1,5/31/2014 11:52,3,1,Another rising theme in # oncology getting max attention # ASCO14: role of # obesity epidemic in # cancer,,,# # # #,4.72767E+17,https://twitter.com/cancerassassin1/status/472767491479834625,,,,
CancerNetwrk,5/31/2014 11:52,1,1,"RT @ ASCO New agent for # thyroid cancer: Lenvatinib is “extremely efficient,” produces high response rate, prolongs survival # ASCO14",,@,# #,4.72767E+17,https://twitter.com/CancerNetwrk/status/472767487667617792,,,,
ProfJohnCrown,5/31/2014 11:51,0,1,Happy 50th Anniversary # ASCO14 !! Sobering to think that a youngster like me has been a member for more than half it's existence.,,,#,4.72767E+17,https://twitter.com/ProfJohnCrown/status/472767387851177984,,,,
RTSinfo,5/31/2014 11:51,2,0,Plusieurs thérapies prometteuses dans la recherche contre le # cancer présentée à un colloque américain @ ASCO: http://ow.ly/xtnxk,,@,#,4.72767E+17,https://twitter.com/RTSinfo/status/472767354729148417,,,,
WayneKoberstein,5/31/2014 11:51,5,3,"At # ASCO14, tracking amazing rise of cancer immunotherapy; real buzz over checkpoint inhibitors, combos immuno/targeted Tx. @ RfwrightLSL",,@,#,4.72767E+17,https://twitter.com/WayneKoberstein/status/472767337305624577,,,,
CBPartners,5/31/2014 11:51,0,1,"Disconnect between price and value - the question is not who is at fault. But how we can work together"" # ASCO14 pic.twitter.com/tuREsibeCm""",,,#,4.72767E+17,https://twitter.com/CBPartners/status/472767301818007552,,,,
CliffordHudis,5/31/2014 11:51,41,17,"5 opportunities after 5 decades for @ ASCO. Increase research $, Assure access. Define # value. Address obesity. Harness information. # ASCO14",,@,# #,4.72767E+17,https://twitter.com/CliffordHudis/status/472767277818200064,,,,
CliffordHudis,5/31/2014 11:51,1,2,Learn about the Global Alliance & how it seeks enable responsible sharing of genomic & clinical data http://bit.ly/1nwpK39 # ASCO14,,,#,4.72767E+17,https://twitter.com/CliffordHudis/status/472767277780451328,,,,
MLIWI,5/31/2014 11:51,2,0,"In 2013, nearly 86% of prescriptions filled in the U.S. were for generic meds. # ASCO14 # mliwi http://buff.ly/1hm8flY pic.twitter.com/VjwePYhitV",,,# #,4.72767E+17,https://twitter.com/MLIWI/status/472767265684066304,,,,
teamoncology,5/31/2014 11:50,0,0,"RT @ CliffordHudis: First @ ASCO meeting was November 5, 1964 in # Chicago. Read about ASCO’s Annual Meeting http://bit.ly/1puJiEo # ASCO14",,@ @,# #,4.72767E+17,https://twitter.com/teamoncology/status/472767198713245696,,,,
Neil_Iyengar,5/31/2014 11:50,0,0,If our partners in industry can see the problem as clearly as we do," we have an enormous opportunity to work together"" Hudis # ASCO14""",,,#,4.72767E+17,https://twitter.com/Neil_Iyengar/status/472767190320828417,,,
FightCRC,5/31/2014 11:50,1,1,Thank you @ carisls for sponsoring our two patient advocates! They're having a blast at # ASCO14 # crcadvocacypic.twitter.com/EfITaz4p1j,,@,# #,4.72767E+17,https://twitter.com/FightCRC/status/472767165381099520,,,,
martinnaley,5/31/2014 11:50,0,0,Hudis: ASCO creating a framework for value assessment in cancer care. It's more than the price of drugs. # ASCO14,,,#,4.72767E+17,https://twitter.com/martinnaley/status/472767157898448896,,,,
Lymphoma_Doc,5/31/2014 11:50,0,0,@ CliffordHudis: @ ASCO is best suited as honest broker of what represents value in oncology care # ASCO14,,@ @,#,4.72767E+17,https://twitter.com/Lymphoma_Doc/status/472767144661221377,,,,
DanBudwick,5/31/2014 11:50,0,1,Beautiful Saturday at # ASCO14 - solid weather for @ MarkSchoenebaum gig tonight!pic.twitter.com/Ru7DFc9Fr5,,@,#,4.72767E+17,https://twitter.com/DanBudwick/status/472767099773800448,,,,
DebiopharmNews,5/31/2014 11:50,1,0,# ASCO14 Successful in- and out-licensing for breakthrough drugs benefiting the # patient http://ow.ly/x935G,,,# #,4.72767E+17,https://twitter.com/DebiopharmNews/status/472767043348201473,,,,
aftimosp,5/31/2014 11:50,0,0,"DLTs were rash, stomatitis, transaminitis, thrombocytopenia # ASCO14",,,#,4.72767E+17,https://twitter.com/aftimosp/status/472767037148631041,,,,
cancerassassin1,5/31/2014 11:50,0,0,As alluded to by @ ASCO CEO Dr Lichter in @ cliffordhudis intro: # ASCO doesn't shy from controversy re: value of # cancer care. # stirringthepot,,@ @,# # #,4.72767E+17,https://twitter.com/cancerassassin1/status/472766966743052288,,,,
KowalyszynMD,5/31/2014 11:49,0,0,# asco2014 pic.twitter.com/LCg5Kf2HVt,,,#,4.72767E+17,https://twitter.com/KowalyszynMD/status/472766925937057794,,,,
aftimosp,5/31/2014 11:49,0,0,"Ras gene sinatures contains 147 genes. Sensitivity to AKT, and pi3k dependant. 50% of luminal and < 30% of TNBC # ASCO14",,,#,4.72767E+17,https://twitter.com/aftimosp/status/472766858857168896,,,,
DebMaskens,5/31/2014 11:49,1,1,Canadians at # ASCO14 -- text 'SUPPORT' to 30333 to support # kidneycancer HOPE team. Raising $ for research & supportpic.twitter.com/35Oy6yOh95,,,# #,4.72767E+17,https://twitter.com/DebMaskens/status/472766840255840259,,,,
dmooneymd,5/31/2014 11:49,0,0,Still unanswered ? of benefit of adj chemo after neoadj crt. Positive benefit in pathologic stage iii. Not likely in pcr. # ASCO14 # crcsm,,,# #,4.72767E+17,https://twitter.com/dmooneymd/status/472766812120424448,,,,
mfrimawi,5/31/2014 11:49,1,0,ASCO president @ CliffordHudis stresses the need for value in cancer care and awareness of cancer care costs. # ASCO14,,@,#,4.72767E+17,https://twitter.com/mfrimawi/status/472766759158939648,,,,
DocSchweitzer,5/31/2014 11:49,0,0,"New trend - super-targeted therapy, for when a targeted therapy just won't do. # ASCO14",,,#,4.72767E+17,https://twitter.com/DocSchweitzer/status/472766733032632320,,,,
aftimosp,5/31/2014 11:48,0,0,Rationale: Abrogation of AKT activation induced by TORC1 inhibition via S6 # ASCO14,,,#,4.72767E+17,https://twitter.com/aftimosp/status/472766673145970688,,,,
ByJonGardner,5/31/2014 11:48,0,1,(More Tweets About Hockey And Food). # ASCO14,,,#,4.72767E+17,https://twitter.com/ByJonGardner/status/472766612186357760,,,,
DrGlenWeiss,5/31/2014 11:48,0,0,Absolutely! Lack of linear relationship between price and benefit of chemotherapy. @ CliffordHudis # ASCO14,,@,#,4.72767E+17,https://twitter.com/DrGlenWeiss/status/472766607744593920,,,,
Agendia,5/31/2014 11:48,0,0,Stop by and learn about # Agendia's 25 year impact on breast cancer outcomes at our brand new booth! # asco14 # bcsmpic.twitter.com/xn3UBsZmLD,,,# # #,4.72767E+17,https://twitter.com/Agendia/status/472766567391191040,,,,
aftimosp,5/31/2014 11:48,3,0,"MK 8669 (mTOR inh) and AKT inh MK2206 in advanced breast and low RAS signatures, and prostate cancer PTEN deficient # ASCO14",,,#,4.72767E+17,https://twitter.com/aftimosp/status/472766553327296513,,,,
ElizBlanchardMD,5/31/2014 11:48,0,1,Dr Hudis: why would there be a financial disincentive to life saving oral cancer drugs (copays etc)? Why indeed??! # ASCO14,,,#,4.72767E+17,https://twitter.com/ElizBlanchardMD/status/472766540081688577,,,,
Lymphoma_Doc,5/31/2014 11:48,6,2,"@ CliffordHudis Financial co-pay for drugs is a compliance disincentive, irrational as avoids more expensive & less effective care # ASCO14",,@,#,4.72767E+17,https://twitter.com/Lymphoma_Doc/status/472766537040797697,,,,
ProfJohnCrown,5/31/2014 11:48,0,0,Delighted to see my old friend @ CliffordHudis giving presidential address ASCO. # ASCO14,,@,#,4.72766E+17,https://twitter.com/ProfJohnCrown/status/472766480610652160,,,,
CBPartners,5/31/2014 11:48,0,0,Strong focus on # value in # oncology @ CliffordHudis address # ASCO14 pic.twitter.com/TtrH0bHemY,,@,# # #,4.72766E+17,https://twitter.com/CBPartners/status/472766454702800896,,,,
ByJonGardner,5/31/2014 11:47,0,0,We're in the middle of the Changing Of The Food in the press room. Bad time to be hungry. # asco14,,,#,4.72766E+17,https://twitter.com/ByJonGardner/status/472766329062445056,,,,
DrHedrick,5/31/2014 11:47,1,1,That we are moving to intend to achieve social justice in cancer care is amazing and powerful. Hope other fields are doing the same. # ASCO14,,,#,4.72766E+17,https://twitter.com/DrHedrick/status/472766299849105409,,,,
JoleneScience,5/31/2014 11:47,1,1,"$ TGTX's ublituximab (TG-1101): good monotherapy ORR in CLL/MZL, low(ish) IRR; need more pts to compare to Gazyva & other Txs # ASCO14 # lymsm",,,# #,4.72766E+17,https://twitter.com/JoleneScience/status/472766215056662528,,,,
cancerassassin1,5/31/2014 11:46,0,0,Value in # cancer care rapidly manifesting as theme of # ASCO14. Goes hand in hand with # cancerresearch investments and value of returns.,,,# # #,4.72766E+17,https://twitter.com/cancerassassin1/status/472766162648846336,,,,
Cortellis,5/31/2014 11:46,0,0,Phase I results show initial evidence of clinical activity with IMGN853 in patients with solid tumor cancer # ASCO14,,,#,4.72766E+17,https://twitter.com/Cortellis/status/472766072223846400,,,,
WilliamDale_MD,5/31/2014 11:46,0,0,# ASCO14 Maggiore: Most dual trainees are in private practice. # gerionc,,,# #,4.72766E+17,https://twitter.com/WilliamDale_MD/status/472766028896677889,,,,
cancercommons,5/31/2014 11:46,0,0,Good overview of # prostatecancer news being discussed at # ASCO14: http://www.medpagetoday.com/HematologyOncology/ProstateCancer/46024 …,,,# #,4.72766E+17,https://twitter.com/cancercommons/status/472766019380187136,,,,
DrMarkham,5/31/2014 11:46,0,0,. @ CliffordHudis We must define value in cancer care. # ASCO14,,@,#,4.72766E+17,https://twitter.com/DrMarkham/status/472765965466624000,,,,
CliffordHudis,5/31/2014 11:46,13,8,Information technology in medicine lags other fields. @ ASCO is developing # CancerLinQ to help catch up: http://bit.ly/1gxqfJy # ASCO14,,@,# #,4.72766E+17,https://twitter.com/CliffordHudis/status/472765964723838976,,,,
dr_turk,5/31/2014 11:46,0,1,Only 0.1% of federal budget is invested in cancer research # ASCO14,,,#,4.72766E+17,https://twitter.com/dr_turk/status/472765947367800832,,,,
AlpineBV_Miller,5/31/2014 11:45,0,0,@ ASCO thanks for listening!,,@,,4.72766E+17,https://twitter.com/AlpineBV_Miller/status/472765944620908544,,,,
sloan_kettering,5/31/2014 11:45,6,3,. @ CliffordHudis: Legislators must understand the price patients pay for DC gridlock. # ASCO14 @ ASCO,,@ @,#,4.72766E+17,https://twitter.com/sloan_kettering/status/472765940409446400,,,,
fischmd,5/31/2014 11:45,5,1,"We need to develop and test new # healthcare delivery models. Our goal is to reward value as opposed to volume, @ CliffordHudis # ASCO14",,@,# #,4.72766E+17,https://twitter.com/fischmd/status/472765900702375936,,,,
drdonsdizon,5/31/2014 11:45,18,7,And Sitting is the new Smoking! RT @ CliffordHudis Obesity is the new tobacco. See @ ASCO resources http://bit.ly/1puQK2p # ASCO14,,@ @,#,4.72766E+17,https://twitter.com/drdonsdizon/status/472765891760123905,,,,
rsm2800,5/31/2014 11:45,1,1,Hudis: Uptake in QOPI shows that we oncologists are in the best position to determine quality # ASCO14,,,#,4.72766E+17,https://twitter.com/rsm2800/status/472765856535949312,,,,
aftimosp,5/31/2014 11:45,1,0,Excellent session this morning on combination strategies # ASCO14,,,#,4.72766E+17,https://twitter.com/aftimosp/status/472765854061309953,,,,
charleneson,5/31/2014 11:45,1,0,NIH funding for # cancer is down 25% since 2003. Only 0.1% of federal budget # ASCO14 @ cliffordhudis,,@,# #,4.72766E+17,https://twitter.com/charleneson/status/472765810302545920,,,,
sjaakvink,5/31/2014 11:45,0,0,key queztion Dr Leroy Hoed raises @ ASCO to realize revolutionary opportunities K4 patient driven medicine: will doctors be too conservative?,,@,,4.72766E+17,https://twitter.com/sjaakvink/status/472765796125401089,,,,
ASCO,5/31/2014 11:45,1,1,Companion Diagnostics & Biomarker Development session will cover changes ahead in clinical trials http://bit.ly/1oGDx9o # ASCO14,,,#,4.72766E+17,https://twitter.com/ASCO/status/472765792799698944,,,,
Novartis,5/31/2014 11:45,1,4,New # Novartis data in patients with # basalcellcarcinoma Jun 1 at 8 am CDT in E Arie Crown Theater; abstr No. 9009a # ASCO14,,,# # #,4.72766E+17,https://twitter.com/Novartis/status/472765786835390464,,,,
theABTA,5/31/2014 11:45,3,1,"P4 medicine-predictive, personalized, predictive & participatory-presented @ # ASCO14 as transformational holistic approach to disease mngmt.",,@,#,4.72766E+17,https://twitter.com/theABTA/status/472765764554870784,,,,
mfrimawi,5/31/2014 11:45,1,1,ASCO president @ CliffordHudis says 0.1% of federal budget for cancer research is not acceptable. # ASCO14,,@,#,4.72766E+17,https://twitter.com/mfrimawi/status/472765755696881666,,,,
EquicareHealth,5/31/2014 11:45,0,0,First day exhibitor excitement - join us at # ASCO2014 booth 4026! @ ASCO,,@,#,4.72766E+17,https://twitter.com/EquicareHealth/status/472765743168503808,,,,
CliffordHudis,5/31/2014 11:45,39,14,Obesity is the new tobacco. See @ ASCO resources http://bit.ly/1puQK2p # ASCO14,,@,#,4.72766E+17,https://twitter.com/CliffordHudis/status/472765742761267200,,,,
genentech,5/31/2014 11:45,3,4,"Stuart Lutzer, Early Clin Dev, says we may need to rethink what a Ph1 clinical trial is at its core. # ASCO14 http://ow.ly/xth8n",,,#,4.72766E+17,https://twitter.com/genentech/status/472765731088908288,,,,
genentech,5/31/2014 11:45,4,1,Congrats Dr. Robison on your # ASCO14 Pediatric Oncology award! We're inspired & we know there's much left to do: http://ow.ly/xtlnj,,,#,4.72766E+17,https://twitter.com/genentech/status/472765727506989057,,,,
LBarreraP,5/31/2014 11:45,1,1,Las diez recomendaciones que da @ ASCO a los periodistas para hacer un uso responsable de las redes sociales (2) pic.twitter.com/O5IiWPS3IY,,@,,4.72766E+17,https://twitter.com/LBarreraP/status/472765702307188737,,,,
hello_torch,5/31/2014 11:45,0,0,"Trend # asco14: Dr. Hudis, @ CliffordHudis, is 1st @ ASCO president to emphasize.. (via @ fischmd @ rsm2800 @ drdonsdizon) http://current.ly/share/us/asco14/5311361/ …",,@ @ @ @ @,#,4.72766E+17,https://twitter.com/hello_torch/status/472765702169194498,,,,
rsm2800,5/31/2014 11:44,6,2,Hudis: We oncologists must discover new healthcare delivery and payment models or others will define them for us # asco14,,,#,4.72766E+17,https://twitter.com/rsm2800/status/472765687232860160,,,,
WilliamDale_MD,5/31/2014 11:44,2,0,# ASCO14 Maggiore: There are few truly integrated programs of # geriatric # oncology . Most are sequential do to training restrictions.,,,# # #,4.72766E+17,https://twitter.com/WilliamDale_MD/status/472765651669360640,,,,
sitcancer,5/31/2014 11:44,4,1,Visit the SITC booth at number 2047! # ASCO14 pic.twitter.com/22wwYj25hZ,,,#,4.72766E+17,https://twitter.com/sitcancer/status/472765584745439232,,,,
dr_turk,5/31/2014 11:44,1,0,Investment in Cancer research should reflect the size of the challenge # ASCO14,,,#,4.72765E+17,https://twitter.com/dr_turk/status/472765498346577920,,,,
Lymphoma_Doc,5/31/2014 11:44,2,0,"@ CliffordHudis Reward value over volume"" # ASCO14""",,@,#,4.72765E+17,https://twitter.com/Lymphoma_Doc/status/472765492180963329,,,,
KUhlendorf,5/31/2014 11:44,3,1,Only .1% of federal budget goes to cancer research - @ CliffordHudis # ASCO14. We must expand our resources.,,@,#,4.72765E+17,https://twitter.com/KUhlendorf/status/472765457129172993,,,,
dansbarrington,5/31/2014 11:44,1,0,@ CliffordHudis @ ASCO # ASCO14 Visit us on booth 2066 to talk all things career. Whether you need a new job or new staff we are here to help,,@ @,#,4.72765E+17,https://twitter.com/dansbarrington/status/472765450406068224,,,,
rsm2800,5/31/2014 11:43,3,1,"Hudis: 2010—>2030 increase in cancer cases of 42%, in cancer survivors of 45% # asco14",,,#,4.72765E+17,https://twitter.com/rsm2800/status/472765356202000384,,,,
oncopaeds,5/31/2014 11:43,0,0,@ sloan_kettering @ ASCO @ CliffordHudis,,@ @ @,,4.72765E+17,https://twitter.com/oncopaeds/status/472765348047892481,,,,
LBarreraP,5/31/2014 11:43,2,1,Las diez recomendaciones que da @ ASCO a los periodistas para hacer un uso responsable de las redes sociales pic.twitter.com/qkJElq8ERy,,@,,4.72765E+17,https://twitter.com/LBarreraP/status/472765327143481345,,,,
tomleblancMD,5/31/2014 11:43,4,1,"RT @ ASCOPost: Statin Use Can Stop When Illness Is Terminal, Study Reports (via News@JAMA) http://ow.ly/xtiM5 # ASCO14 @ PCRCgroup # hpm",,@ @JAMA @,# #,4.72765E+17,https://twitter.com/tomleblancMD/status/472765262270574592,,,,
duemed,5/31/2014 11:43,2,0,@ CliffordHudis tweets ahead of live speech # ASCO14 Amazing!!,,@,#,4.72765E+17,https://twitter.com/duemed/status/472765232255733760,,,,
LarryNortonMD,5/31/2014 11:42,18,13,"“ @ sloan_kettering: . @ CliffordHudis to @ asco members # ASCO14 pic.twitter.com/9yNxJRGLVq” His talk is accurate, brilliant, courageous!",,@ @ @,#,4.72765E+17,https://twitter.com/LarryNortonMD/status/472765138660261888,,,,
ancasa2000,5/31/2014 11:42,1,0,Federal budget for cancer research in US: 0.1%... México surely worse # ASCO14,,,#,4.72765E+17,https://twitter.com/ancasa2000/status/472765110918737920,,,,
JoleneScience,5/31/2014 11:42,1,0,My Sat # ASCO14 watchlist: $ AMGN trebananib+T+H for HER2+ mBC & ECOG Avastin adjuvant (HER2-) final results,,,#,4.72765E+17,https://twitter.com/JoleneScience/status/472765062927507456,,,,
JoleneScience,5/31/2014 11:42,1,0,"My Sat # ASCO14 watchlist: $ AZN olaparib+cediranib ( @ theNCI-sponsored), PharmaMar’s lurbinectidin for ovarian # gyncsm",,@,# #,4.72765E+17,https://twitter.com/JoleneScience/status/472765024612540416,,,,
ShannonWestin,5/31/2014 11:42,0,0,@ AndytweetM study included BRCA mut non HG serous histo too. Now need to eval if non BRCA mut w PI3K aberrations derive benefit # ASCO14,,@,#,4.72765E+17,https://twitter.com/ShannonWestin/status/472765019135168512,,,,
PhRMA,5/31/2014 11:42,3,2,Our own @ JenatPhRMA share 5 facts about the value of # innovative # cancer meds http://onphr.ma/SbIUQd # ASCO14,,@,# # #,4.72765E+17,https://twitter.com/PhRMA/status/472765006941925376,,,,
ConsanoMolly,5/31/2014 11:42,1,2,RT @ Consano At @ ASCO's # ASCO14 meeting? Stop by the http://consano.org booth & learn @ # crowdfunding # researchpic.twitter.com/RQAmX8FUUo,,@ @ @,# # #,4.72765E+17,https://twitter.com/ConsanoMolly/status/472764973400088576,,,,
PDRennert,5/31/2014 11:42,2,2,"NewLink Genetics has quite a presence at # ASCO14 what do you all think of this group? IDO, vaccine tech, ipi combos",,,#,4.72765E+17,https://twitter.com/PDRennert/status/472764952676020224,,,,
christinemphmd,5/31/2014 11:41,1,1,"Our intention is to achieve social justice in cancer care."" @ CliffordHudis # ASCO14""",,@,#,4.72765E+17,https://twitter.com/christinemphmd/status/472764935421067264,,,,
KellyColligan,5/31/2014 11:41,1,1,Yikes is right! >> @ Neil_Iyengar: Proportion of US federal funding allocated to cancer research. Yikes. # ASCO14 pic.twitter.com/vSrWiTVIHE,,@,#,4.72765E+17,https://twitter.com/KellyColligan/status/472764897562853376,,,,
WilliamDale_MD,5/31/2014 11:41,2,0,"# ASCO14 Maggiore: Finding your home"" in a new care setting is a challenge"," requires adaptability to local setting. # gerionc""",,,# #,4.72765E+17,https://twitter.com/WilliamDale_MD/status/472764862561390592,,,
Jehennessy3,5/31/2014 11:41,0,0,# ASCO2014 # YSC2015 new conferences for young women and those who care for them http://www.youngsurvival.org/conferences,,,# #,4.72765E+17,https://twitter.com/Jehennessy3/status/472764850389934080,,,,
rsm2800,5/31/2014 11:41,0,0,Hudis: The Federal investment in cancer research is not commensurate with the burden of disease society faces # asco14,,,#,4.72765E+17,https://twitter.com/rsm2800/status/472764832731508737,,,,
Neil_Iyengar,5/31/2014 11:41,17,3,Proportion of US federal funding allocated to cancer research. Yikes. # ASCO14 pic.twitter.com/wttO4rvRDG,,,#,4.72765E+17,https://twitter.com/Neil_Iyengar/status/472764739005980672,,,,
KUhlendorf,5/31/2014 11:40,2,0,. @ CliffordHudis: we must translate scientific progress to maximize societal benefit by ensuring # patient access to quality care # ASCO14,,@,# #,4.72765E+17,https://twitter.com/KUhlendorf/status/472764671145955328,,,,
Lymphoma_Doc,5/31/2014 11:40,5,1,"@ CliffordHudis NCI budget is ~0.1% of federal budget, 23% <2003 adjusted, worse globally, Resources not equal to challenge # ASCO14",,@,#,4.72765E+17,https://twitter.com/Lymphoma_Doc/status/472764660072996864,,,,
ShabbirHossain,5/31/2014 11:40,1,0,@ CliffordHudis @ Forbes as a primary care physician hearing my specialist colleagues focus on this is great # ASCO14,,@ @,#,4.72765E+17,https://twitter.com/ShabbirHossain/status/472764606470172672,,,,
IBCResearch,5/31/2014 11:40,2,1,Our intention,"..translate scientific progress into societal benefit...social justice..."" @ ASCO @ CliffordHudis # ASCO14""",,@ @,#,4.72765E+17,https://twitter.com/IBCResearch/status/472764534445191169,,,
DebiopharmNews,5/31/2014 11:40,2,0,# ASCO14 Our unique # patientcentric business model for # success: Debiopharm Group http://ow.ly/x92Qa,,,# # #,4.72765E+17,https://twitter.com/DebiopharmNews/status/472764523779465218,,,,
Boehringer,5/31/2014 11:40,2,0,We're looking forward to joining the @ ASCO Tweetup. Will you be there? http://bit.ly/1gOpKZV # ASCO14,,@,#,4.72765E+17,https://twitter.com/Boehringer/status/472764520113659904,,,,
CliffordHudis,5/31/2014 11:40,4,1,Tobacco control has been key to progress against # cancer. See history & @ ASCO efforts here http://bit.ly/1oFegKg # ASCO14,,@,# #,4.72765E+17,https://twitter.com/CliffordHudis/status/472764509774688256,,,,
Boehringer,5/31/2014 11:40,2,0,# PRESS & # HCPs: Every patient has a different journey. Hear one # lungcancer patient's story http://bit.ly/1pJZqT5 # ASCO14,,,# # # #,4.72764E+17,https://twitter.com/Boehringer/status/472764488178225152,,,,
Lhcamacho,5/31/2014 11:40,8,1,"# ASCO14 ASCO turns 50! That is, FIFTY years committed to fighting # Cancer @ ASCO @ CliffordHudis @ ASCOPostpic.twitter.com/zQjfzfGmTi",,@ @ @,# #,4.72764E+17,https://twitter.com/Lhcamacho/status/472764471560396801,,,,
WayneKoberstein,5/31/2014 11:40,3,1,A massive meeting # ASCO14 @ RfwrightLSLpic.twitter.com/VgyXxdDOcu,,@,#,4.72764E+17,https://twitter.com/WayneKoberstein/status/472764471534841856,,,,
DrHollyHolmes,5/31/2014 11:40,4,1,"# ASCO14 Ron Maggiore food for thought: geriatrics and oncology training- asset or liability""""",,,#,4.72764E+17,https://twitter.com/DrHollyHolmes/status/472764440220155905,,,,
rsm2800,5/31/2014 11:40,20,8,Hudis: Our nation’s investment in science is woeful; Federal investment in research on cancer is 0.1% of the Federal budget # asco14,,,#,4.72764E+17,https://twitter.com/rsm2800/status/472764438211084288,,,,
OncologyTimes,5/31/2014 11:39,2,1,"MT @ fischmd: Dr. Hudis, @ CliffordHudis, is 1st @ ASCO president to emphasize his Twitter handle # ASCO14",,@ @ @,#,4.72764E+17,https://twitter.com/OncologyTimes/status/472764435744825344,,,,
mfrimawi,5/31/2014 11:39,1,0,"Inspiring speech by ASCO president @ CliffordHudis : access to care, social justice, NCI funding # ASCO14",,@,#,4.72764E+17,https://twitter.com/mfrimawi/status/472764427033276416,,,,
MaverickNY,5/31/2014 11:39,8,5,Updates to our Day 2 live blog from # asco14 have just posted: http://icar.us/1m0Gf33 $ clvs $ azn $ nvs,,,#,4.72764E+17,https://twitter.com/MaverickNY/status/472764386311147521,,,,
DrBredlau,5/31/2014 11:39,1,2,"Attending ASCO with more than 30,000 people dedicated to making cancer less scary. :-) # ASCO14 # PBTP",,,# #,4.72764E+17,https://twitter.com/DrBredlau/status/472764357231648768,,,,
sjaakvink,5/31/2014 11:39,0,0,@ ASCO 35.000 oncologists focussing at connecting science and society the best and fastest way possible pic.twitter.com/jeoqrn0ldQ,,@,,4.72764E+17,https://twitter.com/sjaakvink/status/472764335727460353,,,,
CancerAfrica,5/31/2014 11:39,3,1,# ASCO14 donate blood only 5 have donated please please support they need 30 donations pic.twitter.com/OSJcCEomXe,,,#,4.72764E+17,https://twitter.com/CancerAfrica/status/472764265590702081,,,,
sloan_kettering,5/31/2014 11:39,33,11,. @ CliffordHudis to @ asco members # ASCO14 pic.twitter.com/xe3EzsXKI5,,@ @,#,4.72764E+17,https://twitter.com/sloan_kettering/status/472764230169411584,,,,
PaoloNuciforo,5/31/2014 11:39,1,0,34.374 # ASCO14,,,#,4.72764E+17,https://twitter.com/PaoloNuciforo/status/472764224469753857,,,,
CliffordHudis,5/31/2014 11:39,2,1,"Stakeholders see the same challenge. First define value in cancer care."" http://goo.gl/xfhFuH # ASCO14""",,,#,4.72764E+17,https://twitter.com/CliffordHudis/status/472764220979699712,,,,
Neil_Iyengar,5/31/2014 11:38,1,0,Dr Hudis: Through research and application," our intention should be social justice in cancer care"" # ASCO14""",,,#,4.72764E+17,https://twitter.com/Neil_Iyengar/status/472764173374722048,,,
drdonsdizon,5/31/2014 11:38,2,0,"HA! RT @ rsm2800 Hudis: @ CliffordHudis assures @ drdonsdizon @ rsm2800 that he is not live-tweeting from the stage. # asco14""",,@ @ @ @,#,4.72764E+17,https://twitter.com/drdonsdizon/status/472764169176248322,,,,
rsm2800,5/31/2014 11:38,5,0,"Hudis: Our intention should be to translate scientific progress into societal benefit “social justice in cancer care” (clap, clap) # asco14",,,#,4.72764E+17,https://twitter.com/rsm2800/status/472764067854045184,,,,
AnneBooms,5/31/2014 11:38,3,0,# ASCO14 Maggiore on thoughts and perspectives of geriatric oncology trainess- http://dx.doi.org/10.1016/j.jgo.2013.10.003 …,,,#,4.72764E+17,https://twitter.com/AnneBooms/status/472764060576923648,,,,
Jehennessy3,5/31/2014 11:38,0,0,# ASCO2014 is it faster to Chicago or by bus?? pic.twitter.com/tBG1kN18bp,,,#,4.72764E+17,https://twitter.com/Jehennessy3/status/472764053937741825,,,,
SamBrownInc,5/31/2014 11:38,1,0,RT @ ASCO: Celebrate 50 years of progress against cancer with ASCO Daily News anniversary issue http://bit.ly/1wAkTCd # ASCO14,,@,#,4.72764E+17,https://twitter.com/SamBrownInc/status/472764046119157760,,,,
DrMarkham,5/31/2014 11:38,3,1,The intention of @ ASCO? The achievement of social justice in cancer care. @ CliffordHudis # ASCO14,,@ @,#,4.72764E+17,https://twitter.com/DrMarkham/status/472764015484370944,,,,
CliffordHudis,5/31/2014 11:38,5,7,Collaboration with all stakeholders needed to define # value in cancer care. See @ ASCO efforts here http://bit.ly/1hutixf # ASCO14,,@,# #,4.72764E+17,https://twitter.com/CliffordHudis/status/472764006504357889,,,,
LindaBohannonRN,5/31/2014 11:38,1,2,@ CliffordHudis @ ASCO and including the patient voice!,,@ @,,4.72764E+17,https://twitter.com/LindaBohannonRN/status/472763997570498560,,,,
WilliamDale_MD,5/31/2014 11:37,2,0,"# ASCO14 Maggiore: Geriatric training in oncology programs is growing...slowly. Few formal programs, but many less formal ones. # gerionc",,,# #,4.72764E+17,https://twitter.com/WilliamDale_MD/status/472763925650370560,,,,
tomleblancMD,5/31/2014 11:37,1,0,@ fischmd on # palliative care in # oncology: http://ow.ly/3lcR9J # hpm # ASCO14 # pallonc @ PCRCgroup,,@ @,# # # # #,4.72764E+17,https://twitter.com/tomleblancMD/status/472763890070470656,,,,
DrHollyHolmes,5/31/2014 11:37,0,1,# ASCO14 Ron Maggiore: geri onc principles important to onc fellows but not enough education.,,,#,4.72764E+17,https://twitter.com/DrHollyHolmes/status/472763801696096256,,,,
OncologyTimes,5/31/2014 11:37,0,0,". @ CliffordHudis: ASCO membership now has 34,374 members # ASCO14",,@,#,4.72764E+17,https://twitter.com/OncologyTimes/status/472763798932054016,,,,
ALLIANCE_org,5/31/2014 11:37,1,1,Not at # ASCO14 ? Follow @ CliffordHudis now for live updates of his presidential address.,,@,#,4.72764E+17,https://twitter.com/ALLIANCE_org/status/472763779508625408,,,,
CliffordHudis,5/31/2014 11:37,18,14,Society is focusing on cost. See @ Forbes article here http://onforb.es/SKV8iT We need to focus on # Value # ASCO14,,@,# #,4.72764E+17,https://twitter.com/CliffordHudis/status/472763754716098560,,,,
NDeVitoMD,5/31/2014 11:37,0,0,@ CliffordHudis highlighting the rise of @ asco since its inception 50 yrs ago pic.twitter.com/QW0JhNorTc,,@ @,,4.72764E+17,https://twitter.com/NDeVitoMD/status/472763714123608064,,,,
rsm2800,5/31/2014 11:37,1,0,Hudis: Growth in ASCO membership to 34K today is an outgrowth of the vision of the founders to improve cancer care # ASCO14,,,#,4.72764E+17,https://twitter.com/rsm2800/status/472763689297141760,,,,
CancerSupportHQ,5/31/2014 11:37,4,2,Day 1 exhibits at # ASCO14! Please come see Megan and Christina in the patient advocacy section! @ GildasClubCHI @ ASCO pic.twitter.com/dxPru00xmB,,@ @,#,4.72764E+17,https://twitter.com/CancerSupportHQ/status/472763683622625280,,,,
tomleblancMD,5/31/2014 11:36,1,0,Mike Fisch on # palliative care in # oncology: http://ow.ly/3lcR9J # hpm # ASCO14 # pallonc,,,# # # # #,4.72764E+17,https://twitter.com/tomleblancMD/status/472763651989192704,,,,
Lhcamacho,5/31/2014 11:36,2,1,# ASCO14 @ CliffordHudis is 50th president of @ ASCO and gives inspirational speech on # Cancer battle. @ drdonsdizonpic.twitter.com/LJCkMvbVWI,,@ @ @,# #,4.72764E+17,https://twitter.com/Lhcamacho/status/472763605666914304,,,,
mgaliano95,5/31/2014 11:36,0,0,Puto dolor de barriga y pecho que no me deja dormiiiiir!!!! # ASCO14,,,#,4.72764E+17,https://twitter.com/mgaliano95/status/472763583609458688,,,,
CliffordHudis,5/31/2014 11:36,10,5,Co-pay can decrease compliance. Is this sensible for cancer treatment? See # JCO http://bit.ly/1nvgDzC # ASCO14,,,# #,4.72764E+17,https://twitter.com/CliffordHudis/status/472763503150116864,,,,
Rad_Nation,5/31/2014 11:36,1,1,Heart volume reduction during neoadjuvant chemoradiation in resectable esophageal cancer http://buff.ly/1k623Pf # ASCO14 # esocsm # radonc,,,# # #,4.72764E+17,https://twitter.com/Rad_Nation/status/472763500889382912,,,,
sphatch,5/31/2014 11:35,1,0,MT @ mtmdphd: # ASCO14 - Abrams of @ theNCI: NCTN - LAPS provide leadership in development and conduct of CTs in assoc with the adult CT groups,,@ @,#,4.72763E+17,https://twitter.com/sphatch/status/472763363785981952,,,,
KUhlendorf,5/31/2014 11:35,2,0,. @ ASCO President @ CliffordHudis emphasizes collective goal of ridding our world from fear of # cancer # ASCO14 pic.twitter.com/ghCTapYJHR,,@ @,# #,4.72763E+17,https://twitter.com/KUhlendorf/status/472763337869393920,,,,
rsm2800,5/31/2014 11:35,0,0,"Hudis: Quoting ASCO co-founder Jane Wright (remarkable physician, remarkable life) # ASCO14",,,#,4.72763E+17,https://twitter.com/rsm2800/status/472763294663467009,,,,
DrMarkham,5/31/2014 11:35,6,3,"The accomplishments over the past 50 years, in the science of oncology & in the US, are astounding. # ASCO14",,,#,4.72763E+17,https://twitter.com/DrMarkham/status/472763274706952192,,,,
CliffordHudis,5/31/2014 11:35,10,2,"4 immediate steps from @ ASCO to address challenges to practice: more research $, new payment models, resolve # SGR, pursue # QOPI # ASCO14",,@,# # #,4.72763E+17,https://twitter.com/CliffordHudis/status/472763251559002113,,,,
fischmd,5/31/2014 11:35,8,7,"Dr. Hudis, @ CliffordHudis, is 1st @ ASCO president to emphasize his twitter handle. He is sending scheduled tweets of # ASCO14 plenary talk!",,@ @,#,4.72763E+17,https://twitter.com/fischmd/status/472763244009238529,,,,
CliffordHudis,5/31/2014 11:35,2,1,"“Whole onc pricing structure needs to be rethought...it’s reached the level that's not sustainable-J Jimenez http://onforb.es/1jX4ySN # ASCO14""",,,#,4.72763E+17,https://twitter.com/CliffordHudis/status/472763242545045504,,,,
DrHollyHolmes,5/31/2014 11:35,0,0,"@ WilliamTewMD at # ASCO14 Discussed 65+"": Impressive multidisciplinary model for geri onc pts at MSKCC""",,@,#,4.72763E+17,https://twitter.com/DrHollyHolmes/status/472763213935689729,,,,
DrHedrick,5/31/2014 11:34,1,0,"Dr. @ CliffordHudis Speaking on @ ASCO founders, particularly Jane C Wright. Discussing the world in 1964. # ASCO14",,@ @,#,4.72763E+17,https://twitter.com/DrHedrick/status/472763178196422657,,,,
eaonc,5/31/2014 11:34,1,1,# ASCO14 follow @ cliffordhudis to receive live updates of president's address,,@,#,4.72763E+17,https://twitter.com/eaonc/status/472763152975683584,,,,
Consano,5/31/2014 11:34,3,0,"If you are at at @ ASCO's # ASCO14 meeting, stop by the http://consano.org booth & learn @ # crowdfunding # researchpic.twitter.com/5xWfQb1gzi",,@ @,# # #,4.72763E+17,https://twitter.com/Consano/status/472763096637775872,,,,
strehan,5/31/2014 11:34,1,0,"Impressive response rates in ph1 data for CO-1686 & AZD9291 in EGFRi-resistant NSCLC, esp T790M+ # ASCO14 # lcsm # lcnscpic.twitter.com/uPFBmqMjrC",,,# # #,4.72763E+17,https://twitter.com/strehan/status/472763093844774912,,,,
CancerAfrica,5/31/2014 11:34,1,1,# ASCO14 please donate blood look for the bus across booth 21159 @ ASCO @ iConquerCancerpic.twitter.com/luWczDCPHL,,@ @,#,4.72763E+17,https://twitter.com/CancerAfrica/status/472763060080619520,,,,
AnneBooms,5/31/2014 11:34,1,1,# ASCO14 Inspiring talk about utilising yellow forms to assess supportive care needs in Australian Regional Cancer Patients- Dr. Steer,,,#,4.72763E+17,https://twitter.com/AnneBooms/status/472762999879393280,,,,
CliffordHudis,5/31/2014 11:34,34,14,“Price is what you pay. Value is what you get.” @ ASCO must define # value in # cancer care & pursue it. # ASCO14,,@,# # #,4.72763E+17,https://twitter.com/CliffordHudis/status/472762978689753089,,,,
myPathMelanoma,5/31/2014 11:34,2,2,Want to learn more about us? Visit our website at http://www.IsThisMelanoma.com # ASCO14,,,#,4.72763E+17,https://twitter.com/myPathMelanoma/status/472762929553494017,,,,
Agendia,5/31/2014 11:33,1,0,# ColorectalCancer Subtyping Consortium identification of a consensus of molecular subtypes # ASCO14 http://owl.li/xtkVm,,,# #,4.72763E+17,https://twitter.com/Agendia/status/472762915205169152,,,,
Neil_Iyengar,5/31/2014 11:33,0,0,"Dr Hudis @ ASCO pres: ridding the fear of cancer"" ""The power of our intention is as clear as it was for our founders 50 years ago"" # ASCO14""",,@,#,4.72763E+17,https://twitter.com/Neil_Iyengar/status/472762909958094848,,,,
JLErsek,5/31/2014 11:33,1,0,Front page of # ASCO14 Daily News - Value in Cancer Care: Implementing clinical care pathways. We are doing this at # LCI @Carolinas!,,@Carolinas,# #,4.72763E+17,https://twitter.com/JLErsek/status/472762906304471040,,,,
WilliamDale_MD,5/31/2014 11:33,3,0,"# ASCO14 So proud of our recent graduate, Dr. Ron Maggiore, presenting on # gerionc training programs.pic.twitter.com/N2lTp3pc2R",,,# #,4.72763E+17,https://twitter.com/WilliamDale_MD/status/472762896401715200,,,,
Lhcamacho,5/31/2014 11:33,4,1,# ASCO2014 FIFTY years committed to searching a cure for # Cancer @ ASCO @ drdonsdizonpic.twitter.com/l4C2hx7L75,,@ @,# #,4.72763E+17,https://twitter.com/Lhcamacho/status/472762836884520961,,,,
BIOARRAYMDx,5/31/2014 11:33,0,0,The power of intention says Cliif Hudis MD 50th president of ASCO @ ASCO @cliffhudis # ASCO 2014,,@ @cliffhudis,#,4.72763E+17,https://twitter.com/BIOARRAYMDx/status/472762708958658560,,,,
OncologyTimes,5/31/2014 11:33,2,3,# ASCO14 Pres @ CliffordHudis: This may be the only mtg in Chicago where neither Rahm nor Ari are the most famous Emanuel # ASCO14,,@,# #,4.72763E+17,https://twitter.com/OncologyTimes/status/472762678503419904,,,,
SanofiUS,5/31/2014 11:32,1,0,"MT @ ASCO: Take a min to enjoy the weather & a view of Lake Michigan. They're grilling on the D2 Terrace, the perfect spot for lunch # ASCO14",,@,#,4.72763E+17,https://twitter.com/SanofiUS/status/472762646857781248,,,,
wallyjc,5/31/2014 11:32,1,3,"Clif Hudis' outstanding Presidential lecture is being live tweeted""! @ WinshipAtEmory @ CliffordHudis @ asco # ASCO14""",,@ @ @,#,4.72763E+17,https://twitter.com/wallyjc/status/472762579778306048,,,,
Lymphoma_Doc,5/31/2014 11:32,0,0,"@ CliffordHudis @ ASCO Our mission is one which we intend to win"" # ASCO14""",,@ @,#,4.72763E+17,https://twitter.com/Lymphoma_Doc/status/472762519753195521,,,,
VonKlotMD,5/31/2014 11:32,0,0,# ASCO14,,,#,4.72762E+17,https://twitter.com/VonKlotMD/status/472762498492661760,,,,
CliffordHudis,5/31/2014 11:32,31,9,Investment in # cancer research is not commensurate to the problem & @ theNCI has lost 23% of its 2003 purchasing power # ASCO14,,@,# #,4.72762E+17,https://twitter.com/CliffordHudis/status/472762496303255552,,,,
rsm2800,5/31/2014 11:32,6,1,Hudis: @ CliffordHudis assures @ drdonsdizon @ rsm2800 that he is not live-tweeting from the stage. But note we can’t see his hands # asco14,,@ @ @,#,4.72762E+17,https://twitter.com/rsm2800/status/472762494675456000,,,,
WilliamDale_MD,5/31/2014 11:31,2,1,"@ drcbsteer # ASCO14 lengthy geri onc screening sent home on yellow paper. I'm calling about the yellow form."" Cancer Nudge! @ R_Thaler""",,@ @,#,4.72762E+17,https://twitter.com/WilliamDale_MD/status/472762332011974656,,,,
sloan_kettering,5/31/2014 11:31,4,1,. @ cliffordhudis is up! @ asco # ASCO14 pic.twitter.com/SINVSBrTxe,,@ @,#,4.72762E+17,https://twitter.com/sloan_kettering/status/472762329499570177,,,,
CliffordHudis,5/31/2014 11:31,8,3,Read @ ASCO’s State of Cancer Care in America 2014 http://bit.ly/1iwTfSn Watch Cap Hill briefing http://bit.ly/1gnoHeO # ASCO14,,@,#,4.72762E+17,https://twitter.com/CliffordHudis/status/472762244758257664,,,,
CliffordHudis,5/31/2014 11:31,13,1,# Cancer rsrch invstmnt lags inflation & fed budget. Zero point one % (0.1%) is 1$ in 1K. Cancer affects 1/3 women & ½ men # ASCO14,,,# #,4.72762E+17,https://twitter.com/CliffordHudis/status/472762244754055168,,,,
GarryChoy,5/31/2014 11:31,1,1,Via “ @ drsteventucker: The message of P4 Medicine is to identify the transition points between wellness and illness. # ASCO14 # digitalhealth”,,@,# #,4.72762E+17,https://twitter.com/GarryChoy/status/472762238659751938,,,,
DrHedrick,5/31/2014 11:31,0,0,@ CliffordHudis makes a joke about the Emanuel Bros. # ASCO14 I got it but not many others did. :),,@,#,4.72762E+17,https://twitter.com/DrHedrick/status/472762208334909440,,,,
RyanMPearson,5/31/2014 11:31,0,0,"Although I can't be there, I'll be following the continuous updates through twitter # ASCO14",,,#,4.72762E+17,https://twitter.com/RyanMPearson/status/472762187111755776,,,,
CancerDotNet,5/31/2014 11:31,2,1,Advocates: # ASCO14 Tweetup happens today @McCormick Place SB 2.5 @5:45 CT. RSVP here: http://bit.ly/1i8XCkX,,@McCormick @5,#,4.72762E+17,https://twitter.com/CancerDotNet/status/472762174990200832,,,,
alantanmd,5/31/2014 11:30,3,0,Opening session # ASCO14 with @ CliffordHudispic.twitter.com/gG3vTjDVKy,,@,#,4.72762E+17,https://twitter.com/alantanmd/status/472762123421253633,,,,
DebiopharmNews,5/31/2014 11:30,1,0,# ASCO14 # DYK US market accounts for 41% of total # oncology drug sales http://ow.ly/x92qA,,,# # #,4.72762E+17,https://twitter.com/DebiopharmNews/status/472762103481520128,,,,
cityofhope,5/31/2014 11:30,1,2,Join us during # ASCO14 in the exhibition hall; we're @booth 2030 http://instagram.com/p/oqkkyrk5o9/ @ ASCO,,@booth @,#,4.72762E+17,https://twitter.com/cityofhope/status/472762074502668290,,,,
CliffordHudis,5/31/2014 11:30,11,7,I believe @ ASCO is a tool to achieve social justice in # cancer care. I’ll expand on that idea in my Pres Address Sat 31May @ # ASCO14,,@ @,# #,4.72762E+17,https://twitter.com/CliffordHudis/status/472761993360048128,,,,
mtmdphd,5/31/2014 11:30,1,1,The Social Oncology Project 2014 - @ BrianReid @ KaylaRodrigue11 @ W2OGroup @ MDigitalLife http://ow.ly/xsgWR # SocOncology # ASCO14,,@ @ @ @,# #,4.72762E+17,https://twitter.com/mtmdphd/status/472761983012720640,,,,
CBPartners,5/31/2014 11:30,1,0,"Interesting talk on the future of P4 medicine, especially on likelihood to implement in single payer systems first @ ISBLeeHood # ASCO14",,@,#,4.72762E+17,https://twitter.com/CBPartners/status/472761938326605824,,,,
SanofiUS,5/31/2014 11:30,1,0,RT @ ASCO: # ASCO14 opening ceremony has begun. @ CliffordHudis will address audience in Chicago in 20 mins. http://bit.ly/1pGZWRn,,@ @,#,4.72762E+17,https://twitter.com/SanofiUS/status/472761933045972992,,,,
Agendia,5/31/2014 11:30,0,0,# MammaPrint has up to 25 yr outcome data. Visit the all new @ Agendia booth 16025 for more info! # ASCO14 # bcsm # hcsmpic.twitter.com/XqX4XSKhQs,,@,# # # #,4.72762E+17,https://twitter.com/Agendia/status/472761928864235521,,,,
rsm2800,5/31/2014 11:29,2,0,Hudis: Beginning presidential address. Note his intro slide has his Twitter handle # ASCO14 cc: @ CliffordHudis,,@,#,4.72762E+17,https://twitter.com/rsm2800/status/472761881187188736,,,,
QIAGENscience,5/31/2014 11:29,2,10,We also offer intuitive web-based apps for quickly analyzing & accurately interpreting biological meaning in genomic data. #5013 # ASCO14,,,#5013 #,4.72762E+17,https://twitter.com/QIAGENscience/status/472761754242781185,,,,
CliffordHudis,5/31/2014 11:29,3,1,. @ ASCO‘s next Pres is @ YupOnc http://bit.ly/1io5QSv & Pres-elect is Julie Vose http://bit.ly/1opApi5 Looking to # ASCO15 & # ASCO16 !,,@ @,# #,4.72762E+17,https://twitter.com/CliffordHudis/status/472761741517291520,,,,
WilliamDale_MD,5/31/2014 11:28,3,0,# ASCO14 @ drcbsteer Adapting # geriatric oncology program to local circumstances through Supportive Care. # gerionc,,@,# # #,4.72762E+17,https://twitter.com/WilliamDale_MD/status/472761664350085120,,,,
TuftsB,5/31/2014 11:28,1,0,@ tomleblancMD @ ASCO -there is no average cancer patient. Only the one with doctor at the time. Help us fight give us choice # MLIWI # ASCO14,,@ @,# #,4.72762E+17,https://twitter.com/TuftsB/status/472761611145732096,,,,
AnneBooms,5/31/2014 11:28,3,0,# ASCO14 Dr. Steer talking on Coordinating Care for the Older Patient With Cancer http://www.medscape.com/viewarticle/773490?src=sttwit …,,,#,4.72762E+17,https://twitter.com/AnneBooms/status/472761581520949248,,,,
DrHollyHolmes,5/31/2014 11:28,2,1,"@ drcbsteer # ASCO14 lengthy geri onc screening sent to pt's home: put it on yellow paper. I'm calling about the yellow form."" Brilliant""",,@,#,4.72762E+17,https://twitter.com/DrHollyHolmes/status/472761580019408896,,,,
tomleblancMD,5/31/2014 11:28,0,0,@ TuftsB @ ASCO - I strongly agree. Arbitrary lines aren't the answer. Stopping waste must be # 1priority.,,@ @,#,4.72762E+17,https://twitter.com/tomleblancMD/status/472761511211855872,,,,
DrHedrick,5/31/2014 11:28,2,0,"Dr. @ CliffordHudis being introduced at # ASCO14 presenting on Science and Society 50 Years Later""""",,@,#,4.72762E+17,https://twitter.com/DrHedrick/status/472761509928763392,,,,
CliffordHudis,5/31/2014 11:28,1,0,See all the Past Presidents of @ ASCO here http://bit.ly/1io5oDC We build on great leaders! # ASCO14,,@,#,4.72761E+17,https://twitter.com/CliffordHudis/status/472761489582194688,,,,
Gene_Antibody,5/31/2014 11:28,0,0,Great start to # asco2014 pic.twitter.com/VVrKHPHjqY,,,#,4.72761E+17,https://twitter.com/Gene_Antibody/status/472761456128036864,,,,
QIAGENscience,5/31/2014 11:28,1,1,We’re a leader in hemato-oncology detection # assays. Have a portfolio of # biomarkers across all the main types of # leukemia. # ASCO14,,,# # # #,4.72761E+17,https://twitter.com/QIAGENscience/status/472761450558418944,,,,
CliffordHudis,5/31/2014 11:27,3,0,Honor @ ASCO founder Jane C. Wright by supporting the endowed @ iConquerCancer YIA that honors her http://bit.ly/Ry22a2 # ASCO14,,@ @,#,4.72761E+17,https://twitter.com/CliffordHudis/status/472761238125309952,,,,
CliffordHudis,5/31/2014 11:27,1,1,"First @ ASCO meeting was November 5, 1964 in # Chicago. Read about ASCO’s Annual Meeting http://bit.ly/1puJiEo # ASCO14",,@,# #,4.72761E+17,https://twitter.com/CliffordHudis/status/472761238033022977,,,,
FirstReportMC,5/31/2014 11:27,1,0,We're at the ASCO annual meeting. Here's a story on Eli Lilly's ramucirumab improving survival in NSCLC - http://www.firstreportnow.com/articles/ramucirumab-improves-overall-survival-patients-non-small-cell-lung-cancer … # ASCO14,,,#,4.72761E+17,https://twitter.com/FirstReportMC/status/472761172349841408,,,,
sloan_kettering,5/31/2014 11:26,3,1,Our very own @ CliffordHudis about to take the stage for his presidential address at # ASCO14 # cancer,,@,# #,4.72761E+17,https://twitter.com/sloan_kettering/status/472761082755313664,,,,
CliffordHudis,5/31/2014 11:26,2,0,. @ ASCO founder Jane C. Wright broke barriers. Learn about her life here http://bit.ly/1lOWMr0 # ASCO14,,@,#,4.72761E+17,https://twitter.com/CliffordHudis/status/472760986366394371,,,,
Marcopochetti,5/31/2014 11:25,0,0,@ danielebanfi83 news da Exel e Molmed da # ASCO14 ?,,@,#,4.72761E+17,https://twitter.com/Marcopochetti/status/472760884700659712,,,,
FoundationATCG,5/31/2014 11:25,2,3,RT @ GoogleVentures: A simple explanation of the basics of cancer and treatment options – http://goo.gl/Vlt3cf # CancerExplained # ASCO14,,@,# #,4.72761E+17,https://twitter.com/FoundationATCG/status/472760804421300224,,,,
WilliamDale_MD,5/31/2014 11:25,0,0,# ASCO14 @ drcbsteer Australia is a large geographic country with a few people. Care Coordination program. # gerioncpic.twitter.com/kLkL7cqw6J,,@,# #,4.72761E+17,https://twitter.com/WilliamDale_MD/status/472760765011599360,,,,
CliffordHudis,5/31/2014 11:25,0,0,@ theBeatles dominated popular music when @ ASCO was founded in #1964. Top hits from that year http://bit.ly/1jYgoNu # ASCO14,,@ @,#1964 #,4.72761E+17,https://twitter.com/CliffordHudis/status/472760735014330369,,,,
MelanomaReAlli,5/31/2014 11:25,3,3,At # ASCO14? Look out for MRA's Science Team and CEO. We're excited to hear about developments in # melanoma treatment.,,,# #,4.72761E+17,https://twitter.com/MelanomaReAlli/status/472760694480588803,,,,
drsteventucker,5/31/2014 11:25,0,0,"If you like P4 Medicine, all of the best articles can be found here. # asco14 # cancer @ ASCOPost http://isbmolecularme.com/tag/dr-lee-hood/ …",,@,# #,4.72761E+17,https://twitter.com/drsteventucker/status/472760683549818880,,,,
Boehringer,5/31/2014 11:25,1,0,"But let’s not forget that @ ASCO turns 50 this year! It is a milestone to be celebrated…"" Julia Knebel http://bit.ly/WhatToExpectASCO14 … # ASCO14""",,@,#,4.72761E+17,https://twitter.com/Boehringer/status/472760679649538048,,,,
caitlin_hool,5/31/2014 11:24,1,0,Awaiting @ CliffordHudis' presidential address at # ASCO14. Sitting right behind the brilliant Jose Baselga and Charles Sawyers.,,@,#,4.72761E+17,https://twitter.com/caitlin_hool/status/472760552750465025,,,,
ElizBlanchardMD,5/31/2014 11:24,1,1,Dr Hood: predicting emergence of a wellness movement and industry--wonderful! # ASCO14,,,#,4.72761E+17,https://twitter.com/ElizBlanchardMD/status/472760550699446273,,,,
mayocliniclabs,5/31/2014 11:24,1,1,"We are at # ASCO14, ready to learn and discuss tests, treatments and services in # cancer care. http://mayocl.in/T1r6rl",,,# #,4.72761E+17,https://twitter.com/mayocliniclabs/status/472760537588432896,,,,
CliffordHudis,5/31/2014 11:24,3,2,". @ ASCO founded April 9, 1964 @Edgewater Beach Hotel in # Chicago. Read about our 7 founders here: http://bit.ly/1pf0hxd # ASCO14",,@ @Edgewater,# #,4.7276E+17,https://twitter.com/CliffordHudis/status/472760482936668161,,,,
PhRMA,5/31/2014 11:24,2,1,"New, better meds often reduce other medical expenses, says @ Celgene on US # healthcare costs http://bit.ly/1ku6YbS # ASCO14",,@,# #,4.7276E+17,https://twitter.com/PhRMA/status/472760416561414144,,,,
FoundationATCG,5/31/2014 11:23,1,1,“ @ GoogleVentures: See how @ FoundationATCG impacts a cancer patient's life: http://www.foundationmedicine.com ” # ASCO14,,@ @,#,4.7276E+17,https://twitter.com/FoundationATCG/status/472760399520358400,,,,
TuftsB,5/31/2014 11:23,0,0,@ tomleblancMD @ ASCO 'drawing an atbitrary line at an average causes patients like me to be denied the care that saves lives # ASCO14 # mliwi,,@ @,# #,4.7276E+17,https://twitter.com/TuftsB/status/472760383422603268,,,,
Lymphoma_Doc,5/31/2014 11:23,0,0,"@ ISBLeeHood Wellness"" focused industry will dominate over ""Illness"" focused industry in the next 10 years # ASCO14""",,@,#,4.7276E+17,https://twitter.com/Lymphoma_Doc/status/472760374739992576,,,,
CliffordHudis,5/31/2014 11:23,1,0,Inflammatory foci (CLS) seen in human adipose associated with increased weight. See Morris et al http://1.usa.gov/1pfeOcg # ASCO14,,,#,4.7276E+17,https://twitter.com/CliffordHudis/status/472760207303389185,,,,
rschilsky,5/31/2014 11:23,4,0,# ASCO14 Lee Hood: a drop of blood will allow assay of 50 proteins to predict organ-based diseases.,,,#,4.7276E+17,https://twitter.com/rschilsky/status/472760205928046592,,,,
davidgrahammd,5/31/2014 11:23,2,1,Great article by @ MulaHussain in Sat ASCO post on cancer care in Iraq. Helps to make a big world smaller # ASCO14,,@,#,4.7276E+17,https://twitter.com/davidgrahammd/status/472760162554769408,,,,
KUhlendorf,5/31/2014 11:22,1,0,"As a proud 3rd gen participant in Framingham study, it's exciting to hear about @ ISBLeeHood's plans for P4 medicine project. # ASCO14",,@,#,4.7276E+17,https://twitter.com/KUhlendorf/status/472760101992820738,,,,
SusanLaufer,5/31/2014 11:22,1,1,Delicious fresh baked cookies at Exelixis booth at # ASCO14. You're welcome.,,,#,4.7276E+17,https://twitter.com/SusanLaufer/status/472759938612477952,,,,
cancereu,5/31/2014 11:21,1,0,have noted in timeline @ jodyms @ stales possibly more.. won't be online more today @ Cascadia # ASCO14 # HCSM # s4pm # bcsm # bcsmeu # hcsmeu,,@ @ @,# # # # # #,4.7276E+17,https://twitter.com/cancereu/status/472759807297200129,,,,
WilliamDale_MD,5/31/2014 11:21,1,0,# ASCO14 @ drcbsteer : Belgium's national program now benefits over 5K individuals. # gerionc,,@,# #,4.7276E+17,https://twitter.com/WilliamDale_MD/status/472759804054622208,,,,
uroegg,5/31/2014 11:21,0,0,@ simon_p_kim @ ASCO who presented it?,,@ @,,4.7276E+17,https://twitter.com/uroegg/status/472759758730956803,,,,
KellyColligan,5/31/2014 11:21,1,0,I'm not at # ASCO14 but looking forward to reading @ CliffordHudis 's auto-tweeted Presidential Address at 10:20am Central from # ASCO14 # NOW,,@,# # #,4.7276E+17,https://twitter.com/KellyColligan/status/472759741945364480,,,,
ShabbirHossain,5/31/2014 11:21,0,0,"Encourage everyone to follow the tweets coming out of # ASCO14 @ ASCO lots of Great info, ideas and observations # hcsm",,@,# #,4.7276E+17,https://twitter.com/ShabbirHossain/status/472759738284130304,,,,
CliffordHudis,5/31/2014 11:21,5,1,# ASCO14 theme: “Science&Society” Intention for @ ASCO next? JFK intended to get us to the moon 1st. His Rice U speech http://1.usa.gov/RwT3G8,,@,#,4.7276E+17,https://twitter.com/CliffordHudis/status/472759728331034624,,,,
CliffordHudis,5/31/2014 11:21,14,7,". @ ASCO is setting records with more than 5000 accepted abstracts, more than 33,000 attendees expected # ASCO14",,@,#,4.7276E+17,https://twitter.com/CliffordHudis/status/472759728125538304,,,,
strehan,5/31/2014 11:20,0,0,Blumenthal from FDA: internal meta-analysis shows no correlation b/t OS and ORR / PFS in mNSCLC submissions # ASCO14 pic.twitter.com/Xo2DUlDFPU,,,#,4.7276E+17,https://twitter.com/strehan/status/472759584973914113,,,,
drsteventucker,5/31/2014 11:20,5,4,The message of P4 Medicine is to identify the transition points between wellness and illness. # ASCO14 # digitalhealth,,,# #,4.7276E+17,https://twitter.com/drsteventucker/status/472759572252221440,,,,
TriageCancer,5/31/2014 11:20,1,2,And we're off...Day 1! Come visit us in the Patient Advocacy Pavilion. # ASCO14 pic.twitter.com/yHsiBLo1VL,,,#,4.7276E+17,https://twitter.com/TriageCancer/status/472759553298542592,,,,
DebiopharmNews,5/31/2014 11:20,1,0,# ASCO14 # DYK High pharma investments & cancer therapies account for > 30% preclinical & phase I clinical developments http://ow.ly/x92lf,,,# #,4.72759E+17,https://twitter.com/DebiopharmNews/status/472759497505927168,,,,
UHhospitals,5/31/2014 11:20,3,1,Study shows a possible new method to predicting response to chemotherapy in triple-negative # breastcancer http://ow.ly/xnWVc # ASCO14,,,# #,4.72759E+17,https://twitter.com/UHhospitals/status/472759479210369025,,,,
CliffordHudis,5/31/2014 11:20,3,3,Live tweeting from the stage? No! But tweeting my Presidential Address from # ASCO14,,,#,4.72759E+17,https://twitter.com/CliffordHudis/status/472759476639248385,,,,
CliffordHudis,5/31/2014 11:20,1,0,Welcome to @ ASCO ‘s 50th scientific meeting. Thanks to all for a great year! # ASCO14,,@,#,4.72759E+17,https://twitter.com/CliffordHudis/status/472759476618264576,,,,
subatomicdoc,5/31/2014 11:20,1,0,Preoperative chemoRT & postop 5-FUoxali vs 5-FU alone in locally adv # rectalcancer http://abstracts.asco.org/144/AbstView_144_133115.html … # ASCO14 # crcsm # hcsm # radonc,,,# # # # #,4.72759E+17,https://twitter.com/subatomicdoc/status/472759420431392768,,,,
AdaptiveBiotech,5/31/2014 11:20,2,0,. @ BrighamWomens data on clinical utility of immunoSEQ to find # skincancer in cutaneous T-cell # lymphoma. At # ASCO14: http://bit.ly/U1BiAX,,@,# # #,4.72759E+17,https://twitter.com/AdaptiveBiotech/status/472759416437997568,,,,
WilliamDale_MD,5/31/2014 11:19,0,0,# ASCO14 Steer: France initiative comes with real budget allocation. # gerionc,,,# #,4.72759E+17,https://twitter.com/WilliamDale_MD/status/472759344375689218,,,,
DrHollyHolmes,5/31/2014 11:19,3,1,@ drcbsteer: Geri onc in France: truly national approach. Using G8 to screen. Geriatrics integrated into routine oncology practice # ASCO14,,@,#,4.72759E+17,https://twitter.com/DrHollyHolmes/status/472759325761347585,,,,
rdoebele,5/31/2014 11:19,2,1,Stop by the @ consano booth # ASCO2014 to learn about directed giving towards cancer research.,,@,#,4.72759E+17,https://twitter.com/rdoebele/status/472759271361241089,,,,
KUhlendorf,5/31/2014 11:19,0,1,Dr Hood's plan to create 20-30 yr Framingham-like wellness study to study genome analyses over time # ASCO14 pic.twitter.com/5SS9esKj6n,,,#,4.72759E+17,https://twitter.com/KUhlendorf/status/472759178977505280,,,,
rsm2800,5/31/2014 11:18,0,0,"Uh-oh, wifi in Hall B1 appears slow this a.m. Hope this isn’t the case for tomorrow # asco14",,,#,4.72759E+17,https://twitter.com/rsm2800/status/472759145662144512,,,,
martinnaley,5/31/2014 11:18,0,0,"Lee Hood proposing a 100,000 person study. Whole genome sequencing up front, & monitor many health variables for 20-30 years. # ASCO14",,,#,4.72759E+17,https://twitter.com/martinnaley/status/472759125236285440,,,,
kgapo,5/31/2014 11:18,0,0,@ ASCO thanks following @ CancerDotNet @ Cascadia,,@ @ @,,4.72759E+17,https://twitter.com/kgapo/status/472759092910768128,,,,
WilliamDale_MD,5/31/2014 11:18,1,0,# ASCO14 Steer: France now has a national geriatric oncology initiative. # gerionc,,,# #,4.72759E+17,https://twitter.com/WilliamDale_MD/status/472759027470848001,,,,
PhRMA,5/31/2014 11:18,0,0,. @ KUhlendorf from # ASCO14: It’s critical that our assessment of value keep pace w/ changes in research http://onphr.ma/1wGFpkH,,@,#,4.72759E+17,https://twitter.com/PhRMA/status/472758970776842241,,,,
ME_Fleury,5/31/2014 11:17,2,2,Lee Hood at # ASCO14: Medicine focuses too much on demystifying disease rather than understanding mechanisms of wellness,,,#,4.72759E+17,https://twitter.com/ME_Fleury/status/472758841432875008,,,,
Neil_Iyengar,5/31/2014 11:17,1,1,"@ genentech Nice piece - great points, esp point 3 on both sides. http://www.gene.com/stories/big-data-and-the-big-c … # ASCO14",,@,#,4.72759E+17,https://twitter.com/Neil_Iyengar/status/472758734767525888,,,,
adeeconda,5/31/2014 11:17,0,0,“ @ Neil_Iyengar: Dr Hood: In five years," I can conceive doing a full human genome in 5 min at a cost of $100 or less"" # progress # ASCO14”""",,@,# #,4.72759E+17,https://twitter.com/adeeconda/status/472758666190680064,,,
JenMerschdorf,5/31/2014 11:17,1,1,At # ASCO14 ? Pick up YSC’s New Research Agenda at their advocacy booth. Answering ?2 improve YWABC. http://bit.ly/1r1002D,,,#,4.72759E+17,https://twitter.com/JenMerschdorf/status/472758658276003842,,,,
PeterHall001,5/31/2014 11:16,1,0,Good explanation of diagnostics terminology and regulation in the US by Dan Hayes http://am.asco.org/next-generation-genomic-testing-understanding-semantics-helps-guide-assay-use-selection … # ASCO2014 @DEC_Leeds,,@DEC_Leeds,#,4.72759E+17,https://twitter.com/PeterHall001/status/472758646166659073,,,,
DrHollyHolmes,5/31/2014 11:16,3,1,"@ drcbsteer # ASCO14 other opportunities to learn geriatric oncology: SIOG 2014 in Lisbon, MASCC 2014 in Miami",,@,#,4.72759E+17,https://twitter.com/DrHollyHolmes/status/472758635085312000,,,,
mplancelotta,5/31/2014 11:16,1,0,Simpler view of cancer and various treatment options https://www.youtube.com/watch?v=UwbuW7oK8rk … …. More on # genomics in # cancer at # ASCO14,,,# # #,4.72759E+17,https://twitter.com/mplancelotta/status/472758627787223041,,,,
FoundationATCG,5/31/2014 11:16,0,1,Simpler view of cancer and various treatment options https://www.youtube.com/watch?v=UwbuW7oK8rk … …. More on # genomics in # cancer at # ASCO14,,,# # #,4.72759E+17,https://twitter.com/FoundationATCG/status/472758627732713474,,,,
LinicalAmericas,5/31/2014 11:16,0,0,"@ NorthwestBio inspired by Cowboy Stadium, that's one big screen - booth looks great. # ASCO14 https://twitter.com/Accelovance/status/472758129101668352/photo/1pic.twitter.com/yDcyVEPbPH pic.twitter.com/FBDLv4ktdV",,@,#,4.72759E+17,https://twitter.com/LinicalAmericas/status/472758621340971008,,,,
DrAnasYounes,5/31/2014 11:16,3,0,RT @ ASCO: Retweet if you're joining us at today's # ASCO14 Tweetup. Details here: http://bit.ly/T1rtlT,,@,#,4.72759E+17,https://twitter.com/DrAnasYounes/status/472758613287530497,,,,
AnneBooms,5/31/2014 11:16,3,1,# ASCO14 Dr.Steer talking about SIOG NR Survey2011 in developing priorities of geriatric oncology pic.twitter.com/34jCgwvuu5,,,#,4.72758E+17,https://twitter.com/AnneBooms/status/472758454877036544,,,,
ElizBlanchardMD,5/31/2014 11:15,0,1,P4 medicine includes wellness and disease study http://blog.p4medicine.com/2006/07/what-is-p4-medicine.html?m=1 … # ASCO14,,,#,4.72758E+17,https://twitter.com/ElizBlanchardMD/status/472758371666644992,,,,
WilliamDale_MD,5/31/2014 11:15,0,0," @ ASCO: Retweet if you're joining us at today's # ASCO14 Tweetup. Details here: http://bit.ly/NvNypj "" # gerionc""",,@,# #,4.72758E+17,https://twitter.com/WilliamDale_MD/status/472758351458082816,,,,
rsm2800,5/31/2014 11:15,1,0,"Hood: Proposing Framingham-like wellness study, follow for decades, then measure “metrics of wellness” of those who become sicek # ASCO14",,,#,4.72758E+17,https://twitter.com/rsm2800/status/472758341328830464,,,,
JessicaEngMD,5/31/2014 11:15,2,1,"Yay! Oncologists talking # gerionc RT @ WilliamDale_MD: # ASCO14 -Tag, you're it! Dr. Tew is back to describe research at Memorial for # gerionc",,@,# # #,4.72758E+17,https://twitter.com/JessicaEngMD/status/472758326137077761,,,,
ASCO,5/31/2014 11:15,3,0,Attend todays From Coley to Cure? Ed Session to learn about # immunotherapy for # melanoma http://bit.ly/1nDkwVP # ASCO14,,,# # #,4.72758E+17,https://twitter.com/ASCO/status/472758223578361856,,,,
corp_UNC,5/31/2014 11:15,0,0,MT @ m_e_nielsen: excellent S.Smith @ yzafar qual.study on unmet needs in oncology financial distress support # asco14 http://ow.ly/xpdKf,,@ @,#,4.72758E+17,https://twitter.com/corp_UNC/status/472758205517660160,,,,
FVazMan,5/31/2014 11:15,0,0,# ASCO14 http://tinyurl.com/p75cw4t Gran sesión! Si señor.pic.twitter.com/HC5T1t5ohf,,,#,4.72758E+17,https://twitter.com/FVazMan/status/472758200945872897,,,,
WilliamDale_MD,5/31/2014 11:15,0,0,"# ASCO14 @ drcbsteer, Tweeter Extraordinaire, presenting international perspectives on # gerionc from @ SIOGorg",,@ @,# #,4.72758E+17,https://twitter.com/WilliamDale_MD/status/472758169504997377,,,,
DrMarkham,5/31/2014 11:15,1,0,I'll be there! RT @ ASCO: Retweet if you're joining us at today's # ASCO14 Tweetup. Details here: http://bit.ly/NvNypj,,@,#,4.72758E+17,https://twitter.com/DrMarkham/status/472758165298483200,,,,
myPathMelanoma,5/31/2014 11:15,0,0,Head over to room E354b now to view our # ASCO14 poster presentation going on right now! # melanoma # clinicaldata,,,# # #,4.72758E+17,https://twitter.com/myPathMelanoma/status/472758149712060416,,,,
heidisa,5/31/2014 11:14,0,0,RT @ SWOG: The SWOG Cancer Research Daily is out! http://swog.org/media/daily Stories via @ CancerFrontline @ nma08244 # ASCO14,,@ @ @,#,4.72758E+17,https://twitter.com/heidisa/status/472758093504589824,,,,
rschilsky,5/31/2014 11:14,3,0,# ASCO14 listening to Lee Hood talk about critical role of N of 1 experiments and social networks in advancing personalized medicine.,,,#,4.72758E+17,https://twitter.com/rschilsky/status/472758016581050368,,,,
DrMarkham,5/31/2014 11:14,0,0,Important issue for many women. MT @ ASCO: @ NYtimes on # ASCO14 study: Drug Saves Fertility for Women with Cancer http://nyti.ms/1hJwZ25,,@ @,#,4.72758E+17,https://twitter.com/DrMarkham/status/472757998595477505,,,,
TuftsB,5/31/2014 11:14,0,0,"Cost controllers lectured docs 4 unnecessary"" tests & treatment. Free doctors to fight 4 care not restrict weapons v cancer # MLIWI # ASCO14""",,,# #,4.72758E+17,https://twitter.com/TuftsB/status/472757928991424512,,,,
rsm2800,5/31/2014 11:14,1,1,"Hood: P4 medicine different from pop-based medicine-is proactive, focuses on individual, wellness; so diff from current clin trials # ASCO14",,,#,4.72758E+17,https://twitter.com/rsm2800/status/472757907600072704,,,,
PSUCHICA,5/31/2014 11:13,0,1,FDA Breakthrough Therapy Designation: Another For Genentech And Cancer # asco14 http://orphandruganaut.wordpress.com/2014/05/31/fda-breakthrough-therapy-designation-another-for-genentech-and-cancer/ …,,,#,4.72758E+17,https://twitter.com/PSUCHICA/status/472757870506029056,,,,
Lymphoma_Doc,5/31/2014 11:13,0,0,"@ ISBLeeHood clinical trial system is broken, should be looking for n=1 experiments due to huge patient heterogeneity # ASCO14",,@,#,4.72758E+17,https://twitter.com/Lymphoma_Doc/status/472757870082019328,,,,
JamesPPinkerton,5/31/2014 11:13,0,0,@ ISBLeeHood at # ASCO14 is speaking in a language of scientific transformation that's light-years away from DC-style zero-sum bean-counting.,,@,#,4.72758E+17,https://twitter.com/JamesPPinkerton/status/472757804823244800,,,,
Cancer_Genetics,5/31/2014 11:13,2,0,Want to learn about new diagnostics tests? Come and see our team @booth 22134 # ASCO2014.,,@booth,#,4.72758E+17,https://twitter.com/Cancer_Genetics/status/472757755678576640,,,,
BIOARRAYMDx,5/31/2014 11:13,0,0,Blood biomarkers hold promise for disease detection through integration of information and biomarker panels # ASCO2014,,,#,4.72758E+17,https://twitter.com/BIOARRAYMDx/status/472757693690957825,,,,
AdvocateDebM,5/31/2014 11:12,0,0,"Less frequent/lower-dose tx effective 4 some cancer pts minimizing symptoms, enhancing QoL. @ ASCOPost Reuters http://ow.ly/xtii7 # ASCO14",,@,#,4.72758E+17,https://twitter.com/AdvocateDebM/status/472757613378433024,,,,
rsm2800,5/31/2014 11:12,1,0,"Hood: P4 medicine=systems medicine, consumer driven social networks, big data # hcsm # asco14",,,# #,4.72758E+17,https://twitter.com/rsm2800/status/472757513629093888,,,,
WilliamDale_MD,5/31/2014 11:12,1,2,# ASCO14 Naim: Geriatric Oncologists are the healthcare leaders of the future. # gerionc,,,# #,4.72757E+17,https://twitter.com/WilliamDale_MD/status/472757486613573632,,,,
AnneBooms,5/31/2014 11:12,0,0,# ASCO14- Dr Steer talking about International Perspectives of Geriatric Oncology pic.twitter.com/7JJSGdXTBn,,,#,4.72757E+17,https://twitter.com/AnneBooms/status/472757457156972544,,,,
ElizBlanchardMD,5/31/2014 11:12,0,1,90% specificity good (not perfect) test is blood based. # ASCO14,,,#,4.72757E+17,https://twitter.com/ElizBlanchardMD/status/472757413527842817,,,,
kbnewport,5/31/2014 11:11,0,1,# gerionc Naeim: Quality care, not cost," results in sustained impact"" # ASCO14""",,,# #,4.72757E+17,https://twitter.com/kbnewport/status/472757360037859328,,
tomleblancMD,5/31/2014 11:11,1,0,@ TuftsB @ ASCO - docs don't want to cut helpful therapies! We need to stop spending lots on ones that don't actually help people # ASCO14,,@ @,#,4.72757E+17,https://twitter.com/tomleblancMD/status/472757341268357121,,,,
JamesPPinkerton,5/31/2014 11:11,0,0,"@ ISBLeeHood, speaking at # ASCO14, shows how blood biomarkers ID actual cancers and thus save healthcare system $3.5b. pic.twitter.com/OQuGLI0zL8",,@,#,4.72757E+17,https://twitter.com/JamesPPinkerton/status/472757274377994240,,,,
PhRMA,5/31/2014 11:11,2,2,# PhRMA’s Castellani: We need insurance system that remains in-step w/ pace of # innovation. More via @ TheHill http://bit.ly/1nDaGmT # ASCO14,,@,# # #,4.72757E+17,https://twitter.com/PhRMA/status/472757191473000448,,,,
carisls,5/31/2014 11:11,3,2,Erkut Borazanci MD from @ TGEN presenting # molecularintel data on # appendiceal cancer at # ASCO14 pic.twitter.com/hHAFIZe5Ve,,@,# # #,4.72757E+17,https://twitter.com/carisls/status/472757162049945600,,,,
Cascadia,5/31/2014 11:10,5,4,Where are patient voices at largest cancer conf? # ASCO14 # HCSM # S4PM # BCSM ^at least 1 session on Tue http://am.asco.org/tuesday-june-3-2014 …,,,# # # #,4.72757E+17,https://twitter.com/Cascadia/status/472757111928397824,,,,
Agendia,5/31/2014 11:10,0,0,@ WhitworthMD MammaPrint-BluePrint molecular subtypes reclassify 23% of BC tumors & improve patient grouping # ASCO14 http://hub.am/1sZPAvV,,@,#,4.72757E+17,https://twitter.com/Agendia/status/472757077090516993,,,,
genentech,5/31/2014 11:10,0,0,@ Neil_Iyengar So true. Here's our take on what it can & can't do in cancer: http://ow.ly/xtiPV # ASCO14,,@,#,4.72757E+17,https://twitter.com/genentech/status/472756974179086336,,,,
DebiopharmNews,5/31/2014 11:10,0,0,"# ASCO14 Phase I basket study Debio1347, # FGFR inhibitor in solid # tumors (abstract/poster # TPS2629) Find out more http://ow.ly/x92eO",,,# # # #,4.72757E+17,https://twitter.com/DebiopharmNews/status/472756968013430785,,,,
cancereu,5/31/2014 11:10,0,1,@ Roche very good question! # asco14 # clinicaltrial,,@,# #,4.72757E+17,https://twitter.com/cancereu/status/472756935985750016,,,,
SymphonySister,5/31/2014 11:10,1,0,@ WhitworthMD MammaPrint-BluePrint molecular subtypes reclassify 23% of BC tumors & improve patient grouping # ASCO2014 http://hub.am/TzfRqT,,@,#,4.72757E+17,https://twitter.com/SymphonySister/status/472756889596723200,,,,
karenhalseypr,5/31/2014 11:09,0,0,"“ @ brianreid: What's hot at # ASCO14? The top 10 most RTed tweets from Friday, @ storify-ed: http://bit.ly/1hm9EJs ” KH: Check #of retweets",,@ @,# #of,4.72757E+17,https://twitter.com/karenhalseypr/status/472756870562598913,,,,
WilliamDale_MD,5/31/2014 11:09,0,1,"# ASCO14 Naim: Risk assessment"" really means ""geriatric assessment"". # gerionc""",,,# #,4.72757E+17,https://twitter.com/WilliamDale_MD/status/472756859690958848,,,,
heidisa,5/31/2014 11:09,1,1,SO IMPORTANT! RT @ ASCO: . @ NYtimes on key # ASCO14 study: “Drug Saves Fertility for Women with Cancer” http://nyti.ms/1hJwZ25,,@ @,#,4.72757E+17,https://twitter.com/heidisa/status/472756857703256064,,,,
rsm2800,5/31/2014 11:09,1,0,"Hood: Using this technique can rule out need for surgery in 40% of benign nodules, save $$ and risks to patients # asco14",,,#,4.72757E+17,https://twitter.com/rsm2800/status/472756816527372288,,,,
ElizBlanchardMD,5/31/2014 11:09,0,1,Dr Hood: systems approach to pulm nodules: ID'd 13 proteins that could predict cancer vs benign in 40% with 90% specificity # ASCO14,,,#,4.72757E+17,https://twitter.com/ElizBlanchardMD/status/472756717780889601,,,,
Merck,5/31/2014 11:09,4,2,# ASCO14 is in full swing. Follow the conversation to learn more about # MerckOncology,,,# #,4.72757E+17,https://twitter.com/Merck/status/472756696147054592,,,,
rsm2800,5/31/2014 11:07,0,0,Hood: Distinguishing benign/malignant lung nodules: Looked at differentially secreted biomarkers shed from nl vs neoplastic cells # ASCO14,,,#,4.72756E+17,https://twitter.com/rsm2800/status/472756357766975488,,,,
carisls,5/31/2014 11:07,5,5,Dr. Igor Astsaturov MD of @ FoxChaseCancer presenting CMI data on 1300+ # neuroendocrine cancers # ASCO14 pic.twitter.com/AyNDxY5GnA,,@,# #,4.72756E+17,https://twitter.com/carisls/status/472756335289700353,,,,
BIOARRAYMDx,5/31/2014 11:06,0,0,Lee Hood MD addresses blood biomarkers using system medicine approaches # ASCO2014,,,#,4.72756E+17,https://twitter.com/BIOARRAYMDx/status/472756111192236032,,,,
KUhlendorf,5/31/2014 11:06,6,8,"Within 5 yrs, 3rd gen # DNA sequencing will allow us to map human genome of indiv # patient in 15 min for less than $100 - Dr Hood # ASCO14",,,# # #,4.72756E+17,https://twitter.com/KUhlendorf/status/472756077348417536,,,,
Neil_Iyengar,5/31/2014 11:06,2,0,Dr Hood: In five years," I can conceive doing a full human genome in 5 min at a cost of $100 or less"" # progress # ASCO14""",,,# #,4.72756E+17,https://twitter.com/Neil_Iyengar/status/472756044184444929,,,
WilliamDale_MD,5/31/2014 11:06,0,1,# ASCO14 Dr. Naim from UCLA to discuss the economics of # gerionc care programs. Meeting @ ASCO Value Proposition. pic.twitter.com/qESlY8gSzn,,@,# #,4.72756E+17,https://twitter.com/WilliamDale_MD/status/472756001410535425,,,,
Boehringer,5/31/2014 11:06,1,1,Read @ thesearemyscars # lungcancer patient survivor’s story here: http://bit.ly/1kdfBHE - # ASCO14 # hcsmeu # hcsm,,@,# # # #,4.72756E+17,https://twitter.com/Boehringer/status/472755898482720768,,,,
danielebanfi83,5/31/2014 11:05,0,0,Sullo sfondo... Odore di carne alla griglia. # ASCO14 pic.twitter.com/4VEDPmltiV,,,#,4.72756E+17,https://twitter.com/danielebanfi83/status/472755858309660673,,,,
nanostringtech,5/31/2014 11:05,0,0,"Hyo Song Kim et al present A phase II and biomarker study of an irreversible pan-human EGF receptor…"" at # ASCO14 http://abstracts.asco.org/144/AbstView_144_133500.html …""",,,#,4.72756E+17,https://twitter.com/nanostringtech/status/472755644571721728,,,,
myriadgenetics,5/31/2014 11:05,0,0,Mult-gene panel tests result in significant treatment changes for # cancer patients. Visit use at Booth 2039 to learn more! # ASCO14,,,# #,4.72756E+17,https://twitter.com/myriadgenetics/status/472755632383475713,,,,
danielebanfi83,5/31/2014 11:04,0,0,Il punto sul congresso con i giornalisti italiani. # ASCO14 pic.twitter.com/6AmA2LUP0O,,,#,4.72756E+17,https://twitter.com/danielebanfi83/status/472755568785235968,,,,
carisls,5/31/2014 11:04,2,0,Dr. Rebecca Feldman presenting molecular profiling of small bowel adenocarcinomas at # ASCO14 pic.twitter.com/6s5279Knr3,,,#,4.72756E+17,https://twitter.com/carisls/status/472755552364134402,,,,
Lymphoma_Doc,5/31/2014 11:04,1,0,"@ ISBLeeHood: 3rd Gen DNA sequencing coming, full human read in 15 minutes (!!!), <$500/sample. # ASCO14",,@,#,4.72756E+17,https://twitter.com/Lymphoma_Doc/status/472755544176877568,,,,
CancerAfrica,5/31/2014 11:04,3,1,# ASCO14 Dr Funmi Olopade @ AORTIC_AFRICA on HR capacity building 4 Africa by university of Chicago global healthpic.twitter.com/xRUkrLpkrS,,@,#,4.72755E+17,https://twitter.com/CancerAfrica/status/472755456960888832,,,,
preventcancer,5/31/2014 11:04,5,3,Oncologists from around the world sporting @ preventcancer sunglasses! # ASCO14 # cancer # Preventionpic.twitter.com/x4w5wo8ySq,,@,# # #,4.72755E+17,https://twitter.com/preventcancer/status/472755422383046656,,,,
PDRennert,5/31/2014 11:03,5,2,$ IMGN modified linker showing less corneal tox. Anti-FRalpha for ovarian Ca. # ASCO14 # ADC,,,# #,4.72755E+17,https://twitter.com/PDRennert/status/472755306728927233,,,,
TuftsB,5/31/2014 11:03,2,4,@ ASCO -value to patient is more than a dollar sign. It includes being at weddings graduations et al. Our lives are worth it # mliwi # ASCO14,,@,# #,4.72755E+17,https://twitter.com/TuftsB/status/472755285141258240,,,,
mvsiguiendo,5/31/2014 11:03,0,1,@ pabloromero Y para hablar de cáncer nada menos. La palabrita es por American Society of Clinical Oncology. # ASCO14,,@,#,4.72755E+17,https://twitter.com/mvsiguiendo/status/472755265314381825,,,,
OncoGenexPharma,5/31/2014 11:03,1,0,# Rainier Trial in Progress Poster Presented by # DrBendell available here: http://Haveyoumetresistance.com # pancsm # ASCO14,,,# # # #,4.72755E+17,https://twitter.com/OncoGenexPharma/status/472755244787834880,,,,
WilliamDale_MD,5/31/2014 11:03,1,1,# ASCO14 The community-based program will be different from academic-based programs. # gerionc,,,# #,4.72755E+17,https://twitter.com/WilliamDale_MD/status/472755158049234945,,,,
davidbeme,5/31/2014 11:02,0,0,Cancer du poumon EGFR+: nouvelle thérapie ciblée en cas de résistances aux traitements actuels # ASCO2014 @ doctissimo http://ow.ly/xtiwm,,@,#,4.72755E+17,https://twitter.com/davidbeme/status/472755096728911872,,,,
AlpineBV_Miller,5/31/2014 11:02,0,3,Important and fascinating. Board 262 Abs 9058 right now S Hall. # asco14 pic.twitter.com/waQGBaA6mo,,,#,4.72755E+17,https://twitter.com/AlpineBV_Miller/status/472755078743719936,,,,
nycdoc29,5/31/2014 11:02,0,0,# ASCO14 nice to see the $ DNDN booth look lively this year now if they can only make the stock come alive! # Provenge,,,# #,4.72755E+17,https://twitter.com/nycdoc29/status/472754983323324417,,,,
questkon,5/31/2014 11:02,0,0,@ ASCO @ nytimes My self Goutam @ questkon i likje this post,,@ @ @,,4.72755E+17,https://twitter.com/questkon/status/472754973424361473,,,,
ASCO,5/31/2014 11:02,11,3,Retweet if you're joining us at today's # ASCO14 Tweetup. Details here: http://bit.ly/NvNypj,,,#,4.72755E+17,https://twitter.com/ASCO/status/472754909721657344,,,,
Novartis,5/31/2014 11:02,0,2,Learn more about # NETCancer by visiting booth 7023 at # ASCO14 and checking out our online resources http://bit.ly/g5U9wB,,,# #,4.72755E+17,https://twitter.com/Novartis/status/472754906647244800,,,,
DrMarkham,5/31/2014 11:01,1,1,Congrats to @ TGeorgeMD & colleagues from @ UF Health on abstract e15014 on esophageal cancer. http://abstracts.asco.org/144/AbstView_144_131019.html … # ASCO14,,@ @,#,4.72755E+17,https://twitter.com/DrMarkham/status/472754837788954624,,,,
BayerPharma,5/31/2014 11:01,2,2,# DYK 1 in 10 people diagnosed with cancer have # colorectalcancer. Learn more about treatments at # ASCO14 # crcsm http://twitpic.com/e55bqi,,,# # # #,4.72755E+17,https://twitter.com/BayerPharma/status/472754782336462848,,,,
ASCO,5/31/2014 11:01,1,2,“Systems Medicine & the Revolution in Healthcare & Society” w/ @ ISBLeeHood Pres of Institute for Systems Biology now N Hall B1 # ASCO14,,@,#,4.72755E+17,https://twitter.com/ASCO/status/472754766737862656,,,,
ASCO,5/31/2014 11:01,3,0,. @ fischmd discusses the changing landscape of palliative care: http://bit.ly/1wnJmuj # ASCO14 # hpm,,@,# #,4.72755E+17,https://twitter.com/ASCO/status/472754763906695168,,,,
ProjectInno,5/31/2014 11:01,0,0,Looking forward to today's # ASCO14 tweetup! Who else will be there?,,,#,4.72755E+17,https://twitter.com/ProjectInno/status/472754761478180864,,,,
DebiopharmNews,5/31/2014 11:01,0,0,"# ASCO14 Clinical PK/PD model for Debio 1143, antagonist of IAPs in # cancer (abstract/poster #2585) Find out more http://ow.ly/x9291",,,# # #2585,4.72755E+17,https://twitter.com/DebiopharmNews/status/472754759120994307,,,,
AlpineBV_Miller,5/31/2014 11:01,0,0,"9058 Brd 262. Older melanoma pts do worse than younger pts, but only when treated with immunotherapies for Stg3 disease. # ASCO14",,,#,4.72755E+17,https://twitter.com/AlpineBV_Miller/status/472754738568916992,,,,
Roche,5/31/2014 11:01,3,3,Learning from negative results: How do you define a “failed” study? http://ow.ly/xkOIq # ASCO14 # ClinicalTrial,,,# #,4.72755E+17,https://twitter.com/Roche/status/472754722752200704,,,,
CRC_Medical,5/31/2014 11:01,0,1,Learn more about our distinguished references in # cancer treatment. Visit Booth #23128 for # ASCO14 show specials on popular # medicine # books,,,# #23128 # # #,4.72755E+17,https://twitter.com/CRC_Medical/status/472754716506882049,,,,
bmsnews,5/31/2014 11:01,2,1,Visit us at the career booth CF-18 or connect with our recruiting team now http://ow.ly/xmojT # ASCO14 # jobs,,,# #,4.72755E+17,https://twitter.com/bmsnews/status/472754678812639233,,,,
SequentaInc,5/31/2014 11:01,1,1,Discuss NGS for # MRD & immune repertoire analysis w/ the LymphoSIGHT platform at booth 18152 http://ow.ly/xm9jg # ASCO14,,,# #,4.72755E+17,https://twitter.com/SequentaInc/status/472754636894773248,,,,
ASCO,5/31/2014 11:00,10,0,. @ NYtimes on key # ASCO14 study: “Drug Saves Fertility for Women with Cancer” http://nyti.ms/1hJwZ25,,@,#,4.72755E+17,https://twitter.com/ASCO/status/472754590476406785,,,,
DrHedrick,5/31/2014 11:00,0,0,Dr. Shailesh Satpute of @ iumedschool presenting on Merkel Cell tumors at # ASCO14 pic.twitter.com/chekJom7d0,,@,#,4.72755E+17,https://twitter.com/DrHedrick/status/472754558054440960,,,,
NEJMGroup,5/31/2014 11:00,2,1,"# ASCO14 Visit the @ NEJMGroup at booth 20127, get a 15% @ NEJM subscription discount.",,@ @,#,4.72755E+17,https://twitter.com/NEJMGroup/status/472754518263083008,,,,
timturnham,5/31/2014 11:00,4,1,Melanoma is most common cancer in pregnant women. A substance in blood of these women makes mel cells grow in the lab. # ASCO14,,,#,4.72755E+17,https://twitter.com/timturnham/status/472754518212354049,,,,
2BBBMedicines,5/31/2014 11:00,1,0,"Meet to-BBB at # ASCO14. We develop therapeutics for devastating brain diseases, like brain tumors @ to_BBB http://ow.ly/xteTR",,@,#,4.72754E+17,https://twitter.com/2BBBMedicines/status/472754438831341568,,,,
FoundationATCG,5/31/2014 11:00,4,1,Not all molecular testing is created equal. Learn about the differences here: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.72754E+17,https://twitter.com/FoundationATCG/status/472754417972703232,,,,
Pharmacyclics,5/31/2014 11:00,7,5,See # cancer # innovation through new lenses: Visit booth 18097 to try # GoogleGlass at # ASCO14,,,# # # #,4.72754E+17,https://twitter.com/Pharmacyclics/status/472754417553256449,,,,
cardinalhealth,5/31/2014 11:00,1,0,See how our BioPharma Analytics Services help pharmaceutical companies make smarter decisions: http://bit.ly/1tXdVoq # ASCO14,,,#,4.72754E+17,https://twitter.com/cardinalhealth/status/472754409378549760,,,,
CancerAfrica,5/31/2014 11:00,0,0,# ASCO14 special session pic.twitter.com/CzLrABdmzZ,,,#,4.72754E+17,https://twitter.com/CancerAfrica/status/472754380929003520,,,,
drsam,5/31/2014 11:00,4,8,Merck Oncology is clearly back! Know how I know? They've got toppings for their Fro-Yo this year! # ASCO14 pic.twitter.com/TLCP5KOgwF,,,#,4.72754E+17,https://twitter.com/drsam/status/472754377217036288,,,,
caitlin_hool,5/31/2014 11:00,2,1,"Reflexively said bless you"" to someone who sneezed at # ASCO14. Based on her look"," I think that is frowned upon here.""",,,#,4.72754E+17,https://twitter.com/caitlin_hool/status/472754371298865152,,,
OphiraG,5/31/2014 10:59,1,1,Dr Leroy Hood fascinating talk @ ASCO on systems approach 2 biology & medicine # asco14,,@,#,4.72754E+17,https://twitter.com/OphiraG/status/472754349597159424,,,,
cancereu,5/31/2014 10:59,1,0,@ OncologyTimes on which grounds is the prediction based? # asco14,,@,#,4.72754E+17,https://twitter.com/cancereu/status/472754321504104448,,,,
nycdoc29,5/31/2014 10:59,0,0,# ASCO14 is it me or has Dx and Testing Cos taken over the exhibit hall once the domain of drug cos and their free pens!,,,#,4.72754E+17,https://twitter.com/nycdoc29/status/472754284451602432,,,,
ASCOPost,5/31/2014 10:59,2,1,"Statin Use Can Stop When Illness Is Terminal, Study Reports (via News@JAMA) http://ow.ly/xtiM5 # ASCO14",,@JAMA,#,4.72754E+17,https://twitter.com/ASCOPost/status/472754282786459648,,,,
SeattleGenetics,5/31/2014 10:59,2,3,Come see our kinetic display at # ASCO14 & we’ll increase our donation to @ iConquerCancer as a tribute to @ ASCO’s 1st 50 years. Booth #22097,,@ @,# #22097,4.72754E+17,https://twitter.com/SeattleGenetics/status/472754282639290369,,,,
PDRennert,5/31/2014 10:59,0,0,# asco14 big turnout in the poster aisles with diverse high impact studies on display. It's a crush tho,,,#,4.72754E+17,https://twitter.com/PDRennert/status/472754255409856512,,,,
teamoncology,5/31/2014 10:59,0,0,"【 # ASCO14 101】 Lenvatinib is an oral tyrosine kinase inhibitor of the VEGFR1-3, FGFR1-4, PDGFRβ, RET, and KIT signaling pathways.",,,#,4.72754E+17,https://twitter.com/teamoncology/status/472754123012444160,,,,
ASCO,5/31/2014 10:58,13,3,# ASCO14 opening ceremony has begun. @ CliffordHudis will address audience in Chicago in 20 mins.pic.twitter.com/J6ATUNOR5U,,@,#,4.72754E+17,https://twitter.com/ASCO/status/472754009460457473,,,,
teamoncology,5/31/2014 10:58,0,0,【 # ASCO14 Update】Lenvatinib (LEN) shows efficacy in patients w/I131 refractory differentiated thyroid cancer. http://abstracts.asco.org/144/AbstView_144_132694.html …,,,#,4.72754E+17,https://twitter.com/teamoncology/status/472753954234056705,,,,
DrBobGoldberg,5/31/2014 10:58,3,3,@ ISBLeeHood developing tests to eliminate genetic noise from genetic signals causing disease progression # asco14 # mliwi,,@,# #,4.72754E+17,https://twitter.com/DrBobGoldberg/status/472753944968822784,,,,
GustaveRoussy,5/31/2014 10:57,2,0,# ASCO14 How to better understand the main stakes of @ ASCO 2014? http://bit.ly/RKqTHQ @ GustaveRoussy,,@ @,#,4.72754E+17,https://twitter.com/GustaveRoussy/status/472753828375187456,,,,
WilliamDale_MD,5/31/2014 10:57,2,1,# ASCO14 Balducci on the importance of collecting outcome data. # gerionc,,,# #,4.72754E+17,https://twitter.com/WilliamDale_MD/status/472753699605839873,,,,
KUhlendorf,5/31/2014 10:56,6,0,We'll see more change in # medicine over the next 5-10 years than we saw in past 50 - @ ISBLeeHood at # ASCO14,,@,# #,4.72754E+17,https://twitter.com/KUhlendorf/status/472753592240074752,,,,
Cascadia,5/31/2014 10:56,3,1,@ kgapo good idea - creating a # ASCO14 tweet list https://twitter.com/cascadia/lists/ASCO14 … w/ everyone but need advocates (+I won’t be online today),,@,#,4.72754E+17,https://twitter.com/Cascadia/status/472753578113630208,,,,
SergiAlc,5/31/2014 10:56,1,0,Common ground on cutting costs of cancer | TheHill http://ow.ly/3lcMIT via @ TheHill # ASCO14,,@,#,4.72754E+17,https://twitter.com/SergiAlc/status/472753560321789953,,,,
ElizBlanchardMD,5/31/2014 10:56,0,0,"Dr Hood: all about big data, but how to interpret? Apply? Look at dynamics of systems and develop new platforms to study diseases # ASCO14",,,#,4.72753E+17,https://twitter.com/ElizBlanchardMD/status/472753462162120705,,,,
cancereu,5/31/2014 10:56,1,1,"@ Doctor_V Hi Bryan, look forward to onco-tweets by an non-oncologist! # asco14 (",,@,#,4.72753E+17,https://twitter.com/cancereu/status/472753404188819456,,,,
Lymphoma_Doc,5/31/2014 10:55,3,0,"@ ISBLeeHood: P4 medicine (predictive, personalized, preventative, and participatory). Sounds like # ASCO14 goals http://1.usa.gov/1khGTwy",,@,#,4.72753E+17,https://twitter.com/Lymphoma_Doc/status/472753269639364608,,,,
OncologyTimes,5/31/2014 10:55,3,3,"Lee Hood, # ASCO14 Opening Session Guest Speaker predicts will be more change in medicine in next 5-10 yrs than in the past 50",,,#,4.72753E+17,https://twitter.com/OncologyTimes/status/472753254325952513,,,,
michael_gilman,5/31/2014 10:55,1,1,"Amidst Day 1 of the # ASCO14 deluge, a profound question: “ @ MartinShkreli: Xbox or Playstation?”",,@,#,4.72753E+17,https://twitter.com/michael_gilman/status/472753165054771200,,,,
davidbeme,5/31/2014 10:55,1,1,Synovite villonodulaire pigmentée: des thérapies ciblées quand la chirurgie n'est plus possible # ASCO2014 @ doctissimo http://ow.ly/xtiiq,,@,#,4.72753E+17,https://twitter.com/davidbeme/status/472753131366129664,,,,
ASCOPost,5/31/2014 10:54,7,2,Expensive Drugs Forcing Cancer Doctors to Weigh Price (via Bloomberg) http://ow.ly/xtirm # ASCO14,,,#,4.72753E+17,https://twitter.com/ASCOPost/status/472753027313860608,,,,
Neil_Iyengar,5/31/2014 10:54,4,2,"Lee Hood- we are sounded by big data."" Opening session # ASCO14 pic.twitter.com/UfJuDRTZJH""",,,#,4.72753E+17,https://twitter.com/Neil_Iyengar/status/472752978315976704,,,,
rsm2800,5/31/2014 10:53,6,3,Hood: Two major problems in systems medicine-the signal:noise ratio and how to make models predictive for individuals # asco14,,,#,4.72753E+17,https://twitter.com/rsm2800/status/472752839018565632,,,,
AlpineBV_Miller,5/31/2014 10:53,1,0,@ asco Not a fan of the mini TPS posters unless you make more room in the rows. Literally gridlock and can't move. # ASCO14,,@,#,4.72753E+17,https://twitter.com/AlpineBV_Miller/status/472752689487814657,,,,
ECMC_UK,5/31/2014 10:53,1,0,Hazel Jones with Clare Shaw supporting UK combinations trials at the NIHR CRN:Cancer stand (4127) # ASCO14,,,#,4.72753E+17,https://twitter.com/ECMC_UK/status/472752666888916993,,,,
WilliamDale_MD,5/31/2014 10:53,0,0,# ASCO14 What is the right screening tool for referral to geriatric oncology clinic? # gerionc,,,# #,4.72753E+17,https://twitter.com/WilliamDale_MD/status/472752656281112578,,,,
stuartgiles01,5/31/2014 10:53,1,2,Always blown away by the pure size and scale of # ASCO14 when I enter the main hall for the opening session pic.twitter.com/SjEeaoUyH1,,,#,4.72753E+17,https://twitter.com/stuartgiles01/status/472752654670905344,,,,
theABTA,5/31/2014 10:53,1,1,We'll be exhibiting at the American Society of Clinical Oncology meeting all weekend. Be sure to stop by our booth and say hello! # ASCO14,,,#,4.72753E+17,https://twitter.com/theABTA/status/472752614938263552,,,,
ASCOPost,5/31/2014 10:52,4,2,"In treating some cancer patients, less is more: U.S. studies (via Reuters) http://ow.ly/xtii7 # ASCO14",,,#,4.72753E+17,https://twitter.com/ASCOPost/status/472752605694021632,,,,
kbnewport,5/31/2014 10:52,1,0,# gerionc Response to questionin Geri session: marriage of geriatrics and pall care in oncology makes sense. # ASCO14,,,# #,4.72753E+17,https://twitter.com/kbnewport/status/472752585590312960,,,,
osservasaluteaz,5/31/2014 10:52,0,0,Osservatorio Salute è ad # asco14 pic.twitter.com/4dRZIsOPNS,,,#,4.72753E+17,https://twitter.com/osservasaluteaz/status/472752572353511424,,,,
rsm2800,5/31/2014 10:52,0,0,Hood: Systems medicine=patients to be surrounded by a virtual cloud of billions of data points # ASCO14,,,#,4.72753E+17,https://twitter.com/rsm2800/status/472752561238200321,,,,
jonodoc,5/31/2014 10:52,0,0,"Hood: P4"" medicine - predictive", preventative, personalized," and participatory. More changes in next 5-10 yrs than in past 50 yrs. # ASCO14""",,,#,4.72753E+17,https://twitter.com/jonodoc/status/472752558209921024,
JacobPlieth,5/31/2014 10:52,0,0,Did @ Thug_BioAnalyst or @ BioTurdCEO make it to yesterday's # ASCO14 tweetup?,,@ @,#,4.72753E+17,https://twitter.com/JacobPlieth/status/472752515155361792,,,,
ChargeAheadMktg,5/31/2014 10:51,0,0,# cancer research falling RT @ ASCO: Review background on the federal funding landscape before the # ASCO14 session: http://bit.ly/QO9c9T,,@,# #,4.72752E+17,https://twitter.com/ChargeAheadMktg/status/472752331168440320,,,,
ElizBlanchardMD,5/31/2014 10:51,0,1,Dr Leroy Hood: more change in medicine in next 5-10 years than in the past 50 # ASCO14,,,#,4.72752E+17,https://twitter.com/ElizBlanchardMD/status/472752302538096640,,,,
ASCOPost,5/31/2014 10:51,1,2,Drug Saves Fertility for Women With Cancer (via NYTimes) http://ow.ly/xticd # ASCO14 # bcsm,,,# #,4.72752E+17,https://twitter.com/ASCOPost/status/472752197374316545,,,,
CancerTherAdvsr,5/31/2014 10:51,0,0,# ASCO14: Reduced-dose Radiation Safe for Certain Patients with Low-risk # HPV-positive Oropharyngeal Cancer # CTAatASCO http://ow.ly/xti9x,,,# # #,4.72752E+17,https://twitter.com/CancerTherAdvsr/status/472752127442706432,,,,
ME_Fleury,5/31/2014 10:51,0,0,Lee Hood at # ASCO14: More changes in medicine in next 5 years than in past 50 years.,,,#,4.72752E+17,https://twitter.com/ME_Fleury/status/472752109340082176,,,,
ByJonGardner,5/31/2014 10:50,0,0,"EGFR Q&A tidbit: AZD9291 presenter Janne asked abt response rate in T790M-. Cited heterogeneity, retreatment effect. Not 1 answer."" # asco14""",,,#,4.72752E+17,https://twitter.com/ByJonGardner/status/472752077543051264,,,,
andygaya,5/31/2014 10:50,0,0,# ASCO14 @ the_RSS # SBRT # SABR # liver # colorectal mets 90% local control at 3yrs suggests better than alternatives esp for larger mets ab3583,,@,# # # # #,4.72752E+17,https://twitter.com/andygaya/status/472752064527745024,,,,
DrBobGoldberg,5/31/2014 10:50,1,0,@ ISBLeeHood says we'll see more progress against cancer in next decade than we've had in last 50 yrs # ASCO14 # MLIWI,,@,# #,4.72752E+17,https://twitter.com/DrBobGoldberg/status/472751945787396096,,,,
eaonc,5/31/2014 10:50,2,0,"# ASCO14 EA members Drs. Gary Cohen, Neal Merapol, Robin Zon just named fellows of ASCO. Congrats!",,,#,4.72752E+17,https://twitter.com/eaonc/status/472751916565659648,,,,
DebiopharmNews,5/31/2014 10:50,0,0,# ASCO14 Phase I/II Debio 1143 combo with CCRT in # patients with # HNSCN (abstract/poster # TPS6097) Find out more http://ow.ly/x921K,,,# # # #,4.72752E+17,https://twitter.com/DebiopharmNews/status/472751912295866368,,,,
genentech,5/31/2014 10:50,1,3,Think navigating the # ASCO14 convention ctr is intense? Try this @ Roche map of biochemical pathways: http://ow.ly/xj21i,,@,#,4.72752E+17,https://twitter.com/genentech/status/472751911482187776,,,,
JacobPlieth,5/31/2014 10:50,0,1,And WAY better that the snow/ice when I was last here - stranded for 24hrs en route back from # ASH13 @ JackWestMD # ASCO14,,@,# #,4.72752E+17,https://twitter.com/JacobPlieth/status/472751889210028032,,,,
TuftsB,5/31/2014 10:50,0,0,Cost panel claimed to be apolitical but why didn't they mention tort reform when talking about supposedly unnecessary tests? # MLIWI # ASCO14,,,# #,4.72752E+17,https://twitter.com/TuftsB/status/472751857405034496,,,,
PaoloNuciforo,5/31/2014 10:49,0,0,Traffic jam # ASCO14 # Chicagopic.twitter.com/ke9znUAUH2,,,# #,4.72752E+17,https://twitter.com/PaoloNuciforo/status/472751817936605184,,,,
satyakri,5/31/2014 10:49,0,0,Interesting article by @ mtmdphd on the use of social media for active use in clinical trials # ASCO14 http://meetinglibrary.asco.org/content/11400101-144#.U4Xz4uvdoOk.twitter …,,@,# #,4.72752E+17,https://twitter.com/satyakri/status/472751800466956288,,,,
MediTech_Media,5/31/2014 10:49,0,0,"Dr Leroy Hood, opening session guest speaker at # ASCO14, predicts in next 5-10 yrs"," we will see more changes in medicine than in last 50""""",,,#,4.72752E+17,https://twitter.com/MediTech_Media/status/472751791520890880,,,
kgapo,5/31/2014 10:49,0,0,many pts/patient advocates twt fm # ASCO14 why not feature thm 2 on an infograph so all cn follow them 2 get 2 the pt view @ Cascadia @ ASCO,,@ @,#,4.72752E+17,https://twitter.com/kgapo/status/472751703188860928,,,,
duemed,5/31/2014 10:49,0,0,ASCO President @ CliffordHudis introducing Dr Hood. LIVE at # ASCO14 pic.twitter.com/9Qx31lCdxx,,@,#,4.72752E+17,https://twitter.com/duemed/status/472751686046347266,,,,
PhRMA,5/31/2014 10:49,2,0,"Tireless research leads to better & more personalized treatments, which means more survivors http://bit.ly/1nAxDqP # ASCO14",,,#,4.72752E+17,https://twitter.com/PhRMA/status/472751664089165824,,,,
GuardantHealth,5/31/2014 10:48,1,2,"Frequency of concurrent gen mutations and copy number alterations in circulating cell-free DNA... 5/31, S Hall A2 # ASCO14 # GuardantHealth",,,# #,4.72751E+17,https://twitter.com/GuardantHealth/status/472751473525555200,,,,
hail_CSER,5/31/2014 10:48,0,0,"At # ASCO14? Be sure to check out the session with Dr. Will Parsons presenting, What’s in an exome?..."" Sunday", 6/1, 9:45am CT," Rm S504""",,,#,4.72751E+17,https://twitter.com/hail_CSER/status/472751456400203778,
ASCO,5/31/2014 10:48,0,0,@ kgapo @ Cascadia Our patient info site @ CancerDotNet conducting robust coverage of # ASCO14 Please follow their handle http://bit.ly/1nPfxie,,@ @ @,#,4.72751E+17,https://twitter.com/ASCO/status/472751424661893121,,,,
sircwn,5/31/2014 10:47,0,0,“ @ adamfeuerstein: $ CLVS '1686 AE profile 22% pats gr3 hyperglycemia. QT prolongation gr3 7% # ASCO14”in layman term?,,@,#,4.72751E+17,https://twitter.com/sircwn/status/472751265030868992,,,,
Lymphoma_Doc,5/31/2014 10:46,0,0,@ YupOnc Congrats on being named a Fellow of @ ASCO (FASCO)!,,@ @,,4.72751E+17,https://twitter.com/Lymphoma_Doc/status/472751064731496448,,,,
drcbsteer,5/31/2014 10:46,1,0,# ASCO14 Naming a # gerionc programme - Theoretically simple but actually a universal challenge.,,,# #,4.72751E+17,https://twitter.com/drcbsteer/status/472751031638818816,,,,
Lymphoma_Doc,5/31/2014 10:46,0,0,@ DrJulieVose Congrats on being named a Fellow of @ ASCO (FASCO)!,,@ @,,4.72751E+17,https://twitter.com/Lymphoma_Doc/status/472750860968013824,,,,
drcbsteer,5/31/2014 10:45,0,0,# ASCO14 Naming a # gerionc programme - Theoretically simple,,,# #,4.72751E+17,https://twitter.com/drcbsteer/status/472750835978752000,,,,
CancerNetwrk,5/31/2014 10:45,3,3,The ONCOLOGY/Cancer Network team is working hard here at # ASCO14. Follow our tweets here and coverage here: http://www.cancernetwork.com/asco-2014,,,#,4.72751E+17,https://twitter.com/CancerNetwrk/status/472750777849888768,,,,
palomaluis,5/31/2014 10:45,0,0," @ oncotuits:Este año se conmemora el 50 aniversario de la creación de # ASCO14 esperamos muchas buenas noticias en la lucha contra el # cáncer""",,@,# #,4.72751E+17,https://twitter.com/palomaluis/status/472750771524861952,,,,
ElizBlanchardMD,5/31/2014 10:45,0,0,@ MaverickNY @ AlpineBV_Miller @ djsampson @ ASCO Warm walk outside helps!,,@ @ @ @,,4.72751E+17,https://twitter.com/ElizBlanchardMD/status/472750766008983552,,,,
abcdiagnosis,5/31/2014 10:45,0,1,"“ @ drattai: Cohen - blending better than juicing. Juicing results in higher glycemic index, less fiber # ASCO14 # bcsm” # breastcancer",,@,# # #,4.72751E+17,https://twitter.com/abcdiagnosis/status/472750757180362752,,,,
LillyPad,5/31/2014 10:45,2,1,Benefits of cancer treatments also should be viewed holistically. Here’s how: http://ow.ly/xseut # ASCO14,,,#,4.72751E+17,https://twitter.com/LillyPad/status/472750710409674752,,,,
mlazqui,5/31/2014 10:45,4,1,RT @ docjavip: Grandes resultados de AZD9291 en T790M+ pic.twitter.com/ROzn1zUfKf # ASCO14,,@,#,4.72751E+17,https://twitter.com/mlazqui/status/472750705716264960,,,,
bmsnews,5/31/2014 10:45,3,2,"R&D will inform # ImmunoOncology strategies, says # BMS researcher # ASCO14",,,# # #,4.72751E+17,https://twitter.com/bmsnews/status/472750699974250496,,,,
ASCO,5/31/2014 10:45,4,1,Review background on the federal funding landscape before the # ASCO14 session: http://bit.ly/QO9c9T via # ASCOConnection,,,# #,4.72751E+17,https://twitter.com/ASCO/status/472750688276328448,,,,
AstellasUS,5/31/2014 10:45,1,1,Visit the Astellas booth today to take in a cutting-edge # 3D printing demonstration of the # DNA double helix # ASCO14,,,# # #,4.72751E+17,https://twitter.com/AstellasUS/status/472750660258394112,,,,
UMRogelCancer,5/31/2014 10:45,1,1,Men who get radiation for # prostatecancer were more likely to develop bladder or rectal cancer: http://umhealth.me/1hFqzBg # ASCO14,,,# #,4.72751E+17,https://twitter.com/UMRogelCancer/status/472750658429681664,,,,
genentech,5/31/2014 10:45,1,1,"Michelle Rohrer, Reg Affairs, talks about evolution of Ph I trials & how we must adapt in future. # ASCO14 # Next50 http://ow.ly/xth0J",,,# #,4.72751E+17,https://twitter.com/genentech/status/472750642428391424,,,,
GustaveRoussy,5/31/2014 10:45,3,0,# ASCO14 Large audience at the opening session. Huge mobilisation. Gustave Roussy is proud to take part to the cause pic.twitter.com/Yc3SfsrUsA,,,#,4.72751E+17,https://twitter.com/GustaveRoussy/status/472750637050896385,,,,
myriadgenetics,5/31/2014 10:45,1,0,Are you attending # ASCO14? Visit us at Booth 2039 to learn about our extensive patient advocacy efforts! # personalmed # hereditarycancer,,,# # #,4.72751E+17,https://twitter.com/myriadgenetics/status/472750599344099328,,,,
OncologyTimes,5/31/2014 10:44,0,1,ASCO Immediate Past President Sandra Swain: @ ASCO now has 1600+ volunteers # ASCO14,,@,#,4.7275E+17,https://twitter.com/OncologyTimes/status/472750480930902016,,,,
hmhyltonpac,5/31/2014 10:44,0,0,Proud sponsor of the great work of the Conquer Cancer Foundation # ASCO14!,,,#,4.7275E+17,https://twitter.com/hmhyltonpac/status/472750467534299136,,,,
kgapo,5/31/2014 10:44,0,0,@ Cascadia good to have all those quoted docs tweeting but where are all the # patients tweeting fm @ ASCO? # ASCO14,,@ @,# #,4.7275E+17,https://twitter.com/kgapo/status/472750405802528768,,,,
HemOncToday,5/31/2014 10:44,0,2,# ASCO14 Lower dose IMRT effective for select patients with HPV positive oropharyngeal cancer at # Vanderbilt-Ingram: http://goo.gl/mfmn88,,,# #,4.7275E+17,https://twitter.com/HemOncToday/status/472750393936846849,,,,
GoHealio,5/31/2014 10:44,0,0,# ASCO14 Lower dose IMRT effective for select patients with HPV positive oropharyngeal cancer at # Vanderbilt-Ingram: http://goo.gl/mfmn88,,,# #,4.7275E+17,https://twitter.com/GoHealio/status/472750393085415424,,,,
subatomicdoc,5/31/2014 10:44,3,1,Tumor HPV status and invasive squamous cell carcinoma of the anus http://abstracts.asco.org/144/AbstView_144_129693.html … > @ umassmemorial # ASCO14 # ancsm,,@,# #,4.7275E+17,https://twitter.com/subatomicdoc/status/472750367110074368,,,,
abcdiagnosis,5/31/2014 10:44,1,1,“ @ drattai: Harvie intermittent fasting - ongoing randomized controlled trials to determine benefit # ASCO14 # bcsm Interesting” # breastcancer,,@,# # #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472750360407605249,,,,
drcbsteer,5/31/2014 10:43,1,1,Mt @ AnneBooms # ASCO14 NP providing individualised care by phone intervention to ovarian cancer patients An innovative research project MSKCC,,@,#,4.7275E+17,https://twitter.com/drcbsteer/status/472750239158665216,,,,
Cascadia,5/31/2014 10:43,0,0,@ markaorourke: # ASCO14 and let women know LCIS isn’t cancer & increased risk of BC happens over decades to make informed choice # bcsm,,@,# #,4.7275E+17,https://twitter.com/Cascadia/status/472750181541097473,,,,
hello_torch,5/31/2014 10:43,0,0,Top topics: 1 # BEA14 2 # nerdland 3 # ASCO14 4 # detroitgp 5 Manchester,,,# # # #,4.7275E+17,https://twitter.com/hello_torch/status/472750099454783488,,,,
TuftsB,5/31/2014 10:42,0,1,@ tomleblancMD @ ASCO - my life sustained by treatment to be denied by cost cutting. Wear a white coat not a green eye shade # mliwi # ASCO14,,@ @,# #,4.7275E+17,https://twitter.com/TuftsB/status/472750082492993536,,,,
abcdiagnosis,5/31/2014 10:42,0,1,"“ @ drattai: Harvie - dietary supplements - almost 50% taking, clinicians give variable advice # ASCO14 # bcsm” # breastcancer",,@,# # #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472750069884919809,,,,
CathyEngMD,5/31/2014 10:42,6,3,"# colorectalcancer poster highlights today at # ASCO14 with a focus on # BRAF MT as well as # rectal # cancer, # crcsm , # endcancer",,,# # # # # # #,4.7275E+17,https://twitter.com/CathyEngMD/status/472750059440730113,,,,
JackWestMD,5/31/2014 10:42,0,2,"Got lucky w/weather for # ASCO14 - Chicago is beautiful right now. Much better than cold/snow when I was last here, in mid-April.",,,#,4.7275E+17,https://twitter.com/JackWestMD/status/472750041283977217,,,,
abcdiagnosis,5/31/2014 10:42,0,1,“ @ drattai: Harvie - healthy diet reduces overall mortality but not cancer-specific mortality # ASCO14 # bcsm” # breastcancer,,@,# # #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472749949843963905,,,,
WilliamDale_MD,5/31/2014 10:42,0,2,# ASCO14 Yew: Important research on post- op delirium coming out in Annals of Surgery. # gerionc,,,# #,4.7275E+17,https://twitter.com/WilliamDale_MD/status/472749934928592896,,,,
LungCancer_Can,5/31/2014 10:42,0,0,"This weekend, Lung Cancer Canada representatives are posting from the @ ASCO. Follow the conversation using # LCCAtASCO!",,@,#,4.7275E+17,https://twitter.com/LungCancer_Can/status/472749931393196033,,,,
ipaulmampilly,5/31/2014 10:42,0,0,# ASCO14 $ teva serves crepes and they come in hordespic.twitter.com/IvSuqEHXSN,,,#,4.7275E+17,https://twitter.com/ipaulmampilly/status/472749861742600193,,,,
JediPD,5/31/2014 10:42,0,0,Combinatorials: Second round effect from one well thought out combo (PTEN+PI3K) success leads to a shotgun approach elsewhere # ASCO14,,,#,4.7275E+17,https://twitter.com/JediPD/status/472749855753117696,,,,
abcdiagnosis,5/31/2014 10:42,0,1,“ @ drattai: Harvie - very high fruit / veggie intake doe not improve outcome of # breastcancer patients # ASCO14 # bcsm” Interesting!,,@,# # #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472749852376707072,,,,
kgapo,5/31/2014 10:41,1,3,@ nxtstop1 think so to! worth a tweetchat with all those HCPs in # ASCO14 @ Boehringer,,@ @,#,4.7275E+17,https://twitter.com/kgapo/status/472749776476598273,,,,
Ghazialot,5/31/2014 10:41,0,0,# ASCO14,,,#,4.7275E+17,https://twitter.com/Ghazialot/status/472749766003015681,,,,
abcdiagnosis,5/31/2014 10:41,0,2,"“ @ drattai: Harvie we need more data on intentional weight loss, benefits in terms of recurrence, mortality # ASCO14 # bcsm” # breastcancer",,@,# # #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472749764497666048,,,,
Bobmorevc,5/31/2014 10:41,0,1,Celebrate the great science and progress. Maintain the sense of urgency because it matters. @ LIVESTRONGCEO # ASCO14,,@,#,4.7275E+17,https://twitter.com/Bobmorevc/status/472749654484852739,,,,
kgapo,5/31/2014 10:40,0,2,@ Boehringer however the question is do HCPs allow patients enough time to ask # notjustdisease questions? # ASCO14,,@,# #,4.7275E+17,https://twitter.com/kgapo/status/472749585325379584,,,,
teamoncology,5/31/2014 10:40,2,2,RT @ pfizer: Infographic: Value of Cancer Meds # asco14 pic.twitter.com/YVUhJAgHR4,,@,#,4.7275E+17,https://twitter.com/teamoncology/status/472749509135462402,,,,
abcdiagnosis,5/31/2014 10:40,1,1,“ @ drattai: Dr. MIchelle Harvie role of nutrition - another important topic # ASCO14 # bcsm” Glad we have someone from @GenesisBCP Manchester!,,@ @GenesisBCP,# #,4.7275E+17,https://twitter.com/abcdiagnosis/status/472749504274628608,,,,
melanoma_Drs,5/31/2014 10:40,0,0,RT @ Melanoma_doctor: It’s # ASCO14 and 1st # melanoma talk is over! My thoughts on the data plus combo therapies: http://ow.ly/3lcKTf,,@,# #,4.72749E+17,https://twitter.com/melanoma_Drs/status/472749495886020608,,,,
Melanoma_doctor,5/31/2014 10:40,1,0,RT @ Melanoma_doctor: It’s # ASCO14 and 1st # melanoma talk is over! My thoughts on the data plus combo therapies: http://ow.ly/3lcKTf,,@,# #,4.72749E+17,https://twitter.com/Melanoma_doctor/status/472749495244308480,,,,
AnneBooms,5/31/2014 10:40,0,0,# ASCO14 the NP providing individualised care by phone intervention to ovarian cancer patients,,,#,4.72749E+17,https://twitter.com/AnneBooms/status/472749473110564864,,,,
drcbsteer,5/31/2014 10:40,0,0,MT “ @ WilliamDale_MD: # ASCO14 Korc - strategic alliance with nursing is key to proving high quality care. # gerionc”,,@,# #,4.72749E+17,https://twitter.com/drcbsteer/status/472749466416476160,,,,
DebiopharmNews,5/31/2014 10:40,0,0,# ASCO14 Phase I study Debio 1143 combo in # patients # leukemia # bloodcancer (abstract/poster #7029) Find out more http://ow.ly/x91UG,,,# # # # #7029,4.72749E+17,https://twitter.com/DebiopharmNews/status/472749403179343872,,,,
Roche,5/31/2014 10:40,7,4,We help you to understand key concepts and terminology around # ClinicalTrials and their analysis. http://ow.ly/xkOwW (*.pdf) # ASCO14,,,# #,4.72749E+17,https://twitter.com/Roche/status/472749390546079744,,,,
Melanoma_doctor,5/31/2014 10:40,2,1,It’s # ASCO14 and 1st # melanoma talk is over! My thoughts on the data plus combo therapies: http://ow.ly/3lcKTf,,,# #,4.72749E+17,https://twitter.com/Melanoma_doctor/status/472749381599637504,,,,
Viscira,5/31/2014 10:39,0,0,Busy weekend for Viscira at # ASCO14 pic.twitter.com/3U2sadY3YJ,,,#,4.72749E+17,https://twitter.com/Viscira/status/472749281737461760,,,,
TuftsB,5/31/2014 10:39,0,0,Cost control panel did not include patient. Step down from podium & talk to US about denying medically justifiable care. # MLIWI # asco14,,,# #,4.72749E+17,https://twitter.com/TuftsB/status/472749169686614016,,,,
drcbsteer,5/31/2014 10:39,0,0,# ASCO14 Tew - # gerionc clinical research vital to programme success.,,,# #,4.72749E+17,https://twitter.com/drcbsteer/status/472749139584094208,,,,
chingosity,5/31/2014 10:39,0,0,Sorry to see prez Cliff Hudis end his term # ASCO14,,,#,4.72749E+17,https://twitter.com/chingosity/status/472749118285021185,,,,
GoPraxis,5/31/2014 10:38,0,0,We're happy to be among the thousands and thousands taking Chicago by storm! # ASCO14,,,#,4.72749E+17,https://twitter.com/GoPraxis/status/472748926412394498,,,,
dougulman,5/31/2014 10:38,2,3,Off to # ASCO14,,,#,4.72749E+17,https://twitter.com/dougulman/status/472748911531020289,,,,
ipaulmampilly,5/31/2014 10:38,0,0,# ASCO14 these scones get people into hearing about these drugs pic.twitter.com/TxrzYeoSgR,,,#,4.72749E+17,https://twitter.com/ipaulmampilly/status/472748877062615040,,,,
JohnCendpts,5/31/2014 10:38,0,0,Lilly's ramucirumab scores a marginal gain for lung cancer patients - $ LLY # asco14 http://www.fiercebiotech.com/story/lillys-ramucirumab-scores-marginal-positive-gain-lung-cancer-patients/2014-05-31 …,,,#,4.72749E+17,https://twitter.com/JohnCendpts/status/472748875745591297,,,,
WilliamDale_MD,5/31/2014 10:37,1,0,"# ASCO14 - Tag, you're it! Dr. Tew is back to describe research at Memorial for # gerionc.",,,# #,4.72749E+17,https://twitter.com/WilliamDale_MD/status/472748824331448321,,,,
ihatebreastcanc,5/31/2014 10:37,0,0,Metastatic Breast Cancer at # ASCO2014: We Are There http://wp.me/p1tnmb-lS via @ ihatebreastcanc,,@,#,4.72749E+17,https://twitter.com/ihatebreastcanc/status/472748799274668032,,,,
wallyjc,5/31/2014 10:37,2,0,The Conquer Cancer Foundation has awarded over $5m in cancer research awards! Thank you! # ASCO14 @ WinshipAtEmory,,@,#,4.72749E+17,https://twitter.com/wallyjc/status/472748778731343872,,,,
teamoncology,5/31/2014 10:37,1,1,@ nycdoc29 @ nxtstop1 Important questions to answer. Resource is limited. # ASCO14,,@ @,#,4.72749E+17,https://twitter.com/teamoncology/status/472748765791547393,,,,
drcbsteer,5/31/2014 10:37,0,0,# ASCO14 Beatriz Korc-Grodzicki - In establishing a # gerionc programme building bridges is key but there are lots of bridges to build.,,,# #,4.72749E+17,https://twitter.com/drcbsteer/status/472748745013358593,,,,
OncologyTimes,5/31/2014 10:37,0,1,We're at Booth 21124! # ASCO14 pic.twitter.com/I8whh2zWxY,,,#,4.72749E+17,https://twitter.com/OncologyTimes/status/472748633751052288,,,,
subatomicdoc,5/31/2014 10:37,0,0,Asking the Right Question at # ASCO 2014: What Are You Hoping For? http://bit.ly/1pFn9DA via @ fischmd @ ASCO,,@ @,#,4.72749E+17,https://twitter.com/subatomicdoc/status/472748588586778624,,,,
nycdoc29,5/31/2014 10:36,1,1,"“ @ nxtstop1: @ nycdoc29 @ teamoncology interesting point. Answer ??” Wish there was easy answer, it's the billion $ Q # ASCO14",,@ @ @,#,4.72749E+17,https://twitter.com/nycdoc29/status/472748557209206784,,,,
Frank_S_David,5/31/2014 10:36,0,1,Someone shld plot # ASCO14 exhibit square footage vs risk-adjusted oncology NPV by company. Many questionable cos w/lots of real estate...,,,#,4.72749E+17,https://twitter.com/Frank_S_David/status/472748548333662209,,,,
LUNGevity,5/31/2014 10:36,0,0,LUNGevity is at ASCO this weekend. You can follow updates about progress in lung cancer research on Twitter # ASCO14 http://fb.me/19jxHan03,,,#,4.72749E+17,https://twitter.com/LUNGevity/status/472748525965819904,,,,
LinicalAmericas,5/31/2014 10:36,0,0,@Accelovance: Interactive hologram @ boehringerus - creative way to differentiate and provide drug info. # ASCO14 pic.twitter.com/Wku3RoCwcV,,@Accelovance @,#,4.72749E+17,https://twitter.com/LinicalAmericas/status/472748523231141888,,,,
RaysNurseK,5/31/2014 10:36,0,0,RT “ @ WilliamDale_MD: # ASCO14 Kiev - strategic alliance with nursing is key to proving high quality care. # gerionc”,,@,# #,4.72748E+17,https://twitter.com/RaysNurseK/status/472748459414794240,,,,
carisls,5/31/2014 10:36,1,1,Visit booth 12096 to discuss any of our 34 # ASCO14 molecular profiling studies # breastcancer # sarcoma # colorectal # gastrointestinal # ovarian,,,# # # # # #,4.72748E+17,https://twitter.com/carisls/status/472748403605381120,,,,
GustaveRoussy,5/31/2014 10:36,1,1,"# ASCO14 This morning @ Gustave Roussy present a poster highlight axitinib in refractory colorectal metastatic cancer""pic.twitter.com/ntEDCuPHe0""",,@,#,4.72748E+17,https://twitter.com/GustaveRoussy/status/472748345383858177,,,,
DrBobGoldberg,5/31/2014 10:35,1,0,@ WellPoint jennifer malin: there are too many new cancer therapies. In an age of personalized care that's a deadly thought # ASCO14 # mliwi,,@,# #,4.72748E+17,https://twitter.com/DrBobGoldberg/status/472748273300959232,,,,
timturnham,5/31/2014 10:35,5,2,Data shows rapid rise in melanoma among men and men less likely to be treated at good melanoma canters. # ASCO14 pic.twitter.com/kHMjjXxeDQ,,,#,4.72748E+17,https://twitter.com/timturnham/status/472748238785626113,,,,
WilliamDale_MD,5/31/2014 10:35,0,0,# ASCO14 Kiev - strategic alliance with nursing is key to proving high quality care. # gerionc,,,# #,4.72748E+17,https://twitter.com/WilliamDale_MD/status/472748234645852160,,,,
CancerAdvocacy,5/31/2014 10:35,2,1,"While we're at # ASCO14 this weekend, here is the news that caught our eye this week http://ow.ly/xtgWX # EOL # PalliativeCare",,,# # #,4.72748E+17,https://twitter.com/CancerAdvocacy/status/472748168749543424,,,,
ElizBlanchardMD,5/31/2014 10:35,0,0,"Comm research forum:Cancerlinq may be one way to increase info from 'real world' patients, help generalizability (or not) of trials # ASCO14",,,#,4.72748E+17,https://twitter.com/ElizBlanchardMD/status/472748164844646400,,,,
nanostringtech,5/31/2014 10:35,0,0,Villaruz et al present “microRNA expression profiling predicts clinical outcome … in metastatic melanoma …” # ASCO14 http://abstracts.asco.org/144/AbstView_144_128853.html …,,,#,4.72748E+17,https://twitter.com/nanostringtech/status/472748124012679169,,,,
DrMarkham,5/31/2014 10:34,0,0,"Finally, in real life! RT @ drattai: Just met @ DrMarkham! # ASCO14",,@ @,#,4.72748E+17,https://twitter.com/DrMarkham/status/472748015711948800,,,,
SellersMPA,5/31/2014 10:34,0,0,@ brockyetso @ millennium_US @UlmanCancerFnd enjoyed learning more about your work. Have a great # ASCO14,,@ @ @UlmanCancerFnd,#,4.72748E+17,https://twitter.com/SellersMPA/status/472747974876221440,,,,
OphiraG,5/31/2014 10:34,1,0,"# ASCO14 theme science & society"". Special awards session now. Only 50% of ""society"" represented. # wherearethewomen? @ ecancer @ OncEd""",,@ @,# #,4.72748E+17,https://twitter.com/OphiraG/status/472747918193995777,,,,
CUCancerCenter,5/31/2014 10:34,2,4,# ASCO14 Interesting data to be released at 1PM ETabout breath test for # lungcancer Stay tuned!,,,# #,4.72748E+17,https://twitter.com/CUCancerCenter/status/472747900443688960,,,,
drsam,5/31/2014 10:34,0,2,Humans being reprogrammed in the AZ/MedImmune booth! # ASCO14 pic.twitter.com/ALdaU4Cbeq,,,#,4.72748E+17,https://twitter.com/drsam/status/472747870769381376,,,,
teamoncology,5/31/2014 10:33,0,0,@ MaverickNY @ JediPD Not that I know how to do the best trials. Some docs just do not know enough basic and clinical science. # ASCO14,,@ @,#,4.72748E+17,https://twitter.com/teamoncology/status/472747789445632000,,,,
ipaulmampilly,5/31/2014 10:33,0,0,What Pfizer wants # ASCO14 pic.twitter.com/KGbMpmSpXz,,,#,4.72748E+17,https://twitter.com/ipaulmampilly/status/472747786275131392,,,,
drcbsteer,5/31/2014 10:33,2,0,"# ASCO14 Beatriz Korc-Grodzicki - barriers include space, convincing oncologists re need, recruitment of geriatricians # gerionc",,,# #,4.72748E+17,https://twitter.com/drcbsteer/status/472747752519380992,,,,
WilliamDale_MD,5/31/2014 10:33,1,1,# ASCO14 Korc - Important to partner with your general medicine colleagues to meet demand. # gerionc,,,# #,4.72748E+17,https://twitter.com/WilliamDale_MD/status/472747675155046400,,,,
NormandBlais,5/31/2014 10:33,0,0,FDA study. Response rates in lung ca trials not well correlated to overall survival. Need better early prediction tools. # lccatasco # ASCO14,,,# #,4.72748E+17,https://twitter.com/NormandBlais/status/472747634143133696,,,,
gherb,5/31/2014 10:32,0,1,# pathology # ASCO14 attending Opening Session & 2014 Special Awards at McCormick Place pic.twitter.com/6Ms2WgpF7P,,,# #,4.72747E+17,https://twitter.com/gherb/status/472747439515246593,,,,
drcbsteer,5/31/2014 10:32,1,1,# ASCO14 Beatriz Korc-Grozdicki difficult but important to build a geriatrics team at a cancer centre. # gerionc,,,# #,4.72747E+17,https://twitter.com/drcbsteer/status/472747385194811393,,,,
jtriestm,5/31/2014 10:31,1,0,Mount Sinai researchers to present at # ASCO14 Meeting | Science Codex http://www.sciencecodex.com/mount_sinai_researchers_to_present_studies_at_american_society_of_clinical_oncology_meeting-134696 … via @ jtriestm,,@,#,4.72747E+17,https://twitter.com/jtriestm/status/472747264356544515,,,,
DrLaraDavis,5/31/2014 10:31,0,0,# ASCO2014 Efficacy of novel proteasome inhibitory platinum complex against osteosarcoma. http://abstracts.asco.org/144/index.html,,,#,4.72747E+17,https://twitter.com/DrLaraDavis/status/472747231770988546,,,,
jdflaysakier,5/31/2014 10:31,2,1,Therapies ciblées : des progrès pour freiner l'évolution des cancers mais parfois au prix de lourds effets secondaires # ASCO14,,,#,4.72747E+17,https://twitter.com/jdflaysakier/status/472747196270391296,,,,
stuxrt,5/31/2014 10:31,0,4,ASCO is one dang BIG meeting. Makes ASTRO look like a couple people getting together. The multi-media is impressive as well. # ASCO14 # LCI,,,# #,4.72747E+17,https://twitter.com/stuxrt/status/472747144806662144,,,,
WilliamDale_MD,5/31/2014 10:31,1,1,"# ASCO14 Dr. Korc explains the thoughtful growth of a # geriatrics team. Targeted, strategic growth is crucial. # gerionc",,,# # #,4.72747E+17,https://twitter.com/WilliamDale_MD/status/472747115999817728,,,,
DebiopharmNews,5/31/2014 10:31,0,0,# ASCO14 Final PK/PD phase I Debio 1143 (AT406) # patients # cancer (abstract/poster #2532). Find out more http://ow.ly/x91Jy,,,# # # #2532,4.72747E+17,https://twitter.com/DebiopharmNews/status/472747105204051969,,,,
ASCO,5/31/2014 10:30,5,1,"After the How to Navigate the AM session, read our 20 tips on getting the most out of # ASCO14 http://bit.ly/1mxgACT # ASCOConnection",,,# #,4.72747E+17,https://twitter.com/ASCO/status/472747062954823680,,,,
bmsnews,5/31/2014 10:30,3,2,# BMS discusses how tumors may evade the immune system through immune signaling pathways # ImmunoOncology # ASCO14 Industry Expert Theater,,,# # #,4.72747E+17,https://twitter.com/bmsnews/status/472747036023218176,,,,
ivanalvarez100,5/31/2014 10:30,0,0,@ ASCO virtual meeting! A must visit on this weekend,,@,,4.72747E+17,https://twitter.com/ivanalvarez100/status/472746999822184449,,,,
teamoncology,5/31/2014 10:30,0,1,@ nycdoc29 Totally agree. Some of the trial designs are total disconnect from the reality in the community practice. # ASCO14,,@,#,4.72747E+17,https://twitter.com/teamoncology/status/472746891214483456,,,,
WileyOnc_Hem,5/31/2014 10:30,0,0,# ASCO14: And don't forget FREE shipping within the US and Canada!,,,#,4.72747E+17,https://twitter.com/WileyOnc_Hem/status/472746864509739008,,,,
SanofiUS,5/31/2014 10:30,0,0,RT @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1kbDosF Want to follow all? Subscribe to our list http://bit.ly/1kbDlx3 # hcsm,,@,# #,4.72747E+17,https://twitter.com/SanofiUS/status/472746851754852352,,,,
nycdoc29,5/31/2014 10:30,2,1,"“ @ teamoncology: all the combination therapy, are they going to be used even.” The Disconnect between academic & community Onc # ASCO14",,@,#,4.72747E+17,https://twitter.com/nycdoc29/status/472746829776707584,,,,
SiliconBio,5/31/2014 10:30,0,0,Attending # ASCO14? Stop by @ SiliconBio booth 24101 to learn more about the isolation recovery & molecular characterization of tumor cells,,@,#,4.72747E+17,https://twitter.com/SiliconBio/status/472746826391883776,,,,
myPathMelanoma,5/31/2014 10:30,1,0,Don't miss our # ASCO14 poster highlight going until 11:45AM in room E354b!,,,#,4.72747E+17,https://twitter.com/myPathMelanoma/status/472746825561014273,,,,
teamoncology,5/31/2014 10:28,1,1,@ JediPD @ MaverickNY Unless drugs have excellent safety profiles as mono it is difficult to justify triplet or even doublet Rx. # ASCO14,,@ @,#,4.72747E+17,https://twitter.com/teamoncology/status/472746557691793408,,,,
UpstageLungCanc,5/31/2014 10:28,0,0,"Today, ULC is attending American Society of Clinical Oncology @ ASCO annual meeting in Chicago",,@,,4.72747E+17,https://twitter.com/UpstageLungCanc/status/472746538050281472,,,,
DrMarkham,5/31/2014 10:28,0,0,Ready for the @ ASCO Special Session: presidential address by @ CliffordHudis # ASCO14,,@ @,#,4.72746E+17,https://twitter.com/DrMarkham/status/472746489404723200,,,,
JediPD,5/31/2014 10:28,1,1,@ teamoncology @ MaverickNY Groupthink of more is better is NOT necessarily true # ASCO14,,@ @,#,4.72746E+17,https://twitter.com/JediPD/status/472746469792182272,,,,
gherb,5/31/2014 10:28,0,2,# pathology # ASCO14 attending annual ASCO meeting in Chicago. My first ASCO meeting and I have joined ASCO in their 50th year anniversary.,,,# #,4.72746E+17,https://twitter.com/gherb/status/472746455455653888,,,,
ElizBlanchardMD,5/31/2014 10:28,3,0,@ rschilsky :ASCO payment reform model proposes compensation for time spent with patients on clinical trials # ASCO14,,@,#,4.72746E+17,https://twitter.com/ElizBlanchardMD/status/472746427073183744,,,,
AJMC_Journal,5/31/2014 10:28,2,0,How Do You Establish Value in Cancer Care? # ASCO14 http://bit.ly/1gPOp1V,,,#,4.72746E+17,https://twitter.com/AJMC_Journal/status/472746366780063744,,,,
MikeHuckman,5/31/2014 10:28,0,1,"Well, it should be much easier to get a table for dinner tomorrow night in Chicago. Just sayin'. # BlackhAwkSCO # ASCO14",,,# #,4.72746E+17,https://twitter.com/MikeHuckman/status/472746362061484032,,,,
carisls,5/31/2014 10:28,2,0,"Tumor profiling in # appendiceal # ovarian # gastrointestinal # pancreatic # neuroendocrine # colorectal, S Hall A2 http://goo.gl/j32X7t # ASCO14",,,# # # # # # #,4.72746E+17,https://twitter.com/carisls/status/472746346575691776,,,,
WilliamDale_MD,5/31/2014 10:27,2,1,"# ASCO14 Memorial tag-team - Beatriz to describe building the Geriatrics Service at a Cancer Center, Oh my gosh!""""",,,#,4.72746E+17,https://twitter.com/WilliamDale_MD/status/472746256175886336,,,,
DrAttai,5/31/2014 10:27,0,0,Just met @ DrMarkham! # ASCO14,,@,#,4.72746E+17,https://twitter.com/DrAttai/status/472746214476480512,,,,
meducate,5/31/2014 10:27,0,1,And upon approach into Chicago on my @ united flight! # asco2014 @Chicago O'Hare International Airport http://instagram.com/p/oqh8RIJpCd/,,@ @Chicago,#,4.72746E+17,https://twitter.com/meducate/status/472746190300528640,,,,
QIAGENscience,5/31/2014 10:27,0,0,"We offer the gold standard in JAK2 V617F detection. Will partner with your lab to give you the best test results. See booth 5013, # ASCO14",,,#,4.72746E+17,https://twitter.com/QIAGENscience/status/472746164346191872,,,,
ALLIANCE_org,5/31/2014 10:27,2,5,# ASCO14 Today | GI Poster Highlights | Racial diffs in KRAS/BRAF mutation rates & survival in colon cancer http://bit.ly/1khzOvG,,,#,4.72746E+17,https://twitter.com/ALLIANCE_org/status/472746119223853056,,,,
ipaulmampilly,5/31/2014 10:27,0,0,# ASCO14 get a free espresso and get some cancer drug info pic.twitter.com/ovStV4XQ0J,,,#,4.72746E+17,https://twitter.com/ipaulmampilly/status/472746086952894464,,,,
CUCancerCenter,5/31/2014 10:27,0,1,"Dr. Karl Lewis & Dr. Nicole Kounalakis # ASCO14 Dr. Lewis' poster lost-great folks able to reprint. Not a small job, pic.twitter.com/tZ5PWGLRgf",,,#,4.72746E+17,https://twitter.com/CUCancerCenter/status/472746082380681216,,,,
JediPD,5/31/2014 10:27,1,0,@ teamoncology @ MaverickNY Remembering Triplets did not work better than Doublets in Lung Cancer (ECOG1394) but >toxicity # ASCO14,,@ @,#,4.72746E+17,https://twitter.com/JediPD/status/472746069609443328,,,,
CaraAnselmo,5/31/2014 10:26,1,0,"@ chemobrainfog @ rsm2800 Whole foods vs single nutrient suppls, extracts, pills, powders? I'm convinced whole foods will always win. # ASCO14",,@ @,#,4.72746E+17,https://twitter.com/CaraAnselmo/status/472746054002032641,,,,
WileyOnc_Hem,5/31/2014 10:26,0,0,# ASCO14 attendees: Stop by Wiley's booth 22125 for your essential oncology resources! 20% off and free journals pic.twitter.com/nDfFy2UIG9,,,#,4.72746E+17,https://twitter.com/WileyOnc_Hem/status/472745833843417088,,,,
subatomicdoc,5/31/2014 10:26,4,0,Gemcitabine vs capecitabine for chemoradiation in locally advanced pancreatic cancer http://bit.ly/1tky6L0 # ASCO14 # pancsm # radonc,,,# # #,4.72746E+17,https://twitter.com/subatomicdoc/status/472745825668714496,,,,
ECMC_UK,5/31/2014 10:26,0,0,"Emerging combinations strategies at # ASCO14 shows exciting progress, and that more rationally designed combination trials are important!",,,#,4.72746E+17,https://twitter.com/ECMC_UK/status/472745819847004161,,,,
Rad_Nation,5/31/2014 10:26,0,0,Gemcitabine vs capecitabine for chemoradiation in locally advanced pancreatic cancer http://bit.ly/1tky6L0 # ASCO14 # pancsm # radonc,,,# # #,4.72746E+17,https://twitter.com/Rad_Nation/status/472745819196907520,,,,
teamoncology,5/31/2014 10:25,0,0,"【 # ASCO14 Ueno Editorial】 You wonder all the combination therapy, are they really going to be used even if the data is positive.",,,#,4.72746E+17,https://twitter.com/teamoncology/status/472745792759816192,,,,
TuftsB,5/31/2014 10:25,0,0," @ SDFatPhRMA: MT @ pfizer: Infographic on Value of # Cancer Meds # asco14 pic.twitter.com/QwFJLlfewE"" # mliwi""",,@ @,# # #,4.72746E+17,https://twitter.com/TuftsB/status/472745721108918272,,,,
Boehringer,5/31/2014 10:25,1,1,"Ready to listen to some sessions here at # ASCO14? If you're here, what are you looking forward to today? pic.twitter.com/6iNKkVqCKr",,,#,4.72746E+17,https://twitter.com/Boehringer/status/472745720282619906,,,,
SiemensHealth,5/31/2014 10:25,0,0,# TheBatonPass visits # ASCO14 in Chicago! Stop by Booth #6141 to pass the baton to support @ SU2C or pass virtually http://ow.ly/wTycH,,@,# # #6141,4.72746E+17,https://twitter.com/SiemensHealth/status/472745628167315456,,,,
Boehringer,5/31/2014 10:25,5,2,"# HCPs: Tell us, what are the top questions asked by your # lungcancer patients? # notjustonedisease > # ASCO14",,,# # # #,4.72746E+17,https://twitter.com/Boehringer/status/472745621729062912,,,,
womenofteal,5/31/2014 10:25,0,1,# ASCO14 # gyncsm ASCO: Drug Helps Save Fertility in Breast Ca http://www.medpagetoday.com/HematologyOncology/BreastCancer/46073 …,,,# #,4.72746E+17,https://twitter.com/womenofteal/status/472745617811181569,,,,
dmooneymd,5/31/2014 10:25,0,0,What about combining pd1 or pdl1 therapy therapy with braf or mek therapy? Wait for # asco15. # ASCO14 # melsm,,,# # #,4.72746E+17,https://twitter.com/dmooneymd/status/472745607627816961,,,,
teamoncology,5/31/2014 10:25,0,0,@ cwrightmd There are some docs who believes that more you shrink the cancer that patients will do well. # ASCO14,,@,#,4.72746E+17,https://twitter.com/teamoncology/status/472745593735876608,,,,
genentech,5/31/2014 10:25,0,2,"# Skincancer has been featured at 5 @ ASCO meetings in a row. Jennifer Low, Med Dir, discusses why: http://ow.ly/xsgKf # ASCO14",,@,# #,4.72746E+17,https://twitter.com/genentech/status/472745586190737408,,,,
aicrtweets,5/31/2014 10:24,0,0,"RT @ djsampson: It's hard to die of a disease you do not get"" Vogel on incidence as appropriate endpoint # asco14""",,@,#,4.72745E+17,https://twitter.com/aicrtweets/status/472745485653278722,,,,
dytcmd,5/31/2014 10:24,0,1,Keep the tweets up! MT @ ERPlimackMD: @ UrologyMatch @ FCUroOnc @ dytcmd @ uretericbud GU immunotherapy session today # asco2014 # gusm stay tuned!,,@ @ @ @ @,# #,4.72745E+17,https://twitter.com/dytcmd/status/472745413796044800,,,,
Cognicum,5/31/2014 10:23,0,0,“ @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,#,4.72745E+17,https://twitter.com/Cognicum/status/472745283160645633,,,,
carisls,5/31/2014 10:23,3,0,Study of 1248 serous # ovarian cancer patients shows potential for targeting treatment http://goo.gl/UvuGDw # gyncsm # ASCO14,,,# # #,4.72745E+17,https://twitter.com/carisls/status/472745245264723969,,,,
ihatebreastcanc,5/31/2014 10:23,0,0,Metastatic Breast Cancer at # ASCO2014: We Are There http://wp.me/p23QgB-ln via @ MBCNbuzz,,@,#,4.72745E+17,https://twitter.com/ihatebreastcanc/status/472745186544480256,,,,
WilliamDale_MD,5/31/2014 10:23,1,2,"Love my colleagues!  @ drcbsteer: # ASCO14 # gerionc @ WilliamDale_MD Geriatric Oncology clinic timeline # gerionc pic.twitter.com/VGOTxFr8eQ""""",,@ @,# # #,4.72745E+17,https://twitter.com/WilliamDale_MD/status/472745146308501504,,,,
yannigunn,5/31/2014 10:23,0,0,@ yamaki120 Ｕeno DrのTwiです。 RT @ teamoncology: # ASCO14 本日より米国臨床腫瘍学会の年次総会開始。このハッシュタグをフォローすることにより、最新のがん情報が入可能。この学会はがんに関する世界最大の学会です。質問があれば、送って下さい。,,@ @,#,4.72745E+17,https://twitter.com/yannigunn/status/472745095398047744,,,,
bpowersphoto,5/31/2014 10:23,0,0,# networking at # asco14 @McCormick Place http://instagram.com/p/oqhb_XrH4C/,,@McCormick,# #,4.72745E+17,https://twitter.com/bpowersphoto/status/472745080907112448,,,,
hello_torch,5/31/2014 10:23,0,0,Top popular tags: 1 # BEA14 2 # IndyCar 3 # detroitgp 4 # ASCO14 5 # nerdland,,,# # # # #,4.72745E+17,https://twitter.com/hello_torch/status/472745069095976960,,,,
NickiDurlester,5/31/2014 10:22,1,3,MRT Many benefits to # acupuncture in treating side effects of # breastcancer treatment reported # ASCO14 @ drattai @ taoofwellness @ askdrmao,,@ @ @,# # #,4.72745E+17,https://twitter.com/NickiDurlester/status/472744987134656512,,,,
RarePOV,5/31/2014 10:22,7,2,MT @ pfizer: Infographic on Value of # Cancer Meds # asco14 pic.twitter.com/XCTLezGCN5,,@,# #,4.72745E+17,https://twitter.com/RarePOV/status/472744946047283202,,,,
OncologyRehab,5/31/2014 10:22,0,0,@ ASCO excited to be at # ASCO14 in Chicago! Visit our booth #17159 pic.twitter.com/os1KNOMvlw,,@,# #17159,4.72745E+17,https://twitter.com/OncologyRehab/status/472744920256880640,,,,
WilliamDale_MD,5/31/2014 10:22,7,4,"True dat! #@tehfem: # ASCO14 Holmes conclusion! pic.twitter.com/lAHNfU2eOd # ASCO14""",,@tehfem,# # #,4.72745E+17,https://twitter.com/WilliamDale_MD/status/472744889327685633,,,,
WHOPressUS,5/31/2014 10:22,0,0,Be the 1st to purchase the NEW WHO Classification title on the female repro organs. Visit booth 20119 at # ASCO14. http://ow.ly/i/5KAnT,,,#,4.72745E+17,https://twitter.com/WHOPressUS/status/472744882357145601,,,,
Cascadia,5/31/2014 10:22,0,0,RT @ ASCO: @ djsampson Thank you for letting us know. We are working to correct room temp . ^real time SM feed-back is powerful for health,,@ @,,4.72745E+17,https://twitter.com/Cascadia/status/472744865949052929,,,,
chemobrainfog,5/31/2014 10:21,2,1,"THIS  @ rsm2800: William: On vitamins/micronutrients to prevent cancer; most prospective trials were negative/showed HARM-Yes HARM # ASCO14 """"",,@,#,4.72745E+17,https://twitter.com/chemobrainfog/status/472744787356160000,,,,
AmbryGenetics,5/31/2014 10:21,1,2,Yes! Booth 8143! Stop by! RT @ OCNA Are you at ASCO this weekend? Drop by our booth to say hello! http://instagram.com/p/oqgrg1n01q/ # ASCO14,,@,#,4.72745E+17,https://twitter.com/AmbryGenetics/status/472744763930992641,,,,
genperisi,5/31/2014 10:21,1,2,"“ @ carisls: Impact of tumor profiling-directed treatment on survival in recurrent # ovarian cancer S Hall A2 http://goo.gl/UvuGDw # ASCO14"",,@,# #,472744726517780481""",https://twitter.com/genperisi/status/472744726517780481,,,,,,,,
dmooneymd,5/31/2014 10:21,0,0,"Increased gi tox with triple therapy"". Unclear how mek inhibition leads to this by interfering in immune celm function. Dr. Cabon # ASCO14""",,,#,4.72745E+17,https://twitter.com/dmooneymd/status/472744701351976960,,,,
Agendia,5/31/2014 10:21,0,0,# MammaPrint - 25 year impact on # breastcancer outcome. # asco14 # bcsm # hcsmpic.twitter.com/s9BVk4e1HS,,,# # # # #,4.72745E+17,https://twitter.com/Agendia/status/472744700265648128,,,,
WilliamDale_MD,5/31/2014 10:21,1,1,# ASCO14 : Bill Tew from Memorial on caring for older patients in NYC. Emphasis on adapting to your circumstances. # gerionc,,,# #,4.72745E+17,https://twitter.com/WilliamDale_MD/status/472744604026945536,,,,
CUCancerCenter,5/31/2014 10:20,1,1,"Dr. Nicole Kounalakis, surgical oncologist, # melanoma poster at # ASCO14 http://bit.ly/1wGqXsM pic.twitter.com/HrJ9KeWkVW",,,# #,4.72745E+17,https://twitter.com/CUCancerCenter/status/472744526843363328,,,,
teamoncology,5/31/2014 10:20,0,0,"@ JediPD @ MaverickNY Some studies, the combi preclinical reasonings R weak but the study is done b/c the 2 drugs are available. :( # ASCO14",,@ @,#,4.72745E+17,https://twitter.com/teamoncology/status/472744516663799809,,,,
YaleCancer,5/31/2014 10:20,7,5,YCC Director Dr. Tom Lynch discusses next gen therapy for EGFR mut. lung cancer. # asco14 @ysm @ YNHHpic.twitter.com/hWQP4DlGAf,,@ysm @,#,4.72745E+17,https://twitter.com/YaleCancer/status/472744504437383168,,,,
Cognicum,5/31/2014 10:20,0,1,“ @ ASCO: Key # ASCO14 research highlights what's new in targeted therapy # gynca # lcsm # lylsm use the app! https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@,# # # #,4.72744E+17,https://twitter.com/Cognicum/status/472744466680664064,,,,
Elekta,5/31/2014 10:20,0,0,Stop by booth 4019 # ASCO14 to discover how single-day treatment for # GammaKnife can work within your treatment protocol.,,,# #,4.72744E+17,https://twitter.com/Elekta/status/472744371519909888,,,,
DebiopharmNews,5/31/2014 10:20,0,0,# ASCO14 Debio1143 results in # HNCSM Find out more http://ow.ly/x91Dt,,,# #,4.72744E+17,https://twitter.com/DebiopharmNews/status/472744362154418176,,,,
jonathanagin,5/31/2014 10:19,4,6,So far following all the tweets from @ ASCO what I don't see is much enthusiasm for anything new in childhood cancer. We must change this,,@,,4.72744E+17,https://twitter.com/jonathanagin/status/472744259813003266,,,,
MartaMarteo,5/31/2014 10:19,1,1,Oncólogos del @ HGUVALENCIA participan en la cita de @ ASCO en Chicago para vencer al cáncer de pulmón http://ow.ly/3lcImW # hcsmeu,,@ @,#,4.72744E+17,https://twitter.com/MartaMarteo/status/472744247876386816,,,,
HGUVALENCIA,5/31/2014 10:19,0,0,Oncólogos del @ HGUVALENCIA participan en la cita de @ ASCO en Chicago para vencer al cáncer de pulmón http://ow.ly/3lcImW # hcsmeu,,@ @,#,4.72744E+17,https://twitter.com/HGUVALENCIA/status/472744246601347072,,,,
markaorourke,5/31/2014 10:19,0,0,# ASCO14 Breast LCIS annual risk of breast ca is 1.3%. We need to better communicate risk/benefit of chemo prevention. # swogonc # bcsm,,,# # #,4.72744E+17,https://twitter.com/markaorourke/status/472744217371234304,,,,
ByJonGardner,5/31/2014 10:19,0,0,". @ bradloncar anyway, I've got bigger plans for # sgenball. Just you wait. $ SGEN # asco14",,@,# #,4.72744E+17,https://twitter.com/ByJonGardner/status/472744137197109248,,,,
teamoncology,5/31/2014 10:19,0,0,True. RT @ JediPD: @ MaverickNY Combinatorials work better when mechanics worked out eg. PTEN and PI3K. # ASCO14,,@ @,#,4.72744E+17,https://twitter.com/teamoncology/status/472744087469060096,,,,
ByJonGardner,5/31/2014 10:18,0,0,. @ bradloncar What. The heck. Is that? $ SGEN # asco14,,@,#,4.72744E+17,https://twitter.com/ByJonGardner/status/472743880950300672,,,,
EquicareHealth,5/31/2014 10:18,0,0,"Booth is ready and we're off to a great start at # ASCO2014, say hi at booth 4026! pic.twitter.com/wTnUrSG9Iu",,,#,4.72744E+17,https://twitter.com/EquicareHealth/status/472743805842907137,,,,
CaraAnselmo,5/31/2014 10:17,2,1,"@ drattai Bingo. So ready to see the juicing trend die out. *Eat* vegetables, fruits, grains, nuts. *Drink* water. # ASCO14 # bcsm # diet",,@,# # #,4.72744E+17,https://twitter.com/CaraAnselmo/status/472743717691211776,,,,
dralvaropinto,5/31/2014 10:17,1,0,"Interesting symposium about immunotherapy in urological tumors, today at 3:00PM, sure I will be there! # ASCO14",,,#,4.72744E+17,https://twitter.com/dralvaropinto/status/472743670190723072,,,,
ByJonGardner,5/31/2014 10:17,0,0,"EGFR agents Q&A tidbit: $ CLVS presenter Sequist said some who haven't achieved PR yet will in future, so that endpoint will change. # ASCO14",,,#,4.72744E+17,https://twitter.com/ByJonGardner/status/472743606525382656,,,,
tehfem,5/31/2014 10:17,5,2,# ASCO14 Holmes conclusion! pic.twitter.com/3n9hqx3hKM,,,#,4.72744E+17,https://twitter.com/tehfem/status/472743596345417728,,,,
ALLIANCE_org,5/31/2014 10:17,1,0,"# ASCO14 Today | 1:15 CT | GI Poster Highlights | OS & outcomes by KRAS, BRAF, DNA mismatch repair in # NCCTG # N0147 http://bit.ly/1hJp6da",,,# # #,4.72744E+17,https://twitter.com/ALLIANCE_org/status/472743570840248321,,,,
WilliamDale_MD,5/31/2014 10:17,2,3,"Fun session!  @ drcbsteer: @ WilliamDale_MD presenting about SOCARE geriatric oncology clinic Chicago # ASCO14 # gerionc pic.twitter.com/E2mUxz44Mb""""",,@ @,# #,4.72744E+17,https://twitter.com/WilliamDale_MD/status/472743566389694464,,,,
drcbsteer,5/31/2014 10:17,1,1,# asco14 # gerionc @ DrHollyHolmes CGA useful pre stem cell transplant - not the place you would think initially. Adaptive model important.,,@,# #,4.72744E+17,https://twitter.com/drcbsteer/status/472743557187784705,,,,
dmooneymd,5/31/2014 10:16,0,0,"Braf inhibition leads to upregulated mhc expression, expansion cd4/8 cells. Combining with ipilumimab should blunt this. # ASCO14 # melsm",,,# #,4.72744E+17,https://twitter.com/dmooneymd/status/472743546630316032,,,,
nxtstop1,5/31/2014 10:16,1,0,@ drcbsteer @ DrHollyHolmes # ASCO14 Might supplement with group clinic visit ~ same stage of disease & decade !,,@ @,#,4.72743E+17,https://twitter.com/nxtstop1/status/472743493589164033,,,,
djsampson,5/31/2014 10:16,0,0,"It's hard to die of a disease you do not get"" Vogel on incidence as appropriate endpoint # asco14""",,,#,4.72743E+17,https://twitter.com/djsampson/status/472743470885396481,,,,
JediPD,5/31/2014 10:15,1,0,@ MaverickNY Combinatorials work better when mechanics worked out eg. PTEN and PI3K. # ASCO14,,@,#,4.72743E+17,https://twitter.com/JediPD/status/472743285967290368,,,,
NEJM,5/31/2014 10:15,2,7,# ASCO14 Copies of RESONATE study on ibrutinib at booth 20127.,,,#,4.72743E+17,https://twitter.com/NEJM/status/472743159127375872,,,,
Cascadia,5/31/2014 10:15,3,1,Thxs @ ASCO # ASCO14 breaking down walls - practicing physicians using # hcsm to share cutting edge cancer research with everyone,,@,# #,4.72743E+17,https://twitter.com/Cascadia/status/472743118077718528,,,,
SpryPub,5/31/2014 10:15,0,0,"Book signing happening now! (between 10-11) Get your copy of Survivorship"" signed by Dr. Cassileth! http://ow.ly/xrt99 # ASCO14""",,,#,4.72743E+17,https://twitter.com/SpryPub/status/472743102894342144,,,,
bmsnews,5/31/2014 10:15,5,1,"Curious about # immunotherapy? In simple terms, it helps the immune system to fight diseases. # ASCO14 Industry Expert Theater",,,# #,4.72743E+17,https://twitter.com/bmsnews/status/472743095415877632,,,,
mtmdphd,5/31/2014 10:15,0,0,"# ASCO14 NCTN - Q: Budget cuts, less n"" total. A: Research not going away. True not as many CT""",,,#,4.72743E+17,https://twitter.com/mtmdphd/status/472743074326519808,,,,
OncLive,5/31/2014 10:14,5,0,Reducing Pills From the Cup: Discontinuing Statins in Late-Stage Cancer Patients http://ow.ly/xtfLu # ASCO14,,,#,4.72743E+17,https://twitter.com/OncLive/status/472742930328092673,,,,
GlopesMd,5/31/2014 10:14,5,3,# ASCO14 new international innovation grant awards funding for projects in low and middle income countries,,,#,4.72743E+17,https://twitter.com/GlopesMd/status/472742928805552128,,,,
OphiraG,5/31/2014 10:14,1,1,Great 2b # ASCO14 intimate gathering of 32 000!? Hope 2 see +++ commitment 2 global cancer control @ uicc @ NCIGlobalHealth @ ncdalliance,,@ @ @,#,4.72743E+17,https://twitter.com/OphiraG/status/472742925378408448,,,,
preventcancer,5/31/2014 10:14,2,2,We are pleased to be a part of the # ASCO14 patient advocacy booth space again this year! # cancer # Preventionpic.twitter.com/WzWZ9tx8Ou,,,# # #,4.72743E+17,https://twitter.com/preventcancer/status/472742864611733504,,,,
WilliamDale_MD,5/31/2014 10:14,1,1,"# ASCO14 Holmes: Make it clear to oncologists what you can offer. We're good at finding problems, not so good at doing things. # gerionc",,,# #,4.72743E+17,https://twitter.com/WilliamDale_MD/status/472742852699496448,,,,
tehfem,5/31/2014 10:13,0,0,# ASCO14 Holmes: oncologists need to know who and when to refer patients for geriatric assessement,,,#,4.72743E+17,https://twitter.com/tehfem/status/472742778355449858,,,,
AnneBooms,5/31/2014 10:13,1,1,# ASCO14 average of 2 Geriatricians for 7000 new older cancer patients - communication and care coordination a vital role for geriatricians,,,#,4.72743E+17,https://twitter.com/AnneBooms/status/472742757325221890,,,,
tomleblancMD,5/31/2014 10:13,1,0,Video of Amy Abernethy discussing the exciting new @ PCRCgroup statin discontinuation study results! http://ow.ly/xtfIq # ASCO14 # hpm,,@,# #,4.72743E+17,https://twitter.com/tomleblancMD/status/472742666745425920,,,,
drcbsteer,5/31/2014 10:13,1,0,# ASCO14 # gerionc @ DrHollyHolmes oncologists need to know who to refer to geriatrician for assessment- unable to see all older adults.,,@,# #,4.72743E+17,https://twitter.com/drcbsteer/status/472742641323737089,,,,
nxtstop1,5/31/2014 10:13,0,0,"NEED PULP! (slows absorp) @ drattai: Cohen-blending better than juicing. Juicing results in higher glycemic index, less fiber # ASCO14 # bcsm”",,@,# #,4.72743E+17,https://twitter.com/nxtstop1/status/472742637099708418,,,,
suvikki12,5/31/2014 10:12,0,0,"Saturday's a GO at #@ASCO press conference,research showing promising results for difficult to treat cancers # ASCO14 pic.twitter.com/vT6tfyskHQ",,@ASCO,# #,4.72743E+17,https://twitter.com/suvikki12/status/472742528504971264,,,,
AlpineBV_Miller,5/31/2014 10:12,1,1,@ MaverickNY I think at least some melanoma docs have moved beyond ipi to PD-1s. That triplet will be interesting. # ASCO14,,@,#,4.72742E+17,https://twitter.com/AlpineBV_Miller/status/472742486717517824,,,,
CaraAnselmo,5/31/2014 10:12,2,0,"@ drcbsteer @ drattai @ rsm2800 When patients insist but it's all natural!"" I remind them hemlock and poison mushrooms are"," too. # ASCO14""",,@ @ @,#,4.72742E+17,https://twitter.com/CaraAnselmo/status/472742429477437440,,,
BurrisSkip,5/31/2014 10:12,4,2,Sarah Cannon featured prominently in ASCO Daily News today # ASCO2014 # SarahCannonDocspic.twitter.com/7lb9hrjyUm,,,# #,4.72742E+17,https://twitter.com/BurrisSkip/status/472742386502619136,,,,
rsm2800,5/31/2014 10:12,0,0,"William: Calling for precision medicine for chemoprevention (use molecular profiling, not just relying on epidemiologic data) # ASCO14",,,#,4.72742E+17,https://twitter.com/rsm2800/status/472742358484676608,,,,
PhRMA,5/31/2014 10:12,4,1,The oncology field is rapidly changing as is our understanding of the value of # cancer treatments http://onphr.ma/SbIUQd # ASCO14,,,# #,4.72742E+17,https://twitter.com/PhRMA/status/472742343011880960,,,,
WilliamDale_MD,5/31/2014 10:12,1,0,"# ASCO14 Holmes: In a cancer center, the oncologist is the PCP, & the geriatrician is the consultant. # gerionc",,,# #,4.72742E+17,https://twitter.com/WilliamDale_MD/status/472742316268998657,,,,
GustaveRoussy,5/31/2014 10:11,4,0,# ASCO2014 General posters hall. Gustave Roussy experts will present 37 posters this year ttp://bit.ly/1nKKbcC pic.twitter.com/qGUSj9GmJe,,,#,4.72742E+17,https://twitter.com/GustaveRoussy/status/472742282861371392,,,,
DoctorEdny,5/31/2014 10:11,2,1,Blumenthal metaanalysis shows strong correlation between ORR and PFS; no OS correlation in met NSCLC trials # ASCO14 pic.twitter.com/cKhyMFJbwA,,,#,4.72742E+17,https://twitter.com/DoctorEdny/status/472742255712034816,,,,
MaverickNY,5/31/2014 10:11,11,0,"Logical combinations have many challenges in research, not least of them is overlapping toxicities; underestimate at your peril! # asco14",,,#,4.72742E+17,https://twitter.com/MaverickNY/status/472742140871983104,,,,
drcbsteer,5/31/2014 10:11,3,0,# ASCO14 @ DrHollyHolmes Geriatricians in oncology - a scarce resource that needs to be used wisely. # gerionc.,,@,# #,4.72742E+17,https://twitter.com/drcbsteer/status/472742110538784769,,,,
MLIWI,5/31/2014 10:11,0,0,Let @ ASCO know medical innovation is the only way to beat # cancer. Sign the petition. # ASCO14 # MLIWI http://buff.ly/1ktOlVI,,@,# # #,4.72742E+17,https://twitter.com/MLIWI/status/472742092637487105,,,,
malsuhail,5/31/2014 10:10,1,0,لايوجد شيء يرفع الحماس للتعلم والاستفادة والتطوير مثل حضور المؤتمرات المتخصصة. تكتشف كيف يتحرك العالم بسرعة نحو حل مشاكله الصحية # ASCO2014,,,#,4.72742E+17,https://twitter.com/malsuhail/status/472741987821813760,,,,
DrAttai,5/31/2014 10:10,2,3,"Cohen - blending better than juicing. Juicing results in higher glycemic index, less fiber # ASCO14 # bcsm",,,# #,4.72742E+17,https://twitter.com/DrAttai/status/472741970574843904,,,,
scientre,5/31/2014 10:10,0,0,@ MaverickNY @ djsampson @ AlpineBV_Miller @ ASCO I'm just feeling lucky to jump online for a few brief moments in Arie!,,@ @ @ @,,4.72742E+17,https://twitter.com/scientre/status/472741953252368384,,,,
DebiopharmNews,5/31/2014 10:10,0,0,"# ASCO14 Phase I-II Debio0932, oral # HSP90 inhibitor, 1st & 2nd line # NSCLC (abstract/poster # TPS2632) Find out more http://ow.ly/x91yz",,,# # # #,4.72742E+17,https://twitter.com/DebiopharmNews/status/472741877578727424,,,,
genentech,5/31/2014 10:10,5,1,A # Genentech medicine received breakthrough designation this week. Why it’s important: http://ow.ly/xteOU # ASCO14,,,# #,4.72742E+17,https://twitter.com/genentech/status/472741868460310528,,,,
PinkSheetMaryJo,5/31/2014 10:10,2,0,FDA meta-analysis of lung cancer trials supports use of ORR as surrogate for PFS; patient-level analysis ongoing to corroborate # ASCO14,,,#,4.72742E+17,https://twitter.com/PinkSheetMaryJo/status/472741851246907392,,,,
JackWestMD,5/31/2014 10:10,2,4,"Dr. Blumenthal, FDA, on correl of resp rates w/PFS in # LungCancer trials submitted to FDA # ASCO14 # lcsmpic.twitter.com/UBq23BVpZD",,,# # #,4.72742E+17,https://twitter.com/JackWestMD/status/472741835581186048,,,,
aicrtweets,5/31/2014 10:10,1,0,RT @ drattai: Harvie - healthy diet reduces overall mortality but not cancer-specific mortality # ASCO14 # bcsm,,@,# #,4.72742E+17,https://twitter.com/aicrtweets/status/472741806657253376,,,,
DrMarkham,5/31/2014 10:09,3,1,Helpful site discussed in Integrative Oncology session - About Herbs from MSKCC: http://www.mskcc.org/cancer-care/integrative-medicine/about-herbs-botanicals-other-products … # ASCO14,,,#,4.72742E+17,https://twitter.com/DrMarkham/status/472741777426751488,,,,
tehfem,5/31/2014 10:09,0,0,# ASCO14 Very instructive the Geriatric Oncology session this morning,,,#,4.72742E+17,https://twitter.com/tehfem/status/472741768950075392,,,,
carisls,5/31/2014 10:09,1,0,"Molecular analysis of non-epithelial # ovarian cancer by histologic subtype S Hall, A2 http://goo.gl/UvuGDw # ASCO14 # gyncsm # MolecularIntel",,,# # # #,4.72742E+17,https://twitter.com/carisls/status/472741744673828864,,,,
WilliamDale_MD,5/31/2014 10:09,3,0,# ASCO14 Holmes: Crucial age-associated variables often absent from geriatric oncology studies. We provide them clinically. # gerionc,,,# #,4.72742E+17,https://twitter.com/WilliamDale_MD/status/472741724322680832,,,,
djsampson,5/31/2014 10:09,0,0,“ @ mcmrhona: @ MaverickNY Hall D2 equally arctic ! # ASCO14” cc @ ASCO,,@ @ @,#,4.72742E+17,https://twitter.com/djsampson/status/472741688943718400,,,,
QIAGENscience,5/31/2014 10:09,0,0,"At QIAGEN, we partner with your lab to give you accurate and precise biomarker detection results. Booth #5013, # ASCO14",,,#5013 #,4.72742E+17,https://twitter.com/QIAGENscience/status/472741685886476290,,,,
n8pennell,5/31/2014 10:09,0,0,Safe to conclude that molecular agents with high response rates will have large PFS benefits in lung cancer trials. # ASCO14,,,#,4.72742E+17,https://twitter.com/n8pennell/status/472741677862752256,,,,
JediPD,5/31/2014 10:09,0,3,The Best Tweetster by far from # ASCO14 @ mtmdphd,,@,#,4.72742E+17,https://twitter.com/JediPD/status/472741580957155328,,,,
kbnewport,5/31/2014 10:08,2,0,# gerionc Holmes: geriatric assessment should be repeated throughout cancer treatment # ASCO14,,,# #,4.72742E+17,https://twitter.com/kbnewport/status/472741535822258176,,,,
drcbsteer,5/31/2014 10:08,2,1,# ASCO14 @ DrHollyHolmes agrees # gerionc - each consult takes time. Needs are often complex.,,@,# #,4.72741E+17,https://twitter.com/drcbsteer/status/472741489106497536,,,,
ABenderRD,5/31/2014 10:08,1,0,"RT @ drattai: Harvie we need more data on intentional weight loss, benefits in terms of cancer recurrence, mortality # ASCO14 # bcsm",,@,# #,4.72741E+17,https://twitter.com/ABenderRD/status/472741466427891716,,,,
dmooneymd,5/31/2014 10:08,0,0,Pmel-1 act...impairs t cell function in vitro and in vivo. Adding dabrafenib or trametinib decreased t cell funct further. # melsm # ASCO14,,,# #,4.72741E+17,https://twitter.com/dmooneymd/status/472741453773668353,,,,
mtmdphd,5/31/2014 10:08,0,0,"Discussion about NCI consent forms and SAE coverage. Insurance, hospital, and network issues... # ASCO14",,,#,4.72741E+17,https://twitter.com/mtmdphd/status/472741443300110336,,,,
rsm2800,5/31/2014 10:08,0,0,William: How to identify best population for chemoprevention strategies; might consider the pts in NLST who got most from screening # asco14,,,#,4.72741E+17,https://twitter.com/rsm2800/status/472741407065509889,,,,
brianreid,5/31/2014 10:08,10,6,"What's hot at # ASCO14? The top 10 most RTed tweets from Friday, @ storify-ed: http://bit.ly/1hm9EJs",,@,#,4.72741E+17,https://twitter.com/brianreid/status/472741369166176256,,,,
mtmdphd,5/31/2014 10:07,5,3,. @ ASCO Perspective Raising the Bar # ClinicalTrials by Deﬁning Clinically Meaningful Outcomes @ recnac1 et al http://ow.ly/uKgxX # ASCO14,,@ @,# #,4.72741E+17,https://twitter.com/mtmdphd/status/472741265583255552,,,,
djsampson,5/31/2014 10:07,0,1,@ MaverickNY @ AlpineBV_Miller @ ASCO maybe he's responding to that data.,,@ @ @,,4.72741E+17,https://twitter.com/djsampson/status/472741219651436544,,,,
LinicalAmericas,5/31/2014 10:07,2,1,Looking forward to a great # ASCO14! pic.twitter.com/5mcgqWua6I,,,#,4.72741E+17,https://twitter.com/LinicalAmericas/status/472741123421515776,,,,
RielyMD,5/31/2014 10:07,2,0,Blumenthal FDA no correlation between pfs and os # ASCO14,,,#,4.72741E+17,https://twitter.com/RielyMD/status/472741068103229440,,,,
MaverickNY,5/31/2014 10:06,0,0,@ AlpineBV_Miller @ djsampson @ ASCO the guy need to me has chattering teeth - I kid you not!,,@ @ @,,4.72741E+17,https://twitter.com/MaverickNY/status/472741007797522432,,,,
drcbsteer,5/31/2014 10:06,2,0,# ASCO14 @ DrHollyHolmes presenting on # gerionc before distinguished panel. Note @ WilliamDale_MD tweeting.pic.twitter.com/xFJKbPqWsI,,@ @,# #,4.72741E+17,https://twitter.com/drcbsteer/status/472740883893587968,,,,
carisls,5/31/2014 10:06,2,1,Impact of tumor profiling-directed treatment on survival in recurrent # ovarian cancer S Hall A2 http://goo.gl/UvuGDw # ASCO14 # gyncsm,,,# # #,4.72741E+17,https://twitter.com/carisls/status/472740853870768128,,,,
WilliamDale_MD,5/31/2014 10:06,1,2,# ASCO14 Holly Holmes from MD Anderson presenting on being 1 of 2 geriatricians in a massive Cancer Center. # gerionc,,,# #,4.72741E+17,https://twitter.com/WilliamDale_MD/status/472740790054055936,,,,
RielyMD,5/31/2014 10:05,1,0,"blumenthal FDA: 12567 pts data at fda, mage <60, 2/3 male, 80% outside us, near perfect correlation between response and pfs r2 0.89 # ASCO14",,,#,4.72741E+17,https://twitter.com/RielyMD/status/472740768499908608,,,,
MaverickNY,5/31/2014 10:05,0,0,"@ djsampson @ AlpineBV_Miller @ ASCO jumper, in Brit speak :)",,@ @ @,,4.72741E+17,https://twitter.com/MaverickNY/status/472740643954249728,,,,
mtmdphd,5/31/2014 10:05,0,0,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnZ7s # ASCO14,,@,# #,4.72741E+17,https://twitter.com/mtmdphd/status/472740628543975425,,,,
UNCurology,5/31/2014 10:05,1,0,Chemoradiation for locally adv penile SCC: multi-inst'n retrospective study M.Milowsky @ UNC_Lineberger et al # asco14 http://ow.ly/xqEW2,,@,#,4.72741E+17,https://twitter.com/UNCurology/status/472740622714290177,,,,
ABenderRD,5/31/2014 10:05,0,0,Will b helpful data. RM @ drattai: Harvie intermittent fastng- ongoing randomized contr trials 2 determine benefit # ASCO14 # bcsm Interesting,,@,# #,4.72741E+17,https://twitter.com/ABenderRD/status/472740620814278656,,,,
genentech,5/31/2014 10:05,2,1,Only 3% of potential clin trial participants volunteer. Find out why & how we’re working to improve access. # ASCO14 http://ow.ly/xmUC8,,,#,4.72741E+17,https://twitter.com/genentech/status/472740597292597248,,,,
AlpineBV_Miller,5/31/2014 10:05,0,0,"@ djsampson @ ASCO @ MaverickNY And me a cap with fluffy ear flaps (Row D, Seat 502)",,@ @ @,,4.72741E+17,https://twitter.com/AlpineBV_Miller/status/472740573473177601,,,,
VOInnovation,5/31/2014 10:05,0,0,Sign the petition to support # cancer # innovation at http://bit.ly/1gJDGGn via @ MLIWI. @ ASCO # ASCO14 # MLIWI,,@ @,# # # #,4.72741E+17,https://twitter.com/VOInnovation/status/472740532842553345,,,,
adamfeuerstein,5/31/2014 10:04,5,4,$ AZN $ CLVS toxicity comparisons from Discussant Tom Lynch # ASCO14 pic.twitter.com/PnE4FrZGI7,,,#,4.7274E+17,https://twitter.com/adamfeuerstein/status/472740472939900929,,,,
n8pennell,5/31/2014 10:04,1,0,Blumenthal: meta analysis of ORR correlation with PFS in phase 3 lung ca trials. Strong corr of ORR and PFS odds ratio. # ASCO14,,,#,4.7274E+17,https://twitter.com/n8pennell/status/472740472604360704,,,,
JenPageWall,5/31/2014 10:04,0,0,50 yrs of cancer research in one infographic # ASCO14 http://www.fromhopetocures.com,,,#,4.7274E+17,https://twitter.com/JenPageWall/status/472740435824500736,,,,
markaorourke,5/31/2014 10:04,0,0,# ASCO14 Great session of diet and hormone therapy for cancer px. We need to learn to better discuss cancer risk reduction. # swogonc,,,# #,4.7274E+17,https://twitter.com/markaorourke/status/472740356283314176,,,,
mcmrhona,5/31/2014 10:04,0,0,@ MaverickNY Hall D2 equally arctic ! # ASCO14,,@,#,4.7274E+17,https://twitter.com/mcmrhona/status/472740334553014272,,,,
mtmdphd,5/31/2014 10:04,3,0,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.7274E+17,https://twitter.com/mtmdphd/status/472740293670748160,,,,
carisls,5/31/2014 10:04,1,1,"Molecular profiling of small bowel adenocarcinomas, S Hall A2 http://goo.gl/UvuGDw # ASCO14 # gastrointestinal // HT @ FoxChaseCancer",,@,# #,4.7274E+17,https://twitter.com/carisls/status/472740284053594112,,,,
adamfeuerstein,5/31/2014 10:03,1,2,Discussant Tom Lynch delivers the 2nd gen TKI comparator slides efficacy $ AZN $ CLVS # ASCO14 pic.twitter.com/FTsU8Tik6L,,,#,4.7274E+17,https://twitter.com/adamfeuerstein/status/472740174133092353,,,,
docpook,5/31/2014 10:03,0,1,Platinum detected in patient blood 20y post cisplatin + correlates with long term toxicity - I used to tell pts chemo gone # ASCO14,,,#,4.7274E+17,https://twitter.com/docpook/status/472740147008913408,,,,
djsampson,5/31/2014 10:03,0,0,@ AlpineBV_Miller maybe @ ASCO can bring @ MaverickNY a sweater.,,@ @ @,,4.7274E+17,https://twitter.com/djsampson/status/472740145079123971,,,,
WilliamDale_MD,5/31/2014 10:03,2,2,# ASCO14 Chapman: Taking care of these older patients is the highlight of our week. # gerionc,,,# #,4.7274E+17,https://twitter.com/WilliamDale_MD/status/472740115907747840,,,,
drmikesevilla,5/31/2014 10:03,0,0,"RT @ Doctor_V: I'm not an oncologist, but I play one on Twitter during # asco14",,@,#,4.7274E+17,https://twitter.com/drmikesevilla/status/472740108232589312,,,,
ABenderRD,5/31/2014 10:03,0,0,MT @ rsm2800: William: Talking on vitamins & micronutrients to prev cancer; most prospective trials negative or showed HARM.Yes harm. # ASCO14,,@,#,4.7274E+17,https://twitter.com/ABenderRD/status/472740087571419136,,,,
ALLIANCE_org,5/31/2014 10:03,2,0,# ASCO14 Today: Assoc of genomic analysis of immune fcn genes & clinical outcome in adj H trial. http://bit.ly/1rtwSS5 # N9831 @ EdithPerezMD,,@,# #,4.7274E+17,https://twitter.com/ALLIANCE_org/status/472740032592093185,,,,
KellyColligan,5/31/2014 10:03,1,0,# ASCO14 Today: Assoc of genomic analysis of immune fcn genes & clinical outcome in adj H trial. http://bit.ly/1rtwSS5 # N9831 @ EdithPerezMD,,@,# #,4.7274E+17,https://twitter.com/KellyColligan/status/472740031325429762,,,,
ChestConsultant,5/31/2014 10:02,0,0,"P4 # cancer medicine—predictive, personalized, preventive, and participatory via @ ASCO http://am.asco.org/daily-news",,@,#,4.7274E+17,https://twitter.com/ChestConsultant/status/472739954247086080,,,,
Melanoma_doctor,5/31/2014 10:02,1,0,# dabrafenib + Ipi + MEK inhib triplet not possible ? sequential addition # trametinib after # ipilimumab complete # asco14,,,# # # #,4.7274E+17,https://twitter.com/Melanoma_doctor/status/472739848114028544,,,,
SanofiCanada,5/31/2014 10:02,0,0,More than 25 000 oncology professionals are attending # ASCO2014 Chicago conference including @ SanofiCanada # SanofiCA,,@,# #,4.7274E+17,https://twitter.com/SanofiCanada/status/472739824106233857,,,,
ProjectInno,5/31/2014 10:02,0,1,"At its heart, Project Innovation is about collaboration to accelerate medical discovery: http://ow.ly/xt9QZ # ASCO14",,,#,4.7274E+17,https://twitter.com/ProjectInno/status/472739803927429120,,,,
rsm2800,5/31/2014 10:02,0,0,"William: Meyskens et al DFMO+Sulindac for polyp prevention NNT=3 (wow, that’s low) # asco14",,,#,4.7274E+17,https://twitter.com/rsm2800/status/472739791709020160,,,,
lizzietoy,5/31/2014 10:02,0,0,"# ASCO14 fabulous data for tki resistant disease with 3 new agents RR >79%,encouraging that we may be treating chronic disease after all",,,#,4.7274E+17,https://twitter.com/lizzietoy/status/472739784851734528,,,,
LoMasTrendyEs,5/31/2014 10:02,0,0,HOT HT a esta hora # nt2t # ASCO14 # MicrosoftGA # HappySaturday # lookingforyou # WatchProblemOnVEVO # LETSGOHEAT pwrd by http://bit.ly/15Y1m4u,,,# # # # # # #,4.7274E+17,https://twitter.com/LoMasTrendyEs/status/472739780330278912,,,,
HHT_US,5/31/2014 10:02,0,0,Twitter says these HT are HOT # ASCO14 # HappySaturday # nt2t # MicrosoftGA # MhoniEnSabadazo pwrd by http://bit.ly/15Y1m4u,,,# # # # #,4.7274E+17,https://twitter.com/HHT_US/status/472739778388299776,,,,
ASCO,5/31/2014 10:01,0,0,ASCO Members: Refer a new member at # ASCO14 Member Services Desk & be entered for an educational credit to ASCO U,,,#,4.7274E+17,https://twitter.com/ASCO/status/472739770951823360,,,,
munevarjuan,5/31/2014 10:01,1,3,Via @ Roche: What goes into the design of a clinical study? http://ow.ly/xkOgi # ASCO14 # ClinicalTrialpic.twitter.com/y3iyhRFJQJ,,@,# #,4.7274E+17,https://twitter.com/munevarjuan/status/472739759908212736,,,,
cancereu,5/31/2014 10:01,0,0,"@ drattai to what does the dark side"" refer to? wonder if @ AnnFonfa is at # ASCO14 - what would she comment...""",,@ @,#,4.7274E+17,https://twitter.com/cancereu/status/472739755307048961,,,,
ASCO,5/31/2014 10:01,0,0,@ CliffordHudis Presidential Address “Science & Society: Fifty Years Later” in N Hall B1 in 30 mins (9:30 am CST) # ASCO14,,@,#,4.7274E+17,https://twitter.com/ASCO/status/472739684029063168,,,,
DebiopharmNews,5/31/2014 10:01,0,0,"# ASCO14 Final Phase I Debio 0932, oral # HSP90 inhibitor, # oncology (abstract/poster #2550) Find out more http://ow.ly/x91nw",,,# # # #2550,4.7274E+17,https://twitter.com/DebiopharmNews/status/472739677171367937,,,,
ASCO,5/31/2014 10:01,3,0,"In today's 'The BRAF Pathway' session, experts highlight this emerging target in pediatric cancers http://bit.ly/SROAzf # ASCO14",,,#,4.7274E+17,https://twitter.com/ASCO/status/472739667583201280,,,,
AlpineBV_Miller,5/31/2014 10:01,0,0,@ ASCO help?!? RT @ MaverickNY: Going to rename Arie Crown 'Chiberia' as is darn cold in here! # asco14,,@ @,#,4.7274E+17,https://twitter.com/AlpineBV_Miller/status/472739646884315136,,,,
MaverickNY,5/31/2014 10:01,4,2,Yikes gr 3 colitis w/ perforations in triplet of dabrafenib + trametinib + ipi. That's 3rd disappointing study in this session # asco14,,,#,4.7274E+17,https://twitter.com/MaverickNY/status/472739613581508608,,,,
appistry,5/31/2014 10:01,0,0,"We’re here on day 2 of # ASCO2014. Learn more about our recent # CloudDx announcement, a cloud-based service that helps hospitals order # LDTs.",,,# # #,4.7274E+17,https://twitter.com/appistry/status/472739611920572416,,,,
Roche,5/31/2014 10:01,8,6,There has never been a time of more opportunity to bring better treatments to patients. http://ow.ly/xkO09 # ASCO14 # healthcare,,,# #,4.7274E+17,https://twitter.com/Roche/status/472739597244719105,,,,
bmsnews,5/31/2014 10:01,0,2,Check out our # ImmunoOncology booth 7081 at # ASCO14 to learn about this evolving approach to cancer research,,,# #,4.7274E+17,https://twitter.com/bmsnews/status/472739571231625216,,,,
rsm2800,5/31/2014 10:00,1,0,William: High throughput molecular targeting eg PI3K mutations in HPV+ head & neck ca may help identify candidate drug # asco14,,,#,4.7274E+17,https://twitter.com/rsm2800/status/472739522417930240,,,,
NCIMedia,5/31/2014 10:00,17,4,From # ASCO14: Clinical trial analysis suggests drug combination may be highly effective in recurrent ovarian cancer: http://1.usa.gov/1kWGQ9l,,,#,4.72739E+17,https://twitter.com/NCIMedia/status/472739473449811969,,,,
BayerPharma,5/31/2014 10:00,1,2,Visit # ASCO14 General Poster Session on Colorectal Cancer to learn more about # colorectalcancer. # crcsm http://bit.ly/1ijkg4X,,,# # #,4.72739E+17,https://twitter.com/BayerPharma/status/472739442881757184,,,,
carisls,5/31/2014 10:00,2,1,"Multiplatform molecular profiling of 2400 # pancreatic adenocarcinomas to identify treatment targets, S Hall A2// HT @ sloan_kettering # ASCO14",,@,# #,4.72739E+17,https://twitter.com/carisls/status/472739426180026368,,,,
subatomicdoc,5/31/2014 10:00,0,1,"Happy Caturday, # ASCO14! http://tmblr.co/ZzLuQy1HO-kOX cc @ mtmdphd",,@,#,4.72739E+17,https://twitter.com/subatomicdoc/status/472739396383674368,,,,
Pharmacyclics,5/31/2014 10:00,1,1,Stop by booth 18097 to walk on the moon at # ASCO14,,,#,4.72739E+17,https://twitter.com/Pharmacyclics/status/472739345728667649,,,,
cardinalhealth,5/31/2014 10:00,1,2,# ASCO14 attendees: visit us at booth 5027 to see how Cardinal Health Specialty Solutions can help you.,,,#,4.72739E+17,https://twitter.com/cardinalhealth/status/472739320126644224,,,,
FoundationATCG,5/31/2014 10:00,5,2,Understand the difference between comprehensive and hot-spot # Nextgensequencing Video: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# # #,4.72739E+17,https://twitter.com/FoundationATCG/status/472739315957501952,,,,
save_fertility,5/31/2014 10:00,0,0,"If you're attending # ASCO14, please stop by Booth 2021 and say hello! We're happy to answer your questions about fertility preservation.",,,#,4.72739E+17,https://twitter.com/save_fertility/status/472739311654154240,,,,
SanofiUS,5/31/2014 10:00,1,0,Are you at # ASCO14? Come visit us at booth 7047.,,,#,4.72739E+17,https://twitter.com/SanofiUS/status/472739293740670976,,,,
HallandPartners,5/31/2014 10:00,0,0,Getting excited for the @ ASCO conference. Get in touch if you're there - we’d love to have a chat! n.harte@hallandpartners.com # ASCO14,,@ @hallandpartners,#,4.72739E+17,https://twitter.com/HallandPartners/status/472739289281732609,,,,
DanaFarber,5/31/2014 10:00,2,2,Dana-Farber research highlighted in ASCO 2014 annual meeting plenary session: http://bit.ly/1k7SE9Q # ASCO14,,,#,4.72739E+17,https://twitter.com/DanaFarber/status/472739280310501376,,,,
Doctor_V,5/31/2014 10:00,7,14,"I'm not an oncologist, but I play one on Twitter during # asco14",,,#,4.72739E+17,https://twitter.com/Doctor_V/status/472739274241376256,,,,
AlpineBV_Miller,5/31/2014 9:59,0,0,"Ipi+dabra+trame triplet in melanoma? Yeah, that's not gonna work (toxic) # ASCO14",,,#,4.72739E+17,https://twitter.com/AlpineBV_Miller/status/472739204322324482,,,,
cancereu,5/31/2014 9:59,0,0,@ matthewherper why not make the cryptic # ASCO14 jargon understandable by all readers?,,@,#,4.72739E+17,https://twitter.com/cancereu/status/472739190162325504,,,,
dmooneymd,5/31/2014 9:59,0,0,"Triple therapy (low dose braf, mek with standard ipi) closed due to toxicity. doublet arm (no mek) less toxicity and active. # melsm # ASCO14",,,# #,4.72739E+17,https://twitter.com/dmooneymd/status/472739158876622848,,,,
DrMarkham,5/31/2014 9:59,1,0,Harvie's summary on diet/nutritional supplements in cancer outcomes: need more data! # ASCO14,,,#,4.72739E+17,https://twitter.com/DrMarkham/status/472739144662134784,,,,
cancerassassin1,5/31/2014 9:59,0,2,Interesting question raised by speaker from UK: would intermittent fasting 2 days prior to treatments sensitize tumors to chemo?? # ASCO14,,,#,4.72739E+17,https://twitter.com/cancerassassin1/status/472739135417892864,,,,
JacobPlieth,5/31/2014 9:59,2,2,Dr Masters (expert chair) would not comment on whether ramu benefit shown in Revel would be practice-changing $ LLY # ASCO14,,,#,4.72739E+17,https://twitter.com/JacobPlieth/status/472739074977980416,,,,
Melanoma_doctor,5/31/2014 9:59,3,0,"# dabrafenib # ipilimumab # trametinib triplet combo Ph1, 1st cohort closed due to life threatening GI toxicity # ASCO14 # melanoma",,,# # # # #,4.72739E+17,https://twitter.com/Melanoma_doctor/status/472739055386755072,,,,
DrAttai,5/31/2014 9:58,0,1,Great integrative oncology session # ASCO14,,,#,4.72739E+17,https://twitter.com/DrAttai/status/472738940303466496,,,,
mtmdphd,5/31/2014 9:58,4,0,Zon - # ASCO14 - Community Cancer Research - Conclusions - future depends on adequate support and funding pic.twitter.com/mCs4FYcmoH,,,#,4.72739E+17,https://twitter.com/mtmdphd/status/472738866894360577,,,,
rsm2800,5/31/2014 9:58,1,0,William: Reverse migration concept: Employ drugs used for advanced disease (eg erlotinib) in the premalignancy stage # asco14,,,#,4.72739E+17,https://twitter.com/rsm2800/status/472738859407507457,,,,
OncoGenexPharma,5/31/2014 9:58,0,0,$ OGXI is at # ASCO14 come visit us at Booth 23085 pic.twitter.com/nJmviBKugC,,,#,4.72739E+17,https://twitter.com/OncoGenexPharma/status/472738818894725120,,,,
Clinitude,5/31/2014 9:58,0,0,Heading to the ASCO meeting # ASCO14 Looking forward to meet some interesting people.,,,#,4.72739E+17,https://twitter.com/Clinitude/status/472738810145427456,,,,
cancerassassin1,5/31/2014 9:58,0,1,Big question of ketogenic diets: energy/calorie restriction may be more important.Randomized controlled trials underway. # ASCO14 # nutrition,,,# #,4.72739E+17,https://twitter.com/cancerassassin1/status/472738809436577792,,,,
GenomeGrl,5/31/2014 9:58,0,0,Exciting next generation TKI's that show promising response rates in T790M resistant patients. # ASCO14 # lungcancer,,,# #,4.72739E+17,https://twitter.com/GenomeGrl/status/472738804000780288,,,,
DrAttai,5/31/2014 9:58,0,2,Harvie intermittent fasting - ongoing randomized controlled trials to determine benefit # ASCO14 # bcsm Interesting.,,,# #,4.72739E+17,https://twitter.com/DrAttai/status/472738789866348544,,,,
weldeiry,5/31/2014 9:58,5,5,Presenting our findings on molecular profiling of 6892 colorectal cancers @ ASCO # ASCO14 pic.twitter.com/thzQBlFl8l,,@,#,4.72739E+17,https://twitter.com/weldeiry/status/472738784585342976,,,,
teamoncology,5/31/2014 9:57,4,1,【 # ASCO14 Update】 There has many vitamin randomized studies presented at ASCO. But they have been all negative.,,,#,4.72739E+17,https://twitter.com/teamoncology/status/472738740180246528,,,,
OmidHamidMD,5/31/2014 9:57,1,0,@ ASCO with Dr. Richard Carvajal leader in # melanoma # therapy # immunotherapy @ MSKHemOncTrials in # NewYorkCitypic.twitter.com/BwGl2YhF6C,,@ @,# # # #,4.72739E+17,https://twitter.com/OmidHamidMD/status/472738734891614208,,,,
JacobPlieth,5/31/2014 9:57,0,1,Dr Masters (re ramu in Revel): steps are small," but cumulative"". $ LLY # ASCO14""",,,#,4.72739E+17,https://twitter.com/JacobPlieth/status/472738725177221121,,,
mtmdphd,5/31/2014 9:57,0,0,Zon - # ASCO14 - Community Cancer Research - CCDR via CancerLinQ?,,,#,4.72739E+17,https://twitter.com/mtmdphd/status/472738714964094976,,,,
CancerTherAdvsr,5/31/2014 9:57,0,0,Press conference at # ASCO14 has concluded! Check in soon for our coverage! Follow us by using the hashtag # CTAatASCO,,,# #,4.72739E+17,https://twitter.com/CancerTherAdvsr/status/472738699764314112,,,,
drcbsteer,5/31/2014 9:57,1,0,# ASCO14 # gerionc @ WilliamDale_MD Geriatric Oncology clinic timeline # gerioncpic.twitter.com/5wRy2a1s6a,,@,# # #,4.72739E+17,https://twitter.com/drcbsteer/status/472738689064640512,,,,
DrMarkham,5/31/2014 9:57,0,1,Agreed! Wish she had more time. RT @ drattai: Dr Harvie is whipping thru the nutritional talk Will need to review this one later! # ASCO14,,@,#,4.72739E+17,https://twitter.com/DrMarkham/status/472738676955283457,,,,
mtmdphd,5/31/2014 9:57,0,0,Zon - # ASCO14 - Community Cancer Research - # CancerLinQ - rapid learning system a game changer? CT matching?pic.twitter.com/N4zaNlXIQP,,,# #,4.72739E+17,https://twitter.com/mtmdphd/status/472738667195138048,,,,
rsm2800,5/31/2014 9:57,1,0,William: Key challenge is identifying which drivers are the most important and should be targeted (using lung ca as model) # asco14,,,#,4.72739E+17,https://twitter.com/rsm2800/status/472738565613309952,,,,
Melanoma_doctor,5/31/2014 9:57,3,0,# dabrafenib + # ipilimumab combo at std doses--no DLT now in expansion phase # melanoma # ASCO14,,,# # # #,4.72739E+17,https://twitter.com/Melanoma_doctor/status/472738550526771201,,,,
JackWestMD,5/31/2014 9:57,1,3,"Lynch: Both AZD9291 & CO1686 offer great promise for EGFR mutn-pos T790M+ acquired resistance, value for T790M- less clear. # ASCO14 # lcsm",,,# #,4.72739E+17,https://twitter.com/JackWestMD/status/472738539327991808,,,,
mtmdphd,5/31/2014 9:56,0,0,"Zon - # ASCO14 - Community Cancer Research - $ - operational efficiency (red reg burden), analytic (new stats), pragmatic (who cares)",,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472738484650647552,,,,
JacobPlieth,5/31/2014 9:56,2,3,Major discussion in # ASCO14 morning briefing about ramu's puny 1.4mth mOS benefit in Revel $ LLY,,,#,4.72738E+17,https://twitter.com/JacobPlieth/status/472738390241079297,,,,
DrAttai,5/31/2014 9:56,0,0,Dr Harvie is whipping thru the nutritional talk Will need to review this one later! # ASCO14,,,#,4.72738E+17,https://twitter.com/DrAttai/status/472738367848067072,,,,
mtmdphd,5/31/2014 9:56,0,0,Zon - # ASCO14 - Community Cancer Research - Cost of conducting research / Cost-effectiveness challenges pic.twitter.com/JgngDSZWru,,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472738356577566720,,,,
rsm2800,5/31/2014 9:56,3,1,"William: Cancer interception concept=halting molecular progression early in the cascade, likely to me more effective # asco14",,,#,4.72738E+17,https://twitter.com/rsm2800/status/472738351255015424,,,,
n8pennell,5/31/2014 9:56,0,0,Gideon Blumenthal from NCI presenting on surrogate outcomes in lung cancer trials. # ASCO14,,,#,4.72738E+17,https://twitter.com/n8pennell/status/472738337250635776,,,,
MarkSchoenebaum,5/31/2014 9:56,32,2,$ LLY's ram in lung: HR of 0.86. Higher than many expected. But may have role in squames as bleeding similar. Need more data on mond. # ASCO14,,,#,4.72738E+17,https://twitter.com/MarkSchoenebaum/status/472738317549596672,,,,
scientre,5/31/2014 9:56,3,0,"Yap on no response for MK8669+MK2206 in PTEN loss prostate cancer, relationship between PI3K & AR pathways may explain # asco14",,,#,4.72738E+17,https://twitter.com/scientre/status/472738302597287936,,,,
bio_clouseau,5/31/2014 9:56,1,3,$ CLVS Licitanib # ASCO14 Solid Tumor study slides. MTD 30mg QD http://www.clovisoncology.com/files/Lucitanib_Oral_Presentation_FINAL_ASCO2014.pdf …,,,#,4.72738E+17,https://twitter.com/bio_clouseau/status/472738300319375360,,,,
cancerassassin1,5/31/2014 9:56,0,0,In head and neck # cancer: Vitamin E during radiation decreased effects of radiation but smokers had worse mortality # ASCO14,,,# #,4.72738E+17,https://twitter.com/cancerassassin1/status/472738292593475584,,,,
carisls,5/31/2014 9:56,4,1,"Potential actionable targets in appendiceal cancer detected by IHC, FISH, and mutational analysis S Hall A2 http://goo.gl/UvuGDw # ASCO14",,,#,4.72738E+17,https://twitter.com/carisls/status/472738267042172929,,,,
drcbsteer,5/31/2014 9:56,0,0,@ WilliamDale_MD presenting about SOCARE geriatric oncology clinic Chicago # ASCO14 # gerioncpic.twitter.com/AujPQALzrq,,@,# #,4.72738E+17,https://twitter.com/drcbsteer/status/472738266689839104,,,,
DoctorEdny,5/31/2014 9:55,5,0,"$ AZN $ CLVS no clear winner"" but very promising data in NSCLC # ASCO14 pic.twitter.com/32Ugq84Cjx""",,,#,4.72738E+17,https://twitter.com/DoctorEdny/status/472738243839279104,,,,
AndyBiotech,5/31/2014 9:55,3,1,Another player in soon-to-be-crowded T790M space: HM61713 from Hanmi http://abstracts.asco.org/144/AbstView_144_129230.html … # ASCO14 pic.twitter.com/7FCt4GcVzn via @ JonEPVantage,,@,#,4.72738E+17,https://twitter.com/AndyBiotech/status/472738189900533761,,,,
DrBobGoldberg,5/31/2014 9:55,1,0,"Personalized medicine, use of new therapies help target treatment &reduce side effects http://reut.rs/1jBn1zG via @ reuters # asco14 # mliwi",,@,# #,4.72738E+17,https://twitter.com/DrBobGoldberg/status/472738160284139521,,,,
ByJonGardner,5/31/2014 9:55,3,2,What do we know about next gen EGFR agents? Also this: $ CLVS $ AZN # ASCO14 pic.twitter.com/4SMUinBnEj,,,#,4.72738E+17,https://twitter.com/ByJonGardner/status/472738153112281088,,,,
tomleblancMD,5/31/2014 9:55,7,1,Defining # value in # cancer care: discussion about # costofcare must continue; current costs unsustainable http://ow.ly/xteuV # ASCO14,,,# # # #,4.72738E+17,https://twitter.com/tomleblancMD/status/472738141460496384,,,,
mtmdphd,5/31/2014 9:55,0,0,Zon - # ASCO14 - Community Cancer Research - More Challenges and Opportunities with Practice Environment Changes pic.twitter.com/DgLQCbxdKs,,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472738085730414592,,,,
DrAttai,5/31/2014 9:55,2,2,"Harvie high doses antioxidants during XRT for head/neck cancer - less toxicity, but mortality was higher, mostly in smokers # ASCO14 # bcsm",,,# #,4.72738E+17,https://twitter.com/DrAttai/status/472738052520280064,,,,
rsm2800,5/31/2014 9:55,1,0,William: Most impt challenge of ca prevention-Rational selection of the most effective agents directed against molecular targets # ASCO14,,,#,4.72738E+17,https://twitter.com/rsm2800/status/472738050275946496,,,,
RamalingamMD,5/31/2014 9:55,0,1,Thus changes the landscape of EGFR inhibition in #lungcancer#lcsm # ASCO14 !,,,#lungcancer #lcsm #,4.72738E+17,https://twitter.com/RamalingamMD/status/472738038410670080,,,,
Lymphoma_Doc,5/31/2014 9:54,1,1,Beautiful start for day 2 of # ASCO14 looking forward to Lymphoma session at 115 in Arie Crown pic.twitter.com/TylEmNBPVx,,,#,4.72738E+17,https://twitter.com/Lymphoma_Doc/status/472737992491401217,,,,
keensmike,5/31/2014 9:54,0,1,Good morning # ASCO14! pic.twitter.com/fl81VieQJ9,,,#,4.72738E+17,https://twitter.com/keensmike/status/472737960551411713,,,,
mtmdphd,5/31/2014 9:54,0,0,Zon - # ASCO14 - Community Cancer Research - smaller trials with more molecularly driven trials,,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472737897565544449,,,,
n8pennell,5/31/2014 9:54,0,0,"Lynch: All 3 drugs active in T790M pts, no clear winner but CO1686 and AZD9291 will likely emerge as winners. # ASCO14",,,#,4.72738E+17,https://twitter.com/n8pennell/status/472737866075086848,,,,
mtmdphd,5/31/2014 9:54,0,0,Zon - # ASCO14 - Community Cancer Research - As the landscape changes current and future challenges exist pic.twitter.com/Ge7m2okqeD,,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472737842745982976,,,,
MaverickNY,5/31/2014 9:54,3,4,Not sure why these investigators thought dabrafenib + trametinib + ipilimumab given the toxicities seen with vemurafenib + ipi!! smh # asco14,,,#,4.72738E+17,https://twitter.com/MaverickNY/status/472737837935513600,,,,
carisls,5/31/2014 9:54,1,0,"Profiling of 1,350 neuroendocrine tumors to identify potential drug targets S Hall A2 http://goo.gl/UvuGDw # ASCO14 HT @ FoxChaseCancer",,@,#,4.72738E+17,https://twitter.com/carisls/status/472737837088264192,,,,
JackWestMD,5/31/2014 9:54,1,2,Lynch: AZD9291 also profoundly active in acq resistance for EGFR mutn-pos. Risk of interstitial lung dzs (ILD) of concern. # ASCO14 # lcsm,,,# #,4.72738E+17,https://twitter.com/JackWestMD/status/472737798228033536,,,,
rsm2800,5/31/2014 9:54,20,5,William: Talking on vitamins and micronutrients to prevent cancer; most prospective trials were negative or showed HARM. Yes harm. # ASCO14,,,#,4.72738E+17,https://twitter.com/rsm2800/status/472737772273278976,,,,
teamoncology,5/31/2014 9:53,0,0,True. RT @ subatomicdoc: in Sentinel node era I'd love nomogram predicting 4+ nodes to decide on nodal radiation # ASCO14 # bcsm,,@,# #,4.72738E+17,https://twitter.com/teamoncology/status/472737704824680448,,,,
mtmdphd,5/31/2014 9:53,0,0,"Zon - # ASCO14 - Community Cancer Research - Change and Opportunity - networks, pharma, non-NCORP affiliates pic.twitter.com/xJgLwB4NIf",,,#,4.72738E+17,https://twitter.com/mtmdphd/status/472737692405346304,,,,
DrAttai,5/31/2014 9:53,0,0,"Harvie - dietary supplements - almost 50% taking, clinicians give variable advice # ASCO14 # bcsm",,,# #,4.72738E+17,https://twitter.com/DrAttai/status/472737689255817217,,,,
teamoncology,5/31/2014 9:53,0,0,@ drattai $100 M for STRA trial for Tamoxifen breast cancer prevention. And this is the impact that we have in the society. :( # bcsm # ASCO14,,@,# #,4.72738E+17,https://twitter.com/teamoncology/status/472737568539172865,,,,
geneticsnews,5/31/2014 9:53,0,0,RT @ JohnCFierce: Clovis preps for a blockbuster showdown with AstraZeneca = $ CLVS $ AZN # asco14 http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31 …,,@,#,4.72738E+17,https://twitter.com/geneticsnews/status/472737565334724608,,,,
cancerassassin1,5/31/2014 9:53,0,1,Recent study showing reduced lifespan of animals treated with nutraceuticals -Spindler et al 2014. Discussed at # ASCO14,,,#,4.72738E+17,https://twitter.com/cancerassassin1/status/472737563082375168,,,,
dmooneymd,5/31/2014 9:53,0,0,"Best of both worlds?...high orr with dabrafenib, less resistance with trametinib and durable response of ipilumimab. # ASCO14",,,#,4.72738E+17,https://twitter.com/dmooneymd/status/472737554497024000,,,,
subatomicdoc,5/31/2014 9:53,0,0,@ teamoncology in Sentinel node era I'd love nomogram predicting 4+ nodes to decide on nodal radiation # ASCO14 # bcsm cc @ sloan_kettering,,@ @,# #,4.72738E+17,https://twitter.com/subatomicdoc/status/472737549942018048,,,,
DoctorEdny,5/31/2014 9:53,9,3,"$ CLVS $ AZN winner will be determine by PFS - appears better with CO-1686; toxicities and side effects will be managed"" # ASCO14""",,,#,4.72738E+17,https://twitter.com/DoctorEdny/status/472737549770031104,,,,
PHCbiomed,5/31/2014 9:53,1,1,The exhibits are open! Be sure to stop by booth 17163 to see how our lab equipment can power your cancer biology research. # ASCO14,,,#,4.72738E+17,https://twitter.com/PHCbiomed/status/472737538898423808,,,,
mtmdphd,5/31/2014 9:52,0,0,"Zon - # ASCO14 - Community Cancer Research - NCORP - $93M - Aug 1 announcements. 17,000 cap on accrual pic.twitter.com/I2NGQmx77A",,,#,4.72737E+17,https://twitter.com/mtmdphd/status/472737488948035584,,,,
n8pennell,5/31/2014 9:52,1,0,Lynch: AZD9291 responses in non-T790M pts probably from retreatment and not real activity in AR. # ASCO14,,,#,4.72737E+17,https://twitter.com/n8pennell/status/472737447496134656,,,,
tomleblancMD,5/31/2014 9:52,0,2,Federal funding for # cancer # research essential for innovation; many major studies at # ASCO14 funded this way! http://ow.ly/xteeO,,,# # #,4.72737E+17,https://twitter.com/tomleblancMD/status/472737399169351680,,,,
OncoPlexDx,5/31/2014 9:52,0,0,"Come meet Dr. Todd Hembrough, PhD - Molecular # Oncology extraordinaire - today at 10AM at #18119 re: Targeted Chemotherpy. # ASCO14 # bcsm",,,# #18119 # #,4.72737E+17,https://twitter.com/OncoPlexDx/status/472737352696070144,,,,
teamoncology,5/31/2014 9:52,0,0,Wow !! RT @ drattai: wow RT rsm2800 Vogel: STAR trial cost &gt;$100M to conduct. Whoa. “Need better trial design.” Absolutely. # bcsm # ASCO14,,@,# #,4.72737E+17,https://twitter.com/teamoncology/status/472737335797235712,,,,
carisls,5/31/2014 9:52,1,0,Molecular profiling of bile duct and # gallbladder cancer to identify different therapeutic options S Hall A2 http://goo.gl/UvuGDw # ASCO14,,,# #,4.72737E+17,https://twitter.com/carisls/status/472737330760282112,,,,
MLIWI,5/31/2014 9:52,1,0,"In 2012, retail prescription medicines accounted for just $0.09 of every dollar spent on # healthcare. http://buff.ly/1twYiC9 # ASCO14 # mliwi",,,# # #,4.72737E+17,https://twitter.com/MLIWI/status/472737329636204544,,,,
MaverickNY,5/31/2014 9:52,0,1,Going to rename Arie Crown 'Chiberia' as is darn cold in here! # asco14,,,#,4.72737E+17,https://twitter.com/MaverickNY/status/472737326561755136,,,,
CERNfoundation,5/31/2014 9:52,1,1,"RT @ drattai: Harvie - healthy diet reduces overall mortality but not cancer-specific mortality # ASCO14 # bcsm""""",,@,# #,4.72737E+17,https://twitter.com/CERNfoundation/status/472737321641472000,,,,
OmidHamidMD,5/31/2014 9:52,2,3,@ ASCO Puzanov presents # dabrafenib # trametinib # ipilimumab triplet sig GI toxicity # melanoma not ready 4 primetimepic.twitter.com/EOYK44tSNm,,@,# # # #,4.72737E+17,https://twitter.com/OmidHamidMD/status/472737306420723712,,,,
mtmdphd,5/31/2014 9:52,0,0,Zon - # ASCO14 - Community Cancer Research - CCDR - @ theNCI definition...pic.twitter.com/S311rZ69s3,,@,#,4.72737E+17,https://twitter.com/mtmdphd/status/472737267463643136,,,,
JackWestMD,5/31/2014 9:52,2,3,"Dr. Tom Lynch offering commentary on new EGFR TKIs for acquired resistance. CO1686 notable for only 4% rash, profound activity. # ASCO14",,,#,4.72737E+17,https://twitter.com/JackWestMD/status/472737261696843776,,,,
cancerassassin1,5/31/2014 9:51,0,0,"Key questions from many patients: will antioxidants help my # cancer""? # ASCO14""",,,# #,4.72737E+17,https://twitter.com/cancerassassin1/status/472737233154232320,,,,
Stigetta,5/31/2014 9:51,0,0,So excited about public/private collaborations & cooperatives to bring trials to community hospitals reported at # ASCO14! Wish I was there!,,,#,4.72737E+17,https://twitter.com/Stigetta/status/472737230805811200,,,,
ByJonGardner,5/31/2014 9:51,0,1,"Thomas Lynch: CO-1686 PFS shows it won't matter"" if there's a hypoglycaemia or QTc side effect. # ASCO14""",,,#,4.72737E+17,https://twitter.com/ByJonGardner/status/472737195661742080,,,,
Katebolam,5/31/2014 9:51,0,0,Not at American Soc of Clin Oncol but will retweet exercise and survivor related tweets @ ASCO # ASCO2014 @ ESSA_NEWS,,@ @,#,4.72737E+17,https://twitter.com/Katebolam/status/472737147372720128,,,,
mtmdphd,5/31/2014 9:51,1,0,"Zon - # ASCO14 - Community Cancer Research - Parallel Reformation in 2013 - NCORP - prevention, control, screening pic.twitter.com/GCkycBf5C9",,,#,4.72737E+17,https://twitter.com/mtmdphd/status/472737128644747264,,,,
drcbsteer,5/31/2014 9:51,0,0,# ASCO14 # gerionc Chapman - major hurdle in GO clinic was the need to win over medical oncologists.,,,# #,4.72737E+17,https://twitter.com/drcbsteer/status/472737123695869953,,,,
n8pennell,5/31/2014 9:51,1,0,"Lynch: The winner between these drugs will be determined by best PFS, not dosing or toxicity. Agree! # ASCO14",,,#,4.72737E+17,https://twitter.com/n8pennell/status/472737102430744576,,,,
cancerassassin1,5/31/2014 9:51,0,0,# integrative: Healthy diet reduces overall (but not cancer specific) mortality. Is this relevant in pts with most aggressive types? # ASCO14,,,# #,4.72737E+17,https://twitter.com/cancerassassin1/status/472737030816800768,,,,
carisls,5/31/2014 9:51,1,0,"Molecular profiling of 6,892 # colorectal cancer patients to identify potential treatment options S Hall A2 http://goo.gl/UvuGDw # ASCO14",,,# #,4.72737E+17,https://twitter.com/carisls/status/472737019979116544,,,,
Medicalfacts,5/31/2014 9:50,0,0,@ ASCO Thanks,,@,,4.72737E+17,https://twitter.com/Medicalfacts/status/472736949724532736,,,,
GustaveRoussy,5/31/2014 9:50,4,2,# ASCO14 30000 oncologists gathered to share latest clinical research results. Gustave Roussy delegates in the place. pic.twitter.com/JSqDEOXOod,,,#,4.72737E+17,https://twitter.com/GustaveRoussy/status/472736933441851393,,,,
dmooneymd,5/31/2014 9:50,0,0,"Melanoma abstract: combining braf, mek, and ctla4 inhibitor. Dr. Puzanov. # ASCO14",,,#,4.72737E+17,https://twitter.com/dmooneymd/status/472736918976081920,,,,
n8pennell,5/31/2014 9:50,0,0,"Lynch: CO1686 almost no rash. Hyperglycemia concerning, as is QTc prolongation. # ASCO14",,,#,4.72737E+17,https://twitter.com/n8pennell/status/472736916203659264,,,,
mtmdphd,5/31/2014 9:50,0,0,Zon - # ASCO14 - Community Cancer Research - Why the Transformation? pic.twitter.com/Of7f5Xgp6c,,,#,4.72737E+17,https://twitter.com/mtmdphd/status/472736911576948736,,,,
Doctor_V,5/31/2014 9:50,0,0,"@ drattai Fascinating tweet, Deanna # ASCO14",,@,#,4.72737E+17,https://twitter.com/Doctor_V/status/472736877930229762,,,,
OSUCCC_James,5/31/2014 9:50,0,1,"Comment in press briefing: Ibrutinib is a transformative drug in CLL. Now we need to look at first-line treatment possibilities."" # ASCO14""",,,#,4.72737E+17,https://twitter.com/OSUCCC_James/status/472736862444871681,,,,
Roche,5/31/2014 9:50,1,5,What goes into the design of a clinical study? http://ow.ly/xkOgi # ASCO14 # ClinicalTrial,,,# #,4.72737E+17,https://twitter.com/Roche/status/472736807889948673,,,,
mtmdphd,5/31/2014 9:50,0,0,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.72737E+17,https://twitter.com/mtmdphd/status/472736796632449024,,,,
drcbsteer,5/31/2014 9:50,0,0,# ASCO14 # gerionc Chapman - Geriatric oncology service - coordination is key.,,,# #,4.72737E+17,https://twitter.com/drcbsteer/status/472736791527968770,,,,
harriseve,5/31/2014 9:50,0,0,<3 her! Dr. Patricia Ganz: “need 2 ensure patients have best quality of life @every stage” # ASCO14 http://bit.ly/1hjxkOD # epatient,,@every,# #,4.72737E+17,https://twitter.com/harriseve/status/472736768778059777,,,,
DoctorEdny,5/31/2014 9:49,0,1,"$ CLVS $ AZN mutant specific TKIs hesitate to compare data"" # ASCO14 pic.twitter.com/PEEcjYxJu0""",,,#,4.72737E+17,https://twitter.com/DoctorEdny/status/472736750322728960,,,,
DrAttai,5/31/2014 9:49,1,3,Harvie - healthy diet reduces overall mortality but not cancer-specific mortality # ASCO14 # bcsm,,,# #,4.72737E+17,https://twitter.com/DrAttai/status/472736713954299904,,,,
mtmdphd,5/31/2014 9:49,0,0,"Robin Zon, MD - # ASCO14 - Community Cancer Research -CCOPs successfully adapt in changing economic times pic.twitter.com/jrSHklyxeT",,,#,4.72737E+17,https://twitter.com/mtmdphd/status/472736693087252482,,,,
scientre,5/31/2014 9:49,0,0,Gupta: Phase 1 dose escalation in breast cancer pts w Ras gene signature. Triple negative Breast cancer patients also Ki67 test # asco14,,,#,4.72737E+17,https://twitter.com/scientre/status/472736661109870592,,,,
carisls,5/31/2014 9:49,1,1,"PD-1 and PD-L1 in # colorectalcancer & their relationship to microsatellite instability status S Hall, A2 http://goo.gl/UvuGDw # ASCO14",,,# #,4.72737E+17,https://twitter.com/carisls/status/472736622094868480,,,,
scientre,5/31/2014 9:49,0,1,"Gupta: MK8669+MK2206: for expansion, 124 breast cancer pts screened, 98 had evaluate tissues, 51 Biomarker eligible, 16 treated # asco14",,,#,4.72737E+17,https://twitter.com/scientre/status/472736614041395202,,,,
AlpineBV_Miller,5/31/2014 9:49,0,0,Is my sched wrong or is E Arie Crown really 10 minutes behind schedule? # ASCO14,,,#,4.72737E+17,https://twitter.com/AlpineBV_Miller/status/472736606596894720,,,,
DrAttai,5/31/2014 9:49,7,3,Harvie - very high fruit / veggie intake doe not improve outcome of breast cancer patients # ASCO14 # bcsm,,,# #,4.72737E+17,https://twitter.com/DrAttai/status/472736590050361344,,,,
n8pennell,5/31/2014 9:49,0,0,"Lynch: HM61713 appears less active than CO1686 and AZD9291, but MTD not yet determined so jury still out. # ASCO14",,,#,4.72737E+17,https://twitter.com/n8pennell/status/472736575001210880,,,,
cancerassassin1,5/31/2014 9:48,0,0,# nutrition in # cancer: lack of data on intentional weight loss is a confounded # ASCO14,,,# # #,4.72736E+17,https://twitter.com/cancerassassin1/status/472736481841131520,,,,
mtmdphd,5/31/2014 9:48,0,0,"Robin Zon, MD - # ASCO14 - Community Cancer Research - 4 Key Principles to CCOP Success pic.twitter.com/P9bPgCaiNN",,,#,4.72736E+17,https://twitter.com/mtmdphd/status/472736467920252929,,,,
WilliamDale_MD,5/31/2014 9:48,0,0,"# ASCO14 Chapman: Here is the elevator speech: Need is there, vulnerable patients, and the right thing to do. # gerionc",,,# #,4.72736E+17,https://twitter.com/WilliamDale_MD/status/472736467630845952,,,,
DrBobGoldberg,5/31/2014 9:48,1,0,"@ rschilsky don't want anyone that'd use this formula to treat me, parents or my kids.. # asco14 # mliwipic.twitter.com/1Uu36eW2wS",,@,# #,4.72736E+17,https://twitter.com/DrBobGoldberg/status/472736458344656896,,,,
LoebStacy,5/31/2014 9:48,13,3,More support for delayed hormones # ASCO14 MT @ OncLive: Delaying ADT Until Symptoms Appear Does Not Impact Survival http://ow.ly/xsBLi,,@,#,4.72736E+17,https://twitter.com/LoebStacy/status/472736433154056194,,,,
DrAttai,5/31/2014 9:48,1,2,"Harvie we need more data on intentional weight loss, benefits in terms of cancer recurrence, mortality # ASCO14 # bcsm",,,# #,4.72736E+17,https://twitter.com/DrAttai/status/472736431895764992,,,,
teamoncology,5/31/2014 9:48,0,0,@ subatomicdoc TY. Not disagreeing with the results but the current nomogram is not pragmatic. # ASCO14,,@,#,4.72736E+17,https://twitter.com/teamoncology/status/472736389121835008,,,,
drcbsteer,5/31/2014 9:48,0,0,# ASCO14 # gerionc Chapman 6 stakeholders/institutional senior leaders needed to be convinced of the utility of the geriatric oncology service,,,# #,4.72736E+17,https://twitter.com/drcbsteer/status/472736382755282946,,,,
rsm2800,5/31/2014 9:48,0,1,Vogel: STAR trial cost >$100M to conduct. Whoa. “Need better trial design.” Absolutely. # bcsm # ASCO14,,,# #,4.72736E+17,https://twitter.com/rsm2800/status/472736317059522560,,,,
KUhlendorf,5/31/2014 9:48,8,1,". @ theNCI's Abrams: I'm fired up"" about NCI MATCH. Chance to bring personalized medicine approach to # clinicaltrials across U.S. # ASCO14""",,@,# #,4.72736E+17,https://twitter.com/KUhlendorf/status/472736295400128513,,,,
mtmdphd,5/31/2014 9:48,1,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research - missing 95% of cancer patients pic.twitter.com/3rRCjqamQh",,,#,4.72736E+17,https://twitter.com/mtmdphd/status/472736287770681346,,,,
n8pennell,5/31/2014 9:48,0,0,Lynch: All 3 compounds have T790M activity with sparing of tox from wild-type activity. # ASCO14,,,#,4.72736E+17,https://twitter.com/n8pennell/status/472736255294574592,,,,
mtmdphd,5/31/2014 9:47,0,0,"Robin Zon, MD - # ASCO14 - 1989 - Minority-based CCOP / 2007 - @ theNCI Comm Cancer Center Prog (NCCCP)pic.twitter.com/AsTbyOkEjf",,@,#,4.72736E+17,https://twitter.com/mtmdphd/status/472736146594611201,,,,
n8pennell,5/31/2014 9:46,2,0,Lynch: Adding compound X to first gen EGFR TKI has been ineffective in acquired resistance. Afatinib/cetuximab effect but toxic # ASCO14,,,#,4.72736E+17,https://twitter.com/n8pennell/status/472735990470426624,,,,
RarePOV,5/31/2014 9:46,0,1,MT @ LillyPad: We can and must define value in # cancer treatments. # ASCO14 http://ow.ly/xseet,,@,# #,4.72736E+17,https://twitter.com/RarePOV/status/472735950120833025,,,,
MediTech_Media,5/31/2014 9:46,0,0,Neutrophil to lymphocyte ratio predictive of outcome in several different studies in multiple solid tumor types. # ASCO14,,,#,4.72736E+17,https://twitter.com/MediTech_Media/status/472735948367597568,,,,
DrMarkham,5/31/2014 9:46,1,0,"For ovarian & endometrial cancers, minimal data on weight loss/gain & mortality. (M. Harvie) # ASCO14 # gyncsm",,,# #,4.72736E+17,https://twitter.com/DrMarkham/status/472735941035974656,,,,
RarePOV,5/31/2014 9:46,2,3,Is there a guide to acronyms at # ASCO14? Tweets from attendees look like they were written by a cat on the keyboard.,,,#,4.72736E+17,https://twitter.com/RarePOV/status/472735883855396864,,,,
dmooneymd,5/31/2014 9:46,0,0,"We need better preclinical modeling and better pharm data of synergy, clearance, toxicity in targeted combo tx, and trial design. # ASCO14",,,#,4.72736E+17,https://twitter.com/dmooneymd/status/472735881397149696,,,,
rsm2800,5/31/2014 9:46,0,1,"Vogel: Pts w/ ADH, LCIS are more likely to be given chemoprevention (but many others have Gail risk >1.66% so might benefit) # bcsm # asco14",,,# #,4.72736E+17,https://twitter.com/rsm2800/status/472735880533139457,,,,
mtmdphd,5/31/2014 9:46,0,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research - 1987 expansion of CCOP scope to include prevention / control pic.twitter.com/wY0joNMfGt",,,#,4.72736E+17,https://twitter.com/mtmdphd/status/472735862317273088,,,,
DrLCohen,5/31/2014 9:46,4,2,More than 400 cancer doctors attend education session on integrative oncology at # ASCO2014,,,#,4.72736E+17,https://twitter.com/DrLCohen/status/472735846089494528,,,,
WilliamDale_MD,5/31/2014 9:46,3,0,# ASCO14 Chapman: Importance of timeliness in evaluations of older patients and reports to referring providers. # gerionc,,,# #,4.72736E+17,https://twitter.com/WilliamDale_MD/status/472735821737365505,,,,
teamoncology,5/31/2014 9:46,0,0,【 # ASCO14 101】 Obesity has an impact on mortality of cancer. But when you look into the molecular cancer subtype results are not consistent.,,,#,4.72736E+17,https://twitter.com/teamoncology/status/472735805304086528,,,,
jrgralow,5/31/2014 9:46,8,4,The Future! MT @ mtmdphd: # ASCO14 Abrams- NCTN Umbrella Protocols - LungMAP # SWOGOnc ALCHEMIST & Basket @ theNCI MATCHpic.twitter.com/llzNPcbDXt,,@ @,# #,4.72736E+17,https://twitter.com/jrgralow/status/472735771200598016,,,,
drcbsteer,5/31/2014 9:45,3,0,# ASCO14 # gerionc Andy Chapman -describes a Geriatric oncology consultative service - not taking over care from medical oncologists.,,,# #,4.72736E+17,https://twitter.com/drcbsteer/status/472735625675014144,,,,
mtmdphd,5/31/2014 9:45,0,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research - CCOP - 1983-2003 pic.twitter.com/S6kOteBwvD",,,#,4.72736E+17,https://twitter.com/mtmdphd/status/472735612311580672,,,,
JackWestMD,5/31/2014 9:45,0,0,Dr. Kim on HM61713 in T790M+ acquired resistance for EGFR mutn-pos # LungCancer # ASCO14 # lcsmpic.twitter.com/vkH07UyiBb,,,# # #,4.72736E+17,https://twitter.com/JackWestMD/status/472735585069568001,,,,
cancerassassin1,5/31/2014 9:45,0,0,Data on weight loss after # cancer diagnosis and effects on mortality: mostly observational # ASCO14,,,# #,4.72736E+17,https://twitter.com/cancerassassin1/status/472735569781329921,,,,
KUhlendorf,5/31/2014 9:45,4,5,NCI-MATCH study: Another great example of public-private collab. 15 biopharma companies involved # ASCO14 pic.twitter.com/Uo8zfsriiv,,,#,4.72736E+17,https://twitter.com/KUhlendorf/status/472735526353502208,,,,
mtmdphd,5/31/2014 9:44,1,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research - Cooperative Group Outreach Program (CGOP) pic.twitter.com/nMOVnYpT92",,,#,4.72735E+17,https://twitter.com/mtmdphd/status/472735455134248960,,,,
rsm2800,5/31/2014 9:44,0,0,"Vogel: Despite several randomized trials of SERMS/AIs, NO appreciable uptake of use for breast ca risk reduction by docs/pts in U.S. # asco14",,,#,4.72735E+17,https://twitter.com/rsm2800/status/472735447492210688,,,,
DrAttai,5/31/2014 9:44,5,2,"Harvie - cancer and overall mortality worse with obesity at diagnosis in breast, prostate, ovarian and colorectal cancer # ASCO14 # bcsm",,,# #,4.72735E+17,https://twitter.com/DrAttai/status/472735388852031488,,,,
JenPageWall,5/31/2014 9:44,0,0,"In ‘64, 1 in 300 # patients died of # cancer. W/the help of innovative meds, that rate has been cut in half http://onphr.ma/1kqAJKe # ASCO14",,,# # #,4.72735E+17,https://twitter.com/JenPageWall/status/472735364021366785,,,,
cancerassassin1,5/31/2014 9:44,0,0,Interesting session on # nutrition in # cancer # integrativeoncology. @ wcrfint and @ AmericanCancer have guidelines for patients # ASCO14,,@ @,# # # #,4.72735E+17,https://twitter.com/cancerassassin1/status/472735302641913857,,,,
GenentechJobs,5/31/2014 9:44,0,0,"# ASCO14 Scientist, Oncology Biomarker Development- Cancer Immunotherapy: http://click2apply.net/429813t Retweet Please.",,,#,4.72735E+17,https://twitter.com/GenentechJobs/status/472735274309390337,,,,
mtmdphd,5/31/2014 9:44,0,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research - back to the 80's... Historical Highlights... pic.twitter.com/EqTlyXUEDk",,,#,4.72735E+17,https://twitter.com/mtmdphd/status/472735271843139584,,,,
myPathMelanoma,5/31/2014 9:44,1,0,Get Myriad myPath # Melanoma updates delivered to your inbox. Sign up for our mailing list TODAY! http://bit.ly/myPathinfo # ASCO14,,,# #,4.72735E+17,https://twitter.com/myPathMelanoma/status/472735247054798848,,,,
jonathanagin,5/31/2014 9:43,1,0,Who from the childhood cancer community is going to be at @ ASCO - will be there Sunday & Monday,,@,,4.72735E+17,https://twitter.com/jonathanagin/status/472735219242377216,,,,
n8pennell,5/31/2014 9:43,2,3,Lynch: we absolutely have improved outcomes for EGFR mutation + pts. # ASCO14,,,#,4.72735E+17,https://twitter.com/n8pennell/status/472735212041158657,,,,
LungCancerFaces,5/31/2014 9:43,1,1,Follow @ RamalingamMD @ ElizBlanchardMD @ JFreemanDaily @ mtmdphd for live tweets from # ASCO14 sessions. # LCSM,,@ @ @ @,# #,4.72735E+17,https://twitter.com/LungCancerFaces/status/472735167253987329,,,,
Dr_Lanie,5/31/2014 9:43,0,1,“ @ AmandaGSzabo: Pill v. infusion for # leukemia chemotherapy - pill wins in this study: http://nbcnews.to/1mV5k2U via @ NBCNews # ASCO14”,,@ @,# #,4.72735E+17,https://twitter.com/Dr_Lanie/status/472735143078404098,,,,
mtmdphd,5/31/2014 9:43,0,1,"Robin Zon, MD - # ASCO14 - Community Cancer Research -> the ultimate team player pic.twitter.com/Tj91NAll5U",,,#,4.72735E+17,https://twitter.com/mtmdphd/status/472735110110801920,,,,
dmooneymd,5/31/2014 9:43,2,0,"Same question...does pi3k inhibition raise the bar"" for parp inhibition in ovarian and breast cancer? Timothy Yap. # ASCO14 # gyncsm # bcsm""",,,# # #,4.72735E+17,https://twitter.com/dmooneymd/status/472735107074121729,,,,
GenentechJobs,5/31/2014 9:43,0,0,"# ASCO14 Talent Hunt: # Scientist, Oncology Biomarker Development- # Hematology: http://click2apply.net/426015t Retweet Please.",,,# # #,4.72735E+17,https://twitter.com/GenentechJobs/status/472735085905469440,,,,
drcbsteer,5/31/2014 9:43,0,0,# ASCO14 #gerionc Geriatric Oncology service - the patient navigator/care coordinator is key to programme success.,,,# #gerionc,4.72735E+17,https://twitter.com/drcbsteer/status/472735068252016640,,,,
WilliamDale_MD,5/31/2014 9:43,2,0,"# ASCO14 Chapman: Truly multidisciplinary set of providers, same day visits, and multidisciplinary rounds. # gerionc",,,# #,4.72735E+17,https://twitter.com/WilliamDale_MD/status/472735067836403712,,,,
jrgralow,5/31/2014 9:43,2,3,Nice RT @ teamoncology: 【 # ASCO14 Update】 Here is a very helpful infogram about the progress of # breastcancer http://am.asco.org/progress-breast-cancer-research … # bcsm,,@,# # #,4.72735E+17,https://twitter.com/jrgralow/status/472735046013829120,,,,
rsm2800,5/31/2014 9:43,0,1,Vogel: Freedman model (cont.): Risk of breast ca rises w/ age but so does risk of endom ca w/ tam; can help decide tam vs ralox vs 0 # asco14,,,#,4.72735E+17,https://twitter.com/rsm2800/status/472735043782074368,,,,
RamalingamMD,5/31/2014 9:43,1,0,HM 61713 is another active drug in T790 positive pts. But response rate lower than other drugs in class. # LCSM # ASCO14,,,# #,4.72735E+17,https://twitter.com/RamalingamMD/status/472735012862054400,,,,
n8pennell,5/31/2014 9:43,0,0,Tom Lynch now discussing third gen EGFR inhibitors. # ASCO14,,,#,4.72735E+17,https://twitter.com/n8pennell/status/472735005920489472,,,,
teamoncology,5/31/2014 9:42,0,0,@ subatomicdoc Do U think that nomogram is truly useful? I have not been using any nomogram for cancer treatment related toxicity. # ASCO14,,@,#,4.72735E+17,https://twitter.com/teamoncology/status/472734952505630720,,,,
Cascadia,5/31/2014 9:42,0,2,@ Sermo: would love to see you sharing your coverage of # ASCO14 with rest of care team (i.e. patients) outside of Sermo too,,@,#,4.72735E+17,https://twitter.com/Cascadia/status/472734941059743744,,,,
GileadSciences,5/31/2014 9:42,2,0,Gilead Research Scholars Prgm. accepting research applications to advance knowledge of # hematology/ # oncology http://bit.ly/1gPEyZX # ASCO14,,,# # #,4.72735E+17,https://twitter.com/GileadSciences/status/472734910373826564,,,,
mtmdphd,5/31/2014 9:42,0,2,"Robin Zon, MD - # ASCO14 - Community Cancer Research - 80-85% Pts treated in the community setting pic.twitter.com/XukUXvWXqv",,,#,4.72735E+17,https://twitter.com/mtmdphd/status/472734909329444864,,,,
PhRMA,5/31/2014 9:42,2,2,. @ JenatPhRMA offers insights into the debate over value & cost of medicine. http://onphr.ma/1kqAJKe # ASCO14,,@,#,4.72735E+17,https://twitter.com/PhRMA/status/472734777619935233,,,,
drcbsteer,5/31/2014 9:41,2,0,# ASCO14 # gerionc Andrew Chapman - average visit 2 hours. Geriatric Oncology - It takes time.,,,# #,4.72735E+17,https://twitter.com/drcbsteer/status/472734712424067073,,,,
DrAttai,5/31/2014 9:41,0,0,Dr. MIchelle Harvie role of nutrition - another important topic # ASCO14 # bcsm,,,# #,4.72735E+17,https://twitter.com/DrAttai/status/472734676843773952,,,,
rsm2800,5/31/2014 9:41,0,0,"Vogel: Freedman (NCI) JCO 2011-Model looked at net benefits of tam or ralox in breast ca risk reduction incl age, race, +/-uterus # asco14",,,#,4.72735E+17,https://twitter.com/rsm2800/status/472734668131807232,,,,
mtmdphd,5/31/2014 9:41,0,1,# ASCO14 - Abrams - @ theNCI MATCH Acknowledgments # SWOGOncpic.twitter.com/h1e8BzQyZR,,@,# #,4.72735E+17,https://twitter.com/mtmdphd/status/472734602755182592,,,,
RamalingamMD,5/31/2014 9:41,0,1,A warm hug to all my patients @ WinshipAtEmory that are on the AZ9291 study#LCSM # ASCO14. We could not have done this without you.,,@,#LCSM #,4.72735E+17,https://twitter.com/RamalingamMD/status/472734579745640448,,,,
carisls,5/31/2014 9:41,0,0,Caris’ # gyncsm cancer [data]...can illuminate...clinical insights to help individualize anticancer therapy,"” http://goo.gl/UvuGDw # ASCO14""",,,# #,4.72735E+17,https://twitter.com/carisls/status/472734574733443073,,,
subatomicdoc,5/31/2014 9:41,0,1,What # coloncancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI # FF # crcsm,,@ @ @ @ @ @ @,# # # #,4.72735E+17,https://twitter.com/subatomicdoc/status/472734524703780865,,,,
SanofiUS,5/31/2014 9:41,0,0,RT @ ASCO: Missed today's # ASCO14 press briefing? View the recording for the latest in targeted therapy: http://bit.ly/1pGNWzg,,@,#,4.72735E+17,https://twitter.com/SanofiUS/status/472734503920996352,,,,
subatomicdoc,5/31/2014 9:41,1,0,Nomogram to predict severe neutropenia in Japanese pts w/ colorectal CA treated with irinotecan http://abstracts.asco.org/144/AbstView_144_125787.html … # ASCO14 # crcsm,,,# #,4.72734E+17,https://twitter.com/subatomicdoc/status/472734491539415040,,,,
WilliamDale_MD,5/31/2014 9:40,1,0,# ASCO14 Andy Chapman from Jefferson to describe a cancer center based # gerionc clinic.,,,# #,4.72734E+17,https://twitter.com/WilliamDale_MD/status/472734484819763201,,,,
mtmdphd,5/31/2014 9:40,2,2,"# ASCO14 - Abrams - @ theNCI MATCH a partnership with pharmaceutical companies, academics, and community sites",,@,#,4.72734E+17,https://twitter.com/mtmdphd/status/472734421984874496,,,,
CancerTherAdvsr,5/31/2014 9:40,0,0,"RT @ mtmdphd: # ASCO14 - Abrams - NCTN - Lung-MAP - Round One - PD-L1, PI3K, DCK4/6, FGFR, HGF - # lcsm # clinicaltrialspic.twitter.com/0EB3gwNk27",,@,# # #,4.72734E+17,https://twitter.com/CancerTherAdvsr/status/472734419011526656,,,,
OrmondOncDoc,5/31/2014 9:40,1,0,"These presentations are making a great case for CancerLinq at the optimizing access to clinical trials..."" # ASCO14""",,,#,4.72734E+17,https://twitter.com/OrmondOncDoc/status/472734414586531842,,,,
BayerPharma,5/31/2014 9:40,0,1,# colorectalcancer is the 3rd most common cancer worldwide. Get more information at # ASCO14 presentations # crcsm http://twitpic.com/e551xf,,,# # #,4.72734E+17,https://twitter.com/BayerPharma/status/472734399109554177,,,,
teamoncology,5/31/2014 9:40,0,0,"Did not know that. RT @ rsm2800: Vogel: STAR trial - Due to funding issues, follow up was capped at 7 yrs (that’s unfortunate) # bcsm # asco14",,@,# #,4.72734E+17,https://twitter.com/teamoncology/status/472734391345496065,,,,
Tony_Calles,5/31/2014 9:40,0,0,On CO-1686 If IGFR blockade has to do with high glucose levels also may has something to do in IGFR tumor acquired resistance pts # ASCO14,,,#,4.72734E+17,https://twitter.com/Tony_Calles/status/472734356222775297,,,,
DrAttai,5/31/2014 9:40,1,2,Cohen - how people process their environment can affect every single cell in the body. This is important for all of us # ASCO14 # bcsm,,,# #,4.72734E+17,https://twitter.com/DrAttai/status/472734351785222144,,,,
drcbsteer,5/31/2014 9:40,1,0,# ASCO14 # gerionc Lodovico Balducci highlighted importance of action research & being open to change in developing geriatric oncology service,,,# #,4.72734E+17,https://twitter.com/drcbsteer/status/472734344868802561,,,,
LungCancerFaces,5/31/2014 9:40,0,0,Follow @ JackWestMD @ n8pennell @ RielyMD for live tweets from # ASCO14 sessions. ASCO=American Society of Clinical Oncology. # LungCancer # LCSM,,@ @ @,# # #,4.72734E+17,https://twitter.com/LungCancerFaces/status/472734339344502784,,,,
adamfeuerstein,5/31/2014 9:40,1,3,$ CLVS '1686 AE profile 22% pats gr3 hyperglycemia. QT prolongation gr3 7% # ASCO14,,,#,4.72734E+17,https://twitter.com/adamfeuerstein/status/472734314502057985,,,,
mtmdphd,5/31/2014 9:40,5,2,# ASCO14 - Abrams - @ theNCI MATCH is a discovery trial. Provide leads to larger phase 2 trials spec histologypic.twitter.com/3PzeSd6IH7,,@,#,4.72734E+17,https://twitter.com/mtmdphd/status/472734302765981696,,,,
n8pennell,5/31/2014 9:40,0,0,"HM61713 18.9 weeks PFS in T790M NSCLC pts. Overall looks active in this setting, but numbers less impressive than first 2 compounds # ASCO14",,,#,4.72734E+17,https://twitter.com/n8pennell/status/472734286572187648,,,,
ipaulmampilly,5/31/2014 9:40,0,0,# ASCO14 the cancer drug marketplace pic.twitter.com/UaNtYW2cXl,,,#,4.72734E+17,https://twitter.com/ipaulmampilly/status/472734268347920384,,,,
NormandBlais,5/31/2014 9:40,0,1,Third agent for T790M+ patients: HM61713. Early results. RR 29.2% in T790M+ vs 11.8% in T790M- # LCCatASCO # ASCO14,,,# #,4.72734E+17,https://twitter.com/NormandBlais/status/472734248609542145,,,,
docpook,5/31/2014 9:39,0,0,Significant proportion of non-seminoma patients with residual masses <5mm harbour viable disease - consider surgery # ASCO14,,,#,4.72734E+17,https://twitter.com/docpook/status/472734224567779330,,,,
rschilsky,5/31/2014 9:39,0,1,# ASCO14 Copur: NCCCP funding led to marked increase in trial portfolio and accrual. If you build it," they will come.""!""",,,#,4.72734E+17,https://twitter.com/rschilsky/status/472734205894737920,,,
rsm2800,5/31/2014 9:39,1,0,"Vogel: STAR trial - Due to funding issues, follow up was capped at 7 yrs (that’s unfortunate) # bcsm # asco14",,,# #,4.72734E+17,https://twitter.com/rsm2800/status/472734201695846400,,,,
ByJonGardner,5/31/2014 9:39,0,0,Conclusions re: HM61713 # ASCO14 pic.twitter.com/f5WyBkE3WE,,,#,4.72734E+17,https://twitter.com/ByJonGardner/status/472734167470735360,,,,
bio_clouseau,5/31/2014 9:39,1,4,$ CLVS Detailed 1686 # ASCO14 slides http://www.clovisoncology.com/files/CO1686_Oral_ASCO2014_FINAL.pdf …,,,#,4.72734E+17,https://twitter.com/bio_clouseau/status/472734124860379136,,,,
mtmdphd,5/31/2014 9:39,1,0,# ASCO14 - Abrams - @ theNCI MATCH - biopsy paid by NCI - assay system componentspic.twitter.com/T6MRRDFky5,,@,#,4.72734E+17,https://twitter.com/mtmdphd/status/472734075782823936,,,,
rsm2800,5/31/2014 9:39,1,1,Vogel: STAR conclusions-ralox had fewer episodes of uterine ca and fewer clots c/w tamoxifen # bcsm # asco14,,,# #,4.72734E+17,https://twitter.com/rsm2800/status/472734033311330305,,,,
ByJonGardner,5/31/2014 9:39,2,1,PFS of HM61713 # ASCO14 pic.twitter.com/IomCu5fehe,,,#,4.72734E+17,https://twitter.com/ByJonGardner/status/472734023937441793,,,,
KUhlendorf,5/31/2014 9:39,0,0,"# ASCO14 panel talks changing # clinicaltrials landscape. >24,000 clinical trials for # cancer are being conducted in US http://onphr.ma/1jxRiiR",,,# # #,4.72734E+17,https://twitter.com/KUhlendorf/status/472734018404745216,,,,
DrAttai,5/31/2014 9:39,1,4,I know many think complementary therapies = vodoo but there are data supporting certain treatments. Mechanisms are fascinating # ASCO14 # bcsm,,,# #,4.72734E+17,https://twitter.com/DrAttai/status/472733994749296641,,,,
djsampson,5/31/2014 9:38,0,0,Victor Vogel: STAR trial showed large net benefit for tamoxifen & raloxifene # asco14 pic.twitter.com/uqjUI2GCuo,,,#,4.72734E+17,https://twitter.com/djsampson/status/472733983277469697,,,,
WilliamDale_MD,5/31/2014 9:38,0,0," @ rschilsky: # ASCO14 Mitchell: 40% of real world pts with mRCC would not qualify for pivotal clinical trials."" Aging? # gerionc""",,@,# #,4.72734E+17,https://twitter.com/WilliamDale_MD/status/472733979527757826,,,,
mtmdphd,5/31/2014 9:38,1,0,"# ASCO14 - Abrams - @ theNCI MATCH - Logistics - multi-arm phase 2 trials, CIRB, single INDpic.twitter.com/Dg93BsSsvY",,@,#,4.72734E+17,https://twitter.com/mtmdphd/status/472733926616612864,,,,
GenentechJobs,5/31/2014 9:38,1,0,Our Immunotherapy Program has a biomarker/diagnostic focus. Read more here: http://bit.ly/1oUPzsH # ASCO14 pic.twitter.com/HwSpa1XeqE,,,#,4.72734E+17,https://twitter.com/GenentechJobs/status/472733879179038720,,,,
jrgralow,5/31/2014 9:38,0,2,"# ASCO14 IDEA Networking event w/ awardees Olga & Hanna from Belarus, Iryna from Ukraine, & mentor L Korde. Congrats! pic.twitter.com/xk3Z7dVlfM",,,#,4.72734E+17,https://twitter.com/jrgralow/status/472733875748478976,,,,
ByJonGardner,5/31/2014 9:38,0,1,Response rate for HM61713 # ASCO14 pic.twitter.com/rqPXWH8PIm,,,#,4.72734E+17,https://twitter.com/ByJonGardner/status/472733859139055616,,,,
RielyMD,5/31/2014 9:38,1,0,"Kim on Hm61713, 83 pts in expansion. 53%l858r. Rare grade 3 tox, MTD not reached, 800 mg ongoing, respo 22% overall, t790m pos 29%. # ASCO14",,,#,4.72734E+17,https://twitter.com/RielyMD/status/472733805254832128,,,,
WilliamDale_MD,5/31/2014 9:38,0,0,"# ASCO14 Balducci: Challenges of # gerionc clinics. Not enough geriatricians, no patient home, and no t patient centered.",,,# #,4.72734E+17,https://twitter.com/WilliamDale_MD/status/472733794940628993,,,,
n8pennell,5/31/2014 9:38,1,0,"HM61713 ORR 21% in all pts with AR, most in T790M pts. 29% in T790M pts, 11% without. # ASCO14",,,#,4.72734E+17,https://twitter.com/n8pennell/status/472733789568110594,,,,
rsm2800,5/31/2014 9:38,4,4,"Vogel: STAR-Tamoxifen reduced risk of breast ca by 50%, ralox by 45%; for tam 40 breast ca’s prevented per 1000 pts/7yrs # bcsm # asco14",,,# #,4.72734E+17,https://twitter.com/rsm2800/status/472733778578636800,,,,
mtmdphd,5/31/2014 9:38,1,1,"# ASCO14 - Abrams - @ theNCI MATCH - 25% slots reserved for rare"" tumors -- MATCH Designpic.twitter.com/3Mayih0Wt7""",,@,#,4.72734E+17,https://twitter.com/mtmdphd/status/472733736597868544,,,,
JacobPlieth,5/31/2014 9:37,0,0,"Key focus for lenvatinib in Select is tox. 20 fatal TEAEs, incl 6 reported by investigator as treatment-related # ASCO14",,,#,4.72734E+17,https://twitter.com/JacobPlieth/status/472733712569094145,,,,
ByJonGardner,5/31/2014 9:37,0,1,More efficacy analysis of HM61713 # ASCO14 pic.twitter.com/8ioWbqzl7e,,,#,4.72734E+17,https://twitter.com/ByJonGardner/status/472733600707002368,,,,
mtmdphd,5/31/2014 9:37,1,1,# ASCO14 - Abrams - @ theNCI MATCH Eligibility - solid tumors or lymphoma. # lymsmpic.twitter.com/GmIPYSfjNR,,@,# #,4.72734E+17,https://twitter.com/mtmdphd/status/472733510289997824,,,,
dmooneymd,5/31/2014 9:37,0,0,Difficult to answer question of whether dual blockade of same pathway pi3k/akt/mtor is more effective than single blockade. # ASCO14,,,#,4.72733E+17,https://twitter.com/dmooneymd/status/472733491231092736,,,,
teamoncology,5/31/2014 9:36,0,0,【 # ASCO14 101】 CO-1686 is EGFR covalent inhibitor. Covalent means irreversible. Once it binds to the enzyme it is stuck.,,,#,4.72733E+17,https://twitter.com/teamoncology/status/472733480237801472,,,,
ByJonGardner,5/31/2014 9:36,1,1,Efficacy analysis of HM61713 # ASCO14 pic.twitter.com/f719MSYTz2,,,#,4.72733E+17,https://twitter.com/ByJonGardner/status/472733473917394945,,,,
stefanomjr,5/31/2014 9:36,0,1,"Espresso, CrossFit Games North East Regionals & # ASCO14. Stimulating morning",,,#,4.72733E+17,https://twitter.com/stefanomjr/status/472733464127864832,,,,
Medicalfacts,5/31/2014 9:36,0,0,Dramatic Progress in 50 years Treatment Based On through Improved Understanding of Biology of Breast cancer # ASCO14 # bcsm,,,# #,4.72733E+17,https://twitter.com/Medicalfacts/status/472733457945485312,,,,
AndyBiotech,5/31/2014 9:36,2,4,$ CLVS CO-1686 vs $ AZN AZD9291 AE Profiles pic.twitter.com/wiCzq1QQ8z pic.twitter.com/9ShFOVLJLz # ASCO14 # LCSM via @ JonEPVantage CC: @ ColfaxCapital,,@ @,# #,4.72733E+17,https://twitter.com/AndyBiotech/status/472733402173816832,,,,
DrAttai,5/31/2014 9:36,0,3,Cohen - benefits of yoga to treat sleep disorder # ASCO14 # bcsm cc: @ chemobrainfog @ ABHuret,,@ @,# #,4.72733E+17,https://twitter.com/DrAttai/status/472733259382931456,,,,
teamoncology,5/31/2014 9:36,0,0,【 # ASCO14 Update】 RT @ n8pennell: CO-1686 may be effective first line EGFR mut and not just in resistance per Dr. Sequist. # ASCO14,,@,# #,4.72733E+17,https://twitter.com/teamoncology/status/472733253514702848,,,,
mtmdphd,5/31/2014 9:36,1,1,# ASCO14 - Abrams - @ theNCI MATCH - Molecular Analysis for Therapy Choice - # clinicaltrialspic.twitter.com/uFn28OjRHD,,@,# #,4.72733E+17,https://twitter.com/mtmdphd/status/472733253166583808,,,,
n8pennell,5/31/2014 9:36,0,0,"HM61713 toxicity low and almost no grade 3 but does have some wild-type effects I.e. Rash, diarrhea. # ASCO14",,,#,4.72733E+17,https://twitter.com/n8pennell/status/472733243507490816,,,,
rsm2800,5/31/2014 9:36,0,1,Vogel: STAR trial tam vs ralox was largest prospective randomized prevention trial; endpt was invasive+noninvasive breast ca # bcsm # asco14,,,# #,4.72733E+17,https://twitter.com/rsm2800/status/472733241850351616,,,,
ByJonGardner,5/31/2014 9:35,1,1,Safety of HM61713 # ASCO14 pic.twitter.com/vcBp5CtZIp,,,#,4.72733E+17,https://twitter.com/ByJonGardner/status/472733228017926145,,,,
novembrrr,5/31/2014 9:35,0,0,# ASCO14 pic.twitter.com/7CJgcMusWA,,,#,4.72733E+17,https://twitter.com/novembrrr/status/472733151916077057,,,,
ByJonGardner,5/31/2014 9:35,1,1,AEs of HM61713 # ASCO14 pic.twitter.com/K1iFcma0xY,,,#,4.72733E+17,https://twitter.com/ByJonGardner/status/472733138964475904,,,,
WayneKoberstein,5/31/2014 9:35,1,1,Waiting for shuttle bus to # ASCO14. @ RfwrightLSLpic.twitter.com/etcCbGocyK,,@,#,4.72733E+17,https://twitter.com/WayneKoberstein/status/472733102394318848,,,,
WilliamDale_MD,5/31/2014 9:35,1,0,"# ASCO14 Balducci: Original clinical model was thorough and complete, but it was time intensive, cost intensive, and personnel intensive.",,,#,4.72733E+17,https://twitter.com/WilliamDale_MD/status/472733091618770944,,,,
rschilsky,5/31/2014 9:35,0,3,# ASCO14 Mitchell: 40% of real world pts with mRCC would not qualify for pivotal clinical trials.,,,#,4.72733E+17,https://twitter.com/rschilsky/status/472733076679036928,,,,
Medicalfacts,5/31/2014 9:35,5,3,"Oncologists should not be gatekeepers on cost, but should be on quality # ASCO14",,,#,4.72733E+17,https://twitter.com/Medicalfacts/status/472733062888185857,,,,
ByJonGardner,5/31/2014 9:35,0,1,PK of HM61713 # ASCO14 pic.twitter.com/nIrF99CNop,,,#,4.72733E+17,https://twitter.com/ByJonGardner/status/472733016293658624,,,,
mtmdphd,5/31/2014 9:35,2,2,# ASCO14 - Abrams - NCTN - ALCHEMIST - Stats Design # lcsmpic.twitter.com/2pz7e6xGqN,,,# #,4.72733E+17,https://twitter.com/mtmdphd/status/472733016159035393,,,,
rsm2800,5/31/2014 9:35,3,2,Vogel: No increase risk of uterine ca in premenopausal women taking tamoxifen for breast ca risk reduction # bcsm # ASCO14,,,# #,4.72733E+17,https://twitter.com/rsm2800/status/472732994856165376,,,,
novembrrr,5/31/2014 9:34,0,1,# ASCO14 pic.twitter.com/V6Et4Oo2N6,,,#,4.72733E+17,https://twitter.com/novembrrr/status/472732959854706690,,,,
AlpineBV_Miller,5/31/2014 9:34,0,0,"Wow. Bring your mukluks to Arie Crown if you're sitting up front. Seriously cold, strong breeze blowing. # ASCO14",,,#,4.72733E+17,https://twitter.com/AlpineBV_Miller/status/472732911134056448,,,,
mtmdphd,5/31/2014 9:34,1,1,# ASCO14 - Abrams - NCTN - ALCHEMIST - follow -omics history of lung cancer patients. # lcsmpic.twitter.com/2nfc16cWXO,,,# #,4.72733E+17,https://twitter.com/mtmdphd/status/472732836579930112,,,,
LguzzardiM,5/31/2014 9:34,0,1,50 Years in BC: Dramatic Progress in Treatment Based On an Improved Understanding of Biology # ASCO14 @ MSKCC_BreastCA http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology …,,@,#,4.72733E+17,https://twitter.com/LguzzardiM/status/472732746520223744,,,,
rsm2800,5/31/2014 9:33,2,0,"Vogel: For tamoxifen, NNT=42 to prevent 1 case of invasive breast cancer. Is that too high or too low? # bcsm # asco14",,,# #,4.72733E+17,https://twitter.com/rsm2800/status/472732690102251520,,,,
mtmdphd,5/31/2014 9:33,1,1,# ASCO14 - Abrams - @ theNCI ALCHEMIST Study Schema # lcsmpic.twitter.com/FWVHNH1LsH,,@,# #,4.72733E+17,https://twitter.com/mtmdphd/status/472732647114801152,,,,
mvillaseca,5/31/2014 9:33,0,0,"New agent for # thyroid cancer: Lenvatinib is “extremely efficient,” produces high response rate, prolongs survival - # ASCO14 press brief",,,# #,4.72732E+17,https://twitter.com/mvillaseca/status/472732496598413312,,,,
ElizBlanchardMD,5/31/2014 9:33,0,0,# ASCO14 Pharma sponsored trials have increasing eligibility requirements--issues for generalizability and access (Ca Ctrl J 2012),,,#,4.72732E+17,https://twitter.com/ElizBlanchardMD/status/472732485579993088,,,,
drdonsdizon,5/31/2014 9:33,1,1,"J Liu @ DanaFarber, LBA5500: Olaprib+cediranib 4 rec # ovca (mBRCA+ or high grade serous/endom) non-chemo, oral option, ?OS # gyncsm # ASCO14",,@,# # #,4.72732E+17,https://twitter.com/drdonsdizon/status/472732480512851968,,,,
DoctorEdny,5/31/2014 9:32,1,1,$ CLVS CO-1686 in NSCLC tumors shrink each time we image," pts who have not responded may still achieve response"" # ASCO14""",,,#,4.72732E+17,https://twitter.com/DoctorEdny/status/472732453904609280,,,
rschilsky,5/31/2014 9:32,1,2,# ASCO14 Mitchell: Real world pts with met. RCC bear little resemblance to trial participants. How can we apply trial results in practice?,,,#,4.72732E+17,https://twitter.com/rschilsky/status/472732452369477632,,,,
mtmdphd,5/31/2014 9:32,1,2,# ASCO14 - Abrams - NCTN - ALCHEMIST - Adj Lung Ca enricHmEnt Marker ID and Sequencing Trial - Precision CA Med Effort pic.twitter.com/Fs7SolqHjW,,,#,4.72732E+17,https://twitter.com/mtmdphd/status/472732444190203904,,,,
WinshipAtEmory,5/31/2014 9:32,1,1,Winship Executive Dir @ wallyjc being interviewed by @ OncLive at # ASCO14 pic.twitter.com/1sWopgBcop,,@ @,#,4.72732E+17,https://twitter.com/WinshipAtEmory/status/472732385696837632,,,,
tomleblancMD,5/31/2014 9:32,2,1,Medication discontinuation: new line of # research with potential to improve QoL and reduce # costofcare: http://ow.ly/xtcqM # ASCO14 # hpm,,,# # # #,4.72732E+17,https://twitter.com/tomleblancMD/status/472732299738742784,,,,
n8pennell,5/31/2014 9:32,0,1,Dong-Wan Kim on HM-61713 in EGFR mut acquired res. needs shorter name for convenient tweeting! # ASCO14,,,#,4.72732E+17,https://twitter.com/n8pennell/status/472732273583079425,,,,
drdonsdizon,5/31/2014 9:32,1,1,"J Liu @ DanaFarber, LBA5500: PFS in Olaparib +/- Cediranib for rec # ovca: mBRCA+: 19.4 v 16.5m; mBRCA- 16.5 v 5.7m. # gyncsm # ASCO14",,@,# # #,4.72732E+17,https://twitter.com/drdonsdizon/status/472732227273383936,,,,
ByJonGardner,5/31/2014 9:31,1,1,Dose escalation of HM61713 # ASCO14 pic.twitter.com/0xbpHU4lCC,,,#,4.72732E+17,https://twitter.com/ByJonGardner/status/472732221934432257,,,,
JFreemanDaily,5/31/2014 9:31,0,0,Phase I CO-1686 effective against EGFR+ NSCLC with T790 acquired mutation. # lcsm # ASCO14,,,# #,4.72732E+17,https://twitter.com/JFreemanDaily/status/472732160538210304,,,,
WilliamDale_MD,5/31/2014 9:31,0,0,# ASCO14 Learning about the original geriatric oncology program from Dr. Balducci. # gerionc,,,# #,4.72732E+17,https://twitter.com/WilliamDale_MD/status/472732090115424257,,,,
mtmdphd,5/31/2014 9:31,2,0,# ASCO14 - Abrams - NCTN - Lung-MAP - Study Design Within Each Sub-study - # lcsmpic.twitter.com/sbioCjaDqT,,,# #,4.72732E+17,https://twitter.com/mtmdphd/status/472732077880664064,,,,
rsm2800,5/31/2014 9:31,0,0,Vogel: Talking on pharmacologic agents to reduce breast ca risk # bcsm # ASCO14,,,# #,4.72732E+17,https://twitter.com/rsm2800/status/472732056749748225,,,,
dmooneymd,5/31/2014 9:31,0,1,58% response even in cns...cool! RT @ JackWestMD: Dr. Sequist on CO1686 in EGFR mutn-pos # LungCancer # ASCO14 # lcsmpic.twitter.com/uHz4jY9Gt1,,@,# # #,4.72732E+17,https://twitter.com/dmooneymd/status/472732022474289153,,,,
drdonsdizon,5/31/2014 9:31,1,0,"J Liu @ DanaFarber, LBA5500: Cediranib+Olaparib signif improved PFS vs olaparib 4 Pt-sens rec # ovca (16.7 v 9.2m) # gyncsm # ASCO14",,@,# # #,4.72732E+17,https://twitter.com/drdonsdizon/status/472731976705638400,,,,
Melanoma_doctor,5/31/2014 9:30,0,0,Fire engines outside at 0800 RT @ matthewherper: Good to know # ASCO14 pic.twitter.com/0me2c6K2wn,,@,#,4.72732E+17,https://twitter.com/Melanoma_doctor/status/472731961996636161,,,,
davidgrahammd,5/31/2014 9:30,5,2,Approachable Researchers: Take This Opportunity to Connect | ASCO Connection http://connection.asco.org/Commentary/Article/ID/3892/Approachable-Researchers-Take-This-Opportunity-to-Connect.aspx … via @ ASCO # ASCO14,,@,#,4.72732E+17,https://twitter.com/davidgrahammd/status/472731940076802048,,,,
JacobPlieth,5/31/2014 9:30,4,2,Cedirinib + olaparib combo in ovarian cancer $ AZN # ASCO14 pic.twitter.com/B3RGb3eBN5,,,#,4.72732E+17,https://twitter.com/JacobPlieth/status/472731932938485760,,,,
mtmdphd,5/31/2014 9:30,3,1,"# ASCO14 - Abrams - NCTN - Lung-MAP partners with pharma. # lcsm Foundation Medicine, Clarientpic.twitter.com/UzMCQbV1gW",,,# #,4.72732E+17,https://twitter.com/mtmdphd/status/472731888579133440,,,,
WCGClinical,5/31/2014 9:30,0,0,# ASCO14 exhibits open at 9 a.m. Would like to meet you at booth 3097.,,,#,4.72732E+17,https://twitter.com/WCGClinical/status/472731838461792256,,,,
DrAttai,5/31/2014 9:30,0,2,Cohen - looking at the relaxation response at the gene level - change in inflammatory gene expression levels. # ASCO14 # bcsm,,,# #,4.72732E+17,https://twitter.com/DrAttai/status/472731824972894208,,,,
Lymphoma_Doc,5/31/2014 9:30,0,1,"Single agent responses: ? wrong assessment of true efficacy, Intelligent combos are key. Busting Robustness # ASCO14 http://bit.ly/1l7EUtj",,,#,4.72732E+17,https://twitter.com/Lymphoma_Doc/status/472731793247186944,,,,
LillyPad,5/31/2014 9:30,4,1,We can and must define value in cancer treatments. # ASCO14 http://ow.ly/xseet,,,#,4.72732E+17,https://twitter.com/LillyPad/status/472731783474454528,,,,
myriadgenetics,5/31/2014 9:30,0,0,Myriad will present data validating the Prolaris test score in predicting # prostatecancer death on MONDAY at # ASCO14. Poster 5059,,,# #,4.72732E+17,https://twitter.com/myriadgenetics/status/472731727060684802,,,,
RamalingamMD,5/31/2014 9:29,3,0,Median PFS likely > 12 months with CO1686 in T790m positive pts # LCSM # ASCO14. Wow!,,,# #,4.72732E+17,https://twitter.com/RamalingamMD/status/472731707221635072,,,,
ByJonGardner,5/31/2014 9:29,0,0,"For reference, I don't know anything about Hanmi Pharma. HM61713 # ASCO14",,,#,4.72732E+17,https://twitter.com/ByJonGardner/status/472731689710800896,,,,
mtmdphd,5/31/2014 9:29,4,2,"# ASCO14 - Abrams - NCTN - Lung-MAP - Round One - PD-L1, PI3K, DCK4/6, FGFR, HGF - # lcsm # clinicaltrialspic.twitter.com/DXI2sEc4gd",,,# # #,4.72732E+17,https://twitter.com/mtmdphd/status/472731607917268992,,,,
carisls,5/31/2014 9:29,2,1,"Molecular analysis of non-epithelial # ovarian cancer by histological subtype, 5/31 8a-11a, S Hall A2 http://goo.gl/UvuGDw # ASCO14 # gyncsm",,,# # #,4.72732E+17,https://twitter.com/carisls/status/472731569200070656,,,,
melanoma_Drs,5/31/2014 9:29,1,0,Upcoming: # dabrafenib + # trametinib + # ipilimumab for # melanoma at # ASCO14 # lookingfortoxicity,,,# # # # # #,4.72732E+17,https://twitter.com/melanoma_Drs/status/472731533980487681,,,,
Melanoma_doctor,5/31/2014 9:29,1,0,Upcoming: # dabrafenib + # trametinib + # ipilimumab for # melanoma at # ASCO14 # lookingfortoxicity,,,# # # # # #,4.72732E+17,https://twitter.com/Melanoma_doctor/status/472731533263261696,,,,
MyelomaTeacher,5/31/2014 9:29,0,0,@ mtmdphd Is exceptional responders 4 solid tumors only? # ASCO14,,@,#,4.72732E+17,https://twitter.com/MyelomaTeacher/status/472731503328497664,,,,
ShannonWestin,5/31/2014 9:28,0,0,30% response rate in PARP/PI3K phase 1 trial! New hope for breast and ovarian cancer. # ASCO14 # gyncsm,,,# #,4.72731E+17,https://twitter.com/ShannonWestin/status/472731429437472768,,,,
DrAttai,5/31/2014 9:28,2,3,Cohen psychological stress can alter the tumor microenvironment via modulation of immune system etc; can lead to progression # ASCO14 # bcsm,,,# #,4.72731E+17,https://twitter.com/DrAttai/status/472731427721998336,,,,
PhRMA,5/31/2014 9:28,2,0,# PhRMA CEO discusses progress we’ve made treating # cancer & what we need to do to cont # progress via @ TheHill http://bit.ly/1nDaGmT # ASCO14,,@,# # # #,4.72731E+17,https://twitter.com/PhRMA/status/472731417785667584,,,,
drdonsdizon,5/31/2014 9:28,0,0,Proud of J Liu @ DanaFarber! Strong work on an important trial! # ASCO14 # gyncsm,,@,# #,4.72731E+17,https://twitter.com/drdonsdizon/status/472731392380375041,,,,
WilliamDale_MD,5/31/2014 9:28,0,0,"# ASCO14 Next up: A Founding Father of geriatric oncology, Dr. Balducci. # gerionc",,,# #,4.72731E+17,https://twitter.com/WilliamDale_MD/status/472731335014891520,,,,
mtmdphd,5/31/2014 9:28,6,2,# ASCO14 - Abrams - NCTN - Umbrella Protocols - LungMAP # SWOGOnc ALCHEMIST and Basket @ theNCI MATCH # clinicaltrialspic.twitter.com/86CyK0DOIc,,@,# # #,4.72731E+17,https://twitter.com/mtmdphd/status/472731266190540800,,,,
Ahhfifah,5/31/2014 9:27,0,0,Pharmaceutical companies always have amazing pens at their booths # ASCO14,,,#,4.72731E+17,https://twitter.com/Ahhfifah/status/472731212922880001,,,,
caitlin_hool,5/31/2014 9:27,0,0,"In the second # ASCO14 press briefing, this one on targeted therapy in NSCLC, thyroid and ovarian # cancer, and CLL. Great stuff!",,,# #,4.72731E+17,https://twitter.com/caitlin_hool/status/472731212654870528,,,,
TargetedOnc,5/31/2014 9:27,2,2,Already getting a lot done here at our first day of # ASCO14. Intravenous coffee please!,,,#,4.72731E+17,https://twitter.com/TargetedOnc/status/472731201858719745,,,,
RamalingamMD,5/31/2014 9:27,0,0,AZ9291 shows Clinical benefit in 94% of # LCSM pts with acquired EGFR TKI resistance T790m # ASCO14,,,# #,4.72731E+17,https://twitter.com/RamalingamMD/status/472731180467769344,,,,
dmooneymd,5/31/2014 9:27,1,0,"A2510: 47 pts, phase I, ovarian or triple neg # bcsm. Combo bkm120 and olaparib. Low toxicity. 20% orr in both cancer types. # ASCO14 # gyncsm",,,# # #,4.72731E+17,https://twitter.com/dmooneymd/status/472731148339384320,,,,
ASCO,5/31/2014 9:27,27,11,"# ASCO14 press brief: Combo of PARP inhibitor + anti-angiogenic improves # ovarian cancer survival, independent of BRCA status",,,# #,4.72731E+17,https://twitter.com/ASCO/status/472731082308485120,,,,
Oncoinfo_it,5/31/2014 9:27,1,0,J.Liu: cediranib + olaparib more active then olaparib alone in # OvarianCancer # ASCO14 pic.twitter.com/UClzMsZJMg,,,# #,4.72731E+17,https://twitter.com/Oncoinfo_it/status/472731031217668096,,,,
JackWestMD,5/31/2014 9:27,1,3,Dr. Sequist on CO1686 in EGFR mutn-pos # LungCancer # ASCO14 # lcsmpic.twitter.com/ftcxEQMmLG,,,# # #,4.72731E+17,https://twitter.com/JackWestMD/status/472730998392623105,,,,
mtmdphd,5/31/2014 9:26,6,1,# ASCO14 - Abrams - @ theNCI Exceptional Responders Initiative - multi-omics planned. Aim for ~100 Ptspic.twitter.com/IdmTzXTFko,,@,#,4.72731E+17,https://twitter.com/mtmdphd/status/472730947213729793,,,,
n8pennell,5/31/2014 9:26,1,1,CO-1686 may be effective first line EGFR mut and not just in resistance per Dr. Sequist. # ASCO14,,,#,4.72731E+17,https://twitter.com/n8pennell/status/472730944743694336,,,,
RielyMD,5/31/2014 9:26,1,0,"Sequist on CO1686 Brain responses observed, but brain progression has occurred as well. # ASCO14",,,#,4.72731E+17,https://twitter.com/RielyMD/status/472730936896151552,,,,
WilliamDale_MD,5/31/2014 9:26,1,0,"# ASCO14 Klepin: What's next for # gerionc? Find experts in all care providers including nursing, social workers, and multiple specialists.",,,# #,4.72731E+17,https://twitter.com/WilliamDale_MD/status/472730895078535168,,,,
DrAttai,5/31/2014 9:26,0,5,Cohen - fascinating discussion about the effects of chronic stress as it relates to cancer. # ASCO14 # bcsm,,,# #,4.72731E+17,https://twitter.com/DrAttai/status/472730826283970562,,,,
KUhlendorf,5/31/2014 9:26,15,8,Jeffrey Abrams describes @ theNCI's efforts to evolve # clinicaltrials strategy to reflect precision medicine # ASCO14 pic.twitter.com/vzJ3VtrwLo,,@,# #,4.72731E+17,https://twitter.com/KUhlendorf/status/472730816951238656,,,,
mtmdphd,5/31/2014 9:25,3,2,# ASCO14 - Abrams - Exceptional Responders pilot - via CTSU OPEN registration -> NCI review -> stratify -> sample pic.twitter.com/jMPAgwP9I9,,,#,4.72731E+17,https://twitter.com/mtmdphd/status/472730711762300928,,,,
n8pennell,5/31/2014 9:25,1,1,CO-1686 also shows responses in the CNS. # ASCO14,,,#,4.72731E+17,https://twitter.com/n8pennell/status/472730694524076032,,,,
rsm2800,5/31/2014 9:25,6,1,"Meyerhardt: Ca survivors are at risk for CVD, DM etc so part of survivorship is maintaing health related to old & new comorbidities # ASCO14",,,#,4.72731E+17,https://twitter.com/rsm2800/status/472730684348309504,,,,
NormandBlais,5/31/2014 9:25,0,1,CNS responses observed with CO-1686 # LCCatASCO # ASCO14,,,# #,4.72731E+17,https://twitter.com/NormandBlais/status/472730649326280704,,,,
DoctorEdny,5/31/2014 9:25,0,0,$ CLVS CO-1686 in PI/II in ORR 58% mPFS will exceed 12 months in NSCLC # ASCO14 pic.twitter.com/F8Z7KoIuDx,,,#,4.72731E+17,https://twitter.com/DoctorEdny/status/472730609807134720,,,,
jefferytrudel,5/31/2014 9:25,0,0,@ adamfeuerstein Stupid signs don't stop crazy people. # ASCO14,,@,#,4.72731E+17,https://twitter.com/jefferytrudel/status/472730586915028992,,,,
NickiDurlester,5/31/2014 9:25,0,1,50 years in # breastcancer Dramatic progress in treatment based on improved understanding of biology @ ASCO @ LguzzardiM http://am.asco.org/50-years-breast-cancer-dramatic-progress-treatment-based-improved-understanding-biology …,,@ @,#,4.72731E+17,https://twitter.com/NickiDurlester/status/472730543323238400,,,,
ASCO,5/31/2014 9:25,10,1,"New agent for # thyroid cancer: Lenvatinib is “extremely efficient,” produces high response rate, prolongs survival - # ASCO14 press brief",,,# #,4.72731E+17,https://twitter.com/ASCO/status/472730502873751552,,,,
DrAttai,5/31/2014 9:25,4,7,"Cohen - cancer"" is many different diseases. Trying to understand relation of stress and mechanisms / survival is very complex # ASCO14""",,,#,4.7273E+17,https://twitter.com/DrAttai/status/472730495818944513,,,,
subatomicdoc,5/31/2014 9:25,1,0,@ matthewherper @ mtmdphd Thank for helping turn gorp into plain language! # ASCO14,,@ @,#,4.7273E+17,https://twitter.com/subatomicdoc/status/472730481554120704,,,,
ByJonGardner,5/31/2014 9:25,0,1,Conclusions re: CO-1686 # ASCO14 $ CLVSpic.twitter.com/vRE29pHpoz,,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472730477712142337,,,,
teamoncology,5/31/2014 9:24,0,0,Interesting. RT @ drattai: L Cohen best predictor of emotional well being after CA Rx = age. Younger pt -&gt; more emotional distress # ASCO14,,@,#,4.7273E+17,https://twitter.com/teamoncology/status/472730435458326529,,,,
carisls,5/31/2014 9:24,1,1,"“Molecular profiling of clear cell # ovarian carcinoma” 5/31 8a-11a E354b, and 11:30 a-12:45p, E354a http://goo.gl/UvuGDw # ASCO14 # gyncsm",,,# # #,4.7273E+17,https://twitter.com/carisls/status/472730402411802624,,,,
djsampson,5/31/2014 9:24,0,0,Meyerhardt: lifestyle studies are hard. Tru dat # ASCO14,,,#,4.7273E+17,https://twitter.com/djsampson/status/472730323495567363,,,,
n8pennell,5/31/2014 9:24,2,1,CO-1686 ORR 58% in EGFR mutant NSCLC T790M across doses. Median PFS not reached but likely >12 months. # ASCO14,,,#,4.7273E+17,https://twitter.com/n8pennell/status/472730305724690432,,,,
ByJonGardner,5/31/2014 9:24,4,3,"PFS curve of CO-1686. Current estimate is median will exceed 12 months"" # ASCO14 $ CLVSpic.twitter.com/8WX2ems2wC""",,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472730288402214912,,,,
rsm2800,5/31/2014 9:24,0,0,"Meyerhardt: Lifestyle studies (for ca prevention) hard to do, intervening on a single lifestyle exposure probably not sufficient # ASCO14",,,#,4.7273E+17,https://twitter.com/rsm2800/status/472730264594948096,,,,
WilliamDale_MD,5/31/2014 9:23,0,1,"# ASCO14 Klepin: If you do geriatric assessment for older adults with cancer, you will identify A LOT of significant impairment. # gerionc",,,# #,4.7273E+17,https://twitter.com/WilliamDale_MD/status/472730158441316352,,,,
ByJonGardner,5/31/2014 9:23,1,3,More efficacy analysis of CO-1686 # ASCO14 $ CLVSpic.twitter.com/lpR8gOwmcF,,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472730036785909760,,,,
rsm2800,5/31/2014 9:23,0,1,"Meyerhardt: 63% of cancer patients taking at least 1 supplement, 52% take MVI (Roswell Park) # ASCO14",,,#,4.7273E+17,https://twitter.com/rsm2800/status/472730012685062145,,,,
mtmdphd,5/31/2014 9:23,0,1,# ASCO14 - Abrams - NCTN - Exceptional Responders Initiative - Phenotype to Genotype - 1-10% Pts outliers pic.twitter.com/oOQDUQxn8K,,,#,4.7273E+17,https://twitter.com/mtmdphd/status/472729972117753856,,,,
NormandBlais,5/31/2014 9:22,1,1,Sequist presents CO-1686 phase I data RR 58% in T790M+ lung cancer pts # LCCatASCO # ASCO14,,,# #,4.7273E+17,https://twitter.com/NormandBlais/status/472729956125245440,,,,
RielyMD,5/31/2014 9:22,1,0,"Sequist on CO-1686 22% grade 3 hyperglycemia, response rate 58% for 40 t790M pos, # ASCO14",,,#,4.7273E+17,https://twitter.com/RielyMD/status/472729943932416000,,,,
ShannonWestin,5/31/2014 9:22,0,0,"“ @ mtmdphd: HINTS (Health Information Trends Survey): 34% of Americans have not heard of a clinical trial. Disturbing news. # ASCO14""",,@,#,4.7273E+17,https://twitter.com/ShannonWestin/status/472729915771457536,,,,
DrAttai,5/31/2014 9:22,7,3,Lorenzo Cohen best predictor of emotional well being after CA treatment = age. Younger pt -> more emotional distress # ASCO14 # bcsm,,,# #,4.7273E+17,https://twitter.com/DrAttai/status/472729868019716096,,,,
ByJonGardner,5/31/2014 9:22,1,1,Efficacy analysis of CO-1686 # ASCO14 $ CLVSpic.twitter.com/U82GSUt3hl,,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472729843004866560,,,,
matthewherper,5/31/2014 9:22,5,14,"I'm at # ASCO14, so lots of gorpy acronym-filled oncology tweets this weekend.",,,#,4.7273E+17,https://twitter.com/matthewherper/status/472729824793210880,,,,
n8pennell,5/31/2014 9:22,1,0,"CO-1686 most common tox nausea and hyperglycemia, only 4% had rash. Doesn't seem to affect wild type EGFR. # ASCO14",,,#,4.7273E+17,https://twitter.com/n8pennell/status/472729765892616193,,,,
jefferytrudel,5/31/2014 9:22,0,0,"@ adamfeuerstein That's right, & if a nut job shoots up this gun-free zone U & the unarmed rent-a-cops can start a hash tag campaign # ASCO14",,@,#,4.7273E+17,https://twitter.com/jefferytrudel/status/472729724226375680,,,,
JacobPlieth,5/31/2014 9:21,1,1,Lenvatinib PFS in Select thyroid cancer study # ASCO14 # Eisaipic.twitter.com/dfU500AKUn,,,# #,4.7273E+17,https://twitter.com/JacobPlieth/status/472729703137419267,,,,
ByJonGardner,5/31/2014 9:21,0,1,AEs of CO-1686 # ASCO14 $ CLVSpic.twitter.com/1j2QE8Q3ms,,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472729661831929857,,,,
dmooneymd,5/31/2014 9:21,0,0,Preclinical synergy between bkm120 (pi3k kinase inhibitor) and olaparib (parp inhibitor) in high grade serous xenograft models. # ASCO14,,,#,4.7273E+17,https://twitter.com/dmooneymd/status/472729628067364864,,,,
mtmdphd,5/31/2014 9:21,0,2,# ASCO14 - Abrams - NCTN - @ theNCI Developing a Natl Strategy for Precision Medicine - adv molecular profilingpic.twitter.com/NpZrIzZ2OT,,@,#,4.7273E+17,https://twitter.com/mtmdphd/status/472729623545933826,,,,
ByJonGardner,5/31/2014 9:21,0,1,PK of CO-1686 # ASCO14 $ CLVSpic.twitter.com/wT3mMGggpa,,,#,4.7273E+17,https://twitter.com/ByJonGardner/status/472729548283731968,,,,
ShannonWestin,5/31/2014 9:21,5,2,Progress. PARP and PI3K are synergistically active in women's cancers. # ASCO14 # gyncsm # SU2C,,,# # #,4.7273E+17,https://twitter.com/ShannonWestin/status/472729515685588992,,,,
cure_magazine,5/31/2014 9:21,1,2,"Investigational drug, lenvatinib, delays cancer progression in thyroid cancer resistant to standard radioiodine. # ASCO14",,,#,4.72729E+17,https://twitter.com/cure_magazine/status/472729499658752000,,,,
rsm2800,5/31/2014 9:20,1,0,Meyerhardt: MVIs & Stage III colon cancer - no association of DFS or OS; but may be connection w/ Vit D # ASCO14,,,#,4.72729E+17,https://twitter.com/rsm2800/status/472729409686753280,,,,
mtmdphd,5/31/2014 9:20,0,0,"# ASCO14 - Abrams - NCTN and NCORP are complementary - share NCI CIRB, other centralized functions pic.twitter.com/W8JFCRiSkx",,,#,4.72729E+17,https://twitter.com/mtmdphd/status/472729400161492992,,,,
WilliamDale_MD,5/31/2014 9:20,0,0,# ASCO14 Klepin: The Cliff Notes version of history of # geriatric # oncology. Great leaders. Improve evidence base. # gerionc,,,# # # #,4.72729E+17,https://twitter.com/WilliamDale_MD/status/472729316145377280,,,,
djsampson,5/31/2014 9:20,0,0,# ASCO14 prevention session: submitted data: SSB drinkers -> 60% increased risk of advanced colon cancer,,,#,4.72729E+17,https://twitter.com/djsampson/status/472729306364252160,,,,
Gene_Antibody,5/31/2014 9:20,0,0,Check us (antibodies) out in this # infographic about evolution of Ph1 clinical trials! # ASCO14 http://ow.ly/xn1Qc,,,# #,4.72729E+17,https://twitter.com/Gene_Antibody/status/472729261267484672,,,,
DrGlenWeiss,5/31/2014 9:20,0,0,Medical oncology fellows come check out @ CancerCenter career booth: CF-1. # clinical # research # trials # ASCO14 @ ASCO,,@ @,# # # #,4.72729E+17,https://twitter.com/DrGlenWeiss/status/472729258486665216,,,,
Oncoinfo_it,5/31/2014 9:20,0,0,Conclusion on SELECT by M.Schlumberger # ASCO14 pic.twitter.com/vHriDDatlW,,,#,4.72729E+17,https://twitter.com/Oncoinfo_it/status/472729252102963200,,,,
DrAttai,5/31/2014 9:19,3,4,"Cassileth most alternative"" therapies are expensive", ineffective," and may be downright dangerous. # ASCO14 # bcsm""",,,# #,4.72729E+17,https://twitter.com/DrAttai/status/472729198378090497,,
ByJonGardner,5/31/2014 9:19,1,1,Dose levels of CO-1686 # ASCO14 $ CLVSpic.twitter.com/nOxHIwTnqA,,,#,4.72729E+17,https://twitter.com/ByJonGardner/status/472729150957289472,,,,
dmooneymd,5/31/2014 9:19,0,1,A2510: oral bkm120 and olaparib for high grade ovarian and breast cancer. # bcsm # ASCO14,,,# #,4.72729E+17,https://twitter.com/dmooneymd/status/472729060452605952,,,,
SJNaggiar,5/31/2014 9:19,0,1,What's new in targeted therapies? How improved understanding of cancer biology allows for targeting tumors more precisely. # ASCO2014,,,#,4.72729E+17,https://twitter.com/SJNaggiar/status/472729027669929984,,,,
rsm2800,5/31/2014 9:19,1,1,Meyerhardt: Observational studies of diet/colon ca (no prspctiv trials)-assoc of glycemic load & Stage 3; BMI might be less impt # ASCO14,,,#,4.72729E+17,https://twitter.com/rsm2800/status/472728999982931970,,,,
OSUCCC_James,5/31/2014 9:19,2,0,"Ibrutinib improved profession free survival, overall survival and response compared to Ofatumumab. # ASCO14 pic.twitter.com/FvwXZgRkCT",,,#,4.72729E+17,https://twitter.com/OSUCCC_James/status/472728982669238272,,,,
DanBudwick,5/31/2014 9:19,0,0,Here's this AM's PR on @ FoundationATCG & @ TheUSONetwork study on impact of FoundationOne on treatment http://investors.foundationmedicine.com/releasedetail.cfm?ReleaseID=851588 … # ASCO14,,@ @,#,4.72729E+17,https://twitter.com/DanBudwick/status/472728962079395840,,,,
mtmdphd,5/31/2014 9:19,0,1,# ASCO14 - Abrams - NCTN - LAPS provide leadership in development and conduct of CTs in assoc with the adult CT groups,,,#,4.72729E+17,https://twitter.com/mtmdphd/status/472728961181810688,,,,
NormandBlais,5/31/2014 9:18,1,1,Great news: FDA grant breakthrough drug status to AZD9291 for T790M+ lung cancer progressing after EGFR TKI therapy # LCCatASCO # ASCO14,,,# #,4.72729E+17,https://twitter.com/NormandBlais/status/472728953179099136,,,,
Ludwig_Cancer,5/31/2014 9:18,1,1,MT @ ASCO: Ludwig’s Jedd Wolchok in Q&A w/ Cancer Ed Cmte Chairs on intersection of science & value at # ASCO14. See http://bit.ly/1gALudr,,@,#,4.72729E+17,https://twitter.com/Ludwig_Cancer/status/472728905577943040,,,,
scientre,5/31/2014 9:18,1,1,Gupta: MK8669 (ridaforolimus; MTor) + MK2206 (AKT inhib) for more complete PI3K pathway inhibition # ASCO14,,,#,4.72729E+17,https://twitter.com/scientre/status/472728902105063425,,,,
davidgrahammd,5/31/2014 9:18,1,1,ASCO University editorial board currently meeting to improve how we serve our members. Suggestions or ideas? # ASCO14,,,#,4.72729E+17,https://twitter.com/davidgrahammd/status/472728866310881280,,,,
ERPlimackMD,5/31/2014 9:18,0,5,@ UrologyMatch @ FCUroOnc @ dytcmd @ uretericbud Thx for the warm welcome! GU immunotherapy session is today at # asco2014 # gusm stay tuned!,,@ @ @ @,# #,4.72729E+17,https://twitter.com/ERPlimackMD/status/472728838070214656,,,,
GailGazelleMD,5/31/2014 9:18,0,0,. @ ACCInTouch @ ASCO @ AmCollSurgeons @ ASALifeline http://bit.ly/1oUx2NV JAMA RCT reveals mindfulness and reflection fight burnout.,,@ @ @ @,,4.72729E+17,https://twitter.com/GailGazelleMD/status/472728824065826816,,,,
mtmdphd,5/31/2014 9:18,1,1,# ASCO14 - Abrams - NCTN Structure - Centralized review and functions pic.twitter.com/uaTVfsHV1h,,,#,4.72729E+17,https://twitter.com/mtmdphd/status/472728804461670401,,,,
MaverickNY,5/31/2014 9:18,2,1,1st presentation on ridaforolimus (mTOR) plus MK2206 (Akt) in low RAS breast cancer & PTEN deficient prostate cancer # asco14 weak efficacy,,,#,4.72729E+17,https://twitter.com/MaverickNY/status/472728804155482112,,,,
DrR_DUNNE,5/31/2014 9:18,0,0,Ready for day 2 of # ASCO14 after rewarding day 1 at my first of many annual meetings,,,#,4.72729E+17,https://twitter.com/DrR_DUNNE/status/472728768268627968,,,,
robinwarshaw,5/31/2014 9:18,0,0,RT: Treatment helps young women preserve their fertility during breast # cancer chemotherapy # ASCO2014 http://go.usa.gov/8yJW @ StupidCancer,,@,# #,4.72729E+17,https://twitter.com/robinwarshaw/status/472728736262283264,,,,
ByJonGardner,5/31/2014 9:18,0,0,"The EGFR session is in the Seagull Room."" Can't wait to listen to my recording. # ASCO14""",,,#,4.72729E+17,https://twitter.com/ByJonGardner/status/472728718398746624,,,,
DrAttai,5/31/2014 9:18,2,4,"Cassileth - the dark side"" to complementary / integrative therapies = quackery. # ASCO14 # bcsm""",,,# #,4.72729E+17,https://twitter.com/DrAttai/status/472728703395708928,,,,
tomleblancMD,5/31/2014 9:17,0,0,"Media coverage of @ PCRCgroup statin discontinuation trial. Practical, important results! http://ow.ly/xtaaR # hpm # ASCO14",,@,# #,4.72729E+17,https://twitter.com/tomleblancMD/status/472728700807811072,,,,
TracyW95,5/31/2014 9:17,0,0,Hey @ DivvyBikes I see 'my' blue bike and would love to pedal to # ASCO14 but is there a docking station over at # McCormickPlace,,@,# #,4.72729E+17,https://twitter.com/TracyW95/status/472728685246558208,,,,
mtmdphd,5/31/2014 9:17,2,0,"# ASCO14 - Abrams - NCTN = National Clinical Trials Network - March 2014 five centers, 30 LAPS, 7 ITSA, 1 Imaging/RadOnc Core, 1 Canadian grp",,,#,4.72729E+17,https://twitter.com/mtmdphd/status/472728602266832896,,,,
yzafar,5/31/2014 9:17,4,1,"Stopping statins doesn't worsen cancer outcome, may improve QOL, decrease costs http://bit.ly/1kuTtJ1 # ASCO14 @ donaldhtaylorjr @ PCRCGroup",,@ @,#,4.72728E+17,https://twitter.com/yzafar/status/472728480824958976,,,,
n8pennell,5/31/2014 9:17,0,0,Lecia Sequist now talking about CO-1686 now in EGFR mutant acquired resistance. # ASCO14,,,#,4.72728E+17,https://twitter.com/n8pennell/status/472728461023662080,,,,
dmooneymd,5/31/2014 9:16,0,0,"Combo mtor and akt inhibition with <10% grade 3/4 events at mtd. 2/18 pr, 7/18 sd. Heavily pretreated. Both pr over 250 days. # bcsm # ASCO14",,,# #,4.72728E+17,https://twitter.com/dmooneymd/status/472728428878110720,,,,
teamoncology,5/31/2014 9:16,1,1,Sustaining your energy and receiving cancer treatment is the two different things. Some docs and patients do not understand this. # ASCO14,,,#,4.72728E+17,https://twitter.com/teamoncology/status/472728421936541697,,,,
BayerPharma,5/31/2014 9:16,2,2,# DYK there are 663K CRC cases in men and 571K cases in women. We discuss # CRC at # ASCO14. # crcsm http://twitpic.com/e54z4m,,,# # # #,4.72728E+17,https://twitter.com/BayerPharma/status/472728360268103681,,,,
DanBudwick,5/31/2014 9:16,0,0,Study by @ FoundationATCG & @ TheUSONetwork - FoundationOne results prompted change in Rx decisions for 28% of patients tested # ASCO14,,@ @,#,4.72728E+17,https://twitter.com/DanBudwick/status/472728290621673472,,,,
subatomicdoc,5/31/2014 9:16,10,5,Survival in metastatic colorectal cancer (mCRC) based on primary site: Results from the S. Australia http://abstracts.asco.org/144/AbstView_144_125549.html … # crcsm # ASCO14,,,# #,4.72728E+17,https://twitter.com/subatomicdoc/status/472728227300253696,,,,
laurentingels,5/31/2014 9:16,0,1,# ASCO14 Press Conference pic.twitter.com/EH80pFmMxi,,,#,4.72728E+17,https://twitter.com/laurentingels/status/472728217229742082,,,,
ShannonWestin,5/31/2014 9:16,0,0,Combo of AKT and mTOR inhibition is safe and shows promising early efficacy in molecularly selected breast and prostate ca. # ASCO14,,,#,4.72728E+17,https://twitter.com/ShannonWestin/status/472728217150050304,,,,
WilliamDale_MD,5/31/2014 9:16,1,0,# ASCO14 Klepin: The importance of complexity and individualization in treating older adults. # gerionc,,,# #,4.72728E+17,https://twitter.com/WilliamDale_MD/status/472728206382862337,,,,
mtmdphd,5/31/2014 9:16,2,0,# ASCO14 - Abrams - NCTN - Recent NCTN Milestones - @ theNCI launched CT Coop Group Prog in late 1950'spic.twitter.com/K5CiiIBDEP,,@,#,4.72728E+17,https://twitter.com/mtmdphd/status/472728202943934464,,,,
JacobPlieth,5/31/2014 9:15,3,2,Resonate conclusion slide $ PCYC # ASCO14 pic.twitter.com/PZeb9hVXuS,,,#,4.72728E+17,https://twitter.com/JacobPlieth/status/472728172216479745,,,,
adamfeuerstein,5/31/2014 9:15,3,3,"$ AZN '9291 ORR updated 53%, 54% at chosen 8mg dose. In T790m+ pats ORR 64%, 68% at 80mg dose # ASCO14",,,#,4.72728E+17,https://twitter.com/adamfeuerstein/status/472728169410465792,,,,
teamoncology,5/31/2014 9:15,2,0,One of the big myths is that current cancer treatments will provide a quick energy fix for cancer patients. No. # ASCO14,,,#,4.72728E+17,https://twitter.com/teamoncology/status/472728156185456640,,,,
rsm2800,5/31/2014 9:15,2,1,Meyerhardt: For breast ca WINS study effect on DFS greatest for ER neg; so may be due more to weight not fat intake # bcsm # ASCO14,,,# #,4.72728E+17,https://twitter.com/rsm2800/status/472728151856906241,,,,
JackWestMD,5/31/2014 9:15,6,1,Dr. Janne on AZD9291 for acquired EGFR mutn-pos # LungCancer # ASCO14 pic.twitter.com/BIa732lGn8,,,# #,4.72728E+17,https://twitter.com/JackWestMD/status/472728151400132608,,,,
Oncoinfo_it,5/31/2014 9:15,0,0,RESONATE by JCByrd: ibrunitinib as an effective new patient friendly therapy 4 CLL/SLL patients # ASCO14 pic.twitter.com/mHJnqvOvCc,,,#,4.72728E+17,https://twitter.com/Oncoinfo_it/status/472728112321798144,,,,
jrgralow,5/31/2014 9:15,1,0,ASCO Proposes Overhaul of Medicare’s Oncology Payment System http://shar.es/V9cOx # ASCO14,,,#,4.72728E+17,https://twitter.com/jrgralow/status/472728102917791745,,,,
ChrisMLindgren,5/31/2014 9:15,0,0,@ JonEPVantage Glad to have you back in the USA. Hope you wore your most comfy sneaks for # ASCO14,,@,#,4.72728E+17,https://twitter.com/ChrisMLindgren/status/472728077387456512,,,,
SpryPub,5/31/2014 9:15,0,0,"Stop by our booth TODAY between 10-11 to get your copy of Survivorship"" signed by Dr. Cassileth! http://ow.ly/xrt12 # ASCO14""",,,#,4.72728E+17,https://twitter.com/SpryPub/status/472728049373683712,,,,
WinshipAtEmory,5/31/2014 9:15,1,1,Huge crowd at # ASCO14 # lungcancer session on targeting EGFR.pic.twitter.com/lU4tXnNxI9,,,# #,4.72728E+17,https://twitter.com/WinshipAtEmory/status/472728038401392640,,,,
rschilsky,5/31/2014 9:15,0,0,Speaker @session Optimizing Access to Clinical Trial in Community Practice E253 “Clinical Trials in the Community: Moving Forward” # ASCO14,,@session,#,4.72728E+17,https://twitter.com/rschilsky/status/472728024753115136,,,,
genentech,5/31/2014 9:15,0,2,Question for @ CliffordHudis @ YupOnc: What cancer advancements will the # Next50 yrs bring? # ASCO14,,@ @,# #,4.72728E+17,https://twitter.com/genentech/status/472728019959054336,,,,
scientre,5/31/2014 9:15,0,0,"Combo session this AM w examples of 3 approaches: parallel pathways, diff steps in same pathway, same target different mechanism # ASCO14",,,#,4.72728E+17,https://twitter.com/scientre/status/472728016074711041,,,,
SarahCannonDocs,5/31/2014 9:15,0,0,Don't miss Clinical Science Symposium on #11010 Sat 8-9:30 S406 Exp biomarker analysis ph I study of AZD4547 # DrArkenau # ASCO14,,,#11010 # #,4.72728E+17,https://twitter.com/SarahCannonDocs/status/472727981820235778,,,,
m_e_nielsen,5/31/2014 9:15,0,1,MT @ corp_unc: Geographic var'n in hi-risk uterine cancer & access to care @dollhouse815 et al @ unchpm # asco14 http://ow.ly/xs6QK,,@ @dollhouse815 @,#,4.72728E+17,https://twitter.com/m_e_nielsen/status/472727971825197057,,,,
mtmdphd,5/31/2014 9:14,5,0,# ASCO14 - Abrams - NCTN - Cooperative Groups: Structure of Clinical Trials Program Prior to NCTN pic.twitter.com/UjRzIFcoI8,,,#,4.72728E+17,https://twitter.com/mtmdphd/status/472727937121525760,,,,
ASCO,5/31/2014 9:14,8,0,"# ASCO14 press briefing: New agent for leukemia, ibrutinib, signif. prolongs survival in phase III study. # lylsm",,,# #,4.72728E+17,https://twitter.com/ASCO/status/472727839926943744,,,,
DrAttai,5/31/2014 9:14,13,13,Dr. Cassileth - a crucial component of integrative oncology is EXERCISE # ASCO14 # bcsm,,,# #,4.72728E+17,https://twitter.com/DrAttai/status/472727797258289152,,,,
teamoncology,5/31/2014 9:14,0,0,When you routine life style can not be maintained. RT @ jrgralow: When is a cancer drug too pricey? # ASCO14 http://www.fiercepharma.com/story/asco-tackles-tough-question-when-cancer-drug-too-pricey/2014-05-30?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4nVIZG6mwQ.twitter …,,@,# #,4.72728E+17,https://twitter.com/teamoncology/status/472727797039767552,,,,
digibrand,5/31/2014 9:14,0,0,Stunning data for advanced # NSCLC 3rd generation EGFR TKI # AZD9291 here in Chicago # ASCO2014,,,# # #,4.72728E+17,https://twitter.com/digibrand/status/472727774382534656,,,,
jrgralow,5/31/2014 9:14,2,2,Where we stand in the fight against cancer # ASCO14 http://fw.to/8QryhqC,,,#,4.72728E+17,https://twitter.com/jrgralow/status/472727752479485952,,,,
rsm2800,5/31/2014 9:13,8,1,"Meyerhardt: Evidence that fruits/vegetables helpful in primary prevention of cancer is weakening, likely related to energy balance # ASCO14",,,#,4.72728E+17,https://twitter.com/rsm2800/status/472727626923012096,,,,
WilliamDale_MD,5/31/2014 9:13,0,0,# ASCO14 Klepin: There are big differences between older adults in trials and those typically in clinic. # gerionc,,,# #,4.72728E+17,https://twitter.com/WilliamDale_MD/status/472727557071048704,,,,
n8pennell,5/31/2014 9:13,2,0,"AZD9291 looks very promising for T790M + pts, less so for other mechanisms of acquired res. phase 3 in this setting planned. # ASCO14",,,#,4.72728E+17,https://twitter.com/n8pennell/status/472727556027084800,,,,
DoctorEdny,5/31/2014 9:13,0,0,$ AZN AZD9291 in NSCLC likely PFS benefit in T790M pos pts # ASCO14 pic.twitter.com/aQV4UcK597,,,#,4.72728E+17,https://twitter.com/DoctorEdny/status/472727548397637632,,,,
DrMisialek,5/31/2014 9:13,0,0,Phase 3 Study Strengthens Support of Ibrutinib as Second-line Therapy for CLL http://shar.es/V9c5v @ OSUCCC_James @ NEJM # ASCO14,,@ @,#,4.72728E+17,https://twitter.com/DrMisialek/status/472727509776474112,,,,
mtmdphd,5/31/2014 9:13,0,0,# ASCO14 - Robert - Comm CA Res # clinicaltrials - CRF is a solution-oriented venue for community research sites to overcome barriers to CT,,,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472727475622281216,,,,
jrgralow,5/31/2014 9:13,0,0,. @ ASCO tackles a tough question: When is a cancer drug too pricey? # ASCO14 http://www.fiercepharma.com/story/asco-tackles-tough-question-when-cancer-drug-too-pricey/2014-05-30?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4nVIZG6mwQ.twitter …,,@,# #,4.72727E+17,https://twitter.com/jrgralow/status/472727471595339776,,,,
DrAttai,5/31/2014 9:13,13,6,"Dr. Cassileth data promising"" but not yet strong for acupuncture in chemo-induced peripheral neuropathy"," also for lymphedema # ASCO14 # bcsm""",,,# #,4.72727E+17,https://twitter.com/DrAttai/status/472727444873822208,,,
teamoncology,5/31/2014 9:12,3,1,【 # ASCO14 Update】 Here is a very helpful infogram about the progress of # breastcancer http://am.asco.org/progress-breast-cancer-research … # bcsm,,,# # #,4.72727E+17,https://twitter.com/teamoncology/status/472727437072011265,,,,
JacobPlieth,5/31/2014 9:12,0,0,"Dr Perol: ramu effect consistent across subgroups, incl non-squam & squam Revel $ LLY # ASCO14",,,#,4.72727E+17,https://twitter.com/JacobPlieth/status/472727327039037441,,,,
carisls,5/31/2014 9:12,2,2,Caris presents data using # MolecularIntel tumor profiling to guide therapy for # ovarian and # breastcancer http://goo.gl/UvuGDw # ASCO14,,,# # # #,4.72727E+17,https://twitter.com/carisls/status/472727272831856640,,,,
mtmdphd,5/31/2014 9:12,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials - Can QOPI help us with clinical trials in the academic and community settings?,,,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472727262497107968,,,,
teamoncology,5/31/2014 9:12,0,0,"【 # ASCO14 101】 As we age, there will be more cancer. Unfortunately the genome gets unstable as we age.",,,#,4.72727E+17,https://twitter.com/teamoncology/status/472727229244243969,,,,
ByJonGardner,5/31/2014 9:12,0,2,PFS of AZD9291 in T790M mutation # ASCO14 $ AZNpic.twitter.com/6PONGGReVc,,,#,4.72727E+17,https://twitter.com/ByJonGardner/status/472727203688763392,,,,
DrAttai,5/31/2014 9:12,3,4,"Dr. Cassileth many benefits to acupuncture - help with joint pains, chemo-induced nausea, hot flashes, xerostomia (dry mouth) # ASCO14 # bcsm",,,# #,4.72727E+17,https://twitter.com/DrAttai/status/472727199045664768,,,,
n8pennell,5/31/2014 9:11,0,1,AZD9291 in non T790M pts who had recent TKI only 11% ORR. # ASCO14,,,#,4.72727E+17,https://twitter.com/n8pennell/status/472727185875144704,,,,
michellevangeld,5/31/2014 9:11,0,0,# neoadjuvant therapy MT @ JNCI_Now: Testing alternate regimens of targeted drugs to overcome resistance to chemo in # ovariancancer # ASCO14,,@,# # #,4.72727E+17,https://twitter.com/michellevangeld/status/472727182117064705,,,,
AndyBiotech,5/31/2014 9:11,3,5,$ CLVS CO-1686: 58% ORR in T790M # NSCLC http://finance.yahoo.com/news/clovis-oncology-co-1686-demonstrates-130000586.html … # ASCO14 $ AZN AZD9291: 64% ORR in T790M pic.twitter.com/pEuFxg7PwB @ JonEPVantage,,@,# #,4.72727E+17,https://twitter.com/AndyBiotech/status/472727166413996032,,,,
mtmdphd,5/31/2014 9:11,0,0,# ASCO14 - Robert - Comm CA Res # clinicaltrials - @ ASCO CRF looking at reducing redundancy esp regulatory concerns pic.twitter.com/HiLTM2qxhN,,@,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472727154938380288,,,,
jrgralow,5/31/2014 9:11,3,2,"In treating some cancer patients, less is more # ASCO14 http://reut.rs/SkmMmm",,,#,4.72727E+17,https://twitter.com/jrgralow/status/472727091247468544,,,,
dmooneymd,5/31/2014 9:11,0,1,"Low ras gene signature implies increased breast cancer dependence of pi3k/akt/mtor pathway. 50% of er +, 30% of er -. # bcsm # ASCO14",,,# #,4.72727E+17,https://twitter.com/dmooneymd/status/472727077964500992,,,,
xavigranda,5/31/2014 9:11,0,0,Buenos días desde @ asco pic.twitter.com/3dYnNrzaAC,,@,,4.72727E+17,https://twitter.com/xavigranda/status/472727075955417088,,,,
yzafar,5/31/2014 9:11,0,0,@ DrMiguelPerales @ drdonsdizon @ ASCO important part of the discussion # ASCO14,,@ @ @,#,4.72727E+17,https://twitter.com/yzafar/status/472727039599198208,,,,
WilliamDale_MD,5/31/2014 9:11,0,0,# ASCO14 Klepin: IOM report on care crisis is primarily an issue of aging. # gerionc,,,# #,4.72727E+17,https://twitter.com/WilliamDale_MD/status/472726998431715328,,,,
MLIWI,5/31/2014 9:11,0,0,# Cancer remission is the goal. Help us get there. Join Us. # ASCO14 # MLIWI http://buff.ly/SjINBT,,,# # #,4.72727E+17,https://twitter.com/MLIWI/status/472726969638191105,,,,
teamoncology,5/31/2014 9:11,0,0,【 # ASCO14 Update】 REVEL: Adding ramucirumab to docetaxel in the 2nd-line Rx of met lung caver is effective. http://abstracts.asco.org/144/AbstView_144_126433.html …,,,#,4.72727E+17,https://twitter.com/teamoncology/status/472726944446824448,,,,
mtmdphd,5/31/2014 9:10,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials - how many training sessions for GCP etc do you have to do? It's getting harder...,,,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472726913635868672,,,,
ByJonGardner,5/31/2014 9:10,0,2,Duration of response of AZD9291 # ASCO14 $ AZNpic.twitter.com/OjOEqjKXw0,,,#,4.72727E+17,https://twitter.com/ByJonGardner/status/472726902252531712,,,,
drdonsdizon,5/31/2014 9:10,0,0,"Published same day as presentation! MT @ NEJM RESONATE: Ibrutinib improves PFS, OS, ad RR in prev treated CLL. # ASCO14 http://nej.md/1hvgQ05",,@,#,4.72727E+17,https://twitter.com/drdonsdizon/status/472726900587368448,,,,
n8pennell,5/31/2014 9:10,0,1,"AZD9291 duration of response data really too short to draw conclusions, longest 7 months and counting. # ASCO14",,,#,4.72727E+17,https://twitter.com/n8pennell/status/472726895961075712,,,,
mtmdphd,5/31/2014 9:10,0,0,"# ASCO14 - Nick Robert, MD - Community CA Res # clinicaltrials - Resources for Researcherspic.twitter.com/0X54qbVDdE",,,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472726869956374528,,,,
YaleCancer,5/31/2014 9:10,6,8,Best tie at # asco14 pic.twitter.com/DXAtkiYBWv,,,#,4.72727E+17,https://twitter.com/YaleCancer/status/472726824272019456,,,,
SnupSnus,5/31/2014 9:10,0,0,I'll stop the ranting now don't want to to interfere with the # ASCO14 stream to much - hope everyone of you there enjoys it!,,,#,4.72727E+17,https://twitter.com/SnupSnus/status/472726795507482624,,,,
RielyMD,5/31/2014 9:10,1,0,"Janne on azd9291, overall response rate (all doses) 53%, not particularly affected by dose, in T790M neg response rate was 22% # ASCO14",,,#,4.72727E+17,https://twitter.com/RielyMD/status/472726788775243777,,,,
jrgralow,5/31/2014 9:10,0,2,S0230: Drug helps breast cancer patients keep fertility. http://wtim.es/1wG2Kmp # ASCO14 # SWOGonc,,,# #,4.72727E+17,https://twitter.com/jrgralow/status/472726786342547458,,,,
boehringerus,5/31/2014 9:10,0,0,HCPs: Visit booth 4079 at # ASCO14 to learn about BI's robust and growing # oncology # pipeline,,,# # #,4.72727E+17,https://twitter.com/boehringerus/status/472726780789678080,,,,
Emory_R,5/31/2014 9:10,0,2,@ AndyBiotech @ tabuhasna will be interesting to compare data dump returns to performance during # ASCO14 http://buff.ly/1mAbofs,,@ @,#,4.72727E+17,https://twitter.com/Emory_R/status/472726768227733504,,,,
jagasquet,5/31/2014 9:09,1,0,@ AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at # ASCO14 http://finance.yahoo.com/news/abbvie-presents-results-studies-investigational-120000424.html …,,@,#,4.72727E+17,https://twitter.com/jagasquet/status/472726685553795072,,,,
ByJonGardner,5/31/2014 9:09,0,1,*THIS* Is response rate in T790M mutation # ASCO14 $ AZNpic.twitter.com/KiFxgShzHf,,,#,4.72727E+17,https://twitter.com/ByJonGardner/status/472726618906300416,,,,
n8pennell,5/31/2014 9:09,0,1,"AZD9291 overall response rate 53% in 205 acquired resistant pts, 107 T790M pts 64% # ASCO14",,,#,4.72727E+17,https://twitter.com/n8pennell/status/472726609452339200,,,,
mtmdphd,5/31/2014 9:09,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials - ASCO Res Program Quality Assessment Tool - avail @ ASCO pic.twitter.com/uilXuu7vmS,,@,# #,4.72727E+17,https://twitter.com/mtmdphd/status/472726532197466113,,,,
ASCO,5/31/2014 9:09,7,3,# ASCO14 press conf: 2nd-line addition of ramucirumab improves lung cancer survival in phase III study. # lcsm,,,# #,4.72727E+17,https://twitter.com/ASCO/status/472726502585667584,,,,
Oncoinfo_it,5/31/2014 9:09,0,0,Conclusion on REVERAL by @ MP_3855 # ASCO14 pic.twitter.com/Hbcib9Z5Vp,,@,#,4.72726E+17,https://twitter.com/Oncoinfo_it/status/472726472114077696,,,,
teamoncology,5/31/2014 9:09,0,0,【 # ASCO14 101】 Ofatumumab is an anti-CD20 antibody.,,,#,4.72726E+17,https://twitter.com/teamoncology/status/472726470058471424,,,,
WilliamDale_MD,5/31/2014 9:09,0,0,# ASCO14 Hy Muss: Thanks to @ ASCO for supporting # gerionc for the last 15 years.,,@,# #,4.72726E+17,https://twitter.com/WilliamDale_MD/status/472726453839089664,,,,
FoundationATCG,5/31/2014 9:08,4,4,"Study finds # FoundationOne informs physician treatment decisions, leading to a therapy switch in 28% of cases # ASCO14 http://bit.ly/1u08BAN",,,# #,4.72726E+17,https://twitter.com/FoundationATCG/status/472726430863077376,,,,
TuteGenomics,5/31/2014 9:08,0,0,# ASCO14 is about to start. Tute is at booth #24086. Learn how genetic interpretation is the future of cancer. pic.twitter.com/Dh6fhkueFF,,,# #24086,4.72726E+17,https://twitter.com/TuteGenomics/status/472726422071824384,,,,
ByJonGardner,5/31/2014 9:08,0,1,Respond rate of AZD9291 in T790M mutation # ASCO14 $ AZNpic.twitter.com/tD3bhn9ZNn,,,#,4.72726E+17,https://twitter.com/ByJonGardner/status/472726377234726912,,,,
dmooneymd,5/31/2014 9:08,0,0,A2509: dual combo therapy targeting pi3k/akt/mtor in advanced breast ca with low ras. Akt and mtor inh to complete blockade. # ASCO14 # bcsm,,,# #,4.72726E+17,https://twitter.com/dmooneymd/status/472726347257622528,,,,
JacobPlieth,5/31/2014 9:08,0,1,Revel ramucirumab $ LLY # ASCO14 pic.twitter.com/QCWtoClFY7,,,#,4.72726E+17,https://twitter.com/JacobPlieth/status/472726321525981184,,,,
teamoncology,5/31/2014 9:08,0,0,"【 # ASCO14 101】 Ibrutinib, a covalent inhibitor of Bruton's tyrosine kinase.",,,#,4.72726E+17,https://twitter.com/teamoncology/status/472726319373901826,,,,
brandonmancini,5/31/2014 9:08,0,0,“ @ theNCI: At # ASCO14? Here are today's sessions involving NCI presenters http://1.usa.gov/1pGAvPW ”,,@,#,4.72726E+17,https://twitter.com/brandonmancini/status/472726317927251968,,,,
mtmdphd,5/31/2014 9:08,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials - Creating Standards to Ensure Access to Quality Researchpic.twitter.com/IqD2wBXq0s,,,# #,4.72726E+17,https://twitter.com/mtmdphd/status/472726299073454081,,,,
drdonsdizon,5/31/2014 9:08,1,0,"It is challenging MT  @ DrMiguelPerales Part of cost discussion needs to look @differential cost of ca drugs in other countries"" # ASCO14""",,@ @differential,#,4.72726E+17,https://twitter.com/drdonsdizon/status/472726280824426496,,,,
ALLIANCE_org,5/31/2014 9:08,1,0,# ASCO14 poster in S Hall A2: Clinical course of patients with oxaliplatin-associated neuropathy: # NCCTG-N08CB http://bit.ly/1tuNGnh,,,# #,4.72726E+17,https://twitter.com/ALLIANCE_org/status/472726264051412992,,,,
PhRMA,5/31/2014 9:08,0,0,. @ leukemiamda @ LillyPad @ myUHC discuss cutting # cancer costs in a joint op-ed via @ thehill http://bit.ly/1tv1yxW # ASCO14,,@ @ @ @,# #,4.72726E+17,https://twitter.com/PhRMA/status/472726238730022912,,,,
jrgralow,5/31/2014 9:08,0,0,LBA505: Fertility Pause Helps Women Have Babies After Chemo. Presentation today breast oral session 3-6 pm. http://nbcnews.to/1k8Dlxz # ASCO14,,,#,4.72726E+17,https://twitter.com/jrgralow/status/472726216248532992,,,,
n8pennell,5/31/2014 9:08,0,0,"AZD9291 toxicity looks good, no DLTs, <5% grade 3 but considerable rash and diarrhea at higher doses. # ASCO14",,,#,4.72726E+17,https://twitter.com/n8pennell/status/472726209970053120,,,,
Rad_Nation,5/31/2014 9:08,3,0,Hepatic oligometastases treated with stereotactic body # radiation: 10-Yr results http://buff.ly/1kPhudB # ASCO14 # radonc,,,# # #,4.72726E+17,https://twitter.com/Rad_Nation/status/472726186549059584,,,,
wordbistro,5/31/2014 9:07,0,0,RT @ JNCI_Now: Pts w/ stage IV NSCLC treated w/ Ramucirumab & standard docetaxel extends survival for pts w/ advanced NSCLC. # ASCO14 # lcsm,,@,# #,4.72726E+17,https://twitter.com/wordbistro/status/472726178403737600,,,,
teamoncology,5/31/2014 9:07,0,0,"【 # ASCO14 Update】 Ibrutinib, compared to ofatumumab, significantly improved PFS & survival among previously Rx’d CLL. http://www.nejm.org/doi/full/10.1056/NEJMoa1400376 …",,,#,4.72726E+17,https://twitter.com/teamoncology/status/472726147541659648,,,,
RielyMD,5/31/2014 9:07,1,1,"Janne on azd9291 201 pts in expansion cohort, mtd not defined, 20 patients treated at 240 mg , very few grade 3 toxicities # ASCO14",,,#,4.72726E+17,https://twitter.com/RielyMD/status/472726142194302976,,,,
mtmdphd,5/31/2014 9:07,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials - Validation of CT workload toolpic.twitter.com/0qKVEhXtQ4,,,# #,4.72726E+17,https://twitter.com/mtmdphd/status/472726077799157760,,,,
ByJonGardner,5/31/2014 9:07,1,4,AEs of AZD9291 in T790M mutation # ASCO14 $ AZNpic.twitter.com/FNWOvDUlI9,,,#,4.72726E+17,https://twitter.com/ByJonGardner/status/472726036741107712,,,,
OSUCCC_James,5/31/2014 9:07,1,0,# TheJames Dr. John Byrd presenting phase 3 data on ibrutinib at # ASCO14 press briefing/published today in NEJM: http://go.osu.edu/huX,,,# #,4.72726E+17,https://twitter.com/OSUCCC_James/status/472726005988085760,,,,
Sermo,5/31/2014 9:07,0,0,We'll be covering # ASCO14 with four physicians inside Sermo. If you're an M.D. or D.O. you can check out daily updates.,,,#,4.72726E+17,https://twitter.com/Sermo/status/472726000791748608,,,,
drdonsdizon,5/31/2014 9:06,0,0,"Words of wisdom! MT  @ AneesChagpar Cost is impt; not just for access but also ."" http://bit.ly/SMmIfF#JOP @ YaleCancer # ASCO14""",,@ @,#JOP #,4.72726E+17,https://twitter.com/drdonsdizon/status/472725918688219136,,,,
mtmdphd,5/31/2014 9:06,0,0,# ASCO14 - Robert - Community CA Res # clinicaltrials associated workload - Rm S100 - come joinpic.twitter.com/eP0ybTvNQ3,,,# #,4.72726E+17,https://twitter.com/mtmdphd/status/472725910295420928,,,,
ByJonGardner,5/31/2014 9:06,0,1,Safety of AZD9291 in T790M mutation # ASCO14 $ AZNpic.twitter.com/rPx2bYokoD,,,#,4.72726E+17,https://twitter.com/ByJonGardner/status/472725907938213888,,,,
sesiegler,5/31/2014 9:06,0,0,"Spoiler: they're still non curative.  @ ASCO: # ASCO14 press briefing. Today's topic: What's new in targeted therapies http://ow.ly/i/5KyP8 """"",,@,#,4.72726E+17,https://twitter.com/sesiegler/status/472725899595747328,,,,
WilliamDale_MD,5/31/2014 9:06,0,0,# ASCO14 We''re off! # gerionc Special Session on care models! Come join us in S103.,,,# #,4.72726E+17,https://twitter.com/WilliamDale_MD/status/472725839763628033,,,,
ByJonGardner,5/31/2014 9:06,0,1,PK of AZD9291 in T790M mutation # ASCO14 $ AZNpic.twitter.com/9d3CXWO0oD,,,#,4.72726E+17,https://twitter.com/ByJonGardner/status/472725776379703296,,,,
SarahCannon_UK,5/31/2014 9:06,1,2,RT @ SarahCannonDocs: Busy start to # ASCO14 with # SCRI today. Join our >70 presentations this weekend http://bit.ly/1kfjJH4 : 10 from UK !,,@,# #,4.72726E+17,https://twitter.com/SarahCannon_UK/status/472725728916545536,,,,
rschilsky,5/31/2014 9:06,0,2,# ASCO14 Where we stand in the fight against cancer http://fw.to/8QryhqC,,,#,4.72726E+17,https://twitter.com/rschilsky/status/472725707961823232,,,,
OncologyTimes,5/31/2014 9:05,0,0,"Monica Morrow stepping down as ASCO Daily News Ed; starting next yr, Ed will be John Sweetenham http://am.asco.org/editor ’s-letter # ASCO14",,,#,4.72726E+17,https://twitter.com/OncologyTimes/status/472725660268769281,,,,
jagasquet,5/31/2014 9:05,0,0,@ Amgen Highlights Results Of Vectibix® ( # panitumumab) Vs # bevacizumab In WT RAS Metastatic # ColorectalCancer # ASCO14 http://finance.yahoo.com/news/amgen-highlights-phase-2-results-120000998.html?.tsrc=applewf …,,@,# # # #,4.72726E+17,https://twitter.com/jagasquet/status/472725577657778176,,,,
WCGClinical,5/31/2014 9:05,1,0,Thoughtful piece: @ mtmdphd Learning to ask the right questions at # ASCO14: http://bit.ly/1kRFkFx CC @ fischmd @ ASCO # ASCOConnection,,@ @ @,# #,4.72726E+17,https://twitter.com/WCGClinical/status/472725536377405440,,,,
ASCO,5/31/2014 9:05,3,4,# ASCO14 press briefing. Today's topic: What's new in targeted therapies http://ow.ly/i/5KyP8,,,#,4.72726E+17,https://twitter.com/ASCO/status/472725523668684800,,,,
mtmdphd,5/31/2014 9:05,0,0,Changing Landscape of Federally Sponsored Trials - # ASCO14 - Robert - # clinicaltrials - Community Research is a moving target,,,# #,4.72726E+17,https://twitter.com/mtmdphd/status/472725505083719680,,,,
DrAttai,5/31/2014 9:05,1,2,"Dr. Cassileth mind-body treatments, nutrition, massage therapy - all forms of integrative / complementary therapy # ASCO14 # bcsm",,,# #,4.72726E+17,https://twitter.com/DrAttai/status/472725503561170944,,,,
genentech,5/31/2014 9:05,0,1,# DIY 75K+ Americans are diagnosed with bladder cancer each yr # gucsm # ASCO14,,,# # #,4.72725E+17,https://twitter.com/genentech/status/472725489208287232,,,,
LillyDiabetes,5/31/2014 9:05,0,0,At # ASCO14 we're celebrating a cancer journey through the painting of a @LlyOncOnCanvas hope mural. Painting starts today. # hopeforward,,@LlyOncOnCanvas,# #,4.72725E+17,https://twitter.com/LillyDiabetes/status/472725489002741760,,,,
Pharmacyclics,5/31/2014 9:05,0,0,Dr. John Byrd from @ OSUCCC_James discusses new IMBRUVICA (ibrutinib) data in the official # ASCO14 press program http://bit.ly/1p6oHGj,,@,#,4.72725E+17,https://twitter.com/Pharmacyclics/status/472725474632663041,,,,
JohnCendpts,5/31/2014 9:04,6,4,Clovis preps for a blockbuster showdown with AstraZeneca = $ CLVS $ AZN # asco14 http://www.fiercebiotech.com/story/clovis-preps-blockbuster-showdown-astrazeneca/2014-05-31 …,,,#,4.72725E+17,https://twitter.com/JohnCendpts/status/472725398649069568,,,,
mtmdphd,5/31/2014 9:04,1,1,The Changing Landscape of Federally Sponsored Trials - # ASCO14 - Robert - Community Research Forum - # clinicaltrialspic.twitter.com/9iK9dD3Hma,,,# #,4.72725E+17,https://twitter.com/mtmdphd/status/472725396837113856,,,,
dmooneymd,5/31/2014 9:04,0,0,Cml is more the outlier than the prototype of how we will have to approach targeted therapy and oncogene addiction in cancer. # ASCO14,,,#,4.72725E+17,https://twitter.com/dmooneymd/status/472725385587589120,,,,
drdonsdizon,5/31/2014 9:04,0,0,@ dmooneymd Hope it was helpful!! In PressBriefing now; # multitasking. # ASCO14,,@,# #,4.72725E+17,https://twitter.com/drdonsdizon/status/472725366713630720,,,,
brentgendleman,5/31/2014 9:04,0,0,# ASCO14 Concept of P4 Medicine to Be Presented by Guest Speaker Dr. Leroy Hood http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4nS2BNxlEk.twitter …,,,# #,4.72725E+17,https://twitter.com/brentgendleman/status/472725308811251712,,,,
CUCancerCenter,5/31/2014 9:04,0,0,Busy day ahead at # ASCO14.,,,#,4.72725E+17,https://twitter.com/CUCancerCenter/status/472725306621427712,,,,
shawnmullings,5/31/2014 9:04,0,0,The big business of Oncology. # ASCO2014 (@ASCO 2014 w/ 2 others) http://4sq.com/1rtncXM,,@ASCO,#,4.72725E+17,https://twitter.com/shawnmullings/status/472725190242467840,,,,
rschilsky,5/31/2014 9:03,11,1,"# ASCO14 In treating some cancer patients, less may be more. http://reut.rs/SkmMmm via @ reuters",,@,#,4.72725E+17,https://twitter.com/rschilsky/status/472725147325960195,,,,
DrAttai,5/31/2014 9:03,0,0,Dr. Cassileth Patients looking for symptom relief. Integrative medicine - non-pharma complementary therapies to control symptoms # ASCO14...,,,#,4.72725E+17,https://twitter.com/DrAttai/status/472725133980078082,,,,
mtmdphd,5/31/2014 9:03,0,0,Changing Landscape of Federally Sponsored Trials # ASCO14 Zon - CCOP -> NCORP Robert - Comm Research Forum Abrams - Future of @ theNCI trials,,@,#,4.72725E+17,https://twitter.com/mtmdphd/status/472725007114567680,,,,
n8pennell,5/31/2014 9:02,0,0,Pasi Janne talking about AZD9291 in EGFR mutant acquired resistance. # ASCO14,,,#,4.72725E+17,https://twitter.com/n8pennell/status/472724921765081088,,,,
Oncoinfo_it,5/31/2014 9:02,0,0,# ASCO14 SELECT: lenvatinib in patients with RR-DTC significantly prolonge median PFS by 14.7 months vs placebo,,,#,4.72725E+17,https://twitter.com/Oncoinfo_it/status/472724845466484737,,,,
rschilsky,5/31/2014 9:02,1,1,# ASCO14 Drug Saves Fertility for Women With Cancer http://nyti.ms/1gJcure,,,#,4.72725E+17,https://twitter.com/rschilsky/status/472724788897525760,,,,
CancerDotNet,5/31/2014 9:02,2,3,Video: @ ASCO Pres Dr. Clifford Hudis @ CliffordHudis abt # ASCO14 study on # fertility presrv & br ca chemo # bcsm http://bit.ly/1kt2vBo,,@ @,# # #,4.72725E+17,https://twitter.com/CancerDotNet/status/472724690294018049,,,,
ASCO,5/31/2014 9:01,11,7,Missed today's # ASCO14 press briefing? View the recording for the latest in targeted therapy: http://bit.ly/QF4Thk,,,#,4.72725E+17,https://twitter.com/ASCO/status/472724669121171456,,,,
DrAttai,5/31/2014 9:01,0,0,First up for me today - integrative oncology # ASCO14 # bcsm,,,# #,4.72724E+17,https://twitter.com/DrAttai/status/472724496223580160,,,,
Roche,5/31/2014 9:01,3,1,Cancer survival rates have increased rapidly in recent years. What might we soon be able to achieve? http://ow.ly/xkNJP # ASCO14,,,#,4.72724E+17,https://twitter.com/Roche/status/472724436471525376,,,,
NovartisScience,5/31/2014 9:01,0,2,LEE011 on tap @ # ASCO14 session “Novel Combination Therapies for Melanoma” TMRW. Details: http://abstracts.asco.org/144/AbstView_144_130034.html …,,@,#,4.72724E+17,https://twitter.com/NovartisScience/status/472724431660646402,,,,
Tony_Calles,5/31/2014 9:00,0,0,Ready for the boss # ASCO14 pic.twitter.com/klZPGhWpF8,,,#,4.72724E+17,https://twitter.com/Tony_Calles/status/472724423058145280,,,,
DrAttai,5/31/2014 9:00,0,4,"Tweeting again today from # ASCO14, will also try to tag w/ # bcsm",,,# #,4.72724E+17,https://twitter.com/DrAttai/status/472724417081262080,,,,
ONAcom,5/31/2014 9:00,0,0,Are you attending ASCO 2014? Come visit the Haymarket Oncology booth (#15081)! # ASCO14,,,#15081 #,4.72724E+17,https://twitter.com/ONAcom/status/472724405295271936,,,,
SarahCannonDocs,5/31/2014 9:00,1,0,Booth 2063 in Zone A is the ultimate destination for clinical excellence @ # ASCO14,,@,#,4.72724E+17,https://twitter.com/SarahCannonDocs/status/472724377843544065,,,,
SarahCannonDocs,5/31/2014 9:00,1,2,Current metastatic pancreatic cancer study (The Rainier Trial) currently is open for enrollment. Learn about the criteria. # ASCO14,,,#,4.72724E+17,https://twitter.com/SarahCannonDocs/status/472724361477382144,,,,
NCIMedia,5/31/2014 9:00,0,1,Here's a list of sessions featuring NCI staff at # ASCO14 that will be taking place today. Check it out: http://1.usa.gov/1nOSCnh,,,#,4.72724E+17,https://twitter.com/NCIMedia/status/472724358428098561,,,,
CRC_Medical,5/31/2014 9:00,0,0,# ASCO14 Attendees! Visit CRC Press Booth #23128 + enter our raffle to win a gift card worth $200.,,,# #23128,4.72724E+17,https://twitter.com/CRC_Medical/status/472724355932504064,,,,
mtmdphd,5/31/2014 9:00,0,0,Learning to ask the right questions at # ASCO14: http://bit.ly/1kRFkFx CC @ fischmd @ ASCO # ASCOConnection,,@ @,# #,4.72724E+17,https://twitter.com/mtmdphd/status/472724277301886978,,,,
pfizer,5/31/2014 9:00,2,3,"Visit the Pfizer Oncology booth at # ASCO14 for info on our clinical development program, enrolling trials & pathways we’re investigating",,,#,4.72724E+17,https://twitter.com/pfizer/status/472724186595876865,,,,
teamoncology,5/31/2014 9:00,1,2,@ subatomicdoc I really believe in that the tweets that is comprehensible to non-medical people are very important. # ASCO14,,@,#,4.72724E+17,https://twitter.com/teamoncology/status/472724182677991424,,,,
medpagetoday,5/31/2014 9:00,4,3,Stopping statins for terminal patients doesn't hasten death and may improve their quality of life # ASCO14 http://bit.ly/1rqtB5P,,,#,4.72724E+17,https://twitter.com/medpagetoday/status/472724181319036928,,,,
myPathMelanoma,5/31/2014 9:00,1,0,Our # ASCO14 Poster Highlight is happening NOW! Myriad myPath # Melanoma Influence of Gene Sign on Melanocytic # Tumors,,,# # #,4.72724E+17,https://twitter.com/myPathMelanoma/status/472724178387214337,,,,
sloan_kettering,5/31/2014 8:59,6,3,. @ CliffordHudis discusses saving fertility after breast cancer w/ @ DrNancyNBCNEWS on @ NBCNightlyNews http://nbcnews.to/1khe2bE # ASCO2014,,@ @ @,#,4.72724E+17,https://twitter.com/sloan_kettering/status/472724101551759360,,,,
ByJonGardner,5/31/2014 8:59,1,0,. @ JacobEPVantage shouldn't let this go to his head. # ASCO14 pic.twitter.com/eRoqofDDpi,,@,#,4.72724E+17,https://twitter.com/ByJonGardner/status/472724022426611712,,,,
Asuragen,5/31/2014 8:59,0,0,"Good morning # Chicago and # ASCO14 attendees. Today is the first day of exhibits, be sure to stop by booth #24089. pic.twitter.com/iiuY22HdHN",,,# # #24089,4.72724E+17,https://twitter.com/Asuragen/status/472723930554187776,,,,
clarisssv,5/31/2014 8:58,0,1,Todo preparado # ASCO14. Lo puedes seguir en @ diariomedicopic.twitter.com/n6CupvDVHU,,@,#,4.72724E+17,https://twitter.com/clarisssv/status/472723782063636480,,,,
subatomicdoc,5/31/2014 8:57,1,0,@ teamoncology Patient care coverage is particularly important at meeting time w/ many away. As I said - exemplary. # ASCO14 @ drattai @ xeni,,@ @ @,#,4.72724E+17,https://twitter.com/subatomicdoc/status/472723591528976384,,,,
Ludwig_Cancer,5/31/2014 8:57,0,0,Check out: Ludwig's Jonathan Cebon's speaking now at # ASCO14 on combining targeted # cancer drugs called kinase inhibitors w/ # immunotherapy,,,# # #,4.72724E+17,https://twitter.com/Ludwig_Cancer/status/472723565142228993,,,,
betht0002,5/31/2014 8:57,0,1,Chicago-bound with @Carolinas # LCI oncologists for # ASCO14!,,@Carolinas,# #,4.72724E+17,https://twitter.com/betht0002/status/472723559102431232,,,,
JacobPlieth,5/31/2014 8:57,0,0,Ramu improves mOS by 1.4 months in Revel. Clinically relevant? $ LLY # ASCO14,,,#,4.72724E+17,https://twitter.com/JacobPlieth/status/472723556590452737,,,,
beerkirk,5/31/2014 8:57,0,0,Seems to be a cab deficient this AM Chicago # ASCO14,,,#,4.72724E+17,https://twitter.com/beerkirk/status/472723527553265664,,,,
dralvaropinto,5/31/2014 8:57,0,0,"Ready to begin the day at # ASCO14, in the Germ Cell Tumors Educational Session pic.twitter.com/hhsOCzZJEW",,,#,4.72724E+17,https://twitter.com/dralvaropinto/status/472723513124859904,,,,
clarisssv,5/31/2014 8:56,0,0,Ya estamos preparados # ASCO14,,,#,4.72723E+17,https://twitter.com/clarisssv/status/472723286137507843,,,,
CDC_Genomics,5/31/2014 8:56,2,1,"It is # Worldnotobaccoday! Smoking, Genomics & Public Health: http://tinyurl.com/mayepvb & http://tinyurl.com/k3dggb3 # ASCO14 pic.twitter.com/bD3l44a3TS",,,# #,4.72723E+17,https://twitter.com/CDC_Genomics/status/472723199218954240,,,,
Oncoinfo_it,5/31/2014 8:56,0,0,# ASCO14 REVEL (docetaxel + ramucirumab) as 2nd-line treatment for advanced NSCLC @ MassimoDiMaio75,,@,#,4.72723E+17,https://twitter.com/Oncoinfo_it/status/472723190708731904,,,,
nanostringtech,5/31/2014 8:55,0,0,"Kilgour et al present “Exploratory biomarker analysis of a phase I study of AZD4547, an inhibitor of FGFR …” # ASCO14 http://abstracts.asco.org/144/AbstView_144_130762.html …",,,#,4.72723E+17,https://twitter.com/nanostringtech/status/472722975473410048,,,,
AlpineBV_Miller,5/31/2014 8:55,0,0,Is it odd I'm really looking forward to seeing what my gold # sgenball is all about? # ASCO14,,,# #,4.72723E+17,https://twitter.com/AlpineBV_Miller/status/472722971271118848,,,,
mtmdphd,5/31/2014 8:55,3,0,. @ ASCO Social Media Info http://ow.ly/xt4Gv # ASCO14 Tweeps: http://ow.ly/xt4GT Ten Tips: http://ow.ly/xt4Kl,,@,#,4.72723E+17,https://twitter.com/mtmdphd/status/472722931110649856,,,,
WCGClinical,5/31/2014 8:54,0,0,Sunset over Chicago last night from The Signature Lounge on the 95th floor of the John Hancock Tower. # ASCO14 pic.twitter.com/WO1inaNno8,,,#,4.72723E+17,https://twitter.com/WCGClinical/status/472722834721353729,,,,
dmooneymd,5/31/2014 8:54,0,1,Representing # uab at css for dual targeted therapy session with Andres forero chairing. # ASCO14,,,# #,4.72723E+17,https://twitter.com/dmooneymd/status/472722802185752576,,,,
DrAttai,5/31/2014 8:54,0,0,@ teamoncology @ xeni sorry you're not at # ASCO14 - hope we get to meet at some point,,@ @,#,4.72723E+17,https://twitter.com/DrAttai/status/472722741196779520,,,,
ShannonWestin,5/31/2014 8:53,0,0,Excited for emerging combination strategies session! These investigators are getting it right. # ASCO14 # gyncsm,,,# #,4.72723E+17,https://twitter.com/ShannonWestin/status/472722656652177410,,,,
BrendonStilesMD,5/31/2014 8:52,4,4,Excited to share our work from @ WeillCornell and @ nyphospital at # asco14 Lots of incredible work here for cancer patients.,,@ @,#,4.72722E+17,https://twitter.com/BrendonStilesMD/status/472722281039691778,,,,
Oncoinfo_it,5/31/2014 8:52,0,0,Our # ASCO14 begin... pic.twitter.com/9cv6BLTTFS,,,#,4.72722E+17,https://twitter.com/Oncoinfo_it/status/472722181831786496,,,,
teamoncology,5/31/2014 8:51,0,0,"@ subatomicdoc @ drattai @ xeni Unfortunately, I am staying home this time to take of care our patients. # ASCO14. Thanks for your kind words.",,@ @ @,#,4.72722E+17,https://twitter.com/teamoncology/status/472722098821922816,,,,
FreemanCo,5/31/2014 8:50,0,1,. @ ASCO Thank YOU for being such an awesome partner! Good luck this wknd on your show!,,@,,4.72722E+17,https://twitter.com/FreemanCo/status/472721772207697921,,,,
Boehringer,5/31/2014 8:50,0,0,We're listening…are you a # lungcancer patient? Tell us your story & help us better understand your world http://bit.ly/1d6Ikr5 # ASCO14,,,# #,4.72722E+17,https://twitter.com/Boehringer/status/472721721423065088,,,,
n8pennell,5/31/2014 8:50,0,0,"Heading to the lung cancer clinical science symposium in D1, join us! # ASCO14",,,#,4.72722E+17,https://twitter.com/n8pennell/status/472721712371347456,,,,
subatomicdoc,5/31/2014 8:50,0,1,@ xeni I will hopefully meet @ drattai IRL at # ASCO14 - met @ teamoncology at @ SWOG. Both are exemplary MDs and advocates # bcsm,,@ @ @ @,# #,4.72722E+17,https://twitter.com/subatomicdoc/status/472721698933182464,,,,
BreastDocUK,5/31/2014 8:50,1,0,Docs who think lifelong follow up needed 'for reassurance' haven't talked to their patients # ASCO14 http://meetinglibrary.asco.org/content/134773-144#.U4nPj68p8sA.twitter …,,,# #,4.72722E+17,https://twitter.com/BreastDocUK/status/472721672848412672,,,,
myriadgenetics,5/31/2014 8:50,1,0,"Myriad myPath # Melanoma presents: Influence of # Gene Signature on Melanocytic Tumors, TODAY 8:00-11:45 am S Hall A at # ASCO14 Poster TPS9111",,,# # #,4.72722E+17,https://twitter.com/myriadgenetics/status/472721657727963137,,,,
CTMMnl,5/31/2014 8:49,0,0,"Congrats to Bob Pinedo, member CTMMnl SuperVisory Board. Today he receives The David A. Karnofsky Memorial Award 2014 in Chicago # ASCO14",,,#,4.72722E+17,https://twitter.com/CTMMnl/status/472721578091106304,,,,
BrendonStilesMD,5/31/2014 8:49,1,1,No survival dif for us in # EsophCa with induction chemo v chemoRT. # asco14 En bloc surgery lessens RT benefit pic.twitter.com/YWhFfsfO7B,,,# #,4.72721E+17,https://twitter.com/BrendonStilesMD/status/472721403666771968,,,,
UpstageLungCanc,5/31/2014 8:48,0,1,ULC attending @ ASCO Annual Meeting in Chicago. 1st day - met with other advocates in lung cancer and connected with BMI,,@,,4.72721E+17,https://twitter.com/UpstageLungCanc/status/472721263354728448,,,,
EIannelli,5/31/2014 8:48,0,0,http://www.cancer.net/research-and-advocacy/research-summaries/caregivers-who-receive-palliative-care-support-immediately-after-advanced-cancer-diagnosis-have … caregivers care 4 better qol # ASCO14 @ cancereu @ kgapo @ favo_it @ InsControCancro @ Cancer_Buzz @ SCinieri @ DoctorNews33,,@ @ @ @ @ @ @,#,4.72721E+17,https://twitter.com/EIannelli/status/472721256127954945,,,,
tgunninkEBD,5/31/2014 8:48,0,0,@ # ASCO14 Excited for day 2!,,@,#,4.72721E+17,https://twitter.com/tgunninkEBD/status/472721179061411840,,,,
drol007,5/31/2014 8:47,0,1,“ @ BreastDocUK: I feel uneasy about a pill for 'chemo brain' but this suggests RCT for donepezil is warranted # ASCO14 http://meetinglibrary.asco.org/content/128460-144#.U4nOmHlrpqs.twitter …”,,@,# #,4.72721E+17,https://twitter.com/drol007/status/472721095863570433,,,,
AndyBiotech,5/31/2014 8:47,2,0,$ PCYC ICYMI NEJM Papers on Resistance Mechanisms for Ibrutinib http://www.nejm.org/doi/pdf/10.1056/NEJMc1402716 … http://www.nejm.org/doi/pdf/10.1056/NEJMoa1400029 … # ASCO14 pic.twitter.com/QFCNGnbuha,,,#,4.72721E+17,https://twitter.com/AndyBiotech/status/472721076532051968,,,,
teamoncology,5/31/2014 8:47,0,0,@ xeni This is why I sometime have a very different perspective from other docs about caner in academia. # ASCO14,,@,#,4.72721E+17,https://twitter.com/teamoncology/status/472721007468236800,,,,
Bronson_Crouch,5/31/2014 8:47,0,0,@ ASCO: # ASCO14 Tweeters infographic http://flip.it/sLdPq Want to follow all? Subscribe to our list http://flip.it/Y7E2W # hcsm,,@,# #,4.72721E+17,https://twitter.com/Bronson_Crouch/status/472720951059427328,,,,
MaverickNY,5/31/2014 8:46,0,0,Wifi is working in Arie Crown this year yee ha! Let's hope it holds up # asco14,,,#,4.72721E+17,https://twitter.com/MaverickNY/status/472720861200646144,,,,
teamoncology,5/31/2014 8:46,0,3,"@ xeni I am one of the few who is cancer researcher, cancer doctor, & cancer patient. 3C. Honored to be one but also sometime :( # ASCO14",,@,#,4.72721E+17,https://twitter.com/teamoncology/status/472720792606633985,,,,
garthsundem,5/31/2014 8:46,0,0,Check out @ Ematich rocking # ASCO14 for @CoCancerCenter !,,@ @CoCancerCenter,#,4.72721E+17,https://twitter.com/garthsundem/status/472720711614599169,,,,
dmooneymd,5/31/2014 8:45,0,0,I plan on being at 3-4 places today at the same time through Twitter and asco website. # ASCO14,,,#,4.72721E+17,https://twitter.com/dmooneymd/status/472720587622608896,,,,
BreastDocUK,5/31/2014 8:45,1,3,I feel uneasy about a pill for 'chemo brain' but this suggests RCT for donepezil is warranted # ASCO14 http://meetinglibrary.asco.org/content/128460-144#.U4nOmHlrpqs.twitter …,,,# #,4.72721E+17,https://twitter.com/BreastDocUK/status/472720565011103744,,,,
catgracesnyder,5/31/2014 8:45,1,0,"Lots of exciting cancer research from # ASCO14 but more importantly, great/caring docs who focus on patient 1st. Love it! Keep it up!",,,#,4.7272E+17,https://twitter.com/catgracesnyder/status/472720475538608128,,,,
UNCurology,5/31/2014 8:45,0,0,"Trends in ADT use among privately insured men with CaP, 2001-2010 S.Ellis, @ m_e_nielsen et al # asco14 http://ow.ly/xqC9x",,@,#,4.7272E+17,https://twitter.com/UNCurology/status/472720475517648896,,,,
Novartis,5/31/2014 8:45,0,1,"We will showcase data at # ASCO14, reinforcing our commitment to advancing patient outcomes http://bit.ly/1n4oXWP",,,#,4.7272E+17,https://twitter.com/Novartis/status/472720457196929024,,,,
ASH_hematology,5/31/2014 8:45,14,3,Patients with chronic lymphocytic leukemia lived longer with ibrutinib versus ofatumumab # ASCO14 http://ow.ly/xt6fq # hematology,,,# #,4.7272E+17,https://twitter.com/ASH_hematology/status/472720449865277440,,,,
CDC_Genomics,5/31/2014 8:44,1,1,Lung Cancer: Can genomic tests improve outcomes? # pm101 http://www.cdc.gov/genomics/update/current.htm#lung … # ASCO14,,,# #lung #,4.7272E+17,https://twitter.com/CDC_Genomics/status/472720353303986176,,,,
WCGClinical,5/31/2014 8:44,0,0,Carb-loading last night on a Chicago delicacy – Lou Malnati's deep-dish pizza – in prep for a busy day today # ASCO14. pic.twitter.com/1lkf5TQlgu,,,#,4.7272E+17,https://twitter.com/WCGClinical/status/472720311105097728,,,,
MediTech_Media,5/31/2014 8:44,0,0,Posters going up for the morning session # ASCO14. We can't wait to see what's new!,,,#,4.7272E+17,https://twitter.com/MediTech_Media/status/472720222865358848,,,,
MatthewHSimmons,5/31/2014 8:44,2,1,"Narrow eligibility criteria improve internal validity, but threaten generalizability of study findings... http://abstracts.asco.org/144/AbstView_144_127782.html … # ASCO14",,,#,4.7272E+17,https://twitter.com/MatthewHSimmons/status/472720185065865217,,,,
dmooneymd,5/31/2014 8:44,0,0,Learning about technology from @ drdonsdizon in the fellows lounge. # ASCO14 # freebreakfast,,@,# #,4.7272E+17,https://twitter.com/dmooneymd/status/472720156326916098,,,,
westr,5/31/2014 8:43,1,0,Nice! RT @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,@,# #,4.7272E+17,https://twitter.com/westr/status/472720068485611520,,,,
DrWaiSun,5/31/2014 8:43,5,2,Ten good tips for Doctors use of social media from the American Society of Clinical Oncology # hcsm # ASCO14 # SoMe http://www.asco.org/sites/www.asco.org/files/asco_socialmedia_card.pdf …,,,# # #,4.7272E+17,https://twitter.com/DrWaiSun/status/472720027959848960,,,,
Medicalfacts,5/31/2014 8:43,1,0,WHO says that 30% of cancer can be prevented by life style changes. # ASCO14,,,#,4.7272E+17,https://twitter.com/Medicalfacts/status/472719983202816000,,,,
teamoncology,5/31/2014 8:42,3,1,WHO thinks that 30% of cancer can be prevented by life style modification. # ASCO14,,,#,4.7272E+17,https://twitter.com/teamoncology/status/472719837752352769,,,,
carisls,5/31/2014 8:42,3,0,"Caris highlights # ovariancancer and metaplastic breast cancer data at # ASCO14, showing the impact of tumor profiling http://goo.gl/VV12lI",,,# #,4.7272E+17,https://twitter.com/carisls/status/472719817145741312,,,,
teamoncology,5/31/2014 8:42,12,7,The median age of cancer diagnosis is 66. So when you have cancer like at mid 40s like myself. You wonder why? # ASCO14,,,#,4.7272E+17,https://twitter.com/teamoncology/status/472719700510511106,,,,
sciencescanner,5/31/2014 8:40,0,0,"With so many trial results particularly in various leukemias, the biggest challenge is to contextualise each new positive result # ASCO14",,,#,4.72719E+17,https://twitter.com/sciencescanner/status/472719268480811010,,,,
CancerDotNet,5/31/2014 8:40,3,3,Pt summary on # CLL: Early research suggests ibrutinib may be effective treatment for older pts # ASCO14 # leusm http://bit.ly/ROLzhV,,,# # #,4.72719E+17,https://twitter.com/CancerDotNet/status/472719172578062336,,,,
AneesChagpar,5/31/2014 8:39,3,0,@ mtmdphd Tweet on! @ ASCO @ drdonsdizon @ subatomicdoc @ jrgralow @ drattai See infographic @ rsm2800 https://twitter.com/rsm2800/status/472702983918981120 … # ASCO14,,@ @ @ @ @ @ @,#,4.72719E+17,https://twitter.com/AneesChagpar/status/472719098393419777,,,,
abbottmd,5/31/2014 8:39,0,0,Concept of P4 Medicine to Be Presented by Guest Speaker Dr. Leroy Hood | ASCO Annual Meeting http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4nNbcV79bM.twitter … # ASCO14,,,# #,4.72719E+17,https://twitter.com/abbottmd/status/472718972853297152,,,,
SJNaggiar,5/31/2014 8:38,0,0,New Pill Helps Leukemia Patients Live Longer # ASCO2014 http://nbcnews.to/1mV5k2U,,,#,4.72719E+17,https://twitter.com/SJNaggiar/status/472718813579190273,,,,
AlpineBV_Miller,5/31/2014 8:37,2,0,Big spread in ASCO Daily News. Anyone still think $ AMGN won't file T-VEC? # ASCO14 pic.twitter.com/M7SF8eTpj4,,,#,4.72718E+17,https://twitter.com/AlpineBV_Miller/status/472718476185182208,,,,
Dra_Guaripete,5/31/2014 8:37,0,0,Chiamo manquesea me voy a enterar un poquito de lo que pase en @ ASCO *-* soy feliz. Gracias @ Medscape.,,@ @,,4.72718E+17,https://twitter.com/Dra_Guaripete/status/472718404701663232,,,,
Frank_S_David,5/31/2014 8:36,1,0,"Roche partners with Roche"" http://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 … by @ JohnCFierce. Cute title summarizes big Q in comboRx: http://www.pharmagellan.com/oncology-combinations-four-key-elements-to-biopharma-success/ … # ASCO14""",,@,#,4.72718E+17,https://twitter.com/Frank_S_David/status/472718349135511552,,,,
VincentRK,5/31/2014 8:36,1,0,Ibrutinib results look very impressive # asco14 # asco2014 @ mtmdphd http://mobile.bloomberg.com/news/2014-05-31/pharmacyclics-leukemia-drug-beats-glaxo-s-in-head-to-head-trial.html …,,@,# #,4.72718E+17,https://twitter.com/VincentRK/status/472718312556593154,,,,
teamoncology,5/31/2014 8:36,1,0,【 # ASCO14 Update】 The importance of biomarkers in drug development will be discussed today. http://am.asco.org/advancing-role-biomarkers-drug-development …,,,#,4.72718E+17,https://twitter.com/teamoncology/status/472718261587431424,,,,
DrAttai,5/31/2014 8:36,0,2,Shuttle bus nightmare. @ uber to the rescue! # ASCO14,,@,#,4.72718E+17,https://twitter.com/DrAttai/status/472718140766318592,,,,
sloan_kettering,5/31/2014 8:35,10,6,MSK's Jedd Wolchok & Jimmie Holland! MT @ OncLive: Awards given to 16 heroes in oncology. http://ow.ly/xsBz5 # giantsCC # ASCO14,,@,# #,4.72718E+17,https://twitter.com/sloan_kettering/status/472718092078829568,,,,
teamoncology,5/31/2014 8:35,0,0,"When you look this infogram, I feel that we are a bit stuck with new drug development. http://am.asco.org/progress-breast-cancer-research … # ASCO14 # breastcancer",,,# #,4.72718E+17,https://twitter.com/teamoncology/status/472717979830861824,,,,
bwoodmd,5/31/2014 8:35,0,0,"@ rsm2800 yes, including the (long) long term future of PGHD, but much methodological work to be done # ASCO14",,@,#,4.72718E+17,https://twitter.com/bwoodmd/status/472717929503789057,,,,
Pharmacyclics,5/31/2014 8:35,0,0,"Get a sneak peak at 3 year follow up data here http://bit.ly/1p6oHGj . Full results presented by Dr. O’Brien Tuesday, June 3 # ASCO14",,,#,4.72718E+17,https://twitter.com/Pharmacyclics/status/472717902378852354,,,,
GenomicHealth,5/31/2014 8:35,0,0,Excited to be back at # ASCO14! Visit us at booth 20007 and check out the enhanced # Oncotype # breastcancer report http://bit.ly/1wE95ia,,,# # #,4.72718E+17,https://twitter.com/GenomicHealth/status/472717890152833024,,,,
DrFerdowsi,5/31/2014 8:34,0,0,. @ subatomicdoc: Statin use and risk of pancreatic cancer http://bit.ly/1kPxBaS > @ UCSFCancer # ASCO14 # pancsm,,@ @,# #,4.72718E+17,https://twitter.com/DrFerdowsi/status/472717803293003776,,,,
teamoncology,5/31/2014 8:34,0,0,【 # ASCO14 Update】 Here is a very helpful infogram about the progress of # breastcancer http://am.asco.org/progress-breast-cancer-research …,,,# #,4.72718E+17,https://twitter.com/teamoncology/status/472717681796214784,,,,
AdnanNagrial,5/31/2014 8:33,0,0,"# ASCO14 Posters for Upper GI, CRC, Gynae and Melanoma first this this morning. Intense start.",,,#,4.72717E+17,https://twitter.com/AdnanNagrial/status/472717457115717632,,,,
subatomicdoc,5/31/2014 8:33,8,3,Statin use and risk of pancreatic cancer http://bit.ly/1kPxBaS > @ UCSFCancer # ASCO14 # pancsm,,@,# #,4.72717E+17,https://twitter.com/subatomicdoc/status/472717397292756992,,,,
davidgrahammd,5/31/2014 8:32,0,0,In a # ASCO14 and wishing you could see another one going on right then? iPlanner app can save the recording for you to watch later,,,#,4.72717E+17,https://twitter.com/davidgrahammd/status/472717212328140800,,,,
ByJonGardner,5/31/2014 8:31,2,1,"Thoughts of a US expat back in America for a bit: Sports betting is illegal, but biotech investing is legal? What a country! # ASCO14",,,#,4.72717E+17,https://twitter.com/ByJonGardner/status/472717013551685632,,,,
rsm2800,5/31/2014 8:31,1,2,Concept of P4 Medicine to Be Presented by Guest Speaker Dr. Leroy Hood http://am.asco.org/concept-p4-medicine-be-presented-guest-speaker-dr-leroy-hood#.U4nLUfsw4CQ.twitter … Looks vy interesting # ASCO14,,,# #,4.72717E+17,https://twitter.com/rsm2800/status/472716986036666368,,,,
teamoncology,5/31/2014 8:31,3,9,乳がんのこれまでの発展を表で表しています。とてもわかり易い。http://am.asco.org/sites/am.asco.org/files/breast-timeline-full.jpg … # ASCO14,,,#,4.72717E+17,https://twitter.com/teamoncology/status/472716873767735298,,,,
Immutep,5/31/2014 8:30,0,0,We Will Host a Conference Call on June 3 11AM AEST (9 PM EST) to Discuss Abstract Presented at ASCO $ PBMD # ASCO14 http://yhoo.it/1hFrnWI,,,#,4.72717E+17,https://twitter.com/Immutep/status/472716766444257280,,,,
CancerDotNet,5/31/2014 8:30,0,0,Advocate Lounge (S402) hours from 7:30am-6:30pm CT today/tomorrow. Refreshments & updates too! # ASCO14,,,#,4.72717E+17,https://twitter.com/CancerDotNet/status/472716753987198976,,,,
ByJonGardner,5/31/2014 8:30,0,0,"Highlight of # ASCO14 so far: watching the Blackhawks come from behind for a win last night. On the TV, yes, but still fun.",,,#,4.72717E+17,https://twitter.com/ByJonGardner/status/472716744176730112,,,,
corp_UNC,5/31/2014 8:30,1,1,Comp eff of contemporary adjuvant chemo among older rectal ca pts J.Lund T.Sturmer H.Sanoff @ UNC_RxEPI @ UNC_Lineberger # ASCO14...,,@ @,#,4.72717E+17,https://twitter.com/corp_UNC/status/472716724895485953,,,,
SarahMMahoney,5/31/2014 8:30,1,1,Boehringer launches # ASCO14 blog to talk about lung cancer http://www.pmlive.com/blogs/digital_intelligence/archive/2014/may/boehringer_launches_asco_blog_to_talk_about_lung_cancer?SQ_DESIGN_NAME=2& …,,,#,4.72717E+17,https://twitter.com/SarahMMahoney/status/472716666351390720,,,,
AneesChagpar,5/31/2014 8:29,0,0,@ drdonsdizon @ ASCO Cost is impt; not just for access but also QOL. See latest issue of JOP! http://bit.ly/SMmIfF#JOP @ YaleCancer # ASCO14,,@ @ @,#JOP #,4.72716E+17,https://twitter.com/AneesChagpar/status/472716486759694338,,,,
AmandaGSzabo,5/31/2014 8:29,0,1,Pill v. infusion for # leukemia chemotherapy - pill wins in this study: http://nbcnews.to/1mV5k2U via @ NBCNews # ASCO14,,@,# #,4.72716E+17,https://twitter.com/AmandaGSzabo/status/472716468530843648,,,,
BreastDocUK,5/31/2014 8:29,0,1,"12 weeks of vaginal DHEA improves desire, arousal and reduces pain post # breastcancer # bcsm # ASCO14 http://meetinglibrary.asco.org/content/125315-144#.U4nKndB9d0g.twitter …",,,# # # #,4.72716E+17,https://twitter.com/BreastDocUK/status/472716424566169600,,,,
rsm2800,5/31/2014 8:28,8,6,Progress in Breast Cancer Research | ASCO Annual Meeting http://am.asco.org/progress-breast-cancer-research#.U4nKpmuVo1A.twitter … # bcsm # ASCO14,,,# # #,4.72716E+17,https://twitter.com/rsm2800/status/472716185427918848,,,,
teamoncology,5/31/2014 8:26,1,0,【 # ASCO14 Update】Zometa efficacy and safety between q4w and q12w. No difference among # breastcancer with bone met. http://abstracts.asco.org/144/AbstView_144_129791.html …,,,# #,4.72716E+17,https://twitter.com/teamoncology/status/472715676717576192,,,,
teamoncology,5/31/2014 8:25,1,1,【 # ASCO14 Update】ENABLE III study shows that importance of supporting the cancer caregiver as soon as possible. http://abstracts.asco.org/144/AbstView_144_131678.html …,,,#,4.72716E+17,https://twitter.com/teamoncology/status/472715608316846080,,,,
teamoncology,5/31/2014 8:25,0,0,【 # ASCO14 Update】Study shows that you can stop statin (anti-cholesterol drug) without harm in pts w/advanced cancer. http://abstracts.asco.org/144/AbstView_144_135132.html …,,,#,4.72716E+17,https://twitter.com/teamoncology/status/472715544588603394,,,,
teamoncology,5/31/2014 8:24,0,0,I wish that I was there. RT @ drattai: @ WhitworthMD hi there! Come to the # ASCO14 tweet up this evening!,,@ @,#,4.72715E+17,https://twitter.com/teamoncology/status/472715263456968704,,,,
AlpineBV_Miller,5/31/2014 8:24,0,2,"ASCO Daily News. Find out which doctor is dating Angelina Jolie."" - From a Daily News ""vendor"" this morning # ASCO14""",,,#,4.72715E+17,https://twitter.com/AlpineBV_Miller/status/472715236727078912,,,,
DrAttai,5/31/2014 8:22,0,1,“ @ AlpineBV_Miller: @ asco. Route 2 bus left people on the curb. FYI. Full. # ASCO14” so far 20 mm wait,,@ @,#,4.72715E+17,https://twitter.com/DrAttai/status/472714673784377344,,,,
DelMarPharma,5/31/2014 8:21,1,0,"We are presenting today VAL-083 interim data from glioblastoma clinical trial at # ASCO14, early activity signs http://buff.ly/1pGFsbk $ DMPI",,,#,4.72715E+17,https://twitter.com/DelMarPharma/status/472714567429423104,,,,
MayurKherdikar,5/31/2014 8:21,0,0,Ramucirumab prolongs survival in pts with NSCLC http://reut.rs/1mV7Aai $ LLY; # asco2014,,,#,4.72714E+17,https://twitter.com/MayurKherdikar/status/472714428740558849,,,,
DrAttai,5/31/2014 8:20,0,0,@ WhitworthMD hi there! Come to the # ASCO14 tweet up this evening!,,@,#,4.72714E+17,https://twitter.com/DrAttai/status/472714178831335424,,,,
SitemanCenter,5/31/2014 8:20,0,0,"Siteman's Kenneth Carson, MD, and @ cancernetwrk discuss pros/cons of follow-up imaging in # lymphoma: http://goo.gl/bdD6zF # ASCO14",,@,# #,4.72714E+17,https://twitter.com/SitemanCenter/status/472714157008363520,,,,
OncLive,5/31/2014 8:20,1,2,Dr. Anna Pavlick on a Phase II Trial of Cyclophosphamide and Ipilimumab in Melanoma http://ow.ly/xsCfl # ASCO14,,,#,4.72714E+17,https://twitter.com/OncLive/status/472714156458913792,,,,
mnewtonPharmD,5/31/2014 8:19,1,0,VEGF + PARP inhibitors MT @ JNCI_Now: Cediranib plus Olaparib significantly increases PFS in women w/ recurrent ovarian cancer. # ASCO14,,@,#,4.72714E+17,https://twitter.com/mnewtonPharmD/status/472714087257092096,,,,
soft_GL,5/31/2014 8:19,3,4,# ASCO2014 non de dieu il y a n'a même un en bas à droite avec son PC-portable prêt à passer son OA ^^ (humour) pic.twitter.com/scA4nXTMDp,,,#,4.72714E+17,https://twitter.com/soft_GL/status/472713855295295489,,,,
AneesChagpar,5/31/2014 8:18,0,0,Should be a great talk @ ASCO by @ YaleTomLynch @ YaleCancer! MT: EGFR: Next 10 yrs... breaking barrier of acquired resistance # ASCO14,,@ @ @,#,4.72714E+17,https://twitter.com/AneesChagpar/status/472713800052113408,,,,
MayurKherdikar,5/31/2014 8:17,2,2,Imbruciva shows promising results in CLL pts who failed other treatments $ J&J ; pharmacyclics # ASCO2014 http://reut.rs/1mV7AqU,,,#,4.72714E+17,https://twitter.com/MayurKherdikar/status/472713582753636352,,,,
WhitworthMD,5/31/2014 8:17,0,0,Love Chicago! Beautiful day for # ASCO14 pic.twitter.com/aJT0oY2r52,,,#,4.72713E+17,https://twitter.com/WhitworthMD/status/472713439559696384,,,,
BioWorld,5/31/2014 8:17,0,3,"Greeted at # ASCO14 today with, Good morning"," doctor."" # feelingimportant""",,,# #,4.72713E+17,https://twitter.com/BioWorld/status/472713408035303425,,,
PennMedNews,5/31/2014 8:16,0,1,"Penn Medicine researchers & docs at # ASCO14 -For news releases and expert comment, visit here http://www.uphs.upenn.edu/news/News_Releases/2014/05/asco/ …pic.twitter.com/ONvq8HmQZx",,,#,4.72713E+17,https://twitter.com/PennMedNews/status/472713341341675520,,,,
Ann_Nonymous_MD,5/31/2014 8:16,0,1,Off to day 2 of # ASCO14,,,#,4.72713E+17,https://twitter.com/Ann_Nonymous_MD/status/472713301886238720,,,,
BayerPharma,5/31/2014 8:16,3,0,There is a 50% chance of someone with CRC passing it onto their children.Learn more http://bit.ly/STP4Vp # ASCO14 http://twitpic.com/e54sgb,,,#,4.72713E+17,https://twitter.com/BayerPharma/status/472713263281868801,,,,
JanssenUS,5/31/2014 8:16,3,1,New blood cancer medicine data announced today at # ASCO14 http://jan4.me/1rtaFDA and http://jan4.me/1rtbNXN,,,#,4.72713E+17,https://twitter.com/JanssenUS/status/472713158201995264,,,,
Dra_Guaripete,5/31/2014 8:15,0,0,"AAAAAAAAAAAAAAAAAAAAAA *-* QT @ Medscape: For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,@,#,4.72713E+17,https://twitter.com/Dra_Guaripete/status/472713093433540608,,,,
teamoncology,5/31/2014 8:14,0,2,"Congratulaiton. RT @ jrgralow: Congrats, Dr. President! RT @ CliffordHudis: on site and ready to go! # asco14 pic.twitter.com/0N6FlddIpl",,@ @,#,4.72713E+17,https://twitter.com/teamoncology/status/472712770916343808,,,,
EIannelli,5/31/2014 8:13,0,0,http://www.cancer.net/blog/2014-05/promising-research-new-targeted-therapies-2014-asco-annual-meeting … buone news da ricerca x nuove terapie mirate # ASCO14 @ InsControCancro @ favo_it @ CesareFassari @ ManuelaPerrone,,@ @ @ @,#,4.72713E+17,https://twitter.com/EIannelli/status/472712511423520768,,,,
mnewtonPharmD,5/31/2014 8:13,0,0,# lcsm MT @ JNCI_Now: Patients w/ stage IV NSCLC treated w/ Ramucirumab & docetaxel extends survival. # ASCO14,,@,# #,4.72712E+17,https://twitter.com/mnewtonPharmD/status/472712370998218752,,,,
adamfeuerstein,5/31/2014 8:10,6,7,Good to know # ASCO14 pic.twitter.com/Qw62whueQ8,,,#,4.72712E+17,https://twitter.com/adamfeuerstein/status/472711836354097152,,,,
dhovekamp42,5/31/2014 8:10,0,1,Feuerstein-Ratain Rule Update: Still Perfect Predicting Small-Cap Cancer Drug Failure -> # ASCO14 too? http://www.thestreet.com/story/12696926/1/the-feuerstein-ratain-rule-update-still-perfect-predicting-small-cap-cancer-drug-failure.html … via @ TheStreet,,@,#,4.72712E+17,https://twitter.com/dhovekamp42/status/472711792255197184,,,,
ASCO,5/31/2014 8:10,3,5,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.72712E+17,https://twitter.com/ASCO/status/472711644351823872,,,,
ASCP_Chicago,5/31/2014 8:10,0,0,"ASCP is exhibiting at the @ ASCO Annual Meeting today, tomorrow and Monday from 9am-5pm. Stop by booth 16163 to say hi! # ASCO14",,@,#,4.72712E+17,https://twitter.com/ASCP_Chicago/status/472711644116963328,,,,
Boehringer,5/31/2014 8:10,73,140,# HCPs: See experts discuss current unmet needs in 2nd line adenocarcinoma # NSCLC http://bit.ly/1knpToJ # ASCO14,,,# # #,4.72712E+17,https://twitter.com/Boehringer/status/472711608251482113,,,,
justamiletogo,5/31/2014 8:09,1,1,Data from a # myeloma study funded by @ theMMRF & conducted w/ partner @ SanofiUS to be presented at # ASCO14: http://www.themmrf.org/about-the-mmrf/powerful-news/press-releases/mmrc-asco-2014.html … - # MMRFASCO,,@ @,# # #,4.72712E+17,https://twitter.com/justamiletogo/status/472711567092744192,,,,
EIannelli,5/31/2014 8:09,1,0,http://www.cancer.net/research-and-advocacy/research-summaries/caregivers-who-receive-palliative-care-support-immediately-after-advanced-cancer-diagnosis-have … # ASCO14 importanza cure anche x familiari di malati # cancro @ InsControCancro @ favo_it @ ManuelaPerrone @ bobpersio,,@ @ @ @,# #,4.72712E+17,https://twitter.com/EIannelli/status/472711535207673856,,,,
lrn_brk,5/31/2014 8:09,0,0,"Colorectal Cancer: All Hands on Deck by Drs. Venook, Weiser, and Tepper from # ASCO14 Educational Book http://bit.ly/1kt0xB4",,,#,4.72712E+17,https://twitter.com/lrn_brk/status/472711500474621952,,,,
Amgen,5/31/2014 8:09,3,1,# Amgen presents new colorectal cancer data at # ASCO14 http://bit.ly/1hJ4Kki,,,# #,4.72711E+17,https://twitter.com/Amgen/status/472711380878241793,,,,
Gimelli1,5/31/2014 8:08,0,0,City of Chicago: who is awake and making pizza? # asco14,,,#,4.72711E+17,https://twitter.com/Gimelli1/status/472711238758043648,,,,
lrn_brk,5/31/2014 8:06,0,0,"Perioperative Management of Esophagogastric Cancer by Drs. Burtness, Ilson, and Iqbal from # ASCO14 Educational Book http://bit.ly/1iFwjLx",,,#,4.72711E+17,https://twitter.com/lrn_brk/status/472710797786091520,,,,
dytcmd,5/31/2014 8:05,0,1,Ph I results out today MT @ AndyBiotech: MPDL3280A (Anti-PD-L1) rx in # BladderCancer:43%ORR w/PD-L1+pts http://goo.gl/dVjZBC # ASCO14 # blcsm,,@,# # #,4.7271E+17,https://twitter.com/dytcmd/status/472710492927320065,,,,
adamfeuerstein,5/31/2014 8:05,4,13,Ever wondered about size of big oral presentation rooms at # ASCO14? Huge. pic.twitter.com/BBFb8N6XIJ,,,#,4.7271E+17,https://twitter.com/adamfeuerstein/status/472710447494606849,,,,
doctorpemm,5/31/2014 8:03,1,1,Pemmaraju et al # Outcomes # BPDCN come visit my poster # ASCO14 Monday 1-5pm # leusm # bloodcancer # raredisease http://abstracts.asco.org/144/AbstView_144_135015.html …,,,# # # # # #,4.7271E+17,https://twitter.com/doctorpemm/status/472710022284079105,,,,
lrn_brk,5/31/2014 8:03,1,0,"50 Years of Progress in the Systemic Therapy of NSCLC by Martin J. Edelman, MD, from # ASCO14 Educational Book http://bit.ly/T12Y8d",,,#,4.7271E+17,https://twitter.com/lrn_brk/status/472709986825809920,,,,
jennycorrigan,5/31/2014 8:03,0,1,# SocOncology report from @ W2OGroup looked at 15 million online conversations about cancer. What we saw: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.7271E+17,https://twitter.com/jennycorrigan/status/472709839001378817,,,,
DrMiguelPerales,5/31/2014 8:02,1,0,"Likely practice changer RT @ Reuters_Health Pharmacyclics, J&J drug shown to improve leukemia survival http://reut.rs/1mV7AqU # ASCO14 # leusm",,@,# #,4.7271E+17,https://twitter.com/DrMiguelPerales/status/472709780013056000,,,,
corp_UNC,5/31/2014 8:01,1,1,On topic for Geriatric Oncology session 8-11a today S103: http://jco.ascopubs.org/content/early/2014/05/20/JCO.2013.54.8586?cmpid=jco_pap_27May2014 … Hy Muss @ UNC_Lineberger via # JCO @ ASCO # asco14 # gerionc,,@ @,# # #,4.7271E+17,https://twitter.com/corp_UNC/status/472709506385076224,,,,
corp_UNC,5/31/2014 8:01,0,0,"Popn-based mortality over time in endometrial cancer M.Eblan, Ron Chen et al @ UNC_Lineberger # asco14 # gyncsm http://ow.ly/xqCYq",,@,# #,4.72709E+17,https://twitter.com/corp_UNC/status/472709487095455744,,,,
ASCO,5/31/2014 8:01,2,1,Interested in the cancer prevention track at # ASCO14? Get the international perspective: http://bit.ly/1sxC42p via # ASCOConnection,,,# #,4.72709E+17,https://twitter.com/ASCO/status/472709443319521280,,,,
FoundationATCG,5/31/2014 8:00,1,0,Take the molecular testing challenge: http://bit.ly/1hIAUfC # FoundationOne # ASCO14,,,# #,4.72709E+17,https://twitter.com/FoundationATCG/status/472709154268659712,,,,
AlpineBV_Miller,5/31/2014 8:00,0,0,@ asco. Route 2 bus left people on the curb. FYI. Full. # ASCO14,,@,#,4.72709E+17,https://twitter.com/AlpineBV_Miller/status/472709142558560256,,,,
Medscape,5/31/2014 8:00,0,3,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.72709E+17,https://twitter.com/Medscape/status/472709095233818624,,,,
JNCI_Now,5/31/2014 8:00,0,0,"Researchers have been exploring alternate regimens using targeted drugs, with the goal of overcoming resistance to chemotherapy. # ASCO14",,,#,4.72709E+17,https://twitter.com/JNCI_Now/status/472709094164267008,,,,
JNCI_Now,5/31/2014 8:00,2,1,"Current standard treatment for recurrent ovarian cancer is chemotherapy, which often causes significant side effects. # ASCO14",,,#,4.72709E+17,https://twitter.com/JNCI_Now/status/472709092679499776,,,,
MedscapeOnc,5/31/2014 8:00,5,1,"For breaking news at # ASCO14 as it happens, check our site: http://bit.ly/1tQLhFs",,,#,4.72709E+17,https://twitter.com/MedscapeOnc/status/472709090540417024,,,,
DanaFarber,5/31/2014 8:00,1,4,Clinical trial suggests drug combo may be effective in recurrent # ovariancancer: http://bit.ly/1k7SE9Q # ASCO14 # gyncsm # SFSCWC,,,# # # #,4.72709E+17,https://twitter.com/DanaFarber/status/472709082416414720,,,,
DrMiguelPerales,5/31/2014 7:59,1,0,@ drdonsdizon @ ASCO Part of cost discussion needs to look @differential cost of cancer drugs in different countries esp US vs Europe # ASCO14,,@ @ @differential,#,4.72709E+17,https://twitter.com/DrMiguelPerales/status/472709064368353281,,,,
mlazqui,5/31/2014 7:59,1,0,Cediranib plus Olaparib increases progression-free survival in women w/ recurrent ovarian cancer. # ASCO14,,,#,4.72709E+17,https://twitter.com/mlazqui/status/472709052255199232,,,,
teamoncology,5/31/2014 7:59,0,1,【 # ASCO14 Update】Ph III study shows that LHRH agonist have a slight edge to protect from an ovarian failure by chemo. http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.72709E+17,https://twitter.com/teamoncology/status/472709026371731456,,,,
Plaza_Bickle,5/31/2014 7:59,0,0,"@ mvsiguiendo Qué envidia, a mí esas cosas ya no me tocan... Disfruta y no curres mucho! # ASCO14",,@,#,4.72709E+17,https://twitter.com/Plaza_Bickle/status/472708881983238144,,,,
teamoncology,5/31/2014 7:59,0,0,"【 # ASCO14 Ueno Editorial】 Ramucirumab and bevacizumab, so far no clear positive data in breast cancer.",,,#,4.72709E+17,https://twitter.com/teamoncology/status/472708861162311681,,,,
AmandaGSzabo,5/31/2014 7:58,0,0,Some promising news for # breastcancer therapy from # ASCO14: Drug Saves Fertility for Women With Cancer http://nyti.ms/1jBaNXT,,,# #,4.72709E+17,https://twitter.com/AmandaGSzabo/status/472708801502535681,,,,
teamoncology,5/31/2014 7:58,0,0,【 # ASCO14 101】 Ramucirumab is anti-VEGFR2 monoclonal antibody. Effective in gastric cancer also. But not in breast cancer.,,,#,4.72709E+17,https://twitter.com/teamoncology/status/472708629158584320,,,,
GlopesMd,5/31/2014 7:58,0,2,# ASCO14 international members receiving awards: Harald zur Hausen and Aron Goldhirsch complete the list.,,,#,4.72709E+17,https://twitter.com/GlopesMd/status/472708621462011904,,,,
adamfeuerstein,5/31/2014 7:57,2,3,$ AZN ‘9291 $ CLVS ‘1686 presentations begin 9 am ET. I’ll be there. Follow lung cancer expert @ JackWestMD for live coverage as well. # ASCO14,,@,#,4.72708E+17,https://twitter.com/adamfeuerstein/status/472708324194914304,,,,
nxtstop1,5/31/2014 7:56,1,1,R U CONNECTING? @ tmlfox: The conversation is unfolding nicely at # ASCO14. Network Centrality Graph via @ symplur pic.twitter.com/UNu2EL1MWY”,,@ @,#,4.72708E+17,https://twitter.com/nxtstop1/status/472708068057182208,,,,
drdonsdizon,5/31/2014 7:55,54,23,"Big theme here at # ASCO14, even in midst of amazing progress- Balance innovation w access. Everyone w cancer deserves this. # ASCO14",,,# #,4.72708E+17,https://twitter.com/drdonsdizon/status/472707907788627968,,,,
JNCI_Now,5/31/2014 7:55,1,2,Confirms preclinical research which suggested that olaparib and cediranib synergize. # ASCO14,,,#,4.72708E+17,https://twitter.com/JNCI_Now/status/472707832098193408,,,,
JNCI_Now,5/31/2014 7:55,5,2,This is first time combination of a PARP inhibitor & an anti-angiogenic drug has been explored in clinical trial for ovarian cancer. # ASCO14,,,#,4.72708E+17,https://twitter.com/JNCI_Now/status/472707830873477120,,,,
JNCI_Now,5/31/2014 7:55,0,0,This combination therapy suggests that this could potentially be an effective alternative to standard chemotherapy. # ASCO14,,,#,4.72708E+17,https://twitter.com/JNCI_Now/status/472707830009450497,,,,
JNCI_Now,5/31/2014 7:55,1,0,Cediranib plus Olaparib significantly increases progression-free survival in women w/ recurrent ovarian cancer. # ASCO14,,,#,4.72708E+17,https://twitter.com/JNCI_Now/status/472707828004552704,,,,
JackWestMD,5/31/2014 7:54,2,7,"In ~1 hr I'll tweet from # ASCO14 session on EGFR: The Next 10 Yrs"""," featuring latest on new drugs AZD9291 & CO1686 for acq'd resistance.""",,,#,4.72708E+17,https://twitter.com/JackWestMD/status/472707577780768768,,,
Medicalfacts,5/31/2014 7:53,0,0,. @ ASCO where can i find the pressroom (room number)at Mc Cormick # ASCO14,,@,#,4.72708E+17,https://twitter.com/Medicalfacts/status/472707546474893313,,,,
teamoncology,5/31/2014 7:53,6,7,【 # ASCO14 Update】LHRH agonistを化学療法中に使用することによって、卵巣機能を温存を多少できることが証明された。ただ、今後も研究が必要、妊娠できるかとは別問題。 http://abstracts.asco.org/144/AbstView_144_129172.html …,,,#,4.72708E+17,https://twitter.com/teamoncology/status/472707500324552704,,,,
GlopesMd,5/31/2014 7:53,0,2,"# ASCO14 international members receiving awards: Surendra Shastri, HM Pinedo, Jaime de la Garza.",,,#,4.72707E+17,https://twitter.com/GlopesMd/status/472707354098544640,,,,
FCUroOnc,5/31/2014 7:52,0,0,Wong et al @ FoxChaseCancer eval trial design for salvage rx of adv UCC # asco14 http://ow.ly/xqEvP # bladdercancer # blcsm,,@,# # #,4.72707E+17,https://twitter.com/FCUroOnc/status/472707307709927424,,,,
drdonsdizon,5/31/2014 7:52,9,6,"Define relative value of cancer Rx: Need 2 consider 3 things: efficacy, side effects, AND cost. @ ASCO initiates discussion. # ASCO14",,@,#,4.72707E+17,https://twitter.com/drdonsdizon/status/472707289271394305,,,,
nxtstop1,5/31/2014 7:52,0,1,From:ASCO: Drug Helps Save Fertility in Breast Ca http://www.medpagetoday.com/HematologyOncology/BreastCancer/46073?xid=nl_mpt_DHE_2014-05-31 … # ASCO14,,,#,4.72707E+17,https://twitter.com/nxtstop1/status/472707232413388800,,,,
AndyBiotech,5/31/2014 7:52,10,4,Roche's MPDL3280A (Anti-PD-L1) granted FDA Breakthrough Designation in # BladderCancer: 43% ORR in PD-L1+ pts http://finance.yahoo.com/news/investigational-immunotherapy-anti-pdl1-mpdl3280a-113000024.html … # ASCO14,,,# #,4.72707E+17,https://twitter.com/AndyBiotech/status/472707220699099137,,,,
adamfeuerstein,5/31/2014 7:52,5,2,$ PCYC $ JNJ Imbruvica “RESONATE” data in r/r CLL —> http://www.thestreet.com/story/12725252/1/pharmacyclics-imbruvica-extends-survival-in-elderly-leukemia-patients.html … # ASCO14,,,#,4.72707E+17,https://twitter.com/adamfeuerstein/status/472707200670916608,,,,
jagasquet,5/31/2014 7:52,0,1,"RESONATE: # Ibrutinib improves PFS, OS, and response rate, in prev treated CLL. # ASCO14 http://nej.md/1hvgQ05 “ @ NEJM",,@,# #,4.72707E+17,https://twitter.com/jagasquet/status/472707165573378048,,,,
teamoncology,5/31/2014 7:52,10,11,【 # ASCO14 Update】進行がんにおける、がんと関連ないような薬、コレステロール抑制剤をやめることが患者のQOLを改善されることが証明された。死に直面しているひとへ無駄な薬を辞める必要があるのかも。 http://abstracts.asco.org/144/AbstView_144_135132.html …,,,#,4.72707E+17,https://twitter.com/teamoncology/status/472707130382745600,,,,
adamfeuerstein,5/31/2014 7:51,2,4,The deluge begins.. $ LLY ramu 2nd line NSCLC cancer data —> http://www.thestreet.com/story/12725161/1/lilly-drug-extends-survival-in-advanced-lung-cancer-patients.html … # ASCO14,,,#,4.72707E+17,https://twitter.com/adamfeuerstein/status/472706828971671553,,,,
dagensmedicin,5/31/2014 7:51,0,1,"Nytt läkemedel tros bli standard mot cancer i sköldkörteln, # asco2014, # dmasco: http://www.dagensmedicin.se/asco/nytt-lakemedel-kan-bli-standard-mot-cancer-i-skoldkorteln/ …",,,# #,4.72707E+17,https://twitter.com/dagensmedicin/status/472706821120327681,,,,
teamoncology,5/31/2014 7:50,1,1,【 # ASCO14 Update】ENABLE III 研究はがん患者の家族などのサポーターに対して早期の介入の重視を証明。 http://abstracts.asco.org/144/AbstView_144_131678.html …,,,#,4.72707E+17,https://twitter.com/teamoncology/status/472706651451953152,,,,
m_e_nielsen,5/31/2014 7:50,0,0,". @ fischmd major issue w incr vertical integration"" highlighted in http://m.content.healthaffairs.org/content/33/5/756.abstract?etoc … and http://www.nationaljournal.com/magazine/how-the-health-law-could-raise-prices-20120216 … # ASCO14""",,@,#,4.72707E+17,https://twitter.com/m_e_nielsen/status/472706605541502977,,,,
jagasquet,5/31/2014 7:50,0,0,Two experimental AstraZeneca drugs show promise in # ovariancancer # ASCO14 http://reut.rs/1kgV5G1 @ Reuters_Health,,@,# #,4.72707E+17,https://twitter.com/jagasquet/status/472706582019850240,,,,
JNCI_Now,5/31/2014 7:50,5,0,"Lenvatinib may be a potential treatment for liver, lung, and kidney cancers and other types of solid tumors. # LCSM # ASCO14",,,# #,4.72707E+17,https://twitter.com/JNCI_Now/status/472706573089783809,,,,
JNCI_Now,5/31/2014 7:50,0,0,"Differentiated thyroid cancer accounts for about 85% of the 60,000 thyroid cancer cases diagnosed each year in the United States. # ASCO14",,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706571898597377,,,,
JNCI_Now,5/31/2014 7:50,4,0,Differentiated thyroid cancer is most common subtype of thyroid cancer. # ASCO14,,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706571009392640,,,,
Pharmacyclics,5/31/2014 7:50,0,1,"We’re excited to share our Phase 3 RESONATE data http://bit.ly/1p6oHGj , highlighted by Dr. John Byrd this morning at # ASCO14",,,#,4.72707E+17,https://twitter.com/Pharmacyclics/status/472706570090864640,,,,
JNCI_Now,5/31/2014 7:50,3,3,"“...Lenvatinib will eventually become a standard treatment for radioiodine-resistant thyroid cancer,”-Martin Schlumberger, MD. # ASCO14",,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706569205854208,,,,
JNCI_Now,5/31/2014 7:50,1,1,"Lenvatinib delayed disease progression by 14.7 months, and nearly two thirds of patients experienced tumor shrinkage. # ASCO14",,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706568538955776,,,,
JNCI_Now,5/31/2014 7:50,2,2,Lenvatinib is highly effective against differentiated thyroid cancer that is resistant to standard radioiodine (RAI) therapy. # ASCO14,,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706567876268032,,,,
JNCI_Now,5/31/2014 7:50,1,0,...CLL confirms that ibrutinib, administered orally, has significant efficacy & is well-tolerated,"-Olatoyosi Odenike, MD. # ASCO14",,,#,4.72707E+17,https://twitter.com/JNCI_Now/status/472706567091929088,
drdonsdizon,5/31/2014 7:50,1,0,A Okamoto- Abstr 5507: Carbo/CPT11 vs Carbo/Pac 4 clear cell # ovca. At 2y: PFS 73/78%; OS 86/87%. # gyncsm # ASCO14 http://bit.ly/1r5Pfw9,,,# # #,4.72707E+17,https://twitter.com/drdonsdizon/status/472706557457604609,,,,
ASH_hematology,5/31/2014 7:49,10,4,New results with ibrutinib in patients with relapsed CLL “will significantly change clinical practice” http://ow.ly/xt51y # ASCO14,,,#,4.72707E+17,https://twitter.com/ASH_hematology/status/472706544636018690,,,,
CDC_Genomics,5/31/2014 7:49,15,7,What's new in cancer targeted therapies? @ ASCO # ASCO14 # pm101 # genomics http://www.asco.org/press-center/studies-reveal-potential-new-targeted-therapies-common-hard-treat-cancers …,,@,# # #,4.72706E+17,https://twitter.com/CDC_Genomics/status/472706436435550208,,,,
teamoncology,5/31/2014 7:48,1,6,【 # ASCO14 Update】ゾメタの効果と安全性は、乳がん骨転移患者では、毎４週でも毎１２週でも、同じです。画期的。 http://abstracts.asco.org/144/AbstView_144_129791.html …,,,#,4.72706E+17,https://twitter.com/teamoncology/status/472706245170716672,,,,
drdonsdizon,5/31/2014 7:48,2,0,K Miller @ eaonc Abstr500: ECOG5103 shows no benefit to adjuvant bevacizumab # bcsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_130506.html …,,@,# #,4.72706E+17,https://twitter.com/drdonsdizon/status/472706054673809408,,,,
mvsiguiendo,5/31/2014 7:46,2,4,"En una hora arranca mi # ASCO14,aquí iré contando lo q se cuece x # Chicago sobre # cancer (eso si consigo despachar al jet lag de mi cuerpo).",,,# # #,4.72706E+17,https://twitter.com/mvsiguiendo/status/472705657146470400,,,,
YaleTomLynch,5/31/2014 7:46,10,6,Looking forward to talks on EGFR: Next 10 Years. I'll talk abt breaking barrier of acquired resistance @ YaleCancer # ASCO14 8-930a EHall D1,,@,#,4.72706E+17,https://twitter.com/YaleTomLynch/status/472705655657484289,,,,
AndyBiotech,5/31/2014 7:45,10,8,$ PCYC $ JNJ - ibrutinib Ph3 RESONATE trial in r/r CLL data published in NEJM http://nej.md/1hvgQ05 # ASCO14 pic.twitter.com/AwHMdhCJqF,,,#,4.72706E+17,https://twitter.com/AndyBiotech/status/472705529224396800,,,,
DrMiguelPerales,5/31/2014 7:45,1,1,RT @ Reuters_Health Cancer doctors urged to consider value when treating patients http://reut.rs/1mU5yay # ASCO14,,@,#,4.72706E+17,https://twitter.com/DrMiguelPerales/status/472705524090568705,,,,
ASCO,5/31/2014 7:45,1,1,Our congratulations to Leslie L Robison PhD on his # ASCO14 Pediatric Oncology Award & Lecture CC @ StJudeResearch,,@,#,4.72705E+17,https://twitter.com/ASCO/status/472705348726714368,,,,
JNCI_Now,5/31/2014 7:45,0,0,Ibrutinib was FDA approved for the treatment of CLL in February 2014 through the FDA’s accelerated review process. # ASCO14,,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705318724456448,,,,
JNCI_Now,5/31/2014 7:45,0,1,"Use of ibrutinib resulted in about 80% of patients still in remission at 1 year, twice as many as expected w/ standard therapy. # ASCO14",,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705317944320000,,,,
JNCI_Now,5/31/2014 7:45,2,0,"elderly patients often can't handle intensive chemotherapy, so Ofatumumab is used an alternative, although is less effective. # ASCO14",,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705317214490624,,,,
JNCI_Now,5/31/2014 7:45,1,0,"Standard treatment for CLL is chemo-immunotherapy, a combination of intensive chemotherapy and an antibody such as rituximab. # ASCO14",,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705316308545536,,,,
JNCI_Now,5/31/2014 7:45,1,1,CLL is the most common form of leukemia in adults. # ASCO14,,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705315184451584,,,,
JNCI_Now,5/31/2014 7:45,0,0,"The therapy was well tolerated by patients, causing few serious side effects. # ASCO14",,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705314131681280,,,,
JNCI_Now,5/31/2014 7:45,0,0,First time an oral drug demonstrated a survival improvement over standard therapy in relapsed CLL. # ASCO14,,,#,4.72705E+17,https://twitter.com/JNCI_Now/status/472705313066323970,,,,
FoundationATCG,5/31/2014 7:45,3,2,"Potentially targetable alts identified in 86% of # gallbladdercancer cases by # FoundationOne Poster Pres: 8-11, S Hall A2, Ab 4142 # ASCO14",,,# # #,4.72705E+17,https://twitter.com/FoundationATCG/status/472705310277128194,,,,
drdonsdizon,5/31/2014 7:44,1,0,"Invited @ ASCO EdBook paper by Dr. G. Colditz on ca preventn. Intro by G Fleming, Ca Ed Cte Chair of # ASCO14. http://www.ncbi.nlm.nih.gov/pubmed/24857053",,@,#,4.72705E+17,https://twitter.com/drdonsdizon/status/472705048070197248,,,,
JohnCendpts,5/31/2014 7:42,5,4,RT @ JohnCFierce: Roche partners with Roche on 'breakthrough' PD-L1 cancer program - # asco14 http://www.fiercebiotech.com/story/roche-partners-roche-breakthrough-pd-l1-cancer-program/2014-05-31 …,,@,#,4.72705E+17,https://twitter.com/JohnCendpts/status/472704787096408064,,,,
DrAnasYounes,5/31/2014 7:42,0,0,@ rsm2800 very impressive! # ASCO14,,@,#,4.72705E+17,https://twitter.com/DrAnasYounes/status/472704783334510592,,,,
JacobPlieth,5/31/2014 7:42,0,0,...and that's for bladder cancer. 43% ORR in PD-L1-positive tumours $ RHHBY # ASCO14 http://bit.ly/1m0iSXq,,,#,4.72705E+17,https://twitter.com/JacobPlieth/status/472704560276856833,,,,
CancerDotNet,5/31/2014 7:41,6,2,"New research! Pt summaries on lung, CLL, thyroid & ovarian ca # lcsm # leusm # thycsm # gyncsm # ASCO14 http://bit.ly/SlvNLV",,,# # # # #,4.72704E+17,https://twitter.com/CancerDotNet/status/472704391909478400,,,,
dagensmedicin,5/31/2014 7:40,0,0,"Bättre överlevnad vid spridd lungcancer, # dmasco, # asco2014: http://www.dagensmedicin.se/asco/battre-overlevnad-vid-spridd-lungcancer/ …",,,# #,4.72704E+17,https://twitter.com/dagensmedicin/status/472704209759268865,,,,
MoffittResearch,5/31/2014 7:40,0,0,At # ASCO14? Check out Moffitt's Dr. Lodovico Balducci's presentation about the existing geriatric # oncology models today at 8:30 a.m.,,,# #,4.72704E+17,https://twitter.com/MoffittResearch/status/472704077076660224,,,,
JNCI_Now,5/31/2014 7:40,4,0,Ibrutinib yields lasting tumor responses & marked improvement in survival over standard ofatumumab for patients w/ relapsed CLL. # ASCO14,,,#,4.72704E+17,https://twitter.com/JNCI_Now/status/472704053659443202,,,,
JNCI_Now,5/31/2014 7:40,2,0,Chronic Lymphocytic Leukemia (CLL) # ASCO14,,,#,4.72704E+17,https://twitter.com/JNCI_Now/status/472704052921257984,,,,
JNCI_Now,5/31/2014 7:40,1,1,"Approved second-line therapies for advanced NSCLC include docetaxel, erlotinib, and pemetrexed (for non-squamous NSCLC only), # ASCO14",,,#,4.72704E+17,https://twitter.com/JNCI_Now/status/472704052027867138,,,,
JNCI_Now,5/31/2014 7:40,4,0,Ramucirumab is currently only approved for advanced gastric cancer treatment. # ASCO14,,,#,4.72704E+17,https://twitter.com/JNCI_Now/status/472704051126099969,,,,
JNCI_Now,5/31/2014 7:40,0,0,There are no other approved anti-angiogenesis drugs available in the second-line setting for advanced NSCLC. # ASCO14,,,#,4.72704E+17,https://twitter.com/JNCI_Now/status/472704050077528064,,,,
ASCO,5/31/2014 7:39,5,1,Key # ASCO14 research highlights what's new in targeted therapy http://bit.ly/1iFtJoP # gynca # lcsm # lylsm # hncsm,,,# # # # #,4.72704E+17,https://twitter.com/ASCO/status/472703936139239424,,,,
rsm2800,5/31/2014 7:35,20,12,Not even 1 full day of # ASCO14 yet and already > 8400 tweets and > 2800 participants. Let’s blow the doors off today pic.twitter.com/F0syoy56aU,,,#,4.72703E+17,https://twitter.com/rsm2800/status/472702983918981120,,,,
NEJM,5/31/2014 7:35,36,16,"RESONATE: Ibrutinib improves progression-free, overall survival, and response rate, in prev treated CLL. # ASCO14 http://nej.md/1hvgQ05",,,#,4.72703E+17,https://twitter.com/NEJM/status/472702807695712257,,,,
JNCI_Now,5/31/2014 7:35,4,1,Ramucirumab is a monoclonal antibody that specifically targets VEGF receptor 2 protein; blocks growth of new blood vessels in tumor. # ASCO14,,,#,4.72703E+17,https://twitter.com/JNCI_Now/status/472702800372068352,,,,
JNCI_Now,5/31/2014 7:35,1,0,Survival improvement is significant b/c those w/ advanced NSCLC typically have very short survival time following 2nd-line therapy. # ASCO14,,,#,4.72703E+17,https://twitter.com/JNCI_Now/status/472702799520604160,,,,
JNCI_Now,5/31/2014 7:35,2,0,"“This is the first treatment in approx. a decade to improve the outcome of patients in the second-line setting,”-Maurice Pérol, MD. # ASCO14",,,#,4.72703E+17,https://twitter.com/JNCI_Now/status/472702798727892992,,,,
JNCI_Now,5/31/2014 7:35,4,0,Patients w/ stage IV NSCLC treated w/ Ramucirumab & standard docetaxel extends survival for patients w/ advanced NSCLC. # ASCO14,,,#,4.72703E+17,https://twitter.com/JNCI_Now/status/472702797889024001,,,,
genentech,5/31/2014 7:34,4,3,Today at # ASCO14: Phase I bladder cancer data for # Genentech investigational immunotherapy http://bit.ly/1oUndiT,,,# #,4.72703E+17,https://twitter.com/genentech/status/472702760857513984,,,,
QuiverVoice,5/31/2014 7:34,5,3,BIG NEWS from # ASCO14: goserelin may preserve ovarian function in premenopausal women receiving chemotherapy http://mobile.nytimes.com/2014/05/31/business/drug-could-protect-fertility-in-breast-cancer-patients.html?referrer= …,,,#,4.72703E+17,https://twitter.com/QuiverVoice/status/472702699277139968,,,,
susanhosbach,5/31/2014 7:33,0,0,Come visit with @MyPearlPoint booth 3005 # ASCO14!,,@MyPearlPoint,#,4.72703E+17,https://twitter.com/susanhosbach/status/472702513863733249,,,,
rsm2800,5/31/2014 7:31,6,4,"At the start of this 2nd day of # ASCO14 and our President's upcoming address, a reminder of why I like Twitter pic.twitter.com/cDP7MnHdWj",,,#,4.72702E+17,https://twitter.com/rsm2800/status/472701834344153088,,,,
drdonsdizon,5/31/2014 7:30,0,0,"Early AM. Starts w presentation on Navigating the Annual Meeting session with Dr E Cohen @ UCSDHealth. Fellows, come say hi! # ASCO14",,@,#,4.72702E+17,https://twitter.com/drdonsdizon/status/472701713967611904,,,,
GenomicHealth,5/31/2014 7:30,1,0,Join us from 8-11:45am in Hall A2! 12-gene colon cancer assay validation & utility: summary of clinical evidence # ASCO14,,,#,4.72702E+17,https://twitter.com/GenomicHealth/status/472701638843850753,,,,
AstraZenecaUS,5/31/2014 7:30,0,0,Dr. Janne of @ DanaFarber presents AZ Phase II results at 8:00 AM CST at # ASCO14 as part of the Clinical Science Symposium,,@,#,4.72702E+17,https://twitter.com/AstraZenecaUS/status/472701595105656832,,,,
genperisi,5/31/2014 7:30,0,0,Bu sene ABDde # onkologların %50si yeni nesil sekanslama (NGS) ile hastalarının genetik profilini öğrendi # ASCO14 pic.twitter.com/EboYzVlbxp,,,# #,4.72702E+17,https://twitter.com/genperisi/status/472701595084668928,,,,
theNCI,5/31/2014 7:30,4,2,At # ASCO14? Here are today's sessions involving NCI presenters http://1.usa.gov/1pGAvPW,,,#,4.72702E+17,https://twitter.com/theNCI/status/472701559521153024,,,,
mnewtonPharmD,5/31/2014 7:29,1,0,"But none"" gets smaller q year! MT @ strehan: New data: mutational drivers in NSCLC -- unfort. 25% have none # ASCO14 pic.twitter.com/nJQubCZs0Y""",,@,#,4.72701E+17,https://twitter.com/mnewtonPharmD/status/472701304997818368,,,,
JacobPlieth,5/31/2014 7:25,0,0,"Great to meet you at last, @ JPZaragoza1 Hope to see you around # ASCO14 today",,@,#,4.727E+17,https://twitter.com/JacobPlieth/status/472700381722460160,,,,
OncLive,5/31/2014 7:25,0,0,Dr. Jason Luke Discusses the Phase III COMBI-d Trial Results http://ow.ly/xsCcK # ASCO14,,,#,4.727E+17,https://twitter.com/OncLive/status/472700301909458944,,,,
UrologyMatch,5/31/2014 7:24,0,0,“ @ 3NT: Our ASCO 2014 Day 2 Blog is now live - updates for subs throughout the day # ASCO14 http://3nt.co/AZD9291 ”,,@,#,4.727E+17,https://twitter.com/UrologyMatch/status/472700027136389120,,,,
donaldhtaylorjr,5/31/2014 7:22,0,0,# ff --> @ yzafar: for 'financial toxicity' & effects re Cancer MT@ASCO why are cancer drugs so pricey? http://bit.ly/1kb6QyM # ASCO14,,@ @ASCO,# #,4.727E+17,https://twitter.com/donaldhtaylorjr/status/472699555080048640,,,,
luayalsaoor,5/31/2014 7:15,0,1,ASCO 2014 Day 2 Live Blog # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-day-2-live-blog-asco14.html/ …,,,#,4.72698E+17,https://twitter.com/luayalsaoor/status/472697802061905921,,,,
SpryPub,5/31/2014 7:15,0,0,"Stop by our booth TODAY between 10-11 to get your copy of Survivorship"" signed by Dr. Cassileth! http://ow.ly/xrsX3 # ASCO14""",,,#,4.72698E+17,https://twitter.com/SpryPub/status/472697781485043712,,,,
3NT,5/31/2014 7:11,1,0,Our ASCO 2014 Day 2 Blog is now live - updates for subs throughout the day # ASCO14 http://3nt.co/AZD9291,,,#,4.72697E+17,https://twitter.com/3NT/status/472696743646461952,,,,
BIGagainstBC,5/31/2014 7:08,0,0,RT @ ASCO Celebrate 50 years of progress against cancer with ASCO Daily News anniversary issue http://bit.ly/1wAkTCd # ASCO14,,@,#,4.72696E+17,https://twitter.com/BIGagainstBC/status/472696201708863488,,,,
BiotechStrategy,5/31/2014 7:08,0,0,ASCO 2014 Day 2 Live Blog # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-day-2-live-blog-asco14.html/ …,,,#,4.72696E+17,https://twitter.com/BiotechStrategy/status/472696037702791169,,,,
AdelphiComms,5/31/2014 7:05,0,0,Rise and Shine Chicago! Looking forward to @ ASCO Day 2 pic.twitter.com/KoyN5jhlCJ,,@,,4.72695E+17,https://twitter.com/AdelphiComms/status/472695426957578240,,,,
BioWorld,5/31/2014 7:03,2,1,"Next step in success with cancer therapy: Quality of life, by 'giving & taking away' http://bit.ly/1oG2DFn # ASCO14",,,#,4.72695E+17,https://twitter.com/BioWorld/status/472694942595559424,,,,
tinypasscontent,5/31/2014 7:03,0,0,"ASCO 2014 Day 2 Live Blog # ASCO14"" http://ift.tt/1hIU6tL # BiotechStrategy # tinypass # paidcontent ""Good morning from Chicago and the a...""",,,# # # #,4.72695E+17,https://twitter.com/tinypasscontent/status/472694738060333056,,,,
Xcenda,5/31/2014 7:00,0,0,Learn how # ASCO14 physicians can participate in # Xcenda Challenging Cases. http://bit.ly/1iv8GoQ,,,# #,4.72694E+17,https://twitter.com/Xcenda/status/472694024369733632,,,,
drdonsdizon,5/31/2014 7:00,0,2,Should've brought skates. LOL # ASCO14,,,#,4.72694E+17,https://twitter.com/drdonsdizon/status/472693977246736384,,,,
dagensmedicin,5/31/2014 6:59,0,0,"Nytt hopp vid resistens mot EFGR-hämmare, # dmasco, # asco2014: http://www.dagensmedicin.se/asco/lakemedel-krympte-lungtumorer-resistenta-mot-egfr-hammare/ …",,,# #,4.72694E+17,https://twitter.com/dagensmedicin/status/472693878253182979,,,,
BRCAinfo,5/31/2014 6:58,2,1,"RT via @ DrMiguelPerales: Drug Saves Fertility For Women With Cancer, via @ nytimes # ASCO14 # bcsm http://nyti.ms/1jBaNXT # brca",,@ @,# # #,4.72694E+17,https://twitter.com/BRCAinfo/status/472693694140018688,,,,
subatomicdoc,5/31/2014 6:52,4,2,"Serum platinum on neuro- & ototoxicity, cardiovascular disease, hypogonadism in testicular CA http://abstracts.asco.org/144/AbstView_144_129600.html … # ASCO14 # tscsm # ayacsm",,,# # #,4.72692E+17,https://twitter.com/subatomicdoc/status/472692111884963842,,,,
SamuelLz,5/31/2014 6:50,0,0,Cancerpatienter mådde bättre när hjärtläkemedel togs bort # dmasco # asco14 http://www.dagensmedicin.se/asco/cancerpatienter-madde-battre-nar-hjartlakemedel-togs-bort/ …,,,# #,4.72692E+17,https://twitter.com/SamuelLz/status/472691542524583936,,,,
ASCO,5/31/2014 6:50,1,0,Join us for Karnofsky Memorial Award&Lecture “Understanding”—HM (Bob) Pinedo MD of VU Uni Med Cntr Netherlands @9:30 N Hall B1 # ASCO14,,@9,#,4.72691E+17,https://twitter.com/ASCO/status/472691496932872192,,,,
SamuelLz,5/31/2014 6:46,0,0,Bra överlevnad vid melanom med ny immunterapi # dmasco # asco14 http://www.dagensmedicin.se/asco/bra-overlevnad-vid-melanom-med-ny-immunterapi/ …,,,# #,4.72691E+17,https://twitter.com/SamuelLz/status/472690663176163328,,,,
yzafar,5/31/2014 6:40,6,0,. @ ASCO tackles a tough question: why are cancer drugs so pricey? http://bit.ly/1kb6QyM # ASCO14 # financialtoxicity,,@,# #,4.72689E+17,https://twitter.com/yzafar/status/472688996439826432,,,,
_SEOM,5/31/2014 6:39,5,0,# OncoNexion permite a periodistas y oncólogos consultar los resultados del congreso mundial de Oncología # ASCO14 http://www.onconexion2014.com/,,,# #,4.72689E+17,https://twitter.com/_SEOM/status/472688715752415232,,,,
subatomicdoc,5/31/2014 6:34,0,0,@ davisa20 Looks like the start of a beautiful day! # ASCO14,,@,#,4.72688E+17,https://twitter.com/subatomicdoc/status/472687570741391361,,,,
davisa20,5/31/2014 6:33,2,3,Beautiful sunrise to welcome in Day 2 of # ASCO14 pic.twitter.com/MnE4ArLTW4,,,#,4.72687E+17,https://twitter.com/davisa20/status/472687344303484929,,,,
adamfeuerstein,5/31/2014 6:32,0,4,Great crowd at last night's # ASCO14 unofficial tweetup. Thx again. Thrilled to meet @ JPZaragoza1. I bought him a hoppy beer!,,@,#,4.72687E+17,https://twitter.com/adamfeuerstein/status/472686927393878016,,,,
HenryJOncology,5/31/2014 6:27,0,1,Let's get a sarcoma conversation going! Looking forward to seeing the best new research in Chicago # ASCO14 # sarcsm,,,# #,4.72686E+17,https://twitter.com/HenryJOncology/status/472685816335331328,,,,
JenPageWall,5/31/2014 6:27,0,0,"New, better meds often reduce other medical expenses, says @ Celgene on US # healthcare costs http://bit.ly/1ku6YbS # ASCO14",,@,# #,4.72686E+17,https://twitter.com/JenPageWall/status/472685767500636160,,,,
redaccionmedica,5/31/2014 6:24,0,0,Opinión | Sala de Espera: # dietasmilagro y @ ASCO toman los periódicos http://www.redaccionmedica.com/opinion/dietas-y-asco-toman-los-periodicos-5526 …,,@,#,4.72685E+17,https://twitter.com/redaccionmedica/status/472685158613929985,,,,
weldeiry,5/31/2014 6:22,3,4,"Beautiful sunrise in Chicago on May 31, 2014 @ ASCO # ASCO14 pic.twitter.com/IjVVUqeB3x",,@,#,4.72684E+17,https://twitter.com/weldeiry/status/472684457041092608,,,,
DagensMedicinDK,5/31/2014 6:20,3,0,"Dagens Medicin rapporterer i weekenden og næste uge fra verdens største kræftkongres, # ASCO14. Følg dækningen her http://www.dagensmedicin.dk/asco/",,,#,4.72684E+17,https://twitter.com/DagensMedicinDK/status/472683940281847808,,,,
DrMqAgMas,5/31/2014 6:15,1,1," @ JAMA_current: Statin Use Can Stop When Illness Is # Terminal @ ASCO Great! We're debating that http://scgig.org due to a Catalan study""",,@ @,#,4.72683E+17,https://twitter.com/DrMqAgMas/status/472682752568229888,,,,
MGHCancerCenter,5/31/2014 6:10,0,0,"8-11:45, S Hall A2: Dr. Faris poster: Phase 2 trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors # ASCO14",,,#,4.72681E+17,https://twitter.com/MGHCancerCenter/status/472681438295638016,,,,
Curiolog,5/31/2014 5:56,0,0,La cancérologie fait son bilan annuel à Chicago http://www.allodocteurs.fr/actualite-sante-la-cancerologie-fait-son-bilan-annuel-a-chicago-13565.asp?1=1 … # ASCO14 # cancerpic.twitter.com/f0LixWnsB4,,,# #,4.72678E+17,https://twitter.com/Curiolog/status/472678036996100096,,,,
dagensmedicin,5/31/2014 5:35,3,1,"Studier behövs för cancer hos äldre""", # asco2014," # dmasco: http://www.dagensmedicin.se/asco/studier-behovs-for-cancer-hos-aldre/ …""",,,# #,4.72673E+17,https://twitter.com/dagensmedicin/status/472672796439756800,,
BoehringerES,5/31/2014 5:30,5,0,Esta tarde celebramos en # ASCO14 un doble evento de # afatinib y # nintedanib con ponencias acerca de # cancerpulmon y # angiogenesis,,,# # # # #,4.72671E+17,https://twitter.com/BoehringerES/status/472671333885562880,,,,
BreastDocUK,5/31/2014 4:55,0,0,Thank goodness for GMT. I can catch up on all your tweets while you conference goers sleep it off # ASCO14,,,#,4.72663E+17,https://twitter.com/BreastDocUK/status/472662624300445696,,,,
dagensmedicin,5/31/2014 4:52,2,0,"Döende cancerpatienter fick bättre livskvalitet utan statiner, # dmasco, # asco2014: http://www.dagensmedicin.se/asco/cancerpatienter-madde-battre-nar-hjartlakemedel-togs-bort/ …",,,# #,4.72662E+17,https://twitter.com/dagensmedicin/status/472661892247617536,,,,
GGOULINET,5/31/2014 4:51,0,0,# ASCO14 Current use and attitudes toward the use of information technologies in healt... | @ scoopit via @ doctorhub http://sco.lt/9KJrhB,,@ @,#,4.72662E+17,https://twitter.com/GGOULINET/status/472661620167278592,,,,
pharmaguapa,5/31/2014 4:39,0,1,"ASCO highlights the # ASCO14 clinician tweeters, & #they favour. This is great! @ pinterest # hcsmeu # pharma http://pinterest.com/pin/275845545901124441/ …",,@,# #they # #,4.72659E+17,https://twitter.com/pharmaguapa/status/472658647760506882,,,,
mediplanetFR,5/31/2014 4:37,0,0,Expensive Drugs Forcing Cancer Doctors to Weigh Price # ASCO14 http://mobile.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html …,,,#,4.72658E+17,https://twitter.com/mediplanetFR/status/472658042195300352,,,,
Progeny,5/31/2014 4:36,0,0,@ Progeny announces plans for a pedigree platform on two continents simultaneously. # ASCO2014 # ESHG14,,@,# #,4.72658E+17,https://twitter.com/Progeny/status/472657983122735104,,,,
onco17twit,5/31/2014 4:35,0,0,# ASCO14 http://tinyurl.com/m249fff,,,#,4.72658E+17,https://twitter.com/onco17twit/status/472657682663366656,,,,
LaurenceVick,5/31/2014 4:34,0,0,# Fertility Freeze Helps Women Have Babies After # Chemotherapy # ASCO2014 via@SJNaggiar by @ maggiemfox & Judy Silverman http://nbcnews.to/1k8Dlxz,,@SJNaggiar @,# # #,4.72657E+17,https://twitter.com/LaurenceVick/status/472657388257177600,,,,
onco17twit,5/31/2014 4:30,0,0,# ASCO14 http://tinyurl.com/m249fff pic.twitter.com/GcZSASxniI,,,#,4.72656E+17,https://twitter.com/onco17twit/status/472656401496821760,,,,
LaurenceVick,5/31/2014 4:29,0,0,"RT @ Medscape: # ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,@,#,4.72656E+17,https://twitter.com/LaurenceVick/status/472656051381489664,,,,
dagensmedicin,5/31/2014 4:25,1,0,"Lovande överlevnad vid melanom med ny immunterapi, # dmasco, # asco2014: http://www.dagensmedicin.se/asco/bra-overlevnad-vid-melanom-med-ny-immunterapi/ …",,,# #,4.72655E+17,https://twitter.com/dagensmedicin/status/472654987387224064,,,,
DocJarad,5/31/2014 4:11,2,2,"Great to see @ TROGfightcancer RADAR RCT results for high risk # ProstateCancer. ADT looks better, for some. # asco2014 http://abstracts.asco.org/144/AbstView_144_132740.html …",,@,# #,4.72651E+17,https://twitter.com/DocJarad/status/472651474510442497,,,,
DocJarad,5/31/2014 4:09,0,1,Adjuvant Docetaxel-estramustine in localized high-risk # ProstateCancer only modest benefits in GETUG 12 RCT # asco2014 http://abstracts.asco.org/144/AbstView_144_127478.html …,,,# #,4.72651E+17,https://twitter.com/DocJarad/status/472651105206169600,,,,
DocJarad,5/31/2014 4:06,0,0,@ DocJarad: Only a few hours before the game changer RCT at # asco2014: Docetaxel with initial ADT for # prostate cancer http://abstracts.asco.org/144/AbstView_144_127755.html …,,@,# #,4.7265E+17,https://twitter.com/DocJarad/status/472650430309089281,,,,
DocJarad,5/31/2014 4:04,0,0,Aggressive chemo-hormone-radiotherapy may be worth exploring after # Prostatectomy # asco2014 http://abstracts.asco.org/144/AbstView_144_133654.html …,,,# #,4.7265E+17,https://twitter.com/DocJarad/status/472649852451422208,,,,
Senology,5/31/2014 3:52,0,0,# ASCO2014 - Check out this page of Annual Meeting - AM 2014 Daily News Anniversary Issue http://read.uberflip.com/i/320982/7,,,#,4.72647E+17,https://twitter.com/Senology/status/472646769911009281,,,,
dagensmedicin,5/31/2014 3:42,0,0,"Ju fler mutationer desto bättre immunterapi, # dmasco, # asco2014: http://www.dagensmedicin.se/asco/ju-fler-mutationer-desto-battre-immunterapi/ …",,,# #,4.72644E+17,https://twitter.com/dagensmedicin/status/472644266607800320,,,,
abcdiagnosis,5/31/2014 3:35,1,1,RT @ NCIMedia: Announced at # ASCO14: Treatment helps young women preserve # fertility during # breastcancer # chemo # bcsm http://1.usa.gov/1psfNFZ,,@,# # # # #,4.72643E+17,https://twitter.com/abcdiagnosis/status/472642536134434816,,,,
OncLive,5/31/2014 3:20,0,1,Dr. Silvia Formenti on Concurrent Adjuvant Systemic Therapy and Accelerated Radiotherapy in TNBC http://ow.ly/xsCsr # ASCO14,,,#,4.72639E+17,https://twitter.com/OncLive/status/472638641919885315,,,,
lenstarnes,5/31/2014 3:02,1,2,"# ASCO14 Twt stats setting new records: April/May leadup+Day 1 > 62m impressions,20k twts,6400 particpts http://bit.ly/1iF4gvH @ ASCO",,@,#,4.72634E+17,https://twitter.com/lenstarnes/status/472634145202782208,,,,
Medicalfacts,5/31/2014 2:53,1,0,Hoe is dit in Nederland? # ASCO14: 50% oncologists have ordered next generation sequencing for their patients.pic.twitter.com/uUX0IrDKOk”,,,#,4.72632E+17,https://twitter.com/Medicalfacts/status/472631854525583361,,,,
LaurenceVick,5/31/2014 2:50,0,0,RT @ NCISymptomMgmt: Treatment helps young women preserve their fertility during # breastcancer # chemotherapy # ASCO2014 http://go.usa.gov/8yJW,,@,# # #,4.72631E+17,https://twitter.com/LaurenceVick/status/472631067342811137,,,,
Medicalfacts,5/31/2014 2:41,0,0,"50 jaar ASCO # ASCO14 - In de erkenning van de evolutie en vooruitgang in de oncologische zorg , zal de American... http://is.gd/6t7fhn",,,#,4.72629E+17,https://twitter.com/Medicalfacts/status/472628935898189825,,,,
MyelomaTeacher,5/31/2014 2:36,1,1,Highlights Day1 # ASCO14 http://www.cancer.net/research-and-advocacy/asco-annual-meetings/highlights-day …,,,#,4.72628E+17,https://twitter.com/MyelomaTeacher/status/472627769894260736,,,,
strehan,5/31/2014 2:21,0,0,New data from Cancer Genome Atlas reveals mutational drivers in NSCLC -- unfort. 25% of cases have none # ASCO14 pic.twitter.com/cVyGoLH2o2,,,#,4.72624E+17,https://twitter.com/strehan/status/472623955019583488,,,,
davidbeme,5/31/2014 2:20,2,0,Cancer : le rôle des proches nécessite un soutien précoce et une meilleure reconnaissance # ASCO2014 @ Doctissimo http://ow.ly/xsROr,,@,#,4.72624E+17,https://twitter.com/davidbeme/status/472623650596999169,,,,
PCRCGroup,5/31/2014 2:12,0,0,RT @ yzafar: Are we justified in excluding patients with prior # cancers from clinical trials? http://bit.ly/1tg8BdB # ASCO14 # hsronc,,@,# # #,4.72622E+17,https://twitter.com/PCRCGroup/status/472621549024215040,,,,
StrandLife,5/31/2014 1:51,0,0,"Strand @ ASCO 2014-Come and meet us at booth 3016 at ASCO,Chicago Illinois from 30 May - 3 June 2014 http://www.strandls.com/news-events/strand-asco-2014-chicago …",,@,,4.72616E+17,https://twitter.com/StrandLife/status/472616281506451456,,,,
PCRCGroup,5/31/2014 1:47,0,0,RT @ RyanNipp: RCT statin discontinue w<12m life expectancy: no survival diff+better QOL+modest $ savings: http://ow.ly/xsR0I # ASCO14,,@,#,4.72615E+17,https://twitter.com/PCRCGroup/status/472615315478564864,,,,
PCRCGroup,5/31/2014 1:41,0,0,@ PCRCGroup study of statin discontinuation toward end of life improved QOL w/o compromising survival: http://ow.ly/xsQEz # ASCO14 # hpm,,@,# #,4.72614E+17,https://twitter.com/PCRCGroup/status/472613909367488513,,,,
PCRCGroup,5/31/2014 1:25,0,0,PCRC Co-Chair Amy Abernethy will present @ PCRCGroup statin discontinuation study results Tuesday at 9:45am http://ow.ly/xrV6B # ASCO14,,@,#,4.7261E+17,https://twitter.com/PCRCGroup/status/472609910773936128,,,,
mmameg,5/31/2014 0:51,0,0,Still rocking the Public # asco2014,,,#,4.72601E+17,https://twitter.com/mmameg/status/472601124583665664,,,,
sunnysaraswat,5/31/2014 0:45,0,0,"If you enjoy wasting time, is that time really wasted? # YR # love # EnjoyDetroit # yolo # prom2k14 # Habs # HappyYoonADay # Kings # FUTWC # ASCO14",,,# # # # # # # # # #,4.726E+17,https://twitter.com/sunnysaraswat/status/472599724118540288,,,,
DrDJagroo,5/31/2014 0:45,0,0,New drug can increase the chances of fertility in some # breastcancer patients: http://online.wsj.com/articles/hormone-suppressor-seen-helping-some-breast-cancer-patients-1401472339 … # ASCO14@ClevelandClinic @ Loftus,,@ClevelandClinic @,# #,4.726E+17,https://twitter.com/DrDJagroo/status/472599614986919936,,,,
ERPlimackMD,5/31/2014 0:25,0,0,"Eric Tetzlaff, FCCC AP-C, shares his perspective on # ASCO14 http://am.asco.org/advanced-practice-provider%E2%80%99s-perspective#.U4lZbwSbrB0.twitter … @ FoxChaseCancer",,@,# #,4.72595E+17,https://twitter.com/ERPlimackMD/status/472594707885719552,,,,
OncLive,5/31/2014 0:25,9,3,"For Premenopausal Women With ER-Positive Disease, Obesity Is a Major Risk Factor in Breast Cancer Mortality http://ow.ly/xsBIv # ASCO14",,,#,4.72595E+17,https://twitter.com/OncLive/status/472594579070676992,,,,
LguzzardiM,5/31/2014 0:24,0,0,@ NCIMedia Treatment helps young women preserve fertility during # breastcancer chemo. # ASCO14 http://m.cancer.gov/news/pressreleases/2014/ASCOPOEMS …,,@,# #,4.72594E+17,https://twitter.com/LguzzardiM/status/472594461579837440,,,,
ArcagyGineco,5/31/2014 0:17,0,0,Les résultats de l'étude AROBASE (cancer sein métastatique) le samedi 31 Mai à 15h15 à la session orale cancer du sein # ASCO14,,,#,4.72593E+17,https://twitter.com/ArcagyGineco/status/472592803789570048,,,,
PascaleCom,5/31/2014 0:15,0,1,Attending @ ASCO? Stop by booth #19156 and learn how our friends at @ GuardantHealth are changing # cancer diagnostics! # ASCO14,,@ @,#19156 # #,4.72592E+17,https://twitter.com/PascaleCom/status/472592275902832640,,,,
GuardantHealth,5/31/2014 0:15,3,2,Circulating tumor DNA as a molecular monitoring tool in metastatic breast cancer presentation tomorrow 1:15 @S Hall A2 # ASCO14 # Guardant360,,@S,# #,4.72592E+17,https://twitter.com/GuardantHealth/status/472592130477916160,,,,
doctorpemm,5/31/2014 0:13,0,2,"@ ShannonWestin Welcome to Twitter, Shannon ! # ASCO14 # gynonc",,@,# #,4.72592E+17,https://twitter.com/doctorpemm/status/472591551395164160,,,,
rsm2800,5/31/2014 0:03,0,0,Go for it! MT @ JFreemanDaily: Day One of # ASCO14 is done. Tomorrow: another patient advocate attempt to drink from the firehose.,,@,#,4.72589E+17,https://twitter.com/rsm2800/status/472589126856740864,,,,
docgovind,5/30/2014 23:51,0,0,@ CancerDotNet @ ASCO,,@ @,,4.72586E+17,https://twitter.com/docgovind/status/472586023541964801,,,,
PVonc,5/30/2014 23:50,0,0,Join us tomorrow evening at the Hyatt Regency for a free CME symposium on Pancreatic Adenocarcinoma http://bit.ly/ASCOpancreatic # ASCO14 # pancsm,,,# #,4.72586E+17,https://twitter.com/PVonc/status/472585903987499008,,,,
RamalingamMD,5/30/2014 23:50,0,2,@ AndytweetM I have not seen clinical data with that combo approach. Check out abs 8126 at # ASCO14 - use of FAK inhibitor in KRAS mt.,,@,#,4.72586E+17,https://twitter.com/RamalingamMD/status/472585845867024384,,,,
afreshchapter,5/30/2014 23:49,0,0,“ @ mclaurin6: @ afreshchapter # asco14 needs Segways?” Yes!!,,@ @,#,4.72586E+17,https://twitter.com/afreshchapter/status/472585595035066368,,,,
SarahCannonDocs,5/30/2014 23:46,3,1,In the world of drug development," it's the patients that do the hard work"" # SCRI @ BurrisSkip # GiantsCC # ASCO14 award pic.twitter.com/XaZfR3O2NQ""",,@,# # #,4.72585E+17,https://twitter.com/SarahCannonDocs/status/472584850353180672,,,
mclaurin6,5/30/2014 23:44,0,1,@ afreshchapter # asco14 needs Segways?,,@,#,4.72585E+17,https://twitter.com/mclaurin6/status/472584500275580928,,,,
MaverickNY,5/30/2014 23:44,2,1,Running on empty... Tired and hungry. Hope we don't miss the train stop # asco14,,,#,4.72584E+17,https://twitter.com/MaverickNY/status/472584331144482816,,,,
JFreemanDaily,5/30/2014 23:41,1,10,Day One of # ASCO14 is done. Tomorrow: another patient advocate attempt to drink from the clinical oncology firehose. **gulp** # LCSM,,,# #,4.72584E+17,https://twitter.com/JFreemanDaily/status/472583663389925377,,,,
melanoma_Drs,5/30/2014 23:39,0,0,RT @ Melanoma_doctor: Preview of a # melanoma Saturday at # ASCO14 from http://ow.ly/3lbqIH @ OmidHamidMD @MDAMelanomaOnc,,@ @ @MDAMelanomaOnc,# #,4.72583E+17,https://twitter.com/melanoma_Drs/status/472583052267618304,,,,
Melanoma_doctor,5/30/2014 23:38,3,2,Preview of a # melanoma Saturday at # ASCO14 from http://themelanomacenter.com http://ow.ly/3lbqIH @ OmidHamidMD @MDAMelanomaOnc,,@ @MDAMelanomaOnc,# #,4.72583E+17,https://twitter.com/Melanoma_doctor/status/472582883065208832,,,,
NirajGusani,5/30/2014 23:37,0,1,Better late than never # FF # ASCO14 tweeps: # CRCSM # EsocSM # HPBCSM # PancSM # HCSM @ rschilsky @ yzafar @ TGeorgeMD @ mtmdphd @ rsm2800 @ fischmd,,@ @ @ @ @ @,# # # # # # #,4.72583E+17,https://twitter.com/NirajGusani/status/472582618962464769,,,,
BairdAM,5/30/2014 23:31,0,0,"# lcsm  @ OncLive: AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xsBEG # ASCO14""""",,@,# #,4.72581E+17,https://twitter.com/BairdAM/status/472580979828072448,,,,
JBBC,5/30/2014 23:30,0,0,.RT @ subatomicdoc: Current use and attitudes toward IT use in health care among cancer patients http://bit.ly/1tVmUGM # ASCO14,,@,#,4.72581E+17,https://twitter.com/JBBC/status/472580783849607168,,,,
womenofteal,5/30/2014 23:30,0,1,"# ASCO14 # gyncsm Improve Quality of Life for Patients, Survivors, and Caregivers from http://Cancer.Net http://www.cancer.net/blog/2014-05/new-strategies-improve-quality-life-patients-survivors-and-caregivers-2014-asco-annual-meeting#.U4lMh5CLRlA.twitter …",,,# # #,4.72581E+17,https://twitter.com/womenofteal/status/472580758565957632,,,,
KP_SEDE,5/30/2014 23:28,0,0,Siguiendo ASCO 2014 “ @ rschilsky: Today is the first day of @ ASCO’s 50th Annual Meeting “Science & Society” Follow & use the tag # ASCO14”,,@ @,#,4.7258E+17,https://twitter.com/KP_SEDE/status/472580297209708544,,,,
OncLive,5/30/2014 23:25,0,0,AZD9291 Shows Robust Activity in Resistant EGFR-positive NSCLC http://ow.ly/xsBEG # ASCO14,,,#,4.72579E+17,https://twitter.com/OncLive/status/472579479953743873,,,,
MargueNrvz,5/30/2014 23:24,0,0,Es 20% persona.. 80% apariencias # ASCO14,,,#,4.72579E+17,https://twitter.com/MargueNrvz/status/472579336592441344,,,,
Lymphoma_Doc,5/30/2014 23:21,9,5,"MD Anderson fellows featured on # ASCO14 main hallway celebrating @ iConquerCancer YIA. Well done, @ ASCO pic.twitter.com/AMHuSuCYuX",,@ @,#,4.72579E+17,https://twitter.com/Lymphoma_Doc/status/472578650752024576,,,,
OncNursingNews,5/30/2014 23:15,0,0,Edith Perez @ MayoClinic receives 2014 Giants of Cancer Care Award for Community Outreach @ OncLive # ASCO14,,@ @,#,4.72577E+17,https://twitter.com/OncNursingNews/status/472577124415864832,,,,
JeffreyMOtto,5/30/2014 23:15,0,0,Stop by booth 7135 and see how the CIRI team can help with your clin trial and trans. research needs. # asco14 @ CHI_Updates @ umbiopark,,@ @,#,4.72577E+17,https://twitter.com/JeffreyMOtto/status/472577114311761921,,,,
teamoncology,5/30/2014 23:15,5,3,# ASCO14 本日より米国臨床腫瘍学会の年次総会開始。このハッシュタグをフォローすると最新のがん情報が入可能。この学会はがんに関する世界最大の学会です。質問があれば、送って下さい。,,,#,4.72577E+17,https://twitter.com/teamoncology/status/472577065980395520,,,,
NirajGusani,5/30/2014 23:10,1,0,A colleague in @ PancSMChat # PancSM RT @ ASCO: Dr. Matthew H. G. Katz: A surgical oncologists experience at # ASCO14 http://bit.ly/1nv1vor,,@ @,# #,4.72576E+17,https://twitter.com/NirajGusani/status/472575839474036736,,,,
OncNursingNews,5/30/2014 23:08,1,2,Congrats to Jimmie Holland @ sloan_kettering winner of 2014 Giants of Cancer Care Award for Supportive Care @ OncLive # ASCO14,,@ @,#,4.72575E+17,https://twitter.com/OncNursingNews/status/472575351676493826,,,,
DraDianePerez,5/30/2014 23:08,8,7,Fascinada con toda la información en la reunión de la @ ASCO en Chicago. Les tendré lo más nuevo sobre cáncer por @ NTelevisa_com y @ Foro_TV,,@ @ @,,4.72575E+17,https://twitter.com/DraDianePerez/status/472575314192007168,,,,
chadfife,5/30/2014 23:08,0,0,11 hours 'til # ASCO14 tipoff. 301 CME courses coming your way.,,,#,4.72575E+17,https://twitter.com/chadfife/status/472575237163597824,,,,
afreshchapter,5/30/2014 23:06,0,0,40 minute walk between events at # asco14 in heels. The blisters are worth it. # chicago # architecture… http://instagram.com/p/opT9kisgbE/,,,# # #,4.72575E+17,https://twitter.com/afreshchapter/status/472574711923101696,,,,
JacobPlieth,5/30/2014 23:04,0,0,EMD1214064 (c-Met inhibitor) phase I # ASCO14 pic.twitter.com/DlJJHFU0EC,,,#,4.72574E+17,https://twitter.com/JacobPlieth/status/472574380682526720,,,,
JacobPlieth,5/30/2014 23:02,0,0,EMD1214063 (c-Met inhibitor) phase I # ASCO14 pic.twitter.com/X69UswFCvW,,,#,4.72574E+17,https://twitter.com/JacobPlieth/status/472573906491277312,,,,
JacobPlieth,5/30/2014 23:01,0,0,EMD1214063 phase I # ASCO14 pic.twitter.com/yqT8TQbx23,,,#,4.72574E+17,https://twitter.com/JacobPlieth/status/472573610520244224,,,,
JacobPlieth,5/30/2014 22:59,0,0,Phase I study of EMD1214063 # ASCO14 pic.twitter.com/P3OGCbvtek,,,#,4.72573E+17,https://twitter.com/JacobPlieth/status/472573041604833280,,,,
JeffreyMOtto,5/30/2014 22:57,2,0,“ @ KUhlendorf: Genetic sequencing could change # cancer treatment forever http://www.cbsnews.com/news/genetic-sequencing-could-change-cancer-treatment-forever … via # ASCO14” I think polyomics is required..,,@,# #,4.72573E+17,https://twitter.com/JeffreyMOtto/status/472572553605574656,,,,
TuftsB,5/30/2014 22:56,0,3,"The most important question to ask a doctor is are you willing to fight cancer as hard as I will?"" not price of the care. # MLIWI # asco14""",,,# #,4.72572E+17,https://twitter.com/TuftsB/status/472572370251939841,,,,
CAPLungCancer,5/30/2014 22:51,0,0,ASCO here I come # ASCO2014,,,#,4.72571E+17,https://twitter.com/CAPLungCancer/status/472571142549831681,,,,
JFreemanDaily,5/30/2014 22:45,0,1,"@ chrisdraft Would love to meet you at # ASCO14. Will you be in bullpen, patient advocate room, or at tweetup?",,@,#,4.72569E+17,https://twitter.com/JFreemanDaily/status/472569405709488128,,,,
WilliamDale_MD,5/30/2014 22:44,1,1,# ASCO14 Ever wanted to know how to clinically integrate # geriatrics with # oncology ? Come find out tomorrow am! http://am.asco.org/saturday-may-31-2014 …,,,# # #,4.72569E+17,https://twitter.com/WilliamDale_MD/status/472569287878516736,,,,
CUCancerCenter,5/30/2014 22:41,2,2,Dr. Paul Bunn named Giant in Cancer Care by @ OncLive . # ASCO14 # lungcancerpic.twitter.com/hF0FUGZrNn,,@,# #,4.72569E+17,https://twitter.com/CUCancerCenter/status/472568600323031041,,,,
SarahCannonDocs,5/30/2014 22:38,3,0,Busy start to # ASCO14 with # SCRI today. Join our over 70 presentations this weekend-full schedule here: http://bit.ly/1kfjJH4,,,# #,4.72568E+17,https://twitter.com/SarahCannonDocs/status/472567758480498688,,,,
scientre,5/30/2014 22:38,0,0,Yes! MT @ rsm2800 (Pt advocate from audience): Can’t make value decision wo incl pts in discussions. No mention of PROs 2day # ASCO14,,@,#,4.72568E+17,https://twitter.com/scientre/status/472567718320046080,,,,
KimKlingler,5/30/2014 22:33,0,0,Inspiring President's Dinner # ASCO2014. Thank you! pic.twitter.com/Yr7XOW5FAF,,,#,4.72566E+17,https://twitter.com/KimKlingler/status/472566490076430336,,,,
SteeleKaterina,5/30/2014 22:26,0,0,"Wow! RT @ PhRMA: Study finds # Medicare # PartD coverage reduced hospitalization by 8%, says @ Celgene http://bit.ly/1ku6YbS # ASCO14",,@ @,# # #,4.72565E+17,https://twitter.com/SteeleKaterina/status/472564759762853888,,,,
OncLive,5/30/2014 22:25,0,1,Novel TKI May Provide New Treatment Option for Patients With Recurrent PVNS http://ow.ly/xsBCm # ASCO14,,,#,4.72564E+17,https://twitter.com/OncLive/status/472564382267101185,,,,
NickAlderslade,5/30/2014 22:17,0,0,Sunset over Chicago! Looking forward to two days at # ASCO14 to talk all things @ WorldCDxpic.twitter.com/ZiYUkFO6s9,,@,#,4.72562E+17,https://twitter.com/NickAlderslade/status/472562366883037184,,,,
maherjend,5/30/2014 22:14,0,0,I created this curation http://www.scoop.it/t/precision-medicine-daily … # ASCO14,,,#,4.72562E+17,https://twitter.com/maherjend/status/472561751578648576,,,,
lisamjarvis,5/30/2014 22:10,1,1,Had to exit the # ASCO14 tweetup to prep for actual asco. happy to see so many familiar faces!,,,#,4.72561E+17,https://twitter.com/lisamjarvis/status/472560797504528384,,,,
drsam,5/30/2014 22:08,0,0,Love this. # chicago # asco14 @Wrigley Building http://instagram.com/p/opNacCqvpy/,,@Wrigley,# #,4.7256E+17,https://twitter.com/drsam/status/472560310184734720,,,,
iman_elhariry,5/30/2014 22:06,0,0,"@ ASCO I am sorry, I meant the AC is very cold inside the rooms. please make it a little warmer. Thank you # ASCO",,@,#,4.7256E+17,https://twitter.com/iman_elhariry/status/472559606284050432,,,,
tinypasscontent,5/30/2014 22:04,0,0,"ASCO 2014 Chicago Day 1 Blog # ASCO14"" http://ift.tt/1oEL6gE # BiotechStrategy # tinypass # paidcontent ""Welcome to ASCO 2014 ( # ASCO14)"," ...""",,,# # # # #,4.72559E+17,https://twitter.com/tinypasscontent/status/472559335412105216,,,
bmsnews,5/30/2014 22:00,8,5,Researchers seek to transform # cancer treatment through immunotherapy discoveries. Learn more at tomorrow’s # ASCO14 Industry Expert Theater,,,# #,4.72558E+17,https://twitter.com/bmsnews/status/472558220733870081,,,,
FightCRC,5/30/2014 21:59,0,2,Enjoying listening to @ stevenbjohnson at @ bmsnews dinner! Inspired by innovation. # ASCO14 # CancerConnectionspic.twitter.com/y7ALJzOqjt,,@ @,# #,4.72558E+17,https://twitter.com/FightCRC/status/472557957193170944,,,,
drdonsdizon,5/30/2014 21:54,0,0,@ littlegoatdiner @ mghcancercenter w Dr Lori Wirth & Liz Sweeney # asco14 http://instagram.com/p/opLxviJw2Q/,,@ @,#,4.72557E+17,https://twitter.com/drdonsdizon/status/472556712495706112,,,,
ScheryllAlken,5/30/2014 21:51,0,0,"Loving my stay @ JamesHotels Chicago and it's only my second night! Amazing room, super service and lots of fun # ASCO14",,@,#,4.72556E+17,https://twitter.com/ScheryllAlken/status/472556031554617344,,,,
CancerGeek,5/30/2014 21:51,0,1,Drug Could Protect Fertility in Breast Cancer Patients http://flip.it/LAPAP # bcsm # ASCO14 # fertility cc: @ JBBC,,@,# # #,4.72556E+17,https://twitter.com/CancerGeek/status/472555886658215936,,,,
ScheryllAlken,5/30/2014 21:49,0,0,Amazing cocktail @ eatatunion can't wait for my first piece of sushi! # ASCO14,,@,#,4.72555E+17,https://twitter.com/ScheryllAlken/status/472555339658043392,,,,
drdonsdizon,5/30/2014 21:48,0,0,@ mghcancercenter asco reception. littlegoat # chicago # asco2014 http://instagram.com/p/opLGwApw1m/,,@,# #,4.72555E+17,https://twitter.com/drdonsdizon/status/472555236695875584,,,,
BiotechStrategy,5/30/2014 21:48,0,0,ASCO 2014 Chicago Day 1 Blog # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-chicago-day-1-blog-asco14.html/ …,,,#,4.72555E+17,https://twitter.com/BiotechStrategy/status/472555063362080769,,,,
ASCO,5/30/2014 21:45,9,6,Photos from the first day of # ASCO14 http://on.fb.me/1mTi4a9 (FB link)pic.twitter.com/yCZNtlCSpj,,,#,4.72554E+17,https://twitter.com/ASCO/status/472554426658332672,,,,
ProjectInno,5/30/2014 21:45,1,0,Let’s make cancer innovation a national priority: http://ow.ly/xs2Gr # ASCO14,,,#,4.72554E+17,https://twitter.com/ProjectInno/status/472554333729718272,,,,
LungCancerFaces,5/30/2014 21:42,1,2,What's a life worth? MT @ OncLive: Study Projects Implementation Outcomes of # LungCancer Screening http://ow.ly/xsBzS # ASCO14 # LCSM,,@,# # #,4.72554E+17,https://twitter.com/LungCancerFaces/status/472553658261835776,,,,
3NT,5/30/2014 21:42,0,0,ASCO 2014 Chicago Day 1 Blog with commentary on some noteworthy posters # ASCO14 http://3nt.co/1hHyjTh,,,#,4.72554E+17,https://twitter.com/3NT/status/472553602209570816,,,,
Jehennessy3,5/30/2014 21:41,0,1,# ASCO14 White Sox vs. Padres. No immunotherapy talks scheduled. pic.twitter.com/upJeX5O9Fb,,,#,4.72553E+17,https://twitter.com/Jehennessy3/status/472553321182818304,,,,
UrologyMatch,5/30/2014 21:39,2,5,GU Med Onc Powerhouse @ ERPlimackMD Joins Twitter. Welcome! # ASCO14 # KOL @ FCUroOnc,,@ @,# #,4.72553E+17,https://twitter.com/UrologyMatch/status/472553006706470912,,,,
DLanger1,5/30/2014 21:39,0,0,Very moving! @ drseisenberg: What is it like to receive a cancer diagnosis http://shar.es/VOXqk via @ PatientCommando # lcsm # ASCO14,,@ @,# #,4.72553E+17,https://twitter.com/DLanger1/status/472552873424068608,,,,
BiostatGirl,5/30/2014 21:34,0,0,All work and no play makes this statistician a dull girl... White Sox vs Padres. # chicago # asco2014… http://instagram.com/p/opJeBOAzBf/,,,# #,4.72552E+17,https://twitter.com/BiostatGirl/status/472551642572017664,,,,
DebConference,5/30/2014 21:34,0,0,I'll be at # ASCO14 tomorrow. Wait for me!!!,,,#,4.72552E+17,https://twitter.com/DebConference/status/472551583142903809,,,,
UrologyMatch,5/30/2014 21:33,3,1,"“ @ ERPlimackMD: Dr. Eisen discusses: neoadjuvant TKI shrinks most primary RCCs, can lower nephrometry score # ASCO14 pic.twitter.com/g2rp1i8uJi”",,@,#,4.72551E+17,https://twitter.com/UrologyMatch/status/472551445112578049,,,,
bmsnews,5/30/2014 21:30,1,4,Many thanks to our advocacy partners and @ StevenBJohnson for an inspiring discussion on innovation in oncology. # ASCO14 # CancerConnections,,@,# #,4.72551E+17,https://twitter.com/bmsnews/status/472550633636380672,,,,
cityofhope,5/30/2014 21:29,2,3,". @ ClevelandClinic study finds tweak to # breastcancer therapy can protect # fertility, increase # survival. http://bit.ly/SkYkkQ # ASCO14",,@,# # # #,4.7255E+17,https://twitter.com/cityofhope/status/472550293700231168,,,,
drseisenberg,5/30/2014 21:28,0,0,@ suleikajaouad This meeting is really about human beings. # ASCO14,,@,#,4.7255E+17,https://twitter.com/drseisenberg/status/472550107305357315,,,,
birthlovedeath,5/30/2014 21:27,0,1,# palliativecare can be hidden/solitary. http://loveinourowntime.com pulls back the curtains & facilitates discussion. $5 off code ASCO14 # ASCO14,,,# #,4.7255E+17,https://twitter.com/birthlovedeath/status/472549955643514880,,,,
OncLive,5/30/2014 21:25,0,0,"As Lung Cancer Screening Debate Continues, Study Projects Implementation Outcomes http://ow.ly/xsBzS # ASCO14",,,#,4.72549E+17,https://twitter.com/OncLive/status/472549281673805825,,,,
AlpineBV_Miller,5/30/2014 21:24,0,1,Anyone who is anyone in the # ASCO14 Twitterverse has cycled thru the unofficial Tweetup here at the Hubbard Inn. Amazing.,,,#,4.72549E+17,https://twitter.com/AlpineBV_Miller/status/472549128963375104,,,,
CancerSupportHQ,5/30/2014 21:22,0,1,@ stevenbjohnson thanks for a GREAT talk this evening! # ASCO14 pic.twitter.com/6a0kd48XFu,,@,#,4.72549E+17,https://twitter.com/CancerSupportHQ/status/472548639051907072,,,,
bio_clouseau,5/30/2014 21:21,0,0,"$ AMBI RT @ doctorpemm: # ASCO14 Dr Andreeff et al novel # FLT3 # inhibitor combo GCSF,plerixafor,sorafenib http://abstracts.asco.org/144/AbstView_144_134574.html …",,@,# # #,4.72548E+17,https://twitter.com/bio_clouseau/status/472548400534011904,,,,
Boehringer,5/30/2014 21:20,0,1,# PRESS & # HCPs: Learn about the ErbB family in a specific type of # lungcancer here http://bit.ly/TTAgaf # ASCO14,,,# # # #,4.72548E+17,https://twitter.com/Boehringer/status/472548034556219392,,,,
RS_Flinn,5/30/2014 21:19,0,1,Missing @ megtirrell & @ ToddRingler the unofficial # ASCO14 tweet up. However @ Loder5 is KILLING IT,,@ @ @,#,4.72548E+17,https://twitter.com/RS_Flinn/status/472547827818983425,,,,
doctorpemm,5/30/2014 21:16,3,2,"# ASCO14 Dr Andreeff et al novel # FLT3 # inhibitor combo GCSF,plerixafor,sorafenib http://abstracts.asco.org/144/AbstView_144_134574.html …",,,# # #,4.72547E+17,https://twitter.com/doctorpemm/status/472547082310406144,,,,
drseisenberg,5/30/2014 21:16,1,2,What is it like to receive a cancer diagnosis http://shar.es/VOXqk via @ PatientCommando # lcsm # ASCO14,,@,# #,4.72547E+17,https://twitter.com/drseisenberg/status/472547054619602944,,,,
myriadgenetics,5/30/2014 21:15,1,3,At # ASCO14? Visit Booth 2039 to learn about Myriad’s superior accuracy in # genetictesting & variant classification program! # UnofficialASCO,,,# # #,4.72547E+17,https://twitter.com/myriadgenetics/status/472546756635271168,,,,
roseherring,5/30/2014 21:14,0,0,Are there any healthcare system/cancer institute marketers out there that want to meet up on Saturday afternoon? # ASCO14,,,#,4.72547E+17,https://twitter.com/roseherring/status/472546725337763841,,,,
DrMiguelPerales,5/30/2014 21:14,2,1,"Drug Saves Fertility For Women With Cancer, via @ nytimes # ASCO14 # bcsm http://nyti.ms/1jBaNXT",,@,# #,4.72547E+17,https://twitter.com/DrMiguelPerales/status/472546710607388673,,,,
UICancerCenter,5/30/2014 21:12,1,0,Great brainstorming at the @ BigTenCRC here at @ ASCO!b,,@ @,,4.72546E+17,https://twitter.com/UICancerCenter/status/472546045642432513,,,,
drseisenberg,5/30/2014 21:11,0,5,@ ASCO = Advancements | Survivorship | Compassion | Oneness # endcancer # ASCO14,,@,# #,4.72546E+17,https://twitter.com/drseisenberg/status/472545926041460736,,,,
OncologyTimes,5/30/2014 21:10,0,1,"Wowee ! MT @ CliffordHudis: Tweeps, if things go right, am taking a page fr @ rsm2800 & will auto-tweet my Pres Address @10:20am CT # ASCO14",,@ @ @10,#,4.72546E+17,https://twitter.com/OncologyTimes/status/472545649955987456,,,,
donaldhtaylorjr,5/30/2014 21:10,1,0,"Via @ RyanNipp: RCT statin discontinue w<12m life expectancy: no survival diff+better QOL+modest $ savings: http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/559?xid=nl_mpt_ASCO_2014-05-30&utm_source=%20ASCO_&utm_medium=email&utm_content=mpt&utm_campaign=05%7C30%7C2014&userid=&eun=g6103806d17r&email=ryan.nipp@gmail.com&mu_id=6103806 … # ASCO14""",,@ @gmail,#,4.72546E+17,https://twitter.com/donaldhtaylorjr/status/472545594297155584,,,,
wendyselig,5/30/2014 21:09,0,0,"Another banner year for # melanoma progress expected at # asco14, starting tomorrow with talks by @ MelanomaReAlli researchers",,@,# #,4.72545E+17,https://twitter.com/wendyselig/status/472545463363571712,,,,
iman_elhariry,5/30/2014 21:08,0,0,# ASCO14 - Why air-conditioning inside the convention centre needs to be too cold! Please make it comfortable,,,#,4.72545E+17,https://twitter.com/iman_elhariry/status/472545051520671745,,,,
iman_elhariry,5/30/2014 21:06,0,1,"It is official # ASCO14 started, and is great to be back in Chicago",,,#,4.72545E+17,https://twitter.com/iman_elhariry/status/472544593402032129,,,,
adamfeuerstein,5/30/2014 21:05,0,7,The unofficial # ASCO14 tweetup is packed! Thx to everyone who showed up.,,,#,4.72544E+17,https://twitter.com/adamfeuerstein/status/472544470077276160,,,,
Boehringer,5/30/2014 21:05,4,1,# PRESS: Interested in our # lungcancer treatment afatinib? Learn more about how it works here: http://bit.ly/SeYCcV # ASCO14,,,# # #,4.72544E+17,https://twitter.com/Boehringer/status/472544298387648512,,,,
RyhMd,5/30/2014 21:05,0,0,# ASCO14 # lung cancerpic.twitter.com/KzJKIhvvyE,,,# #,4.72544E+17,https://twitter.com/RyhMd/status/472544255186325504,,,,
GenentechJobs,5/30/2014 21:02,0,1,immunotherapy is one of today’s promising approaches to treating cancer. See details: http://bit.ly/1oUPzsH # ASCO14 pic.twitter.com/nGaAdfYGw5,,,#,4.72544E+17,https://twitter.com/GenentechJobs/status/472543635674632192,,,,
JonathanHirsch,5/30/2014 21:02,0,0,"Join me at  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.72544E+17,https://twitter.com/JonathanHirsch/status/472543577424531458,,,,
bmsnews,5/30/2014 21:00,7,4,“Innovation is often the unintended consequence of a confluence of good ideas.” @ StevenBJohnson # ASCO14 # CancerConnections,,@,# #,4.72543E+17,https://twitter.com/bmsnews/status/472543150696062976,,,,
ATIVSoftware,5/30/2014 21:00,0,1,Great # ASCO14 conference app video http://bcove.me/urums205 in # Chicago # eventprofs # eventtech,,,# # # #,4.72543E+17,https://twitter.com/ATIVSoftware/status/472542995699355651,,,,
GraniteDoc,5/30/2014 20:59,0,0,RT @ RyanNipp ENABLE III randomized trial - is pall care immediately at dx better than if provided later? # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/558 …,,@,#,4.72543E+17,https://twitter.com/GraniteDoc/status/472542784038379520,,,,
megtirrell,5/30/2014 20:59,0,8,There is an amazing high school prom happening tonight at the McCormick Hyatt. I WISH I had been this stylish in hs. # ASCO14,,,#,4.72543E+17,https://twitter.com/megtirrell/status/472542771929444352,,,,
SarahCannonDocs,5/30/2014 20:56,0,0,Current metastatic pancreatic cancer study (The Rainier Trial) currently is open for enrollment. Learn about the criteria. # ASCO14 240b,,,#,4.72542E+17,https://twitter.com/SarahCannonDocs/status/472542191093428224,,,,
JanBresch,5/30/2014 20:56,0,0,Great talk by @ stevenbjohnson at BMS patient advocacy reception. # ASCO14,,@,#,4.72542E+17,https://twitter.com/JanBresch/status/472542103994515456,,,,
SarahCannonDocs,5/30/2014 20:54,1,0,Don't miss Clinical Science Symposium on #11010 Sat 8-9:30 S406 Exp biomarker analysis ph I study of AZD4547 # SCRI # ASCO14,,,#11010 # #,4.72541E+17,https://twitter.com/SarahCannonDocs/status/472541495057448960,,,,
PatriciaMWinter,5/30/2014 20:46,0,0,Shout out if youre at the # ASCO14 unofficial tweetup!,,,#,4.7254E+17,https://twitter.com/PatriciaMWinter/status/472539695067693057,,,,
RyhMd,5/30/2014 20:46,1,0,# asco14 # lung cancerpic.twitter.com/1tPd3a1iyr,,,# #,4.7254E+17,https://twitter.com/RyhMd/status/472539635466256384,,,,
MaverickNY,5/30/2014 20:46,0,2,@ mtmdphd perhaps part of the issue is that we need more scientist-physicians to offset too many phase 3 failures # asco14,,@,#,4.7254E+17,https://twitter.com/MaverickNY/status/472539614318960640,,,,
SarahCannonDocs,5/30/2014 20:46,1,1,# ASCO14 exhibit hall opens tomorrow! Stop by booth 2063 to learn more about # SCRI.,,,# #,4.72539E+17,https://twitter.com/SarahCannonDocs/status/472539489953673217,,,,
Gene_Antibody,5/30/2014 20:45,0,0,We'll be there! MT @ 3nt: RT @ rsm2800: There’s the Official # ASCO14 Tweetup http://tweetvite.com/event/ASCO14 & the Unofficial # asco14 Tweetup...,,@ @,# #,4.72539E+17,https://twitter.com/Gene_Antibody/status/472539242556841984,,,,
azzi,5/30/2014 20:45,0,0,Just landed in Chicago for my fifth # ASCO14.,,,#,4.72539E+17,https://twitter.com/azzi/status/472539205428850688,,,,
dbasanta,5/30/2014 20:42,0,1,A collaborator with IMO RT @ MoffittResearch Dr. Gupta's presentation on emerging combo therapies for # breast & # prostate # cancer at # ASCO14.,,@,# # # #,4.72539E+17,https://twitter.com/dbasanta/status/472538629488013312,,,,
brenab63,5/30/2014 20:40,0,0,# ASCO14,,,#,4.72538E+17,https://twitter.com/brenab63/status/472538155132788736,,,,
BoysenMeb,5/30/2014 20:40,0,0,1. # ASCO14 dag er gået. Læs i @DagMedicin bl.a om lovende Fase1 forsøg og om næste års ASCO-præsidents mål pic.twitter.com/lTkvafQ9EK,,@DagMedicin,#,4.72538E+17,https://twitter.com/BoysenMeb/status/472538125441712128,,,,
DoctorEdny,5/30/2014 20:40,2,1,Unofficial tweetup at Hubbard Inn w/ @ adamfeuerstein. Nitro milk stout @ LeftHandBrewing in bottle (gasp) winner - sorry Chicago # ASCO14,,@ @,#,4.72538E+17,https://twitter.com/DoctorEdny/status/472538037969104896,,,,
RyanNipp,5/30/2014 20:40,0,0,ENABLE III randomized trial - is palliative care immediately at diagnosis better than if provided later? # ASCO14 http://www.medpagetoday.com/ASCOVideoConferenceReporter/MeetingCoverage-Videos/558 …,,,#,4.72538E+17,https://twitter.com/RyanNipp/status/472537965882015745,,,,
myriadgenetics,5/30/2014 20:40,0,0,Attending # ASCO14? Visit us at Booth 2039 to find out about our # companiondiagnostic BRACAnalysis with # PARP inhibitors! # UnofficialASCO,,,# # # #,4.72538E+17,https://twitter.com/myriadgenetics/status/472537948093550592,,,,
duemed,5/30/2014 20:39,0,0,Taking advantage of # ASCO14 @ USCellularField @ whitesox vs @ SDPadres @pedrazosfroilan @eduagutierrezpic.twitter.com/iUOKxWWfMo,,@ @ @ @pedrazosfroilan @eduagutierrezpic,#,4.72538E+17,https://twitter.com/duemed/status/472537765704257537,,,,
birthlovedeath,5/30/2014 20:33,0,0,Film http://loveinourowntime.com bears witness to lives beginning & ending. # palliativecare # oncology # nursing # psych education/training # ASCO14,,,# # # # #,4.72536E+17,https://twitter.com/birthlovedeath/status/472536308745650177,,,,
bmsnews,5/30/2014 20:30,4,2,"Future of # cancer care? @ StevenBJohnson says an environment that fosters collaboration, creativity & new ideas. # ASCO14 # CancerConnections",,@,# # #,4.72536E+17,https://twitter.com/bmsnews/status/472535532065783809,,,,
Amgen,5/30/2014 20:30,3,2,Want to know how # BiTE® antibodies are designed to help target tumors and fight cancer? Visit http://bit.ly/RLq5m5 # ASCO14,,,# #,4.72535E+17,https://twitter.com/Amgen/status/472535485639032832,,,,
tonishi0610,5/30/2014 20:28,24,23,乳がん骨転移へのゾメタ、４週毎に１年間投与したあとは３ヵ月に１回投与で、毎月投与と治療効果は変らず、顎骨壊死の危険性は減少、らしい @ ASCO 2014での発表。 http://www.cancer.net/research-and-advocacy/research-summaries/taking-zoledronic-acid-less-often-after-first-year-treatment-safe-women-metastatic-breast-cancer#.U4kiJvPLcqB.twitter …,,@,#,4.72535E+17,https://twitter.com/tonishi0610/status/472535110730780672,,,,
Gene_Antibody,5/30/2014 20:27,0,0,Hanging up our coats and rolling up our sleeves for # ASCO14 http://ow.ly/xsCHw # instascience,,,# #,4.72535E+17,https://twitter.com/Gene_Antibody/status/472534898524561409,,,,
krystadawn,5/30/2014 20:27,1,0,On my way to # UnofficialASCO TweetUp with @ cam_arnold and @ EdwardLangJr. Looking forward to seeing peeps! # ASCO14,,@ @,# #,4.72535E+17,https://twitter.com/krystadawn/status/472534806283419650,,,,
SarahCannonDocs,5/30/2014 20:23,2,2,Welcome to # ASCO14 – get our take on some of the hottest news to come out this weekend: http://bit.ly/1pt8rSQ # SCRI,,,# #,4.72534E+17,https://twitter.com/SarahCannonDocs/status/472533835868286977,,,,
sreggie,5/30/2014 20:21,0,0,On break from Research to Practice # ASCO14 (at @ HiltonHotels w/ 3 others) http://4sq.com/1jCgxk0,,@,#,4.72533E+17,https://twitter.com/sreggie/status/472533203623096321,,,,
ecancer,5/30/2014 20:20,0,1,Reduced zoledronic acid from monthly to every three months fine for breast cancer with bone metastases http://bit.ly/1ptcPRQ # ASCO14,,,#,4.72533E+17,https://twitter.com/ecancer/status/472533144902832128,,,,
Medzineapp,5/30/2014 20:20,0,0,"# ASCO14: Lower-dose radiation therapy is safe for certain patients with lower-risk,... http://bit.ly/1oT87Ky",,,#,4.72533E+17,https://twitter.com/Medzineapp/status/472533092805382144,,,,
aftimosp,5/30/2014 20:18,1,1,Join us at the unofficial tweetup organised by @ adamfeuerstein at the Hubbard Inn # ASCO14,,@,#,4.72533E+17,https://twitter.com/aftimosp/status/472532632342114305,,,,
MatthewHSimmons,5/30/2014 20:17,0,0,# ASCO14 pic.twitter.com/P8fBxn9ZXV,,,#,4.72532E+17,https://twitter.com/MatthewHSimmons/status/472532256477569024,,,,
davidbeme,5/30/2014 20:15,0,0,L'obésité augmente le risque de mortalité de certains cancers du sein # ASCO2014 @ Doctissimo http://ow.ly/xsBLa,,@,#,4.72532E+17,https://twitter.com/davidbeme/status/472531760312770560,,,,
Medzineapp,5/30/2014 20:14,0,1,What is the latest at # ASCO14? Tell us so we can help you share your findings to our HCP followers! # hcsmpic.twitter.com/tXdZN33EOz,,,# #,4.72532E+17,https://twitter.com/Medzineapp/status/472531616024506369,,,,
PatriciaMWinter,5/30/2014 20:13,1,1,"A patients perspective: What is it like to receive a cancer diagnosis"" http://shar.es/VDN3S # hcsm # hcsmeu # asco14 # notjustonedisease""",,,# # # #,4.72531E+17,https://twitter.com/PatriciaMWinter/status/472531259478921216,,,,
KUhlendorf,5/30/2014 20:10,5,3,Transit art in Chicago. # ASCO14 @ Celgenepic.twitter.com/K7Xrz9Ge2Z,,@,#,4.72531E+17,https://twitter.com/KUhlendorf/status/472530643151519745,,,,
eugeniosantoro,5/30/2014 20:10,0,0,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 http://ow.ly/xcxgz,,@,#,4.72531E+17,https://twitter.com/eugeniosantoro/status/472530524637265920,,,,
timturnham,5/30/2014 20:10,2,2,A lot of energy around using the immune system to fight cancer. Good data expected in the next 3 days. # ASCO14 .,,,#,4.72531E+17,https://twitter.com/timturnham/status/472530507658326016,,,,
myriadgenetics,5/30/2014 20:10,0,1,Myriad will present data from 6 new key studies on its myRisk # Hereditary # Cancer # genepanel test at # ASCO14! # UnofficialASCO,,,# # # # #,4.7253E+17,https://twitter.com/myriadgenetics/status/472530397327138816,,,,
Medzineapp,5/30/2014 20:09,0,1,"Studies Reveal New Strategies to Improve Quality of Life for Patients, Survivors and Caregivers http://bit.ly/1oT6HQ4 # ASCO14 # hcsm",,,# #,4.7253E+17,https://twitter.com/Medzineapp/status/472530153403580416,,,,
HotelBlueChi,5/30/2014 20:08,0,1,Good night sweetheart well it's time to go. @ HotelBlueChi welcomes # ASCO14 to @ ChooseChicagopic.twitter.com/fg2C7jSZCj,,@ @,#,4.7253E+17,https://twitter.com/HotelBlueChi/status/472530137201016832,,,,
BairdAM,5/30/2014 20:05,0,1,"# lcsm  @ Boehringer: # PRESS: Learn more about targeting angiogenesis here http://bit.ly/1gI4TJo # LungCancer # ASCO14""""",,@,# # # #,4.72529E+17,https://twitter.com/BairdAM/status/472529371710779392,,,,
Boehringer,5/30/2014 20:05,1,0,# PRESS: Learn more about targeting angiogenesis here http://bit.ly/1gI4TJo # LungCancer # ASCO14,,,# # #,4.72529E+17,https://twitter.com/Boehringer/status/472529205218258944,,,,
LungCancerFaces,5/30/2014 20:03,11,2,Tell Congress: Invest in Lung Cancer Research NOW: https://bit.ly/PxgMTa @ DSShopper # LCSM # HCSM # ASCO14 pic.twitter.com/nd3qQZInTf,,@,# # #,4.72529E+17,https://twitter.com/LungCancerFaces/status/472528825478156289,,,,
hagsie,5/30/2014 20:02,0,0,"@ BairdAM @ RamalingamMD why suboptimal? Low awareness, high cost, lack of tissue?????? # ASCO14 # lungcancer anything from rest of planet?",,@ @,# #,4.72529E+17,https://twitter.com/hagsie/status/472528621412679680,,,,
fischmd,5/30/2014 20:02,70,10,"Emanuel at # ASCO14: The median income in US is $51,371. One of our cancer drugs wipes out the median income of a household. # costsofcare",,,# #,4.72529E+17,https://twitter.com/fischmd/status/472528500252225536,,,,
CancerDotNet,5/30/2014 20:01,0,1,"Looking for a quick round-up of today's research highlights from # ASCO14? Pt summaries, podcast: http://bit.ly/1mRL4iv",,,#,4.72528E+17,https://twitter.com/CancerDotNet/status/472528272681877505,,,,
AneesChagpar,5/30/2014 20:01,4,2,"@ rsm2800 Cool coincidence! My @ ASCO Connection blog featuring Zeke's comments @ YaleSOM in Best of"" issue at # ASCO14 pic.twitter.com/eVL4vYX3n7""",,@ @ @,#,4.72528E+17,https://twitter.com/AneesChagpar/status/472528165974573057,,,,
bmsnews,5/30/2014 20:00,3,2,Collaboration community is critical to fostering innovation # ASCO14 # CancerConnections,,,# #,4.72528E+17,https://twitter.com/bmsnews/status/472528102607060992,,,,
BairdAM,5/30/2014 20:00,2,0," @ mtmdphd: Rudin # lcsm # ASCO14 - Team science in lung cancer - targeted therapies clinical trials not doable alone pic.twitter.com/It9sa4A73K""""",,@,# #,4.72528E+17,https://twitter.com/BairdAM/status/472527997493198848,,,,
BairdAM,5/30/2014 19:59,0,0,"RT  @ Roche: Chance to survive a year with # lungcancer In the 1980s: 10%. In the late 2000s: Over 50%. http://ow.ly/xkL6m # ASCO14 # lcsm""""",,@,# # #,4.72528E+17,https://twitter.com/BairdAM/status/472527701371150336,,,,
BairdAM,5/30/2014 19:56,1,0,"RT  @ RamalingamMD: # LCSM molecular testing frequency for lung cancer among US oncologists is suboptimal. Abs 8097 # ASCO14""""",,@,# #,4.72527E+17,https://twitter.com/BairdAM/status/472527079150350336,,,,
WillisCD,5/30/2014 19:56,0,0,Anti-CD38 hot topic # mechanism RT @ JanssenUS New data on investigational compound daratumumab featured in poster presentation # ASCO14,,@,# #,4.72527E+17,https://twitter.com/WillisCD/status/472526953832935424,,,,
BairdAM,5/30/2014 19:55,0,0,"RT  @ JFreemanDaily: # ASCO14 Andrei Goga: MYC pathway appears to play role in KRAS-driven lung cancer--target for inhibitor research. # LCSM""""",,@,# #,4.72527E+17,https://twitter.com/BairdAM/status/472526796294868992,,,,
RichardWJoseph,5/30/2014 19:55,0,0,Congratulations to @ EdithPerezMD for her Giant of Cancer Care award at # ASCO14. Very deserving along with all other awardees.,,@,#,4.72527E+17,https://twitter.com/RichardWJoseph/status/472526717236838400,,,,
LungCancerFaces,5/30/2014 19:55,3,0,Tell @ BarackObama seniors deserve lifesaving # LungCancer screening: http://capwiz.com/lca/issues/alert/?alertid=63205511 … @ DSShopper # LCSM # ASCO14 pic.twitter.com/0mzQqPt7a0,,@ @,# # #,4.72527E+17,https://twitter.com/LungCancerFaces/status/472526661225676800,,,,
KUhlendorf,5/30/2014 19:52,0,0,"I wouldn't call # ASCO14 serene, but here's the view of Lake Michigan from back side of McCormick Place. pic.twitter.com/UoBtd305AK",,,#,4.72526E+17,https://twitter.com/KUhlendorf/status/472525896797024256,,,,
buzzin77,5/30/2014 19:51,0,0,Chicago is one beautiful city in the sunshine # ASCO14 @ ASCO pic.twitter.com/ip5zuz8XWZ,,@,#,4.72526E+17,https://twitter.com/buzzin77/status/472525631683854336,,,,
rjperez_phd,5/30/2014 19:50,0,0,# ASCO14 day 1 is over. Looking forward to another great day tomorrow! # cancer # oncologypic.twitter.com/ttcs5jRwUR,,,# # #,4.72526E+17,https://twitter.com/rjperez_phd/status/472525504139251713,,,,
teamoncology,5/30/2014 19:48,0,0,【 # ASCO14 101】 Oral sex has been linked to oral cancer.,,,#,4.72525E+17,https://twitter.com/teamoncology/status/472524872690569216,,,,
szusmani,5/30/2014 19:47,0,1,"# Clinical Research Nurses/Data Managers attending # ASCO2014, @Carolinas Levine Cancer Institute has several positions open- pls contact me",,@Carolinas,# #,4.72525E+17,https://twitter.com/szusmani/status/472524765123858433,,,,
Merck,5/30/2014 19:47,5,1,"As # ASCO14 kicks off, keep an eye out for our 16 abstracts being presented. # MerckOncology",,,# #,4.72525E+17,https://twitter.com/Merck/status/472524693518712832,,,,
teamoncology,5/30/2014 19:47,0,0,"RT @ JNCI_Now: Lower-dose Radiation therapy is safe for certain patients w/ lower-risk, HPV-Positive head and neck cancer. # ASCO14",,@,#,4.72525E+17,https://twitter.com/teamoncology/status/472524683019960320,,,,
teamoncology,5/30/2014 19:47,0,0,RT @ JNCI_Now: Patients with HPV-positive tumors tend to have better outcomes compared to patients with HPV-negative disease. # ASCO14,,@,#,4.72525E+17,https://twitter.com/teamoncology/status/472524643887108096,,,,
_gabrielaleman,5/30/2014 19:46,0,0,Ver alos hombres con uñas largas? # ASCO14,,,#,4.72524E+17,https://twitter.com/_gabrielaleman/status/472524364655898624,,,,
subatomicdoc,5/30/2014 19:45,0,1,@ giasison Thank you :) I'm looking forward to finally meeting many tweeps at # ASCO14 in person. Was great when I did that @ MayoClinic,,@ @,#,4.72524E+17,https://twitter.com/subatomicdoc/status/472524351632588800,,,,
fischmd,5/30/2014 19:45,11,3,"Newcomer at # ASCO14 on United Healthcare's avg costs for chemo: MD office: CMS+22%, Hosp owned: CMS + 146%. Asks What value?""""",,,#,4.72524E+17,https://twitter.com/fischmd/status/472524315733544960,,,,
Gene_Antibody,5/30/2014 19:45,0,0,Mix learning w/ fun: http://ow.ly/xslDb MT @ cancernetwrk: 10 Tricks for Surviving & Thriving at ASCO’s Annual Mtg # ASCO14,,@,#,4.72524E+17,https://twitter.com/Gene_Antibody/status/472524115765911554,,,,
WillisCD,5/30/2014 19:42,0,0,Anti-CD38 mAb MT @ Cortellis 1st-in-human study of SAR650984 shows manageable safety profile as novel approach in # multiplemyeloma # ASCO14,,@,# #,4.72524E+17,https://twitter.com/WillisCD/status/472523552843767808,,,,
BioPharmaMike,5/30/2014 19:41,1,0,"“ @ PinkSheetMaryJo: Zeke Emanuel tells # ASCO14, not going to get out of high cost of cancer care problem without payment reform”",,@,#,4.72523E+17,https://twitter.com/BioPharmaMike/status/472523279068954625,,,,
Medicalfacts,5/30/2014 19:41,0,0,Merck Serono presenteert nieuwe onderzoeksresultaten van moeilijk behandelbare kankersoorten tijdens # ASCO14 -... http://is.gd/PJqwwe,,,#,4.72523E+17,https://twitter.com/Medicalfacts/status/472523126363152384,,,,
PinkSheetMaryJo,5/30/2014 19:40,0,0,"Zeke Emanuel tells # ASCO14, not going to get out of high cost of cancer care problem without payment reform",,,#,4.72523E+17,https://twitter.com/PinkSheetMaryJo/status/472522937808195584,,,,
eugeniosantoro,5/30/2014 19:39,0,0,Use # ASCO14 hashtag to follow tweets related to the American society of clinical oncology annual meeting,,,#,4.72523E+17,https://twitter.com/eugeniosantoro/status/472522759709687808,,,,
KUhlendorf,5/30/2014 19:39,0,0,Common ground on cutting costs of # cancer http://thehill.com/blogs/congress-blog/healthcare/207631-common-ground-on-cutting-costs-of-cancer#.U4kWTAcJE_Q.twitter … via @ TheHill # ASCO14,,@,# # #,4.72523E+17,https://twitter.com/KUhlendorf/status/472522600833236992,,,,
JediPD,5/30/2014 19:38,1,0,Zoladex: Ovarian function on chemo: Not a lot here. 5/66 fail & 16 of 61 conceive 5/15 fail & 8/10 conceive # ASCO14 http://www.medscape.com/viewarticle/825989?src=wnl_edit_cfna&uac=17589HT …,,,#,4.72522E+17,https://twitter.com/JediPD/status/472522416691093504,,,,
drseisenberg,5/30/2014 19:37,1,1,RT @ hmhyltonpac: Dr. Ezekiel Emanuel: Just one oncology drug can potentially wipe out the median income of the US household. # ASCO14,,@,#,4.72522E+17,https://twitter.com/drseisenberg/status/472522314404225024,,,,
drseisenberg,5/30/2014 19:36,1,1,RT @ drsteventucker Unsustainable! Oncology drug pricing report from Bloomberg. i http://mobile.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html … # asco14 # bcsm # health,,@,# # #,4.72522E+17,https://twitter.com/drseisenberg/status/472522025869660161,,,,
sonialf,5/30/2014 19:36,1,2,"# Palliative Care: It's for Caregivers Too, Says Study http://www.medscape.com/viewarticle/826011?src=wnl_edit_cfna&uac=218769PY?src=sttwit … # asco14 # hpmglobal",,,# # #,4.72522E+17,https://twitter.com/sonialf/status/472522012485627905,,,,
PinkSheetMaryJo,5/30/2014 19:36,2,0,"Industry payment assistance programs are a bandaid to a system that's broken, AstraZeneca's Rossi says # ASCO14",,,#,4.72522E+17,https://twitter.com/PinkSheetMaryJo/status/472521859255136256,,,,
drsteventucker,5/30/2014 19:35,3,2,Unsustainable! Oncology drug pricing report from Bloomberg. i http://mobile.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html … # asco14 # bcsm # health,,,# # #,4.72522E+17,https://twitter.com/drsteventucker/status/472521823532240897,,,,
DrHealeyBird,5/30/2014 19:35,0,0,# ASCO14 common theme of splitting cancer into ever more unique diseases poses challenges for clinical trials.,,,#,4.72522E+17,https://twitter.com/DrHealeyBird/status/472521818671431681,,,,
AneesChagpar,5/30/2014 19:34,2,2,"Thrilled to meet Dr. Abu Bakar Hafeez Bhatti, our @ ASCO IDEA mentee from Lahore @ YaleCancer @ Yale # ASCO14 pic.twitter.com/p9pxGnJV4D",,@ @ @,#,4.72521E+17,https://twitter.com/AneesChagpar/status/472521425811959809,,,,
ScientaAline,5/30/2014 19:33,0,0,Crashing the # asco14 tweetup. Rock on.,,,#,4.72521E+17,https://twitter.com/ScientaAline/status/472521188141723649,,,,
GenentechJobs,5/30/2014 19:32,0,0,"# ASCO14 Talent Hunt: Scientist, Oncology Biomarker Development- Cancer Immunotherapy: http://click2apply.net/429813t",,,#,4.72521E+17,https://twitter.com/GenentechJobs/status/472520954837344256,,,,
Novartis,5/30/2014 19:30,0,3,"We’re presenting several # advancedBC abstracts at # ASCO14, including 2 on best managing adverse events http://bit.ly/1hTavz3",,,# #,4.7252E+17,https://twitter.com/Novartis/status/472520480860426240,,,,
CancerDotNet,5/30/2014 19:30,5,1,Pt summary: # ASCO14 research on stopping use of cholesterol-lowering drugs toward the end of life http://bit.ly/1pEPmKs,,,#,4.7252E+17,https://twitter.com/CancerDotNet/status/472520373096173568,,,,
lsaldanamd,5/30/2014 19:28,0,0,@ Doctor_V @ ASCO docs fail to ask ourselves why enough times. I know I am guilty as well.,,@ @,,4.7252E+17,https://twitter.com/lsaldanamd/status/472519829459841024,,,,
drdonsdizon,5/30/2014 19:27,2,1,Amazing time at asco IDEA award reception w @ jrgralow @ glopesMD and A Rahman # asco14 http://instagram.com/p/oo69byJw_W/,,@ @,#,4.7252E+17,https://twitter.com/drdonsdizon/status/472519731576975360,,,,
drdonsdizon,5/30/2014 19:26,0,3,“ @ GlopesMd: With ASCO's star blogger and tweeter @ drdonsdizon pic.twitter.com/nMgsA2GKWI” another F2F W an amazing # tweep # ASCO14,,@ @,# #,4.72519E+17,https://twitter.com/drdonsdizon/status/472519428223938560,,,,
fischmd,5/30/2014 19:26,4,3,"Rossi cites Clark's 3rd law at # ASCO14: Any sufficiently advanced technology is indistinguishable from magic."" # biotech""",,,# #,4.72519E+17,https://twitter.com/fischmd/status/472519363430723584,,,,
subatomicdoc,5/30/2014 19:25,3,5,"Thank you everyone for the kind retweets, shares & follows. Lots of # ASCO14 cancer research coming thru 6/3. Apologies for high volume!",,,#,4.72519E+17,https://twitter.com/subatomicdoc/status/472519266143834112,,,,
Doctor_V,5/30/2014 19:25,0,0,@ lsaldanamd @ ASCO He was also getting his statin….,,@ @,,4.72519E+17,https://twitter.com/Doctor_V/status/472519255032733697,,,,
PinkSheetMaryJo,5/30/2014 19:25,0,0,Newcomer argues for value-based insurance design at # ASCO14: differential cost sharing on high v low value services,,,#,4.72519E+17,https://twitter.com/PinkSheetMaryJo/status/472519214389944321,,,,
teamoncology,5/30/2014 19:24,1,0,Thanks. RT @ cancereu: tweets to follow from # asco14 @ teamoncology @ drsteventucker @ MaverickNY,,@ @ @ @,#,4.72519E+17,https://twitter.com/teamoncology/status/472518887989190656,,,,
LurieCancer,5/30/2014 19:22,1,0,Asking the Right Question at # ASCO14: What Are You Hoping For? http://connection.asco.org/Commentary/Article/ID/3891/Asking-the-Right-Question-at-ASCO-2014-What-Are-You-Hoping-For.aspx … via @ ASCO Connection @ fischmd # hcsm,,@ @,# #,4.72519E+17,https://twitter.com/LurieCancer/status/472518564436774912,,,,
RxProcess,5/30/2014 19:22,1,0,@ DrMarkham you're welcome! Looking forward to following your updates throughout # ASCO14.,,@,#,4.72518E+17,https://twitter.com/RxProcess/status/472518460128624640,,,,
HealthyLivingGI,5/30/2014 19:21,0,0,Excited for # ASCO14 !!! # chicago,,,# #,4.72518E+17,https://twitter.com/HealthyLivingGI/status/472518239642087425,,,,
JLErsek,5/30/2014 19:21,0,0,@ ASCO good session! Thanks for the follow up. # LCI,,@,#,4.72518E+17,https://twitter.com/JLErsek/status/472518210475270144,,,,
lsaldanamd,5/30/2014 19:21,0,0,"@ Doctor_V @ ASCO ask way"" a great question and should be asked more""",,@ @,,4.72518E+17,https://twitter.com/lsaldanamd/status/472518137116897280,,,,
megtirrell,5/30/2014 19:20,0,5,Hi Chicago. So happy to be back. # ASCO14,,,#,4.72518E+17,https://twitter.com/megtirrell/status/472517931184574464,,,,
MoffittResearch,5/30/2014 19:20,1,0,Don't miss Dr. Shilpa Gupta's presentation on emerging combo therapies for # breast & # prostate # cancer tomorrow at 8 a.m. # ASCO14.,,,# # # #,4.72518E+17,https://twitter.com/MoffittResearch/status/472517859554648065,,,,
ERPlimackMD,5/30/2014 19:18,4,0,Dr. Manuela Schmidinger discusses: PDL1 may be promising target in non clear cell RCC. # gusm # ASCO14,,,# #,4.72518E+17,https://twitter.com/ERPlimackMD/status/472517530540466177,,,,
Pharmafocus,5/30/2014 19:18,2,0,# ASCO14 panel discussion on value in cancer care raises question of individual dynamics and preferences in measuring value,,,#,4.72517E+17,https://twitter.com/Pharmafocus/status/472517413288693760,,,,
giasison,5/30/2014 19:16,0,1,@ rsm2800 Love the engagement # ASCO14,,@,#,4.72517E+17,https://twitter.com/giasison/status/472516818125328384,,,,
Novartis,5/30/2014 19:15,0,1,Pinball and treating # advancedBC seem to have something in common http://bit.ly/1gBI7TH # ASCO14,,,# #,4.72517E+17,https://twitter.com/Novartis/status/472516634922721280,,,,
AdaptiveBiotech,5/30/2014 19:13,0,0,Find out about the most sensitive assay for MRD Adaptivebiotech @ booth 2097 # ASCO14 learn more about what we do http://bit.ly/U1BiAX,,@,#,4.72516E+17,https://twitter.com/AdaptiveBiotech/status/472516246123347968,,,,
GlopesMd,5/30/2014 19:13,3,3,# ASCO14 IDEA and LIFE award recipients. pic.twitter.com/u1wvefoCUb,,,#,4.72516E+17,https://twitter.com/GlopesMd/status/472516070578720768,,,,
rogersro,5/30/2014 19:12,0,0,Myriad Genetics is proud to participate in # asco14.,,,#,4.72516E+17,https://twitter.com/rogersro/status/472515981630128130,,,,
brianreid,5/30/2014 19:12,0,0,Damn good question from @ whysirsf on the low volume of pancreatic conversations in # SocOncology: http://blog.wcgworld.com/2014/05/why-cant-we-raise-the-volume-on-pancreatic-cancer … # asco14,,@,# #,4.72516E+17,https://twitter.com/brianreid/status/472515917373792256,,,,
audvin,5/30/2014 19:12,0,1,@ mtmdphd just sent you some data analytics for # ASCO14. Enjoy :),,@,#,4.72516E+17,https://twitter.com/audvin/status/472515844744835072,,,,
audvin,5/30/2014 19:11,0,0,"@ drattai Dr. Attai, how's # ASCO14 so far?",,@,#,4.72516E+17,https://twitter.com/audvin/status/472515556017319936,,,,
rogersro,5/30/2014 19:10,0,0,Myriad Presents Data on BRACAnalysis CDx(TM) and HRD(TM) at 2014 ASCO Meeting http://finance.yahoo.com/news/myriad-presents-data-bracanalysis-cdx-110500823.html?soc_src=mediacontentstory … # asco14 # Companiondiagnostics $ mygn,,,# #,4.72515E+17,https://twitter.com/rogersro/status/472515373758038016,,,,
NateDahlPharmD,5/30/2014 19:09,0,0,RT @ theNCI: Learn more about how # cancer treatment can affect fertility http://1.usa.gov/1oDjZTa # ASCO14,,@,# #,4.72515E+17,https://twitter.com/NateDahlPharmD/status/472515270984994816,,,,
Doctor_V,5/30/2014 19:09,1,1,In the final weeks of my dad's life he was anti-coagulated for a-fib. Then I asked why # palliativecaregonewild @ ASCO @ lsaldanamd # lemmings,,@ @,# #,4.72515E+17,https://twitter.com/Doctor_V/status/472515252995624960,,,,
krnmsw,5/30/2014 19:08,0,0,“ @ ASCO : study of the impact of income and distress on patients' requests for support http://myemail.constantcontact.com/Impact-of-income-and-distress-on-patients--requests-for-support.html?soid=1111597226270&aid=FG791sfsSLg …”,,@,,4.72515E+17,https://twitter.com/krnmsw/status/472514793702965248,,,,
BeatrixChicago,5/30/2014 19:07,0,0,. @ drattai Hope your GF lunch was delish :) # ASCO14,,@,#,4.72515E+17,https://twitter.com/BeatrixChicago/status/472514715294646272,,,,
myriadgenetics,5/30/2014 19:05,0,0,Data from 2 clinical studies on Myriad myPath # Melanoma show it can differentiate melanoma from benign nevi. # ASCO14 # UnofficialASCO,,,# # #,4.72514E+17,https://twitter.com/myriadgenetics/status/472514041558999040,,,,
rsm2800,5/30/2014 19:03,7,5,(Patient advocate from audience): Can’t make value decision w/o including pts in the discussions. There was no mention of PROs 2day # ASCO14,,,#,4.72514E+17,https://twitter.com/rsm2800/status/472513569813057537,,,,
DrZahwa,5/30/2014 19:02,0,0,"RT Pathologists: RT ASCO: Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meetin... http://bit.ly/1tW6XQG",,,#,4.72514E+17,https://twitter.com/DrZahwa/status/472513522493313024,,,,
JamesPPinkerton,5/30/2014 19:01,0,0,@ DrBobGoldberg challenging # ASCO14 panel on bleak tradeoff between rationing schemes and innovation. pic.twitter.com/7lrzZ2Vnfj,,@,#,4.72513E+17,https://twitter.com/JamesPPinkerton/status/472513106212818944,,,,
CancerDotNet,5/30/2014 19:00,3,0,Pt summary: early study on HPV+ head&neck cancer suggts OK to treat w/ lower dose rad therapy # ASCO14 # hncsm http://bit.ly/1kRxOKF,,,# #,4.72513E+17,https://twitter.com/CancerDotNet/status/472513017947885568,,,,
bmsnews,5/30/2014 19:00,1,0,Proud to welcome @ StevenBJohnson to # ASCO14 to offer perspective on innovation and collaboration in oncology # CancerConnections,,@,# #,4.72513E+17,https://twitter.com/bmsnews/status/472512981155446784,,,,
RamalingamMD,5/30/2014 19:00,0,0,# LCSM molecular testing frequency for lung cancer among US oncologists is suboptimal. Abs 8097 # ASCO14,,,# #,4.72513E+17,https://twitter.com/RamalingamMD/status/472512870073110529,,,,
Agendia,5/30/2014 19:00,2,0,@ drattai BluePrint mol subtyping + MP reclassified up to 25% of breast cancers. # bettertogether # ASCO14 # bcsm # hcsmpic.twitter.com/1bEM8VnQzJ,,@,# # # #,4.72513E+17,https://twitter.com/Agendia/status/472512792046878722,,,,
DanaFarber,5/30/2014 19:00,9,3,"Life-prolonging # ovariancancer chemotherapy underused, study finds: http://bit.ly/1k7SE9Q # ASCO14 # gyncsm # SFSCWC",,,# # # #,4.72513E+17,https://twitter.com/DanaFarber/status/472512786615250944,,,,
krnmsw,5/30/2014 18:59,0,1,# ASCO14 # AOSW2014 Oncology social workers are prepared to help you meet ACOS accreditation! @ ASCO,,@,# #,4.72513E+17,https://twitter.com/krnmsw/status/472512759817834496,,,,
drdonsdizon,5/30/2014 18:59,3,3,asco IDEA award reception with @ jrgralow @ glopesmd and @ aneeschagpar # ASCO14 http://instagram.com/p/oo3uM4Jw6-/,,@ @ @,#,4.72513E+17,https://twitter.com/drdonsdizon/status/472512610748084226,,,,
hospicedoctor,5/30/2014 18:58,0,0,Good to follow @ fischmd @ drdonsdizon @ subatomicdoc who will be tweeting on # hpm # meded # hcsm from # ASCO14 Cancer Conference,,@ @ @,# # # #,4.72512E+17,https://twitter.com/hospicedoctor/status/472512487230013440,,,,
braincancer_AU,5/30/2014 18:58,1,0,Interesting RT “ @ ASCO: Educational Book articles on topics in Central Nervous System Tumors from # ASCO14 speakers: http://bit.ly/1kHWXax ”,,@,#,4.72512E+17,https://twitter.com/braincancer_AU/status/472512486592094209,,,,
cancereu,5/30/2014 18:58,0,0,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq,,,#,4.72512E+17,https://twitter.com/cancereu/status/472512414681165827,,,,
teamoncology,5/30/2014 18:58,0,0,@ rsm2800 We have casually approved the use of many new imagines without the prospective studies based on innovation as a reason. # ASCO14,,@,#,4.72512E+17,https://twitter.com/teamoncology/status/472512343079784448,,,,
rsm2800,5/30/2014 18:58,0,0,"Diane Blum: Discussions about cost have to be introduced earlier in the doctor-patient relationship, need more transparency # asco14",,,#,4.72512E+17,https://twitter.com/rsm2800/status/472512306434162688,,,,
GlopesMd,5/30/2014 18:57,0,2,There were 23 recipients of the IDEA award this year. # ASCO14 pic.twitter.com/JlYXp4Mgwf,,,#,4.72512E+17,https://twitter.com/GlopesMd/status/472512271558512640,,,,
teamoncology,5/30/2014 18:57,0,0,@ rsm2800 Cost control is important but what we failed is that there is not lots of prospective studies for imaging and biomarkers. # ASCO14,,@,#,4.72512E+17,https://twitter.com/teamoncology/status/472512085486600192,,,,
PhRMA,5/30/2014 18:57,7,2,"Its small advances that will help us transform # cancer into a chronic, manageable disease says @ Celgene http://bit.ly/1hFWamh # ASCO14",,@,# #,4.72512E+17,https://twitter.com/PhRMA/status/472512043010904064,,,,
GlopesMd,5/30/2014 18:56,7,10,IDEA reception # ASCO14 - bringing together young oncologists from around the world and their mentors. pic.twitter.com/LP3Q3i7kgg,,,#,4.72512E+17,https://twitter.com/GlopesMd/status/472511969308594176,,,,
CancerMedMDA,5/30/2014 18:55,0,0,See Dr. Michael S. Lee's poster Sat. 8 AM: PFS w CpG island methylator phenotype in metastatic colorectal cancer w anti-EGFR Rx. # ASCO14,,,#,4.72512E+17,https://twitter.com/CancerMedMDA/status/472511544295948289,,,,
CBlotner_,5/30/2014 18:54,0,1,# BTSM at # ASCO14 http://wp.me/p3PeUH-ns,,,# #,4.72511E+17,https://twitter.com/CBlotner_/status/472511467959238657,,,,
hospicedoctor,5/30/2014 18:54,12,5,Another study showing early palliative care reduces caregiver stress & depression from # ASCO14 # hpm http://abstracts.asco.org/144/AbstView_144_131678.html …,,,# #,4.72511E+17,https://twitter.com/hospicedoctor/status/472511460330192897,,,,
cancereu,5/30/2014 18:54,0,0,@ alantanmd oncologists of which country?USA only? how is the cost of the sequencing re-imbursed by public healthcare systems? # ASCO14,,@,#,4.72511E+17,https://twitter.com/cancereu/status/472511331275665409,,,,
rsm2800,5/30/2014 18:53,4,1,Emanuel: Americans don’t want value thresholds like UK’s NICE but we do want some proportionality btwn cost of drug & benefit # ASCO14,,,#,4.72511E+17,https://twitter.com/rsm2800/status/472511080652996608,,,,
KTHaub,5/30/2014 18:52,0,0,"# deprescribing  # Statin Use Can Stop When Illness Is # Terminal @ ASCO http://wp.me/p13lz7-389 # EOL # palliativecare pic.twitter.com/FpPvn5BTNg""""",,@,# # # # #,4.72511E+17,https://twitter.com/KTHaub/status/472511007063932928,,,,
hmhyltonpac,5/30/2014 18:52,2,1,"Dr. Ezekiel Emanuel @ # ASCO14-encouraging us 2 take solutions to Washington. IMHO, ASCO's payment reform model is a step in this direction.",,@,#,4.72511E+17,https://twitter.com/hmhyltonpac/status/472510909840392192,,,,
cancereu,5/30/2014 18:51,0,0,"@ stales R we still, quoted by Siddarta Muckerzee as said by one of the oncology geniuses of last century, sad it still holds true # ASCO14",,@,#,4.72511E+17,https://twitter.com/cancereu/status/472510721130262528,,,,
Novartis,5/30/2014 18:50,1,5,We are explaining targeting # advancedBC pathways using the analogy of pinball. http://bit.ly/1gBI7TH # ASCO14,,,# #,4.7251E+17,https://twitter.com/Novartis/status/472510317113909249,,,,
genentech,5/30/2014 18:50,2,2,Can’t attend # ASCO14? Visit our newsroom for perspectives on progress in # CancerResearch http://ow.ly/xmTs4,,,# #,4.7251E+17,https://twitter.com/genentech/status/472510308708528128,,,,
CancerMedMDA,5/30/2014 18:50,0,1,"Learn about prognostic value of a molecular classification of ampullary adenocarcinoma. See # ASCO14 poster Sat. 8 AM. Dr. Schueneman, fellow",,,#,4.7251E+17,https://twitter.com/CancerMedMDA/status/472510299539795968,,,,
OncoPlexDx,5/30/2014 18:48,0,0,"Recently heard If your mother had an ALK rearrangement wouldnt you want more information before you treated?"" # ASCO14 # proteomics # genomics""",,,# # #,4.7251E+17,https://twitter.com/OncoPlexDx/status/472509819308736512,,,,
Lymphoma_Doc,5/30/2014 18:46,0,0,Wifi in # ASCO14 Arie Crown developmental therapeutics poster highlight session = 'no go' decision,,,#,4.72509E+17,https://twitter.com/Lymphoma_Doc/status/472509409248022529,,,,
rsm2800,5/30/2014 18:46,5,4,Emanuel: Get rid of unnecessary testing & use cheaper therapeutic equivalents & we’ll have the $ for real payment reform in oncology # ASCO14,,,#,4.72509E+17,https://twitter.com/rsm2800/status/472509376205299712,,,,
hmhyltonpac,5/30/2014 18:46,1,1,"Dr. Ezekiel Emanuel had such a command presence at the podium at # ASCO14, I forgot to Tweet!",,,#,4.72509E+17,https://twitter.com/hmhyltonpac/status/472509337064046593,,,,
aftimosp,5/30/2014 18:46,0,0,Well differentiated liposarcoma seems a promising indication (MDM2 amplification) # ASCO14,,,#,4.72509E+17,https://twitter.com/aftimosp/status/472509283570298882,,,,
aftimosp,5/30/2014 18:45,0,0,RG7388 is a second generation MDM2 antagonist. DLTs in phase 1 were GI or hematological depening on schedule. # ASCO14,,,#,4.72509E+17,https://twitter.com/aftimosp/status/472509120848093184,,,,
CancerDotNet,5/30/2014 18:45,0,1,Advocates: Don't forget about the # ASCO14 Tweetup tomorrow 5/31 @5:45 CST. RSVP here: http://bit.ly/1i8XCkX,,@5,#,4.72509E+17,https://twitter.com/CancerDotNet/status/472509067165196288,,,,
AndreaMiyahira,5/30/2014 18:45,4,1,Alan Kristal: obesity is far more dangerous for African American men than Caucasians for risk of developing # prostatecancer # ASCO14,,,# #,4.72509E+17,https://twitter.com/AndreaMiyahira/status/472509007974768642,,,,
PVonc,5/30/2014 18:44,2,1,How should the latest data impact selection/sequencing of therapies for mCRPC? Join our expert discussion: http://bit.ly/ASCOprostate # ASCO14,,,#,4.72509E+17,https://twitter.com/PVonc/status/472508813300346880,,,,
martinnaley,5/30/2014 18:43,6,2,Ezekiel Emanuel's call to oncologists: ordering unnecessary tests or treatments is not a victimless crime - we all pay. # ASCO14,,,#,4.72509E+17,https://twitter.com/martinnaley/status/472508747097853952,,,,
DrMunibMundia,5/30/2014 18:43,0,1,"Healthcare spending in US ~$3 Trillion greater than entire French Economy"" Ezekiel Emanuel at # ASCO14. That's a earth shattering stat.""",,,#,4.72509E+17,https://twitter.com/DrMunibMundia/status/472508690600169473,,,,
CBlotner_,5/30/2014 18:42,1,1,The 2014 @ ASCO # SocOncology report names # bcsm the number 1 and # btsm the number 2 most used cancer-related hashtags! http://mdigitallife.com/socialoncology/,,@,# # #,4.72508E+17,https://twitter.com/CBlotner_/status/472508467261870080,,,,
aftimosp,5/30/2014 18:42,0,1,The NCI uses the cut-off of 50% tumor cells for next-generation sequencing # ASCO14,,,#,4.72508E+17,https://twitter.com/aftimosp/status/472508301595258880,,,,
rsm2800,5/30/2014 18:42,0,1,@sjbraitsch @ ASCO He didn’t say but it’s probably cost. Sometimes cost for same service is much less in UK,,@sjbraitsch @,,4.72508E+17,https://twitter.com/rsm2800/status/472508300961923072,,,,
rdhoble,5/30/2014 18:42,0,1,Yes“ @ rsm2800: Emanuel: We should get rid of unnecessary tests and treatments before we should start limiting life-extending therapy # ASCO14”,,@,#,4.72508E+17,https://twitter.com/rdhoble/status/472508293643268097,,,,
sandisues,5/30/2014 18:42,0,0,At # ASCO14 with awesome advocates. Looking to hear great talks.,,,#,4.72508E+17,https://twitter.com/sandisues/status/472508250726752256,,,,
hmhyltonpac,5/30/2014 18:41,2,2,Dr. Ezekiel Emanuel at # ASCO14: We have an obligation to expose our practices that are not adding value.,,,#,4.72508E+17,https://twitter.com/hmhyltonpac/status/472508208120995840,,,,
Boehringer,5/30/2014 18:41,3,0,RT @ ASCO: Twitter's role during scientific meetings? http://bit.ly/1mAmiDB # ASCO14 # hcsm CC @ ASCOPost @ rsm2800,,@ @ @,# #,4.72508E+17,https://twitter.com/Boehringer/status/472508202089984000,,,,
ScripMandy,5/30/2014 18:41,0,0,@ AlpineBV_Miller @ ASCO But what about the patient who can't afford it?,,@ @,,4.72508E+17,https://twitter.com/ScripMandy/status/472508151325925376,,,,
CBlotner_,5/30/2014 18:41,0,1,. @ ASCO's latest # SocOncology report says that grassroots efforts like the # bcsm and # btsm chats matter. Our chats make a difference. # ASCO14,,@,# # # #,4.72508E+17,https://twitter.com/CBlotner_/status/472508086733647872,,,,
rsm2800,5/30/2014 18:41,2,1,Emanuel: Advanced gastric ca: 50 fold diff in price among preferred NCCN chemo; we have an obligation to prescribe lower priced Rx # ASCO14,,,#,4.72508E+17,https://twitter.com/rsm2800/status/472508061437788160,,,,
BekRx,5/30/2014 18:40,0,0,"@ ASCO no questions, I'll tell you no lies. Here in # Chicago and ready for # ASCO14 ! # LancetUSA",,@,# # #,4.72508E+17,https://twitter.com/BekRx/status/472507879539228672,,,,
Novartis,5/30/2014 18:40,2,4,Great discussion at 50 Years of Lung Cancer Session. Great to learn how much the research community has accomplished. # ASCO14,,,#,4.72508E+17,https://twitter.com/Novartis/status/472507837206503424,,,,
CancerMedMDA,5/30/2014 18:40,0,0,"Dr. William William, Thoracic/Head & Neck Medical Oncology, discusses reverse migration"" as way to prevent cancer. # ASCO14 Sat. 8:40 AM.""",,,#,4.72508E+17,https://twitter.com/CancerMedMDA/status/472507803060674560,,,,
EFEciencia,5/30/2014 18:39,2,0,Demuestran que una hormona preserva la fertilidad en mujeres con cáncer de mama http://www.efefuturo.com/noticia/demuestran-que-una-hormona-preserva-la-fertilidad-en-mujeres-con-cancer-de-mama/ … # ASCO14,,,#,4.72508E+17,https://twitter.com/EFEciencia/status/472507648403714050,,,,
rsm2800,5/30/2014 18:39,1,0,Emanuel: We should get rid of unnecessary tests and treatments before we should start limiting life-extending therapy # ASCO14,,,#,4.72508E+17,https://twitter.com/rsm2800/status/472507613163171841,,,,
rsm2800,5/30/2014 18:38,4,2,Emanuel: We are part of the problem. Examples: single vs mult fraction XRT for bone mets; hypofractionation of XRT for breast ca # ASCO14,,,#,4.72507E+17,https://twitter.com/rsm2800/status/472507325324865536,,,,
aftimosp,5/30/2014 18:37,0,1,"Promising activity for vemurafenib in NSCLC, cholangiocarcinoma, Erdheim-Chester disease: VE-basket trial # ASCO14",,,#,4.72507E+17,https://twitter.com/aftimosp/status/472507090905620480,,,,
ASTCT,5/30/2014 18:35,1,1,"# ASCO14 exhibit hall opens tomorrow! Stop by booth 3030 in the Patient Advocacy Pavilion for info on membership, education and more.",,,#,4.72507E+17,https://twitter.com/ASTCT/status/472506634905067520,,,,
SpryPub,5/30/2014 18:35,0,0,"Stop by our booth TOMORROW between 10-11 to get your copy of Survivorship"" signed by Dr. Cassileth! http://ow.ly/xrsUa # ASCO14""",,,#,4.72507E+17,https://twitter.com/SpryPub/status/472506533436461056,,,,
rsm2800,5/30/2014 18:35,5,0,"Emanuel: There are lots of unnecessary tests we get that add no value e.g., PET/CT in early-stage breast ca (see Ramsey et al) # ASCO14",,,#,4.72507E+17,https://twitter.com/rsm2800/status/472506531863224320,,,,
drcbsteer,5/30/2014 18:35,1,1,# ASCO14 @ WilliamDale_MD Collaboration between geriatrics and oncology vital and can be done in the clinic... but more research needed.,,@,#,4.72507E+17,https://twitter.com/drcbsteer/status/472506519276109824,,,,
ARUPLabs,5/30/2014 18:35,1,0,RT @ Roche: Chance to survive a year with # lungcancer In the 1980s: 10%. In the late 2000s: Over 50%. http://ow.ly/xkL6m # ASCO14 # lcsm,,@,# # #,4.72507E+17,https://twitter.com/ARUPLabs/status/472506502851596288,,,,
rsm2800,5/30/2014 18:34,0,0,"Emanuel: Yes we are concerned about value but we are also concerned about total cost, which is comprised of cost x volume # ASCO14",,,#,4.72506E+17,https://twitter.com/rsm2800/status/472506309682528256,,,,
marcodoc,5/30/2014 18:33,0,0,# asco2014 # chicago @Millennium Park http://instagram.com/p/oo0uvHhKP6/,,@Millennium,# #,4.72506E+17,https://twitter.com/marcodoc/status/472506033277898752,,,,
drcbsteer,5/30/2014 18:32,3,2,# ASCO14 @ WilliamDale_MD # gerionc Frailty but not older age predictive of readmission following major surgery (Whipples proc),,@,# #,4.72506E+17,https://twitter.com/drcbsteer/status/472505767015096320,,,,
PhRMA,5/30/2014 18:31,2,0,"Study finds # Medicare # PartD coverage reduced hospitalization by 8%, says @ Celgene http://bit.ly/1ku6YbS # ASCO14",,@,# # #,4.72506E+17,https://twitter.com/PhRMA/status/472505508079759360,,,,
GuardantHealth,5/30/2014 18:31,1,2,Gearing up for tomorrow at @ ASCO! Be sure to stop by our booth #19156. # ASCO14 pic.twitter.com/AFuelc9Sn5,,@,#19156 #,4.72506E+17,https://twitter.com/GuardantHealth/status/472505503445053440,,,,
Cortellis,5/30/2014 18:30,0,0,Once daily TGR1202 demonstrates promising single agent activity in patients with hematologic malignancies # ASCO14,,,#,4.72505E+17,https://twitter.com/Cortellis/status/472505451540926464,,,,
ASCO,5/30/2014 18:30,1,1,Attended the # ASCO14 Grant Writing Workshop? Follow up w/10 tips from a successful researcher: http://bit.ly/1ov4rAK # ASCOConnection,,,# #,4.72505E+17,https://twitter.com/ASCO/status/472505440388259841,,,,
ASCO,5/30/2014 18:30,3,3,Read Educational Book articles on topics in Melanoma/Skin Cancers from # ASCO14 Education Session Speakers: http://bit.ly/1oFM4qw,,,#,4.72505E+17,https://twitter.com/ASCO/status/472505376299286528,,,,
aftimosp,5/30/2014 18:30,0,1,DMOT4039A is an ADC in development showing 1 partial responsein pancreas cancer and 3 partial responses in ovarian cancer # ASCO14,,,#,4.72505E+17,https://twitter.com/aftimosp/status/472505310385815552,,,,
CancerDotNet,5/30/2014 18:30,3,1,# ASCO14 study: Reducing freq of bone drug safe after 1st yr of treatment to reduce side effects # bcsm Summary: http://bit.ly/1wAJyqg,,,# #,4.72505E+17,https://twitter.com/CancerDotNet/status/472505283097657344,,,,
myPathMelanoma,5/30/2014 18:30,0,1,Have some downtime between presentations? Read our publications online at http://www.IsThisMelanoma.com # ASCO14 # Melanoma # clinical,,,# # #,4.72505E+17,https://twitter.com/myPathMelanoma/status/472505282430377984,,,,
SarahMMahoney,5/30/2014 18:30,0,0,Studies show rise in oncology social media ahead of # ASCO14 event http://searchhealthit.techtarget.com/feature/Studies-show-rise-in-oncology-social-media-ahead-of-2014-ASCO-event …,,,#,4.72505E+17,https://twitter.com/SarahMMahoney/status/472505259592798209,,,,
myriadgenetics,5/30/2014 18:30,1,0,Data presented at # ASCO14 will demonstrate the clinical utility of the BRACAnalysis CDx to improve patient therapy. http://bit.ly/1tWn80k,,,#,4.72505E+17,https://twitter.com/myriadgenetics/status/472505242102153216,,,,
hmhyltonpac,5/30/2014 18:29,34,11,Dr. Ezekiel Emanuel at # ASCO14: Just one oncology drug can potentially wipe out the median income of the US household.,,,#,4.72505E+17,https://twitter.com/hmhyltonpac/status/472505227493400577,,,,
rsm2800,5/30/2014 18:29,0,0,Zeke Emanuel: “I have a close relative in this town who doesn’t like to do division” And what is Rahm saying about him :) # ASCO14,,,#,4.72505E+17,https://twitter.com/rsm2800/status/472505123445280768,,,,
rsm2800,5/30/2014 18:28,4,0,Emanuel: Median income in U.S. $52K - as much as a year of a new targeted therapy # ASCO14,,,#,4.72505E+17,https://twitter.com/rsm2800/status/472504866384797698,,,,
jagasquet,5/30/2014 18:28,0,0,"# ASCO14: @ Boehringer to present oncology research, including results for # Giotrif® ( # afatinib) in NSCLC # lungcancer http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2014/30_may_2014_oncology.html …",,@,# # # #,4.72505E+17,https://twitter.com/jagasquet/status/472504857689993216,,,,
rsm2800,5/30/2014 18:27,8,2,Emanuel: Cancer care costs 10x as much as the profits of all of the health insurance companies in the U.S. # ASCO14,,,#,4.72505E+17,https://twitter.com/rsm2800/status/472504626067935232,,,,
matthewherper,5/30/2014 18:27,0,0,"@ sci2mrow @ ASCO @ ivanoransky I am, tho in my room making calls. We have to leave New York to run into each other...",,@ @ @,,4.72505E+17,https://twitter.com/matthewherper/status/472504511287033857,,,,
DrMarkham,5/30/2014 18:26,2,0,Talking milestones & entrustable professional activities at @ ASCO's program director session. How best to eval our fellows? # ASCO14 # meded,,@,# #,4.72504E+17,https://twitter.com/DrMarkham/status/472504413135724544,,,,
rsm2800,5/30/2014 18:26,6,3,Zeke Emanuel: No slides (that’s # bold). “We spend more on healthcare in the US approx $3B than entire French economy” # asco14,,,# #,4.72504E+17,https://twitter.com/rsm2800/status/472504387814690816,,,,
yzafar,5/30/2014 18:26,1,0,"MT @ hmhyltonpac: Gregory Rossi on pt assistance programs It is inappropriate for us to be taxing patients who are ill"" Well stated! # ASCO14""",,@,#,4.72504E+17,https://twitter.com/yzafar/status/472504335788933120,,,,
jagasquet,5/30/2014 18:26,0,0,@ AstraZeneca - Demonstrating our oncology science at # ASCO14 http://www.astrazeneca.com/About-Us/Features/Article/20140530--demonstrating-AstraZeneca-oncology-science-ASCO-2014 …,,@,#,4.72504E+17,https://twitter.com/jagasquet/status/472504257715789825,,,,
hmhyltonpac,5/30/2014 18:25,0,1,Dr. Ezekiel Emanuel at # ASCO14: The US spent $3 trillion on healthcare last year. This is larger than the entire French economy.,,,#,4.72504E+17,https://twitter.com/hmhyltonpac/status/472504192490143744,,,,
drcbsteer,5/30/2014 18:25,4,0,# ASCO14 @ WilliamDale_MD Anxious men with prostate cancer more likely to receive ADT earlier regardless of other risk factors for progression,,@,#,4.72504E+17,https://twitter.com/drcbsteer/status/472504155563515904,,,,
Boehringer,5/30/2014 18:25,2,2,"# FF for some # ASCO14 Tweeters: @ asco, @ mtmdphd, @ drattai, @ docbkw, @shewithlynch, @ flabiotechnews, @ drcbsteer, @ subatomicdoc , @ jeffreymotto",,@ @ @ @ @shewithlynch @ @ @ @,# #,4.72504E+17,https://twitter.com/Boehringer/status/472504097934163970,,,,
nanostringtech,5/30/2014 18:25,0,0,"The NanoString nCounter Dx Analysis System delivers direct, multiplexed measurements of gene expression. See more @Booth 5019. # ASCO14",,@Booth,#,4.72504E+17,https://twitter.com/nanostringtech/status/472503997899608065,,,,
CancerMedMDA,5/30/2014 18:25,0,1,Join Dr. Patrick Hwu in discussing the future of adoptive cell transfer to Tx melanoma. # ASCO14 Sat. 3:40 PM.,,,#,4.72504E+17,https://twitter.com/CancerMedMDA/status/472503990429962240,,,,
yamandaka,5/30/2014 18:24,0,0," @ ASCO: Educational Book articles on topics in Breast Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1jqCCSH """"",,@,#,4.72504E+17,https://twitter.com/yamandaka/status/472503813392568321,,,,
aftimosp,5/30/2014 18:24,0,0,3 partial responses in patients with gastro-esophageal cancers treated with BBI603 in combo with paclitaxel # ASCO14,,,#,4.72504E+17,https://twitter.com/aftimosp/status/472503775681576960,,,,
yamandaka,5/30/2014 18:23,0,0, @ EFEciencia: La inmunoterapia," entre los puntos fuertes del congreso de oncología clínica en Chicago. # ASCO14""""",,@,#,4.72504E+17,https://twitter.com/yamandaka/status/472503698682568705,,,
drcbsteer,5/30/2014 18:23,2,0,# ASCO14 #@WilliamDale_MD # gerionc in GU cancers. Comorbidities common in older men with prostate cancer and impacts outcome,,@WilliamDale_MD,# # #,4.72504E+17,https://twitter.com/drcbsteer/status/472503670076997632,,,,
hmhyltonpac,5/30/2014 18:23,3,0,"Dr. Gregory Rossi on patient assistance programs at # ASCO14 It is inappropriate for us to be taxing patients who are ill."" Well stated!""",,,#,4.72504E+17,https://twitter.com/hmhyltonpac/status/472503603505397760,,,,
stales,5/30/2014 18:23,3,1,wow RT @ ASCO: Are only a few highly recurrently mutated driver genes. We’re looking for a thousand needles in a huge haystack # ASCO14 # bcsm,,@,# #,4.72504E+17,https://twitter.com/stales/status/472503597134249984,,,,
Cortellis,5/30/2014 18:23,1,0,400mg QD was found to be the maximum recommended dose and recommended ph2 dose for GSK2636771 # ASCO14,,,#,4.72503E+17,https://twitter.com/Cortellis/status/472503472021987328,,,,
ERPlimackMD,5/30/2014 18:23,3,2,"Dr. Tim Eisen discusses: neoadjuvant TKI shrinks most primary RCCs, can lower nephrometry score # ASCO14 pic.twitter.com/oDMMt2X7Zt",,,#,4.72503E+17,https://twitter.com/ERPlimackMD/status/472503467584389121,,,,
AlpineBV_Miller,5/30/2014 18:22,3,1,$ AZN spent $1B in 2013 to support patients via their patient assistance programs. Billion with a 'B' # ASCO14,,,#,4.72503E+17,https://twitter.com/AlpineBV_Miller/status/472503442649645056,,,,
aftimosp,5/30/2014 18:22,1,0,BBI503 and BBI603 are novel inhibitors of cancer stem cells # ASCO14,,,#,4.72503E+17,https://twitter.com/aftimosp/status/472503428489707520,,,,
OlgaKubassova,5/30/2014 18:22,2,0,Just released - # ASCO14 strategies on # Cancer # CancerSurvivorsDayhttp://www.cancer.net/blog/2014-05/new-strategies-improve-quality-life-patients-survivors-and-caregivers-2014-asco-annual-meeting …,,,# # #,4.72503E+17,https://twitter.com/OlgaKubassova/status/472503251045470208,,,,
davidgrahammd,5/30/2014 18:21,0,0,Mittal etal pros study of Rx break in responding RCC. Duration of 1st break median > 12 mos # gusm # ASCO14,,,# #,4.72503E+17,https://twitter.com/davidgrahammd/status/472503148528271361,,,,
CancerMedMDA,5/30/2014 18:21,1,0,Attending # asco14? Be sure to attend our reception this Sunday at 6pm. # endcancerpic.twitter.com/9V4BHfxIu7,,,# #,4.72503E+17,https://twitter.com/CancerMedMDA/status/472503002050199552,,,,
UCCancerCenter,5/30/2014 18:20,0,2,Soni Smith summarized 4 lymphoma trials including those showing best frontline treatment for follicular lymphoma remains debatable # ASCO14,,,#,4.72503E+17,https://twitter.com/UCCancerCenter/status/472502891098697728,,,,
genentech,5/30/2014 18:20,13,3,"In the # Next50 yrs: A tumor’s immune profile will be a core aspect of cancer biology.” I. Mellman # ASCO14 pic.twitter.com/uEjq9D44oy""",,,# #,4.72503E+17,https://twitter.com/genentech/status/472502804842831872,,,,
aftimosp,5/30/2014 18:20,2,2,"LEE011 is a CDK4/6 inh. Partial response in patients with specific genomic alterations: CDKN2A loss, PI3K mut + CCND1 amplification # ASCO14",,,#,4.72503E+17,https://twitter.com/aftimosp/status/472502771191934976,,,,
mlazqui,5/30/2014 18:19,2,1,RT @ davidgrahammd: Pts in need of partial nephrectomy but not candidates…neoadj pazopanib allowed conversion to PN in 90% # gusm # ASCO14,,@,# #,4.72503E+17,https://twitter.com/mlazqui/status/472502712177655809,,,,
abcdiagnosis,5/30/2014 18:18,1,2,RT @ drattai: at least 6 different subtypes of triple negative # breastcancer # ASCO14 # bcsm # TNBC,,@,# # # #,4.72502E+17,https://twitter.com/abcdiagnosis/status/472502397353594881,,,,
scientre,5/30/2014 18:18,0,2,Rossi (AZ) talk on value priced drugs is interesting with data rich slides. In case you want to watch later.... # ASCO14,,,#,4.72502E+17,https://twitter.com/scientre/status/472502376554061824,,,,
CliffordHudis,5/30/2014 18:18,7,7,"Tweeps...if things go right, am taking a page from @ rsm2800 & will be auto-tweeting my Presidential Address at 10:20am Central from # ASCO14",,@,#,4.72502E+17,https://twitter.com/CliffordHudis/status/472502364629250048,,,,
drcbsteer,5/30/2014 18:18,0,1,# ASCO14 Galsky - novel agents in bladder cancer? Evidence of effectiveness of FGFR3 mutation targeting drug BGJ398 # watchthisspace,,,# #,4.72502E+17,https://twitter.com/drcbsteer/status/472502232265400321,,,,
timturnham,5/30/2014 18:17,0,2,Some companies struggle to get patients into studies of drugs that might prevent recurrence. Do doctors not talk about this? # ASCO14,,,#,4.72502E+17,https://twitter.com/timturnham/status/472502149482831873,,,,
TedOkonCOA,5/30/2014 18:17,0,0,Running/meeting at # asco14 so fast/much that no time to tweet! Great advances in cancer treatment but how do we pay for them?,,,#,4.72502E+17,https://twitter.com/TedOkonCOA/status/472502103001542657,,,,
melanoma_Drs,5/30/2014 18:17,2,2,RT @ Melanoma_doctor: First post of # ASCO14 is up at http://TheMelanomaCenter.com ; a preview of things to come # melanoma http://ow.ly/3laUVJ,,@,# #,4.72502E+17,https://twitter.com/melanoma_Drs/status/472501977558286336,,,,
davidgrahammd,5/30/2014 18:17,5,1,Rini etal prospective study of timing of Rx in asymp metastatic RCC. Low tumor burden median time of obs was 18 mos # gusm # ASCO14,,,# #,4.72502E+17,https://twitter.com/davidgrahammd/status/472501975222059008,,,,
kbnewport,5/30/2014 18:16,3,2,"# gerionc W Dale: Strategy for geriatric oncology: stage the ca, stage the aging, make informed choices # ASCO14",,,# #,4.72502E+17,https://twitter.com/kbnewport/status/472501883933032448,,,,
IAG_Team,5/30/2014 18:16,0,0,Rules should allow # cancer # researchers to be bold # pharma # clinicaltrials # ASCO14 http://www.newsobserver.com/2014/05/23/3883621/rules-should-allow-cancer-researchers.html#storylink=cpy … http://www.newsobserver.com/2014/05/23/3883621/rules-should-allow-cancer-researchers.html …,,,# # # # # #storylink,4.72502E+17,https://twitter.com/IAG_Team/status/472501788248395776,,,,
megtirrell,5/30/2014 18:15,0,3,Also # ff my BBG buddy @ ArmstrongDrew and awesome CNBC producer @ jodigralnick for # ASCO14 news this wknd!,,@ @,# #,4.72502E+17,https://twitter.com/megtirrell/status/472501688373231616,,,,
inkkr,5/30/2014 18:15,0,2,@ QIAGEN Looking forward to meeting up at @ ASCO # ASCO14,,@ @,#,4.72502E+17,https://twitter.com/inkkr/status/472501597625671680,,,,
aftimosp,5/30/2014 18:15,0,0,MSC2156119j (oral agent) and INC280 are 2 novel MET inhibitors with promising results in phase1 monotherapy trials # ASCO14,,,#,4.72502E+17,https://twitter.com/aftimosp/status/472501574548611073,,,,
ASCO,5/30/2014 18:15,0,0,"Ed Book Invited Article: Michael J. Birrer, MD, PhD, on ovarian cancer, introduction by @ drdonsdizon # ASCO14",,@,#,4.72502E+17,https://twitter.com/ASCO/status/472501522090459136,,,,
Gene_Antibody,5/30/2014 18:15,0,0,Will most # clinicaltrials happen via # telemedicine in the future? # ASCO14 # Next50 http://ow.ly/xn1l1,,,# # # #,4.72502E+17,https://twitter.com/Gene_Antibody/status/472501521486450688,,,,
CancerDotNet,5/30/2014 18:15,0,0,Advocates: Reminder about tomorrow's Research Review session on # ASCO14 sci highlights 5:30 PM CT in Pt Adv Lounge S402,,,#,4.72502E+17,https://twitter.com/CancerDotNet/status/472501510610636800,,,,
sfuldnasso,5/30/2014 18:14,0,1,"When this session is over, I need to thaw out, because I am frozen solid by the AC blasting. # ASCO14",,,#,4.72501E+17,https://twitter.com/sfuldnasso/status/472501429996113920,,,,
stuartgiles01,5/30/2014 18:14,1,3,Sad 2 farewell @ cathiereid & @saschagiles at LAX as they head 2 # DWEN but got a bright Chicago welcome for # ASCO14 pic.twitter.com/KZYOWR1uFi,,@ @saschagiles,# #,4.72501E+17,https://twitter.com/stuartgiles01/status/472501351457361920,,,,
javierpadillab,5/30/2014 18:14,2,0,"@dr_bonis Los medicamentos para reducir riesgos a años vista pueden dejarse cuando no existen esos años a la vista""O_O @ JAMA_current @ ASCO""",,@dr_bonis @ @,,4.72501E+17,https://twitter.com/javierpadillab/status/472501213557444610,,,,
davidgrahammd,5/30/2014 18:14,1,1,Pts in need of partial nephrectomy but not candidates...neoadj pazopanib allowed conversion to PN in 90% # gusm # ASCO14,,,# #,4.72501E+17,https://twitter.com/davidgrahammd/status/472501207102402560,,,,
hmhyltonpac,5/30/2014 18:13,0,0,Dr. Gregory Rossi at # ASCO14: Success rates in pharma drug development are about 5%.,,,#,4.72501E+17,https://twitter.com/hmhyltonpac/status/472501135438118913,,,,
melanoma_Drs,5/30/2014 18:13,1,1,"Bristol, Merck, AstraZeneca Bring New ‘Checkpoint Inhibitor” Data to # asco14 http://bit.ly/SkvLnF via @ NJresearch @ adamfeuerstein",,@ @,#,4.72501E+17,https://twitter.com/melanoma_Drs/status/472501125007302657,,,,
Melanoma_doctor,5/30/2014 18:13,0,0,"Bristol, Merck, AstraZeneca Bring New ‘Checkpoint Inhibitor” Data to # asco14 http://bit.ly/SkvLnF via @ NJresearch @ adamfeuerstein",,@ @,#,4.72501E+17,https://twitter.com/Melanoma_doctor/status/472501123677708288,,,,
OlgaKubassova,5/30/2014 18:13,0,0,Rules should allow # cancer researchers to be bold http://www.newsobserver.com/2014/05/23/3883621/rules-should-allow-cancer-researchers.html#storylink=cpy … # ASCO14 http://www.newsobserver.com/2014/05/23/3883621/rules-should-allow-cancer-researchers.html …,,,# #storylink #,4.72501E+17,https://twitter.com/OlgaKubassova/status/472501091645403136,,,,
KUhlendorf,5/30/2014 18:12,2,1,. @ AstraZeneca's Greg Rossi cites Philipson data showing 2.9 year gain in life expectancy if diagnosed with # cancer in 2000 v 1998 # ASCO14,,@,# #,4.72501E+17,https://twitter.com/KUhlendorf/status/472500828289241090,,,,
aftimosp,5/30/2014 18:11,0,0,"VGX-100 (anti-vefg-c) in combo with bevacizumab. Unfortunately, still no valid biomarker for anti-angiogenic therapy # ASCO14",,,#,4.72501E+17,https://twitter.com/aftimosp/status/472500654788055041,,,,
martinnaley,5/30/2014 18:11,0,0,Chemo costs 6.6X more at hospital clinics than in private practice. Acquisitions by hospitals cost payers $millions more. (Newcomer) # ASCO14,,,#,4.72501E+17,https://twitter.com/martinnaley/status/472500601331650560,,,,
BurrisSkip,5/30/2014 18:11,4,2,Responses in lung cancer w/ INC280 Met-I called out by discussant -- Dr Bauer led for SCRI. # ASCO14 @ SarahCannonDocs,,@,#,4.72501E+17,https://twitter.com/BurrisSkip/status/472500573372026880,,,,
JacobPlieth,5/30/2014 18:11,0,0,"Dr Colman discussed search for biomarkers in GBM. Called Berghoff poster intriguing"""," but have to wait until some pts are treated # ASCO14""",,,#,4.72501E+17,https://twitter.com/JacobPlieth/status/472500533413306368,,,
dhjutsw1,5/30/2014 18:11,0,0,Highlights from @ Dana-Farber for @ ASCO annual meeting. # ASCO14. http://www.dana-farber.org/Research/ASCO-Annual-Meeting-2014.aspx#.U4kBk3RYMlo.twitter …,,@ @,# #,4.72501E+17,https://twitter.com/dhjutsw1/status/472500526538428416,,,,
CancerMedMDA,5/30/2014 18:10,0,0,Dr. Van Morris: Poster Sat. 8 AM: Biomarker screening efficiency ATTACC enriched metastatic colorectal cancer trials. Dr. Kopetz. # ASCO14,,,#,4.725E+17,https://twitter.com/CancerMedMDA/status/472500269830660096,,,,
WilliamDale_MD,5/30/2014 18:10,6,1,# ASCO14 Galsky: Tx for older adults with bladder cancer should account for renal function and performance status rather than age. # gerionc,,,# #,4.725E+17,https://twitter.com/WilliamDale_MD/status/472500207289376769,,,,
JacobPlieth,5/30/2014 18:10,2,0,Berghoff et al conclusion on PD-L1 analysis in GBM # ASCO14 pic.twitter.com/CEJgjxEE2c,,,#,4.725E+17,https://twitter.com/JacobPlieth/status/472500196195438593,,,,
RichardWJoseph,5/30/2014 18:09,0,0,@ melanoma_mama @ openbiotechjobs @ MedTreatments @ DrMitchellKline Thanks for tweet. Would love to meet up if you're here at # ASCO14.,,@ @ @ @,#,4.725E+17,https://twitter.com/RichardWJoseph/status/472499975768006656,,,,
AdvocateDebM,5/30/2014 18:08,0,0,Looking forward to presentation on a new therapy 4 a # childhoodcancer w/fewer side effects for enhanced QoL. http://bit.ly/1tXOyCX # ASCO14,,,# #,4.725E+17,https://twitter.com/AdvocateDebM/status/472499930440171520,,,,
cancereu,5/30/2014 18:08,5,6,RT @ rsm2800 from my talk on Monday re social media & clinical trials.Never neglect pt privacy # ASCO14 pic.twitter.com/Ifj7TKOv2W cc @ esmart_eu,,@ @,#,4.725E+17,https://twitter.com/cancereu/status/472499860688883715,,,,
DrR_DUNNE,5/30/2014 18:08,0,0,Dr. Maitland bringing us back to high school providing audience with mandatory summer reading list on pharmacodynics # ASCO14,,,#,4.725E+17,https://twitter.com/DrR_DUNNE/status/472499851762991104,,,,
OlgaKubassova,5/30/2014 18:08,1,1,# Patient Role in # Cancer # Research # ASCO14 http://lnkd.in/dxY92e8,,,# # # #,4.725E+17,https://twitter.com/OlgaKubassova/status/472499770846486528,,,,
drcbsteer,5/30/2014 18:08,1,0,# ASCO14 # gerionc Concurrent radiation and twice weekly gemcitabine useful in older adults with bladder cancer - phase 1 data,,,# #,4.725E+17,https://twitter.com/drcbsteer/status/472499742937583616,,,,
BurrisSkip,5/30/2014 18:08,6,2,Congrats to Dr Falchook -- new SCRI ph1 lead in Denver -- as discussant hails his work on the EMD Met inhibitor. # ASCO14 @ SarahCannonDocs,,@,#,4.725E+17,https://twitter.com/BurrisSkip/status/472499701166510080,,,,
hmhyltonpac,5/30/2014 18:07,0,0,Compelling slide by Diane Blum at # ASCO14 explaining how value in cancer care is different. pic.twitter.com/sXxGhdqEZO,,,#,4.725E+17,https://twitter.com/hmhyltonpac/status/472499579100078080,,,,
JacobPlieth,5/30/2014 18:07,1,2,Berghoff et al investigated PD-L1 expression in GBM samples # ASCO14 pic.twitter.com/J0qoRmbPDP,,,#,4.725E+17,https://twitter.com/JacobPlieth/status/472499538922831872,,,,
2dayswork,5/30/2014 18:07,0,0,Come visit the # jtcancercenter booth - #20157 at # ASCO14 in # chicago this weekend! # espresso # cappuccino # aplaceo...pic.twitter.com/vrz4ypN4mG,,,# #20157 # # # # #,4.72499E+17,https://twitter.com/2dayswork/status/472499467762302976,,,,
mlazqui,5/30/2014 18:07,3,1,RT @ HemOncToday: # ASCO14 Discontinuation of # statin use near end of life improved QOL @ DukeU http://goo.gl/3V1SZk,,@ @,# #,4.72499E+17,https://twitter.com/mlazqui/status/472499445972877312,,,,
OlgaKubassova,5/30/2014 18:06,0,0,# Patient Role in # Cancer # Research # ASCO14 http://www.newswise.com/articles/-cancer-research-month-shines-light-on-patient-role-in-research …,,,# # # #,4.72499E+17,https://twitter.com/OlgaKubassova/status/472499387868774400,,,,
KUhlendorf,5/30/2014 18:06,1,0,"Consumers buy health plans, but patients use those plans, @ myUHC's Newcomer observes. A simple but difficult dynamic # ASCO14",,@,#,4.72499E+17,https://twitter.com/KUhlendorf/status/472499380876877825,,,,
WilliamDale_MD,5/30/2014 18:06,2,0,# ASCO14 Galsky: The typical patients enrolled in bladder cancer trials aren't the ones with disease too often. # gerionc,,,# #,4.72499E+17,https://twitter.com/WilliamDale_MD/status/472499379757400064,,,,
KellyColligan,5/30/2014 18:06,0,0,Agree! cc: @ theNCI >> @ drattai: We learned much of what we know via Cooperatve Grp studies. Imprtnt pont. Research matters # ASCO14 # bcsm,,@ @,# #,4.72499E+17,https://twitter.com/KellyColligan/status/472499340746182656,,,,
DrBobGoldberg,5/30/2014 18:06,0,0,Lee newcomer of @ myUHC gets it right: cost driven by site of service and lack of adherence based on patient redlining # MLIWI # ASCO14,,@,# #,4.72499E+17,https://twitter.com/DrBobGoldberg/status/472499309607280642,,,,
aftimosp,5/30/2014 18:06,0,0,Phase I trials lesson 1: Learning versus confirming in clinical drug development http://www.ncbi.nlm.nih.gov/pubmed/9084453 # ASCO14,,,#,4.72499E+17,https://twitter.com/aftimosp/status/472499220990427136,,,,
MaurerStats,5/30/2014 18:06,0,0,MT @ StefanoLuminari # ASCO14 # lymphoma poster highlight conclusions by dr Smith pic.twitter.com/fjJG9yvy8J # lymsm,,@,# # #,4.72499E+17,https://twitter.com/MaurerStats/status/472499209073983488,,,,
scientre,5/30/2014 18:05,0,0,"Newcomer: Site of service impacts cost of care (value). Avg chemo @United: CMS+22% @doc office, CMS+146% #hospital facilities # ASCO14",,@United @doc,#hospital #,4.72499E+17,https://twitter.com/scientre/status/472499149129404416,,,,
genentech,5/30/2014 18:05,4,4,Let’s change this in the # Next50 MT @ LungProject ASCO13: 3 of 4 people have negative # lungcancer bias # ASCO14 http://ow.ly/xmUja,,@,# # #,4.72499E+17,https://twitter.com/genentech/status/472499046574473216,,,,
SarahCannonDocs,5/30/2014 18:05,2,0,"Primary challenge of anti-angiogenic therapy in cancer is maximizing the therapeutic index..."" # ASCO14""",,,#,4.72499E+17,https://twitter.com/SarahCannonDocs/status/472499022931181569,,,,
CancerMedMDA,5/30/2014 18:05,0,0,Dr. Isabella Glitza shows clinical benefit of treating metastatic melanoma w tumor infiltrating lymphocytes. Poster Sat. 8 AM # ASCO14,,,#,4.72499E+17,https://twitter.com/CancerMedMDA/status/472498995504619520,,,,
jtriestm,5/30/2014 18:04,0,0,"Check out  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.72499E+17,https://twitter.com/jtriestm/status/472498917121069057,,,,
kbnewport,5/30/2014 18:04,0,0,Galsky: treatment decisions in geriatric bladder ca should not be based on chronological age alone#gerionc # ASCO14,,,#gerionc #,4.72499E+17,https://twitter.com/kbnewport/status/472498701756538881,,,,
HemOncToday,5/30/2014 18:03,2,1,# ASCO14 Discontinuation of # statin use near end of life improved QOL @ DukeU http://goo.gl/3V1SZk,,@,# #,4.72499E+17,https://twitter.com/HemOncToday/status/472498587415629825,,,,
GoHealio,5/30/2014 18:03,0,0,# ASCO14 Discontinuation of # statin use near end of life improved QOL @ DukeU http://goo.gl/3V1SZk,,@,# #,4.72499E+17,https://twitter.com/GoHealio/status/472498586702598145,,,,
WilliamDale_MD,5/30/2014 18:03,1,1,# ASCO14 Galsky: Can older adults tolerate the standard therapies for bladder cancer? Not when they have significant renal failure. # gerionc,,,# #,4.72498E+17,https://twitter.com/WilliamDale_MD/status/472498456284901377,,,,
2dayswork,5/30/2014 18:03,0,0,Come visit the # jtcancercenter booth - #20157 at # ASCO14 in # chicago this weekend! # espresso # cappuccino... http://fb.me/16m5PsvtS,,,# #20157 # # # #,4.72498E+17,https://twitter.com/2dayswork/status/472498437586288640,,,,
drseisenberg,5/30/2014 18:02,1,1,The Real Housewives of Chemotherapy: http://youtu.be/JkYvHsA3JPc via @ suleikajaouad # ASCO14 # suleikaROCKS,,@,# #,4.72498E+17,https://twitter.com/drseisenberg/status/472498431324192768,,,,
DrHealeyBird,5/30/2014 18:02,0,0,# ASCO14 http://tinyurl.com/mz3hcgq really important biomarker study in DLBCLpic.twitter.com/PktQqovVPP,,,#,4.72498E+17,https://twitter.com/DrHealeyBird/status/472498393525145600,,,,
EMcCallister01,5/30/2014 18:02,3,1,@ myUHC Lee Newcomer: chemo in office = cms fee+22%; chemo in hospital = cms fee+146% # ASCO14,,@,#,4.72498E+17,https://twitter.com/EMcCallister01/status/472498198062571520,,,,
AlpineBV_Miller,5/30/2014 18:02,5,4,Here's one slide that should make us think. # ASCO14. You think the care and OS are 663% higher? # ASCO14 pic.twitter.com/tONH6f4X78,,,# #,4.72498E+17,https://twitter.com/AlpineBV_Miller/status/472498197534113793,,,,
cancereu,5/30/2014 18:01,0,0,tweets to follow from # asco14 @ teamoncology @ drsteventucker @ MaverickNY,,@ @ @,#,4.72498E+17,https://twitter.com/cancereu/status/472498144585187329,,,,
hmhyltonpac,5/30/2014 18:01,0,0,Dr. Lee Newcomer at # ASCO14: Cost for giving chemotherapy in hospital-owned facilities is >6x the cost as giving in MD office per UHC data.,,,#,4.72498E+17,https://twitter.com/hmhyltonpac/status/472498101715222528,,,,
RamalingamMD,5/30/2014 18:01,3,3,# LCSM don't miss a 'must attend' clinical science symposium on lung cancer at 8am tomorrow # ASCO14,,,# #,4.72498E+17,https://twitter.com/RamalingamMD/status/472498080797831168,,,,
ERPlimackMD,5/30/2014 18:01,0,1,Petros Grivas MD discusses promising biomarker data in neoadjuvant bladder cancer # ASCO2014,,,#,4.72498E+17,https://twitter.com/ERPlimackMD/status/472498043225268225,,,,
JacobPlieth,5/30/2014 18:01,1,2,From Berghoff et al poster # ASCO14 pic.twitter.com/Xo7R6g9oXw,,,#,4.72498E+17,https://twitter.com/JacobPlieth/status/472498036024020993,,,,
scientre,5/30/2014 18:01,0,1,Newcomer from United Health talking Value Based Insurance # asco14 Different approach than WellPoint doc payments http://m.jnci.oxfordjournals.org/content/early/2013/01/30/jnci.djt020.full …,,,#,4.72498E+17,https://twitter.com/scientre/status/472498007192403968,,,,
CancerDotNet,5/30/2014 18:01,10,2,New study on caregivers: Benefits of a palliative care support program post-diagnosis of loved one. # ASCO14 http://bit.ly/1nB2Z0r,,,#,4.72498E+17,https://twitter.com/CancerDotNet/status/472497972903968768,,,,
ASCO,5/30/2014 18:01,6,4,Read Educational Book articles on topics in Lymphoma & Plasma Cell Disorders from # ASCO14 Speakers: http://bit.ly/1wg0pOO,,,#,4.72498E+17,https://twitter.com/ASCO/status/472497934651912192,,,,
dhjutsw1,5/30/2014 18:00,0,0,Old idea w/ 'new' results; drug helps young women protect fertility during chemo. # ASCO14. http://www.usatoday.com/story/news/nation/2014/05/30/preserving-fertility-after-chemo/9763633/ … via @ usatoday,,@,#,4.72498E+17,https://twitter.com/dhjutsw1/status/472497927051431937,,,,
Novartis,5/30/2014 18:00,2,6,"As we celebrate ASCO’s 50-year birthday, tweet to us your vision for # lungcancer treatment in 50 years. # ASCO14",,,# #,4.72498E+17,https://twitter.com/Novartis/status/472497916922580992,,,,
WilliamDale_MD,5/30/2014 18:00,1,0,"# ASCO14 Galsky: Cystectomy effective treatment for locally invasive bladder cancer, but offered less often to older adults. # gerionc",,,# #,4.72498E+17,https://twitter.com/WilliamDale_MD/status/472497710856421376,,,,
KUhlendorf,5/30/2014 17:59,2,1,. @ myUHC's Newcomer: move to value in insurance coverage will be gradual process with a lot of education necessary # ASCO14,,@,#,4.72498E+17,https://twitter.com/KUhlendorf/status/472497669647388673,,,,
tabASCOsauce3,5/30/2014 17:59,1,0,Yes back to the future was part of a GCT presentation # classicmovie # ASCO14 pic.twitter.com/vfFI6EZgpN,,,# #,4.72498E+17,https://twitter.com/tabASCOsauce3/status/472497655374184448,,,,
StefanoLuminari,5/30/2014 17:59,1,0,# ASCO14 poster highlight conclusions by dr Smith pic.twitter.com/0OxtthjKlU,,,#,4.72498E+17,https://twitter.com/StefanoLuminari/status/472497611807526912,,,,
Lymphoma_Doc,5/30/2014 17:58,0,0,"ABT199, BCL2 inhibitor, shows 48% prelim ORR in relapsed NHL, dose escalation continues to determine MTD # ASCO14",,,#,4.72497E+17,https://twitter.com/Lymphoma_Doc/status/472497418089426944,,,,
inkkr,5/30/2014 17:58,0,1,"Chemoradiation touted as positive therapeutic option NSLC, but I thought fallen out of favor, esp in Europe? # ASCO14",,,#,4.72497E+17,https://twitter.com/inkkr/status/472497359671549952,,,,
RyhMd,5/30/2014 17:58,0,0,RADIANT study (adjuvant Erlotinjb in NSCLC) results coming on Monday # ASCO14,,,#,4.72497E+17,https://twitter.com/RyhMd/status/472497273960951808,,,,
xavigranda,5/30/2014 17:57,0,2,"Entrevista al Dr. Hudis, presidente de @ asco Da gusto hablar con gente tan amable y profesional pic.twitter.com/bbjc7Ce5Oq",,@,,4.72497E+17,https://twitter.com/xavigranda/status/472497032075436032,,,,
WilliamDale_MD,5/30/2014 17:57,2,0,"# ASCO14 Dr. Galsky up next on bladder cancer in older patients. An evidence based approach"". # gerionc""",,,# #,4.72497E+17,https://twitter.com/WilliamDale_MD/status/472496988114923520,,,,
kbnewport,5/30/2014 17:57,0,0,Galsky: tx for bladder ca in elderly- there is a knowledge gap between efficacy of treatments in general population versus elderly # ASCO14,,,#,4.72497E+17,https://twitter.com/kbnewport/status/472496937124777985,,,,
TuftsB,5/30/2014 17:56,1,1,ASCO talks about value and cost but ignores that all revenues they get come from patients. # MLIWI # ASCO14,,,# #,4.72497E+17,https://twitter.com/TuftsB/status/472496862323568641,,,,
cancereu,5/30/2014 17:56,0,0,"@ JNCI_Now Doctors argue that near end of life, it isn't necessary to continue drugs for not life-threatening chronic illness # ASCO14",,@,#,4.72497E+17,https://twitter.com/cancereu/status/472496710267441152,,,,
Pathologists,5/30/2014 17:56,1,0,"RT @ ASCO: Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1tW6XQG",,@,#,4.72497E+17,https://twitter.com/Pathologists/status/472496674535780352,,,,
inkkr,5/30/2014 17:55,0,0,"@ matthewherper, are you here at @ ASCO # ASCO14? I'm just waiting to run into @ ivanoransky, master attendee of nearly everything.",,@ @ @,#,4.72497E+17,https://twitter.com/inkkr/status/472496644702109696,,,,
PhRMA,5/30/2014 17:55,3,1,America’s # biopharma researchers go to work every day to bring hope to # cancer patients http://bit.ly/1nAxDqP # ASCO14,,,# # #,4.72496E+17,https://twitter.com/PhRMA/status/472496479861358592,,,,
martinnaley,5/30/2014 17:55,2,0,"Premiums & out-of-pocket costs are 50% of ave US income today, could be 100% by 2028. Need value-based healthcare. (Lee Newcomer) # ASCO14",,,#,4.72496E+17,https://twitter.com/martinnaley/status/472496445380370432,,,,
sfuldnasso,5/30/2014 17:54,2,0,"Diane Blum: great job representing the patient perspective on value, importance of shared decision-making. # ASCO14",,,#,4.72496E+17,https://twitter.com/sfuldnasso/status/472496314484539392,,,,
OncLive,5/30/2014 17:54,3,2,An interesting new addition at # ASCO14 pic.twitter.com/rUPU1zpLkh,,,#,4.72496E+17,https://twitter.com/OncLive/status/472496265289560064,,,,
inkkr,5/30/2014 17:53,1,0,"In NSCLC, ERCC1 immunohistochemistry shows potential as biomarker, but need better antibody. # ASCO14",,,#,4.72496E+17,https://twitter.com/inkkr/status/472496165888749569,,,,
WilliamDale_MD,5/30/2014 17:53,3,0,# ASCO14 Mohile: There are more options than ever for older men with prostate cancer. # gerionc,,,# #,4.72496E+17,https://twitter.com/WilliamDale_MD/status/472496124394471424,,,,
ralanshirley,5/30/2014 17:53,1,0,"@ JAMA_current @ Richard_GP @ ASCO “we found during the study ...clinicians saying, ‘Hey, I never thought about stopping people’s statins !!!""",,@ @ @,,4.72496E+17,https://twitter.com/ralanshirley/status/472496089569193984,,,,
corinaramers,5/30/2014 17:53,0,0,"Need for more communication and tools to aid discussion on value of oncology care"" @ dianeblum # ASCO14""",,@,#,4.72496E+17,https://twitter.com/corinaramers/status/472496043754389504,,,,
carisls,5/30/2014 17:53,0,0,"Thanks for the RT, @ mtmdphd. Happy # ASCO14 :)",,@,#,4.72496E+17,https://twitter.com/carisls/status/472495936971624448,,,,
Mills_I,5/30/2014 17:53,3,2,"Discussions of cancer care costs MUST be addressed by HCPs during appts, hard as is. Assess pts' values. # ASCO14 @ CancerSupportCm",,@,#,4.72496E+17,https://twitter.com/Mills_I/status/472495928386273280,,,,
TGeorgeMD,5/30/2014 17:53,6,2,How faculty can improve supervision and mentorship of the new oncology learner; Dr. Wolanskyj @ Mayo @ ASCO # ASCO14 pic.twitter.com/dAgqh3m0Yc,,@ @,#,4.72496E+17,https://twitter.com/TGeorgeMD/status/472495923428204544,,,,
BurrisSkip,5/30/2014 17:52,5,3,Infante / SCRI attract attention presenting the Ph1 results of the novel CDK 4:6 inhibitor LEE011. # ASCO14 @ SarahCannonDocs,,@,#,4.72496E+17,https://twitter.com/BurrisSkip/status/472495886287638528,,,,
CancerMedMDA,5/30/2014 17:52,1,0,Attending ASCO's Annual Mtg? Follow @ fischmd for updates about medical education & hospice/palliative care developments. # endcancer # ASCO14,,@,# #,4.72496E+17,https://twitter.com/CancerMedMDA/status/472495679911120897,,,,
WilliamDale_MD,5/30/2014 17:51,2,1,"# ASCO14 Most older men in trials don't have comorbidities, disabilities, or functional losses. But most older men with cancer do. # gerionc",,,# #,4.72496E+17,https://twitter.com/WilliamDale_MD/status/472495611636641792,,,,
TaraAnnGall,5/30/2014 17:51,0,0,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72495E+17,https://twitter.com/TaraAnnGall/status/472495440361840640,,,,
BurrisSkip,5/30/2014 17:50,3,1,"Bendell / SCRI present interesting FIM data on XMT-1107, a polymer conjugated fumagillin derivative. # ASCO14 @ SarahCannonDocs",,@,#,4.72495E+17,https://twitter.com/BurrisSkip/status/472495343540899841,,,,
Lymphoma_Doc,5/30/2014 17:50,1,1,"Ublituximab, novel glycoengineered anti-CD20, shows 41% ORR in relapsed NHL, 86% stable disease. Combo trials underway. # ASCO14",,,#,4.72495E+17,https://twitter.com/Lymphoma_Doc/status/472495319167410176,,,,
cancereu,5/30/2014 17:50,1,1,@ EIannelli Elisabetta surprise! you feature on the # asco14 network centrality!,,@,#,4.72495E+17,https://twitter.com/cancereu/status/472495289916329984,,,,
JRperez77,5/30/2014 17:50,0,1,Attending # ASCO14 pic.twitter.com/w1uFiO7iNu,,,#,4.72495E+17,https://twitter.com/JRperez77/status/472495271465996288,,,,
EMcCallister01,5/30/2014 17:50,2,0,From # ASCO14 value session: @ CancerCare Blum: We need more education for providers and patients about value.,,@,#,4.72495E+17,https://twitter.com/EMcCallister01/status/472495206894284800,,,,
LillyTrials,5/30/2014 17:50,2,1,Congratulations to all! MT @ ASCO: . @ iConquerCancer awards 50 Young Investigator Awards http://bit.ly/1pggzWv # clinicalresearch,,@ @,#,4.72495E+17,https://twitter.com/LillyTrials/status/472495197746909185,,,,
mtmdphd,5/30/2014 17:50,1,1,The Social Oncology Project 2014 - @ BrianReid @ KaylaRodrigue11 @ W2OGroup @ MDigitalLife http://ow.ly/xsgP9 # SocOncology # ASCO14,,@ @ @ @,# #,4.72495E+17,https://twitter.com/mtmdphd/status/472495179652677632,,,,
myPathMelanoma,5/30/2014 17:50,0,0,Visit Myriad's # ASCO14 Poster Highlights on Sat May 31st 8am-11:45am Myriad myPath # Melanoma Influence of Gene Sign. on Melanocytic Tumors,,,# #,4.72495E+17,https://twitter.com/myPathMelanoma/status/472495165320347648,,,,
davidgrahammd,5/30/2014 17:50,0,1,A number of posters of genetic markers in bladder ca. Discussant very correctly states requirement for prospective validation # gusm # ASCO14,,,# #,4.72495E+17,https://twitter.com/davidgrahammd/status/472495164846788608,,,,
skipbidder,5/30/2014 17:49,2,1,"# hpm MT @ JAMA_current: # Statin Use Can Stop When Illness Is # Terminal, Study Reports @ ASCO http://wp.me/p13lz7-389 pic.twitter.com/Ga0wuRcB3X",,@ @,# # #,4.72495E+17,https://twitter.com/skipbidder/status/472494950232629248,,,,
Melanoma_doctor,5/30/2014 17:49,1,2,First post of # ASCO14 is up at http://TheMelanomaCenter.com ; a preview of things to come # melanoma http://www.themelanomacenter.com/?p=488,,,# #,4.72495E+17,https://twitter.com/Melanoma_doctor/status/472494949267542016,,,,
JFreemanDaily,5/30/2014 17:48,1,1,# ASCO14 Andrei Goga: MYC pathway appears to play role in KRAS-driven lung cancer--target for inhibitor research. # LCSM,,,# #,4.72495E+17,https://twitter.com/JFreemanDaily/status/472494841981833216,,,,
cantcu,5/30/2014 17:48,0,0,@ JAMA_current @ ASCO It is a very poor drug anyway!,,@ @,,4.72495E+17,https://twitter.com/cantcu/status/472494781416103937,,,,
ltbello,5/30/2014 17:48,0,0,Greetings from # ASCO14! Dr Schnipper says that pt centered includes awareness of value & financial toxicity of cancer care @ Medicina_CFM,,@,#,4.72495E+17,https://twitter.com/ltbello/status/472494737027792896,,,,
rschilsky,5/30/2014 17:48,9,5,Shared decision making helps pts. assess value of treatment options. Diane Blum @ # ASCO14 session on value of cancer care.,,@,#,4.72495E+17,https://twitter.com/rschilsky/status/472494721462706176,,,,
MedscapeUrology,5/30/2014 17:47,1,3,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeUrology/status/472494657255923712,,,,
MedscapeSurgery,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeSurgery/status/472494657180409856,,,,
MedscapePharm,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapePharm/status/472494657100726272,,,,
MedscapePath,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapePath/status/472494657062981633,,,,
MedscapeObGyn,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeObGyn/status/472494657008435200,,,,
MedscapeKidney,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeKidney/status/472494656932937728,,,,
MedscapeGastro,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeGastro/status/472494656895213568,,,,
MedscapeOnc,5/30/2014 17:47,4,4,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeOnc/status/472494656828080129,,,,
MedscapeNurses,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeNurses/status/472494656735821824,,,,
MedscapeStudent,5/30/2014 17:47,0,0,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/MedscapeStudent/status/472494656651935744,,,,
Medscape,5/30/2014 17:47,1,1,"# ASCO2014 Breast cancer with bone mets: less of a bone building drug is ok -- not associated with less fractures, etc http://bit.ly/1rqBzMm",,,#,4.72495E+17,https://twitter.com/Medscape/status/472494656605786112,,,,
DrLen,5/30/2014 17:47,0,1,"P Workman (ICR) made comment that we only have rx for 5% of genomic druggable"" targets. Much work remains to be done # ASCO14""",,,#,4.72495E+17,https://twitter.com/DrLen/status/472494654152540160,,,,
hmhyltonpac,5/30/2014 17:47,3,0,Diane Blum # ASCO14 quoting @ drdonsdizon I will listen to my patient, her values," & preferences-proceed w/what we are both comfortable with""""",,@,#,4.72495E+17,https://twitter.com/hmhyltonpac/status/472494624494215168,,
whysirsf,5/30/2014 17:47,0,1,"In my parents honor, hoping for some breakthrough bladder and pancreatic cancer news at # ASCO14",,,#,4.72495E+17,https://twitter.com/whysirsf/status/472494584572825600,,,,
cancereu,5/30/2014 17:47,0,0,just going through the # asco14 timeline to see who's there tweeting this year!,,,#,4.72495E+17,https://twitter.com/cancereu/status/472494531406233600,,,,
seattlechildren,5/30/2014 17:47,8,6,Dr. Hawkins is presenting @ ASCO about a new therapy for a common # childhoodcancer that has fewer side effects http://bit.ly/1tXOyCX # ASCO14,,@,# #,4.72494E+17,https://twitter.com/seattlechildren/status/472494494676312064,,,,
EBOncology,5/30/2014 17:46,0,0,Shared decision making between physician and patient an help the patient assess value of care- Diane Blum # ASCO14,,,#,4.72494E+17,https://twitter.com/EBOncology/status/472494407589957632,,,,
yzafar,5/30/2014 17:46,0,0,"Good point: MT @ scientre: value=benefit/costs, do we have enough data 2 define benefits (surv/QOL/tox) of even routine regimens # ASCO14",,@,#,4.72494E+17,https://twitter.com/yzafar/status/472494376586072064,,,,
BurrisSkip,5/30/2014 17:46,3,2,Bauer / SCRI present on successfully using NGS in 900+ patients to prospectively guide trial selection. # ASCO14 @ SarahCannonDocs,,@,#,4.72494E+17,https://twitter.com/BurrisSkip/status/472494355060903936,,,,
PeterHall001,5/30/2014 17:46,0,1,I guess QALYs are too abstract for patients to use for their own treatment decisions. ..not sure clinical trial results are better. # ASCO14,,,#,4.72494E+17,https://twitter.com/PeterHall001/status/472494309145870337,,,,
cancercommons,5/30/2014 17:45,0,0,"Promising results for Melapuldencel-T, personalized immunotherapy treatment for # melanoma, to be presented @ # ASCO14: http://www.cancercommons.org/news/neostem-presents-data-at-asco-annual-meeting/ …",,@,# #,4.72494E+17,https://twitter.com/cancercommons/status/472494112457773056,,,,
KUhlendorf,5/30/2014 17:45,2,0,"Discussions on costs with # cancer patients emotional and difficult but necessary, @ dianeblum says at # ASCO14 pic.twitter.com/h6BaRBEcgk",,@,# #,4.72494E+17,https://twitter.com/KUhlendorf/status/472494091377188865,,,,
ShannonWestin,5/30/2014 17:45,0,0,FIH study of PI3K inhibitor GSK2636771 shows promise in PTEN deficient tumors # ASCO14,,,#,4.72494E+17,https://twitter.com/ShannonWestin/status/472494005096558593,,,,
CincyWorkinMama,5/30/2014 17:45,1,1,Excited to hear @ OSUCCC_James's Dr. John Byrd talk about how ibrutinib is improving the lives of CLL patients at # ASCO14 tomorrow AM!,,@,#,4.72494E+17,https://twitter.com/CincyWorkinMama/status/472493994589839360,,,,
ASCO,5/30/2014 17:45,5,1,Read Educational Book articles on topics in Central Nervous System Tumors from # ASCO14 speakers: http://bit.ly/1kHWXax,,,#,4.72494E+17,https://twitter.com/ASCO/status/472493974419439616,,,,
CancerDotNet,5/30/2014 17:45,11,3,"Dr. Patricia Ganz shares abt need to ensure patients have the best quality of life at every stage"" # ASCO14 http://bit.ly/1hjxkOD""",,,#,4.72494E+17,https://twitter.com/CancerDotNet/status/472493972586528768,,,,
DrMiguelPerales,5/30/2014 17:45,1,0,"Statin Use Can Stop When Illness Is Terminal, Study Reports http://wp.me/p13lz7-389 via @newsatJAMA # ASCO14",,@newsatJAMA,#,4.72494E+17,https://twitter.com/DrMiguelPerales/status/472493961869672448,,,,
Amgen,5/30/2014 17:45,1,1,Learn more about why minimal residual disease detection is important in acute lymphoblastic # leukemia. Visit booth #19042 @ # ASCO14,,@,# #19042 #,4.72494E+17,https://twitter.com/Amgen/status/472493948838367232,,,,
ProjectInno,5/30/2014 17:45,1,0,Join the movement to accelerate cancer breakthroughs: http://ow.ly/xs2YA # innovatenow # ASCO14,,,# #,4.72494E+17,https://twitter.com/ProjectInno/status/472493921164341248,,,,
scientre,5/30/2014 17:44,3,2,"value=benefit/costs, wondering if have sufficient/the right/gd enough data 2 define benefits (surv/QOL/tox) of even routine regimens # ASCO14",,,#,4.72494E+17,https://twitter.com/scientre/status/472493824775028737,,,,
MMarchioneAP,5/30/2014 17:44,0,0,Very full room late on a sunny Friday afternoon for talks on value in cancer care at # ASCO14,,,#,4.72494E+17,https://twitter.com/MMarchioneAP/status/472493740079476737,,,,
JAMA_current,5/30/2014 17:44,74,29,"# Statin Use Can Stop When Illness Is # Terminal, Study Reports @ ASCO http://wp.me/p13lz7-389 # EOL # palliativecarepic.twitter.com/YdhQdwlwy3",,@,# # # #,4.72494E+17,https://twitter.com/JAMA_current/status/472493708748009473,,,,
TuftsB,5/30/2014 17:43,0,0,Patients are the ultimate stakeholders. We have the disease & pay insurance copays that are the income of complaining doctors # mliwi # ASCO14,,,# #,4.72494E+17,https://twitter.com/TuftsB/status/472493545756966912,,,,
WilliamDale_MD,5/30/2014 17:43,2,0,# ASCO14 Mohile: Older men on Abiraterone for prostate cancer outcomes similar to younger patients. # gerionc,,,# #,4.72493E+17,https://twitter.com/WilliamDale_MD/status/472493487410003968,,,,
drcbsteer,5/30/2014 17:43,0,0,MT # ASCO14 # geriatriconcology # lymsm # CLL # myeloma Great to see a full room of people learning about haem malignancies in older adults,,,# # # # #,4.72493E+17,https://twitter.com/drcbsteer/status/472493448814424065,,,,
TriageCancer,5/30/2014 17:43,0,0,@ mylifelineorg we'll see you in Chicago at # ASCO14 bright and early tomorrow!,,@,#,4.72493E+17,https://twitter.com/TriageCancer/status/472493441122054144,,,,
cancerassassin1,5/30/2014 17:43,0,0,@ ASCO great thing about visionaries is that they see beyond the present. They must be/would have been proud of what # ASCO14 has become.,,@,#,4.72493E+17,https://twitter.com/cancerassassin1/status/472493417016987648,,,,
LButlerRocks,5/30/2014 17:42,0,0,Poll this year 50% of # oncologists ordered next generation # sequencing 4 their patients pic.twitter.com/v0NA1M2WfG via @ alantanmd # ASCO14,,@,# # #,4.72493E+17,https://twitter.com/LButlerRocks/status/472493390639022081,,,,
yzafar,5/30/2014 17:42,4,1,"Schnipper: Addressing # FinancialToxicity is a part of patient-centered, value-based cancer care # ASCO14",,,# #,4.72493E+17,https://twitter.com/yzafar/status/472493250428018688,,,,
mtmdphd,5/30/2014 17:41,0,0,CCF @ iConquerCancer Mission Endowment - 3 days and counting ... https://secure2.convio.net/asco/site/Donation2?df_id=1840&1840.donation=landing … # ASCO14,,@,#,4.72493E+17,https://twitter.com/mtmdphd/status/472493068395241472,,,,
cancerassassin1,5/30/2014 17:41,0,0,@ ASCO very interesting! And first meeting was here in # Chicago! # ASCO14,,@,# #,4.72493E+17,https://twitter.com/cancerassassin1/status/472492960500555776,,,,
AlpineBV_Miller,5/30/2014 17:41,2,2,"An oncologist's job is choosing most efficacious Tx. NOT say, You can't have this because @ ASCO rated it too expensive."" # ASCO14""",,@,#,4.72493E+17,https://twitter.com/AlpineBV_Miller/status/472492950044557312,,,,
Ivocu,5/30/2014 17:40,0,0,"My hotel view... So far, I'm looooving Chicago!!! # hardwork # job # ASCO14 # conventionpic.twitter.com/DwJeLJILp9",,,# # # #,4.72493E+17,https://twitter.com/Ivocu/status/472492883107278851,,,,
StefanoLuminari,5/30/2014 17:40,1,0,Barr et al # asco14 romidepsin in PTCL response rate of 30% rate across all subtypes,,,#,4.72493E+17,https://twitter.com/StefanoLuminari/status/472492812861050880,,,,
drcbsteer,5/30/2014 17:40,0,1,# asco14 ABT199 active in relapsed lymphoma including an encouraging RR in Mantle cell # lymsm,,,# #,4.72493E+17,https://twitter.com/drcbsteer/status/472492806968463360,,,,
Medicalfacts,5/30/2014 17:40,0,0,@ AlpineBV_Miller @ ASCO Totally agree!,,@ @,,4.72493E+17,https://twitter.com/Medicalfacts/status/472492737221378048,,,,
hmhyltonpac,5/30/2014 17:39,4,0,"Diane Blum at # ASCO14: What determines value to the pt? Clinical benefit, SEs/late effects, cost, & individual preference",,,#,4.72493E+17,https://twitter.com/hmhyltonpac/status/472492612859879424,,,,
polo525,5/30/2014 17:39,0,1,@ WinshipAtEmory @ wallyjc @ ASCO Fantastic,,@ @ @,,4.72493E+17,https://twitter.com/polo525/status/472492581360644096,,,,
Medicalfacts,5/30/2014 17:39,0,0,@ cancerassassin1 @ ASCO you’re welcome,,@ @,,4.72493E+17,https://twitter.com/Medicalfacts/status/472492546133098496,,,,
KUhlendorf,5/30/2014 17:39,0,0,. @ CancerCare's @ dianeblum: many # cancer patients approach value with mindset if I don't try," I just won't forgive myself"" # ASCO14""",,@ @,# #,4.72493E+17,https://twitter.com/KUhlendorf/status/472492530760572928,,,
WilliamDale_MD,5/30/2014 17:39,1,0,"# ASCO14 Mohile: Older men with castrate resistant # prostate # cancer benefit from carbazitaxel, but neutrapenia and diarrhea are common.",,,# # #,4.72492E+17,https://twitter.com/WilliamDale_MD/status/472492460414087168,,,,
BurrisSkip,5/30/2014 17:39,5,3,Cavelli discusses PI3K delta-I TGR 1202 presented by SCRI 'excellent safety profile and promising activity.' # ASCO14 @ SarahCannonDocs,,@,#,4.72492E+17,https://twitter.com/BurrisSkip/status/472492397814108160,,,,
Medicalfacts,5/30/2014 17:38,0,0,Schipper: Patient centered includes awareness of value & financial toxicity of cancer care # ASCO14,,,#,4.72492E+17,https://twitter.com/Medicalfacts/status/472492169325187072,,,,
davidgrahammd,5/30/2014 17:38,0,0,4512 neoadj MVAC vs GC comparable pT0 and OS. Validates community practice # gusm # ASCO14,,,# #,4.72492E+17,https://twitter.com/davidgrahammd/status/472492164233322496,,,,
PenaultLlorca,5/30/2014 17:37,0,0,@ rschilsky @ ASCO,,@ @,,4.72492E+17,https://twitter.com/PenaultLlorca/status/472492115977850880,,,,
scientre,5/30/2014 17:37,1,1,Blum: notes Michael Porter desc of value incl creation of value for patients determines rewards 4 all others # asco14 http://www.nejm.org/doi/full/10.1056/NEJMp1011024?viewType=Print …,,,#,4.72492E+17,https://twitter.com/scientre/status/472492100769312768,,,,
StefanoLuminari,5/30/2014 17:37,1,0,O’Connor # ASCO14 ublituximab 43% ORR in rituximab refractory patients,,,#,4.72492E+17,https://twitter.com/StefanoLuminari/status/472491918799040512,,,,
cancerassassin1,5/30/2014 17:37,0,1,@ Medicalfacts @ ASCO nice work! # historyofmedicine # respectforfounders # ASCO14,,@ @,# # #,4.72492E+17,https://twitter.com/cancerassassin1/status/472491905515679745,,,,
lisajkjac,5/30/2014 17:36,1,1,Alla som är intresserade av cancernyheter måste följa @ CM_Hake @ SamuelLz som rapporterar från # ASCO14 . Läs även på dagensmedicin.se,,@ @,#,4.72492E+17,https://twitter.com/lisajkjac/status/472491761143934976,,,,
BIOARRAYMDx,5/30/2014 17:36,0,0,Team BIOARRAY in action! # ASCO2014,,,#,4.72492E+17,https://twitter.com/BIOARRAYMDx/status/472491683234332673,,,,
Medicalfacts,5/30/2014 17:36,0,0,Hope for cancer: genomics will make every cancer a rare cancer. Interesting thought! # ASCO14,,,#,4.72492E+17,https://twitter.com/Medicalfacts/status/472491680700964864,,,,
hmhyltonpac,5/30/2014 17:35,1,0,"Diane Blum at # ASCO14: For the patient, value rests not only in clinical response but sometimes in trying.",,,#,4.72492E+17,https://twitter.com/hmhyltonpac/status/472491619044700160,,,,
StefanoLuminari,5/30/2014 17:35,1,0,2 yr PFS 89% with Rituximab + lenalidomide in first line FL # ASCO14,,,#,4.72492E+17,https://twitter.com/StefanoLuminari/status/472491561737936896,,,,
TGeorgeMD,5/30/2014 17:35,4,3,50yrs of @ ASCO assoc w/ dramatic changes in oncology trainee educational needs Dr. Wolanskyj @ Mayo; Virtual Mtg must watch if educator,,@ @,,4.72492E+17,https://twitter.com/TGeorgeMD/status/472491525260455936,,,,
BioNJ_Org,5/30/2014 17:35,1,0,BioNJ Statement Marking ASCO 50th Annual Meeting # ASCO14 http://www.businesswire.com/news/home/20140530005888/en/BioNJ-Statement-Marking-ASCO-50th-Annual-Meeting#.U4j3WnI7vLk …,,,# #,4.72491E+17,https://twitter.com/BioNJ_Org/status/472491496336150528,,,,
DrLen,5/30/2014 17:35,0,0,N Meropol reminds us that we are on a path where genomics will make every cancer a rare cancer. Interesting thought! # ASCO14,,,#,4.72491E+17,https://twitter.com/DrLen/status/472491485183877121,,,,
appistry,5/30/2014 17:35,0,0,Day 1 of # ASCO14! Join us at booth 16152 to learn about our # NGS tools & CloudDx for # genomic testing!,,,# # #,4.72491E+17,https://twitter.com/appistry/status/472491445702914048,,,,
OvarianCanada,5/30/2014 17:35,0,0,It's the @ asco 50th Annual Meeting this weekend. This year's meeting theme is science & society. Should be an interesting weekend. # ASCO,,@,#,4.72491E+17,https://twitter.com/OvarianCanada/status/472491424332918784,,,,
OvarianCancerDY,5/30/2014 17:35,1,2,It's the @ asco 50th Annual Meeting this weekend. This year's meeting theme is science & society. Should be an interesting weekend. # ASCO,,@,#,4.72491E+17,https://twitter.com/OvarianCancerDY/status/472491419475906560,,,,
Gene_Antibody,5/30/2014 17:35,0,0,Thanks @ McCormick_Place for the warm welcome to Chicago & the @ ASCO annual meeting! pic.twitter.com/fhOaKJdhQ5,,@ @,,4.72491E+17,https://twitter.com/Gene_Antibody/status/472491411259281408,,,,
Medicalfacts,5/30/2014 17:34,0,1,"@ cancerassassin1 @ ASCO and MD,Jane C. Wright, MD Arnoldus Goudsmit, MD, PhD",,@ @,,4.72491E+17,https://twitter.com/Medicalfacts/status/472491379420327936,,,,
Medicalfacts,5/30/2014 17:34,0,1,"@ cancerassassin1 @ ASCO Fred J. Ansfield, MD Robert Talley, MD, Harry F. Bisel, MD, William Wilson, MD,Herman H. Freckman,",,@ @,,4.72491E+17,https://twitter.com/Medicalfacts/status/472491342711762945,,,,
AlpineBV_Miller,5/30/2014 17:34,1,2,@ ASCO should create frameworks for adjudicating which drugs are better (efficacy/QoL). This cost effort is cart b4 horse # ASCO14,,@,#,4.72491E+17,https://twitter.com/AlpineBV_Miller/status/472491266295758849,,,,
christinemphmd,5/30/2014 17:33,0,0,Be open for change. Be ready to be part of the steep part of the learning curve, @ pfizer Dr. Mace Rothenberg on industry careers. # ASCO14,,@,#,4.72491E+17,https://twitter.com/christinemphmd/status/472491082979098624,,,
weldeiry,5/30/2014 17:33,0,0,Arie Crown Theater holding discussion of Developmental Therapeutics @ ASCO # ASCO14 pic.twitter.com/ONoIGEzsxv,,@,#,4.72491E+17,https://twitter.com/weldeiry/status/472491042869358592,,,,
TargetedOnc,5/30/2014 17:33,1,0,The whole crew has arrived here in Chicago and we're ready for # ASCO14!,,,#,4.72491E+17,https://twitter.com/TargetedOnc/status/472491008450519040,,,,
cancerassassin1,5/30/2014 17:33,0,1,When I saw this I thought of the scene in # TheGodfather when Don Corleone went to meet the 5 Families # ASCO14 pic.twitter.com/gkWKknAjzL,,,# #,4.72491E+17,https://twitter.com/cancerassassin1/status/472490946542575616,,,,
SamuelLz,5/30/2014 17:32,0,0,Lake Michigan precis utanför pressrummet # dmasco # ASCO14 pic.twitter.com/Bg1GOINGmV,,,# #,4.72491E+17,https://twitter.com/SamuelLz/status/472490789281337344,,,,
PinkSheetMaryJo,5/30/2014 17:32,0,1,"ACA uses the term value 200 times but never defines, Diane Blum tells # ASCO14",,,#,4.72491E+17,https://twitter.com/PinkSheetMaryJo/status/472490680304939008,,,,
DrLen,5/30/2014 17:32,7,3,Greetings from # ASCO14! Dr Schnipper says that pt centered includes awareness of value & financial toxicity of cancer care,,,#,4.72491E+17,https://twitter.com/DrLen/status/472490661158334464,,,,
KUhlendorf,5/30/2014 17:31,3,0,# ASCO14 Will be interesting to see how value initiative will equate to improved patient-level decision-making pic.twitter.com/JfpNv6OTqQ,,,#,4.72491E+17,https://twitter.com/KUhlendorf/status/472490535098134528,,,,
PeterHall001,5/30/2014 17:31,0,0,An individual patient preference-based expected QALY should capture all info needed for an individual treatment decision # ASCO14 ??,,,#,4.72491E+17,https://twitter.com/PeterHall001/status/472490525275488256,,,,
hmhyltonpac,5/30/2014 17:31,3,1,Diane Blum at # ASCO14: The ACA uses the term value 200 times but does not define,,,#,4.7249E+17,https://twitter.com/hmhyltonpac/status/472490495940104192,,,,
MaverickNY,5/30/2014 17:31,3,5,Hah # blisterwalk is lit up this year! First run of many # asco14 pic.twitter.com/v95jLI6hp0,,,# #,4.7249E+17,https://twitter.com/MaverickNY/status/472490428709994496,,,,
YasirYousifE,5/30/2014 17:30,0,0,Big crowd at 50 years of lung cancer talk # ASCO14,,,#,4.7249E+17,https://twitter.com/YasirYousifE/status/472490379296534528,,,,
Medicalfacts,5/30/2014 17:30,0,0,Schipper: Cost has to be factored into the care equation in the privacy of the exam room # ASCO14,,,#,4.7249E+17,https://twitter.com/Medicalfacts/status/472490375870160897,,,,
ASCO,5/30/2014 17:30,3,2,Attended the fertility preservation session at # ASCO14? Read about recent research: http://bit.ly/1ov4wo4 via # ASCOConnection,,,# #,4.7249E+17,https://twitter.com/ASCO/status/472490348833685504,,,,
BurrisSkip,5/30/2014 17:30,6,3,Tobi Arkenau's poster on PI3K-beta inhibitor attracts lots of attention -- encouraging data reported. # ASCO14 @ SarahCannonDocs,,@,#,4.7249E+17,https://twitter.com/BurrisSkip/status/472490327321088002,,,,
ASCO,5/30/2014 17:30,2,1,Read Educational Book articles on topics in Cancer Genetics from # ASCO14 Education Session Speakers: http://bit.ly/1h9G49O,,,#,4.7249E+17,https://twitter.com/ASCO/status/472490280638504960,,,,
AbbottNews,5/30/2014 17:30,4,2,Discover how personalized meds changed the lives & treatment options 4 cancer patients like Richard Heimler # ASCO14 http://bit.ly/1hGVuwV,,,#,4.7249E+17,https://twitter.com/AbbottNews/status/472490213408002048,,,,
CancerDotNet,5/30/2014 17:30,3,1,"We're @ ASCO's patient ed program so follow us for # ASCO14 news for pts: summaries & podcasts, such as today’s news: http://bit.ly/1hjxkOD",,@,#,4.7249E+17,https://twitter.com/CancerDotNet/status/472490170840023040,,,,
Medicalfacts,5/30/2014 17:30,0,0,"Schipper: in-process value model will probably be score balancing clinical benefit, toxicity & cost # ASCO14",,,#,4.7249E+17,https://twitter.com/Medicalfacts/status/472490165316112384,,,,
EMcCallister01,5/30/2014 17:30,1,0,@ BIDMChealth Schnipper: Cost has to be factored into the care equation in the privacy of the exam room # ASCO14,,@,#,4.7249E+17,https://twitter.com/EMcCallister01/status/472490161557618688,,,,
cancerassassin1,5/30/2014 17:30,2,0,Trivia time @ ASCO Annual Meeting (my interest is piqued): Who were the Sentinel 7? # ASCO14 pic.twitter.com/fcrcDHVDIo,,@,#,4.7249E+17,https://twitter.com/cancerassassin1/status/472490158072164353,,,,
jdflaysakier,5/30/2014 17:29,14,2,Cancer du sein : moins de ménopauses précoces et d'avantages de grossesses grace à la Gosereline. Sur le blog http://www.docteurjd.com/?p=3207 # ASCO14,,,#,4.7249E+17,https://twitter.com/jdflaysakier/status/472490052589613056,,,,
RyhMd,5/30/2014 17:29,0,0,Preferred regimen in CNS lymphoma MTX/Procarbazine/Vc plus Rituxan (MTP) # ASCO14,,,#,4.7249E+17,https://twitter.com/RyhMd/status/472490051205885952,,,,
hmhyltonpac,5/30/2014 17:29,0,0,Looking forward to hearing Diane Blum share the patient's perspective on value in cancer care at # ASCO14,,,#,4.7249E+17,https://twitter.com/hmhyltonpac/status/472489991726456832,,,,
PinkSheetMaryJo,5/30/2014 17:29,1,1,"Schipper says in-process value model will probably be score balancing clinical benefit, toxicity & cost # ASCO14 pic.twitter.com/xjrQuTdKHL",,,#,4.7249E+17,https://twitter.com/PinkSheetMaryJo/status/472489935090761728,,,,
DrBobGoldberg,5/30/2014 17:28,0,0,This is @ asco rationing formula. NICE lite # ASCO14 pic.twitter.com/LqcTL1CMC9,,@,#,4.7249E+17,https://twitter.com/DrBobGoldberg/status/472489665652875264,,,,
cancerassassin1,5/30/2014 17:27,0,0,"Ten years later, what's the verdict? Are we succeeding in increments or in leaps and bounds? @ ASCO # ASCO14 pic.twitter.com/9mlGfi8nkn",,@,#,4.7249E+17,https://twitter.com/cancerassassin1/status/472489576171573248,,,,
KMilehamMD,5/30/2014 17:27,0,0,"“ @ JLErsek: Highlights Amin's abstr: AGS-003 w/sunitinib 50% increase in median PFS, doubling of expected median OS # LCI @Carolinas” # ASCO14",,@ @Carolinas,# #,4.72489E+17,https://twitter.com/KMilehamMD/status/472489388170289152,,,,
ShepardDale,5/30/2014 17:26,0,0,Encouraging to see so many exciting new therapies for # cancer in phase I trials at # ASCO14,,,# #,4.72489E+17,https://twitter.com/ShepardDale/status/472489307434139650,,,,
moniekidd,5/30/2014 17:26,0,1,"@ chemobrainfog @ ASCO This is awesome, thank you!",,@ @,,4.72489E+17,https://twitter.com/moniekidd/status/472489304648712193,,,,
PeterHall001,5/30/2014 17:26,0,0,"How would one compare a value score"" in lung cancer with one in myeloma? Why not use the QALY? # ASCO14""",,,#,4.72489E+17,https://twitter.com/PeterHall001/status/472489253872893952,,,,
audvin,5/30/2014 17:25,5,2,http://Cancer.Net Social Media Coverage of ASCO's Annual Meeting # ASCO14 via @ foxggf http://www.cancer.net/research-and-advocacy/asco-annual-meetings/cancernet-social-media-coverage-ascos-annual-meeting …,,@,#,4.72489E+17,https://twitter.com/audvin/status/472488987266121728,,,,
DrBobGoldberg,5/30/2014 17:25,0,0,@ asco value app. No discussion of real quality of life.. None. Nada zero # MLIWI,,@,#,4.72489E+17,https://twitter.com/DrBobGoldberg/status/472488940642254848,,,,
OncLive,5/30/2014 17:25,0,2,"We'll be posting multiple articles and videos daily from # ASCO14 -- View all the coverage, at http://ow.ly/xsjrj",,,#,4.72489E+17,https://twitter.com/OncLive/status/472488883431940097,,,,
AlpineBV_Miller,5/30/2014 17:24,0,1,"@ ASCO cost effort keeps saying *only* a few mths extra"". If they don't know median is worst #to use"," this effort already failed # ASCO14""",,@,#to #,4.72489E+17,https://twitter.com/AlpineBV_Miller/status/472488804339949568,,,
ChapinMD,5/30/2014 17:23,1,3,Explains why millennials are the way they are today. # ASCO14 pic.twitter.com/hScyRoq6Cl,,,#,4.72488E+17,https://twitter.com/ChapinMD/status/472488489985273856,,,,
inkkr,5/30/2014 17:22,0,0,"@ operatic Nope! So close to @ FieldMuseum, but no extra time on this trip. All @ ASCO all the time. I hear there's a good music scene too...",,@ @ @,,4.72488E+17,https://twitter.com/inkkr/status/472488177945808898,,,,
PhRMA,5/30/2014 17:22,0,0,. @ robzirk addresses the reality of prescription med costs in 3 simple charts http://onphr.ma/TRMIal # ASCO14,,@,#,4.72488E+17,https://twitter.com/PhRMA/status/472488149763911681,,,,
appistry,5/30/2014 17:20,0,0,"Are you at # ASCO14? If so, stop by our booth at 16152! # cancergenomics # NGS",,,# # #,4.72488E+17,https://twitter.com/appistry/status/472487863859564545,,,,
inkkr,5/30/2014 17:20,0,0,@ ASCO glad to be here.,,@,,4.72488E+17,https://twitter.com/inkkr/status/472487786613075968,,,,
inkkr,5/30/2014 17:20,0,1,@ ArmstrongDrew I'm sure it'll be easy to spot you! :-) hope paths do cross @ ASCO,,@ @,,4.72488E+17,https://twitter.com/inkkr/status/472487703179968513,,,,
myriadgenetics,5/30/2014 17:20,1,0,Myriad will present results from 11 clinical studies with 4 products at # ASCO14. Visit Booth 2039 to find out more! http://bit.ly/1qFsz5H,,,#,4.72488E+17,https://twitter.com/myriadgenetics/status/472487618110705665,,,,
inkkr,5/30/2014 17:19,0,3,"Ready for 50 years of lung cancer - current status of treating NSCLC"" session @ ASCO # ASCO14 to begin! pic.twitter.com/Kna24V5Grv""",,@,#,4.72487E+17,https://twitter.com/inkkr/status/472487469632741376,,,,
christinemphmd,5/30/2014 17:19,0,0,Be open to serendipity, oncology career advice from Dr. Dan Hayes @ umich # ASCO14,,@,#,4.72487E+17,https://twitter.com/christinemphmd/status/472487437927583744,,,
kbnewport,5/30/2014 17:19,0,0,Value in cancer care includes patient AND physician satisfaction # ASCO14,,,#,4.72487E+17,https://twitter.com/kbnewport/status/472487374111670272,,,,
ChapinMD,5/30/2014 17:18,3,1,3 words that define Gen Xers. So you agree with my wife. # ASCO14 pic.twitter.com/U5qOAaWqIb,,,#,4.72487E+17,https://twitter.com/ChapinMD/status/472487239055048705,,,,
BethMHovey,5/30/2014 17:18,1,1,Next big advancement for melanoma and NSCLC patients: checkpoint inhibitors. # ASCO14,,,#,4.72487E+17,https://twitter.com/BethMHovey/status/472487224802807810,,,,
StaceyDiNuzzo,5/30/2014 17:18,0,0,Dr. Hawkins to present new therapy for common childhood # cancer that has fewer side effects @ ASCO http://bit.ly/1jBJvR1 @ seattlechildren,,@ @,#,4.72487E+17,https://twitter.com/StaceyDiNuzzo/status/472487208675340288,,,,
davidgrahammd,5/30/2014 17:17,4,1,iPlanner app just reminded me that the next session I wanted to see starts in 15 minutes. You should be use this to better survive # ASCO14,,,#,4.72487E+17,https://twitter.com/davidgrahammd/status/472487041914400769,,,,
amedinacol,5/30/2014 17:17,0,0,"Over 50, colonoscopy can save your life. # Delawareexperencience # ASCO14",,,# #,4.72487E+17,https://twitter.com/amedinacol/status/472487038571515904,,,,
christinemphmd,5/30/2014 17:16,0,0,@ MedscapeStudent @CWiebeMedStdnt I'll be live tweeting from # ASCO14!,,@ @CWiebeMedStdnt,#,4.72487E+17,https://twitter.com/christinemphmd/status/472486831783571456,,,,
Mills_I,5/30/2014 17:16,1,1,"Clinical research in all subtypes of # lungcancer will depend -increasingly- on complex genomic information.""Dr Rudin # ASCO14 # lcsm""",,,# # #,4.72487E+17,https://twitter.com/Mills_I/status/472486684052172801,,,,
carisls,5/30/2014 17:15,1,1,Caris's # ASCO14 schedule of tumor profiling studies is now available online http://goo.gl/5EZMnR # MolecularIntel,,,# #,4.72486E+17,https://twitter.com/carisls/status/472486456200818688,,,,
mtmdphd,5/30/2014 17:15,1,1,Asking the Right Question at # ASCO14: What Are You Hoping For? - @ FischMD # ASCOConnection http://ow.ly/xshs7,,@,# #,4.72486E+17,https://twitter.com/mtmdphd/status/472486452324859905,,,,
ASCO,5/30/2014 17:15,4,4,Read Educational Book articles on topics in Cancer Prevention/Epidemiology from # ASCO14 speakers: http://bit.ly/1kHXtW1,,,#,4.72486E+17,https://twitter.com/ASCO/status/472486422243733505,,,,
AlpineBV_Miller,5/30/2014 17:14,1,1,The concept of how USA consumers bear more than their fair share of R&D in >140 char. (from 2010) http://ow.ly/3laNXj # ASCO14,,,#,4.72486E+17,https://twitter.com/AlpineBV_Miller/status/472486338856751104,,,,
KUhlendorf,5/30/2014 17:14,3,1,"In considering value of # cancer care, # patient-centeredness is key - @ BIDMChealth's Schnipper at # ASCO14",,@,# # #,4.72486E+17,https://twitter.com/KUhlendorf/status/472486234611150848,,,,
CUCancerCenter,5/30/2014 17:14,2,1,Dr. Christopher Lieu at poster presentation # ASCO14 # coloncancer anti-EGFR antibodies http://bit.ly/1gK1Kcd pic.twitter.com/HyufRfeg7N,,,# #,4.72486E+17,https://twitter.com/CUCancerCenter/status/472486133750693888,,,,
drol007,5/30/2014 17:13,0,1,And for when # asco14 goes too genome focused I have the # Bridge & # Borgen replacement - # Mammon - 6 hours Nordic Noirpic.twitter.com/SRkfMqAFeu,,,# # # #,4.72486E+17,https://twitter.com/drol007/status/472485902082928640,,,,
drugwonks,5/30/2014 17:13,14,23,New # cancer therapies account for less than 1% of money spent on healthcare. # ASCO14 # MLIWI http://buff.ly/1nANBkO,,,# # #,4.72486E+17,https://twitter.com/drugwonks/status/472485872873766912,,,,
yzafar,5/30/2014 17:12,0,0,From # ASCO14 value session: Schnipper: What degree of benefit and quality do we get for healthcare dollar we expend? MT @ EMcCallister01,,@,#,4.72486E+17,https://twitter.com/yzafar/status/472485784894078976,,,,
Cortellis,5/30/2014 17:11,1,0,First-in-human study of SAR650984 shows a manageable safety profile as a novel approach in multiple myeloma patients # ASCO14,,,#,4.72486E+17,https://twitter.com/Cortellis/status/472485594258362368,,,,
PinkSheetMaryJo,5/30/2014 17:11,0,0,"W. smaller, defined populations, need to move from traditional Ph3 trials to new ways to rapidly gather evidence, Meropol tells # ASCO14",,,#,4.72486E+17,https://twitter.com/PinkSheetMaryJo/status/472485588424065024,,,,
AlpineBV_Miller,5/30/2014 17:11,7,1,"Drug cost=mfg+R&D+R&D failures+R&D future+profit. When EU govs negotiate for less, companies make it up"" in US. # ASCO14""",,,#,4.72485E+17,https://twitter.com/AlpineBV_Miller/status/472485499798831104,,,,
aftimosp,5/30/2014 17:11,0,0,# ASCO14 wifi in the bus shuttles to Mc Cormick place,,,#,4.72485E+17,https://twitter.com/aftimosp/status/472485430038761472,,,,
EMcCallister01,5/30/2014 17:10,1,0,BIDMC's Schnipper: What degree of benefit and quality do we get for healthcare dollar we expend? # ASCO14,,,#,4.72485E+17,https://twitter.com/EMcCallister01/status/472485256381997056,,,,
m_e_nielsen,5/30/2014 17:10,0,0,@ chrisfilson great question--I'm not directly inv w study (& not at # asco14 for present'n--can ask Milowsky when back home) @ B_C_A_N,,@ @,#,4.72485E+17,https://twitter.com/m_e_nielsen/status/472485193698521088,,,,
MedscapeUrology,5/30/2014 17:09,0,1,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeUrology/status/472485044884213761,,,,
MedscapeSurgery,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeSurgery/status/472485044867461120,,,,
MedscapePharm,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapePharm/status/472485044796149760,,,,
MedscapePath,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapePath/status/472485044766785536,,,,
MedscapeObGyn,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeObGyn/status/472485044674494464,,,,
MedscapeKidney,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeKidney/status/472485044569640960,,,,
MedscapeGastro,5/30/2014 17:09,0,2,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeGastro/status/472485044468998144,,,,
MedscapeOnc,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeOnc/status/472485044318007296,,,,
MedscapeNurses,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeNurses/status/472485044276060160,,,,
MedscapeStudent,5/30/2014 17:09,0,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/MedscapeStudent/status/472485043554631680,,,,
Medscape,5/30/2014 17:09,1,0,# ASCO2014 Halt the presses: Zosia Chustecka of Medscape Medical News is live blogging from meeting. She's loving it! http://bit.ly/1rqqSJz,,,#,4.72485E+17,https://twitter.com/Medscape/status/472485043516878848,,,,
KUhlendorf,5/30/2014 17:09,1,0,". @ BIDMChealth's Schnipper on value: focus on cost alone demeans"" collective goal of improving patient care # ASCO2014""",,@,#,4.72485E+17,https://twitter.com/KUhlendorf/status/472484958456406016,,,,
hmhyltonpac,5/30/2014 17:09,2,1,Dr. Lowell Schnipper at # ASCO14 : Cancer costs are rising 15-18% per year,,,#,4.72485E+17,https://twitter.com/hmhyltonpac/status/472484951561355264,,,,
PinkSheetMaryJo,5/30/2014 17:09,10,3,"Oncologists should not be gatekeepers on cost, but should be on value - Neal Meropol introducing key theme for # ASCO14",,,#,4.72485E+17,https://twitter.com/PinkSheetMaryJo/status/472484947505475584,,,,
drol007,5/30/2014 17:09,1,1,Friday @ ASCO # ASCO14 - good to see focus on quality of life in oncology http://www.medscape.com/viewarticle/825956?src=soc_stm_edit …,,@,#,4.72485E+17,https://twitter.com/drol007/status/472484930103287809,,,,
CUCancerCenter,5/30/2014 17:08,4,1,Dr. Colin Weekes at poster presentation # ASCO14 similar antigen in # ovariancancer and # pancreaticcancerpic.twitter.com/1ajWV2bDpj,,,# # #,4.72485E+17,https://twitter.com/CUCancerCenter/status/472484746522406913,,,,
scientre,5/30/2014 17:08,1,0,MT @ AlpineBV_Miller Orphanization of Drug Devlpmt (my term) will inc costs as all tx become orphans via molecular differentiation # ASCO14,,@,#,4.72485E+17,https://twitter.com/scientre/status/472484736511012865,,,,
EBOncology,5/30/2014 17:07,0,0,"The stakeholders need to work together to find solutions to drive policy and achieve reform- Neal Meropol, Case Western # ASCO14",,,#,4.72484E+17,https://twitter.com/EBOncology/status/472484384780853248,,,,
juicepharma,5/30/2014 17:07,1,1,"We're live at ASCO '14, which is focused on how far the field has come since its first gathering 50 years ago # ASCO14 pic.twitter.com/xQrmzlJCwx",,,#,4.72484E+17,https://twitter.com/juicepharma/status/472484357232283648,,,,
myPathMelanoma,5/30/2014 17:07,0,0,Questions about Myriad myPath # Melanoma? Visit booth 2039 for answers! Sign up to receive email updates TODAY http://bit.ly/myPathinfo # ASCO14,,,# #,4.72484E+17,https://twitter.com/myPathMelanoma/status/472484344863281152,,,,
EMcCallister01,5/30/2014 17:06,1,0,Meropol There will be more drugs with potentially great outcomes for patients need to be sure developing drugs of high value. # ASCO14,,,#,4.72484E+17,https://twitter.com/EMcCallister01/status/472484214454374400,,,,
AlpineBV_Miller,5/30/2014 17:06,0,1,"It's nonsense to believe oncologists can be gatekeepers based on value"" w/o being gatekeepers on cost. Sorry"," @ ASCO # ASCO14""",,@,#,4.72484E+17,https://twitter.com/AlpineBV_Miller/status/472484181751386112,,,
TGeorgeMD,5/30/2014 17:06,1,0,Congrats Dr. Michael Levy for the inaugural # ASCO14 Excellence in Teaching Award; Dr. Swain noting his impact on palliative care edu,,,#,4.72484E+17,https://twitter.com/TGeorgeMD/status/472484172410679296,,,,
scientre,5/30/2014 17:06,1,0,"Meropol: at point of care, oncologists can't be gatekeepers on cost but can be POC gatekeepers on value # ASCO14",,,#,4.72484E+17,https://twitter.com/scientre/status/472484162918944770,,,,
sciberomics,5/30/2014 17:06,0,0,And affordability! RT @Matt_SCRI_UK: Another challenge of genomics is how to get easy widespread access to molecular testing... # ASCO14,,@Matt_SCRI_UK,#,4.72484E+17,https://twitter.com/sciberomics/status/472484135437492224,,,,
nick_faris,5/30/2014 17:05,0,0,"Stakeholder perspectives on value in cancer care"" at # ASCO14 is fantastic already. Great and worthy discussion!""",,,#,4.72484E+17,https://twitter.com/nick_faris/status/472484085852430336,,,,
Melanoma_doctor,5/30/2014 17:05,1,0,Arrived in Chicago for # ASCO14! First # melanoma sessions on Saturday. Also attending # immunotherapy sessions on # DevelopmentalTherapeutics,,,# # # #,4.72484E+17,https://twitter.com/Melanoma_doctor/status/472484061819060224,,,,
genentech,5/30/2014 17:05,0,0,Indeed: http://ow.ly/xshMV MT @ jacobepvantage: Cancer immunotherapy - not all that new a concept-Dr Fong # ASCO14,,@,#,4.72484E+17,https://twitter.com/genentech/status/472483851760332800,,,,
sciberomics,5/30/2014 17:04,0,0,1+ MT @ Awesomics: Spotlight on # Immunotherapy at # ASCO14 http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews … via @ NatureNews @ heidiledford # Cancerpic.twitter.com/fISukcNXdt,,@ @ @,# # #,4.72484E+17,https://twitter.com/sciberomics/status/472483769115353088,,,,
brendanweiss,5/30/2014 17:04,0,1,I am taking a deep breath as I am about to hear how to educate # millennials in medicine # ASCO14,,,# #,4.72484E+17,https://twitter.com/brendanweiss/status/472483742876196865,,,,
MaurerStats,5/30/2014 17:04,0,0,MT @ mtmdphd R2CHOP DLBCL data w/ @ GregNowakowski Sat 5/31 - 2:03-2:15p E Arie Crown Theater # lymsm # ASCO14 @MayoClinicLymph,,@ @ @MayoClinicLymph,# #,4.72484E+17,https://twitter.com/MaurerStats/status/472483626014089216,,,,
DrR_DUNNE,5/30/2014 17:04,0,0,Dr. Venook argues that colonoscopy and screening better tool than any chemo-immunotherapy we have for CRC # ASCO14,,,#,4.72484E+17,https://twitter.com/DrR_DUNNE/status/472483606804193280,,,,
AlpineBV_Miller,5/30/2014 17:03,5,8,Orphanization of Drug Development (my term) will drive costs higher as all drug become orphans via molecular differentiation # ASCO14,,,#,4.72484E+17,https://twitter.com/AlpineBV_Miller/status/472483569353654273,,,,
CancerFrontline,5/30/2014 17:03,0,0,@ DrBobGoldberg Is that a presentation at # ASCO14 today?,,@,#,4.72484E+17,https://twitter.com/CancerFrontline/status/472483515607416832,,,,
Awesomics,5/30/2014 17:03,0,1,Spotlight on # Immunotherapy at # ASCO14 in Chicago http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews … via @ NatureNews @ heidiledford # Cancerpic.twitter.com/jhMx6um9mH,,@ @,# # #,4.72483E+17,https://twitter.com/Awesomics/status/472483349324247040,,,,
MedscapeUrology,5/30/2014 17:02,0,1,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeUrology/status/472483327157358592,,,,
MedscapePath,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapePath/status/472483327111213056,,,,
MedscapeSurgery,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeSurgery/status/472483327086059520,,,,
MedscapeObGyn,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeObGyn/status/472483326964416512,,,,
MedscapeKidney,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeKidney/status/472483326909894656,,,,
MedscapeGastro,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeGastro/status/472483326867951616,,,,
MedscapeOnc,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeOnc/status/472483326612099072,,,,
MedscapeNurses,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeNurses/status/472483326507249664,,,,
MedscapeStudent,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapeStudent/status/472483326423351297,,,,
MedscapePharm,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/MedscapePharm/status/472483326410764288,,,,
Medscape,5/30/2014 17:02,0,0,# ASCO2014 First cup!!!--start your day with the daily ASCO preview article from Medscape; missed Friday? here it is: http://bit.ly/1tXKp1Z,,,#,4.72483E+17,https://twitter.com/Medscape/status/472483325773225984,,,,
scientre,5/30/2014 17:02,0,0,"Meropol: chart of oral cancer drug spend over last ~decade: from ~$2.5B to ~$5.5B. Remember co-pays, deductible means pts impacted # ASCO14",,,#,4.72483E+17,https://twitter.com/scientre/status/472483233935151106,,,,
AlpineBV_Miller,5/30/2014 17:02,0,0,Out of pocket costs for imatinib is 50% higher in 2011 than in 2002. # ASCO14,,,#,4.72483E+17,https://twitter.com/AlpineBV_Miller/status/472483230525194240,,,,
Immutep,5/30/2014 17:02,1,0,We are excited to be here at @ ASCO # ASCO14 !,,@,#,4.72483E+17,https://twitter.com/Immutep/status/472483168176857088,,,,
practiceupdate,5/30/2014 17:01,1,1,"We're at # ASCO14! Come visit the PracticeUpdate booth, 21113, before heading out.",,,#,4.72483E+17,https://twitter.com/practiceupdate/status/472483014132641793,,,,
ASCO,5/30/2014 17:01,6,2,Attended the # ASCO14 Genomic Profiling session? Explore clinical trials in the genomic age: http://bit.ly/QO8I3x via # ASCOConnection,,,# #,4.72483E+17,https://twitter.com/ASCO/status/472483006876487680,,,,
Cortellis,5/30/2014 17:01,2,0,Phase I study of ABT-199 in patients with NHL demonstrates an acceptable safety profile and an overall response rate of 48% # ASCO14,,,#,4.72483E+17,https://twitter.com/Cortellis/status/472482952664719362,,,,
ASCO,5/30/2014 17:01,8,2,Our congratulations to Michael H Levy MD on his # ASCO14 Excellence in Teaching Award CC @ FoxChaseCancer,,@,#,4.72483E+17,https://twitter.com/ASCO/status/472482920742289408,,,,
genentech,5/30/2014 17:01,3,2,Sometimes only 1 # lungcancer biopsy is possible. Why this matters for new treatment options: http://ow.ly/xr21R # ASCO14 # lcsm,,,# # #,4.72483E+17,https://twitter.com/genentech/status/472482879646482432,,,,
ASCO,5/30/2014 17:01,5,1,Educational Book articles on topics in Breast Cancer from # ASCO14 Education Session Speakers: http://bit.ly/1jqCCSH,,,#,4.72483E+17,https://twitter.com/ASCO/status/472482875640934400,,,,
YNHH,5/30/2014 17:01,3,4,Attending # ASCO14 This Weekend? Visit # Smilow Cancer Hospital Booth #13118 http://bit.ly/U1tNdr @ yalecancer # YNHHpic.twitter.com/mu2rINN8Zl,,@,# # #13118 #,4.72483E+17,https://twitter.com/YNHH/status/472482873778651136,,,,
AlpineBV_Miller,5/30/2014 17:00,15,6,"Oncology drugs are now top of all classes of all drugs by spending, but drug spending is still <5% of healthcare spending. # ASCO14",,,#,4.72483E+17,https://twitter.com/AlpineBV_Miller/status/472482760998019072,,,,
MatthewHSimmons,5/30/2014 17:00,0,1,Another challenge of genomics is how to get easy widespread access to molecular testing... # ASCO14,,,#,4.72483E+17,https://twitter.com/MatthewHSimmons/status/472482682106945536,,,,
MedscapeOnc,5/30/2014 17:00,0,0,Attending # ASCO14 tomorrow? Stop by booth #14153 to chat with us and grab a cup of coffee.,,,# #14153,4.72483E+17,https://twitter.com/MedscapeOnc/status/472482602062868480,,,,
Medscape,5/30/2014 17:00,0,0,Attending # ASCO14 tomorrow? Stop by booth #14153 to chat with us and grab a cup of coffee.,,,# #14153,4.72483E+17,https://twitter.com/Medscape/status/472482595620417537,,,,
DanaFarber,5/30/2014 17:00,4,8,New data shows continued long-term effectiveness of immunotherapy in advanced melanoma: http://bit.ly/1k7SE9Q # ASCO14 # melsm,,,# #,4.72483E+17,https://twitter.com/DanaFarber/status/472482588272390144,,,,
KUhlendorf,5/30/2014 16:59,1,0,". @ UHhospitals’ Neal Meropol: our health system - including high OOP costs - is unsustainable, threatens access to high-quality care # ASCO14",,@,#,4.72482E+17,https://twitter.com/KUhlendorf/status/472482424329621504,,,,
PDRennert,5/30/2014 16:59,0,1,Wow airport is crazy. No cabs. Now huge traffic. Can't learn much oncology this way # asco14 so I worked on an # MS piece instead!,,,# #,4.72482E+17,https://twitter.com/PDRennert/status/472482342464786432,,,,
DrBobGoldberg,5/30/2014 16:58,0,0,Why care about cancer costs. Claim cancer costs skyrocketing...in fact projected to decline # ASCO14,,,#,4.72482E+17,https://twitter.com/DrBobGoldberg/status/472482215444500481,,,,
Mykalt45,5/30/2014 16:58,0,0,"If people really look at the data, I think $ KPTI will be appreciated more. They are being smart about their compound. # ASCO14",,,#,4.72482E+17,https://twitter.com/Mykalt45/status/472482174718205954,,,,
dandunlop,5/30/2014 16:58,1,1,MT @TT_MDAnderson: Just touched down in Chicago for # ASCO14 Join us @the @ MDAndersonNews booth & hear abt the talks by our faculty this wk!,,@TT_MDAnderson @the @,#,4.72482E+17,https://twitter.com/dandunlop/status/472482164295368704,,,,
dmooneymd,5/30/2014 16:58,0,0,Expensive genomic testing: how can we offer equal access or free access to all patients? Cost effective? Effective at all? # ASCO14 # bcsm,,,# #,4.72482E+17,https://twitter.com/dmooneymd/status/472482094086508544,,,,
XinHu0129,5/30/2014 16:58,0,0,The 2014 MDigitalLIfe Social Oncology Project Report by @ w2ogroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report?ref=http://mdigitallife.com/socialoncology/ … via @ SlideShare,,@ @,# #,4.72482E+17,https://twitter.com/XinHu0129/status/472482091007889408,,,,
davidgrahammd,5/30/2014 16:57,0,0,That time you think the program is fried because you refresh your # ASCO14 feed and there are no new tweets # hcsm,,,# #,4.72482E+17,https://twitter.com/davidgrahammd/status/472482031331717120,,,,
Jehennessy3,5/30/2014 16:57,0,1,# ASCO14 the end is apparently near... pic.twitter.com/Wj8OCG2umX,,,#,4.72482E+17,https://twitter.com/Jehennessy3/status/472481937135640577,,,,
hmhyltonpac,5/30/2014 16:57,0,0,"Sobering statistic: US spends 18% GDP on healthcare, and cost-sharing trends show no evidence of plateauing per Dr. Meropol at # ASCO14",,,#,4.72482E+17,https://twitter.com/hmhyltonpac/status/472481918370709504,,,,
mtmdphd,5/30/2014 16:57,0,0,"@AltosSolutions Great. Rec use # ASCO14 for people to see"" your tweets in filters/searches""",,@AltosSolutions,#,4.72482E+17,https://twitter.com/mtmdphd/status/472481853320867840,,,,
MedscapeObGyn,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeObGyn/status/472481842491174912,,,,
MedscapeUrology,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeUrology/status/472481842164011008,,,,
MedscapeSurgery,5/30/2014 16:57,0,1,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeSurgery/status/472481842113703936,,,,
MedscapePharm,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapePharm/status/472481842042400768,,,,
MedscapePath,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapePath/status/472481841937518593,,,,
MedscapeKidney,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeKidney/status/472481841778139136,,,,
MedscapeGastro,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeGastro/status/472481841681674240,,,,
MedscapeOnc,5/30/2014 16:57,1,1,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeOnc/status/472481841551646720,,,,
MedscapeNurses,5/30/2014 16:57,0,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeNurses/status/472481841471975425,,,,
MedscapeStudent,5/30/2014 16:57,1,1,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/MedscapeStudent/status/472481841312571392,,,,
Medscape,5/30/2014 16:57,2,0,"# ASCO2014 Multiple docs say study is practice changing"": as drug preserves fertility during chemo http://bit.ly/1tXJ7ny""",,,#,4.72482E+17,https://twitter.com/Medscape/status/472481841279025152,,,,
corimckeever,5/30/2014 16:56,0,0,Hello friend. It literally feels like just yesterday. # ASCO14 pic.twitter.com/DkuhYgmqYj,,,#,4.72482E+17,https://twitter.com/corimckeever/status/472481743572725760,,,,
Mykalt45,5/30/2014 16:56,1,0,If they catch enough attention I think $ KPTI will gets some nice love at # ASCO14. In the right background KPT-330 is potent.,,,#,4.72482E+17,https://twitter.com/Mykalt45/status/472481742197387265,,,,
Emory_R,5/30/2014 16:56,2,6,Track the stocks of the 40+ public companies presenting at # ASCO14 http://buff.ly/1mAbofs,,,#,4.72482E+17,https://twitter.com/Emory_R/status/472481594058764289,,,,
OphiraG,5/30/2014 16:55,0,0,Dr Olopade -epitome of gr8 leadership in global cancer control @ ASCO @ AORTIC_AFRICA @ NCIGlobalHealthpic.twitter.com/umgI1thH1J,,@ @ @,,4.72482E+17,https://twitter.com/OphiraG/status/472481540958470145,,,,
ConsanoScott,5/30/2014 16:55,0,3,Team @ consano has arrived! Come visit us and meet @ ConsanoMolly in the patient advocate section tomorrow! # asco14 pic.twitter.com/9GneIqo08A,,@ @,#,4.72482E+17,https://twitter.com/ConsanoScott/status/472481530724769793,,,,
dmooneymd,5/30/2014 16:55,2,0,Personalized medicine: validate concept that high throughput genomics leading to targeted tx improves outcome over standardized arm. # ASCO14,,,#,4.72481E+17,https://twitter.com/dmooneymd/status/472481497610321920,,,,
MatthewHSimmons,5/30/2014 16:55,0,0,"Screening of huge numbers of patients to find rare mutations is a going to be the biggest challenge of stratified medicine""... # ASCO14""",,,#,4.72481E+17,https://twitter.com/MatthewHSimmons/status/472481493806481408,,,,
jamesian,5/30/2014 16:55,0,0,"# seattle # cancer doc MT @ jrgralow With Gertrude Nakagudde, breast cancer advocate from Uganda at # ASCO14. pic.twitter.com/r9obcF00BK",,@,# # #,4.72481E+17,https://twitter.com/jamesian/status/472481486457671681,,,,
ASCO,5/30/2014 16:55,0,0,Want a demo of # CancerLinQ? Please visit the Institute for Quality booth at # ASCO14 http://bit.ly/1kIto90 # ascoaction,,,# # #,4.72481E+17,https://twitter.com/ASCO/status/472481407861006336,,,,
DrAttai,5/30/2014 16:55,1,1,Great session on genomics. A little intimidating how far we have to go # ASCO14 # bcsm,,,# #,4.72481E+17,https://twitter.com/DrAttai/status/472481354006134784,,,,
AlpineBV_Miller,5/30/2014 16:55,0,0,"Will this be the drug value"" lecture that finally mentions the USA consumer bears the brunt of R&D expense worldwide # ASCO14""",,,#,4.72481E+17,https://twitter.com/AlpineBV_Miller/status/472481341955923968,,,,
MediTech_Media,5/30/2014 16:55,0,0,We made it! # ASCO14 looks great! Lots of people learning about new developments in # CancerResearchpic.twitter.com/mBzN5ljS4f,,,# #,4.72481E+17,https://twitter.com/MediTech_Media/status/472481325346467841,,,,
JenPageWall,5/30/2014 16:54,0,0,Castellani says many cancer patients expected to pay up to 40 percent out of pocket for their medicines-unfair to patients @ thehill # ASCO14,,@,#,4.72481E+17,https://twitter.com/JenPageWall/status/472481286926249984,,,,
jagasquet,5/30/2014 16:54,1,0,# ASCO14 Daily news - day 1 http://am.asco.org/daily-news?j=33849372&e=jgasquet@amgen.com&l=18382267_HTML&u=424565360&mid=10297795&jb=0&et_cid=33849372&et_rid=463756385&linkid=ASCO+Daily+News+Home …,,@amgen,#,4.72481E+17,https://twitter.com/jagasquet/status/472481212359913473,,,,
KUhlendorf,5/30/2014 16:54,0,0,# ASCO14 panelists are discussing value in # cancer now. Read 5 facts on value of innovative # cancer meds here: http://onphr.ma/SbIUQd,,,# # #,4.72481E+17,https://twitter.com/KUhlendorf/status/472481156164632576,,,,
Medscape,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/Medscape/status/472481083116638208,,,,
MedscapeUrology,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeUrology/status/472481070852481024,,,,
MedscapeSurgery,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeSurgery/status/472481070823116800,,,,
MedscapePharm,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapePharm/status/472481070705696768,,,,
MedscapePath,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapePath/status/472481070680514561,,,,
MedscapeObGyn,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeObGyn/status/472481070625980416,,,,
MedscapeKidney,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeKidney/status/472481070537916416,,,,
MedscapeGastro,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeGastro/status/472481070428872704,,,,
MedscapeOnc,5/30/2014 16:54,1,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeOnc/status/472481070340788224,,,,
MedscapeNurses,5/30/2014 16:54,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeNurses/status/472481070298828801,,,,
MedscapeStudent,5/30/2014 16:53,0,0,# ASCO2014 Medscape Medical News is in the house -- check out our live blog featuring Dr Brandon Smaglow http://bit.ly/1rqqSJz,,,#,4.72481E+17,https://twitter.com/MedscapeStudent/status/472481069581619200,,,,
dmooneymd,5/30/2014 16:53,2,2,"Challenge of stratified medicine: high screening to find small pop, patient accrual. # ASCO14",,,#,4.72481E+17,https://twitter.com/dmooneymd/status/472481058961649664,,,,
DrBobGoldberg,5/30/2014 16:53,0,1,Comic relief.. Cancer doc lecturing cancer docs on economics # ASCO14,,,#,4.72481E+17,https://twitter.com/DrBobGoldberg/status/472481037461639170,,,,
hmhyltonpac,5/30/2014 16:53,0,0,"Historical protection by insurance is eroding""-well stated by Dr. Neal Meropol at # ASCO14""",,,#,4.72481E+17,https://twitter.com/hmhyltonpac/status/472481033041223682,,,,
nxtstop1,5/30/2014 16:53,0,0,"Time 4 Further Scrutiny~ @ subatomicdoc: Cancer Center Ads Use Emotion, Promise Cure http://www.medscape.com/viewarticle/825701?nlid=58150_2202?src=sttwit … > @ medscape # ASCO14 # hcsm # cancer",,@ @,# # #,4.72481E+17,https://twitter.com/nxtstop1/status/472480861078556672,,,,
dmooneymd,5/30/2014 16:52,0,0,Stratified medicine genomics: fragmenting patients into specific small mutation frequencies. Test whether targeted therapy effective. # ASCO14,,,#,4.72481E+17,https://twitter.com/dmooneymd/status/472480809798995968,,,,
drcbsteer,5/30/2014 16:52,0,0,# ASCO14 Wildes # myeloma # geriatriconcology ...and don't forget supportive care ... eg VZV prophylaxis with proteosome inhibitors,,,# # #,4.72481E+17,https://twitter.com/drcbsteer/status/472480576319258625,,,,
OphiraG,5/30/2014 16:51,4,2,Great summary of interdisciplinary approach 2 # africa # cancer control plan @ AORTIC_AFRICA @ ASCO @ NCIGlobalHealthpic.twitter.com/5PM5rWq7VD,,@ @ @,# #,4.72481E+17,https://twitter.com/OphiraG/status/472480506647310336,,,,
ASH_hematology,5/30/2014 16:50,3,1,RT @ drcbsteer: # ASCO14 # geriatriconcology # lymsm # CLL # myeloma Great to see a full room of people learning about haem malignancies in...,,@,# # # # #,4.7248E+17,https://twitter.com/ASH_hematology/status/472480238371610625,,,,
DrAttai,5/30/2014 16:50,4,2,Can genomics identify immune defects in patients with metastatic breast cancer? # ASCO14 # bcsm,,,# #,4.7248E+17,https://twitter.com/DrAttai/status/472480207694471169,,,,
CanaleComm,5/30/2014 16:50,0,0,Science editor Anette Breindl & writer Randy Osborne are headed to # ASCO14 to deliver top # cancer news. Tune in for live tweets @ BioWorld,,@,# #,4.7248E+17,https://twitter.com/CanaleComm/status/472480167873753088,,,,
JacobPlieth,5/30/2014 16:50,0,0,"Etykieta na ruchomych schodach: stoimy po prawej, idziemy po lewej # ASCO14 @ AlpineBV_Miller",,@,#,4.7248E+17,https://twitter.com/JacobPlieth/status/472480154108067840,,,,
drcbsteer,5/30/2014 16:50,0,0,# ASCO14 Wiles - Duration of therapy in # myeloma? FIRST trial - survival better with continuous LenDex. # geriatriconcology,,,# # #,4.7248E+17,https://twitter.com/drcbsteer/status/472480132104720384,,,,
scientre,5/30/2014 16:49,0,0,WellPoint news this wk Re # asco14 session Can We Find Common Ground? Stakeholder Perspectives on Value in Cancer Care http://m.us.wsj.com/articles/insurer-to-reward-cancer-doctors-for-adhering-to-regimens-1401220033?mobile=y&mg=reno64-wsj …,,,#,4.7248E+17,https://twitter.com/scientre/status/472480046016643072,,,,
EdwardWinstead,5/30/2014 16:49,1,0,"@ MaverickNY Ah, good to see your # ASCO14 tweets, Sally. I'll look for many more. Enjoy.",,@,#,4.7248E+17,https://twitter.com/EdwardWinstead/status/472479995156504576,,,,
MBakerUT,5/30/2014 16:49,0,0,# ASCO14 Wish I were there !!!!!,,,#,4.7248E+17,https://twitter.com/MBakerUT/status/472479828005122048,,,,
JenPageWall,5/30/2014 16:48,0,0,. @ thehill Castellani says cost-containment is built into the system thru medicine lifecycle # ASCO14 http://thehill.com/blogs/congress-blog/healthcare/207738-health-insurance-model-must-evolve …,,@,#,4.7248E+17,https://twitter.com/JenPageWall/status/472479799701942272,,,,
dmooneymd,5/30/2014 16:47,3,0,"Little"" lethal subclones (esr1 in breast ca?) in initial tumor resistant to driver mutation. Ultradeep sequencing needed. # bcsm # ASCO14""",,,# #,4.72479E+17,https://twitter.com/dmooneymd/status/472479494641434624,,,,
CurtMcCormick,5/30/2014 16:47,0,0,# FF: # ASCO14 to learn of some incredible progress and innovation underway in oncology. Great things are going on in this field of medicine!,,,# #,4.72479E+17,https://twitter.com/CurtMcCormick/status/472479430921580544,,,,
DrR_DUNNE,5/30/2014 16:47,1,0,"Dr. Tepper's prediction on XRT in 2064: it will be very different and I have no idea what will be done"" # ASCO14""",,,#,4.72479E+17,https://twitter.com/DrR_DUNNE/status/472479401678872576,,,,
brendanweiss,5/30/2014 16:46,5,1,Wildes of WashU: brief geriatric assessment better than ECOG PS in assessing outcomes in elderly myeloma # ASCO14 # mmsm,,,# #,4.72479E+17,https://twitter.com/brendanweiss/status/472479251552559104,,,,
drcbsteer,5/30/2014 16:46,1,0,# ASCO14 # geriatriconcology Wildes presenting Larocco # myeloma study from # ASH13. Frailty score predicted for toxicity but EGOC PS did not.,,,# # # #,4.72479E+17,https://twitter.com/drcbsteer/status/472479175467876352,,,,
DrZahwa,5/30/2014 16:46,0,0,"RT Pathologists: # pathologists at # ASCO14: share your experience: tag Pathologists, post a photo",,,# #,4.72479E+17,https://twitter.com/DrZahwa/status/472479081720979456,,,,
ASCO,5/30/2014 16:45,1,2,Learning to ask the right questions at # ASCO14: http://bit.ly/1kRFkFx CC @ fischmd # ASCOConnection,,@,# #,4.72479E+17,https://twitter.com/ASCO/status/472478924908548096,,,,
lrn_brk,5/30/2014 16:45,0,0,"# ASCO14 Educational Book article: Progress in Multiple Myeloma by P. Leif Bergsagel, MD http://bit.ly/1oDNmoC",,,#,4.72479E+17,https://twitter.com/lrn_brk/status/472478873343782913,,,,
davidgrahammd,5/30/2014 16:45,0,0,# gusm RT @ m_e_nielsen: Comp.eff GC vs MVAC as neoadj for musc-inv bladder cancer (spoiler alert:equivalent) # asco14 http://ow.ly/xqFzF,,@,# #,4.72479E+17,https://twitter.com/davidgrahammd/status/472478822139703296,,,,
MaverickNY,5/30/2014 16:44,0,0,"@ Teamoncology what's the kanji? RT @ AlpineBV_Miller: # ASCO14 Escalator etiquette. Stand right, walk left. Please share (and translate).",,@ @,#,4.72479E+17,https://twitter.com/MaverickNY/status/472478726580871168,,,,
dmooneymd,5/30/2014 16:44,0,0,Intratumoral heterogeneity: cll data shows high heterogeneity in tumor leads to poor outcome. # ASCO14,,,#,4.72479E+17,https://twitter.com/dmooneymd/status/472478711627800577,,,,
Pharmacyclics,5/30/2014 16:43,1,1,We are pleased to be presenting new IMBRUVICA data at # ASCO14 http://bit.ly/1qPkTh9,,,#,4.72478E+17,https://twitter.com/Pharmacyclics/status/472478355108167680,,,,
nxtstop1,5/30/2014 16:43,0,1,A PRIMER: @ ASCO: Dr. Matthew H. G. Katz: A surgical oncologists experience at # ASCO14 http://bit.ly/1nv1vor ”,,@,#,4.72478E+17,https://twitter.com/nxtstop1/status/472478337680420864,,,,
drseisenberg,5/30/2014 16:43,0,0,RT @ Roche: Chance to survive a year with # lungcancer In the 1980s: 10%. In the late 2000s: Over 50%. http://ow.ly/xkL6m # lcsm # ASCO14,,@,# # #,4.72478E+17,https://twitter.com/drseisenberg/status/472478317887889408,,,,
Continuumhealth,5/30/2014 16:42,0,0,Longest taxi line ever @ ASCO # ASCO2014 pic.twitter.com/WHMTGnBDMA,,@,#,4.72478E+17,https://twitter.com/Continuumhealth/status/472478218642292736,,,,
AlpineBV_Miller,5/30/2014 16:42,1,2,"# ASCO14 Escalator etiquette. Stand right, walk left. Please share (and translate).",,,#,4.72478E+17,https://twitter.com/AlpineBV_Miller/status/472478149780180992,,,,
christinemphmd,5/30/2014 16:42,0,0,"Searching for some inspiration on career choices at my next session,Why I Love the Career I Chose"" @ ElizBlanchardMD # ASCO14 # oncology""",,@,# #,4.72478E+17,https://twitter.com/christinemphmd/status/472478141969993728,,,,
MLIWI,5/30/2014 16:42,0,0,RT @ Genentech: # ASCO14 is an opp for our community to look beyond data & think abt quality of care.” http://buff.ly/1tunmJS,,@,#,4.72478E+17,https://twitter.com/MLIWI/status/472478106847289344,,,,
scientre,5/30/2014 16:41,1,0,Thread inadvertent ex MT @ chimoose What WalterWhite & AngelinaJolie Teach Re Cancer Convo Online http://bit.ly/1oCSM2Z @ brianreid # ASCO14,,@ @,#,4.72478E+17,https://twitter.com/scientre/status/472477965717368832,,,,
DrAttai,5/30/2014 16:41,1,0,MANY questions to be answered. Research matters. # ASCO14 # bcsm,,,# #,4.72478E+17,https://twitter.com/DrAttai/status/472477872381521920,,,,
dmooneymd,5/30/2014 16:41,4,1,"Implications of coexisting mutations...could be associated with resistance to targeting driver"" mutation. # bcsm # ASCO14""",,,# #,4.72478E+17,https://twitter.com/dmooneymd/status/472477838323355649,,,,
Britticares,5/30/2014 16:41,0,0,"RT @ CancerDotNet: Just released! Today's # ASCO14 cancer research highlights, on short- & long-term side effects # bcsmhttp://bit.ly/1hjxkOD",,@,# #,4.72478E+17,https://twitter.com/Britticares/status/472477832929497089,,,,
drcbsteer,5/30/2014 16:40,0,0,# ASCO14 # geriatriconcology # lymsm # CLL # myeloma Great to see a full room of people learning about haem malignancies in olde adults,,,# # # # #,4.72478E+17,https://twitter.com/drcbsteer/status/472477677371523072,,,,
dhjutsw1,5/30/2014 16:40,0,0,Sorafenib Shows Benefit in Refractory Differentiated Thyroid Cancer | # ASCO14 Virtual Meeting is terrific! http://am.asco.org/sorafenib-shows-benefit-refractory-differentiated-thyroid-cancer#.U4jr73p-R5g.twitter …,,,# #,4.72478E+17,https://twitter.com/dhjutsw1/status/472477632836030466,,,,
DrAttai,5/30/2014 16:40,0,0,Is the driver the single mutation or are there co-existing mutations? # ASCO14 # bcsm,,,# #,4.72478E+17,https://twitter.com/DrAttai/status/472477606059978752,,,,
subatomicdoc,5/30/2014 16:39,1,1,"Cancer Center Ads Use Emotion, Promise Cure http://www.medscape.com/viewarticle/825701?nlid=58150_2202?src=sttwit … > @ medscape # ASCO14 # hcsm",,@,# #,4.72478E+17,https://twitter.com/subatomicdoc/status/472477520864878592,,,,
MyelomaTeacher,5/30/2014 16:39,0,0,“ @ drseisenberg: # PatientAdvocacy groups are a critical component of the fight http://www.accc-cancer.org/cancer_care/patients/Advocacy.asp … # cancer # ASCO14”,,@,# # #,4.72478E+17,https://twitter.com/MyelomaTeacher/status/472477507909066752,,,,
drseisenberg,5/30/2014 16:39,0,0,"RT @ lrn_brk # ASCO14 Educational Book article: Progress in Multiple Myeloma by P. Leif Bergsagel, MD http://bit.ly/1o81brz",,@,#,4.72478E+17,https://twitter.com/drseisenberg/status/472477507422126080,,,,
DrAttai,5/30/2014 16:39,0,0,"How to better identify the tumor driver, actionable mutation in each single patient? # ASCO14 # bcsm",,,# #,4.72477E+17,https://twitter.com/DrAttai/status/472477434034790401,,,,
ipaulmampilly,5/30/2014 16:39,0,0,# ASCO14 traffic pic.twitter.com/Stm74XD7lP,,,#,4.72477E+17,https://twitter.com/ipaulmampilly/status/472477411989544961,,,,
dmooneymd,5/30/2014 16:39,6,1,"Oncogenic driver: can we identify? 10-20 actionable drivers, most are <10% of patients, clinical results suboptimal for now. # bcsm # ASCO14",,,# #,4.72477E+17,https://twitter.com/dmooneymd/status/472477363016445952,,,,
DrFloresAyala,5/30/2014 16:38,0,0," @ slibutti: On my way to # ASCO2014 looking forward to a great meeting"" // # Success""",,@,# #,4.72477E+17,https://twitter.com/DrFloresAyala/status/472477203217670144,,,,
AnjeeDavis,5/30/2014 16:38,2,1,I am ready for the super bowel for oncology. # ASCO14 @ FightCRC stay tuned this year I am taking a before and after pic.,,@,#,4.72477E+17,https://twitter.com/AnjeeDavis/status/472477199959064576,,,,
MyelomaTeacher,5/30/2014 16:38,1,0,“ @ tmlfox: The conversation is unfolding nicely at # ASCO14. Network Centrality Graph via @ symplur pic.twitter.com/judZm2EBfI”,,@ @,#,4.72477E+17,https://twitter.com/MyelomaTeacher/status/472477169961418753,,,,
lrn_brk,5/30/2014 16:38,0,0,"# ASCO14 Educational Book article: 50 Years of Systemic Therapy for Breast Cancer by Harold J. Burstein, MD, PhD http://bit.ly/SkE3fl",,,#,4.72477E+17,https://twitter.com/lrn_brk/status/472477111383785472,,,,
alantanmd,5/30/2014 16:38,95,50,Poll this year = 50% oncologists have ordered next generation sequencing for their patients. # ASCO14 pic.twitter.com/PoDVI8gP0J,,,#,4.72477E+17,https://twitter.com/alantanmd/status/472477067314221056,,,,
DrAttai,5/30/2014 16:37,0,2,Goal is to understand the biology of each single patient # ASCO14 # bcsm,,,# #,4.72477E+17,https://twitter.com/DrAttai/status/472476893749710848,,,,
BiostatGirl,5/30/2014 16:37,0,0,Can the weather be any nicer today?! # chicago # asco2014 # asco14 http://instagram.com/p/oondROgzON/,,,# # #,4.72477E+17,https://twitter.com/BiostatGirl/status/472476845049249793,,,,
CancerFrontline,5/30/2014 16:36,2,0,Women with metastatic # breast cancer can safely receive bisphosphonates less frequently: http://www.mdanderson.org/newsroom/news-releases/2014/women-with-metastatic-breast-cancer-can-safely-receive-bisphosphonates.html#.U4jrnLZt69s.twitter … # ASCO14 # endcancer,,,# # # #,4.72477E+17,https://twitter.com/CancerFrontline/status/472476634046418944,,,,
DrAttai,5/30/2014 16:36,1,0,Last talk of session - new horizons in genomics for breast cancer patients # ASCO14 # bcsm,,,# #,4.72477E+17,https://twitter.com/DrAttai/status/472476586269499393,,,,
AnjeeDavis,5/30/2014 16:35,0,0,@ MaverickNY hope I see you at # ASCO14,,@,#,4.72476E+17,https://twitter.com/AnjeeDavis/status/472476484977037312,,,,
slibutti,5/30/2014 16:35,0,0,On my way to # ASCO2014 looking forward to a great meeting,,,#,4.72476E+17,https://twitter.com/slibutti/status/472476477632827392,,,,
DrAttai,5/30/2014 16:35,4,1,"Currently available genomic platforms have some clinical utility, but don't have answers for all pts. Not sure which is best # ASCO14 # bcsm",,,# #,4.72476E+17,https://twitter.com/DrAttai/status/472476454937444353,,,,
medbiomarketing,5/30/2014 16:35,0,0,"RT @ cityofhope New drug may reverse # LungCancer's chemo resistance, according to @ ASCO study by @ KarenReckampMD http://ow.ly/xscLx",,@ @ @,#,4.72476E+17,https://twitter.com/medbiomarketing/status/472476305167245312,,,,
drcbsteer,5/30/2014 16:34,0,0,# ASCO14 # geriatriconcology CLL Goede - TUG test predictive of OS older patients but early data and confirmation needed.,,,# #,4.72476E+17,https://twitter.com/drcbsteer/status/472476142373699584,,,,
Join_ImIn,5/30/2014 16:34,0,0,Be sure to follow @ ASCO and # ASCO14 for all things oncology.,,@,#,4.72476E+17,https://twitter.com/Join_ImIn/status/472476121280565248,,,,
CancerFrontline,5/30/2014 16:33,0,0,"Old cancer drug, IL-2, gets fresh look http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296 … # ASCO14 # endcancer",,,# #,4.72476E+17,https://twitter.com/CancerFrontline/status/472475859886956544,,,,
drcbsteer,5/30/2014 16:32,0,0,# ASCO14 # geriatriconcology Goede CLL CIRS score used in eligibility criteria in trials. Not useful in predicting toxicity.,,,# #,4.72476E+17,https://twitter.com/drcbsteer/status/472475712503689216,,,,
OphiraG,5/30/2014 16:32,0,0,@ AORTIC_AFRICA North America reception @ ASCO Chicago- learning from hands-on # cancer care providers throughout # africa !,,@ @,# #,4.72476E+17,https://twitter.com/OphiraG/status/472475544916066304,,,,
LillyPad,5/30/2014 16:31,5,0,. @ ASCO projects costs of cancer care will reach $173 billion by 2020. How do we cut costs? http://ow.ly/xsdWg # ASCO14,,@,#,4.72476E+17,https://twitter.com/LillyPad/status/472475523185385472,,,,
drcbsteer,5/30/2014 16:31,0,0,# ASCO14 CLL Goede - Clinical judgement still standard in deciding treatment options as no evidence for CGA tools yet.,,,#,4.72475E+17,https://twitter.com/drcbsteer/status/472475470869852160,,,,
ASCO,5/30/2014 16:30,5,1,New at # ASCO14: ASCO Book Club explores the human experience of illness http://bit.ly/1ju7KQY,,,#,4.72475E+17,https://twitter.com/ASCO/status/472475252170457088,,,,
DrAttai,5/30/2014 16:30,9,6,"expecting results of randomized genomic trials: TAILORx (node-) Responder Trial (node+), MINDACT study (node- and 1-3+) # ASCO14, # bcsm",,,# #,4.72475E+17,https://twitter.com/DrAttai/status/472475249146355712,,,,
m_e_nielsen,5/30/2014 16:30,3,2,Comp.eff of GC vs MVAC as neoadjuvant for muscle-inv bladder cancer (spoiler alert:equivalent) cc @ B_C_A_N # asco14 http://ow.ly/xqFzF,,@,#,4.72475E+17,https://twitter.com/m_e_nielsen/status/472475205164879872,,,,
InterConChicago,5/30/2014 16:30,0,0,. @ ASCO We hope to see those attending # ASCO14 at Eno for a glass of wine to toast the beginning of a great weekend! http://ow.ly/xraQt,,@,#,4.72475E+17,https://twitter.com/InterConChicago/status/472475183929110528,,,,
EMDSerono,5/30/2014 16:30,0,0,Visit us at booth 14087 to learn about our growing focus in immuno-oncology # ASCO14,,,#,4.72475E+17,https://twitter.com/EMDSerono/status/472475073245609986,,,,
Lymphoma_Doc,5/30/2014 16:30,1,1,Chicago in the summer lends itself to taking breaks from the # ASCO14 fire hydrant of exciting data. pic.twitter.com/FSmh1HCyCl,,,#,4.72475E+17,https://twitter.com/Lymphoma_Doc/status/472475069189734403,,,,
ipaulmampilly,5/30/2014 16:30,0,0,# ASCO14 break therapy on Lake Michigan pic.twitter.com/OnKqWkJ639,,,#,4.72475E+17,https://twitter.com/ipaulmampilly/status/472475044879560704,,,,
MMarchioneAP,5/30/2014 16:28,4,1,3 of these kids might not be here if it were not for a study this # breastcancer patient participated in http://tinyurl.com/n7rrb5e # ASCO14,,,# #,4.72475E+17,https://twitter.com/MMarchioneAP/status/472474629530210304,,,,
drcbsteer,5/30/2014 16:27,0,1,CLL # ASCO14 Goede - rituximab monotherapy in older patients is not evidenced-based.,,,#,4.72474E+17,https://twitter.com/drcbsteer/status/472474458436157441,,,,
dmooneymd,5/30/2014 16:27,0,1,"Oncotype dx validated first node negative, then node positive to predict benefit of chemotherapy. Retrospective cohorts. # bcsm # ASCO14",,,# #,4.72474E+17,https://twitter.com/dmooneymd/status/472474390198636544,,,,
lrn_brk,5/30/2014 16:26,0,0,"# ASCO14 Educational Book Article: Management Options for Endocrine Therapy Toxicity by N. Lynn Henry, MD, PhD http://bit.ly/1iAHp4o",,,#,4.72474E+17,https://twitter.com/lrn_brk/status/472474274717265920,,,,
BRCAresponder,5/30/2014 16:26,1,3,# fridayreads @ dianeradfordmd @ barronlerner @ ASCO @ FranMVisco @ womenshealth @ sistersnetwork @ ASBrS # BRCA NEWS is out! https://storify.com/BRCAresponder/5-30-14-brcaresponder-weekly …,,@ @ @ @ @ @ @,# #,4.72474E+17,https://twitter.com/BRCAresponder/status/472474144492113921,,,,
Chiltern_CRO,5/30/2014 16:26,0,0,"# Chiltern would like to wish you a safe and happy weekend. If you are at # ASCO14, come by and meet some great colleagues!",,,# #,4.72474E+17,https://twitter.com/Chiltern_CRO/status/472474034873966592,,,,
brentgendleman,5/30/2014 16:25,0,0,Panorama would show 2000 iPhone users not listening to genomic talk # ASCO14 pic.twitter.com/iu0JlnvF6M,,,#,4.72474E+17,https://twitter.com/brentgendleman/status/472473896072261632,,,,
drdonsdizon,5/30/2014 16:24,1,0,"“ @ jrgralow: With Gertrude Nakagudde, breast cancer patient advocate from Uganda at # ASCO14. pic.twitter.com/rsimsT5GnC” such a great pic",,@,#,4.72474E+17,https://twitter.com/drdonsdizon/status/472473704925265920,,,,
DrAttai,5/30/2014 16:24,2,2,"DIfferent genomic tests: MammaPrint, PAM50, Oncotype Dx # ASCO14 # bcsm Can help predict prognosis, response to therapy, optimal therapy",,,# #,4.72474E+17,https://twitter.com/DrAttai/status/472473653310156800,,,,
KUhlendorf,5/30/2014 16:24,3,0,50 years of # cancer research and progress... and so much more to come. http://Fromhopetocures.org # ASCO14 http://www.fromhopetocures.org/media/Fifty-Years-of-Cancer-Research-and-Counting.pdf …,,,# #,4.72474E+17,https://twitter.com/KUhlendorf/status/472473528584122368,,,,
dmooneymd,5/30/2014 16:23,2,1,Breast cancer index to predict patients who could benefit from extended letrozole adjuvant therapy? Would be very useful. # bcsm # ASCO14,,,# #,4.72473E+17,https://twitter.com/dmooneymd/status/472473316368723968,,,,
myPathMelanoma,5/30/2014 16:23,1,0,Myriad myPath # Melanoma # gene expression score is a valuable part of a comp. case evaluation # melanomadiagnostic # isthismelanoma # ASCO14,,,# # # # #,4.72473E+17,https://twitter.com/myPathMelanoma/status/472473272097832960,,,,
carisls,5/30/2014 16:22,0,0,Molecular profiling of testicular cancer. Poster 1-4p; Pres. 4:30p http://goo.gl/5EZMnR # ASCO14 # MolecularIntel,,,# #,4.72473E+17,https://twitter.com/carisls/status/472473260622610432,,,,
IASLC,5/30/2014 16:22,1,1,Its got that NEW BOOK smell! See it at # ASCO2014 http://ow.ly/i/5KgAk,,,#,4.72473E+17,https://twitter.com/IASLC/status/472473170067587073,,,,
drcbsteer,5/30/2014 16:22,0,0,# ASCO14 Geode - Age alone not predictive of time to first treatment or need for treatment in CLL.,,,#,4.72473E+17,https://twitter.com/drcbsteer/status/472473115717812224,,,,
DoctorEdny,5/30/2014 16:22,0,1,"Woot! @ BioMedTracker: # ASCO14 begins, follow @BMTRobert @BMTEdny for live coverage and @BMTJolene for insight pic.twitter.com/HABLNmWrT7”",,@ @BMTRobert @BMTEdny @BMTJolene,#,4.72473E+17,https://twitter.com/DoctorEdny/status/472473093131481089,,,,
subatomicdoc,5/30/2014 16:22,2,2,Implementing # HPV vaccine to reach young girls in Thailand http://bit.ly/1jrYY6d # ASCO14 # gyncsm # globalhealth,,,# # # #,4.72473E+17,https://twitter.com/subatomicdoc/status/472473042401361920,,,,
carisls,5/30/2014 16:21,1,0,# ASCO14 Comprehensive molecular profiling of # gliomas & potential therapeutic implications. Poster 1-4p; Pres. 4:30p http://goo.gl/5EZMnR,,,# #,4.72473E+17,https://twitter.com/carisls/status/472473016765784065,,,,
drcbsteer,5/30/2014 16:21,0,0,# ASCO14 # geriatriconcology NHL. eIPI score where e=elderly a useful prognostic tool. Elderly = >70.,,,# #,4.72473E+17,https://twitter.com/drcbsteer/status/472472799605702656,,,,
ipaulmampilly,5/30/2014 16:20,0,0,This the 3 biotech drug cocktail...future of cancer medicine # ASCO14 pic.twitter.com/VrcY6LV81k,,,#,4.72473E+17,https://twitter.com/ipaulmampilly/status/472472623973429248,,,,
UHhospitals,5/30/2014 16:20,3,0,"Dr. Neal Meropol recognized as a 2014 @ ASCO fellow during the # ASCO14 Annual Meeting, http://ow.ly/xnWNb",,@,#,4.72473E+17,https://twitter.com/UHhospitals/status/472472576430972928,,,,
Roche,5/30/2014 16:20,14,5,Chance to survive a year with # lungcancer In the 1980s: 10%. In the late 2000s: Over 50%. http://ow.ly/xkL6m # ASCO14 # lcsm,,,# # #,4.72473E+17,https://twitter.com/Roche/status/472472575189475328,,,,
lenstarnes,5/30/2014 16:18,0,1,@ tmlfox Nice work Tom. Conversation unfolding nicely at # ASCO14 Netwk Centrality Graph via @ symplur pic.twitter.com/HzwGGtImi9 4 # ESCcongress ?,,@ @,# #,4.72472E+17,https://twitter.com/lenstarnes/status/472472246691586049,,,,
KUhlendorf,5/30/2014 16:18,0,0,"# Cancer death rates have fallen 20% since ’91 thanks to prevention, detection, treatment advances # ASCO14 http://onphr.ma/SbIUQd",,,# #,4.72472E+17,https://twitter.com/KUhlendorf/status/472472237652860928,,,,
ipaulmampilly,5/30/2014 16:18,0,0,# ASCO14 lots of interest for TG Therapeutics poster phase 1 trial for P13l inhibitor pic.twitter.com/0IDLR4Hv4E,,,#,4.72472E+17,https://twitter.com/ipaulmampilly/status/472472165288538113,,,,
Lymphoma_Doc,5/30/2014 16:18,3,1,Huge crowds at lymphoma and developmental therapeutics highlighted poster sessions # ASCO14,,,#,4.72472E+17,https://twitter.com/Lymphoma_Doc/status/472472066432585728,,,,
brentgendleman,5/30/2014 16:18,0,0,crossing the chasm to chicago and predictive response with genomics at # ASCO14 pic.twitter.com/QtrZqgRpPj,,,#,4.72472E+17,https://twitter.com/brentgendleman/status/472472057444573184,,,,
Biomedtracker,5/30/2014 16:17,1,0,"# ASCO14 begins, plan smart w/ BMT pre-report; follow @BMTRobert @BMTEdny for live coverage and @BMTJolene for insight pic.twitter.com/IrvkKYJpCi",,@BMTRobert @BMTEdny @BMTJolene,#,4.72472E+17,https://twitter.com/Biomedtracker/status/472472005036769280,,,,
scientre,5/30/2014 16:17,0,0,"Reis-Filho: Lawrence, Nature 2014 paper on freq of mutations. Impact on low frequency breast cancer mutns # asco14 http://www.ncbi.nlm.nih.gov/m/pubmed/24390350/ …",,,#,4.72472E+17,https://twitter.com/scientre/status/472471987093536768,,,,
SAJansky,5/30/2014 16:17,0,0,"Hello, Chicago! # ASCO14 pic.twitter.com/daSwqAw3nv",,,#,4.72472E+17,https://twitter.com/SAJansky/status/472471921104523264,,,,
drseisenberg,5/30/2014 16:16,1,0,RT @ subatomicdoc: Current use and attitudes toward IT use in health care among cancer patients http://bit.ly/1tVmUGM # hcsm # ASCO14,,@,# #,4.72472E+17,https://twitter.com/drseisenberg/status/472471643764183040,,,,
JediPD,5/30/2014 16:16,0,0,RT @ mtmdphd: Rudin # lcsm # ASCO14 - (TCGA) - signif mu genes in AdCA. New report pending in Nature pic.twitter.com/zmBDFeiqCr,,@,# #,4.72472E+17,https://twitter.com/JediPD/status/472471608163336192,,,,
DrAttai,5/30/2014 16:15,0,0,markers beyond Ki67 and grade are important for clinical decision making # ASCO14 # bcsm,,,# #,4.72472E+17,https://twitter.com/DrAttai/status/472471503024717824,,,,
Roche,5/30/2014 16:15,6,2,Will we have enough clinicians and scientists in # oncology in coming years? http://ow.ly/xkDGP # ASCO14,,,# #,4.72471E+17,https://twitter.com/Roche/status/472471340373790720,,,,
jrgralow,5/30/2014 16:15,6,16,"With Gertrude Nakagudde, breast cancer patient advocate from Uganda at # ASCO14. pic.twitter.com/7GFLo11pba",,,#,4.72471E+17,https://twitter.com/jrgralow/status/472471296744632321,,,,
genentech,5/30/2014 16:15,2,6,# NEXT50 RT @ theabta: The future is now - about 90% of genetic targets don't have drugs associated with them. There is much to do. # ASCO14,,@,# #,4.72471E+17,https://twitter.com/genentech/status/472471275211079680,,,,
myriadgenetics,5/30/2014 16:15,0,0,"Attending # ASCO14? Check out Myriad Posters 1542, 1553, 1548 & 1541 SUNDAY 8-11:45am in S Hall A! # hereditarycancerhttp://bit.ly/1qFsz5H",,,# #,4.72471E+17,https://twitter.com/myriadgenetics/status/472471259905654784,,,,
drseisenberg,5/30/2014 16:14,0,1,Hey Jack! RT @ JackWestMD via @ FayCortez: Saving you time: @ DrMarkham @ mtmdphd @ drdonsdizon @ CliffordHudis @ drattai @ rsm2800 @ fischmd # ASCO14,,@ @ @ @ @ @ @ @ @,#,4.72471E+17,https://twitter.com/drseisenberg/status/472471230071599104,,,,
LTbioinvestor,5/30/2014 16:14,0,1,time to hear something (good) from # ASCO2014 ....,,,#,4.72471E+17,https://twitter.com/LTbioinvestor/status/472471147758751744,,,,
afreshchapter,5/30/2014 16:14,0,1,Thank you @ Celgene for a great discussion on innovation and impacting lives! Great to meet fellow advocates! # ASCO14 pic.twitter.com/4vmjvad8ml,,@,#,4.72471E+17,https://twitter.com/afreshchapter/status/472471065739157504,,,,
scientre,5/30/2014 16:14,0,0,Reis-Filho: distinct breast cancer subtypes have diff repertoires of mutns but no highly recurrently mutated gene subtype specific # ASCO14,,,#,4.72471E+17,https://twitter.com/scientre/status/472471054397763584,,,,
MontefioreNYC,5/30/2014 16:14,1,2,Our doctors are getting ready for # ASCO14. Click here to learn about some of the studies being presented: http://bit.ly/1lV3aNs,,,#,4.72471E+17,https://twitter.com/MontefioreNYC/status/472471024093913088,,,,
brentgendleman,5/30/2014 16:13,0,1,can people be spared therapy through prognostic tools today? check adjuvant! online as something used and useful today # ASCO14,,,#,4.72471E+17,https://twitter.com/brentgendleman/status/472470970280976384,,,,
drseisenberg,5/30/2014 16:12,0,0,Hi Rich! RT @ rschilsky: Today is the first day of @ ASCO’s 50th Annual Meeting “Science & Society” Follow & use the tag # ASCO14,,@ @,#,4.72471E+17,https://twitter.com/drseisenberg/status/472470702176886784,,,,
SanofiUS,5/30/2014 16:12,2,0,RT @ SanofiCanada: # SanofiCA is proud to present its posters at annual meeting # oncology conference @ ASCO # ASCO2014,,@ @,# # #,4.72471E+17,https://twitter.com/SanofiUS/status/472470678084800512,,,,
afreshchapter,5/30/2014 16:12,0,0,Loved the graphic artist's ability to capture the celgene patient advocate lunch at # asco14.… http://instagram.com/p/ooko9hMgeF/,,,#,4.72471E+17,https://twitter.com/afreshchapter/status/472470649488027648,,,,
AlpineBV_Miller,5/30/2014 16:12,0,0,Is it just me or does S102a smell a little... off? # ASCO14,,,#,4.72471E+17,https://twitter.com/AlpineBV_Miller/status/472470593011712000,,,,
jrgralow,5/30/2014 16:12,1,0,S0230 study MT @ CancerDotNet: Fertility preserv rsch on hormone-suppr drug during br ca chemo # bcsm http://bit.ly/1oScqpk # SWOGonc # ASCO14,,@,# # #,4.72471E+17,https://twitter.com/jrgralow/status/472470560891752452,,,,
ArcagyGineco,5/30/2014 16:11,0,0,Résultats de l'étude italienne pazopanib + taxol hebdomadaire dans les cancers de l'ovaire en rechute précoce le samedi 31 mai à l' # ASCO14,,,#,4.7247E+17,https://twitter.com/ArcagyGineco/status/472470375562215425,,,,
drseisenberg,5/30/2014 16:11,0,0,A Surgical Oncologist’s Perspective | @ ASCO # ASCO14 http://am.asco.org/surgical-oncologist%E2%80%99s-perspective#.U4jl0haEfh4.twitter …,,@,# #,4.7247E+17,https://twitter.com/drseisenberg/status/472470351654301696,,,,
dhjutsw1,5/30/2014 16:11,4,1,@ ASCO invites widespread use of Federally Funded Research badge; visit site for more info. http://bit.ly/1izuy2k # ASCO14 # ascoaction,,@,# #,4.7247E+17,https://twitter.com/dhjutsw1/status/472470264123371520,,,,
DrAttai,5/30/2014 16:10,1,1,Not all drivers of mets and drug resistance have not been identified. Wide variation between and within breast cancers. # ASCO14 # bcsm,,,# #,4.7247E+17,https://twitter.com/DrAttai/status/472470190299836417,,,,
dmooneymd,5/30/2014 16:10,1,0,"Have we found all drivers in breast cancer? Currently, we can only detect mutations if > 2% of tumors. # bcsm # ASCO14",,,# #,4.7247E+17,https://twitter.com/dmooneymd/status/472470151606976512,,,,
JFreemanDaily,5/30/2014 16:10,0,0,# asco2014 Dr Wolchok: Immunotherapies are attacking several segments of the immune cycle in cancer.,,,#,4.7247E+17,https://twitter.com/JFreemanDaily/status/472470111212040192,,,,
ASCO,5/30/2014 16:10,3,0,Please be counted in our 2014 National Oncology Census. No user ID or password is required http://svy.mk/1o86eJy # ASCO14,,,#,4.7247E+17,https://twitter.com/ASCO/status/472470089720430592,,,,
drdonsdizon,5/30/2014 16:10,1,2,@ mtmdphd @ ShannonWestin # mutualadmirationsociety All are welcome! # ASCO14,,@ @,# #,4.7247E+17,https://twitter.com/drdonsdizon/status/472470084934713344,,,,
AbsolutelyTours,5/30/2014 16:10,0,0,Welcome # ASCO14 attendees & exhibitors! You're invited to a Segway Tour of # Chicago - bring show badge for $10 off! http://ow.ly/xm24P,,,# #,4.7247E+17,https://twitter.com/AbsolutelyTours/status/472470084150370304,,,,
jrgralow,5/30/2014 16:10,3,0,# ASCO14 embargo lifted on this LBA: important info from S0230 br ca study! Drug Can Help Avoid Infertility from Chemo http://shar.es/VDCBe,,,#,4.7247E+17,https://twitter.com/jrgralow/status/472470068865941505,,,,
tracyrode,5/30/2014 16:10,0,0,Very excited to be at my third ASCO! Visit @mypearlpoint in pt advo area # ASCO14,,@mypearlpoint,#,4.7247E+17,https://twitter.com/tracyrode/status/472470045256212480,,,,
journalclubapp,5/30/2014 16:10,0,0,Nothing like # ASCO14 to motivate updates to the oncology section of http://wikijournalclub.org .,,,#,4.7247E+17,https://twitter.com/journalclubapp/status/472470031906119680,,,,
Rahul_Mangalore,5/30/2014 16:10,0,0,"“ @ PunitDhillon: Nice to see @ Oncosec P2 Melanoma data as the featured presenter on the # ASCO14 site: http://meetinglibrary.asco.org  BOOM!""",,@ @,#,4.7247E+17,https://twitter.com/Rahul_Mangalore/status/472470015451488256,,,,
genentech,5/30/2014 16:10,0,0,@ Pathologists - More impt than ever to # personalizedmedicine... essential to solving the tissue issue: http://ow.ly/xs7AW # ASCO14,,@,# #,4.7247E+17,https://twitter.com/genentech/status/472470013316960257,,,,
lenstarnes,5/30/2014 16:09,0,1,"@ mtmdphd Mike, As a never smoker you made my day # lcsm # ASCO14 - Never smokers tend to have simpler"" cancers (fewer mutations)""",,@,# #,4.7247E+17,https://twitter.com/lenstarnes/status/472469958715535360,,,,
DrR_DUNNE,5/30/2014 16:09,0,0,Dr. Weiser from MSK jokes he is gonna teach us all there is to know about Rectal Surgery/TME in 20 min # ASCO14,,,#,4.7247E+17,https://twitter.com/DrR_DUNNE/status/472469957683318784,,,,
MoffittResearch,5/30/2014 16:09,0,0,Did you get a chance to hear Dr. Gwendolyn Quinn talk about # fertility preservation before # cancer at # ASCO14? What did you think?,,,# # #,4.7247E+17,https://twitter.com/MoffittResearch/status/472469854474481665,,,,
ipaulmampilly,5/30/2014 16:09,0,0,# ASCO14 pic.twitter.com/aH1SRQcnO2,,,#,4.7247E+17,https://twitter.com/ipaulmampilly/status/472469836044709889,,,,
cityofhope,5/30/2014 16:08,7,1,"New drug may reverse # LungCancer's chemo resistance, according to @ ASCO study by @ KarenReckampMD http://breakthroughs.cityofhope.org/asco-2014-new-drug-lung-cancer … # LCSM # ASCO14",,@ @,# # #,4.7247E+17,https://twitter.com/cityofhope/status/472469740250607616,,,,
dhjutsw1,5/30/2014 16:08,0,0,MT: @ ASCO using this badge to raise awareness of federal funding for # cancer research. Sign up & download it http://bit.ly/1hFFQlq # ASCO14,,@,# #,4.7247E+17,https://twitter.com/dhjutsw1/status/472469738564489217,,,,
sfuldnasso,5/30/2014 16:08,2,0,Looking forward to an interesting and likely lively discussion on value in cancer care. # ASCO14,,,#,4.7247E+17,https://twitter.com/sfuldnasso/status/472469736434176001,,,,
SarahCannonDocs,5/30/2014 16:08,0,0,Want to learn about novel anti-angiogenic agents? Check out Poster 41 Abs#2526 # ASCO14 DrBendell pic.twitter.com/hEqu1o0ugR,,,#2526 #,4.7247E+17,https://twitter.com/SarahCannonDocs/status/472469709888454657,,,,
carol_gallagher,5/30/2014 16:08,0,1,Beautiful day in Chicago! Can't wait to spend the next three days in dark rooms hearing the latest Cancer data! # ASCO2014,,,#,4.7247E+17,https://twitter.com/carol_gallagher/status/472469679467151361,,,,
tonihaubs,5/30/2014 16:08,0,1,Great lesson of new # SocOncology report: ignore pop culture at your peril when educating on cancer: http://bit.ly/1oCSM2Z # ASCO14,,,# #,4.7247E+17,https://twitter.com/tonihaubs/status/472469679274217472,,,,
tonihaubs,5/30/2014 16:08,0,1,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.7247E+17,https://twitter.com/tonihaubs/status/472469574127218688,,,,
DrAttai,5/30/2014 16:07,1,1,"different subtypes have different mutations, but no highly mutated gene is subtype specific - now gets really difficult # ASCO14 # bcsm",,,# #,4.72469E+17,https://twitter.com/DrAttai/status/472469278000943105,,,,
dmooneymd,5/30/2014 16:06,0,0,"Very few highly recurrent mutations in breast ca: p53 and pi3kca. These are not subtype specific, others are kinda specific. # bcsm # ASCO14",,,# #,4.72469E+17,https://twitter.com/dmooneymd/status/472469238410518528,,,,
OncologyTimes,5/30/2014 16:06,0,0,"@ thecancergeek @ TCORobin Yes, that particular study had just ER-neg pts. Here's a news release w some info: http://www.asco.org/press-center/studies-reveal-new-strategies-improve-quality-life-patients-survivors-and-caregivers?et_cid=33849446&et_rid=464866688&linkid=Read+more … # ASCO14",,@ @,#,4.72469E+17,https://twitter.com/OncologyTimes/status/472469188905144320,,,,
DrR_DUNNE,5/30/2014 16:06,1,0,"Lymphoma pstr ssin highlights arguments for less testing after treatment and in surveillance, BMBs, scheduled CTs # ASCO14",,,#,4.72469E+17,https://twitter.com/DrR_DUNNE/status/472469146643746816,,,,
genentech,5/30/2014 16:05,0,0,"Briana, age 8, may bring a robot to # ASCO64. How will @ ASCO mtg look in # Next50 yrs? # ASCO14 http://ow.ly/xmU9J",,@,# # #,4.72469E+17,https://twitter.com/genentech/status/472468841654923264,,,,
JFreemanDaily,5/30/2014 16:04,1,0,"# asco2014 Dr Wolchok: Immune pathway blockade therapies can produce temporary progression or new tumors, then show prolonged response. # lcsm",,,# #,4.72469E+17,https://twitter.com/JFreemanDaily/status/472468558317117440,,,,
AlexYperifanos,5/30/2014 16:03,0,1,"Not new but Gr8 piece! MT @ drseisenberg Life, Interrupted: The Cost of Cancer http://nyti.ms/160DMzC by @ suleikajaouad # ASCO14 # cancersucks",,@ @,# #,4.72468E+17,https://twitter.com/AlexYperifanos/status/472468326040350720,,,,
appistry,5/30/2014 16:02,0,0,. @ cure_magazine Having a good time at # ASCO14? Swing by booth 16152 to learn about what we're doing with genomically enhanced medicine.,,@,#,4.72468E+17,https://twitter.com/appistry/status/472468223741288448,,,,
DrAttai,5/30/2014 16:02,2,1,"fascinated each time I hear a genomics talk. Incredibly complex stuff, but so important - this is how we will make progress # ASCO14 # BCSM",,,# #,4.72468E+17,https://twitter.com/DrAttai/status/472468173137395712,,,,
dmooneymd,5/30/2014 16:02,2,1,Molecular complexity of genomes different even in same molecular subtype by gene expression profiling. My head hurts! # bcsm # ASCO14,,,# #,4.72468E+17,https://twitter.com/dmooneymd/status/472468103125680129,,,,
UNCurology,5/30/2014 16:02,3,1,eligibility/RCT design for salvage of adv Uroth.Ca Matt Milowsky @ UNC_Lineberger et al # asco14 http://ow.ly/xqEvP,,@,#,4.72468E+17,https://twitter.com/UNCurology/status/472468003750412288,,,,
BayerPharma,5/30/2014 16:01,1,2,We will present data from our # oncology portfolio at # ASCO14. Learn ore about # cancer on http://bit.ly/XNDmuN http://twitpic.com/e52rvi,,,# # #,4.72468E+17,https://twitter.com/BayerPharma/status/472467970938404864,,,,
ASCO,5/30/2014 16:01,0,0,ASCO Members: Refer a new member at an # ASCO14 Member Services Desk to receive thank you gifts,,,#,4.72468E+17,https://twitter.com/ASCO/status/472467963753558017,,,,
ASCO,5/30/2014 16:01,8,2,Dr. Matthew H. G. Katz: A surgical oncologists experience at # ASCO14 http://bit.ly/1nv1vor,,,#,4.72468E+17,https://twitter.com/ASCO/status/472467935576195072,,,,
ASCO,5/30/2014 16:01,2,0,Learning to ask the right questions at # ASCO14: http://bit.ly/1kRFkFx CC @ fischmd # ASCOConnection,,@,# #,4.72468E+17,https://twitter.com/ASCO/status/472467856857501697,,,,
appistry,5/30/2014 16:01,0,0,". @ ClevelandClinic: Come swing by booth 16152 at # ASCO14 to learn about our new cloud-based service for # genomics testing, # CloudDx",,@,# # #,4.72468E+17,https://twitter.com/appistry/status/472467839727587328,,,,
VOInnovation,5/30/2014 16:01,0,0,“Let’s measure the value of care in terms of the months we have with loved ones.” - @ drbobgoldberg http://bit.ly/1mA4sPw @ BioWorld # ASCO14,,@ @,#,4.72468E+17,https://twitter.com/VOInnovation/status/472467805489479680,,,,
bmsnews,5/30/2014 16:01,2,1,Excited to kick off # ASCO14 w/ @ StevenBJohnson & cancer advocates! Use # CancerConnections to follow the discussion,,@,# #,4.72468E+17,https://twitter.com/bmsnews/status/472467767262978048,,,,
Rad_Nation,5/30/2014 16:01,1,0,Dosimetric criteria for prophylactic gastrostomy in H&N cancer chemoradiation http://buff.ly/RI6LGj # ASCO14 # hncsm # radonc,,,# # #,4.72468E+17,https://twitter.com/Rad_Nation/status/472467747381993473,,,,
CancerDotNet,5/30/2014 16:00,3,2,# Fertility preserv research from # ASCO14 on hormone-suppr drug goserelin during br ca chemo # bcsmhttp://bit.ly/1oScqpk,,,# # #,4.72468E+17,https://twitter.com/CancerDotNet/status/472467628519596032,,,,
ClevelandClinic,5/30/2014 16:00,5,7,# ASCO14 NEWS: Drug helps avoid infertility as a result of chemo http://health.clevelandclinic.org/2014/05/drug-can-help-women-avoid-infertility-from-chemotherapy/?utm_campaign=cc+tweets&utm_medium=social&utm_source=twitter&utm_content=140530+drug+women+infertility&dynid=twitter-_-cc+tweets-_-social-_-social-_-140530+drug+women+infertility …,,,#,4.72468E+17,https://twitter.com/ClevelandClinic/status/472467559837470720,,,,
dhjutsw1,5/30/2014 16:00,1,1,Letter from @ ASCO President @ CliffordHudis | Congrats on a gr8 yearDr. Hudis! | # ASCO14 http://am.asco.org/letter-president#.U4ji6tDOFp8.twitter …,,@ @,# #,4.72468E+17,https://twitter.com/dhjutsw1/status/472467559812325376,,,,
CancerDotNet,5/30/2014 16:00,4,1,Podcast: Dr. Patricia Ganz from @ UCLAJCCC discusses highlights from # ASCO14 on pt care & quality of life http://bit.ly/1lYuURc,,@,#,4.72468E+17,https://twitter.com/CancerDotNet/status/472467542288916480,,,,
ElizBlanchardMD,5/30/2014 15:59,1,0,"Thinking about career choices? Join us from 3:45 PM – 6:00 PM in Room S404 for Why I chose the career I love"" # ASCO14""",,,#,4.72467E+17,https://twitter.com/ElizBlanchardMD/status/472467311686082561,,,,
SEOR3,5/30/2014 15:59,0,0,Sessions of Interest for Radiation Oncologists at # ASCO2014 http://am.asco.org/sessions-interest-radiation-oncologists …,,,#,4.72467E+17,https://twitter.com/SEOR3/status/472467288755830786,,,,
Oncoangel,5/30/2014 15:59,0,0,Sessions of Interest for Radiation Oncologists at # ASCO2014 http://am.asco.org/sessions-interest-radiation-oncologists …,,,#,4.72467E+17,https://twitter.com/Oncoangel/status/472467288046960641,,,,
Monthy_A,5/30/2014 15:59,0,1,Sessions of Interest for Radiation Oncologists at # ASCO2014 http://am.asco.org/sessions-interest-radiation-oncologists …,,,#,4.72467E+17,https://twitter.com/Monthy_A/status/472467287132618753,,,,
GEORM_SEOR,5/30/2014 15:59,0,0,Sessions of Interest for Radiation Oncologists at # ASCO2014 http://am.asco.org/sessions-interest-radiation-oncologists …,,,#,4.72467E+17,https://twitter.com/GEORM_SEOR/status/472467286440562688,,,,
mtmdphd,5/30/2014 15:58,1,1,Rudin # lcsm # ASCO14 - Genomic analysis to ID (at least the large) slices of the lung cancer pie is a SOC for AdCA pic.twitter.com/bcTOLsdxqe,,,# #,4.72467E+17,https://twitter.com/mtmdphd/status/472467119515262976,,,,
kgapo,5/30/2014 15:57,0,0,@ drattai really? can't believe it! good that you quoted it # asco14 should be more considerate..,,@,#,4.72467E+17,https://twitter.com/kgapo/status/472466969724456960,,,,
wordbistro,5/30/2014 15:57,0,0,Wow. Did not know that. “ @ drattai: at least 6 different subtypes of triple negative breast cancer # ASCO14 # bcsm”,,@,# #,4.72467E+17,https://twitter.com/wordbistro/status/472466951365992448,,,,
drseisenberg,5/30/2014 15:57,2,1,RT @ MDAnderson_POE # ASCO14 - MD Anderson Cancer Screening Algorithms: http://bit.ly/1tQ5mvP # endcancer,,@,# #,4.72467E+17,https://twitter.com/drseisenberg/status/472466945208377344,,,,
NDeVitoMD,5/30/2014 15:57,4,1,# ASCO14 rising recognition of PD1/PD1L in checkpoint inhibition. Several antibodies in trials. # nivolumab # melanomapic.twitter.com/f7OYperrVJ,,,# # #,4.72467E+17,https://twitter.com/NDeVitoMD/status/472466923591319552,,,,
DrAttai,5/30/2014 15:57,1,1,but precision medicine IS possible # ASCO14 # bcsm,,,# #,4.72467E+17,https://twitter.com/DrAttai/status/472466906176569344,,,,
mtmdphd,5/30/2014 15:57,0,0,"Rudin # lcsm # ASCO14 - SCLC and MYC signaling - amp, fusions, inactivation of MAX, loss of BRG1 (transciptional regulator of MAX)",,,# #,4.72467E+17,https://twitter.com/mtmdphd/status/472466860600872960,,,,
brentgendleman,5/30/2014 15:57,1,1,"15 years of microarrays did not guide treatment, clinical + pathology is not enough for precision medicine # ASCO14 so what now?",,,#,4.72467E+17,https://twitter.com/brentgendleman/status/472466810223476737,,,,
christinemphmd,5/30/2014 15:57,0,0,Programmed Death-1: Patients must love the name of that, Dr. Jedd Wolchok # ASCO14 pic.twitter.com/PqmvdUEkNf,,,#,4.72467E+17,https://twitter.com/christinemphmd/status/472466791193907201,,,
DrAttai,5/30/2014 15:56,1,1,"for true precision based therapy, a more comprehensive and integrative approach is needed. Patient / Drug / Tumor factors # ASCO14 # bcsm",,,# #,4.72467E+17,https://twitter.com/DrAttai/status/472466652857397249,,,,
mtmdphd,5/30/2014 15:56,0,0,Rudin # lcsm # ASCO14 - SCLC genes mut - predominance of tumor suppressor genes - somewhat disappointing,,,# #,4.72467E+17,https://twitter.com/mtmdphd/status/472466640961933312,,,,
ByJonGardner,5/30/2014 15:56,0,0,"Jedd Wolchok's exam room conversation: What does 'PD' stand for?"" ""Programmed death."" ""Sign me up for that."" # ASCO14""",,,#,4.72467E+17,https://twitter.com/ByJonGardner/status/472466629872607233,,,,
dmooneymd,5/30/2014 15:56,1,1,Microarrays cant define best therapy for each pt...only treat or not. We need genomic and epigenetic data for precision med. # bcsm # ASCO14,,,# #,4.72467E+17,https://twitter.com/dmooneymd/status/472466598297489408,,,,
JeffreyMOtto,5/30/2014 15:56,0,0,"CR: mutation analysis - the difficulty is not in getting the data, it is in analyzing the data # ASCO14",,,#,4.72467E+17,https://twitter.com/JeffreyMOtto/status/472466571533623297,,,,
DCarrizosaMD,5/30/2014 15:56,0,1,Arrived safe in chicago for # ASCO14 - I'm excited but my wife is unhappy - USAir misplaced her bag :(,,,#,4.72467E+17,https://twitter.com/DCarrizosaMD/status/472466563824492544,,,,
mtmdphd,5/30/2014 15:56,0,0,Rudin # lcsm # ASCO14 - Global mutational spectrum of SCLC - difficulty is not getting sequence but analyzing the seq pic.twitter.com/wYsmlPBGte,,,# #,4.72466E+17,https://twitter.com/mtmdphd/status/472466489908281344,,,,
DrAttai,5/30/2014 15:55,5,1,"Outcome of ER+ breast cancers can be predicted by proliferation related genes, but of ER- by immune response related genes # ASCO14 # bcsm",,,# #,4.72466E+17,https://twitter.com/DrAttai/status/472466334610366464,,,,
jagasquet,5/30/2014 15:55,0,0,# ASCO14 preview: What's the outlook for cancer vaccines? - FierceVaccines: http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4jhx8SoPUg.twitter …,,,# #,4.72466E+17,https://twitter.com/jagasquet/status/472466312656998400,,,,
MLIWI,5/30/2014 15:55,0,0,RT @ TuftsB: @ DrBobGoldberg @ ASCO - 3 months is a guess of average mortality. Some like me live longer. Do not kill us to save money. # mliwi,,@ @ @,#,4.72466E+17,https://twitter.com/MLIWI/status/472466282525523968,,,,
genentech,5/30/2014 15:55,2,0,Agree! http://ow.ly/xs4pE MT @ drattai: Dr. Burstein- we also need to standardize pathology testing & reporting for breast cancer # ASCO14,,@,#,4.72466E+17,https://twitter.com/genentech/status/472466249193385984,,,,
mtmdphd,5/30/2014 15:55,0,0,"Rudin # lcsm # ASCO14 - @ theNCI MATCH Protocol - buckets - PI3K, CDK4/6, HGF,...pic.twitter.com/6urYVhl0Mu",,@,# #,4.72466E+17,https://twitter.com/mtmdphd/status/472466241802616832,,,,
drugwonks,5/30/2014 15:55,2,0,RT @ TuftsB: @ DrBobGoldberg @ ASCO - 3 months is a guess of average mortality. Some like me live longer. Do not kill us to save money. # mliwi,,@ @ @,#,4.72466E+17,https://twitter.com/drugwonks/status/472466239382892544,,,,
kgapo,5/30/2014 15:54,0,0,the French Connection # asco14>Current use & attitudes toward ITuse in healthcare amng cancer patients http://bit.ly/1tVmUGM v @ cathcerisey,,@,#,4.72466E+17,https://twitter.com/kgapo/status/472466205786525696,,,,
mtmdphd,5/30/2014 15:53,0,0,Rudin # lcsm # ASCO14 - Sq cell NSCLC targets - FGFR1 amp... pic.twitter.com/0DtY3FUi0g,,,# #,4.72466E+17,https://twitter.com/mtmdphd/status/472465926021861376,,,,
mtmdphd,5/30/2014 15:52,0,0,"Rudin # lcsm # ASCO14 - Rx targets in Sq cell NSCLC - Class 1, Class 2. FGFR is one.",,,# #,4.72466E+17,https://twitter.com/mtmdphd/status/472465693762265088,,,,
drseisenberg,5/30/2014 15:52,0,0,@Matt_SCRI_UK hahaha # ASCO14,,@Matt_SCRI_UK,#,4.72466E+17,https://twitter.com/drseisenberg/status/472465538023567360,,,,
mtmdphd,5/30/2014 15:52,0,0,Rudin # lcsm # ASCO14 - TCGA - Complementary genetic and epigenetic mechanisms - Nature 2012 pic.twitter.com/XBAsynzHi0,,,# #,4.72466E+17,https://twitter.com/mtmdphd/status/472465514766155776,,,,
MatthewHSimmons,5/30/2014 15:52,0,0,"And in other # ASCO14 news, the vending machines now have Coke not Pepsi...",,,#,4.72465E+17,https://twitter.com/MatthewHSimmons/status/472465472458211329,,,,
brendanweiss,5/30/2014 15:52,3,0,@ Transplant_Doc reports Mel v BuMel as prep for ASCT in MM - BuMel lower CR more toxic - still Mel after all # ASCO14 @ nsc_natalie # mmsm,,@ @,# #,4.72465E+17,https://twitter.com/brendanweiss/status/472465472005611521,,,,
dmooneymd,5/30/2014 15:51,0,0,Just getting more complicated. 6 molecular subtypes just in triple negative breast cancer. # bcsm # ASCO14,,,# #,4.72465E+17,https://twitter.com/dmooneymd/status/472465425477824512,,,,
ASCO,5/30/2014 15:51,3,4,@ CliffordHudis during today's # ASCO14 press brief. Miss it? Here's the enitre brief: http://bit.ly/1nLJKPj pic.twitter.com/tuDmRRSng7,,@,#,4.72465E+17,https://twitter.com/ASCO/status/472465341990576128,,,,
MoyraCosgrove,5/30/2014 15:51,0,0,Two of my fav US tweeters @ meducate @ drseisenberg will be at American Society of Clinical Oncology 2014 # ASCO14 >shall be following,,@ @,#,4.72465E+17,https://twitter.com/MoyraCosgrove/status/472465333685858304,,,,
mtmdphd,5/30/2014 15:51,0,0,"Rudin # lcsm # ASCO14 - TCGA data on Sq Cell NSCLC mutations - TP53, others pic.twitter.com/fTZ1xoDxbc",,,# #,4.72465E+17,https://twitter.com/mtmdphd/status/472465253893017600,,,,
drseisenberg,5/30/2014 15:51,0,0,@ drattai that's a lot! # ASCO14,,@,#,4.72465E+17,https://twitter.com/drseisenberg/status/472465229981302785,,,,
DrAttai,5/30/2014 15:50,3,4,at least 6 different subtypes of triple negative breast cancer # ASCO14 # bcsm,,,# #,4.72465E+17,https://twitter.com/DrAttai/status/472465134334771200,,,,
drseisenberg,5/30/2014 15:50,0,0,@ zebrafinch @ drattai cool! # ASCO14,,@ @,#,4.72465E+17,https://twitter.com/drseisenberg/status/472465100688084994,,,,
tmlfox,5/30/2014 15:50,0,0,@ drseisenberg Hi Steven! Are you at # ASCO14 or are you following virtually?,,@,#,4.72465E+17,https://twitter.com/tmlfox/status/472465080236642306,,,,
mtmdphd,5/30/2014 15:50,1,0,Rudin # lcsm # ASCO14 - Lung AdCA Drivers: KRAS > EGFR > BRAF > MET > NF1 > Others,,,# #,4.72465E+17,https://twitter.com/mtmdphd/status/472465042429194241,,,,
Perthera,5/30/2014 15:50,0,0,Not too late to register! Breakfast mtg at # ASCO14 on Turning Molecular Analyses into Actionable Treatment Decisions http://ow.ly/wNot9,,,#,4.72465E+17,https://twitter.com/Perthera/status/472465013064880128,,,,
DrAttai,5/30/2014 15:49,1,0,Many molecular subtypes of breast cancer; they differ in their clinical behavior # ASCO14 # bcsm,,,# #,4.72465E+17,https://twitter.com/DrAttai/status/472464953673543680,,,,
drseisenberg,5/30/2014 15:49,3,4,# PatientAdvocacy groups are a critical component of the fight http://www.accc-cancer.org/cancer_care/patients/Advocacy.asp … # cancer # ASCO14,,,# # #,4.72465E+17,https://twitter.com/drseisenberg/status/472464857544290305,,,,
mtmdphd,5/30/2014 15:49,0,1,Rudin # lcsm # ASCO14 - The Cancer Genome Atlas Project (TCGA) - signif mu genes in AdCA. New report pending in Nature pic.twitter.com/BBEKjfSj2a,,,# #,4.72465E+17,https://twitter.com/mtmdphd/status/472464823578394625,,,,
DrBobGoldberg,5/30/2014 15:49,0,0,@ asco value app will betray patients if it leaves these facts out # MLIWI # ASCO14 pic.twitter.com/XyTxq2jtaG,,@,# #,4.72465E+17,https://twitter.com/DrBobGoldberg/status/472464729206968321,,,,
christinemphmd,5/30/2014 15:48,0,0,Immunologists need to have at least 3 names for the same thing... Keeps people famous, Dr. Jedd Wolchok. # ASCO14 pic.twitter.com/NBKSnGKCmK,,,#,4.72465E+17,https://twitter.com/christinemphmd/status/472464678346850305,,,
WUSTLmed,5/30/2014 15:48,2,4,Shout out to our researchers and physicians with @ SitemanCenter who are sharing their # cancer expertise at # ASCO14,,@,# #,4.72465E+17,https://twitter.com/WUSTLmed/status/472464658062778368,,,,
cancerassassin1,5/30/2014 15:48,0,0,Other thing I took away from upper # gi # cancer review: ? Of whether to use neoadj chemoRT vs periop # chemo depends on perspective # ASCO14,,,# # # #,4.72465E+17,https://twitter.com/cancerassassin1/status/472464649032847360,,,,
BradRad17,5/30/2014 15:48,0,0,“ @ PunitDhillon: Nice to see @ Oncosec P2 Melanoma data as the featured presenter on the # ASCO14 site: http://meetinglibrary.asco.org $ ONCS,,@ @,#,4.72465E+17,https://twitter.com/BradRad17/status/472464567491362816,,,,
SanofiCanada,5/30/2014 15:48,0,0,# SanofiCA is proud to present its posters at annual meeting # oncology conference @ ASCO # ASCO2014,,@,# # #,4.72465E+17,https://twitter.com/SanofiCanada/status/472464540878512132,,,,
SanofiCanada,5/30/2014 15:48,0,1,"RT @ ASCO Today marks the first day of # ASCO14. This year's theme: Science & Society"" @ CliffordHudis @ rschilsky @ YupOnc""",,@ @ @ @,#,4.72465E+17,https://twitter.com/SanofiCanada/status/472464526320082944,,,,
mtmdphd,5/30/2014 15:48,3,1,Rudin # lcsm # ASCO14 - Lung AdCA - hitting drivers matters - Kwak et al. @ NEJM 2010pic.twitter.com/61TAxAcaT9,,@,# #,4.72465E+17,https://twitter.com/mtmdphd/status/472464500096921600,,,,
DrMiguelPerales,5/30/2014 15:48,2,0,"In treating some cancer patients, less is more: U.S. studies http://reut.rs/SkqY5K via @ reuters # ASCO14",,@,#,4.72464E+17,https://twitter.com/DrMiguelPerales/status/472464474415194112,,,,
Pathologists,5/30/2014 15:48,2,2,"# pathologists at # ASCO14: share your experience: tag @ Pathologists, post a photo",,@,# #,4.72464E+17,https://twitter.com/Pathologists/status/472464462163623936,,,,
subatomicdoc,5/30/2014 15:48,0,0,@ drseisenberg @ ASCO @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI Thanks Steven! Will I get to see you again in Chicago? # ASCO14,,@ @ @ @ @ @ @ @,#,4.72464E+17,https://twitter.com/subatomicdoc/status/472464461803319296,,,,
drallysonocean,5/30/2014 15:47,1,4,Just arrived in Chicago for # ASCO14 Here's to making strides in # Cancer @ MMfightsCRC @ ASCO,,@ @,# #,4.72464E+17,https://twitter.com/drallysonocean/status/472464371256279040,,,,
GenentechJobs,5/30/2014 15:47,0,1,"# ASCO14 Talent Hunt: Scientist, Oncology Biomarker Development- Hematology: http://click2apply.net/426015t",,,#,4.72464E+17,https://twitter.com/GenentechJobs/status/472464367082946562,,,,
mtmdphd,5/30/2014 15:47,0,0,Rudin # lcsm # ASCO14 - Team science in lung cancer - targeted therapies clinical trials not doable alone pic.twitter.com/h08lkxXnea,,,# #,4.72464E+17,https://twitter.com/mtmdphd/status/472464317330120704,,,,
Ethane28,5/30/2014 15:47,2,2,"$ MACK, $ CYTR gear up for # ASCO14 weekend.",,,#,4.72464E+17,https://twitter.com/Ethane28/status/472464258404716544,,,,
DrAttai,5/30/2014 15:47,4,2,Good session coming up - applications of genomic tools in breast cancer treatment # ASCO14 # bcsm,,,# #,4.72464E+17,https://twitter.com/DrAttai/status/472464253187022848,,,,
PCRCGroup,5/30/2014 15:46,0,1,@ PCRCGroup members Abernethy and Bakitas present at # ASCO14 press conference # hpmpic.twitter.com/i2hZ19RvGE,,@,# #,4.72464E+17,https://twitter.com/PCRCGroup/status/472464199633731584,,,,
dmooneymd,5/30/2014 15:46,1,0,Frontiers in genomic therapy of breast cancer. # bcsm # ASCO14,,,# #,4.72464E+17,https://twitter.com/dmooneymd/status/472464193111605248,,,,
NickZdenkowski,5/30/2014 15:46,0,0,"The seagulls seem to be enjoying # ASCO14 too, at least in E Hall D1!",,,#,4.72464E+17,https://twitter.com/NickZdenkowski/status/472464105970757632,,,,
JeffreyMOtto,5/30/2014 15:46,0,0,@ JeffreyMOtto but pie is shrinking w/ new panels # ASCO14,,@,#,4.72464E+17,https://twitter.com/JeffreyMOtto/status/472464030280335360,,,,
exchequerpub,5/30/2014 15:46,0,0,The @ ASCO convention at @ McCormick_Place continues this weekend. Come by for great food & drinks! Kitchen open late Friday & Saturday.,,@ @,,4.72464E+17,https://twitter.com/exchequerpub/status/472463981035388928,,,,
nanostringtech,5/30/2014 15:45,0,2,This year’s # ASCO14 is the 50th Annual Meeting. Learn more about “Science and Society” from Dr. Clifford Hudis http://bit.ly/1rh2DNZ,,,#,4.72464E+17,https://twitter.com/nanostringtech/status/472463923065942016,,,,
drseisenberg,5/30/2014 15:45,0,0,"hey there, @ subatomicdoc! you're rockin' it! cc: @ ASCO @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI # ASCO14",,@ @ @ @ @ @ @ @,#,4.72464E+17,https://twitter.com/drseisenberg/status/472463887996948480,,,,
RaisBahrami,5/30/2014 15:45,0,0,In Chicago for the first day of # ASCO14,,,#,4.72464E+17,https://twitter.com/RaisBahrami/status/472463877527969792,,,,
JeffreyMOtto,5/30/2014 15:45,0,0,"CR: no oncogenic driver mutations detected in 36% of lung adenocarcinoma (NGS project in 1,000 tumors) # asco14",,,#,4.72464E+17,https://twitter.com/JeffreyMOtto/status/472463848813764608,,,,
Jehennessy3,5/30/2014 15:45,0,0,# ASCO14 sitting in the back of the hall is looking down from Willis tower without the shattered glass pic.twitter.com/0oTskQQC5N,,,#,4.72464E+17,https://twitter.com/Jehennessy3/status/472463830216224768,,,,
mtmdphd,5/30/2014 15:45,1,0,Rudin # lcsm # ASCO14 - Kris et al. JAMA 2014 - LCMC: driver mutations in lung AdCA http://jama.jamanetwork.com/article.aspx?articleid=1872815 …pic.twitter.com/XOeza6pkxL,,,# #,4.72464E+17,https://twitter.com/mtmdphd/status/472463817553620992,,,,
LesleyLesleys,5/30/2014 15:45,1,2,"Oncology isn't just about helping people live longer"" P.Ganz @ ASCO # ASCO14 press briefing http://bit.ly/1gJAxGo << Couldn't agree more!""",,@,#,4.72464E+17,https://twitter.com/LesleyLesleys/status/472463765087477760,,,,
yzafar,5/30/2014 15:45,0,0,Now at # ASCO14: 50 years of treating # colorectalcancer http://bit.ly/1k9Jfxl # crcsm,,,# # #,4.72464E+17,https://twitter.com/yzafar/status/472463743377362946,,,,
cancerassassin1,5/30/2014 15:45,0,1,upper # gi: Ramucirumab was superior in 2nd line trials; 1st line trial to be presented Monday reportedly negative. # ASCO14 # staytuned,,,# # #,4.72464E+17,https://twitter.com/cancerassassin1/status/472463737111453696,,,,
ONAcom,5/30/2014 15:45,0,1,Are you attending ASCO 2014? Come visit the Haymarket Oncology booth (#15081)! # ASCO14,,,#15081 #,4.72464E+17,https://twitter.com/ONAcom/status/472463736733986817,,,,
subatomicdoc,5/30/2014 15:45,5,2,What gynecologic cancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI # FF # gyncsm,,@ @ @ @ @ @ @,# # #,4.72464E+17,https://twitter.com/subatomicdoc/status/472463712402833409,,,,
drseisenberg,5/30/2014 15:44,0,0,Guide to # QuittingSmoking: http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittingsmoking/index?sitearea … # lcsm # ASCO14,,,# # #,4.72464E+17,https://twitter.com/drseisenberg/status/472463571813539840,,,,
scientre,5/30/2014 15:44,1,1,Remember NuCana got $58M Series B last month for ProTides (nucleotide analogs)? # ASCO14 abstract 2531 phase 1/2 of Acelarin (NUC-1031),,,#,4.72464E+17,https://twitter.com/scientre/status/472463510287695872,,,,
mtmdphd,5/30/2014 15:43,0,0,Rudin # lcsm # ASCO14 - Lung CA Mutation Consortium - Paul Bunn initiated. Now housed at UW Madison for data,,,# #,4.72463E+17,https://twitter.com/mtmdphd/status/472463420348829696,,,,
mtmdphd,5/30/2014 15:43,1,0,Rudin # lcsm # ASCO14 - Lung cancer at MSKCC (2000-2010; N=14K) - use NGS routinely at MSKCC. @ MSK_Strategypic.twitter.com/IesmTh85kl,,@,# #,4.72463E+17,https://twitter.com/mtmdphd/status/472463278954647552,,,,
PunitDhillon,5/30/2014 15:42,6,10,Nice to see @ Oncosec P2 Melanoma data as the featured presenter on the # ASCO14 site: http://meetinglibrary.asco.org # immunotherapy # ImmunoOncology,,@,# # #,4.72463E+17,https://twitter.com/PunitDhillon/status/472463191587700736,,,,
NDeVitoMD,5/30/2014 15:42,5,12,Made it to @ ASCO and enjoying the first of many immunotherapy lectures. pic.twitter.com/pz4UIb5c9R,,@,,4.72463E+17,https://twitter.com/NDeVitoMD/status/472463152454860800,,,,
drseisenberg,5/30/2014 15:42,1,2,RT @ mtmdphd Rudin # lcsm - lung cancer leading cause of cancer death in US & world. Also high mutation burden pic.twitter.com/wo50eabfse # ASCO14,,@,# #,4.72463E+17,https://twitter.com/drseisenberg/status/472463132460584961,,,,
DrGregHarrisDO,5/30/2014 15:42,0,1,Enjoying my first ASCO! This is going to be fun! # ASCO14,,,#,4.72463E+17,https://twitter.com/DrGregHarrisDO/status/472463080426078208,,,,
JeffreyMOtto,5/30/2014 15:42,0,0,CR - tobacco exposure leads to higher mutation burden compared to non-smokers. # ASCO14,,,#,4.72463E+17,https://twitter.com/JeffreyMOtto/status/472463025979400192,,,,
mtmdphd,5/30/2014 15:42,1,0,"Rudin # lcsm # ASCO14 - Never smokers tend to have simpler"" cancers (fewer mutations)""",,,# #,4.72463E+17,https://twitter.com/mtmdphd/status/472462974011977728,,,,
SurvBC2004,5/30/2014 15:42,0,0,# ASCO14,,,#,4.72463E+17,https://twitter.com/SurvBC2004/status/472462955586813952,,,,
drseisenberg,5/30/2014 15:41,0,1,"RT @ ASCO: Missed today's # ASCO14 press briefing? View the recording for the latest in # patientcare, # qualityoflife: http://bit.ly/QF4Thk",,@,# # #,4.72463E+17,https://twitter.com/drseisenberg/status/472462938683736064,,,,
cancerassassin1,5/30/2014 15:41,0,0,My early prediction: advances in biomarkers are going to dominate # ASCO14. Or at least recognition of the need for better biomarkers @ ASCO,,@,#,4.72463E+17,https://twitter.com/cancerassassin1/status/472462932559687681,,,,
mtmdphd,5/30/2014 15:41,0,0,Rudin # lcsm # ASCO14 - Circus plot - Tobacco exposure and the genomes of lung cancers pic.twitter.com/XKVPQAeoRR,,,# #,4.72463E+17,https://twitter.com/mtmdphd/status/472462883779932160,,,,
PrevGenetics,5/30/2014 15:40,0,1,Visit us at booth 2042 at # ASCO14 tomorrow! See you there!,,,#,4.72463E+17,https://twitter.com/PrevGenetics/status/472462697444167680,,,,
JeffreyMOtto,5/30/2014 15:40,0,0,CR: lung cancers have exceptionally high mutation burden # ASCO14,,,#,4.72463E+17,https://twitter.com/JeffreyMOtto/status/472462649590956032,,,,
mtmdphd,5/30/2014 15:40,5,1,Rudin # lcsm # ASCO14 - lung cancer leading cause of cancer death in US and world. Also high mutation burden pic.twitter.com/jEo3jboMas,,,# #,4.72463E+17,https://twitter.com/mtmdphd/status/472462584285642752,,,,
JacobPlieth,5/30/2014 15:40,5,3,Nice summary slide on immunoconjugates - Dr Weiner # ASCO14 pic.twitter.com/pyMqclOgIG,,,#,4.72463E+17,https://twitter.com/JacobPlieth/status/472462518133469187,,,,
JeffreyMOtto,5/30/2014 15:40,0,1,"Next up: Charles Rudin Therapuetic dissection of lung cancer: onen""slice"" at a time # ASCO14""",,,#,4.72462E+17,https://twitter.com/JeffreyMOtto/status/472462478920523777,,,,
ChapinMD,5/30/2014 15:39,0,0,Dr Higano describes hard lessons learned in immunotherapy trials for PCa. # ASCO14,,,#,4.72462E+17,https://twitter.com/ChapinMD/status/472462411190923264,,,,
ArulPerumal,5/30/2014 15:39,0,0,The # oncology treatment environment has changed substantially over the last couple of years. http://ow.ly/xp3Rs # ASCO14,,,# #,4.72462E+17,https://twitter.com/ArulPerumal/status/472462359542235136,,,,
mtmdphd,5/30/2014 15:39,0,0,Walsh # gyncsm # ASCO14 Clinical practice guidelines don't always exist for mutated genes in homologous recom pathways for hereditary CA risk,,,# #,4.72462E+17,https://twitter.com/mtmdphd/status/472462352097353728,,,,
JeffreyMOtto,5/30/2014 15:38,0,0,Cw: classification of genetic variants not for the faint-of-heart. # ASCO14 BTW - I agree!,,,#,4.72462E+17,https://twitter.com/JeffreyMOtto/status/472462152914051073,,,,
drfuzita,5/30/2014 15:38,0,0,# ASCO14 http://tinyurl.com/m7n2kkk,,,#,4.72462E+17,https://twitter.com/drfuzita/status/472462096911716352,,,,
scientre,5/30/2014 15:38,1,1,BBI poster at # asco14 on Phase 1b of BBI608 combo w paclitaxel. Questions at posters incl exact target ID. http://abstracts.asco.org/144/AbstView_144_135212.html …,,,#,4.72462E+17,https://twitter.com/scientre/status/472462054314737664,,,,
mtmdphd,5/30/2014 15:38,0,0,"Walsh # gyncsm # ASCO14 - BRCA test costs are dropping, but it can be very difficult to interpret genetic panels pic.twitter.com/9NP1XaU2MS",,,# #,4.72462E+17,https://twitter.com/mtmdphd/status/472462048475881472,,,,
JanssenUS,5/30/2014 15:37,1,1,New data evaluating Janssen compound in prostate cancer to be featured in 13 abstracts at # ASCO14 http://bit.ly/1sBC6Gz,,,#,4.72462E+17,https://twitter.com/JanssenUS/status/472461870507757568,,,,
mtmdphd,5/30/2014 15:37,0,2,"Walsh # gyncsm # ASCO14 - ID the target population - HR - BRCA (Myriad until recently) -> Ambry, Gene by Gene, GeneDx, Invitae, Quest, UW, etc",,,# #,4.72462E+17,https://twitter.com/mtmdphd/status/472461825317949440,,,,
JeffreyMOtto,5/30/2014 15:37,0,0,Cw: no validated # biomarker exists for non BRCA Homologous recombination genes in ovarian cancer # ASCO14,,,# #,4.72462E+17,https://twitter.com/JeffreyMOtto/status/472461803700899840,,,,
ByJonGardner,5/30/2014 15:37,0,0,"Mabs are now immunotherapy, I guess. # ASCO14",,,#,4.72462E+17,https://twitter.com/ByJonGardner/status/472461758700220416,,,,
SarahCannonDocs,5/30/2014 15:36,1,1,Drs Arkenau & Russo presenting Poster 2514 on GSK2636771 in PTEN deficient tumours... # ASCO14 pic.twitter.com/Fbwt4p2zTw,,,#,4.72462E+17,https://twitter.com/SarahCannonDocs/status/472461562939052032,,,,
JacobPlieth,5/30/2014 15:36,1,2,Dr Weiner's checkpoint alphabet soup # ASCO14 pic.twitter.com/oSTHh0TUD6,,,#,4.72461E+17,https://twitter.com/JacobPlieth/status/472461496170319872,,,,
JeffreyMOtto,5/30/2014 15:36,0,0,Cw: PARP inhibitors are showing robust pre-clinical data for ovarian cancers # ASCO14,,,#,4.72461E+17,https://twitter.com/JeffreyMOtto/status/472461455283847168,,,,
mtmdphd,5/30/2014 15:35,0,0,Walsh # gyncsm # ASCO14 - PARPi summary pic.twitter.com/1Ur4qp3PRD,,,# #,4.72461E+17,https://twitter.com/mtmdphd/status/472461388472807424,,,,
Roche,5/30/2014 15:35,5,5,The # oncology treatment environment has changed substantially over the last couple of years. http://ow.ly/xp3Rs # ASCO14,,,# #,4.72461E+17,https://twitter.com/Roche/status/472461265164832770,,,,
myriadgenetics,5/30/2014 15:35,0,0,"If you’re attending # ASCO14, visit us at Booth 2039 to find out about our BRACAnalysis # CDx with # PARP inhibitors! http://bit.ly/1tWn80k",,,# # #,4.72461E+17,https://twitter.com/myriadgenetics/status/472461191801892864,,,,
PharmSource,5/30/2014 15:34,0,0,We’re covering # ASCO14 in Chicago: watch the PharmSource Lead Sheet for the very latest clinical # oncology updates http://bit.ly/1hdbfjx,,,# #,4.72461E+17,https://twitter.com/PharmSource/status/472461170918830080,,,,
drseisenberg,5/30/2014 15:34,0,0,"RT @ ASCO: # ASCO14 Highlighted Studies: Strategies to Improve Quality of Life for # Patients, # Survivors & # Caregivers http://bit.ly/1gJAxGo",,@,# # # #,4.72461E+17,https://twitter.com/drseisenberg/status/472461146482835457,,,,
mtmdphd,5/30/2014 15:34,0,0,Walsh # gyncsm # ASCO14 - Veliparib mono and w/ chemoRx - complicated to interpret data w/ heterogeneous combos. Maybe better tolerated?,,,# #,4.72461E+17,https://twitter.com/mtmdphd/status/472461106259058690,,,,
AdnanNagrial,5/30/2014 15:34,1,0,Just an average meeting hall at # ASCO14 pic.twitter.com/nPt9TjT7wd,,,#,4.72461E+17,https://twitter.com/AdnanNagrial/status/472461081961443328,,,,
drseisenberg,5/30/2014 15:33,4,6,Hey Thomas! RT @ tmlfox: The conversation is unfolding nicely at # ASCO14. Network Centrality Graph via @ symplurpic.twitter.com/bBEtqw0eZy,,@ @,#,4.72461E+17,https://twitter.com/drseisenberg/status/472460871554183168,,,,
mtmdphd,5/30/2014 15:33,2,0,Walsh # gyncsm # ASCO14 - Olaparib PARPi w/ chemotherapy = incr gr 3/4 heme toxicities. MonoRx tolerated well pic.twitter.com/ZEVkmajID2,,,# #,4.72461E+17,https://twitter.com/mtmdphd/status/472460779459854336,,,,
EdwinPosadasMD,5/30/2014 15:33,0,1,Tia Higano gave a great review and perspective on # immunotherapy for # ProstateCancer # ASCO14,,,# # #,4.72461E+17,https://twitter.com/EdwinPosadasMD/status/472460755543941120,,,,
LesleyLesleys,5/30/2014 15:33,1,1,Fantastic that @ ASCO # ASCO14 press briefing highlights a study (POEMS) on reducing a conseq of treatment ie infertility due to chemo,,@,#,4.72461E+17,https://twitter.com/LesleyLesleys/status/472460707699904512,,,,
BiotechMoney18,5/30/2014 15:33,1,1,$ MACK perking up volumes toward EoD heading to # ASCO14 could be big popper in coming weeks or months.,,,#,4.72461E+17,https://twitter.com/BiotechMoney18/status/472460692101271553,,,,
whysirsf,5/30/2014 15:32,0,0,What Walter White and Angelina Jolie teach us about # SocOncology. New @ W2OGroup post: http://bit.ly/1oCSM2Z # ASCO14,,@,# #,4.72461E+17,https://twitter.com/whysirsf/status/472460681040506880,,,,
mtmdphd,5/30/2014 15:32,4,1,Walsh # gyncsm # ASCO14 - What is most appropriate clinical trial endpoint for ovarian cancer drug development? Sequential therapies...,,,# #,4.7246E+17,https://twitter.com/mtmdphd/status/472460492464594944,,,,
drseisenberg,5/30/2014 15:32,7,5,"Life, Interrupted: The Cost of Cancer http://nyti.ms/160DMzC by @ suleikajaouad # ASCO14 # doctorpatient # patientdoctor",,@,# # #,4.7246E+17,https://twitter.com/drseisenberg/status/472460473158209537,,,,
scientre,5/30/2014 15:31,0,0,BBI # asco14 poster: Phase 1 dose escalation trial of BBI503 (cancer stemness kinase inhibitor) RP2D 300 mg/day http://meetinglibrary.asco.org/content/135094-144 …,,,#,4.7246E+17,https://twitter.com/scientre/status/472460415642128384,,,,
meducate,5/30/2014 15:31,0,0,I'll be there tomorrow! RT @ drseisenberg: American Society of Clinical Oncology 2014 Annual Meeting = # ASCO14,,@,#,4.7246E+17,https://twitter.com/meducate/status/472460415033962496,,,,
mtmdphd,5/30/2014 15:31,0,0,Walsh # gyncsm # ASCO14 - A pause in development by Astra-Zeneca - Dec 2011. Ledermann et al. # ASCO13 data led to Ph3 studies,,,# # #,4.7246E+17,https://twitter.com/mtmdphd/status/472460345705893890,,,,
ASCO,5/30/2014 15:31,9,3,"Missed today's # ASCO14 press briefing? View the recording for the latest in patient care, quality of life: http://bit.ly/QF4Thk",,,#,4.7246E+17,https://twitter.com/ASCO/status/472460260092182532,,,,
nbferrara,5/30/2014 15:31,0,0,MT @ CancerSupportCm Low-income patients more likely to seek social/emotional support from health care team http://bit.ly/1oRyh09 # ASCO14,,@,#,4.7246E+17,https://twitter.com/nbferrara/status/472460243247845377,,,,
PhRMA,5/30/2014 15:31,0,0,.@JenniatPhRMA dicusses how high deductibles in Silver # HIX plans single out patients who need meds http://onphr.ma/1nP9oV4 # ASCO14,,@JenniatPhRMA,# #,4.7246E+17,https://twitter.com/PhRMA/status/472460216244502528,,,,
ASCO,5/30/2014 15:31,1,1,Dr. Sidnei Epelman: An international members experience at # ASCO14 http://bit.ly/1k1BtXm,,,#,4.7246E+17,https://twitter.com/ASCO/status/472460213166297088,,,,
corp_UNC,5/30/2014 15:30,1,1,"Geographic var'n in hi-risk uterine cancer histology & access to care K.Doll, E.Basch et al @ UNC_Lineberger # asco14 http://ow.ly/xqDVu",,@,#,4.7246E+17,https://twitter.com/corp_UNC/status/472460156509626369,,,,
GenentechJobs,5/30/2014 15:30,0,0,# ASCO14 Talent Hunt: Companion Diagnostic Manager: http://click2apply.net/428990t Retweet please,,,#,4.7246E+17,https://twitter.com/GenentechJobs/status/472460150154862592,,,,
tmlfox,5/30/2014 15:30,5,5,The conversation is unfolding nicely at # ASCO14. Network Centrality Graph via @ symplurpic.twitter.com/Jygy3sSBAu,,@,#,4.7246E+17,https://twitter.com/tmlfox/status/472460129304973312,,,,
mtmdphd,5/30/2014 15:30,0,0,"Walsh # gyncsm # ASCO14 - Ph2 olaparib PARPi in maintenance setting - Study 19 - Ledermann et al. @ NEJM 2012 - longer PFS, no diff OS",,@,# #,4.7246E+17,https://twitter.com/mtmdphd/status/472460051794247680,,,,
SanfordHealth,5/30/2014 15:30,0,1,Results from HPV/cancer study involving # SanfordResearch & @ ChronixBio to be presented at @ ASCO annual conference http://ow.ly/xs0Sb,,@ @,#,4.7246E+17,https://twitter.com/SanfordHealth/status/472460045528334337,,,,
ONAcom,5/30/2014 15:30,0,0,"RT @ hughmccafferty: RT @ Pharmafocus: # ASCO14 first press conference: themes flagged include value in healthcare, the need to harness big...",,@ @,#,4.7246E+17,https://twitter.com/ONAcom/status/472460002465423360,,,,
JacobPlieth,5/30/2014 15:29,1,1,What's in a name? Dr Weiner slide on MAbs # ASCO14 pic.twitter.com/lPrsyawvSg,,,#,4.7246E+17,https://twitter.com/JacobPlieth/status/472459843929141248,,,,
aliciacollin,5/30/2014 15:29,0,0,@ drattai But does anyone TWEET their qs? Only those in their 20s? # ASCO14,,@,#,4.7246E+17,https://twitter.com/aliciacollin/status/472459825327374336,,,,
christinemphmd,5/30/2014 15:29,1,1,What's in a name? # monoclonalantibodies explained. # ASCO14 pic.twitter.com/yerUhb3iwQ,,,# #,4.7246E+17,https://twitter.com/christinemphmd/status/472459822240374784,,,,
KMilehamMD,5/30/2014 15:29,2,0,Wow: as mom and oncologist. Prob won't look at this word the same again # ASCO14 # LCI @Carolinaspic.twitter.com/U8B7zV4pXf,,@Carolinaspic,# #,4.7246E+17,https://twitter.com/KMilehamMD/status/472459721061187586,,,,
aliciacollin,5/30/2014 15:29,1,0,"That's hysterical. @ drattai: Q&A - if under 40, text your ?s; 40-70 go to the mike; >70 stay seated & raise your hand # ASCO14",,@,#,4.7246E+17,https://twitter.com/aliciacollin/status/472459702140690432,,,,
DrAttai,5/30/2014 15:28,0,0,"EXCELLENT session on 50 years of breast cancer therapy - thank you Drs. Burstein, Hunt and Harris # ASCO14 # bcsm",,,# #,4.7246E+17,https://twitter.com/DrAttai/status/472459630338375681,,,,
OrmondOncDoc,5/30/2014 15:28,0,0,Made it to # ASCO14. Got my coffee. Ready to learn something new.,,,#,4.7246E+17,https://twitter.com/OrmondOncDoc/status/472459626945204224,,,,
alessiominuzzo,5/30/2014 15:28,0,0,The amazing power of # twitter.You can stay on your sofa reading the best of one year in oncology. # ASCO14,,,# #,4.7246E+17,https://twitter.com/alessiominuzzo/status/472459596880424961,,,,
mtmdphd,5/30/2014 15:28,0,0,Walsh # gyncsm # ASCO14 - Olaparib proof of concept studies in ov ca and breast cancer - efficacy and tolerable # bcsmpic.twitter.com/unBn57Rjo8,,,# # #,4.7246E+17,https://twitter.com/mtmdphd/status/472459589200265216,,,,
cancerassassin1,5/30/2014 15:28,0,0,Great session on upper GI # cancer. much left to do to ID biomarkers + resolve ?'s which is better: neoadj chemoRT vs periop chemo # ASCO14,,,# #,4.7246E+17,https://twitter.com/cancerassassin1/status/472459567763185664,,,,
DrAttai,5/30/2014 15:28,0,0,Would need so many patients to enroll to prove the hypothesis; not likely to accrue # ASCO14 # bcsm (2/2),,,# #,4.72459E+17,https://twitter.com/DrAttai/status/472459485454561281,,,,
KaylaRodrigue11,5/30/2014 15:28,0,2,The @ breakingbad_AMC finale created bigger spike in lung cancer convo than any day of awareness month http://buff.ly/1nAQt10 # LCSM # ASCO14,,@,# #,4.72459E+17,https://twitter.com/KaylaRodrigue11/status/472459446556585986,,,,
teamoncology,5/30/2014 15:28,2,0,【 # ASCO14 101】 Neoadjuvant therapy for breast cancer was started at Istituto Nazionale del Tumori & MD Anderson in 1973.,,,#,4.72459E+17,https://twitter.com/teamoncology/status/472459437580361730,,,,
drseisenberg,5/30/2014 15:27,0,0,F.D.A. Announces Stricter Rules on Tanning Beds http://nyti.ms/1gEK7KE # ASCO14 # melanoma,,,# #,4.72459E+17,https://twitter.com/drseisenberg/status/472459415769976832,,,,
LungCancerFaces,5/30/2014 15:27,2,1,. @ nbferrara @ chimoose @ brianreid WW is no AJ. Lung cancer pts are stigmatized. We want to distance ourselves from Breaking Bad # LCSM # ASCO14,,@ @ @,# #,4.72459E+17,https://twitter.com/LungCancerFaces/status/472459404801867776,,,,
datacision,5/30/2014 15:27,2,1,Interesting poster on Next Generation Sequencing # NGS by Dr Todd Bauer @ SarahCannonDocs # ASCO14 pic.twitter.com/SSXtYhWgcF,,@,# #,4.72459E+17,https://twitter.com/datacision/status/472459341099200513,,,,
DrAttai,5/30/2014 15:27,0,0,European trial looking at axillary US to try to avoid sentinel node biopsy. Trial turned down by US cooperative groups. # ASCO14 # bcsm (1/2),,,# #,4.72459E+17,https://twitter.com/DrAttai/status/472459324422619138,,,,
mtmdphd,5/30/2014 15:27,2,0,"Walsh # gyncsm # ASCO14 - Reviews PARPi - olaparib - Ph1 initiated in 2005, reported i2009, 2010. For BRCA1/2+ 63% CBR. ORR limited to BRCA.",,,# #,4.72459E+17,https://twitter.com/mtmdphd/status/472459280541446144,,,,
stefaniei,5/30/2014 15:27,0,1,"Adding hormone suppressor to chemo can help preserve fertility in breast-cancer patients, study at # ASCO14. @ Loftus http://on.wsj.com/1kRr4wo",,@,#,4.72459E+17,https://twitter.com/stefaniei/status/472459180968669184,,,,
christinemphmd,5/30/2014 15:26,1,1,453% expected increase in US sales of the top 12 monoclonal antibodies from 2010-2014? Wow! # ASCO14 # mabsarebigbusiness,,,# #,4.72459E+17,https://twitter.com/christinemphmd/status/472459156168118272,,,,
DrAttai,5/30/2014 15:26,0,0,Can we avoid sentinel node biopsy in some pts with early stage breast cancer? Women > 70 likely not. Not enough data for most pts # ASCO14,,,#,4.72459E+17,https://twitter.com/DrAttai/status/472459130620616704,,,,
ECMC_UK,5/30/2014 15:26,0,1,Advances in breast cancer at # ASCO14 shows the complexity of disease and the value of investigating more combinations,,,#,4.72459E+17,https://twitter.com/ECMC_UK/status/472459108168531969,,,,
scientre,5/30/2014 15:26,0,0,Poster on FIH phase 1 results for Mersana XMT-1107 (based on their Fleximer tech) # asco14 abstract 2526 http://www.mersana.com/product-pipeline/xmt-1107.php …,,,#,4.72459E+17,https://twitter.com/scientre/status/472459049020452865,,,,
ASCO,5/30/2014 15:26,11,3,"# ASCO14 Highlighted Studies: Strategies to Improve Quality of Life for Patients, Survivors & Caregivers http://bit.ly/1gJAxGo",,,#,4.72459E+17,https://twitter.com/ASCO/status/472459036349464577,,,,
JoleneScience,5/30/2014 15:25,0,0,Many current Tx guidelines do not suggest GnRH agonsts for fertility preservation; previous lack of evidence # ayacsm # ASCO14,,,# #,4.72459E+17,https://twitter.com/JoleneScience/status/472458832967237632,,,,
ipaulmampilly,5/30/2014 15:25,0,0,# ASCO14 $30 bill monoclonal antibody sales..453% increase in sales 2010 to 2014..another focus of FDA trader,,,#,4.72459E+17,https://twitter.com/ipaulmampilly/status/472458801166442496,,,,
AmbryGenetics,5/30/2014 15:25,0,0,"We're here for # ASCO14! RT @ ChooseChicago W/ 2.6 million sq ft of exhibit space, @ McCormick_Place is North America’s largest exhibition ctr.",,@ @,#,4.72459E+17,https://twitter.com/AmbryGenetics/status/472458797567713281,,,,
survivornetca,5/30/2014 15:25,1,2,We've created a brand new news section on our website for updates from # ASCO14! Take a look - http://survivornet.ca/en/news/topic/american_society_of_clinical_oncology_asco_conference_2014 …,,,#,4.72459E+17,https://twitter.com/survivornetca/status/472458714671091712,,,,
CancerDotNet,5/30/2014 15:25,0,0,Advocates: Compl shuttles service from several hotels to/from McCormick Place # ASCO14 See PDF for details: http://bit.ly/1wtGpsk,,,#,4.72459E+17,https://twitter.com/CancerDotNet/status/472458711026663424,,,,
DrAttai,5/30/2014 15:25,0,1,Dr. Hunt addressing increasing rates of bilat mastectomy. Multiple factors involved. # ASCO14. Will also discuss next week # isgjc # bcsm,,,# # #,4.72459E+17,https://twitter.com/DrAttai/status/472458697512611840,,,,
ByJonGardner,5/30/2014 15:24,7,2,"For the record: raw material per gram, $2. # ASCO14 pic.twitter.com/KQvN89QJdb",,,#,4.72459E+17,https://twitter.com/ByJonGardner/status/472458641476706304,,,,
LungCancerFaces,5/30/2014 15:24,1,3,. @ chimoose @ brianreid Don't you understand the stigma lung cancer patients face? Not all publicity is good. Think about it. # LCSM # ASCO14,,@ @,# #,4.72459E+17,https://twitter.com/LungCancerFaces/status/472458520973963264,,,,
anvillani,5/30/2014 15:24,0,1,Curious to see if # ASCO14 will beat out # GrumpyCat for biggest news out of Chicago.,,,# #,4.72459E+17,https://twitter.com/anvillani/status/472458520294879232,,,,
DrAttai,5/30/2014 15:23,0,1,"Optimal margin for DCIS - probably NOT no tumor on ink"""," but maybe 2mm. More study needed # ASCO14 # bcsm""",,,# #,4.72458E+17,https://twitter.com/DrAttai/status/472458300274262019,,,
jamienholloway,5/30/2014 15:23,0,0,Tip of the day: never head to a doctor appt with an uncharged cell. Glad to catch up on # ASCO14 while I wait! # bcsm,,,# #,4.72458E+17,https://twitter.com/jamienholloway/status/472458194003189760,,,,
JacobPlieth,5/30/2014 15:22,0,3,Dr Adams slide on strategies for tumours rich in tumour-infiltrating lymphocytes # ASCO14 pic.twitter.com/nWfnLiDzcX,,,#,4.72458E+17,https://twitter.com/JacobPlieth/status/472458118287605760,,,,
JeffreyMOtto,5/30/2014 15:22,0,0,CW - non BRCA homologous recombination genes account for 6% of ovarian cancers # ASCO14,,,#,4.72458E+17,https://twitter.com/JeffreyMOtto/status/472458105981124608,,,,
theABTA,5/30/2014 15:22,0,1,The future is now - about 90% of genetic targets don't have drugs associated with them. There is much to do. # ASCO14,,,#,4.72458E+17,https://twitter.com/theABTA/status/472458084204699649,,,,
LungCancerFaces,5/30/2014 15:21,0,0,". @ chimoose @ brianreid Walter White is no Angelina. Didn't leverage"" Breaking Bad popularity because would add to STIGMA of LC # ASCO14 # LCSM""",,@ @,# #,4.72458E+17,https://twitter.com/LungCancerFaces/status/472457900447645696,,,,
ipaulmampilly,5/30/2014 15:21,0,0,# ASCO14 poster board 32..a new kind of antibody oligoclonal... pic.twitter.com/lSn40On9V7,,,#,4.72458E+17,https://twitter.com/ipaulmampilly/status/472457882517401602,,,,
teamoncology,5/30/2014 15:21,3,2,Basic info. RT @ ASCO: Our 10 tips for use of social media http://bit.ly/1mzloFy # hcsm # ASCO14 pic.twitter.com/Iteoecjp0i,,@,# #,4.72458E+17,https://twitter.com/teamoncology/status/472457811004096512,,,,
JoleneScience,5/30/2014 15:21,0,0,POEMS results # ASCO14: goserelin reduces ovarian failure due to # chemo in premenopausal HR- # breastcancer pts; maybe better DFS/OS too,,,# # #,4.72458E+17,https://twitter.com/JoleneScience/status/472457728690900992,,,,
DrBobGoldberg,5/30/2014 15:20,0,0,@ ASCO value app ignores fact that new rx less than .5% of medical costs and adds trillions in value. Shameful http://www.biocenturytv.com/player/3368170720001/3372492220001 …,,@,,4.72458E+17,https://twitter.com/DrBobGoldberg/status/472457617915535360,,,,
DrAttai,5/30/2014 15:20,0,0,Dr. Harris discussing MIlan IORT trial - surprised by higher than expected local recurrence rates # ASCO14 # bcsm,,,# #,4.72458E+17,https://twitter.com/DrAttai/status/472457575636946945,,,,
LungCancerFaces,5/30/2014 15:20,0,0,. @ KellyMDavisson Walter White is no Angelina Jolie. Didn't leverage Breaking Bad popularity because would add to STIGMA of LC. # ASCO14 # LCSM,,@,# #,4.72457E+17,https://twitter.com/LungCancerFaces/status/472457454920294400,,,,
LesleyLesleys,5/30/2014 15:20,1,1,# ASCO14 Chicago - Gill Levitt spkng Mon2Jun 08.40 on Implemntn of # Survivorship Programs in a Nationalized Health Care System [aka the NHS!],,,# #,4.72457E+17,https://twitter.com/LesleyLesleys/status/472457423832514563,,,,
christinemphmd,5/30/2014 15:19,0,1,All T-cells are equal... But some more equal than others, Dr. Cassian Yee # ASCO14 # Orwellpic.twitter.com/AE1937ILfz,,,# #,4.72457E+17,https://twitter.com/christinemphmd/status/472457317452365825,,,
danielebanfi83,5/30/2014 15:19,0,1,Aeroporto alle grandi manovre... Intanto un'ora di ritardo. Facciamoci una cultura culinaria va'... # ASCO14 pic.twitter.com/vMDvAhUVeQ,,,#,4.72457E+17,https://twitter.com/danielebanfi83/status/472457257209585665,,,,
drseisenberg,5/30/2014 15:19,0,0,@ASCOConnection's Songs of the Soul: http://connection.asco.org/Magazine/Article/ID/3676/Songs-of-the-Soul.aspx … # youmatter # ASCO14,,@ASCOConnection,# #,4.72457E+17,https://twitter.com/drseisenberg/status/472457248296271872,,,,
DrAttai,5/30/2014 15:19,6,9,"O/A session - if you're under 40, text your ?s; 40-70 go to the mike; >70 just stay seated and raise your hand :) # ASCO14",,,#,4.72457E+17,https://twitter.com/DrAttai/status/472457172774039552,,,,
EMDSerono,5/30/2014 15:19,1,1,At THE # oncology conference of the year! Helping celebrate its 50 years of leadership. # ASCO14 pic.twitter.com/WoGRrUGKpm,,,# #,4.72457E+17,https://twitter.com/EMDSerono/status/472457166017019905,,,,
sciberomics,5/30/2014 15:18,0,0,Christine Walsh (Cedars Sinai): Homologous recombination a target for # cancer # therapy since BRCA1 and BRCA2 isolation # ASCO14,,,# # #,4.72457E+17,https://twitter.com/sciberomics/status/472457131115835393,,,,
scientre,5/30/2014 15:18,1,2,Kudos @ Novartis for easy-to-take-with-you posters (aka QR code) at # asco14 cc @ NovartisSciencepic.twitter.com/u1EJVykDfQ,,@ @,#,4.72457E+17,https://twitter.com/scientre/status/472457039298695168,,,,
EBOncology,5/30/2014 15:18,1,2,"# ASCO14 Next-gen sequencing is still a developing field-Elaine Mardis, Genome Institute",,,#,4.72457E+17,https://twitter.com/EBOncology/status/472456975134240768,,,,
DrAttai,5/30/2014 15:18,1,1,We need the NEXT BIG THING Dr. Burstein # ASCO14 # BCSM (1/2),,,# #,4.72457E+17,https://twitter.com/DrAttai/status/472456955957895168,,,,
bobpersio,5/30/2014 15:17,2,2,Proud @ EIannelli brings # ASCO14 the voice of our European community! @ kgapo @ cancereu @ favo_it @ ecancer @ ailar_it,,@ @ @ @ @ @,#,4.72457E+17,https://twitter.com/bobpersio/status/472456860826861569,,,,
DrAttai,5/30/2014 15:17,0,1,"Despite extraordinary innovation and progress, we are reminded daily that we need more Dr. Burstein # ASCO14 # bcsm (1/2)",,,# #,4.72457E+17,https://twitter.com/DrAttai/status/472456811648647169,,,,
DrLaraDavis,5/30/2014 15:17,0,0,Important data for fertility preservation: # ASCO2014 Phase III trial of LHRH analog during chemotherapy to reduce ovarian failure # POEMS,,,# #,4.72457E+17,https://twitter.com/DrLaraDavis/status/472456722942922752,,,,
DrAttai,5/30/2014 15:16,1,0,"Concerns regarding access, availability of specialists, costs, and more given changes in healthcare system Dr. Burstein # ASCO14 # bcsm (2/2)",,,# #,4.72457E+17,https://twitter.com/DrAttai/status/472456603078492160,,,,
JeffreyMOtto,5/30/2014 15:16,0,0,Next up: Christine Walsh homologous recombination: target, predictive # biomarker," prognostic biomarker # ASCO14""",,,# #,4.72457E+17,https://twitter.com/JeffreyMOtto/status/472456599290662912,,
BioWorld,5/30/2014 15:16,1,2,"Out the back door of a quality-of-life session at # ASCO14 , there it is. pic.twitter.com/f3JWfGK0Je",,,#,4.72457E+17,https://twitter.com/BioWorld/status/472456572518801409,,,,
gr8genes,5/30/2014 15:16,0,0,@GeneticCoun Yes! Representing genetic counselors @ # ASCO14,,@GeneticCoun @,#,4.72457E+17,https://twitter.com/gr8genes/status/472456566202195968,,,,
SarahCannonDocs,5/30/2014 15:16,0,0,Targeted therapy exploring PTEN mutant cell lines in ongoing Phase I/II trial Poster 28 Abs#2514 # ASCO14 # DrArkenaupic.twitter.com/NW6t9e9ez4,,,#2514 # #,4.72457E+17,https://twitter.com/SarahCannonDocs/status/472456552742649856,,,,
KellyMDavisson,5/30/2014 15:16,0,1,Great lesson of new # SocOncology report: ignore pop culture at your peril when educating on cancer: http://bit.ly/1oCSM2Z # ASCO14,,,# #,4.72457E+17,https://twitter.com/KellyMDavisson/status/472456504524959744,,,,
smerv,5/30/2014 15:16,2,0,Women with metastatic # breastcancer can safely receive bisphosphonates less frequently. # ASCO2014 # endcancerhttp://www.mdanderson.org/newsroom/news-releases/2014/women-with-metastatic-breast-cancer-can-safely-receive-bisphosphonates.html#.U4jYsakzInE.twitter …,,,# # # #,4.72456E+17,https://twitter.com/smerv/status/472456446559256576,,,,
nbferrara,5/30/2014 15:16,0,0,MT @ chimoose What Walter White and Angelina Teach Us About Cancer Conversation Online http://bit.ly/1oCSM2Z by @ brianreid # ASCO14,,@ @,#,4.72456E+17,https://twitter.com/nbferrara/status/472456436879196160,,,,
DrAttai,5/30/2014 15:16,3,1,There are a LOT of providers across multiple specialties needed to care for breast cancer patients Dr. Burstein # ASCO14 # bcsm (1/2),,,# #,4.72456E+17,https://twitter.com/DrAttai/status/472456432831709184,,,,
SitemanCenter,5/30/2014 15:15,0,0,"Siteman's Tanya Wildes, MD, discusses multiple myeloma treatment options for older patients: 3:25-3:45 pm, Rm E253 # ASCO14",,,#,4.72456E+17,https://twitter.com/SitemanCenter/status/472456366846914560,,,,
mtmdphd,5/30/2014 15:15,1,1,Mardis # ASCO14 - Next Generation Sequencing (NGS) - Will this ever get easier (yes)... pic.twitter.com/Kv0S8Zohzb,,,#,4.72456E+17,https://twitter.com/mtmdphd/status/472456363298136064,,,,
CathyEngMD,5/30/2014 15:15,2,0,"# ASCO14 # colorectalcancer poster presentations at 8am tomorrow, # crcsm, # endcancer, # cancer",,,# # # # #,4.72456E+17,https://twitter.com/CathyEngMD/status/472456319778435073,,,,
aliepea,5/30/2014 15:15,0,0,"Interesting stuff “ @ CancerDotNet: Today's # ASCO14 cancer research highlights, on short- & long-term side effects: http://bit.ly/1hjxkOD ”",,@,#,4.72456E+17,https://twitter.com/aliepea/status/472456273683050496,,,,
JacobPlieth,5/30/2014 15:15,0,0,Dr Yee on engineered T-cell therapy # ASCO14 pic.twitter.com/qTWYzEjsxW,,,#,4.72456E+17,https://twitter.com/JacobPlieth/status/472456268834414592,,,,
MaurerStats,5/30/2014 15:15,1,0,MT @ ALLIANCE_org # ASCO14 CALGB-50803: Phase2 trial of R+lenolidomide in pts w/ prev untreat FL http://meetinglibrary.asco.org/content/132800-144 … … # AllianceNCTN # lymsm,,@,# # #,4.72456E+17,https://twitter.com/MaurerStats/status/472456232754634752,,,,
JeffreyMOtto,5/30/2014 15:15,0,0,"EM: most false due to low coverage, most false positives can be dealt with bioinformatically # ASCO14",,,#,4.72456E+17,https://twitter.com/JeffreyMOtto/status/472456210189258753,,,,
AlpineBV_Miller,5/30/2014 15:15,0,0,Ready.... Go! # asco14 pic.twitter.com/HT1pilkcxt,,,#,4.72456E+17,https://twitter.com/AlpineBV_Miller/status/472456204678352897,,,,
ipaulmampilly,5/30/2014 15:15,0,0,# ASCO14 this is interesting...a biotech cocktail trial... pic.twitter.com/TY20g7oPkr,,,#,4.72456E+17,https://twitter.com/ipaulmampilly/status/472456178107445248,,,,
mtmdphd,5/30/2014 15:14,0,0,Mardis # ASCO14 - PCR-related problems in NGS: Somatic Variant Discovery Pipeline - input / analysis / results / beautiful figure for pub,,,#,4.72456E+17,https://twitter.com/mtmdphd/status/472456040521297920,,,,
DrAttai,5/30/2014 15:14,4,1,"neoadjuvant therapy as a platform for discovery"" - model for drug discovery"," info used to tailor therapy? Dr. Burstein # ASCO14 # bcsm""",,,# #,4.72456E+17,https://twitter.com/DrAttai/status/472456017729818624,,,
drseisenberg,5/30/2014 15:14,1,0,Life Beyond the Cancer Clinic http://nyti.ms/1hgIIe9 # ASCO14 # bcsm # lcsm,,,# # #,4.72456E+17,https://twitter.com/drseisenberg/status/472455908400705537,,,,
BioWorld,5/30/2014 15:13,3,2,"Vital but often neglected"" family caregiver stress ""equal to and sometimes greater"" than cancer pts: Marie Bakitas paper on study # ASCO14""",,,#,4.72456E+17,https://twitter.com/BioWorld/status/472455795515621376,,,,
BioWorld,5/30/2014 15:13,3,2,Obesity the new tobacco," says prez Clifford Hudis at # ASCO14, but digital economy way behind in cancer care.",,,#,4.72456E+17,https://twitter.com/BioWorld/status/472455792508284928,,,
mtmdphd,5/30/2014 15:13,1,0,Mardis # ASCO14 - PCR-related problems in NGS: RefCov - Coverage Depth and Breadth from Hybrid Capture - URL in slides,,,#,4.72456E+17,https://twitter.com/mtmdphd/status/472455771658018817,,,,
AGMednet,5/30/2014 15:13,0,0,Congrats! RT @ ASCO Our congratulations to James O Armitage MD on his # ASCO14 Special Recognition Award cc @ unmc @ ASCOPost,,@ @ @,#,4.72456E+17,https://twitter.com/AGMednet/status/472455741732052992,,,,
drseisenberg,5/30/2014 15:13,2,0,Drug Could Protect Fertility in Breast Cancer Patients http://nyti.ms/1gJcure # ASCO14 # bcsm,,,# #,4.72456E+17,https://twitter.com/drseisenberg/status/472455706629509121,,,,
AnneBooms,5/30/2014 15:12,1,0,“ @ drcbsteer: # ASCO14 # geriatriconcology. Importance of care coordination mentioned in 3/3 talks so far.” Early PC improving QOL,,@,# #,4.72456E+17,https://twitter.com/AnneBooms/status/472455630796910592,,,,
rschilsky,5/30/2014 15:12,0,0,Busy day at # ASCO14. Now attending EORTC-ASCO meeting on translational research.,,,#,4.72456E+17,https://twitter.com/rschilsky/status/472455626908766208,,,,
ASCO,5/30/2014 15:12,8,1,"This is really an incredible study. We've been waiting for something like this"" - Dr. Patricia Ganz on POEMS findings # ASCO14""",,,#,4.72455E+17,https://twitter.com/ASCO/status/472455476341665792,,,,
FarmaOnco,5/30/2014 15:12,1,0,@ mjmbauti @ chuslamas Yo también estoy enganchada ;)) # ASCO14,,@ @,#,4.72455E+17,https://twitter.com/FarmaOnco/status/472455447522607105,,,,
rojasanne,5/30/2014 15:12,0,0,Ready for # ASCO14,,,#,4.72455E+17,https://twitter.com/rojasanne/status/472455408100323328,,,,
KMilehamMD,5/30/2014 15:11,0,0,“ @ ASCO: Digitally see today's Daily News http://bit.ly/1wAkTCd # ASCO14 pic.twitter.com/gv7OfmjbgA” great way to access news # LCI @Carolinas,,@ @Carolinas,# #,4.72455E+17,https://twitter.com/KMilehamMD/status/472455350697082880,,,,
drseisenberg,5/30/2014 15:11,1,1,@ mtmdphd = THE tweetologist of # ASCO14,,@,#,4.72455E+17,https://twitter.com/drseisenberg/status/472455278332354560,,,,
UAZCancer,5/30/2014 15:11,1,4,More than 25K # cancer specialsts are in Chicago at # ASCO14. Our physician/scientists are among them,,,# #,4.72455E+17,https://twitter.com/UAZCancer/status/472455241808363520,,,,
MLIWI,5/30/2014 15:11,2,1,Our lives are not measured in 5 year increments. # cancer Sign the petition. # ASCO14 # MLIWI http://bit.ly/1ktKlV4,,,# # #,4.72455E+17,https://twitter.com/MLIWI/status/472455179619823616,,,,
JTCancerCenter,5/30/2014 15:10,0,1,# ASCO14 prep is underway at the McCormick Place in Chicago. We are proud to be among the exhibitors at booth 20157. pic.twitter.com/mBtn82kBtM,,,#,4.72455E+17,https://twitter.com/JTCancerCenter/status/472455077224255490,,,,
mtmdphd,5/30/2014 15:10,1,1,"Mardis # ASCO14 - PCR-related problems in NGS: human genome is large, repetititve, and somewhat complex to analyze pic.twitter.com/EkB9glcimf",,,#,4.72455E+17,https://twitter.com/mtmdphd/status/472455056722112512,,,,
DrAttai,5/30/2014 15:10,4,1,Dr. Burstein - we also need to standardize pathology testing and reporting for breast cancer # ASCO14 # bcsm,,,# #,4.72455E+17,https://twitter.com/DrAttai/status/472454970911227904,,,,
CancerDotNet,5/30/2014 15:10,0,1,"RT @ ASCO: Looking for a place to take a break and power up? Enjoy a coffee, meet up with colleagues and plug-in at a Networking Cafe # ASCO14",,@,#,4.72455E+17,https://twitter.com/CancerDotNet/status/472454916930560000,,,,
BIOTECH888,5/30/2014 15:09,0,1,# ASCO14 # breastcancerpic.twitter.com/8FvKUNsDWR,,,# #,4.72455E+17,https://twitter.com/BIOTECH888/status/472454896747569153,,,,
mtmdphd,5/30/2014 15:09,1,1,Mardis # ASCO14 - PCR-related problems in NGS: Post Data Generation Analyses - data alignment is the crucial first step,,,#,4.72455E+17,https://twitter.com/mtmdphd/status/472454867886153728,,,,
EdwinPosadasMD,5/30/2014 15:09,0,0,# CHAARTED To be presented at # ASCO14 Early chemotherapy in # prostatecancer ?,,,# # #,4.72455E+17,https://twitter.com/EdwinPosadasMD/status/472454772725796865,,,,
mtmdphd,5/30/2014 15:09,0,0,Mardis # ASCO14 - PCR-related problems in NGS: Ion Torrent PGM vs Proton pic.twitter.com/5I49TkJuDS,,,#,4.72455E+17,https://twitter.com/mtmdphd/status/472454722507390976,,,,
SvenC,5/30/2014 15:09,0,0,"Using Breaking Bad to break cancer? # SocOncology shows risks, potential of pop culture and cancer: http://buff.ly/1mzUSfl # ASCO14",,,# #,4.72455E+17,https://twitter.com/SvenC/status/472454653398224896,,,,
BIOTECH888,5/30/2014 15:08,0,0,# ASCO14 # breastcancer # mutationspic.twitter.com/027o0y0saV,,,# # #,4.72455E+17,https://twitter.com/BIOTECH888/status/472454628517625857,,,,
LungDocDoug,5/30/2014 15:08,2,2,"To all my friends at # ASCO14, I ask only one thing of you while in my hometown. # NoKetchup on your hot dogs. http://www.portillos.com",,,# #,4.72455E+17,https://twitter.com/LungDocDoug/status/472454537987760128,,,,
BIOTECH888,5/30/2014 15:08,0,0,# ASCO14 # breastcancerpic.twitter.com/VYgfKtNNF9,,,# #,4.72455E+17,https://twitter.com/BIOTECH888/status/472454511081295873,,,,
MatthewHSimmons,5/30/2014 15:08,0,1,People are actually using the QR codes on the posters... # ASCO14,,,#,4.72454E+17,https://twitter.com/MatthewHSimmons/status/472454447281356800,,,,
subatomicdoc,5/30/2014 15:07,0,0,"@ drattai True, # radonc is very competitive. But that doesn't mean the doctors are necessarily better # ASCO14",,@,# #,4.72454E+17,https://twitter.com/subatomicdoc/status/472454393892458496,,,,
mtmdphd,5/30/2014 15:07,0,0,Mardis # ASCO14 - PCR-related problems in NGS: Ion Torrent-pH sensing synthesis is another platform,,,#,4.72454E+17,https://twitter.com/mtmdphd/status/472454381988638720,,,,
BIOTECH888,5/30/2014 15:07,0,0,# ASCO14 # 50YearsofBreastCancerpic.twitter.com/QQwHaCz9Xa,,,# #,4.72454E+17,https://twitter.com/BIOTECH888/status/472454303295504384,,,,
DrAttai,5/30/2014 15:07,7,4,big challenge - coming to grips with implications of gene mutations other than BRCA 1/2 Dr. Burstein # ASCO14 # bcsm,,,# #,4.72454E+17,https://twitter.com/DrAttai/status/472454264259088384,,,,
mtmdphd,5/30/2014 15:07,0,0,Mardis # ASCO14 - PCR-related problems in NGS: Illumina platform - some can produce a genome overnight,,,#,4.72454E+17,https://twitter.com/mtmdphd/status/472454260576112640,,,,
UCCancerCenter,5/30/2014 15:07,0,0,Jonas De Souza discusses value of head neck cancer treatment and important patient outcomes beyond survival # ASCO14 pic.twitter.com/6rM00cHmhl,,,#,4.72454E+17,https://twitter.com/UCCancerCenter/status/472454229916147712,,,,
ALLIANCE_org,5/30/2014 15:06,0,1,Prognostic & predictive tumor-based biomarkers in pts w/ adv RCC treated w/ IFN w/ or w/o Bev # CALGB90206. # ASCO14 http://bit.ly/1tuNGnh,,,# #,4.72454E+17,https://twitter.com/ALLIANCE_org/status/472454122721914880,,,,
DrLaraDavis,5/30/2014 15:06,0,0,Fertility preservation for oncologic conditions within a publicly financed health care program. # ASCO2014 http://abstracts.asco.org/144/index.html,,,#,4.72454E+17,https://twitter.com/DrLaraDavis/status/472454003314286592,,,,
CurtMcCormick,5/30/2014 15:05,0,0,Stop in and say hello to us at @ mySCRS at # ASCO14. So proud to be at a place filled with so many incredible researchers! # clinicaltrials,,@,# #,4.72454E+17,https://twitter.com/CurtMcCormick/status/472453748434796544,,,,
Roche,5/30/2014 15:05,12,9,"# Immunotherapy combinations of the future will pair immunotherapies with targeted, non-immunological drugs: http://ow.ly/xkDeN # ASCO14",,,# #,4.72454E+17,https://twitter.com/Roche/status/472453739161604097,,,,
JFreemanDaily,5/30/2014 15:05,2,2,# asco14 Bright future for therapeutic cancer vaccines when combined with other therapies (but not when used alone).,,,#,4.72454E+17,https://twitter.com/JFreemanDaily/status/472453700896948224,,,,
ClevelandClinic,5/30/2014 15:05,15,7,New drug can increase the chances of fertility preservation in some # breastcancer patients: http://online.wsj.com/articles/hormone-suppressor-seen-helping-some-breast-cancer-patients-1401472339 … (via @ Loftus) # ASCO14,,@,# #,4.72454E+17,https://twitter.com/ClevelandClinic/status/472453662032138241,,,,
Boehringer,5/30/2014 15:05,0,2,# PRESS: PFS? OS? EGFR? ErbB? NSCLC? Get to grips with the # jargon # ASCO14 Full # oncology glossary here http://bit.ly/RKr4CU,,,# # # #,4.72454E+17,https://twitter.com/Boehringer/status/472453659289485313,,,,
DrAttai,5/30/2014 15:05,1,1,"Who doesn't need chemo? Advances: ballpark risk estimate, Adjuvant! Online; now tumor genomics can be evaluated # ASCO14 # bcsm Dr. Buerstein",,,# #,4.72454E+17,https://twitter.com/DrAttai/status/472453642705203202,,,,
kbnewport,5/30/2014 15:04,0,1,"Dr. Shih geriatric cancer costs: it's not about cost savings, it's about appropriate, quality care # ASCO14",,,#,4.72454E+17,https://twitter.com/kbnewport/status/472453617329647616,,,,
JacobPlieth,5/30/2014 15:04,1,1,Ongoing cancer vaccine trials - Dr Bhardwaj # ASCO14 pic.twitter.com/SetlB4WLUU,,,#,4.72454E+17,https://twitter.com/JacobPlieth/status/472453527345057792,,,,
mtmdphd,5/30/2014 15:04,1,0,Mardis # ASCO14 - PCR-related problems NGS: 5ng input DNA for clinical samples - multiplex PCR - that could be a fine needle aspirate (FNA),,,#,4.72454E+17,https://twitter.com/mtmdphd/status/472453524110856193,,,,
christinemphmd,5/30/2014 15:04,1,2,"Combination, combination, combination... Vaccines and chemotherapy together may be the future of cancer therapies. # ASCO14",,,#,4.72453E+17,https://twitter.com/christinemphmd/status/472453393374785536,,,,
richardmarciINC,5/30/2014 15:04,0,0,The Ariad Healthcare Daily is out! http://paper.li/ariadhealthcare Stories via @ ASCO,,@,,4.72453E+17,https://twitter.com/richardmarciINC/status/472453389415378944,,,,
ipaulmampilly,5/30/2014 15:04,0,0,Immunotherapy is one of the focuses of FDA Trader...slide of trials shows about 30 clinical trials ongoing... # ASCO14 pic.twitter.com/HZMmDrYCHU,,,#,4.72453E+17,https://twitter.com/ipaulmampilly/status/472453389239214081,,,,
SitemanCenter,5/30/2014 15:03,0,0,"Siteman and @ WUSTLmed's Elaine Mardis, PhD, discusses evolving technologies in somatic tumor genetics. # ASCO14 pic.twitter.com/6vGcxP4hoY",,@,#,4.72453E+17,https://twitter.com/SitemanCenter/status/472453347291987969,,,,
JeffreyMOtto,5/30/2014 15:03,0,0,"I think it is important to understand the natural bias of the employed NGS methodogy, and calibrate confidence accordingly # asco14",,,#,4.72453E+17,https://twitter.com/JeffreyMOtto/status/472453273555718145,,,,
ASCO,5/30/2014 15:03,7,4,# ASCO14 opening press briefing highlights: POEMS: Highly sig. reduction in ovarian failure @2 years for chemo + goserelin,,@2,#,4.72453E+17,https://twitter.com/ASCO/status/472453261728169986,,,,
mtmdphd,5/30/2014 15:03,0,0,Mardis # ASCO14 - PCR-related problems in NGS: Multiplex PCR amplification targets can also be used for hot spots instead of hybrid capture,,,#,4.72453E+17,https://twitter.com/mtmdphd/status/472453188159692800,,,,
nanostringtech,5/30/2014 15:02,1,2,"We invite # ASCO14 attendees to visit us at booth 5019, located near @ ASCO Central",,@,#,4.72453E+17,https://twitter.com/nanostringtech/status/472453087060578304,,,,
gumedcenter,5/30/2014 15:02,2,1,"For young # breastcancer patients, goal is normal life", says @ LombardiCancer doc re: # menopause prev. study http://reut.rs/1kdwnpR # ASCO14,,@,# # #,4.72453E+17,https://twitter.com/gumedcenter/status/472453026700349441,,,
mtmdphd,5/30/2014 15:02,1,1,Mardis # ASCO14 - PCR-related problems in NGS: large exon may have multiple probes to select -- hybrid capture,,,#,4.72453E+17,https://twitter.com/mtmdphd/status/472452998971416578,,,,
drcbsteer,5/30/2014 15:02,1,1,# ASCO14 # geriatriconcology. Importance of care coordination mentioned in 3/3 talks so far.,,,# #,4.72453E+17,https://twitter.com/drcbsteer/status/472452966763741184,,,,
ASCO,5/30/2014 15:02,2,2,# ASCO14 opening press briefing highlights: POEMS: Few data currently available on pregnancy outcomes w/ hormone suppressing drugs,,,#,4.72453E+17,https://twitter.com/ASCO/status/472452963777413120,,,,
scientre,5/30/2014 15:02,0,0,Seems like new thing: ASCO-specific pharma co website MT @ NovartisScience Check out @ Novartis’ website for # ASCO14 http://bit.ly/1ipAxGQ,,@ @,#,4.72453E+17,https://twitter.com/scientre/status/472452953757188096,,,,
DrAttai,5/30/2014 15:02,7,1,10yrs endocrine therapy now recommended for premenopausal women and some post. Who does NOT need extended therapy? RESEARCH # ASCO14 # bcsm,,,# #,4.72453E+17,https://twitter.com/DrAttai/status/472452936552169472,,,,
Novartis,5/30/2014 15:02,2,2,Keep up with the latest data on # polycythemiavera & # myelofibrosis from # Novartis at # ASCO14 http://bit.ly/1i93rtE,,,# # # #,4.72453E+17,https://twitter.com/Novartis/status/472452923155574784,,,,
christinemphmd,5/30/2014 15:02,0,0,Very informative and concise talk by Dr. Nina Bhardwaj on Principles of Adaptive Immunity # ASCO14 @ MountSinaiNYC,,@,#,4.72453E+17,https://twitter.com/christinemphmd/status/472452917648429056,,,,
ASCO,5/30/2014 15:02,7,5,Our congratulations to Jaime De La Garza MD on his # ASCO14 Distinguished Achievement Award CC @ incanMX,,@,#,4.72453E+17,https://twitter.com/ASCO/status/472452910400684033,,,,
mtmdphd,5/30/2014 15:02,0,0,"Mardis # ASCO14 - PCR-related probs in NGS: whole genome is highly complex, hybrid capture - frag from WG eg exome or custom capture reagents",,,#,4.72453E+17,https://twitter.com/mtmdphd/status/472452899646087168,,,,
SequentaInc,5/30/2014 15:02,0,1,Study used LymphoSIGHT pltfrm to assess immune response to # immunotherapy http://ow.ly/xm5Z5 ; # ASCO14 data too: http://ow.ly/xm7XJ,,,# #,4.72453E+17,https://twitter.com/SequentaInc/status/472452894240047106,,,,
ONAcom,5/30/2014 15:01,0,0,"@ ASCO You've been quoted in my # Storify story Early impressions and comments from ASCO thought leaders"" http://sfy.co/fjRt""",,@,#,4.72453E+17,https://twitter.com/ONAcom/status/472452856235425792,,,,
ASCO,5/30/2014 15:01,0,2,"Myc, RAF, Autophagy: Signaling Pathways to Therapeutics Education Session today http://bit.ly/1pkrjmI # ASCO14",,,#,4.72453E+17,https://twitter.com/ASCO/status/472452842155171840,,,,
ASCO,5/30/2014 15:01,1,3,# ASCO14 opening press briefing highlights: POEMS: Ovarian function is particularly susceptible to damage from chemo,,,#,4.72453E+17,https://twitter.com/ASCO/status/472452759485427713,,,,
KellyMDavisson,5/30/2014 15:01,0,0,# SocOncology report from @ W2OGroup looked at 15 million online conversations about cancer. What we saw: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72453E+17,https://twitter.com/KellyMDavisson/status/472452746193694720,,,,
JeffreyMOtto,5/30/2014 15:01,0,0,"EM - low input amts of DNA leads to PCR induced errors. But, most errors can be detected and corrected bioinformatically # ASCO14",,,#,4.72453E+17,https://twitter.com/JeffreyMOtto/status/472452730208784384,,,,
ajrsferreira,5/30/2014 15:01,0,0,"E no # CHLN?  @ tomleblancMD: # burnout among # palliative care clinicians; an astounding 61%! http://ow.ly/xriOB # ASCO14""""",,@,# # # #,4.72453E+17,https://twitter.com/ajrsferreira/status/472452697657212930,,,,
drcbsteer,5/30/2014 15:01,0,0,# ASCO14 # geriatriconcology. Multiple challenges ahead to contain costs. Need to # choosewisely.,,,# # #,4.72453E+17,https://twitter.com/drcbsteer/status/472452641252212736,,,,
KUhlendorf,5/30/2014 15:01,0,0,Excited for Stakeholder Perspectives on Value in # Cancer panel this pm. Hoping to hear the word “patient” dominate discussion # asco14,,,# #,4.72453E+17,https://twitter.com/KUhlendorf/status/472452635149500416,,,,
CancerDotNet,5/30/2014 15:00,1,0,Advocates: Research highlights on Sat/Sun 5:30pm Advocate Lounge S402. Hear about the news of each day # ASCO14 http://bit.ly/1o1oseP,,,#,4.72453E+17,https://twitter.com/CancerDotNet/status/472452615054577664,,,,
nbferrara,5/30/2014 15:00,0,0,RT @ NCIMedia Announced at # ASCO14: Treatment helps young women preserve their fertility during breast cancer chemotherapy # bcsm...,,@,# #,4.72453E+17,https://twitter.com/nbferrara/status/472452560721555456,,,,
mtmdphd,5/30/2014 15:00,0,0,Mardis # ASCO14 5/30 - PCR-related problems in NGS: if substitution is early in PCR can appear as a true variant. Not a problem if sub later,,,#,4.72453E+17,https://twitter.com/mtmdphd/status/472452560515649537,,,,
ALLIANCE_org,5/30/2014 15:00,0,0,# ASCO14 CALGB-50803: A Phase II trial of lenalidomide + rituximab in pts w/ prev untreated FL http://abstracts.asco.org/144/index.html # AllianceNCTN,,,# #,4.72453E+17,https://twitter.com/ALLIANCE_org/status/472452559588700161,,,,
zorgnieu_ws,5/30/2014 15:00,0,0,Merck Serono presenteert nieuwe onderzoeksresultaten van moeilijk behandelbare kankersoorten tijdens # ASCO14 http://wp.me/p2ZL1H-6qL,,,#,4.72453E+17,https://twitter.com/zorgnieu_ws/status/472452548175994880,,,,
jodyms,5/30/2014 15:00,0,0,Off to Galveston for the weekend. Follow # ASCO14 tweets by @ DrAttai @ TeamOncology @ fischmd @resm2800 @ AdvocateDebM @ MaverickNY @ 3NT Later:),,@ @ @ @resm2800 @ @ @,#,4.72453E+17,https://twitter.com/jodyms/status/472452530589683713,,,,
ASCO,5/30/2014 15:00,2,8,Highlights from # ASCO14 opening press briefing: Dr Halle Moore presented findings of POEMS: prevention of early menopause study,,,#,4.72452E+17,https://twitter.com/ASCO/status/472452488332083201,,,,
ONAcom,5/30/2014 15:00,0,0,"RT @ drattai: next up - systemic therapy advances (chemo, hormonal therapy, targeted agents) # ASCO14 # bcsm",,@,# #,4.72452E+17,https://twitter.com/ONAcom/status/472452458904829955,,,,
mtmdphd,5/30/2014 15:00,0,0,Mardis # ASCO14 5/30 - PCR-related problems in NGS: jackpotting favored esp w/ limited clinical samples,,,#,4.72452E+17,https://twitter.com/mtmdphd/status/472452397906665472,,,,
DanaFarber,5/30/2014 15:00,4,6,Combo therapy shows promise against forms of breast and ovarian cancer in early clinical trial: http://bit.ly/1k7SE9Q # ASCO14 # bcsm # SFSCWC,,,# # #,4.72452E+17,https://twitter.com/DanaFarber/status/472452391359762432,,,,
mtmdphd,5/30/2014 14:59,0,0,"Mardis # ASCO14 5/30 - PCR-related problems in NGS: 1) preferential amplification (jackpotting"")"," 2) artifact substitution errors from polym""",,,#,4.72452E+17,https://twitter.com/mtmdphd/status/472452333457010688,,,
drcbsteer,5/30/2014 14:59,0,0,MT Ppl from all over the world gathered for # ASCO14? can allow # flu viruses to spread easily. # fightflu: http://1.usa.gov/1gxhXkT @ CDCFlu,,@,# # #,4.72452E+17,https://twitter.com/drcbsteer/status/472452293854756864,,,,
ipaulmampilly,5/30/2014 14:59,0,0,Immunotherapy session packed house # ASCO14 pic.twitter.com/zHTufSQqlM,,,#,4.72452E+17,https://twitter.com/ipaulmampilly/status/472452292948815872,,,,
MayoCancerCare,5/30/2014 14:59,1,1,MT @ NCIMedia Announced at # ASCO14: Treatment helps young women preserve fertility during breast cancer chemo # bcsm http://1.usa.gov/1psfNFZ,,@,# #,4.72452E+17,https://twitter.com/MayoCancerCare/status/472452292264734720,,,,
ONAcom,5/30/2014 14:59,0,0,RT @ faycortez: # ASCO14 Tweeters # FF: @ subatomicdoc @ YupOnc @ rschilsky @ yzafar @ TGeorgeMD http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf … -30-,,@ @ @ @ @ @,# #,4.72452E+17,https://twitter.com/ONAcom/status/472452228264247296,,,,
dmooneymd,5/30/2014 14:58,0,0,Iqbal: New ramucirumab abstract: negative results frontline combined with folfox compared to rainbow trial second line. # stcsm # ASCO14,,,# #,4.72452E+17,https://twitter.com/dmooneymd/status/472452125868707840,,,,
cure_magazine,5/30/2014 14:58,3,4,ENABLE III study shows palliative care phone-based support program helped caregivers of advanced cancer patients cope better. # ASCO14,,,#,4.72452E+17,https://twitter.com/cure_magazine/status/472452001859530752,,,,
GenentechJobs,5/30/2014 14:58,0,0,# McCormickPlace in # Chicago is the place to be. Download # ASCO14 mobile app: http://bit.ly/1hKnSy3 & iplanner: http://bit.ly/1i93rtE .,,,# # #,4.72452E+17,https://twitter.com/GenentechJobs/status/472451975682875393,,,,
mtmdphd,5/30/2014 14:58,0,0,Mardis - Next Generation Sequencing (NGS) is really massively parallel sequencing # ASCO14 pic.twitter.com/VAvaZPMxAW,,,#,4.72452E+17,https://twitter.com/mtmdphd/status/472451963854942212,,,,
FayCortez,5/30/2014 14:58,0,0,# ASCO14 Tweeters # FF: @ subatomicdoc @ YupOnc @ rschilsky @ yzafar @ TGeorgeMD http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf … -30-,,@ @ @ @ @,# #,4.72452E+17,https://twitter.com/FayCortez/status/472451934398337024,,,,
dmooneymd,5/30/2014 14:57,0,0,Iqbal: is n American gastric ca different than Asian gastric ca? Re avagast trial and bevacizumab. # stcsm # ASCO14,,,# #,4.72452E+17,https://twitter.com/dmooneymd/status/472451657138073600,,,,
ByJonGardner,5/30/2014 14:56,0,0,Reminder: your cancer drug is now an immunotherapy. # ASCO14,,,#,4.72452E+17,https://twitter.com/ByJonGardner/status/472451597138935809,,,,
DrAttai,5/30/2014 14:56,5,3,We know tamoxifen only effective for ER+ breast cancer. Not the case when first used. Research is important (recurring theme) # ASCO14 # bcsm,,,# #,4.72452E+17,https://twitter.com/DrAttai/status/472451578025504769,,,,
GuardantHealth,5/30/2014 14:56,1,3,Bivona at # ASCO14 talking about need for genomically profiling patients before and after therapy to detect resistance and change treatment.,,,#,4.72452E+17,https://twitter.com/GuardantHealth/status/472451576146432001,,,,
FayCortez,5/30/2014 14:56,3,2,Saving you time: # ASCO14 tweeters # FF: @ DrMarkham @ mtmdphd @ drdonsdizon @ CliffordHudis @ drattai @ rsm2800 @ fischmd @ n8pennell @ JackWestMD 1o2,,@ @ @ @ @ @ @ @ @,# #,4.72452E+17,https://twitter.com/FayCortez/status/472451534572490754,,,,
SpecialtyPTimes,5/30/2014 14:56,0,0,ASCO Kicks Off 50th Annual Meeting # ASCO14 http://ow.ly/xrZzB,,,#,4.72452E+17,https://twitter.com/SpecialtyPTimes/status/472451514687324160,,,,
AdelphiComms,5/30/2014 14:56,0,0,Happy 50th Birthday @ ASCO. Delighted to be in Chicago celebrating 50 years of remarkable progress! # ASCO,,@,#,4.72451E+17,https://twitter.com/AdelphiComms/status/472451393593561088,,,,
mtmdphd,5/30/2014 14:55,0,0,R2CHOP DLBCL data w/ @ GregNowakowski Sat 5/31 - 2:03-2:15p E Arie Crown Theater # lymsm # ASCO14,,@,# #,4.72451E+17,https://twitter.com/mtmdphd/status/472451238911414272,,,,
ALLIANCE_org,5/30/2014 14:55,0,0,Phase II trial of VOR w/ TMZ and RT for newly diagnosed GBM (N0874/ABTC-0902). # ASCO14 http://abstracts.asco.org/144/index.html # AllianceNCTN,,,# #,4.72451E+17,https://twitter.com/ALLIANCE_org/status/472451182368006145,,,,
OncLive,5/30/2014 14:55,3,3,. @ CliffordHudis kicks off the first press briefing of # ASCO14 - we're looking forward to a great meeting! pic.twitter.com/9SuHmSrf6a,,@,#,4.72451E+17,https://twitter.com/OncLive/status/472451146477342720,,,,
BreastDocUK,5/30/2014 14:55,0,0,@ research_ramble # ASCO14 is the best example of massive rapid data sharing. Got to be good IMHO,,@,#,4.72451E+17,https://twitter.com/BreastDocUK/status/472451142618980352,,,,
drseisenberg,5/30/2014 14:54,0,0,"Letter from the @ ASCO President, @ CliffordHudis. http://am.asco.org/letter-president#.U4jSh9k7TtQ.twitter … Busy few days for you! # ASCO14",,@ @,# #,4.72451E+17,https://twitter.com/drseisenberg/status/472450933344174080,,,,
liemeij,5/30/2014 14:54,1,0,@ ASCO Thank you! Looking forward to give a presentation about social media for the dutch attendees. Great # asco is using this tools too.,,@,#,4.72451E+17,https://twitter.com/liemeij/status/472450932815708162,,,,
JeffreyMOtto,5/30/2014 14:54,0,0,EM - going to provide an overview of # ngs technologies # ASCO14,,,# #,4.72451E+17,https://twitter.com/JeffreyMOtto/status/472450927274651648,,,,
MLIWI,5/30/2014 14:53,0,0,". @ ASCO value czar schnipper: 3 mo. of life not worth it: trumped by greater benefits to many that would have to be foregone to provide it.""""",,@,,4.72451E+17,https://twitter.com/MLIWI/status/472450664627712001,,,,
teamoncology,5/30/2014 14:53,1,1,"Can Myc be targeted in cancer? Myc, Education Session Tackles Tough Pathway Targets | # ASCO14 http://am.asco.org/myc-raf-autophagy-education-session-tackles-tough-pathway-targets#.U4jTb3GVa_4.twitter …",,,# #,4.72451E+17,https://twitter.com/teamoncology/status/472450651545272320,,,,
JeffreyMOtto,5/30/2014 14:52,0,0,"Next up: Elaine Mardis evolving technologies in somatic tumor genetics"" # ASCO14""",,,#,4.72451E+17,https://twitter.com/JeffreyMOtto/status/472450578056900609,,,,
mtmdphd,5/30/2014 14:52,2,1,"Workman - We've only got 5% of the druggable genome drugged."" HSP90i has potential # ASCO14""",,,#,4.72451E+17,https://twitter.com/mtmdphd/status/472450575481597952,,,,
DrAttai,5/30/2014 14:52,0,0,"next up - systemic therapy advances (chemo, hormonal therapy, targeted agents) # ASCO14 # bcsm",,,# #,4.72451E+17,https://twitter.com/DrAttai/status/472450537829695490,,,,
z_phd,5/30/2014 14:52,0,0,"# ASCO14 Lots of interviews today, including @ ASCO President @ CliffordHudis:pic.twitter.com/p20JemnSF6",,@ @,#,4.72451E+17,https://twitter.com/z_phd/status/472450523543506944,,,,
YaleCancer,5/30/2014 14:52,3,3,"Just a few of the 30k people attending # asco14, world's largest cancer meeting. Yale experts present on new therapies pic.twitter.com/HKCy9VtL7M",,,#,4.7245E+17,https://twitter.com/YaleCancer/status/472450498189336576,,,,
BiostatGirl,5/30/2014 14:52,0,0,It's that time of year again! # chicago # asco2014 # asco14 http://instagram.com/p/oobbLMAzI7/,,,# # #,4.7245E+17,https://twitter.com/BiostatGirl/status/472450384917590016,,,,
Merck,5/30/2014 14:51,1,1,Follow along with the # ASCO14 and # lcsm chatter; learn more: http://bit.ly/1mNrrc9,,,# #,4.7245E+17,https://twitter.com/Merck/status/472450211949084673,,,,
dmooneymd,5/30/2014 14:51,0,0,Iqbal: toga trial most significant os benefit in her2 3+ ihc and fish +. Inconsistent testing. # stcsm # ASCO14,,,# #,4.7245E+17,https://twitter.com/dmooneymd/status/472450211265011712,,,,
YupOnc,5/30/2014 14:51,2,0,Record breaking attendance at # ASCO2014. Setting the bar high @ CliffordHudis !,,@,#,4.7245E+17,https://twitter.com/YupOnc/status/472450208937574400,,,,
AdvocateDebM,5/30/2014 14:51,0,0,"Dr. Harris: w/radiation tx for # breastcancer, major coronary events increase proportionally w/mean heart dose with no threshold. # ASCO14",,,# #,4.7245E+17,https://twitter.com/AdvocateDebM/status/472450170786177024,,,,
Pharmafocus,5/30/2014 14:50,2,0,"# ASCO14 first press conference: themes flagged include value in healthcare, the need to harness big data, rise of obesity # cancer risk",,,# #,4.7245E+17,https://twitter.com/Pharmafocus/status/472450115450728448,,,,
JacobPlieth,5/30/2014 14:50,3,4,"Cancer immunotherapy - not all that new a concept, says Dr Fong # ASCO14 pic.twitter.com/X1NQWRZNgB",,,#,4.7245E+17,https://twitter.com/JacobPlieth/status/472450057120514048,,,,
drseisenberg,5/30/2014 14:50,1,2,American Society of Clinical Oncology 2014 Annual Meeting = # ASCO14,,,#,4.7245E+17,https://twitter.com/drseisenberg/status/472450041383489536,,,,
MGHCancerCenter,5/30/2014 14:50,0,1,"Tonight:4:30-5:45, S100 bc: Dr. O'Donnell talks of her poster, tumor genomic mutation profiling of germ cell tumors using “Profile” # ASCO14",,,#,4.7245E+17,https://twitter.com/MGHCancerCenter/status/472449947795980288,,,,
CovanceCareers,5/30/2014 14:50,0,0,Career opp for Executive Director in Covance's Molecule Development Group. Learn more http://bit.ly/1wANAyP # ASCO2014,,,#,4.7245E+17,https://twitter.com/CovanceCareers/status/472449916602945536,,,,
adamfeuerstein,5/30/2014 14:49,0,0,. @ DrMatt30 Wrong. Same $ NLNK data now published in a journal no one has ever heard of. # ASCO14 hanger-on stock promoting bullshit.,,@,#,4.7245E+17,https://twitter.com/adamfeuerstein/status/472449836776574976,,,,
lammers_andy,5/30/2014 14:49,0,0,Just landed at OHare for # ASCO14,,,#,4.7245E+17,https://twitter.com/lammers_andy/status/472449693541478400,,,,
teamoncology,5/30/2014 14:49,4,1,"Letter from the # ASCO14 President, Dr Clifford A. Hudis. http://am.asco.org/letter-president#.U4jSh9k7TtQ.twitter …",,,# #,4.7245E+17,https://twitter.com/teamoncology/status/472449651308625920,,,,
kbnewport,5/30/2014 14:48,1,1,N Wenger geriatric session: patients need to be fully informed so they can make the decisions that are appropriate for them. # ASCO14,,,#,4.72449E+17,https://twitter.com/kbnewport/status/472449406793682944,,,,
JeffreyMOtto,5/30/2014 14:47,0,0,Pw: over expression of mutant pik3ca confers resistance to p13k inhibition # ASCO14,,,#,4.72449E+17,https://twitter.com/JeffreyMOtto/status/472449329651658752,,,,
EIannelli,5/30/2014 14:47,3,1,# ASCO14 here we are to represent italian & european cancer patient advocate @ kgapo @ cancereu @ favo_it @ ecancerpic.twitter.com/dFQo4kaAh7,,@ @ @ @,#,4.72449E+17,https://twitter.com/EIannelli/status/472449286441947136,,,,
JacobPlieth,5/30/2014 14:47,0,2,Some docs tweeting at # ASCO14 http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf …,,,#,4.72449E+17,https://twitter.com/JacobPlieth/status/472449197770551296,,,,
mtmdphd,5/30/2014 14:47,0,0,Workman - Polyomics - # ASCO14 - ...don't worry," it's in the paper..."" PNAS 111"," 6834-9; 2014 RE: CUL5 and RBX2 http://www.pnas.org/content/111/18/6834.abstract?sid=3eb4b3bf-09c0-41ef-9ed4-efe48a1b7987 …""",,,#,4.72449E+17,https://twitter.com/mtmdphd/status/472449191323504640,,
YaleCancer,5/30/2014 14:47,3,1,"Harriet Kluger, MD, discusses her team's highlighted poster on kidney cancer @ysm @ YNHH # asco14 pic.twitter.com/Lcd1zxhgxG",,@ysm @,#,4.72449E+17,https://twitter.com/YaleCancer/status/472449153440952321,,,,
DrAttai,5/30/2014 14:47,1,0,More studies ongoing regarding breast cancer XRT - can we decrease treatment dose / time? Dr. Harris # ASCO14 # bcsm,,,# #,4.72449E+17,https://twitter.com/DrAttai/status/472449122826723328,,,,
teamoncology,5/30/2014 14:46,0,0,【 # ASCO14 info】 RT @ tomleblancMD: Improved # caregiver outcomes with earlier # palliative care! ENBALE III Rand Study http://ow.ly/xrXLs,,@,# # #,4.72449E+17,https://twitter.com/teamoncology/status/472448892512907264,,,,
ShannonWestin,5/30/2014 14:45,0,0,@ rschmandt99 present and accounted for in Chicago. # ASCO14,,@,#,4.72449E+17,https://twitter.com/ShannonWestin/status/472448820400648192,,,,
Health2morrow,5/30/2014 14:45,1,2,Why delivering the future of healthcare - # personalisedmedicine is far more complex than many might think. http://ow.ly/xr1QU # ASCO14,,,# #,4.72449E+17,https://twitter.com/Health2morrow/status/472448735411470336,,,,
eyoste,5/30/2014 14:44,0,0,Abernethy: Discontinuing statins during last year of life does not adversely affect 60-day mortality or overall survival # asco14,,,#,4.72449E+17,https://twitter.com/eyoste/status/472448567119196160,,,,
teamoncology,5/30/2014 14:44,3,1,【 # ASCO14 info】 Patient w/metastatic # breastcancer can receive Zometa safely every 12 wks w/o reducing efficacy. http://app.bronto.com/public/?q=preview_message&fn=Link&t=1&ssid=6781&id=byhasyplvb4k6lkftvy4sw1fu4yuo&id2=4txjsb7qenqwfh6a68qv82vx8sgp3&subscriber_id=bxaiztdnltfqeipdignhcrsyksyibgm&messageversion_id=aqwoozmyfzwrkkxhdydqyamuxsdvbdj&delivery_id=akugkdsbkzoajbvjsuilamcnunzrbmf&tid=3.Gn0.AdwvDg.CwWV.AU7iFQ..ArqoCg.b..l._no.a.U4j_YA.U4j_YA.suT1GA …,,,# #,4.72449E+17,https://twitter.com/teamoncology/status/472448506834071552,,,,
DrAttai,5/30/2014 14:44,2,0,"Dr. Harris discussing complications of XRT. Cardiac risk is low, but no truly safe dose to the heart. Weigh risk/benefit # ASCO14 # bcsm",,,# #,4.72448E+17,https://twitter.com/DrAttai/status/472448487305801728,,,,
PHB92,5/30/2014 14:43,0,0,@ mtmdphd @ ASCO what is interactome ????,,@ @,,4.72448E+17,https://twitter.com/PHB92/status/472448347127939072,,,,
tomleblancMD,5/30/2014 14:43,3,1,Improved # caregiver outcomes with earlier # palliative care! New ENABLEIII results from Bakitas at # ASCO14: http://ow.ly/xrXLs,,,# # #,4.72448E+17,https://twitter.com/tomleblancMD/status/472448346586898432,,,,
mtmdphd,5/30/2014 14:43,0,0,Workman - Polyomics - # ASCO14 - Molec pharm RAF/MEK/ERK signaling 17-AAG HSP90i blocks signaling from client protein pic.twitter.com/KzUlACK8NM,,,#,4.72448E+17,https://twitter.com/mtmdphd/status/472448299035660289,,,,
urotoday,5/30/2014 14:43,1,0,"Meeting has started, stay tuned! # ASCO14 pic.twitter.com/oBsLVJ34NW",,,#,4.72448E+17,https://twitter.com/urotoday/status/472448193372770304,,,,
MaverickNY,5/30/2014 14:43,3,5,Real life friends - my stream is going to be a tsunami of cancer tweets from # asco14 until Tues pm. Pls feel free to mute for 5 days!,,,#,4.72448E+17,https://twitter.com/MaverickNY/status/472448174922407936,,,,
dytcmd,5/30/2014 14:43,1,1,MT @UMCancerCenter: Radiation for # prostatecancer linked to second cancers: http://umhealth.me/1hFqzBg # ASCO14 **Key for young men to be aware,,@UMCancerCenter,# #,4.72448E+17,https://twitter.com/dytcmd/status/472448141393137664,,,,
jdflaysakier,5/30/2014 14:43,7,0,Arreter les statines chez des patients ayant un cancer évolué n'affecte pas l'esperance de vie # ASCO14,,,#,4.72448E+17,https://twitter.com/jdflaysakier/status/472448138809450496,,,,
cure_magazine,5/30/2014 14:43,5,6,ASCO celebrates its 50th birthday this year - Here's hoping for cancer research that has an immediate impact on your cancer journey # asco14,,,#,4.72448E+17,https://twitter.com/cure_magazine/status/472448108639449088,,,,
christinemphmd,5/30/2014 14:42,1,2,Immunology for non-immunologists. Great way to start # ASCO14 pic.twitter.com/WWMtcq7YXb,,,#,4.72448E+17,https://twitter.com/christinemphmd/status/472448048292192256,,,,
krnmsw,5/30/2014 14:42,0,0,# ASCO14 The Association of Oncology Social Work wishes you a great meeting! # AOSW2014,,,# #,4.72448E+17,https://twitter.com/krnmsw/status/472447873121271808,,,,
SusanLaufer,5/30/2014 14:41,0,0,30 minutes into my 1st session at # ASCO14 and I'm already nodding off. Not a good start! Must find coffee!,,,#,4.72448E+17,https://twitter.com/SusanLaufer/status/472447717638438914,,,,
mtmdphd,5/30/2014 14:41,0,0,Workman - Polyomics - # ASCO14 - CRC cells- enriched for mut BRAF = highly sensitive to HSP90i (not true for melanoma) # crcsm # melsm,,,# # #,4.72448E+17,https://twitter.com/mtmdphd/status/472447602957365249,,,,
BCRFcure,5/30/2014 14:40,0,1,"We have a responsibility to be wise stewards of financial resources our patients, society spend on meds & research— @ CliffordHudis # ASCO2014",,@,#,4.72447E+17,https://twitter.com/BCRFcure/status/472447419872194560,,,,
CancerTherAdvsr,5/30/2014 14:40,0,1,Landing in Chicago soon. Next stop is # ASCO14! Check back soon for our coverage http://ow.ly/xpzJM,,,#,4.72447E+17,https://twitter.com/CancerTherAdvsr/status/472447401052356609,,,,
BiologicsMcK,5/30/2014 14:40,1,1,"Whether you’re attending # ASCO14 or following along from home, don’t miss the annual Tweetup Saturday! RSVP here: http://bit.ly/RLIwal",,,#,4.72447E+17,https://twitter.com/BiologicsMcK/status/472447361268981761,,,,
FCUroOnc,5/30/2014 14:39,2,2,"RT @ ASCO: Eric Tetzlaff, MHS, PA-C: An advanced practice providers experience at # ASCO14 http://bit.ly/1pyGHJM cc @ FoxChaseCancer",,@ @,#,4.72447E+17,https://twitter.com/FCUroOnc/status/472447287692890114,,,,
DrAttai,5/30/2014 14:39,1,1,Postlumpectomy XRT and in some cases post-mastectomy XRT reduce risk of local recurrence and improve survival # ASCO14 # bcsm Dr. Harris,,,# #,4.72447E+17,https://twitter.com/DrAttai/status/472447283360190464,,,,
mtmdphd,5/30/2014 14:39,0,0,Workman - Polyomics - # ASCO14 - CRC cell sensitivity to HSP90 inhibition -> response in 70 cell lines - low NQO1 = resistant,,,#,4.72447E+17,https://twitter.com/mtmdphd/status/472447266238636034,,,,
BioCenturyTV,5/30/2014 14:39,0,0,. @ steveusdin1 to # ASCO14 Schilsky: what shld happen 2 change how oncology services are paid for? @ BioCentury http://ow.ly/xrX10,,@ @,#,4.72447E+17,https://twitter.com/BioCenturyTV/status/472447183556722688,,,,
BioCentury,5/30/2014 14:39,1,1,. @ steveusdin1 to # ASCO14 Schilsky: what shld happen 2 change how oncology services are paid for? @ BioCentury http://ow.ly/xrWYb,,@ @,#,4.72447E+17,https://twitter.com/BioCentury/status/472447182826897408,,,,
LungCancerFaces,5/30/2014 14:39,1,1,". @ TaraAnnGall @ W2OGroup Didn't want to further # LungCancer stigma by leveraging"" Breaking Bad popularity. Lousy idea. # hcsm # LCSM # ASCO14""",,@ @,# # # #,4.72447E+17,https://twitter.com/LungCancerFaces/status/472447120054558720,,,,
DrAttai,5/30/2014 14:38,0,0,Multiple studies show benefit to radiation therapy both after lumpectomy and in selected mastectomy patients # ASCO14 # bcsm (1/2),,,# #,4.72447E+17,https://twitter.com/DrAttai/status/472447061678641152,,,,
dytcmd,5/30/2014 14:38,0,0,@ ERPlimackMD Welcome to Twitter! # ASCO14 lacks a GU cancer commentator--could be you! Tweeters infographic http://bit.ly/TKIMrT # hcsm,,@,# #,4.72447E+17,https://twitter.com/dytcmd/status/472446966191120384,,,,
eyoste,5/30/2014 14:38,2,1,"Bakitas reports on federally funded study that shows palliative care provided at or near diagnosis helps family caregivers, too. # ASCO14",,,#,4.72447E+17,https://twitter.com/eyoste/status/472446886474182656,,,,
subatomicdoc,5/30/2014 14:38,1,1,"Association of tumor-infiltrating lymphocytes w/edema, survival in brain metastases. http://abstracts.asco.org/144/AbstView_144_129576.html … # ASCO14 # btsm # lcsm # bcsm # hcsm",,,# # # # #,4.72447E+17,https://twitter.com/subatomicdoc/status/472446849308442625,,,,
Rad_Nation,5/30/2014 14:38,0,0,"Association of tumor-infiltrating lymphocytes w/edema, survival in brain metastases. http://buff.ly/1gv8EBU # ASCO14 # btsm # lcsm # bcsm",,,# # # #,4.72447E+17,https://twitter.com/Rad_Nation/status/472446848591228928,,,,
mtmdphd,5/30/2014 14:37,0,0,"Workman - Polyomics - # ASCO14 - HSP90 as a cancer-selective network target - esp mutant/amplified ERBB2, EGFR, ALK, BRAF, AR",,,#,4.72447E+17,https://twitter.com/mtmdphd/status/472446799035109377,,,,
sciberomics,5/30/2014 14:37,0,0,"RT @ mtmdphd: Workman - Polyomics - # ASCO14 - Network view of cancer genes and drugs, including interactome (eg HSP90) pic.twitter.com/Obg9Qd0se3",,@,#,4.72447E+17,https://twitter.com/sciberomics/status/472446727648051201,,,,
DrR_DUNNE,5/30/2014 14:37,0,0,Good start to # asco14 at update on esophageal cancer. Is CROSS trial enough to prevent distant mets? Utility of PET examined,,,#,4.72447E+17,https://twitter.com/DrR_DUNNE/status/472446703619293185,,,,
FayCortez,5/30/2014 14:37,0,0,"First taste of # ASCO14 from # CNBC's @ megtirrell. http://cnb.cx/1nAUlPB Glad to hear there's more ahead. It's 17% of the economy, people.",,@,# #,4.72447E+17,https://twitter.com/FayCortez/status/472446697327841280,,,,
mtmdphd,5/30/2014 14:36,7,1,"Workman - Polyomics - # ASCO14 - Network view of cancer genes and drugs, including interactome (eg HSP90) pic.twitter.com/QqyJH7ZD2E",,,#,4.72447E+17,https://twitter.com/mtmdphd/status/472446538312974336,,,,
AdvocateDebM,5/30/2014 14:36,0,0,Critical advance in tx of BC & QoL. RT: @ drattai: NSABP landmark study-no diff in survival Halsted Rad vs Modified Rad mastectomy # ASCO14,,@,#,4.72447E+17,https://twitter.com/AdvocateDebM/status/472446522567954432,,,,
drcbsteer,5/30/2014 14:36,0,0,"# ASCO14 # geriatriconcology Team approach but coordination between teams vital. Aim is patient (and family)-centred"" care.""",,,# #,4.72447E+17,https://twitter.com/drcbsteer/status/472446513889968128,,,,
YupOnc,5/30/2014 14:36,2,1,First day of @ ASCO 50th birthday Jay Harris on breast conservation improvements with better imaging RT and targeted tx # ASCO2014,,@,#,4.72446E+17,https://twitter.com/YupOnc/status/472446372609015810,,,,
eyoste,5/30/2014 14:36,1,1,"Cancer caregivers have psychological distress, poor physical health,higher death risk: truly an unrecognized public health crisis"" # ASCO14""",,,#,4.72446E+17,https://twitter.com/eyoste/status/472446345609900033,,,,
UCCancerCenter,5/30/2014 14:35,0,0,Education sessions # ASCO14 organized by Dr Gini Fleming reflect science and society meeting theme. Hot topics are genomics & immunotherapy,,,#,4.72446E+17,https://twitter.com/UCCancerCenter/status/472446224365531137,,,,
UCSF_RDO,5/30/2014 14:35,0,0,Strong @ UCSF presence at # ASCO14 | http://tinyurl.com/lonbtnf,,@,#,4.72446E+17,https://twitter.com/UCSF_RDO/status/472446187375587329,,,,
DrAttai,5/30/2014 14:34,0,1,you bet we are! RT @ scientre Are the docs at # asco14 actually tweeting? Yes! Handles & hashtags here: http://www.cancer.net/research-and-advocacy/asco-annual-meetings/cancernet-social-media-coverage-ascos-annual-meeting …,,@,#,4.72446E+17,https://twitter.com/DrAttai/status/472446041036685312,,,,
mtmdphd,5/30/2014 14:34,1,0,"Workman - Polyomics - # ASCO14 - Analysis of the recent @ TCGAupdates pan-cancer data - large-scale omics, objective assess cancer drivers",,@,#,4.72446E+17,https://twitter.com/mtmdphd/status/472446030256939008,,,,
krnmsw,5/30/2014 14:34,0,0,@ ASCO Oncology Social Workers can help your patients negotiate the work/treatment balance. # experts # AOSW2014,,@,# #,4.72446E+17,https://twitter.com/krnmsw/status/472446012293144576,,,,
mtmdphd,5/30/2014 14:34,1,0,Workman - Polyomics - # ASCO14 - Objective assessment of CA genes for drug discovery - Patel et al. Nat Rev Drug Disc http://www.ncbi.nlm.nih.gov/pubmed/23274470,,,#,4.72446E+17,https://twitter.com/mtmdphd/status/472445872232361985,,,,
KUhlendorf,5/30/2014 14:33,0,2,Big thx to @BayerHealthCare @ AstellasUS @ boehringerus @ eisai @ bmsnews @ Teva for sponsoring free wifi at # ASCO14,,@BayerHealthCare @ @ @ @ @,#,4.72446E+17,https://twitter.com/KUhlendorf/status/472445778678394881,,,,
JeffreyMOtto,5/30/2014 14:33,0,1,Pw - only 5% of cancer genome is currently drugged # ASCO14,,,#,4.72446E+17,https://twitter.com/JeffreyMOtto/status/472445771501953024,,,,
mjmbauti,5/30/2014 14:33,0,0,Enganchada!! ;)) “ @ chuslamas: Pues habrá que seguir # ASCO14.”,,@,#,4.72446E+17,https://twitter.com/mjmbauti/status/472445744797212672,,,,
dmooneymd,5/30/2014 14:33,0,0,Post chemo xrt treatment pet scan for ge cancer...predicts os but does not correlate with pcr. # ASCO14 # esocsm,,,# #,4.72446E+17,https://twitter.com/dmooneymd/status/472445624466427904,,,,
JeffreyMOtto,5/30/2014 14:33,0,0,Ow: need to extend the druggable cancer genome to all nodes - and linked # biomarkers # ASCO14,,,# #,4.72446E+17,https://twitter.com/JeffreyMOtto/status/472445606061801472,,,,
adamfeuerstein,5/30/2014 14:33,8,5,# ASCO14 What’s on tap for Saturday —> http://www.thestreet.com/story/12727197/1/asco-14-whats-on-tap-for-saturday.html …,,,#,4.72446E+17,https://twitter.com/adamfeuerstein/status/472445600110092288,,,,
mtmdphd,5/30/2014 14:32,0,1,Workman - Polyomics - # ASCO14 - Extending the druggable cancer genome to provide drugs for all key pathways and nodes - much to do,,,#,4.72445E+17,https://twitter.com/mtmdphd/status/472445488638066688,,,,
krnmsw,5/30/2014 14:32,0,0,@ ASCO Oncology Social Workers are poised to support you in the delivery of quality # cancer care. # AOSW2014,,@,# #,4.72445E+17,https://twitter.com/krnmsw/status/472445382027669505,,,,
duemed,5/30/2014 14:32,0,2,# ASCO14 ID pic.twitter.com/3IVT8CgYno,,,#,4.72445E+17,https://twitter.com/duemed/status/472445369008136193,,,,
dukeleuk,5/30/2014 14:31,0,0,@ ASCO IOM recommendations for cancer care in older adults. Preparing for an # epidemic,,@,#,4.72445E+17,https://twitter.com/dukeleuk/status/472445292022071298,,,,
KimmelCancerCtr,5/30/2014 14:31,0,0,RT @ JNCI_Now: study shows benefits of specific # PalliativeCare phone-based support prg for caregivers of patients w advanced cancer # ASCO14,,@,# #,4.72445E+17,https://twitter.com/KimmelCancerCtr/status/472445222463733760,,,,
ASCO,5/30/2014 14:31,0,1,"Looking for a place to take a break and power up? Enjoy a coffee, meet up with colleagues, and plug-in at a Networking Cafe # ASCO14",,,#,4.72445E+17,https://twitter.com/ASCO/status/472445123234906112,,,,
CancerDotNet,5/30/2014 14:31,0,1,"Come & visit http://Cancer.Net @ASCO Central"" (booth 7004) - the # ASCO14 Onc Prof Hall 9am-5pm Sat-Mon http://bit.ly/1hCKq3R""",,@,#,4.72445E+17,https://twitter.com/CancerDotNet/status/472445112476520448,,,,
ASCO,5/30/2014 14:31,1,0,Dr. M. Elizabeth Hammond: A pathologists experience at # ASCO14 http://bit.ly/1wmLvqi,,,#,4.72445E+17,https://twitter.com/ASCO/status/472445087998574594,,,,
SanofiUS,5/30/2014 14:31,2,0,Cancer patients worldwide are the inspiration for # ASCO14. RT to show your support in the fight for a cure.,,,#,4.72445E+17,https://twitter.com/SanofiUS/status/472445082940243969,,,,
JeffreyMOtto,5/30/2014 14:30,0,0,"Pw - need a longitudinal, iterative, profile, treat cycle, with profiling using polyomics # ASCO14",,,#,4.72445E+17,https://twitter.com/JeffreyMOtto/status/472445035737141248,,,,
DrAttai,5/30/2014 14:30,0,0,next up - Dr. Jay Harris discussing 50 year history of radiation therapy for breast cancer. Another excellent speaker. # ASCO14 # bcsm,,,# #,4.72445E+17,https://twitter.com/DrAttai/status/472444998181724160,,,,
mtmdphd,5/30/2014 14:30,2,0,Claim CME credit while AT THE SESSION in the iPlanner (so you don't forget) # ASCO14,,,#,4.72445E+17,https://twitter.com/mtmdphd/status/472444979718021121,,,,
ClevelandClinic,5/30/2014 14:30,13,8,Drug helps young women protect fertility during chemo http://www.usatoday.com/story/news/nation/2014/05/30/preserving-fertility-after-chemo/9763633/ … (via @ LizSzabo) # ASCO14,,@,#,4.72445E+17,https://twitter.com/ClevelandClinic/status/472444902937071617,,,,
medpagetoday,5/30/2014 14:30,0,1,"We are on the scene at # ASCO14! To get the latest breaking news, visit us at: http://bit.ly/1rpS1fK @ ASCOPost",,@,#,4.72445E+17,https://twitter.com/medpagetoday/status/472444864072650752,,,,
cardinalhealth,5/30/2014 14:30,0,1,Be sure to add our 6/2 poster session to your # ASCO14 itinerary! More info: http://iplanner.asco.org/am2014 # essentialtooncology,,,# #,4.72445E+17,https://twitter.com/cardinalhealth/status/472444859421184000,,,,
JNCI_Now,5/30/2014 14:30,0,1,The number of medications patients take doubles in the last year of life for those with terminal illnesses. # ASCO14,,,#,4.72445E+17,https://twitter.com/JNCI_Now/status/472444859287347200,,,,
JeffreyMOtto,5/30/2014 14:29,0,0,"Pw: metabolomics is in its infancy, but will be very important in the future # ASCO14",,,#,4.72445E+17,https://twitter.com/JeffreyMOtto/status/472444759215071232,,,,
IQVIA_Biotech,5/30/2014 14:29,0,1,Participating in # ASCO14 Lymphoma and Plasma Cell sessions? Learn why hematological cancers are so hard to classify. http://ow.ly/xp3Hg,,,#,4.72445E+17,https://twitter.com/IQVIA_Biotech/status/472444707411619840,,,,
DrAttai,5/30/2014 14:29,0,0,excellent talk by Dr. Kelly Hunt on surgical advances for breast cancer therapy # ASCO14 # bcsm,,,# #,4.72445E+17,https://twitter.com/DrAttai/status/472444696472862720,,,,
chuslamas,5/30/2014 14:29,0,0,Pues habrá que seguir # ASCO14.,,,#,4.72445E+17,https://twitter.com/chuslamas/status/472444678672248835,,,,
KimmelCancerCtr,5/30/2014 14:29,0,1,RT @ MCristofanill: # ASCO14: Selecting patients with more aggressive & mutated tumors for treatment with new # immunotherapies. # BreastCancer,,@,# # #,4.72445E+17,https://twitter.com/KimmelCancerCtr/status/472444677430714369,,,,
EIannelli,5/30/2014 14:29,4,3,Oncofertility: hope of life after cancer! Cancer patient right all over the world # ASCO14 @ InsControCancro @ favo_itpic.twitter.com/IrzvlAAt06,,@ @,#,4.72445E+17,https://twitter.com/EIannelli/status/472444676767612928,,,,
NLintheUSA,5/30/2014 14:29,2,0,Congratulations to Dr. Bob Pinedo who will be honored by the American Society of Clinical Oncology tomorrow. @ ASCO Amehttp://on.fb.me/19N9Nle,,@,,4.72445E+17,https://twitter.com/NLintheUSA/status/472444605192216576,,,,
sciberomics,5/30/2014 14:28,0,0,"RT @ JeffreyMOtto: Heard a new term that I like from PW: poly-omics"" # ASCO14. I will be using this!""",,@,#,4.72445E+17,https://twitter.com/sciberomics/status/472444553761280000,,,,
tomleblancMD,5/30/2014 14:28,2,1,"# ASCO14 press conf Patient Care and Quality of Life"" includes Amy Abernethy presenting @ PCRCgroup statin trial! http://ow.ly/xrV6B # hpm""",,@,# #,4.72445E+17,https://twitter.com/tomleblancMD/status/472444540432179200,,,,
ASCO,5/30/2014 14:28,3,5,Digitally flip thru today's Daily News http://bit.ly/1wAkTCd # ASCO14 pic.twitter.com/t2o1LCcrtE,,,#,4.72444E+17,https://twitter.com/ASCO/status/472444450795692032,,,,
JeffreyMOtto,5/30/2014 14:28,0,0,"Heard a new term that I like from PW: poly-omics"" # ASCO14. I will be using this!""",,,#,4.72444E+17,https://twitter.com/JeffreyMOtto/status/472444335917498369,,,,
theABTA,5/30/2014 14:28,6,2,The role of personalized cancer therapies based on individual molecular difference is a focal theme at # ASCO14. Very interesting & important,,,#,4.72444E+17,https://twitter.com/theABTA/status/472444328145846272,,,,
KimmelCancerCtr,5/30/2014 14:27,0,0,RT @ MCristofanill: Frequent # BRCA 1/2 and BARD1 germline mutations in TNBC patients. | # ASCO14 Meeting Abstracts http://abstracts.asco.org/144/index.html,,@,# #,4.72444E+17,https://twitter.com/KimmelCancerCtr/status/472444318410891264,,,,
PeterJTCoe,5/30/2014 14:27,0,0,In Chicago Friday & Saturday for # ASCO14 . Congratulations ASCO on your 50th anniversary!,,,#,4.72444E+17,https://twitter.com/PeterJTCoe/status/472444127637151744,,,,
cure_magazine,5/30/2014 14:26,5,3,"Patients, survivors and advocates can follow the # asco14 hashtag for updates from ASCO, the world's leading # Cancer research meeting",,,# #,4.72444E+17,https://twitter.com/cure_magazine/status/472444023022432256,,,,
DrAttai,5/30/2014 14:26,1,1,Clinical trials are ongoing to answer some of these remaining questions. Trials are how we make progress # ASCO14 # bcsm,,,# #,4.72444E+17,https://twitter.com/DrAttai/status/472443881217601536,,,,
SJNaggiar,5/30/2014 14:25,0,0,# ASCO2014 Friday press briefing with a focus on improving patient quality of life,,,#,4.72444E+17,https://twitter.com/SJNaggiar/status/472443744487493634,,,,
JanssenUS,5/30/2014 14:25,2,0,Check out our upcoming presentations at # ASCO14 http://bit.ly/1sBC6Gz,,,#,4.72444E+17,https://twitter.com/JanssenUS/status/472443741396303872,,,,
JeffreyMOtto,5/30/2014 14:25,0,0,"Next up: Paul Workman (pw) looking forward: application of genomics to guiding clinical investigation"" # ASCO14""",,,#,4.72444E+17,https://twitter.com/JeffreyMOtto/status/472443726527070208,,,,
nevitdilmen,5/30/2014 14:25,0,0,# Goserelin & breast # cancer # ASCO2014 http://go.usa.gov/8yJW,,,# # #,4.72444E+17,https://twitter.com/nevitdilmen/status/472443675608625152,,,,
DrAttai,5/30/2014 14:25,3,2,"Over past 50 years, we've proven that less is more when it comes to breast cancer surgery. But many unanswered questions # ASCO14 # bcsm",,,# #,4.72444E+17,https://twitter.com/DrAttai/status/472443665198379008,,,,
JNCI_Now,5/30/2014 14:25,3,0,"“Our study provides the first evidence that stopping statins is safe & improves patient quality of life.” -Amy P. Abernethy, MD, PhD # ASCO14",,,#,4.72444E+17,https://twitter.com/JNCI_Now/status/472443597388673024,,,,
JNCI_Now,5/30/2014 14:25,5,3,"Doctors argue that near end of life, it isn't necessary to continue medications for chronic illnesses that are not life-threatening. # ASCO14",,,#,4.72444E+17,https://twitter.com/JNCI_Now/status/472443592825257985,,,,
JNCI_Now,5/30/2014 14:25,2,0,"Discontinuing statins provided important benefits, including reduced pill and symptom burden and improved overall quality of life. # ASCO14",,,#,4.72444E+17,https://twitter.com/JNCI_Now/status/472443591931858944,,,,
JNCI_Now,5/30/2014 14:25,5,0,New study suggests that it is safe to stop statin therapy in patients with a life expectancy of less than a year. # ASCO14,,,#,4.72444E+17,https://twitter.com/JNCI_Now/status/472443589994110978,,,,
CBlotner_,5/30/2014 14:24,6,4,For everyone attending # ASCO14: use # btsm to track any brain tumor information/coverage you come across. Thanks!,,,# #,4.72444E+17,https://twitter.com/CBlotner_/status/472443518657785856,,,,
K_BasenEngquist,5/30/2014 14:24,0,0,Goodbye # ACSMAnnualmtg Hello # ASCO14 !,,,# #,4.72443E+17,https://twitter.com/K_BasenEngquist/status/472443456540139520,,,,
jdflaysakier,5/30/2014 14:24,3,0,La Gosereline preserve les ovaires des femmes prémenopausées traitées pour cancer du sein. 21% de grossesses vs 11% sans # ASCO14,,,#,4.72443E+17,https://twitter.com/jdflaysakier/status/472443451427278848,,,,
eyoste,5/30/2014 14:24,1,0,"POEMS study shows young women w HR-neg breast cancer treated with goserelin had better chance of pregnancy, improved survival # asco14",,,#,4.72443E+17,https://twitter.com/eyoste/status/472443393176776704,,,,
DrLisaCurcio,5/30/2014 14:23,0,0,“ @ CancerDotNet: Just released # ASCO14 cancer research on short- & long-term side effects: # bcsm # hncsm http://bit.ly/1hjxkOD ”,,@,# # #,4.72443E+17,https://twitter.com/DrLisaCurcio/status/472443306169733120,,,,
CancerResearch,5/30/2014 14:23,0,1,Very excited to be at @ ASCO this year. # Immunotherapy promises to be a hot area of progress again this year.,,@,#,4.72443E+17,https://twitter.com/CancerResearch/status/472443303221141504,,,,
JeffreyMOtto,5/30/2014 14:23,0,0,TGB: use rational Tx to select treatment designed to address major polyclonal tumor subtypes in order to maximize effectiveness ex # ASCO14,,,#,4.72443E+17,https://twitter.com/JeffreyMOtto/status/472443289451249664,,,,
ADCReview,5/30/2014 14:23,0,0,Navigate Antibody-drug Conjugates (ADCs) abstracts to be presented @ ASCO # Cancer @ ASCO14 http://adcreview.com/page/asco-2014-a-sneak-preview-of-exciting-trial-results-in-adcs …,,@ @,#,4.72443E+17,https://twitter.com/ADCReview/status/472443253334507520,,,,
DrAttai,5/30/2014 14:22,0,0,"More studies ongoing to answer question of who needs axillary dissection - mastectomy patients, neoadjuvant chemotherapy. # ASCO14 # bcsm",,,# #,4.72443E+17,https://twitter.com/DrAttai/status/472442920331935745,,,,
scientre,5/30/2014 14:22,3,0,Are the docs at # asco14 actually tweeting? Yes! Handles & hashtags here: http://www.cancer.net/research-and-advocacy/asco-annual-meetings/cancernet-social-media-coverage-ascos-annual-meeting …,,,#,4.72443E+17,https://twitter.com/scientre/status/472442883996655616,,,,
OncoZine,5/30/2014 14:21,0,0,Navigate Antibody-drug Conjugates (ADCs) abstracts to be presented @ ASCO # Cancer @ ASCO14 http://adcreview.com/page/asco-2014-a-sneak-preview-of-exciting-trial-results-in-adcs …,,@ @,#,4.72443E+17,https://twitter.com/OncoZine/status/472442798898413568,,,,
CancerDotNet,5/30/2014 14:21,11,5,"Just released! Today's # ASCO14 cancer research highlights, on short- & long-term side effects: # bcsm # hncsm http://bit.ly/1hjxkOD",,,# # #,4.72443E+17,https://twitter.com/CancerDotNet/status/472442762500272129,,,,
BlackstoneHotel,5/30/2014 14:21,0,0,Staying with us during @ ASCO this weekend? Let us know so we can say hello. # ASCO14,,@,#,4.72443E+17,https://twitter.com/BlackstoneHotel/status/472442747669196800,,,,
OncologyTimes,5/30/2014 14:21,6,4,Halle Moore at # ASCO14 news conf: Goserelin can preserve fertility in women having chemo for HR-neg # breastcancer; P Ganz says very imp info,,,# #,4.72443E+17,https://twitter.com/OncologyTimes/status/472442724986388480,,,,
DrHealeyBird,5/30/2014 14:21,1,1,http://abbviescience.com/614119315/3?cid=GASZ1XX3141193153 … ABT-199 exciting new anti bcl2 drug for lymphoma - make the cell forget it's immortal # ASCO14,,,#,4.72443E+17,https://twitter.com/DrHealeyBird/status/472442704891088897,,,,
drcbsteer,5/30/2014 14:21,0,0,# ASCO14 # geriatriconcology. Given shortage of professional carers a lot of care will be provided in the the home - Hurria.,,,# #,4.72443E+17,https://twitter.com/drcbsteer/status/472442636398526464,,,,
mtmdphd,5/30/2014 14:21,0,0,# lcsm - Bivona # ASCO14 - Molecular evolution & therapy of polyclonal drug resistance - fn studies & molecular modeling - Johnson/Baltimore,,,# #,4.72443E+17,https://twitter.com/mtmdphd/status/472442593167437824,,,,
DrAttai,5/30/2014 14:20,1,2,Loving that the lead off talk on breast cancer treatment advances is from a surgeon :) # ASCO14,,,#,4.72443E+17,https://twitter.com/DrAttai/status/472442552491474944,,,,
AdvocateDebM,5/30/2014 14:20,2,1,So happy to be at the Annual # ASCO14 meeting in Chicago w/many incredible advocates. Current session on last 50 yrs of # breastcancer treatmt,,,# #,4.72442E+17,https://twitter.com/AdvocateDebM/status/472442415543234561,,,,
DrAttai,5/30/2014 14:20,9,0,Next advance - do all pts with + sentinel node need axillary dissection? ACOSOG Z11 study. Answer = NO. # ASCO14 # bcsm,,,# #,4.72442E+17,https://twitter.com/DrAttai/status/472442412527521792,,,,
Boehringer,5/30/2014 14:20,63,123,What is it like to receive a cancer diagnosis? Read @ thesearemyscars # lungcancer survivor’s story: http://bit.ly/1kdfBHE - # ASCO14 # hcsmeu,,@,# # #,4.72442E+17,https://twitter.com/Boehringer/status/472442381187682304,,,,
JNCI_Now,5/30/2014 14:20,0,1,"Palliative care is focused on providing patients with relief from the symptoms, pain, and stress of a serious illness. # ASCO14",,,#,4.72442E+17,https://twitter.com/JNCI_Now/status/472442339890196480,,,,
JNCI_Now,5/30/2014 14:20,1,0,Palliative care services are rarely taken advantage of because it is often introduced too late in the course of cancer treatment. # ASCO14,,,#,4.72442E+17,https://twitter.com/JNCI_Now/status/472442336320819201,,,,
PPDCRO,5/30/2014 14:20,0,1,Visit us at booth 8115 to learn why we have the leading # clinicalresearch team in # oncology. # ASCO14 http://ht.ly/xrKmm,,,# # #,4.72442E+17,https://twitter.com/PPDCRO/status/472442336061177857,,,,
JNCI_Now,5/30/2014 14:20,2,0,Early intervention had positive effect on decreasing depression & improving QOL & lowering perceived burden of caregiving. # ASCO14,,,#,4.72442E+17,https://twitter.com/JNCI_Now/status/472442335502925824,,,,
JNCI_Now,5/30/2014 14:20,4,0,"When caregivers began receiving palliative care support at time of patient’s cancer diagnosis, they had better quality of life. # ASCO14",,,#,4.72442E+17,https://twitter.com/JNCI_Now/status/472442334710210560,,,,
JNCI_Now,5/30/2014 14:20,0,0,"...both parties benefit when caregivers receive palliative care."" Marie Bakitas"," DNSc. # ASCO14""",,,#,4.72442E+17,https://twitter.com/JNCI_Now/status/472442333053456384,,,
mtmdphd,5/30/2014 14:19,1,1,"# lcsm - Bivona # ASCO14 - A lot of the action is on chrom 7..."" (EGFR"," MET) - amplification evolve during EGFR TKI Rx""",,,# #,4.72442E+17,https://twitter.com/mtmdphd/status/472442257887358976,,,
SAJansky,5/30/2014 14:18,1,0,Dr. Halle Moore from @ clevelandclinic presents results of @ SWOG POEMS study at # ASCO14 # bcsmpic.twitter.com/AoBjJo903t,,@ @,# #,4.72442E+17,https://twitter.com/SAJansky/status/472442057836228608,,,,
JeffreyMOtto,5/30/2014 14:18,0,0,TGB: analysis of case study patient indicated that some of the other mutations had existed at low freq in original tumor. # ASCO14,,,#,4.72442E+17,https://twitter.com/JeffreyMOtto/status/472442052718776320,,,,
scientre,5/30/2014 14:18,0,0,"Friday-Tuesday follow # ASCO14 for data & news from American Society of Clinical Oncology annual mtg. Pts, docs, tx devlprs, journos et al",,,#,4.72442E+17,https://twitter.com/scientre/status/472442046603866112,,,,
DrAttai,5/30/2014 14:18,2,0,"NSABP B-30 - no difference OS, DFS, regional control sentinel node alone vs axillary dissection # ASCO14 # bcsm",,,# #,4.72442E+17,https://twitter.com/DrAttai/status/472441946896867328,,,,
MyelomaTeacher,5/30/2014 14:18,0,0,"Phase I trial of # SAR650984, a # CD38 monoclonal antibody, in relapsed or refractory multiple # myeloma. # ASCO14 # MMSM http://abstracts.asco.org/144/index.html",,,# # # # #,4.72442E+17,https://twitter.com/MyelomaTeacher/status/472441870715342848,,,,
mtmdphd,5/30/2014 14:17,0,0,# lcsm - Bivona # ASCO14 - Co-expression of EGFR L858R and BRAF V600E evolve during TKI Rx,,,# #,4.72442E+17,https://twitter.com/mtmdphd/status/472441756857151488,,,,
WinshipAtEmory,5/30/2014 14:16,0,1,Winship is excited to be a part of # ASCO14. 1st press briefing underway. pic.twitter.com/GsM3Kppy2f,,,#,4.72442E+17,https://twitter.com/WinshipAtEmory/status/472441537021095936,,,,
justamiletogo,5/30/2014 14:16,1,2,For # myeloma clinical updates live from # ASCO14 follow @ theMMRF! Check daily for the latest news: http://www.themmrf.org/living-with-multiple-myeloma/2014-asco-coverage.html … - # MMRFASCO,,@,# # #,4.72442E+17,https://twitter.com/justamiletogo/status/472441522000887809,,,,
Pharmaspectra,5/30/2014 14:16,0,1,RT @ ASCO: Celebrate 50 years of progress against cancer with ASCO Daily News anniversary issue http://bit.ly/1wAkTCd # ASCO14,,@,#,4.72441E+17,https://twitter.com/Pharmaspectra/status/472441484512608256,,,,
drcbsteer,5/30/2014 14:16,0,0,# asco14 # geriatriconcology Scary shortage of geriatricians in the future - Hurria... Novel models of patient care needed.,,,# #,4.72441E+17,https://twitter.com/drcbsteer/status/472441452854009856,,,,
DrHealeyBird,5/30/2014 14:16,0,0,# ASCO14 inotuzumab ineffective for rrDLBCL,,,#,4.72441E+17,https://twitter.com/DrHealeyBird/status/472441441759670272,,,,
christinemphmd,5/30/2014 14:16,0,0,"# ASCO14 starting now! @Mccormick Place, Illinois http://instagram.com/p/ooXWeoia1s/",,@Mccormick,#,4.72441E+17,https://twitter.com/christinemphmd/status/472441427507425280,,,,
DrAttai,5/30/2014 14:16,3,0,Sentinel lymph node dissection has changed management of axilla. No full axillary dissection for clinically node - disease # ASCO14 # bcsm,,,# #,4.72441E+17,https://twitter.com/DrAttai/status/472441390858010628,,,,
JeffreyMOtto,5/30/2014 14:16,0,0,TGB: case study patient that developed EGFR Tx resistance had developed concurrent driver mutations # asco14,,,#,4.72441E+17,https://twitter.com/JeffreyMOtto/status/472441388374581248,,,,
Pharmaspectra,5/30/2014 14:16,0,0,Don't forget to use # ASCO14 tag for all updates rt @ rschilsky: Today is the first day of @ ASCO’s 50th Annual Meeting “Science & Society”,,@ @,#,4.72441E+17,https://twitter.com/Pharmaspectra/status/472441333958057984,,,,
MolecularHealth,5/30/2014 14:16,0,0,Attending # ASCO14? So are we! Look for members of the MolecularHealth team this weekend.,,,#,4.72441E+17,https://twitter.com/MolecularHealth/status/472441322608267264,,,,
ClevelandClinic,5/30/2014 14:15,27,13,BREAKING @ ASCO: Fertility freeze helps women have babies after chemo http://www.nbcnews.com/health/cancer/fertility-freeze-helps-women-have-babies-after-chemo-n117616 … (via @ NBCNewsHealth) # ASCO14,,@ @,#,4.72441E+17,https://twitter.com/ClevelandClinic/status/472441212310679552,,,,
SpryPub,5/30/2014 14:15,0,0,"Stop by our booth TOMORROW between 10-11 to get your copy of Survivorship"" signed by Dr. Cassileth! http://ow.ly/xrsH9 # ASCO14""",,,#,4.72441E+17,https://twitter.com/SpryPub/status/472441199274786816,,,,
CancerDotNet,5/30/2014 14:15,0,0,Advocates: McCormick Place can be hard to navigate if this is your first time here. Check out this map [PDF] # ASCO14 http://bit.ly/1ny6BQW,,,#,4.72441E+17,https://twitter.com/CancerDotNet/status/472441187002228736,,,,
mtmdphd,5/30/2014 14:15,0,0,"# lcsm - Bivona # ASCO14 - Deep sequencing reveals EGFR TKI-induced selection of concurrent driver mutations - Blakely, Asthana",,,# #,4.72441E+17,https://twitter.com/mtmdphd/status/472441178382925825,,,,
Gene_Antibody,5/30/2014 14:15,0,0,"# OnceUponATime, scientists had not yet accepted that cells could even cause disease. http://ow.ly/xr76S # ASCO14 # Next50",,,# # #,4.72441E+17,https://twitter.com/Gene_Antibody/status/472441152445378560,,,,
theNCI,5/30/2014 14:15,13,6,Learn more about how # cancer treatment can affect fertility http://1.usa.gov/1oDjZTa # ASCO14,,,# #,4.72441E+17,https://twitter.com/theNCI/status/472441148091666432,,,,
JNCI_Now,5/30/2014 14:15,2,0,The earlier the palliative care services are introduced to caregivers the better they will be able to cope w/ caregiving experience. # ASCO14,,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441086498336768,,,,
JNCI_Now,5/30/2014 14:15,0,0,New study shows benefits of a specific palliative care phone-based support program for caregivers of patients with advanced cancer. # ASCO14,,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441085659475968,,,,
JNCI_Now,5/30/2014 14:15,2,0,Patients with HPV-positive tumors tend to have better outcomes compared to patients with HPV-negative disease. # ASCO14,,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441083524567040,,,,
JNCI_Now,5/30/2014 14:15,10,3,Approx. 70% of newly-diagnosed oropharyngeal cancers are related to HPV & the incidence of HPV-related disease appears to be rising. # ASCO14,,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441082614382592,,,,
JNCI_Now,5/30/2014 14:15,1,1,Study suggests that certain patients with HPV-positive oropharyngeal cancer can safely receive lower-dose radiation therapy. # ASCO14,,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441081091870720,,,,
JNCI_Now,5/30/2014 14:15,5,0,"Lower-dose Radiation therapy is safe for certain patients w/ lower-risk, HPV-Positive head and neck cancer. # ASCO14",,,#,4.72441E+17,https://twitter.com/JNCI_Now/status/472441080223662080,,,,
DrAttai,5/30/2014 14:15,2,1,More surgical advances - management of lymph nodes # ASCO14 # bcsm,,,# #,4.72441E+17,https://twitter.com/DrAttai/status/472441076276801536,,,,
DrAttai,5/30/2014 14:14,1,1,"Smaller margins -> no detriment in outcomes, better cosmetic results # ASCO14 # bcsm",,,# #,4.72441E+17,https://twitter.com/DrAttai/status/472440991715426304,,,,
Frank_S_David,5/30/2014 14:14,0,0,FYI I will be tweeting intermittently from # ASCO14 over the next few days. (Nice to be back in Chicago!),,,#,4.72441E+17,https://twitter.com/Frank_S_David/status/472440892880867329,,,,
mtmdphd,5/30/2014 14:14,1,0,# lcsm - Longitudinal integrated genomics in cancer research & care to optimize (poly)therapy - Bivona # ASCO14,,,# #,4.72441E+17,https://twitter.com/mtmdphd/status/472440878255337472,,,,
eyoste,5/30/2014 14:14,0,1,First press conference for # asco14 explores quality of life issues in cancer care.,,,#,4.72441E+17,https://twitter.com/eyoste/status/472440836873936896,,,,
DrAttai,5/30/2014 14:14,3,3,More on margins http://www.surgonc.org/margins-study # ASCO14 # bcsm,,,# #,4.72441E+17,https://twitter.com/DrAttai/status/472440830809350144,,,,
SWOG,5/30/2014 14:13,3,2,# SWOGonc S0230 POEMS @ # ASCO14: Goserelin during # breastcancer chemo helped young women preserve fertility http://swog.org/Media/Newsroom.asp … # bcsm,,@,# # # #,4.72441E+17,https://twitter.com/SWOG/status/472440772801748993,,,,
JeffreyMOtto,5/30/2014 14:13,0,0,TGB: need to monitor Pts longitudinally using whole exome and transcriptome technologies # ASCO14,,,#,4.72441E+17,https://twitter.com/JeffreyMOtto/status/472440638319771648,,,,
DrAttai,5/30/2014 14:13,4,1,What is appropriate margin? Practices vary from quadrantectomy to 2mm. Making some progress on this. # ASCO14 # bcsm https://www.breastsurgeons.org/new_layout/about/statements/PDF_Statements/Lumpectomy_Margins.pdf …,,,# #,4.72441E+17,https://twitter.com/DrAttai/status/472440621832368128,,,,
drcbsteer,5/30/2014 14:12,0,0,@ SIOGorg president Arti Hurria kicking off the # geriatriconcology discussions at # ASCO14. IOM report documents problems but also solutions.,,@,# #,4.72441E+17,https://twitter.com/drcbsteer/status/472440543763771394,,,,
sciberomics,5/30/2014 14:12,0,0,Bivona: Longitudinal integrated # genomics in # cancer research and # clinical care to optimize (poly)therapy # ASCO14,,,# # # #,4.7244E+17,https://twitter.com/sciberomics/status/472440461886373888,,,,
JeffreyMOtto,5/30/2014 14:12,0,0,TGB: understanding mechanisms of resistance evolution is key to developing effective treatment options # ASCO14,,,#,4.7244E+17,https://twitter.com/JeffreyMOtto/status/472440337110032386,,,,
EBDgroup,5/30/2014 14:11,2,1,EBD is in the house! # ASCO14 @ ASCO Look for @ tgunninkEBD in the sessions!,,@ @,#,4.7244E+17,https://twitter.com/EBDgroup/status/472440270513242112,,,,
mtmdphd,5/30/2014 14:11,0,0,"# lcsm Classes of mech of res to targeted Rx - target alteration, bypass signalling, EMT # ASCO14",,,# #,4.7244E+17,https://twitter.com/mtmdphd/status/472440232940675072,,,,
danielebanfi83,5/30/2014 14:11,0,3,E visto che non l'ho mai fatto... Selfie dall'aereoporto. # ASCO14 pic.twitter.com/TTAMx5LXyO,,,#,4.7244E+17,https://twitter.com/danielebanfi83/status/472440224380108800,,,,
DrAttai,5/30/2014 14:11,2,0,NSABP B-06 - no difference survival modified radical mastectomy compared to lumpectomy # ASCO14 # bcsm,,,# #,4.7244E+17,https://twitter.com/DrAttai/status/472440186341978113,,,,
NuCana_news,5/30/2014 14:11,0,0,"NuCana will be presenting at the American Society of Clinical Oncology ( @ ASCO ) annual meeting on May 30-June 3, 2014 in Chicago, Illinois.",,@,,4.7244E+17,https://twitter.com/NuCana_news/status/472440104947302400,,,,
Tracypep,5/30/2014 14:11,1,0,Help me spread the word that # cancer # innovation matters. # mliwi # asco14 http://mylifeisworthit.org?kid=39RMEmylifeisworthit.org/?kid=39RME,,,# # # #,4.7244E+17,https://twitter.com/Tracypep/status/472440092812787712,,,,
myPathMelanoma,5/30/2014 14:11,0,0,Myriad myPath # Melanoma delivers # diagnostic information unavailable from any other # test # MelanomaDiagnostic # isthismelanoma # ASCO14,,,# # # # # #,4.7244E+17,https://twitter.com/myPathMelanoma/status/472440053369548800,,,,
DrAttai,5/30/2014 14:10,11,2,NSABP B-04 landmark study - no difference in survival Halsted radical mastectomy vs Modified Radical mastectomy # ASCO14 # bcsm,,,# #,4.7244E+17,https://twitter.com/DrAttai/status/472439991600414721,,,,
danielebanfi83,5/30/2014 14:10,0,0,In diretta dal # JFK in attesa di andare in quel di Chicago. Pronti per # ASCO14. Intanto approfitto della mitica promozione @ boingo!,,@,# #,4.7244E+17,https://twitter.com/danielebanfi83/status/472439937288404992,,,,
n8pennell,5/30/2014 14:10,2,0,"At the # ASCO14 MOC workshop. If you haven't thought about MOC yet, time to start! Haven't thought about non lung cancer topics in a while",,,#,4.7244E+17,https://twitter.com/n8pennell/status/472439927486312448,,,,
rsm2800,5/30/2014 14:10,0,1,And behind Door #1…RT @ OncologyTimes: Gr8 photo! RT @ CliffordHudis: on site and ready to go! # asco14 pic.twitter.com/csgtzewFeE,,@ @,#1 #,4.7244E+17,https://twitter.com/rsm2800/status/472439910058954753,,,,
Novartis,5/30/2014 14:10,1,1,# DYK treating # advancedBC requires hitting “targets” within a tumor cell like bumpers in pinball? http://bit.ly/1gBI7TH # ASCO14,,,# # #,4.7244E+17,https://twitter.com/Novartis/status/472439880854032384,,,,
theNCI,5/30/2014 14:10,12,6,MT @ NCIMedia Treatment helps young women preserve their fertility during breast cancer chemotherapy # bcsm http://1.usa.gov/1psfNFZ # ASCO14,,@,# #,4.7244E+17,https://twitter.com/theNCI/status/472439867126071296,,,,
TaraAnnGall,5/30/2014 14:10,1,0,"Lung, colon cancer conversations rose last year, breast cancer fell, says @ W2OGroup’s # SocOncology: http://buff.ly/RLoH2N ) # ASCO14 # hcsm",,@,# # #,4.7244E+17,https://twitter.com/TaraAnnGall/status/472439832665665538,,,,
DrAttai,5/30/2014 14:10,0,1,Dr. Kelly Hunt from @ MDAndersonNews discussing breast cancer surgical advances over the past 50 years # ASCO14 # bcsm,,@,# #,4.7244E+17,https://twitter.com/DrAttai/status/472439828840472576,,,,
JNCI_Now,5/30/2014 14:10,2,2,"Zoledronic acid is commonly used to reduce complications from bone metastases, such as bone fractures and spinal cord compression. # ASCO14",,,#,4.7244E+17,https://twitter.com/JNCI_Now/status/472439822951661569,,,,
JNCI_Now,5/30/2014 14:10,1,0,...less frequent treatment may reduce the risk of serious side effects," w/ added benefits in reduced patient inconvenience & cost.” # ASCO14""",,,#,4.7244E+17,https://twitter.com/JNCI_Now/status/472439817264197632,,,
JNCI_Now,5/30/2014 14:10,1,2,“...adding drugs like zoledronic acid has dramatically improved the care of patients w/ bone metastases.-Gabriel N. Hortobagyi," MD. # ASCO14""",,,#,4.7244E+17,https://twitter.com/JNCI_Now/status/472439816433700864,,,
JNCI_Now,5/30/2014 14:10,3,1,"After a year of monthly treatment w/ zoledronic acid, women w/ BC & bone metastasis can cut back treatment to every 3 months. # ASCO14",,,#,4.7244E+17,https://twitter.com/JNCI_Now/status/472439815703887872,,,,
JNCI_Now,5/30/2014 14:10,0,1,Less frequent zoledronic acid has comparable efficacy for women w/ BC & bone metastases compared to standard monthly treatment. # ASCO14,,,#,4.7244E+17,https://twitter.com/JNCI_Now/status/472439814881837056,,,,
JeffreyMOtto,5/30/2014 14:09,0,0,"TGB: EGFR T790M is a gatekeeper mutation,often leading to EGFR targeted therapy resistance # ASCO14",,,#,4.7244E+17,https://twitter.com/JeffreyMOtto/status/472439655728574467,,,,
SJNaggiar,5/30/2014 14:09,1,0,Fertility Freeze Helps Women Have Babies After Chemo # ASCO2014 by my colleagues @ maggiemfox and Judy Silverman http://nbcnews.to/1k8Dlxz,,@,#,4.7244E+17,https://twitter.com/SJNaggiar/status/472439637777334275,,,,
Agendia,5/30/2014 14:09,1,1,MINT # breastcancer prospective trial # ASCO14: Molecular profiling (BluePrint etc.) and neoadjuvant chemotherapy http://hub.am/1sZM1G1,,,# #,4.7244E+17,https://twitter.com/Agendia/status/472439633310408706,,,,
Medicalfacts,5/30/2014 14:08,0,1,Merck Serono presenteert nieuwe onderzoeksresultaten van moeilijk behandelbare kankersoorten tijdens # ASCO14 http://www.medicalfacts.nl/?p=206896,,,#,4.7244E+17,https://twitter.com/Medicalfacts/status/472439513026138112,,,,
c_cerrado,5/30/2014 14:08,1,2,: Announced at # ASCO14: Treatment helps young women preserve their fertility during breast cancer chemotherapy # bcsm http://1.usa.gov/1psfNFZ ”,,,# #,4.72439E+17,https://twitter.com/c_cerrado/status/472439430377406466,,,,
SymphonySister,5/30/2014 14:08,1,2,MINT # breastcancer prospective trial # ASCO14: Molecular profiling (BluePrint etc.) and neoadjuvant chemotherapy http://hub.am/Tzc0Km,,,# #,4.72439E+17,https://twitter.com/SymphonySister/status/472439419732230144,,,,
sciberomics,5/30/2014 14:08,0,1,Trevor Bivona: # genomics-based targeted therapy effective but almost all # tumors develop # resistance # ASCO14,,,# # # #,4.72439E+17,https://twitter.com/sciberomics/status/472439417118797824,,,,
z_phd,5/30/2014 14:08,0,0,"Howdy, # ASCO14! pic.twitter.com/jVg7tqYds5",,,#,4.72439E+17,https://twitter.com/z_phd/status/472439414056960000,,,,
ancasa2000,5/30/2014 14:08,0,0,"ASCO’s First Member in Latin America, Dr. Jaime de la Garza, Receives Distinguished Achievement Award | ASCO Annual Meeting # ASCO14",,,#,4.72439E+17,https://twitter.com/ancasa2000/status/472439356503113728,,,,
westonmagazines,5/30/2014 14:08,0,0,RT “ @ YaleMed: RT @ YaleCancer: Dr. Dan Petrylak discusses role of chemotherapy in prostate cancer @ysm # asco14 @ YNHH http://www.cancernetwork.com/asco-2014-prostate-cancer/asco-role-chemotherapy-and-novel-targeted-agents-prostate-cancer …”,,@ @ @ysm @,#,4.72439E+17,https://twitter.com/westonmagazines/status/472439306628648960,,,,
SAJansky,5/30/2014 14:07,0,0,More than 5100 abstracts accepted to # ASCO14 - @ CliffordHudis at the press conferencepic.twitter.com/FM49DcBZhg,,@,#,4.72439E+17,https://twitter.com/SAJansky/status/472439257177817089,,,,
JeffreyMOtto,5/30/2014 14:07,0,0,"TGB: LC Dx has become more precise in last 12 years, incorporating genomic information # ASCO14",,,#,4.72439E+17,https://twitter.com/JeffreyMOtto/status/472439216178085889,,,,
NCISymptomMgmt,5/30/2014 14:07,3,2,NEWS: Drug that puts women into temp menopause helps preserve fertility during breast cancer treatment. http://go.usa.gov/8yJW # ASCO14,,,#,4.72439E+17,https://twitter.com/NCISymptomMgmt/status/472439189905350657,,,,
mtmdphd,5/30/2014 14:07,5,0,Discussion about genetics / genomics in lung cancer - S100 at # ASCO14 imprecise -> precise medicine # lcsm,,,# #,4.72439E+17,https://twitter.com/mtmdphd/status/472439185710649344,,,,
DrAttai,5/30/2014 14:07,4,5,"wow. RT OncologyTimes At # ASCO14 Opening news conf, @ ASCO Pres @ CliffordHudis says expectation is about 33,000 attendees, most ever",,@ @,#,4.72439E+17,https://twitter.com/DrAttai/status/472439170540257281,,,,
nhasan,5/30/2014 14:07,0,0,Everything you wanted to know about online cancer discussions (but were afraid to ask): http://bit.ly/SOCONC ) # SocOncology # ASCO14,,,# #,4.72439E+17,https://twitter.com/nhasan/status/472439098670456832,,,,
AnneBooms,5/30/2014 14:06,0,0,# ASCO14 Delivering High Quality Cancer Care-shift in 2030- largest growth in cancer patients who are 70+,,,#,4.72439E+17,https://twitter.com/AnneBooms/status/472439035072643072,,,,
NCIMedia,5/30/2014 14:06,7,2,Announced at # ASCO14: Treatment helps young women preserve their fertility during breast cancer chemotherapy # bcsm http://1.usa.gov/1psfNFZ,,,# #,4.72439E+17,https://twitter.com/NCIMedia/status/472438936464527360,,,,
NCISymptomMgmt,5/30/2014 14:06,13,2,Treatment helps young women preserve their fertility during breast # cancer chemotherapy # ASCO2014 http://go.usa.gov/8yJW,,,# #,4.72439E+17,https://twitter.com/NCISymptomMgmt/status/472438832076697601,,,,
JeffreyMOtto,5/30/2014 14:06,0,0,"TGB: targeted Tx is effective, but almost all tumors develop resistance. # ASCO14",,,#,4.72439E+17,https://twitter.com/JeffreyMOtto/status/472438825445122048,,,,
n8pennell,5/30/2014 14:06,0,1,@bilgecan25 @ ASCO @ drdonsdizon Thanks!,,@bilgecan25 @ @,,4.72439E+17,https://twitter.com/n8pennell/status/472438807367667714,,,,
Roche,5/30/2014 14:05,4,2,# Personalizedmedicine means we can target precisely those patients most likely to be helped. http://ow.ly/xkCuV # ASCO14,,,# #,4.72439E+17,https://twitter.com/Roche/status/472438647078543360,,,,
myCME,5/30/2014 14:05,0,0,@ ASCO updating its guidelines on adjuvant endocrine therapy to recommend tamoxifen for up to 10 yrs http://ow.ly/xpxJZ # oncology # bcsm,,@,# #,4.72439E+17,https://twitter.com/myCME/status/472438601322856448,,,,
genentech,5/30/2014 14:05,3,0,We’ve come a long way in # breastcancer tx. What’s next? # ASCO2014 # Next50,,,# # #,4.72439E+17,https://twitter.com/genentech/status/472438600374960129,,,,
JNCI_Now,5/30/2014 14:05,3,1,Goserelin increased the odds of becoming pregnant and delivering a healthy baby following chemotherapy. # ASCO14,,,#,4.72439E+17,https://twitter.com/JNCI_Now/status/472438566618820608,,,,
JNCI_Now,5/30/2014 14:05,0,0,...and these findings offer a simple, new option for women with breast cancer," or possibly other cancers.” # ASCO14""",,,#,4.72439E+17,https://twitter.com/JNCI_Now/status/472438565109256192,,
JNCI_Now,5/30/2014 14:05,2,2,“Preserving fertility is a common and important concern among younger women diagnosed w/ cancer... Halle Moore," MD. # ASCO14""",,,#,4.72439E+17,https://twitter.com/JNCI_Now/status/472438562864889857,,,
JNCI_Now,5/30/2014 14:05,2,0,Women who received goserelin w/ chemo were 64% less likely to develop premature ovarian failure. # ASCO14,,,#,4.72439E+17,https://twitter.com/JNCI_Now/status/472438562017652736,,,,
JNCI_Now,5/30/2014 14:05,3,2,New clinical trial shows that adding goserelin to standard chemotherapy can help preserve fertility in women w/ HR- BC. # ASCO14,,,#,4.72439E+17,https://twitter.com/JNCI_Now/status/472438561220730880,,,,
JeffreyMOtto,5/30/2014 14:05,0,0,TGB: discussion will focus on lung cancer and new work with Tx options # ASCO14,,,#,4.72439E+17,https://twitter.com/JeffreyMOtto/status/472438556380524545,,,,
drdonsdizon,5/30/2014 14:04,0,1,@bilgecan25 @ lrn_brk @ n8pennell @ ASCO Thank You So Much. Welcome to twitter too!,,@bilgecan25 @ @ @,,4.72438E+17,https://twitter.com/drdonsdizon/status/472438388185120768,,,,
OncologyTimes,5/30/2014 14:04,1,1,"At # ASCO14 Opening news conf, @ ASCO Pres @ CliffordHudis says expectation is about 33,000 attendees, most ever",,@ @,#,4.72438E+17,https://twitter.com/OncologyTimes/status/472438306165501952,,,,
DrAttai,5/30/2014 14:03,2,5,We learned much of what we know via cooperative group studies. Important pont. Research matters # ASCO14 # bcsm,,,# #,4.72438E+17,https://twitter.com/DrAttai/status/472438248795832320,,,,
YaleMed,5/30/2014 14:03,2,3,RT @ YaleCancer: Dr. Dan Petrylak discusses role of chemotherapy in prostate cancer @ysm # asco14 @ YNHH http://www.cancernetwork.com/asco-2014-prostate-cancer/asco-role-chemotherapy-and-novel-targeted-agents-prostate-cancer …,,@ @ysm @,#,4.72438E+17,https://twitter.com/YaleMed/status/472438167526977536,,,,
SeattleGenetics,5/30/2014 14:03,3,2,"Saluting the 1st 50 years of excellence at # ASCO14, contributing to the 2nd with donations to @ iConquerCancer when you visit booth 22097.",,@,#,4.72438E+17,https://twitter.com/SeattleGenetics/status/472438041072517120,,,,
KUhlendorf,5/30/2014 14:02,0,0,"So tempting to include the handful of smokers outside # ASCO14, but I'll respect their privacy. Crazy... pic.twitter.com/hkULHiBDQv",,,#,4.72438E+17,https://twitter.com/KUhlendorf/status/472437948022259712,,,,
Boehringer,5/30/2014 14:02,2,2,RT @ ASCO: Celebrate 50 years of progress against cancer with ASCO Daily News anniversary issue http://bit.ly/1wAkTCd # ASCO14,,@,#,4.72438E+17,https://twitter.com/Boehringer/status/472437932218122240,,,,
sciberomics,5/30/2014 14:02,0,0,# ASCO14 begins in Chicago - waiting for session: # Tumor # Genomic Profiling and Its Application to # PersonalizedMedicine,,,# # # #,4.72438E+17,https://twitter.com/sciberomics/status/472437891411349504,,,,
dhjutsw1,5/30/2014 14:02,2,0,"Dr. James Armitage, International Expert on Lymphoma, honored w 2014 @ ASCO Special Recognition Award. Kudos # ASCO14 http://am.asco.org/dr-james-o-armitage-leading-international-expert-non-hodgkin-lymphoma-honored-2014-special#.U4jHMkkmc18.twitter …",,@,# #,4.72438E+17,https://twitter.com/dhjutsw1/status/472437814244552704,,,,
ASCO,5/30/2014 14:02,1,2,Looking for a colleague? Want to meet others in your specialty? Connect w/the Message & Networking Center # ASCO14 http://am.asco.org/arc,,,#,4.72438E+17,https://twitter.com/ASCO/status/472437789775388673,,,,
ASCO,5/30/2014 14:01,2,2,Our congratulations to James O Armitage MD on his # ASCO14 Special Recognition Award cc @ unmc @ ASCOPost,,@ @,#,4.72438E+17,https://twitter.com/ASCO/status/472437752387354624,,,,
DrAttai,5/30/2014 14:01,0,2,"Breast Cancer - 50 years of treatment - what have we learned, where are we going - fantastic session to open the meeting # ASCO14 # bcsm",,,# #,4.72438E+17,https://twitter.com/DrAttai/status/472437736583208960,,,,
ASCO,5/30/2014 14:01,0,0,Hear perspectives on value in cancer care at today's Extended Education Session http://bit.ly/1oKijVy # ASCO14,,,#,4.72438E+17,https://twitter.com/ASCO/status/472437735643684864,,,,
BayerPharma,5/30/2014 14:01,2,5,BHC News: Bayer presents data at 50th annual # ASCO14. Meeting abstracts are available online http://bit.ly/1pn42Rl,,,#,4.72438E+17,https://twitter.com/BayerPharma/status/472437719575318528,,,,
drdonsdizon,5/30/2014 14:01,0,0,@bilgecan25 TYSM! S/O to @ lrn_brk @ n8pennell @ ASCO,,@bilgecan25 @ @ @,,4.72438E+17,https://twitter.com/drdonsdizon/status/472437644493094912,,,,
Roche,5/30/2014 14:00,4,4,Achieving universal access to medical # innovation and quality healthcare remains a global challenge. http://ow.ly/xkAgh # ASCO14,,,# #,4.72438E+17,https://twitter.com/Roche/status/472437532249309185,,,,
ChargeAheadMktg,5/30/2014 14:00,0,0,Definitely following # ASCO14 tweets. Miss my days at this great event. Remember being part of the first ever tweetup there.,,,#,4.72437E+17,https://twitter.com/ChargeAheadMktg/status/472437498317406208,,,,
OncologyTimes,5/30/2014 14:00,2,3,Gr8 photo! RT @ CliffordHudis: on site and ready to go! # asco14 pic.twitter.com/Y5Ies0uLNP,,@,#,4.72437E+17,https://twitter.com/OncologyTimes/status/472437463534043137,,,,
BladderCancerUS,5/30/2014 14:00,0,0,BCAN will be at # ASCO14 this weekend! Come visit our booth in the Patient Advocacy Booth!,,,#,4.72437E+17,https://twitter.com/BladderCancerUS/status/472437458039472128,,,,
SarahCannonDocs,5/30/2014 14:00,0,0,Targeted therapy exploring PTEN mutant cell lines in ongoing Phase I/II trial can be seen at Poster 28 Abs#2514 # ASCO14,,,#2514 #,4.72437E+17,https://twitter.com/SarahCannonDocs/status/472437430101217280,,,,
JeffreyMOtto,5/30/2014 14:00,0,1,"First speaker: Trevor Grant Bivona (TGB), Future visions for integrating tumor biology into treatment. # ASCO14""",,,#,4.72437E+17,https://twitter.com/JeffreyMOtto/status/472437377286172672,,,,
RxProcess,5/30/2014 14:00,1,1,# FF ASCO social media contributors @ DrMarkham @ drdonsdizon @ CliffordHudis @ DrAttai @ rsm2800 @ mtmdphd @ fischmd @ TGeorgeMD # ASCO2014,,@ @ @ @ @ @ @ @,# #,4.72437E+17,https://twitter.com/RxProcess/status/472437347637026816,,,,
myriadgenetics,5/30/2014 14:00,0,0,"Do you want to find out if you're at # risk of # hereditarycancer? Take this simple, 30-second quiz! http://bit.ly/17zeRbJ # hboc # ASCO14",,,# # # #,4.72437E+17,https://twitter.com/myriadgenetics/status/472437315973816321,,,,
BlueJCHost,5/30/2014 14:00,0,0,Still time 2 join us at # BlueJC to dissect this study looking at caesarean & childhood cancer risks http://bit.ly/RI5Cib # ASCO14 # ecrchat,,,# # #,4.72437E+17,https://twitter.com/BlueJCHost/status/472437287113199616,,,,
bergenm2,5/30/2014 13:59,0,0,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72437E+17,https://twitter.com/bergenm2/status/472437250597220352,,,,
EIannelli,5/30/2014 13:59,2,0,# ASCO14 http://tinyurl.com/m7n2kkk futuro della presrvaz fertilità x malati # cancro @ InsControCancro @ favo_it @ ManuelaPerrone @ marghiadnsal,,@ @ @ @,# #,4.72437E+17,https://twitter.com/EIannelli/status/472437234382028800,,,,
Ann_Nonymous_MD,5/30/2014 13:58,0,0,50 yrs of breast cancer session starting soon. # ASCO14 pic.twitter.com/9OkyOVfWLW,,,#,4.72437E+17,https://twitter.com/Ann_Nonymous_MD/status/472436988314791936,,,,
DrSherifMorgan,5/30/2014 13:58,0,0,# ASCO14 begins! (@McCormick Place Lakeside Center w/ 6 others) http://4sq.com/1mRhFF5,,@McCormick,#,4.72437E+17,https://twitter.com/DrSherifMorgan/status/472436967398207488,,,,
DrAttai,5/30/2014 13:58,1,2,congrats! RT CliffordHudis on site and ready to go! # asco14 pic.twitter.com/U5aaaJsMSU,,,#,4.72437E+17,https://twitter.com/DrAttai/status/472436932740669441,,,,
GantosJ,5/30/2014 13:57,0,0,$ MRK over 1180 21June $60 calls traded today .. someone is betting on # ASCO14 surprise !!!,,,#,4.72437E+17,https://twitter.com/GantosJ/status/472436730659098624,,,,
mmameg,5/30/2014 13:57,0,0,"Finding small indications in BIG tumors is # ASCO2014 Targeted therapies 46% of Onc sales today. Great 4 Pts, Pharma and payors if done right",,,#,4.72437E+17,https://twitter.com/mmameg/status/472436698014818304,,,,
Agendia,5/30/2014 13:57,2,2,# MammaPrint has up to 25 yr outcome data. Visit the all new Agendia booth 16025 for more info! # ASCO14 # bcsm # hcsmpic.twitter.com/lUJQUDWJhR,,,# # # #,4.72437E+17,https://twitter.com/Agendia/status/472436648853377024,,,,
JulieNormart,5/30/2014 13:56,0,0,Great lesson of new # SocOncology report: ignore pop culture at your peril when educating on cancer: http://bit.ly/1oCSM2Z # ASCO14,,,# #,4.72436E+17,https://twitter.com/JulieNormart/status/472436296926126080,,,,
EIannelli,5/30/2014 13:55,2,0,# ASCO14 http://tinyurl.com/qccjmnw popolazione anziana: epidemia cancro. Sostenibilità sistema sanit @ InsControCancro @ ManuelaPerrone @ favo_it,,@ @ @,#,4.72436E+17,https://twitter.com/EIannelli/status/472436196006576128,,,,
fukkun_dayo,5/30/2014 13:55,0,0,さあ始まりますね # ASCO14 pic.twitter.com/iorQekXSxu,,,#,4.72436E+17,https://twitter.com/fukkun_dayo/status/472436071293530112,,,,
JeffreyMOtto,5/30/2014 13:54,0,1,First # ASCO14 session: genomic tumor profiling and its application in # personalizedmedicine,,,# #,4.72436E+17,https://twitter.com/JeffreyMOtto/status/472435977756360704,,,,
BosBizDon,5/30/2014 13:54,0,0,# ASCO14 is the biggest annual conference for cancer biotechs. An overview of what Cambridge-area biotechs are doing http://www.bizjournals.com/boston/blog/bioflash/2014/05/biggest-annual-cancer-drug-conference-to-feature.html …,,,#,4.72436E+17,https://twitter.com/BosBizDon/status/472435928321904640,,,,
jodigralnick,5/30/2014 13:54,1,0,Ahead of # ASCO14: How much progress have we made in the fight against cancer? # CNBC's @ megtirrell has a look: http://cnb.cx/1nAUlPB,,@,# #,4.72436E+17,https://twitter.com/jodigralnick/status/472435878107693057,,,,
primaris_health,5/30/2014 13:51,0,1,We're on our way to exhibit at # ASCO14 to engage with industry experts. Also looking forward to visiting @ UCCancerCenter,,@,#,4.72435E+17,https://twitter.com/primaris_health/status/472435171594342400,,,,
EIannelli,5/30/2014 13:50,8,0,50 Years of Systemic Therapy for Breast Cancer: From One Size Fits All to Tailored Therapy # ASCO14 http://meetinglibrary.asco.org/content/11400001-144#.U4jEusic5Bo.twitter … @ InsControCancro,,@,# #,4.72435E+17,https://twitter.com/EIannelli/status/472435010633342977,,,,
DrAttai,5/30/2014 13:50,2,4,Made it! # ASCO14 pic.twitter.com/aqXqLHSgSS,,,#,4.72435E+17,https://twitter.com/DrAttai/status/472434904241020929,,,,
CanaleComm,5/30/2014 13:50,0,0,"*We'll read them!* MT @ adamfeuerstein Adam, what are you doing today? Not much, just writing a gazillion embargoed stories for # ASCO14.",,@,#,4.72435E+17,https://twitter.com/CanaleComm/status/472434800465567744,,,,
scientre,5/30/2014 13:49,0,3,How I'm feeling leading into # ASCO14 http://ow.ly/i/5K8xb Knowing my slides are oncologist approved! Thanks @ mtmdphd,,@,#,4.72435E+17,https://twitter.com/scientre/status/472434622006300673,,,,
TuftsB,5/30/2014 13:49,0,0,The Value of Innovative Medical Therapies - I am. proof http://huff.to/1l9UBiu via @ HealthyLiving # mliwi # asco14,,@,# #,4.72435E+17,https://twitter.com/TuftsB/status/472434554985148416,,,,
drdonsdizon,5/30/2014 13:48,0,1,@ ShannonWestin I'm ur 1st follower. how excellent! # ASCO14,,@,#,4.72434E+17,https://twitter.com/drdonsdizon/status/472434434776768512,,,,
dmooneymd,5/30/2014 13:48,0,0,"In Chicago, ready for first session on GE cancer. # ASCO14",,,#,4.72434E+17,https://twitter.com/dmooneymd/status/472434335749275648,,,,
InterConChicago,5/30/2014 13:46,0,1,"@ ConsanoScott After # ASCO14, we'd love for you & @ ConsanoMolly to join us at Eno for a glass of wine to celebrate your anniversary!",,@ @,#,4.72434E+17,https://twitter.com/InterConChicago/status/472434002910277632,,,,
MyelomaTeacher,5/30/2014 13:45,1,0,"Tweeting from # ASCO14 ? Let me know. Making a list and checkin it more than twice"" # RealTimeASCO # hcsm""",,,# # #,4.72434E+17,https://twitter.com/MyelomaTeacher/status/472433670889148417,,,,
GlopesMd,5/30/2014 13:45,0,4,In Chicago for # ASCO14 pic.twitter.com/UNLL1KDItl,,,#,4.72434E+17,https://twitter.com/GlopesMd/status/472433665692028929,,,,
strategicTy,5/30/2014 13:45,0,0,Just touched down in Chicago for # ASCO14 Come join us at the @ MDAndersonNews booth and hear about the great talks our faculty this week!,,@,#,4.72434E+17,https://twitter.com/strategicTy/status/472433626437931008,,,,
ASCO,5/30/2014 13:45,1,1,Attending the MOC workshop at # ASCO14? Brush up on the new ABIM http://bit.ly/RH8HiG via # ASCOConnection,,,# #,4.72434E+17,https://twitter.com/ASCO/status/472433624521129985,,,,
SarahCannonDocs,5/30/2014 13:45,0,0,"Meet Dr. Infante to discuss Ph.1 study of LEE011, an orally bioavailable, highly specific CDK4/6 inhibitor at Poster 43 Abs#2528 # ASCO14",,,#2528 #,4.72434E+17,https://twitter.com/SarahCannonDocs/status/472433523480330242,,,,
TuftsB,5/30/2014 13:45,0,0,@ DrBobGoldberg @ ASCO -3 months is a guess of average mortality. Some like me live longer. Do not kill us to supposedly save $ # mliwi # ASCO14,,@ @,# #,4.72434E+17,https://twitter.com/TuftsB/status/472433511270731776,,,,
ipaulmampilly,5/30/2014 13:43,0,0,Cancer research jamboree # ASCO14 pic.twitter.com/yixDByPbrx,,,#,4.72433E+17,https://twitter.com/ipaulmampilly/status/472433126078021632,,,,
pfcosgrove,5/30/2014 13:43,0,0,Lets not rest until every patient has great # cancer treatment. Sign the petition. # asco14 # mliwi http://mylifeisworthit.org/,,,# # #,4.72433E+17,https://twitter.com/pfcosgrove/status/472433124417490945,,,,
Lymphoma_Doc,5/30/2014 13:43,1,2,"@ mtmdphd add one more to your list: @ ShannonWestin, Gyn Onc specialist from MD Anderson, brand new to twitter for # ASCO14 # gyncsm",,@ @,# #,4.72433E+17,https://twitter.com/Lymphoma_Doc/status/472433074857578496,,,,
SitemanCenter,5/30/2014 13:42,1,1,Will you @ fly2ohare on your way to # ASCO14? Check out our sign there. pic.twitter.com/C1EEiFpti1,,@,#,4.72433E+17,https://twitter.com/SitemanCenter/status/472432950592937985,,,,
tkdmHawkeye,5/30/2014 13:42,0,0,I'm looking forward to seeing the cutting edge data!! See you soon!! # ASCO14 pic.twitter.com/PCdbfvqcdl,,,#,4.72433E+17,https://twitter.com/tkdmHawkeye/status/472432872063000576,,,,
Ann_Nonymous_MD,5/30/2014 13:41,0,0,Surprised to see stream of tweets on screen at # ASCO14. Does anyone read tweets? Mine solve a puzzle.,,,#,4.72433E+17,https://twitter.com/Ann_Nonymous_MD/status/472432682375581696,,,,
n8pennell,5/30/2014 13:41,0,1,Why are people taking the bridge inside to building E? Beautiful day at # ASCO14! pic.twitter.com/NzKnyigotE,,,#,4.72433E+17,https://twitter.com/n8pennell/status/472432671998496769,,,,
TuftsB,5/30/2014 13:41,0,0,@ DrBobGoldberg @ ASCO - cutting bloated hospital administrators would also help?,,@ @,,4.72433E+17,https://twitter.com/TuftsB/status/472432669520048129,,,,
Novartis,5/30/2014 13:40,2,3,"At # ASCO14 5/30-6/3 # Novartis presents updated # CML data, including treatment-free remission trials-in progress http://bit.ly/1n4oXWP",,,# # #,4.72432E+17,https://twitter.com/Novartis/status/472432303592198144,,,,
ChantalR,5/30/2014 13:37,0,1,Everything you wanted to know about online cancer discussions (but were afraid to ask): http://bit.ly/SOCONC ) # SocOncology # ASCO14,,,# #,4.72432E+17,https://twitter.com/ChantalR/status/472431641235697664,,,,
APublicCompany,5/30/2014 13:37,0,0,The 2014 MDigitalLIfe Social Oncology Project Report by @ w2ogroup # asco14 # mdigitallife http://www.slideshare.net/WCGWorld/the-2014-mdigitallife-social-oncology-project-report?ref=http://mdigitallife.com/socialoncology/ … via @ SlideShare,,@ @,# #,4.72432E+17,https://twitter.com/APublicCompany/status/472431588890796032,,,,
CareAcross,5/30/2014 13:37,0,1,# ASCO14: Year 50....day 1. Looking forward to hearing the latest on the fight against cancer pic.twitter.com/bCsodZQqKu,,,#,4.72432E+17,https://twitter.com/CareAcross/status/472431531701460992,,,,
CarissaO,5/30/2014 13:35,1,0,# SocOncology report from @ W2OGroup looked at 15 million online conversations about # cancer. What we saw: http://bit.ly/SOCONC # ASCO14,,@,# # #,4.72431E+17,https://twitter.com/CarissaO/status/472431214218190848,,,,
LivingBeyondBC,5/30/2014 13:35,2,0,"You can also register for our webinar, Breaking News: Updates from # ASCO14, for an overview! http://www.lbbc.org/Events/2014-06-24-ASCO-Update …pic.twitter.com/8W8WQE97yx",,,#,4.72431E+17,https://twitter.com/LivingBeyondBC/status/472431145662308353,,,,
MollyR09,5/30/2014 13:35,0,0,Great lesson of new # SocOncology report: ignore pop culture at your peril when educating on cancer: http://bit.ly/1oCSM2Z # ASCO14,,,# #,4.72431E+17,https://twitter.com/MollyR09/status/472431100267331584,,,,
RCSHChicago,5/30/2014 13:35,0,1,It's a sunny # Friday & we are excited to have # ASCO14 in town! Some great reso times are still open. Call us ASAP to reserve! 312-321-2725,,,# #,4.72431E+17,https://twitter.com/RCSHChicago/status/472431084664135680,,,,
MGHCancerCenter,5/30/2014 13:35,0,0,"Today 4:30-5:45 E Arie Theatre Dr. Reynolds talks of her poster, phase 1 study, LJM716 in pts w/ esophageal squamous cell carcinoma # ASCO14",,,#,4.72431E+17,https://twitter.com/MGHCancerCenter/status/472431055111454720,,,,
EIannelli,5/30/2014 13:34,2,1,# ASCO14 http://tinyurl.com/m7n2kkk fertility preservation 4 young Cancer patients @ InsControCancro @ favo_it @ marghiadnsal @ ManuelaPerrone,,@ @ @ @,#,4.72431E+17,https://twitter.com/EIannelli/status/472430978145611776,,,,
ShannonWestin,5/30/2014 13:34,0,3,Excited to join twitter for # ASCO14 # gyncsm,,,# #,4.72431E+17,https://twitter.com/ShannonWestin/status/472430936874029056,,,,
jrgralow,5/30/2014 13:34,4,0,"Congrats, Dr. President! RT @ CliffordHudis: on site and ready to go! # asco14 pic.twitter.com/TOPIOeFoIq",,@,#,4.72431E+17,https://twitter.com/jrgralow/status/472430870021033984,,,,
chimoose,5/30/2014 13:33,3,3,"Online cancer dialog continues to get DEEPER, if not LARGER. All the pre- # ASCO14 analysis here: http://bit.ly/SOCONC @ MTMDPhD @ FischMD",,@ @,#,4.72431E+17,https://twitter.com/chimoose/status/472430710658056194,,,,
qbertina,5/30/2014 13:32,0,0,@ ASCO it will take that long to get through the line to print out my badge,,@,,4.7243E+17,https://twitter.com/qbertina/status/472430318495219713,,,,
ASCO,5/30/2014 13:31,0,1,Where will you watch # ASCO14 Plenary Session on Sunday? Watch in N Hall B1 or catch the simulcast in E Hall D1 & Networking Cafes,,,#,4.7243E+17,https://twitter.com/ASCO/status/472430027989323776,,,,
Novartis,5/30/2014 13:31,5,3,"# Novartis is presenting pivotal data in blood, skin and lung cancers at # ASCO14, learn more here: http://bit.ly/1pzVmnW",,,# #,4.7243E+17,https://twitter.com/Novartis/status/472430024164143104,,,,
ASCO,5/30/2014 13:31,2,0,Check out this # ASCOConnection article before todays # ASCO14 session on Surgeon Generals Report on Tobacco: http://bit.ly/1hOZVpg,,,# #,4.7243E+17,https://twitter.com/ASCO/status/472430004387999744,,,,
ASCO,5/30/2014 13:31,1,3,"Eric Tetzlaff, MHS, PA-C: An advanced practice providers experience at # ASCO14 http://bit.ly/1pyGHJM",,,#,4.7243E+17,https://twitter.com/ASCO/status/472429992941744128,,,,
m_e_nielsen,5/30/2014 13:30,1,0,Comprehensive molecular profiling of urothelial bladder ca at DNA/RNA/protein levels: A @ TCGAupdates project # ASCO14 http://ow.ly/xpivG,,@,#,4.7243E+17,https://twitter.com/m_e_nielsen/status/472429876751106048,,,,
LTbioinvestor,5/30/2014 13:30,0,1,expectations are very low or even ZERO so maybe some turd will surprise .... $ ARQL $ OXGN $ AVEO $ CYCC $ TLOG $ GTXI $ VSTM $ ONTX .... # ASCO2014,,,#,4.7243E+17,https://twitter.com/LTbioinvestor/status/472429873529905152,,,,
SitemanCenter,5/30/2014 13:30,0,1,"Elaine Mardis, PhD, of @ GenomeInstitute discusses evolving technologies in somatic tumor genetics: 1:40-2 pm, Rm S100bc # ASCO14 @ WUSTLmed",,@ @,#,4.7243E+17,https://twitter.com/SitemanCenter/status/472429840810135552,,,,
n8pennell,5/30/2014 13:30,4,8,"Just picked up my print copy of the # ASCO14 Ed Book, perfect size for carrying and looks great! @ asco @ drdonsdizonpic.twitter.com/ifhuaO1XYt",,@ @,#,4.7243E+17,https://twitter.com/n8pennell/status/472429781128994816,,,,
MeganSvensen,5/30/2014 13:29,0,0,What’s big in # SocOncology? Annual @ W2OGroup report says cancer hashtags and doc tweets: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.7243E+17,https://twitter.com/MeganSvensen/status/472429539193126912,,,,
GageGrammer,5/30/2014 13:27,0,1,# SocOncology report from @ W2OGroup looked at 15 million online conversations about cancer. What we saw: http://bit.ly/SOCONC # ASCO14,,@,# #,4.72429E+17,https://twitter.com/GageGrammer/status/472429103266545664,,,,
davidgrahammd,5/30/2014 13:27,1,0,Welcome friends... I need to get back to Brugge RT @ mediplanetFR: Belgian doctors are now following # ASCO14 on http://www.mediplanet.be,,@,#,4.72429E+17,https://twitter.com/davidgrahammd/status/472429085176905728,,,,
ASCO,5/30/2014 13:27,19,8,Celebrate 50 years of progress against cancer with ASCO Daily News anniversary issue http://bit.ly/1wAkTCd # ASCO14,,,#,4.72429E+17,https://twitter.com/ASCO/status/472429009494867968,,,,
PromotingGHL,5/30/2014 13:26,2,3,MMPeeps # myeloma clinical updates live from # ASCO14 follow @ theMMRF! Check daily for the latest news: http://www.themmrf.org/asco - # MMRFASCO,,@,# # #,4.72429E+17,https://twitter.com/PromotingGHL/status/472428936178458624,,,,
twist_mktg,5/30/2014 13:26,0,0,Everything you wanted to know about online cancer discussions (but were afraid to ask): http://bit.ly/SOCONC # SocOncology # ASCO14,,,# #,4.72429E+17,https://twitter.com/twist_mktg/status/472428847518851074,,,,
DrYashGad,5/30/2014 13:26,0,0,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72429E+17,https://twitter.com/DrYashGad/status/472428727205658626,,,,
Chad__Maxwell,5/30/2014 13:25,0,0,Excited to be operating the graphics for @ ASCO and it's # ASCO14 convention all weekend long for thousands of doctors pic.twitter.com/ObMwMU2f8T,,@,#,4.72429E+17,https://twitter.com/Chad__Maxwell/status/472428723967631361,,,,
WCGWorld,5/30/2014 13:25,1,0,What’s big in # SocOncology? Annual @ W2OGroup report says cancer hashtags and doc tweets: http://bit.ly/SOCONC # ASCO14,,@,# #,4.72429E+17,https://twitter.com/WCGWorld/status/472428662273216512,,,,
OncoZine,5/30/2014 13:25,0,0,Penn Medicine’s Abramson Cancer Ctr Dispels Commonly-Held Beliefs about Cancer Care + Patient Demands for Treatment @ ASCO Abstr 6530 # Cancer,,@,#,4.72429E+17,https://twitter.com/OncoZine/status/472428661392830466,,,,
peterduckler,5/30/2014 13:25,0,0,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72429E+17,https://twitter.com/peterduckler/status/472428658590638080,,,,
corp_UNC,5/30/2014 13:25,0,0,The key components of survivorship care plans: Results from an ASCO multidisciplinary consensus conference # ASCO14 http://ow.ly/xqzE4,,,#,4.72429E+17,https://twitter.com/corp_UNC/status/472428544002625536,,,,
peterduckler,5/30/2014 13:25,0,0,Annual # SocOncology report from @ W2OGroup shows breast cancer again dominates online conversation: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72429E+17,https://twitter.com/peterduckler/status/472428520631971840,,,,
NovartisScience,5/30/2014 13:25,2,2,Check out @ Novartis’ website for # ASCO14 http://bit.ly/1ipAxGQ # cancer,,@,# #,4.72429E+17,https://twitter.com/NovartisScience/status/472428508841779201,,,,
PPDCRO,5/30/2014 13:25,0,0,Interested in imaging for # oncology # clinicaltrials? Watch our webinar to learn more. # ASCO14 http://youtu.be/SqB4zaC1vQ8,,,# # #,4.72428E+17,https://twitter.com/PPDCRO/status/472428496774791168,,,,
W2OGroup,5/30/2014 13:24,0,1,What’s big in # SocOncology? Our annual report says cancer hashtags and doc tweets: http://bit.ly/SOCONC # ASCO14,,,# #,4.72428E+17,https://twitter.com/W2OGroup/status/472428407188639744,,,,
KailKilmartin,5/30/2014 13:24,0,0,What Walter White and Angelina Jolie teach us about # SocOncology. New @ W2OGroup post: http://bit.ly/1oCSM2Z # ASCO14,,@,# #,4.72428E+17,https://twitter.com/KailKilmartin/status/472428370953662464,,,,
Barnesduh,5/30/2014 13:24,0,1,Everything you wanted to know about online cancer discussions (but were afraid to ask): http://bit.ly/SOCONC ) # SocOncology # ASCO14,,,# #,4.72428E+17,https://twitter.com/Barnesduh/status/472428263596630016,,,,
JWMarriottChi,5/30/2014 13:24,0,1,Excited to welcome all our guests in town for the 50th Annual @ ASCO Meeting this weekend! # ASCO14,,@,#,4.72428E+17,https://twitter.com/JWMarriottChi/status/472428233762557953,,,,
StJudeResearch,5/30/2014 13:23,18,20,. @ stjude Dr. Les Robison to get @ ASCO Pediatric Oncology Award at # ASCO14 for work w/childhood cancer survivors http://bit.ly/SJ-LR,,@ @,#,4.72428E+17,https://twitter.com/StJudeResearch/status/472428177126871040,,,,
P_Thornton10,5/30/2014 13:23,0,0,Everything you wanted to know about online cancer discussions (but were afraid to ask) -- http://bit.ly/SOCONC # SocOncology # ASCO14,,,# #,4.72428E+17,https://twitter.com/P_Thornton10/status/472428166636519425,,,,
adaghest,5/30/2014 13:22,0,0,Isn't time for buses drivers to be trained before we keep getting lost on the first day coming to convention # ASCO14,,,#,4.72428E+17,https://twitter.com/adaghest/status/472427899732373504,,,,
WCGClinical,5/30/2014 13:22,0,6,"Our booth’s ready for action! Looking forward to having some insightful discussions at booth #3097, # ASCO14 tomorrow. pic.twitter.com/cnBOGefTFD",,,#3097 #,4.72428E+17,https://twitter.com/WCGClinical/status/472427875355082752,,,,
ElliotMFox,5/30/2014 13:22,0,0,What’s big in # SocOncology? Annual @ W2OGroup report says cancer hashtags and doc tweets: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72428E+17,https://twitter.com/ElliotMFox/status/472427770207666177,,,,
CancerDotNet,5/30/2014 13:21,2,0,Int'l Pt Advocates - RT @ ASCO: Unique resources for international attendees at # ASCO14: http://bit.ly/1oKhOuI,,@,#,4.72428E+17,https://twitter.com/CancerDotNet/status/472427691300646912,,,,
PresCancerPanel,5/30/2014 13:21,0,0,MT @NCIExhibits: # ASCO14 has begun! Check out info on all NCI events at this year's meeting: http://1.usa.gov/1oD9Shp http://bit.ly/1oD9Shs,,@NCIExhibits,#,4.72428E+17,https://twitter.com/PresCancerPanel/status/472427676423442433,,,,
Dr_Schawan,5/30/2014 13:21,0,0,"Is attending # ASCO14, and presenting in Breast Cancer clinical trial session",,,#,4.72428E+17,https://twitter.com/Dr_Schawan/status/472427649155883008,,,,
PAN_Foundation,5/30/2014 13:21,0,1,It's officially the start of # ASCO14 come visit our booth tmrw thru Mon in the patient advocacy pavilion!,,,#,4.72428E+17,https://twitter.com/PAN_Foundation/status/472427629023617024,,,,
LionelGeek,5/30/2014 13:21,0,0,What Walter White and Angelina Jolie teach us about # SocOncology. New @ W2OGroup post: http://bit.ly/1oCSM2Z # ASCO14,,@,# #,4.72428E+17,https://twitter.com/LionelGeek/status/472427608831832064,,,,
mediplanetFR,5/30/2014 13:21,1,0,Belgian doctors are now following # ASCO14 on http://www.mediplanet.be,,,#,4.72428E+17,https://twitter.com/mediplanetFR/status/472427563189796864,,,,
KaylaRodrigue11,5/30/2014 13:20,1,2,# SocOncology report from @ W2OGroup looked at 15 million online conversations about cancer. What we saw: http://bit.ly/SOCONC ) # ASCO14,,@,# #,4.72427E+17,https://twitter.com/KaylaRodrigue11/status/472427447838052352,,,,
taylorcarr90,5/30/2014 13:20,0,0,What Walter White and Angelina Jolie teach us about # SocOncology. New @ W2OGroup post: http://bit.ly/1oCSM2Z # ASCO14,,@,# #,4.72427E+17,https://twitter.com/taylorcarr90/status/472427434097541121,,,,
DrBobGoldberg,5/30/2014 13:20,0,0,"@ ASCO value czar schnipper: 3 mo. of life not worth it: trumped by greater benefits to many that would have to be foregone to provide it.”""",,@,,4.72427E+17,https://twitter.com/DrBobGoldberg/status/472427390082494464,,,,
Boehringer,5/30/2014 13:20,2,0,Happy 50th Bday @ ASCO!! What a milestone! We hope even better outcomes are achieved f/ patients in next 50yrs http://bit.ly/1qkY4wt # ASCO14,,@,#,4.72427E+17,https://twitter.com/Boehringer/status/472427277134082049,,,,
SarahCannonDocs,5/30/2014 13:20,0,0,Want to learn about novel anti-angiogenic agents? Check out our Phase 1 Fumagillol derivatives study. Poster 41 Abs#2526 # ASCO14,,,#2526 #,4.72427E+17,https://twitter.com/SarahCannonDocs/status/472427264970608640,,,,
Boehringer,5/30/2014 13:19,4,2,We've arrived in # Chicago ready for # ASCO14! RT if you're here too! pic.twitter.com/zVf0WgANPm,,,# #,4.72427E+17,https://twitter.com/Boehringer/status/472427160008159232,,,,
JenaidMRees,5/30/2014 13:19,0,0,Top cancer picks in time for # ASCO14 @ERJournals! Some reading between talks :),,@ERJournals,#,4.72427E+17,https://twitter.com/JenaidMRees/status/472426993263591425,,,,
ScheryllAlken,5/30/2014 13:18,0,0,Excited to be in Chicago for @ ASCO # ASCO14 meeting!,,@,#,4.72427E+17,https://twitter.com/ScheryllAlken/status/472426786362363905,,,,
DrBobGoldberg,5/30/2014 13:17,0,0,@ ASCO value czar schnipper: not worth treating patients if it ‘only’ adds three months of life # ASCO14 # mliwi,,@,# #,4.72427E+17,https://twitter.com/DrBobGoldberg/status/472426646130401280,,,,
lisamjarvis,5/30/2014 13:17,0,1,"nice! MT @ bmahersciwriter in time for # ASCO14, @ heidiledford rounds up @ NatureNews cancer immunotherapy coverage http://flip.it/q6NmF",,@ @ @,#,4.72427E+17,https://twitter.com/lisamjarvis/status/472426508363898880,,,,
CliffordHudis,5/30/2014 13:17,14,16,on site and ready to go! # asco14 pic.twitter.com/Bggp353RuX,,,#,4.72426E+17,https://twitter.com/CliffordHudis/status/472426480702861313,,,,
genentech,5/30/2014 13:15,0,0,"@ TomBeer @ communityonc: Do you agree? 3 barriers in Bringing Trials to Patients"" by Corsee Sanders http://ow.ly/xk5vc # ASCO14""",,@ @,#,4.72426E+17,https://twitter.com/genentech/status/472426043371192320,,,,
SitemanCenter,5/30/2014 13:15,0,0,"Siteman's Albert Lockhart, MD, chairs an overview of the evolution of prostate cancer research and treatments: 1-3:15 pm, Rm S406 # ASCO14",,,#,4.72426E+17,https://twitter.com/SitemanCenter/status/472426001176485888,,,,
myriadgenetics,5/30/2014 13:15,3,0,"Are you attending # ASCO14? Visit us at Booth 2039 to find out about our next generation # genepanel test, Myriad myRisk # HereditaryCancer!",,,# # #,4.72426E+17,https://twitter.com/myriadgenetics/status/472425960034144256,,,,
luuuferreiraa,5/30/2014 13:12,0,0,Le hace falta aguita y jabon a los que van en este bondi. # ASCO14,,,#,4.72425E+17,https://twitter.com/luuuferreiraa/status/472425452662169600,,,,
xavigranda,5/30/2014 13:12,0,0,La sala de prensa de @ ASCO abarrotada desde la mañana temprano pic.twitter.com/8WOM0af0DT,,@,,4.72425E+17,https://twitter.com/xavigranda/status/472425437029621762,,,,
umichmedicine,5/30/2014 13:12,1,2,"RT @UMCancerCenter: Radiation for # prostate # cancer linked to secondary cancers, study finds: http://umhealth.me/1hFqzBg # ASCO14",,@UMCancerCenter,# # #,4.72425E+17,https://twitter.com/umichmedicine/status/472425432860868608,,,,
OncoZine,5/30/2014 13:12,0,0,Ibrutinib (Pharmacyclics; Abstr 7014) efficacy 3 yrs post-initiation monotherapy in ptn with CLL to be presented @ ASCO @ ASCO14 # Cancer,,@ @,#,4.72425E+17,https://twitter.com/OncoZine/status/472425409163046912,,,,
davidgrahammd,5/30/2014 13:12,1,0,Nice pragmatic touch by @ ASCO for # asco14 ... Tables with power strips are clearly marked,,@,#,4.72425E+17,https://twitter.com/davidgrahammd/status/472425395598659584,,,,
bwoodmd,5/30/2014 13:12,0,1,"@ fischmd Asking # SoWhat gives meaning/urgency to # ASCO14 Science and Society"" theme. Maybe we can start a movement!""",,@,# #,4.72425E+17,https://twitter.com/bwoodmd/status/472425253549768704,,,,
n8pennell,5/30/2014 13:12,0,1,Just got here and # ASCO14 is already hopping! pic.twitter.com/CwWI4m9Pwm,,,#,4.72425E+17,https://twitter.com/n8pennell/status/472425246729842688,,,,
TuftsB,5/30/2014 13:11,3,1,Over 50 million life years added by innovative cancer therapies. And I am 5 years and counting of that number # mliwi # ASCO14,,,# #,4.72425E+17,https://twitter.com/TuftsB/status/472424962796838912,,,,
myPathMelanoma,5/30/2014 13:11,2,0,"As # MelanomaAwarenessMonth wraps up, do you know the sunscreen facts? http://bit.ly/1rloaoN # ASCO14 # isthismelanoma # melanoma # infographic",,,# # # # #,4.72425E+17,https://twitter.com/myPathMelanoma/status/472424955406082048,,,,
Roche,5/30/2014 13:10,3,4,"Personalised Healthcare"" has been improving # healthcare practice and cancer treatment for over a decade http://ow.ly/xkA0m # ASCO14""",,,# #,4.72425E+17,https://twitter.com/Roche/status/472424762384584704,,,,
Biosector2,5/30/2014 13:10,0,0,RT @ ASCO: Twitter's role during scientific meetings? http://bit.ly/1mAmiDB # ASCO14 # hcsm CC @ ASCOPost @ RSM2800,,@ @ @,# #,4.72425E+17,https://twitter.com/Biosector2/status/472424757280129024,,,,
BioCenturyTV,5/30/2014 13:09,0,0,"What needs to happen to change how oncology services are paid for?"" @ BioCentury's @ steveusdin1 asks ASCO's Schilsky # ASCO14...""",,@ @,#,4.72425E+17,https://twitter.com/BioCenturyTV/status/472424666792198144,,,,
BioCentury,5/30/2014 13:09,0,0,"What needs to happen to change how oncology services are paid for?"" @ BioCentury's @ steveusdin1 asks ASCO's Schilsky # ASCO14...""",,@ @,#,4.72425E+17,https://twitter.com/BioCentury/status/472424666133708800,,,,
jrgralow,5/30/2014 13:09,0,0,@ drdonsdizon See you at TweetUp? # ASCO14,,@,#,4.72425E+17,https://twitter.com/jrgralow/status/472424579856891904,,,,
Boehringer,5/30/2014 13:09,3,0,BLOG POST: What is it like to receive a cancer diagnosis? Read @ thesearemyscars # lungcancer survivor’s story # ASCO14 http://bit.ly/1kdfBHE,,@,# #,4.72425E+17,https://twitter.com/Boehringer/status/472424568926502912,,,,
BarringtonJNC,5/30/2014 13:09,1,0,Barrington James are all set up and ready to go for # ASCO14 come and find us at booth 2066 for the chance to win prizes and play spoof!,,,#,4.72425E+17,https://twitter.com/BarringtonJNC/status/472424564287606784,,,,
JanssenUS,5/30/2014 13:08,3,2,New data on investigational compound daratumumab featured in poster presentation starting at 1 pm CT in S405 # ASCO14,,,#,4.72424E+17,https://twitter.com/JanssenUS/status/472424223307075584,,,,
adamfeuerstein,5/30/2014 13:08,1,0,Just FYI: Embargoes on $ LLY ramu 2nd line NSCLC and $ PCYC $ JNJ Imbruvica RESONATE CLL lift tomorrow morning 7:30 am ET # ASCO14,,,#,4.72424E+17,https://twitter.com/adamfeuerstein/status/472424223131308032,,,,
TomHalkin,5/30/2014 13:07,2,1,If you're at # ASCO14 stop by Booth 3005 to learn what @ NBTStweets is doing to advance # braintumor treatments,,@,# #,4.72424E+17,https://twitter.com/TomHalkin/status/472424169393909760,,,,
BoehringerDE,5/30/2014 13:06,0,1,BLOG POST: What is it like to receive a cancer diagnosis? Read @ thesearemyscars # lungcancer survivor’s story # ASCO14 http://bit.ly/1kdfBHE,,@,# #,4.72424E+17,https://twitter.com/BoehringerDE/status/472423929131581440,,,,
genpharmmena,5/30/2014 13:06,0,0,First day od # ASCO2014 # ASCO14. Get all the news and updates.,,,# #,4.72424E+17,https://twitter.com/genpharmmena/status/472423866610884611,,,,
UNCurology,5/30/2014 13:05,3,3,"Comparative effectiveness of neoadjuvant GC vs MVAC for MIBC Galsky, Milowsky et al @ B_C_A_N # asco14 http://ow.ly/xqFbH",,@,#,4.72424E+17,https://twitter.com/UNCurology/status/472423593079738368,,,,
drdonsdizon,5/30/2014 13:05,0,0,@ jrgralow I'm on it! ;-) Hope 2 say hi F2F at # ASCO14,,@,#,4.72424E+17,https://twitter.com/drdonsdizon/status/472423576016936960,,,,
mtmdphd,5/30/2014 13:05,0,1,MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,@,#,4.72424E+17,https://twitter.com/mtmdphd/status/472423559634366464,,,,
genentech,5/30/2014 13:05,4,4,P. Bishop: Big data will be a huge part of revolutionizing cancer care in the # Next50 # ASCO14 http://ow.ly/xrAOs pic.twitter.com/F0xhx8i0So,,,# #,4.72423E+17,https://twitter.com/genentech/status/472423471835013120,,,,
OncoZine,5/30/2014 13:04,0,0,@ ASCO @ asco14 More on http://www.oncozine.com,,@ @,,4.72423E+17,https://twitter.com/OncoZine/status/472423318847762432,,,,
DrMisialek,5/30/2014 13:04,2,0,Genetic Profile Predicts Which Bladder Cancer Patients Will Benefit from Early Chemo http://www.fccc.edu/information/news/press-releases/2014/2014-05-30-ASCO-genetic-profile-bladder-cancer.html … @ FoxChaseCancer @ ASCO # ASCO14,,@ @,#,4.72423E+17,https://twitter.com/DrMisialek/status/472423202720067585,,,,
OncoZine,5/30/2014 13:03,0,0,"Starting Today, @ OncoZine reports life from @ ASCO @ ASCO14 # Cancer",,@ @ @,#,4.72423E+17,https://twitter.com/OncoZine/status/472423119563816960,,,,
ottohoffmann,5/30/2014 13:03,0,0, @ EFEciencia: Hoy empieza # ASCO14," con más de 25.000 expertos en # cáncer. Desde @ efeciencia os lo contaremos.""""",,@ @,# #,4.72423E+17,https://twitter.com/ottohoffmann/status/472423103390564353,,,
DrAttai,5/30/2014 13:03,0,0,Can't tweet on an empty stomach. Great pre # ASCO14 GF lunch at @ BeatrixChicago - ready to head to convention center,,@,#,4.72423E+17,https://twitter.com/DrAttai/status/472423064777408512,,,,
ottohoffmann,5/30/2014 13:03,0,0, @ EFEciencia: La inmunoterapia," entre los puntos fuertes del congreso de oncología clínica en Chicago. # ASCO14""""",,@,#,4.72423E+17,https://twitter.com/ottohoffmann/status/472422975623675904,,,
Novartis,5/30/2014 13:02,0,3,# ASCO14 has kicked off! Don’t miss your chance to learn more about # NETCancer by visiting the # Novartis booth.,,,# # #,4.72423E+17,https://twitter.com/Novartis/status/472422799018311680,,,,
ZskiTexas,5/30/2014 13:02,0,1,@ asco # ASCO14 being discussed on @ CNBC now.,,@ @,#,4.72423E+17,https://twitter.com/ZskiTexas/status/472422689483653120,,,,
InterConChicago,5/30/2014 13:01,0,0,Attending # ASCO14? Stop into our Lobby to see our video board customized just for you! @ ASCO pic.twitter.com/lQ8FrKKAOR,,@,#,4.72423E+17,https://twitter.com/InterConChicago/status/472422570659422209,,,,
bmsnews,5/30/2014 13:01,1,1,"Stop by career booth CF-18 and say hello to our recruiting team at # ASCO14. If you miss us, network here: http://ow.ly/xmmI9",,,#,4.72423E+17,https://twitter.com/bmsnews/status/472422543891390466,,,,
dhovekamp42,5/30/2014 13:01,0,1,$ AZN AstraZeneca to showcase new cancer drugs AZD9291 & MEDI4736 at US conference # ASCO14 http://gu.com/p/3py3z/tw via @ guardian,,@,#,4.72423E+17,https://twitter.com/dhovekamp42/status/472422527659020288,,,,
OncoZine,5/30/2014 13:01,0,0,Phase II ( @ ASCO Abstr. 3530) chemotherapy before radiation + surgery: more patients tolerate it + receive full regimen of treatment. # Cancer,,@,#,4.72423E+17,https://twitter.com/OncoZine/status/472422514766143488,,,,
Boehringer,5/30/2014 13:00,2,1,"We are still far from winning the fight against cancer"" Dr Thomas Lechner http://bit.ly/1isb8MN # notjustonedisease # ASCO14""",,,# #,4.72422E+17,https://twitter.com/Boehringer/status/472422425502945280,,,,
ASCO,5/30/2014 13:00,1,1,Unique resources for international attendees at # ASCO14: http://bit.ly/1oKhOuI,,,#,4.72422E+17,https://twitter.com/ASCO/status/472422423057268738,,,,
planner_media,5/30/2014 13:00,0,0,2014 # ASCO Annual Meeting Tweeters http://ow.ly/xqWps # ASCO14 # ehealth # pmsocial,,,# # # #,4.72422E+17,https://twitter.com/planner_media/status/472422291562053632,,,,
KUhlendorf,5/30/2014 13:00,0,1,"Timely views by @ PhRMA's S. Haverfield on need for collaboration to drive # drug discovery, expand access http://shar.es/V8VY3 # ASCO14",,@,# #,4.72422E+17,https://twitter.com/KUhlendorf/status/472422197919641602,,,,
DanaFarber,5/30/2014 13:00,4,5,Drug-resistant lung tumors respond to new precision therapy in early-stage trial: http://bit.ly/1k7SE9Q # ASCO14 # lcsm,,,# #,4.72422E+17,https://twitter.com/DanaFarber/status/472422195424395264,,,,
mtmdphd,5/30/2014 12:58,1,0,More # ASCO14 # FF - @ Lymphoma_Doc @ DrAnasYounes # lymsm @ JackWestMD @ n8pennell @ DrGlenWeiss # lcsm @ TapKadia # leusm @ luriecancer,,@ @ @ @ @ @ @,# # # # #,4.72422E+17,https://twitter.com/mtmdphd/status/472421914158575617,,,,
BioPharmaJosh,5/30/2014 12:56,3,1,RT @ BioCentury: ASCO promotes access program for off-label cancer drugs. Good model? # ASCO14 http://ow.ly/xrD9I,,@,#,4.72421E+17,https://twitter.com/BioPharmaJosh/status/472421299747565568,,,,
annaazvolinsky,5/30/2014 12:56,0,0,RT @ jrgralow: . @ drdonsdizon: OPTIMIZE 2 is 1 of my top 5 clinically-impactful abstracts in breast cancer @ # ASCO14,,@ @ @,#,4.72421E+17,https://twitter.com/annaazvolinsky/status/472421223784534016,,,,
MLIWI,5/30/2014 12:56,2,1,# ASCO14 will discuss true value of # cancer drugs: how can we provide cost-effective therapy to save lives? http://buff.ly/1mzhoVM @ bioworld,,@,# #,4.72421E+17,https://twitter.com/MLIWI/status/472421209121259520,,,,
drugwonks,5/30/2014 12:56,1,1,# ASCO14 will discuss true value of # cancer drugs: how can we provide cost-effective therapy to save lives? http://buff.ly/1mzhpc6 @ bioworld,,@,# #,4.72421E+17,https://twitter.com/drugwonks/status/472421194533453824,,,,
scottrberry,5/30/2014 12:55,2,0,Follow @ OncEd to get the latest updates from # ASCO14 I will be providing the latest colorectal cancer updates # crcsm,,@,# #,4.72421E+17,https://twitter.com/scottrberry/status/472421020226179072,,,,
networkpharma,5/30/2014 12:55,0,0,From Policy and Medicine today >> @ ASCO Not Enforcing Pharmaceutical and Device Speaker Ban in 2014 http://bit.ly/1kpC4fU # medcomms,,@,#,4.72421E+17,https://twitter.com/networkpharma/status/472421010114088962,,,,
BioCenturyTV,5/30/2014 12:54,2,1,ASCO promotes access program for off-label cancer drugs. Good model? # ASCO14 http://ow.ly/xrEhQ,,,#,4.72421E+17,https://twitter.com/BioCenturyTV/status/472420869600739330,,,,
BioCentury,5/30/2014 12:54,1,0,ASCO promotes access program for off-label cancer drugs. Good model? # ASCO14 http://ow.ly/xrD9I,,,#,4.72421E+17,https://twitter.com/BioCentury/status/472420868774449152,,,,
DrMisialek,5/30/2014 12:54,0,1,Research Shows Overall Survival Benefit for Patients with Stage III Soft Tissue Sarcoma @ FoxChaseCancer @ ASCO # ASCO14 http://www.fccc.edu/information/news/press-releases/2014/2014-05-30-ASCO-Survival-Stage-III-Soft-Tissue-sarcoma.html …,,@ @,#,4.72421E+17,https://twitter.com/DrMisialek/status/472420780740214785,,,,
wendyselig,5/30/2014 12:54,1,1,Great thoughts for the day at # asco14 advocacy meeting: empathy is a superpower about WE not ME. @ MelanomaReAlli,,@,#,4.72421E+17,https://twitter.com/wendyselig/status/472420768223985664,,,,
ChapinMD,5/30/2014 12:53,0,2,"Gave a talk at ASCO today robotic surgery: do outcomes support increased cost"". Conclusion: I dunno # ASCO14""",,,#,4.7242E+17,https://twitter.com/ChapinMD/status/472420422797893632,,,,
jrgralow,5/30/2014 12:52,4,5,. @ drdonsdizon: OPTIMIZE 2 is 1 of my top 5 clinically-impactful abstracts in breast cancer @ # ASCO14,,@ @,#,4.7242E+17,https://twitter.com/jrgralow/status/472420389369692160,,,,
DrMisialek,5/30/2014 12:52,5,5,Researchers Find More Patients with Ovarian Cancer Are Receiving Chemo Before Surgery @ FoxChaseCancer @ ASCO # ASCO14 http://www.fccc.edu/information/news/press-releases/2014/2014-05-30-ASCO-jain-chemotherapy-ovarian-cancer.html …,,@ @,#,4.7242E+17,https://twitter.com/DrMisialek/status/472420366108098561,,,,
carisls,5/30/2014 12:51,0,1,Our groundbreaking tumor profiling studies are available at # ASCO14. The schedule: http://goo.gl/uyxmDj # MolecularIntel,,,# #,4.7242E+17,https://twitter.com/carisls/status/472419932974903296,,,,
DrFloresAyala,5/30/2014 12:50,0,1,Éxito # ASCO14,,,#,4.7242E+17,https://twitter.com/DrFloresAyala/status/472419851152400384,,,,
DebiopharmNews,5/30/2014 12:50,0,1,# ASCO14 How do we develop drug today? With the future # patient in mind ! http://ow.ly/x8Xnq,,,# #,4.7242E+17,https://twitter.com/DebiopharmNews/status/472419774933504000,,,,
bmaher,5/30/2014 12:50,1,1,"Just in time for the # ASCO14 frenzy, @ heidiledford rounds up @ NatureNews cancer immunotherapy coverage http://flip.it/q6NmF",,@ @,#,4.7242E+17,https://twitter.com/bmaher/status/472419717387649024,,,,
stales,5/30/2014 12:49,0,0,RT @ drdonsdizon Hortobagyi LBA9500: OPTIMIZE2 = no diff in skeletal related events if zoledronic acid q4 vs q12w for bone mets # bcsm # ASCO14,,@,# #,4.7242E+17,https://twitter.com/stales/status/472419587603312642,,,,
stales,5/30/2014 12:49,0,0,RT @ MCristofanill: LBA9500: OPTIMIZE2 shows no diff in skeletal related events if zoledronic acid q4 vs q12w for bone mets # bcsm # ASCO14,,@,# #,4.72419E+17,https://twitter.com/stales/status/472419421961850880,,,,
davidgrahammd,5/30/2014 12:48,3,1,How do you stay twitter engaged after # asco14 ? Contact @ drdonsdizon or myself. We’d like to hear tips or issues for future analysis,,@,#,4.72419E+17,https://twitter.com/davidgrahammd/status/472419294438252544,,,,
MarikaSboros,5/30/2014 12:46,0,1,MRT Wow! . @ drsteventucker MORE fruits & veg link to # obesity | http://bit.ly/1m8TrUV # ASCO14 cc: @ bigfatsurprise via @ ACS @ RandCorporation,,@ @ @ @,# #,4.72419E+17,https://twitter.com/MarikaSboros/status/472418667150733312,,,,
PollywogPrinces,5/30/2014 12:45,0,1,"Watching # ASCO14 for # LungCancer news. To those who are there, say hello to @ freetobreathe.",,@,# #,4.72418E+17,https://twitter.com/PollywogPrinces/status/472418497578795008,,,,
kellywagnerLS,5/30/2014 12:45,0,0,"Welcome to # ASCO14 friends, colleagues, and collaborators! Looking forward to hearing about your stay.",,,#,4.72418E+17,https://twitter.com/kellywagnerLS/status/472418480319262720,,,,
subatomicdoc,5/30/2014 12:45,2,2,What # coloncancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI # FF # crcsm,,@ @ @ @ @ @ @,# # # #,4.72418E+17,https://twitter.com/subatomicdoc/status/472418421993639937,,,,
nicolaashton,5/30/2014 12:42,0,0,In Chicago for # asco14. Great to see Twitter buzzing already - here are ASCO's guidelines on using social media: http://bit.ly/1mzloFy,,,#,4.72418E+17,https://twitter.com/nicolaashton/status/472417801966460928,,,,
drdonsdizon,5/30/2014 12:42,0,0,@MKrychman I'm going to quote you during my # asco14 talk,,@MKrychman,#,4.72418E+17,https://twitter.com/drdonsdizon/status/472417662333906944,,,,
MLIWI,5/30/2014 12:41,0,0,RT @ UCCancerCenter: Getting excited for # ASCO14 starting today in Chicago as best & brightest in # cancerresearch share newest breakthroughs.,,@,# #,4.72418E+17,https://twitter.com/MLIWI/status/472417572550627329,,,,
samariette,5/30/2014 12:40,0,0,Excited for the conference! # ASCO14,,,#,4.72417E+17,https://twitter.com/samariette/status/472417333651451904,,,,
DebiopharmNews,5/30/2014 12:40,0,1,# ASCO14 We are convinced that developing for # patients will shape the # future of # medicine http://ow.ly/x8Xhm,,,# # # #,4.72417E+17,https://twitter.com/DebiopharmNews/status/472417255654182912,,,,
genentech,5/30/2014 12:40,2,1,Thx! MT @ARKgenome: Biotech fans should look at the @ genentech # ASCO14 portal. It's well designed & informative. http://ow.ly/xrAma,,@ARKgenome @,#,4.72417E+17,https://twitter.com/genentech/status/472417184799793152,,,,
SamBrownInc,5/30/2014 12:39,0,0,We love the Twitter IDs on the badges idea! Smart move. RT @ morrison_pharma: RT @ davidgrahammd: # ASCO14 look for twitter handles on badges.,,@ @,#,4.72417E+17,https://twitter.com/SamBrownInc/status/472417098443276288,,,,
OncoZine,5/30/2014 12:39,0,0,"Afatinib (Gilotrif, Boehringer Ingelheim) improvement OS in lung cancer with common EGFR mutation. ASCO Abstr 8004/8019 @ ASCO # Cancer # LUNG",,@,# #,4.72417E+17,https://twitter.com/OncoZine/status/472417072220499969,,,,
CourtneyKagan,5/30/2014 12:37,0,1,"Heading to ASCO soon! This year, at ASCO, all eyes are on pharma http://fw.to/w8AwNxC # ASCO14",,,#,4.72417E+17,https://twitter.com/CourtneyKagan/status/472416625749020672,,,,
KUhlendorf,5/30/2014 12:37,0,0,. @ genentech Thx for sharing. This piques my interest all the more. And nicely reflects how far we've come in # clinical research # ASCO14,,@,# #,4.72416E+17,https://twitter.com/KUhlendorf/status/472416441883295744,,,,
merck_es,5/30/2014 12:35,2,2,# ASCO14: Merck Serono anunciará nuevos datos de sus moléculas en investigación para cáncer @ la_informacion http://ow.ly/xqQM5,,@,#,4.72416E+17,https://twitter.com/merck_es/status/472415965603708929,,,,
PharmaSte,5/30/2014 12:35,0,0,@ chemfan83 follow # ASCO14 I'm sure you'll find it interesting,,@,#,4.72416E+17,https://twitter.com/PharmaSte/status/472415945148071937,,,,
Boehringer,5/30/2014 12:35,0,0,Looking at this year’s programme," three themes stood out for us…"" Julia Knebel # lungcancer http://bit.ly/WhatToExpectASCO14 … # ASCO14""",,,# #,4.72416E+17,https://twitter.com/Boehringer/status/472415928664485888,,,
WFFCancer,5/30/2014 12:34,1,0,RT @ DrBobGoldberg: @ MLIWI @ JamesPPinkerton We spend $7 a day per cancer survivor. How's that too much ? # ASCO14 # MLIWI # cancer,,@ @ @,# # #,4.72416E+17,https://twitter.com/WFFCancer/status/472415866622332928,,,,
BGI_Genomics,5/30/2014 12:34,0,1,"See you all at @ ASCO! RT Today marks the first day of # ASCO14. This year's theme: Science & Society"" pic.twitter.com/wZNMxcwikv""",,@,#,4.72416E+17,https://twitter.com/BGI_Genomics/status/472415661587578881,,,,
OncoZine,5/30/2014 12:32,1,1,Multiple Studies on MammaPrint and BluePrint Tests (Agendia) to be Presented at 50th Annual ASCO Meeting @ ASCO # Cancer # breastcancer,,@,# #,4.72415E+17,https://twitter.com/OncoZine/status/472415181688283139,,,,
ASCO,5/30/2014 12:31,0,0,Early-career ASCO members have access to unique benefits at the # ASCO14 Trainee & Jr Faculty Lounge: http://bit.ly/1pktiaE,,,#,4.72415E+17,https://twitter.com/ASCO/status/472414951043518464,,,,
drdonsdizon,5/30/2014 12:31,0,0,@ jrgralow Totally agree. And a relief! # bcsm # ASCO14,,@,# #,4.72415E+17,https://twitter.com/drdonsdizon/status/472414947386073088,,,,
NBCCStopBC,5/30/2014 12:31,4,0,What doctors tweet about when they tweet about # cancer http://buzz.mw/b0zcj_f We need to add # BCD2020 to this list! # BCSM # ASCO14,,,# # # #,4.72415E+17,https://twitter.com/NBCCStopBC/status/472414886912602113,,,,
DebiopharmNews,5/30/2014 12:30,0,1,"# ASCO14 The more the # patient benefits from our drug, the more accomplished we feel http://ow.ly/x8XeT",,,# #,4.72415E+17,https://twitter.com/DebiopharmNews/status/472414877899063297,,,,
fischmd,5/30/2014 12:30,1,2,"New software tool, pVAAST, identifies genetic mutations contributing to incr # cancer risk, via @ NatureBiotech http://ow.ly/xryOH # ASCO14",,@,# #,4.72415E+17,https://twitter.com/fischmd/status/472414829438070784,,,,
SarahCannonDocs,5/30/2014 12:30,0,0,"Meet # DrInfante discuss Ph.1 study of LEE011, an orally bioavailable, highly specific CDK4/6 inhibitor at Poster 43 Abs#2528 # ASCO14 1 CST",,,# #2528 #,4.72415E+17,https://twitter.com/SarahCannonDocs/status/472414642808320001,,,,
davidgrahammd,5/30/2014 12:29,2,1,# ASCO14 look for twitter handles on badges,,,#,4.72415E+17,https://twitter.com/davidgrahammd/status/472414520816590848,,,,
MRFCureOM,5/30/2014 12:28,0,1,MT @ CureMelanoma: There are 170 # melanoma abstracts listed for # ASCO14 annual conf! Incredible. Follow @ timturnham for conf updates.,,@ @,# #,4.72414E+17,https://twitter.com/MRFCureOM/status/472414361894793216,,,,
WFFCancer,5/30/2014 12:28,0,0,RT @ MLIWI: # Cancer remission is the goal. Help us get there. Join Us. # ASCO14 # MLIWI http://buff.ly/1wzzAFy,,@,# # #,4.72414E+17,https://twitter.com/WFFCancer/status/472414235927273473,,,,
SarahCannonDocs,5/30/2014 12:28,1,0,Visit Poster 49 for response rates of Next-generation sequencing (NGS). 10-25% of pts. enrolled on a matched trial. Abs#2534 # ASCO14,,,#2534 #,4.72414E+17,https://twitter.com/SarahCannonDocs/status/472414186962968576,,,,
davidgrahammd,5/30/2014 12:27,0,0,LBA9500 zoladronic acid equally effective q12w vs q4w. Cannot discount significant $ saved as a result. # ASCO14,,,#,4.72414E+17,https://twitter.com/davidgrahammd/status/472414043152453632,,,,
CureMelanoma,5/30/2014 12:26,1,2,There are 170 # melanoma/ # skincancer abstracts listed for # ASCO14 annual conf! Incredible. Follow @ TimTurnham for conf updates.,,@,# # #,4.72414E+17,https://twitter.com/CureMelanoma/status/472413865968668672,,,,
CredibleMeds,5/30/2014 12:26,1,3,"RT @ MLIWI: Since 1970, the number of people surviving cancer has increased by nearly 400% to 14 million in 2013. Follow us. # MLIWI # ASCO14",,@,# #,4.72414E+17,https://twitter.com/CredibleMeds/status/472413778932682753,,,,
MoleDigital,5/30/2014 12:26,0,0,View of beautiful Chicago from the Hyatt Downtown - looking forward to getting started. # asco14 pic.twitter.com/C40cU4LwRg,,,#,4.72414E+17,https://twitter.com/MoleDigital/status/472413694564237312,,,,
pdherron,5/30/2014 12:26,6,5,RT @ ASCO: 10 tips for use of social media http://bit.ly/1mzloFy # hcsm # ASCO14 pic.twitter.com/fZEiMreP7E,,@,# #,4.72414E+17,https://twitter.com/pdherron/status/472413671147458560,,,,
IMFmyeloma,5/30/2014 12:26,4,5,"Excited for @ ASCO, starting today in Chicago (http://am.asco.org/ ), especially awarding advocates like Mike Katz!pic.twitter.com/G4SbCNuYZl",,@,,4.72414E+17,https://twitter.com/IMFmyeloma/status/472413633046016000,,,,
SarahCannonDocs,5/30/2014 12:25,1,1,Covering featured SCRI lead and/or co-authored abstracts all day. Type abstract #into http://abstracts2.asco.org/ to see full details # ASCO14.,,,#into #,4.72413E+17,https://twitter.com/SarahCannonDocs/status/472413468378017792,,,,
LungProject,5/30/2014 12:24,5,1,ASCO13: 3 of 4 people have negative # lungcancer bias # ASCO14 http://bit.ly/1rpozqi # lcsm,,,# # #,4.72413E+17,https://twitter.com/LungProject/status/472413291785252864,,,,
liemeij,5/30/2014 12:23,0,0,@ ASCO Wish you a great and inspiring conference. Looking forward to join at sunday. # asco14,,@,#,4.72413E+17,https://twitter.com/liemeij/status/472413060657717248,,,,
mnewtonPharmD,5/30/2014 12:23,0,0,I knew it!! RT @ drdonsdizon: Hortobagyi- LBA9500: OPTIMIZE2: no difference in SREs if zoledronic acid q4 vs q12w for bone mets # bcsm # ASCO14,,@,# #,4.72413E+17,https://twitter.com/mnewtonPharmD/status/472412960292634624,,,,
KUhlendorf,5/30/2014 12:22,0,1,# ASCO14 attendees & others interested in medical progress: Check out http://ProjectInnovation.org from @ NPAF_tweets. http://projectinnovation.org/,,@,#,4.72413E+17,https://twitter.com/KUhlendorf/status/472412785021046784,,,,
BIGagainstBC,5/30/2014 12:22,0,0,"How far we have come. ASCO: 50 Years of Progress, More to Come http://www.medpagetoday.com/MeetingCoverage/ASCO/46049?utm_source=twitterfeed … # ASCO14",,,#,4.72413E+17,https://twitter.com/BIGagainstBC/status/472412668347686912,,,,
SarahCannonDocs,5/30/2014 12:22,0,0,Getting the day started at # ASCO14. Looking forward to learning about all the new research being presented. http://ow.ly/i/5K3So,,,#,4.72413E+17,https://twitter.com/SarahCannonDocs/status/472412662983577600,,,,
christinemphmd,5/30/2014 12:21,1,1,It's a beautiful day in # Chicago to officially start @ ASCO Annual Meeting. May the # ASCO14 tweets stream in abundantly!,,@,# #,4.72413E+17,https://twitter.com/christinemphmd/status/472412605056053248,,,,
BiologicsMcK,5/30/2014 12:20,0,0,"# ASCO14 presenter, Andrew Lowy, MD, from @ UCSDHealth, discusses advancements in the management of GI # cancers. http://bit.ly/1gIGyTK",,@,# #,4.72412E+17,https://twitter.com/BiologicsMcK/status/472412226339360768,,,,
ASCO,5/30/2014 12:20,1,2,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.72412E+17,https://twitter.com/ASCO/status/472412224460718080,,,,
DebiopharmNews,5/30/2014 12:20,0,0,"# ASCO14 The # patients are at the core of our business, we care for them! http://ow.ly/x8X0I",,,# #,4.72412E+17,https://twitter.com/DebiopharmNews/status/472412205045280768,,,,
CancerTherAdvsr,5/30/2014 12:20,0,0,RT @ CancerNetwrk: ASCO: Molecular Diagnostics Allow Further Understanding of Medulloblastoma http://dlvr.it/5pZTLp # ASCO14,,@,#,4.72412E+17,https://twitter.com/CancerTherAdvsr/status/472412164880596992,,,,
inPracticePOC,5/30/2014 12:20,1,0,Setting up the booth at # ASCO2014 today! Stop by and see inPractice & @ CCO_Oncology at booth #16026,,@,# #16026,4.72412E+17,https://twitter.com/inPracticePOC/status/472412144261402626,,,,
timturnham,5/30/2014 12:19,1,1,Thanks to @ Celgene for mtg of pt groups on innovating to improve patient experience. # ASCO14,,@,#,4.72412E+17,https://twitter.com/timturnham/status/472411978850263040,,,,
SynergyVision,5/30/2014 12:18,0,1,# ASCO14 starts today in Chicago - what will be the major topics at this year's meeting? Let us know if you're attending.,,,#,4.72412E+17,https://twitter.com/SynergyVision/status/472411857693970432,,,,
Xcenda,5/30/2014 12:18,0,1,Great tips! RT @ ASCO: Our 10 tips for use of social media http://bit.ly/1mzloFy # hcsm # ASCO14 pic.twitter.com/pTuH4sDY3f,,@,# #,4.72412E+17,https://twitter.com/Xcenda/status/472411744376078336,,,,
julian_hong,5/30/2014 12:18,0,2,key info RT @ adamfeuerstein: Before # ASCO14 there is lunch at Frontera Grill.,,@,#,4.72412E+17,https://twitter.com/julian_hong/status/472411735928745984,,,,
Rad_Nation,5/30/2014 12:18,1,0,How to minimize uncertainties in ITV on 4DCT for lung stereotactic ablative radiotherapy http://buff.ly/1kPiyOB # ASCO14 # radonc # lcsm,,,# # #,4.72412E+17,https://twitter.com/Rad_Nation/status/472411683445829633,,,,
mtmdphd,5/30/2014 12:18,4,0,A few of many # ASCO14 # FFs - @ FischMD @ DrDonSDizon @ rsm2800 @ Scientre @ obogler @ drattai @ TeamOncology @ MaverickNY @ OncologyTimes @ BrianReid,,@ @ @ @ @ @ @ @ @ @,# #,4.72412E+17,https://twitter.com/mtmdphd/status/472411681344458752,,,,
subatomicdoc,5/30/2014 12:18,4,2,How to minimize uncertainties in ITV on 4DCT for lung stereotactic ablative radiotherapy http://bit.ly/1kPiAWG # ASCO14 # radonc # lcsm,,,# # #,4.72412E+17,https://twitter.com/subatomicdoc/status/472411661899677697,,,,
tamrasami,5/30/2014 12:17,1,0,ASCO unveils proposed bundle payment system for docs but no details on how drugs are reimbursed. http://bit.ly/U0gBW4 @ BioCentury # ASCO14,,@,#,4.72411E+17,https://twitter.com/tamrasami/status/472411426666348545,,,,
Jamieprints,5/30/2014 12:16,5,4,RT @ ASCO: Our 10 tips for use of social media http://bit.ly/1mzloFy # hcsm # ASCO14 pic.twitter.com/vM3ecBEg29 .,,@,# #,4.72411E+17,https://twitter.com/Jamieprints/status/472411225989844992,,,,
fhoro,5/30/2014 12:16,0,0,What to watch at # ASCO14 $ BMY $ AZN # Roche http://www.bnn.ca/Video/player.aspx?vid=373144 …,,,# #,4.72411E+17,https://twitter.com/fhoro/status/472411177155584000,,,,
DrBobGoldberg,5/30/2014 12:15,0,0,@ MLIWI @ JamesPPinkerton We spend $7 a day per cancer survivor. How's that too much ? # ASCO14 # mliwi,,@ @,# #,4.72411E+17,https://twitter.com/DrBobGoldberg/status/472411044158398465,,,,
ASCO,5/30/2014 12:15,27,15,Our 10 tips for use of social media http://bit.ly/1mzloFy # hcsm # ASCO14 pic.twitter.com/cCcjaf0vva,,,# #,4.72411E+17,https://twitter.com/ASCO/status/472410901526896640,,,,
Boehringer,5/30/2014 12:15,1,0,# PRESS & # HCPs: Come & visit our first international booth at @ ASCO - stand N. 2071 # lungcancer # notjustonedisease # ASCO14,,@,# # # # #,4.72411E+17,https://twitter.com/Boehringer/status/472410874737868800,,,,
myriadgenetics,5/30/2014 12:15,0,0,Myriad announced a new 160 patient study of its HRD test to predict response to therapy in # TNBC patients http://bit.ly/1tWn80k # ASCO14,,,# #,4.72411E+17,https://twitter.com/myriadgenetics/status/472410860258729985,,,,
jrgralow,5/30/2014 12:13,5,3,Important data MT @ drdonsdizon LBA9500: OPTIMIZE2 no difference in skeletal events if zoledronic acid q4 vs q12w for bone mets # bcsm # ASCO14,,@,# #,4.72411E+17,https://twitter.com/jrgralow/status/472410554636972033,,,,
brianreid,5/30/2014 12:13,3,3,"Heisenberg Principle: Breaking Bad, Angelina and lessons from our # SocOncology report on cancer discussions: http://bit.ly/SYoTwP # ASCO14",,,# #,4.7241E+17,https://twitter.com/brianreid/status/472410489038077952,,,,
SarahCannonDocs,5/30/2014 12:11,1,0,Don't miss Clinical Science Symposium on #11010 Sat 8-9:30 S406 Exp biomarker analysis ph I study of AZD4547 # DrArkenau # ASCO14,,,#11010 # #,4.7241E+17,https://twitter.com/SarahCannonDocs/status/472410002310037504,,,,
DebiopharmNews,5/30/2014 12:10,0,0,# ASCO14 Convert your molecule into a successful drug http://ow.ly/x8WNx,,,#,4.7241E+17,https://twitter.com/DebiopharmNews/status/472409733287399424,,,,
adamfeuerstein,5/30/2014 12:09,0,0,Before # ASCO14 there is lunch at Frontera Grill.,,,#,4.72409E+17,https://twitter.com/adamfeuerstein/status/472409452000575488,,,,
DrBobGoldberg,5/30/2014 12:08,0,0,"Lowell Schnipper, @ asco value czar Goal:make health care system", not just the cancer care system," more rational& just."" # asco14""",,@,#,4.72409E+17,https://twitter.com/DrBobGoldberg/status/472409133116051456,,
SarahCannonDocs,5/30/2014 12:06,1,0,"See Poster 27 for safety, efficacy, PK, & PD data: TGR-1202, a PI3K inhibitor, in pts w/relapsed malignancies Abs#2513 @ BurrisSkip # ASCO14",,@,#2513 #,4.72409E+17,https://twitter.com/SarahCannonDocs/status/472408657691697153,,,,
SarahCannon_UK,5/30/2014 12:06,0,0,Can't make it to # ASCO14 ? Sign up to receive a summary of exciting developments presented... http://sarahcannonresearch.com/locations/meeting-site/forms/asco-recap.dot …pic.twitter.com/wUvcRoDcCa,,,#,4.72409E+17,https://twitter.com/SarahCannon_UK/status/472408648270880768,,,,
genentech,5/30/2014 12:05,1,1,Cool chart takes @ theNCI # survivorship rates & extrapolates thru 2200. # ASCO14 # Next50 http://ow.ly/xr66n,,@,# # #,4.72408E+17,https://twitter.com/genentech/status/472408482977968128,,,,
aurmanARK,5/30/2014 12:05,0,0,Biotech fans should look at the @ genentech ($RHHYBY subsidiary) # ASCO2014 portal. It's well designed & informative. http://ow.ly/xrbpO,,@,#,4.72408E+17,https://twitter.com/aurmanARK/status/472408423435632640,,,,
Boehringer,5/30/2014 12:05,86,180,"# HCPs: # DoYouKnow about Plk inhibition, a novel therapeutic approach in # haematology? http://bit.ly/1kcg392 # ASCO14",,,# # # #,4.72408E+17,https://twitter.com/Boehringer/status/472408417911721984,,,,
UMRogelCancer,5/30/2014 12:05,11,4,"Radiation for # prostate # cancer linked to secondary cancers, study finds: http://umhealth.me/1hFqzBg # ASCO14",,,# # #,4.72408E+17,https://twitter.com/UMRogelCancer/status/472408374836211712,,,,
HughMcCafferty,5/30/2014 12:04,0,0,Pharmafocus has finally arrived at McCormick Place for # ASCO14. Looking forward to this afternoon's session on value in # cancer care.,,,# #,4.72408E+17,https://twitter.com/HughMcCafferty/status/472408244905066496,,,,
chimoose,5/30/2014 12:03,2,0,This year's Angelina? What Walter White and Angelina Teach Us About Cancer Conversation Online http://bit.ly/1oCSM2Z by @ brianreid # ASCO14,,@,#,4.72408E+17,https://twitter.com/chimoose/status/472407946618744832,,,,
drdonsdizon,5/30/2014 12:03,3,2,LBA9513 Dionne-Odom @ UABMedicine: ENABLE III trial shows caregivers benefit with early initiation of pallaitive care # hpm # ASCO14,,@,# #,4.72408E+17,https://twitter.com/drdonsdizon/status/472407839382585344,,,,
DebiopharmNews,5/30/2014 12:02,0,0,# ASCO14 # Innovation is precious and we take care of it by transforming it into a drug for the # patients http://ow.ly/x8WTq,,,# # #,4.72408E+17,https://twitter.com/DebiopharmNews/status/472407720520187904,,,,
BCRFcure,5/30/2014 12:02,0,1,Kicking off # ASCO2014 w/ 3rd Fellows Forum in # breast # oncology. 60+ fellows participating in discussions led by grantees & @ larrynortonMD!,,@,# # #,4.72408E+17,https://twitter.com/BCRFcure/status/472407707052695552,,,,
ASCO,5/30/2014 12:02,0,1,Learn more about membership benefits for all oncology professionals at # ASCO14 Member Services Desks: http://bit.ly/1kofnO0,,,#,4.72408E+17,https://twitter.com/ASCO/status/472407673691185152,,,,
myPathMelanoma,5/30/2014 12:02,0,0,"Who is Helen"" and why should you care? Find out at http://www.IsThisMelanoma.com # ASCO14 # isthismelanoma # melanoma""",,,# # #,4.72408E+17,https://twitter.com/myPathMelanoma/status/472407589922148353,,,,
Amgen,5/30/2014 12:01,1,0,Visit booth #19042 to learn how # Amgen # Oncology is working to advance # cancer care # ASCO14,,,#19042 # # # #,4.72407E+17,https://twitter.com/Amgen/status/472407496913846272,,,,
carisls,5/30/2014 12:01,1,0,New EGFR-targeted therapy shrinks worsening # lungcancer with fewer side effects. http://goo.gl/4YPI43 # ASCO14,,,# #,4.72407E+17,https://twitter.com/carisls/status/472407484695867392,,,,
Immutep,5/30/2014 12:01,0,0,Dr. Gray & Dr. Monk will host a call on 6/3 @ 11am (Sydney local time) to Discuss Abstract Presented at # ASCO14 $ PRR http://buff.ly/1nKPHfp,,@,#,4.72407E+17,https://twitter.com/Immutep/status/472407403825491968,,,,
kevinmichelskim,5/30/2014 12:00,0,0,esp. Twitter for realtime RT @ lenstarnes: Many ways to connect with @ ASCO on social media during # ASCO14 http://goo.gl/o4m1u4 # hcsmeu,,@ @,# #,4.72407E+17,https://twitter.com/kevinmichelskim/status/472407254692814849,,,,
Xcenda,5/30/2014 12:00,0,0,Attending # ASCO14? # Xcenda has market research opportunities following the event. Learn more: http://bit.ly/nocr1,,,# #,4.72407E+17,https://twitter.com/Xcenda/status/472407111649853440,,,,
JamesPPinkerton,5/30/2014 12:00,0,0,"@ Bioworld Capturing cancer drugs’ true value calls for clear thinking"" http://bit.ly/RL1ygY # ASCO14""",,@,#,4.72407E+17,https://twitter.com/JamesPPinkerton/status/472407111201472512,,,,
Medscape,5/30/2014 12:00,0,0,Breaking news from # ASCO14 available on Medscape: http://bit.ly/1tQLhFs,,,#,4.72407E+17,https://twitter.com/Medscape/status/472407099683528704,,,,
MedscapeOnc,5/30/2014 12:00,0,0,Breaking news from # ASCO14 available on Medscape: http://bit.ly/1tQLhFs,,,#,4.72407E+17,https://twitter.com/MedscapeOnc/status/472407094650368001,,,,
fischmd,5/30/2014 11:59,0,0,"MT @ LizSzabo: Embattled VA chief Shinseki resigns over problems with healthcare for veterans, http://www.usatoday.com/story/news/nation/2014/05/30/shinseki-va-veteran-scandal-health-care-delays/9758061/ … # ASCO14",,@,#,4.72407E+17,https://twitter.com/fischmd/status/472406857693548545,,,,
drdonsdizon,5/30/2014 11:59,6,0,G Hortobagyi- LBA9500: OPTIMIZE2 shows no difference in skeletal related events if zoledronic acid q4 vs q12w for bone mets # bcsm # ASCO14,,,# #,4.72407E+17,https://twitter.com/drdonsdizon/status/472406832737038336,,,,
InsControCancro,5/30/2014 11:58,2,2,Al via oggi 50° congresso @ ASCO a Chicago # ASCO14,,@,#,4.72407E+17,https://twitter.com/InsControCancro/status/472406750109630464,,,,
DrBobGoldberg,5/30/2014 11:58,0,1,"Instead of @ asco app to discuss costs, how about an app to help eliminate cancer co- insurance bias? # mliwi # mylifeisworthit",,@,# #,4.72407E+17,https://twitter.com/DrBobGoldberg/status/472406656379150336,,,,
AmbryGenetics,5/30/2014 11:56,0,1,We have a few on their way! :) RT @ GeneticCouns Are any genetic counselors at # ASCO14? Let us know!,,@,#,4.72406E+17,https://twitter.com/AmbryGenetics/status/472406192086872064,,,,
Immutep,5/30/2014 11:56,0,0,We Are Hosting a Conference Call on June 3 11AM AEST (9 PM EST) to Discuss Abstract Presented at @ ASCO $ PBMD # ASCO14 http://yhoo.it/1hFrnWI,,@,#,4.72406E+17,https://twitter.com/Immutep/status/472406101703786496,,,,
DrBobGoldberg,5/30/2014 11:55,0,0,@ jrgralow @ JackWestMD @ asco value app will be used to target patients already 'redlined' by insurers w narrow networks and rx lists,,@ @ @,,4.72406E+17,https://twitter.com/DrBobGoldberg/status/472406049686032384,,,,
EIannelli,5/30/2014 11:55,5,2,"pic.twitter.com/ZFZGBKhbpI # ASCO14 il tema è scienza e società"" x la cura dei malati di # cancro @ favo_it @ InsControCancro @ ManuelaPerrone""",,@ @ @,# #,4.72406E+17,https://twitter.com/EIannelli/status/472406040508514305,,,,
Boehringer,5/30/2014 11:55,2,0,# PRESS: Hello # Chicago! Exciting wk ahead at # ASCO14. We are excited to be presenting 7 abstracts this year http://bit.ly/1tWxMEf,,,# # #,4.72406E+17,https://twitter.com/Boehringer/status/472405841023631360,,,,
drdonsdizon,5/30/2014 11:55,0,0,"Moore @ SWOG LBA505: POEMS: Goserelin assoc w improved DFS (HR 0.49, 95%CI .24-.97) & OS (HR 0.43; 95%CI 0.18-1.0) # bcsm # ASCO14",,@,# #,4.72406E+17,https://twitter.com/drdonsdizon/status/472405828452892672,,,,
zbiotech,5/30/2014 11:54,0,3,"for those who've not seen, # ASCO14 embargo lifts/press briefing sched - http://www.asco.org/press-center/2014-asco-annual-meeting-press-program-highlight-major-advances-cancer-research … $ BMY $ MRK $ AZN $ LLY",,,#,4.72406E+17,https://twitter.com/zbiotech/status/472405805707186177,,,,
TheCuckoosNest,5/30/2014 11:54,0,0," @ LUNGevity: # LungCancer takes more lives annually than the next top four cancers combined. # lcsm http://ow.ly/i/5JW9N "" # asco14""",,@,# # #,4.72406E+17,https://twitter.com/TheCuckoosNest/status/472405685548748800,,,,
SpryPub,5/30/2014 11:53,0,0,"If you're at # ASCO14, be sure to stop by our booth TOMORROW between 10-11 to get your copy of Survivorship signed by Dr. Cassileth!",,,#,4.72405E+17,https://twitter.com/SpryPub/status/472405388319416320,,,,
RonnieLass,5/30/2014 11:53,0,0,:-) RT @ MaverickNY: Always entertaining watching the researchers huff and puff to get their poster tubes in the overhead bins # asco14,,@,#,4.72405E+17,https://twitter.com/RonnieLass/status/472405349048528896,,,,
pfizer,5/30/2014 11:53,35,17,Infographic: Value of Cancer Meds # asco14 pic.twitter.com/SgHYgqw3Nz,,,#,4.72405E+17,https://twitter.com/pfizer/status/472405335366705152,,,,
stales,5/30/2014 11:52,0,0,RT @ ASCO: # ASCO14 Twitter feed displaying in D1 & Arie Crown @ CliffordHudis @ rschilsky @ YupOncpic.twitter.com/KgPilExgyc,,@ @ @ @,#,4.72405E+17,https://twitter.com/stales/status/472405278030581760,,,,
BCSMChat,5/30/2014 11:52,3,0,RT @ ASCO: # ASCO14 Twitter feed displaying in D1 & Arie Crown @ CliffordHudis @ rschilsky @ YupOncpic.twitter.com/oVBEZrL4XS,,@ @ @ @,#,4.72405E+17,https://twitter.com/BCSMChat/status/472405277032321024,,,,
DrBobGoldberg,5/30/2014 11:52,0,0,@ CliffordHudis will @ asco side with insurers or patients http://www.bioworld.com/perspectives/2014/05/30/capturing-cancer-drugs-true-value-calls-for-clear-thinking/ … # mylifeisworthit,,@ @,#,4.72405E+17,https://twitter.com/DrBobGoldberg/status/472405265669959680,,,,
BCSMChat,5/30/2014 11:52,0,1,RT @ jodyms: Watch for these! @ drattai Tweets from # ASCO14 will start this afternoon # bcsm,,@ @,# #,4.72405E+17,https://twitter.com/BCSMChat/status/472405130722430976,,,,
LurieCancer,5/30/2014 11:52,0,1,MT @ mtmdphd Love the science at # ASCO14 but constantly reminded about patients watching for # science to translate to better medicine.,,@,# #,4.72405E+17,https://twitter.com/LurieCancer/status/472405100192083968,,,,
stales,5/30/2014 11:52,0,0,RT @ drattai: Tweets from # ASCO14 will start this afternoon # bcsm,,@,# #,4.72405E+17,https://twitter.com/stales/status/472405092575227904,,,,
BCSMChat,5/30/2014 11:52,0,1,RT @ drattai: Tweets from # ASCO14 will start this afternoon # bcsm,,@,# #,4.72405E+17,https://twitter.com/BCSMChat/status/472405091895767042,,,,
drdonsdizon,5/30/2014 11:52,0,0,Moore @ SWOG LBA505: POEMS study- Reduced incid of ovarian failure w goserelin during CT for breastca (8 vs 22% if not given). # bcsm # ASCO14,,@,# #,4.72405E+17,https://twitter.com/drdonsdizon/status/472405073008418817,,,,
BCSMChat,5/30/2014 11:51,1,1,RT @ jrgralow: # ASCO14: Dr. Hope Rugo gives her top picks in breast cancer research http://ow.ly/xr2Zp # bcsm,,@,# #,4.72405E+17,https://twitter.com/BCSMChat/status/472404949604007936,,,,
coileain,5/30/2014 11:50,3,3,Presenting scientific research to the medical masses # ASCO14 @ ProfJohnCrown # CCRT # MTCI @ TheCarolineFDNpic.twitter.com/5QzqnzB2qV,,@ @,# # #,4.72405E+17,https://twitter.com/coileain/status/472404740228534272,,,,
myESMO,5/30/2014 11:50,2,3,@ ASCO hope you have a great # ASCO14! We'll be following from near and afar,,@,#,4.72405E+17,https://twitter.com/myESMO/status/472404696528076800,,,,
DebiopharmNews,5/30/2014 11:50,0,0,# ASCO14 Successful in- and out-licensing for breakthrough drugs benefiting the # patient http://ow.ly/x8WH5,,,# #,4.72405E+17,https://twitter.com/DebiopharmNews/status/472404671450345472,,,,
SHAREing,5/30/2014 11:50,0,0,"Learn abt targeted therapies 4 # metastatic disease & other # ASCO14 news at free webinar: Th, 6/12, 12:30-1:30 PM ET http://ow.ly/xm0Uu",,,# #,4.72405E+17,https://twitter.com/SHAREing/status/472404632011296768,,,,
JSchneide12,5/30/2014 11:48,0,1,Heading to # asco14 take 2 after last nights 5hr delay and cancelled flight. Today's flight is delayed too. Chicago here I come. Hopefully.,,,#,4.72404E+17,https://twitter.com/JSchneide12/status/472404217471451137,,,,
GenomicHealth,5/30/2014 11:48,0,0,Heading to # ASCO14? Visit us at booth 20007 & check out the enhanced # Oncotype DX # breastcancer report!,,,# # #,4.72404E+17,https://twitter.com/GenomicHealth/status/472404181114814464,,,,
GeneticCouns,5/30/2014 11:47,1,3,Are any genetic counselors at # ASCO14? Let us know!,,,#,4.72404E+17,https://twitter.com/GeneticCouns/status/472403851396775937,,,,
RamalingamMD,5/30/2014 11:46,4,4,"# Lcsm EGFR TKI and anti-PD1 combo shows promising early results, abs 8022 at # ASCO14.",,,# #,4.72404E+17,https://twitter.com/RamalingamMD/status/472403790499299329,,,,
Boehringer,5/30/2014 11:46,0,0,"# HCPs: EGFR mutations occur in 13% of # NSCLC tumours, or approx 178,000 new cases each year globally. http://bit.ly/1stP7Ug # ASCO14",,,# # #,4.72404E+17,https://twitter.com/Boehringer/status/472403735759814656,,,,
TGeorgeMD,5/30/2014 11:46,0,0,RT @ DrMarkham: Looking forward to a great meeting! 2014 ASCO Annual Meeting Tweeters (via @ ASCO) http://buff.ly/1gEtNJU # ASCO14,,@ @,#,4.72404E+17,https://twitter.com/TGeorgeMD/status/472403564284092417,,,,
Sports_bios,5/30/2014 11:45,0,0,@ MaverickNY r u ready with a new pair of comfy walking shoes?..still using fitbit? TIA for the coverage..will be ready 4all # ASCO14 tweets.,,@,#,4.72403E+17,https://twitter.com/Sports_bios/status/472403488404557826,,,,
JediPD,5/30/2014 11:45,0,0,CONCEPT for # ASCO14 FDA reduce the hoops and paperwork boatload for Trials Pharma cut cost & Markup Doctors treat need Patients BENEFIT!!,,,#,4.72403E+17,https://twitter.com/JediPD/status/472403486429433856,,,,
SyneosHealth,5/30/2014 11:45,2,0,Just in time for # ASCO14! INC's Nicholas Kenny shares his # oncology insight with @ Pharmafocus Meet him at booth 11115 http://ow.ly/d/2dcN,,@,# #,4.72403E+17,https://twitter.com/SyneosHealth/status/472403469492817922,,,,
GustaveRoussy,5/30/2014 11:45,3,0,Find out @ GustaveRoussy 's presentations at # ASCO14 ! @ ASCO http://bit.ly/1nKKbcC,,@ @,#,4.72403E+17,https://twitter.com/GustaveRoussy/status/472403361598550016,,,,
womenofteal,5/30/2014 11:45,0,1,Missing # ASCO14 this year.Will follow along here in NJ with the help of @ DrMarkham @ drdonsdizon @ rsm2800 etc,,@ @ @,#,4.72403E+17,https://twitter.com/womenofteal/status/472403321924624384,,,,
BioPharmaJosh,5/30/2014 11:44,0,0,MT @ chemobrainfog: Nowhere is twitter more powerful than this. # ASCO14 Presentations can be followed by global audience in enormous numbers,,@,#,4.72403E+17,https://twitter.com/BioPharmaJosh/status/472403184544415744,,,,
tomleblancMD,5/30/2014 11:43,0,0,"In # myeloma not eligible for transplant, Rev/Dex assoc/w improved OS and QoL; fewer side effects c/t MPT: http://ow.ly/xrobL # ASCO14",,,# #,4.72403E+17,https://twitter.com/tomleblancMD/status/472402841223847936,,,,
BoysenMeb,5/30/2014 11:42,7,2,Om et par timer begynder den 50. ASCO-kongres. Vi er klar og glæder os @DagMedicin # ASCO14 pic.twitter.com/5l3ukjjEiG,,@DagMedicin,#,4.72403E+17,https://twitter.com/BoysenMeb/status/472402674881937409,,,,
fischmd,5/30/2014 11:41,2,1,. @ WoodBD # SoWhat? That is a perfect question..Our patients want our # ASCO14 science to make a difference for their lives,,@,# #,4.72402E+17,https://twitter.com/fischmd/status/472402371747012609,,,,
DebiopharmNews,5/30/2014 11:40,0,0,# ASCO14 Our unique # patientcentric business model for # success: Debiopharm Group http://ow.ly/x8WzN,,,# # #,4.72402E+17,https://twitter.com/DebiopharmNews/status/472402133678292993,,,,
CancerConseil,5/30/2014 11:40,0,0,RT @ teamoncology: ASCO was funded in 1964. 50th birthday. HB ! # ASCO14,,@,#,4.72402E+17,https://twitter.com/CancerConseil/status/472402049947414528,,,,
ASCO,5/30/2014 11:38,4,7,# ASCO14 Twitter feed displaying in D1 & Arie Crown @ CliffordHudis @ rschilsky @ YupOncpic.twitter.com/erWyLzG6hJ,,@ @ @,#,4.72402E+17,https://twitter.com/ASCO/status/472401636728770560,,,,
fischmd,5/30/2014 11:37,0,4,An app to break through language barriers with patients: @ MediBabble http://ow.ly/xrm63 HT @ davidgrahammd at # ASCO14,,@ @,#,4.72401E+17,https://twitter.com/fischmd/status/472401329588301824,,,,
womenofteal,5/30/2014 11:37,2,1,MT @ genentech Delivering # personalizedmedicine is more complex than many think. See why: http://ow.ly/xr1QU # ASCO14 # gyncsm,,@,# # #,4.72401E+17,https://twitter.com/womenofteal/status/472401309338177536,,,,
chrisdraft,5/30/2014 11:36,0,2,Just landed in Chicago ... Heading to McCormick Place # ASCO14 # TeamDraft # Tacklinglungcancer,,,# # #,4.72401E+17,https://twitter.com/chrisdraft/status/472401249217019904,,,,
DrBobGoldberg,5/30/2014 11:36,0,0,@ ASCO drug cost app ignores true value of innovation #mliwi#voinnovation # asco14 http://www.bioworld.com/perspectives/2014/05/30/capturing-cancer-drugs-true-value-calls-for-clear-thinking/ …,,@,#mliwi #voinnovation #,4.72401E+17,https://twitter.com/DrBobGoldberg/status/472401219332616194,,,,
MaverickNY,5/30/2014 11:36,1,6,Always entertaining watching the researchers huff and puff to get their poster tubes in the overhead bins # asco14,,,#,4.72401E+17,https://twitter.com/MaverickNY/status/472401050809688066,,,,
PCGAdvisory,5/30/2014 11:32,0,0,.@PrimaBioMed to Host Conference Call to Discuss Abstract Shown at @ ASCO on June 3 at 9AM AEST(9PM EST) $ PBMD # ASCO14 http://yhoo.it/1hFrnWI,,@PrimaBioMed @,#,4.724E+17,https://twitter.com/PCGAdvisory/status/472400242793799680,,,,
MLIWI,5/30/2014 11:32,0,1,# Cancer remission is the goal. Help us get there. Join Us. # ASCO14 # MLIWI http://buff.ly/1wzzAFy,,,# # #,4.724E+17,https://twitter.com/MLIWI/status/472400179338158080,,,,
chris4cure,5/30/2014 11:32,1,1,@mikechris4life & Chris4Life team headed to # ASCO14 today! Looking forward to hopefully hearing about new research for colorectal cancer.,,@mikechris4life,#,4.724E+17,https://twitter.com/chris4cure/status/472400074228899841,,,,
drugwonks,5/30/2014 11:32,9,2,Personalized medicine will help 18 million people survive cancer by 2020. Innovation matters. # ASCO14 # MLIWI http://buff.ly/1kcOnRk,,,# #,4.724E+17,https://twitter.com/drugwonks/status/472400073864011776,,,,
Novartis,5/30/2014 11:31,4,1,# Oncology researcher Dr.Steven Stein shares thoughts on combining therapies to optimize # advancedBC treatment http://bit.ly/1ipAxGQ # ASCO14,,,# # #,4.724E+17,https://twitter.com/Novartis/status/472399851339382784,,,,
ASCO,5/30/2014 11:31,8,3,Dr. Laurie Gaspar: A radiation oncologists experience at # ASCO14 http://bit.ly/1gBhspP,,,#,4.724E+17,https://twitter.com/ASCO/status/472399807093702657,,,,
DebiopharmNews,5/30/2014 11:30,0,0,# ASCO14 # DYK US market accounts for 41% of total # oncology drug sale http://ow.ly/x8Wqt,,,# # #,4.724E+17,https://twitter.com/DebiopharmNews/status/472399769936351235,,,,
LillyDiabetes,5/30/2014 11:30,0,0,From Sat. to Mon. we'll be bringing @LlyOncOnCanvas art to life in the form of a mural at # ASCO14! # hopeforward http://ow.ly/i/5Jts8,,@LlyOncOnCanvas,# #,4.724E+17,https://twitter.com/LillyDiabetes/status/472399760528510977,,,,
teamoncology,5/30/2014 11:30,1,0,RT @NCIExhibits: Welcome to # ASCO14! Check out info on all NCI events at this year's meeting: http://1.usa.gov/1oCL6hs https://twitter.com/NCIExhibits/status/472399557687779328/photo/1pic.twitter.com/911uSvPVdH,,@NCIExhibits,#,4.724E+17,https://twitter.com/teamoncology/status/472399647151882240,,,,
Femecap,5/30/2014 11:30,0,0,La cita mundial de la oncología comienza en Chicago. http://www.efesalud.com/noticias/asco-la-cita-mundial-de-la-oncologia-cumple-su-50-aniversario/ … @ ASCO cumple su 50 aniversario. RT @ efesalud # ASCO14,,@ @,#,4.724E+17,https://twitter.com/Femecap/status/472399596488912896,,,,
KTMcGraw_HIT,5/30/2014 11:30,0,0,# ASCO14 tackles a tough question: When is a # cancer # drug too pricey? - FiercePharma: http://www.fiercepharma.com/story/asco-tackles-tough-question-when-cancer-drug-too-pricey/2014-05-30?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4ijx51tzbw.twitter …,,,# # # #,4.724E+17,https://twitter.com/KTMcGraw_HIT/status/472399583213932546,,,,
tomleblancMD,5/30/2014 11:28,1,1,"Poor prognostic awareness in # BMT; worsening # QoL, fatigue, and depression each week: http://ow.ly/xrkXz # pallonc # ASCO14 # hpm",,,# # # # #,4.72399E+17,https://twitter.com/tomleblancMD/status/472399132066611200,,,,
MyelomaTeacher,5/30/2014 11:27,0,1,@ MaverickNY @ jodyms I'm counting on U to tweet the news! Sending you a virtual gift! # ASCO14 # mmsmpic.twitter.com/4NvvgQudX6,,@ @,# #,4.72399E+17,https://twitter.com/MyelomaTeacher/status/472399027242545152,,,,
GenentechJobs,5/30/2014 11:27,1,0,# ASCO14 Talent Hunt: Companion Diagnostic Manager: http://click2apply.net/428990t Retweet please.,,,#,4.72399E+17,https://twitter.com/GenentechJobs/status/472398990151925760,,,,
Neil_Iyengar,5/30/2014 11:27,0,1,Starting # asco14 at the PLATO foundations' fellows forum in breast oncology. Outstanding expert panel! pic.twitter.com/MJwz2c7DyU,,,#,4.72399E+17,https://twitter.com/Neil_Iyengar/status/472398845197156352,,,,
DrMisialek,5/30/2014 11:26,0,2,New Clinical Guidelines for Cancer-Related Fatigue @ MoffittNews @ ASCO # ASCO14 http://moffitt.org/home/moffitt-in-the-news/press-releases/2014/jacobsen-asco-fatigue-guidelines …,,@ @,#,4.72399E+17,https://twitter.com/DrMisialek/status/472398736342384640,,,,
WileyOnc_Hem,5/30/2014 11:26,0,0,AstraZeneca will present clinical trial data for several of its highly-anticipated # cancer therapies # ASCO14 http://my.chicagotribune.com/#section/-1/article/p2p-80345218/ …,,,# # #section,4.72399E+17,https://twitter.com/WileyOnc_Hem/status/472398701676068864,,,,
DrMarkham,5/30/2014 11:26,0,0,Looking forward to a great meeting! 2014 ASCO Annual Meeting Tweeters (via ASCO) http://buff.ly/1gEtNJU # ASCO14,,,#,4.72399E+17,https://twitter.com/DrMarkham/status/472398527126339584,,,,
OncoPlexDx,5/30/2014 11:25,0,0,It's officially # ASCO14! Stop by #18119 to meet KOLs and learn how we are linking # proteomics and # genomics in the clinical space. # nsclc,,,# #18119 # # #,4.72398E+17,https://twitter.com/OncoPlexDx/status/472398395177705472,,,,
MatthewHSimmons,5/30/2014 11:25,1,0,When are my @ SarahCannonDocs colleagues presenting at # ASCO14 ? Let's take a look: http://sarahcannonresearch.com/locations/meeting-site/accepted-abstracts/index.dot …pic.twitter.com/zYQQTuZZCg,,@,#,4.72398E+17,https://twitter.com/MatthewHSimmons/status/472398281872400384,,,,
BioWorld,5/30/2014 11:23,2,1,# ASCO14 not all immunotherapy: Angiochem reports on peptide drug conjugate in HER2+ breast cancer pts w/brain metastases; ph IIb underway,,,#,4.72398E+17,https://twitter.com/BioWorld/status/472397938090459136,,,,
ByJonGardner,5/30/2014 11:23,3,1,"I have a great idea: tomorrow at 4, everybody have a pickup game of catch with their # sgenball on the # ASCO14 show floor...wait, what? $ SGEN",,,# #,4.72398E+17,https://twitter.com/ByJonGardner/status/472397930926583808,,,,
teamoncology,5/30/2014 11:22,0,0,Nice pictures. RT @ JacobEPVantage: Chicago # ASCO14 pic.twitter.com/p8MtsqfctI,,@,#,4.72398E+17,https://twitter.com/teamoncology/status/472397710859853826,,,,
teamoncology,5/30/2014 11:22,0,0,"# ASCO14 is attended by doctors, nurses, pharmacists, industry, government staff, cancer survivors, advocates, etc.",,,#,4.72398E+17,https://twitter.com/teamoncology/status/472397631210016768,,,,
MidAmPrint,5/30/2014 11:22,0,0,# ASCO14 is officially underway. Already running out of brochures? Give this Chicago Printer a call to restock! (312) 663-4720 @ MidAmPrint,,@,#,4.72398E+17,https://twitter.com/MidAmPrint/status/472397529414639616,,,,
ByJonGardner,5/30/2014 11:21,0,0,I haven't touched # sgenball all day. $ SGEN # ASCO14,,,# #,4.72397E+17,https://twitter.com/ByJonGardner/status/472397429757603841,,,,
premal2000,5/30/2014 11:21,0,1,"# healthcare companies need to attend more # tech/consumer confs. They'd see how communicating via iPads, social media changes lives. # ASCO14",,,# # #,4.72397E+17,https://twitter.com/premal2000/status/472397388213010433,,,,
DebiopharmNews,5/30/2014 11:20,0,0,# ASCO14 # DYK High pharma investments & cancer therapies account for > 30% preclinical & phase I clinical developments http://ow.ly/x8W63,,,# #,4.72397E+17,https://twitter.com/DebiopharmNews/status/472397105785745408,,,,
tomleblancMD,5/30/2014 11:19,1,0,Important findings on # burnout in # palliative care clinicians; an astounding 61%! http://ow.ly/xriOB from @ arifkamalmd # ASCO14 # hpm,,@,# # # #,4.72397E+17,https://twitter.com/tomleblancMD/status/472396982456430592,,,,
tomleblancMD,5/30/2014 11:18,7,3,Important new findings about # burnout among # palliative care clinicians; an astounding 61%! http://ow.ly/xriOB # ASCO14 # pallonc,,,# # # #,4.72397E+17,https://twitter.com/tomleblancMD/status/472396538619367425,,,,
GileadSciences,5/30/2014 11:18,0,1,"For news media covering chronic lymphocytic leukemia at # ASCO14, here is a Gilead infographic on # CLLhttp://twitpic.com/e52ajh",,,# #,4.72397E+17,https://twitter.com/GileadSciences/status/472396526523002880,,,,
teamoncology,5/30/2014 11:16,0,0,RT @ jrgralow: Results From Trials Of New Immunotherapies To Be Released # ASCO14 http://www.reuters.com/article/2014/05/29/us-health-cancer-astrazeneca-idUSKBN0E91S320140529 …,,@,#,4.72396E+17,https://twitter.com/teamoncology/status/472396142991269889,,,,
chicagocapman,5/30/2014 11:16,0,0,Kale prepped! Join us for Kale/Carrot Smoothies @ ASCO. @ Hospira_Inc Booth #19135 # ASCO14 pic.twitter.com/920DCpTimb,,@ @,#19135 #,4.72396E+17,https://twitter.com/chicagocapman/status/472396137337720833,,,,
WCGClinical,5/30/2014 11:16,0,0,"Down on the # ASCO14 exhibit floor, building our booth (#3097). Hope that you will visit us tomorrow. pic.twitter.com/yN1JyAb34V",,,# #3097,4.72396E+17,https://twitter.com/WCGClinical/status/472396112759128064,,,,
teamoncology,5/30/2014 11:16,0,1,Agree. RT @ rsm2800: A slide from my talk on Monday re social media; clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/z0JFgYh0yj,,@,#,4.72396E+17,https://twitter.com/teamoncology/status/472396086741442560,,,,
McCormick_Place,5/30/2014 11:16,2,6,McCormick Place is proud to host ASCO's 50 Annual Meeting. Congratulations! http://am.asco.org/ # ASCO14,,,#,4.72396E+17,https://twitter.com/McCormick_Place/status/472396013311778816,,,,
teamoncology,5/30/2014 11:15,0,1,@ mtmdphd I personally feel that if we can bring AACR and ASCO together like 20 years ago. :) # ASCO14 This will bring science even stronger.,,@,#,4.72396E+17,https://twitter.com/teamoncology/status/472396004981878785,,,,
NCIEpi,5/30/2014 11:15,1,0,"Sunday, 1:30 PM CT, @NCI Booth #3071, an overview of # cancer # epidemiology cohorts supported by @ theNCI. # ASCO14 @NCIExhibits",,@NCI @ @NCIExhibits,#3071 # # #,4.72396E+17,https://twitter.com/NCIEpi/status/472395908379070464,,,,
CancerSupportHQ,5/30/2014 11:15,5,3,Study: Low-income cancer patients more likely to seek social and emotional support from health care team http://bit.ly/1oRyh09 # ASCO14,,,#,4.72396E+17,https://twitter.com/CancerSupportHQ/status/472395854968786944,,,,
GenomicHealth,5/30/2014 11:15,2,1,Today’s the day! Learn more abt the enhanced $ GHDX # Oncotype # breastcancer report here http://bit.ly/1h5KAGx # ASCO14 http://ow.ly/i/5HJZX,,,# # #,4.72396E+17,https://twitter.com/GenomicHealth/status/472395850518638593,,,,
mtmdphd,5/30/2014 11:15,1,0,"Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xiafn # hcsm # ASCO14",,@,# #,4.72396E+17,https://twitter.com/mtmdphd/status/472395842222292992,,,,
KiraTani,5/30/2014 11:14,0,0,Good luck at # ASCO14 @ fischmd! Sending some new followers via MD Anderson General Oncology FB page!,,@,#,4.72396E+17,https://twitter.com/KiraTani/status/472395757547315200,,,,
DrBobGoldberg,5/30/2014 11:13,0,0,@ asco has app that tells docs what a drug cost but ignores what makes life worthwhile # mliwi # cancerpatients # asco14 http://www.bloomberg.com/news/2014-05-30/expensive-drugs-forcing-cancer-doctors-to-weigh-price.html …,,@,# # #,4.72395E+17,https://twitter.com/DrBobGoldberg/status/472395344387780608,,,,
teamoncology,5/30/2014 11:12,6,4,# ASCO14 The hashtag stands for ASCO annual meeting in Chicago which will start today. There are many great people tweeting. :),,,#,4.72395E+17,https://twitter.com/teamoncology/status/472395184475344898,,,,
teamoncology,5/30/2014 11:12,6,3,Why follow # ASCO14 ? This will be a great source for new info about the latest development in the clinical cancer world.,,,#,4.72395E+17,https://twitter.com/teamoncology/status/472395143832543232,,,,
corp_UNC,5/30/2014 11:12,0,2,MT @ UNCurology Thrilled: brilliant Deb Mayer named as Director of Cancer Survivorship @ UNC_Lineberger! http://www.unclineberger.org/news/deborah-mayer-to-be-unc-lineberger-director-of-cancer-survivorship-1 … # asco14,,@ @,#,4.72395E+17,https://twitter.com/corp_UNC/status/472395078385012736,,,,
Biothera,5/30/2014 11:12,0,1,# Biothera to present biomarker data for immunotherapy # ImprimePGG linked to ph 2 clinical NSCLC data at # ASCO14. http://tinyurl.com/omrfl4y,,,# # #,4.72395E+17,https://twitter.com/Biothera/status/472395067525562368,,,,
teamoncology,5/30/2014 11:12,3,0,ASCO was funded in 1964. 50th birthday. HB ! # ASCO14,,,#,4.72395E+17,https://twitter.com/teamoncology/status/472395038639407104,,,,
teamoncology,5/30/2014 11:11,1,0,ASCO stands for American Society of Clinical Oncology. A professional society for who are involved in cancer care and treatment. # ASCO14,,,#,4.72395E+17,https://twitter.com/teamoncology/status/472394955755765760,,,,
MLIWI,5/30/2014 11:11,0,0,"Since 1970, the number of people surviving cancer has increased by nearly 400% to 14 million in 2013. Follow us. # MLIWI # ASCO14",,,# #,4.72395E+17,https://twitter.com/MLIWI/status/472394771236139008,,,,
teamoncology,5/30/2014 11:11,2,1,# ASCO14 本日より米国臨床腫瘍学会の年次総会開始。このハッシュタグをフォローすることにより、最新のがん情報が入可能。この学会はがんに関する世界最大の学会です。質問があれば、送って下さい。,,,#,4.72395E+17,https://twitter.com/teamoncology/status/472394766852710400,,,,
DebiopharmNews,5/30/2014 11:10,0,0,"# ASCO14 Phase I basket study Debio1347, # FGFR inhibitor in solid # tumors (abstract/poster # TPS2629) Find out more http://ow.ly/x8VCb",,,# # # #,4.72395E+17,https://twitter.com/DebiopharmNews/status/472394588377079808,,,,
mtmdphd,5/30/2014 11:10,0,0,Twitter 102 - Account Settings - via @ SubAtomicDoc http://ow.ly/xiac0 # hcsm # ASCO14,,@,# #,4.72395E+17,https://twitter.com/mtmdphd/status/472394572174471168,,,,
Novartis,5/30/2014 11:10,0,2,ALK+ NSCLC data to be featured on 5/31 in S Hall A2 at 1:15pm CDT. Look for poster board No.259 # ASCO14,,,#,4.72395E+17,https://twitter.com/Novartis/status/472394567162281984,,,,
tabASCOsauce3,5/30/2014 11:09,0,0,"After 12 hours of sleep, we are ready for some poster sessions! # ASCO14",,,#,4.72394E+17,https://twitter.com/tabASCOsauce3/status/472394451818532866,,,,
AndreaMiyahira,5/30/2014 11:09,2,0,The @ PCFnews Science Team is at # ASCO14 ! Looking forward to an exciting meeting! pic.twitter.com/F8pLDO8Gtk,,@,#,4.72394E+17,https://twitter.com/AndreaMiyahira/status/472394292246622208,,,,
SymphonySister,5/30/2014 11:08,1,0,# ASCO14 MammaPrint-BluePrint molecular subtypes reclassify 23% of # breastcancer tumors & improve patient grouping http://hub.am/TzbwUu,,,# #,4.72394E+17,https://twitter.com/SymphonySister/status/472394220691812352,,,,
Agendia,5/30/2014 11:08,1,1,# ASCO14 MammaPrint-BluePrint molecular subtypes reclassify 23% of # breastcancer tumors & improve patient grouping http://hub.am/1sZLBPV,,,# #,4.72394E+17,https://twitter.com/Agendia/status/472394015900700672,,,,
nolamelanie,5/30/2014 11:07,0,0,"Should you change your overall treatment plan based upon rebiopsy if previous targets are no longer present, eg ER+ --> TNBC? # bcsm # ASCO14",,,# #,4.72394E+17,https://twitter.com/nolamelanie/status/472393979561254912,,,,
ANguyen_ERG,5/30/2014 11:07,0,0,A quick guide to ASCO & Immunotherapies: http://bit.ly/1pEhgX2 # asco2014 # environicspharma # cancer,,,# # #,4.72394E+17,https://twitter.com/ANguyen_ERG/status/472393944152547328,,,,
LungCancerFaces,5/30/2014 11:07,3,5,"Powerful statements of resilience, survivorship & determination. Read # LungCancer # ImStillHere https://storify.com/LungCancerFaces/imstillhere … # LCSM # HCSM # ASCO14",,,# # # # #,4.72394E+17,https://twitter.com/LungCancerFaces/status/472393766515384320,,,,
save_fertility,5/30/2014 11:06,0,0,Attending # ASCO14? Don’t miss “Fertility Preservation: State of the Art and Future Directions” today at 1 pm. http://bit.ly/1pEhmhy,,,#,4.72394E+17,https://twitter.com/save_fertility/status/472393709879693312,,,,
NikolaidesLaura,5/30/2014 11:06,0,0,"Just arrived at Chicago's miracle mile, the taxi line. Here we go! # ASCO14",,,#,4.72394E+17,https://twitter.com/NikolaidesLaura/status/472393500961832961,,,,
SWOG,5/30/2014 11:05,0,0,"# ASCO14 Assoc of higher inst volume w improved OS in stg III testicular cancer. Fri 1-4, S102 http://abstracts.asco.org/144/AbstView_144_134968.html … # SWOGonc @ TestisCancer",,@,# #,4.72393E+17,https://twitter.com/SWOG/status/472393462500061184,,,,
mtmdphd,5/30/2014 11:05,1,0,Twitter 101 - Signing up - via @ SubAtomicDoc http://ow.ly/xia9p # hcsm # ASCO14 @ Twitter,,@ @,# #,4.72393E+17,https://twitter.com/mtmdphd/status/472393346330419201,,,,
CureMelanoma,5/30/2014 11:05,0,0,Will you be at # ASCO14? We're there! Follow us & our exec dir @ timturnham for # melanoma updates. # cancer # oncology # skincancer,,@,# # # # #,4.72393E+17,https://twitter.com/CureMelanoma/status/472393312654356481,,,,
genentech,5/30/2014 11:05,3,3,"# ASCO14 is an opp for our community to look beyond data & think abt quality of care.” C. Gilmour, VP US Med Affairs http://ow.ly/xrbhS",,,#,4.72393E+17,https://twitter.com/genentech/status/472393283948527616,,,,
RarePOV,5/30/2014 11:03,0,0,"MT @ JenAtPhRMA: Covering the # ASCO14 meeting? If so, check out @ PhRMA # cancer chart pack resource http://www.phrma.org/sites/default/files/pdf/cancer-chart-pack-5-22-14.pdf … # lcsm # bcsm",,@ @,# # # #,4.72393E+17,https://twitter.com/RarePOV/status/472392750344990720,,,,
ASCO,5/30/2014 11:02,12,6,Your chance to discuss # cancer care with fellow Tweeters is tomorrow at the # ASCO14 Tweetup. Details & RSVP: http://bit.ly/NvNypj,,,# #,4.72393E+17,https://twitter.com/ASCO/status/472392641699909632,,,,
myPathMelanoma,5/30/2014 11:02,1,0,Myriad myPath # Melanoma provides diagnostic value beyond what is achieved w/ histopath alone # melanomadiagnostic # isthismelanoma # ASCO14,,,# # # #,4.72392E+17,https://twitter.com/myPathMelanoma/status/472392489983164417,,,,
ASCO,5/30/2014 11:01,6,2,"Welcome to # ASCO14! Review program highlights, networking opportunities, & resources http://bit.ly/1k35dBY",,,#,4.72392E+17,https://twitter.com/ASCO/status/472392467158155264,,,,
DebiopharmNews,5/30/2014 11:01,0,0,"# ASCO14 Clinical PK/PD model for Debio 1143, antagonist of IAPs in # cancer (abstract/poster #2585) Find out more http://ow.ly/x8Vqu",,,# # #2585,4.72392E+17,https://twitter.com/DebiopharmNews/status/472392443330318337,,,,
Novartis,5/30/2014 11:01,1,2,Stay tuned for # ASCO14 # multiplemyeloma presentation updates. Learn more here: http://bit.ly/1i93rtE,,,# #,4.72392E+17,https://twitter.com/Novartis/status/472392423759708160,,,,
tamrasami,5/30/2014 11:01,0,1,Payers provide docs with incentives to follow their prescribed treatment plans: http://bit.ly/U0bchL . ASCO released plan too # ASCO14,,,#,4.72392E+17,https://twitter.com/tamrasami/status/472392340368556032,,,,
SequentaInc,5/30/2014 11:01,1,0,Using minimal residual disease testing in clinical mgmt? Come to bth 18152 to learn abt the ClonoSIGHT test http://ow.ly/xm90K # ASCO14,,,#,4.72392E+17,https://twitter.com/SequentaInc/status/472392315886374912,,,,
genentech,5/30/2014 11:00,0,0,@ stales @ harriseve Thanks for helping us spread the word about QoC # ASCO14 http://ow.ly/xr2mA,,@ @,#,4.72392E+17,https://twitter.com/genentech/status/472392049485156352,,,,
cpgYALE,5/30/2014 10:58,0,0,Rereading Bach's poignant piece on losing wife to # breastcancer while on way to # ASCO14. Inspired. A must-read http://nym.ag/1oCCAis,,,# #,4.72392E+17,https://twitter.com/cpgYALE/status/472391526215987201,,,,
LGG1,5/30/2014 10:57,0,0,"Myc, RAF, Autophagy: Education Session Tackles Tough Pathway Targets # ASCO14 http://ow.ly/xreKN",,,#,4.72391E+17,https://twitter.com/LGG1/status/472391338055696384,,,,
subatomicdoc,5/30/2014 10:57,0,1,What # prostatecancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # pcsm,,@ @ @ @ @ @,# # # #,4.72391E+17,https://twitter.com/subatomicdoc/status/472391258150035456,,,,
AstellasUS,5/30/2014 10:56,2,2,"All social media managers attending # ASCO14 this weekend, let’s # TweetUp 5:45pm Sat @the McCormick Place Food Court! http://bit.ly/1gOpKZV",,@the,# #,4.72391E+17,https://twitter.com/AstellasUS/status/472391107926835200,,,,
hmhyltonpac,5/30/2014 10:55,0,0,"Eric Tetzlaff, PA-C, speaking on the business of Medicine at # ASCO14 Pre-Annual Meeting Seminar pic.twitter.com/89e0iPtXQ2",,,#,4.72391E+17,https://twitter.com/hmhyltonpac/status/472390765000138752,,,,
MyelomaTeacher,5/30/2014 10:55,0,1,Made it to 2000 followers on Twitter just in time for # ASCO14! pic.twitter.com/f90u5mNZn6,,,#,4.72391E+17,https://twitter.com/MyelomaTeacher/status/472390738555047937,,,,
Larvol,5/30/2014 10:54,0,0,Our # pharma clients are heading to # ASCO14 armed with the latest clinical intelligence in their field. Learn more at http://Larvol.com,,,# #,4.72391E+17,https://twitter.com/Larvol/status/472390635685965824,,,,
DrMisialek,5/30/2014 10:54,0,0,Radiation for prostate cancer linked to secondary cancers http://www.mcancer.org/news/archive/radiation-prostate-cancer-linked-secondary-cancers-study-finds#.U4ibeBgqls4.twitter … @ UMHealthSystem @ ASCO # ASCO14,,@ @,# #,4.72391E+17,https://twitter.com/DrMisialek/status/472390591985483776,,,,
DriehausCapital,5/30/2014 10:54,0,0,# ASCO14 wknd in Chicago. Haven’t made dinner res yet? You’re competing w/30k oncologists & PhDs for an open table. MC pic.twitter.com/9qiFQfIWo5,,,#,4.7239E+17,https://twitter.com/DriehausCapital/status/472390476037767168,,,,
drdonsdizon,5/30/2014 10:53,0,1,“ @ ConsanoScott: Celebrating 10yr anniversary with @ ConsanoMolly at # ASCO14. Romantic? No. Helping us get to 20yr anniversary. YES! # hcldr”,,@ @,# #,4.7239E+17,https://twitter.com/drdonsdizon/status/472390445985968128,,,,
DrMisialek,5/30/2014 10:53,0,0,Study Highlights Side Effects in BRCA Carriers After Cancer Risk-Reducing Surgical Procedure http://www.uphs.upenn.edu/news/News_Releases/2014/05/rrso/ … @ PennMedicine # ASCO14,,@,#,4.7239E+17,https://twitter.com/DrMisialek/status/472390342743195648,,,,
ASCO,5/30/2014 10:53,35,15,"Today marks the first day of # ASCO14. This year's theme: Science & Society"" @ CliffordHudis @ rschilsky @ YupOncpic.twitter.com/y3ascQxdik""",,@ @ @,#,4.7239E+17,https://twitter.com/ASCO/status/472390296140267520,,,,
WilliamDale_MD,5/30/2014 10:51,1,2,"Developing a Geriatric Oncology Presence at your Institution"" # ASCO14 will be Saturday morning 8-11am in S103. Awesome line-up! # gerionc""",,,# #,4.7239E+17,https://twitter.com/WilliamDale_MD/status/472389871752208384,,,,
ConsanoScott,5/30/2014 10:50,1,2,Celebrating 10yr anniversary with @ ConsanoMolly at # ASCO14. Romantic? No. Helping us get to 20yr anniversary. YES! # hcldr,,@,# #,4.7239E+17,https://twitter.com/ConsanoScott/status/472389605799763969,,,,
DebiopharmNews,5/30/2014 10:50,0,0,# ASCO14 Phase I/II Debio 1143 combo with CCRT in # patients with # HNSCN (abstract/poster # TPS6097) Find out more http://ow.ly/x8VeI,,,# # # #,4.7239E+17,https://twitter.com/DebiopharmNews/status/472389544042848256,,,,
myriadgenetics,5/30/2014 10:50,0,0,Did you know that 1 in 6 men will be diagnosed with # prostatecancer in their lifetime? http://bit.ly/1gk3CYs # Prolaris # menshealth # ASCO14,,,# # # #,4.72389E+17,https://twitter.com/myriadgenetics/status/472389469002162177,,,,
BracketGlobal,5/30/2014 10:49,1,0,RT @ ASCO: We’re using this badge to raise awareness of federal funding for # cancer research. Sign up & download: http://bit.ly/1hFFQlq,,@,#,4.72389E+17,https://twitter.com/BracketGlobal/status/472389453747863553,,,,
DKarikios,5/30/2014 10:49,0,0,Looking forward to having a cheezborger cheezborger cheezborger again with @ cdiakos # ASCO14,,@,#,4.72389E+17,https://twitter.com/DKarikios/status/472389365679665153,,,,
mtsiatas,5/30/2014 10:49,0,0,"@ ASCO, Chicago USA",,@,,4.72389E+17,https://twitter.com/mtsiatas/status/472389216261783552,,,,
OAkkerman_ERG,5/30/2014 10:48,3,1,Don't miss a thing at # ASCO14. NexaLive from # EnvironicsPharma shows conversations happening now. http://asco.nexalive.com/ @ mtmdphd,,@,# #,4.72389E+17,https://twitter.com/OAkkerman_ERG/status/472389178383011840,,,,
genentech,5/30/2014 10:45,4,1,Delivering # personalizedmedicine is far more complex than many might think. See why here: http://ow.ly/xr1QU # ASCO14,,,# #,4.72388E+17,https://twitter.com/genentech/status/472388345210085376,,,,
evaluatepharma,5/30/2014 10:45,0,0,Join @ EPVantage’s @ JonEPVantage & @ FierceBiotech for a post # ASCO2014 Twitter chat on June 5 at 2pm using # FierceASCO http://ow.ly/xonFe,,@ @ @,# #,4.72388E+17,https://twitter.com/evaluatepharma/status/472388301836812288,,,,
Novartis,5/30/2014 10:45,3,2,Plan your # ASCO14: Visit our oral presentation on Phase II # basalcellcarcinoma data; June 1 at 8 am CDT; abstract No. 9009a,,,# #,4.72388E+17,https://twitter.com/Novartis/status/472388285550325760,,,,
UBCPharma,5/30/2014 10:45,2,2,# ASCO14 - Board Certified Oncology Pharmacist Provides Exceptional Care for Oncology Patients: http://bit.ly/1k8OOfK # oncology # pharma,,,# # #,4.72388E+17,https://twitter.com/UBCPharma/status/472388223935975424,,,,
ASH_hematology,5/30/2014 10:44,1,0,"We're wrapping up Hematology for the Oncologist at # ASCO14 with our final session, The Abnormal Hemogram.""""",,,#,4.72388E+17,https://twitter.com/ASH_hematology/status/472388053588520960,,,,
dhjutsw1,5/30/2014 10:42,2,0,MT: An Early-Career Oncologist’s Perspective from former @ VUMChealth resident now @ DanaFarber fellow. # ASCO14 http://am.asco.org/early-career-oncologist%E2%80%99s-perspective#.U4iYW_4cgA4.twitter …,,@ @,# #,4.72388E+17,https://twitter.com/dhjutsw1/status/472387567959027712,,,,
MediTech_Media,5/30/2014 10:42,0,0,On our way to # ASCO14. Follow us! We will be tweeting highlights of exciting advances in # CancerResearch,,,# #,4.72388E+17,https://twitter.com/MediTech_Media/status/472387553702973440,,,,
JohnCendpts,5/30/2014 10:41,3,6,"I have to admit, every time I hear something about 'dendritic cells,' I cringe a little. # ASCO14",,,#,4.72387E+17,https://twitter.com/JohnCendpts/status/472387318079578112,,,,
theABTA,5/30/2014 10:41,0,0,ABTA Chief Mission Officer is at # ASCO14 where neuro-oncologists are discussing need for standardized imaging criteria for meningioma. # btsm,,,# #,4.72387E+17,https://twitter.com/theABTA/status/472387272084840448,,,,
Medicalfacts,5/30/2014 10:40,0,1,"50 jaar ASCO # ASCO14 - In de erkenning van de evolutie en vooruitgang in de oncologische zorg , zal de American... http://is.gd/6t7fhn",,,#,4.72387E+17,https://twitter.com/Medicalfacts/status/472387099854110721,,,,
DebiopharmNews,5/30/2014 10:40,0,0,# ASCO14 Phase I study Debio 1143 combo in # patients # leukemia # bloodcancer (abstract/poster #7029) Find out more http://ow.ly/x8UTQ,,,# # # # #7029,4.72387E+17,https://twitter.com/DebiopharmNews/status/472387066530394113,,,,
Boehringer,5/30/2014 10:40,85,198,"# HCPs: EGFR mutations occur in 13% of # NSCLC tumours or approx 178,000 new cases each year globally. More: http://bit.ly/1stP7Ug > # ASCO14",,,# # #,4.72387E+17,https://twitter.com/Boehringer/status/472387050789171201,,,,
aurmanARK,5/30/2014 10:40,0,0,# ASCO2014 is here! Check out the abstracts: http://ow.ly/xr9zz Should be an interesting weekend for research and # biotech.,,,# #,4.72387E+17,https://twitter.com/aurmanARK/status/472386977145184256,,,,
ACGTFoundation,5/30/2014 10:39,0,1,"ACGT fellows, June & Coukos, to discuss # immunotherapy during @ ASCO annual meeting on 06/02. # ASCO14 # CancerResearch http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …",,@,# # #,4.72387E+17,https://twitter.com/ACGTFoundation/status/472386921575227392,,,,
stales,5/30/2014 10:39,1,0,RT @ jrgralow: # ASCO14: Dr. Hope Rugo gives her top picks in breast cancer research http://ow.ly/xr2Zp # bcsm,,@,# #,4.72387E+17,https://twitter.com/stales/status/472386916265230336,,,,
drugwonks,5/30/2014 10:39,2,0,We must accelerate development of new # cancer medications. Sign the petition. # ASCO14 # MLIWI http://buff.ly/1jACf88,,,# # #,4.72387E+17,https://twitter.com/drugwonks/status/472386838930657280,,,,
smerv,5/30/2014 10:39,0,0,What if combine them w/checkpoint blockade? # ASCO2014 preview: Outlook for # cancer vaccines? - FierceVaccines: http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4iXSNY2U3M.twitter …,,,# # #,4.72387E+17,https://twitter.com/smerv/status/472386769875255296,,,,
KinzieHotel,5/30/2014 10:37,0,1,We hope everyone staying w/ us for # ASCO14 has a wonderful time in # Chicago! @ ChooseChicago @ ASCO Happy Friday! :),,@ @,# #,4.72386E+17,https://twitter.com/KinzieHotel/status/472386317477609472,,,,
ASCO,5/30/2014 10:37,8,0,We’re using this badge to raise awareness of federal funding for # cancer research. Sign up & download it http://bit.ly/1hFFQlq # ASCO14,,,# #,4.72386E+17,https://twitter.com/ASCO/status/472386257377845248,,,,
theABTA,5/30/2014 10:36,0,0,@ subatomicdoc We will be exhibiting at # ASCO14 - please stop by and say hello!,,@,#,4.72386E+17,https://twitter.com/theABTA/status/472386163979071489,,,,
ASCO,5/30/2014 10:35,5,0,We invite widespread use of Federally Funded Research badge http://bit.ly/1izuy2k # ASCO14 # ascoaction,,,# #,4.72386E+17,https://twitter.com/ASCO/status/472385925180583936,,,,
jamesian,5/30/2014 10:35,0,0,As # ASCO14 begins - study shows more docs tweet during conferences http://abstracts.asco.org/144/AbstView_144_132049.html … h/t @ RichardSimcock1 # hcsm # Cancer,,@,# # #,4.72386E+17,https://twitter.com/jamesian/status/472385879630032896,,,,
Boehringer,5/30/2014 10:35,1,0,Happy 50th Bday @ ASCO! What a milestone! We hope even better outcomes are achieved for patients in next 50yrs http://bit.ly/1qkY4wt # ASCO14,,@,#,4.72386E+17,https://twitter.com/Boehringer/status/472385763444019201,,,,
RareDiseases,5/30/2014 10:35,1,0,"RT @ ronwinslow: There were 82,383 tweets about cancer by U.S. docs in 2013. New # ASCO14 data: http://ow.ly/x6RcW",,@,#,4.72386E+17,https://twitter.com/RareDiseases/status/472385752891162624,,,,
ConquerCancerFd,5/30/2014 10:35,1,1,Attending # ASCO14? Join us June 1 for breakfast and a free info session on estate planning: http://bit.ly/1lFwtVc,,,#,4.72386E+17,https://twitter.com/ConquerCancerFd/status/472385751855140864,,,,
MelanomaReAlli,5/30/2014 10:35,4,3,# ASCO14 is all abuzz about immunotherapies & # melanoma treatment http://ow.ly/xqVze,,,# #,4.72386E+17,https://twitter.com/MelanomaReAlli/status/472385722675367936,,,,
DebiopharmNews,5/30/2014 10:31,0,0,# ASCO14 Final PK/PD phase I Debio 1143 (AT406) # patients # cancer (abstract/poster #2532). Find out more http://ow.ly/x8Uyp,,,# # # #2532,4.72385E+17,https://twitter.com/DebiopharmNews/status/472384823097839616,,,,
corp_UNC,5/30/2014 10:31,0,0,Prostate brachy technique & long-term incontinence: 5y prosp.cohort outcomes Ron Chen @ UNC_Lineberger et al # asco14 http://ow.ly/xqAcR,,@,#,4.72385E+17,https://twitter.com/corp_UNC/status/472384781041565696,,,,
ASCO,5/30/2014 10:31,1,1,Dr. Daniel G. Stover: An early-career oncologists experience at # ASCO14 http://bit.ly/1nVxDNK,,,#,4.72385E+17,https://twitter.com/ASCO/status/472384756462915585,,,,
EFEciencia,5/30/2014 10:30,3,0,"El lema de # ASCO14, # Ciencia y sociedad: los próximos 50 años. # Chicago",,,# # #,4.72385E+17,https://twitter.com/EFEciencia/status/472384680503685121,,,,
mtmdphd,5/30/2014 10:30,0,0,Getting Started in Social Media - What to Do Before You Join [5/2014] - via @ SubAtomicDoc http://ow.ly/xc9zL # hcsm # ASCO14,,@,# #,4.72385E+17,https://twitter.com/mtmdphd/status/472384609800699905,,,,
cardinalhealth,5/30/2014 10:30,1,0,Attending # ASCO14? See what Cardinal Health Specialty Solutions can do for you: http://bit.ly/1nOTqu2 # essentialtooncology,,,# #,4.72384E+17,https://twitter.com/cardinalhealth/status/472384472805949440,,,,
myPathMelanoma,5/30/2014 10:30,1,0,@ MyriadGenetics' products will be at # ASCO14 Booth 2039. Find out how Myriad myPath # Melanoma can help your # diagnosis # isthismelanoma,,@,# # # #,4.72384E+17,https://twitter.com/myPathMelanoma/status/472384437074685954,,,,
WCGClinical,5/30/2014 10:29,0,0,"In case you have forgotten how beautiful Chicago is, here’s an aerial reminder while traveling to # ASCO14 pic.twitter.com/Wd0bTVWHvi",,,#,4.72384E+17,https://twitter.com/WCGClinical/status/472384422130757632,,,,
mchilberg,5/30/2014 10:29,0,0,$ CLVS $ CLDX two to watch going into @ ASCO,,@,,4.72384E+17,https://twitter.com/mchilberg/status/472384346402607104,,,,
MyelomaTeacher,5/30/2014 10:27,2,0,I learned that # immunotherapy aims 2 stimulate a immune response that long-lived @ AACR SSP. Excited to hear # ASCO14 CT results 4 # mmsm,,@,# # #,4.72384E+17,https://twitter.com/MyelomaTeacher/status/472383897775636480,,,,
CitelineRachelM,5/30/2014 10:27,1,0,Look at new blog @ CitelineRachelM about # immunotherapies besides PD1 and PDL1 at # ASCO14 http://bit.ly/SVNyCm,,@,# #,4.72384E+17,https://twitter.com/CitelineRachelM/status/472383737108639744,,,,
lenstarnes,5/30/2014 10:27,0,0,MT @ rsm2800 Asked op re top advance of @ ASCO 's 50 yrs. I said penetration of internet & pt access to info # ASCO14 # ESCcongress # ePatient,,@ @,# # #,4.72384E+17,https://twitter.com/lenstarnes/status/472383718934740992,,,,
EFEciencia,5/30/2014 10:26,6,1,"La inmunoterapia, entre los puntos fuertes del congreso de oncología clínica en Chicago. # ASCO14",,,#,4.72384E+17,https://twitter.com/EFEciencia/status/472383564923686912,,,,
hmhyltonpac,5/30/2014 10:25,1,0,@ todd_ap speaking at # ASCO14 pre-AM seminar on productivity and value of advanced practice providers. pic.twitter.com/zTWQd30Tza,,@,#,4.72383E+17,https://twitter.com/hmhyltonpac/status/472383243057364992,,,,
AstellasUS,5/30/2014 10:25,1,0,Astellas welcomes participants for @ ASCO’s 50th annual meeting to the Windy City! Track the event here: http://bit.ly/1lQaPwB # ASCO14,,@,#,4.72383E+17,https://twitter.com/AstellasUS/status/472383212816437248,,,,
CancerDotNet,5/30/2014 10:25,0,0,Advocates at # ASCO14: Did you just get in & not have time to go to your hotel? Baggage checks throughout the hall: http://bit.ly/1ny5ock,,,#,4.72383E+17,https://twitter.com/CancerDotNet/status/472383207607123968,,,,
EFEciencia,5/30/2014 10:23,3,0,"El congreso # ASCO14 cumple 50 años, la mayor cita mundial de oncología. # chicago",,,# #,4.72383E+17,https://twitter.com/EFEciencia/status/472382712603353089,,,,
BreastDocUK,5/30/2014 10:21,4,2,Looks like we are about to hit a big cancer tweet 'aggregation' # ASCO14 http://abstracts.asco.org/144/AbstView_144_132049.html …,,,#,4.72382E+17,https://twitter.com/BreastDocUK/status/472382342926180352,,,,
EFEciencia,5/30/2014 10:21,3,0,"Hoy empieza # ASCO14, con más de 25.000 expertos en # cáncer. Desde @ efeciencia os lo contaremos.",,@,# #,4.72382E+17,https://twitter.com/EFEciencia/status/472382191242981376,,,,
UNC_Lineberger,5/30/2014 10:20,0,0,RT @ corp_UNC: Popn-based eval of Rx patterns/survival: localized CaP w hi PSA Chen et al # pcsm # hsronc # ASCO14 http://ow.ly/xpjN3,,@,# # #,4.72382E+17,https://twitter.com/UNC_Lineberger/status/472382027158016000,,,,
DebiopharmNews,5/30/2014 10:20,0,0,# ASCO14 Debio1143 results in # HNCSM Find out more http://ow.ly/x8UlN,,,# #,4.72382E+17,https://twitter.com/DebiopharmNews/status/472381997932093440,,,,
bwoodmd,5/30/2014 10:20,0,1,"@ fischmd by the way, one of my favorite ?s: (from the patient perspective), so what?"" Need to know what will emerge from the # ASCO14 noise.""",,@,#,4.72382E+17,https://twitter.com/bwoodmd/status/472381918067978240,,,,
DrAttai,5/30/2014 10:18,1,0,RT @ rsm2800 Official # ASCO14 Tweetup http://tweetvite.com/event/ASCO14 and Unofficial # asco14 Tweetup http://tweetvite.com/event/UnofficialASCO14 … …. Why choose? Do both!,,@,# #,4.72381E+17,https://twitter.com/DrAttai/status/472381448188489729,,,,
WilliamDale_MD,5/30/2014 10:18,4,0,"For those of you planning your # gerionc day at # ASCO14, check out Why Functional Age Matters"" at 4:30 in E253. # prostate # bladder # cancer.""",,,# # # # #,4.72381E+17,https://twitter.com/WilliamDale_MD/status/472381417566248960,,,,
Institut_cancer,5/30/2014 10:17,17,4,"# ASCO14 : la France, premier pays d’Europe en matière de représentation scientifique - http://www.e-cancer.fr/rss-recherche/8888-asco-2014--la-france-premier-pays-deurope-en-matiere-de-representation-scientifique- …",,,#,4.72381E+17,https://twitter.com/Institut_cancer/status/472381411375472640,,,,
jodyms,5/30/2014 10:17,0,1,"Even though it is a # blisterwalk I wish I were there @ MaverickNY # ASCO14 I love hearing the presentations live, with 7,000 other friends.",,@,# #,4.72381E+17,https://twitter.com/jodyms/status/472381377766109184,,,,
KMilehamMD,5/30/2014 10:17,1,0,"Read a one-pager about # LCI @Carolinas in the # usairways inflight magazine on way to Chicago, arrived for # ASCO14",,@Carolinas,# # #,4.72381E+17,https://twitter.com/KMilehamMD/status/472381203895832577,,,,
susanhosbach,5/30/2014 10:15,0,0,Headed to # ASCO14 celebrating its 50th anniversary this year! Can’t wait to share @mypearpoint with attendees. Stay tuned for updates!,,@mypearpoint,#,4.72381E+17,https://twitter.com/susanhosbach/status/472380818011484160,,,,
ASCO,5/30/2014 10:15,0,0,Visit booth #7004 at # ASCO14 for info on the Survivorship Compendium: your one-stop shop for enhancing survivorship care.,,,#7004 #,4.72381E+17,https://twitter.com/ASCO/status/472380813724901376,,,,
mtmdphd,5/30/2014 10:15,2,1,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnZ3J # ASCO14,,@,# #,4.72381E+17,https://twitter.com/mtmdphd/status/472380781403594753,,,,
michaelmchugh,5/30/2014 10:15,0,3,RT @ UCCancerCenter: Getting excited for # ASCO14 starting today in Chicago. Follow live updates on # cancerresearch and newest breakthroughs.,,@,# #,4.72381E+17,https://twitter.com/michaelmchugh/status/472380715535826944,,,,
JanssenIE,5/30/2014 10:15,3,2,Wonderful day with @ IrishCancerSoc launching Man to Man storybook for men with prostate cancer. Get the book http://bit.ly/1tWDLZP # ASCO14,,@,#,4.72381E+17,https://twitter.com/JanssenIE/status/472380668920754176,,,,
ByJoFagg,5/30/2014 10:14,1,1,Follow our reporters @ JonEPVantage and @ JacobEPVantage for live updates from # ASCO14,,@ @,#,4.72381E+17,https://twitter.com/ByJoFagg/status/472380631075553281,,,,
ConsanoMolly,5/30/2014 10:14,1,1,"A # crowdfunding first? Just pushed a @ Consano project live from 30,000 ft enroute to # ASCO14! https://www.consano.org/projects/47-why-does-cancer-kill-you … cc: @ sloan_kettering",,@ @,# #,4.72381E+17,https://twitter.com/ConsanoMolly/status/472380605267988481,,,,
MartineCarret,5/30/2014 10:14,0,0,Enjeux du congrès @ ASCO qui s'ouvre à Chicago http://goo.gl/xlUBkB # cancer # ASCO14 via @ GustaveRoussy,,@ @,# #,4.72381E+17,https://twitter.com/MartineCarret/status/472380593809149952,,,,
ACInvestorBlog,5/30/2014 10:14,2,1,$ GNBT is on High alert !! Unusual volume.... # ASCO14,,,#,4.72381E+17,https://twitter.com/ACInvestorBlog/status/472380561835950080,,,,
JanssenUS,5/30/2014 10:14,0,0,We are thrilled to be at # ASCO14! Stop by booth17081 to learn more about our latest research and advances in # cancer care,,,# #,4.72381E+17,https://twitter.com/JanssenUS/status/472380543129387008,,,,
alisonwoo,5/30/2014 10:14,0,1,Excited to be @ ASCO!,,@,,4.7238E+17,https://twitter.com/alisonwoo/status/472380410526461952,,,,
lenstarnes,5/30/2014 10:13,1,1,MT @ mtmdphd doc convos abt multiple myeloma on Twtr more than quadrupled 2012 > 2013 http://ow.ly/xh3sU # ASCO14 # hcsm # hcsmeu @ symplur,,@ @,# # #,4.7238E+17,https://twitter.com/lenstarnes/status/472380379882876928,,,,
DrAttai,5/30/2014 10:13,8,6,"+1 MT @ mtmdphd Love the science at # ASCO14 but constantly reminded about Pts watching, waiting for science to translate to better medicine",,@,#,4.7238E+17,https://twitter.com/DrAttai/status/472380189763043328,,,,
PeteStock11,5/30/2014 10:13,0,1,As I mentioned many bios were sells yesterday a day prior to # ASCO14 but watch closely next week for direction with $ QQQ at highs,,,#,4.7238E+17,https://twitter.com/PeteStock11/status/472380171593318400,,,,
LTbioinvestor,5/30/2014 10:12,0,0,no buyers into # ASCO2014 here ... $ CYCC $ OXGN $ ARQL $ GTXI ... and many others ....maybe after it ... MAYBE,,,#,4.7238E+17,https://twitter.com/LTbioinvestor/status/472380024122015744,,,,
CRC_Medical,5/30/2014 10:12,0,0,Can't make it to the American Society of Clinical Oncology # ASCO14 this year? You can still update your # library... http://fb.me/3xuoWpicv,,,# #,4.7238E+17,https://twitter.com/CRC_Medical/status/472380008947007488,,,,
jodyms,5/30/2014 10:12,0,0,Watch for these! @ drattai Tweets from # ASCO14 will start this afternoon # bcsm,,@,# #,4.7238E+17,https://twitter.com/jodyms/status/472379972351717376,,,,
chintykap,5/30/2014 10:11,0,0,@ genentech Immunotherapy / Vaccines for cancer + Epigenetic Chemotherapy # Next50 # ASCO14,,@,# #,4.7238E+17,https://twitter.com/chintykap/status/472379706290216960,,,,
CRC_Medical,5/30/2014 10:11,0,0,Can't make it to American Society of Clinical Oncology # ASCO14 this year? You can still update your library and... http://fb.me/6EkglvlYj,,,#,4.7238E+17,https://twitter.com/CRC_Medical/status/472379674145067009,,,,
jodyms,5/30/2014 10:10,3,0,Yay! @ rsm2800 ... was asked my opinion re top advance of @ ASCO 's 50 yrs. I said penetration of the Internet & pt access to info # ASCO14,,@ @,#,4.7238E+17,https://twitter.com/jodyms/status/472379613994565634,,,,
DrAttai,5/30/2014 10:10,3,3,+1 RT @ rsm2800 Slide from my talk on Monday re social media & clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/LsyixzZ9QL # hcsm,,@,# #,4.7238E+17,https://twitter.com/DrAttai/status/472379592041574401,,,,
DebiopharmNews,5/30/2014 10:10,0,0,"# ASCO14 Phase I-II Debio0932, oral # HSP90 inhibitor, 1st & 2nd line # NSCLC (abstract/poster # TPS2632) Find out more http://ow.ly/x8TXS",,,# # # #,4.7238E+17,https://twitter.com/DebiopharmNews/status/472379551713361920,,,,
GenentechJobs,5/30/2014 10:10,0,1,# HappyFriday. # ASCO14 is celebrating the organization's 50th anniversary during conf. in Chicago. The 5-day event kicks off today!,,,# #,4.7238E+17,https://twitter.com/GenentechJobs/status/472379507823747072,,,,
ASCO,5/30/2014 10:10,4,2,# ASCO14 Tweeters infographic http://bit.ly/TKIMrT Want to follow all? Subscribe to our list http://bit.ly/TKIO2Y # hcsm,,,# #,4.72379E+17,https://twitter.com/ASCO/status/472379494222012417,,,,
MLIWI,5/30/2014 10:10,2,1,"Through medical innovation, we can add years to lives of people with cancer. Join Us. # ASCO14 # MLIWI http://bit.ly/1ktKlV4",,,# #,4.72379E+17,https://twitter.com/MLIWI/status/472379488660385792,,,,
corp_UNC,5/30/2014 10:10,1,0,Popn-based eval of Rx patterns/survival: localized CaP w hi PSA Chen et al @ UNC_Lineberger # pcsm # hsronc # ASCO14 http://ow.ly/xpjN3,,@,# # #,4.72379E+17,https://twitter.com/corp_UNC/status/472379457349910528,,,,
TedOkonCOA,5/30/2014 10:10,0,0,Immune Therapy’s Cancer Promise Creates Research Rush. http://ow.ly/xqGIo Problem is paying for these drugs. # asco14,,,#,4.72379E+17,https://twitter.com/TedOkonCOA/status/472379431307448320,,,,
nolamelanie,5/30/2014 10:10,0,0,@ ASCO Fellows Forum on Breast Cancer just getting started with some of the biggest names in breast cancer today! # brsm # breastcancer # ASCO14,,@,# # #,4.72379E+17,https://twitter.com/nolamelanie/status/472379402802954240,,,,
SkinMelanoma,5/30/2014 10:07,0,0,"Attending # ASCO14? Stop by @Castle_Biosci’s booth #20137 to learn more about DecisionDx-Melanoma, a gene test for Stage1&2 # melanoma pts",,@Castle_Biosci,# #20137 #,4.72379E+17,https://twitter.com/SkinMelanoma/status/472378737321721856,,,,
wearecare,5/30/2014 10:06,0,0,See you today at our CORE @ ASCO meeting!,,@,,4.72378E+17,https://twitter.com/wearecare/status/472378454202417152,,,,
GustaveRoussy,5/30/2014 10:05,6,1,Pour en savoir plus sur les enjeux du grand congrès de l' @ ASCO qui débute aujourd'hui à Chicago : http://bit.ly/RKqTHQ # ASCO14,,@,#,4.72378E+17,https://twitter.com/GustaveRoussy/status/472378301013823489,,,,
Gene_Antibody,5/30/2014 10:05,0,0,Today research has advanced beyond what even Dr. Ehrlich could have imagined. Just imagine the # Next50! # ASCO14 http://ow.ly/xmTRy,,,# #,4.72378E+17,https://twitter.com/Gene_Antibody/status/472378227504476160,,,,
MsShanBo,5/30/2014 10:05,0,2,"Every year @ ASCO is in town, I say I'm going to learn another language. It's been 5 years now and... # conciergeproblems # ASCO14",,@,# #,4.72378E+17,https://twitter.com/MsShanBo/status/472378198316306432,,,,
YSCBuzz,5/30/2014 10:05,0,1,Heading to @ ASCO 50th Annual Meeting in Chicago this weekend? Stop by the YSC booth and say hi!,,@,,4.72378E+17,https://twitter.com/YSCBuzz/status/472378148240117762,,,,
Amtrak,5/30/2014 10:04,0,0,@ mtmdphd Thank you for you kind words. Enjoy your trip to # ASCO14.,,@,#,4.72378E+17,https://twitter.com/Amtrak/status/472378123011383298,,,,
SWOG,5/30/2014 10:04,1,0,"# SWOGonc S1108 results: alisertib in patients w T-cell lymphoma. # ASCO14 poster, Fri 1-4, S405 http://abstracts.asco.org/144/AbstView_144_129433.html …",,,# #,4.72378E+17,https://twitter.com/SWOG/status/472378087737655296,,,,
Emory_R,5/30/2014 10:03,1,0,Immune Therapy’s Cancer Promise Creates Research Rush- # ASCO14 - Bloomberg http://buff.ly/1o5oRNh $ BMY $ MRK $ RHHBY $ AZN,,,#,4.72378E+17,https://twitter.com/Emory_R/status/472377678985953280,,,,
jrgralow,5/30/2014 10:03,0,0,Seems like they started days ago!! Looking forward to the mtg. RT @ drattai: Tweets from # ASCO14 will start this afternoon # bcsm,,@,# #,4.72378E+17,https://twitter.com/jrgralow/status/472377653383946240,,,,
DebiopharmNews,5/30/2014 10:03,0,0,"# ASCO14 Final Phase I Debio 0932, oral # HSP90 inhibitor, # oncology (abstract/poster #2550) Find out more http://ow.ly/x8T1c",,,# # # #2550,4.72378E+17,https://twitter.com/DebiopharmNews/status/472377652008214528,,,,
genection,5/30/2014 10:02,0,0,Come find out about the AMLome at Genection's booth 23108 at # ASCO14,,,#,4.72378E+17,https://twitter.com/genection/status/472377581388693505,,,,
ASCO,5/30/2014 10:02,0,2,Not an ASCO Member? Join at # ASCO14 @Member Services Desk & receive a membership dues credit & thank you gift,,@Member,#,4.72378E+17,https://twitter.com/ASCO/status/472377550820630529,,,,
ASCO,5/30/2014 10:02,2,1,"Exhibits, posters, food court, ASCO Bistro, career fair, & more at # ASCO14 Oncology Professionals Hall: http://bit.ly/1pjPkKN",,,#,4.72378E+17,https://twitter.com/ASCO/status/472377507199864832,,,,
DrAttai,5/30/2014 10:02,0,0,"@ Brandie185 @ double_whammied sorry late to the convo ladies, got caught up reviewing # ASCO14 abstracts last night - hope you are both ok",,@ @,#,4.72377E+17,https://twitter.com/DrAttai/status/472377389108830209,,,,
mtmdphd,5/30/2014 10:01,0,1,...physician conversations about multiple myeloma on Twitter more than quadrupled b/w 2012 & 2013 http://ow.ly/xh3sU # mmsm # ASCO14,,,# #,4.72377E+17,https://twitter.com/mtmdphd/status/472377330221187072,,,,
CureMelanoma,5/30/2014 10:01,0,1,RT @ rschilsky: Today is the first day of @ ASCO’s 50th Annual Meeting “Science & Society” Follow & use the tag # ASCO14,,@ @,#,4.72377E+17,https://twitter.com/CureMelanoma/status/472377324110114816,,,,
AstraZeneca,5/30/2014 10:01,9,4,Looking forward to demonstrating the exciting science driving our pipeline at # ASCO2014 http://ow.ly/xr0A8 pic.twitter.com/1ucqyHpkc2,,,#,4.72377E+17,https://twitter.com/AstraZeneca/status/472377288890519552,,,,
Novartis,5/30/2014 10:01,2,4,Data in ALK+ NSCLC to be presented at # ASCO14: poster session on 5/31; oral presentation on 6/2. Details to follow,,,#,4.72377E+17,https://twitter.com/Novartis/status/472377257781374976,,,,
bmsnews,5/30/2014 10:01,4,4,It’s officially # ASCO14. Follow us on Twitter as we present new data from our # ImmunoOncology pipeline.,,,# #,4.72377E+17,https://twitter.com/bmsnews/status/472377241155149824,,,,
myPathMelanoma,5/30/2014 10:01,0,0,Want to be the first to know about Myriad myPath # Melanoma news? Sign up for our e-mail list: http://bit.ly/myPathinfo # ASCO14,,,# #,4.72377E+17,https://twitter.com/myPathMelanoma/status/472377137643520000,,,,
TGeorgeMD,5/30/2014 10:00,1,0,MT @ fischmd: overview of @ theNCI National Clinical Trials Network (NCTN) http://ow.ly/xqWAC # ASCO14 @ NRGOnc @ SWOG @ Alliance_org @ EAOnc,,@ @ @ @ @ @,#,4.72377E+17,https://twitter.com/TGeorgeMD/status/472377109047169024,,,,
Lymphoma_Doc,5/30/2014 10:00,0,0,"Should I wear @googleglass to the # ASCO14 poster hall for easy QR code use and poster photos, or too much?",,@googleglass,#,4.72377E+17,https://twitter.com/Lymphoma_Doc/status/472376949575528449,,,,
NCIMedia,5/30/2014 10:00,1,0,Interested in or attending # ASCO14? Here is a list of sessions featuring NCI staff that will take place today: http://1.usa.gov/1prnAE2,,,#,4.72377E+17,https://twitter.com/NCIMedia/status/472376910589460480,,,,
DrAttai,5/30/2014 9:59,3,3,Tweets from # ASCO14 will start this afternoon # bcsm,,,# #,4.72377E+17,https://twitter.com/DrAttai/status/472376682976788481,,,,
UdderlySmooth,5/30/2014 9:58,0,0,Setup for # asco14 Expecting to see cancer breakthroughs this week http://ift.tt/1prnkoE pic.twitter.com/Cfgqid2vQ0,,,#,4.72377E+17,https://twitter.com/UdderlySmooth/status/472376631118798848,,,,
jrgralow,5/30/2014 9:58,0,0,MT @IntMedNews: Top picks for # ASCO14 http://www.oncologypractice.com/news/specialty-meetings-conference-news/asco-annual-meeting.html …,,@IntMedNews,#,4.72376E+17,https://twitter.com/jrgralow/status/472376494178959361,,,,
ECMC_UK,5/30/2014 9:57,0,0,Hazel Jones arrived at # ASCO14 looking for new partners to join the ECMC Combinations Alliance,,,#,4.72376E+17,https://twitter.com/ECMC_UK/status/472376316352663552,,,,
IQVIA_Biotech,5/30/2014 9:56,0,0,"We’re proud to join more than 25,000 oncology professionals at # ASCO14. Be sure to stop by booth 24097 to say hi!",,,#,4.72376E+17,https://twitter.com/IQVIA_Biotech/status/472376009875259392,,,,
jrgralow,5/30/2014 9:55,10,3,# ASCO14: Dr. Hope Rugo gives her top picks in breast cancer research http://ow.ly/xr2Zp # bcsm,,,# #,4.72376E+17,https://twitter.com/jrgralow/status/472375724981362688,,,,
harrisonandstar,5/30/2014 9:55,0,0,50th Annual ASCO Meeting begins today! Check out meeting highlights and what is to come: http://ow.ly/wFppj # ASCO14,,,#,4.72376E+17,https://twitter.com/harrisonandstar/status/472375709034631168,,,,
dhovekamp42,5/30/2014 9:55,0,0,# ASCO14 Biotechnologie: Neue Bausteine im Kampf gegen Krebs 30.05.2014 | Nachricht | http://finanzen.net http://www.finanzen.net/t/3593288,,,#,4.72376E+17,https://twitter.com/dhovekamp42/status/472375663681216512,,,,
SarahCannonDocs,5/30/2014 9:54,0,0,Want to know about featured abstracts @ # ASCO14? Follow our @ SarahCannonDocs,,@ @,#,4.72376E+17,https://twitter.com/SarahCannonDocs/status/472375508387508225,,,,
DiplomatRx,5/30/2014 9:54,0,0,Ready to kick off # ASCO14 – stop by to learn about our oncology medication management programs!,,,#,4.72375E+17,https://twitter.com/DiplomatRx/status/472375412648321024,,,,
RS_Flinn,5/30/2014 9:51,0,0,About to take off for # ASCO14 and who do I see on the jetway? @ scooperpr - we're on the PR express to chi-town!,,@,#,4.72375E+17,https://twitter.com/RS_Flinn/status/472374754637131776,,,,
SamBrownInc,5/30/2014 9:51,0,0,MT @ FiercePharma: Top-read on Fierce # Vaccines Thurs: # ASCO14 preview: What's the outlook for cancer vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29 …,,@,# #,4.72375E+17,https://twitter.com/SamBrownInc/status/472374667618320385,,,,
subatomicdoc,5/30/2014 9:51,0,1,@ShewithLynch @ NBTStweets @ lbjc13 @ AmbryGenetics Excellent! I'll come by Sunday or Monday. Looking forward to it! # ASCO14,,@ShewithLynch @ @ @,#,4.72375E+17,https://twitter.com/subatomicdoc/status/472374634198077440,,,,
Y_Prime,5/30/2014 9:50,0,0,We're at # ASCO2014 right now in # Chicago!!! Come say hi at booth 21157. # oncology,,,# # #,4.72375E+17,https://twitter.com/Y_Prime/status/472374544326733825,,,,
QIAGENscience,5/30/2014 9:50,2,0,Arrived in sunny Chicago and preparing for a busy and productive # ASCO14.,,,#,4.72374E+17,https://twitter.com/QIAGENscience/status/472374463867392000,,,,
mtmdphd,5/30/2014 9:50,8,5,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.72374E+17,https://twitter.com/mtmdphd/status/472374406963269634,,,,
mtmdphd,5/30/2014 9:49,0,0,@ Amtrak Nice social media presence and demo of customer service! I'm heading to # ASCO14 to talk about social media. Love train to C-town.,,@,#,4.72374E+17,https://twitter.com/mtmdphd/status/472374261488033792,,,,
xavigranda,5/30/2014 9:49,0,0,"Buenos días desde Chicago, camino de la sesión inaugural de @ ASCO",,@,,4.72374E+17,https://twitter.com/xavigranda/status/472374156978188288,,,,
WilliamDale_MD,5/30/2014 9:49,3,1,Tweeting for next 3-4 days from # ASCO14 on # gerionc # geriatrics and # oncology topics. http://www.asco.org/,,,# # # #,4.72374E+17,https://twitter.com/WilliamDale_MD/status/472374132538351617,,,,
JamesPPinkerton,5/30/2014 9:48,0,0,"Agenda-Setting Plan Issued to Accelerate Cancer Research, Biomedical Discovery http://prn.to/1nAcNYs # ASCO14",,,#,4.72374E+17,https://twitter.com/JamesPPinkerton/status/472374071095599104,,,,
SamBrownInc,5/30/2014 9:46,0,0,Heading to # ASCO14. Will you be there?,,,#,4.72373E+17,https://twitter.com/SamBrownInc/status/472373469259526144,,,,
jrgralow,5/30/2014 9:46,8,4,"Nice review MT @ fischmd: Overview of NCI National Clinical Trials Network (NCTN), newly posted via @ theNCI http://ow.ly/xr1rm # ASCO14",,@ @,#,4.72373E+17,https://twitter.com/jrgralow/status/472373427085803522,,,,
corp_UNC,5/30/2014 9:45,1,0,"RCT result adopt'n: novel inst'nal # quality metric? SLNB and early-stage breast ca Bainbridge,S.Wheeler et al # ASCO14 http://ow.ly/xpgpa",,,# #,4.72373E+17,https://twitter.com/corp_UNC/status/472373254024622080,,,,
myriadgenetics,5/30/2014 9:45,0,0,Data support efficacy of Myriad’s HRD and BRACAnalysis CDx to predict treatment response in # cancer patients. # ASCO14 http://bit.ly/1tWn80k,,,# #,4.72373E+17,https://twitter.com/myriadgenetics/status/472373116249731072,,,,
kylewdennis,5/30/2014 9:44,2,1,$ PGNX also has poster presentation this weekend at @ ASCO. Nice exposure for company's data,,@,,4.72373E+17,https://twitter.com/kylewdennis/status/472373052777304065,,,,
SarahCannon_UK,5/30/2014 9:44,0,0,RT @ SarahCannonDocs: Are you attending # ASCO14? Come visit us at booth #2063 and learn about SCRI... pic.twitter.com/HD50lu5qir,,@,# #2063,4.72373E+17,https://twitter.com/SarahCannon_UK/status/472372886435409921,,,,
jrgralow,5/30/2014 9:43,7,2,Intersecting Science and Value Key Theme Throughout Program # ASCO14 Annual Meeting http://am.asco.org/intersecting-science-and-value-key-theme-throughout-program#.U4iK9ADGbiU.twitter …,,,# #,4.72373E+17,https://twitter.com/jrgralow/status/472372760539176960,,,,
cathcerisey,5/30/2014 9:43,0,0,:) @ subatomicdoc: Current use and attitudes toward IT use in health care among cancer patients http://bit.ly/1tVmUGM # ASCO14,,@,#,4.72373E+17,https://twitter.com/cathcerisey/status/472372752285200385,,,,
KUhlendorf,5/30/2014 9:42,1,1,Reagan National is joining the # ASCO14 buzz. pic.twitter.com/UzWYMeMHVU,,,#,4.72372E+17,https://twitter.com/KUhlendorf/status/472372366723411969,,,,
DaveDolton,5/30/2014 9:41,0,0,MT @ StupidCancerCEO Hello # chicago! @McCormick Place http://instagram.com/p/on10nKM6Ix/ # ASCO14 @ jodyms wish I was there!,,@ @McCormick @,# #,4.72372E+17,https://twitter.com/DaveDolton/status/472372307634429953,,,,
JeffreyMOtto,5/30/2014 9:41,1,0,Good morning # chicago! # ASCO14 opens today. Looking fwd to a great meeting. pic.twitter.com/pfZjI3Lcj0,,,# #,4.72372E+17,https://twitter.com/JeffreyMOtto/status/472372220581265408,,,,
hmhyltonpac,5/30/2014 9:40,3,1,Cancer patients are more than 2.5 times more likely to struggle with bankruptcy-Dr. Leah Zullig at # ASCO14,,,#,4.72372E+17,https://twitter.com/hmhyltonpac/status/472372066990030848,,,,
CancerDotNet,5/30/2014 9:40,0,0,Advocate Lounge (S402) opens today at 12:30pm CT! - A place for advocates to relax before the many # ASCO14 sessions,,,#,4.72372E+17,https://twitter.com/CancerDotNet/status/472371930289672192,,,,
MaurerStats,5/30/2014 9:40,0,0,"Looking forward to it! MT @ DrMarkham If you're interested in # gyncsm or # lymsm at # ASCO14, stay tuned over next few days!",,@,# # #,4.72372E+17,https://twitter.com/MaurerStats/status/472371912270942208,,,,
jodyms,5/30/2014 9:39,0,0,@ StupidCancerCEO don't forget to add # asco14. One day over 40 and your memory is already failing.....:),,@,#,4.72372E+17,https://twitter.com/jodyms/status/472371742590402560,,,,
myCME,5/30/2014 9:39,0,0,RT @ jrgralow: ASCO preview: What's the outlook for cancer # vaccines? # ASCO14 http://ow.ly/3l9WwL # oncology,,@,# # #,4.72372E+17,https://twitter.com/myCME/status/472371680254631937,,,,
jerryschranz,5/30/2014 9:38,0,0,@ 3NT would love to connect you with expert sources @ # ASCO14 insight in the area of cervical cancer in particular,,@ @,#,4.72372E+17,https://twitter.com/jerryschranz/status/472371579578777600,,,,
charlesornstein,5/30/2014 9:38,2,2,Just in time for # ASCO14 Expensive Drugs Forcing Cancer Doctors to Weigh Price http://bloom.bg/1jzvRhd via @BloombergNews,,@BloombergNews,#,4.72372E+17,https://twitter.com/charlesornstein/status/472371531507851266,,,,
DrMarkham,5/30/2014 9:37,4,7,"If you're interested in # gyncsm or # lymsm (or anything else I find worth sharing) at # ASCO14, stay tuned over next few days!",,,# # #,4.72371E+17,https://twitter.com/DrMarkham/status/472371304780541953,,,,
harriseve,5/30/2014 9:35,1,0,Podcast by @ CancerDotNet 4 patient advocates abt # ASCO14 Highlights http://www.cancer.net/2014-asco-annual-meeting-highlights-may-14-2014-webcast-cancernet-editor-chief-robert-miller-md-facp … via @ rsm2800,,@ @,#,4.72371E+17,https://twitter.com/harriseve/status/472370722099445760,,,,
LungCaNetwork,5/30/2014 9:35,1,0,CRAB CTC members will be at # ASCO14,,,#,4.72371E+17,https://twitter.com/LungCaNetwork/status/472370627853434880,,,,
SanofiUS,5/30/2014 9:35,0,0,"RT @ ASCO Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o5MhSS",,@,#,4.72371E+17,https://twitter.com/SanofiUS/status/472370608261840896,,,,
jrgralow,5/30/2014 9:34,4,1,Results From Trials Of New Immunotherapies To Be Released # ASCO14 http://www.reuters.com/article/2014/05/29/us-health-cancer-astrazeneca-idUSKBN0E91S320140529 …,,,#,4.72371E+17,https://twitter.com/jrgralow/status/472370504385314817,,,,
knwachter,5/30/2014 9:34,0,0,RT @ jrgralow: ASCO preview: What's the outlook for cancer vaccines? # ASCO14 http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4iIit0BRNg.twitter …,,@,# #,4.7237E+17,https://twitter.com/knwachter/status/472370469031931904,,,,
jrgralow,5/30/2014 9:33,3,0,ASCO preview: What's the outlook for cancer vaccines? # ASCO14 http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4iIit0BRNg.twitter …,,,# #,4.7237E+17,https://twitter.com/jrgralow/status/472370192526229504,,,,
janinegug,5/30/2014 9:32,0,2,Looking forward to representing @ LivingBeyondBC at # ASCO14 but sad 2 be away from my 10 mo old for 4 days! # mommyIsMakingItWork!,,@,# #,4.7237E+17,https://twitter.com/janinegug/status/472370015191465984,,,,
jrgralow,5/30/2014 9:32,2,2,"ASCO: 50 Years of Progress, More to Come # ASCO14 http://www.medpagetoday.com/MeetingCoverage/ASCO/46049 …",,,#,4.7237E+17,https://twitter.com/jrgralow/status/472369943074193410,,,,
ASCO,5/30/2014 9:31,3,0,How do science and value intersect in the # ASCO14 program? Q&A w/Cancer Ed Cmte Chairs: http://bit.ly/1gALudr,,,#,4.7237E+17,https://twitter.com/ASCO/status/472369682520227840,,,,
Novartis,5/30/2014 9:31,3,2,# ASCO14 begins today. Learn more about # Novartis abstracts in various types of # cancer http://bit.ly/1n4oXWP,,,# # #,4.7237E+17,https://twitter.com/Novartis/status/472369652098932738,,,,
NannetteSC,5/30/2014 9:31,0,1,"Love, love, love the # socialmedia guidance for # ASCO14 - way to help people engage! Kudos to the organizers! http://ow.ly/xqMLk",,,# #,4.7237E+17,https://twitter.com/NannetteSC/status/472369638098341888,,,,
AbsolutelyTours,5/30/2014 9:30,0,0,Welcome # ASCO14 attendees & exhibitors! You're invited to a Segway Tour of # Chicago - bring show badge for $10 off! http://ow.ly/xm2iJ,,,# #,4.7237E+17,https://twitter.com/AbsolutelyTours/status/472369574655311872,,,,
OphiraG,5/30/2014 9:30,0,1,@ IanJohnPereira great! Please tweet away :)! Off 2 @ ASCO for fun & frolick- not. But yay 2 @ AORTIC_AFRICA meetings! @ NCIGlobalHealth,,@ @ @ @,,4.72369E+17,https://twitter.com/OphiraG/status/472369498670899200,,,,
LivingBeyondBC,5/30/2014 9:30,1,0,We are headed to # ASCO14 to learn the latest in # BreastCancer. Follow our updates through June 3!,,,# #,4.72369E+17,https://twitter.com/LivingBeyondBC/status/472369484963917824,,,,
Asuragen,5/30/2014 9:30,0,0,We're gearing up for # ASCO14! Visit us at booth #24089 to learn more about our best in class clinical testing solutions. @ ASCO,,@,# #24089,4.72369E+17,https://twitter.com/Asuragen/status/472369464357298176,,,,
SanofiUS,5/30/2014 9:30,0,0,"Hello # ASCO14! If you're attending the conference, stop by our Sanofi Oncology booth 7047.",,,#,4.72369E+17,https://twitter.com/SanofiUS/status/472369378680635393,,,,
Curiolog,5/30/2014 9:29,0,0,"To all european attending the # ASCO14 not knowing how to use their jetlaggy nights in Chicago,use the hashtag # ASCOjetlag to join and enjoy!",,,# #,4.72369E+17,https://twitter.com/Curiolog/status/472369198292017153,,,,
MDEdgeTweets,5/30/2014 9:28,1,0,Check out our coverage of the American Society of Clinical Oncology (ASCO) annual meeting in Chicago # ASCO14 # cancer http://www.oncologypractice.com/news/specialty-meetings-conference-news/asco-annual-meeting.html …,,,# #,4.72369E+17,https://twitter.com/MDEdgeTweets/status/472368839900942337,,,,
DrBobGoldberg,5/30/2014 9:27,0,0,@ megtirrell @ RobertLangreth the bad Pharma-drug cost meme plays into health plan redlining of dying patients. # ASCO14,,@ @,#,4.72369E+17,https://twitter.com/DrBobGoldberg/status/472368771328651264,,,,
YaleCancer,5/30/2014 9:27,1,0,Dr. Dan Petrylak discusses role of chemotherapy in prostate cancer @ysm # asco14 @ YNHH http://www.cancernetwork.com/asco-2014-prostate-cancer/asco-role-chemotherapy-and-novel-targeted-agents-prostate-cancer …,,@ysm @,#,4.72369E+17,https://twitter.com/YaleCancer/status/472368701497290754,,,,
NBCCStopBC,5/30/2014 9:27,1,0,"# ASCO14 begins today. Annette Bar-Cohen, ( @ AnatBarC) Executive Director for NBCC Advocacy Training, is there now! # BCD2020 # BCSM",,@,# # #,4.72369E+17,https://twitter.com/NBCCStopBC/status/472368592936509440,,,,
CRC_Medical,5/30/2014 9:26,0,0,@ jrgralow Hi Julie! Stop by Booth #23128 to enter our # giveaway & update your library # ASCO14 - mention this post for an extra discount :),,@,#23128 # #,4.72368E+17,https://twitter.com/CRC_Medical/status/472368370764238848,,,,
FORMAInc,5/30/2014 9:26,0,0,"Today is opening day for ASCO # ASCO14, the most comprehensive # oncology conference. Follow @ ASCO to keep up on the latest advances.",,@,# #,4.72368E+17,https://twitter.com/FORMAInc/status/472368352107560961,,,,
CME_Scout,5/30/2014 9:25,0,0,Big changes ahead for cancer clinical trials? NCI has reorganized how trials are organized and administered http://goo.gl/VYYnbw # ASCO14,,,#,4.72368E+17,https://twitter.com/CME_Scout/status/472368295342272513,,,,
TheSamfund,5/30/2014 9:25,0,2,"More than 25,000 cancer professionals gathering to start # ASCO2014 today in Chicago...look for # ayacsm for YA research news and updates!",,,# #,4.72368E+17,https://twitter.com/TheSamfund/status/472368291629903873,,,,
CRC_Medical,5/30/2014 9:25,0,0,@ RamalingamMD Hi Suresh! Stop by Booth #23128 to enter our # giveaway & update your library # ASCO14 - mention this post for an extra discount,,@,#23128 # #,4.72368E+17,https://twitter.com/CRC_Medical/status/472368181051686912,,,,
mtmdphd,5/30/2014 9:25,0,0,"# ASCO14 Annual Meeting Tips - Abdul-Rahman Jazieh, MD, MPH ( @ jaziehoncology ) http://ow.ly/xpZq2",,@,#,4.72368E+17,https://twitter.com/mtmdphd/status/472368104987979777,,,,
MRCCTU,5/30/2014 9:23,0,0,"ICON8 poster at # ASCO14 8.00-11.45 am, Gynaecological Cancer, abstract No.TPS5611 (129128), S Hall A2; Board 393A http://bit.ly/SXMWff",,,#,4.72368E+17,https://twitter.com/MRCCTU/status/472367591546437633,,,,
DrBobGoldberg,5/30/2014 9:23,0,0,@ megtirrell It's because health plans r 'redlining' HIV and cancer patients .. Hope u cover that @ ASCO !! http://business.gotnewswire.com/news/4-insurers-accused-of-bias-against-hiv-patients …,,@ @,,4.72368E+17,https://twitter.com/DrBobGoldberg/status/472367588929200128,,,,
fischmd,5/30/2014 9:21,14,4,"An extensive overview of the NCI National Clinical Trials Network (NCTN), newly posted via @ theNCI http://ow.ly/xqWAC # ASCO14",,@,#,4.72367E+17,https://twitter.com/fischmd/status/472367151710744577,,,,
jdflaysakier,5/30/2014 9:20,0,3,"Bon c'est pas le tout, faut aller bosser maintenant. # ASCO14 pic.twitter.com/vGkAMCblCh",,,#,4.72367E+17,https://twitter.com/jdflaysakier/status/472367025739030528,,,,
MMGHealth,5/30/2014 9:20,0,0,Connect with VP Helen West at # ASCO14 via hwest@mmgct.com! # oncology # innovation # mhealth # epharma,,@mmgct,# # # # #,4.72367E+17,https://twitter.com/MMGHealth/status/472366963205754880,,,,
boehringerus,5/30/2014 9:20,1,1,"Today is the first day of # ASCO14, the largest # oncology data conference of the year. Follow @ ASCO to learn more.",,@,# #,4.72367E+17,https://twitter.com/boehringerus/status/472366929332936704,,,,
MMGHealth,5/30/2014 9:19,0,1,Headed to # ASCO14! See you there? Connect with VP Helen West for inside info on # patientsevent2014 winner Custom Conversations. # innovation,,,# # #,4.72367E+17,https://twitter.com/MMGHealth/status/472366619008589825,,,,
cancerassassin1,5/30/2014 9:17,0,0,Lifelong & proactive learning: key to # cancer care # oncology. Life Beyond the Cancer Clinic http://nyti.ms/1mvhuO5 . @ MikkaelSekeres # ASCO14,,@,# # #,4.72366E+17,https://twitter.com/cancerassassin1/status/472366140514004992,,,,
CRC_Medical,5/30/2014 9:17,0,0,@ DrAnasYounes Hi Anas! Update your # medical bookshelf with us- Use promo EMN13 & Save 20% on # oncology # books http://ow.ly/xqWfl # ASCO14,,@,# # # #,4.72366E+17,https://twitter.com/CRC_Medical/status/472366130657783808,,,,
rschilsky,5/30/2014 9:16,3,1,# ASCO14 reviews progress of last 50 years and looks to the future. http://www.medpagetoday.com/MeetingCoverage/ASCO/46049 …,,,#,4.72366E+17,https://twitter.com/rschilsky/status/472365929553469440,,,,
cancerassassin1,5/30/2014 9:16,0,0,@ MikkaelSekeres- enjoyed your article in the @ nytimes. You are correct about wealth of # cancer info = reason why I look forward to # ASCO14,,@ @,# #,4.72366E+17,https://twitter.com/cancerassassin1/status/472365858291867649,,,,
TheSamfund,5/30/2014 9:15,1,0,Wish we were going to be at # asco2014... Look for @ mcbennett6 rocking his # TeamSAMFund shirt! # cancerisntfree,,@,# # #,4.72366E+17,https://twitter.com/TheSamfund/status/472365778054836224,,,,
ASCO,5/30/2014 9:15,0,1,"See what # ASCO14 Concierge Services has to offer - tech support, travel asst, restaurant reservations & more: http://bit.ly/1k364Tc",,,#,4.72366E+17,https://twitter.com/ASCO/status/472365707012112385,,,,
VaradhKrish,5/30/2014 9:14,0,0," @ rsm2800: A slide from my talk on Monday re social media & clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/KmfOxFmzHG"" +1""",,@,#,4.72365E+17,https://twitter.com/VaradhKrish/status/472365456053907457,,,,
rschilsky,5/30/2014 9:14,22,4,Today is the first day of @ ASCO’s 50th Annual Meeting “Science & Society” Follow & use the tag # ASCO14,,@,#,4.72365E+17,https://twitter.com/rschilsky/status/472365331919687680,,,,
CRC_Medical,5/30/2014 9:12,0,0,It’s officially # ASCO14. Follow us on Twitter as we present new # books and discounts from our # medicine bookshelf.,,,# # #,4.72365E+17,https://twitter.com/CRC_Medical/status/472365006760452096,,,,
GenentechJobs,5/30/2014 9:12,0,0,@ ASCO thanks for these great online resource tools. The conf. mobile app and online resources help attendees better navigate # ASCO14.,,@,#,4.72365E+17,https://twitter.com/GenentechJobs/status/472364891672555520,,,,
hmhyltonpac,5/30/2014 9:12,0,0,Interesting presentation by Dr. Brian Chapin from MDA on robotic surgery cost and outcomes during pre-AM seminar at # ASCO14,,,#,4.72365E+17,https://twitter.com/hmhyltonpac/status/472364868176478208,,,,
ArcagyGineco,5/30/2014 9:12,0,0,"Résultats de l’étude olaparib + cediranib dans les cancers de l’ovaire en rechute sensible, samedi 31 mai à l’ # ASCO14 session cancer gynéco",,,#,4.72365E+17,https://twitter.com/ArcagyGineco/status/472364836824043520,,,,
rbsalute,5/30/2014 9:11,0,0,"# ASCO14 Al via il 50° meeting Asco, sotto il segno dell’immunoterapia http://www.doctor33.it/al-via-il-meeting-asco-sotto-il-segno-dell-immunoterapia/clinica/news-51432.html?xrtd=SYLYRYCCSLYTXXPASRCTYY#.U4iDb6JdsVs.twitter …",,,# #,4.72365E+17,https://twitter.com/rbsalute/status/472364667977748480,,,,
LGG1,5/30/2014 9:10,0,0,Lots of value discussions happening at # ASCO14: The Complexity of Value: Weighing Perspectives of Various Stakeholders | ASCO Annual...,,,#,4.72364E+17,https://twitter.com/LGG1/status/472364463572918272,,,,
SHAREing,5/30/2014 9:10,0,0,"Webinar w/ Medical oncologist Dr. Dizon on # ASCO14 news relating to # metastatic disease: Th, 6/12, 12:30-1:30 PM ET http://ow.ly/xm0P3",,,# #,4.72364E+17,https://twitter.com/SHAREing/status/472364385567272960,,,,
genentech,5/30/2014 9:10,0,1,We’ve heard lots of great predictions for the # Next50 yrs of cancer care. Tweet us yours! # ASCO14,,,# #,4.72364E+17,https://twitter.com/genentech/status/472364384514482176,,,,
fwpharma,5/30/2014 9:10,3,1,"As # ASCO14 kicks off, see the questions asked in our Physician Views poll ahead of the meeting http://bit.ly/1rjdoiP pic.twitter.com/aaS2GTgaNU",,,#,4.72364E+17,https://twitter.com/fwpharma/status/472364382186639360,,,,
bioclinica,5/30/2014 9:10,0,0,RT @ ASCO Expand your network at # ASCO14 w/ Message & Networking Center: Search for colleagues & make new connections http://am.asco.org/arc,,@,#,4.72364E+17,https://twitter.com/bioclinica/status/472364360288190464,,,,
knwachter,5/30/2014 9:09,0,0,RT @ rsm2800: A slide from my talk on Monday re social media & clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/TjbiWj40GE,,@,#,4.72364E+17,https://twitter.com/knwachter/status/472364253866098688,,,,
knwachter,5/30/2014 9:08,0,0,RT @ RamalingamMD: Very Disappointing results with Metmab in lung cancer. Is it the wrong drug or wrong target? Upcoming discuss. @ # ASCO14 .,,@ @,#,4.72364E+17,https://twitter.com/knwachter/status/472363905243947008,,,,
rsm2800,5/30/2014 9:07,28,14,A slide from my talk on Monday re social media & clinical trials. Never neglect pt privacy # ASCO14 pic.twitter.com/X0XjRDEM8f,,,#,4.72364E+17,https://twitter.com/rsm2800/status/472363652473835520,,,,
knwachter,5/30/2014 9:06,0,0,RT @ theNCI: Today NCI staff will be involved in # ASCO14 sessions on grant writing & developmental therapeutics. More http://1.usa.gov/1mPMDgS,,@,#,4.72363E+17,https://twitter.com/knwachter/status/472363473616502784,,,,
ConsanoScott,5/30/2014 9:06,0,2,Can't wait! “ @ ConsanoMolly: # ASCO14 here we come! Come find me and @ ConsanoScott at the @ Consano table! pic.twitter.com/PmXh1vwwtk”,,@ @ @,#,4.72363E+17,https://twitter.com/ConsanoScott/status/472363396327698434,,,,
BIOARRAYMDx,5/30/2014 9:05,0,0,"The theme of this year's ASCO meeting is Science and Society: The Next 50 Years."" # ASCO2014 http://www.medscape.com/viewarticle/825630 …""",,,#,4.72363E+17,https://twitter.com/BIOARRAYMDx/status/472363249606721537,,,,
UCCancerCenter,5/30/2014 9:05,3,2,Getting excited for # ASCO14 starting today in Chicago as best & brightest in # cancerresearch share newest breakthroughs. Follow live updates,,,# #,4.72363E+17,https://twitter.com/UCCancerCenter/status/472363213388906498,,,,
genentech,5/30/2014 9:05,8,2,We’re making predictions for # Next50 years of cancer care. RT w/ your prediction! # ASCO14,,,# #,4.72363E+17,https://twitter.com/genentech/status/472363187703414784,,,,
ConsanoMolly,5/30/2014 9:05,0,1,# ASCO14 here we come! Come find me and @ ConsanoScott at the @ Consano table!pic.twitter.com/bBE5Sxl0TQ,,@ @,#,4.72363E+17,https://twitter.com/ConsanoMolly/status/472363181247963137,,,,
myPathMelanoma,5/30/2014 9:05,0,0,Visit us! # ASCO14 Poster Highlights Sat. May 31st 8am-11:45am Myriad myPath # Melanoma Influence of # Gene Signature on Melanocytic # Tumors,,,# # # #,4.72363E+17,https://twitter.com/myPathMelanoma/status/472363044513673217,,,,
knwachter,5/30/2014 9:04,0,0,RT @ wallyjc: Exciting discussions this afternoon on value in cancer care led by Neal Meropol # ASCO14 @ WinshipAtEmory,,@ @,#,4.72363E+17,https://twitter.com/knwachter/status/472362964289601536,,,,
knwachter,5/30/2014 9:04,0,0,RT @ WinshipAtEmory: # ASCO14 kicks off today! Follow our docs: @ wallyjc @ ramalingamMD @ SagarLonialMD @ virajmaster,,@ @ @ @ @,#,4.72363E+17,https://twitter.com/knwachter/status/472362902775922688,,,,
giasison,5/30/2014 9:04,0,0,"+1/RT @ ASCO: Streamline, organize, & simplify your # ASCO14 experience with online resources: http://bit.ly/1kLblit",,@,#,4.72363E+17,https://twitter.com/giasison/status/472362854411030528,,,,
BIOARRAYMDx,5/30/2014 9:04,0,0,Reflection at ASCO in celebration to its 50th anniversary! # ASCO2014,,,#,4.72363E+17,https://twitter.com/BIOARRAYMDx/status/472362820437159936,,,,
BIOARRAYMDx,5/30/2014 9:02,1,1,ASCO annual meeting promises important updates for molecular diagnostics for personalized treatments # ASCO2014,,,#,4.72362E+17,https://twitter.com/BIOARRAYMDx/status/472362409902895104,,,,
UdderlySmooth,5/30/2014 9:02,0,0,@ miriama59 Going to # ASCO14 Enjoy your weekend!,,@,#,4.72362E+17,https://twitter.com/UdderlySmooth/status/472362408397139969,,,,
GuardantHealth,5/30/2014 9:02,2,5,Attending . @ ASCO? We'll be there at booth #19156. # ASCO14 # GuardantHealth,,@,#19156 # #,4.72362E+17,https://twitter.com/GuardantHealth/status/472362366332854272,,,,
ASCO,5/30/2014 9:02,9,4,"Streamline, organize, & simplify your # ASCO14 experience with online resources: http://bit.ly/1kLblit",,,#,4.72362E+17,https://twitter.com/ASCO/status/472362308363358208,,,,
ClinMedJournals,5/30/2014 9:01,0,0,Get a # SupportiveCare in Cancer issue at @ ASCO! Visit MASCC booth 4053 @ CancerCareMASCC to pick one up.,,@ @,#,4.72362E+17,https://twitter.com/ClinMedJournals/status/472362268873994241,,,,
Novartis,5/30/2014 9:01,4,2,Headed to # ASCO14? Learn more about # NETCancer by checking out the # Novartis booth.,,,# # #,4.72362E+17,https://twitter.com/Novartis/status/472362262607724544,,,,
CRC_Medical,5/30/2014 9:01,0,2,# ASCO2014 Attendees! Visit us at Booth #23128 today for special show prices on # medicine # books. Mention this post for an extra discount!,,,# #23128 # #,4.72362E+17,https://twitter.com/CRC_Medical/status/472362233209831424,,,,
bradloncar,5/30/2014 9:01,0,3,On my way to chi-town. Looking forward to seeing many of you later this afternoon! # ASCO14,,,#,4.72362E+17,https://twitter.com/bradloncar/status/472362081262776320,,,,
cardinalhealth,5/30/2014 9:00,0,0,RT if you’re heading to Chicago for the @ ASCO Annual Meeting. # ASCO14,,@,#,4.72362E+17,https://twitter.com/cardinalhealth/status/472361834826047489,,,,
Medscape,5/30/2014 9:00,1,1,Attending # ASCO14 tomorrow? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.72362E+17,https://twitter.com/Medscape/status/472361808141881344,,,,
MedscapeOnc,5/30/2014 9:00,0,0,Attending # ASCO14 tomorrow? Stop by booth #14153 to chat with us and grab a cappuccino.,,,# #14153,4.72362E+17,https://twitter.com/MedscapeOnc/status/472361794791415809,,,,
NatRevClinOncol,5/30/2014 8:59,0,0,"Meet our chief editor, Lisa Hutchinson at # ASCO2014 !",,,#,4.72362E+17,https://twitter.com/NatRevClinOncol/status/472361778903797761,,,,
amandamicklus,5/30/2014 8:58,3,1,"Strategic Transactions page highlights immune ckpt deals, links to @ BioMedTracker's # ASCO2014 preview, drug records http://bit.ly/SXOZ37",,@,#,4.72361E+17,https://twitter.com/amandamicklus/status/472361420919939072,,,,
rsm2800,5/30/2014 8:58,13,4,No more does a convention ctr have walls MT @ chemobrainfog: Nowhere is Twitter more powerful. # ASCO14 can be followed by global audience,,@,#,4.72361E+17,https://twitter.com/rsm2800/status/472361303240351744,,,,
FierceBiotech,5/30/2014 8:57,4,1,Tune in Sunday at 2:30pm ET for the 2nd # FierceASCO chat with @DamianFierce and @ MarkSchoenebaum. More here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … # ASCO14,,@DamianFierce @,# #,4.72361E+17,https://twitter.com/FierceBiotech/status/472361182121443328,,,,
CaitlinDemchuk,5/30/2014 8:56,0,0,Wheels up! Chicago-bound for # ASCO14.,,,#,4.72361E+17,https://twitter.com/CaitlinDemchuk/status/472360895755321344,,,,
asembiarx,5/30/2014 8:55,0,1,# FF @ ASCO for all things related to the # oncology meeting. There have been 1500+ tweets already and it hasn't even started yet! # ASCO14,,@,# # #,4.72361E+17,https://twitter.com/asembiarx/status/472360653114851328,,,,
myelomabeacon,5/30/2014 8:53,1,0,# ASCO14 starts today. Here's the popular (and detailed) # myeloma preview we published earlier this month http://www.myelomabeacon.com/news/2014/05/15/multiple-myeloma-asco-2014-overview/ …,,,# #,4.7236E+17,https://twitter.com/myelomabeacon/status/472360158681907201,,,,
ECMC_UK,5/30/2014 8:53,0,0,Johann de Bono ECMC Lead @ ICR_London presenting at the 50th @ ASCO conference starting today http://tinyurl.com/kqyqq5a,,@ @,,4.7236E+17,https://twitter.com/ECMC_UK/status/472360055015088130,,,,
wallyjc,5/30/2014 8:53,4,2,CancerLinQ: ASCO's innovative approach employing big data to transform cancer care # ASCO14 @ WinshipAtEmory @ EmoryMedicine,,@ @,#,4.7236E+17,https://twitter.com/wallyjc/status/472360031279517697,,,,
theNCI,5/30/2014 8:50,9,7,Today NCI staff will be involved in # ASCO14 sessions on grant writing & developmental therapeutics. More http://1.usa.gov/1mPMDgS,,,#,4.72359E+17,https://twitter.com/theNCI/status/472359351341285376,,,,
chemobrainfog,5/30/2014 8:50,9,6,No where is twitter more powerful than this. # ASCO14 in Chicago. Presentations can be followed by global audience in enormous numbers.,,,#,4.72359E+17,https://twitter.com/chemobrainfog/status/472359330512371712,,,,
myESMO,5/30/2014 8:49,0,0,"Hope to see you at the ESMO booth (nr 3053) at # ASCO14. We open at 09h tomorrow, bright & early :-) pic.twitter.com/7cZnAjFmWo",,,#,4.72359E+17,https://twitter.com/myESMO/status/472359242515898368,,,,
WinshipAtEmory,5/30/2014 8:49,1,0,# ASCO14 kicks off today! Follow our docs: @ wallyjc @ ramalingamMD @ SagarLonialMD @ virajmaster,,@ @ @ @,#,4.72359E+17,https://twitter.com/WinshipAtEmory/status/472359234592833536,,,,
chemobrainfog,5/30/2014 8:48,2,1,@ rsm2800 Internet changed everything & patient access (hopefully) helping w/ better shared decision making! Looking forward # ASCO14 stream!,,@,#,4.72359E+17,https://twitter.com/chemobrainfog/status/472358904555663360,,,,
wallyjc,5/30/2014 8:47,1,1,Exciting discussions this afternoon on value in cancer care led by Neal Meropol # ASCO14 @ WinshipAtEmory,,@,#,4.72359E+17,https://twitter.com/wallyjc/status/472358623973089280,,,,
rsm2800,5/30/2014 8:46,0,0,As # ASCO14 starts wish to say how privileged I am to work w/ wonderful Hopkins colleagues & amazing collaborators from Boston to WI to LA,,,#,4.72359E+17,https://twitter.com/rsm2800/status/472358509992869888,,,,
dansbarrington,5/30/2014 8:46,0,0,# ASCO14,,,#,4.72358E+17,https://twitter.com/dansbarrington/status/472358486958178304,,,,
kevinmichelskim,5/30/2014 8:45,0,0,RT @ BreastDocUK: Got my virtual pass for # ASCO14 so instead of jet lag and a hangover I will have a small carbon footprint and sore...,,@,#,4.72358E+17,https://twitter.com/kevinmichelskim/status/472358150029709312,,,,
mtmdphd,5/30/2014 8:45,10,9,Love the science at # ASCO14 but constantly reminded including this morning about Pts watching for science to translate to better medicine,,,#,4.72358E+17,https://twitter.com/mtmdphd/status/472358080450420737,,,,
FiercePharma,5/30/2014 8:45,7,3,Top-read on Fierce # Vaccines Thurs: # ASCO2014 preview: What's the outlook for cancer vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29 … by @ EmilyMFierce,,@,# #,4.72358E+17,https://twitter.com/FiercePharma/status/472358077325275136,,,,
chemobrainfog,5/30/2014 8:45,3,0,The ones to follow: @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to list http://bit.ly/RSJamR,,@,#,4.72358E+17,https://twitter.com/chemobrainfog/status/472358055263600640,,,,
Advaxis,5/30/2014 8:45,0,0,Who's attending # ASCO14? We look forward to seeing you there!,,,#,4.72358E+17,https://twitter.com/Advaxis/status/472358011688603649,,,,
nocopas,5/30/2014 8:42,0,0,Seen at # asco14- 51M+ life-years saved from cancer by # medicalinnovation! clientpic.twitter.com/0k7Xtq7FsY,,,# #,4.72357E+17,https://twitter.com/nocopas/status/472357404773203968,,,,
PVonc,5/30/2014 8:40,1,0,Are you finding it difficult to navigate the current # prostate # cancer treatment landscape? Register now: http://bit.ly/ASCOprostate # ASCO14,,,# # #,4.72357E+17,https://twitter.com/PVonc/status/472357000106737664,,,,
Boehringer,5/30/2014 8:40,2,0,# HCPs: What did you learn at your 1st @ ASCO that has changed the way you practice? # ASCO14,,@,# #,4.72357E+17,https://twitter.com/Boehringer/status/472356815586754561,,,,
BlackstoneHotel,5/30/2014 8:40,1,2,Welcome to # Chicago for your 50th Annual Convention @ ASCO! Enjoy your meeting and our beautiful city. # ASCO14,,@,# #,4.72357E+17,https://twitter.com/BlackstoneHotel/status/472356762910474240,,,,
MartinStockler,5/30/2014 8:37,0,1,. @wickywoo123 @ cdiakos We miss you two too. @ DKarikios @ BelindaKiely @ AdnanNagrial @ AnneLong888 # ASCO14,,@wickywoo123 @ @ @ @ @,#,4.72356E+17,https://twitter.com/MartinStockler/status/472356018887081985,,,,
kristen_hallam,5/30/2014 8:35,1,2,# ff @ ArmstrongDrew & @ Ostaley for # asco14 news and food reviews.,,@ @,# #,4.72356E+17,https://twitter.com/kristen_hallam/status/472355727823372288,,,,
TedOkonCOA,5/30/2014 8:35,0,0,New study raises concerns re hospital acquisitions of MD # cancer clinics tied to 340B program. http://ow.ly/xqFdM # asco14,,,# #,4.72356E+17,https://twitter.com/TedOkonCOA/status/472355561280143360,,,,
asembiarx,5/30/2014 8:31,0,0,Researchers will discuss the value of # cancer drugs at # ASCO14 for the first time this year http://armada.ht/1ktAQoR,,,# #,4.72355E+17,https://twitter.com/asembiarx/status/472354693642219520,,,,
CancerTherAdvsr,5/30/2014 8:31,0,0,@ ASCO: Tamoxifen May Be Used Up to 10 Years # breastcancer http://ow.ly/xpyPz,,@,#,4.72355E+17,https://twitter.com/CancerTherAdvsr/status/472354520920752128,,,,
corp_UNC,5/30/2014 8:30,0,0,"Unanticipated hospital admissions in pts rcv'g palliative RT w/wo concurrent chemo Waddle,Chen et al @ UNC_Lineberger # ASCO14...",,@,#,4.72354E+17,https://twitter.com/corp_UNC/status/472354400326123520,,,,
ConquerCancerFd,5/30/2014 8:30,3,3,"In honor of @ ASCO's 50th, we're raising $50k to support the future of cancer care. Learn more & give at http://ccf.asco.org ! # ASCO14",,@,#,4.72354E+17,https://twitter.com/ConquerCancerFd/status/472354315286614016,,,,
dralvaropinto,5/30/2014 8:28,0,1,"Good morning, Chicago!! # ASCO14 pic.twitter.com/cKA7E1yrFC",,,#,4.72354E+17,https://twitter.com/dralvaropinto/status/472353781519515648,,,,
OAkkerman_ERG,5/30/2014 8:26,3,2,"As # ASCO14 begins, drug makers compete for attention in the virtual part of the conference like never before. http://lnkd.in/dQaBjva",,,#,4.72353E+17,https://twitter.com/OAkkerman_ERG/status/472353310653939712,,,,
Chiltern_CRO,5/30/2014 8:23,1,1,Today is day 1 of # ASCO14 - meet # Chiltern and join in the conversation!,,,# #,4.72353E+17,https://twitter.com/Chiltern_CRO/status/472352647001825281,,,,
FiercePharma,5/30/2014 8:22,5,1,Top-read on FP Thursday: Top 10 best-selling cancer drugs of 2013 http://www.fiercepharma.com/special-reports/top-10-best-selling-cancer-drugs-2013 … # ASCO2014 # pharma by @ CarlyHFierce and @ EricPFierce,,@ @,# #,4.72352E+17,https://twitter.com/FiercePharma/status/472352364809048064,,,,
ASCO,5/30/2014 8:20,3,0,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.72352E+17,https://twitter.com/ASCO/status/472351799274663936,,,,
Gene_Antibody,5/30/2014 8:15,0,0,Is it time to start the countdown to @ ASCO?! http://ow.ly/xa8tq # ASCO14,,@,#,4.72351E+17,https://twitter.com/Gene_Antibody/status/472350563771109378,,,,
sanofi,5/30/2014 8:09,1,0,# ASCO14 starts today in Chicago. Check official website for more information http://bit.ly/1oQVShr,,,#,4.72349E+17,https://twitter.com/sanofi/status/472349144309575680,,,,
TedOkonCOA,5/30/2014 8:05,1,0,MD Shortage Is Cited in Delays at VA Hospitals. @ nytimes http://ow.ly/xqHc0 MD shortage getting worse everywhere # asco14,,@,#,4.72348E+17,https://twitter.com/TedOkonCOA/status/472348033104216064,,,,
boehringerus,5/30/2014 8:05,4,3,# ASCO14 BI to present 7 abstracts including new data for in advanced # lungcancer http://bit.ly/RHfj02,,,# #,4.72348E+17,https://twitter.com/boehringerus/status/472347979496833024,,,,
MatthewHSimmons,5/30/2014 8:03,0,0,So maybe something NOT to do while in Chicago for # ASCO14... http://www.nbcchicago.com/news/local/chicago-willis-tower-sky-deck-ledge-crack-261079001.html …,,,#,4.72348E+17,https://twitter.com/MatthewHSimmons/status/472347547386667008,,,,
jopalazzo,5/30/2014 8:03,0,1,# ASCO14,,,#,4.72347E+17,https://twitter.com/jopalazzo/status/472347444358180865,,,,
Elekta,5/30/2014 8:01,0,0,Visit booth 4019 at # ASCO14 to experience Elekta’s # GammaKnife Perfexion and # MOSAIQ Oncology Information System.,,,# # #,4.72347E+17,https://twitter.com/Elekta/status/472347172579835904,,,,
zorgnieu_ws,5/30/2014 8:00,0,0,50 jaar ASCO # ASCO14 http://wp.me/p2ZL1H-6qE,,,#,4.72347E+17,https://twitter.com/zorgnieu_ws/status/472346765539045378,,,,
m_e_nielsen,5/30/2014 8:00,1,0,Nice @ RHamiltonUrol analysis of common meds (statins etc) on response in CRPC trials http://abstracts.asco.org/144/AbstView_144_129251.html … # asco14 HT @ subatomicdoc,,@ @,#,4.72347E+17,https://twitter.com/m_e_nielsen/status/472346707620286466,,,,
rsm2800,5/30/2014 7:59,5,3,Few months ago was asked my opinion re top advance of @ ASCO 's 50 yrs. I said penetration of the Internet & pt access to information # ASCO14,,@,#,4.72347E+17,https://twitter.com/rsm2800/status/472346599301996545,,,,
z_phd,5/30/2014 7:58,0,0,Sunrise over Chicago... # ASCO14 pic.twitter.com/HEcb1kvc00,,,#,4.72346E+17,https://twitter.com/z_phd/status/472346385581633536,,,,
CureMelanoma,5/30/2014 7:58,0,0,RT @ timturnham: I'll be at # ASCO14 and tweeting # melanoma news. Will you be there?,,@,# #,4.72346E+17,https://twitter.com/CureMelanoma/status/472346294347112448,,,,
timturnham,5/30/2014 7:57,1,1,I'll be at # ASCO14 and tweeting # melanoma news. Will you be there?,,,# #,4.72346E+17,https://twitter.com/timturnham/status/472346054739128320,,,,
brendanweiss,5/30/2014 7:54,3,3,@ MyelomaTeacher @ IMFmyeloma heading to # ASCO14 now will be tweeting # MMSM,,@ @,# #,4.72345E+17,https://twitter.com/brendanweiss/status/472345334316679168,,,,
punkcap,5/30/2014 7:52,0,0,CLDX following the good Dr.J @ optionmonster into @ CLDX ahead of @ ASCO this weekend…most tgt are in the 30-40's was caught in this sell-off,,@ @ @,,4.72345E+17,https://twitter.com/punkcap/status/472344907164975104,,,,
teamoncology,5/30/2014 7:51,6,2,# ASCO14 本日より米国臨床腫瘍学会の年次総会が開始。このハッシュタグをフォローすることにより、最新のがん情報が入可能。この学会はがんに関する世界最大の学会です。質問があれば、送って下さい。,,,#,4.72345E+17,https://twitter.com/teamoncology/status/472344564200509441,,,,
teamoncology,5/30/2014 7:49,2,1,# ASCO14 This hashtag stands for ASCO annual meeting in Chicago which will start today. There are many great people tweeting. :),,,#,4.72344E+17,https://twitter.com/teamoncology/status/472344027677728768,,,,
zorgnl,5/30/2014 7:46,3,1,Happy anniversary @ ASCO 50 years of oncology innovations # ASCO14 pic.twitter.com/KZFnkTHlpV,,@,#,4.72343E+17,https://twitter.com/zorgnl/status/472343233759313920,,,,
MedicalFactsEU,5/30/2014 7:46,0,0,Happy anniversary @ ASCO 50 years of oncology innovations # ASCO14 pic.twitter.com/KKbUIkEO63,,@,#,4.72343E+17,https://twitter.com/MedicalFactsEU/status/472343233746702336,,,,
Medicalfacts,5/30/2014 7:46,0,0,Happy anniversary @ ASCO 50 years of oncology innovations # ASCO14 pic.twitter.com/PrkRdkHXdl,,@,#,4.72343E+17,https://twitter.com/Medicalfacts/status/472343231989293056,,,,
EmergentAustin,5/30/2014 7:44,0,0,"Have a educational day RT @ DrMarkham: Heading to # ASCO14 this morning. After a cup of coffee or 3, I'll be ready.",,@,#,4.72343E+17,https://twitter.com/EmergentAustin/status/472342781281972225,,,,
EmergentAustin,5/30/2014 7:43,0,0,@ INC_Research Which study are you looking forward to talking about most at # ASCO2014?,,@,#,4.72343E+17,https://twitter.com/EmergentAustin/status/472342598540353537,,,,
teamoncology,5/30/2014 7:43,2,0,So why follow # ASCO14 ? Because this is a great source for new info about the latest development in the clinical cancer world.,,,#,4.72343E+17,https://twitter.com/teamoncology/status/472342575316082689,,,,
Medicalfacts,5/30/2014 7:42,0,0,50 jaar ASCO # ASCO14 http://www.medicalfacts.nl/?p=206891,,,#,4.72342E+17,https://twitter.com/Medicalfacts/status/472342234743189505,,,,
teamoncology,5/30/2014 7:42,0,0,"ASCO was funded in 1964, when I was born. LOL # ASCO14",,,#,4.72342E+17,https://twitter.com/teamoncology/status/472342217198014465,,,,
teamoncology,5/30/2014 7:41,0,0,ASCO stands for American Society of Clinical Oncology. It is a professional society for who are involved in cancer. # ASCO14,,,#,4.72342E+17,https://twitter.com/teamoncology/status/472342117872721920,,,,
EmergentAustin,5/30/2014 7:40,0,0,"Just don't lose the chargers RT @ Ostaley: Flying to Chicago for # ASCO14 with iPhone, iPad, Blackberry & laptop + 4 chargers # progress",,@,# #,4.72342E+17,https://twitter.com/EmergentAustin/status/472341865044647936,,,,
teamoncology,5/30/2014 7:40,0,0,# ASCO14 I wish that I can attend but I have too much patient care and grants to complete.,,,#,4.72342E+17,https://twitter.com/teamoncology/status/472341768197783553,,,,
GustaveRoussy,5/30/2014 7:39,4,1,Happy birthday @ ASCO : 50th annual meeting # ASCO14 begins today. See you at Chicago !,,@,#,4.72341E+17,https://twitter.com/GustaveRoussy/status/472341449162645504,,,,
EmergentAustin,5/30/2014 7:36,0,0,Wishing you a productive conference RT @ DKarikios: @ MartinStockler joining you soon from NYC!! # ASCO14 pic.twitter.com/Ub9uFE7Ycw,,@ @,#,4.72341E+17,https://twitter.com/EmergentAustin/status/472340769970589697,,,,
drprunellab,5/30/2014 7:34,0,1,"Not v happy about missing # ASCO14, would so love to be jet lagged & in # Chicago right now...",,,# #,4.7234E+17,https://twitter.com/drprunellab/status/472340201960775681,,,,
ICON4CANCER,5/30/2014 7:27,0,1,"Follow # ASCO14 for updates on the @ ASCO 50th annual meeting which kicked off today in Chicago, Illinois",,@,#,4.72338E+17,https://twitter.com/ICON4CANCER/status/472338432287846400,,,,
sarah_blagden,5/30/2014 7:25,1,0,"Oncologists descend on Chicago, # ASCO2014 conference starts today! Will we hear of exciting new advances or just more of the same?",,,#,4.72338E+17,https://twitter.com/sarah_blagden/status/472337932276092928,,,,
Tony_Calles,5/30/2014 7:23,0,1,Heading to # ASCO14 50th Annual Meeting: Science & Society. Here we go Chicago. # lcsm # lungcancer,,,# # #,4.72337E+17,https://twitter.com/Tony_Calles/status/472337472161333248,,,,
Nelson_Carreras,5/30/2014 7:22,1,0,"One in 10,000: find out about our approach to discovering better # oncology treatments http://ow.ly/xkMRo (*.pdf) # ASCO14 # research"",,,# # #,472337249364115456""",https://twitter.com/Nelson_Carreras/status/472337249364115456,,,,,,,,
jagasquet,5/30/2014 7:22,0,0,@ Amgen To Host Post-American Society of Clinical Oncology ( # ASCO14) Summary Webcast - FierceBiotech: http://www.fiercebiotech.com/press-releases/amgen-host-post-american-society-clinical-oncology-asco-summary-webcast?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4hpmVi5E7s.twitter …,,@,# #,4.72337E+17,https://twitter.com/jagasquet/status/472337200730734592,,,,
jagasquet,5/30/2014 7:20,0,0,"# ASCO14 Agenda for Friday, May 30th, 2014. http://am.asco.org/friday-may-30-2014 …",,,#,4.72337E+17,https://twitter.com/jagasquet/status/472336656012292096,,,,
_SEOM,5/30/2014 7:16,2,3,Estaremos bien atentos a los video-resumenes diarios con los highlights del congreso # ASCO14 gracias a @ AstraZeneca http://www.seom.org/es/acceso-a-onconexion …,,@,#,4.72336E+17,https://twitter.com/_SEOM/status/472335670417969153,,,,
World_ADC,5/30/2014 7:16,1,0,First day of # ASCO2014! Plan your time by reading our summary ebook of # ADC programs being covered @ ASCO http://www.adc-summit.com/content-library,,@,# #,4.72336E+17,https://twitter.com/World_ADC/status/472335638491299840,,,,
LPMissy1202,5/30/2014 7:15,0,2,# FF @ cancerpre @ theNCI @ abolishcancer @ LFPancreaticCan @ MACancerFDN @ curePCcampaign @ ASCO @ DanaFarber @ AACR @ cancer_connect,,@ @ @ @ @ @ @ @ @ @,#,4.72336E+17,https://twitter.com/LPMissy1202/status/472335546812207104,,,,
FightCRC,5/30/2014 7:15,1,3,"We are at the 50th annual @ ASCO meeting this weekend, follow us for the latest pictures and information from this event! # ASCO14",,@,#,4.72335E+17,https://twitter.com/FightCRC/status/472335401752215552,,,,
SanofiPolska,5/30/2014 7:11,0,0,Już dziś pierwszy dzień # ASCO2014! @ Sanofi też tam jest – najnowsze informacje na @ ASCO i http://www.asco.org,,@ @,#,4.72334E+17,https://twitter.com/SanofiPolska/status/472334390279020544,,,,
DKarikios,5/30/2014 7:09,0,0,@ MartinStockler joining you soon from NYC!! # ASCO14 pic.twitter.com/AzB6y3Vqv5,,@,#,4.72334E+17,https://twitter.com/DKarikios/status/472333986677944320,,,,
cancermd,5/30/2014 7:08,3,0,Follow @ OncEd to get the latest updates from # ASCO2014 # ASCO14 I will be providing the latest breast cancer updates # bcsm,,@,# # #,4.72334E+17,https://twitter.com/cancermd/status/472333672079581185,,,,
MartinStockler,5/30/2014 7:06,0,1,It beckons # ASCO14 # Chicagopic.twitter.com/rtLH3zJUfk,,,# #,4.72333E+17,https://twitter.com/MartinStockler/status/472333314020216833,,,,
JanssenIE,5/30/2014 7:02,0,1,The storybooks have landed @ IrishCancerSoc # mantoman # ASCO14 pic.twitter.com/SUSdp8Wt2E,,@,# #,4.72332E+17,https://twitter.com/JanssenIE/status/472332128546717696,,,,
GSKUS,5/30/2014 7:00,0,0,"We are in @ Chicago for # ASCO14. We invite you to visit us at booths #10051, for R&D exchange, & #4063, for approved product discussions",,@,# #10051 #4063,4.72332E+17,https://twitter.com/GSKUS/status/472331739151740928,,,,
rohal,5/30/2014 6:56,1,1,"MT @ lenstarnes @ andrewspong @ asco # ASCO14 clinician Twitter users, and the hashtags they favor http://bit.ly/SXvJmn # hcsmeu # pharma # onco",,@ @ @,# # # #,4.72331E+17,https://twitter.com/rohal/status/472330604382785536,,,,
sjaakvink,5/30/2014 6:54,0,1,On my way to chicago with Dr Jan de Witt @ myTomorrows to reach out for latest developments cancertreatments @ ASCO,,@ @,,4.7233E+17,https://twitter.com/sjaakvink/status/472330169257295873,,,,
Ostaley,5/30/2014 6:53,0,1,"Flying to Chicago for # ASCO14 with iPhone, iPad, Blackberry & laptop + 4 chargers # progress",,,# #,4.7233E+17,https://twitter.com/Ostaley/status/472329894480052224,,,,
megtirrell,5/30/2014 6:43,16,5,"Really great story by Bloomberg colleague @ robertlangreth on high prices of cancer drugs, ahead of # ASCO14 http://bloom.bg/1jzvRhd",,@,#,4.72327E+17,https://twitter.com/megtirrell/status/472327360952291329,,,,
DrMarkham,5/30/2014 6:42,0,0,"Heading to # ASCO14 this morning. After a cup of coffee or 3, I'll be ready.",,,#,4.72327E+17,https://twitter.com/DrMarkham/status/472327276806561793,,,,
corp_UNC,5/30/2014 6:31,1,1,"Trends in ADT use among privately insured men with prostate cancer, 2001-2010 S.Ellis, @ m_e_nielsen et al # asco14 http://ow.ly/xqBRw",,@,#,4.72324E+17,https://twitter.com/corp_UNC/status/472324481642676225,,,,
PMLiVEcom,5/30/2014 6:30,2,1,. @ AstraZeneca's Susan Galbraith on the company's # cancer prospects ahead of # ASCO14 http://bit.ly/1oQEM3p pic.twitter.com/Jx3ouY9MYc,,@,# #,4.72324E+17,https://twitter.com/PMLiVEcom/status/472324260057608192,,,,
drdonsdizon,5/30/2014 6:26,3,0,"Invited @ ASCO EdBook paper by Dr. P Chapman re: melanoma rx. Intro by J Wolchok, Scient Program Cte Chair of # ASCO14 http://www.ncbi.nlm.nih.gov/pubmed/24857055",,@,#,4.72323E+17,https://twitter.com/drdonsdizon/status/472323032115994626,,,,
wearemedsir,5/30/2014 6:25,0,0,MedSIR at ASCO # ASCO14 https://medsir.org/asco-2014,,,#,4.72323E+17,https://twitter.com/wearemedsir/status/472322868253298688,,,,
oncotuits,5/30/2014 6:21,1,0,Este año se conmemora el 50 aniversario de la creación de # ASCO14 esperamos muchas buenas noticias en la lucha contra el # cáncer!,,,# #,4.72322E+17,https://twitter.com/oncotuits/status/472321951529435136,,,,
mtmdphd,5/30/2014 6:21,1,0,+1 # FF rec -> MT @ teamoncology: # ASCO14 will start tomorrow. Interests in information that make sense. Follow me.,,@,# #,4.72322E+17,https://twitter.com/mtmdphd/status/472321794356310016,,,,
oncotuits,5/30/2014 6:18,0,0,Listos para # ASCO14 ?,,,#,4.72321E+17,https://twitter.com/oncotuits/status/472321220558348288,,,,
drdonsdizon,5/30/2014 6:13,1,2,Excellent # hcldr chat this week- MDs and Philanthropy @ Consano @ MGHCancerCenter @ ASCO https://storify.com/colin_hung/physicians-and-philanthropy …,,@ @ @,#,4.7232E+17,https://twitter.com/drdonsdizon/status/472319956315815936,,,,
Sports_bios,5/30/2014 6:11,0,0,@ adamfeuerstein Have good one.. I have my list of people to follow for the # ASCO14 in next couple of days.. gonna have data brain freeze.,,@,#,4.72319E+17,https://twitter.com/Sports_bios/status/472319444912734208,,,,
Novartis,5/30/2014 6:10,1,2,# ASCO14 begins on May 30. Stay connected with # NETCancer patient stories by visiting: http://bit.ly/g5U9wB,,,# #,4.72319E+17,https://twitter.com/Novartis/status/472319064648720384,,,,
adamfeuerstein,5/30/2014 6:08,0,8,Flying to Chicago this morning for # ASCO14 where everyone will be hyper-focused on $ NWBO exhibition booth and DCVAX-Direct. Excited!,,,#,4.72319E+17,https://twitter.com/adamfeuerstein/status/472318535348543488,,,,
bioclinica,5/30/2014 6:05,0,0,"RT @ Loftus: Cancer immunotherapies seen costing $100,000 per patient, fueling $20B market by 2025, Goldman estimates # ASCO14",,@,#,4.72318E+17,https://twitter.com/bioclinica/status/472317801802506240,,,,
jennystenbacka,5/30/2014 6:02,0,1,Pharma industry finally congress tweeting! # justdoit “ @ Novartis: . @ Novartis is about to be taken over by our # Oncology colleagues.. # ASCO14”,,@ @,# # #,4.72317E+17,https://twitter.com/jennystenbacka/status/472317035620630528,,,,
efesalud,5/30/2014 6:00,10,2,La cita mundial de la oncología comienza en Chicago. http://www.efesalud.com/noticias/asco-la-cita-mundial-de-la-oncologia-cumple-su-50-aniversario/ … @ ASCO cumple su 50 aniversario. # ASCO14 pic.twitter.com/vkTyiLUORt,,@,#,4.72317E+17,https://twitter.com/efesalud/status/472316690911723520,,,,
RonnieLass,5/30/2014 6:00,2,2,Another good one from # ASCO14 about # hcsm: Social Media in Clinical Trials -> @ mtmdphd http://ow.ly/xqxpw via @ rsm2800,,@ @,# #,4.72317E+17,https://twitter.com/RonnieLass/status/472316586884628480,,,,
vallhebron,5/30/2014 6:00,0,0,"Els MIR d' # Oncolologia # hvhebron presentaran, a partir d'avui, els seus treballs a . @ ASCO http://bit.ly/1gfS5tM",,@,# #,4.72317E+17,https://twitter.com/vallhebron/status/472316557675098112,,,,
MedicalFactsEU,5/30/2014 5:56,0,0,On your way to # ASCO14,,,#,4.72316E+17,https://twitter.com/MedicalFactsEU/status/472315517890748416,,,,
zorgnl,5/30/2014 5:56,0,0,On your way to # ASCO14,,,#,4.72316E+17,https://twitter.com/zorgnl/status/472315517777485824,,,,
Medicalfacts,5/30/2014 5:56,0,0,On your way to # ASCO14,,,#,4.72316E+17,https://twitter.com/Medicalfacts/status/472315517760729088,,,,
Roche,5/30/2014 5:55,15,5,"Watch our latest Drawn to # Science"" video explaining # ClinicalTrials - http://ow.ly/xoVg4 # ASCO14""",,,# # #,4.72315E+17,https://twitter.com/Roche/status/472315269617303552,,,,
drdonsdizon,5/30/2014 5:50,0,0,@ nursefriendly TY Andrew! Early AM flight 2 # ASCO14 @ DrFerdowsi @ DrFibro @ drflanders @ DrGlennKolansky @ DrGreene @ DrGrumble @ DrHubaEvaluator,,@ @ @ @ @ @ @ @,#,4.72314E+17,https://twitter.com/drdonsdizon/status/472314103433023488,,,,
OncologyTimes,5/30/2014 5:48,2,2,+1! MT @ rsm2800: Gr8 summary fr @ mtmdphd--> Social Media in Clinical Trials |2014 Educ Book | Mtg Library http://meetinglibrary.asco.org/content/11400101-144#.U4eipxKj7Gg.twitter … # ASCO14,,@ @,# #,4.72314E+17,https://twitter.com/OncologyTimes/status/472313679896014848,,,,
CitelineIanL,5/30/2014 5:42,6,0,Great report from @ CitelineRachelM on # immunotherapies for # oncology being presented at # ASCO2014 at http://bit.ly/SVNyCm,,@,# # #,4.72312E+17,https://twitter.com/CitelineIanL/status/472312037377597441,,,,
naomikresge,5/30/2014 5:37,1,1,Expensive cancer drugs are forcing doctors to weigh price # ASCO14 http://bloom.bg/1jzvRhd via @BloombergNews @ RobertLangreth,,@BloombergNews @,#,4.72311E+17,https://twitter.com/naomikresge/status/472310748920971264,,,,
Medicalfacts,5/30/2014 5:34,0,0,Anyone at # ASCO14 planning to go to the Sydeck of the WIllisbuilding. See this first http://www.nydailynews.com/news/national/tourists-notice-cracks-chicago-tower-glass-103rd-floor-article-1.1809953 …,,,#,4.7231E+17,https://twitter.com/Medicalfacts/status/472309975923310592,,,,
G4Porg,5/30/2014 5:27,0,0,# ASCO14: Bob Pinedo ontvangt internationale award voor zijn baanbrekende ... - Medical facts http://ow.ly/2HhXTR,,,#,4.72308E+17,https://twitter.com/G4Porg/status/472308276303233024,,,,
Roche,5/30/2014 5:25,2,2,"One in 10,000: find out about our approach to discovering better # oncology treatments http://ow.ly/xkMRo (*.pdf) # ASCO14 # research",,,# # #,4.72308E+17,https://twitter.com/Roche/status/472307705236189184,,,,
ITCC_eu,5/30/2014 5:22,1,0,"# ASCO14 begins today! Discover @ ITCC_eu studies Monday June 2, 8:00 AM to 11:45 AM in S Hall A2 http://bit.ly/1k8MP63 # ChildhoodCancer",,@,# #,4.72307E+17,https://twitter.com/ITCC_eu/status/472307124899680257,,,,
Medicalfacts,5/30/2014 5:20,0,0,Obesity impacts breastca mortality specifically in pre/perimenopausal women. # ASCO14 http://abstracts.asco.org/144/AbstView_144_133648.html …,,,#,4.72307E+17,https://twitter.com/Medicalfacts/status/472306521138028545,,,,
SarahCannon_UK,5/30/2014 5:18,1,0,10 # ASCO14 abstracts with contributions from authors affiliated with us @SCRI UK: http://sarahcannonresearch.co.uk/news/scri-at-2014-asco-annual-meeting/ …pic.twitter.com/DTveJ69PvA,,@SCRI,#,4.72306E+17,https://twitter.com/SarahCannon_UK/status/472305981179691008,,,,
myESMO,5/30/2014 5:04,3,3,Don't miss @ vitaloptions tribute to its founder Selma Schimmel on Sun. 01/06 & focussing on # cancer in young adults # ASCO14,,@,# #,4.72302E+17,https://twitter.com/myESMO/status/472302424578076672,,,,
roche_es,5/30/2014 4:58,1,1,"Con motivo del 50 aniversario, destacamos los principales avances en la lucha contra el cáncer # ASCO14 http://ow.ly/xkxTU",,,#,4.72301E+17,https://twitter.com/roche_es/status/472301115015712768,,,,
lenstarnes,5/30/2014 4:54,0,0,Many ways to connect with @ ASCO on social media during # ASCO14 http://bit.ly/1o8Ltk4 # hcsmeu # futuremed # FOAMed # CMEchat # epatient,,@,# # # # # #,4.723E+17,https://twitter.com/lenstarnes/status/472299987670687744,,,,
Medicalfacts,5/30/2014 4:42,0,0,# ASCO14: Bob Pinedo ontvangt internationale award voor zijn baanbrekende werk aan kanker http://www.medicalfacts.nl/?p=206888,,,#,4.72297E+17,https://twitter.com/Medicalfacts/status/472297105378508800,,,,
BoehringerES,5/30/2014 4:20,2,0,Hoy comienza # ASCO14 con más de 200 sesiones con las principales novedades en # oncología. No te pierdas nada: http://bit.ly/1tFyjKJ,,,# #,4.72291E+17,https://twitter.com/BoehringerES/status/472291436382400512,,,,
ArcagyGineco,5/30/2014 4:16,0,0,# ASCO14 Session orale cancer gynéco samedi 31 mai de 13h à 16H : résultats de l’étude dans les cancers de l’ovaire à cellules claires,,,#,4.7229E+17,https://twitter.com/ArcagyGineco/status/472290497528999938,,,,
clarisssv,5/30/2014 4:14,0,1,Saliendo para # ASCO14. Con muchas ganas...,,,#,4.7229E+17,https://twitter.com/clarisssv/status/472290054476668928,,,,
lenstarnes,5/30/2014 4:11,1,1,This is how 2 integrate SM into med soc confs HT @ andrewspong : # ASCO14 Twt docs & hashtags they favour http://buff.ly/1pCX1cn # hcsm,,@,# #,4.72289E+17,https://twitter.com/lenstarnes/status/472289239305314305,,,,
lenstarnes,5/30/2014 4:10,0,0,@ escardio Take a look at # ASCO14 's use of 'Twitter docs' http://buff.ly/1pCX1cn Gr8t learnings 4 # ESCcongress and other ESC events,,@,# #,4.72289E+17,https://twitter.com/lenstarnes/status/472288958865752064,,,,
nxtstop1,5/30/2014 3:49,1,0,"Today.Fri. May 30:On The Docket: # ASCO14 (Am.Soc.Clin.Onc), # MCME14 (Mobile Computing in Medical Education) and HIT tweetchat: # HITsm Delight!",,,# # #,4.72284E+17,https://twitter.com/nxtstop1/status/472283678337273856,,,,
darrenfergus,5/30/2014 3:47,0,0,When is a cancer breakthrough 'financially toxic'? At # ASCO14 Why Health will share how value is considered in scientific breakthroughs.,,,#,4.72283E+17,https://twitter.com/darrenfergus/status/472283160244281344,,,,
merck_es,5/30/2014 3:30,2,0,Hoy empieza # ASCO14: oncólogos de todo el mundo se reúnen en Chicago http://ow.ly/xps3m,,,#,4.72279E+17,https://twitter.com/merck_es/status/472278754002501632,,,,
networkpharma,5/30/2014 3:29,0,0,RT @ ASCO # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # medcomms,,@,# #,4.72279E+17,https://twitter.com/networkpharma/status/472278508413390849,,,,
FsnAntibodies,5/30/2014 3:26,0,1,Friday Follow Time! @ LundbeckUS @BayerHealthCare @ SelexisSA @ BioMedTracker @ ASCO # FF,,@ @BayerHealthCare @ @ @,#,4.72278E+17,https://twitter.com/FsnAntibodies/status/472277894115635200,,,,
CI4CC,5/30/2014 3:25,0,0,Looking forward to # ASCO14 ... it's also all about the Data!,,,#,4.72278E+17,https://twitter.com/CI4CC/status/472277705312854016,,,,
LeahPeyton,5/30/2014 3:08,0,0,@ ASCO starts today...wonder what this year's big news. Have my suspicions/hopes!,,@,,4.72273E+17,https://twitter.com/LeahPeyton/status/472273390083260416,,,,
PaoloFoggi,5/30/2014 3:07,2,0,HER2+ & TN # breastcancer: immune-related genes including PD1 PDL1 & CTLA4 predict response to carboplatin # ASCO14. http://abstracts.asco.org/144/AbstView_144_132115.html …,,,# #,4.72273E+17,https://twitter.com/PaoloFoggi/status/472273169588703232,,,,
BreastDocUK,5/30/2014 2:42,2,4,Got my virtual pass for # ASCO14 so instead of jet lag and a hangover I will have a small carbon footprint and sore screen eyes,,,#,4.72267E+17,https://twitter.com/BreastDocUK/status/472266866162163712,,,,
roche_es,5/30/2014 2:15,9,4,Hoy comienza el 50 Congreso de la Sociedad Americana de Oncología Clínicia. Se presentan novedades en los avances contra el cáncer # ASCO14,,,#,4.7226E+17,https://twitter.com/roche_es/status/472259988208254976,,,,
CureTalks,5/30/2014 0:55,0,1,Learn More about CancerLinQ™ at the Institute for Quality Booth at # ASCO2014 Annual Meeting | http://www.asco.org/advocacy/learn-more-about-cancerlinq%E2%84%A2-institute-quality-booth-asco%E2%80%99s-annual-meeting#.U4gO91pYJfU.twitter …,,,# #,4.7224E+17,https://twitter.com/CureTalks/status/472239850217680897,,,,
MoleDigital,5/30/2014 0:48,1,0,In Chicago preparing for # ASCO14 conference seminar filming and expert KOL interviews # oncology,,,# #,4.72238E+17,https://twitter.com/MoleDigital/status/472238082612551680,,,,
DrAttai,5/30/2014 0:16,16,5,# ASCO14 - Science and Society - reflections by @ ASCO President @ CliffordHudis https://www.youtube.com/watch?v=FCFvTi5SVI8 …,,@ @,#,4.7223E+17,https://twitter.com/DrAttai/status/472230155436306432,,,,
DrAttai,5/30/2014 0:11,2,1,What is the ASCO Annual Meeting? | http://Cancer.Net http://www.cancer.net/blog/2014-05/what-asco-annual-meeting#.U4gE7J4XJxk.twitter … via @ CancerDotNet # ASCO14,,@,# #,4.72229E+17,https://twitter.com/DrAttai/status/472228853822140416,,,,
braincancer_AU,5/30/2014 0:00,3,1,"Interesting i/v on an explosion of understanding"" in # medulloblastoma ahead of # ASCO14 http://buff.ly/1wvKXya # braincancer""",,,# # #,4.72226E+17,https://twitter.com/braincancer_AU/status/472225985736499200,,,,
scottsaxe,5/29/2014 23:55,1,1,"The key theme at @ ASCO meetings in # Chicago will be # immunotherapies, drugs that harness the immune system to fight # cancer. # ASCO14",,@,# # # #,4.72225E+17,https://twitter.com/scottsaxe/status/472224874954366976,,,,
DrBobGoldberg,5/29/2014 23:51,0,1,The campaign to declare the value of medical innovation to patients begins! # ASCO14 pic.twitter.com/u5t6UyavqN,,,#,4.72224E+17,https://twitter.com/DrBobGoldberg/status/472223660187873280,,,,
RemedyInformatx,5/29/2014 23:31,0,0,"Excited to be in Chicago for # ASCO2014, looks to be a great meeting! (We’re in booth 21165)",,,#,4.72219E+17,https://twitter.com/RemedyInformatx/status/472218678822727680,,,,
DrAttai,5/29/2014 23:25,1,0,"helpful info RT @ mtmdphd More # ASCO14 Annual Meeting Tips - Abdul-Rahman Jazieh, MD, MPH ( @ jaziehoncology ) http://ow.ly/xpZca",,@ @,#,4.72217E+17,https://twitter.com/DrAttai/status/472217191920984064,,,,
DrAttai,5/29/2014 23:20,0,5,time zone difference working to my advantage - reviewing # ASCO14 abstracts - need to keep up with @ rsm2800 @ drdonsdizon @ mtmdphd @ fischmd,,@ @ @ @,#,4.72216E+17,https://twitter.com/DrAttai/status/472216021638852608,,,,
OncLive,5/29/2014 23:20,0,0,Rare Skin Cancer on Palms and Soles More Likely to Come Back Compared to Other Melanomas http://ow.ly/xp12A # ASCO14,,,#,4.72216E+17,https://twitter.com/OncLive/status/472215869251399681,,,,
GuardantHealth,5/29/2014 23:12,1,4,Big thanks to UCSF for including our tests in their pre-ASCO session today! Can't wait to start # ASCO14 tomorrow! http://goo.gl/Cnm1TN,,,#,4.72214E+17,https://twitter.com/GuardantHealth/status/472213969315172352,,,,
RamalingamMD,5/29/2014 23:12,1,1,Feels great to be at Chicago for # ASCO14. Looking forward to the next 5 days.,,,#,4.72214E+17,https://twitter.com/RamalingamMD/status/472213880542732290,,,,
TGeorgeMD,5/29/2014 23:07,2,1,Personalized # Cancer Prevention via WGS @ genentech: Predictions 4 # CancerResearch advancements # Next50 yrs? # ASCO14 @ mtmdphd @ subatomicdoc,,@ @ @,# # # #,4.72213E+17,https://twitter.com/TGeorgeMD/status/472212673904787456,,,,
subatomicdoc,5/29/2014 22:56,0,0,@ dr_coops Speaking of statins for CRPC...http://abstracts.asco.org/144/AbstView_144_129251.html … # ASCO14 # pcsm,,@,# #,4.7221E+17,https://twitter.com/subatomicdoc/status/472209902677811200,,,,
subatomicdoc,5/29/2014 22:52,0,1,"@ davisa20 @ FightCRC Excellent! Marked and coming soon, thank you :) # ASCO14",,@ @,#,4.72209E+17,https://twitter.com/subatomicdoc/status/472208935777472513,,,,
davisa20,5/29/2014 22:40,4,3,# ASCO14 attendees have access to Virtual Meeting. No need to photograph slides. Remember your iPad can block the view of those behind you.,,,#,4.72206E+17,https://twitter.com/davisa20/status/472205973818327040,,,,
Rad_Nation,5/29/2014 22:37,0,0,@ marykge Great! Hope to see you there. I'll be there Sun-Mon. # ASCO14,,@,#,4.72205E+17,https://twitter.com/Rad_Nation/status/472205207875891201,,,,
DrMiguelPerales,5/29/2014 22:37,0,2,@ rsm2800 for those not attending # ASCO14 there should also be a virtual Tweetup,,@,#,4.72205E+17,https://twitter.com/DrMiguelPerales/status/472205088996737024,,,,
davisa20,5/29/2014 22:32,2,1,"After days of prep, so excited to see all the attendees at # ASCO14. We are ready to go!",,,#,4.72204E+17,https://twitter.com/davisa20/status/472203928999034880,,,,
33charts,5/29/2014 22:32,0,1,. @ rsm2800: There’s the Official # ASCO14 Tweetup http://tweetvite.com/event/ASCO14 and the Unofficial # asco14 Tweetup http://tweetvite.com/event/UnofficialASCO14 …,,@,# #,4.72204E+17,https://twitter.com/33charts/status/472203868848525312,,,,
marykge,5/29/2014 22:26,0,2,@ Rad_Nation @ jpil @ MKnoll_MD @ wallyjc @ cd_fuller @ jamesbyu Going to # ASCO14,,@ @ @ @ @ @,#,4.72202E+17,https://twitter.com/marykge/status/472202336044326912,,,,
DrBobGoldberg,5/29/2014 22:23,0,0,Join me @ ASCO say no to those who would redline cancer patients to save money http://www.businesswire.com/news/home/20140529005104/en/LIFE-WORTH-Campaign-Launches-Premier-Cancer-Conference …,,@,,4.72202E+17,https://twitter.com/DrBobGoldberg/status/472201508646559746,,,,
DrAnasYounes,5/29/2014 22:18,1,2,# ASCO14 Tweetup on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt,,,# # #,4.722E+17,https://twitter.com/DrAnasYounes/status/472200464868450304,,,,
szusmani,5/29/2014 22:18,0,1,"@ VincentRK @ myelomacinderel Vincent- will email you the LOI draft over the weekend, at # ASCO14 right now",,@ @,#,4.722E+17,https://twitter.com/szusmani/status/472200451749056512,,,,
Bri_Hundley,5/29/2014 22:18,0,0,THE BEAN # chicago # ASCO14 # typicaltouristmove http://instagram.com/p/ompiVaxSzM/,,,# # #,4.722E+17,https://twitter.com/Bri_Hundley/status/472200351731310592,,,,
Gene_Antibody,5/29/2014 22:15,1,0,I took the # Immunotherapy Challenge & got a score of 18!—what did you get? # games # ASCO14 http://ow.ly/xpSAs,,,# # #,4.72199E+17,https://twitter.com/Gene_Antibody/status/472199477517107200,,,,
rsm2800,5/29/2014 22:14,13,4,There’s the Official # ASCO14 Tweetup http://tweetvite.com/event/ASCO14 and the Unofficial # asco14 Tweetup http://tweetvite.com/event/UnofficialASCO14 …. Why choose? Do both!,,,# #,4.72199E+17,https://twitter.com/rsm2800/status/472199427822600193,,,,
mtmdphd,5/29/2014 22:12,0,0,"# ASCO14 Annual Meeting Tips - Abdul-Rahman Jazieh, MD, MPH ( @ jaziehoncology ) http://ow.ly/xpZca",,@,#,4.72199E+17,https://twitter.com/mtmdphd/status/472198888192217088,,,,
teamoncology,5/29/2014 22:10,4,0,# ASCO14 米国臨床腫瘍学会が明日より開幕。最新がん医療情報に興味ある方はフォローをよろしくお願いいたします,,,#,4.72198E+17,https://twitter.com/teamoncology/status/472198343368523776,,,,
teamoncology,5/29/2014 22:07,0,2,# ASCO14 will start tomorrow. Interests in information that make sense. Follow me.,,,#,4.72198E+17,https://twitter.com/teamoncology/status/472197644635238400,,,,
motorrecilla,5/29/2014 22:07,0,1,Chicago # ASCO14 pic.twitter.com/EHjOHMJHbX,,,#,4.72198E+17,https://twitter.com/motorrecilla/status/472197554319679490,,,,
BayerPharma,5/29/2014 22:01,0,0,Are you attending # ASCO14? Follow @BayerHealthCare for meeting updates,,@BayerHealthCare,#,4.72196E+17,https://twitter.com/BayerPharma/status/472196182631268352,,,,
drdonsdizon,5/29/2014 22:00,12,2,H Pan of EBCTCG: #503 Obesity impacts breastca mortality specifically in pre/perimenopausal women. # bcsm # ASCO14 http://abstracts.asco.org/144/AbstView_144_133648.html …,,,#503 # #,4.72196E+17,https://twitter.com/drdonsdizon/status/472195704417300481,,,,
elenaptobin,5/29/2014 21:59,1,2,. @ ASCO Conference starts tomorrow. Follow # ASCO14 for latest on # oncology # cancer # research # melsm # health.,,@,# # # # # #,4.72196E+17,https://twitter.com/elenaptobin/status/472195548007501824,,,,
daviesbj,5/29/2014 21:55,0,1,For reasons unrelated to # ASCO14 I shall be at the @ FSChicago fri - sun with my crew. Feel free to send my free drinks,,@,#,4.72195E+17,https://twitter.com/daviesbj/status/472194658286989312,,,,
CRC_Medical,5/29/2014 21:51,0,0,"Will you be at # ASCO2014 in # Chicago tomorrow? If so, be sure to stop by our exciting Booth #23128 for special... http://fb.me/6u5kFuICP",,,# # #23128,4.72194E+17,https://twitter.com/CRC_Medical/status/472193534951292928,,,,
exchequerpub,5/29/2014 21:50,0,0,Exchequer would like to welcome everyone attending the @ ASCO annual meetings & convention! Stop by for some great food & drinks! # ASCO14,,@,#,4.72193E+17,https://twitter.com/exchequerpub/status/472193396694843392,,,,
BiziFranklin,5/29/2014 21:46,1,2,"Being in # Chicago for # ASCO14 makes me remember how much I love this place. It's the best city in the US, especially in the summer.",,,# #,4.72192E+17,https://twitter.com/BiziFranklin/status/472192382218547201,,,,
DrLaraDavis,5/29/2014 21:45,0,0,In Chicago for # ASCO14 and SARC meeting.,,,#,4.72192E+17,https://twitter.com/DrLaraDavis/status/472192077011632128,,,,
DrMiguelPerales,5/29/2014 21:45,1,0,Neoantigen landscape underlying clinical response to ipilimumab @ sloan_kettering study # ASCO14 http://bit.ly/1ixhI4E # immunotherapy,,@,# #,4.72192E+17,https://twitter.com/DrMiguelPerales/status/472192063933399041,,,,
OAkkerman_ERG,5/29/2014 21:44,1,2,BI makes curious Twitter play in # lungcancer for # ASCO14. More in our blog. # environicspharma http://www.environics.ca/environics-health--pharma-blog/category/1/ASCO-2014 …,,,# # #,4.72192E+17,https://twitter.com/OAkkerman_ERG/status/472191828524273665,,,,
z_phd,5/29/2014 21:40,0,1,"Who's ready for # ASCO14? Just as importantly, who's ready for some of @ genentech's cookies?",,@,#,4.72191E+17,https://twitter.com/z_phd/status/472190749187260417,,,,
genentech,5/29/2014 21:40,2,1,What are your predictions for # CancerResearch advancements in the # Next50 yrs? # ASCO14 @ TGeorgeMD @ mtmdphd @ subatomicdoc,,@ @ @,# # #,4.72191E+17,https://twitter.com/genentech/status/472190694933954560,,,,
mtmdphd,5/29/2014 21:40,2,1,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnYYm # ASCO14,,@,# #,4.72191E+17,https://twitter.com/mtmdphd/status/472190693205889024,,,,
DrMiguelPerales,5/29/2014 21:33,1,2,Ph I/II of romidepsin + lenalidomide in relrefr lymphoma & myeloma http://bit.ly/1nIvve3 @ sloan_kettering study @ # ASCO14 # mmsm # lymsm,,@ @,# # #,4.72189E+17,https://twitter.com/DrMiguelPerales/status/472188964066299904,,,,
subatomicdoc,5/29/2014 21:30,0,0,"@ drseisenberg Thanks for the mention, Steven! Will you be in Chicago for # ASCO14?",,@,#,4.72188E+17,https://twitter.com/subatomicdoc/status/472188340830502912,,,,
TracyW95,5/29/2014 21:30,1,1,# ASCO14 BEST CITY EVER # Chicagopic.twitter.com/5tmZdgjE5R,,,# #,4.72188E+17,https://twitter.com/TracyW95/status/472188231224934400,,,,
MyelomaTeacher,5/29/2014 21:25,1,0,# Myeloma at # ASCO14: A Preview of the Highlights # MMSM @ BrianDurieMD @ IMFmyeloma http://myeloma.org/MtEntryPage.action?source=/imf_blogs/myeloma_voices/2014/05/myeloma-at-asco-2014-a-preview-of-the-highlights.html …,,@ @,# # #,4.72187E+17,https://twitter.com/MyelomaTeacher/status/472186949390721024,,,,
adamfeuerstein,5/29/2014 21:21,1,1,. @Sport234a Most of the impt I-O data presents Mon. & Tues. # ASCO14,,@Sport234a,#,4.72186E+17,https://twitter.com/adamfeuerstein/status/472185982637596672,,,,
Sports_bios,5/29/2014 21:20,0,1,"# ASCO14 technically start tmrw, though huge wave of data from wknd sessions..",,,#,4.72186E+17,https://twitter.com/Sports_bios/status/472185771106267137,,,,
DrMiguelPerales,5/29/2014 21:18,1,0,Assoc of progression on ibrutinib w acquisition of resistance mutations: @ OSUCCC_James experience 267 pts http://bit.ly/1o2Kiyy # ASCO14,,@,#,4.72185E+17,https://twitter.com/DrMiguelPerales/status/472185311335038977,,,,
MyelomaTeacher,5/29/2014 21:15,2,3,2014 ASCO Coverage http://www.themmrf.org/living-with-multiple-myeloma/2014-asco-coverage.html#sthash.zhMLXBFP.uxfs … via @ sharethis # ASCO14 # MMSM @ theMMRF,,@ @,#sthash # #,4.72184E+17,https://twitter.com/MyelomaTeacher/status/472184424855904256,,,,
DrMiguelPerales,5/29/2014 21:07,5,1,Haplo+cord results in much faster engraftment than dUCB transplant w trend to improved survival http://bit.ly/1oA910Y # ASCO14 # bmtsm,,,# #,4.72183E+17,https://twitter.com/DrMiguelPerales/status/472182528745693185,,,,
DrMiguelPerales,5/29/2014 21:04,0,0,Next-generation seq identifies high frequency of potentially prognostic mutations in allo-SCT patients w AML http://bit.ly/1nIqnqv # ASCO14,,,#,4.72182E+17,https://twitter.com/DrMiguelPerales/status/472181657945255937,,,,
SurgeonsSOS,5/29/2014 21:00,0,1,Attending # ASCO14 & interested in # globalsurgery? Look for Dr Alatishe from Nigeria. He & @ SurgeonsSOSPrez have a great CRC project,,@,# #,4.72181E+17,https://twitter.com/SurgeonsSOS/status/472180759130697728,,,,
MyelomaTeacher,5/29/2014 20:56,0,0,@ OnyxPharm @ ASCO I'll be following along on Twitter!,,@ @,,4.7218E+17,https://twitter.com/MyelomaTeacher/status/472179759028252673,,,,
cesarlopezhouse,5/29/2014 20:53,0,0,"@ informador_JAL cuándo los soltaran? Ni recibirlos querían, @ quepena @ asco",,@ @ @,,4.72179E+17,https://twitter.com/cesarlopezhouse/status/472178906607665154,,,,
DrMiguelPerales,5/29/2014 20:47,4,0,Potential link b/w inflammation and depression in allogeneic stem cell transplant http://bit.ly/SWaMZ1 # ASCO14 # bmtsm,,,# #,4.72178E+17,https://twitter.com/DrMiguelPerales/status/472177503545458689,,,,
yzafar,5/29/2014 20:46,5,0,"For met # colorectalcancer, drop the oxaliplatin after 6 cycles and continue maintenance cape+bev http://bit.ly/1lVF7hj # ASCO14 # crcsm",,,# # #,4.72177E+17,https://twitter.com/yzafar/status/472177153459900416,,,,
DrMiguelPerales,5/29/2014 20:43,0,0,Potential benefit of HSV-TK+ suicide gene donor lymphocytes after haplo-HSCT http://bit.ly/1hhGNGa # ASCO14 # bmtsm,,,# #,4.72176E+17,https://twitter.com/DrMiguelPerales/status/472176482648072192,,,,
ChapinMD,5/29/2014 20:43,0,0,No twitter parties at # ASCO14?,,,#,4.72176E+17,https://twitter.com/ChapinMD/status/472176449546252288,,,,
ByJonGardner,5/29/2014 20:38,0,0,The # sgenball did not raise any alerts with Heathrow security. It has become my # ASCO14 Flat Stanley. $ SGEN,,,# #,4.72175E+17,https://twitter.com/ByJonGardner/status/472175072250040320,,,,
UNCurology,5/29/2014 20:30,1,0,Surgical ischemia & detection of clear cell RCC biomarkers @NC_KidneyCancer @ UroOncMD et al # ASCO14 http://ow.ly/xphj0,,@NC_KidneyCancer @,#,4.72173E+17,https://twitter.com/UNCurology/status/472173165247213569,,,,
corp_UNC,5/29/2014 20:30,1,0,Surgical ischemia & detection of clear cell RCC biomarkers @NC_KidneyCancer @ UroOncMD et al # ASCO14 http://ow.ly/xpgS7,,@NC_KidneyCancer @,#,4.72173E+17,https://twitter.com/corp_UNC/status/472173122272387072,,,,
BayerPharma,5/29/2014 20:24,0,0,Bayer HealthCare is getting ready for # ASCO14. We are happy to welcome # ASCO14 visitors tomorrow!,,,# #,4.72172E+17,https://twitter.com/BayerPharma/status/472171683097612288,,,,
ASCO,5/29/2014 20:20,6,6,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.72171E+17,https://twitter.com/ASCO/status/472170576648634368,,,,
CancerSupportHQ,5/29/2014 20:17,3,2,We're ready - largest medical oncology meeting in the world - the 50th annual mtg of @ ASCO! Stay tuned for updates! pic.twitter.com/jGxC4nZN7s,,@,,4.7217E+17,https://twitter.com/CancerSupportHQ/status/472169837050232832,,,,
FightCRC,5/29/2014 20:16,4,0,"RT @ myriadgenetics: Here are 10 Things You Need to Know About # LynchSyndrome, a common cause of # coloncancer: http://bit.ly/JOM2wD # ASCO14",,@,# # #,4.7217E+17,https://twitter.com/FightCRC/status/472169611761577984,,,,
DNM_Chicago,5/29/2014 20:14,0,0,RT @ # ASCO14 We created a special cocktail just for you!! Welcome! http://fb.me/1hfr62wCK http://bit.ly/SiTzs1,,@,#,4.72169E+17,https://twitter.com/DNM_Chicago/status/472169076802850816,,,,
DNM_Chi_Dining,5/29/2014 20:14,0,0,RT @ # ASCO14 We created a special cocktail just for you!! Welcome! http://fb.me/1hfr62wCK http://bit.ly/SiTzs1,,@,#,4.72169E+17,https://twitter.com/DNM_Chi_Dining/status/472169075452280832,,,,
JackWestMD,5/29/2014 20:13,0,7,"Judging by my flight, I think there may be a screaming baby convention in Chicago in addition to # ASCO14. # FindingMyHappyPlace",,,# #,4.72169E+17,https://twitter.com/JackWestMD/status/472168988760219648,,,,
MyelomaTeacher,5/29/2014 20:08,0,0,OncoBriefs: # Myeloma Studies Presented at # ASCO14 http://www.medpagetoday.com/MeetingCoverage/ASCO/46050?utm_source=feedburner …,,,# #,4.72168E+17,https://twitter.com/MyelomaTeacher/status/472167709141004288,,,,
LockwoodChicago,5/29/2014 20:04,1,0,# ASCO14 We created a special cocktail just for you!! Welcome! http://fb.me/1hfr62wCK,,,#,4.72167E+17,https://twitter.com/LockwoodChicago/status/472166664315084800,,,,
DrAnasYounes,5/29/2014 20:04,1,1,Was planning to visit during # ASCO14 => Chicago Skydeck on 103rd floor begins to crack under family http://fxn.ws/1tseOTW,,,#,4.72167E+17,https://twitter.com/DrAnasYounes/status/472166604600786944,,,,
ASCO,5/29/2014 20:01,5,6,"# ASCO14 begins tomorrow in Chicago. For media interviews, email mediateam@asco.org or visit the Interview Request Booth in the Press Room",,@asco,#,4.72166E+17,https://twitter.com/ASCO/status/472165835709374464,,,,
Rad_Nation,5/29/2014 19:54,3,3,@ jpil @ marykge @ MKnoll_MD @ wallyjc @ cd_fuller @ jamesbyu Going to # ASCO14? We'll be tweeting new # radonc research from the meeting.,,@ @ @ @ @ @,# #,4.72164E+17,https://twitter.com/Rad_Nation/status/472164139205660672,,,,
DrR_DUNNE,5/29/2014 19:53,0,0,"Looking forward to # Asco14 tomorrow, which will be my first. Any tips or recs welcome",,,#,4.72164E+17,https://twitter.com/DrR_DUNNE/status/472163804433088512,,,,
MatthewHSimmons,5/29/2014 19:51,0,0,Loooooooooong taxi line @ORD... # ASCO14,,@ORD,#,4.72163E+17,https://twitter.com/MatthewHSimmons/status/472163470155481090,,,,
MyelomaTeacher,5/29/2014 19:51,3,2,Who is tweeting about # myeloma from # ASCO14? I want to make a group list that I will share.,,,# #,4.72163E+17,https://twitter.com/MyelomaTeacher/status/472163391155732480,,,,
DrMStiegler,5/29/2014 19:49,0,1,"LOL RT @ JackWestMD: Heading for # ASCO14 Expecting a plane full of pharma folks (upgraded, they fly >100K miles/yr), w/oncologists in coach",,@,#,4.72163E+17,https://twitter.com/DrMStiegler/status/472162773036974080,,,,
rdoebele,5/29/2014 19:48,0,0,Going to # ASCO14? Stop by my poster #8048 on Sat 1-5p and say hi. http://meetinglibrary.asco.org/content/135058-144 …,,,# #8048,4.72162E+17,https://twitter.com/rdoebele/status/472162484002897921,,,,
emilylmullin,5/29/2014 19:47,0,1,# ASCO14 kicks off tomorrow. Check out my piece on the outlook for cancer vaccines http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29 …,,,#,4.72162E+17,https://twitter.com/emilylmullin/status/472162395025326081,,,,
WrigleyTom,5/29/2014 19:36,0,2,# ASCO14 Nice preview by @ megtirrell on @ CNBCFastMoney http://video.cnbc.com/gallery/?video=3000279633 … $ BMY $ MRK $ AZN $ INCY $ PCYC $ ABBV $ GILD $ INFI $ CLVS $ GILD $ CLDX,,@ @,#,4.7216E+17,https://twitter.com/WrigleyTom/status/472159611479281664,,,,
wordbistro,5/29/2014 19:32,0,0,RT @ jrgralow: What is the ASCO Annual Meeting? | http://Cancer.Net http://www.cancer.net/blog/2014-05/what-asco-annual-meeting#.U4emH-fbUSw.twitter … # ASCO14,,@,# #,4.72159E+17,https://twitter.com/wordbistro/status/472158682936279040,,,,
corp_UNC,5/29/2014 19:30,1,1,Initial Rx w TACE vs Y90 radioemboliz'n for HCC in SEER-MC Hanna Sanoff et al @ UNC_Lineberger @ UNC_RxEPI # asco14 http://ow.ly/xpfRW,,@ @,#,4.72158E+17,https://twitter.com/corp_UNC/status/472158187530252288,,,,
AmbryGenetics,5/29/2014 19:29,0,2,"Stop by and say hi! RT @ FightCRC @ ASCO Going to the 50th annual @ ASCO meeting tomorrow? So are we, be sure to swing by our booth! # ASCO14",,@ @ @,#,4.72158E+17,https://twitter.com/AmbryGenetics/status/472157777285357568,,,,
Boehringer,5/29/2014 19:29,1,2,BLOG POST: What to expect @ # ASCO14 - # lungcancer beyond treatment. http://bit.ly/WhatToExpectASCO14 … - # NotJustOneDisease,,@,# # #,4.72158E+17,https://twitter.com/Boehringer/status/472157729549983744,,,,
FightCRC,5/29/2014 19:25,0,2,"Going to the 50th annual @ ASCO meeting tomorrow? So are we, be sure to swing by our booth! # ASCO14",,@,#,4.72157E+17,https://twitter.com/FightCRC/status/472156725441990656,,,,
myriadgenetics,5/29/2014 19:25,0,0,"Here are 10 Things You Need to Know About # LynchSyndrome, a common cause of # coloncancer: http://bit.ly/JOM2wD # ASCO14 # hereditarycancer",,,# # # #,4.72157E+17,https://twitter.com/myriadgenetics/status/472156684492632064,,,,
MaisaCorp,5/29/2014 19:23,0,0,@ TravisMKnight @ kumarlove09 @ mediausma90 see a surge in biotech sector lately due to # ASCO14 hope $ ABBV $ ENTA will get priority review 6 mon,,@ @ @,#,4.72156E+17,https://twitter.com/MaisaCorp/status/472156415017353216,,,,
DrMarkham,5/29/2014 19:12,2,0,Promising! MT @ rsm2800: # ASCO14 Analytics. 1500+ tweets & mtg hasn't started yet! Terrific engagement http://www.symplur.com/healthcare-hashtags/ASCO14/analytics/?hashtag=ASCO14&fdate=05%2F27%2F2014&shour=0&smin=0&tdate=05%2F29%2F2014&thour=5&tmin=24&ssec=00&tsec=00&img=1 … via @ symplur,,@ @,#,4.72154E+17,https://twitter.com/DrMarkham/status/472153536281980928,,,,
ygitya,5/29/2014 19:09,0,3,"Curious! @BayerHealthCare: Just one day left until # ASCO14 kicks off. We will talk about # oncology # R&D.""""",,@BayerHealthCare,# # #,4.72153E+17,https://twitter.com/ygitya/status/472152761367158786,,,,
FoundationATCG,5/29/2014 19:02,2,2,Looking forward to the start of # ASCO14 tomorrow. Check out the schedule of our posters and presentations! http://www.foundationone.com/asco2014/ @ ASCO,,@,#,4.72151E+17,https://twitter.com/FoundationATCG/status/472151125320556545,,,,
subatomicdoc,5/29/2014 19:02,0,0,@ FightCRC What's your booth #at # ASCO14?,,@,#at #,4.72151E+17,https://twitter.com/subatomicdoc/status/472151046023041024,,,,
subatomicdoc,5/29/2014 19:01,0,1,@ FightCRC Yes - I'll swing by Sunday or Monday! # ASCO14,,@,#,4.72151E+17,https://twitter.com/subatomicdoc/status/472150876443140096,,,,
appistry,5/29/2014 19:00,0,0,Stay tuned for an exciting announcement around our new cloud-based service for # genomics at booth 16152 at # ASCO14! # Ayrris # NGS,,,# # # #,4.72151E+17,https://twitter.com/appistry/status/472150596611768321,,,,
EXDIOW,5/29/2014 18:57,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8mmC",,,#,4.7215E+17,https://twitter.com/EXDIOW/status/472149804017922048,,,,
maciawto,5/29/2014 18:57,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8mkX",,,#,4.7215E+17,https://twitter.com/maciawto/status/472149799228030976,,,,
dpriyarn,5/29/2014 18:57,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8mhj",,,#,4.7215E+17,https://twitter.com/dpriyarn/status/472149794878545920,,,,
RizkiMki,5/29/2014 18:57,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8mZN",,,#,4.7215E+17,https://twitter.com/RizkiMki/status/472149782018789376,,,,
RamalingamMD,5/29/2014 18:57,0,0,Congratulations to # IASLC on the release of the next edition of the most authoritative Lung Cancer textbook during # ASCO14.,,,# #,4.7215E+17,https://twitter.com/RamalingamMD/status/472149767431409666,,,,
myPathMelanoma,5/29/2014 18:57,0,0,Myriad myPath # Melanoma is presenting Influence of Gene Signature on Melanocytic Tumors on Sat. May 31st 8am-11:45am # isthismelanoma # ASCO14,,,# # #,4.7215E+17,https://twitter.com/myPathMelanoma/status/472149637986410496,,,,
stales,5/29/2014 18:43,0,1,I should be there RT @ Gene_Antibody: We’re in! MT @ Roche @ ASCO: Twitter’s role during scientific meetings? http://ow.ly/xl2oP # ASCO14,,@ @ @,#,4.72146E+17,https://twitter.com/stales/status/472146158648033280,,,,
Gene_Antibody,5/29/2014 18:40,0,1,We're in! MT @ Roche @ ASCO: Twitter's role during scientific meetings? http://ow.ly/xl2oP # ASCO14 # hcsm,,@ @,# #,4.72145E+17,https://twitter.com/Gene_Antibody/status/472145411567009792,,,,
rioconsulado,5/29/2014 18:39,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8X77",,,#,4.72145E+17,https://twitter.com/rioconsulado/status/472145169098100736,,,,
sidanews,5/29/2014 18:39,0,0,"Renowned Radiation Oncologist Can Breakdown # ASCO14 Studies, Advise On Radiation-Toxicity Levels http://dlvr.it/5q8X3C",,,#,4.72145E+17,https://twitter.com/sidanews/status/472145159115665408,,,,
AlpineBV_Miller,5/29/2014 18:36,0,0,I think we landed at Midway and are now taxiing to O'Hare. # ASCO14,,,#,4.72144E+17,https://twitter.com/AlpineBV_Miller/status/472144353683841026,,,,
FoxChaseCancer,5/29/2014 18:35,3,3,Fox Chase faculty are ready to share their research findings at # ASCO14. Stay tuned for more tweets from the meeting! # Oncology # Cancer,,,# # #,4.72144E+17,https://twitter.com/FoxChaseCancer/status/472144324940300289,,,,
rsm2800,5/29/2014 18:29,5,7,# ASCO14 Analytics. 1500+ tweets (some prob spam tho') & the mtg hasn't started yet! Terrific engagement http://www.symplur.com/healthcare-hashtags/ASCO14/analytics/?hashtag=ASCO14&fdate=05%2F27%2F2014&shour=0&smin=0&tdate=05%2F29%2F2014&thour=5&tmin=24&ssec=00&tsec=00&img=1 … via @ symplur,,@,#,4.72143E+17,https://twitter.com/rsm2800/status/472142720194981888,,,,
CCBrooksScience,5/29/2014 18:25,1,0,. @ CitelineRachelM looking deeper into the early # oncology # immunotherapy pipelines by analyzing # ASCO2014 abstracts. http://bit.ly/SVNyCm,,@,# # #,4.72142E+17,https://twitter.com/CCBrooksScience/status/472141710005243905,,,,
JoleneScience,5/29/2014 18:25,0,0,$ GHDX's OncotypeDX predicts # breastcancer pts likely to benefit from extended tamoxifen (>5yrs) # ASCO14 @MedTechRobert @ MedDeviceTrackr,,@MedTechRobert @,# #,4.72142E+17,https://twitter.com/JoleneScience/status/472141656016171009,,,,
CancerMedMDA,5/29/2014 18:25,0,0,"Curious about adoptive T-cell therapy for cancer, but not an immunologist? Attend Dr. Cassian Yee's education session Fri. 2 PM. # ASCO14",,,#,4.72142E+17,https://twitter.com/CancerMedMDA/status/472141617231826945,,,,
dfgaddy,5/29/2014 18:23,0,0,Abuzz About # Immunotherapies: A Preview of the Latest in Cancer Therapy http://ow.ly/xpmql # ASCO14,,,# #,4.72141E+17,https://twitter.com/dfgaddy/status/472141293804851200,,,,
rschilsky,5/29/2014 18:22,2,3,Listening to terrific presentations from ASCO's Leadership Development Program members at # ASCO14.,,,#,4.72141E+17,https://twitter.com/rschilsky/status/472141050879176704,,,,
Gene_Antibody,5/29/2014 18:20,1,0,Read about how we (antibodies) act as “beacons” to flag a tumor for destruction by immune system # ASCO14 http://ow.ly/xn22g,,,#,4.7214E+17,https://twitter.com/Gene_Antibody/status/472140402653659136,,,,
CancerMedMDA,5/29/2014 18:20,0,0,Don't miss breast cancer Dr. Banu Arun's educational session Fri. 3 PM on communicating genomics results to patients # ASCO14 # endcancer,,,# #,4.7214E+17,https://twitter.com/CancerMedMDA/status/472140386253946880,,,,
5amsolutions,5/29/2014 18:19,1,0,5AM is a trusted partner in cancer research. Look out Chicago - we're # ASCO14 bound! http://info.5amsolutions.com/a-trusted-partner-in-cancer-research …,,,#,4.7214E+17,https://twitter.com/5amsolutions/status/472140320562741248,,,,
JanssenUS,5/29/2014 18:19,2,0,Janssen to present new data in hematological malignancies and solid tumors at # ASCO14 http://bit.ly/1sBC6Gz,,,#,4.7214E+17,https://twitter.com/JanssenUS/status/472140269430005761,,,,
EdwinPosadasMD,5/29/2014 18:18,0,0,# ASCO14 starts tomorrow. Stay tuned for updates in # prostatecancer # KidneyCancer and # bladdercancer,,,# # # #,4.7214E+17,https://twitter.com/EdwinPosadasMD/status/472140012990246912,,,,
Boehringer,5/29/2014 18:18,1,1,RT @ ASCO: Many ways to connect with us on social media during # ASCO14 http://bit.ly/1o8Ltk4 # hcsm # hcsmeu,,@,# # #,4.7214E+17,https://twitter.com/Boehringer/status/472140004891054080,,,,
subatomicdoc,5/29/2014 18:17,0,0,@ FightCRC Do you have a booth at # ASCO14?,,@,#,4.7214E+17,https://twitter.com/subatomicdoc/status/472139805930049537,,,,
FightCRC,5/29/2014 18:17,0,2,MT So are we @ carisls // @ FightCRC You're very welcome! Looking forward to seeing you at @ ASCO!! # ASCO14,,@ @ @,#,4.7214E+17,https://twitter.com/FightCRC/status/472139606306340864,,,,
IFitzy5,5/29/2014 18:16,5,0,Great Blog @ CitelineRachelM! What # immunotherapies warrant our attention at # ASCO14? http://bit.ly/SVNyCm,,@,# #,4.72139E+17,https://twitter.com/IFitzy5/status/472139474148007936,,,,
ClevelandClinic,5/29/2014 18:16,12,4,New @ ASCO guidelines focus on common symptoms that affect the 13M Americans surviving # cancer:http://consultqd.clevelandclinic.org/2014/05/for-cancer-survivorship-programs-the-evidence-is-in/?utm_campaign=cc+tweets&utm_medium=social&utm_source=twitter&utm_content=140529+asco+guidelines&dynid=twitter-_-cc+tweets-_-social-_-social-_-140529+asco+guidelines …,,@,#,4.72139E+17,https://twitter.com/ClevelandClinic/status/472139365863264256,,,,
NCIgenomics,5/29/2014 18:15,0,0,RT @ mtmdphd: Let’s “Connect The Dots” Faster -- Can We Build A Kickstarter For Cancer? - Forbes http://ow.ly/nB8Ho HT @ ASCO # CancerLinQ,,@ @,#,4.72139E+17,https://twitter.com/NCIgenomics/status/472139168081252354,,,,
OncLive,5/29/2014 18:15,0,0,Dr. Formenti on Concurrent Adjuvant Systemic Therapy and Accelerated Radiotherapy in TNBC http://ow.ly/xpyMV # ASCO14 # bcsm,,,# #,4.72139E+17,https://twitter.com/OncLive/status/472139091505840130,,,,
existent_io,5/29/2014 18:10,0,0,@ Viscira - Thousands defending on # Chicago in anticipation of # ASCO14 looking forward to seeing familiar faces,,@,# #,4.72138E+17,https://twitter.com/existent_io/status/472138030065938432,,,,
BrentApplegate,5/29/2014 18:10,2,1,RT @ ElizBlanchardMD: Beautiful day in Chicago! # ASCO14 pic.twitter.com/la3LiRPYpN,,@,#,4.72138E+17,https://twitter.com/BrentApplegate/status/472137895932071936,,,,
JTCancerCenter,5/29/2014 18:05,1,2,This weekend # JTCancerCenter will be partaking in @ ASCO's 50th Annual Science&Society Conference in Chicago. # ASCO14 http://bcove.me/2nxkdk7j,,@,# #,4.72137E+17,https://twitter.com/JTCancerCenter/status/472136566610341889,,,,
SHAREing,5/29/2014 18:00,1,0,"Webinar w/ @drdondizon on what # ASCO14 news means for # metastatic disease Th, 6/12, 12:30-1:30 PM ET http://ow.ly/xm0Er",,@drdondizon,# #,4.72135E+17,https://twitter.com/SHAREing/status/472135481233518593,,,,
SanofiUS,5/29/2014 18:00,2,0,We're looking forward to a great # ASCO14 beginning tomorrow! See all of you attendees in Chicago. Safe travels!,,,#,4.72135E+17,https://twitter.com/SanofiUS/status/472135313075490816,,,,
myPathMelanoma,5/29/2014 18:00,0,0,Myriad myPath # Melanoma objectively differentiates # malignant melanoma from # benign nevi # melanomadiagnostic # isthismelanoma # ASCO14,,,# # # # # #,4.72135E+17,https://twitter.com/myPathMelanoma/status/472135298671849473,,,,
SWOG,5/29/2014 17:56,3,2,MT @ jrgralow Social Media in Clinical Trials # ASCO14 Educational Book by @ mtmdphd http://meetinglibrary.asco.org/content/11400101-144 … # SWOGonc,,@ @,# #,4.72135E+17,https://twitter.com/SWOG/status/472134509698105344,,,,
BayerPharma,5/29/2014 17:55,2,1,Just one day left until # ASCO14 kicks off. We will talk about # oncology # R&D.,,,# # #,4.72134E+17,https://twitter.com/BayerPharma/status/472134205049438208,,,,
davidgrahammd,5/29/2014 17:54,0,0,Good to know I'm in the right room # ASCO14 # hiltonpic.twitter.com/KL9fSCsHnq,,,# #,4.72134E+17,https://twitter.com/davidgrahammd/status/472133874936721408,,,,
GenentechJobs,5/29/2014 17:53,0,0,# ASCO14 Talent Hunt: Clinical Scientist Specialist: http://click2apply.net/0412468t Retweet please.,,,#,4.72134E+17,https://twitter.com/GenentechJobs/status/472133764827463681,,,,
GenentechJobs,5/29/2014 17:53,0,0,Our VP of Clinical Oncology - Dietmar Berger and the role of the HER2 receptor in metastatic breast cancer. http://bit.ly/1mMs4C7 # ASCO14,,,#,4.72134E+17,https://twitter.com/GenentechJobs/status/472133535810088960,,,,
appistry,5/29/2014 17:51,0,0,Tomorrow is the day! # ASCO14 begins & we can’t wait to showcase our services at booth 16152 # Genomics # GEM # Ayrris,,,# # # #,4.72133E+17,https://twitter.com/appistry/status/472133127679524864,,,,
Biorunner1,5/29/2014 17:50,0,0,@ megtirrell @ regis @ ASCO @ CNBCFastMoney thanks for the $ clvs mention!,,@ @ @ @,,4.72133E+17,https://twitter.com/Biorunner1/status/472132857130139650,,,,
AndyMalavsky,5/29/2014 17:50,0,0,ADVAXIS selects inVentiv Clinical to conduct trials of immunotherapy candidates. Visit us at booth 7127 # ASCO2014,,,#,4.72133E+17,https://twitter.com/AndyMalavsky/status/472132831544487937,,,,
GenentechJobs,5/29/2014 17:48,0,0,# ASCO14 Talent Hunt: Companion Diagnostic Leader: http://click2apply.net/419110t Retweet please.,,,#,4.72132E+17,https://twitter.com/GenentechJobs/status/472132422541115392,,,,
LinicalAmericas,5/29/2014 17:48,1,2,@Accelovance will be live-tweeting from # ASCO14 sessions this weekend. Looking forward to the latest Onc research news. Safe travels!,,@Accelovance,#,4.72132E+17,https://twitter.com/LinicalAmericas/status/472132288780992512,,,,
JamesPPinkerton,5/29/2014 17:46,4,4,Help me spread the word that # cancer # innovation matters. # mliwi # asco14 http://mylifeisworthit.org?kid=39HP3mylifeisworthit.org/?kid=39HP3,,,# # # #,4.72132E+17,https://twitter.com/JamesPPinkerton/status/472131950639984640,,,,
VistaMME,5/29/2014 17:46,0,0,Our @ ASCO # Chicago groups have arrived! Getting them settled into the hotels & then going to dinner. Can't wait for the convention to start!,,@,#,4.72132E+17,https://twitter.com/VistaMME/status/472131786084859905,,,,
DrHedrick,5/29/2014 17:45,0,0,Excited to be heading to # ASCO14 this weekend in Chicago. Last year was so rewarding and met many great minds live tweeting. See you there!,,,#,4.72132E+17,https://twitter.com/DrHedrick/status/472131649438613506,,,,
ConquerCancerFd,5/29/2014 17:45,2,1,We're all set up! @ iConquerCancer donors at # ASCO14 - be sure to stop by the Donor Lounge (S401) & say hello! http://ow.ly/i/5Juy1,,@,#,4.72132E+17,https://twitter.com/ConquerCancerFd/status/472131628790456322,,,,
GenentechJobs,5/29/2014 17:45,0,0,"# ASCO14 Talent Hunt: Medical Director, Pi3Kinase: http://click2apply.net/430228t Retweet please.",,,#,4.72132E+17,https://twitter.com/GenentechJobs/status/472131613497638912,,,,
LinicalAmericas,5/29/2014 17:45,2,1,"Attending # ASCO14? Our Work/Play Guide is a MUST for conference info/tips, hot spots, and trivia! http://accelovance.com/workplay.php @Accelovance",,@Accelovance,#,4.72132E+17,https://twitter.com/LinicalAmericas/status/472131556405178368,,,,
MaverickNY,5/29/2014 17:44,0,0,@ mtmdphd is there and official # asco14 tweetup this year? Can't find it in the iplanner,,@,#,4.72131E+17,https://twitter.com/MaverickNY/status/472131405590585345,,,,
GenentechJobs,5/29/2014 17:44,0,0,"# ASCO14 Talen Hunt: Senior Medical Director, Zelboraf: http://click2apply.net/429263t Retweet please.",,,#,4.72131E+17,https://twitter.com/GenentechJobs/status/472131304847196160,,,,
rsm2800,5/29/2014 17:43,2,1,Endocrine Therapy Toxicity: Management Options | 2014 Educational Book | Meeting Library http://meetinglibrary.asco.org/content/11400025-144#.U4epy0v8S9Y.twitter … # ASCO14,,,# #,4.72131E+17,https://twitter.com/rsm2800/status/472131125175803904,,,,
ASCO,5/29/2014 17:42,9,11,Many ways to connect with us on social media during # ASCO14 http://bit.ly/1o8Ltk4 # hcsm,,,# #,4.72131E+17,https://twitter.com/ASCO/status/472130993198219264,,,,
GenentechJobs,5/29/2014 17:39,0,1,"Follow us on http://Facebook.com/genentechjobs , LinkedIn & here as we head to # ASCO14 for 50th anniversary conference # cancerresearch.",,,# #,4.7213E+17,https://twitter.com/GenentechJobs/status/472130208481288193,,,,
ematich,5/29/2014 17:37,0,1,Excited for # ASCO14. Heading to Chicago to highlight work of # CUCancer.,,,# #,4.7213E+17,https://twitter.com/ematich/status/472129724433432576,,,,
johnwrght473,5/29/2014 17:36,0,0,@ megtirrell @ regis @ ASCO @ CNBCFastMoney I like how the healthy cells are extracted then reinforce then reinserted to fight off the cancer.,,@ @ @ @,,4.72129E+17,https://twitter.com/johnwrght473/status/472129488927481857,,,,
SiliconBio,5/29/2014 17:35,0,0,Excited to be heading to Chicago for # ASCO14. Visit @ SiliconBio at booth 24101 for exciting product updates! http://hub.am/1iwESbh @ ASCO,,@ @,#,4.72129E+17,https://twitter.com/SiliconBio/status/472129099377704960,,,,
megtirrell,5/29/2014 17:32,1,5,"From chatting Cialis with @ regis y'day to # ASCO14 today. Looking at what's hot, in addn to immunotherapy, at @ ASCO on @ CNBCFastMoney tonight",,@ @ @,#,4.72128E+17,https://twitter.com/megtirrell/status/472128484815683584,,,,
malachigriffith,5/29/2014 17:32,0,1,@ bgood I’m at ASCO and just learned about http://www.strandomics.com/ “From reads to clinical reports….” # ASCO14,,@,#,4.72128E+17,https://twitter.com/malachigriffith/status/472128407589761024,,,,
smerv,5/29/2014 17:31,0,0,Stay tuned to # ASCO2014 RT @ jrgralow What is the ASCO Annual Meeting? | http://Cancer.Net http://www.cancer.net/blog/2014-05/what-asco-annual-meeting#.U4emH-fbUSw.twitter … …,,@,# #,4.72128E+17,https://twitter.com/smerv/status/472128144267169792,,,,
EdwardLangJr,5/29/2014 17:31,0,0,Almost forgot my badge for # asco14 ! See you in the Windy City @Genentech http://instagram.com/p/omI1rxveZN/,,@Genentech,#,4.72128E+17,https://twitter.com/EdwardLangJr/status/472128038797185025,,,,
myPathMelanoma,5/29/2014 17:31,0,1,Visit Myriad myPath # Melanoma at # ASCO14 booth 2039 & learn how @ MyriadGenetics can help you make a more informed diagnosis # isthismelanoma,,@,# # #,4.72128E+17,https://twitter.com/myPathMelanoma/status/472127995574886400,,,,
jrgralow,5/29/2014 17:31,0,0,Social Media in Clinical Trials # ASCO14 Educational Book http://meetinglibrary.asco.org/content/11400101-144#.U4em4q4HQAV.twitter …,,,# #,4.72128E+17,https://twitter.com/jrgralow/status/472127993930735618,,,,
CancerDotNet,5/29/2014 17:28,4,1,Advocates: Not at @ ASCO's Annual Meeting but want to access to presentations? Info about # ASCO14 Virtual Mtg: http://bit.ly/SVGpBO,,@,#,4.72127E+17,https://twitter.com/CancerDotNet/status/472127256396312578,,,,
CancerNetwrk,5/29/2014 17:23,1,1,ASCO: Molecular Diagnostics Allow Further Understanding of Medulloblastoma http://dlvr.it/5pZTLp # ASCO14,,,#,4.72126E+17,https://twitter.com/CancerNetwrk/status/472126106922151936,,,,
drdonsdizon,5/29/2014 17:17,1,1,@AvonMarc I teamed up w @ Consano 2 study # qualityofcare 4 # survivorswithcancer. Check it out & LMK if UR at # ASCO14 https://www.consano.org/projects/38-is-less-more-for-women-living-with-metastatic-cancer …,,@AvonMarc @,# # #,4.72125E+17,https://twitter.com/drdonsdizon/status/472124707178033152,,,,
mtmdphd,5/29/2014 17:17,0,0,@ rsm2800 Thanks. A lot of social media talks at # ASCO14. They should all complement each other.,,@,#,4.72125E+17,https://twitter.com/mtmdphd/status/472124561560178688,,,,
WCGClinical,5/29/2014 17:11,0,0,"We have reviewed 4,000+ # oncology # protocols in the past four years. Attending # ASCO14 to keep abreast of latest technologies/techniques.",,,# # #,4.72123E+17,https://twitter.com/WCGClinical/status/472123058984345601,,,,
CancerNetwrk,5/29/2014 17:07,5,0,ASCO: Chemotherapy Key Part of Curative Lung Cancer Therapies http://dlvr.it/5py1M9 # ASCO14,,,#,4.72122E+17,https://twitter.com/CancerNetwrk/status/472122048752680960,,,,
Novartis,5/29/2014 17:05,3,3,Be sure to check out our # advancedBC # ASCO14 page throughout the meeting: http://bit.ly/1ipAxGQ,,,# #,4.72122E+17,https://twitter.com/Novartis/status/472121522199732224,,,,
practiceupdate,5/29/2014 17:02,0,0,Will you be in # Chicago this weekend? We'll be at # ASCO14 exhibiting our PracticeUpdate site in booth 21113! @ ASCO # Oncology,,@,# # #,4.72121E+17,https://twitter.com/practiceupdate/status/472120701118590976,,,,
ASCO,5/29/2014 17:01,3,3,ReviewEducational Book articles in advance of # ASCO14 educational sessions http://bit.ly/SLvfQa,,,#,4.7212E+17,https://twitter.com/ASCO/status/472120444431400960,,,,
SCUniversityTV,5/29/2014 16:56,0,1,Will you be attending # ASCO14 this weekend? Visit our sister site # Oncology.TV at booth #20126!,,,# # #20126,4.72119E+17,https://twitter.com/SCUniversityTV/status/472119259674714112,,,,
MPNUniversityTV,5/29/2014 16:55,0,0,Will you be attending # ASCO14 this weekend? Visit our sister site # Oncology.TV at booth #20126!,,,# # #20126,4.72119E+17,https://twitter.com/MPNUniversityTV/status/472119124920119296,,,,
CancerAdvocacy,5/29/2014 16:55,0,0,NCCS looks forward to attending the # ASCO14 conference starting tomorrow @ sfuldnasso @ ASCO # survivorship,,@ @,# #,4.72119E+17,https://twitter.com/CancerAdvocacy/status/472118959752630272,,,,
myPathMelanoma,5/29/2014 16:54,1,0,@ MyriadGenetics' myPath # Melanoma is a clinically validated assay for difficult-to-diagnose # melanocytic lesions # ASCO14 # isthismelanoma,,@,# # # #,4.72119E+17,https://twitter.com/myPathMelanoma/status/472118683251126272,,,,
bgood,5/29/2014 16:49,0,0,I'm looking for competitors for Ingenuity Clinical http://www.ingenuity.com/blog/events/ingenuity-clinical-at-acmg-2014 … maybe someone at # ASCO14 could help ?,,,#,4.72118E+17,https://twitter.com/bgood/status/472117536545202176,,,,
BiologicsMcK,5/29/2014 16:49,0,1,Great read for # ASCO14 attendees! RT @ CancerNetwrk 10 Tricks for Surviving and Thriving at ASCO's Annual Meeting http://dlvr.it/5pzRB4,,@,#,4.72117E+17,https://twitter.com/BiologicsMcK/status/472117447139815424,,,,
Mytrus,5/29/2014 16:45,0,1,RT @ Novartis: . @ Novartis is about to be taken over by our # Oncology colleagues. Join our # advancedBC LIVE Q&A starting in 15 mins. # ASCO14,,@ @,# # #,4.72117E+17,https://twitter.com/Mytrus/status/472116590889029632,,,,
TakedaOncology,5/29/2014 16:45,0,0,"Stepping it up: In an effort to address the obesity-cancer connection, @ ASCO offers new weight-management tools. http://ow.ly/xjGLP",,@,,4.72116E+17,https://twitter.com/TakedaOncology/status/472116497826193408,,,,
oncologyTVfeed,5/29/2014 16:45,0,0,Will you be attending # ASCO14 this weekend? Visit Oncology.TV at booth #20126!,,,# #20126,4.72116E+17,https://twitter.com/oncologyTVfeed/status/472116495338971136,,,,
fwpharma,5/29/2014 16:45,0,0,See the questions we're asking in our latest Physician Views poll ahead of # ASCO14 http://bit.ly/1rjdoiP pic.twitter.com/aaS2GTgaNU # pharma,,,# #,4.72116E+17,https://twitter.com/fwpharma/status/472116477899063297,,,,
WCGClinical,5/29/2014 16:45,0,0,Touched down in Chicago. Sears/Willis Tower dominates the horizon and seems to beckon us toward McCormick Place in prep for # ASCO14.,,,#,4.72116E+17,https://twitter.com/WCGClinical/status/472116455199494146,,,,
ConquerCancerFd,5/29/2014 16:45,6,2,What is # ASCO14 and why is it important to patients w/ # cancer? Find out on the @ CancerDotNet blog: http://bit.ly/1kOQYAO,,@,# #,4.72116E+17,https://twitter.com/ConquerCancerFd/status/472116437805727744,,,,
ventana,5/29/2014 16:40,0,0,RT @ genentech: See how Ph I trials in # CancerResearch are evolving. http://ow.ly/xk5iJ # ASCO14 # Next50,,@,# # #,4.72115E+17,https://twitter.com/ventana/status/472115174510698496,,,,
Harsharajasimha,5/29/2014 16:38,0,0,At # ASCO14 Chicago presenting Strandomics and strand centers for genomics and personalised medicine. Visit booth#3016.,,,# #3016,4.72115E+17,https://twitter.com/Harsharajasimha/status/472114739909111808,,,,
hkrupka,5/29/2014 16:37,0,1,"Heading to # ASCO14! Will be watching data from $ NVS on sonidegib, dabrafenib/trametinib combi-D $ GSK, $ MRK on pembro, $ RHHBY on aPDL1, ADCs",,,#,4.72115E+17,https://twitter.com/hkrupka/status/472114525412810752,,,,
JacobPlieth,5/29/2014 16:32,1,1,Chicago # ASCO14 pic.twitter.com/8flwy8Za02,,,#,4.72113E+17,https://twitter.com/JacobPlieth/status/472113287912755200,,,,
mtmdphd,5/29/2014 16:32,0,1,Dr. Davies presents on Sun --> Novel Combination Rx for Melanoma MT @MDAMelanomaOnc: # ASCO14 iPlanner http://bit.ly/1i3wYK4 # melsm,,@MDAMelanomaOnc,# #,4.72113E+17,https://twitter.com/mtmdphd/status/472113258535858176,,,,
malachigriffith,5/29/2014 16:31,1,1,"A complementary resource to MyCancerGenome, but aimed more at researchers is http://DGIdb.org (http://tinyurl.com/m567zvp ) # ASCO14",,,#,4.72113E+17,https://twitter.com/malachigriffith/status/472113140063150080,,,,
mnewtonPharmD,5/29/2014 16:31,0,1,"Poster printed, ready for # ASCO14 . Thanks @ Dr_Curley !",,@,#,4.72113E+17,https://twitter.com/mnewtonPharmD/status/472112979354591233,,,,
DrMarkham,5/29/2014 16:30,0,0,Immune Therapy’s Cancer Promise Creates Research Rush (via @bloombergnews) http://buff.ly/1kkYDlW # asco14,,@bloombergnews,#,4.72113E+17,https://twitter.com/DrMarkham/status/472112648486924289,,,,
malachigriffith,5/29/2014 16:29,4,2,MyCancerGenome (http://tinyurl.com/n4f7mzp ) is a great resource for cancer clinicians. # ASCO14,,,#,4.72113E+17,https://twitter.com/malachigriffith/status/472112579939028992,,,,
YaleCancer,5/29/2014 16:29,2,0,MT @ ASCO: . @ iconquercancer awards 50 Young Investigator Awards: Kudos to @ YaleCancer's @ simon_p_kim winner of a CDA! http://bit.ly/1pggzWv,,@ @ @ @,,4.72113E+17,https://twitter.com/YaleCancer/status/472112567033143296,,,,
malachigriffith,5/29/2014 16:27,0,0,Dr. Levy: “BRAF positive” is not precise enough. Need to know “primary resistance” vs “primary sensitivity” vs “acquired resistance” # ASCO14,,,#,4.72112E+17,https://twitter.com/malachigriffith/status/472111920267276288,,,,
myPathMelanoma,5/29/2014 16:26,2,0,"Myriad myPath # Melanoma presents: Influence of # Gene Signature on Melanocytic Tumors, Sat. May 31st from 8-11:45am # isthismelanoma # ASCO14",,,# # # #,4.72112E+17,https://twitter.com/myPathMelanoma/status/472111639978713088,,,,
malachigriffith,5/29/2014 16:24,0,0,Dr Levy: Vanderbilt has designed a system for reporting mutation results in electronic medical records (EMRs) # ASCO14,,,#,4.72111E+17,https://twitter.com/malachigriffith/status/472111345328848896,,,,
malachigriffith,5/29/2014 16:22,0,0,Mia Levy: Negative results from targeted sequencing can prevent patients from receiving therapies that would not be effective. # ASCO14,,,#,4.72111E+17,https://twitter.com/malachigriffith/status/472110668548554752,,,,
malachigriffith,5/29/2014 16:20,0,1,Mia Levy: Vanderbilt has applied their targeted cancer panel to ~3400 cases to date. # ASCO14,,,#,4.7211E+17,https://twitter.com/malachigriffith/status/472110247507529728,,,,
YaleCancer,5/29/2014 16:20,1,3,One more day until # asco14. Yale cancer experts are on the way. We'll keep you informed. pic.twitter.com/WH06kVMNnN,,,#,4.7211E+17,https://twitter.com/YaleCancer/status/472110215505408000,,,,
myriadgenetics,5/29/2014 16:20,0,0,# Knowledgeispower! You can find out in 30 seconds about your risk of # hereditarycancer with this simple quiz: http://bit.ly/17zeRbJ # ASCO14,,,# # #,4.7211E+17,https://twitter.com/myriadgenetics/status/472110130134126592,,,,
RfwrightLSL,5/29/2014 16:19,0,0,@ ASCO Life Science Leader magazine's @ WayneKoberstein will be attending # ASCO14 so be sure to introduce yourself,,@ @,#,4.7211E+17,https://twitter.com/RfwrightLSL/status/472110098907537408,,,,
funkyvromero,5/29/2014 16:19,0,0,@ CNBCClosingBell @ ASCO would love to see @ megtirrell do a piece on the @ Nuvilex CEO and COO Q&A.,,@ @ @ @,,4.7211E+17,https://twitter.com/funkyvromero/status/472109982498836482,,,,
EMDSerono,5/29/2014 16:15,0,0,"We’ll be at # ASCO14, booth 14087. What are you looking forward to most at this year’s event?",,,#,4.72109E+17,https://twitter.com/EMDSerono/status/472108925677207553,,,,
SJNaggiar,5/29/2014 16:08,0,0,Made it to Chicago. Much ahead the next few days from # ASCO2014,,,#,4.72107E+17,https://twitter.com/SJNaggiar/status/472107178284032000,,,,
BayerPharma,5/29/2014 16:07,2,1,Preparing for # ASCO14? Check out the meeting abstracts now available online http://am.asco.org/,,,#,4.72107E+17,https://twitter.com/BayerPharma/status/472107016887234560,,,,
InterConChicago,5/29/2014 16:05,0,0,We would like to welcome all of our guests attending # ASCO14. We hope you have a great time in the Windy City! @ ASCO,,@,#,4.72106E+17,https://twitter.com/InterConChicago/status/472106422411722752,,,,
DrMiguelPerales,5/29/2014 16:05,0,0,@ subatomicdoc @ ASCO Won't be attending # ASCO14 but plan to follow on @ twitter,,@ @ @,#,4.72106E+17,https://twitter.com/DrMiguelPerales/status/472106352698220544,,,,
damiangarde,5/29/2014 16:04,6,5,Here's a handy Storify of @ FierceBiotech's # ASCO14 chat with @ PennMedNews' Dr. David Porter. https://storify.com/DamianFierce/fiercebiotech-s-asco14-chat-with-pennmednews-dr-da …,,@ @,#,4.72106E+17,https://twitter.com/damiangarde/status/472106105636925441,,,,
MikeHuckman,5/29/2014 16:02,1,1,Good simple primer  @ megtirrell: Pre # ASCO14,"we look @how immunotherapies work.An animation we call:Immuno-WHAT? http://video.cnbc.com/gallery/?video=3000279876&play=1 …”""",,@ @how,#,4.72106E+17,https://twitter.com/MikeHuckman/status/472105691726221312,,,
bioclinica,5/29/2014 16:01,0,1,See you at the @ ASCO 50th Annual Meeting tomorrow. Stop by and visit us at booth 6109. http://ow.ly/xbnGF # oncology # ASCO14,,@,# #,4.72106E+17,https://twitter.com/bioclinica/status/472105532766318592,,,,
OncTimes_AsstEd,5/29/2014 16:00,0,1,"Look 4 @ OncologyTimes reporting on-site, and @ OncTimes_AsstEd reporting remotely... @ subatomicdoc Have a great # ASCO14!",,@ @ @,#,4.72105E+17,https://twitter.com/OncTimes_AsstEd/status/472105239969951744,,,,
mtmdphd,5/29/2014 16:00,0,0,"The signature program, a series of tissue-agnostic, mutation-specific signal finding trials – TPS2646 – 6/1 8:00-11:45a # ASCO14",,,#,4.72105E+17,https://twitter.com/mtmdphd/status/472105235348221952,,,,
CancerNetwrk,5/29/2014 16:00,1,0,ASCO Annual Meeting Promises Important Updates for CRC Research http://dlvr.it/5pXWmW # ASCO14,,,#,4.72105E+17,https://twitter.com/CancerNetwrk/status/472105166649298944,,,,
RajTriv6,5/29/2014 16:00,0,1,http://digitalinsightsgroup.com/infographic-connected-physician-oncologist-q4-2013/ … # ASCO14 # digital,,,# #,4.72105E+17,https://twitter.com/RajTriv6/status/472105158311428096,,,,
Novartis,5/29/2014 16:00,0,0,We're wrapping up our # advancedBC tweetchat. Pls visit http://bit.ly/1ipAxGQ for more about # Novartis at # ASCO14,,,# # #,4.72105E+17,https://twitter.com/Novartis/status/472105139520933888,,,,
jodigralnick,5/29/2014 16:00,0,0,ICYMI: Immuno-WHAT? @ megtirrell's cool animated explanation of what will be a hot topic at # ASCO14: immunotherapies. http://cnb.cx/1oNX3hV,,@,#,4.72105E+17,https://twitter.com/jodigralnick/status/472105106922409984,,,,
SHAREing,5/29/2014 15:57,0,0,RT @ Novartis We are dedicated to creating awareness & researching treatments for # advancedBC & are looking forward to being a partof # ASCO14,,@,# #,4.72105E+17,https://twitter.com/SHAREing/status/472104533561446400,,,,
JediPD,5/29/2014 15:57,0,0,OncotypeDX predicts Late 5 and 15 year risk of recurrence in breast cancer. # ASCO14 http://www.marketwatch.com/story/oncotype-dx-breast-cancer-test-predicts-late-recurrence-five-to-15-years-out-2014-05-29 …,,,#,4.72104E+17,https://twitter.com/JediPD/status/472104472882454528,,,,
Novartis,5/29/2014 15:56,2,4,We are dedicated to creating awareness & researching treatments for # advancedBC & are looking forward to being a part of # ASCO14,,,# #,4.72104E+17,https://twitter.com/Novartis/status/472104171689476096,,,,
JLErsek,5/29/2014 15:56,0,1,Packing 4 my 1st trip to # ASCO14! Excited abt 4 days of onc news and edu and a night with other # LCI staff. I'll be tweeting! @Carolinas,,@Carolinas,# #,4.72104E+17,https://twitter.com/JLErsek/status/472104137606193152,,,,
Novartis,5/29/2014 15:53,4,2,A9: Novartis Oncology researchers discuss potential for combination therapies for # advancedBC here http://bit.ly/1ipAxGQ (3/3) # ASCO14,,,# #,4.72103E+17,https://twitter.com/Novartis/status/472103385228120064,,,,
mariempowers,5/29/2014 15:52,2,1,"@ BioWorld Science Editor Anette Breindl, Staff Writer @ ORandyO are headed to # ASCO14. Follow for breaking news, live tweets.",,@ @,#,4.72103E+17,https://twitter.com/mariempowers/status/472103309931978753,,,,
PennMedNews,5/29/2014 15:52,0,1,"We're chatting w Dr. David Porter, CAR T cell investigator @ PennMedicine and @ FierceBiotech for # asco14 # fierceASCO",,@ @,# #,4.72103E+17,https://twitter.com/PennMedNews/status/472103202293555200,,,,
jaziehoncology,5/29/2014 15:50,0,0," @ ASCO: 20 tips to get the most of # ASCO14 http://bit.ly/1mxgACT CC @ jaziehoncology"" # ascomeetingtips""",,@ @,# #,4.72103E+17,https://twitter.com/jaziehoncology/status/472102789175590913,,,,
KUhlendorf,5/29/2014 15:50,1,1,"# fierceASCO: Thx for your dedication, Dr Porter. Can you describe the collaborative nature of your work Partnerships, etc? # ASCO14",,,# #,4.72103E+17,https://twitter.com/KUhlendorf/status/472102623123095552,,,,
chemobrainfog,5/29/2014 15:48,1,0,One to watch tomorrow @ ASCO http://am.asco.org/complexity-value-weighing-perspectives-various-stakeholders … Can We Find Common Ground? Stakeholder Perspectives on Value in Cancer Care,,@,,4.72102E+17,https://twitter.com/chemobrainfog/status/472102155428835328,,,,
NickDunnCNBC,5/29/2014 15:47,0,1,"It's the hot topic at the @ ASCO Conference, but what is Immunotherapy? @ megtirrell explains. http://www.cnbc.com/id/101714810 # ASCO14",,@ @,#,4.72102E+17,https://twitter.com/NickDunnCNBC/status/472102033990754304,,,,
Levity63,5/29/2014 15:46,0,0,When does the data hype become creating a demand and promoting before a licence # ASCO14,,,#,4.72102E+17,https://twitter.com/Levity63/status/472101627542138880,,,,
GfK,5/29/2014 15:45,0,1,"Our very own, Alex Bastian, will be highlighting a # health study that was accepted for publication by @ ASCO. # ASCO14",,@,# #,4.72101E+17,https://twitter.com/GfK/status/472101386478690304,,,,
GfK,5/29/2014 15:44,0,0,Presenting at # ASCO14 - “Les Petites Populations: Are Manufacturers Targeting Smaller Patient Populations & Are They Being Rewarded for It”,,,#,4.72101E+17,https://twitter.com/GfK/status/472101221336363010,,,,
MatthewHSimmons,5/29/2014 15:44,0,0,What ? Something OTHER than # ASCO14 going down in Chicago this weekend ? @ PeopleForBikes http://www.peopleforbikes.org/pages/ride-on-chicago …,,@,#,4.72101E+17,https://twitter.com/MatthewHSimmons/status/472101211081281536,,,,
BioWorld,5/29/2014 15:42,2,1,Science editor Anette Breindl & writer Randy Osborne are headed to # ASCO14 to deliver top cancer news. Tune in for live tweets,,,#,4.72101E+17,https://twitter.com/BioWorld/status/472100776634888193,,,,
Fakman1971,5/29/2014 15:42,0,1,Just arrived in Chicago...looking forward to a great # ASCO14,,,#,4.72101E+17,https://twitter.com/Fakman1971/status/472100755219177472,,,,
GfK,5/29/2014 15:42,0,1,"If you’re at # ASCO14, come visit us at Booth #6104 and see our study of the French National # Health Authority. @ ASCO",,@,# #6104 #,4.72101E+17,https://twitter.com/GfK/status/472100668086697985,,,,
malachigriffith,5/29/2014 15:42,0,0,Barry Taylor: somatic hypermutation in clinical cancer samples exacerbates an already fraught analysis step. # ASCO14,,,#,4.72101E+17,https://twitter.com/malachigriffith/status/472100613128335360,,,,
MelanomaMom,5/29/2014 15:41,0,0,"@MDAMelanomaOnc: Book on # ASCO14 iPlanner http://bit.ly/1i3wYK4 for MD Anderson # Melanoma Dr. Patrick Hwu's presentation on ACT Saturday""""",,@MDAMelanomaOnc,# #,4.721E+17,https://twitter.com/MelanomaMom/status/472100461487476736,,,,
PennMedNews,5/29/2014 15:41,0,0,I will present in ed sess for CLL novel therapies @1:15 CT 6/2 in E450 at McC Place # ASCO14 # fierceASCO,,@1,# #,4.721E+17,https://twitter.com/PennMedNews/status/472100412565504000,,,,
damiangarde,5/29/2014 15:39,3,0,Reminder that @ FierceBiotech is talking # ASCO14 with @ PennMedNews' Dr. David Porter. Follow along here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …,,@ @,#,4.721E+17,https://twitter.com/damiangarde/status/472100006611402753,,,,
malachigriffith,5/29/2014 15:39,0,0,@ malachigriffith meant to say … fascinating and complementary ASCO *talks*. # ASCO14,,@,#,4.721E+17,https://twitter.com/malachigriffith/status/472099869725691904,,,,
survive_conquer,5/29/2014 15:38,0,1,Anyone have 2 guest passes to # ASCO14? I'm developing an AYA Survivorship Program and was hoping to attend a Mon morning ed session. Thx.,,,#,4.721E+17,https://twitter.com/survive_conquer/status/472099805586817024,,,,
PunitDhillon,5/29/2014 15:37,0,0,"@ ericgriesser @ TheCKelsey Thanks guys. Next up, # ASCO14!",,@ @,#,4.72099E+17,https://twitter.com/PunitDhillon/status/472099371639898113,,,,
theMMRF,5/29/2014 15:35,4,3,. @ TheMMRF will provide # myeloma clinical updates live from # ASCO14! Check daily for updates: http://www.themmrf.org/living-with-multiple-myeloma/2014-asco-coverage.html … - # MMRFASCO,,@,# # #,4.72099E+17,https://twitter.com/theMMRF/status/472098966340136960,,,,
ERFitzgerald1,5/29/2014 15:35,0,0,"RT @MDAMelanomaOnc: Friday at # ASCO14,MD Anderson Dr. Cassian Yee to discuss adoptive T-cell therapy in 'Immunology for Nonimmunologists'...",,@MDAMelanomaOnc,#,4.72099E+17,https://twitter.com/ERFitzgerald1/status/472098888292519936,,,,
Boehringer,5/29/2014 15:35,1,2,"# HCPs: # DoYouKnow about Plk inhibition, a novel therapeutic target in # haematology? http://bit.ly/1ixVK0s > # ASCO14",,,# # # #,4.72099E+17,https://twitter.com/Boehringer/status/472098871796314113,,,,
malachigriffith,5/29/2014 15:34,0,0,"Anthony Lafrate, Michael Berger, and Barry Taylor gave really fascinating and complementary ASCO: http://tinyurl.com/lr2p4dm # ASCO14",,,#,4.72099E+17,https://twitter.com/malachigriffith/status/472098598499270656,,,,
CNBCClosingBell,5/29/2014 15:33,1,1,"The biggest cancer conference of the year, @ ASCO kicks off tomorrow. @ megtirrell with a preview next!",,@ @,,4.72098E+17,https://twitter.com/CNBCClosingBell/status/472098316537589761,,,,
malachigriffith,5/29/2014 15:32,0,2,"Gave a talk today at the ASCO, Genetics and Genomics for the Practicing Clinician Seminar. http://tinyurl.com/lr2p4dm # ASCO14",,,#,4.72098E+17,https://twitter.com/malachigriffith/status/472098189118423040,,,,
LillyDiabetes,5/29/2014 15:30,2,1,"From May 30-June 3, Lilly will be in Chicago with more than 25,000 # oncology professionals at the 50th Annual # ASCO Meeting # ASCO14",,,# # #,4.72098E+17,https://twitter.com/LillyDiabetes/status/472097787388362752,,,,
Rad_Nation,5/29/2014 15:27,1,1,Short vs standard chemoradiotherapy in elderly glioblastoma http://buff.ly/1kErOoC # ASCO14 # btsm # radonc,,,# # #,4.72097E+17,https://twitter.com/Rad_Nation/status/472096819871481856,,,,
PennMedNews,5/29/2014 15:24,0,0,"Stay tuned for chat w Dr. David Porter, one of @ PennMedicine’s CAR T cell cancer trial investigators, & @ FierceBiotech before # ASCO14",,@ @,#,4.72096E+17,https://twitter.com/PennMedNews/status/472096113341001728,,,,
rsm2800,5/29/2014 15:22,0,1,RT=endorsement RT @ mtmdphd: I am thankful for @ ASCO staff for providing such great support for all the meetings happening at once # ASCO14,,@ @,#,4.72096E+17,https://twitter.com/rsm2800/status/472095600629276672,,,,
MatthewHSimmons,5/29/2014 15:19,0,0,BNA > ORD # ASCO14 pic.twitter.com/oE9jgKIc8x,,,#,4.72095E+17,https://twitter.com/MatthewHSimmons/status/472094833012535296,,,,
rsm2800,5/29/2014 15:15,2,2,Nice! # ASCO14 pic.twitter.com/Wd6JxoMaUQ,,,#,4.72094E+17,https://twitter.com/rsm2800/status/472093974451453953,,,,
AlpineBV_Miller,5/29/2014 15:15,0,0,At what point will all these researchers eager to start checkpoint/vaccine combo trials figure out to hunt down Provenge patients? # ASCO14,,,#,4.72094E+17,https://twitter.com/AlpineBV_Miller/status/472093952137781248,,,,
LapkaDenise,5/29/2014 15:11,0,0,# ASCO14,,,#,4.72093E+17,https://twitter.com/LapkaDenise/status/472092972671336448,,,,
AbsolutelyTours,5/29/2014 15:10,1,0,Welcome # ASCO14 attendees & exhibitors! You're invited to a Segway Tour of # Chicago - bring show badge for $10 off! http://ow.ly/xm22C,,,# #,4.72093E+17,https://twitter.com/AbsolutelyTours/status/472092614611968000,,,,
INVIVOcom,5/29/2014 15:09,0,0,Lots of buzz about # ASCO14 today - excited our interactive work for clients will be there!,,,#,4.72092E+17,https://twitter.com/INVIVOcom/status/472092436492476416,,,,
AlpineBV_Miller,5/29/2014 15:08,0,1,"# ASCO14 RT @ MeredithFrost: NOPE. Chicago's Willis Tower ‘Ledge’ cracks under tourists’ feet"" http://www.suntimes.com/news/metro/27746004-418/willis-tower-ledge-cracks-under-tourists-feet.html …pic.twitter.com/ZRMe3ZRLxH""",,@,#,4.72092E+17,https://twitter.com/AlpineBV_Miller/status/472092224193568769,,,,
LillyDiabetes,5/29/2014 15:05,2,3,We're excited to announce that @LlyOncOnCanvas will be creating a mural at # ASCO14! http://ow.ly/xp7ZN # hopeforward,,@LlyOncOnCanvas,# #,4.72091E+17,https://twitter.com/LillyDiabetes/status/472091338012635136,,,,
myPathMelanoma,5/29/2014 15:05,1,0,# ASCO14 Poster Highlights on Sat. May 31st from 8am-11:45am # Myriad myPath # Melanoma Influence of Gene Sign. on Melanocytic # Tumors,,,# # # #,4.72091E+17,https://twitter.com/myPathMelanoma/status/472091255111819264,,,,
MsStefanieC,5/29/2014 15:04,1,2,"# ASCO14 social media faves, feat. @ teamoncology—had the pleasure of talking Twitter w/ him in an # AACR14 session http://ow.ly/xpcyU",,@,# #,4.72091E+17,https://twitter.com/MsStefanieC/status/472091154872541184,,,,
KoontzOncology,5/29/2014 15:02,0,0,"@ ASCO Ok, thanks for the reply.",,@,,4.72091E+17,https://twitter.com/KoontzOncology/status/472090710498619392,,,,
innovpartners,5/29/2014 15:02,0,0,Get ready! RT @ ASCO: # ASCO14 Tweeters infographic http://buff.ly/Sk34aG,,@,#,4.72091E+17,https://twitter.com/innovpartners/status/472090537366147072,,,,
KoontzOncology,5/29/2014 15:00,1,1,# ASCO14 Beautiful weather in Chicago for the meeting! Maybe we can hold sessions outside like we sometimes did in college?,,,#,4.7209E+17,https://twitter.com/KoontzOncology/status/472090134330867712,,,,
Yale,5/29/2014 15:00,3,5,"MT @ YaleCancer: Yale experts to attend # ASCO14, the largest meeting on cancer research & treatment. http://bit.ly/RCGsRU",,@,#,4.7209E+17,https://twitter.com/Yale/status/472090031520100352,,,,
KoontzOncology,5/29/2014 14:57,0,0,@ ASCO Nice that you have created disease-specific tags! What do we use for pediatric oncology topics? # ASCO14,,@,#,4.72089E+17,https://twitter.com/KoontzOncology/status/472089381239803905,,,,
ALLIANCE_org,5/29/2014 14:56,0,0,# ASCO14 abstracts featuring work from @ Alliance_org -- a @ TheNCI Nat'l Clinical Trial Network: http://bit.ly/1pBtcZO,,@ @,#,4.72089E+17,https://twitter.com/ALLIANCE_org/status/472088991698006016,,,,
Novartis,5/29/2014 14:55,4,4,Join our # advancedBC Q&A starting momentarily # ASCO14 pic.twitter.com/6Z3suBmk8P,,,# #,4.72089E+17,https://twitter.com/Novartis/status/472088846537355264,,,,
mtmdphd,5/29/2014 14:55,0,0,On # ASCO14 eve (at least for me) I am thankful for ASCO staff for providing such great support for the all the meetings happening at once,,,#,4.72089E+17,https://twitter.com/mtmdphd/status/472088742313099264,,,,
OncNursingNews,5/29/2014 14:50,0,0,MT @ mtmdphd: Phase II trial exploring cyclophosphamide & ipilimumab in melanoma = incr toxicity http://ow.ly/xp0Pv # ASCO14 MT @ OncLive,,@ @,#,4.72088E+17,https://twitter.com/OncNursingNews/status/472087509766516736,,,,
subatomicdoc,5/29/2014 14:49,0,0,@ OncTimes_AsstEd Thanks! Will you or @ LolaButcher be attending # ASCO14 ?,,@ @,#,4.72087E+17,https://twitter.com/subatomicdoc/status/472087396889399297,,,,
Novartis,5/29/2014 14:45,6,3,. @ Novartis is about to be taken over by our # Oncology colleagues. Join our # advancedBC LIVE Q&A starting in 15 mins. # ASCO14,,@,# # #,4.72086E+17,https://twitter.com/Novartis/status/472086420207960064,,,,
Perthera,5/29/2014 14:45,0,1,Not too late to register! Breakfast mtg at # ASCO14 on Turning Molecular Analyses into Actionable Treatment Decisions http://ow.ly/wNot9,,,#,4.72086E+17,https://twitter.com/Perthera/status/472086331422937088,,,,
subatomicdoc,5/29/2014 14:45,0,1,@ theABTA Nice! Will you be at # ASCO14 ? I thought I'd stop by the booth if so.,,@,#,4.72086E+17,https://twitter.com/subatomicdoc/status/472086331330686976,,,,
DigitalBulldog,5/29/2014 14:44,0,0,20 ways to get the most out of # ASCO2014 http://bit.ly/1iwaLAQ,,,#,4.72086E+17,https://twitter.com/DigitalBulldog/status/472086140825391104,,,,
ASCO,5/29/2014 14:42,0,1,@ WinshipAtEmory @ wallyjc @ RamalingamMD @ SagarLonialMD We welcome you to join the conversation&contribute thoughts. Please use tag # ASCO14,,@ @ @ @,#,4.72086E+17,https://twitter.com/ASCO/status/472085567505977344,,,,
Harsharajasimha,5/29/2014 14:41,0,0,# ASCO14 John Iafrate from MGH says 40% of tumor samples genetically profiled come out negative for mutations - but still clinically useful.,,,#,4.72085E+17,https://twitter.com/Harsharajasimha/status/472085243843735553,,,,
MaurerStats,5/29/2014 14:41,1,1,MT @ ALLIANCE_org # ASCO14 abstracts featuring work from @ TheNCI Nat'l Clinical Trial Network: http://bit.ly/1pBtcZO,,@ @,#,4.72085E+17,https://twitter.com/MaurerStats/status/472085225871130626,,,,
mtmdphd,5/29/2014 14:40,3,0,Let’s “Connect The Dots” Faster -- Can We Build A Kickstarter For Cancer? - Forbes http://ow.ly/nB8Ho HT @ ASCO # CancerLinQ,,@,#,4.72085E+17,https://twitter.com/mtmdphd/status/472085016097599488,,,,
JoseA_Vidal,5/29/2014 14:39,0,0,"I'm going to follow hastag # ASCO14 these days, I'd like to be in # Chicago, and you @ afonsera1, will you be there?",,@,# #,4.72085E+17,https://twitter.com/JoseA_Vidal/status/472084785398288384,,,,
MedocityInc,5/29/2014 14:39,0,0,Visit us at # ASCO2014 at # booth4031 where we are showcasing our patient centric # cancer platform.,,,# # #,4.72085E+17,https://twitter.com/MedocityInc/status/472084708747395073,,,,
PetraGeerts,5/29/2014 14:38,0,0,“ @ liemeij: Op hemelvaart met # klm de lucht in ;) Onderweg naar # chicago waar ik presentatie mag verzorgen conferentie # asco14”. Succes!!,,@,# # #,4.72085E+17,https://twitter.com/PetraGeerts/status/472084518888026112,,,,
RS_Flinn,5/29/2014 14:37,0,0,"RT @ megtirrell: Ahead of # ASCO14, we take a look into how immunotherapies work. An animation we title: Immuno-WHAT? http://video.cnbc.com/gallery/?video=3000279876&play=1 …",,@,#,4.72084E+17,https://twitter.com/RS_Flinn/status/472084340474929152,,,,
tkdmHawkeye,5/29/2014 14:37,0,0,たくさんの遺伝子パネルを用いた分析結果を知りたいと思う臨床医は少ない。そもそも何を意味しているかわからないからだ。この遺伝子に関する教育も今後必要になる # ASCO14,,,#,4.72084E+17,https://twitter.com/tkdmHawkeye/status/472084320568356864,,,,
JackWestMD,5/29/2014 14:37,0,1,"Literally worst traffic in history of Seattle, per news teams, as I'm trying to get to airport to fly to # ASCO14. Stress will kill me.",,,#,4.72084E+17,https://twitter.com/JackWestMD/status/472084235114000385,,,,
GregoryDennis,5/29/2014 14:36,0,0,@ yzafar Thanks for the RT on upcoming # ASCO14 poster about molecular diagnostics and African-American women.,,@,#,4.72084E+17,https://twitter.com/GregoryDennis/status/472084115052040192,,,,
tkdmHawkeye,5/29/2014 14:36,0,0,next generation sequencingの発展には膨大なデータを瞬時に処理できるようになったITの発展の寄与も大きい # ASCO14,,,#,4.72084E+17,https://twitter.com/tkdmHawkeye/status/472083962798424064,,,,
rsm2800,5/29/2014 14:35,0,0,"BWI>ORD. Arrived, plane was small enough to fit in the parking garage at Hopkins but hey. Hello # ASCO14",,,#,4.72084E+17,https://twitter.com/rsm2800/status/472083928442875904,,,,
myPathMelanoma,5/29/2014 14:35,1,0,Attending # ASCO14? Stop by the @ MyriadGenetics myPath # Melanoma booth 2039 to check out our new # MelanomaDiagostic assay. # isthismelanoma,,@,# # # #,4.72084E+17,https://twitter.com/myPathMelanoma/status/472083706220261376,,,,
genentech,5/29/2014 14:31,10,3,On your way to # ASCO14? Take the immunotherapy challenge! http://ow.ly/xmQhh (Note: best on an iPad) http://ow.ly/xmQpW,,,#,4.72083E+17,https://twitter.com/genentech/status/472082810875170817,,,,
genentech,5/29/2014 14:31,3,2,"Dan Chen on combo trials, intrigue of the ADCC paradox, & the cautious optimism of #immunotherapyhttp://ow.ly/xoGVz # ASCO14",,,#immunotherapyhttp #,4.72083E+17,https://twitter.com/genentech/status/472082736837324801,,,,
PunitDhillon,5/29/2014 14:30,2,4,"Great turnout at # MarcumMicroCap presentation and now that's complete, heading over to # ASCO14 and @ Oncosec Clinical Advisory Board meeting",,@,# #,4.72083E+17,https://twitter.com/PunitDhillon/status/472082676418371584,,,,
megtirrell,5/29/2014 14:28,9,6,"Ahead of # ASCO14, we take a look into how immunotherapies work. An animation we title: Immuno-WHAT? http://video.cnbc.com/gallery/?video=3000279876&play=1 …",,,#,4.72082E+17,https://twitter.com/megtirrell/status/472082002217140224,,,,
ASCO,5/29/2014 14:25,0,0,"@ tacobelly5 Hope you can join us onsite next year, but you can keep with the news by following # ASCO14.",,@,#,4.72081E+17,https://twitter.com/ASCO/status/472081418802434049,,,,
mtmdphd,5/29/2014 14:24,0,0,The Changing Landscape of Federally Sponsored Trials - # ASCO14 5/31 8:00a - S100a,,,#,4.72081E+17,https://twitter.com/mtmdphd/status/472081032804831233,,,,
ASCO,5/29/2014 14:24,0,0,@ LaurenceVick Thanks very much. We invite you to follow the official hashtag # ASCO14.,,@,#,4.72081E+17,https://twitter.com/ASCO/status/472081017541771264,,,,
ALLIANCE_org,5/29/2014 14:23,0,0,Many of the # ASCO14 abstracts feature work from @ TheNCI Nat'l Clinical Trial Netwrk. Here's where you can find us: http://bit.ly/1pBtcZO,,@,#,4.72081E+17,https://twitter.com/ALLIANCE_org/status/472080803783278592,,,,
KUhlendorf,5/29/2014 14:20,0,0,"Interesting @BloombergNews article on promise, clinical dev challenges in immune therapies for # cancer http://bloom.bg/1iuazlG # ASCO14",,@BloombergNews,# #,4.7208E+17,https://twitter.com/KUhlendorf/status/472080044399931392,,,,
corp_UNC,5/29/2014 14:20,0,0,"MT @ rsm2800: Follow dz hashtags [+ # hsronc ] & # ASCO14 tweeps! http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf … Most importantly, join in on the conversation yrself",,@,# #,4.7208E+17,https://twitter.com/corp_UNC/status/472079959364993024,,,,
ASCO,5/29/2014 14:19,4,0,20 tips to get the most of # ASCO14 http://bit.ly/1mxgACT CC @ jaziehoncology,,@,#,4.7208E+17,https://twitter.com/ASCO/status/472079910308442112,,,,
Y_Prime,5/29/2014 14:18,1,0,Will you be in Chicago this weekend? We'll be at # ASCO2014 exhibiting in booth 21157!! http://hub.am/1k8tnLp pic.twitter.com/fAVJUeQoeb,,,#,4.7208E+17,https://twitter.com/Y_Prime/status/472079507437125632,,,,
Gmills31,5/29/2014 14:16,0,0,Made it to # ASCO2014 in genomics/genetics course for clinicians.,,,#,4.72079E+17,https://twitter.com/Gmills31/status/472079161142427648,,,,
Mira_Kind,5/29/2014 14:16,0,1,...for # ASCO14 abstracts on the KRAS-variant see: http://goo.gl/OGnSB1 and http://goo.gl/LsmMcw,,,#,4.72079E+17,https://twitter.com/Mira_Kind/status/472079049909497856,,,,
urotoday,5/29/2014 14:14,0,1,Greetings at the airport! Live reporting about to begin # ASCO14 pic.twitter.com/IubrSDGKKs,,,#,4.72078E+17,https://twitter.com/urotoday/status/472078492252012545,,,,
Mira_Kind,5/29/2014 14:13,0,1,We're excited our founder @ JoanneWeidhaas will be at # ASCO14 to present # personalizedmedicine for # KRAS-variant individuals!,,@,# # #,4.72078E+17,https://twitter.com/Mira_Kind/status/472078215675011072,,,,
KUhlendorf,5/29/2014 14:11,0,0,"@BayerHealthCare I'll be at # ASCO14, but still look forward to your updates.",,@BayerHealthCare,#,4.72078E+17,https://twitter.com/KUhlendorf/status/472077824497819648,,,,
communitycts,5/29/2014 14:10,0,0,Study by @ ASCO shows too few oncologists in rural areas # savecancercare http://ow.ly/xouqw,,@,#,4.72077E+17,https://twitter.com/communitycts/status/472077497128222720,,,,
BayerPharma,5/29/2014 14:07,0,0,Unable to make it to # ASCO14? Follow # ASCO14 and @BayerHealthCare for updates.,,@BayerHealthCare,# #,4.72077E+17,https://twitter.com/BayerPharma/status/472076813540556801,,,,
Agendia,5/29/2014 14:07,1,0,# ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okTAH8,,,# #,4.72077E+17,https://twitter.com/Agendia/status/472076805047074817,,,,
LivingBeyondBC,5/29/2014 14:05,0,0,Looking forward to tweeting about # metastatic # breastcancer! MT @ Novartis Follow # advancedBC today at 3PM EDT for a pre- # ASCO14 Q&A,,@,# # # #,4.72076E+17,https://twitter.com/LivingBeyondBC/status/472076238820212737,,,,
SymphonySister,5/29/2014 14:04,0,0,# ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okTy23,,,# #,4.72076E+17,https://twitter.com/SymphonySister/status/472076033462902786,,,,
rjbuick,5/29/2014 14:03,1,0," @ NatureNews: Old cancer immunotherapy approach is getting a new look at # ASCO14 http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews …"" @ FsnAntibodies @ Kerr72Paul""",,@ @ @,#,4.72076E+17,https://twitter.com/rjbuick/status/472075805468917760,,,,
IQVIA_Biotech,5/29/2014 14:02,0,0,Don’t miss # ASCO14’s # Hematology pre-show seminar. Learn how to overcome hematological # oncology trial challenges. http://ow.ly/xp3Hg,,,# # #,4.72076E+17,https://twitter.com/IQVIA_Biotech/status/472075627844362240,,,,
practiceupdate,5/29/2014 14:02,0,0,"Do you know what sessions you'll be attending at # ASCO2014? Check out our board member recommendations on our site, http://ow.ly/xofrq !",,,#,4.72075E+17,https://twitter.com/practiceupdate/status/472075483631611905,,,,
carisls,5/29/2014 14:01,1,1,"From breadth and depth of our studies to the caliber of our research partnerships, # MolecularIntel has raised the research bar at # ASCO14",,,# #,4.72075E+17,https://twitter.com/carisls/status/472075277213130752,,,,
Rad_Nation,5/29/2014 14:01,2,1,Short vs standard chemoradiotherapy in elderly glioblastoma multiforme http://abstracts.asco.org/144/AbstView_144_131054.html … # ASCO14 # btsm # radonc # hcsm,,,# # # #,4.72075E+17,https://twitter.com/Rad_Nation/status/472075232132747264,,,,
subatomicdoc,5/29/2014 14:01,8,1,Short vs standard chemoradiotherapy in elderly glioblastoma multiforme http://abstracts.asco.org/144/AbstView_144_131054.html … # ASCO14 # btsm # radonc # hcsm,,,# # # #,4.72075E+17,https://twitter.com/subatomicdoc/status/472075184238002176,,,,
bmsnews,5/29/2014 14:01,1,1,Going to # ASCO14? Visit us at the career booth CF-18 and see why it is a great time to join our # oncology team # jobshttp://ow.ly/xmmnk,,,# # #,4.72075E+17,https://twitter.com/bmsnews/status/472075169914425344,,,,
SanofiUS,5/29/2014 14:00,0,3,We're excited to attend the Annual Meeting of the American Society of Clinical Oncology in Chicago tomorrow. # ASCO14,,,#,4.72075E+17,https://twitter.com/SanofiUS/status/472075105158578176,,,,
myPathMelanoma,5/29/2014 14:00,1,0,Myriad myPath Melanoma will be presenting some interesting validation data at # ASCO14 regarding our gene signature! # isthismelanoma,,,# #,4.72075E+17,https://twitter.com/myPathMelanoma/status/472074926174633984,,,,
corp_UNC,5/29/2014 13:59,0,1,# ASCO14 tweeps: yr mission this week (if you choose to accept it)=get Ethan Basch on Twitter http://www.unclineberger.org/news/2012-news/basch-leads-cancer-outcomes-research-program …pic.twitter.com/NYNFISe8HI,,,#,4.72075E+17,https://twitter.com/corp_UNC/status/472074805588811777,,,,
foxggf,5/29/2014 13:59,0,0,RT @ jonathanagin: @ foxggf @ ASCO @ symplur @ subatomicdoc Thx. Once again peds/childhood remains underrepresented. #1 disease killer of our...,,@ @ @ @ @,#1,4.72075E+17,https://twitter.com/foxggf/status/472074762911772672,,,,
smerv,5/29/2014 13:56,0,1,Nice. RT @ annaazvolinsky 10 Tricks for Surviving and Thriving at ASCO’s Annual Meeting # ASCO14 http://www.cancernetwork.com/blog/10-tricks-surviving-thriving-at-asco-annual-meeting?GUID=0971C389-6D48-4B5B-A9A7-D7168DDAD2DF&rememberme=1&ts=29052014 … … # endcancer,,@,# #,4.72074E+17,https://twitter.com/smerv/status/472074100555268096,,,,
realdealneiman,5/29/2014 13:52,0,3,Any good last minute # biotech plays with # ASCO14 starting soon? Already in $ GTXI and $ NAVB. # stocks # money # letsgetrich,,,# # # # #,4.72073E+17,https://twitter.com/realdealneiman/status/472072882353602561,,,,
jenlieman,5/29/2014 13:49,0,0,“ @ drsteventucker: Immunotherapy for # cancer will happen # asco14 @ ASCOPost http://mobile.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …” TY for your work @ Merck @ bmsnews,,@ @ @ @,# #,4.72072E+17,https://twitter.com/jenlieman/status/472072270580436992,,,,
annaazvolinsky,5/29/2014 13:48,0,1,10 Tricks for Surviving and Thriving at ASCO’s Annual Meeting # ASCO14 http://www.cancernetwork.com/blog/10-tricks-surviving-thriving-at-asco-annual-meeting?GUID=0971C389-6D48-4B5B-A9A7-D7168DDAD2DF&rememberme=1&ts=29052014 …,,,#,4.72072E+17,https://twitter.com/annaazvolinsky/status/472071919043624960,,,,
NatureNews,5/29/2014 13:45,31,18,Old cancer immunotherapy approach is getting a new look at # ASCO14 preview by @ heidiledfordhttp://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews …,,@,#,4.72071E+17,https://twitter.com/NatureNews/status/472071243337056257,,,,
PSUCHICA,5/29/2014 13:45,0,0,@ DrugInfoAssn is getting ready for # ASCO14 # DIA2014 # BIO2014 # DIAontheroad,,@,# # # #,4.72071E+17,https://twitter.com/PSUCHICA/status/472071178493124610,,,,
AmbryGenetics,5/29/2014 13:44,0,0,Ambry will be exhibiting at the @ ASCO Annual Meeting...May 31 - June 2. Stop by booth 8143! # ASCO14,,@,#,4.72071E+17,https://twitter.com/AmbryGenetics/status/472071117092302848,,,,
PVonc,5/29/2014 13:39,0,1,Earn 2.0 CME at # ASCO14! Pancreatic Adenocarcinoma: New Therapies and Novel Concepts for Daily Practice http://bit.ly/ASCOpancreatic # pancsm,,,# #,4.7207E+17,https://twitter.com/PVonc/status/472069661618892800,,,,
inkkr,5/29/2014 13:36,0,1,@ mattrussell_PhD @ ASCO Thanks. Looking forward to it!,,@ @,,4.72069E+17,https://twitter.com/inkkr/status/472068931403137025,,,,
mattrussell_PhD,5/29/2014 13:35,0,0,@ sci2mrow @ ASCO Bon voyage! Have fun!,,@ @,,4.72069E+17,https://twitter.com/mattrussell_PhD/status/472068769414934528,,,,
Boehringer,5/29/2014 13:35,1,0,# PRESS & # HCPs: Know your hashtags & make the most of your time at # ASCO14. Great resource from @ ASCO http://bit.ly/1jrObN6 # hcsm # hcsmeu,,@,# # # # #,4.72069E+17,https://twitter.com/Boehringer/status/472068691304394752,,,,
inkkr,5/29/2014 13:34,0,2,"Ready... set... @ ASCO in # Chicago. See you next from the Windy City. First time? Yes, it is.",,@,#,4.72069E+17,https://twitter.com/inkkr/status/472068563839488000,,,,
ElizBlanchardMD,5/29/2014 13:33,1,1,Beautiful day in Chicago! # ASCO14 pic.twitter.com/jtgeMMnclj,,,#,4.72068E+17,https://twitter.com/ElizBlanchardMD/status/472068315599613952,,,,
PVonc,5/29/2014 13:33,0,0,"mCRPC CME satellite on 6/1: Real cases, difficult choices—you make the call! Register here: http://bit.ly/ASCOprostate # ASCO14 # gucsm",,,# #,4.72068E+17,https://twitter.com/PVonc/status/472068251665858560,,,,
afreshchapter,5/29/2014 13:32,0,0,Hello again # yvr airport. Feels like I am always here. Next stop? Chicago for the # ASCO14 conference.… http://instagram.com/p/oltkn5sgbh/,,,# #,4.72068E+17,https://twitter.com/afreshchapter/status/472068079829008384,,,,
Frank_S_David,5/29/2014 13:32,0,0,Thoughtful take on immunotherapy combos by @ PDRennert: http://lnkd.in/dWdaN_B -> good warmup for # ASCO14 this week,,@,#,4.72068E+17,https://twitter.com/Frank_S_David/status/472067956412018688,,,,
USBULLBULL,5/29/2014 13:31,1,0, @ biotech: Janney # ASCO14 Previews For $ CYCC, $ MDVN $ BMRN – Phase I BMN 673 data in SCLC. On Sunday," June 1 (cont) http://stks.co/t0NRP """"",,@,#,4.72068E+17,https://twitter.com/USBULLBULL/status/472067803357671424,,
ASCO,5/29/2014 13:31,0,1,Attending a Pre-AM Seminar? Shuttle Service avail tonight to downtown Chicago. Check the schedule at http://bit.ly/1mBTq0L # ASCO14,,,#,4.72068E+17,https://twitter.com/ASCO/status/472067668343013376,,,,
rjperez_phd,5/29/2014 13:29,1,0,“ @ scienega: Immuno-what? at # ASCO14 http://cnb.cx/1kkWYwy @ MegTirrell @ CNBC ” @ EstherNPerez Check out the video,,@ @ @ @,#,4.72067E+17,https://twitter.com/rjperez_phd/status/472067318806495232,,,,
BIOARRAYMDx,5/29/2014 13:28,0,1,ONE day to ASCO annual meeting! # ASCO2014 # breastcancer,,,# #,4.72067E+17,https://twitter.com/BIOARRAYMDx/status/472067026253389825,,,,
dansbarrington,5/29/2014 13:27,1,0,Come and play spoof with us at # ASCO14 to win prizes from @ Harrods or our very own spoof tokens.pic.twitter.com/VbrF24T53b,,@,#,4.72067E+17,https://twitter.com/dansbarrington/status/472066682476040192,,,,
SarahCannonDocs,5/29/2014 13:22,0,0,Are you attending # ASCO14? Come visit us at booth #2063 and learn about SCRI. pic.twitter.com/H34NZasjB9,,,# #2063,4.72066E+17,https://twitter.com/SarahCannonDocs/status/472065500328255489,,,,
FiercePharma,5/29/2014 13:21,1,0,# ASCO2014 preview: What's the outlook for cancer vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29 … # vaccines # pharma by @ EmilyMFierce,,@,# # #,4.72065E+17,https://twitter.com/FiercePharma/status/472065097951498240,,,,
scienega,5/29/2014 13:18,0,0,Immuno-what? at # ASCO14 http://cnb.cx/1kkWYwy @ MegTirrell @ CNBC,,@ @,#,4.72064E+17,https://twitter.com/scienega/status/472064481418567681,,,,
carisls,5/29/2014 13:18,0,1,@ FightCRC You're very welcome! Looking forward to seeing you at @ ASCO!! # ASCO14,,@ @,#,4.72064E+17,https://twitter.com/carisls/status/472064405044097024,,,,
chelsbells4,5/29/2014 13:18,1,0,. @ NCIsbir is coming to town & we don't just mean # ASCO14 # JLabsBay http://jlabsbay-nci2014-tw.eventbrite.com,,@,# #,4.72064E+17,https://twitter.com/chelsbells4/status/472064343434358784,,,,
GSK,5/29/2014 13:17,1,2,Happy Birthday @ ASCO. 50 years ago a group of # cancer specialists held a meeting and ASCO was born. # throwbackthursday,,@,# #,4.72064E+17,https://twitter.com/GSK/status/472064190124154880,,,,
PersonalisInc,5/29/2014 13:13,1,1,"Come by our Booth 17152, Sat. 5/31 # ASCO14 for refreshments, learn about the advanced ACE Exome for # cancer researchpic.twitter.com/IGTecJ1r0E",,,# #,4.72063E+17,https://twitter.com/PersonalisInc/status/472063237815431168,,,,
theMMRF,5/29/2014 13:13,4,0,"The MMRC, an affiliate organization of @ theMMRF, will present # myeloma data at # ASCO14 -June 2 in Chicago: http://www.themmrf.org/about-the-mmrf/powerful-news/press-releases/mmrc-asco-2014.html …. # MMRFASCO",,@,# # #,4.72063E+17,https://twitter.com/theMMRF/status/472063074930028544,,,,
ldtimmerman,5/29/2014 13:11,7,6,Big $ flowing to cancer immunotherapy. An # ASCO14 preview by Bloomberg's @ naomikresge @ robertlangreth http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …,,@ @,#,4.72063E+17,https://twitter.com/ldtimmerman/status/472062674160074752,,,,
harriseve,5/29/2014 13:10,2,1,# OH at # REV2014 “Patients R the key 2improving quality care” http://ow.ly/xiY4L # ASCO14 via @ stales @ genentech # epatient,,@ @,# # # #,4.72062E+17,https://twitter.com/harriseve/status/472062353903976450,,,,
MV_pharma,5/29/2014 13:05,0,0,Starts tomorrow! # ASCO14 @ ASCO,,@,#,4.72061E+17,https://twitter.com/MV_pharma/status/472061270787887104,,,,
GSK,5/29/2014 13:05,6,3,Follow us @GSK_conferences as we attend # ASCO14 for the latest in # cancerresearch,,@GSK_conferences,# #,4.72061E+17,https://twitter.com/GSK/status/472061142236692480,,,,
PDRennert,5/29/2014 13:05,0,0,Themes for # ASCO14 - I have to organize my thoughts somehow or I just get overwhelmed http://www.sugarconebiotech.com/?p=657,,,#,4.72061E+17,https://twitter.com/PDRennert/status/472061124632788992,,,,
Boehringer,5/29/2014 13:05,0,0,"Our efforts over the last decade taught us the importance of persistence ” Gerd Stehle http://bit.ly/RwVI2G # notjustonedisease # ASCO14""",,,# #,4.72061E+17,https://twitter.com/Boehringer/status/472061117540618240,,,,
amy_cully,5/29/2014 13:04,0,2,"Off to Chicago for my first clinical oncology meeting, the huge # ASCO14!",,,#,4.72061E+17,https://twitter.com/amy_cully/status/472061042390880256,,,,
ASCO,5/29/2014 13:02,5,3,"Stay connected during # ASCO14 - charge your device while you meet with colleagues at any of the 5,000 seats at networking tables",,,#,4.7206E+17,https://twitter.com/ASCO/status/472060403804274688,,,,
mtmdphd,5/29/2014 13:01,0,0,MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,@,#,4.7206E+17,https://twitter.com/mtmdphd/status/472060147846893568,,,,
BiologicsMcK,5/29/2014 13:00,0,0,"This weekend, @ ASCO will host its 50th Annual Meeting to discuss this year's theme –  # Science and Society"" http://ar.gy/5pD3 # ASCO14""",,@,# #,4.7206E+17,https://twitter.com/BiologicsMcK/status/472059858418954240,,,,
judyfortin,5/29/2014 12:59,1,2,Looking forward to representing the communications team from @ WinshipAtEmory at this weekend's # ASCO14 meeting in Chicago. # Cancer,,@,# #,4.7206E+17,https://twitter.com/judyfortin/status/472059584430211073,,,,
scienega,5/29/2014 12:57,0,0,Immunopalooza at # ASCO14 http://bit.ly/1gEmnGC @ JohnCFierce @ FierceBiotech,,@ @,#,4.72059E+17,https://twitter.com/scienega/status/472059271598080000,,,,
GenentechJobs,5/29/2014 12:55,0,0,# ASCO14 Talent Hunt: Assoc. Medical Director TDM1: http://click2apply.net/416279t Retweet please.,,,#,4.72059E+17,https://twitter.com/GenentechJobs/status/472058751776604160,,,,
ccheddarberk,5/29/2014 12:55,0,1,Ahead of # ASCO14 @ megtirrell explains what immunotherapy is all about http://cnb.cx/1tr5Ia2,,@,#,4.72059E+17,https://twitter.com/ccheddarberk/status/472058548558376960,,,,
DanBudwick,5/29/2014 12:53,0,0,"@ brianreid @ mcbennett6 @ GeoffreyCurtis @ adamfeuerstein You're getting your hair done for that # ASCO14 poster, aren't you. Admit it.",,@ @ @ @,#,4.72058E+17,https://twitter.com/DanBudwick/status/472058190323265536,,,,
akc1970,5/29/2014 12:51,0,0,Arrived in # Chicago for # ASCO2014 (@The Talbott Hotel) http://4sq.com/1kkPRo3,,@The,# #,4.72058E+17,https://twitter.com/akc1970/status/472057686025310208,,,,
DanBudwick,5/29/2014 12:51,0,0,"Great #, Coop...see u all Fri RT @ scooperpr @ mcbennett6 @ brianreid @ GeoffreyCurtis @ adamfeuerstein # BourbonDaysAreHereAgain # ASCO14",,@ @ @ @ @,# # #,4.72058E+17,https://twitter.com/DanBudwick/status/472057616861257728,,,,
mammographykc,5/29/2014 12:50,0,1,"New research, released at the @ ASCO Meeting discussed obesity and breast cancer. Obesity is a known risk factor. http://am.asco.org",,@,,4.72057E+17,https://twitter.com/mammographykc/status/472057346114719744,,,,
FairfieldChcago,5/29/2014 12:47,0,1,Welcome # ASCO14 and Happy 50th Anniversary! pic.twitter.com/5tFIHPLzBU,,,#,4.72057E+17,https://twitter.com/FairfieldChcago/status/472056641396162560,,,,
chemobrainfog,5/29/2014 12:46,3,0,"More thanks to @ ASCO for patient access to pubs. Just rec'd a copy of study referenced here: http://www.chicagotribune.com/health/sns-rt-us-chemo-brain-mri-20140527,0,3300989.story … # chemobrain # bcsm",,@,# #,4.72056E+17,https://twitter.com/chemobrainfog/status/472056469828157440,,,,
eubiomedcom,5/29/2014 12:45,0,0,RT @ Novartis: Follow @ Novartis today from 3-4PM EDT today for a live Q&A on # advancedBC to get ready for # ASCO14,,@ @,# #,4.72056E+17,https://twitter.com/eubiomedcom/status/472056152118001664,,,,
krystadawn,5/29/2014 12:45,0,0,"+1 “ @ cam_arnold: Heading to # ASCO14. Looking forward to the hustle, catching up with people, & learning what's new for people facing cancer”",,@,#,4.72056E+17,https://twitter.com/krystadawn/status/472056050619650049,,,,
nycdoc29,5/29/2014 12:42,0,0,Leaving for # ASCO14. Whole gang with me this time. They'll enjoy the Lincoln Park Zoo & I'll enjoy the ASCO one! pic.twitter.com/oYAjNKWzjw,,,#,4.72055E+17,https://twitter.com/nycdoc29/status/472055358748651521,,,,
OncTimes_AsstEd,5/29/2014 12:40,0,0,Nice! @ subatomicdoc Looking forward to your # ASCO14 updates @ ASCO,,@ @,#,4.72055E+17,https://twitter.com/OncTimes_AsstEd/status/472054877833527296,,,,
RemedyInformatx,5/29/2014 12:40,1,4,Our group is getting everything setup in Chicago for ASCO. Looking forward to a great show. Check us out at booth number 21165 @ ASCO # ASCO14,,@,#,4.72055E+17,https://twitter.com/RemedyInformatx/status/472054783722135553,,,,
HealthInFocus,5/29/2014 12:38,1,0,RT @ Boehringer We are looking forward to presenting at # ASCO14 - keep updated here http://bit.ly/1hNptTI # lungcancer # notjustonedisease,,@,# # #,4.72054E+17,https://twitter.com/HealthInFocus/status/472054403248435201,,,,
GenentechJobs,5/29/2014 12:34,0,0,# ASCO14 Talent Hunt - Assoc. Medical Director PD-L1: http://click2apply.net/431199t Retweet please.,,,#,4.72053E+17,https://twitter.com/GenentechJobs/status/472053475761606658,,,,
CancerNetwrk,5/29/2014 12:32,1,0,10 Tricks for Surviving and Thriving at ASCO’s Annual Meeting http://dlvr.it/5pzRB4 # ASCO14,,,#,4.72053E+17,https://twitter.com/CancerNetwrk/status/472052869911564289,,,,
CancerNetwrk,5/29/2014 12:31,1,2,# ASCO14 begins tomorrow! Follow us here for highlights and check out our page dedicated to the meeting here: http://www.cancernetwork.com/asco-2014,,,#,4.72053E+17,https://twitter.com/CancerNetwrk/status/472052727795941376,,,,
Advaxis,5/29/2014 12:30,1,0,"Retweet if you are attending our presentation May 31, 2014 at # ASCO14 $ ADXS",,,#,4.72052E+17,https://twitter.com/Advaxis/status/472052247493218305,,,,
GenentechJobs,5/29/2014 12:28,0,0,@ ASCO thank you. The video tutorials and the planning tools are very helpful. Looking forward to seeing everyone in Chicago for # ASCO14,,@,#,4.72052E+17,https://twitter.com/GenentechJobs/status/472051952268763136,,,,
krystadawn,5/29/2014 12:28,0,0,"ha! It's a whole new meeting with twitter these days “ @ michael_gilman: # ASCO14 for the rest of us: Quiet office, crazy Twitter feed.”",,@,#,4.72052E+17,https://twitter.com/krystadawn/status/472051825864998912,,,,
cam_arnold,5/29/2014 12:28,0,1,"Heading to # ASCO14. Looking forward to the usual hustle, catching up with people, & learning what's new for people facing cancer",,,#,4.72052E+17,https://twitter.com/cam_arnold/status/472051775831154688,,,,
GenentechJobs,5/29/2014 12:26,0,0,Corsee Sanders shares some thoughts on the biggest barriers that keep patients from enrolling in trials. http://bit.ly/1sxNumX # ASCO14,,,#,4.72051E+17,https://twitter.com/GenentechJobs/status/472051395135160320,,,,
harriseve,5/29/2014 12:25,0,1,@ JackWestMD fellows & patient advocates at the train station # ASCO14,,@,#,4.72051E+17,https://twitter.com/harriseve/status/472051192571650048,,,,
JackWestMD,5/29/2014 12:24,4,3,"Heading for # ASCO14 in a few hrs. Expecting a plane full of pharma folks (upgraded, since they fly >100K miles/yr), w/oncologists in coach",,,#,4.72051E+17,https://twitter.com/JackWestMD/status/472050793533550592,,,,
GenentechJobs,5/29/2014 12:23,0,0,Heading to Chicago today. Follow us this week for conference highlights and relevant # job opportunities listed under the hashtag # ASCO14.,,,# #,4.72051E+17,https://twitter.com/GenentechJobs/status/472050581956075520,,,,
MelanomaMom,5/29/2014 12:22,0,1,Just arrived in Chicago. Looking forward to hearing about all the progress in # melanoma at # ASCO14 pic.twitter.com/qez5buXAaW,,,# #,4.7205E+17,https://twitter.com/MelanomaMom/status/472050376624332800,,,,
subatomicdoc,5/29/2014 12:21,0,0,MT @ ASCO: # ASCO14 Tweeters http://bit.ly/1oBW0RQ Want to follow all? Subscribe to our list http://bit.ly/1oBW2Jq # hcsm # meded,,@,# # #,4.7205E+17,https://twitter.com/subatomicdoc/status/472049992430268418,,,,
ASCO,5/29/2014 12:20,10,2,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.7205E+17,https://twitter.com/ASCO/status/472049828713996288,,,,
Clinigen,5/29/2014 12:19,0,0,New data on cardiotoxicity and 2nd malignant neoplasms assoc. w/ dexrazoxane in children @ # ASCO14 | 2 June 8-11.45am http://tiny.cc/h86jgx,,@,#,4.7205E+17,https://twitter.com/Clinigen/status/472049666990026752,,,,
OmidHamidMD,5/29/2014 12:16,3,2,Getting on a midnite flight to chicago for @ ASCO. Folllow for updates on # Immunotherapy # PD1 # PDL1 etc.,,@,# # #,4.72049E+17,https://twitter.com/OmidHamidMD/status/472048756368867329,,,,
Boehringer,5/29/2014 12:15,0,0,# PRESS: We are looking forward to presenting at # ASCO14 - keep updated here http://bit.ly/1hNptTI # lungcancer # notjustonedisease,,,# # # #,4.72049E+17,https://twitter.com/Boehringer/status/472048599459983360,,,,
FightCRC,5/29/2014 12:15,2,0,"Our June 18 webinar in partnership w/ @ CCAlliance , will cover highlights from the @ ASCO conference happening this weekend - don't miss it!",,@ @,,4.72049E+17,https://twitter.com/FightCRC/status/472048522511265792,,,,
GregoryDennis,5/29/2014 12:11,0,0,@ CliffordHudis # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.72048E+17,https://twitter.com/GregoryDennis/status/472047693762920448,,,,
GregoryDennis,5/29/2014 12:11,0,0,@ drattai # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.72048E+17,https://twitter.com/GregoryDennis/status/472047624506572800,,,,
Roche,5/29/2014 12:10,5,5,# ASCO14 begins tomorrow. We're proud to be there highlighting the progress made against cancer in the last 50 years http://ow.ly/xkxTU,,,#,4.72047E+17,https://twitter.com/Roche/status/472047350681448449,,,,
existent_io,5/29/2014 12:08,0,0,"33k' and rising. Heading to # ASCO14 representing @ Viscira , looking forward to seeing friends and making new ones.",,@,#,4.72047E+17,https://twitter.com/existent_io/status/472046710722949121,,,,
TJH0828,5/29/2014 12:05,2,0,@ ASCO Guideline Update: Tamoxifen for Up to 10 Years for Women Hormone Receptor–Positive # BreastCancer http://www.acrrm.org.au/tele-medicine,,@,#,4.72046E+17,https://twitter.com/TJH0828/status/472046040347324416,,,,
FightCRC,5/29/2014 12:05,0,1,"We will be attending the @ ASCO conference this weekend, follow us to stay updated on what's happening there! # ASCO14",,@,#,4.72046E+17,https://twitter.com/FightCRC/status/472046018423693313,,,,
PresCancerPanel,5/29/2014 12:05,0,0,"RT @ mtmdphd ASCO's social media tips for oncology professionals - # ASCO14 # hcsm "" http://ow.ly/xogpN""",,@,# #,4.72046E+17,https://twitter.com/PresCancerPanel/status/472046002028171264,,,,
davidgrahammd,5/29/2014 12:04,0,0,On the road to # ASCO14…looking forward to seeing the peeps,,,#,4.72046E+17,https://twitter.com/davidgrahammd/status/472045790614274048,,,,
BioPharmaJosh,5/29/2014 12:01,0,0,"MT @ Loftus: Cancer immunotherapies seen costing $100K per patient, fueling $20B mkt by 2025, Goldman estimates $ BMY $ MRK $ RHHBY $ AZN # ASCO14",,@,#,4.72045E+17,https://twitter.com/BioPharmaJosh/status/472045151087775744,,,,
BrentApplegate,5/29/2014 12:01,1,0,RT @ QIAGEN: Attending the # asco14? Make sure to follow our channel @ QIAGENscience for regular updates and news from the meeting!,,@ @,#,4.72045E+17,https://twitter.com/BrentApplegate/status/472045097727848450,,,,
subatomicdoc,5/29/2014 12:01,1,2,@ NBTStweets @ lbjc13 Looking forward to # ASCO14. I also will stop by the booth to see what NBTS is doing. See you soon! # btsm,,@ @,# #,4.72045E+17,https://twitter.com/subatomicdoc/status/472044972699836416,,,,
Syapse,5/29/2014 12:00,1,0,"Join @ JonathanHirsch, @ neandrothal, @ GWinokur at # ASCO14 Booth 21159! Happy to chat about collab. with @ Intermountain http://syapse.com/blog/intermountain-healthcare-and-syapse-collaborate-to-improve-access-to-clinical-genomics-for-community-oncologists/ …",,@ @ @ @,#,4.72045E+17,https://twitter.com/Syapse/status/472044754465988609,,,,
DanaHolmes911,5/29/2014 11:56,0,0,Asymptomatic “Smoldering” Myeloma is “HOT” http://www.myelomacrowd.org/asymptomatic-smoldering-myeloma-is-hot/ … @ SagarLonialMD @ eaonc @ ASCO @ SWOG,,@ @ @ @,,4.72044E+17,https://twitter.com/DanaHolmes911/status/472043892326420481,,,,
PPDCRO,5/29/2014 11:55,0,1,We're just one day away from # ASCO14. Here's to another incredible 50 years! @ ASCO http://ht.ly/xoxrA,,@,#,4.72043E+17,https://twitter.com/PPDCRO/status/472043483096940544,,,,
adamfeuerstein,5/29/2014 11:50,2,0,A reminder for all # ASCO14 attendees. Join me for drinks on Fri. night at Hubbard Inn. Details —> http://tweetvite.com/event/UnofficialASCO14 …,,,#,4.72042E+17,https://twitter.com/adamfeuerstein/status/472042284578791425,,,,
DTRFoundation,5/29/2014 11:50,0,0,RT @ CliffordHudis: Getting ready for # ASCO14 ... Already in # Chicago waiting for the start of our 50th annual meeting! Moving forward...,,@,# #,4.72042E+17,https://twitter.com/DTRFoundation/status/472042220682739712,,,,
mtmdphd,5/29/2014 11:49,3,2,Phase II trial exploring cyclophosphamide & ipilimumab in melanoma = incr toxicity http://ow.ly/xoEbs # ASCO14 # melsm MT @ OncLive,,@,# #,4.72042E+17,https://twitter.com/mtmdphd/status/472042026339680256,,,,
stales,5/29/2014 11:46,1,0,"RT @ drdonsdizon Just 2 clarify @ ASCO guidance re endocrine RX- it's up to"" 10y"," not 10y 4 all. There R > optns # bcsm http://www.medpagetoday.com/HematologyOncology/BreastCancer/46007?xid=nl_mpt_DHE_2014-05-28 …""",,@ @,#,4.72041E+17,https://twitter.com/stales/status/472041189160808448,,,
subatomicdoc,5/29/2014 11:45,2,0,What brain tumor trial results are coming at # ASCO14? Follow @ ASCO @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # btsm # BrainTumorThursday,,@ @ @ @ @ @,# # # #,4.72041E+17,https://twitter.com/subatomicdoc/status/472040955731013634,,,,
stales,5/29/2014 11:44,0,0,RT @ MBCNbuzz: News frm # ASCO14 webinar on 6/12 for those living with # bcmets by @ drdonsdizon @ SHAREing http://bit.ly/1wrKLjq # bcsm,,@ @ @,# # #,4.72041E+17,https://twitter.com/stales/status/472040870964109312,,,,
CancerAdvocacy,5/29/2014 11:44,0,0,NCCS is proud to announce @LlyOncOnCanvas # HopeMurals project will be at # ASCO14; Check it out via @ WSJ http://ow.ly/xoCLH,,@LlyOncOnCanvas @,# #,4.72041E+17,https://twitter.com/CancerAdvocacy/status/472040815083405312,,,,
DanBudwick,5/29/2014 11:39,0,0,RT @ jodigralnick Immuno-WHAT? @ megtirrell's super-cool animated explanation of hot topic for # ASCO14-immunotherapies http://cnb.cx/1oNX3hV,,@ @,#,4.72039E+17,https://twitter.com/DanBudwick/status/472039438499844096,,,,
AndyWoodsmt,5/29/2014 11:36,0,0,Heading to Chicago for # ASCO14 to # cure # childhoodcancer! http://bcove.me/2nxkdk7j,,,# # #,4.72039E+17,https://twitter.com/AndyWoodsmt/status/472038887280222208,,,,
evaluatevantage,5/29/2014 11:34,2,1,"If you are heading off to # ASCO14, check out our free preview stories: http://ow.ly/xoAuR http://ow.ly/xoABk http://ow.ly/xoAF2",,,#,4.72038E+17,https://twitter.com/evaluatevantage/status/472038225075511296,,,,
jodigralnick,5/29/2014 11:32,0,1,Immuno-WHAT? @ megtirrell's super cool animated explanation of what will be a hot topic at # ASCO14 - immunotherapies. http://cnb.cx/1oNX3hV,,@,#,4.72038E+17,https://twitter.com/jodigralnick/status/472037844936949760,,,,
suvikki12,5/29/2014 11:32,1,4,Life never seizes to surprise me! Wheels up to # chicago for @ ASCO annual meeting. # lifeofanerd # grateful @ HeathrowAirport,,@ @,# # #,4.72038E+17,https://twitter.com/suvikki12/status/472037740125892608,,,,
OncTimes_AsstEd,5/29/2014 11:32,0,0,Whose attended the MOST @ ASCO annual meetings? Take our @ OncologyTimes QUICK POLL & share YOUR #http://journals.lww.com/oncology-times/pages/Quick-Poll.aspx …,,@ @,#http,4.72038E+17,https://twitter.com/OncTimes_AsstEd/status/472037673440268288,,,,
EncoreBioMed,5/29/2014 11:30,0,1,Development of # cancer vaccines has been difficult. Several new investigational vaccines to be presented at # ASCO14. http://bit.ly/TX0GYJ,,,# #,4.72037E+17,https://twitter.com/EncoreBioMed/status/472037237342093312,,,,
DentalOncology,5/29/2014 11:27,0,1,The very real link between gum disease and # cancer. http://ow.ly/xoxHW # HCSM # ASCO14,,,# # #,4.72037E+17,https://twitter.com/DentalOncology/status/472036560771485696,,,,
DrewMoghanaki,5/29/2014 11:25,0,0,@ ASCO adjuvant Erlotinib for # lungcancer increases risk of brain mets. But Lily funded abstract concludes otherwise. http://abstracts.asco.org/144/AbstView_144_130009.html …,,@,#,4.72036E+17,https://twitter.com/DrewMoghanaki/status/472036100026814464,,,,
CRC_Medical,5/29/2014 11:25,0,0,CRC Press will be at the @ ASCO Meeting in # Chicago tomorrow . . . we can't wait! See you all there. # ASCO14,,@,# #,4.72036E+17,https://twitter.com/CRC_Medical/status/472035908095856640,,,,
corp_UNC,5/29/2014 11:23,0,2,Excited to get in the mix @ m_e_nielsen @ UNC_Lineberger --bear with us as we figure out how this works # ASCO14 pic.twitter.com/koFxjMXl8v,,@ @,#,4.72036E+17,https://twitter.com/corp_UNC/status/472035611411771393,,,,
scooperpr,5/29/2014 11:21,0,0,@ mcbennett6 @ brianreid @ GeoffreyCurtis @ adamfeuerstein Will be there in force. # BourbonDaysAreHereAgain # ASCO14,,@ @ @ @,# #,4.72035E+17,https://twitter.com/scooperpr/status/472034938158465025,,,,
jlariasr,5/29/2014 11:21,0,0,RT @ bmsnews: # ASCO14 begins tomorrow! Follow us as we tweet highlights from the conference using the hashtag # ASCO14,,@,# #,4.72035E+17,https://twitter.com/jlariasr/status/472034893225275392,,,,
jtriestm,5/29/2014 11:20,0,0,“ @ DanaFarber: Old cancer drug gets fresh look: http://bit.ly/STX1tK ” # ASCO14 # pdl1,,@,# #,4.72035E+17,https://twitter.com/jtriestm/status/472034870223331328,,,,
m_e_nielsen,5/29/2014 11:20,3,0,Just in time for # ASCO14: @UNC_corp ( @ UNC_Lineberger Cancer Outcomes Research Program) joins the fray # hsronc,,@UNC_corp @,# #,4.72035E+17,https://twitter.com/m_e_nielsen/status/472034667034849280,,,,
WinshipAtEmory,5/29/2014 11:18,0,0,"@ ASCO Hi there, would you please add @ wallyjc, @ RamalingamMD and @ SagarLonialMD to your Twitter list? Thanks!",,@ @ @ @,,4.72034E+17,https://twitter.com/WinshipAtEmory/status/472034254848016384,,,,
Clinigen,5/29/2014 11:17,1,1,Members of the Clinigen GAP and SP teams are at # ASCO14 this weekend. In Chicago too? Tweet us @ Clinigen to arrange a meeting,,@,#,4.72034E+17,https://twitter.com/Clinigen/status/472033960584048640,,,,
corp_UNC,5/29/2014 11:16,2,2,Excited to dip our toes in the pool / join the conversation. Looking forward to an awesome # ASCO14 # hsronc # myfirstTweet,,,# # #,4.72034E+17,https://twitter.com/corp_UNC/status/472033800512606208,,,,
ASH_hematology,5/29/2014 11:16,1,0,Going to # ASCO14? Don't miss the Hematology for the Oncologist Seminar. Learn more: http://ow.ly/xowt1,,,#,4.72034E+17,https://twitter.com/ASH_hematology/status/472033659357499392,,,,
drsam,5/29/2014 11:12,0,0,Big accident on I-5 almost put a crimp in my # ASCO14 plans but made my flight. Off we go! # iflyalaska,,,# #,4.72033E+17,https://twitter.com/drsam/status/472032771641475072,,,,
Novartis,5/29/2014 11:10,2,0,Follow # advancedBC today at 3PM EDT for a pre- # ASCO14 Q&A (advanced # breastcancer also refers to # metastatic or stage IV),,,# # # #,4.72032E+17,https://twitter.com/Novartis/status/472032143418609666,,,,
emilylmullin,5/29/2014 11:10,0,0,# ASCO2014: Big Four immuno-oncology players wager $1.3B on next-gen cancer drugs http://www.fiercebiotech.com/story/asco-big-four-immuno-oncology-players-wager-13b-next-gen-cancer-drugs/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4dNLFDtkFg.twitter …,,,# #,4.72032E+17,https://twitter.com/emilylmullin/status/472032128129974273,,,,
LifeSciAdvisors,5/29/2014 11:08,0,0,NeoStem $ NBS Presents 5-Yr Survival Data for Autologous Melanoma Immunotherapy Targeting Cancer Stem Cells at # ASCO14 http://ow.ly/xouO9,,,#,4.72032E+17,https://twitter.com/LifeSciAdvisors/status/472031617205424128,,,,
SymphonySister,5/29/2014 11:07,0,0,"@ davidjdabbsmd Outcomes of pts assessed w/both MammaPrint & OncotypeDX. ODX test has many intermediates"" # ASCO14 http://hub.am/1okT3Fo""",,@,#,4.72031E+17,https://twitter.com/SymphonySister/status/472031457268203520,,,,
michael_gilman,5/29/2014 11:06,1,4,"# ASCO14 for the rest of us: Quiet office, crazy Twitter feed.",,,#,4.72031E+17,https://twitter.com/michael_gilman/status/472031155525386241,,,,
AlpineBV_Miller,5/29/2014 11:05,0,0,Safe travels to everyone headed to Chicago today and tomorrow for # ASCO14,,,#,4.72031E+17,https://twitter.com/AlpineBV_Miller/status/472031104959283200,,,,
Amgen,5/29/2014 11:05,0,1,# Amgen is headed to # ASCO14! Follow @ Amgen for updates from the meeting,,@,# #,4.72031E+17,https://twitter.com/Amgen/status/472030971664302081,,,,
Boehringer,5/29/2014 11:05,0,0,# PRESS & # HCPs: Know your hashtags & make the most of your time at # ASCO14. Great resource from @ ASCO http://bit.ly/151m8Mc,,@,# # #,4.72031E+17,https://twitter.com/Boehringer/status/472030925619232768,,,,
Agendia,5/29/2014 11:05,1,0,"@ davidjdabbsmd Outcomes of pts assessed w/both MammaPrint & OncotypeDX. ODX test has many intermediates"" # ASCO14 http://hub.am/1okT0sX""",,@,#,4.72031E+17,https://twitter.com/Agendia/status/472030905859866624,,,,
CancerDotNet,5/29/2014 11:05,4,1,"Research: Obesity may affect survival for premenopausal, ER+ # breastcancer # bcsm # ASCO14 http://bit.ly/1mKwitP",,,# # #,4.72031E+17,https://twitter.com/CancerDotNet/status/472030869872730113,,,,
Sophia_Maprayil,5/29/2014 11:04,0,0,# ASCO14 tweeters: would you be interested in writing a meeting report for @ERJournals # AnticancerTherapy? http://bit.ly/1keGYMH,,@ERJournals,# #,4.72031E+17,https://twitter.com/Sophia_Maprayil/status/472030770026930176,,,,
ASCO,5/29/2014 11:02,8,9,Headed to Chicago for # ASCO14? We hope to see you at our annual Tweetup on Saturday. Details & RSVP here: http://bit.ly/NvNypj,,,#,4.7203E+17,https://twitter.com/ASCO/status/472030277599252480,,,,
SequentaInc,5/29/2014 11:02,0,1,Interested in how ClonoSIGHT # MRD testing can be used in clinical mgmt in # bloodcancers? Visit us ( # ASCO14 bth 18152) http://ow.ly/xm5Gx,,,# # #,4.7203E+17,https://twitter.com/SequentaInc/status/472030260280954880,,,,
MyCancer,5/29/2014 11:01,4,2,"Clinical trials are delivering on the promise of # personalizedmedicine for both common and rare cancers."" http://goo.gl/mjz882 # ASCO14""",,,# #,4.7203E+17,https://twitter.com/MyCancer/status/472029962401112066,,,,
annaazvolinsky,5/29/2014 10:58,0,0,"# cancer immunotherapy preview for # ASCO14 from Johns Hopkins immunotherapy researcher, Charles Drake http://www.oncotherapynetwork.com/podcasts/asco-presentation-preview-immunotherapy-approaches-urological-cancers …",,,# #,4.72029E+17,https://twitter.com/annaazvolinsky/status/472029294664093696,,,,
Cara_PR_Comms,5/29/2014 10:58,0,0,Many of our # oncologists are headed to # ASCO14 today. Need an interview w/ one of them? Call 310.423.7798 or cara.martinez@cshs.org,,@cshs,# #,4.72029E+17,https://twitter.com/Cara_PR_Comms/status/472029232176975873,,,,
Loftus,5/29/2014 10:57,9,4,"Cancer immunotherapies seen costing $100,000 per patient, fueling $20B market by 2025, Goldman estimates $ BMY $ MRK $ RHHBY $ AZN # ASCO14",,,#,4.72029E+17,https://twitter.com/Loftus/status/472029085984911360,,,,
GlopesMd,5/29/2014 10:55,3,0,@ ASCO Important update for resource-constrained settings http://lnkd.in/b7CGrpV,,@,,4.72029E+17,https://twitter.com/GlopesMd/status/472028528599257088,,,,
NeuroOnc,5/29/2014 10:55,0,1,"More than 25,000 oncology professionals will be @ ASCO's Annual Meeting, Chicago, IL, May 30-June 3 http://ow.ly/xjoXU",,@,,4.72028E+17,https://twitter.com/NeuroOnc/status/472028377390784512,,,,
Carla_Jacobs,5/29/2014 10:51,0,0,"Top, succes RT @ liemeij Op hemelvaart met # klm de lucht in ;) Onderweg naar chicago waar ik presentatie mag verzorgen op conferentie # asco14",,@,# #,4.72027E+17,https://twitter.com/Carla_Jacobs/status/472027363929501696,,,,
Boehringer,5/29/2014 10:49,1,1,"During my 15 years in pharma I've witnessed some remarkable discoveries"" Dr Lechner http://bit.ly/1isb8MN # notjustonedisease # ASCO14""",,,# #,4.72027E+17,https://twitter.com/Boehringer/status/472026852736118784,,,,
ASCO,5/29/2014 10:48,3,1,Expand your network at # ASCO14 with the Message & Networking Center: Search for colleagues & make new connections http://am.asco.org/arc,,,#,4.72027E+17,https://twitter.com/ASCO/status/472026730497327104,,,,
mcbennett6,5/29/2014 10:48,1,0,Getting ready for # ASCO14? Don't forget that # cancerisntfree Follow @ TheSAMFund - they help young adult # cancer survivors. Pls RT,,@,# # #,4.72027E+17,https://twitter.com/mcbennett6/status/472026718434521088,,,,
KinzieHotel,5/29/2014 10:48,0,0,Welcome to all the # ASCO2014 guests staying w/ us in # Chicago this week! We're happy to have you! :) @ ASCO @ ChooseChicago,,@ @,# #,4.72027E+17,https://twitter.com/KinzieHotel/status/472026699635245056,,,,
6DegreesPR,5/29/2014 10:48,0,0,"# Cancer # immunotherapy programs to be showcased at @ ASCO,as # pharma races for a piece of the potential $35B/yr market http://bloom.bg/1iuazlG",,@,# # #,4.72027E+17,https://twitter.com/6DegreesPR/status/472026664994488321,,,,
ASCO,5/29/2014 10:46,1,1,Fellows - Interested in the # ASCO14 Genomics pre-meeting seminar? Read background: http://bit.ly/1iZh2J4 via # ASCOConnection,,,# #,4.72026E+17,https://twitter.com/ASCO/status/472026148504088576,,,,
LillyDiabetes,5/29/2014 10:46,0,0,We're looking forward to a successful and informative # ASCO14!,,,#,4.72026E+17,https://twitter.com/LillyDiabetes/status/472026130825113601,,,,
harrisonandstar,5/29/2014 10:45,0,0,ASCO's pre-annual meeting seminars are happening now. Check out the topics and highlights from these meetings # ASCO14 http://ow.ly/wFp8X,,,#,4.72026E+17,https://twitter.com/harrisonandstar/status/472025978408275968,,,,
AbsolutelyTours,5/29/2014 10:45,1,0,Welcome # ASCO14 attendees & exhibitors! You're invited to a Segway Tour of # Chicago - bring show badge for $10 off! http://ow.ly/xm20B,,,# #,4.72026E+17,https://twitter.com/AbsolutelyTours/status/472025970946629632,,,,
ASCP_Chicago,5/29/2014 10:45,0,0,ASCP will be exhibiting at the @ ASCO Annual Meeting May 31 to June 2. Stop by booth 16163 to say hi! # ASCO14 http://am.asco.org/,,@,#,4.72026E+17,https://twitter.com/ASCP_Chicago/status/472025909428764672,,,,
mkmackey,5/29/2014 10:45,0,0,MT @ drsteventucker: Immunotherapy for # cancer will happen # asco14 @ ASCOPost http://mobile.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …”,,@ @,# #,4.72026E+17,https://twitter.com/mkmackey/status/472025856366616576,,,,
DanBudwick,5/29/2014 10:44,0,0,@ brettchase @ nbcchicago Looks like I'm crossing this off the list for # ASCO14,,@ @,#,4.72026E+17,https://twitter.com/DanBudwick/status/472025590002769920,,,,
RickMSherwood,5/29/2014 10:43,0,0,Heading to # ASCO14; stop by to talk about # DoubleHitLymphoma. http://am.asco.org/friday-may-30-2014 …,,,# #,4.72026E+17,https://twitter.com/RickMSherwood/status/472025537561755648,,,,
AmandaBinDC,5/29/2014 10:43,0,0,Thinking of my @ ASCO friends this week! Best of luck for a successful # ASCO14!,,@,#,4.72026E+17,https://twitter.com/AmandaBinDC/status/472025516799954944,,,,
ASCO,5/29/2014 10:43,1,0,Skip lines & save time onsite - download your meeting materials now at http://am.asco.org/arc # ASCO14,,,#,4.72025E+17,https://twitter.com/ASCO/status/472025472256462850,,,,
carisls,5/29/2014 10:43,3,0,Great reference for # lungcancer patients learning about clinical trials and treatment options. # ASCO14 http://goo.gl/4YPI43,,,# #,4.72025E+17,https://twitter.com/carisls/status/472025389221838848,,,,
conditglobal,5/29/2014 10:42,0,1,"Retweet if you're headed to @ ASCO this week. We sure are, for our client @ clovisoncology # tradeshows",,@ @,#,4.72025E+17,https://twitter.com/conditglobal/status/472025121058983937,,,,
mcbennett6,5/29/2014 10:42,0,0,"@ brianreid You're a maybe""?! @ scooperpr you're going?! Unofficial # asco14 tweetup http://bit.ly/1k7CX1c @ GeoffreyCurtis @ adamfeuerstein""",,@ @ @ @,#,4.72025E+17,https://twitter.com/mcbennett6/status/472025091082289152,,,,
bmsnews,5/29/2014 10:42,0,0,# ASCO14 begins tomorrow! Follow us as we tweet highlights from the conference using the hashtag # ASCO14,,,# #,4.72025E+17,https://twitter.com/bmsnews/status/472025065606090752,,,,
mtmdphd,5/29/2014 10:40,1,1,Digital Product and Resource Tutorials for # ASCO14 http://ow.ly/xgIT5 HT @ rschilsky,,@,#,4.72025E+17,https://twitter.com/mtmdphd/status/472024731261370368,,,,
appistry,5/29/2014 10:40,0,0,We’re excited for # ASCO14! Let us know if you’ll be there and want to connect! cc: @ ASCO # cancergenomics # GEM,,@,# # #,4.72025E+17,https://twitter.com/appistry/status/472024583361818625,,,,
ASCO,5/29/2014 10:35,3,1,# ASCO14 Tweeters infographic http://bit.ly/TKIMrT Want to follow all? Subscribe to our list http://bit.ly/TKIO2Y # hcsm,,,# #,4.72023E+17,https://twitter.com/ASCO/status/472023386584285184,,,,
Novartis,5/29/2014 10:33,0,2,Follow @ Novartis today from 3-4PM EDT today for a live Q&A on # advancedBC to get ready for # ASCO14,,@,# #,4.72023E+17,https://twitter.com/Novartis/status/472022868088619008,,,,
QIAGEN,5/29/2014 10:33,0,0,Attending the # asco14? Make sure to follow our channel @ QIAGENscience for regular updates and news from the meeting!,,@,#,4.72023E+17,https://twitter.com/QIAGEN/status/472022823117275137,,,,
JohnCendpts,5/29/2014 10:32,6,3,# immunopalooza ASCO: Big Four immuno-oncology players wager $1.3B on next-gen cancer drugs - # ASCO14 @ bloomberg - http://www.fiercebiotech.com/story/asco-big-four-immuno-oncology-players-wager-13b-next-gen-cancer-drugs/2014-05-29 …,,@,# #,4.72023E+17,https://twitter.com/JohnCendpts/status/472022797238423552,,,,
genentech,5/29/2014 10:32,2,0,"@ RedSunshineKim, check out our slideshow on why we must address the “tissue issue” quickly. # ASCO14 http://ow.ly/xmTjf # Next50",,@,# #,4.72023E+17,https://twitter.com/genentech/status/472022728426663936,,,,
OncNursingNews,5/29/2014 10:30,0,0,"Benefits of longer treatment with # tamoxifen outweigh the possible risks, prompting new @ ASCO treatment guideline http://ow.ly/xmxjv",,@,#,4.72022E+17,https://twitter.com/OncNursingNews/status/472022090204590080,,,,
FightCRC,5/29/2014 10:29,2,2,"THANK YOU, @ carisls, for your sponsorship allowing two of our RATS attend the annual @ ASCO meeting! # ASCO14",,@ @,#,4.72022E+17,https://twitter.com/FightCRC/status/472021922637938688,,,,
MyelomaTeacher,5/29/2014 10:29,0,0,# Myeloma Updates 2014 Post # ASCO14 / # EHA14 / # IMWG14 June 26 Webinar @ IMFmyeloma @ BrianDurieMD https://online.myeloma.org/NetCommunity/myeloma-updates-2014-post-asco/eha/imwg?erid=4350431&trid=9e49b154-eaae-4455-b746-5a1b806a6e5e …,,@ @,# # # #,4.72022E+17,https://twitter.com/MyelomaTeacher/status/472021916010967040,,,,
GenomicHealth,5/29/2014 10:28,0,0,# Oncotype predicts late # breastcancer recurrence; may ID pts w/ greatest potential extended tamoxifen benefit # ASCO14 http://bit.ly/SUbGVW,,,# # #,4.72022E+17,https://twitter.com/GenomicHealth/status/472021677975412737,,,,
OncologySurgery,5/29/2014 10:28,0,0,"RT @ ASCO: Those using , we invite you to use the official tag http://bit.ly/SUeimI",,@,,4.72022E+17,https://twitter.com/OncologySurgery/status/472021591614709760,,,,
ASCO,5/29/2014 10:28,3,1,"Those using # ASCO2014, we invite you to use the official tag # ASCO14",,,# #,4.72022E+17,https://twitter.com/ASCO/status/472021542940196864,,,,
ClinMedJournals,5/29/2014 10:27,0,0,Visit # Springer at @ ASCO May 30-June 3 at booth 22119!,,@,#,4.72022E+17,https://twitter.com/ClinMedJournals/status/472021512799928320,,,,
AdvClinical,5/29/2014 10:26,0,3,Advanced Clinical looks forward to making connections tomorrow at the ASCO Annual Meeting! # ASCO14,,,#,4.72021E+17,https://twitter.com/AdvClinical/status/472021249112035329,,,,
Aiims1742,5/29/2014 10:25,1,0,MT @ rschilsky: # Immunotherapy buzz at # ASCO14 http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html … Big thanks to Jim Allison # MDAnderson # endcancer # ipilimumab,,@,# # # # #,4.72021E+17,https://twitter.com/Aiims1742/status/472020992009977857,,,,
teamdraft,5/29/2014 10:23,0,0,Change is happening everyday! # ASCO14,,,#,4.7202E+17,https://twitter.com/teamdraft/status/472020459181993986,,,,
NextGenClinical,5/29/2014 10:15,1,1,We'll be at # ASCO14! Follow our tweet highlights. This year's meeting theme: Science & Society. pic.twitter.com/c8zXGObkNL,,,#,4.72018E+17,https://twitter.com/NextGenClinical/status/472018347119632384,,,,
myelomacinderel,5/29/2014 10:14,1,0,# myeloma # ASCO14 R u a caregiver or kno one? this book illuminates the stages of caregiving & how 2 cope http://myelomacinderella.net/2014/05/passages-for-caregivers-by-gail-sheehy/ …,,,# #,4.72018E+17,https://twitter.com/myelomacinderel/status/472018189111410688,,,,
OMedLive,5/29/2014 10:14,0,0,Attending # ASCO14 stop by our booth 19154 - Learn How to Engage Live & Online with Leading # oncologists about # RCC & # LungCancer,,,# # # #,4.72018E+17,https://twitter.com/OMedLive/status/472018109042536448,,,,
knwachter,5/29/2014 10:13,0,0,RT @ NatureNews: # OutlookCancer Scientists are beginning to solve the great puzzles concerning cancer http://bit.ly/1hgBEOH # ASCO14,,@,# #,4.72018E+17,https://twitter.com/knwachter/status/472017796495593472,,,,
knwachter,5/29/2014 10:08,0,0,"RT @ OncologyTimes: Regarding immunotherapy buzz"" at # ASCO14"," here's what Dr Jeffrey Weber told @ OncTimes_AsstEd: http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/post.aspx?blogId=16&postId=7 …""",,@ @,#,4.72017E+17,https://twitter.com/knwachter/status/472016722380455936,,,
knwachter,5/29/2014 10:08,0,1,In retrospect immune-tx seems obvious RT @ drsteventucker: Cancer immunotherapy will happen; follow the money # asco14 http://mobile.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …,,@,#,4.72017E+17,https://twitter.com/knwachter/status/472016605111910400,,,,
MBCNbuzz,5/29/2014 10:06,2,1,News frm # ASCO14 webinar on 6/12 for those living with # bcmets by @ drdonsdizon @ SHAREing http://bit.ly/1wrKLjq # bcsm,,@ @,# # #,4.72016E+17,https://twitter.com/MBCNbuzz/status/472016132489371648,,,,
stefanomjr,5/29/2014 10:06,2,0,"$ CLVS presents, this Saturday, at # ASCO14, last year stock shot up 130% after their presentation. Watch out for Monday",,,#,4.72016E+17,https://twitter.com/stefanomjr/status/472016035315732480,,,,
knwachter,5/29/2014 10:03,0,0,RT @ SWOG: # SWOGonc @ # ASCO14: Abstracts @ SWOG investigators will present or have contributed to: http://swog.org/Members/Download/BulletinBoard/Article221.pdf …,,@ @ @,# #,4.72015E+17,https://twitter.com/knwachter/status/472015321969475585,,,,
SWOG,5/29/2014 10:02,0,1,# SWOGonc @ # ASCO14: Abstracts @ SWOG investigators will present or have contributed to: http://swog.org/Members/Download/BulletinBoard/Article221.pdf …,,@ @,# #,4.72015E+17,https://twitter.com/SWOG/status/472015048697602049,,,,
theMMRF,5/29/2014 10:01,2,0,Are you going to # ASCO14? Visit @ theMMRF at Booth 3024 to learn about how we are leading the way in # myeloma & # cancer research! # MMRFASCO,,@,# # # #,4.72015E+17,https://twitter.com/theMMRF/status/472014860524748800,,,,
BayerPharma,5/29/2014 10:00,1,1,Already on your way to Chicago for # ASCO14? The meeting iPlanner helps you not to miss interesting events. https://iplanner.asco.org/am2014,,,#,4.72015E+17,https://twitter.com/BayerPharma/status/472014670518566912,,,,
CarlyHFierce,5/29/2014 10:00,1,1,# ICYMI earlier: Top-10 best selling cancer drugs of 2013 http://www.fiercepharma.com/special-reports/top-10-best-selling-cancer-drugs-2013 … # pharma # ASCO14,,,# # #,4.72015E+17,https://twitter.com/CarlyHFierce/status/472014527836332033,,,,
fwpharma,5/29/2014 9:59,0,0,See the questions we're asking in our latest Physician Views poll ahead of # ASCO14 http://bit.ly/1rjdoiP pic.twitter.com/aaS2GTgaNU,,,#,4.72014E+17,https://twitter.com/fwpharma/status/472014445867458560,,,,
jonathanagin,5/29/2014 9:55,0,1,"@ foxggf @ ASCO @ symplur @ subatomicdoc Thx. Once again peds/childhood remains underrepresented. #1 disease killer of our kids, including mine",,@ @ @ @,#1,4.72013E+17,https://twitter.com/jonathanagin/status/472013321772617728,,,,
myriadgenetics,5/29/2014 9:55,0,0,Do you want to find out more about Myriad's # Prolaris test for # prostatecancer aggressiveness? Visit http://prolaris.com/ ! # ASCO14,,,# # #,4.72013E+17,https://twitter.com/myriadgenetics/status/472013242840006656,,,,
AmadixDx,5/29/2014 9:54,0,1,"Con las maletas ya en Chicago, calentamos motores para # ASCO14 en el curso Genetics and Genomics for the Clinician",,,#,4.72013E+17,https://twitter.com/AmadixDx/status/472013006671728640,,,,
OncologyTimes,5/29/2014 9:52,2,1,"Regarding immunotherapy buzz"" at # ASCO14"," here's what Dr Jeffrey Weber told @ OncTimes_AsstEd: http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/post.aspx?blogId=16&postId=7 …""",,@,#,4.72013E+17,https://twitter.com/OncologyTimes/status/472012587568488448,,,
rbsalute,5/29/2014 9:48,0,1,# Oncologia Da domani è # ASCO14,,,# #,4.72012E+17,https://twitter.com/rbsalute/status/472011567517958145,,,,
FiercePharma,5/29/2014 9:43,1,0,# ASCO2014 preview: What's the outlook for cancer # vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29 … by @ EmilyMFierce,,@,# #,4.7201E+17,https://twitter.com/FiercePharma/status/472010359461527553,,,,
ESchattner,5/29/2014 9:42,0,2,via @ ASCO: Former Head Of Maryland County To Raise Awareness Of Lung Cancer Disparities - http://wapo.st/TUp6lp,,@,,4.7201E+17,https://twitter.com/ESchattner/status/472010145841438722,,,,
ABIMcert,5/29/2014 9:37,0,0,05/30-06/3: Speak with an @ ABIMcert representative about MOC at @ ASCO’s # ASCO14 (booth 6031).,,@ @,#,4.72009E+17,https://twitter.com/ABIMcert/status/472008877798858753,,,,
JohnCendpts,5/29/2014 9:36,2,0,Good story - tough field RT @ EmilyMFierce: # ASCO2014 preview: What's the outlook for cancer vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4c1X12Lkjk.twitter …,,@,# #,4.72009E+17,https://twitter.com/JohnCendpts/status/472008587292999680,,,,
foxggf,5/29/2014 9:33,0,0,"RT @ ASCO: @ jonathanagin Also, we invite you to refer to this @ Symplur @ subatomicdoc cancer tag ontology list as well: http://flip.it/eIFWv",,@ @ @ @,,4.72008E+17,https://twitter.com/foxggf/status/472007834876772352,,,,
emilylmullin,5/29/2014 9:27,1,0,# ASCO2014 preview: What's the outlook for cancer vaccines? http://www.fiercevaccines.com/story/asco-preview-whats-outlook-cancer-vaccines/2014-05-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4c1X12Lkjk.twitter …,,,# #,4.72006E+17,https://twitter.com/emilylmullin/status/472006221554126848,,,,
MediTech_Media,5/29/2014 9:25,0,0,We're excited to learn what's new in # Cancer research @ ASCO We will be tweeting from # ASCO14 in # Chicago Stay tuned!,,@,# # #,4.72006E+17,https://twitter.com/MediTech_Media/status/472005932252413952,,,,
CliffordHudis,5/29/2014 9:24,5,3,Getting ready for # ASCO14 ... Already in # Chicago waiting for the start of our 50th annual meeting! Moving forward while glancing back....,,,# #,4.72005E+17,https://twitter.com/CliffordHudis/status/472005440076013570,,,,
wordbistro,5/29/2014 9:21,0,0,Wishing all my @ asco and @ CancerDotNet colleagues safe travels to Chicago! Will be following # ASCO14 activity from home,,@ @,#,4.72005E+17,https://twitter.com/wordbistro/status/472004712557182976,,,,
sammyuill,5/29/2014 9:20,0,0,Amazing “ @ genentech: POV from Dan Chen on why immunotherapy is one of the most promising cancer approaches # ASCO14 http://ow.ly/xmQTb ”,,@,#,4.72005E+17,https://twitter.com/sammyuill/status/472004666747019264,,,,
DrAnasYounes,5/29/2014 9:20,1,0,RT @ ASCO: Review Educational Book articles in advance of # ASCO14 educational sessions: http://bit.ly/1wrvCyO,,@,#,4.72004E+17,https://twitter.com/DrAnasYounes/status/472004483569176579,,,,
stales,5/29/2014 9:18,1,1,RT @ genentech: # OH at # REV2014: “Patients are the key to improving quality care.” - @ stales | http://ow.ly/xiY4L # ASCO14 cc: @ mhqp,,@ @ @,# # #,4.72004E+17,https://twitter.com/stales/status/472004029921628160,,,,
HyattMcCormick,5/29/2014 9:18,0,1,A BIG welcome to all the @ ASCO # ASCO14 attendees checking in with us this week! Please tweet if you have questions or need assistance.,,@,#,4.72004E+17,https://twitter.com/HyattMcCormick/status/472004021847220224,,,,
mtmdphd,5/29/2014 9:18,1,0,"@ rsm2800 @ ASCO Better, but still some follower bots RT'ing. Will require some filtering for post hoc analytics. S/N improved.",,@ @,,4.72004E+17,https://twitter.com/mtmdphd/status/472003975265677312,,,,
Novartis,5/29/2014 9:09,6,8,# Novartis research shows progress in advancing research for patients with # cancer and hematological diseases http://bit.ly/1ipAxGQ # ASCO14,,,# # #,4.72002E+17,https://twitter.com/Novartis/status/472001748429987841,,,,
mtmdphd,5/29/2014 9:08,0,2,ASCO's social media tips for oncology professionals - # ASCO14 http://ow.ly/xo7Ms,,,#,4.72002E+17,https://twitter.com/mtmdphd/status/472001506112458753,,,,
ASCOPost,5/29/2014 9:07,0,1,@ ASCO’s Visionary Founders http://ow.ly/xo7DI,,@,,4.72001E+17,https://twitter.com/ASCOPost/status/472001233642090496,,,,
MSKCC_Library,5/29/2014 9:06,1,0,via @ rsm2800: So exciting this may be a viable Rx for many cancers RT @ rschilsky: Immune therapy buzz # ASCO14 http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …,,@ @,#,4.72001E+17,https://twitter.com/MSKCC_Library/status/472001009133580289,,,,
ASCOPost,5/29/2014 9:05,5,2,"Celebrating @ ASCO's History, 1964-2014: Reflections From ASCO's Past Presidents http://ow.ly/xo7jj",,@,,4.72001E+17,https://twitter.com/ASCOPost/status/472000896956899328,,,,
rsm2800,5/29/2014 9:04,9,7,So exciting this may be a viable Rx for many cancers RT @ rschilsky: Immune therapy buzz # ASCO14 http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html … # didntseeitcoming,,@,# #,4.72001E+17,https://twitter.com/rsm2800/status/472000596581826560,,,,
BrianAlperMD,5/29/2014 9:01,0,0,Getting ready to fly to Chicago for # ASCO14. Who else is will be there learning more about advances in # cancer treatment?,,,# #,4.72E+17,https://twitter.com/BrianAlperMD/status/471999757502533632,,,,
rschilsky,5/29/2014 8:59,4,0,Immune therapy buzz at # ASCO14.http://www.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …,,,#,4.71999E+17,https://twitter.com/rschilsky/status/471999184262819840,,,,
subatomicdoc,5/29/2014 8:57,1,1,What # lungcancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # lcsm,,@ @ @ @ @ @,# # # #,4.71999E+17,https://twitter.com/subatomicdoc/status/471998652081532930,,,,
bioinfosm,5/29/2014 8:54,1,1,"Bookmarked! MT @ CarlyHFierce:Top 10 best-selling cancer drugs of 2013, just in time for # ASCO14. http://www.fiercepharma.com/special-reports/top-10-best-selling-cancer-drugs-2013 … # pharma # cancer",,@,# # #,4.71998E+17,https://twitter.com/bioinfosm/status/471997905914830848,,,,
MatthewHSimmons,5/29/2014 8:54,0,0,RT @ genentech: See how Ph I trials in # CancerResearch are evolving. http://ow.ly/xk5iJ # ASCO14 # Next50,,@,# # #,4.71998E+17,https://twitter.com/MatthewHSimmons/status/471997891620265986,,,,
ehealth_CCC,5/29/2014 8:53,0,1,"MT  @ disparityreport # SocialMedia: a tool for overcoming # clinicaltrials barriers? # ASCO14 http://bit.ly/1tPNUaP # hcsm"" Cc @ marta_wanat""",,@ @,# # # #,4.71998E+17,https://twitter.com/ehealth_CCC/status/471997779032948736,,,,
mtmdphd,5/29/2014 8:46,0,0,Let’s “Connect The Dots” Faster -- Can We Build A Kickstarter For Cancer? - Forbes http://ow.ly/nB8Ho HT @ ASCO # CancerLinQ,,@,#,4.71996E+17,https://twitter.com/mtmdphd/status/471996031081930754,,,,
rsm2800,5/29/2014 8:45,0,1,Off to Chicago for the Oncology Therapy Access Physician Working Group mtg w/ Alliance for Patient Access http://allianceforpatientaccess.org/about-afpa/ # ASCO14,,,#,4.71996E+17,https://twitter.com/rsm2800/status/471995664176799744,,,,
Chiltern_CRO,5/29/2014 8:44,0,1,"# ASCO14 begins tomorrow! # Chiltern will be there, and we will be following the conference conversation on Twitter.pic.twitter.com/1lu1Foc62Z",,,# #,4.71995E+17,https://twitter.com/Chiltern_CRO/status/471995392066719744,,,,
rsm2800,5/29/2014 8:42,3,2,Dare I say it too soon? Seems to be less sp*m on the # ASCO14 hashtag the past 48 hrs. Your efforts are working! Keeping blocking/reporting!,,,#,4.71995E+17,https://twitter.com/rsm2800/status/471995094334459905,,,,
CGTCatapult,5/29/2014 8:42,0,0,RT @ FierceBiotech: Tune in today for an # ASCO14 chat w/ @ JohnCFierce & @ PennMedicine's David Porter at 3:30 EST. More info:...,,@ @ @,#,4.71995E+17,https://twitter.com/CGTCatapult/status/471994991095865344,,,,
ejpc_emma,5/29/2014 8:42,0,0,RT @ FierceBiotech: Tune in today for an # ASCO14 chat w/ @ JohnCFierce & @ PennMedicine's David Porter at 3:30 EST. More info:...,,@ @ @,#,4.71995E+17,https://twitter.com/ejpc_emma/status/471994990332477441,,,,
szusmani,5/29/2014 8:41,0,1,@Carolinas On the way to # ASCO14,,@Carolinas,#,4.71995E+17,https://twitter.com/szusmani/status/471994810367098880,,,,
mtmdphd,5/29/2014 8:39,0,1,An analysis of cancer-specific Twitter conversations among physicians in 2013 - @ brianreid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz,,@,#,4.71994E+17,https://twitter.com/mtmdphd/status/471994119062315008,,,,
mtmdphd,5/29/2014 8:37,0,1,Tweeting at ASCO Annual Mtgs Can Enhance the Experience [10/15/12] <- old school - via @ ASCOPost & @ rsm2800 http://ow.ly/xo1lz # ASCO14,,@ @,#,4.71994E+17,https://twitter.com/mtmdphd/status/471993720599220225,,,,
JeremyMooreFCCC,5/29/2014 8:36,0,0,# ASCO14 looks to be all immunotherapy all the time again http://tinyurl.com/n7w5582 @ RobertLangreth @BloombergNews,,@ @BloombergNews,#,4.71994E+17,https://twitter.com/JeremyMooreFCCC/status/471993548091699200,,,,
redaccionmedica,5/29/2014 8:35,0,1,Industria | @ mercksalud promete presetar nuevos datos de nueve moléculas en desarrollo en @ ASCO http://www.redaccionmedica.com/secciones/industria/merck-promete-nuevos-datos-de-nueve-moleculas-en-desarrollo-2064 …,,@ @,,4.71993E+17,https://twitter.com/redaccionmedica/status/471993298421551105,,,,
drsteventucker,5/29/2014 8:31,12,6,Immunotherapy for # cancer will happen...just follow the money # asco14 @ ASCOPost # singapore http://mobile.bloomberg.com/news/2014-05-29/immune-therapy-s-cancer-promise-creates-research-rush.html …,,@,# # #,4.71992E+17,https://twitter.com/drsteventucker/status/471992313988653056,,,,
subatomicdoc,5/29/2014 8:30,8,3,@ ASCO Releases First Guidelines on Survivorship Care http://bit.ly/SRQ1xu > @ OncologyTimes,,@ @,,4.71992E+17,https://twitter.com/subatomicdoc/status/471991941455179776,,,,
CarlyHFierce,5/29/2014 8:28,8,4,"Our newest special report is here! Top 10 best-selling cancer drugs of 2013, just in time for # ASCO14. http://www.fiercepharma.com/special-reports/top-10-best-selling-cancer-drugs-2013 … # pharma",,,# #,4.71992E+17,https://twitter.com/CarlyHFierce/status/471991584842457089,,,,
mtmdphd,5/29/2014 8:26,2,1,Caveat Surfor: What You Need Before Tweeting at the Meeting - @ SubAtomicDoc # ASCOConnection http://ow.ly/xnYSX # ASCO14,,@,# #,4.71991E+17,https://twitter.com/mtmdphd/status/471990929143115776,,,,
darrenfergus,5/29/2014 8:17,0,0,# ASCO14 What will the next 5 years look like? We sat in the 1st ASCO social media session. How will it change CTs ov…http://lnkd.in/dSC732Z,,,#,4.71989E+17,https://twitter.com/darrenfergus/status/471988593943003136,,,,
AdnanNagrial,5/29/2014 8:12,0,0,"Arrived in Chicago, looking forward to hearing about the advances in cancer care at # ASCO14, tips on jet lag?",,,#,4.71987E+17,https://twitter.com/AdnanNagrial/status/471987338365501440,,,,
FierceBiotech,5/29/2014 8:09,8,0,Tune in today for an # ASCO14 chat w/ @ JohnCFierce & @ PennMedicine's David Porter at 3:30 EST. More info: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … # FierceASCO,,@ @,# #,4.71987E+17,https://twitter.com/FierceBiotech/status/471986769437941760,,,,
ESchattner,5/29/2014 8:06,1,0,"to Chicago! Looking forward to seeing old and new friends, # ASCO14",,,#,4.71986E+17,https://twitter.com/ESchattner/status/471985879171743744,,,,
UdderlySmooth,5/29/2014 8:02,0,0,Good morning and a Happy Thursday to all! Week is going fast. Packed and ready to go to # ASCO14 What do you have planned?,,,#,4.71985E+17,https://twitter.com/UdderlySmooth/status/471984856851689472,,,,
2XBCSURVIVOR76,5/29/2014 7:57,0,4,"Together we CAN make a difference in the lives of cancer patients and their families. People just like me."" # ASCO14""",,,#,4.71984E+17,https://twitter.com/2XBCSURVIVOR76/status/471983733487042560,,,,
BayerPharma,5/29/2014 7:52,2,2,Bayer HealthCare is heading to Chicago for # ASCO14. See you all there! pic.twitter.com/jfETGDdmkn,,,#,4.71982E+17,https://twitter.com/BayerPharma/status/471982363669716992,,,,
EFEciencia,5/29/2014 7:49,2,1,Mañana arranca la reunión número 50 de la Sociedad Americana de Oncología http://www.efefuturo.com/noticia/manana-arranca-la-reunion-numero-50-de-la-sociedad-americana-de-oncologia/ … # ASCO14,,,#,4.71982E+17,https://twitter.com/EFEciencia/status/471981541326077952,,,,
OncoPlexDx,5/29/2014 7:45,1,6,Safe travels to all attendees of # ASCO14. Visit booth 11819 to learn how chemotherapy can be used as targeted therapy # proteomics # genomics,,,# # #,4.71981E+17,https://twitter.com/OncoPlexDx/status/471980611113324544,,,,
philtalamo,5/29/2014 7:42,0,1,On the way to # ASCO14 - looking forward to to a great meeting! See you there!,,,#,4.7198E+17,https://twitter.com/philtalamo/status/471979929975136257,,,,
Bladdertrio,5/29/2014 7:33,0,0,"We're sitting out # ASCO14 this year, sadly. We'll definitely be following the action, though, so keep tweeting about the good stuff!",,,#,4.71978E+17,https://twitter.com/Bladdertrio/status/471977584079958016,,,,
ckonto,5/29/2014 7:31,0,1,Back to Chicago for another # ASCO14 marathon I just ran 3.76 mi with Nike+. http://go.nike.com/ipj3e5 # nikepluspic.twitter.com/iz3C7tpYGf,,,# #,4.71977E+17,https://twitter.com/ckonto/status/471977186627686400,,,,
jagasquet,5/29/2014 7:30,0,0,On my way to Chicago! # ASCO14,,,#,4.71977E+17,https://twitter.com/jagasquet/status/471976761660817408,,,,
ShabbirHossain,5/29/2014 7:23,1,3,"Looking forward to following # asco14 for the 1s time! And this time, I've got a # SoMe emissary from @ StonyBrookMed there @ christinemphmd !",,@ @,# #,4.71975E+17,https://twitter.com/ShabbirHossain/status/471975101060362240,,,,
OncLive,5/29/2014 7:23,1,2,"Anna C. Pavlick, DO, discusses a phase II trial exploring cyclophosphamide and ipilimumab in melanoma http://ow.ly/xmvIT # ASCO14",,,#,4.71975E+17,https://twitter.com/OncLive/status/471975094022320128,,,,
NatRevClinOncol,5/29/2014 7:19,3,0,@ ASCO guidelines update on adjuvant endocrine therapy for women with hormone receptor positive # breastcancer http://jco.ascopubs.org/content/early/2014/05/20/JCO.2013.54.2258.short?rss=1 …,,@,#,4.71974E+17,https://twitter.com/NatRevClinOncol/status/471974046406426625,,,,
sammyuill,5/29/2014 7:14,0,0,Watch the video and get excited # ASCO14 Annual Meeting attendees - Science and Society http://www.youtube.com/watch?v=FCFvTi5SVI8&sns=tw … via @ youtube,,@,#,4.71973E+17,https://twitter.com/sammyuill/status/471972923528335360,,,,
Sports_bios,5/29/2014 7:14,0,0,Beyond # ASCO14 will be EHA meeting.. ex-mtgs.. the big Vtrx-Icpt-Geva trio binaries come in play..,,,#,4.71973E+17,https://twitter.com/Sports_bios/status/471972768935055360,,,,
Sports_bios,5/29/2014 7:12,0,2,"Big wave of # ASCO14 data coming this wknd.. $ CLVS is one ex-big pharma I wanna watch.. $ INCY is fun, but IDO Not Care.. ..",,,#,4.71972E+17,https://twitter.com/Sports_bios/status/471972371558309888,,,,
HughMcCafferty,5/29/2014 7:12,0,1,Chicago-bound for this year's # ASCO14 cancer conference. Expecting plenty of new therapy advances to get excited about.,,,#,4.71972E+17,https://twitter.com/HughMcCafferty/status/471972323357360128,,,,
JSwatercooler,5/29/2014 7:06,0,0,"So happy to be a co-author on an ASCO presented poster!  @ peterculpepper: # ASCO14 http://abstracts.asco.org/144/AbstView_144_132320.html …”""",,@,#,4.71971E+17,https://twitter.com/JSwatercooler/status/471970888338788352,,,,
PDRennert,5/29/2014 7:03,0,1,"just found the unofficial # ASCO14 tweetup, May 30th. RSVP at http://twvt.us/UnofficialASCO14 … # UnofficialASCO # twvt",,,# # #,4.7197E+17,https://twitter.com/PDRennert/status/471970144193761280,,,,
drdonsdizon,5/29/2014 6:43,5,5,Invited @ ASCO EdBook piece: Cancer log-kill by Dr. Larry Norton. Intro by @ CliffordHudis is PubMed abstract http://www.ncbi.nlm.nih.gov/m/pubmed/24857052/?i=2&from=norton%20l …. # ASCO14,,@ @,#,4.71965E+17,https://twitter.com/drdonsdizon/status/471964955198386176,,,,
YaleCancer,5/29/2014 6:38,0,0,MT ASCO has great meeting tools # ASCO14 tools: http://bit.ly/1gCf8Py Login to the Attendee Resource Center & prepare for the meeting,,,#,4.71964E+17,https://twitter.com/YaleCancer/status/471963801743806464,,,,
tabASCOsauce3,5/29/2014 6:35,0,0,Pilot does not know where we are going # help # ASCO14,,,# #,4.71963E+17,https://twitter.com/tabASCOsauce3/status/471963102293274624,,,,
tabASCOsauce3,5/29/2014 6:28,0,0,4:00 am wake up call. 6:15 am flight. Chicago here we come! # ASCO14,,,#,4.71961E+17,https://twitter.com/tabASCOsauce3/status/471961369223630848,,,,
mtmdphd,5/29/2014 6:16,3,1,"There Is No Little Blue Pill for This: Female Sexuality after Gynecologic CA - @ DrDonSDizon - Mon, Jun 2 - 1:15-2:30p E354a # ASCO14 # gyncsm",,@,# #,4.71958E+17,https://twitter.com/mtmdphd/status/471958207523721217,,,,
subatomicdoc,5/29/2014 5:57,2,1,What # breastcancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # bcsm,,@ @ @ @ @ @,# # # #,4.71953E+17,https://twitter.com/subatomicdoc/status/471953354558832640,,,,
Aifa_ufficiale,5/29/2014 5:53,2,2,# Tamoxifene le nuove linee guida @ ASCO raccomandano trattamento più lungo per pazienti con tumore al seno http://agenziafarmaco.gov.it/it/content/nuo …,,@,#,4.71952E+17,https://twitter.com/Aifa_ufficiale/status/471952492981678080,,,,
liemeij,5/29/2014 5:44,1,0,Op hemelvaart met # klm de lucht in ;) Onderweg naar # chicago waar ik presentatie mag verzorgen op conferentie # asco14,,,# # #,4.7195E+17,https://twitter.com/liemeij/status/471950227466096640,,,,
MilesHarleyHW,5/29/2014 5:05,2,1,Clinical updates of # ADC programs covered at # ASCO14 - exclusive summary ebook available at http://adc-summit.com/content-library @ World_ADC @ ADC_drugs,,@ @,# #,4.7194E+17,https://twitter.com/MilesHarleyHW/status/471940395682004992,,,,
remigiopina,5/29/2014 5:02,0,0,Se va conociendo más sobre la inmunoterapia contra cáncer @ rosayague @el_país. Esperando resultados de lo que se presenta en # ASCO14,,@ @el_país,#,4.7194E+17,https://twitter.com/remigiopina/status/471939738472300544,,,,
SiljaChouquet,5/29/2014 4:58,1,3,@ boehringer Gr8 initiative! Hope there will b epat posts too? MT @ pharmaphorum # ASCO14 # hcsmeu blog http://asco-2014.boehringer-ingelheim.com/,,@ @,# #,4.71939E+17,https://twitter.com/SiljaChouquet/status/471938680626900993,,,,
jdflaysakier,5/29/2014 4:43,12,0,Dans le JT13h de @ France2tv l''initiative bordelaise d'education therapeutique pour prevenir la récidive du cancer du sein # cancer # ASCO14,,@,# #,4.71935E+17,https://twitter.com/jdflaysakier/status/471934803000844288,,,,
brandingscience,5/29/2014 4:42,0,1,ASCO 2014 promises to celebrate 50 years of science for society with a bang! # asco # asco14 # science # health # society http://ow.ly/xlPWN,,,# # # # #,4.71935E+17,https://twitter.com/brandingscience/status/471934525807665153,,,,
ecancer,5/29/2014 4:31,0,0,ecancer will be filming at this year's # ASCO14 - sign up to register with us here http://ecancer.org/account/register.php …,,,#,4.71932E+17,https://twitter.com/ecancer/status/471931890220273664,,,,
YasirYousifE,5/29/2014 4:15,0,0,Off to # ASCO14,,,#,4.71928E+17,https://twitter.com/YasirYousifE/status/471927688975089664,,,,
fwpharma,5/29/2014 4:06,2,3,Physician Views - see the questions we're asking in our latest poll ahead of # ASCO14 http://bit.ly/1rjdoiP pic.twitter.com/aaS2GTgaNU,,,#,4.71926E+17,https://twitter.com/fwpharma/status/471925549514752001,,,,
alemomene,5/29/2014 4:04,0,0,"Mña comienza el 50 congreso de @ ASCO ,Asoc. Americana de Oncología Clínica.Se presentan ppales novedades en investigación en cáncer # asco14",,@,#,4.71925E+17,https://twitter.com/alemomene/status/471925044851924992,,,,
Pharmafocus,5/29/2014 4:02,0,0,Pharmafocus will be at the # ASCO14 cancer conference in Chicago this week - say hello to @ HughMcCafferty who will be reporting for us,,@,#,4.71925E+17,https://twitter.com/Pharmafocus/status/471924628487565312,,,,
alfonso_simon,5/29/2014 3:58,0,1,"Sobrevivir al cáncer, un poco más cerca http://ow.ly/xnviq vía @ CincoDiascom congreso American Society of Cilinal Oncology # ASCO14",,@,#,4.71924E+17,https://twitter.com/alfonso_simon/status/471923606511837184,,,,
EIannelli,5/29/2014 3:51,3,3,@ iConquerCancer thanks for your support to cancer patients advocate joining # asco14! We are arriving from Italy @ favo_it @ InsControCancro,,@ @ @,#,4.71922E+17,https://twitter.com/EIannelli/status/471921806606356480,,,,
Rasayanika,5/29/2014 3:36,0,0,# ClearbridgeBioMedics Launches The Next Gen Device ‘ # ClearCell(R) FX System’ At @ ASCO 2014 - http://www.rasayanika.com/9124/clearbridge-biomedics-launches-next-gen-device-clearcellr-fx-system-asco-2014/ …,,@,# #,4.71918E+17,https://twitter.com/Rasayanika/status/471917916510617601,,,,
buzzin77,5/29/2014 3:20,0,0,Off to Chicago this afternoon # ASCO14 # longday,,,# #,4.71914E+17,https://twitter.com/buzzin77/status/471913986896564224,,,,
iWomanish,5/29/2014 3:05,2,0,. @ _SEOM contará lo más destacado de @ ASCO 2014 a quien no pueda asistir http://www.seom.org/onconexion-highlights-asco-2014 … # oncologia,,@ @,#,4.7191E+17,https://twitter.com/iWomanish/status/471910210596925442,,,,
EuropeanCancer,5/29/2014 3:00,3,3,"Good luck to all travelling to # ASCO14. If you're there, pop over to ECCO booth #4055 and we'll share the latest ECCO news with you.",,,# #4055,4.71909E+17,https://twitter.com/EuropeanCancer/status/471908856495239168,,,,
peterculpepper,5/29/2014 2:57,1,0,# ASCO14 http://abstracts.asco.org/144/AbstView_144_132288.html …,,,#,4.71908E+17,https://twitter.com/peterculpepper/status/471908213214826496,,,,
peterculpepper,5/29/2014 2:57,0,0,# ASCO14 http://abstracts.asco.org/144/AbstView_144_132320.html …,,,#,4.71908E+17,https://twitter.com/peterculpepper/status/471908052417794048,,,,
andygaya,5/29/2014 2:54,0,0,# ASCO14 # cancer # mortality CR-UK Press release: Poorer people more likely to get and die from cancer http://bit.ly/1nUyBda,,,# # #,4.71908E+17,https://twitter.com/andygaya/status/471907529476145152,,,,
ByJonGardner,5/29/2014 2:50,0,1,Let's see what security at Heathrow has to say about # sgenball as I fly to # ASCO14. $ SGEN,,,# #,4.71907E+17,https://twitter.com/ByJonGardner/status/471906505025781760,,,,
LaurenceVick,5/29/2014 2:47,0,0,Interesting to follow cutting edge # oncology developments at major world conference this weekend in Chicago # ASCO2014 @ ASCO,,@,# #,4.71906E+17,https://twitter.com/LaurenceVick/status/471905690139643904,,,,
twiterney,5/29/2014 2:38,0,1,Aaaaaaaaaand here we go # ASCO14,,,#,4.71903E+17,https://twitter.com/twiterney/status/471903383477972993,,,,
Sonakshi1122,5/29/2014 2:15,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/NebOYlIQZ2,,,# # # # # # # # # # # #,4.71898E+17,https://twitter.com/Sonakshi1122/status/471897617484349440,,,,
Sonakshi1122,5/29/2014 2:14,0,2,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/ids7J7Zig8 # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71897E+17,https://twitter.com/Sonakshi1122/status/471897454535651328,,,,
aftimosp,5/29/2014 1:53,0,0,Adjuvant Endocrine Therapy for Women With HR+ # BreastCancer: @ ASCO Guideline Update http://www.asco.org/quality-guidelines/adjuvant-endocrine-therapy-women-hormone-receptor …–positive-breast-cancer-american,,@,#,4.71892E+17,https://twitter.com/aftimosp/status/471891998224314368,,,,
StefanoLuminari,5/29/2014 1:18,0,0,going to # ASCO14,,,#,4.71883E+17,https://twitter.com/StefanoLuminari/status/471883305663463424,,,,
rsm2800,5/29/2014 1:00,3,2,Looks like @ mtmdphd @ obogler & I are speaking at the same time as @ drdonsdizon 6/2 at # ASCO14. How to confirm # tweetingfromthepodium? Hmm...,,@ @ @,# #,4.71879E+17,https://twitter.com/rsm2800/status/471878637956767744,,,,
CI4CC,5/29/2014 0:59,0,0,Everyone ready for @ ASCO # ASCO14 ?!!!,,@,#,4.71879E+17,https://twitter.com/CI4CC/status/471878511834066944,,,,
subatomicdoc,5/29/2014 0:52,0,0,@ LGG1 See you at the @ ASCO booth? # ASCO14,,@ @,#,4.71877E+17,https://twitter.com/subatomicdoc/status/471876602188410882,,,,
SofiRodriguez94,5/29/2014 0:08,1,1,@ AyelenRomera # BoludecesNO tirarle un beso volador a la negra ! Diuu lo peor que escuche en mi vida # ASCO14,,@,# #,4.71866E+17,https://twitter.com/SofiRodriguez94/status/471865740337750016,,,,
Lymphoma_Doc,5/28/2014 23:58,1,0,@ ASCO I received my meeting badge in the mail but didn't have my twitter name. Can I print a new one at the meeting?,,@,,4.71863E+17,https://twitter.com/Lymphoma_Doc/status/471863158420697088,,,,
DrAttai,5/28/2014 23:56,0,0,"reviewing # ASCO14 abstracts, loading up the planner. Brain will be exploding in no time...",,,#,4.71863E+17,https://twitter.com/DrAttai/status/471862630001295361,,,,
christinemphmd,5/28/2014 23:48,1,0,Enroute to Chicago for # ASCO14! Finally have my schedule planned out on # iplanner hopefully. @ asco @ CliffordHudis,,@ @,# #,4.7186E+17,https://twitter.com/christinemphmd/status/471860494291046401,,,,
ASCO,5/28/2014 23:22,2,2,# ASCO14 tools: http://bit.ly/1gCf8Py Login to the Attendee Resource Center & prepare for the meeting,,,#,4.71854E+17,https://twitter.com/ASCO/status/471853945367695362,,,,
davisa20,5/28/2014 23:14,1,0,Just downloaded the # ASCO14 eTote to my iPad. Don't forget to download all your resources before you arrive at http://am.asco.org/arc,,,#,4.71852E+17,https://twitter.com/davisa20/status/471851998782820352,,,,
PPHMBULL,5/28/2014 23:11,0,0,@ steveharper2012 @ genentech What do you think about targeting phosphatidylserine for # immunotherapy? Seems like such a no brainer # ASCO14,,@ @,# #,4.71851E+17,https://twitter.com/PPHMBULL/status/471851392831721472,,,,
Gene_Antibody,5/28/2014 22:40,0,0,Cool! MT @ ASCO @ RahmEmanuel proclaimed June as Oncology Month in Chicago in honor of 50th meeting http://bit.ly/TLmJl4,,@ @,,4.71843E+17,https://twitter.com/Gene_Antibody/status/471843398287384577,,,,
drseisenberg,5/28/2014 22:18,0,0,@ DrMisialek @ drdonsdizon @ ASCO me too,,@ @ @,,4.71838E+17,https://twitter.com/drseisenberg/status/471837907905282049,,,,
ASCO,5/28/2014 22:13,0,1,@ FreemanCo Thank you for sharing the image & thank you for the work you're doing to make # ASCO14 possible.,,@,#,4.71837E+17,https://twitter.com/ASCO/status/471836737950720000,,,,
Rad_Nation,5/28/2014 22:04,1,1,MT @ Roche: In 1903 doctors reported the 1st successful use of radiation to treat # Cancer http://buff.ly/1k2wSo2 # ASCO14 / # radonc,,@,# # #,4.71834E+17,https://twitter.com/Rad_Nation/status/471834407125667840,,,,
fimmgnotizie,5/28/2014 21:53,0,0,“ @ genentech: POV from Dan Chen on why immunotherapy is one of the most promising cancer approaches # ASCO14 http://ow.ly/xmQTb ”,,@,#,4.71832E+17,https://twitter.com/fimmgnotizie/status/471831544131502080,,,,
GenentechJobs,5/28/2014 21:52,0,0,Check out this video tutorial http://bit.ly/1nwDhHL it shows you the best way to use the # ASCO14 iMeeting app and iplanner.,,,#,4.71831E+17,https://twitter.com/GenentechJobs/status/471831368498814976,,,,
genentech,5/28/2014 21:45,8,6,POV from Dan Chen on why immunotherapy is one of the most promising cancer approaches # ASCO14 http://ow.ly/xmQTb,,,#,4.7183E+17,https://twitter.com/genentech/status/471829589803925506,,,,
DrMisialek,5/28/2014 21:39,0,2,@ drdonsdizon @ drseisenberg I'll be following along with # ASCO14 for all the breaking news @ ASCO,,@ @ @,#,4.71828E+17,https://twitter.com/DrMisialek/status/471828110686830593,,,,
aicrtweets,5/28/2014 21:25,0,1,RT @ drdonsdizon: Now out! Survivorship in gyn cancers w @ LDuska and AFader # ASCO14 http://www.ncbi.nlm.nih.gov/m/pubmed/24857115/?i=1&from=duska …,,@ @,#,4.71825E+17,https://twitter.com/aicrtweets/status/471824541120204801,,,,
rschilsky,5/28/2014 21:24,0,0,@ DrBobGoldberg @ ASCO ASCO will always place the needs of patients first.,,@ @,,4.71824E+17,https://twitter.com/rschilsky/status/471824360253054977,,,,
drdonsdizon,5/28/2014 21:13,3,1,“ @ drseisenberg: The Cancer Chronicles is out! http://paper.li/drseisenberg/1355447143 … Stories via @ drdonsdizon @ DrMisialek” excellent!!! See u at # ASCO14?,,@ @ @,#,4.71821E+17,https://twitter.com/drdonsdizon/status/471821496982441984,,,,
ElizBlanchardMD,5/28/2014 20:54,0,0,Check out the # SWOG # ASCO14 abstracts https://swog.org/Members/Download/BulletinBoard/Article221.pdf …,,,# #,4.71817E+17,https://twitter.com/ElizBlanchardMD/status/471816928722305024,,,,
cancerassassin1,5/28/2014 20:53,0,0,Revving up for a storm of tweets and updates at # ASCO14; trying to determine if more efficient to use stylus w/ iPad or use iPhone instead?,,,#,4.71817E+17,https://twitter.com/cancerassassin1/status/471816603688923136,,,,
FishburnSimone,5/28/2014 20:44,2,0,In Chicago for # ASCO14 ? Check out Thursday's Women In Bio event on Precision Medicine. Details here: http://bit.ly/1hf5FhA walkins welcome,,,#,4.71814E+17,https://twitter.com/FishburnSimone/status/471814348839452673,,,,
bnichols9883,5/28/2014 20:32,0,1,Been writing tech for @ themotleyfool not following biotech as closely. Yet story lines for # ASCO14 don't seem as rich as last year. $ PCYC,,@,#,4.71811E+17,https://twitter.com/bnichols9883/status/471811168211066880,,,,
Perthera,5/28/2014 20:25,1,0,The Perthera team is ramping up for # ASCO14 Annual Meeting in Chicago this wknd! Join us! Booth #4040! # cancer # genomics # treatment,,,# #4040 # # #,4.7181E+17,https://twitter.com/Perthera/status/471809609041461248,,,,
MyelomaTeacher,5/28/2014 20:13,0,0,At What Price? Discussing Cost of Care with Patients | ASCO Connection http://connection.asco.org/Commentary/Article/ID/3843/At-What-Price-Discussing-Cost-of-Care-with-Patients.aspx … via @ ASCO,,@,,4.71807E+17,https://twitter.com/MyelomaTeacher/status/471806515410513920,,,,
Bronson_Crouch,5/28/2014 20:12,0,1,Advances in medicine @ asco @cliffhudishttp://newsle.com/article/0/154133391/,,@ @cliffhudishttp,,4.71806E+17,https://twitter.com/Bronson_Crouch/status/471806215786225665,,,,
markaorourke,5/28/2014 20:07,2,0,# Obesity and # Cancer | # ASCO14 http://www.asco.org/practice-research/obesity-and-cancer#.U4Z5ycxR-io.twitter … Excellent monograph for # oncology providers. # swogonc # bcsm # pcsm,,,# # # # # # # #,4.71805E+17,https://twitter.com/markaorourke/status/471805047538319360,,,,
markaorourke,5/28/2014 20:05,0,0,# Obesity and # cancer risk reduction # ASCO14 http://bit.ly/1koO1Y8 Obesity is the elephant in the room for cancer risk reduction. # swogonc,,,# # # #,4.71804E+17,https://twitter.com/markaorourke/status/471804411959078912,,,,
ThePublicHealth,5/28/2014 20:00,0,0,Let's make tumors rumors. @ ASCO,,@,,4.71803E+17,https://twitter.com/ThePublicHealth/status/471803184466259968,,,,
drdonsdizon,5/28/2014 19:52,0,1,TY @ kevinMD for picking up this @ ASCO Connection post on cancer care for international pts. http://evpo.st/1tRotWc,,@ @,,4.71801E+17,https://twitter.com/drdonsdizon/status/471801255778459648,,,,
genentech,5/28/2014 19:45,3,2,A major challenge in personalized medicine for # lungcancer: The issue with tissue. # ASCO14 # LCSM http://ow.ly/xmTwu,,,# # #,4.71799E+17,https://twitter.com/genentech/status/471799342681321472,,,,
myriadgenetics,5/28/2014 19:40,3,1,Watch this video to find out more about # BRCA1 and # BRCA2 # genetictesting! http://bit.ly/1dgAjP9 # hereditarycancer # ASCO14 # ovariancancer,,,# # # # # #,4.71798E+17,https://twitter.com/myriadgenetics/status/471798071727104000,,,,
GenentechJobs,5/28/2014 19:37,0,1,We're on our way to the # windycity this week for # ASCO14. Retweet if you're heading that direction.,,,# #,4.71797E+17,https://twitter.com/GenentechJobs/status/471797464526106624,,,,
GenentechJobs,5/28/2014 19:32,0,1,"# ASCO14 Talent Hunt: Medical Director, Pi3Kinase - http://click2apply.net/430228t",,,#,4.71796E+17,https://twitter.com/GenentechJobs/status/471796070826008576,,,,
GenentechJobs,5/28/2014 19:25,0,1,"# ASCO14 Talent Hunt: Sr. Medical Director, Zelboraf - http://click2apply.net/429263t",,,#,4.71795E+17,https://twitter.com/GenentechJobs/status/471794517243211776,,,,
ConquerCancerFd,5/28/2014 19:25,0,1,"RT @ ASCO: . @ iConquerCancer supports clinical research & early-career oncologists w/ 2014 ACRA, YIA & CDA Awards http://bit.ly/1pggzWv",,@ @,,4.71794E+17,https://twitter.com/ConquerCancerFd/status/471794350809440257,,,,
CancerDotNet,5/28/2014 19:15,3,4,Social Media at # ASCO14: Handles & hashtags to follow for more specific coverage http://bit.ly/PYjFQf,,,#,4.71792E+17,https://twitter.com/CancerDotNet/status/471791851734065152,,,,
SequentaInc,5/28/2014 19:01,0,1,"# Immunotherapy big # ASCO14 focus, new data on how LymphoSIGHT pltfrm could be used to assess response of therapies http://ow.ly/xm50w",,,# #,4.71788E+17,https://twitter.com/SequentaInc/status/471788311061987328,,,,
MatthewHSimmons,5/28/2014 18:57,1,0,Follow @ SarahCannonDocs for # ASCO14 updates... pic.twitter.com/5XkoseILhC,,@,#,4.71787E+17,https://twitter.com/MatthewHSimmons/status/471787302251802624,,,,
wendyselig,5/28/2014 18:56,2,1,Stay tuned for updates from # asco14 where many @ MelanomaReAlli funded docs will have # melanoma data showing more progress for patients!,,@,# #,4.71787E+17,https://twitter.com/wendyselig/status/471787062614843392,,,,
jagasquet,5/28/2014 18:53,0,0,Attending # ASCO14? Chicago Weather forecast. http://www.weather.com/weather/5-day/USIL0225?cm_ven=Twitter … via @ weatherchannel,,@,#,4.71786E+17,https://twitter.com/jagasquet/status/471786265763799040,,,,
YaleCancer,5/28/2014 18:51,6,5,"Yale experts to attend # ASCO14, the largest meeting on cancer research & treatment. We're presenting on these & more http://bit.ly/RCGsRU",,,#,4.71786E+17,https://twitter.com/YaleCancer/status/471785956119691264,,,,
AmbryGenetics,5/28/2014 18:42,0,3,"We are headed your way! See you soon! RT @ ASCO Those using # ASCO2014, we invite you to use the official tag # ASCO14",,@,# #,4.71784E+17,https://twitter.com/AmbryGenetics/status/471783646479671296,,,,
ASCO,5/28/2014 18:40,12,9,"Those using # ASCO2014, we invite you to use the official tag # ASCO14",,,# #,4.71783E+17,https://twitter.com/ASCO/status/471782998258757634,,,,
ventana,5/28/2014 18:40,0,0,"RT @ genentech: A magnificent obsession"" led to worldwide # innovation & eventually discoveries in cancer: http://ow.ly/xk013 # ASCO14""",,@,# #,4.71783E+17,https://twitter.com/ventana/status/471782988234379264,,,,
CancerMedMDA,5/28/2014 18:39,1,0,Congrats our Fellows Drs. Megan Karuturi & Yanyan Lou: ASCO Conquer Cancer Fdtn Young Investigator Awards. # endcancer # ASCO14,,,# #,4.71783E+17,https://twitter.com/CancerMedMDA/status/471782841265553408,,,,
AmazzoneFuriosa,5/28/2014 18:36,0,0,"@ NancysPoint they can recommend whatever they want, i already have a womb polyp and I'll stop after 5 years @ ASCO",,@ @,,4.71782E+17,https://twitter.com/AmazzoneFuriosa/status/471782110953742337,,,,
scientre,5/28/2014 18:35,1,1,"MT @ 3NT Heading to # ASCO14? Don't forget Unofficial"" Tweetup hosts @ brianreid @ GeoffreyCurtis @ adamfeuerstein RSVP http://twvt.us/UnofficialASCO14 …""",,@ @ @ @,#,4.71782E+17,https://twitter.com/scientre/status/471781764047077376,,,,
ChemoCompanion,5/28/2014 18:35,0,0,Excited to be attending # ASCO14 in Chicago!,,,#,4.71782E+17,https://twitter.com/ChemoCompanion/status/471781735559348224,,,,
CanaleComm,5/28/2014 18:35,1,1,". @ ASCO is 2 days away! 25,000+ onc professionals spend 5 days discussing cutting-edge research. Now THAT is exciting! http://asco.org/",,@,,4.71782E+17,https://twitter.com/CanaleComm/status/471781726038294529,,,,
drdonsdizon,5/28/2014 18:31,6,3,"Just 2 clarify @ ASCO guidance re endocrine RX- it's up to"" 10y"," not 10y 4 all. There R >1 optns. # LookClosely # bcsm http://www.medpagetoday.com/HematologyOncology/BreastCancer/46007?xid=nl_mpt_DHE_2014-05-28 …""",,@,# #,4.71781E+17,https://twitter.com/drdonsdizon/status/471780756646154240,,,
Tuli__11,5/28/2014 18:25,0,0,https://www.facebook.com/photo.php?v=282379101929590&set=vb.272585542908946&type=2&theater … PORFAVOR VEAN ESTO ! JAJAJAJAJAJAJA @ asco @misganasdevomitar,,@ @misganasdevomitar,,4.71779E+17,https://twitter.com/Tuli__11/status/471779237964554240,,,,
GregoryDennis,5/28/2014 18:23,0,0,@prIME_Oncology # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@prIME_Oncology,# #,4.71779E+17,https://twitter.com/GregoryDennis/status/471778864319168512,,,,
GregoryDennis,5/28/2014 18:23,0,0,@ drdonsdizon # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71779E+17,https://twitter.com/GregoryDennis/status/471778803665367040,,,,
GregoryDennis,5/28/2014 18:23,1,0,@ ImmohMD # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71779E+17,https://twitter.com/GregoryDennis/status/471778741484806144,,,,
GregoryDennis,5/28/2014 18:22,0,0,@ DrRakeshPatel # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71779E+17,https://twitter.com/GregoryDennis/status/471778617249501184,,,,
GregoryDennis,5/28/2014 18:22,0,0,@ JediPD # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71779E+17,https://twitter.com/GregoryDennis/status/471778573393874944,,,,
GregoryDennis,5/28/2014 18:22,0,0,@ dhjutsw1 # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778495400779776,,,,
GlopesMd,5/28/2014 18:22,1,2,# ASCO14 disparidades regionais no tratamento de câncer do sistema nervoso central http://abstracts.asco.org/144/AbstView_144_130872.html …,,,#,4.71778E+17,https://twitter.com/GlopesMd/status/471778491856601088,,,,
GregoryDennis,5/28/2014 18:21,0,0,@ iConquerCancer # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778433597710337,,,,
GregoryDennis,5/28/2014 18:21,0,0,@ DrMarkham # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778381236023297,,,,
GregoryDennis,5/28/2014 18:21,0,0,@ YupOnc # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778330438803458,,,,
GregoryDennis,5/28/2014 18:21,1,0,@ yzafar # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778282284007424,,,,
GregoryDennis,5/28/2014 18:21,0,0,@ jagasquet # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778210251022336,,,,
GlopesMd,5/28/2014 18:21,2,2,# ASCO14 Study shows regional disparities in CNS cancer treatment in a large middle income country. http://abstracts.asco.org/144/AbstView_144_130872.html …,,,#,4.71778E+17,https://twitter.com/GlopesMd/status/471778189375995904,,,,
GregoryDennis,5/28/2014 18:20,0,0,@ OncJournal # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778131305848833,,,,
harriseve,5/28/2014 18:20,0,0,"Smacktlk! @ rsm2800 sez: On it! MT @ n8pennell: In '13 @ JackWestMD live tweetd while chairng session. This yr, tweet while presenting? # ASCO14",,@ @ @,#,4.71778E+17,https://twitter.com/harriseve/status/471778113974992896,,,,
AlpineBV_Miller,5/28/2014 18:20,0,1,Only 350 items on my itinerary for # ASCO14,,,#,4.71778E+17,https://twitter.com/AlpineBV_Miller/status/471778053002375168,,,,
GregoryDennis,5/28/2014 18:20,0,0,@ Annals_Oncology # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471778051366596610,,,,
GregoryDennis,5/28/2014 18:20,0,0,@ myESMO # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471777976565366784,,,,
GregoryDennis,5/28/2014 18:19,0,0,@ Mills_I # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471777898350010368,,,,
GregoryDennis,5/28/2014 18:19,1,0,@ DrPaulyDeSantis # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471777821665542144,,,,
GregoryDennis,5/28/2014 18:18,0,0,@ EncoreBioMed # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471777669156446208,,,,
GregoryDennis,5/28/2014 18:18,0,0,@ DrMiguelPerales # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71778E+17,https://twitter.com/GregoryDennis/status/471777603331039232,,,,
GregoryDennis,5/28/2014 18:18,0,0,@ BreastOncology # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71777E+17,https://twitter.com/GregoryDennis/status/471777457100832769,,,,
GregoryDennis,5/28/2014 18:17,0,0,@ OncologySurgery # ASCO14 Genomic profiling of African-American women with breast cancer -- new insights. # BCSM http://hub.am/1okjIC1,,@,# #,4.71777E+17,https://twitter.com/GregoryDennis/status/471777345427501056,,,,
3NT,5/28/2014 18:07,6,3,"Heading to # ASCO14? Don't forget The ""Unofficial"" Tweetup hosted by @ brianreid @ GeoffreyCurtis @ adamfeuerstein RSVP http://twvt.us/UnofficialASCO14 …""",,@ @ @,#,4.71775E+17,https://twitter.com/3NT/status/471774739241787392,,,,
AndreaMiyahira,5/28/2014 18:04,1,0,FDA Grants Merck’s Anti-PD1 Antibody Priority Review – 6 Oral abstracts at # ASCO14 ! http://ow.ly/xmN1B @ ASCO,,@,#,4.71774E+17,https://twitter.com/AndreaMiyahira/status/471774012729610240,,,,
robinwhitsell,5/28/2014 18:02,0,0,Great Conversation! MT @ AmandaBoldersto Twitter's role during scientific meetings. http://ow.ly/xl2oP # ASCO14 # hcsm # DIA2014,,@,# # #,4.71773E+17,https://twitter.com/robinwhitsell/status/471773428698316800,,,,
NateDahlPharmD,5/28/2014 18:01,0,0,RT @PACENetworkUSA: Cost & value aren't the same when it comes to # cancer medicines. http://ow.ly/xmcbU # ASCO14,,@PACENetworkUSA,# #,4.71773E+17,https://twitter.com/NateDahlPharmD/status/471773406694608896,,,,
Roche,5/28/2014 17:50,7,3,In 1903 doctors reported the 1st successful use of radiation to treat # Cancer http://ow.ly/xkxli # ASCO14 # oncology,,,# # #,4.7177E+17,https://twitter.com/Roche/status/471770441410154496,,,,
brochman,5/28/2014 17:47,0,1,The CerviScope in the Field http://nyti.ms/1hehG6X @ ASCO @ acognews @ WHO @ GHhub @ PATHTweets @ UNfEWEC @ ToyinSaraki @ WomenDeliver @mchipnet,,@ @ @ @ @ @ @ @ @mchipnet,,4.7177E+17,https://twitter.com/brochman/status/471769680219082752,,,,
genentech,5/28/2014 17:45,6,2,See how Ph I trials in # CancerResearch are evolving. http://ow.ly/xk5iJ # ASCO14 # Next50,,,# # #,4.71769E+17,https://twitter.com/genentech/status/471769208871993344,,,,
jfclearywisc,5/28/2014 17:39,2,2,"MT @ ASCO: Pain Management, Special Series w/reviews on pain tx & overview “Pain in Patients w Cancer” http://bit.ly/1tntUdh # hpmglobal",,@,#,4.71768E+17,https://twitter.com/jfclearywisc/status/471767797958447104,,,,
drdonsdizon,5/28/2014 17:19,1,1,MT @ genentech: We were inspired by # REV2014. RE: QoC: http://ow.ly/xk3vt # ASCO14 Now need # actionable steps @ Livestrong @ iConquerCancer,,@ @ @,# # #,4.71763E+17,https://twitter.com/drdonsdizon/status/471762661605011456,,,,
NextGenClinical,5/28/2014 17:19,0,0,Watch ASCO President Dr. Hudis Discuss 2014 Annual Meeting Theme: Science & Society http://bcove.me/2nxkdk7j See you there! # ASCO14,,,#,4.71763E+17,https://twitter.com/NextGenClinical/status/471762632970866689,,,,
ConquerCancerFd,5/28/2014 17:15,6,3,"Congrats to the 2014 @ iConquerCancer YIA, CDA, & ACRA recipients! Full list here: http://bit.ly/1gBtM9R # ASCO14",,@,#,4.71762E+17,https://twitter.com/ConquerCancerFd/status/471761623594852352,,,,
AsimJshaikh,5/28/2014 17:06,0,1,Let's Meet at # ASCO14,,,#,4.71759E+17,https://twitter.com/AsimJshaikh/status/471759401389658112,,,,
ASCO,5/28/2014 17:01,4,3,Review Educational Book articles in advance of # ASCO14 educational sessions: http://bit.ly/SLvfQa,,,#,4.71758E+17,https://twitter.com/ASCO/status/471758066523062272,,,,
GenentechJobs,5/28/2014 17:00,0,0,We’re jazzed about attending # ASCO2014 and proud to be a meeting supporter for... http://talent.gene.com/go/a-kc1a # Genentech,,,# #,4.71758E+17,https://twitter.com/GenentechJobs/status/471757830748254208,,,,
pharmaphorum,5/28/2014 16:51,1,1,Finding myself in interesting company on the # ASCO14 blog from @ Boehringer - # notjustonedisease http://asco-2014.boehringer-ingelheim.com/,,@,# #,4.71756E+17,https://twitter.com/pharmaphorum/status/471755571180601345,,,,
KUhlendorf,5/28/2014 16:48,0,1,Prepping for # ASCO14 and torn by concurrent panels: value & ethics of # cancer care or design of clinical trials for targeted therapies?,,,# #,4.71755E+17,https://twitter.com/KUhlendorf/status/471754936536293376,,,,
JenPageWall,5/28/2014 16:47,1,1,# ASCO14 did you know that only 20% of cancer spending is on meds. What about other 80 percent of HC spending pie? http://shar.es/VkOCL,,,#,4.71755E+17,https://twitter.com/JenPageWall/status/471754570805575680,,,,
CancerTherAdvsr,5/28/2014 16:45,0,0,RT @ subatomicdoc: What # prostatecancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF...,,@ @ @ @ @ @ @,# # #,4.71754E+17,https://twitter.com/CancerTherAdvsr/status/471754080428515329,,,,
Curiolog,5/28/2014 16:36,0,0,"Durant les 6 prochains jours, tweets en direct de Chicago pour rendre compte du congrès mondial de cancérologie # ASCO14 pour Allodocteurs.fr",,,#,4.71752E+17,https://twitter.com/Curiolog/status/471751861654257664,,,,
EBantug,5/28/2014 16:32,0,0,"@ asco guideline update 4 # endocrine tx 4 # breast cancer. http://goo.gl/91bOep . How 2 support pts for 10 yrs? http://goo.gl/i9yzDl "",,@,# #,471750950864945154""",https://twitter.com/EBantug/status/471750950864945154,,,,,,,,
myPathMelanoma,5/28/2014 16:29,0,0,Visit # Myriad @ ASCO Poster Highlights on Sat. May 31st 8am-11:45am # Myriad myPath Melanoma Influence of Gene Signature on Melanocytic Tumor,,@,# #,4.7175E+17,https://twitter.com/myPathMelanoma/status/471750129137897472,,,,
CCO_Oncology,5/28/2014 16:28,0,0,Visit us in Chicago at # ASCO2014 this weekend! We have 3 satellites and we'll be in the exhibit hall at booth #16026!,,,# #16026,4.7175E+17,https://twitter.com/CCO_Oncology/status/471749896438304768,,,,
Mytrus,5/28/2014 16:27,0,0,"MT @ Novartis: Novartis committed to advancing patient care, presenting data from 150+ abstracts at # ASCO14 & # EHA14 http://bit.ly/1bCGPm8",,@,# #,4.7175E+17,https://twitter.com/Mytrus/status/471749580099313664,,,,
AlpineBV_Miller,5/28/2014 16:26,0,0,"Ah, E Hall D2 to N Hall B1 sprint, how I already hate thee... # ASCO14",,,#,4.71749E+17,https://twitter.com/AlpineBV_Miller/status/471749426630131712,,,,
MediTech_Media,5/28/2014 16:26,0,1,@ ASCO This is a great idea! We will be following along!,,@,,4.71749E+17,https://twitter.com/MediTech_Media/status/471749258857963520,,,,
subatomicdoc,5/28/2014 16:26,0,0,"@ RonnieLass Thanks, Ronnie. I'm glad you think it has value. Still a ways to go but should be interesting to see what happens after # ASCO14",,@,#,4.71749E+17,https://twitter.com/subatomicdoc/status/471749251752812544,,,,
OncTimes_AsstEd,5/28/2014 16:20,2,0,Heading to # ASCO14? Find out how many @ ASCO AMs @ OncologyTimes readers have attended... http://journals.lww.com/oncology-times/pages/Quick-Poll.aspx …,,@ @,#,4.71748E+17,https://twitter.com/OncTimes_AsstEd/status/471747938499035136,,,,
myriadgenetics,5/28/2014 16:20,1,1,"Physicians, visit MyriadPro for information that can help you serve your patients! http://bit.ly/1dgJ7EA # brca # ASCO14 # prostatecancer",,,# # #,4.71748E+17,https://twitter.com/myriadgenetics/status/471747745263284224,,,,
genentech,5/28/2014 16:15,1,0,@ drdonsdizon: We were inspired by the quality discussion at # REV2014. Here's what we think abt QoC: http://ow.ly/xk3vt # ASCO14,,@,# #,4.71747E+17,https://twitter.com/genentech/status/471746561396183040,,,,
genentech,5/28/2014 16:05,4,2,"# OH at # REV2014: Every cancer center will have a psychosocial program."" – Jimmie Holland @ MSKCC Chair Psych Onc # Next50 # ASCO14""",,@,# # # #,4.71744E+17,https://twitter.com/genentech/status/471744038472003584,,,,
BCRFcure,5/28/2014 16:02,0,1,Twice the # tamoxifen backed for # breastcancer patients http://ow.ly/xmyDj @ abcnews @ ASCO,,@ @,# #,4.71743E+17,https://twitter.com/BCRFcure/status/471743378779291648,,,,
Novartis,5/28/2014 16:01,0,1,"# Novartis is committed to advancing patient care, presenting data from 150+ abstracts at # ASCO14 & # EHA14 http://bit.ly/1bCGPm8",,,# # #,4.71743E+17,https://twitter.com/Novartis/status/471743095093362688,,,,
ASCO,5/28/2014 16:01,6,3,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.71743E+17,https://twitter.com/ASCO/status/471743062331654145,,,,
oncodocsydney,5/28/2014 16:01,0,0,"“ @ ASCO: Those using # ASCO2014, we invite you to use the official tag # ASCO14” will do!",,@,# #,4.71743E+17,https://twitter.com/oncodocsydney/status/471743015954817024,,,,
RoswellPark,5/28/2014 16:01,1,0,"From @ medpagetoday, Dr. O'Connor shares thoughts on @ ASCO's new guidelines on long-term tamoxifen for breast cancer: http://goo.gl/GcZORP",,@ @,,4.71743E+17,https://twitter.com/RoswellPark/status/471742958849765376,,,,
jagasquet,5/28/2014 15:58,0,1,# ASCO14 Annual Meeting Promises Important Updates for # colorectalcancer Research http://www.cancernetwork.com/asco-2014-colorectal-cancer/asco-annual-meeting-promises-important-updates-crc-research …,,,# #,4.71742E+17,https://twitter.com/jagasquet/status/471742282581172225,,,,
andygaya,5/28/2014 15:53,1,1,# ASCO14 # Cancer # Oncology starts 30 May. Small steps lead to giant leaps.,,,# # #,4.71741E+17,https://twitter.com/andygaya/status/471740968845467648,,,,
PVonc,5/28/2014 15:50,0,2,Expert & community oncologists tackle cases in pancreatic cancer! Attend a free CME symposium on 5/31 http://bit.ly/ASCOpancreatic # ASCO14 # pancsm,,,# #,4.7174E+17,https://twitter.com/PVonc/status/471740243305975808,,,,
CancerTherAdvsr,5/28/2014 15:50,0,0,Gearing up for # ASCO14 coverage! Are you ready? http://ow.ly/xlx94,,,#,4.7174E+17,https://twitter.com/CancerTherAdvsr/status/471740242081632257,,,,
SequentaInc,5/28/2014 15:31,2,1,What # ASCO14 # bloodcancer data excites you? (http://ow.ly/xk016 ) # mmsm # lymsm,,,# # # #,4.71735E+17,https://twitter.com/SequentaInc/status/471735430015377408,,,,
Boehringer,5/28/2014 15:30,0,1,“I felt I should directly contribute to making novel anticancer drugs available to patients” Gerd Stehle http://bit.ly/RwVI2G # ASCO14,,,#,4.71735E+17,https://twitter.com/Boehringer/status/471735399686356992,,,,
PVonc,5/28/2014 15:29,2,0,Register now for a # prostate # cancer CME symposium with learner-directed content in Chicago on 6/1: http://bit.ly/ASCOprostate # ASCO14 # meded,,,# # # #,4.71735E+17,https://twitter.com/PVonc/status/471734951772033024,,,,
yolandafacio,5/28/2014 15:28,0,0,ASCO 2014 CLL and iNHL Preview # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-cll-and-inhl-preview-asco14.html/ …,,,#,4.71735E+17,https://twitter.com/yolandafacio/status/471734880590512128,,,,
GenentechJobs,5/28/2014 15:28,0,0,Thought leaders from across our organization will take center stage during # ASCO14 presenting and attending sessions. http://bit.ly/RzC4mw,,,#,4.71735E+17,https://twitter.com/GenentechJobs/status/471734864580857856,,,,
Sports_bios,5/28/2014 15:28,0,0,"$ CLVS data to ptesent at # ASCO14 http://phx.corporate-ir.net/phoenix.zhtml?c=247187&p=irol-newsArticle_Print&ID=1930986&highlight= … so everything this coming wknd... frankly ex-1686, I dont giv-a-sheeet.",,,#,4.71735E+17,https://twitter.com/Sports_bios/status/471734840682106880,,,,
adamfeuerstein,5/28/2014 15:28,1,2,"For the record, I have nothing embargoed regarding $ CLVS at # ASCO14. Might be a leak, or not, but I don’t know.",,,#,4.71735E+17,https://twitter.com/adamfeuerstein/status/471734827599659008,,,,
GenentechJobs,5/28/2014 15:26,0,0,"# ASCO14 meeting supporter for these conference tracks: Gynecologic Cancer, Lung Cancer, Melanoma/Skin Cancer, Tumor Biology plus more.",,,#,4.71734E+17,https://twitter.com/GenentechJobs/status/471734238501294080,,,,
GenentechJobs,5/28/2014 15:24,0,0,"We’re jazzed about attending # ASCO14 & proud to be a meeting supporter for these conference tracks: Breast Cancer, Clinical Trials and more.",,,#,4.71734E+17,https://twitter.com/GenentechJobs/status/471733841439096832,,,,
mtmdphd,5/28/2014 15:24,0,0,Hashtag Folksonomy for Cancer Communities on Twitter http://ow.ly/t6LXp Updated w/ Cancer Tag Ontology http://ow.ly/t6M9Y # ASCO14,,,#,4.71734E+17,https://twitter.com/mtmdphd/status/471733804366065665,,,,
brandonmancini,5/28/2014 15:16,1,0,“ @ NCIEpi: Find out when & where NCI staff will be speaking at the @ ASCO Annual Meeting: http://1.usa.gov/1pyzObj # ASCO14”,,@ @,#,4.71732E+17,https://twitter.com/brandonmancini/status/471731747349360641,,,,
Emory_R,5/28/2014 15:11,5,9,# ASCO14 stock returns since the May 14th Data Dump show wide dispersion $ TGTX $ DYAX $ ADHFX $ VSTM $ MACK $ CYTR $ PCYCpic.twitter.com/CCkOynXkzl,,,#,4.7173E+17,https://twitter.com/Emory_R/status/471730414303068160,,,,
SyneosHealth,5/28/2014 15:10,2,1,"INC has a specialized passion for Oncology, with experience from more than 600 clinical trials. Learn more by visiting # ASCO14 booth 11115",,,#,4.7173E+17,https://twitter.com/SyneosHealth/status/471730261915631616,,,,
peaces38,5/28/2014 15:08,0,0,@ Merck @ ASCO thank you. I already checked out their site and could not ascertain the info. That's why I asked you. ;),,@ @,,4.7173E+17,https://twitter.com/peaces38/status/471729789616001024,,,,
SarahArrow,5/28/2014 15:08,0,0,What's hot at ASCO 2014 in CLL and NHL? # ASCO14 | Biotech Strategy Blog http://buff.ly/1tnWZFI,,,#,4.7173E+17,https://twitter.com/SarahArrow/status/471729773899948032,,,,
OncEd,5/28/2014 15:07,0,0,Visit our booth at ASCO & Watch for Daily Newsletter Updates # ASCO14 http://eepurl.com/VkVCb,,,#,4.7173E+17,https://twitter.com/OncEd/status/471729565870866432,,,,
Merck,5/28/2014 15:07,0,1,@ peaces38 Check out @ ASCO's site for event info: http://bit.ly/1isLN5j . And for product inquiries please call our NSC at 1.800.672.6372.,,@ @,,4.71729E+17,https://twitter.com/Merck/status/471729435297996800,,,,
ASCO,5/28/2014 15:02,0,0,New @ # ASCO14 - Network with faculty at poster highlights sessions. Use the iPlanner to add one to your schedule http://bit.ly/1lDjy8m,,@,#,4.71728E+17,https://twitter.com/ASCO/status/471728232497414144,,,,
Novartis,5/28/2014 15:02,1,3,# advancedBC is taking over @ Novartis tomorrow from 3-4PM EST. Tweet your questions to us now. # ASCO14,,@,# #,4.71728E+17,https://twitter.com/Novartis/status/471728192869634048,,,,
Xcenda,5/28/2014 15:00,0,0,Learn more about Challenging Cases for qualitative and quantitative assessments in oncology & hematology. http://bit.ly/1a54Owd # ASCO2014,,,#,4.71728E+17,https://twitter.com/Xcenda/status/471727674235170816,,,,
disparityreport,5/28/2014 15:00,4,2,Social Media: a tool for overcoming # clinicaltrials barriers? MT @ MaurerStats @ mtmdphd # ASCO14 http://bit.ly/1tPNUaP # hcsm # mccsm,,@ @,# # # #,4.71728E+17,https://twitter.com/disparityreport/status/471727671664050176,,,,
Keith_Terry,5/28/2014 15:00,0,0,We’re jazzed about attending # ASCO2014 and proud to be a meeting supporter for... http://talent.gene.com/go/ioghv2 # Genentech,,,# #,4.71728E+17,https://twitter.com/Keith_Terry/status/471727623232442368,,,,
EKrolikiewicz,5/28/2014 15:00,0,0,We’re jazzed about attending # ASCO2014 and proud to be a meeting supporter for... http://talent.gene.com/go/9-1qli # Genentech,,,# #,4.71728E+17,https://twitter.com/EKrolikiewicz/status/471727621294665729,,,,
DrMarkham,5/28/2014 14:59,0,0,Just downloaded the # ASCO14 meeting app. Very exciting!,,,#,4.71727E+17,https://twitter.com/DrMarkham/status/471727408912293888,,,,
LGG1,5/28/2014 14:59,2,5,It's going to be a great meeting! # ASCO14 pic.twitter.com/V3Luv0fmje,,,#,4.71727E+17,https://twitter.com/LGG1/status/471727362447769600,,,,
DrMarkham,5/28/2014 14:53,5,2,"Objective chemo brain"" --> Chemotherapy Changes Brain Activity", Based on MRI," via @ asco http://buff.ly/RC3JTT""",,@,,4.71726E+17,https://twitter.com/DrMarkham/status/471726002071412737,,
AmandaBoldersto,5/28/2014 14:52,2,2,"A look at Twitter's role during (ASCO) scientific meetings. Lessons for # CAMRT2014? http://ow.ly/xl2oP # ASCO14 # hcsm"",,,# # #,471725839843725313""",https://twitter.com/AmandaBoldersto/status/471725839843725313,,,,,,,,
adamfeuerstein,5/28/2014 14:52,1,6,"Adam, what are you doing today? Not much, just writing a gazillion embargoed stories for # ASCO14. Lips zipped!",,,#,4.71726E+17,https://twitter.com/adamfeuerstein/status/471725795451219969,,,,
3NT,5/28/2014 14:52,0,0,What's hot at ASCO 2014 in CLL and NHL? quite a lot according to @ MaverickNY # ASCO14 http://3nt.co/1mGgvMC,,@,#,4.71726E+17,https://twitter.com/3NT/status/471725652312588288,,,,
tinypasscontent,5/28/2014 14:50,0,0,"ASCO 2014 CLL and iNHL Preview # ASCO14"" http://ift.tt/1k3FedE # BiotechStrategy # tinypass # paidcontent ""Chronic lymphocytic leukemia (...""",,,# # # #,4.71725E+17,https://twitter.com/tinypasscontent/status/471725221670838272,,,,
CancerDotNet,5/28/2014 14:50,3,2,"25,000+ onc professionals spend 5 days discussing cutting-edge research – learn what it’s all about # ASCO14 http://bit.ly/1jXc4Nu",,,#,4.71725E+17,https://twitter.com/CancerDotNet/status/471725195850706944,,,,
NCIEpi,5/28/2014 14:45,6,4,Find out when & where NCI staff will be speaking at the @ ASCO Annual Meeting: http://1.usa.gov/1pyzObj # ASCO14,,@,#,4.71724E+17,https://twitter.com/NCIEpi/status/471723883100635136,,,,
AbsolutelyTours,5/28/2014 14:45,0,0,Welcome # ASCO14 attendees & exhibitors! You're invited to a Segway Tour of # Chicago - bring show badge for $10 off! http://ow.ly/xm1Ll,,,# #,4.71724E+17,https://twitter.com/AbsolutelyTours/status/471723873541849088,,,,
Physns1stWatch,5/28/2014 14:42,3,1,New @ ASCO guidelines recommend 10 yr of # tamoxifen for breast cancer instead of just 5: http://jwat.ch/RC1Gz7,,@,#,4.71723E+17,https://twitter.com/Physns1stWatch/status/471723193896808448,,,,
BiotechStrategy,5/28/2014 14:41,0,0,ASCO 2014 CLL and iNHL Preview via @ MaverickNY # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-cll-and-inhl-preview-asco14.html/ …,,@,#,4.71723E+17,https://twitter.com/BiotechStrategy/status/471722973259243520,,,,
MsShanBo,5/28/2014 14:37,0,0,"@ ThatGirlRenita 1 of the biggest conventions of the year, @ ASCO checks into CHI tomorrow so rates will be super high, if not soldout. :-(",,@ @,,4.71722E+17,https://twitter.com/MsShanBo/status/471721903498215424,,,,
genentech,5/28/2014 14:35,5,2,"A magnificent obsession"" led to worldwide innovation & eventually discoveries in cancer: http://ow.ly/xk013 # ASCO14""",,,#,4.71721E+17,https://twitter.com/genentech/status/471721374579691520,,,,
Xcenda,5/28/2014 14:35,0,0,# ASCO2014 Attendees: Find out the dates for our upcoming Challenging Cases events. Learn more: http://bit.ly/1a54Owd,,,#,4.71721E+17,https://twitter.com/Xcenda/status/471721336562139136,,,,
Barrenboos,5/28/2014 14:27,0,1,"@ caseofdees @ ASCO ja dat is waar. Mijn jongste is 4, is 14 toch beter.",,@ @,,4.7172E+17,https://twitter.com/Barrenboos/status/471719505526546432,,,,
OxfordJournals,5/28/2014 14:25,0,0,"RT @ Annals_Oncology It's # ASCO14 this week, in Chicago. # Annals will be there, we hope you can stop by and see us http://bit.ly/1ooySJ6",,@,# #,4.71719E+17,https://twitter.com/OxfordJournals/status/471718845590568960,,,,
peaces38,5/28/2014 14:15,0,0,@ Merck can patients attend # ASCO14 and is there a benefit and a cost for a patient to attend. Starting MK-3475 next month. Need info ASAP,,@,#,4.71716E+17,https://twitter.com/peaces38/status/471716456397168640,,,,
Advaxis,5/28/2014 14:15,0,0,Looking forward to # ASCO14? Us too! Learn more about our presentation: http://bit.ly/1sONQHO $ ADXS,,,#,4.71716E+17,https://twitter.com/Advaxis/status/471716283520536576,,,,
Boehringer,5/28/2014 14:10,0,4,Excited to be en route to @ ASCO to share # lungcancer data from our oncology portfolio: who's joining us? # ASCO14,,@,# #,4.71715E+17,https://twitter.com/Boehringer/status/471715126987735040,,,,
myriadgenetics,5/28/2014 14:10,1,0,Do you have 30 seconds? Take this simple quiz to find out if you're at # risk of # hereditarycancer: http://bit.ly/17zeRbJ # BRCA # ASCO14,,,# # # #,4.71715E+17,https://twitter.com/myriadgenetics/status/471715027691372544,,,,
ASCO,5/28/2014 14:02,2,1,"# ASCO14 Virtual Meeting: Access videos of speakers, abstracts, podcasts, iMeeting apps @your convenience http://bit.ly/1tVXB8r",,@your,#,4.71713E+17,https://twitter.com/ASCO/status/471713160836419584,,,,
MyCancer,5/28/2014 14:01,1,1,Great reference for # lungcancer patients learning about clinical trials and treatment options. # ASCO14 http://goo.gl/4YPI43,,,# #,4.71713E+17,https://twitter.com/MyCancer/status/471712851263225856,,,,
vrouwenarts,5/28/2014 14:00,0,0,@ caseofdees @ ASCO En leg zo'n richtlijn voor het contrast een naast die voor hormoontherapie bij prostaatkanker @ IvanWolffers,,@ @ @,,4.71713E+17,https://twitter.com/vrouwenarts/status/471712610673774594,,,,
caseofdees,5/28/2014 13:58,0,0,@ Priskiller20 Het is vooralsnog de @ ASCO richtlijn en niet de Nederlandse richtlijn. Hier en daar wordt verlenging wel voorgesteld.,,@ @,,4.71712E+17,https://twitter.com/caseofdees/status/471712210306478080,,,,
caseofdees,5/28/2014 13:58,0,0,"@ Barrenboos Dat zou kunnen, maar als je 70 bent en 10 jr kunt verlengen....? @ ASCO",,@ @,,4.71712E+17,https://twitter.com/caseofdees/status/471712023869673472,,,,
vrouwenarts,5/28/2014 13:56,0,1,@ caseofdees @ ASCO Straks gaan ze nog naar # levenslang hormoontherapie na borstkanker.,,@ @,#,4.71712E+17,https://twitter.com/vrouwenarts/status/471711602711224320,,,,
vrouwenarts,5/28/2014 13:55,0,0,@ caseofdees @ ASCO Het lijkt me heel belangrijk dat die cijfers boven water komen.,,@ @,,4.71711E+17,https://twitter.com/vrouwenarts/status/471711446620180480,,,,
Barrenboos,5/28/2014 13:55,0,0,@ caseofdees @ ASCO is dat geen uitstel vraag ik mij dan af,,@ @,,4.71711E+17,https://twitter.com/Barrenboos/status/471711425933869056,,,,
BiologicsMcK,5/28/2014 13:55,0,0,"What a great resource! RT @ ASCO To follow the action at # ASCO14, follow the official tweeters: # infographic http://bit.ly/1lBa5hq .",,@,# #,4.71711E+17,https://twitter.com/BiologicsMcK/status/471711265849880576,,,,
bmsnews,5/28/2014 13:54,2,1,Interested in a career in # ImmunoOncology? Find us at # ASCO14 career booth CF-18 or click here and network http://ow.ly/xmgjn # jobs,,,# # #,4.71711E+17,https://twitter.com/bmsnews/status/471711130927505408,,,,
incanMX,5/28/2014 13:51,3,1,"RT @ ASCO: The importance of palliative care principles & practices in cancer care"" http://goo.gl/9N8sus cc @ fischmd # hpm""",,@ @,#,4.7171E+17,https://twitter.com/incanMX/status/471710400153915392,,,,
Xcenda,5/28/2014 13:49,0,0,Learn more about Challenging Cases for qualitative and quantitative assessments in oncology & hematology. http://bit.ly/1a54Owd # ASCO2014,,,#,4.7171E+17,https://twitter.com/Xcenda/status/471709909701394432,,,,
caseofdees,5/28/2014 13:47,0,0,@ vrouwenarts Ook mijn zorg. Ik weet het niet. Ik las het net als @ ASCO richtlijn,,@ @,,4.71709E+17,https://twitter.com/caseofdees/status/471709314726387712,,,,
SpryPub,5/28/2014 13:44,0,0,"Meet Dr. Barrie Cassileth, author of Survivorship, at # ASCO14. Saturday May 31, 10 - 11AM, @ sprypub booth 20125, McCormick Place, Chicago!",,@,#,4.71709E+17,https://twitter.com/SpryPub/status/471708611459035136,,,,
MaurerStats,5/28/2014 13:42,0,0,Surveillance Imaging for # Lymphoma: Pros and Cons | # asco14 Educational Book | Meeting Library http://meetinglibrary.asco.org/content/11400388-144#.U4YfxSs1jMw.twitter … # lymsm,,,# # # #,4.71708E+17,https://twitter.com/MaurerStats/status/471708218284965889,,,,
MaurerStats,5/28/2014 13:38,0,1,Social media is democratising healthcare meetings # asco14 http://shar.es/Vkptw via @ Boehringer # hcsm # mccsm,,@,# # #,4.71707E+17,https://twitter.com/MaurerStats/status/471707110858686464,,,,
FolioBio,5/28/2014 13:37,0,1,See Folio at # ASCO14! We’re in booth 4122,,,#,4.71707E+17,https://twitter.com/FolioBio/status/471706897553174528,,,,
caseofdees,5/28/2014 13:36,2,0,Poeh heftig... nieuwe @ ASCO richtlijn om bij hormoongevoelige # borstkanker na 5 jr hormoontherapie nog 5 jr voor te stellen....,,@,#,4.71706E+17,https://twitter.com/caseofdees/status/471706475342356481,,,,
subatomicdoc,5/28/2014 13:34,0,0,What # bladdercancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # blcsm,,@ @ @ @ @ @,# # # #,4.71706E+17,https://twitter.com/subatomicdoc/status/471705969215668225,,,,
magnusfovaeus,5/28/2014 13:32,0,0,On my way to to # ASCO14 # gucsm Looking forward to seeing a few fellow urologists soon! Nifty planner here: https://iplanner.asco.org/am2014,,,# #,4.71706E+17,https://twitter.com/magnusfovaeus/status/471705701652627456,,,,
Merck,5/28/2014 13:28,8,2,Looking forward to # ASCO14. Keep an eye out for our 16 abstracts being presented at the event. # MerckOncology,,,# #,4.71704E+17,https://twitter.com/Merck/status/471704479956742146,,,,
FierceBiotech,5/28/2014 13:27,6,0,Tune into tomorrow's chat on CAR-T w @ JohnCFierce & @ PennMedicine's David Porter at 3:30pm ET: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … # ASCO14 # FierceASCO,,@ @,# #,4.71704E+17,https://twitter.com/FierceBiotech/status/471704300100812800,,,,
AGMednet,5/28/2014 13:20,0,0,We'll be at # ASCO14 later this week http://am.asco.org/ & # PCTMD14 next week http://www.iirusa.com/medicaldevice/homepage.xml?registration=XP1903MDAY&utm_source=NMM&utm_medium=Blog&utm_term=PCTMemDayFlashSale052214&utm_campaign=PCTMemDayFlashSale052214 … See you there!,,,# #,4.71703E+17,https://twitter.com/AGMednet/status/471702611876642817,,,,
rsc_medchem,5/28/2014 13:10,0,1,MT @ roche: 1947 saw 1st ever remission of paediatric # leukaemia Today 5-year survival rates are >80% http://ow.ly/xlGAC # ASCO14 # ayacsm,,@,# # #,4.717E+17,https://twitter.com/rsc_medchem/status/471699996686172160,,,,
RonnieLass,5/28/2014 13:10,0,1,Another interesting article: Social media is democratising healthcare meetings http://shar.es/VkHk3 # ASCO14,,,#,4.717E+17,https://twitter.com/RonnieLass/status/471699964096020481,,,,
scimegaresearch,5/28/2014 13:09,0,0,"Taking Lung Cancer Treatment to the 'Next Level'"" # oncology # scimega ^RL # ASCO14 http://feedly.com/e/8c2yn3E3""",,,# # #,4.717E+17,https://twitter.com/scimegaresearch/status/471699785590636544,,,,
genentech,5/28/2014 13:05,2,0,# ASCO14 RT @ patientslikeme: It's Time to Prioritize Quality of Care- @ genentech and @ patientslikeme http://www.gene.com/asco/its-time-to-prioritize-quality-of-care …,,@ @ @,#,4.71699E+17,https://twitter.com/genentech/status/471698702802112512,,,,
Lymphoma_Doc,5/28/2014 13:03,1,1,Just downloaded the iPlanner app for the # ASCO14 meeting. Looks great! Can it help me be in 2 places at once?,,,#,4.71698E+17,https://twitter.com/Lymphoma_Doc/status/471698164324397056,,,,
Xcenda,5/28/2014 13:01,0,0,Join us at # ASCO2014. We’re honored to present 2 posters. Learn more: http://bit.ly/1jXRsje,,,#,4.71698E+17,https://twitter.com/Xcenda/status/471697775839944704,,,,
mtmdphd,5/28/2014 13:01,0,0,MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,@,#,4.71698E+17,https://twitter.com/mtmdphd/status/471697745309609985,,,,
sciberomics,5/28/2014 13:00,0,0,# ASCO14 about to start in a few days - excited to be there for this year’s conference! # Cancer # research # clinical,,,# # # #,4.71697E+17,https://twitter.com/sciberomics/status/471697458754777088,,,,
SyLapostolle,5/28/2014 12:59,1,0,# ASCO14 la recherche française première après les USA dans le programme # INCA sur @ APMinfos,,@,# #,4.71697E+17,https://twitter.com/SyLapostolle/status/471697371819421696,,,,
jonellms,5/28/2014 12:58,0,1,Off to # ASCO14. It's gonna be great.,,,#,4.71697E+17,https://twitter.com/jonellms/status/471697005132013568,,,,
Boehringer,5/28/2014 12:56,2,1,BLOG POST: Some ups some downs in research but always moving forward http://bit.ly/1isb8MN # notjustonedisease # ASCO14,,,# #,4.71697E+17,https://twitter.com/Boehringer/status/471696650478821376,,,,
cabsylvia,5/28/2014 12:56,0,0,"FYI...for those using # ASCO2014, the official tag is # ASCO14. https://twitter.com/ASCO",,,# #,4.71696E+17,https://twitter.com/cabsylvia/status/471696405002600449,,,,
mtmdphd,5/28/2014 12:53,0,1,Tweeting at ASCO Annual Mtgs Can Enhance the Experience [10/15/12] <- old school - via @ ASCOPost & @ rsm2800 http://ow.ly/xm148 # ASCO14,,@ @,#,4.71696E+17,https://twitter.com/mtmdphd/status/471695794748530688,,,,
RS_Flinn,5/28/2014 12:53,0,0,RT @ mtmdphd: Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlXvQ,,@ @,#,4.71696E+17,https://twitter.com/RS_Flinn/status/471695689693806592,,,,
RS_Flinn,5/28/2014 12:52,1,0,MT @ chimoose: What are the favorite social media tools of the # ASCO14 Super-Users? Your Favorite Social Media Tools http://bit.ly/1oH8ckh,,@,#,4.71696E+17,https://twitter.com/RS_Flinn/status/471695594613125120,,,,
chimoose,5/28/2014 12:52,3,2,What are the favorite social media tools of the # ASCO14 Super-Users? Your Favorite Social Media Tools http://bit.ly/1oH8ckh @ TeamOncology,,@,#,4.71695E+17,https://twitter.com/chimoose/status/471695396637790208,,,,
mtmdphd,5/28/2014 12:48,4,1,Social media is democratising healthcare meetings - eg # ASCO14 - via @ pharmaphorum http://ow.ly/xlXvQ,,@,#,4.71695E+17,https://twitter.com/mtmdphd/status/471694553733693440,,,,
bioclinica,5/28/2014 12:45,0,1,See u there booth 6109! RT @ Boehringer Excited to be en route to @ ASCO to share # lungcancer data from our oncology portfolio... # ASCO14,,@ @,# #,4.71694E+17,https://twitter.com/bioclinica/status/471693723181785089,,,,
JackWestMD,5/28/2014 12:43,3,8,. @ n8pennell maybe I'll do first selfie from # ASCO14 podium.,,@,#,4.71693E+17,https://twitter.com/JackWestMD/status/471693187568791552,,,,
SWOG,5/28/2014 12:38,1,0,CALGB/ # SWOGonc 80405 # ASCO14 plenary: bev v cetux w chemo 4 metCRC @ subatomicdoc @ ALLIANCE_org @ eaonc @ NRGonc # crcsm http://abstracts.asco.org/144/AbstView_144_126013.html …,,@ @ @ @,# # #,4.71692E+17,https://twitter.com/SWOG/status/471692071750107137,,,,
YaleCOPPER,5/28/2014 12:35,3,1,"Congrats to @ jamesbyu, Tisheeka Graham-Steed and other @ YaleCOPPER investigators presenting at # ASCO14",,@ @,#,4.71691E+17,https://twitter.com/YaleCOPPER/status/471691182792511488,,,,
Novartis,5/28/2014 12:31,2,1,Our # Oncology team thinks pinball and # advancedBC have something in common – but what? http://bit.ly/1jHoqub # ASCO14,,,# # #,4.7169E+17,https://twitter.com/Novartis/status/471690139333582848,,,,
FreemanCo,5/28/2014 12:30,4,7,Behind the scenes rigging set up for @ ASCO # ASCO14 at McCormick Place - that's 425 motors in the air! pic.twitter.com/96YNPeIOz4,,@,#,4.7169E+17,https://twitter.com/FreemanCo/status/471689923347488768,,,,
subatomicdoc,5/28/2014 12:29,0,0,What # stomachcancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # stcsm,,@ @ @ @ @ @,# # # #,4.7169E+17,https://twitter.com/subatomicdoc/status/471689624705044480,,,,
CynthiaManley,5/28/2014 12:29,0,0,Social media is democratising healthcare meetings http://shar.es/VANPR via @ Boehringer # ASCO14 # HCSM # MCCSM,,@,# # #,4.7169E+17,https://twitter.com/CynthiaManley/status/471689611484225536,,,,
ConsanoMolly,5/28/2014 12:25,0,0,Only thing missing: ability to be in 2 places at once! Grt sessions! MT @ CliffordHudis Counting down days to # ASCO14 https://iplanner.asco.org/am2014,,@,#,4.71689E+17,https://twitter.com/ConsanoMolly/status/471688707679223808,,,,
MedWriterMike,5/28/2014 12:25,0,1,Nice way to follow ASCO discussions - thanks RT @ rsm2800: Follow these disease-specific hashtags and # ASCO14 tweeps! http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf …,,@,#,4.71689E+17,https://twitter.com/MedWriterMike/status/471688641837006848,,,,
KirstenGoldberg,5/28/2014 12:21,0,0,"RT @ ASCO: . @ RahmEmanuel proclaimed June Oncology Month in Chicago"" in honor of our 50th Annual Meeting http://bit.ly/TLmJl4 # ASCO14""",,@ @,#,4.71688E+17,https://twitter.com/KirstenGoldberg/status/471687755240833024,,,,
ASCO,5/28/2014 12:20,1,3,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.71687E+17,https://twitter.com/ASCO/status/471687433319612417,,,,
jrgralow,5/28/2014 12:01,4,0,". @ ASCO Conquer Cancer Fnd Awards $5M to Support Patient-Focused Clinical Cancer Research, Young Investigators # ASCO14 http://www.conquercancerfoundation.org/conquer-cancer-foundation-awards-5-million-support-patient-focused-clinical-cancer-research-young#.U4YIHT-_xEQ.twitter …",,@,# #,4.71683E+17,https://twitter.com/jrgralow/status/471682794767147008,,,,
Carpowich,5/28/2014 12:00,0,0,New study: patient education/training helps cut risk of lymphedema in @ breastcancer survivors via @ nyuniversity @ asco http://ow.ly/xlkKu,,@ @ @,,4.71682E+17,https://twitter.com/Carpowich/status/471682467368562688,,,,
jrgralow,5/28/2014 11:59,0,0,ACA Resource Center: Understanding ACA's Impact on Cancer Care | @ ASCO http://www.asco.org/practice-research/aca-resource-center-understanding-new-laws-impact-cancer-care#.U4YHyPWchmc.twitter …,,@,#,4.71682E+17,https://twitter.com/jrgralow/status/471682158306660352,,,,
DrBobGoldberg,5/28/2014 11:58,0,0,@ rschilsky: insurers want standard pathway not personalized meds. Will @ ASCO value plan side w insurers or patients? http://online.wsj.com/article/SB10001424052702304587704579588170876612100.html …,,@ @,,4.71682E+17,https://twitter.com/DrBobGoldberg/status/471681953792798720,,,,
genentech,5/28/2014 11:55,2,0,<15% of patients learn abt clin trials from their MDs; # hcsm will improve this in the # Next50 yrs. http://ow.ly/xk45Z # ASCO14,,,# # #,4.71681E+17,https://twitter.com/genentech/status/471681101099171840,,,,
subatomicdoc,5/28/2014 11:50,3,1,Twitter releasing trove of user data to scientists for research http://bit.ly/1k0fvnG > @ arstechnica cc @ ASCO @ astro_org,,@ @ @,,4.7168E+17,https://twitter.com/subatomicdoc/status/471679832049586176,,,,
PPDCRO,5/28/2014 11:50,1,0,PPD has conducted more than 400 studies in # hematology & # oncology in the last 5 years. http://ht.ly/xlhbD # ASCO14,,,# # #,4.7168E+17,https://twitter.com/PPDCRO/status/471679830053105664,,,,
DrBobGoldberg,5/28/2014 11:49,0,0,Will @ ASCO value calculator reward cancer docs for treating by insurer or patient? # asco14 http://online.wsj.com/article/SB10001424052702304587704579588170876612100.html …,,@,#,4.7168E+17,https://twitter.com/DrBobGoldberg/status/471679577379864576,,,,
ASH_hematology,5/28/2014 11:49,0,0,"RT @ davidgrahammd: In advance of my # ASCO14 talk, an Aussie lymphoma trials app that has had serious impact http://bloodjournal.hematologylibrary.org/content/122/21/5600.short … # lymsm",,@,# #,4.7168E+17,https://twitter.com/ASH_hematology/status/471679566134927360,,,,
CancerDotNet,5/28/2014 11:40,0,0,@ EmberG Glad to hear you'll be able to follow the news from # ASCO14. For more info on getting up-to-date info http://bit.ly/PYjFQf,,@,#,4.71677E+17,https://twitter.com/CancerDotNet/status/471677333364297728,,,,
JWatch,5/28/2014 11:32,4,1,New @ ASCO guidelines for treating advanced HER2-positive breast # cancer: William Gradishar highlights key points. http://jwat.ch/SMq42d,,@,#,4.71675E+17,https://twitter.com/JWatch/status/471675363618476032,,,,
DrPaulyDeSantis,5/28/2014 11:32,0,0,I'm checking out $ INCY @ alsabogal looks good going into # ASCO14 Next week slow stoch macd look ready to cross pic.twitter.com/3j30b33vJR,,@,#,4.71675E+17,https://twitter.com/DrPaulyDeSantis/status/471675276124893184,,,,
ASCO,5/28/2014 11:30,7,3,"Those using # ASCO2014, we invite you to use the official tag # ASCO14",,,# #,4.71675E+17,https://twitter.com/ASCO/status/471674818308620288,,,,
LindaKnorr,5/28/2014 11:14,0,0,We’re jazzed about attending # ASCO2014 and proud to be a meeting supporter for... http://talent.gene.com/go/l0b-20 # Genentech,,,# #,4.71671E+17,https://twitter.com/LindaKnorr/status/471670731617484800,,,,
PPDCRO,5/28/2014 11:10,1,0,"Visit our team at # ASCO14, booth 8115, to learn why we have the leading # clinicalresearch team in # oncology. http://ht.ly/xlwJJ",,,# # #,4.7167E+17,https://twitter.com/PPDCRO/status/471669742319976449,,,,
SEEdPublisher,5/28/2014 11:08,0,0,The MediSEEd Daily is out! http://paper.li/SEEdPublisher/1369393739 … Stories via @ ASCO,,@,,4.71669E+17,https://twitter.com/SEEdPublisher/status/471669441936523264,,,,
MyCancer,5/28/2014 11:02,1,1,New EGFR-targeted therapy shrinks worsening # lungcancer with fewer side effects. http://goo.gl/4YPI43 # ASCO14,,,# #,4.71668E+17,https://twitter.com/MyCancer/status/471667841339752448,,,,
Roche,5/28/2014 11:01,11,4,"1947 saw the 1st ever remission of paediatric # leukaemia, today 5-year survival rates are >80% http://ow.ly/xkxvk # ASCO14 # ayacsm",,,# # #,4.71668E+17,https://twitter.com/Roche/status/471667545435811840,,,,
MidAmPrint,5/28/2014 10:51,0,0,# ASCO14 starts FRIDAY. Do you have your print materials ready? If not - @ MidAmPrint can help! http://ow.ly/wiZIs,,@,#,4.71665E+17,https://twitter.com/MidAmPrint/status/471664965791662082,,,,
mtmdphd,5/28/2014 10:50,0,0,Digital Product and Resource Tutorials for # ASCO14 http://ow.ly/xgIRZ HT @ rschilsky,,@,#,4.71665E+17,https://twitter.com/mtmdphd/status/471664792177225728,,,,
ChooseChicago,5/28/2014 10:46,0,2,Hey # ASCO2014 attendees need help navigating # Chicago or looking for recommendations? We are only a tweet away and here to help.,,,# #,4.71664E+17,https://twitter.com/ChooseChicago/status/471663766321373184,,,,
subatomicdoc,5/28/2014 10:41,0,0,What # prostatecancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # pcsm,,@ @ @ @ @ @,# # # #,4.71662E+17,https://twitter.com/subatomicdoc/status/471662430658248705,,,,
Perthera,5/28/2014 10:40,0,0,Attending # ASCO14 Annual Meeting in Chicago? Stop by Perthera at booth #4040 to discuss latest in personalized # cancer therapy! # genomics,,,# #4040 # #,4.71662E+17,https://twitter.com/Perthera/status/471662282892906496,,,,
DELUXE_CHI,5/28/2014 10:39,0,1,RT @ KinzieHotel: Welcome to all the # ASCO2014 attendees staying w/ us in # Chicago this week! We're happy to have you :) @ ASCO @ ChooseChicago,,@ @ @,# #,4.71662E+17,https://twitter.com/DELUXE_CHI/status/471662044341469185,,,,
YaleMed,5/28/2014 10:39,0,0,RT @ AneesChagpar: @ ASCO Thanks for the tweet! Congrats to my mentee Kathleen Fenn @ Yale and others @ YaleCancer for this important work!,,@ @ @ @,,4.71662E+17,https://twitter.com/YaleMed/status/471662025232613376,,,,
MaurerStats,5/28/2014 10:35,4,4,Social Media in Clinical Trials @ mtmdphd | 2014 # ASCO14 Educational Book | Meeting Library http://meetinglibrary.asco.org/content/11400101-144#.U4Xz4uvdoOk.twitter … # hcsm # mccsm,,@,# # # #,4.71661E+17,https://twitter.com/MaurerStats/status/471661102770561024,,,,
Boehringer,5/28/2014 10:35,0,1,Excited to be en route to @ ASCO to share # lungcancer data from our oncology portfolio: who's joining us? > # ASCO14,,@,# #,4.71661E+17,https://twitter.com/Boehringer/status/471660991181488128,,,,
KinzieHotel,5/28/2014 10:31,1,1,Welcome to all the # ASCO2014 attendees staying w/ us in # Chicago this week! We're happy to have you :) @ ASCO @ ChooseChicago,,@ @,# #,4.7166E+17,https://twitter.com/KinzieHotel/status/471660059693314048,,,,
rsm2800,5/28/2014 10:27,6,3,"I'm on it MT @ n8pennell: Last yr@JackWestMD broke the mold by live tweeting while chairing session. This yr, tweet while presenting? # ASCO14",,@ @JackWestMD,#,4.71659E+17,https://twitter.com/rsm2800/status/471659116445061121,,,,
AJCCancer,5/28/2014 10:27,1,1,RT @ ASCO Examining the association between financial burdens caused by # cancer & reported quality of life http://bit.ly/SMmIfF#JOP,,@,# #JOP,4.71659E+17,https://twitter.com/AJCCancer/status/471659086191136769,,,,
n8pennell,5/28/2014 10:26,5,4,"Last year @ JackWestMD broke the mold by live tweeting from the podium while chairing session. This year, tweet while presenting? # ASCO14",,@,#,4.71659E+17,https://twitter.com/n8pennell/status/471658852359098368,,,,
SWOG,5/28/2014 10:26,3,0,"# SWOGonc S0230 Prev of Early Menopause Study (POEMS) oral pres of results # ASCO14, Sat, 5/31, 3-6PM, N Hall B1 http://abstracts.asco.org/144/AbstView_144_129172.html …",,,# #,4.71659E+17,https://twitter.com/SWOG/status/471658759404945408,,,,
n8pennell,5/28/2014 10:24,11,8,"Warming up my thumbs for live tweeting on # lungcancer from # ASCO14, along with @ JackWestMD. Stay posted and pass it on! # LCSM",,@,# # #,4.71658E+17,https://twitter.com/n8pennell/status/471658150916288512,,,,
OncologySurgery,5/28/2014 10:22,0,0,RT @ ASCO: The theme is “Science and Society” – hear from what this means for the oncology community: http://bit.ly/1wlal9Z,,@,,4.71658E+17,https://twitter.com/OncologySurgery/status/471657865703215106,,,,
harrisonandstar,5/28/2014 10:20,0,0,Prepare yourself for all of # ASCO with the 50th Annual Meeting iPlanner. Find it here: http://ow.ly/wFoJE # ASCO14,,,# #,4.71657E+17,https://twitter.com/harrisonandstar/status/471657243075964928,,,,
MRCCTU,5/28/2014 10:17,1,0,"Several # MRCCTU staff are jetting off to # ASCO14 tomorrow. There will be presentations and/or posters by ICON8, PATCH, OE05 and Add-Aspirin.",,,# #,4.71656E+17,https://twitter.com/MRCCTU/status/471656454257401856,,,,
StrandLife,5/28/2014 10:15,0,0,"Come & meet us @booth 3016 @ ASCO, 50th Annual meeting, Science & Society, Chicago Illinois from 30 May-3 June 2014. http://www.strandls.com/news-events/strand-asco-2014-chicago …",,@booth @,,4.71656E+17,https://twitter.com/StrandLife/status/471656112593195008,,,,
CAPLungCancer,5/28/2014 10:08,0,0,@ ASCO @ CliffordHudis,,@ @,,4.71654E+17,https://twitter.com/CAPLungCancer/status/471654226205368320,,,,
Wildune521,5/28/2014 10:06,0,0,"@ NancysPoint @ ASCO at 6 months of tmx not thrilled with an additional 4.5 +5 years of nite sweats and no sleep. if it means no mets, good.",,@ @,,4.71654E+17,https://twitter.com/Wildune521/status/471653781818863617,,,,
chimoose,5/28/2014 10:06,0,1,"The experts follow @ MTMDPhD @ RSM2800 @ MaverickNY @ JodyMS @ FischMD Your Must-Follow People on Twitter"" http://bit.ly/1oH7JyA VIDEO # ASCO14""",,@ @ @ @ @,#,4.71654E+17,https://twitter.com/chimoose/status/471653630618394625,,,,
SarahCannonDocs,5/28/2014 10:05,0,0,Syndax Announces Presentation of Entinostat Data in Two Posters # ASCO14 http://www.wsmv.com/story/25617304/syndax-announces-presentation-of-entinostat-data-in-two-posters-at-the-2014-american-society-of-clinical-oncology-asco-annual-meeting#.U4XtAx8ZxrM.twitter …,,,# #,4.71654E+17,https://twitter.com/SarahCannonDocs/status/471653602998484994,,,,
ASCO,5/28/2014 10:05,4,2,The # ASCO14 theme is “Science and Society” – hear from @ cliffordhudis what this means for the oncology community: http://bit.ly/T7Ej2e,,@,#,4.71653E+17,https://twitter.com/ASCO/status/471653488913821696,,,,
m_e_nielsen,5/28/2014 10:01,0,0,Thoughtful @ MarkRobsonMD comment on challenges re advent of multiplex testing in clinical cancer genetics http://jco.ascopubs.org/content/early/2014/05/20/JCO.2014.56.0474?cmpid=jco_pap_27May2014 … # ASCO14,,@,#,4.71653E+17,https://twitter.com/m_e_nielsen/status/471652608340688897,,,,
SWOG,5/28/2014 10:01,0,0,"# SWOGonc S0230 Prev of Early Menopause Study (POEMS) oral presentation of results at # ASCO14, Sat, 5/31, 3-6PM session, N Hall B1",,,# #,4.71653E+17,https://twitter.com/SWOG/status/471652500030754816,,,,
WinshipAtEmory,5/28/2014 10:00,1,0,Winship experts to speak at 2014 ASCO meeting this weekend. Learn more: http://ow.ly/xiJe1 # ASCO14,,,#,4.71652E+17,https://twitter.com/WinshipAtEmory/status/471652356783099905,,,,
NancysPoint,5/28/2014 9:53,1,1,"10 Years of Hormones for Breast Cancer, @ ASCO Says http://www.medpagetoday.com/HematologyOncology/BreastCancer/46007 … # bcsm",,@,#,4.71651E+17,https://twitter.com/NancysPoint/status/471650566364332033,,,,
myriadgenetics,5/28/2014 9:50,1,1,Myriad will present data from 6 new key studies on its myRisk Hereditary Cancer # genepanel test at # ASCO14 http://bit.ly/1qFsz5H # cancer,,,# # #,4.7165E+17,https://twitter.com/myriadgenetics/status/471649597152964608,,,,
DebiopharmNews,5/28/2014 9:38,4,1,Debiopharm moves forward 3 of its oncology clinical programs and will present them at # ASCO14 https://www.debiopharm.com/medias/press-release/item/3458-debiopharm-group-moves-forward-three-of-its-oncology-clinical-programs-and-will-present-the-recent-progresses-at-the-50th-american-society-of-clinical-oncology-asco-annual-meeting.html …,,,#,4.71647E+17,https://twitter.com/DebiopharmNews/status/471646719269425152,,,,
bioclinica,5/28/2014 9:30,0,0,RT @ ASCO # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,@,# #,4.71645E+17,https://twitter.com/bioclinica/status/471644785170989057,,,,
jrgralow,5/28/2014 9:26,1,1,Nature: Old cancer drug (IL-2) gets fresh look at # ASCO14 http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296 …,,,#,4.71644E+17,https://twitter.com/jrgralow/status/471643623918804992,,,,
Cancer_Cell,5/28/2014 9:23,1,0,"MT @ ASCO To follow the action at # ASCO14, follow the official tweeters: infographic http://bit.ly/1lBa5hq",,@,#,4.71643E+17,https://twitter.com/Cancer_Cell/status/471642976100573184,,,,
Cancer_Cell,5/28/2014 9:21,0,0,"# ASCO14 starts this Friday in Chicago. Editor Li-Kuo Su will be in attendance - See if you can spot him among the >25,000 attendees!",,,#,4.71642E+17,https://twitter.com/Cancer_Cell/status/471642388306604032,,,,
Survivorship,5/28/2014 9:15,2,0,Thanks @ ASCO for having # survivorship issues on the #list for # ASCO14,,@,# #list #,4.71641E+17,https://twitter.com/Survivorship/status/471640886032736257,,,,
NorthwestBio,5/28/2014 9:00,1,1,Early positive responses such as tumor shrinkage & cancer cell death seen in # DCVax-Direct patients http://bit.ly/1tKAEnE $ NWBO # ASCO14,,,# #,4.71637E+17,https://twitter.com/NorthwestBio/status/471637044460937216,,,,
timturnham,5/28/2014 8:52,1,11,Looking forward to this year's annual @ ASCO conference & updates from esteemed # melanoma reseachers,,@,#,4.71635E+17,https://twitter.com/timturnham/status/471635173793349634,,,,
KirstenGoldberg,5/28/2014 8:46,0,1,"Check out  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.71634E+17,https://twitter.com/KirstenGoldberg/status/471633647557431299,,,,
tomleblancMD,5/28/2014 8:36,0,1,"Is # chemo really a solution to psychosocial issues in cancer? Debating early tx vs watch-and-live"" http://ow.ly/xlaPq # lymphoma # ASCO14""",,,# # #,4.71631E+17,https://twitter.com/tomleblancMD/status/471631038427713536,,,,
AneesChagpar,5/28/2014 8:19,0,0,@ ASCO Thanks for the tweet! Congrats to my mentee Kathleen Fenn @ YaleMed @ Yale and others @ YaleCancer for this important work!,,@ @ @ @,,4.71627E+17,https://twitter.com/AneesChagpar/status/471626871961317376,,,,
DrHealeyBird,5/28/2014 8:18,0,0,@ ASCO financial burden of cancer care and survivorship impacts us all. Helping patients return to normal helps us all,,@,,4.71626E+17,https://twitter.com/DrHealeyBird/status/471626493031096320,,,,
drdonsdizon,5/28/2014 8:16,1,0,Now out! Survivorship in gyn cancers w @ LDuska and AFader # ASCO14 http://www.ncbi.nlm.nih.gov/m/pubmed/24857115/?i=1&from=duska …,,@,#,4.71626E+17,https://twitter.com/drdonsdizon/status/471625984056504320,,,,
rsm2800,5/28/2014 8:15,3,1,Pt-friendly summary of @ ASCO guideline via @ CancerDotNet: Hormonal Therapy for Hormone Receptor-Positive Breast Ca http://www.cancer.net/research-and-advocacy/asco-care-and-treatment-recommendations-patients/hormonal-therapy-hormone-receptor-positive-breast-cancer …,,@ @,,4.71626E+17,https://twitter.com/rsm2800/status/471625735174897665,,,,
CancerGeek,5/28/2014 8:06,1,1,MT: Please check out--> @ drdonsdizon: Now out! Survivorship in gyn cancers w @ LDuska and AFader # ASCO14 http://evpo.st/1pxsEUP,,@ @,#,4.71623E+17,https://twitter.com/CancerGeek/status/471623463971467265,,,,
MarkSchoenebaum,5/28/2014 7:54,93,6,I have the time! My twitter chat with @DamianFierce will be on Sunday at 1:30pm Chicago time (that means 2:30 ET). # ASCO14. # fierceasco,,@DamianFierce,# #,4.71621E+17,https://twitter.com/MarkSchoenebaum/status/471620555037491200,,,,
BairdAM,5/28/2014 7:49,0,0," @ IASLC: Be sure to see the new IASLC Textbook at # ASCO14. Stop by the IASLC booth (5054) for more information. http://ow.ly/x3rbx """"",,@,#,4.71619E+17,https://twitter.com/BairdAM/status/471619363909271552,,,,
TradeShowLabor,5/28/2014 7:48,0,0,Heading to # ASCO14 at # mccormickplace to see the amazing work of the # onlocation team. http://wwww.onlocationind.com,,,# # #,4.71619E+17,https://twitter.com/TradeShowLabor/status/471618982189862913,,,,
iWomanish,5/28/2014 7:34,0,0,Twitter at @ ASCO 2014 http://www.asco.org/about-asco/social-media … # socialmedia # RRSS,,@,# #,4.71615E+17,https://twitter.com/iWomanish/status/471615367207718912,,,,
RonnieLass,5/28/2014 7:31,4,2,Very interesting post:: RT @ Roche: MT @ ASCO: Twitter's role during scientific meetings? http://ow.ly/xl2oP # ASCO14 # hcsm,,@ @,# #,4.71615E+17,https://twitter.com/RonnieLass/status/471614718755753986,,,,
MarkSchoenebaum,5/28/2014 7:31,134,12,"I will be having a Twitter chat with @DamianFierce this Sunday during # ASCO14. Working on time. Focus on data for $ BMY, $ MRK, $ LLY, $ AZN etc",,@DamianFierce,#,4.71615E+17,https://twitter.com/MarkSchoenebaum/status/471614624908193793,,,,
Roche,5/28/2014 7:28,9,7,MT @ asco: Twitter's role during scientific meetings? http://ow.ly/xl2oP # ASCO14 # hcsm,,@,# #,4.71614E+17,https://twitter.com/Roche/status/471613984429592577,,,,
scientre,5/28/2014 7:27,0,1,# ASCO14 MT @ BioPharmaJosh Cancer doctors to get bonuses for using insurer's recommended treatments http://on.wsj.com/1gy81Yu $ WLP,,@,#,4.71614E+17,https://twitter.com/scientre/status/471613653259911168,,,,
ecancer,5/28/2014 7:24,6,1,Guideline update from @ ASCO on the use of tamoxifen in # breastcancer http://ecancer.org/news/5711-guideline-update-recommends-tamoxifen-for-up-to-10-years-for-women-with-non-metastatic-hormone-receptor-positive-breast-cancer.php …,,@,#,4.71613E+17,https://twitter.com/ecancer/status/471613006334660608,,,,
Sports_bios,5/28/2014 7:18,0,2,"With the head scratching drop yesterday - $ CLVS could well be the most interesting # ASCO14 play in the pure bios, small-midcap space.",,,#,4.71611E+17,https://twitter.com/Sports_bios/status/471611351626833920,,,,
rsm2800,5/28/2014 7:16,11,7,"Follow these disease-specific hashtags and # ASCO14 tweeps! http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf … Most importantly, join in on the conversation yourself",,,#,4.71611E+17,https://twitter.com/rsm2800/status/471610923514597377,,,,
GroupeUNICANCER,5/28/2014 7:03,0,0,17 communications orales présentées par des médecins chercheurs des CLCC à l' @ ASCO 2014. Découvrez-les : http://bit.ly/1rfUeKL,,@,,4.71608E+17,https://twitter.com/GroupeUNICANCER/status/471607802268770304,,,,
lymphomahub,5/28/2014 6:55,1,0,ASCO 2014 Annual Meeting: Top abstract selection http://ow.ly/xkXEF # ASCO2014 pic.twitter.com/WsglPfA5aR,,,#,4.71606E+17,https://twitter.com/lymphomahub/status/471605733604474880,,,,
NirajGusani,5/28/2014 6:38,1,2,Yes # ASCO14 strongly features & promotes # hcsm “ @ drattai: @ MikeCowher see this @ ASCOPost re: twitter at meetings http://www.ascopost.com/issues/october-15-2012/tweeting-at-asco-annual-meetings-can-enhance-the-experience.aspx …”,,@ @ @,# #,4.71601E+17,https://twitter.com/NirajGusani/status/471601273629061120,,,,
World_ADC,5/28/2014 6:14,2,1,Clinical updates of # ADC programs being covered at # ASCO14 - exclusive summary ebook available at http://adc-summit.com/content-library,,,# #,4.71595E+17,https://twitter.com/World_ADC/status/471595298255810560,,,,
Bispecific,5/28/2014 6:06,3,1,Clinical updates of # bispecific # antibodies at # ASCO14 - exclusive summary ebook. Download yours at http://bispecific.com/content-library/downloads …,,,# # #,4.71593E+17,https://twitter.com/Bispecific/status/471593455102488576,,,,
sogug1,5/28/2014 5:55,2,1,¿Qué se cuece en el congreso anual de # ASCO14? ¿Qué será lo más destacado? Nos lo cuentan desde @ MedscapeOnc http://www.medscape.com/viewarticle/825630 …,,@,#,4.71591E+17,https://twitter.com/sogug1/status/471590504493510656,,,,
CLCCLeonBerard,5/28/2014 5:26,3,0,"Les équipes du CLB présentes à l' @ ASCO 2014, avec @ GroupeUNICANCER . Découvrez leurs présentations : http://bit.ly/19SE7VC",,@ @,,4.71583E+17,https://twitter.com/CLCCLeonBerard/status/471583158480437248,,,,
falsoguaritore,5/28/2014 5:10,1,1,Nanobiotix SA $ NANO.EPA +43% in un mese. NBTXR3 in STS ad # ASCO14,,,#,4.71579E+17,https://twitter.com/falsoguaritore/status/471579250148278272,,,,
ByJonGardner,5/28/2014 5:04,0,0,The # sgenball is very similar to something I've seen before ... http://ow.ly/xkJyH $ SGEN # asco14 # allglorytothehypnotoad,,,# # #,4.71578E+17,https://twitter.com/ByJonGardner/status/471577677791768576,,,,
favo_it,5/28/2014 4:42,3,2,"Da venerdì favo sarà a Chicago per # ASCO14,per fare la propria parte di Patient Advocate.Seguiteci x aggiornamenti! @ EIannelli @ ALCASEItalia",,@ @,#,4.71572E+17,https://twitter.com/favo_it/status/471572139037163520,,,,
MyelomaUK,5/28/2014 4:40,0,1,"Latest myeloma research to be presented at the largest international cancer conference, # ASCO14 http://bit.ly/1tO01Fh @ ASCO",,@,#,4.71572E+17,https://twitter.com/MyelomaUK/status/471571577994108928,,,,
jdflaysakier,5/28/2014 4:15,3,0,Demain au # JT13h de @ france2 on explique pourquoi l'éducation thérapeutique réduit le risque de récidive du cancer du sein # ASCO14 # cancer,,@,# # #,4.71565E+17,https://twitter.com/jdflaysakier/status/471565387679932416,,,,
OncLive,5/28/2014 4:15,0,0,Dr. Jason Luke Discusses Results from the Phase III COMBI-d Trial http://ow.ly/xkasT # ASCO14,,,#,4.71565E+17,https://twitter.com/OncLive/status/471565326568923137,,,,
falsoguaritore,5/28/2014 4:14,0,0,@ nikmarnik sempre sperare bene... e prepararsi al peggio :) # ASCO14,,@,#,4.71565E+17,https://twitter.com/falsoguaritore/status/471565216141283329,,,,
jdflaysakier,5/28/2014 4:13,1,4,A compter de vendredi je tweeterai et bloguerai depuis Chicago où se tiendra la conférence annuelle sur le cancer # ASCO14,,,#,4.71565E+17,https://twitter.com/jdflaysakier/status/471564952353124352,,,,
MDigitalLife,5/28/2014 4:04,3,2,What are the favorite social media tools of the # ASCO14 Super-Users? Your Favorite Social Media Tools https://www.youtube.com/watch?v=zUTPs0K5URA … @ TeamOncology,,@,#,4.71563E+17,https://twitter.com/MDigitalLife/status/471562560903589888,,,,
Lionsdencomms,5/28/2014 4:04,0,0,I'm off to # asco14 in Chicago. Lking fwd to gr8 data re # cancerdrugs. Am there till Monday. Get in touch if you're around for meeting up.,,,# #,4.71563E+17,https://twitter.com/Lionsdencomms/status/471562556839305216,,,,
MEDIANTechno,5/28/2014 4:01,0,0,MEDIAN Technologies to Participate in the 2014 # ASCO14 Annual Conference http://www.mediantechnologies.com/news-item-108.en.htm …,,,#,4.71562E+17,https://twitter.com/MEDIANTechno/status/471561767353868288,,,,
SarahCannon_UK,5/28/2014 3:54,0,0,. @ SarahCannonDocs will be presenting 74 abstracts on the latest cancer therapies at # ASCO14 http://sarahcannonresearch.com/locations/meeting-site/accepted-abstracts/index.dot …,,@,#,4.7156E+17,https://twitter.com/SarahCannon_UK/status/471560050738483200,,,,
selukmutlu4,5/28/2014 3:38,0,3,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/y3jvejqzfm # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71556E+17,https://twitter.com/selukmutlu4/status/471556221997035520,,,,
MrJugnu1,5/28/2014 3:37,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/tJlcCMXXgf,,,# # # # # # # # # # # #,4.71556E+17,https://twitter.com/MrJugnu1/status/471555724347047937,,,,
BiotechTrade_fr,5/28/2014 3:31,0,0,# Bourse # Pharma # Bitoech # MEDIAN Technologies $ ALMED annonce sa participation à la conférence annuelle de l' # ASCO2014 http://biotechtrade.fr/biotech-france/median-technologies-2/median-technologies-annonce-participation-conference-annuelle-lasco-2014 …,,,# # # # #,4.71554E+17,https://twitter.com/BiotechTrade_fr/status/471554347290361856,,,,
mediplanetFR,5/28/2014 3:24,0,0,"From May 30th, follow the # ASCO14 live on MediPlanet website ! @ mediplanetFR @ mediplanetNL # oncologie # cancer # kanker",,@ @,# # # #,4.71552E+17,https://twitter.com/mediplanetFR/status/471552498713772032,,,,
selukmutlu4,5/28/2014 3:08,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/Eu9lFdQQpu,,,# # # # # # # # # # # #,4.71549E+17,https://twitter.com/selukmutlu4/status/471548607435255808,,,,
marielitobonito,5/28/2014 2:55,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/h2gUnQ8muW,,,# # # # # # # # # # # #,4.71545E+17,https://twitter.com/marielitobonito/status/471545226062856192,,,,
EIannelli,5/28/2014 2:39,1,1,Inviata speciale # ASCO14 x riportare in Italia scienza e buone prassi x malati # cancro stay tuned @ favo_it @ aimac_it @ InsControCancro,,@ @ @,# #,4.71541E+17,https://twitter.com/EIannelli/status/471541323284361216,,,,
ashbro053,5/28/2014 1:44,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/YhRiYTWlTN # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71528E+17,https://twitter.com/ashbro053/status/471527506382565376,,,,
Ishmael_Gritli,5/28/2014 1:30,0,0,Off to Chicago # ASCO14,,,#,4.71524E+17,https://twitter.com/Ishmael_Gritli/status/471523990050058240,,,,
DrHealeyBird,5/28/2014 1:09,0,0,“ @ myelomabeacon: myeloma survival graph in # ASCO14 http://www.myelomabeacon.com/forum/multiple-myeloma-survival-2014-t3338.html … pic.twitter.com/FJCWUR2wcL”,,@,#,4.71519E+17,https://twitter.com/DrHealeyBird/status/471518598075514880,,,,
survivor_lady,5/28/2014 0:26,0,0,"“ @ GregoryDennis: @ survivor_lady Sounds like good stuff! # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb ”",,@ @,# #,4.71508E+17,https://twitter.com/survivor_lady/status/471507780277641216,,,,
Ethane28,5/28/2014 0:15,0,0,"@ pick1998_2 With # ASCO14 good data, $ MACK might go to $10 in June",,@,#,4.71505E+17,https://twitter.com/Ethane28/status/471505058707013632,,,,
MDigitalLife,5/28/2014 0:11,1,1,"The experts follow @ MTMDPhD @ RSM2800 @ MaverickNY @ JodyMS @ FischMD Your Must-Follow People on Twitter"" https://www.youtube.com/watch?v=7141YnUsXcY … VIDEO # ASCO14""",,@ @ @ @ @,#,4.71504E+17,https://twitter.com/MDigitalLife/status/471503884125749248,,,,
drallysonocean,5/27/2014 23:28,1,1,@ Alinea Two oncologist foodies coming to @ ASCO this weekend- any tables for 2 available Friday-Sunday? Fingers crossed!,,@ @,,4.71493E+17,https://twitter.com/drallysonocean/status/471493306585587713,,,,
DrAttai,5/27/2014 22:59,1,0,"wouldn't miss it! MT @ rsm2800 Join me & @ obogler @ mtmdphd -Internet, Social Media, Privacy Regulations, Clinical Trials 6/2, 1:15-pm # ASCO14",,@ @ @,#,4.71486E+17,https://twitter.com/DrAttai/status/471485865697353728,,,,
DrAttai,5/27/2014 22:55,2,0,+1 MT @ mtmdphd MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14,,@ @,#,4.71485E+17,https://twitter.com/DrAttai/status/471484939016634368,,,,
DrAttai,5/27/2014 22:54,0,0,"MT @ brianreid Must-Follow People on Social Media: http://youtu.be/7141YnUsXcY # ASCO14 (You go, @ MTMDPHD, @ FischMD, @ rsm2800, @ drattai!) # ASCO14",,@ @ @ @ @,# #,4.71485E+17,https://twitter.com/DrAttai/status/471484629623767040,,,,
DrAttai,5/27/2014 22:50,1,0,RT @ ASCO Twitter's role during scientific meetings? http://bit.ly/1mAmiDB # ASCO14 # hcsm CC @ ASCOPost @ RSM2800,,@ @ @,# #,4.71484E+17,https://twitter.com/DrAttai/status/471483748262084609,,,,
DrAttai,5/27/2014 22:49,2,0,"good read: @ mtmdphd More Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xiamR # ASCO14",,@ @,#,4.71483E+17,https://twitter.com/DrAttai/status/471483359252975617,,,,
EK_Drake,5/27/2014 22:26,0,0,# AYACSM - I developed in partnership with @ StupidCancer - will be used to report from @ ASCO # huge,,@ @,# #,4.71478E+17,https://twitter.com/EK_Drake/status/471477502880120832,,,,
twittmanda,5/27/2014 22:25,0,1,@ DiemBrownMTV @ nma08244 @ ASCO It does doesn't it Diem!,,@ @ @,,4.71477E+17,https://twitter.com/twittmanda/status/471477276136071168,,,,
DrAnasYounes,5/27/2014 22:11,1,1,"RT @ ASCO: Who are the researchers receiving this year's 2014 ACRA, YIA & CDA Awards? http://bit.ly/1tkPhMt CC @ iconquercancer",,@ @,,4.71474E+17,https://twitter.com/DrAnasYounes/status/471473879391928320,,,,
ASCO,5/27/2014 22:10,5,7,# ASCO14 Tweeters infographic: http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.71473E+17,https://twitter.com/ASCO/status/471473486553432064,,,,
JustTHATNiggga,5/27/2014 21:52,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/djKmkDOvmA,,,# # # # # # # # # # # #,4.71469E+17,https://twitter.com/JustTHATNiggga/status/471468956234956800,,,,
Cangela25,5/27/2014 21:51,0,0,@ AmandaHaddock @ CBlotner_ @ ASCO Agreed!,,@ @ @,,4.71469E+17,https://twitter.com/Cangela25/status/471468748785078273,,,,
subatomicdoc,5/27/2014 21:29,0,2,@ CBlotner_ @ ASCO No problem. Caveat = some will be remote tweeting since my daughter's performance delays my Chicago arrival. # ASCO14,,@ @,#,4.71463E+17,https://twitter.com/subatomicdoc/status/471463163029106688,,,,
ASCO,5/27/2014 21:27,0,0,@ weloveannarose Perhaps review cancer tag ontology http://bit.ly/1nybBSY I.D. area of interest & follow the tag during # ASCO14,,@,#,4.71463E+17,https://twitter.com/ASCO/status/471462844979216385,,,,
CBlotner_,5/27/2014 21:27,0,0,"@ subatomicdoc @ ASCO Fantastic news, Matt!",,@ @,,4.71463E+17,https://twitter.com/CBlotner_/status/471462700401184768,,,,
phillybilly2,5/27/2014 21:22,0,2,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/2VjK3gTK3i # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71461E+17,https://twitter.com/phillybilly2/status/471461351437520896,,,,
jonathanagin,5/27/2014 21:21,1,1,@ subatomicdoc @ ASCO Thank you. The community is growing and gaining in voice & reach. DIPG community is one exp. http://jonathanagin.com,,@ @,,4.71461E+17,https://twitter.com/jonathanagin/status/471461213768269824,,,,
subatomicdoc,5/27/2014 21:18,2,1,"@ jonathanagin @ ASCO Thanks Jonathan. The hashtag is # pedcsm currently recommended. No large community - yet. Best, matt",,@ @,#,4.7146E+17,https://twitter.com/subatomicdoc/status/471460395471736833,,,,
AmandaHaddock,5/27/2014 21:04,0,2,@ CBlotner_ @ ASCO I'd love to see # btsm listed! It's a significant way to find resources in the brain tumor/brain cancer community.,,@ @,#,4.71457E+17,https://twitter.com/AmandaHaddock/status/471456933304889344,,,,
bioclinica,5/27/2014 21:01,0,1,RT @ ASCO Apps for # ASCO14 & how to use them http://bcove.me/urums205 (VIDEO),,@,#,4.71456E+17,https://twitter.com/bioclinica/status/471456092300800001,,,,
phillybilly2,5/27/2014 20:55,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/mE6VIHuGue,,,# # # # # # # # # # # #,4.71455E+17,https://twitter.com/phillybilly2/status/471454634507116546,,,,
subatomicdoc,5/27/2014 20:54,2,4,"@ CBlotner_ @ ASCO No problem, Catherine. I'll be sharing for # btsm. Stay tuned! :)",,@ @,#,4.71454E+17,https://twitter.com/subatomicdoc/status/471454343493718017,,,,
GenomicHealth,5/27/2014 20:38,1,1,Looking forward to # ASCO14! Who else will be there? $ GHDX # hcsm,,,# #,4.7145E+17,https://twitter.com/GenomicHealth/status/471450448004923393,,,,
EK_Drake,5/27/2014 19:52,2,3,"Excited to see that @ fischmd will be using the hashtag I developed, # ayacsm, to report from @ ASCO # yacancer # cancer",,@ @,# # #,4.71439E+17,https://twitter.com/EK_Drake/status/471438915220819968,,,,
afreshchapter,5/27/2014 19:34,0,0,Hope to see you there! RT @ innovpartners: Looking forward to # ASCO2014 -- tweet us @ innovpartners if we'll see you there!,,@ @,#,4.71434E+17,https://twitter.com/afreshchapter/status/471434287267713025,,,,
Oncoinfo_it,5/27/2014 19:34,0,0,@ mtmdphd @ subatomicdoc # waitingforASCO14 Not to be missed! @ PAscierto @ lucianodf @ Tecnoetica # ASCO14,,@ @ @ @ @,# #,4.71434E+17,https://twitter.com/Oncoinfo_it/status/471434179444740096,,,,
BekRx,5/27/2014 19:28,0,0,Following all of you # ASCOnauts! @ ASCO's @ RSM2800 Twitter's role in scientific meetings http://bit.ly/1mAmiDB # ASCO14 # LancetUSA @ TheLancet,,@ @ @,# # #,4.71433E+17,https://twitter.com/BekRx/status/471432857353596928,,,,
CBlotner_,5/27/2014 19:27,1,2,"@ ASCO Yes, I have seen the infographic. It appears as though # btsm does not yet have a seat at the table.",,@,#,4.71433E+17,https://twitter.com/CBlotner_/status/471432608526516225,,,,
jonathanagin,5/27/2014 19:26,0,0,@ ASCO understood. That's why we in the childhood community need to demand more and raise our voices. Thx for the conversation,,@,,4.71432E+17,https://twitter.com/jonathanagin/status/471432246147444736,,,,
jonathanagin,5/27/2014 19:24,0,1,@ ASCO absolutely will be doing so. Wish there were more pediatric sessions but I will be providing my thoughts when I can. Thx,,@,,4.71432E+17,https://twitter.com/jonathanagin/status/471431756751863809,,,,
ASCO,5/27/2014 19:22,0,0,"@ jonathanagin Also, we invite you to join the # ASCO14 conversation & contribute your thoughts during the meeting.",,@,#,4.71431E+17,https://twitter.com/ASCO/status/471431166315462657,,,,
chimoose,5/27/2014 19:05,5,3,Who are the must-follows at # ASCO14? Find out from pros like @ EBantug @ drdonsdizon @ raykerins @ JackWestMD. [VIDEO]http://youtu.be/7141YnUsXcY,,@ @ @ @,#,4.71427E+17,https://twitter.com/chimoose/status/471427124121726976,,,,
jackiefox12,5/27/2014 18:26,0,0,"RT @ ASCO: “Chemotherapy Changes Brain Activity, Based on MRI.” http://bit.ly/RyseBu # JCO exclusive on # ASCOconnection # validation # bcsm",,@,# # # #,4.71417E+17,https://twitter.com/jackiefox12/status/471417089140334592,,,,
GenentechJobs,5/27/2014 18:25,1,0,The 50th # ASCO14 meeting kicks off on May 30th. http://bit.ly/1lQaPwB Download the Meeting Mobile Conf. App: http://bit.ly/1hKnSy3 .,,,#,4.71417E+17,https://twitter.com/GenentechJobs/status/471417014875992064,,,,
GenentechJobs,5/27/2014 18:23,0,0,"# ASCO14 Talent Hunt: Sr. Medical Director, Hemophilia: http://click2apply.net/429905t",,,#,4.71416E+17,https://twitter.com/GenentechJobs/status/471416362535878657,,,,
JWMarriottChi,5/27/2014 18:22,0,0,"In honor of the 50th Annual @ ASCO Meeting this weekend, we're offering $12 ASCO Smash & Classic Whiskey Smash cocktails in our Lobby Lounge",,@,,4.71416E+17,https://twitter.com/JWMarriottChi/status/471416112177872897,,,,
NorthwestBio,5/27/2014 18:15,3,1,We are excited to already begin seeing some initial positive responses, said $ NWBO CEO http://bit.ly/1tKAEnE # ASCO14,,,#,4.71414E+17,https://twitter.com/NorthwestBio/status/471414305397559296,,,
SymphonySister,5/27/2014 18:14,2,1,"# MammaPrint: Only # breastcancer recurrence assay backed by peer-reviewed, prospective outcome data. # ASCO14 # bcsm http://hub.am/1tLSKFW",,,# # # #,4.71414E+17,https://twitter.com/SymphonySister/status/471414239345651713,,,,
Agendia,5/27/2014 18:14,0,0,"# MammaPrint: Only # breastcancer recurrence assay backed by peer-reviewed, prospective outcome data. # ASCO14 # bcsm http://hub.am/1nxpl0g",,,# # # #,4.71414E+17,https://twitter.com/Agendia/status/471414239299514369,,,,
jagasquet,5/27/2014 18:14,0,0,Bristol-Myers scores 2 more immuno-oncology deals as # ASCO14 approaches # immunotherapy http://www.fiercepharma.com/story/bristol-myers-scores-2-more-immuno-oncology-deals-asco-approaches/2014-05-27?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4UN_TLgxrU.twitter …,,,# # #,4.71414E+17,https://twitter.com/jagasquet/status/471414149805654017,,,,
GregoryDennis,5/27/2014 18:10,0,0,@bcsctweet Thanks. See also: Genomic profiling of breast cancer in African-American women. # ASCO2014 abstract. http://ow.ly/x3KEo,,@bcsctweet,#,4.71413E+17,https://twitter.com/GregoryDennis/status/471413118073978882,,,,
mmameg,5/27/2014 18:00,1,3,"Helping patients get new innovation, while paying oncologist fairly for their work. # ASCO2014 underway.. http://prn.to/1gysZGy",,,#,4.71411E+17,https://twitter.com/mmameg/status/471410760774459393,,,,
CBlotner_,5/27/2014 17:57,0,0,@ ASCO Is it possible for # btsm (brain tumor social media) to be added to this year's hashtag infographics and group of tweeters?,,@,#,4.7141E+17,https://twitter.com/CBlotner_/status/471409800169803777,,,,
DrMisialek,5/27/2014 17:56,1,0,Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: Guideline Update http://www.asco.org/quality-guidelines/adjuvant-endocrine-therapy-women-hormone-receptor%E2%80%93positive-breast-cancer-american#.U4UJf9PLOI8.twitter … @ ASCO # bcsm,,@,# #,4.7141E+17,https://twitter.com/DrMisialek/status/471409605860667392,,,,
CBlotner_,5/27/2014 17:53,0,0,. @ ASCO tweeters and hashtags to keep an eye on: http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf …,,@,,4.71409E+17,https://twitter.com/CBlotner_/status/471408995513946112,,,,
knwachter,5/27/2014 17:53,0,0,RT @ TGeorgeMD: FDA approval for Pmab in mCRC gives our patients another tx option @ ASCOPost http://www.ascopost.com/viewnews.aspx?nid=16258 … | # cancer # ASCO14,,@ @,# #,4.71409E+17,https://twitter.com/knwachter/status/471408834268106753,,,,
MSLGROUP_PRx,5/27/2014 17:52,0,0,What are you most looking forward to hearing about at # ASCO14? Message us with your answer.,,,#,4.71409E+17,https://twitter.com/MSLGROUP_PRx/status/471408752953155584,,,,
knwachter,5/27/2014 17:51,0,0,"I'm going to say NO RT @ yzafar: Are cancer clin trial patients similar to cancer patients in real world""? http://bit.ly/1oG6Xln # ASCO14""",,@,#,4.71408E+17,https://twitter.com/knwachter/status/471408317852819456,,,,
jagasquet,5/27/2014 17:49,0,2,# Amgen highlights data to be presented at # ASCO14 http://bit.ly/1jYtDxO @ Amgen,,@,# #,4.71408E+17,https://twitter.com/jagasquet/status/471407845498712065,,,,
PeoplesPharmacy,5/27/2014 17:45,0,0,"Brain activity changes after # chemotherapy: foggy thinking, difficulty # multitasking: http://pllqt.it/mp88dL # chemobrain study via @ ASCO",,@,# # #,4.71407E+17,https://twitter.com/PeoplesPharmacy/status/471406744459952128,,,,
jagasquet,5/27/2014 17:44,0,2,What's Trending at # ASCO14 This Year? http://www.primeoncology.org/online_education/primelines/2014_may.aspx#link8 …pic.twitter.com/MWHOyUPSbT,,,# #link8,4.71407E+17,https://twitter.com/jagasquet/status/471406736373710848,,,,
jonathanagin,5/27/2014 17:43,0,1,@ ASCO there is no specific pediatric hashtag that I can see. Did I miss it? Looking forward to being present for the childhood community,,@,,4.71406E+17,https://twitter.com/jonathanagin/status/471406372639092738,,,,
NOCC_Illinois,5/27/2014 17:43,0,1,Thank you for your continued support of our Chapter. We will be visiting @ ASCO this weekend!,,@,,4.71406E+17,https://twitter.com/NOCC_Illinois/status/471406264769994754,,,,
MatthewZachary,5/27/2014 17:36,0,3,. @ LIVESTRONGCEO @ brockyetso Nothing screams Milestone Birthday Party like @ ASCO,,@ @ @,,4.71405E+17,https://twitter.com/MatthewZachary/status/471404699825217538,,,,
NeoGriCee,5/27/2014 17:34,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/WxXvI83a3Q,,,# # # # # # # # # # # #,4.71404E+17,https://twitter.com/NeoGriCee/status/471404107404541955,,,,
LesleyLesleys,5/27/2014 17:28,0,0,"@ ASCO I hope this will prompt more research into better t'mnt of hot flushes, sexual effects etc in order to improve adherence to tamoxifen?",,@,,4.71403E+17,https://twitter.com/LesleyLesleys/status/471402580531486720,,,,
stales,5/27/2014 17:19,1,1,RT @ genentech: # OH at # REV2014: “Patients are key to improving quality care.” - @ stales | http://ow.ly/xiY4L # ASCO14 cc: @ aliciacollin,,@ @ @,# # #,4.714E+17,https://twitter.com/stales/status/471400322129473537,,,,
timealopez,5/27/2014 17:18,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/YzIi1nqjaO,,,# # # # # # # # # # # #,4.714E+17,https://twitter.com/timealopez/status/471399953185533952,,,,
LesleyLesleys,5/27/2014 17:16,0,0,Is it ok that the new @ asco guideline for 10yrs of tamoxifen is based on studies which did not report QoL outcomes? http://jco.ascopubs.org/content/early/2014/05/20/JCO.2013.54.2258.full.pdf …,,@,,4.714E+17,https://twitter.com/LesleyLesleys/status/471399522137284609,,,,
J_omurchu,5/27/2014 17:13,0,1,@ ASCO thanks!,,@,,4.71399E+17,https://twitter.com/J_omurchu/status/471398884070408192,,,,
LungCancerFaces,5/27/2014 17:05,1,2,"Just after, on Thursday 6/5 at 8pm ET, 5pm PT. @ IanJohnPereira: Will there be an # lcsm chat from # ASCO14 @ LungCancerFaces & @ JFreemanDaily?",,@ @ @,# #,4.71397E+17,https://twitter.com/LungCancerFaces/status/471396784149782530,,,,
SanofiUS,5/27/2014 17:05,1,0,RT @ ASCO # ASCO14 Tweeters infographic http://bit.ly/1pvMSyf Want to follow all? Subscribe to our list http://bit.ly/1pvMUGd # hcsm,,@,# #,4.71397E+17,https://twitter.com/SanofiUS/status/471396687853142016,,,,
ASCO,5/27/2014 17:00,13,6,Review 2014 ASCO Educational Book articles in advance of # ASCO14 educational sessions: http://bit.ly/SLvfQa,,,#,4.71396E+17,https://twitter.com/ASCO/status/471395591306899456,,,,
GenentechJobs,5/27/2014 17:00,0,0,We're just 3-days away from # ASCO14. Team Genentech will be presenting new data... http://talent.gene.com/go/mi5tw6 # Genentech,,,# #,4.71395E+17,https://twitter.com/GenentechJobs/status/471395443784421376,,,,
J_omurchu,5/27/2014 16:56,0,1,@ ASCO which chemo drugs were used in the study?,,@,,4.71395E+17,https://twitter.com/J_omurchu/status/471394577392599040,,,,
ASCO,5/27/2014 16:45,0,1,Please visit the Institute for Quality booth at # ASCO14 to view live # CancerLinQ demos http://bit.ly/1kIto90 # ascoaction,,,# # #,4.71392E+17,https://twitter.com/ASCO/status/471391838302388224,,,,
BJRimelMD,5/27/2014 16:43,0,0,"Important but now what? @ ASCO: “Chemotherapy Changes Brain Activity, Based on MRI.” http://bit.ly/RyseBu # JCO exclusive on # ASCOconnection”",,@,# #,4.71391E+17,https://twitter.com/BJRimelMD/status/471391364437913600,,,,
BGI_Genomics,5/27/2014 16:38,0,0,"This will be our first year at # ASCO14 If you're attending, we will be at booth 19140 this weekend. pic.twitter.com/9OpoFgLSni",,,#,4.7139E+17,https://twitter.com/BGI_Genomics/status/471389970696273920,,,,
TomHalkin,5/27/2014 16:34,2,3,". @ ASCO Tumor Board on GBM, ft. Drs. Al Yung of @ MDAndersonNews & Paul Mischel of @ Ludwig_Cancer (sponsor @ NBTStweets) http://bit.ly/1jr9PgE",,@ @ @ @,,4.71389E+17,https://twitter.com/TomHalkin/status/471389077477273600,,,,
mtmdphd,5/27/2014 16:34,2,0,"Critical Role of Phase I # ClinicalTrials in Cancer Treatment - @ ASCO # JCO 15(2), 1997 http://ow.ly/xjH0i",,@,# #,4.71389E+17,https://twitter.com/mtmdphd/status/471388963320905728,,,,
TGeorgeMD,5/27/2014 16:32,1,1,Warning: Your Results May Vary | # chemo benefits differ in real world as limited dosing mods avail for pills @ ASCO http://jco.ascopubs.org/content/early/2014/04/03/JCO.2013.53.0204?cmpid=jco_pap_7Apr2014#.U0PTJdVnxBA.twitter …,,@,# #,4.71389E+17,https://twitter.com/TGeorgeMD/status/471388574282420224,,,,
ASCO,5/27/2014 16:30,0,1,Join ASCO during # ASCO14: visit a Member Services Desk to calculate your membership dues credit.,,,#,4.71388E+17,https://twitter.com/ASCO/status/471388106277810177,,,,
JenPageWall,5/27/2014 16:30,7,1,"Covering the # ASCO14 meeting? If so, check out @ PhRMA cancer chart pack resource http://www.phrma.org/sites/default/files/pdf/cancer-chart-pack-5-22-14.pdf …",,@,#,4.71388E+17,https://twitter.com/JenPageWall/status/471388034148343810,,,,
GregoryDennis,5/27/2014 16:30,0,0,"@ bigshotfuller Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71388E+17,https://twitter.com/GregoryDennis/status/471387875888869377,,,,
GregoryDennis,5/27/2014 16:29,0,0,"@ tigerlilycares Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71388E+17,https://twitter.com/GregoryDennis/status/471387776949420032,,,,
GregoryDennis,5/27/2014 16:29,0,0,"@ beitsch Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71388E+17,https://twitter.com/GregoryDennis/status/471387646796005377,,,,
griffith4141,5/27/2014 16:28,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/tWzDIJZeYN,,,# # # # # # # # # # # #,4.71388E+17,https://twitter.com/griffith4141/status/471387543510843393,,,,
GregoryDennis,5/27/2014 16:28,0,0,"@ YMEBreastCancer Breast and colon cancer studies, including molecular subtyping, featured: # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71388E+17,https://twitter.com/GregoryDennis/status/471387502817705984,,,,
GregoryDennis,5/27/2014 16:28,0,0,"@P_TownCares Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@P_TownCares,# #,4.71387E+17,https://twitter.com/GregoryDennis/status/471387384496787457,,,,
jagasquet,5/27/2014 16:27,0,0,New FDA approval for Pmab in mCRC gives our patients another treatment option @ ASCOPost http://www.ascopost.com/viewnews.aspx?nid=16258 … | # crcsm # ASCO14 @ TGeorgeMD,,@ @,# #,4.71387E+17,https://twitter.com/jagasquet/status/471387254238486528,,,,
GregoryDennis,5/27/2014 16:27,0,0,"@ PatSanPedro Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71387E+17,https://twitter.com/GregoryDennis/status/471387241684926464,,,,
GregoryDennis,5/27/2014 16:27,0,0,"@ latestbreastcan Breast and colon cancer studies, including molecular subtyping, featured: # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71387E+17,https://twitter.com/GregoryDennis/status/471387141738889216,,,,
cancerassassin1,5/27/2014 16:26,0,0,I am willing to bet the price of entrees at # Chicago restaurants doubles the first week of June every year - who's ready for # ASCO14?!,,,# #,4.71387E+17,https://twitter.com/cancerassassin1/status/471387032162275329,,,,
CancerDotNet,5/27/2014 16:25,2,3,"Hormonal Therapy for Hormone Receptor-Positive Breast Cancer"" @ ASCO guideline summary: http://bit.ly/1nRlBFe""",,@,,4.71387E+17,https://twitter.com/CancerDotNet/status/471386634714640384,,,,
MyelomaTeacher,5/27/2014 16:22,1,0,# ASCO14 Multiple # Myeloma Preview @ MaverickNY http://biotechstrategyblog.com/2014/05/asco-2014-multiple-myeloma-preview-asco14.html/ …,,@,# #,4.71386E+17,https://twitter.com/MyelomaTeacher/status/471386104839434240,,,,
GregoryDennis,5/27/2014 16:21,0,0,"@ Askdrjane Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71386E+17,https://twitter.com/GregoryDennis/status/471385643583827968,,,,
ventana,5/27/2014 16:20,0,0,"RT @ Roche: According to the theme of # ASCO14  # Science and Society"""," we've prepared some exciting feature articles: http://ow.ly/xiMKC""",,@,# #,4.71385E+17,https://twitter.com/ventana/status/471385423139581954,,,
GregoryDennis,5/27/2014 16:19,0,0,"@ TeamR0XY Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471385335239553024,,,,
GregoryDennis,5/27/2014 16:19,0,0,"@ CancerPhysio Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471385212681977856,,,,
GregoryDennis,5/27/2014 16:18,0,0,"@ MyHopeChest Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471385076782350336,,,,
smerv,5/27/2014 16:18,3,1,Interesting RT @ ASCO Oral Anticancer Drugs: How Limited Dosing Options and Dose Reductions May Affect Outcomes http://bit.ly/1nQcvs9 # JCO,,@,#,4.71385E+17,https://twitter.com/smerv/status/471385058155057152,,,,
GregoryDennis,5/27/2014 16:18,0,0,"@bcsctweet Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@bcsctweet,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471384990589411328,,,,
KimmelCancerCtr,5/27/2014 16:18,1,1,RT @ ASCO: Oral # Anticancer Drugs: How Limited Dosing Options and Dose Reductions May Affect Outcomes http://bit.ly/1nQcvs9 # JCO,,@,# #,4.71385E+17,https://twitter.com/KimmelCancerCtr/status/471384893344481280,,,,
Amgen,5/27/2014 16:18,6,3,# Amgen highlights data to be presented at # ASCO14 http://bit.ly/1jYtDxO,,,# #,4.71385E+17,https://twitter.com/Amgen/status/471384892400758784,,,,
GregoryDennis,5/27/2014 16:17,0,0,"@ survivor_lady Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471384667640590336,,,,
GregoryDennis,5/27/2014 16:16,0,0,"@EfratCureDiva Breast and colon cancer studies, including molecular subtyping, featured at # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@EfratCureDiva,# #,4.71385E+17,https://twitter.com/GregoryDennis/status/471384588405964800,,,,
IanJPereira,5/27/2014 16:15,0,0,Will there be an # lcsm chat from # ASCO14 @ LungCancerFaces & @ JFreemanDaily?,,@ @,# #,4.71384E+17,https://twitter.com/IanJPereira/status/471384286906843137,,,,
GregoryDennis,5/27/2014 16:14,0,0,"@ ThinkPinkRocks4 Breast and colon cancer studies, including molecular subtyping, featured: # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@,# #,4.71384E+17,https://twitter.com/GregoryDennis/status/471384023592615936,,,,
GregoryDennis,5/27/2014 16:14,0,0,"@MaurerFoundatio Breast and colon cancer studies, including molecular subtyping, featured: # ASCO14, # bcsm Abstracts: http://ow.ly/xacKb",,@MaurerFoundatio,# #,4.71384E+17,https://twitter.com/GregoryDennis/status/471383920941207552,,,,
myriadgenetics,5/27/2014 16:10,3,0,Myriad will present results from 11 clinical studies with 4 products at # ASCO14! http://bit.ly/1qFsz5H # hereditarycancer # brca # melanoma,,,# # # #,4.71383E+17,https://twitter.com/myriadgenetics/status/471382836503531522,,,,
Cognicum,5/27/2014 16:08,0,0,Visiting @ ASCO? Make the most of your networking! Use the app and connact! @ connactapp https://itunes.apple.com/nl/app/connact/id859436298?mt=8 …,,@ @,,4.71382E+17,https://twitter.com/Cognicum/status/471382412644327424,,,,
Novartis,5/27/2014 16:01,2,5,# ASCO14 will be held from May 30 – June 3 in Chicago. Follow @ Novartis to learn more about # Novartis data at the meeting,,@,# #,4.71381E+17,https://twitter.com/Novartis/status/471380663397261313,,,,
HemOncToday,5/27/2014 16:01,0,0,"# Tamoxifen may be used up to 10 years for non-metastatic, HR-positive # BreastCancer @ ASCO http://goo.gl/s06dil",,@,# #,4.71381E+17,https://twitter.com/HemOncToday/status/471380589237796864,,,,
GoHealio,5/27/2014 16:01,0,0,"# Tamoxifen may be used up to 10 years for non-metastatic, HR-positive # BreastCancer @ ASCO http://goo.gl/s06dil",,@,# #,4.71381E+17,https://twitter.com/GoHealio/status/471380587404857344,,,,
wendyselig,5/27/2014 15:57,2,0,Gearing up to learn about the latest # melanoma progress at # ASCO14. Look for @ MelanomaReAlli and our partners throughout the meeting.,,@,# #,4.7138E+17,https://twitter.com/wendyselig/status/471379714263642112,,,,
FierceBiotech,5/27/2014 15:56,4,4,"Thursday: @ JohnCFierce, @ PennMedicine's David Porter will chat, break down # ASCO2014. More: http://bit.ly/1ip27nQ # FierceASCO",,@ @,# #,4.7138E+17,https://twitter.com/FierceBiotech/status/471379526518603776,,,,
gotheimer,5/27/2014 15:52,0,0,@ ASCO @ ASCOPost @ rsm2800,,@ @ @,,4.71378E+17,https://twitter.com/gotheimer/status/471378496313638912,,,,
PCGAdvisory,5/27/2014 15:51,0,0,OncoSec Medical To Present at Four Events in June $ ONCS # ASCO14 # ASCO # advanced # development # pharmaceuticals # food http://yhoo.it/1jXzFyB,,,# # # # # #,4.71378E+17,https://twitter.com/PCGAdvisory/status/471378159930462208,,,,
KarenMiddleton1,5/27/2014 15:50,0,0,"Avastin makes the shortlist @ stephnaylor76: What are the top 5 clinical advances since ASCO was founded? http://bit.ly/1griBAB # ASCO14”""",,@,#,4.71378E+17,https://twitter.com/KarenMiddleton1/status/471377884402446336,,,,
elruper79,5/27/2014 15:48,1,0," @ yzafar: Are cancer clinical trial patients similar to cancer patients treated in the ""real world""? http://bit.ly/1oG6Xln # ASCO14 # hsronc""""",,@,# #,4.71377E+17,https://twitter.com/elruper79/status/471377449776062464,,,,
EMDSerono,5/27/2014 15:48,0,0,Are you attending # ASCO14? Stop by booth 14087 to see what we’re up to. pic.twitter.com/GkyPx2yrtx,,,#,4.71377E+17,https://twitter.com/EMDSerono/status/471377381085958145,,,,
ECSalud_com,5/27/2014 15:45,2,0,"El viernes @boehringer_esp estará en la 50edición de # ASCO14, el mayor evento científico internacional sobre # cancer http://bit.ly/1m1U03b",,@boehringer_esp,# #,4.71377E+17,https://twitter.com/ECSalud_com/status/471376613545099264,,,,
CancerTherAdvsr,5/27/2014 15:40,0,0,"RT @ fischmd: The @ ASCO iPlanner and iMeeting apps for the iPad are phenomenal, # ASCO14",,@ @,#,4.71375E+17,https://twitter.com/CancerTherAdvsr/status/471375321594617856,,,,
GenentechJobs,5/27/2014 15:37,0,0,"# ASCO14 Talent Hunt: Medical Director, Hematology GDC - job details here: http://click2apply.net/413854t",,,#,4.71375E+17,https://twitter.com/GenentechJobs/status/471374724291776513,,,,
CHI_CIRI,5/27/2014 15:37,0,0,"Join Dr. Mehmet Copur at # ASCO14 - 5/31/14 - 8:00am - Room E253 - “Optimizing Access to # ClinicalTrials in Community Practice"",,,# #,471374658772561920""",https://twitter.com/CHI_CIRI/status/471374658772561920,,,,,,,,
GenentechJobs,5/27/2014 15:35,0,0,Tweeting during # ASCO14 may help an attendees have a better conference experience. http://bit.ly/TReGD8 Follow us and retweet please.,,,#,4.71374E+17,https://twitter.com/GenentechJobs/status/471374183830536192,,,,
AdaptiveBiotech,5/27/2014 15:33,0,0,# ASCO14: Adaptive & Collaborators to Present Data Advancing the Clinical Utility of Immunosequencing: http://bit.ly/ScGccL # immunotherapy,,,# #,4.71374E+17,https://twitter.com/AdaptiveBiotech/status/471373664571518976,,,,
twittmanda,5/27/2014 15:33,1,2,@ mtmdphd @ ASCO @ subatomicdoc Thank you for posting this. I've had to block many porn sites with this hashtag.,,@ @ @,,4.71374E+17,https://twitter.com/twittmanda/status/471373545407520768,,,,
GenentechJobs,5/27/2014 15:31,0,0,A video tutorial http://bit.ly/1nwDhHL will help optimize your # ASCO14 experience by showing you how to use iMeeting app and iplanner.,,,#,4.71373E+17,https://twitter.com/GenentechJobs/status/471373123850211328,,,,
tomleblancMD,5/27/2014 15:30,0,0,New study shows deceptive information rampant in # cancer center # advertising - http://ow.ly/xjwlE @ ASCOpost # ASCO14,,@,# # #,4.71373E+17,https://twitter.com/tomleblancMD/status/471372867192758272,,,,
GenentechJobs,5/27/2014 15:26,3,2,We'll be presenting new data on 27 different medicines during this year's 50th # ASCO14. anniversary meeting. http://bit.ly/1wb63Sm,,,#,4.71372E+17,https://twitter.com/GenentechJobs/status/471371885020602368,,,,
twittmanda,5/27/2014 15:22,0,0,@ jonathanagin @ ASCO Thank you Jonathan. I saw @ fischmd had a adol &YA hashtag but nothing for pedi although it appears to be incl discuss,,@ @ @,,4.71371E+17,https://twitter.com/twittmanda/status/471370861707288577,,,,
Boehringer,5/27/2014 15:20,1,3,# HCPs: What are the top 5 clinical advances since @ ASCO was founded 50 years ago? http://bit.ly/1griBAB # ASCO14,,@,# #,4.7137E+17,https://twitter.com/Boehringer/status/471370312287010816,,,,
DentalOncology,5/27/2014 15:19,0,1,Great read! RT @ ASCO: Twitter's role during scientific meetings? http://bit.ly/1mAmiDB # ASCO14 # hcsm CC @ ASCOPost @ rsm2800,,@ @ @,# #,4.7137E+17,https://twitter.com/DentalOncology/status/471370230108004352,,,,
Oncoinfo_it,5/27/2014 15:18,0,0,# aspettandoASCO14 Le aspettative degli oncologi in partenza... http://tinyurl.com/nr7fjrc @ PAscierto @ carmine_pinto @ lucadf # ASCO14,,@ @ @,# #,4.7137E+17,https://twitter.com/Oncoinfo_it/status/471369748094414848,,,,
TGeorgeMD,5/27/2014 15:17,7,0,New FDA approval for Pmab in mCRC gives our patients another treatment option @ ASCOPost http://www.ascopost.com/viewnews.aspx?nid=16258 … | # crcsm # cancer # ASCO14,,@,# # #,4.7137E+17,https://twitter.com/TGeorgeMD/status/471369625184137216,,,,
bayessoft365,5/27/2014 15:13,0,0,On our way to # ASCO14 in a few days. Looking forward to seeing # oncology and # epidemiology colleges in Chicago!,,,# # #,4.71369E+17,https://twitter.com/bayessoft365/status/471368583847497728,,,,
rschilsky,5/27/2014 15:12,2,0,Something to chat about at # ASCO14. See you there! Physician Payment Reform | http://ASCO.org http://www.asco.org/advocacy/physician-payment-reform#.U4TjkQomjak.twitter …,,,# #,4.71368E+17,https://twitter.com/rschilsky/status/471368420185739265,,,,
jonathanagin,5/27/2014 15:09,0,2,@ ASCO looking for the creation for a pediatric hashtag for the conference. http://www.jonathanagin.com,,@,,4.71368E+17,https://twitter.com/jonathanagin/status/471367533157965824,,,,
Sports_bios,5/27/2014 15:09,0,0,Head scratcher action over $ CLVS someone knows something.. the leaky gas of # ASCO14,,,#,4.71367E+17,https://twitter.com/Sports_bios/status/471367494759096321,,,,
SyneosHealth,5/27/2014 15:09,0,0,Discover how INC works with 430+ specialists working exclusively on # oncology clinical trials at # ASCO14 5/30-6/3 http://ow.ly/i/5HQwZ,,,# #,4.71367E+17,https://twitter.com/SyneosHealth/status/471367490128576512,,,,
LurieCancer,5/27/2014 15:05,2,3,"Join the Cancer Survivors' Celebration Walk / 5K in Chicago 6/1! http://www.ascopost.com/issues/april-15,-2014/join-the-21st-annual-cancer-survivors …’-celebration-walk-5k.aspx via @ ASCOPost # ASCO14",,@,#,4.71367E+17,https://twitter.com/LurieCancer/status/471366620225736704,,,,
mtmdphd,5/27/2014 15:05,1,0,"Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xiamR # ASCO14",,@,#,4.71367E+17,https://twitter.com/mtmdphd/status/471366511173861378,,,,
innovpartners,5/27/2014 15:02,0,1,Looking forward to # ASCO2014 -- tweet us @ innovpartners if we'll see you there!,,@,#,4.71366E+17,https://twitter.com/innovpartners/status/471365801979944960,,,,
Novartis,5/27/2014 15:01,8,7,Our # advancedBC team is taking over our Twitter channel on Thursday from 3-4PM EST to conduct a live Q&A! # ASCO14 pic.twitter.com/TFCsaY7cJ6,,,# #,4.71366E+17,https://twitter.com/Novartis/status/471365705699688449,,,,
ASCO,5/27/2014 15:01,9,3,Twitter's role during scientific meetings? http://bit.ly/1mAmiDB # ASCO14 # hcsm CC @ ASCOPost @ RSM2800,,@ @,# #,4.71366E+17,https://twitter.com/ASCO/status/471365677883068416,,,,
carisls,5/27/2014 15:01,3,0,"Clinical trials are delivering on the promise of # personalizedmedicine for both common and rare cancers."" http://goo.gl/mjz882 # ASCO14""",,,# #,4.71366E+17,https://twitter.com/carisls/status/471365651295383554,,,,
Keith_Terry,5/27/2014 15:00,0,0,We're just 3-days away from # ASCO14. Team Genentech will be presenting new data... http://talent.gene.com/go/br6igs # Genentech,,,# #,4.71365E+17,https://twitter.com/Keith_Terry/status/471365233659744256,,,,
EKrolikiewicz,5/27/2014 15:00,0,0,We're just 3-days away from # ASCO14. Team Genentech will be presenting new data... http://talent.gene.com/go/qmck8u # Genentech,,,# #,4.71365E+17,https://twitter.com/EKrolikiewicz/status/471365231461924864,,,,
BCRFcure,5/27/2014 14:57,1,3,RT @ CliffordHudis: Counting down the days to # ASCO14 Looking forward to seeing everyone soon! Nifty planner here: http://iplanner.asco.org/am2014,,@,#,4.71365E+17,https://twitter.com/BCRFcure/status/471364631962066944,,,,
MDigitalLife,5/27/2014 14:56,0,1,RT @ drattai: The Social Oncology Project at # ASCO14 http://mdigitallife.com/socialoncology/ via @ chimoose @ brianreid,,@ @ @,#,4.71364E+17,https://twitter.com/MDigitalLife/status/471364214347804672,,,,
CancerDotNet,5/27/2014 14:55,0,0,Pt summary: Study on potential treatment option for # PVNS neoplastic joint disease # ASCO14 http://bit.ly/1jqnuok,,,# #,4.71364E+17,https://twitter.com/CancerDotNet/status/471363977872949249,,,,
dq2025,5/27/2014 14:54,0,1,"Join me at  # ASCO14 Tweetup"" on May 31st. RSVP at http://twvt.us/ASCO14 # ASCO14 # twvt""",,,# # #,4.71364E+17,https://twitter.com/dq2025/status/471363707792932864,,,,
StomachCancer_,5/27/2014 14:50,0,3,"We will be attending # ASCO2014 this weekend and cannot wait to collaborate with other Advocacy Groups! Chicago, here we come!",,,#,4.71363E+17,https://twitter.com/StomachCancer_/status/471362871910100993,,,,
drdonsdizon,5/27/2014 14:49,0,1,“ @ MaurerStats: Looking 4ward to following # ASCO14 via Twitter this year. # lymsm # gynsm # lymphoma” TY 4 that! DSD @ DrMarkham @ mtmdphd MT,,@ @ @,# # # #,4.71362E+17,https://twitter.com/drdonsdizon/status/471362468611358720,,,,
AJCCancer,5/27/2014 14:48,0,0,RT @ ASCO: Our 'Consolidated Payments for Oncology: Payment Reform to Support Patient-Centered Care for Cancer' http://bit.ly/1iRl3k2,,@,,4.71362E+17,https://twitter.com/AJCCancer/status/471362256203034624,,,,
yzafar,5/27/2014 14:47,10,7,"Are cancer clinical trial patients similar to cancer patients treated in the real world""? http://bit.ly/1oG6Xln # ASCO14 # hsronc""",,,# #,4.71362E+17,https://twitter.com/yzafar/status/471362150045589504,,,,
MaurerStats,5/27/2014 14:46,0,1,Looking forward to following everything at # ASCO14 via @ mtmdphd @ DrMarkham @ drdonsdizon on Twitter this year. # lymsm # gynsm # lymphoma,,@ @ @,# # # #,4.71362E+17,https://twitter.com/MaurerStats/status/471361782309613568,,,,
ProfJHHW,5/27/2014 14:42,0,0,“ @ NatureNews: A revival for a risky cancer therapy? # ASCO14 preview by @ heidiledford http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews …” # ChesterBiomed,,@ @,# #,4.71361E+17,https://twitter.com/ProfJHHW/status/471360708878557184,,,,
falsoguaritore,5/27/2014 14:37,0,0,"@ BayAreaBiotechI @ InnatePharma # ASCO14, just a coincidence, real event is BTD for nivo http://cerealkiller.it/asco-14-prime-impressioni/ …",,@ @,#,4.71359E+17,https://twitter.com/falsoguaritore/status/471359463061217280,,,,
SanofiUS,5/27/2014 14:36,1,2,"RT @ ASCO Those using # ASCO2014, we invite you to use the official tag # ASCO14",,@,# #,4.71359E+17,https://twitter.com/SanofiUS/status/471359260522463232,,,,
CollHuss,5/27/2014 14:31,1,2,Love seeing the twitter buzz about # ASCO14. Good luck to my friends & fmr ASCO colleagues in Chicago this week! # hcsm,,,# #,4.71358E+17,https://twitter.com/CollHuss/status/471358108800139264,,,,
mtmdphd,5/27/2014 14:30,0,1,How to Smartly Use Smartphones to Efficiently Enhance Clinical Practice - Dr. Graham - @ DavidGrahamMD 6/2/14 # ASCO14 Ticked Session,,@,#,4.71358E+17,https://twitter.com/mtmdphd/status/471357711733751808,,,,
ASCO,5/27/2014 14:20,1,2,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.71355E+17,https://twitter.com/ASCO/status/471355258879627265,,,,
EuNGSeqConf,5/27/2014 14:20,0,0,# HCPs: What are the top 5 clinical advances since @ ASCO was founded 50 years ago? http://bit.ly/OVXgCp # ASCO14,,@,# #,4.71355E+17,https://twitter.com/EuNGSeqConf/status/471355235009826817,,,,
LungCancerFaces,5/27/2014 14:15,0,11,Just met up w @ JFreemanDaily IRL in Los Angeles. She stopped here on her way to # ASCO14. Fantastic to see her in person! # LungCancer # LCSM,,@,# # #,4.71354E+17,https://twitter.com/LungCancerFaces/status/471353980010782720,,,,
ASCO,5/27/2014 14:12,0,0,@ NatureNews @ heidiledford Thank you for sharing the # ASCO14 preview.,,@ @,#,4.71353E+17,https://twitter.com/ASCO/status/471353274852200448,,,,
vbarsan,5/27/2014 14:12,0,3,"Science does not operate in a vacuum—it operates in service to society.” Dr.Clifford Hudis @ ASCO""",,@,,4.71353E+17,https://twitter.com/vbarsan/status/471353246783520769,,,,
Roche,5/27/2014 14:10,9,6,"According to the theme of # ASCO14  # Science and Society"""," we've prepared some exciting feature articles: http://ow.ly/xiMKC""",,,# #,4.71353E+17,https://twitter.com/Roche/status/471352764694798336,,,
jim1036,5/27/2014 14:08,0,0,RT @ mtmdphd: MT @ ASCO # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list...,,@ @,#,4.71352E+17,https://twitter.com/jim1036/status/471352230814437376,,,,
ASCO,5/27/2014 14:02,0,0,Plan ahead: Download meeting materials now at http://am.asco.org/arc # ASCO14,,,#,4.71351E+17,https://twitter.com/ASCO/status/471350646751653888,,,,
EncoreBioMed,5/27/2014 14:01,0,0,What's hot at # ASCO14 http://bit.ly/1jXborr,,,#,4.71351E+17,https://twitter.com/EncoreBioMed/status/471350607459414016,,,,
GuneetWalia,5/27/2014 13:59,0,0,"Refinements to disfavored # immunotherapy with IL-2 offer safer, more effective cancer treatment http://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296 … # ASCO14",,,# #,4.7135E+17,https://twitter.com/GuneetWalia/status/471349919366672384,,,,
mtmdphd,5/27/2014 13:59,3,4,How to Use Social Media & Cancer Communities in Clinical Practice - via Dr. Katz ( @ SubAtomicDoc ) - 6/2/14 ticketed session # ASCO14,,@,#,4.7135E+17,https://twitter.com/mtmdphd/status/471349918800838656,,,,
ESchattner,5/27/2014 13:54,3,1,"MT @ rsm2800: Very helpful!--> Connect with # ASCO14 Attendees via Message & Networking Center, @ ASCO - http://bit.ly/1kkTyyZ",,@ @,#,4.71349E+17,https://twitter.com/ESchattner/status/471348805678288897,,,,
mtmdphd,5/27/2014 13:54,2,0,"The Future Is Now: Incorporating EHR, Web-Based Decision & Social Media into Your Practice 4:45 -6p S504 @ FischMD @ Scientre @ mtmdphd # ASCO14",,@ @ @,#,4.71349E+17,https://twitter.com/mtmdphd/status/471348696974897152,,,,
GuneetWalia,5/27/2014 13:46,1,2,New blog covering # LungCancer at the ASCO Annual Meeting launched by @ Boehringer http://asco-2014.boehringer-ingelheim.com/ # NotJustOneDisease # LCSM # ASCO14,,@,# # # #,4.71347E+17,https://twitter.com/GuneetWalia/status/471346822020337664,,,,
genentech,5/27/2014 13:45,7,7,"All life, incl. cancer, speaks the language of biochemistry. Here's a guide from @ Roche in prep for # ASCO2014: http://ow.ly/xj1RX",,@,#,4.71346E+17,https://twitter.com/genentech/status/471346361380917248,,,,
VistaMME,5/27/2014 13:44,0,1,"Hope everyone had a great weekend! We're back in the office, hard at work! Super busy with @ ASCO coming up! # Chicago # meetings # events",,@,# # #,4.71346E+17,https://twitter.com/VistaMME/status/471346276953751552,,,,
brianreid,5/27/2014 13:43,0,2,"# SocOncology: Must-Follow People on Social Media: http://youtu.be/7141YnUsXcY # ASCO14 (You go, @ MTMDPHD, FischMD, @ rsm2800, @ drattai!)",,@ @ @,# #,4.71346E+17,https://twitter.com/brianreid/status/471346089337950208,,,,
NatureNews,5/27/2014 13:42,9,6,A revival for a risky cancer therapy? # ASCO14 preview by @ heidiledfordhttp://www.nature.com/news/old-cancer-drug-gets-fresh-look-1.15296?WT.mc_id=TWT_NatureNews …,,@,#,4.71346E+17,https://twitter.com/NatureNews/status/471345766800576512,,,,
Pathologists,5/27/2014 13:40,0,2,RT @ ASCO: Our 'Consolidated Payments for Oncology: Payment Reform to Support Patient-Centered Care for Cancer' http://bit.ly/1iRl3k2,,@,,4.71345E+17,https://twitter.com/Pathologists/status/471345087390023681,,,,
mtmdphd,5/27/2014 13:30,1,0,MT @ ASCO # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,@,# #,4.71343E+17,https://twitter.com/mtmdphd/status/471342746952032256,,,,
brianreid,5/27/2014 13:24,0,0,"At # ASCO13, we asked luminaries who made the must-follow list: http://bit.ly/1nvZrKj # ASCO14 # SocOncology",,,# # #,4.71341E+17,https://twitter.com/brianreid/status/471341128688889856,,,,
PVonc,5/27/2014 13:23,0,0,What is the role of # SPARC in pancreatic cancer cells? Register now to find out: http://bit.ly/ASCOpancreatic . # ASCO14 # pancsm # hcsmc,,,# # # #,4.71341E+17,https://twitter.com/PVonc/status/471340948304048129,,,,
mtmdphd,5/27/2014 13:20,1,1,Very encouraging Myeloma survival graph - HT @ myelomabeacon http://ow.ly/xiWUG Bergsagel Ed Bk # ASCO14 http://ow.ly/xiX5S # mmsm,,@,# #,4.7134E+17,https://twitter.com/mtmdphd/status/471340132747194368,,,,
NextGenClinical,5/27/2014 13:18,0,0,We hope to see you at # ASCO14! # Chicagopic.twitter.com/Zg1lwQ0qgW,,,# #,4.7134E+17,https://twitter.com/NextGenClinical/status/471339737400504320,,,,
AlpineBV_Miller,5/27/2014 13:17,0,1,"My # sgenball thinks it is time for a pause/break. Sorry, not for another hour or so. # ASCO14 pic.twitter.com/BX56q5P7vO",,,# #,4.71339E+17,https://twitter.com/AlpineBV_Miller/status/471339396231602176,,,,
FierceMedTech,5/27/2014 13:16,1,0,"Editors @ JohnCFierce, @DamianFierce, @ EricPFierce will chat w/ experts, break down # ASCO2014. More here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 …",,@ @DamianFierce @,#,4.71339E+17,https://twitter.com/FierceMedTech/status/471339111778095104,,,,
mtmdphd,5/27/2014 13:05,3,2,MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,@,#,4.71336E+17,https://twitter.com/mtmdphd/status/471336369844154368,,,,
mogeslamet,5/27/2014 13:05,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/MML6dYoWg9 # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71336E+17,https://twitter.com/mogeslamet/status/471336351158128640,,,,
genentech,5/27/2014 13:05,1,1,# OH at # REV2014: “Patients are the key to improving quality care.” - @ stales | We couldn’t agree more: http://ow.ly/xiY4L # ASCO14,,@,# # #,4.71336E+17,https://twitter.com/genentech/status/471336340614021120,,,,
knwachter,5/27/2014 13:04,0,0,pretty interesting RT @ chimoose: RT @ drattai: The Social Oncology Project at # ASCO14 http://bit.ly/1puYXnk,,@ @,#,4.71336E+17,https://twitter.com/knwachter/status/471336196044779520,,,,
jesslamb053,5/27/2014 12:54,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/MzwGM5VU1d,,,# # # # # # # # # # # #,4.71334E+17,https://twitter.com/jesslamb053/status/471333575334187008,,,,
Matheus01717,5/27/2014 12:53,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/FWRWsSTPrR # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71333E+17,https://twitter.com/Matheus01717/status/471333299441242112,,,,
Matheus01717,5/27/2014 12:52,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/KUcXZhrgzR,,,# # # # # # # # # # # #,4.71333E+17,https://twitter.com/Matheus01717/status/471333246119075840,,,,
chimoose,5/27/2014 12:52,0,0,RT @ drattai: The Social Oncology Project at # ASCO14 http://bit.ly/1puYXnk via @ chimoose @ brianreid,,@ @ @,#,4.71333E+17,https://twitter.com/chimoose/status/471333010806411264,,,,
Annals_Oncology,5/27/2014 12:50,1,2,"It's # ASCO14 this week, in Chicago. # Annals will be there, we hope you can stop by and see us http://bit.ly/1ooySJ6",,,# #,4.71333E+17,https://twitter.com/Annals_Oncology/status/471332557100154880,,,,
NorthwestBio,5/27/2014 12:40,0,0,Early positive responses seen in over 50% of DCVax-Direct patients to date; more info available at # ASCO14 http://bit.ly/1tKAEnE -$NWBO,,,#,4.7133E+17,https://twitter.com/NorthwestBio/status/471330151255396352,,,,
subatomicdoc,5/27/2014 12:34,2,0,What # lungcancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # lcsm,,@ @ @ @ @ @,# # # #,4.71329E+17,https://twitter.com/subatomicdoc/status/471328503242432512,,,,
stales,5/27/2014 12:33,0,0,Ready for # ASCO14? @ cam_arnold @ anvillani @ krystadawn @ hkdickson @ EdwardLangJR @ EmmyWang I'll be following your tweets!,,@ @ @ @ @ @,#,4.71328E+17,https://twitter.com/stales/status/471328452646158336,,,,
BCRFcure,5/27/2014 12:30,0,3,Looking fwd to attending/reporting! RT @ CancerDotNet: What is the @ ASCO Annual Meeting? And why is it so important? # ASCO14...,,@ @,#,4.71328E+17,https://twitter.com/BCRFcure/status/471327662347386880,,,,
LungProject,5/27/2014 12:28,0,2,What are you looking forward to at # ASCO14? We can’t wait to hear the developments in # lungcancer! # hcsm # lcsm,,,# # # #,4.71327E+17,https://twitter.com/LungProject/status/471327057784619009,,,,
Larvol,5/27/2014 12:25,0,0,"Our work supports # CancerCare, which is just one of the reasons we’re looking forward to # ASCO14. Will you be there?",,,# #,4.71326E+17,https://twitter.com/Larvol/status/471326349823442944,,,,
ASCO,5/27/2014 12:22,0,0,@pedrazosfroilan Glad to hear that you'll join us for # ASCO14.,,@pedrazosfroilan,#,4.71326E+17,https://twitter.com/ASCO/status/471325701355110400,,,,
boehringerus,5/27/2014 12:20,0,1,BI is looking forward to joining the world’s leading # cancer specialists at # ASCO14,,,# #,4.71325E+17,https://twitter.com/boehringerus/status/471325070229790720,,,,
ASCO,5/27/2014 12:20,1,1,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.71325E+17,https://twitter.com/ASCO/status/471325046745886720,,,,
RS_Flinn,5/27/2014 12:16,0,0,"RT @ fischmd: The @ ASCO iPlanner and iMeeting apps for the iPad are phenomenal, # ASCO14",,@ @,#,4.71324E+17,https://twitter.com/RS_Flinn/status/471324064804794368,,,,
Roche,5/27/2014 12:15,4,5,Ready to mark another year of progress in # CancerCare at # ASCO14? See how far we have already come: http://ow.ly/xiLD2,,,# #,4.71324E+17,https://twitter.com/Roche/status/471323797522771969,,,,
Boehringer,5/27/2014 12:15,0,1,Every patient is different," their disease is as unique as they are..."" read more # lungcancer diagnosis http://bit.ly/1hftXCy # ASCO14""",,,# #,4.71324E+17,https://twitter.com/Boehringer/status/471323783467646977,,,
RS_Flinn,5/27/2014 12:14,0,0,RT @ drattai: The Social Oncology Project at # ASCO14 http://mdigitallife.com/socialoncology/ via @ chimoose @ brianreid,,@ @ @,#,4.71324E+17,https://twitter.com/RS_Flinn/status/471323585576181761,,,,
fafadetalence,5/27/2014 12:14,0,0,@ fischmd @ ASCO a,,@ @,,4.71324E+17,https://twitter.com/fafadetalence/status/471323527166324736,,,,
fafadetalence,5/27/2014 12:14,0,0,@ fischmd @ ASCO -,,@ @,,4.71324E+17,https://twitter.com/fafadetalence/status/471323509495713792,,,,
fafadetalence,5/27/2014 12:14,0,0,@ fischmd @ ASCO,,@ @,,4.71324E+17,https://twitter.com/fafadetalence/status/471323500964478976,,,,
mtmdphd,5/27/2014 12:08,0,0,MT @ myriadgenetics data on 2 studies w/ myPath Melanoma 2 differentiate # melanoma vs benign nevi. http://bit.ly/1qFsz5H # ASCO14 # melsm,,@,# # #,4.71322E+17,https://twitter.com/mtmdphd/status/471321958815383552,,,,
elaineleung,5/27/2014 12:02,0,0,RT @ mtmdphd: Analysis cancer-related Twitter convos physicians 2013 - @ BrianReid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz ”,,@ @,#,4.7132E+17,https://twitter.com/elaineleung/status/471320467685793792,,,,
SequentaInc,5/27/2014 12:02,0,0,3 days ‘til # ASCO14! We're following @ mtmdphd & @ DrMarkham for # lymsm & # mmsm news & checkout @ ASCO’s # hcsm guide http://ow.ly/xbWMc,,@ @ @,# # # #,4.7132E+17,https://twitter.com/SequentaInc/status/471320428959776769,,,,
ASCO,5/27/2014 12:01,5,2,"Those using # ASCO2014, we invite you to use the official tag # ASCO14",,,# #,4.7132E+17,https://twitter.com/ASCO/status/471320301977239552,,,,
myriadgenetics,5/27/2014 12:00,0,1,Myriad's # Prolaris tests provides personalized # risk assessment for men with # prostatecancer. http://bit.ly/1rl1EJd # personalmed # ASCO14,,,# # # # #,4.7132E+17,https://twitter.com/myriadgenetics/status/471319946757017600,,,,
etchare,5/27/2014 11:59,0,0,Endocyte $ ECYT to Present Data # ASCO14 @ ASCO American Society of Clinical Oncology @ McCormick_Place May 30-June 3rd http://finance.yahoo.com/news/endocyte-present-data-ec1456-etarfolatide-200100133.html …,,@ @,#,4.7132E+17,https://twitter.com/etchare/status/471319700442329088,,,,
LindaKnorr,5/27/2014 11:58,0,0,We're just 3-days away from # ASCO14. Team Genentech will be presenting new data... http://talent.gene.com/go/hqt1zm # Genentech,,,# #,4.7132E+17,https://twitter.com/LindaKnorr/status/471319646121910272,,,,
Carpowich,5/27/2014 11:55,0,0,"Cancer care in rural America found to be lacking - & likely to worsen, via Univ of Iowa http://ow.ly/xitTb @ uiowa @ asco # cancerresearch",,@ @,#,4.71319E+17,https://twitter.com/Carpowich/status/471318775409946624,,,,
DrAttai,5/27/2014 11:55,0,1,"let's see how well I can stick to my plan! RT @ fischmd The @ ASCO iPlanner and iMeeting apps for the iPad are phenomenal, # ASCO14",,@ @,#,4.71319E+17,https://twitter.com/DrAttai/status/471318744506335234,,,,
CancerDotNet,5/27/2014 11:50,10,7,What is the @ ASCO Annual Meeting? And why is it so important? # ASCO14 http://bit.ly/1jXc4Nu,,@,#,4.71318E+17,https://twitter.com/CancerDotNet/status/471317522147721217,,,,
mogeslamet,5/27/2014 11:47,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/nKBJzOOiNk,,,# # # # # # # # # # # #,4.71317E+17,https://twitter.com/mogeslamet/status/471316784000167936,,,,
Boehringer,5/27/2014 11:41,2,2,"RT @ ASCO: Those using # ASCO2014, we invite you to use the official tag # ASCO14",,@,# #,4.71315E+17,https://twitter.com/Boehringer/status/471315197295329280,,,,
thorsten_poehl,5/27/2014 11:40,0,0,Esta semana estaremos en # ASCO14 con la presentación de novedades en # cáncer de pulmón. Síguelo: http://am.asco.org/,,,# #,4.71315E+17,https://twitter.com/thorsten_poehl/status/471315136326946816,,,,
Boehringer,5/27/2014 11:40,1,2,Hearing about advances in drug development tops our poll of what u look forward to most @ # ASCO14 Still time to vote http://bit.ly/TAW5Ly,,@,#,4.71315E+17,https://twitter.com/Boehringer/status/471314917765967872,,,,
stefanomjr,5/27/2014 11:39,0,0,"$ CLVS worth a shot on this bounce, ahead of # ASCO14 this weekend. Still long from $51.74 http://screencast.com/t/7MjW7YLwCJ",,,#,4.71315E+17,https://twitter.com/stefanomjr/status/471314768159322112,,,,
Merck,5/27/2014 11:26,4,1,"As we gear up for @ ASCO, we remain focused on innovating ways to help extend & improve the lives of people w/ cancer: http://bit.ly/1puOU1w",,@,,4.71311E+17,https://twitter.com/Merck/status/471311445733683200,,,,
ByJonGardner,5/27/2014 11:16,0,0,The # sgenball is already telling me that # ASCO14 is going to be a difficult five days. $ SGEN,,,# #,4.71309E+17,https://twitter.com/ByJonGardner/status/471308921668661248,,,,
MidAmPrint,5/27/2014 11:15,0,0,"Who is getting packed & ready for # ASCO14? Don't forget to order table tents, fliers, banners & posters locally from @ MidAmPrint in Chicago!",,@,#,4.71309E+17,https://twitter.com/MidAmPrint/status/471308731838627842,,,,
cabsylvia,5/27/2014 11:05,0,0,"@ ChicagosMayor @ RahmEmanuel proclaims June Oncology Month in Chicago"" to honor @ ASCO 's 50th Annual Meeting http://bit.ly/TLmJl4""",,@ @ @,,4.71306E+17,https://twitter.com/cabsylvia/status/471306258595598337,,,,
EncoreBioMed,5/27/2014 11:05,0,0,Three days until # ASCO14 - which presentations are you looking most forward to? # cancer # oncology,,,# # #,4.71306E+17,https://twitter.com/EncoreBioMed/status/471306188098142208,,,,
Consano,5/27/2014 11:03,0,0,"If you will be in Chicago for the # ASCO14 meeting, swing by the http://consano.org table & say hi!"" And grab a pen - win/win!""",,,#,4.71306E+17,https://twitter.com/Consano/status/471305724489134080,,,,
ASCO,5/27/2014 11:02,3,1,"Don't forget to RSVP for the # ASCO14 Tweetup, May 31 in Chicago: http://bit.ly/NvNypj",,,#,4.71306E+17,https://twitter.com/ASCO/status/471305524613767168,,,,
Roche,5/27/2014 10:52,4,3,Check out our # ASCO14 feature articles! http://ow.ly/xiF5e # oncology,,,# #,4.71303E+17,https://twitter.com/Roche/status/471302858680578048,,,,
DrAttai,5/27/2014 10:50,2,1,RT @ BreastOncology Looking forward to # ASCO annual meeting. Will follow # ASCO14 Tweeters http://bit.ly/1lBa5hq # hcsm # bcsm,,@,# # # #,4.71302E+17,https://twitter.com/DrAttai/status/471302338851115009,,,,
FrancieGrace,5/27/2014 10:44,0,1,Also: ask patients what to study RT @ drattai RT @ mtmdphd MT @ ASCO Time to reignite our commitment to cancer research http://ow.ly/sd1bp,,@ @ @,,4.71301E+17,https://twitter.com/FrancieGrace/status/471300795213025280,,,,
inPracticePOC,5/27/2014 10:42,0,1,Heading to Chicago this weekend for # ASCO2014? So is inPractice! Stop by booth 16026 to learn more about inPractice # Oncology!,,,# #,4.71301E+17,https://twitter.com/inPracticePOC/status/471300504371597312,,,,
Boehringer,5/27/2014 10:38,1,1,BLOG POST: Read about the joys&challenges of starting research in # lungcancer in our # notjustonedisease blog http://bit.ly/RwVI2G # ASCO14,,,# # #,4.713E+17,https://twitter.com/Boehringer/status/471299522875121664,,,,
subatomicdoc,5/27/2014 10:34,2,2,What # coloncancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # crcsm,,@ @ @ @ @ @,# # # #,4.71298E+17,https://twitter.com/subatomicdoc/status/471298335199207424,,,,
inversbio,5/27/2014 10:31,0,0,"$ ACAD 3500A5 10 860,92 € $ SGEN 4500I4 65 4.405,36 € $ KERX 2000A5 7 615,47 € $ BDSI 1500L4 65 4.524,42 € # ASCO14",,,#,4.71298E+17,https://twitter.com/inversbio/status/471297671941337088,,,,
ASCO,5/27/2014 10:31,0,0,"Confused about changes to MOC? Attend MOC 101: Orientation to MOC Requirements"" @ # ASCO14 (Mon 6/2"," 4:45-6PM in E354a)""",,@,#,4.71298E+17,https://twitter.com/ASCO/status/471297640408559616,,,
DrAttai,5/27/2014 10:30,0,0,RT @ mtmdphd MT @ ASCO It’s time to reignite our nation’s commitment to # cancer # research. What can you do? http://ow.ly/sd1bp # JACR,,@ @,# # #,4.71297E+17,https://twitter.com/DrAttai/status/471297387794034688,,,,
emmakirton,5/27/2014 10:22,0,1,My flight to Chicago tomorrow is already delayed by an hour. Yay! # ASCO2014 here we come!,,,#,4.71295E+17,https://twitter.com/emmakirton/status/471295402210504704,,,,
DrAttai,5/27/2014 10:20,1,1,Twitter at # ASCO14 http://www.asco.org/about-asco/social-media …,,,#,4.71295E+17,https://twitter.com/DrAttai/status/471294819349065728,,,,
bartkrist,5/27/2014 10:17,0,0,Prof Pinedo gets the American David A Karnofsky Memorial Award. congratulations! #emiritus#professor#VUmc http://connection.asco.org/Magazine/Article/ID/3821/2014-Special-Awards-Honor-Professional-Achievements-Outstanding-Service.aspx … via @ ASCO,,@,#emiritus #professor #VUmc,4.71294E+17,https://twitter.com/bartkrist/status/471294248604540928,,,,
SAKK_ch,5/27/2014 10:17,0,0,"Die SAKK präsentiert ihre Forschungsergebnisse am @ ASCO Meeting, welches vom 30. Mai - 3. Juni in Chicago stattfindet http://bit.ly/1hugDun",,@,,4.71294E+17,https://twitter.com/SAKK_ch/status/471294182158778368,,,,
DanBudwick,5/27/2014 10:16,0,0,Catching up with world traveler @ MikeHuckman - looking forward to seeing him and those of you attending # ASCO14 this weekend!,,@,#,4.71294E+17,https://twitter.com/DanBudwick/status/471293912435666944,,,,
HyattMcCormick,5/27/2014 10:15,0,0,"@ dominiquejessee Welcome back!!As always, let us know if you need anything! # ASCO14",,@,#,4.71294E+17,https://twitter.com/HyattMcCormick/status/471293722156482561,,,,
Novartis,5/27/2014 10:15,0,3,What could pinball & # advancedBC possibly have in common? # comingsoon for the 50th # ASCO14 http://bit.ly/1jHoqub,,,# # #,4.71294E+17,https://twitter.com/Novartis/status/471293680213827585,,,,
Perthera,5/27/2014 10:15,0,0,The Perthera team is ramping up for # ASCO14 Annual Meeting in Chicago this wknd! Join us! Booth #4040! # cancer # genomics # treatment,,,# #4040 # # #,4.71294E+17,https://twitter.com/Perthera/status/471293610970079232,,,,
ConquerCancerFd,5/27/2014 10:12,1,0,RT @ rschilsky: Welcome to Chicago for # ASCO14 and Oncology Month in Chicago as proclaimed by the mayor! http://connection.asco.org/forums/forumid/7/postid/1079/scope/posts.aspx#1079 …,,@,# #1079,4.71293E+17,https://twitter.com/ConquerCancerFd/status/471292909380435968,,,,
DrAttai,5/27/2014 10:10,0,1,Social Oncology Project # ASCO14 via @ chimoose @ brianreid http://mdigitallife.com/socialoncology/,,@ @,#,4.71292E+17,https://twitter.com/DrAttai/status/471292298211651584,,,,
6DegreesPR,5/27/2014 10:09,0,0,"Days before @ ASCO, $ BMY inks $1.24B deal with # CytomX, $ INCY partnership in immuno- # oncology deal frenzy http://www.fiercebiotech.com/story/bristol-myers-adds-348m-deal-plus-partnership-immuno-oncology-deal-frenzy/2014-05-27?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.U4SaEdbNJmc.twitter … # pharma",,@,# # # #,4.71292E+17,https://twitter.com/6DegreesPR/status/471292022167322624,,,,
MaurerStats,5/27/2014 10:08,0,0,RT @ DrMarkham From @ asco & # ASCO14 Education Book: Surveillance Imaging for # Lymphoma: Pros and Cons http://buff.ly/1jKXSID # lymsm,,@ @,# # #,4.71292E+17,https://twitter.com/MaurerStats/status/471291809638125568,,,,
drcbsteer,5/27/2014 10:07,0,0,Clearly not referring to # ASCO14 @ guardian The Boring Conference-the fascinating world of the mundane and ordinary http://gu.com/p/3phy8/tw ”,,@,#,4.71292E+17,https://twitter.com/drcbsteer/status/471291714045353984,,,,
Advaxis,5/27/2014 10:05,0,0,"Be sure to catch our presentation on ADXS-HPV at # ASCO14 on May 31, 2014. http://bit.ly/1sONQHO $ ADXS",,,#,4.71291E+17,https://twitter.com/Advaxis/status/471290982214811648,,,,
Boehringer,5/27/2014 10:04,58,130,"# PRESS: brush up on your # lungcancer knowledge ahead of # ASCO14 - Find infographics, videos & more here http://bit.ly/1otvvQM",,,# # #,4.71291E+17,https://twitter.com/Boehringer/status/471290916092014592,,,,
mtmdphd,5/27/2014 10:02,0,0,Digital Product and Resource Tutorials for # ASCO14 http://ow.ly/xgIKw HT @ rschilsky,,@,#,4.7129E+17,https://twitter.com/mtmdphd/status/471290271477813248,,,,
greendreamangel,5/27/2014 10:01,0,0,@ mtmdphd Maybe your conference can address the gross overuse of hashtags. By medical tweeters. @ rsm2800 # ASCO14,,@ @,#,4.7129E+17,https://twitter.com/greendreamangel/status/471290072248360960,,,,
DrAttai,5/27/2014 10:00,1,1,The Social Oncology Project at # ASCO14 http://mdigitallife.com/socialoncology/ via @ chimoose @ brianreid,,@ @,#,4.7129E+17,https://twitter.com/DrAttai/status/471289910646013952,,,,
cardinalhealth,5/27/2014 9:59,2,0,"New research at # ASCO14, # ISPORMontreal shows our Clinical Pathways hit “triple aim of healthcare.” Learn more:http://bit.ly/1jWFpra",,,# #,4.7129E+17,https://twitter.com/cardinalhealth/status/471289565131853825,,,,
harrisonandstar,5/27/2014 9:50,0,0,Watch ASCO's 2014 Annual Meeting Video Overview to find out what will be happening this year # ASCO14 http://ow.ly/wFoni,,,#,4.71287E+17,https://twitter.com/harrisonandstar/status/471287302694928384,,,,
MaverickNY,5/27/2014 9:49,1,1,@ mtmdphd @ ASCO @ rsm2800 I ruthlessly block the spammers and then they disappear in the hashtag search,,@ @ @,,4.71287E+17,https://twitter.com/MaverickNY/status/471287144011825153,,,,
ScripAlexS,5/27/2014 9:48,0,1,"RT @ ASCO: Those using # ASCO2014, we invite you to use the official tag # ASCO14",,@,# #,4.71287E+17,https://twitter.com/ScripAlexS/status/471286907889283072,,,,
AlpineBV_Miller,5/27/2014 9:46,0,0,@ mtmdphd Using a Twitter client like @ HootSuite really helps because you can filter them out of the feed. # ASCO14,,@ @,#,4.71286E+17,https://twitter.com/AlpineBV_Miller/status/471286428702609411,,,,
ethan_hunt999,5/27/2014 9:46,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/YGYODGmtR9,,,# # # # # # # # # # # #,4.71286E+17,https://twitter.com/ethan_hunt999/status/471286217674199040,,,,
3NT,5/27/2014 9:45,0,0,Looks like there's interesting Multiple Myeloma data at # ASCO14. Subs can read @ MaverickNY preview http://3nt.co/1puyWo7,,@,#,4.71286E+17,https://twitter.com/3NT/status/471286115476185089,,,,
myriadgenetics,5/27/2014 9:45,2,2,Myriad will present data on 2 studies with myPath Melanoma test to differentiate # melanoma from benign nevi. http://bit.ly/1qFsz5H # ASCO14,,,# #,4.71286E+17,https://twitter.com/myriadgenetics/status/471285947384872960,,,,
mtmdphd,5/27/2014 9:43,2,2,Please help crowdsource to clean up the spam/porn/promotions using # ASCO14. Improve signal-to-noise ratio. cc: @ ASCO @ rsm2800,,@ @,#,4.71286E+17,https://twitter.com/mtmdphd/status/471285590995251200,,,,
BiotechStrategy,5/27/2014 9:42,0,0,ASCO 2014 Multiple Myeloma Preview via @ MaverickNY # ASCO14 http://biotechstrategyblog.com/2014/05/asco-2014-multiple-myeloma-preview-asco14.html/ …,,@,#,4.71285E+17,https://twitter.com/BiotechStrategy/status/471285416323084288,,,,
mtmdphd,5/27/2014 9:41,1,2,MT @ rsm2800 If tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,@,#,4.71285E+17,https://twitter.com/mtmdphd/status/471285071690104832,,,,
bioclinica,5/27/2014 9:39,0,0,See you at the ASCO 50th Annual Meeting this week. Stop by and visit us at booth 6109. # oncology # ASCO14 http://fb.me/6RitKw9hd,,,# #,4.71285E+17,https://twitter.com/bioclinica/status/471284616838803457,,,,
PDRennert,5/27/2014 9:37,0,0,"Exciting morning, getting us pumped up for # ASCO14 http://www.sugarconebiotech.com/?p=644",,,#,4.71284E+17,https://twitter.com/PDRennert/status/471283955824885761,,,,
DrNeilLove,5/27/2014 9:30,0,0,Still time to register for our 4 unique CME offerings this coming weekend in Chicago in conjunction with # ASCO14 http://www.researchtopractice.com/upcoming-events,,,#,4.71282E+17,https://twitter.com/DrNeilLove/status/471282279038582784,,,,
FierceBiotech,5/27/2014 9:29,2,0,"Editors @ JohnCFierce, @DamianFierce, @ EricPFierce will chat w/ experts, break down # ASCO2014. More here: http://www.fiercebiotech.com/pages/fiercebiotech-twitter-chat-asco-2014 … # FierceASCO",,@ @DamianFierce @,# #,4.71282E+17,https://twitter.com/FierceBiotech/status/471281936217174016,,,,
OncEd,5/27/2014 9:09,0,0,Visit us at booth 5046 at # ASCO14,,,#,4.71277E+17,https://twitter.com/OncEd/status/471276939769307136,,,,
scientre,5/27/2014 9:07,0,0,"Cc @ ADC_drugs MT @ PDRennert preliminary ADC roundup for # ASCO14. Most abbrv self-explanatory, but feel free DM pic.twitter.com/ZLcwQLl2R9",,@ @,#,4.71277E+17,https://twitter.com/scientre/status/471276502106275840,,,,
scientre,5/27/2014 9:07,1,1,# ASCO14 first! MT @ BioForward MT @ gdecd Just noticed that # BIO2014 is exactly a month away.,,@ @,# #,4.71276E+17,https://twitter.com/scientre/status/471276446858903553,,,,
karmamiu,5/27/2014 9:06,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/NifA34XNrA,,,# # # # # # # # # # # #,4.71276E+17,https://twitter.com/karmamiu/status/471276360296431616,,,,
marcsouthern,5/27/2014 9:05,0,2,MT @ nxtstop1: SMART ID! @ ASCO: Add your Twitter Handle to your 2014 ASCO Annual Meeting Badge: http://bit.ly/1k49xiQ # ASCO14 # health2eu,,@ @,# #,4.71276E+17,https://twitter.com/marcsouthern/status/471276028988755969,,,,
SequentaInc,5/27/2014 9:01,0,0,Excited # ASCO14 is almost here! Sequenta (booth 18152) presenting data related to # lymphoma & # immunotherapy http://ow.ly/xbW94 # lymsm,,,# # # #,4.71275E+17,https://twitter.com/SequentaInc/status/471275107307241472,,,,
YaleMed,5/27/2014 8:57,1,1,RT @ YaleCancer: YCC experts are involved in more than 25 # ASCO14 presentations or posters. See our tip sheet: http://www.yalecancercenter.org/news/article.aspx?id=7493 …,,@,#,4.71274E+17,https://twitter.com/YaleMed/status/471274009955688449,,,,
Elodiaoza,5/27/2014 8:56,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/IVONV2Ogno # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71274E+17,https://twitter.com/Elodiaoza/status/471273830866886656,,,,
LurieCancer,5/27/2014 8:56,2,2,"Join @ rsm2800 @ obogler & @ mtmdphd for Internet, Social Media, Privacy Regulations & ClinicalTrials: Mon 6/2-1:15-2:30 pm in S504 # ASCO14",,@ @ @,#,4.71274E+17,https://twitter.com/LurieCancer/status/471273757332361218,,,,
emmakirton,5/27/2014 8:55,0,0,Who's going to # ASCO2014? What about you @ tyrone_dinky?,,@,#,4.71273E+17,https://twitter.com/emmakirton/status/471273392029831168,,,,
tinypasscontent,5/27/2014 8:53,0,0,"ASCO 2014 Multiple Myeloma Preview # ASCO14"" http://ift.tt/1mksxcJ # BiotechStrategy # tinypass # paidcontent ""The ASCO 2014 annual meeti...""",,,# # # #,4.71273E+17,https://twitter.com/tinypasscontent/status/471272873064407040,,,,
CancerDotNet,5/27/2014 8:50,3,2,Advocates: Planning your trip to Chicago? Book airport shuttle services in advance here & save $ # ASCO14 http://bit.ly/1mko9uz,,,#,4.71272E+17,https://twitter.com/CancerDotNet/status/471272172347211776,,,,
BoehringerES,5/27/2014 8:48,1,2,"El viernes estaremos en la 50edición de # ASCO14, el mayor evento científico internacional sobre # cancer http://bit.ly/1m1U03b # OncologiaBIE",,,# # #,4.71272E+17,https://twitter.com/BoehringerES/status/471271838547709952,,,,
AhmedSamyezz,5/27/2014 8:48,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/394m73ea6t # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71272E+17,https://twitter.com/AhmedSamyezz/status/471271662973747200,,,,
mtmdphd,5/27/2014 8:45,0,0,Here's how to add your Twitter Handle to your 2014 ASCO Annual Meeting Badge: http://bit.ly/1k49xiQ # ASCO14 # hcsm,,,# #,4.71271E+17,https://twitter.com/mtmdphd/status/471270955525111809,,,,
Chiltern_CRO,5/27/2014 8:44,0,0,Meet Chiltern at # ASCO14 50th annual meeting: http://am.asco.org/,,,#,4.71271E+17,https://twitter.com/Chiltern_CRO/status/471270703967117313,,,,
myESMO,5/27/2014 8:38,1,0,Will you be attending # ASCO14? So will we! Please drop by our booth nr 3053 http://ow.ly/xif1C pic.twitter.com/jpCAxrrYXd,,,#,4.71269E+17,https://twitter.com/myESMO/status/471269230982471680,,,,
Elodiaoza,5/27/2014 8:32,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/pQfv2MXOA2,,,# # # # # # # # # # # #,4.71268E+17,https://twitter.com/Elodiaoza/status/471267663927209984,,,,
Chiltern_CRO,5/27/2014 8:31,0,0,"# Chiltern will be @ ASCO Chicago, IL 30 May - 03 June. Meet Dr. Newel, Kathy S. and Denise E.",,@,#,4.71268E+17,https://twitter.com/Chiltern_CRO/status/471267571853840384,,,,
EEEGR,5/27/2014 8:28,0,0,@ ASCO acquires majority interest in Bonnie Rock Transport. http://ow.ly/xietG,,@,,4.71267E+17,https://twitter.com/EEEGR/status/471266738215350272,,,,
teamoncology,5/27/2014 8:24,3,0,米国臨床腫瘍学会 年次総会がこの週末から始まります。テーマは社会と科学です。 # ASCO2014 http://fb.me/1fIXyGN9Z,,,#,4.71266E+17,https://twitter.com/teamoncology/status/471265757213376512,,,,
teamoncology,5/27/2014 8:23,5,2,ASCO Annual Meeting will start this weekend. Theme “Science and Society.” # ASCO2014 http://journals.lww.com/oncology-times/Fulltext/2014/05250/ASCO14_Sneak_Peek___Relating_the_Science_of.1.aspx …,,,#,4.71265E+17,https://twitter.com/teamoncology/status/471265374055317504,,,,
yzafar,5/27/2014 8:20,0,0,Are we justified in excluding patients with prior # cancers from clinical trials? http://bit.ly/1tg8BdB # ASCO14 # hsronc,,,# # #,4.71265E+17,https://twitter.com/yzafar/status/471264590056013824,,,,
dytcmd,5/27/2014 8:17,4,2,"Final result on best"" try 2 show benefit of adj chemo 4 MIBC"," but unfort poor acrual & underpowered http://abstracts.asco.org/144/AbstView_144_130351.html … # blcsm # ASCO14""",,,# #,4.71264E+17,https://twitter.com/dytcmd/status/471263801376264192,,,
Kamalrahman73,5/27/2014 8:15,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/o021GuFH2y # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71263E+17,https://twitter.com/Kamalrahman73/status/471263364887216128,,,,
mass_83,5/27/2014 8:11,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/IfSz2GBMUz # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71263E+17,https://twitter.com/mass_83/status/471262500676059136,,,,
bradloncar,5/27/2014 8:07,0,6,Give $ TSRO credit for webcasting their # ASCO14 briefing on Sunday night. Not everybody does. http://stks.co/r0MrJ,,,#,4.71261E+17,https://twitter.com/bradloncar/status/471261348459188226,,,,
BMTjunkie,5/27/2014 8:06,0,0,Myeloma is becoming a chronic disease: continuous tx better than fixed duration in newly diagnosed patients # ASCO14 http://meetinglibrary.asco.org/content/128803-144#.U4R_M4t7PMM.twitter …,,,# #,4.71261E+17,https://twitter.com/BMTjunkie/status/471261063837532160,,,,
AhmedSamyezz,5/27/2014 8:00,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/DyOqCbexNN,,,# # # # # # # # # # # #,4.7126E+17,https://twitter.com/AhmedSamyezz/status/471259598599385088,,,,
mtmdphd,5/27/2014 7:58,4,1,MT @ disparityreport: Why it's so difficult to enroll patients to # clinicaltrials http://bit.ly/1k6cNMC # ASCO14,,@,# #,4.71259E+17,https://twitter.com/mtmdphd/status/471259055898787840,,,,
PDRennert,5/27/2014 7:43,4,5,The Hammer Stock blog is out with a free # ASCO14 preview (thx Ohad!). http://www.orf-blog.com/drugs-to-watch-at-asco-2014/ …,,,#,4.71255E+17,https://twitter.com/PDRennert/status/471255436432523264,,,,
Boehringer,5/27/2014 7:35,1,1,# HCPs: What are the top 5 clinical advances since @ ASCO was founded 50 years ago? http://bit.ly/OVXgCp # ASCO14,,@,# #,4.71253E+17,https://twitter.com/Boehringer/status/471253279817879552,,,,
ByJonGardner,5/27/2014 7:31,0,0,"Oh, # sgenball, I implore you: What should I have for lunch? # asco14 $ SGEN",,,# #,4.71252E+17,https://twitter.com/ByJonGardner/status/471252352591462400,,,,
jagasquet,5/27/2014 7:28,5,1,# ASCO14: Experimental drug # veliparib (ABT-888) has potential for BRCA-linked # breastcancer @ cityofhope http://breakthroughs.cityofhope.org/asco-drug-breast-cancer-brca …,,@,# # #,4.71252E+17,https://twitter.com/jagasquet/status/471251684035817472,,,,
nxtstop1,5/27/2014 7:25,0,0,# ASCO14 TALK @ FierceBiotech:Thurs @ JohnCFierce & @ PennMedicine's David Porter discuss # ASCO14 Follow # FierceASCO 3:30 EST.Sponsor: @ Covance.,,@ @ @ @,# # #,4.71251E+17,https://twitter.com/nxtstop1/status/471250723921858560,,,,
rsm2800,5/27/2014 7:22,3,2,Very helpful!--> Connect with Annual Meeting Attendees with New Meeting Message and Networking Center http://connection.asco.org/Magazine/Article/ID/3878/Connect-with-Annual-Meeting-Attendees-with-New-Meeting-Message-and-Networking-Center.aspx … # ASCO14,,,#,4.7125E+17,https://twitter.com/rsm2800/status/471250128586551297,,,,
FierceBiotech,5/27/2014 7:16,1,2,"Thursday, @ JohnCFierce and @ PennMedicine's David Porter will chat, break down # ASCO2014. Follow # FierceASCO at 3:30 EST. Sponsor: @ Covance.",,@ @ @,# #,4.71249E+17,https://twitter.com/FierceBiotech/status/471248626870931456,,,,
nxtstop1,5/27/2014 7:14,0,0,EDU=SOCIAL @ ASCO: # ASCO14 Meeting Message&Networking Center:Connect via direct messaging & in-person network opportun. http://bit.ly/1fEIRHb,,@,#,4.71248E+17,https://twitter.com/nxtstop1/status/471248041563811841,,,,
nxtstop1,5/27/2014 7:12,1,0,SMART ID! @ ASCO: Here's how to add your Twitter Handle to your 2014 ASCO Annual Meeting Badge: http://bit.ly/1k49xiQ # ASCO14 # hcsm”,,@,# #,4.71247E+17,https://twitter.com/nxtstop1/status/471247480613396480,,,,
BairdAM,5/27/2014 6:49,0,0, @ ASCO: Those using # ASCO2014," we invite you to use the official tag # ASCO14""""",,@,# #,4.71242E+17,https://twitter.com/BairdAM/status/471241819125055488,,,
BairdAM,5/27/2014 6:48,0,1," @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm""""",,@,# #,4.71242E+17,https://twitter.com/BairdAM/status/471241641156542465,,,,
drdonsdizon,5/27/2014 6:16,0,0,Incidence of severe pain assoc w Pegfilgrastim= 30%. s/o from @ schwartz_joanna congrats on @ ASCO abstract http://meetinglibrary.asco.org/content/130880-144 …,,@ @,,4.71233E+17,https://twitter.com/drdonsdizon/status/471233365866471424,,,,
rdys_,5/27/2014 6:11,1,0,@ _SEOM pone a disposición de los periodistas y de sus socios las principales novedades presentadas en @ ASCO http://ow.ly/xhYCH,,@ @,,4.71232E+17,https://twitter.com/rdys_/status/471232152794050560,,,,
Elekta,5/27/2014 5:31,1,0,We look forward to seeing you at # ASCO14 in Chicago to discuss how Elekta can be part of a strategic solution for your # oncology practice.,,,# #,4.71222E+17,https://twitter.com/Elekta/status/471222031644909568,,,,
IksudaT,5/27/2014 5:25,0,0,Our Commercial Director Ian Evetts will attend @ ASCO Annual Meeting on May 30-June 3 at McCormick Place Chicago http://www.glythera.com/news-events/upcoming-events …,,@,,4.71221E+17,https://twitter.com/IksudaT/status/471220731842686976,,,,
ByJonGardner,5/27/2014 5:05,0,0,The # sgenball is currently balanced on my keyboard ... watching me. Watching me. http://ow.ly/xhRSh # asco14,,,# #,4.71216E+17,https://twitter.com/ByJonGardner/status/471215569828843520,,,,
ByJonGardner,5/27/2014 5:03,0,0,The # sgenball obviously has magical qualities. It managed to cross an ocean inside a box that was *inside a box*! # asco14,,,# #,4.71215E+17,https://twitter.com/ByJonGardner/status/471215134455902208,,,,
ByJonGardner,5/27/2014 5:01,0,1,I wonder if there's a way to start a # sgenball stream for # asco14. I envision something like 3 Wolf Moon on Amazon. http://ow.ly/xhRlx,,,# #,4.71215E+17,https://twitter.com/ByJonGardner/status/471214558913515520,,,,
Roche,5/27/2014 4:40,5,2,RT @ ASCO: # ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,@,# #,4.71209E+17,https://twitter.com/Roche/status/471209192309915648,,,,
DrHealeyBird,5/27/2014 4:34,0,0,Looking forward to lymphoma and GI sessions # ASCO14,,,#,4.71208E+17,https://twitter.com/DrHealeyBird/status/471207868340142080,,,,
BIGagainstBC,5/27/2014 4:23,0,0,This week at # ASCO14 - Dr. Martine Piccart will present first results from the phase III ALTTO trial: http://abstracts.asco.org/144/index.html,,,#,4.71205E+17,https://twitter.com/BIGagainstBC/status/471204927344500736,,,,
ByJonGardner,5/27/2014 3:56,1,0,On the left: the package. In the middle: the package inside the package. On the right: the metal ball. # asco14 $ SGENpic.twitter.com/s4D8SS1gJ0,,,#,4.71198E+17,https://twitter.com/ByJonGardner/status/471198237278609408,,,,
merck_es,5/27/2014 3:45,0,0,# ASCO2014: Nuevos datos muestran beneficios con Erbitux en supervivencia en un tipo de # cáncercolorrectal http://ow.ly/xhGRO,,,# #,4.71195E+17,https://twitter.com/merck_es/status/471195395830595584,,,,
LeemFrance,5/27/2014 3:30,13,1,"# Cancer : Du 30 mai au 3 juin, retrouvez les présentations des médecins-chercheurs de @ GustaveRoussy # ASCO14 http://bit.ly/1noP5OZ",,@,# #,4.71192E+17,https://twitter.com/LeemFrance/status/471191628145647617,,,,
EIannelli,5/27/2014 2:46,2,2,@ ASCO's 50th Mtg learn more abt the last 50 yrs & what's to come in # cancerprogress & # cancersurvivorship # asco14 @ favo_it @ InsControCancro,,@ @ @,# # #,4.71181E+17,https://twitter.com/EIannelli/status/471180544999690240,,,,
cutedrishti8,5/27/2014 2:17,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/nfGEudW3pz,,,# # # # # # # # # # # #,4.71173E+17,https://twitter.com/cutedrishti8/status/471173342100086785,,,,
kailashp67001,5/27/2014 2:05,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/yaXwTeWuk8,,,# # # # # # # # # # # #,4.7117E+17,https://twitter.com/kailashp67001/status/471170227409911809,,,,
braincancer_AU,5/27/2014 0:38,1,0,"We'll watch for # braincancer news # ASCO14 RT @ theIBTA We will soon be heading to # ASCO14, drop by and see us at patient advocacy booth #3005",,@,# # # #3005,4.71148E+17,https://twitter.com/braincancer_AU/status/471148397802446848,,,,
_vTg_,5/27/2014 0:29,0,1,Mega-meeting embraces technology MT @ ASCO: How to add your Twitter Handle to your 2014 ASCO Meeting Badge: http://bit.ly/1k49xiQ # ASCO14,,@,#,4.71146E+17,https://twitter.com/_vTg_/status/471146117116088321,,,,
Anniecantoo,5/26/2014 23:55,0,1,@ WEHI_research @CureCancerAust @ ASCO # thisiscantoo Everyone @ CanTooRunSwim will be really interested,,@ @CureCancerAust @ @,#,4.71138E+17,https://twitter.com/Anniecantoo/status/471137712888479744,,,,
MerfeKe,5/26/2014 22:21,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/JIczupNOy2,,,# # # # # # # # # # # #,4.71114E+17,https://twitter.com/MerfeKe/status/471113902483206145,,,,
yzafar,5/26/2014 22:16,3,3,"In subset of # pancreaticcancer patients, second-line ruxolitinib + capecitabine improve OS http://bit.ly/1tg5DGb # ASCO14 # pancsm",,,# # #,4.71113E+17,https://twitter.com/yzafar/status/471112565943463936,,,,
HendHalawy,5/26/2014 22:10,0,4,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/YsLpIPXIvw # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.71111E+17,https://twitter.com/HendHalawy/status/471111261963304960,,,,
HendHalawy,5/26/2014 22:05,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/NCnXoEb2jr,,,# # # # # # # # # # # #,4.7111E+17,https://twitter.com/HendHalawy/status/471109799455633408,,,,
33charts,5/26/2014 21:44,0,0,"“ @ fischmd: The @ ASCO iPlanner and iMeeting apps for the iPad are phenomenal, # ASCO14”",,@ @,#,4.71105E+17,https://twitter.com/33charts/status/471104546153172993,,,,
Pharmaspectra,5/26/2014 21:44,0,0,"FYI. @ FierceBiotech Thu., @ JohnCFierce and David Porter of @ PennMedicine will chat, break down # ASCO2014. Follow # FierceASCO at 3:30 EST.",,@ @ @,# #,4.71105E+17,https://twitter.com/Pharmaspectra/status/471104509620813824,,,,
fischmd,5/26/2014 21:29,2,2,"The @ ASCO iPlanner and iMeeting apps for the iPad are phenomenal, # ASCO14",,@,#,4.71101E+17,https://twitter.com/fischmd/status/471100780192497665,,,,
ASCO,5/26/2014 21:00,5,6,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.71094E+17,https://twitter.com/ASCO/status/471093597425913857,,,,
markaorourke,5/26/2014 20:13,1,1,"Venlafaxine for hot flashes http://bit.ly/1waN5eO V reduced hot flashes by half in study, less in my experience. # bcsm # swogonc # ASCO14",,,# # #,4.71082E+17,https://twitter.com/markaorourke/status/471081671195107328,,,,
szusmani,5/26/2014 20:12,0,0,@ VincentRK absolutely Vincent. Are you coming to # ASCO2014?,,@,#,4.71081E+17,https://twitter.com/szusmani/status/471081481788723200,,,,
OncNursingNews,5/26/2014 19:05,4,2,Caught our eye: what doctors tweet about when they tweet about cancer via @ KevinMD http://ow.ly/x79Z0 # ASCO14 # bcsm,,@,# #,4.71065E+17,https://twitter.com/OncNursingNews/status/471064564810129408,,,,
Advaxis,5/26/2014 19:00,0,0,We look forward to presenting on ADXS-HPV at the upcoming # ASCO14! $ ADXS,,,#,4.71063E+17,https://twitter.com/Advaxis/status/471063262096654337,,,,
CancerDotNet,5/26/2014 18:35,0,0,Early research from # ASCO14 shows a targeted therapy may shrink worsening # NSCLC w/ less side effects # lcsm http://bit.ly/1k1k2QW,,,# # #,4.71057E+17,https://twitter.com/CancerDotNet/status/471056992111697920,,,,
DrMarkham,5/26/2014 18:14,0,1,"So much work to do before # asco14, but I'll be ready!",,,#,4.71052E+17,https://twitter.com/DrMarkham/status/471051871113601025,,,,
DoctorEdny,5/26/2014 18:10,0,0,Hitting up the Midwest early before # ASCO14 begins @ indyindians @ SunKingBrewing # MemorialDay # baseballpic.twitter.com/Meh6z07lXo,,@ @,# # #,4.71051E+17,https://twitter.com/DoctorEdny/status/471050851952640001,,,,
EquicareHealth,5/26/2014 18:10,0,0,RT @ asco: Our # Cancer # Survivorship Compendium: tools & resources to implement or improve survivorship care http://bit.ly/1oal4BJ,,@,# #,4.71051E+17,https://twitter.com/EquicareHealth/status/471050725905432576,,,,
DrAdamMurphy,5/26/2014 18:04,0,1,# ProstateCancer: No benefit to immediately starting ADT after PSA-only relapse http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/post.aspx?blogId=9&postId=102 … # ASCO14,,,# #,4.71049E+17,https://twitter.com/DrAdamMurphy/status/471049173215633408,,,,
theIBTA,5/26/2014 17:14,0,1,"We will soon be heading to # ASCO14, drop by and see us at patient advocacy booth #3005! CNS abstracts here http://abstracts.asco.org/144/index.html",,,# #3005,4.71037E+17,https://twitter.com/theIBTA/status/471036636260605952,,,,
UrologyMatch,5/26/2014 16:16,0,0,"“ @ mtmdphd: Also # ASCO14 Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xgklp -> to increase signal-to-noise”",,@ @,#,4.71022E+17,https://twitter.com/UrologyMatch/status/471022165819523072,,,,
FierceBiotech,5/26/2014 16:15,0,3,"Thursday, @ JohnCFierce and David Porter of @ PennMedicine will chat, break down # ASCO2014. Follow # FierceASCO at 3:30 EST. Sponsor: @ Covance.",,@ @ @,# #,4.71022E+17,https://twitter.com/FierceBiotech/status/471021916875403264,,,,
christinemphmd,5/26/2014 15:57,0,1,Reading through the # ASCO14 program preview and already getting pretty excited for the annual meeting this week. @ ASCO # chicago,,@,# #,4.71017E+17,https://twitter.com/christinemphmd/status/471017330345279488,,,,
ASCO,5/26/2014 15:57,12,6,"Those using # ASCO2014, we invite you to use the official tag # ASCO14",,,# #,4.71017E+17,https://twitter.com/ASCO/status/471017191241166848,,,,
DianeRadfordMD,5/26/2014 15:53,0,0,"@ Mom2TLE thanks, you too @ ASCO @ elocio @ HeartRumbles @ CBaileyMD",,@ @ @ @ @,,4.71016E+17,https://twitter.com/DianeRadfordMD/status/471016356381741056,,,,
Boehringer,5/26/2014 15:50,2,1,POLL: What do you most look forward to at @ ASCO 2014? Take part in our poll http://bit.ly/TAW5Ly # ASCO14,,@,#,4.71015E+17,https://twitter.com/Boehringer/status/471015479445041152,,,,
rsm2800,5/26/2014 15:42,1,0,+1 RT @ rschilsky: Welcome to Chicago for # ASCO14 and Oncology Month in Chicago as proclaimed by the mayor! http://connection.asco.org/forums/forumid/7/postid/1079/scope/posts.aspx#1079 …,,@,# #1079,4.71013E+17,https://twitter.com/rsm2800/status/471013454577270784,,,,
fischmd,5/26/2014 15:22,5,2,Please add your Twitter handle to your 2014 @ ASCO Annual Meeting Badge: Here's how http://bit.ly/1k49xiQ # ASCO14,,@,#,4.71008E+17,https://twitter.com/fischmd/status/471008495480090624,,,,
IrPsych,5/26/2014 15:18,0,1,"@ mitwittle @ JBBC @ ASCO @ chris1mcb Yep, thanks Marie. 'Tis good. I actually tweeted it last week, but didn't add any names to it. Apologies.",,@ @ @ @,,4.71007E+17,https://twitter.com/IrPsych/status/471007417036443648,,,,
mitwittle,5/26/2014 15:15,0,1,This is a terrific resource! Thank you Marie! RT @ ASCO: Our # Cancer # Survivorship Compendium http://bit.ly/1oal4BJ http://fb.me/6vMbHi0oX,,@,# #,4.71007E+17,https://twitter.com/mitwittle/status/471006634710290432,,,,
mitwittle,5/26/2014 15:12,0,0,@ JBBC @ ASCO @ chris1mcb @ IrPsych Thanks so much Marie.,,@ @ @ @,,4.71006E+17,https://twitter.com/mitwittle/status/471006081049976833,,,,
rsm2800,5/26/2014 15:06,17,10,"Join me & @ obogler @ mtmdphd for Internet, Social Media, Privacy Regulations, and Clinical Trials on Mon 6/2, 1:15-2;30 pm in S504 # ASCO14",,@ @,#,4.71005E+17,https://twitter.com/rsm2800/status/471004568550383616,,,,
EquicareHealth,5/26/2014 15:05,0,1,"Can't wait for # ASCO2014 - we'll be at booth 4026, and following these tweeters http://ow.ly/xgx2T Who else will be there? @ ASCO",,@,#,4.71004E+17,https://twitter.com/EquicareHealth/status/471004160406847488,,,,
medbiomarketing,5/26/2014 15:05,1,0,"Taking Lung # Cancer Treatment to the ‘Next Level’, new research being presented at # asco14 http://ow.ly/3kTbTG",,,# #,4.71004E+17,https://twitter.com/medbiomarketing/status/471004154954260480,,,,
EKrolikiewicz,5/26/2014 15:00,0,0,"With # ASCO2014 approaching, we wanted to see what kids today thought of when ask... http://talent.gene.com/go/9-o4yc # Genentech",,,# #,4.71003E+17,https://twitter.com/EKrolikiewicz/status/471002841989931008,,,,
FlynMonKey33,5/26/2014 14:58,0,0,Can't wait! Excited to attend the new Heme pre-conference sessions!! # ASCO14,,,#,4.71002E+17,https://twitter.com/FlynMonKey33/status/471002416167809025,,,,
rschilsky,5/26/2014 14:48,12,4,Welcome to Chicago for # ASCO14 and Oncology Month in Chicago as proclaimed by the mayor! http://connection.asco.org/forums/forumid/7/postid/1079/scope/posts.aspx#1079 …,,,# #1079,4.71E+17,https://twitter.com/rschilsky/status/470999854374600704,,,,
ASCO,5/26/2014 14:35,3,3,Here's how to add your Twitter Handle to your 2014 ASCO Annual Meeting Badge: http://bit.ly/1k49xiQ # ASCO14 # hcsm,,,# #,4.70997E+17,https://twitter.com/ASCO/status/470996617781579778,,,,
jagasquet,5/26/2014 14:24,1,0,SEOM retransmitirá en español los Highlights de # ASCO14 http://shar.es/VeECQ vía @ _SEOM,,@,#,4.70994E+17,https://twitter.com/jagasquet/status/470993817249017856,,,,
jagasquet,5/26/2014 14:22,4,1,What’s in Store at # ASCO14? Kantar Health Offers a Preview http://obroncology.com/obrgreen/article/Whats-in-Store-at-ASCO-2014#sthash.9QYEVd0v.dpuf …pic.twitter.com/art1duNVZt,,,# #sthash,4.70994E+17,https://twitter.com/jagasquet/status/470993513535242240,,,,
innovpartners,5/26/2014 14:11,0,0,"NEW BioBlog Weekly: @ ASCO CancerLinQ, Payment Reform, and Personalized Cancer Treatment http://buff.ly/1h3qCfx",,@,,4.70991E+17,https://twitter.com/innovpartners/status/470990502377299968,,,,
JaneyBusby,5/26/2014 14:09,3,2,We KNOW @ 4Nathalie can beat back rare cancer w/the help of immunotherapy meds! # CompassionateUse # PDL1 # ASCO14 RT pic.twitter.com/tcsr7BXEfH,,@,# # #,4.7099E+17,https://twitter.com/JaneyBusby/status/470990222692343809,,,,
JaneyBusby,5/26/2014 14:08,3,2,@ 4Nathalie meets all criteria 4 # PDL1 # PD1!! Read her blog http://kickasps.wordpress.com/its-hard-to-fight-when-the-fight-aint-fair/ … … … # ASCO14 pic.twitter.com/Any9wdRupc # TYACancer # ayacsm,,@,# # # # #,4.7099E+17,https://twitter.com/JaneyBusby/status/470989747620298752,,,,
ASCO,5/26/2014 14:02,2,0,# ASCO14 Meeting Message & Networking Center: Connect via direct messaging & see in-person networking opps http://bit.ly/1fEIRHb,,,#,4.70988E+17,https://twitter.com/ASCO/status/470988256390438914,,,,
rsm2800,5/26/2014 13:02,0,0,A virtual consult service to optimize clinical trial participation in pts w/ metastatic breast ca http://abstracts.asco.org/144/index.html # ASCO14 # bcsm # mbc,,,# # #,4.70973E+17,https://twitter.com/rsm2800/status/470973170707468289,,,,
javiquintano,5/26/2014 12:51,0,0,"Rt @ Plaza_Bickle Esto está bien. La @ _SEOM ofrecerá vídeos resumen d principales novedades presentadas en @ ASCO. Hechos x oncólogos, además",,@ @ @,,4.7097E+17,https://twitter.com/javiquintano/status/470970417579302912,,,,
FightCRC,5/26/2014 12:37,0,0,"We'll be at @ ASCO this week, remember to follow us to keep updated on the latest news & happenings there!",,@,,4.70967E+17,https://twitter.com/FightCRC/status/470967053235793920,,,,
JFreemanDaily,5/26/2014 12:28,0,0,Taking Amtrak to # ASCO14 provides fascinating scenery and conversations. # lcsmpic.twitter.com/IMa1JfFLOp,,,# #,4.70965E+17,https://twitter.com/JFreemanDaily/status/470964717905657856,,,,
ASCO,5/26/2014 12:20,2,2,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.70963E+17,https://twitter.com/ASCO/status/470962662449610752,,,,
subatomicdoc,5/26/2014 12:18,2,2,What # breastcancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # bcsm,,@ @ @ @ @ @,# # # #,4.70962E+17,https://twitter.com/subatomicdoc/status/470962081068773376,,,,
ASTRO_org,5/26/2014 12:02,1,1,Interested in the latest innovative Tx for lung cancer? Come to Chicago for # thoracic2014 http://ow.ly/ttO6I @ ASCO @ IASLC @ UChicago,,@ @ @,#,4.70958E+17,https://twitter.com/ASTRO_org/status/470958266609336321,,,,
Jenikings,5/26/2014 11:55,0,0,@ ASCO Please/ RETWEET/Standardize T cell Therapy as an option in treatment for Canine Lymphoma http://petitions.moveon.org/s/DGOwam @ moveon,,@ @,,4.70956E+17,https://twitter.com/Jenikings/status/470956443105898496,,,,
Accucoms,5/26/2014 11:50,0,0,@ ASCO Nice infographic :-),,@,,4.70955E+17,https://twitter.com/Accucoms/status/470955036923928576,,,,
Boehringer,5/26/2014 11:45,1,1,# PRESS: # Lungcancer is # notjustonedisease with devastating impact. Refresh your knowledge ahead of # ASCO14 http://bit.ly/1jxDlkz,,,# # # #,4.70954E+17,https://twitter.com/Boehringer/status/470953829920681984,,,,
Boehringer,5/26/2014 11:35,2,1,PRESS: # Lungcancer is # notjustonedisease w/ devastating impact. Refresh your knowledge ahead of # ASCO14 http://bit.ly/1lAfKWZ,,,# # #,4.70951E+17,https://twitter.com/Boehringer/status/470951313992597506,,,,
subatomicdoc,5/26/2014 11:33,2,0,What # pancreascancer trial results are coming at # ASCO14? Follow @ ASCO @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG # FF # pancsm,,@ @ @ @ @ @,# # # #,4.70951E+17,https://twitter.com/subatomicdoc/status/470950794452537346,,,,
desampa64,5/26/2014 11:21,0,0,"@ Acedotor @ _SEOM @ ASCO una idea fenomenal, así tendremos acceso a información básica para nosotros y q no siempre nos dan. Gracias!!",,@ @ @,,4.70948E+17,https://twitter.com/desampa64/status/470947935380049920,,,,
FJEsteva,5/26/2014 11:19,2,2,"Looking forward to ASCO annual meeting. Will follow # ASCO14 Tweeters http://bit.ly/1lBa5hq # hcsm, # bcsm",,,# # #,4.70947E+17,https://twitter.com/FJEsteva/status/470947377923493888,,,,
Plaza_Bickle,5/26/2014 11:11,0,0,"@ danimateria @ _SEOM @ ASCO Y no sólo va a periodistas, parece, sino a propios socios de la asociación. Imagino que serán diferentes vías",,@ @ @,,4.70945E+17,https://twitter.com/Plaza_Bickle/status/470945419821060096,,,,
Plaza_Bickle,5/26/2014 11:11,0,0,"@ danimateria @ _SEOM @ ASCO Doy por hecha cierta supervisión y buena elección de comunicadores. Puede salir rana, pero puede estar bien...",,@ @ @,,4.70945E+17,https://twitter.com/Plaza_Bickle/status/470945250069204993,,,,
Plaza_Bickle,5/26/2014 11:09,0,0,"@ danimateria @ _SEOM @ ASCO Si son buenos divulgadores y si colabora el gabinete de comunicación (espero), puede funcionar y ser ejemplo...",,@ @ @,,4.70945E+17,https://twitter.com/Plaza_Bickle/status/470944809176559616,,,,
EncoreBioMed,5/26/2014 11:05,0,0,Four days until # ASCO14 - which presentations are you looking most forward to? # cancer # oncology,,,# # #,4.70944E+17,https://twitter.com/EncoreBioMed/status/470943770775937024,,,,
el_gerontologo,5/26/2014 11:00,0,1,El NoTWEETciero MEDtropolitano is out! http://paper.li/medtropoli Stories via @ RespiraINER @ BioTay @ ASCO,,@ @ @,,4.70943E+17,https://twitter.com/el_gerontologo/status/470942586681974785,,,,
danimateria,5/26/2014 10:59,0,0,@ Plaza_Bickle @ _SEOM @ ASCO Lo de vídeos hechos por oncólogos no es un poco como mastectomías hechas por periodistas?,,@ @ @,,4.70942E+17,https://twitter.com/danimateria/status/470942230191304704,,,,
sciberomics,5/26/2014 10:43,0,0,"RT @ ASCO: @ RahmEmanuel officially proclaimed June '14 as Oncology Month in Chicago"" in honor of 50th Annual Meeting http://bit.ly/TLmJl4""",,@ @,,4.70938E+17,https://twitter.com/sciberomics/status/470938363269496832,,,,
Perthera,5/26/2014 10:40,0,0,Attending # ASCO14 Annual Meeting in Chicago? Stop by Perthera at booth #4040 to discuss latest in personalized # cancer therapy! # genomics,,,# #4040 # #,4.70937E+17,https://twitter.com/Perthera/status/470937467055792129,,,,
mtmdphd,5/26/2014 10:27,1,1,"Also # ASCO14 @ rsm2800 view -> Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xgklp -> to increase signal-to-noise",,@ @,#,4.70934E+17,https://twitter.com/mtmdphd/status/470934292659720192,,,,
mtmdphd,5/26/2014 10:19,0,0,@ DrVGimino See this deep data dive from 2013 - http://ow.ly/xgj93 # lcsm # ASCO13 # ASCO14,,@,# # #,4.70932E+17,https://twitter.com/mtmdphd/status/470932280912130049,,,,
subatomicdoc,5/26/2014 10:18,4,2,What gynecologic cancer trial results are coming at @ ASCO's # ASCO14? Follow @ ALLIANCE_org @ eaonc @ EORTC @ NRGonc @ SWOG @ theNCI # FF # gyncsm,,@ @ @ @ @ @ @,# # #,4.70932E+17,https://twitter.com/subatomicdoc/status/470931864640049152,,,,
PDRennert,5/26/2014 10:14,5,4,"fixed the table, one typo for IMMU-132 # ASCO14 # ADCpic.twitter.com/V141XoZ67l",,,# #,4.70931E+17,https://twitter.com/PDRennert/status/470930877099552768,,,,
jonathanagin,5/26/2014 10:14,0,0,@ ASCO What about pediatric cancer? Need a hashtag for pediatric. http://www.jonathanagin.com looking forward to being there,,@,,4.70931E+17,https://twitter.com/jonathanagin/status/470930868182482945,,,,
ASCO,5/26/2014 10:10,2,1,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.7093E+17,https://twitter.com/ASCO/status/470929981426892800,,,,
PDRennert,5/26/2014 10:05,2,2,Anti-CD38 antibody race at ASCO w/nice data from $ IMGN & $ SNY vs Genmab & $ JNJ. No sign of $ MOR & $ CELG? No ADCs? # myeloma # ASCO14,,,# #,4.70929E+17,https://twitter.com/PDRennert/status/470928744429797378,,,,
ProjectInno,5/26/2014 10:05,2,0,"As # ASCO14 celebrates 50 years, a chance to celebrate our progress against cancer & commit to future innovation: http://ow.ly/xcu3F",,,#,4.70929E+17,https://twitter.com/ProjectInno/status/470928646371561472,,,,
ESchattner,5/26/2014 9:55,0,1,"valuable, for doctors & patients, MT @ rschilsky: ASCO Cancer # Survivorship Compendium, @ ASCO - http://bit.ly/1paBdHH",,@ @,#,4.70926E+17,https://twitter.com/ESchattner/status/470926298257190913,,,,
SamuelLz,5/26/2014 9:52,2,1,Om du är läkare/sjuksköterska/forskare och ska till Asco. Hör gärna av dig och berätta vad du tycker att vi ska rapportera om # ASCO14,,,#,4.70925E+17,https://twitter.com/SamuelLz/status/470925372574691328,,,,
SamuelLz,5/26/2014 9:34,2,0,På torsdag åker jag och @ CM_Hake till Chicago för att bevaka # ASCO2014. Särskild sajt på Dagens Medicins webb,,@,#,4.70921E+17,https://twitter.com/SamuelLz/status/470920997810753536,,,,
JBBC,5/26/2014 9:20,5,4,This is a terrific resource! RT @ ASCO: Our # Cancer # Survivorship Compendium http://bit.ly/1oal4BJ cc @ chris1mcb @ mitwittle @ IrPsych...,,@ @ @ @,# #,4.70917E+17,https://twitter.com/JBBC/status/470917286547951616,,,,
kkkollection_,5/26/2014 9:17,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/xhi3c3EwsR # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.70917E+17,https://twitter.com/kkkollection_/status/470916689136082944,,,,
dfdffasdfasfasd,5/26/2014 9:16,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/shYwa02HU0 # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.70916E+17,https://twitter.com/dfdffasdfasfasd/status/470916496294563841,,,,
dfdffasdfasfasd,5/26/2014 9:16,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/JFNkWkW06a,,,# # # # # # # # # # # #,4.70916E+17,https://twitter.com/dfdffasdfasfasd/status/470916323690569728,,,,
karim93285697,5/26/2014 9:12,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/wkot5IlvYK,,,# # # # # # # # # # # #,4.70916E+17,https://twitter.com/karim93285697/status/470915501170782209,,,,
kkkollection_,5/26/2014 9:10,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/yAOdr0pCaT,,,# # # # # # # # # # # #,4.70915E+17,https://twitter.com/kkkollection_/status/470914851141738496,,,,
ITCC_eu,5/26/2014 8:57,2,1,# ASCO14 is coming up and results of @ ITCC_eu studies will be presented! Find out when and where here http://bit.ly/1k8MP63 # childhoodcancer,,@,# #,4.70912E+17,https://twitter.com/ITCC_eu/status/470911595519160320,,,,
Acedotor,5/26/2014 8:45,2,1,@ _SEOM retransmitirá en español los Highlights de @ ASCO 2014: http://noticiadesalud.blogspot.com.es/2014/05/seom-retransmitira-en-espanol-los.html …,,@ @,,4.70909E+17,https://twitter.com/Acedotor/status/470908500995231744,,,,
mtmdphd,5/26/2014 8:26,0,2,"Twitter 103 - Trolls, Malware & Spam - via @ SubAtomicDoc http://ow.ly/xg47X # hcsm # ASCO14",,@,# #,4.70904E+17,https://twitter.com/mtmdphd/status/470903738719539200,,,,
mtmdphd,5/26/2014 8:26,2,2,Twitter 102 - Account Settings - via @ SubAtomicDoc http://ow.ly/xg45Y # hcsm # ASCO14,,@,# #,4.70904E+17,https://twitter.com/mtmdphd/status/470903694800998400,,,,
mtmdphd,5/26/2014 8:25,0,1,Twitter 101 - Signing up - via @ SubAtomicDoc http://ow.ly/xg43o # hcsm # ASCO14 @ Twitter,,@ @,# #,4.70904E+17,https://twitter.com/mtmdphd/status/470903629185314816,,,,
BIOSPAIN_AseBio,5/26/2014 8:19,0,0,La @ _SEOM ofrecerá vídeos resumen de las principales novedades presentadas en @ ASCO vía @ Plaza_Bickle. También estará en # BioSpain2014,,@ @ @,#,4.70902E+17,https://twitter.com/BIOSPAIN_AseBio/status/470902165293527040,,,,
rubenlzunyiga,5/26/2014 8:18,0,0,"Esto está bien. La @ _SEOM ofrecerá vídeos resumen de las principales novedades presentadas en @ ASCO. Hechos por oncólogos, además @ jagasquet",,@ @ @,,4.70902E+17,https://twitter.com/rubenlzunyiga/status/470901740351807488,,,,
Plaza_Bickle,5/26/2014 8:17,3,0,"Esto está bien. La @ _SEOM ofrecerá vídeos resumen de las principales novedades presentadas en @ ASCO. Hechos por oncólogos, además",,@ @,,4.70901E+17,https://twitter.com/Plaza_Bickle/status/470901473233371137,,,,
Boehringer,5/26/2014 8:05,2,2,"• …patients often describe it as being on an emotional rollercoaster"" read more http://bit.ly/1hftXCy # lungcancer # ASCO14""",,,# #,4.70898E+17,https://twitter.com/Boehringer/status/470898430702010368,,,,
GlobalVisionNGO,5/26/2014 7:41,0,0,@ fischmd @ ASCO Thanks for your post!!,,@ @,,4.70892E+17,https://twitter.com/GlobalVisionNGO/status/470892420322717696,,,,
JSwatercooler,5/26/2014 7:24,0,0,@ PinkSheetSutter unprecedented disclosure- you'll also get to see the submission on an # ASCO14 presented poster. Abstract no 9027,,@,#,4.70888E+17,https://twitter.com/JSwatercooler/status/470888265503866882,,,,
mikedenver51,5/26/2014 7:22,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/i3FtnDrlGi # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.70888E+17,https://twitter.com/mikedenver51/status/470887735712968704,,,,
maxkasper,5/26/2014 6:51,0,0,@ ASCO,,@,,4.7088E+17,https://twitter.com/maxkasper/status/470879865516748800,,,,
nxtstop1,5/26/2014 6:36,0,1,TWEET TALK. @ mtmdphd: Analysis cancer-related Twitter convos physicians 2013 - @ BrianReid et al # ASCO14 Abst e17644 http://ow.ly/xcxgz ”,,@ @,#,4.70876E+17,https://twitter.com/nxtstop1/status/470876053569695744,,,,
OncologyAdvance,5/26/2014 4:33,0,0,"RT @ ASCO: RT @ fischmd: Assessment and management of chemical coping in # cancer pts, via @ ASCO # JCO. http://bit.ly/1jm99sT # hpm",,@ @ @,# # #,4.70845E+17,https://twitter.com/OncologyAdvance/status/470845273653387264,,,,
ebooksm,5/26/2014 4:23,0,1,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/KbAr7d8e4S,,,# # # # # # # # # # # #,4.70843E+17,https://twitter.com/ebooksm/status/470842536018202624,,,,
ArcagyGineco,5/26/2014 4:16,0,0,Le GINECO sera présent à l’ASCO du 30 mai au 3 juin : 2 présentations orales et 8 posters ! # ASCO14,,,#,4.70841E+17,https://twitter.com/ArcagyGineco/status/470840990274961408,,,,
sogug1,5/26/2014 3:57,1,0,"El presidente de # ASCO14, Dr. @ CliffordHudis habla de # cienciaysociedad dentro de la reunión anual: http://am.asco.org/",,@,# #,4.70836E+17,https://twitter.com/sogug1/status/470836194881064960,,,,
jmarieturpin,5/26/2014 3:54,0,0,Les travaux de # GustaveRoussy présentés à l' # ASCO14 mis en ligne http://www.gustaveroussy.fr/asco2014/presentation/index.html#10 …,,,# # #10,4.70835E+17,https://twitter.com/jmarieturpin/status/470835409732526080,,,,
sogug1,5/26/2014 3:51,1,1,"No puedes asistir a # ASCO14, # ASCO2014? No te preocupes, puedes hacerlo de forma virtual: http://bit.ly/1kDSe9U",,,# #,4.70835E+17,https://twitter.com/sogug1/status/470834514508644352,,,,
duemed,5/26/2014 3:33,0,0,@ duemed: The city of Chicago and @ ChicagosMayor welcome all oncologists to # ASCO14 # ASCO2014 @ ASCO pic.twitter.com/5UYMXeK3Sj,,@ @ @,# #,4.7083E+17,https://twitter.com/duemed/status/470830126406840320,,,,
JBBC,5/25/2014 23:53,1,1,.RT @ fischmd: MT @ disparityreport: Why it's so difficult to enroll patients to # clinicaltrials http://flip.it/LrLQk # ASCO14,,@ @,# #,4.70775E+17,https://twitter.com/JBBC/status/470774595973566464,,,,
fischmd,5/25/2014 23:33,2,4,"Assessment and management of chemical coping in # cancer pts, via @ ASCO # JCO. http://ow.ly/xfoqv # hpm",,@,# # #,4.7077E+17,https://twitter.com/fischmd/status/470769624590852096,,,,
fischmd,5/25/2014 23:24,8,4,MT @ disparityreport: Why it's so difficult to enroll patients to # clinicaltrials http://bit.ly/1k6cNMC # ASCO14,,@,# #,4.70768E+17,https://twitter.com/fischmd/status/470767504772841472,,,,
etbiluvoltours,5/25/2014 22:34,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/1BzFeGtIM5,,,# # # # # # # # # # # #,4.70755E+17,https://twitter.com/etbiluvoltours/status/470754726867243008,,,,
rschilsky,5/25/2014 22:30,1,2,Follow me and other ASCO tweeters for # ASCO14. http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf …,,,#,4.70754E+17,https://twitter.com/rschilsky/status/470753857094447107,,,,
WEHI_research,5/25/2014 22:11,5,1,Interested in # cancer research? The # ASCO14 meeting starts this week; @ ASCO have produced a handy guide for tweeters http://www.asco.org/sites/www.asco.org/files/asco14_tweeters_0.pdf …,,@,# #,4.70749E+17,https://twitter.com/WEHI_research/status/470748947221209088,,,,
Pharmaspectra,5/25/2014 22:08,0,0,RT @ jagasquet: # Merrimack to Present Clinical Data Across Oncology Pipeline at # ASCO14 - FirstWord Pharma http://www.firstwordpharma.com/node/1212398?tsid=1#axzz32a9Hkxtv … @ fwpharma,,@ @,# # #axzz32a9Hkxtv,4.70748E+17,https://twitter.com/Pharmaspectra/status/470748333989187584,,,,
ASCO,5/25/2014 22:01,7,2,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.70746E+17,https://twitter.com/ASCO/status/470746390541664256,,,,
giasison,5/25/2014 21:09,1,1,Yes! RT @ ASCO: Our # Cancer # Survivorship Compendium: tools & resources to implement or improve survivorship care http://bit.ly/1oal4BJ,,@,# #,4.70733E+17,https://twitter.com/giasison/status/470733416191643648,,,,
rsm2800,5/25/2014 21:08,12,4,Pls RT! If the tweet is nothing but hashtags it’s probably spam. Please block & report any accounts that do this for # ASCO14. Keep it classy,,,#,4.70733E+17,https://twitter.com/rsm2800/status/470733155511840768,,,,
davisa20,5/25/2014 20:59,1,0,"The new Networking area in E354b is worth a visit. See a poster, charge your phone, and grab a coffee. It's a don't miss! # ASCO14",,,#,4.70731E+17,https://twitter.com/davisa20/status/470730846345768960,,,,
RomanGarza9,5/25/2014 19:49,0,2,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/uLPWPq0VMv,,,# # # # # # # # # # # #,4.70713E+17,https://twitter.com/RomanGarza9/status/470713409348960257,,,,
JornalFairPlay,5/25/2014 19:45,0,2,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/jGpArKu2wP,,,# # # # # # # # # # # #,4.70712E+17,https://twitter.com/JornalFairPlay/status/470712277276954625,,,,
JornalFairPlay,5/25/2014 19:45,0,2,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/HQZL1gO5Mt # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.70712E+17,https://twitter.com/JornalFairPlay/status/470712248772464640,,,,
AneesChagpar,5/25/2014 19:05,3,1,"Looking forward to meeting my IDEA mentee @ ASCO # ASCO14 -- connections that make a world of difference in cancer care"". @ YaleCancer""",,@ @,#,4.70702E+17,https://twitter.com/AneesChagpar/status/470702329172209666,,,,
b_chinnian5,5/25/2014 18:42,0,0,@ yzafar @ ASCO Those who think oncology drugs are excessively profitable should try investing in development-stage biotechs.,,@ @,,4.70697E+17,https://twitter.com/b_chinnian5/status/470696520048594944,,,,
rsm2800,5/25/2014 18:00,2,7,Endocrine Therapy Toxicity: Management Options | 2014 Educational Book http://meetinglibrary.asco.org/content/11400025-144#.U4Jn_UEGxYI.twitter … # ASCO14,,,# #,4.70686E+17,https://twitter.com/rsm2800/status/470685967485894656,,,,
DrHealeyBird,5/25/2014 17:56,0,0,“ @ DrAnasYounes: # ASCO14: The anti-BCl2 ABT199 http://fb.me/6VK3QzSjY ” great drugs participated in early research @ NCI,,@ @,#,4.70685E+17,https://twitter.com/DrHealeyBird/status/470684734205722624,,,,
Advaxis,5/25/2014 16:45,0,1,Only 5 days until # ASCO14! We look forward to sharing final results from our Phase 2 clinical study of ADXS-HPV. $ ADXS,,,#,4.70667E+17,https://twitter.com/Advaxis/status/470666869947387904,,,,
BekRx,5/25/2014 16:05,0,1,Planning for # ASCO2014 in # Chicago ! I'll be there on behalf of @ TheLancet. Will you be there? @ ASCO # LancetUS,,@ @,# # #,4.70657E+17,https://twitter.com/BekRx/status/470657003229298688,,,,
kicaukan1,5/25/2014 15:36,0,0,https://twitter.com/Brodalumab/status/465059297152356352/photo/1pic.twitter.com/MNb4fDxG32 # MedEd # SCOTUS # hcsm # hcsmfr # hcsmeu # hcsmca # Harvard # STEM # Help # Pls # ICRE2014 # mHealth # hcmktg # ASCO14,,,# # # # # # # # # # # # # #,4.7065E+17,https://twitter.com/kicaukan1/status/470649544057683968,,,,
DanaHolmes911,5/25/2014 15:05,0,0,"@ DrAnasYounes @ ASCO Dr. Younes I've read about study of ABT199 in a subset of Multiple # Myeloma, hopeful for promising activity as well.",,@ @,#,4.70642E+17,https://twitter.com/DanaHolmes911/status/470641885623885825,,,,
Larvol,5/25/2014 14:58,0,0,The Larvol team will be in Chicago for # ASCO14. We're looking forward to seeing everyone!,,,#,4.7064E+17,https://twitter.com/Larvol/status/470640081401692160,,,,
LurieCancer,5/25/2014 14:55,3,2,It's official--Sun 6/1 weather in Chicago will = today's! Join us! http://vimeo.com/m/95305733 # LurieSurvivorsCelebration @ JasonChan1 @ ASCO,,@ @,#,4.70639E+17,https://twitter.com/LurieCancer/status/470639307548422144,,,,
ASCO,5/25/2014 14:20,1,0,# ASCO14 Tweeters infographic http://bit.ly/1lBa5hq Want to follow all? Subscribe to our list http://bit.ly/RSJamR # hcsm,,,# #,4.7063E+17,https://twitter.com/ASCO/status/470630438109982720,,,,
ConquerCancerFd,5/25/2014 14:05,0,1,May is Nat'l Brain Tumor Awareness Month! Check out @ ASCO's interactive timeline of progress vs brain cancer: http://bit.ly/1r4VgsP,,@,,4.70627E+17,https://twitter.com/ConquerCancerFd/status/470626635952427008,,,,
manvendratiwar8,5/25/2014 14:01,0,0,# ASCO14 # MedEd # Help # Research # China # Anatomy # FOAMed http://drsocial.org # MedX # ACA # money # music # STEMpic.twitter.com/vYC5US0xGZ,,,# # # # # # # # # # # #,4.70626E+17,https://twitter.com/manvendratiwar8/status/470625737741836290,,,,
JaneyBusby,5/25/2014 13:52,0,0,@ 4Nathalie fights # ASPS w/grace dignity & grit. Needs # PD1 # PDL1 # kickasps.com # ASCO14 pic.twitter.com/flBKtp2luG,,@,# # # # #,4.70623E+17,https://twitter.com/JaneyBusby/status/470623455088373760,,,,
JaneyBusby,5/25/2014 13:31,0,0,THIS is the face of a FIERCE FIGHTER @ genentech who NEEDS # CompassionateUse NOW to # kickASPS PLS do an n=1 pic.twitter.com/5t2WATDJKI # ASCO14,,@,# # #,4.70618E+17,https://twitter.com/JaneyBusby/status/470618117073149952,,,,
JaneyBusby,5/25/2014 13:29,0,0,Cancer does not wait till 18 so.. # CompassionateUse # PD1 @ 4Nathalie Amazing teen w/Stage IV # ASPS cancer PLS! pic.twitter.com/tSUVtAdhkX # ASCO14,,@,# # # #,4.70618E+17,https://twitter.com/JaneyBusby/status/470617763283623936,,,,
CancerDotNet,5/25/2014 13:20,2,1,New study on hormone therapy for men w/ rising PSA levels post-treatment. Pt summary: # ASCO14 # pcsm http://bit.ly/1p06woo,,,# #,4.70615E+17,https://twitter.com/CancerDotNet/status/470615330600255488,,,,
ASCO,5/25/2014 12:20,3,2,"Tools for # ASCO14: Video tutorials walk you thru iMeeting app, iPlanner/Virtual Meeting websites http://bit.ly/1o1Sanr",,,#,4.706E+17,https://twitter.com/ASCO/status/470600229130342400,,,,
EncoreBioMed,5/25/2014 12:05,0,0,Five days until # ASCO14 - which presentations are you looking most forward to? # cancer # oncology,,,# # #,4.70596E+17,https://twitter.com/EncoreBioMed/status/470596481284849664,,,,
PPHMBULL,5/25/2014 11:39,0,0,"@ RielyMD # ASCO14 Sums it up: A correlation between ORR or PFS and OS is not established"" Surrogate endpoint paradigm shift occurring soon""",,@,#,4.7059E+17,https://twitter.com/PPHMBULL/status/470590081217339392,,,,
mtmdphd,5/25/2014 10:30,3,2,What doctors tweet about when they tweet about cancer - @ brianreid via @ kevinmd http://ow.ly/x4Nuk # ASCO14 # hcsm,,@ @,# #,4.70573E+17,https://twitter.com/mtmdphd/status/470572705558044674,,,,
Mom2TLE,5/25/2014 10:25,0,1,@ dianeradfordmd @ ASCO @ elocio @ HeartRumbles @ CBaileyMD Hope you're all enjoying the long weekend!,,@ @ @ @ @,,4.70571E+17,https://twitter.com/Mom2TLE/status/470571417990217729,,,,
OncologyTimes,5/25/2014 10:24,3,0,Model tackles benefits&costs of annual LDCT # lungcancer screening in Medicare program # ASCO14 http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/post.aspx?blogId=9&postId=106 …,,,# #,4.70571E+17,https://twitter.com/OncologyTimes/status/470571074149552130,,,,
dytcmd,5/25/2014 9:49,1,0,RT @ OncologyTimes: . # ProstateCancer: No benefit to immediately starting ADT after PSA-only relapse http://mobile.journals.lww.com/oncology-times/_layouts/oaks.journals.mobile/post.aspx?blogId=9&postId=102 … # ASCO14 # pcsm,,@,# # #,4.70562E+17,https://twitter.com/dytcmd/status/470562305428570113,,,,
XRT4U,5/25/2014 9:42,0,2,"@ disparityreport @ nadinehousri @ Clin_Trials @ ASCO Until it is easier to put pt on trial than not, slow. Trials of simple ?'s not done. Waste",,@ @ @ @,,4.70561E+17,https://twitter.com/XRT4U/status/470560568756424704,,,,
CancerDotNet,5/25/2014 9:35,1,0,Advocates: Headed for # ASCO14? Download the iPlanner to easily schedule your time! http://bit.ly/1na1tjd,,,#,4.70559E+17,https://twitter.com/CancerDotNet/status/470558676273889281,,,,
tbaupuig,5/25/2014 5:33,0,0,Si ets pacient de cancer @ patientpowereu serà a # ASCO14 per preguntar a investigadors. Envía pregunta a http://www.patientpower.info/series/asco-2014/multiple-myeloma/?utm_source=google-plus&utm_medium=post&utm_campaign=MMY-US-2014-008 … # tengocancer,,@,# #,4.70498E+17,https://twitter.com/tbaupuig/status/470497853727846400,,,,
rschilsky,5/24/2014 23:41,3,6,Must have apps for # ASCO14. Digital Product and Resource Tutorials | ASCO Annual Meeting http://am.asco.org/am-videos#.U4FmQJIXJsY.twitter …,,,# #,4.70409E+17,https://twitter.com/rschilsky/status/470409296547545088,,,,
drsteventucker,5/24/2014 22:50,0,3,MORE fruits & veg associated w increasing # obesity | http://bit.ly/1m8TrUV # ASCO14 cc: @ bigfatsurprise via @ ACS @ RandCorporation,,@ @ @,# #,4.70396E+17,https://twitter.com/drsteventucker/status/470396398345936897,,,,
RielyMD,5/24/2014 22:43,0,2,looking forward to: response rate as potential surrogate for progression-free survival in NSCLC. # ASCO14 8012 http://abstracts.asco.org/144/AbstView_144_124927.html …,,,#,4.70395E+17,https://twitter.com/RielyMD/status/470394822432661504,,,,
melanoma_Drs,5/24/2014 22:36,0,0,"Countdown to # ASCO14, first sessions Friday 5-30-14!!! Lots of # melanoma data of interest-- anti- # PD1 # Yervoy plus combos",,,# # # #,4.70393E+17,https://twitter.com/melanoma_Drs/status/470392906894041088,,,,
Melanoma_doctor,5/24/2014 22:36,0,0,"Countdown to # ASCO14, first sessions Friday 5-30-14!!! Lots of # melanoma data of interest-- anti- # PD1 # Yervoy plus combos",,,# # # #,4.70393E+17,https://twitter.com/Melanoma_doctor/status/470392906155835392,,,,
DCarrizosaMD,5/24/2014 21:09,4,1,# ASCO14 abstract about why pts don't go on trials http://bit.ly/1k6cNMC - # LCI vision should hopefully remove all 4 reasons! @Carolinas,,@Carolinas,# #,4.70371E+17,https://twitter.com/DCarrizosaMD/status/470370930372644864,,,,
womenofteal,5/24/2014 20:04,0,0,@ ASCO Great Thanks !,,@,,4.70355E+17,https://twitter.com/womenofteal/status/470354725033226240,,,,
